PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Blazquez-Bernal, A; Fernandez-Costa, JM; Bargiela, A; Artero, R				Blazquez-Bernal, Agueda; Fernandez-Costa, Juan M.; Bargiela, Ariadna; Artero, Ruben			Inhibition of autophagy rescues muscle atrophy in a LGMDD2 Drosophila model	FASEB JOURNAL			English	Article						autophagy; chloroquine; Drosophila melanogaster; limb-girdle muscular dystrophy D2; muscle atrophy; transportin 3	GIRDLE MUSCULAR-DYSTROPHY; NUCLEAR IMPORT; SPLICING FACTORS; GENE-EXPRESSION; PROTEINS; DEGENERATION; DEGRADATION; ASSAYS; HEART; 1F	Limb-girdle muscular dystrophy D2 (LGMDD2) is an ultrarare autosomal dominant myopathy caused by mutation of the normal stop codon of the TNPO3 nuclear importin. The mutant protein carries a 15 amino acid C-terminal extension associated with pathogenicity. Here we report the first animal model of the disease by expressing the human mutant TNPO3 gene in Drosophila musculature or motor neurons and concomitantly silencing the endogenous expression of the fly protein ortholog. A similar genotype expressing wildtype TNPO3 served as a control. Phenotypes characterization revealed that mutant TNPO3 expression targeted at muscles or motor neurons caused LGMDD2-like phenotypes such as muscle degeneration and atrophy, and reduced locomotor ability. Notably, LGMDD2 mutation increase TNPO3 at the transcript and protein level in the Drosophila model Upregulated muscle autophagy observed in LGMDD2 patients was also confirmed in the fly model, in which the anti-autophagic drug chloroquine was able to rescue histologic and functional phenotypes. Overall, we provide a proof of concept of autophagy as a target to treat disease phenotypes and propose a neurogenic component to explain mutant TNPO3 pathogenicity in diseased muscles.	[Blazquez-Bernal, Agueda; Fernandez-Costa, Juan M.; Bargiela, Ariadna; Artero, Ruben] Univ Valencia, Univ Inst Biotechnol & Biomed BIOTECMED, Translat Genom Grp, Valencia, Spain; [Blazquez-Bernal, Agueda; Fernandez-Costa, Juan M.; Bargiela, Ariadna; Artero, Ruben] Incl Hlth Res Inst, Area Metab & Organ Failure, Valencia, Spain; [Blazquez-Bernal, Agueda; Fernandez-Costa, Juan M.; Bargiela, Ariadna; Artero, Ruben] Incliva CIPF Joint Unit, Valencia, Spain	University of Valencia	Bargiela, A (corresponding author), Univ Valencia, Univ Inst Biotechnol & Biomed BIOTECMED, Translat Genom Grp, Valencia, Spain.	ariadna.bargiela@uv.es	Artero, Ruben/K-6815-2014; Fernandez-Costa, Juan M/Q-1670-2015; Bargiela, Ariadna/ABF-9125-2020	Artero, Ruben/0000-0003-1596-047X; Fernandez-Costa, Juan M/0000-0002-1854-6082; Blazquez-Bernal, Agueda/0000-0001-7556-452X	Regional Government of Valencia | Conselleria d'Educacio, Investigacio, Cultura i Esport (Ministry of Education, Research, Culture and Sports)	Regional Government of Valencia | Conselleria d'Educacio, Investigacio, Cultura i Esport (Ministry of Education, Research, Culture and Sports)	Asociacion Conquistando Escalones; Regional Government of Valencia | Conselleria d'Educacio, Investigacio, Cultura i Esport (Ministry of Education, Research, Culture and Sports)	Aguet F, 2020, SCIENCE, V369, P1318, DOI 10.1126/science.aaz1776; Allemand E, 2002, MOL BIOL CELL, V13, P2436, DOI 10.1091/mbc.E02-02-0102; Allikian MJ, 2007, HUM MOL GENET, V16, P2933, DOI 10.1093/hmg/ddm254; Angelini C, 2019, THER ADV NEUROL DISO, V12, DOI 10.1177/1756286419850433; Babcock DT, 2014, JOVE-J VIS EXP, DOI 10.3791/51223; Bargiela A, 2019, P NATL ACAD SCI USA, V116, P25203, DOI 10.1073/pnas.1820297116; Bargiela A, 2015, DIS MODEL MECH, V8, P679, DOI 10.1242/dmm.018127; BRAND AH, 1993, DEVELOPMENT, V118, P401; Bushby Kate, 2009, Pract Neurol, V9, P314, DOI 10.1136/jnnp.2009.193938; Cenacchi G, 2013, NEUROPATHOLOGY, V33, P276, DOI 10.1111/neup.12003; Cerro-Herreros E, 2020, MOL THER-NUCL ACIDS, V21, P837, DOI 10.1016/j.omtn.2020.07.021; Chakraborty M, 2015, DIS MODEL MECH, V8, P1569, DOI 10.1242/dmm.021428; Costa R, 2021, MOL CELL BIOCHEM, V476, P1797, DOI 10.1007/s11010-020-04023-y; Costa R, 2020, NEUROMUSCULAR DISORD, V30, P685, DOI 10.1016/j.nmd.2020.05.006; De Iaco A, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-98; Dobi KC, 2015, WIRES DEV BIOL, V4, P357, DOI 10.1002/wdev.182; Fanin M, 2015, MUSCLE NERVE, V52, P305, DOI 10.1002/mus.24539; Fernandez-Costa JM, 2013, HUM MOL GENET, V22, P704, DOI 10.1093/hmg/dds478; Gamez J, 2001, NEUROLOGY, V56, P450, DOI 10.1212/WNL.56.4.450; Garcia-Lopez A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001595; GELLERT M, 1965, J MOL BIOL, V11, P445, DOI 10.1016/S0022-2836(65)80001-8; Gibertini S, 2018, ACTA NEUROPATHOL COM, V6, DOI 10.1186/s40478-018-0648-4; Hunt LC, 2013, NAT PROTOC, V8, P2496, DOI 10.1038/nprot.2013.156; Klionsky DJ, 2021, AUTOPHAGY, V17, P1, DOI 10.1080/15548627.2020.1797280; Knuijt S, 2014, DISABIL REHABIL, V36, P1285, DOI 10.3109/09638288.2013.845255; Konieczny P, 2020, FASEB J, V34, P3021, DOI 10.1096/fj.201802554RRR; Kreipke RE, 2017, CURR TOP DEV BIOL, V121, P83, DOI 10.1016/bs.ctdb.2016.07.003; Lai MC, 2001, P NATL ACAD SCI USA, V98, P10154, DOI 10.1073/pnas.181354098; Li SQ, 2016, HUM MOL GENET, V25, P936, DOI 10.1093/hmg/ddv627; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Llamusi B, 2013, DIS MODEL MECH, V6, P184, DOI 10.1242/dmm.009563; Lloyd TE, 2010, ANN NY ACAD SCI, V1184, pE1, DOI 10.1111/j.1749-6632.2010.05432.x; Maertens GN, 2014, P NATL ACAD SCI USA, V111, P2728, DOI 10.1073/pnas.1320755111; Mammucari C, 2007, CELL METAB, V6, P458, DOI 10.1016/j.cmet.2007.11.001; Mao YH, 2014, NUCLEIC ACIDS RES, V42, P4813, DOI 10.1093/nar/gku159; Markstein M, 2008, NAT GENET, V40, P476, DOI 10.1038/ng.101; Mauthe M, 2018, AUTOPHAGY, V14, P1435, DOI 10.1080/15548627.2018.1474314; Mauvezin C, 2014, METHODS, V68, P134, DOI 10.1016/j.ymeth.2014.03.014; Melia MJ, 2013, BRAIN, V136, P1508, DOI 10.1093/brain/awt074; Mizushima N, 2011, ANNU REV CELL DEV BI, V27, P107, DOI 10.1146/annurev-cellbio-092910-154005; Nagy P, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003664; Nigro Vincenzo, 2014, Acta Myol, V33, P1; Pal E, 2019, EUR J MED GENET, V62, DOI 10.1016/j.ejmg.2019.05.001; Palenzuela L, 2003, NEUROLOGY, V61, P404, DOI 10.1212/01.WNL.0000073984.46546.4F; Perkins LA, 2015, GENETICS, V201, P843, DOI 10.1534/genetics.115.180208; Peterle E, 2013, J NEUROL, V260, P2033, DOI 10.1007/s00415-013-6931-1; Raben N, 2008, HUM MOL GENET, V17, P3897, DOI 10.1093/hmg/ddn292; Rai M, 2014, CURR TOP DEV BIOL, V108, P247, DOI 10.1016/B978-0-12-391498-9.00007-3; Rodriguez-Mora S, 2019, PLOS PATHOG, V15, DOI 10.1371/journal.ppat.1007958; Sapra AK, 2009, MOL CELL, V34, P179, DOI 10.1016/j.molcel.2009.02.031; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Selma-Soriano E, 2020, DIS MODEL MECH, V13, DOI 10.1242/dmm.041509; Spring AM, 2019, FRONT MOL NEUROSCI, V12, DOI 10.3389/fnmol.2019.00113; Straub V, 2018, NEUROMUSCULAR DISORD, V28, P702, DOI 10.1016/j.nmd.2018.05.007; Takats S, 2013, J CELL BIOL, V201, P531, DOI 10.1083/jcb.201211160; Tavakol S, 2019, BIOMOLECULES, V9, DOI 10.3390/biom9100530; Torella A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063536; Vihola A., 2019, NEUROL-GENET, V5, P1; Zhao J, 2007, CELL METAB, V6, P472, DOI 10.1016/j.cmet.2007.11.004	59	3	3	3	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2021	35	10							e21914	10.1096/fj.202100539RR	http://dx.doi.org/10.1096/fj.202100539RR			19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	UZ5IH	34547132				2022-12-26	WOS:000702238200039
J	Susan-Resiga, D; Girard, E; Essalmani, R; Roubtsova, A; Marcinkiewicz, J; Derbali, RM; Evagelidis, A; Byun, JH; Lebeau, PF; Austin, RC; Seidah, NG				Susan-Resiga, Delia; Girard, Emmanuelle; Essalmani, Rachid; Roubtsova, Anna; Marcinkiewicz, Jadwiga; Derbali, Rabeb M.; Evagelidis, Alexandra; Byun, Jae H.; Lebeau, Paul F.; Austin, Richard C.; Seidah, Nabil G.			Asialoglycoprotein receptor 1 is a novel PCSK9-independent ligand of liver LDLR cleaved by furin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROPROTEIN CONVERTASE; PCSK9; TRAFFICKING; DEGRADATION; MUTATIONS; RISK	The hepatic carbohydrate-recognizing asialoglycoprotein receptor (ASGR1) mediates the endocytosis/lysosomal degradation of desialylated glycoproteins following binding to terminal galactose/N-acetylgalactosamine. Human heterozygote carriers of ASGR1 deletions exhibit -34% lower risk of coronary artery disease and -10% to 14% reduction of non-HDL cholesterol. Since the proprotein convertase PCSK9 is a major degrader of the low-density lipoprotein receptor (LDLR), we investigated the degradation and functionality of LDLR and/or PCSK9 by endogenous/overexpressed ASGR1 using Western blot and immunofluorescence in HepG2-naive and HepG2PCSK9-knockout cells. ASGR1, like PCSK9, targets LDLR, and both independently interact with/enhance the degradation of the receptor. This lack of cooperativity between PCSK9 and ASGR1 was confirmed in livers of wildtype (WT) and Pcsk9-/- mice. ASGR1 knockdown in HepG2-naive cells significantly increased total (-1.2-fold) and cell-surface (-4-fold) LDLR protein. In HepG2-PCSK9-knockout cells, ASGR1 silencing led to -2-fold higher levels of LDLR protein and DiI (1,1'-dio-ctadecyl-3,3,3',3'-tetramethylindocarbocyanine perchlorate)LDL uptake associated with similar to 9-fold increased cell-surface LDLR. Overexpression of WT-ASGR1/2 primarily reduced levels of immature non-O-glycosylated LDLR (-110 kDa), whereas the triple Ala-mutant of Gln240/Trp244/Glu253 (characterized by loss of carbohydrate binding) reduced expression of the mature form of LDLR (-150 kDa), suggesting that ASGR1 binds the LDLR in both a sugar-dependent and-independent fashion. The protease furin cleaves ASGR1 at the RKMK103 down arrow motif into a secreted form, likely resulting in a loss of function on LDLR. Altogether, we demonstrate that LDLR is the first example of a liver-receptor ligand of ASGR1. We conclude that silencing of ASGR1 and PCSK9 may lead to higher LDL uptake by hepatocytes, thereby providing a novel approach to further reduce LDL cholesterol levels.	[Susan-Resiga, Delia; Girard, Emmanuelle; Essalmani, Rachid; Roubtsova, Anna; Marcinkiewicz, Jadwiga; Derbali, Rabeb M.; Evagelidis, Alexandra; Seidah, Nabil G.] Univ Montreal, Lab Biochem Neuroendocrinol, Montreal Clin Res Inst IRCM, Montreal, PQ, Canada; [Byun, Jae H.; Lebeau, Paul F.; Austin, Richard C.] McMaster Univ, St Josephs Healthcare Hamilton, Div Nephrol, Dept Med, Hamilton, ON, Canada	Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; McMaster University	Seidah, NG (corresponding author), Univ Montreal, Lab Biochem Neuroendocrinol, Montreal Clin Res Inst IRCM, Montreal, PQ, Canada.	seidahn@ircm.qc.ca		Girard, Emmanuelle/0000-0001-8375-7970	CIHR Foundation Scheme grant [148363]; Canada Research Chair [950-231335]; Leducq Foundation grant [13 CVD 03]; Heart and Stroke Foundation of Canada [G-13-0003064, G-15-0009389]; Canadian Institutes of Health Research [74477, 173520]	CIHR Foundation Scheme grant(Canadian Institutes of Health Research (CIHR)); Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs); Leducq Foundation grant(Leducq Foundation); Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported in part by research grants to N. G. S. from the CIHR Foundation Scheme grant (148363) , a Canada Research Chair (950-231335) , and a Leducq Foundation grant (13 CVD 03) , as well as to R. C. A. from the Heart and Stroke Foundation of Canada (G-13-0003064, G-15-0009389) and the Canadian Institutes of Health Research (74477, 173520).	Abifadel M, 2003, NAT GENET, V34, P154, DOI 10.1038/ng1161; ASHWELL G, 1982, ANNU REV BIOCHEM, V51, P531, DOI 10.1146/annurev.bi.51.070182.002531; Benjannet S, 2006, J BIOL CHEM, V281, P30561, DOI 10.1074/jbc.M606495200; BISCHOFF J, 1987, J BIOL CHEM, V262, P11825; Cohen J, 2005, NAT GENET, V37, P328, DOI 10.1038/ng0305-328c; Cohen JC, 2006, NEW ENGL J MED, V354, P1264, DOI 10.1056/NEJMoa054013; Cuervo NZ, 2020, ELIFE, V9, DOI 10.7554/eLife.61390; Demers A, 2015, ARTERIOSCL THROM VAS, V35, P2517, DOI 10.1161/ATVBAHA.115.306032; Demina EP, 2021, J AM HEART ASSOC, V10, DOI 10.1161/JAHA.120.018756; Dubuc G, 2004, ARTERIOSCL THROM VAS, V24, P1454, DOI 10.1161/01.ATV.0000134621.14315.43; Duval S, 2020, CELL DEATH DIS, V11, DOI 10.1038/s41419-020-02893-0; Essalmani R., 2021, IMPLICATIONS SPIKE G; Essalmani R, 2011, J BIOL CHEM, V286, P4257, DOI 10.1074/jbc.M110.192104; Gu Y., 2020, INTERACTION NETWORK, DOI [10.1101/2020.09.09.287508, DOI 10.1101/2020.09.09.287508]; Gupta N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010682; Hassan HH, 2008, J BIOL CHEM, V283, P11164, DOI 10.1074/jbc.M707720200; Igdoura SA, 2017, CURR OPIN LIPIDOL, V28, P209, DOI 10.1097/MOL.0000000000000395; Lichtenthaler SF, 2018, EMBO J, V37, DOI 10.15252/embj.201899456; Maxwell KN, 2004, P NATL ACAD SCI USA, V101, P7100, DOI 10.1073/pnas.0402133101; McNutt MC, 2007, J BIOL CHEM, V282, P20799, DOI 10.1074/jbc.C700095200; Meier M, 2000, J MOL BIOL, V300, P857, DOI 10.1006/jmbi.2000.3853; Mokhtari T, 2020, J MOL HISTOL, V51, P613, DOI 10.1007/s10735-020-09915-3; Morens DM, 2020, CELL, V182, P1077, DOI 10.1016/j.cell.2020.08.021; Munzer JS, 1997, J BIOL CHEM, V272, P19672, DOI 10.1074/jbc.272.32.19672; Nassoury N, 2007, TRAFFIC, V8, P718, DOI 10.1111/j.1600-0854.2007.00562.x; Nioi P, 2016, NEW ENGL J MED, V374, P2131, DOI 10.1056/NEJMoa1508419; Ouadda AB, 2019, ARTERIOSCL THROM VAS, V39, P1996, DOI 10.1161/ATVBAHA.119.313247; Ozden S, 2008, J BIOL CHEM, V283, P21899, DOI 10.1074/jbc.M802444200; Pedersen NB, 2014, J BIOL CHEM, V289, P17312, DOI 10.1074/jbc.M113.545053; Roubtsova A, 2015, J LIPID RES, V56, P2133, DOI 10.1194/jlr.M061952; Roubtsova A, 2011, ARTERIOSCL THROM VAS, V31, P785, DOI 10.1161/ATVBAHA.110.220988; Sabatine MS, 2017, LANCET DIABETES ENDO, V5, P941, DOI 10.1016/S2213-8587(17)30313-3; Schaum N, 2018, NATURE, V562, P367, DOI 10.1038/s41586-018-0590-4; Seidah NG, 2019, CARDIOVASC RES, V115, P510, DOI 10.1093/cvr/cvz003; Seidah NG, 2017, PHARMACOL REV, V69, P33, DOI 10.1124/pr.116.012989; Seidah NG, 2012, NAT REV DRUG DISCOV, V11, P367, DOI 10.1038/nrd3699; Seidah NG, 2003, P NATL ACAD SCI USA, V100, P928, DOI 10.1073/pnas.0335507100; Seidah NG, 1999, P NATL ACAD SCI USA, V96, P1321, DOI 10.1073/pnas.96.4.1321; Stoekenbroek RM, 2018, FUTUR CARDIOL, V14, P433, DOI 10.2217/fca-2018-0067; Susan-Resiga D, 2017, J BIOL CHEM, V292, P1573, DOI 10.1074/jbc.M116.769430; Tanowitz M, 2017, NUCLEIC ACIDS RES, V45, P12388, DOI 10.1093/nar/gkx960; Thomas G, 2002, NAT REV MOL CELL BIO, V3, P753, DOI 10.1038/nrm934; Wadhera RK, 2016, J CLIN LIPIDOL, V10, P472, DOI 10.1016/j.jacl.2015.11.010; Ward SE, 2018, BLOOD, V131, P911, DOI 10.1182/blood-2017-06-787853; Weigel PH, 2002, BBA-GEN SUBJECTS, V1572, P341, DOI 10.1016/S0304-4165(02)00318-5; Zaid A, 2008, HEPATOLOGY, V48, P646, DOI 10.1002/hep.22354	46	4	4	4	9	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT	2021	297	4							101177	10.1016/j.jbc.2021.101177	http://dx.doi.org/10.1016/j.jbc.2021.101177			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	WP4BY	34508778	gold, Green Published			2022-12-26	WOS:000713080600002
J	Soderberg, DN; Kyre, B; Bonello, P; Bentz, BJ				Soderberg, David N.; Kyre, Bethany; Bonello, Pierluigi; Bentz, Barbara J.			Lignin concentrations in phloem and outer bark are not associated with resistance to mountain pine beetle among high elevation pines	PLOS ONE			English	Article							BLUE-STAIN FUNGI; SPHAEROPSIS-SAPINEA; SPECIES RESISTANT; BRISTLECONE-PINE; INDUCED DEFENSE; STONE CELLS; RESIN DUCTS; SCOTS PINE; HOST; LODGEPOLE	A key component in understanding plant-insect interactions is the nature of host defenses. Research on defense traits among Pinus species has focused on specialized metabolites and axial resin ducts, but the role of lignin in defense within diverse systems is unclear. We investigated lignin levels in the outer bark and phloem of P. longaeva, P. balfouriana, and P. flexilis; tree species growing at high elevations in the western United States known to differ in susceptibility to mountain pine beetle (Dendroctonus ponderosae; MPB). Pinus longaeva and P. balfouriana are attacked by MPB less frequently than P. flexilis, and MPB brood production in P. longaeva is limited. Because greater lignification of feeding tissues has been shown to provide defense against bark beetles in related genera, such as Picea, we hypothesized that P. longaeva and P. balfouriana would have greater lignin concentrations than P. flexilis. Contrary to expectations, we found that the more MPB-susceptible P. flexilis had greater phloem lignin levels than the less susceptible P. longaeva and P. balfouriana. No differences in outer bark lignin levels among the species were found. We conclude that lignification in Pinus phloem and outer bark is likely not adaptive as a physical defense against MPB.	[Soderberg, David N.; Bentz, Barbara J.] Utah State Univ, Wildland Resources Dept, Logan, UT 84322 USA; [Soderberg, David N.] Utah State Univ, Ecol Ctr, Logan, UT 84322 USA; [Kyre, Bethany] Univ Kentucky, Dept Entomol, Lexington, KY USA; [Bonello, Pierluigi] Ohio State Univ, Dept Plant Pathol, Columbus, OH 43210 USA; [Bentz, Barbara J.] US Forest Serv, Rocky Mt Res Stn, Logan, UT USA	Utah System of Higher Education; Utah State University; Utah System of Higher Education; Utah State University; University of Kentucky; University System of Ohio; Ohio State University; United States Department of Agriculture (USDA); United States Forest Service	Soderberg, DN (corresponding author), Utah State Univ, Wildland Resources Dept, Logan, UT 84322 USA.; Soderberg, DN (corresponding author), Utah State Univ, Ecol Ctr, Logan, UT 84322 USA.	davidsoderberg@gmail.com		Soderberg, David/0000-0002-8517-4143	USDA Forest Service, Forest Health Monitoring [EM-14-168]; Rocky Mountain Research Station; Quinney College of Natural Resources; Utah State University; Ohio Agricultural Research and Development Center; Ohio State University	USDA Forest Service, Forest Health Monitoring; Rocky Mountain Research Station(United States Department of Agriculture (USDA)United States Forest Service); Quinney College of Natural Resources; Utah State University; Ohio Agricultural Research and Development Center; Ohio State University(Ohio State University)	Financial support was provided by the USDA Forest Service, Forest Health Monitoring [EM-14-168] and The Rocky Mountain Research Station in the form of funds to BB. The Rocky Mountain Research Station, the Quinney College of Natural Resources, and Utah State University provided support in the form of graduate wages/stipend for DS. State and federal funds were provided by The Ohio Agricultural Research and Development Center and The Ohio State University in the form of wages/salary for BK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ATKINS MD, 1966, CAN ENTOMOL, V98, P285, DOI 10.4039/Ent98285-3; BALLARD RG, 1984, CAN J BOT, V62, P1724, DOI 10.1139/b84-233; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Bentz BJ, 2021, WEST N AM NATURALIST, V81, P19, DOI 10.3398/064.081.0102; Bentz BJ, 2017, NEW PHYTOL, V213, P611, DOI 10.1111/nph.14191; Bhuiyan NH, 2009, PLANT SIGNAL BEHAV, V4, P158, DOI 10.4161/psb.4.2.7688; Biedermann PHW, 2019, TRENDS ECOL EVOL, V34, P914, DOI 10.1016/j.tree.2019.06.002; Boerjan W, 2003, ANNU REV PLANT BIOL, V54, P519, DOI 10.1146/annurev.arplant.54.031902.134938; Bonawitz ND, 2010, ANNU REV GENET, V44, P337, DOI 10.1146/annurev-genet-102209-163508; BONELLO P, 1993, NEW PHYTOL, V124, P653, DOI 10.1111/j.1469-8137.1993.tb03855.x; Bonello P, 2003, PHYSIOL MOL PLANT P, V63, P249, DOI 10.1016/j.pmpp.2004.02.002; Borg-Karlson AK, 2006, J CHEM ECOL, V32, P943, DOI 10.1007/s10886-006-9050-y; BOUDET AM, 1995, NEW PHYTOL, V129, P203, DOI 10.1111/j.1469-8137.1995.tb04292.x; BRUCE RJ, 1989, PLANT PHYSIOL, V91, P889, DOI 10.1104/pp.91.3.889; Chiu CC, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08983-y; Cipollini D., 2010, CAB Reviews: Perspectives in Agriculture, Veterinary Science, Nutrition and Natural Resources, V5, P1, DOI 10.1079/PAVSNNR20105005; Cipollini D, 2011, J CHEM ECOL, V37, P450, DOI 10.1007/s10886-011-9954-z; Cleaver CM, 2015, FOREST ECOL MANAG, V358, P139, DOI 10.1016/j.foreco.2015.09.010; COOK SP, 1988, J ENTOMOL SCI, V23, P287, DOI 10.18474/0749-8004-23.3.287; Cooke BJ, 2017, FOREST ECOL MANAG, V396, P11, DOI 10.1016/j.foreco.2017.04.008; Dowle EJ, 2017, MOL ECOL, V26, P6071, DOI 10.1111/mec.14342; Eidson EL, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196732; Eidson EL, 2017, FOREST ECOL MANAG, V402, P12, DOI 10.1016/j.foreco.2017.06.034; Erbilgin N, 2014, NEW PHYTOL, V201, P940, DOI 10.1111/nph.12573; Ferrenberg S, 2017, ECOSPHERE, V8, DOI 10.1002/ecs2.1975; Ferrenberg S, 2014, OECOLOGIA, V174, P1283, DOI 10.1007/s00442-013-2841-2; Franceschi VR, 2005, NEW PHYTOL, V167, P353, DOI 10.1111/j.1469-8137.2005.01436.x; Freudenberg K., 1968, CONSTITUTION BIOSYNT; Gaylord ML, 2013, NEW PHYTOL, V198, P567, DOI 10.1111/nph.12174; Grau M., 2001, BARK TRAITS RELATED; Gray CA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135752; Hood S, 2015, ECOLOGY, V96, P1846, DOI 10.1890/14-0487.1; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; Johnson MTJ, 2009, P NATL ACAD SCI USA, V106, P18079, DOI 10.1073/pnas.0904695106; Kane JM, 2010, OECOLOGIA, V164, P601, DOI 10.1007/s00442-010-1683-4; Keefover-Ring K, 2016, J CHEM ECOL, V42, P1, DOI 10.1007/s10886-015-0659-6; Keeling CI, 2006, NEW PHYTOL, V170, P657, DOI 10.1111/j.1469-8137.2006.01716.x; King JN, 2011, FORESTRY, V84, P83, DOI 10.1093/forestry/cpq047; Kirk TK., 1979, LIGNIN BIODEGRADATIO, VII, P235; Krokene Paal, 2008, P147, DOI 10.1007/978-1-4020-8182-8_7; LANGOR DW, 1989, CAN ENTOMOL, V121, P149, DOI 10.4039/Ent121149-2; LANGSTROM B, 1993, EUR J FOREST PATHOL, V23, P400; Lewis GN., 1998, ACS SYM SER, V697, P436; Little E., 1971, CONIFERS IMPORTANT H, V1; Lopez-Goldar X, 2019, J ECOL, V107, P2464, DOI 10.1111/1365-2745.13159; Lopez-Goldar X, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.01651; Luchi N, 2005, PLANTA, V221, P75, DOI 10.1007/s00425-004-1414-3; Moura JCMS, 2010, J INTEGR PLANT BIOL, V52, P360, DOI 10.1111/j.1744-7909.2010.00892.x; Moreira X, 2015, TREE PHYSIOL, V35, P112, DOI 10.1093/treephys/tpu106; NICHOLSON RL, 1992, ANNU REV PHYTOPATHOL, V30, P369, DOI 10.1146/annurev.py.30.090192.002101; Phillips MA, 1999, TRENDS PLANT SCI, V4, P184, DOI 10.1016/S1360-1385(99)01401-6; R Core Team, 2020, R LANG ENV STAT COMP; Raffa Kenneth F., 1993, P103; Raffa KF, 2017, PLANT CELL ENVIRON, V40, P1791, DOI 10.1111/pce.12985; Raffa KF, 2013, P NATL ACAD SCI USA, V110, P2193, DOI 10.1073/pnas.1216666110; RAFFA KF, 1983, CAN ENTOMOL, V115, P723, DOI 10.4039/Ent115723-7; Reid ML, 2017, J CHEM ECOL, V43, P351, DOI 10.1007/s10886-017-0824-1; Rhoades MJC, 1985, BIOCH PLANT PHENOLIC, V25, P99; Rubin EM, 2008, NATURE, V454, P841, DOI 10.1038/nature07190; Sadeghifar H, 2020, POLYMERS-BASEL, V12, DOI 10.3390/polym12051134; Sarkar P, 2009, J EXP BOT, V60, P3615, DOI 10.1093/jxb/erp245; Sattler SE, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00070; Steppuhn Anke, 2008, P61, DOI 10.1007/978-1-4020-8182-8_3; Swain T., 1979, Herbivores: their interaction with secondary plant metabolites, P657; Taft S, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00342; Tao ST, 2009, PLANT SCI, V176, P413, DOI 10.1016/j.plantsci.2008.12.011; VANCE CP, 1980, ANNU REV PHYTOPATHOL, V18, P259, DOI 10.1146/annurev.py.18.090180.001355; Villari C, 2014, TREE PHYSIOL, V34, P919, DOI 10.1093/treephys/tpu063; Voelker SL, 2011, PLANT CELL ENVIRON, V34, P655, DOI 10.1111/j.1365-3040.2010.02270.x; WAINHOUSE D, 1990, OECOLOGIA, V85, P257, DOI 10.1007/BF00319411; Wainhouse D, 1998, J CHEM ECOL, V24, P1551, DOI 10.1023/A:1020915901756; Wainhouse D, 1996, FUNCT ECOL, V10, P137, DOI 10.2307/2390272; Weng JK, 2010, NEW PHYTOL, V187, P273, DOI 10.1111/j.1469-8137.2010.03327.x; Whitehill JGA, 2019, NEW PHYTOL, V221, P1503, DOI 10.1111/nph.15477; Whitehill JGA, 2016, PLANT CELL ENVIRON, V39, P2545, DOI 10.1111/pce.12810; Whitehill JGA, 2014, OECOLOGIA, V176, P1047, DOI 10.1007/s00442-014-3082-8; Whitehill JGA, 2012, J CHEM ECOL, V38, P499, DOI 10.1007/s10886-012-0125-7; Wood S. L., 1982, The bark and ambrosia beetles of North and Central America (Coleoptera : Scolytidae), a taxonomic monograph.; Wullschleger SD, 2004, CAN J FOREST RES, V34, P2387, DOI 10.1139/X04-118; ZAVARIN E, 1993, BIOCHEM SYST ECOL, V21, P381, DOI 10.1016/0305-1978(93)90029-Q; Zhang SH, 2007, J INTEGR PLANT BIOL, V49, P993, DOI 10.1111/j.1672-9072.2007.00478.x	81	1	1	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2021	16	9							e0250395	10.1371/journal.pone.0250395	http://dx.doi.org/10.1371/journal.pone.0250395			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XH8RH	34555045	gold, Green Published			2022-12-26	WOS:000725694500003
J	Hoke, AK; Reynoso, G; Smith, MR; Gardner, MI; Lockwood, DJ; Gilbert, NE; Wilhelm, SW; Becker, IR; Brennan, GJ; Crider, KE; Farnan, SR; Mendoza, V; Poole, AC; Zimmerman, ZP; Utz, LK; Wurch, LL; Steffen, MM				Hoke, Alexa K.; Reynoso, Guadalupe; Smith, Morgan R.; Gardner, Malia, I; Lockwood, Dominique J.; Gilbert, Naomi E.; Wilhelm, Steven W.; Becker, Isabella R.; Brennan, Grant J.; Crider, Katherine E.; Farnan, Shannon R.; Mendoza, Victoria; Poole, Alison C.; Zimmerman, Zachary P.; Utz, Lucy K.; Wurch, Louie L.; Steffen, Morgan M.			Genomic signatures of Lake Erie bacteria suggest interaction in the Microcystis phycosphere	PLOS ONE			English	Article							PAENIBACILLUS-CURDLANOLYTICUS B-6; HETEROTROPHIC BACTERIA; CYANOBACTERIAL BLOOMS; TOXIC CYANOBACTERIUM; IRON UPTAKE; PHYTOPLANKTON; AERUGINOSA; GROWTH; STRAIN; ALGAE	Microbial interactions in harmful algal bloom (HAB) communities have been examined in marine systems, but are poorly studied in fresh waters. To investigate HAB-microbe interactions, we isolated bacteria with close associations to bloom-forming cyanobacteria, Microcystis spp., during a 2017 bloom in the western basin of Lake Erie. The genomes of five isolates (Exiguobacterium sp. JMULE1, Enterobacter sp. JMULE2, Deinococcus sp. JMULE3, Paenibacillus sp. JMULE4, and Acidovorax sp. JMULE5.) were sequenced on a PacBio Sequel system. These genomes ranged in size from 3.1 Mbp (Exiguobacterium sp. JMULE1) to 5.7 Mbp (Enterobacter sp. JMULE2). The genomes were analyzed for genes relating to critical metabolic functions, including nitrogen reduction and carbon utilization. All five of the sequenced genomes contained genes that could be used in potential signaling and nutrient exchange between the bacteria and cyanobacteria such as Microcystis. Gene expression signatures of algal-derived carbon utilization for two isolates were identified in Microcystis blooms in Lake Erie and Lake Tai (Taihu) at low levels, suggesting these organisms are active and may have a functional role during Microcystis blooms in aggregates, but were largely missing from whole water samples. These findings build on the growing evidence that the bacterial microbiome associated with bloom-forming algae have the functional potential to contribute to nutrient exchange within bloom communities and interact with important bloom formers like Microcystis.	[Hoke, Alexa K.; Reynoso, Guadalupe; Smith, Morgan R.; Gardner, Malia, I; Lockwood, Dominique J.; Gilbert, Naomi E.; Becker, Isabella R.; Brennan, Grant J.; Crider, Katherine E.; Farnan, Shannon R.; Mendoza, Victoria; Poole, Alison C.; Zimmerman, Zachary P.; Utz, Lucy K.; Wurch, Louie L.; Steffen, Morgan M.] James Madison Univ, Harrisonburg, VA 22807 USA; [Reynoso, Guadalupe] Virginia Tech, Blacksburg, VA USA; [Smith, Morgan R.] Texas A&M Univ, College Stn, TX USA; [Gilbert, Naomi E.; Wilhelm, Steven W.] Univ Tennessee, Knoxville, TN USA	James Madison University; Virginia Polytechnic Institute & State University; Texas A&M University System; Texas A&M University College Station; University of Tennessee System; University of Tennessee Knoxville	Steffen, MM (corresponding author), James Madison Univ, Harrisonburg, VA 22807 USA.	steffemm@jmu.edu	; Wilhelm, Steven/B-8963-2008	Smith, Morgan/0000-0002-3083-5354; Wilhelm, Steven/0000-0001-6283-8077	National Science Foundation [MCB-1716015]	National Science Foundation(National Science Foundation (NSF))	MMS, LLW, and AKH were supported by National Science Foundation award MCB-1716015 (www.nsf.gov).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akins L, 2020, HYDROBIOLOGIA, V847, P75, DOI 10.1007/s10750-019-04073-4; Amin SA, 2015, NATURE, V522, P98, DOI 10.1038/nature14488; Arandia-Gorostidi N, 2017, ISME J, V11, P641, DOI 10.1038/ismej.2016.156; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; BELL W, 1972, BIOL BULL, V143, P265, DOI 10.2307/1540052; Berg KA, 2009, ISME J, V3, P314, DOI 10.1038/ismej.2008.110; Boedecker AR, 2020, J GREAT LAKES RES, V46, P920, DOI 10.1016/j.jglr.2020.04.010; Boer JL, 2014, ARCH BIOCHEM BIOPHYS, V544, P142, DOI 10.1016/j.abb.2013.09.002; BRAUN V, 1995, FEMS MICROBIOL REV, V16, P295, DOI 10.1111/j.1574-6976.1995.tb00177.x; Brettin T, 2015, SCI REP-UK, V5, DOI 10.1038/srep08365; Brittain SM, 2000, J GREAT LAKES RES, V26, P241, DOI 10.1016/S0380-1330(00)70690-3; Brunberg AK, 1999, FEMS MICROBIOL ECOL, V29, P13, DOI 10.1111/j.1574-6941.1999.tb00594.x; Butler RR, 2016, GENOME ANNOUNCEMENTS, V4, DOI 10.1128/genomeA.01717-15; Cai HY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102879; Cho BC, 1996, MAR ECOL PROG SER, V142, P19, DOI 10.3354/meps142019; Chun SJ, 2017, ANTON LEEUW INT J G, V110, P1199, DOI 10.1007/s10482-017-0892-9; Collier JL, 2009, ENVIRON MICROBIOL, V11, P3118, DOI 10.1111/j.1462-2920.2009.02016.x; Cook KV, 2020, LIMNOL OCEANOGR, V65, pS194, DOI 10.1002/lno.11361; Croft MT, 2005, NATURE, V438, P90, DOI 10.1038/nature04056; Tommaso P, 2011, NUCLEIC ACIDS RES, V39, pW13, DOI 10.1093/nar/gkr245; DIXON NE, 1975, J AM CHEM SOC, V97, P4131, DOI 10.1021/ja00847a045; Dziallas C, 2012, MAR BIOL, V159, P2389, DOI 10.1007/s00227-012-1927-4; FALLON RD, 1979, APPL ENVIRON MICROB, V37, P820, DOI 10.1128/AEM.37.5.820-830.1979; Federle MJ, 2009, CONTRIB MICROBIOL, V16, P18, DOI 10.1159/000219371; Fernandes GD, 2014, RES MICROBIOL, V165, P571, DOI 10.1016/j.resmic.2014.06.002; Fischbach MA, 2006, NAT CHEM BIOL, V2, P132, DOI 10.1038/nchembio771; Forni C, 1997, PHYCOLOGIA, V36, P181, DOI 10.2216/i0031-8884-36-3-181.1; Giroldo D, 2007, FRESHWATER BIOL, V52, P1281, DOI 10.1111/j.1365-2427.2007.01764.x; GOLDMAN SJ, 1983, J BACTERIOL, V156, P1144, DOI 10.1128/JB.156.3.1144-1150.1983; Goris J, 2007, INT J SYST EVOL MICR, V57, P81, DOI 10.1099/ijs.0.64483-0; Harke MJ, 2016, HARMFUL ALGAE, V54, P4, DOI 10.1016/j.hal.2015.12.007; Harke MJ, 2016, ENVIRON SCI TECHNOL, V50, P604, DOI 10.1021/acs.est.5b03931; Harvey EL, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00059; HELLEBUST J. A., 1965, LIMNOL OCEANOGR, V10, P192; Hertlein G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108272; Ho L, 2007, WATER RES, V41, P4685, DOI 10.1016/j.watres.2007.06.057; Jankowiak JG, 2020, FRONT MICROBIOL, V11, DOI 10.3389/fmicb.2020.01016; Kamennaya NA, 2008, LIMNOL OCEANOGR, V53, P2485, DOI 10.4319/lo.2008.53.6.2485; Kaneko T, 2007, DNA RES, V14, P247, DOI 10.1093/dnares/dsm026; Kazamia E, 2012, ENVIRON MICROBIOL, V14, P1466, DOI 10.1111/j.1462-2920.2012.02733.x; Kim M, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-56882-1; Konstantinidis KT, 2014, MICROBE, V9, P111, DOI [10.1128/microbe.9.111.1, DOI 10.1128/MICROBE.9.111.1]; Kouzuma A, 2015, CURR OPIN BIOTECH, V33, P125, DOI 10.1016/j.copbio.2015.02.007; Krausfeldt LE, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.01064; Krishnan A, 2018, B ENVIRON CONTAM TOX, V101, P617, DOI 10.1007/s00128-018-2468-4; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Landa M, 2017, ISME J, V11, P2677, DOI 10.1038/ismej.2017.117; Lau WWY, 2006, ENVIRON MICROBIOL, V8, P1688, DOI 10.1111/j.1462-2920.2006.01092.x; Lau WWY, 2007, APPL ENVIRON MICROB, V73, P2440, DOI 10.1128/AEM.01965-06; Lau YY, 2014, SENSORS-BASEL, V14, P13913, DOI 10.3390/s140813913; Lee C, 2019, ALGAL RES, V41, DOI 10.1016/j.algal.2019.101547; Li Q, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00746; Liu XM, 2019, PEERJ, V7, DOI 10.7717/peerj.7445; LYONS EM, 1995, J BACTERIOL, V177, P1570, DOI 10.1128/jb.177.6.1570-1575.1995; MOBLEY HLT, 1989, MICROBIOL REV, V53, P85, DOI 10.1128/MMBR.53.1.85-108.1989; Mou XZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061890; NAKAGAWA M, 1987, AGR BIOL CHEM TOKYO, V51, P329, DOI 10.1080/00021369.1987.10868065; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Oh HM, 2001, BIOTECHNOL LETT, V23, P1229, DOI 10.1023/A:1010577319771; Ohtsubo Y, 2012, J BACTERIOL, V194, P6970, DOI 10.1128/JB.01848-12; Ollinger J, 2006, J BACTERIOL, V188, P3664, DOI 10.1128/JB.188.10.3664-3673.2006; Overbeek R, 2005, NUCLEIC ACIDS RES, V33, P5691, DOI 10.1093/nar/gki866; Overbeek R, 2014, NUCLEIC ACIDS RES, V42, pD206, DOI 10.1093/nar/gkt1226; Paver SF, 2010, MICROB ECOL, V60, P406, DOI 10.1007/s00248-010-9722-6; Powell RJ, 2013, APPL ENVIRON MICROB, V79, P6093, DOI 10.1128/AEM.01496-13; Qin BQ, 2010, ENVIRON MANAGE, V45, P105, DOI 10.1007/s00267-009-9393-6; Rastogi RP, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01254; Reynoso G, 2019, WATER SCI TECHNOL, V80, P675, DOI 10.2166/wst.2019.311; Saitou T, 2003, J WATER SUPPLY RES T, V52, P13, DOI 10.2166/aqua.2003.0002; Sakka M, 2011, APPL ENVIRON MICROB, V77, P4260, DOI 10.1128/AEM.00226-11; Sathya K, 2015, DESALINATION, V369, P175, DOI 10.1016/j.desal.2015.05.008; Sermsathanaswadi J, 2017, ENZYME MICROB TECH, V96, P75, DOI 10.1016/j.enzmictec.2016.09.015; Seymour JR, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.65; Sharma AK, 2008, ENVIRON MICROBIOL, V10, P1039, DOI 10.1111/j.1462-2920.2007.01525.x; Shi LM, 2010, J FRESHWATER ECOL, V25, P193; SHIRAI M, 1989, APPL ENVIRON MICROB, V55, P2569, DOI 10.1128/AEM.55.10.2569-2571.1989; Steffen MM, 2017, ENVIRON SCI TECHNOL, V51, P6745, DOI 10.1021/acs.est.7b00856; Steffen MM, 2015, APPL ENVIRON MICROB, V81, P3268, DOI 10.1128/AEM.04101-14; Steffen MM, 2014, ISME J, V8, P2080, DOI 10.1038/ismej.2014.78; Steffen MM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044002; Tang Jie, 2013, Genome Announc, V1, DOI 10.1128/genomeA.01059-13; Tang J, 2015, ENVIRON SCI POLLUT R, V22, P9686, DOI 10.1007/s11356-015-4138-y; Tang YZ, 2010, P NATL ACAD SCI USA, V107, P20756, DOI 10.1073/pnas.1009566107; Tarao M, 2009, APPL ENVIRON MICROB, V75, P4720, DOI 10.1128/AEM.00251-09; Tatusova T, 2016, NUCLEIC ACIDS RES, V44, P6614, DOI 10.1093/nar/gkw569; Van den Meersche K, 2004, LIMNOL OCEANOGR, V49, P862, DOI 10.4319/lo.2004.49.3.0862; Van Hullebusch E, 2002, ENVIRON POLLUT, V120, P627, DOI 10.1016/S0269-7491(02)00192-6; Vendeville A, 2005, NAT REV MICROBIOL, V3, P383, DOI 10.1038/nrmicro1146; Visser PM, 2016, AQUAT ECOL, V50, P423, DOI 10.1007/s10452-015-9537-0; Wang J, 2015, BIOTECHNOL LETT, V37, P2201, DOI 10.1007/s10529-015-1918-x; Wang WJ, 2016, J APPL PHYCOL, V28, P1111, DOI 10.1007/s10811-015-0659-5; Weiss G, 2019, ENVIRON MICROBIOL, V21, P1140, DOI 10.1111/1462-2920.14561; WELCH I M, 1990, Journal of Applied Phycology, V2, P231, DOI 10.1007/BF02179780; Wildermuth MC, 2001, NATURE, V414, P562, DOI 10.1038/35107108; WILHELM SW, 1995, CAN J MICROBIOL, V41, P145, DOI 10.1139/m95-019; WILLIAMS PH, 1979, INFECT IMMUN, V26, P925, DOI 10.1128/IAI.26.3.925-932.1979; Wilson MK, 2006, BIOCHEM BIOPH RES CO, V348, P320, DOI 10.1016/j.bbrc.2006.07.055; Woodhouse JN, 2016, ISME J, V10, P1337, DOI 10.1038/ismej.2015.218; Worm J, 1998, AQUAT MICROB ECOL, V14, P19, DOI 10.3354/ame014019; Wu Q, 2019, J FRESHWATER ECOL, V34, P663, DOI 10.1080/02705060.2019.1665115; Xavier KB, 2005, J BACTERIOL, V187, P238, DOI 10.1128/JB.187.1.238-248.2005; Xie ML, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00056; Xing W, 2007, CURR MICROBIOL, V55, P94, DOI 10.1007/s00284-006-0470-2; Xu L, 2018, SCI TOTAL ENVIRON, V634, P488, DOI 10.1016/j.scitotenv.2018.03.327; Yamamoto Y, 2005, PHYCOL RES, V53, P201, DOI 10.1111/j.1440-183.2005.00387.x; Yang CY, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01202; Yang F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086216; Yokoo S, 2018, BIOSCIENCE REP, V38, DOI 10.1042/BSR20171457; Zeng YD, 2021, SCI TOTAL ENVIRON, V769, DOI 10.1016/j.scitotenv.2020.144489; Zheng Q, 2019, FEMS MICROBIOL ECOL, V95, DOI 10.1093/femsec/fiz017	110	6	6	5	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2021	16	9							e0257017	10.1371/journal.pone.0257017	http://dx.doi.org/10.1371/journal.pone.0257017			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YS4WS	34550975	Green Published, gold			2022-12-26	WOS:000750679800011
J	Mejia-Ortiz, L; Christman, MC; Pipan, T; Culver, DC				Mejia-Ortiz, Luis; Christman, Mary C.; Pipan, Tanja; Culver, David C.			What's the relative humidity in tropical caves?	PLOS ONE			English	Article							WATER; NICHE; DEEP	Relative humidity (RH) was measured at hourly intervals for approximately one year in two caves at seven stations near Playa del Carmen in Quintana Roo, Mexico. Sistema Muevelo Rico is a 1.1 km long cave with 12 entrances and almost no dark zone. Rio Secreto (Tuch) is a large river cave with more than 40 km of passages, and an extensive dark zone. Given the need for cave specialists to adapt to saturated humidity, presumably by cuticular thinning, the major stress of RH would be its deviation from saturation. RH in Rio Secreto (Tuch) was invariant at three sites and displayed short deviations from 100% RH at the other four sites. These deviations were concentrated at the end of the nortes and beginning of the rainy season. Three of the sites in Sistema Muevelo Rico showed a similar pattern although the timing of the deviations from 100% RH was somewhat displaced. Four sites in Sistema Muevelo Rico were more variable, and were analyzed using a measure of amount of time of deviation from 100% RH for each 24 hour period. Strong seasonality was evident but, remarkably, periods of constant high humidity were not the same at all sites. In most Sistema Muevelo Rico sites, there was a detectable 24 hour cycle in RH, although it was quite weak in about half of them. For Rio Secreto (Tuch) only one site showed any sign of a 24 hour cycle. The troglomorphic fauna was more or less uniformly spread throughout the caves and did not concentrate in any one area or set of RH conditions. Compared to temperature, RH is much more constant, perhaps even more constant than the amount of light. However, changes in RH as a result of global warming may have a major negative effect on the subterranean fauna.	[Mejia-Ortiz, Luis] Univ Quintana Roo, Div Desarrollo Sustentable, Lab Bioespeleol & Carcinol, Cozumel, Mexico; [Christman, Mary C.] Univ Florida, Dept Biol, Gainesville, FL USA; [Christman, Mary C.] MCC Stat Consulting LLC, Gainesville, FL USA; [Pipan, Tanja] ZRC SAZU Karst Res Inst, Ljubljana, Slovenia; [Pipan, Tanja] Univ Nova Gor, UNESCO Chair Karst Educ, Vipava, Slovenia; [Culver, David C.] Amer Univ, Dept Environm Sci, Washington, DC 20016 USA	Universidad de Quintana Roo; State University System of Florida; University of Florida; Slovenian Academy of Sciences & Arts (SASA); Karst Research Institute, SASA; University of Nova Gorica; American University	Culver, DC (corresponding author), Amer Univ, Dept Environm Sci, Washington, DC 20016 USA.	dculver@american.edu		Culver, David/0000-0002-8866-9053	CONACYT [258494]; (Fondo Sectorial de Investigacion para la Educacion)	CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); (Fondo Sectorial de Investigacion para la Educacion)	LMMO was supported by CONACYT (www.conacyt.gob.mx) grant 258494 (Fondo Sectorial de Investigacion para la Educacion). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. MCC Statistical Consulting LLC provided support in the form of salaries for MCC, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of the author is articulated in the author contribution section.	[Anonymous], 2021, TIME AND DATE AS; Badino G., 2004, SPELEOGENESIS EVOLUT, V2, P1; Badino G., 2004, INT J SPELEOL, V33, P103, DOI [10.5038/1827-806X.33.1.10, DOI 10.5038/1827-806X.33.1.10]; Badino G., 2000, INT J SPELEOL, V29, P89, DOI [10.5038/1827-806X.29.1.5, DOI 10.5038/1827-806X.29.1.5]; Badino G, 2010, ACTA CARSOLOGICA, V39, P427; BARR T C JR, 1971, Annales de Speleologie, V26, P47; Covington MD, 2015, ACTA CARSOLOGICA, V44, P363; Cropley JB., 1965, B NAT SPELEOLOGICAL, V26, P1; Culver DC, 2015, ACTA CARSOLOGICA, V44, P415; Dublyansky V.N., 1998, J CAVE KARST STUD, V60, P3; Eigenmann C. H., 1909, CAVE VERTEBRATES AM; Forbes Jeffrey, 1998, J CAVE KARST STUD, V60, P27; Geze B, 1965, SPELEOLOGIE SCI; Gregoric A, 2014, INT J CLIMATOL, V34, P1488, DOI 10.1002/joc.3778; HADLEY NF, 1981, J ARACHNOL, V9, P215; Hild S, 2009, J STRUCT BIOL, V168, P426, DOI 10.1016/j.jsb.2009.07.017; Hill C., 1997, CAVE MINERALS WORLD; HOWARTH FG, 1980, EVOLUTION, V34, P394, DOI 10.1111/j.1558-5646.1980.tb04827.x; HOWARTH FG, 1983, ANNU REV ENTOMOL, V28, P365, DOI 10.1146/annurev.en.28.010183.002053; HUMPHREYS WF, 1990, COMP BIOCHEM PHYS A, V95, P101, DOI 10.1016/0300-9629(90)90016-L; Jernigan JW, 2001, J CAVE KARST STUD, V63, P3; Kambesis P.N., 2013, COASTAL RES LIB, P347, DOI [10.5066/P91D2OUN, DOI 10.1007/978-94-007-5016-6_16]; Lases-Hernandez F, 2019, GEOCHIM COSMOCHIM AC, V246, P41, DOI 10.1016/j.gca.2018.11.028; Liu W, 2017, ARAB J GEOSCI, V10, DOI 10.1007/s12517-016-2761-7; Mammola S, 2019, BIOSCIENCE, V69, P641, DOI 10.1093/biosci/biz064; Mammola S, 2019, ANTHROPOCENE REV, V6, P98, DOI 10.1177/2053019619851594; Mammola S, 2016, INVERTEBR BIOL, V135, P20, DOI 10.1111/ivb.12113; Mammola S, 2014, INT J SPELEOL, V43, P343, DOI 10.5038/1827-806X.43.3.11; Mejia-Ortiz L, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0237051; Mejia-Ortiz LM, 2018, INT J SPELEOL, V47, P69, DOI 10.5038/1827-806X.47.1.2155; Nicolosi G, 2021, INT J SPELEOL, V50, P53, DOI 10.5038/1827-806X.50.1.2370; Olson RA, 2017, MAMMOTH CAVE HUMAN N, P163; Palmer A.N., 2007, CAVE GEOLOGY; POULSON TL, 1969, SCIENCE, V165, P971; QRSS, 2017, QUINT ROO SPEL SURV; Sanchez-Fernandez D, 2021, NAT CLIM CHANGE, V11, P458, DOI 10.1038/s41558-021-01057-y; Sebela S, 2011, ACTA GEOGR SLOV, V51, P43, DOI 10.3986/AGS51102; Simoes Matheus Henrique, 2015, Subterranean Biology, V16, P103, DOI 10.3897/subtbiol.16.5470; Tobin BW, 2013, INT J SPELEOL, V42, P203, DOI 10.5038/1827-806X.42.3.4; Ward W.C., 1985, GEOLOGY HYDROGEOLOGY, P23, DOI DOI 10.1016/J.PROENG.2015.08.363	40	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2021	16	9							e0250396	10.1371/journal.pone.0250396	http://dx.doi.org/10.1371/journal.pone.0250396			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YS4WS	34550989	gold, Green Published, Green Submitted			2022-12-26	WOS:000750679800001
J	Paoletti, S; Bekaert, K; Barbut, L; Lacroix, G; Volckaert, FAM; Hostens, K				Paoletti, Silvia; Bekaert, Karen; Barbut, Leo; Lacroix, Genevieve; Volckaert, Filip A. M.; Hostens, Kris			Validating a biophysical dispersal model with the early life-history traits of common sole (Solea solea L.)	PLOS ONE			English	Article							PLAICE PLEURONECTES-PLATESSA; NORTH-SEA; VERTICAL-DISTRIBUTION; AGE ESTIMATION; 0-GROUP SOLE; DOVER SOLE; IRISH SEA; EGG SIZE; GROWTH; LARVAE	Larval dispersal and juvenile survival are crucial in determining variation in recruitment, stock size and adult distribution of commercially important fish. This study investigates the dispersal of early-life stages of common sole (Solea solea L.) in the southern North Sea, both empirically and through modeling. Age at different life-history events of juvenile flatfish sampled along the coasts of Belgium, the Netherlands and the United Kingdom in 2013, 2014 and 2016, was determined through the counting of daily growth rings in the otoliths. Juveniles captured between August and October were estimated to be on average 140 days old with an average pelagic larval duration of 34 days. The hatching period was estimated between early April and mid-May followed by arrival and settlement in the nurseries between May and mid-June. Growth rates were higher off the Belgian coast than in the other nursery areas, especially in 2013, possibly due to a post-settlement differentiation. Empirical pelagic larval duration and settlement distributions were compared with the LARVAE&CO larval dispersal model, which combines local hydrodynamics in the North Sea with sole larval behavior. Yearly predicted and observed settlement matched partially, but the model estimated a longer pelagic phase. The observations fitted even better with the modelled average (1995-2015) distribution curves. Aberrant results for the small juvenile sole sampled along the UK coast in March 2016, led to the hypothesis of a winter disruption in the deposition of daily growth rings, potentially related to starvation and lower food availability. The similarities between measured and modelled distribution curves cross-validated both types of estimations and accredited daily ageing of juveniles as a useful method to calibrate biophysical models and to understand early-life history of fish, both important tools in support of efficient fisheries management strategies.	[Paoletti, Silvia; Bekaert, Karen; Hostens, Kris] Flanders Res Inst Agr Fisheries & Food ILVO, Marine Res, Oostende, Belgium; [Paoletti, Silvia; Barbut, Leo; Lacroix, Genevieve] Royal Belgian Inst Nat Sci RBINS, Brussels, Belgium; [Barbut, Leo; Volckaert, Filip A. M.] Katholieke Univ Leuven, Lab Biodivers & Evolutionary Genom, Leuven, Belgium	Institute For Agricultural & Fisheries Research; Royal Belgian Institute of Natural Sciences; KU Leuven	Paoletti, S (corresponding author), Flanders Res Inst Agr Fisheries & Food ILVO, Marine Res, Oostende, Belgium.; Paoletti, S (corresponding author), Royal Belgian Inst Nat Sci RBINS, Brussels, Belgium.	spaoletti@naturalsciences.be		Hostens, Kris/0000-0002-8476-1362; Paoletti, Silvia/0000-0002-1150-9027	Research Foundation -Flanders [G.0702.13N]	Research Foundation -Flanders(FWO)	The B-FishConnect project was funded by the Research Foundation -Flanders (project number G.0702.13N). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALMAGHAZACHI SJ, 1984, J EXP MAR BIOL ECOL, V82, P35, DOI 10.1016/0022-0981(84)90137-0; Amara R, 2007, MAR ECOL PROG SER, V351, P201, DOI 10.3354/meps07154; AMARA R, 1993, J FISH BIOL, V43, P17; Amara R, 2003, ENVIRON BIOL FISH, V67, P191, DOI 10.1023/A:1025646622066; AMARA R, 1994, NETH J SEA RES, V32, P287, DOI 10.1016/0077-7579(94)90006-X; Amara R, 2000, OCEANOL ACTA, V23, P469, DOI 10.1016/S0399-1784(00)00134-1; [Anonymous], 1992, CAN SPEC PUBL FISH A; Barbut L, 2019, LIMNOL OCEANOGR, V64, P1150, DOI 10.1002/lno.11104; Baynes SM, 1996, J EXP MAR BIOL ECOL, V199, P59, DOI 10.1016/0022-0981(95)00189-1; BEJDA AJ, 1992, ENVIRON BIOL FISH, V34, P321, DOI 10.1007/BF00004780; Berglund M, 2012, ECOL MODEL, V240, P105, DOI 10.1016/j.ecolmodel.2012.04.011; Berntsen Jarle, 1994, Fisheries Oceanography, V3, P81, DOI 10.1111/j.1365-2419.1994.tb00051.x; Burt Gary J., 2008, CEFAS Science Series Technical Report, V144, P1; Campana SE, 2001, CAN J FISH AQUAT SCI, V58, P30, DOI 10.1139/f00-177; CAMPANA SE, 1985, CAN J FISH AQUAT SCI, V42, P1014, DOI 10.1139/f85-127; Cardoso JFMF, 2016, J SEA RES, V111, P88, DOI 10.1016/j.seares.2016.01.010; Catchpole TL, 2005, MAR POLICY, V29, P421, DOI 10.1016/j.marpol.2004.07.001; Christensen A, 2007, MAR ECOL PROG SER, V347, P221, DOI 10.3354/meps06980; Chung MT, 2019, COMMUN BIOL, V2, DOI 10.1038/s42003-018-0266-5; Cuveliers EL, 2012, MAR BIOL, V159, P1239, DOI 10.1007/s00227-012-1905-x; Cuveliers EL, 2010, MAR ECOL PROG SER, V401, P211, DOI 10.3354/meps08439; de Pontual H, 2003, J SEA RES, V50, P199, DOI 10.1016/S1385-1101(03)00080-7; Delerue-Ricard S, 2019, J SEA RES, V155, DOI 10.1016/j.seares.2019.101822; Delerue-Ricard S, 2019, HYDROBIOLOGIA, V845, P95, DOI 10.1007/s10750-018-3736-3; Duffy-Anderson JT, 2015, FLATFISHES: BIOLOGY AND EXPLOITATION, 2ND EDITION, P132; Ellis J.R., 2012, SCI SER TECH REP CEF, V147, P19; Erftemeijer PLA, 2009, MAR ECOL PROG SER, V390, P167, DOI 10.3354/meps08173; Fedewa EJ, 2016, J SEA RES, V111, P25, DOI 10.1016/j.seares.2015.11.008; Fincham JI, 2013, J SEA RES, V75, P69, DOI 10.1016/j.seares.2012.07.004; Fogarty MJ, 2007, OCEANOGRAPHY, V20, P112, DOI 10.5670/oceanog.2007.34; Folkvord A, 2000, FISH RES, V46, P91, DOI 10.1016/S0165-7836(00)00136-3; FONDS M, 1979, MAR ECOL PROG SER, V1, P91, DOI 10.3354/meps001091; Fox CJ, 2007, MAR ECOL PROG SER, V345, P255, DOI 10.3354/meps06967; Gilliers C, 2006, ESTUAR COAST SHELF S, V69, P96, DOI 10.1016/j.ecss.2006.02.006; Guoqiang H, 2018, J MARINE BIOL AQUACU, V4, P21; Handeland SO, 2008, AQUACULTURE, V283, P36, DOI 10.1016/j.aquaculture.2008.06.042; HORWOOD J, 1993, ADV MAR BIOL, V29, P215, DOI 10.1016/S0065-2881(08)60132-7; ICES, 2019, REP ICES ADV COMM IC; ICES, 2017, 2017EOSG06 ICES CM; ICES, 2018, FISH OV GREAT N SEA; ICES-FishMap, 2005, SOL SOL; KOUTSIKOPOULOS C, 1991, J PLANKTON RES, V13, P923, DOI 10.1093/plankt/13.5.923; Lacroix G, 2004, J SEA RES, V52, P149, DOI 10.1016/j.seares.2004.01.003; Lacroix G, 2018, GLOBAL CHANGE BIOL, V24, P85, DOI 10.1111/gcb.13915; Lacroix G, 2013, J SEA RES, V84, P13, DOI 10.1016/j.seares.2012.07.010; Lagardere F, 1999, ENVIRON BIOL FISH, V56, P213, DOI 10.1023/A:1007581818941; Lagardere F, 1997, MAR ECOL PROG SER, V155, P223, DOI 10.3354/meps155223; Le Pape O, 2016, J SEA RES, V107, P43, DOI 10.1016/j.seares.2015.06.001; Lelievre S, 2014, J SEA RES, V91, P1, DOI 10.1016/j.seares.2014.03.008; Loewe P, 2003, D 20305 HAMBURG BOX; Luyten P. J., 1999, COHERENS USER DOCUME; Luyten PJ, 2003, J PHYS OCEANOGR, V33, P37, DOI 10.1175/1520-0485(2003)033<0037:ANSOTL>2.0.CO;2; Mollet FM, 2013, J SEA RES, V84, P109, DOI 10.1016/j.seares.2012.12.005; Morales-Nin B, 2000, FISH RES, V46, P53, DOI 10.1016/S0165-7836(00)00133-8; Nash RDM, 2005, FLATFISHES: BIOLOGY AND EXPLOITATION, P138, DOI 10.1002/9780470995259.ch7; R Core Team, 2020, R LANG ENV STAT COMP; Ramsey CA, 2005, ENVIRON FORENSICS, V6, P71, DOI 10.1080/15275920590913877; Randon M, 2018, J SEA RES, V142, P91, DOI 10.1016/j.seares.2018.09.012; RIJNSDORP AD, 1994, NETH J SEA RES, V32, P255, DOI 10.1016/0077-7579(94)90003-5; RIJNSDORP AD, 1992, MAR ECOL PROG SER, V88, P19, DOI 10.3354/meps088019; Rochette S, 2012, FISH OCEANOGR, V21, P229, DOI 10.1111/j.1365-2419.2012.00621.x; Rogers S.I., 1998, SCI SERIES, P108; Savina M, 2010, J MARINE SYST, V81, P86, DOI 10.1016/j.jmarsys.2009.12.008; Schram E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061357; Teal LR, 2008, MAR ECOL PROG SER, V358, P219, DOI 10.3354/meps07367; Teal LR, 2012, GLOBAL CHANGE BIOL, V18, P3291, DOI 10.1111/j.1365-2486.2012.02795.x; Thia JA, 2018, J ANIM ECOL, V87, P1353, DOI 10.1111/1365-2656.12844; Uehara M, 2020, J FISH BIOL, V97, P121, DOI 10.1111/jfb.14332; van der Molen J, 2007, J SEA RES, V58, P313, DOI 10.1016/j.seares.2007.07.003; van der Veer HW, 2000, ICES J MAR SCI, V57, P202, DOI 10.1006/jmsc.1999.0523; VANDERLAND MA, 1991, NETH J SEA RES, V27, P277, DOI 10.1016/0077-7579(91)90030-5; Vaz AC, 2019, AQUAT ECOL, V53, P281, DOI 10.1007/s10452-019-09688-2; Vinagre C, 2008, ESTUAR COAST SHELF S, V78, P521, DOI 10.1016/j.ecss.2008.01.012; Vinagre C, 2013, J SEA RES, V76, P89, DOI 10.1016/j.seares.2012.11.004; Visser AW, 1997, MAR ECOL PROG SER, V158, P275, DOI 10.3354/meps158275; Volckaert F. A. M, 2021, DRYAD DIGITAL REPOSI, DOI [10.5061/dryad.mw6m905ws, DOI 10.5061/DRYAD.MW6M905WS]; Walters D, 2017, GEOSCI MODEL DEV, V10, P1487, DOI 10.5194/gmd-10-1487-2017	77	0	0	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2021	16	9							e0257709	10.1371/journal.pone.0257709	http://dx.doi.org/10.1371/journal.pone.0257709			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YS4WS	34551018	gold, Green Published			2022-12-26	WOS:000750679800045
J	Hanson, M; Hollingshead, N; Schuler, K; Siemer, WF; Martin, P; Bunting, EM				Hanson, Melissa; Hollingshead, Nicholas; Schuler, Krysten; Siemer, William F.; Martin, Patrick; Bunting, Elizabeth M.			Species, causes, and outcomes of wildlife rehabilitation in New York State	PLOS ONE			English	Article							WEST-NILE-VIRUS; DOMESTIC CATS; UNITED-STATES; SURVEILLANCE; MORTALITY; ADMISSION; SYSTEM; HEALTH; ISLAND; LEAD	Wildlife rehabilitation is a publicly popular practice, though not without controversy. State wildlife agencies frequently debate the ecological impact of rehabilitation. By analyzing case records, we can clarify and quantify the causes for rehabilitation, species involved, and treatment outcomes. This data would aid regulatory agencies and rehabilitators in making informed decisions, as well as gaining insight into causes of species mortality. In New York State, the Department of Environmental Conservation (NYSDEC) has licensed rehabilitators since 1980 and annual reporting is required. In this study, we analyzed 58,185 individual wildlife cases that were attended by New York rehabilitators between 2012 and 2014. These encompassed 30,182 (51.9%) birds, 25,447 (43.7%) mammals, 2,421 (4.2%) reptiles, and 75 (0.1%) amphibians. We identified patterns among taxonomic representation, reasons for presentation to a rehabilitation center, and animal disposition. Major causes of presentation were trauma (n = 22,156; 38.1%) and orphaning (n = 21,679; 37.3%), with habitat loss (n = 3,937; 6.8%), infectious disease (n = 1,824; 3.1%), and poisoning or toxin exposure (n = 806; 1.4%) playing lesser roles. The overall release rate for animals receiving care was 50.2% while 45.3% died or were euthanized during the rehabilitation process. A relatively small number (0.3%) were permanently non-releasable and placed in captivity; 4.1% had unknown outcomes. A comparable evaluation in 1989 revealed that wildlife submissions have increased (annual mean 12,583 vs 19,395), and are accompanied by a significant improvement in release (50.2% in the study period vs 44.4% in 1989) (chi(2) (1) = 90.43, p < 0.0001). In this manuscript, we aim to describe the rehabilitator community in New York State, and present the causes and outcomes for rehabilitation over a three-year period.	[Hanson, Melissa; Hollingshead, Nicholas; Schuler, Krysten; Bunting, Elizabeth M.] Cornell Univ, Coll Vet Med, Cornell Wildlife Hlth Lab, New York State Vet Diagnost Lab, Ithaca, NY 14853 USA; [Siemer, William F.] Cornell Univ, Ctr Conservat Social Sci, Ithaca, NY USA; [Martin, Patrick] New York State Dept Environm Conservat, Albany, NY USA; [Hanson, Melissa] Cornell Univ, Coll Vet Med, Ithaca, NY 14853 USA	Cornell University; Cornell University; Cornell University	Hanson, M (corresponding author), Cornell Univ, Coll Vet Med, Cornell Wildlife Hlth Lab, New York State Vet Diagnost Lab, Ithaca, NY 14853 USA.; Hanson, M (corresponding author), Cornell Univ, Coll Vet Med, Ithaca, NY 14853 USA.	meh352@cornell.edu						Alba A, 2017, BMC VET RES, V13, DOI 10.1186/s12917-017-1292-0; Ancillotto L, 2013, MAMM BIOL, V78, P369, DOI 10.1016/j.mambio.2013.01.003; Baker L, 2015, ENDANGER SPECIES RES, V29, P13, DOI 10.3354/esr00696; Barnes Emily, 2017, Plymouth Student Scientist, V10, P1; Bernard KA, 2001, EMERG INFECT DIS, V7, P679; Blehert DS, 2009, SCIENCE, V323, P227, DOI 10.1126/science.1163874; Burton E, 2016, ANIMALS, V6, DOI 10.3390/ani6090056; Ceballos G, 2017, P NATL ACAD SCI USA, V114, pE6089, DOI 10.1073/pnas.1704949114; Cornell Wildlife Health Lab, 2017, BALD EAGL LEAD TOX 2; De Francisco N, 2003, AVIAN PATHOL, V32, P3, DOI 10.1080/0307945021000070660; Decker D, 2016, CONSERV LETT, V9, P290, DOI 10.1111/conl.12211; Deem Sharon L., 2003, Veterinary Clinics of North America Exotic Animal Practice, V6, P363, DOI 10.1016/S1094-9194(03)00004-5; Deem SL, 2001, CONSERV BIOL, V15, P1224, DOI 10.1046/j.1523-1739.2001.00336.x; Dirzo R, 2014, SCIENCE, V345, P401, DOI 10.1126/science.1251817; Eidson M, 2001, EMERG INFECT DIS, V7, P631, DOI 10.3201/eid0704.010405; Eidson M, 2001, EMERG INFECT DIS, V7, P615; Erb LA, 2015, J WILDLIFE MANAGE, V79, P1062, DOI 10.1002/jwmg.921; Frick WF, 2010, SCIENCE, V329, P679, DOI 10.1126/science.1188594; Harris MC, 2007, J ZOO WILDLIFE MED, V38, P62, DOI 10.1638/05-099.1; Herring G, 2018, WILDLIFE SOC B, V42, P284, DOI 10.1002/wsb.892; Koenig J, 2002, J HERPETOL, V36, P62; Long RB, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0238805; Loss SR, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2380; Loyd KAT, 2017, WILDLIFE SOC B, V41, P55, DOI 10.1002/wsb.737; Martin PA, 2018, ARCH ENVIRON CON TOX, V74, P305, DOI 10.1007/s00244-017-0479-5; Matheny K., 2018, MICHIGAN HUNTING MAJ; Mcruer DL, 2017, J WILDLIFE MANAGE, V81, P163, DOI 10.1002/jwmg.21181; Montesdeoca N, 2016, J WILDLIFE DIS, V52, P647, DOI 10.7589/2015-09-255; Moore M, 2007, MAR MAMMAL SCI, V23, P731, DOI 10.1111/j.1748-7692.2007.00146.x; Mullineaux E, 2014, J SMALL ANIM PRACT, V55, P293, DOI 10.1111/jsap.12213; National Wildlife Rehabilitators Association, 2015, OUR MEMB; Nemeth NM, 2007, AM J TROP MED HYG, V76, P431, DOI 10.4269/ajtmh.2007.76.431; New York State Department of Environmental Conservation, 2016, CONS PLAN BALD EAGL; New York State Department of Environmental Conservation, WILDLIFE REHABILITAT; New York State Department of Environmental Conservation Division of Fish and Wildlife, 2019, CHECKLIST AMPHIBIANS; NYS Dept. of Environmental Conservation, 2015, LIST END THREAT SPEC; Oros J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149398; Page-Karjian A, 2014, J ZOO WILDLIFE MED, V45, P507, DOI 10.1638/2013-0132R1.1; Rabies Laboratory Wadsworth Center NYSD of H, 2015, RAB ANN REP; Rio-Maior H, 2016, J WILDLIFE MANAGE, V80, P729, DOI 10.1002/jwmg.1055; RodriguezLainz AJ, 1997, PREV VET MED, V31, P175, DOI 10.1016/S0167-5877(96)01137-3; Rules and Regulations of the State of New York, 2019, 182 4 LIST SPEC SPEC; Russell RE, 2014, WILDLIFE SOC B, V38, P697, DOI 10.1002/wsb.469; Schellenberg A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094353; Siemer WF, 1992, WILDLIFE REHABILITAT, P205, DOI [10.1007/BF00374465, DOI 10.1007/BF00374465]; Siemer WF, 1992, CHARACTERISTICS ACTI, DOI [10.1007/BF00374465, DOI 10.1007/BF00374465]; Smith KA, 2018, J WILDLIFE DIS, V54, P261, DOI 10.7589/2017-07-157; Stitt T, 2007, CAN VET J, V48, P83; The New York State Ornithological Association I, 2019, CHECKL BIRDS NEW YOR; Tribe Andrew, 2000, Human Dimensions of Wildlife, V5, P69; U.S. Department of the Interior U.S. Fish and Wildlife Service and U.S. Department of Commerce USCB, 2016, 2016 NAT SURV FISH H; United States Census Bureau, 2020 CENS APP RES, P2021; Vogelnest Larry, 2008, P133	53	5	5	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2021	16	9							e0257675	10.1371/journal.pone.0257675	http://dx.doi.org/10.1371/journal.pone.0257675			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YM4DR	34547048	Green Published, gold, Green Submitted			2022-12-26	WOS:000746527400033
J	Omale, UI				Omale, Ugwu, I			Knowledge, attitude, and practice of the National Guidelines for Diagnosis and Treatment of Malaria among medical doctors in Ebonyi state, Nigeria: A cross-sectional survey	PLOS ONE			English	Article								Background The Guidelines for Diagnosis and Treatment of Malaria are meant to guide medical practitioners to enhance optimal management of patients suspected of having malaria which is vital to malarial control and elimination. Medical doctors have the main responsibility for treating patients with malaria so there was need to evaluate the extent to which the medical doctors in Ebonyi state, Nigeria, knew, viewed, and practiced the 2015 National Guidelines for Diagnosis and Treatment of Malaria. Methods A cross-sectional survey was carried out in May, 2019 among medical doctors who were involved in the management of malaria patients and selected via convenience sampling. Data was collected using a structured self-administered questionnaire. Each respondent was categorized as having poor, fair, or good knowledge, attitude, and practice respectively based on knowledge, attitude, and practice scores of <50%, 50-75%, and >75%. Associated factors were evaluated through bivariate and multivariate binomial logistic regressions at 5% probability of type one error and the overall test for the effect of each independent factor on practice level was done using the "postestimation test" command in Stata. Results A total of 156 medical doctors were surveyed. Most, 138 (88.5%) were aware there was a national guideline for diagnosis and treatment of malaria. Among the medical doctors, 19 (12.2%) had good knowledge, 110 (70.5%) had fair knowledge, and 27 (17.3%) had poor knowledge; 38 (24.4%) had good attitude, 74 (47.4%) had fair attitude, and 44 (28.2%) had poor attitude; and 59 (37.8%) had good practice, 90 (57.7%) had fair practice, and 7 (4.5%) had poor practice. The attitude level of the medical doctors toward the 2015 National Guidelines for Diagnosis and Treatment of Malaria was a predictor of good practice (adjusted p-value of overall effect = 0.0003). Conclusions Although most of the medical doctors in Ebonyi state, Nigeria, were aware of the existence of a national guideline, only just over a third of them had good practice of the 2015 National Guidelines for Diagnosis and Treatment of Malaria. Policy interventions should focus on improving the attitude of the medical doctors toward the National Guidelines through training and re-training.	[Omale, Ugwu, I] Alex Ekwueme Fed Univ Teaching Hosp, Dept Community Med, Abakaliki AEFUTHA, Ebonyi State, Nigeria		Omale, UI (corresponding author), Alex Ekwueme Fed Univ Teaching Hosp, Dept Community Med, Abakaliki AEFUTHA, Ebonyi State, Nigeria.	omaleiu@gmail.com		Omale, Ugwu/0000-0001-6586-8992				Bamiselu OF, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3495-x; Bawate C, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1153-5; Blanco M, 2021, MALARIA J, V20, DOI 10.1186/s12936-020-03528-7; Budimu A, 2020, J TROP MED-US, V2020, DOI 10.1155/2020/1918583; Cohen J, 2015, AM ECON REV, V105, P609, DOI 10.1257/aer.20130267; Ebonyi State Ministry of Health, 2016, 2016 ANN OP PLAN MAL; Ebonyi State Ministry of Health, 2021, DIR HLTH FAC; Federal Ministry of Health (FMoH), 2020, NAT GUID DIAGN TREAT, V4; Federal Ministry of Health (FMoH) and National Malaria Control Programme (NMCP), 2015, NAT MAL STRAT PLAN 2; FMOH, 2015, NAT CANC CONTR PLAN; National Malaria Elimination Programme (NMEP); National Population Commission (NPopC); National Bureau of Statistics (NBS) and ICF International, 2016, NIG MAL IND SURV NMI; Ndibuagu E. O., 2018, Health, V10, P971, DOI 10.4236/health.2018.107072; Ndibuagu EO., 2017, J BIOSCI MED, V5, P1; Riley C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145616; Suarez-Sanchez P, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0220789; WHO, 2010, WORLD MALARIA REPORT 2010, P1; WHO, 2015, GLOB TECHN STRAT MAL; WHO, 2010, GUID TREATM MAL, V2nd; WHO, 2011, U ACC MAL DIAGN TEST; World Health Organization, 2015, GUID TREATM MAL, Vthird	20	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2021	16	9							e0257600	10.1371/journal.pone.0257600	http://dx.doi.org/10.1371/journal.pone.0257600			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	WG6BN	34543317	Green Published, gold			2022-12-26	WOS:000707078200058
J	Narh-Bana, SA; Kawonga, M; Chirwa, ED; Ibisomi, L; Bonsu, F; Chirwa, TF				Narh-Bana, Solomon A.; Kawonga, Mary; Chirwa, Esnat D.; Ibisomi, Latifat; Bonsu, Frank; Chirwa, Tobias F.			Fidelity of implementation of TB screening guidelines by health providers at selected HIV clinics in Ghana	PLOS ONE			English	Article							PREVENTION PROGRAM; TUBERCULOSIS; OUTCOMES	Introduction Tuberculosis screening of people living with human immunodeficiency virus is an intervention recommended by the WHO to control the dual epidemic of TB and HIV. The extent to which the intervention is adhered to by the HIV healthcare providers (fidelity) determines the intervention's effectiveness as measured by patient outcomes, but literature on fidelity is scarce. This study assessed provider implementation fidelity to national guidelines on TB screening at HIV clinics in Ghana. Methods It was a cross-sectional study that used structured questionnaires to gather data, involving 226 of 243 HIV healthcare providers in 27 HIV clinics across Ghana. The overall fidelity score comprised sixteen items with a maximum score of 48 grouped into three components of the screening intervention (TB diagnosis, TB awareness and TB symptoms questionnaire). Simple summation of item scores was done to determine fidelity score per provider. In this paper, we define the level of fidelity as low if the scores were below the median score and were otherwise categorized as high. Background factors potentially associated with implementation fidelity level were assessed using cluster-based logistic regression. Odds ratio with 95% confidence interval (CI) was used as the measure of association. Results Of the 226 healthcare providers interviewed, 60% (135) were females with a mean age of 34.5 years (SD = 8.3). Most of them were clinicians [63% (142)] and had post-secondary non-tertiary education [62% (141)]. Overall, 53% (119) of the healthcare providers were categorized to have implemented the intervention with high fidelity. Also, 56% (126), 53% (120), and 59% (134) of the providers implemented the TB diagnosis, TB awareness and TB symptoms questionnaire components respectively with high fidelity. After adjusting for cluster effect, female providers (AOR = 2.36, 95%CI: 1.09-5.10, p = <0.029), those with tertiary education (AOR = 4.31, 95%CI: 2.12-9.10, p = 0.040), and clinicians (AOR = 1.78, 95%CI: 1.07-3.50, p = 0.045) were more likely to adhere to the guidelines compared to their counterparts. Conclusion The number of providers with fidelity scores above the median was marginally greater (6%) than the number with fidelity score below the median. Similarly, for each of the components, the number of providers with fidelity scores higher than the median was marginally higher. This could explain the existing fluctuations in the intervention outcomes in Ghana. We found gender, profession and education were associated with provider implementation fidelity. To improve fidelity level among HIV healthcare providers, and realize the aims of the TB screening intervention among PLHIV in Ghana, further training on implementing all components of the intervention is critical.	[Narh-Bana, Solomon A.; Kawonga, Mary; Chirwa, Esnat D.; Ibisomi, Latifat; Chirwa, Tobias F.] Univ Witwatersrand, Fac Hlth Sci, Sch Publ Hlth, Johannesburg, South Africa; [Narh-Bana, Solomon A.] Dodowa Hlth Res Ctr, Ghana Hlth Serv, Res & Dev Div, Accra, Ghana; [Kawonga, Mary] Charlotte Maxeke Johannesburg Acad Hosp, Dept Community Hlth, Johannesburg, South Africa; [Chirwa, Esnat D.] MRC, Gender & Hlth Res Unit, Johannesburg, South Africa; [Ibisomi, Latifat] Nigerian Inst Med Res, Lagos, Nigeria; [Bonsu, Frank] Natl TB Control Programme, Accra, Ghana	University of Witwatersrand; Ghana Health Service; University of Witwatersrand	Narh-Bana, SA (corresponding author), Univ Witwatersrand, Fac Hlth Sci, Sch Publ Hlth, Johannesburg, South Africa.; Narh-Bana, SA (corresponding author), Dodowa Hlth Res Ctr, Ghana Hlth Serv, Res & Dev Div, Accra, Ghana.	narhbana@gmail.com	Kawonga, Mary/ABC-6823-2021	Kawonga, Mary/0000-0001-9807-7847; Ibisomi, Latifat/0000-0002-1607-1685; Narh-Bana, Solomon A./0000-0001-8010-2637	TDR [B40299]; UNICEF; UNDP; World Bank; WHO	TDR; UNICEF; UNDP; World Bank(The World Bank India); WHO(World Health Organization)	SNB received the funding. Funding for this study was from TDR (grant no: B40299), the Special Programme for Research and Training in Tropical Diseases, which is hosted at the World Health Organization and co-sponsored by UNICEF, UNDP, the World Bank and WHO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abebe R., 2013, AM J TROP MED HYG, V89, P232; Abry T, 2015, AM J EVAL, V36, P320, DOI 10.1177/1098214014557009; Addo KK, 2018, J TUBERC RES, V6, P135; Ahorlu CK, 2013, J TUBERCULOSIS RES, V1, P29; Albert A, 2014, J CONSTR ENG M, V140, DOI 10.1061/(ASCE)CO.1943-7862.0000860; Ansa G. A., 2015, Asian Pacific Journal of Tropical Disease, V5, P841, DOI 10.1016/S2222-1808(15)60927-6; Ansa GA, 2012, INFECT DIS POVERTY, V1, DOI 10.1186/2049-9957-1-13; Blodgett JG, 1997, J RETAILING, V73, P185, DOI 10.1016/S0022-4359(97)90003-8; Breitenstein SM, 2010, NURS RES, V59, P158, DOI 10.1097/NNR.0b013e3181dbb2e2; Breitenstein SM, 2010, RES NURS HEALTH, V33, P164, DOI 10.1002/nur.20373; Brown T., CONFIRMATORY FACTOR; Carroll C, 2007, IMPLEMENT SCI, V2, DOI 10.1186/1748-5908-2-40; Clark A, 2016, J NURS SCHOLARSHIP, V48, P371, DOI 10.1111/jnu.12221; Cochrane LJ, 2007, J CONTIN EDUC HEALTH, V27, P94, DOI 10.1002/chp.106; Crosse S, PREVALENCE IMPLEMENT; Damschroder LJ, 2009, IMPLEMENT SCI, V4, DOI 10.1186/1748-5908-4-50; Date A, 2015, JAIDS-J ACQ IMM DEF, V68, pS270, DOI 10.1097/QAI.0000000000000485; Department of Health and Human Services. USA, 2013, IMP QUAL IMPL RES; Dobson KS, 2005, CLIN PSYCHOL-SCI PR, V12, P384, DOI 10.1093/clipsy/bpi046; Durak U, 2015, AM I AERONAUTICS AST; Durlak JA., 2011, CHILD TRENDS, V34, P1; Durlak JA, 2008, AM J COMMUN PSYCHOL, V41, P327, DOI 10.1007/s10464-008-9165-0; Dusenbury L., 2014, WHO, V15, P1; Eboreime EA, 2019, INT J HEALTH PLAN M, V34, pE369, DOI 10.1002/hpm.2655; Elbeck M, 1987, Health Care Manage Rev, V12, P47; Ennett ST, 2011, HEALTH EDUC RES, V26, P361, DOI 10.1093/her/cyr013; Getahun H, 2004, INTERIM POLICY COLLA; Getahun H, 2010, CLIN INFECT DIS, V50, pS201, DOI 10.1086/651492; Ghana Health Service, 2014, IMPL TB HIV COLL ACT; Ghana Health Service USAID-Ghana QHP, 2007, IMPL TB HIV COLL ACT; Gupta S, 2014, INT J TUBERC LUNG D, V18, P1149, DOI 10.5588/ijtld.13.0889; Guyatt GH, 2008, BRIT MED J, V336, P924, DOI 10.1136/bmj.39489.470347.AD; Hasson H, 2012, IMPLEMENT SCI, V7, DOI 10.1186/1748-5908-7-23; Hasson H, 2010, IMPLEMENT SCI, V5, DOI 10.1186/1748-5908-5-67; Hernandez M, 2001, J EMOT BEHAV DISORD, V9, P43, DOI 10.1177/106342660100900105; Hulleman ChrisS., 2013, APPL IMPLEMENTATION; Klimes-Dougan B, 2009, PROF PSYCHOL-RES PR, V40, P467, DOI 10.1037/a0014623; Kok MSY, 2018, HEALTH EDUC, V118, P62, DOI [10.1108/he-04-2017-0019, 10.1108/HE-04-2017-0019]; Lebina L, 2019, BMC HEALTH SERV RES, V19, DOI 10.1186/s12913-019-4785-7; Lewis CC, 2015, IMPLEMENT SCI, V10, DOI 10.1186/s13012-015-0342-x; Lonnroth K, 2013, INT J TUBERC LUNG D, V17, P289, DOI 10.5588/ijtld.12.0797; Mihalic S., 2002, IMPORTANCE IMPLEMENT; Mihalic SharonF., BLUEPRINTS VIOLENCE; Mowbray CT, 2003, AM J EVAL, V24, P315, DOI 10.1177/109821400302400303; Naleppa MJ, 2010, RES SOCIAL WORK PRAC, V20, P674, DOI 10.1177/1049731509352088; Nilsen P, 2019, BMC HEALTH SERV RES, V19, DOI 10.1186/s12913-019-4015-3; Nurjono M, 2019, BMC HEALTH SERV RES, V19, DOI 10.1186/s12913-019-3980-x; Osei E, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2598-z; Peters DH, 2013, INPLEMENTATION RESEARCH IN HEALTH: A PRACTICAL GUIDE, pCOVER1; Roberts G, 2017, TREATMENT FIDELITY IN STUDIES OF EDUCATIONAL INTERVENTION, P1; Roberts GH, 2017, MATERIAL CULTURE IN RUSSIA AND THE USSR: THINGS, VALUES, IDENTITIES, P1; Sanchez V., FIDELITY IMPLEMENTAT; Schmidt B, 2017, BMC HEALTH SERV RES, V17, DOI 10.1186/s12913-017-2320-2; Sidani S, 1980, HLTH IRVINE CALIF, V7, P1687; StataCorp, 2017, STAT REL 15 STAT SOF, DOI DOI 10.2307/2234838; Steiber S R, 1989, Health Care Strateg Manage, V7, P13; Tavakol M, 2011, INT J MED EDUC, V2, P53, DOI 10.5116/ijme.4dfb.8dfd; VanDevanter N, 2017, IMPLEMENT SCI, V12, DOI 10.1186/s13012-017-0558-z; Velligan DI, 2009, J CLIN PSYCHIAT, V70, P6; World Health Organisation, 2020, TUB COUNTR PROF GHAN; World Health Organization, 2012, WHO POL COLL TB HIV; World Health Organization, 2021, 10 THREATS GLOB HLTH	62	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2021	16	9							e0257486	10.1371/journal.pone.0257486	http://dx.doi.org/10.1371/journal.pone.0257486			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	WG5ZQ	34534240	Green Published, gold			2022-12-26	WOS:000707073300032
J	Ansari, E				Ansari, Ejaz			5-year outcomes of single iStent (G1) trabecular microbypass implantation with phacoemulsification in moderately advanced primary open angle glaucoma	PLOS ONE			English	Article							STENT IMPLANTATION; CATARACT-SURGERY; SAFETY	Purpose To evaluate the safety and efficacy of combined phacoemulsification and single iStent (G1) (iStent, Glaukos Corp. San Clemente, USA), implantation in moderately advanced primary open angle glaucoma (POAG) with 5-years follow-up. Methods Retrospective, interventional case series. All subjects had POAG and underwent single iStent implantation+ phaco+IOL by a single surgeon, with 5 years follow-up. Primary outcome measures: reduction in intraocular pressure (IOP) and proportion of eyes achieving at least 20% reduction of IOP at 5 years. Secondary outcome measures: number of glaucoma drops at 1 through to 5 years; change in visual field mean deviation (MD) at year 5 compared to baseline. Results 35 eyes of 26 patients were included. Mean (sd) medicated pre-op IOP was 18.5 (3.2) mm Hg on mean (sd) 2.3 (1.0) medications. Mean IOP was reduced to 15.9 (4.5) mm Hg on 2.2 (0.9) drops, 15.0mm (4.5) mm Hg on 2.3 (0.9) drops, 15.6 (3.6) mm Hg on 2.5 (1.0) drops, 15.7 (4.43) mmHg on 2.6 (1.0) drops and 14.7 (3.02) mmHg (P<0.001) on 2.7 (1.14) drops (P = 0.06) from 1 through to 5 years. At year 5, 62% of eyes had achieved at least 20% reduction in IOP. MD reduced from -8 (8.1) dB to -10.7 (13.4) dB over 5 years (p = 0.8) at 0.54dB/ annum. One eye required filtering surgery. There were no sight-threatening complications. Conclusion This study showed sustained IOP reduction and excellent safety profile for single iStent implantation. Uniquely it provides data for a more severe stage of glaucoma, and also visual field data, which indicated no significant change through 5 years.	[Ansari, Ejaz] Maidstone & Tunbridge Wells NHS Trust, Maidstone, Kent, England; [Ansari, Ejaz] Canterbury Christ Church Univ, Canterbury, Kent, England	Canterbury Christ Church University	Ansari, E (corresponding author), Maidstone & Tunbridge Wells NHS Trust, Maidstone, Kent, England.; Ansari, E (corresponding author), Canterbury Christ Church Univ, Canterbury, Kent, England.	e.ansari@nhs.net		Ansari, Ejaz/0000-0001-6610-0125				Armstrong JJ, 2017, J GLAUCOMA, V26, P511, DOI 10.1097/IJG.0000000000000643; Boland MV, 2013, ANN INTERN MED, V158, P271, DOI 10.7326/0003-4819-158-4-201302190-00008; Chen J, 2019, CURR OPIN OPHTHALMOL, V30, P125, DOI 10.1097/ICU.0000000000000549; Craven ER, 2012, J CATARACT REFR SURG, V38, P1339, DOI 10.1016/j.jcrs.2012.03.025; Donnenfeld ED, 2015, CLIN OPHTHALMOL, V9, P2057, DOI 10.2147/OPTH.S91732; Ferguson T, 2018, J GLAUCOMA, V27, P71, DOI 10.1097/IJG.0000000000000825; Ferguson TJ, 2020, CLIN OPHTHALMOL, V14, P1859, DOI 10.2147/OPTH.S247910; Ferguson TJ, 2019, J CATARACT REFR SURG, V45, P414, DOI 10.1016/j.jcrs.2018.11.005; Ferguson TJ, 2016, CLIN OPHTHALMOL, V10, P1767, DOI 10.2147/OPTH.S114306; Flaxman SR, 2017, LANCET GLOB HEALTH, V5, pE1221, DOI 10.1016/S2214-109X(17)30393-5; Heijl A, 2002, ARCH OPHTHALMOL-CHIC, V120, P1268, DOI 10.1001/archopht.120.10.1268; Jampel HD, 2005, AM J OPHTHALMOL, V140, P16, DOI 10.1016/j.ajo.2005.02.013; Juzych MS, 2004, OPHTHALMOLOGY, V111, P1853, DOI 10.1016/j.ophtha.2004.04.030; Lavia C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183142; Neuhann TH, 2019, J CATARACT REFR SURG, V45, P312, DOI 10.1016/j.jcrs.2018.10.029; Poley BJ, 2008, J CATARACT REFR SURG, V34, P735, DOI 10.1016/j.jcrs.2007.12.045; Richter GM, 2016, CLIN OPHTHALMOL, V10, P189, DOI 10.2147/OPTH.S80490; Rulli E, 2013, JAMA OPHTHALMOL, V131, P1573, DOI 10.1001/jamaophthalmol.2013.5059; Saheb H, 2012, CURR OPIN OPHTHALMOL, V23, P96, DOI 10.1097/ICU.0b013e32834ff1e7; Samuelson TW, 2011, OPHTHALMOLOGY, V118, P459, DOI 10.1016/j.ophtha.2010.07.007; Shah M, 2019, EYE VISION, V6, DOI 10.1186/s40662-019-0154-1; Tsai JC, 2009, OPHTHALMOLOGY, V116, pS30, DOI 10.1016/j.ophtha.2009.06.024; Vold SD, 2016, OPHTHALMOL THER, V5, P161, DOI 10.1007/s40123-016-0065-3; Yousefi S, 2018, OPHTHALMOL GLAUCOMA, V1, P52, DOI 10.1016/j.ogla.2018.05.005	24	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2021	16	9							e0257015	10.1371/journal.pone.0257015	http://dx.doi.org/10.1371/journal.pone.0257015			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	WG5YY	34529692	Green Published, gold			2022-12-26	WOS:000707071500026
J	Rud, D; Marjoram, P; Siegmund, K; Shibata, D				Rud, Daniel; Marjoram, Paul; Siegmund, Kimberly; Shibata, Darryl			Functional human genes typically exhibit epigenetic conservation	PLOS ONE			English	Article							STEM-CELLS; METHYLATION; EXPRESSION; GENOME	Recent DepMap CRISPR-Cas9 single gene disruptions have identified genes more essential to proliferation in tissue culture. It would be valuable to translate these finding with measurements more practical for human tissues. Here we show that DepMap essential genes and other literature curated functional genes exhibit cell-specific preferential epigenetic conservation when DNA methylation measurements are compared between replicate cell lines and between intestinal crypts from the same individual. Culture experiments indicate that epigenetic drift accumulates through time with smaller differences in more functional genes. In NCI-60 cell lines, greater targeted gene conservation correlated with greater drug sensitivity. These studies indicate that two measurements separated in time allow normal or neoplastic cells to signal through conservation which human genes are more essential to their survival in vitro or in vivo.	[Rud, Daniel; Marjoram, Paul; Siegmund, Kimberly] Univ Southern Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA 90007 USA; [Shibata, Darryl] Univ Southern Calif, Keck Sch Med, Dept Pathol, Los Angeles, CA 90007 USA	University of Southern California; University of Southern California	Shibata, D (corresponding author), Univ Southern Calif, Keck Sch Med, Dept Pathol, Los Angeles, CA 90007 USA.	dshibata@usc.edu		Shibata, Darryl/0000-0002-4567-1639	NIH [U54 U54CA217376]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by NIH Grant U54 U54CA217376 (DS) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allis CD, 2016, NAT REV GENET, V17, P487, DOI 10.1038/nrg.2016.59; Bartha I, 2018, NAT REV GENET, V19, P51, DOI 10.1038/nrg.2017.75; Behan FM, 2019, NATURE, V568, P511, DOI 10.1038/s41586-019-1103-9; Bolt CC, 2020, DEVELOPMENT, V147, DOI 10.1242/dev.171736; Deschamps J, 2017, GENE DEV, V31, P1406, DOI 10.1101/gad.303123.117; Fabregat A, 2018, NUCLEIC ACIDS RES, V46, pD649, DOI [10.1093/nar/gkx1132, 10.1093/nar/gkz1031]; Fortin JP, 2017, BIOINFORMATICS, V33, P558, DOI 10.1093/bioinformatics/btw691; Fraser A, 2015, CELL SYST, V1, P381, DOI 10.1016/j.cels.2015.12.007; Gehart H, 2019, NAT REV GASTRO HEPAT, V16, P19, DOI 10.1038/s41575-018-0081-y; Ghen HB, 2020, BRIEF BIOINFORM, V21, P1397, DOI 10.1093/bib/bbz072; Haerty W, 2014, ANNU REV GENOM HUM G, V15, P71, DOI 10.1146/annurev-genom-090413-025621; Hvitfeldt E, 2020, JCO CLIN CANCER INFO, V4, P100, DOI 10.1200/CCI.19.00109; Iorio F, 2016, CELL, V166, P740, DOI 10.1016/j.cell.2016.06.017; Koras K, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-65927-9; Li HL, 2014, ONCOTARGET, V5, P587, DOI 10.18632/oncotarget.1782; Mallo M, 2013, DEVELOPMENT, V140, P3951, DOI 10.1242/dev.068346; Moran S, 2016, EPIGENOMICS-UK, V8, P389, DOI 10.2217/epi.15.114; NAKAMURA S, 1994, GASTROENTEROLOGY, V106, P100, DOI 10.1016/S0016-5085(94)94651-5; Ryser MD, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-35621-y; Yang WJ, 2013, NUCLEIC ACIDS RES, V41, pD955, DOI 10.1093/nar/gks1111; Yang XJ, 2014, CANCER CELL, V26, P577, DOI 10.1016/j.ccr.2014.07.028; Yatabe Y, 2001, P NATL ACAD SCI USA, V98, P10839, DOI 10.1073/pnas.191225998	22	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2021	16	9							e0253250	10.1371/journal.pone.0253250	http://dx.doi.org/10.1371/journal.pone.0253250			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	WG5RP	34520456	Green Published, Green Submitted, gold			2022-12-26	WOS:000707052100004
J	Takeuchi, K; Akizuki, K; Nakamura, M				Takeuchi, Kosuke; Akizuki, Kazunori; Nakamura, Masatoshi			Time course of changes in the range of motion and muscle-tendon unit stiffness of the hamstrings after two different intensities of static stretching	PLOS ONE			English	Article							LOWER-BODY STIFFNESS; INJURY INCIDENCE; FLEXIBILITY; DURATIONS; STRENGTH; NUMBER	Objectives The purpose of this study was to examine the time course of changes in the range of motion and muscle-tendon unit stiffness of the hamstrings after two different intensities of static stretching. Methods Fourteen healthy men (20.9 0.7 years, 169.1 7.5cm, 61.6 +/- 6.5kg) received static stretching for 60 seconds at two different intensities based on the point of discomfort (100%POD and 120%POD) of each participant, in random order. To evaluate the time course of changes in the flexibility of the hamstrings, the knee extension range of motion (ROM), passive torque at end ROM, and muscle-tendon unit stiffness were measured pre-stretching, post-stretching, and at both 10 and 20 minutes after static stretching. Results For both intensities, ROM and passive torque at pre-stretching were significantly smaller than those at post-stretching (p < 0.01 in both intensities), 10 minutes (p < 0.01 in both intensities), and 20 minutes (p < 0.01 in both intensities). The muscle-tendon unit stiffness at pre-stretching was significantly higher than that at post-stretching (p < 0.01), 10 minutes (p < 0.01), and 20 minutes (p < 0.01) only in the 120%POD, but it showed no change in the 100%POD. Conclusion The results showed that ROM and passive torque increased in both intensities, and the effects continued for at least 20 minutes after stretching regardless of stretching intensity. However, the muscle-tendon unit stiffness of the hamstrings decreased only after static stretching at the intensity of 120%POD, and the effects continued for at least 20 minutes after stretching.	[Takeuchi, Kosuke; Akizuki, Kazunori] Kobe Int Univ, Dept Phys Therapy, Kobe, Hyogo, Japan; [Nakamura, Masatoshi] Niigata Univ Hlth & Welf, Inst Human Movement & Med Sci, Niigata, Japan	Niigata University	Nakamura, M (corresponding author), Niigata Univ Hlth & Welf, Inst Human Movement & Med Sci, Niigata, Japan.	masatoshi-nakamura@nuhw.ac.jp		Akizuki, Kazunori/0000-0001-9576-9952	Japan Society for the Promotion of Science [19K20028, 19K19890]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was funded in the form of a grant by the Japan Society for the Promotion of Science, 19K20028, awarded to (K.T.) and by Japan Society for the Promotion of Science (JP), 19K19890 awarded to (M.N.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad CS, 2014, AM J SPORT MED, V42, P1464, DOI 10.1177/0363546514529083; Bandy WD, 1997, PHYS THER, V77, P1090, DOI 10.1093/ptj/77.10.1090; Behm DG, 2016, APPL PHYSIOL NUTR ME, V41, P1, DOI 10.1139/apnm-2015-0235; Boyce David, 2008, Physiotherapy Theory and Practice, V24, P113, DOI 10.1080/09593980701378298; Chaabene H, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.01468; DePino GM, 2000, J ATHL TRAINING, V35, P56; Fukaya T, 2020, FRONT PHYSIOL, V11, DOI 10.3389/fphys.2020.601912; Fukaya T, 2021, EUR J APPL PHYSIOL, V121, P513, DOI 10.1007/s00421-020-04539-7; Hatano G, 2019, J SPORT REHABIL, V28, P325, DOI 10.1123/jsr.2017-0203; Kataura S, 2017, J STRENGTH COND RES, V31, P3403, DOI 10.1519/JSC.0000000000001752; Kay AD, 2009, J APPL PHYSIOL, V106, P1249, DOI 10.1152/japplphysiol.91476.2008; Konrad A, 2019, EUR J SPORT SCI, V19, P1195, DOI 10.1080/17461391.2019.1580319; Konrad A, 2020, J SPORT SCI MED, V19, P52; Magnusson SP, 1996, J PHYSIOL-LONDON, V497, P291, DOI 10.1113/jphysiol.1996.sp021768; Magnusson SP, 1997, SCAND J MED SCI SPOR, V7, P195; Matsuo S, 2013, J STRENGTH COND RES, V27, P3367, DOI 10.1519/JSC.0b013e318290c26f; Mizuno T, 2013, INT J SPORTS MED, V34, P484, DOI 10.1055/s-0032-1327655; Mizuno T, 2013, SCAND J MED SCI SPOR, V23, P23, DOI 10.1111/j.1600-0838.2011.01329.x; Morse CI, 2011, EUR J APPL PHYSIOL, V111, P2149, DOI 10.1007/s00421-011-1845-z; Muanjai P, 2017, EUR J APPL PHYSIOL, V117, P1217, DOI 10.1007/s00421-017-3608-y; Nakamura M., 2019, J PHYS FITNESS SPORT, V8, P113, DOI [10.7600/jpfsm.8.113, DOI 10.7600/JPFSM.8.113]; Nakamura M, 2021, FRONT PHYSIOL, V11, DOI 10.3389/fphys.2020.628870; Nakamura M, 2013, MANUAL THER, V18, P211, DOI 10.1016/j.math.2012.09.010; Orchard JW, 2020, BRIT J SPORT MED, V54, P1103, DOI 10.1136/bjsports-2019-100755; Rodriguez ECP, 2017, SPORT BIOMECH, V16, P361, DOI 10.1080/14763141.2017.1319970; Ryan ED, 2008, J ORTHOP SPORT PHYS, V38, P632, DOI 10.2519/jospt.2008.2843; Ryan ED, 2009, J SPORT SCI, V27, P957, DOI 10.1080/02640410902998254; Schuermans J, 2016, AM J SPORT MED, V44, P1276, DOI 10.1177/0363546515626538; Simenz CJ, 2005, J STRENGTH COND RES, V19, P495, DOI 10.1519/15264.1; Soligard T, 2017, BRIT J SPORT MED, V51, P1265, DOI 10.1136/bjsports-2017-097956; Takeuchi K., 2019, INT J SPORT HLTH SCI, V17, P72, DOI [10.5432/ijshs.201829, DOI 10.5432/IJSHS.201829]; Takeuchi K, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-91645-x; Takeuchi K, 2020, FRONT PHYSIOL, V11, DOI 10.3389/fphys.2020.612967; Takeuchi K, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0240181; Takeuchi K, 2020, J SPORT SCI MED, V19, P429; Takeuchi K, 2021, J STRENGTH COND RES, V35, P141, DOI 10.1519/JSC.0000000000002642; Watsford ML, 2010, AM J SPORT MED, V38, P2058, DOI 10.1177/0363546510370197	37	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2021	16	9							e0257367	10.1371/journal.pone.0257367	http://dx.doi.org/10.1371/journal.pone.0257367			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	WG5RP	34520498	Green Published, gold			2022-12-26	WOS:000707052100024
J	Kafita, D; Nkhoma, P; Zulu, M; Sinkala, M				Kafita, Doris; Nkhoma, Panji; Zulu, Mildred; Sinkala, Musalula			Proteogenomic analysis of pancreatic cancer subtypes	PLOS ONE			English	Article							MOLECULAR SUBTYPES; TUMOR PROGRESSION; GENOME; PATHWAYS; EVOLUTION; RESISTANCE; MUTATIONS; PLAYS; BRAF	Pancreatic cancer remains a significant public health problem with an ever-rising incidence of disease. Cancers of the pancreas are characterised by various molecular aberrations, including changes in the proteomics and genomics landscape of the tumour cells. Therefore, there is a need to identify the proteomic landscape of pancreatic cancer and the specific genomic and molecular alterations associated with disease subtypes. Here, we carry out an integrative bioinformatics analysis of The Cancer Genome Atlas dataset, including proteomics and whole-exome sequencing data collected from pancreatic cancer patients. We apply unsupervised clustering on the proteomics dataset to reveal the two distinct subtypes of pancreatic cancer. Using functional and pathway analysis based on the proteomics data, we demonstrate the different molecular processes and signalling aberrations of the pancreatic cancer subtypes. In addition, we explore the clinical characteristics of these subtypes to show differences in disease outcome. Using datasets of mutations and copy number alterations, we show that various signalling pathways previously associated with pancreatic cancer are altered among both subtypes of pancreatic tumours, including the Wnt pathway, Notch pathway and PI3K-mTOR pathways. Altogether, we reveal the proteogenomic landscape of pancreatic cancer subtypes and the altered molecular processes that can be leveraged to devise more effective treatments.	[Kafita, Doris; Nkhoma, Panji; Sinkala, Musalula] Univ Zambia, Sch Hlth Sci, Dept Biomed Sci, Lusaka, Zambia; [Zulu, Mildred] Univ Zambia, Sch Med, Dept Pathol & Microbiol, Lusaka, Zambia	University of Zambia; University of Zambia	Sinkala, M (corresponding author), Univ Zambia, Sch Hlth Sci, Dept Biomed Sci, Lusaka, Zambia.	smsinks@icloud.com		Zulu, Mildred/0000-0002-3250-4196; Nkhoma, Panji/0000-0003-2031-7999				Abdi H, 2010, WIRES COMPUT STAT, V2, P433, DOI 10.1002/wics.101; ACM Special Interest Group for Algorithms and Computation Theory. D SIAM Activity Group on Discrete Mathematics. S Association for Computing Machinery. Society for Industrial and Applied Mathematics, 2007, P 18 ANN ACM SIAM S; Aguirre AJ, 2017, CANCER CELL, V32, P185, DOI 10.1016/j.ccell.2017.07.007; Ansari D, 2019, CELL BIOL TOXICOL, V35, P333, DOI 10.1007/s10565-019-09465-9; Bahceci I, 2017, BIOINFORMATICS, V33, P2238, DOI 10.1093/bioinformatics/btx149; Bailey P, 2016, NATURE, V531, P47, DOI 10.1038/nature16965; Balmanno K, 2009, CELL DEATH DIFFER, V16, P368, DOI 10.1038/cdd.2008.148; Belpomme D, 2007, INT J ONCOL, V30, P1037; Boikos SA, 2016, JAMA ONCOL, V2, P922, DOI 10.1001/jamaoncol.2016.0256; Bouvier AM, 2010, PANCREAS, V39, P1243, DOI 10.1097/MPA.0b013e3181e1d5b3; Calinski R.B., 1974, COMMUNICATIONS STAT, V3, P1, DOI [10.1080/03610927408827101, DOI 10.1080/03610927408827101]; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chang DK, 2014, CURR OPIN GENET DEV, V24, P74, DOI 10.1016/j.gde.2013.12.001; Chatterjee A, 2018, SEMIN CANCER BIOL, V51, P149, DOI 10.1016/j.semcancer.2017.08.004; Chen FJ, 2019, MOL CANCER RES, V17, P476, DOI 10.1158/1541-7786.MCR-18-0601; Collisson EA, 2011, NAT MED, V17, P500, DOI 10.1038/nm.2344; Coyle KM, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/9620870; Duesberg P, 1998, P NATL ACAD SCI USA, V95, P13692, DOI 10.1073/pnas.95.23.13692; Dzobo K, 2021, OMICS, V25, P313, DOI 10.1089/omi.2021.0025; Ellison EC, 2018, SURGERY, V163, P553, DOI 10.1016/j.surg.2017.09.035; Forbes SA, 2015, NUCLEIC ACIDS RES, V43, pD805, DOI 10.1093/nar/gku1075; Gelbart MA, 2014, UNCERTAINTY IN ARTIFICIAL INTELLIGENCE, P250; Goel Manish Kumar, 2010, Int J Ayurveda Res, V1, P274, DOI 10.4103/0974-7788.76794; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hao K, 2013, ONCOL REP, V29, P1124, DOI 10.3892/or.2012.2210; Heidorn SJ, 2010, CELL, V140, P209, DOI 10.1016/j.cell.2009.12.040; Ishimura N, 2003, CANCER LETT, V199, P169, DOI 10.1016/S0304-3835(03)00384-7; Jolliffe I., 2011, INT ENCY STAT SCI, P1094, DOI [DOI 10.1007/978-3-642-04898-2_455, 10.1007/978-3-642-04898-2_455, DOI 10.1007/978-3-642-04898-2]; Kafita D, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0248984; Kazanets A, 2016, BBA-REV CANCER, V1865, P275, DOI 10.1016/j.bbcan.2016.04.001; Khatri I, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-36328-w; Kim J, 2019, EUR UROL, V75, P961, DOI 10.1016/j.eururo.2019.02.017; Lachmann A, 2010, BIOINFORMATICS, V26, P2438, DOI 10.1093/bioinformatics/btq466; Lachmann A, 2009, BIOINFORMATICS, V25, P684, DOI 10.1093/bioinformatics/btp026; Larbouret C, 2012, NEOPLASIA, V14, P121, DOI 10.1593/neo.111602; Liu YN, 2017, J GENET GENOMICS, V44, P119, DOI 10.1016/j.jgg.2016.12.004; Lomberk G, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04383-6; Macgregor-Das AM, 2013, J SURG ONCOL, V107, P8, DOI 10.1002/jso.23213; Makohon-Moore A, 2016, NAT REV CANCER, V16, P553, DOI 10.1038/nrc.2016.66; McCleary-Wheeler AL, 2012, MOL CARCINOGEN, V51, P25, DOI 10.1002/mc.20827; McCubrey JA, 2014, ONCOTARGET, V5, P2881, DOI 10.18632/oncotarget.2037; Mertins P, 2016, NATURE, V534, P55, DOI 10.1038/nature18003; Mishra NK, 2017, ONCOTARGET, V8, P28990, DOI 10.18632/oncotarget.15993; Moffitt RA, 2015, NAT GENET, V47, P1168, DOI 10.1038/ng.3398; Noll EM, 2016, NAT MED, V22, P278, DOI 10.1038/nm.4038; Notta F, 2016, NATURE, V538, P378, DOI 10.1038/nature19823; Ogino S, 2012, EXPERT REV MOL DIAGN, V12, P621, DOI [10.1586/ERM.12.46, 10.1586/erm.12.46]; Pan S, 2020, CANCER LETT, V469, P429, DOI 10.1016/j.canlet.2019.11.020; Puleo F, 2018, GASTROENTEROLOGY, V155, P1999, DOI 10.1053/j.gastro.2018.08.033; Reddy KB, 2015, CANCER CELL INT, V15, DOI 10.1186/s12935-015-0185-1; Sharma S, 2010, CARCINOGENESIS, V31, P27, DOI 10.1093/carcin/bgp220; Shen H, 2013, CELL, V153, P38, DOI 10.1016/j.cell.2013.03.008; Sidaway Peter, 2017, Nat Rev Clin Oncol, V14, P648, DOI 10.1038/nrclinonc.2017.146; Singla S, 2012, ONCOL REP, V28, P2211, DOI 10.3892/or.2012.2053; Sinkala M., 2021, J BIOINFORMA SYST BI, V4, P33, DOI [10.26502/jbsb.5107020, DOI 10.26502/JBSB.5107020]; Sinkala M, 2021, COMMUN BIOL, V4, DOI 10.1038/s42003-020-01552-6; Sinkala M, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-58290-2; Sinkala M, 2019, COMMUN BIOL, V2, DOI 10.1038/s42003-019-0666-1; Sinkala Musalula, 2018, Oncotarget, V9, P29123, DOI 10.18632/oncotarget.25632; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Testa JR, 2001, P NATL ACAD SCI USA, V98, P10983, DOI 10.1073/pnas.211430998; TheUniProtConsortium, 2017, Nucleic Acids Res, V45, pD158, DOI 10.1093/nar/gkw1099; Trevor Hastie, 2009, ELEMENTS STAT LEARNI, VSecond, DOI [10.1007/978-0-387-84858-7, DOI 10.1007/978-0-387-84858-7]; Waddell N, 2015, NATURE, V518, P495, DOI 10.1038/nature14169; Weinstein JN, 2013, NAT GENET, V45, P1113, DOI 10.1038/ng.2764; Witkiewicz AK, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7744; Wong CK, 2013, NUCLEIC ACIDS RES, V41, pW218, DOI 10.1093/nar/gkt473; Wong MCS, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02997-2; Wu YQ, 2002, PATTERN RECOGN, V35, P2311, DOI 10.1016/S0031-3203(01)00132-7; Yabuuchi S, 2013, CANCER LETT, V335, P41, DOI 10.1016/j.canlet.2013.01.054; Yachida S, 2013, ONCOGENE, V32, P5253, DOI 10.1038/onc.2013.29; Yachida S, 2010, NATURE, V467, P1114, DOI 10.1038/nature09515; Zhang H, 2016, CELL, V166, P755, DOI 10.1016/j.cell.2016.05.069; Zhang S, 2020, J CELL PHYSIOL, V235, P1013, DOI 10.1002/jcp.29017; Zhang YE, 2009, CELL RES, V19, P128, DOI 10.1038/cr.2008.328; Zhao M, 2016, NUCLEIC ACIDS RES, V44, pD1023, DOI 10.1093/nar/gkv1268	77	0	0	3	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2021	16	9							e0257084	10.1371/journal.pone.0257084	http://dx.doi.org/10.1371/journal.pone.0257084			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XM9EM	34506537	Green Published, gold, Green Submitted			2022-12-26	WOS:000729120700054
J	Gupta, A; Sasse, SK; Gruca, MA; Sanford, L; Dowell, RD; Gerber, AN				Gupta, Arnav; Sasse, Sarah K.; Gruca, Margaret A.; Sanford, Lynn; Dowell, Robin D.; Gerber, Anthony N.			Deconvolution of multiplexed transcriptional responses to wood smoke particles defines rapid aryl hydrocarbon receptor signaling dynamics	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; GLUCOCORTICOID-RECEPTOR; AIR-POLLUTION; CELLS; ACTIVATION; MECHANISMS; REPRESSOR; EXPOSURE; GENOMICS; WILDFIRE	The heterogeneity of respirable particulates and compounds complicates our understanding of transcriptional responses to air pollution. Here, we address this by applying precision nuclear run-on sequencing and the assay for transposaseaccessible chromatin sequencing to measure nascent transcription and chromatin accessibility in airway epithelial cells after wood smoke particle (WSP) exposure. We used transcription factor enrichment analysis to identify temporally distinct roles for ternary response factor-serum response factor complexes, the aryl hydrocarbon receptor (AHR), and NF kappa B in regulating transcriptional changes induced by WSP. Transcription of canonical targets of the AHR, such as CYP1A1 and AHRR, was robustly increased after just 30 min of WSP exposure, and we discovered novel AHR-regulated pathways and targets including the DNA methyltransferase, DNMT3L. Transcription of these genes and associated enhancers rapidly returned to near baseline by 120 min after exposure. The kinetics of AHR-and NF kappa B-regulated responses to WSP were distinguishable based on the timing of both transcriptional responses and chromatin remodeling, with induction of several cytokines implicated in maintaining NF kappa B-mediated responses through 120 min of exposure. In aggregate, our data establish a direct and primary role for AHR in mediating airway epithelial responses to WSP and identify crosstalk between AHR and NF kappa B signaling in controlling proinflammatory gene expression. This work also defines an integrated genomics-based strategy for deconvoluting multiplexed transcriptional responses to heterogeneous environmental exposures.	[Gupta, Arnav; Sasse, Sarah K.; Gerber, Anthony N.] Natl Jewish Hlth, Dept Med, Denver, CO 80206 USA; [Gupta, Arnav; Gerber, Anthony N.] Univ Colorado, Dept Med, Aurora, CO 80045 USA; [Gruca, Margaret A.; Sanford, Lynn; Dowell, Robin D.] Univ Colorado, BioFrontiers Inst, Boulder, CO USA; [Dowell, Robin D.] Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA; [Dowell, Robin D.] Univ Colorado, Dept Comp Sci, Boulder, CO 80309 USA; [Gerber, Anthony N.] Natl Jewish Hlth, Dept Immunol & Genom Med, Denver, CO 80045 USA	National Jewish Health; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; National Jewish Health	Gerber, AN (corresponding author), Natl Jewish Hlth, Dept Med, Denver, CO 80206 USA.; Gerber, AN (corresponding author), Univ Colorado, Dept Med, Aurora, CO 80045 USA.; Gerber, AN (corresponding author), Natl Jewish Hlth, Dept Immunol & Genom Med, Denver, CO 80045 USA.	gerbera@njhealth.org		Gupta, Arnav/0000-0002-7439-8168; DOWELL, ROBIN/0000-0001-7665-9985; Gruca, Margaret/0000-0001-5808-5308	NIH [2T32HL007085, R01HL109557, R01GM125871]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported in part through NIH 2T32HL007085 (to A. G.) ; NIH R01HL109557 (to A. N. G.) ; and NIH R01GM125871 (to R. D. D.) . The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abatzoglou JT, 2016, P NATL ACAD SCI USA, V113, P11770, DOI 10.1073/pnas.1607171113; Adetona O, 2016, INHAL TOXICOL, V28, P95, DOI 10.3109/08958378.2016.1145771; Afonina IS, 2017, NAT IMMUNOL, V18, P861, DOI 10.1038/ni.3772; Altonsy MO, 2014, J BIOL CHEM, V289, P8231, DOI 10.1074/jbc.M113.545178; Arif AT, 2017, ATMOS ENVIRON, V163, P138, DOI 10.1016/j.atmosenv.2017.05.019; Azofeifa JG, 2018, GENOME RES, V28, P334, DOI 10.1101/gr.225755.117; Azofeifa JG, 2017, IEEE ACM T COMPUT BI, V14, P1070, DOI 10.1109/TCBB.2016.2520919; Azofeifa JG, 2017, BIOINFORMATICS, V33, P227, DOI 10.1093/bioinformatics/btw599; Bock KW, 2018, BIOCHEM PHARMACOL, V155, P419, DOI 10.1016/j.bcp.2018.07.032; Bowman DMJS, 2017, NAT ECOL EVOL, V1, DOI 10.1038/s41559-016-0058; Buenrostro Jason D, 2015, Curr Protoc Mol Biol, V109, DOI 10.1002/0471142727.mb2129s109; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Cohen AJ, 2017, LANCET, V389, P1907, DOI [10.1016/s0140-6736(17)30505-6, 10.1016/S0140-6736(17)30505-6]; Corces MR, 2017, NAT METHODS, V14, P959, DOI [10.1038/NMETH.4396, 10.1038/nmeth.4396]; Danielsen PH, 2011, CHEM RES TOXICOL, V24, P168, DOI 10.1021/tx100407m; Dilger M, 2016, ARCH TOXICOL, V90, P3029, DOI 10.1007/s00204-016-1659-1; Dukler N, 2017, GENOME RES, V27, P1816, DOI 10.1101/gr.222935.117; Esnault C, 2017, MOL CELL, V65, P1081, DOI 10.1016/j.molcel.2017.02.005; Eze Ikenna C, 2020, Environ Health Perspect, V128, P67003, DOI 10.1289/EHP6174; Feng JX, 2012, NAT PROTOC, V7, P1728, DOI 10.1038/nprot.2012.101; Gally F, 2021, JCI INSIGHT, V6, DOI 10.1172/jci.insight.144294; Ghio AJ, 2015, CHEM RES TOXICOL, V28, P2104, DOI 10.1021/acs.chemrestox.5b00270; Gomez A, 2018, BIOCHEM J, V475, P3827, DOI 10.1042/BCJ20180347; Grant CE, 2011, BIOINFORMATICS, V27, P1017, DOI 10.1093/bioinformatics/btr064; Grilli A, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-4679-9; Hime NJ, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15061206; Holloway JW, 2012, RESPIROLOGY, V17, P590, DOI 10.1111/j.1440-1843.2012.02164.x; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Kim DI, 2021, BIOMOLECULES, V11, DOI 10.3390/biom11010067; Kocbach A, 2008, TOXICOL APPL PHARM, V232, P317, DOI 10.1016/j.taap.2008.07.002; Lambert SA, 2018, CELL, V172, P650, DOI 10.1016/j.cell.2018.01.029; Larigot Lucie, 2018, Biochim Open, V7, P1, DOI 10.1016/j.biopen.2018.05.001; Laufer BI, 2021, EPIGENET CHROMATIN, V14, DOI 10.1186/s13072-021-00387-7; Luo YH, 2017, TOXICOL APPL PHARM, V324, P1, DOI 10.1016/j.taap.2017.03.019; MacPherson L, 2014, INT J MOL SCI, V15, P7939, DOI 10.3390/ijms15057939; Martin EM, 2018, ANNU REV PUBL HEALTH, V39, P309, DOI 10.1146/annurev-publhealth-040617-014629; O'Beirne SL, 2018, AM J RESP CRIT CARE, V198, P1413, DOI 10.1164/rccm.201712-2526OC; O'Driscoll CA, 2019, TOXICOLOGY, V414, P14, DOI 10.1016/j.tox.2019.01.002; Ovrevik J, 2015, BIOMOLECULES, V5, P1399, DOI 10.3390/biom5031399; Park EJ, 2009, TOXICOL LETT, V184, P126, DOI 10.1016/j.toxlet.2008.10.028; Provoost S, 2011, J IMMUNOL, V187, P3331, DOI 10.4049/jimmunol.1004062; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rao LZ, 2021, CELL DEATH DIFFER, V28, P1270, DOI 10.1038/s41418-020-00650-6; Reid CE, 2016, ENVIRON HEALTH PERSP, V124, P1334, DOI 10.1289/ehp.1409277; Rider CF, 2019, CLIN EPIGENETICS, V11, DOI 10.1186/s13148-019-0713-2; Rossner P, 2020, MUTAT RES-GEN TOX EN, V853, DOI 10.1016/j.mrgentox.2020.503173; Rothhammer V, 2019, NAT REV IMMUNOL, V19, P184, DOI 10.1038/s41577-019-0125-8; Rubin J.D, 2020, PREPRINT BIORXIV, DOI [10.1101/2020.01.25.919738, DOI 10.1101/2020.01.25.919738]; Sasse SK, 2019, GENOME RES, V29, P1753, DOI 10.1101/gr.248187.119; Sasse SK, 2013, MOL CELL BIOL, V33, P2104, DOI 10.1128/MCB.01474-12; Schwartz C, 2020, PART FIBRE TOXICOL, V17, DOI 10.1186/s12989-020-00375-x; Suhaimi N. F., 2020, REV ENV HLTH, V36, P77; Tal TL, 2010, TOXICOL APPL PHARM, V243, P46, DOI 10.1016/j.taap.2009.11.011; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Traboulsi H, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18020243; Tripodi IJ, 2018, MOLECULES, V23, DOI 10.3390/molecules23051136; Verstrepen L, 2014, ADV EXP MED BIOL, V809, P13; Vogel CFA, 2019, CHEMOSPHERE, V220, P993, DOI 10.1016/j.chemosphere.2018.12.178; Vu YH, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21249412; Weng CM, 2018, ALLERGY, V73, P2192, DOI 10.1111/all.13462; Williams AE, 2020, TOXICOL SCI, V175, P113, DOI 10.1093/toxsci/kfaa030; Wilson CL, 1998, TOXICOL PATHOL, V26, P657, DOI 10.1177/019262339802600510; Wojcik-Pszczola K, 2018, CYTOKINE, V102, P187, DOI 10.1016/j.cyto.2017.09.002; Wu CM, 2020, ARCH ENVIRON OCCUP H, V75, P65, DOI 10.1080/19338244.2018.1562413; Yang SY, 2018, ARCH TOXICOL, V92, P225, DOI 10.1007/s00204-017-2022-x; Yates PR, 1999, EMBO J, V18, P968, DOI 10.1093/emboj/18.4.968; Zoch A, 2020, NATURE, V584, P635, DOI 10.1038/s41586-020-2557-5	67	3	3	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT	2021	297	4							101147	10.1016/j.jbc.2021.101147	http://dx.doi.org/10.1016/j.jbc.2021.101147			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	WP3BJ	34520756	Green Published, gold			2022-12-26	WOS:000713011000013
J	Bohland, M; Tharun, L; Scherr, T; Mikut, R; Hagenmeyer, V; Thompson, LDR; Perner, S; Reischl, M				Boehland, Moritz; Tharun, Lars; Scherr, Tim; Mikut, Ralf; Hagenmeyer, Veit; Thompson, Lester D. R.; Perner, Sven; Reischl, Markus			Machine learning methods for automated classification of tumors with papillary thyroid carcinoma-like nuclei: A quantitative analysis	PLOS ONE			English	Article							FOLLICULAR LESIONS; SEGMENTATION; INTEROBSERVER; DIAGNOSIS; FEATURES	When approaching thyroid gland tumor classification, the differentiation between samples with and without "papillary thyroid carcinoma-like" nuclei is a daunting task with high inter-observer variability among pathologists. Thus, there is increasing interest in the use of machine learning approaches to provide pathologists real-time decision support. In this paper, we optimize and quantitatively compare two automated machine learning methods for thyroid gland tumor classification on two datasets to assist pathologists in decision-making regarding these methods and their parameters. The first method is a feature-based classification originating from common image processing and consists of cell nucleus segmentation, feature extraction, and subsequent thyroid gland tumor classification utilizing different classifiers. The second method is a deep learning-based classification which directly classifies the input images with a convolutional neural network without the need for cell nucleus segmentation. On the Tharun and Thompson dataset, the feature-based classification achieves an accuracy of 89.7% (Cohen's Kappa 0.79), compared to the deep learning-based classification of 89.1% (Cohen's Kappa 0.78). On the Nikiforov dataset, the feature-based classification achieves an accuracy of 83.5% (Cohen's Kappa 0.46) compared to the deep learning-based classification 77.4% (Cohen's Kappa 0.35). Thus, both automated thyroid tumor classification methods can reach the classification level of an expert pathologist. To our knowledge, this is the first study comparing feature-based and deep learning-based classification regarding their ability to classify samples with and without papillary thyroid carcinoma-like nuclei on two large-scale datasets.	[Boehland, Moritz; Scherr, Tim; Mikut, Ralf; Hagenmeyer, Veit; Reischl, Markus] Karlsruhe Inst Technol, Inst Automat & Appl Informat, Eggenstein Leopoldshafen, Germany; [Tharun, Lars; Perner, Sven] Univ Lubeck, Inst Pathol, Lubeck, Germany; [Tharun, Lars; Perner, Sven] Univ Hosp Schleswig Holstein, Campus Luebeck, Lubeck, Germany; [Thompson, Lester D. R.] Southern Calif Permanente Med Grp, Dept Pathol, Woodland Hills Med Ctr, Los Angeles, CA USA	Helmholtz Association; Karlsruhe Institute of Technology; University of Lubeck; University of Kiel; Schleswig Holstein University Hospital; Permanente Medical Groups	Bohland, M (corresponding author), Karlsruhe Inst Technol, Inst Automat & Appl Informat, Eggenstein Leopoldshafen, Germany.	moritz.boehland@kit.edu	Reischl, Markus/H-6970-2013; Mikut, Ralf/A-5949-2013	Reischl, Markus/0000-0002-7780-6374; Mikut, Ralf/0000-0001-9100-5496; Scherr, Tim/0000-0001-8755-2825; Bohland, Moritz/0000-0002-9321-8169; Hagenmeyer, Veit/0000-0002-3572-9083	Helmholtz Association in the program Natural, Artificial, and Cognitive Information Processing; KIT Publication Fund of the Karlsruhe Institute of Technology	Helmholtz Association in the program Natural, Artificial, and Cognitive Information Processing; KIT Publication Fund of the Karlsruhe Institute of Technology	We are grateful for funding by the Helmholtz Association in the program Natural, Artificial, and Cognitive Information Processing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. We acknowledge support by the KIT Publication Fund of the Karlsruhe Institute of Technology.	Buslaev A, 2020, INFORMATION, V11, DOI 10.3390/info11020125; Caicedo JC, 2019, NAT METHODS, V16, P1247, DOI 10.1038/s41592-019-0612-7; Cawley GC, 2010, J MACH LEARN RES, V11, P2079; Deng J, 2009, PROC CVPR IEEE, P248, DOI 10.1109/CVPRW.2009.5206848; Dolezal JM, 2021, MODERN PATHOL, V34, P862, DOI 10.1038/s41379-020-00724-3; Dov D, 2021, MED IMAGE ANAL, V67, DOI 10.1016/j.media.2020.101814; Elsheikh TM, 2008, AM J CLIN PATHOL, V130, P736, DOI 10.1309/AJCPKP2QUVN4RCCP; Hataya Ryuichiro, 2020, Computer Vision - ECCV 2020. 16th European Conference. Proceedings. Lecture Notes in Computer Science (LNCS 12370), P1, DOI 10.1007/978-3-030-58595-2_1; He KM, 2016, PROC CVPR IEEE, P770, DOI 10.1109/CVPR.2016.90; Hou L, 2020, SCI DATA, V7, DOI 10.1038/s41597-020-0528-1; Jothi AA, 2016, APPL SOFT COMPUT, V46, P652, DOI 10.1016/j.asoc.2016.02.030; Kingma D., 2014, P 3 INT C LEARNING R, DOI DOI 10.1038/S41598-021-83424-5; Kumar N, 2020, IEEE T MED IMAGING, V39, P1380, DOI 10.1109/TMI.2019.2947628; Kumar N, 2017, IEEE T MED IMAGING, V36, P1550, DOI 10.1109/TMI.2017.2677499; Lloyd RV, 2017, WHO CLASSIFICATION T, V4th; Lundberg SM, 2017, ADV NEUR IN, V30; McHugh ML, 2012, BIOCHEM MEDICA, V22, P276, DOI 10.11613/bm.2012.031; Nikiforov YE, 2016, JAMA ONCOL, V2, P1023, DOI 10.1001/jamaoncol.2016.0386; Ozolek JA, 2014, MED IMAGE ANAL, V18, P772, DOI 10.1016/j.media.2014.04.004; Pedregosa F., 2011, J MACH LEARN RES, V12, P2825; Raschka S., 2018, J OPEN SOURCE SOFTW, V3, P638, DOI [10.21105/joss.00638, DOI 10.21105/JOSS.00638]; Ribeiro MT, 2016, KDD'16: PROCEEDINGS OF THE 22ND ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P1135, DOI 10.1145/2939672.2939778; Ronneberger O., 2015, INT C MED IM COMP CO, P234; Scherr T, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0243219; Suzuki A, 2015, DIAGN CYTOPATHOL, V43, P108, DOI 10.1002/dc.23191; Thompson LDR, 2018, ENDOCR PATHOL, V29, P242, DOI 10.1007/s12022-018-9520-0; Wang W, 2010, CYTOM PART A, V77A, P485, DOI 10.1002/cyto.a.20853; Wang YJ, 2019, ANN TRANSL MED, V7, DOI 10.21037/atm.2019.08.54; Yang YC, 2020, PROC CVPR IEEE, P4084, DOI 10.1109/CVPR42600.2020.00414	29	3	3	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2021	16	9							e0257635	10.1371/journal.pone.0257635	http://dx.doi.org/10.1371/journal.pone.0257635			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YS4WS	34550999	gold, Green Published			2022-12-26	WOS:000750679800034
J	Kawaguchi, Y; Hanaoka, J; Ohshio, Y; Okamoto, K; Kaku, R; Hayashi, K; Shiratori, T; Akazawa, A				Kawaguchi, Yo; Hanaoka, Jun; Ohshio, Yasuhiko; Okamoto, Keigo; Kaku, Ryosuke; Hayashi, Kazuki; Shiratori, Takuya; Akazawa, Akira			Sarcopenia increases the risk of post-operative recurrence in patients with non-small cell lung cancer	PLOS ONE			English	Article							CLINICAL-IMPLICATIONS; SKELETAL-MUSCLE; PROGNOSIS; OBESITY; MASS	Background Sarcopenia is among the most prevalent and serious cancer-related symptom, and is strongly correlated with a poor prognosis. Moreover, it reportedly predicts poor prognosis after surgery in patients with lung cancer. However, it is unclear whether sarcopenia directly affects post-operative recurrence. The purpose of this study was to evaluate whether sarcopenia can be a risk indicator for post-operative recurrence, and whether it suppresses antitumor immunity, in a cohort of patients with resected non-small cell lung cancer. Methods This study retrospectively reviewed the data of 256 consecutive patients who underwent curative lobectomy and lymph node dissection for non-small cell lung cancer at our institution. The psoas muscle mass index was calculated as the total psoas muscle area at the third lumbar vertebral level/height(2) (cm(2)/m(2)). Sarcopenia was defined by a psoas muscle mass index of under 5.03 cm(2)/m(2) and 3.17 cm(2)/m(2) in male and female patients, respectively. Post-operative prognosis and cumulative incidence of recurrence rates were calculated. Results The 5-year overall survival and disease-free survival rates post-surgery were 59.5% and 38.6%, respectively, in patients with sarcopenia versus 81.1% and 72.1%, respectively, in patients without sarcopenia (p < 0.001). The 5-year cumulative incidence of recurrence rate in patients with sarcopenia was significantly higher than those without sarcopenia (49.9% versus 22.4%, respectively) in every pathological stage. Pathological stages II and III (hazard ratio, 3.36; p = 0.004), histological type (hazard ratio, 2.31; p = 0.025), and sarcopenia (hazard ratio, 2.52; p = 0.001) were independent risk factors for post-operative recurrence according to multivariate analysis. Conclusion Sarcopenia is a risk indicator for post-operative recurrence in patients with non-small cell lung cancer.	[Kawaguchi, Yo; Hanaoka, Jun; Ohshio, Yasuhiko; Okamoto, Keigo; Kaku, Ryosuke; Hayashi, Kazuki; Shiratori, Takuya; Akazawa, Akira] Shiga Univ Med Sci, Dept Surg, Div Gen Thorac Surg, Otsu, Shiga, Japan	Shiga University of Medical Science	Kawaguchi, Y (corresponding author), Shiga Univ Med Sci, Dept Surg, Div Gen Thorac Surg, Otsu, Shiga, Japan.	kawaguchi1228@yahoo.co.jp		Kawaguchi, Yo/0000-0002-7828-4635				Argiles JM, 2009, DRUG DISCOV TODAY, V14, P208, DOI 10.1016/j.drudis.2008.10.010; Bosma M, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11314; Chen XL, 2011, CANCER PREV RES, V4, P1409, DOI 10.1158/1940-6207.CAPR-10-0355; Chen YM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136252; Christensen JF, 2014, ANN ONCOL, V25, P947, DOI 10.1093/annonc/mdt551; Cruz-Jentoft AJ, 2010, AGE AGEING, V39, P412, DOI 10.1093/ageing/afq034; El Amrani M, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000012076; Hamaguchi Y, 2016, NUTRITION, V32, P1200, DOI 10.1016/j.nut.2016.04.003; Harimoto N, 2013, BRIT J SURG, V100, P1523, DOI 10.1002/bjs.9258; Icard P, 2020, CANCERS, V12, DOI 10.3390/cancers12020266; Kawaguchi Y, 2021, J THORAC DIS, V13, P1358, DOI 10.21037/jtd-20-3072; Kawaguchi Y, 2019, GEN THORAC CARDIOVAS, V67, P949, DOI 10.1007/s11748-019-01125-3; Kawamura T, 2018, ANN SURG ONCOL, V25, P1625, DOI 10.1245/s10434-018-6452-3; Kuroki LM, 2015, ANN SURG ONCOL, V22, P972, DOI 10.1245/s10434-014-4040-8; Lucia A, 2016, NEW ENGL J MED, V375, P892, DOI 10.1056/NEJMcibr1606456; Minna JD, 2002, CANCER CELL, V1, P49, DOI 10.1016/S1535-6108(02)00027-2; Nakamura R, 2018, J THORAC ONCOL, V13, P895, DOI 10.1016/j.jtho.2018.04.035; Noguchi G, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0226581; Ozeki N, 2020, INT J CLIN ONCOL, V25, P876, DOI 10.1007/s10147-020-01624-x; Pedersen BK, 2012, NAT REV ENDOCRINOL, V8, P457, DOI 10.1038/nrendo.2012.49; Prado CMM, 2008, LANCET ONCOL, V9, P629, DOI 10.1016/S1470-2045(08)70153-0; Shibutani M, 2017, BMC CANCER, V17, DOI 10.1186/s12885-017-3395-1; Shinohara S, 2020, ANN SURG ONCOL, V27, P2427, DOI 10.1245/s10434-020-08224-z; Shoji F, 2017, ANTICANCER RES, V37, P6997, DOI 10.21873/anticanres.12168; Suzuki Y, 2016, LUNG CANCER, V101, P92, DOI 10.1016/j.lungcan.2016.08.007; Tsukioka T, 2018, GEN THORAC CARDIOVAS, V66, P716, DOI 10.1007/s11748-018-0985-z; Tsukioka T, 2017, JPN J CLIN ONCOL, V47, P363, DOI 10.1093/jjco/hyx009; Vergara-Fernandez O, 2020, WORLD J CLIN CASES, V8, P1188, DOI 10.12998/wjcc.v8.i7.1188; Wang Y, 2019, ONCOL RES TREAT, V42, P523, DOI 10.1159/000501726	29	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2021	16	9							e0257594	10.1371/journal.pone.0257594	http://dx.doi.org/10.1371/journal.pone.0257594			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YS4WS	34551011	gold, Green Published			2022-12-26	WOS:000750679800029
J	Tugin, S; Souza, VH; Nazarova, MA; Novikov, PA; Tervo, AE; Nieminen, JO; Lioumis, P; Ziemann, U; Nikulin, VV; Ilmoniemi, RJ				Tugin, Sergei; Souza, Victor H.; Nazarova, Maria A.; Novikov, Pavel A.; Tervo, Aino E.; Nieminen, Jaakko O.; Lioumis, Pantelis; Ziemann, Ulf; Nikulin, Vadim V.; Ilmoniemi, Risto J.			Effect of stimulus orientation and intensity on short-interval intracortical inhibition (SICI) and facilitation (SICF): A multi-channel transcranial magnetic stimulation study	PLOS ONE			English	Article							PRIMARY MOTOR CORTEX; COIL ORIENTATION; TMS; MECHANISMS; HAND; EXCITABILITY; AXONS	Besides stimulus intensities and interstimulus intervals (ISI), the electric field (E-field) orientation is known to affect both short-interval intracortical inhibition (SICI) and facilitation (SICF) in paired-pulse transcranial magnetic stimulation (TMS). However, it has yet to be established how distinct orientations of the conditioning (CS) and test stimuli (TS) affect the SICI and SICF generation. With the use of a multi-channel TMS transducer that provides electronic control of the stimulus orientation and intensity, we aimed to investigate how changes in the CS and TS orientation affect the strength of SICI and SICF. We hypothesized that the CS orientation would play a major role for SICF than for SICI, whereas the CS intensity would be more critical for SICI than for SICF. In eight healthy subjects, we tested two ISIs (1.5 and 2.7 ms), two CS and TS orientations (anteromedial (AM) and posteromedial (PM)), and four CS intensities (50, 70, 90, and 110% of the resting motor threshold (RMT)). The TS intensity was fixed at 110% RMT. The intensities were adjusted to the corresponding RMT in the AM and PM orientations. SICI and SICF were observed in all tested CS and TS orientations. SICI depended on the CS intensity in a U-shaped manner in any combination of the CS and TS orientations. With 70% and 90% RMT CS intensities, stronger PM-oriented CS induced stronger inhibition than weaker AM-oriented CS. Similar SICF was observed for any CS orientation. Neither SICI nor SICF depended on the TS orientation. We demonstrated that SICI and SICF could be elicited by the CS perpendicular to the TS, which indicates that these stimuli affected either overlapping or strongly connected neuronal populations. We concluded that SICI is primarily sensitive to the CS intensity and that CS intensity adjustment resulted in similar SICF for different CS orientations.	[Tugin, Sergei; Souza, Victor H.; Tervo, Aino E.; Nieminen, Jaakko O.; Lioumis, Pantelis; Ilmoniemi, Risto J.] Aalto Univ, Dept Neurosci & Biomed Engn, Sch Sci, Espoo, Finland; [Tugin, Sergei; Souza, Victor H.; Tervo, Aino E.; Nieminen, Jaakko O.; Lioumis, Pantelis; Ilmoniemi, Risto J.] Univ Helsinki, BioMag Lab, Helsinki, Finland; [Tugin, Sergei; Souza, Victor H.; Tervo, Aino E.; Nieminen, Jaakko O.; Lioumis, Pantelis; Ilmoniemi, Risto J.] Helsinki Univ Hosp, HUS Med Imaging Ctr, Helsinki, Finland; [Souza, Victor H.] Univ Fed Juiz de Fora, Sch Physiotherapy, Juiz De Fora, MG, Brazil; [Nazarova, Maria A.; Novikov, Pavel A.; Nikulin, Vadim V.] Natl Res Univ Higher Sch Econ, Ctr Cognit & Decis Making, Inst Cognit Neurosci, Moscow, Russia; [Nazarova, Maria A.] Fed Med Biol Agcy, Fed State Budgetary Inst, Fed Ctr Brain Res & Neurotechnol, Moscow, Russia; [Ziemann, Ulf] Eberhard Karls Univ Tubingen, Dept Neurol & Stroke, Tubingen, Germany; [Ziemann, Ulf] Eberhard Karls Univ Tubingen, Hertie Inst Clin Brain Res, Tubingen, Germany; [Nikulin, Vadim V.] Max Planck Inst Human Cognit & Brain Sci, Dept Neurol, Leipzig, Germany	Aalto University; University of Helsinki; Hyvinkaan Sairaala; University of Helsinki; Helsinki University Central Hospital; Universidade Federal de Juiz de Fora; HSE University (National Research University Higher School of Economics); Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Max Planck Society	Tugin, S (corresponding author), Aalto Univ, Dept Neurosci & Biomed Engn, Sch Sci, Espoo, Finland.; Tugin, S (corresponding author), Univ Helsinki, BioMag Lab, Helsinki, Finland.	sergei.tugin@aalto.fi	Ilmoniemi, Risto/E-9704-2012; Nieminen, Jaakko O./E-7311-2012; Souza, Victor Hugo/D-1611-2012; Tugin, Sergei/GQY-8574-2022; Nazarova, Maria/D-8810-2012	Ilmoniemi, Risto/0000-0002-3340-2618; Nieminen, Jaakko O./0000-0002-7826-3519; Souza, Victor Hugo/0000-0002-0254-4322; Tugin, Sergei/0000-0002-1274-8863; Nazarova, Maria/0000-0001-5347-5948; Nieminen, Aino/0000-0002-6841-7043; Ziemann, Ulf/0000-0001-8372-3615; Novikov, Pavel/0000-0003-4102-1580	European Research Council (ERC) under the European Union [810377]; Jane and Aatos Erkko Foundation; Academy of Finland [294625, 306845, 327326]; Finnish Cultural Foundation; Aalto AScI Visiting Researcher Programme; RFBR [20-315-70048]	European Research Council (ERC) under the European Union(European Research Council (ERC)); Jane and Aatos Erkko Foundation; Academy of Finland(Academy of Finland); Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); Aalto AScI Visiting Researcher Programme; RFBR(Russian Foundation for Basic Research (RFBR))	This project has received funding from the European Research Council (ERC) under the European Union's Horizon 2020 research and innovation programme (grant agreement No 810377), the Jane and Aatos Erkko Foundation, the Academy of Finland (Decisions No. 294625, 306845, and 327326) and the Finnish Cultural Foundation. Pavel A. Novikov was funded by Aalto AScI Visiting Researcher Programme and by RFBR, project number 20-315-70048. Maria A. Nazarova was funded by RFBR, project number 20-315-70048.	Alle H, 2009, J PHYSIOL-LONDON, V587, P5163, DOI 10.1113/jphysiol.2009.179820; Awiszus F, 2003, SUPPL CLIN NEUROPHYS, V56, P13; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Cash RFH, 2009, EXP BRAIN RES, V193, P1, DOI 10.1007/s00221-008-1590-7; Chan JHL, 2002, J PHYSIOL-LONDON, V542, P951, DOI 10.1113/jphysiol.2002.018937; Chen M, 2018, NEUROMODULATION, V21, P368, DOI 10.1111/ner.12773; Chen R, 2004, EXP BRAIN RES, V154, P1, DOI 10.1007/s00221-003-1684-1; Cirillo J, 2018, BRAIN STIMUL, V11, P1296, DOI 10.1016/j.brs.2018.07.047; Cirillo J, 2016, EUR J NEUROSCI, V44, P2614, DOI 10.1111/ejn.13369; D'Ostilio K, 2016, CLIN NEUROPHYSIOL, V127, P675, DOI 10.1016/j.clinph.2015.05.017; Davila-Perez P, 2018, NEUROSCIENCE, V393, P97, DOI 10.1016/j.neuroscience.2018.09.044; Delvendahl I, 2014, BRAIN STIMUL, V7, P49, DOI 10.1016/j.brs.2013.08.002; Esser SK, 2005, J NEUROPHYSIOL, V94, P622, DOI 10.1152/jn.01230.2004; Fisher RJ, 2002, EXP BRAIN RES, V143, P240, DOI 10.1007/s00221-001-0988-2; Furuya S, 2018, J PHYSIOL-LONDON, V596, P2397, DOI 10.1113/JP275813; Hanajima R, 2008, CLIN NEUROPHYSIOL, V119, P1400, DOI 10.1016/j.clinph.2008.02.009; Hanajima R, 2002, J PHYSIOL-LONDON, V538, P253, DOI 10.1113/jphysiol.2001.013094; Hanajima R, 1998, J PHYSIOL-LONDON, V509, P607, DOI 10.1111/j.1469-7793.1998.607bn.x; Hanajima R, 2003, EXP BRAIN RES, V151, P427, DOI 10.1007/s00221-003-1455-z; Hashemirad F, 2017, BASIC CLIN NEUROSCI, V8, P43, DOI 10.15412/J.BCN.03080106; Ilic TV, 2002, J PHYSIOL-LONDON, V545, P153, DOI 10.1113/jphysiol.2002.030122; Janssen AM, 2015, J NEUROENG REHABIL, V12, DOI 10.1186/s12984-015-0036-2; Kallioniemi E, 2018, BRAIN STIMUL, V11, P322, DOI 10.1016/j.brs.2017.10.014; Koponen LM, 2018, HUM BRAIN MAPP, V39, P2405, DOI 10.1002/hbm.24010; Koponen LM, 2018, BRAIN STIMUL, V11, P849, DOI 10.1016/j.brs.2018.03.014; KUJIRAI T, 1993, J PHYSIOL-LONDON, V471, P501, DOI 10.1113/jphysiol.1993.sp019912; Laakso I, 2014, PHYS MED BIOL, V59, P203, DOI 10.1088/0031-9155/59/1/203; Ljubisavljevic M, 2006, EXP BRAIN RES, V173, P215, DOI 10.1007/s00221-006-0538-z; Miranda PC, 2003, IEEE T BIO-MED ENG, V50, P1074, DOI 10.1109/TBME.2003.816079; Nieminen JO, 2019, NEUROIMAGE, V203, DOI 10.1016/j.neuroimage.2019.116194; Nieminen JO, 2015, BRAIN STIMUL, V8, P582, DOI 10.1016/j.brs.2015.01.004; Orth M, 2003, CLIN NEUROPHYSIOL, V114, P2362, DOI 10.1016/S1388-2457(03)00243-8; Peterchev AV, 2014, J NEURAL ENG, V11, DOI 10.1088/1741-2560/11/5/056023; Peurala SH, 2008, CLIN NEUROPHYSIOL, V119, P2291, DOI 10.1016/j.clinph.2008.05.031; Porter LL, 2000, SOMATOSENS MOT RES, V17, P67; Rosenkranz K, 2008, NEUROLOGY, V70, P304, DOI 10.1212/01.wnl.0000296829.66406.14; Rossi S, 2021, CLIN NEUROPHYSIOL, V132, P269, DOI 10.1016/j.clinph.2020.10.003; Rossini PM, 2015, CLIN NEUROPHYSIOL, V126, P1071, DOI 10.1016/j.clinph.2015.02.001; Roth Y, 2020, BRAIN STIMUL, V13, P900, DOI 10.1016/j.brs.2020.03.010; Sale MV, 2016, CLIN NEUROPHYSIOL, V127, P635, DOI 10.1016/j.clinph.2015.04.062; Shirota Y, 2016, BRAIN STIMUL, V9, P755, DOI 10.1016/j.brs.2016.04.019; Sommer M, 2018, BRAIN STIMUL, V11, P558, DOI 10.1016/j.brs.2018.01.001; Souza VH, FINE MULTICOIL ELECT, V2021, DOI [10.1101/2021.08.20.457096, DOI 10.1101/2021.08.20.457096]; Souza VH, PROBING ORIENTATION, V2021, DOI [10.1101/2021.08.20.457101, DOI 10.1101/2021.08.20.457101]; ter Braack EM, 2019, BRAIN TOPOGR, V32, P17, DOI 10.1007/s10548-018-0662-7; Tervo AE, 2020, NEUROIMAGE, V220, DOI 10.1016/j.neuroimage.2020.117082; Thielscher A, 2011, NEUROIMAGE, V54, P234, DOI 10.1016/j.neuroimage.2010.07.061; Van den Bos MAJ, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00240; Vucic S, 2011, CEREB CORTEX, V21, P1639, DOI 10.1093/cercor/bhq235; Wagle-Shukla A, 2009, J PHYSIOL-LONDON, V587, P5665, DOI 10.1113/jphysiol.2009.181446; Ziemann U, 1996, J PHYSIOL-LONDON, V496, P873, DOI 10.1113/jphysiol.1996.sp021734; Ziemann U, 2020, EXP BRAIN RES, V238, P1601, DOI 10.1007/s00221-020-05764-4; Ziemann U, 2015, CLIN NEUROPHYSIOL, V126, P1847, DOI 10.1016/j.clinph.2014.08.028	53	2	2	3	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2021	16	9							e0257554	10.1371/journal.pone.0257554	http://dx.doi.org/10.1371/journal.pone.0257554			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YS4WS	34550997	Green Published, gold			2022-12-26	WOS:000750679800023
J	Nazario-Yepiz, NO; Sobaberas, JF; Lyman, R; Campbell, MR; Shankar, V; Anholt, RRH; Mackay, TFC				Nazario-Yepiz, Nestor O.; Sobaberas, Jaime Fernandez; Lyman, Roberta; Campbell, Marion R.; Shankar, Vijay; Anholt, Robert R. H.; Mackay, Trudy F. C.			Physiological and metabolomic consequences of reduced expression of the Drosophila brummer triglyceride Lipase	PLOS ONE			English	Article							FAT STORAGE; OBESITY; SLEEP; MELANOGASTER; PHENOTYPES; RESISTANCE; PROFILES; LIBRARY	Disruption of lipolysis has widespread effects on intermediary metabolism and organismal phenotypes. Defects in lipolysis can be modeled in Drosophila melanogaster through genetic manipulations of brummer (bmm), which encodes a triglyceride lipase orthologous to mammalian Adipose Triglyceride Lipase. RNAi-mediated knock-down of bmm in all tissues or metabolic specific tissues results in reduced locomotor activity, altered sleep patterns and reduced lifespan. Metabolomic analysis on flies in which bmm is downregulated reveals a marked reduction in medium chain fatty acids, long chain saturated fatty acids and long chain monounsaturated and polyunsaturated fatty acids, and an increase in diacylglycerol levels. Elevated carbohydrate metabolites and tricarboxylic acid intermediates indicate that impairment of fatty acid mobilization as an energy source may result in upregulation of compensatory carbohydrate catabolism. bmm downregulation also results in elevated levels of serotonin and dopamine neurotransmitters, possibly accounting for the impairment of locomotor activity and sleep patterns. Physiological phenotypes and metabolomic changes upon reduction of bmm expression show extensive sexual dimorphism. Altered metabolic states in the Drosophila model are relevant for understanding human metabolic disorders, since pathways of intermediary metabolism are conserved across phyla.	[Nazario-Yepiz, Nestor O.; Sobaberas, Jaime Fernandez; Lyman, Roberta; Campbell, Marion R.; Shankar, Vijay; Anholt, Robert R. H.; Mackay, Trudy F. C.] Clemson Univ, Dept Biochem & Genet, Greenwood, SC 29634 USA; [Nazario-Yepiz, Nestor O.; Sobaberas, Jaime Fernandez; Lyman, Roberta; Campbell, Marion R.; Shankar, Vijay; Anholt, Robert R. H.; Mackay, Trudy F. C.] Clemson Univ, Ctr Human Genet, Greenwood, SC 29634 USA; [Sobaberas, Jaime Fernandez] Heidelberg Univ, Ctr Organismal Studies, Heidelberg, Germany	Clemson University; Clemson University; Ruprecht Karls University Heidelberg	Mackay, TFC (corresponding author), Clemson Univ, Dept Biochem & Genet, Greenwood, SC 29634 USA.; Mackay, TFC (corresponding author), Clemson Univ, Ctr Human Genet, Greenwood, SC 29634 USA.	tmackay@clemson.edu		Mackay, Trudy/0000-0002-2312-7245; Nazario-Yepiz, Nestor Octavio/0000-0002-3511-0109	National Institutes of Health [R01 GM128974]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was funded by the National Institutes of Health grant R01 GM128974 (https://www.nigms.nih.gov/) to T. F. C. M. and R. R. R.H. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afshin A, 2017, NEW ENGL J MED, V377, P13, DOI 10.1056/NEJMoa1614362; Bharucha KN, 2008, J EXP BIOL, V211, P3103, DOI 10.1242/jeb.016451; Bi JF, 2012, J CELL SCI, V125, P3568, DOI 10.1242/jcs.101329; Blumrich A, 2021, ISCIENCE, V24, DOI 10.1016/j.isci.2021.102288; Bostock M, 2011, IEEE T VIS COMPUT GR, V17, P2301, DOI 10.1109/TVCG.2011.185; Carvalho M, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.29; Cazarez-Garcia D, 2017, INTEGR BIOL-UK, V9, P885, DOI 10.1039/c7ib00155j; Cichewicz K, 2018, COMMUN BIOL, V1, DOI 10.1038/s42003-018-0031-9; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Fischer J, 2007, NAT GENET, V39, P28, DOI 10.1038/ng1951; Franz M, 2016, BIOINFORMATICS, V32, P309, DOI 10.1093/bioinformatics/btv557; Gronke S, 2007, PLOS BIOL, V5, P1248, DOI 10.1371/journal.pbio.0050137; Gronke S, 2005, CELL METAB, V1, P323, DOI 10.1016/j.cmet.2005.04.003; Gutierrez E, 2007, NATURE, V445, P275, DOI 10.1038/nature05382; Harbison ST, 2004, GENETICS, V166, P1807, DOI 10.1534/genetics.166.4.1807; Harbison ST, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-281; Heier C, 2018, GENETICS, V210, P1163, DOI 10.1534/genetics.118.301583; Jaime Maria D L A, 2017, J Genomics, V5, P128, DOI 10.7150/jgen.22393; Liu ZH, 2013, ACTA BIOCH BIOPH SIN, V45, P44, DOI 10.1093/abbs/gms105; Locke AE, 2015, NATURE, V518, P197, DOI 10.1038/nature14177; Luo JN, 2012, CELL MOL LIFE SCI, V69, P471, DOI 10.1007/s00018-011-0789-0; Majeed ZR, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/7291438; Mangge H, 2014, OBESITY, V22, P195, DOI 10.1002/oby.20491; Mattila J, 2017, GENETICS, V207, P1231, DOI 10.1534/genetics.117.199885; Mattson MP, 2019, TRENDS COGN SCI, V23, P200, DOI 10.1016/j.tics.2019.01.003; Molaei M, 2019, DEV CELL, V49, P802, DOI 10.1016/j.devcel.2019.04.009; Monda V, 2017, DIABETES METAB SYNDR, V10, DOI 10.2147/DMSO.S148392; Musselman LP, 2018, J EXP BIOL, V221, DOI 10.1242/jeb.163881; Musselman LP, 2011, DIS MODEL MECH, V4, P842, DOI 10.1242/dmm.007948; Nam SB, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22814-8; Nazario-Yepiz NO, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183007; Noordam R, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12958-0; Ogilvie RP, 2017, SLEEP HEALTH, V3, P383, DOI 10.1016/j.sleh.2017.07.013; Oxenkrug G, 2011, FLY, V5, P307, DOI 10.4161/fly.5.4.18414; Palm W, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002828; Patel RT, 2005, J BIOL CHEM, V280, P22624, DOI 10.1074/jbc.M413128200; Pendleton RG, 2002, BEHAV GENET, V32, P89, DOI 10.1023/A:1015279221600; Rajan A, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-38; Reed LK, 2014, GENETICS, V197, P781, DOI 10.1534/genetics.114.163857; Rehman N, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0247175; Saklayen MG, 2018, CURR HYPERTENS REP, V20, DOI 10.1007/s11906-018-0812-z; Sayej WN, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/7867852; Shaw PJ, 2000, SCIENCE, V287, P1834, DOI 10.1126/science.287.5459.1834; Thompson SN, 2003, ADV INSECT PHYSIOL, V31, P205, DOI 10.1016/S0065-2806(03)31004-5; Ugur B, 2016, DIS MODEL MECH, V9, P235, DOI 10.1242/dmm.023762; Vozoris NT, 2016, SLEEP, V39, P551, DOI 10.5665/sleep.5524; Wang GJ, 2001, LANCET, V357, P354, DOI 10.1016/S0140-6736(00)03643-6; Wat LW, 2020, PLOS BIOL, V18, DOI 10.1371/journal.pbio.3000595; Williams S, 2015, G3-GENES GENOM GENET, V5, P2817, DOI 10.1534/g3.115.023564; Yuan Q, 2006, CURR BIOL, V16, P1051, DOI 10.1016/j.cub.2006.04.032; Zhou SS, 2020, GENOME RES, V30, P392, DOI 10.1101/gr.243030.118	51	2	2	4	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2021	16	9							e0255198	10.1371/journal.pone.0255198	http://dx.doi.org/10.1371/journal.pone.0255198			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YM4DR	34547020	Green Published, Green Submitted, gold			2022-12-26	WOS:000746527400004
J	Kitazawa, A; Maeda, S; Fukuda, Y				Kitazawa, Atsushi; Maeda, Shotaro; Fukuda, Yoshiharu			Fatty liver index as a predictive marker for the development of diabetes: A retrospective cohort study using Japanese health check-up data	PLOS ONE			English	Article							DISEASE; RISK; EPIDEMIOLOGY; ASSOCIATION; PREVALENCE; DIAGNOSIS; MELLITUS; NONOBESE	Background & aims Fatty liver is associated with incident diabetes, and the fatty liver index (FLI) is a surrogate marker for non-alcoholic fatty liver disease (NAFLD). We aimed to determine whether or not FLI was associated with incident diabetes in relation to obesity and prediabetic levels in the general Japanese population. Methods This was a retrospective study using the Japanese health check-up database of one health insurance from FY2015 to FY2018. This study included 28,991 individuals with prediabetes. First, we stratified all participants into two groups: "high-risk," comprising patients with HbA1c >6.0%, and "standard," comprising the rest. Subsequently, we divided them into four groups according to FLI (<30 or not) and obesity (BMI <25 kg/m(2) or not). Subsequently, the incidence rate of diabetes was compared among the groups after 3 years of follow-up using multiple logistic regression models after adjusting for potential confounders. Results After 3 years of follow-up, 1,547 new cases of diabetes were found, and the cumulative incidence was 2.96% for the standard group and 26.1% for the high-risk group. In non-obese individuals, odds ratios (95% confidence interval) for FLI >= 30 versus FLI <30 were: 1.44 (1.09-1.92) for the standard group and 1.42 (0.99-2.03) for the high-risk group. In the high-risk group, obesity (BMI <greater than or equal to>25 kg/m(2)) but FLI <30 was not a risk factor for developing diabetes. Conclusion Although high FLI is generally considered to be a risk factor for developing diabetes, obesity might have been a confounding factor. However, the present study showed that high FLI is a risk factor for the development of diabetes, even in non-obese individuals. Our results include suggestion to develop a screening tool to effectively identify people at high risk of developing diabetes from the population (especially non-obese prediabetes) who are apparently at low health risk and are unlikely to be targeted for health guidance.	[Kitazawa, Atsushi; Maeda, Shotaro; Fukuda, Yoshiharu] Teikyo Univ, Grad Sch Publ Hlth, Tokyo, Japan; [Kitazawa, Atsushi] Dokkyo Med Univ, Dept Nephrol, Saitama Med Ctr, Saitama, Japan	Teikyo University; Dokkyo Medical University	Kitazawa, A (corresponding author), Teikyo Univ, Grad Sch Publ Hlth, Tokyo, Japan.; Kitazawa, A (corresponding author), Dokkyo Med Univ, Dept Nephrol, Saitama Med Ctr, Saitama, Japan.	sph-akitazawa@med.teikyo-u.ac.jp		Maeda, Shotaro/0000-0002-0750-2172; Kitazawa, Atsushi/0000-0001-9513-6426				Agresti A., 2013, CATEGORICAL DATA ANA, V3rd ed.; Amer Diabet Assoc, 2021, DIABETES CARE, V44, pS15, DOI 10.2337/dc21-S002; Balkau B, 2010, BMC GASTROENTEROL, V10, DOI 10.1186/1471-230X-10-56; Bedogni G, 2006, BMC GASTROENTEROL, V6, DOI 10.1186/1471-230X-6-33; Bennet L, 2015, DIABETES RES CLIN PR, V110, P66, DOI 10.1016/j.diabres.2015.07.011; Chalasani N, 2018, HEPATOLOGY, V67, P328, DOI 10.1002/hep.29367; Eguchi Y, 2012, J GASTROENTEROL, V47, P586, DOI 10.1007/s00535-012-0533-z; Franch-Nadal J, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198327; Fukuda T, 2016, LIVER INT, V36, P275, DOI 10.1111/liv.12912; Hamaguchi M, 2005, ANN INTERN MED, V143, P722, DOI 10.7326/0003-4819-143-10-200511150-00009; Heianza Y, 2011, LANCET, V378, P147, DOI 10.1016/S0140-6736(11)60472-8; Hirata A, 2018, HEPATOL RES, V48, P708, DOI 10.1111/hepr.13065; Huang XL, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001682; Jager S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124749; Japan society for the study of obesity, 2016, GUIDELINES MANAGEMEN, V1st; Jung CH, 2013, DIABETIC MED, V30, P428, DOI 10.1111/dme.12104; Jung CH, 2016, OBESITY, V24, P1373, DOI 10.1002/oby.21483; Kadowaki S, 2019, J ENDOCR SOC, V3, P1409, DOI 10.1210/js.2019-00052; Kim D, 2017, CLIN GASTROENTEROL H, V15, P474, DOI 10.1016/j.cgh.2016.08.028; Kim SS, 2018, DIGEST LIVER DIS, V50, P370, DOI 10.1016/j.dld.2017.12.018; Mantovani A, 2018, DIABETES CARE, V41, P372, DOI 10.2337/dc17-1902; Matsuzawa Yuji., 2005, J JPN SOC INT MED, V94, P188, DOI [10.5551/jat.12.301, DOI 10.5551/JAT.12.301]; Movahedian M, 2020, PRIM CARE DIABETES, V14, P577, DOI 10.1016/j.pcd.2020.02.011; Nazare JA, 2012, AM J CLIN NUTR, V96, P714, DOI 10.3945/ajcn.112.035758; Nishi T, 2015, J DIABETES INVEST, V6, P309, DOI 10.1111/jdi.12290; Olubamwo OO, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-026949; Omagari K, 2002, J GASTROEN HEPATOL, V17, P1098, DOI 10.1046/j.1440-1746.2002.02846.x; Sinn DH, 2019, EUR J ENDOCRINOL, V181, P185, DOI 10.1530/EJE-19-0143; Sung KC, 2019, NUTR METAB CARDIOVAS, V29, P489, DOI 10.1016/j.numecd.2019.01.016; von Elm E, 2008, J CLIN EPIDEMIOL, V61, P344, DOI 10.2471/BLT.07.045120; Wargny M, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0221524; Wei L., 2020, DIABETES METAB, V16; World Health Organization IOTF, 2000, AS PAC PERSP RED OB; Yadav D, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000004447; Yang BL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120443; Ye Q, 2020, LANCET GASTROENTEROL, V5, P739, DOI 10.1016/S2468-1253(20)30077-7; Young S, 2020, HEPATOL COMMUN, V4, P953, DOI 10.1002/hep4.1519; Younossi ZM, 2016, HEPATOLOGY, V64, P73, DOI 10.1002/hep.28431	38	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2021	16	9							e0257352	10.1371/journal.pone.0257352	http://dx.doi.org/10.1371/journal.pone.0257352			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	WG6BN	34543321	Green Published, gold			2022-12-26	WOS:000707078200029
J	Edge, R; Meyers, J; Tiernan, G; Li, ZC; Schiavuzzi, A; Chan, P; Vassallo, A; Morrow, A; Mazariego, C; Wakefield, CE; Canfell, K; Taylor, N				Edge, Rhiannon; Meyers, Josh; Tiernan, Gabriella; Li, Zhicheng; Schiavuzzi, Alexandra; Chan, Priscilla; Vassallo, Amy; Morrow, April; Mazariego, Carolyn; Wakefield, Claire E.; Canfell, Karen; Taylor, Natalie			Cancer care disruption and reorganisation during the COVID-19 pandemic in Australia: A patient, carer and healthcare worker perspective	PLOS ONE			English	Article							TELEHEALTH	The COVID-19 pandemic has dramatically impacted cancer care worldwide. Disruptions have been seen across all facets of care. While the long-term impact of COVID-19 remains unclear, the immediate impacts on patients, their carers and the healthcare workforce are increasingly evident. This study describes disruptions and reorganisation of cancer services in Australia since the onset of COVID-19, from the perspectives of people affected by cancer and healthcare workers. Two separate online cross-sectional surveys were completed by: a) cancer patients, survivors, carers, family members or friends (n = 852) and b) healthcare workers (n = 150). Descriptive analyses of quantitative survey data were conducted, followed by inductive thematic content analyses of qualitative survey responses relating to cancer care disruption and perceptions of telehealth. Overall, 42% of cancer patients and survivors reported experiencing some level of care disruption. A further 43% of healthcare workers reported atypical delays in delivering cancer care, and 50% agreed that patient access to research and clinical trials had been reduced. Almost three quarters (73%) of patients and carers reported using telehealth following the onset of COVID-19, with high overall satisfaction. However, gaps were identified in provision of psychological support and 20% of participants reported that they were unlikely to use telehealth again. The reorganisation of cancer care increased the psychological and practical burden on carers, with hospital visitation restrictions and appointment changes reducing their ability to provide essential support. COVID-19 has exacerbated a stressful and uncertain time for people affected by cancer and healthcare workers. Service reconfiguration and the adoption of telehealth have been essential adaptations for the pandemic response, offering long-term value. However, our findings highlight the need to better integrate psychosocial support and the important role of carers into evolving pandemic response measures. Learnings from this study could inform service improvements that would benefit patients and carers longer-term.	[Edge, Rhiannon; Tiernan, Gabriella; Li, Zhicheng; Schiavuzzi, Alexandra; Chan, Priscilla; Morrow, April; Mazariego, Carolyn; Canfell, Karen; Taylor, Natalie] Univ Sydney, Daffodil Ctr, Sydney, NSW, Australia; [Meyers, Josh] Canc Council NSW, Sydney, NSW, Australia; [Vassallo, Amy] UNSW, George Inst Global Hlth, Sydney, NSW, Australia; [Mazariego, Carolyn; Canfell, Karen; Taylor, Natalie] Univ Sydney, Sch Publ Hlth, Fac Med & Hlth, Sydney, NSW, Australia; [Wakefield, Claire E.] Sydney Childrens Hosp, Kids Canc Ctr, Behav Sci Unit, Sydney, NSW, Australia; [Wakefield, Claire E.] UNSW Sydney, Sch Womens & Childrens Hlth, Sydney, NSW, Australia	University of Sydney; Cancer Council New South Wales; George Institute for Global Health; University of New South Wales Sydney; University of Sydney; University of Sydney; University of Sydney; University of New South Wales Sydney	Meyers, J (corresponding author), Canc Council NSW, Sydney, NSW, Australia.	Joshua.meyers@nswcc.org.au		Edge, Rhiannon/0000-0003-0638-0852; Mazariego, Carolyn/0000-0003-3965-4960; Meyers, Josh/0000-0002-6152-8824				Australia Cancer., 2020, REV IMP COVID 19 MED; Bradford NK, 2016, RURAL REMOTE HEALTH, V16; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Cancer Australia, 2021, COVID 19 VACC CANC; Cancer Council NSW, 2021, COVID 19 CANC GLOB M; Cox A, 2017, J MED INTERNET RES, V19, DOI 10.2196/jmir.6575; Department of Health, 2020, COR COVID 19 GLANC 3; Department of Health, 2021, COR COVID 19 GLANC 1; Department of Health, 2020, COVID 19 TEL IT GUID; Dhawan N, 2020, CURR TREAT OPTION ON, V21, DOI 10.1007/s11864-020-00795-z; Edge R, 2021, SUPPORT CARE CANCER, V29, P5463, DOI 10.1007/s00520-021-06101-3; Feletto E, 2020, PUBLIC HEALTH RES PR, V30, DOI 10.17061/phrp3042026; Hanna TP, 2020, BMJ-BRIT MED J, V371, DOI 10.1136/bmj.m4087; Lowy Institute, 2021, COV PERF IND DEC PAN; Morgan DG, 2014, TELEMED E-HEALTH, V20, P997, DOI 10.1089/tmj.2014.0002; Nelson R, 2020, LANCET ONCOL, V21, P1020, DOI 10.1016/S1470-2045(20)30389-2; Ng KYY, 2020, JCO GLOB ONCOL, V6, P1494, DOI 10.1200/GO.20.00374; Ng WH, 2021, MBIO, V12, DOI 10.1128/mBio.03647-20; Nickson C PP., 2020, COVID 19 SCENARIO MO; Parliament of Australia, 2020, EFF COVID 19 AUSTR; Pearce C., 2020, OUTCOME HLTH GP INSI; Sabesan S, 2015, AUST J RURAL HEALTH, V23, P19, DOI 10.1111/ajr.12170; Saini KS, 2020, LANCET HAEMATOL, V7, pE432, DOI 10.1016/S2352-3026(20)30123-X; Sansom-Daly UM, 2020, PSYCHO-ONCOLOGY, V29, P1404, DOI 10.1002/pon.5462; Schulz T, 2022, J TELEMED TELECARE, V28, P445, DOI 10.1177/1357633X20942045; Sud A, 2020, LANCET ONCOL, V21, P1035, DOI 10.1016/S1470-2045(20)30392-2; Sun L, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0207993; Sutherland K, 2020, PUBLIC HEALTH RES PR, V30, DOI 10.17061/phrp3042030; Taylor N, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-015-0879-z; te Marvelde L, 2021, MED J AUSTRALIA, V214, P281, DOI 10.5694/mja2.50968; van de Haar J, 2020, NAT MED, V26, P665, DOI [10.1038/s41591-020-0874-8, 10.1038/s41591-020-0948-7]; van Dorn A, 2020, LANCET, V396, P523, DOI [10.1377/hblog20200702.963588/full, 10.1016/S0140-6736(20)31787-6]; Weinkove R, 2020, MED J AUSTRALIA, V212, P481, DOI 10.5694/mja2.50607; Yellowlees P, 2001, J TELEMED TELECARE, V7, P29, DOI 10.1258/1357633011937056; Young AM, 2020, SUPPORT CARE CANCER, V28, P4001, DOI 10.1007/s00520-020-05604-9; Young JM, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-298	36	21	21	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2021	16	9							e0257420	10.1371/journal.pone.0257420	http://dx.doi.org/10.1371/journal.pone.0257420			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	WG5ZQ	34534231	Green Published, gold			2022-12-26	WOS:000707073300028
J	Miari, R; Azzam, N; Bar-Shalom, R; Fares, F				Miari, Reem; Azzam, Naiel; Bar-Shalom, Rinat; Fares, Fuad			5-aza-2'-deoxycytidine induces apoptosis and inhibits tumour growth in vivo of FaDu cells, a specific HPVnegative HNSCC cell line	PLOS ONE			English	Article							CYCLE ARREST; MYELODYSPLASTIC SYNDROME; MOLECULAR PATHOGENESIS; DNA METHYLATION; HEAD; CANCER; 5-AZA-2'-DEOXYCYTIDINE; EXPRESSION; PATHWAY; AZACITIDINE	Head and neck cancer squamous cell carcinoma (HNSCC) is the sixth most common cancer worldwide, resulting in over 600,000 new diagnoses annually. Traditionally, HNCC has been related to tobacco and alcohol exposure; however, over the past decade, a growing number of head and neck cancers are attributed to human papillomavirus (HPV) infection. 5-Aza-2'-deoxycytidine (5-AzaD) was demonstrated as an effective chemotherapeutic agent for acute myelogenous leukaemia. Preclinical data revealed that 5-aza inhibits growth and increases cell death of HPV(+) cancer cells. These effects are associated with reduced expression of HPV genes, stabilization of TP53, and activation of TP53-dependent apoptosis. The aim of the present study is to test the effect of 5-AzaD on growth of human squamous cell carcinoma (FaDu), a HPV(-) and p53 mutated cells, in vitro and in vivo. The effect of 5-AzaD on cell viability, cell cycle progression and induction of apoptosis was tested in vitro. The effect of 5-AzaD on tumour growth in vivo was tested using xenograft mice inoculated with FaDu cells. The results indicated that 5-AzaD reduced cell viability and induced apoptosis in FaDu cells in vitro. In vivo studies revealed that 5-AzaD suppresses the growth of tumours in xenograft mice inoculated with FaDu cells through inhibition of proliferation and induction of apoptosis. These findings may emphasis that 5-AzaD is effective in treatment of HPV(-) HNSCC tumours through TP53 independent pathway. Future studies are needed in order to clarify the molecular mechanism of action of 5-AzaD in HPV(-) cancer cells.	[Miari, Reem; Azzam, Naiel; Bar-Shalom, Rinat; Fares, Fuad] Univ Haifa, Fac Nat Sci, Dept Human Biol, Haifa, Israel; [Azzam, Naiel] MIGAL Galilee Res Inst, Kiryat Shmona, Israel	University of Haifa	Fares, F (corresponding author), Univ Haifa, Fac Nat Sci, Dept Human Biol, Haifa, Israel.	ffares@sci.haifa.ac.il			Carmel-University of Haifa-Economic Corporation Ltd	Carmel-University of Haifa-Economic Corporation Ltd	The authors would like to thank Carmel-University of Haifa-Economic Corporation Ltd for supporting this project. A special thanks to Dr. Abraham Nyska, Tel-Aviv University, Faculty of Medicine, Tel-Aviv, Israel for Histochemical analysis. We thanks Dr. Sagie Schif-Zuck for the use of FACSCanto II (BD) equipment and the stuff of the animal house at University of Haifa.	Alexander VM, 2010, INT J CLIN EXP MED, V3, P95; Alsahafi E, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1769-9; Appel CK, 2019, PAIN, V160, P619, DOI 10.1097/j.pain.0000000000001442; Bendinelli P, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2016.403; Biktasova A, 2017, CLIN CANCER RES, V23, P7276, DOI 10.1158/1078-0432.CCR-17-1438; Budden T, 2018, BMC CANCER, V18, DOI 10.1186/s12885-018-4010-9; Castilho RM, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18071506; Dynlacht BD, 1997, NATURE, V389, P149, DOI 10.1038/38225; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Elmore SA, 2016, TOXICOL PATHOL, V44, P173, DOI 10.1177/0192623315625859; Farnoodian M, 2018, J OPHTHAL VIS RES, V13, P470, DOI 10.4103/jovr.jovr_67_18; Feldman R, 2016, HEAD NECK-J SCI SPEC, V38, pE1625, DOI 10.1002/hed.24290; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Fischer M, 2016, NUCLEIC ACIDS RES, V44, P164, DOI 10.1093/nar/gkv927; Fung C, 2010, EXPERT OPIN EMERG DR, V15, P355, DOI 10.1517/14728214.2010.497754; Granata R, 2007, J THROMB HAEMOST, V5, P835, DOI 10.1111/j.1538-7836.2007.02431.x; Hassler MR, 2012, BIOCHIMIE, V94, P2297, DOI 10.1016/j.biochi.2012.05.029; Hellebrekers DMEI, 2006, MOL CANCER THER, V5, P467, DOI 10.1158/1535-7163.MCT-05-0417; Ichimura N, 2015, CANCER PREV RES, V8, P702, DOI 10.1158/1940-6207.CAPR-14-0306; Issa JPJ, 2009, CLIN CANCER RES, V15, P3938, DOI 10.1158/1078-0432.CCR-08-2783; Issa JPJ, 2004, BLOOD, V103, P1635, DOI 10.1182/blood-2003-03-0687; Kaminskas E, 2005, CLIN CANCER RES, V11, P3604, DOI 10.1158/1078-0432.CCR-04-2135; Klein JD, 2010, CANCER BIOL THER, V9, P1; Klepin HD, 2016, CLIN GERIATR MED, V32, P155, DOI 10.1016/j.cger.2015.08.010; Kozakiewicz P, 2018, ONCOL LETT, V15, P7497, DOI 10.3892/ol.2018.8300; Lawler PR, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006627; Lawrence MS, 2015, NATURE, V517, P576, DOI 10.1038/nature14129; Leemans CR, 2011, NAT REV CANCER, V11, P9, DOI 10.1038/nrc2982; Leone G, 2003, CLIN IMMUNOL, V109, P89, DOI 10.1016/S1521-6616(03)00207-9; Maes K, 2014, ONCOTARGET, V5, P3115, DOI 10.18632/oncotarget.1821; MORGAN DO, 1995, NATURE, V374, P131, DOI 10.1038/374131a0; Nakamura K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120545; Napso T, 2014, INT J ONCOL, V44, P1971, DOI 10.3892/ijo.2014.2386; Navada SC, 2014, J CLIN INVEST, V124, P40, DOI 10.1172/JCI69739; Nyska A, 2005, TOXICOL SCI, V83, P388, DOI 10.1093/toxsci/kfi034; Osuna MAL, 2019, CANCER RES, V79, P1054, DOI 10.1158/0008-5472.CAN-18-1255; Pan Cassie, 2018, Cancers Head Neck, V3, P12, DOI 10.1186/s41199-018-0039-3; Patra SK, 2008, FEBS J, V275, P5217, DOI 10.1111/j.1742-4658.2008.06658.x; Rothenberg SM, 2012, J CLIN INVEST, V122, P1951, DOI 10.1172/JCI59889; Russo P, 2002, INT J CANCER, V100, P266, DOI 10.1002/ijc.10461; Santra M, 1997, J CLIN INVEST, V100, P149, DOI 10.1172/JCI119507; Seol JG, 1999, BIOCHEM BIOPH RES CO, V265, P400, DOI 10.1006/bbrc.1999.1697; Silverman LR, 2002, J CLIN ONCOL, V20, P2429, DOI 10.1200/JCO.2002.04.117; SOMERS KD, 1992, CANCER RES, V52, P5997; Stich M, 2017, ONCOTARGET, V8, P52104, DOI 10.18632/oncotarget.10631; Thoolen B, 2010, TOXICOL PATHOL, V38, p5S, DOI 10.1177/0192623310386499; Wahl AF, 1996, NAT MED, V2, P72, DOI 10.1038/nm0196-72; Wenzel A, 2000, J NEUROSCI, V20, P81, DOI 10.1523/JNEUROSCI.20-01-00081.2000; Xiong HH, 2009, J HUAZHONG U SCI-MED, V29, P498, DOI 10.1007/s11596-009-0421-9; You BR, 2014, MOL CARCINOGEN, V53, P847, DOI 10.1002/mc.22042; Zerp SF, 2015, RADIAT ONCOL, V10, DOI 10.1186/s13014-015-0474-9	51	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2021	16	9							e0253756	10.1371/journal.pone.0253756	http://dx.doi.org/10.1371/journal.pone.0253756			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	WG5ZQ	34534222	gold, Green Published			2022-12-26	WOS:000707073300004
J	Nuertey, BD; Ekremet, K; Haidallah, AR; Mumuni, K; Addai, J; Attibu, RIE; Damah, MC; Duorinaa, E; Seidu, AS; Adongo, VC; Adatsi, RK; Suri, HC; Komei, AAK; Abubakari, BB; Weyori, E; Allegye-Cudjoe, E; Sylverken, A; Owusu, M; Phillips, RO				Nuertey, Benjamin Demah; Ekremet, Kwame; Haidallah, Abdul-Rashid; Mumuni, Kareem; Addai, Joyce; Attibu, Rosemary Ivy E.; Damah, Michael C.; Duorinaa, Elvis; Seidu, Anwar Sadat; Adongo, Victor C.; Adatsi, Richard Kujo; Suri, Hisyovi Caedenas; Komei, Abass Abdul-Karim; Abubakari, Braimah Baba; Weyori, Enoch; Allegye-Cudjoe, Emmanuel; Sylverken, Augustina; Owusu, Michael; Phillips, Richard O.			Performance of COVID-19 associated symptoms and temperature checking as a screening tool for SARS-CoV-2 infection	PLOS ONE			English	Article								Introduction Coronavirus disease-19 (COVID-19), which started in late December, 2019, has spread to affect 216 countries and territories around the world. Globally, the number of cases of SARS-CoV-2 infection has been growing exponentially. There is pressure on countries to flatten the curves and break transmission. Most countries are practicing partial or total lockdown, vaccination, massive education on hygiene, social distancing, isolation of cases, quarantine of exposed and various screening approaches such as temperature and symptom-based screening to break the transmission. Some studies outside Africa have found the screening for fever using non-contact thermometers to lack good sensitivity for detecting SARS-CoV-2 infection. The aim of this study was to determine the usefulness of clinical symptoms in accurately predicting a final diagnosis of COVID-19 disease in the Ghanaian setting. Method The study analysed screening and test data of COVID-19 suspected, probable and contacts for the months of March to August 2020. A total of 1,986 participants presenting to Tamale Teaching hospital were included in the study. Logistic regression and receiver operator characteristics (ROC) analysis were carried out. Results Overall SARS-CoV-2 positivity rate was 16.8%. Those with symptoms had significantly higher positivity rate (21.6%) compared with asymptomatic (17.0%) [chi-squared 15.5, p-value, <0.001]. Patients that were positive for SARS-CoV-2 were 5.9 [3.9-8.8] times more likely to have loss of sense of smell and 5.9 [3.8-9.3] times more likely to having loss of sense of taste. Using history of fever as a screening tool correctly picked up only 14.8% of all true positives of SARS-CoV-2 infection and failed to pick up 86.2% of positive cases. Using cough alone would detect 22.4% and miss 87.6%. Non-contact thermometer used alone, as a screening tool for COVID-19 at a cut-off of 37.8 would only pick 4.8% of positive SARS-CoV-2 infected patients. Conclusion The use of fever alone or other symptoms individually [or in combination] as a screening tool for SARS-CoV-2 infection is not worthwhile based on ROC analysis. Use of temperature check as a COVID-19 screening tool to allow people into public space irrespective of the temperature cut-off is of little benefit in diagnosing infected persons. We recommend the use of facemask, hand hygiene, social distancing as effective means of preventing infection.	[Nuertey, Benjamin Demah; Ekremet, Kwame; Haidallah, Abdul-Rashid; Mumuni, Kareem; Attibu, Rosemary Ivy E.; Damah, Michael C.; Duorinaa, Elvis; Seidu, Anwar Sadat; Adongo, Victor C.; Adatsi, Richard Kujo; Suri, Hisyovi Caedenas] Tamale Teaching Hosp, COVID 19 Management Team, Accra, Ghana; [Nuertey, Benjamin Demah] Univ Ghana, Community Hlth Dept, Med Sch, Accra, Ghana; [Nuertey, Benjamin Demah; Attibu, Rosemary Ivy E.; Seidu, Anwar Sadat] Tamale Teaching Hosp, Publ Hlth Dept, Tamale, Ghana; [Mumuni, Kareem] Univ Ghana, Dept Obstetr & Gynaecol, Med Sch, Accra, Ghana; [Addai, Joyce] Korle Bu Teaching Hosp, Dept Med, Accra, Ghana; [Damah, Michael C.] Tamale Teaching Hosp, Pharm Dept, Tamale, Ghana; [Duorinaa, Elvis] Tamale Teaching Hosp, Dept Surg, Tamale, Ghana; [Adongo, Victor C.; Adatsi, Richard Kujo] Tamale Teaching Hosp, Lab Dept, Tamale, Ghana; [Suri, Hisyovi Caedenas] Tamale Teaching Hosp, Intens Care Unit, Tamale, Ghana; [Komei, Abass Abdul-Karim; Weyori, Enoch] Zonal Publ Hlth Reference Lab, Tamale, Ghana; [Abubakari, Braimah Baba] Reg Hlth Directorate, Tamale, Northern Region, Ghana; [Abubakari, Braimah Baba] Univ Dev Studies, Sch Med Sci, Tamale, Ghana; [Allegye-Cudjoe, Emmanuel] Vet Serv Lab, Pong Tamale, Ghana; [Sylverken, Augustina] Kwame Nkrumah Univ Sci & Technol, Dept Theoret & Appl Biol, Kumasi, Ghana; [Sylverken, Augustina; Owusu, Michael; Phillips, Richard O.] Kwame Nkrumah Univ Sci & Technol, Kumasi Ctr Collaborat Res, Kumasi, Ghana; [Owusu, Michael] Kwame Nkrumah Univ Sci & Technol, Dept Med Diagnost, Kumasi, Ghana	University of Ghana; University of Ghana; University for Development Studies; Kwame Nkrumah University Science & Technology; Kumasi Center for Collaborative Research; Kwame Nkrumah University Science & Technology; Kwame Nkrumah University Science & Technology	Nuertey, BD (corresponding author), Tamale Teaching Hosp, COVID 19 Management Team, Accra, Ghana.; Nuertey, BD (corresponding author), Univ Ghana, Community Hlth Dept, Med Sch, Accra, Ghana.	ben.nuertey@gmail.com	Nuertey, Benjamin/ABD-4678-2021	Nuertey, Benjamin/0000-0003-4946-508X; Ekremet, Kwame/0000-0003-4330-2677				Ai T, 2020, RADIOLOGY, V296, pE32, DOI 10.1148/radiol.2020200642; Australian Library and Information Association, 2020, COVID 19 LIV LIT SEA; Bai HX, 2020, RADIOLOGY, V296, pE46, DOI 10.1148/radiol.2020200823; Bai Y, 2020, JAMA-J AM MED ASSOC, V323, P1406, DOI [10.1056/NEJMoa2001316, 10.1001/jama.2020.2565]; Bielecki M, 2020, TRAVEL MED INFECT DI, V37, DOI 10.1016/j.tmaid.2020.101832; Bwire GM, 2020, TROP MED HEALTH, V48, DOI 10.1186/s41182-020-00201-2; Chan JFW, 2020, LANCET, V395, P514, DOI 10.1016/S0140-6736(20)30154-9; Chudik A., 2020, NATL BUREAU EC RES; Corman VM, 2020, EUROSURVEILLANCE, V25, P23, DOI 10.2807/1560-7917.ES.2020.25.3.2000045; Dyer O, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1439; Ekelund S, 2012, POINT CARE, V11, P16, DOI 10.1097/POC.0b013e318246a642; Fosu GO., 2020, FLATTENING EXPONENTI, DOI [10.2139/ssrn.3565147, DOI 10.2139/SSRN.3565147]; Gandhi M, 2020, NEW ENGL J MED, V382, P2158, DOI 10.1056/NEJMe2009758; Gostic K, 2020, ELIFE, V9, DOI 10.7554/eLife.55570; Han SW, 2020, CANCER MED-US, V9, P6667, DOI 10.1002/cam4.3289; Hui KPY, 2020, LANCET RESP MED, V8, P687, DOI 10.1016/S2213-2600(20)30193-4; Jiang F, 2020, J GEN INTERN MED, V35, P1545, DOI 10.1007/s11606-020-05762-w; Jin YH, 2020, MILITARY MED RES, V7, DOI 10.1186/s40779-020-0233-6; Khanna N, 2021, SILICON-NETH, V13, P2445, DOI 10.1007/s12633-020-00588-x; Kimball A, 2020, MMWR-MORBID MORTAL W, V69, P377, DOI 10.15585/mmwr.mm6913e1; Lai CC, 2020, J MICROBIOL IMMUNOL, V53, P404, DOI 10.1016/j.jmii.2020.02.012; Li Y, 2020, AM J ROENTGENOL, V214, P1280, DOI 10.2214/AJR.20.22954; Li ZT, 2020, J MED VIROL, V92, P1518, DOI 10.1002/jmv.25727; Liou JM, 2021, GUT, V70, P806, DOI 10.1136/gutjnl-2020-322125; Lippi G, 2020, CLIN CHEM LAB MED, V58, P1070, DOI 10.1515/cclm-2020-0285; Mandrekar JN, 2010, J THORAC ONCOL, V5, P1315, DOI 10.1097/JTO.0b013e3181ec173d; Mitra B, 2020, EMERG MED AUSTRALAS, V32, P867, DOI 10.1111/1742-6723.13578; Mizumoto K, 2020, EUROSURVEILLANCE, V25, P2, DOI 10.2807/1560-7917.ES.2020.25.10.2000180; Nguyen T, 2020, MICROMACHINES-BASEL, V11, DOI 10.3390/mi11030306; Nuertey BD., 2021, COVID 19 TAMALE TEAC, DOI [10.1002/jmv.27211, DOI 10.1002/JMV.27211]; Ong SWX, 2020, JAMA-J AM MED ASSOC, V323, P1610, DOI 10.1001/jama.2020.3227; Pamuk Z., 2020, PATTERN ANAL APPL, DOI DOI 10.1007/S10044-021-00984-Y; Pan F, 2020, RADIOLOGY, V295, P715, DOI 10.1148/radiol.2020200370; Pang JX, 2020, J CLIN MED, V9, DOI 10.3390/jcm9030623; Quilty BJ, 2020, EUROSURVEILLANCE, V25, P4, DOI 10.2807/1560-7917.ES.2020.25.5.2000080; Roland LT, 2020, INT FORUM ALLERGY RH, V10, P832, DOI 10.1002/alr.22602; Russell B, 2020, ECANCERMEDICALSCIENC, V14, DOI 10.3332/ecancer.2020.ed98; Sheridan C, 2020, NAT BIOTECHNOL, V38, P515, DOI 10.1038/d41587-020-00010-2; Sun PF, 2020, J MED VIROL, V92, P548, DOI 10.1002/jmv.25722; Tay MR, 2015, PUBLIC HEALTH, V129, P1471, DOI 10.1016/j.puhe.2015.07.023; Vilke GM, 2020, J EMERG MED, V59, P952, DOI 10.1016/j.jemermed.2020.09.048; Wilder-Smith A, 2020, J TRAVEL MED, V27, DOI 10.1093/jtm/taaa020; Wong HYF, 2020, RADIOLOGY, V296, pE72, DOI 10.1148/radiol.2020201160; World Health Organization (WHO), 2020, WHO COR DIS COVID 19; Wright WF, 2021, OPEN FORUM INFECT DI, V8, DOI 10.1093/ofid/ofaa603; Wu YC, 2020, J CHIN MED ASSOC, V83, P217, DOI 10.1097/JCMA.0000000000000270; Yu XX, 2020, INFLUENZA OTHER RESP, V14, P474, DOI 10.1111/irv.12743; Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3	48	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2021	16	9							e0257450	10.1371/journal.pone.0257450	http://dx.doi.org/10.1371/journal.pone.0257450			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	WG5ZQ	34534249	gold, Green Published			2022-12-26	WOS:000707073300030
J	Pontes-Nogueira, M; Martins, M; Alencar, LRV; Sawaya, RJ				Pontes-Nogueira, Matheus; Martins, Marcio; Alencar, Laura R., V; Sawaya, Ricardo J.			The role of vicariance and dispersal on the temporal range dynamics of forest vipers in the Neotropical region	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; LATE MIOCENE RISE; ATLANTIC FOREST; HISTORICAL BIOGEOGRAPHY; MOLECULAR PHYLOGENY; DISTRIBUTION PATTERNS; BOLIVIAN ALTIPLANO; PAST CONNECTIONS; MODEL SELECTION; SOUTH-AMERICA	The emergence of the diagonal of open/dry vegetations, including Chaco, Cerrado and Caatinga, is suggested to have acted as a dispersal barrier for terrestrial organisms by fragmenting a single large forest that existed in South America into the present Atlantic and Amazon forests. Here we tested the hypothesis that the expansion of the South American diagonal of open/dry landscapes acted as a vicariant process for forest lanceheads of the genus Bothrops, by analyzing the temporal range dynamics of those snakes. We estimated ancestral geographic ranges of the focal lancehead clade and its sister clade using a Bayesian dated phylogeny and the BioGeoBEARS package. We compared nine Maximum Likelihood models to infer ancestral range probabilities and their related biogeographic processes. The best fitting models (DECTS and DIVALIKETS) recovered the ancestor of our focal clade in the Amazon biogeographic region of northwestern South America. Vicariant processes in two different subclades resulted in disjunct geographic distributions in the Amazon and the Atlantic Forest. Dispersal processes must have occurred mostly within the Amazon and the Atlantic Forest and not between them. Our results suggest the fragmentation of a single ancient large forest into the Atlantic and Amazon forests acting as a driver of vicariant processes for the snake lineage studied, highlighting the importance of the diagonal of open/dry landscapes in shaping distribution patterns of terrestrial biota in South America.	[Pontes-Nogueira, Matheus] Univ Fed Sao Paulo, Grad Ciencias Biol, Diadema, Brazil; [Martins, Marcio] Univ Sao Paulo, Inst Biociencias, Dept Ecol, Sao Paulo, Brazil; [Alencar, Laura R., V] Clemson Univ, Dept Biol Sci, Clemson, SC 29634 USA; [Sawaya, Ricardo J.] Univ Fed ABC, Ctr Ciencias Nat & Humanas, Sao Bernardo Do Campo, Brazil; [Pontes-Nogueira, Matheus] Univ Fed ABC, Programa Posgrad Evolucao & Diversidade, Sao Bernardo Do Campo, Brazil	Universidade Federal de Sao Paulo (UNIFESP); Universidade de Sao Paulo; Clemson University; Universidade Federal do ABC (UFABC)	Pontes-Nogueira, M (corresponding author), Univ Fed Sao Paulo, Grad Ciencias Biol, Diadema, Brazil.; Pontes-Nogueira, M (corresponding author), Univ Fed ABC, Programa Posgrad Evolucao & Diversidade, Sao Bernardo Do Campo, Brazil.	mpnogueira26@gmail.com	Pontes-Nogueira, Matheus/D-2151-2019; Martins, Marcio Arêdes/M-4671-2019; Martins, Marcio/C-1150-2011	Martins, Marcio Arêdes/0000-0001-5705-9431; Martins, Marcio/0000-0001-8108-6309; Pontes-Nogueira, Matheus/0000-0002-2146-1346; Sawaya, Ricardo/0000-0003-1897-1836	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2014/23677-9, 2017/11796-1, 2018/14091-1]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [312795/2018-1, 306961/2015-6]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	MPN was granted by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP; https://fapesp.br/) with the grant numbers Proc. 2014/23677-9 and Proc. 2017/11796-1. RJS was granted by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP; https://fapesp.br/) with the grant number proc. 2014/23677-9 and by Conselho Nacional de Desenvolvimento Cientifico e Tecnolo ' gico (CNPq; https://www.gov.br/cnpq/pt-br) with the grant number 312795/2018-1. MMwas granted by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP; https://fapesp.br/) with the grant number proc. 2018/14091-1 and by Conselho Nacional de Desenvolvimento Cientifico e Tecnolo ' gico (CNPq; https://www.gov.br/cnpq/ptbr) with the grant number 306961/2015-6. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Aldous DJ, 2001, STAT SCI, V16, P23, DOI 10.1214/ss/998929474; Alencar LRV, 2016, MOL PHYLOGENET EVOL, V105, P50, DOI 10.1016/j.ympev.2016.07.029; Antonelli A., 2016, BIOGEOGRAFIA AM, V2, P279; Auler AS, 2004, J QUATERNARY SCI, V19, P693, DOI 10.1002/jqs.876; Azevedo JAR, 2016, J BIOGEOGR, V43, P2454, DOI 10.1111/jbi.12803; Bacon CD, 2015, P NATL ACAD SCI USA, V112, P6110, DOI 10.1073/pnas.1423853112; Barbo FE, 2021, J BIOGEOGR, V48, P823, DOI 10.1111/jbi.14040; Batalha H, 2013, J ORNITHOL, V154, P41, DOI 10.1007/s10336-012-0866-7; Bauchot R., 1994, SNAKES NATURAL HIST; Benson DA, 2012, NUCLEIC ACIDS RES, V40, pD48, DOI 10.1093/nar/gkr1202; Bigarella JJ, 1975, AN ACAD BRAS CIENC, V47, P411; Bouckaert R, 2019, PLOS COMPUT BIOL, V15, DOI 10.1371/journal.pcbi.1006650; Burbrink FT, 2011, REPROD BIOL PHYLOGEN, V9, P19; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; Cabanne GS, 2019, MOL PHYLOGENET EVOL, V133, P198, DOI 10.1016/j.ympev.2019.01.011; Cabanne GS, 2008, MOL PHYLOGENET EVOL, V49, P760, DOI 10.1016/j.ympev.2008.09.013; Carrasco PA, 2019, ZOOTAXA, V4565, P301, DOI 10.11646/zootaxa.4565.3.1; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Charif D., 2007, SEQINR 10 2 CONTRIBU, P207, DOI [10.1007/978-3-540-35306-5_10, DOI 10.1007/978-3-540-35306-5_10]; Cohen KM, 2013, EPISODES, V36, P199, DOI 10.18814/epiiugs/2013/v36i3/002; Costa LP, 2003, J BIOGEOGR, V30, P71, DOI 10.1046/j.1365-2699.2003.00792.x; Dal Vechio F, 2018, J BIOGEOGR, V45, P2415, DOI 10.1111/jbi.13421; DASILVA NJ, 1995, CONSERV BIOL, V9, P873, DOI 10.1046/j.1523-1739.1995.09040873.x; De Oliveira PE, 1999, PALAEOGEOGR PALAEOCL, V152, P319, DOI 10.1016/S0031-0182(99)00061-9; Ledo RMD, 2017, J BIOGEOGR, V44, P2551, DOI 10.1111/jbi.13049; Dinerstein E, 2017, BIOSCIENCE, V67, P534, DOI 10.1093/biosci/bix014; Donoghue P, 2009, J VERTEBR PALEONTOL, V29, p89A; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Dupin J, 2017, J BIOGEOGR, V44, P887, DOI 10.1111/jbi.12898; Escalante T, 2017, BIOL J LINN SOC, V120, P349; FOODEN J, 1972, SCIENCE, V175, P894, DOI 10.1126/science.175.4024.894; Fouquet A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001109; Fouquet A, 2014, J BIOGEOGR, V41, P855, DOI 10.1111/jbi.12250; Fouquet A, 2012, MOL PHYLOGENET EVOL, V62, P826, DOI 10.1016/j.ympev.2011.11.023; Garzione CN, 2006, EARTH PLANET SC LETT, V241, P543, DOI 10.1016/j.epsl.2005.11.026; Guedes TB, 2018, GLOBAL ECOL BIOGEOGR, V27, P14, DOI 10.1111/geb.12679; Guedes TB, 2014, J BIOGEOGR, V41, P919, DOI 10.1111/jbi.12272; Hartley AJ, 2007, EARTH PLANET SC LETT, V259, P625, DOI 10.1016/j.epsl.2007.04.012; Haug GH, 1998, NATURE, V393, P673, DOI 10.1038/31447; Herold N, 2009, AUST J EARTH SCI, V56, P1049, DOI 10.1080/08120090903246170; Hoorn C, 2010, SCIENCE, V330, P927, DOI 10.1126/science.1194585; Hoorn C, 2017, GLOBAL PLANET CHANGE, V153, P51, DOI 10.1016/j.gloplacha.2017.02.005; Joly C., 2008, BIOTA NEOTROP, V8, P1, DOI 10.1590/s1519-69842008000500019; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Katoh K, 2019, BRIEF BIOINFORM, V20, P1160, DOI 10.1093/bib/bbx108; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kay RF, 2015, MOL PHYLOGENET EVOL, V82, P358, DOI 10.1016/j.ympev.2013.12.002; KENDALL DG, 1948, ANN MATH STAT, V19, P1, DOI 10.1214/aoms/1177730285; Kuraku S, 2013, NUCLEIC ACIDS RES, V41, pW22, DOI 10.1093/nar/gkt389; Landis MJ, 2013, SYST BIOL, V62, P789, DOI 10.1093/sysbio/syt040; Lanfear R, 2017, MOL BIOL EVOL, V34, P772, DOI 10.1093/molbev/msw260; Lanfear R, 2012, MOL BIOL EVOL, V29, P1695, DOI 10.1093/molbev/mss020; Luebert F, 2011, MOL PHYLOGENET EVOL, V61, P90, DOI 10.1016/j.ympev.2011.06.001; Machado AF, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0250016; Machado T, 2014, MOL PHYLOGENET EVOL, V71, P1, DOI 10.1016/j.ympev.2013.10.003; Maddison WP., 2019, CHROMASEQ MESQUITE P; Martins FM, 2009, BMC EVOL BIOL, V9, DOI [10.1186/1471-2148-9-36, 10.1186/1471-2148-9-294]; Mattison C., 2006, SNAKE ESSENTIAL VISU, V2; Matzke N.J., 2013, FRONT BIOGEOGR, V5, P242, DOI [DOI 10.21425/F5FBG19694, 10.21425/F5FBG19694]; Matzke NJ, 2014, SYST BIOL, V63, P951, DOI 10.1093/sysbio/syu056; McDermott A, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2102396118; MORI SA, 1981, BRITTONIA, V33, P233, DOI 10.2307/2806330; Morrone J. J., 1998, Zoologische Mededelingen (Leiden), V72, P73; Morrone J. J., 1996, Zoologische Mededelingen (Leiden), V70, P1; Morrone JJ, 2006, ANNU REV ENTOMOL, V51, P467, DOI 10.1146/annurev.ento.50.071803.130447; Morrone JJ, 2014, ZOOTAXA, V 3782, P1, DOI 10.11646/zootaxa.3782.1.1; Nogueira C, 2003, J HERPETOL, V37, P653, DOI 10.1670/120-02A; Nogueira C, 2011, J BIOGEOGR, V38, P1907, DOI 10.1111/j.1365-2699.2011.02538.x; Nogueira CC, 2019, S AM J HERPETOL, V14, pS1, DOI 10.2994/SAJH-D-19-00120.1; Oliveira-Filho A. T., 1995, Edinburgh Journal of Botany, V52, P141; Olson DM, 2001, BIOSCIENCE, V51, P933, DOI 10.1641/0006-3568(2001)051[0933:TEOTWA]2.0.CO;2; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Paradis E, 2019, BIOINFORMATICS, V35, P526, DOI 10.1093/bioinformatics/bty633; Parham JF, 2012, SYST BIOL, V61, P346, DOI 10.1093/sysbio/syr107; Pellegrino KCM, 2011, MOL PHYLOGENET EVOL, V61, P446, DOI 10.1016/j.ympev.2011.07.010; Peres EA, 2017, BIOL J LINN SOC, V121, P771, DOI 10.1093/biolinnean/blx036; Por F. D., 1992, Sooretama: the Atlantic rain forest of Brazil.; Prates I, 2017, MOL PHYLOGENET EVOL, V113, P49, DOI 10.1016/j.ympev.2017.05.009; Prates I, 2016, MOL ECOL, V25, P5174, DOI 10.1111/mec.13821; Quental TB, 2010, TRENDS ECOL EVOL, V25, P434, DOI 10.1016/j.tree.2010.05.002; Rahbek C, 2001, P NATL ACAD SCI USA, V98, P4534, DOI 10.1073/pnas.071034898; RAUP DM, 1986, SCIENCE, V231, P1528, DOI 10.1126/science.11542058; RAVEN PH, 1974, ANN MO BOT GARD, V61, P539, DOI 10.2307/2395021; REDFORD KH, 1986, BIOTROPICA, V18, P126, DOI 10.2307/2388755; Ree RH, 2008, SYSTEMATIC BIOL, V57, P4, DOI 10.1080/10635150701883881; Ree RH, 2018, J BIOGEOGR, V45, P741, DOI 10.1111/jbi.13173; Rodrigues MT, 2014, MOL PHYLOGENET EVOL, V81, P137, DOI 10.1016/j.ympev.2014.07.019; Ronquist F, 1997, SYST BIOL, V46, P195, DOI 10.2307/2413643; Ruskin BG, 2011, PALAEOGEOGR PALAEOCL, V308, P293, DOI 10.1016/j.palaeo.2011.05.033; Salas-Gismondi R, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.2490; Sanmartin I., 2016, BIOGEOGRAFIA AM, V2, P119; Sarver BAJ, 2019, PEERJ, V7, DOI 10.7717/peerj.6334; Silva Jose Maria Cardoso Da, 1995, Steenstrupia, V21, P49; Simon MF, 2009, P NATL ACAD SCI USA, V106, P20359, DOI 10.1073/pnas.0903410106; Sobral-Souza T, 2015, EVOL ECOL, V29, P643, DOI 10.1007/s10682-015-9780-9; Talavera G, 2007, SYST BIOL, V56, P564, DOI 10.1080/10635150701472164; Trujillo-Arias N, 2018, MOL PHYLOGENET EVOL, V128, P221, DOI 10.1016/j.ympev.2018.08.005; Trujillo-Arias N, 2017, MOL PHYLOGENET EVOL, V112, P107, DOI 10.1016/j.ympev.2017.03.025; Uetz P., 2021, REPTILE DATABASE; Vidal Nicolas, 2009, P390; Vitt LJ., 2014, HERPETOLOGY, V4, DOI [10.1016/b978-0-12-386919-7.00005%26%23x2013%3B8, DOI 10.1016/B978-0-12-386919-7.00005%26%23X2013%3B8]; Wagenmakers EJ, 2004, PSYCHON B REV, V11, P192, DOI 10.3758/BF03206482; Wang XF, 2004, NATURE, V432, P740, DOI 10.1038/nature03067; Wesselingh F.P., 2006, Scripta Geologica (Leiden), V133, P439; Wuster W, 2008, MOL PHYLOGENET EVOL, V49, P445, DOI 10.1016/j.ympev.2008.08.019; Yule GU, 1925, PHILOS T R SOC LON B, V213, P21, DOI 10.1098/rstb.1925.0002; Zanella FC V., 2011, BIOGEOGRAFIA AM PADR, V1, P198	110	0	0	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2021	16	9							e0257519	10.1371/journal.pone.0257519	http://dx.doi.org/10.1371/journal.pone.0257519			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	WG5ZQ	34534245	gold, Green Published			2022-12-26	WOS:000707073300035
J	Fan, C; Huang, SY; Xiang, CH; An, TH; Song, Y				Fan, Cheng; Huang, Shiyuan; Xiang, Chunhua; An, Tianhui; Song, Yi			Identification of key genes and immune infiltration modulated by CPAP in obstructive sleep apnea by integrated bioinformatics analysis	PLOS ONE			English	Article							EXPRESSION	Patients with obstructive sleep apnea (OSA) experience partial or complete upper airway collapses during sleep resulting in nocturnal hypoxia-normoxia cycling, and continuous positive airway pressure (CPAP) is the golden treatment for OSA. Nevertheless, the exact mechanisms of action, especially the transcriptome effect of CPAP on OSA patients, remain elusive. The goal of this study was to evaluate the longitudinal alterations in peripheral blood mononuclear cells transcriptome profiles of OSA patients in order to identify the hub gene and immune response. GSE133601 was downloaded from Gene Expression Omnibus (GEO). We identified black module via weighted gene co-expression network analysis (WGCNA), the genes in which were correlated significantly with the clinical trait of CPAP treatment. Finally, eleven hub genes (TRAV10, SNORA36A, RPL10, OBP2B, IGLV1-40, H2BC8, ESAM, DNASE1L3, CD22, ANK3, ACP3) were traced and used to construct a random forest model to predict therapeutic efficacy of CPAP in OSA with a good performance with AUC of 0.92. We further studied the immune cells infiltration in OSA patients with CIBERSORT, and monocytes were found to be related with the remission of OSA and partially correlated with the hub genes identified. In conclusion, these key genes and immune infiltration may be of great importance in the remission of OSA and related research of these genes may provide a new therapeutic target for OSA in the future.	[Fan, Cheng; Huang, Shiyuan; Xiang, Chunhua; An, Tianhui; Song, Yi] Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Dept Geriatr, Wuhan, Peoples R China	Huazhong University of Science & Technology	Song, Y (corresponding author), Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Dept Geriatr, Wuhan, Peoples R China.	yisong@hust.edu.cn	Fan, Cheng/GXW-3204-2022	Song, Yi/0000-0003-2334-4896				Almendros I, 2022, J SLEEP RES, V31, DOI 10.1111/jsr.13418; Behzadi P, 2019, ACTA MICROBIOL IMM H, V66, P19, DOI 10.1556/030.65.2018.028; Bonsignore MR, 2013, EUR RESPIR REV, V22, P353, DOI 10.1183/09059180.00003413; Brozyna-Tkaczyk K, 2021, MEDICINA-LITHUANIA, V57, DOI 10.3390/medicina57040310; Carbon S, 2019, NUCLEIC ACIDS RES, V47, pD330, DOI 10.1093/nar/gky1055; Chan BKC, 2018, ADV EXP MED BIOL, V1082, P47, DOI 10.1007/978-3-319-93791-5_2; Charkoftaki G, 2019, HUM GENOMICS, V13, DOI 10.1186/s40246-019-0191-9; Chen H, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-35; Degenhardt F, 2019, BRIEF BIOINFORM, V20, P492, DOI 10.1093/bib/bbx124; Di Luca M, 2020, INT J MED ROBOT COMP, V16, DOI 10.1002/rcs.2106; DOWDY SF, 1991, NUCLEIC ACIDS RES, V19, P5763, DOI 10.1093/nar/19.20.5763; Dyugovskaya L, 2002, AM J RESP CRIT CARE, V165, P934, DOI 10.1164/ajrccm.165.7.2104126; Gharib SA, 2020, SLEEP, V43, DOI 10.1093/sleep/zsz314; Hernandez-Jimenez E, 2017, EUR RESPIR J, V49, DOI 10.1183/13993003.02456-2016; Hoffmann MS, 2013, ATHEROSCLEROSIS, V231, P378, DOI 10.1016/j.atherosclerosis.2013.09.033; Jellusova J, 2012, FRONT IMMUNOL, V2, DOI 10.3389/fimmu.2011.00096; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Lacazette E, 2000, HUM MOL GENET, V9, P289, DOI 10.1093/hmg/9.2.289; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Lefranc MP, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00022; Loftus TM, 1997, BIOCHEMISTRY-US, V36, P8224, DOI 10.1021/bi970288d; Maher LLM, 2022, J AM ASSOC NURSE PRA, V34, P389, DOI 10.1097/JXX.0000000000000632; Maniaci A, 2021, J CLIN MED, V10, DOI 10.3390/jcm10020277; Newman AM, 2015, NAT METHODS, V12, P453, DOI [10.1038/nmeth.3337, 10.1038/NMETH.3337]; Nilsson RH, 2019, NAT REV MICROBIOL, V17, P95, DOI 10.1038/s41579-018-0116-y; Parsons C, 2017, FUTUR CARDIOL, V13, P397, DOI 10.2217/fca-2017-0004; Rigatti Steven J, 2017, J Insur Med, V47, P31, DOI 10.17849/insm-47-01-31-39.1; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Speiser JL, 2015, STAT MED, V34, P887, DOI 10.1002/sim.6351; Tserenpil G, 2020, CUREUS, V12, DOI 10.7759/cureus.9905; Wang HZ, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-0900-5; Wang XT, 2019, CURR MED SCI, V39, P52, DOI 10.1007/s11596-019-1999-1; Zhang H, 2021, ONCOTARGETS THER, V14, P1021, DOI 10.2147/OTT.S294500	34	1	1	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2021	16	9							e0255708	10.1371/journal.pone.0255708	http://dx.doi.org/10.1371/journal.pone.0255708			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	WG5YY	34529670	gold, Green Submitted, Green Published			2022-12-26	WOS:000707071500010
J	Kominakis, A; Tarsani, E; Hager-Theodorides, AL; Mastranestasis, I; Gkelia, D; Hadjigeorgiou, I				Kominakis, Antonios; Tarsani, Eirini; Hager-Theodorides, Ariadne L.; Mastranestasis, Ioannis; Gkelia, Dimitra; Hadjigeorgiou, Ioannis			Genetic differentiation of mainland-island sheep of Greece: Implications for identifying candidate genes for long-term local adaptation	PLOS ONE			English	Article							ADIPOSE-TISSUE; SELECTION; SIGNATURES; CYTOSCAPE; MODEL; ENVIRONMENT; METABOLISM; INSIGHTS; STEAP4; BROWN	In Greece, a number of local sheep breeds are raised in a wide range of ecological niches across the country. These breeds can be used for the identification of genetic variants that contribute to local adaptation. To this end, 50k genotypes of 90 local sheep from mainland Greece (Epirus, n = 35 and Peloponnesus, n = 55) were used, as well as 147 genotypes of sheep from insular Greece (Skyros, n = 21), Lemnos, n = 36 and Lesvos, n = 90). Principal components and phylogenetic analysis along with admixture and spatial point patterns analyses suggested genetic differentiation of 'mainland-island' populations. Genome scans for signatures of selection and genome-wide association analysis (GWAS) pointed to one highly differentiating marker on OAR4 (F-ST = 0.39, FLK = 21.93, FDR p-value = 0.10) that also displayed genome wide significance (FDR p-value = 0.002) during GWAS. A total number of 6 positional candidate genes (LOC106990429, ZNF804B, TEX47, STEAP4, SRI and ADAM22) were identified within 500 kb flanking regions around the significant marker. In addition, two QTLs related to fat tail deposition are reported in genomic regions 800 kb downstream the significant marker. Based on gene ontology analysis and literature evidence, the identified candidate genes possess biological functions relevant to local adaptation that worth further investigation.	[Kominakis, Antonios; Tarsani, Eirini; Hager-Theodorides, Ariadne L.; Hadjigeorgiou, Ioannis] Agr Univ Athens, Dept Anim Sci, Athens, Greece; [Mastranestasis, Ioannis] Breeders Assoc Lesvos Sheep, Anaxos Lesvos, Greece; [Gkelia, Dimitra] Assoc Pastoral Farmers Epirus, Ioannina, Greece	Agricultural University of Athens	Tarsani, E (corresponding author), Agr Univ Athens, Dept Anim Sci, Athens, Greece.	etarsani@aua.gr	Ioannis, Hadjigeorgiou/I-2675-2012	Tarsani, Eirini/0000-0002-1498-0738	'Terra Lemnia' project - 'MAVA Fondation pour la Nature'	'Terra Lemnia' project - 'MAVA Fondation pour la Nature'	This work was partially supported by the `Terra Lemnia' project funded by the `MAVA Fondation pour la Nature'. Ioannis Hadjigeorgiou received this financial support.	Abied A, 2020, GENES-BASEL, V11, DOI 10.3390/genes11050494; Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; Anderson CA, 2010, NAT PROTOC, V5, P1564, DOI 10.1038/nprot.2010.116; Bakhtiarizadeh MR, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-70527-8; Bierne N, 2010, EVOLUTION, V64, P3254, DOI 10.1111/j.1558-5646.2010.01050.x; Bindea G, 2013, BIOINFORMATICS, V29, P661, DOI 10.1093/bioinformatics/btt019; Bindea G, 2009, BIOINFORMATICS, V25, P1091, DOI 10.1093/bioinformatics/btp101; Bonhomme M, 2010, GENETICS, V186, P241, DOI 10.1534/genetics.104.117275; Booker TR, 2021, EVOL LETT, V5, P4, DOI 10.1002/evl3.208; Cashmore AR, 2003, CELL, V114, P537, DOI 10.1016/j.cell.2003.08.004; Chilliard Y, 2000, P NUTR SOC, V59, P127, DOI 10.1017/S002966510000015X; Chouchani ET, 2019, NAT METAB, V1, P189, DOI 10.1038/s42255-018-0021-8; Ciani E, 2020, GENET SEL EVOL, V52, DOI 10.1186/s12711-020-00545-7; Costa RB, 2015, GENET SEL EVOL, V47, DOI 10.1186/s12711-015-0146-0; Gouveia JJD, 2017, LIVEST SCI, V197, P36, DOI 10.1016/j.livsci.2017.01.006; Elbein SC, 2011, DIABETES, V60, P1019, DOI 10.2337/db10-1270; Lopez ME, 2019, FRONT GENET, V10, DOI 10.3389/fgene.2019.00901; Fariello MI, 2013, GENETICS, V193, P929, DOI 10.1534/genetics.112.147231; Fariello MI, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103813; Foll M, 2008, GENETICS, V180, P977, DOI 10.1534/genetics.108.092221; Franceschini S, 2008, FASEB J, V22, P295, DOI 10.1096/fj.07-8988com; Gutierrez-Gil B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094623; Harms M, 2013, NAT MED, V19, P1252, DOI 10.1038/nm.3361; HILL W G, 1968, Theoretical and Applied Genetics, V38, P226, DOI 10.1007/BF01245622; Hu XJ, 2019, MOL BIOL EVOL, V36, P283, DOI 10.1093/molbev/msy208; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Joost S, 2007, MOL ECOL, V16, P3955, DOI 10.1111/j.1365-294X.2007.03442.x; Kang HM, 2010, NAT GENET, V42, P348, DOI 10.1038/ng.548; Kijas JW, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001258; Kim ES, 2016, HEREDITY, V116, P255, DOI 10.1038/hdy.2015.94; Kominakis A, 2005, WORKSH SAV FDN RAR L; Kominakis A, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0247787; Kopelman NM, 2015, MOL ECOL RESOUR, V15, P1179, DOI 10.1111/1755-0998.12387; LEWONTIN RC, 1973, GENETICS, V74, P175; Librado P, 2018, MOL BIOL EVOL, V35, P1520, DOI 10.1093/molbev/msy053; Liu HL, 2009, J BIOL CHEM, V284, P29077, DOI 10.1074/jbc.M109.014258; Liu YR, 2016, GENET MOL RES, V15, DOI 10.4238/gmr.15027298; Liu ZH, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-3212-2; Lu XR., 2019, GENOME WIDE ANAL REV, P701045, DOI [10.1101/701045, DOI 10.1101/701045]; Luo LP, 2016, J ENDOCRINOL, V231, pR77, DOI 10.1530/JOE-16-0211; Lv FH, 2014, MOL BIOL EVOL, V31, P3324, DOI 10.1093/molbev/msu264; Mastranestasis I, 2015, SMALL RUMINANT RES, V130, P54, DOI 10.1016/j.smallrumres.2015.07.015; Mastrangelo S, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0209632; Megdiche S, 2019, FRONT GENET, V10, DOI 10.3389/fgene.2019.01025; Mendez JD, 2010, MOL CELL BIOCHEM, V344, P185, DOI 10.1007/s11010-010-0541-3; MORAN PAP, 1950, BIOMETRIKA, V37, P17, DOI 10.1093/biomet/37.1-2.17; NCBI, NCBI OV AR ANN REL 1; NCBI, COORD REM SERV NCBI; O'Brien AMP, 2014, GENET SEL EVOL, V46, DOI 10.1186/1297-9686-46-19; Ojha S, 2013, PEDIATR RES, V74, P246, DOI 10.1038/pr.2013.107; Perez O'Brien Ana M., 2013, ISAFG 2013 5 INT S A, P63; Purfield DC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176780; Qanbari S, 2010, ANIM GENET, V41, P346, DOI 10.1111/j.1365-2052.2009.02011.x; Qanbari S, 2020, FRONT GENET, V10, DOI 10.3389/fgene.2019.01304; Sakamoto T, 2019, GENETICS, V212, P1383, DOI 10.1534/genetics.119.302311; Scarl RT, 2017, J ENDOCRINOL, V234, pR123, DOI 10.1530/JOE-16-0594; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Signer-Hasler H, 2019, ANIM GENET, V50, P512, DOI 10.1111/age.12828; Souza JSM, 2020, GENOMICS, V112, P3108, DOI 10.1016/j.ygeno.2020.05.010; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Wright S, 1922, AM NAT, V56, P330, DOI 10.1086/279872; Xu J, 2019, FRONT GENET, V10, DOI 10.3389/fgene.2019.00660; Xu SS, 2017, ANIM GENET, V48, P560, DOI 10.1111/age.12572; Yang J, 2016, MOL BIOL EVOL, V33, P2576, DOI 10.1093/molbev/msw129; Yang J, 2011, EUR J HUM GENET, V19, P807, DOI 10.1038/ejhg.2011.39; Yang T., 2020, VOLLEYBALL TEACHING, DOI [10.21203/rs.3.rs-104008/v1, DOI 10.21203/RS.3.RS-104008/V1, 10.21203/RS.3.RS-111081/V1, DOI 10.21203/RS.3.RS-111081/V1]; Yu JM, 2006, NAT GENET, V38, P203, DOI 10.1038/ng1702; Zhang CM, 2008, ACTA PHARMACOL SIN, V29, P587, DOI 10.1111/j.1745-7254.2008.00793.x	68	4	5	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2021	16	9							e0257461	10.1371/journal.pone.0257461	http://dx.doi.org/10.1371/journal.pone.0257461			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	WG5YY	34529728	gold, Green Published			2022-12-26	WOS:000707071500061
J	Ng, D; Pinharanda, A; Vogt, MC; Litwin-Kumar, A; Stearns, K; Thopte, U; Cannavo, E; Enikolopov, A; Fiederling, F; Kosmidis, S; Noro, B; Rodrigues-Vaz, I; Shayya, H; Andolfatto, P; Peterka, DS; Tabachnik, T; D'Armiento, J; Goldklang, M; Bendesky, A				Ng, David; Pinharanda, Ana; Vogt, Merly C.; Litwin-Kumar, Ashok; Stearns, Kyle; Thopte, Urvashi; Cannavo, Enrico; Enikolopov, Armen; Fiederling, Felix; Kosmidis, Stylianos; Noro, Barbara; Rodrigues-Vaz, Ines; Shayya, Hani; Andolfatto, Peter; Peterka, Darcy S.; Tabachnik, Tanya; D'Armiento, Jeanine; Goldklang, Monica; Bendesky, Andres			WHotLAMP: A simple, inexpensive, and sensitive molecular test for the detection of SARS-CoV-2 in saliva	PLOS ONE			English	Article								Despite the development of effective vaccines against SARS-CoV-2, epidemiological control of the virus is still challenging due to slow vaccine rollouts, incomplete vaccine protection to current and emerging variants, and unwillingness to get vaccinated. Therefore, frequent testing of individuals to identify early SARS-CoV-2 infections, contact-tracing and isolation strategies remain crucial to mitigate viral spread. Here, we describe WHotLAMP, a rapid molecular test to detect SARS-CoV-2 in saliva. WHotLAMP is simple to use, highly sensitive (~4 viral particles per microliter of saliva) and specific, as well as inexpensive, making it ideal for frequent screening. Moreover, WHotLAMP does not require toxic chemicals or specialized equipment and thus can be performed in point-of-care settings, and may also be adapted for resource-limited environments or home use. While applied here to SARS-CoV-2, WHotLAMP can be modified to detect other pathogens, making it adaptable for other diagnostic assays, including for use in future outbreaks.	[Ng, David; Litwin-Kumar, Ashok; Thopte, Urvashi; Cannavo, Enrico; Fiederling, Felix; Kosmidis, Stylianos; Noro, Barbara; Rodrigues-Vaz, Ines; Shayya, Hani; Peterka, Darcy S.; Tabachnik, Tanya; Bendesky, Andres] Columbia Univ, Zuckerman Mind Brain Behav Inst, New York, NY 10027 USA; [Pinharanda, Ana; Vogt, Merly C.; Andolfatto, Peter] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA; [Vogt, Merly C.] Columbia Univ, Howard Hughes Med Inst, New York, NY 10032 USA; [Stearns, Kyle; D'Armiento, Jeanine; Goldklang, Monica] Columbia Univ, Dept Anesthesiol, Irving Med Ctr, New York, NY USA; [D'Armiento, Jeanine; Goldklang, Monica] Columbia Univ, Ctr LAM & Rare Lung Dis, Irving Med Ctr, New York, NY USA; [Bendesky, Andres] Columbia Univ, Dept Ecol Evolut & Environm Biol, New York, NY 10027 USA	Columbia University; Columbia University; Columbia University; Howard Hughes Medical Institute; Columbia University; NewYork-Presbyterian Hospital; Columbia University; NewYork-Presbyterian Hospital; Columbia University	Bendesky, A (corresponding author), Columbia Univ, Zuckerman Mind Brain Behav Inst, New York, NY 10027 USA.; Bendesky, A (corresponding author), Columbia Univ, Dept Ecol Evolut & Environm Biol, New York, NY 10027 USA.	a.bendesky@columbia.edu		Thopte, Urvashi/0000-0003-3927-6146; Pinharanda, Ana/0000-0002-4696-9218; Stearns, Kyle/0000-0002-5166-7927	Friends of the Zuckerman Institute; NIH [GM112758]; Columbia University	Friends of the Zuckerman Institute; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Columbia University	This study was funded by Friends of the Zuckerman Institute and Columbia University and NIH grant GM112758 to PA. AB is a Searle Scholar (https://www.searlescholars.net/), KlingensteinSimons Neuroscience Fellow (https://klingenstein.org/esther-a-joseph-klingenstein-fund/neuroscience/) and a Sloan Neuroscience Fellow (https://sloan.org/fellowships/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	A. Marc, 2021, medRxiv, DOI 10.1101/2021.05.07.21256341; Baro B, 2021, J INFECTION, V82, P269, DOI 10.1016/j.jinf.2021.04.009; Batejat Christophe, 2021, J Biosaf Biosecur, V3, P1, DOI 10.1016/j.jobb.2020.12.001; Ben-Assa N, 2020, EXP BIOL MED, V245, P1187, DOI 10.1177/1535370220941819; Bonney LC, 2020, PLOS NEGLECT TROP D, V14, DOI 10.1371/journal.pntd.0008496; Butler D, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-21361-7; Casey-Bryars M, 2021, BMJ OPEN, V11, DOI 10.1136/bmjopen-2020-041240; Cevik M, 2021, LANCET MICROBE, V2, pE13, DOI 10.1016/S2666-5247(20)30172-5; Cheng PKC, 2004, LANCET, V363, P1699, DOI 10.1016/S0140-6736(04)16255-7; Choi Jung Eun, 2017, BDJ Open, V3, P17015, DOI 10.1038/bdjopen.2017.15; Corman VM, 2021, LANCET MICROBE, V2, pE311, DOI 10.1016/S2666-5247(21)00056-2; Dekker RJ., 2020, BIORXIV PREPRINT, DOI [10.1101/2020.06.12.147819v2.full.pdf+html, DOI 10.1101/2020.06.12.147819V2.FULL.PDF+HTML]; Eisenberg E, 2013, TRENDS GENET, V29, P569, DOI 10.1016/j.tig.2013.05.010; G. Regev-Yochay, 2021, medRxiv, DOI 10.1101/2021.03.02.21252400; Johansson MA, 2021, JAMA NETW OPEN, V4, DOI 10.1001/jamanetworkopen.2020.35057; Joung J, 2020, NEW ENGL J MED, V383, P1492, DOI 10.1056/NEJMc2026172; La Scola B, 2020, EUR J CLIN MICROBIOL, V39, P1059, DOI 10.1007/s10096-020-03913-9; Larremore DB, 2021, SCI ADV, V7, DOI [10.1101/2020.06.22.20136309, 10.1126/sciadv.abd5393]; Liu CC, 2011, ANALYST, V136, P2069, DOI 10.1039/c1an00007a; Madhi SA, 2021, NEW ENGL J MED, V384, P1885, DOI 10.1056/NEJMoa2102214; Mak GCK, 2020, J CLIN VIROL, V129, DOI 10.1016/j.jcv.2020.104500; Marks M, 2021, LANCET INFECT DIS, V21, P629, DOI 10.1016/S1473-3099(20)30985-3; Mina MJ, 2021, LANCET, V397, P1425, DOI 10.1016/S0140-6736(21)00425-6; Muik A, 2021, SCIENCE, V371, P1152, DOI 10.1126/science.abg6105; Notomi T, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.12.e63; Paltiel AD, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.16818; Pondaven-Letourmy S, 2020, EUR ANN OTORHINOLARY, V137, P325, DOI 10.1016/j.anorl.2020.06.001; Rabe BA, 2020, P NATL ACAD SCI USA, V117, P24450, DOI 10.1073/pnas.2011221117; Savela E. S., 2021, SARS COV 2 IS DETECT, DOI [DOI 10.1101/2021.04.02.21254771, 10.1101/2021.04.02.21254771]; Scohy A, 2020, J CLIN VIROL, V129, DOI 10.1016/j.jcv.2020.104455; Singanayagam A, 2020, EUROSURVEILLANCE, V25, P2, DOI 10.2807/1560-7917.ES.2020.25.32.2001483; Standl F, 2021, LANCET INFECT DIS, V21, pE77, DOI [10.1016/S1473-3099(20)30648-4, 10.1016/S1473-3099(20)30484-9]; Teo AKJ, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-82787-z; US Food and Drug Administration, 2020, 109931 USDA ISO; Walsh KA, 2020, J INFECTION, V81, P357, DOI 10.1016/j.jinf.2020.06.067; Wang CD, 2021, SIGNAL TRANSDUCT TAR, V6, DOI 10.1038/s41392-021-00527-1; Wang Zijun, 2021, bioRxiv, DOI [10.1038/s41586-021-03324-6, 10.1101/2021.01.15.426911]; Wei S, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-81487-y; Wouters OJ, 2021, LANCET, V397, P1023, DOI 10.1016/S0140-6736(21)00306-8; Wyllie AL, 2020, NEW ENGL J MED, V383, P1283, DOI 10.1056/NEJMc2016359; Yamayoshi S, 2020, VIRUSES-BASEL, V12, DOI 10.3390/v12121420; Zhang Y., 2020, RAPID MOL DETECTION, DOI [10.1101/2020.02.26.20028373v1.full.pdf+html, DOI 10.1101/2020.02.26.20028373V1.FULL.PDF+HTML]; Zou YP, 2017, PLOS BIOL, V15, DOI 10.1371/journal.pbio.2003916	44	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2021	16	9							e0257464	10.1371/journal.pone.0257464	http://dx.doi.org/10.1371/journal.pone.0257464			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	WG5YY	34529736	gold, Green Published, Green Submitted			2022-12-26	WOS:000707071500062
J	Schilberg, L; Ten Oever, S; Schuhmann, T; Sack, AT				Schilberg, Lukas; Ten Oever, Sanne; Schuhmann, Teresa; Sack, Alexander T.			Phase and power modulations on the amplitude of TMS-induced motor evoked potentials	PLOS ONE			English	Article							BRAIN-STIMULATION; EEG; VARIABILITY; EXCITABILITY; SYSTEM; CORTEX; SYNCHRONIZATION; OSCILLATIONS; PLASTICITY; RESPONSES	The evaluation of transcranial magnetic stimulation (TMS)-induced motor evoked potentials (MEPs) promises valuable information about fundamental brain related mechanisms and may serve as a diagnostic tool for clinical monitoring of therapeutic progress or surgery procedures. However, reports about spontaneous fluctuations of MEP amplitudes causing high intra-individual variability have led to increased concerns about the reliability of this measure. One possible cause for high variability of MEPs could be neuronal oscillatory activity, which reflects fluctuations of membrane potentials that systematically increase and decrease the excitability of neuronal networks. Here, we investigate the dependence of MEP amplitude on oscillation power and phase by combining the application of single pulse TMS over the primary motor cortex with concurrent recordings of electromyography and electroencephalography. Our results show that MEP amplitude is correlated to alpha phase, alpha power as well as beta phase. These findings may help explain corticospinal excitability fluctuations by highlighting the modulatory effect of alpha and beta phase on MEPs. In the future, controlling for such a causal relationship may allow for the development of new protocols, improve this method as a (diagnostic) tool and increase the specificity and efficacy of general TMS applications.	[Schilberg, Lukas; Ten Oever, Sanne; Schuhmann, Teresa; Sack, Alexander T.] Maastricht Univ, Fac Psychol & Neurosci, Dept Cognit Neurosci, Sect Brain Stimulat & Cognit, Maastricht, Netherlands; [Ten Oever, Sanne] Max Planck Inst Psycholinguist, Language & Computat Neural Syst Grp, Nijmegen, Netherlands; [Ten Oever, Sanne] Radboud Univ Nijmegen, Donders Inst Neuroimaging, Nijmegen, Netherlands; [Schuhmann, Teresa; Sack, Alexander T.] Maastricht Univ, Maastricht Brain Imaging Ctr MBIC, Maastricht, Netherlands; [Schuhmann, Teresa; Sack, Alexander T.] Maastricht Univ, Fac Psychol & Neurosci, Fac Hlth Med & Life Sci, Ctr Integrat Neurosci, Maastricht, Netherlands; [Sack, Alexander T.] Maastricht Univ, Fac Hlth Med & Life Sci, Sch Mental Hlth & Neurosci MHeNS, Dept Psychiat & Neuropsychol,Med Ctr, Maastricht, Netherlands	Maastricht University; Max Planck Society; Radboud University Nijmegen; Maastricht University; Maastricht University; Maastricht University	Sack, AT (corresponding author), Maastricht Univ, Fac Psychol & Neurosci, Dept Cognit Neurosci, Sect Brain Stimulat & Cognit, Maastricht, Netherlands.; Sack, AT (corresponding author), Maastricht Univ, Maastricht Brain Imaging Ctr MBIC, Maastricht, Netherlands.; Sack, AT (corresponding author), Maastricht Univ, Fac Psychol & Neurosci, Fac Hlth Med & Life Sci, Ctr Integrat Neurosci, Maastricht, Netherlands.; Sack, AT (corresponding author), Maastricht Univ, Fac Hlth Med & Life Sci, Sch Mental Hlth & Neurosci MHeNS, Dept Psychiat & Neuropsychol,Med Ctr, Maastricht, Netherlands.	a.sack@maastrichtuniversity.nl		ten Oever, Sanne/0000-0001-7547-5842; Sack, Alexander/0000-0002-1471-0885	Netherlands Organization for Scientific Research (NWO) [453-15008]	Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	This work was funded by the research program NWO VICI "The rhythms of cognition: Using simultaneous TMS-fMRI-EEG to integrate brain-wide network and oscillatory communication mechanisms for enhancing human cognition" (awarded to ATS) with project number 453-15008, which is financed by the Netherlands Organization for Scientific Research (NWO).	Berens P, 2009, J STAT SOFTW, V31, P1, DOI 10.18637/jss.v031.i10; Berger B, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/936096; Bergmann TO, 2019, J NEUROSCI, V39, P10034, DOI 10.1523/JNEUROSCI.1730-19.2019; Bergmann TO, 2016, NEUROIMAGE, V140, P4, DOI 10.1016/j.neuroimage.2016.02.012; BURKE D, 1995, ELECTROMYOGR MOTOR C, V97, P231, DOI 10.1016/0924-980X(95)00005-4; Devanne H, 1997, EXP BRAIN RES, V114, P329, DOI 10.1007/PL00005641; Feurra M, 2011, J NEUROSCI, V31, P12165, DOI 10.1523/JNEUROSCI.0978-11.2011; GASSER T, 1982, ELECTROEN CLIN NEURO, V53, P119, DOI 10.1016/0013-4694(82)90112-2; Goetz SM, 2014, BRAIN STIMUL, V7, P541, DOI 10.1016/j.brs.2014.03.002; Gomez-Herrero G, 2006, 2006 7TH NORDIC SIGNAL PROCESSING SYMPOSIUM, P130; Guerrero APC, 2016, CONTRADICCIONES DE LOS SISTEMAS DE GESTION DE CALIDAD: ENTRE LA ESTANDARIZACION Y LA INNOVACION PEDAGOGICA, P1, DOI 10.1093/cercor/bhw245; Haegens S, 2014, NEUROIMAGE, V92, P46, DOI 10.1016/j.neuroimage.2014.01.049; Hussain SJ, 2019, CEREB CORTEX, V29, P3766, DOI 10.1093/cercor/bhy255; Jackson AF, 2014, PSYCHOPHYSIOLOGY, V51, P1061, DOI 10.1111/psyp.12283; Jones PR, 2019, ATTEN PERCEPT PSYCHO, V81, P1189, DOI 10.3758/s13414-019-01726-3; Kayser J, 2006, CLIN NEUROPHYSIOL, V117, P348, DOI 10.1016/j.clinph.2005.08.034; Keil J, 2014, J NEUROPHYSIOL, V111, P513, DOI 10.1152/jn.00387.2013; Khademi F, 2019, BRAIN STIMUL, V12, P296, DOI 10.1016/j.brs.2018.10.015; KIERS L, 1993, ELECTROEN CLIN NEURO, V89, P415, DOI 10.1016/0168-5597(93)90115-6; Kilavik BE, 2013, EXP NEUROL, V245, P15, DOI 10.1016/j.expneurol.2012.09.014; KUHLMAN WN, 1978, ELECTROEN CLIN NEURO, V44, P83, DOI 10.1016/0013-4694(78)90107-4; Lepage JF, 2008, J NEUROSCI METH, V175, P17, DOI 10.1016/j.jneumeth.2008.07.021; Maki H, 2010, CLIN NEUROPHYSIOL, V121, P492, DOI 10.1016/j.clinph.2009.11.078; Mathewson KE, 2009, J NEUROSCI, V29, P2725, DOI 10.1523/JNEUROSCI.3963-08.2009; Mitchell WK, 2007, J PHYSIOL-LONDON, V583, P567, DOI 10.1113/jphysiol.2007.134031; Muellbacher W, 2000, CLIN NEUROPHYSIOL, V111, P344, DOI 10.1016/S1388-2457(99)00243-6; NICHOLSON C, 1975, J NEUROPHYSIOL, V38, P356, DOI 10.1152/jn.1975.38.2.356; Niedermeyer E., 2005, ELECTROEN CLIN NEURO; Ogata K, 2019, BRAIN STIMUL, V12, P1508, DOI 10.1016/j.brs.2019.06.013; Oostenveld R, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/156869; Pellegrini M, 2021, NEUROSCI RES, V166, P12, DOI 10.1016/j.neures.2020.06.002; Pellegrini M, 2018, BRAIN RES, V1700, P190, DOI 10.1016/j.brainres.2018.09.002; Peters JC, 2020, COMMUN BIOL, V3, DOI 10.1038/s42003-020-0764-0; PFURTSCHELLER G, 1994, NEUROSCI LETT, V174, P93, DOI 10.1016/0304-3940(94)90127-9; Raco V, 2016, FRONT CELL NEUROSCI, V10, DOI 10.3389/fncel.2016.00143; Rossi S, 2004, TRENDS COGN SCI, V8, P273, DOI 10.1016/j.tics.2004.04.012; Sauseng P, 2009, NEUROPSYCHOLOGIA, V47, P284, DOI 10.1016/j.neuropsychologia.2008.07.021; Schaworonkow N, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00954; Schaworonkow N, 2019, BRAIN STIMUL, V12, P110, DOI 10.1016/j.brs.2018.09.009; Schilberg L, 2018, CORTEX, V103, P142, DOI 10.1016/j.cortex.2018.03.001; Schilberg L, 2017, J COGNITIVE NEUROSCI, V29, P1022, DOI 10.1162/jocn_a_01100; Schulz H, 2014, CEREB CORTEX, V24, P1708, DOI 10.1093/cercor/bht024; Smulders FTY, 2018, EUR J NEUROSCI, V48, P2585, DOI 10.1111/ejn.13854; Sohn Young H, 2004, Phys Med Rehabil Clin N Am, V15, P117, DOI 10.1016/S1047-9651(03)00105-0; Stefanou MI, 2019, JOVE-J VIS EXP, DOI 10.3791/59711; ten Oever S, 2015, P NATL ACAD SCI USA, V112, P15833, DOI 10.1073/pnas.1517519112; Thies M, 2018, BRAIN STIMUL, V11, P1119, DOI 10.1016/j.brs.2018.06.006; Torrecillos F, 2020, J NEUROSCI, V40, P369, DOI 10.1523/JNEUROSCI.1953-19.2019; Wassermann EM, 1996, EXP BRAIN RES, V109, P158; Wassermann EM, 2002, CLIN NEUROPHYSIOL, V113, P1165, DOI 10.1016/S1388-2457(02)00144-X; Zarkowski P, 2006, CLIN EEG NEUROSCI, V37, P247, DOI 10.1177/155005940603700316; Zrenner C, 2018, BRAIN STIMUL, V11, P374, DOI 10.1016/j.brs.2017.11.016	52	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2021	16	9							e0255815	10.1371/journal.pone.0255815	http://dx.doi.org/10.1371/journal.pone.0255815			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	WG5YY	34529682	Green Published, gold			2022-12-26	WOS:000707071500011
J	Xu, L; Earl, J; Pichichero, ME				Xu, Lei; Earl, Joshua; Pichichero, Michael E.			Nasopharyngeal microbiome composition associated with Streptococcus pneumoniae colonization suggests a protective role of Corynebacterium in young children	PLOS ONE			English	Article							ACUTE-OTITIS-MEDIA; UPPER RESPIRATORY-INFECTION; HAEMOPHILUS-INFLUENZAE; HEALTH; IMPACT	Streptococcus pneumoniae (Spn) is a leading respiratory tract pathogen that colonizes the nasopharynx (NP) through adhesion to epithelial cells and immune evasion. Spn actively interacts with other microbiota in NP but the nature of these interactions are incompletely understood. Using 16S rRNA gene sequencing, we analyzed the microbiota composition in the NP of children with or without Spn colonization. 96 children were included in the study cohort. 74 NP samples were analyzed when children were 6 months old and 85 NP samples were analyzed when children were 12 months old. We found several genera that correlated negatively or positively with Spn colonization, and some of these correlations appeared to be influenced by daycare attendance or other confounding factors such as upper respiratory infection (URI) or Moraxella colonization. Among these genera, Corynebacterium showed a consistent inverse relationship with Spn colonization with little influence by daycare attendance or other factors. We isolated Corynebacterium propinquum and C. pseudodiphtheriticum and found that both inhibited the growth of Spn serotype 22F strain in vitro.	[Xu, Lei; Pichichero, Michael E.] Rochester Gen Hosp, Ctr Infect Dis & Immunol, Res Inst, Rochester, NY 14621 USA; [Earl, Joshua] Drexel Univ, Coll Med, Dept Microbiol & Immunol, Ctr Genom Sci, Philadelphia, PA 19104 USA; [Earl, Joshua] Drexel Univ, Coll Med, Dept Microbiol & Immunol, Ctr Adv Microbial Proc, Philadelphia, PA 19104 USA	Rochester General Hospital; Drexel University; Drexel University	Pichichero, ME (corresponding author), Rochester Gen Hosp, Ctr Infect Dis & Immunol, Res Inst, Rochester, NY 14621 USA.	michael.pichichero@rochesterregional.org	Core, UNC Microbiome/AAB-3304-2022; Pichichero, Michael E/AID-7886-2022		Rochester General Hospital Kidd Fund	Rochester General Hospital Kidd Fund	This work was supported by the Rochester General Hospital Kidd Fund grant awarded to LX. Sponsors did not play a role in study design, data collection and analysis, decision to publish or preparation of manuscript.	Atarashi K, 2011, CURR OPIN IMMUNOL, V23, P761, DOI 10.1016/j.coi.2011.11.002; Badal VD, 2019, MICROBIOME, V7, DOI 10.1186/s40168-019-0742-2; Bergenfelz Caroline, 2017, Curr Otorhinolaryngol Rep, V5, P115, DOI 10.1007/s40136-017-0152-6; Biesbroek G, 2014, AM J RESP CRIT CARE, V190, P1283, DOI 10.1164/rccm.201407-1240OC; Bomar L, 2018, CURR OPIN MICROBIOL, V41, P8, DOI 10.1016/j.mib.2017.10.023; Bomar L, 2016, MBIO, V7, DOI 10.1128/mBio.01725-15; Bousbia S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032486; Brugger SD, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005633; Callahan BJ, 2016, NAT METHODS, V13, P581, DOI [10.1038/NMETH.3869, 10.1038/nmeth.3869]; Chapman TJ, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0243942; Chien YW, 2013, PEDIATR INFECT DIS J, V32, P72, DOI 10.1097/INF.0b013e318270d850; Dunne EM, 2013, VACCINE, V31, P2333, DOI 10.1016/j.vaccine.2013.03.024; Edouard S, 2018, EUR J CLIN MICROBIOL, V37, P1725, DOI 10.1007/s10096-018-3305-8; Enoksson F, 2020, INFECT IMMUN, V88, DOI 10.1128/IAI.00147-20; Feldman Charles, 2016, F1000Res, V5, P2320; Friedel V, 2013, PEDIATR INFECT DIS J, V32, P27, DOI 10.1097/INF.0b013e31826f6144; Funke G, 1997, CLIN MICROBIOL REV, V10, P125, DOI 10.1128/CMR.10.1.125; Hardy BL, 2021, J BACTERIOL, V203, DOI 10.1128/JB.00480-20; Ibironke O, 2020, GIGASCIENCE, V9, DOI 10.1093/gigascience/giaa038; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Kalu SU, 2011, PEDIATR INFECT DIS J, V30, P95, DOI 10.1097/INF.0b013e3181f253d5; Kanmani P, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01613; Kaspar U, 2016, ENVIRON MICROBIOL, V18, P2130, DOI 10.1111/1462-2920.12891; Kaur R, 2017, PEDIATRICS, V140, DOI 10.1542/peds.2017-0181; Kayhty H, 2009, IMMUNOLOGICAL BASIS; Kelly MS, 2017, PEDIATR INFECT DIS J, V36, pE211, DOI 10.1097/INF.0000000000001607; Khamis A, 2004, J CLIN MICROBIOL, V42, P3925, DOI 10.1128/JCM.42.9.3925-3931.2004; Koliou MG, 2018, BMC PEDIATR, V18, DOI 10.1186/s12887-018-1119-6; Kong P, 2005, J MICROBIOL METH, V61, P25, DOI 10.1016/j.mimet.2004.10.019; Kriegel MA, 2011, P NATL ACAD SCI USA, V108, P11548, DOI 10.1073/pnas.1108924108; Lappan R, 2018, BMC MICROBIOL, V18, DOI 10.1186/s12866-018-1154-3; Laufer AS, 2011, MBIO, V2, DOI 10.1128/mBio.00245-10; Lemon KP, 2010, MBIO, V1, DOI 10.1128/mBio.00129-10; Lieberthal AS, 2013, PEDIATRICS, V131, pE964, DOI 10.1542/peds.2012-3488; Man WH, 2017, NAT REV MICROBIOL, V15, P259, DOI 10.1038/nrmicro.2017.14; McCauley K, 2019, J ALLERGY CLIN IMMUN, V144, P1187, DOI 10.1016/j.jaci.2019.05.035; Mika M, 2015, J ALLERGY CLIN IMMUN, V135, P905, DOI 10.1016/j.jaci.2014.12.1909; Neumann RP, 2018, ERJ OPEN RES, V4, DOI 10.1183/23120541.00066-2018; Moyano RO, 2020, MICROORGANISMS, V8, DOI 10.3390/microorganisms8050727; Patel JA, 2009, PEDIATR INFECT DIS J, V28, P1002, DOI 10.1097/INF.0b013e3181aa5b13; Perez AC, 2014, PATHOG DIS, V70, P280, DOI 10.1111/2049-632X.12129; Petraitiene S, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1149-8; Pettigrew MM, 2008, EMERG INFECT DIS, V14, P1584, DOI 10.3201/eid1410.080119; Pettigrew MM, 2012, APPL ENVIRON MICROB, V78, P6262, DOI 10.1128/AEM.01051-12; Pichichero ME, 2016, PEDIATR INFECT DIS J, V35, P1027, DOI 10.1097/INF.0000000000001216; Pichichero ME, 2013, PEDIATR CLIN N AM, V60, P391, DOI 10.1016/j.pcl.2012.12.007; Pichichero ME, 2010, VACCINE, V28, P7184, DOI 10.1016/j.vaccine.2010.08.063; Piters WAAD, 2020, CELL HOST MICROBE, V28, P223, DOI 10.1016/j.chom.2020.07.004; Piters WAAD, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10814-9; Planer JD, 2016, NATURE, V534, P263, DOI 10.1038/nature17940; Ren DB, 2019, CLIN INFECT DIS, V68, P1566, DOI 10.1093/cid/ciy750; Round JL, 2010, J AUTOIMMUN, V34, pJ220, DOI 10.1016/j.jaut.2009.11.007; Santee CA, 2016, MICROBIOME, V4, DOI 10.1186/s40168-016-0179-9; Stubbendieck RM, 2019, APPL ENVIRON MICROB, V85, DOI 10.1128/AEM.02406-18; Toivonen L, 2019, THORAX, V74, P592, DOI 10.1136/thoraxjnl-2018-212629; Weiser JN, 2018, NAT REV MICROBIOL, V16, P354, DOI 10.1038/s41579-018-0001-8; Wortham JM, 2014, CLIN INFECT DIS, V58, P1250, DOI 10.1093/cid/ciu108; Xu L, 2021, INT J PEDIATR OTORHI, V143, DOI 10.1016/j.ijporl.2021.110629; Xu QF, 2017, J INFECTION, V75, P26, DOI 10.1016/j.jinf.2017.04.003; Xu QF, 2012, EMERG INFECT DIS, V18, P1738, DOI 10.3201/eid1811.111904; Xu QF, 2012, PEDIATR INFECT DIS J, V31, P638, DOI 10.1097/INF.0b013e31824ba6f7	61	2	2	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2021	16	9							e0257207	10.1371/journal.pone.0257207	http://dx.doi.org/10.1371/journal.pone.0257207			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	WG5YY	34529731	Green Published, gold			2022-12-26	WOS:000707071500034
J	Neault, N; O'Reilly, S; Baig, AT; Plaza-Diaz, J; Azimi, M; Farooq, F; Baird, SD; MacKenzie, A				Neault, Nafisa; O'Reilly, Sean; Baig, Aiman Tariq; Plaza-Diaz, Julio; Azimi, Mehrdad; Farooq, Faraz; Baird, Stephen D.; MacKenzie, Alex			High-throughput kinome-RNAi screen identifies protein kinase R activator (PACT) as a novel genetic modifier of CUG foci integrity in myotonic dystrophy type 1 (DM1)	PLOS ONE			English	Article							TRINUCLEOTIDE REPEAT; SKELETAL-MUSCLE; RECEPTOR; EXPANSION; OVEREXPRESSION; MECHANISMS; INHIBITORS; MOLECULES; STRESS; MODEL	Myotonic Dystrophy Type 1 (DM1) is the most common form of adult muscular dystrophy (~1:8000). In DM1, expansion of CTG trinucleotide repeats in the 3' untranslated region of the dystrophia myotonica protein kinase (DMPK) gene results in DMPK mRNA hairpin structures which aggregate as insoluble ribonuclear foci and sequester several RNA-binding proteins. The resulting sequestration and misregulation of important splicing factors, such as muscleblind-like 1 (MBNL1), causes the aberrant expression of fetal transcripts for several genes that contribute to the disease phenotype. Previous work has shown that antisense oligonucleotide-mediated disaggregation of the intranuclear foci has the potential to reverse downstream anomalies. To explore whether the nuclear foci are, to some extent, controlled by cell signalling pathways, we have performed a screen using a small interfering RNA (siRNA) library targeting 518 protein kinases to look at kinomic modulation of foci integrity. RNA foci were visualized by in situ hybridization of a fluorescent-tagged (CAG)(10) probe directed towards the expanded DMPK mRNA and the cross-sectional area and number of foci per nuclei were recorded. From our screen, we have identified PACT (protein kinase R (PKR) activator) as a novel modulator of foci integrity and have shown that PACT knockdown can both increase MBNL1 protein levels; however, these changes are not suffcient for significant correction of downstream spliceopathies.	[Neault, Nafisa; O'Reilly, Sean; Baig, Aiman Tariq; Azimi, Mehrdad; Farooq, Faraz; MacKenzie, Alex] Univ Ottawa, Fac Med, Dept Cellular & Mol Med, Ottawa, ON, Canada; [Neault, Nafisa; O'Reilly, Sean; Baig, Aiman Tariq; Plaza-Diaz, Julio; Azimi, Mehrdad; Farooq, Faraz; Baird, Stephen D.; MacKenzie, Alex] Childrens Hosp Eastern Ontario Res Inst, Ottawa, ON, Canada	University of Ottawa; University of Ottawa; Children's Hospital of Eastern Ontario	Neault, N; MacKenzie, A (corresponding author), Univ Ottawa, Fac Med, Dept Cellular & Mol Med, Ottawa, ON, Canada.; Neault, N; MacKenzie, A (corresponding author), Childrens Hosp Eastern Ontario Res Inst, Ottawa, ON, Canada.	ntasn064@uottawa.ca; mackenzie@cheo.on.ca	Baig, Aiman/AAZ-6862-2021; Plaza-Diaz, Julio/C-8094-2016	Baig, Aiman/0000-0002-0467-8017; Plaza-Diaz, Julio/0000-0002-5171-9408; Neault, Nafisa/0000-0002-6870-6013	Genome Canada; Canadian Institutes of Health Research [400349]; Ontario Genomics [OGI-049]; Children's Hospital of Eastern Ontario (CHEO) Foundation; CIHR; E-Rare Joint Transnational Call JTC 2018 "Translational Research Projects on Rare Diseases"; "Fundacion Ramon Areces," Madrid, Spain	Genome Canada(Genome Canada); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Ontario Genomics; Children's Hospital of Eastern Ontario (CHEO) Foundation; CIHR(Canadian Institutes of Health Research (CIHR)); E-Rare Joint Transnational Call JTC 2018 "Translational Research Projects on Rare Diseases"; "Fundacion Ramon Areces," Madrid, Spain	This work was supported by Genome Canada; the Canadian Institutes of Health Research [400349] (https://cihr-irsc.gc.ca/e/193.html), the Ontario Genomics [OGI-049] (http://www.ontariogenomics.ca/), and the Children's Hospital of Eastern Ontario (CHEO) Foundation (https://cheofoundation.donordrive.com/index.cfm?fuseaction=donordrive.home) in the form of funds to AM. This study was funded in part by the CIHR and E-Rare Joint Transnational Call JTC 2018 "Translational Research Projects on Rare Diseases" (ReCognitION project: Recognition and validation of druggable targets from the response to Cognitive Behaviour Therapy in Myotonic Dystrophy type 1 patients from integrated -omics networks). This study was also funded by the "Fundacion Ramon Areces," Madrid, Spain in the form of a grant for postdoctoral researchers at foreign universities and research centers awarded to JP-D. The funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript.	Boutros M, 2008, NAT REV GENET, V9, P554, DOI 10.1038/nrg2364; BROOK JD, 1992, CELL, V68, P799, DOI 10.1016/0092-8674(92)90154-5; Chamberlain CM, 2012, HUM MOL GENET, V21, P4645, DOI 10.1093/hmg/dds306; Charlet-B N, 2002, MOL CELL, V10, P45, DOI 10.1016/S1097-2765(02)00572-5; Courteau L, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.209; Dansithong W, 2005, J BIOL CHEM, V280, P5773, DOI 10.1074/jbc.M410781200; Davis BM, 1997, P NATL ACAD SCI USA, V94, P7388, DOI 10.1073/pnas.94.14.7388; Hino S, 2007, HUM MOL GENET, V16, P2834, DOI 10.1093/hmg/ddm239; Huguet A, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003043; Huichalaf C, 2010, FASEB J, V24, P3706, DOI 10.1096/fj.09-151159; HUNTER A, 1992, J MED GENET, V29, P774, DOI 10.1136/jmg.29.11.774; Jammi NV, 2003, BIOCHEM BIOPH RES CO, V308, P50, DOI 10.1016/S0006-291X(03)01318-4; Kanadia RN, 2006, P NATL ACAD SCI USA, V103, P11748, DOI 10.1073/pnas.0604970103; Karlas A, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11320; Ketley A, 2014, HUM MOL GENET, V23, P1551, DOI 10.1093/hmg/ddt542; Kimura T, 2005, HUM MOL GENET, V14, P2189, DOI 10.1093/hmg/ddi223; Kino Y, 2004, HUM MOL GENET, V13, P495, DOI 10.1093/hmg/ddh056; Lee JE, 2009, BIOCHEM SOC T, V37, P1281, DOI 10.1042/BST0371281; Lee YS, 2020, WIRES RNA, V11, DOI 10.1002/wrna.1558; Li L, 2007, P NATL ACAD SCI USA, V104, P7951, DOI 10.1073/pnas.0701916104; Lin XY, 2006, HUM MOL GENET, V15, P2087, DOI 10.1093/hmg/ddl132; Lo YC, 2019, BIOINFORMATICS, V35, P235, DOI 10.1093/bioinformatics/bty582; Lopez-Morato M, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00349; Mankodi A, 2003, ANN NEUROL, V54, P760, DOI 10.1002/ana.10763; Marques JT, 2008, J INTERF CYTOK RES, V28, P469, DOI 10.1089/jir.2007.0006; Miller JW, 2000, EMBO J, V19, P4439, DOI 10.1093/emboj/19.17.4439; Napierala M, 1997, J BIOL CHEM, V272, P31079, DOI 10.1074/jbc.272.49.31079; Owen M R., 2015, IEEE ANTENNAS WIREL, V14, P1, DOI [10.1016/j.immuni.2010.12.017.Two-stage, DOI 10.1016/J.IMMUNI.2010.12.017.TWO-STAGE]; Patel RC, 1998, EMBO J, V17, P4379, DOI 10.1093/emboj/17.15.4379; Peters GA, 2001, MOL CELL BIOL, V21, P1908, DOI 10.1128/MCB.21.6.1908-1920.2001; Savkur RS, 2001, NAT GENET, V29, P40, DOI 10.1038/ng704; Singh M, 2012, J CELL BIOCHEM, V113, P2754, DOI 10.1002/jcb.24152; Sun C, 2014, TRENDS BIOCHEM SCI, V39, P465, DOI 10.1016/j.tibs.2014.08.010; Tian B, 2000, RNA, V6, P79, DOI 10.1017/S1355838200991544; TSILFIDIS C, 1992, NAT GENET, V1, P192, DOI 10.1038/ng0692-192; Wang PY, 2018, CELL REP, V22, P2294, DOI 10.1016/j.celrep.2018.02.025; Wheeler TM, 2012, NATURE, V488, P111, DOI 10.1038/nature11362; Wojciechowska M, 2014, RNA BIOL, V11, P742, DOI 10.4161/rna.28799	38	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2021	16	9							e0256276	10.1371/journal.pone.0256276	http://dx.doi.org/10.1371/journal.pone.0256276			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	WG5RP	34520479	Green Published, gold			2022-12-26	WOS:000707052100006
J	Setayesh, L; Ebrahimi, R; Pooyan, S; Yarizadeh, H; Rashidbeygi, E; Badrooj, N; Imani, H; Mirzaei, K				Setayesh, Leila; Ebrahimi, Reyhane; Pooyan, Sara; Yarizadeh, Habib; Rashidbeygi, Elaheh; Badrooj, Negin; Imani, Hossein; Mirzaei, Khadijeh			The possible mediatory role of adipokines in the association between low carbohydrate diet and depressive symptoms among overweight and obese women	PLOS ONE			English	Article							INFLAMMATORY BIOMARKER; LOW-FAT; STRESS; WEIGHT; ADULTS; MOOD; DISORDERS; SCALES	Background Previous studies showed the possible association between obesity, dietary pattern, and depressive symptoms. Due to the lack of enough data to confirm the association of obesity and depression in the Middle East, here, we aimed to explore the possible mediatory role of adipokines Galectin-3, transforming growth factor-beta (TGF-beta), and endothelial plasminogen activator inhibitor (PAI-1) in the association between low carbohydrate diet (LCD) and depressive symptoms. Methods A total of 256 women aged 17-56 years old were grouped based on their LCD score. Depression anxiety stress scales-21 (DASS-21) self-administered questionnaire was used to evaluate the three negative emotional states of stress, depressive symptoms, and anxiety. Body composition and dietary intake were assessed. Enzyme-linked immunosorbent assay (ELISA) was used to measure the serum levels of Galectin-3, TGF-beta, and PAI-1. Results No significant difference was observed regarding Galectin-3, TGF-beta, and PAI-1 levels between the groups with dissimilar adherence to LCD or the groups with different levels of depressive symptoms (P>0.05). However, there was a negative association between LCD score as a covariant and depressive symptoms as an independent variable (P = 0.02) and remarkably, a regression model linear analysis using Galectin-3, TGF-beta, and PAI-1 as confounding variables indicated the mediatory role of these adipokines in this association (P>0.05). In other words, adipokines eliminated the significance of the relationship between adherence to LCD and depressive symptoms. Conclusion It seems that higher adherence to LCD is probably associated with a lower prevalence of depressive symptoms in obese adults through the mediatory role of adipokines.	[Setayesh, Leila; Pooyan, Sara; Yarizadeh, Habib; Rashidbeygi, Elaheh; Badrooj, Negin; Mirzaei, Khadijeh] Univ Tehran Med Sci, Sch Nutr Sci & Dietet, Dept Community Nutr, Tehran, Iran; [Setayesh, Leila; Ebrahimi, Reyhane] Univ Tehran Med Sci, Students Sci Res Ctr SSRC, Tehran, Iran; [Ebrahimi, Reyhane] Univ Tehran Med Sci, Sch Med, Dept Clin Biochem, Tehran, Iran; [Imani, Hossein] Univ Tehran Med Sci, Sch Nutr Sci & Dietet, Dept Clin Nutr, Tehran, Iran	Tehran University of Medical Sciences; Tehran University of Medical Sciences; Tehran University of Medical Sciences; Tehran University of Medical Sciences	Mirzaei, K (corresponding author), Univ Tehran Med Sci, Sch Nutr Sci & Dietet, Dept Community Nutr, Tehran, Iran.; Imani, H (corresponding author), Univ Tehran Med Sci, Sch Nutr Sci & Dietet, Dept Clin Nutr, Tehran, Iran.	dr.imani20@gmail.com; mirzaei_kh@tums.ac.ir	Ebrahimi, Reyhane/HGB-1088-2022	Ebrahimi, Reyhane/0000-0003-4938-2639; Setayesh, Leila/0000-0002-5617-7310	Tehran University of Medical Sciences [34988, 34479, 33893, 33833]	Tehran University of Medical Sciences(Tehran University of Medical Sciences)	This study was supported by Tehran University of Medical Sciences (Grant No: 34988, 34479, 33893, 33833). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2017, INT J PEDIATR ENDOCR, P15; Bornstein SR, 2006, MOL PSYCHIATR, V11, P892, DOI 10.1038/sj.mp.4001873; Boyle NB, 2018, NUTRIENTS, V10, DOI 10.3390/nu10020192; Breymeyer KL, 2016, APPETITE, V107, P253, DOI 10.1016/j.appet.2016.08.008; Brinkworth GD, 2009, ARCH INTERN MED, V169, P1873, DOI 10.1001/archinternmed.2009.329; Brouns F, 2018, EUR J NUTR, V57, P1301, DOI 10.1007/s00394-018-1636-y; Brown TA, 1997, BEHAV RES THER, V35, P79, DOI 10.1016/S0005-7967(96)00068-X; Caraci F, 2018, PHARMACOL RES, V130, P374, DOI 10.1016/j.phrs.2018.02.007; Chang E, 2018, CURR DIABETES REP, V18, DOI 10.1007/s11892-018-1031-3; Chooi YC, 2019, METABOLISM, V92, P6, DOI 10.1016/j.metabol.2018.09.005; Churuangsuk C, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-70905-2; Cizza Giovanni, 2011, Dialogues Clin Neurosci, V13, P73; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; D'Anci KE, 2009, APPETITE, V52, P96, DOI 10.1016/j.appet.2008.08.009; Del Olmo N, 2018, FRONT CELL NEUROSCI, V12, DOI 10.3389/fncel.2018.00439; Ebrahimi R, 2020, DIABETOL METAB SYNDR, V12, DOI 10.1186/s13098-020-00544-0; Ebrahimi R, 2022, ARCH PHYSIOL BIOCHEM, V128, P24, DOI 10.1080/13813455.2019.1661496; Eslamian G, 2014, ARCH IRAN MED, V17, P417, DOI 014176/AIM.008; Everson-Rose SA, 2018, PSYCHONEUROENDOCRINO, V97, P20, DOI 10.1016/j.psyneuen.2018.07.011; Fan YY, 2019, MEDIAT INFLAMM, V2019, DOI 10.1155/2019/8373060; Farhadnejad H, 2020, NUTR METAB CARDIOVAS, V30, P581, DOI 10.1016/j.numecd.2019.11.012; Francisco V, 2018, BRIT J PHARMACOL, V175, P1569, DOI 10.1111/bph.14181; Guo YZ, 2020, LIFE SCI, V258, DOI 10.1016/j.lfs.2020.118124; Hall KD, 2018, MED CLIN N AM, V102, P183, DOI 10.1016/j.mcna.2017.08.012; Hass U, 2019, NUTRIENTS, V11, DOI 10.3390/nu11102315; Heggen E, 2012, METAB SYNDR RELAT D, V10, P437, DOI 10.1089/met.2012.0012; Hognogi LDM, 2018, DIS MARKERS, V2018, DOI 10.1155/2018/3406028; King DR, 2021, J AFFECT DISORDERS, V281, P384, DOI 10.1016/j.jad.2020.12.050; Ladwig KH, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-71204-6; Larsen SC, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0213573; Lu XY, 2007, CURR OPIN PHARMACOL, V7, P648, DOI 10.1016/j.coph.2007.10.010; Maddahi NS, 2020, BMC RES NOTES, V13, DOI 10.1186/s13104-020-05025-1; Melin EO, 2018, ENDOCR CONNECT, V7, P819, DOI 10.1530/EC-18-0108; Miranda AM, 2019, TRANSL PSYCHIAT, V9, DOI 10.1038/s41398-019-0478-6; Mirmiran P, 2011, J HEALTH POPUL NUTR, V29, P39; Mooradian AD, 2020, J NUTR HEALTH AGING, V24, P805, DOI 10.1007/s12603-020-1417-1; Moradi N, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192159; Natvik E, 2018, INT J QUAL STUD HEAL, V13, DOI 10.1080/17482631.2018.1487762; Nobis A, 2020, J CLIN MED, V9, DOI 10.3390/jcm9123793; Philippou E, 2019, PUBLIC HEALTH NUTR, V22, P1415, DOI 10.1017/S136898001800352X; PRICE DD, 1983, PAIN, V17, P45, DOI 10.1016/0304-3959(83)90126-4; Rajan TM, 2017, J POSTGRAD MED, V63, P182, DOI 10.4103/jpgm.JPGM_712_16; Singh M, 2019, SLEEP BREATH, V23, P1107, DOI 10.1007/s11325-019-01788-5; Stoica RA, 2021, EXP THER MED, V21, DOI 10.3892/etm.2020.9522; Tan LJ, 2020, NUTRIENTS, V12, DOI 10.3390/nu12051307; Tavakoli A, 2021, BMC WOMENS HEALTH, V21, DOI 10.1186/s12905-021-01240-5; Taylor VH, 2010, J OBES, V2010, DOI 10.1155/2010/748048; Trepanowski JF, 2018, CLIN NUTR, V37, P1871, DOI 10.1016/j.clnu.2017.11.018; Tyagi K, 2021, DIABET METAB SYND OB, V14, P705, DOI 10.2147/DMSO.S294555; van der Valk ES, 2018, CURR OBES REP, V7, P193, DOI 10.1007/s13679-018-0306-y; van Rossum EFC, 2017, OBESITY, V25, P500, DOI 10.1002/oby.21774; Blasco BV, 2020, PSYCHIAT INVEST, V17, P715, DOI 10.30773/pi.2020.0099; Vink RG, 2017, PHYSIOL REP, V5, DOI 10.14814/phy2.13450; Weiss F, 2020, J CLIN MED, V9, DOI 10.3390/jcm9082344; Wharton S, 2020, CAN MED ASSOC J, V192, pE875, DOI 10.1503/cmaj.191707; Yarizadeh H, 2020, BMC RES NOTES, V13, DOI 10.1186/s13104-020-04976-9	56	1	1	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2021	16	9							e0257275	10.1371/journal.pone.0257275	http://dx.doi.org/10.1371/journal.pone.0257275			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	WG6OR	34516574	gold, Green Published			2022-12-26	WOS:000707114200022
J	Chen, C; Huang, XS; Zhu, WQ; Ding, C; Huang, PP; Li, R				Chen, Chang; Huang, Xiansheng; Zhu, Wenqiang; Ding, Chen; Huang, Piaopiao; Li, Rong			H2O2 gel bleaching induces cytotoxicity and pain conduction in dental pulp stem cells via intracellular reactive oxygen species on enamel/dentin disc	PLOS ONE			English	Article							POTENTIAL ANKYRIN 1; HYDROGEN-PEROXIDE; OXIDATIVE STRESS; RECEPTOR; TRPA1; CHANNELS; TOOTH; HYPERALGESIA; ACTIVATION; RESPONSES	Background Bleaching is widely accepted for improving the appearance of discolored teeth; however, patient compliance is affected by bleaching-related complications, especially bleaching sensitivity. This study aimed to investigate the role of reactive oxygen species (ROS) in cytotoxicity and pain conduction activated by experimental tooth bleaching. Methods Dental pulp stem cells with or without N-acetyl-L-cysteine (NAC), an ROS scavenger, were cultured on the dentin side of the enamel/dentin disc. Subsequently, 15% (90 min) and 40% (30 min) bleaching gels were painted on the enamel surface. Cell viability, intracellular ROS, Ca2+, adenosine triphosphate (ATP), and extracellular ATP levels were evaluated using the Cell Counting Kit-8 assay, 2',7'-dichlorodihydrofluorescein diacetate, CellROX, fura-3AM fluorescence assay, and ATP measurement kit. The rat incisor model was used to evaluate in vivo effects after 0, 1, 3, 7, and 30 days of bleaching. Changes in gene and protein expression of interleukin 6 (IL-6), tumor necrosis factor-alpha (TNF alpha), transient receptor potential ankyrin 1 (TRPA1), and Pannexin1 (PANX1) in dental pulp stem cells and pulp tissue were detected through RT-PCR, western blotting, and immunofluorescence. Results The bleaching gel suppressed dental pulp stem cell viability and extracellular ATP levels and increased intracellular ROS, Ca2+, and intracellular ATP levels. The mRNA and protein expression of IL-6, TNF alpha, TRPA1, and PANX1 were up-regulated in vitro and in vivo. Furthermore, the 40% gel had a stronger effect than the 15% gel, and NAC ameliorated the gel effects. Conclusions Our findings suggest that bleaching gels induce cytotoxicity and pain conduction in dental pulp stem cells via intracellular ROS, which may provide a potential therapeutic target for alleviating tooth bleaching nociception.	[Chen, Chang; Li, Rong] Cent South Univ, Xiangya Hosp 2, Dept Stomatol, Changsha, Hunan, Peoples R China; [Huang, Xiansheng; Zhu, Wenqiang; Ding, Chen; Huang, Piaopiao] Cent South Univ, Xiangya Hosp 2, Dept Cardiovasc Med, Changsha, Hunan, Peoples R China	Central South University; Central South University	Li, R (corresponding author), Cent South Univ, Xiangya Hosp 2, Dept Stomatol, Changsha, Hunan, Peoples R China.	rongli@csu.edu.cn			National Nature Science Foundation of China [81700999, 81974281]; Science Foundation of Hunan Province [2018JJ3741, 2020JJ2052]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science Foundation of Hunan Province	This work was financially supported by National Nature Science Foundation of China (Nos. 81700999 and 81974281) and Science Foundation of Hunan Province (Nos. 2018JJ3741 and 2020JJ2052).	Akarslan Zuhre Zafersoy, 2009, Indian J Dent Res, V20, P195, DOI 10.4103/0970-9290.52902; Andersson DA, 2008, J NEUROSCI, V28, P2485, DOI 10.1523/JNEUROSCI.5369-07.2008; Cintra LTA, 2013, J ENDODONT, V39, P1576, DOI 10.1016/j.joen.2013.08.007; Bautista DM, 2006, CELL, V124, P1269, DOI 10.1016/j.cell.2006.02.023; Benetti F, 2017, ARCH ORAL BIOL, V81, P103, DOI 10.1016/j.archoralbio.2017.04.013; Bravo D, 2015, PHARMACOL RES, V101, P86, DOI 10.1016/j.phrs.2015.07.016; Bravo D, 2014, PAIN, V155, P2108, DOI 10.1016/j.pain.2014.07.024; Chew JRJ, 2019, ACTA BIOMATER, V89, P252, DOI 10.1016/j.actbio.2019.03.021; Costa RTF, 2020, OPER DENT, V45, pE66, DOI 10.2341/18-250-L; De Colli M, 2015, CLIN ORAL INVEST, V19, P1269, DOI 10.1007/s00784-014-1344-9; Costa CAD, 2010, ORAL SURG ORAL MED O, V109, pE59, DOI 10.1016/j.tripleo.2009.12.002; Deng QY, 2019, J DENT SCI, V14, P370, DOI 10.1016/j.jds.2019.05.003; Diomede F, 2020, MATERIALS, V13, DOI 10.3390/ma13010130; El Karim IA, 2011, J ENDODONT, V37, P473, DOI 10.1016/j.joen.2010.12.017; Galluzzi L, 2018, CELL DEATH DIFFER, V25, P486, DOI 10.1038/s41418-017-0012-4; Ha J, 2021, BIOMED RES INT, V2021, DOI 10.1155/2021/8858412; Hall BE, 2016, J DENT RES, V95, P188, DOI 10.1177/0022034515612022; Haug SR, 2019, J ORAL FACIAL PAIN H, V33, P227, DOI 10.11607/ofph.2007; Hernandez-Monjaraz B, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19040944; Hewlett Edmond R, 2007, J Calif Dent Assoc, V35, P499; Huang PF, 2014, TOXINS, V6, P2568, DOI 10.3390/toxins6082568; Jiang LW, 2019, J HEADACHE PAIN, V20, DOI 10.1186/s10194-019-0978-z; Julius D, 2013, ANNU REV CELL DEV BI, V29, P355, DOI 10.1146/annurev-cellbio-101011-155833; KIM S, 1990, J ENDODONT, V16, P48, DOI 10.1016/S0099-2399(06)81563-3; Kim YS, 2012, J ENDODONT, V38, P1087, DOI 10.1016/j.joen.2012.04.024; Kothari S, 2019, J DENT, V84, P22, DOI 10.1016/j.jdent.2019.03.007; Llena C, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-44223-1; Martacic JD, 2016, ARCH ORAL BIOL, V70, P32, DOI 10.1016/j.archoralbio.2016.06.002; Pecci-Lloret MP, 2017, J CRANIOFAC SURG, V28, P939, DOI 10.1097/SCS.0000000000003596; Perczel-Kovach K, 2021, ARCH ORAL BIOL, V122, DOI 10.1016/j.archoralbio.2020.104995; Rodrigues FT, 2017, WEAR, V374, P21, DOI 10.1016/j.wear.2016.11.001; Schiavuzzo JG, 2015, NEUROSCIENCE, V285, P24, DOI 10.1016/j.neuroscience.2014.11.020; Shi Y, 2019, CCS CHEM, V1, P373, DOI 10.31635/ccschem.019.20190017; Sinha K, 2013, ARCH TOXICOL, V87, P1157, DOI 10.1007/s00204-013-1034-4; Soares DG, 2015, ARCH ORAL BIOL, V60, P1428, DOI 10.1016/j.archoralbio.2015.06.014; Soares DG, 2015, J DENT, V43, P750, DOI 10.1016/j.jdent.2014.12.006; Soares DG, 2014, J DENT, V42, P185, DOI 10.1016/j.jdent.2013.10.021; Soares DG, 2013, CLIN ORAL INVEST, V17, P1901, DOI 10.1007/s00784-012-0883-1; Stanford KR, 2019, BRAIN RES, V1715, P94, DOI 10.1016/j.brainres.2019.03.029; Sugiyama D, 2017, ANESTHESIOLOGY, V127, P695, DOI 10.1097/ALN.0000000000001756; Sun WW, 2016, CELL STRESS CHAPERON, V21, P367, DOI 10.1007/s12192-015-0663-3; Trevisan G, 2014, FREE RADICAL BIO MED, V72, P200, DOI 10.1016/j.freeradbiomed.2014.04.021; Vaz MM, 2016, J APPL ORAL SCI, V24, P509, DOI 10.1590/1678-775720160137; Viana F, 2016, J PHYSIOL-LONDON, V594, P4151, DOI 10.1113/JP270935; Wang S, 2018, NEUROSCIENCE, V384, P290, DOI 10.1016/j.neuroscience.2018.05.048; Xie H, 2017, DENT MATER, V33, pE13, DOI 10.1016/j.dental.2016.09.030; Zhang Y, 2019, OXID MED CELL LONGEV, V2019, DOI 10.1155/2019/1301736	47	6	6	3	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2021	16	9							e0257221	10.1371/journal.pone.0257221	http://dx.doi.org/10.1371/journal.pone.0257221			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XM9EM	34506603	gold, Green Published			2022-12-26	WOS:000729120700086
J	Costeira, R; Lee, KRA; Murray, B; Christiansen, C; Castillo-Fernandez, J; Lochlainn, MN; Pujol, JC; Macfarlane, H; Kenny, LC; Buchan, I; Wolf, J; Rymer, J; Ourselin, S; Steves, CJ; Spector, TD; Newson, LR; Bell, JT				Costeira, Ricardo; Lee, Karla A.; Murray, Benjamin; Christiansen, Colette; Castillo-Fernandez, Juan; Ni Lochlainn, Mary; Capdevila Pujol, Joan; Macfarlane, Heather; Kenny, Louise C.; Buchan, Iain; Wolf, Jonathan; Rymer, Janice; Ourselin, Sebastien; Steves, Claire J.; Spector, Timothy D.; Newson, Louise R.; Bell, Jordana T.			Estrogen and COVID-19 symptoms: Associations in women from the COVID Symptom Study	PLOS ONE			English	Article							ACUTE RESPIRATORY SYNDROME; HUMAN-PAPILLOMAVIRUS; SEX-DIFFERENCES; PREVALENCE; INFECTION; HORMONES	It has been widely observed that adult men of all ages are at higher risk of developing serious complications from COVID-19 when compared with women. This study aimed to investigate the association of COVID-19 positivity and severity with estrogen exposure in women, in a population based matched cohort study of female users of the COVID Symptom Study application in the UK. Analyses included 152,637 women for menopausal status, 295,689 women for exogenous estrogen intake in the form of the combined oral contraceptive pill (COCP), and 151,193 menopausal women for hormone replacement therapy (HRT). Data were collected using the COVID Symptom Study in May-June 2020. Analyses investigated associations between predicted or tested COVID-19 status and menopausal status, COCP use, and HRT use, adjusting for age, smoking and BMI, with follow-up age sensitivity analysis, and validation in a subset of participants from the TwinsUK cohort. Menopausal women had higher rates of predicted COVID-19 (P = 0.003). COCP-users had lower rates of predicted COVID-19 (P = 8.03E-05), with reduction in hospital attendance (P = 0.023). Menopausal women using HRT or hormonal therapies did not exhibit consistent associations, including increased rates of predicted COVID-19 (P = 2.22E-05) for HRT users alone. The findings support a protective effect of estrogen exposure on COVID-19, based on positive association between predicted COVID-19 with menopausal status, and negative association with COCP use. HRT use was positively associated with COVID-19, but the results should be considered with caution due to lack of data on HRT type, route of administration, duration of treatment, and potential unaccounted for confounders and comorbidities.	[Costeira, Ricardo; Lee, Karla A.; Christiansen, Colette; Castillo-Fernandez, Juan; Ni Lochlainn, Mary; Steves, Claire J.; Spector, Timothy D.; Bell, Jordana T.] Kings Coll London, Dept Twin Res & Genet Epidemiol, London, England; [Murray, Benjamin; Ourselin, Sebastien] Kings Coll London, Sch Biomed Engn Imaging Sci, London, England; [Capdevila Pujol, Joan; Wolf, Jonathan] Zoe Global Ltd, London, England; [Macfarlane, Heather] Univ Liverpool, Dept Womens & Childrens Hlth, Liverpool, Merseyside, England; [Kenny, Louise C.] Univ Liverpool, Dept Publ Hlth Policy & Syst, Liverpool, Merseyside, England; [Buchan, Iain] Kings Coll London, Dept Womens Hlth, London, England; [Rymer, Janice] Newson Hlth Menopause Wellbeing Ctr, Stratford Upon Avon, England	University of London; King's College London; University of London; King's College London; University of Liverpool; University of Liverpool; University of London; King's College London	Bell, JT (corresponding author), Kings Coll London, Dept Twin Res & Genet Epidemiol, London, England.	jordana.bell@kcl.ac.uk	Kenny, Louise/G-1112-2011; Ourselin, Sebastien/K-6960-2015; Buchan, Iain/H-5767-2013	Kenny, Louise/0000-0002-9011-759X; Ourselin, Sebastien/0000-0002-5694-5340; Ni Lochlainn, Mary/0000-0001-5702-1759; Lee, Karla/0000-0001-5904-5586; Buchan, Iain/0000-0003-3392-1650	Wellcome Trust; MRC/BHF; Alzheimer's Society; EU; NIHR; CDRF; ESRC; European Community's Seventh Framework Programme (FP7/2007-2013); National Institute for Health Research (NIHR); UK Economic and Social Research Council [ES/N000404/1]; NIHR Doctoral Fellowship [NIHR300159]	Wellcome Trust(Wellcome TrustEuropean Commission); MRC/BHF(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Alzheimer's Society; EU(European Commission); NIHR(National Institute for Health Research (NIHR)); CDRF; ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); European Community's Seventh Framework Programme (FP7/2007-2013)(European Commission); National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); UK Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); NIHR Doctoral Fellowship	Zoe Global provided in kind support for all aspects of building, running, and supporting the app and service to all users worldwide. Investigators received support from the Wellcome Trust, the MRC/BHF, Alzheimer's Society, EU, NIHR, CDRF, ESRC. The TwinsUK study was funded by the Wellcome Trust; European Community's Seventh Framework Programme (FP7/2007-2013); National Institute for Health Research (NIHR)-funded BioResource, Clinical Research Facility and Biomedical Research Centre based at Guy's and St Thomas' NHS Foundation Trust in partnership with King's College London. Epigenetic ageing estimates were generated from the UK Economic and Social Research Council (ES/N000404/1 to JTB). MNL is supported by an NIHR Doctoral Fellowship (grant code NIHR300159). Zoe Global provided support in the form of salaries for authors JCP and JW and contributed to data collection which was carried via the Zoe app. The roles of these authors are articulated in the `Author Contributions' section. The funders did not have any additional role in the study design, data analysis, decision to publish, or preparation of the manuscript.	Abbassi-Ghanavati M, 2009, OBSTET GYNECOL, V114, P1326, DOI 10.1097/AOG.0b013e3181c2bde8; Allotey J, 2020, BMJ-BRIT MED J, V370, DOI 10.1136/bmj.m3320; Amer Soc Reprod Med, 2017, FERTIL STERIL, V107, P43, DOI 10.1016/j.fertnstert.2016.09.027; [Anonymous], 1992, BMJ, V304, P809; Aryee MJ, 2014, BIOINFORMATICS, V30, P1363, DOI 10.1093/bioinformatics/btu049; Bereshchenko O, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01332; Channappanavar R, 2017, J IMMUNOL, V198, P4046, DOI 10.4049/jimmunol.1601896; Chen BH, 2016, AGING-US, V8, P1844, DOI 10.18632/aging.101020; Chen YH, 2012, AM J OBSTET GYNECOL, V207, DOI 10.1016/j.ajog.2012.08.023; Davey DA, 2018, CLIMACTERIC, V21, P454, DOI 10.1080/13697137.2018.1439915; Ding T., 2021, CLIN INFECT DIS, V72, pe240, DOI [10.1093/cid/ciaa1022, DOI 10.1093/CID/CIAA1022]; Dominguez-Lopez I, 2020, NUTRIENTS, V12, DOI 10.3390/nu12082456; Du P, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-587; Franceschi S, 2006, INT J CANCER, V119, P2677, DOI 10.1002/ijc.22241; Galluzzi L, 2017, EMBO J, V36, P1811, DOI 10.15252/embj.201796697; Gonzalez P, 2010, CANCER EPIDEM BIOMAR, V19, P3044, DOI 10.1158/1055-9965.EPI-10-0645; Hannah MF, 2008, BRAIN BEHAV IMMUN, V22, P503, DOI 10.1016/j.bbi.2007.10.005; Hannum G, 2013, MOL CELL, V49, P359, DOI 10.1016/j.molcel.2012.10.016; Horvath S, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-10-r115; Jiang J., 2020, 20043943 MEDRXIV; Karlberg J, 2004, AM J EPIDEMIOL, V159, P229, DOI 10.1093/aje/kwh056; Klein SL, 2016, NAT REV IMMUNOL, V16, P626, DOI 10.1038/nri.2016.90; Kurushima Y, 2019, CLIN EPIGENETICS, V11, DOI 10.1186/s13148-019-0614-4; L'Hermite M, 2017, CLIMACTERIC, V20, P331, DOI 10.1080/13697137.2017.1291607; Leong HN, 2006, ANN ACAD MED SINGAP, V35, P326; Levine ME, 2018, AGING-US, V10, P573, DOI 10.18632/aging.101414; Levine ME, 2016, P NATL ACAD SCI USA, V113, P9327, DOI 10.1073/pnas.1604558113; Lu AT, 2019, AGING-US, V11, P303, DOI 10.18632/aging.101684; Lusignan Sd., 2021, 21251853 MEDRXIV; Meditz AL, 2012, JAIDS-J ACQ IMM DEF, V59, P221, DOI 10.1097/QAI.0b013e31823fd215; Menni C, 2020, MEDRXIV, DOI [10.1101/2020.04.05.20048421, 10.1038/s41591-020-0916-2, DOI 10.1038/S41591-020-0916-2]; Menni C, 2020, NAT MED, V26, P1037, DOI 10.1038/s41591-020-0916-2; Molteni E, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-86452-3; Moulton VR, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02279; Olsen NJ, 1996, ENDOCR REV, V17, P369, DOI 10.1210/edrv-17-4-369; Robinson DP, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002149; Scully EP, 2020, NAT REV IMMUNOL, V20, P442, DOI 10.1038/s41577-020-0348-8; Seeland U, 2020, BMC MED, V18, DOI 10.1186/s12916-020-01851-z; Shah NM, 2019, FRONT ENDOCRINOL, V10, DOI 10.3389/fendo.2019.00198; Smith JS, 2008, J ADOLESCENT HEALTH, V43, pS5, DOI 10.1016/j.jadohealth.2008.07.009; Sudre CH, 2021, NAT MED, V27, DOI 10.1038/s41591-021-01292-y; TALAL N, 1981, ARTHRITIS RHEUM, V24, P1054, DOI 10.1002/art.1780240811; Trenti A, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19030859; Vermillion MS, 2018, BIOL SEX DIFFER, V9, DOI 10.1186/s13293-018-0184-8; vom Steeg LG, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005374; Xu ZL, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkv907	46	22	22	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2021	16	9							e0257051	10.1371/journal.pone.0257051	http://dx.doi.org/10.1371/journal.pone.0257051			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XM9EM	34506535	Green Published, gold, Green Accepted, Green Submitted			2022-12-26	WOS:000729120700097
J	Yu, HB; Cao, CM; Zhang, QF; Bao, YH				Yu, Hongbo; Cao, Congming; Zhang, Qiaofeng; Bao, Yuhai			Construction of an evapotranspiration model and analysis of spatiotemporal variation in Xilin River Basin, China	PLOS ONE			English	Article							FLUX; EVAPORATION	Surface evapotranspiration is a water exchange process between the atmosphere, biosphere, and hydrosphere. Accurate evapotranspiration estimations in arid and semi-arid regions are important for monitoring droughts and protecting the ecological environment. The main objective of this study is to build an evapotranspiration estimation model suitable for an effective scientific and objective evaluation of water consumption in the arid and semi-arid regions of the Xilin River Basin based on comprehensive parameters, including meteorological parameters, vegetation coverage, and soil water content. In this study, the community evapotranspiration model was initially constructed using field data, which was then expanded for applicability to the Xilin River Basin based on Geographic Information System technology and spatial heterogeneity characteristics of remote sensing data; both models were significant at the 0.05 level. The monthly evapotranspiration values in July during 2000-2017 and those from April to September (growing season) during the dry, normal, and wet years were calculated using the model at the basin scale. The evapotranspiration showed a generally increasing trend, which was consistent with the fluctuation trend in precipitation in July during 2000-2017. The trend curve for evapotranspiration was gentle during the growing season in dry years, but steep during wet years. The evapotranspiration was the lowest in April, with negligible spatial variations throughout the Xilin River Basin. During May-July, the evapotranspiration was higher than that in other months, in the following order: upper reaches > middle reaches > lower reaches; this was consistent with the vegetation coverage. The evapotranspiration declined and spatial variations were not evident during August-September. The results of this study provide a reference for evapotranspiration model construction and a scientific basis for evaluating regional water resources and protecting the ecological environment.	[Yu, Hongbo; Cao, Congming; Zhang, Qiaofeng] Inner Mongolia Normal Univ, Sch Geog Sci, Hohhot, Peoples R China; [Yu, Hongbo; Zhang, Qiaofeng; Bao, Yuhai] Inner Mongolia Normal Univ, Inner Mongolia Key Lab Remote Sensing & Geog Info, Hohhot, Peoples R China	Inner Mongolia Normal University; Inner Mongolia Normal University	Zhang, QF (corresponding author), Inner Mongolia Normal Univ, Sch Geog Sci, Hohhot, Peoples R China.; Zhang, QF (corresponding author), Inner Mongolia Normal Univ, Inner Mongolia Key Lab Remote Sensing & Geog Info, Hohhot, Peoples R China.	zhangqf@imnu.edu.cn			National Natural Science Foundation of China [41661009, 41961144019, 61631011]; Inner Mongolia Natural Science Foundation [2021MS04015]; National Science and Technology Support Projects of China [2013BAK05B01]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Inner Mongolia Natural Science Foundation; National Science and Technology Support Projects of China	This study was financially supported by the National Natural Science Foundation of China (No. 41661009, No. 41961144019, and No.61631011), the Inner Mongolia Natural Science Foundation (No. 2021MS04015), and the National Science and Technology Support Projects of China under Grant No. 2013BAK05B01. We would like to thank the anonymous reviewers for providing constructive suggestions, and to thank the MODIS and Landsat science teams for providing accessible data products.	Aboutalebi M, 2020, REMOTE SENS-BASEL, V12, DOI 10.3390/rs12010050; Allen R. G., 1998, FAO Irrigation and Drainage Paper; [钞然 Chao Ran], 2018, [干旱区研究, Arid Zone Research], V35, P1068; Congming C., 2018, 8 ANN M RISK AN COUN, DOI [10.1073/pnas.1804225115, DOI 10.1073/PNAS.1804225115]; DOLMAN AJ, 1993, AGR FOREST METEOROL, V65, P21, DOI 10.1016/0168-1923(93)90036-H; Du T, 2020, REMOTE SENS-BASEL, V12, DOI 10.3390/rs12091434; Fisher JB, 2008, REMOTE SENS ENVIRON, V112, P901, DOI 10.1016/j.rse.2007.06.025; Fisher JB, 2011, GLOBAL ECOL BIOGEOGR, V20, P1, DOI 10.1111/j.1466-8238.2010.00578.x; [郭剑 Guo Jian], 2017, [地理研究, Geographical Research], V36, P37; [郭晓寅 Guo Xiaoyin], 2004, [地球科学进展, Advance in Earth Sciences], V19, P107; Hadria R, 2021, J ARID ENVIRON, V184, DOI 10.1016/j.jaridenv.2020.104318; [哈斯塔木嘎 Hasitamuga], 2017, [灾害学, Journal of Catastrophology], V32, P90; Hongbo Y., 2017, RES SOIL WATER CONSE, V24, P367; Hou Qiong, 2011, Acta Prataculturae Sinica, V20, P34; Hssaine BA, 2020, HYDROL EARTH SYST SC, V24, P1781, DOI 10.5194/hess-24-1781-2020; Hu ZM, 2009, AGR FOREST METEOROL, V149, P1410, DOI 10.1016/j.agrformet.2009.03.014; Kachholz F, 2020, WATER-SUI, V12, DOI 10.3390/w12113089; Li ChunMei, 2004, Ganhanqu Yanjiu (Arid Zone Research), V21, P338; [李霞 Li Xia], 2020, [水土保持研究, Research of Soil and Water Conservation], V27, P153; [刘国水 Liu Guoshui], 2011, [水利学报, Journal of Hydraulic Engineering], V42, P284; [刘绍民 Liu Shaomin], 2003, [自然资源学报, Journal of Natural Resources], V18, P161; Liu Yu, 2000, Transactions of the Chinese Society of Agricultural Engineering, V16, P26; Meng W, 2019, AGR WATER MANAGE, V226, DOI 10.1016/j.agwat.2019.105804; Mingyang L., 2019, ART GRAND VIEW, P1; Monteith J L, 1965, Symp Soc Exp Biol, V19, P205; Nagler PL, 2007, J ARID ENVIRON, V70, P443, DOI 10.1016/j.jaridenv.2006.12.026; Oki T, 2006, SCIENCE, V313, P1068, DOI 10.1126/science.1128845; PRIESTLEY CHB, 1972, MON WEATHER REV, V100, P81, DOI 10.1175/1520-0493(1972)100<0081:OTAOSH>2.3.CO;2; Rosenberg N.J., 1983, MICROCLIMATE BIOL EN; Shi LJ, 2020, J HYDROL, V590, DOI 10.1016/j.jhydrol.2020.125394; SHUTTLEWORTH WJ, 1985, Q J ROY METEOR SOC, V111, P839, DOI 10.1256/smsqj.46909; Suli P., 2019, ATMOSPHERE-BASEL, V10, DOI [10.3390/atmos10080464, DOI 10.3390/ATMOS10080464]; Sun SK, 2020, AGR FOREST METEOROL, V291, DOI 10.1016/j.agrformet.2020.108056; Wang Jing, 2007, Shengtaixue Zazhi, V26, P1148; Wang S, 2019, AGR WATER MANAGE, V221, P220, DOI 10.1016/j.agwat.2019.03.027; [王学 Wang Xue], 2013, [地理学报, Acta Geographica Sinica], V68, P694; Wang Yong-Fen, 2008, Zhiwu Shengtai Xuebao, V32, P1052, DOI 10.3773/j.issn.1005-264x.2008.05.010; Wang ZiShen, 2016, Transactions of the Chinese Society of Agricultural Engineering, V32, P126; Wei C., 2013, ACTA AGRESTIA SINICA, V21, P244; Wei GX, 2020, WATER RESOUR RES, V56, DOI 10.1029/2020WR027367; Wei GX, 2019, HYDROL EARTH SYST SC, V23, P2877, DOI 10.5194/hess-23-2877-2019; Wen YeQiang, 2017, Transactions of the Chinese Society of Agricultural Engineering, V33, P138; [吴方涛 Wu Fangtao], 2018, [干旱区研究, Arid Zone Research], V35, P306; Wu GN, 2020, J GEOPHYS RES-BIOGEO, V125, DOI 10.1029/2019JG005504; Xiang G., 2020, J AGRIC METEOROL, V76, P155; Xiao Z., 2014, IMPROVEMENT SENSIBLE; Xiaoyan Z., 2016, EVAPOTRANSPIRATION H; [辛晓洲 Xin Xiaozhou], 2003, [遥感学报, Journal of Remote Sensing], V7, P233; Xue JY, 2020, AGR WATER MANAGE, V238, DOI 10.1016/j.agwat.2020.106228; Yadeta D, 2020, MODEL EARTH SYST ENV, V6, P2165, DOI 10.1007/s40808-020-00831-9; Yang Fu-lin, 2013, Yingyong Shengtai Xuebao, V24, P1209; Yaya F., 2018, EFFECTS DIFFERENT MU; Ye J., 2004, CHIN J PLANT ECOL, V34, P1132; [阴晓伟 Yin Xiaowei], 2021, [水文地质工程地质, Hydrogeology & Engineering Geology], V48, P20; Yu B, 2020, REMOTE SENS-BASEL, V12, DOI 10.3390/rs12050865; Yu Hong-bo, 2008, Shengtaixue Zazhi, V27, P1071; [于红博 Yu Hongbo], 2014, [水土保持研究, Research of Soil and Water Conservation], V21, P224; [韩文霆 Han Wenting], 2018, [农业机械学报, Transactions of the Chinese Society for Agricultural Machinery], V49, P134; Zhang QiaoFeng, 2017, Acta Prataculturae Sinica, V26, P1; [张雪峰 Zhang Xuefeng], 2016, [干旱区研究, Arid Zone Research], V33, P814; Zhao LiWen, 2010, Scientia Agricultura Sinica, V43, P4016	61	3	3	30	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2021	16	9							e0256981	10.1371/journal.pone.0256981	http://dx.doi.org/10.1371/journal.pone.0256981			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XM9EM	34506534	gold, Green Published			2022-12-26	WOS:000729120700008
J	Andrisse, S; Feng, MX; Wang, ZQ; Awe, O; Yu, LX; Zhang, HY; Bi, S; Wang, HB; Li, LH; Joseph, S; Heller, N; Mauvais-Jarvis, F; Wong, GW; Segars, J; Wolfe, A; Divall, S; Ahima, R; Wu, S				Andrisse, Stanley; Feng, Mingxiao; Wang, Zhiqiang; Awe, Olubusayo; Yu, Lexiang; Zhang, Haiying; Bi, Sheng; Wang, Hongbing; Li, Linhao; Joseph, Serene; Heller, Nicola; Mauvais-Jarvis, Franck; Wong, Guang William; Segars, James; Wolfe, Andrew; Divall, Sara; Ahima, Rexford; Wu, Sheng			Androgen-induced insulin resistance is ameliorated by deletion of hepatic androgen receptor in females	FASEB JOURNAL			English	Article						androgen; androgen receptor; glucose; insulin signaling; liver; PCOS	POLYCYSTIC-OVARY-SYNDROME; LOW-DOSE DIHYDROTESTOSTERONE; METABOLIC DYSFUNCTION; LIVER; MODEL; MICE; ENDOCRINE; KNOCKOUT; EXCESS; DAMS	Androgen excess is one of the most common endocrine disorders of reproductive-aged women, affecting up to 20% of this population. Women with elevated androgens often exhibit hyperinsulinemia and insulin resistance. The mechanisms of how elevated androgens affect metabolic function are not clear. Hyperandrogenemia in a dihydrotestosterone (DHT)-treated female mouse model induces whole body insulin resistance possibly through activation of the hepatic androgen receptor (AR). We investigated the role of hepatocyte AR in hyperandrogenemia-induced metabolic dysfunction by using several approaches to delete hepatic AR via animal-, cell-, and clinical-based methodologies. We conditionally disrupted hepatocyte AR in female mice developmentally (LivARKO) or acutely by tail vein injection of an adeno-associated virus with a liver-specific promoter for Cre expression in AR(fl/fl) mice (adLivARKO). We observed normal metabolic function in littermate female Control (AR(fl/fl)) and LivARKO (AR(fl/fl); Cre(+/-)) mice. Following chronic DHT treatment, female Control mice treated with DHT (Con-DHT) developed impaired glucose tolerance, pyruvate tolerance, and insulin tolerance, not observed in LivARKO mice treated with DHT (LivARKO-DHT). Furthermore, during an euglycemic hyperinsulinemic clamp, the glucose infusion rate was improved in LivARKO-DHT mice compared to Con-DHT mice. Liver from LivARKO, and primary hepatocytes derived from LivARKO, and adLivARKO mice were protected from DHT-induced insulin resistance and increased gluconeogenesis. These data support a paradigm in which elevated androgens in females disrupt metabolic function via hepatic AR and insulin sensitivity was restored by deletion of hepatic AR.	[Andrisse, Stanley; Feng, Mingxiao; Wang, Zhiqiang; Awe, Olubusayo; Yu, Lexiang; Wolfe, Andrew; Wu, Sheng] Johns Hopkins Univ, Sch Med, Dept Pediat, Baltimore, MD 21205 USA; [Andrisse, Stanley] Howard Univ, Dept Physiol & Biophys, Washington, DC 20059 USA; [Awe, Olubusayo; Wong, Guang William; Wu, Sheng] Johns Hopkins Univ, Sch Med, Dept Cellular & Mol Physiol, Baltimore, MD USA; [Zhang, Haiying; Bi, Sheng] Johns Hopkins Univ, Sch Med, Dept Psychiat & Behav Sci, Baltimore, MD 21205 USA; [Wang, Hongbing; Li, Linhao] Univ Maryland, Dept Pharmaceut Sci, Baltimore, MD 21201 USA; [Joseph, Serene; Wu, Sheng] Temple Univ, Dept Cardiovasc Sci, Ctr Metab Dis Res, Sch Med, Philadelphia, PA 19140 USA; [Heller, Nicola] Johns Hopkins Univ, Sch Med, Dept Anesthesiol & Crit Care Med, Baltimore, MD 21205 USA; [Mauvais-Jarvis, Franck] Tulane Univ, Dept Med, Hlth Sci Ctr, New Orleans, LA 70118 USA; [Mauvais-Jarvis, Franck] Tulane Ctr Excellence Sex Based Biol & Med, New Orleans, LA USA; [Mauvais-Jarvis, Franck] VA Med Ctr, New Orleans, LA USA; [Segars, James; Wu, Sheng] Johns Hopkins Univ, Sch Med, Dept Gynecol & Obstet, Baltimore, MD 21205 USA; [Divall, Sara] Univ Washington, Dept Pediat, Seattles Childrens Hosp, Seattle, WA 98195 USA; [Ahima, Rexford] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA	Johns Hopkins University; Howard University; Johns Hopkins University; Johns Hopkins University; University System of Maryland; University of Maryland Baltimore; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Johns Hopkins University; Tulane University; Johns Hopkins University; Seattle Children's Hospital; University of Washington; University of Washington Seattle; Johns Hopkins University	Wu, S (corresponding author), Temple Univ, Dept Physiol, Ctr Metab Dis Res, Sch Med, 3500 North Broad St MERB 456, Philadelphia, PA 19140 USA.	sheng.wu@temple.edu			HHS | NIH | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) [HD09551201A1]	HHS | NIH | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)	HHS | NIH | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), Grant/Award Number: HD09551201A1	Abbott DH, 2010, AM J PHYSIOL-ENDOC M, V299, pE741, DOI 10.1152/ajpendo.00058.2010; Allard C, 2019, DIABETES, V68, P490, DOI 10.2337/db18-0293; Ambroziak U, 2016, CLIN ENDOCRINOL, V84, P23, DOI 10.1111/cen.12935; Andrisse S, 2018, AM J PHYSIOL-ENDOC M, V314, pE353, DOI 10.1152/ajpendo.00195.2017; Andrisse S, 2017, ENDOCRINOLOGY, V158, P531, DOI 10.1210/en.2016-1553; Andrisse S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066027; Arkun Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149684; Ayala JE, 2010, DIS MODEL MECH, V3, P525, DOI 10.1242/dmm.006239; Azziz R, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.57; Barber Thomas M, 2015, Clin Med (Lond), V15 Suppl 6, ps72, DOI [10.7861/clinmedicine.16-3-262, 10.7861/clinmedicine.15-6-s72]; Batista TM, 2020, P NATL ACAD SCI USA, V117, P6733, DOI 10.1073/pnas.1922370117; Caldwell ASL, 2014, ENDOCRINOLOGY, V155, P3146, DOI 10.1210/en.2014-1196; Cardoso RC, 2015, NEUROENDOCRINOLOGY, V102, P226, DOI 10.1159/000381830; Chang Chawnshang, 2013, Nucl Recept Signal, V11, pe001, DOI 10.1621/nrs.11001; Cox MJ, 2020, ENDOCRINOLOGY, V161, DOI 10.1210/endocr/bqaa061; Cumming G, 2007, J CELL BIOL, V177, P7, DOI 10.1083/jcb.200611141; De Gendt K, 2004, P NATL ACAD SCI USA, V101, P1327, DOI 10.1073/pnas.0308114100; DUNAIF A, 1992, DIABETES, V41, P1257, DOI 10.2337/diabetes.41.10.1257; Ehrmann DA, 2012, STEROIDS, V77, P290, DOI 10.1016/j.steroids.2011.12.001; Escobar-Morreale HF, 2014, HUM REPROD, V29, P2083, DOI 10.1093/humrep/deu198; Geraghty RJ, 2014, BRIT J CANCER, V111, P1021, DOI 10.1038/bjc.2014.166; Jensen TL, 2013, LAB ANIM-UK, V47, P225, DOI 10.1177/0023677213501659; Jitrapakdee S, 2012, INT J BIOCHEM CELL B, V44, P33, DOI 10.1016/j.biocel.2011.10.001; Kobayashi A, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21186683; Lai H, 2014, BIOL REPROD, V91, DOI 10.1095/biolreprod.114.120063; Lazic SE, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2005282; LeCluyse Edward L, 2005, Methods Mol Biol, V290, P207; LeCluyse EL, 2010, METHODS MOL BIOL, V640, P57, DOI 10.1007/978-1-60761-688-7_3; Lee B, 2014, AM J PHYSIOL-ENDOC M, V306, pE1144, DOI 10.1152/ajpendo.00002.2014; Leonie E, 2012, ENDOCRINOLOGY, V153, P2861, DOI 10.1210/en.2011-1754; Levin ER, 2016, NAT REV MOL CELL BIO, V17, DOI 10.1038/nrm.2016.122; Li L, 2016, ENDOCRINOLOGY, V157, P4842, DOI 10.1210/en.2016-1662; Lin HY, 2008, HEPATOLOGY, V47, P1924, DOI 10.1002/hep.22252; Ma YP, 2017, ENDOCRINOLOGY, V158, P98, DOI 10.1210/en.2016-1608; Manneras L, 2007, ENDOCRINOLOGY, V148, P3781, DOI 10.1210/en.2007-0168; Marino JS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048643; Naegle K, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aab1125; Navarro G, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.98607; Navarro G, 2015, OBESITY, V23, P713, DOI 10.1002/oby.21033; Padmanabhan V, 2013, MOL CELL ENDOCRINOL, V373, P8, DOI 10.1016/j.mce.2012.10.005; Postic C, 2004, DIABETES METAB, V30, P398, DOI 10.1016/S1262-3636(07)70133-7; Qiu SQ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01937-4; Roland AV, 2010, J ENDOCRINOL, V207, P213, DOI 10.1677/JOE-10-0217; Sanchez-Garrido MA, 2020, MOL METAB, V35, DOI 10.1016/j.molmet.2020.01.001; Santoleri D, 2019, CELL MOL GASTROENTER, V7, P447, DOI 10.1016/j.jcmgh.2018.10.016; Silfen ME, 2003, J CLIN ENDOCR METAB, V88, P4682, DOI 10.1210/jc.2003-030617; Stener-Victorin E, 2020, ENDOCR REV, V41, DOI 10.1210/endrev/bnaa010; Taniguchi CM, 2006, NAT REV MOL CELL BIO, V7, P85, DOI 10.1038/nrm1837; van Houten ELAF, 2014, REPROD BIOL, V14, P32, DOI 10.1016/j.repbio.2013.09.007; Van Schaftingen E, 2002, BIOCHEM J, V362, P513, DOI 10.1042/0264-6021:3620513; Vassilatou E, 2014, WORLD J GASTROENTERO, V20, P8351, DOI 10.3748/wjg.v20.i26.8351; Walters KA, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.097808; Wang ZQ, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.127817; Wang ZQ, 2018, ENDOCRINOLOGY, V159, P1242, DOI 10.1210/en.2017-03078; Xu WE, 2019, J ENDOCRINOL, V240, pR97, DOI 10.1530/JOE-18-0573; Xue P, 2018, JOVE-J VIS EXP, DOI 10.3791/58379; Yeh SY, 2002, P NATL ACAD SCI USA, V99, P13498, DOI 10.1073/pnas.212474399	57	8	8	3	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2021	35	10							e21921	10.1096/fj.202100961R	http://dx.doi.org/10.1096/fj.202100961R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	UZ5IH	34547140	Green Accepted			2022-12-26	WOS:000702238200013
J	Jin, LL; Li, QY; Li, J; Pan, Y; Zou, J; Wu, XY; Wang, Z				Jin, Liangli; Li, Quanyi; Li, Jing; Pan, Yang; Zou, Jue; Wu, Xiaoyuan; Wang, Zhi			Apela inhibits systemic and renal inflammatory reactions in mice with type I cardiorenal syndrome	FASEB JOURNAL			English	Article						apela; apelin peptide jejunum receptor; inflammation; nuclear factor kappa B; type I cardiorenal syndrome	FACTOR-KAPPA-B; AXIS PROTECTS; IMPROVES; ELABELA; EXPRESSION; HORMONE; CELLS	This study investigated the effect of apela on renal function and anti-inflammatory effect on whole body and kidney tissue in mice with type I cardiorenal syndrome (CRS). The murine type I CRS model was established and apela was subcutaneously infused for two weeks. Cardiac and renal functions were evaluated by echocardiography and blood biochemistry, respectively. The systemic and renal inflammatory responses were examined with molecular biological and histological methods. Human renal glomerular endothelial cells (RGECs) were used to evaluate the adhesion effect of monocytes in vitro. Compared to mice from the control group (CRS + vehicle), the plasma levels of N-terminal pro-brain natriuretic peptide, blood urea nitrogen and creatinine were significantly decreased, while the mean left ventricular ejection fraction was increased in apela-treated CRS mice at the 4th week. The expression of monocyte chemoattractant protein-1 (MCP-1) and tumor necrosis factor-alpha (TNF-alpha) in the circulation and kidney was decreased in apela-treated mice compared with control mice, and apela improved cardio-renal pathology in mice with type I CRS. Additionally, Apela significantly suppressed the expression of MCP-1, TNF-alpha, intercellular adhesion molecule-1 and vascular intercellular adhesion molecule-1 in RGECs induced by angiotensin II (Ang II), and inhibited the promoting effect of Ang II on the adhesion of THP-1 cells to RGECs. Western blot results showed that the expression of phosphorylated nuclear factor kappa B (phospho-NF kappa B) in CRS mice was increased, but the expression of phospho-NF kappa B was down-regulated after apela treatment. Furthermore, apela significantly inhibited the Ang II-mediated increase in phospho-NF kappa B expression in RGECs in vitro, but the administration of an apelin peptide jejunum receptor (APJ) inhibitor blocked the inhibitory effect of apela. This study revealed that apela improves cardiorenal function and reduces systemic and renal inflammatory response in type I CRS mice and the apela/APJ system may alleviate renal inflammatory responses by inhibiting the NF kappa B signalling pathway.	[Jin, Liangli; Li, Quanyi; Li, Jing; Pan, Yang; Wang, Zhi] Nanjing Med Univ, Affiliated Nanjing Brain Hosp, Dept Cardiovasc Med, 264 Guangzhou Rd, Nanjing 210029, Peoples R China; [Zou, Jue] Nanjing Med Univ, Affiliated Nanjing Brain Hosp, Dept Pathol, Nanjing, Peoples R China; [Wu, Xiaoyuan] Nanjing Med Univ, Affiliated Nanjing Brain Hosp, Dept Cent Lab, Nanjing, Peoples R China	Nanjing Medical University; Nanjing Medical University; Nanjing Medical University	Wang, Z (corresponding author), Nanjing Med Univ, Affiliated Nanjing Brain Hosp, Dept Cardiovasc Med, 264 Guangzhou Rd, Nanjing 210029, Peoples R China.	wangzhi1977nj@126.com	Wang, Zhi/AAW-9056-2021		National Natural Science Foundation of China (NSFC) [81570365]; Nanjing Medical and Health Science and Technology Project [201803022]; Nanjing Science and Technology Development Project [ZKX17046]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Nanjing Medical and Health Science and Technology Project; Nanjing Science and Technology Development Project	National Natural Science Foundation of China (NSFC), Grant/Award Number: 81570365; Nanjing Medical and Health Science and Technology Project, Grant/Award Number: 201803022; Nanjing Science and Technology Development Project, Grant/Award Number: ZKX17046	Avila VF, 2019, HYPERTENS RES, V42, P779, DOI 10.1038/s41440-019-0226-6; Bircan B, 2016, RENAL FAILURE, V38, P1122, DOI 10.1080/0886022X.2016.1184957; Cabandugama PK, 2017, MED CLIN N AM, V101, P129, DOI 10.1016/j.mcna.2016.08.009; Chen H, 2017, J AM SOC NEPHROL, V28, P2695, DOI 10.1681/ASN.2016111210; Chen H, 2015, BBA-MOL BASIS DIS, V1852, P1278, DOI 10.1016/j.bbadis.2015.02.013; Chng SC, 2013, DEV CELL, V27, P672, DOI 10.1016/j.devcel.2013.11.002; Clementi A, 2019, CARDIORENAL MED, V9, P265, DOI 10.1159/000500715; Coquerel D, 2017, CRIT CARE MED, V45, pE1139, DOI 10.1097/CCM.0000000000002639; Costa JCSR, 2006, AM J NEPHROL, V26, P281, DOI 10.1159/000093960; Costanzo MR, 2020, HEART FAIL CLIN, V16, P81, DOI 10.1016/j.hfc.2019.08.010; Dong Y, 2019, CURR PHARM DESIGN, V25, P4235, DOI 10.2174/1381612825666191119094354; Feghali Carol A., 1997, Frontiers in Bioscience (online), V2, pD12; Guijarro C, 2001, KIDNEY INT, V59, P415, DOI 10.1046/j.1523-1755.2001.059002415.x; Khwaja A, 2012, NEPHRON CLIN PRACT, V120, pC179, DOI 10.1159/000339789; Kuba K, 2019, PEPTIDES, V111, P62, DOI 10.1016/j.peptides.2018.04.011; Kumar U, 2019, CARDIOL CLIN, V37, P251, DOI 10.1016/j.ccl.2019.04.001; Kurmani Sameer, 2017, Curr Heart Fail Rep, V14, P385, DOI 10.1007/s11897-017-0351-y; Lawrence T, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001651; Li LF, 2012, AM J PHYSIOL-HEART C, V303, pH605, DOI 10.1152/ajpheart.00366.2012; Li XC, 2008, CURR OPIN NEPHROL HY, V17, P37, DOI 10.1097/MNH.0b013e3282f2903c; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Meng Y, 2014, AM J RESP CELL MOL, V50, P723, DOI 10.1165/rcmb.2012-0451OC; Monu SR, 2013, HYPERTENSION, V62, P310, DOI 10.1161/HYPERTENSIONAHA.111.00495; Oeckinghaus A, 2011, NAT IMMUNOL, V12, P695, DOI 10.1038/ni.2065; Ong SB, 2018, PHARMACOL THERAPEUT, V186, P73, DOI 10.1016/j.pharmthera.2018.01.001; Palazzuoli A, 2018, ADV CHRONIC KIDNEY D, V25, P408, DOI 10.1053/j.ackd.2018.08.013; Pan Y, 2020, J CELL MOL MED, V24, P10382, DOI 10.1111/jcmm.15651; Pauli A, 2014, SCIENCE, V343, P746, DOI 10.1126/science.1248636; Pesce P, 2015, J ULTRASOUND, V18, P229, DOI 10.1007/s40477-014-0129-y; Rangaswami J, 2019, CIRCULATION, V139, pE840, DOI 10.1161/CIR.0000000000000664; Rischpler C, 2016, Q J NUCL MED MOL IM, V60, P236; Sanz-Rosa D, 2005, AM J PHYSIOL-HEART C, V288, pH111, DOI 10.1152/ajpheart.01061.2003; Sato T, 2017, CARDIOVASC RES, V113, P760, DOI 10.1093/cvr/cvx061; Sharma N, 2019, BIOMED PHARMACOTHER, V110, P764, DOI 10.1016/j.biopha.2018.12.018; Sunjaya Anthony P, 2019, Glob Cardiol Sci Pract, V2019, pe201915, DOI 10.21542/gcsp.2019.15; Tatemoto K, 1998, BIOCHEM BIOPH RES CO, V251, P471, DOI 10.1006/bbrc.1998.9489; Thind GS, 2018, CLEV CLIN J MED, V85, P231, DOI 10.3949/ccjm.85a.17019; Vinod P, 2017, CARDIOL RES, V8, P87, DOI 10.14740/cr553w; Vlahakos DV, 2019, J HYPERTENS, V37, P2145, DOI 10.1097/HJH.0000000000002111; Westman PC, 2016, J AM COLL CARDIOL, V67, P2050, DOI 10.1016/j.jacc.2016.01.073; Xu CM, 2020, AM J PHYSIOL-RENAL, V318, pF1122, DOI 10.1152/ajprenal.00606.2019; Yang F, 2015, PEPTIDES, V69, P133, DOI 10.1016/j.peptides.2015.04.025; Yogasundaram H, 2019, CAN J CARDIOL, V35, P1208, DOI 10.1016/j.cjca.2019.04.002; Zhang HL, 2018, CELL PHYSIOL BIOCHEM, V49, P1918, DOI 10.1159/000493653	44	1	1	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2021	35	10							e21907	10.1096/fj.202101030R	http://dx.doi.org/10.1096/fj.202101030R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	UZ5IH	34516679				2022-12-26	WOS:000702238200045
J	Pang, HM; Li, JZ; Wang, YZ; Su, XM; Gao, YT; Li, SJ				Pang, Huimin; Li, Jinzhi; Wang, Yuzhou; Su, Xiaomin; Gao, Yingtang; Li, Shu Jie			Mice lacking the proton channel Hv1 exhibit sex-specific differences in glucose homeostasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR FOXO1; INSULIN-RESPONSE UNIT; FACTOR FKHR; TESTOSTERONE; EXPRESSION; GENDER; HYPOGONADISM; RESISTANCE; MOUSE; MEN	Sex as a physiologic factor has a strong association with the features of metabolic syndrome. Our previous study showed that loss of the voltage-gated proton channel Hv1 inhibits insulin secretion and leads to hyperglycemia and glucose intolerance in male mice. However, there are significant differences in blood glucose between male and female Hv1-knockout (KO) mice. Here, we investigated the differences in glucose metabolism and insulin sensitivity between male and female KO mice and how sex steroids contribute to these differences. We found that the fasting blood glucose in female KO mice was visibly lower than that in male KO mice, which was accompanied by hypotestosteronemia. KO mice in both sexes exhibited higher expression of gluconeogenesis-related genes in liver compared with WT mice. Also, the livers from KO males displayed a decrease in glycolysis-related gene expression and an increase in gluconeogenesis-related gene expression compared with KO females. Furthermore, exogenous testosterone supplementation decreased blood glucose levels in male KO mice, as well as enhancing insulin signaling. Taken together, our data demonstrate that knockout of Hv1 results in higher blood glucose levels in male than female mice, despite a decreased insulin secretion in both sexes. This sex-related difference in glucose homeostasis is associated with the glucose metabolism in liver tissue, likely due to the physiological levels of testosterone in KO male mice.	[Pang, Huimin; Li, Shu Jie] Nankai Univ, Sch Phys Sci, Dept Biophys, Key Lab Bioact Mat,Minist Educ, Tianjin, Peoples R China; [Li, Jinzhi] Tianjin High Sch, Biol Lab, Tianjin, Peoples R China; [Wang, Yuzhou; Su, Xiaomin] Nankai Univ, Coll Life Sci, Lab Anim Ctr, Tianjin, Peoples R China; [Gao, Yingtang] Nankai Univ, Inst Hepatobiliary Dis, Tianjin Key Lab Extracorporeal Life Support Crit, Ctr Hosp 3, Tianjin, Peoples R China; [Li, Shu Jie] Biomed Res Ctr, Qilu Inst Technol, Jinan, Shandong, Peoples R China	Nankai University; Nankai University; Nankai University	Li, SJ (corresponding author), Nankai Univ, Sch Phys Sci, Dept Biophys, Key Lab Bioact Mat,Minist Educ, Tianjin, Peoples R China.; Gao, YT (corresponding author), Nankai Univ, Inst Hepatobiliary Dis, Tianjin Key Lab Extracorporeal Life Support Crit, Ctr Hosp 3, Tianjin, Peoples R China.; Li, SJ (corresponding author), Biomed Res Ctr, Qilu Inst Technol, Jinan, Shandong, Peoples R China.	31017014@nankai.edu.cn; shujieli@nankai.edu.cn	Gao, Yingtang/AGK-4112-2022		Science and Technology Program of Jiangsu Province [LYL-SZ201915]; Natural Science Foundation of Shandong Province [ZR2020MC056]; Tianjin Science and Technology Plan Project [19ZXDBSY00030]; Natural Science Foundation of Tianjin City [19JCYBJC26000]	Science and Technology Program of Jiangsu Province; Natural Science Foundation of Shandong Province(Natural Science Foundation of Shandong Province); Tianjin Science and Technology Plan Project; Natural Science Foundation of Tianjin City(Natural Science Foundation of Tianjin)	We would like to thank Dr Y. Okamura (School of Medicine, Osaka University) for providing Hv1/VSOP KO mice. This work was partly supported by the Science and Technology Program of Jiangsu Province (LYL-SZ201915), the Natural Science Foundation of Shandong Province (ZR2020MC056), the Tianjin Science and Technology Plan Project (19ZXDBSY00030), and the Natural Science Foundation of Tianjin City (19JCYBJC26000).	Allard C, 2019, DIABETES, V68, P490, DOI 10.2337/db18-0293; Ayala JE, 1999, DIABETES, V48, P1885, DOI 10.2337/diabetes.48.9.1885; Bennett PA, 1998, NEUROENDOCRINOLOGY, V67, P29, DOI 10.1159/000054295; Benz V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037794; Chen Xin, 2006, Zhonghua Yi Xue Za Zhi, V86, P1474; DeFronzo RA, 2010, AM J MED, V123, pS38, DOI 10.1016/j.amjmed.2009.12.008; Dhindsa S, 2004, J CLIN ENDOCR METAB, V89, P5462, DOI 10.1210/jc.2004-0804; Dong XC, 2006, J CLIN INVEST, V116, P101, DOI 10.1172/JCI25735; Dong XC, 2008, CELL METAB, V8, P65, DOI 10.1016/j.cmet.2008.06.006; Harris RBS, 2003, PHYSIOL BEHAV, V78, P543, DOI 10.1016/S0031-9384(03)00035-0; Huang XF, 2003, BRAIN RES, V992, P9, DOI 10.1016/j.brainres.2003.08.019; Kahn Steven E., 2000, American Journal of Medicine, V108, p2S, DOI 10.1016/S0002-9343(00)00336-3; Kaikaew K, 2019, ENDOCRINOLOGY, V160, P2367, DOI 10.1210/en.2019-00194; Kapoor D, 2007, DIABETES CARE, V30, P911, DOI 10.2337/dc06-1426; Kautzky-Willer A, 2016, ENDOCR REV, V37, P278, DOI 10.1210/er.2015-1137; Matsumoto M, 2007, CELL METAB, V6, P208, DOI 10.1016/j.cmet.2007.08.006; Mauvais-Jarvis F, 2017, CELL METAB, V25, P1216, DOI 10.1016/j.cmet.2017.04.033; Medak KD, 2019, PSYCHONEUROENDOCRINO, V110, DOI 10.1016/j.psyneuen.2019.104413; Morris PD, 2012, ASIAN J ANDROL, V14, P428, DOI 10.1038/aja.2012.21; Muthusamy T, 2011, MOL CELL BIOCHEM, V352, P35, DOI 10.1007/s11010-011-0737-1; Nakae J, 2001, J CLIN INVEST, V108, P1359, DOI 10.1172/JCI200112876; Pal M, 2016, NUTR DIABETES, V6, DOI 10.1038/nutd.2016.45; Pang HM, 2020, J BIOL CHEM, V295, P3601, DOI 10.1074/jbc.RA119.010489; Pang HM, 2020, BMJ OPEN DIAB RES CA, V8, DOI 10.1136/bmjdrc-2019-000951; Perry RJ, 2014, NATURE, V510, P84, DOI 10.1038/nature13478; PILKIS SJ, 1992, ANNU REV PHYSIOL, V54, P885, DOI 10.1146/annurev.ph.54.030192.004321; Quiroga DT, 2019, MOL CELL ENDOCRINOL, V498, DOI 10.1016/j.mce.2019.110587; Rich-Edwards JW, 2018, ENDOCR REV, V39, P424, DOI 10.1210/er.2017-00246; Saad F, 2012, CURR DIABETES REV, V8, P131, DOI 10.2174/157339912799424573; Salam Ranabir, 2012, Indian J Endocrinol Metab, V16 Suppl 1, pS12, DOI 10.4103/2230-8210.94248; Schmoll D, 2000, J BIOL CHEM, V275, P36324, DOI 10.1074/jbc.M003616200; Shen MQ, 2015, INT J ENDOCRINOL, V2015, DOI 10.1155/2015/294278; Streeper RS, 1997, J BIOL CHEM, V272, P11698, DOI 10.1074/jbc.272.18.11698; Tramunt B, 2020, DIABETOLOGIA, V63, P453, DOI 10.1007/s00125-019-05040-3; Wiedmer P, 2004, J EXP BIOL, V207, P2859, DOI 10.1242/jeb.01120; Xia FZ, 2013, REPROD BIOL ENDOCRIN, V11, DOI 10.1186/1477-7827-11-106; Yabiku K, 2018, BMC ENDOCR DISORD, V18, DOI 10.1186/s12902-018-0266-y; Yang YB, 2014, OBESITY, V22, P2147, DOI 10.1002/oby.20811; Yassin A, 2019, DIABETES CARE, V42, P1104, DOI 10.2337/dc18-2388; Zhao Q, 2015, BIOCHEM BIOPH RES CO, V468, P746, DOI 10.1016/j.bbrc.2015.11.027; Zhao XS, 2004, BIOCHEM J, V378, P839, DOI 10.1042/BJ20031450; Zhu L, 2013, DIABETES, V62, P424, DOI 10.2337/db11-1718	42	3	2	2	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT	2021	297	4							101212	10.1016/j.jbc.2021.101212	http://dx.doi.org/10.1016/j.jbc.2021.101212			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	WP4JL	34547291	Green Published, gold			2022-12-26	WOS:000713100100004
J	Shead, S; Durand, RB; Thomas, S				Shead, Steven; Durand, Robert B.; Thomas, Stephanie			Predicting price intervals under exogenously induced stress	PLOS ONE			English	Article							COLD-PRESSOR TEST; FINANCIAL RISK; OVERCONFIDENCE; CONFIDENCE; ACTIVATION; GENDER; MARKET; TESTS	We present an experimental protocol to examine the relationship between exogenously induced stress and confidence in a setting applicable to financial markets. Confidence will be measured by a prediction interval for a one period ahead price forecast, based on a series of 100 previous prices; narrower (wider) prediction intervals will be indicative of greater (lower) confidence. Stress will be induced using the Cold Pressor Arm Wrap, a variation of the Cold Pressor Test. Risk attitudes, and personality traits are also considered as mediating factors.	[Shead, Steven; Durand, Robert B.; Thomas, Stephanie] Curtin Univ, Sch Accounting Econ & Finance, Bentley, WA, Australia	Curtin University	Shead, S (corresponding author), Curtin Univ, Sch Accounting Econ & Finance, Bentley, WA, Australia.	steven.shead@curtin.edu.au	Thomas, Stephanie/Q-6179-2019	Thomas, Stephanie/0000-0001-5910-9551; Durand, Robert/0000-0002-4796-5024	Curtin Experimental Economics Lab	Curtin Experimental Economics Lab	Funding is provided by the Curtin Experimental Economics Lab, as well as Mr Shead's student resource consumables fund. The Director of the lab (S Thomas) is a co-author and has been involved in the design of the study.	Barber BM, 2001, Q J ECON, V116, P261, DOI 10.1162/003355301556400; Benet-Martinez V, 1998, J PERS SOC PSYCHOL, V75, P729, DOI 10.1037/0022-3514.75.3.729; Budescu DV, 2007, MANAGE SCI, V53, P1731, DOI 10.1287/mnsc.1070.0727; Campbell JY., 1997, ECONOMETRICS FINANCI, V1955; Cettolin E, 2020, EXP ECON, V23, P554, DOI 10.1007/s10683-019-09624-z; Coates JM, 2008, P NATL ACAD SCI USA, V105, P6167, DOI 10.1073/pnas.0704025105; Costa P.T., 2003, PERSONALITY ADULTHOO; Daniel K., 2000, MARKET EFFICIENCY IR; De Bondt WFM, 1998, EUR ECON REV, V42, P831, DOI 10.1016/S0014-2921(98)00009-9; DEBONDT WFM, 1993, INT J FORECASTING, V9, P355, DOI 10.1016/0169-2070(93)90030-Q; Deuter CE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049866; Durand R., 2014, J CONT ACCOUNTING EC, V10, P176, DOI [10.1016/j.jcae.2014.08.001, DOI 10.1016/J.JCAE.2014.08.001]; Durand R, 2013, REV BEHAV FINANCE, V5, P104, DOI 10.1108/RBF-07-2012-0011; FAMA EF, 1991, J FINANC, V46, P1575, DOI 10.2307/2328565; FAMA EF, 1970, J FINANC, V25, P383, DOI 10.2307/2325486; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149; FERRACUTI S, 1994, INT J PSYCHOPHYSIOL, V17, P261, DOI 10.1016/0167-8760(94)90068-X; Glaser M., 2007, REV FINANC, V11, P325, DOI [10.1093/rof/rfm008, DOI 10.1093/ROF/RFM008, DOI 10.1093/rof/rfm008]; Glaser M, 2013, J BEHAV DECIS MAKING, V26, P405, DOI 10.1002/bdm.1773; GOLDSTEIN DS, 1987, BAILLIERE CLIN ENDOC, V1, P253, DOI 10.1016/S0950-351X(87)80063-0; Grinblatt M, 2009, J FINANC, V64, P549, DOI 10.1111/j.1540-6261.2009.01443.x; Hirshleifer D, 2001, J FINANC, V56, P1533, DOI 10.1111/0022-1082.00379; Hoffmann AOI, 2016, J BEHAV EXP FINANC, V12, P65, DOI 10.1016/j.jbef.2016.09.003; Holt CA, 2002, AM ECON REV, V92, P1644, DOI 10.1257/000282802762024700; Huberman G, 2001, J FINANC, V56, P387, DOI 10.1111/0022-1082.00330; Jegadeesh N, 2010, REV FINANC STUD, V23, P901, DOI 10.1093/rfs/hhp093; John O. P., 2008, HDB PERSONALITY THEO, P114, DOI DOI 10.1016/S0191-8869(97)81000-8; John O.P., 1991, BIG 5 INVENTORY VERS; Johnson DDP, 2011, NATURE, V477, P317, DOI 10.1038/nature10384; Juergens JL, 2009, J FINANC, V64, P2327, DOI 10.1111/j.1540-6261.2009.01502.x; Lighthall NR, 2012, SOC COGN AFFECT NEUR, V7, P476, DOI 10.1093/scan/nsr026; Lighthall NR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006002; List JA, 2011, EXP ECON, V14, P439, DOI 10.1007/s10683-011-9275-7; Meier C, 2020, J BEHAV FINANC, V21, P369, DOI 10.1080/15427560.2019.1692845; Minkley N, 2014, PSYCHONEUROENDOCRINO, V45, P119, DOI 10.1016/j.psyneuen.2014.03.022; Nosic A, 2010, DECIS ANAL, V7, P282, DOI 10.1287/deca.1100.0178; Olsen R., 1996, FINANCIAL ANAL J, V52, P37, DOI DOI 10.2469/faj.v52.n4.2009; PAESE PW, 1991, ORGAN BEHAV HUM DEC, V48, P100, DOI 10.1016/0749-5978(91)90008-H; Porcelli AJ, 2009, PSYCHOL SCI, V20, P278, DOI 10.1111/j.1467-9280.2009.02288.x; Porcelli AJ, 2014, JOVE-J VIS EXP, DOI 10.3791/50849; Prechter RR., 2001, J PSYCHOL FINANCIAL, V2, P120, DOI [10.1207/S15327760JPFM0203_1, DOI 10.1207/S15327760JPFM0203_1]; Schaefer PS, 2004, J RES PERS, V38, P473, DOI 10.1016/j.jrp.2003.09.010; Schlag KH, 2015, JUDGM DECIS MAK, V10, P456; SEALS DR, 1990, CLIN PHYSIOL, V10, P123, DOI 10.1111/j.1475-097X.1990.tb00246.x; Soll JB, 2004, J EXP PSYCHOL LEARN, V30, P299, DOI 10.1037/0278-7393.30.2.299; Stankov L, 1997, INTELLIGENCE, V25, P93, DOI 10.1016/S0160-2896(97)90047-7	48	0	0	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2021	16	9							e0255038	10.1371/journal.pone.0255038	http://dx.doi.org/10.1371/journal.pone.0255038			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XH8RH	34555026	Green Published, gold			2022-12-26	WOS:000725694500007
J	Bertonati, G; Amadeo, MB; Campus, C; Gori, M				Bertonati, Giorgia; Amadeo, Maria Bianca; Campus, Claudio; Gori, Monica			Auditory speed processing in sighted and blind individuals	PLOS ONE			English	Article							SOUND LOCALIZATION; EARLY-ONSET; MOTION; PERCEPTION; DISCRIMINATION; ABILITIES; VELOCITY; SPACE	Multisensory experience is crucial for developing a coherent perception of the world. In this context, vision and audition are essential tools to scaffold spatial and temporal representations, respectively. Since speed encompasses both space and time, investigating this dimension in blindness allows deepening the relationship between sensory modalities and the two representation domains. In the present study, we hypothesized that visual deprivation influences the use of spatial and temporal cues underlying acoustic speed perception. To this end, ten early blind and ten blindfolded sighted participants performed a speed discrimination task in which spatial, temporal, or both cues were available to infer moving sounds' velocity. The results indicated that both sighted and early blind participants preferentially relied on temporal cues to determine stimuli speed, by following an assumption that identified as faster those sounds with a shorter duration. However, in some cases, this temporal assumption produces a misperception of the stimulus speed that negatively affected participants' performance. Interestingly, early blind participants were more influenced by this misleading temporal assumption than sighted controls, resulting in a stronger impairment in the speed discrimination performance. These findings demonstrate that the absence of visual experience in early life increases the auditory system's preference for the time domain and, consequentially, affects the perception of speed through audition.	[Bertonati, Giorgia; Amadeo, Maria Bianca; Campus, Claudio; Gori, Monica] Ist Italiano Tecnol, Unit Visually Impaired People VIP, Genoa, Italy; [Bertonati, Giorgia] Univ Genoa, Dept Informat Bioengn Robot & Syst Engn DIBRIS, Genoa, Italy	Istituto Italiano di Tecnologia - IIT; University of Genoa	Gori, M (corresponding author), Ist Italiano Tecnol, Unit Visually Impaired People VIP, Genoa, Italy.	monica.gori@iit.it	Campus, Claudio/I-7036-2016	Campus, Claudio/0000-0002-7097-4500; amadeo, maria bianca/0000-0002-9601-0187	MYSpace project - European Research Council (ERC) under the European Union [948349]	MYSpace project - European Research Council (ERC) under the European Union	The research is partially supported by the MYSpace project (PI Monica Gori), which has received funding from the European Research Council (ERC) under the European Union's Horizon 2020 research and innovation program (grant agreement No 948349). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alais D, 2004, CURR BIOL, V14, P257, DOI 10.1016/j.cub.2004.01.029; Amadeo MB, 2020, FRONT NEUROSCI-SWITZ, V14, DOI 10.3389/fnins.2020.00812; Amadeo MB, 2019, BEHAV BRAIN RES, V376, DOI 10.1016/j.bbr.2019.112185; Amadeo MB, 2019, ISCIENCE, V19, P369, DOI 10.1016/j.isci.2019.07.042; Bedny M, 2010, CURR BIOL, V20, P1900, DOI 10.1016/j.cub.2010.09.044; Burr D, 2009, EXP BRAIN RES, V198, P49, DOI 10.1007/s00221-009-1933-z; Carlile S, 2002, J ACOUST SOC AM, V111, P1026, DOI 10.1121/1.1436067; Carlile S, 2016, TRENDS HEAR, V20, DOI [10.1177/2331216516644254, 10.1177/2331216516614254]; Champion RA, 2010, J VISION, V10, DOI 10.1167/10.6.14; Chaplin TA, 2018, FRONT NEURAL CIRCUIT, V12, DOI 10.3389/fncir.2018.00093; Dormal G, 2016, NEUROIMAGE, V134, P630, DOI 10.1016/j.neuroimage.2016.04.027; Finocchietti S, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01357; Freeman TCA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102864; Gal O. fit_ellipse, MATLAB CENT FILE EXC; GEGENFURTNER KR, 1995, VISION RES, V35, P1547, DOI 10.1016/0042-6989(94)00264-M; Gori M, 2020, NEUROSCI BIOBEHAV R, V109, P54, DOI 10.1016/j.neubiorev.2019.12.031; Gori M, 2018, ISCIENCE, V6, P319, DOI 10.1016/j.isci.2018.07.003; Gori M, 2017, NEUROPSYCHOLOGIA, V99, P350, DOI 10.1016/j.neuropsychologia.2017.03.025; Gori M, 2014, BRAIN, V137, P288, DOI 10.1093/brain/awt311; Gougoux F, 2005, PLOS BIOL, V3, P324, DOI 10.1371/journal.pbio.0030027; Guttman SE, 2005, PSYCHOL SCI, V16, P228, DOI 10.1111/j.0956-7976.2005.00808.x; Hotting K, 2009, HEARING RES, V258, P165, DOI 10.1016/j.heares.2009.07.012; HUANG YL, 1982, PERCEPT PSYCHOPHYS, V32, P7, DOI 10.3758/BF03204862; Jiang F, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00324; Jiang F, 2014, J VISION, V14, DOI 10.1167/14.13.4; Lessard N, 1998, NATURE, V395, P278, DOI 10.1038/26228; Lewald J, 2013, NEUROPSYCHOLOGIA, V51, P181, DOI 10.1016/j.neuropsychologia.2012.11.017; Locke SM, 2016, SCI REP-UK, V6, DOI 10.1038/srep27725; MIDDLEBROOKS JC, 1991, ANNU REV PSYCHOL, V42, P135, DOI 10.1146/annurev.ps.42.020191.001031; Mohan A, 2017, PROG NEUROBIOL, V153, P1, DOI 10.1016/j.pneurobio.2017.03.010; Nava E, 2008, EXP BRAIN RES, V190, P179, DOI 10.1007/s00221-008-1459-9; Parise CV, 2014, P NATL ACAD SCI USA, V111, P6104, DOI 10.1073/pnas.1322705111; Pavani F., 2012, NEURAL BASES MULTISE, V22, DOI 10.1201/b11092-28; Poirier C, 2006, NEUROIMAGE, V31, P279, DOI 10.1016/j.neuroimage.2005.11.036; Poirier C, 2004, COGN PROCESS, V5, P254, DOI [10.1007/s10339-004-0031-1, DOI 10.1007/S10339-004-0031-1]; POIZNER H, 1987, BRAIN LANG, V30, P52, DOI 10.1016/0093-934X(87)90027-7; Reisbeck TE, 1999, VISION RES, V39, P3267, DOI 10.1016/S0042-6989(99)00017-6; Roder B, 1999, NATURE, V400, P162, DOI 10.1038/22106; Senna I, 2017, P ROY SOC B-BIOL SCI, V284, DOI 10.1098/rspb.2017.0673; Senna I, 2015, SCI REP-UK, V5, DOI 10.1038/srep14054; Stevens AA, 2005, NEUROPSYCHOLOGIA, V43, P1901, DOI 10.1016/j.neuropsychologia.2005.03.007; Van der Lubbe RHJ, 2010, J COGNITIVE NEUROSCI, V22, P1541, DOI 10.1162/jocn.2009.21285; Vercillo T, 2016, DEV PSYCHOL, V52, P847, DOI 10.1037/dev0000103; Voss P, 2004, CURR BIOL, V14, P1734, DOI 10.1016/j.cub.2004.09.051; Voss P, 2015, J NEUROSCI, V35, P6051, DOI 10.1523/JNEUROSCI.4544-14.2015; Wardle SG, 2013, J VISION, V13, DOI 10.1167/13.1.17; Weeks R, 2000, J NEUROSCI, V20, P2664; Wolbers T, 2011, NEUROIMAGE, V56, P681, DOI 10.1016/j.neuroimage.2010.04.266; Zwiers MP, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-09-j0002.2001	49	4	4	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2021	16	9							e0257676	10.1371/journal.pone.0257676	http://dx.doi.org/10.1371/journal.pone.0257676			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	YS4WS	34551010	Green Published, gold			2022-12-26	WOS:000750679800041
J	Ciria-Suarez, L; Jimenez-Fonseca, P; Palacin-Lois, M; Antonanzas-Basa, M; Fernandez-Montes, A; Manzano-Fernandez, A; Castelo, B; Asensio-Martinez, E; Hernando-Polo, S; Calderon, C				Ciria-Suarez, Laura; Jimenez-Fonseca, Paula; Palacin-Lois, Maria; Antonanzas-Basa, Monica; Fernandez-Montes, Ana; Manzano-Fernandez, Aranzazu; Castelo, Beatriz; Asensio-Martinez, Elena; Hernando-Polo, Susana; Calderon, Caterina			Breast cancer patient experiences through a journey map: A qualitative study	PLOS ONE			English	Article								Background Breast cancer is one of the most prevalent diseases in women. Prevention and treatments have lowered mortality; nevertheless, the impact of the diagnosis and treatment continue to impact all aspects of patients' lives (physical, emotional, cognitive, social, and spiritual). Objective This study seeks to explore the experiences of the different stages women with breast cancer go through by means of a patient journey. Methods This is a qualitative study in which 21 women with breast cancer or survivors were interviewed. Participants were recruited at 9 large hospitals in Spain and intentional sampling methods were applied. Data were collected using a semi-structured interview that was elaborated with the help of medical oncologists, nurses, and psycho-oncologists. Data were processed by adopting a thematic analysis approach. Results The diagnosis and treatment of breast cancer entails a radical change in patients' day-today that linger in the mid-term. Seven stages have been defined that correspond to the different medical processes: diagnosis/unmasking stage, surgery/cleaning out, chemotherapy/loss of identity, radiotherapy/transition to normality, follow-up care/the "new" day-today, relapse/starting over, and metastatic/time-limited chronic breast cancer. The most relevant aspects of each are highlighted, as are the various cross-sectional aspects that manifest throughout the entire patient journey. Conclusions Comprehending patients' experiences in depth facilitates the detection of situations of risk and helps to identify key moments when more precise information should be offered. Similarly, preparing the women for the process they must confront and for the sequelae of medical treatments would contribute to decreasing their uncertainty and concern, and to improving their quality-of-life.	[Ciria-Suarez, Laura; Calderon, Caterina] Univ Barcelona, Fac Psychol, Clin Psychol & Psychobiol Dept, Barcelona, Spain; [Jimenez-Fonseca, Paula] Hosp Univ Cent Asturias, Med Oncol Dept, Oviedo, Spain; [Palacin-Lois, Maria] Univ Barcelona, Fac Psychol, Social Psychol & Quantitat Psychol Dept, Barcelona, Spain; [Antonanzas-Basa, Monica; Manzano-Fernandez, Aranzazu] Hosp Univ Clin San Carlos, Med Oncol Dept, Madrid, Spain; [Fernandez-Montes, Ana] Complejo Hosp Univ Orense, Med Oncol Dept, Orense, Spain; [Castelo, Beatriz] Hosp Univ La Paz, Med Oncol Dept, Madrid, Spain; [Asensio-Martinez, Elena] Hosp Gen Univ Elche, Med Oncol Dept, Elche, Spain; [Hernando-Polo, Susana] Hosp Univ Fdn Alcorcon, Med Oncol Dept, Madrid, Spain	University of Barcelona; Central University Hospital Asturias; University of Barcelona; Complexo Hospitalario Universitario de Ourense, Verin e O Barco de Valdeorras; Hospital Universitario La Paz; Alcorcon Foundation University Hospital	Ciria-Suarez, L (corresponding author), Univ Barcelona, Fac Psychol, Clin Psychol & Psychobiol Dept, Barcelona, Spain.	laura.ciria.suarez@gmail.com		Ciria Suarez, Laura/0000-0002-1388-6686; CASTELO FERNANDEZ, Beatriz/0000-0002-5824-9808	Spanish Society of Medical Oncology (SEOM)	Spanish Society of Medical Oncology (SEOM)	This work was funded by the Spanish Society of Medical Oncology (SEOM) in 2018. The sponsor of this research has not participated in the design of research, in writing the report, or in the decision to submit the article for publication.	Adam A, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0231691; Baeyens-Fernandez JA, 2018, BMC CANCER, V18, DOI 10.1186/s12885-018-4682-1; Blows E, 2012, J ADV NURS, V68, P2155, DOI 10.1111/j.1365-2648.2012.05995.x; Bower JE, 2015, CANCER-AM CANCER SOC, V121, P1231, DOI 10.1002/cncr.29194; Cameron LD, 2007, PSYCHO-ONCOLOGY, V16, P171, DOI 10.1002/pon.1050; Campbell-Enns HJ, 2017, PSYCHO-ONCOLOGY, V26, P1711, DOI 10.1002/pon.4281; Cardoso F, 2016, BREAST, V28, P5, DOI 10.1016/j.breast.2016.04.004; Cherif E, 2020, BMC HEALTH SERV RES, V20, DOI 10.1186/s12913-020-05569-9; Ciria-Suarez L, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0244355; Cleries R, 2018, CLIN TRANSL ONCOL, V20, P313, DOI 10.1007/s12094-017-1718-y; Cordova MJ, 2017, LANCET PSYCHIAT, V4, P330, DOI 10.1016/S2215-0366(17)30014-7; de Ligt KM, 2019, EUR J CANCER CARE, V28, DOI 10.1111/ecc.13092; Drageset S, 2020, NORWEGIAN SURVIVORS, DOI [10.1097/NCC.0000000000000656, DOI 10.1097/NCC.0000000000000656]; Engelhardt EG, 2020, MED DECIS MAKING, V40, P52, DOI 10.1177/0272989X19889905; Esplen MJ, 2020, CURR OPIN SUPPORT PA, V14, P74, DOI 10.1097/SPC.0000000000000484; Faccio F, 2020, EUR J CANCER CARE, V29, DOI 10.1111/ecc.13214; Fouladi N, 2018, PSYCHO-ONCOLOGY, V27, P434, DOI 10.1002/pon.4479; Geurts YM, 2017, BREAST CANCER RES TR, V165, P709, DOI 10.1007/s10549-017-4340-3; Gieseler F, 2018, ONCOLOGIST, V23, P752, DOI 10.1634/theoncologist.2017-0478; Gomez-Acebo I, 2020, BREAST CANCER RES TR, V181, P667, DOI 10.1007/s10549-020-05600-x; Graneheim UH, 2004, NURS EDUC TODAY, V24, P105, DOI 10.1016/j.nedt.2003.10.001; Gualandi R, 2021, BMC HEALTH SERV RES, V21, DOI 10.1186/s12913-021-06341-3; Guil R, 2020, FRONT PSYCHOL, V11, DOI 10.3389/fpsyg.2020.595713; Hall LK, 2015, J MED INTERNET RES, V17, DOI 10.2196/jmir.3652; Jakobsen K, 2018, SCAND J OCCUP THER, V25, P298, DOI 10.1080/11038128.2017.1335777; Khoshnazar TAK, 2016, INDIAN J PALLIAT CAR, V22, P402, DOI 10.4103/0973-1075.191763; KRISTJANSON LJ, 1994, CANCER NURS, V17, P1, DOI 10.1097/00002820-199402000-00001; Lin JJ, 2017, WOMEN HEALTH, V57, P976, DOI 10.1080/03630242.2016.1235071; Lindop E, 2001, Eur J Oncol Nurs, V5, P91, DOI 10.1054/ejon.2000.0116; Vila MM, 2020, BREAST, V53, P44, DOI 10.1016/j.breast.2020.06.007; Matthews H, 2017, J ADV NURS, V73, P1355, DOI 10.1111/jan.13237; Mirosevic S, 2019, EUR J CANCER CARE, V28, DOI 10.1111/ecc.13060; Mortensen GL, 2018, ACTA ONCOL, V57, P146, DOI 10.1080/0284186X.2017.1406141; Mustafa M, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004253.pub4; Muzzatti B, 2020, BMC CANCER, V20, DOI 10.1186/s12885-020-07272-8; Namkoong K, 2017, HEALTH COMMUN, V32, P1422, DOI 10.1080/10410236.2016.1230808; Nanton V, 2009, BRIT J HEALTH PSYCH, V14, P437, DOI 10.1348/135910708X342890; Palesh O, 2018, BREAST J, V24, P167, DOI 10.1111/tbj.12862; Pineros M, 2019, LANCET ONCOL, V20, pE103, DOI 10.1016/S1470-2045(18)30897-0; Purkayastha D, 2017, INDIAN J PALLIAT CAR, V23, P268, DOI 10.4103/IJPC.IJPC_6_17; Rajagopal Lalithambigai, 2019, Asian Pac J Cancer Prev, V20, P3233, DOI 10.31557/APJCP.2019.20.11.3233; Rapport F, 2019, BMC HEALTH SERV RES, V19, DOI 10.1186/s12913-019-3881-z; Richter P., 2019, P 14 INT C WIRTSCH, P997; Sanson-Fisher R, 2019, SUPPORT CARE CANCER, V27, P1997, DOI 10.1007/s00520-019-04740-1; dos Santos ATC, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0239811; SEOM, 2020, EST INC CANC ESP; Sinclair M, 2019, EUR J CANCER CARE, V28, DOI 10.1111/ecc.13153; Smit A, 2019, SOC SCI MED, V222, P231, DOI 10.1016/j.socscimed.2019.01.020; Stephens C, 2016, J CANCER SURVIV, V10, P865, DOI 10.1007/s11764-016-0532-9; Tat S, 2018, J CANCER EDUC, V33, P477, DOI 10.1007/s13187-016-1090-6; Trebble TM, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c4078; Triberti S, 2019, CANCER TREAT REV, V74, P1, DOI 10.1016/j.ctrv.2019.01.003; van Maarschalkerweerd PEA, 2020, DISABIL REHABIL, V42, P3052, DOI 10.1080/09638288.2019.1583779; Waks AG, 2019, JAMA-J AM MED ASSOC, V321, P288, DOI 10.1001/jama.2018.19323; Zhai JX, 2019, HEALTH CARE WOMEN IN, V40, P554, DOI 10.1080/07399332.2019.1578360	55	1	1	5	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2021	16	9							e0257680	10.1371/journal.pone.0257680	http://dx.doi.org/10.1371/journal.pone.0257680			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	YS4WS	34550996	gold, Green Published			2022-12-26	WOS:000750679800042
J	Banks, GC; Whelpley, CE; Crawford, ER; O'Boyle, EH; Kepes, S				Banks, George C.; Whelpley, Christopher E.; Crawford, Eean R.; O'Boyle, Ernest H.; Kepes, Sven			Getting along to get ahead: The role of social context in tournament promotion and reward systems	PLOS ONE			English	Article							ORGANIZATIONAL COMMUNITIES; PAY DISPERSION; PERFORMANCE; PERSPECTIVE; DIVERSITY; INDIVIDUALS; PREDICTORS; MANAGEMENT; NETWORKS; CLIMATE	Tournament theory posits that some organizations are modeled after sports tournaments whereby individuals are incentivized to compete and win against other members of the organization. A persistent criticism of tournament theory is that rank-order success of employees is entirely dependent on non-interacting or at least non-cooperating entities. To address what part, if any, cooperation plays in competitive tournaments, this study examines the role of social networks in tournament-style promotion and reward systems. Specifically, we seek to identify the importance of social relationships, such as group dissimilarity, initial tie formation, and tie strength in predicting tournament success. Bringing two largely independent research streams together (one focused on cooperation and one framed around competition), we examine how individuals' performance interacts with their social relationships-their social networks-to influence their chances of winning a tournament. Using the Survivor television series, we analyze the behaviors of 535 interacting contestants across 30 tournaments. In general, the findings help to illustrate how performance and social networks predict tournament advancement. Interestingly, we find that group dissimilarity based on gender, race, and age, largely does not play a role in advancement in the tournaments. Further, the strength of ties fails to mediate between variables such as group dissimilarity and initial tie formation. We conclude by discussing future directions for theoretical and practical exploration of tournament-style promotion systems. Recommendations include continuing to explore and test the role of social dynamics in compensation and promotion systems.	[Banks, George C.] Univ North Carolina Charlotte, Dept Management, Charlotte, NC 28223 USA; [Whelpley, Christopher E.; Kepes, Sven] Virginia Commonwealth Univ, Dept Management & Entrepreneurship, Richmond, VA USA; [Crawford, Eean R.] Univ Iowa, Dept Management & Entrepreneurship, Iowa City, IA USA; [O'Boyle, Ernest H.] Univ Indiana, Dept Management & Entrepreneurship, Bloomington, IN USA	University of North Carolina; University of North Carolina Charlotte; Virginia Commonwealth University; University of Iowa; Indiana University System; Indiana University Bloomington	Banks, GC (corresponding author), Univ North Carolina Charlotte, Dept Management, Charlotte, NC 28223 USA.	gcbanks@gmail.com	Crawford, Eean/AGW-2661-2022					Aguinis H, 2018, MANAG RES, V16, P3, DOI 10.1108/MRJIAM-02-2017-0731; Aral S, 2014, MANAGE SCI, V60, P1352, DOI 10.1287/mnsc.2014.1936; Arend RJ, 2019, BRQ-BUS RES Q, V22, P216, DOI 10.1016/j.brq.2018.10.003; Becker TE, 2005, ORGAN RES METHODS, V8, P274, DOI 10.1177/1094428105278021; Bernerth JB, 2016, PERS PSYCHOL, V69, P229, DOI 10.1111/peps.12103; Bloom M, 1999, ACAD MANAGE J, V42, P25, DOI 10.2307/256872; Bloom M, 2002, ACAD MANAGE J, V45, P33, DOI 10.2307/3069283; Borgatti SP, 2014, RES SOCIOL ORGAN-RES, V40, P1, DOI 10.1108/S0733-558X(2014)0000040001; Bothner MS, 2007, ADMIN SCI QUART, V52, P208, DOI 10.2189/asqu.52.2.208; Boyle E, 2012, ORGAN SCI, V23, P1100, DOI 10.1287/orsc.1110.0690; CALDEIRA GA, 1987, J POLIT, V49, P953, DOI 10.2307/2130779; Connelly BL, 2014, J MANAGE, V40, P16, DOI 10.1177/0149206313498902; Cordery JL, 2015, J MANAGE, V41, P644, DOI 10.1177/0149206314545087; EHRENBERG RG, 1990, IND LABOR RELAT REV, V43, pS74, DOI 10.2307/2523572; Ekinci E, 2019, ECON J, V129, P2342, DOI 10.1111/ecoj.12631; Festinger L., 1950, SOCIAL PROCESSES INF, DOI [10.1037/h0056932, DOI 10.1037/H0056932]; Fitzsimmons TW, 2016, LEADERSHIP QUART, V27, P354, DOI 10.1016/j.leaqua.2015.11.003; Fuhrmans V., 2018, WALL STR J; GALANTER M, 1990, VA LAW REV, V76, P747, DOI 10.2307/1073211; Gerhart B., 2003, COMPENSATION THEORY; Gerhart B, 2009, ACAD MANAG ANN, V3, P251, DOI 10.1080/19416520903047269; GRANOVETTER MS, 1973, AM J SOCIOL, V78, P1360, DOI 10.1086/225469; Guillaume YRF, 2014, ACAD MANAGE J, V57, P1284, DOI 10.5465/amj.2013.0046; Guiteierrez C., 2020, STRATEGIC MANAGEJ, V42, P774; Hampton KN, 2000, LECT NOTES COMPUT SC, V1765, P194; Hansen MT, 1999, ADMIN SCI QUART, V44, P82, DOI 10.2307/2667032; Harrison DA, 2007, ACAD MANAGE REV, V32, P1199, DOI 10.5465/AMR.2007.26586096; Henderson AD, 2001, ACAD MANAGE J, V44, P96, DOI 10.2307/3069339; Heneman RL., 1990, RES PERSONNEL HUMAN; Hogan J, 2003, J APPL PSYCHOL, V88, P100, DOI 10.1037/0021-9010.88.1.100; HUNTER JE, 1984, PSYCHOL BULL, V96, P72, DOI 10.1037/0033-2909.96.1.72; IBARRA H, 1992, ADMIN SCI QUART, V37, P422, DOI 10.2307/2393451; Jassawalla A. R., 1999, ACAD MANAGEMENT EXEC, V13, P50, DOI DOI 10.5465/AME.1999.2210314; Kepes S, 2009, PERS PSYCHOL, V62, P497, DOI 10.1111/j.1744-6570.2009.01146.x; Kirkman BL, 2011, J APPL PSYCHOL, V96, P1234, DOI 10.1037/a0024198; Lau DC, 2005, ACAD MANAGE J, V48, P645, DOI 10.2307/20159684; LAZEAR EP, 1981, J POLIT ECON, V89, P841, DOI 10.1086/261010; Lazear EP, 1979, RANK ORDER TOURNAMEN; LEARY MR, 1990, PSYCHOL BULL, V107, P34, DOI 10.1037/0033-2909.107.1.34; Li JY, 2022, J MANAGE, V48, P380, DOI 10.1177/0149206320921438; Longenecker C.O., 1987, ACAD MANAGE EXEC, V1, P183, DOI [10.5465/ame.1987.4275731, DOI 10.5465/AME.1987.4275731]; MAIN BGM, 1993, J LABOR ECON, V11, P606, DOI 10.1086/298309; MARSDEN PV, 1984, SOC FORCES, V63, P482, DOI 10.2307/2579058; Martell RF, 1996, AM PSYCHOL, V51, P157, DOI 10.1037/0003-066X.51.2.157; McKay PF, 2007, PERS PSYCHOL, V60, P35, DOI 10.1111/j.1744-6570.2007.00064.x; McPherson M, 2001, ANNU REV SOCIOL, V27, P415, DOI 10.1146/annurev.soc.27.1.415; Mehra A, 1998, ACAD MANAGE J, V41, P441, DOI 10.2307/257083; MILGROM P, 1988, AM J SOCIOL, V94, pS154, DOI 10.1086/228945; Murphy K.R., 1995, UNDERSTANDING PERFOR; Nahapiet J, 1998, ACAD MANAGE REV, V23, P242, DOI 10.2307/259373; Ng TWH, 2005, PERS PSYCHOL, V58, P367, DOI 10.1111/j.1744-6570.2005.00515.x; Norton SW., 2003, EC MANAGEMENT FRANCH, P17; Pepper A, 2015, HUM RELAT, V68, P1291, DOI 10.1177/0018726714554663; Pfeffer J., 2000, KNOWING DOING GAP SM; Pruijssers JL, 2020, J BUS ETHICS, V162, P149, DOI 10.1007/s10551-018-3991-2; Roberson Q, 2017, ACAD MANAG ANN, V11, P189, DOI 10.5465/annals.2014.0019; Rosen S., 1985, PRIZES INCENTIVES EL; SALANCIK GR, 1978, ADMIN SCI QUART, V23, P224, DOI 10.2307/2392563; Seibert SE, 2001, ACAD MANAGE J, V44, P219, DOI 10.2307/3069452; Spurk D, 2019, J OCCUP ORGAN PSYCH, V92, P74, DOI 10.1111/joop.12238; Srikanth K, 2016, ACAD MANAG ANN, V10, P453, DOI 10.1080/19416520.2016.1120973; SUDMAN S, 1988, SOC NETWORKS, V10, P93, DOI 10.1016/0378-8733(88)90012-3; Tasselli S, 2015, J MANAGE, V41, P1361, DOI 10.1177/0149206315573996; Wenger E., 2002, GUIDE MANAGING KNOWL, P284	64	0	0	23	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2021	16	9							e0257389	10.1371/journal.pone.0257389	http://dx.doi.org/10.1371/journal.pone.0257389			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	WG6BN	34543309	Green Published, gold			2022-12-26	WOS:000707078200031
J	Selva-Sevilla, C; Fernandez-Gines, FD; Cortinas-Saenz, M; Geronimo-Pardo, M				Selva-Sevilla, Carmen; Damaso Fernandez-Gines, F.; Cortinas-Saenz, Manuel; Geronimo-Pardo, Manuel			Cost-effectiveness analysis of domiciliary topical sevoflurane for painful leg ulcers	PLOS ONE			English	Article							REAL-WORLD DATA; ECONOMIC-EVALUATION; TASK-FORCE; COVARIATE ADJUSTMENT; SUBGROUP ANALYSIS; OF-ILLNESS; UNCERTAINTY; GUIDELINES; MANAGEMENT; FRAMEWORK	Objectives The general anesthetic sevoflurane is being repurposed as a topical analgesic for painful chronic wounds. We conducted a Bayesian cost-effectiveness analysis (CEA) comparing the addition of domiciliary topical sevoflurane to conventional analgesics (SEVOFLURANE, n = 38) versus conventional analgesics alone (CONVENTIONAL, n = 26) for the treatment of nonrevascularizable painful leg ulcers in an outpatient Pain Clinic of a Spanish tertiary hospital. Methods We used real-world data collected from charts to conduct this CEA from a public healthcare perspective and with a one-year time horizon. Costs of analgesics, visits and admissions were considered, expressed in Euro2016. Analgesic effectiveness was measured with SPID (Sum of Pain Intensity Difference). A Bayesian regression model was constructed, including "treatment" and baseline characteristics for patients ("arterial hypertension") and ulcers ("duration", "number", "depth", "pain") as covariates. The findings were summarized as a cost-effectiveness plane and a cost-effectiveness acceptability curve. One-way sensitivity analyses, a re-analysis excluding those patients who died or suffered from leg amputation, and an extreme scenario analysis were conducted to reduce uncertainty. Results Compared to CONVENTIONAL, SEVOFLURANE was associated with a 46% reduction in costs, and the mean incremental effectiveness (28.153.70 effectiveness units) was favorable to SEVOFLURANE. The estimated probability for SEVOFLURANE being dominant was 99%. The regression model showed that costs were barely influenced by any covariate, whereas effectiveness was noticeably influenced by "treatment". All sensitivity analyses showed the robustness of the model, even in the extreme scenario analysis against SEVOFLURANE. Conclusions SEVOFLURANE was dominant over CONVENTIONAL as it was less expensive and much more effective.	[Selva-Sevilla, Carmen] Univ Castilla La Mancha, Fac Econ, Dept Appl Econ, Albacete, Spain; [Damaso Fernandez-Gines, F.] Torrecardenas Hosp Complex, Dept Hosp Pharm, Almeria, Spain; [Cortinas-Saenz, Manuel] Torrecardenas Hosp Complex, Dept Anesthesiol, Unit Pain, Almeria, Spain; [Geronimo-Pardo, Manuel] Complejo Hosp Univ, Dept Anesthesiol, Albacete, Spain; [Damaso Fernandez-Gines, F.] Hosp La Inmaculada, Dept Hosp Pharm, Almeria, Spain; [Cortinas-Saenz, Manuel] Hosp Univ Virgen Nieves, Dept Anesthesiol, Granada, Spain	Universidad de Castilla-La Mancha; Hospital Torrecardenas; Hospital Torrecardenas; Hospital Universitario Virgen de las Nieves	Geronimo-Pardo, M (corresponding author), Complejo Hosp Univ, Dept Anesthesiol, Albacete, Spain.	sergepu@hotmail.com	Selva, Carmen/ACN-4521-2022; Gerónimo-Pardo, Manuel/AGD-8316-2022	Gerónimo-Pardo, Manuel/0000-0001-9911-7572; Selva Sevilla, Carmen/0000-0002-2672-8409				Valenciano PA, 2018, EMERGENCIAS, V30, P138; Argoff CE, 2013, MAYO CLIN PROC, V88, P195, DOI 10.1016/j.mayocp.2012.11.015; Barshes NR, 2012, J VASC SURG, V56, P1015, DOI 10.1016/j.jvs.2012.02.069; Berger ML, 2017, VALUE HEALTH, V20, P1003, DOI 10.1016/j.jval.2017.08.3019; Berger ML, 2009, VALUE HEALTH, V12, P1044, DOI 10.1111/j.1524-4733.2009.00600.x; Briggs A, 2006, DECISION MODELLING H; Briggs AH, 1999, HEALTH ECON, V8, P257, DOI 10.1002/(SICI)1099-1050(199905)8:3<257::AID-HEC427>3.0.CO;2-E; Briggs AH, 1999, HLTH TECHNOLOGY ASSE, V3, P1, DOI DOI 10.3310/hta3020; Carter MJ, 2014, APPL HEALTH ECON HEA, V12, P373, DOI 10.1007/s40258-014-0094-9; Chan B, 2017, J WOUND CARE, V26, pS4, DOI 10.12968/jowc.2017.26.Sup4.S4; D'Haese J, 1998, EUR J ANAESTH, V15, P297, DOI 10.1097/00003643-199805000-00009; Fernandez-Gines FD, 2020, INT WOUND J, V17, P83, DOI 10.1111/iwj.13235; Fernandez-Gines FD, 2019, EUR J HOSP PHARM, V26, P229, DOI 10.1136/ejhpharm-2017-001421; Fernandez-Gines FD, 2017, AM J HEALTH-SYST PH, V74, pE176, DOI 10.2146/ajhp151008; Fernandez-Gines FD, 2022, BMJ SUPPORT PALLIAT, V12, pE192, DOI 10.1136/bmjspcare-2019-002023; Garrison LP, 2007, VALUE HEALTH, V10, P326, DOI 10.1111/j.1524-4733.2007.00186.x; GEMAN S, 1984, IEEE T PATTERN ANAL, V6, P721, DOI 10.1109/TPAMI.1984.4767596; Geronimo-Pardo M, 2011, PHLEBOLOGIE, V40, P95, DOI 10.1055/s-0037-1621757; Gilks W.R., 1996, MARKOV CHAIN MONTE C; Gilligan AM, 2018, ADV WOUND CARE, V7, P380, DOI 10.1089/wound.2018.0817; Gordon L, 2006, J Wound Care, V15, P348; Green J, 2014, J WOUND CARE, V23, P601, DOI 10.12968/jowc.2014.23.12.601; Heitjan DF, 1999, HEALTH ECON, V8, P191, DOI 10.1002/(SICI)1099-1050(199905)8:3<191::AID-HEC409>3.0.CO;2-R; Hoch JS, 2002, HEALTH ECON, V11, P415, DOI 10.1002/hec.678; Husereau D, 2013, VALUE HEALTH, V16, P231, DOI 10.1016/j.jval.2013.02.002; Imbernon-Moya Adrian, 2017, EJVES Short Rep, V36, P9, DOI 10.1016/j.ejvssr.2017.08.001; Kreif N, 2013, HEALTH ECON, V22, P486, DOI 10.1002/hec.2806; Laoire AN, 2018, BMJ SUPPORT PALLIAT, V8, P400, DOI 10.1136/bmjspcare-2017-001359; Manca A, 2005, HEALTH ECON, V14, P471, DOI 10.1002/hec.914; Martinengo L, 2019, ANN EPIDEMIOL, V29, P8, DOI 10.1016/j.annepidem.2018.10.005; Martinez-Monsalve A, 2013, HERIDAS CICATRIZACIO, V1, P16; Martinez-Monsalve A., 2011, HERIDAS CICATRIZACIO, V6, P46; Martinez-Monsalve A, 2019, J VASC SURG, V69, P1532, DOI 10.1016/j.jvs.2018.08.175; McGhan WF, 2009, VALUE HEALTH, V12, P1086, DOI 10.1111/j.1524-4733.2009.00605.x; Navarro-Buendia GA, 2020, HOSP DOMIC, V4, P45, DOI [10.22585/hospdomic.v4i2.101, DOI 10.22585/HOSPDOMIC.V4I2.101]; Negrin MA, 2008, J HEALTH ECON, V27, P1250, DOI 10.1016/j.jhealeco.2008.03.005; Negrin MA, 2010, INT J ENV RES PUB HE, V7, P1577, DOI 10.3390/ijerph7041577; Nielsen S, 2016, PHARMACOEPIDEM DR S, V25, P733, DOI 10.1002/pds.3945; Nixon RM, 2005, HEALTH ECON, V14, P1217, DOI 10.1002/hec.1008; Nussbaum SR, 2018, VALUE HEALTH, V21, P27, DOI 10.1016/j.jval.2017.07.007; O'Hagan A, 2001, HEALTH ECON, V10, P303, DOI 10.1002/hec.617; O'Hagan A, 2001, STAT MED, V20, P733, DOI 10.1002/sim.861; O'Hagan Anthony, 2002, BMC Med Res Methodol, V2, P5, DOI 10.1186/1471-2288-2-5; Olsson M, 2019, WOUND REPAIR REGEN, V27, P114, DOI 10.1111/wrr.12683; Padilla del Rey M, 2019, REV SOC ESP DOLOR, V26, P253; Lazaro JJP, 2012, REV ESP ANEST REANIM, V59, P423, DOI 10.1016/j.redar.2012.04.023; Pinar Sanchez J, 2020, MED PALIATIVA, V27, P141, DOI [10.20986/medpal.2020.1130/2019, DOI 10.20986/MEDPAL.2020.1130/2019]; Polo Francisco-Jose Vazquez, 2005, Eur J Health Econ, V6, P45, DOI 10.1007/s10198-004-0256-z; Purwins S, 2010, INT WOUND J, V7, P97, DOI 10.1111/j.1742-481X.2010.00660.x; Servicio Andaluz de Salud, 2012, RETR PERS CTR I SAN; Servicio Andaluz de Salud, 2015, RETR PERS CTR I SAN; Servicio Andaluz de Salud, 2016, RETR PERS CTR I SAN; Tricco AC, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0326-3; Vazquez-Polo FJ, 2005, HEALTH ECON, V14, P545, DOI 10.1002/hec.947; von Elm E, 2008, J CLIN EPIDEMIOL, V61, P344, DOI 10.2471/BLT.07.045120; Willan AR, 2004, HEALTH ECON, V13, P461, DOI 10.1002/hec.843	56	2	2	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2021	16	9							e0257494	10.1371/journal.pone.0257494	http://dx.doi.org/10.1371/journal.pone.0257494			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	WG6BN	34543330	Green Published, gold			2022-12-26	WOS:000707078200040
J	Ding, KY; Li, CJ; Jia, HB; Zhang, MM; Yu, DC				Ding, Keya; Li, Chuanjiang; Jia, Huibin; Zhang, Mingming; Yu, Dongchuan			Is left-behind a real reason for children's social cognition deficit? An fNIRS study on the effect of social interaction on left-behind preschooler's prefrontal activation	PLOS ONE			English	Article							JOINT ATTENTION; UNFAMILIAR FACES; MIGRATION; FMRI; REMITTANCES; SENSITIVITY; FAMILIAR; SKILL	The left-behind phenomenon, caused by parent out-migration, has become a common social issue and might lead to long-term and potential risks for children in rural areas of China. It is important to investigate the effect of social interaction on prefrontal activation of left-behind children in China because of possible effects of parent out-migration on children's social cognition. We recruited 81 rural Chinese preschoolers aged 52-76 months (mean = 64.98 +/- 6.321 months) preschoolers with three different statuses of parental out-migration (including non-, partially, and completely left-behind children). Using functional Near-Infrared Spectroscopy (fNIRS), we compared behavior and brain activation and in three groups (non-, partially-, completely-left-behind children) under two different social interaction conditions (child-teacher and child-stranger situation). Results revealed that initiating joint attention (IJA) may evoke higher brain activation than responding to joint attention (RJA) in the prefrontal cortex (PFC), especially in the case of initiating joint attention with the stranger. In addition, the activation of joint attention was positively correlated with children's language score, cognitive flexibility, and facial expression recognition. More importantly, partially-left-behind children evoked higher brain activation in the IJA condition and presented a higher language level than completely/non-left-behind children. The current study provides insight into the neural basis of left-behind children's development and revealed for the first time that family economic level and left-behind status may contribute to the lower social cognition.	[Ding, Keya; Yu, Dongchuan] Southeast Univ, Sch Biol Sci & Med Engn, Key Lab Child Dev & Learning Sci, Minist Educ, Nanjing, Peoples R China; [Ding, Keya] Washington Univ, Div Child & Adolescent Psychiat, St Louis, MO 63110 USA; [Li, Chuanjiang] Zhejiang Normal Univ, Hangzhou Coll Early Childhood Teachers Educ, Hangzhou, Peoples R China; [Jia, Huibin] Henan Univ, Sch Psychol, Kaifeng, Peoples R China; [Zhang, Mingming] Shanghai Normal Univ, Sch Psychol, Shanghai, Peoples R China; [Yu, Dongchuan] Zhengzhou Univ, Affiliated Hosp 3, Zhengzhou, Henan, Peoples R China	Southeast University - China; Washington University (WUSTL); Zhejiang Normal University; Henan University; Shanghai Normal University; Zhengzhou University	Yu, DC (corresponding author), Southeast Univ, Sch Biol Sci & Med Engn, Key Lab Child Dev & Learning Sci, Minist Educ, Nanjing, Peoples R China.; Yu, DC (corresponding author), Zhengzhou Univ, Affiliated Hosp 3, Zhengzhou, Henan, Peoples R China.	dcyu@seu.edu.cn		Ding, Keya/0000-0001-8327-8195	National Natural Science Foundation of China [62073077, 61673113]; China Scholarship Council [201906090155]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Scholarship Council(China Scholarship Council)	National Natural Science Foundation of China, 62073077 and 61673113, Dongchuan Yu The scholarship from China Scholarship Council, 201906090155, Keya Ding.	[Anonymous], 1992, CANADIAN PSYCHOL; Azam JP, 2006, J AFR ECON, V15, P426, DOI 10.1093/jae/ejl030; Baron-Cohen S., 2004, MIND READING INTERAC; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bilek E, 2015, P NATL ACAD SCI USA, V112, P5207, DOI 10.1073/pnas.1421831112; Callaghan BL, 2016, NEUROPSYCHOPHARMACOL, V41, P163, DOI 10.1038/npp.2015.204; Caruana N, 2015, NEUROIMAGE, V108, P34, DOI 10.1016/j.neuroimage.2014.12.041; Chang WW, 2020, EXPERT SYST APPL, V158, DOI 10.1016/j.eswa.2020.113448; Charman T, 2003, PHILOS T R SOC B, V358, P315, DOI 10.1098/rstb.2002.1199; Chohan M, 2019, BEHAV DEV, V24, P29, DOI [10.1037/bdb0000087, DOI 10.1037/BDB0000087]; Chugani HT, 2001, NEUROIMAGE, V14, P1290, DOI 10.1006/nimg.2001.0917; DELPY DT, 1988, PHYS MED BIOL, V33, P1433, DOI 10.1088/0031-9155/33/12/008; Duan C. R, 2008, POPULATION RES, V32, P15, DOI [10.3969/j.issn.1000-6087.2008.03.002, DOI 10.3969/J.ISSN.1000-6087.2008.03.002]; Ewbank MP, 2008, NEUROIMAGE, V40, P1857, DOI 10.1016/j.neuroimage.2008.01.049; Grossmann T, 2013, DEV COGN NEUROS-NETH, V6, P155, DOI 10.1016/j.dcn.2013.09.004; Hu BY, 2020, EARLY CHILD RES Q, V51, P317, DOI 10.1016/j.ecresq.2019.12.011; Huppert TJ, 2009, APPL OPTICS, V48, pD280, DOI 10.1364/AO.48.00D280; Li CJ, 2020, FRONT PSYCHOL, V11, DOI 10.3389/fpsyg.2020.01939; Li YW, 2017, DEV COGN NEUROS-NETH, V25, P138, DOI 10.1016/j.dcn.2016.07.002; Lloyd-Fox S, 2017, DEV COGN NEUROS-NETH, V25, P92, DOI 10.1016/j.dcn.2016.11.005; Lu L., 1998, XIUDING BIBAODE TUHU; Lu Y, 2015, HEALTH PLACE, V36, P118, DOI 10.1016/j.healthplace.2015.09.008; Ming W. D. Q., 1989, PSYCHOL SCI, V5; Ministry of Civil Affairs of China, 2018, CHART DAT LEFT BEH C; Mundy P., 2006, DEV PSYCHOPATHOL, P293, DOI DOI 10.7551/MITPRESS/2137.003.0015; Mundy P, 2007, CURR DIR PSYCHOL SCI, V16, P269, DOI 10.1111/j.1467-8721.2007.00518.x; Mundy P, 2010, NEURAL NETWORKS, V23, P985, DOI 10.1016/j.neunet.2010.08.009; Natu V, 2011, BRIT J PSYCHOL, V102, P726, DOI 10.1111/j.2044-8295.2011.02053.x; Oberwelland E, 2016, NEUROIMAGE, V130, P248, DOI 10.1016/j.neuroimage.2016.02.026; Pfeiffer UJ, 2014, NEUROIMAGE, V101, P124, DOI 10.1016/j.neuroimage.2014.06.061; Pierce K, 2008, BIOL PSYCHIAT, V64, P552, DOI 10.1016/j.biopsych.2008.05.013; Quinones-Camacho LE, 2019, DEV COGN NEUROS-NETH, V38, DOI 10.1016/j.dcn.2019.100651; Redcay E, 2010, NEUROIMAGE, V50, P1639, DOI 10.1016/j.neuroimage.2010.01.052; Schilbach L., 2009, NEUROIMAGE, V47, pS183, DOI DOI 10.1016/S1053-8119(09)72028-2; Schilbach L, 2010, J COGNITIVE NEUROSCI, V22, P2702, DOI 10.1162/jocn.2009.21401; Scholkmann F, 2010, PHYSIOL MEAS, V31, P649, DOI 10.1088/0967-3334/31/5/004; Semyonov M, 2008, POPUL RES POLICY REV, V27, P619, DOI 10.1007/s11113-008-9084-7; Shen Y., 2017, CHINESE EDUC SOC, V50, P217, DOI [https://doi.org/10.1080/10611932.2017.1331014, DOI 10.1080/10611932.2017.1331014, 10.1080/10611932.2017.1331014]; Shepherd SV, 2010, FRONT INTEGR NEUROSC, V4, DOI 10.3389/fnint.2010.00005; Strangman G, 2002, NEUROIMAGE, V17, P719, DOI 10.1006/nimg.2002.1227; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; TOMASELLO M, 1986, CHILD DEV, V57, P1454, DOI 10.2307/1130423; Van Hecke AV, 2007, CHILD DEV, V78, P53; Van Hecke AV, 2012, INFANT BEHAV DEV, V35, P303, DOI 10.1016/j.infbeh.2011.12.001; Zeng Rong, 2009, Zhonghua Liu Xing Bing Xue Za Zhi, V30, P706; Zhou N, 2012, STUDIES EARLY CHILDH, P7, DOI [10.3969/j.issn.1007-8169.2012.11.005, DOI 10.3969/J.ISSN.1007-8169.2012.11.005]	46	0	0	5	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2021	16	9							e0254010	10.1371/journal.pone.0254010	http://dx.doi.org/10.1371/journal.pone.0254010			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	WG5ZQ	34534229	Green Published, gold			2022-12-26	WOS:000707073300005
J	Tora, E; Abayneh, E; Seyoum, W; Shurbe, M				Tora, Ephrem; Abayneh, Edget; Seyoum, Wasihun; Shurbe, Mesfin			Longitudinal study of calf morbidity and mortality on smallholder farms in southern Ethiopia	PLOS ONE			English	Article							HEALTH; SYSTEMS; CALVES	Calf morbidity and mortality are serious constraints in the success of dairy calf production. Thus, the current study was carried out with the objective to estimate the incidence of calf morbidity and mortality and associated risk factors in milk-shed districts of Gamo Zone, Southern Ethiopia. A prospective cohort and cross-sectional survey were employed from November 2019 to April 2020. A total of 196 calves were recruited by simple random sampling. Recruitment of calves was deployed by both the concurrent and prospective cohorts in calves aged below three months in study herds. The crude incidence of calf morbidity and mortality was 30.9% and 8.64%, respectively. The most frequently encountered disorder was calf diarrhea (10.17%), followed by pneumonia (6.5%). The other disorders were septicemia, omphalitis, arthritis, eye problem and miscellaneous cases. Multivariable Cox regression was revealed significant association for the calf vigor status, colostrum ingestion time, colostrum feeding status, dam parity, age at first calving, and related disorders were found risk factors of calf morbidity; likewise, calf vigor status at birth, time of colostrum ingestion and weaning were risk factors determining calf mortality. Calf morbidity and mortality rates recorded in this study were marginally higher than economically tolerable level, therefore, could affect the productivity of smallholder dairying by decreasing the obtainability of replacement heifers. Among significant explanatory factors investigated, colostrum ingestion time, method and amount were found important determinant factors of calf mortality and morbidity under the small-holder farming in the milk-shed districts of the Gamo zone. Therefore, rigorous calf husbandry practice is a need to manipulate the aforementioned calf determinants with subsequent application of tailor-made interventions.	[Tora, Ephrem; Abayneh, Edget; Seyoum, Wasihun; Shurbe, Mesfin] Arba Minch Univ, Coll Agr Sci, Dept Anim Sci & Hlth, Arba Minch, Ethiopia	Arba Minch University	Tora, E (corresponding author), Arba Minch Univ, Coll Agr Sci, Dept Anim Sci & Hlth, Arba Minch, Ethiopia.	adech.tor@gmail.com	Tora, Ephrem/ABD-7955-2021; Alembo, Edget/GPK-1812-2022	Tora, Ephrem/0000-0002-3115-0824; Alembo, Edget/0000-0002-8942-0321; Seyoum, Wasihun/0000-0001-9613-1184				Ababu D., 2006, ETH J ANIM PROD, V6, P33; Admasu M.T., 2016, J VET SCIE TECHNOL, V7, P1; Ahmed MAM, 2004, 123 EPTD INT FOOD PO; Aliyu H., 2017, ETHIOPIA J ANIM SCI, V49, P1; Amuamuta A, 2006, REV MED VET-TOULOUSE, V157, P525; Arbaminch Zuria District Livestock and Fishery Resource Office (AZDLFRO), 2020, REP ARB ZUR DISTR LI; Arsham H., 2005, QUESTIONNAIRE DESIGN; Assefa A., 2016, ETHIOPIA J ANIM SCI, V49, P44; Bebe O., 2008, DAIRY HEIFER REARING; Behnke R., 2010, 0210 IGAD LPI; Bekele Megersa, 2009, Ethiopian Veterinary Journal, V13, P59; Bernard J. P, 2008, THESIS MASSEY U; BRITNEY JB, 1984, PREV VET MED, V3, P45, DOI 10.1016/0167-5877(84)90023-0; Central Statistical Agency (CSA), 2018, REP LIV LIV CHAR, VII; FAO NZAGGRC, 2017, SUPP LOW EM DEV ETH; Fentie Tsegaw, 2020, Vet Med Int, V2020, P3075429, DOI 10.1155/2020/3075429; Ferede Y., 2015, THESIS RESPOSITORY A; Fox LS, 2007, Tri-State Dairy Nutrition Conference, Proceedings, P43; Gitau GK, 2010, TROP ANIM HEALTH PRO, V42, P1643, DOI 10.1007/s11250-010-9614-2; Gojjam Y., 2002, P 16 C ETH VET ASS, P103; GZLFRD, 2019, GAM ZON LIV FISH RE; Habib A., 2014, J DENTA MEDIC SCIE, V13, P21; Hossain F., 2009, THESIS CHITTAGONG VE; ILCA, 1994, ILCA ANN PROGR REP 1, P73; Islam M. N., 2015, Bangladesh Journal of Veterinary Medicine, V13, P37, DOI 10.3329/bjvm.v13i1.23715; Lema M, 2001, TROP ANIM HEALTH PRO, V33, P85, DOI 10.1023/A:1005203628744; Martin S.W., 1987, VET EPIDEMIOLOGY PRI; Mesele G., 2018, THESIS ARB MINCH U; Minten B, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0237456; Moran JB, 2011, ASIAN AUSTRAL J ANIM, V24, P1318, DOI 10.5713/ajas.2011.11099; Muluken T., 2017, J ANIM DISEA, V6, P67; Radostitis O.M., 2001, HERD HLTH FOOD ANIMA, V3rd, P333; Radostits O.M., 2007, VET MED TXB DIS CATT, V8, P857; Rahma Mohammed, 2020, Veterinary Medicine International, V2020, DOI 10.1155/2020/6490710; Rousie S., 2000, VET RECOR, V147, P160; Roy J.H., 1990, CALF, V5; Sabapara G.P., 2016, LIVES RES INT, V4, P88; Shibru D, 2014, ANIM PROD, V16, P121; Solomon G., 2016, 23 INT LIV RES I; Tintagu T, 2017, B ANIM HEALTH PROD, V66, P207; Tsegaw F., 2016, FEED FUTURE RES AWAR; WITTUM TE, 1995, AM J VET RES, V56, P1149; Wudu T, 2008, TROP ANIM HEALTH PRO, V40, P369, DOI 10.1007/s11250-007-9104-3; Wymann MN, 2006, LIVEST SCI, V100, P169, DOI 10.1016/j.livprodsci.2005.08.010	44	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2021	16	9							e0257139	10.1371/journal.pone.0257139	http://dx.doi.org/10.1371/journal.pone.0257139			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	WG5YY	34529700	Green Published, gold			2022-12-26	WOS:000707071500029
J	Waturuocha, UW; Athira, PJ; Singh, KK; Malhotra, V; Krishna, MS; Saini, DK				Waturuocha, Uchenna Watson; Athira, P. J.; Singh, Krishna Kumar; Malhotra, Vandana; Krishna, M. S.; Saini, Deepak Kumar			A high-frequency single nucleotide polymorphism in the MtrB sensor kinase in clinical strains of Mycobacterium tuberculosis alters its biochemical and physiological properties	PLOS ONE			English	Article							CROSS-TALK; IN-VITRO; SYSTEM; MUTANT	The DNA polymorphisms found in clinical strains of Mycobacterium tuberculosis drive altered physiology, virulence, and pathogenesis in them. Although the lineages of these clinical strains can be traced back to common ancestor/s, there exists a plethora of difference between them, compared to those that have evolved in the laboratory. We identify a mutation present in ~80% of clinical strains, which maps in the HATPase domain of the sensor kinase MtrB and alters kinase and phosphatase activities, and affects its physiological role. The changes conferred by the mutation were probed by in-vitro biochemical assays which revealed changes in signaling properties of the sensor kinase. These changes also affect bacterial cell division rates, size and membrane properties. The study highlights the impact of DNA polymorphisms on the pathophysiology of clinical strains and provides insights into underlying mechanisms that drive signal transduction in pathogenic bacteria.	[Waturuocha, Uchenna Watson; Krishna, M. S.] Univ Mysore, Dept Studies Zool, Mysore, Karnataka, India; [Waturuocha, Uchenna Watson; Athira, P. J.; Singh, Krishna Kumar; Saini, Deepak Kumar] Indian Inst Sci, Dept Mol Reprod Dev & Genet, Bangalore, Karnataka, India; [Malhotra, Vandana] Univ Delhi, Sri Venkateswara Coll, Dept Biochem, Delhi, India; [Saini, Deepak Kumar] Indian Inst Sci, Ctr Biosyst Sci & Engn, Bangalore, Karnataka, India	University of Mysore; Indian Institute of Science (IISC) - Bangalore; University of Delhi; Indian Institute of Science (IISC) - Bangalore	Saini, DK (corresponding author), Indian Inst Sci, Dept Mol Reprod Dev & Genet, Bangalore, Karnataka, India.; Saini, DK (corresponding author), Indian Inst Sci, Ctr Biosyst Sci & Engn, Bangalore, Karnataka, India.	deepaksaini@iisc.ac.in		Saini, Deepak/0000-0001-6671-7256	INSPIRE scholarship, Department of Science and Technology [IF150491]; Department of Biotechnology, India [BT/PR17357/MED/29/1019/2016, BIRAC/PMU/2019/Sentinels-001]; DBT [BT/PR27952-INF/22/212/2018]; Infosys Foundation; DST [SR/FST/LSII-036/2016]; University Grants Commission [F.4.13/2018/DRS-III (SAP-II)]	INSPIRE scholarship, Department of Science and Technology; Department of Biotechnology, India(Department of Biotechnology (DBT) India); DBT(Department of Biotechnology (DBT) India); Infosys Foundation; DST(Department of Science & Technology (India)); University Grants Commission(University Grants Commission, India)	UW (IF150491): INSPIRE scholarship, Department of Science and Technology https://www.online-inspire.gov.in DKS: Department of Biotechnology, India (Grant No. BT/PR17357/MED/29/1019/2016 and BT/PR17357/MED/29/1019/2016 and BIRAC/PMU/2019/Sentinels-001); DBT partnership program to Indian Institute of Science (BT/PR27952-INF/22/212/2018) http://dbtindia.gov.in and Infosys Foundation https://www.infosys.com/infosys-foundation/initiatives/education.html; Equipment support by DST-Funds for Infrastructure in Science and Technology program (SR/FST/LSII-036/2016) https://dst.gov.in and University Grants Commission [F.4.13/2018/DRS-III (SAP-II)] https://www.ugc.ac.in.	Agrawal R, 2016, FUTURE MICROBIOL, V11, P685, DOI 10.2217/fmb-2016-0001; Agrawal R, 2015, BIOCHEM J, V469, P121, DOI 10.1042/BJ20150268; Baena A, 2019, VIRULENCE, V10, P695, DOI 10.1080/21505594.2019.1642045; Banerjee S, 2019, J BIOL CHEM, V294, P19862, DOI 10.1074/jbc.RA119.009449; Betts JC, 2000, MICROBIOL-SGM, V146, P3205, DOI 10.1099/00221287-146-12-3205; Bhaskarla C, 2016, MICROBIOL-SGM, V162, P764, DOI 10.1099/mic.0.000271; Boradia VM, 2016, MICROB CELL FACT, V15, DOI 10.1186/s12934-016-0537-0; Bourret RB, 2010, CURR OPIN MICROBIOL, V13, P113, DOI 10.1016/j.mib.2010.02.003; Braden CR, 2001, CLIN INFECT DIS, V33, pE42, DOI 10.1086/322635; Cardona ST, 2018, J MEMBRANE BIOL, V251, P75, DOI 10.1007/s00232-017-9995-5; Casali N, 2012, GENOME RES, V22, P735, DOI 10.1101/gr.128678.111; Chatterjee A, 2018, MICROBIOL-SGM, V164, P99, DOI 10.1099/mic.0.000585; Chernyaeva EN, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-308; Coll F, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5812; Comas I, 2012, NAT GENET, V44, P106, DOI 10.1038/ng.1038; Coscolla M, 2014, SEMIN IMMUNOL, V26, P431, DOI 10.1016/j.smim.2014.09.012; Fleischmann RD, 2002, J BACTERIOL, V184, P5479, DOI 10.1128/JB.184.19.5479-5490.2002; Fol M, 2006, MOL MICROBIOL, V60, P643, DOI 10.1111/j.1365-2958.2006.05137.x; Frigui W, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040033; Gagneux S, 2006, P NATL ACAD SCI USA, V103, P2869, DOI 10.1073/pnas.0511240103; Gao R, 2009, ANNU REV MICROBIOL, V63, P133, DOI 10.1146/annurev.micro.091208.073214; Gorla P, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.02839; Hohl M, 2019, MOL MICROBIOL, V111, P1263, DOI 10.1111/mmi.14220; Hosseini H, 2014, ASIAN PAC J TROP MED, V7, pS199, DOI 10.1016/S1995-7645(14)60232-7; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Madeira F, 2019, NUCLEIC ACIDS RES, V47, pW636, DOI 10.1093/nar/gkz268; Malhotra V, 2009, TUBERCULOSIS, V89, P169, DOI 10.1016/j.tube.2008.12.003; Manca C, 1999, J IMMUNOL, V162, P6740; Moker N, 2007, J BACTERIOL, V189, P3645, DOI 10.1128/JB.01920-06; Pang XH, 2007, MICROBIOL-SGM, V153, P1229, DOI 10.1099/mic.0.29281-0; Plocinska R, 2012, J BIOL CHEM, V287, P23887, DOI 10.1074/jbc.M112.346544; Rajagopalan M, 2010, J BIOL CHEM, V285, P15816, DOI 10.1074/jbc.M109.040097; Ramaswamy S., 1998, Tubercle and Lung Disease, V79, P3, DOI 10.1054/tuld.1998.0002; Rodrigues L, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-35; Saini DK, 2002, PROTEIN EXPRES PURIF, V25, P203, DOI 10.1006/prep.2002.1628; Sarkar R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043170; Sharma AK, 2015, MICROBIOL-SGM, V161, P1271, DOI 10.1099/mic.0.000087; Singh KK, 2019, J MOL BIOL, V431, P777, DOI 10.1016/j.jmb.2019.01.004; Soto CY, 2002, J CLIN MICROBIOL, V40, P3021, DOI 10.1128/JCM.40.8.3021-3024.2002; Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183; Stucki D, 2013, TUBERCULOSIS, V93, P30, DOI 10.1016/j.tube.2012.11.002; Vashist A, 2018, J BIOL CHEM, V293, P16413, DOI 10.1074/jbc.RA118.004331; Vorachek-Warren MK, 2002, J BIOL CHEM, V277, P14186, DOI 10.1074/jbc.M200408200; Zahrt TC, 2000, J BACTERIOL, V182, P3832, DOI 10.1128/JB.182.13.3832-3838.2000; Zheng HJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002375; Zhou L, 2015, INT J ANTIMICROB AG, V46, P73, DOI 10.1016/j.ijantimicag.2015.02.018	46	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2021	16	9							e0256664	10.1371/journal.pone.0256664	http://dx.doi.org/10.1371/journal.pone.0256664			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	WG5YY	34529706	Green Published, Green Accepted, gold			2022-12-26	WOS:000707071500015
J	Franz, M; Schmidt, B; Hecht, H; Naumann, E; Miltner, WHR				Franz, Marcel; Schmidt, Barbara; Hecht, Holger; Naumann, Ewald; Miltner, Wolfgang H. R.			Suggested visual blockade during hypnosis: Top-down modulation of stimulus processing in a visual oddball task	PLOS ONE			English	Article							EVOKED POTENTIALS; INTRACEREBRAL POTENTIALS; RARE TARGET; SOURCE LOCALIZATION; HYPNOTIC ANALGESIA; NEURAL MECHANISMS; BRAIN; P300; EEG; ATTENTION	Several theories of hypnosis assume that responses to hypnotic suggestions are implemented through top-down modulations via a frontoparietal network that is involved in monitoring and cognitive control. The current study addressed this issue re-analyzing previously published event-related-potentials (ERP) (N1, P2, and P3b amplitudes) and combined it with source reconstruction and connectivity analysis methods. ERP data were obtained from participants engaged in a visual oddball paradigm composed of target, standard, and distractor stimuli during a hypnosis (HYP) and a control (CON) condition. In both conditions, participants were asked to count the rare targets presented on a video screen. During HYP participants received suggestions that a wooden board in front of their eyes would obstruct their view of the screen. The results showed that participants' counting accuracy was significantly impaired during HYP compared to CON. ERP components in the N1 and P2 window revealed no amplitude differences between CON and HYP at sensor-level. In contrast, P3b amplitudes in response to target stimuli were significantly reduced during HYP compared to CON. Source analysis of the P3b amplitudes in response to targets indicated that HYP was associated with reduced source activities in occipital and parietal brain areas related to stimulus categorization and attention. We further explored how these brain sources interacted by computing time-frequency effective connectivity between electrodes that best represented frontal, parietal, and occipital sources. This analysis revealed reduced directed information flow from parietal attentional to frontal executive sources during processing of target stimuli. These results provide preliminary evidence that hypnotic suggestions of a visual blockade are associated with a disruption of the coupling within the frontoparietal network implicated in top-down control.	[Franz, Marcel; Schmidt, Barbara; Hecht, Holger; Miltner, Wolfgang H. R.] Friedrich Schiller Univ Jena, Inst Psychol, Jena, Germany; [Naumann, Ewald] Univ Trier, Inst Psychol, Trier, Germany	Friedrich Schiller University of Jena; Universitat Trier	Miltner, WHR (corresponding author), Friedrich Schiller Univ Jena, Inst Psychol, Jena, Germany.	wolfgang.miltner@uni-jena.de	Schmidt, Barbara/AAH-4517-2020	Schmidt, Barbara/0000-0002-6828-5546	Deutsche Forschungsgemeinschaft [NA 482/5-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	Deutsche Forschungsgemeinschaft (Award number: MI 265/15-1 | recipient: W.H.R. Miltner); Deutsche Forschungsgemeinschaft (Award number: NA 482/5-1 | recipient: Ewald Naumann).	Babiloni C, 2006, CEREB CORTEX, V16, P37, DOI 10.1093/cercor/bhi082; Babiloni C, 2009, HUM BRAIN MAPP, V30, P998, DOI 10.1002/hbm.20567; Baccala LA, 2001, BIOL CYBERN, V84, P463, DOI 10.1007/PL00007990; BARABASZ AF, 1983, J ABNORM PSYCHOL, V92, P520, DOI 10.1037/0021-843X.92.4.520; BAUDENA P, 1995, ELECTROEN CLIN NEURO, V94, P251, DOI 10.1016/0013-4694(95)98476-O; Bigdely-Shamlo N, 2013, IEEE ENG MED BIO, P5845, DOI 10.1109/EMBC.2013.6610881; Bledowski C, 2004, J NEUROSCI, V24, P9353, DOI 10.1523/JNEUROSCI.1897-04.2004; Bocquillon P, 2011, CLIN NEUROPHYSIOL, V122, P1991, DOI 10.1016/j.clinph.2011.03.014; BOWERS KS, 1992, CONSCIOUS COGN, V1, P32, DOI 10.1016/1053-8100(92)90042-9; Braboszcz C, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10310-4; Buzsaki G, 2011, RHYTHMS BRAIN; Buzsaki G, 2013, NEURON, V80, P751, DOI 10.1016/j.neuron.2013.10.002; Cavina-Pratesi C, 2006, J NEUROSCI, V26, P2704, DOI 10.1523/JNEUROSCI.3176-05.2006; Clarke JM, 1999, CLIN NEUROPHYSIOL, V110, P1210, DOI 10.1016/S1388-2457(99)00063-2; Cojan Y, 2009, NEURON, V62, P862, DOI 10.1016/j.neuron.2009.05.021; Connors MH, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00361; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; CRAWFORD HJ, 1994, INT J CLIN EXP HYP, V42, P204, DOI 10.1080/00207149408409352; Crawford HJ, 1998, INT J CLIN EXP HYP, V46, P92, DOI 10.1080/00207149808409992; DAVISON GC, 1967, INT J CLIN EXP HYP, V15, P57, DOI 10.1080/00207146708407509; De Pascalis V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128474; DEHAENE S, 1992, COGNITION, V44, P1, DOI 10.1016/0010-0277(92)90049-N; DEHAENE S, 1994, J EXP PSYCHOL HUMAN, V20, P958, DOI 10.1037/0096-1523.20.5.958; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Delorme A, 2007, NEUROIMAGE, V34, P1443, DOI 10.1016/j.neuroimage.2006.11.004; Delorme A, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/130714; Dienes Z., 2007, HYPNOSIS CONSCIOUS S, P293; DiMaio V, 1995, PERCEPT MOTOR SKILL, V81, P1315, DOI 10.2466/pms.1995.81.3f.1315; Eger E, 2009, CURR BIOL, V19, P1608, DOI 10.1016/j.cub.2009.08.047; Egner T, 2005, NEUROIMAGE, V27, P969, DOI 10.1016/j.neuroimage.2005.05.002; Florin E, 2010, NEUROIMAGE, V50, P577, DOI 10.1016/j.neuroimage.2009.12.050; Friederich M, 2001, PSYCHOPHYSIOLOGY, V38, P768, DOI 10.1017/S0048577201000221; Friedrich J, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-61025-y; Gazzaley A, 2012, TRENDS COGN SCI, V16, P129, DOI 10.1016/j.tics.2011.11.014; Gmaj B, 2016, ACTA NEUROBIOL EXP, V76, P75, DOI 10.21307/ane-2017-007; Goebel R, 2004, HUMAN NERVOUS SYSTEM, VSecond, P1280; Gruzelier J.H., 2006, CONT HYPN, V23, P15, DOI DOI 10.1002/CH.35; HALGREN E, 1995, ELECTROEN CLIN NEURO, V94, P191, DOI 10.1016/0013-4694(94)00259-N; HALGREN E, 1995, ELECTROEN CLIN NEURO, V94, P229, DOI 10.1016/0013-4694(95)98475-N; Herrmann MJ, 2004, J PSYCHOPHYSIOL, V18, P1, DOI 10.1027/0269-8803.18.1.1; Hilgard E. R., 1991, THEORIES HYPNOSIS CU, P83; Hilgard E.R., 1977, DIVIDED CONSCIOUSNES; Hopfinger JB, 2000, NAT NEUROSCI, V3, P284, DOI 10.1038/72999; Jasiukaitis P, 1996, NEUROPSYCHOLOGIA, V34, P661, DOI 10.1016/0028-3932(95)00149-2; JOHNSON R, 1986, PSYCHOPHYSIOLOGY, V23, P367, DOI 10.1111/j.1469-8986.1986.tb00649.x; Jung TP, 2000, PSYCHOPHYSIOLOGY, V37, P163, DOI 10.1017/S0048577200980259; Kallio S, 2016, INT J CLIN EXP HYP, V64, P261, DOI 10.1080/00207144.2016.1171088; Kilner JM, 2010, ANN APPL STAT, V4, P1272, DOI 10.1214/10-AOAS337; Kirenskaya AV, 2019, INT J CLIN EXP HYP, V67, P81, DOI 10.1080/00207144.2019.1553764; Kirino E, 2000, J NEUROSCI, V20, P6612, DOI 10.1523/JNEUROSCI.20-17-06612.2000; Knight RT, 1998, J CLIN NEUROPHYSIOL, V15, P3, DOI 10.1097/00004691-199801000-00003; Kok A, 2001, PSYCHOPHYSIOLOGY, V38, P557, DOI 10.1017/S0048577201990559; Kosslyn SM, 2000, AM J PSYCHIAT, V157, P1279, DOI 10.1176/appi.ajp.157.8.1279; Lakens D, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00863; Leistritz L, 2013, PHILOS T R SOC A, V371, DOI 10.1098/rsta.2011.0616; Litvak V, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/852961; LUCK SJ, 1994, PSYCHOPHYSIOLOGY, V31, P291, DOI 10.1111/j.1469-8986.1994.tb02218.x; Luck SJ, 2011, OXFORD HDB EVENT REL, P329, DOI DOI 10.1093/0XF0RDHB/9780195374148.013.0161; Mallard D, 2001, INT J CLIN EXP HYP, V49, P330, DOI 10.1080/00207140108410082; Matsumoto E, 2004, EXP BRAIN RES, V158, P9, DOI 10.1007/s00221-004-1872-7; McGeown WJ, 2012, CONSCIOUS COGN, V21, P100, DOI 10.1016/j.concog.2011.10.015; Miller B. L., 2018, HUMAN FRONTAL LOBES; Miltner WHR., 1993, HYPNOSE KOGNITION, V10, P22; Oakley DA, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.01924; Oakley DA, 2013, NAT REV NEUROSCI, V14, P565, DOI 10.1038/nrn3538; Oakley DA, 2009, TRENDS COGN SCI, V13, P264, DOI 10.1016/j.tics.2009.03.004; Omoto S, 2010, CLIN NEUROPHYSIOL, V121, P386, DOI 10.1016/j.clinph.2009.12.005; Oostenveld R, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/156869; PASCUALMARQUI RD, 1994, INT J PSYCHOPHYSIOL, V18, P49, DOI 10.1016/0167-8760(84)90014-X; Piazza M, 2003, P ROY SOC B-BIOL SCI, V270, P1237, DOI 10.1098/rspb.2003.2356; Piazza M, 2016, NEUROPSYCHOLOGIA, V83, P257, DOI 10.1016/j.neuropsychologia.2015.09.025; POLICH J, 1995, BIOL PSYCHOL, V41, P103, DOI 10.1016/0301-0511(95)05130-9; Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; Scharmuller W, 2011, BRAIN RES, V1397, P10, DOI 10.1016/j.brainres.2011.04.018; Scherg Michael, 1992, Brain Topography, V5, P103, DOI 10.1007/BF01129037; Schmidt B, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05195-2; Schuler G, 1996, HYPN KOGN, V13, P79; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Shomstein S, 2012, FRONT INTEGR NEUROSC, V6, DOI 10.3389/fnint.2012.00038; Spiegel D, 2013, DEPRESS ANXIETY, V30, P342, DOI 10.1002/da.22046; Terhune DB, 2017, NEUROSCI BIOBEHAV R, V81, P59, DOI 10.1016/j.neubiorev.2017.02.002; Terhune DB, 2011, PSYCHOPHYSIOLOGY, V48, P1444, DOI 10.1111/j.1469-8986.2011.01211.x; Trippe RH, 2004, ANASTH INTENSIVMED, V45, P642; VERLEGER R, 1994, COGNITIVE BRAIN RES, V2, P103, DOI 10.1016/0926-6410(94)90007-8; Verleger R, 2020, PSYCHOPHYSIOLOGY, V57, DOI 10.1111/psyp.13542; Woody EZ, 2008, DISSOCIATION THEORIE	86	2	2	4	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2021	16	9							e0257380	10.1371/journal.pone.0257380	http://dx.doi.org/10.1371/journal.pone.0257380			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	WG6DR	34525129	Green Published, gold			2022-12-26	WOS:000707084400033
J	Atsukawa, M; Tsubota, A; Kondo, C; Uchida-Kobayashi, S; Takaguchi, K; Tsutsui, A; Nozaki, A; Chuma, M; Hidaka, I; Ishikawa, T; Iwasa, M; Tamai, Y; Tobari, M; Matsuura, K; Nagura, Y; Abe, H; Kato, K; Suzuki, K; Okubo, T; Arai, T; Itokawa, N; Toyoda, H; Enomoto, M; Tamori, A; Tanaka, Y; Kawada, N; Takei, Y; Iwakiri, K				Atsukawa, Masanori; Tsubota, Akihito; Kondo, Chisa; Uchida-Kobayashi, Sawako; Takaguchi, Koichi; Tsutsui, Akemi; Nozaki, Akito; Chuma, Makoto; Hidaka, Isao; Ishikawa, Tsuyoshi; Iwasa, Motoh; Tamai, Yasuyuki; Tobari, Maki; Matsuura, Kentaro; Nagura, Yoshihito; Abe, Hiroshi; Kato, Keizo; Suzuki, Kenta; Okubo, Tomomi; Arai, Taeang; Itokawa, Norio; Toyoda, Hidenori; Enomoto, Masaru; Tamori, Akihiro; Tanaka, Yasuhito; Kawada, Norifumi; Takei, Yoshiyuki; Iwakiri, Katsuhiko			A novel noninvasive formula for predicting cirrhosis in patients with chronic hepatitis C	PLOS ONE			English	Article							III PROCOLLAGEN PEPTIDE; MAC-2 BINDING-PROTEIN; HCV GENOTYPE 1; HEPATOCELLULAR-CARCINOMA; LIVER FIBROSIS; VIROLOGICAL RESPONSE; RISK; COLLAGEN; ELASTOGRAPHY; ASSOCIATION	Evaluating liver fibrosis is crucial for disease severity assessment, treatment decisions, and hepatocarcinogenic risk prediction among patients with chronic hepatitis C. In this retrospective multicenter study, we aimed to construct a novel model formula to predict cirrhosis. A total of 749 patients were randomly allocated to training and validation sets at a ratio of 2:1. Liver stiffness measurement (LSM) was made via transient elastography using FibroScan. Patients with LSM >= 12.5 kPa were regarded as having cirrhosis. The best model formula for predicting cirrhosis was constructed based on factors significantly and independently associated with LSM (>= 12.5 kPa) using multivariate regression analysis. Among the 749 patients, 198 (26.4%) had LSM >= 12.5 kPa. In the training set, multivariate analysis identified logarithm natural (ln) type IV collagen 7S, ln hyaluronic acid, and ln Wisteria floribunda agglutinin positive Mac-2-binding protein (WFA(+)-Mac-2 BP) as the factors that were significantly and independently associated with LSM >= 12.5 kPa. Thus, the formula was constructed as follows: score = -6.154 + 1.166 x ln type IV collagen 7S + 0.526 x ln hyaluronic acid + 1.069 x WFA(+)-Mac-2 BP. The novel formula yielded the highest area under the curve (0.882; optimal cutoff, -0.381), specificity (81.5%), positive predictive values (62.6%), and predictive accuracy (81.6%) for predicting LSM >= 12.5 kPa among fibrosis markers and indices. These results were almost similar to those in the validated set, indicating the reproducibility and validity of the novel formula. The novel formula scores were significantly, strongly, and positively correlated with LSM values in both the training and validation data sets (correlation coefficient, 0.721 and 0.762; p = 2.67 x 10(-81) and 1.88 x 10(-48), respectively). In conclusion, the novel formula was highly capable of diagnosing cirrhosis in patients with chronic hepatitis C and exhibited better diagnostic performance compared to conventional fibrosis markers and indices.	[Atsukawa, Masanori; Kondo, Chisa; Suzuki, Kenta; Arai, Taeang; Itokawa, Norio; Iwakiri, Katsuhiko] Nippon Med Sch, Div Gastroenterol & Hepatol, Tokyo, Japan; [Tsubota, Akihito] Jikei Univ, Sch Med, Core Res Facil, Tokyo, Japan; [Uchida-Kobayashi, Sawako; Enomoto, Masaru; Tamori, Akihiro; Kawada, Norifumi] Osaka City Univ, Grad Sch Med, Dept Hepatol, Osaka, Japan; [Takaguchi, Koichi; Tsutsui, Akemi] Kagawa Prefectural Cent Hosp, Dept Hepatol, Takamatsu, Kagawa, Japan; [Nozaki, Akito; Chuma, Makoto] Yokohama City Univ, Med Ctr, Gastroenterol Ctr, Yokohama, Kanagawa, Japan; [Hidaka, Isao; Ishikawa, Tsuyoshi] Yamaguchi Univ, Grad Sch Med, Dept Gastroenterol & Hepatol, Yamaguchi, Japan; [Iwasa, Motoh; Tamai, Yasuyuki; Takei, Yoshiyuki] Mie Univ, Sch Med, Dept Gastroenterol & Hepatol, Tsu, Mie, Japan; [Tobari, Maki] Tokyo Womens Med Univ Yachiyo, Med Ctr, Dept Internal Med & Gastroenterol, Chiba, Japan; [Matsuura, Kentaro; Nagura, Yoshihito] Nagoya City Univ, Grad Sch Med Sci, Dept Virol & Liver Unit, Nagoya, Aichi, Japan; [Abe, Hiroshi; Kato, Keizo] Shinmatusdo Cent Gen Hosp, Dept Internal Med, Div Gastroenterol & Hepatol, Matsudo, Chiba, Japan; [Okubo, Tomomi] Chiba Hokusoh Hosp, Nippon Med Sch, Dept Gastroenterol, Chiba, Chiba, Japan; [Toyoda, Hidenori] Ogaki Municipal Hosp, Dept Gastroenterol, Ogaki, Japan; [Tanaka, Yasuhito] Kumamoto Univ, Dept Gastroenterol & Hepatol, Kumamoto, Japan	Nippon Medical School; Jikei University; Osaka Metropolitan University; Yokohama City University; Yamaguchi University; Mie University; Nagoya City University; Nippon Medical School; Ogaki Municipal Hospital; Kumamoto University	Atsukawa, M (corresponding author), Nippon Med Sch, Div Gastroenterol & Hepatol, Tokyo, Japan.	momogachi@yahoo.co.jp	ENOMOTO, Masaru/I-3864-2019; Nozaki, Akito/AAT-3562-2021	ENOMOTO, Masaru/0000-0002-4028-4381; Tamai, Yasuyuki/0000-0002-8012-8578; Tanaka, Yasuhito/0000-0002-2473-6966				Abe M, 2015, J GASTROENTEROL, V50, P776, DOI 10.1007/s00535-014-1007-2; Afdhal N, 2014, NEW ENGL J MED, V370, P1889, DOI 10.1056/NEJMoa1402454; Atsukawa M, 2020, INFECT DIS THER, V9, P851, DOI 10.1007/s40121-020-00329-y; Atsukawa M, 2019, ALIMENT PHARM THER, V49, P1230, DOI 10.1111/apt.15218; Atsukawa M, 2019, HEPATOL RES, V49, P369, DOI 10.1111/hepr.13292; Atsukawa M, 2019, J GASTROEN HEPATOL, V34, P364, DOI 10.1111/jgh.14447; Castera L, 2005, GASTROENTEROLOGY, V128, P343, DOI 10.1053/j.gastro.2004.11.018; Drafting Comm For Hepatitis, 2020, HEPATOL RES, V50, P791, DOI 10.1111/hepr.13503; El-Serag HB, 2016, HEPATOLOGY, V64, P130, DOI 10.1002/hep.28535; HAHN E, 1980, GUT, V21, P63, DOI 10.1136/gut.21.1.63; Horslev-Petersen K., 1988, EUR J CLIN INVEST, V6, P752, DOI [10.1111/j.1365-2362.1988.tb01023.x, DOI 10.1111/J.1365-2362.1988.TB01023.X]; HORSLEVPETERSEN K, 1988, APMIS, V96, P793, DOI 10.1111/j.1699-0463.1988.tb00946.x; Ichikawa Y, 2017, HEPATOL RES, V47, P226, DOI 10.1111/hepr.12712; Ikeda H, 2019, J VIRAL HEPATITIS, V26, P1266, DOI 10.1111/jvh.13170; Imbert-Bismut F, 2001, LANCET, V357, P1069, DOI 10.1016/S0140-6736(00)04258-6; Ioannou GN, 2018, J HEPATOL, V69, P1088, DOI 10.1016/j.jhep.2018.07.024; Itokawa N, 2019, HEPATOL RES, V49, P125, DOI 10.1111/hepr.13256; Kanwal F, 2017, GASTROENTEROLOGY, V153, P996, DOI 10.1053/j.gastro.2017.06.012; Kuno A, 2013, SCI REP-UK, V3, DOI 10.1038/srep01065; Laurent TC, 1996, ANN MED, V28, P241, DOI 10.3109/07853899609033126; Loomba R, 2020, GUT, V69, P1343, DOI 10.1136/gutjnl-2018-317593; Lurie Y, 2015, WORLD J GASTROENTERO, V21, P11567, DOI 10.3748/wjg.v21.i41.11567; Masuzaki R, 2009, HEPATOLOGY, V49, P1954, DOI 10.1002/hep.22870; MURAWAKI Y, 1994, HEPATOLOGY, V20, P780, DOI 10.1002/hep.1840200403; Nishikawa H, 2016, HEPATOL RES, V46, P1194, DOI 10.1111/hepr.12662; Ogawa E, 2018, ALIMENT PHARM THER, V47, P104, DOI 10.1111/apt.14380; Omata M, 2016, HEPATOL INT, V10, P681, DOI 10.1007/s12072-016-9736-3; Omata M, 2014, J VIRAL HEPATITIS, V21, P762, DOI 10.1111/jvh.12312; Ono E, 1999, HEPATOL RES, V15, P192, DOI 10.1016/S1386-6346(98)00075-8; Pawlotsky JM, 2020, J HEPATOL, V73, P1170, DOI 10.1016/j.jhep.2020.08.018; Sharma S, 2014, WORLD J GASTROENTERO, V20, P16820, DOI 10.3748/wjg.v20.i45.16820; Singh S, 2017, GASTROENTEROLOGY, V152, P1544, DOI 10.1053/j.gastro.2017.03.016; Toyoda H, 2019, OPEN FORUM INFECT DI, V6, DOI 10.1093/ofid/ofz185; Tsubota A, 1997, J HEPATOL, V27, P49, DOI 10.1016/S0168-8278(97)80279-6; Vallet-Pichard A, 2007, HEPATOLOGY, V46, P32, DOI 10.1002/hep.21669; Wai CT, 2003, HEPATOLOGY, V38, P518, DOI 10.1053/jhep.2003.50346; Yamasaki K, 2014, HEPATOLOGY, V60, P1563, DOI 10.1002/hep.27305; Zeuzem S, 2018, NEW ENGL J MED, V378, P354, DOI 10.1056/NEJMoa1702417; Ziol M, 2005, HEPATOLOGY, V41, P48, DOI 10.1002/hep.20506	39	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2021	16	9							e0257166	10.1371/journal.pone.0257166	http://dx.doi.org/10.1371/journal.pone.0257166			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XM9EM	34506563	Green Published, gold			2022-12-26	WOS:000729120700127
J	Hososhima, S; Kandori, H; Tsunoda, SP				Hososhima, Shoko; Kandori, Hideki; Tsunoda, Satoshi P.			Ion transport activity and optogenetics capability of light-driven Na+-pump KR2	PLOS ONE			English	Article							BACTERIORHODOPSIN; RHODOPSIN	KR2 from marine bacteria Krokinobacter eikastus is a light-driven Na+ pumping rhodopsin family (NaRs) member that actively transports Na+ and/or H+ depending on the ionic state. We here report electrophysiological studies on KR2 to address ion-transport properties under various electrochemical potentials of Delta[Na+], Delta pH, membrane voltage and light quality, because the contributions of these on the pumping activity were less understood so far. After transient expression of KR2 in mammalian cultured cells (ND7/23 cells), photocurrents were measured by whole-cell patch clamp under various intracellular Na+ and pH conditions. When KR2 was continuously illuminated with LED light, two distinct time constants were obtained depending on the Na+ concentration. KR2 exhibited slow ion transport (tau(off) of 28 ms) below 1.1 mM NaCl and rapid transport (tau(off) of 11 ms) above 11 mM NaCl. This indicates distinct transporting kinetics of H+ and Na+. Photocurrent amplitude (current density) depends on the intracellular Na+ concentration, as is expected for a Na+ pump. The M-intermediate in the photocycle of KR2 could be transferred into the dark state without net ion transport by blue light illumination on top of green light. The M intermediate was stabilized by higher membrane voltage. Furthermore, we assessed the optogenetic silencing effect of rat cortical neurons after expressing KR2. Light power dependency revealed that action potential was profoundly inhibited by 1.5 mW/mm(2) green light illumination, confirming the ability to apply KR2 as an optogenetics silencer.	[Hososhima, Shoko; Kandori, Hideki; Tsunoda, Satoshi P.] Nagoya Inst Technol, Dept Life Sci & Appl Chem, Showa Ku, Nagoya, Aichi, Japan; [Kandori, Hideki] Nagoya Inst Technol, OptoBio Technol Res Ctr, Showa Ku, Nagoya, Aichi, Japan; [Tsunoda, Satoshi P.] Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama, Japan	Nagoya Institute of Technology; Nagoya Institute of Technology; Japan Science & Technology Agency (JST)	Tsunoda, SP (corresponding author), Nagoya Inst Technol, Dept Life Sci & Appl Chem, Showa Ku, Nagoya, Aichi, Japan.; Tsunoda, SP (corresponding author), Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama, Japan.	tsunoda.satoshi@nitech.ac.jp		Tsunoda, Satoshi/0000-0003-3636-1521	Japanese Ministry of Education, Culture, Sports, Science and Technology [18H03986, 18K06109]; JST CREST grant [JPMJCR1753]; JST PRESTO [JPMJPR1688]	Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); JST CREST grant; JST PRESTO(Japan Science & Technology Agency (JST))	This work was supported by the Japanese Ministry of Education, Culture, Sports, Science and Technology (18H03986 to H.K and 18K06109 to S.P.T.), JST CREST grant (JPMJCR1753 to H.K.) and JST PRESTO grant (JPMJPR1688 to S.P.T). S.H. is a Research Fellow of the Japan Society for the Promotion of Science (JSPS Research Fellow). https://www.jst.go.jp/kisoken/presto/en/index.html https://www.jst.go.jp/kisoken/crest/en/index.html https://www.jsps.go.jp/english/index.html.	Balashov SP, 2014, BIOCHEMISTRY-US, V53, P7549, DOI 10.1021/bi501064n; Ernst OP, 2014, CHEM REV, V114, P126, DOI 10.1021/cr4003769; Geibel S, 2001, BIOPHYS J, V81, P2059, DOI 10.1016/S0006-3495(01)75855-9; Geibel S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073338; Grimm C, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-27690-w; Gushchin I, 2015, NAT STRUCT MOL BIOL, V22, P390, DOI 10.1038/nsmb.3002; Hogue MR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166820; Inoue K, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2689; Ishizuka T, 2006, NEUROSCI RES, V54, P85, DOI 10.1016/j.neures.2005.10.009; Kandori H, 2018, CHEM REV, V118, P10646, DOI 10.1021/acs.chemrev.7b00548; Kato HE, 2015, NATURE, V521, P48, DOI 10.1038/nature14322; Kato Y, 2015, J PHYS CHEM LETT, V6, P5111, DOI 10.1021/acs.jpclett.5b02371; Lorinczi E, 2009, J MOL BIOL, V393, P320, DOI 10.1016/j.jmb.2009.07.055; Nagel G, 1998, BIOPHYS J, V74, P403, DOI 10.1016/S0006-3495(98)77797-5; Suomivuori CM, 2017, P NATL ACAD SCI USA, V114, P7043, DOI 10.1073/pnas.1703625114; Tsunoda SP, 2006, BIOPHYS J, V91, P1471, DOI 10.1529/biophysj.106.086421; Tsunoda SP, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179232; Vierock J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09600-8; Vogt A, 2015, SCI REP-UK, V5, DOI 10.1038/srep16450; Vogt A, 2019, BIOPHYS J, V116, P1941, DOI 10.1016/j.bpj.2019.04.001; Vogt A, 2013, BIOPHYS J, V105, P2055, DOI 10.1016/j.bpj.2013.08.031; Wang HX, 2009, J BIOL CHEM, V284, P5685, DOI 10.1074/jbc.M807632200; WOOD JN, 1990, P ROY SOC B-BIOL SCI, V241, P187, DOI 10.1098/rspb.1990.0084	23	2	2	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2021	16	9							e0256728	10.1371/journal.pone.0256728	http://dx.doi.org/10.1371/journal.pone.0256728			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XM9EM	34506508	Green Published, gold			2022-12-26	WOS:000729120700019
J	Limothai, U; Tachaboon, S; Dinhuzen, J; Hunsawong, T; Ong-ajchaowlerd, P; Thaisomboonsuk, B; Fernandez, S; Trongkamolchai, S; Wanpaisitkul, M; Chulapornsiri, C; Tiawilai, A; Tiawilai, T; Tantawichien, T; Thisyakorn, U; Srisawat, N				Limothai, Umaporn; Tachaboon, Sasipha; Dinhuzen, Janejira; Hunsawong, Taweewun; Ong-ajchaowlerd, Prapapun; Thaisomboonsuk, Butsaya; Fernandez, Stefan; Trongkamolchai, Supachoke; Wanpaisitkul, Mananya; Chulapornsiri, Chatchai; Tiawilai, Anongrat; Tiawilai, Thawat; Tantawichien, Terapong; Thisyakorn, Usa; Srisawat, Nattachai			Dengue pre-vaccination screening test evaluation for the use of dengue vaccine in an endemic area	PLOS ONE			English	Article							ANTIBODY; NEUTRALIZATION; ENCEPHALITIS; INFECTION; SENSITIVITY	Background The dengue vaccine (Dengvaxia) is only recommended for individuals with prior dengue infection (PDI). This study aimed to perform a serosurvey to inform decision-making for vaccine introduction and identify appropriate target populations. We also evaluated the performance of the serological tests using plaque reduction neutralization test (PRNT) as a reference test in identifying PDI to determine suitability for pre-vaccination screening. Methods We enrolled 115 healthy individuals between 10 and 22 years of age living in the Ratchaburi province of Thailand. The serum samples were tested by PRNT to measure the prevalence and concentration of serotype-specific neutralizing antibodies. The performance of the IgG rapid diagnostic test (RDT, SD Bioline, Korea) and IgG enzyme-linked immunosorbent assay (ELISA, EUROIMMUN, Germany) in identifying PDI were evaluated by using PRNT as a reference method. Results Ninety-four (81.7%) individuals neutralized one or more dengue serotypes at a titer threshold greater than or equal to 10. Multitypic profiles were observed in 70.4% of the samples which increased to 91.9% in subjects aged 19-22. Among monotypic samples, the highest proportion was reactive against DENV-1 followed by DENV-2, DENV-3, and DENV-4. The highest anti-dengue antibody titers were recorded against DENV-1 and increased with age to a geometric mean NT50 titer (GMT) of 188.6 in the 19-22 age group. While both RDT and ELISA exhibited 100% specificity, RDT demonstrated low sensitivity (35%) with ELISA displaying much greater sensitivity (87%). Conclusions Almost 80% of adolescents and youth in Ratchaburi province had already been exposed to one or more of the dengue virus serotypes. The dengue IgG RDT displayed low sensitivity and is likely not be suitable for dengue pre-vaccination screening. These results support the use of IgG ELISA test for dengue vaccination in endemic areas.	[Limothai, Umaporn; Tachaboon, Sasipha; Dinhuzen, Janejira; Srisawat, Nattachai] King Chulalongkorn Mem Hosp, Excellence Ctr Crit Care Nephrol, Bangkok, Thailand; [Limothai, Umaporn; Tachaboon, Sasipha; Dinhuzen, Janejira; Srisawat, Nattachai] Chulalongkorn Univ, Fac Med, Crit Care Nephrol Res Unit, Bangkok, Thailand; [Hunsawong, Taweewun; Ong-ajchaowlerd, Prapapun; Thaisomboonsuk, Butsaya; Fernandez, Stefan] Armed Forces Res Inst Med Sci, Dept Virol, Bangkok, Thailand; [Trongkamolchai, Supachoke; Wanpaisitkul, Mananya; Chulapornsiri, Chatchai] Banpong Hosp, Dept Med, Ratchaburi, Thailand; [Tiawilai, Anongrat; Tiawilai, Thawat] Photharam Hosp, Dept Med, Ratchaburi, Thailand; [Tantawichien, Terapong] Chulalongkorn Univ, Fac Med, Dept Med, Div Infect Dis, Bangkok, Thailand; [Tantawichien, Terapong; Thisyakorn, Usa; Srisawat, Nattachai] Chulalongkorn Univ, Trop Med Cluster, Bangkok, Thailand; [Srisawat, Nattachai] King Chulalongkorn Mem Hosp, Fac Med, Dept Med, Div Nephrol, Bangkok, Thailand; [Srisawat, Nattachai] Univ Pittsburgh, Sch Med, Dept Crit Care Med, Ctr Crit Care Nephrol,CRISMA Ctr, Pittsburgh, PA 15260 USA; [Srisawat, Nattachai] Royal Soc Thailand, Acad Sci, Bangkok, Thailand	Chulalongkorn University; Chulalongkorn University; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); Armed Forces Research Institute of Medical Science (AFRIMS); Chulalongkorn University; Chulalongkorn University; Chulalongkorn University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Srisawat, N (corresponding author), King Chulalongkorn Mem Hosp, Excellence Ctr Crit Care Nephrol, Bangkok, Thailand.; Srisawat, N (corresponding author), Chulalongkorn Univ, Fac Med, Crit Care Nephrol Res Unit, Bangkok, Thailand.; Srisawat, N (corresponding author), Chulalongkorn Univ, Trop Med Cluster, Bangkok, Thailand.; Srisawat, N (corresponding author), King Chulalongkorn Mem Hosp, Fac Med, Dept Med, Div Nephrol, Bangkok, Thailand.; Srisawat, N (corresponding author), Univ Pittsburgh, Sch Med, Dept Crit Care Med, Ctr Crit Care Nephrol,CRISMA Ctr, Pittsburgh, PA 15260 USA.; Srisawat, N (corresponding author), Royal Soc Thailand, Acad Sci, Bangkok, Thailand.	drnattachai@yahoo.com	Limothai, Umaporn/AGN-2570-2022	Limothai, Umaporn/0000-0003-1521-5592	Ratchadapiseksompotch Fund Chulalongkorn University; Second Century Fund (C2F), Chulalongkorn University; Jongkolneenithi foundation; Medical Association of Thailand; Tropical Medicine Cluster, Chulalongkorn University	Ratchadapiseksompotch Fund Chulalongkorn University; Second Century Fund (C2F), Chulalongkorn University; Jongkolneenithi foundation; Medical Association of Thailand; Tropical Medicine Cluster, Chulalongkorn University	This research project is supported by Ratchadapiseksompotch Fund Chulalongkorn University and the Second Century Fund (C2F), Chulalongkorn University (Umaporn Limothai received the grant). Nattachai Srisawat received funding from the Jongkolneenithi foundation, the Medical Association of Thailand, and the Tropical Medicine Cluster, Chulalongkorn University. The funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript.	Anantapreecha S., 2004, Dengue Bulletin, V28, P1; [Anonymous], 2019, VACCINE, V37, P4848, DOI 10.1016/j.vaccine.2018.09.063; Bonaparte M, 2020, DIAGN MICR INFEC DIS, V96, DOI 10.1016/j.diagmicrobio.2019.114918; Daag JV, 2021, CLIN MICROBIOL INFEC, V27, P904, DOI 10.1016/j.cmi.2020.08.026; Doum D, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17239134; Endy TP, 2004, J INFECT DIS, V189, P990, DOI 10.1086/382280; Flasche S, 2019, LANCET INFECT DIS, V19, P465, DOI 10.1016/S1473-3099(19)30167-7; Hadinegoro SR, 2015, NEW ENGL J MED, V373, P1195, DOI 10.1056/NEJMoa1506223; Imrie A, 2007, VIRAL IMMUNOL, V20, P672, DOI 10.1089/vim.2007.0050; Jang WS, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0213451; Khamim K, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003396; Lanciotti RS, 1997, J GEN VIROL, V78, P2279, DOI 10.1099/0022-1317-78-9-2279; Limkittikul K, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003241; Luo R, 2019, CLIN MICROBIOL INFEC, V25, P659, DOI 10.1016/j.cmi.2019.01.002; Maeki T, 2019, J INFECT CHEMOTHER, V25, P786, DOI 10.1016/j.jiac.2019.04.003; Malhotra RK, 2010, INDIAN J OPHTHALMOL, V58, P519, DOI 10.4103/0301-4738.71699; Olsen SJ, 2010, INT J INFECT DIS, V14, pE888, DOI 10.1016/j.ijid.2010.03.022; Peeling RW, 2010, NAT REV MICROBIOL, pS30, DOI 10.1038/nrmicro2459; Pengsaa K, 2008, PEDIATR INFECT DIS J, V27, P461, DOI 10.1097/INF.0b013e3181646d45; Raafat N, 2019, T ROY SOC TROP MED H, V113, P653, DOI 10.1093/trstmh/trz068; Rigau-Perez JG, 1998, LANCET, V352, P971, DOI 10.1016/S0140-6736(97)12483-7; Rodriguez-Barraquer I, 2019, LANCET INFECT DIS, V19, P132, DOI 10.1016/S1473-3099(18)30799-0; Roehrig JT, 2008, VIRAL IMMUNOL, V21, P123, DOI 10.1089/vim.2008.0007; RUSSELL PK, 1967, J IMMUNOL, V99, P285; Sabchareon A, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001732; Saito Y, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1873-8; Sridhar S, 2018, NEW ENGL J MED, V379, P327, DOI 10.1056/NEJMoa1800820; Thomas SJ, 2009, AM J TROP MED HYG, V81, P825, DOI 10.4269/ajtmh.2009.08-0625; Tsai Theodore F., 2000, Vaccine, V18, P1, DOI 10.1016/S0264-410X(00)00037-2; Vongpunsawad S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180560; WHO, 2009, WHO TECH REP SER, V958, P1; Wilder-Smith A, 2019, VACCINE, V37, P5137, DOI 10.1016/j.vaccine.2019.07.016; Wilder-Smith A, 2016, J INFECT DIS, V214, P1796, DOI 10.1093/infdis/jiw341; World Health Organization, 2007, GUID PLAQ RED NEUTR; World Hlth Org, 2017, VACCINE, V35, P1200, DOI 10.1016/j.vaccine.2016.10.070; Yamada KI, 2003, CLIN DIAGN LAB IMMUN, V10, P725, DOI 10.1128/CDLI.10.4.725-728.2003	36	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2021	16	9							e0257182	10.1371/journal.pone.0257182	http://dx.doi.org/10.1371/journal.pone.0257182			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XM9EM	34507347	Green Published, gold			2022-12-26	WOS:000729120700078
J	Guerfali, MM; Charaabi, K; Hamden, H; Djobbi, W; Fadhl, S; Mosbah, A; Cherif, A				Msaad Guerfali, Meriem; Charaabi, Kamel; Hamden, Haytham; Djobbi, Wafa; Fadhl, Salma; Mosbah, Amor; Cherif, Ameur			Probiotic based-diet effect on the immune response and induced stress in irradiated mass reared Ceratitis capitata males (Diptera: Tephritidae) destined for the release in the sterile insect technique programs	PLOS ONE			English	Article							MEDITERRANEAN FRUIT-FLY; HEAT-SHOCK-PROTEIN; DROSOPHILA-MELANOGASTER; ANTIBACTERIAL PEPTIDES; ANTIMICROBIAL PEPTIDE; EXPRESSION; CECROPIN; HSP70; RADIATION; FITNESS	Ceratitis capitata (medfly) is one of the most devastating crop pests worldwide. The Sterile Insect Technique (SIT) is a control method that is based on the mass rearing of males, their sterilization, and release in the field. However, the effectiveness of the technique depends on the quality of the released males and their fitness. We previously isolated and selected a probiotic bacteria (Enterobacter sp.), from wild-caught medflies, according to criteria that improved biological quality traits of reared medfly males.We firstly evaluated the impact of the irradiation on the expression of different immune and stress genes in the medfly sterile males. Expression was measured at differents time points ranging from 0 to 168 h after irradiation to capture the response of genes with distinct temporal expression patterns. Then, we supplemented the larval diet with previously isolated Enterobacter sp.strain, live and autoclaved at various concentrations to see whether the probiotic treatments affect, through their protective role, the gene expression level, and quality traits. The irradiation had significant effect on the genes attacin, cecropin, PGPR-LC, hsp23, and hsp70 level expression. The expression of attacin and PGPR-LC was up-regulated while that of cecropin was down-regulated. Hsp genes showed decreased levels between 0 and 18 h to peak at 72 h. However, the supplementation of the probiotic strain, either live or autoclaved, was statistically significant only for attacingene. However, significant interaction time x probiotic was noticed for attacin, cecropin, hsp23 and hsp70. The probiotic treatments also improved the quality control parameters like pupal weight. From this work we can conclude that a consortium of parabiotics (autoclaved probiotics) treatment will be recommended in insectaries considering both the beneficial effects on mass reared insects and its general safety for insectary workers and for environment.	[Msaad Guerfali, Meriem; Charaabi, Kamel; Hamden, Haytham; Djobbi, Wafa; Fadhl, Salma] Natl Ctr Nucl Sci & Technol, Lab Biotechnol & Nucl Technol LR16CNSTN01, Ariana, Tunisia; [Mosbah, Amor; Cherif, Ameur] Univ Manouba, Higher Inst Biotechnol Sidi Thabet, Lab Biol & Biogeo Resources LR11ES31, Ariana, Tunisia	Centre National des Sciences Technologies Nucleaires; Universite de la Manouba	Guerfali, MM (corresponding author), Natl Ctr Nucl Sci & Technol, Lab Biotechnol & Nucl Technol LR16CNSTN01, Ariana, Tunisia.	msaad_tn@yahoo.fr	Cherif, Ameur/AAC-6136-2021		Ministry of higher education and scientific research [PRIMA2019/INTOMED, PRF2019D6P2]	Ministry of higher education and scientific research(Ministry of Higher Education & Scientific Research (MHESR))	MMG Grant 1: PRIMA2019/INTOMED Ministry of higher education and scientific research http://www.mes.tn/?langue=fr Grant 2: PRF2019D6P2 Ministry of higher education and scientific research http://www.mes.tn/?langue=fr The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams CA, 2010, NUTR RES REV, V23, P37, DOI 10.1017/S0954422410000090; Aharon Y, 2013, APPL ENVIRON MICROB, V79, P303, DOI 10.1128/AEM.02761-12; Anantanawat K, 2020, J ECON ENTOMOL, V113, P2495, DOI 10.1093/jee/toaa147; Antosh M, 2014, DOSE-RESPONSE, V12, P551, DOI 10.2203/dose-response.13-047.Antosh; Arnal ME, 2016, NUTR REV, V74, P181, DOI 10.1093/nutrit/nuv104; Augustinos AA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136459; Ayyasamy A, 2021, MICROB ECOL, V82, P783, DOI 10.1007/s00248-021-01682-2; Azis K, 2019, BMC BIOTECHNOL, V19, DOI 10.1186/s12896-019-0584-9; Behar A, 2008, J INSECT PHYSIOL, V54, P1377, DOI 10.1016/j.jinsphys.2008.07.011; Ben Ami E, 2010, ISME J, V4, P28, DOI 10.1038/ismej.2009.82; Bian X, 2016, FOOD CONTROL, V66, P183, DOI 10.1016/j.foodcont.2016.02.004; Bogdandi EN, 2010, RADIAT RES, V174, P480, DOI 10.1667/RR2160.1; BOMAN HG, 1981, TRENDS BIOCHEM SCI, V6, P306, DOI 10.1146/annurev.mi.41.100187.000535; Cao Y, 2013, P NATL ACAD SCI USA, V110, pE1752, DOI 10.1073/pnas.1306220110; Cayol JP, 2000, FRUIT FLIES (TEPHRITIDAE): PHYLOGENY AND EVOLUTION OF BEHAVIOR, P843; Cheftel J. C., 1985, FOOD CHEM, P279; Darrington M., 2021, CHARACTERISATION SYM, DOI [10.1101/2021.06.09.447743, DOI 10.1101/2021.06.09.447743]; Datkhile KD, 2011, INT J RADIAT BIOL, V87, P213, DOI 10.3109/09553002.2010.518215; Ditu LM, 2014, MICROB ECOL HEALTH D, V25, DOI 10.3402/mehd.v25.23239; Ekengren S, 1999, INSECT BIOCHEM MOLEC, V29, P965, DOI 10.1016/S0965-1748(99)00071-5; Engel P, 2013, FEMS MICROBIOL REV, V37, P699, DOI 10.1111/1574-6976.12025; Enkerlin WR, 2005, STERILE INSECT TECHNIQUE: PRINCIPLES AND PRACTICE IN AREA-WIDE INTEGRATED PEST MANAGEMENT, P651, DOI 10.1007/1-4020-4051-2_25; Evans JD, 2004, J ECON ENTOMOL, V97, P752, DOI 10.1603/0022-0493(2004)097[0752:BPIAIR]2.0.CO;2; FAO/IAEA/USDA) Food and Agriculture Organization of the United Nations/International Atomic Energy Agency/United States Department of Agriculture, 2003, MAN PROD QUAL CONTR; FEDER JH, 1992, GENE DEV, V6, P1402, DOI 10.1101/gad.6.8.1402; Flatt T, 2008, J EXP BIOL, V211, P2712, DOI 10.1242/jeb.014878; Franz G, 2005, STERILE INSECT TECHNIQUE: PRINCIPLES AND PRACTICE IN AREA-WIDE INTEGRATED PEST MANAGEMENT, P427, DOI 10.1007/1-4020-4051-2_16; Gavriel S, 2011, J APPL ENTOMOL, V135, P564, DOI 10.1111/j.1439-0418.2010.01605.x; Gomulski LM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030857; Guerfali M. M'Saad, 2007, P535, DOI 10.1007/978-1-4020-6059-5_50; Guerfali MM, 2011, FLA ENTOMOL, V94, P1042, DOI 10.1653/024.094.0443; Guerfali MM, 2011, J ECON ENTOMOL, V104, P188, DOI 10.1603/EC10065; Guerfali MM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196343; HALLIWELL B, 1984, LANCET, V1, P1396; Hamden H, 2020, J RADIAT RES APPL SC, V13, P776, DOI 10.1080/16878507.2020.1848010; Hamden H, 2013, J ECON ENTOMOL, V106, P641, DOI 10.1603/EC12362; HARTL FU, 1992, ANNU REV BIOPH BIOM, V21, P293, DOI 10.1146/annurev.bb.21.060192.001453; Hendrichs J, 2002, FLA ENTOMOL, V85, P1, DOI 10.1653/0015-4040(2002)085[0001:MASITP]2.0.CO;2; Huang XS, 2016, SCI REP-UK, V6, DOI 10.1038/srep25190; HULTMARK D, 1983, EMBO J, V2, P571, DOI 10.1002/j.1460-2075.1983.tb01465.x; Ighodaro OM, 2018, ALEX J MED, V54, P287, DOI 10.1016/j.ajme.2017.09.001; Isaacs K, 2008, INFLAMM BOWEL DIS, V14, P1597, DOI 10.1002/ibd.20465; JANG EB, 1995, J INSECT PHYSIOL, V41, P705, DOI 10.1016/0022-1910(95)00015-M; Khan M, 2019, BMC BIOTECHNOL, V19, DOI 10.1186/s12896-019-0580-0; Klassen W, 2005, STERILE INSECT TECHNIQUE: PRINCIPLES AND PRACTICE IN AREA-WIDE INTEGRATED PEST MANAGEMENT, P39, DOI 10.1007/1-4020-4051-2_2; KNIPLING EF, 1955, J ECON ENTOMOL, V48, P459, DOI 10.1093/jee/48.4.459; Kortenkamp A, 2007, ENVIRON HEALTH PERSP, V115, P98, DOI 10.1289/ehp.9357; Krebs RA, 1997, EVOLUTION, V51, P173, DOI 10.1111/j.1558-5646.1997.tb02398.x; KREBS RA, 1994, FUNCT ECOL, V8, P730, DOI 10.2307/2390232; KYLSTEN P, 1990, EMBO J, V9, P217, DOI 10.1002/j.1460-2075.1990.tb08098.x; Kyritsis GA, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02064; Lance DR, 2000, ANN ENTOMOL SOC AM, V93, P1179, DOI 10.1603/0013-8746(2000)093[1179:CASAWC]2.0.CO;2; Lazzaro BP, 2008, CURR OPIN MICROBIOL, V11, P284, DOI 10.1016/j.mib.2008.05.001; Leftwich PT, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.1372; Li XY, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01309; Liquido N.J., 2013, ENCY BIBLIO HOST PLA; LIQUIDO NJ, 1990, J ECON ENTOMOL, V83, P1863, DOI 10.1093/jee/83.5.1863; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lumniczky K, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00517; Lux SA, 2002, FLA ENTOMOL, V85, P102, DOI 10.1653/0015-4040(2002)085[0102:EOIOTC]2.0.CO;2; Mahroof R, 2005, COMP BIOCHEM PHYS A, V141, P247, DOI 10.1016/j.cbpb.2005.05.044; Malacrino A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194131; Martinez-Ferrer MT, 2012, J APPL ENTOMOL, V136, P181, DOI 10.1111/j.1439-0418.2011.01628.x; Marxer M, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0302; McInnis DO, 1996, ANN ENTOMOL SOC AM, V89, P739, DOI 10.1093/aesa/89.5.739; Miyauchi E, 2009, J DAIRY SCI, V92, P2400, DOI 10.3168/jds.2008-1698; Moy RH, 2013, J INNATE IMMUN, V5, P444, DOI 10.1159/000350326; Nikolouli K, 2020, BMC GENET, V21, DOI 10.1186/s12863-020-00946-z; Petersen AJ, 2012, P NATL ACAD SCI USA, V109, pE656, DOI 10.1073/pnas.1110470109; Pirsaheb Meghdad, 2015, Med J Islam Repub Iran, V29, P228; Ramirez-Santos E, 2017, J ECON ENTOMOL, V110, P1483, DOI 10.1093/jee/tox119; Ramirez-Santos EM, 2017, J ECON ENTOMOL, V110, P24, DOI 10.1093/jee/tow239; ROSETTO M, 1993, GENE, V134, P241, DOI 10.1016/0378-1119(93)90100-H; Royet J, 2011, NAT REV IMMUNOL, V11, P837, DOI 10.1038/nri3089; Ryu JH, 2008, SCIENCE, V319, P777, DOI 10.1126/science.1149357; SAMAKOVLIS C, 1990, EMBO J, V9, P2969, DOI 10.1002/j.1460-2075.1990.tb07489.x; Segawa S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023278; SEO ST, 1990, J ECON ENTOMOL, V83, P1948, DOI 10.1093/jee/83.5.1949; Seong KM, 2011, BIOGERONTOLOGY, V12, P93, DOI 10.1007/s10522-010-9295-2; Shim JK, 2009, J STORED PROD RES, V45, P75, DOI 10.1016/j.jspr.2008.09.005; Shrestha A, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0220344; Silbermann R, 2000, EVOLUTION, V54, P2038; Slade G., 2014, BMC P, V8, P43, DOI [10.1186/1753-6561-8-s4-o43, DOI 10.1186/1753-6561-8-S4-O43]; STEINER H, 1988, BIOCHIM BIOPHYS ACTA, V939, P260, DOI 10.1016/0005-2736(88)90069-7; Sudmeier LJ, 2015, G3-GENES GENOM GENET, V5, P2299, DOI 10.1534/g3.115.021782; Sugawara T, 2018, BRIT J NUTR, V120, P872, DOI 10.1017/S0007114518001563; Suwal S, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.02675; Taverniti V, 2011, GENES NUTR, V6, P261, DOI 10.1007/s12263-011-0218-x; Taylor PW, 2001, PHYTOPARASITICA, V29, P7, DOI 10.1007/BF02981808; Thomas M.C., 2013, MEDITERRANEAN FRUIT, P214; Thundiyil JG, 2008, B WORLD HEALTH ORGAN, V86, P205, DOI [10.2471/BLT.08.041814, 10.2471/BLT.07.041814]; Valanne S, 2011, J IMMUNOL, V186, P649, DOI 10.4049/jimmunol.1002302; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wang LJ, 2014, ENVIRON ENTOMOL, V43, P1427, DOI 10.1603/EN13240; Wen LF, 2012, BRIT J NUTR, V108, P1756, DOI 10.1017/S0007114511007240; Wu SD, 2012, PEPTIDES, V35, P225, DOI 10.1016/j.peptides.2012.03.030; Xiao H, 2015, J ANIM SCI BIOTECHNO, V6, DOI 10.1186/s40104-015-0018-z; Yao MY, 2017, ENTOMOL EXP APPL, V162, P197, DOI 10.1111/eea.12529; Yi HY, 2014, APPL MICROBIOL BIOT, V98, P5807, DOI 10.1007/s00253-014-5792-6; Yousefi B, 2019, J CELL PHYSIOL, V234, P8008, DOI 10.1002/jcp.27559; Zhao L, 2012, ISJ-INVERT SURVIV J, V9, P93; Zhikrevetskaya S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133840; Zylicz M, 2001, IUBMB LIFE, V51, P283	103	0	0	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2021	16	9							e0257097	10.1371/journal.pone.0257097	http://dx.doi.org/10.1371/journal.pone.0257097			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XM9EM	34506561	gold, Green Published			2022-12-26	WOS:000729120700043
J	Woods, T; Nies, MA				Woods, Tanna; Nies, Mary A.			Health belief model factors as predictors of parental misclassification of the weight of the preschool child	PLOS ONE			English	Article							SELF-EFFICACY; BODY-WEIGHT; OBESITY; PERCEPTIONS; MISPERCEPTION; ASSOCIATIONS; OVERWEIGHT; RISK; BEHAVIORS; KNOWLEDGE	Background Parental misperception and underestimation of their child's weight are documented in studies. Demographic factors like age and gender have been linked to misclassification. However, modifiable factors that could potentially frame future intervention and prevention strategies have not been explored. This study aimed to assess factors that could predict parental misclassification of their preschool child's weight. Methods This was a cross-sectional study with 198 parents and their 2- to 5-year-old children who attended standalone preschools or childcare centers with preschools. Parents completed a questionnaire that asked about demographic features, personal and family health, and the assessment of their child's weight using the three most frequently utilized measures. Logistic regression was conducted to assess the association between parental factors and child weight classification status. Instruments included the Parental Self-Efficacy for Promoting Healthy Physical Activity and Dietary Behaviors in Children Scale (PSEPAD), the Obesity Risk Scale (ORK-10), and the Adolescent Obesity Risk Scale (AORK). Analyses included frequencies, chi-square tests, Kappa coefficients, and logistic regressions. Results Parents were least accurate (35.9%) identifying child weight when selecting a picture (kappa = -.028, p = .42). The pictorial and Likert method (kappa = -.032, p = .37) showed parental agreement with child weight was not significantly better than chance. Statistically, a significant agreement was found in the weight-reporting method (kappa = .21). Two of the three HBM-related measures were significantly related to accurate classification. Logistic regression showed child sex, PSEPAD scores, and ORK-10 scores were statistically significant predictors in the Likert method. The model had no statistical significance for the pictorial or weight-reporting method. Conclusion Results indicate parents support intervening if aware of child weight problems. However, parents do not accurately recognize healthy versus unhealthy weights and report that health providers are not informing them of weight deviations. Further, important relationships between the HBM variables were identified. Results show barriers (self-efficacy) mediate the impact of perceived severity (knowledge) regarding the parental ability to assess child weight accurately. These relationships and incorporation of the HBM principles of barriers and severity into prevention/intervention strategies need further exploration.	[Woods, Tanna] Nightingale Coll, Nursing Educ Serv, Salt Lake City, UT 84111 USA; [Nies, Mary A.] Idaho State Univ, Coll Hlth, Pocatello, ID 83209 USA	Idaho; Idaho State University	Woods, T (corresponding author), Nightingale Coll, Nursing Educ Serv, Salt Lake City, UT 84111 USA.	twoods@nightingale.edu		Woods, Tanna/0000-0001-5233-7850	Sigma Theta Tau; American Nurses' Foundation [14306]	Sigma Theta Tau; American Nurses' Foundation	Sigma Theta Tau and the American Nurses' Foundation Submission 14306 Tanna Woods, PI https://www.sigmanursing.org/advance-elevate/research/research-grants The funders did not play any role in the study design, data collection and analysis, dTYecision to publish, or preparation of the manuscript.	Adams AK, 2005, OBES RES, V13, P146, DOI 10.1038/oby.2005.19; Almoosawi S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0144931; Baidal JAW, 2015, J OBES, V2015, DOI 10.1155/2015/945918; Baranowski T, 2003, OBES RES, V11, p23S, DOI 10.1038/oby.2003.222; Berenson AB, 2016, J ACAD NUTR DIET, V116, P69, DOI 10.1016/j.jand.2015.04.023; Bohman B, 2013, EUR J PSYCHOL ASSESS, V29, P291, DOI 10.1027/1015-5759/a000159; Bridger T, 2009, PAED CHILD HEALT-CAN, V14, P177, DOI 10.1093/pch/14.3.177; Campbell K, 2010, INT J PEDIATR OBES, V5, P501, DOI 10.3109/17477161003777425; Campbell MWC, 2006, MED J AUSTRALIA, V184, P274, DOI 10.5694/j.1326-5377.2006.tb00236.x; Carpenter CJ, 2010, HEALTH COMMUN, V25, P661, DOI 10.1080/10410236.2010.521906; CDC, 2017, CHILDH OB FACTS; CDC, 2018, CHILD TEEN BMI; Chaparro MP, 2011, OBESITY, V19, P2026, DOI 10.1038/oby.2011.105; Conger RD, 2010, J MARRIAGE FAM, V72, P685, DOI 10.1111/j.1741-3737.2010.00725.x; Cullinan J, 2017, ECON HUM BIOL, V24, P92, DOI 10.1016/j.ehb.2016.11.001; Daddario Diane K, 2007, Medsurg Nurs, V16, P363; Doolen J, 2009, J AM ACAD NURSE PRAC, V21, P160, DOI 10.1111/j.1745-7599.2008.00382.x; Eckstein KC, 2006, PEDIATRICS, V117, P681, DOI 10.1542/peds.2005-0910; Ekim A, 2016, COMPR CHILD ADOLES N, V39, P30, DOI 10.3109/01460862.2015.1090500; Etelson D, 2003, OBES RES, V11, P1362, DOI 10.1038/oby.2003.184; Fryrear A., 2015, SURVEY RESPONSE RATE; Garrett-Wright D, 2011, J PEDIATR NURS, V26, P435, DOI 10.1016/j.pedn.2010.07.009; Gordon NP, 2015, BMC PEDIATR, V15, DOI 10.1186/s12887-015-0320-0; He M, 2007, CAN FAM PHYSICIAN, V53, P1493; Hochdorn A, 2018, J HEALTH PSYCHOL, V23, P114, DOI 10.1177/1359105316676328; Howe CJ, 2017, J PEDIATR NURS, V37, P57, DOI 10.1016/j.pedn.2017.06.005; Hudson Cindy E, 2009, J Pediatr Nurs, V24, P292, DOI 10.1016/j.pedn.2008.04.006; Ice CL, 2014, EDUC URBAN SOC, V46, P699, DOI 10.1177/0013124512468004; Jeffery AN, 2015, CHILD CARE HLTH DEV, V41, P434, DOI 10.1111/cch.12167; Leary J. M., 2013, J COMMUN HEALTHC, V6, P115; Lobstein T, 2016, PEDIATR OBES, V11, P321, DOI 10.1111/ijpo.12185; Loprinzi PD, 2013, AM J HEALTH EDUC, V44, P9, DOI 10.1080/19325037.2012.749685; Lundahl A, 2014, PEDIATRICS, V133, pE689, DOI 10.1542/peds.2013-2690; Manios Y, 2008, ACTA PAEDIATR, V97, P494, DOI 10.1111/j.1651-2227.2008.00729.x; Maximova K, 2008, INT J OBESITY, V32, P1008, DOI 10.1038/ijo.2008.15; Maynard LM, 2003, PEDIATRICS, V111, P1226; Mazloomy-Mahmoodabad Seyed Saeed, 2017, ARYA Atheroscler, V13, P176; McKee C, 2016, J PEDIATR NURS, V31, P196, DOI 10.1016/j.pedn.2015.10.003; Miller D, 2016, CHILD CARE HLTH DEV, V42, P370, DOI 10.1111/cch.12318; Ogden CL, 2012, JAMA-J AM MED ASSOC, V307, P483, DOI 10.1001/jama.2012.40; Ogden Cynthia L, 2010, Natl Health Stat Report, P1; Parekh N, 2018, HEALTH EDUC BEHAV, V45, P238, DOI 10.1177/1090198117714019; Parkinson KN, 2011, INT J OBESITY, V35, P510, DOI 10.1038/ijo.2010.260; Petricevic N, 2012, EUR J PEDIATR, V171, P1209, DOI 10.1007/s00431-012-1707-7; Polit D.F., 2017, RESOURCE MANUAL NURS; Regber S, 2013, PEDIATR OBES, V8, P118, DOI 10.1111/j.2047-6310.2012.00093.x; Rune KT, 2015, HEALTH PROMOT J AUST, V26, P129, DOI 10.1071/HE14060; Seidell JC, 2015, ANN NUTR METAB, V66, P7, DOI 10.1159/000375143; Swift JA, 2006, INT J OBESITY, V30, P661, DOI 10.1038/sj.ijo.0803165; Tompkins CL, 2015, J CHILD FAM STUD, V24, P1384, DOI 10.1007/s10826-014-9945-0; Visscher TLS, 2017, OBESITY FACTS, V10, P52, DOI 10.1159/000457958; WHO, 2017, OV OB W PAC REG EQ P; Woods T, 2019, MOST APPROPRIATE MEC, V4, P1; World Health Organization, 2013, NUTR PHYS ACT OB UK; Wright DR, 2016, ACAD PEDIATR, V16, P475, DOI 10.1016/j.acap.2016.02.007; Xu HL, 2015, J OBES, V2015, DOI 10.1155/2015/546925; Xu HL, 2014, J PAEDIATR CHILD H, V50, P680, DOI 10.1111/jpc.12604	57	1	1	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2021	16	9							e0252981	10.1371/journal.pone.0252981	http://dx.doi.org/10.1371/journal.pone.0252981			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	XM9EM	34506502	Green Published, gold			2022-12-26	WOS:000729120700077
J	Ansari, F; Yoval-Sanchez, B; Niatsetskaya, Z; Sosunov, S; Stepanova, A; Garcia, C; Owusu-Ansah, E; Ten, V; Wittig, I; Galkin, A				Ansari, Fariha; Yoval-Sanchez, Belem; Niatsetskaya, Zoya; Sosunov, Sergey; Stepanova, Anna; Garcia, Christian; Owusu-Ansah, Edward; Ten, Vadim; Wittig, Ilka; Galkin, Alexander			Quantification of NADH:ubiquinone oxidoreductase (complex I) content in biological samples	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NADH-UBIQUINONE OXIDOREDUCTASE; FLUORESCENT FLAVOPROTEINS; FLAVIN; MITOCHONDRIA; SUBUNIT; IDENTIFICATION; DEHYDROGENASE; SUBSTRATE; REDUCTASE; PROTEIN	Impairments in mitochondrial energy metabolism have been implicated in human genetic diseases associated with mito-chondrial and nuclear DNA mutations, neurodegenerative and cardiovascular disorders, diabetes, and aging. Alteration in mitochondrial complex I structure and activity has been shown to play a key role in Parkinson's disease and ischemia/reperfu-sion tissue injury, but significant difficulty remains in assessing the content of this enzyme complex in a given sample. The present study introduces a new method utilizing native poly-acrylamide gel electrophoresis in combination with flavin fluo-rescence scanning to measure the absolute content of complex I, as well as alpha-ketoglutarate dehydrogenase complex, in any preparation. We show that complex I content is 19 +/- 1 pmol/mg of protein in the brain mitochondria, whereas varies up to 10-fold in different mouse tissues. Together with the measure-ments of NADH-dependent specific activity, our method also allows accurate determination of complex I catalytic turnover, which was calculated as 104 min-1 for NADH:ubiquinone reductase in mouse brain mitochondrial preparations. alpha-keto-glutarate dehydrogenase complex content was determined to be 65 +/- 5 and 123 +/- 9 pmol/mg protein for mouse brain and bovine heart mitochondria, respectively. Our approach can also be extended to cultured cells, and we demonstrated that about 90 x 103 complex I molecules are present in a single human embryonic kidney 293 cell. The ability to determine complex I content should provide a valuable tool to investigate the enzyme status in samples after in vivo treatment in mutant organisms, cells in culture, or human biopsies.	[Ansari, Fariha; Yoval-Sanchez, Belem; Niatsetskaya, Zoya; Sosunov, Sergey; Stepanova, Anna; Ten, Vadim; Galkin, Alexander] Columbia Univ, Dept Pediat, Div Neonatol, Med Ctr, New York, NY 10032 USA; [Garcia, Christian; Owusu-Ansah, Edward] Columbia Univ, Dept Physiol & Cellular Biophys, New York, NY USA; [Wittig, Ilka] Goethe Univ, Funct Prote, Inst Cardiovasc Physiol, Frankfurt, Germany; [Wittig, Ilka] German Ctr Cardiovasc Res DZHK, Partner Site RheinMain, Frankfurt, Germany; [Galkin, Alexander] Weill Cornell Med, Feil Family Brain & Mind Res Inst, New York, NY 10065 USA	Columbia University; Columbia University; Goethe University Frankfurt; German Centre for Cardiovascular Research; Cornell University	Galkin, A (corresponding author), Columbia Univ, Dept Pediat, Div Neonatol, Med Ctr, New York, NY 10032 USA.; Galkin, A (corresponding author), Weill Cornell Med, Feil Family Brain & Mind Res Inst, New York, NY 10065 USA.	alg2057@med.cornell.edu		Yoval-Sanchez, Belem/0000-0002-7276-278X	National Institutes of Health [RO1NS112381, R21NS125466, NS100850]; Deutsche Forschungsgemeinschaft [SFB815/Z1]; BMBF mitoNET-German Network for Mitochondrial Disorders [01GM1906D]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); BMBF mitoNET-German Network for Mitochondrial Disorders(Federal Ministry of Education & Research (BMBF))	This work was partially supported by grants from the National Institutes of Health RO1NS112381 and R21NS125466 (to A. G.) , NS100850 (to V. T.) , and Deutsche Forschungsgemeinschaft: SFB815/Z1 (to I. W.) and BMBF mitoNET-German Network for Mitochondrial Disorders 01GM1906D (to I. W.) The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Andreyev AI, 2005, BIOCHEMISTRY-MOSCOW+, V70, P200, DOI 10.1007/s10541-005-0102-7; Babot M, 2014, BBA-BIOENERGETICS, V1837, P929, DOI 10.1016/j.bbabio.2014.02.013; BELOGRUDOV G, 1994, BIOCHEMISTRY-US, V33, P4571, DOI 10.1021/bi00181a018; Berrisford JM, 2016, BBA-BIOENERGETICS, V1857, P892, DOI 10.1016/j.bbabio.2016.01.012; Birrell JA, 2009, BIOCHEMISTRY-US, V48, P12005, DOI 10.1021/bi901706w; Blinova K, 2008, BIOCHEMISTRY-US, V47, P9636, DOI 10.1021/bi800307y; BONNER WD, 1961, NATURE, V191, P682, DOI 10.1038/191682a0; Borna NN, 2020, GENES-BASEL, V11, DOI 10.3390/genes11111325; Bridges HR, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18950-3; Bridges HR, 2017, BBA-BIOENERGETICS, V1858, P197, DOI 10.1016/j.bbabio.2016.12.001; CHANCE B, 1967, P NATL ACAD SCI USA, V57, P1498, DOI 10.1073/pnas.57.5.1498; CHANCE B, 1960, NATURE, V185, P666, DOI 10.1038/185666a0; Chorvat D, 2005, BIOPHYS J, V89, pL55, DOI 10.1529/biophysj.105.073866; Chouchani ET, 2014, NATURE, V515, P431, DOI 10.1038/nature13909; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; DEKOK A, 1987, FEBS LETT, V218, P135, DOI 10.1016/0014-5793(87)81033-5; Drose S, 2002, BBA-BIOENERGETICS, V1556, P65, DOI 10.1016/S0005-2728(02)00307-9; Erhardt H, 2012, BBA-BIOENERGETICS, V1817, P863, DOI 10.1016/j.bbabio.2011.10.008; Fernandez-Vizarra E, 2021, BBA-BIOENERGETICS, V1862, DOI 10.1016/j.bbabio.2021.148414; Fiedorczuk K, 2018, TRENDS CELL BIOL, V28, P835, DOI 10.1016/j.tcb.2018.06.006; Galban J, 2016, METHODS APPL FLUORES, V4, DOI 10.1088/2050-6120/4/4/042005; Galkin A, 2019, BIOCHEMISTRY-MOSCOW+, V84, P1411, DOI 10.1134/S0006297919110154; Garcia CJ, 2017, CELL REP, V20, P264, DOI 10.1016/j.celrep.2017.06.015; GARLAND PB, 1967, P NATL ACAD SCI USA, V58, P1696, DOI 10.1073/pnas.58.4.1696; GAVRIKOVA EV, 1995, BBA-BIOENERGETICS, V1230, P23, DOI 10.1016/0005-2728(95)00015-B; Gostimskaya Irina, 2010, J Vis Exp, DOI 10.3791/2202; Gostimskaya IS, 2007, FEBS LETT, V581, P5803, DOI 10.1016/j.febslet.2007.11.048; Grivennikova VG, 2001, J BIOL CHEM, V276, P9038, DOI 10.1074/jbc.M009661200; Grivennikova VG, 1997, BBA-BIOENERGETICS, V1319, P223, DOI 10.1016/S0005-2728(96)00163-6; Guerrero-Castillo S, 2017, BBA-BIOENERGETICS, V1858, P208, DOI 10.1016/j.bbabio.2016.12.004; Hansford RG, 1997, J BIOENERG BIOMEMBR, V29, P89, DOI 10.1023/A:1022420007908; HASSINEN I, 1968, BIOCHEM BIOPH RES CO, V31, P895, DOI 10.1016/0006-291X(68)90536-6; HASSINEN IE, 1986, METHOD ENZYMOL, V123, P311; Hassinen IE, 2014, J INNOV OPT HEAL SCI, V7, DOI 10.1142/S1793545813500582; Hatefi Y, 1967, METHOD ENZYMOL, V10, P235; Heazlewood JL, 2003, BBA-BIOENERGETICS, V1604, P159, DOI 10.1016/S0005-2728(03)00045-8; Hirst J, 2013, ANNU REV BIOCHEM, V82, P551, DOI 10.1146/annurev-biochem-070511-103700; Holt PJ, 2016, BBA-BIOENERGETICS, V1857, P1777, DOI 10.1016/j.bbabio.2016.08.008; HORGAN DJ, 1968, J BIOL CHEM, V243, P5967; Hou J, 2016, J BIOMED OPT, V21, DOI 10.1117/1.JBO.21.6.060503; Incecik F, 2018, J PEDIATR NEUROSCI, V13, P205, DOI 10.4103/jpn.JPN_138_17; Kahl A, 2018, STROKE, V49, P1223, DOI 10.1161/STROKEAHA.117.019687; Keeney PM, 2006, J NEUROSCI, V26, P5256, DOI 10.1523/JNEUROSCI.0984-06.2006; Korshunov SS, 1997, FEBS LETT, V416, P15, DOI 10.1016/S0014-5793(97)01159-9; KOZIOL J., 1971, Methods in Enzymology, V18B, P253, DOI 10.1016/S0076-6879(71)18089-5; KUNZ WS, 1986, FEBS LETT, V195, P92, DOI 10.1016/0014-5793(86)80137-5; KUNZ WS, 1993, BIOCHEM MED METAB B, V50, P103, DOI 10.1006/bmmb.1993.1051; KUNZ WS, 1985, BIOCHIM BIOPHYS ACTA, V841, P237, DOI 10.1016/0304-4165(85)90064-9; Lasserre JP, 2006, ELECTROPHORESIS, V27, P3306, DOI 10.1002/elps.200500912; LEIF H, 1995, EUR J BIOCHEM, V230, P538, DOI 10.1111/j.1432-1033.1995.tb20594.x; Letts JA, 2016, NATURE, V537, P644, DOI 10.1038/nature19774; Lienhart WD, 2013, ARCH BIOCHEM BIOPHYS, V535, P150, DOI 10.1016/j.abb.2013.02.015; Liu YB, 2002, J NEUROCHEM, V80, P780, DOI 10.1046/j.0022-3042.2002.00744.x; Maklashina E, 2003, BBA-BIOENERGETICS, V1606, P95, DOI 10.1016/S0005-2728(03)00087-2; Maldonado M, 2020, ELIFE, V9, DOI 10.7554/eLife.56664; Nagy B, 2021, BBA-GEN SUBJECTS, V1865, DOI 10.1016/j.bbagen.2021.129889; Niatsetskaya ZV, 2012, J NEUROSCI, V32, P3235, DOI 10.1523/JNEUROSCI.6303-11.2012; O'Meara RW, 2011, JOVE-J VIS EXP, DOI 10.3791/3324; Palacios-Callender M, 2007, J CELL SCI, V120, P160, DOI 10.1242/jcs.03308; Perez-Perez R, 2016, CELL REP, V16, P2387, DOI 10.1016/j.celrep.2016.07.081; Quinlan CL, 2013, REDOX BIOL, V1, P304, DOI 10.1016/j.redox.2013.04.005; RAGAN CI, 1976, BIOCHEM J, V154, P295, DOI 10.1042/bj1540295; Rao N., 1967, METHODS ENZYMOL, P494; Ryan K, 2012, J NEUROSCI, V32, P11250, DOI 10.1523/JNEUROSCI.0907-12.2012; Sazanov LA, 2006, SCIENCE, V311, P1430, DOI 10.1126/science.1123809; Schlegel A, 2020, EBIOMEDICINE, V60, DOI 10.1016/j.ebiom.2020.103014; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; SLED VD, 1994, BIOCHEMISTRY-US, V33, P10069, DOI 10.1021/bi00199a034; Srivastava A, 2018, EUR J HUM GENET, V26, P1582, DOI 10.1038/s41431-018-0209-0; Stepanova A, 2019, ANTIOXID REDOX SIGN, V31, P608, DOI 10.1089/ars.2018.7693; Stepanova A, 2017, J CEREBR BLOOD F MET, V37, P3649, DOI 10.1177/0271678X17730242; Stroh A, 2004, J BIOL CHEM, V279, P5000, DOI 10.1074/jbc.M309505200; Stroud DA, 2016, NATURE, V538, P123, DOI 10.1038/nature19754; Suthammarak W, 2009, J BIOL CHEM, V284, P6425, DOI 10.1074/jbc.M805733200; Swerdlow RH, 1996, ANN NEUROL, V40, P663, DOI 10.1002/ana.410400417; Tahara EB, 2009, FREE RADICAL BIO MED, V46, P1283, DOI 10.1016/j.freeradbiomed.2009.02.008; Varghese F, 2015, HUM MOL GENET, V24, P6350, DOI 10.1093/hmg/ddv344; Vinogradov AD, 1998, BBA-BIOENERGETICS, V1364, P169, DOI 10.1016/S0005-2728(98)00026-7; Vinothkumar KR, 2014, NATURE, V515, P80, DOI 10.1038/nature13686; Vogel RO, 2007, J BIOL CHEM, V282, P7582, DOI 10.1074/jbc.M609410200; VOLTTI H, 1979, J BIOENERG BIOMEMBR, V10, P45; Votyakova TV, 2001, J NEUROCHEM, V79, P266, DOI 10.1046/j.1471-4159.2001.00548.x; Wang L, 2020, TRANSPLANT DIRECT, V6, DOI 10.1097/TXD.0000000000001046; Wirth C, 2016, BBA-BIOENERGETICS, V1857, P902, DOI 10.1016/j.bbabio.2016.02.013; Wittig I, 2007, MOL CELL PROTEOMICS, V6, P1215, DOI 10.1074/mcp.M700076-MCP200; Wittig I, 2006, NAT PROTOC, V1, P418, DOI 10.1038/nprot.2006.62; Yip CY, 2011, J BIOL CHEM, V286, P5023, DOI 10.1074/jbc.M110.194993	88	4	4	0	9	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT	2021	297	4							101204	10.1016/j.jbc.2021.101204	http://dx.doi.org/10.1016/j.jbc.2021.101204			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	WP2YR	34543622	Green Published, gold			2022-12-26	WOS:000713003600013
J	Gao, X; Grayden, D; McDonnell, M				Gao, Xiao; Grayden, David; McDonnell, Mark			Unifying information theory and machine learning in a model of electrode discrimination in cochlear implants	PLOS ONE			English	Article							STIMULATED AUDITORY-NERVE; PITCH RANKING; SPEECH-INTELLIGIBILITY; PLACE DISCRIMINATION; NEURON INTERFACE; STOCHASTIC-MODEL; PARTIAL TRIPOLAR; CHANNEL MODEL; PERCEPTION; SPREAD	Despite the development and success of cochlear implants over several decades, wide inter-subject variability in speech perception is reported. This suggests that cochlear implant user-dependent factors limit speech perception at the individual level. Clinical studies have demonstrated the importance of the number, placement, and insertion depths of electrodes on speech recognition abilities. However, these do not account for all inter-subject variability and to what extent these factors affect speech recognition abilities has not been studied. In this paper, an information theoretic method and machine learning technique are unified in a model to investigate the extent to which key factors limit cochlear implant electrode discrimination. The framework uses a neural network classifier to predict which electrode is stimulated for a given simulated activation pattern of the auditory nerve, and mutual information is then estimated between the actual stimulated electrode and predicted ones. We also investigate how and to what extent the choices of parameters affect the performance of the model. The advantages of this framework include i) electrode discrimination ability is quantified using information theory, ii) it provides a flexible framework that may be used to investigate the key factors that limit the performance of cochlear implant users, and iii) it provides insights for future modeling studies of other types of neural prostheses.	[Gao, Xiao; Grayden, David] Univ Melbourne, Dept Biomed Engn, Parkville, Vic, Australia; [Gao, Xiao] Univ Sydney, Sch Phys, Sydney, NSW, Australia; [McDonnell, Mark] Univ South Australia, Sch Informat Technol & Math Sci, Computat Learning Syst Lab, Mawson Lakes, SA, Australia	University of Melbourne; University of Sydney; University of South Australia	Gao, X (corresponding author), Univ Melbourne, Dept Biomed Engn, Parkville, Vic, Australia.; Gao, X (corresponding author), Univ Sydney, Sch Phys, Sydney, NSW, Australia.	xiao.gao@unimelb.edu.au		Gao, Demi/0000-0002-7059-5594	University of Melbourne	University of Melbourne(University of Melbourne)	XG receives a McKenzie Fellowship from the University of Melbourne (https://sites.research.unimelb.edu.au/research-funding/researcherdevelopment-schemes/mckenzie-fellowship).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2006, FDN PERCEPTION; Bai SW, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.01312; Bianchi F, 2019, JARO-J ASSOC RES OTO, V20, P263, DOI 10.1007/s10162-018-00710-2; Bierer JA, 2010, EAR HEARING, V31, P247, DOI 10.1097/AUD.0b013e3181c7daf4; BLACK RC, 1980, J ACOUST SOC AM, V67, P868, DOI 10.1121/1.383966; Blamey P, 1996, Audiol Neurootol, V1, P293; Borst A, 1999, NAT NEUROSCI, V2, P947, DOI 10.1038/14731; Boulet J, 2016, JARO-J ASSOC RES OTO, V17, P1, DOI 10.1007/s10162-015-0545-5; Bruce IC, 1999, IEEE T BIO-MED ENG, V46, P1393, DOI 10.1109/10.804567; Bruce IC, 1999, IEEE T BIO-MED ENG, V46, P630, DOI 10.1109/10.764939; Bruce IC, 1999, IEEE T BIO-MED ENG, V46, P617, DOI 10.1109/10.764938; Busby PA, 2008, EAR HEARING, V29, P853, DOI 10.1097/AUD.0b013e318181a878; Clark GM, 2015, HEARING RES, V322, P4, DOI 10.1016/j.heares.2014.08.002; Cohen LT, 2009, HEARING RES, V248, P15, DOI 10.1016/j.heares.2008.11.008; Collins LM, 1997, J ACOUST SOC AM, V101, P440, DOI 10.1121/1.417989; Donaldson GS, 2005, J ACOUST SOC AM, V118, P623, DOI 10.1121/1.1937362; Finley CC, 2008, OTOL NEUROTOL, V29, P920, DOI 10.1097/MAO.0b013e318184f492; Fredelake S, 2012, HEARING RES, V287, P76, DOI 10.1016/j.heares.2012.03.005; Gao X, 2014, INFO THEOR WORKSH, P346; Gao X, 2017, IEEE T BIO-MED ENG, V64, P2219, DOI 10.1109/TBME.2016.2634461; Gao X, 2015, I IEEE EMBS C NEUR E, P691, DOI 10.1109/NER.2015.7146717; Gao X, 2014, IEEE INT SYMP INFO, P2919, DOI 10.1109/ISIT.2014.6875368; Gao X, 2013, IEEE ENG MED BIO, P5974, DOI 10.1109/EMBC.2013.6610913; Gao X, 2014, PHYS REV E, V90, DOI 10.1103/PhysRevE.90.022722; Goehring JL, 2014, J ACOUST SOC AM, V136, P715, DOI 10.1121/1.4884881; Goldwyn JH, 2010, HEARING RES, V268, P93, DOI 10.1016/j.heares.2010.05.005; Grayden D. B., 2006, COCHLEAR IMPLANTS PR, P1; Henry BA, 2000, J ACOUST SOC AM, V108, P1269, DOI 10.1121/1.1287711; Hochmair I, 2015, HEARING RES, V322, P14, DOI 10.1016/j.heares.2014.10.006; Huang GB, 2006, NEUROCOMPUTING, V70, P489, DOI 10.1016/j.neucom.2005.12.126; Huang GB, 2012, IEEE T SYST MAN CY B, V42, P513, DOI 10.1109/TSMCB.2011.2168604; Jurgens T, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193842; Kalkman RK, 2015, HEARING RES, V322, P89, DOI 10.1016/j.heares.2014.12.004; Kenway B, 2015, OTOL NEUROTOL, V36, P1472, DOI 10.1097/MAO.0000000000000845; Landsberger DM, 2014, J ACOUST SOC AM, V135, pEL75, DOI 10.1121/1.4862875; Landsberger DM, 2012, HEARING RES, V284, P16, DOI 10.1016/j.heares.2011.12.009; Litvak LM, 2007, J ACOUST SOC AM, V122, P967, DOI 10.1121/1.2749414; Long CJ, 2014, JARO-J ASSOC RES OTO, V15, P293, DOI 10.1007/s10162-013-0437-5; MCDERMOTT HJ, 1992, J ACOUST SOC AM, V91, P3367, DOI 10.1121/1.402826; McDonnell MD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134254; McDonnell MD, 2010, IEEE T INFORM THEORY, V56, P928, DOI 10.1109/TIT.2009.2037054; McKay CM, 2001, J ACOUST SOC AM, V110, P1514, DOI 10.1121/1.1394222; Meffin H, 2014, J NEURAL ENG, V11, DOI 10.1088/1741-2560/11/6/065004; Meffin H, 2012, J NEURAL ENG, V9, DOI 10.1088/1741-2560/9/6/065005; Moroz AS, 2012, IEEE ENG MED BIO, P2965, DOI 10.1109/EMBC.2012.6346586; Nogueira W, 2016, J ACOUST SOC AM, V139, P728, DOI 10.1121/1.4939896; O'Connell BP, 2016, OTOL NEUROTOL, V37, P1016, DOI 10.1097/MAO.0000000000001125; de Miguel AR, 2018, EUR ARCH OTO-RHINO-L, V275, P1385, DOI 10.1007/s00405-018-4943-2; Saeedi NE, 2017, HEARING RES, V344, P135, DOI 10.1016/j.heares.2016.11.005; Saeedi NE, 2014, HEARING RES, V316, P129, DOI 10.1016/j.heares.2014.08.006; Schatzer R, 2014, HEARING RES, V309, P26, DOI 10.1016/j.heares.2013.11.003; Shannon RV, 2004, ACTA OTO-LARYNGOL, V124, P50, DOI 10.1080/03655230410017562; Snel-Bongers J, 2013, JARO-J ASSOC RES OTO, V14, P781, DOI 10.1007/s10162-013-0395-y; Srinivasan AG, 2013, HEARING RES, V299, P29, DOI 10.1016/j.heares.2013.02.004; Sucher CM, 2007, HEARING RES, V230, P80, DOI 10.1016/j.heares.2007.05.002; Tahayori B, 2014, J NEURAL ENG, V11, DOI 10.1088/1741-2560/11/6/065005; Tahayori B, 2012, J NEURAL ENG, V9, DOI 10.1088/1741-2560/9/6/065006; Wilson BS, 2008, HEARING RES, V242, P3, DOI 10.1016/j.heares.2008.06.005	58	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2021	16	9							e0257568	10.1371/journal.pone.0257568	http://dx.doi.org/10.1371/journal.pone.0257568			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	WG6BN	34543336	gold, Green Published, Green Accepted			2022-12-26	WOS:000707078200052
J	Burgum, P; Smith, DT				Burgum, Paul; Smith, Daniel T.			Reduced mood variability is associated with enhanced performance during ultrarunnning	PLOS ONE			English	Article							ATHLETIC PERFORMANCE; EMOTION REGULATION; STATES; PROFILE; SPORT; ANXIETY; STRATEGIES; EXERCISE; FOCUS	Ultrarunning requires extraordinary endurance but the psychological factors involved in successful ultrarunning are not well understood. One widely held view is that fluctuations in mood play a pivotal role in performance during endurance events. However, this view is primarily based on comparisons of mood before and after marathons and shorter running events. Indeed, to date no study has explicitly examined mood changes during a competive ultramarathon. To address this issue, we measured mood fluctuations in athletes competing in the Hardmoors 60, a 100 km, single day continuous trail-ultramarathon, and examined how variation in mood related to performance, as measured by completion time. The key finding was that the variability of athletes Total Mood Disturbance (TMD) score was significantly and positively correlated with completion time, consistent with the idea that mood is an important factor in determining race performance. Athletes also experienced a significant increase in tension immediately prior to race onset. This effect was more pronounced in less experienced athletes and significantly attenuated by measurement stage 1 at 35.4 km, which suggests the effect was driven by the release of pre-competition anxiety. Depression, anger and TMD were significantly lower at the pre-race measurement compared to the baseline measurement taken the week before. Consistent with previous studies, there were also significant increases in fatigue, anger and TMD during the race. The data are interpreted in terms of the Psychobiological model of endurance and may have broader implications for the understanding of endurance performance in other domains.	[Burgum, Paul; Smith, Daniel T.] Univ Durham, Dept Psychol, Durham, England	Durham University	Smith, DT (corresponding author), Univ Durham, Dept Psychol, Durham, England.	daniel.smith2@durham.ac.uk	Smith, Daniel/A-2230-2009	Smith, Daniel/0000-0001-7030-6994	Laidlaw Undergraduate Research Bursary	Laidlaw Undergraduate Research Bursary	The research was supported by a Laidlaw Undergraduate Research Bursary awarded to PB (The Laidlaw Foundation - Undergraduate Scholars). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2021, HARDMOORS RACE SERIE; [Anonymous], 2021, ARC FREEDOM RUN; Baron B, 2011, BRIT J SPORT MED, V45, P511, DOI 10.1136/bjsm.2009.059964; Beedie CJ, 2005, COGNITION EMOTION, V19, P847, DOI 10.1080/02699930541000057; Beedie CJ, 2000, J APPL SPORT PSYCHOL, V12, P49, DOI 10.1080/10413200008404213; Bosquet L, 2007, MED SCI SPORT EXER, V39, P1358, DOI 10.1249/mss.0b013e31806010e0; Brick N, 2015, PSYCHOL SPORT EXERC, V19, P1, DOI 10.1016/j.psychsport.2015.02.003; Brick N, 2014, INT REV SPORT EXER P, V7, P106, DOI 10.1080/1750984X.2014.885554; Brick NE, 2020, INT J SPORT EXERC PS, V18, P362, DOI 10.1080/1612197X.2018.1519841; Eubank M, 1997, PERS INDIV DIFFER, V23, P1031, DOI 10.1016/S0191-8869(97)00125-6; Graham SM, 2012, CLIN J SPORT MED, V22, P462, DOI 10.1097/JSM.0b013e3182694734; Graham SM, 2021, EUR J SPORT SCI, V21, P100, DOI 10.1080/17461391.2020.1733670; Hanton S, 2008, EUR J SPORT SCI, V8, P143, DOI 10.1080/17461390801987984; Howe CCF, 2019, J SCI MED SPORT, V22, P763, DOI 10.1016/j.jsams.2019.02.008; Krokosz D, 2018, FRONT PSYCHOL, V9, DOI 10.3389/fpsyg.2018.00980; Lane AM, 2011, SCAND J MED SCI SPOR, V21, pE445, DOI 10.1111/j.1600-0838.2011.01364.x; Lane AM, 2000, J APPL SPORT PSYCHOL, V12, P16, DOI 10.1080/10413200008404211; Lane AM., 2019, ENDURANCE PERFORMANC, P70; Lane AM, 2012, J SPORT SCI, V30, P1189, DOI 10.1080/02640414.2012.693621; Lane AM, 2011, J SCI MED SPORT, V14, P358, DOI 10.1016/j.jsams.2011.03.001; LeUnes A, 2000, J APPL SPORT PSYCHOL, V12, P5, DOI 10.1080/10413200008404210; Lochbaum M, 2021, EUR J INVEST HEALTH, V11, P50, DOI 10.3390/ejihpe11010005; Marcora S., 2019, ENDURANCE PERFORMANC, P15, DOI DOI 10.4324/9781315167312-2; McCormick A., 2019, ENDURANCE PERFORMANC, P212; McNair D., 1971, MANUAL PROFILE MOOD; McNair DM., 1992, EDITS MANUAL PROFILE; Micklewright D., 2009, South African Journal of Sports Medicine, V21, P167; Pedlar CR, 2007, WILD ENVIRON MED, V18, P127, DOI 10.1580/06-WEME-BR-039R1.1; RAUCH TM, 1988, J SPORT MED PHYS FIT, V28, P237; Reed J, 2006, PSYCHOL SPORT EXERC, V7, P477, DOI 10.1016/j.psychsport.2005.11.003; Rundfeldt LC, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00035; Salovey P., 1990, IMAGINATION COGNITIO, V9, P185, DOI [https://doi.org/10.2190/DUGG-P24E-52WK-6CDG, 10.2190/DUGG-P24E-52WK-6CDG, DOI 10.2190/DUGG-P24E-52WK-6CDG]; Scheer V, 2020, INT J SPORTS MED, V41, P275, DOI 10.1055/a-1096-0980; Rocha VVS, 2018, ARCH CLIN PSYCHIAT, V45, P67, DOI 10.1590/0101-60830000000160; Terry PC, 2003, PSYCHOL SPORT EXERC, V4, P125, DOI 10.1016/S1469-0292(01)00035-8; THARION WJ, 1988, J SPORT EXERCISE PSY, V10, P229, DOI 10.1123/jsep.10.2.229; THARION WJ, 1990, PERCEPT MOTOR SKILL, V71, P1311, DOI 10.2466/PMS.71.8.1311-1316; Van Cutsem J., 2021, MOTIVATION SELF REGU, V1, P134, DOI [10.4324/9781003176695-10, DOI 10.4324/9781003176695-10]; Van Cutsem J, 2017, SPORTS MED, V47, P1569, DOI 10.1007/s40279-016-0672-0; Waskiewicz Z, 2019, PSYCHOL RES BEHAV MA, V12, P31, DOI 10.2147/PRBM.S189061	40	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2021	16	9							e0256888	10.1371/journal.pone.0256888	http://dx.doi.org/10.1371/journal.pone.0256888			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	WG5YY	34529656	Green Accepted, gold, Green Published, Green Submitted			2022-12-26	WOS:000707071500022
J	Lanyero, H; Ocan, M; Obua, C; Lundborg, CS; Agaba, K; Kalyango, JN; Eriksen, J; Nanzigu, S				Lanyero, Hindum; Ocan, Moses; Obua, Celestino; Lundborg, Cecilia Stalsby; Agaba, Katureebe; Kalyango, Joan N.; Eriksen, Jaran; Nanzigu, Sarah			Validity of caregivers' reports on prior use of antibacterials in children under five years presenting to health facilities in Gulu, northern Uganda	PLOS ONE			English	Article							COTRIMOXAZOLE PROPHYLAXIS; ANTIBIOTICS	Introduction Given the frequent initiation of antibacterial treatment at home by caregivers of children under five years in low-income countries, there is a need to find out whether caregivers' reports of prior antibacterial intake by their children before being brought to the healthcare facility are accurate. The aim of this study was to describe and validate caregivers' reported use of antibacterials by their children prior to seeking care at the healthcare facility. Methods A cross sectional study was conducted among children under five years seeking care at healthcare facilities in Gulu district, northern Uganda. Using a researcher administered questionnaire, data were obtained from caregivers regarding reported prior antibacterial intake in their children. These reports were validated by comparing them to common antibacterial agents detected in blood and urine samples from the children using liquid chromatography with tandem mass spectrometry (LC-MS/MS) methods. Results A total of 355 study participants had a complete set of data on prior antibacterial use collected using both self-report and LC-MS/MS. Of the caregivers, 14.4% (51/355, CI: 10.9-18.5%) reported giving children antibacterials prior to visiting the healthcare facility. However, LC-MS/MS detected antibacterials in blood and urine samples in 63.7% (226/355, CI: 58.4-68.7%) of the children. The most common antibacterials detected from the laboratory analysis were cotrimoxazole (29%, 103/355), ciprofloxacin (13%, 46/355), and metronidazole (9.9%, 35/355). The sensitivity, specificity, positive predictive value (PPV), negative predictive value and agreement of self-reported antibacterial intake prior to healthcare facility visit were 17.3% (12.6-22.8), 90.7% (84.3-95.1), 76.5% (62.5-87.2), 38.5% (33.0-44.2) and 43.9% (k 0.06) respectively. Conclusion There is low validity of caregivers' reports on prior intake of antibacterials by these children. There is need for further research to understand the factors associated with under reporting of prior antibacterial use.	[Lanyero, Hindum; Ocan, Moses; Nanzigu, Sarah] Makerere Univ, Dept Pharmacol & Therapeut, Coll Hlth Sci, Kampala, Uganda; [Obua, Celestino] Mbarara Univ Sci & Technol, Mbarara, Uganda; [Lundborg, Cecilia Stalsby; Eriksen, Jaran] Karolinska Inst, Dept Global Publ Hlth, Stockholm, Sweden; [Agaba, Katureebe] Infect Dis Res Collaborat, Kampala, Uganda; [Kalyango, Joan N.] Makerere Univ, Dept Pharm, Coll Hlth Sci, Kampala, Uganda; [Kalyango, Joan N.] Makerere Univ, Clin Epidemiol Unit, Coll Hlth Sci, Kampala, Uganda; [Eriksen, Jaran] South Gen Hosp, Dept Infect Dis, Stockholm, Sweden	Makerere University; Mbarara University of Science & Technology; Karolinska Institutet; Makerere University; Makerere University	Nanzigu, S (corresponding author), Makerere Univ, Dept Pharmacol & Therapeut, Coll Hlth Sci, Kampala, Uganda.	snanzigu@yahoo.com		Stalsby Lundborg, Cecilia/0000-0001-6525-1861	Makerere University - SIDA collaboration [Sida PI0010]	Makerere University - SIDA collaboration	Makerere University - SIDA collaboration (Sida PI0010) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Austin DJ, 1999, P NATL ACAD SCI USA, V96, P1152, DOI 10.1073/pnas.96.3.1152; Badri M, 2001, AIDS, V15, P1143, DOI 10.1097/00002030-200106150-00009; Bashahun D., 2015, LIVESTOCK RES RURAL, V27; Caudron JM, 2008, TROP MED INT HEALTH, V13, P1062, DOI 10.1111/j.1365-3156.2008.02106.x; Flower RJ., 2018, RANG DALES PHARM E B; Hafferty JD, 2018, J CLIN EPIDEMIOL, V94, P132, DOI 10.1016/j.jclinepi.2017.10.013; Henderson G., 2014, RANG DALES PHARM E B; Hildenwall H, 2009, T ROY SOC TROP MED H, V103, P95, DOI 10.1016/j.trstmh.2008.04.046; Iramiot JS, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-7798-6; Johnson LC, 2000, INT J STRESS MANAGE, V7, P247, DOI 10.1023/A:1009589812697; Kamwesiga J., 2011, UGANDA HLTH CARE SYS, DOI [10.1186/1745-6215-12-192, DOI 10.1186/1745-6215-12-192]; Kish L, 1965, SURVEY SAMPLING; Lanyero H, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0235164; Lerbech AM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113055; Li N, 2017, ENVIRON INT, V108, P246, DOI 10.1016/j.envint.2017.08.014; Mermin J, 2005, AIDS, V19, P1035, DOI 10.1097/01.aids.0000174449.32756.c7; Ministry of Health of Uganda, 2017, NAT HLTH FAC MAST LI; Ministry of Health Uganda, 2020, 2019 HIV EP SURV REP; Ministry of Health Uganda, 2002, UG NAT DRUG POL; Moise K, 2017, PAN AFR MED J, V28, DOI 10.11604/pamj.2017.28.4.12589; Monte AA, 2015, J CLIN PHARMACOL, V55, P33, DOI 10.1002/jcph.368; Namakula J, 2011, COUNTRY SITUATION AN; National Drug Authority, 2021, LIC OUTL; National Drug Authority, 2021, DRUG SHOPS LIC; Nayiga Susan, 2020, JAC-Antimicrobial Resistance, V2, pdlaa082, DOI 10.1093/jacamr/dlaa082; Nsimba SED, 2002, TROP MED INT HEALTH, V7, P201, DOI 10.1046/j.1365-3156.2002.00847.x; O'Connor R, 2018, IRISH J MED SCI, V187, P969, DOI 10.1007/s11845-018-1774-5; Ocan M, 2015, BMC PHARMACOL TOXICO, V16, DOI 10.1186/s40360-015-0027-8; Ocan M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092323; Omolase CO, 2007, ANN IBADAN POSTGRADU, V5, P64, DOI [DOI 10.4314/AIPM.V5I2.64032, 10.4314/aipm.v5i2.64032]; Omona S, 2020, BMC INFECT DIS, V20, DOI 10.1186/s12879-020-4770-0; Radyowijati A, 2003, SOC SCI MED, V57, P733, DOI 10.1016/S0277-9536(02)00422-7; Simple Ouma, 2018, Malar Res Treat, V2018, P5482136, DOI 10.1155/2018/5482136; Stirratt MJ, 2015, TRANSL BEHAV MED, V5, P470, DOI 10.1007/s13142-015-0315-2; UNICEF, 2020, UG UGA DEM HLTH INF; Wellcome Trust UK Government, 2015, REV ANTIMICROBIAL RE	36	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2021	16	9							e0257328	10.1371/journal.pone.0257328	http://dx.doi.org/10.1371/journal.pone.0257328			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	WG5YY	34529730	Green Published, gold			2022-12-26	WOS:000707071500048
J	Meyer, TJ; Gerhard-Hartmann, E; Lodes, N; Scherzad, A; Hagen, R; Steinke, M; Hackenberg, S				Meyer, Till Jasper; Gerhard-Hartmann, Elena; Lodes, Nina; Scherzad, Agmal; Hagen, Rudolf; Steinke, Maria; Hackenberg, Stephan			Pilot study on the value of Raman spectroscopy in the entity assignment of salivary gland tumors	PLOS ONE			English	Article							FINE-NEEDLE-ASPIRATION; ADENOID CYSTIC CARCINOMA; FROZEN-SECTION; BASAL-CELL; PLEOMORPHIC ADENOMA; NEOPLASMS; DIAGNOSIS; DISCRIMINATION; ADENOCARCINOMA; EXPRESSION	Background The entity assignment of salivary gland tumors (SGT) based on histomorphology can be challenging. Raman spectroscopy has been applied to analyze differences in the molecular composition of tissues. The aim of this study was to evaluate the suitability of RS for entity assignment in SGT. Methods Raman data were collected in deparaffinized sections of pleomorphic adenomas (PA) and adenoid cystic carcinomas (ACC). Multivariate data and chemometric analysis were completed using the Unscrambler software. Results The Raman spectra detected in ACC samples were mostly assigned to nucleic acids, lipids, and amides. In a principal component-based linear discriminant analysis (LDA) 18 of 20 tumor samples were classified correctly. Conclusion In this proof of concept study, we show that a reliable SGT diagnosis based on LDA algorithm appears possible, despite variations in the entity-specific mean spectra. However, a standardized workflow for tissue sample preparation, measurement setup, and chemometric algorithms is essential to get reliable results.	[Meyer, Till Jasper; Scherzad, Agmal; Hagen, Rudolf; Hackenberg, Stephan] Univ Hosp Wurzburg, Dept Otorhinolaryngol Plast Aesthet & Reconstruct, Wurzburg, Germany; [Gerhard-Hartmann, Elena] Univ Wurzburg, Inst Pathol, Wurzburg, Germany; [Lodes, Nina; Steinke, Maria] Univ Hosp Wurzburg, Chair Tissue Engn & Regenerat Med, Wurzburg, Germany; [Steinke, Maria] Fraunhofer Inst Silicate Res ISC, Wurzburg, Germany; [Hackenberg, Stephan] RWTH Aachen Univ Hosp, Dept Otorhinolaryngol Head & Neck Surg, Aachen, Germany	University of Wurzburg; University of Wurzburg; University of Wurzburg; Fraunhofer Gesellschaft; RWTH Aachen University; RWTH Aachen University Hospital	Meyer, TJ (corresponding author), Univ Hosp Wurzburg, Dept Otorhinolaryngol Plast Aesthet & Reconstruct, Wurzburg, Germany.	meyer_t2@ukw.de			Interdisciplinary Centre for Clinical Science (IZKF) of the University of Wu<spacing diaeresis> rzburg [Z-2/78]	Interdisciplinary Centre for Clinical Science (IZKF) of the University of Wu<spacing diaeresis> rzburg	This work was founded by the Interdisciplinary Centre for Clinical Science (IZKF) of the University of Wu<spacing diaeresis> rzburg, Grant Number Z-2/78 to TJM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bradley PJ, 2013, BRIT J ORAL MAX SURG, V51, P399, DOI 10.1016/j.bjoms.2012.10.002; Brozek-Pluska B, 2015, ANALYST, V140, P2107, DOI 10.1039/c4an01394h; Charwat V, 2015, J BIOTECHNOL, V205, P70, DOI 10.1016/j.jbiotec.2015.02.007; Edwards PC, 2004, ORAL SURG ORAL MED O, V97, P613, DOI 10.1016/j.tripleo.2003.09.010; El-Naggar AK, 2017, WHO CLASSIFICATION H, V4th, P261; Fakhry N, 2014, INT J ORAL MAX SURG, V43, P802, DOI 10.1016/j.ijom.2014.01.002; Faolain EO, 2005, J HISTOCHEM CYTOCHEM, V53, P121, DOI 10.1177/002215540505300114; Galli R, 2014, J BIOMED OPT, V19, DOI 10.1117/1.JBO.19.7.071402; Israel Y, 2016, ANTICANCER RES, V36, P4151; Koch S, 2013, PROC SPIE, V8798, DOI 10.1117/12.2033542; Kong K, 2015, ADV DRUG DELIVER REV, V89, P121, DOI 10.1016/j.addr.2015.03.009; Liu CC, 2016, OTOLARYNG HEAD NECK, V154, P9, DOI 10.1177/0194599815607841; Malini R, 2006, BIOPOLYMERS, V81, P179, DOI 10.1002/bip.20398; Meade AD, 2010, ANAL BIOANAL CHEM, V396, P1781, DOI 10.1007/s00216-009-3411-7; Meksiarun P, 2017, SCI REP-UK, V7, DOI 10.1038/srep44890; Movasaghi Z, 2007, APPL SPECTROSC REV, V42, P493, DOI 10.1080/05704920701551530; Olsen KD, 2013, JAMA OTOLARYNGOL, V139, P1275, DOI 10.1001/jamaoto.2013.5217; Ouyang DQ, 2017, MEDICINE, V96, DOI 10.1097/MD.0000000000005964; Pusztaszeri MP, 2014, CANCER CYTOPATHOL, V122, P257, DOI 10.1002/cncy.21381; Rooney SL, 2017, J ORAL PATHOL MED, V46, P798, DOI 10.1111/jop.12617; Seethala RR, 2005, HEAD NECK-J SCI SPEC, V27, P217, DOI 10.1002/hed.20142; Stanley MW, 1996, AM J CLIN PATHOL, V106, P35; Steinke M, 2014, BIOMATERIALS, V35, P7355, DOI 10.1016/j.biomaterials.2014.05.031; Talari ACS, 2015, APPL SPECTROSC REV, V50, P46, DOI 10.1080/05704928.2014.923902; Ueda K, 2020, HEAD NECK-J SCI SPEC, V42, P1721, DOI 10.1002/hed.26081; Valstar MH, 2017, ORAL ONCOL, V66, P93, DOI 10.1016/j.oraloncology.2017.01.004; Yan B, 2014, LASER PHYS, V24, DOI 10.1088/1054-660X/24/11/115601; Yan B, 2011, ORAL ONCOL, V47, P430, DOI 10.1016/j.oraloncology.2011.02.021; Yosef HK, 2017, ANAL CHEM, V89, P6893, DOI 10.1021/acs.analchem.7b01403; Zbaren P, 2008, OTOLARYNG HEAD NECK, V139, P811, DOI 10.1016/j.otohns.2008.09.013; Zbaren P, 2004, CANCER-AM CANCER SOC, V100, P1876, DOI 10.1002/cncr.20186; Zhan KY, 2016, OTOLARYNG CLIN N AM, V49, P327, DOI 10.1016/j.otc.2015.10.005	32	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2021	16	9							e0257470	10.1371/journal.pone.0257470	http://dx.doi.org/10.1371/journal.pone.0257470			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	WG5YY	34529739	Green Published, gold			2022-12-26	WOS:000707071500063
J	de Oteyza, GG; de Toledo, JA; Barraquer, RI; Kling, S				Garcia de Oteyza, Gonzalo; Alvarez de Toledo, Juan; Barraquer, Rafael, I; Kling, Sabine			Refractive changes of a new asymmetric intracorneal ring segment with variable thickness and base width: A 2D finite-element model	PLOS ONE			English	Article							IMPLANTATION; CORNEA; ICRS	Purpose To evaluate the local geometric effects of a unilateral intrastromal ring segment with a combined variation of ring thickness and base width in a finite element simulation, and to compare it against the isolated effect of thickness or base width variation alone. Methods A two-dimensional finite-element model of a transversely isotropic cornea was created assuming either axisymmetric stress or plane strain condition. The model geometry was composed of a three-layered corneal tissue (epithelium, anterior and posterior stroma) fixed at the limbus. The implantation of a triangular-shape asymmetric ring segment with varying ring thickness (150 to 300 mu m) and base width (600 to 800 mu m) was simulated. Also, changes induced by thickness or base width alone were studied and compared their combined effect in the asymmetric ring segment. Geometrical deformation of the simulated cornea and sagittal curvature were the main parameters of study. Results Increasing ring thickness and base width along the arc of the asymmetric ring segment produced a more pronounced flattening in this part of the ring. The asymmetric design did find a good balance between maximizing corneal flattening at one end and minimizing it at the other end, compared to the isolated effect of ring thickness and width. Ring thickness was the most robust parameter in flattening both, the central and peripheral cornea. Conclusion The finite-element model permitted a theoretical study of corneal deformation undergoing implantation of realistic and hypothetical ring geometries. Intracorneal asymmetric ring segments with varying thickness and base width can be a good alternative in corneas with asymmetric keratoconus phenotypes.	[Garcia de Oteyza, Gonzalo] Clin Oftalmol Garcia Oteyza, Barcelona, Spain; [Garcia de Oteyza, Gonzalo] Univ Autonoma Barcelona UAB, Escuela Doctorado, Barcelona, Spain; [Alvarez de Toledo, Juan; Barraquer, Rafael, I] Ctr Oftalmol Barraquer, Barcelona, Spain; [Barraquer, Rafael, I] Univ Int Catalunya UIC, Barcelona, Spain; [Kling, Sabine] Swiss Fed Inst Technol, Dept Informat Technol & Elect Engn, Comp Assisted Applicat Med Grp, OPTIC Team, Zurich, Switzerland	Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Universitat Internacional de Catalunya (UIC); Swiss Federal Institutes of Technology Domain; ETH Zurich	de Oteyza, GG (corresponding author), Clin Oftalmol Garcia Oteyza, Barcelona, Spain.; de Oteyza, GG (corresponding author), Univ Autonoma Barcelona UAB, Escuela Doctorado, Barcelona, Spain.	gonzalo_gdeoteyza@hotmail.com	; Garcia de Oteyza, Gonzalo/L-3965-2018	Kling, Sabine/0000-0001-7202-7200; Garcia de Oteyza, Gonzalo/0000-0002-8169-8791	Swiss National Science Foundation [PZ00P2_174113]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	SK Ambizione PZ00P2_174113 to SK Swiss National Science Foundation www.snf.ch NO The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Tuwairqi WS, 2017, INT OPHTHALMOL, V37, P1185, DOI 10.1007/s10792-016-0385-2; Anderson K, 2004, J R SOC INTERFACE, V1, P3, DOI 10.1098/rsif.2004.0002; Ariza-Gracia MA, 2020, TRANSL VIS SCI TECHN, V9, DOI 10.1167/tvst.9.11.26; Bautista-Llamas MJ, 2019, J REFRACT SURG, V35, P740, DOI 10.3928/1081597X-20191010-02; Chan K, 2017, CORNEA, V36, P244, DOI 10.1097/ICO.0000000000001075; Cochener B, 2000, J CATARACT REFR SURG, V26, P978, DOI 10.1016/S0886-3350(00)00537-X; Consejo A, 2018, CORNEA, V37, P1047, DOI 10.1097/ICO.0000000000001565; d'Azy CB, 2019, TRANSL VIS SCI TECHN, V8, DOI 10.1167/tvst.8.3.38; Dhaese SE, 2021, CONTACT LENS ANTERIO, V44, DOI 10.1016/j.clae.2020.08.010; Djotyan GP, 2001, J BIOMECH ENG-T ASME, V123, P440, DOI 10.1115/1.1388293; Ebrahimian A., 2019, CRONICON EC OPHTHALM, V10, P345; Fleming J F, 1989, CLAO J, V15, P146; Glass DH, 2008, INVEST OPHTH VIS SCI, V49, P3919, DOI 10.1167/iovs.07-1321; Hennighausen H, 1998, INVEST OPHTH VIS SCI, V39, P253; Kling S, 2020, INVEST OPHTH VIS SCI, V61, DOI 10.1167/iovs.61.6.29; Kling S, 2020, FRONT BIOENG BIOTECH, V7, DOI 10.3389/fbioe.2019.00453; Kling S, 2013, INVEST OPHTH VIS SCI, V54, P881, DOI 10.1167/iovs.12-10852; Kubaloglu A, 2010, J CATARACT REFR SURG, V36, P978, DOI 10.1016/j.jcrs.2009.12.031; Lago MA, 2015, J MECH BEHAV BIOMED, V51, P260, DOI 10.1016/j.jmbbm.2015.07.023; Lyra JM, 2017, J REFRACT SURG, V33, P110, DOI 10.3928/1081597X-20161027-02; Mart?nez CP., 2014, MONOGRAFIAS SECOIR, P165; Monteiro T, 2018, CORNEA, V37, P182, DOI 10.1097/ICO.0000000000001449; Pandolfi A, 2006, BIOMECH MODEL MECHAN, V5, P237, DOI 10.1007/s10237-005-0014-x; Park SE, 2019, CURR OPIN OPHTHALMOL, V30, P220, DOI 10.1097/ICU.0000000000000582; PATEL S, 1995, J REFRACT SURG, V11, P248; Pinero DP, 2010, INVEST OPHTH VIS SCI, V51, P5583, DOI 10.1167/iovs.09-5017; PINSKY PM, 1991, J BIOMECH, V24, P907, DOI 10.1016/0021-9290(91)90169-N; Prisant O, 2020, CORNEA, V39, P155, DOI 10.1097/ICO.0000000000002160; Roy AS, 2011, INVEST OPHTH VIS SCI, V52, P9174, DOI 10.1167/iovs.11-7395; Schanzlin DJ, 1997, OPHTHALMOLOGY, V104, P1067, DOI 10.1016/S0161-6420(97)30183-3; Siganos D, 2002, J CATARACT REFR SURG, V28, P1947, DOI 10.1016/S0886-3350(02)01495-5; SILVESTRINI TA, 1994, INVEST OPHTH VIS SCI, V35, P2023; Torquetti L, 2018, CORNEA, V37, P1299, DOI 10.1097/ICO.0000000000001709; Vega-Estrada A, 2019, CORNEA, V38, P1228, DOI 10.1097/ICO.0000000000002062	34	1	1	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2021	16	9							e0257222	10.1371/journal.pone.0257222	http://dx.doi.org/10.1371/journal.pone.0257222			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	WG6DR	34525102	Green Published, gold			2022-12-26	WOS:000707084400027
J	Ayeh, SK; Abbey, EJ; Khalifa, BAA; Nudotor, RD; Osei, AD; Chidambaram, V; Osuji, N; Khan, S; Salia, EL; Oduwole, MO; Yusuf, HE; Lasisi, O; Nosakhare, E; Karakousis, PC				Ayeh, Samuel K.; Abbey, Enoch J.; Khalifa, Banda A. A.; Nudotor, Richard D.; Osei, Albert Danso; Chidambaram, Vignesh; Osuji, Ngozi; Khan, Samiha; Salia, Emmanuella L.; Oduwole, Modupe O.; Yusuf, Hasiya E.; Lasisi, Oluwatobi; Nosakhare, Esosa; Karakousis, Petros C.			Statins use and COVID-19 outcomes in hospitalized patients	PLOS ONE			English	Article							SIGNIFICANTLY CORRELATE; RADIOLOGICAL EXTENT; IN-VIVO; HDL-C; DISEASE; THERAPY; ACE2	Background There is an urgent need for novel therapeutic strategies for reversing COVID-19-related lung inflammation. Recent evidence has demonstrated that the cholesterol-lowering agents, statins, are associated with reduced mortality in patients with various respiratory infections. We sought to investigate the relationship between statin use and COVID-19 disease severity in hospitalized patients. Methods A retrospective analysis of COVID-19 patients admitted to the Johns Hopkins Medical Institutions between March 1, 2020 and June 30, 2020 was performed. The outcomes of interest were mortality and severe COVID-19 infection, as defined by prolonged hospital stay (>= 7 days) and/ or invasive mechanical ventilation. Logistic regression, Cox proportional hazards regression and propensity score matching were used to obtain both univariable and multivariable associations between covariates and outcomes in addition to the average treatment effect of statin use. Results Of the 4,447 patients who met our inclusion criteria, 594 (13.4%) patients were exposed to statins on admission, of which 340 (57.2%) were male. The mean age was higher in statin users compared to non-users [64.9 +/- 13.4 vs. 45.5 +/- 16.6 years, p <0.001]. The average treatment effect of statin use on COVID-19-related mortality was RR = 1.00 (95% CI: 0.99-1.01, p = 0.928), while its effect on severe COVID-19 infection was RR = 1.18 (95% CI: 1.11-1.27, p <0.001). Conclusion Statin use was not associated with altered mortality, but with an 18% increased risk of severe COVID-19 infection.	[Ayeh, Samuel K.; Abbey, Enoch J.; Chidambaram, Vignesh; Osuji, Ngozi; Khan, Samiha; Oduwole, Modupe O.; Karakousis, Petros C.] Johns Hopkins Sch Med, Dept Med, Baltimore, MD 21205 USA; [Khalifa, Banda A. A.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA; [Nudotor, Richard D.] Johns Hopkins Sch Med, Dept Surg, Baltimore, MD USA; [Osei, Albert Danso] Medstar Union Mem Hosp, Dept Internal Med, Baltimore, MD USA; [Salia, Emmanuella L.] Univ Tennessee, Ctr Hlth Sci, Dept Genet Genom & Informat, Memphis, TN 38163 USA; [Yusuf, Hasiya E.] Johns Hopkins Sch Med, Dept Pediat, Baltimore, MD USA; [Lasisi, Oluwatobi] Wayne State Univ, Sch Med, Dept Internal Med, Detroit, MI 48201 USA; [Nosakhare, Esosa] Johns Hopkins Med, Armstrong Inst Patient Safety & Qual, Baltimore, MD USA; [Karakousis, Petros C.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Medicine; Union Memorial Hospital; University of Tennessee System; University of Tennessee Health Science Center; Johns Hopkins University; Johns Hopkins Medicine; Wayne State University; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Karakousis, PC (corresponding author), Johns Hopkins Sch Med, Dept Med, Baltimore, MD 21205 USA.; Karakousis, PC (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD 21205 USA.	petros@jhmi.edu	CHIDAMBARAM, VIGNESH/AAH-9488-2021; Khalifa, Banda/GRF-1928-2022	Nudotor, Richard/0000-0002-2281-4924; Khalifa, Banda Abdallah Abubakar/0000-0002-2525-5531; Chidambaram, Vignesh/0000-0002-4240-1027; Abbey, Enoch/0000-0002-3286-0529	National Institute of Allergy and Infectious Diseases (NIAID)/National Institutes of Health (NIH) [UH3AI122309, K24AI143447]	National Institute of Allergy and Infectious Diseases (NIAID)/National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This retrospective cohort study was supported by the National Institute of Allergy and Infectious Diseases (NIAID)/National Institutes of Health (NIH) grants UH3AI122309 and K24AI143447 to P.C.K. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blanc M, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000598; Bruiners N, 2020, J LIPID RES, V61, P1617, DOI 10.1194/jlr.RA120000895; Cariou B, 2021, DIABETES METAB, V47, DOI 10.1016/j.diabet.2020.10.001; Chidambaram V, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0241541; Cuervo NZ, 2020, ELIFE, V9, DOI 10.7554/eLife.61390; Damiani I, 2020, EXPERT OPIN DRUG MET, V16, P1133, DOI 10.1080/17425255.2020.1822324; Daniels LB, 2020, AM J CARDIOL, V136, P149, DOI 10.1016/j.amjcard.2020.09.012; Dashti-Khavidaki S, 2020, PHARMACOTHERAPY, V40, P484, DOI 10.1002/phar.2397; De Spiegeleer A, 2020, J AM MED DIR ASSOC, V21, P909, DOI 10.1016/j.jamda.2020.06.018; Deniz O, 2006, CLIN BIOCHEM, V39, P287, DOI 10.1016/j.clinbiochem.2006.01.015; Deniz O, 2007, CLIN BIOCHEM, V40, P162, DOI 10.1016/j.clinbiochem.2006.10.015; Dutta NK, 2020, J INFECT DIS, V221, P1079, DOI 10.1093/infdis/jiz517; Dutta NK, 2016, J ANTIMICROB CHEMOTH, V71, P1570, DOI 10.1093/jac/dkw014; Elahi S, 2016, AIDS, V30, P171, DOI 10.1097/QAD.0000000000000917; Gower TL, 2001, ANTIMICROB AGENTS CH, V45, P1231, DOI 10.1128/AAC.45.4.1231-1237.2001; Greenwood J, 2006, NAT REV IMMUNOL, V6, P358, DOI 10.1038/nri1839; Guan W, 2020, NEW ENGL J MED, V382, P1708, DOI 10.1056/NEJMoa2002032; Hariyanto TI, 2020, DIABETES METAB SYND, V14, P1613, DOI 10.1016/j.dsx.2020.08.023; Henry Christopher, 2018, Proc (Bayl Univ Med Cent), V31, P419, DOI 10.1080/08998280.2018.1499293; Hoffmann M, 2020, CELL, V181, P271, DOI 10.1016/j.cell.2020.02.052; Jain MK, 2005, NAT REV DRUG DISCOV, V4, P977, DOI 10.1038/nrd1901; Karakousis PC., 2021, ADV HOST DIRECTED TH, DOI [10.1007/978-3-030-56905-1, DOI 10.1007/978-3-030-56905-1]; Kwak B, 2000, NAT MED, V6, P1399, DOI 10.1038/82219; Li J, 2020, J CLIN TRANSL HEPATO, V8, P13, DOI 10.14218/JCTH.2020.00019; Liao JK, 2005, ANNU REV PHARMACOL, V45, P89, DOI 10.1146/annurev.pharmtox.45.120403.095748; Ludwig S, 2020, ANESTH ANALG, V131, P93, DOI 10.1213/ANE.0000000000004845; Moore BJ, 2017, MED CARE, V55, P698, DOI 10.1097/MLR.0000000000000735; Parihar SP, 2019, NAT REV IMMUNOL, V19, P104, DOI 10.1038/s41577-018-0094-3; Peymani Payam, 2021, Transl Med Commun, V6, P3, DOI 10.1186/s41231-021-00082-5; Potena L, 2004, CIRCULATION, V109, P532, DOI 10.1161/01.CIR.0000109485.79183.81; Rodriguez-Nava G, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-03154-4; Rossi R, 2020, INTERN EMERG MED, V15, P1573, DOI 10.1007/s11739-020-02504-y; Sapey E, 2019, AM J RESP CRIT CARE, V200, P1282, DOI 10.1164/rccm.201812-2328OC; Shin YH, 2017, HEART VESSELS, V32, P618, DOI 10.1007/s00380-016-0936-5; Skerry C, 2014, J ANTIMICROB CHEMOTH, V69, P2453, DOI 10.1093/jac/dku166; Stamatogiannis N, 2009, RECENT PATENTS INFLA, V3, P167, DOI 10.2174/187221309789257469; Tikoo K, 2015, BIOCHEM PHARMACOL, V93, P343, DOI 10.1016/j.bcp.2014.11.013; Totura AL, 2015, MBIO, V6, DOI 10.1128/mBio.00638-15; Volpato S, 2000, GERONTOLOGY, V46, P22, DOI 10.1159/000022129; Wei XQ, 2020, J CLIN LIPIDOL, V14, P297, DOI 10.1016/j.jacl.2020.04.008; Xia Y, 2018, CELL, V175, P1059, DOI 10.1016/j.cell.2018.08.070	41	15	15	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2021	16	9							e0256899	10.1371/journal.pone.0256899	http://dx.doi.org/10.1371/journal.pone.0256899			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XM9EM	34506533	gold, Green Published			2022-12-26	WOS:000729120700089
J	Feng, MLE; Che-Castaldo, J				Feng, Mei-Ling Emily; Che-Castaldo, Judy			Comparing the reliability of relative bird abundance indices from standardized surveys and community science data at finer resolutions	PLOS ONE			English	Article							BIODIVERSITY; ECOLOGY; MODELS	Biodiversity loss is a global ecological crisis that is both a driver of and response to environmental change. Understanding the connections between species declines and other components of human-natural systems extends across the physical, life, and social sciences. From an analysis perspective, this requires integration of data from different scientific domains, which often have heterogeneous scales and resolutions. Community science projects such as eBird may help to fill spatiotemporal gaps and enhance the resolution of standardized biological surveys. Comparisons between eBird and the more comprehensive North American Breeding Bird Survey (BBS) have found these datasets can produce consistent multi-year abundance trends for bird populations at national and regional scales. Here we investigate the reliability of these datasets for estimating patterns at finer resolutions, inter-annual changes in abundance within town boundaries. Using a case study of 14 focal species within Massachusetts, we calculated four indices of annual relative abundance using eBird and BBS datasets, including two different modeling approaches within each dataset. We compared the correspondence between these indices in terms of multi-year trends, annual estimates, and inter-annual changes in estimates at the state and town-level. We found correspondence between eBird and BBS multi-year trends, but this was not consistent across all species and diminished at finer, inter-annual temporal resolutions. We further show that standardizing modeling approaches can increase index reliability even between datasets at coarser temporal resolutions. Our results indicate that multiple datasets and modeling methods should be considered when estimating species population dynamics at finer temporal resolutions, but standardizing modeling approaches may improve estimate correspondence between abundance datasets. In addition, reliability of these indices at finer spatial scales may depend on habitat composition, which can impact survey accuracy.	[Feng, Mei-Ling Emily; Che-Castaldo, Judy] Lincoln Pk Zoo, Alexander Ctr Appl Populat Biol, Chicago, IL 60614 USA		Feng, MLE (corresponding author), Lincoln Pk Zoo, Alexander Ctr Appl Populat Biol, Chicago, IL 60614 USA.	mefeng7@gmail.com			National Science Foundation's Harnessing the Data Revolution program [1940276]	National Science Foundation's Harnessing the Data Revolution program	M.-L.E.F. and J.P.C. were supported by the National Science Foundation's Harnessing the Data Revolution program, award #1940276, https://nsf.gov/. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alldredge MW, 2007, ECOL APPL, V17, P948, DOI 10.1890/06-0685; Amano T, 2016, BIOSCIENCE, V66, P393, DOI 10.1093/biosci/biw022; [Anonymous], 2020, CHRISTM BIRD COUNT H; Bailey JJ, 2017, GLOBAL ECOL BIOGEOGR, V26, P763, DOI 10.1111/geb.12574; Bates D, LME4 LINEAR MIXED EF; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Buckland ST, 2005, PHILOS T R SOC B, V360, P243, DOI 10.1098/rstb.2004.1589; Butchart SHM, 2010, SCIENCE, V328, P1164, DOI 10.1126/science.1187512; D'Amico M, 2019, DIVERS DISTRIB, V25, P975, DOI 10.1111/ddi.12903; DeNormandie J, 2011, STATE BIRDS 2011 DOC; Diefenbach DR, 2003, AUK, V120, P1168, DOI 10.1642/0004-8038(2003)120[1168:VIGBCR]2.0.CO;2; Dirzo R, 2014, SCIENCE, V345, P401, DOI 10.1126/science.1251817; Fang JC, 2019, ENVIRON SCI POLLUT R, V26, P1455, DOI 10.1007/s11356-018-3634-2; Farley SS, 2018, BIOSCIENCE, V68, P563, DOI 10.1093/biosci/biy068; Fink D, 2020, ECOL APPL, V30, DOI 10.1002/eap.2056; Furnas BJ, 2020, BIOL CONSERV, V241, DOI 10.1016/j.biocon.2019.108347; Ganter B, 2001, BIRD STUDY, V48, P90, DOI 10.1080/00063650109461206; Graham LJ, 2019, METHODS ECOL EVOL, V10, P767, DOI 10.1111/2041-210X.13177; Heim W, 2020, GLOB ECOL CONSERV, V24, DOI 10.1016/j.gecco.2020.e01215; Horns JJ, 2018, BIOL CONSERV, V221, P151, DOI 10.1016/j.biocon.2018.02.027; Iliff M.., 2020, EBIRD STATUS TRENDS, DOI 10.2173/ebirdst.2018; James G, 2013, SPRINGER TEXTS STAT, V103, P1, DOI 10.1007/978-1-4614-7138-7; Johnston A., 2020, ANALYTICAL GUIDELINE; Kamm M., 2013, MASSACHUSETTS BREEDI; Kulaga K, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0211970; Lele SR, 2012, J PLANT ECOL-UK, V5, P22, DOI 10.1093/jpe/rtr042; Liu L, 2019, NAT SUSTAIN, V2, P206, DOI 10.1038/s41893-019-0235-0; Neate-Clegg MHC., BIOL CONSERV, V248; Olimpi EM, 2020, ECOL APPL, V30, DOI 10.1002/eap.2115; Pacifici K, 2008, AUK, V125, P600, DOI 10.1525/auk.2008.07078; Panjabi AO, 2020, PARTNERS FLIGHT AVIA; Pardieck K, 2019, **DATA OBJECT**, DOI [10.5066/P9HE8XYJ, DOI 10.5066/P9HE8XYJ]; Polat O, 2016, IOP CONF SER-MAT SCI, V161, DOI 10.1088/1757-899X/161/1/012091; R Core Team, 2020, R LANG ENV STAT COMP; Rigby EA, 2019, CONDOR, V121, DOI 10.1093/condor/duz030; Rosenberg KV, 2019, SCIENCE, V366, P120, DOI 10.1126/science.aaw1313; Rosenberg KV, 2017, CONDOR, V119, P594, DOI 10.1650/CONDOR-17-57.1; Sauer J.R., 2017, N AM BREEDING BIRD S; Sauer John R., 2013, North American Fauna, V79, P2, DOI 10.3996/nafa.79.0001; Sekercioglu CH., 2016, WHY BIRDS MATTER AVI, P368; Specht A, 2020, RES DISCIPLINARY BOU; Stehfest E., 2014, INTEGRATED ASSESSMEN; Strimas-Mackey M., 2018, AUK EBIRD DATA EXTRA; Strimas-Mackey M., 2020, EBIRDST TOOLS LOADIN, DOI DOI 10.5281/ZENODO.3620739; Sullivan BL, 2009, BIOL CONSERV, V142, P2282, DOI 10.1016/j.biocon.2009.05.006; Walker J, 2017, AVIAN CONSERV ECOL, V12, DOI 10.5751/ACE-00960-120104; Walsh JM, 2017, STATE BIRDS 2017 MAS; Weyant J, 2017, REV ENV ECON POLICY, V11, P115, DOI 10.1093/reep/rew018; Wright MN, 2017, J STAT SOFTW, V77, P1, DOI 10.18637/jss.v077.i01; Yang LM, 2018, ISPRS J PHOTOGRAMM, V146, P108, DOI 10.1016/j.isprsjprs.2018.09.006	51	0	0	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2021	16	9							e0257226	10.1371/journal.pone.0257226	http://dx.doi.org/10.1371/journal.pone.0257226			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XM9EM	34506572	Green Published, gold			2022-12-26	WOS:000729120700081
J	Li, Y; Sun, YQ; Zhu, NN				Li, Yang; Sun, Yuqing; Zhu, Nana			BERTtoCNN: Similarity-preserving enhanced knowledge distillation for stance detection	PLOS ONE			English	Article								In recent years, text sentiment analysis has attracted wide attention, and promoted the rise and development of stance detection research. The purpose of stance detection is to determine the author's stance (favor or against) towards a specific target or proposition in the text. Pre-trained language models like BERT have been proven to perform well in this task. However, in many reality scenes, they are usually very expensive in computation, because such heavy models are difficult to implement with limited resources. To improve the efficiency while ensuring the performance, we propose a knowledge distillation model BERTtoCNN, which combines the classic distillation loss and similarity-preserving loss in a joint knowledge distillation framework. On the one hand, BERTtoCNN provides an efficient distillation process to train a novel 'student' CNN structure from a much larger 'teacher' language model BERT. On the other hand, based on the similarity-preserving loss function, BERTtoCNN guides the training of a student network, so that input pairs with similar (dissimilar) activation in the teacher network have similar (dissimilar) activation in the student network. We conduct experiments and test the proposed model on the open Chinese and English stance detection datasets. The experimental results show that our model outperforms the competitive baseline methods obviously.	[Li, Yang; Sun, Yuqing] Northeast Forestry Univ, Coll Informat & Comp Engn, Harbin, Heilongjiang, Peoples R China; [Zhu, Nana] Harbin Univ, Lib, Harbin, Heilongjiang, Peoples R China; [Zhu, Nana] Heilongjiang Univ, Sch Informat Management, Harbin, Heilongjiang, Peoples R China	Northeast Forestry University - China; Harbin University; Heilongjiang University	Li, Y (corresponding author), Northeast Forestry Univ, Coll Informat & Comp Engn, Harbin, Heilongjiang, Peoples R China.	yli@nefu.edu.cn		Yang, Li/0000-0002-0403-7287	National Natural Science Foundation of China [61806049]; Heilongjiang Postdoctoral Science Foundation [LBH-Z20104]; Heilongjiang Province Art Planning Project [2019C027]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Heilongjiang Postdoctoral Science Foundation; Heilongjiang Province Art Planning Project	This work was supported by the National Natural Science Foundation of China [61806049], the Heilongjiang Postdoctoral Science Foundation [LBH-Z20104] and the Heilongjiang Province Art Planning Project [2019C027].	Aldayel Abeer, 2019, Proceedings of the ACM on Human-Computer Interaction, V3, DOI 10.1145/3359307; ALDayel A, 2021, INFORM PROCESS MANAG, V58, DOI 10.1016/j.ipm.2021.102597; Aono M, 3 C DAT MIN BIG DAT, DOI [10.1007/978-3-319-93803-5_45, DOI 10.1007/978-3-319-93803-5_45]; Augenstein I., 2016, P 2016 C EMP METH NA, P876; Ba Jimmy, 2014, ADV NEURAL INFORM PR, P2654; Bai J., 2018, COMP APPL SOFTWARE, V35, P266, DOI [10.3969/j.issn.1000-386x.2018.03.051, DOI 10.3969/J.ISSN.1000-386X.2018.03.051]; Devlin J., 2018, ARXIV181004805; [奠雨洁 Dian Yujie], 2017, [计算机工程与应用, Computer Engineering and Application], V53, P77; Du JC, 2020, IEEE INTELL SYST, V35, P102, DOI 10.1109/MIS.2020.2983497; Du J, 2017, SMART INNOV SYST TEC, V53, P1, DOI 10.1007/978-981-10-2398-9_1; Ebrahimi J., 2016, P COLING 2016 26 INT, P2656; Elfardy H., 2016, P 10 INT WORKSHOP SE, P434, DOI 10.18653/v1/s16-1070; Jiao X. Q., 2020, PROC FINDINGS ASS CO, P4163; Kim Yoon, 2014, P 2014 C EMPIRICAL M, P1746, DOI [DOI 10.3115/V1/D14-1181, 10.3115/v1/D14-1181]; Kingma DP., 2014, ADAM METHOD STOCHAST; LIU C, 2020, BEIJING DA XUE XUE B, V56, P16, DOI DOI 10.13209/J.0479-8023.2019.096; Liu Q, ARXIV200404037; Liu Yinhan, 2019, COMPUTING RES REPOSI; Lu LM., 2019, COMPUTER SYSTEMS APP, V28, P45; Mohammad S, 2016, 2016 INTERNATIONAL CONFERENCE ON RESEARCH ADVANCES IN INTEGRATED NAVIGATION SYSTEMS (RAINS); Radford Alec, 2018, TECHNICAL REPORT, DOI 10.48550/ARXIV.1802.05365; Siddiqua U., 2019, P 2019 C N AM CHAPTE, P1868; Sun QY, 2019, FRONT COMPUT SCI-CHI, V13, P127, DOI 10.1007/s11704-018-7150-9; Sun Qingying, 2018, P 27 INT C COMP LING, P2399; Sun SQ, 2019, 2019 CONFERENCE ON EMPIRICAL METHODS IN NATURAL LANGUAGE PROCESSING AND THE 9TH INTERNATIONAL JOINT CONFERENCE ON NATURAL LANGUAGE PROCESSING (EMNLP-IJCNLP 2019), P4323; Tang Raphael, 2019, ARXIV190312136; Tung F, 2019, IEEE I CONF COMP VIS, P1365, DOI 10.1109/ICCV.2019.00145; Vaswani A, 2017, ADV NEUR IN, V30; Vijayaraghavan P., 2016, P 10 INT WORKSH SEM, P413, DOI 10.18653/v1/S16-1067; Wang, 2017, CICLING, P35, DOI [10.1007/978-3-319-77116-8_32017, DOI 10.1007/978-3-319-77116-8_32017]; Wei J, 2019, 2019 CONFERENCE ON EMPIRICAL METHODS IN NATURAL LANGUAGE PROCESSING AND THE 9TH INTERNATIONAL JOINT CONFERENCE ON NATURAL LANGUAGE PROCESSING (EMNLP-IJCNLP 2019), P6382; Xu, 2020, ACL; XU JM, ICCPOL 2016 NLPCC 20, DOI DOI 10.1007/978-3-319-50496-4_61; XU RF, ICCPOL 2016 NLPCC 20, DOI DOI 10.1007/978-3-319-50496-4_85; Yang ZW, 2021, ANIM BIOTECHNOL, V32, P67, DOI 10.1080/10495398.2019.1653901; Yuanyu Yang, 2020, 2020 IEEE Fifth International Conference on Data Science in Cyberspace (DSC). Proceedings, P22, DOI 10.1109/DSC50466.2020.00012; YUE T, 2019, J GUANGXI NORMAL U N, V37, P12; Zarrella G., 2016, P 57 ANN M ASS COMPU, DOI DOI 10.18653/V1/P19-1513	39	2	2	4	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2021	16	9							e0257130	10.1371/journal.pone.0257130	http://dx.doi.org/10.1371/journal.pone.0257130			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XM9EM	34506549	Green Published, gold			2022-12-26	WOS:000729120700042
J	Ontiri, S; Kabue, M; Biesma, R; Stekelenburg, J; Gichangi, P				Ontiri, Susan; Kabue, Mark; Biesma, Regien; Stekelenburg, Jelle; Gichangi, Peter			Assessing quality of family planning counseling and its determinants in Kenya: Analysis of health facility exit interviews	PLOS ONE			English	Article							CONTRACEPTIVE USE; PROGRAMS; SERVICE	Background Available evidence suggests that provision of quality of care in family planning services is crucial to increasing uptake and continuation of use of contraception. Kenya achieved a modern contraceptive prevalence rate of 60% in 2018, surpassing its 2020 target of 58%. With the high prevalence, focus is geared towards improved quality of family planning services. The objective of this study is to examine the quality of family planning counseling and its associated factors in health facilities in Kenya. Methods We conducted a secondary analysis of the 2019 Kenya Performance Monitoring and Action, client exit data of women who had received family planning services. Quality of counseling was assessed using the Method Information Index Plus. We conducted a multivariable ordinal logistic regression analysis of data from 3,731 women to establish determinants of receiving quality family planning services. Results The Method Information Index Plus score for higher-quality counseling was 56.7%, lower-quality counseling 32.4%, and no counseling 10.9%. Women aged 15-24 years (aOR = 0.69, 95% CI = 0.56-0.86, p = 0.001) had lower odds of receiving better counseling compared to women aged 35 years and above. Those with no education (aOR = 0.52, 95% CI = 0.33-0.82, p = 0.005), primary (aOR = 0.56, 95% CI = 0.44-0.71, p<0.001) and secondary (aOR = 0.79, 95% CI = 0.65-0.98, p = 0.028) were less likely to receive better counseling compared to those with tertiary education. Women who received long acting and reversible contraception methods (aOR = 1.75, 95% CI = 1.42-2.17, p<0.001), and those who were method switchers (aOR = 1.24, 95% CI = 1.03-1.50, p = 0.027), had a higher likelihood of receiving better quality of counseling as compared to those on short-term methods and those who were continuers, respectively. Conclusion The quality of family planning counseling in Kenya is still sub-optimal considering that some women receive no form of counseling at service delivery point. There is need to review the existing FP guidelines and training packages to increase focus on the quality of counseling services offered by health providers. Social accountability strategies that empower women to demand quality services should be included in community-level family planning interventions.	[Ontiri, Susan; Biesma, Regien; Stekelenburg, Jelle] Univ Med Ctr Groningen, Dept Hlth Sci, Global Hlth Unit, Groningen, Netherlands; [Kabue, Mark] Johns Hopkins Univ, Dept Monitoring Evaluat & Res, Nairobi, Kenya; [Stekelenburg, Jelle] Leeuwarden Med Ctr, Dept Obstet & Gynecol, Leeuwarden, Netherlands; [Gichangi, Peter] Tech Univ Mombasa, Dept Res, Mombasa, Kenya; [Gichangi, Peter] Univ Ghent, Dept Publ Hlth & Primary Care, Fac Med & Hlth Sci, Ghent, Belgium; [Gichangi, Peter] Int Ctr Reprod Hlth Kenya ICRH K, Mombasa, Kenya	University of Groningen; Medical Center Leeuwarden; Technical University of Mombasa; Ghent University; Ghent University Hospital	Ontiri, S (corresponding author), Univ Med Ctr Groningen, Dept Hlth Sci, Global Hlth Unit, Groningen, Netherlands.	s.k.ontiri@umcg.nl	Stekelenburg, Jelle/B-3129-2017	Stekelenburg, Jelle/0000-0002-2732-6620				Ali MM., 2012, WHO CAUSES CONSEQUEN; Amir D, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0226550; Barden-O'Fallon J, 2018, BMC WOMENS HEALTH, V18, DOI 10.1186/s12905-018-0529-9; Blanc AK, 2002, STUD FAMILY PLANN, V33, P127, DOI 10.1111/j.1728-4465.2002.00127.x; Blanc AK, 2009, INT PERSPECT SEX R H, V35, P63, DOI 10.1363/ipsrh.35.063.09; Castle S., 2015, POPULATION COUNCIL F; Chakraborty NM, 2019, GLOB HEALTH-SCI PRAC, V7, P87, DOI 10.9745/GHSP-D-18-00407; Chang KT, 2019, STUD FAMILY PLANN, V50, P25, DOI 10.1111/sifp.12081; Confederation Suisse, 2016, SWISS POS FRAM SUST; Dadi Hailemichael B., 2020, INT J REPROD MED, DOI [10.1155/2020/2649340, DOI 10.1155/2020/2649340]; Feeser K., 2019, GATES OPEN RES, V3, DOI [10.12688/gatesopenres.12974.2, DOI 10.12688/GATESOPENRES.12974.2]; Hrusa G, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0228714; International Centre for Reproductive Health Kenya (ICRHK) and The Bill & Melinda Gates Institute for Population and Reproductive Health at The Johns Hopkins Bloomberg School of Public Health, 2018, PERF MON ACC 2020 PM, DOI [10.34976/p9dy-5h35, DOI 10.34976/P9DY-5H35]; International Centre for Reproductive Health Kenya (ICRHK) and The Bill & Melinda Gates Institute for Population and Reproductive Health at The Johns Hopkins Bloomberg School of Public Health, 2019, PERF MON ACT PMA KEN; International Centre for Reproductive Health Kenya (ICRHK); The Bill & Melinda Gates Institute for Population and Reproductive Health at The Johns Hopkins Bloomberg School of Public Health; and Jhpiego, BILL MEL GAT I POP R, DOI [10.34976/5w8--8512, DOI 10.34976/5W8--8512]; Jacobstein R, 2018, GLOB HEALTH-SCI PRAC, V6, P17, DOI 10.9745/GHSP-D-17-00396; Jain AK., 2018, PROPOSED METRICS MEA; Jain AK, 2016, INT PERSPECT SEX R H, V42, P131, DOI 10.1363/42e1616; Jain Anrudh K, 2013, Int Perspect Sex Reprod Health, V39, P133, DOI 10.1363/3913313; Jain A, 2019, GLOB HEALTH-SCI PRAC, V7, P289, DOI 10.9745/GHSP-D-19-00028; Kenya National Bureau of Statistics Ministry of Health/Kenya National AIDS Control Council/Kenya Kenya Medical Research Institute Population NCf Development/Kenya., 2015, REP KEN KEN DEM HLTH; Lee JK, 2011, J GEN INTERN MED, V26, P731, DOI 10.1007/s11606-011-1647-3; Leisher SH., 2015, QUALITY MEASUREMENT; RamaRao S, 2003, STUD FAMILY PLANN, V34, P227, DOI 10.1111/j.1728-4465.2003.00227.x; RamaRao S, 2015, STUD FAMILY PLANN, V46, P97, DOI 10.1111/j.1728-4465.2015.00017.x; Sprockett A, 2017, HEALTH POLICY PLANN, V32, P292, DOI 10.1093/heapol/czw123; Tefera A.S., 2015, SCI J PUBLIC HLTH, V3, P143, DOI [10.11648/j.sjph.20150301.33, DOI 10.11648/J.SJPH.20150301.33]; Tessema GA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165627; Track, 2020, S CURVE PUTTING MCPR; Tumlinson K, 2015, INT PERSPECT SEX R H, V41, P69, DOI 10.1363/4106915; Tumlinson K, 2015, CONTRACEPTION, V92, P143, DOI 10.1016/j.contraception.2015.04.002; Zimmerman L, 2017, STUD FAMILY PLANN, V48, P293, DOI 10.1111/sifp.12031	32	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2021	16	9							e0256295	10.1371/journal.pone.0256295	http://dx.doi.org/10.1371/journal.pone.0256295			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	XM9EM	34506509	Green Published, gold			2022-12-26	WOS:000729120700026
J	Pan, Y; Zhao, X; Wang, Y; Tan, J; Chen, DX				Pan, Yuan; Zhao, Xiao; Wang, Yu; Tan, Jun; Chen, Da-xia			Metabolomics integrated with transcriptomics reveals the distribution of iridoid and crocin metabolic flux in Gardenia jasminoides Ellis	PLOS ONE			English	Article							IDENTIFICATION; BIOSYNTHESIS; QUANTIFICATION; CONSTITUENTS; ANNOTATION; GENIPOSIDE; GENERATION; SEQUENCE; TISSUES; GENE	Gardenia jasminoides Ellis (G. jasminoides) fruits are used as a resource for obtaining natural colorants and in traditional Chinese herbal medicine. However, G. jasminoides presents a relatively long flowering period and different ripening periods, so there are significant differences in the accumulation of metabolites in fruits of different colors. In addition, the complete metabolic pathways of iridoidsand crocins, which are used as medicinal composition of G. jasminoides, are poorly understood at present. In this research, we comprehensively compared the transcriptome and metabolites profiles of the developmental stages and locations of iridoid and crocin biosynthesis. A large number of differentially expressed genes (DEGs) and differentially accumulated metabolites (DAMs) were detected in four groups of samples, and clear variation in the pattern of metabolite abundance and gene expression were observed among different fruit colors and parts. Geniposide and gardenoside mainly accumulated in the sarcocarp of green fruit (GFS) and the sarcocarp of red fruit (FS), respectively. Crocin mainly accumulated in the peel and sarcocarp of red fruits. In the iridoid pathway, we hypothesized that there was a transport mechanism from the sarcocarp to the peel of G. jasminoides because of the inconsistent expression of G8O, 10-HGO and IS associated with differences in fruit ripening. UGTs play an important role in the biosynthesis of the active components of G. jasminoides. Combined transcriptome and metabonomics analysis showed a negative correlation between the biosynthesis of geniposide and crocin. The redirection of the metabolic flux and the regulation of key enzymes may be the main reasons for the changes in the biosynthesis of iridoid and crocin in G. jasminoides fruit. Our study expended valuable information for functional genomic library and provided new insights for metabolic engineering of secondary metabolite in G. Jasminoides.	[Pan, Yuan; Zhao, Xiao; Wang, Yu; Tan, Jun; Chen, Da-xia] Chongqing Acad Chinese Mat Med, Chongqing, Peoples R China; [Pan, Yuan; Zhao, Xiao; Wang, Yu; Tan, Jun; Chen, Da-xia] Fine Variety Breeding Techn Chinese Mat Med, Chongqing Engn Res Ctr, Chongqing, Peoples R China; [Pan, Yuan; Zhao, Xiao; Wang, Yu; Tan, Jun; Chen, Da-xia] China Acad Chinese Med Sci, Chongqing Subctr Natl Resource Ctr Chinese Materi, Chongqing, Peoples R China	China Academy of Chinese Medical Sciences	Chen, DX (corresponding author), Chongqing Acad Chinese Mat Med, Chongqing, Peoples R China.; Chen, DX (corresponding author), Fine Variety Breeding Techn Chinese Mat Med, Chongqing Engn Res Ctr, Chongqing, Peoples R China.; Chen, DX (corresponding author), China Acad Chinese Med Sci, Chongqing Subctr Natl Resource Ctr Chinese Materi, Chongqing, Peoples R China.	17837@163.com			Natural Science Foundation of Chongqing province of China [cstc2018jcyjAX0553]	Natural Science Foundation of Chongqing province of China(Natural Science Foundation of Chongqing)	This work was supported by Natural Science Foundation of Chongqing province of China, grant number- cstc2018jcyjAX0553 (Yuan Pan).	Ahrazem O, 2010, J EXP BOT, V61, P105, DOI 10.1093/jxb/erp283; Alagna F, 2016, J BIOL CHEM, V291, P5542, DOI 10.1074/jbc.M115.701276; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Buchfink B, 2015, NAT METHODS, V12, P59, DOI 10.1038/nmeth.3176; Burlat V, 2004, PLANT J, V38, P131, DOI 10.1111/j.1365-313X.2004.02030.x; Chen W, 2013, MOL PLANT, V6, P1769, DOI 10.1093/mp/sst080; Chen Y, 2010, FITOTERAPIA, V81, P269, DOI 10.1016/j.fitote.2009.09.011; Debnath T, 2011, FOOD CHEM, V128, P697, DOI 10.1016/j.foodchem.2011.03.090; Finn RD, 2008, NUCLEIC ACIDS RES, V36, pD281, DOI 10.1093/nar/gkm960; Frusciante S, 2014, P NATL ACAD SCI USA, V111, P12246, DOI 10.1073/pnas.1404629111; Gao L, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/686351; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; Hong IK, 2015, J IND ENG CHEM, V24, P326, DOI 10.1016/j.jiec.2014.10.004; Ji AJ, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00518; Khan N, 2019, PLANT CELL ENVIRON, V42, P115, DOI 10.1111/pce.13195; Kuratsune H, 2010, PHYTOMEDICINE, V17, P840, DOI 10.1016/j.phymed.2010.03.025; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Lim H, 2008, BIOMOL THER, V16, P82, DOI 10.4062/biomolther.2008.16.2.082; Liu Y, 2017, SCI REP-UK, V7, DOI 10.1038/srep43108; Loke KK, 2017, PEERJ, V5, DOI 10.7717/peerj.2938; Mao XZ, 2005, BIOINFORMATICS, V21, P3787, DOI 10.1093/bioinformatics/bti430; Nagatoshi M, 2012, FEBS LETT, V586, P1055, DOI 10.1016/j.febslet.2012.03.003; Nagatoshi M, 2011, J BIOL CHEM, V286, P32866, DOI 10.1074/jbc.M111.242586; Nisar N, 2015, MOL PLANT, V8, P68, DOI 10.1016/j.molp.2014.12.007; Pandey A, 2016, SCI REP-UK, V6, DOI 10.1038/srep34464; Rai A, 2017, J NAT MED-TOKYO, V71, P1, DOI 10.1007/s11418-016-1041-x; Salim V, 2013, PLANT J, V76, P754, DOI 10.1111/tpj.12330; Sheu SJ, 1998, HRC-J HIGH RES CHROM, V21, P523, DOI 10.1002/(SICI)1521-4168(19980901)21:9&lt;523::AID-JHRC523&gt;3.0.CO;2-B; Tao WW, 2014, MOLECULES, V19, P19350, DOI 10.3390/molecules191219350; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Vashisht I, 2016, MOL BIOL REP, V43, P1395, DOI 10.1007/s11033-016-4073-0; Wang ZR, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01990; Wu SY, 2009, ACTA PHARMACOL SIN, V30, P202, DOI 10.1038/aps.2008.17; Xiao WP, 2017, J FOOD DRUG ANAL, V25, P43, DOI 10.1016/j.jfda.2016.11.005; Xu HB, 2016, MOL PLANT, V9, P949, DOI 10.1016/j.molp.2016.03.010; Xu JD, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21134797; Xu ZC, 2016, CHIN HERB MED, V8, P3, DOI 10.1016/S1674-6384(16)60002-3; Xu ZC, 2020, BMC BIOL, V18, DOI 10.1186/s12915-020-00795-3; Xu ZC, 2016, FRONT PLANT SCI, V7, DOI [10.3389/fpla.2016.00100, 10.3389/fpls.2016.00100]; Xu ZC, 2015, PLANT J, V82, P951, DOI 10.1111/tpj.12865; Ye P, 2019, IND CROP PROD, V132, P48, DOI 10.1016/j.indcrop.2019.02.002; Yuan HJ, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/9415409; Zhang Z, 2020, BMC PLANT BIOL, V20, DOI 10.1186/s12870-020-02344-0; Zhou YY, 2015, IND CROP PROD, V64, P224, DOI 10.1016/j.indcrop.2014.09.041; Zhu GT, 2018, CELL, V172, P249, DOI 10.1016/j.cell.2017.12.019; Zou K, 2019, FRONT PLANT SCI, V10, DOI 10.3389/fpls.2019.00983	48	6	6	8	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2021	16	9							e0256802	10.1371/journal.pone.0256802	http://dx.doi.org/10.1371/journal.pone.0256802			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XM9EM	34506519	Green Published, gold			2022-12-26	WOS:000729120700105
J	Wellek, S				Wellek, Stefan			Testing for goodness rather than lack of fit of continuous probability distributions	PLOS ONE			English	Article							REGRESSION-MODELS	The vast majority of testing procedures presented in the literature as goodness-of-fit tests fail to accomplish what the term is promising. Actually, a significant result of such a test indicates that the true distribution underlying the data differs substantially from the assumed model, whereas the true objective is usually to establish that the model fits the data sufficiently well. Meeting that objective requires to carry out a testing procedure for a problem in which the statement that the deviations between model and true distribution are small, plays the role of the alternative hypothesis. Testing procedures of this kind, for which the term tests for equivalence has been coined in statistical usage, are available for establishing goodness-of-fit of discrete distributions. We show how this methodology can be extended to settings where interest is in establishing goodness-of-fit of distributions of the continuous type.	[Wellek, Stefan] Heidelberg Univ, CIMH Mannheim, Mannheim Med Sch, Dept Biostat, Mannheim, Germany; [Wellek, Stefan] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Med Biostat Epidemiol & Informat, Mainz, Germany	Central Institute of Mental Health; Ruprecht Karls University Heidelberg; Johannes Gutenberg University of Mainz	Wellek, S (corresponding author), Heidelberg Univ, CIMH Mannheim, Mannheim Med Sch, Dept Biostat, Mannheim, Germany.; Wellek, S (corresponding author), Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Med Biostat Epidemiol & Informat, Mainz, Germany.	stefan.wellek@zi-mannheim.de		Wellek, Stefan/0000-0001-8369-8122				[Anonymous], 2010, TESTING STAT HYPOTHE, DOI DOI 10.1201/EBK1439808184; BERGER RL, 1982, TECHNOMETRICS, V24, P295, DOI 10.2307/1267823; CHRISTENSEN R, 1989, ANN STAT, V17, P673, DOI 10.1214/aos/1176347133; COX DR, 1972, J R STAT SOC B, V34, P187; Cramer H., 1946, MATH METHODS STAT; DasGupta A, 2008, SPRINGER TEXTS STAT, P1; Freedman DA, 2007, AM STAT, V61, P291, DOI 10.1198/000313007X243061; Kendall MG., 1999, CLASSICAL INFERENCE, V2A; LEHMANN E. L., 2005, TESTING STAT HYPOTHE; Lehmann E.L., 2006, TESTING STAT HYPOTHE, V3rd ed; LEHMANN EL, 1953, ANN MATH STAT, V24, P23, DOI 10.1214/aoms/1177729080; Lehmann EL, 1959, TESTING STAT HYPOTHE; Miller FR, 2016, J MULTIVARIATE ANAL, V150, P14, DOI 10.1016/j.jmva.2016.05.005; NEILL JW, 1984, COMMUN STAT-THEOR M, V13, P485, DOI 10.1080/03610928408828696; WELLEK S, 1993, BIOMETRICS, V49, P877, DOI 10.2307/2532208	16	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2021	16	9							e0256499	10.1371/journal.pone.0256499	http://dx.doi.org/10.1371/journal.pone.0256499			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XM9EM	34506518	Green Published, gold			2022-12-26	WOS:000729120700080
J	Caffrey, B; Zhu, X; Berezuk, A; Tuttle, K; Chittori, S; Subramaniam, S				Caffrey, Brian; Zhu, Xing; Berezuk, Alison; Tuttle, Katharine; Chittori, Sagar; Subramaniam, Sriram			AAA+ ATPase p97/VCP mutants and inhibitor binding disrupt inter-domain coupling and subsequent allosteric activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYO-EM STRUCTURE; FRONTOTEMPORAL DEMENTIA; P97; DISEASE; MUTATIONS; CONFORMATION; MECHANISM; VCP	The human AAA+ ATPase p97, also known as valosin-containing protein, a potential target for cancer therapeutics,plays a vital role in the clearing of misfolded proteins. p97 dysfunction is also known to play a crucial role in severalneurodegenerative disorders, such as MultiSystem Proteinop-athy 1 (MSP-1) and Familial Amyotrophic Lateral Sclerosis(ALS). However, the structural basis of its role in such diseasesremains elusive. Here, we present cryo-EM structural analysesof four disease mutants p97(R155H), p97(R191Q), p97(A232E), p97(D592N),as well as p97(E470D), implicated in resistance to the drug CB-5083, a potent p97 inhibitor. Our cryo-EM structuresdemonstrate that these mutations affect nucleotide-drivenallosteric activation across the three principal p97 domains(N, D1, and D2) by predominantly interfering with either (1)the coupling between the D1 and N-terminal domains(p97(R155H) and p97(R191Q)), (2) the interprotomer interactions(p97(A232E)), or (3) the coupling between D1 and D2 nucleotidedomains (p97(D592N), p97(E470D)). We also show that binding ofthe competitive inhibitor, CB-5083, to the D2 domain preventsconformational changes similar to those seen for mutationsthat affect coupling between the D1 and D2 domains. Ourstudies enable tracing of the path of allosteric activation acrossp 97 and establish a common mechanistic link between activesite inhibition and defects in allosteric activation by disease-causing mutations and have potential implications for thedesign of novel allosteric compounds that can modulate p97 function.	[Caffrey, Brian; Zhu, Xing; Berezuk, Alison; Tuttle, Katharine; Chittori, Sagar; Subramaniam, Sriram] Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC, Canada	University of British Columbia	Subramaniam, S (corresponding author), Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC, Canada.	sriram.subramaniam@ubc.ca	Chittori, Sagar/B-9412-2009; Tuttle, Katharine/HDN-7517-2022; Caffrey, Brian/AAC-9169-2019	Chittori, Sagar/0000-0003-1417-6552; Caffrey, Brian/0000-0001-5040-4247; Zhu, Xing/0000-0003-4839-4857; Tuttle, Katharine Susanne/0000-0002-9788-1830	Canada Excellence Research Chair Award; Canadian Foundation for Innovation; VGH Foundation	Canada Excellence Research Chair Award; Canadian Foundation for Innovation(Canada Foundation for Innovation); VGH Foundation	This work was supported by grants to S. S. from a Canada Excellence Research Chair Award, the Canadian Foundation for Innovation, and the VGH Foundation. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Anderson DJ, 2015, CANCER CELL, V28, P653, DOI 10.1016/j.ccell.2015.10.002; Arita M, 2012, J VIROL, V86, P5541, DOI 10.1128/JVI.00114-12; Banerjee S, 2016, SCIENCE, V351, P871, DOI 10.1126/science.aad7974; Barthelme D, 2015, PROTEIN SCI, V24, P1521, DOI 10.1002/pro.2740; Bastola P, 2017, CELL DEATH DISCOV, V3, DOI 10.1038/cddiscovery.2017.65; Blythe EE, 2019, STRUCTURE, V27, P1820, DOI 10.1016/j.str.2019.09.011; Blythe EE, 2017, P NATL ACAD SCI USA, V114, pE4380, DOI 10.1073/pnas.1706205114; Bulfer SL, 2016, ACS CHEM BIOL, V11, P2112, DOI 10.1021/acschembio.6b00350; Cooney I, 2019, SCIENCE, V365, P502, DOI 10.1126/science.aax0486; Deshaies RJ, 2014, BMC BIOL, V12, DOI 10.1186/s12915-014-0094-0; Erzberger JP, 2006, ANNU REV BIOPH BIOM, V35, P93, DOI 10.1146/annurev.biophys.35.040405.101933; Hanzelmann P, 2017, FRONT MOL BIOSCI, V4, DOI 10.3389/fmolb.2017.00021; Huryn DM, 2020, J MED CHEM, V63, P1892, DOI 10.1021/acs.jmedchem.9b01318; Johnson JO, 2010, NEURON, V68, P857, DOI 10.1016/j.neuron.2010.11.036; Li GT, 2012, P NATL ACAD SCI USA, V109, P3737, DOI 10.1073/pnas.1200255109; Liebschner D, 2019, ACTA CRYSTALLOGR D, V75, P861, DOI 10.1107/S2059798319011471; Mills JEJ, 1996, J COMPUT AID MOL DES, V10, P607, DOI 10.1007/BF00134183; Muller JMM, 2007, BIOCHEM BIOPH RES CO, V354, P459, DOI 10.1016/j.bbrc.2006.12.206; Niwa H, 2012, J BIOL CHEM, V287, P8561, DOI 10.1074/jbc.M111.302778; Pan M, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-020-20359-x; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pettersen EF, 2021, PROTEIN SCI, V30, P70, DOI 10.1002/pro.3943; Punjani A, 2017, NAT METHODS, V14, P290, DOI [10.1038/nmeth.4169, 10.1038/NMETH.4169]; Rose R, 2019, BIOINFORMATICS, V35, P1963, DOI 10.1093/bioinformatics/bty901; Rosenthal PB, 2003, J MOL BIOL, V333, P721, DOI 10.1016/j.jmb.2003.07.013; Roux B, 2021, SCI TRANSL MED, V13, DOI 10.1126/scitranslmed.abg1168; Schuetz AK, 2016, ELIFE, V5, DOI 10.7554/eLife.20143; Shi ZH, 2016, J HUM GENET, V61, P1003, DOI 10.1038/jhg.2016.92; Song CC, 2003, J BIOL CHEM, V278, P3648, DOI 10.1074/jbc.M208422200; Stach L, 2017, BIOCHEM J, V474, P2953, DOI 10.1042/BCJ20160783; Tang WK, 2019, MOL PHARMACOL, V95, P286, DOI 10.1124/mol.118.114256; Tang WK, 2013, J BIOL CHEM, V288, P36624, DOI 10.1074/jbc.M113.488924; Tang WK, 2010, EMBO J, V29, P2217, DOI 10.1038/emboj.2010.104; Twomey EC, 2019, SCIENCE, V365, P462, DOI 10.1126/science.aax1033; Watts GDJ, 2004, NAT GENET, V36, P377, DOI 10.1038/ng1332; Zhang XY, 2015, P NATL ACAD SCI USA, V112, pE1705, DOI 10.1073/pnas.1418820112; Zhou HJ, 2015, J MED CHEM, V58, P9480, DOI 10.1021/acs.jmedchem.5b01346	37	3	3	1	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT	2021	297	4							101187	10.1016/j.jbc.2021.101187	http://dx.doi.org/10.1016/j.jbc.2021.101187			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	WP4BY	34520757	gold, Green Published			2022-12-26	WOS:000713080600005
J	Chrobok, L; Jeczmien-Lazur, JS; Bubka, M; Pradel, K; Klekocinska, A; Klich, JD; Rahim, AR; Myung, J; Kepczynski, M; Lewandowski, MH				Chrobok, Lukasz; Jeczmien-Lazur, Jagoda Stanislawa; Bubka, Monika; Pradel, Kamil; Klekocinska, Aleksandra; Klich, Jasmin Daniela; Rahim, Amalia Ridla; Myung, Jihwan; Kepczynski, Mariusz; Lewandowski, Marian Henryk			Daily coordination of orexinergic gating in the rat superior colliculus-Implications for intrinsic clock activities in the visual system	FASEB JOURNAL			English	Article						circadian clock; multi-electrode array; orexin; superior colliculus; visual system	PROTEIN-COUPLED RECEPTORS; INTERGENICULATE LEAFLET; CIRCADIAN OSCILLATORS; HYPOCRETIN-OREXIN; NUCLEUS; NEURONS; IMMUNOREACTIVITY; BRAIN; TIME; HALLUCINATIONS	The orexinergic system delivers excitation for multiple brain centers to facilitate behavioral arousal, with its malfunction resulting in narcolepsy, somnolence, and notably, visual hallucinations. Since the circadian clock underlies the daily arousal, a timed coordination is expected between the orexin system and its target subcortical visual system, including the superior colliculus (SC). Here, we use a combination of electrophysiological, immunohistochemical, and molecular approaches across 24 h, together with the neuronal tract-tracing methods to investigate the daily coordination between the orexin system and the rodent SC. Higher orexinergic input was found to occur nocturnally in the superficial layers of the SC, in time for nocturnal silencing of spontaneous firing in this visual brain area. We identify autonomous daily and circadian expression of clock genes in the SC, which may underlie these day-night changes. Additionally, we establish the lateral hypothalamic origin of the orexin innervation to the SC and that the SC neurons robustly respond to orexin A via OX2 receptor in both excitatory and GABA(A) receptor-dependent inhibitory manners. Together, our evidence elucidates the combination of intrinsic and extrinsic clock mechanisms that shape the daily function of the visual layers of the SC.	[Chrobok, Lukasz; Jeczmien-Lazur, Jagoda Stanislawa; Pradel, Kamil; Klekocinska, Aleksandra; Klich, Jasmin Daniela; Lewandowski, Marian Henryk] Jagiellonian Univ Krakow, Inst Zool & Biomed Res, Dept Neurophysiol & Chronobiol, Gronostajowa St 9, PL-30387 Krakow, Poland; [Bubka, Monika] Jagiellonian Univ Krakow, Inst Zool & Biomed Res, Dept Glycoconjugate Biochem, Krakow, Poland; [Rahim, Amalia Ridla; Myung, Jihwan] Taipei Med Univ, Grad Inst Mind Brain & Consciousness, Taipei, Taiwan; [Myung, Jihwan] Taipei Med Univ, Brain & Consciousness Res Ctr, Shuang Ho Hosp, Minist Hlth & Welf, New Taipei, Taiwan; [Kepczynski, Mariusz] Jagiellonian Univ Krakow, Fac Chem, Dept Phys Chem & Electrochem, Krakow, Poland	Jagiellonian University; Jagiellonian University; Taipei Medical University; Taipei Medical University; Shuang Ho Hospital; Jagiellonian University	Chrobok, L; Lewandowski, MH (corresponding author), Jagiellonian Univ Krakow, Inst Zool & Biomed Res, Dept Neurophysiol & Chronobiol, Gronostajowa St 9, PL-30387 Krakow, Poland.	lukasz.chrobok@uj.edu.pl; marian.lewandowski@uj.edu.pl	Myung, Jihwan/D-2048-2013	Myung, Jihwan/0000-0002-2529-8013; Jeczmien-Lazur, Jagoda/0000-0002-3103-2887; Klich, Jasmin/0000-0003-2951-3582; Kepczynski, Mariusz/0000-0002-7304-6881	Polish National Science Centre [2018/28/C/NZ4/00099, 2017/27/N/NZ4/00785]; "Etiuda 8" doctoral scholarship [2020/36/T/NZ4/00341]; European Regional Development Fund [POIG.02.01.00-12-023/08]; Taiwan Ministry of Science and Technology [109-2320-B-038-020, 109-2314-B-038-071, 109-2314-B-038-106-MY3, 108-2321-B-006-023-MY2, 107-2410-H-038-004-MY2]; Taiwan Ministry of Education [DP2-109-21121-01-N-01, DP2-110-21121-01-N-01]; Taipei Medical University [TMU-107-AE1-B15, 107-3805-003-110, 107TMU-SHH-03]; Priority Research Area BioS under the program "Excellence Initiative-Research University" at the Jagiellonian University in Krakow	Polish National Science Centre; "Etiuda 8" doctoral scholarship; European Regional Development Fund(European Commission); Taiwan Ministry of Science and Technology; Taiwan Ministry of Education(Ministry of Education, Taiwan); Taipei Medical University; Priority Research Area BioS under the program "Excellence Initiative-Research University" at the Jagiellonian University in Krakow	This work was financially supported by a project "Sonatina 2" 2018/28/C/NZ4/00099 given to LC and "Preludium 14" 2017/27/N/NZ4/00785 to KP from the Polish National Science Centre. KP was additionally supported by "Etiuda 8" doctoral scholarship 2020/36/T/NZ4/00341. The research was carried out using equipment purchased through financial support from the European Regional Development Fund in the framework of the Polish Innovation Economy Operational Program (contract No. POIG.02.01.00-12-023/08). JM was supported by the Taiwan Ministry of Science and Technology (109-2320-B-038-020, 109-2314-B-038-071, 109-2314-B-038-106-MY3, 108-2321-B-006-023-MY2, 107-2410-H-038-004-MY2), the Higher Education Sprout Project by the Taiwan Ministry of Education (DP2-109-21121-01-N-01, DP2-110-21121-01-N-01), and Taipei Medical University (TMU-107-AE1-B15, 107-3805-003-110, 107TMU-SHH-03). The open-access publication of this article was funded by the Priority Research Area BioS under the program "Excellence Initiative-Research University" at the Jagiellonian University in Krakow.	Azeez IA, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.01061; Bano-Otalora B, 2017, PHARMACOL BIOCHEM BE, V162, P46, DOI 10.1016/j.pbb.2017.06.007; Bayer L, 2004, J NEUROSCI, V24, P6760, DOI 10.1523/JNEUROSCI.1783-04.2004; Bayer L, 2002, J NEUROSCI, V22, P7835; Begemann K, 2020, ACTA PHYSIOL, V229, DOI 10.1111/apha.13446; Belle MDC, 2021, METHODS MOL BIOL, V2130, P263, DOI 10.1007/978-1-0716-0381-9_20; Belle MDC, 2018, EUR J NEUROSCI, V48, P2696, DOI 10.1111/ejn.13856; Belle MDC, 2017, EUR J NEUROSCI, V45, P723, DOI 10.1111/ejn.13506; Belle MDC, 2014, J NEUROSCI, V34, P3607, DOI 10.1523/JNEUROSCI.3388-13.2014; Cang JH, 2018, ANNU REV VIS SCI, V4, P239, DOI 10.1146/annurev-vision-091517-034142; Ch'ng SS, 2015, J CHEM NEUROANAT, V66-67, P1, DOI 10.1016/j.jchemneu.2015.03.002; Challet E, 2015, DIABETES OBES METAB, V17, P76, DOI 10.1111/dom.12516; Challet E, 2019, NAT REV ENDOCRINOL, V15, P393, DOI 10.1038/s41574-019-0210-x; Chrobok L, 2021, BRAIN RES, V1768, DOI 10.1016/j.brainres.2021.147603; Chrobok L, 2021, J PHYSIOL-LONDON, V599, P231, DOI 10.1113/JP280275; Chrobok L, 2020, COMMUN BIOL, V3, DOI 10.1038/s42003-020-0960-y; Chrobok L, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08202-8; Chrobok L, 2016, NEUROPHARMACOLOGY, V103, P236, DOI 10.1016/j.neuropharm.2015.12.008; Cluderay JE, 2002, REGUL PEPTIDES, V104, P131, DOI 10.1016/S0167-0115(01)00357-3; Cutler DJ, 1999, PEPTIDES, V20, P1455, DOI 10.1016/S0196-9781(99)00157-6; De Lecea L, 1998, P NATL ACAD SCI USA, V95, P322, DOI 10.1073/pnas.95.1.322; Deboer T, 2004, NEUROSCIENCE, V129, P727, DOI 10.1016/j.neuroscience.2004.07.049; Erskine D, 2017, AM J GERIAT PSYCHIAT, V25, P595, DOI 10.1016/j.jagp.2017.01.005; Gandhi NJ, 2011, ANNU REV NEUROSCI, V34, P205, DOI 10.1146/annurev-neuro-061010-113728; Guilding C, 2010, NEUROSCIENCE, V169, P1630, DOI 10.1016/j.neuroscience.2010.06.015; Guilding C, 2007, EUR J NEUROSCI, V25, P3195, DOI 10.1111/j.1460-9568.2007.05581.x; Guilding C, 2009, MOL BRAIN, V2, DOI 10.1186/1756-6606-2-28; Han Y, 2020, NEUROSCI BULL, V36, P432, DOI 10.1007/s12264-019-00447-9; Ito S, 2018, FRONT NEURAL CIRCUIT, V12, DOI 10.3389/fncir.2018.00010; Iyer R, 2014, FRONT SYST NEUROSCI, V8, DOI 10.3389/fnsys.2014.00164; Klisch C, 2009, EUR J NEUROSCI, V30, P65, DOI 10.1111/j.1460-9568.2009.06794.x; Krauzlis RJ, 2013, ANNU REV NEUROSCI, V36, P165, DOI 10.1146/annurev-neuro-062012-170249; Kukkonen JP, 2017, CURR TOP BEHAV NEURO, V33, P17, DOI 10.1007/7854_2016_49; Li SB, 2020, NEUROPHARMACOLOGY, V167, DOI 10.1016/j.neuropharm.2020.107993; Marcus JN, 2001, J COMP NEUROL, V435, P6, DOI 10.1002/cne.1190; Marston OJ, 2008, MOL BRAIN, V1, DOI 10.1186/1756-6606-1-19; Masullo L, 2019, CURR BIOL, V29, P2892, DOI 10.1016/j.cub.2019.07.083; May PJ, 2006, PROG BRAIN RES, V151, P321, DOI 10.1016/S0079-6123(05)51011-2; McGranaghan PA, 2001, BRAIN RES, V904, P234, DOI 10.1016/S0006-8993(01)02463-5; Mei L, 2018, P NATL ACAD SCI USA, V115, P4276, DOI 10.1073/pnas.1717735115; Meredith MA, 1998, J NEUROPHYSIOL, V79, P1597, DOI 10.1152/jn.1998.79.3.1597; Muehlan C, 2020, EXPERT OPIN DRUG MET, V16, P1063, DOI 10.1080/17425255.2020.1817380; Myung J, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03507-2; Myung J, 2012, J NEUROSCI, V32, P8900, DOI 10.1523/JNEUROSCI.5586-11.2012; Northeast RC, 2020, FASEB J, V34, P974, DOI 10.1096/fj.201901111R; Orlowska-Feuer P, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-53012-9; Pachitariu M., 2016, BIORXIV, DOI [10.1101/061481, DOI 10.1101/061481]; Palus K, 2015, NEUROSCIENCE, V300, P370, DOI 10.1016/j.neuroscience.2015.05.039; Palus-Chramiec K, 2019, EUR J NEUROSCI, V50, P2683, DOI 10.1111/ejn.14394; Paul JR, 2020, EUR J NEUROSCI, V51, P109, DOI 10.1111/ejn.14343; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Pekala D, 2011, EUR J NEUROSCI, V34, P1406, DOI 10.1111/j.1460-9568.2011.07868.x; Peyron C, 1998, J NEUROSCI, V18, P9996; Qiao SN, 2017, INVEST OPHTH VIS SCI, V58, P4712, DOI 10.1167/iovs.17-21835; Sakurai T, 1998, CELL, V92, P573, DOI 10.1016/S0092-8674(00)80949-6; Shine JM, 2014, PROG NEUROBIOL, V116, P58, DOI 10.1016/j.pneurobio.2014.01.004; Taheri S, 1999, FEBS LETT, V457, P157, DOI 10.1016/S0014-5793(99)01030-3; Taheri S, 2000, NEUROSCI LETT, V279, P109, DOI 10.1016/S0304-3940(99)00955-6; Takahashi JS, 2017, NAT REV GENET, V18, P164, DOI 10.1038/nrg.2016.150; Thompson MD, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00057; van den Pol AN, 2012, NEURON, V76, P98, DOI 10.1016/j.neuron.2012.09.014; Webb IC, 2008, EUR J NEUROSCI, V27, P828, DOI 10.1111/j.1460-9568.2008.06074.x; Webb IC, 2014, BEHAV NEUROSCI, V128, P304, DOI 10.1037/a0035885; Whyland KL, 2020, J COMP NEUROL, V528, P308, DOI 10.1002/cne.24754; Xu YL, 2004, EUR J PHARMACOL, V500, P243, DOI 10.1016/j.ejphar.2004.07.029; Yoo SH, 2004, P NATL ACAD SCI USA, V101, P5339, DOI 10.1073/pnas.0308709101; Zeitzer JM, 2003, J NEUROSCI, V23, P3555; Zhang G, 2018, NEUROPHARMACOLOGY, V133, P38, DOI 10.1016/j.neuropharm.2018.01.007; Zhang SW, 2004, SLEEP, V27, P619, DOI 10.1093/sleep/27.4.619	69	5	5	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2021	35	10							e21930	10.1096/fj.202100779RR	http://dx.doi.org/10.1096/fj.202100779RR			19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	UZ5IH	34533886	Green Published			2022-12-26	WOS:000702238200078
J	Jana, S; Aujla, P; Hu, M; Kilic, T; Zhabyeyev, P; McCulloch, CA; Oudit, GY; Kassiri, Z				Jana, Sayantan; Aujla, Preetinder; Hu, Mei; Kilic, Tolga; Zhabyeyev, Pavel; McCulloch, Christopher A.; Oudit, Gavin Y.; Kassiri, Zamaneh			Gelsolin is an important mediator of Angiotensin II-induced activation of cardiac fibroblasts and fibrosis	FASEB JOURNAL			English	Article						AMPK; fibroblast; fibrosis; gelsolin	MYOCARDIAL-INFARCTION; AMPK; TARGET; INJURY; PHOSPHORYLATION; HYPERTROPHY; EXPRESSION; PATHOLOGY; FAILURE; TIMP3	Myocardial fibrosis is a characteristic of various cardiomyopathies, and myocardial fibroblasts play a central role in this process. Gelsolin (GSN) is an actin severing and capping protein that regulates actin assembly and may be involved in fibroblast activation. While the role of GSN in mechanical stress-mediated cardiac fibrosis has been explored, its role in myocardial fibrosis in the absence of mechanical stress is not defined. In this study, we investigated the role of GSN in myocardial fibrosis induced by Angiotensin II (Ang II), a profibrotic hormone that is elevated in cardiovascular disease. We utilized mice lacking GSN (Gsn(-/-)) and cultured primary adult cardiac fibroblasts (cFB). In vivo, Ang II infusion in mice resulted in significantly less severe myocardial fibrosis in Gsn(-/-) compared with Gsn(+/+) mice, along with diminished activation of the TGF beta 1-Smad2/3 pathway, and reduced expression of cardiac extracellular matrix proteins (collagen, fibronectin, periostin). Moreover, Gsn-deficient hearts exhibited suppressed activity of the AMPK pathway and its downstream effectors, mTOR and P70S6Kinase, which could contribute to the suppressed TGF beta 1 activity. In vitro, the Ang II-induced activation of cFBs was reduced in Gsn-deficient fibroblasts evident from decreased expression of alpha SMA and periostin, diminished actin filament turnover; which also exhibited reduced activity of the AMPK-mTOR pathway, and P70S6K phosphorylation. AMPK inhibition compensated for the loss of GSN, restored the levels of G-actin in Gsn(-/-) cFBs and promoted activation to myofibroblasts by increasing alpha SMA and periostin levels. This study reveals a novel role for GSN in mediating myocardial fibrosis by regulating the AMPK-mTOR-P70S6K pathway in cFB activation independent from mechanical stress-induced factors.	[Jana, Sayantan; Aujla, Preetinder; Hu, Mei; Kilic, Tolga; Zhabyeyev, Pavel; Oudit, Gavin Y.; Kassiri, Zamaneh] Univ Alberta, Cardiovasc Res Ctr, Dept Physiol, Edmonton, AB T6G 2S2, Canada; [Zhabyeyev, Pavel; Oudit, Gavin Y.] Univ Alberta, Cardiovasc Res Ctr, Mazankowski Alberta Heart Inst, Dept Med,Div Cardiol, Edmonton, AB, Canada; [McCulloch, Christopher A.] Univ Toronto, Fac Med & Dent, Toronto, ON, Canada	University of Alberta; University of Alberta; University of Toronto	Kassiri, Z (corresponding author), Univ Alberta, Cardiovasc Res Ctr, Dept Physiol, Edmonton, AB T6G 2S2, Canada.	z.kassiri@ualberta.ca		JANA, SAYANTAN/0000-0003-2855-1560	Canadian Institute for Health Research [CIHR-PJ-153328, CIHR-PJ-156266]	Canadian Institute for Health Research(Canadian Institutes of Health Research (CIHR))	Canadian Institute for Health Research, Grant/Award Number: CIHR-PJ-153328 and CIHR-PJ-156266	Acosta-Jaquez HA, 2009, MOL CELL BIOL, V29, P4308, DOI 10.1128/MCB.01665-08; Angliker Nico, 2013, Bioarchitecture, V3, P113, DOI 10.4161/bioa.26497; Arora PD, 1996, J BIOL CHEM, V271, P20516, DOI 10.1074/jbc.271.34.20516; Beauloye C, 2011, CARDIOVASC RES, V90, P224, DOI 10.1093/cvr/cvr034; Becker PM, 2003, AM J RESP CELL MOL, V28, P478, DOI 10.1165/rcmb.2002-0024OC; Biernacka A, 2011, GROWTH FACTORS, V29, P196, DOI 10.3109/08977194.2011.595714; Burtnick L D, 2001, Results Probl Cell Differ, V32, P201; Chan MWC, 2009, J CELL SCI, V122, P2769, DOI 10.1242/jcs.044008; Chen CC, 2017, ONCOTARGET, V8, P77152, DOI 10.18632/oncotarget.20414; Copp J, 2009, CANCER RES, V69, P1821, DOI 10.1158/0008-5472.CAN-08-3014; CUNNINGHAM CC, 1991, SCIENCE, V251, P1233, DOI 10.1126/science.1848726; Daskalopoulos EP, 2016, J MOL CELL CARDIOL, V91, P188, DOI 10.1016/j.yjmcc.2016.01.001; Dyck JRB, 2006, J PHYSIOL-LONDON, V574, P95, DOI 10.1113/jphysiol.2006.109389; Fan D, 2014, CARDIOVASC RES, V103, P268, DOI 10.1093/cvr/cvu072; Gelinas R, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02795-4; Han CS, 2013, EXP BIOL MED, V238, P1318, DOI 10.1177/1535370213503256; Harada H, 2001, P NATL ACAD SCI USA, V98, P9666, DOI 10.1073/pnas.171301998; Jana S, 2020, ARTERIOSCL THROM VAS, V40, P1918, DOI 10.1161/ATVBAHA.120.314600; Jana S, 2018, J AM HEART ASSOC, V7, DOI 10.1161/JAHA.118.010427; JANMEY PA, 1987, NATURE, V325, P362, DOI 10.1038/325362a0; Kandalam V, 2010, CIRC RES, V106, P796, DOI 10.1161/CIRCRESAHA.109.209189; Kim SW, 2019, INVEST OPHTH VIS SCI, V60, P82, DOI 10.1167/iovs.18-25376; Kiuru-Enari S, 2013, HAND CLINIC, V115, P659, DOI 10.1016/B978-0-444-52902-2.00039-4; Kothakota S, 1997, SCIENCE, V278, P294, DOI 10.1126/science.278.5336.294; Kusano H, 2000, ONCOGENE, V19, P4807, DOI 10.1038/sj.onc.1203868; Lader AS, 1999, AM J PHYSIOL-CELL PH, V277, pC1277, DOI 10.1152/ajpcell.1999.277.6.C1277; Leifeld L, 2006, AM J PATHOL, V168, P778, DOI 10.2353/ajpath.2006.050323; Li GH, 2009, CIRC RES, V104, P896, DOI 10.1161/CIRCRESAHA.108.172882; Li JZ, 2015, KIDNEY INT, V88, P515, DOI 10.1038/ki.2015.119; Li X, 2019, BIOSCIENCE REP, V39, DOI 10.1042/BSR20181767; Li Y, 2014, ARCH BIOCHEM BIOPHYS, V558, P79, DOI 10.1016/j.abb.2014.06.023; Moon S, 2014, SCI REP-UK, V4, DOI 10.1038/srep04376; O'Connell Timothy D, 2007, Methods Mol Biol, V357, P271; Oikonomou N, 2009, THORAX, V64, P467, DOI 10.1136/thx.2008.107946; Opie LH, 2001, CIRC RES, V88, P654, DOI 10.1161/hh0701.089175; Patel VB, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07812-8; Rettinger CL, 2018, J OCUL PHARMACOL TH, V34, P521, DOI 10.1089/jop.2018.0021; Schrickel JW, 2009, J INTERV CARD ELECTR, V26, P3, DOI 10.1007/s10840-009-9425-4; Shen MC, 2015, ARTERIOSCL THROM VAS, V35, P888, DOI 10.1161/ATVBAHA.114.305115; Solomon JP, 2012, CRIT REV BIOCHEM MOL, V47, P282, DOI 10.3109/10409238.2012.661401; STRONGIN AY, 1995, J BIOL CHEM, V270, P5331, DOI 10.1074/jbc.270.10.5331; Takawale A, 2017, AM J PHYSIOL-HEART C, V313, pH224, DOI 10.1152/ajpheart.00108.2017; Tomasek JJ, 2002, NAT REV MOL CELL BIO, V3, P349, DOI 10.1038/nrm809; Wang DJ, 2004, J BIOL CHEM, V279, P43725, DOI 10.1074/jbc.M407368200; Whyte M, 2009, THORAX, V64, P461, DOI 10.1136/thx.2008.110577; WITKE W, 1995, CELL, V81, P41, DOI 10.1016/0092-8674(95)90369-0; Zhang L, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18020390	47	3	3	2	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2021	35	10							e21932	10.1096/fj.202100038RR	http://dx.doi.org/10.1096/fj.202100038RR			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	UZ5IH	34549830				2022-12-26	WOS:000702238200075
J	Kern, P; Balzer, NR; Blank, N; Cygon, C; Wunderling, K; Bender, F; Frolov, A; Sowa, JP; Bonaguro, L; Ulas, T; Homrich, M; Kiermaier, E; Thiele, C; Schultze, JL; Canbay, A; Bauer, R; Mass, E				Kern, Paul; Balzer, Nora R.; Blank, Nelli; Cygon, Cornelia; Wunderling, Klaus; Bender, Franziska; Frolov, Alex; Sowa, Jan-Peter; Bonaguro, Lorenzo; Ulas, Thomas; Homrich, Mirka; Kiermaier, Eva; Thiele, Christoph; Schultze, Joachim L.; Canbay, Ali; Bauer, Reinhard; Mass, Elvira			Creld2 function during unfolded protein response is essential for liver metabolism homeostasis	FASEB JOURNAL			English	Article						Creld2; ER stress; liver steatosis; NASH; UPR	ENDOPLASMIC-RETICULUM STRESS; HIGH-FAT DIET; ER STRESS; HEPATIC STEATOSIS; LIPID-METABOLISM; INSULIN-RESISTANCE; GLUCOSE; ACTIVATION; DISEASE; MICE	The unfolded protein response (UPR) is associated with hepatic metabolic function, yet it is not well understood how endoplasmic reticulum (ER) disturbance might influence metabolic homeostasis. Here, we describe the physiological function of Cysteine-rich with EGF-like domains 2 (Creld2), previously characterized as a downstream target of the ER-stress signal transducer Atf6. To this end, we generated Creld2-deficient mice and induced UPR by injection of tunicamycin. Creld2 augments protein folding and creates an interlink between the UPR axes through its interaction with proteins involved in the cellular stress response. Thereby, Creld2 promotes tolerance to ER stress and recovery from acute stress. Creld2-deficiency leads to a dysregulated UPR and causes the development of hepatic steatosis during ER stress conditions. Moreover, Creld2-dependent enhancement of the UPR assists in the regulation of energy expenditure. Furthermore, we observed a sex dimorphism in human and mouse livers with only male patients showing an accumulation of CRELD2 protein during the progression from non-alcoholic fatty liver disease to non-alcoholic steatohepatitis and only male Creld2-deficient mice developing hepatic steatosis upon aging. These results reveal a Creld2 function at the intersection between UPR and metabolic homeostasis and suggest a mechanism in which chronic ER stress underlies fatty liver disease in males.	[Kern, Paul; Balzer, Nora R.; Blank, Nelli; Cygon, Cornelia; Frolov, Alex; Mass, Elvira] Univ Bonn, Life & Med Sci LIMES Inst, Dev Biol Immune Syst, D-53115 Bonn, Germany; [Kern, Paul; Bender, Franziska; Bauer, Reinhard] Univ Bonn, Life & Med Sci LIMES Inst, Dev Genet & Mol Physiol, Bonn, Germany; [Wunderling, Klaus; Thiele, Christoph] Univ Bonn, Life & Med Sci LIMES Inst, Biochem & Cell Biol Lipids, Bonn, Germany; [Sowa, Jan-Peter; Canbay, Ali] Univ Hosp Magdeburg, Dept Gastroenterol Hepatol & Infect Dis, Magdeburg, Germany; [Sowa, Jan-Peter; Canbay, Ali] Ruhr Univ Bochum, Univ Hosp Knappschaftskrankenhaus Bochum, Dept Med, Bochum, Germany; [Bonaguro, Lorenzo; Ulas, Thomas; Schultze, Joachim L.] Univ Bonn, Life & Med Sci LIMES Inst, Genom & Immunoregulat, Bonn, Germany; [Bonaguro, Lorenzo; Ulas, Thomas; Schultze, Joachim L.] Univ Bonn, Deutsch Zentrum Neurodegenerat Erkrankungen DZNE, Platform Single Cell Genom & Epigen, Bonn, Germany; [Homrich, Mirka; Kiermaier, Eva] Univ Bonn, Life & Med Sci LIMES Inst, Immune & Tumor Biol, Bonn, Germany; [Schultze, Joachim L.] Deutsch Zentrum Neurodegenerat Erkrankungen DZNE, Syst Med, Bonn, Germany	University of Bonn; University of Bonn; University of Bonn; University Hospital Magdeburg; Ruhr University Bochum; University of Bonn; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); University of Bonn; University of Bonn; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE)	Mass, E (corresponding author), Univ Bonn, Life & Med Sci LIMES Inst, Dev Biol Immune Syst, D-53115 Bonn, Germany.	emass@uni-bonn.de	Schultze, Joachim L./ABA-8176-2020; Mass, Elvira/AAH-3805-2019	Schultze, Joachim L./0000-0003-2812-9853; Mass, Elvira/0000-0003-2318-2356; Kiermaier, Eva/0000-0001-6165-5738	Fritz Thyssen Stiftung (Fritz Thyssen Foundation) [Az.10.18.2.029MN]; Deutsche Forschungsgemeinschaft (DFG) [EXC2151-390873048, CA267/14-1]; Bundesministerium fur Bildung und Forschung (BMBF) [01EA1809A]; Daimler und Benz Stiftung (Daimler and Benz Foundation) [32-058/18]	Fritz Thyssen Stiftung (Fritz Thyssen Foundation); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Bundesministerium fur Bildung und Forschung (BMBF)(Federal Ministry of Education & Research (BMBF)); Daimler und Benz Stiftung (Daimler and Benz Foundation)	Fritz Thyssen Stiftung (Fritz Thyssen Foundation), Grant/Award Number: Az.10.18.2.029MN; Deutsche Forschungsgemeinschaft (DFG), Grant/Award Number: EXC2151-390873048 and CA267/14-1; Bundesministerium fur Bildung und Forschung (BMBF), Grant/Award Number: DietBB (01EA1809A); Daimler und Benz Stiftung (Daimler and Benz Foundation), Grant/Award Number: 32-058/18	Adachi Y, 2008, CELL STRUCT FUNCT, V33, P75, DOI 10.1247/csf.07044; Adamson B, 2016, CELL, V167, P1867, DOI 10.1016/j.cell.2016.11.048; Alberti A, 2009, AM J PHYSIOL-ENDOC M, V297, pE812, DOI 10.1152/ajpendo.00053.2009; Ballestri S, 2017, ADV THER, V34, P1291, DOI 10.1007/s12325-017-0556-1; Beckert V, 2021, J MOL CELL CARDIOL, V156, P45, DOI 10.1016/j.yjmcc.2021.03.008; Bedossa P, 2012, HEPATOLOGY, V56, P1751, DOI 10.1002/hep.25889; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Board PG, 2013, BBA-GEN SUBJECTS, V1830, P3267, DOI 10.1016/j.bbagen.2012.11.019; Bonaguro L, 2020, NAT IMMUNOL, V21, P1517, DOI 10.1038/s41590-020-00811-2; Boyle ST, 2020, NAT CELL BIOL, V22, P882, DOI 10.1038/s41556-020-0523-y; Bray NL, 2016, NAT BIOTECHNOL, V34, P888, DOI 10.1038/nbt0816-888d; Chen DL, 2012, BIOCHEM BIOPH RES CO, V426, P324, DOI 10.1016/j.bbrc.2012.08.072; Chen MF, 2019, BONE JOINT RES, V8, P179, DOI 10.1302/2046-3758.84.BJR-2018-0291.R1; D'Alessandro M, 2018, ELIFE, V7, DOI 10.7554/eLife.39649; Dennis EP, 2020, J BONE MINER RES, V35, P1452, DOI 10.1002/jbmr.4010; DeZwaan-McCabe D, 2017, CELL REP, V19, P1794, DOI 10.1016/j.celrep.2017.05.020; Fu SN, 2011, NATURE, V473, P528, DOI 10.1038/nature09968; Gloeckner Christian Johannes, 2009, Methods Mol Biol, V564, P359, DOI 10.1007/978-1-60761-157-8_21; Gonen N, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-38705-5; Han J, 2016, J LIPID RES, V57, P1329, DOI 10.1194/jlr.R067595; Hartley CL, 2013, HUM MOL GENET, V22, P5262, DOI 10.1093/hmg/ddt383; Hatahet F, 2007, FEBS J, V274, P5223, DOI 10.1111/j.1742-4658.2007.06058.x; Hetz C, 2012, NAT REV MOL CELL BIO, V13, P89, DOI 10.1038/nrm3270; Hodeify R, 2013, AM J PHYSIOL-RENAL, V304, pF875, DOI 10.1152/ajprenal.00590.2012; Horna-Terron E, 2014, INT J MOL SCI, V15, P23501, DOI 10.3390/ijms151223501; Kammoun HL, 2009, J CLIN INVEST, V119, P1201, DOI 10.1172/JCI37007; Kim Y, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.92896; Kurek K, 2014, LIVER INT, V34, P1074, DOI 10.1111/liv.12331; Leek JT, 2019, SVA SURROGATE VARIAB; Lefere S, 2019, JHEP REP, V1, P30, DOI 10.1016/j.jhepr.2019.02.004; Liu GM, 2019, PATHOL RES PRACT, V215, DOI 10.1016/j.prp.2019.152510; Lonardo A, 2019, HEPATOBIL SURG NUTR, V8, P164, DOI 10.21037/hbsn.2018.12.04; Longato L, 2012, HEPATOL RES, V42, P412, DOI 10.1111/j.1872-034X.2011.00934.x; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Malhi H, 2011, J HEPATOL, V54, P795, DOI 10.1016/j.jhep.2010.11.005; Mass E, 2014, DEV CELL, V28, P711, DOI 10.1016/j.devcel.2014.02.012; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Medrikova D, 2012, INT J OBESITY, V36, P262, DOI 10.1038/ijo.2011.87; Musso G, 2018, GASTROENTEROLOGY, V155, P282, DOI 10.1053/j.gastro.2018.06.031; Ozcan U, 2006, SCIENCE, V313, P1137, DOI 10.1126/science.1128294; Oh-hashi K, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-30362-4; Oh-hashi K, 2011, FEBS LETT, V585, P2481, DOI 10.1016/j.febslet.2011.06.029; Oh-Hashi K, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-664; Oh-hashi K, 2009, BIOCHEM BIOPH RES CO, V387, P504, DOI 10.1016/j.bbrc.2009.07.047; Oyadomari S, 2008, CELL METAB, V7, P520, DOI 10.1016/j.cmet.2008.04.011; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Palmisano BT, 2017, FRONT ENDOCRINOL, V8, DOI 10.3389/fendo.2017.00044; Pibiri M, 2018, AGING-US, V10, P1801, DOI 10.18632/aging/101524; Picelli S, 2013, NAT METHODS, V10, P1096, DOI [10.1038/nmeth.2639, 10.1038/NMETH.2639]; Rosvall M, 2008, P NATL ACAD SCI USA, V105, P1118, DOI 10.1073/pnas.0706851105; Rupp PA, 2002, GENE, V293, P47, DOI 10.1016/S0378-1119(02)00696-0; Rutkowski DT, 2008, DEV CELL, V15, P829, DOI 10.1016/j.devcel.2008.10.015; Savic S, 2014, J AUTOIMMUN, V50, P59, DOI 10.1016/j.jaut.2013.11.002; Sheedfar F, 2013, AGING CELL, V12, P950, DOI 10.1111/acel.12128; Song MJ, 2019, PHARMACOL THERAPEUT, V203, DOI 10.1016/j.pharmthera.2019.107401; Strunk BS, 2009, RNA, V15, P2083, DOI 10.1261/rna.1792109; Usui M, 2012, METABOLISM, V61, P1118, DOI 10.1016/j.metabol.2012.01.004; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Wang CX, 2010, CELL RES, V20, P174, DOI 10.1038/cr.2010.4; Wang SD, 2020, FRONT ONCOL, V10, DOI 10.3389/fonc.2020.01539; Wu J, 2007, DEV CELL, V13, P351, DOI 10.1016/j.devcel.2007.07.005; Yamamoto K, 2010, MOL BIOL CELL, V21, P2975, DOI 10.1091/mbc.E09-02-0133; Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118; Zhang KZ, 2011, EMBO J, V30, P1357, DOI 10.1038/emboj.2011.52; Zhang Z, 2019, REDOX BIOL, V25, DOI 10.1016/j.redox.2018.11.005	66	3	3	1	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2021	35	10							e21939	10.1096/fj.202002713RR	http://dx.doi.org/10.1096/fj.202002713RR			20	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	UZ5IH	34549824	Green Submitted			2022-12-26	WOS:000702238200063
J	Peshenko, IV; Olshevskaya, EV; Dizhoor, AM				Peshenko, Igor V.; Olshevskaya, Elena V.; Dizhoor, Alexander M.			Retinal degeneration-3 protein attenuates photoreceptor degeneration in transgenic mice expressing dominant mutation of human retinal guanylyl cyclase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONE-ROD DYSTROPHY; 1 RETGC1; DIMERIZATION DOMAIN; CALCIUM SENSITIVITY; TARGET ENZYME; BINDING; RD3; PHOTOTRANSDUCTION; LOCALIZATION; ACTIVATION	Different forms of photoreceptor degeneration cause blindness. Retinal degeneration-3 protein (RD3) deficiency in photoreceptors leads to recessive congenital blindness. We proposed that aberrant activation of the retinal membrane guanylyl cyclase (RetGC) by its calcium-sensor proteins (guanylyl cyclase-activating protein [GCAP]) causes this retinal degeneration and that RD3 protects photoreceptors by preventing such activation. We here present in vivo evidence that RD3 protects photoreceptors by suppressing activation of both RetGC1 and RetGC2 isozymes. We further suggested that insufficient inhibition of RetGC by RD3 could contribute to some dominant forms of retinal degeneration. The R838S substitution in RetGC1 that causes autosomal-dominant cone- rod dystrophy 6, not only impedes deceleration of RetGC1 activity by Ca(2+)GCAPs but also elevates this isozyme's resistance to inhibition by RD3. We found that RD3 prolongs the survival of photoreceptors in transgenic mice harboring human R838S RetGC1 (R838S(+)). Overexpression of GFP-tagged human RD3 did not improve the calcium sensitivity of cGMP production in R838S(+) retinas but slowed the progression of retinal blindness and photoreceptor degeneration. Fluorescence of the GFP-tagged RD3 in the retina only partially overlapped with immunofluorescence of RetGC1 or GCAP1, indicating that RD3 separates from the enzyme before the RetGC1:GCAP1 complex is formed in the photoreceptor outer segment. Most importantly, our in vivo results indicate that, in addition to the abnormal Ca2+ sensitivity of R838S RetGC1 in the outer segment, the mutated RetGC1 becomes resistant to inhibition by RD3 in a different cellular compartment(s) and suggest that RD3 overexpression could be utilized to reduce the severity of cone-rod dystrophy 6 pathology.	[Peshenko, Igor V.; Olshevskaya, Elena V.; Dizhoor, Alexander M.] Salus Univ, Penn Coll Optometry, Elkins Pk, PA 19027 USA		Dizhoor, AM (corresponding author), Salus Univ, Penn Coll Optometry, Elkins Pk, PA 19027 USA.	adizhoor@salus.edu			<bold>National Institutes of Health from National Eye Institute</bold> [<bold>EY11522</bold>]; <bold>CURE Formula grant from Pennsylvania Department of Healt</bold>h	<bold>National Institutes of Health from National Eye Institute</bold>; <bold>CURE Formula grant from Pennsylvania Department of Healt</bold>h	<BOLD>This work was supported by the National Institutes of Health grant EY11522 from National Eye Institute and by a CURE Formula grant from Pennsylvania Department of Health. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. </BOLD>	Arshavsky VY, 2002, ANNU REV PHYSIOL, V64, P153, DOI 10.1146/annurev.physiol.64.082701.102229; Azadi S, 2010, P NATL ACAD SCI USA, V107, P21158, DOI 10.1073/pnas.1010460107; Baehr W, 2007, J BIOL CHEM, V282, P8837, DOI 10.1074/jbc.M610369200; CHANG B, 1993, GENOMICS, V16, P45, DOI 10.1006/geno.1993.1138; Dizhoor AM, 2021, J BIOL CHEM, V296, DOI 10.1016/j.jbc.2021.100362; Dizhoor AM, 2021, PFLUG ARCH EUR J PHY, V473, P1393, DOI 10.1007/s00424-021-02523-4; Dizhoor AM, 2019, J BIOL CHEM, V294, P13729, DOI 10.1074/jbc.RA119.009948; Dizhoor AM, 2016, J BIOL CHEM, V291, P24504, DOI 10.1074/jbc.M116.755553; Dizhoor AM, 2010, MOL CELL BIOCHEM, V334, P117, DOI 10.1007/s11010-009-0328-6; DIZHOOR AM, 1994, NEURON, V12, P1345, DOI 10.1016/0896-6273(94)90449-9; Downes SM, 2001, ARCH OPHTHALMOL-CHIC, V119, P1667; Friedman JS, 2006, AM J HUM GENET, V79, P1059, DOI 10.1086/510021; Fu YB, 2007, PFLUG ARCH EUR J PHY, V454, P805, DOI 10.1007/s00424-006-0194-y; Huber G, 2009, INVEST OPHTH VIS SCI, V50, P5888, DOI 10.1167/iovs.09-3724; Hunt DM, 2010, MOL CELL BIOCHEM, V334, P157, DOI 10.1007/s11010-009-0331-y; Koch KW, 2015, FRONT MOL NEUROSCI, V8, DOI 10.3389/fnmol.2015.00067; LOWE DG, 1995, P NATL ACAD SCI USA, V92, P5535, DOI 10.1073/pnas.92.12.5535; Makino CL, 2008, J BIOL CHEM, V283, P29135, DOI 10.1074/jbc.M804445200; Molday LL, 2014, FRONT MOL NEUROSCI, V7, DOI 10.3389/fnmol.2014.00044; Molday LL, 2013, HUM MOL GENET, V22, P3894, DOI 10.1093/hmg/ddt244; Nemet I, 2014, CHANNELS, V8, P528, DOI 10.4161/19336950.2014.973776; Olshevskaya EV, 2012, J NEUROSCI, V32, P7208, DOI 10.1523/JNEUROSCI.0976-12.2012; Peshenko IV, 2008, J BIOL CHEM, V283, P21747, DOI 10.1074/jbc.M801899200; Peshenko IV, 2006, J BIOL CHEM, V281, P23830, DOI 10.1074/jbc.M600257200; Peshenko IV, 2020, J BIOL CHEM, V295, P18301, DOI 10.1074/jbc.RA120.015553; Peshenko IV, 2019, J BIOL CHEM, V294, P3476, DOI 10.1074/jbc.RA118.006180; Peshenko IV, 2019, J BIOL CHEM, V294, P2318, DOI 10.1074/jbc.RA118.006106; Peshenko IV, 2016, J BIOL CHEM, V291, P19713, DOI 10.1074/jbc.M116.742288; Peshenko IV, 2015, J BIOL CHEM, V290, P19584, DOI 10.1074/jbc.M115.661371; Peshenko IV, 2015, J BIOL CHEM, V290, P6913, DOI 10.1074/jbc.M114.629642; Peshenko IV, 2014, J BIOL CHEM, V289, P10140, DOI 10.1074/jbc.M113.540716; Peshenko IV, 2012, J BIOL CHEM, V287, P13972, DOI 10.1074/jbc.M112.341883; Peshenko IV, 2011, BIOCHEMISTRY-US, V50, P9511, DOI 10.1021/bi201342b; Peshenko IV, 2011, BIOCHEMISTRY-US, V50, P5590, DOI 10.1021/bi200491b; Peshenko IV, 2004, BIOCHEMISTRY-US, V43, P13796, DOI 10.1021/bi048943m; Plana-Bonamaiso A, 2020, CELL DEATH DIS, V11, DOI 10.1038/s41419-020-2255-0; Pugh EN, 1999, CURR OPIN NEUROBIOL, V9, P410, DOI 10.1016/S0959-4388(99)80062-2; Ramamurthy V, 2001, J BIOL CHEM, V276, P26218, DOI 10.1074/jbc.M010495200; Sato S, 2018, J NEUROSCI, V38, P2990, DOI 10.1523/JNEUROSCI.2985-17.2018; Sharon D, 2018, PROG RETIN EYE RES, V63, P69, DOI 10.1016/j.preteyeres.2017.10.003; TSIEN R, 1989, METHOD ENZYMOL, V172, P230; Tucker CL, 1999, P NATL ACAD SCI USA, V96, P9039, DOI 10.1073/pnas.96.16.9039; Vocke F, 2017, HUM MOL GENET, V26, P133, DOI 10.1093/hmg/ddw374; Wang T, 2017, HUM MOL GENET, V26, P2299, DOI 10.1093/hmg/ddx121; Xu JH, 2013, J NEUROSCI, V33, P14939, DOI 10.1523/JNEUROSCI.0909-13.2013; Yang RB, 1999, J NEUROSCI, V19, P5889, DOI 10.1523/JNEUROSCI.19-14-05889.1999; YANG RB, 1995, P NATL ACAD SCI USA, V92, P602, DOI 10.1073/pnas.92.2.602; Zhang PF, 2017, P NATL ACAD SCI USA, V114, pE2937, DOI 10.1073/pnas.1620572114; Zulliger R, 2015, J BIOL CHEM, V290, P3488, DOI 10.1074/jbc.M114.616656	49	1	1	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT	2021	297	4							101201	10.1016/j.jbc.2021.101201	http://dx.doi.org/10.1016/j.jbc.2021.101201			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	WP2YR	34537244	gold, Green Published			2022-12-26	WOS:000713003600005
J	Reijneveld, JF; Marino, L; Cao, TP; Cheng, TY; Dam, D; Shahine, A; Witte, MD; Filippov, DV; Suliman, S; van der Marel, GA; Moody, DB; Minnaard, AJ; Rossjohn, J; Codee, JDC; Van Rhijn, I				Reijneveld, Josephine F.; Marino, Laura; Cao, Thinh-Phat; Cheng, Tan-Yun; Dam, Dennis; Shahine, Adam; Witte, Martin D.; Filippov, Dmitri, V; Suliman, Sara; van der Marel, Gijsbert A.; Moody, D. Branch; Minnaard, Adriaan J.; Rossjohn, Jamie; Codee, Jeroen D. C.; Van Rhijn, Ildiko			Rational design of a hydrolysis-resistant mycobacterial phosphoglycolipid antigen presented by CD1c to T cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							B-CELLS; RECOGNITION; EXPRESSION; RESTRICTS; RESPONSES; ANATOMY; LIPIDS; TOOL	Whereas proteolytic cleavage is crucial for peptide presentation by classical major histocompatibility complex (MHC) proteins to T cells, glycolipids presented by CD1 molecules are typically presented in an unmodified form. However, the mycobacterial lipid antigen mannosyl-beta 1-phosphomycoketide (MPM) may be processed through hydrolysis in antigen presenting cells, forming mannose and phosphomycoketide (PM). To further test the hypothesis that some lipid antigens are processed, and to generate antigens that lead to defined epitopes for future tuberculosis vaccines or diagnostic tests, we aimed to create hydrolysis-resistant MPM variants that retain their antigenicity. Here, we designed and tested three different, versatile synthetic strategies to chemically stabilize MPM analogs. Crystallographic studies of CD1c complexes with these three new MPM analogs showed anchoring of the lipid tail and phosphate group that is highly comparable to nature-identical MPM, with considerable conformational flexibility for the mannose head group. MPM-3, a difluoromethylene-modified version of MPM that is resistant to hydrolysis, showed altered recognition by cells, but not by CD1c proteins, supporting the cellular antigen processing hypothesis. Furthermore, the synthetic analogs elicited T cell responses that were cross-reactive with nature-identical MPM, fulfilling important requirements for future clinical use.	[Reijneveld, Josephine F.; Cheng, Tan-Yun; Suliman, Sara; Moody, D. Branch; Van Rhijn, Ildiko] Brigham & Womens Hosp, Div Rheumatol Inflammat & Immun, 75 Francis St, Boston, MA 02115 USA; [Reijneveld, Josephine F.; Cheng, Tan-Yun; Suliman, Sara; Moody, D. Branch; Van Rhijn, Ildiko] Harvard Med Sch, Boston, MA 02115 USA; [Reijneveld, Josephine F.; Van Rhijn, Ildiko] Univ Utrecht, Fac Vet Med, Dept Infect Dis & Immunol, Utrecht, Netherlands; [Reijneveld, Josephine F.; Witte, Martin D.; Minnaard, Adriaan J.] Univ Groningen, Stratingh Inst Chem, Groningen, Netherlands; [Marino, Laura; Dam, Dennis; Filippov, Dmitri, V; van der Marel, Gijsbert A.; Codee, Jeroen D. C.] Leiden Univ, Fac Sci, Leiden Inst Chem, Dept Bioorgan Synth, Leiden, Netherlands; [Cao, Thinh-Phat; Shahine, Adam; Rossjohn, Jamie] Monash Univ, Biomed Discovery Inst, Infect & Immun Program, Clayton, Vic, Australia; [Cao, Thinh-Phat; Shahine, Adam; Rossjohn, Jamie] Monash Univ, Dept Biochem & Mol Biol, Biomed Discovery Inst, Clayton, Vic, Australia; [Shahine, Adam; Rossjohn, Jamie] Monash Univ, Australian Res Council Ctr Excellence Adv Mol Ima, Clayton, Vic, Australia; [Rossjohn, Jamie] Cardiff Univ, Sch Med, Inst Infect & Immun, Cardiff, Wales	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Utrecht University; University of Groningen; Leiden University; Leiden University - Excl LUMC; Monash University; Monash University; Monash University; Cardiff University	Van Rhijn, I (corresponding author), Brigham & Womens Hosp, Div Rheumatol Inflammat & Immun, 75 Francis St, Boston, MA 02115 USA.; Van Rhijn, I (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.; Van Rhijn, I (corresponding author), Univ Utrecht, Fac Vet Med, Dept Infect Dis & Immunol, Utrecht, Netherlands.; Codee, JDC (corresponding author), Leiden Univ, Fac Sci, Leiden Inst Chem, Dept Bioorgan Synth, Leiden, Netherlands.	jcodee@chem.leidenuniv.nl; i.vanrhijn@uu.nl	; Rossjohn, Jamie/F-9032-2013	Reijneveld, Josephine/0000-0001-8695-964X; Dam, Dennis/0000-0002-2510-9913; Van Rhijn, Ildiko/0000-0002-1446-5701; Rossjohn, Jamie/0000-0002-2020-7522; Cao, Thinh-Phat/0000-0001-9387-5460; Minnaard, Adriaan/0000-0002-5966-1300	Nederlands Wetenschappelijk Onderzoek (NWO) Toppunt grant [15.002]; National Institutes of Health [R01 AI049313]; NIH Tuberculosis Research Unit Network [U19 AI111224]; ARC DECRA Fellowship [DE210101031]; Australian ARC Laureate Fellowship	Nederlands Wetenschappelijk Onderzoek (NWO) Toppunt grant; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Tuberculosis Research Unit Network; ARC DECRA Fellowship(Australian Research Council); Australian ARC Laureate Fellowship	Funding and additional information-J. C., G. A. v. d. M., and A. J. M. were supported by Nederlands Wetenschappelijk Onderzoek (NWO) Toppunt grant 15.002. D. B. M. was supported by National Institutes of Health grant R01 AI049313. D. B. M. and I. V. R. were supported by and NIH Tuberculosis Research Unit Network, Grant U19 AI111224. A. S. was supported by an ARC DECRA Fellowship (DE210101031) . J. R. is supported by an Australian ARC Laureate Fellowship. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Akai S, 2013, J ORG CHEM, V78, P8802, DOI 10.1021/jo4007128; Allan LL, 2011, J IMMUNOL, V186, P5261, DOI 10.4049/jimmunol.1003615; Aragao D, 2018, J SYNCHROTRON RADIAT, V25, P885, DOI 10.1107/S1600577518003120; Beckman EM, 1996, J IMMUNOL, V157, P2795; Briken V, 2000, J EXP MED, V192, P281, DOI 10.1084/jem.192.2.281; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cotton RN, 2021, J CLIN INVEST, V131, DOI 10.1172/JCI140706; de Jong A, 2007, CHEM BIOL, V14, P1232, DOI 10.1016/j.chembiol.2007.09.010; de la Salle H, 2005, SCIENCE, V310, P1321, DOI 10.1126/science.1115301; Dondoni A, 2013, EUR J ORG CHEM, V2013, P5370, DOI 10.1002/ejoc.201300780; Dougan SK, 2007, CURR TOP MICROBIOL, V314, P113; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Enotarpi J, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18279-x; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Evans PR, 2011, ACTA CRYSTALLOGR D, V67, P282, DOI 10.1107/S090744491003982X; Gao Q, 2012, ORG BIOMOL CHEM, V10, P6673, DOI 10.1039/c2ob25222h; Gherardin NA, 2021, SCI IMMUNOL, V6, DOI 10.1126/sciimmunol.abg4176; Grant EP, 1999, J EXP MED, V189, P195, DOI 10.1084/jem.189.1.195; Gratien J, 2008, CARBOHYD RES, V343, P18, DOI 10.1016/j.carres.2007.10.006; Guo TX, 2018, J IMMUNOL, V200, P500, DOI 10.4049/jimmunol.1700677; Huang SX, 2011, P NATL ACAD SCI USA, V108, P19335, DOI 10.1073/pnas.1112969108; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Lebedev AA, 2012, ACTA CRYSTALLOGR D, V68, P431, DOI 10.1107/S090744491200251X; Ly D, 2013, J EXP MED, V210, P729, DOI 10.1084/jem.20120624; Mansour S, 2016, P NATL ACAD SCI USA, V113, pE1266, DOI 10.1073/pnas.1519246113; Matsunaga I, 2004, J EXP MED, V200, P1559, DOI 10.1084/jem.20041429; McCarthy C, 2007, J EXP MED, V204, P1131, DOI 10.1084/jem.20062342; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Moody DB, 2005, NAT REV IMMUNOL, V5, P387, DOI 10.1038/nri1605; Moody DB, 2003, NAT REV IMMUNOL, V3, P11, DOI 10.1038/nri979; Moody DB, 2000, NATURE, V404, P884, DOI 10.1038/35009119; Moriarty NW, 2009, ACTA CRYSTALLOGR D, V65, P1074, DOI 10.1107/S0907444909029436; PORCELLI S, 1992, NATURE, V360, P593, DOI 10.1038/360593a0; Prigozy TI, 2001, SCIENCE, V291, P664, DOI 10.1126/science.291.5504.664; Roy S, 2014, P NATL ACAD SCI USA, V111, pE4648, DOI 10.1073/pnas.1408549111; Scharf L, 2010, IMMUNITY, V33, P853, DOI 10.1016/j.immuni.2010.11.026; Shahine A, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-07898-0; Shahine A, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aao1384; SMITH MEF, 1988, J PATHOL, V156, P169, DOI 10.1002/path.1711560212; Stick RV, 2005, J CARBOHYD CHEM, V24, P529, DOI 10.1081/CAR-200067125; Sugita M, 2000, P NATL ACAD SCI USA, V97, P8445, DOI 10.1073/pnas.150236797; van Summeren RP, 2006, J AM CHEM SOC, V128, P4546, DOI 10.1021/ja060499i; Villani AC, 2017, SCIENCE, V356, DOI 10.1126/science.aah4573; Waschke D, 2011, ORG LETT, V13, P3628, DOI 10.1021/ol2012764; Weller S, 2004, BLOOD, V104, P3647, DOI 10.1182/blood-2004-01-0346; Welsh RM, 2007, NAT REV MICROBIOL, V5, P555, DOI 10.1038/nrmicro1709; Wun KS, 2018, NAT IMMUNOL, V19, P397, DOI 10.1038/s41590-018-0065-7; Xu BX, 2014, ANGEW CHEM INT EDIT, V53, P9597, DOI 10.1002/anie.201405008; Yakimchuk K, 2011, EUR J IMMUNOL, V41, P694, DOI 10.1002/eji.201040808; Zechel DL, 2000, ACCOUNTS CHEM RES, V33, P11, DOI 10.1021/ar970172+	51	0	0	0	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT	2021	297	4							101197	10.1016/j.jbc.2021.101197	http://dx.doi.org/10.1016/j.jbc.2021.101197			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	WP2YR	34536421	Green Accepted, Green Published, gold			2022-12-26	WOS:000713003600002
J	Piersson, AD; Ibrahim, B; Suppiah, S; Mohamad, M; Abu Hassan, H; Omar, NF; Ibrahim, MI; Yusoff, AN; Ibrahim, N; Saripan, MI; Razali, RM				Piersson, Albert Dayor; Ibrahim, Buhari; Suppiah, Subapriya; Mohamad, Mazlyfarina; Abu Hassan, Hasyma; Omar, Nur Farhayu; Ibrahim, Mohd Izuan; Yusoff, Ahmad Nazlim; Ibrahim, Normala; Saripan, M. Iqbal; Razali, Rizah Mazzuin			Multiparametric MRI for the improved diagnostic accuracy of Alzheimer's disease and mild cognitive impairment: Research protocol of a case-control study design	PLOS ONE			English	Article							MAGNETIC-RESONANCE-SPECTROSCOPY; FUNCTIONAL CONNECTIVITY; DTI; BIOMARKERS; SAMPLE	Background Alzheimer's disease (AD) is a major neurocognitive disorder identified by memory loss and a significant cognitive decline based on previous level of performance in one or more cognitive domains that interferes in the independence of everyday activities. The accuracy of imaging helps to identify the neuropathological features that differentiate AD from its common precursor, mild cognitive impairment (MCI). Identification of early signs will aid in risk stratification of disease and ensures proper management is instituted to reduce the morbidity and mortality associated with AD. Magnetic resonance imaging (MRI) using structural MRI (sMRI), functional MRI (fMRI), diffusion tensor imaging (DTI), and magnetic resonance spectroscopy (1 H-MRS) performed alone is inadequate. Thus, the combination of multiparametric MRI is proposed to increase the accuracy of diagnosing MCI and AD when compared to elderly healthy controls. Methods This protocol describes a non-interventional case control study. The AD and MCI patients and the healthy elderly controls will undergo multi-parametric MRI. The protocol consists of sMRI, fMRI, DTI, and single-voxel proton MRS sequences. An eco-planar imaging (EPI) will be used to perform resting-state fMRI sequence. The structural images will be analysed using Computational Anatomy Toolbox-12, functional images will be analysed using Statistical Parametric Mapping-12, DPABI (Data Processing & Analysis for Brain Imaging), and Conn software, while DTI and H-1-MRS will be analysed using the FSL (FMRIB's Software Library) and Tarquin respectively. Correlation of the MRI results and the data acquired from the APOE genotyping, neuropsychological evaluations (i.e. Montreal Cognitive Assessment [MoCA], and Mini-Mental State Examination [MMSE] scores) will be performed. The imaging results will also be correlated with the sociodemographic factors. The diagnosis of AD and MCI will be standardized and based on the DSM-5 criteria and the neuropsychological scores. Discussion The combination of sMRI, fMRI, DTI, and MRS sequences can provide information on the anatomical and functional changes in the brain such as regional grey matter volume atrophy, impaired functional connectivity among brain regions, and decreased metabolite levels specifically at the posterior cingulate cortex/precuneus. The combination of multiparametric MRI sequences can be used to stratify the management of MCI and AD patients. Accurate imaging can decide on the frequency of follow-up at memory clinics and select classifiers for machine learning that may aid in the disease identification and prognostication. Reliable and consistent quantification, using standardised protocols, are crucial to establish an optimal diagnostic capability in the early detection of Alzheimer's disease.	[Piersson, Albert Dayor; Mohamad, Mazlyfarina; Ibrahim, Mohd Izuan; Yusoff, Ahmad Nazlim] Univ Kebangsaan Malaysia, Diagnost Imaging & Radiotherapy Programme, Kuala Lumpur, Malaysia; [Piersson, Albert Dayor] Univ Cape Coast, Sch Allied Hlth Sci, Dept Imaging Technol & Sonog, Cape Coast, Ghana; [Ibrahim, Buhari; Suppiah, Subapriya; Abu Hassan, Hasyma; Omar, Nur Farhayu] Univ Putra Malaysia, Fac Med & Hlth Sci, Dept Radiol, Seri Kembangan, Malaysia; [Ibrahim, Buhari; Suppiah, Subapriya] Univ Putra Malaysia, Fac Med & Hlth Sci, Neurosci Lab Cognit Funct & Behav Imaging NeuroCo, Seri Kembangan, Malaysia; [Ibrahim, Buhari] Bauchi State Univ, Fac Basic Med Sci, Dept Physiol, PMB 65, Gadau, Nigeria; [Ibrahim, Normala] Univ Putra Malaysia, Fac Med & Hlth Sci, Dept Psychiat, Seri Kembangan, Malaysia; [Saripan, M. Iqbal] Univ Putra Malaysia, Fac Engn, Dept Comp & Commun Syst, Seri Kembangan, Malaysia; [Razali, Rizah Mazzuin] Hosp Kuala Lumpur, Dept Med, Gerontol Unit, Kuala Lumpur, Malaysia	Universiti Kebangsaan Malaysia; University of Cape Coast; Universiti Putra Malaysia; Universiti Putra Malaysia; Universiti Putra Malaysia; Universiti Putra Malaysia	Suppiah, S (corresponding author), Univ Putra Malaysia, Fac Med & Hlth Sci, Dept Radiol, Seri Kembangan, Malaysia.; Suppiah, S (corresponding author), Univ Putra Malaysia, Fac Med & Hlth Sci, Neurosci Lab Cognit Funct & Behav Imaging NeuroCo, Seri Kembangan, Malaysia.	subapriya@upm.edu.my	SUPPIAH, SUBAPRIYA/A-4922-2017; mohamad, mazly/AEH-7967-2022; Saripan, M Iqbal/A-9582-2010; bin Ibrahim, Mohd Izuan/ABF-8071-2020	SUPPIAH, SUBAPRIYA/0000-0002-2495-6408; Saripan, M Iqbal/0000-0002-3005-5331; bin Ibrahim, Mohd Izuan/0000-0003-3461-2956	Malaysian Ministry of Education/Higher Education [FRGS/1/2019/SKK03/UPM/02/4]	Malaysian Ministry of Education/Higher Education	SS FRGS/1/2019/SKK03/UPM/02/4) Malaysian Ministry of Education/Higher Education NO -The funders had and will not have a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alzheimer's Disease International, 2014, WORLD ALZHEIMER REPO; American Psychiatric Association, 2013, DSM 5 TASK FORCE DIA, DOI DOI 10.1176/APPI.BOOKS.9780890425596; Barker PB., 2010, CLIN MR SPECTROSCOPY; Blum S, 2013, MR SPECTROSCOPY PEDI, P25; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Braak H, 2015, BRAIN, V138, P2814, DOI 10.1093/brain/awv236; Chabran E, 2020, ALZHEIMERS RES THER, V12, DOI 10.1186/s13195-019-0575-z; Dorszewska J, 2016, CURR ALZHEIMER RES, V13, P952, DOI 10.2174/1567205013666160314150501; Frisoni GB, 2010, NAT REV NEUROL, V6, P67, DOI 10.1038/nrneurol.2009.215; Gaugler J, 2019, ALZHEIMERS DEMENT, V15, P321, DOI 10.1016/j.jalz.2019.01.010; Gomar JJ, 2014, BIOL PSYCHIAT, V75, P686, DOI 10.1016/j.biopsych.2013.05.022; Graff-Radford J, 2013, NEUROPSYCH DIS TREAT, V9, P687, DOI 10.2147/NDT.S35440; Greve DN, 2009, NEUROIMAGE, V48, P63, DOI 10.1016/j.neuroimage.2009.06.060; He Y, 2007, NEUROIMAGE, V35, P488, DOI 10.1016/j.neuroimage.2006.11.042; Hickey GL, 2018, EUR J CARDIO-THORAC, V54, P4, DOI 10.1093/ejcts/ezy169; Hussin NM, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-7508-4; Jack CR, 2010, LANCET NEUROL, V9, P119, DOI 10.1016/S1474-4422(09)70299-6; Johari SM, 2014, INT J GERONTOL, V8, P74, DOI 10.1016/j.ijge.2013.07.002; Kantarci K, 2011, NEUROLOGY, V77, P951, DOI 10.1212/WNL.0b013e31822dc7e1; Kantarci K, 2017, NEUROBIOL AGING, V56, P172, DOI 10.1016/j.neurobiolaging.2017.04.024; Kirilina E, 2016, NEUROIMAGE, V126, P49, DOI 10.1016/j.neuroimage.2015.10.071; Lau HJ, 2019, CLIN INTERV AGING, V14, P43, DOI 10.2147/CIA.S183425; Lau Huijin, 2017, Curr Gerontol Geriatr Res, V2017, P4218756, DOI 10.1155/2017/4218756; Lee LK, 2012, ARCH GERONTOL GERIAT, V54, P185, DOI 10.1016/j.archger.2011.03.015; Lehmann M, 2010, J ALZHEIMERS DIS, V20, P587, DOI 10.3233/JAD-2010-1401; Lindsay J, 2002, AM J EPIDEMIOL, V156, P445, DOI 10.1093/aje/kwf074; Lombardi G, 2020, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009628.pub2; Maggipinto T, 2017, PHYS MED BIOL, V62, P2361, DOI 10.1088/1361-6560/aa5dbe; Matthews PM, 2016, NEURON, V91, P511, DOI 10.1016/j.neuron.2016.07.031; Minoshima S, 1997, ANN NEUROL, V42, P85, DOI 10.1002/ana.410420114; Nisbet RM, 2015, ACTA NEUROPATHOL, V129, P207, DOI 10.1007/s00401-014-1371-2; Oishi K, 2011, J ALZHEIMERS DIS, V26, P287, DOI 10.3233/JAD-2011-0007; Oz G, 2014, RADIOLOGY, V270, P658, DOI 10.1148/radiol.13130531; Piersson AD, 2021, ACAD RADIOL, V28, P1447, DOI 10.1016/j.acra.2020.06.006; Prince M. J., 2016, WORLD ALZHEIMER REPO, DOI DOI 10.13140/RG.2.2.22580.04483; Sperling RA, 2011, ALZHEIMERS DEMENT, V7, P280, DOI 10.1016/j.jalz.2011.03.003; Su L, 2016, TRANSL PSYCHIAT, V6, DOI 10.1038/tp.2016.140; Suppiah S, 2019, DIAGNOSTICS, V9, DOI 10.3390/diagnostics9020065; Teipel SJ, 2019, J ALZHEIMERS DIS, V72, P455, DOI 10.3233/JAD-190446; United Nations Department of Economic and Social Affairs Population Division, 2015, ESAPWP241 UN, DOI DOI 10.1017/CBO9781107415324.004; Vemuri P, 2010, NEUROLOGY, V75, P143, DOI 10.1212/WNL.0b013e3181e7ca82; Vemuri P, 2012, ALZHEIMERS RES THER, V4, DOI 10.1186/alzrt100; Wang H, 2015, J ALZHEIMERS DIS, V46, P1049, DOI 10.3233/JAD-143225; Wang K, 2007, HUM BRAIN MAPP, V28, P967, DOI 10.1002/hbm.20324; Whitfield-Gabrieli S, 2012, BRAIN CONNECT, V2, P125, DOI 10.1089/brain.2012.0073; Wilson M, 2019, MAGN RESON MED, V82, P527, DOI 10.1002/mrm.27742; Wilson M, 2011, MAGN RESON MED, V65, P1, DOI 10.1002/mrm.22579; Yan CG, 2016, NEUROINFORMATICS, V14, P339, DOI 10.1007/s12021-016-9299-4; You YX, 2020, J MAGN RESON IMAGING, V51, P1142, DOI 10.1002/jmri.26891	49	2	2	7	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2021	16	9							e0252883	10.1371/journal.pone.0252883	http://dx.doi.org/10.1371/journal.pone.0252883			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YM4DR	34547018	gold, Green Published			2022-12-26	WOS:000746527400003
J	Zhang, WW; Wang, MY				Zhang, Weiwei; Wang, Mingyan			An improved deep forest model for prediction of e-commerce consumers' repurchase behavior	PLOS ONE			English	Article							BIG DATA; NEURAL-NETWORKS; TREE; ALGORITHM; KNN	As the Internet retail industry continues to rise, more and more consumers choose to shop online, especially Chinese consumers. Using consumer behavior data left on the Internet to predict repurchase behavior is of great significance for companies to achieve precision marketing. This paper proposes an improved deep forest model, and the interactive behavior characteristics of users and goods are added into the original feature model to predict the repurchase behavior of e-commerce consumers. Based on the Alibaba mobile e-commerce platform data set, first construct a feature engineering that includes user characteristics, product characteristics, and interactive behavior characteristics. And then use our proposed model to make predictions. Experiments show that the model's overall performance with increased interactive behavior features is better and has higher accuracy. Compared with the existing prediction models, the improved deep forest model has certain advantages, which not only improves the prediction accuracy but also reduces the cost of training time.	[Zhang, Weiwei; Wang, Mingyan] Shanghai Univ Engn Sci, Sch Management, Shanghai, Peoples R China	Shanghai University of Engineering Science	Wang, MY (corresponding author), Shanghai Univ Engn Sci, Sch Management, Shanghai, Peoples R China.	wmycindy2020@126.com		Zhang, Weiwei/0000-0003-4860-675X				Ahmad MW, 2017, ENERG BUILDINGS, V147, P77, DOI 10.1016/j.enbuild.2017.04.038; Alswaina F, 2018, IEEE ACCESS, V6, P76217, DOI 10.1109/ACCESS.2018.2883975; Basith S, 2018, COMPUT STRUCT BIOTEC, V16, P412, DOI 10.1016/j.csbj.2018.10.007; Bhatti UA, 2021, J MED IMAG HEALTH IN, V11, P7, DOI 10.1166/jmihi.2021.3313; Bratu S., 2019, REV CONT PHILOS, V18, P157, DOI DOI 10.22381/RCP18201910; Chen HC, 2012, MIS QUART, V36, P1165; Chen T., 2016, KDD16 P 22 ACM, DOI DOI 10.1145/2939672.2939785; Chen W, 2015 INT ACM REC SYS, P1; Chen XW, 2014, IEEE ACCESS, V2, P514, DOI 10.1109/ACCESS.2014.2325029; Cheng Y., 2020, 46 CHINA STAT REPORT, V7, P36; Cherkassky V, 1997, IEEE Trans Neural Netw, V8, P1564, DOI 10.1109/TNN.1997.641482; Chiu CC, 2017, 2017 IEEE INTERNATIONAL CONFERENCE ON INNOVATIONS IN INTELLIGENT SYSTEMS AND APPLICATIONS (INISTA), P345, DOI 10.1109/INISTA.2017.8001183; Claveria O, 2014, ECON MODEL, V36, P220, DOI 10.1016/j.econmod.2013.09.024; Geurts P, 2006, MACH LEARN, V63, P3, DOI 10.1007/s10994-006-6226-1; Goel S., 2014, ECON MODEL, V36, P220; Goel S, 2010, P NATL ACAD SCI USA, V107, P17486, DOI 10.1073/pnas.1005962107; Hamsa H, 2016, PROC TECH, V25, P326, DOI 10.1016/j.protcy.2016.08.114; Hou CY, 2018, IEICE T INF SYST, VE101D, P1441, DOI 10.1587/transinf.2017EDL8210; Koehn D, 2020, EXPERT SYST APPL, V150, DOI 10.1016/j.eswa.2020.113342; Kumar A, 2019, NEURAL COMPUT APPL, V31, P877, DOI 10.1007/s00521-017-3047-z; Lee TS, 2006, COMPUT STAT DATA AN, V50, P1113, DOI 10.1016/j.csda.2004.11.006; Liu CJ, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0243105; Lzroiu G, 2020, SHS WEB C, V74, P1209; Ma C, 2020, PATTERN RECOGN, V107, DOI 10.1016/j.patcog.2020.107499; Manavalan B, 2019, COMPUT STRUCT BIOTEC, V17, P972, DOI 10.1016/j.csbj.2019.06.024; Nadeem MA, 2020, DATA TECHNOL APPL, V54, P625, DOI 10.1108/DTA-10-2019-0182; Obermeyer Z, 2016, NEW ENGL J MED, V375, P1216, DOI 10.1056/NEJMp1606181; Prodanova J, 2020, J ORG COMP ELECT COM, V30, P187, DOI 10.1080/10919392.2020.1739395; Riaz MU, 2021, BEHAV INFORM TECHNOL, V40, P99, DOI 10.1080/0144929X.2020.1846790; Rodriguez-Galiano V, 2015, ORE GEOL REV, V71, P804, DOI 10.1016/j.oregeorev.2015.01.001; Sanjar K, 2020, ISPRS INT J GEO-INF, V9, DOI 10.3390/ijgi9040227; Song PY, 2020, TEH VJESN, V27, P1467, DOI 10.17559/TV-20200808113807; Uddin M.T., 2015, HUMAN ACTIVITY RECOG; Vapnik V.N., 1998, STAT LEARNING THEORY, P123; Verma VK, 2018, J CLEAN PROD, V172, P1152, DOI 10.1016/j.jclepro.2017.10.047; Victor Mayer-Schonberger., 2013, ERA BIG DATA BIG CHA, P20; Wang YC, 2019, IND MANAGE DATA SYST, V120, P21, DOI 10.1108/IMDS-01-2019-0016; Wang ZL, 2015, J HYDROL, V527, P1130, DOI 10.1016/j.jhydrol.2015.06.008; Wu XD, 2014, IEEE T KNOWL DATA EN, V26, P97, DOI 10.1109/TKDE.2013.109; Xia B, 2015, IEEE T NANOBIOSCI, V14, P882, DOI 10.1109/TNB.2015.2491303; Xu YL, 2019, SUSTAINABILITY-BASEL, V11, DOI 10.3390/su11113164; Yin Z, 2016, NEUROCOMPUTING, V174, P643, DOI 10.1016/j.neucom.2015.09.081; Zerbini C, 2019, FOOD RES INT, V122, P167, DOI 10.1016/j.foodres.2019.04.008; Zhou Z., 2017, P IJCAI, P3553	44	4	4	12	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2021	16	9							e0255906	10.1371/journal.pone.0255906	http://dx.doi.org/10.1371/journal.pone.0255906			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	WG6BN	34543319	Green Published, gold			2022-12-26	WOS:000707078200010
J	Brady, PL; Springer, MS				Brady, Peggy L.; Springer, Mark S.			The effects of fossil taxa, hypothetical predicted ancestors, and a molecular scaffold on pseudoextinction analyses of extant placental orders	PLOS ONE			English	Article							PHYLOGENY; MORPHOLOGY; MAMMALS; RADIATION; ORIGINS; TREE	Pseudoextinction analyses, which simulate extinction in extant taxa, use molecular phylogenetics to assess the accuracy of morphological phylogenetics. Previous pseudoextinction analyses have shown a failure of morphological phylogenetics to place some individual placental orders in the correct superordinal clade. Recent work suggests that the inclusion of hypothetical ancestors of extant placental clades, estimated by ancestral state reconstructions of morphological characters, may increase the accuracy of morphological phylogenetic analyses. However, these studies reconstructed direct hypothetical ancestors for each extant taxon based on a well-corroborated molecular phylogeny, which is not possible for extinct taxa that lack molecular data. It remains to be determined if pseudoextinct taxa, and by proxy extinct taxa, can be accurately placed when their immediate hypothetical ancestors are unknown. To investigate this, we employed molecular scaffolds with the largest available morphological data set for placental mammals. Each placental order was sequentially treated as pseudoextinct by exempting it from the molecular scaffold and recoding soft morphological characters as missing for all its constituent species. For each pseudoextinct data set, we omitted the pseudoextinct taxon and performed a parsimony ancestral state reconstruction to obtain hypothetical predicted ancestors. Each pseudoextinct order was then evaluated in seven parsimony analyses that employed combinations of fossil taxa, hypothetical predicted ancestors, and a molecular scaffold. In treatments that included fossils, hypothetical predicted ancestors, and a molecular scaffold, only 8 of 19 pseudoextinct placental orders (42%) retained the same interordinal placement as on the molecular scaffold. In treatments that included hypothetical predicted ancestors but not fossils or a scaffold, only four placental orders (21%) were recovered in positions that are congruent with the scaffold. These results indicate that hypothetical predicted ancestors do not increase the accuracy of pseudoextinct taxon placement when the immediate hypothetical ancestor of the taxon is unknown. Hypothetical predicted ancestors are not a panacea for morphological phylogenetics.	[Brady, Peggy L.; Springer, Mark S.] Univ Calif Riverside, Dept Evolut Ecol & Evolutionary Biol, Riverside, CA 92521 USA	University of California System; University of California Riverside	Brady, PL; Springer, MS (corresponding author), Univ Calif Riverside, Dept Evolut Ecol & Evolutionary Biol, Riverside, CA 92521 USA.	pbrad003@ucr.edu; springer@ucr.edu		Brady, Peggy/0000-0003-1732-6122	National Science Foundation (NSF) [DEB-1457735]	National Science Foundation (NSF)(National Science Foundation (NSF))	This work was supported by National Science Foundation (NSF) grant DEB-1457735 (M.S.S.). https://www.nsf.gov/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1877, DIFFERENT FORMS FLOW; Asher RJ, 2006, SYST BIOL, V55, P181, DOI 10.1080/10635150500433649; Asher Robert J., 2003, Journal of Mammalian Evolution, V10, P131, DOI 10.1023/A:1025504124129; Asher RJ, 2019, ROY SOC OPEN SCI, V6, DOI 10.1098/rsos.190387; Beck RMD, 2018, P ROY SOC B-BIOL SCI, V285, DOI 10.1098/rspb.2018.1632; Butler P.M., 1972, P253; Butler P.M., 1988, Systematics Association Special Volume Series, P117; BUTLER P. M., 1956, PROC ZOOL SOC LONDON, V126, P453; Carrillo JD, 2017, PALAEONTOL ELECTRON, V20; dos Reis M, 2012, P ROY SOC B-BIOL SCI, V279, P3491, DOI 10.1098/rspb.2012.0683; Emerling CA, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.1817; Esselstyn JA, 2017, GENOME BIOL EVOL, V9, P2308, DOI 10.1093/gbe/evx168; Foley NM, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0140; Giribet G, 2015, ZOOL ANZ, V256, P96, DOI 10.1016/j.jcz.2015.01.003; Goloboff PA, 2019, SYST BIOL, V68, P494, DOI 10.1093/sysbio/syy077; Goloboff PA, 2018, CLADISTICS, V34, P407, DOI 10.1111/cla.12205; Goloboff PA, 2016, CLADISTICS, V32, P221, DOI 10.1111/cla.12160; Guillerme T, 2016, BIOL LETTERS, V12, DOI 10.1098/rsbl.2015.1003; HILLIS DM, 1987, ANNU REV ECOL SYST, V18, P23, DOI 10.1146/annurev.es.18.110187.000323; Hofreiter M, 2001, NAT REV GENET, V2, P353, DOI 10.1038/35072071; Koch NM, 2021, P ROY SOC B-BIOL SCI, V288, DOI 10.1098/rspb.2021.0044; Koch NM, 2020, SYST BIOL, V69, P1052, DOI 10.1093/sysbio/syaa023; Leche W., 1885, KUNGL SVENSKA VETENS, V21, P1; Lee MSY, 2015, CURR BIOL, V25, pR922, DOI 10.1016/j.cub.2015.07.009; MACPHEE RDE, 1993, MAMMAL PHYLOGENY : PLACENTALS, P13; Maddison WP., 2018, MESQUITE MODEULAR SY; Madsen O, 2001, NATURE, V409, P610, DOI 10.1038/35054544; Meredith RW, 2011, SCIENCE, V334, P521, DOI 10.1126/science.1211028; Murphy WJ, 2021, ANNU REV ANIM BIOSCI, V9, P29, DOI 10.1146/annurev-animal-061220-023149; Murphy WJ, 2001, SCIENCE, V294, P2348, DOI 10.1126/science.1067179; Murphy WJ, 2001, NATURE, V409, P614, DOI 10.1038/35054550; NOVACEK M J, 1986, Cladistics, V2, P257, DOI 10.1111/j.1096-0031.1986.tb00463.x; NOVACEK MJ, 1992, SYST BIOL, V41, P58, DOI 10.2307/2992506; NOVACEK MJ, 1992, NATURE, V356, P121, DOI 10.1038/356121a0; O'Leary MA, 2013, SCIENCE, V339, P662, DOI 10.1126/science.1229237; Parins-Fukuchi C, 2018, SYST BIOL, V67, P328, DOI 10.1093/sysbio/syx072; Pattinson DJ, 2015, SYST BIOL, V64, P169, DOI 10.1093/sysbio/syu077; ROBINSON DF, 1981, MATH BIOSCI, V53, P131, DOI 10.1016/0025-5564(81)90043-2; Sansom RS, 2018, BIOL LETTERS, V14, DOI 10.1098/rsbl.2018.0263; Sansom RS, 2013, SCI REP-UK, V3, DOI 10.1038/srep02545; Schrago CG, 2018, J EVOLUTION BIOL, V31, P1477, DOI 10.1111/jeb.13344; Shoshani J, 1998, MOL PHYLOGENET EVOL, V9, P572, DOI 10.1006/mpev.1998.0520; Springer MS, 2008, SYST BIOL, V57, P499, DOI 10.1080/10635150802164504; Springer MS, 2007, SYST BIOL, V56, P673, DOI 10.1080/10635150701491149; Springer Mark S., 2005, P37; Springer MS, 2019, FRONT GENET, V10, DOI 10.3389/fgene.2019.01241; Springer MS, 2017, MOL PHYLOGENET EVOL, V106, P86, DOI 10.1016/j.ympev.2016.09.017; Springer MS, 2013, SCIENCE, V341, DOI 10.1126/science.1238025; Springer MS, 1997, NATURE, V388, P61, DOI 10.1038/40386; Springer MS, 2003, P NATL ACAD SCI USA, V100, P1056, DOI 10.1073/pnas.0334222100; Springer MS, 2001, P NATL ACAD SCI USA, V98, P6241, DOI 10.1073/pnas.111551998; Stanhope MJ, 1998, P NATL ACAD SCI USA, V95, P9967, DOI 10.1073/pnas.95.17.9967; Stanhope MJ, 1998, MOL PHYLOGENET EVOL, V9, P501, DOI 10.1006/mpev.1998.0517; Swofford D.L, 1998, PAUP 4 0 PHYLOGENETI; Szalay Frederick S., 1993, P187; Tarver JE, 2016, GENOME BIOL EVOL, V8, P330, DOI 10.1093/gbe/evv261; Waddell PJ, 1999, SYST BIOL, V48, P1, DOI 10.1093/sysbio/48.1.1; Wagner JA, 1855, SAUGTIERE ABBILDUNGE; Walker FM, 2020, PALAEONTOLOGY, V63, P313, DOI 10.1111/pala.12458; Wiens JJ, 2004, SYST BIOL, V53, P653, DOI 10.1080/10635150490472959; Zou ZT, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12758	61	0	0	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2021	16	9							e0257338	10.1371/journal.pone.0257338	http://dx.doi.org/10.1371/journal.pone.0257338			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	WG5ZQ	34534236	Green Published, gold			2022-12-26	WOS:000707073300024
J	Kaitala, V; Koivu-Jolma, M; Laakso, J				Kaitala, Veijo; Koivu-Jolma, Mikko; Laakso, Jouni			Infective prey leads to a partial role reversal in a predator-prey interaction	PLOS ONE			English	Article							APOSTICHOPUS-JAPONICUS SELENKA; BIOLOGICAL-CONTROL; POPULATION-DYNAMICS; VIBRIO-SPLENDIDUS; BACTERIA; PATHOGENS; SEDIMENTS; BIOMASS; BIODIVERSITY; TEMPERATURE	An infective prey has the potential to infect, kill and consume its predator. Such a prey-predator relationship fundamentally differs from the predator-prey interaction because the prey can directly profit from the predator as a growth resource. Here we present a population dynamics model of partial role reversal in the predator-prey interaction of two species, the bottom dwelling marine deposit feeder sea cucumber Apostichopus japonicus and an important food source for the sea cucumber but potentially infective bacterium Vibrio splendidus. We analyse the effects of different parameters, e.g. infectivity and grazing rate, on the population sizes. We show that relative population sizes of the sea cucumber and V. Splendidus may switch with increasing infectivity. We also show that in the partial role reversal interaction the infective prey may benefit from the presence of the predator such that the population size may exceed the value of the carrying capacity of the prey in the absence of the predator. We also analysed the conditions for species extinction. The extinction of the prey, V. splendidus, may occur when its growth rate is low, or in the absence of infectivity. The extinction of the predator, A. japonicus, may follow if either the infectivity of the prey is high or a moderately infective prey is abundant. We conclude that partial role reversal is an undervalued subject in predator-prey studies.	[Kaitala, Veijo; Laakso, Jouni] Univ Helsinki, Fac Biol & Environm Sci, Organismal & Evolutionary Biol Res Programme, Helsinki, Finland; [Koivu-Jolma, Mikko] Univ Helsinki, Fac Sci, Dept Phys, Helsinki, Finland	University of Helsinki; University of Helsinki	Kaitala, V (corresponding author), Univ Helsinki, Fac Biol & Environm Sci, Organismal & Evolutionary Biol Res Programme, Helsinki, Finland.	Veijo.Kaitala@Helsinki.Fi	Laakso, Jouni/I-7794-2013	Laakso, Jouni/0000-0001-8245-9912; Koivu-Jolma, Mikko/0000-0002-2854-7927; kaitala, veijo/0000-0001-5626-9752				Amaro T, 2012, DEEP-SEA RES PT I, V63, P82, DOI 10.1016/j.dsr.2012.01.007; Amaro T, 2009, DEEP-SEA RES PT I, V56, P1834, DOI 10.1016/j.dsr.2009.05.014; ANDERSON RM, 1979, NATURE, V280, P361, DOI 10.1038/280361a0; ANDERSON RM, 1981, PHILOS T R SOC B, V291, P451, DOI 10.1098/rstb.1981.0005; Anttila J, 2017, OIKOS, V126, P910, DOI 10.1111/oik.03242; Anttila J, 2016, OIKOS, V125, P1144, DOI 10.1111/oik.02913; Anttila J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145511; Anttila J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071621; BARKAI A, 1988, SCIENCE, V242, P62, DOI 10.1126/science.242.4875.62; BRATBAK G, 1985, APPL ENVIRON MICROB, V49, P1488, DOI 10.1128/AEM.49.6.1488-1493.1985; Briggs CJ., 2012, ENCY THEORETICAL ECO, P498, DOI [10.1525/9780520951785-089, DOI 10.1525/9780520951785-089]; Brown SP, 2012, TRENDS MICROBIOL, V20, P336, DOI 10.1016/j.tim.2012.04.005; Casadevall A, 2008, ANNU REV MICROBIOL, V62, P19, DOI 10.1146/annurev.micro.61.080706.093305; Cator LJ, 2020, FRONT ECOL EVOL, V8, DOI 10.3389/fevo.2020.00189; Cermak N, 2017, ISME J, V11, P825, DOI 10.1038/ismej.2016.161; DEMING JW, 1982, APPL ENVIRON MICROB, V44, P1222, DOI 10.1128/AEM.44.5.1222-1230.1982; Deng H, 2009, AQUACULTURE, V287, P18, DOI 10.1016/j.aquaculture.2008.10.015; Dobson AP, 1996, BIOSCIENCE, V46, P115, DOI 10.2307/1312814; Edelstein-Keshet L., 1988, MATH MODELS BIOL; Gao F., 2020, J FISH CHINA, V34, P760; Gao F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100092; Han QX, 2016, REV FISH SCI AQUAC, V24, P326, DOI 10.1080/23308249.2016.1193472; Hardaway S.C., 2016, ENCY ESTUARIES, DOI [10.1007/978-94-017-8801-4_312, DOI 10.1007/978-94-017-8801-4_312, DOI 10.1007/978-94-017-8801-4_15]; Hassell M.P., 1976, DYNAMICS COMPETITION; Hassell MP., 1978, DYNAMICS ARTHROPOD P; Heesterbeek J. A. P., 1995, P90, DOI 10.1017/CBO9780511629396.004; IVES AR, 1992, AM NAT, V140, P1, DOI 10.1086/285400; Jagtap SS, 2014, APPL ENVIRON MICROB, V80, P4207, DOI 10.1128/AEM.01285-14; Kaitala V, 2017, ADV ENV MICROBIOLOGY, V4, P213, DOI 10.1007/978-3-319-60616-3_8; Lafferty KD, 2006, P NATL ACAD SCI USA, V103, P11211, DOI 10.1073/pnas.0604755103; Liu NN, 2017, AQUACULTURE, V470, P68, DOI 10.1016/j.aquaculture.2016.12.028; Liu SL, 2018, MICROBIOLOGYOPEN, V7, DOI 10.1002/mbo3.600; Liu XJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058293; Lotka A. J., 1925, ELEMENTS PHYS BIOL, DOI 10.1038/116461b0; Lysenko VN, 2018, RUSS J MAR BIOL+, V44, P164, DOI 10.1134/S1063074018020074; MAY RM, 1981, J ANIM ECOL, V50, P855, DOI 10.2307/4142; MAY RM, 1979, NATURE, V280, P455, DOI 10.1038/280455a0; Merikanto I, 2018, THEOR BIOL MED MODEL, V15, DOI 10.1186/s12976-018-0079-8; Merikanto I, 2017, ECOL MODEL, V347, P85, DOI 10.1016/j.ecolmodel.2017.01.002; Merikanto I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113436; Merikanto I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050158; Mills NJ, 1996, ECOL MODEL, V92, P121, DOI 10.1016/0304-3800(95)00177-8; MORIARTY DJW, 1982, AUST J MAR FRESH RES, V33, P255, DOI 10.1071/MF9820255; Navarro PG, 2014, J EXP MAR BIOL ECOL, V453, P123, DOI 10.1016/j.jembe.2014.01.008; Neidhardt FC., 1996, ESCHERICIA COLI SALM, V2nd; Nicholson A. J., 1935, P ZOOL SOC LOND, V105, P551, DOI DOI 10.1111/J.1096-3642.1935.TB01680.X; Nilsson J, 2019, J ANIM ECOL, V88, P927, DOI 10.1111/1365-2656.12981; Plotieau T, 2013, MAR BIOL, V160, P3087, DOI 10.1007/s00227-013-2297-2; Sanchez-Garduno F, 2014, ROY SOC OPEN SCI, V1, DOI 10.1098/rsos.140186; SCAVIA D, 1988, LIMNOL OCEANOGR, V33, P1220, DOI 10.4319/lo.1988.33.5.1220; SchmidHempel P, 2011, EVOLUTIONARY PARASITOLOGY: THE INTEGRATED STUDY OF INFECTIONS, IMMUNOLOGY, ECOLOGY, AND GENETICS, P1; Scott ME., 1994, PARASITIC INFECT DIS; Sun JM, 2015, PHYSIOL BEHAV, V139, P336, DOI 10.1016/j.physbeh.2014.11.051; Thompson FL, 2004, MICROBIOL MOL BIOL R, V68, P403, DOI 10.1128/MMBR.68.3.403-431.2004; Veneault-Fourrey C, 2011, CURR OPIN PLANT BIOL, V14, P444, DOI 10.1016/j.pbi.2011.03.022; Vezzulli L, 2015, ENVIRON MICROBIOL, V17, P1065, DOI 10.1111/1462-2920.12484; VOLTERRA VITO, 1926, MEM R ACCAD NAZ LINCEI CL FIS MAT E NAT, V2, P31; WATSON SW, 1977, APPL ENVIRON MICROB, V33, P940, DOI 10.1128/AEM.33.4.940-946.1977; Xu HC, 2019, AQUAC RES, V50, P1257, DOI 10.1111/are.14002; Xu Q., 2015, DEV AQUA FISH SCI, V39, P153; Yamazaki Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep21631; Yang HS, 2005, AQUAC RES, V36, P1085, DOI 10.1111/j.1365-2109.2005.01325.x; YINGST JY, 1976, J EXP MAR BIOL ECOL, V23, P55, DOI 10.1016/0022-0981(76)90085-X; Zhang Z, 2019, AQUACULTURE, V513, DOI 10.1016/j.aquaculture.2019.734427; Zhang Z, 2019, AQUACULTURE, V507, P155, DOI 10.1016/j.aquaculture.2019.03.054	65	0	0	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2021	16	9							e0249156	10.1371/journal.pone.0249156	http://dx.doi.org/10.1371/journal.pone.0249156			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	WG5ZQ	34534219	Green Published, gold, Green Submitted			2022-12-26	WOS:000707073300001
J	Browning, TN; Sawyer, DE				Browning, Trevor N.; Sawyer, Derek E.			Erosion and deposition vulnerability of small (<5,000 km(2)) tropical islands	PLOS ONE			English	Article							ST-JOHN; CORAL-REEFS; SEDIMENT PRODUCTION; WATER-QUALITY; RUNOFF; ROADS; GIS; RUSLE; LAND; QUEENSLAND	The tropics are naturally vulnerable to watershed erosion. This region is rapidly growing (projected to be 50% of the global population by 2050) which exacerbates erosional issues by the subsequent land use change. The issue is particularly of interest on the many (~45,000) small tropical (<5,000 km(2)) islands, and their >115M residents, where ecotourism and sediment intolerant ecosystems such as coral reefs are the main driver of their economies. However, vulnerability to erosion and deposition is poorly quantified in these regions due to the misclassification or exclusion of small islands in coarse global analyses. We use the only vulnerability assessment method that connects watershed erosion and coastal deposition to compare locally sourced, high-resolution datasets (5 x 5 m) to satellite-collected, remotely sensed low-resolution datasets (463 x 463 m). We find that on the island scale (~52 km(2)) the difference in vulnerability calculated by the two methods is minor. On the watershed scale however, low-resolution datasets fail to accurately demonstrate watershed and coastal deposition vulnerability when compared to high-resolution analysis. Specifically, we find that anthropogenic development (roads and buildings) is poorly constrained at a global scale. Structures and roads are difficult to identify in heavily forested regions using satellite algorithms and the rapid, ongoing rate of development aggravates the issue. We recommend that end-users of this method obtain locally sourced anthropogenic development datasets for the best results while using low resolution datasets for the other variables. Fortunately, anthropogenic development data can be easily collected using community-based research or identified using satellite imagery by any level of user. Using high-resolution results, we identify a development trend across St. John and regions that are both high risk and possible targets for future development. Previously published modeled and measured sedimentation rates demonstrate the method is accurate when using low-resolution or high-resolution data but, anthropogenic development, watershed slope, and earthquake probability datasets should be of the highest resolution depending on the region specified.	[Browning, Trevor N.; Sawyer, Derek E.] Ohio State Univ, Sch Earth Sci, Columbus, OH 43210 USA; [Browning, Trevor N.] Elmira Coll, Dept Math & Nat Sci, New York, NY USA	University System of Ohio; Ohio State University	Browning, TN (corresponding author), Ohio State Univ, Sch Earth Sci, Columbus, OH 43210 USA.	browning.257@osu.edu	Sawyer, Derek/GRR-9387-2022; Sawyer, Derek/S-3968-2019	Sawyer, Derek/0000-0002-0779-7775; 				Alexakis DD, 2013, ATMOS RES, V131, P108, DOI 10.1016/j.atmosres.2013.02.013; Alminas HV, 1994, GEOCHEMISTRY MINERAL; Army Corps of Engineers US, 2012, USCE NCMP 4 BAND 8 B; Arnberger H., 2001, TROPICAL ISLANDS IND; Barbier EB, 2011, ECOL MONOGR, V81, P169, DOI 10.1890/10-1510.1; Beck MW, 2001, BIOSCIENCE, V51, P633, DOI 10.1641/0006-3568(2001)051[0633:TICAMO]2.0.CO;2; Behera R, 2019, NAT HAZARDS, V96, P731, DOI 10.1007/s11069-018-03566-0; Bjork M, 1995, AMBIO, V24, P502; Borrelli P, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02142-7; Boruff BJ, 2005, J COASTAL RES, V21, P932, DOI 10.2112/04-0172.1; Brooks GR, 2007, CARIBB J SCI, V43, P226; Brooks GR, 2015, HOLOCENE, V25, P1015, DOI 10.1177/0959683615575357; Browning TN., COMPILATION CENSUS D; Browning TN, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-020-79402-y; Browning TN, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-43062-4; Browning TN, 2016, CARIBB J SCI, V49, P38, DOI 10.18475/cjos.v49i1.a5; Bureau UC, 2017, MAST ADDR FIL TOP IN; Carroll S, 2013, WATER RESOUR MANAG, V27, P3433, DOI 10.1007/s11269-013-0356-6; Census US, 2014, 2010 CENS POP HOUS U; Chatterjee S, 2014, ENVIRON EARTH SCI, V71, P357, DOI 10.1007/s12665-013-2439-3; Cosner OJ., 1972, WATER ST JOHN US VIR, P2331; Cruz-Palacios V, 2005, J EXP MAR BIOL ECOL, V324, P44, DOI 10.1016/j.jembe.2005.04.002; Edmunds PJ, 2014, HYDROBIOLOGIA, V734, P143, DOI 10.1007/s10750-014-1876-7; Emanuel K, 2005, NATURE, V436, P686, DOI 10.1038/nature03906; Fernandez C, 2003, J SOIL WATER CONSERV, V58, P128; Forsyth AR, 2006, FOREST ECOL MANAG, V221, P194, DOI 10.1016/j.foreco.2005.09.018; Giardini D, 1999, ANN GEOFIS, V42, P1225; Goldsmith ST, 2010, GEOCHIM COSMOCHIM AC, V74, P85, DOI 10.1016/j.gca.2009.10.009; Gornitz VM., 1992, 3913 OAK RIDG NAT LA; GRAYSON RB, 1993, J HYDROL, V150, P459, DOI 10.1016/0022-1694(93)90121-O; Group GC, 2019, GEBCO 2019 GRID; Gutierrez BT., 2014, US GEOLOGICAL SURVEY, P2331; Harding SM., 2014, STATE OF THE TROPICS; Hartmann J, 2009, GLOBAL PLANET CHANGE, V69, P185, DOI 10.1016/j.gloplacha.2009.07.007; Heck K., 1996, ECOLOGICAL ANAL SEAG; Information NNCfE, 2015, H12272 NOAA; Irving AD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018311; Jana A, 2013, J INDIAN SOC REMOTE, V41, P675, DOI 10.1007/s12524-012-0251-2; Jaramillo F, 2016, LAND DEGRAD DEV, V27, P1064, DOI 10.1002/ldr.2347; Kane HH, 2012, J COASTAL RES, V28, P533, DOI 10.2112/JCOASTRES-D-11-00114.1; Koshiba S, 2013, WETL ECOL MANAG, V21, P157, DOI 10.1007/s11273-013-9288-4; Larson RA, 2015, APPL GEOCHEM, V63, P573, DOI 10.1016/j.apgeochem.2015.01.008; Latrubesse EM, 2009, GEOMORPHOLOGY, V113, P239, DOI 10.1016/j.geomorph.2009.03.014; Ludwig W., 2011, ISLSCP 2 GLOBAL RIVE; MacDonald LH, 1997, ENVIRON MANAGE, V21, P851, DOI 10.1007/s002679900072; MacDonald LH, 2001, EARTH SURF PROC LAND, V26, P251, DOI 10.1002/1096-9837(200103)26:3&lt;251::AID-ESP173&gt;3.0.CO;2-X; Management NOfC, 2013, NOAA TOP LID US VIRG; Management NOfC, USVI STJOHN 2012 LAN; Millward AA, 1999, CATENA, V38, P109, DOI 10.1016/S0341-8162(99)00067-3; Moberg F, 1999, ECOL ECON, V29, P215, DOI 10.1016/S0921-8009(99)00009-9; Montz BE., 2017, NATURAL HAZARDS; Mueller C, 2010, EARTHQ SPECTRA, V26, P169, DOI 10.1193/1.3277667; Murali RM, 2013, NAT HAZARD EARTH SYS, V13, P3291, DOI 10.5194/nhess-13-3291-2013; Nagle GN, 1999, ENVIRON MANAGE, V23, P441, DOI 10.1007/s002679900199; Naipal V, 2015, GEOSCI MODEL DEV, V8, P2893, DOI 10.5194/gmd-8-2893-2015; Nam P.T., 2003, GEOINFORMATICS, V14, P49, DOI [10.6010/geoinformatics.14.49, DOI 10.6010/GEOINFORMATICS.14.49]; Nations U, LEAST DEV COUNTR DAT; O'Gorman PA, 2015, CURR CLIM CHANGE REP, V1, P49, DOI 10.1007/s40641-015-0009-3; Panagos P, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04282-8; Parthasarathy A, 2015, NAT HAZARDS, V75, P1713, DOI 10.1007/s11069-014-1394-y; Pidwirny M., 2006, SURFACE AREA OUR PLA; PREEN AR, 1995, AQUAT BOT, V52, P3, DOI 10.1016/0304-3770(95)00491-H; Ramos-Scharron CE, 2012, J SOIL WATER CONSERV, V67, P87, DOI [10.2489/jSWC.67.2.87, 10.2489/jswc.67.2.87]; Ramos-Scharron CE, 2007, J ENVIRON MANAGE, V84, P157, DOI 10.1016/j.jenvman.2006.05.019; Ramos-Scharron CE, 2018, GEODERMA, V310, P107, DOI 10.1016/j.geoderma.2017.08.035; Ramos-Scharron CE, 2016, J HYDROL, V533, P168, DOI 10.1016/j.jhydrol.2015.11.051; Rogers CS, 2019, DIVERSITY-BASEL, V11, DOI 10.3390/d11080130; ROGERS CS, 1990, MAR ECOL PROG SER, V62, P185, DOI 10.3354/meps062185; Shanley JB, 2011, WATER RESOUR RES, V47, DOI 10.1029/2010WR009788; Shedlock K., 2000, SEISMOL RES LETT, V71, P679; Sheppard C, 2005, ESTUAR COAST SHELF S, V64, P223, DOI 10.1016/j.ecss.2005.02.016; Soil Survey, 2019, SOIL SURV GEOGR SSUR; Thieler ER., 2000, NATL ASSESSSMENT COA, P2327; Wemple BC, 2018, ECOHYDROLOGY, V11, DOI 10.1002/eco.1881; White AT, 2000, MAR POLLUT BULL, V40, P598, DOI 10.1016/S0025-326X(00)00022-9; WRI NOAA, 2005, REL VULN ER ST JOHN; Yates KK, 2014, BIOGEOSCIENCES, V11, P4321, DOI 10.5194/bg-11-4321-2014; Zhang HM, 2017, GEODERMA, V308, P36, DOI 10.1016/j.geoderma.2017.08.006; Zitello AG., 2009, SHALLOW WATER BENTHI	79	0	0	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2021	16	9							e0253080	10.1371/journal.pone.0253080	http://dx.doi.org/10.1371/journal.pone.0253080			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	WG5YY	34529668	Green Published, gold			2022-12-26	WOS:000707071500006
J	Cevik, AA; Alao, DO; Eid, HO; Grivna, M; Abu-Zidan, FM				Cevik, Arif Alper; Alao, David O.; Eid, Hani O.; Grivna, Michal; Abu-Zidan, Fikri M.			Current changes in the epidemiology of fall-related injuries in Al Ain City, United Arab Emirates	PLOS ONE			English	Article							MORTALITY; TRENDS; TRAUMA	Background Falls in the Gulf countries are the second most common cause of injuries. The United Arab Emirates government implemented various preventive measures to decrease injuries in the country. We aimed to evaluate the changes in the epidemiology of fall-related injuries in Al-Ain City over the last decade. Methods Data of hospitalized patients who presented with fall-related injuries to the Al-Ain Hospital during the two periods of March 2003 to March 2006 and January 2014 to December 2017 were compared. This included patients' demographics, mechanism, location, anatomical distribution and parameters related to injury severity. Non-parametric tests were used for the statistical analysis. Results 882 in the first and 1358 patients in the second period were studied. The incidence of falls decreased by 30.5% over ten years. The number of elderly, female patients, and UAE nationals increased, (p < 0.001, p = 0.004, and p < 0.001). Falls from height decreased by 32.5% (p < 0.001) while fall on the same level increased by 22.5% (p < 0.001). Fall-related injuries at home have increased significantly by 22.6% (p <0.001), while falls in workplaces decreased by 24.4% (p <0.001). Conclusions Our study showed that the overall incidence of falls decreased compared to a decade ago. The preventive measures were effective in reducing falls from height and workplace injuries. Future preventive measures should target falls at the same level and homes.	[Cevik, Arif Alper; Alao, David O.] UAE Univ, Coll Med & Hlth Sci, Dept Internal Med, Al Ain, U Arab Emirates; [Alao, David O.] Al Ain Hosp, Dept Emergency Med, Al Ain, U Arab Emirates; [Eid, Hani O.] Mediclin Airport Rd Hosp, Emergency Dept, Abu Dhabi, U Arab Emirates; [Grivna, Michal] UAE Univ, Coll Med & Hlth Sci, Inst Publ Hlth, Al Ain, U Arab Emirates; [Abu-Zidan, Fikri M.] UAE Univ, Coll Med & Hlth Sci, Dept Surg, Al Ain, U Arab Emirates	United Arab Emirates University; United Arab Emirates University; United Arab Emirates University	Cevik, AA (corresponding author), UAE Univ, Coll Med & Hlth Sci, Dept Internal Med, Al Ain, U Arab Emirates.	aacevik@uaeu.ac.ae	Abu-Zidan, Fikri/GWE-2835-2022	Eid, Hani/0000-0003-0936-0419; Cevik, Arif Alper/0000-0001-6691-6298				Abolfotouh MA, 2018, OPEN ACCESS EMERG M, V10, P89, DOI 10.2147/OAEM.S166026; Abu Dhabi United Arab Emirates: Ministry of Health, 2006, PREV MED SECT ANN R; Abu-Zidan FM, 2012, CLIN J SPORT MED, V22, P467, DOI 10.1097/JSM.0b013e318258772a; Adam SH, 2008, ARCH GERONTOL GERIAT, V47, P377, DOI 10.1016/j.archger.2007.08.018; Al-Balushi Hassan, 2012, Oman Med J, V27, P486, DOI 10.5001/omj.2012.116; Al-Rubaee Faisal Rabia, 2011, Oman Med J, V26, P315, DOI 10.5001/omj.2011.79; Alao DO, 2020, WORLD J EMERG SURG, V15, DOI 10.1186/s13017-020-00327-y; Asim Mohammad, 2014, J Emerg Trauma Shock, V7, P88, DOI 10.4103/0974-2700.130878; Barss P, 2009, OCCUP MED-OXFORD, V59, P493, DOI 10.1093/occmed/kqp101; Bener A, 2012, INT J INJ CONTROL SA, V19, P368, DOI 10.1080/17457300.2012.656314; Goetz S M, 2000, Ther Umsch, V57, P733, DOI 10.1024/0040-5930.57.12.733; Grivna M, 2014, SCAND J TRAUMA RESUS, V22, DOI 10.1186/s13049-014-0051-5; Grivna M, 2012, INT J INJ CONTROL SA, V19, P278, DOI 10.1080/17457300.2012.696660; Guizzo WA., 2020, REV COL BRAS CIR, V47, DOI [10.1590/0100-6991e-20202408, DOI 10.1590/0100-6991E-20202408]; Haagsma JA, 2016, INJURY PREV, V22, P3, DOI 10.1136/injuryprev-2015-041616; Hassard TH., 1991, UNDERSTANDING BIOSTA, VFirst, P75; Hussain Ashraf Ma, 2019, Qatar Med J, V2019, P14, DOI 10.5339/qmj.2019.14; Khan HTA, 2017, AGEING INT, V42, P466, DOI 10.1007/s12126-017-9303-9; Rahman MH, 2016, INT J INJ CONTROL SA, V23, P214, DOI 10.1080/17457300.2014.908225; Sasidharan DK, 2020, BMJ OPEN, V10, DOI 10.1136/bmjopen-2019-033691; Schonwetter RS, 2010, J PALLIAT MED, V13, P1353, DOI 10.1089/jpm.2010.0140; Shaban Sami, 2009, World J Emerg Surg, V4, P42, DOI 10.1186/1749-7922-4-42; Shaban Sami, 2010, BMC Res Notes, V3, P187, DOI 10.1186/1756-0500-3-187; Statistics Centre, AB DHAB; Stevens JA, 2005, INJURY PREV, V11, P115, DOI 10.1136/ip.2004.005835; Timsina LR, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176561; Tuma Mazin A, 2013, Int J Crit Illn Inj Sci, V3, P3, DOI 10.4103/2229-5151.109408; United Arab Emirates Government Portal, HLTH SAF WORKPL; United Arab Emirates Ministry of Economy, 2006, PREL RES POP HOUS, P6; Verma SK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150939; WHO, 2018, GLOB HLTH EST 2019 D; WHO, 2007, WHO GLOB REP FALLP; World Health Organization, 2002, INJURY CHART BOOK GR; World Health Organization, 2018, FALLS; World Health Organization, 2014, INJ VIOL FACTS 2014	35	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2021	16	9							e0257398	10.1371/journal.pone.0257398	http://dx.doi.org/10.1371/journal.pone.0257398			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	WG5YY	34529683	Green Published, gold			2022-12-26	WOS:000707071500054
J	Gafni, A; Dite, GS; Tuff, ES; Allman, R; Hopper, JL				Gafni, Aviv; Dite, Gillian S.; Tuff, Erika Spaeth; Allman, Richard; Hopper, John L.			Ability of known colorectal cancer susceptibility SNPs to predict colorectal cancer risk: A cohort study within the UK Biobank	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; FAMILY-HISTORY; GENETIC RISK; POLYGENIC RISK; MODEL; INDIVIDUALS; SCORE; AGE	Colorectal cancer risk stratification is crucial to improve screening and risk-reducing recommendations, and consequently do better than a one-size-fits-all screening regimen. Current screening guidelines in the UK, USA and Australia focus solely on family history and age for risk prediction, even though the vast majority of the population do not have any family history. We investigated adding a polygenic risk score based on 45 single-nucleotide polymorphisms to a family history model (combined model) to quantify how it improves the stratification and discriminatory performance of 10-year risk and full lifetime risk using a prospective population-based cohort within the UK Biobank. For both 10-year and full lifetime risk, the combined model had a wider risk distribution compared with family history alone, resulting in improved risk stratification of nearly 2-fold between the top and bottom risk quintiles of the full lifetime risk model. Importantly, the combined model can identify people (n = 72,019) who do not have family history of colorectal cancer but have a predicted risk that is equivalent to having at least one affected first-degree relative (n = 44,950). We also confirmed previous findings by showing that the combined full lifetime risk model significantly improves discriminatory accuracy compared with a simple family history model 0.673 (95% CI 0.664-0.682) versus 0.666 (95% CI 0.657-0.675), p = 0.0065. Therefore, a combined polygenic risk score and first-degree family history model could be used to improve risk stratified population screening programs.	[Gafni, Aviv; Dite, Gillian S.; Allman, Richard] Genet Technol Ltd, Fitzroy, Vic, Australia; [Tuff, Erika Spaeth] Phenogen Sci Inc, Charlotte, NC USA; [Allman, Richard; Hopper, John L.] Univ Melbourne, Ctr Epidemiol & Biostat, Parkville, Vic, Australia	University of Melbourne	Gafni, A (corresponding author), Genet Technol Ltd, Fitzroy, Vic, Australia.	aviv.gafni@gtglabs.com		Spaeth, Erika/0000-0002-5397-3493; Dite, Gillian/0000-0002-2448-2548; Allman, Richard/0000-0002-8635-5237	Medical Research Council [MC_PC_17228, MC_QA137853] Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Aaltonen L, 2007, CLIN CANCER RES, V13, P356, DOI 10.1158/1078-0432.CCR-06-1256; Archambault AN, 2020, GASTROENTEROLOGY, V158, P1274, DOI 10.1053/j.gastro.2019.12.012; Biobank UK., 2006, PROTOCOL LARGE SCALE; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Bycroft C, 2018, NATURE, V562, P203, DOI 10.1038/s41586-018-0579-z; Carr PR, 2020, GASTROENTEROLOGY, V159, P129, DOI 10.1053/j.gastro.2020.03.016; Carr PR, 2018, GASTROENTEROLOGY, V155, P1805, DOI 10.1053/j.gastro.2018.08.044; Czene K, 2002, INT J CANCER, V99, P260, DOI 10.1002/ijc.10332; Dekker E, 2019, LANCET, V394, P1467, DOI 10.1016/S0140-6736(19)32319-0; Delgado-Rodriguez M, 2004, J EPIDEMIOL COMMUN H, V58, P635, DOI 10.1136/jech.2003.008466; Dunlop MG, 2013, GUT, V62, P871, DOI 10.1136/gutjnl-2011-300537; Fry A, 2017, AM J EPIDEMIOL, V186, P1026, DOI 10.1093/aje/kwx246; FUCHS CS, 1994, NEW ENGL J MED, V331, P1669, DOI 10.1056/NEJM199412223312501; Henrikson NB, 2015, GENET MED, V17, P702, DOI 10.1038/gim.2014.188; Hsu L, 2015, GASTROENTEROLOGY, V148, P1330, DOI 10.1053/j.gastro.2015.02.010; Jenkins MA, 2019, FAM CANCER, V18, P389, DOI 10.1007/s10689-019-00136-6; Jenkins MA, 2018, MED J AUSTRALIA, V209, P455, DOI 10.5694/mja18.00142; Jenkins MA, 2016, FUTURE ONCOL, V12, P503, DOI 10.2217/fon.15.303; Kachuri L, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-19600-4; Koo S, 2017, RISK MANAG HEALTHC P, V10, P177, DOI 10.2147/RMHP.S109116; KUNE GA, 1987, DIS COLON RECTUM, V30, P600, DOI 10.1007/BF02554806; Ladabaum U, 2019, GASTROENTEROLOGY, V157, P137, DOI 10.1053/j.gastro.2019.03.023; Li S, 2021, AM J HUM GENET, V108, P525, DOI 10.1016/j.ajhg.2021.02.002; Li X, 2020, INT J CANCER, V147, P3431, DOI 10.1002/ijc.33191; Lichtenstein P, 2000, NEW ENGL J MED, V343, P78, DOI 10.1056/NEJM200007133430201; Lin JS, 2016, SCREENING COLORECTAL; Lowery JT, 2016, CANCER-AM CANCER SOC, V122, P2633, DOI 10.1002/cncr.30080; MacInnis RJ, 2013, BRIT J CANCER, V109, P1296, DOI 10.1038/bjc.2013.382; Mai PL, 2011, JNCI-J NATL CANCER I, V103, P788, DOI 10.1093/jnci/djr114; Mealiffe ME, 2010, JNCI-J NATL CANCER I, V102, P1618, DOI 10.1093/jnci/djq388; Mitchell RJ, 2004, GUT, V53, P291, DOI 10.1136/gut.2003.027896; Montazeri Z, 2020, GUT, V69, P1460, DOI 10.1136/gutjnl-2019-319313; Naber SK, 2020, JNCI CANCER SPECT, V4, DOI 10.1093/jncics/pkz086; ONS, 2006, CANC REGISTRATION ST; ONS, 2013, CANC REGISTRATION ST; Parkin C, 2018, AUST J GEN PRACT, V47, P859, DOI 10.31128/AJGP-01-18-4472; Patel AP, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.3959; Patel Swati G, 2020, Gastrointest Endosc Clin N Am, V30, P441, DOI 10.1016/j.giec.2020.03.001; Patel VD, 2018, DIGEST DIS SCI, V63, P3084, DOI 10.1007/s10620-018-5187-0; Rabeneck L, 2020, GASTROENTEROLOGY, V158, P447, DOI 10.1053/j.gastro.2019.10.007; Ramsey SD, 2006, GENET MED, V8, P571, DOI 10.1097/01.gim.0000237867.34011.12; Roos VH, 2019, CLIN GASTROENTEROL H, V17, P2657, DOI 10.1016/j.cgh.2019.09.007; Schmit SL, 2016, CARCINOGENESIS, V37, P547, DOI 10.1093/carcin/bgw046; Schoen RE, 2015, GASTROENTEROLOGY, V149, P1438, DOI 10.1053/j.gastro.2015.07.055; Siegel RL, 2017, CA-CANCER J CLIN, V67, P177, DOI 10.3322/caac.21395; Siegel RL, 2009, CANCER EPIDEM BIOMAR, V18, P1695, DOI 10.1158/1055-9965.EPI-09-0186; Stanesby O, 2017, EUR J HUM GENET, V25, P832, DOI 10.1038/ejhg.2017.60; StataCorp, 2019, STAT REL 16 STAT SOF; STEPHENSON BM, 1991, BRIT J SURG, V78, P1162, DOI 10.1002/bjs.1800781005; STJOHN DJB, 1993, ANN INTERN MED, V118, P785, DOI 10.7326/0003-4819-118-10-199305150-00005; Sudlow C, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001779; Sullivan BA, 2020, CANCER EPIDEM BIOMAR, V29, P2269, DOI 10.1158/1055-9965.EPI-20-0465; Syngal S, 2015, AM J GASTROENTEROL, V110, P223, DOI 10.1038/ajg.2014.435; Thomas M, 2020, AM J HUM GENET, V107, P432, DOI 10.1016/j.ajhg.2020.07.006; Wang HS, 2017, INT J CANCER, V140, P2728, DOI 10.1002/ijc.30687; Wang HS, 2013, HUM MOL GENET, V22, P5048, DOI 10.1093/hmg/ddt337; Weigl K, 2019, CLIN TRANSL GASTROEN, V10, DOI 10.14309/ctg.0000000000000106; Weigl K, 2018, GASTROENTEROLOGY, V155, P88, DOI 10.1053/j.gastro.2018.03.030; Weigl K, 2018, CLIN EPIDEMIOL, V10, P143, DOI 10.2147/CLEP.S145636; Weinberg BA, 2019, CURR ONCOL REP, V21, DOI 10.1007/s11912-019-0756-8; Wolf AMD, 2018, CA-CANCER J CLIN, V68, P250, DOI 10.3322/caac.21457; Wong MCS, 2020, CLIN GASTROENTEROL H, V18, P553, DOI 10.1016/j.cgh.2019.07.016	62	2	2	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2021	16	9							e0251469	10.1371/journal.pone.0251469	http://dx.doi.org/10.1371/journal.pone.0251469			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	WG6DR	34525106	Green Published, Green Submitted, gold			2022-12-26	WOS:000707084400003
J	Furuya, R; Yokoyama, H; Dimic, M; Yanai, T; Vogt, T; Kanosue, K				Furuya, Ryosuke; Yokoyama, Hikaru; Dimic, Milos; Yanai, Toshimasa; Vogt, Tobias; Kanosue, Kazuyuki			Difference in racket head trajectory and muscle activity between the standard volley and the drop volley in tennis	PLOS ONE			English	Article							ELBOW FUNCTION	Among tennis coaches and players, the standard volley and drop volley are considered basically similar, but muscles need to be relaxed (deactivation) just at the moment of impact when hitting the drop volley. However, this is not evidence-based. The aim of this study was to clarify racket head trajectory and muscle activity during the drop volley and to compare them with those of the standard volley. We hypothesized that 1) the racket head would move less forward for the drop volley than for the standard volley and 2) the wrist and elbow muscles be relaxed for the drop volley at the time of ball impact. Eleven male college students with sufficient tennis experience volunteered to participate in this study. Wireless EMG sensors recorded activation of the four arm muscles. Each subject performed the standard volley or the drop volley with both a forehand and a backhand from a position near the net. Four high speed video cameras (300 Hz) were set up on the court to measure ball speed and racket head trajectory. Returned ball speed of the drop volley was significantly lower than that of the standard volley (p < 0.05). The racket head moved less forward than in the standard volley, supporting the first hypothesis. Muscle activity of the drop volley, just before and after ball impact for both the forehand and backhand, was lower than that of the standard volley. However, the activity was in the form of a gradual increase as impact time approached, rather than a sudden deactivation (relaxation), which did not support the second hypothesis. For the drop volley, lower muscle activity in the forearm enabled a softer grip and thus allowed a "flip" movement of the racket to diminish the speed of the returned ball.	[Furuya, Ryosuke; Dimic, Milos] Waseda Univ, Grad Sch Sport Sci, Tokorozawa, Saitama, Japan; [Yokoyama, Hikaru] Univ Tokyo, Grad Sch Arts & Sci, Dept Life Sci, Meguro Ku, Tokyo, Japan; [Yanai, Toshimasa; Kanosue, Kazuyuki] Waseda Univ, Fac Sport Sci, Tokorozawa, Saitama, Japan; [Vogt, Tobias] German Sport Univ Cologne, Inst Profess Sport Educ & Sport Qualificat, Cologne, Germany	Waseda University; University of Tokyo; Waseda University; German Sport University Cologne	Kanosue, K (corresponding author), Waseda Univ, Fac Sport Sci, Tokorozawa, Saitama, Japan.	kanosue@waseda.jp	Yokoyama, Hikaru/GLT-6054-2022					Abdel-Aziz Y. I., 1971, P ASP UI S CLOS RANG, P1, DOI [DOI 10.1080/10671188.1967.10616517, 10.14358/PERS.81.2.103]; Chow JW, 2007, BRIT J SPORT MED, V41, DOI 10.1136/bjsm.2007.037184; Chow JW, 1999, MED SCI SPORT EXER, V31, P846, DOI 10.1097/00005768-199906000-00013; Chow JW, 1999, MED SCI SPORT EXER, V31, P855, DOI 10.1097/00005768-199906000-00014; Friston K. J., 1994, Human Brain Mapping, V2, P189, DOI 10.1002/hbm.460020402; GIANGARRA CE, 1993, AM J SPORT MED, V21, P394, DOI 10.1177/036354659302100312; Hoskins-Burney T., 2014, HUMAN KINETICS, P28; MORRIS M, 1989, AM J SPORT MED, V17, P241, DOI 10.1177/036354658901700215; Ozawa Y, 2019, SPORT BIOMECH, DOI 10.1080/14763141.2019.1609072; Pataky TC, 2012, COMPUT METHOD BIOMEC, V15, P295, DOI 10.1080/10255842.2010.527837; Roetert P., 2001, HUMAN KINETICS, P239; Tanabe S, 2007, SPORT BIOMECH, V6, P418, DOI 10.1080/14763140701491500	12	0	0	4	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2021	16	9							e0257295	10.1371/journal.pone.0257295	http://dx.doi.org/10.1371/journal.pone.0257295			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	WG5RP	34520488	Green Published, gold			2022-12-26	WOS:000707052100018
J	Yum, HR; Park, SH; Shin, SY				Yum, Hae Ri; Park, Shin Hae; Shin, Sun Young			Influence of coronavirus disease 2019 on myopic progression in children treated with low-concentration atropine	PLOS ONE			English	Article							TIME SPENT OUTDOORS; CHILDHOOD MYOPIA; EFFICACY	Purpose The outbreak of coronavirus disease 2019 (COVID-19) has caused many children to stay indoors. Increased near work and insufficient outdoor activities are considered important risk factors for myopic progression. This study aimed to compare the changes in myopic progression before and after COVID-19 in children treated with low-concentration atropine. Methods The records of 103 eyes of 103 children who were treated with low-concentration atropine eye drops were retrospectively reviewed. We classified children according to the concentration of atropine eye drops and children's age. The beginning of the pre-COVID-19 period was set from January 2019 to May 2019, and the endpoint was set in March 2020. The beginning of the post-COVID-19 period was set in March 2020, and the endpoint was set from January 2021 to March 2021. We evaluated the questionnaires administered to children's parents. Results A significant myopic progression was observed in the post-COVID-19 period compared to the pre-COVID-19 period in the 0.05% and 0.025% atropine groups (P < 0.001 and P = 0.020, respectively). For children aged 5 to 7 and 8 to 10 years, the axial elongations were significantly faster in the post-COVID-19 period than in the pre-COVID-19 period (P = 0.022 and P = 0.005, respectively). However, the rates of axial elongation and myopic progression were not significantly different between pre- and post-COVID-19 in children aged 11 to 15 years (P = 0.065 and P = 0.792, respectively). The average time spent using computers and smartphones and reading time were significantly increased, and the times of physical and outdoor activity were significantly decreased in the post-COVID-19 period compared to the pre-COVID-19 period. Conclusions The rates of myopic progression have increased substantially after the spread of COVID-19 with an increase in the home confinement of children. Therefore, it is necessary to control the environmental risk factors for myopia, even in children undergoing treatment for the inhibition of myopic progression.	[Yum, Hae Ri] Catholic Univ Korea, Coll Med, Dept Ophthalmol & Visual Sci, Eunpyeong St Marys Hosp, Seoul, South Korea; [Park, Shin Hae; Shin, Sun Young] Catholic Univ Korea, Coll Med, Dept Ophthalmol & Visual Sci, Seoul St Marys Hosp, Seoul, South Korea	Catholic University of Korea; Catholic University of Korea; Seoul St. Mary's Hospital	Shin, SY (corresponding author), Catholic Univ Korea, Coll Med, Dept Ophthalmol & Visual Sci, Seoul St Marys Hosp, Seoul, South Korea.	eyeshin@catholic.ac.kr		Yum, Hae-Ri/0000-0002-4388-8025	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning [NRF-2017R1C1B5076784]; Research Institute of Medical Science, Eunpyeong St.Mary's Hospital, The Catholic University of Korea	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning; Research Institute of Medical Science, Eunpyeong St.Mary's Hospital, The Catholic University of Korea	This study was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by Ministry of Science, ICT & Future Planning (NRF-2017R1C1B5076784) and Research Institute of Medical Science, Eunpyeong St.Mary's Hospital, The Catholic University of Korea. HRY received grants.	Bao JH, 2022, BRIT J OPHTHALMOL, V106, P1171, DOI 10.1136/bjophthalmol-2020-318367; Chia A, 2016, OPHTHALMOLOGY, V123, P391, DOI 10.1016/j.ophtha.2015.07.004; Chia A, 2012, OPHTHALMOLOGY, V119, P347, DOI 10.1016/j.ophtha.2011.07.031; Clark TY, 2015, J OCUL PHARMACOL TH, V31, P541, DOI 10.1089/jop.2015.0043; Enthoven CA, 2020, PREV MED, V132, DOI 10.1016/j.ypmed.2020.105988; Gong QW, 2017, JAMA OPHTHALMOL, V135, P624, DOI 10.1001/jamaophthalmol.2017.1091; He MG, 2015, JAMA-J AM MED ASSOC, V314, P1142, DOI 10.1001/jama.2015.10803; Huang HM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140419; Huang JH, 2016, OPHTHALMOLOGY, V123, P697, DOI 10.1016/j.ophtha.2015.11.010; Kennedy R H, 2000, Binocul Vis Strabismus Q, V15, P281; Lam CSY, 2022, BRIT J OPHTHALMOL, V106, P1110, DOI 10.1136/bjophthalmol-2020-317664; Lin Z, 2016, GRAEF ARCH CLIN EXP, V254, P2247, DOI 10.1007/s00417-016-3440-9; Lingham G, 2020, BRIT J OPHTHALMOL, V104, P593, DOI 10.1136/bjophthalmol-2019-314675; McCrann S, 2021, CLIN EXP OPTOM, V104, P35, DOI 10.1111/cxo.13092; Moon JS, 2018, INT J OPHTHALMOL-CHI, V11, P1657, DOI 10.18240/ijo.2018.10.13; Morens DM, 2020, NEW ENGL J MED, V382, P1293, DOI 10.1056/NEJMp2002106; Polling JR, 2020, EYE, V34, P2020, DOI 10.1038/s41433-020-1122-7; Sacchi M, 2019, ACTA OPHTHALMOL, V97, pE1136, DOI 10.1111/aos.14166; Sherwin JC, 2012, OPHTHALMOLOGY, V119, P2141, DOI 10.1016/j.ophtha.2012.04.020; Shih KC, 2016, EYE CONTACT LENS, V42, P16, DOI 10.1097/ICL.0000000000000189; Sumitha M, 2020, INDIAN J OPHTHALMOL, V68, DOI 10.4103/ijo.IJO_1443_20; UNESCO, COVID 19 ED DISR RES; Wang JX, 2021, JAMA OPHTHALMOL, V139, P293, DOI 10.1001/jamaophthalmol.2020.6239; Wen LB, 2020, BRIT J OPHTHALMOL, V104, P1542, DOI 10.1136/bjophthalmol-2019-315258; World Health Organization, WHO DIR GEN OPEN REM; Xu L., 2021, OPHTHALMOLOGY, DOI [10.1016/j.ophtha.2021.04.001, DOI 10.1016/J.OPHTHA.2021.04.001]	26	7	7	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2021	16	9							e0257480	10.1371/journal.pone.0257480	http://dx.doi.org/10.1371/journal.pone.0257480			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	WG5RP	34520481	gold, Green Published			2022-12-26	WOS:000707052100036
J	Nishiyama, D; Iwasaki, H; Taniguchi, T; Fukui, D; Yamanaka, M; Harada, T; Yamada, H				Nishiyama, Daisuke; Iwasaki, Hiroshi; Taniguchi, Takaya; Fukui, Daisuke; Yamanaka, Manabu; Harada, Teiji; Yamada, Hiroshi			Deep generative models for automated muscle segmentation in computed tomography scanning	PLOS ONE			English	Article							RESECTION; IMAGES; VOLUME	Accurate gluteus medius (GMd) volume evaluation may aid in the analysis of muscular atrophy states and help gain an improved understanding of patient recovery via rehabilitation. However, the segmentation of muscle regions in GMd images for cubic muscle volume assessment is time-consuming and labor-intensive. This study automated GMd-region segmentation from the computed tomography (CT) images of patients diagnosed with hip osteoarthritis using deep learning and evaluated the segmentation accuracy. To this end, 5250 augmented pairs of training data were obtained from five participants, and a conditional generative adversarial network was used to identify the relationships between the image pairs. Using the preserved test datasets, the results of automatic segmentation with the trained deep learning model were compared to those of manual segmentation in terms of the dice similarity coefficient (DSC), volume similarity (VS), and shape similarity (MS). As observed, the average DSC values for automatic and manual segmentations were 0.748 and 0.812, respectively, with a significant difference (p < 0.0001); the average VS values were 0.247 and 0.203, respectively, with no significant difference (p = 0.069); and the average MS values were 1.394 and 1.156, respectively, with no significant difference (p = 0.308). The GMd volumes obtained by automatic and manual segmentation were 246.2 cm(3) and 282.9 cm(3), respectively. The noninferiority of the DSC obtained by automatic segmentation was verified against that obtained by manual segmentation. Accordingly, the proposed GAN-based automatic GMd-segmentation technique is confirmed to be noninferior to manual segmentation. Therefore, the findings of this research confirm that the proposed method not only reduces time and effort but also facilitates accurate assessment of the cubic muscle volume.	[Nishiyama, Daisuke; Iwasaki, Hiroshi; Taniguchi, Takaya; Fukui, Daisuke; Yamanaka, Manabu; Harada, Teiji; Yamada, Hiroshi] Wakayama Med Univ, Dept Orthoped Surg, Wakayama, Japan	Wakayama Medical University	Nishiyama, D (corresponding author), Wakayama Med Univ, Dept Orthoped Surg, Wakayama, Japan.	dnishiya@wakayama-med.ac.jp		nishiyama, daisuke/0000-0002-0096-4067; Iwasaki, Hiroshi/0000-0002-8096-3362; Harada, Teiji/0000-0003-3335-7316; Fukui, Daisuke/0000-0002-8939-8494				Amini N, 2015, J GASTROINTEST SURG, V19, P1593, DOI 10.1007/s11605-015-2835-y; Andrews S, 2015, IEEE T MED IMAGING, V34, P1773, DOI 10.1109/TMI.2015.2403299; CANNY J, 1986, IEEE T PATTERN ANAL, V8, P679, DOI 10.1109/TPAMI.1986.4767851; Castiglione J, 2021, RADIOL-ARTIF INTELL, V3, DOI 10.1148/ryai.2021200130; Chaurasia P, 2014, BIOMETRICS MINUTIAE; DICE LR, 1945, ECOLOGY, V26, P297, DOI 10.2307/1932409; Galbusera Fabio, 2018, Eur Radiol Exp, V2, P29, DOI 10.1186/s41747-018-0060-7; Goodfellow Ian., 2016, ARXIV, DOI DOI 10.1145/3422622; Hiasa Y, 2020, IEEE T MED IMAGING, V39, P1030, DOI 10.1109/TMI.2019.2940555; HU M, 1962, IRE T INFORM THEOR, V8, P179, DOI 10.1109/tit.1962.1057692; Isola P, 2018, IEEE C COMP VIS PATT; Jamaludin A, 2017, MED IMAGE ANAL, V41, P63, DOI 10.1016/j.media.2017.07.002; Jamaludin A, 2017, EUR SPINE J, V26, P1374, DOI 10.1007/s00586-017-4956-3; Kamiya N, 2012, RADIOL PHYS TECHNOL, V5, P5, DOI 10.1007/s12194-011-0127-0; Kemnitz J, 2017, MAGN RESON MATER PHY, V30, P489, DOI 10.1007/s10334-017-0622-3; Le Troter A, 2016, MAGN RESON MATER PHY, V29, P245, DOI 10.1007/s10334-016-0535-6; Lee H, 2017, J DIGIT IMAGING, V30, P487, DOI 10.1007/s10278-017-9988-z; Man YZ, 2019, IEEE T MED IMAGING, V38, P1971, DOI 10.1109/TMI.2019.2911588; Popa T, 2006, PROC SPIE, V6141, DOI 10.1117/12.655213; Rasch A, 2009, J BONE JOINT SURG BR, V91B, P583, DOI 10.1302/0301-620X.91B5.21477; Simard PY, 2003, PROC INT CONF DOC, P958; SUZUKI S, 1985, COMPUT VISION GRAPH, V30, P32, DOI 10.1016/0734-189X(85)90016-7; Uemura K, 2016, J ARTHROPLASTY, V31, P906, DOI 10.1016/j.arth.2015.10.036; Valero V, 2015, J GASTROINTEST SURG, V19, P272, DOI 10.1007/s11605-014-2680-4; Yokota F, 2018, INT J COMPUT ASS RAD, V13, P977, DOI 10.1007/s11548-018-1758-y	25	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2021	16	9							e0257371	10.1371/journal.pone.0257371	http://dx.doi.org/10.1371/journal.pone.0257371			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XM9EM	34506602	Green Published, gold			2022-12-26	WOS:000729120700036
J	Upadhyay, V; Lucas, A; Panja, S; Miyauchi, R; Mallela, KMG				Upadhyay, Vaibhav; Lucas, Alexandra; Panja, Sudipta; Miyauchi, Ryuki; Mallela, Krishna M. G.			Receptor binding, immune escape, and protein stability direct the natural selection of SARS-CoV-2 variants	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEUTRALIZING ANTIBODIES; QUALITY CONTROL; CORONAVIRUS; MUTATIONS; EVOLUTION; REPLICATION; MECHANISMS; PNEUMONIA; PROMOTES; VACCINE	Emergence of new severe acute respiratory syndrome coronavirus 2 variants has raised concerns related to the effectiveness of vaccines and antibody therapeutics developed against the unmutated wildtype virus. Here, we examined the effect of the 12 most commonly occurring mutations in the receptorbinding domain of the spike protein on its expression, stability, activity, and antibody escape potential. Stability was measured using thermal denaturation, and the activity and antibody escape potential were measured using isothermal titration calorimetry in terms of binding to the human angiotensin-converting enzyme 2 and to neutralizing human antibody CC12.1, respectively. Our results show that mutants differ in their expression levels. Of the eight best-expressed mutants, two (N501Y and K417T/E484K/N501Y) showed stronger affinity to angiotensin-converting enzyme 2 compared with the wildtype, whereas four (Y453F, S477N, T478I, and S494P) had similar affinity and two (K417N and E484K) had weaker affinity than the wildtype. Compared with the wildtype, four mutants (K417N, Y453F, N501Y, and K417T/E484K/ N501Y) had weaker affinity for the CC12.1 antibody, whereas two (S477N and S494P) had similar affinity, and two (T478I and E484K) had stronger affinity than the wildtype. Mutants also differ in their thermal stability, with the two least stable mutants showing reduced expression. Taken together, these results indicate that multiple factors contribute toward the natural selection of variants, and all these factors need to be considered to understand the evolution of the virus. In addition, since not all variants can escape a given neutralizing antibody, antibodies to treat new variants can be chosen based on the specific mutations in that variant.	[Upadhyay, Vaibhav; Lucas, Alexandra; Panja, Sudipta; Miyauchi, Ryuki; Mallela, Krishna M. G.] Univ Colorado Anschutz Med Campus, Skaggs Sch Pharm & Pharmaceut Sci, Dept Pharmaceut Sci, Aurora, CO 80045 USA; [Miyauchi, Ryuki] Daiichi Sankyo Co Ltd, Modal Res Labs, Tokyo 1348630, Japan	University of Colorado System; University of Colorado Anschutz Medical Campus; Daiichi Sankyo Company Limited	Mallela, KMG (corresponding author), Univ Colorado Anschutz Med Campus, Skaggs Sch Pharm & Pharmaceut Sci, Dept Pharmaceut Sci, Aurora, CO 80045 USA.	krishna.mallela@cuanschutz.edu	Panja, Sudipta/ACE-6392-2022	Panja, Sudipta/0000-0001-8413-2913; Miyauchi, Ryuki/0000-0001-9125-7554; Upadhyay, Vaibhav/0000-0002-0916-6408; Mallela, Krishna/0000-0001-8308-5318; LUCAS, ALEXANDRA/0000-0001-7655-3590				Karim SAS, 2021, NEW ENGL J MED, V384, P1866, DOI 10.1056/NEJMc2100362; Alter G, 2020, NAT BIOTECHNOL, V38, P1132, DOI [10.1038/s41587-020-0732-8, 10.1038/s41587-020-0697-7]; Arbeitman CR, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-78711-6; Baden LR, 2021, NEW ENGL J MED, V384, P403, DOI 10.1056/NEJMoa2035389; Barnes CO, 2020, NATURE, V588, P682, DOI 10.1038/s41586-020-2852-1; Baum A, 2020, SCIENCE, V369, P1014, DOI 10.1126/science.abd0831; Bershtein S, 2013, MOL CELL, V49, P133, DOI 10.1016/j.molcel.2012.11.004; Bevington P. R., 2003, DATA REDUCTION ERROR, DOI 10.2307/2284752; Bloom JD, 2006, P NATL ACAD SCI USA, V103, P5869, DOI 10.1073/pnas.0510098103; Chappell Keith J, 2021, Lancet Infect Dis, V21, P1383, DOI 10.1016/S1473-3099(21)00200-0; Dearlove B, 2020, P NATL ACAD SCI USA, V117, P23652, DOI 10.1073/pnas.2008281117; Denison MR, 2011, RNA BIOL, V8, P270, DOI 10.4161/rna.8.2.15013; Dinner AR, 1999, PROTEINS, V35, P34, DOI 10.1002/(SICI)1097-0134(19990401)35:1<34::AID-PROT4>3.0.CO;2-Q; Dowd KA, 2009, GASTROENTEROLOGY, V136, P2377, DOI 10.1053/j.gastro.2009.02.080; Elena SF, 2006, EMBO REP, V7, P168, DOI 10.1038/sj.embor.7400636; Fagiani F, 2020, SIGNAL TRANSDUCT TAR, V5, DOI 10.1038/s41392-020-00287-4; Gastaldello S, 2008, AM J PATHOL, V173, P170, DOI 10.2353/ajpath.2008.071146; Goepfert PA, 2021, LANCET INFECT DIS, V21, P1257, DOI [10.1016/S1473-3099(21)00227-9, 10.1016/S1473-3099(21)00147-X]; Gottlieb RL, 2021, JAMA-J AM MED ASSOC, V325, P632, DOI 10.1001/jama.2021.0202; Greenfield NJ, 2006, NAT PROTOC, V1, P2527, DOI 10.1038/nprot.2006.204; Hacisuleyman E, 2021, NEW ENGL J MED, V384, P2212, DOI [10.1056/NEJMoa2105000, 10.1056/NEJMc2107808]; Hansen J, 2020, SCIENCE, V369, P1010, DOI 10.1126/science.abd0827; Hoffmann M, 2020, CELL, V181, P271, DOI 10.1016/j.cell.2020.02.052; Huang BY, 2021, LANCET MICROBE, V2, pE285, DOI 10.1016/S2666-5247(21)00082-3; Jiang SB, 2020, TRENDS IMMUNOL, V41, P355, DOI 10.1016/j.it.2020.03.007; Jones BE, 2021, SCI TRANSL MED, V13, DOI 10.1126/scitranslmed.abf1906; Keech C, 2020, NEW ENGL J MED, V383, P2320, DOI 10.1056/NEJMoa2026920; Khattar V, 2019, FASEB BIOADV, V1, P180, DOI 10.1096/fba.2018-00023; Kim Jeong-Min, 2020, Osong Public Health Res Perspect, V11, P3, DOI 10.24171/j.phrp.2020.11.1.02; Klein EY, 2018, MSPHERE, V3, DOI 10.1128/mSphereDirect.00554-17; Ksiazek TG, 2003, NEW ENGL J MED, V348, P1953, DOI 10.1056/NEJMoa030781; Lan J, 2020, NATURE, V581, P215, DOI 10.1038/s41586-020-2180-5; Larson D, 2021, CLIN INFECT DIS, V73, pE2827, DOI 10.1093/cid/ciaa1436; Letko M, 2020, NAT MICROBIOL, V5, P562, DOI [10.1038/s41564-020-0688-y, 10.1101/2020.01.22.915660]; Li F, 2016, ANNU REV VIROL, V3, P237, DOI 10.1146/annurev-virology-110615-042301; Li MC, 2021, SIGNAL TRANSDUCT TAR, V6, DOI 10.1038/s41392-021-00592-6; Liang JG, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-21634-1; Liu ZM, 2021, CELL HOST MICROBE, V29, P477, DOI 10.1016/j.chom.2021.01.014; Lu RJ, 2020, LANCET, V395, P565, DOI 10.1016/S0140-6736(20)30251-8; Luchsinger Larry L, 2020, medRxiv, DOI 10.1101/2020.06.08.20124792; Madhi SA, 2021, NEW ENGL J MED, V384, P1885, DOI 10.1056/NEJMoa2102214; Micsonai A, 2018, NUCLEIC ACIDS RES, V46, pW315, DOI 10.1093/nar/gky497; Perlman S, 2009, NAT REV MICROBIOL, V7, P439, DOI 10.1038/nrmicro2147; Perlmutter JD, 2015, ANNU REV PHYS CHEM, V66, P217, DOI 10.1146/annurev-physchem-040214-121637; Petrova VN, 2018, NAT REV MICROBIOL, V16, P60, DOI [10.1038/nrmicro.2017.146, 10.1038/nrmicro.2017.118]; Polack FP, 2020, NEW ENGL J MED, V383, P2603, DOI 10.1056/NEJMoa2034577; Rausch JW, 2020, P NATL ACAD SCI USA, V117, P24614, DOI 10.1073/pnas.2017726117; Richman DD, 2003, P NATL ACAD SCI USA, V100, P4144, DOI 10.1073/pnas.0630530100; Robbiani DF, 2020, NATURE, V584, P437, DOI 10.1038/s41586-020-2456-9; Rogers TF, 2020, SCIENCE, V369, P956, DOI 10.1126/science.abc7520; Rotem A, 2018, MOL BIOL EVOL, V35, P2390, DOI 10.1093/molbev/msy131; Sadoff J, 2021, NEW ENGL J MED, V384, P1824, DOI 10.1056/NEJMoa2034201; Shang J, 2020, NATURE, V581, P221, DOI 10.1038/s41586-020-2179-y; Starr TN, 2021, CELL REP MED, V2, DOI 10.1016/j.xcrm.2021.100255; Starr Tyler N, 2021, Science, V371, P850, DOI [10.1101/2020.11.30.405472, 10.1126/science.abf9302]; Sun ZH, 2019, J CELL BIOL, V218, P3171, DOI 10.1083/jcb.201906047; To KKW, 2020, CLIN INFECT DIS, V71, P841, DOI 10.1093/cid/ciaa149; van Dorp L, 2020, INFECT GENET EVOL, V83, DOI 10.1016/j.meegid.2020.104351; Van Elslande J, 2021, CLIN INFECT DIS, V73, P354, DOI 10.1093/cid/ciaa1330; Voloch CM, 2021, J VIROL, V95, DOI 10.1128/JVI.00119-21; Voysey M, 2021, LANCET, V397, P99, DOI 10.1016/S0140-6736(20)32661-1; Walls AC, 2020, CELL, V181, P281, DOI [10.1016/j.cell.2020.02.058, 10.1016/j.cell.2020.11.032]; Wang Zijun, 2021, bioRxiv, DOI [10.1038/s41586-021-03324-6, 10.1101/2021.01.15.426911]; Weisblum Yiska, 2020, bioRxiv, DOI 10.1101/2020.07.21.214759; Wolfel R, 2020, NATURE, V581, P465, DOI 10.1038/s41586-020-2196-x; Wylie CS, 2011, P NATL ACAD SCI USA, V108, P9916, DOI 10.1073/pnas.1017572108; Yang JY, 2020, NATURE, V586, P572, DOI 10.1038/s41586-020-2599-8; Yang SL, 2021, LANCET INFECT DIS, V21, P1107, DOI 10.1016/S1473-3099(21)00127-4; Yuan M, 2020, SCIENCE, V369, P1119, DOI 10.1126/science.abd2321; Zaki AM, 2012, NEW ENGL J MED, V367, P1814, DOI 10.1056/NEJMoa1211721; Zhong NS, 2003, LANCET, V362, P1353, DOI 10.1016/S0140-6736(03)14630-2; Zhou P., 2020, NATURE, V579, P270; Zhu FC, 2020, LANCET, V396, P479, DOI 10.1016/S0140-6736(20)31605-6; Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017	74	17	17	5	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT	2021	297	4							101208	10.1016/j.jbc.2021.101208	http://dx.doi.org/10.1016/j.jbc.2021.101208			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	WP2YR	34543625	Green Submitted, Green Published, gold			2022-12-26	WOS:000713003600001
J	Hjertner, B; Lutzelschwab, C; Schieck, E; Nzau, B; Henson, S; Sjolund, M; Fossum, C; Magnusson, U				Hjertner, Bernt; Lutzelschwab, Claudia; Schieck, Elise; Nzau, Benjamin; Henson, Sonal; Sjolund, Marie; Fossum, Caroline; Magnusson, Ulf			Development of a 3-transcript host expression assay to differentiate between viral and bacterial infections in pigs	PLOS ONE			English	Article							ACTINOBACILLUS-PLEUROPNEUMONIAE; INTERFERON-ALPHA; IMMUNE-RESPONSE; MARKERS; INTERLEUKIN-6; BIOMARKERS; CYTOKINES; CHILDREN; PROTEIN	Indiscriminate use of antibiotics to treat infections that are of viral origin contributes to unnecessary use which potentially may induce resistance in commensal bacteria. To counteract this a number of host gene transcriptional studies have been conducted to identify genes that are differently expressed during bacterial and viral infections in humans, and thus could be used as a tool to base decisions on the use of antibiotics. In this paper, we aimed to evaluate the potential of a selection of genes that have been considered biomarkers in humans, to differentially diagnose bacterial from viral infections in the pig. First porcine PBMC were induced with six toll-like receptor (TLR) agonists (FliC, LPS, ODN 2216, Pam3CSK4, poly I:C, R848) to mimic host gene expression induced by bacterial or viral pathogens, or exposed to heat-killed Actinobacillus pleuropneumoniae or a split influenza virus. Genes that were differentially expressed between bacterial and viral inducers were further evaluated on clinical material comprising eleven healthy pigs, and six pigs infected with A. pleuropneumoniae. This comprised three virally upregulated genes (IFI44L, MxA, RSAD2) and four bacterially upregulated genes (IL-1 beta, IL-8, FAM89A, S100PBP). All six infected pigs could be differentially diagnosed to healthy pigs using a host gene transcription assay based on the geometric average of the bacterially induced genes IL-8 and S100PBP over that of the virally induced gene MxA.	[Hjertner, Bernt; Lutzelschwab, Claudia; Fossum, Caroline] Swedish Univ Agr Sci, SLU, Dept Biomed Sci & Vet Publ Hlth, Uppsala, Sweden; [Schieck, Elise; Nzau, Benjamin; Henson, Sonal] Int Livestock Res Inst, Nairobi, Kenya; [Sjolund, Marie] SVA, Natl Vet Inst, Dept Anim Hlth & Antimicrobial Strategies, Uppsala, Sweden; [Magnusson, Ulf] Swedish Univ Agr Sci, SLU, Dept Clin Sci, Uppsala, Sweden	Swedish University of Agricultural Sciences; CGIAR; International Livestock Research Institute (ILRI); National Veterinary Institute SVA; Swedish University of Agricultural Sciences	Hjertner, B (corresponding author), Swedish Univ Agr Sci, SLU, Dept Biomed Sci & Vet Publ Hlth, Uppsala, Sweden.	Bernt.Hjertner@slu.se	Schieck, Elise/AGJ-2046-2022	Schieck, Elise/0000-0003-1756-6337; Henson, Sonal P/0000-0002-2002-5462; Fossum, Caroline/0000-0003-4639-1652; Hjertner, Bernt/0000-0002-7827-2589; Magnusson, Ulf/0000-0002-7087-6820	Animal Health Flagship of the CGIAR research Program on Livestock; Animal Health Flagship	Animal Health Flagship of the CGIAR research Program on Livestock(CGIAR); Animal Health Flagship	This study was financially supported by the Animal Health Flagship of the CGIAR research Program on Livestock (https://livestock.cgiar.org).Department of Biomedical Sciences and Veterinary Public Health (Uppsala, Sweden) and the International Livestock Research Institute (Nairobi, Kenya) were allocated funds by the Animal Health Flagship to perform this study (consumables and salaries). BH, CL, ES and UM received parts of their salaries from this fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlberg V, 2017, VET RES, V48, DOI 10.1186/s13567-017-0437-2; Eckersall PD, 2010, VET J, V185, P23, DOI 10.1016/j.tvjl.2010.04.009; Ferri M, 2017, CRIT REV FOOD SCI, V57, P2857, DOI 10.1080/10408398.2015.1077192; Fossum C, 1998, VET IMMUNOL IMMUNOP, V64, P161, DOI 10.1016/S0165-2427(98)00126-3; Fossum C, 1998, DOMEST ANIM ENDOCRIN, V15, P439, DOI 10.1016/S0739-7240(98)80001-5; Gomez-Carballa A, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-48162-9; Graham DW, 2019, ANN NY ACAD SCI, V1441, P17, DOI 10.1111/nyas.14036; Herberg JA, 2016, JAMA-J AM MED ASSOC, V316, P835, DOI 10.1001/jama.2016.11236; Hu XR, 2013, P NATL ACAD SCI USA, V110, P12792, DOI 10.1073/pnas.1302968110; Hulten C, 2003, VET MICROBIOL, V95, P75, DOI 10.1016/S0378-1135(03)00136-6; Johansson E, 2001, VET MICROBIOL, V79, P171, DOI 10.1016/S0378-1135(00)00353-9; Khabar KSA, 1997, J EXP MED, V186, P1077, DOI 10.1084/jem.186.7.1077; Lines KE, 2012, AM J PATHOL, V180, P1485, DOI 10.1016/j.ajpath.2011.12.031; Llibre A, 2018, COMP IMMUNOL MICROB, V59, P57, DOI 10.1016/j.cimid.2018.09.008; Malle E, 1996, EUR J CLIN INVEST, V26, P427, DOI 10.1046/j.1365-2362.1996.159291.x; Miller RR, 2018, AM J RESP CRIT CARE, V198, P903, DOI [10.1164/rccm.201712-2472OC, 10.1164/rccm.201712-2472oc]; Morozumi T, 2009, MOL IMMUNOL, V46, P858, DOI 10.1016/j.molimm.2008.09.019; Moulin F, 1996, PEDIATR INFECT DIS J, V15, P883, DOI 10.1097/00006454-199610000-00010; Obermajer N, 2008, IMMUNOLOGY, V124, P76, DOI 10.1111/j.1365-2567.2007.02740.x; Peters SM, 2011, VET IMMUNOL IMMUNOP, V139, P67, DOI 10.1016/j.vetimm.2010.08.001; Shirley M, 2019, MOL DIAGN THER, V23, P803, DOI 10.1007/s40291-019-00433-x; Sjolund M, 2011, VET REC, V169, DOI 10.1136/vr.d2268; Sjolund M, 2009, VET REC, V164, P550, DOI 10.1136/vr.164.18.550; Sjolund M, 2020, ACTA VET SCAND, V62, DOI 10.1186/s13028-020-00552-0; Strom G, 2018, ANTIMICROB RESIST IN, V7, DOI 10.1186/s13756-018-0328-y; Tsao YT, 2020, TRENDS MOL MED, V26, P1118, DOI 10.1016/j.molmed.2020.09.004; Van Boeckel TP, 2019, SCIENCE, V365, P1266, DOI 10.1126/science.aaw1944; Van Boeckel TP, 2015, P NATL ACAD SCI USA, V112, P5649, DOI 10.1073/pnas.1503141112; WALLGREN P, 1993, J VET MED B, V40, P1, DOI 10.1111/j.1439-0450.1993.tb00102.x; Wallgren P., 1993, Svensk Veterinartidning, V45, P733; Wattrang E, 1998, COMP IMMUNOL MICROB, V21, P135, DOI 10.1016/S0147-9571(97)00025-8; Werling D, 2009, TRENDS IMMUNOL, V30, P124, DOI 10.1016/j.it.2008.12.001; Wikstrom FH, 2011, VET IMMUNOL IMMUNOP, V139, P156, DOI 10.1016/j.vetimm.2010.09.010; Xia C, 2018, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01908; Xiong WG, 2018, ENVIRON SCI POLLUT R, V25, P18377, DOI 10.1007/s11356-018-1852-2	35	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2021	16	9							e0256106	10.1371/journal.pone.0256106	http://dx.doi.org/10.1371/journal.pone.0256106			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XH8RH	34555028	Green Published, gold			2022-12-26	WOS:000725694500011
J	Jin, L; Lyu, J; Jin, N; Xie, JM; Wu, Y; Zhang, GB; Feng, Z; Tang, ZQ; Liu, ZC; Luo, SL; Yu, JH				Jin, Li; Lyu, Jian; Jin, Ning; Xie, Jianming; Wu, Yue; Zhang, Guobin; Feng, Zhi; Tang, Zhongqi; Liu, Zeci; Luo, Shilei; Yu, Jihua			Effects of different vegetable rotations on the rhizosphere bacterial community and tomato growth in a continuous tomato cropping substrate	PLOS ONE			English	Article							MICROBIAL COMMUNITIES; SOIL; DIVERSITY; PHOTOSYNTHESIS; CUCUMBER; TILLAGE; DISEASE; SYSTEMS; TOOLS	In this study, High throughput sequencing was used to analyze the effects of different vegetable rotations on the rhizosphere bacterial diversity and community structure in a substrate that was used for continuous tomato cropping (CK). The vegetable rotations tested were cabbage/tomato (B), kidney bean/tomato (D), and celery/tomato (Q). The results revealed that the substrate bacterial diversity and richness of each crop rotation were higher than those of CK. The highest bacterial diversity was found in the B substrate, followed by the Q and D substrates. Further comparison showed that the rhizosphere bacterial community structure of Q substrate was significantly different to that of CK. Compared with the CK, the Q substrate had a significantly higher relative abundance of several dominant microflora, such as Acidobacteria, Chloroflexi, and Firmicutes. Additionally, the Q rotation significantly increased the abundance of beneficial bacteria, such as Actinobacteria_unclassified and Anaerolineaceae_unclassified. A redundancy analysis showed that Most dominant bacteria correlated positively with the substrate pH, total N, and alkali-hydrolyzable N but negatively with the available P, available K, total P, total K, and organic matter contents and substrate EC. The substrates after crop rotation improved the growth and physiological condition of the subsequent tomato plants, among which those from the Q rotation performed the best. Therefore, celery rotation not only increased the richness and diversity of bacterial communities in the substrate but also significantly increased the richness of the beneficial bacterial communities, allowing better maintenance of the substrate microenvironment for the healthy growth of crops.	[Jin, Li; Lyu, Jian; Jin, Ning; Xie, Jianming; Wu, Yue; Zhang, Guobin; Feng, Zhi; Tang, Zhongqi; Liu, Zeci; Luo, Shilei; Yu, Jihua] Gansu Agr Univ, Coll Hort, Lanzhou, Peoples R China; [Lyu, Jian; Yu, Jihua] Key Lab Crop Sci Arid Environm Gansu Prov, Lanzhou, Peoples R China	Gansu Agricultural University	Lyu, J; Yu, JH (corresponding author), Gansu Agr Univ, Coll Hort, Lanzhou, Peoples R China.; Lyu, J; Yu, JH (corresponding author), Key Lab Crop Sci Arid Environm Gansu Prov, Lanzhou, Peoples R China.	lvjiangs@126.com; yujihuagg@163.com			Special project of central government guiding local science and technology development [ZCYD-2020-5-2]; National key RD plan [2018YFD0201205]; Special project of national modern agricultural industrial system [CARS-23-C-07]; Gansu people's livelihood science and technology project [20CX9NA099]	Special project of central government guiding local science and technology development; National key RD plan; Special project of national modern agricultural industrial system; Gansu people's livelihood science and technology project	This research was supported by Special project of central government guiding local science and technology development (ZCYD-2020-5-2), National key R&D plan (2018YFD0201205), Special project of national modern agricultural industrial system (CARS-23-C-07), Gansu people's livelihood science and technology project (20CX9NA099).	Ahmad I, 2013, PAK J BOT, V45, P1889; Bokulich NA, 2013, NAT METHODS, V10, P57, DOI [10.1038/nmeth.2276, 10.1038/NMETH.2276]; Calonego JC, 2010, EUR J AGRON, V33, P242, DOI 10.1016/j.eja.2010.06.002; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Cole JR, 2014, NUCLEIC ACIDS RES, V42, pD633, DOI 10.1093/nar/gkt1244; D'Acunto L, 2018, AGR ECOSYST ENVIRON, V257, P159, DOI 10.1016/j.agee.2018.02.011; De Corato U, 2020, APPL SOIL ECOL, V154, DOI 10.1016/j.apsoil.2020.103601; Duangma K, 2014, INT J SYST EVOL MICR, V64, P3559, DOI 10.1099/ijs.0.065169-0; Emmert EAB, 1999, FEMS MICROBIOL LETT, V171, P1, DOI 10.1111/j.1574-6968.1999.tb13405.x; Fierer N, 2007, ECOLOGY, V88, P1354, DOI 10.1890/05-1839; Fu HD, 2017, SUSTAINABILITY-BASEL, V9, DOI 10.3390/su9020317; Ghimire R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103901; Haichar FE, 2008, ISME J, V2, P1221, DOI 10.1038/ismej.2008.80; Huang W, 2019, MICROBIOLOGYOPEN, V8, DOI 10.1002/mbo3.644; Jiang X, 2011, APPL SOIL ECOL, V48, P168, DOI 10.1016/j.apsoil.2011.03.009; Lee S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157637; Li G-j., 2001, ACTA AGR ZHEJIANGENS, V13, P61; [李天来 LI Tianlai], 2005, [沈阳农业大学学报, Journal of Shenyang Agricultural University], V36, P131; Li TZ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173923; Li Wei, 2012, Acta Horticulturae Sinica, V39, P73; Li WH, 2018, J INTEGR AGR, V17, P2570, DOI [10.1016/S2095-3119(18)61944-6, 10.1016/s2095-3119(18)61944-6]; Liu X, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0086610, 10.1371/journal.pone.0087996]; Lozupone C, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-371; Lv J., 2013, J GANSU AGR U, V2, P37; Lyu J, 2020, FRONT MICROBIOL, V11, DOI 10.3389/fmicb.2020.00829; Mendes R, 2011, SCIENCE, V332, P1097, DOI 10.1126/science.1203980; Nacke H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017000; Navarro-Noya YE, 2013, SOIL BIOL BIOCHEM, V65, P86, DOI 10.1016/j.soilbio.2013.05.009; Oksanen J., 2017, COMMUNITY ECOLOGY PA; Pervaiz ZH, 2020, SOIL SYST, V4, DOI 10.3390/soilsystems4040059; Qi MingFang, 2011, Scientia Agricultura Sinica, V44, P531; Qin SH, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00845; Qiu RJ, 2013, AGR WATER MANAGE, V130, P44, DOI 10.1016/j.agwat.2013.08.013; Rognes T, 2016, PEERJ, V4, DOI 10.7717/peerj.2584; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Shiomi Y, 1999, APPL ENVIRON MICROB, V65, P3996; Studdert GA, 1997, SOIL SCI SOC AM J, V61, P1466, DOI 10.2136/sssaj1997.03615995006100050026x; Suhui L., 2016, AGR SCI TECHNOLOGY, V17; Tiemann LK, 2015, ECOL LETT, V18, P761, DOI 10.1111/ele.12453; Venter ZS, 2016, PEDOBIOLOGIA, V59, P215, DOI 10.1016/j.pedobi.2016.04.001; Wang C, 2019, MULTIVAR BEHAV RES, V54, P307, DOI [10.1007/s00248-018-1166-4, 10.1080/00273171.2018.1513829]; Wen XY, 2016, J INTEGR AGR, V15, P1892, DOI [10.1016/s2095-3119(15)61147-9, 10.1016/S2095-3119(15)61147-9]; Williams AS, 2015, THE DYNAMIC INTERACT; Xie JM, 2018, AGRON SUSTAIN DEV, V38, DOI 10.1007/s13593-018-0540-4; Xiong W, 2015, MICROB ECOL, V70, P209, DOI 10.1007/s00248-014-0516-0; Zhang JJ, 2014, BIOINFORMATICS, V30, P614, DOI 10.1093/bioinformatics/btt593; Zheng XF, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-70737-0; Zhou XG, 2017, PLANT SOIL, V415, P507, DOI 10.1007/s11104-017-3181-5; Zhou XG, 2011, EUR J SOIL BIOL, V47, P279, DOI 10.1016/j.ejsobi.2011.07.001; Zhu P, 2018, APPL SOIL ECOL, V130, P159, DOI 10.1016/j.apsoil.2018.06.003	50	4	4	8	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2021	16	9							e0257432	10.1371/journal.pone.0257432	http://dx.doi.org/10.1371/journal.pone.0257432			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XH8RH	34555071	Green Published, gold			2022-12-26	WOS:000725694500034
J	Gan, RW; Sun, DN; Tatro, AR; Cohen-Mekelburg, S; Wiitala, WL; Zhu, J; Waljee, AK				Gan, Ryan W.; Sun, Diana; Tatro, Amanda R.; Cohen-Mekelburg, Shirley; Wiitala, Wyndy L.; Zhu, Ji; Waljee, Akbar K.			Replicating prediction algorithms for hospitalization and corticosteroid use in patients with inflammatory bowel disease	PLOS ONE			English	Article							ULCERATIVE-COLITIS; CROHNS-DISEASE; PREVALENCE	Introduction Previous work had shown that machine learning models can predict inflammatory bowel disease (IBD)-related hospitalizations and outpatient corticosteroid use based on patient demographic and laboratory data in a cohort of United States Veterans. This study aimed to replicate this modeling framework in a nationally representative cohort. Methods A retrospective cohort design using Optum Electronic Health Records (EHR) were used to identify IBD patients, with at least 12 months of follow-up between 2007 and 2018. IBD flare was defined as an inpatient/emergency visit with a diagnosis of IBD or an outpatient corticosteroid prescription for IBD. Predictors included demographic and laboratory data. Logistic regression and random forest (RF) models were used to predict IBD flare within 6 months of each visit. A 70% training and 30% validation approach was used. Results A total of 95,878 patients across 780,559 visits were identified. Of these, 22,245 (23.2%) patients had at least one IBD flare. Patients were predominantly White (87.7%) and female (57.1%), with a mean age of 48.0 years. The logistic regression model had an area under the receiver operating curve (AuROC) of 0.66 (95% CI: 0.65-0.66), sensitivity of 0.69 (95% CI: 0.68-0.70), and specificity of 0.74 (95% CI: 0.73-0.74) in the validation cohort. The RF model had an AuROC of 0.80 (95% CI: 0.80-0.81), sensitivity of 0.74 (95% CI: 0.73-0.74), and specificity of 0.72 (95% CI: 0.72-0.72) in the validation cohort. Important predictors of IBD flare in the RF model were the number of previous flares, age, potassium, and white blood cell count. Conclusion The machine learning modeling framework was replicated and results showed a similar predictive accuracy in a nationally representative cohort of IBD patients. This modeling framework could be embedded in routine practice as a tool to distinguish high-risk patients for disease activity.	[Gan, Ryan W.; Sun, Diana] Genentech Inc, San Francisco, CA 94080 USA; [Tatro, Amanda R.] Roche Pharma AG, Basel, Switzerland; [Cohen-Mekelburg, Shirley; Waljee, Akbar K.] Univ Michigan Hlth Syst, Ann Arbor, MI 48109 USA; [Cohen-Mekelburg, Shirley; Wiitala, Wyndy L.; Waljee, Akbar K.] Vet Affairs Hlth Care Syst, Ctr Clin Management Res, Ann Arbor, MI 48109 USA; [Zhu, Ji] Univ Michigan, Dept Stat, Ann Arbor, MI 48109 USA	Roche Holding; Genentech; Roche Holding; University of Michigan System; University of Michigan; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Michigan System; University of Michigan	Waljee, AK (corresponding author), Univ Michigan Hlth Syst, Ann Arbor, MI 48109 USA.; Waljee, AK (corresponding author), Vet Affairs Hlth Care Syst, Ctr Clin Management Res, Ann Arbor, MI 48109 USA.	awaljee@umich.edu	Waljee, Akbar K/G-2067-2010; zhu, ji/HDM-1538-2022	Waljee, Akbar K/0000-0003-1964-8790; Cohen-Mekelburg, Shirley/0000-0001-5058-5527	Roche/Genentech	Roche/Genentech(Roche HoldingGenentech)	Funding to license Optum data was provided by Roche/Genentech. The funder (Roche/Genentech) provided support in the form of salaries for authors Ryan Gan, Diana Sun, Amanda Tatro, and licensing fees for Optum EHR, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	Azur MJ, 2011, INT J METH PSYCH RES, V20, P40, DOI 10.1002/mpr.329; Bayer M., 2012, ARCHITECTURE OPEN SO; Breiman L., 2001, MACH LEARN, V45, P5; Brier G. W., 1950, MONTHLY WEATHER REVI, V78, P1, DOI DOI 10.1175/1520-0493(1950)078<0001:VOFEIT>2.0.CO;2; Collins GS, 2015, CIRCULATION, V131, P211, DOI [10.1016/j.jclinepi.2014.11.010, 10.1161/CIRCULATIONAHA.114.014508, 10.1002/bjs.9736, 10.7326/M14-0697, 10.1016/j.eururo.2014.11.025, 10.1186/s12916-014-0241-z, 10.1136/bmj.g7594, 10.1038/bjc.2014.639, 10.7326/M14-0698]; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Hou JK, 2014, DIGEST DIS SCI, V59, P2406, DOI 10.1007/s10620-014-3174-7; Hunter JD, 2007, COMPUT SCI ENG, V9, P90, DOI 10.1109/MCSE.2007.55; Kappelman MD, 2007, CLIN GASTROENTEROL H, V5, P1424, DOI 10.1016/j.cgh.2007.07.012; Lemaitre G, 2017, J MACH LEARN RES, V18; Loftus EV, 2004, GASTROENTEROLOGY, V126, P1504, DOI 10.1053/j.gastro.2004.01.063; Lundberg SM, 2020, NAT MACH INTELL, V2, P56, DOI 10.1038/s42256-019-0138-9; Mao R, 2012, INFLAMM BOWEL DIS, V18, P1894, DOI 10.1002/ibd.22861; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Peng RD, 2011, SCIENCE, V334, P1226, DOI 10.1126/science.1213847; Preface, TER DAT SQL FUNCT OP; Reback Jeff, 2020, **DATA OBJECT**, DOI [10.5281/zenodo.3715232, DOI 10.5281/ZENODO.3715232]; Saerens M, 2002, NEURAL COMPUT, V14, P21, DOI 10.1162/089976602753284446; Strobl C, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-25; Tibshirani R, 2011, J R STAT SOC B, V73, P273, DOI 10.1111/j.1467-9868.2011.00771.x; van der Walt S, 2011, COMPUT SCI ENG, V13, P22, DOI 10.1109/MCSE.2011.37; Vickers AJ, 2006, MED DECIS MAKING, V26, P565, DOI 10.1177/0272989X06295361; Waljee AK, 2018, INFLAMM BOWEL DIS, V24, P45, DOI 10.1093/ibd/izx007; Waljee AK, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-002847; Wallach OD, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2006930; Waskom M.L., 2021, JOSS, V6, P3021, DOI [DOI 10.21105/JOSS.03021, 10.21105/joss.03021, 10.5281/ZENODO.592845]	26	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2021	16	9							e0257520	10.1371/journal.pone.0257520	http://dx.doi.org/10.1371/journal.pone.0257520			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	WG6BN	34543353	Green Published, gold			2022-12-26	WOS:000707078200042
J	Hong, SW; Park, KT; Chung, YS; Choi, YJ; Kang, JH				Hong, Seok Woo; Park, Ki Tae; Chung, Yoon-Sok; Choi, Yong Jun; Kang, Jeong-Hyun			Bone mineral density, cervical spine degeneration, head and neck posture, and neck pain in the post-menopausal females: A pilot study	PLOS ONE			English	Article							DISC DEGENERATION; DIAGNOSTIC-CRITERIA; LUMBAR; DIFFUSION; DECREASE	The purpose of the present study was to reveal the relationship between degenerative changes in the cervical spine, head and neck postures, neck pain, and bone mineral density (BMD) of the total hip, femoral neck, and lumbar spine in post-menopausal females. In total, 116 females (mean age 60.4 +/- 7.1 years; age range 50-80 years) were included. Participants were classified into three groups based on the T-score criteria of the total hip, femoral neck, and lumbar spine set by World Health Organization, respectively. The degree of neck pain was assessed using self-administered questionnaire, the Neck Disability Index. Cervical spine degeneration and head and neck postures were identified using the lateral cephalograms. Grading system for cervical degeneration included three categories of the radiographic alterations including disc height loss, osteophyte formation, and diffuse sclerosis. The areal BMD of the total hip, femoral neck, and lumbar spine were determined using dual-energy x-ray absorptiometry. Females with lower BMD exhibited lesser degree of neck pain and forward head posture (FHP) compared to those with normal BMD. Higher BMD seemed to be associated with more notable loss of the disc height at the level of C4-5. More prominent degenerative changes in the cervical spine were associated with higher areal BMD of the hip, femoral neck, and lumbar spine, altered head posture, and development of neck pain.	[Hong, Seok Woo; Park, Ki Tae] Sungkyunkwan Univ, Dept Orthoped Surg, Kangbuk Samsung Hosp, Sch Med, Seoul, South Korea; [Chung, Yoon-Sok; Choi, Yong Jun] Ajou Univ, Dept Endocrinol & Metab, Sch Med, Suwon, Gyeonggi Do, South Korea; [Kang, Jeong-Hyun] Ajou Univ, Sch Med, Inst Oral Hlth Sci, Clin Oral Med & Orofacial Pain, Suwon, Gyeonggi Do, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Ajou University; Ajou University	Kang, JH (corresponding author), Ajou Univ, Sch Med, Inst Oral Hlth Sci, Clin Oral Med & Orofacial Pain, Suwon, Gyeonggi Do, South Korea.	irene85@snu.ac.kr		Kang, Jeong Hyun/0000-0001-7124-8693; HONG, SEOK WOO/0000-0003-4059-1557	National Research Foundation of Korea (NRF) - Korea government [2020R1I1A1A01071537]	National Research Foundation of Korea (NRF) - Korea government(National Research Foundation of Korea)	This study was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (2020R1I1A1A01071537). The recient was JHK.	Adams M, 2012, J BONE MINER RES, V27, P1432, DOI 10.1002/jbmr.1626; Ahmad M, 2009, ORAL SURG ORAL MED O, V107, P844, DOI 10.1016/j.tripleo.2009.02.023; BUCKWALTER JA, 1995, SPINE, V20, P1307, DOI 10.1097/00007632-199506000-00022; Cavanaugh JA, 2006, J BONE JOINT SURG AM, V88A, P63, DOI 10.2106/JBJS.E.01411; Neto JPD, 2010, ARCH ORAL BIOL, V55, P670, DOI 10.1016/j.archoralbio.2010.06.002; DUNLOP RB, 1984, J BONE JOINT SURG BR, V66, P706, DOI 10.1302/0301-620X.66B5.6501365; Dworkin Samuel F., 1992, Journal of Craniomandibular Disorders, V6, P301; Frobin W, 2002, CLIN BIOMECH, V17, P423, DOI 10.1016/S0268-0033(02)00044-X; GORE DR, 1986, SPINE, V11, P521, DOI 10.1097/00007632-198607000-00003; Harada A, 1998, SPINE, V23, P857, DOI 10.1097/00007632-199804150-00003; Hong SW, 2019, ARCH GERONTOL GERIAT, V81, P119, DOI 10.1016/j.archger.2018.12.004; Hongo M, 2012, OSTEOPOROSIS INT, V23, P1029, DOI 10.1007/s00198-011-1624-z; Kang JH, 2021, ACTA ODONTOL SCAND, V79, P43, DOI 10.1080/00016357.2020.1774649; Kang JH, 2020, ARCH ORAL BIOL, V114, DOI 10.1016/j.archoralbio.2020.104718; Kettler A, 2006, EUR SPINE J, V15, P732, DOI 10.1007/s00586-005-1037-9; Kwok AWL, 2012, SPINE, V37, pE1415, DOI 10.1097/BRS.0b013e31826f561e; Lee KE, 2009, J PAIN, V10, P436, DOI 10.1016/j.jpain.2008.11.009; Leib Edward S, 2002, J Clin Densitom, V5 Suppl, pS5, DOI 10.1385/JCD:5:3S:S05; Livshits G, 2010, ANN RHEUM DIS, V69, P2102, DOI 10.1136/ard.2010.131441; Mahmoud NF, 2019, CURR REV MUSCULOSKE, V12, P562, DOI 10.1007/s12178-019-09594-y; NACHEMSON A, 1970, ACTA ORTHOP SCAND, V41, P589, DOI 10.3109/17453677008991550; Nanjo Y, 2003, J BONE MINER METAB, V21, P22, DOI 10.1007/s007740300004; Niosi Christina A, 2004, Spine J, V4, p202S; Ozbek MM, 1998, EUR J ORTHODONT, V20, P133, DOI 10.1093/ejo/20.2.133; Paiva Lúcia Costa, 2002, Sao Paulo Med. J., V120, P09; Pye SR, 2006, ANN RHEUM DIS, V65, P234, DOI 10.1136/ard.2005.038224; Salo S, 2014, MATURITAS, V79, P449, DOI 10.1016/j.maturitas.2014.09.003; Schiffman E, 2014, J ORAL FACIAL PAIN H, V28, P6, DOI 10.11607/jop.1151; Simon DG, 1999, MYOFASCIAL PAIN DYSF; Susarla SM, 2010, J ORAL MAXIL SURG, V68, P2846, DOI 10.1016/j.joms.2010.06.196; Wada K, 2018, BMC MUSCULOSKEL DIS, V19, DOI 10.1186/s12891-018-2055-1; Wang JQ, 2018, SPINE, V43, pE607, DOI 10.1097/BRS.0000000000002482; Wang YXJ, 2011, OSTEOPOROSIS INT, V22, P91, DOI 10.1007/s00198-010-1200-y; Wang YXJ, 2011, MED HYPOTHESES, V77, P18, DOI 10.1016/j.mehy.2011.03.014; Wang Y, 2011, J BONE MINER RES, V26, P2785, DOI 10.1002/jbmr.476	35	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2021	16	9							e0257735	10.1371/journal.pone.0257735	http://dx.doi.org/10.1371/journal.pone.0257735			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	WG6BN	34543361	Green Published, gold			2022-12-26	WOS:000707078200076
J	Van Hoeck, V; Somers, I; Abdelqader, A; Wealleans, AL; Van de Craen, S; Morisset, D				Van Hoeck, Veerle; Somers, Ingrid; Abdelqader, Anas; Wealleans, Alexandra L.; Van de Craen, Sandy; Morisset, Dany			Xylanase impact beyond performance: A microbiome approach in laying hens	PLOS ONE			English	Article							WHEAT-BASED DIET; NUTRIENT DIGESTIBILITY; PRODUCTIVE PERFORMANCE; GASTROINTESTINAL-TRACT; TITANIUM-DIOXIDE; BROILER-CHICKENS; SUPPLEMENTATION; EGG; MICROFLORA; QUALITY	Anti-nutritional compounds such as non-starch polysaccharides (NSP) are present in viscous cereals used in feed for poultry. Therefore, exogenous carbohydrases are commonly added to monogastric feed to degrade these NSP. Our hypothesis is that xylanase not only improves laying hen performance and digestibility, but also induces a significant shift in microbial composition within the intestinal tract and thereby might exert a prebiotic effect. In this context, a better understanding on whether and how the chicken gut microbial population can be modulated by xylanase is required. To do so, the effects of dietary supplementation of xylanase on performance, apparent total tract digestibility (ATTD) and cecal microbiome in laying hens were evaluated in the present study. A total of 96 HiSex laying hens were used in this experiment (3 diets and 16 replicates of 2 hens). Xylanase was added to the diets at concentrations of 0, 45,000 (15 g/t Xygest(TM) HT) and 90,000 U/kg (30 g/t Xygest HT). The diets were based on wheat (~55%), soybean and sunflower meal. The lowest dosage, 45,000 U/kg, significantly increased average egg weight and improved feed efficiency compared to the control treatment (P<0.05). Egg quality parameters were significantly improved in the experiment in response to the xylanase addition. For example, during the last 28 days of the trial, birds receiving the 45,000 U/kg and the 90,000 U/kg treatments exhibited an increase in Haugh units and albumin heights (P<0.05). Compared with the control, the ATTD of organic matter and crude protein were drastically improved in the 45,000 U/kg treatment group (P<0.05). Furthermore, gross energy and the ATTD of crude fat were improved significantly for birds fed 90,000 U/kg group compared to the control. Importantly, 16S rRNA gene analysis revealed that xylanase at 45,000 U/kg dosage can exert a change in the cecal microbiome. A significant increase in beneficial bacteria (Bacilli class; Enterococcaceae and Lactobacillales orders; Merdibacter, Enterococcus and Nocardiopsis genera; Enterococcus casseliflavus species) was documented when adding 45,000 U/kg xylanase to the diet of laying hens. In conclusion, dietary supplementation of xylanase 45,000 U/kg significantly improved laying hen performance and digestibility. Furthermore, microbiome data suggest that xylanase modulates the laying hen bacterial population beneficially, thus potentially exerting a prebiotic effect.	[Van Hoeck, Veerle; Somers, Ingrid; Wealleans, Alexandra L.; Van de Craen, Sandy; Morisset, Dany] Kemin Europa NV, Anim Nutr & Hlth, Antwerp, Belgium; [Abdelqader, Anas] Univ Jordan, Dept Anim Prod, Amman, Jordan	University of Jordan	Van Hoeck, V (corresponding author), Kemin Europa NV, Anim Nutr & Hlth, Antwerp, Belgium.	Veerle.vanhoeck@kemin.com		Somers, Ingrid/0000-0001-5617-6572; Morisset, Dany/0000-0001-8967-9424; Van Hoeck, Veerle/0000-0003-1931-5136	Kemin Europa N.V.	Kemin Europa N.V.	The funder, Kemin Europa N.V., provided support in the form of salaries for authors VVH, IS, AW, SVdC, DM, but did not have any additional role in the study design, data collection and analysis, decision to Furthermore, author roles have been updated in the Author Contributions section of the online submission form.publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.'	Akbari H, 2021, PROBIOTICS ANTIMICRO, V13, P1316, DOI 10.1007/s12602-021-09771-x; [Anonymous], 2020, HISEX WHITE PRODUCT; Aoac, 1997, OFFICIAL METHODS ANA, DOI DOI 10.1016/0165-9936(90)87098-7; Arreguin-Nava MA, 2019, ANIMALS-BASEL, V9, DOI 10.3390/ani9090696; Cerrate S, 2019, POULTRY SCI, V98, P3994, DOI 10.3382/ps/pez142; Cho HM, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0240264; Choct M, 2006, WORLD POULTRY SCI J, V62, P5, DOI 10.1079/WPS200480; de Lima MR, 2019, J APPL POULTRY RES, V28, P1150, DOI 10.3382/japr/pfz081; Dillon GP., 2015, J APPL ANIMAL NUTR, V3, P1; Ding XM, 2018, POULTRY SCI, V97, P874, DOI 10.3382/ps/pex372; Edgar RC, 2013, NAT METHODS, V10, P996, DOI [10.1038/NMETH.2604, 10.1038/nmeth.2604]; EISEN EJ, 1962, POULTRY SCI, V41, P1461, DOI 10.3382/ps.0411461; Erdaw MM, 2016, WORLD POULTRY SCI J, V72, P307, DOI 10.1017/S0043933916000271; Fathi M, 2018, ITAL J ANIM SCI, V17, P804, DOI 10.1080/1828051X.2018.1425104; Ferreira CB, 2015, ARQ BRAS MED VET ZOO, V67, P249, DOI 10.1590/1678-7051; Forte C, 2016, POULTRY SCI, V95, P2528, DOI 10.3382/ps/pew164; Gao F, 2008, ANIM FEED SCI TECH, V142, P173, DOI 10.1016/j.anifeedsci.2007.07.008; Glamocic D., 2011, Biotechnology in Animal Husbandry, V27, P583; Gonzalez-Ortiz G, 2019, VALUE OF FIBRE: ENGAGING THE SECOND BRAIN FOR ANIMAL NUTRITION, P233, DOI 10.3920/978-90-8686-893-3_14; Hahn-Didde D, 2014, J APPL POULTRY RES, V23, P23, DOI 10.3382/japr.2013-00764; Iebba V, 2016, NEW MICROBIOL, V39, P1; Kemgang TS, 2014, J APPL MICROBIOL, V117, P303, DOI 10.1111/jam.12521; Kim H, 2020, J MICROBIOL, V58, P193, DOI 10.1007/s12275-020-9556-y; Kogut MH, 2017, J APPL POULTRY RES, V26, P605, DOI 10.3382/japr/pfx028; Kogut MH, 2019, ANIM FEED SCI TECH, V250, P32, DOI 10.1016/j.anifeedsci.2018.10.008; Li Y, 2010, ANIM FEED SCI TECH, V158, P146, DOI 10.1016/j.anifeedsci.2010.03.017; Liu D, 2012, AVIAN PATHOL, V41, P291, DOI 10.1080/03079457.2012.684089; Liu ZZ, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm541; Liu ZZ, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn491; MARQUARDT RR, 1983, POULTRY SCI, V62, P2106, DOI 10.3382/ps.0622106; Mathlouthi N, 2003, BRIT POULTRY SCI, V44, P60, DOI 10.1080/0007166031000085374; Mendes AR, 2013, J APPL POULTRY RES, V22, P92, DOI 10.3382/japr.2012-00610; Mirzaie S, 2012, POULTRY SCI, V91, P413, DOI 10.3382/ps.2011-01686; Myers WD, 2004, J ANIM SCI, V82, P179; Niemiec J, 2012, ANN ANIM SCI, V12, P105, DOI 10.2478/v10220-012-0009-3; Paloheimo M, 2010, ENZYMES IN FARM ANIMAL NUTRITION, 2ND EDITION, P12, DOI 10.1079/9781845936747.0012; Petry AL, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0246144; Pourabedin M, 2015, MICROBIOME, V3, DOI 10.1186/s40168-015-0079-4; Roberts JR, 2006, BRIT POULTRY SCI, V47, P501, DOI 10.1080/00071660600834175; Shirmohammad F, 2011, AFR J BIOTECHNOL, V10, P7541; Short FJ, 1996, ANIM FEED SCI TECH, V59, P215, DOI 10.1016/0377-8401(95)00916-7; Silva T.M., 2013, AFR J BIOTECHNOL, V12, P1874, DOI [10.5897/AJB12.2830, DOI 10.5897/AJB12.2830]; Skrivan M, 2015, CZECH J ANIM SCI, V60, P89, DOI 10.17221/8073-CJAS; Smeets N, 2015, POULTRY SCI, V94, P1584, DOI 10.3382/ps/pev116; Vandeplas S, 2010, CAN J ANIM SCI, V90, P221, DOI 10.4141/CJAS09067; Vandeplas S, 2009, POULTRY SCI, V88, P1643, DOI 10.3382/ps.2008-00479; Wexler HM, 2007, CLIN MICROBIOL REV, V20, P593, DOI 10.1128/CMR.00008-07; Zhang L, 2014, ASIAN AUSTRAL J ANIM, V27, P855, DOI 10.5713/ajas.2014.14006	49	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2021	16	9							e0257681	10.1371/journal.pone.0257681	http://dx.doi.org/10.1371/journal.pone.0257681			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	WG6BN	34543338	Green Published, gold			2022-12-26	WOS:000707078200069
J	Jacobs, M; Ellis, C				Jacobs, Molly; Ellis, Charles			Estimating the cost and value of functional changes in communication ability following telepractice treatment for aphasia	PLOS ONE			English	Article								Context Aphasia is a post-stroke condition that can dramatically impact a person with aphasia's (PWA) communication abilities. To date, few if any studies have considered the cost and cost-effectiveness of functional change in aphasia nor considered measures of patient's value for aphasia treatment. Objective To assess the cost, cost-effectiveness, and perceived value associated with improved functional communication in individuals receiving telerehabilitation treatment for aphasia. Design Twenty PWA completed between 5 and 12 telehealth rehabilitation sessions of 45-60 minutes within a 6-week time frame using a Language-Oriented Treatment (LOT) designed to address a range of language issues among individuals with aphasia. National Outcomes Measures (NOMS) comprehension and verbal expression and the ASHA Quality of Communication Life (QCL) were completed prior to and at the completion of rehabilitation to obtain baseline and treatment measures. Results Age, education, and race are significantly correlated with improvement in the NOMS verbal expression. African Americans (OR = 2.0917) are twice as likely as Whites to experience improvement after treatment. The likelihood of improvement also increases with each additional year of education (OR = 1.002) but decrease with age (OR = 0.9463). A total of 15 PWA showed improvement in NOMS comprehension and nine patients showed improvement in NOMS verbal expression. Improving patients attended between five and 12 treatment sessions. The average cost of improvement in NOMS comprehension was $1,152 per patient and NOMS verbal expression was $1,128 per patient with individual treatment costs varying between $540 and $1,296. However, on average, the monetary equivalent in patient's improved QCL was between $1,790.39 to $3,912,54-far exceeding the financial cost of treatment. Conclusions When measuring the functional improvement of patients with aphasia, patient's quality of communication life received from treatment exceeded financial cost of services provided.	[Jacobs, Molly] Univ Florida, Dept Hlth Serv Res Management & Policy, Gainesville, FL 32611 USA; [Ellis, Charles] Univ Florida, Dept Speech Language & Hearing Sci, Gainesville, FL USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida	Jacobs, M (corresponding author), Univ Florida, Dept Hlth Serv Res Management & Policy, Gainesville, FL 32611 USA.	mollyjacobs@ufl.edu			Agency for Healthcare Research and Quality [1 R03 HS025043-01A1]	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	This study was funded by the Agency for Healthcare Research and Quality https://www.ahrq.gov/Grant #: 1 R03 HS025043-01A1 awarded to CE. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Speech-Language Hearing Association, 2020, APH OV; American Speech-Language-Hearing Association, 2021, ASHAS NAT OUTCC MEAS; [Anonymous], 2010, PUBLIC LAW, P111; Armstrong E, 2013, AM J SPEECH-LANG PAT, V22, pS268, DOI 10.1044/1058-0360(2012/12-0084); Bandur DL., 2008, LANGUAGE INTERVENTIO, P756; Bettger JP, 2017, CIRC-CARDIOVASC QUAL, V10, DOI 10.1161/CIRCOUTCOMES.115.002391; Butzer JF, 2019, ARCH PHYS MED REHAB, V100, P990, DOI 10.1016/j.apmr.2018.11.008; Dalemans RJP, 2010, DISABIL REHABIL, V32, P1678, DOI 10.3109/09638281003649938; Doedens WJ, 2020, APHASIOLOGY, V34, P492, DOI 10.1080/02687038.2019.1702848; Ellis C, 2018, APHASIOLOGY, V32, P1075, DOI 10.1080/02687038.2017.1385052; Ellis C, 2012, STROKE, V43, P1429, DOI 10.1161/STROKEAHA.111.647339; Fucetola R, 2015, AM J SPEECH-LANG PAT, V24, pS790, DOI 10.1044/2015_AJSLP-14-0135; Guyomard V, 2009, J AM GERIATR SOC, V57, P2101, DOI 10.1111/j.1532-5415.2009.02526.x; Jacobs M, 2021, J TELEMED TELECARE, DOI 10.1177/1357633X20982773; Jebahi F., 2021, CURRENT TRENDS NEURO, P1; Kertesz A., 2007, W APHASIA BATTERY; Mazaux JM, 2013, J REHABIL MED, V45, P341, DOI 10.2340/16501977-1122; MULLEN R., 2016, ASHA LEADER, V21, P38, DOI [10.1044/leader.OTP.21102016.38, DOI 10.1044/LEADER.OTP.21102016.38]; Oakes AH, 2021, JAMA-J AM MED ASSOC, V325, P1715, DOI 10.1001/jama.2021.3308; Palmer R, 2012, STROKE, V43, P1904, DOI 10.1161/STROKEAHA.112.650671; Paul D., 2005, QUALITY COMMUNICATIO; Porter ME, 2010, NEW ENGL J MED, V363, P2477, DOI 10.1056/NEJMp1011024; Roth EJ., 2021, ARCH PHYS MED REHAB; Schumacher R, 2020, BRAIN COMMUN, V2, DOI 10.1093/braincomms/fcaa118; Shewan CM., 1986, TREATMENT APHASIA LA; Simmons-Mackie N., 2018, APHASIA N AM STATE A; Wegner Steven E, 2016, N C Med J, V77, P276, DOI 10.18043/ncm.77.4.276; Wenke R, 2014, INT J SPEECH-LANG PA, V16, P250, DOI 10.3109/17549507.2014.887777	28	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2021	16	9							e0257462	10.1371/journal.pone.0257462	http://dx.doi.org/10.1371/journal.pone.0257462			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	WG5ZQ	34534254	Green Published, gold			2022-12-26	WOS:000707073300031
J	Karmi, N; Bangma, A; Spekhorst, LM; van Dullemen, HM; Visschedijk, MC; Dijkstra, G; Weersma, RK; Voskuil, MD; Festen, EAM				Karmi, Naomi; Bangma, Amber; Spekhorst, Lieke M.; van Dullemen, Hendrik M.; Visschedijk, Marijn C.; Dijkstra, Gerard; Weersma, Rinse K.; Voskuil, Michiel D.; Festen, Eleonora A. M.			Polygenetic risk scores do not add predictive power to clinical models for response to anti-TNF alpha therapy in inflammatory bowel disease	PLOS ONE			English	Article							SUSCEPTIBILITY; ASSOCIATION	Background Anti-tumour necrosis factor alpha (TNF alpha) therapy is widely used in the management of Crohn's disease (CD) and ulcerative colitis (UC). However, up to a third of patients do not respond to induction therapy and another third of patients lose response over time. To aid patient stratification, polygenetic risk scores have been identified as predictors of response to anti-TNF alpha therapy. We aimed to replicate the association between polygenetic risk scores and response to anti-TNF alpha therapy in an independent cohort of patients, to establish its clinical validity. Materials and methods Primary non-response, primary response, durable response and loss of response to anti-TNF alpha therapy was retrospectively assessed for each patient using stringent definitions. Genome wide genotyping was performed and previously described polygenetic risk scores for primary non-response and durable response were calculated. We compared polygenetic risk scores between patients with primary response and primary non-response, and between patients with durable response and loss of response, using separate analyses for CD and UC. Results Out of 334 patients with CD, 15 (4%) patients met criteria for primary non-response, 221 (66%) for primary response, 115 (34%) for durable response and 35 (10%) for loss of response. Out of 112 patients with UC, 12 (11%) met criteria for primary non-response, 68 (61%) for primary response, 19 (17%) for durable response and 20 (18%) for loss of response. No significant differences in polygenetic risk scores were found between primary non-responders and primary responders, and between durable responders and loss of responders. Conclusions We could not replicate the previously reported association between polygenetic risk scores and response to anti-TNF alpha therapy in an independent cohort of patients with CD or UC. Currently, there is insufficient evidence to use polygenetic risk scores to predict response to anti-TNF alpha therapy in patients with IBD.	[Karmi, Naomi; Bangma, Amber; Spekhorst, Lieke M.; van Dullemen, Hendrik M.; Visschedijk, Marijn C.; Dijkstra, Gerard; Weersma, Rinse K.; Voskuil, Michiel D.; Festen, Eleonora A. M.] Univ Groningen, Univ Med Ctr Groningen, Dept Gastroenterol & Hepatol, Groningen, Netherlands; [Karmi, Naomi; Bangma, Amber; Voskuil, Michiel D.; Festen, Eleonora A. M.] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, Groningen, Netherlands	University of Groningen; University of Groningen	Festen, EAM (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Gastroenterol & Hepatol, Groningen, Netherlands.; Festen, EAM (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Genet, Groningen, Netherlands.	e.a.m.festen@umcg.nl	Weersma, Rinse/ABE-3807-2021	/0000-0003-4563-7462; Karmi, Naomi/0000-0001-8519-6812	Dutch Digestive Foundation [D1614]; MLDS Career Development grant [CDG 14-04]	Dutch Digestive Foundation; MLDS Career Development grant	R.K.W. is supported by a Diagnostics Grant from the Dutch Digestive Foundation (D1614). www.narcis.nl Yes -played a role in: Conceptualization Data curation Formal analysis Funding acquisition Resources Supervision Validation Writing -review & editing E.A.M.F. is supported by a MLDS Career Development grant (CDG 14-04). www.mlds.nl Yes -played a role in: Conceptualization Data curation Formal analysis Funding acquisition Investigation Methodology Project administration Resources Software Supervision Validation Visualization Writing original draft Writing -review & editing.	Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Barber GE, 2016, AM J GASTROENTEROL, V111, P1816, DOI 10.1038/ajg.2016.408; Burke KE, 2018, INFLAMM BOWEL DIS, V24, P1840, DOI 10.1093/ibd/izy083; Das S, 2016, NAT GENET, V48, P1284, DOI 10.1038/ng.3656; de Lange KM, 2017, NAT GENET, V49, P256, DOI 10.1038/ng.3760; Ferguson CJ, 2012, PERSPECT PSYCHOL SCI, V7, P555, DOI 10.1177/1745691612459059; Hendriks F, 2020, PUBLIC UNDERST SCI, V29, P270, DOI 10.1177/0963662520902383; Imhann F, 2019, BMC GASTROENTEROL, V19, DOI 10.1186/s12876-018-0917-5; Jostins L, 2012, NATURE, V491, P119, DOI 10.1038/nature11582; KNAW, 2018, REP STUD IMPR REPR E; Kuhnen A, 2019, SURG CLIN N AM, V99, P1197, DOI 10.1016/j.suc.2019.08.014; Lewis CM, 2020, GENOME MED, V12, DOI 10.1186/s13073-020-00742-5; Liu JZ, 2015, NAT GENET, V47, P979, DOI 10.1038/ng.3359; Ogura Y, 2001, NATURE, V411, P603, DOI 10.1038/35079114; Roda G, 2016, CLIN TRANSL GASTROEN, V7, DOI 10.1038/ctg.2015.63; Sazonovs A, 2020, GASTROENTEROLOGY, V158, P189, DOI 10.1053/j.gastro.2019.09.041; Vachon A, 2020, CURR OPIN GASTROEN, V36, P247, DOI 10.1097/MOG.0000000000000653; van der Valk ME, 2014, GUT, V63, P72, DOI 10.1136/gutjnl-2012-303376; Voskuil MD, 2019, WORLD J GASTROENTERO, V25, P2539, DOI 10.3748/wjg.v25.i21.2539	19	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2021	16	9							e0256860	10.1371/journal.pone.0256860	http://dx.doi.org/10.1371/journal.pone.0256860			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	WG5ZQ	34534227	Green Published, gold			2022-12-26	WOS:000707073300011
J	Arruda, EF; Das, SS; Dias, CM; Pastore, DH				Arruda, Edilson F.; Das, Shyam S.; Dias, Claudia M.; Pastore, Dayse H.			Modelling and optimal control of multi strain epidemics, with application to COVID-19	PLOS ONE			English	Article							SARS-COV-2	Reinfection and multiple viral strains are among the latest challenges in the current COVID-19 pandemic. In contrast, epidemic models often consider a single strain and perennial immunity. To bridge this gap, we present a new epidemic model that simultaneously considers multiple viral strains and reinfection due to waning immunity. The model is general, applies to any viral disease and includes an optimal control formulation to seek a trade-off between the societal and economic costs of mitigation. We validate the model, with and without mitigation, in the light of the COVID-19 epidemic in England and in the state of Amazonas, Brazil. The model can derive optimal mitigation strategies for any number of viral strains, whilst also evaluating the effect of distinct mitigation costs on the infection levels. The results show that relaxations in the mitigation measures cause a rapid increase in the number of cases, and therefore demand more restrictive measures in the future.	[Arruda, Edilson F.] Univ Southampton, Southampton Business Sch, Dept Decis Analyt & Risk, Southampton, Hants, England; [Pastore, Dayse H.] Fed Ctr Technol Educ Celso Suckow Fonseca, Dept Basic & Gen Disciplines, Rio De Janeiro, RJ, Brazil; [Das, Shyam S.; Dias, Claudia M.] Univ Fed Rural Rio de Janeiro, Multidisciplinary Inst, Grad Program Math & Computat Modeling, Nova Iguacu, RJ, Brazil	Solent University; University of Southampton; Universidade Federal Rural do Rio de Janeiro (UFRRJ)	Arruda, EF (corresponding author), Univ Southampton, Southampton Business Sch, Dept Decis Analyt & Risk, Southampton, Hants, England.	e.f.arruda@southamton.ac.uk	Das, Shyam Sumanta/AHA-8591-2022; Arruda, Edilson/T-8718-2018; Pastore, Dayse/AGU-7778-2022	Arruda, Edilson/0000-0002-9835-352X; Pastore, Dayse/0000-0002-0905-0085; Mazza Dias, Claudia/0000-0001-7376-1554	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico-CNPq [311075/2018-5]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior-Brasil (CAPES) [001]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico-CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior-Brasil (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This study was partly supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico-CNPq, under grant 311075/2018-5 and by Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior-Brasil (CAPES) [Finance Code 001].	[Anonymous], 2020, SARS COV 2 GENOMES R, DOI [10.1101/2020.04.30.069039, DOI 10.1101/2020.04.30.069039]; Bacaer N, 2011, SHORT HISTORY OF MATHEMATICAL POPULATION DYNAMICS, P89, DOI 10.1007/978-0-85729-115-8_16; Barreto-Vieira DF, 2021, MEM I OSWALDO CRUZ, V116, DOI 10.1590/0074-02760200443; Bentaleb D, 2020, DIFFER EQUAT DYN SYS, DOI 10.1007/s12591-020-00544-6; Bertozzi AL, 2020, P NATL ACAD SCI USA, V117, P16732, DOI 10.1073/pnas.2006520117; Bonifacio LP, 2020, REV SOC BRAS MED TRO, V53, DOI 10.1590/0037-8682-0619-2020; Bootsma MCJ, 2007, P NATL ACAD SCI USA, V104, P7588, DOI 10.1073/pnas.0611071104; Buss LF, 2021, SCIENCE, V371, P288, DOI 10.1126/science.abe9728; Candido DS, 2020, SCIENCE, V369, P1255, DOI 10.1126/science.abd2161; Carcione JM, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00230; CDC, 2021, SCI BRIEF EM SARS CO; Dan JM, 2021, SCIENCE, V371, P587, DOI 10.1126/science.abf4063; Dawood AA, 2020, NEW MICROB NEW INFEC, V35, DOI 10.1016/j.nmni.2020.100673; Edridge AWD, 2020, NAT MED, V26, P1691, DOI 10.1038/s41591-020-1083-1; Etbaigha F, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0202493; Eubank S, 2020, B MATH BIOL, V82, DOI 10.1007/s11538-020-00726-x; Fontanet A, 2020, NAT REV IMMUNOL, V20, P583, DOI 10.1038/s41577-020-00451-5; Frid H, 2003, ESAIM-MATH MODEL NUM, V37, P709, DOI 10.1051/m2an:2003045; Fudolig M, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0243408; Gubar E, 2017, L N INST COMP SCI SO, V212, P108, DOI 10.1007/978-3-319-67540-4_10; Jia JW, 2020, ELECTRON J DIFFER EQ; Kantner M, 2020, J MATH IND, V10, DOI 10.1186/s13362-020-00091-3; Kermack WO, 1927, P R SOC LOND A-CONTA, V115, P700, DOI 10.1098/rspa.1927.0118; Khyar O, 2020, NONLINEAR DYNAM, V102, P489, DOI 10.1007/s11071-020-05929-4; Kirby T, 2021, LANCET RESP MED, V9, pE20, DOI 10.1016/S2213-2600(21)00005-9; Korber B, 2020, CELL, V182, P812, DOI 10.1016/j.cell.2020.06.043; Latif Siddique, 2020, IEEE Transactions on Artificial Intelligence, V1, P85, DOI 10.1109/TAI.2020.3020521; Long QX, 2020, NAT MED, V26, P1200, DOI 10.1038/s41591-020-0965-6; Madubueze CE, 2020, COMPUT MATH METHOD M, V2020, DOI 10.1155/2020/6862516; McMahon A, 2020, JMIR PUBLIC HLTH SUR, V6, P279, DOI 10.2196/21168; Naveca FG, 2021, NAT MED, V27, P1230, DOI 10.1038/s41591-021-01378-7; Overbaugh J, 2020, NAT MED, V26, P1680, DOI 10.1038/s41591-020-1121-z; Perkins TA, 2020, B MATH BIOL, V82, DOI 10.1007/s11538-020-00795-y; R Core Team, 2020, R LANG ENV STAT COMP; Rawson T, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00262; Rodriguez-Morales AJ, 2020, TRAVEL MED INFECT DI, V34, DOI 10.1016/j.tmaid.2020.101623; Ruktanonchai NW, 2020, SCIENCE, V369, P1465, DOI 10.1126/science.abc5096; Sabino EC, 2021, LANCET, V397, P452, DOI 10.1016/S0140-6736(21)00183-5; Seow J, 2020, NAT MICROBIOL, V5, P1598, DOI 10.1038/s41564-020-00813-8; Shao N, 2020, MATH METHOD APPL SCI, V43, P4943, DOI 10.1002/mma.6345; Tarrataca L, 2021, J MATH IND, V11, DOI 10.1186/s13362-020-00098-w; Tegally H, 2020, MEDRXIV, DOI [10.1101/2020.12.21.20248640, DOI 10.1101/2020.12.21.20248640, 10.1101/2020.12.21.20248640(2020]; Tillett RL, 2021, LANCET INFECT DIS, V21, P52, DOI 10.1016/S1473-3099(20)30764-7; To Kelvin Kai-Wang, 2021, Clin Infect Dis, V73, pe2946, DOI 10.1093/cid/ciaa1275; Nonaka CKV, 2021, EMERG INFECT DIS, V27, P1522, DOI 10.3201/eid2705.210191; Wang Jin, 2020, J Public Health Emerg, V4, DOI 10.21037/jphe-2020-05; Zhu H, 2020, ESTIMATING NUMBER IN, DOI [10.25561/77731, DOI 10.25561/77731]	49	19	19	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2021	16	9							e0257512	10.1371/journal.pone.0257512	http://dx.doi.org/10.1371/journal.pone.0257512			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	WG5YY	34529745	Green Submitted, Green Published, gold, Green Accepted			2022-12-26	WOS:000707071500066
J	Roy, S; Showstark, M; Tolchin, B; Kashyap, N; Bonito, J; Salazar, MC; Herbst, JL; Nash, KA; Tiako, MJN; Jubanyik, K; Kim, N; Galusha, D; Wang, KH; Oladele, C				Roy, Shireen; Showstark, Mary; Tolchin, Benjamin; Kashyap, Nitu; Bonito, Jennifer; Salazar, Michelle C.; Herbst, Jennifer L.; Nash, Katherine A.; Tiako, Max Jordan Nguemeni; Jubanyik, Karen; Kim, Nancy; Galusha, Deron; Wang, Karen H.; Oladele, Carol			The potential impact of triage protocols on racial disparities in clinical outcomes among COVID-positive patients in a large academic healthcare system	PLOS ONE			English	Article							SOFA SCORE	Background The COVID-19 pandemic has had a devastating impact in the United States, particularly for Black populations, and has heavily burdened the healthcare system. Hospitals have created protocols to allocate limited resources, but there is concern that these protocols will exacerbate disparities. The sequential organ failure assessment (SOFA) score is a tool often used in triage protocols. In these protocols, patients with higher SOFA scores are denied resources based on the assumption that they have worse clinical outcomes. The purpose of this study was to assess whether using SOFA score as a triage tool among COVID-positive patients would exacerbate racial disparities in clinical outcomes. Methods We analyzed data from a retrospective cohort of hospitalized COVID-positive patients in the Yale-New Haven Health System. We examined associations between race/ethnicity and peak overall/24-hour SOFA score, in-hospital mortality, and ICU admission. Other predictors of interest were age, sex, primary language, and insurance status. We used one-way ANOVA and chi-square tests to assess differences in SOFA score across racial/ethnic groups and linear and logistic regression to assess differences in clinical outcomes by sociodemographic characteristics. Results Our final sample included 2,554 patients. Black patients had higher SOFA scores compared to patients of other races. However, Black patients did not have significantly greater in-hospital mortality or ICU admission compared to patients of other races. Conclusion While Black patients in this sample of hospitalized COVID-positive patients had higher SOFA scores compared to patients of other races, this did not translate to higher in-hospital mortality or ICU admission. Results demonstrate that if SOFA score had been used to allocate care, Black COVID patients would have been denied care despite having similar clinical outcomes to white patients. Therefore, using SOFA score to allocate resources has the potential to exacerbate racial inequities by disproportionately denying care to Black patients and should not be used to determine access to care. Healthcare systems must develop and use COVID-19 triage protocols that prioritize equity.	[Roy, Shireen] Yale Sch Publ Hlth, Dept Chron Dis Epidemiol, New Haven, CT 06510 USA; [Showstark, Mary] Yale Sch Med, Yale Inst Global Hlth, Natl Disaster Med Syst, Phys Assistant Online Program, New Haven, CT USA; [Tolchin, Benjamin] Yale New Haven Hlth, Yale Sch Med, Dept Neurol, Epilepsy Ctr Excellence,VA Connecticut Healthcare, New Haven, CT USA; [Kashyap, Nitu] Yale New Haven Hlth, New Haven, CT USA; [Bonito, Jennifer; Jubanyik, Karen] Yale Sch Med, Dept Emergency Med, New Haven, CT USA; [Salazar, Michelle C.] Yale Sch Med, Dept Surg, Natl Clinician Scholars Program, New Haven, CT USA; [Herbst, Jennifer L.] Quinnipiac Univ, Sch Law, Frank H Netter MD Sch Med, North Haven, CT USA; [Nash, Katherine A.] Yale Sch Med, Dept Pediat, Natl Clinician Scholars Program, New Haven, CT USA; [Tiako, Max Jordan Nguemeni; Galusha, Deron] Yale Sch Med, New Haven, CT USA; [Kim, Nancy; Wang, Karen H.; Oladele, Carol] Yale Sch Med, Equ Res & Innovat Ctr, New Haven, CT USA	Yale University; Yale University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Connecticut Healthcare System; Yale University; Yale University; Yale University; Yale University; Quinnipiac University; Yale University; Yale University; Yale University	Roy, S (corresponding author), Yale Sch Publ Hlth, Dept Chron Dis Epidemiol, New Haven, CT 06510 USA.	shireenroy@wustl.edu	Nguemeni Tiako, Max Jordan/AAZ-7373-2020	Nguemeni Tiako, Max Jordan/0000-0002-5468-8926; Nash, Katherine/0000-0002-8294-9994; Salazar, Michelle/0000-0001-7922-4223; Roy, Shireen/0000-0002-6733-5054				[Anonymous], 2020, ARIZONA CSC PLAN ARI; [Anonymous], COVID 19 DEATHS ANAL; Antommaria AHM, 2020, ANN INTERN MED, V173, P188, DOI 10.7326/M20-1738; Anyane-Yeboa A, 2020, J INTERN MED, V288, P479, DOI 10.1111/joim.13117; Azar KMJ, 2020, HEALTH AFFAIR, V39, P1253, DOI 10.1377/hlthaff.2020.00598; Caraccio C, 2020, J COMP EFFECT RES, V9, P829, DOI 10.2217/cer-2020-0090; Ferreira FL, 2001, JAMA-J AM MED ASSOC, V286, P1754, DOI 10.1001/jama.286.14.1754; Gross CP, 2020, J GEN INTERN MED, V35, P3097, DOI 10.1007/s11606-020-06081-w; Gupta A, 2017, AM J RESP CRIT CARE, V195; Gupta A, 2017, AM J RESP CRIT CARE, V195; Hamblin J., ATLANTIC; Hanfling D., 2016, CRISIS STANDARDS CAR; Herreros B, 2020, J MED ETHICS, V46, P455, DOI 10.1136/medethics-2020-106352; Hertz RP, 2005, ARCH INTERN MED, V165, P2098, DOI 10.1001/archinte.165.18.2098; Holtgrave DR, 2020, ANN EPIDEMIOL, V48, P9, DOI 10.1016/j.annepidem.2020.06.010; Hsu J, 2008, CLIN J AM SOC NEPHRO, V3, P992, DOI 10.2215/CJN.00090108; Khan A., 2020, MEDRXIV PUBLISHED ON, DOI [10.1101/2020.05.10.20090167, DOI 10.1101/2020.05.10.20090167]; Khan Z, 2009, ANAESTHESIA, V64, P1283, DOI 10.1111/j.1365-2044.2009.06135.x; Klinger EV, 2015, J GEN INTERN MED, V30, P719, DOI 10.1007/s11606-014-3102-8; Laventhal N, 2020, PEDIATRICS, V146, DOI 10.1542/peds.2020-1243; LillieBlanton M, 1996, SOC SCI MED, V43, P83, DOI 10.1016/0277-9536(95)00337-1; Millett GA, 2020, ANN EPIDEMIOL, V47, P37, DOI 10.1016/j.annepidem.2020.05.003; Minne L, 2008, CRIT CARE, V12, DOI 10.1186/cc7160; New York State Task Force on Life and the Law New York State Department of Health, 2015, VENT ALL GUID; Nord E, 2005, SOC SCI MED, V60, P257, DOI 10.1016/j.socscimed.2004.05.003; Price-Haywood EG, 2020, NEW ENGL J MED, V382, P2534, DOI 10.1056/NEJMsa2011686; Schmidt H, 2022, J MED ETHICS, V48, P126, DOI 10.1136/medethics-2020-106856; Shahpori R, 2011, CRIT CARE MED, V39, P827, DOI 10.1097/CCM.0b013e318206d548; Sundararajan V, 2004, J CLIN EPIDEMIOL, V57, P1288, DOI 10.1016/j.jclinepi.2004.03.012; Tolchin Benjamin, 2020, J Clin Ethics, V31, P303; United States of America, WHO COR DIS COVID 19; van Dorn A, 2020, LANCET, V395, P1243, DOI 10.1016/S0140-6736(20)30893-X; Vincent JL, 1998, CRIT CARE MED, V26, P1793, DOI 10.1097/00003246-199811000-00016; von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X; Vyas DA, 2020, NEW ENGL J MED, V383, P874, DOI 10.1056/NEJMms2004740; Wiemers Emily E, 2020, medRxiv, DOI 10.1101/2020.05.28.20115899; Zou XJ, 2020, CRIT CARE MED, V48, pE657, DOI 10.1097/CCM.0000000000004411	37	3	3	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2021	16	9							e0256763	10.1371/journal.pone.0256763	http://dx.doi.org/10.1371/journal.pone.0256763			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	WG5YY	34529684	Green Published, gold			2022-12-26	WOS:000707071500019
J	Squier, K; Scott, A; Hunt, MA; Brunham, LR; Wilson, DR; Screen, H; Waugh, CM				Squier, Kipling; Scott, Alexander; Hunt, Michael A.; Brunham, Liam R.; Wilson, David R.; Screen, Hazel; Waugh, Charlie M.			The effects of cholesterol accumulation on Achilles tendon biomechanics: A cross-sectional study	PLOS ONE			English	Article							FAMILIAL HYPERCHOLESTEROLEMIA; MUSCLE-TENDON; ENERGY; SERUM; TENDINOPATHY; HOMEOSTASIS; COLLAGEN	Familial hypercholesterolemia, a common genetic metabolic disorder characterized by high cholesterol levels, is involved in the development of atherosclerosis and other preventable diseases. Familial hypercholesterolemia can also cause tendinous abnormalities, such as thickening and xanthoma (tendon lipid accumulation) in the Achilles, which may impede tendon biomechanics. The objective of this study was to investigate the effect of cholesterol accumulation on the biomechanical performance of Achilles tendons, in vivo. 16 participants (10 men, 6 women; 37 +/- 6 years) with familial hypercholesterolemia, diagnosed with tendon xanthoma, and 16 controls (10 men, 6 women; 36 +/- 7 years) underwent Achilles biomechanical assessment. Achilles biomechanical data was obtained during preferred pace, shod, walking by analysis of lower limb kinematics and kinetics utilizing 3D motion capture and an instrumented treadmill. Gastrocnemius medialis muscle-tendon junction displacement was imaged using ultrasonography. Achilles stiffness, hysteresis, strain and force were calculated from displacement-force data acquired during loading cycles, and tested for statistical differences using one-way ANOVA. Statistical parametric mapping was used to examine group differences in temporal data. Participants with familial hypercholesterolemia displayed lower Achilles stiffness compared to the control group (familial hypercholesterolemia group: 87 +/- 20 N/mm; controls: 111 +/- 18 N/mm; p = 0.001), which appeared to be linked to Achilles loading rate rather than an increased strain (FH: 5.27 +/- 1.2%; controls: 4.95 +/- 0.9%; p = 0.413). We found different Achilles loading patterns in the familial hypercholesterolemia group, which were traced to differences in the centre of pressure progression that affected ankle moment. This finding may indicate that individuals with familial hypercholesterolemia use different Achilles loading strategies. Participants with familial hypercholesterolemia also demonstrated significantly greater Achilles hysteresis than the control group (familial hypercholesterolemia: 57.5 +/- 7.3%; controls: 43.8 +/- 10%; p<0.001), suggesting that walking may require a greater metabolic cost. Our results indicate that cholesterol accumulation could contribute to reduced Achilles function, while potentially increasing the chance of injury.	[Squier, Kipling; Scott, Alexander; Hunt, Michael A.; Waugh, Charlie M.] Univ British Columbia, Fac Med, Dept Phys Therapy, Vancouver, BC, Canada; [Squier, Kipling; Scott, Alexander; Hunt, Michael A.; Wilson, David R.; Waugh, Charlie M.] Vancouver Coastal Hlth Res Inst, Ctr Hip Hlth & Mobil, Vancouver, BC, Canada; [Brunham, Liam R.] Univ British Columbia, Ctr Heart Lung Innovat, Vancouver, BC, Canada; [Wilson, David R.] Univ British Columbia, Fac Med, Dept Orthopaed, Vancouver, BC, Canada; [Screen, Hazel] Queen Mary Univ London, Sch Engn & Mat Sci, London, England	University of British Columbia; Vancouver Coastal Health Research Institute; University of British Columbia; University of British Columbia; University of London; Queen Mary University London	Squier, K (corresponding author), Univ British Columbia, Fac Med, Dept Phys Therapy, Vancouver, BC, Canada.; Squier, K (corresponding author), Vancouver Coastal Hlth Res Inst, Ctr Hip Hlth & Mobil, Vancouver, BC, Canada.	kip.squier@hiphealth.ca	; Waugh, Charlie/J-3687-2015	Wilson, David/0000-0001-6893-0894; Brunham, Liam/0000-0002-3686-3807; Squier, Kip/0000-0001-6293-8270; Waugh, Charlie/0000-0002-3090-046X	European Union's Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie grant [704333]; Canadian Institutes of Health Research [PJT-166129]	European Union's Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie grant(SKA South Africa); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	CW received funding from the European Union's Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie grant agreement (No. 704333). AS received funding from the Canadian Institutes of Health Research (PJT-166129). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abate M, 2013, RHEUMATOLOGY, V52, P599, DOI 10.1093/rheumatology/kes395; Abboud JA, 2010, CLIN ORTHOP RELAT R, V468, P1493, DOI 10.1007/s11999-009-1151-9; Akturk M, 2007, EXP CLIN ENDOCR DIAB, V115, P92, DOI 10.1055/s-2007-955097; ALEXANDER RM, 1977, NATURE, V265, P114, DOI 10.1038/265114a0; Arya S, 2010, J APPL PHYSIOL, V108, P670, DOI 10.1152/japplphysiol.00259.2009; Beason D, 2004, 55 ANN M ORTH RES SO, P184; Beason DP, 2013, J SHOULDER ELB SURG, V22, P681, DOI 10.1016/j.jse.2012.07.008; Beason DP, 2011, J ORTHOP RES, V29, P380, DOI 10.1002/jor.21255; Beeharry D, 2006, ANN RHEUM DIS, V65, P312, DOI 10.1136/ard.2005.040766; Cronin NJ, 2010, CLIN BIOMECH, V25, P476, DOI 10.1016/j.clinbiomech.2010.01.018; de Ferranti SD, 2016, CIRCULATION, V133, P1067, DOI 10.1161/CIRCULATIONAHA.115.018791; Finni T, 2013, J APPL PHYSIOL, V114, P515, DOI 10.1152/japplphysiol.01005.2012; Fukunaga T, 2001, P ROY SOC B-BIOL SCI, V268, P229, DOI 10.1098/rspb.2000.1361; Gerus P, 2011, J BIOMECH, V44, P2333, DOI 10.1016/j.jbiomech.2011.05.021; Giddings VL, 2000, MED SCI SPORT EXER, V32, P627, DOI 10.1097/00005768-200003000-00012; GOLDSTEIN JL, 1973, J CLIN INVEST, V52, P1544, DOI 10.1172/JCI107332; Goldstein JL, 2015, CELL, V161, P161, DOI 10.1016/j.cell.2015.01.036; Grewal N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114214; Griffith JF, 2017, RADIOLOGY, V285, P876, DOI 10.1148/radiol.2017161435; Hawkins D, 2009, J BIOMECH, V42, P2813, DOI 10.1016/j.jbiomech.2009.08.023; Ishikawa M, 2005, J APPL PHYSIOL, V99, P603, DOI 10.1152/japplphysiol.00189.2005; JOZSA L, 1984, INT ORTHOP, V7, P251; KRUTH HS, 1985, AM J PATHOL, V121, P311; Lichtwark GA, 2005, J EXP BIOL, V208, P4715, DOI 10.1242/jeb.01950; Lozano PF, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-44306-z; Maganaris CN, 1999, J PHYSIOL-LONDON, V521, P307, DOI 10.1111/j.1469-7793.1999.00307.x; Magnusson SP, 2016, ADV EXP MED BIOL, V920, P11, DOI 10.1007/978-3-319-33943-6_2; Mathiak G, 1999, ARCH ORTHOP TRAUM SU, V119, P280, DOI 10.1007/s004020050410; Munteanu SE, 2011, J FOOT ANKLE RES, V4, DOI 10.1186/1757-1146-4-15; Nordestgaard BG, 2013, EUR HEART J, V34, P3478, DOI 10.1093/eurheartj/eht273; Ogbonmwan I, 2018, GAIT POSTURE, V62, P146, DOI 10.1016/j.gaitpost.2018.03.010; Orselli MIv., 2018, J BIOMECH, V60, P227; Ozgurtas T, 2003, CLIN CHIM ACTA, V331, P25, DOI 10.1016/S0009-8981(03)00075-5; Paavola M, 2002, J BONE JOINT SURG AM, V84A, P2062, DOI 10.2106/00004623-200211000-00024; Pataky TC, 2013, J BIOMECH, V46, P2394, DOI 10.1016/j.jbiomech.2013.07.031; Pearson SJ, 2007, CLIN BIOMECH, V22, P712, DOI 10.1016/j.clinbiomech.2007.02.006; Petrovic M, 2018, J APPL PHYSIOL, V124, P1333, DOI 10.1152/japplphysiol.00290.2017; PROCTER P, 1982, J BIOMECH, V15, P627, DOI 10.1016/0021-9290(82)90017-3; RONNEMAA T, 1975, ATHEROSCLEROSIS, V21, P315, DOI 10.1016/0021-9150(75)90045-3; Sawicki GS., 2013, EXERC SPORT SCI REV, V37, P1; Schaiff RAB, 2008, AM HEALTH DRUG BENEF, V1, P39; Screen HRC, 2015, J ORTHOP RES, V33, P793, DOI 10.1002/jor.22818; Soslowsky LJ, 2016, ADV EXP MED BIOL, V920, P151, DOI 10.1007/978-3-319-33943-6_14; Steplewski A, 2019, J ORTHOP SURG RES, V14, DOI 10.1186/s13018-019-1217-7; Stosic J, 2011, EUR J APPL PHYSIOL, V111, P3151, DOI 10.1007/s00421-011-1929-9; Theis N, 2012, J ELECTROMYOGR KINES, V22, P947, DOI 10.1016/j.jelekin.2012.06.004; Thorpe CT, 2013, INT J EXP PATHOL, V94, pA3; Tsouli SG, 2005, EUR J CLIN INVEST, V35, P236, DOI 10.1111/j.1365-2362.2005.01484.x; Van Ginckel A, 2009, GAIT POSTURE, V29, P387, DOI 10.1016/j.gaitpost.2008.10.058; Wang JHC, 2006, J BIOMECH, V39, P1563, DOI 10.1016/j.jbiomech.2005.05.011; Zelik KE, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179976	51	2	2	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2021	16	9							e0257269	10.1371/journal.pone.0257269	http://dx.doi.org/10.1371/journal.pone.0257269			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	WG5YY	34529718	Green Published, gold			2022-12-26	WOS:000707071500040
J	Sato, R; Akita, K; Ikoma, T; Iguchi, K; Murase, T; Nakamura, T; Akari, S; Mogi, S; Naruse, Y; Ohtani, H; Maekawa, Y				Sato, Ryota; Akita, Keitaro; Ikoma, Takenori; Iguchi, Keisuke; Murase, Takayo; Nakamura, Takashi; Akari, Seigo; Mogi, Satoshi; Naruse, Yoshihisa; Ohtani, Hayato; Maekawa, Yuichiro			Association between plasma xanthine oxidoreductase activity and in-hospital outcomes in patients with stable coronary artery disease after percutaneous coronary intervention	PLOS ONE			English	Article							HIGHLY SENSITIVE ASSAY; OXIDATIVE STRESS; URIC-ACID	Objectives Reactive oxygen species generated by xanthine oxidoreductase (XOR) are associated with the progression of atherosclerosis. However, changes in plasma XOR (pXOR) activity after percutaneous coronary intervention (PCI) for stable coronary artery disease (CAD) remains unknown. Methods Herein, we compared the change in the pXOR activity in patients undergoing PCI with that in patients undergoing coronary angiography (CAG) and further evaluated the relation between changes in pXOR activity and in-hospital and long-term outcomes of patients undergoing PCI. The pXOR activity of 80 consecutive patients who underwent PCI and 25 patients who underwent CAG during the hospitalization was analyzed daily. The percentage changes from baseline regulated time interval was evaluated. Results We found that although pXOR activity decreased after PCI, and remained low until discharge, no significant changes were observed in patients undergoing CAG. Furthermore, among the patients undergoing PCI, those who experienced in-hospital adverse events, had a higher percentage of pXOR reduction 3 days after PCI. There was no association between these changes and long-term events. Conclusions A significant change in pXOR activity was observed in patients undergoing PCI than in patients undergoing CAG, and there seems to be a correlation between the in-hospital outcomes and the percentage reduction from baseline in pXOR activity.	[Sato, Ryota; Akita, Keitaro; Ikoma, Takenori; Iguchi, Keisuke; Mogi, Satoshi; Naruse, Yoshihisa; Ohtani, Hayato; Maekawa, Yuichiro] Hamamatsu Univ Sch Med, Div Cardiol, Internal Med 3, Hamamatsu, Shizuoka, Japan; [Murase, Takayo; Nakamura, Takashi; Akari, Seigo] Sanwa Kagaku Kenkyusho Co Ltd, Nagoya, Aichi, Japan	Hamamatsu University School of Medicine; Sanwa Kagaku Kenkyusho Co., Ltd.	Maekawa, Y (corresponding author), Hamamatsu Univ Sch Med, Div Cardiol, Internal Med 3, Hamamatsu, Shizuoka, Japan.	ymaekawa@hama-med.ac.jp	Akita, Keitaro/AAX-5712-2020	Akita, Keitaro/0000-0001-5395-1887; Akari, Seigo/0000-0001-6641-1062				Andrikou I, 2018, CLIN EXP PHARMACOL P, V45, P866, DOI 10.1111/1440-1681.12928; Burtenshaw D, 2019, FRONT CARDIOVASC MED, V6, DOI 10.3389/fcvm.2019.00089; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Feig DI, 2008, NEW ENGL J MED, V359, P1811, DOI 10.1056/NEJMra0800885; Frohlich GM, 2013, EUR HEART J, V34, P1714, DOI 10.1093/eurheartj/eht090; Fujimura Y, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182699; Furuhashi M, 2020, J DIABETES INVEST, V11, P878, DOI 10.1111/jdi.13207; Furuhashi M, 2018, CIRC J, V82, P1892, DOI 10.1253/circj.CJ-18-0082; Harrison D, 2003, AM J CARDIOL, V91, p7A; He F, 2015, INT J MOL SCI, V16, P27770, DOI 10.3390/ijms161126059; Juni RP, 2013, J AM COLL CARDIOL, V61, P1471, DOI 10.1016/j.jacc.2012.11.068; Kawaguchi Y, 2019, J INTERV CARDIOL, V2019, DOI 10.1155/2019/4532862; Knuuti J, 2020, EUR HEART J, V41, P407, DOI 10.1093/eurheartj/ehz425; Kochiadakis GE, 2010, INT J CARDIOL, V142, P33, DOI 10.1016/j.ijcard.2008.12.105; Mannarino MR, 2021, J AM HEART ASSOC, V10, DOI 10.1161/JAHA.120.020419; Matsushita Masato, 2020, Circ Rep, V2, P104, DOI 10.1253/circrep.CR-19-0116; Mehran R, 2011, CIRCULATION, V123, P2736, DOI 10.1161/CIRCULATIONAHA.110.009449; Mogi S, 2013, CORONARY ARTERY DIS, V24, P602, DOI 10.1097/MCA.0b013e3283650254; Moussa ID, 2013, J AM COLL CARDIOL, V62, P1563, DOI 10.1016/j.jacc.2013.08.720; Murase T, 2016, J CHROMATOGR B, V1039, P51, DOI 10.1016/j.jchromb.2016.10.033; Murase T, 2016, J LABELLED COMPD RAD, V59, P214, DOI 10.1002/jlcr.3390; Murase T, 2016, J CHROMATOGR B, V1008, P189, DOI 10.1016/j.jchromb.2015.11.030; Nakatani A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15419-0; Okazaki H, 2019, ESC HEART FAIL, V6, P336, DOI 10.1002/ehf2.12390; Otaki Y, 2017, INT J CARDIOL, V228, P151, DOI 10.1016/j.ijcard.2016.11.077; Seddon M, 2007, HEART, V93, P903, DOI 10.1136/hrt.2005.068270; Sukegawa H, 2016, CORONARY ARTERY DIS, V27, P405, DOI 10.1097/MCA.0000000000000375; Tscharre M, 2018, ATHEROSCLEROSIS, V270, P173, DOI 10.1016/j.atherosclerosis.2018.02.003; Tziomalos K, 2009, FRONT BIOSCI-LANDMRK, V14, P237, DOI 10.2741/3243; Washio K, 2017, METABOLISM, V70, P51, DOI 10.1016/j.metabol.2017.01.031; Watanabe K, 2019, HEART VESSELS, V34, P1, DOI 10.1007/s00380-018-1207-4; Yoshida S, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-61463-8; Zdrenghea M, 2017, CARDIOVASC J AFR, V28, P201, DOI 10.5830/CVJA-2016-068	33	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2021	16	9							e0257227	10.1371/journal.pone.0257227	http://dx.doi.org/10.1371/journal.pone.0257227			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	WG5RP	34520495	Green Published, gold			2022-12-26	WOS:000707052100016
J	Guo, AX; Smith, S; Khan, YM; Langabeer, II; Foraker, RE				Guo, Aixia; Smith, Sakima; Khan, Yosef M.; Langabeer, James R., II; Foraker, Randi E.			Application of a time-series deep learning model to predict cardiac dysrhythmias in electronic health records	PLOS ONE			English	Article								Background Cardiac dysrhythmias (CD) affect millions of Americans in the United States (US), and are associated with considerable morbidity and mortality. New strategies to combat this growing problem are urgently needed. Objectives Predicting CD using electronic health record (EHR) data would allow for earlier diagnosis and treatment of the condition, thus improving overall cardiovascular outcomes. The Guideline Advantage (TGA) is an American Heart Association ambulatory quality clinical data registry of EHR data representing 70 clinics distributed throughout the US, and has been used to monitor outpatient prevention and disease management outcome measures across populations and for longitudinal research on the impact of preventative care. Methods For this study, we represented all time-series cardiovascular health (CVH) measures and the corresponding data collection time points for each patient by numerical embedding vectors. We then employed a deep learning technique-long-short term memory (LSTM) model-to predict CD from the vector of time-series CVH measures by 5-fold cross validation and compared the performance of this model to the results of deep neural networks, logistic regression, random forest, and Naive Bayes models. Results We demonstrated that the LSTM model outperformed other traditional machine learning models and achieved the best prediction performance as measured by the average area under the receiver operator curve (AUROC): 0.76 for LSTM, 0.71 for deep neural networks, 0.66 for logistic regression, 0.67 for random forest, and 0.59 for Naive Bayes. The most influential feature from the LSTM model were blood pressure. Conclusions These findings may be used to prevent CD in the outpatient setting by encouraging appropriate surveillance and management of CVH.	[Guo, Aixia; Foraker, Randi E.] Washington Univ, Inst Informat I2, Sch Med, St Louis, MO 63130 USA; [Smith, Sakima] Ohio State Univ, Dept Internal Med, Columbus, OH 43210 USA; [Khan, Yosef M.] Amer Heart Assoc, Ctr Hlth Metr, Hlth Informat & Analyt, Dallas, TX USA; [Langabeer, James R., II] Univ Texas Houston, Hlth Sci Ctr Houston, Sch Biomed Informat, Houston, TX USA; [Foraker, Randi E.] Washington Univ, Sch Med, Dept Internal Med, St Louis, MO 63110 USA	Washington University (WUSTL); University System of Ohio; Ohio State University; University of Texas System; University of Texas Health Science Center Houston; Washington University (WUSTL)	Foraker, RE (corresponding author), Washington Univ, Inst Informat I2, Sch Med, St Louis, MO 63130 USA.; Foraker, RE (corresponding author), Washington Univ, Sch Med, Dept Internal Med, St Louis, MO 63110 USA.	randi.foraker@wustl.edu						American Heart Association, 2015, WHAT IS ARRH, DOI [10.1002/sia.740150809, DOI 10.1002/SIA.740150809]; Anderson AE, 2016, J BIOMED INFORM, V60, P162, DOI 10.1016/j.jbi.2015.12.006; Baytas IM, 2017, KDD'17: PROCEEDINGS OF THE 23RD ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P65, DOI 10.1145/3097983.3097997; Bhattacharya M, 2017, CIRCULATION, V136; Breiman L., 2001, MACH LEARN, V45, P5; Bufalino V, 2014, CA-CANCER J CLIN, V64, P157, DOI 10.3322/caac.21233; Friedman N, 1997, MACH LEARN, V29, P131, DOI 10.1023/A:1007465528199; Goodfellow I, 2016, ADAPT COMPUT MACH LE, P1; Greenlee RT, 2005, CURR OPIN CARDIOL, V20, P7; Han J., 1995, LECT NOTES COMPUTER, P195, DOI DOI 10.1007/3-540-59497-3_175; Hannun AY, 2019, NAT MED, V25, P65, DOI 10.1038/s41591-018-0268-3; Hochreiter S., 1997, STUD COMPUT INTELL, DOI DOI 10.1007/978-3-642-24797-2; Hosmer DW, 2013, WILEY SER PROBAB ST, P89; Jensen PB, 2012, NAT REV GENET, V13, P395, DOI 10.1038/nrg3208; Jozefowicz R, 2015, PR MACH LEARN RES, V37, P2342; Karnik S, 2012, IEEE ENG MED BIO, P5562, DOI 10.1109/EMBC.2012.6347254; Khurshid S, 2016, AM J CARDIOL, V117, P221, DOI 10.1016/j.amjcard.2015.10.031; Kingma DP., 2014, ADAM METHOD STOCHAST; Kolek MJ, 2016, JAMA CARDIOL, V1, P1007, DOI 10.1001/jamacardio.2016.3366; Levenshtein VI, 1966, SOV PHYS DOKL, V10, P707; Lloyd-Jones DM, 2010, CIRCULATION, V121, P586, DOI 10.1161/CIRCULATIONAHA.109.192703; Lubitz Steven A, 2010, Heart Fail Clin, V6, P239, DOI 10.1016/j.hfc.2009.12.004; Mehra R, 2007, J ELECTROCARDIOL, V40, pS118, DOI 10.1016/j.jelectrocard.2007.06.023; Mikolov T., 2013, 1 INT C LEARN REPR I; Rajkomar A, 2018, NPJ DIGIT MED, V1, DOI 10.1038/s41746-018-0029-1; Shashikumar SP, 2017, 2017 IEEE EMBS INTERNATIONAL CONFERENCE ON BIOMEDICAL & HEALTH INFORMATICS (BHI), P141, DOI 10.1109/BHI.2017.7897225; Shickel B, 2018, IEEE J BIOMED HEALTH, V22, P1589, DOI 10.1109/JBHI.2017.2767063; Solares JRA, 2020, J BIOMED INFORM, V101, DOI 10.1016/j.jbi.2019.103337; van der Maaten L, 2008, J MACH LEARN RES, V9, P2579; Vidaillet H, 2002, AM J MED, V113, P365, DOI 10.1016/S0002-9343(02)01253-6; Xiao C, 2018, J AM MED INFORM ASSN, V25, P1419, DOI 10.1093/jamia/ocy068; Zhang Y, 2019, PROCEEDINGS OF THE TWENTY-EIGHTH INTERNATIONAL JOINT CONFERENCE ON ARTIFICIAL INTELLIGENCE, P4369	32	1	1	3	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2021	16	9							e0239007	10.1371/journal.pone.0239007	http://dx.doi.org/10.1371/journal.pone.0239007			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	WG6OR	34516567	Green Published, gold			2022-12-26	WOS:000707114200001
J	Watanabe, T; Matsumoto, Y; Nishimiya, K; Shindo, T; Amamizu, H; Sugisawa, J; Tsuchiya, S; Sato, K; Morosawa, S; Ohyama, K; Watanabe-Asaka, T; Hayashi, M; Kawai, Y; Takahashi, J; Yasuda, S; Shimokawa, H				Watanabe, Tasuku; Matsumoto, Yasuharu; Nishimiya, Kensuke; Shindo, Tomohiko; Amamizu, Hirokazu; Sugisawa, Jun; Tsuchiya, Satoshi; Sato, Koichi; Morosawa, Susumu; Ohyama, Kazuma; Watanabe-Asaka, Tomomi; Hayashi, Moyuru; Kawai, Yoshiko; Takahashi, Jun; Yasuda, Satoshi; Shimokawa, Hiroaki			Low-intensity pulsed ultrasound therapy suppresses coronary adventitial inflammatory changes and hyperconstricting responses after coronary stent implantation in pigs in vivo	PLOS ONE			English	Article							ADIPOSE-TISSUE INFLAMMATION; VASOSPASTIC ANGINA; VASA VASORUM; ASSOCIATION; ANGIOGENESIS; DYSFUNCTION; PROGRESSION; ARTERY; ENOS	Backgrounds We demonstrated that coronary adventitial inflammation plays important roles in the pathogenesis of drug-eluting stent (DES)-induced coronary hyperconstricting responses in pigs in vivo. However, no therapy is yet available to treat coronary adventitial inflammation. We thus developed the low-intensity pulsed ultrasound (LIPUS) therapy that ameliorates myocardial ischemia by enhancing angiogenesis. Aims We aimed to examine whether our LIPUS therapy suppresses DES-induced coronary hyperconstricting responses in pigs in vivo, and if so, what mechanisms are involved. Methods Sixteen normal male pigs were randomly assigned to the LIPUS or the sham therapy groups after DES implantation into the left anterior descending (LAD) coronary artery. In the LIPUS group, LIPUS (32 cycles, 193 mW/cm(2)) was applied to the heart at 3 different levels (segments proximal and distal to the stent edges and middle of the stent) for 20 min at each level for every other day for 2 weeks. The sham therapy group was treated in the same manner but without LIPUS. At 4 weeks after stent implantation, we performed coronary angiography, followed by immunohistological analysis. Results Coronary vasoconstricting responses to serotonin in LAD at DES edges were significantly suppressed in the LIPUS group compared with the sham group. Furthermore, lymph transport speed in vivo was significantly faster in the LIPUS group than in the sham group. Histological analysis at DES edges showed that inflammatory changes and Rho-kinase activity were significantly suppressed in the LIPUS group, associated with eNOS up-regulation and enhanced lymph-angiogenesis. Conclusions These results suggest that our non-invasive LIPUS therapy is useful to treat coronary functional abnormalities caused by coronary adventitial inflammation, indicating its potential for the novel and safe therapeutic approach of coronary artery disease.	[Watanabe, Tasuku; Matsumoto, Yasuharu; Nishimiya, Kensuke; Shindo, Tomohiko; Amamizu, Hirokazu; Sugisawa, Jun; Tsuchiya, Satoshi; Sato, Koichi; Morosawa, Susumu; Ohyama, Kazuma; Takahashi, Jun; Yasuda, Satoshi; Shimokawa, Hiroaki] Tohoku Univ, Dept Cardiovasc Med, Grad Sch Med, Sendai, Miyagi, Japan; [Watanabe-Asaka, Tomomi; Hayashi, Moyuru; Kawai, Yoshiko] Tohoku Med & Pharmaceut Univ, Div Physiol, Sendai, Miyagi, Japan; [Shimokawa, Hiroaki] Int Univ Hlth & Welf, Narita, Japan	Tohoku University; Tohoku Medical & Pharmaceutical University; International University of Health & Welfare	Shimokawa, H (corresponding author), Tohoku Univ, Dept Cardiovasc Med, Grad Sch Med, Sendai, Miyagi, Japan.; Shimokawa, H (corresponding author), Int Univ Hlth & Welf, Narita, Japan.	shimo@cardio.med.tohoku.ac.jp			Sakakibara Memorial Research Grant from the Japan Research Promotion Society for Cardiovascular Diseases; Mitsui Sumitomo Insurance Welfare Foundation;  [18K15877];  [19K11762];  [19K17511]	Sakakibara Memorial Research Grant from the Japan Research Promotion Society for Cardiovascular Diseases; Mitsui Sumitomo Insurance Welfare Foundation(Mitsui Sumitomo Insurance Welfare Foundation); ; ; 	This work was supported in part by the grants-in-aid for the Scientific Research (18K15877, 19K11762, 19K17511), Mitsui Sumitomo Insurance Welfare Foundation, and Sakakibara Memorial Research Grant from the Japan Research Promotion Society for Cardiovascular Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors received no specific funding for this work.	Amamizu H, 2019, ARTERIOSCL THROM VAS, V39, P741, DOI 10.1161/ATVBAHA.119.312396; Brakenhielm E, 2020, J AM COLL CARDIOL, V76, P735, DOI 10.1016/j.jacc.2020.05.076; Brakenhielm E, 2019, NAT REV CARDIOL, V16, P56, DOI 10.1038/s41569-018-0087-8; Cheng C, 2005, BLOOD, V106, P3691, DOI 10.1182/blood-2005-06-2326; Eguchi K, 2018, BRAIN STIMUL, V11, P959, DOI 10.1016/j.brs.2018.05.012; Gutierrez E, 2013, EUR HEART J, V34, P3175, DOI 10.1093/eurheartj/eht351; Hagendoorn J, 2004, CIRC RES, V95, P204, DOI 10.1161/01.RES.0000135549.72828.24; Hanawa K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104863; Kawana A, 2013, CIRC J, V77, P1267, DOI 10.1253/circj.CJ-12-1486; KOHCHI K, 1985, CIRCULATION, V71, P709, DOI 10.1161/01.CIR.71.4.709; Kolodgie FD, 2003, NEW ENGL J MED, V349, P2316, DOI 10.1056/NEJMoa035655; Laine P, 1999, CIRCULATION, V99, P361, DOI 10.1161/01.CIR.99.3.361; Monma Y, 2021, CARDIOVASC RES, V117, P1325, DOI 10.1093/cvr/cvaa221; Morishige K, 2000, J AM COLL CARDIOL, V35, P1040, DOI 10.1016/S0735-1097(99)00625-7; Munn LL, 2015, SEMIN CELL DEV BIOL, V38, P67, DOI 10.1016/j.semcdb.2015.01.010; Nishimiya K, 2016, JACC-CARDIOVASC INTE, V9, P281, DOI 10.1016/j.jcin.2015.09.041; Nishimiya K, 2016, J AM COLL CARDIOL, V67, P598, DOI 10.1016/j.jacc.2015.11.031; Nishimiya K, 2015, CIRC J, V79, P1787, DOI 10.1253/circj.CJ-15-0149; Ogata T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185555; Ohyama K, 2018, J AM COLL CARDIOL, V71, P414, DOI 10.1016/j.jacc.2017.11.046; Ohyama K, 2017, ARTERIOSCL THROM VAS, V37, P1757, DOI 10.1161/ATVBAHA.117.309843; Oikonomou EK, 2018, LANCET, V392, P929, DOI 10.1016/S0140-6736(18)31114-0; Ridker PM, 2019, NEW ENGL J MED, V380, P752, DOI 10.1056/NEJMoa1809798; Sandler A, 2006, NEW ENGL J MED, V355, P2542, DOI 10.1056/NEJMoa061884; Shimokawa H, 2014, EUR HEART J, V35, P3180, DOI 10.1093/eurheartj/ehu427; Shindo T, 2016, ARTERIOSCL THROM VAS, V36, P1220, DOI 10.1161/ATVBAHA.115.306477; Shiroto T, 2009, J AM COLL CARDIOL, V54, P2321, DOI 10.1016/j.jacc.2009.07.045; Uzuka H, 2017, ARTERIOSCL THROM VAS, V37, P1869, DOI 10.1161/ATVBAHA.117.309777; Vieira JM, 2018, J CLIN INVEST, V128, P3402, DOI 10.1172/JCI97192; Vilahur G, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/907575; Virmani R, 2005, ARTERIOSCL THROM VAS, V25, P2054, DOI 10.1161/01.ATV.0000178991.71605.18; Yamaguchi T, 2007, AM J PHYSIOL-HEART C, V292, pH1435, DOI 10.1152/ajpheart.00282.2006; Zhang B, 2020, AUTOPHAGY, V16, P1262, DOI 10.1080/15548627.2019.1664705	33	0	0	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2021	16	9							e0257175	10.1371/journal.pone.0257175	http://dx.doi.org/10.1371/journal.pone.0257175			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	WG6OR	34516572	gold, Green Published			2022-12-26	WOS:000707114200015
J	Ghamkharinejad, G; Marashi, SH; Foolad, F; Javan, M; Fathollahi, Y				Ghamkharinejad, Ghazaleh; Marashi, Seyed Hossein; Foolad, Forough; Javan, Mohammad; Fathollahi, Yaghoub			Unconditioned and learned morphine tolerance influence hippocampal-dependent short-term memory and the subjacent expression of GABA-A receptor alpha subunits	PLOS ONE			English	Article							ANALGESIC TOLERANCE; COGNITIVE FUNCTION; SODIUM VALPROATE; MICE LACKING; RATS; WITHDRAWAL; INCREASES; MAZE; ACQUISITION; MECHANISMS	Background ?-aminobutyric acid (GABA) facilitator valproic acid may be able to curb memory disruption induced by morphine exposure. Objective The effects of the GABA facilitator valproic acid on the behavioral tolerance induced by morphine were investigated. Then hippocampal-dependent tasks named spatial-working and short-term memory procedures using the Y-maze apparatus were examined in morphine tolerant rats. Finally, the changes in the expression of hippocampal GABA-A receptors underlying morphine tolerance were also examined. Methods Rats were treated with daily morphine injections, with or without distinct contextual pairing. To examine the effect of valproic acid on morphine tolerance expression, valproic acid was pretreated an hour before morphine. Spatial-working and short-term memory procedures using the Y-maze apparatus were examined in morphine tolerant rats. Afterwards the changes in the expression of hippocampal GABA alpha receptors using the quantitative real-time PCR and western blot techniques to detect GABAr alpha subunits mRNAs and protein level were studied. Results Our results showed that both learned and non-associative morphine tolerance influence short-term memory and the subjacent expression of GABAr alpha mRNAs and protein level. Despite its attenuating effects on the development and expression of both learned and non-associative morphine tolerance, only associative morphine tolerance-induced memory dysfunction was ameliorated by valproic acid pretreatment. We also found that the expression of GABAr alpha 1, alpha 2, alpha 5 subunits mRNAs and GABA alpha protein level were affected heavier in associative morphine tolerant rats. Conclusion Our data supports the hypothesis that unconditioned and learned morphine tolerance influences short-term memory and the expression of GABAr alpha 1, alpha 2, alpha 5 mRNAs and GABAr alpha protein level differently, and adds to our understanding of the behavioral and molecular aspects of the learned tolerance to morphine effects.	[Ghamkharinejad, Ghazaleh; Marashi, Seyed Hossein; Foolad, Forough; Javan, Mohammad; Fathollahi, Yaghoub] Tarbiat Modares Univ, Dept Physiol, Fac Med Sci, Tehran, Iran	Tarbiat Modares University	Fathollahi, Y (corresponding author), Tarbiat Modares Univ, Dept Physiol, Fac Med Sci, Tehran, Iran.	fatolahi@modares.ac.ir	; Javan, Mohammad/C-6758-2008	Marashi, Seyed Hossein/0000-0003-3771-3736; Javan, Mohammad/0000-0003-2045-6171; fathollahi, yghoub/0000-0002-3695-4805				Aben B, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00301; Aldenkamp AP, 2000, EPILEPSIA, V41, P1167, DOI 10.1111/j.1528-1157.2000.tb00322.x; Alvandi MS, 2017, ADDICT BIOL, V22, P1883, DOI 10.1111/adb.12547; Belozertseva I. V., 2000, Eksperimental'naya i Klinicheskaya Farmakologiya, V63, P19; BRAIDA D, 1994, EUR J PHARMACOL, V271, P497, DOI 10.1016/0014-2999(94)90811-7; Collinson N, 2002, J NEUROSCI, V22, P5572; Crestani F, 2002, P NATL ACAD SCI USA, V99, P8980, DOI 10.1073/pnas.142288699; Dai WL, 2018, EXP MOL MED, V50, DOI 10.1038/s12276-018-0175-1; Dawson GR, 2006, J PHARMACOL EXP THER, V316, P1335, DOI 10.1124/jpet.105.092320; del Rio JC, 2001, J NEUROCHEM, V79, P183; Donegan JJ, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10800-1; Eisch AJ, 2000, P NATL ACAD SCI USA, V97, P7579, DOI 10.1073/pnas.120552597; El Sabaa RM, 2020, NEUROPSYCH DIS TREAT, V16, P1945, DOI 10.2147/NDT.S256117; Eyre MD, 2012, J NEUROSCI, V32, P5853, DOI 10.1523/JNEUROSCI.6495-11.2012; Farahmandfar M, 2010, BEHAV BRAIN RES, V211, P156, DOI 10.1016/j.bbr.2010.03.013; Ghafouri S, 2016, EPILEPSY RES, V126, P37, DOI 10.1016/j.eplepsyres.2016.06.010; Ginawi O. T., 2006, Saudi Pharmaceutical Journal, V14, P149; Gorji HM, 2008, PHYSIOL BEHAV, V93, P622, DOI 10.1016/j.physbeh.2007.11.002; Grisel JE, 1996, PSYCHOPHARMACOLOGY, V128, P248, DOI 10.1007/s002130050132; Hines RM, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05481-1; Hortnagl H, 2013, NEUROSCIENCE, V236, P345, DOI 10.1016/j.neuroscience.2013.01.008; Homanics GE, 2005, GENES BRAIN BEHAV, V4, P10, DOI 10.1111/j.1601-183X.2004.00090.x; Kreek MJ, 2001, ANN NY ACAD SCI, V937, P27; LeDoux JE., 1986, MIND BRAIN DIALOGUES; LEONARD CM, 1985, BEHAV BRAIN RES, V15, P159, DOI 10.1016/0166-4328(85)90062-2; Li Z, 2001, PHARMACOL BIOCHEM BE, V68, P507, DOI 10.1016/S0091-3057(01)00456-7; Lieberman R, 2015, ALCOHOL CLIN EXP RES, V39, P1654, DOI 10.1111/acer.12807; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loscher W, 1999, PROG NEUROBIOL, V58, P31, DOI 10.1016/S0301-0082(98)00075-6; Louie A., 1991, NEUROBIOLOGY OPIOIDS, P417; Mitchell JM, 2000, NAT NEUROSCI, V3, P47, DOI 10.1038/71120; Mohajeri M, 2015, NEUROPHARMACOLOGY, V99, P156, DOI 10.1016/j.neuropharm.2015.07.013; Okada H, 2004, J NEUROCHEM, V89, P7, DOI 10.1111/j.1471-4159.2004.02271.x; OLPE HR, 1988, N-S ARCH PHARMACOL, V338, P655, DOI 10.1007/BF00165630; Reid CA, 2012, BRIT J PHARMACOL, V165, P49, DOI 10.1111/j.1476-5381.2011.01507.x; Rezayof A, 2007, EUR NEUROPSYCHOPHARM, V17, P24, DOI 10.1016/j.euroneuro.2006.02.003; Rivat C, 2016, PAIN REP, V1, DOI 10.1097/PR9.0000000000000570; Rodriguez-Menendez V, 2008, ANTICANCER RES, V28, P335; Roeckel LA, 2016, NEUROSCIENCE, V338, P160, DOI 10.1016/j.neuroscience.2016.06.029; Rudolph U, 2006, CURR OPIN PHARMACOL, V6, P18, DOI 10.1016/j.coph.2005.10.003; Sadegh M, 2013, EUR J PHARMACOL, V704, P1, DOI 10.1016/j.ejphar.2013.02.017; Satarian L, 2008, NEUROSCI LETT, V430, P213, DOI 10.1016/j.neulet.2007.10.038; Schubert M, 2005, LEARN MEMORY, V12, P520, DOI 10.1101/lm.4205; Shaerzadeh F, 2014, NEUROMOL MED, V16, P175, DOI 10.1007/s12017-013-8272-8; SPAIN JW, 1991, PSYCHOPHARMACOLOGY, V105, P101, DOI 10.1007/BF02316870; Sun Y, 2018, TRANSL PSYCHIAT, V8, DOI 10.1038/s41398-018-0180-0; Takeshima T, 2016, NEUROL CLIN NEUROSCI, V4, P134, DOI 10.1111/ncn3.12053; Tao R, 2002, J PHARMACOL EXP THER, V303, P704, DOI 10.1124/jpet.102.038133; TIFFANY ST, 1981, J COMP PHYSIOL PSYCH, V95, P747, DOI 10.1037/h0077839; Tsutsui KI, 2016, FRONT SYST NEUROSCI, V10, DOI 10.3389/fnsys.2016.00099; Vahidi S., 2012, DANESHVAR MED BASIC, V20, P61; VIONDURY J, 1987, BRAIN RES, V408, P243, DOI 10.1016/0006-8993(87)90380-5; Vorma H, 2011, HEROIN ADDICT REL CL, V13, P15; Wang JH, 2006, EXP NEUROL, V199, P438, DOI 10.1016/j.expneurol.2006.01.005; White NM, 1996, ADDICTION, V91, P921, DOI 10.1111/j.1360-0443.1996.tb03586.x; Wu P, 2016, MED SCI MONITOR, V22, P5197, DOI 10.12659/MSM.898859; Xi XJ, 2020, EPILEPSY RES, V163, DOI 10.1016/j.eplepsyres.2020.106328; Xuan AG, 2015, MOL NEUROBIOL, V51, P300, DOI 10.1007/s12035-014-8751-4; Ye GL, 2010, NEUROMETHODS, V44, P65, DOI 10.1007/978-1-60761-474-6_4; Yee BK, 2004, EUR J NEUROSCI, V20, P1928, DOI 10.1111/j.1460-9568.2004.03642.x; Zarrindast MR, 2002, J PSYCHOPHARMACOL, V16, P313, DOI 10.1177/026988110201600405; Zarrinkalam E, 2016, LIFE SCI, V157, P19, DOI 10.1016/j.lfs.2016.05.034; Zhang TJ, 2019, PAIN RES MANAG, V2019, DOI 10.1155/2019/9432965; Zurek AA, 2016, ANN CLIN TRANSL NEUR, V3, P392, DOI 10.1002/acn3.303	64	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2021	16	9							e0253902	10.1371/journal.pone.0253902	http://dx.doi.org/10.1371/journal.pone.0253902			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XR9EB	34500453	gold, Green Published			2022-12-26	WOS:000732522400009
J	Gandolphe, MC; Nandrino, JL; Hendrickx, M; Willem, C; Cottencin, O; Gerardin, P; Guardia, D; Buttitta, M; Zanini, V; Dodin, V				Gandolphe, Marie-Charlotte; Nandrino, Jean-Louis; Hendrickx, Marion; Willem, Clemence; Cottencin, Olivier; Gerardin, Priscille; Guardia, Dewi; Buttitta, Marie; Zanini, Virginie; Dodin, Vincent			Specificity and wealth of autobiographical memories in restrictive and mixed anorexic patients	PLOS ONE			English	Article							EMOTION REGULATION; EATING-DISORDERS; DEPRESSION; NERVOSA; PSYCHOPATHOLOGY; METAANALYSIS; INDIVIDUALS; VALIDATION; RUMINATION; AVOIDANCE	The reduced specificity of positive and negative autobiographical memories observed in anorexic (AN) patients may reflect a global disturbance in their emotional information processing. However, their emotional difficulties may differ according to the subtype of AN, implying possible differences in the manifestation of autobiographical memory impairments. The aims of the study were (1) to confirm the autobiographical memory deficits in AN patients in terms of specificity and wealth of memories, and (2) to compare autobiographical deficits according to the AN subtype: restrictive type (AR) or binge/purging type (AB). Ninety-five non-clinical (NC) individuals and 95 AN patients including 69 AR and 22 AB patients were administered the Williams' and Scott's Autobiographical Memory Test. The results confirmed a lack of specificity regardless of emotional valence in the overall AN patient group without any distinction of subtype, which was linked to the number of hospitalizations. When the AN subtype was considered, AR patients demonstrated reduced specificity for negative memories only, suggesting differences in emotional functioning or in the mechanisms underlying reduced specificity between AR and AB patients. Furthermore, the overall AN group demonstrated lower variability and complexity in their memory content than the NC group. However, this difference in the complexity of recalled memories was only found in response to negative cues. When AN subtypes were considered, AR patients showed fewer complex memories than NC individuals. Beyond a reduced specificity, AN patients also depict a poverty in the range of event recall and a difficulty in developing narrative content. The clinical implications of such autobiographical memory deficits need to be further investigated.	[Gandolphe, Marie-Charlotte; Nandrino, Jean-Louis; Willem, Clemence] Univ Lille, CNRS, UMR 9193, SCALab Sci Cognit & Sci Affect, F-59000 Lille, France; [Hendrickx, Marion; Dodin, Vincent] Hop Saint Vincent Paul, GHICL Serv Psychiatrie, Lille, France; [Willem, Clemence; Buttitta, Marie] Lille Cathol Hosp, Delegat Clin Res & Innovat, Lille, France; [Cottencin, Olivier] CHRU Lille, Hopt Fontan 2, Serv Addictol, Lille, France; [Gerardin, Priscille; Zanini, Virginie] CHU Rouen, Serv Psychiatrie Enfant & Adolescent, Rouen, France; [Guardia, Dewi] Clin Lautramont, Serv Psychiatrie Adolescent, Loos, France; [Buttitta, Marie] Univ Lille, PSITEC Lab EA 4072, Lille, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Humanities & Social Sciences (INSHS); Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; CHU Lille; CHU de Rouen; Universite de Lille - ISITE; Universite de Lille	Gandolphe, MC (corresponding author), Univ Lille, CNRS, UMR 9193, SCALab Sci Cognit & Sci Affect, F-59000 Lille, France.	marie-charlotte.gandolphe@univ-lille.fr	/I-4024-2015	/0000-0003-3663-1405	Fondation de France; French Ministry of Health (OLFANOR, PHRC-Inter-region Nord-Ouest 2014) [14.078]	Fondation de France(Fondation de France); French Ministry of Health (OLFANOR, PHRC-Inter-region Nord-Ouest 2014)	This study was supported by a grant from the Fondation de France and the French Ministry of Health (OLFANOR, PHRC-Inter-region Nord-Ouest 2014 number 14.078). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldao A, 2010, CLIN PSYCHOL REV, V30, P217, DOI 10.1016/j.cpr.2009.11.004; American Psychiatric Association, 2000, DIAGN STAT MAN MENT, V4th; Anderson LK, 2018, J CLIN PSYCHOL, V74, P1867, DOI 10.1002/jclp.22638; Barry TJ, 2019, MEMORY, V27, P916, DOI 10.1080/09658211.2019.1607876; Beaman A, 2007, Q J EXP PSYCHOL, V60, P1275, DOI 10.1080/17470210600943450; Bomba M, 2014, EUR EAT DISORD REV, V22, P479, DOI 10.1002/erv.2321; Brockmeyer T, 2014, COMPR PSYCHIAT, V55, P565, DOI 10.1016/j.comppsych.2013.12.001; Brockmeyer T, 2013, PSYCHIAT RES, V210, P548, DOI 10.1016/j.psychres.2013.06.024; Brockmeyer T, 2012, COMPR PSYCHIAT, V53, P496, DOI 10.1016/j.comppsych.2011.09.003; Bruce KR, 2003, INT J EAT DISORDER, V33, P92, DOI 10.1002/eat.10116; Burns EE, 2012, CHILD ABUSE NEGLECT, V36, P32, DOI 10.1016/j.chiabu.2011.08.005; Cagar-Nazai HP, 2014, NEUROSCI BIOBEHAV R, V42, P55, DOI 10.1016/j.neubiorev.2013.12.002; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Cohen J.E., 1988, STAT POWER ANAL BEHA; Conway MA, 2000, PSYCHOL REV, V107, P261, DOI 10.1037//0033-295X.107.2.261; Criquillon-Doublet S, 1995, PSYCHOPATHOLOGIE QUA, P249; Dalgleish T, 2003, EMOTION, V3, P211, DOI 10.1037/1528-3542.3.3.211; Dalgleish T, 2014, TRENDS COGN SCI, V18, P596, DOI 10.1016/j.tics.2014.06.010; Danner UN, 2012, EUR EAT DISORD REV, V20, P490, DOI 10.1002/erv.2184; Erten MN, 2018, FRONT PSYCHOL, V9, DOI 10.3389/fpsyg.2018.00419; Field A, 2013, DISCOVERING STAT USI; Gandolphe MC, 2019, MEMORY, V27, P637, DOI 10.1080/09658211.2018.1548624; Gandolphe MC, 2013, CAN J BEHAV SCI, V45, P305, DOI 10.1037/a0033219; GARNER DM, 1983, INT J EAT DISORDER, V2, P15, DOI 10.1002/1098-108X(198321)2:2<15::AID-EAT2260020203>3.0.CO;2-6; Hallford DJ, 2018, BEHAV RES THER, V102, P42, DOI 10.1016/j.brat.2018.01.003; Hitchcock C, 2016, J BEHAV THER EXP PSY, V52, P92, DOI 10.1016/j.jbtep.2016.03.012; Hudson JI, 2007, BIOL PSYCHIAT, V61, P348, DOI 10.1016/j.biopsych.2006.03.040; Kovacs T, 2011, J COGN BEHAV PSYCHOT, V11, P57; Laberg S, 2004, EUR EAT DISORD REV, V12, P34, DOI 10.1002/erv.534; Lavender JM, 2015, CLIN PSYCHOL REV, V40, P111, DOI 10.1016/j.cpr.2015.05.010; Luchetti M, 2018, MEMORY, V26, P117, DOI 10.1080/09658211.2017.1335326; Miller GA, 2001, J ABNORM PSYCHOL, V110, P40, DOI 10.1037//0021-843X.110.1.40; Moradi AR, 2021, CLIN PSYCHOL SCI, V9, P686, DOI 10.1177/2167702620982576; Nandrino JL, 2006, J PSYCHOSOM RES, V61, P537, DOI 10.1016/j.jpsychores.2006.02.008; Nandrino JL, 2017, DRUG ALCOHOL DEPEN, V179, P61, DOI 10.1016/j.drugalcdep.2017.06.027; Nandrino JL, 2002, PSYCHOPATHOLOGY, V35, P335, DOI 10.1159/000068591; Naumann E, 2016, COGNITIVE THER RES, V40, P304, DOI 10.1007/s10608-015-9723-3; Oldershaw A, 2011, NEUROSCI BIOBEHAV R, V35, P970, DOI 10.1016/j.neubiorev.2010.11.001; Ono M, 2016, PSYCHOL TRAUMA-US, V8, P157, DOI 10.1037/tra0000027; Peters SL, 2019, MEM COGNITION, V47, P1592, DOI 10.3758/s13421-019-00953-1; PUFFET A, 1991, European Psychiatry, V6, P141; Raes F, 2006, J ABNORM PSYCHOL, V115, P699, DOI 10.1037/0021-843X.115.4.699; Raes F, 2009, J BEHAV THER EXP PSY, V40, P24, DOI 10.1016/j.jbtep.2008.03.001; Rawal A, 2010, BEHAV RES THER, V48, P851, DOI 10.1016/j.brat.2010.05.009; RAZAVI D, 1989, REV PSYCHOL APPL, V39, P295; Ridout N, 2015, PSYCHIAT RES, V228, P295, DOI 10.1016/j.psychres.2015.06.030; Rosval L, 2006, INT J EAT DISORDER, V39, P590, DOI 10.1002/eat.20296; Rubin DC, 1998, MEM COGNITION, V26, P3, DOI 10.3758/BF03211366; Sumner JA, 2010, BEHAV RES THER, V48, P614, DOI 10.1016/j.brat.2010.03.013; Van Daele T, 2013, J BEHAV THER EXP PSY, V44, P135, DOI 10.1016/j.jbtep.2011.12.005; Weinbach N, 2018, J ABNORM CHILD PSYCH, V46, P1351, DOI 10.1007/s10802-017-0365-7; Williams HL, 2008, MEMORY IN THE REAL WORLD, THIRD EDITION, P21; Williams J.M.G., 1996, REMEMBERING OUR STUD, P244, DOI DOI 10.1017/CBO9780511527913.010; Williams JMG, 2007, PSYCHOL BULL, V133, P122, DOI 10.1037/0033-2909.133.1.122; Williams JMG, 2006, COGNITION EMOTION, V20, P548, DOI 10.1080/02699930500450465; WILLIAMS JMG, 1986, J ABNORM PSYCHOL, V95, P144, DOI 10.1037/0021-843X.95.2.144; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	57	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2021	16	9							e0256959	10.1371/journal.pone.0256959	http://dx.doi.org/10.1371/journal.pone.0256959			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	XM9EM	34506532	Green Published, gold			2022-12-26	WOS:000729120700038
J	Sanhajariya, S; Duffull, SB; Isbister, GK				Sanhajariya, Suchaya; Duffull, Stephen B.; Isbister, Geoffrey K.			Investigating myotoxicity following Australian red-bellied black snake (Pseudechis porphyriacus) envenomation	PLOS ONE			English	Article							EARLY ANTIVENOM THERAPY; TOXIC PHOSPHOLIPASE; SKELETAL-MUSCLE; CREATINE-KINASE; MULGA SNAKE; VENOM; PROJECT	Background Myotoxicity is one of the common clinical manifestations of red-bellied black snake (Pseudechis porphyriacus) envenomation characterised by elevated creatine kinase (CK) concentrations of greater than 1000 U/L. This study aimed to investigate the occurrence of myotoxicity in patients following envenomation. Methods/Principal findings Patient characteristics and serial blood samples (timed venom concentrations and CK concentrations, pre- and post- antivenom) from 114 patients (median age 41, 2-90y; 80 male) were extracted from the Australian Snakebite Project database. Patients were categorised into three groups based on peak CK concentrations [no myotoxicity (<1000 U/L), mild (1000-10,000 U/L) and severe (>10,000 U/L)]. The odds of (mild or severe) myotoxicity was lower in patients that received early antivenom (within 6 hours post-bite) compared to those that received late or no antivenom (odd ratio was 0.186; 95% confidence interval, 0.052-0.664). A population pharmacokinetic-pharmacodynamic (PKPD) model was developed to describe the relationship between the time course of venom (a mixture of toxins) and effect (elevated CK). In addition, a kinetic-pharmacodynamic (KPD) model was developed to describe the relationship between time course of a theoretical toxin and effect. Model development and parameter estimation was performed using NONMEM v7.3. No single set of parameter values from either the PKPD or KPD models were found that could accurately describe the time course of different levels of severity of myotoxicity. The predicted theoretical toxin half-life from the KPD model was 11 +/- 3.9 hours compared to the half-life of venom of 5.3 +/- 0.36 hours. This indicates that the putative causative toxin's concentration-time profile does not parallel that of venom. Conclusion Early antivenom administration reduces the incidence of myotoxicity. The venom concentration profile does not appear to be the driver for myotoxicity following envenomation. Additional factors that affect the sensitivity of the patient to snake venom/toxins must be explored to understand the relationship with myotoxicity.	[Sanhajariya, Suchaya; Isbister, Geoffrey K.] Univ Newcastle, Clin Toxicol Res Grp, Newcastle, NSW, Australia; [Sanhajariya, Suchaya; Duffull, Stephen B.] Univ Otago, Sch Pharm, Dunedin, New Zealand	University of Newcastle; University of Otago	Sanhajariya, S (corresponding author), Univ Newcastle, Clin Toxicol Res Grp, Newcastle, NSW, Australia.; Sanhajariya, S (corresponding author), Univ Otago, Sch Pharm, Dunedin, New Zealand.	suchaya.sanhajariya@uon.edu.au	Isbister, Geoffrey K/G-8052-2015	Isbister, Geoffrey K/0000-0003-1519-7419	Australian Government Research Training Program Scholarship; National Health and Medical Research Council Senior Research Fellowship [1061041]; National Health and Medical Research Council Centre for Research Excellence [1110343]	Australian Government Research Training Program Scholarship(Australian GovernmentDepartment of Industry, Innovation and Science); National Health and Medical Research Council Senior Research Fellowship(National Health and Medical Research Council (NHMRC) of Australia); National Health and Medical Research Council Centre for Research Excellence	SS is supported by the Australian Government Research Training Program Scholarship. GKI is supported by a National Health and Medical Research Council Senior Research Fellowship, ID 1061041. The Australian Snakebite Project is funded by a National Health and Medical Research Council Centre for Research Excellence (ID 1110343).	Baird MF, 2012, J NUTR METAB, V2012, DOI 10.1155/2012/960363; Churchman A, 2010, MED J AUSTRALIA, V193, P696, DOI 10.5694/j.1326-5377.2010.tb04108.x; Dixon RW, 1996, J NEUROPATH EXP NEUR, V55, P1230, DOI 10.1097/00005072-199612000-00006; Fry BG, 1999, TOXICON, V37, P11, DOI 10.1016/S0041-0101(98)00125-1; Gutierrez JM, 2003, TOXICON, V42, P915, DOI 10.1016/j.toxicon.2003.11.005; HARRIS JB, 1978, CLIN EXP PHARMACOL P, V5, P587, DOI 10.1111/j.1440-1681.1978.tb00714.x; Hart AJ, 2014, CLIN TOXICOL, V52, P604, DOI 10.3109/15563650.2014.914526; Huerta-Alardin AL, 2005, CRIT CARE, V9, P158, DOI 10.1186/cc2978; Ireland G, 2010, MED J AUSTRALIA, V193, P285, DOI 10.5694/j.1326-5377.2010.tb03909.x; Isbister GK, 2013, MED J AUSTRALIA, V199, P763, DOI 10.5694/mja12.11172; Johnston CI, 2013, CLIN TOXICOL, V51, P417, DOI 10.3109/15563650.2013.787535; Johnston CI, 2021, CLIN TOXICOL, V59, P611, DOI 10.1080/15563650.2020.1836377; Johnston CI, 2017, MED J AUSTRALIA, V207, P119, DOI 10.5694/mja17.00094; Johnston CI, 2017, CLIN TOXICOL, V55, P115, DOI 10.1080/15563650.2016.1250903; Kasturiratne A, 2008, PLOS MED, V5, P1591, DOI 10.1371/journal.pmed.0050218; LINDENA J, 1979, ENZYME, V24, P120, DOI 10.1159/000458640; MEBS D, 1980, TOXICON, V18, P443, DOI 10.1016/0041-0101(80)90052-5; Ooi QX, 2020, BRIT J CLIN PHARMACO, V86, P196, DOI 10.1111/bcp.14154; Sanhajariya S, 2021, CLIN TOXICOL, V59, P956, DOI 10.1080/15563650.2021.1896731; Sanhajariya S, 2020, TOXINS, V12, DOI 10.3390/toxins12030188; Sanhajariya S, 2018, TOXINS, V10, DOI 10.3390/toxins10020073; Sayers SP, 2003, MED SCI SPORT EXER, V35, P762, DOI 10.1249/01.MSS.0000064933.43824.ED; VAUGHAN GT, 1981, TOXICON, V19, P95, DOI 10.1016/0041-0101(81)90121-5; Waiddyanatha S, 2019, TOXINS, V11, DOI 10.3390/toxins11040193; WALLIMANN T, 1992, BIOCHEM J, V281, P21, DOI 10.1042/bj2810021; Zhang LP, 2003, J PHARMACOKINET PHAR, V30, P387, DOI 10.1023/B:JOPA.0000012998.04442.1f	26	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2021	16	9							e0256653	10.1371/journal.pone.0256653	http://dx.doi.org/10.1371/journal.pone.0256653			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XM9EM	34506531	Green Published, gold			2022-12-26	WOS:000729120700082
J	Ahmad, J; Jiang, JS; Boyd, LF; Zeher, A; Huang, R; Xia, D; Natarajan, K; Margulies, DH				Ahmad, Javeed; Jiang, Jiansheng; Boyd, Lisa F.; Zeher, Allison; Huang, Rick; Xia, Di; Natarajan, Kannan; Margulies, David H.			Structures of synthetic nanobody-SARS-CoV-2 receptor-binding domain complexes reveal distinct sites of interaction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SARS-COV-2; NANOBODIES; ANTIBODIES; VARIANT; SYSTEM	Combating the worldwide spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the emergence of new variants demands understanding of the structural basis of the interaction of antibodies with the SARS-CoV-2 receptor binding domain (RBD). Here, we report five X-ray crystal structures of sybodies (synthetic nanobodies) including those of binary and ternary complexes of Sb16-RBD, Sb45-RBD, Sb14-RBD-Sb68, and Sb45-RBD-Sb68, as well as unliganded Sb16. These structures reveal that Sb14, Sb16, and Sb45 bind the RBD at the angiotensin-converting enzyme 2 interface and that the Sb16 interaction is accompanied by a large conformational adjustment of complementarity-determining region 2. In contrast, Sb68 interacts at the periphery of the SARSCoV-2 RBD-angiotensin-converting enzyme 2 interface. We also determined cryo-EM structures of Sb45 bound to the SARS-CoV-2 spike protein. Superposition of the X-ray structures of sybodies onto the trimeric spike protein cryo-EM map indicates that some sybodies may bind in both "up" and "down" configurations, but others may not. Differences in sybody recognition of several recently identified RBD variants are explained by these structures.	[Ahmad, Javeed; Jiang, Jiansheng; Boyd, Lisa F.; Natarajan, Kannan; Margulies, David H.] NIAID, Mol Biol Sect, Lab Immune Syst Biol, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Zeher, Allison; Huang, Rick; Xia, Di] NCI, Lab Cell Biol, Ctr Canc Res, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Margulies, DH (corresponding author), NIAID, Mol Biol Sect, Lab Immune Syst Biol, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	dmargulies@niaid.nih.gov		Jiang, Jiansheng/0000-0003-0964-5481	Intramural Research Program of the NIAID, National Institutes of Health; CARES Act; National Institutes of Health. [S10_RR25528, S10_RR028976]; U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences [W-31-109-Eng-38]; NCI, National Institutes of Health; NIH Intramural Research Program Cryo-EM Consortium (NICE)	Intramural Research Program of the NIAID, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); CARES Act; National Institutes of Health.(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH Intramural Research Program Cryo-EM Consortium (NICE)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We appreciate the help of Joy (Huaying) Zhao and Peter Schuck, National Institute of Biomedical Imaging and Bioengineering, NIH, in analyzing SPR data and thank Peter Sun, NIAID, NIH, for access to his program, HINGE. We thank Barney Graham, NIAID, NIH, for plasmids used in initial aspects of the work, and Apostolos Gittis, NIAID, NIH, for help in protein char-acterization. We appreciate the advice of Michael Mage and D. K. Taylor during this work. This work was supported by the Intramural Research Program of the NIAID, National Institutes of Health, including funds from the CARES Act. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. X-ray data were collected at Southeast Regional Collaborative Access Team (SER-CAT) 22-ID (or 22-BM) beamline at the Advanced Photon Source, Argonne National Laboratory. SER-CAT is supported by its member institutions ( www.ser-cat. org/members.html) and equipment grants (S10_RR25528 and S10_RR028976) from the National Institutes of Health. Use of the Advanced Photon Source was supported by the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract No. W-31-109-Eng-38. The Electron Microscopy Resource is supported by the NCI, National Institutes of Health, and NIH Intramural Research Program Cryo-EM Consortium (NICE) .	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Baden LR, 2021, NEW ENGL J MED, V384, P403, DOI 10.1056/NEJMoa2035389; Barnes CO, 2020, NATURE, V588, P682, DOI 10.1038/s41586-020-2852-1; Boehm E, 2021, CLIN MICROBIOL INFEC, V27, P1109, DOI 10.1016/j.cmi.2021.05.022; Cao YL, 2020, CELL, V182, P73, DOI 10.1016/j.cell.2020.05.025; Cerutti G, 2021, STRUCTURE, V29, P655, DOI 10.1016/j.str.2021.05.014; Chan KK, 2020, SCIENCE, V369, P1261, DOI 10.1126/science.abc0870; Conti P, 2021, J BIOL REG HOMEOS AG, V35, P1; Custodio TF, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-19204-y; Edara Venkata Viswanadh, 2021, bioRxiv, DOI 10.1101/2021.02.20.432046; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Halaby DM, 1999, PROTEIN ENG, V12, P563, DOI 10.1093/protein/12.7.563; Hanke L, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18174-5; Hansen J, 2020, SCIENCE, V369, P1010, DOI 10.1126/science.abd0827; Hsieh CL, 2020, SCIENCE, V369, P1501, DOI 10.1126/science.abd0826; Hsu TA, 1997, J BIOL CHEM, V272, P9062; Huo JD, 2020, CELL HOST MICROBE, V28, P445, DOI [10.1016/j.chom.2020.06.010, 10.1016/j.chom.2020.07.002]; Ingram JR, 2018, ANNU REV IMMUNOL, V36, P695, DOI 10.1146/annurev-immunol-042617-053327; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kirby T, 2021, LANCET RESP MED, V9, pE20, DOI 10.1016/S2213-2600(21)00005-9; Koenig PA, 2021, SCIENCE, V371, P691, DOI 10.1126/science.abe6230; Lan J, 2020, NATURE, V581, P215, DOI 10.1038/s41586-020-2180-5; Li HM, 1998, J MOL BIOL, V283, P179, DOI 10.1006/jmbi.1998.2091; Liebschner D, 2019, ACTA CRYSTALLOGR D, V75, P861, DOI 10.1107/S2059798319011471; Mastronarde DN, 2005, J STRUCT BIOL, V152, P36, DOI 10.1016/j.jsb.2005.07.007; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Natarajan K., 2015, ENCY LIFE SCI, DOI [10.1002/9780470015902.a0000926.pub2, DOI 10.1002/9780470015902.A0000926.PUB2]; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Planas D, 2021, NAT MED, V27, P917, DOI 10.1038/s41591-021-01318-5; Punjani A., 2021, 3D FLEXIBLE REFINEME, DOI [10.1101/2021.04.22.440893, DOI 10.1101/2021.04.22.440893]; Punjani A, 2021, J STRUCT BIOL, V213, DOI 10.1016/j.jsb.2021.107702; Punjani A, 2020, NAT METHODS, V17, P1214, DOI 10.1038/s41592-020-00990-8; Punjani A, 2017, NAT METHODS, V14, P290, DOI [10.1038/nmeth.4169, 10.1038/NMETH.4169]; Rai BK, 2006, PROTEINS, V63, P644, DOI 10.1002/prot.20835; Ramanathan M, 2021, LANCET INFECT DIS, V21, P1070, DOI 10.1016/S1473-3099(21)00262-0; Rudd PM, 2000, BIOCHEMISTRY-US, V39, P1596, DOI 10.1021/bi9918285; Schoof M, 2020, SCIENCE, V370, P1473, DOI 10.1126/science.abe3255; Shajahan A, 2021, GLYCOBIOLOGY, V31, P410, DOI 10.1093/glycob/cwaa101; Shang J, 2020, P NATL ACAD SCI USA, V117, P11727, DOI 10.1073/pnas.2003138117; Singh J, 2021, VIRUSES-BASEL, V13, DOI 10.3390/v13030439; Starr TN, 2021, SCIENCE, V371, P850, DOI 10.1126/science.abf9302; Tang JW, 2020, J INFECTION, V80, P350, DOI 10.1016/j.jinf.2020.01.014; Walter J. D., 2020, HIGHLY POTENT BISPEC; Wang PF, 2021, NATURE, V593, P130, DOI 10.1038/s41586-021-03398-2; Wang QH, 2020, CELL, V181, P894, DOI 10.1016/j.cell.2020.03.045; Wang Zijun, 2021, bioRxiv, DOI [10.1038/s41586-021-03324-6, 10.1101/2021.01.15.426911]; Wibmer CK, 2021, NAT MED, V27, DOI [10.1038/s41591-021-01285-x, 10.1101/2021.01.18.427166]; Wrapp D, 2020, CELL, V181, P1004, DOI 10.1016/j.cell.2020.04.031; WU TT, 1970, J EXP MED, V132, P211, DOI 10.1084/jem.132.2.211; Wu Y, 2020, SCIENCE, V368, P1274, DOI 10.1126/science.abc2241; Xiang YF, 2020, SCIENCE, V370, P1479, DOI 10.1126/science.abe4747; Xu C, 2021, SCI ADV, V7, DOI 10.1126/sciadv.abe5575; Xu JL, 2021, NATURE, V595, P278, DOI 10.1038/s41586-021-03676-z; Zhao Huaying, 2017, Curr Protoc Protein Sci, V88, DOI 10.1002/cpps.31; Zhao HY, 2013, METHODS, V59, P328, DOI 10.1016/j.ymeth.2012.12.007; Zhao P, 2020, CELL HOST MICROBE, V28, P586, DOI [10.1016/j.chom.2020.08.004, 10.1101/2020.06.25.172403]; Zhu X, 2021, PLOS BIOL, V19, DOI 10.1371/journal.pbio.3001237; Zimmermann I, 2020, NAT PROTOC, V15, P1707, DOI 10.1038/s41596-020-0304-x	58	8	8	0	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT	2021	297	4							101202	10.1016/j.jbc.2021.101202	http://dx.doi.org/10.1016/j.jbc.2021.101202			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	WP2YR	34537245	Green Published, gold			2022-12-26	WOS:000713003600007
J	Gao, Y; Luo, CL; Rui, TY; Fan, YY; Yao, Y; Shen, HJ; Gao, C; Wang, T; Wang, HC; Chen, XS; Zhang, JX; Li, DY; Xia, CJ; Li, LL; Wang, ZF; Zhang, MY; Chen, XP; Tao, LY				Gao, Yuan; Luo, Chengliang; Rui, Tongyu; Fan, Yanyan; Yao, Yi; Shen, Hengji; Gao, Cheng; Wang, Tao; Wang, Haochen; Chen, Xueshi; Zhang, Jiaxin; Li, Dongya; Xia, Chongjian; Li, Li-Li; Wang, Zufeng; Zhang, Mingyang; Chen, Xiping; Tao, Luyang			Autophagy inhibition facilitates wound closure partially dependent on the YAP/IL-33 signaling in a mouse model of skin wound healing	FASEB JOURNAL			English	Article						autophagy; hippo signaling pathway; interleukin-33; skin wound healing; ST2; YAP	STEM-CELLS; YAP; TAZ	Autophagy is a self-phagocytic and highly evolutionarily conserved intracellular lysosomal catabolic system, which plays a vital role in a variety of trauma models, including skin wound healing (SWH). However, the roles and potential mechanisms of autophagy in SWH are still controversial. We firstly investigated the role of autophagy in SWH-induced wound closure rate, inflammatory response, and histopathology, utilizing an inhibitor of autophagy 3-methyladenine (3-MA) and its agonist rapamycin (RAP). As expected, we found 3-MA treatment remarkably increased the wound closure rate, combated inflammation response, and mitigated histopathological changes, while RAP delivery aggravated SWH-induced pathological damage. To further exploit the underlying mechanism of autophagy regulating inflammation, the specific inhibitors of yes-associated protein (YAP), Verteporfin, and Anti-IL-33 were applied. Herein, treating with 3-MA markedly suppressed the expression of tumor necrosis factor-alpha (TNF-alpha), IL-1 beta, and IL-6, promoted that of IL-10, IL-33, and ST2, while RAP administration reverted SWH-induced the up-regulation of these inflammatory cytokines mentioned above. Importantly, Verteporfin administration not only down-regulated the expression levels of YAP, TNF-alpha, and IL-6 but also up-regulated that of IL-33 and IL-10. Unexpectedly, 3-MA or RAP retreatment did not have any impact on the changes in IL-33 among these inflammatory indicators. Furthermore, elevated expression of IL-33 promoted wound closure and alleviated the pathological damage, whereas, its antagonist Anti-IL-33 treatment overtly reversed the above-mentioned effects of IL-33. Moreover, 3-MA in combination with anti-IL-33 treatment reversed the role of 3-MA alone in mitigated pathological changes, but they failed to revert the effect of anti-IL-33 alone on worsening pathological damage. In sum, emerging data support the novel contribution of the YAP/IL-33 pathway in autophagy inhibition against SWH-induced pathological damage, and highlight that the autophagy/YAP/IL-33 signal axis is expected to become a new therapeutic target for SWH.	[Gao, Yuan; Luo, Chengliang; Rui, Tongyu; Gao, Cheng; Wang, Tao; Wang, Haochen; Chen, Xueshi; Zhang, Jiaxin; Wang, Zufeng; Zhang, Mingyang; Chen, Xiping; Tao, Luyang] Soochow Univ, Dept Forens Sci, Med Sch, 178 Ganjiang East Rd, Suzhou 215123, Peoples R China; [Gao, Yuan; Fan, Yanyan; Yao, Yi; Shen, Hengji; Xia, Chongjian] Wenzhou Med Univ, Dept Forens Sci, Wenzhou, Peoples R China; [Gao, Yuan] Acad Forens Sci, Dept Shanghai Key Lab Forens Med, Shanghai Forens Serv Platform, Shanghai, Peoples R China; [Li, Dongya] Soochow Univ, Affiliated Hosp 1, Orthoped Inst, Dept Orthoped, Suzhou, Peoples R China; [Li, Li-Li] Soochow Univ, Dept Child & Adolescent Healthcare, Childrens Hosp, Suzhou, Peoples R China	Soochow University - China; Wenzhou Medical University; Soochow University - China; Soochow University - China	Chen, XP; Tao, LY (corresponding author), Soochow Univ, Dept Forens Sci, Med Sch, 178 Ganjiang East Rd, Suzhou 215123, Peoples R China.	xiping.chen@163.com; taoluyang@suda.edu.cn	Mingyang, Zhang/J-7412-2019	Mingyang, Zhang/0000-0001-7084-6237	National Natural Science Foundation	National Natural Science Foundation(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation	Allan D, 2016, ACTA NEUROPATHOL COM, V4, DOI 10.1186/s40478-016-0344-1; Bharath LP, 2020, CELL METAB, V32, P44, DOI 10.1016/j.cmet.2020.04.015; Cheng JB, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.00281; Chiu HW, 2016, J MOL MED, V94, P809, DOI 10.1007/s00109-016-1389-0; Davis FM, 2019, J IMMUNOL, V202, P1777, DOI 10.4049/jimmunol.1801258; Elbediwy A, 2016, DEVELOPMENT, V143, P1674, DOI 10.1242/dev.133728; Fallah M, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-1106-8; Ferhat M, 2018, J AM SOC NEPHROL, V29, P1272, DOI 10.1681/ASN.2017060650; Gao Y, 2017, ONCOGENESIS, V6, DOI 10.1038/oncsis.2017.83; Gao Y, 2020, FRONT NEUROSCI-SWITZ, V14, DOI 10.3389/fnins.2020.00898; Gorbunov NV, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18081693; Griffin DR, 2021, NAT MATER, V20, P560, DOI 10.1038/s41563-020-00844-w; Guo YY, 2016, SCI REP-UK, V6, DOI 10.1038/srep36416; Hao D, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-018-1261-y; He RG, 2017, MOL IMMUNOL, V90, P42, DOI 10.1016/j.molimm.2017.06.249; He ZH, 2017, AUTOPHAGY, V13, P1884, DOI 10.1080/15548627.2017.1359449; Holgado A, 2019, J ALLERGY CLIN IMMUN, V144, P204, DOI 10.1016/j.jaci.2019.02.028; Huang LP, 2020, EXP NEUROL, V333, DOI 10.1016/j.expneurol.2020.113431; Jin GX, 2018, NAT IMMUNOL, V19, P29, DOI 10.1038/s41590-017-0002-1; Kessing BF, 2014, AM J GASTROENTEROL, V109, P1196, DOI 10.1038/ajg.2014.165; Kim W, 2018, GUT, V67, P1692, DOI 10.1136/gutjnl-2017-314061; Kim YH, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08773-2; Koo Jeung-Hyun, 2019, Exp Mol Med, V51, P1, DOI 10.1038/s12276-019-0248-9; Lee MJ, 2014, J INVEST DERMATOL, V134, P518, DOI 10.1038/jid.2013.339; Lei M, 2019, INFLAMM RES, V68, P665, DOI 10.1007/s00011-019-01250-y; Leyva-Castillo JM, 2019, IMMUNITY, V50, P1262, DOI 10.1016/j.immuni.2019.03.023; Li W, 2017, J EXP CLIN CANC RES, V36, DOI 10.1186/s13046-017-0612-3; Liu B, 2016, CELL, V164, P406, DOI 10.1016/j.cell.2015.12.029; Liu J, 2017, AM J PATHOL, V187, P1313, DOI 10.1016/j.ajpath.2017.02.010; Lv Y, 2018, CIRC RES, V123, P43, DOI 10.1161/CIRCRESAHA.118.313143; Maday S, 2016, J NEUROSCI, V36, P5933, DOI 10.1523/JNEUROSCI.4401-15.2016; Manfredi AA, 2017, PHARMACOL RES, V123, P146, DOI 10.1016/j.phrs.2016.08.008; Meng CL, 2020, CELL DEATH DIFFER, V27, P2797, DOI 10.1038/s41418-020-0544-x; Mills RE, 2008, J IMMUNOL, V181, P3974, DOI 10.4049/jimmunol.181.6.3974; Mooring M, 2020, HEPATOLOGY, V71, P1813, DOI 10.1002/hep.30928; Naik S, 2017, NATURE, V550, P475, DOI 10.1038/nature24271; Nussbaum SR, 2018, VALUE HEALTH, V21, P27, DOI 10.1016/j.jval.2017.07.007; Rak GD, 2016, J INVEST DERMATOL, V136, P487, DOI 10.1038/JID.2015.406; Romeo-Guitart D, 2020, THERANOSTICS, V10, P5154, DOI 10.7150/thno.43765; Sandri M, 2010, FEBS LETT, V584, P1411, DOI 10.1016/j.febslet.2010.01.056; Sangiovanni E, 2019, PHYTOTHER RES, V33, P2083, DOI 10.1002/ptr.6400; SARDA AK, 1990, ANN ROY COLL SURG, V72, P18; Scott RC, 2007, CURR BIOL, V17, P1, DOI 10.1016/j.cub.2006.10.053; Song XZ, 2017, REDOX BIOL, V11, P219, DOI 10.1016/j.redox.2016.12.015; Sun X, 2020, NUCLEIC ACIDS RES, V48, P7182, DOI 10.1093/nar/gkaa482; Taniguchi S, 2020, SCIENCE, V369, P269, DOI 10.1126/science.aay1813; Totaro A, 2019, P NATL ACAD SCI USA, V116, P17848, DOI 10.1073/pnas.1908228116; Tuncel J, 2019, J EXP MED, V216, P1328, DOI 10.1084/jem.20182002; Wicher G, 2017, J NEUROTRAUM, V34, P3173, DOI 10.1089/neu.2016.4900; Williams SE, 2011, NATURE, V470, P353, DOI 10.1038/nature09793; Wu YL, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13393; Xue R, 2018, OXID MED CELL LONGEV, V2018, DOI 10.1155/2018/2798070; Yang Y, 2020, BBA-MOL CELL BIOL L, V1865, DOI 10.1016/j.bbalip.2020.158779; Yang YY, 2017, J NEUROSCI, V37, P4692, DOI 10.1523/JNEUROSCI.3233-16.2017; Yuan P, 2020, CELL DEATH DIS, V11, DOI 10.1038/s41419-020-2343-1	55	1	1	4	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2021	35	10							e21920	10.1096/fj.202002623RRR	http://dx.doi.org/10.1096/fj.202002623RRR			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	UZ5IH	34547141				2022-12-26	WOS:000702238200010
J	King, WT; Axelrod, CL; Zunica, ERM; Noland, RC; Davuluri, G; Fujioka, H; Tandler, B; Pergola, K; Hermann, GE; Rogers, RC; Lopez-Domenech, S; Dantas, WS; Stadler, K; Hoppel, CL; Kirwan, JP				King, William T.; Axelrod, Christopher L.; Zunica, Elizabeth R. M.; Noland, Robert C.; Davuluri, Gangarao; Fujioka, Hisashi; Tandler, Bernard; Pergola, Kathryn; Hermann, Gerlinda E.; Rogers, Richard C.; Lopez-Domenech, Sandra; Dantas, Wagner S.; Stadler, Krisztian; Hoppel, Charles L.; Kirwan, John P.			Dynamin-related protein 1 regulates substrate oxidation in skeletal muscle by stabilizing cellular and mitochondrial calcium dynamics	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INSULIN-RESISTANCE; FISSION; DRP1; FUSION; PHOSPHORYLATION; DEGRADATION; TRANSPORT; PROTECTS; CELLS; CA2+	Mitochondria undergo continuous cycles of fission and fusion to promote inheritance, regulate quality control, and mitigate organelle stress. More recently, this process of mitochondrial dy-namics has been demonstrated to be highly sensitive to nutrient supply, ultimately conferring bioenergetic plasticity to the organ-elle. However, whether regulators of mitochondrial dynamics play a causative role in nutrient regulation remains unclear. In this study, we generated a cellular loss-of-function model for dynamin-related protein 1 (DRP1), the primary regulator of outer membrane mitochondrial fission. Loss of DRP1 (shDRP1) resulted in exten-sive ultrastructural and functional remodeling of mitochondria, characterized by pleomorphic enlargement, increased electron density of the matrix, and defective NADH and succinate oxida-tion. Despite increased mitochondrial size and volume, shDRP1 cells exhibited reduced cellular glucose uptake and mitochondrial fatty acid oxidation. Untargeted transcriptomic profiling revealed severe downregulation of genes required for cellular and mito-chondrial calcium homeostasis, which was coupled to loss of ATP-stimulated calcium flux and impaired substrate oxidation stimulated by exogenous calcium. The insights obtained herein suggest that DRP1 regulates substrate oxidation by altering whole-cell and mitochondrial calcium dynamics. These findings are relevant to the targetability of mitochondrial fission and have clinical relevance in the identification of treatments for fission-related pathologies such as hereditary neuropathies, inborn errors in metabolism, cancer, and chronic diseases.	[King, William T.; Axelrod, Christopher L.; Pergola, Kathryn] Pennington Biomed Res Ctr, Dept Translat Serv, 6400 Perkins Rd, Baton Rouge, LA 70808 USA; [King, William T.; Axelrod, Christopher L.; Zunica, Elizabeth R. M.; Davuluri, Gangarao; Pergola, Kathryn; Lopez-Domenech, Sandra; Dantas, Wagner S.; Hoppel, Charles L.; Kirwan, John P.] Pennington Biomed Res Ctr, Integrated Physiol & Mol Med Lab, 6400 Perkins Rd, Baton Rouge, LA 70808 USA; [Zunica, Elizabeth R. M.; Kirwan, John P.] Case Western Reserve Univ, Sch Med, Dept Nutr, Cleveland, OH 44106 USA; [Noland, Robert C.] Pennington Biomed Res Ctr, Skeletal Muscle Metab Lab, 6400 Perkins Rd, Baton Rouge, LA 70808 USA; [Fujioka, Hisashi; Tandler, Bernard; Hoppel, Charles L.] Case Western Reserve Univ, Sch Med, Ctr Mitochondrial Dis, Cleveland, OH USA; [Fujioka, Hisashi] Case Western Reserve Univ, Electron Microscope Facil, Sch Med, Cleveland, OH USA; [Tandler, Bernard] Case Western Reserve Univ, Dept Biol Sci, Sch Dent Med, Cleveland, OH USA; [Hermann, Gerlinda E.; Rogers, Richard C.] Pennington Biomed Res Ctr, Dept Auton Neurosci, 6400 Perkins Rd, Baton Rouge, LA 70808 USA; [Lopez-Domenech, Sandra] Univ Hosp Dr Peset, Valencia, Spain; [Stadler, Krisztian] Pennington Biomed Res Ctr, Dept Oxidat Stress & Dis, 6400 Perkins Rd, Baton Rouge, LA 70808 USA; [Hoppel, Charles L.] Case Western Reserve Univ, Sch Med, Dept Pharmacol, Cleveland, OH 44106 USA	Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center; Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center; Case Western Reserve University; Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center; Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center; Case Western Reserve University	Kirwan, JP (corresponding author), Pennington Biomed Res Ctr, Integrated Physiol & Mol Med Lab, 6400 Perkins Rd, Baton Rouge, LA 70808 USA.; Kirwan, JP (corresponding author), Case Western Reserve Univ, Sch Med, Dept Nutr, Cleveland, OH 44106 USA.	john.kirwan@pbrc.edu	Dantas, Wagner/AEQ-8169-2022; Domènech, Sandra López/AAA-9732-2020	Domènech, Sandra López/0000-0003-2067-9308; King, William/0000-0003-2312-6207; Noland, Robert/0000-0001-5543-3450; Axelrod, Christopher/0000-0002-1444-8557; Zunica, Elizabeth/0000-0002-6850-6054; Belmont, Kathryn Pergola/0000-0003-2658-1459	United States National Institutes of Health [P20 GM135002, P20 GM103528, P30 DK072476, U54 GM104940, R01 DK108089, R01 DK103860, R01 DK108765, R01 DK115749]	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This article contains supporting information. Acknowledgments-The authors wish to thank Jacob R. Hall, Rachel Marino, and Cameron A. Matherne for technical support. The au-thors also wish to thank Richard Carmouche, Sara Webb, Jasleen Kaur, and Susan Newman of the Pennington Biomedical Research Center Genomics Core Facility for performing RNA sequencing. This research utilized core facilities funded in part by grants from the United States National Institutes of Health P20 GM135002, P20 GM103528, P30 DK072476, and U54 GM104940. Author contributions-W. T. K., C. L. A., G. D., C. L. H., and J. P. K. conceptualization; W. T. K., C. L. A., E. R. M. Z., R. C. N., H. F., R. C. R., K. S., C. L. H., and J. P. K. methodology; W. T. K., C. L. A., E. R. M. Z., R. C. N., G. D., H. F., B. T., G. E. H., R. C. R., W. S. D., K. S., C. L. H., and J. P. K. formal analysis; W. T. K., E. R. M. Z., R. C. N., G. D., H. F., K. P., R. C. R., S. L.-D, W. S. D., K. S., and C. L. H. investigation; W. T. K. and C. L. A. data curation; W. T. K. and C. L. A. writing - original draft; W. T. K., C. L. A., E. R. M. Z., R. C. N., G. D., H. F., B. T., K. P., G. E. H., R. C. R., S. L.-D., W. S. D., K. S., C. L. H., and J. P. K. writing - review & editing; W. T. K., C. L. A., R. C. N., K. P., G. E. H., and R. C. R. visualization; C. L. A., C. L. H., and J. P. K. supervision; W. T. K., C. L. A., and J. P. K. project administration; R. C. N., R. C. R., K. S., and J. P. K. funding acquisition. Funding and additional information-This research was funded, in part, by grants from the United States National Institutes of Health R01 DK108089 (J. P. K.) , R01 DK103860 (R. C. N.) , R01 DK108765 (R. C. R.) , and R01 DK115749 (K. S.) . The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. Conflicts of interest-The authors declare that they have no conflicts of interest with the contents of this article.	Akepati VR, 2008, J NEUROCHEM, V106, P372, DOI 10.1111/j.1471-4159.2008.05401.x; Archer SL, 2013, NEW ENGL J MED, V369, P2236, DOI 10.1056/NEJMra1215233; Axelrod CL, 2020, EMBO MOL MED, V12, DOI 10.15252/emmm.202012088; Axelrod CL, 2019, ACTA PHYSIOL, V225, DOI 10.1111/apha.13216; Balu Darrick, 2016, Biochem Biophys Rep, V5, P365, DOI 10.1016/j.bbrep.2016.01.007; BEREITERHAHN J, 1994, MICROSC RES TECHNIQ, V27, P198, DOI 10.1002/jemt.1070270303; Burke SJ, 2015, AM J PHYSIOL-ENDOC M, V309, pE715, DOI 10.1152/ajpendo.00153.2015; Chan DC, 2006, CELL, V125, P1241, DOI 10.1016/j.cell.2006.06.010; Chen HC, 2003, J CELL BIOL, V160, P189, DOI 10.1083/jcb.200211046; Cho HM, 2019, MOL CELL, V73, P364, DOI 10.1016/j.molcel.2018.11.009; Covington JD, 2015, J CLIN ENDOCR METAB, V100, P3683, DOI 10.1210/JC.2014-4125; Detmer SA, 2007, NAT REV MOL CELL BIO, V8, P870, DOI 10.1038/nrm2275; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Favaro G, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10226-9; Fealy CE, 2014, J APPL PHYSIOL, V117, P239, DOI 10.1152/japplphysiol.01064.2013; Fujioka H, 2014, ULTRASTRUCT PATHOL, V38, P204, DOI 10.3109/01913123.2014.888114; Fujioka H, 2014, ULTRASTRUCT PATHOL, V38, P13, DOI 10.3109/01913123.2013.831158; Galgani JE, 2012, OBESITY, V20, P1387, DOI 10.1038/oby.2011.166; Geisler S, 2010, NAT CELL BIOL, V12, P119, DOI 10.1038/ncb2012; Georgiou DK, 2015, J BIOL CHEM, V290, P23751, DOI 10.1074/jbc.M115.643544; Ghosh S, 2019, J BIOL CHEM, V294, P12313, DOI 10.1074/jbc.RA118.006074; Gomes LC, 2011, NAT CELL BIOL, V13, P589, DOI 10.1038/ncb2220; Hagenbuchner J, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21519-2; Houten SM, 2010, J INHERIT METAB DIS, V33, P469, DOI 10.1007/s10545-010-9061-2; Hu QX, 2020, CIRC RES, V126, P456, DOI 10.1161/CIRCRESAHA.119.315252; Ishihara N, 2009, NAT CELL BIOL, V11, P958, DOI 10.1038/ncb1907; Jheng HF, 2012, MOL CELL BIOL, V32, P309, DOI 10.1128/MCB.05603-11; Kalia R, 2018, NATURE, V558, P401, DOI 10.1038/s41586-018-0211-2; Kashatus JA, 2015, MOL CELL, V57, P537, DOI 10.1016/j.molcel.2015.01.002; Koves TR, 2008, CELL METAB, V7, P45, DOI 10.1016/j.cmet.2007.10.013; Liesa M, 2013, CELL METAB, V17, P491, DOI 10.1016/j.cmet.2013.03.002; Loson OC, 2013, MOL BIOL CELL, V24, P659, DOI 10.1091/mbc.E12-10-0721; Mears JA, 2011, NAT STRUCT MOL BIOL, V18, P20, DOI 10.1038/nsmb.1949; Mitra K, 2009, P NATL ACAD SCI USA, V106, P11960, DOI 10.1073/pnas.0904875106; Molina AJA, 2009, DIABETES, V58, P2303, DOI 10.2337/db07-1781; Muoio DM, 2012, CELL METAB, V15, P764, DOI 10.1016/j.cmet.2012.04.005; Nieuwoudt S, 2017, AM J PHYSIOL-CELL PH, V313, pC575, DOI 10.1152/ajpcell.00123.2017; Okamoto K, 2005, ANNU REV GENET, V39, P503, DOI 10.1146/annurev.genet.38.072902.093019; Palma E, 2019, AM J PATHOL, V189, P580, DOI 10.1016/j.ajpath.2018.11.008; Patron M, 2013, J BIOL CHEM, V288, P10750, DOI 10.1074/jbc.R112.420752; Rambold AS, 2011, P NATL ACAD SCI USA, V108, P10190, DOI 10.1073/pnas.1107402108; Rizzuto R, 2009, BBA-BIOENERGETICS, V1787, P1342, DOI 10.1016/j.bbabio.2009.03.015; Santoro A, 2017, CELL METAB, V25, P647, DOI 10.1016/j.cmet.2017.01.003; SCHULZ H, 1991, BIOCHIM BIOPHYS ACTA, V1081, P109, DOI 10.1016/0005-2760(91)90015-A; Serasinghe MN, 2017, HANDB EXP PHARMACOL, V240, P159, DOI 10.1007/164_2016_38; Shi HL, 2005, ARCH BIOCHEM BIOPHYS, V437, P59, DOI 10.1016/j.abb.2005.02.028; Smirnova E, 1998, J CELL BIOL, V143, P351, DOI 10.1083/jcb.143.2.351; Smirnova E, 2001, MOL BIOL CELL, V12, P2245, DOI 10.1091/mbc.12.8.2245; Taguchi N, 2007, J BIOL CHEM, V282, P11521, DOI 10.1074/jbc.M607279200; Tanwar J, 2021, MITOCHONDRION, V57, P9, DOI 10.1016/j.mito.2020.12.001; Tsushima K, 2018, CIRC RES, V122, P58, DOI 10.1161/CIRCRESAHA.117.311307; van der Bliek AM, 2017, GENETICS, V207, P843, DOI 10.1534/genetics.117.300262; Waterham HR, 2007, NEW ENGL J MED, V356, P1736, DOI 10.1056/NEJMoa064436; Westermann B, 2010, NAT REV MOL CELL BIO, V11, P872, DOI 10.1038/nrm3013; Witczak CA, 2007, DIABETES, V56, P1403, DOI 10.2337/db06-1230; Wright DC, 2004, DIABETES, V53, P330, DOI 10.2337/diabetes.53.2.330; Ye F, 2013, ANAL BIOCHEM, V437, P52, DOI 10.1016/j.ab.2013.02.010; Yoon JC, 2010, GENE DEV, V24, P1507, DOI 10.1101/gad.1924910	58	2	2	2	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT	2021	297	4							101196	10.1016/j.jbc.2021.101196	http://dx.doi.org/10.1016/j.jbc.2021.101196			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	WP2YR	34529976	gold, Green Published			2022-12-26	WOS:000713003600012
J	Yesuf, NS; Getahun, S; Hassen, S; Alemayehu, Y; Danu, KG; Alemu, Z; Tesfaye, T; Hei, NB; Blasch, G				Yesuf, Nurhussein Seid; Getahun, Sileshi; Hassen, Shiferaw; Alemayehu, Yoseph; Danu, Kitessa Gutu; Alemu, Zemedkun; Tesfaye, Tsegaab; Hei, Netsanet Bacha; Blasch, Gerald			Distribution, dynamics, and physiological races of wheat stem rust (Puccinia graminis f.sp. tritici) on irrigated wheat in the Awash River Basin of Ethiopia	PLOS ONE			English	Article							VIRULENCE	Wheat is one of the high-value major crops in the world. However, wheat stem rust is considered one of the determinant threats to wheat production in Ethiopia and the world. So this study was conducted to assess the disease intensity, seasonal distribution dynamics pattern, the genetic variability of Puccinia graminis f. sp. tritici, and to determine the virulence spectrum in the irrigated ecology of the Awash River Basin. Totally 137 wheat farms were evaluated, from 2014/15-2019/20 in six districts representing the Upper, Middle, and Lower Awash River Basin. Farm plots were assessed, in every 5-10 km intervals, with 'X' fashion, and data on disease incidence, severity, healthy plants were counted and recorded. Diseased samples were collected from the diseased wheat stem by Puccinia graminis physiological and genetic race analysis. The seasonal trend of stem rust disease progress showed its importance to infer the future progresses of the disease for the country's potential production plan of irrigated wheat. The result revealed that the disease prevalence, disease incidence, and severity were significantly varied; among the different districts and seasons in the two regions. The survey results also indicated that about 71.7% of the wheat fields were affected by stem rust during the 2018/19 growing period. The disease's overall incidence and mean severity during the same season were 49.02% and 29.27%, respectively. In 2019/20, about 63.7% of the wheat fields were affected by stem rust, disease incidence 30.97%, and severity 17.22% were lower than the previous season. In 2019/20, even though seasonal disease distribution decreased, the spatial distribution was expanding in Afambo and Dubti districts. Four, stem rust dominant races were identified (TTTTF, TKTTF TKKTF, and TTKTF) by physiological and genetic race analysis during 2018/19 and one additional race (TKPTF) in 2019/20, production year. The result indicated that the races are highly virulent and affect most Sr genes except Sr31 and Sr24. From the race analysis result, TTTTF, and TKKTF have the broadest virulence spectrum race, which affects 90% of the Sr genes. Generally, we can conclude that the spatial and seasonal distribution of the disease is expanding. Most of the races in the irrigated areas in the Basin were similar to that of rain-fed wheat production belts in Ethiopia, so care must be given, to effective management of the diseases, in both production ecologies towards controlling the spore pressure than race variability. Therefore, these findings provide inputs for wheat producers to reduce the spread and disease' damage in the irrigated ecologies of Ethiopia. Also, it gives an insight for breeders to think about the breeding program in their crossing lines.	[Yesuf, Nurhussein Seid; Getahun, Sileshi; Hassen, Shiferaw; Alemu, Zemedkun] Werer Agr Res Ctr, Werer, Afar, Ethiopia; [Alemayehu, Yoseph] Int Wheat & Maize Improvement Ctr CIMMYT, Addis Ababa, Ethiopia; [Danu, Kitessa Gutu; Tesfaye, Tsegaab] Ambo Agr Res Ctr, Ambo, Oromia, Ethiopia; [Hei, Netsanet Bacha] Ethiopian Inst Agr Res, Addis Ababa, Ethiopia; [Blasch, Gerald] Int Maize & Wheat Improvement Ctr CIMMYT, Texcoco, Mexico	Ethiopian Institute of Agricultural Research (EIAR); CGIAR; International Maize & Wheat Improvement Center (CIMMYT)	Yesuf, NS (corresponding author), Werer Agr Res Ctr, Werer, Afar, Ethiopia.	nurhusseinsy@yahoo.com	Yesuf, Nurhussein/AAD-1922-2022	Blasch, Gerald/0000-0002-8265-0052; Yesuf, Nurhussein S/0000-0003-2590-4957	DGGW Project; Cambridge University	DGGW Project; Cambridge University(University of Cambridge)	DGGW Project for the 2018/19 budget year financial support, and Cambridge University 2019/20 Production year survey.	Abebe T., 2012, J PLANT PATHOLOGY MI; Abrahim A., 2018, ANN AGR CROP SCI, V3, P1037; Admassu B, 2009, PLANT PATHOL, V58, P362, DOI 10.1111/j.1365-3059.2008.01976.x; Afshari F., 2015, SURVEILLANCE PGT RAC; [Anonymous], 2005, PHYTOPATHOL MEDITERR, V44, P313; Ayele B., 2008, INCREASING CROP PROD, V1, P375; Belayneh Admassu, 2012, African Crop Science Journal, V20, P149; Bete-sellassie Naod., 2005, P 10 ANN C CROP PROT, P14; CSA (Central Statistical Authority), 2019, REP AR PROD MAJ CROP, V1, P15; Diriba G., 2018, OVERCOMING AGR FOOD; Edmeades G., 2010, FOOD SECURITY SUSTAI, V72, P35; FAO (Food and Agricultural Organization of the United Nations), 2017, SPREAD DAM WHEAT RUS; Fetch TG., 2004, CANADA J PLANT PATHO, V26, P44; Gomez K.A., 1984, STAT PROCEDURES AGR; Hailu A, 2015, ADV CROP SCI TECHNOL, V3, P189; Hailu E., 2018, ETHIOPIA 2016 MAIN C; Hei N., 2018, J AGR CROP RES, V6, P88; Hodson D. P., 2012, Proceedings, Borlaug Global Rust Initiative, 2012 Technical Workshop, September 1-4, Beijing, China: Oral presentations., P11; Jin Y, 2008, PLANT DIS, V92, P923, DOI 10.1094/PDIS-92-6-0923; Kumar A., 2011, J PLANT BREEDING CRO, V3, P209; Lemma A., 2015, ADV CROP SCI TECHNOL, P1; Lidiya T., 2019, THESIS JIMMA U ETHIO; Meyer M, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0245697; MOA (Ministry of Agriculture), 2020, IRR BAS WHEAT PROD T; Olivera P., 2017, PHYTOPATHOLOGY, V107, p12S; Park RF, 2007, AUST J AGR RES, V58, P558, DOI 10.1071/AR07117; Park R, 2011, EUPHYTICA, V179, P109, DOI 10.1007/s10681-011-0375-4; PETERSON RF, 1948, CAN J RES C, V26, P496, DOI 10.1139/cjr48c-033; Roelfs A.P., 1992, RUST DIS WHEAT CONCE, P34; ROELFS AP, 1988, PHYTOPATHOLOGY, V78, P526, DOI 10.1094/Phyto-78-526; Rosegrant MW., 2010, GLOBAL FOOD DEMAND S; Sileshi A., 2015, THESIS HARAMAYA U ET; Stakman E.C., 1962, E617 USDAARS; Stubbs R., 1986, CEREAL DIS METHODOLO; Szabo LJ., 2018, WHEAT STEM RUST PATH; Tadesse W, 2019, INT J CLIM CHANG STR, V11, P696, DOI 10.1108/IJCCSM-02-2018-0015; Tesfaye Tesemma, 1991, Wheat research in Ethiopia: a historical perspective., P47; Tolossa Mosisa., 2019, THESIS JIMMA U ETHIO; Weigand C, 2011, WHEAT IMPORT PROJECT; Worku D., 2016, African Crop Science Journal, V24, P25; Worku D., 2018, ETHIOPIAN BREAD WHEA; Yehizbalem Azmeraw, 2020, Ethiopian Journal of Agricultural Sciences, V30, P87; Zegeye T, 2001, CIMMYT; Zhang DD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103747	44	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2021	16	9							e0249507	10.1371/journal.pone.0249507	http://dx.doi.org/10.1371/journal.pone.0249507			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XH8RH	34555040	Green Published, gold			2022-12-26	WOS:000725694500002
J	Accardo, A; Silveri, G; Ajcevic, M; Miladinovic, A; Pascazio, L				Accardo, Agostino; Silveri, Giulia; Ajcevic, Milos; Miladinovic, Aleksandar; Pascazio, Lorenzo			Influence of smoking and other cardiovascular risk factors on heart rate circadian rhythm in normotensive and hypertensive subjects	PLOS ONE			English	Article							AMBULATORY BLOOD-PRESSURE; CIGARETTE-SMOKING; MORTALITY; DISEASE; SMOKERS; IMPACT; DYSLIPIDEMIA; OBESITY	Circadian heart rate (HR) is influenced by hypertension and other cardiovascular risk factors particularly smoking, obesity and dyslipidemia. Until now, to evaluate the HR changes due to presence of these risk factors, a single HR office measure or a mean evaluated on day time or night time or 24h was used. However, since HR shows a circadian behavior, a single value represents only a rough approximation of this behavior. In this study, we analyzed the influence of smoking, obesity and dyslipidemia on the circadian rhythm in normotensive and hypertensive subject groups presenting only one of these risk factors. The 24h HR recordings of 170 normotensive (83 without risk factors, 20 smokers, 44 with dyslipidemia, 23 obese) and 353 hypertensive (169 without risk factors, 32 smokers, 99 with dyslipidemia, 53 obese) subjects were acquired using a Holter Blood Pressure Monitor. Results highlighted a specific circadian behavior with three characteristic periods presenting different HR means and rates of HR change in the eight subject groups. The slopes could be used both to estimate the morning HR surge associated with acute cardiovascular effects in the awakening and to evaluate the decline during the night. Moreover, we suggest to use three HR mean values (one for each identified period of the day) rather than two HR values to better describe the circadian HR behavior. Furthermore, smoking increased and dyslipidemia decreased mean HR values from 10:00 to 04:00, both in normotensive and hypertensive subjects in comparison with subjects without risk factors. In this time interval, hypertensive obese subjects showed higher values while normotensive ones presented quite similar values than subjects without risk factors. During the awakening (05:00-10:00) the slopes were similar among all groups with no significant difference among the mean HR values.	[Accardo, Agostino; Silveri, Giulia; Ajcevic, Milos; Miladinovic, Aleksandar] Univ Trieste, Dept Engn & Architecture, Trieste, Italy; [Pascazio, Lorenzo] Univ Trieste, Dept Med Surg & Hlth Care, CS Geriatr, Trieste, Italy; [Pascazio, Lorenzo] ASUGI, Trieste, Italy	University of Trieste; University of Trieste	Silveri, G (corresponding author), Univ Trieste, Dept Engn & Architecture, Trieste, Italy.	giulia1391@libero.it	Miladinovic, Aleksandar/ABA-6702-2020	Miladinovic, Aleksandar/0000-0002-6156-1464; Silveri, Giulia/0000-0003-2438-7484; Ajcevic, Milos/0000-0001-8307-4360				Al-Safi Saafan A, 2005, Eur J Cardiovasc Nurs, V4, P286, DOI 10.1016/j.ejcnurse.2005.03.004; Bang LE, 2000, BLOOD PRESS MONIT, V5, P271, DOI 10.1097/00126097-200010000-00004; Benetos A, 1999, HYPERTENSION, V33, P44, DOI 10.1161/01.HYP.33.1.44; Bolinder G, 1998, AM J HYPERTENS, V11, P1153, DOI 10.1016/S0895-7061(98)00137-X; Casiglia E, 1996, J HYPERTENS, V14, P47; Ceconi C, 2011, EUR HEART J SUPPL, V13, pC4, DOI 10.1093/eurheartj/sur014; Cholesterol and hypercholesterolemia, EP EP PUBL HLTH; CLARKE JM, 1976, LANCET, V2, P508, DOI 10.1016/S0140-6736(76)90801-1; CRYER PE, 1976, NEW ENGL J MED, V295, P573, DOI 10.1056/NEJM197609092951101; DYER AR, 1980, AM J EPIDEMIOL, V112, P736, DOI 10.1093/oxfordjournals.aje.a113046; Freitas IF, 2012, BMC PEDIATR, V12, DOI 10.1186/1471-2431-12-5; Giles TD, 2006, J HYPERTENS, V24, pS11, DOI 10.1097/01.hjh.0000220098.12154.88; GRASSI G, 1995, HYPERTENSION, V25, P560, DOI 10.1161/01.HYP.25.4.560; Hansen TW, 2008, HYPERTENSION, V52, P229, DOI 10.1161/HYPERTENSIONAHA.108.113191; KANNEL WB, 1987, AM HEART J, V113, P1489, DOI 10.1016/0002-8703(87)90666-1; Kotsis V, 2005, HYPERTENSION, V45, P602, DOI 10.1161/01.HYP.0000158261.86674.8e; Lee JS, 2017, DIABETES CARE, V40, P529, DOI 10.2337/dc16-1958; Lee JF, 2014, CLIN AUTON RES, V24, P39, DOI 10.1007/s10286-013-0222-x; MANCIA G, 1983, CIRC RES, V53, P96, DOI 10.1161/01.RES.53.1.96; Palatini P, 2006, DRUGS, V66, P133, DOI 10.2165/00003495-200666020-00001; PALATINI P, 1992, ARCH INTERN MED, V152, P1855, DOI 10.1001/archinte.152.9.1855; Palatini P, 2013, INT J CARDIOL, V168, P1490, DOI 10.1016/j.ijcard.2012.12.103; Perlini S, 2013, J HUM HYPERTENS, V27, P412, DOI 10.1038/jhh.2012.61; Rossi RC, 2015, AUTON NEUROSCI-BASIC, V193, P138, DOI 10.1016/j.autneu.2015.07.424; Silveri G, 2020, 2020 11TH CONFERENCE OF THE EUROPEAN STUDY GROUP ON CARDIOVASCULAR OSCILLATIONS (ESGCO): COMPUTATION AND MODELLING IN PHYSIOLOGY NEW CHALLENGES AND OPPORTUNITIES; Silveri G, 2019, P 15 MED C MED BIOL; Silveri G, 2018, COMPUT CARDIOL CONF, V45, DOI 10.22489/CinC.2018.273; Sorensen K, 2004, BLOOD PRESSURE, V13, P362, DOI 10.1080/08037050410004837; Sun JC, 2014, BIOMED ENVIRON SCI, V27, P601, DOI 10.3967/bes2014.092; Thomas F, 2001, HYPERTENSION, V37, P1256, DOI 10.1161/01.HYP.37.5.1256; Tsuda A, 1996, PSYCHOPHARMACOLOGY, V126, P226, DOI 10.1007/BF02246452; TUOMILEHTO J, 1989, HYPERTENSION, V13, P773, DOI 10.1161/01.HYP.13.6.773; VERDECCHIA P, 1995, J HYPERTENS, V13, P1209, DOI 10.1097/00004872-199510000-00016; Wang AX, 2014, J HYPERTENS, V32, P1600, DOI 10.1097/HJH.0000000000000230; WHO, 2006, BMI CLASS; Williams B., 2018, EUR HEART J, V39, P3021, DOI [10.1093/eurheartj/ehy339, DOI 10.1093/EURHEARTJ/EHY339]	36	2	2	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2021	16	9							e0257660	10.1371/journal.pone.0257660	http://dx.doi.org/10.1371/journal.pone.0257660			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YS4WS	34551022	Green Published, gold			2022-12-26	WOS:000750679800037
J	Vieland, VJ; Seok, SC				Vieland, Veronica J.; Seok, Sang-Cheol			The PPLD has advantages over conventional regression methods in application to moderately sized genome-wide association studies	PLOS ONE			English	Article							POSTERIOR PROBABILITY; 2-LOCUS HETEROGENEITY; LINKAGE; EPISTASIS; TRAIT	In earlier work, we have developed and evaluated an alternative approach to the analysis of GWAS data, based on a statistic called the PPLD. More recently, motivated by a GWAS for genetic modifiers of the X-linked Mendelian disorder Duchenne Muscular Dystrophy (DMD), we adapted the PPLD for application to time-to-event (TE) phenotypes. Because DMD itself is relatively rare, this is a setting in which the very large sample sizes generally assembled for GWAS are simply not attainable. For this reason, statistical methods specially adapted for use in small data sets are required. Here we explore the behavior of the TE-PPLD via simulations, comparing the TE-PPLD with Cox Proportional Hazards analysis in the context of small to moderate sample sizes. Our results will help to inform our approach to the DMD study going forward, and they illustrate several respects in which the TE-PPLD, and by extension the original PPLD, offer advantages over regression-based approaches to GWAS in this context.	[Vieland, Veronica J.; Seok, Sang-Cheol] Nationwide Childrens Hosp, Battelle Ctr Math Med, Abigail Wexner Res Inst, Columbus, OH 43205 USA; [Vieland, Veronica J.] Ohio State Univ, Dept Pediat, Columbus, OH 43210 USA; [Vieland, Veronica J.] Ohio State Univ, Dept Stat, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; Nationwide Childrens Hospital; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Vieland, VJ (corresponding author), Nationwide Childrens Hosp, Battelle Ctr Math Med, Abigail Wexner Res Inst, Columbus, OH 43205 USA.; Vieland, VJ (corresponding author), Ohio State Univ, Dept Pediat, Columbus, OH 43210 USA.; Vieland, VJ (corresponding author), Ohio State Univ, Dept Stat, Columbus, OH 43210 USA.	Veronica.Vieland@nationwidechildrens.org			National Institutes of Health grant (NINDS) [NS085238]	National Institutes of Health grant (NINDS)	This work was supported by National Institutes of Health grant (NINDS) NS085238 to VJV. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartlett CW, 2007, GENET EPIDEMIOL, V31, pS61, DOI 10.1002/gepi.20281; Bartlett CW, 2007, GENET EPIDEMIOL, V31, P91, DOI 10.1002/gepi.20193; Bello L, 2019, METH PHYS S, P9, DOI 10.1007/978-1-4939-9802-9_2; Bello L, 2016, AM J HUM GENET, V99, P1163, DOI 10.1016/j.ajhg.2016.08.023; ELSTON RC, 1971, HUM HERED, V21, P523, DOI 10.1159/000152448; Flanigan KM, 2013, ANN NEUROL, V73, P481, DOI 10.1002/ana.23819; Flanigan KM, 2011, HUM MUTAT, V32, P299, DOI 10.1002/humu.21426; Flanigan KM, 2009, HUM MUTAT, V30, P1657, DOI 10.1002/humu.21114; Guan WJ, 2020, EUR RESPIR J, V55, DOI 10.1183/13993003.00547-2020; Heydemann A, 2009, J CLIN INVEST, V119, P3703, DOI 10.1172/JCI39845; Huang YG, 2010, GENET EPIDEMIOL, V34, P835, DOI 10.1002/gepi.20537; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Mendell JR, 2012, ANN NEUROL, V71, P304, DOI 10.1002/ana.23528; Moat SJ, 2013, EUR J HUM GENET, V21, P1049, DOI 10.1038/ejhg.2012.301; Pegoraro E, 2011, NEUROLOGY, V76, P219, DOI 10.1212/WNL.0b013e318207afeb; Royall R., 1997, STAT EVIDENCE LIKELI; Seok SC, 2009, J COMPUT BIOL, V16, P659, DOI 10.1089/cmb.2008.0175; SMITH CAB, 1963, ANN HUM GENET, V27, P175, DOI 10.1111/j.1469-1809.1963.tb00210.x; Soltanzadeh P, 2010, NEUROMUSCULAR DISORD, V20, P499, DOI 10.1016/j.nmd.2010.05.010; Stewart William Cl, 2014, BMC Proc, V8, pS111, DOI 10.1186/1753-6561-8-S1-S111; Strug LJ, 2018, GENET EPIDEMIOL, V42, P590, DOI 10.1002/gepi.22151; Therneau T, PACKAGE SURVIVAL ANA; Vieira NM, 2015, CELL, V163, P1204, DOI 10.1016/j.cell.2015.10.049; Vieland VJ, 2019, SYNTHESE, V196, P3139, DOI 10.1007/s11229-017-1666-7; Vieland VJ, 2011, HUM HERED, V72, P276, DOI 10.1159/000330634; Vieland VJ, 2003, AM J HUM GENET, V73, P1471, DOI 10.1086/380313; Vieland VJ, 2003, AM J HUM GENET, V73, P223, DOI 10.1086/376563; Vieland VJ, 1996, AM J HUM GENET, V58, P1072; Vieland VJ, 1998, AM J HUM GENET, V63, P283; Wasserstein RL, 2016, AM STAT, V70, P129, DOI 10.1080/00031305.2016.1154108; Weiss RB, 2018, ANN NEUROL, V84, P234, DOI 10.1002/ana.25283; Wratten NS, 2009, AM J PSYCHIAT, V166, P434, DOI 10.1176/appi.ajp.2008.08081266; Yang XQ, 2005, HUM HERED, V59, P210, DOI 10.1159/000086699	33	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2021	16	9							e0257164	10.1371/journal.pone.0257164	http://dx.doi.org/10.1371/journal.pone.0257164			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YS4WS	34550985	Green Published, Green Submitted, gold			2022-12-26	WOS:000750679800015
J	Hsu, YL; Lin, CL; Wei, CC				Hsu, Yu-Lung; Lin, Cheng-Li; Wei, Chang-Ching			Association between vesicoureteral reflux, urinary tract infection and antibiotics exposure in infancy and risk of childhood asthma	PLOS ONE			English	Article							EARLY-LIFE EXPOSURE; HYGIENE HYPOTHESIS; ALLERGIC DISEASES; BIRTH COHORT; CHILDREN; BURDEN	Background The use of antibiotics for treating infection in childhood and their association with increased risk of asthma remain controversial. Infants diagnosed with vesicoureteral reflux (VUR) belong to a unique population who are administered antibiotics for a long time and are susceptible to recurrent UTI. It is interesting to study the risk of asthma in these infants with or without VUR. Methods Taiwanese children born between 2000 and 2007 were enrolled in population-based birth cohort study. Participants diagnosed with VUR and UTI within first year were classified into four groups (VUR, UTI, VUR and UTI, and control). We calculated follow-up person-years for each participant from the index date until the asthma diagnosis, their withdrawal from the insurance system (because of death or loss to follow-up), or till the end of 2008. The risk of asthma was compared between the 4 cohorts by using Cox proportional hazards model analysis, adjusted hazard ratio (aHR), and 95% confidence interval (95% CI). Results Children diagnosed with VUR (n = 350), UTI (n = 15542), VUR and UTI (n = 1696), and randomly selected controls (n = 17588) were enrolled. The overall rate of incidence of asthma was found to be 1.64-fold, 1.45-fold, and 1.17-fold higher in the UTI, VUR/UTI, and VUR cohorts than in the controls (5.60, 5.07, and 4.10 vs. 3.17 per 100 person-years), respectively. After adjusting the potential factors, the overall risk of asthma remained the highest in UTI (aHR: 1.74, 95% CI : 1.65 to 1.80) followed by VUR/UTI (aHR: 1.56, 95% CI 1.40 to 1.75) and VUR cohorts (aHR: 1.25, 95% CI: 0.96 to 1.62). The incidence of asthma was higher in boys than in girls. Conclusion The nationwide retrospective cohort study demonstrated that short-term therapeutic dose of antibiotics for UTI in infants with or without VUR has a positive correlation with the prevalence of childhood asthma. Significant risk of childhood asthma was not observed when VUR cohort was exposed to long-term low-dose of prophylactic antibiotics.	[Hsu, Yu-Lung] China Med Univ Hosp, Childrens Hosp, Dept Pediat, Div Pediat Infect Dis, Taichung, Taiwan; [Lin, Cheng-Li] China Med Univ Hosp, Management Off Hlth Data, Taichung, Taiwan; [Lin, Cheng-Li] China Med Univ, Coll Publ Hlth, Taichung, Taiwan; [Wei, Chang-Ching] China Med Univ Hosp, Childrens Hosp, Dept Pediat, Div Pediat Allergy Immunol & Rheumatol, Taichung, Taiwan; [Wei, Chang-Ching] China Med Univ, Sch Med, Taichung, Taiwan	China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan	Wei, CC (corresponding author), China Med Univ Hosp, Childrens Hosp, Dept Pediat, Div Pediat Allergy Immunol & Rheumatol, Taichung, Taiwan.; Wei, CC (corresponding author), China Med Univ, Sch Med, Taichung, Taiwan.	weilonger@gmail.com	Hsu, Yu-Lung/GVS-4803-2022	Hsu, Yu-Lung/0000-0002-3010-2767	Department of Chinese Medicine and Pharmacy, Ministry of Health and Welfare [MOHW109-TDU-B-212-114004]; China Medical University Hospital [DMR-HHC-110-7]; Clinical Trial Center	Department of Chinese Medicine and Pharmacy, Ministry of Health and Welfare; China Medical University Hospital; Clinical Trial Center	This study is supported in part by Clinical Trial Center and Department of Chinese Medicine and Pharmacy, Ministry of Health and Welfare (MOHW109-TDU-B-212-114004), China Medical University Hospital (DMR-HHC-110-7). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almqvist C, 2008, ALLERGY, V63, P47, DOI 10.1111/j.1398-9995.2007.01524.x; Asher I, 2014, INT J TUBERC LUNG D, V18, P1269, DOI 10.5588/ijtld.14.0170; Brooks C, 2013, CURR OPIN ALLERGY CL, V13, P70, DOI 10.1097/ACI.0b013e32835ad0d2; Castro-Rodriguez JA, 2016, J ALLER CL IMM-PRACT, V4, P1111, DOI 10.1016/j.jaip.2016.05.003; Cheng TM, 2010, SIX COUNTRIES SIX RE, P171; Cho I, 2012, NATURE, V488, P621, DOI 10.1038/nature11400; Daley D, 2014, CURR OPIN ALLERGY CL, V14, P390, DOI 10.1097/ACI.0000000000000101; Davis K, 2008, ANN INTERN MED, V148, P313, DOI 10.7326/0003-4819-148-4-200802190-00011; Elder JS, 2006, J UROLOGY, V175, P716, DOI 10.1016/S0022-5347(05)00210-7; Hiraoka M, 1999, KIDNEY INT, V55, P1486, DOI 10.1046/j.1523-1755.1999.00380.x; Hoberman A, 2003, NEW ENGL J MED, V348, P195, DOI 10.1056/NEJMoa021698; Hoskin-Parr L, 2013, PEDIAT ALLERG IMM-UK, V24, P762, DOI 10.1111/pai.12153; Illi S, 2001, BMJ-BRIT MED J, V322, P390, DOI 10.1136/bmj.322.7283.390; Johnson CC, 2002, EPIDEMIOL REV, V24, P154, DOI 10.1093/epirev/mxf013; Kozyrskyj AL, 2007, CHEST, V131, P1753, DOI 10.1378/chest.06-3008; Lin CH, 2015, EUR J CLIN MICROBIOL, V34, P1773, DOI 10.1007/s10096-015-2411-0; Marra F, 2006, CHEST, V129, P610, DOI 10.1378/chest.129.3.610; Midodzi WK, 2010, J ASTHMA, V47, P7, DOI 10.3109/02770900903380996; Murk W, 2011, PEDIATRICS, V127, P1125, DOI 10.1542/peds.2010-2092; Normann E, 2006, THORAX, V61, P1054, DOI 10.1136/thx.2005.051656; Ortqvist AK, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g6979; Pitter G, 2016, EUR J EPIDEMIOL, V31, P85, DOI 10.1007/s10654-015-0038-1; Platts-Mills TAE, 2015, J ALLERGY CLIN IMMUN, V136, P3, DOI 10.1016/j.jaci.2015.03.048; Prescott SL, 2013, J ALLERGY CLIN IMMUN, V131, P23, DOI 10.1016/j.jaci.2012.11.019; Roberts KB, 2011, PEDIATRICS, V128, P595, DOI 10.1542/peds.2011-1330; Russell SL, 2012, EMBO REP, V13, P440, DOI 10.1038/embor.2012.32; Shaikh N, 2008, PEDIATR INFECT DIS J, V27, P302, DOI 10.1097/INF.0b013e31815e4122; Sly PD, 2010, J ALLERGY CLIN IMMUN, V125, P1202, DOI 10.1016/j.jaci.2010.01.024; STRACHAN DP, 1989, BRIT MED J, V299, P1259, DOI 10.1136/bmj.299.6710.1259; van Schayck OCP, 2013, PRIM CARE RESP J, V22, P239, DOI 10.4104/pcrj.2013.00052; Wei CC, 2014, ANN EPIDEMIOL, V24, P340, DOI 10.1016/j.annepidem.2014.02.003; Wickens K, 2008, CLIN EXP ALLERGY, V38, P1318, DOI 10.1111/j.1365-2222.2008.03024.x; Wu CS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112257; Yeoh JS, 2013, J PEDIATR UROL, V9, P503, DOI 10.1016/j.jpurol.2012.05.006	34	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2021	16	9							e0257531	10.1371/journal.pone.0257531	http://dx.doi.org/10.1371/journal.pone.0257531			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YM4DR	34547047	Green Published, gold			2022-12-26	WOS:000746527400015
J	Cho, YS; Sohn, YJ; Hyun, JH; Baek, YJ; Kim, MH; Kim, JH; Ahn, JY; Jeong, SJ; Ku, NS; Choi, JY; Yeom, JS; Song, YG				Cho, Yun Suk; Sohn, Yu Jin; Hyun, Jong Hoon; Baek, Yae Jee; Kim, Moo Hyun; Kim, Jung Ho; Ahn, Jin Young; Jeong, Su Jin; Ku, Nam Su; Choi, Jun Yong; Yeom, Joon-Sup; Song, Young Goo			Risk factors for unfavorable clinical outcomes in patients with brain abscess in South Korea	PLOS ONE			English	Article							SEVERE HEAD-INJURY; SOFA SCORE; COMORBIDITY; IMPAIRMENT; PROGNOSIS; ADMISSION; SEQUELAE; UPDATE	Background Brain abscess can be life-threatening and manifest various neurological findings, although the mortality rate has decreased recently. We investigated the risk factors for unfavorable outcomes of patients with brain abscess. Methods A retrospective cohort study examined patients with brain abscess seen from May 2005 to December 2018 in a tertiary care hospital in Seoul, South Korea. We reviewed the medical records for clinical findings, therapeutic modalities, and prognostic factors of brain abscess. Unfavorable clinical outcomes were defined as death, moderate to severe disability with neurological deficits, or vegetative state at 1 year or at the time of discharge from outpatient follow-up. Results The study enrolled 135 patients: 65.2% were males; the mean age was 56 years. 35.6% had unfavorable outcomes. In multivariate analysis, higher Sequential Organ Failure Assessment (SOFA) (p < 0.001), pre-existing hemiplegia (p = 0.049), and higher Charlson comorbidity index (CCI) (p = 0.028) were independently associated with unfavorable outcomes. Conclusions Higher SOFA, pre-existing hemiplegia and higher Charlson comorbidity index were significant risk factors for unfavorable clinical outcomes in patients with brain abscess.	[Cho, Yun Suk; Sohn, Yu Jin; Hyun, Jong Hoon; Baek, Yae Jee; Kim, Moo Hyun; Kim, Jung Ho; Ahn, Jin Young; Jeong, Su Jin; Ku, Nam Su; Choi, Jun Yong; Yeom, Joon-Sup; Song, Young Goo] Yonsei Univ, Dept Internal Med, Coll Med, Seoul, South Korea; [Cho, Yun Suk; Sohn, Yu Jin; Hyun, Jong Hoon; Baek, Yae Jee; Kim, Moo Hyun; Kim, Jung Ho; Ahn, Jin Young; Jeong, Su Jin; Ku, Nam Su; Choi, Jun Yong; Yeom, Joon-Sup; Song, Young Goo] Yonsei Univ, AIDS Res Inst, Coll Med, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Ku, NS (corresponding author), Yonsei Univ, Dept Internal Med, Coll Med, Seoul, South Korea.; Ku, NS (corresponding author), Yonsei Univ, AIDS Res Inst, Coll Med, Seoul, South Korea.	smileboy9@yuhs.ac	Yeom, Joon Sup/Q-5559-2019; Song, Young Goo/AGV-5104-2022	Yeom, Joon Sup/0000-0001-8940-7170; Song, Young Goo/0000-0002-0733-4156; Jeong, Su Jin/0000-0003-4025-4542; Hyun, JongHoon/0000-0002-9621-0250; Kim, Jung Ho/0000-0002-5033-3482; Ahn, Jin Young/0000-0002-3740-2826; Choi, Jun Yong/0000-0002-2775-3315; Ku, Nam Su/0000-0002-9717-4327				Adukauskiene D, 2007, MED LITH, V43, P170, DOI 10.3390/medicina43020021; Amornpojnimman T, 2018, J CLIN NEUROSCI, V53, P135, DOI 10.1016/j.jocn.2018.04.059; Baradari AG, 2016, SCIENTIFICA, V2016, DOI 10.1155/2016/7379325; Bodilsen J, 2020, CLIN MICROBIOL INFEC, V26, P95, DOI 10.1016/j.cmi.2019.05.016; Brouwer MC, 2017, CURR OPIN INFECT DIS, V30, P129, DOI 10.1097/QCO.0000000000000334; Brouwer MC, 2014, NEW ENGL J MED, V371, P447, DOI 10.1056/NEJMra1301635; Brouwer MC, 2014, NEUROLOGY, V82, P806, DOI 10.1212/WNL.0000000000000172; BUONAGURO A, 1989, CHILD NERV SYST, V5, P153, DOI 10.1007/BF00272117; CAREY ME, 1971, J NEUROSURG, V34, P652, DOI 10.3171/jns.1971.34.5.0652; Carpenter JP, 2020, J VASC SURG, V72, P918, DOI 10.1016/j.jvs.2019.11.039; CHARLSON M, 1994, J CLIN EPIDEMIOL, V47, P1245, DOI 10.1016/0895-4356(94)90129-5; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; de Grooth HJ, 2017, CRIT CARE, V21, DOI 10.1186/s13054-017-1609-1; DHOORE W, 1993, METHOD INFORM MED, V32, P382; Ferreira FL, 2001, JAMA-J AM MED ASSOC, V286, P1754, DOI 10.1001/jama.286.14.1754; Fried LP, 2004, J GERONTOL A-BIOL, V59, P255; Garbero RD, 2019, TURK J EMERG MED, V19, P106, DOI 10.1016/j.tjem.2019.05.002; HARRIS LF, 1985, SOUTH MED J, V78, P704, DOI 10.1097/00007611-198506000-00022; Helweg-Larsen J, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-332; Karakike E, 2019, CRIT CARE, V23, DOI 10.1186/s13054-019-2665-5; Kim HJ, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.97105; Lambden S, 2019, CRIT CARE, V23, DOI 10.1186/s13054-019-2663-7; Lange N, 2018, ACTA NEUROCHIR, V160, P2055, DOI 10.1007/s00701-018-3633-6; Mathisen GE, 1997, CLIN INFECT DIS, V25, P763, DOI 10.1086/515541; McLean RR, 2014, J GERONTOL A-BIOL, V69, P576, DOI 10.1093/gerona/glu012; Menon S, 2008, J MED MICROBIOL, V57, P1259, DOI 10.1099/jmm.0.47814-0; Nakashima T, 2020, J INTENSIVE CARE MED, V35, P656, DOI 10.1177/0885066618775959; NICOLOSI A, 1991, NEUROEPIDEMIOLOGY, V10, P122, DOI 10.1159/000110257; NIELSEN H, 1983, ACTA NEUROL SCAND, V67, P330; Oda S, 2000, INTENS CARE MED, V26, P1786, DOI 10.1007/s001340000710; Poses RM, 1996, J CLIN EPIDEMIOL, V49, P743, DOI 10.1016/0895-4356(96)00021-2; ROUSSEAUX M, 1985, ACTA NEUROCHIR, V74, P61, DOI 10.1007/BF01413280; Sharma R, 2009, INFECTION, V37, P39, DOI 10.1007/s15010-008-7359-x; Sinn Chi-Ling Joanna, 2020, CMAJ Open, V8, pE796, DOI 10.9778/cmajo.20200083; Song JU, 2018, CRIT CARE, V22, DOI 10.1186/s13054-018-1952-x; Sonneville R, 2017, CLIN MICROBIOL INFEC, V23, P614, DOI 10.1016/j.cmi.2017.05.004; Sveinsson OA, 2013, LAEKNABLADID, V99, P25, DOI 10.17992/lbl.2013.01.478; Tattevin P, 2003, AM J MED, V115, P143, DOI 10.1016/S0002-9343(03)00292-4; Teasdale GM, 1998, J NEUROTRAUM, V15, P587, DOI 10.1089/neu.1998.15.587; Thygesen SK, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-83; Vincent JL, 1998, CRIT CARE MED, V26, P1793, DOI 10.1097/00003246-199811000-00016; YEN JK, 1978, SURG NEUROL, V9, P323; Zhang CR, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-311	43	2	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2021	16	9							e0257541	10.1371/journal.pone.0257541	http://dx.doi.org/10.1371/journal.pone.0257541			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	WG6BN	34543311	gold, Green Published			2022-12-26	WOS:000707078200045
J	Jayatissa, R; Haturusinghe, C; Knowles, J; Codling, K; Gorstein, J; Gebremedhin, S				Jayatissa, Renuka; Haturusinghe, Chandima; Knowles, Jacky; Codling, Karen; Gorstein, Jonathan; Gebremedhin, Samson			Estimated contribution of most commonly consumed industrialized processed foods to salt intake and iodine intakes in Sri Lanka	PLOS ONE			English	Article								In Sri Lanka dietary patterns are shifting towards increased consumption of industrially processed foods (IPF). This study aimed to estimate the contribution of IPF to salt and iodine intake and assess the possible impact of salt reduction on iodized salt intake. The assessment was conducted using guidance published by the Iodine Global Network. National nutrition and household income expenditure surveys were used to estimate adult per capita consumption of household salt and commonly consumed salt-containing IPF. Industry and laboratory data were used to quantify salt content of IPF. Modelling estimated the potential and current iodine intake from consumption of household salt and using iodized salt in the identified IPF. Estimates were adjusted to investigate the likely impact on iodine intake of achieving 30% salt reduction. IPF included were bread, dried fish and biscuits, with daily per capita consumption of 32g, 10g and 7g respectively. Daily intake of household salt was estimated to be 8.5g. Potential average national daily iodine intake if all salt in these products was iodized was 166 mu g. Estimated current daily iodine intake, based on iodization of 78% of household salt and dried fish being made with non-iodized salt, was 111 mu g nationally, ranging from 90 to 145 mu g provincially. Estimated potential and current iodine intakes were above the estimated average requirement of 95 mu g iodine for adults, however, current intake was below the recommended nutrient intake of 150 mu g. If the 30% salt reduction target is achieved, estimated current iodine intake from household salt, bread and biscuits could decrease to 78 mu g. The assessment together with data for iodine status suggest that current iodine intake of adults in Sri Lanka is adequate. Recommendations to sustain with reduced salt intake are to strengthen monitoring of population iodine status and of food industry use of iodized salt, and to adjust the salt iodine levels if needed.	[Jayatissa, Renuka; Haturusinghe, Chandima] Med Res Inst, Dept Nutr, Colombo, Sri Lanka; [Knowles, Jacky; Codling, Karen; Gorstein, Jonathan; Gebremedhin, Samson] Iodine Global Network, Ottawa, ON, Canada	Medical Research Institute Sri Lanka (MRI)	Jayatissa, R (corresponding author), Med Res Inst, Dept Nutr, Colombo, Sri Lanka.	renukajayatissa@ymail.com		Jayatissa, Renuka/0000-0002-3961-8735	Bill and Melinda Gate Foundation [OPP1195090]	Bill and Melinda Gate Foundation	Initials of the authors who received each award -RJ Grant numbers awarded to each author -Investment ID OPP1195090 The full name of each funder -Bill and Melinda Gate Foundation URL of each funder website -None Did the sponsors or funders play any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript? No The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen LH, 2020, ADV NUTR, V11, P469, DOI 10.1093/advances/nmz096; Department of Census and Statistics, 2018, HOUS INC EXP SURV 20; Dharshini DA., 2018, PHARMA INNOVATION J, V7, P01; Jayatissa R, 2021, J NATL SCI FOUND SRI, V49, P111, DOI 10.4038/jnsfsr.v49i1.10057; Jayatissa R., 2017, NATL NUTR SURVEY LAC, DOI [10.3390/ma11010036, DOI 10.3390/MA11010036]; Jayatissa R., 2016, IODINE DEFICIENCY ST; Jayatissa R., 2015, NATL NUTR MICRONUTRI, DOI [10.1016/j.msec.2015.04.024, DOI 10.1016/J.MSEC.2015.04.024]; Jayatissa R, 2020, NUTRIENTS, V12, DOI 10.3390/nu12041109; Knowles J., 2018, IDD NEWSL, P2; Ministry of Health Nutrition and Indigenous Medicine, 2016, NAT MULT SECT ACT PL; Popkin BM, 2001, ASIA PAC J CLIN NUTR, V10, pS13, DOI 10.1046/j.1440-6047.2001.00211.x; Reardon T., 2014, URBANIZATION DIET CH; The World Health Organization, 2015, NONC DIS RISK FACT S; UNICEF, 2018, GUIDANCE MONITORING; WHO, 2020, SALT RED IOD FORT ST; World Health Organisation, 2013, 66 WORLD HLTH ASS FO; World Health Organization, 2014, GUID FORT FOODGR SAL	17	0	0	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2021	16	9							e0257488	10.1371/journal.pone.0257488	http://dx.doi.org/10.1371/journal.pone.0257488			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	WG6BN	34543289	Green Published, gold			2022-12-26	WOS:000707078200038
J	Komura, K; Inamoto, T; Tsujino, T; Matsui, Y; Konuma, T; Nishimura, K; Uchimoto, T; Tsutsumi, T; Matsunaga, T; Maenosono, R; Yoshikawa, Y; Taniguchi, K; Tanaka, T; Uehara, H; Hirata, K; Hirano, H; Nomi, H; Hirose, Y; Ono, F; Azuma, H				Komura, Kazumasa; Inamoto, Teruo; Tsujino, Takuya; Matsui, Yusuke; Konuma, Tsuyoshi; Nishimura, Kazuki; Uchimoto, Taizo; Tsutsumi, Takeshi; Matsunaga, Tomohisa; Maenosono, Ryoichi; Yoshikawa, Yuki; Taniguchi, Kohei; Tanaka, Tomohito; Uehara, Hirofumi; Hirata, Koichi; Hirano, Hajime; Nomi, Hayahito; Hirose, Yoshinobu; Ono, Fumihito; Azuma, Haruhito			Increased BUB1B/BUBR1 expression contributes to aberrant DNA repair activity leading to resistance to DNA-damaging agents	ONCOGENE			English	Article							FOXM1/BUB1B SIGNALING PATHWAY; CELL-LINE; BUBR1; ATM; BLADDER; TRANSCRIPTION; INHIBITOR; PLATFORM; REGIONS; APC/C	There has been accumulating evidence for the clinical benefit of chemoradiation therapy (CRT), whereas mechanisms in CRT-recurrent clones derived from the primary tumor are still elusive. Herein, we identified an aberrant BUB1B/BUBR1 expression in CRT-recurrent clones in bladder cancer (BC) by comprehensive proteomic analysis. CRT-recurrent BC cells exhibited a cell-cycle-independent upregulation of BUB1B/BUBR1 expression rendering an enhanced DNA repair activity in response to DNA double-strand breaks (DSBs). With DNA repair analyses employing the CRISPR/cas9 system, we revealed that cells with aberrant BUB1B/BUBR1 expression dominantly exploit mutagenic nonhomologous end joining (NHEJ). We further found that phosphorylated ATM interacts with BUB1B/BUBR1 after ionizing radiation (IR) treatment, and the resistance to DSBs by increased BUB1B/BUBR1 depends on the functional ATM. In vivo, tumor growth of CRT-resistant T24R cells was abrogated by ATM inhibition using AZD0156. A dataset analysis identified FOXM1 as a putative BUB1B/BUBR1-targeting transcription factor causing its increased expression. These data collectively suggest a redundant role of BUB1B/BUBR1 underlying mutagenic NHEJ in an ATM-dependent manner, aside from the canonical activity of BUB1B/BUBR1 on the G2/M checkpoint, and offer novel clues to overcome CRT resistance.	[Komura, Kazumasa; Inamoto, Teruo; Nishimura, Kazuki; Uchimoto, Taizo; Matsunaga, Tomohisa; Maenosono, Ryoichi; Yoshikawa, Yuki; Uehara, Hirofumi; Hirano, Hajime; Nomi, Hayahito; Azuma, Haruhito] Osaka Med & Pharmaceut Univ, Dept Urol, Osaka 5698686, Japan; [Komura, Kazumasa; Taniguchi, Kohei; Tanaka, Tomohito; Ono, Fumihito] Osaka Med & Pharmaceut Univ, Translat Res Program, Osaka 5698686, Japan; [Tsujino, Takuya; Tsutsumi, Takeshi] Harvard Med Sch, Brigham & Womens Hosp, Dept Surg, Div Urol, Boston, MA 02115 USA; [Matsui, Yusuke] Nagoya Univ, Dept Integrated Hlth Sci, Biomed & Hlth Informat Unit, Grad Sch Med, Nagoya, Aichi 4618673, Japan; [Matsui, Yusuke] Nagoya Univ, Inst Glycocore Res iGCORE, Nagoya, Aichi 4618673, Japan; [Konuma, Tsuyoshi] Yokohama City Univ, Grad Sch Med Life Sci, Yokohama, Kanagawa 2300045, Japan; [Hirata, Koichi; Hirose, Yoshinobu] Osaka Med & Pharmaceut Univ, Dept Pathol, Osaka 5698686, Japan; [Ono, Fumihito] Osaka Med & Pharmaceut Univ, Dept Physiol, Osaka 5698686, Japan	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Nagoya University; Nagoya University; Yokohama City University	Komura, K (corresponding author), Osaka Med & Pharmaceut Univ, Dept Urol, Osaka 5698686, Japan.; Komura, K (corresponding author), Osaka Med & Pharmaceut Univ, Translat Res Program, Osaka 5698686, Japan.	kazumasa.komura@ompu.ac.jp	Hirose, Yoshinobu/AAW-9079-2020	Hirose, Yoshinobu/0000-0002-3860-0293; Konuma, Tsuyoshi/0000-0002-4412-2849; Nishimura, Kazuki/0000-0002-2878-7664	Japan Society for the Promotion of Science: JSPS [21H03070, 19K18624, 17K16821, 16K11033, 16K11034]; Uehara Memorial Foundation; NOVARTIS Foundation (Japan) for the Promotion of Science; Japan Research Foundation for Clinical Pharmacology; Yamaguchi Endocrine Disease Research Foundation; Takeda Science Foundation; Young Research Grant of Japanese Urological Association (JUA)	Japan Society for the Promotion of Science: JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Uehara Memorial Foundation(Uehara Memorial Foundation); NOVARTIS Foundation (Japan) for the Promotion of Science(Novartis); Japan Research Foundation for Clinical Pharmacology; Yamaguchi Endocrine Disease Research Foundation; Takeda Science Foundation(Takeda Science Foundation (TSF)); Young Research Grant of Japanese Urological Association (JUA)	This work was partially supported by the Grant-in-Aid No. 21H03070, 19K18624, 17K16821, 16K11033, and 16K11034 (Japan Society for the Promotion of Science: JSPS), the Uehara Memorial Foundation, the NOVARTIS Foundation (Japan) for the Promotion of Science, Japan Research Foundation for Clinical Pharmacology, Yamaguchi Endocrine Disease Research Foundation, the Takeda Science Foundation, and Young Research Grant of Japanese Urological Association (JUA).	Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Balmus G, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-07729-2; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Bergom C, 2019, INT J RADIAT ONCOL, V105, P698, DOI 10.1016/j.ijrobp.2019.07.026; Betermier M, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004086; Bolanos-Garcia VM, 2011, TRENDS BIOCHEM SCI, V36, P141, DOI 10.1016/j.tibs.2010.08.004; Cancer Genome Atlas Research Network, 2014, Nature, V511, P543, DOI [10.1038/s41586-018-0228-6, 10.1038/nature13385]; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chai N, 2018, BIOCHEM BIOPH RES CO, V500, P924, DOI 10.1016/j.bbrc.2018.04.201; Chang HHY, 2017, NAT REV MOL CELL BIO, V18, P495, DOI 10.1038/nrm.2017.48; Chao WCH, 2012, NATURE, V484, P208, DOI 10.1038/nature10896; Davenport JW, 1999, GENOMICS, V55, P113, DOI 10.1006/geno.1998.5629; Degorce SL, 2016, J MED CHEM, V59, P6281, DOI 10.1021/acs.jmedchem.6b00519; DINNEY CPN, 1995, J UROLOGY, V154, P1532, DOI 10.1016/S0022-5347(01)66923-4; Dyrskjot L, 2004, CANCER RES, V64, P4040, DOI 10.1158/0008-5472.CAN-03-3620; Fang Y, 2006, ONCOGENE, V25, P3598, DOI 10.1038/sj.onc.1209392; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Gertz J, 2013, MOL CELL, V52, P25, DOI 10.1016/j.molcel.2013.08.037; Guo T, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-018-1518-x; Jette NR, 2019, BRIT J CANCER, V121, P600, DOI 10.1038/s41416-019-0565-8; Kapanidou M, 2015, TRENDS MOL MED, V21, P364, DOI 10.1016/j.molmed.2015.04.003; Karess RE, 2013, INT REV CEL MOL BIO, V306, P223, DOI 10.1016/B978-0-12-407694-5.00006-7; Kato-Inui T, 2018, NUCLEIC ACIDS RES, V46, P4677, DOI 10.1093/nar/gky264; Kirmitzoglou I, 2015, BIOINFORMATICS, V31, P2208, DOI 10.1093/bioinformatics/btv115; Lambert SA, 2018, CELL, V172, P650, DOI 10.1016/j.cell.2018.01.029; Laoukili J, 2005, NAT CELL BIOL, V7, P126, DOI 10.1038/ncb1217; Lara-Gonzalez P, 2011, J CELL SCI, V124, P4332, DOI 10.1242/jcs.094763; Lee JH, 2007, ONCOGENE, V26, P7741, DOI 10.1038/sj.onc.1210872; Lee JS, 2010, J CLIN ONCOL, V28, P2660, DOI 10.1200/JCO.2009.25.0977; Ma Q, 2017, ONCOL REP, V38, P3367, DOI 10.3892/or.2017.6032; Mcree AJ, 2011, FUTURE ONCOL, V7, P409, DOI [10.2217/FON.11.7, 10.2217/fon.11.7]; Miyaoka Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep23549; MORITA T, 1995, UROL RES, V23, P143, DOI 10.1007/BF00389565; Myslinski E, 2007, NUCLEIC ACIDS RES, V35, P3453, DOI 10.1093/nar/gkm239; Randon G, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-39525-3; Riches LC, 2020, MOL CANCER THER, V19, P13, DOI 10.1158/1535-7163.MCT-18-1394; Robertson AG, 2017, CELL, V171, P540, DOI 10.1016/j.cell.2017.09.007; Rodgers K, 2016, J CELL PHYSIOL, V231, P15, DOI 10.1002/jcp.25053; Sanchez-Carbayo M, 2006, J CLIN ONCOL, V24, P778, DOI 10.1200/JCO.2005.03.2375; Sanders DA, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0696-z; Sanders DA, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-1-r6; Shen MJ, 2019, J EXP CLIN CANC RES, V38, DOI 10.1186/s13046-019-1161-8; Stransky N, 2006, NAT GENET, V38, P1386, DOI 10.1038/ng1923; Sudakin V, 2001, J CELL BIOL, V154, P925, DOI 10.1083/jcb.200102093; Tang ZY, 2001, DEV CELL, V1, P227, DOI 10.1016/S1534-5807(01)00019-3; Thompson R, 2015, MOL CELL, V58, P767, DOI 10.1016/j.molcel.2015.03.034; Traven A, 2005, BIOESSAYS, V27, P397, DOI 10.1002/bies.20204; Wan XL, 2012, CANCER RES, V72, P5889, DOI 10.1158/0008-5472.CAN-12-1991; Wang C, 2017, TRANSL ONCOL, V10, P190, DOI 10.1016/j.tranon.2017.01.007; Weston VJ, 2010, BLOOD, V116, P4578, DOI 10.1182/blood-2010-01-265769; Zuiverloon TCM, 2018, BLADDER CANCER, V4, P169, DOI 10.3233/BLC-180167	51	5	5	2	5	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 28	2021	40	43					6210	6222		10.1038/s41388-021-02021-y	http://dx.doi.org/10.1038/s41388-021-02021-y		SEP 2021	13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	WO5HW	34545188	Green Published, hybrid			2022-12-26	WOS:000698130400002
J	Woo, J; Kim, JB; Cho, T; Yoo, EH; Moon, BI; Kwon, H; Lim, W				Woo, Joohyun; Kim, Jong Bin; Cho, Taeeun; Yoo, Eun Hye; Moon, Byung-In; Kwon, Hyungju; Lim, Woosung			Selenium inhibits growth of trastuzumab-resistant human breast cancer cells via downregulation of Akt and beclin-1	PLOS ONE			English	Article							METHYLSELENINIC ACID; INDUCED APOPTOSIS; SODIUM SELENITE; IN-VITRO; AUTOPHAGY; CYTOTOXICITY; MODULATION; ANTIBODY; COMBINATION; GENERATION	The response rate to treatment with trastuzumab (Tz), a recombinant humanized anti-HER2 monoclonal antibody, is only 12-34% despite demonstrated effectiveness on improving the survival of patients with HER2-positive breast cancers. Selenium has an antitumor effect against cancer cells and can play a cytoprotective role on normal cells. This study investigated the effect of selenium on HER2-positive breast cancer cells and the mechanism in relation to the response of the cells to Tz. HER2-positive breast cancer cell lines, SK-BR-3 as trastuzumab-sensitive cells, and JIMT-1 as Tz-resistant cells were treated with Tz and sodium selenite (selenite). Cell survival rates and expression of Her2, Akt, and autophagy-related proteins, including LC3B and beclin 1, in both cell lines 72 h after treatment were evaluated. Significant cell death was induced at different concentrations of selenite in both cell lines. A combined effect of selenite and Tz at 72 h was similar to or significantly greater than each drug alone. The expression of phosphorylated Akt (p-Akt) was decreased in JIMT-1 after combination treatment compared to that after only Tz treatment, while p-Akt expression was increased in SK-BR-3. The expression of beclin1 increased particularly in JIMT-1 after only Tz treatment and was downregulated by combination treatment. These results showed that combination of Tz and selenite had an antitumor effect in Tz-resistant breast cancer cells through downregulation of phosphorylated Akt and beclin1-related autophagy. Selenite might be a potent drug to treat Tz-resistant breast cancer by several mechanisms.	[Woo, Joohyun; Moon, Byung-In; Kwon, Hyungju; Lim, Woosung] Ewha Womans Univ, Dept Surg, Coll Med, Seoul, South Korea; [Kim, Jong Bin; Cho, Taeeun; Yoo, Eun Hye] Ewha Inst Convergence Med, Seoul, South Korea	Ewha Womans University	Lim, W (corresponding author), Ewha Womans Univ, Dept Surg, Coll Med, Seoul, South Korea.	limw@ewha.ac.kr		Lim, Woosung/0000-0002-2863-9346	Ewha Womans University	Ewha Womans University	This work was supported by the Ewha Womans University Research Grant of 2017.	Abdel-Aziz AK, 2015, BASIC CLIN PHARMACOL, V116, P37, DOI 10.1111/bcpt.12281; Bapat P., 2015, THESIS TEXAS TU LUBB; Barok M, 2007, MOL CANCER THER, V6, P2065, DOI 10.1158/1535-7163.MCT-06-0766; Bortul R, 2005, BRIT J HAEMATOL, V129, P677, DOI 10.1111/j.1365-2141.2005.05504.x; CHEN H, 1995, FREE RADICAL BIO MED, V18, P949, DOI 10.1016/0891-5849(94)00238-F; EJADI S, 1989, CARCINOGENESIS, V10, P823, DOI 10.1093/carcin/10.5.823; Esteva FJ, 2002, J CLIN ONCOL, V20, P1800, DOI 10.1200/JCO.2002.07.058; He CC, 2009, ANNU REV GENET, V43, P67, DOI 10.1146/annurev-genet-102808-114910; Husbeck B, 2006, PROSTATE, V66, P218, DOI 10.1002/pros.20337; Ip C, 2000, CANCER RES, V60, P2882; Juliger S, 2007, CANCER RES, V67, P10984, DOI 10.1158/0008-5472.CAN-07-0519; Kondo Y, 2005, NAT REV CANCER, V5, P726, DOI 10.1038/nrc1692; Kralova V, 2012, TOXICOL IN VITRO, V26, P258, DOI 10.1016/j.tiv.2011.12.010; Li S, 2007, MOL CANCER THER, V6, P1031, DOI 10.1158/1535-7163.MCT-06-0643; Marte BM, 1997, TRENDS BIOCHEM SCI, V22, P355, DOI 10.1016/S0968-0004(97)01097-9; Molina MA, 2001, CANCER RES, V61, P4744; Nagata Y, 2004, CANCER CELL, V6, P117, DOI 10.1016/j.ccr.2004.06.022; Nielsen DL, 2009, CANCER TREAT REV, V35, P121, DOI 10.1016/j.ctrv.2008.09.003; O'Brien NA, 2010, MOL CANCER THER, V9, P1489, DOI 10.1158/1535-7163.MCT-09-1171; Park S, 2015, ANN SURG TREAT RES, V88, P55, DOI 10.4174/astr.2015.88.2.55; PRATT SE, 1993, CANCER RES, V53, P5193; Reid ME, 2004, J TRACE ELEM MED BIO, V18, P69, DOI 10.1016/j.jtemb.2004.03.004; Ren Y, 2009, BMB REP, V42, P599, DOI 10.5483/BMBRep.2009.42.9.599; Rubinstein AD, 2012, J CELL SCI, V125, P5259, DOI 10.1242/jcs.115865; SOULE HD, 1990, CANCER RES, V50, P6075; Spallholz JE, 1997, BIOMED ENVIRON SCI, V10, P260; Trempe G L, 1976, Recent Results Cancer Res, P33; Vadgama JV, 2000, ANTICANCER RES, V20, P1391; Valabrega G, 2007, ANN ONCOL, V18, P977, DOI 10.1093/annonc/mdl475; Valabrega G, 2005, ONCOGENE, V24, P3002, DOI 10.1038/sj.onc.1208478; Wang RC, 2012, SCIENCE, V338, P956, DOI 10.1126/science.1225967; WATRACH AM, 1984, CANCER LETT, V25, P41, DOI 10.1016/S0304-3835(84)80024-5; Wu Y, 2006, MOL CANCER THER, V5, P246, DOI 10.1158/1535-7163.MCT-05-0376; Yakes FM, 2002, CANCER RES, V62, P4132; Zarzynska JM, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/710345; Zhang JL, 2018, INT J BIOL MACROMOL, V107, P1406, DOI 10.1016/j.ijbiomac.2017.09.117	36	3	3	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2021	16	9							e0257298	10.1371/journal.pone.0257298	http://dx.doi.org/10.1371/journal.pone.0257298			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	WG6DR	34525121	Green Published, gold			2022-12-26	WOS:000707084400030
J	Skervin, TK; Thomas, NM; Schofield, AJ; Hollands, MA; Maganaris, CN; O'Brien, TD; Baltzopoulos, V; Foster, RJ				Skervin, Timmion K.; Thomas, Neil M.; Schofield, Andrew J.; Hollands, Mark A.; Maganaris, Constantinos N.; O'Brien, Thomas D.; Baltzopoulos, Vasilios; Foster, Richard J.			Using a stair horizontal-vertical illusion to increase foot clearance over an inconsistently taller stair-riser	PLOS ONE			English	Article							DYNAMIC STABILITY; OLDER-PEOPLE; DESCENT; STEP; AGE; NEGOTIATION; ADULTS	Introduction Stair falls can be caused by inconsistent stair dimensions. During ascent, inconsistently taller stair risers lead to reduced foot clearances as the inconsistency goes unnoticed. A stair horizontal-vertical illusion increases perceived riser heights and foot clearance and could offset reduced foot clearances over inconsistently taller risers, though this might impact other stair safety measures. Method Twelve participants (age: 22 (3) years) ascended a seven-step staircase under three conditions: i) all steps consistent in riser height (consistent), ii) a 1cm increase in step 5 riser height (inconsistent) and iii) a 1cm increase in step 5 riser height, superimposed with a stair horizontal-vertical illusion (illusion). Vertical foot clearance, foot overhang, and margins of stability were assessed over step 4, 5 and 6. Perceived riser height due to the illusion was determined through a computer perception test. A One-Way Repeated Measures ANOVA compared biomechanical variables between conditions. A One Sample t test compared perceived riser height to the true height. Results Over the inconsistent step 5, foot clearance reduced by 0.8cm compared to consistent. Illusion increased foot clearance by 1.1cm and decreased foot overhang by 4% compared to inconsistent. On step 4 the illusion led to more anterior instability compared to inconsistent. Illusion and inconsistent led to more mediolateral stability compared to consistent. The illusion increased perceived riser height by 12%. Discussion Foot clearance reductions over inconsistently taller risers can be offset by a stair horizontal-vertical illusion. Additional benefits included a safer foot overhang and unaffected stability over the inconsistent riser. Changes to step 4 stability might have resulted from leaning forward to look at the step 5 illusion. The stair horizontal-vertical illusion could be a practical solution for inconsistently taller stair risers, where a rebuild is usually the only solution.	[Skervin, Timmion K.; Thomas, Neil M.; Hollands, Mark A.; Maganaris, Constantinos N.; O'Brien, Thomas D.; Baltzopoulos, Vasilios; Foster, Richard J.] Liverpool John Moores Univ, Fac Sci, Sch Sport & Exercise Sci, Res Improve Stair Climbing Safety, Liverpool, Merseyside, England; [Schofield, Andrew J.] Aston Univ, Coll Hlth & Life Sci, Sch Psychol, Birmingham, W Midlands, England; [Schofield, Andrew J.] Aston Univ, Coll Hlth & Life Sci, Aston Res Ctr Hlth Ageing, Birmingham, W Midlands, England	Liverpool John Moores University; Aston University; Aston University	Foster, RJ (corresponding author), Liverpool John Moores Univ, Fac Sci, Sch Sport & Exercise Sci, Res Improve Stair Climbing Safety, Liverpool, Merseyside, England.	R.J.Foster@ljmu.ac.uk	Skervin, Timmion/HGF-0117-2022	Foster, Richard/0000-0003-2410-9839; Thomas, Neil/0000-0002-0789-9173; Baltzopoulos, Vasilios/0000-0003-2050-9501; Schofield, Andrew J./0000-0002-0589-4678; O'Brien, Thomas/0000-0003-2968-5173; , mark/0000-0002-4043-1839	Liverpool John Moores University (UK)	Liverpool John Moores University (UK)	TKS was awarded a PhD scholarship, funded by Liverpool John Moores University (UK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGLIOTI S, 1995, CURR BIOL, V5, P679, DOI 10.1016/S0960-9822(95)00133-3; Bach M, 1996, OPTOMETRY VISION SCI, V73, P49, DOI 10.1097/00006324-199601000-00008; Bosse I, 2012, HUM MOVEMENT SCI, V31, P1560, DOI 10.1016/j.humov.2012.05.003; BSI, 2010, COR PRACT DES STAI 1; Cohen J., 2009, PROF SAF, V54; Dempster W. J., 1955, WADCTR55159 WRIGHT P; Elliott DB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004577; Foster RJ, 2019, GAIT POSTURE, V73, P305, DOI 10.1016/j.gaitpost.2019.08.004; Foster RJ, 2016, ERGONOMICS, V59, P884, DOI 10.1080/00140139.2015.1105304; Foster RJ, 2015, INVEST OPHTH VIS SCI, V56, P2950, DOI 10.1167/iovs.14-16018; Foster RJ, 2014, EXP GERONTOL, V55, P152, DOI 10.1016/j.exger.2014.04.009; Francksen NC, 2020, APPL ERGON, V87, DOI 10.1016/j.apergo.2020.103131; Gov, 2010, PROT FALL COLL IMP N; Hamel KA, 2005, GAIT POSTURE, V21, P135, DOI 10.1016/j.gaitpost.2004.01.006; Heasley K, 2004, INVEST OPHTH VIS SCI, V45, P2122, DOI 10.1167/iovs.03-1199; Hof AL, 2005, J BIOMECH, V38, P1, DOI 10.1016/j.jbiomech.2004.03.025; Hsue BJ, 2014, ARCH PHYS MED REHAB, V95, P1860, DOI 10.1016/j.apmr.2014.05.001; Jacobs JV, 2016, GAIT POSTURE, V49, P159, DOI 10.1016/j.gaitpost.2016.06.030; Johnson D., 2012, TRIAL NEWS, V47, P11; Johnson DA, 2010, CONTEMPORARY ERGONOMICS AND HUMAN FACTORS 2010, P453; Kopiske KK, 2016, CORTEX, V79, P130, DOI 10.1016/j.cortex.2016.03.020; Kuo AD, 2005, EXERC SPORT SCI REV, V33, P88, DOI 10.1097/00003677-200504000-00006; Lakens D, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00863; Milner AD, 2008, NEUROPSYCHOLOGIA, V46, P774, DOI 10.1016/j.neuropsychologia.2007.10.005; Miyasike-daSilva V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044722; NHS Digital SCAT, 2020, HOSP ADM PAT CAR ACT; Novak AC, 2016, APPL ERGON, V52, P275, DOI 10.1016/j.apergo.2015.07.027; Rhea CK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011544; Roys MS, 2001, APPL ERGON, V32, P135, DOI 10.1016/S0003-6870(00)00049-1; SIMONEAU GG, 1991, J GERONTOL, V46, pM188, DOI 10.1093/geronj/46.6.M188; Skervin TK, 2021, EXP GERONTOL, V149, DOI 10.1016/j.exger.2021.111309; Startzell JK, 2000, J AM GERIATR SOC, V48, P567, DOI 10.1111/j.1532-5415.2000.tb05006.x; Wright M, 2008, CONTEMPORARY ERGONOMICS 2008, P632	33	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2021	16	9							e0257159	10.1371/journal.pone.0257159	http://dx.doi.org/10.1371/journal.pone.0257159			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	WG5RP	34520496	Green Accepted, gold, Green Published			2022-12-26	WOS:000707052100014
J	Deruelle, P; Couffignal, C; Sibiude, J; Vivanti, AJ; Anselem, O; Luton, D; Benachi, A; Mandelbrot, L; Vauloup-Fellous, C; Cordier, AG; Picone, O				Deruelle, Philippe; Couffignal, Camile; Sibiude, Jeanne; Vivanti, Alexandre J.; Anselem, Olivia; Luton, Dominique; Benachi, Alexandra; Mandelbrot, Laurent; Vauloup-Fellous, Christelle; Cordier, Anne Gael; Picone, Olivier			Prenatal care providers' perceptions of the SARS-Cov-2 vaccine for themselves and for pregnant women	PLOS ONE			English	Article							HESITANCY; KNOWLEDGE; ATTITUDES; INFLUENZA; RISK	Background Prenatal care providers will play an important role in the acceptance of SARS-Cov-2 vaccination for pregnant women. Objective To determine the perceptions of French prenatal care providers: midwives, general practitioners (GPs) and obstetricians and gynaecologists (Ob-Gyn) regarding SARS-CoV-2 vaccination during pregnancy. Study design An anonymous online survey was sent to members of French professional societies representing prenatal practitioners. The participants were asked to answer questions on their characteristics and give their opinions of the SARS-CoV-2 vaccine for themselves and women who are pregnant or willing to become pregnant. Results Access to the survey was opened from January 11th, 2021, to March 1st, 2021. A total of 1,416 responses were collected from 749 Ob-Gyn, 598 midwives and 69 GPs. Most respondents (86.7% overall, 90.4% for Ob-GYN, 81.1% for GPs and 80.1% for midwives) agreed to receive the SARS-CoV-2 vaccine. Vaccination against SARS-CoV-2 would be offered to pregnant women by 49.4% 95%CI [48.1-50.8] of the participants. Midwives were less likely to recommend vaccination than GP and Ob-Gyn (37.5%, 50.7% and 58.8%, respectively). The multinomial logistic regression revealed that being an obstetrician, working in a group, usually offering a flu vaccine and wanting to be vaccinated against SARS-CoV-2 were positively associated with considering pregnant women for SARS-CoV-2 vaccination. Conclusion Most French prenatal healthcare providers are favourable towards vaccinating pregnant women, but a large minority express reservation. More evidence on safety and involvement by professional organisations will be important to encourage the access of pregnant women to vaccination against SARS-CoV-2.	[Deruelle, Philippe] Hop Univ Strasbourg, Pole Gynecol Obstet, Strasbourg, France; [Deruelle, Philippe; Sibiude, Jeanne; Vivanti, Alexandre J.; Anselem, Olivia; Luton, Dominique; Benachi, Alexandra; Mandelbrot, Laurent; Vauloup-Fellous, Christelle; Cordier, Anne Gael; Picone, Olivier] Grp Rech Sur Infect Pendant Grossesse GRIG, Velizy Villacoublay, France; [Couffignal, Camile] Hop Bichat Claude Bernard, AP HP, Clin Res Biostat & Epidemiol Dept, Paris, France; [Couffignal, Camile; Sibiude, Jeanne; Mandelbrot, Laurent; Picone, Olivier] Univ Paris, IAME, INSERM, Paris, France; [Sibiude, Jeanne; Mandelbrot, Laurent; Picone, Olivier] Hop Louis Mourier, Assistance Publ Hop Paris, Serv Gynecol Obstet, Colombes, France; [Vivanti, Alexandre J.; Benachi, Alexandra; Cordier, Anne Gael] Univ Paris Saclay, Hop Antoine Beclere, AP HP, Clamart, France; [Anselem, Olivia] Ctr Univ Paris, Hop Cochin, AP HP, Maternite Port Royal, Paris, France; [Luton, Dominique] Paris Univ, Bichat Hosp, Assistance Publ Hop Paris, FHU Prematur,Serv Gynecol Obstet, Paris, France; [Luton, Dominique] Inst Imagine, INSERM U1016, Paris, France; [Vauloup-Fellous, Christelle] Univ Paris Saclay, Dept Virol, Hop Paul Brousse, AP HP, Villejuif, France; [Picone, Olivier] FHU PREMA, Paris, France	CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Louis-Mourier - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Antoine-Beclere - APHP; UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Paul-Brousse - APHP; UDICE-French Research Universities; Universite Paris Saclay	Deruelle, P (corresponding author), Hop Univ Strasbourg, Pole Gynecol Obstet, Strasbourg, France.	philippe.deruelle@chru-strasbourg.fr	Vivanti, Alexandre/AAN-1693-2020; Christelle, Vauloup/AAI-9221-2021; Sibiude, Jeanne/GRS-5411-2022; Vauloup-Fellous, Christelle/AAE-5567-2021; Mandelbrot, Laurent/AAD-3554-2019; Deruelle, Philippe/O-3689-2016	Vivanti, Alexandre/0000-0002-4921-0047; Mandelbrot, Laurent/0000-0002-5883-7597; Deruelle, Philippe/0000-0003-4273-6553				Abrams P, 2002, AM J OBSTET GYNECOL, V187, P126, DOI 10.1067/mob.2002.125704; [Anonymous], Les Enquetes Nationales Perinatales[:en]French National Perinatal Surveys; Attwell K, 2018, VACCINE, V36, P6531, DOI 10.1016/j.vaccine.2018.02.028; Badr DA, 2020, AM J OBSTET GYNECOL, V223, P764, DOI 10.1016/j.ajog.2020.07.045; Black S, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001738; Carbone L, 2021, AM J OBST GYNEC MFM, V3, DOI 10.1016/j.ajogmf.2021.100352; Di Mascio D, 2020, AM J OBST GYNEC MFM, V2, DOI 10.1016/j.ajogmf.2020.100107; Dolan SM, 2012, J AM PHARM ASSOC, V52, P43, DOI 10.1331/JAPhA.2012.10141; Dube E, 2020, HUM VACC IMMUNOTHER, V16, P2789, DOI 10.1080/21645515.2020.1735225; Gonik B, 2000, OBSTET GYNECOL, V96, P81, DOI 10.1016/S0029-7844(00)00860-7; Gray KJ, 2021, AM J OBSTET GYNECOL, V225, DOI 10.1016/j.ajog.2021.03.023; Huntley BJF, 2020, OBSTET GYNECOL, V136, P303, DOI 10.1097/AOG.0000000000004010; Karafillakis E, 2016, VACCINE, V34, P5013, DOI 10.1016/j.vaccine.2016.08.029; Karlsson LC, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0224330; Kreps S, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.25594; Le Roux B., 2010, MULTIPLE CORRES ANAL; Ledford H, 2020, NATURE, V588, P205, DOI 10.1038/d41586-020-03441-8; Lerner AM, 2020, JAMA-J AM MED ASSOC, V324, P1935, DOI 10.1001/jama.2020.21946; Logunov DY, 2020, LANCET, V396, P887, DOI 10.1016/S0140-6736(20)31866-3; Lutz CS, 2018, VACCINE, V36, P7445, DOI 10.1016/j.vaccine.2018.10.046; Lyu W, 2020, HEALTH AFFAIR, V39, P1419, DOI 10.1377/hlthaff.2020.00818; Vilca LM, 2018, MATERN CHILD HLTH J, V22, P1016, DOI 10.1007/s10995-018-2481-6; Martinez-Portilla RJ, 2021, ULTRASOUND OBST GYN, V57, P224, DOI 10.1002/uog.23575; Maykin MM, 2021, VACCINE, V39, P171, DOI 10.1016/j.vaccine.2020.12.007; Meyer MN, 2021, JAMA NETW OPEN, V4, DOI 10.1001/jamanetworkopen.2021.5344; Nichol KL, 2001, ARCH INTERN MED, V161, P2702, DOI 10.1001/archinte.161.22.2702; Paterson P, 2016, VACCINE, V34, P6700, DOI 10.1016/j.vaccine.2016.10.042; Poland GA, 2003, AM J PREV MED, V25, P144, DOI 10.1016/S0749-3797(03)00120-X; Power ML, 2009, AM J PREV MED, V37, P231, DOI 10.1016/j.amepre.2009.05.019; Ramasamy MN, 2020, LANCET, V396, P1979, DOI 10.1016/S0140-6736(20)32466-1; Rasmussen SA, 2021, JAMA-J AM MED ASSOC, V325, P1099, DOI 10.1001/jama.2021.1683; Skjefte M, 2021, EUR J EPIDEMIOL, V36, P197, DOI 10.1007/s10654-021-00728-6; Voysey M, 2021, LANCET, V397, P99, DOI 10.1016/S0140-6736(20)32661-1; Wilcox CR, 2019, PEDIATR INFECT DIS J, V38, P944, DOI 10.1097/INF.0000000000002384; Williams JL, 2006, MATERN CHILD HLTH J, V10, pS67, DOI 10.1007/s10995-006-0088-9; Wilson R, 2020, VACCINE, V38, P1144, DOI 10.1016/j.vaccine.2019.11.018; Wilson RJ, 2015, VACCINE, V33, P6420, DOI 10.1016/j.vaccine.2015.08.046; Zhu FC, 2020, LANCET, V396, P479, DOI 10.1016/S0140-6736(20)31605-6; Zhu FC, 2020, LANCET, V395, P1845, DOI 10.1016/S0140-6736(20)31208-3	40	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2021	16	9							e0256080	10.1371/journal.pone.0256080	http://dx.doi.org/10.1371/journal.pone.0256080			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	WG6OR	34516551	gold, Green Published			2022-12-26	WOS:000707114200006
J	Di Giulio, S; Colicchia, V; Pastorino, F; Pedretti, F; Fabretti, F; di Robilant, VN; Ramponi, V; Scafetta, G; Moretti, M; Licursi, V; Belardinilli, F; Peruzzi, G; Infante, P; Goffredo, BM; Coppa, A; Canettieri, G; Bartolazzi, A; Ponzoni, M; Giannini, G; Petroni, M				Di Giulio, Stefano; Colicchia, Valeria; Pastorino, Fabio; Pedretti, Flaminia; Fabretti, Francesca; di Robilant, Vittoria Nicolis; Ramponi, Valentina; Scafetta, Giorgia; Moretti, Marta; Licursi, Valerio; Belardinilli, Francesca; Peruzzi, Giovanna; Infante, Paola; Goffredo, Bianca Maria; Coppa, Anna; Canettieri, Gianluca; Bartolazzi, Armando; Ponzoni, Mirco; Giannini, Giuseppe; Petroni, Marialaura			A combination of PARP and CHK1 inhibitors efficiently antagonizes MYCN-driven tumors	ONCOGENE			English	Article							N-MYC; HUMAN NEUROBLASTOMA; REPLICATION STRESS; EXPRESSION; CELLS; PROGRESSION; SENSITIVITY; DELETION; ONCOGENE; HMGI(Y)	MYCN drives aggressive behavior and refractoriness to chemotherapy, in several tumors. Since MYCN inactivation in clinical settings is not achievable, alternative vulnerabilities of MYCN-driven tumors need to be explored to identify more effective and less toxic therapies. We previously demonstrated that PARP inhibitors enhance MYCN-induced replication stress and promote mitotic catastrophe, counteracted by CHK1. Here, we showed that PARP and CHK1 inhibitors synergized to induce death in neuroblastoma cells and in primary cultures of SHH-dependent medulloblastoma, their combination being more effective in MYCN amplified and MYCN overexpressing cells compared to MYCN non-amplified cells. Although the MYCN amplified IMR-32 cell line carrying the p.Val2716Ala ATM mutation showed the highest sensitivity to the drug combination, this was not related to ATM status, as indicated by CRISPR/Cas9-based correction of the mutation. Suboptimal doses of the CHK1 inhibitor MK-8776 plus the PARP inhibitor olaparib led to a MYCN-dependent accumulation of DNA damage and cell death in vitro and significantly reduced the growth of four in vivo models of MYCN-driven tumors, without major toxicities. Our data highlight the combination of PARP and CHK1 inhibitors as a new potential chemo-free strategy to treat MYCN-driven tumors, which might be promptly translated into clinical trials.	[Di Giulio, Stefano; Colicchia, Valeria; Pedretti, Flaminia; Fabretti, Francesca; di Robilant, Vittoria Nicolis; Ramponi, Valentina; Belardinilli, Francesca; Canettieri, Gianluca; Giannini, Giuseppe; Petroni, Marialaura] Univ Roma La Sapienza, Dept Mol Med, I-00161 Rome, Italy; [Pastorino, Fabio; Ponzoni, Mirco] IRCCS Ist Giannina Gaslini, Lab Expt Therapies Oncol, I-16147 Genoa, Italy; [Scafetta, Giorgia; Bartolazzi, Armando] St Andrea Univ Hosp, Pathol Res Lab, I-00189 Rome, Italy; [Moretti, Marta; Coppa, Anna] Univ Roma La Sapienza, Dept Expt Med, I-00161 Rome, Italy; [Licursi, Valerio] Univ Roma La Sapienza, Dept Biol & Biotechnol Charles Darwin, I-00185 Rome, Italy; [Peruzzi, Giovanna; Infante, Paola] Fdn Ist Italiano Tecnol IIT, Ctr Life Nano & Neuro Sci, Rome, Italy; [Goffredo, Bianca Maria] Osped Pediat Bambino Gesu, Metab Pathol Lab, I-00165 Rome, Italy; [Canettieri, Gianluca; Giannini, Giuseppe] Ist Pasteur Fdn Cenci Bolognetti, I-00161 Rome, Italy; [Colicchia, Valeria] Univ Tor Vergata, Dept Biol, I-00173 Rome, Italy; [Pedretti, Flaminia] Vail dHebron Inst Oncol VHIO, Vail dHebron Res Inst VHIR, Expt Therapeut Grp, Barcelona, Spain; [Ramponi, Valentina] Barcelona Inst Sci & Technol BIST, Inst Res Biomed IRB Barcelona, Cellular Plast & Dis Grp, Barcelona 08028, Spain	Sapienza University Rome; University of Genoa; IRCCS Istituto Giannina Gaslini; Sapienza University Rome; Azienda Ospedaliera Sant'Andrea; Sapienza University Rome; Sapienza University Rome; Istituto Italiano di Tecnologia - IIT; IRCCS Bambino Gesu; Fondazione Cenci Bolognetti; University of Rome Tor Vergata; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); Vall d'Hebron Institut d'Oncologia (VHIO); Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona	Giannini, G (corresponding author), Univ Roma La Sapienza, Dept Mol Med, I-00161 Rome, Italy.; Giannini, G (corresponding author), Ist Pasteur Fdn Cenci Bolognetti, I-00161 Rome, Italy.	giuseppe.giannini@uniroma1.it	Scafetta, Giorgia/AAB-9787-2022; Giannini, Giuseppe/B-5672-2013	Peruzzi, Giovanna/0000-0002-6517-9107; Giannini, Giuseppe/0000-0003-0299-4056; Belardinilli, Francesca/0000-0003-4966-7044; Infante, Paola/0000-0003-0682-3916; CANETTIERI, Gianluca/0000-0001-6694-2613	Italian Ministry of Education, Universities and Research-Dipartimenti di Eccellenza [L. 232/2016]; Associazione Italiana per la Ricerca sul Cancro (AIRC) [IG17734, IG24329]; Italian Ministry of University and Research, PRIN projects; Istituto Pasteur-Fondazione Cenci Bolognetti; fondi Ricerca Ateneo La Sapienza; AIRC [IG17575]; AFM-Telethon grant [21025]; PhD Programme in Tecnologie Biomediche in Medicina Clinica, University La Sapienza; Fondazione Umberto Veronesi	Italian Ministry of Education, Universities and Research-Dipartimenti di Eccellenza(Ministry of Education, Universities and Research (MIUR)); Associazione Italiana per la Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); Italian Ministry of University and Research, PRIN projects; Istituto Pasteur-Fondazione Cenci Bolognetti(Istituto Pasteur Italia Fondazione Cenci Bolognetti); fondi Ricerca Ateneo La Sapienza; AIRC(Fondazione AIRC per la ricerca sul cancro); AFM-Telethon grant; PhD Programme in Tecnologie Biomediche in Medicina Clinica, University La Sapienza; Fondazione Umberto Veronesi(Fondazione Umberto Veronesi)	We are grateful to Michele Cilli and Laura Emionite for technical supports in the animal facility and Antonio Daga for the luciferase transfection of IMR-32 cells. We are also grateful to Simone De Panfilis (CLN2S@Sapienza Imaging Facility of the Istituto Italiano di Tecnologia, Rome, Italy) for the acquisition of confocal microscopy data. This work was supported by: Italian Ministry of Education, Universities and Research-Dipartimenti di Eccellenza-L. 232/2016; Associazione Italiana per la Ricerca sul Cancro (AIRC) grant IG17734 and IG24329, Italian Ministry of University and Research, PRIN projects, Istituto Pasteur-Fondazione Cenci Bolognetti and fondi Ricerca Ateneo La Sapienza (to GG); AIRC grant IG17575, AFM-Telethon grant #21025, and Istituto Pasteur-Fondazione Cenci Bolognetti (to GC). FF and FB were recipients of fellowships from the PhD Programme in Tecnologie Biomediche in Medicina Clinica, University La Sapienza and Fondazione Umberto Veronesi, respectively.	Althoff K, 2015, ONCOGENE, V34, P3357, DOI 10.1038/onc.2014.269; Bendell JC, 2020, INVEST NEW DRUG, V38, P1145, DOI 10.1007/s10637-019-00873-6; Bryant HE, 2005, NATURE, V434, P913, DOI 10.1038/nature03443; Cash T, 2021, PEDIATR BLOOD CANCER, V68, DOI 10.1002/pbc.29065; Chayka O, 2015, J BIOL CHEM, V290, P2198, DOI 10.1074/jbc.M114.624056; Chesler L, 2011, SEMIN CANCER BIOL, V21, P245, DOI 10.1016/j.semcancer.2011.09.011; Cole KA, 2011, P NATL ACAD SCI USA, V108, P3336, DOI 10.1073/pnas.1012351108; Colicchia V, 2017, ONCOGENE, V36, P4682, DOI 10.1038/onc.2017.40; Cossu I, 2015, BIOMATERIALS, V68, P89, DOI 10.1016/j.biomaterials.2015.07.054; Daud AI, 2015, J CLIN ONCOL, V33, P1060, DOI 10.1200/JCO.2014.57.5027; Demuth I, 2011, NEUROGENETICS, V12, P273, DOI 10.1007/s10048-011-0299-0; Farmer H, 2005, NATURE, V434, P917, DOI 10.1038/nature03445; Feng FY, 2015, MOL CELL, V58, P925, DOI 10.1016/j.molcel.2015.04.016; Forment JV, 2018, PHARMACOL THERAPEUT, V188, P155, DOI 10.1016/j.pharmthera.2018.03.005; Gaillard H, 2015, NAT REV CANCER, V15, P276, DOI 10.1038/nrc3916; Giannini G, 1999, CANCER RES, V59, P2484; Giannini G, 2000, BRIT J CANCER, V83, P1503, DOI 10.1054/bjoc.2000.1494; Gu L, 2015, EBIOMEDICINE, V2, P1923, DOI 10.1016/j.ebiom.2015.11.016; Hatton BA, 2006, CANCER RES, V66, P8655, DOI 10.1158/0008-5472.CAN-06-1621; Hou HG, 2015, INT J CANCER, V136, P1688, DOI 10.1002/ijc.29132; Judware R, 1995, ONCOGENE, V11, P2599; Kamentsky L, 2011, BIOINFORMATICS, V27, P1179, DOI 10.1093/bioinformatics/btr095; Lee EK, 2019, TRENDS CANCER, V5, P524, DOI 10.1016/j.trecan.2019.06.004; Lowery CD, 2019, CLIN CANCER RES, V25, P2278, DOI 10.1158/1078-0432.CCR-18-2728; Lowery CD, 2017, CLIN CANCER RES, V23, P4354, DOI 10.1158/1078-0432.CCR-16-2876; Lupo B, 2014, BBA-REV CANCER, V1846, P201, DOI 10.1016/j.bbcan.2014.07.004; Lutz W, 1996, ONCOGENE, V13, P803; Mandriota SJ, 2015, ONCOTARGET, V6, P18558, DOI 10.18632/oncotarget.4061; Matthay KK, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.78; Murai J, 2012, CANCER RES, V72, P5588, DOI 10.1158/0008-5472.CAN-12-2753; Murga M, 2011, NAT STRUCT MOL BIOL, V18, P1331, DOI 10.1038/nsmb.2189; Olsen RR, 2017, ONCOGENE, V36, P5075, DOI 10.1038/onc.2017.128; Paquet D, 2016, NATURE, V533, P125, DOI 10.1038/nature17664; Pastorino F, 2003, CANCER RES, V63, P7400; Petroni M, 2016, CELL DEATH DIFFER, V23, P197, DOI 10.1038/cdd.2015.81; Petroni M, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-56057-y; Petroni M, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0924-z; Petroni M, 2016, MOL CELL ONCOL, V3, DOI 10.1080/23723556.2015.1079673; Petroni M, 2012, FRONT ONCOL, V2, DOI 10.3389/fonc.2012.00141; Petroni M, 2011, MOL CANCER RES, V9, P67, DOI 10.1158/1541-7786.MCR-10-0227; Rickman DS, 2018, CANCER DISCOV, V8, P150, DOI 10.1158/2159-8290.CD-17-0273; Rundle S, 2017, CANCERS, V9, DOI 10.3390/cancers9050041; Russell MR, 2013, CANCER RES, V73, P776, DOI 10.1158/0008-5472.CAN-12-2669; Sanmartin E, 2017, CLIN CANCER RES, V23, P6875, DOI 10.1158/1078-0432.CCR-17-0593; Scott SP, 2002, P NATL ACAD SCI USA, V99, P925, DOI 10.1073/pnas.012329699; Sonnenblick A, 2015, NAT REV CLIN ONCOL, V12, P27, DOI 10.1038/nrclinonc.2014.163; Southgate HED, 2020, FRONT ONCOL, V10, DOI 10.3389/fonc.2020.00371; Swartling FJ, 2010, GENE DEV, V24, P1059, DOI 10.1101/gad.1907510; Takagi M, 2019, BMC PEDIATR, V19, DOI 10.1186/s12887-019-1409-7; Takagi M, 2017, JNCI-J NATL CANCER I, V109, DOI 10.1093/.inci/djx062; Ubhi T, 2019, CANCER RES, V79, P1730, DOI 10.1158/0008-5472.CAN-18-3631; Valentijn LJ, 2012, P NATL ACAD SCI USA, V109, P19190, DOI 10.1073/pnas.1208215109; Wehler T, 2017, LUNG CANCER, V108, P212, DOI 10.1016/j.lungcan.2017.03.001; Weiss WA, 1997, EMBO J, V16, P2985, DOI 10.1093/emboj/16.11.2985; Whitfield JR, 2017, FRONT CELL DEV BIOL, V5, DOI 10.3389/fcell.2017.00010; Yang ZJ, 2008, CANCER CELL, V14, P135, DOI 10.1016/j.ccr.2008.07.003; Yap Timothy A, 2019, Am Soc Clin Oncol Educ Book, V39, P185, DOI 10.1200/EDBK_238473	57	7	7	1	2	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 28	2021	40	43					6143	6152		10.1038/s41388-021-02003-0	http://dx.doi.org/10.1038/s41388-021-02003-0		SEP 2021	10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	WO5HW	34508175	hybrid, Green Published			2022-12-26	WOS:000694774500002
J	Baccini, M; Cereda, G				Baccini, Michela; Cereda, Giulia			Screening plans for SARS-CoV-2 based on sampling and rotation: An example in a European school setting	PLOS ONE			English	Article							VIRAL LOAD; COVID-19	Screening plans for prevention and containment of SARS-CoV-2 infection should take into account the epidemic context, the fact that undetected infected individuals may transmit the disease and that the infection spreads through outbreaks, creating clusters in the population. In this paper, we compare through simulations the performance of six screening plans based on poorly sensitive individual tests, in detecting infection outbreaks at the level of single classes in a typical European school context. The performance evaluation is done by simulating different epidemic dynamics within the class during the four weeks following the day of the initial infection. The plans have different costs in terms of number of individual tests required for the screening and are based on recurrent evaluations on all students or subgroups of students in rotation. Especially in scenarios where the rate of contagion is high, at an equal cost, testing half of the class in rotation every week appears to be better in terms of sensitivity than testing all students every two weeks. Similarly, testing one-fourth of the students every week is comparable with testing all students every two weeks, despite the first one is a much cheaper strategy. In conclusion, we show that in the presence of natural clusters in the population, testing subgroups of individuals belonging to the same cluster in rotation may have a better performance than testing all the individuals less frequently. The proposed simulations approach can be extended to evaluate more complex screening plans than those presented in the paper.	[Baccini, Michela; Cereda, Giulia] Univ Florence, Dept Stat, Comp Sci, Applicat DISIA, Florence, Italy	University of Florence	Baccini, M (corresponding author), Univ Florence, Dept Stat, Comp Sci, Applicat DISIA, Florence, Italy.	michela.baccini@unifi.it			Agenzia Regionale di Sanita della Toscana; Department of Statistics, Computer Science, Applications, University of Florence [ARS -REP 2321/2020]	Agenzia Regionale di Sanita della Toscana; Department of Statistics, Computer Science, Applications, University of Florence	This work was conducted within a Research Agreeement between Agenzia Regionale di Sanita della Toscana and Department of Statistics, Computer Science, Applications, University of Florence (ARS -REP 2321/2020 "Epidemia da SARS-CoV-2 -strumenti di analisi in grado di modellare e prevedere le dinamiche del contagio e la loro ricaduta sul servizio sanitario", Responsible: MB). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2020, LANCET, V396, P1607, DOI 10.1016/S0140-6736(20)32472-7; Auger KA, 2020, JAMA-J AM MED ASSOC, V324, P859, DOI 10.1001/jama.2020.14348; Baccini M, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0251589; Baccini M, 2020, EPIDEMIOL PREV, V44, P193, DOI 10.19191/EP20.5-6.S2.118; Brauer F, 2008, LECT NOTES MATH, V1945, P19; Burki T, 2021, LANCET, V397, P462, DOI 10.1016/S0140-6736(21)00298-1; CDC, 2021, CDC GUID EXP SCREEN; Cheng MP, 2020, ANN INTERN MED, V172, P726, DOI 10.7326/M20-1301; Dibner KA, 2020, JAMA-J AM MED ASSOC, V324, P833, DOI 10.1001/jama.2020.14745; Donohue JM, 2020, JAMA-J AM MED ASSOC, V324, P845, DOI 10.1001/jama.2020.13092; Gandini S, 2021, LANCET REG HEALTH-EU, V5, DOI 10.1016/j.lanepe.2021.100092; Griffin DWJ, 2020, INTERN MED J, V50, P1594, DOI 10.1111/imj.15083; Hogan CA, 2020, JAMA-J AM MED ASSOC, V323, P1967, DOI 10.1001/jama.2020.5445; Honein MA, 2021, JAMA-J AM MED ASSOC, V325, P823, DOI 10.1001/jama.2021.0374; Inglesby TV, 2020, JAMA-J AM MED ASSOC, V323, P2186, DOI 10.1001/jama.2020.7878; Lordan R, 2020, SCIENCE, V369, P1146, DOI 10.1126/science.abe5765; Ludvigsson JF, 2020, ACTA PAEDIATR, V109, P1525, DOI 10.1111/apa.15371; Lyng GD, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0248783; Majra D, 2021, J INFECTION, V82, P36, DOI 10.1016/j.jinf.2020.11.021; Mohapatra RK, 2021, OPEN MED-WARSAW, V16, P491, DOI 10.1515/med-2021-0266; Nguyen NT, 2019, J TRANSL MED, V17, DOI 10.1186/s12967-019-1992-2; OECD, 2020, TERRITORIAL IMPACT C, DOI DOI 10.1787/0CCAFA0B-EN; Organisation for Economic Co-operation and Development (OECD), 2020, ED GLANC 2020 OECD I, DOI [10.1787/69096873-en, DOI 10.1787/69096873-EN]; Paltiel AD, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.16818; Panovska-Griffiths J, 2020, LANCET CHILD ADOLESC, V4, P817, DOI 10.1016/S2352-4642(20)30250-9; Regen F, 2020, INT J INFECT DIS, V100, P324, DOI 10.1016/j.ijid.2020.08.063; Rewley J, 2020, EPIDEMIOLOGY, V31, P832, DOI 10.1097/EDE.0000000000001244; Walsh KA, 2020, J INFECTION, V81, P357, DOI 10.1016/j.jinf.2020.06.067; Wells CR, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-020-20742-8	29	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2021	16	9							e0257099	10.1371/journal.pone.0257099	http://dx.doi.org/10.1371/journal.pone.0257099			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XM9EM	34506536	Green Published, gold			2022-12-26	WOS:000729120700046
J	Bakebillah, M; Billah, MA; Wubishet, BL; Nuruzzaman, M				Bakebillah, Md.; Billah, Md. Arif; Wubishet, Befikadu L.; Khan, Md. Nuruzzaman			Community's misconception about COVID-19 and its associated factors in Satkhira, Bangladesh: A cross-sectional study	PLOS ONE			English	Article							HEALTH; KNOWLEDGE; ATTITUDE	Introduction Misconception related to coronavirus disease-2019 (COVID-19) have been spread out broadly and the the World Health Organization declared these as a major challenge to fight against the pandemic. This study aimed to assess COVID-19 related misconception among rural people in Bangladesh and associated socio-demographic and media related factors. Methods Multistage sampling method was used to collect data (n = 210) from three unions of Satkhira District, Bangladesh. The dependent variable was the presence of COVID-19 related misconception (Yes, No) which was generated based on respondents' responses to a set of six questions on various types of misconception. Exposure variables were respondents' socio-demographic characteristics, mass media and social media exposure. Descriptive statistics were used to describe the characteristics of the respondents. Bivariate and multivariate logistic regression models were used to determine the factors associated with COVID-19 misconception. Results More than half of the study respondents had one or more COVID-19 related misconception. Over 50% of the total respondents considered this disease as a punishment from God. Besides, many of the respondents reported that they do not think the virus causing COVID-19 is dangerous (59%) and it is a disease (19%). Around 7% reported they believe the virus is the part of a virus war (7.2%). The bivariate analysis found the presence of socio-demographic factors of the respondents, as well as the factors related to social and mass media, were significantly associated with the COVID-19's misconception. However, once all factors considered together in the multivariate model, misconception were found to be lower among secondary (AOR, 0.33, 95% CI: 0.13-0.84) and tertiary (AOR, 0.29, 95% CI: 0.09-0.92) educated respondents compared to the respondents with primary education. Conclusion This study obtained a very higher percentage of misconception about the COVID-19 among the respondents of Satkhira district in Bangladesh. This could be a potential challenge to fight against this pandemic which is now ongoing. Prioritizing mass and social media to disseminate evidence-based information as well as educate people about this disease are necessary.	[Bakebillah, Md.] Jatiya Kabi Kazi Nazrul Islam Univ, Fac Social Sci, Dept Folklore, Trishal, Mymensingh, Bangladesh; [Billah, Md. Arif] Univ Malaysia Terengganu, Fac Business Econ & Social Dev, Dept Psychol & Counselling, Terengganu, Malaysia; [Wubishet, Befikadu L.] Univ Queensland, Hlth Serv Res Ctr, Fac Med, Brisbane, Qld, Australia; [Khan, Md. Nuruzzaman] Jatiya Kabi Kazi Najrul Islam Univ, Fac Social Sci, Dept Populat Sci, Trishal, Mymensingh, Bangladesh	Universiti Malaysia Terengganu; University of Queensland	Nuruzzaman, M (corresponding author), Jatiya Kabi Kazi Najrul Islam Univ, Fac Social Sci, Dept Populat Sci, Trishal, Mymensingh, Bangladesh.	mdnuruzzaman.khan@uon.edu.au	Billah, Md Arif/AAR-2267-2021	Billah, Md Arif/0000-0002-0235-5935; Khan, Md Nuruzzaman/0000-0002-4550-4363				Abuhammad S, 2021, INT J CLIN PRACT, V75, DOI 10.1111/ijcp.13671; Adongo PB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149627; Akalu Y, 2020, INFECT DRUG RESIST, V13, P1949, DOI 10.2147/IDR.S258736; Aminu Julius A, 2020, J INFECT DIS EPIDEMI, V6, DOI [10.23937/2474-3658/1510156, DOI 10.23937/2474-3658/1510156]; Anikwe CC, 2020, INT J GYNECOL OBSTET, V151, P197, DOI 10.1002/ijgo.13293; [Anonymous], EARL HERD IMM COVID; [Anonymous], 2020, FRONT PUBLIC HEALTH, V8, P357, DOI [10.3389/fpubh.2020.00357, DOI 10.3389/FPUBH.2020.00357, DOI 10.3389/FPUBH.2020.00008]; Anwar S, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00154; Baig M, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0243526; Bates BR, 2020, J COMMUN HEALTH, V45, P1158, DOI 10.1007/s10900-020-00916-7; BODRUDDOZA M, 2020, FRONT PUBLIC HEALTH, P8, DOI DOI 10.3389/FPUBH.2020.00008; Brooks RA, 2018, INT J STD AIDS, V29, P375, DOI 10.1177/0956462417727691; Dahal P, 2020, BBC NEWS 1002; Etemesi AK, 2020, VOICES PANDEMIC POLY, VXLII, P27; Ferdous MZ, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0239254; Gao JL, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0231924; GeneviThve, 2020, COVID 19 IS MESSAGE; Hasan MT, 2020, MINERVA PSICH, V61, P184, DOI 10.23736/S0391-1772.20.02088-9; Honarvar B, 2020, INT J PUBLIC HEALTH, V65, P731, DOI 10.1007/s00038-020-01406-2; Imhoff R, 2020, SOC PSYCHOL PERS SCI, V11, P1110, DOI 10.1177/1948550620934692; Iradukunda PG, 2021, J COMMUN HEALTH, V46, P245, DOI 10.1007/s10900-020-00938-1; Isah MB, 2020, CORONAVIRUS DISEASE, DOI [10.1101/2020.06.11.20127936, DOI 10.1101/2020.06.11.20127936]; Islam AKMN, 2020, TECHNOL FORECAST SOC, V159, DOI 10.1016/j.techfore.2020.120201; Junior DPL., 2020, FORENSIC RES CRIMINO, V8, P205, DOI [10.15406/frcij.2020.08.00329, DOI 10.15406/FRCIJ.2020.08.00329]; Karikari AB., 2020, COVID 19 KNOWLEDGE P, DOI [10.20944/preprints202008.0060.v1, DOI 10.20944/PREPRINTS202008.0060.V1]; Kaszeta D., 2020, WASH POST; Kaur H., 2020, THE CNN; Khalid Z, 2020, PAK J ZOOL, V52, P2377, DOI 10.17582/journal.pjz/20200608144416; Linkous, 2014, FEDERATION AM SCI; Mekonnen HS, 2020, TROP MED HEALTH, V48, DOI 10.1186/s41182-020-00279-8; Muniyappa R, 2020, AM J PHYSIOL-ENDOC M, V318, pE736, DOI 10.1152/ajpendo.00124.2020; Nie JB, 2020, J BIOETHIC INQ, V17, P567, DOI 10.1007/s11673-020-10025-8; Nirenberg D., 2020, FAITH SHAPES FEELING; Ranscombe P, 2020, LANCET INFECT DIS, V20, P545, DOI 10.1016/S1473-3099(20)30301-7; Rashid SF, 2001, TROP MED INT HEALTH, V6, P249, DOI 10.1046/j.1365-3156.2001.00702.x; Reuters, 2020, ISL STAT CALLS COVID; Salman M, 2020, J INFECT DEV COUNTR, V14, P707, DOI 10.3855/jidc.12878; Shammi M, 2020, HELIYON, V6, DOI 10.1016/j.heliyon.2020.e04063; Soumya Roy, 2020, Indian Journal of Medical Sciences, V72, P5, DOI 10.25259/IJMS_26_2020; Stewart M K, 1994, Med Anthropol, V15, P377; Tamang N, 2020, BMC PUBLIC HEALTH, V20, DOI 10.1186/s12889-020-10025-8; WHO, 2020, IMM PUBL MIS; Worldometer, COVID LIV UPD 179 41; Xiong JQ, 2020, J AFFECT DISORDERS, V277, P55, DOI 10.1016/j.jad.2020.08.001	44	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2021	16	9							e0257410	10.1371/journal.pone.0257410	http://dx.doi.org/10.1371/journal.pone.0257410			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XM9EM	34506614	Green Published, gold			2022-12-26	WOS:000729120700049
J	Gasparutto, X; Gueugnon, M; Laroche, D; Martz, P; Hannouche, D; Armand, S				Gasparutto, Xavier; Gueugnon, Mathieu; Laroche, Davy; Martz, Pierre; Hannouche, Didier; Armand, Stephane			Which functional tasks present the largest deficits for patients with total hip arthroplasty before and six months after surgery? A study of the timed up-and-go test phases	PLOS ONE			English	Article							PERFORMANCE-BASED TESTS; GAIT ANALYSIS; OSTEOARTHRITIS; WALKING	Six to eight months after total hip arthroplasty, patients only attain 80% of the functional level of control groups. Understanding which functional tasks are most affected could help reduce this deficit by guiding rehabilitation towards them. The timed up-and-go test bundles multiple tasks together in one test and is a good indicator of a patient's overall level of function. Previously, biomechanical analysis of its phases was used to identify specific functional deficits in pathological populations. To the best of our knowledge, this analysis has never been performed in patients who have undergone total hip arthroplasty. Seventy-one total hip arthroplasty patients performed an instrumented timed up-and-go test in a gait laboratory before and six months after surgery; fifty-two controls performed it only once. Biomechanical features were selected to analyse the test's four phases (sit-to-stand, walking, turning, turn-to-sit) and mean differences between groups were evaluated for each phase. On average, six months after surgery, patients' overall test time rose to 80% of the mean of the control group. The walking phase was revealed as the main deficiency before and after surgery (-41 +/- 47% and -22 +/- 32% slower, respectively). High standard deviations indicated that variability between patients was high. On average, patients showed improved results in every phase of the timed up-and-go test six months after surgery, but residual deficits in function differed between those phases. This simple test could be appropriate for quantifying patient-specific deficits in function and hence guiding and monitoring post-operative rehabilitation in clinical settings.	[Gasparutto, Xavier; Armand, Stephane] Geneva Univ Hosp, Kinesiol Lab, Geneva, Switzerland; [Gasparutto, Xavier; Hannouche, Didier; Armand, Stephane] Univ Geneva, Geneva, Switzerland; [Gueugnon, Mathieu; Laroche, Davy] Univ Hosp Dijon Burgundy, Plateforme Invest Technol, INSERM, Ctr Clin Invest,Module Plurithemat,CIC 1432, Dijon, France; [Martz, Pierre] Univ Burgundy, INSERM, Fac Sports, CAPS,UMR 1093, Dijon, France; [Martz, Pierre] Univ Hosp Dijon Burgundy, Div Orthopaed Surg & Musculoskeletal Trauma Care, Dijon, France; [Hannouche, Didier] Geneva Univ Hosp, Surg Dept, Div Orthopaed Surg & Musculoskeletal Trauma Care, Geneva, Switzerland	University of Geneva; University of Geneva; CHU Dijon Bourgogne; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bourgogne; CHU Dijon Bourgogne; University of Geneva	Gasparutto, X (corresponding author), Geneva Univ Hosp, Kinesiol Lab, Geneva, Switzerland.; Gasparutto, X (corresponding author), Univ Geneva, Geneva, Switzerland.	xavier.gasparutto@hcuge.ch	Laroche, Davy/K-4298-2015; ARMAND, Stephane/Q-4395-2016	Laroche, Davy/0000-0003-1599-4258; ARMAND, Stephane/0000-0001-9144-4982; Gasparutto, Xavier/0000-0001-8617-6522	Division of Orthopaedics and Trauma Surgery at the University Hospitals of Geneva; ''Fondation pour la recherche osteoarticulaire" of Geneva; "Programme Hospitalier de Recherche Clinique"; conseil regional de Bourgogne Franche-Comte	Division of Orthopaedics and Trauma Surgery at the University Hospitals of Geneva; ''Fondation pour la recherche osteoarticulaire" of Geneva; "Programme Hospitalier de Recherche Clinique"; conseil regional de Bourgogne Franche-Comte(Region Bourgogne-Franche-Comte)	This work was supported by the Division of Orthopaedics and Trauma Surgery at the University Hospitals of Geneva, the "Fondation pour la recherche osteoarticulaire" of Geneva, the "Programme Hospitalier de Recherche Clinique" and the "conseil regional de Bourgogne Franche-Comte". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abujaber SB, 2015, J ARTHROPLASTY, V30, P2027, DOI 10.1016/j.arth.2015.05.024; Aissaoui R., 1999, IEEE SMC'99 Conference Proceedings. 1999 IEEE International Conference on Systems, Man, and Cybernetics (Cat. No.99CH37028), P141, DOI 10.1109/ICSMC.1999.814072; ALEXANDER NB, 1991, J GERONTOL, V46, pM91, DOI 10.1093/geronj/46.3.M91; ALTMAN R, 1991, ARTHRITIS RHEUM, V34, P505, DOI 10.1002/art.1780340502; Aresti N, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i3405; Bahl JS, 2018, OSTEOARTHR CARTILAGE, V26, P847, DOI 10.1016/j.joca.2018.02.897; Baker R.L.F., 2017, HDB HUMAN MOTION, P1, DOI [10.1007/978-3-319-30808-1_25-2, DOI 10.1007/978-3-319-30808-1_25-2]; Baker R, 2009, GAIT POSTURE, V30, P265, DOI 10.1016/j.gaitpost.2009.05.020; Barre A, 2014, COMPUT METH PROG BIO, V114, DOI 10.1016/j.cmpb.2014.01.012; Beyea J, 2017, SENSORS-BASEL, V17, DOI 10.3390/s17040934; Boonstra MC, 2011, PHYS THER, V91, P547, DOI 10.2522/ptj.20090376; Caronni A, 2019, GAIT POSTURE, V70, P33, DOI 10.1016/j.gaitpost.2019.02.010; Caronni A, 2018, GAIT POSTURE, V61, P287, DOI 10.1016/j.gaitpost.2018.01.015; CATTELL RB, 1966, MULTIVAR BEHAV RES, V1, P245, DOI 10.1207/s15327906mbr0102_10; Cimolin V, 2019, J ELECTROMYOGR KINES, V44, P78, DOI 10.1016/j.jelekin.2018.12.001; Coulthard JT, 2015, GAIT POSTURE, V41, P882, DOI 10.1016/j.gaitpost.2015.03.009; Dayton MR, 2016, AM J PHYS MED REHAB, V95, P132, DOI 10.1097/PHM.0000000000000357; Dobson F, 2013, OSTEOARTHR CARTILAGE, V21, P1042, DOI 10.1016/j.joca.2013.05.002; Gandhi R, 2009, CLIN RHEUMATOL, V28, P253, DOI 10.1007/s10067-008-1021-y; Gloersen O, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152616; Hansen BJ, 2011, CURR REV MUSCULOSKE, V4, P132, DOI 10.1007/s12178-011-9093-8; Hollands KL, 2010, NEUROREHAB NEURAL RE, V24, P358, DOI 10.1177/1545968309348508; HOLM S, 1979, SCAND J STAT, V6, P65; Janssen WGM, 2002, PHYS THER, V82, P866, DOI 10.1093/ptj/82.9.866; Liu XW, 2015, INT J CLIN EXP MED, V8, P27, DOI 10.14257/ijsip.2015.8.11.04; Lovelock TM, 2018, J ARTHROPLASTY, V33, P273, DOI 10.1016/j.arth.2017.08.024; MASSEY FJ, 1951, J AM STAT ASSOC, V46, P68, DOI 10.2307/2280095; Mokkink LB, 2010, QUAL LIFE RES, V19, P539, DOI 10.1007/s11136-010-9606-8; MOORE AT, 1957, J BONE JOINT SURG AM, V39, P811, DOI 10.2106/00004623-195739040-00005; Nankaku M, 2007, J ORTHOP SCI, V12, P550, DOI 10.1007/s00776-007-1178-2; Nankaku M, 2013, PHYS THER, V93, P88, DOI 10.2522/ptj.20120016; Nilsdotter AK, 2003, BMC MUSCULOSKEL DIS, V4, DOI 10.1186/1471-2474-4-10; Petis SM, 2016, J ARTHROPLASTY, V31, P1427, DOI 10.1016/j.arth.2016.01.005; PODSIADLO D, 1991, J AM GERIATR SOC, V39, P142, DOI 10.1111/j.1532-5415.1991.tb01616.x; Rylander JH, 2019, CLIN ORTHOP RELAT R, V477, P1848, DOI 10.1097/CORR.0000000000000865; Salarian A, 2010, IEEE T NEUR SYS REH, V18, P303, DOI 10.1109/TNSRE.2010.2047606; Sasaki K, 2010, ACTA MED OKAYAMA, V64, P197; Schot PK, 2003, RES Q EXERCISE SPORT, V74, P1; Smith E, 2021, AGING CLIN EXP RES, V33, P2157, DOI 10.1007/s40520-020-01733-7; Vissers MM, 2011, PHYS THER, V91, P615, DOI 10.2522/ptj.20100201; Weiss A, 2016, J AM MED DIR ASSOC, V17, DOI 10.1016/j.jamda.2016.06.025; World Health Organization, 2013, US ICF PRACT MAN US; Zampieri C, 2010, J NEUROL NEUROSUR PS, V81, P171, DOI 10.1136/jnnp.2009.173740	43	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2021	16	9							e0255037	10.1371/journal.pone.0255037	http://dx.doi.org/10.1371/journal.pone.0255037			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	XM9EM	34506498	gold, Green Published			2022-12-26	WOS:000729120700114
J	Matovu, JKB; Bukenya, JN; Kasozi, D; Kisaka, S; Kisa, R; Nyabigambo, A; Tugume, A; Bwanika, JB; Mugenyi, L; Murungi, I; Serwadda, D; Wanyenze, RK				Matovu, Joseph K. B.; Bukenya, Justine N.; Kasozi, Dickson; Kisaka, Stephens; Kisa, Rose; Nyabigambo, Agnes; Tugume, Abdulaziz; Bwanika, John Baptist; Mugenyi, Levicatus; Murungi, Irene; Serwadda, David; Wanyenze, Rhoda K.			Sexual-risk behaviours and HIV and syphilis prevalence among in- and out-of-school adolescent girls and young women in Uganda: A cross-sectional study	PLOS ONE			English	Article							COMMUNICATION; AFRICA; ATTENDANCE; INFECTION; PREGNANCY; EDUCATION; DROPOUT	Background Adolescent girls and young women (AGYW) are at increased risk of sexually transmitted infections (STIs). We assessed sexual-risk behaviours and HIV and syphilis prevalence among AGYW in Uganda to inform the design of target-specific risk-reduction interventions. Methods This analysis utilizes data from 8,236 AGYW aged 10-24 years, collected in 20 districts, between July and August 2018. AGYW engaged in sexual-risk behaviour if they: a) reported a history of STIs; or b) had their sexual debut before age 15; or c) engaged in sex with 2+ partners in the past 12 months; or c) did not use or used condoms inconsistently with their most recent partners. We diagnosed HIV using Determine(TM) HIV-1/2, Stat-Pak(TM) HIV-1/2 and SD Bioline. We used SD Bioline Syphilis test kits to diagnose syphilis and Treponema Pallidum Hemagglutination Assay for confirmatory syphilis testing. Comparison of proportions was done using Chi-square (chi(2)) tests. Data were analysed using STATA (version 14.1). Results Of 4,488 AGYW (54.5%) that had ever had sex, 12.9% (n = 581) had their sexual debut before age 15; 19.1% (n = 858) reported a history of STIs. Of those that had ever had sex, 79.6% (n = 3,573) had sex in the 12 months preceding the survey; 75.6% (n = 2,707) with one (1) and 24.2% (n = 866) with 2+ partners. Condom use with the most recent sexual partner was low, with only 20.4% (n = 728) reporting consistent condom use while 79.6% (n = 2,842) reported inconsistent or no condom use. In-school AGYW were significantly less likely to have ever had sex (35.6% vs. 73.6%, P<0.001), to have had sexual debut before age 15 (7.7% vs. 15.5%, P<0.001) or to engage in sex with 2+ partners (5.3% vs. 15.8%, P<0.001). Consistent condom use was significantly higher among in-school than out-of-school AGYW (40.1% vs. 12.7%, P<0.001). Overall, 1.7% (n = 143) had HIV while 1.3% (n = 104) had syphilis. HIV and syphilis prevalence was higher among out-of-school than in-school AGYW (HIV: 2.6% vs. 0.9%; syphilis: 2.1% vs. 0.5%, respectively). Conclusion In-school AGYW engaged in more protective sexual behaviors and had less HIV and syphilis than their out-of-school counterparts. These findings suggest a need for target-specific risk-reduction interventions stratified by schooling status.	[Matovu, Joseph K. B.; Bukenya, Justine N.; Kasozi, Dickson; Kisaka, Stephens; Kisa, Rose; Nyabigambo, Agnes; Tugume, Abdulaziz; Bwanika, John Baptist; Serwadda, David; Wanyenze, Rhoda K.] Makerere Univ, Sch Publ Hlth, Kampala, Uganda; [Matovu, Joseph K. B.] Busitema Univ, Fac Hlth Sci, Mbale, Uganda; [Mugenyi, Levicatus; Murungi, Irene] AIDS Support Org, Kampala, Uganda	Makerere University	Matovu, JKB (corresponding author), Makerere Univ, Sch Publ Hlth, Kampala, Uganda.; Matovu, JKB (corresponding author), Busitema Univ, Fac Hlth Sci, Mbale, Uganda.	jmatovu@musph.ac.ug		Matovu, Joseph KB/0000-0001-6480-2940	Global Fund through The AIDS Support Organization [UGA-C-TASO-1449]	Global Fund through The AIDS Support Organization	This study was supported by a grant from the Global Fund through The AIDS Support Organization (Grant#: UGA-C-TASO-1449) awarded to Makerere University School of Public Health to conduct formative research on HIV, sexual and reproductive health and gender-based violence status among adolescent girls and young women in Uganda.	Amin S., 2013, ADOLESCENT GIRLS VUL; Behrman JA, 2015, SOC SCI MED, V127, P108, DOI 10.1016/j.socscimed.2014.06.034; Birdthistle I, 2009, SOC SCI MED, V68, P1810, DOI 10.1016/j.socscimed.2009.02.035; Bukenya JN, 2020, TROP MED INT HEALTH, V25, P81, DOI 10.1111/tmi.13329; Burke HM, 2020, BMJ GLOB HEALTH, V5, DOI 10.1136/bmjgh-2019-002029; De Neve JW, 2020, TROP MED INT HEALTH, V25, P70, DOI 10.1111/tmi.13328; Gavin Lorrie, 2006, J Adolesc Health, V39, DOI 10.1016/j.jadohealth.2006.03.002; Handa S, 2017, GLOB PUBLIC HEALTH, V12, P617, DOI 10.1080/17441692.2015.1134617; Hargreaves JR, 2008, J EPIDEMIOL COMMUN H, V62, P113, DOI 10.1136/jech.2006.053827; Heinrich CJ, 2017, ECON DEV CULT CHANGE, V65, P619, DOI 10.1086/691552; Hutchinson MK, 2003, J ADOLESCENT HEALTH, V33, P98, DOI 10.1016/S1054-139X(03)00183-6; Hutchinson MK, 1998, FAM RELAT, V47, P185, DOI 10.2307/585623; Karofsky PS, 2001, J ADOLESCENT HEALTH, V28, P41, DOI 10.1016/S1054-139X(00)00156-7; Katamba Cibangu, 2019, F1000Res, V8, P562, DOI [10.12688/f1000research.17983.2, 10.12688/f1000research.17983.1]; Keto T, 2020, BMC PUBLIC HEALTH, V20, DOI 10.1186/s12889-020-09371-4; Kilburn K, 2020, SOC INDIC RES, V151, P865, DOI 10.1007/s11205-020-02367-y; Lemeshow S., 1991, SAMPLE SIZE DETERMIN; Lynn WA, 2004, LANCET INFECT DIS, V4, P456, DOI 10.1016/S1473-3099(04)01061-8; Mabaso M, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5051-3; Mathur S, 2020, INT J PUBLIC HEALTH, V65, P399, DOI 10.1007/s00038-020-01350-1; Maughan-Brown B, 2018, JAIDS-J ACQ IMM DEF, V78, P155, DOI 10.1097/QAI.0000000000001656; Mee P, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198898; Melesse DY, 2020, BMJ GLOB HEALTH, V5, DOI 10.1136/bmjgh-2019-002231; Ministry of Health, 2016, NAT HIV TEST SERV PO; Ministry of Health Uganda, 2019, UG POP BAS HIV IMP A; Muanda FM, 2018, REPROD HEALTH, V15, DOI 10.1186/s12978-018-0517-4; Pettifor A, 2016, LANCET GLOB HEALTH, V4, pE978, DOI [10.1016/S2214-109X(16)30253-4, 10.1016/s2214-109x(16)30253-4]; Pettifor AE, 2008, INT J EPIDEMIOL, V37, P1266, DOI 10.1093/ije/dyn131; Rosenberg M, 2015, INT J EPIDEMIOL, V44, P928, DOI 10.1093/ije/dyv007; Santelli JS, 2015, GLOB SOC WELFARE, V2, P87, DOI 10.1007/s40609-015-0029-x; Schaefer R, 2017, AIDS, V31, P1461, DOI [10.1097/qad.0000000000001506, 10.1097/QAD.0000000000001506]; Ssewamala FM, 2018, J ADOLESCENT HEALTH, V62, pS29, DOI 10.1016/j.jadohealth.2017.09.026; Stoner MCD, 2019, AIDS, V33, P83, DOI 10.1097/QAD.0000000000002037; Stoner MCD, 2017, AIDS, V31, P2127, DOI 10.1097/QAD.0000000000001584; Stroeken K, 2012, AIDS CARE, V24, P186, DOI 10.1080/09540121.2011.596519; The Global Fund, 2019, INV FUT WOM GIRLS AL; The Global Fund, 2018, GLOB FUND MEAS FRAM; UBOS ICF, 2018, UGANDA DEMOGRAPHIC H; Uganda Bureau of Statistics (UBOS), 2016, NAT POP HOUS CENS 20; UNAIDS, 2020, SEIZ MOM TACKL ENTR	40	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2021	16	9							e0257321	10.1371/journal.pone.0257321	http://dx.doi.org/10.1371/journal.pone.0257321			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	XM9EM	34506577	gold, Green Published			2022-12-26	WOS:000729120700129
J	Ochiai, C; Miyauchi, S; Kudo, Y; Naruke, Y; Yoneyama, S; Tomita, K; Dongze, L; Chiba, Y; Hirata, TI; Ichijo, T; Nagai, K; Kobayashi, S; Yamada, S; Hikono, H; Murakami, K				Ochiai, Chihiro; Miyauchi, Sonoko; Kudo, Yuta; Naruke, Yuta; Yoneyama, Syuji; Tomita, Keisuke; Dongze, Leng; Chiba, Yusuke; Hirata, To-ichi; Ichijo, Toshihiro; Nagai, Kazuya; Kobayashi, Sota; Yamada, Shinji; Hikono, Hirokazu; Murakami, Kenji			Characterization of microRNA expression in B cells derived from Japanese black cattle naturally infected with bovine leukemia virus by deep sequencing	PLOS ONE			English	Article							CHRONIC LYMPHOCYTIC-LEUKEMIA; PROMOTES TUMOR PROGRESSION; BREAST-CANCER CELLS; COLORECTAL-CANCER; DAIRY-CATTLE; DNA-REPLICATION; HEPATOCELLULAR-CARCINOMA; PROSTATE-CANCER; DOWN-REGULATION; GASTRIC-CANCER	Bovine leukemia virus (BLV) is the causative agent of enzootic bovine leukosis (EBL), a malignant B cell lymphoma. However, the mechanisms of BLV-associated lymphomagenesis remain poorly understood. Here, after deep sequencing, we performed comparative analyses of B cell microRNAs (miRNAs) in cattle infected with BLV and those without BLV. In BLV-infected cattle, BLV-derived miRNAs (blv-miRNAs) accounted for 38% of all miRNAs in B cells. Four of these blv-miRNAs (blv-miR-B1-5p, blv-miR-B2-5p, blv-miR-B4-3p, and blv-miR-B5-5p) had highly significant positive correlations with BLV proviral load (PVL). The read counts of 90 host-derived miRNAs (bta-miRNAs) were significantly down-regulated in BLV-infected cattle compared to those in uninfected cattle. Only bta-miR-375 had a positive correlation with PVL in BLV-infected cattle and was highly expressed in the B cell lymphoma tissue of EBL cattle. There were a few bta-miRNAs that correlated with BLV tax/rex gene expression; however, BLV AS1 expression had a significant negative correlation with many of the down-regulated bta-miRNAs that are important for tumor development and/or tumor suppression. These results suggest that BLV promotes lymphomagenesis via AS1 and blv-miRNAs, rather than tax/rex, by down-regulating the expression of bta-miRNAs that have a tumor-suppressing function, and this downregulation is linked to increased PVL.	[Ochiai, Chihiro; Miyauchi, Sonoko; Kudo, Yuta; Naruke, Yuta; Ichijo, Toshihiro; Nagai, Kazuya; Yamada, Shinji; Murakami, Kenji] Iwate Univ, Fac Agr, Cooperat Dept Vet Med, Morioka, Iwate, Japan; [Yoneyama, Syuji; Tomita, Keisuke; Dongze, Leng; Chiba, Yusuke; Yamada, Shinji; Murakami, Kenji] Iwate Univ, Grad Sch Vet Sci, Morioka, Iwate, Japan; [Hirata, To-ichi] Iwate Univ, Field Sci Ctr, Fac Agr, Shizukuishi, Iwate, Japan; [Kobayashi, Sota] Natl Inst Anim Hlth, Div Bacterial & Parasit Dis, Tsukuba, Ibaraki, Japan; [Hikono, Hirokazu] Teikyo Univ Sci, Dept Anim Sci, Adachi Ku, Tokyo, Japan	Iwate University; Iwate University; Iwate University; National Agriculture & Food Research Organization - Japan; National Institute of Animal Health - Japan	Murakami, K (corresponding author), Iwate Univ, Fac Agr, Cooperat Dept Vet Med, Morioka, Iwate, Japan.; Murakami, K (corresponding author), Iwate Univ, Grad Sch Vet Sci, Morioka, Iwate, Japan.	muraken@iwate-u.ac.jp		Ichijo, Toshihiro/0000-0003-0812-1168	Japan Racing and Livestock Promotion Foundation	Japan Racing and Livestock Promotion Foundation	This study was partly supported by the Japan Racing and Livestock Promotion Foundation.	Asama H, 2019, PANCREATOLOGY, V19, P196, DOI 10.1016/j.pan.2018.10.012; Bai H, 2019, J REPROD DEVELOP, V65, P313, DOI 10.1262/jrd.2018-150; Bai XT, 2015, J BIOL CHEM, V290, P5381, DOI 10.1074/jbc.M114.626325; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bellon M, 2009, BLOOD, V113, P4914, DOI 10.1182/blood-2008-11-189845; Bollaert E, 2019, CELL MOL LIFE SCI, V76, P1529, DOI 10.1007/s00018-019-03012-9; Borlado LR, 2008, CARCINOGENESIS, V29, P237, DOI 10.1093/carcin/bgm268; Calin GA, 2002, P NATL ACAD SCI USA, V99, P15524, DOI 10.1073/pnas.242606799; Cao JM, 2017, BIOMED PHARMACOTHER, V93, P554, DOI 10.1016/j.biopha.2017.06.084; Chen JY, 2020, EXP THER MED, V20, P1169, DOI 10.3892/etm.2020.8771; Chen PJ, 2018, EXP THER MED, V15, P1686, DOI 10.3892/etm.2017.5581; Chen SJ, 2019, BIOMED PHARMACOTHER, V117, DOI 10.1016/j.biopha.2019.109055; Chen YY, 2016, ONCOTARGET, V7, P41306, DOI 10.18632/oncotarget.9320; Cobb BS, 2006, J EXP MED, V203, P2519, DOI 10.1084/jem.20061692; Colamaio M, 2011, J CLIN ENDOCR METAB, V96, pE1915, DOI 10.1210/jc.2011-0408; Croce CM, 2009, NAT REV GENET, V10, P704, DOI 10.1038/nrg2634; Decker T, 2002, J CLIN INVEST, V109, P1271, DOI 10.1172/JCI200215770; Do DN, 2017, SCI REP-UK, V7, DOI 10.1038/srep44605; Dong JL, 2018, BIOMED PHARMACOTHER, V105, P922, DOI 10.1016/j.biopha.2018.06.052; Durkin K, 2016, RETROVIROLOGY, V13, DOI 10.1186/s12977-016-0267-8; Fang LZ, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-27729-y; Felli N, 2005, P NATL ACAD SCI USA, V102, P18081, DOI 10.1073/pnas.0506216102; Ferrer G, 2013, LEUKEMIA LYMPHOMA, V54, P2016, DOI 10.3109/10428194.2012.763123; Fiori ME, 2014, CELL DEATH DIFFER, V21, P774, DOI 10.1038/cdd.2014.6; Frank AC, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08989-2; Fu X, 2017, CANCER SCI, V108, P620, DOI 10.1111/cas.13177; Fukumoto I, 2015, BRIT J CANCER, V112, P891, DOI 10.1038/bjc.2015.19; Gao J, 2011, ONCOL LETT, V2, P1019, DOI 10.3892/ol.2011.413; Gillet NA, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005588; Guan GF, 2014, INT J CLIN EXP PATHO, V7, P5683; Guha D, 2016, J CELL BIOCHEM, V117, P1902, DOI 10.1002/jcb.25489; Haghparast A, 2012, J ANIM VET ADV, V11, P276, DOI 10.3923/javaa.2012.276.280; Hamada R, 2020, FRONT VET SCI, V7, DOI 10.3389/fvets.2020.00608; Higuchi Y, 2019, HTLV 1 DYSREGULATES; Hu SP, 2017, ONCOL REP, V38, P1569, DOI 10.3892/or.2017.5810; Huang JL, 2007, NAT MED, V13, P1241, DOI 10.1038/nm1639; Huang L., 2019, RERG EXP THER MED, DOI [10.3892/etm.2019.8186, DOI 10.3892/ETM.2019.8186]; Ioannidis J, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-4646-5; Ivanovska I, 2008, MOL CELL BIOL, V28, P2167, DOI 10.1128/MCB.01977-07; Jia CM, 2018, PATHOL RES PRACT, V214, P1388, DOI 10.1016/j.prp.2018.07.025; Jia L, 2017, BIOCHEM BIOPH RES CO, V488, P425, DOI 10.1016/j.bbrc.2017.05.074; Jia WZ, 2018, EXP THER MED, V16, P1225, DOI 10.3892/etm.2018.6288; Jiang HS, 2014, ONCOL REP, V31, P1509, DOI 10.3892/or.2014.3036; Jiang Z, 2010, J GASTROENTEROL, V45, P17, DOI 10.1007/s00535-009-0135-6; Kettmann R., 1994, The retroviridae: Volume 3, P39; Kincaid RP, 2012, P NATL ACAD SCI USA, V109, P3077, DOI 10.1073/pnas.1116107109; Klein U, 2010, CANCER CELL, V17, P28, DOI 10.1016/j.ccr.2009.11.019; Kobayashi T, 2020, PREV VET MED, V178, DOI 10.1016/j.prevetmed.2019.04.009; Kovacic B, 2006, CANCER CELL, V10, P77, DOI 10.1016/j.ccr.2006.05.025; KOYAMA H, 1992, J VET MED B, V39, P32, DOI 10.1111/j.1439-0450.1992.tb01134.x; Kozomara A, 2019, NUCLEIC ACIDS RES, V47, pD155, DOI 10.1093/nar/gky1141; LaDronka Rebecca M, 2018, Vet Med Int, V2018, P5831278, DOI 10.1155/2018/5831278; Li H, 2017, HEPATOLOGY, V66, P136, DOI 10.1002/hep.29116; Li JL, 2018, ARCH BIOCHEM BIOPHYS, V640, P53, DOI 10.1016/j.abb.2018.01.002; Li LH, 2018, MOL MED REP, V17, P4003, DOI 10.3892/mmr.2017.8299; Li SQ, 2018, ONCOL LETT, V16, P2709, DOI 10.3892/ol.2018.8932; Li T, 2017, BIOMED PHARMACOTHER, V96, P153, DOI 10.1016/j.biopha.2017.09.102; Li W, 2021, STEM CELL RES THER, V12, DOI 10.1186/s13287-020-02119-2; Li XN, 2013, J BIOL CHEM, V288, P18121, DOI 10.1074/jbc.M113.478560; Li XR, 2014, FEBS LETT, V588, P3298, DOI 10.1016/j.febslet.2014.07.020; Li Y, 2020, DIAGN PATHOL, V15, DOI 10.1186/s13000-020-00946-8; Li ZX, 2014, ANIM GENET, V45, P20, DOI 10.1111/age.12096; Liu C, 2018, VIRAL IMMUNOL, V31, P676, DOI 10.1089/vim.2018.0067; Liu C, 2019, AM J TRANSL RES, V11, P7376; Liu DC, 2014, BIOCHEM BIOPH RES CO, V445, P151, DOI 10.1016/j.bbrc.2014.01.140; Liu S, 2019, J BIOSCIENCES, V44, DOI 10.1007/s12038-019-9920-4; Liu T, 2009, CANCER LETT, V273, P233, DOI 10.1016/j.canlet.2008.08.003; Long MM, 2017, MOL CANCER, V16, DOI 10.1186/s12943-017-0723-7; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Lv KT, 2018, INT J MED SCI, V15, P142, DOI 10.7150/ijms.21645; MAFF, 2019, ANN STAT NOT DIS; Mansoori B, 2019, J CELL PHYSIOL, V234, P9816, DOI 10.1002/jcp.27670; Mei Q, 2015, J PATHOL, V236, P165, DOI 10.1002/path.4525; Merhautova J, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/941980; Mishan MA, 2020, GENE CHROMOSOME CANC, V59, P722, DOI 10.1002/gcc.22889; Miyamoto K, 2016, BRIT J CANCER, V115, P354, DOI 10.1038/bjc.2016.179; Moles R, 2015, NEOPLASIA, V17, P449, DOI 10.1016/j.neo.2015.04.005; Morris VA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075815; Motoyama M, 2016, MEAT SCI, V120, P10, DOI 10.1016/j.meatsci.2016.04.026; Mraz M, 2014, BLOOD, V124, P84, DOI 10.1182/blood-2013-09-527234; Murakami K., 2013, J VET MED SCI; Ndou Rendani V., 2011, Journal of Human Ecology, V36, P53; Ni JS, 2019, ONCOL LETT, V17, P2317, DOI 10.3892/ol.2018.9848; Nishitani H, 2002, GENES CELLS, V7, P523, DOI 10.1046/j.1365-2443.2002.00544.x; Ochirkhuu N, 2016, ARCH VIROL, V161, P985, DOI 10.1007/s00705-015-2676-8; OIE, 2019, MANUAL DIAGNOSTIC TE, P1113; Pacifico F, 2010, J CLIN ENDOCR METAB, V95, P1421, DOI 10.1210/jc.2009-1128; Papakonstantinou N, 2013, MOL MED, V19, P115, DOI 10.2119/molmed.2013.00005; Corredor-Figueroa AP, 2020, INFECT GENET EVOL, V80, DOI 10.1016/j.meegid.2020.104171; Pekarsky Y, 2015, CELL DEATH DIFFER, V22, P6, DOI 10.1038/cdd.2014.87; Pfeffer S, 2006, ONCOGENE, V25, P6211, DOI 10.1038/sj.onc.1209915; Pichler K, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-100; Polakova KM, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-41; Polat M, 2015, ARCH VIROL, V160, P285, DOI 10.1007/s00705-014-2280-3; Rahman S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034490; Rosewick N, 2013, P NATL ACAD SCI USA, V110, P2306, DOI 10.1073/pnas.1213842110; Ruggero K, 2010, MOL ASPECTS MED, V31, P367, DOI 10.1016/j.mam.2010.05.001; Scheibner KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050895; Schneider C, 2014, P NATL ACAD SCI USA, V111, P8185, DOI 10.1073/pnas.1322466111; Sclafani RA, 2007, ANNU REV GENET, V41, P237, DOI 10.1146/annurev.genet.41.110306.130308; Sevik M, 2015, TROP ANIM HEALTH PRO, V47, P715, DOI 10.1007/s11250-015-0783-x; Shen WJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086871; Son D, 2019, CANCER LETT, V454, P224, DOI 10.1016/j.canlet.2019.04.006; Song YX, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-1; Stoye J.P., 2011, VIRUS TAXONOMY, VVolume 9, P477; Suffert G, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002405; Sun Q, 2014, PROSTATE, V74, P1613, DOI 10.1002/pros.22878; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Tang XB, 2018, EXP THER MED, V15, P4723, DOI 10.3892/etm.2018.6015; Tomita Mariko, 2012, ISRN Microbiol, V2012, P978607, DOI 10.5402/2012/978607; Tomita M, 2012, INT J CANCER, V130, P2300, DOI 10.1002/ijc.25115; Trono KG, 2001, VET MICROBIOL, V83, P235, DOI 10.1016/S0378-1135(01)00420-5; Tsutsui T, 2016, PREV VET MED, V124, P96, DOI 10.1016/j.prevetmed.2015.11.019; Ueda T, 2010, LANCET ONCOL, V11, P136, DOI 10.1016/S1470-2045(09)70343-2; de Souza DRV, 2020, ONCOL LETT, V20, P2311, DOI 10.3892/ol.2020.11803; VanLeeuwen JA, 2006, CAN VET J, V47, P783; Wang C, 2020, CANCER SCI, V111, P1146, DOI 10.1111/cas.14325; Wang GB, 2015, TUMOR BIOL, V36, P4715, DOI 10.1007/s13277-015-3120-0; Wang HY, 2019, ARTIF CELL NANOMED B, V47, P3671, DOI 10.1080/21691401.2019.1596930; Wang JY, 2018, BIOSCIENCE REP, V38, DOI 10.1042/BSR20171265; Wang W, 2016, ONCOTARGETS THER, V9, P1371, DOI 10.2147/OTT.S97969; Wang X, 2009, BLOOD, V113, P671, DOI 10.1182/blood-2008-09-175000; Watanabe A, 2011, LEUKEMIA, V25, P1324, DOI 10.1038/leu.2011.81; Wicik Z, 2016, J ANIM BREED GENET, V133, P31, DOI 10.1111/jbg.12172; Xia HM, 2015, BIOMED PHARMACOTHER, V75, P105, DOI 10.1016/j.biopha.2015.07.037; Xu DD, 2016, FRONT PHARMACOL, V7, DOI 10.3389/fphar.2016.00439; Xue L, 2018, J BUON, V23, P1633; Yamagishi M, 2012, CANCER CELL, V21, P121, DOI 10.1016/j.ccr.2011.12.015; Yan JW, 2014, INT J CANCER, V135, P1011, DOI 10.1002/ijc.28563; Yang R, 2016, MOL CANCER, V15, DOI 10.1186/s12943-016-0569-4; Yang Y, 2016, J DAIRY SCI, V99, P3688, DOI 10.3168/jds.2015-10580; Yang YJ, 2015, CLIN CANCER RES, V21, P2399, DOI 10.1158/1078-0432.CCR-14-1437; Yeung ML, 2008, CANCER RES, V68, P8976, DOI 10.1158/0008-5472.CAN-08-0769; Zhai W, 2018, BRIT J CANCER, V119, P591, DOI 10.1038/s41416-018-0196-5; Zhang XY, 2015, ONCOTARGET, V6, P1605, DOI 10.18632/oncotarget.2748; Zhang X, 2014, MOL CANCER RES, V12, P1535, DOI 10.1158/1541-7786.MCR-13-0641; Zhang Z, 2017, MOL MED REP, V16, P9317, DOI 10.3892/mmr.2017.7826; Zhao JJ, 2010, BLOOD, V115, P2630, DOI 10.1182/blood-2009-09-243147; Zhao L, 2016, ONCOTARGET, V7, P45370, DOI 10.18632/oncotarget.9659; Zheng YS, 2019, MOL CELL PROBE, V48, DOI 10.1016/j.mcp.2019.101445; Zhou JX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068469	141	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2021	16	9							e0256588	10.1371/journal.pone.0256588	http://dx.doi.org/10.1371/journal.pone.0256588			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XM9EM	34506539	Green Published, gold			2022-12-26	WOS:000729120700016
J	Timerga, A; Haile, K				Timerga, Abebe; Haile, Kassahun			Evaluation of uric acid disorders and associated factors in essential hypertensive patients at Wolkite University specialized hospital, Southern Ethiopia	PLOS ONE			English	Article							DIABETES-MELLITUS PATIENTS; HYPERURICEMIA; DETERMINANTS; PREVALENCE	Background Essential hypertension is a condition characterized by a rise in blood pressure of undetermined cause, includes 90% of all hypertensive cases and is a highly important public health challenge with major modifiable cause of morbidity and mortality. Uric acids disorders in particular hyperuricemia are significant problems in essential hypertensive patients and can cause substantial morbidity and mortality. Determination of uric acid disorders may play a major role in the management and early aversion of complications in hypertensive patient. Therefore, this study aimed to determine uric acid disorders and associated factors among essential hypertensive adults in the outpatient department at Wolkite University specialized Hospital, Southern Ethiopia from November 1 to February 30, 2021. Methods and materials An institional based cross sectional study was conducted on 270 essential hypertensive adults on follow-up in outpatient department from November 1 to February 30, 2021. Structured questionnaires through face to face interviews and participants' medical records were used to collect information on determinants related with uric acid disorders. The blood specimen was collected and level of serum uric acid, blood sugar and lipid profile was measured using standard principles and procedures with an ABX Pentra 400 automated chemistry analyzer. Bivariate and multivariate logistic regression analyses were done to identify factors associated with hyperuricemia. The p-value was set at Results A total of 270 adult essential hypertensive patients were participated in the study, among those 196(27.4%) of study participants were hyperuricemic with 95%CI (21.9, 33.3). Being alcoholic [(AOR: 15.68, 95% CI: (5.93, 21.41)], taking antihypertensive medication [(AOR: 11.56, 95% CI: (3.94, 23.80)], BMI > = 30 [(AOR: 4.89, 95% CI: (1.46, 25.5)] and being centrally obese [(AOR: 6.87, 95% CI: (2.53, 18.63)] were factors significantly associated with hyperuricemia. Conclusion In this study, the high burden of hyperuricemia (27.4%) was observed in essential hypertensive patients with follow-up in outpatient department. Taking alcohol and antihypertensive medication, being overweight and centrally obese were identified factors of uric acid disorders. The finding of this study should be taken into consideration to implement preventive interventions on identified predictors in hypertensive patients. Taking fruit and vegetable, and promoting physical exercise and determinations of serum uric acid level in adult essential hypertensive patients was recommended to minimize the emergence of hyperuricemia.	[Timerga, Abebe] Wolkite Univ, Dept Biomed Sci, Coll Med & Hlth Sci, Wolkite, Ethiopia; [Haile, Kassahun] Wolkite Univ, Dept Med Lab Sci, Coll Med & Hlth Sci, Wolkite, Ethiopia	University of Gondar; University of Gondar	Timerga, A (corresponding author), Wolkite Univ, Dept Biomed Sci, Coll Med & Hlth Sci, Wolkite, Ethiopia.	abebetimerga125@gmail.com		Haile, Kassahun/0000-0002-2520-9244				Ali N, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-64884-7; Ali N, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-45680-4; Arersa KK, 2020, DIABET METAB SYND OB, V13, P2059, DOI 10.2147/DMSO.S252825; Article O., 2015, J CLIN DIAGNOSTIC RE, V9, P5, DOI [10.7860/JCDR/2015/10905.5530, DOI 10.7860/JCDR/2015/10905.5530]; Babikr WG., 2016, BIOMED PHARMACOL J, V9, P1005, DOI DOI 10.13005/bpj/1040; Ben Salem C, 2017, RHEUMATOLOGY, V56, P679, DOI 10.1093/rheumatology/kew293; Bolivar JJ, 2013, INT J HYPERTENS, V2013, DOI 10.1155/2013/547809; CASPERSEN CJ, 1985, PUBLIC HEALTH REP, V100, P126; Conen D, 2004, BMC PUBLIC HEALTH, V4, DOI 10.1186/1471-2458-4-9; de Oliveira EP, 2013, NUTR J, V12, DOI 10.1186/1475-2891-12-11; de Oliveira EP, 2012, DIABETOL METAB SYNDR, V4, DOI 10.1186/1758-5996-4-12; Dependence S, 2000, INT GUID MON ALC CON, P1; El Din UAAS, 2017, J ADV RES, V8, P537, DOI 10.1016/j.jare.2016.11.004; Fouad M., 2016, URIC ACID EARLY NEPH, V38, P403, DOI [10.5935/0101-2800.20160065, DOI 10.5935/0101-2800.20160065]; Id NA., 2018, PLOS ONE, V13, P1; Kumar S., J NOBEL MED COLL, V3, P16; Kuwabara M, 2015, PULSE, V3, P242, DOI 10.1159/000443769; Lanaspa MA, 2020, HYPERTENS RES, V43, P832, DOI 10.1038/s41440-020-0481-6; Lee Jung Hyun, 2019, Korean J Pediatr, V62, P317, DOI 10.3345/kjp.2019.00444; Li F, 2021, DIABET METAB SYND OB, V14, P627, DOI 10.2147/DMSO.S286299; Liu M, 2014, INT J ENDOCRINOL, V2014, DOI 10.1155/2014/754678; Mishra A., 2017, J INT MED RES, V4, P404; Mohanalakshmi T, 2016, RES J PHARM BIOL CHE, V7, P2667; Raja R, 2019, CUREUS, V11, DOI 10.7759/cureus.5457; Shirasawa T., 2014, BMC ENDOCR DISORD, V14, P1; Wang J, 2013, ASIA PAC J CLIN NUTR, V22, P590, DOI 10.6133/apjcn.2013.22.4.16; Woldeamlak Birhanu, 2019, EJIFCC, V30, P325; Woyesa SB, 2017, BMC ENDOCR DISORD, V17, DOI 10.1186/s12902-017-0226-y	30	1	1	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2021	16	9							e0256557	10.1371/journal.pone.0256557	http://dx.doi.org/10.1371/journal.pone.0256557			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XM9EM	34506522	Green Published, gold			2022-12-26	WOS:000729120700064
J	Zhu, D; Ding, HY; Zviman, MM; Halperin, H; Schar, M; Herzka, DA				Zhu, Dan; Ding, Haiyan; Zviman, M. Muz; Halperin, Henry; Schar, Michael; Herzka, Daniel A.			Accelerating whole-heart 3D T2 mapping: Impact of undersampling strategies and reconstruction techniques	PLOS ONE			English	Article							MRI; DISEASE; SENSE	Purpose We aim to determine an advantageous approach for the acceleration of high spatial resolution 3D cardiac T2 relaxometry data by comparing the performance of different undersampling patterns and reconstruction methods over a range of acceleration rates. Methods Multi-volume 3D high-resolution cardiac images were acquired fully and undersampled retrospectively using 1) optimal CAIPIRINHA and 2) a variable density random (VDR) sampling. Data were reconstructed using 1) multi-volume sensitivity encoding (SENSE), 2) joint-sparsity SENSE and 3) model-based SENSE. Four metrics were calculated on 3 naive swine and 8 normal human subjects over a whole left-ventricular region of interest: root-mean-square error (RMSE) of image signal intensity, RMSE of T2, the bias of mean T2, and standard deviation (SD) of T2. Fully sampled data and volume-by-volume SENSE with standard equally spaced undersampling were used as references. The Jaccard index calculated from one swine with acute myocardial infarction (MI) was used to demonstrate preservation of segmentation of edematous tissues with elevated T2. Results In naive swine and normal human subjects, all methods had similar performance when the net reduction factor (R-net) <2.5. VDR sampling with model-based SENSE showed the lowest RMSEs (10.5%-14.2%) and SDs (+1.7-2.4 ms) of T2 when R-net>2.5, while VDR sampling with the joint-sparsity SENSE had the lowest bias of mean T2 (0.0-1.1ms) when R-net>3. The RMSEs of parametric T2 values (9.2%-24.6%) were larger than for image signal intensities (5.2%-18.4%). In the swine with MI, VDR sampling with either joint-sparsity or model-based SENSE showed consistently higher Jaccard index for all R-net (0.71-0.50) than volume-by-volume SENSE (0.68-0.30). Conclusions Retrospective exploration of undersampling and reconstruction in 3D whole-heart T2 parametric mapping revealed that maps were more sensitive to undersampling than images, presenting a more stringent limiting factor on R-net. The combination of VDR sampling patterns with model-based or joint-sparsity SENSE reconstructions were more robust for R-net>3.	[Zhu, Dan; Herzka, Daniel A.] Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Baltimore, MD 21205 USA; [Schar, Michael] Johns Hopkins Univ, Div MR Res, Russell H Morgan Dept Radiol & Radiol Sci, Sch Med, Baltimore, MD USA; [Ding, Haiyan] Tsinghua Univ, Dept Biomed Engn, Beijing, Peoples R China; [Zviman, M. Muz; Halperin, Henry] Johns Hopkins Univ, Div Cardiol, Dept Med, Sch Med, Baltimore, MD USA; [Zviman, M. Muz] Univ Penn, Dept Radiol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Herzka, Daniel A.] NHLBI, Lab Cardiovasc Intervent, NIH, Bldg 10, Bethesda, MD 20892 USA	Johns Hopkins University; Johns Hopkins University; Tsinghua University; Johns Hopkins University; University of Pennsylvania; Pennsylvania Medicine; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Herzka, DA (corresponding author), Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Baltimore, MD 21205 USA.; Herzka, DA (corresponding author), NHLBI, Lab Cardiovasc Intervent, NIH, Bldg 10, Bethesda, MD 20892 USA.	daniel.herzka@gmail.com		Herzka, Daniel/0000-0002-9400-7814; Zhu, Dan/0000-0002-0940-1519	American Heart Association [11SDG5280025, 17SDG33671007]	American Heart Association(American Heart Association)	This work was supported in part by two grants from the American Heart Association (Grant 11SDG5280025, Grant 17SDG33671007). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Bilgic B, 2018, MAGN RESON MED, V80, P619, DOI 10.1002/mrm.27076; Bohnen S, 2015, CIRC-CARDIOVASC IMAG, V8, DOI 10.1161/CIRCIMAGING.114.003073; Breuer FA, 2006, MAGN RESON MED, V55, P549, DOI 10.1002/mrm.20787; Breuer FA, 2005, MAGNET RESON MED, V53, P684, DOI 10.1002/mrm.20401; BRITTAIN JH, 1995, MAGNET RESON MED, V33, P689, DOI 10.1002/mrm.1910330515; Chow K, 2014, MAGN RESON MED, V71, P2082, DOI 10.1002/mrm.24878; Dabir D, 2019, EUR J RADIOL, V113, P217, DOI 10.1016/j.ejrad.2019.02.026; Ding HY, 2015, MAGN RESON MED, V74, P803, DOI 10.1002/mrm.25458; Doneva M, 2010, MAGN RESON MED, V64, P1114, DOI 10.1002/mrm.22483; Ferreira VM, 2014, J THORAC IMAG, V29, P147, DOI 10.1097/RTI.0000000000000077; Ferreira VM, 2012, J CARDIOVASC MAGN R, V14, DOI 10.1186/1532-429X-14-42; Giri S, 2009, J CARDIOVASC MAGN R, V11, DOI 10.1186/1532-429X-11-56; Greiser A, 2003, MAGN RESON MED, V50, P1266, DOI 10.1002/mrm.10647; Griswold MA, 2002, MAGN RESON MED, V47, P1202, DOI 10.1002/mrm.10171; Guo R, 2018, J CARDIOVASC MAGN R, V20, DOI 10.1186/s12968-018-0487-2; Henningsson M., 2013, J CARDIOVASC MAGN R, V15, DOI [10.1186/1532-429X-15-S1-P44, DOI 10.1186/1532-429X-15-S1-P44]; Huang JZ, 2014, MAGN RESON IMAGING, V32, P1344, DOI 10.1016/j.mri.2014.08.025; Kali A, 2013, RADIOLOGY, V269, P386, DOI 10.1148/radiol.13122397; Karamitsos TD, 2013, JACC-CARDIOVASC IMAG, V6, P488, DOI 10.1016/j.jcmg.2012.11.013; Kellman P, 2014, J CARDIOVASC MAGN R, V16, DOI 10.1186/1532-429X-16-2; Look D. C., 1970, Review of Scientific Instruments, V41, P250, DOI 10.1063/1.1684482; Lustig M, 2007, MAGN RESON MED, V58, P1182, DOI 10.1002/mrm.21391; Marseille GJ, 1996, J MAGN RESON SER B, V111, P70, DOI 10.1006/jmrb.1996.0061; Messroghli DR, 2004, MAGN RESON MED, V52, P141, DOI 10.1002/mrm.20110; Nayak KS, 1998, P 6 ANN M ISMRM SYDN, P670; NOLL DC, 1991, IEEE T MED IMAGING, V10, P154, DOI 10.1109/42.79473; Nordio G, 2019, MAGN RESON MATER PHY, V32, P281, DOI 10.1007/s10334-018-0703-y; Nordio G, 2017, J MAGN RESON IMAGING, V46, P218, DOI 10.1002/jmri.25575; Otazo R, 2015, MAGN RESON MED, V73, P1125, DOI 10.1002/mrm.25240; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Piechnik SK, 2010, J CARDIOVASC MAGN R, V12, DOI 10.1186/1532-429X-12-69; Pruessmann KP, 1999, MAGNET RESON MED, V42, P952, DOI 10.1002/(SICI)1522-2594(199911)42:5<952::AID-MRM16>3.0.CO;2-S; Pruessmann KP, 2001, MAGNET RESON MED, V46, P638, DOI 10.1002/mrm.1241; Puntmann VO, 2013, JACC-CARDIOVASC IMAG, V6, P475, DOI 10.1016/j.jcmg.2012.08.019; Sado DM, 2013, CIRC-CARDIOVASC IMAG, V6, P392, DOI 10.1161/CIRCIMAGING.112.000070; Samsonov A., 2015, P INT SOC MAGNETIC R, V23, P3711; Samsonov AA, 2004, MAGN RESON MED, V52, P1397, DOI 10.1002/mrm.20285; Schar M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139859; Schar M, 2010, MAGN RESON MED, V63, P419, DOI 10.1002/mrm.22234; Tsai CM, 2000, MAGNET RESON MED, V43, P452, DOI 10.1002/(SICI)1522-2594(200003)43:3<452::AID-MRM18>3.0.CO;2-B; Tsao J, 2005, MAGNET RESON MED, V53, P1372, DOI 10.1002/mrm.20483; Vasanawala SS, 2011, I S BIOMED IMAGING, P1039, DOI 10.1109/ISBI.2011.5872579; Wang G, 2019, JACC-CARDIOVASC IMAG, V12, P693, DOI 10.1016/j.jcmg.2018.01.018; Wang J, 2001, P 1 WURZB WORKSH PAR, P89; Wang XQ, 2018, MAGN RESON MED, V79, P730, DOI 10.1002/mrm.26726; Weingartner S, 2015, MAGN RESON MED, V74, P1032, DOI 10.1002/mrm.25495; Weingartner S, 2014, MAGN RESON MED, V71, P1024, DOI 10.1002/mrm.24761; Yang HJ, 2016, MAGN RESON MED, V75, P126, DOI 10.1002/mrm.25576	48	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2021	16	9							e0252777	10.1371/journal.pone.0252777	http://dx.doi.org/10.1371/journal.pone.0252777			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XM9EM	34506496	Green Published, gold			2022-12-26	WOS:000729120700028
J	Rumpret, M; von Richthofen, HJ; van der Linden, M; Westerlaken, GHA; Ormeno, CT; van Strijp, JAG; Landau, M; Ovaa, H; van Sorge, NM; Meyaard, L				Rumpret, Matevz; von Richthofen, Helen J.; van der Linden, Maarten; Westerlaken, Geertje H. A.; Ormeno, Cami Talavera; van Strijp, Jos A. G.; Landau, Meytal; Ovaa, Huib; van Sorge, Nina M.; Meyaard, Linde			Signal inhibitory receptor on leukocytes-1 recognizes bacterial and endogenous amphipathic alpha-helical peptides	FASEB JOURNAL			English	Article						cathelicidin LL-37; phenol-soluble modulin; SIRL-1; Staphylococcus	PHENOL-SOLUBLE MODULINS; STAPHYLOCOCCUS-AUREUS BIOFILMS; HUMAN CATHELICIDIN LL-37; ANTIMICROBIAL PEPTIDES; ANTIBACTERIAL PEPTIDE; HUMAN SKIN; EXPRESSION; KERATINOCYTES; DETERMINANTS; INFLAMMATION	Signal inhibitory receptor on leukocytes-1 (SIRL-1) is a negative regulator of myeloid cell function and dampens antimicrobial responses. We here show that different species of the genus Staphylococcus secrete SIRL-1-engaging factors. By screening a library of single-gene transposon mutants in Staphylococcus aureus, we identified these factors as phenol-soluble modulins (PSMs). PSMs are amphipathic alpha-helical peptides involved in multiple aspects of staphylococcal virulence and physiology. They are cytotoxic and activate the chemotactic formyl peptide receptor 2 (FPR2) on immune cells. Human cathelicidin LL-37 is also an amphipathic alpha-helical peptide with antimicrobial and chemotactic activities, structurally and functionally similar to alpha-type PSMs. We demonstrate that alpha-type PSMs from multiple staphylococcal species as well as human cathelicidin LL-37 activate SIRL-1, suggesting that SIRL-1 recognizes alpha-helical peptides with an amphipathic arrangement of hydrophobicity, although we were not able to show direct binding to SIRL-1. Upon rational peptide design, we identified artificial peptides in which the capacity to ligate SIRL-1 is segregated from cytotoxic and FPR2-activating properties, allowing specific engagement of SIRL-1. In conclusion, we propose staphylococcal PSMs and human LL-37 as a potential new class of natural ligands for SIRL-1.	[Rumpret, Matevz; von Richthofen, Helen J.; van der Linden, Maarten; Westerlaken, Geertje H. A.; Meyaard, Linde] Univ Utrecht, Univ Med Ctr Utrecht, Ctr Translat Immunol, Lundlaan 6, NL-3584 EA Utrecht, Netherlands; [Rumpret, Matevz; von Richthofen, Helen J.; Westerlaken, Geertje H. A.; Ormeno, Cami Talavera; Ovaa, Huib; Meyaard, Linde] Oncode Inst, Utrecht, Netherlands; [Ormeno, Cami Talavera; Ovaa, Huib] Leiden Univ, Dept Cell & Chem Biol, Med Ctr, Leiden, Netherlands; [van Strijp, Jos A. G.; van Sorge, Nina M.] Univ Utrecht, Univ Med Ctr Utrecht, Dept Med Microbiol, Utrecht, Netherlands; [Landau, Meytal] Technion Israel Inst Technol, Dept Biol, Haifa, Israel; [van Sorge, Nina M.] Univ Amsterdam, Locat Amsterdam Med Ctr, Amsterdam Inst Infect & Immun,Amsterdam UMC, Dept Med Microbiol & Infect Prevent,Netherlands R, Amsterdam, Netherlands	Utrecht University; Utrecht University Medical Center; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Utrecht University; Utrecht University Medical Center; Technion Israel Institute of Technology; University of Amsterdam	Meyaard, L (corresponding author), Univ Utrecht, Univ Med Ctr Utrecht, Ctr Translat Immunol, Lundlaan 6, NL-3584 EA Utrecht, Netherlands.	l.meyaard@umcutrecht.nl	Rumpret, Matevž/GQY-5895-2022; van Sorge, Nina/E-3290-2017; Landau, Meytal/J-3075-2012; Van Strijp, Jos A. G./J-9549-2014	Rumpret, Matevž/0000-0002-8631-8049; van Sorge, Nina/0000-0002-2695-5863; Talavera Ormeno, Cami Margaretha Paula/0000-0001-5502-2985; Landau, Meytal/0000-0002-1743-3430; Meyaard, Linde/0000-0003-0707-4793; Van Strijp, Jos A. G./0000-0001-6253-0830	Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO) [91815608]	Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO)(Netherlands Organization for Scientific Research (NWO))	Nederlandse Organisatie voor Wetenschappelijk Onderzoek (NWO), Grant/Award Number: 91815608	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Armbruster NS, 2016, INT J MED MICROBIOL, V306, P666, DOI 10.1016/j.ijmm.2016.09.002; Bals R, 1998, P NATL ACAD SCI USA, V95, P9541, DOI 10.1073/pnas.95.16.9541; Becker K, 2014, CLIN MICROBIOL REV, V27, P870, DOI 10.1128/CMR.00109-13; Besteman SB, 2020, CLIN IMMUNOL, V211, DOI 10.1016/j.clim.2019.108324; Bianchi ME, 2007, J LEUKOCYTE BIOL, V81, P1, DOI 10.1189/jlb.0306164; Braff MH, 2005, J IMMUNOL, V174, P4271, DOI 10.4049/jimmunol.174.7.4271; Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098; Brown MM, 2020, PLOS PATHOG, V16, DOI 10.1371/journal.ppat.1009026; Byrd AL, 2018, NAT REV MICROBIOL, V16, P143, DOI 10.1038/nrmicro.2017.157; CHEUNG AL, 1994, J BACTERIOL, V176, P4168, DOI 10.1128/JB.176.13.4168-4172.1994; Cheung GYC, 2015, SCI REP-UK, V5, DOI 10.1038/srep18023; Cheung GYC, 2014, FEMS MICROBIOL REV, V38, P698, DOI 10.1111/1574-6976.12057; Christensen GJM, 2014, BENEF MICROBES, V5, P201, DOI 10.3920/BM2012.0062; Coffelt SB, 2009, MOL CANCER RES, V7, P907, DOI 10.1158/1541-7786.MCR-08-0326; Cogen AL, 2008, BRIT J DERMATOL, V158, P442, DOI 10.1111/j.1365-2133.2008.08437.x; Da F, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00206; Dastgheyb SS, 2015, INFECT IMMUN, V83, P2966, DOI 10.1128/IAI.00394-15; De Jong NWM, 2019, MICROBIOL SPECTR, V7, DOI 10.1128/microbiolspec.GPP3-0061-2019; Drozdetskiy A, 2015, NUCLEIC ACIDS RES, V43, pW389, DOI 10.1093/nar/gkv332; Edwards AM, 2011, TRENDS MICROBIOL, V19, P184, DOI 10.1016/j.tim.2010.12.005; Engelberg Y, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17736-x; Erridge C, 2010, J LEUKOCYTE BIOL, V87, P989, DOI 10.1189/jlb.1209775; Foster TJ, 2005, NAT REV MICROBIOL, V3, P948, DOI 10.1038/nrmicro1289; Frohm M, 1997, J BIOL CHEM, V272, P15258, DOI 10.1074/jbc.272.24.15258; Gautier R, 2008, BIOINFORMATICS, V24, P2101, DOI 10.1093/bioinformatics/btn392; Geoghegan JA, 2018, TRENDS MICROBIOL, V26, P484, DOI 10.1016/j.tim.2017.11.008; Glaser R, 2005, NAT IMMUNOL, V6, P57, DOI 10.1038/ni1142; Hase K, 2002, INFECT IMMUN, V70, P953, DOI 10.1128/IAI.70.2.953-963.2002; Into T, 2010, CELL IMMUNOL, V264, P104, DOI 10.1016/j.cellimm.2010.05.005; Joo HS, 2011, J BIOL CHEM, V286, P8933, DOI 10.1074/jbc.M111.221382; Kanda N, 2012, ALLERGY, V67, P804, DOI 10.1111/j.1398-9995.2012.02824.x; Kretschmer D, 2010, CELL HOST MICROBE, V7, P463, DOI 10.1016/j.chom.2010.05.012; Krismer B, 2017, NAT REV MICROBIOL, V15, P675, DOI 10.1038/nrmicro.2017.104; Kumar D, 2017, GENOME MED, V9, DOI 10.1186/s13073-017-0404-6; Lai YP, 2009, TRENDS IMMUNOL, V30, P131, DOI 10.1016/j.it.2008.12.003; LARRICK JW, 1995, INFECT IMMUN, V63, P1291, DOI 10.1128/IAI.63.4.1291-1297.1995; Lebbink RJ, 2006, J EXP MED, V203, P1419, DOI 10.1084/jem.20052554; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; Lyon GJ, 2000, P NATL ACAD SCI USA, V97, P13330, DOI 10.1073/pnas.97.24.13330; Mallbris L, 2010, EXP DERMATOL, V19, P442, DOI 10.1111/j.1600-0625.2009.00918.x; Malm J, 2000, INFECT IMMUN, V68, P4297, DOI 10.1128/IAI.68.7.4297-4302.2000; Morizane S, 2012, J INVEST DERMATOL, V132, P135, DOI 10.1038/jid.2011.259; Morizane S, 2010, J INVEST DERMATOL, V130, P1297, DOI 10.1038/jid.2009.435; Nakamura Y, 2013, NATURE, V503, P397, DOI 10.1038/nature12655; Novick RP, 2008, ANNU REV GENET, V42, P541, DOI 10.1146/annurev.genet.42.110807.091640; O'Riordan K, 2004, CLIN MICROBIOL REV, V17, P218, DOI 10.1128/CMR.17.1.218-234.2004; Ong PY, 2002, NEW ENGL J MED, V347, P1151, DOI 10.1056/NEJMoa021481; Oren Z, 1999, BIOCHEM J, V341, P501, DOI 10.1042/0264-6021:3410501; Otto M, 2004, J INFECT DIS, V190, P748, DOI 10.1086/422157; Otto M, 2014, INT J MED MICROBIOL, V304, P164, DOI 10.1016/j.ijmm.2013.11.019; Pace CN, 1998, BIOPHYS J, V75, P422, DOI 10.1016/S0006-3495(98)77529-0; Periasamy S, 2012, P NATL ACAD SCI USA, V109, P1281, DOI 10.1073/pnas.1115006109; Pistolic J, 2009, J INNATE IMMUN, V1, P254, DOI 10.1159/000171533; Qin L, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01293; Rautenberg M, 2011, FASEB J, V25, P1254, DOI 10.1096/fj.10-175208; Richardson JR, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02603; Rumpret M, 2021, EUR J IMMUNOL, V51, P2210, DOI 10.1002/eji.202149278; Rumpret M, 2020, NAT REV IMMUNOL, V20, P771, DOI 10.1038/s41577-020-0352-z; Schittek B, 2012, J INNATE IMMUN, V4, P349, DOI 10.1159/000336844; Schroder JM, 1999, INT J BIOCHEM CELL B, V31, P645, DOI 10.1016/S1357-2725(99)00013-8; Schwartz K, 2014, INFECT IMMUN, V82, P3837, DOI 10.1128/IAI.02111-14; Schwartz K, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002744; Scott MG, 2002, J IMMUNOL, V169, P3883, DOI 10.4049/jimmunol.169.7.3883; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Sims GP, 2010, ANNU REV IMMUNOL, V28, P367, DOI 10.1146/annurev.immunol.021908.132603; Sorensen OE, 2001, BLOOD, V97, P3951, DOI 10.1182/blood.V97.12.3951; Steevels TAM, 2013, EUR J IMMUNOL, V43, P1297, DOI 10.1002/eji.201242916; Steevels TAM, 2010, J IMMUNOL, V184, P4741, DOI 10.4049/jimmunol.0902039; Tayeb-Fligelman E, 2017, SCIENCE, V355, P831, DOI 10.1126/science.aaf4901; Thennarasu S, 2010, BIOPHYS J, V98, P248, DOI 10.1016/j.bpj.2009.09.060; Tomasinsig L, 2008, J BIOL CHEM, V283, P30471, DOI 10.1074/jbc.M802185200; Tsompanidou E, 2013, APPL ENVIRON MICROB, V79, P886, DOI 10.1128/AEM.03157-12; Van Avondt K, 2016, J IMMUNOL, V196, P3686, DOI 10.4049/jimmunol.1501650; Van Avondt K, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004644; Van Avondt K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078459; van der Vlist M, 2016, NAT REV RHEUMATOL, V12, P593, DOI 10.1038/nrrheum.2016.131; Vandamme D, 2012, CELL IMMUNOL, V280, P22, DOI 10.1016/j.cellimm.2012.11.009; von Richthofen HJ, 2020, CELL IMMUNOL, V357, DOI 10.1016/j.cellimm.2020.104199; Wang R, 2007, NAT MED, V13, P1510, DOI 10.1038/nm1656; Wang R, 2011, J CLIN INVEST, V121, P238, DOI 10.1172/JCI42520; Williams MR, 2017, CELL HOST MICROBE, V22, P579, DOI 10.1016/j.chom.2017.10.015; Xhindoli D, 2016, BBA-BIOMEMBRANES, V1858, P546, DOI 10.1016/j.bbamem.2015.11.003; Yamasaki K, 2007, NAT MED, V13, P975, DOI 10.1038/nm1616; Yang D, 2017, IMMUNOL REV, V280, P41, DOI 10.1111/imr.12577	85	3	3	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2021	35	10							e21875	10.1096/fj.202100812R	http://dx.doi.org/10.1096/fj.202100812R			19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	UZ5IH	34533845				2022-12-26	WOS:000702238200037
J	Zhu, P; Dyka, F; Ma, XJ; Yin, L; Yu, H; Baehr, W; Hauswirth, WW; Deng, WT				Zhu, Ping; Dyka, Frank; Ma, Xiaojie; Yin, Ling; Yu, Heather; Baehr, Wolfgang; Hauswirth, William W.; Deng, Wen-Tao			Disease mechanisms of X-linked cone dystrophy caused by missense mutations in the red and green cone opsins	FASEB JOURNAL			English	Article						blue cone monochromacy; cone dystrophy; cone opsin; disease mechanism; photoreceptors	RHODOPSIN RETINITIS-PIGMENTOSA; COLOR-VISION; MOLECULAR-GENETICS; RETINAL STRUCTURE; MOUSE MODEL; EXON 3; BLUE; GENES; DISRUPTION; PHENOTYPE	Cone photoreceptors are responsible for the visual acuity and color vision of the human eye. Red/green cone opsin missense mutations N94K, W177R, P307L, R330Q, and G338E have been identified in subjects with congenital blue cone monochromacy or color-vision deficiency. Studies on disease mechanisms due to these cone opsin mutations have been previously carried out exclusively in vitro, and the reported impairments were not always consistent. Here we expressed these mutants via AAV specifically in vivo in M-opsin knockout mouse cones to investigate their subcellular localization, the pathogenic effects on cone structure, function, and cone viability. We show that these mutations alter the M-opsin structure, function, and localization. N94K and W177R mutants appeared to be misfolded since they localized exclusively in cone inner segments and endoplasmic reticulum. In contrast, P307L, R330Q, and G338E mutants were detected predominately in cone outer segments. Expression of R330Q and G338E, but not P307L opsins, also partially restored expression and correct localization of cone PDE6 alpha' and cone transducin gamma and resulted in partial rescue of M-cone-mediated light responses. Expression of W177R and P307L mutants significantly reduced cone viability, whereas N94K, R330Q, and G338E were only modestly toxic. We propose that although the underlying biochemical and cellular defects caused by these mutants are distinct, they all seem to exhibit a dominant phenotype, resembling autosomal dominant retinitis pigmentosa associated with the majority of rhodopsin missense mutations. The understanding of the molecular mechanisms associated with these cone opsin mutants is fundamental to developing targeted therapies for cone dystrophy/dysfunction.	[Zhu, Ping; Dyka, Frank; Ma, Xiaojie; Yin, Ling; Yu, Heather; Hauswirth, William W.; Deng, Wen-Tao] Univ Florida, Dept Ophthalmol, Gainesville, FL USA; [Baehr, Wolfgang] Univ Utah, Hlth Sci Ctr, Dept Ophthalmol, John A Moran Eye Ctr, Salt Lake City, UT 84132 USA; [Baehr, Wolfgang] Univ Utah, Hlth Sci Ctr, Dept Neurobiol & Anat, Salt Lake City, UT USA; [Baehr, Wolfgang] Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA; [Deng, Wen-Tao] West Virginia Univ, Dept Ophthalmol & Visual Sci, Morgantown, WV 26501 USA; [Deng, Wen-Tao] West Virginia Univ, Dept Biochem, Morgantown, WV 26501 USA	State University System of Florida; University of Florida; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; West Virginia University; West Virginia University	Deng, WT (corresponding author), West Virginia Univ, Dept Ophthalmol & Visual Sci, 1 Med Ctr Dr,Box 9193, Morgantown, WV 26506 USA.	wen.deng@hsc.wvu.edu			National Institutes of Health [R01 EY030056, EY021721, R01 EY08123, 1S10OD028476]; National Eye Institute [EY014800-039003]; Research to Prevent Blindness	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Research to Prevent Blindness(Research to Prevent Blindness (RPB))	National Institutes of Health, Grant/Award Number: R01 EY030056, EY021721, R01 EY08123 and 1S10OD028476; National Eye Institute, Grant/Award Number: EY014800-039003; Research to Prevent Blindness; National Institutes of Health, Grant/Award Number: R01 EY030056, EY021721, R01 EY08123 and 1S10OD028476	Athanasiou D, 2018, PROG RETIN EYE RES, V62, P1, DOI 10.1016/j.preteyeres.2017.10.002; Ayyagari R, 1999, MOL VIS, V5; Bakondi B, 2016, MOL THER, V24, P556, DOI 10.1038/mt.2015.220; Baralle D, 2005, J MED GENET, V42, P737, DOI 10.1136/jmg.2004.029538; BLANKS JC, 1983, J COMP NEUROL, V221, P31, DOI 10.1002/cne.902210103; Buena-Atienza E, 2016, SCI REP-UK, V6, DOI 10.1038/srep28253; Carroll J, 2004, P NATL ACAD SCI USA, V101, P8461, DOI 10.1073/pnas.0401440101; Carroll J, 2012, INVEST OPHTH VIS SCI, V53, P8006, DOI 10.1167/iovs.12-11087; Carroll J, 2010, VISION RES, V50, P1989, DOI 10.1016/j.visres.2010.07.009; Carroll J, 2009, P NATL ACAD SCI USA, V106, P20948, DOI 10.1073/pnas.0910128106; Cideciyan AV, 2018, P NATL ACAD SCI USA, V115, pE8547, DOI 10.1073/pnas.1805055115; Cideciyan AV, 2013, HUM GENE THER, V24, P993, DOI 10.1089/hum.2013.153; Crognale MA, 2004, VISUAL NEUROSCI, V21, P197, DOI 10.1017/S0952523804213384; CURCIO CA, 1991, J COMP NEUROL, V312, P610, DOI 10.1002/cne.903120411; CURCIO CA, 1990, J COMP NEUROL, V292, P497, DOI 10.1002/cne.902920402; DEEB SS, 1992, AM J HUM GENET, V51, P687; Deming JD, 2015, INVEST OPHTH VIS SCI, V56, P7618, DOI 10.1167/iovs.15-17832; Deng WT, 2018, MOL VIS, V24, P17; Faustino NA, 2003, GENE DEV, V17, P419, DOI 10.1101/gad.1048803; Gardner JC, 2014, HUM MUTAT, V35, P1354, DOI 10.1002/humu.22679; Gardner JC, 2010, AM J HUM GENET, V87, P26, DOI 10.1016/j.ajhg.2010.05.019; Gardner JC, 2009, MOL VIS, V15, P876; Giannelli SG, 2018, HUM MOL GENET, V27, P761, DOI 10.1093/hmg/ddx438; Greenwald SH, 2017, TRANSL VIS SCI TECHN, V6, DOI 10.1167/tvst.6.3.2; Griciuc A, 2011, TRENDS MOL MED, V17, P442, DOI 10.1016/j.molmed.2011.04.002; Hofmann L, 2017, BIOCHEMISTRY-US, V56, P2338, DOI 10.1021/acs.biochem.7b00165; Hwa J, 1999, P NATL ACAD SCI USA, V96, P1932, DOI 10.1073/pnas.96.5.1932; Jagla WM, 2002, HUM MOL GENET, V11, P23, DOI 10.1093/hmg/11.1.23; Jones BW, 2011, J COMP NEUROL, V519, P2713, DOI 10.1002/cne.22703; Kazmi MA, 1997, INVEST OPHTH VIS SCI, V38, P1074; Kellner U, 2004, GRAEF ARCH CLIN EXP, V242, P729, DOI 10.1007/s00417-004-0921-z; Kirchberg K, 2011, P NATL ACAD SCI USA, V108, P18690, DOI 10.1073/pnas.1015461108; Li PJ, 2018, CRISPR J, V1, P55, DOI 10.1089/crispr.2017.0009; Mancuso K, 2009, NATURE, V461, P784, DOI 10.1038/nature08401; Mao HY, 2012, HUM GENE THER, V23, P356, DOI 10.1089/hum.2011.213; Mao HY, 2011, HUM GENE THER, V22, P567, DOI 10.1089/hum.2010.140; Mendes HF, 2005, TRENDS MOL MED, V11, P177, DOI 10.1016/j.molmed.2005.02.007; Michaelides M, 2005, OPHTHALMOLOGY, V112, P1448, DOI 10.1016/j.ophtha.2005.02.021; Michaelides M, 2005, EYE, V19, P2, DOI 10.1038/sj.eye.6701391; Mizrahi-Meissonnier L, 2010, INVEST OPHTH VIS SCI, V51, P3884, DOI 10.1167/iovs.09-4592; Mustafi D, 2009, PROG RETIN EYE RES, V28, P289, DOI 10.1016/j.preteyeres.2009.05.003; NATHANS J, 1993, AM J HUM GENET, V53, P987; NATHANS J, 1989, SCIENCE, V245, P831, DOI 10.1126/science.2788922; NATHANS J, 1986, SCIENCE, V232, P203, DOI 10.1126/science.3485310; NATHANS J, 1986, SCIENCE, V232, P193, DOI 10.1126/science.2937147; Neitz J, 2011, VISION RES, V51, P633, DOI 10.1016/j.visres.2010.12.002; Neitz M, 2004, VISUAL NEUROSCI, V21, P205, DOI 10.1017/S0952523804213293; Nemet I, 2015, PROG MOL BIOL TRANSL, V132, P39, DOI 10.1016/bs.pmbts.2015.02.007; Orosz O, 2017, INVEST OPHTH VIS SCI, V58, P1834, DOI 10.1167/iovs.16-21405; Ostrer H, 1997, Mol Vis, V3, P16; Ostrer H, 1998, Mol Vis, V4, P28; Pang JJ, 2008, INVEST OPHTH VIS SCI, V49, P4278, DOI 10.1167/iovs.07-1622; Pang JJ, 2006, MOL THER, V13, P565, DOI 10.1016/j.ymthe.2005.09.001; Park Paul Shin-Hyun, 2014, Adv Pharmacol, V70, P1, DOI 10.1016/B978-0-12-417197-8.00001-8; REYNIERS E, 1995, GENOMICS, V29, P323, DOI 10.1006/geno.1995.9998; Riedmayr LM, 2020, HUM MOL GENET, V29, P295, DOI 10.1093/hmg/ddz291; Rivera-De la Parra D, 2013, GENE, V519, P173, DOI 10.1016/j.gene.2013.01.048; Sohocki MM, 2001, HUM MUTAT, V17, P42, DOI 10.1002/1098-1004(2001)17:1<42::AID-HUMU5>3.0.CO;2-K; Srinivasan S, 2017, BBA-MOL BASIS DIS, V1863, P1840, DOI 10.1016/j.bbadis.2017.05.006; Stenkamp RE, 2002, BBA-BIOMEMBRANES, V1565, P168, DOI 10.1016/S0005-2736(02)00567-9; Sullivan LS, 2006, INVEST OPHTH VIS SCI, V47, P3052, DOI 10.1167/iovs.05-1443; Sumaroka A, 2018, INVEST OPHTH VIS SCI, V59, P5762, DOI 10.1167/iovs.18-25280; Tanner G, 2009, HUM MUTAT, V30, P255, DOI 10.1002/humu.20861; Ueyama H, 2002, BIOCHEM BIOPH RES CO, V294, P205, DOI 10.1016/S0006-291X(02)00458-8; Ueyama H, 2012, BIOCHEM BIOPH RES CO, V424, P152, DOI 10.1016/j.bbrc.2012.06.094; Vissers PMAM, 1996, FEBS LETT, V396, P26, DOI 10.1016/0014-5793(96)01064-2; Wang GS, 2007, NAT REV GENET, V8, P749, DOI 10.1038/nrg2164; WINDERICKX J, 1992, NAT GENET, V1, P251, DOI 10.1038/ng0792-251; YOSHIZAWA T, 1992, PHOTOCHEM PHOTOBIOL, V56, P859, DOI 10.1111/j.1751-1097.1992.tb09707.x; Zhang F, 1998, Yan Ke Xue Bao, V14, P210; Zhang YX, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06982-7; Zolotukhin S, 2002, METHODS, V28, P158, DOI 10.1016/S1046-2023(02)00220-7	72	0	0	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2021	35	10							e21927	10.1096/fj.202101066R	http://dx.doi.org/10.1096/fj.202101066R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	UZ5IH	34547123	hybrid, Green Published			2022-12-26	WOS:000702238200005
J	Barmpoutis, P; Di Capite, M; Kayhanian, H; Waddingham, W; Alexander, DC; Jansen, M; Kwong, FNK				Barmpoutis, Panagiotis; Di Capite, Matthew; Kayhanian, Hamzeh; Waddingham, William; Alexander, Daniel C.; Jansen, Marnix; Kwong, Francois Ng Kee			Tertiary lymphoid structures (TLS) identification and density assessment on H&E-stained digital slides of lung cancer	PLOS ONE			English	Article							ACTIVE CONTOURS DRIVEN; SEGMENTATION; CLASSIFICATION; IMAGES	Tertiary lymphoid structures (TLS) are ectopic aggregates of lymphoid cells in inflamed, infected, or tumoral tissues that are easily recognized on an H&E histology slide as discrete entities, distinct from lymphocytes. TLS are associated with improved cancer prognosis but there is no standardised method available to quantify their presence. Previous studies have used immunohistochemistry to determine the presence of specific cells as a marker of the TLS. This has now been proven to be an underestimate of the true number of TLS. Thus, we propose a methodology for the automated identification and quantification of TLS, based on H&E slides. We subsequently determined the mathematical criteria defining a TLS. TLS regions were identified through a deep convolutional neural network and segmentation of lymphocytes was performed through an ellipsoidal model. This methodology had a 92.87% specificity at 95% sensitivity, 88.79% specificity at 98% sensitivity and 84.32% specificity at 99% sensitivity level based on 144 TLS annotated H&E slides implying that the automated approach was able to reproduce the histopathologists' assessment with great accuracy. We showed that the minimum number of lymphocytes within TLS is 45 and the minimum TLS area is 6,245 mu m(2). Furthermore, we have shown that the density of the lymphocytes is more than 3 times those outside of the TLS. The mean density and standard deviation of lymphocytes within a TLS area are 0.0128/mu m(2) and 0.0026/mu m(2) respectively compared to 0.004/mu m(2) and 0.001/mu m(2) in non-TLS regions. The proposed methodology shows great potential for automated identification and quantification of the TLS density on digital H&E slides.	[Barmpoutis, Panagiotis; Kayhanian, Hamzeh; Waddingham, William; Jansen, Marnix] UCL, UCL Canc Inst, Dept Pathol, London, England; [Barmpoutis, Panagiotis; Alexander, Daniel C.] UCL, Ctr Med Image Comp, London, England; [Di Capite, Matthew; Kwong, Francois Ng Kee] Norfolk & Norwich Univ Hosp, Dept Histopathol, Norwich, Norfolk, England	University of London; University College London; University of London; University College London; Norfolk & Norwich University Hospitals NHS Foundation Trust; Norfolk & Norwich University Hospital	Barmpoutis, P (corresponding author), UCL, UCL Canc Inst, Dept Pathol, London, England.; Barmpoutis, P (corresponding author), UCL, Ctr Med Image Comp, London, England.	p.barmpoutis@ucl.ac.uk		Alexander, Daniel/0000-0003-2439-350X	Engineering and Physical Sciences Research Council [EP/M020533/1]; NIHR UCLH Biomedical Research Centre	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); NIHR UCLH Biomedical Research Centre	Financial support for the work was provided by Engineering and Physical Sciences Research Council under grant EP/M020533/1.; We acknowledge the department of Pathology, of UCL Cancer Institute, the UCL Centre for Medical Image Computing and the Department of Histopathology of the Norfolk and Norwich University Hospital for their general support. We also acknowledge the support of the NIHR UCLH Biomedical Research Centre.	Al-Kofahi Y, 2018, BMC BIOINFORMATICS, V19, DOI 10.1186/s12859-018-2375-z; Alqazzaz S, 2019, COMPUT VIS MEDIA, V5, P209, DOI 10.1007/s41095-019-0139-y; Altini N, 2020, ELECTRONICS-SWITZ, V9, DOI 10.3390/electronics9030503; Badrinarayanan V, 2017, IEEE T PATTERN ANAL, V39, P2481, DOI 10.1109/TPAMI.2016.2644615; Barbier M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156942; BenTaieb Aicha, 2016, Medical Image Computing and Computer-Assisted Intervention - MICCAI 2016. 19th International Conference. Proceedings: LNCS 9901, P460, DOI 10.1007/978-3-319-46723-8_53; Cabrita R, 2020, NATURE, V577, P561, DOI 10.1038/s41586-019-1914-8; Chen LCE, 2018, LECT NOTES COMPUT SC, V11211, P833, DOI 10.1007/978-3-030-01234-2_49; Chen X, P IEEE CVF C COMP VI, P11632; Cicek Ozgun, 2016, Medical Image Computing and Computer-Assisted Intervention - MICCAI 2016. 19th International Conference. Proceedings: LNCS 9901, P424, DOI 10.1007/978-3-319-46723-8_49; Dabass M, 2018, 2018 4 INT C COMP CO, P1; Dieu-Nosjean MC, 2016, IMMUNOL REV, V271, P260, DOI 10.1111/imr.12405; Dieu-Nosjean MC, 2014, TRENDS IMMUNOL, V35, P571, DOI 10.1016/j.it.2014.09.006; Dimitropoulos K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185110; Dimitropoulos K, 2017, SIGNAL IMAGE VIDEO P, V11, P145, DOI 10.1007/s11760-016-0913-6; Donahue J, 2014, PR MACH LEARN RES, V32; Falk T, 2019, NAT METHODS, V16, P67, DOI 10.1038/s41592-018-0261-2; GRAHAM DM, 1990, MODERN PATHOL, V3, P332; Huang ZP, 2016, 2016 3RD INTERNATIONAL CONFERENCE ON INFORMATION SCIENCE AND CONTROL ENGINEERING (ICISCE), P1011, DOI 10.1109/ICISCE.2016.218; Ing N, 2018, PROC SPIE, V10581, DOI 10.1117/12.2293000; Ji ZX, 2015, INFORM SCIENCES, V301, P285, DOI 10.1016/j.ins.2015.01.006; Jiang YQ, 2020, BRIT J DERMATOL, V182, P754, DOI 10.1111/bjd.18026; Krithiga R, 2021, ARCH COMPUT METHOD E, V28, P2607, DOI 10.1007/s11831-020-09470-w; Krizhevsky A., 2012, ADV NEURAL INF PROCE; Kucharski D, 2020, SENSORS-BASEL, V20, DOI 10.3390/s20061546; Lee HG, 2018, IEEE J BIOMED HEALTH, V22, P235, DOI 10.1109/JBHI.2017.2700518; Lei Pan, 2008, 5th International Conference on Information Technology and Applications in Biomedicine (ITAB 2008) in conjunction with 2nd International Symposium & Summer School on Biomedical and Health Engineering (IS3BHE 2008), P82, DOI 10.1109/ITAB.2008.4570542; Liang YB, 2019, INT J PATTERN RECOGN, V33, DOI 10.1142/S0218001419540193; Liao M, 2016, NEUROCOMPUTING, V173, P615, DOI 10.1016/j.neucom.2015.08.006; Liu N, 2017, INT C BIOMETRICS ICB, P1; Lu ZX, 2020, JCO CLIN CANCER INFO, V4, P480, DOI 10.1200/CCI.19.00126; Molnar C, 2016, SCI REP-UK, V6, DOI 10.1038/srep32412; Moshkov N, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-61808-3; Munoz-Erazo L, 2020, CELL MOL IMMUNOL, V17, P570, DOI 10.1038/s41423-020-0457-0; Pan SJ, 2010, IEEE T KNOWL DATA EN, V22, P1345, DOI 10.1109/TKDE.2009.191; Panagiotakis C, 2020, IMAGE VISION COMPUT, V93, DOI 10.1016/j.imavis.2019.09.001; Posch F, 2018, ONCOIMMUNOLOGY, V7, DOI 10.1080/2162402X.2017.1378844; Pratondo A, 2017, J VIS COMMUN IMAGE R, V43, P1, DOI 10.1016/j.jvcir.2016.11.019; Priya Verma VS, 2017, 2017 3 INT C COMPUTA, P1; Ronneberger O., 2015, INT C MED IM COMP CO, P234; Sautes-Fridman C, 2019, NAT REV CANCER, V19, P307, DOI 10.1038/s41568-019-0144-6; Sautes-Fridman C, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00407; Silina K, 2018, METHODS MOL BIOL, V1845, P71, DOI 10.1007/978-1-4939-8709-2_5; Silina K, 2018, CANCER RES, V78, P1308, DOI 10.1158/0008-5472.CAN-17-1987; Su H, 2015, LECT NOTES COMPUT SC, V9351, P383, DOI 10.1007/978-3-319-24574-4_46; Sun LT, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-58674-4; Sun SJ, 2020, I S BIOMED IMAGING, P476, DOI 10.1109/ISBI45749.2020.9098695; Szegedy C, 2017, AAAI CONF ARTIF INTE, P4278; Tang J, 2018, PROCEEDINGS 2018 33RD YOUTH ACADEMIC ANNUAL CONFERENCE OF CHINESE ASSOCIATION OF AUTOMATION (YAC), P1078; Tang W, 2020, NEURAL COMPUT APPL, V32, P6769, DOI 10.1007/s00521-019-04700-0; Tareef A, 2018, IEEE T MED IMAGING, V37, P2044, DOI 10.1109/TMI.2018.2815013; Travis WD, 2015, J THORAC ONCOL, V10, P1243, DOI 10.1097/JTO.0000000000000630; Ueno H, 2007, AM J CLIN PATHOL, V127, P287, DOI 10.1309/903UT10VQ3LC7B8L; Wan T, 2019, NEUROCOMPUTING, V365, P157, DOI 10.1016/j.neucom.2019.06.086; Wang L, 2009, SIGNAL PROCESS, V89, P2435, DOI 10.1016/j.sigpro.2009.03.014; Win KY, 2017, 2017 INTERNATIONAL CONFERENCE ON DIGITAL ARTS, MEDIA AND TECHNOLOGY (ICDAMT): DIGITAL ECONOMY FOR SUSTAINABLE GROWTH, P14, DOI 10.1109/ICDAMT.2017.7904925; Withey DJ, 2007, 2007 JOINT MEETING OF THE 6TH INTERNATIONAL SYMPOSIUM ON NONINVASIVE FUNCTIONAL SOURCE IMAGING OF THE BRAIN AND HEART AND THE INTERNATIONAL CONFERENCE ON FUNCTIONAL BIOMEDICAL IMAGING, P143; Xiao WT, 2018, IEEE INT C ELECTR TA	58	5	5	4	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2021	16	9							e0256907	10.1371/journal.pone.0256907	http://dx.doi.org/10.1371/journal.pone.0256907			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XH8RH	34555057	Green Published, gold			2022-12-26	WOS:000725694500015
J	Ares-Blanco, S; Alvarez, MP; Larrondo, IG; Munoz, C; Ruiz, VA; Jurado, MC; Guisado-Clavero, M				Ares-Blanco, Sara; Perez Alvarez, Marta; Gefaell Larrondo, Ileana; Munoz, Cristina; Aguilar Ruiz, Vanesa; Castelo Jurado, Marta; Guisado-Clavero, Marina			SARS-CoV-2 pneumonia follow-up and long COVID in primary care: A retrospective observational study in Madrid city	PLOS ONE			English	Article								Background Patients with COVID-19 are follow-up in primary care and long COVID is scarcely defined. The study aim was to describe SARS-CoV-2 pneumonia and cut-offs for defining long COVID in primary care follow-up patients. Methods A retrospective observational study in primary care in Madrid, Spain, was conducted. Data was collected during 6 months (April to September) in 2020, during COVID-19 first wave, from patients >= 18 years with SARS-CoV-2 pneumonia diagnosed. Variables: sociodemographic, comorbidities, COVID-19 symptoms and complications, laboratory test and chest X-ray. Descriptive statistics were used, mean (standard deviation (SD)) and medians (interquartile range (IQR)) respectively. Differences were detected applying X-2 test, Student's T-test, ANOVA, Wilcoxon-Mann-Whitney or Kruskal-Wallis depending on variable characteristics. Results 155 patients presented pneumonia in day 7.8 from the onset (79.4% were hospitalized, median length of 7.0 days (IQR: 3.0, 13.0)). After discharge, the follow-up lasted 54.0 median days (IQR 42.0, 88.0) and 12.2 mean (SD 6.4) phone calls were registered per patient. The main symptoms and their duration were: cough (41.9%, 12 days), dyspnoea (31.0%, 15 days), asthenia (26.5%, 21 days). Different cut-off points were applied for long COVID and week 4 was considered the best milestone (28.3% of the sample still had symptoms after week 4) versus week 12 (8.3%). Patients who still had symptoms > 4 weeks follow-up took place over 81.0 days (IQR: 50.5, 103.0), their symptoms were more prevalent and lasted longer than those <= 4 weeks: cough (63.6% 30 days), dyspnoea (54.6%, 46 days), and asthenia (56.8%, 29 days). Embolism was more frequent in patients who still had symptoms > 4 weeks than those with symptoms <= 4 weeks (9.1% vs 1.8%, p value 0.034). Conclusion Most patients with SARS-CoV-2 pneumonia recovered during the first 4 weeks from the beginning of the infection. The cut-off point to define long COVID, as persisting symptoms, should be between 4 to 12 weeks from the onset of the symptoms.	[Ares-Blanco, Sara; Perez Alvarez, Marta; Gefaell Larrondo, Ileana; Aguilar Ruiz, Vanesa; Castelo Jurado, Marta] Gerencia Asistencial Atenc Primaria, Madrid Hlth Serv, Feder Montseny Primary Hlth Care Ctr, Madrid, Spain; [Munoz, Cristina] Gerencia Asistencial Atenc Primaria, Madrid Hlth Serv, Serv Atenc Rural Norte, Madrid, Spain; [Guisado-Clavero, Marina] Gerencia Asistencial Atenc Primaria, Unidad Docente Multiprofes Atenc Familiar & Comun, Madrid Hlth Serv, Madrid, Spain		Guisado-Clavero, M (corresponding author), Gerencia Asistencial Atenc Primaria, Unidad Docente Multiprofes Atenc Familiar & Comun, Madrid Hlth Serv, Madrid, Spain.	marina.guisado@salud.madrid.org	Ares Blanco, Sara/L-6502-2018	Ares Blanco, Sara/0000-0002-4984-8788; Gefaell, Ileana/0000-0002-1635-1003; Guisado-Clavero, Marina/0000-0002-8448-2929	Foundation for Biomedical Research and Innovation in Primary Care (FIIBAP)	Foundation for Biomedical Research and Innovation in Primary Care (FIIBAP)	This manuscript has received a grant from the Foundation for Biomedical Research and Innovation in Primary Care (FIIBAP) for publication in 2021 (FIIBAP/mar21).	[Anonymous], 2020, NATURE, V586, P170, DOI 10.1038/d41586-020-02796-2; Arnold DT, PATIENT OUTCOMES HOS; British Thoracic Society, BRIT THOR SOC GUID R; Carfi A, 2020, JAMA-J AM MED ASSOC, V324, P603, DOI 10.1001/jama.2020.12603; Choi MH, 2020, J CLIN MED, V9, DOI 10.3390/jcm9061959; Comunidad de Madrid, CONS SAN DAT COVID 1; Crameri Giovanni Andrea Gerardo, 2020, Euro Surveill, V25, DOI 10.2807/1560-7917.ES.2020.25.36.2001542; England PH, 2020, GUID COVID 19 LONG T; Fraser E, 2020, BMJ-BRIT MED J, V370, DOI 10.1136/bmj.m3001; Frija-Masson J, 2020, EUR RESPIR J, V56, DOI 10.1183/13993003.01754-2020; Gorna R., 2020, LANCET LONDON ENGLAN, V6736, P19; Greenhalgh T, 2020, BMJ-BRIT MED J, V370, DOI 10.1136/bmj.m3026; Halpin SJ, 2021, J MED VIROL, V93, P1013, DOI 10.1002/jmv.26368; Huang CL, 2021, LANCET, V397, P220, DOI 10.1016/S0140-6736(20)32656-8; Kingstone Tom, 2020, BJGP Open, V4, DOI 10.3399/bjgpopen20X101143; Lee K, 2009, GLOB INST, P1; Mahase E, 2020, BMJ-BRIT MED J, V370, DOI 10.1136/bmj.m2815; Mandal S, 2021, THORAX, V76, P396, DOI 10.1136/thoraxjnl-2020-215818; Ministerio de Sanidad Consumo y Bienestar Social, SIT ACT COR; NICE, COVID 19 RAP GUID MA; O'Grady NP, 2002, CLIN INFECT DIS, V35, P1281, DOI 10.1086/344188; Pollan M, 2020, LANCET, V396, P535, DOI 10.1016/S0140-6736(20)31483-5; Raghu G, 2020, LANCET RESP MED, V8, P839, DOI 10.1016/S2213-2600(20)30349-0; Struyf T, 2020, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD013665; Tenforde MW, 2020, MMWR-MORBID MORTAL W, V69, P993, DOI [10.15585/mmwr.mm6930e1, 10.15585/mmwr.mm6930e1externalicon]; Zhao YM, 2020, ECLINICALMEDICINE, V25, DOI 10.1016/j.eclinm.2020.100463; Zheng Z, 2020, J MED VIROL, V92, P2412, DOI 10.1002/jmv.25994; Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3	28	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2021	16	9							e0257604	10.1371/journal.pone.0257604	http://dx.doi.org/10.1371/journal.pone.0257604			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YS4WS	34551007	gold, Green Published			2022-12-26	WOS:000750679800030
J	Ogoina, D; Mahmood, D; Oyeyemi, AS; Okoye, OC; Kwaghe, V; Habib, Z; Unigwe, U; Iroezindu, MO; Garbati, MA; Rotifa, S; Adekanmbi, O; Garba, I; Dayyab, FM; Ibrahim, SM; Kida, IM; Adamu, A; Alasia, D; Awang, SK; Ohaju-Obodo, JO; Usman, R; Mohammed, Y; Omololu, A; Tobin, EA; Okogbenin, S; Asogun, D; Kelly, I; Waziri, B; Nauzo, AM; Jibrin, Y; Habib, AG				Ogoina, Dimie; Mahmood, Dalhat; Oyeyemi, Abisoye Sunday; Okoye, Ogochukwu Chinedum; Kwaghe, Vivian; Habib, Zayaid; Unigwe, Uche; Iroezindu, Michael Onyebuchi; Garbati, Musa Abubakar; Rotifa, Stella; Adekanmbi, Olukemi; Garba, Iliyasu; Dayyab, Farouq Muhammad; Ibrahim, Sanusi Mohammed; Kida, Ibrahim Musa; Adamu, Adamu; Alasia, Datonye; Awang, Sati Klein; Ohaju-Obodo, John Oghenevwirhe; Usman, Rabi; Mohammed, Yahaya; Omololu, Ayanfe; Tobin, Ekaete Alice; Okogbenin, Sylvanus; Asogun, Danny; Kelly, Iraoyah; Waziri, Bala; Nauzo, Aliyu Mamman; Jibrin, Yusuf; Habib, Abdulrazaq Garba			A national survey of hospital readiness during the COVID-19 pandemic in Nigeria	PLOS ONE			English	Article							PREPAREDNESS	Introduction The COVID-19 pandemic continues to overwhelm health systems across the globe. We aimed to assess the readiness of hospitals in Nigeria to respond to the COVID-19 outbreak. Method Between April and October 2020, hospital representatives completed a modified World Health Organisation (WHO) COVID-19 hospital readiness checklist consisting of 13 components and 124 indicators. Readiness scores were classified as adequate (score >= 80%), moderate (score 50-79.9%) and not ready (score < 50%). Results Among 20 (17 tertiary and three secondary) hospitals from all six geopolitical zones of Nigeria, readiness score ranged from 28.2% to 88.7% (median 68.4%), and only three (15%) hospitals had adequate readiness. There was a median of 15 isolation beds, four ICU beds and four ventilators per hospital, but over 45% of hospitals established isolation facilities and procured ventilators after the onset of COVID-19. Of the 13 readiness components, the lowest readiness scores were reported for surge capacity (61.1%), human resources (59.1%), staff welfare (50%) and availability of critical items (47.7%). Conclusion Most hospitals in Nigeria were not adequately prepared to respond to the COVID-19 outbreak. Current efforts to strengthen hospital preparedness should prioritize challenges related to surge capacity, critical care for COVID-19 patients, and staff welfare and protection.	[Ogoina, Dimie] Niger Delta Univ, Dept Internal Med, Niger Delta Univ Teaching Hosp, Yenagoa, Bayelsa State, Nigeria; [Mahmood, Dalhat] African Field Epidemiol Network, Abuja, Nigeria; [Oyeyemi, Abisoye Sunday] Niger Delta Univ, Dept Community Med, Niger Delta Univ Teaching Hosp, Yenagoa, Bayelsa State, Nigeria; [Okoye, Ogochukwu Chinedum; Ohaju-Obodo, John Oghenevwirhe] Delta State Univ, Fac Clin Med, Dept Internal Med, Abraka, Delta State, Nigeria; [Kwaghe, Vivian; Habib, Zayaid] Univ Abuja, Dept Internal Med, Teaching Hosp, Gwagwalada, Nigeria; [Unigwe, Uche; Iroezindu, Michael Onyebuchi] Univ Nigeria, Dept Med, Teaching Hosp, Ituku Ozalla, Enugu, Nigeria; [Garbati, Musa Abubakar; Ibrahim, Sanusi Mohammed; Kida, Ibrahim Musa; Adamu, Adamu] Univ Maiduguri, Univ Maiduguri Teaching Hosp, Maiduguri, Borno State, Nigeria; [Rotifa, Stella] Fed Med Ctr Yenagoa, Dept Community Med, Yenagoa, Bayelsa State, Nigeria; [Adekanmbi, Olukemi] Univ Ibadan, Dept Med, Univ Coll Hosp, Ibadan, Oyo State, Nigeria; [Garba, Iliyasu; Habib, Abdulrazaq Garba] Bayero Univ Kano, Coll Hlth Sci, Dept Med, Infect Dis & Trop Med Unit, Kano, Nigeria; [Dayyab, Farouq Muhammad] Infect Dis Hosp, Kano, Nigeria; [Alasia, Datonye] Univ Port Harcourt, Dept Internal Med, Coll Hlth Sci, Port Harcourt, Nigeria; [Awang, Sati Klein] Fed Med Ctr, Dept Internal Med, Yola, Adamawa State, Nigeria; [Usman, Rabi] Zamfara State Minist Hlth, Zamfara, Nigeria; [Mohammed, Yahaya] Usmanu Danfodiyo Univ Sokoto, Dept Med Microbiol & Parasitol, Sokoto, Nigeria; [Omololu, Ayanfe] Fed Med Ctr Abeokuta, Dept Med, Abeokuta, Ogun State, Nigeria; [Tobin, Ekaete Alice] Irrua Specialist Teaching Hosp, Inst Lassa Fever Res & Control, Irrua, Nigeria; [Okogbenin, Sylvanus] Irrua Specialist Teaching Hosp, Dept Obstet & Gynaecol, Irrua, Nigeria; [Asogun, Danny] Irrua Specialist Teaching Hosp, Dept Community Hlth, Irrua, Nigeria; [Kelly, Iraoyah] Irrua Specialist Teaching Hosp, Dept Internal Med, Irrua, Nigeria; [Waziri, Bala] Ibrahim Badamasi Babangida Specialist Hosp, Dept Med, Minna, Niger State, Nigeria; [Nauzo, Aliyu Mamman] Fed Med Ctr Birnin Kebbi, Dept Paediat, Birnin Kebbi, Kebbi State, Nigeria; [Jibrin, Yusuf] Abubakar Tafawa Balewa Univ, Dept Med, Teaching Hosp Bauchi, Bauchi, Nigeria	University of Nigeria; University of Ibadan; University College Hospital, Ibadan; Bayero University; University of Port Harcourt	Ogoina, D (corresponding author), Niger Delta Univ, Dept Internal Med, Niger Delta Univ Teaching Hosp, Yenagoa, Bayelsa State, Nigeria.	dimieogoina@gmail.com	Ibrahim, Sanusi Mohammed/AAE-6044-2022	Ibrahim, Sanusi Mohammed/0000-0003-2937-3452; Ogoina, Dimie/0000-0002-2098-6300; Dayyab, Farouq/0000-0001-8920-6483; Omololu, Ayanfe/0000-0003-0052-7622; ALASIA, DATONYE/0000-0002-2873-8651				Barasa EW, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0236308; Cori A., 2020, REPORT 6 RELATIVE SE, P1, DOI [10.21203/rs.3.rs-72304/v1, DOI 10.21203/RS.3.RS-72304/V1]; COVID, 2020, COVID 19 PREPAREDNES; Editorial, 2020, THISDAY; Gilbert M, 2020, LANCET, V395, P871, DOI 10.1016/S0140-6736(20)30411-6; Grimm CA, 2020, HOSP EXPERIENCES RES; Moein Khorsand Chobdar, 2020, Journal of Military Medicine, V22, pfa553, DOI 10.30491/JMM.22.6.553; Pan American Health Organisation, 2020, HOSP READ ACT RESP C; Presidential Task Force Price Waterhouse Coopers, 2020, PRES TASK FORC COVID; Sonenthal PD, 2020, LANCET GLOB HEALTH, V8, pE890, DOI 10.1016/S2214-109X(20)30250-3; Verma VR, 2020, INFECT DIS MODEL, V5, P608, DOI 10.1016/j.idm.2020.08.011; WINTAC, 2020, WORKPL READ SKILLS T; World Health Organisation, 2015, FRAM PUBL HLTH EM OP; World Health Organisation, 2021, WEEKLY EPIDEMIOLOGIC; World Health Organisation, 2011, HOSP EMERGENCY RESPO; World Health Organisation, 2020, WHO AFR REG COVID 19; World Health Organisation, 2020, COR DIS COVID 19 OUT; World Health Organisation, 2020, WHO RAMPS PREP NOV C; World Health Organisation, 2020, LIST PRIOR MED DEV C; World Health Organisation,, 2020, MENT HLTH PSYCH CONS; World Health Organisation, 2020, EXP HOSP MAN OUTBR C; World Health Organisation (WHO), 2020, PULS SURV CONT ESS H	22	3	3	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2021	16	9							e0257567	10.1371/journal.pone.0257567	http://dx.doi.org/10.1371/journal.pone.0257567			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YM4DR	34547038	Green Published, gold			2022-12-26	WOS:000746527400019
J	Amaral, CD; Correa, GRE; Mujica, LKS; Fiorenza, MF; Rosa, SG; Nogueira, CW; Portela, VM; Comim, FV; Schoenau, W; Smirnova, NP; Antoniazzi, AQ				Amaral, Carolina dos Santos; Everling Correa, Gabrielle Rebeca; Serrano Mujica, Lady Katerine; Fiorenza, Mariani Farias; Rosa, Suzan Goncalves; Nogueira, Cristina Wayne; Portela, Valerio Marques; Comim, Fabio Vasconcellos; Schoenau, William; Smirnova, Natalia Pavlovna; Antoniazzi, Alfredo Quites			Heat stress modulates polymorphonuclear cell response in early pregnancy cows: I. interferon pathway and oxidative stress	PLOS ONE			English	Article							TIMED ARTIFICIAL-INSEMINATION; STIMULATED GENE-EXPRESSION; DAIRY-COWS; EMBRYONIC MORTALITY; BLOOD LEUKOCYTES; BOVINE EMBRYOS; MESSENGER-RNA; TAU; PROGESTERONE; ENZYMES	One of the major causes of early pregnancy loss is heat stress. In ruminants, interferon tau (IFNT) is the embryo signal to the mother. Once the interferon signaling pathway is activated, it drives gene expression for interferon-stimulated genes (ISGs) and alters neutrophils responses. The aim of the present study was to evaluate interferon (IFN) pathway, ISGs and gene expression in polymorphonuclear leukocytes (PMN) and oxidative stress in dairy cows under heat stress. Pregnant cows had their estrous cycle synchronized and randomly assigned to a comfort or heat stress group. Blood samples were collected at artificial insemination (AI) and on Days 10, 14 and 18 following AI. Pregnant cows were pregnancy checked by ultrasound on Day 30 and confirmed on Day 60 post-AI. Results are presented as mean +/- SEM. The corpus luteum (CL) diameter was not different between groups of pregnant cows; concentration of progesterone of pregnant cows on Day 18 following AI was greater in comfort group compared to heat stressed group. Comfort pregnant cows had higher expression of all analyzed genes from interferon pathway, except for IFNAR1, on both Days 14 and 18. Conversely, heat stressed cows did not show altered expression of IFNT pathway genes and ISGs between Days 10, 14, and 18 after AI. The oxidative stress, determined as malondialdehyde (MDA) levels, was greater in heat stress group on Days 10, 14 and 18, independent of pregnancy status. Heat stress negatively influences expression of ISGs, IFN pathway gene expression in neutrophils, and oxidative stress. Our data suggest that lower conception rates in cows under heat stress are multifactorial, with the association of interferon pathway activation and the unbalanced oxidative stress being main contributing factors.	[Amaral, Carolina dos Santos; Everling Correa, Gabrielle Rebeca; Serrano Mujica, Lady Katerine; Fiorenza, Mariani Farias; Rosa, Suzan Goncalves; Portela, Valerio Marques; Comim, Fabio Vasconcellos; Schoenau, William; Antoniazzi, Alfredo Quites] Univ Fed Santa Maria, Biotechnol & Anim Reprod Lab, Santa Maria, RS, Brazil; [Nogueira, Cristina Wayne] Univ Fed Santa Maria, Synth React & Organocalcogens Pharmacol & Toxicol, Santa Maria, RS, Brazil	Universidade Federal de Santa Maria (UFSM); Universidade Federal de Santa Maria (UFSM)	Antoniazzi, AQ (corresponding author), Univ Fed Santa Maria, Biotechnol & Anim Reprod Lab, Santa Maria, RS, Brazil.	alfredo.antoniazzi@ufsm.br	Comim, Fabio Vasconcellos/L-1298-2015; Farias Fiorenza, Mariani/AAD-9099-2022; Antoniazzi, Alfredo/L-5498-2016	Comim, Fabio Vasconcellos/0000-0002-2726-233X; Farias Fiorenza, Mariani/0000-0001-8202-0678; dos Santos Amaral, Carolina/0000-0002-5932-0522; Antoniazzi, Alfredo/0000-0003-4866-5944; Schoenau, William/0000-0002-6453-6301	Coordination for the Improvement of Higher Education Personnel (CAPES) [001]; Research Support Foundation of the State of Rio Grande do Sul (FAPERGS); National Council for Scientific and Technological Development (CNPq)	Coordination for the Improvement of Higher Education Personnel (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Research Support Foundation of the State of Rio Grande do Sul (FAPERGS)(Fundacao de Amparo a Ciencia e Tecnologia do Estado do Rio Grande do Sul (FAPERGS)); National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	CSA and AQA were supported by Coordination for the Improvement of Higher Education Personnel (CAPES; Financial code 001), Research Support Foundation of the State of Rio Grande do Sul (FAPERGS), and National Council for Scientific and Technological Development (CNPq).	AEBI H, 1984, METHOD ENZYMOL, V105, P121; Al-Katanani YM, 2002, J DAIRY SCI, V85, P390, DOI 10.3168/jds.S0022-0302(02)74086-1; Alhussien MN, 2018, THERIOGENOLOGY, V114, P149, DOI 10.1016/j.theriogenology.2018.03.036; Amaral CS, 2020, MOL REPROD DEV, V87, P899, DOI 10.1002/mrd.23407; Ander SE, 2019, SCI IMMUNOL, V4, DOI 10.1126/sciimmunol.aat6114; Antoniazzi AQ, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.112.105684; AYALON N, 1978, J REPROD FERTIL, V54, P483, DOI 10.1530/jrf.0.0540483; BAZER FW, 1986, J REPROD FERTIL, V76, P841, DOI 10.1530/jrf.0.0760841; Bernabucci U, 2002, J DAIRY SCI, V85, P2173, DOI 10.3168/jds.S0022-0302(02)74296-3; Binelli M, 2001, BIOL REPROD, V64, P654, DOI 10.1095/biolreprod64.2.654; Bott RC, 2010, BIOL REPROD, V82, P725, DOI 10.1095/biolreprod.109.079467; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bridges PJ, 2005, DOMEST ANIM ENDOCRIN, V29, P508, DOI 10.1016/j.domaniend.2005.02.017; Carvalho PD, 2017, J DAIRY SCI, V100, P3233, DOI 10.3168/jds.2016-11996; Chelmonska-Soyta A, 2002, ARCH IMMUNOL THER EX, V50, P47; Chen K, 2017, J AUTOIMMUN, V83, P1, DOI 10.1016/j.jaut.2017.03.008; De Rensis F, 2017, THERIOGENOLOGY, V91, P145, DOI 10.1016/j.theriogenology.2016.12.024; De Rensis F, 2003, THERIOGENOLOGY, V60, P1139, DOI 10.1016/S0093-691X(03)00126-2; Duhe RJ, 1998, P NATL ACAD SCI USA, V95, P126, DOI 10.1073/pnas.95.1.126; FARIN CE, 1990, BIOL REPROD, V43, P210, DOI 10.1095/biolreprod43.2.210; FERGUSON JD, 1994, J DAIRY SCI, V77, P2695, DOI 10.3168/jds.S0022-0302(94)77212-X; Garcia-Ispierto I, 2017, THERIOGENOLOGY, V90, P20, DOI 10.1016/j.theriogenology.2016.11.006; Green JC, 2010, ANIM REPROD SCI, V121, P24, DOI 10.1016/j.anireprosci.2010.05.010; Grotto D, 2007, J PHARMACEUT BIOMED, V43, P619, DOI 10.1016/j.jpba.2006.07.030; Guo J, 2018, ASIAN AUSTRAL J ANIM, V31, P47, DOI 10.5713/ajas.16.0428; Han HC, 2006, J ENDOCRINOL, V191, P505, DOI 10.1677/joe.1.07015; Hansen TR, 2017, REPRODUCTION, V154, pF45, DOI 10.1530/REP-17-0315; Haq IU, 2016, REPROD BIOL, V16, P255, DOI 10.1016/j.repbio.2016.10.001; Hirayama H, 2014, THERIOGENOLOGY, V81, P1108, DOI 10.1016/j.theriogenology.2014.01.039; IMAKAWA K, 1987, NATURE, V330, P377, DOI 10.1038/330377a0; Kizaki K, 2013, REPROD BIOL ENDOCRIN, V11, DOI 10.1186/1477-7827-11-6; Lonergan P, 2016, ANIM REPROD, V13, P143, DOI 10.21451/1984-3143-AR867; Lucio AC, 2016, THERIOGENOLOGY, V86, P924, DOI 10.1016/j.theriogenology.2016.03.015; Mader TL, 2006, J ANIM SCI, V84, P712, DOI 10.2527/2006.843712x; Mantovani A, 2011, NAT REV IMMUNOL, V11, P519, DOI 10.1038/nri3024; McCracken JA, 1999, PHYSIOL REV, V79, P263, DOI 10.1152/physrev.1999.79.2.263; McCracken VL, 2015, J DAIRY SCI, V98, P3152, DOI 10.3168/jds.2014-8826; Meng D, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/160859; MISRA HP, 1972, J BIOL CHEM, V247, P3170; Morales DJ, 2013, J MOL BIOL, V425, P4995, DOI 10.1016/j.jmb.2013.09.041; Niswender GD, 2000, PHYSIOL REV, V80, P1, DOI 10.1152/physrev.2000.80.1.1; Oliveira JF, 2008, ENDOCRINOLOGY, V149, P1252, DOI 10.1210/en.2007-0863; OMAR RA, 1987, CANCER RES, V47, P3473; Ott TL, 2020, THERIOGENOLOGY, V150, P498, DOI 10.1016/j.theriogenology.2020.04.010; Pereira MHC, 2015, J DAIRY SCI, V98, P947, DOI 10.3168/jds.2014-8523; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Rivera RM, 2001, REPRODUCTION, V121, P107, DOI 10.1530/rep.0.1210107; Romero JJ, 2015, BIOL REPROD, V93, DOI 10.1095/biolreprod.115.132860; Rosenfeld CS, 2002, BIOL REPROD, V67, P847, DOI 10.1095/biolreprod.102.004267; Roth Z, 2015, J ANIM SCI, V93, P2034, DOI 10.2527/jas.2014-8625; Sakatani M, 2012, ANIM SCI J, V83, P394, DOI 10.1111/j.1740-0929.2011.00967.x; Sangsritavong S, 2002, J DAIRY SCI, V85, P2831, DOI 10.3168/jds.S0022-0302(02)74370-1; Sheikh AA, 2018, THERIOGENOLOGY, V120, P61, DOI 10.1016/j.theriogenology.2018.07.028; Shi LY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162194; Shirasuna K, 2012, J REPROD DEVELOP, V58, P84, DOI 10.1262/jrd.11-094K; Shoemaker ML, 2009, J INTERF CYTOK RES, V29, P23, DOI 10.1089/jir.2008.0033; Slimen IB, 2014, INT J HYPERTHER, V30, P513, DOI 10.3109/02656736.2014.971446; Soysal P, 2017, MATURITAS, V99, P66, DOI 10.1016/j.maturitas.2017.01.006; Spencer TE, 1996, ENDOCRINOLOGY, V137, P1144, DOI 10.1210/en.137.3.1144; Srikanth K, 2017, CELL STRESS CHAPERON, V22, P29, DOI 10.1007/s12192-016-0739-8; Toji N, 2017, VET J, V229, P37, DOI 10.1016/j.tvjl.2017.10.007; Wiltbank MC, 2016, THERIOGENOLOGY, V86, P239, DOI 10.1016/j.theriogenology.2016.04.037; Wolfenson D, 2000, ANIM REPROD SCI, V60, P535, DOI 10.1016/S0378-4320(00)00102-0; Yao N, 2009, REPROD DOMEST ANIM, V44, P132, DOI 10.1111/j.1439-0531.2007.01009.x	64	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2021	16	9							e0257418	10.1371/journal.pone.0257418	http://dx.doi.org/10.1371/journal.pone.0257418			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	WG6BN	34543299	gold, Green Published			2022-12-26	WOS:000707078200033
J	Gopalan, N; Srinivasalu, VA; Chinnayan, P; Velayutham, B; Bhaskar, A; Santhanakrishnan, R; Senguttuvan, T; Rathinam, S; Ayyamperumal, M; Satagopan, K; Rajendran, D; Manoharan, T; Lakshmanan, S; Paramasivam, P; Angamuthu, D; Ganesan, M; Arockia, JWE; Venkatesan, RB; Lakshmipathy, V; Shanmugham, S; Subramanyam, B; Shankar, S; Shaheed, JM; Dhanaraj, B; Ramiyengar, NP; Swaminathan, S; Chandrasekaran, P				Gopalan, Narendran; Srinivasalu, Vignes Anand; Chinnayan, Ponnuraja; Velayutham, Banurekha; Bhaskar, Adhin; Santhanakrishnan, Ramesh; Senguttuvan, Thirumaran; Rathinam, Sridhar; Ayyamperumal, Mahilmaran; Satagopan, Kumar; Rajendran, Dhanalakshmi; Manoharan, Tamizhselvan; Lakshmanan, Sekar; Paramasivam, Paulkumaran; Angamuthu, Dhanalakshmi; Ganesan, Mangalambal; Arockia, John Washington Easudoss; Venkatesan, Ramesh Babu; Lakshmipathy, Venkatesan; Shanmugham, Shivakumar; Subramanyam, Balaji; Shankar, Shakila; Shaheed, Jawahar Mohideen; Dhanaraj, Baskaran; Ramiyengar, Narayanan Paranji; Swaminathan, Soumya; Chandrasekaran, Padmapriyadarsini			Predictors of unfavorable responses to therapy in rifampicin-sensitive pulmonary tuberculosis using an integrated approach of radiological presentation and sputum mycobacterial burden	PLOS ONE			English	Article							MOXIFLOXACIN; RIFAPENTINE; REGIMENS; DISEASE; SCORE	Introduction Despite the exalted status of sputum mycobacterial load for gauging pulmonary tuberculosis treatment and progress, Chest X-rays supplement valuable information for taking instantaneous therapeutic decisions, especially during the COVID-19 pandemic. Even though literature on individual parameters is overwhelming, few studies have explored the interaction between radiographic parameters denoting severity with mycobacterial burden signifying infectivity. By using a sophisticated approach of integrating Chest X-ray parameters with sputum mycobacterial characteristics, evaluated at all the three crucial time points of TB treatment namely pre-treatment, end of intensive phase and completion of treatment, utilizing the interactive Cox Proportional Hazards model, we aimed to precisely deduce predictors of unfavorable response to TB treatment. Materials and method We extracted de-identified data from well characterized clinical trial cohorts that recruited rifampicin-sensitive Pulmonary TB patients without any comorbidities, taking their first spell of anti-tuberculosis therapy under supervision and meticulous follow up for 24 months post treatment completion, to accurately predict TB outcomes. Radiographic data independently obtained, interpreted by two experienced pulmonologists was collated with demographic details and, sputum smear and culture grades of participants by an independent statistician and analyzed using the Cox Proportional Hazards model, to not only adjust for confounding factors including treatment effect, but also explore the interaction between radiological and bacteriological parameters for better therapeutic application. Results Of 667 TB patients with data available, cavitation, extent of involvement, lower zone involvement, smear and culture grade at baseline were significant parameters predisposing to an unfavorable TB treatment outcome in the univariate analysis. Reduction in radiological lesions in Chest X-ray by at least 50% at 2 months and 75% at the end of treatment helped in averting unfavorable responses. Smear and Culture conversion at the end of 2 months was highly significant as a predictor (p<0.001). In the multivariate analysis, the adjusted hazards ratios (HR) for an unfavorable response to TB therapy for extent of involvement, baseline cavitation and persistence (post treatment) were 1.21 (95% CI: 1.01-1.44), 1.73 (95% CI: 1.05-2.84) and 2.68 (95% CI: 1.4-5.12) respectively. A 3+ smear had an HR of 1.94 (95% CI: 0.81-4.64). Further probing into the interaction, among patients with 3+ and 2+ smears, HRs for cavitation were 3.26 (95% CI: 1.33-8.00) and 1.92 (95% CI: 0.80-4.60) while for >2 zones, were 3.05 (95% CI: 1.12-8.23) and 1.92 (95% CI: 0.72-5.08) respectively. Patients without cavitation, zonal involvement <2, and a smear grade less than 2+ had a better prognosis and constituted minimal disease. Conclusion Baseline Cavitation, Opacities occupying >2 zones and 3+ smear grade individually and independently forecasted a poorer TB outcome. The interaction model revealed that Zonal involvement confined to 2 zones, without a cavity and smear grade up to 2+, constituting "minimal disease", had a better prognosis. Radiological clearance >50% along with smear conversion at the end of intensive phase of treatment, observed to be a reasonable alternative to culture conversion in predicting a successful outcome. These parameters may potentially take up key positions as stratification factors for future trials contemplating on shorter TB regimens.	[Gopalan, Narendran; Srinivasalu, Vignes Anand; Chinnayan, Ponnuraja; Velayutham, Banurekha; Bhaskar, Adhin; Santhanakrishnan, Ramesh; Senguttuvan, Thirumaran; Rajendran, Dhanalakshmi; Manoharan, Tamizhselvan; Lakshmanan, Sekar; Paramasivam, Paulkumaran; Angamuthu, Dhanalakshmi; Ganesan, Mangalambal; Arockia, John Washington Easudoss; Venkatesan, Ramesh Babu; Lakshmipathy, Venkatesan; Shanmugham, Shivakumar; Subramanyam, Balaji; Shankar, Shakila; Shaheed, Jawahar Mohideen; Dhanaraj, Baskaran; Ramiyengar, Narayanan Paranji; Chandrasekaran, Padmapriyadarsini] Indian Council Med Res, Natl Inst Res TB, Dept Clin Res, TB Res Ctr, Chennai, Tamil Nadu, India; [Rathinam, Sridhar; Satagopan, Kumar] Govt Hosp Thorac Med Tambaram, Dept Thorac Med, Chennai, Tamil Nadu, India; [Ayyamperumal, Mahilmaran] Madras Med Coll & Govt Gen Hosp, Inst Thorac Med, Dept Thorac Med, Chennai, Tamil Nadu, India; [Swaminathan, Soumya] WHO, Geneva, Switzerland	Indian Council of Medical Research (ICMR); ICMR - National Institute for Research in Tuberculosis (NIRT); Madras Medical College & General Hospital; World Health Organization	Gopalan, N (corresponding author), Indian Council Med Res, Natl Inst Res TB, Dept Clin Res, TB Res Ctr, Chennai, Tamil Nadu, India.	gopalannaren@yahoo.co.in		Rajendran, Dr. Dhanalakshmi/0000-0003-3332-8400; Senguttuvan, Thirumaran/0000-0003-1497-8678; Srinivasalu, Vignes Anand/0000-0002-4932-0617; Gopalan, Narendran/0000-0002-8049-7541	World Health Organization [001] Funding Source: Medline	World Health Organization(World Health Organization)		Abu-Raddad LJ, 2009, P NATL ACAD SCI USA, V106, P13980, DOI 10.1073/pnas.0901720106; [Anonymous], GLOBAL TUBERCULOSIS; Benator D, 2002, LANCET, V360, P528, DOI 10.1016/S0140-6736(02)09742-8; Chakraborthy A, 2018, ADV RESPIR MED, V86, P205, DOI 10.5603/ARM.2018.0032; Chiang CY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093397; Churchyard GJ, 2018, NAT MED, V24, P1639, DOI 10.1038/s41591-018-0244-y; Dorman SE, 2021, NEW ENGL J MED, V384, P1705, DOI 10.1056/NEJMoa2033400; Falk A, 1969, DIAGNOSTIC STANDARDS, P68; Gillespie SH, 2014, NEW ENGL J MED, V371, P1577, DOI 10.1056/NEJMoa1407426; Grozdanovic Z, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138070; Hamilton CD, 2008, INT J TUBERC LUNG D, V12, P1059; Huang QS, 2016, EUR J MED RES, V21, DOI 10.1186/s40001-016-0214-0; Imperial MZ, 2018, NAT MED, V24, P1708, DOI 10.1038/s41591-018-0224-2; Jawahar MS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067030; Jindani A, 2014, NEW ENGL J MED, V371, P1599, DOI 10.1056/NEJMoa1314210; Merle CS, 2014, NEW ENGL J MED, V371, P1588, DOI 10.1056/NEJMoa1315817; Nachiappan AC, 2017, RADIOGRAPHICS, V37, P52, DOI 10.1148/rg.2017160032; Nahid P, 2016, CLIN INFECT DIS, V63, pe147, DOI 10.1093/cid/ciw376; Narendran G., 2013, TB C RETR OPP INF 20; Narendran G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063541; Palaci M, 2007, J CLIN MICROBIOL, V45, P4064, DOI 10.1128/JCM.01780-07; Ralph AP, 2010, THORAX, V65, P863, DOI 10.1136/thx.2010.136242; Romanowski K, 2019, THORAX, V74, P291, DOI 10.1136/thoraxjnl-2017-211120; Schueller G, 2005, EUR J RADIOL, V53, P489, DOI 10.1016/j.ejrad.2004.06.009; Peiro JS, 2014, ARCH BRONCONEUMOL, V50, P484, DOI 10.1016/j.arbres.2013.07.009; Swaminathan S., 2007, Indian Journal of Chest Diseases and Allied Sciences, V49, P133; Urbanowski ME, 2020, LANCET INFECT DIS, V20, pE117, DOI 10.1016/S1473-3099(20)30148-1; Velayutham B, 2020, TROP MED INT HEALTH, V25, P483, DOI 10.1111/tmi.13371	28	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2021	16	9							e0257647	10.1371/journal.pone.0257647	http://dx.doi.org/10.1371/journal.pone.0257647			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	WG6BN	34543329	Green Accepted, gold, Green Published			2022-12-26	WOS:000707078200064
J	Rankothgedera, S; Atukorala, I; Fernando, C; Munidasa, D; Wijayaratne, L; Udagama, P				Rankothgedera, Sakuni; Atukorala, Inoshi; Fernando, Chandrika; Munidasa, Duminda; Wijayaratne, Lalith; Udagama, Preethi			A potential diagnostic serum immunological marker panel to differentiate between primary and secondary knee osteoarthritis	PLOS ONE			English	Article							LOW-GRADE INFLAMMATION; MILK CONSUMPTION; RISK-FACTORS; PATHOGENESIS; CYTOKINES; SYNOVIUM	Inflammation contributes to knee osteoarthritis (KOA) where many immunological mediators participate in its initiation and progression. Most clinicians manage primary (pKOA) and secondary osteoarthritis (sKOA) alike. Whether immunological profiles of pKOA and sKOA differ remains obscure. Hence, we aimed to differentially identify potential serum immunologic diagnostic markers of pKOA and of sKOA. This case control study used 46 KOA patients (pKOA, n = 30; sKOA, n = 16), and 60 age, gender matched controls (normal healthy, n = 30; systemic lupus erythematosus [SLE] disease controls, n = 30) where serum was assayed for cytokines (TNF-alpha, IL-1 beta, IL-6, IL-10) and nitric oxide derivatives (NOx). Sandwich ELISA assessed cytokine levels, while the 'Griess assay' quantified NOx levels. The diagnostic accuracy of optimal marker combinations was evaluated by the CombiROC web tool. Compared with pKOA, sKOA serum displayed significantly elevated levels of pro inflammatory cytokines (TNF-alpha, IL-1 beta, IL-6) with a concurrent decrease in the anti-inflammatory cytokine, IL-10 (P<0.05). This was reiterated by significantly higher Th1:Th2 (TNF-<alpha>: IL-10) serum cytokine ratio observed in sKOA compared to that of pKOA. The CombiROC curves identified TNF-alpha, IL-1 beta, IL-6 and NOx as the best performing panel of potential diagnostic markers to discriminate pKOA from control groups (~97% accuracy, 90% Sensitivity [SE] and 98% specificity [SP]), while TNF-alpha, IL-1 beta and IL-6 discriminated sKOA from control groups (~100% accuracy, 100% SE, and 98% SP). The study identified discrete serum immune biomarker panels to differentiate between pKOA (TNF-alpha, IL-1 beta, IL-6 and NOx) and sKOA (TNF-alpha, IL-1 beta and IL-6). These findings may assist in developing distinct therapeutic agents for the two types of KOA.	[Rankothgedera, Sakuni; Udagama, Preethi] Univ Colombo, Fac Sci, Dept Zool & Environm Sci, Colombo, Sri Lanka; [Atukorala, Inoshi] Univ Colombo, Fac Med, Dept Clin Med, Colombo, Sri Lanka; [Fernando, Chandrika] Curtin Univ, Fac Sci & Engn, Sch Elect Engn Comp & Math Sci EECMS, Perth, WA, Australia; [Munidasa, Duminda] Rheumatol & Rehabil Hosp, Ragama, Sri Lanka; [Wijayaratne, Lalith] Nawaloka Hosp PLC, Colombo, Sri Lanka	University of Colombo; University of Colombo; Curtin University	Udagama, P (corresponding author), Univ Colombo, Fac Sci, Dept Zool & Environm Sci, Colombo, Sri Lanka.	preethi@zoology.cmb.ac.lk			University of Colombo	University of Colombo	Provision of special funds to PU by the Vice Chancellor, University of Colombo for interdisciplinary undergraduate research carried out between the Science and Medical Faculties of the University of Colombo, Sri Lanka. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramson SB, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2463; ALTMAN R, 1986, ARTHRITIS RHEUM, V29, P1039, DOI 10.1002/art.1780290816; Bonnet CS, 2005, RHEUMATOLOGY, V44, P7, DOI 10.1093/rheumatology/keh344; Canete JD, 2000, ANN RHEUM DIS, V59, P263, DOI 10.1136/ard.59.4.263; Cross M, 2014, ANN RHEUM DIS, V73, P1323, DOI 10.1136/annrheumdis-2013-204763; Franz A, 2018, ORTHOP REV, V10, DOI 10.4081/or.2018.7460; Ghasemi A., 2007, JMSR, V2, P29; Goldring MB, 2011, CURR OPIN RHEUMATOL, V23, P471, DOI 10.1097/BOR.0b013e328349c2b1; Hame SL, 2013, CURR REV MUSCULOSKE, V6, P182, DOI 10.1007/s12178-013-9164-0; Hay FC., 2002, PRACTICAL IMMUNOLOGY, VFourth, DOI [10.1046/j.1365-2567.2002.01425.x, DOI 10.1046/J.1365-2567.2002.01425.X]; Heidari B, 2011, CASP J INTERN MED, V2, P205; Imamura M, 2015, INT J INFLAMM, V2015, DOI 10.1155/2015/329792; Ishii H, 2002, OSTEOARTHR CARTILAGE, V10, P277, DOI 10.1053/joca.2001.0509; Kacar C, 2004, CLIN EXP RHEUMATOL, V22, P473; Kim JR, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19030674; Kraus VB, 2017, ANN RHEUM DIS, V76, P186, DOI 10.1136/annrheumdis-2016-209252; Lu B, 2014, ARTHRIT CARE RES, V66, P802, DOI 10.1002/acr.22297; Lwanga SK, 1991, SAMPLE SIZE DETERMIN; Mabey T, 2015, WORLD J ORTHOP, V6, P95, DOI 10.5312/wjo.v6.i1.95; Mazzara S, 2017, SCI REP-UK, V7, DOI 10.1038/srep45477; Mugwe JN., 2013, INT J SCI RES PUBL, V3, P2250; Musumeci G, 2015, INT J MOL SCI, V16, P6093, DOI 10.3390/ijms16036093; Noordzij M, 2010, NEPHROL DIAL TRANSPL, V25, P1388, DOI 10.1093/ndt/gfp732; Ohl K, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/432595; Ozbek S, 2003, ACTA MED OKAYAMA, V57, P187; Petersen KK, 2016, CLIN J PAIN, V32, P841, DOI 10.1097/AJP.0000000000000334; Robinson WH, 2016, NAT REV RHEUMATOL, V12, P580, DOI 10.1038/nrrheum.2016.136; Roman-Blas JA, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2791; Roos Ewa M, 2003, Health Qual Life Outcomes, V1, P64, DOI 10.1186/1477-7525-1-64; Samson David J, 2007, Evid Rep Technol Assess (Full Rep), P1; Scanzello CR, 2017, CURR OPIN RHEUMATOL, V29, P79, DOI 10.1097/BOR.0000000000000353; Singh Y, 2014, CHRISMED J HLTH RES, V1, P258, DOI [10.4103/2348-3334.142998, DOI 10.4103/2348-3334.142998]; Sun J, 2003, SENSORS-BASEL, V3, P276, DOI 10.3390/s30800276; Tedeschi SK, 2018, ARTHRIT CARE RES, V70, P327, DOI 10.1002/acr.23295; Van Tunen JAC, 2018, BMC MUSCULOSKEL DIS, V19, DOI 10.1186/s12891-018-2183-7; Wojdasiewicz P, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/561459	36	2	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2021	16	9							e0257507	10.1371/journal.pone.0257507	http://dx.doi.org/10.1371/journal.pone.0257507			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	WG6BN	34543351	gold, Green Published			2022-12-26	WOS:000707078200041
J	Tolchin, B; Oladele, C; Galusha, D; Kashyap, N; Showstark, M; Bonito, J; Salazar, MC; Herbst, JL; Martino, S; Kim, N; Nash, KA; Tiako, MJN; Roy, S; Greeno, RV; Jubanyik, K				Tolchin, Benjamin; Oladele, Carol; Galusha, Deron; Kashyap, Nitu; Showstark, Mary; Bonito, Jennifer; Salazar, Michelle C.; Herbst, Jennifer L.; Martino, Steve; Kim, Nancy; Nash, Katherine A.; Tiako, Max Jordan Nguemeni; Roy, Shireen; Greeno, Rebeca Vergara; Jubanyik, Karen			Racial disparities in the SOFA score among patients hospitalized with COVID-19	PLOS ONE			English	Article							INEQUALITIES; MORTALITY; ADULTS; CARE	Background Sequential Organ Failure Assessment (SOFA) score predicts probability of in-hospital mortality. Many crisis standards of care suggest the use of SOFA scores to allocate medical resources during the COVID-19 pandemic. Research question Are SOFA scores elevated among Non-Hispanic Black and Hispanic patients hospitalized with COVID-19, compared to Non-Hispanic White patients? Study design and methods Retrospective cohort study conducted in Yale New Haven Health System, including 5 hospitals with total of 2681 beds. Study population drawn from consecutive patients aged >= 18 admitted with COVID-19 from March 29(th) to August 1(st), 2020. Patients excluded from the analysis if not their first admission with COVID-19, if they did not have SOFA score recorded within 24 hours of admission, if race and ethnicity data were not Non-Hispanic Black, Non-Hispanic White, or Hispanic, or if they had other missing data. The primary outcome was SOFA score, with peak score within 24 hours of admission dichotomized as <6 or <greater than or equal to>6. Results Of 2982 patients admitted with COVID-19, 2320 met inclusion criteria and were analyzed, of whom 1058 (45.6%) were Non-Hispanic White, 645 (27.8%) were Hispanic, and 617 (26.6%) were Non-Hispanic Black. Median age was 65.0 and 1226 (52.8%) were female. In univariate logistic screen and in full multivariate model, Non-Hispanic Black patients but not Hispanic patients had greater odds of an elevated SOFA score >= 6 when compared to Non-Hispanic White patients (OR 1.49, 95%CI 1.11-1.99). Interpretation Given current unequal patterns in social determinants of health, US crisis standards of care utilizing the SOFA score to allocate medical resources would be more likely to deny these resources to Non-Hispanic Black patients.	[Tolchin, Benjamin] Yale Sch Med, Dept Neurol, New Haven, CT 06510 USA; [Oladele, Carol; Galusha, Deron; Tiako, Max Jordan Nguemeni; Greeno, Rebeca Vergara] Yale Sch Med, Equ Res & Innovat Ctr, New Haven, CT USA; [Kashyap, Nitu] Yale New Haven Hlth, Informat Technol, New Haven, CT USA; [Showstark, Mary] Yale Sch Med Phys, Assistant Online Program, New Haven, CT USA; [Bonito, Jennifer; Jubanyik, Karen] Yale Sch Med, Dept Emergency Med, New Haven, CT USA; [Salazar, Michelle C.] Yale Sch Med, Dept Surg, New Haven, CT USA; [Herbst, Jennifer L.] Quinnipiac Univ, Sch Law, North Haven, CT USA; [Martino, Steve] Yale Univ, Sch Med, Dept Psychiat, New Haven, CT USA; [Kim, Nancy] Yale Sch Med, Dept Med, New Haven, CT USA; [Nash, Katherine A.] Yale Sch Med, Dept Pediat, New Haven, CT USA; [Roy, Shireen] Washington Univ, Sch Med St Louis, St Louis, MO 63110 USA	Yale University; Yale University; Yale University; Yale University; Yale University; Quinnipiac University; Yale University; Yale University; Yale University; Saint Louis University; Washington University (WUSTL)	Tolchin, B (corresponding author), Yale Sch Med, Dept Neurol, New Haven, CT 06510 USA.	benjamin.tolchin@yale.edu	Nguemeni Tiako, Max Jordan/AAZ-7373-2020	Nguemeni Tiako, Max Jordan/0000-0002-5468-8926; Salazar, Michelle/0000-0001-7922-4223; Roy, Shireen/0000-0002-6733-5054	US Department of Veterans Affairs; C.G. Swebilius Foundation; National Clinician Scholars Program; CTSA Grant from National Center for Advancing Translational Science (NCATS), a component of the National Institutes of Health (NIH) [TL1 TR001864]	US Department of Veterans Affairs(US Department of Veterans Affairs); C.G. Swebilius Foundation; National Clinician Scholars Program; CTSA Grant from National Center for Advancing Translational Science (NCATS), a component of the National Institutes of Health (NIH)	The authors received no specific funding for this work. BT receives research support from the US Department of Veterans Affairs (https://www.newengland.va.gov/research/v1cda/) and the C.G. Swebilius Foundation (https://fconline.foundationcenter.org/fdo-grantmaker-profile/?key= SWEB001). KN and MS are supported by the National Clinician Scholars Program and the CTSA Grant Number TL1 TR001864 from the National Center for Advancing Translational Science (NCATS), a component of the National Institutes of Health (NIH). (https://ncats.nih.gov/) The manuscript's contents are solely the responsibility of the authors and do not necessarily represent the official view of the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antommaria AHM, 2020, ANN INTERN MED, V173, P188, DOI 10.7326/M20-1738; Asch DA, 2021, JAMA NETW OPEN, V4, DOI 10.1001/jamanetworkopen.2021.12842; Ashana DC, 2021, AM J RESP CRIT CARE, V204, P178, DOI 10.1164/rccm.202012-4383OC; Benefits.gov, RHOD ISL MED ASS MED; Benefits.gov, 2021, CONN MED; Bezrukova K, 2016, PSYCHOL BULL, V142, P1227, DOI 10.1037/bul0000067; Biddison ELD, 2019, CHEST, V155, P848, DOI 10.1016/j.chest.2018.09.025; Block JP, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001914; Brooks Tricia, 2020, MEDICAID CHIP ELIGIB; Manchanda EC, 2020, NEW ENGL J MED, V383, DOI 10.1056/NEJMp2011359; Manchanda ECC, 2021, JAMA NETW OPEN, V4, DOI 10.1001/jamanetworkopen.2021.4527; Cookson R, 2016, FISC STUD, V37, P371, DOI 10.1111/j.1475-5890.2016.12109; Cowger TL, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.16933; Craxi L, 2020, ASIAN BIOETHICS REV, V12, P325, DOI 10.1007/s41649-020-00127-1; Cuevas AG, 2020, BRAIN BEHAV IMMUN, V89, P465, DOI 10.1016/j.bbi.2020.07.017; Egede LE, 2020, NEW ENGL J MED, V383, DOI 10.1056/NEJMp2023616; Emeruwa UN, 2020, JAMA-J AM MED ASSOC, V324, P390, DOI 10.1001/jama.2020.11370; Ferreira FL, 2001, JAMA-J AM MED ASSOC, V286, P1754, DOI 10.1001/jama.286.14.1754; FitzGerald C, 2017, BMC MED ETHICS, V18, DOI 10.1186/s12910-017-0179-8; Galvani AP, 2020, ECLINICALMEDICINE, V23, DOI 10.1016/j.eclinm.2020.100380; Garcia MA., 2020, J GERONTOL B-PSYCHOL; Gibson M, 2011, HEALTH PLACE, V17, P175, DOI 10.1016/j.healthplace.2010.09.011; Grasselli G, 2020, JAMA-J AM MED ASSOC, V323, P1545, DOI 10.1001/jama.2020.4031; Hanchate AD, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.10816; Jones CP, 2012, RACE ETHNICITY HLTH, V26, P57; Knighton Andrew J, 2016, EGEMS (Wash DC), V4, P1238, DOI 10.13063/2327-9214.1238; Lee Wei-Chen, 2016, Perspect Health Inf Manag, V13, p1g; McCormack G, 2020, JAMA-J AM MED ASSOC, V324, P388, DOI 10.1001/jama.2020.11366; Morris AM, 2010, J AM COLL SURGEONS, V211, P105, DOI 10.1016/j.jamcollsurg.2010.02.051; National Center for Health Statistics, 2019, HLTH US 2018; New York State Task Force on Life and the Law, 2015, VENT ALL GUID; Nuru-Jeter AM, 2018, ANNU REV PUBL HEALTH, V39, P169, DOI 10.1146/annurev-publhealth-040617-014230; Peralta CA, 2010, AM J NEPHROL, V31, P202, DOI 10.1159/000268955; Persoskie A, 2013, NICOTINE TOB RES, V15, P2088, DOI 10.1093/ntr/ntt101; Price-Haywood EG, 2020, NEW ENGL J MED, V382, P2534, DOI 10.1056/NEJMsa2011686; Raith EP, 2017, JAMA-J AM MED ASSOC, V317, P290, DOI 10.1001/jama.2016.20328; Ramos RD, 2020, CANCER EPIDEMIOL, V68, DOI 10.1016/j.canep.2020.101792; Raschke RA, 2021, JAMA-J AM MED ASSOC, V325, P1469, DOI 10.1001/jama.2021.1545; Reinhart E, 2020, HEALTH AFFAIR, V39, P1412, DOI 10.1377/hlthaff.2020.00652; Rhode Island Department of Health, 2020, COVID 19 INF RES UND; Societa Italiana Anestesia Analgesia Rianimazione e Terapia Intensiva, 2021, DEC CUR INT CAS SPRO; Sullivan LW., 2004, REPORT SULLIVAN COMM; Supady A, 2021, LANCET RESP MED, V9, P430, DOI 10.1016/S2213-2600(20)30580-4; Tolchin B., 2020, J MED ETHICS; Tolchin Benjamin, 2020, J Clin Ethics, V31, P303; Tuomala M., 2016, OPTIMAL REDISTRIBUTI; White DB, 2021, AM J RESP CRIT CARE, V203, P287, DOI 10.1164/rccm.202010-3809CP; White DB, 2020, JAMA-J AM MED ASSOC, V323, P1773, DOI 10.1001/jama.2020.5046; WHO, 2018, WHO HOUSING HLTH GUI; Williamson EJ, 2020, NATURE, V584, P430, DOI 10.1038/s41586-020-2521-4; Zou XJ, 2020, CRIT CARE MED, V48, pE657, DOI 10.1097/CCM.0000000000004411	51	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2021	16	9							e0257608	10.1371/journal.pone.0257608	http://dx.doi.org/10.1371/journal.pone.0257608			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	WG5ZQ	34535009	Green Published, gold, Green Submitted			2022-12-26	WOS:000707073300041
J	Herrera, CL; Bowman, ME; McIntire, DD; Nelson, DB; Smith, R				Herrera, Christina L.; Bowman, Maria E.; McIntire, Donald D.; Nelson, David B.; Smith, Roger			Revisiting the placental clock: Early corticotrophin-releasing hormone rise in recurrent preterm birth	PLOS ONE			English	Article							20 WEEKS GESTATION; ALPHA-FETOPROTEIN; BINDING-PROTEIN; PLASMA CRH; DELIVERY; LENGTH; TERM	Objective To determine if maternal plasma CRH and preterm birth history were associated with recurrent preterm birth risk in a high-risk cohort. Study design Secondary analysis of pregnant women with a prior preterm birth <= 35 weeks receiving 17-alpha hydroxyprogesterone caproate for the prevention of recurrent spontaneous preterm birth. All women with a 24-week blood sample were included. Maternal plasma CRH level at 24- and 32-weeks' gestation was measured using both enzyme-linked immunosorbent assay (ELISA) and extracted radioimmunoassay (RIA) technologies. The primary outcome was spontaneous preterm birth <37 weeks. The association of CRH, prior preterm birth history, and the two combined was assessed in relation to recurrent preterm birth risk. Results Recurrent preterm birth in this cohort of 169 women was 24.9%. Comparing women who subsequently delivered <37 versus >= 37 weeks, mean levels of CRH measured by RIA were significantly different at 24 weeks (111.187.5 vs. 66.1 +/- 45.4 pg/mL, P = .002) and 32 weeks (440.9 +/- 275.6 vs. 280.2 +/- 214.5 pg/mL, P = .003). The area under the receiver operating curve (AUC) at 24 and 32 weeks for (1) CRH level was 0.68 (95% CI 0.59-0.78) and 0.70 (95% CI 0.59-0.81), (2) prior preterm birth history was 0.75 (95% CI 0.67-0.83) and 0.78 (95% CI 0.69-0.87), and (3) combined was 0.81 (95% CI 0.73-0.88, P = .001) and 0.81 (95% CI 0.72-0.90, P = .01) respectively for delivery <37 weeks. CRH measured by ELISA failed to correlate with gestational age or other clinical parameters. Conclusion In women with a prior preterm birth, CRH levels were higher and had an earlier rise in women who experienced recurrent preterm birth. Second trimester CRH may be useful in identifying a sub-group of women with preterm birth due to early activation of the placenta-fetal adrenal axis. Assay methodology is a variable that contributes to difficulties in reproducibility of CRH levels in the obstetric literature.	[Herrera, Christina L.; McIntire, Donald D.; Nelson, David B.] Univ Texas Southwestern Med Ctr Dallas, Dept Obstet & Gynecol, Dallas, TX 75390 USA; [Bowman, Maria E.; Smith, Roger] Univ Newcastle, Hunter Med Res Inst, Mothers & Babies Res Ctr, Newcastle, NSW, Australia	University of Texas System; University of Texas Southwestern Medical Center Dallas; Hunter Medical Research Institute; University of Newcastle	Herrera, CL (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Obstet & Gynecol, Dallas, TX 75390 USA.	christina.herrera@utsouthwestern.edu		Herrera, Christina/0000-0002-6484-9850; Bowman, Maria/0000-0002-2333-7883; Smith, Roger/0000-0003-4720-0280				Berkowitz GS, 1996, AM J OBSTET GYNECOL, V174, P1477, DOI 10.1016/S0002-9378(96)70591-4; Bloom SL, 2001, OBSTET GYNECOL, V98, P379, DOI 10.1016/S0029-7844(01)01466-1; Challis JRG, 2000, ENDOCR REV, V21, P514, DOI 10.1210/er.21.5.514; Esplin MS, 2017, JAMA-J AM MED ASSOC, V317, P1047, DOI 10.1001/jama.2017.1373; GOLAND RS, 1986, J CLIN ENDOCR METAB, V63, P1199, DOI 10.1210/jcem-63-5-1199; Hobel CJ, 1999, AM J OBSTET GYNECOL, V180, pS257, DOI 10.1016/S0002-9378(99)70712-X; Hobel CJ, 1999, ANN NY ACAD SCI, V897, P54, DOI 10.1111/j.1749-6632.1999.tb07878.x; Holzman C, 2001, OBSTET GYNECOL, V97, P657, DOI 10.1016/S0029-7844(00)01209-6; Inder WJ, 2001, J CLIN ENDOCR METAB, V86, P5706, DOI 10.1210/jc.86.12.5706; Iwata R, 2020, SCIENCE, V369, P1431, DOI 10.1126/science.abe0953; Latendresse G, 2008, BIOL RES NURS, V10, P54, DOI 10.1177/1099800408320970; LINTON EA, 1995, J ENDOCRINOL, V146, P45, DOI 10.1677/joe.0.1460045; Lockwood CJ, 2001, PAEDIATR PERINAT EP, V15, P78, DOI 10.1046/j.1365-3016.2001.00010.x; Martin Joyce A, 2018, Natl Vital Stat Rep, V67, P1; Matsuda M, 2020, SCIENCE, V369, P1450, DOI 10.1126/science.aba7668; MCLEAN M, 1995, NAT MED, V1, P460, DOI 10.1038/nm0595-460; McLean M, 1999, AM J OBSTET GYNECOL, V181, P207, DOI 10.1016/S0002-9378(99)70461-8; McManemy J, 2007, AM J OBSTET GYNECOL, V196, P576, DOI 10.1016/j.ajog.2007.01.039; Moawad AH, 2002, AM J OBSTET GYNECOL, V186, P990, DOI 10.1067/mob.2002.121727; Nelson D, 2017, AM J OBSTET GYNECOL, V216, pS609; Rayon T, 2020, SCIENCE, V369, P1449, DOI 10.1126/science.aba7667; Schaaf JM, 2013, AM J PERINAT, V30, P433, DOI 10.1055/s-0032-1326988; Sibai B, 2005, AM J OBSTET GYNECOL, V193, P1181, DOI 10.1016/j.ajog.2005.06.036; Siler-Khodr TM, 2003, OBSTET GYNECOL, V101, P557, DOI 10.1016/S0029-7844(02)03072-7; Smith R, 2007, FRONT BIOSCI, V12, P912, DOI 10.2741/2113; Smith R, 2009, J CLIN ENDOCR METAB, V94, P2066, DOI 10.1210/jc.2008-2257; Wadhwa PD, 2004, AM J OBSTET GYNECOL, V191, P1063, DOI 10.1016/j.ajog.2004.06.070; Wadhwa PD, 1998, AM J OBSTET GYNECOL, V179, P1079, DOI 10.1016/S0002-9378(98)70219-4; Xie JL, 2019, CURR BIOL, V29, P737, DOI 10.1016/j.cub.2019.01.029	29	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2021	16	9							e0257422	10.1371/journal.pone.0257422	http://dx.doi.org/10.1371/journal.pone.0257422			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	WG5YY	34529698	Green Published, gold			2022-12-26	WOS:000707071500056
J	Speca, S; Dubuquoy, C; Rousseaux, C; Chavatte, P; Desreumaux, P; Spagnolo, P				Speca, Silvia; Dubuquoy, Caroline; Rousseaux, Christel; Chavatte, Philippe; Desreumaux, Pierre; Spagnolo, Paolo			GED-0507 attenuates lung fibrosis by counteracting myofibroblast transdifferentiation in vivo and in vitro	PLOS ONE			English	Article							PROLIFERATOR-ACTIVATED RECEPTOR; PPAR-GAMMA MODULATOR; PULMONARY-FIBROSIS; PIRFENIDONE; EXPRESSION; NINTEDANIB; ROSIGLITAZONE; MECHANISMS; TARGET; INJURY	The development of more effective, better tolerated drug treatments for progressive pulmonary fibrosis (of which idiopathic pulmonary fibrosis is the most common and severe form) is a research priority. The peroxisome proliferator-activated receptor gamma (PPAR-gamma) is a key regulator of inflammation and fibrosis and therefore represents a potential therapeutic target. However, the use of synthetic PPAR-gamma agonists may be limited by their potentially severe adverse effects. In a mouse model of bleomycin (BLM)-induced pulmonary fibrosis, we have demonstrated that the non-racemic selective PPAR-gamma modulator GED-0507 is able to reduce body weight loss, ameliorate clinical and histological features of pulmonary fibrosis, and increase survival rate without any safety concerns. Here, we focused on the biomolecular effects of GED-0507 on various inflammatory/fibrotic pathways. We demonstrated that preventive and therapeutic administration of GED-0507 reduced the BLM-induced mRNA expression of several markers of fibrosis, including transforming growth factor (TGF)-beta, alpha-smooth muscle actin, collagen and fibronectin as well as epithelial-to-mesenchymal transition (EMT) and expression of mucin 5B. The beneficial effect of GED-0507 on pulmonary fibrosis was confirmed in vitro by its ability to control TGF beta -induced myofibroblast activation in the A549 human alveolar epithelial cell line, the MRC-5 lung fibroblast line, and primary human lung fibroblasts. Compared with the US Food and Drug Administration-approved antifibrotic drugs pirfenidone and nintedanib, GED-0507 displayed greater antifibrotic activity by controlling alveolar epithelial cell dysfunction, EMT, and extracellular matrix remodeling. In conclusion, GED-0507 demonstrated potent antifibrotic properties and might be a promising drug candidate for the treatment of pulmonary fibrosis.	[Speca, Silvia; Chavatte, Philippe; Desreumaux, Pierre] Univ Lille, U1286 Infinite Inst Translat Res Inflammat, INSERM, Lille, France; [Dubuquoy, Caroline; Rousseaux, Christel] Intestinal Biotech Dev, Lille, France; [Chavatte, Philippe] Fac Sci Pharmaceut & Biol, Lab Pharm Clin, Lille, France; [Desreumaux, Pierre] CHU Lille, Hepatogastroenterol Dept, Lille, France; [Spagnolo, Paolo] Univ Padua, Dept Cardiac Thorac Vasc Sci & Publ Hlth, Resp Dis Unit, Padua, Italy	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; CHU Lille; University of Padua	Speca, S (corresponding author), Univ Lille, U1286 Infinite Inst Translat Res Inflammat, INSERM, Lille, France.; Spagnolo, P (corresponding author), Univ Padua, Dept Cardiac Thorac Vasc Sci & Publ Hlth, Resp Dis Unit, Padua, Italy.	silviaspeca@icloud.com; paolo.spagnolo@unipd.it						American Thoracic Society, 2005, AM J RESP CRIT CARE, V171, P912, DOI 10.1164/rccm.200406-710ST; Aoki Y, 2009, RESPIRATION, V77, P311, DOI 10.1159/000168676; Bellaye PS, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0412-6; Bertin B, 2013, CURR DRUG TARGETS, V14, P1501, DOI 10.2174/13894501113149990162; Burgess HA, 2005, AM J PHYSIOL-LUNG C, V288, pL1146, DOI 10.1152/ajplung.00383.2004; Chen KJ, 2018, BIOSCIENCE REP, V38, DOI 10.1042/BSR20180445; Di Gregorio J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171093; Dubuquoy L, 2002, LANCET, V360, P1410, DOI 10.1016/S0140-6736(02)11395-X; Fujisawa T, 2011, AM J RESP CELL MOL, V45, P246, DOI 10.1165/rcmb.2009-0313OC; Fumery M, 2017, EMBO MOL MED, V9, P1471, DOI 10.15252/emmm.201707795; Galli JA, 2017, RESPIROLOGY, V22, P1171, DOI 10.1111/resp.13024; Genovese T, 2005, EUR RESPIR J, V25, P225, DOI 10.1183/09031936.05.00049704; Hancock LA, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07768-9; Henderson NC, 2020, NATURE, V587, P555, DOI 10.1038/s41586-020-2938-9; Hostettler KE, 2014, RESP RES, V15, DOI 10.1186/s12931-014-0157-3; Huang THW, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-102; Iyer SN, 1999, J PHARMACOL EXP THER, V291, P367; Jensen EC, 2013, ANAT REC, V296, P378, DOI 10.1002/ar.22641; JUNQUEIRA LCU, 1979, HISTOCHEM J, V11, P447, DOI 10.1007/BF01002772; Kakugawa T, 2004, EUR RESPIR J, V24, P57, DOI 10.1183/09031936.04.00120803; King TE, 2014, NEW ENGL J MED, V370, P2083, DOI 10.1056/NEJMoa1402582; Kung J, 2012, EXPERT OPIN DRUG SAF, V11, P565, DOI 10.1517/14740338.2012.691963; Lee JW, 2017, J AGR FOOD CHEM, V65, P4472, DOI 10.1021/acs.jafc.7b00923; Lehtonen ST, 2016, RESP RES, V17, DOI 10.1186/s12931-016-0328-5; Ley B, 2011, AM J RESP CRIT CARE, V183, P431, DOI 10.1164/rccm.201006-0894CI; Li LF, 2017, J CELL MOL MED, V21, P2937, DOI 10.1111/jcmm.13206; Lukaszewicz A, 2019, ADV EXP MED BIOL, V1176, P101, DOI 10.1007/5584_2019_387; Lv XX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068631; Malur A, 2019, AM J RESP CELL MOL, V61, P198, DOI 10.1165/rcmb.2018-0346OC; Mangoni M, 2015, LUNG CANCER, V90, P405, DOI 10.1016/j.lungcan.2015.11.005; Martinez FJ, 2018, CHEST, V154, P978, DOI 10.1016/j.chest.2018.08.1021; Mastrofrancesco A, 2014, J INVEST DERMATOL, V134, P1001, DOI 10.1038/jid.2013.448; Milam JE, 2008, AM J PHYSIOL-LUNG C, V294, pL891, DOI 10.1152/ajplung.00333.2007; Mouratis MA, 2011, CURR OPIN PULM MED, V17, P355, DOI 10.1097/MCP.0b013e328349ac2b; Nair Anroop B, 2016, J Basic Clin Pharm, V7, P27, DOI 10.4103/0976-0105.177703; Noble PW, 2011, LANCET, V377, P1760, DOI 10.1016/S0140-6736(11)60405-4; Pirat C, 2012, J MED CHEM, V55, P4027, DOI 10.1021/jm101360s; Qian WB, 2018, J CELL MOL MED, V22, P4354, DOI 10.1111/jcmm.13725; Rangarajan S, 2016, AM J RESP CELL MOL, V54, P51, DOI 10.1165/rcmb.2014-0445OC; Rehan VK, 2007, AM J PHYSIOL-LUNG C, V293, pL182, DOI 10.1152/ajplung.00319.2006; Richeldi L, 2014, NEW ENGL J MED, V370, P2071, DOI 10.1056/NEJMoa1402584; Rosenbloom J, 2017, METHODS MOL BIOL, V1627, P1, DOI 10.1007/978-1-4939-7113-8_1; Samah M, 2012, EUR J PHARMACOL, V689, P186, DOI 10.1016/j.ejphar.2012.05.026; Schwartz David A, 2016, Trans Am Clin Climatol Assoc, V127, P34; Shi Q, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028134; Sime PJ, 2008, J INVEST MED, V56, P534, DOI 10.2310/JIM.0b013e31816464e9; Spagnolo P, 2021, PHARMACOL THERAPEUT, V222, DOI 10.1016/j.pharmthera.2020.107798; Speca S, 2020, CELL MOL IMMUNOL, V17, P1272, DOI 10.1038/s41423-020-0394-y; Speca S, 2016, INFLAMM BOWEL DIS, V22, P279, DOI 10.1097/MIB.0000000000000618; Tanaka KI, 2012, CHEST, V142, P1011, DOI 10.1378/chest.11-2879; Trackman PC, 2017, METHODS MOL BIOL, V1489, P481, DOI 10.1007/978-1-4939-6430-7_39; Tyagi S, 2011, J ADV PHARM TECHNOL, V2, P236, DOI 10.4103/2231-4040.90879; U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER), 2005, GUID IND; Vetuschi A, 2018, EUR REV MED PHARMACO, V22, P8839, DOI 10.26355/eurrev_201812_16652; Weng CM, 2020, BIOSCIENCE REP, V40, DOI 10.1042/BSR20190756; Wijsenbeek M, 2020, NEW ENGL J MED, V383, P958, DOI 10.1056/NEJMra2005230; Wollin L, 2015, EUR RESPIR J, V45, P1434, DOI 10.1183/09031936.00174914; Wolters PJ, 2014, ANNU REV PATHOL-MECH, V9, P157, DOI 10.1146/annurev-pathol-012513-104706; Wynn TA, 2008, J PATHOL, V214, P199, DOI 10.1002/path.2277	59	2	2	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2021	16	9							e0257281	10.1371/journal.pone.0257281	http://dx.doi.org/10.1371/journal.pone.0257281			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	WG5YY	34529707	gold, Green Published			2022-12-26	WOS:000707071500044
J	Zhang, JY; Li, F; Augi, T; Williamson, KM; Onishi, K; Hogan, MV; Neal, MD; Wang, JHC				Zhang, Jianying; Li, Feng; Augi, Tyler; Williamson, Kelly M.; Onishi, Kentaro; Hogan, MaCalus, V; Neal, Matthew D.; Wang, James H-C			Platelet HMGB1 in Platelet-Rich Plasma (PRP) promotes tendon wound healing	PLOS ONE			English	Article							GROUP BOX 1; CHRONIC ACHILLES TENDINOPATHY; DOUBLE-BLIND; PROTEIN; CELLS; REGENERATION; INFLAMMATION; SURFACE; INNATE; DAMAGE	Platelet-rich plasma (PRP) is a widely used autologous treatment for tendon injuries in clinics. Platelets (PLTs) are a major source of high mobility group box1 (HMGB1) that is gaining attention as a chemoattractant that can recruit stem cells to the wound area to enhance healing of injured tissues; however, the contribution of PLT HMGB1 in wounded tendon healing remains unexplored. This study investigated the effect of PLT HMGB1 within PRP on tendon healing using PLT HMGB1 knockout (KO) and GFP mice. A window defect was created in the patellar tendons of both groups of mice, and wounds were treated with either saline, PRP isolated from PLT HMGB1-KO mice, or PRP isolated from GFP mice. Seven days post-treatment, animals were sacrificed and analyzed by gross inspection, histology, and immunostaining for characteristic signs of tendon healing and repair. Our results showed that in comparison to mice treated with PRP from PLT HMGB1-KO mice, wounds treated with PRP from GFP mice healed faster and exhibited a better organization in tendon structure. Mice treated with PRP from PLT HMGB1-KO mice produced tendon tissue with large premature wound areas and low cell densities. However, wounds of PLT HMGB1-KO mice showed better healing with PRP from HMGB1-KO mice compared to saline treatment. Moreover, wounds treated with PRP from GFP mice had increased extracellular HMGB1, decreased CD68, increased stem cell markers CD146 and CD73, and increased collagen III protein expression levels compared to those treated with PRP from PLT HMGB1-KO mice. Thus, PLT HMGB1 within PRP plays an important role in tendon wound healing by decreasing inflammation, increasing local HMGB1 levels, and recruiting stem cells to the wound area in the tendon. Our findings also suggest that the efficacy of PRP treatment for tendon injuries in clinics may depend on PLT HMGB1 within PRP preparations.	[Zhang, Jianying; Li, Feng; Augi, Tyler; Williamson, Kelly M.; Onishi, Kentaro; Hogan, MaCalus, V; Wang, James H-C] Univ Pittsburgh, Dept Orthopaed Surg, MechanoBiol Lab, Pittsburgh, PA 15260 USA; [Onishi, Kentaro; Hogan, MaCalus, V; Wang, James H-C] Univ Pittsburgh, Dept Phys Med & Rehabil, Pittsburgh, PA 15260 USA; [Hogan, MaCalus, V; Wang, James H-C] Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA 15260 USA; [Neal, Matthew D.] Univ Pittsburgh, Dept Surg, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Wang, JHC (corresponding author), Univ Pittsburgh, Dept Orthopaed Surg, MechanoBiol Lab, Pittsburgh, PA 15260 USA.; Wang, JHC (corresponding author), Univ Pittsburgh, Dept Phys Med & Rehabil, Pittsburgh, PA 15260 USA.; Wang, JHC (corresponding author), Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA 15260 USA.	wanghc@pitt.edu	Neal, Matthew/GMW-5601-2022; Hogan, Macalus/AFS-7589-2022; Hogan, MaCalus/N-5484-2017	Neal, Matthew/0000-0001-8931-6236; Hogan, MaCalus/0000-0002-6598-1095; Williamson, Kelly/0000-0002-7529-0220	National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases [AR065949, AR070340]	National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	All funding source received during this study was in part from the National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases (https://www.niams.nih.gov) awards AR065949 and AR070340 (JHW). There was no additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson U, 2011, J INTERN MED, V270, P296, DOI 10.1111/j.1365-2796.2011.02430.x; Andia I, 2018, EXPERT OPIN BIOL TH, V18, P389, DOI 10.1080/14712598.2018.1424626; Andia I, 2010, EXPERT OPIN BIOL TH, V10, P1415, DOI 10.1517/14712598.2010.514603; Barros MHM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080908; Baum CL, 2005, DERMATOL SURG, V31, P674; Bianchi ME, 2017, IMMUNOL REV, V280, P74, DOI 10.1111/imr.12601; Campana L, 2014, J IMMUNOL, V192, P5257, DOI 10.4049/jimmunol.1300938; Chavakis E, 2007, CIRC RES, V100, P204, DOI 10.1161/01.RES.0000257774.55970.f4; de Jonge S, 2011, AM J SPORT MED, V39, P1623, DOI 10.1177/0363546511404877; de Vos RJ, 2010, JAMA-J AM MED ASSOC, V303, P144, DOI 10.1001/jama.2009.1986; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Dormoy-Raclet V, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3388; Dragoo JL, 2014, AM J SPORT MED, V42, P610, DOI 10.1177/0363546513518416; Eisinger F, 2018, FRONT MED-LAUSANNE, V5, DOI 10.3389/fmed.2018.00317; Foster TE, 2009, AM J SPORT MED, V37, P2259, DOI 10.1177/0363546509349921; HOLNESS CL, 1993, BLOOD, V81, P1607; Kon E, 2011, KNEE SURG SPORT TR A, V19, P516, DOI 10.1007/s00167-010-1306-y; Kon E, 2009, INJURY, V40, P598, DOI 10.1016/j.injury.2008.11.026; Lee G, 2018, P NATL ACAD SCI USA, V115, pE4463, DOI 10.1073/pnas.1802893115; LIU SH, 1995, CLIN ORTHOP RELAT R, P265; Lv FJ, 2014, STEM CELLS, V32, P1408, DOI 10.1002/stem.1681; Mardente S, 2018, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01946; Maugeri N, 2014, J THROMB HAEMOST, V12, P2074, DOI 10.1111/jth.12710; Maugeri N, 2012, AUTOIMMUNITY, V45, P584, DOI 10.3109/08916934.2012.719946; Menter DG, 2017, CANCER METAST REV, V36, P199, DOI 10.1007/s10555-017-9682-0; Menter DG, 2014, CANCER METAST REV, V33, P231, DOI 10.1007/s10555-014-9498-0; Monto RR, 2012, FOOT ANKLE INT, V33, P379, DOI 10.3113/FAI.2012.0379; Oishi Y, 2018, INT IMMUNOL, V30, P511, DOI 10.1093/intimm/dxy054; Palumbo R, 2004, BIOCHEM PHARMACOL, V68, P1165, DOI 10.1016/j.bcp.2004.03.048; Roszer T, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/816460; Rouhiainen A, 2000, THROMB HAEMOSTASIS, V84, P1087; Saclier M, 2013, FEBS J, V280, P4118, DOI 10.1111/febs.12166; Scaffidi P, 2002, NATURE, V418, P191, DOI 10.1038/nature00858; Schepull T, 2011, AM J SPORT MED, V39, P38, DOI 10.1177/0363546510383515; Serra MB, 2017, INT J INFLAMM, V2017, DOI 10.1155/2017/3406215; Son M, 2016, BLOOD, V128, P2218, DOI 10.1182/blood-2016-05-719757; Stark K, 2016, BLOOD, V128, P2435, DOI 10.1182/blood-2016-04-710632; Tamai K, 2011, P NATL ACAD SCI USA, V108, P6609, DOI 10.1073/pnas.1016753108; Tirone M, 2018, J EXP MED, V215, P303, DOI 10.1084/jem.20160217; Venereau E, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00422; Vogel S, 2015, J CLIN INVEST, V125, P4638, DOI 10.1172/JCI81660; Vogel S, 2014, J BIOL CHEM, V289, P11068, DOI 10.1074/jbc.M113.530287; Wang HZ, 2014, AM J PATHOL, V184, P1167, DOI 10.1016/j.ajpath.2013.12.020; Wynn TA, 2016, IMMUNITY, V44, P450, DOI 10.1016/j.immuni.2016.02.015; Zhang XF, 2014, BIOCHEM BIOPH RES CO, V450, P1547, DOI 10.1016/j.bbrc.2014.07.027; Zhao RL, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17122085; Zhou YQ, 2017, J TISSUE ENG REGEN M, V11, P3445, DOI 10.1002/term.2258	47	4	4	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2021	16	9							e0251166	10.1371/journal.pone.0251166	http://dx.doi.org/10.1371/journal.pone.0251166			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	WG5YY	34529657	Green Published, gold			2022-12-26	WOS:000707071500004
J	Denning, SK; Valleau, MA; Pelowski, WJ; Chaisson, CM; Grimes, KE; Erath, BD				Denning, Samantha K.; Valleau, Michael A.; Pelowski, William J.; Chaisson, Claire M.; Grimes, Kelli E.; Erath, Byron D.			An automatic water-occluding device to enable laryngectomee participation in water activities	PLOS ONE			English	Article							QUALITY-OF-LIFE; VOICE RESTORATION; REHABILITATION; ELECTROLARYNX	Individuals with a laryngectomy face a host of challenges ranging from restricted vocal communication to significant lifestyle modifications associated with breathing through a stoma. Although there are significant mental and physical health benefits achieved by returning to recreational pursuits that were enjoyed pre-surgery, there can be significant obstacles in doing so. One particular challenge arises during participation in water activities (e.g, fishing, boating, etc.) where accidental submersion poses a significant risk of drowning. This manuscript describes a proof-of-concept device that protects the airway from accidental incursion of water into the airway during unanticipated submersion in water, thereby allowing laryngectomees to return to participation in water activities. The device is designed to be worn comfortably for long periods of time, while not interfering with the common methods of replacement speech that are utilized post-laryngectomy.	[Denning, Samantha K.; Valleau, Michael A.; Pelowski, William J.; Grimes, Kelli E.; Erath, Byron D.] Clarkson Univ, Dept Mech & Aeronaut Engn, Potsdam, NY 13699 USA; [Chaisson, Claire M.] Clarkson Univ, David D Reh Sch Business, Potsdam, NY USA	Clarkson University; Clarkson University	Erath, BD (corresponding author), Clarkson Univ, Dept Mech & Aeronaut Engn, Potsdam, NY 13699 USA.	berath@clarkson.edu			National Science Foundation (NSF), Division of Chemical, Bioengineering, Environmental, and Transport Systems (CBET) [1510367]	National Science Foundation (NSF), Division of Chemical, Bioengineering, Environmental, and Transport Systems (CBET)(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	This work was supported by the National Science Foundation (NSF), Division of Chemical, Bioengineering, Environmental, and Transport Systems (CBET), under Grant No. 1510367, awarded to B.D.E. (https://www.nsf.gov/div/index.jsp?div=CBET) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmadi F, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192257; ASAI R, 1972, ARCHIV OTOLARYNGOL, V95, P114; Bien S, 2010, EUR ARCH OTO-RHINO-L, V267, P429, DOI 10.1007/s00405-009-1018-4; Brook I., 2013, LARYNGECTOMEE GUIDE; Buntzel J, 2016, ANTICANCER RES, V36, P3191; Ceachir Octavian, 2014, Maedica (Bucur), V9, P210; CHALSTREY SE, 1994, J LARYNGOL OTOL, V108, P852, DOI 10.1017/S0022215100128312; Chaturvedi SK, 1996, SUPPORT CARE CANCER, V4, P186, DOI 10.1007/BF01682338; DAmbrosio N, 2017, P SUMM BION BIOM BIO; Eadie TL, 2005, J REHABIL RES DEV, V42, P115, DOI 10.1682/JRRD.2004.01.0007; EISELE DW, 1989, AM J SURG, V157, P230, DOI 10.1016/0002-9610(89)90534-5; Goektas O, 2008, AM J RHINOL, V22, P487, DOI 10.2500/ajr.2008.22.3213; HILGERS FJM, 1990, CLIN OTOLARYNGOL, V15, P421, DOI 10.1111/j.1365-2273.1990.tb00494.x; Karamzadeh AM, 2001, OTOLARYNG HEAD NECK, V125, P528, DOI 10.1016/S0194-5998(01)65511-6; Kaye R, 2017, MED DEVICES-EVID RES, V10, P133, DOI 10.2147/MDER.S133225; Kim JH, 2015, INT J OCCUP MED ENV, V28, P71, DOI 10.13075/ijomeh.1896.00153; Landis BN, 2003, AM J MED, V114, P341, DOI 10.1016/S0002-9343(02)01532-2; Li YK, 2017, CLIN EXP OTORHINOLAR, V10, P203, DOI 10.21053/ceo.2017.00199; Liu H, 2007, AURIS NASUS LARYNX, V34, P327, DOI 10.1016/j.anl.2006.11.010; Lorenz KJ, 2017, FRONT MED-LAUSANNE, V4, DOI 10.3389/fmed.2017.00081; Maddox PT, 2012, OTOLARYNG HEAD NECK, V147, P85, DOI 10.1177/0194599812438170; Mittal R, 2013, ANNU REV FLUID MECH, V45, P437, DOI 10.1146/annurev-fluid-011212-140636; Pawar PV, 2008, J CANCER RES THER, V4, P186, DOI 10.4103/0973-1482.44289; PITORAK EF, 1968, AM J NURS, V68, P780; SINGER MI, 1980, ANN OTO RHINOL LARYN, V89, P529, DOI 10.1177/000348948008900608; SINGER MI, 1981, ANN OTO RHINOL LARYN, V90, P498, DOI 10.1177/000348948109000518; Tang CG, 2015, OTOLARYNG CLIN N AM, V48, P687, DOI 10.1016/j.otc.2015.04.013; Terrell JE, 1998, ARCH OTOLARYNGOL, V124, P964, DOI 10.1001/archotol.124.9.964; Titze IR, 1994, PRINCIPLES VOICE PRO; Tuttle TG, 2018, J MED DEVICES, V12, DOI 10.1115/1.4038222; Verkerke GJ, 2014, ANNU REV BIOMED ENG, V16, P215, DOI 10.1146/annurev-bioeng-071811-150014	31	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2021	16	9							e0257463	10.1371/journal.pone.0257463	http://dx.doi.org/10.1371/journal.pone.0257463			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	WG6OR	34516593	gold, Green Published			2022-12-26	WOS:000707114200035
J	Anchoori, RK; George, L; Tseng, SH; Lam, B; Polkampally, S; Amiano, AD; Foran, P; Tsingine, H; Samanapally, H; Velasquez, FC; Das, S; Xing, DY; Bin Salam, A; Karanam, B; Hung, CF; Roden, RBS				Anchoori, Ravi K.; George, Logan; Tseng, Ssu-Hsueh; Lam, Brandon; Polkampally, Srinidhi; Amiano, Anjali D.; Foran, Palmer; Tsingine, Hannah; Samanapally, Harideep; Carrizo Velasquez, Fernanda; Das, Samarjit; Xing, Deyin; Bin Salam, Ahmad; Karanam, Balasubramanyam; Hung, Chien-Fu; Roden, Richard B. S.			Chirality and asymmetry increase the potency of candidate ADRM1/RPN13 inhibitors	PLOS ONE			English	Article							UBIQUITIN RECEPTOR RPN13; DEUBIQUITINATING ENZYME; OVARIAN-CANCER; PROTEASOME INHIBITOR; MOUSE MODEL; BORTEZOMIB; ACTIVATION; RPN13/ADRM1; GENERATION; TARGET	Bortezomib and the other licensed 20S proteasome inhibitors show robust activity against liquid tumors like multiple myeloma, but have disappointed against solid tumors including ovarian cancer. Consequently, interest is mounting in alternative non-peptide based drugs targeting the proteasome's 19S regulatory particle subunit, including its ubiquitin receptor RPN13. RA183 and RA375 are more potent analogs of the prototypic inhibitor of RPN13 (iRPN13) called RA190, and they show promise for the treatment of ovarian cancer. Here we demonstrate that rendering these candidate RPN13 inhibitors chiral and asymmetric through the addition of a single methyl to the core piperidone moiety increases their potency against cancer cell lines, with the S-isomer being more active than the R-isomer. The enhanced cancer cell cytotoxicities of these compounds are associated with improved binding to RPN13 in cell lysates, ATP depletion by inhibition of glycolysis and mitochondrial electron chain transport, mitochondrial depolarization and perinuclear clustering, oxidative stress and glutathione depletion, and rapid accumulation of high molecular weight polyubiquitinated proteins with a consequent unresolved ubiquitin proteasome system (UPS) stress response. Cytotoxicity was associated with an early biomarker of apoptosis, increased surface annexin V binding. As for cisplatin, BRCA2 and ATM deficiency conferred increased sensitivity to these iRPN13s. Ubiquitination plays an important role in coordinating DNA damage repair and the iRPN13s may compromise this process by depletion of monomeric ubiquitin following its sequestration in high molecular weight polyubiquitinated protein aggregates. Indeed, a synergistic cytotoxic response was evident upon treatment of several ovarian cancer cell lines with either cisplatin or doxorubicin and our new candidate iRPN13s, suggesting that such a combination approach warrants further exploration for the treatment of ovarian cancer.	[Anchoori, Ravi K.; George, Logan; Tseng, Ssu-Hsueh; Lam, Brandon; Polkampally, Srinidhi; Amiano, Anjali D.; Foran, Palmer; Tsingine, Hannah; Samanapally, Harideep; Carrizo Velasquez, Fernanda; Das, Samarjit; Xing, Deyin; Hung, Chien-Fu; Roden, Richard B. S.] Johns Hopkins Univ, Dept Pathol, Baltimore, MD 21218 USA; [Anchoori, Ravi K.; Roden, Richard B. S.] Johns Hopkins Univ, Dept Oncol, Baltimore, MD 21218 USA; [Carrizo Velasquez, Fernanda; Das, Samarjit] Johns Hopkins Univ, Dept Anesthesiol & Crit Care Med, Baltimore, MD USA; [Bin Salam, Ahmad; Karanam, Balasubramanyam] Tuskegee Univ, Dept Biol, Tuskegee, AL 36088 USA; [Bin Salam, Ahmad; Karanam, Balasubramanyam] Tuskegee Univ, Ctr Canc Res, Tuskegee, AL 36088 USA; [Roden, Richard B. S.] Johns Hopkins Univ, Dept Obstet Gynecol, Baltimore, MD 21218 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Tuskegee University; Tuskegee University; Johns Hopkins University	Roden, RBS (corresponding author), Johns Hopkins Univ, Dept Pathol, Baltimore, MD 21218 USA.; Roden, RBS (corresponding author), Johns Hopkins Univ, Dept Oncol, Baltimore, MD 21218 USA.; Roden, RBS (corresponding author), Johns Hopkins Univ, Dept Obstet Gynecol, Baltimore, MD 21218 USA.	roden@jhmi.edu		Carrizo Velasquez, Fernanda Elisabeth/0000-0003-1800-8644; Foran, Palmer/0000-0003-0876-2678; Lam, Brandon/0000-0001-9737-2000	National Institutes of Health [P50CA098252, P50CA228991, P30CA06973]; Allegheny Health Network-Johns Hopkins Cancer Research Fund; Ovarian Cancer Research Fund Alliance [458972]; Dr. Richard W. TeLinde endowment	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Allegheny Health Network-Johns Hopkins Cancer Research Fund; Ovarian Cancer Research Fund Alliance; Dr. Richard W. TeLinde endowment	This work was supported by grants from the National Institutes of Health (https://www.nih.gov/) grant P50CA098252, P50CA228991 and P30CA06973, the Allegheny Health Network-Johns Hopkins Cancer Research Fund (https://www.ahn.org/cancer-institute), and the Ovarian Cancer Research Fund Alliance (https://ocrahope.org/) #458972 (to RKA, C-FH, and RBSR). The project was also supported in part by the Dr. Richard W. TeLinde endowment (https://professorships.jhu.edu/professorship/richard-w-telinde-distinguished-professorship-in-gynecological-pathology/). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aguileta MA, 2015, J BIOL CHEM, V290, P7492, DOI 10.1074/jbc.M114.614925; Al-Shami A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013654; Anchoori RK, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0227727; Anchoori RK, 2018, ACS OMEGA, V3, P11917, DOI 10.1021/acsomega.8b01479; Anchoori RK, 2013, CANCER CELL, V24, P791, DOI 10.1016/j.ccr.2013.11.001; Bazzaro M, 2020, J MED CHEM, V63, P15075, DOI 10.1021/acs.jmedchem.0c00812; Chen X, 2010, MOL CELL, V38, P404, DOI 10.1016/j.molcel.2010.04.019; Conejo-Garcia JR, 2004, NAT MED, V10, P950, DOI 10.1038/nm1097; Cron KR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073710; D'Arcy P, 2011, NAT MED, V17, P1636, DOI 10.1038/nm.2536; DelloRusso C, 2007, MOL CANCER RES, V5, P35, DOI 10.1158/1541-7786.MCR-06-0234; Dickson P, 2020, CELL CHEM BIOL, V27, P1371, DOI 10.1016/j.chembiol.2020.08.007; Fejzo MS, 2011, GENE CHROMOSOME CANC, V50, P434, DOI 10.1002/gcc.20868; Fernandez-Checa JC, 1998, SEMIN LIVER DIS, V18, P389, DOI 10.1055/s-2007-1007172; Fernandez-Checa JC, 2003, BIOCHEM BIOPH RES CO, V304, P471, DOI 10.1016/S0006-291X(03)00619-3; Golnik R, 2016, J BIOL CHEM, V291, P8805, DOI 10.1074/jbc.M115.705178; Gu Y, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.537; Hamazaki J, 2006, EMBO J, V25, P4524, DOI 10.1038/sj.emboj.7601338; Hamazaki J, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005401; Hemmis CW, 2019, J BIOL CHEM, V294, P9659, DOI 10.1074/jbc.AC119.008881; Hucl T, 2008, CANCER RES, V68, P5023, DOI 10.1158/0008-5472.CAN-07-6189; Hurley PJ, 2007, ONCOGENE, V26, P2535, DOI 10.1038/sj.onc.1210049; Jandial DA, 2017, GYNECOL ONCOL, V145, P236, DOI 10.1016/j.ygyno.2017.03.013; Jannuzzi AT, 2020, REDOX BIOL, V32, DOI 10.1016/j.redox.2020.101502; Jiang RT, 2017, J OVARIAN RES, V10, DOI 10.1186/s13048-017-0347-y; Lee BH, 2010, NATURE, V467, P179, DOI 10.1038/nature09299; Lee MJ, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.R110.003871; Leznicki P, 2015, J CELL SCI, V128, P3187, DOI 10.1242/jcs.165209; Li J, 2017, NAT CHEM BIOL, V13, P486, DOI [10.1038/NCHEMBIO.2326, 10.1038/nchembio.2326]; Lim HS, 2007, J AM CHEM SOC, V129, P12936, DOI 10.1021/ja075469+; Ling YH, 2003, J BIOL CHEM, V278, P33714, DOI 10.1074/jbc.M302559200; Lu XX, 2020, STRUCTURE, V28, P495, DOI 10.1016/j.str.2020.02.007; Lu XX, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15540; Ludman T, 2019, MOL PAIN, V15, DOI 10.1177/1744806919837429; Luker GD, 2003, NAT MED, V9, P969, DOI 10.1038/nm894; McCarthy MK, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00021; Miller Z, 2013, CURR PHARM DESIGN, V19, P4140, DOI 10.2174/1381612811319220018; Mofers A, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0223807; Muli CS, 2019, CHEMBIOCHEM, V20, P1739, DOI 10.1002/cbic.201900017; Neri P, 2011, BLOOD, V118, P6368, DOI 10.1182/blood-2011-06-363911; Osei-Amponsa V, 2020, MOL CELL BIOL, V40, DOI 10.1128/MCB.00122-20; Otsubo R, 2019, CELL MICROBIOL, V21, DOI 10.1111/cmi.12974; Perez-Galan P, 2006, BLOOD, V107, P257, DOI 10.1182/blood-2005-05-2091; Qiu XB, 2006, EMBO J, V25, P5742, DOI 10.1038/sj.emboj.7601450; Rabl J, 2020, BIOMOLECULES, V10, DOI 10.3390/biom10111503; Rao G, 2018, FRONT CHEM, V6, DOI 10.3389/fchem.2018.00392; Ray A, 2019, BLOOD CANCER J, V9, DOI 10.1038/s41408-019-0224-6; Roby KF, 2000, CARCINOGENESIS, V21, P585, DOI 10.1093/carcin/21.4.585; Rowinsky EK, 2020, INVEST NEW DRUG, V38, P1448, DOI 10.1007/s10637-020-00915-4; Schwertman P, 2016, NAT REV MOL CELL BIO, V17, P379, DOI 10.1038/nrm.2016.58; Song Y, 2016, LEUKEMIA, V30, P1877, DOI 10.1038/leu.2016.97; Song Y, 2019, LEUKEMIA, V33, P2685, DOI 10.1038/s41375-019-0467-z; Soong RS, 2016, ONCOTARGET, V7, P68489, DOI 10.18632/oncotarget.12095; Trader DJ, 2015, J AM CHEM SOC, V137, P6312, DOI 10.1021/jacs.5b02069; Wang X, 2015, CHEM BIOL DRUG DES, V86, P1036, DOI 10.1111/cbdd.12571; Wang YW, 2018, CELL RES, V28, P1186, DOI 10.1038/s41422-018-0091-x; Ward JA, 2020, J MED CHEM, V63, P3756, DOI 10.1021/acs.jmedchem.0c00144; Wilson SM, 2002, NAT GENET, V32, P420, DOI 10.1038/ng1006; Xing DY, 2006, CANCER RES, V66, P8949, DOI 10.1158/0008-5472.CAN-06-1495; Yadav B, 2015, COMPUT STRUCT BIOTEC, V13, P504, DOI 10.1016/j.csbj.2015.09.001; Yao TT, 2006, NAT CELL BIOL, V8, P994, DOI 10.1038/ncb1460; Zheng H, 2012, EXP NEUROL, V238, P225, DOI 10.1016/j.expneurol.2012.08.023	62	1	1	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2021	16	9							e0256937	10.1371/journal.pone.0256937	http://dx.doi.org/10.1371/journal.pone.0256937			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XM9EM	34506530	Green Published, gold			2022-12-26	WOS:000729120700069
J	Christensen, K; Melstrom, KM				Christensen, Kiana; Melstrom, Keegan M.			Quantitative analyses of squamate dentition demonstrate novel morphological patterns	PLOS ONE			English	Article							SPINY-TAILED IGUANA; HERBIVOROUS LIZARD; TOOTH REPLACEMENT; MARINE IGUANA; GREEN IGUANA; DIET; CONSUMPTION; SELECTION; ECOLOGY; GROWTH	Squamates are ideal subjects for investigating relationships between diet and dental patterns because they exhibit wide dietary diversity, marked variation in dental shape, and are taxonomically abundant. Despite this, well-established links between diet and dental morphology are primarily qualitative in nature, with specific patterns of squamate dental complexity remaining largely unknown. Here, we use quantitative methods and a broad taxonomic dataset to quantify key patterns in squamate dental morphology, including re-examining the relationship between dentition and diet, testing for differences in complexity between dentigerous elements, and exploring the effect of ontogenetic dietary shifts in dental complexity in two iguanid genera. Our findings support previous research by demonstrating that species consuming more plant material possess more complex teeth. We did not find significant complexity differences between the left and right dentigerous elements nor the upper and lower jaws, with the exception of Amblyrhynchus cristatus, the marine iguana, which possesses significantly more complex dentary teeth than premaxillary and maxillary teeth. We find discordant patterns when testing for dental complexity changes through ontogeny. Amblyrhynchus, which is primarily herbivorous throughout its lifetime, increases dental complexity through ontogeny, whereas Ctenosaura, which is generally insectivorous as juveniles and herbivorous as adults, decreases dental complexity. Although preliminary, this research documents and quantifies novel patterns of squamate dental complexity and exhibits the possibilities for further research on the diversity of squamate dental morphology.	[Christensen, Kiana; Melstrom, Keegan M.] Univ Utah, Nat Hist Museum Utah, Salt Lake City, UT USA; [Melstrom, Keegan M.] Nat Hist Museum Los Angeles Cty, Los Angeles, CA USA	Utah System of Higher Education; University of Utah	Christensen, K (corresponding author), Univ Utah, Sch Dent, Salt Lake City, UT 84112 USA.	kiana.christensen@hsc.utah.edu		Melstrom, Keegan/0000-0002-6313-6146				Berkovitz B, 2017, TEETH OF NON- MAMMALIAN VERTEBRATES, P1; Blazquez MC, 2007, BIOTROPICA, V39, P496, DOI 10.1111/j.1744-7429.2007.00294.x; Boyer DM, 2010, AM J PHYS ANTHROPOL, V142, P194, DOI 10.1002/ajpa.21211; COOPER JS, 1970, J ZOOL, V162, P85; Cooper WE, 2002, J ZOOL, V257, P487, DOI 10.1017/S0952836902001085; COOPER WE, 1989, AM NAT, V133, P729, DOI 10.1086/284948; Durtsche RD, 2000, OECOLOGIA, V124, P185, DOI 10.1007/s004420050006; Durtsche RD., 1999, THESIS U OKLAHOMA; Edmund AG., 1960, TOOTH REPLACEMENT PH, DOI [10.5962/bhl.title.52196, DOI 10.5962/BHL.TITLE.52196]; Eronen JT, 2017, CURR BIOL, V27, P3384, DOI 10.1016/j.cub.2017.09.050; Estes R., 1984, Journal of Vertebrate Paleontology, V4, P96; Evans AR, 2007, NATURE, V445, P78, DOI 10.1038/nature05433; FITCH H S, 1978, University of Kansas Science Bulletin, V51, P483; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; HOTTON NICHOLAS, 1955, AMER MIDLAND NAT, V53, P88; KLINE LW, 1985, J MORPHOL, V186, P265, DOI 10.1002/jmor.1051860303; Knowlton GF, 1934, J ECON ENTOMOL, V27, P998, DOI 10.1093/jee/27.5.998; Laia R.C., 2015, SPRINGER SCI REV, V3, P13; LICHTENBELT WDV, 1993, OECOLOGIA, V95, P246, DOI 10.1007/BF00323497; MAUTZ WJ, 1987, PHYSIOL ZOOL, V60, P640, DOI 10.1086/physzool.60.6.30159980; Melstrom KM, 2019, CURR BIOL, V29, P2389, DOI 10.1016/j.cub.2019.05.076; Melstrom KM, 2017, J MORPHOL, V278, P500, DOI 10.1002/jmor.20645; Mendyk Robert W., 2015, Biawak, V9, P44; Mitchell JC, 1986, J HERPETOL, V15, P1; MONTANUCCI RR, 1989, HERPETOLOGICA, V45, P208; Moody SM., 1980, THESIS U MICH; Mora J.M., 1991, Bulletin of the Chicago Herpetological Society, V26, P197; NAGY KA, 1984, PHYSIOL ZOOL, V57, P281, DOI 10.1086/physzool.57.3.30163716; OSBORN JW, 1974, J THEOR BIOL, V46, P509, DOI 10.1016/0022-5193(74)90012-5; Pianka E., 1986, ECOLOGY NATURAL HIST; Pineda-Munoz S, 2017, METHODS ECOL EVOL, V8, P481, DOI 10.1111/2041-210X.12691; PRESCH W, 1974, Herpetologica, V30, P344; Rannikko J, 2020, J MORPHOL, V281, P348, DOI 10.1002/jmor.21103; RIEPPEL O, 1979, HERPETOLOGICA, V35, P158; Santana SE, 2011, FUNCT ECOL, V25, P839, DOI 10.1111/j.1365-2435.2011.01832.x; Shepherd SA, 2005, B MAR SCI, V77, P51; Structure TroyerK, 1984, PHYSIOL ZOOL, V57, P1; Taylor E.H., 1922, LIZARDS PHILIPPINE I; TEAFORD MF, 1989, AM J PHYS ANTHROPOL, V80, P73, DOI 10.1002/ajpa.1330800109; THROCKMORTON GS, 1976, J MORPHOL, V148, P363, DOI 10.1002/jmor.1051480307; Torres-Carvajal O, 2007, J HERPETOL, V41, P528, DOI 10.1670/0022-1511(2007)41[528:HGOMTI]2.0.CO;2; TROYER K, 1984, OECOLOGIA, V61, P201, DOI 10.1007/BF00396761; van Devender R.W., 1982, P162; Wilson GP, 2012, NATURE, V483, P457, DOI 10.1038/nature10880	44	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2021	16	9							e0257427	10.1371/journal.pone.0257427	http://dx.doi.org/10.1371/journal.pone.0257427			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XM9EM	34506601	Green Published, gold			2022-12-26	WOS:000729120700024
J	Nlinwe, ON; Ofori, EA; Akyea-Mensah, K; Kyei-Baafour, E; Ganeshan, H; Belmonte, M; Peters, B; Villasante, E; Sedegah, M; Kusi, KA				Nlinwe, Omarine N.; Ofori, Ebenezer A.; Akyea-Mensah, Kwadwo; Kyei-Baafour, Eric; Ganeshan, Harini; Belmonte, Maria; Peters, Bjoern; Villasante, Eileen; Sedegah, Martha; Kusi, Kwadwo Asamoah			Comparative analysis of the ex vivo IFN-gamma responses to CD8+T cell epitopes within allelic forms of PfAMA1 in subjects with natural exposure to malaria	PLOS ONE			English	Article							EFFICACY; VACCINE; PROMISCUITY; RECOGNITION; RTS	Antigen polymorphisms in essential malarial antigens are a key challenge to the design and development of broadly effective malaria vaccines. The effect of polymorphisms on antibody responses is fairly well studied while much fewer studies have assessed this for T cell responses. This study investigated the effect of allelic polymorphisms in the malarial antigen apical membrane antigen 1 (AMA1) on ex vivo T cell-specific IFN-gamma responses in subjects with lifelong exposure to malaria. Human leukocyte antigen (HLA) class I-restricted peptides from the 3D7 clone AMA1 were bioinformatically predicted and those with variant amino acid positions used to select corresponding allelic sequences from the 7G8, FVO, FC27 and tm284 parasite strains. A total of 91 AMA1 9-10mer peptides from the five parasite strains were identified, synthesized, grouped into 42 allele sets and used to stimulate PBMCs from seven HLA class 1-typed subjects in IFN-gamma ELISpot assays. PBMCs from four of the seven subjects (57%) made positive responses to 18 peptides within 12 allele sets. Fifty percent of the 18 positive peptides were from the 3D7 parasite variant. Amino acid substitutions that were associated with IFN-gamma response abrogation were more frequently found at positions 1 and 6 of the tested peptides, but substitutions did not show a clear pattern of association with response abrogation. Thus, while we show some evidence of polymorphisms affecting T cell response induction, other factors including TCR recognition of HLA-peptide complexes may also be at play.	[Nlinwe, Omarine N.; Ofori, Ebenezer A.; Akyea-Mensah, Kwadwo; Kyei-Baafour, Eric; Kusi, Kwadwo Asamoah] Univ Ghana, Coll Hlth Sci, Noguchi Mem Inst Med Res, Immunol Dept, Legon, Ghana; [Ganeshan, Harini; Belmonte, Maria; Villasante, Eileen; Sedegah, Martha] Naval Med Res Ctr, Malaria Dept, Silver Spring, MD USA; [Ganeshan, Harini; Belmonte, Maria] Henry M Jackson Fdn Adv Mil Med, Bethesda, MD USA; [Peters, Bjoern] Infect Dis & Vaccine Ctr, La Jolla Inst Immunol, La Jolla, CA USA	University of Ghana; Naval Medical Research Center (NMRC); Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc; La Jolla Institute for Immunology	Kusi, KA (corresponding author), Univ Ghana, Coll Hlth Sci, Noguchi Mem Inst Med Res, Immunol Dept, Legon, Ghana.	akusi@noguchi.ug.edu.gh	Eric, Kyei-Baafour/X-7280-2019	Eric, Kyei-Baafour/0000-0001-6423-1885; Kusi, Kwadwo/0000-0001-5483-9985; OFORI, Ebenezer Addo/0000-0001-8163-1936	Noguchi Postdoctoral Training in Infectious Diseases Research program award; Bill and Melinda Gates Foundation [OPP52155]	Noguchi Postdoctoral Training in Infectious Diseases Research program award; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	This study was funded by a Noguchi Postdoctoral Training in Infectious Diseases Research program award (Omarine Nlinwe). Grant for this training program was originally from the Bill and Melinda Gates Foundation awarded to the Noguchi Memorial Institute for Medical Research (Global Health Grant number OPP52155, Kwadwo Koram). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adjah J, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-3350-z; Adland E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073117; [Anonymous], 2018, 1 MALARIA VACCINE RE; Behrendt R, 2016, J PEPT SCI, V22, P4, DOI 10.1002/psc.2836; Cortes A, 2005, INFECT IMMUN, V73, P422, DOI 10.1128/IAI.73.1.422-430.2005; DEGROOT AS, 1989, J IMMUNOL, V142, P4000; Ekeruche-Makinde J, 2013, BLOOD, V121, P1112, DOI 10.1182/blood-2012-06-437202; Epstein JE, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.89154; Frahm N, 2007, EUR J IMMUNOL, V37, P2419, DOI 10.1002/eji.200737365; Ganeshan H, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1098-8; GUTTINGER M, 1988, EMBO J, V7, P2555, DOI 10.1002/j.1460-2075.1988.tb03104.x; Hoffman S L, 1994, Curr Top Microbiol Immunol, V189, P187; Hsu SC, 2012, IMMUNOLOGY, V136, P139, DOI 10.1111/j.1365-2567.2011.03542.x; Kusi KA, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0228177; Kusi KA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008110; Neafsey DE, 2015, NEW ENGL J MED, V373, P2025, DOI 10.1056/NEJMoa1505819; Nielsen M, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0288-x; Nkhoma SC, 2018, INFECT GENET EVOL, V65, P414, DOI 10.1016/j.meegid.2018.08.018; Nlinwe ON, 2018, VACCINE, V36, P2237, DOI 10.1016/j.vaccine.2018.03.023; Olotu A, 2016, NEW ENGL J MED, V374, P2519, DOI 10.1056/NEJMoa1515257; Ouattara A, 2013, J INFECT DIS, V207, P511, DOI 10.1093/infdis/jis709; PIRCHER H, 1990, NATURE, V346, P629, DOI 10.1038/346629a0; Rao XY, 2011, IMMUNOGENETICS, V63, P691, DOI 10.1007/s00251-011-0552-6; Remarque EJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038898; Ritmahan W, 2020, IMMUNOGENETICS, V72, P109, DOI 10.1007/s00251-019-01134-9; Sedegah M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163026; Sedegah M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106241; Sedegah M, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-185; Sedegah M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024586; Sondo P, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-36493-y; Takala SL, 2007, PLOS MED, V4, P523, DOI 10.1371/journal.pmed.0040093; Walk J, 2017, BMC MED, V15, DOI 10.1186/s12916-017-0923-4; White MT, 2015, LANCET INFECT DIS, V15, P1450, DOI 10.1016/S1473-3099(15)00239-X; White MT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061395; WHO, 2013, WORLD MALARIA REPORT 2013, P1; WHO, 2015, GLOB TECHN STRAT MAL; Zevering Y, 1998, IMMUNOLOGY, V94, P445, DOI 10.1046/j.1365-2567.1998.00514.x; Zhang YH, 2017, SCI REP-UK, V7, DOI 10.1038/srep42768	38	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2021	16	9							e0257219	10.1371/journal.pone.0257219	http://dx.doi.org/10.1371/journal.pone.0257219			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XM9EM	34506564	gold, Green Published			2022-12-26	WOS:000729120700103
J	Dwivedi, R; Samanta, P; Sharma, P; Zhang, FM; Mishra, SK; Kucheryavy, P; Kim, SB; Aderibigbe, AO; Linhardt, RJ; Tandon, R; Doerksen, RJ; Pomin, VH				Dwivedi, Rohini; Samanta, Priyanka; Sharma, Poonam; Zhang, Fuming; Mishra, Sushil K.; Kucheryavy, Pavel; Kim, Seon Beom; Aderibigbe, AyoOluwa O.; Linhardt, Robert J.; Tandon, Ritesh; Doerksen, Robert J.; Pomin, Vitor H.			Structural and kinetic analyses of holothurian sulfated glycans suggest potential treatment for SARS-CoV-2 infection	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FUCOSYLATED CHONDROITIN SULFATE; HEPARAN-SULFATE; ANTICOAGULANT ACTIVITY; ANTITHROMBOTIC ACTIVITIES; MOLECULAR-DYNAMICS; POLYSACCHARIDES; GLYCOSAMINOGLYCANS; BINDING; SPIKE; MECHANISMS	Certain sulfated glycans, including those from marine sources, can show potential effects against SARS-CoV-2. Here, a new fucosylated chondroitin sulfate (FucCS) from the sea cucumber Pentacta pygmaea (PpFucCS) (MW similar to 10-60 kDa) was isolated and structurally characterized by NMR. PpFucCS is composed of {-> 3)-beta-GalNAcX-(1 -> 4)-beta-GlcA-[(3 -> 1)Y]-(1 ->}, where X = 4S (80%), 6S (10%) or nonsulfated (10%), Y = alpha- Fuc2,4S (40%), alpha-Fuc2,4S-(1 -> 4)-alpha-Fuc (30%), or alpha-Fuc4S (30%), and S = SO3-. The anti-SARS-CoV-2 activity of PpFucCS and those of the FucCS and sulfated fucan isolated from Isostichopus badionotus (IbFucCS and IbSF) were compared with that of heparin. IC50 values demonstrated the activity of the three holothurian sulfated glycans to be similar to 12 times more effi- cient than heparin, with no cytotoxic effects. The dissociation constant (KD) values obtained by surface plasmon resonance of the wildtype SARS-CoV-2 spike (S)-protein receptor-binding domain (RBD) and N501Y mutant RBD in interactions with the heparin-immobilized sensor chip were 94 and 1.8 x 10(3) nM, respectively. Competitive surface plasmon resonance inhibition analysis of PpFucCS, IbFucCS, and IbSF against heparin binding to wildtype S-protein showed IC50 values (in the nanomolar range) 6, 25, and 6 times more efficient than heparin, respectively. Data from computational simulations suggest an influence of the sulfation patterns of the Fuc units on hydrogen bonding with GlcA and that conformational change of some of the oligosaccharide structures occurs upon S -protein RBD binding. Compared with heparin, negligible anticoagulant action was observed for IbSF. Our results suggest that IbSF may represent a promising molecule for future investigations against SARS-CoV-2.	[Dwivedi, Rohini; Samanta, Priyanka; Mishra, Sushil K.; Kucheryavy, Pavel; Kim, Seon Beom; Aderibigbe, AyoOluwa O.; Doerksen, Robert J.; Pomin, Vitor H.] Univ Mississippi, Dept BioMol Sci, Oxford, MS 38677 USA; [Sharma, Poonam; Tandon, Ritesh] Univ Mississippi, Med Ctr, Dept Microbiol & Immunol, Jackson, MS 39216 USA; [Zhang, Fuming; Linhardt, Robert J.] Rensselaer Polytech Inst, Ctr Biotechnol & Interdisciplinary Studies, Troy, NY 12180 USA; [Doerksen, Robert J.; Pomin, Vitor H.] Univ Mississippi, Sch Pharm, Res Inst Pharmaceut Sci, Oxford, MS 38677 USA	University of Mississippi; University of Mississippi; University of Mississippi Medical Center; Rensselaer Polytechnic Institute; University of Mississippi	Pomin, VH (corresponding author), Univ Mississippi, Dept BioMol Sci, Oxford, MS 38677 USA.; Pomin, VH (corresponding author), Univ Mississippi, Sch Pharm, Res Inst Pharmaceut Sci, Oxford, MS 38677 USA.	vpomin@olemiss.edu	Kim, Seon Beom/AGP-7639-2022; Mishra, Sushil K./O-4779-2014	Kim, Seon Beom/0000-0001-8015-1404; Mishra, Sushil K./0000-0002-3080-9754; Aderibigbe, AyoOluwa/0000-0002-0391-5244	AACP New Investigator Award; National Institutes of Health [1P20GM130460-01A1-7936, 1R03NS110996-01A1, 1S10OD028523-01]; GlycoMIP (a National Science Foundation Materials Innovation Platform) [DMR-1933525]; NASA [80NSSC19K1603]; University of Mississippi	AACP New Investigator Award; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); GlycoMIP (a National Science Foundation Materials Innovation Platform); NASA(National Aeronautics & Space Administration (NASA)); University of Mississippi	Funding and additional information-This work was supported by funds from the AACP 2019 New Investigator Award (V. H. P.) , the National Institutes of Health (1P20GM130460-01A1-7936 [R. J. D. and V. H. P.] , 1R03NS110996-01A1 [V. H. P.] , and 1S10OD028523-01 [F. Z. and R. J. L.] ) , GlycoMIP (a National Science Foundation Materials Innovation Platform funded through Cooperative Agreement DMR-1933525 [F. Z. and R. J. L.] ) , NASA #80NSSC19K1603 (R. T.) , and the University of Mississippi (V. H. P.) . The content of the information does not necessarily reflect the position, or the policy of the sponsors, and no official endorsement should be inferred. The funders had no role in the design, writing, or decision of this publication. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ahmed I, 2007, POSTGRAD MED J, V83, DOI 10.1136/pgmj.2007.059188; [Anonymous], PYMOL MOL GRAPHICS S; Beaudet JM, 2011, J PHARM SCI-US, V100, P3396, DOI 10.1002/jps.22527; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Bezerra FF, 2020, J STRUCT BIOL, V209, DOI 10.1016/j.jsb.2019.107407; Bonsall D., 2021, COVID 19 GENOMICS UK; Bose S, 2002, VIROLOGY, V298, P73, DOI 10.1006/viro.2002.1484; Cagno V, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11070596; Cesaretti M, 2003, CARBOHYD POLYM, V54, P59, DOI 10.1016/S0144-8617(03)00144-9; CHEATHAM TE, 1995, J AM CHEM SOC, V117, P4193, DOI 10.1021/ja00119a045; Chen SG, 2013, BBA-GEN SUBJECTS, V1830, P3054, DOI 10.1016/j.bbagen.2013.01.001; Chen SG, 2012, BBA-GEN SUBJECTS, V1820, P989, DOI 10.1016/j.bbagen.2012.03.002; Chen SG, 2011, CARBOHYD POLYM, V83, P688, DOI 10.1016/j.carbpol.2010.08.040; Clausen TM, 2020, CELL, V183, P1043, DOI [10.1016/j.cell.2020.09.033, 10.1101/2020.07.14.201616]; COMPTON T, 1993, VIROLOGY, V193, P834, DOI 10.1006/viro.1993.1192; Cuervo NZ, 2020, ELIFE, V9, DOI 10.7554/eLife.61390; Dechecchi MC, 2000, VIROLOGY, V268, P382, DOI 10.1006/viro.1999.0171; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; Farias WRL, 2000, J BIOL CHEM, V275, P29299, DOI 10.1074/jbc.M002422200; FARNDALE RW, 1982, CONNECT TISSUE RES, V9, P247, DOI 10.3109/03008208209160269; Fiorentini S, 2021, LANCET INFECT DIS, V21, pE147, DOI 10.1016/S1473-3099(21)00007-4; Fonseca RJC, 2009, THROMB HAEMOSTASIS, V102, P829, DOI 10.1160/TH08-11-0773; GASTEIGER J, 1978, TETRAHEDRON LETT, P3181; Gong PX, 2021, CARBOHYD POLYM, V262, DOI 10.1016/j.carbpol.2021.117969; Gupta Y, 2021, INT J BIOL MACROMOL, V183, P203, DOI 10.1016/j.ijbiomac.2021.04.148; Hao W, 2021, SCI BULL, V66, P1205, DOI 10.1016/j.scib.2021.01.010; Hirsh J, 2001, CIRCULATION, V103, P2994, DOI 10.1161/01.CIR.103.24.2994; Hu B, 2021, NAT REV MICROBIOL, V19, P141, DOI 10.1038/s41579-020-00459-7; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jin WH, 2020, INT J BIOL MACROMOL, V163, P1649, DOI 10.1016/j.ijbiomac.2020.09.184; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kim SY, 2020, ANTIVIR RES, V181, DOI 10.1016/j.antiviral.2020.104873; Kirschner KN, 2008, J COMPUT CHEM, V29, P622, DOI 10.1002/jcc.20820; Kwon PS, 2020, CELL DISCOV, V6, DOI 10.1038/s41421-020-00192-8; Kyriakidis NC, 2021, NPJ VACCINES, V6, DOI 10.1038/s41541-021-00292-w; Lan J, 2020, NATURE, V581, P215, DOI 10.1038/s41586-020-2180-5; Li JH, 2017, EUR J MED CHEM, V139, P191, DOI 10.1016/j.ejmech.2017.07.065; Li WH, 2003, NATURE, V426, P450, DOI 10.1038/nature02145; Liu L, 2021, ACS CENTRAL SCI, V7, P1009, DOI [10.1101/2020.05.10.087288, 10.1021/acscentsci.1c00010]; Lovekamp JJ, 2006, BIOMATERIALS, V27, P1507, DOI 10.1016/j.biomaterials.2005.08.003; Luan BQ, 2021, FEBS LETT, V595, P1454, DOI 10.1002/1873-3468.14076; Maier JA, 2015, J CHEM THEORY COMPUT, V11, P3696, DOI 10.1021/acs.jctc.5b00255; McVoy, 2021, ANTIVIR RES, V190; Melo FR, 2008, THROMB HAEMOSTASIS, V99, P531, DOI 10.1160/TH07-10-0649; Melo FR, 2004, J BIOL CHEM, V279, P20824, DOI 10.1074/jbc.M308688200; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Mourao PAS, 1996, J BIOL CHEM, V271, P23973, DOI 10.1074/jbc.271.39.23973; Mourao PAS, 2018, CURR OPIN STRUC BIOL, V50, P33, DOI 10.1016/j.sbi.2017.10.011; Mourao PAS, 2015, MAR DRUGS, V13, P2770, DOI 10.3390/md13052770; Mycroft-West CJ, 2020, THROMB HAEMOSTASIS, V120, P1700, DOI 10.1055/s-0040-1721319; Ngernyuang N, 2018, NEOPLASIA, V20, P182, DOI 10.1016/j.neo.2017.11.011; Ni WT, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-03120-0; Niu QF, 2020, CARBOHYD POLYM, V230, DOI 10.1016/j.carbpol.2019.115698; OCKELFORD PA, 1982, THROMB RES, V27, P679, DOI 10.1016/0049-3848(82)90006-8; Pacheco RG, 2000, BLOOD COAGUL FIBRIN, V11, P563, DOI 10.1097/00001721-200009000-00009; Panagos CG, 2014, J BIOL CHEM, V289, P28284, DOI 10.1074/jbc.M114.572297; Pomin VH, 2005, GLYCOBIOLOGY, V15, P369, DOI 10.1093/glycob/cwi021; Pomin VH, 2019, MOLECULES, V24, DOI 10.3390/molecules24152803; Pomin VH, 2018, PHARMACEUTICALS-BASE, V11, DOI 10.3390/ph11010027; Pomin VH, 2017, CURR TOP MED CHEM, V17, P319, DOI 10.2174/1568026615666150605104444; Pomin VH, 2015, PHARMACEUTICALS, V8, P848, DOI 10.3390/ph8040848; Pomin VH, 2015, CARBOHYD RES, V413, P41, DOI 10.1016/j.carres.2015.05.004; Pomin VH, 2014, GLYCOCONJUGATE J, V31, P341, DOI 10.1007/s10719-014-9530-1; Pomin VH, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00033; Pomin VH, 2014, MAR DRUGS, V12, P232, DOI 10.3390/md12010232; Pomin VH, 2012, BBA-GEN SUBJECTS, V1820, P1971, DOI 10.1016/j.bbagen.2012.08.022; Pomin VH, 2012, MAR DRUGS, V10, P793, DOI 10.3390/md10040793; Pomin VH, 2012, GLYCOBIOLOGY, V22, P826, DOI 10.1093/glycob/cws055; Pomin VH, 2008, GLYCOBIOLOGY, V18, P1016, DOI 10.1093/glycob/cwn085; Pramanik A, 2021, NANOSCALE ADV, V3, DOI 10.1039/d0na01007c; Pramanik A, 2021, J PHYS CHEM LETT, V12, P2166, DOI 10.1021/acs.jpclett.0c03570; Rezagholizadeh A, 2021, EUR J PHARMACOL, V897, DOI 10.1016/j.ejphar.2021.173926; Schuurs ZP, 2021, COMPUT STRUCT BIOTEC, V19, P2806, DOI 10.1016/j.csbj.2021.05.002; Shang J, 2020, NATURE, V581, P221, DOI 10.1038/s41586-020-2179-y; Shukla D, 2001, J CLIN INVEST, V108, P503, DOI 10.1172/JCI13799; Soares PAG, 2018, GLYCOBIOLOGY, V28, P565, DOI 10.1093/glycob/cwy048; Song S, 2020, FOOD FUNCT, V11, P7415, DOI 10.1039/d0fo02017f; Summerford C, 1998, J VIROL, V72, P1438, DOI 10.1128/JVI.72.2.1438-1445.1998; Tandon R, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-76135-w; Tandon R, 2021, J VIROL, V95, DOI [10.1128/JVI.01987-20, 10.1101/2020.06.08.140236]; Tiwari Vaibhav, 2020, bioRxiv, DOI 10.1101/2020.10.08.331751; Truhlar DG, 2007, J COMPUT CHEM, V28, P73, DOI 10.1002/jcc.20529; Tyagi M, 2001, J BIOL CHEM, V276, P3254, DOI 10.1074/jbc.M006701200; Ustyuzhanina NE, 2020, MAR DRUGS, V18, DOI 10.3390/md18110540; Ustyuzhanina NE, 2017, CARBOHYD POLYM, V164, P8, DOI 10.1016/j.carbpol.2017.01.034; Vabret N, 2020, IMMUNITY, V52, P910, DOI 10.1016/j.immuni.2020.05.002; Vasconcelos AA, 2018, MAR DRUGS, V16, DOI 10.3390/md16090304; Vasconcelos AA, 2017, MICROORGANISMS, V5, DOI 10.3390/microorganisms5030051; Vasconcelos AA, 2018, MAR DRUGS, V16, DOI 10.3390/md16070233; Vives RR, 2005, J BIOL CHEM, V280, P21353, DOI 10.1074/jbc.M500911200; Wang QH, 2020, CELL, V181, P894, DOI 10.1016/j.cell.2020.03.045; WARKENTIN TE, 1995, NEW ENGL J MED, V332, P1330, DOI 10.1056/NEJM199505183322003; Welte T, 2021, EUR RESPIR REV, V30, DOI 10.1183/16000617.0384-2020; Woods Group, 2005, GLYCAM WEB; Wrapp D, 2020, SCIENCE, V367, P1260, DOI [10.1101/2020.02.11.944462, 10.1126/science.abb2507]; Xu L, 2018, EUR J MED CHEM, V154, P133, DOI 10.1016/j.ejmech.2018.05.024; Yan LF, 2021, CARBOHYD POLYM, V260, DOI 10.1016/j.carbpol.2021.117797; Yim SK, 2021, MAR DRUGS, V19, DOI 10.3390/md19040219; Yu MJ, 2021, FRONT MOL BIOSCI, V7, DOI 10.3389/fmolb.2020.628551; Zong AZ, 2012, CARBOHYD POLYM, V90, P1395, DOI 10.1016/j.carbpol.2012.07.026	101	11	12	3	20	ELSEVIER	AMSTERDAM	RADARWEG 29a, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT	2021	297	4							101207	10.1016/j.jbc.2021.101207	http://dx.doi.org/10.1016/j.jbc.2021.101207			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	WP2YR	34537241	Green Published, gold			2022-12-26	WOS:000713003600003
J	Kaler, KMR; Nix, JC; Schubot, FD				Kaler, Kylie M. Ryan; Nix, Jay C.; Schubot, Florian D.			RetS inhibits Pseudomonas aeruginosa biofilm formation by disrupting the canonical histidine kinase dimerization interface of GacS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							2-COMPONENT SIGNAL-TRANSDUCTION; MEDIATED MULTISTEP PHOSPHORELAY; PROTEINS; SYSTEM; IDENTIFICATION; SPECIFICITY; MECHANISMS; INFECTION; INSIGHTS; NETWORK	Bacterial signaling histidine kinases (HKs) have long been postulated to function exclusively through linear signal transduction chains. However, several HKs have recently been shown to form complex multikinase networks (MKNs). The most prominent MKN, involving the enzymes RetS and GacS, controls the switch between the motile and biofilm lifestyles in the pathogenic bacterium Pseudomonas aeruginosa. While GacS promotes biofilm formation, RetS counteracts GacS using three distinct mechanisms. Two are dephosphorylating mechanisms. The third, a direct binding between the RetS and GacS HK regions, blocks GacS autophosphorylation. Focusing on the third mechanism, we determined the crystal structure of a cocomplex between the HK region of RetS and the dimerization and histidine phosphotransfer (DHp) domain of GacS. This is the first reported structure of a complex between two distinct bacterial signaling HKs. In the complex, the canonical HK homodimerization interface is replaced by a strikingly similar heterodimeric interface between RetS and GacS. We further demonstrate that GacS autophosphorylates in trans, thus explaining why the formation of a RetS-GacS complex inhibits GacS autophosphorylation. Using mutational analysis in conjunction with bacterial two-hybrid and biofilm assays, we not only corroborate the biological role of the observed RetSGacS interactions, but also identify a residue critical for the equilibrium between the RetS-GacS complex and the respective RetS and GacS homodimers. Collectively, our findings suggest that RetS and GacS form a domain-swapped hetero-oligomer during the planktonic growth phase of P. aeruginosa before unknown signals cause its dissociation and a relief of GacS inhibition to promote biofilm formation.	[Kaler, Kylie M. Ryan; Schubot, Florian D.] Virginia Polytech Inst & State Univ, Dept Biol Sci, Blacksburg, VA 24061 USA; [Nix, Jay C.] Lawrence Berkeley Natl Lab, Adv Light Source, Berkeley, CA USA	Virginia Polytechnic Institute & State University; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory	Schubot, FD (corresponding author), Virginia Polytech Inst & State Univ, Dept Biol Sci, Blacksburg, VA 24061 USA.	fschubot@vt.edu		Schubot, Florian/0000-0002-7403-4735	NIH [R21AI128255-01A1]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was supported by NIH grant R21AI128255-01A1 to F. D. S. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams PD, 2011, METHODS, V55, P94, DOI 10.1016/j.ymeth.2011.07.005; Albanesi D, 2009, P NATL ACAD SCI USA, V106, P16185, DOI 10.1073/pnas.0906699106; Ashenberg O, 2013, J MOL BIOL, V425, P1198, DOI 10.1016/j.jmb.2013.01.011; Assmann G, 2016, J APPL CRYSTALLOGR, V49, P1021, DOI 10.1107/S1600576716005471; Bhagirath AY, 2017, ACS INFECT DIS, V3, P162, DOI 10.1021/acsinfecdis.6b00153; Bhate MP, 2015, STRUCTURE, V23, P981, DOI 10.1016/j.str.2015.04.002; Bordi C, 2010, MOL MICROBIOL, V76, P1427, DOI 10.1111/j.1365-2958.2010.07146.x; Bouillet S, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-42653-5; Brencic A, 2009, MOL MICROBIOL, V73, P434, DOI 10.1111/j.1365-2958.2009.06782.x; Buschiazzo A, 2019, ANNU REV MICROBIOL, V73, P507, DOI 10.1146/annurev-micro-091018-054627; Capra EJ, 2012, MOL MICROBIOL, V86, P1393, DOI 10.1111/mmi.12064; Capra EJ, 2012, CELL, V150, P222, DOI 10.1016/j.cell.2012.05.033; Casino P, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4258; Chambonnier G, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006032; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Evans PR, 2011, ACTA CRYSTALLOGR D, V67, P282, DOI 10.1107/S090744491003982X; Francis VI, 2019, ANNU REV MICROBIOL, V73, P199, DOI 10.1146/annurev-micro-020518-115846; Francis VI, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04640-8; Gao R, 2009, ANNU REV MICROBIOL, V63, P133, DOI 10.1146/annurev.micro.091208.073214; Goodman AL, 2004, DEV CELL, V7, P745, DOI 10.1016/j.devcel.2004.08.020; Goodman AL, 2009, GENE DEV, V23, P249, DOI 10.1101/gad.1739009; Hsu JL, 2008, J BIOL CHEM, V283, P9933, DOI 10.1074/jbc.M708836200; Jing X, 2010, PROTEINS, V78, P1631, DOI 10.1002/prot.22679; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Karimova G, 2005, J BACTERIOL, V187, P2233, DOI 10.1128/JB.187.7.2233-2243.2005; Kinoshita-Kikuta E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148294; Kong WN, 2013, MOL MICROBIOL, V88, P784, DOI 10.1111/mmi.12223; Lapouge K, 2008, MOL MICROBIOL, V67, P241, DOI 10.1111/j.1365-2958.2007.06042.x; Laskowski MA, 2006, INFECT IMMUN, V74, P4462, DOI 10.1128/IAI.00575-06; Laskowski RA, 2018, PROTEIN SCI, V27, P129, DOI 10.1002/pro.3289; Latour X, 2020, MICROORGANISMS, V8, DOI 10.3390/microorganisms8111746; Laub MT, 2007, ANNU REV GENET, V41, P121, DOI 10.1146/annurev.genet.41.042007.170548; LeRoux M, 2015, ELIFE, V4, DOI 10.7554/eLife.05701; Lin CT, 2006, RES MICROBIOL, V157, P169, DOI 10.1016/j.resmic.2005.06.012; Mancl J. M., 2018, THESIS VIRGINIA POLY; Mancl JM, 2019, STRUCTURE, V27, P785, DOI 10.1016/j.str.2019.02.006; Mann TH, 2018, P NATL ACAD SCI USA, V115, pE7166, DOI 10.1073/pnas.1808543115; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Moradali MF, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00039; O'Toole GA, 2011, JOVE-J VIS EXP, DOI 10.3791/2437; Parkinson JS, 2010, ANNU REV MICROBIOL, V64, P101, DOI 10.1146/annurev.micro.112408.134215; Petrova OE, 2011, J BACTERIOL, V193, P6614, DOI 10.1128/JB.00305-11; Podgornaia AI, 2013, CURR OPIN MICROBIOL, V16, P156, DOI 10.1016/j.mib.2013.01.004; Qiu DR, 2008, APPL ENVIRON MICROB, V74, P7422, DOI 10.1128/AEM.01369-08; Rodrigue A, 2000, TRENDS MICROBIOL, V8, P498, DOI 10.1016/S0966-842X(00)01833-3; Rupp B, 2010, BIOMOLECULAR CRYSTALLOGRAPHY: PRINCIPLES, PRACTICE, AND APPLICATION TO STRUCTURAL BIOLOGY, P1; Sonnleitner E, 2011, APPL MICROBIOL BIOT, V91, P63, DOI 10.1007/s00253-011-3332-1; Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183; Huynh TN, 2011, MOL MICROBIOL, V82, P275, DOI 10.1111/j.1365-2958.2011.07829.x; Ulrich LE, 2005, BIOINFORMATICS, V21, P45, DOI 10.1093/bioinformatics/bti1204; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510; Ventre I, 2006, P NATL ACAD SCI USA, V103, P171, DOI 10.1073/pnas.0507407103; Vincent F, 2010, ENVIRON MICROBIOL, V12, P1775, DOI 10.1111/j.1462-2920.2010.02264.x; Wang BX, 2021, CURR BIOL, V31, P90, DOI 10.1016/j.cub.2020.09.088; Wei X, 2013, J BACTERIOL, V195, P3387, DOI 10.1128/JB.00214-13; West AH, 2001, TRENDS BIOCHEM SCI, V26, P369, DOI 10.1016/S0968-0004(01)01852-7; Workentine ML, 2009, FEMS MICROBIOL LETT, V292, P50, DOI 10.1111/j.1574-6968.2008.01445.x; Yan Q, 2018, MBIO, V9, DOI 10.1128/mBio.01845-17; ZHANG XG, 1995, J BIOL CHEM, V270, P11181, DOI 10.1074/jbc.270.19.11181; Zschiedrich CP, 2016, J MOL BIOL, V428, P3752, DOI 10.1016/j.jmb.2016.08.003	62	7	7	1	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT	2021	297	4							101193	10.1016/j.jbc.2021.101193	http://dx.doi.org/10.1016/j.jbc.2021.101193			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	WP4BY	34529974	Green Published, gold			2022-12-26	WOS:000713080600003
J	Song, R; Lei, H; Feng, L; Cheng, WW; Li, Y; Yao, LL; Liu, J				Song, Rui; Lei, Han; Feng, Li; Cheng, Wanwen; Li, Ying; Yao, Ling Ling; Liu, Jie			TFEB insufficiency promotes cardiac hypertrophy by blocking autophagic degradation of GATA4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTORS; IN-VITRO; HEART; ACTIVATION; CLEARANCE; FIBROSIS; PROTECTS; DISEASE; DYSFUNCTION; REVEALS	Autophagosome-lysosome pathway (ALP) insufficiency has been suggested to play a critical role in the pathogenesis of cardiac hypertrophy. However, the mechanisms underlying ALP insufficiency remain largely unknown, and strategies to specifically manipulate ALP insufficiency for treating cardiac hypertrophy are lacking. Transcription factor EB (TFEB), as a master regulator of ALP, regulates the generation and function of autophagosomes and lysosomes. We found that TFEB was significantly decreased, whereas autophagosome markers were increased in phenylephrine (PE)-induced and transverse aortic constriction-induced cardiomyocyte hypertrophy and failing hearts from patients with dilated cardiomyopathy. Knocking down TFEB induced ALP insufficiency, as indicated by increased autophagosome markers, decreased light chain 3II flux, and cardiomyocyte hypertrophy manifested through increased levels of atrial natriuretic peptide and beta-myosin heavy chain and enlarged cell size. The effects of TFEB knockdown were abolished by promoting autophagy. TFEB overexpression improved autophagic flux and attenuated PE-stimulated cardiomyocyte hypertrophy and transverse aortic constriction-induced hypertrophic remodeling, fibrosis, and cardiac dysfunction. Curcumin analog compound C1, a specific TFEB activator, similarly attenuated PE-induced ALP insufficiency and cardiomyocyte hypertrophy. TFEB knockdown increased the accumulation of GATA4, a transcription factor for several genes causing cardiac hypertrophy by blocking autophagic degradation of GATA4, whereas knocking down GATA4 attenuated TFEB downregulation-induced cardiomyocyte hypertrophy. Both TFEB overexpression and C1 promoted GATA4 autophagic degradation and alleviated PE-induced cardiomyocyte hypertrophy. In conclusion, TFEB downregulation plays a vital role in the development of pressure overload-induced cardiac hypertrophy by causing ALP insufficiency and blocking autophagic degradation. Activation of TFEB represents a potential therapeutic strategy for treating cardiac hypertrophy.	[Song, Rui; Cheng, Wanwen; Li, Ying; Liu, Jie] Shenzhen Univ, Hlth Sci Ctr, Guangdong Key Lab Genome Stabil & Human Dis Preve, Dept Pathophysiol, Shenzhen, Peoples R China; [Song, Rui] Shenzhen Univ, Coll Phys & Optoelect Engn, Shenzhen, Peoples R China; [Lei, Han] Fudan Univ, Sch Basic Med Sci, Dept Physiol & Pathophysiol, Shanghai, Peoples R China; [Feng, Li] Zhongshan Peoples Hosp, Dept Cardiol, Guangzhou, Peoples R China; [Yao, Ling Ling] Guangdong Coll Pharm, Affiliated Hosp 1, Dept Cardiol, Guangzhou, Peoples R China	Shenzhen University; Shenzhen University; Fudan University; Guangdong Pharmaceutical University	Liu, J (corresponding author), Shenzhen Univ, Hlth Sci Ctr, Guangdong Key Lab Genome Stabil & Human Dis Preve, Dept Pathophysiol, Shenzhen, Peoples R China.; Yao, LL (corresponding author), Guangdong Coll Pharm, Affiliated Hosp 1, Dept Cardiol, Guangzhou, Peoples R China.	yaolingling1979@gmail.com; liuj@szu.edu.cn			National Natural Science Foundation of China [31671179, 81970250, 81870274]; Shenzhen Key Laboratory of Metabolism and Cardiovascular Homeostasis [ZDSYS20190902092903237]; Basic Research Foundation of Shenzhen [JCYJ20180508152222104]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shenzhen Key Laboratory of Metabolism and Cardiovascular Homeostasis; Basic Research Foundation of Shenzhen	The authors thank Dr Jessica Tamanini (Shenzhen University Health Science Center, China and ETediting, United Kingdom) for editing this article before submission. This work was supported by grants from the National Natural Science Foundation of China (grant no.: 31671179, 81970250, and 81870274), Shenzhen Key Laboratory of Metabolism and Cardiovascular Homeostasis (grant no.: ZDSYS20190902092903237), and Basic Research Foundation of Shenzhen (grant no.: JCYJ20180508152222104).	Akazawa H, 2003, CIRC RES, V92, P1079, DOI 10.1161/01.RES.0000072977.86706.23; Bartlett JJ, 2016, BIOCHEM J, V473, P3769, DOI 10.1042/BCJ20160385; Decressac M, 2013, P NATL ACAD SCI USA, V110, pE1817, DOI 10.1073/pnas.1305623110; Dehay B, 2010, J NEUROSCI, V30, P12535, DOI 10.1523/JNEUROSCI.1920-10.2010; Evans TD, 2019, SCI SIGNAL, V12, DOI 10.1126/scisignal.aau2281; Frey N, 2004, CIRCULATION, V109, P1580, DOI 10.1161/01.CIR.0000120390.68287.BB; Godar RJ, 2015, AUTOPHAGY, V11, P1537, DOI 10.1080/15548627.2015.1063768; Gottlieb RA, 2015, CIRC RES, V116, P504, DOI 10.1161/CIRCRESAHA.116.303787; Harris H, 2012, NAT REV NEUROL, V8, P108, DOI 10.1038/nrneurol.2011.200; Hidvegi T, 2015, J BIOL CHEM, V290, P29742, DOI 10.1074/jbc.M115.691253; Javaheri A, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.127312; Kang C, 2015, SCIENCE, V349, DOI 10.1126/science.aaa5612; Kenny H. C., 2021, CARDIAC SPECIFIC OVE; Khalique OK, 2019, HYPERTENSION, V74, P257, DOI 10.1161/HYPERTENSIONAHA.119.13169; Kim J, 2021, NAT METAB, V3, P410, DOI 10.1038/s42255-021-00368-w; Kustermann M, 2018, AUTOPHAGY, V14, P1911, DOI 10.1080/15548627.2018.1491491; Li MH, 2014, EUR J PHARMACOL, V728, P67, DOI 10.1016/j.ejphar.2014.01.061; Li Y, 2014, ARCH BIOCHEM BIOPHYS, V558, P79, DOI 10.1016/j.abb.2014.06.023; Liang QR, 2001, J BIOL CHEM, V276, P30245, DOI 10.1074/jbc.M102174200; Liu SL, 2016, ARCH BIOCHEM BIOPHYS, V590, P37, DOI 10.1016/j.abb.2015.11.001; Liu YY, 2019, AUTOPHAGY, V15, P493, DOI 10.1080/15548627.2018.1531196; Ma XC, 2019, J AM HEART ASSOC, V8, DOI 10.1161/JAHA.118.010866; Maejima Y, 2015, AM J PHYSIOL-HEART C, V308, pH259, DOI 10.1152/ajpheart.00711.2014; Matsumura N, 2017, AM J PHYSIOL-HEART C, V312, pH561, DOI 10.1152/ajpheart.00604.2016; Mozaffarian D, 2016, CIRCULATION, V133, pE38, DOI 10.1161/CIR.0000000000000350; Napolitano G, 2016, J CELL SCI, V129, P2475, DOI 10.1242/jcs.146365; Oka T, 2006, CIRC RES, V98, P837, DOI 10.1161/01.RES.0000215985.18538.c4; Palmieri M, 2011, HUM MOL GENET, V20, P3852, DOI 10.1093/hmg/ddr306; Pan B, 2017, J MOL CELL CARDIOL, V113, P51, DOI 10.1016/j.yjmcc.2017.10.003; Pan W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053950; Pastore N, 2013, EMBO MOL MED, V5, P397, DOI 10.1002/emmm.201202046; Polito VA, 2014, EMBO MOL MED, V6, P1142, DOI 10.15252/emmm.201303671; Ponikowski P, 2014, ESC HEART FAIL, V1, P4, DOI 10.1002/ehf2.12005; Qi GM, 2014, ENDOCRINOLOGY, V155, P2254, DOI 10.1210/en.2013-2011; Qin QY, 2016, HYPERTENSION, V67, P107, DOI 10.1161/HYPERTENSIONAHA.115.06062; Santin Y, 2016, ANTIOXID REDOX SIGN, V25, P10, DOI 10.1089/ars.2015.6522; Sardiello M, 2009, SCIENCE, V325, P473, DOI 10.1126/science.1174447; Schiattarella GG, 2016, J MOL CELL CARDIOL, V95, P86, DOI 10.1016/j.yjmcc.2015.11.019; Sciarretta S, 2018, J AM COLL CARDIOL, V71, P1999, DOI 10.1016/j.jacc.2018.02.066; Scrivo A, 2018, LANCET NEUROL, V17, P802, DOI 10.1016/S1474-4422(18)30238-2; Settembre C, 2011, SCIENCE, V332, P1429, DOI 10.1126/science.1204592; Shi JJ, 2019, FASEB J, V33, P7348, DOI 10.1096/fj.201802510R; Shirakabe A, 2016, CIRCULATION, V133, P1249, DOI 10.1161/CIRCULATIONAHA.115.020502; Song JX, 2016, AUTOPHAGY, V12, P1372, DOI 10.1080/15548627.2016.1179404; Sun JJ, 2021, ARTERIOSCL THROM VAS, V41, P783, DOI 10.1161/ATVBAHA.120.315310; Toledo M, 2018, CELL METAB, V28, P268, DOI 10.1016/j.cmet.2018.05.023; Torra A, 2018, MOL THER, V26, P1552, DOI 10.1016/j.ymthe.2018.02.022; Trivedi PC, 2016, BBA-MOL CELL BIOL L, V1861, P1893, DOI 10.1016/j.bbalip.2016.09.004; Tsunemi T, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003799; Wang HJ, 2016, ENEURO, V3, DOI 10.1523/ENEURO.0042-16.2016; Wang K, 2018, AUTOPHAGY, V14, P269, DOI 10.1080/15548627.2017.1409405; Wang XP, 2020, J EXP CLIN CANC RES, V39, DOI 10.1186/s13046-020-01595-x; Wang XJ, 2017, AM J PHYSIOL-HEART C, V313, pH304, DOI 10.1152/ajpheart.00145.2017; Wang XJ, 2014, J MOL CELL CARDIOL, V71, P16, DOI 10.1016/j.yjmcc.2013.11.006; Weng LQ, 2014, ACTA PHARMACOL SIN, V35, P1005, DOI 10.1038/aps.2014.45; Wilkins BJ, 2004, CIRC RES, V94, P110, DOI 10.1161/01.RES.0000109415.17511.18; Yamamura S, 2020, HYPERTENSION, V75, P98, DOI 10.1161/HYPERTENSIONAHA.119.13357; Yan CH, 2015, BBA-MOL BASIS DIS, V1852, P353, DOI 10.1016/j.bbadis.2014.05.027; Yin XS, 2013, MOL CELL BIOCHEM, V379, P1, DOI 10.1007/s11010-012-1552-z; Zhang KZ, 2018, DIABETES, V67, P180, DOI 10.2337/dbi17-0048; Zhu HX, 2007, J CLIN INVEST, V117, P1782, DOI 10.1172/JCI27523	61	1	1	3	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT	2021	297	4							101189	10.1016/j.jbc.2021.101189	http://dx.doi.org/10.1016/j.jbc.2021.101189			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	WP4BY	34517007	Green Published, gold			2022-12-26	WOS:000713080600008
J	Xie, KY; Chien, SJ; Tan, BCM; Chen, YW				Xie, Ke-Yun; Chien, Shao-Ju; Tan, Bertrand Chin-Ming; Chen, Yun-Wen			RNA editing of 5-HT2CR impairs insulin secretion of pancreatic beta cells via altered store-operated calcium entry	FASEB JOURNAL			English	Article						5-hydroxytryptamine 2C receptor; calcium homeostasis; RNA editing; type II diabetes mellitus	PLASMA-GLUCOSE; FATTY-ACIDS; RECEPTOR; RESISTANCE; NEURONS; DESENSITIZATION; HOMEOSTASIS; EXPRESSION; OBESITY; ENERGY	Recent studies emphasize the importance of 5-HT2C receptor (5-HT2CR) signaling in the regulation of energy homeostasis. The 5-HT2CR is the only G-protein-coupled receptor known to undergo post-transcriptional adenosine to inosine (A-to-I) editing by adenosine deaminase acting on RNA (ADAR). 5-HT2CR has emerged as an important role in the modulation of pancreatic beta cell functions. This study investigated mechanisms behind the effects of palmitic acid (PA) on insulin secretion in different overexpressed 5-HT2CR edited isoforms in pancreatic MIN6 beta cells. Results showed that the expressions of 5HT(2C)R and ADAR2 were upregulated in the pancreatic islets of mice fed with high-fat diet (HFD) compared to control mice. PA treatment significantly induced the expressions of 5-HT2CR and ADAR2 in pancreatic MIN6 beta cells. PA treatment significantly induced the editing of 5-HT2CR in pancreatic MIN6 beta cells. There was no significant difference in cell viability between naive cells and three overexpressed 5-HT2CR edited isoforms in pancreatic MIN6 beta cells. Overexpressed 5-HT2CR edited isoforms showed reduced glucose-stimulated insulin secretion (GSIS) compared with green fluorescent protein (GFP) expressed cells. Moreover, 5-HT2CR edited isoforms displayed reduced endoplasmic reticulum (ER) calcium release and store-operated calcium entry (SOCE) activation, probably through inhibition of stromal interaction molecule 1 trafficking under PA treatment. Altogether, our results show that PA-mediated editing of 5-HT2CR modulates GSIS through alteration of ER calcium release and SOCE activation in pancreatic MIN6 beta cells.	[Xie, Ke-Yun; Chien, Shao-Ju; Chen, Yun-Wen] Natl Cheng Kung Univ, Coll Med, Dept Pharmacol, Tainan 701, Taiwan; [Tan, Bertrand Chin-Ming] Chang Gung Univ, Coll Med, Grad Inst Biomed Sci, Taoyuan, Taiwan; [Tan, Bertrand Chin-Ming] Chang Gung Univ, Coll Med, Dept Biomed Sci, Taoyuan, Taiwan; [Tan, Bertrand Chin-Ming] Chang Gung Mem Hosp, Linkou Med Ctr, Dept Neurosurg, Linkou, Taiwan; [Tan, Bertrand Chin-Ming] Chang Gung Univ, Res Ctr Emerging Viral Infect, Taoyuan, Taiwan	National Cheng Kung University; Chang Gung University; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University	Chen, YW (corresponding author), Natl Cheng Kung Univ, Coll Med, Dept Pharmacol, Tainan 701, Taiwan.	yunwen_chen@mail.ncku.edu.tw			Ministry of Science and Technology, Taiwan (MOST) [MOST 106-2320-B-006-058-MY3]	Ministry of Science and Technology, Taiwan (MOST)(Ministry of Science and Technology, Taiwan)	Ministry of Science and Technology, Taiwan (MOST), Grant/Award Number: MOST 106-2320-B-006-058-MY3	Asadzadeh Azizeh, 2019, Avicenna Journal of Medical Biotechnology, V11, P239; Berg KA, 2001, J PHARMACOL EXP THER, V299, P593; Berglund ED, 2013, J CLIN INVEST, V123, P5061, DOI 10.1172/JCI70338; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Carafoli E, 2001, CRIT REV BIOCHEM MOL, V36, P107, DOI 10.1080/20014091074183; Chagraoui A, 2016, PROG NEURO-PSYCHOPH, V66, P120, DOI 10.1016/j.pnpbp.2015.12.006; Chang HY, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03747-0; Chaudhari S, 2016, EXP BIOL MED, V241, P343, DOI 10.1177/1535370215609693; Chaudhari S, 2014, AM J PHYSIOL-RENAL, V306, pF1069, DOI 10.1152/ajprenal.00463.2013; Chen YF, 2013, J BIOMED SCI, V20, DOI 10.1186/1423-0127-20-23; Chen YW, 2016, SCI REP-UK, V6, DOI 10.1038/srep22142; Eggington JM, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1324; HASHIMOTO Y, 1985, BIOCHIM BIOPHYS ACTA, V841, P283, DOI 10.1016/0304-4165(85)90070-4; Heisler LK, 2007, GENES BRAIN BEHAV, V6, P491, DOI 10.1111/j.1601-183X.2007.00316.x; Kawahara Y, 2008, J NEUROSCI, V28, P12834, DOI 10.1523/JNEUROSCI.3896-08.2008; Kono T, 2018, DIABETES, V67, P2293, DOI 10.2337/db17-1351; Lanfranco MF, 2009, J NEUROSCI METH, V179, P247, DOI 10.1016/j.jneumeth.2009.01.027; Lazarte J, 2020, CAN J DIABETES, V44, P53, DOI 10.1016/j.jcjd.2019.07.003; Maas Stefan, 2006, RNA Biol, V3, P1; Marion S, 2004, J BIOL CHEM, V279, P2945, DOI 10.1074/jbc.M308742200; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; MIYAZAKI JI, 1990, ENDOCRINOLOGY, V127, P126, DOI 10.1210/endo-127-1-126; Morabito MV, 2010, NEUROBIOL DIS, V39, P169, DOI 10.1016/j.nbd.2010.04.004; Nelson HA, 2018, EXP BIOL MED, V243, P451, DOI 10.1177/1535370218754524; Niswender CM, 1998, ANN NY ACAD SCI, V861, P38, DOI 10.1111/j.1749-6632.1998.tb10171.x; Nonogaki K, 1998, NAT MED, V4, P1152, DOI 10.1038/2647; PAOLISSO G, 1995, DIABETOLOGIA, V38, P1213, DOI 10.1007/BF00422371; Parekh AB, 2010, NAT REV DRUG DISCOV, V9, P399, DOI 10.1038/nrd3136; Paulmann N, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000229; Peng PL, 2006, NEURON, V49, P719, DOI 10.1016/j.neuron.2006.01.025; Pooley EC, 2004, AM J MED GENET B, V126B, P124, DOI 10.1002/ajmg.b.20143; Putney JW, 2009, IMMUNOL REV, V231, P10, DOI 10.1111/j.1600-065X.2009.00810.x; Rorsman P, 2013, ANNU REV PHYSIOL, V75, P155, DOI 10.1146/annurev-physiol-030212-183754; Sabourin J, 2015, J BIOL CHEM, V290, P30530, DOI 10.1074/jbc.M115.682583; Saeedi P, 2019, DIABETES RES CLIN PR, V157, DOI 10.1016/j.diabres.2019.107843; Slotkin W, 2013, GENOME MED, V5, DOI 10.1186/gm508; Srinivasan K, 2007, INDIAN J MED RES, V125, P451; Tamarina NA, 2008, CELL CALCIUM, V44, P533, DOI 10.1016/j.ceca.2008.03.007; TECOTT LH, 1995, NATURE, V374, P542, DOI 10.1038/374542a0; Werry TD, 2008, PHARMACOL THERAPEUT, V119, P7, DOI 10.1016/j.pharmthera.2008.03.012; Wu HT, 2016, DIABETOLOGIA, V59, P1732, DOI 10.1007/s00125-016-3991-7; Xu Y, 2010, NAT NEUROSCI, V13, P1457, DOI 10.1038/nn.2664; Yang L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048611; Zhang Q, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0054250, 10.1371/journal.pone.0059667]; ZHOU YP, 1994, J CLIN INVEST, V93, P870, DOI 10.1172/JCI117042; Zuurbier CJ, 2008, ANESTH ANALG, V106, P135, DOI 10.1213/01.ane.0000297299.91527.74	47	2	2	1	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2021	35	10							e21929	10.1096/fj.202100265RR	http://dx.doi.org/10.1096/fj.202100265RR			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	UZ5IH	34553421				2022-12-26	WOS:000702238200002
J	Omidi, N; Arabloo, J; Rezapour, A; Alaeddini, F; Bragazzi, NL; Pourasghari, H; Behzadifar, M; Salarifar, M; Khorgami, M; Ghorashi, SM; Azari, S				Omidi, Negar; Arabloo, Jalal; Rezapour, Aziz; Alaeddini, Farshid; Bragazzi, Nicola Luigi; Pourasghari, Hamid; Behzadifar, Masoud; Salarifar, Mojtaba; Khorgami, MohammdRafie; Ghorashi, Seyyed Mojtaba; Azari, Samad			Burden of Hypertensive Heart Disease in Iran during 1990-2017: Findings from the Global Burden of Disease study 2017	PLOS ONE			English	Article							HIGH BLOOD-PRESSURE; AMERICAN-COLLEGE; HYPERTROPHY; PREVENTION; MANAGEMENT	Background Hypertension and its consequent end-organ damage including Hypertensive Heart Disease (HHD) are a major concern that impact health, resulting into impairment and reduced quality of life (QOL). The purpose of this study was to describe the burden of HHD in Iran and comparing it with the World Bank upper middle-income countries (UMICs) in terms of disability-adjusted life years (DALY), mortality and prevalence. Methods Using data from the Global Burden of Disease study 2017, we compared the number of DALYs, deaths and prevalence trends for HHD from 1990 to 2017 in all age groups for both sex in Iran, and compared the epidemiology and trends with UMICs and globally. Results The age-standardized DALY rate for HHD increased by 51.6% for men (95% uncertainty interval [UI] 305.8 to 436.7 per 100,000) and 4.4% for women (95% UI 429.4 to 448.7 per 100,000) in Iran. The age-standardized prevalence of HHD in Iran was almost twice times higher than globally and 1.5-times more than the World Bank UMICs. The age-standardized death rate for HDD increased by 60.1% (95% UI 17.3 to 27.7% per 100,000) for men and by 21.7% (95% UI 25.85 to 31.48 per 100,000) for women from 1990 to 2017. Age-standardized death rate in Iran was 2.4 and 1.9 times higher than globally and UMICs, respectively. Conclusion The higher prevalence and death rate in Iran in comparison with UMICs and globally should encourage health care provider to perform intensive screening activities in at risk population to prevent HHD and mitigate its mortality.	[Omidi, Negar; Alaeddini, Farshid; Salarifar, Mojtaba; Ghorashi, Seyyed Mojtaba] Univ Tehran Med Sci, Tehran Heart Ctr, Tehran, Iran; [Arabloo, Jalal; Rezapour, Aziz] Iran Univ Med Sci, Hlth Management & Econ Res Ctr, Tehran, Iran; [Bragazzi, Nicola Luigi] York Univ, Dept Math & Stat, Lab Ind & Appl Math LIAM, Toronto, ON, Canada; [Pourasghari, Hamid; Azari, Samad] Iran Univ Med Sci, Hosp Management Res Ctr, Tehran, Iran; [Behzadifar, Masoud] Lorestan Univ Med Sci, Social Determinants Hlth Res Ctr, Khorramabad, Iran; [Khorgami, MohammdRafie] Iran Univ Med Sci, Rajaie Cardiovasc Med & Res Ctr, Tehran, Iran	Tehran University of Medical Sciences; Iran University of Medical Sciences; York University - Canada; Iran University of Medical Sciences; Lorestan University of Medical Sciences; Iran University of Medical Sciences	Azari, S (corresponding author), Iran Univ Med Sci, Hosp Management Res Ctr, Tehran, Iran.	Samadazari1010@gmail.com	Arabloo, Jalal/K-1829-2019	Arabloo, Jalal/0000-0003-1223-4528; Yousefzadeh, Negar/0000-0002-2569-5860; Ghorashi, Seyyed Mojtaba/0000-0002-7933-5633				Bank TW, 2019, LIF EXP BIRTH TOT YE; Bank W, WORLD BANK COUNTR LE; Bluher M, 2019, NAT REV ENDOCRINOL, V15, P288, DOI 10.1038/s41574-019-0176-8; Carey RM, 2018, ANN INTERN MED, V168, P351, DOI 10.7326/M17-3203; Cuspidi C, 2010, BLOOD PRESS MONIT, V15, P124, DOI 10.1097/MBP.0b013e328337ceeb; Danaei G, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000058; Dicker D, 2018, LANCET, V392, P1684, DOI [10.1016/S0140-6736(18)31891-9, 10.1016/s0140-6736(18)31891-9]; Djalalinia S, 2020, FRONT ENDOCRINOL, V11, DOI 10.3389/fendo.2020.00042; Drazner MH, 2011, CIRCULATION, V123, P327, DOI 10.1161/CIRCULATIONAHA.108.845792; Egan BM, 2019, J HYPERTENS, V37, P1148, DOI 10.1097/HJH.0000000000002021; Forouzanfar MH, 2017, JAMA-J AM MED ASSOC, V317, P165, DOI 10.1001/jama.2016.19043; Gakidou E, 2017, LANCET, V390, P1345, DOI 10.1016/S0140-6736(17)32366-8; James SL, 2018, LANCET, V392, P1789, DOI [10.1016/S0140-6736(18)32279-7, 10.1016/s0140-6736(18)32279-7]; Krepp JM, 2014, ANN NONINVAS ELECTRO, V19, P552, DOI 10.1111/anec.12166; Kyu HH, 2018, LANCET, V392, P1859, DOI 10.1016/s0140-6736(18)32335-3; Mills KT, 2016, CIRCULATION, V134, P441, DOI 10.1161/CIRCULATIONAHA.115.018912; Organization(WHO) WH, OB OV 2017; Qin WN, 2003, CIRC RES, V93, P69, DOI 10.1161/01.RES.0000080521.15238.E5; Roth GA, 2018, LANCET, V392, P1736, DOI [10.1016/S0140-6736(18)32203-7, 10.1016/s0140-6736(18)32203-7]; Slivnick J, 2019, HEART FAIL CLIN, V15, P531, DOI 10.1016/j.hfc.2019.06.007; Stevens GA, 2016, LANCET, V388, pE19, DOI 10.1016/S0140-6736(16)30388-9; Vakili BA, 2001, AM HEART J, V141, P334, DOI 10.1067/mhj.2001.113218; Whelton PK, 2018, HYPERTENSION, V71, pE13, DOI [10.1161/HYP.0000000000000065, 10.1161/HYP.0000000000000066]	23	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2021	16	9							e0257617	10.1371/journal.pone.0257617	http://dx.doi.org/10.1371/journal.pone.0257617			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YS4WS	34551003	Green Published, gold			2022-12-26	WOS:000750679800031
J	Roy, N; Amin, MB; Maliha, MJ; Sarker, B; Aktarujjaman, M; Hossain, E; Talukdar, G				Roy, Nitai; Amin, Md Bony; Maliha, Maskura Jahan; Sarker, Bibhuti; Aktarujjaman, Md; Hossain, Ekhtear; Talukdar, Gourango			Prevalence and factors associated with family planning during COVID-19 pandemic in Bangladesh: A cross-sectional study	PLOS ONE			English	Article							CONTRACEPTIVE USE	Background and objectives The COVID-19 pandemic has negatively impacted health systems worldwide, including in Bangladesh, limiting access to family planning information (FP) and services. Unfortunately, the evidence on the factors linked to such disruption is limited, and no study has addressed the link among Bangladeshis. This study aimed to examine the socioeconomic, demographic, and other critical factors linked to the use of FP in the studied areas during the COVID-19 pandemic. Methods The characteristics of the respondents were assessed using a cross-sectional questionnaire survey and descriptive statistics. The variables that were substantially linked with FP usage were identified using a Chi-square test. In addition, a multivariate logistic regression model was used to identify the parameters linked to FP in the study areas during the COVID-19 pandemic. Results The prevalence of FP use among currently married 15-49 years aged women was 36.03% suggesting a 23% (approximately) decrease compared to before pandemic data. Results also showed that 24.42% of the respondents were using oral contraceptive pills (OCP) which is lower than before pandemic data (61.7%). Multivariate regression analysis provided broader insight into the factors affecting FP use. Results showed that woman's age, education level of the respondents, working status of the household head, locality, reading a newspaper, FP workers' advice, currently using OCP, ever used OCP, husbands' supportive attitude towards OCP use, duration of the marriage, ever pregnant, the number of children and dead child were significantly associated with FP use in the study areas during COVID-19 pandemic. Conclusions This study discusses unobserved factors that contributed to a reduction in FP use and identifies impediments to FP use in Bangladesh during the COVID-19 epidemic. This research further adds to our understanding of FP usage by revealing the scope of the COVID-19 pandemic's impact on FP use in Bangladesh's rural and urban areas.	[Roy, Nitai; Maliha, Maskura Jahan] Patuakhali Sci & Technol Univ, Dept Biochem & Food Anal, Patuakhali, Bangladesh; [Amin, Md Bony; Aktarujjaman, Md] Patuakhali Sci & Technol Univ, Fac Nutr & Food Sci, Patuakhali, Bangladesh; [Sarker, Bibhuti] Univ Manitoba, Dept Econ, Winnipeg, MB, Canada; [Sarker, Bibhuti] Bangabandhu Sheikh Mujibur Rahman Sci & Technol U, Dept Econ, Gopalganj, Bangladesh; [Hossain, Ekhtear] Southern Univ & A&M Coll, Dept Biol Sci & Chem, Baton Rouge, LA USA; [Talukdar, Gourango] Univ Minnesota, Dept Neurosci, Minneapolis, MN USA	University of Manitoba; Bangabandhu Sheikh Mujibur Rahman Science & Technology University; Southern University System; Southern University & A&M College; University of Minnesota System; University of Minnesota Twin Cities	Roy, N (corresponding author), Patuakhali Sci & Technol Univ, Dept Biochem & Food Anal, Patuakhali, Bangladesh.	nitai@pstu.ac.bd	Sarker, Bibhuti/AHA-1732-2022; Sarker, Bibhuti/GLR-9612-2022; Roy, Nitai/AAY-8128-2021	Sarker, Bibhuti/0000-0002-4123-8571; Roy, Nitai/0000-0002-8454-6128				Abedin M MN, 2021, LOG FRAM WORKSH 5 HL, P23; Alege Stephen Galla, 2016, Pan Afr Med J, V24, P39, DOI 10.11604/pamj.2016.24.39.5836; Bietsch K, 2020, STUD FAMILY PLANN, V51, P71, DOI 10.1111/sifp.12110; Cavana R., 2001, APPL BUSINESS RES QU, V3rd; Central Statistics Organization/Afghanistan Ministry of Public Health/Afghanistan ICF, 2021, AFGH DEM HLTH SURV 2; Chaurasia AR, 2012, INT J POPULATION RES, V2014, DOI [10.1155/2014/821436, DOI 10.1155/2014/821436]; Cleland J, 1994, NATL TECHNICAL REPOR, P199; Eliason S, 2014, REPROD HEALTH, V11, DOI 10.1186/1742-4755-11-65; Ferdousi S., 2010, J DHAKA MED COLL, V19, P11, DOI [10.3329/jdmc.v19i1.6244, DOI 10.3329/JDMC.V19I1.6244]; Haq Iqramul, 2017, Med Sci (Basel), V5, DOI 10.3390/medsci5040031; Henry BP, 2021, HLTH ALL BANGLADESH; Hossain MB, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5098-1; Hossain MB, 2005, J BIOSOC SCI, V37, P529, DOI 10.1017/S0021932004007096; Huda FA, 2017, REPROD HEALTH, V14, DOI 10.1186/s12978-017-0333-2; Islam M, 1998, ASIA PAC POPULAT J, V13; Islam MT, 2020, J PUBLIC HEALTH RES, V9, P389, DOI 10.4081/jphr.2020.1794; Jayaraman A, 2009, INT PERSPECT SEX R H, V35, P29, DOI 10.1363/ifpp.35.029.09; Kamal N, 2000, HEALTH POLICY PLANN, V15, P43, DOI 10.1093/heapol/15.1.43; Kamruzzaman A, 2015, INT J BIOINFORMATICS, V2015; Khan HTA, 1997, CONTRACEPTION, V55, P91, DOI 10.1016/S0010-7824(96)00278-8; Kibria GMA., 2016, J MOL STUD MED RES, V2, P70, DOI [10.18801/jmsmr.020116.09, DOI 10.18801/JMSMR.020116.09]; KOENIG MA, 1987, STUD FAMILY PLANN, V18, P117, DOI 10.2307/1966807; KOENIG MA, 1990, DEMOGRAPHY, V27, P251, DOI 10.2307/2061452; Lakew Y, 2013, REPROD HEALTH, V10, DOI 10.1186/1742-4755-10-52; Lasong J, 2020, BMJ OPEN, V10, DOI 10.1136/bmjopen-2019-030980; Ministry of Health and Population MOHP-Nepal, 2021, NEP DEM HLTH SURV 20; Mulatu T, 2020, BIOMED RES INT, V2020, DOI 10.1155/2020/6096280; Murarkar S, 2011, NATL J COMMUNITY MED, V2; National Institute of Population Research and Training Medical Education and Family Welfare Division Ministry of Health and Family Welfare, 2021, BANGL DEM HLTH SURV; National Institute of Population Studies-NIPS/Pakistan Institute for Resource Development-IRD/ Macro International, 2021, PAK DEM HLTH SURV 19; Nightengale L., 2020, DAILY STAR; O'Grady NP, 2002, CLIN INFECT DIS, V35, P1281, DOI 10.1086/344188; Ochako R, 2017, REPROD HEALTH, V14, DOI 10.1186/s12978-017-0316-3; Purdy C., 2020, DEVEX; Richters J, 2003, AUST NZ J PUBL HEAL, V27, P210, DOI 10.1111/j.1467-842X.2003.tb00810.x; Rosliza A, 2010, MALAYSIAN J PUBLIC H; Santoshini S., 2020, FAMILY PLANNING EFFO; Sharma Vasundhara, 2012, J Family Med Prim Care, V1, P43, DOI 10.4103/2249-4863.94451; Shree V, 2017, INT J COMMUNITY MED, V4, P1882, DOI [10.18203/2394-6040.ijcmph20172060, DOI 10.18203/2394-6040.IJCMPH20172060]; Singh A., PREGNANCY COVID 19 I; Uddin M, 1985, RURAL DEMOGRAPHY, V12; Ullah M S, 1993, Asia Pac Popul J, V8, P19; Unicef, PREGN MOTH BAB BORN; United Nations Population Fund (UNFPA), 2020, IMP COVID 19 PAND FA	44	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2021	16	9							e0257634	10.1371/journal.pone.0257634	http://dx.doi.org/10.1371/journal.pone.0257634			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	YM4DR	34547041	Green Published, gold			2022-12-26	WOS:000746527400030
J	Chen, PC; Li, PC; Ding, DC				Chen, Pei-Chen; Li, Pei-Chen; Ding, Dah-Ching			Pelvic inflammatory disease and causative pathogens in older women in a medical center in eastern Taiwan: A retrospective cross-sectional study	PLOS ONE			English	Article								Objectives Most research into the management of pelvic inflammatory disease (PID) is in younger women and focuses on sexually transmitted pathogens such as N. gonorrhoeae or C. trachomatis. Non-sexually transmitted bacterial pathogens and PID in older women are rarely examined. The objective of this study is to explore cervical culture pathogens in women of different age groups in a medical center in eastern Taiwan. Methods We enrolled patients whose medical records were diagnosed with PID (ICD-9-CM 614.0 [N70.01-03], 614.1[N70.11-13], 614.9 [N73.5, N73.9]) at our hospital from October 2014 to March 2020. Patients were divided into three groups according to age: the age <25 years, age 25-44 years, and the <greater than or equal to> 45 years group. Chi-square test, ANOVA and logistic regression were used for statistical analysis. In subgroup analysis, endocervical pathogens were further stratified into vaginal, respiratory, enteric, skin, oral, and other. Results A total of 96 patients were included in the study. There were 31 patients in the age >= 45 years group, 52 patients in the age 25-44 years group, and 13 patients in the age <25 years group. Vagina and enteric pathogens were the most common pathogens among all groups. The isolated respiratory and other pathogens were more in the age <greater than or equal to> 45 years group than in the other two groups. Prevotella bivia was more common in the age <25 years and 25-44 years groups. Conclusions This may be due to different pathogeneses of PID in the age <greater than or equal to> 45 years patients. Our study can be used as a reference for antibiotic choice of non-sexually transmitted PID and to prevent long-term sequelae of PID.	[Chen, Pei-Chen; Li, Pei-Chen; Ding, Dah-Ching] Tzu Chi Univ, Hualien Tzu Chi Hosp, Buddhist Tzu Chi Med Fdn, Dept Obstet & Gynecol, Hualien, Taiwan; [Ding, Dah-Ching] Tzu Chi Univ, Inst Med Sci, Hualien, Taiwan	Buddhist Tzu Chi General Hospital; Hualien Tzu Chi Hospital; Tzu Chi University; Tzu Chi University	Ding, DC (corresponding author), Tzu Chi Univ, Hualien Tzu Chi Hosp, Buddhist Tzu Chi Med Fdn, Dept Obstet & Gynecol, Hualien, Taiwan.; Ding, DC (corresponding author), Tzu Chi Univ, Inst Med Sci, Hualien, Taiwan.	dah1003@yahoo.com.tw		Ding, Dah-Ching/0000-0001-5105-068X	 [TCMF-EP-108-02]		DC: TCMF-EP-108-02, The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alauzet C, 2010, ANTIMICROB AGENTS CH, V54, P60, DOI 10.1128/AAC.01003-09; Brunham RC, 2015, NEW ENGL J MED, V372, P2039, DOI 10.1056/NEJMra1411426; Burnett AM, 2012, AM J EMERG MED, V30, P1114, DOI 10.1016/j.ajem.2011.07.014; Curry A, 2019, AM FAM PHYSICIAN, V100, P357; Eze E. M., 2018, Novel Research in Microbiology Journal, V2, P147, DOI 10.21608/NRMJ.2018.22707; Gradison M, 2012, AM FAM PHYSICIAN, V85, P791; Haggerty Catherine L, 2011, Infect Dis Obstet Gynecol, V2011, P959816, DOI 10.1155/2011/959816; Hollier LM, 2003, OBSTET GYN CLIN N AM, V30, P751, DOI 10.1016/S0889-8545(03)00087-1; Hubacher David, 2014, Indian J Med Res, V140 Suppl, pS53; Jackson S L, 1999, Infect Dis Obstet Gynecol, V7, P248, DOI 10.1155/S1064744999000459; Jennings LK, 2020, PELVIC INFLAMMATORY; Khan S, 2017, J CLIN DIAGN RES, V11, pLC5, DOI 10.7860/JCDR/2017/24559.9433; Naga O, 2015, PEDIAT BOARD STUDY G, V193; Ness RB, 2005, AM J EPIDEMIOL, V162, P585, DOI 10.1093/aje/kwi243; Peipert JF, 2001, AM J OBSTET GYNECOL, V184, P856, DOI 10.1067/mob.2001.113847; Price MJ, 2016, J INFECT DIS, V214, P617, DOI 10.1093/infdis/jiw178; Rathore M., 2003, INDIAN J COMMUNITY M, V28, P117; Sharma R, 2020, CHEST, V158, p2600A, DOI 10.1016/j.chest.2020.09.194; Soper DE, 2010, OBSTET GYNECOL, V116, P419, DOI 10.1097/AOG.0b013e3181e92c54; Spencer T H I, 2014, Afr J Infect Dis, V8, P9; Veloo ACM, 2019, CLIN MICROBIOL INFEC, V25, DOI 10.1016/j.cmi.2019.02.017; Veloo ACM, 2018, J ANTIMICROB CHEMOTH, V73, P2687, DOI 10.1093/jac/dky236; Wang B, 2019, MEDICINE, V98, DOI 10.1097/MD.0000000000017362; Workowski KA, 2021, MMWR RECOMM REP, V70, P1; Xu JY, 2020, AM J REPROD IMMUNOL, V83, DOI 10.1111/aji.13220	25	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2021	16	9							e0257627	10.1371/journal.pone.0257627	http://dx.doi.org/10.1371/journal.pone.0257627			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	WG6BN	34543349	Green Published, gold			2022-12-26	WOS:000707078200061
J	Demissie, GD; Yeshaw, Y; Aleminew, W; Akalu, Y				Demissie, Getu Debalkie; Yeshaw, Yigizie; Aleminew, Wallelign; Akalu, Yonas			Diarrhea and associated factors among under five children in sub-Saharan Africa: Evidence from demographic and health surveys of 34 sub-Saharan countries	PLOS ONE			English	Article							RISK-FACTORS; CHILDHOOD DIARRHEA; WATER; SANITATION; DETERMINANTS; MORBIDITY; DISEASE	Introduction Diarrhea is responsible for the death of more than 90% of under-five children in low and lower-middle income countries. Regionally, South Asia and sub-Saharan Africa accounted for 88% of deaths with the same age group. Therefore, the aim of this study was to determine the prevalence and associated factors of diarrhea among children under-five years in sub-Saharan Africa. Methods The appended, most recent demographic and health survey datasets of 34 sub-Saharan African countries were used to determine the prevalence and associated factors of diarrhea among under-five children in the region. A total weighted sample of 330,866 under-five children were included in the study. Both bivariable and multivariable multilevel logistic regression were done to determine the associated factors of diarrhea among under five children in sub-Saharan Africa. The Odds Ratio (OR) with a 95% Confidence Interval (CI) was calculated for those potential factors included in the final model. Result The overall prevalence of diarrhea in this study was 15.3% (95% CI: 15.1-15.4). Those children of mothers aged 15-24 (AOR = 1.26; 95% CI: 1.23, 1.30) and 25-34 years (AOR = 1.15; 95%CI: 1.12, 1.18), those children of mothers with no education (AOR = 1.69; 95%CI: 1.57-1.82), primary education (AOR = 1.73; 95%CI: 1.61-1.86) and secondary education (AOR = 1.49; 95%CI: 1.38-1.59) had higher odds of having diarrhea. Those children from poorest (AOR = 1.14; 95%CI: 1.10, 1.19), poorer (AOR = 1.12; 95%CI: 1.08-1.17), middle (AOR = 1.06; 95%CI: 1.02, 1.10), and richer (AOR = 1.14; 95%CI: 1.04-1.12) households had higher chance of having diarrhea compared to their counterparts. Conclusion This study found that the prevalence of childhood diarrhea morbidity in sub-Saharan Africa was high. Maternal age, wealth index, maternal education, maternal occupation, age of child, time of initiation of breast feeding and time to get water source were significantly associated with diarrhea. Therefore, intervention through health education and health promotion for mothers/caretakers who are poor, less educated, and young should be designed to prevent diarrhea in the region.	[Demissie, Getu Debalkie; Aleminew, Wallelign] Univ Gondar, Coll Med & Hlth Sci, Inst Publ Hlth, Dept Hlth Educ & Behav Sci, Gondar, Ethiopia; [Yeshaw, Yigizie; Akalu, Yonas] Univ Gondar, Coll Med & Hlth Sci, Sch Med, Dept Human Physiol, Gondar, Ethiopia; [Yeshaw, Yigizie] Univ Gondar, Coll Med & Hlth Sci, Inst Publ Hlth, Dept Epidemiol & Biostat, Gondar, Ethiopia	University of Gondar; University of Gondar; University of Gondar	Demissie, GD (corresponding author), Univ Gondar, Coll Med & Hlth Sci, Inst Publ Hlth, Dept Hlth Educ & Behav Sci, Gondar, Ethiopia.	getud2006@gmail.com		Yeshaw, Yigizie/0000-0003-4587-7925; Akalu, Yonas/0000-0002-0914-7768				Acharya D, 2018, J INFECT PUBLIC HEAL, V11, P69, DOI 10.1016/j.jiph.2017.04.007; Agegnehu MD, 2019, J ENVIRON PUBLIC HEA, V2019, DOI 10.1155/2019/5490716; Ahmed S, 2010, INT J HLTH SCI, V2; Aikins M, 2010, J INFECT DIS, V202, pS126, DOI 10.1086/653573; Alambo K. A., 2015, ABC RES ALERT, V3; Alebel A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199684; Atnafu A, 2020, TROP MED HEALTH, V48, DOI 10.1186/s41182-020-00252-5; Azage M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186933; Bado AR, 2016, GLOBAL HEALTH ACTION, V9, P1, DOI 10.3402/gha.v9.30166; Bakir H, 2017, E MEDITERR HEALTH J, V23, P525, DOI 10.26719/2017.23.8.525; Bartlett S, 2003, ENVIRON URBAN, V15, P57, DOI 10.1177/095624780301500220; Bezatu Mengistie, 2013, Open Journal of Preventive Medicine, V3, P446, DOI 10.4236/ojpm.2013.37060; Cairncross S, 2010, INT J EPIDEMIOL, V39, P193, DOI 10.1093/ije/dyq035; Colombara DV, 2016, AM J TROP MED HYG, V94, P544, DOI 10.4269/ajtmh.15-0750; Croft TN, 2018, GUIDE DHS STAT; Dagnew AB, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-019-4030-3; Danquah L., 2015, SCI J PUBLIC HLTH, V3, P344, DOI [10.11648/j.sjph.20150303.17, DOI 10.11648/J.SJPH.20150303.17]; Dessalegn M, 2011, ETHIOP J HEALTH DEV, V25, P192; Dhingra D, 2018, TROP DOCT, V48, P298, DOI 10.1177/0049475518787425; Escobar AL, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1534-7; Ferrer SR, 2008, INT J EPIDEMIOL, V37, P805, DOI 10.1093/ije/dyn093; Fetensa G, 2020, SAGE OPEN MED, V8, DOI 10.1177/2050312120944201; Fewtrell L, 2004, HLTH NUTR POPULATION; Finlay JE, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2011-000226; Gakidou E, 2017, LANCET, V390, P1345, DOI 10.1016/S0140-6736(17)32366-8; Gedamu G., 2017, MAGNITUDE ASS FACTOR, V4, P199; Gupta A, 2014, INDIAN J SCI RES, V7, P1315; Hajara A., 2017, INT RES J NATURAL AP, V4; Hatt LE, 2006, SOC SCI MED, V62, P375, DOI 10.1016/j.socscimed.2005.06.007; Hodge J, 2016, ENVIRON HEALTH PERSP, V124, P1560, DOI 10.1289/EHP156; Hung BV, 2006, MOST COMMON CAUSES R; Hussien H, 2017, PREVALENCE DIARRHEA; Katharina D., 2014, GLOBAL HEALTH ACTION, V7; Kumar S G, 2012, Kathmandu Univ Med J (KUMJ), V10, P83; Kunii O, 2002, PUBLIC HEALTH, V116, P68, DOI [10.1016/S0033-3506(02)00506-1, 10.1038/sj.ph.1900828]; Lamberti LM, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S3-S15; Lee HY, 2016, GLOBAL HEALTH ACTION, V9, P21, DOI 10.3402/gha.v9.29304; MALDONADO G, 1993, AM J EPIDEMIOL, V138, P923, DOI 10.1093/oxfordjournals.aje.a116813; Mediratta RP, 2010, J HEALTH POPUL NUTR, V28, P253; Mohanna M., 2018, HAMDAN MED J, V11, P29; Moon J., 2019, J GLOBAL HLTH SCI, V1, P45; Nasir WA, 2020, NAGOYA J MED SCI, V82, P545, DOI 10.18999/nagjms.82.3.545; Pickering AJ, 2012, ENVIRON SCI TECHNOL, V46, P2391, DOI 10.1021/es203177v; Rahman A, 2006, GEOJOURNAL, V65, P211, DOI 10.1007/s10708-005-3127-y; Rohmawati N, 2007, THESIS; Samwel M., 2014, ETUDE POPUL AFRICAIN, V28, P1046; Siziya S, 2009, ITAL J PEDIATR, V35, DOI 10.1186/1824-7288-35-8; Tambe A., 2016, CHALLENGES, V6, P229; UNICEF, ON IS TOO MAN END CH; Unicef, 1998, STATE WORLD CHILDREN; UNICEF/WHO, 2009, WHY CHILDR AR STILL; World Health Organization, 2005, HOSP CAR CHILDR, P109	52	5	5	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2021	16	9							e0257522	10.1371/journal.pone.0257522	http://dx.doi.org/10.1371/journal.pone.0257522			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	WG6BN	34543347	gold, Green Published			2022-12-26	WOS:000707078200043
J	Sarmin, M; Begum, M; Islam, F; Afroze, F; Shahrin, L; Sharifuzzaman; Alam, T; Bin Shahid, AMS; Ahmed, T; Chisti, MJ				Sarmin, Monira; Begum, Monjory; Islam, Farhana; Afroze, Farzana; Shahrin, Lubaba; Sharifuzzaman; Alam, Tahmina; Bin Shahid, Abu Sadat Mohammad Sayeem; Ahmed, Tahmeed; Chisti, Mohammod Jobayer			Factors associated with severe sepsis in diarrheal adults and their outcome at an urban hospital, Bangladesh: A retrospective analysis	PLOS ONE			English	Article							SYSTEMIC INFLAMMATORY RESPONSE; SEPTIC SHOCK; MORTALITY; DEFINITIONS; CHILDREN; EPIDEMIOLOGY; MANAGEMENT; PNEUMONIA; PRESSURE	Background To describe factors associated with severe sepsis in diarrheal adults and their outcomes and offender in blood and stool to understand their interplay as clinical features of sepsis and severe diarrhea often overlap. Methods and results We used this retrospective chart analysis employing an unmatched case-control design to study critically ill diarrheal adults aged >= 18 years treated in ICU of Dhaka hospital, icddr,b between January 2011 to December 2015. Of 8,863 in-patient diarrheal adults, 350 having severe sepsis were cases and an equal number of randomly selected non-septic patients were the controls. Cases died significantly more (14.9% vs 4.6%, p = <0.001) than controls. 69% of the cases progressed to septic shock. In logistic regression analysis, steroid intake, ileus, acute kidney injury (AKI), metabolic acidosis, and hypocalcemia were significantly associated with severe sepsis in diarrheal adults (all, p<0.05). 12% of cases (40/335) had bacteremia. Streptococcus pneumoniae [9 (22.5%)] was the single most common pathogen and gram-negatives [27 (67.5%)] were prevailing as a group. Conclusion Diarrheal adults who had ileus, AKI, metabolic acidosis, hypocalcemia, and also took steroids were found to have an association with severe sepsis. Strikingly, gram-negative were the predominant bacteria among the diarrheal adults having severe sepsis.	[Sarmin, Monira; Begum, Monjory; Islam, Farhana; Afroze, Farzana; Shahrin, Lubaba; Sharifuzzaman; Alam, Tahmina; Bin Shahid, Abu Sadat Mohammad Sayeem; Ahmed, Tahmeed; Chisti, Mohammod Jobayer] Int Ctr Diarhoeal Dis Res Bangladesh Icddr B, Nutr & Clin Serv Div NCSD, Dhaka, Bangladesh	International Centre for Diarrhoeal Disease Research (ICDDR)	Chisti, MJ (corresponding author), Int Ctr Diarhoeal Dis Res Bangladesh Icddr B, Nutr & Clin Serv Div NCSD, Dhaka, Bangladesh.	aahmed@icddrb.org; chisti@icddrb.org		sarmin, Monira/0000-0001-9924-0060; Shahrin, Lubaba/0000-0002-5676-3280; Afroze, Farzana/0000-0002-9545-2266; Chisti, Mohammod/0000-0001-9958-3071				Ahmed T, 1999, LANCET, V353, P1919, DOI 10.1016/S0140-6736(98)07499-6; Ahmed Tahmeed, 2001, Indian Journal of Pediatrics, V68, P45, DOI 10.1007/BF02728857; Alberti C, 2005, AM J RESP CRIT CARE, V171, P461, DOI 10.1164/rccm.200403-324OC; Allegranzi B, 2011, LANCET, V377, P228, DOI 10.1016/S0140-6736(10)61458-4; Angus DC, 2015, INTENS CARE MED, V41, P1549, DOI 10.1007/s00134-015-3822-1; [Anonymous], 2018, SEPSIS SYNDROMES ADU; Blanco J, 2008, CRIT CARE, V12, DOI 10.1186/cc7157; Brun-Buisson C, 2000, INTENS CARE MED, V26, pS64, DOI 10.1007/s001340051121; Chisti MJ., 2014, BANGLADESH CRITICAL, V2, P10; Chisti MJ, 2015, LANCET, V386, P1057, DOI 10.1016/S0140-6736(15)60249-5; Das R, 2016, CLIN RISK FACTORS BA, P1; Dellepiane S, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1219-3; Dellinger RP., 2014, CONSULTANT, V54, P767; Ferrer R, 2014, CRIT CARE MED, V42, P1749, DOI 10.1097/CCM.0000000000000330; Fleischmann C, 2016, AM J RESP CRIT CARE, V193, P259, DOI 10.1164/rccm.201504-0781OC; Fuchs G, 2004, J PEDIATR GASTR NUTR, V39, pS670, DOI 10.1097/00005176-200406002-00014; GARNER JS, 1988, AM J INFECT CONTROL, V16, P128, DOI 10.1016/0196-6553(88)90053-3; Gul F, 2017, TURK J ANAESTHESIOL, V45, P129, DOI 10.5152/TJAR.2017.93753; JONES CJP, 1983, ANN RHEUM DIS, V42, P56, DOI 10.1136/ard.42.1.56; Konigsrainer I, 2011, CELL PHYSIOL BIOCHEM, V28, P753, DOI 10.1159/000335769; Levy MM, 2003, CRIT CARE MED, V31, P1250, DOI 10.1097/01.CCM.0000050454.01978.3B; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; Mayhall CG., 2012, HOSP EPIDEMIOLOGY IN; O'Boyle CJ, 1998, GUT, V42, P29, DOI 10.1136/gut.42.1.29; Phua J, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d3245; RANGELFRAUSTO MS, 1995, JAMA-J AM MED ASSOC, V273, P117, DOI 10.1001/jama.273.2.117; Rhodes A, 2017, INTENS CARE MED, V43, P304, DOI 10.1007/s00134-017-4683-6; Rivers E, 2001, NEW ENGL J MED, V345, P1368, DOI 10.1056/NEJMoa010307; Sarmin M, 2018, SE ASIAN J TROP MED, V49, P133; Sarmin M, 2014, ACTA PAEDIATR, V103, pe306, DOI 10.1111/apa.12640; SCHLEIMER RP, 1989, J PHARMACOL EXP THER, V250, P598; Schmidt M., 2017, EVALUATION MANAGEMEN; Sudarmono P, 2017, LANCET GLOB HEALTH, V5, pE157, DOI 10.1016/S2214-109X(17)30007-4; Tamanna, 2013, BANGLADESH CRIT CARE, V1, P8, DOI [10.3329/bccj.v1i1.14359, DOI 10.3329/BCCJ.V1I1.14359]; Victora CG, 2000, B WORLD HEALTH ORGAN, V78, P1246; Vinayak AG, 2006, ARCH INTERN MED, V166, P2132, DOI 10.1001/archinte.166.19.2132; Wakai T, 2013, CELL CALCIUM, V53, P63, DOI 10.1016/j.ceca.2012.11.010; Waljee AK, 2017, BMJ-BRIT MED J, V357, DOI 10.1136/bmj.j1415; Welch TR., 2016, J PEDIATR-US, V169, P1; Zhang ZH, 2015, SPRINGERPLUS, V4, DOI 10.1186/s40064-015-1387-7	41	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2021	16	9							e0257596	10.1371/journal.pone.0257596	http://dx.doi.org/10.1371/journal.pone.0257596			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	WG6BN	34543323	Green Published, Green Submitted, gold			2022-12-26	WOS:000707078200056
J	Riman, S; Iyer, H; Vallone, PM				Riman, Sarah; Iyer, Hari; Vallone, Peter M.			Examining performance and likelihood ratios for two likelihood ratio systems using the PROVEDIt dataset	PLOS ONE			English	Article							DNA MIXTURES; INTERNATIONAL SOCIETY; FORENSIC GENETICS; SINGLE-SOURCE; PROFILES; SOFTWARE; STRMIX(TM); MODELS; VALIDATION; COMMISSION	A likelihood ratio (LR) system is defined as the entire pipeline of the measurement and interpretation processes where probabilistic genotyping software (PGS) is a piece of the whole LR system. To gain understanding on how two LR systems perform, a total of 154 two-person, 147 three-person, and 127 four-person mixture profiles of varying DNA quality, DNA quantity, and mixture ratios were obtained from the filtered (.CSV) files of the GlobalFiler 29 cycles 15s PROVEDIt dataset and deconvolved in two independently developed fully continuous programs, STRmix v2.6 and EuroForMix v2.1.0. Various parameters were set in each software and LR computations obtained from the two software were based on same/fixed EPG features, same pair of propositions, number of contributors, theta, and population allele frequencies. The ability of each LR system to discriminate between contributor (H1-true) and non-contributor (H2-true) scenarios was evaluated qualitatively and quantitatively. Differences in the numeric LR values and their corresponding verbal classifications between the two LR systems were compared. The magnitude of the differences in the assigned LRs and the potential explanations for the observed differences greater than or equal to 3 on the log(10) scale were described. Cases of LR < 1 for H1-true tests and LR > 1 for H2-true tests were also discussed. Our intent is to demonstrate the value of using a publicly available ground truth known mixture dataset to assess discrimination performance of any LR system and show the steps used to understand similarities and differences between different LR systems. We share our observations with the forensic community and describe how examining more than one PGS with similar discrimination power can be beneficial, help analysts compare interpretation especially with low-template profiles or minor contributor cases, and be a potential additional diagnostic check even if software in use does contain certain diagnostic statistics as part of the output.	[Riman, Sarah; Vallone, Peter M.] NIST, Appl Genet Grp, Gaithersburg, MD 20899 USA; [Iyer, Hari] NIST, Stat Design, Anal, Modeling Grp, Gaithersburg, MD 20899 USA	National Institute of Standards & Technology (NIST) - USA; National Institute of Standards & Technology (NIST) - USA	Riman, S (corresponding author), NIST, Appl Genet Grp, Gaithersburg, MD 20899 USA.	sarah.riman@nist.gov			NIST Special Programs Office: Forensic Genetics	NIST Special Programs Office: Forensic Genetics	Yes-This work was funded by NIST Special Programs Office: Forensic Genetics. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitken CGG, 1998, SCI JUSTICE, V38, P279, DOI 10.1016/S1355-0306(98)72128-8; Alfonse LE, 2018, FORENSIC SCI INT-GEN, V32, P62, DOI 10.1016/j.fsigen.2017.10.006; Alladio E, 2018, FORENSIC SCI INT-GEN, V37, P143, DOI 10.1016/j.fsigen.2018.08.002; [Anonymous], 2018, STRMIX V2 6 0 OPERAT; [Anonymous], 2018, STRMIX V2 6 0 USER M; [Anonymous], 2019, MANUAL EUROFORMIX V2; Arscott E, 2017, SCI JUSTICE, V57, P221, DOI 10.1016/j.scijus.2017.02.002; Balding DJ, 2009, FORENSIC SCI INT-GEN, V4, P1, DOI 10.1016/j.fsigen.2009.03.003; BALDING DJ, 1994, FORENSIC SCI INT, V64, P125, DOI 10.1016/0379-0738(94)90222-4; Barrio PA, 2018, FORENSIC SCI INT-GEN, V35, P156, DOI 10.1016/j.fsigen.2018.05.005; Benschop CCG, 2019, FORENSIC SCI INT-GEN, V42, P31, DOI 10.1016/j.fsigen.2019.06.005; Bille TW, 2014, ELECTROPHORESIS, V35, P3125, DOI 10.1002/elps.201400110; Bleka O, INTRO EUROFORMIX 201; Bleka O., NEW UPDATE EUROFORMI; Bleka O, 2016, FORENSIC SCI INT-GEN, V25, P85, DOI 10.1016/j.fsigen.2016.07.016; Bleka O, 2016, FORENSIC SCI INT-GEN, V21, P35, DOI 10.1016/j.fsigen.2015.11.008; Bregu J, 2013, J FORENSIC SCI, V58, P120, DOI 10.1111/1556-4029.12008; Bright JA, 2019, FORENSIC SCI INT-GEN, V40, P1, DOI 10.1016/j.fsigen.2019.01.006; Bright JA, 2018, FORENSIC SCI INT-GEN, V34, P11, DOI 10.1016/j.fsigen.2018.01.003; Bright JA, 2017, FORENSIC SCI INT-GEN, V31, pE24, DOI 10.1016/j.fsigen.2017.08.005; Bright JA, 2016, FORENSIC SCI INT-GEN, V23, P226, DOI 10.1016/j.fsigen.2016.05.007; Bright JA, 2015, FORENSIC SCI INT-GEN, V14, P125, DOI 10.1016/j.fsigen.2014.09.019; Bright JA, 2014, FORENSIC SCI INT-GEN, V13, P79, DOI 10.1016/j.fsigen.2014.07.003; Bright JA, 2013, FORENSIC SCI INT-GEN, V7, P296, DOI 10.1016/j.fsigen.2012.11.013; Buckleton, 2019, WIRES FORENSIC SCI, V1, pE1354, DOI [10.1002/wfs2.1354, DOI 10.1002/WFS2.1354]; Buckleton J, 2016, FORENSIC SCI INT-GEN, V23, P91, DOI 10.1016/j.fsigen.2016.03.004; Buckleton JS, 2018, FORENSIC SCI INT-GEN, V37, P172, DOI 10.1016/j.fsigen.2018.08.014; Buckleton JS, 2019, J FORENSIC SCI, V64, P393, DOI 10.1111/1556-4029.13898; Butler JM., 2015, ADV TOPICS FORENSIC; Butler JM, VALIDATION PRINCIPLE; Coble MD, 2019, FORENSIC SCI INT-GEN, V38, P219, DOI 10.1016/j.fsigen.2018.11.009; Cooper S, 2015, FORENSIC SCI INT-GEN, V16, P121, DOI 10.1016/j.fsigen.2014.12.009; Cowell RG, 2007, BAYESIAN ANAL, V2, P333, DOI 10.1214/07-BA214; Cowell RG, 2015, J R STAT SOC C-APPL, V64, P1, DOI 10.1111/rssc.12071; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; EVETT IW, 1991, J FORENSIC SCI SOC, V31, P41, DOI 10.1016/S0015-7368(91)73116-2; Gelman A., 1992, STAT SCI, V7, P457, DOI [10.1214/ss/1177011136, DOI 10.1214/SS/1177011136]; Gilder JR, 2007, J FORENSIC SCI, V52, P97, DOI 10.1111/j.1556-4029.2006.00318.x; Gill P, 2006, FORENSIC SCI INT, V160, P90, DOI 10.1016/j.forsciint.2006.04.009; Gill P, 2020, FORENSIC SCI INT-GEN, V44, DOI 10.1016/j.fsigen.2019.102186; Gill P, 2018, FORENSIC SCI INT-GEN, V36, P189, DOI 10.1016/j.fsigen.2018.07.003; Green D. M., 1966, SIGNAL DETECTION THE, DOI DOI 10.1086/405615; Hannig J, 2019, FORENS SCI INT-GEN S, V7, P572, DOI 10.1016/j.fsigss.2019.10.094; Hill CR, 2013, FORENSIC SCI INT-GEN, V7, pE82, DOI 10.1016/j.fsigen.2012.12.004; Jackson G, 2006, SCI JUSTICE, V46, P33, DOI 10.1016/S1355-0306(06)71565-9; Kelly H, 2018, FORENSIC SCI INT-GEN, V35, P113, DOI 10.1016/j.fsigen.2018.04.009; Kelly H, 2014, SCI JUSTICE, V54, P66, DOI 10.1016/j.scijus.2013.07.003; LINDLEY DV, 1977, BIOMETRIKA, V64, P207, DOI 10.1093/biomet/64.2.207; Manabe S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188183; Monich UJ, 2015, FORENSIC SCI INT-GEN, V19, P107, DOI 10.1016/j.fsigen.2015.07.001; Moretti TR, 2017, FORENSIC SCI INT-GEN, V29, P126, DOI 10.1016/j.fsigen.2017.04.004; Noel S, 2019, FORENSIC SCI INT-GEN, V41, P24, DOI 10.1016/j.fsigen.2019.03.017; Perlin MW, 2011, J FORENSIC SCI, V56, P1430, DOI 10.1111/j.1556-4029.2011.01859.x; President's Council of Advisors on Science and Technology,, 2016, REP PRES FOR SCI CRI; Puch-Solis R, 2013, FORENSIC SCI INT-GEN, V7, P555, DOI 10.1016/j.fsigen.2013.05.009; R Core Team, 2020, R LANG ENV STAT COMP; Scientific Working Group on DNA Analysis Methods (SWGDAM), 2015, GUID VAL PROB GEN SY; Slooten K, 2018, FORENSIC SCI INT-GEN, V36, P119, DOI 10.1016/j.fsigen.2018.06.009; Steele CD, 2016, STAT APPL GENET MOL, V15, P431, DOI 10.1515/sagmb-2016-0038; Swaminathan H, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0207599; Swaminathan H, 2016, FORENSIC SCI INT-GEN, V22, P149, DOI 10.1016/j.fsigen.2016.02.005; SWGDAM, 2018, REC SWGDAM AD HOC WO; Taylor D, 2020, FORENSIC SCI INT-GEN, V48, DOI 10.1016/j.fsigen.2020.102361; Taylor D, 2016, FORENSIC SCI INT-GEN, V20, P6, DOI 10.1016/j.fsigen.2015.09.011; Taylor D, 2015, FORENSIC SCI INT-GEN, V16, P13, DOI 10.1016/j.fsigen.2014.11.001; Taylor D, 2014, FORENSIC SCI INT-GEN, V11, P144, DOI 10.1016/j.fsigen.2014.03.008; Taylor D, 2013, FORENSIC SCI INT-GEN, V7, P516, DOI 10.1016/j.fsigen.2013.05.011; You YP, 2019, FORENSIC SCI INT-GEN, V40, P114, DOI 10.1016/j.fsigen.2019.02.014	68	6	6	4	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2021	16	9							e0256714	10.1371/journal.pone.0256714	http://dx.doi.org/10.1371/journal.pone.0256714			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	WG5ZQ	34534241	Green Submitted, Green Published, gold			2022-12-26	WOS:000707073300009
J	El Zein, S; Chehab, O; Kanj, A; Akrawe, S; Alkassis, S; Mishra, T; Shatta, M; El-Hor, N; Salimnia, H; Chandrasekar, P				El Zein, Said; Chehab, Omar; Kanj, Amjad; Akrawe, Sandy; Alkassis, Samer; Mishra, Tushar; Shatta, Maya; El-Hor, Nivine; Salimnia, Hossein; Chandrasekar, Pranatharthi			SARS-CoV-2 infection: Initial viral load (iVL) predicts severity of illness/outcome, and declining trend of iVL in hospitalized patients corresponds with slowing of the pandemic	PLOS ONE			English	Article							DISEASE	Background Hospitalization of patients infected with the severe acute respiratory syndrome virus 2 (SARS-CoV-2) have remained considerable worldwide. Patients often develop severe complications and have high mortality rates. The cycle threshold (Ct) value derived from nasopharyngeal swab samples using real time polymerase chain reaction (RT-PCR) may be a useful prognostic marker in hospitalized patients with SARS-CoV-2 infection, however, its role in predicting the course of the pandemic has not been evaluated thus far. Methods We conducted a retrospective cohort study which included all patients who had a nasopharyngeal sample positive for SARS-CoV-2 between April 4 -June 5, 2020. The Ct value was used to estimate the number of viral particles in a patient sample. The trend in initial viral load on admission on a population level was evaluated. Moreover, patient characteristics and outcomes stratified by viral load categories were compared and initial viral load was assessed as an independent predictor of intubation and in-hospital mortality. Results A total of 461 hospitalized patients met the inclusion criteria. This study consisted predominantly of acutely infected patients with a median of 4 days since symptom onset to PCR. As the severity of the pandemic eased, there was an increase in the percentage of samples in the low initial viral load category, coinciding with a decrease in deaths. Compared to an initial low viral load, a high initial viral load was an independent predictor of in-hospital mortality (OR 5.5, CI 3.1-9.7, p < 0.001) and intubation (OR 1.82 CI 1.07-3.11, p = 0.03), while an initial intermediate viral load was associated with increased risk of inpatient mortality (OR 1.9, CI 1.14-3.21, p = 0.015) but not with increased risk for intubation. Conclusion The Ct value obtained from nasopharyngeal samples of hospitalized patients on admission may serve as a prognostic marker at an individual level and may help predict the course of the pandemic when evaluated at a population level.	[El Zein, Said; Chehab, Omar; Akrawe, Sandy; Alkassis, Samer; Mishra, Tushar; Shatta, Maya; El-Hor, Nivine] Wayne State Univ, Dept Internal Med, Detroit Med Ctr, Detroit, MI 48202 USA; [Kanj, Amjad] Mayo Clin, Div Pulm & Crit Care Med, Rochester, MN USA; [Salimnia, Hossein] Wayne State Univ, Dept Pathol, Detroit Med Ctr, Detroit, MI 48202 USA; [Chandrasekar, Pranatharthi] Wayne State Univ, Sch Med, Dept Internal Med, Div Infect Dis, Detroit, MI 48201 USA	Detroit Medical Center; Wayne State University; Mayo Clinic; Detroit Medical Center; Wayne State University; Wayne State University	Chandrasekar, P (corresponding author), Wayne State Univ, Sch Med, Dept Internal Med, Div Infect Dis, Detroit, MI 48201 USA.	pchandrasekar@med.wayne.edu		Kanj, Amjad/0000-0003-0470-3603				Bryan A., 2020, OPEN FORUM INFECT DI, V7, pofaa535, DOI [10.1093/ofid/ofaa535, DOI 10.1093/ofid/ofaa535]; Centers for Disease Control and Prevention, 2021, COR DIS 2019 COVID 1; Cepheid, 2012, GENEXPERT DX SYST OP; Chu CM, 2004, CAN MED ASSOC J, V171, P1349, DOI 10.1503/cmaj.1040398; Clementi N, 2020, CLIN CHEM LAB MED, V58, P1573, DOI 10.1515/cclm-2020-0815; Fairfax MR, 2010, MOLECULAR DIAGNOSTICS: TECHNIQUES AND APPLICATIONS FOR THE CLINICAL LABORATORY, 1ST EDITION, P3, DOI 10.1016/B978-0-12-369428-7.00001-X; Fajnzylber J, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-19057-5; Feikin DR, 2015, EMERG INFECT DIS, V21, P2029, DOI 10.3201/eid2111.150764; Gandhi M, 2020, NEW ENGL J MED, V383, DOI 10.1056/NEJMp2026913; Granados A, 2017, J CLIN VIROL, V86, P14, DOI 10.1016/j.jcv.2016.11.008; Hay JA, 2021, SCIENCE, V373, DOI 10.1126/science.abh0635; Kabarriti R, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.19795; Khazanchi R, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.19933; Lalueza A, 2019, EUR J CLIN MICROBIOL, V38, P667, DOI 10.1007/s10096-019-03514-1; Magleby R, 2021, CLIN INFECT DIS, V73, pE4197, DOI 10.1093/cid/ciaa851; Masia M, 2021, OPEN FORUM INFECT DI, V8, DOI 10.1093/ofid/ofab005; Miller EH, 2021, OPEN FORUM INFECT DI, V8, DOI 10.1093/ofid/ofab003; Miller J, 2021, CLIN INFECT DIS, V72, pE704, DOI 10.1093/cid/ciaa1420; National Vector Borne Disease Control Program, 2021, MON US E CIG SAL STA; Pujadas E, 2020, LANCET RESP MED, V8, pE70, DOI 10.1016/S2213-2600(20)30354-4; Quan DN, 2021, J GEN INTERN MED, V36, P1302, DOI 10.1007/s11606-020-06527-1; Rao SN, 2020, INFECT DIS THER, V9, P573, DOI 10.1007/s40121-020-00324-3; Tejada CDJ, 2021, CLIN TRANSPLANT, V35, DOI 10.1111/ctr.14169; Westblade LF, 2020, CANCER CELL, V38, P661, DOI 10.1016/j.ccell.2020.09.007; Zheng SF, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1443	25	14	14	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2021	16	9							e0255981	10.1371/journal.pone.0255981	http://dx.doi.org/10.1371/journal.pone.0255981			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	WG5YY	34529675	gold, Green Published			2022-12-26	WOS:000707071500012
J	Ticona, JPA; Nery, N; Doss-Gollin, S; Gambrah, C; Lessa, M; Rastely-Junior, V; Matos, A; Freitas, BD; Borja, A; Wunder, EA; Ballalai, V; Vieira, C; Cruz, JS; de Oliveira, D; Araujo, DB; Oliveira, DB; Maeda, DLNF; Mendes, EA; Soares, CP; Durigon, EL; Ferreira, LCD; Belfort, R; Almeida, ARP; Oliveira, J; Reis, MG; Ko, AI; Costa, F				Aguilar Ticona, Juan P.; Nery, Nivison; Doss-Gollin, Simon; Gambrah, Claudia; Lessa, Millani; Rastely-Junior, Valmir; Matos, Adriana; Freitas, Bruno de Paula; Borja, Ana; Wunder, Elsio A.; Ballalai, Verena; Vieira, Carina; Cruz, Jaqueline S.; de Oliveira, Daiana; Araujo, Danielle Bastos; Oliveira, Danielle B.; Nascimento Fabris Maeda, Denicar Lina; Mendes, Erica A.; Soares, Camila Pereira; Durigon, Edison L.; de Souza Ferreira, Luis Carlos; Belfort, Rubens; Almeida, Antonio R. P.; Oliveira-Filho, Jamary; Reis, Mitermayer G.; Ko, Albert, I; Costa, Federico			Heterogeneous development of children with Congenital Zika Syndrome-associated microcephaly	PLOS ONE			English	Article							INFANT NEUROLOGICAL EXAMINATION; CEREBRAL-PALSY	Objective To describe the neurological and neurodevelopmental outcomes of children with Congenital Zika Syndrome (CZS) associated microcephaly beyond 2 years of age. Method We followed children with CZS-associated microcephaly in an outpatient clinic in Salvador, Brazil. Neurological and neurodevelopmental assessments were performed using the Hammersmith Infant Neurological Examination (HINE) and Bayley Scales of Infant and Toddler Neurodevelopment (Bayley-III) respectively. Results Of the 42 children included, 19 were male (45.2%); median (interquartile range) age at neurological evaluation was 28 (25-32) months, and 36 (85.7%) had severe microcephaly. HINE and Bayley-III results were completed for 35/42 (83.3%) and 33/42 (78.5%) children respectively. Bayley-III identified a severe developmental delay in 32/33 (97.0%) children while 1/33 (3.0%) had only a mild delay. In the multivariable analysis, we found that Bayley-III and HINE scores were correlated. Better HINE scores were associated with higher Bayley-III cognitive raw scores (beta = 0.29; CI 95% = 0.02-0.57) and motor raw scores (beta = 0.43; CI 95% = 0.04-0.82) after adjusting for head circumference, prematurity, and age at neurodevelopmental evaluation. Furthermore, we found that greater head circumference at follow up was associated with higher cognitive (beta = 1.27; CI 95% = 0.01-2.53) and motor raw scores (beta = 2.03; CI 95% = 0.25-3.81). Conclusion Children with CZS-associated microcephaly demonstrate severe neurodevelopmental delays and slower growth rates than their peers over time. Still, they have remarkably heterogeneous neurodevelopmental profiles according to neurological exam scores which correlate with their long-term outcomes. We found that HINE scores effectively captured the heterogeneity of neurological capabilities among these children and could be predictive of cognitive and motor development progress.	[Aguilar Ticona, Juan P.; Nery, Nivison; Lessa, Millani; Costa, Federico] Univ Fed Bahia, Inst Saude Colet, Salvador, BA, Brazil; [Aguilar Ticona, Juan P.; Nery, Nivison; Wunder, Elsio A.; Cruz, Jaqueline S.; de Oliveira, Daiana; Reis, Mitermayer G.; Ko, Albert, I; Costa, Federico] Minist Saude, Inst Goncalo Moniz, Fundacao Oswaldo Cruz, Salvador, BA, Brazil; [Doss-Gollin, Simon] Boston Childrens Hosp, Div Infect Dis, Precis Vaccines Program, Boston, MA USA; [Gambrah, Claudia; Wunder, Elsio A.; Reis, Mitermayer G.; Ko, Albert, I; Costa, Federico] Yale Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT USA; [Rastely-Junior, Valmir; Oliveira-Filho, Jamary; Reis, Mitermayer G.] Univ Fed Bahia, Fac Med Bahia, Salvador, BA, Brazil; [Matos, Adriana; Freitas, Bruno de Paula; Ballalai, Verena; Vieira, Carina; Almeida, Antonio R. P.] Hosp Geral Roberto Santos HGRS, Salvador, BA, Brazil; [Freitas, Bruno de Paula; Belfort, Rubens] Univ Fed Sao Paulo, Fac Med, Sao Paulo, SP, Brazil; [Borja, Ana] Univ Fed Bahia, Inst Ciencias Saude, Dept Fonoaudiol, Salvador, BA, Brazil; [Araujo, Danielle Bastos; Oliveira, Danielle B.; Mendes, Erica A.; Soares, Camila Pereira; Durigon, Edison L.] Univ Sao Paulo, Inst Ciencias Biomed, Dept Microbiol, Sao Paulo, Brazil; [Nascimento Fabris Maeda, Denicar Lina; de Souza Ferreira, Luis Carlos] Univ Sao Paulo, Inst Ciencias Biomed, Dept Microbiol, Lab Desenvolvimento Vacinas, Sao Paulo, Brazil; [Oliveira-Filho, Jamary] Univ Fed Bahia, Programa Posgrad Ciencias Saude PPgCS, Salvador, BA, Brazil	Universidade Federal da Bahia; Fundacao Oswaldo Cruz; Harvard University; Boston Children's Hospital; Yale University; Universidade Federal da Bahia; Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal da Bahia; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade Federal da Bahia	Costa, F (corresponding author), Univ Fed Bahia, Inst Saude Colet, Salvador, BA, Brazil.; Ko, AI; Costa, F (corresponding author), Minist Saude, Inst Goncalo Moniz, Fundacao Oswaldo Cruz, Salvador, BA, Brazil.	albert.ko@yale.edu; federico.costa@ufba.br	Ko, Albert/P-2343-2015; Aguilar Ticona, Juan Pablo/AAE-3068-2021; Gambrah-Lyles, Claudia/AHD-6105-2022	Ko, Albert/0000-0001-9023-2339; Aguilar Ticona, Juan Pablo/0000-0002-6971-2677; Gambrah-Lyles, Claudia/0000-0002-2448-2265; Borja, Ana/0000-0002-8250-9366; Nascimento Rastely Junior, Valmir/0000-0001-8350-6995; Souza de Almeida Lessa, Millani/0000-0002-3535-6926; Oliveira, Danielle/0000-0002-0534-0886; Doss-Gollin, Simon/0000-0001-8797-7452	National Institutes of Health (NIAID) [R01 AI052473, R25 U01AI088752, R25 TW009338, F31 AI114245, R01 AI121207, R01 TW009504]; Wellcome Trust [102330/Z/13/Z, 218987/Z/19/Z]; Bahia State Research Support Foundation (FAPESB) ZIKA-FAPESB T.O. [PET0021/2016]; Sao Paulo Research Foundation (FAPESP) [2016/20045-7]; European Union's Horizon 2020 research and innovation programme [734584]; Coordination for the Improvement of Higher Education (CAPES) from Brazil	National Institutes of Health (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Wellcome Trust(Wellcome TrustEuropean Commission); Bahia State Research Support Foundation (FAPESB) ZIKA-FAPESB T.O.; Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); European Union's Horizon 2020 research and innovation programme; Coordination for the Improvement of Higher Education (CAPES) from Brazil(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	The study was supported by grants from the National Institutes of Health (NIAID R01 AI052473 (AK), R25 U01AI088752 (AK), FIC R01 TW009504 (AK), R25 TW009338 (AK), F31 AI114245 (AK), R01 AI121207(AK)) (https://www.niaid.nih.gov/), Wellcome Trust (102330/Z/13/Z (FC); 218987/Z/19/Z (FC)) (https://wellcome.ac.uk/), Bahia State Research Support Foundation (FAPESB) ZIKA-FAPESB T.O. n degrees PET0021/2016 (www.fapesb.ba.gov.br), Sao Paulo Research Foundation (FAPESP) under Project 2016/20045-7 (LCSF) (www.fapesp.br), the European Union's Horizon 2020 research and innovation programme under Grant Agreement No. 734584 (DBA) (www.ec.europa.eu) and the Coordination for the Improvement of Higher Education (CAPES) from Brazil (https://www.capes.gov.br/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ticona JPA, 2021, PLOS NEGLECT TROP D, V15, DOI 10.1371/journal.pntd.0009162; Albers CA, 2007, J PSYCHOEDUC ASSESS, V25, P180, DOI 10.1177/0734282906297199; Alves LV, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-021304; Carvalho A, 2019, BRAIN DEV-JPN, V41, P587, DOI 10.1016/j.braindev.2019.03.005; de Carvalho AL, 2020, J CHILD NEUROL, V35, P202, DOI 10.1177/0883073819885724; de Carvalho AL, 2018, EMERG INFECT DIS, V24, P2128, DOI 10.3201/eid2411.180883; de Onis Mercedes, 2004, Food Nutr Bull, V25, pS15; Moreira MEL, 2018, NEW ENGL J MED, V379, P2377, DOI 10.1056/NEJMc1800098; Pereira HVFS, 2020, LANCET CHILD ADOLESC, V4, P378, DOI 10.1016/S2352-4642(20)30041-9; Ferreira LL, 2021, JAMA NETW OPEN, V4, DOI 10.1001/jamanetworkopen.2021.9878; Freitas BD, 2016, JAMA OPHTHALMOL, V134, P529, DOI 10.1001/jamaophthalmol.2016.0267; Guimaraes CD, 2019, BMC PEDIATR, V19, DOI 10.1186/s12887-019-1762-6; Hills SL, 2017, J INFECT DIS, V216, pS868, DOI 10.1093/infdis/jix434; Jary S, 2011, J PEDIATR-US, V159, P211, DOI 10.1016/j.jpeds.2011.01.037; Lind A, 2011, PEDIATR RADIOL, V41, P953, DOI 10.1007/s00247-011-2071-x; Moore CA, 2017, JAMA PEDIATR, V171, P288, DOI 10.1001/jamapediatrics.2016.3982; Mulkey SB, 2020, JAMA PEDIATR, V174, P269, DOI 10.1001/jamapediatrics.2019.5204; Nielsen-Saines K, 2019, NAT MED, V25, P1213, DOI 10.1038/s41591-019-0496-1; Pecanha PM, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0229434; Romeo DM, 2016, DEV MED CHILD NEUROL, V58, P240, DOI 10.1111/dmcn.12876; Romeo DMM, 2008, EUR J PAEDIATR NEURO, V12, P24, DOI 10.1016/j.ejpn.2007.05.006; Villar J, 2014, LANCET, V384, P857, DOI 10.1016/S0140-6736(14)60932-6	22	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2021	16	9							e0256444	10.1371/journal.pone.0256444	http://dx.doi.org/10.1371/journal.pone.0256444			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	WG6DR	34525107	Green Published, gold			2022-12-26	WOS:000707084400015
J	Malik, A; Malik, J; Ishaq, U				Malik, Asmara; Malik, Jahanzeb; Ishaq, Uzma			Acceptance of COVID-19 vaccine in Pakistan among health care workers	PLOS ONE			English	Article							HESITANCY; DETERMINANTS	Objective Acceptance of the COVID-19 vaccine will impart a pivotal role in eradicating the virus. In Pakistan, health care workers (HCWs) are the first group to receive vaccination. This survey aimed at the level of acceptance to the COVID-19 vaccine and predictors of non-acceptance in HCWs. Method This was a cross-sectional study design and data were collected through 3rd December 2020 and February 14th, 2021. An English questionnaire was distributed through social media platforms and administration of affiliate hospitals along with snowball sampling for private hospitals. Results Out of 5,237 responses, 3,679 (70.2%) accepted COVID-19 vaccination and 1,284 (24.5%) wanted to delay until more data was available. Only 5.2% of HCWs rejected being vaccinated. Vaccine acceptance was more in young (76%) and female gender (63.3%) who worked in a tertiary care hospital (51.2%) and were direct patient care providers (61.3%). The reason for rejection in females was doubtful vaccine effectiveness (31.48%) while males rejected due to prior COVID-19 exposure (42.19%) and side effect profile of the vaccine (33.17%). Logistic regression analysis demonstrated age between 51-60 years, female gender, Pashtuns, those working in the specialty of medicine and allied, taking direct care of COVID-19 patients, higher education, and prior COVID-19 infection as the predictors for acceptance or rejection of COVID-19 vaccine. Conclusion In conclusion, this survey suggests that early on in a vaccination drive, majority of the HCWs in Pakistan are willing to be vaccinated and only a small number of participants would actually reject being vaccinated.	[Malik, Asmara] Natl Univ Med Sci, Army Med Coll, Dept Community Med, Rawalpindi, Pakistan; [Malik, Jahanzeb] Rawalpindi Inst Cardiol, Dept Cardiol, Rawalpindi, Pakistan; [Ishaq, Uzma] Fdn Univ Med Coll, Dept Hematol, Islamabad, Pakistan	National University of Sciences & Technology - Pakistan	Malik, J (corresponding author), Rawalpindi Inst Cardiol, Dept Cardiol, Rawalpindi, Pakistan.	Heartdoc86@gmail.com	Malik, Jahanzeb/AAU-5877-2020	Malik, Jahanzeb/0000-0002-9343-4187; Malik, Dr Asmara Ahmed/0000-0002-4175-7689				Abbas Q., 2021, AUTHOREA PREPR, DOI [10.22541/au.161519250.03425961/v1, DOI 10.22541/AU.161519250.03425961/V1]; Abid K, 2020, ASIA-PAC J PUBLIC HE, V32, P154, DOI 10.1177/1010539520927259; Ali M, 2019, LANCET, V394, P915, DOI 10.1016/S0140-6736(19)32101-4; Ali M, 2020, PLOS ONE, V15, DOI [10.1371/journal.pone.0242762, 10.1371/journal.pone.02427620]; [Anonymous], 2002, Bull World Health Organ, V80, P983; Babakhel Z., 2020, ISLAMIC ADVISORY GRO; Butler R, 2015, VACCINE, V33, P4176, DOI 10.1016/j.vaccine.2015.04.038; Cohen JI, 2021, CLIN INFECT DIS, V73, pE4223, DOI 10.1093/cid/ciaa1866; Dasgupta A, 2020, J PAK MED ASSOC, V70, pS131, DOI 10.5455/JPMA.32; Elbarazi I, 2021, HUM VACC IMMUNOTHER, V17, P2018, DOI 10.1080/21645515.2020.1855953; Hanif M, 2020, CUREUS J MED SCIENCE, V12, DOI 10.7759/cureus.11176; Harapan H, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00381; Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5; Jennings L, 2013, INT J EQUITY HEALTH, V12, DOI 10.1186/1475-9276-12-85; Karafillakis E, 2016, VACCINE, V34, P5013, DOI 10.1016/j.vaccine.2016.08.029; Khan F, 2020, CHAOS SOLITON FRACT, V140, DOI 10.1016/j.chaos.2020.110189; Kuter BJ, 2021, VACCINE, V39, P1693, DOI 10.1016/j.vaccine.2021.02.029; Lopez-Leon S, 2021, SCI REP-UK, V11, DOI [10.1038/s41598-021-95565-8, 10.1101/2021.01.27.21250617]; Lucia VC, 2021, J PUBLIC HEALTH-UK, V43, P445, DOI 10.1093/pubmed/fdaa230; National Command Operation, 2020, NAT COMM OP CTR; Nawaz A, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.573431; Nzaji MK, 2020, PRAGMAT OBS RES, V11, P103, DOI 10.2147/POR.S271096; Panezai S, 2017, DEV PRACT, V27, P813, DOI 10.1080/09614524.2017.1344188; Robertson E, 2021, BRAIN BEHAV IMMUN, V94, P41, DOI 10.1016/j.bbi.2021.03.008; Rodriguez-Morales AJ, 2020, TRAVEL MED INFECT DI, V34, DOI 10.1016/j.tmaid.2020.101623; Rueda ST., 2020, HLTH SECTOR COST DIF; Saied SM, 2021, J MED VIROL, V93, P4280, DOI 10.1002/jmv.26910; Sallam M, 2021, VACCINES-BASEL, V9, DOI 10.3390/vaccines9020160; Sallam M, 2021, VACCINES-BASEL, V9, DOI 10.3390/vaccines9010042; Schwarzinger M, 2021, LANCET PUBLIC HEALTH, V6, pE210, DOI 10.1016/S2468-2667(21)00012-8; Shah SFA, 2019, VACCINE, V37, P3694, DOI 10.1016/j.vaccine.2019.05.029; Tabah A, 2020, J CRIT CARE, V59, P70, DOI 10.1016/j.jcrc.2020.06.005; Verger P, 2015, EBIOMEDICINE, V2, P891, DOI 10.1016/j.ebiom.2015.06.018; Web Correspondant, 2021, PHAS 2 PAK START VAC; WHO, 2020, INF	35	23	23	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2021	16	9							e0257237	10.1371/journal.pone.0257237	http://dx.doi.org/10.1371/journal.pone.0257237			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	WG6DR	34525110	Green Published, Green Submitted, gold			2022-12-26	WOS:000707084400028
J	Denomy, C; Lazarou, C; Hogan, D; Facciuolo, A; Scruten, E; Kusalik, A; Napper, S				Denomy, Connor; Lazarou, Conor; Hogan, Daniel; Facciuolo, Antonio; Scruten, Erin; Kusalik, Anthony; Napper, Scott			PIIKA 2.5: Enhanced quality control of peptide microarrays for kinome analysis	PLOS ONE			English	Article								Peptide microarrays consisting of defined phosphorylation target sites are an effective approach for high throughput analysis of cellular kinase (kinome) activity. Kinome peptide arrays are highly customizable and do not require species-specific reagents to measure kinase activity, making them amenable for kinome analysis in any species. Our group developed software, Platform for Integrated, Intelligent Kinome Analysis (PIIKA), to enable more effective extraction of meaningful biological information from kinome peptide array data. A subsequent version, PIIKA2, unveiled new statistical tools and data visualization options. Here we introduce PIIKA 2.5 to provide two essential quality control metrics and a new background correction technique to increase the accuracy and consistency of kinome results. The first metric alerts users to improper spot size and informs them of the need to perform manual resizing to enhance the quality of the raw intensity data. The second metric uses inter-array comparisons to identify outlier arrays that sometimes emerge as a consequence of technical issues. In addition, a new background correction method, background scaling, can sharply reduce spatial biases within a single array in comparison to background subtraction alone. Collectively, the modifications of PIIKA 2.5 enable identification and correction of technical issues inherent to the technology and better facilitate the extraction of meaningful biological information. We show that these metrics demonstrably enhance kinome analysis by identifying low quality data and reducing batch effects, and ultimately improve clustering of treatment groups and enhance reproducibility. The web-based and stand-alone versions of PIIKA 2.5 are freely accessible at via http://saphire.usask.ca.	[Denomy, Connor; Lazarou, Conor; Hogan, Daniel; Kusalik, Anthony] Univ Saskatchewan, Dept Comp Sci, Saskatoon, SK, Canada; [Facciuolo, Antonio; Scruten, Erin; Napper, Scott] Vaccine & Infect Dis Org, Saskatoon, SK, Canada; [Napper, Scott] Univ Saskatchewan, Dept Biochem Microbiol & Immunol, Saskatoon, SK, Canada	University of Saskatchewan; University of Saskatchewan; University of Saskatchewan	Kusalik, A (corresponding author), Univ Saskatchewan, Dept Comp Sci, Saskatoon, SK, Canada.; Napper, S (corresponding author), Vaccine & Infect Dis Org, Saskatoon, SK, Canada.; Napper, S (corresponding author), Univ Saskatchewan, Dept Biochem Microbiol & Immunol, Saskatoon, SK, Canada.	kusalik@cs.usask.ca; scott.napper@usask.ca		Facciuolo, Antonio/0000-0003-4551-9386	Natural Sciences and Engineering Research Council of Canada [RGPIN-2017-05486, RGPIN-05690-2018]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	AK received funding from Natural Sciences and Engineering Research Council of Canada Discovery Grant RGPIN-2017-05486 (https://www.nserc-crsng.gc.ca/) SN received funding from Natural Sciences and Engineering Research Council of Canada Discovery Grant RGPIN-05690-2018 (https://www.nserc-crsng.gc.ca/) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Arsenault RJ, 2009, J RECEPT SIG TRANSD, V29, P299, DOI 10.3109/10799890903295127; Baharani A, 2017, BIOCHEM SOC T, V45, P65, DOI 10.1042/BST20160163; Buness A, 2005, BIOINFORMATICS, V21, P554, DOI 10.1093/bioinformatics/bti052; Cohen P, 2002, NAT REV DRUG DISCOV, V1, P309, DOI 10.1038/nrd773; Dago ND., 2017, BIOTECHNOL J INT, P1; Diks SH, 2004, J BIOL CHEM, V279, P49206, DOI 10.1074/jbc.M405028200; Dong JS, 2018, BMC VET RES, V14, DOI 10.1186/s12917-018-1360-0; Dussaq AM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0202139; Eijssen LMT, 2013, NUCLEIC ACIDS RES, V41, pW71, DOI 10.1093/nar/gkt293; Facciuolo A, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.00765; FEIST W, 1992, FEMS MICROBIOL IMMUN, V89, P73, DOI 10.1016/0378-1097(92)90264-O; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Jalal S, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.254pl1; Kauffmann A, 2010, GENOMICS, V95, P138, DOI 10.1016/j.ygeno.2010.01.003; Kauffmann Audrey, 2009, Bioinformatics, V25, P415, DOI 10.1093/bioinformatics/btn647; Kindrachuk J, 2014, J VIROL, V88, P9877, DOI 10.1128/JVI.01410-14; Koren A, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-164; Li Y, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002429; Perry F, 2020, MICROORGANISMS, V8, DOI 10.3390/microorganisms8071041; R Core Team, 2021, R LANGUAGE ENV STAT; Roskoski R, 2021, PHARMACOL RES, V165, DOI 10.1016/j.phrs.2021.105463; Shai O., 2003, PSI200321; Sifakis EG, 2012, COMPUT BIOL MED, V42, P19, DOI 10.1016/j.compbiomed.2011.10.003; Trost B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080837; Trost B, 2013, BIOINFORMATICS, V29, P1693, DOI 10.1093/bioinformatics/btt265	27	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2021	16	9							e0257232	10.1371/journal.pone.0257232	http://dx.doi.org/10.1371/journal.pone.0257232			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XM9EM	34506584	gold, Green Published			2022-12-26	WOS:000729120700074
J	Duran-Meza, AL; Villagrana-Escareno, MV; Ruiz-Garcia, J; Knobler, CM; Gelbart, WM				Duran-Meza, A. L.; Villagrana-Escareno, M. V.; Ruiz-Garcia, J.; Knobler, C. M.; Gelbart, W. M.			Controlling the surface charge of simple viruses	PLOS ONE			English	Article							ELECTROPHORETIC MOBILITY; PROTEIN; PARTICLES; NANOCARRIERS; DELIVERY	The vast majority of plant viruses are unenveloped, i.e., they lack a lipid bilayer that is characteristic of most animal viruses. The interactions between plant viruses, and between viruses and surfaces, properties that are essential for understanding their infectivity and to their use as bionanomaterials, are largely controlled by their surface charge, which depends on pH and ionic strength. They may also depend on the charge of their contents, i.e., of their genes or-in the instance of virus-like particles-encapsidated cargo such as nucleic acid molecules, nanoparticles or drugs. In the case of enveloped viruses, the surface charge of the capsid is equally important for controlling its interaction with the lipid bilayer that it acquires and loses upon leaving and entering host cells. We have previously investigated the charge on the unenveloped plant virus Cowpea Chlorotic Mottle Virus (CCMV) by measurements of its electrophoretic mobility. Here we examine the electrophoretic properties of a structurally and genetically closely related bromovirus, Brome Mosaic Virus (BMV), of its capsid protein, and of its empty viral shells, as functions of pH and ionic strength, and compare them with those of CCMV. From measurements of both solution and gel electrophoretic mobilities (EMs) we find that the isoelectric point (pI) of BMV (5.2) is significantly higher than that of CCMV (3.7), that virion EMs are essentially the same as those of the corresponding empty capsids, and that the same is true for the pIs of the virions and of their cleaved protein subunits. We discuss these results in terms of current theories of charged colloidal particles and relate them to biological processes and the role of surface charge in the design of new classes of drug and gene delivery systems.	[Duran-Meza, A. L.; Knobler, C. M.; Gelbart, W. M.] Univ Calif Los Angeles, Dept Chem & Biochem, 405 Hilgard Ave, Los Angeles, CA 90024 USA; [Villagrana-Escareno, M. V.; Ruiz-Garcia, J.] Univ Autonoma San Luis Potosi, Lab Fis Biol, Inst Fis, San Luis Potosi, San Luis Potosi, Mexico	University of California System; University of California Los Angeles; Universidad Autonoma de San Luis Potosi	Knobler, CM; Gelbart, WM (corresponding author), Univ Calif Los Angeles, Dept Chem & Biochem, 405 Hilgard Ave, Los Angeles, CA 90024 USA.	knobler@chem.ucla.edu; gelbart@chem.ucla.edu		RUIZ-GARCIA, JAIME/0000-0003-3730-3825	National Science Foundation (US) [MCB 1716925]; CONACYT [CB-254981, CB-237439]	National Science Foundation (US)(National Science Foundation (NSF)); CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	CMK and WMG acknowledge support from National Science Foundation (US)(https://www.nsf.gov/) Grant No. MCB 1716925, and JRG acknowledges support from CONACYT (https://www.conacyt.gob.mx) Grants No. CB-254981 and CB-237439. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asokan A, 2002, J PHARM SCI-US, V91, P903, DOI 10.1002/jps.10095; BANCROFT JB, 1967, VIROLOGY, V31, P354, DOI 10.1016/0042-6822(67)90180-8; Belyi VA, 2006, P NATL ACAD SCI USA, V103, P17174, DOI 10.1073/pnas.0608311103; Biddlecome A, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0215031; BOCKSTAHLER LE, 1962, BIOPHYS J, V2, P1, DOI 10.1016/S0006-3495(62)86836-2; Bozic AL, 2012, J BIOL PHYS, V38, P657, DOI 10.1007/s10867-012-9278-4; Cadena-Nava RD, 2012, J VIROL, V86, P3318, DOI 10.1128/JVI.06566-11; Carrillo-Tripp M, 2009, NUCLEIC ACIDS RES, V37, pD436, DOI 10.1093/nar/gkn840; Chakravarty A, 2020, J VIROL, V94, DOI 10.1128/JVI.01794-19; Chang CB, 2008, ACS NANO, V2, P281, DOI 10.1021/nn700385z; Chatterji A, 2005, NANO LETT, V5, P597, DOI 10.1021/nl048007s; Dosta P, 2015, ACTA BIOMATER, V20, P82, DOI 10.1016/j.actbio.2015.03.029; Duran-Meza AL, 2020, MOLECULES, V25, DOI 10.3390/molecules25112628; Feng ZD, 2013, NATURE, V496, P367, DOI 10.1038/nature12029; Filion MC, 1997, BBA-BIOMEMBRANES, V1329, P345, DOI 10.1016/S0005-2736(97)00126-0; Garmann RF, 2014, J MOL BIOL, V426, P1050, DOI 10.1016/j.jmb.2013.10.017; Green JJ, 2007, NANO LETT, V7, P874, DOI 10.1021/nl062395b; Hagan MF, 2009, J CHEM PHYS, V130, DOI 10.1063/1.3086041; Henry DC, 1931, P R SOC LOND A-CONTA, V133, P106, DOI 10.1098/rspa.1931.0133; Hernando-Perez M, 2012, SMALL, V8, P2366, DOI 10.1002/smll.201200664; Hu YF, 2008, BIOPHYS J, V94, P1428, DOI 10.1529/biophysj.107.117473; JOHNSON MW, 1973, J GEN VIROL, V19, P263, DOI 10.1099/0022-1317-19-2-263; Langlet J, 2008, BIOPHYS J, V94, P3293, DOI 10.1529/biophysj.107.115477; Lavelle L, 2007, J VIROL METHODS, V146, P311, DOI 10.1016/j.jviromet.2007.07.020; Loredo-Tovias M, 2017, NANOSCALE, V9, P11625, DOI 10.1039/c7nr02118f; Michel JP, 2004, J VIROL METHODS, V122, P195, DOI 10.1016/j.jviromet.2004.09.005; Nunez-Rivera A, 2020, BEILSTEIN J NANOTECH, V11, P372, DOI 10.3762/bjnano.11.28; OHSHIMA H, 1995, COLLOID SURFACE A, V103, P249, DOI 10.1016/0927-7757(95)03293-M; PFEIFFER P, 1974, VIROLOGY, V61, P160, DOI 10.1016/0042-6822(74)90251-7; Prinsen P, 2010, J PHYS CHEM B, V114, P5522, DOI 10.1021/jp911040z; Singh R, 2008, ACS NANO, V2, P1040, DOI 10.1021/nn8000565; Suci PA, 2005, LANGMUIR, V21, P8686, DOI 10.1021/la050217c; van der Schoot P, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.061928; Vega-Acosta JR, 2014, J PHYS CHEM B, V118, P1984, DOI 10.1021/jp407379t	34	2	2	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2021	16	9							e0255820	10.1371/journal.pone.0255820	http://dx.doi.org/10.1371/journal.pone.0255820			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XM9EM	34506491	gold, Green Published			2022-12-26	WOS:000729120700132
J	Enbiale, M; Getie, A; Haile, F; Tekabe, B; Misekir, D				Enbiale, Mulusew; Getie, Asmare; Haile, Frehiwot; Tekabe, Beemnet; Misekir, Direslgn			Magnitude of syphilis sero-status and associated factors among pregnant women attending antenatal care in Jinka town public health facilities, Southern Ethiopia, 2020	PLOS ONE			English	Article							OUTCOMES; SEROPREVALENCE; CLINICS; RISK; HIV	Introduction Syphilis is one of the leading causes of perinatal morbidity and mortality and is one of the most important public health problems. There was no study showing syphilis serostatus and its related factors among pregnant women in the current study area. This study was aimed to assess the magnitude of syphilis serostatus and associated factors among pregnant women attending antenatal care in Jinka town public health facilities. Method Institution based cross-sectional study design was conducted in Jinka town public health facilities, southern Ethiopia from the 1(st) July to the 1(st) September, 2020. A systematic sampling technique was used to select 629 study subjects. Data were collected using a structured questionnaire through face-to-face interviews and records were reviewed to check syphilis test results. Data were coded and entered by using Epi-data version 4.432 and analyzed using SPSS version 25. The binary logistic regression model was used to investigate factors associated with syphilis. A p-value of < 0.05 at multivariable analysis was considered statistically significant. Result In this study, syphilis sero-prevalence among pregnant women attending antenatal care clinics was 4.8% (95% CI: 3.12, 6.48). Rural residence [AOR: 2.873; 95%CI (1.171, 7.050)], alcohol use [AOR: 3.340; 95% CI (1.354, 8.241)] and having multiple sexual partner [AOR: 5.012; 95% CI (1.929, 13.020)] were statistically significantly associated with syphilis. Conclusion Sero-prevalence of syphilis was high. Being a rural residence, having multiple sexual partners, alcohol use were factors associated with syphilis. Therefore, substantial efforts have to be made to provide regular health education for pregnant women at the antenatal clinic on the avoidance of risky behaviors and the risk of syphilis on their pregnancy.	[Enbiale, Mulusew; Haile, Frehiwot; Tekabe, Beemnet; Misekir, Direslgn] Arba Minch Univ, Sch Publ Hlth, Arba Minch, Ethiopia; [Getie, Asmare] Arba Minch Univ, Sch Nursing, Arba Minch, Ethiopia	Arba Minch University; Arba Minch University	Getie, A (corresponding author), Arba Minch Univ, Sch Nursing, Arba Minch, Ethiopia.	asmaregetie2017@gmail.com		Getie, Asmare/0000-0002-4078-0078				Amsalu A, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-2998-8; Baldeh AK, 2019, AFR J REPROD HEALTH, V23, P49, DOI 10.29063/ajrh2019/v23i3.5; Balla E, 2018, EUR J OBSTET GYN R B, V228, P274, DOI 10.1016/j.ejogrb.2018.07.022; Blencowe H, 2011, BMC PUBLIC HEALTH, V11, DOI [10.1186/1471-2458-11-S3-S9, 10.1186/1471-2458-11-S3-S11]; Cooper JM, 2018, SEMIN PERINATOL, V42, P176, DOI 10.1053/j.semperi.2018.02.005; Emmanuel SKea, 2010, PREVALENCE ASS FACTO; Endris M, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0848-5; Ethiopian Public Health Institute (EPHI), 2015, REP 2014 ROUND ANT C; Gomez GB, 2013, B WORLD HEALTH ORGAN, V91, P217, DOI 10.2471/BLT.12.107623; Hussen S, 2019, BIOMED RES INT, V2019, DOI 10.1155/2019/4562385; Korenromp EL, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0211720; Lawi JDT, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0434-2; Manyahi J, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1848-5; Melku M, 2015, HIV AIDS-RES PALLIAT, V7, P175, DOI 10.2147/HIV.S81481; Nessa A, 2011, J OBSTET GYNAECOL RE, V37, P1625, DOI 10.1111/j.1447-0756.2011.01587.x; Opone CA., 2019, TROP J OBSTET GYNAEC, V36, P224; Sakala Jacob, 2016, Pan Afr Med J, V24, P75; Benedetti KCSV, 2019, AM J TROP MED HYG, V101, P761, DOI 10.4269/ajtmh.18-0912; Tareke K, 2019, BMC RES NOTES, V12, DOI 10.1186/s13104-019-4106-6; Taylor MM, 2014, INT J STD AIDS, V25, P716, DOI 10.1177/0956462413518194; Trivedi S, 2020, J GLOB HEALTH, V10, DOI 10.7189/jogh.10.010504; WHO, 2017, GUID SYPH SCREEN TRE; Wijesooriya NS, 2016, LANCET GLOB HEALTH, V4, pE525, DOI 10.1016/S2214-109X(16)30135-8; World Health Organization, 2008, GLOB EL CONG SYPH RA; World Health Organization, 2018, REP GLOB SEX TRANSM; Yitbarek GY, 2019, J PREGNANCY, V2019, DOI 10.1155/2019/1584527; Zhang XH, 2019, BMC PREGNANCY CHILDB, V19, DOI 10.1186/s12884-019-2569-z; Zhou H, 2007, SEX TRANSM INFECT, V83, P476, DOI 10.1136/sti.2007.026187	28	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2021	16	9							e0257290	10.1371/journal.pone.0257290	http://dx.doi.org/10.1371/journal.pone.0257290			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XM9EM	34506600	gold, Green Published			2022-12-26	WOS:000729120700096
J	Kayambankadzanja, RK; Schell, CO; Mbingwani, I; Mndolo, SK; Castegren, M; Baker, T				Kayambankadzanja, Raphael Kazidule; Schell, Carl Otto; Mbingwani, Isaac; Mndolo, Samson Kwazizira; Castegren, Markus; Baker, Tim			Unmet need of essential treatments for critical illness in Malawi	PLOS ONE			English	Article							CRITICAL-CARE; BURDEN; MET	Background Critical illness is common throughout the world and has been the focus of a dramatic increase in attention during the COVID-19 pandemic. Severely deranged vital signs such as hypoxia, hypotension and low conscious level can identify critical illness. These vital signs are simple to check and treatments that aim to correct derangements are established, basic and low-cost. The aim of the study was to estimate the unmet need of such essential treatments for severely deranged vital signs in all adults admitted to hospitals in Malawi. Methods We conducted a point prevalence cross-sectional study of adult hospitalized patients in Malawi. All in-patients aged >= 18 on single days Queen Elizabeth Central Hospital (QECH) and Chiradzulu District Hospital (CDH) were screened. Patients with hypoxia (oxygen saturation <90%), hypotension (systolic blood pressure <90mmHg) and reduced conscious level (Glasgow Coma Scale <9) were included in the study. The a-priori defined essential treatments were oxygen therapy for hypoxia, intravenous fluid for hypotension and an action to protect the airway for reduced consciousness (placing the patient in the lateral position, insertion of an oro-pharyngeal airway or endo-tracheal tube or manual airway protection). Results Of the 1135 hospital in-patients screened, 45 (4.0%) had hypoxia, 103 (9.1%) had hypotension, and 17 (1.5%) had a reduced conscious level. Of those with hypoxia, 40 were not receiving oxygen (88.9%). Of those with hypotension, 94 were not receiving intravenous fluids (91.3%). Of those with a reduced conscious level, nine were not receiving an action to protect the airway (53.0%). Conclusion There was a large unmet need of essential treatments for critical illness in two hospitals in Malawi.	[Kayambankadzanja, Raphael Kazidule; Mbingwani, Isaac; Baker, Tim] Univ Malawi, Coll Med, Blantyre, Malawi; [Kayambankadzanja, Raphael Kazidule; Mndolo, Samson Kwazizira; Baker, Tim] Queen Elizabeth Cent Hosp, Dept Anaesthesia & Intens Care, Blantyre, Malawi; [Schell, Carl Otto; Baker, Tim] Karolinska Inst, Hlth Syst & Policy, Dept Global Publ Hlth, Stockholm, Sweden; [Schell, Carl Otto] Uppsala Univ, Ctr Clin Res Sormland, Eskilstuna, Sweden; [Schell, Carl Otto] Nykoping Hosp, Dept Internal Med, Nykoping, Sweden; [Mbingwani, Isaac] Chiradzulu Dist Hosp, Chiradzulu, Malawi; [Castegren, Markus] Karolinska Inst, CLINTEC & FyFa, Stockholm, Sweden; [Castegren, Markus; Baker, Tim] Karolinska Univ Hosp, Perioperat Med & Intens Care, Stockholm, Sweden	University of Malawi; University of Malawi; Karolinska Institutet; Uppsala University; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital	Kayambankadzanja, RK (corresponding author), Univ Malawi, Coll Med, Blantyre, Malawi.; Kayambankadzanja, RK (corresponding author), Queen Elizabeth Cent Hosp, Dept Anaesthesia & Intens Care, Blantyre, Malawi.	raphkazidule@gmail.com		MNDOLO, SAMSON/0000-0002-2483-8882; Baker, Tim/0000-0001-8727-7018; Kazidule Kayambankadzanja, Raphael/0000-0003-2242-8975; Schell, Carl Otto/0000-0002-7904-1336	Swedish Research Council; Association of Anaesthetists of Great Britain and Ireland; Laerdal Foundation; Martin Rinds Stiftelse; Life Support Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Association of Anaesthetists of Great Britain and Ireland; Laerdal Foundation; Martin Rinds Stiftelse; Life Support Foundation	TB received grants for the study from the Swedish Research Council, Laerdal Foundation, the Association of Anaesthetists of Great Britain and Ireland, Martin Rinds Stiftelse and Life Support Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikari NKJ, 2010, LANCET, V376, P1339, DOI 10.1016/S0140-6736(10)60446-1; Andrews B, 2017, JAMA-J AM MED ASSOC, V318, P1233, DOI 10.1001/jama.2017.10913; Baker T, 2020, LANCET, V395, P1253, DOI 10.1016/S0140-6736(20)30793-5; Baker T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144801; Bank W., 2020, SUPPORTING COUNTRIES; Bell MB, 2006, RESUSCITATION, V70, P66, DOI 10.1016/j.resuscitation.2005.11.011; Bolkan HA, 2015, SURGERY, V157, P992, DOI 10.1016/j.surg.2014.12.028; Friman O, 2019, ACTA ANAESTH SCAND, V63, P215, DOI 10.1111/aas.13245; Kellett J, 2017, EUR J INTERN MED, V45, P13, DOI 10.1016/j.ejim.2017.09.018; Kruk ME, 2018, LANCET GLOB HEALTH, V6, pE1196, DOI 10.1016/S2214-109X(18)30386-3; Maaloe N, 2021, LANCET GLOB HEALTH, V9, pE875, DOI 10.1016/S2214-109X(21)00059-0; Prin M, 2016, WORLD J SURG, V40, P2635, DOI 10.1007/s00268-016-3578-y; Rudd KE, 2018, JAMA-J AM MED ASSOC, V319, P2202, DOI 10.1001/jama.2018.6229; Schell CO, 2018, CRIT CARE, V22, DOI 10.1186/s13054-018-2219-2; Sutherland T, 2019, ANN AM THORAC SOC, V16, P1138, DOI 10.1513/AnnalsATS.201811-763QI; Vincent JL, 2014, LANCET RESP MED, V2, P380, DOI 10.1016/S2213-2600(14)70061-X; Wu ZY, 2020, JAMA-J AM MED ASSOC, V323, P1239, DOI 10.1001/jama.2020.2648	17	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2021	16	9							e0256361	10.1371/journal.pone.0256361	http://dx.doi.org/10.1371/journal.pone.0256361			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XM9EM	34506504	Green Published, Green Accepted, gold, Green Submitted			2022-12-26	WOS:000729120700104
J	Pan, T; Chen, XL; Hao, YP; Jiang, CW; Wang, S; Wang, JS; Wei, Q; Chen, SJ; Yu, XS; Cheng, F; Xu, LY				Pan, Ting; Chen, Xue-lian; Hao, Yan-ping; Jiang, Chun-wu; Wang, Song; Wang, Jin-shan; Wei, Qiang; Chen, Shi-juan; Yu, Xiao-song; Cheng, Feng; Xu, Liu-yi			Optimization of factors affecting the rooting of pine wilt disease resistant Masson pine (Pinus massoniana) stem cuttings	PLOS ONE			English	Article							BURSAPHELENCHUS-XYLOPHILUS; NEMATODE; GROWTH; MATURE	Pine wilt disease (PWD) is a devastating disease affecting trees belonging to the genus Pinus. To control the spread of PWD in the Masson pine forest in China, PWD resistant Masson pine clones have been selected by the Anhui Academy of Forestry. However, because Masson pine is a difficult-to-root species, producing seedlings is challenging, especially from trees older than 5 years of age, which impedes the application of PWD resistant clones. In this study, we investigated the factors affecting rooting of PWD resistant clones and established a cheap, reliable, and simple method that promotes rooting. We tested the effects of three management methods, four substrates, two cutting materials, two cutting treatments, and three collection times on the rooting of cuttings obtained from 9-year-old PWD resistant clones. Rooting was observed only in stem cuttings treated with the full-light automatic spray management method. Additionally, stem cuttings showed a significantly higher rooting rate and root quality than needles cuttings. Compared with other substrates, stem cuttings planted in perlite produced the longest adventitious root and the highest total root length and lateral root number. Moreover, stem cuttings of PWD resistant clones collected in May showed a significantly higher rooting rate and root quality than those collected in June and July. Moreover, stem cuttings prepared with a horizontal cut while retaining the needles showed significantly higher rooting rate and root quality than those prepared with a diagonal cut while partly removing the needles. This study promotes the reproduction of seedlings of PWD-resistant Masson pine clones which helps control the spread of PWD, meanwhile, provides a technical reference for the propagation of mature pine trees via cuttings.	[Pan, Ting; Chen, Xue-lian; Hao, Yan-ping; Jiang, Chun-wu; Wang, Jin-shan; Wei, Qiang; Chen, Shi-juan; Yu, Xiao-song; Cheng, Feng; Xu, Liu-yi] Anhui Forestry Acad, Dept Forest Tree Genet Breeding, Hefei, Anhui, Peoples R China; [Pan, Ting; Chen, Xue-lian; Hao, Yan-ping; Jiang, Chun-wu; Wei, Qiang; Xu, Liu-yi] Key Lab State Forestry Adm Prevent & Control Pine, Hefei, Anhui, Peoples R China; [Wang, Song] Washan State Own Forest Farm Quanjiao, Chuzhou, Anhui, Peoples R China		Xu, LY (corresponding author), Anhui Forestry Acad, Dept Forest Tree Genet Breeding, Hefei, Anhui, Peoples R China.; Xu, LY (corresponding author), Key Lab State Forestry Adm Prevent & Control Pine, Hefei, Anhui, Peoples R China.	xly13856910135@163.com	hao, yan/HGB-0465-2022		National Key Research and Development Program of China [2017YFD0600301]; Fifth Batch of "Special Support Plan" of Anhui Province [T000522]	National Key Research and Development Program of China; Fifth Batch of "Special Support Plan" of Anhui Province	Xu L. [2017YFD0600301] National Key Research and Development Program of China https://service.most.gov.cn/index/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Xu L. [No. T000522] Fifth Batch of "Special Support Plan" of Anhui Province http://www.ahxf.gov.cn/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akakpo D. B., 2014, American Journal of Plant Sciences, V5, P313; Agullo-Anton MA, 2011, J PLANT GROWTH REGUL, V30, P100, DOI 10.1007/s00344-010-9174-8; Aumond ML, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01734; Busov VB, 2004, PLANTA, V218, P916, DOI 10.1007/s00425-003-1175-4; Cai W., 2005, ANHUI AGR SCI, V33, P248, DOI [10.3969/j.issn.0517-6611.2005.02.036, DOI 10.3969/J.ISSN.0517-6611.2005.02.036]; Chen H., 2005, J FUJIAN FORESTRY SC, P64, DOI [10.3969/j.issn.1002-7351.2005.02.016, DOI 10.3969/J.ISSN.1002-7351.2005.02.016]; Chen Y., 2012, CHINA FORESTRY SCI T, V26, P107, DOI [10.3969/j.issn.1000-8101.2012.05.028, DOI 10.3969/J.ISSN.1000-8101.2012.05.028]; Druege U, 2019, ANN BOT-LONDON, V123, P929, DOI 10.1093/aob/mcy234; ELIASSON L, 1978, PHYSIOL PLANTARUM, V43, P13, DOI 10.1111/j.1399-3054.1978.tb01560.x; Gao RH, 2017, ECOL EVOL, V7, P3455, DOI 10.1002/ece3.2642; Gao RH, 2015, ECOL EVOL, V5, P1702, DOI 10.1002/ece3.1326; Hartmann H. T., 2011, PLANT PROPAGATION PR; He B., 2004, GUANGDONG FORESTRY S, P16, DOI [10.3969/j.issn.1006-4427.2004.01.004, DOI 10.3969/J.ISSN.1006-4427.2004.01.004]; Hirao T, 2019, BMC PLANT BIOL, V19, DOI 10.1186/s12870-019-2045-y; Hu G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036432; Ji K., 1998, J NANJING FORESTRY U, P3, DOI [10.3969/j.jssn.1000-2006.1998.03.015, DOI 10.3969/J.JSSN.1000-2006.1998.03.015]; Ji K., 1997, SCI SILVAE SINICAE, P47; Kiyohara T., 1971, Journal of the Japanese Forestry Society, V53, P210; Li J., 1993, FORESTRY RES, P493; Li X., 2020, FOREST PEST DIS, V39, P44, DOI [10.19688/j.cnki.issn1671-0886.20200013, DOI 10.19688/J.CNKI.ISSN1671-0886.20200013]; Li YongJin, 2010, Journal of Zhejiang Forestry College, V27, P507; Lin W A., 2000, ACTA AGRIC UNIV JIAN, V22, P294, DOI [10.3969/j.issn.1000-2286.2000.03.017, DOI 10.3969/J.ISSN.1000-2286.2000.03.017]; Liu B, 2021, PLANT CELL ENVIRON, V44, P257, DOI 10.1111/pce.13873; Liu QH, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04944-7; Liu W., 2007, GUANGXI FORESTRY SCI, V36, P93, DOI [10.3969/j.issn.1006-1126.2007.02.008, DOI 10.3969/J.ISSN.1006-1126.2007.02.008]; Nakai A, 2009, ECOL RES, V24, P1057, DOI 10.1007/s11284-009-0583-8; Niu J., 1995, NEW RURAL TECHNOLOGY, P10; OKU H, 1980, NATURWISSENSCHAFTEN, V67, P198, DOI 10.1007/BF01086307; Pan T., 2016, ANHUI FORESTRY SCI T, V42, P13, DOI [10.3969/j.issn.2095-0152.2016.06.003, DOI 10.3969/J.ISSN.2095-0152.2016.06.003]; Proenca DN, 2017, MICROBIOLOGYOPEN, V6, DOI 10.1002/mbo3.415; Qin G., 1993, FORESTRY SCI TECHNOL, P11; Rapaka VK, 2005, PLANT SCI, V168, P1547, DOI 10.1016/j.plantsci.2005.02.006; Schmitz D., 2013, American Journal of Plant Sciences, V4, P955, DOI 10.4236/ajps.2013.45118; Shi J, 2007, J INTEGR PLANT BIOL, V49, P1763, DOI 10.1111/j.1744-7909.2007.00613.x; Sun Y., 1982, JIANGSU SCI TECHNOL, V04, P47; Swamy SL, 2002, AGROFOREST SYST, V55, P231, DOI 10.1023/A:1020579516144; Tan J., 2006, GUANGXI SCI, P228, DOI [10.3969/j.issn.1005-9164.2006.03.020, DOI 10.3969/J.ISSN.1005-9164.2006.03.020]; Toda T, 2002, SILVAE GENET, V51, P42; Tombesi S, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00973; Wang Y, 2019, BIOTECH HISTOCHEM, V94, P546, DOI 10.1080/10520295.2019.1608468; Wu J., 2007, HUNAN FORESTRY SCI T, P4, DOI [10.3969/j.issn.1003-5710.2007.06.002, DOI 10.3969/J.ISSN.1003-5710.2007.06.002]; Xavier A., 2002, CLONAL FORESTRY 1 PR; Xu L., 2006, J ANHUI AGR SCI, V34, P119, DOI [10.3969/j.issn.0517-6611.2006.17.057, DOI 10.3969/J.ISSN.0517-6611.2006.17.057]; Xu L.-Y., 2012, CHINA SCI TECHNOL, V26, P27, DOI DOI 10.3969/J.ISSN.1000-8101.2012.04.007; Xu LiuYi, 2011, Journal of Anhui Agricultural University, V38, P848; Yu MJ, 2011, BIOL INVASIONS, V13, P1283, DOI 10.1007/s10530-010-9889-2; Zhang HB, 2010, TREE PHYSIOL, V30, P514, DOI 10.1093/treephys/tpp130; Zhao B.G., 2008, PINE WILT DISEASE, P18; Zhao LL, 2007, J CHEM ECOL, V33, P1207, DOI 10.1007/s10886-007-9289-y; Zhong W., 2014, GUIZHOU FORESTRY SCI, V42, P1; Zhou WL, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0241060; Zhu Lu-tao, 2010, Journal of Wuhan University of Technology, V32, P33, DOI 10.3963/j.issn.1671-4431.2010.18.009	53	1	1	21	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2021	16	9							e0251937	10.1371/journal.pone.0251937	http://dx.doi.org/10.1371/journal.pone.0251937			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XM9EM	34506505	Green Published, gold			2022-12-26	WOS:000729120700053
J	Samvelyan, HJ; Mathers, JC; Skerry, TM				Samvelyan, Hasmik Jasmine; Mathers, John Cummings; Skerry, Timothy Michael			Feeding intervention potentiates the effect of mechanical loading to induce new bone formation in mice	FASEB JOURNAL			English	Article						aging; analysis of bone; exercise; nutrition; osteoporosis	SERUM GROWTH-HORMONE; PARATHYROID-HORMONE; ADAPTIVE RESPONSE; SOMATIC GROWTH; ADULT HAMSTERS; CORTICAL BONE; LEPTIN; AGE; OSTEOBLASTS; RECEPTOR	The benefits of increased human lifespan depend upon duration of healthy, independent living; the healthspan. Bone-wasting disorders contribute significantly to loss of independence, frailty, and morbidity in older people. Therefore, there is an unmet need globally for lifestyle interventions to reduce the likelihood of bone fractures with age. Although many mechanisms are involved in disorders of bone loss, there is no single regulatory pathway and, therefore, there is no single treatment available to prevent their occurrence. Our aim in these studies was to determine whether fasting/feeding interventions alter the effect of mechanical loading on bone anabolic activities and increase bone mass. In young 17-week-old mice, 16-hour fasting period followed by reintroduction of food for 2 hours increased markedly the potency of mechanical loading, that mimics the effect of exercise, to induce new cortical bone formation. Consistent with this finding, fasting and re-feeding increased the response of bone to a loading stimulus that, alone, does not stimulate new bone formation in ad-lib fed mice. Older mice (20 months) experienced no potentiation of loading-induced bone formation with the same timing of feeding interventions. Interestingly, the pre-, prandial, and postprandial endocrine responses in older mice were different from those in young animals. The hormones that change in response to timing of feeding have osteogenic effects that interact with loading-mediated effects. Our findings indicate associations between timing of food ingestion and bone adaptation to loading. If translated to humans, such non-pharmacological lifestyle interventions may benefit skeletal health of humans throughout life-course and in older age.	[Samvelyan, Hasmik Jasmine; Mathers, John Cummings; Skerry, Timothy Michael] Univ Sheffield, MRC Versus Arthrit Ctr Integrated Res Musculoskel, CIMA, Sheffield, S Yorkshire, England; [Samvelyan, Hasmik Jasmine; Skerry, Timothy Michael] Univ Sheffield, Mellanby Ctr Bone Res, Med Sch, Dept Oncol & Metab, Sheffield, S Yorkshire, England; [Mathers, John Cummings] Newcastle Univ, Human Nutr Res Ctr, Ctr Healthier Lives, Populat Hlth Sci Inst, Newcastle Upon Tyne, Tyne & Wear, England; [Samvelyan, Hasmik Jasmine] Anglia Ruskin Univ, Fac Hlth Educ Med & Social Care, Sch Med, Chelmsford, Essex, England	University of Sheffield; University of Sheffield; Newcastle University - UK; Anglia Ruskin University	Skerry, TM (corresponding author), Univ Sheffield, Med Sch, Dept Oncol & Metab, Beech Hill Rd, Sheffield S10 2RX, S Yorkshire, England.	t.skerry@sheffield.ac.uk		Mathers, John/0000-0003-3406-3002; Skerry, Timothy/0000-0003-1319-5575; Samvelyan, Jasmine/0000-0001-9576-8001	CIMA [MR/K006312/1]	CIMA(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	CIMA, Grant/Award Number: MR/ K006312/1	Ahima RS, 1996, NATURE, V382, P250, DOI 10.1038/382250a0; Ahren B, 1997, AM J PHYSIOL-REG I, V273, pR113, DOI 10.1152/ajpregu.1997.273.1.R113; Asakawa A, 2001, GASTROENTEROLOGY, V120, P337, DOI 10.1053/gast.2001.22158; Bollag RJ, 2000, ENDOCRINOLOGY, V141, P1228, DOI 10.1210/en.141.3.1228; Bonnet N., 2010, IBMS BONEKEY, V7, P235, DOI [10.1138/20100453, DOI 10.1138/20100453]; Borer KT, 2019, NUTRIENTS, V11, DOI 10.3390/nu11071494; BORER KT, 1979, NEUROENDOCRINOLOGY, V29, P22, DOI 10.1159/000122901; BORER KT, 1978, AM J PHYSIOL, V234, pE611, DOI 10.1152/ajpendo.1978.234.6.E611; BORER KT, 1977, GROWTH, V41, P1; Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141; Cornish J, 1996, CALCIFIED TISSUE INT, V59, P492, DOI 10.1007/BF00369216; D'Amour P, 2012, CLIN BIOCHEM, V45, P964, DOI 10.1016/j.clinbiochem.2012.04.029; de Paula FJA, 2013, BONE RES, V1, DOI 10.4248/BR201301005; De Souza RL, 2005, BONE, V37, P810, DOI 10.1016/j.bone.2005.07.022; Dempster DW, 2013, J BONE MINER RES, V28, P1, DOI 10.1002/jbmr.1805; Elefteriou F, 2005, CELL MOL LIFE SCI, V62, P2339, DOI 10.1007/s00018-005-5175-3; Fritton SP., 2001, BONE MECH HDB, V8, P8, DOI 10.1201/b14263-11; Frost H. M., 2003, Journal of Musculoskeletal & Neuronal Interactions, V3, P136; Fukushima N, 2005, J BONE MINER RES, V20, P790, DOI 10.1359/JBMR.041237; Fulzele K, 2007, J BIOL CHEM, V282, P25649, DOI 10.1074/jbc.M700651200; Govoni Kristen E, 2012, Curr Mol Pharmacol, V5, P143; Hamrick MW, 2008, OSTEOPOROSIS INT, V19, P905, DOI 10.1007/s00198-007-0487-9; He W, 2016, P95161 US CENS BUR; HILLAM RA, 1995, J BONE MINER RES, V10, P683; Kim CH, 2003, J BONE MINER RES, V18, P2116, DOI 10.1359/jbmr.2003.18.12.2116; Kojima M, 2005, PHYSIOL REV, V85, P495, DOI 10.1152/physrev.00012.2004; Konda NN, 2019, NPJ MICROGRAVITY, V5, DOI 10.1038/s41526-019-0073-4; LANYON LE, 1986, CALCIFIED TISSUE INT, V38, P209, DOI 10.1007/BF02556712; Li J, 2003, ENDOCRINOLOGY, V144, P1226, DOI 10.1210/en.2002-220821; Ma YF, 1999, J BONE MINER RES, V14, P439, DOI 10.1359/jbmr.1999.14.3.439; Meakin LB, 2014, J BONE MINER RES, V29, P1859, DOI 10.1002/jbmr.2222; Perrini S, 2010, J ENDOCRINOL, V205, P201, DOI 10.1677/JOE-09-0431; PUN KK, 1989, J BONE MINER RES, V4, P853; Sadler AM, 2013, LAB ANIM-UK, V47, P316, DOI 10.1177/0023677213494366; Sanz C, 2010, AM J PHYSIOL-ENDOC M, V298, pE634, DOI 10.1152/ajpendo.00460.2009; Schemitsch EH, 2019, J ORTHOP TRAUMA, V33, P292, DOI 10.1097/BOT.0000000000001444; Shibamoto A, 2018, INT J ORAL SCI, V10, DOI 10.1038/s41368-018-0009-y; Sugiyama T, 2008, BONE, V43, P238, DOI 10.1016/j.bone.2008.04.012; Sugiyama T, 2012, J BONE MINER RES, V27, P1784, DOI 10.1002/jbmr.1599; Thomas DM, 1998, BONE, V23, P181, DOI 10.1016/S8756-3282(98)00095-7; Thomas T, 1999, ENDOCRINOLOGY, V140, P1630, DOI 10.1210/en.140.4.1630; Trayhurn P, 1998, ARCH ANIM NUTR, V51, P177, DOI 10.1080/17450399809381917; Upadhyay J, 2015, METABOLISM, V64, P105, DOI 10.1016/j.metabol.2014.10.021; van der Velde M, 2012, ENDOCRINOLOGY, V153, P3593, DOI 10.1210/en.2012-1277; Wolff J, 1870, VIRCHOWS ARCH PATHOL, V50, P389, DOI [10.1007/BF01944490, DOI 10.1007/BF01944490]; Xie D, 2007, BONE, V40, P1352, DOI 10.1016/j.bone.2007.01.007; Yamada C, 2008, ENDOCRINOLOGY, V149, P574, DOI 10.1210/en.2007-1292; Zhong Q, 2007, AM J PHYSIOL-ENDOC M, V292, pE543, DOI 10.1152/ajpendo.00364.2006	48	1	1	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2021	35	10							e21792	10.1096/fj.202100334RR	http://dx.doi.org/10.1096/fj.202100334RR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	UZ5IH	34516688	Green Submitted, Green Accepted, hybrid			2022-12-26	WOS:000702238200030
J	Bidulka, P; Vestergaard, SV; Hlupeni, A; Kjaersgaard, A; Wong, AYS; Langan, SM; Schmidt, SAJ; Lyon, S; Christiansen, CF; Nitsch, D				Bidulka, Patrick; Vestergaard, Soren Viborg; Hlupeni, Admire; Kjaersgaard, Anders; Wong, Angel Y. S.; Langan, Sinead M.; Schmidt, Sigrun Alba Johannesdottir; Lyon, Susan; Christiansen, Christian Fynbo; Nitsch, Dorothea			Adverse outcomes after partner bereavement in people with reduced kidney function: Parallel cohort studies in England and Denmark	PLOS ONE			English	Article							MYOCARDIAL-INFARCTION; MORTALITY; RISK; DISEASE; DEATH; HEART; DIALYSIS; FAILURE; SPOUSE; WOMEN	Objectives To investigate whether partner bereavement is associated with adverse cardiovascular and kidney-related events in people with reduced kidney function. Design Two parallel matched cohort studies using linked routinely collected health data. Setting England (general practices and hospitals using linked Clinical Practice Research Datalink, Hospital Episode Statistics, and Office of National Statistics) and Denmark (hospitals and community pharmacies using the Danish National Patient, Prescription and Education Registries and the Civil Registration System). Participants Bereaved people with reduced kidney function (estimated glomerular filtration rate (eGFR) <60mL/min/1.73m(2) (England) or hospital-coded chronic kidney disease (Denmark)) and non-bereaved people with reduced kidney function similarly defined, matched on age, sex, general practice (England), and county of residence (Denmark) and followed-up from the bereavement date of the exposed person. Main outcome measures Cardiovascular disease (CVD) or acute kidney injury (AKI) hospitalization, or death. Results In people with reduced kidney function, we identified 19,820 (England) and 5,408 (Denmark) bereaved individuals and matched them with 134,828 (England) and 35,741 (Denmark) non-bereaved individuals. Among the bereaved, the rates of hospitalizations (per 1000 person-years) with CVD were 31.7 (95%-CI: 30.5-32.9) in England and 78.8 (95%-CI: 74.9-82.9) in Denmark; the rates of hospitalizations with AKI were 13.2 (95%-CI: 12.5-14.0) in England and 11.2 (95%-CI: 9.9-12.7) in Denmark; and the rates of death were 70.2 (95%-CI: 68.5-72.0) in England and 126.4 (95%-CI: 121.8-131.1) in Denmark. After adjusting for confounders, we found increased rates of CVD (England, HR 1.06 [95%-CI: 1.01-1.12]; Denmark, HR 1.10 [95%-CI: 1.04-1.17]), of AKI (England, HR 1.20 [95%-CI: 1.10-1.31]; Denmark HR 1.36 [95%-CI: 1.17-1.58]), and of death (England, HR 1.10 [95%-CI: 1.05-1.14]; Denmark HR 1.20 [95%-CI: 1.15-1.25]) in bereaved compared with non-bereaved people. Conclusions Partner bereavement is associated with an increased rate of CVD and AKI hospitalization, and death in people with reduced kidney function. Additional supportive care for this at-risk population may help prevent serious adverse events.	[Bidulka, Patrick; Hlupeni, Admire; Wong, Angel Y. S.; Langan, Sinead M.; Nitsch, Dorothea] London Sch Hyg & Trop Med, Dept Noncommunicable Dis Epidemiol, London, England; [Vestergaard, Soren Viborg; Kjaersgaard, Anders; Schmidt, Sigrun Alba Johannesdottir; Christiansen, Christian Fynbo] Aarhus Univ Hosp, Dept Clin Epidemiol, Aarhus, Denmark; [Schmidt, Sigrun Alba Johannesdottir] Aarhus Univ Hosp, Dept Dermatol, Aarhus, Denmark; [Lyon, Susan] Kidney Transplant Recipient, London, England; [Lyon, Susan] Widow Kidney Transplant Recipient, London, England	University of London; London School of Hygiene & Tropical Medicine; Aarhus University; Aarhus University	Bidulka, P (corresponding author), London Sch Hyg & Trop Med, Dept Noncommunicable Dis Epidemiol, London, England.	patrick.bidulka1@lshtm.ac.uk	Christiansen, Christian/ABE-9423-2021	Christiansen, Christian/0000-0002-0727-953X; Schmidt, Sigrun/0000-0001-5527-0698; Vestergaard, Soren Viborg/0000-0002-8445-7758; Nitsch, Dorothea/0000-0001-5767-248X; Langan, Sinead/0000-0002-7022-7441	Beckett Foundation - Wellcome Senior Clinical Fellowship in Science [205039/Z/16/Z]	Beckett Foundation - Wellcome Senior Clinical Fellowship in Science	The Danish analyses were partly funded by the Beckett Foundation. SML is funded by a Wellcome Senior Clinical Fellowship in Science (205039/Z/16/Z). For the purpose of Open Access, the author has applied a CC BY public copyright license to any Author Accepted Manuscript (AAM) version arising from this submission. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barron E., 2014, CHRONIC KIDNEY DIS P; Bhaskaran K, 2018, LANCET DIABETES ENDO, V6, P944, DOI [10.1016/S2213-8587(18)30288-2, 10.1016/s2213-8587(18)30288-2]; Culp S, 2016, J PAIN SYMPTOM MANAG, V51, P756, DOI 10.1016/j.jpainsymman.2015.11.017; Dhingra R, 2011, CIRC-HEART FAIL, V4, P138, DOI 10.1161/CIRCHEARTFAILURE.109.899070; Einio E, 2017, J EPIDEMIOL COMMUN H, V71, P599, DOI 10.1136/jech-2016-207987; Gustafsson TM, 1998, AGE AGEING, V27, P585, DOI 10.1093/ageing/27.5.585; Herrett E, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2350; Herrett E, 2015, INT J EPIDEMIOL, V44, P827, DOI 10.1093/ije/dyv098; HOLMES TH, 1967, J PSYCHOSOM RES, V11, P213, DOI 10.1016/0022-3999(67)90010-4; Hsu CY, 2008, KIDNEY INT, V74, P101, DOI 10.1038/ki.2008.107; Iwagami M, 2017, NEPHROL DIAL TRANSPL, V32, P142, DOI 10.1093/ndt/gfw318; JAGGER C, 1991, STAT MED, V10, P395, DOI 10.1002/sim.4780100311; Jensen VM, 2011, SCAND J PUBLIC HEALT, V39, P91, DOI 10.1177/1403494810394715; Jones BW, 2010, AM J HOSP PALLIAT ME, V27, P187, DOI 10.1177/1049909109349248; Khanfer R, 2011, BRAIN BEHAV IMMUN, V25, P1182, DOI 10.1016/j.bbi.2011.03.008; Kolhe NV, 2016, INT J CLIN PRACT, V70, P330, DOI 10.1111/ijcp.12774; Koren-Morag N, 2006, NEUROLOGY, V67, P224, DOI 10.1212/01.wnl.0000229099.62706.a3; Kottgen A, 2007, J AM SOC NEPHROL, V18, P1307, DOI 10.1681/ASN.2006101159; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Mahmoodi BK, 2014, STROKE, V45, P1925, DOI 10.1161/STROKEAHA.114.004900; Manor O, 2003, SOC SCI MED, V56, P405, DOI 10.1016/S0277-9536(02)00046-1; Martikainen P, 1996, AM J PUBLIC HEALTH, V86, P1087, DOI 10.2105/AJPH.86.8_Pt_1.1087; Martikainen P, 1996, J EPIDEMIOL COMMUN H, V50, P264, DOI 10.1136/jech.50.3.264; Meisinger C, 2006, EUR HEART J, V27, P1245, DOI 10.1093/eurheartj/ehi880; Mostofsky E, 2012, CIRCULATION, V125, P491, DOI 10.1161/CIRCULATIONAHA.111.061770; Nitsch D C.B., 2017, 1 NATL CKD AUDIT REP; PARKES CM, 1969, BMJ-BRIT MED J, V1, P740, DOI 10.1136/bmj.1.5646.740; Pottegard A, 2017, INT J EPIDEMIOL, V46, P798, DOI 10.1093/ije/dyw213; SCHAEFER C, 1995, AM J EPIDEMIOL, V141, P1142, DOI 10.1093/oxfordjournals.aje.a117387; Schmidt M, 2015, CLIN EPIDEMIOL, V7, P449, DOI 10.2147/CLEP.S91125; Schmidt M, 2014, EUR J EPIDEMIOL, V29, P541, DOI 10.1007/s10654-014-9930-3; Schmidt SAJ, 2017, CLIN INFECT DIS, V64, P572, DOI 10.1093/cid/ciw840; Stevens PE, 2013, ANN INTERN MED, V158, P825, DOI 10.7326/0003-4819-158-11-201306040-00007; Stroebe M, 2007, LANCET, V370, P1960, DOI 10.1016/S0140-6736(07)61816-9; Vestergaard S.V., 2021, COMP DIFFERENT ALGOR, DOI [10.2215/CJN.15691020, DOI 10.2215/CJN.15691020]; Vitlic A, 2014, IMMUN AGEING, V11, DOI 10.1186/1742-4933-11-13; von Kanel R, 2012, PSYCHOSOM MED, V74, P214, DOI 10.1097/PSY.0b013e3182408c14; White IR, 2010, STAT MED, V29, P2920, DOI 10.1002/sim.3944; Williamson EJ, 2020, NATURE, V584, P430, DOI 10.1038/s41586-020-2521-4; Wong AYS, 2020, BRIT J DERMATOL, V183, P321, DOI 10.1111/bjd.18740; YOUNG M, 1963, LANCET, V2, P454	41	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2021	16	9							e0257255	10.1371/journal.pone.0257255	http://dx.doi.org/10.1371/journal.pone.0257255			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XH8RH	34555018	Green Published, gold, Green Accepted			2022-12-26	WOS:000725694500023
J	Coratella, G; Longo, S; Rampichini, S; Doria, C; Borrelli, M; Limonta, E; Michielon, G; Ce, E; Esposito, F				Coratella, Giuseppe; Longo, Stefano; Rampichini, Susanna; Doria, Christian; Borrelli, Marta; Limonta, Eloisa; Michielon, Giovanni; Ce, Emiliano; Esposito, Fabio			Passive stretching decreases muscle efficiency in balance tasks	PLOS ONE			English	Article							SKELETAL-MUSCLE; ELECTROMECHANICAL DELAY; POSTURAL STABILITY; TIME-COURSE; FORCE; STIFFNESS; MECHANOMYOGRAM; RESPONSES; MIDDLE	The current study aimed to verify whether or not passive static stretching affects balance control capacity. Thirty-eight participants (19 women and 19 men) underwent a passive static stretching session, involving the knee extensor/flexor and dorsi/plantarflexor muscles, and a control session (no stretching, CTRL). Before (PRE), immediately after (POST), after 15 (POST15) and 30 min (POST30) from stretching (or rest in CTRL), balance control was evaluated under static and dynamic conditions, with open/closed eyes, and with/without somatosensory perturbation (foam under the feet). During tests, centre of pressure (CoP) sway area and perimeter and antero-posterior and medio-lateral sway mean speed were computed. Surface electromyography root mean square (sEMG RMS) was calculated from the vastus lateralis, biceps femoris, gastrocnemius medialis, and tibialis anterior muscles during MVC and during the balance tests. Hip flexion/extension and dorsi/plantarflexion range of motion (ROM), maximum voluntary contraction (MVC) and sEMG RMS during MVC were measured at the same time points. After stretching, ROM increased (approximate to 6.5%; P < 0.05), while MVC and sEMG RMS decreased (approximate to 9% and approximate to 7.5%, respectively; P < 0.05). Regardless of the testing condition, CoP sway area and the perimeter remained similar, while antero-posterior and medio-lateral sway mean speed decreased by approximate to 8% and approximate to 12%, respectively (P < 0.05). sEMG RMS during the balance tests increased in all muscles in POST (approximate to 7%, P < 0.05). All variables recovered in POST30. No changes occurred in CTRL. Passive static stretching did not affect the overall balance control ability. However, greater muscle activation was required to maintain similar CoP sway, thus suggesting a decrease in muscle efficiency.	[Coratella, Giuseppe; Longo, Stefano; Rampichini, Susanna; Doria, Christian; Borrelli, Marta; Limonta, Eloisa; Michielon, Giovanni; Ce, Emiliano; Esposito, Fabio] Univ Milan, Dept Biomed Sci Hlth SCIBIS, Milan, Italy; [Limonta, Eloisa; Ce, Emiliano; Esposito, Fabio] IRCCS Galeazzi Orthoped Inst, Milan, Italy	University of Milan; IRCCS Istituto Ortopedico Galeazzi	Coratella, G (corresponding author), Univ Milan, Dept Biomed Sci Hlth SCIBIS, Milan, Italy.	giuseppe.coratella@unimi.it	; Longo, Stefano/D-5486-2012; Esposito, Fabio/E-9340-2011	CORATELLA, GIUSEPPE/0000-0001-7523-9102; Longo, Stefano/0000-0001-5806-8305; Esposito, Fabio/0000-0002-4420-2611	Department of Biomedical Sciences for Health, Universita degli Studi di Milano	Department of Biomedical Sciences for Health, Universita degli Studi di Milano	The present study was funded by a dedicated grant (PSR Fondi Linea 2 -Tipologia A - 2019) assigned to FE and GM from the Department of Biomedical Sciences for Health, Universita degli Studi di Milano. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Avela J, 1999, J APPL PHYSIOL, V86, P1283, DOI 10.1152/jappl.1999.86.4.1283; Behm DG, 2004, MED SCI SPORT EXER, V36, P1397, DOI 10.1249/01.MSS.0000135788.23012.5F; Belkhiria-Turki L, 2014, J SPORT MED PHYS FIT, V54, P279; Bisconti AV, 2020, J PHYSIOL-LONDON, V598, P3645, DOI 10.1113/JP279866; Budini F, 2019, J MUSCULOSKEL NEURON, V19, P30; Budini F, 2017, EXP PHYSIOL, V102, P901, DOI 10.1113/EP086374; Ce E, 2018, SCAND J MED SCI SPOR, V28, P2443, DOI 10.1111/sms.13240; Ce E, 2020, MED SCI SPORT EXER, V52, P1294, DOI 10.1249/MSS.0000000000002255; Ce E, 2015, J ELECTROMYOGR KINES, V25, P469, DOI 10.1016/j.jelekin.2015.03.001; Cohen HS, 2019, J NEUROPHYSIOL, V122, P81, DOI 10.1152/jn.00819.2018; Cohen J.E., 1988, STAT POWER ANAL BEHA; Costa PB, 2009, J STRENGTH COND RES, V23, P141, DOI 10.1519/JSC.0b013e31818eb052; Esposito F, 2016, NEUROMUSCULAR DISORD, V26, P60, DOI 10.1016/j.nmd.2015.09.013; Esposito F, 2011, J ELECTROMYOGR KINES, V21, P795, DOI 10.1016/j.jelekin.2011.07.012; Esposito F, 2011, EUR J APPL PHYSIOL, V111, P485, DOI 10.1007/s00421-010-1659-4; Handrakis JP, 2010, J STRENGTH COND RES, V24, P825, DOI 10.1519/JSC.0b013e3181ad4f89; Hemmati L, 2016, ANN REHABIL MED-ARM, V40, P845, DOI 10.5535/arm.2016.40.5.845; Hermens HJ., 1999, EUROPEAN RECOMMENDAT, DOI DOI 10.1016/S1050-6411(00)00027-4; Hrysomallis C, 2011, SPORTS MED, V41, P221, DOI 10.2165/11538560-000000000-00000; Lee IC, 2018, GAIT POSTURE, V59, P117, DOI 10.1016/j.gaitpost.2017.09.014; Lewis NL, 2009, ARCH PHYS MED REHAB, V90, P454, DOI 10.1016/j.apmr.2008.09.570; Lima BN, 2014, J SPORT SCI MED, V13, P564; Longo S, 2014, EXP PHYSIOL, V99, P1359, DOI 10.1113/expphysiol.2014.080366; Magnusson SP, 1996, J PHYSIOL-LONDON, V497, P291, DOI 10.1113/jphysiol.1996.sp021768; Nelson AG, 2012, J STRENGTH COND RES, V26, P3095, DOI 10.1519/JSC.0b013e3182430185; Palmer TB, 2018, PHYSICIAN SPORTSMED, V46, P78, DOI 10.1080/00913847.2018.1421396; Paneroni M, 2020, SPORT SCI HLTH, DOI [10.1007/s11332-020-00694-8, DOI 10.1007/S11332-020-00694-8]; Pulverenti TS, 2020, J NEUROPHYSIOL, V123, P1896, DOI 10.1152/jn.00578.2019; Pulverenti TS, 2019, EUR J APPL PHYSIOL, V119, P2287, DOI 10.1007/s00421-019-04212-8; Rey MCB, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00631; Sung ES, 2018, J EXERC REHABIL, V14, P638, DOI 10.12965/jer.1836266.133; Trajano GS, 2017, SPORTS MED, V47, P1531, DOI 10.1007/s40279-017-0682-6; Venturelli M, 2019, J APPL PHYSIOL, V127, P376, DOI 10.1152/japplphysiol.00823.2018; Venturelli M, 2017, J APPL PHYSIOL, V122, P112, DOI 10.1152/japplphysiol.00721.2016; WIESENDANGER R, 1985, EXP BRAIN RES, V59, P105	35	1	1	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2021	16	9							e0256656	10.1371/journal.pone.0256656	http://dx.doi.org/10.1371/journal.pone.0256656			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YS4WS	34550984	gold, Green Published, Green Submitted			2022-12-26	WOS:000750679800006
J	Gomez-Salgado, J; Adanaque-Bravo, I; Ortega-Moreno, M; Allande-Cusso, R; Arias-Ulloa, CA; Ruiz-Frutos, C				Gomez-Salgado, Juan; Adanaque-Bravo, Ingrid; Ortega-Moreno, Monica; Allande-Cusso, Regina; Arturo Arias-Ulloa, Cristian; Ruiz-Frutos, Carlos			Psychological distress during the first phase of the COVID-19 pandemic in Ecuador: Cross-sectional study	PLOS ONE			English	Article							HEALTH-CARE; OUTBREAK; IMPACT	Background The effects of the COVID 19 pandemic on the mental health of citizens from Asia, Europe, or North America begin to be known, but there are fewer publications on its effects in Latin American countries. In this study, its impact in Ecuador is described, with data collected during the first phase of the pandemic. The objective of this study was to analyse the level of psychological distress in the population of Ecuador during the first phase of the COVID-19 pandemic. Methods and findings Cross-sectional observational study. The questionnaires were collected through an online self-developed questionnaire, between April 2 and May 17, 2020, using the non-probabilistic sampling methodology: snowball method. The variables considered were sociodemographic variables, physical symptoms, health status, COVID-19 contact history, preventive measures, and the General Health Questionnaire (GHQ-12). The percentage with high psychological distress (PD) (GHQ-12 >= 3) has been somewhat lower than that found in Europe, being women, young people, people with higher level of education, living without a partner, not living with children or children under 16 years of age, and with worse perception of health the groups with the highest PD. Differences have been observed with European studies regarding common symptoms, preventive measures to avoid contagion, percentage of infected relatives, or diagnostic tests performed. Conclusions The use of the same research instrument, validated in Europe and adapted to Ecuador, has facilitated the comparison of the found results and differences, which can be explained by socio-economic or cultural variables, the health system, level of information, or by preventive measures put in place to prevent the pandemic.	[Gomez-Salgado, Juan; Ruiz-Frutos, Carlos] Univ Huelva, Fac Labour Sci, Dept Sociol Social Work & Publ Hlth, Huelva, Spain; [Gomez-Salgado, Juan; Arturo Arias-Ulloa, Cristian; Ruiz-Frutos, Carlos] Univ Espiritu Santo, Safety & Hlth Postgrad Programme, Guayaquil, Ecuador; [Adanaque-Bravo, Ingrid] Escuela Super Politecn Litoral, Fac Engn Mech & Prod Sci, Guayaquil, Ecuador; [Ortega-Moreno, Monica] Univ Huelva, Fac Labour Sci, Dept Econ, Huelva, Spain; [Allande-Cusso, Regina] Univ Seville, Dept Nursing, Seville, Spain	Universidad de Huelva; Universidad de Especialidades Espiritu Santo; Escuela Superior Politecnica del Litoral; Universidad de Huelva; University of Sevilla	Gomez-Salgado, J (corresponding author), Univ Huelva, Fac Labour Sci, Dept Sociol Social Work & Publ Hlth, Huelva, Spain.; Gomez-Salgado, J (corresponding author), Univ Espiritu Santo, Safety & Hlth Postgrad Programme, Guayaquil, Ecuador.; Ortega-Moreno, M (corresponding author), Univ Huelva, Fac Labour Sci, Dept Econ, Huelva, Spain.	Salgado@uhu.es; Ortegamo@uhu.es	Gómez -Salgado, Juan/G-7252-2017; Ortega-Moreno, Mónica/AAA-8843-2020; Ortega, Monica/AHD-4873-2022; ALLANDE CUSSO, REGINA/Z-2152-2019	Gómez -Salgado, Juan/0000-0001-9053-7730; Ortega-Moreno, Mónica/0000-0003-3317-9898; ALLANDE CUSSO, REGINA/0000-0001-8325-0838				Alcover CM, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17207413; Benitez MA, 2020, HEALTH POLICY TECHN, V9, P525, DOI 10.1016/j.hlpt.2020.08.014; Bank World, 2020, COR NOT GEND BLIND S; Bermejo-Martins E, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18052253; Callejas D, 2020, CURR TROP MED REP, V7, P120, DOI 10.1007/s40475-020-00219-w; Chang D, 2020, LANCET RESP MED, V8, pE13, DOI 10.1016/S2213-2600(20)30066-7; Dagnino P, 2020, FRONT PSYCHIATRY, V11, DOI 10.3389/fpsyt.2020.591142; Dominguez-Salas S, 2020, HEALTHCARE-BASEL, V8, DOI 10.3390/healthcare8030190; Eurofound, 2020, LIV WORK COVID 19 CO; Gobierno de Ecuador, INF SIT 002 CAS COR; Gobierno de Ecuador, DECR EJEC; Gobierno de Ecuador, INF SITCOVID 19 EC; Gobierno de Ecuador, INF SIT 60 CAS COR E; Goldberg DP, 1997, PSYCHOL MED, V27, P191, DOI 10.1017/S0033291796004242; Gomez-Salgado J, 2021, BRAIN SCI, V11, DOI 10.3390/brainsci11030328; Gomez-Salgado J, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17113947; Gonzalez-Bustamante B, 2021, WORLD DEV, V137, DOI 10.1016/j.worlddev.2020.105180; Idler EL, 1997, J HEALTH SOC BEHAV, V38, P21, DOI 10.2307/2955359; Izaguirre-Torres D, 2020, MED HYPOTHESES, V143, DOI [10.1016/j.mehy.2020.109846, DOI 10.1016/J.MEHY.2020.109846]; Johns Hopkins University, COVID 19 DASHB CENT; Kang LJ, 2020, LANCET PSYCHIAT, V7, pE14, DOI 10.1016/S2215-0366(20)30047-X; Mahase E, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m408; Martinez L, 2020, DATA BRIEF, V32, DOI 10.1016/j.dib.2020.106287; Maunder R, 2003, CAN MED ASSOC J, V168, P1245; Monterrosa-Castro A, 2020, J INVEST MED, V68, P1228, DOI 10.1136/jim-2020-001456; Pappa S, 2020, BRAIN BEHAV IMMUN, V88, P901, DOI [10.1016/j.bbi.2020.05.026, 10.1016/j.bbi.2020.11.023]; Patel SKS, 2020, INDIAN J MICROBIOL, V60, P263, DOI 10.1007/s12088-020-00893-4; del Pino S, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12176930; Preti E, 2020, CURR PSYCHIAT REP, V22, DOI 10.1007/s11920-020-01166-z; Rishi P, 2020, INDIAN J MICROBIOL, V60, P420, DOI 10.1007/s12088-020-00908-0; Ruiz-Frutos C, 2021, SAFETY SCI, V133, DOI 10.1016/j.ssci.2020.104996; SCHWARTZ J, 2020, CLIN INFECT DIS, V71, P858, DOI DOI 10.1093/CID/CIAA255; Thakur V, 2020, BRAIN BEHAV IMMUN, V88, P952, DOI 10.1016/j.bbi.2020.04.062; da Silva FCT, 2021, PROG NEURO-PSYCHOPH, V104, DOI 10.1016/j.pnpbp.2020.110062; Wang CY, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17051729; World Health Organization, WHO DIR GEN OPEN REM; World Health Organization, 1 WORLD HLTH ORG; World Health Organization, COVID 19 GLOB; World Health Organization (WHO), 2005, STATEMENT 2 M INT HL; Wu P, 2009, CAN J PSYCHIAT, V54, P302, DOI 10.1177/070674370905400504; Wu ZY, 2020, JAMA-J AM MED ASSOC, V323, P1239, DOI 10.1001/jama.2020.2648; Xiang YT, 2020, LANCET PSYCHIAT, V7, P228, DOI 10.1016/S2215-0366(20)30046-8; Zhang BC, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0235458	43	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2021	16	9							e0257661	10.1371/journal.pone.0257661	http://dx.doi.org/10.1371/journal.pone.0257661			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	YS4WS	34551016	Green Published, gold			2022-12-26	WOS:000750679800038
J	Martoni, F; Blacket, MJ				Martoni, Francesco; Blacket, Mark J.			Description of an Australian endemic species of Trioza (Hemiptera: Triozidae) pest of the endemic tea tree, Melaleuca alternifolia (Myrtaceae)	PLOS ONE			English	Article							BIOLOGICAL-CONTROL; PLANT; GENUS; QUINQUENERVIA	Psyllids, also known as jumping plant lice, are phloem feeding Hemiptera that often show a strict species-specific relationship with their host plants. When psyllid-plant associations involve economically important crops, this may lead to the recognition of a psyllid species as an agricultural or horticultural pest. The Australian endemic tea tree, Melaleuca alternifolia (Maiden & Betche) Cheel., has been used for more than a century to extract essential oils and, long before that, as a traditional medicine by Indigenous Australian people. Recently, a triozid species has been found to damage the new growth of tea trees both in Queensland and New South Wales, raising interest around this previously undocumented pest. Furthermore, adults of the same species were also collected from Citrus plantations, leading to potential false-positive records of the exotic pest Trioza erytreae (Del Guercio 1918), the African Citrus psyllid. Here we describe for the first time Trioza melaleucae Martoni sp. nov. providing information on its distribution, host plant associations and phylogenetic relationships to other Trioza species. This work enables both morphological and molecular identification of this new species, allowing it to be recognized and distinguished for the first time from exotic pests as well as other Australian native psyllids. Furthermore, the haplotype network analysis presented here suggests a close relationship between Trioza melaleucae and the other Myrtaceae-feeding Trioza spp. from Australia, New Zealand, and Taiwan.	[Martoni, Francesco; Blacket, Mark J.] Agr Victoria Res, AgriBio Ctr, Bundoora, Vic, Australia		Martoni, F (corresponding author), Agr Victoria Res, AgriBio Ctr, Bundoora, Vic, Australia.	francesco.martoni@agriculture.vic.gov.au	Martoni, Francesco/AAB-1742-2019	Martoni, Francesco/0000-0001-8064-4460	Agriculture Victoria Research	Agriculture Victoria Research	Funding for this work was provided by Agriculture Victoria Research.	AgriFuturesAustralia, 2021, TEA TREE OIL OV; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Burckhardt D, 2021, EUR J TAXON, V736, P137, DOI 10.5852/ejt.2021.736.1257; Burckhardt D, 2014, FLA ENTOMOL, V97, P242, DOI 10.1653/024.097.0132; Carson CF, 2006, CLIN MICROBIOL REV, V19, P50, DOI 10.1128/CMR.19.1.50-62.2006; Center TD, 2006, BIOL CONTROL, V39, P363, DOI 10.1016/j.biocontrol.2006.08.009; Center TD, 2012, BIOCONTROL, V57, P151, DOI 10.1007/s10526-011-9390-6; Dale PJ., 1985, THESIS U AUCKLAND; Del Guercio G, 1918, L AGRICOLTURA COLONI, V12, P355; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Froggatt W. W., 1903, Proceedings of the Linnean Society of New South Wales, P315; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, P313, DOI 10.1098/rspb.2002.2218; Hollis D, 2004, AUSTR PSYLLOIDEA JUM; ICZN, 1999, INT CODE ZOOLOGICAL; Int Commission Zoological Nomencla, 2012, ZOOKEYS, P1, DOI 10.3897/zookeys.219.3944; Rendon-Mera DI, 2017, ZOOTAXA, V4350, P436, DOI 10.11646/zootaxa.4350.3.2; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Leigh JW, 2015, METHODS ECOL EVOL, V6, P1110, DOI 10.1111/2041-210X.12410; Low T, 1990, BUSH MED PHARMACOPOE; Martoni F, 2021, NZ ENTOMOL, V44, P9, DOI 10.1080/00779962.2021.1891849; Martoni F, 2020, INSECTS, V11, DOI 10.3390/insects11060354; Martoni F, 2019, AUSTRAL ENTOMOL, V58, P848, DOI 10.1111/aen.12419; MOORE K. M., 1964, PROC LINN SOC NEW S WALES, V89, P221; Ouvrard D, 2021, PSYLLIST THE WORLD P; Ouvrard D, 2015, SYST BIODIVERS, V13, P434, DOI 10.1080/14772000.2015.1046969; Percy DM, 2018, SYST ENTOMOL, V43, P762, DOI 10.1111/syen.12302; Plant Health Australia, 2019, BIOS PLAN TEA TREE I; Plant Health Australia, 2019, PLANT HLTH AUSTR DAT; Taylor G, 2008, AUST J ENTOMOL, V47, P330, DOI 10.1111/j.1440-6055.2008.00664.x; Taylor GS, 2020, B ENTOMOL RES, V110, P340, DOI 10.1017/S0007485319000695; Taylor GS, 2016, ZOOTAXA, V4073, P1, DOI 10.11646/zootaxa.4073.1.1; Taylor GS, 2011, ZOOTAXA, P1; Taylor GS, 2010, ZOOTAXA, P1; Taylor GS, 2014, INSECT SYST EVOL, V45, P283, DOI 10.1163/1876312X-00002107; Taylor GS, 2013, AUST J ENTOMOL, V52, P42, DOI 10.1111/j.1440-6055.2012.00872.x; Wang N, 2017, ANNU REV PHYTOPATHOL, V55, P451, DOI 10.1146/annurev-phyto-080516-035513; Yen AL., 1980, THESIS TROBE U	38	0	0	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2021	16	9							e0257031	10.1371/journal.pone.0257031	http://dx.doi.org/10.1371/journal.pone.0257031			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YS4WS	34550976	Green Published, gold			2022-12-26	WOS:000750679800012
J	Heltemes-Harris, LM; Hubbard, GK; LaRue, RS; Munro, SA; Yang, RD; Henzler, CM; Starr, TK; Sarver, AL; Kornblau, SM; Farrar, MA				Heltemes-Harris, Lynn M.; Hubbard, Gregory K.; LaRue, Rebecca S.; Munro, Sarah A.; Yang, Rendong; Henzler, Christine M.; Starr, Timothy K.; Sarver, Aaron L.; Kornblau, Steven M.; Farrar, Michael A.			Identification of mutations that cooperate with defects in B cell transcription factors to initiate leukemia	ONCOGENE			English	Article							STAT5 ACTIVATION; LYMPHOBLASTIC-LEUKEMIA; KAPPA-B; CBL-B; DIFFERENTIATION; GENE; TRANSFORMATION; RESISTANCE; DELETION; FAILURE	The transcription factors PAX5, IKZF1, and EBF1 are frequently mutated in B cell acute lymphoblastic leukemia (B-ALL). We demonstrate that compound heterozygous loss of multiple genes critical for B and T cell development drives transformation, including Pax5(+/-)xEbf1(+/-), Pax5(+/-)xikzf1(+/-), and Ebf1(+/-)xlkzf1(+/-) mice for B-ALL, or Tcf7(+/-)xlkzf1(+/-) mice for T-ALL. To identify genetic defects that cooperate with Pax5 and Ebf1 compound heterozygosity to initiate leukemia, we performed a Sleeping Beauty (SB) transposon screen that identified cooperating partners including gain-of-function mutations in Stat5b (similar to 65%) and Jak7 (similar to 68%), or loss-of-function mutations in Cblb (61%) and Myb (32%). These findings underscore the role of JAK/STAT5B signaling in B cell transformation and demonstrate roles for loss-of-function mutations in Cblb and Myb in transformation. RNA-Seq studies demonstrated upregulation of a PDK1>SGK3>MYC pathway; treatment of Pax5(+/-)xEbf1(+/- )leukemia cells with PDK1 inhibitors blocked proliferation in vitro. In addition, we identified a conserved transcriptional gene signature between human and murine leukemias characterized by upregulation of myeloid genes, most notably involving the GM-CSF pathway, that resemble a B cell/myeloid mixed-lineage leukemia. Thus, our findings identify multiple mechanisms that cooperate with defects in B cell transcription factors to generate either progenitor B cell or mixed B/myeloid-like leukemias.	[Heltemes-Harris, Lynn M.; Hubbard, Gregory K.; Farrar, Michael A.] Univ Minnesota, Ctr Immunol, Minneapolis, MN 55455 USA; [Heltemes-Harris, Lynn M.; Hubbard, Gregory K.; Starr, Timothy K.; Sarver, Aaron L.; Farrar, Michael A.] Univ Minnesota, Masonic Canc Ctr, Minneapolis, MN 55455 USA; [Heltemes-Harris, Lynn M.; Hubbard, Gregory K.; Farrar, Michael A.] Univ Minnesota, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA; [LaRue, Rebecca S.; Munro, Sarah A.; Yang, Rendong; Henzler, Christine M.] Univ Minnesota, Minnesota Supercomp Inst, Minneapolis, MN 55455 USA; [Starr, Timothy K.] Univ Minnesota, Dept Obstet Gynecol & Womens Hlth, Minneapolis, MN 55455 USA; [Kornblau, Steven M.] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA; [Yang, Rendong] Univ Minnesota, Hormel Inst, Austin, MN 55912 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Texas System; UTMD Anderson Cancer Center; University of Minnesota System	Farrar, MA (corresponding author), Univ Minnesota, Ctr Immunol, Minneapolis, MN 55455 USA.; Farrar, MA (corresponding author), Univ Minnesota, Masonic Canc Ctr, Minneapolis, MN 55455 USA.; Farrar, MA (corresponding author), Univ Minnesota, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA.	farra005@umn.edu	; yang, rendong/I-5552-2014	Starr, Timothy/0000-0002-6308-3451; yang, rendong/0000-0002-9512-2240; Heltemes Harris, Lynn/0000-0002-2668-8005; Kornblau, Steven/0000-0002-5990-9548; Farrar, Michael/0000-0002-5569-0366	Cancer Research Institute Investigator award; Leukemia and Lymphoma Society Scholar award; UMN Masonic Cancer center; NIH [RO1 CA232317]; Randy Shaver Cancer Research and Community Fund; Masonic Cancer Center; NCI [CA211249]; Masonic Cancer Center Support Grant [CA077598]; CPRIT MIRA RP [160693]; NIH/NCI [P50 CA100632-09]; NIH NCI [R21 CA216652]	Cancer Research Institute Investigator award; Leukemia and Lymphoma Society Scholar award(Leukemia and Lymphoma Society); UMN Masonic Cancer center; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Randy Shaver Cancer Research and Community Fund; Masonic Cancer Center; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Masonic Cancer Center Support Grant; CPRIT MIRA RP; NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank A. Rost, for technical assistance with mouse breeding; the University of Minnesota's Supercomputing Institute for providing computing and bioinformatic resources; Dr. Meinrad Busslinger (Pax5+/-), Dr. Rudolf Grosschedl (Ebf1-/-), Dr. Peter Johnson (Cebpa-/-), Dr. Andrew Wells (Ikzf1-/-) and Dr. David Largaespada (Rosa26LSLSB11T2/OncxRosa26LSL-SB11) for providing the indicated mouse strains. The results published here are in part based upon data generated by the Therapeutically Applicable Research to Generate Effective Treatments (TARGET) initiative, phs000218, managed by the NCI. This work was supported by a Cancer Research Institute Investigator award, a Leukemia and Lymphoma Society Scholar award, funding from the UMN Masonic Cancer center and grants from the NIH (RO1 CA232317) to MAF. TKS was supported by grants from the Randy Shaver Cancer Research and Community Fund, NIH NCI (R21 CA216652), and the Masonic Cancer Center. ALS was supported by NCI (CA211249) and Masonic Cancer Center Support Grant (CA077598). SMK was supported by CPRIT MIRA RP 160693 and NIH/NCI P50 CA100632-09.	Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Badger-Brown KM, 2013, LEUKEMIA, V27, P1146, DOI 10.1038/leu.2012.331; Beckmann PJ, 2019, CANCER RES, V79, P905, DOI 10.1158/0008-5472.CAN-18-1261; Castel P, 2016, CANCER CELL, V30, P229, DOI 10.1016/j.ccell.2016.06.004; Chen EY, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-128; Chen F, 2007, CANCER RES, V67, P11093, DOI 10.1158/0008-5472.CAN-07-1576; Chiang YPJ, 2000, NATURE, V403, P216, DOI 10.1038/35003235; Churchman ML, 2018, CANCER CELL, V33, P937, DOI 10.1016/j.ccell.2018.03.021; Dupuy AJ, 2009, CANCER RES, V69, P8150, DOI 10.1158/0008-5472.CAN-09-1135; Fahl SP, 2009, J IMMUNOL, V183, P5582, DOI 10.4049/jimmunol.0901187; Goetz CA, 2004, J IMMUNOL, V172, P4770, DOI 10.4049/jimmunol.172.8.4770; Heath V, 2004, BLOOD, V104, P1639, DOI 10.1182/blood-2003-11-3963; Heltemes-Harris LM, 2016, ONCOGENE, V35, P3454, DOI 10.1038/onc.2015.405; Heltemes-Harris LM, 2011, J EXP MED, V208, P1135, DOI 10.1084/jem.20101947; Katerndahl CDS, 2017, NAT IMMUNOL, V18, P694, DOI 10.1038/ni.3716; Kollmann S, 2019, LEUKEMIA, V33, P1583, DOI 10.1038/s41375-018-0369-5; Kornblau SM, 2009, BLOOD, V113, P154, DOI 10.1182/blood-2007-10-119438; Kuleshov MV, 2016, NUCLEIC ACIDS RES, V44, pW90, DOI 10.1093/nar/gkw377; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Lee YH, 1997, MOL CELL BIOL, V17, P6014, DOI 10.1128/MCB.17.10.6014; LIN HH, 1995, NATURE, V376, P263, DOI 10.1038/376263a0; Mullighan CG, 2008, NATURE, V453, P110, DOI 10.1038/nature06866; Mullighan CG, 2007, NATURE, V446, P758, DOI 10.1038/nature05690; Mullighan CG, 2014, HEMATOL-AM SOC HEMAT, P174, DOI 10.1182/asheducation-2014.1.174; Mullighan CG, 2009, NEW ENGL J MED, V360, P470, DOI 10.1056/NEJMoa0808253; Najafov A, 2011, BIOCHEM J, V433, P357, DOI 10.1042/BJ20101732; Oliveros J.C., 2007, VENNY INTERACTIVE TO; Papathanasiou P, 2003, IMMUNITY, V19, P131, DOI 10.1016/S1074-7613(03)00168-7; Prasad MAJ, 2015, BLOOD, V125, P4052, DOI 10.1182/blood-2014-12-617282; Roberts KG, 2014, NEW ENGL J MED, V371, P1005, DOI 10.1056/NEJMoa1403088; Sarver AL, 2021, LAB INVEST, V101, P701, DOI 10.1038/s41374-021-00573-x; Scott MC, 2018, CANCER RES, V78, P326, DOI 10.1158/0008-5472.CAN-17-0576; Shah S, 2013, NAT GENET, V45, P1226, DOI 10.1038/ng.2754; Tan J, 2013, CANCER DISCOV, V3, P1156, DOI 10.1158/2159-8290.CD-12-0595; Temiz NA, 2016, GENOME RES, V26, P119, DOI 10.1101/gr.188649.114; URBANEK P, 1994, CELL, V79, P901, DOI 10.1016/0092-8674(94)90079-5; van der Weyden L, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1586-1; VERBEEK S, 1995, NATURE, V374, P70, DOI 10.1038/374070a0; Wang JH, 1996, IMMUNITY, V5, P537, DOI 10.1016/S1074-7613(00)80269-1; WINANDY S, 1995, CELL, V83, P289, DOI 10.1016/0092-8674(95)90170-1; Xia YF, 2014, CANCER IMMUNOL RES, V2, P823, DOI 10.1158/2326-6066.CIR-14-0112; Xiao X, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2617-2; Zhou JJ, 2021, NAT IMMUNOL, V22, P460, DOI 10.1038/s41590-021-00888-3	43	3	3	1	3	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 28	2021	40	43					6166	6179		10.1038/s41388-021-02012-z	http://dx.doi.org/10.1038/s41388-021-02012-z		SEP 2021	14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	WO5HW	34535769	Green Accepted, Green Submitted			2022-12-26	WOS:000696766300001
J	Guo, XJ; Zhang, J; Wu, XL				Guo, Xiaojia; Zhang, Jing; Wu, Xueling			Spatio-temporal characteristics of the novel coronavirus attention network and its influencing factors in China	PLOS ONE			English	Article								The outbreak of a novel coronavirus pneumonia (COVID-19), wherein more than 200 million people have been infected and millions have died, poses a great threat to achieving the United Nations 2030 sustainable development goal (SDGs). Based on the Baidu index of 'novel coronavirus', this paper analyses the spatial and temporal characteristics of and factors that influenced the attention network for COVID-19 from January 9, 2020, to April 15, 2020. The study found that (1) Temporally, the attention in the new coronavirus network showed an upward trend from January 9 to January 29, with the largest increase from January 23 to January 29 and a peak on January 29, and then a slow downward trend. The level of attention in the new coronavirus network was basically flat when comparing January 22 and March 4. (2) Spatially, first, from the perspective of regional differences, the network attention in the eastern and central regions decreased in turn. The network users in the eastern region exhibited the highest attention to the new coronavirus, especially in Guangdong, Shandong, Jiangsu and other provinces and cities. The network attention in Tibet, Xinjiang, Qinghai and Ningxia in the western region was the lowest in terms of the national network attention. Second, from the perspective of interprovincial differences, the attention in the new coronavirus network was highly consistent with the Hu Huanyong line of China's population boundary. The east of the Hu Huanyong line is densely populated, and the network showed high concern, mostly ranking at the third to fifth levels. (3) The number of Internet users in the information technology field, the population, and the culture and age characteristics of individuals are important factors that influence the novel coronavirus attention network.	[Guo, Xiaojia; Zhang, Jing; Wu, Xueling] Shanxi Normal Univ, Coll Geog Sci, Taiyuan, Shanxi, Peoples R China; [Guo, Xiaojia] Chinese Acad Sci, Inst Geosci & Resources, Beijing, Peoples R China	Shanxi Normal University; Chinese Academy of Sciences	Zhang, J (corresponding author), Shanxi Normal Univ, Coll Geog Sci, Taiyuan, Shanxi, Peoples R China.	zhang15103443549@163.com		Guo, Xiaojia/0000-0001-8360-3656	Science and Technology Basic Resources Survey Project of China [2017FY101304]; Ministry of Education in China Liberal Arts and Social Sciences Foundation [20YJC630032]; Applied Basic Research Programs of Science and Technology Commission Foundation of Sichuan Province, Spatial Equity of Healthcare Resources in Sichuan Province Based on Precise Population Distribution and Spatial Behavioral Preference of Seeking Healthcare [2020YJ0428]	Science and Technology Basic Resources Survey Project of China; Ministry of Education in China Liberal Arts and Social Sciences Foundation; Applied Basic Research Programs of Science and Technology Commission Foundation of Sichuan Province, Spatial Equity of Healthcare Resources in Sichuan Province Based on Precise Population Distribution and Spatial Behavioral Preference of Seeking Healthcare	This study is sponsored by the Science and Technology Basic Resources Survey Project of China (2017FY101304), the Ministry of Education in China Liberal Arts and Social Sciences Foundation (20YJC630032), and the Applied Basic Research Programs of Science and Technology Commission Foundation of Sichuan Province, Spatial Equity of Healthcare Resources in Sichuan Province Based on Precise Population Distribution and Spatial Behavioral Preference of Seeking Healthcare (2020YJ0428). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2020, J ENG; [Anonymous], 2020, CLIN INFECT DIS, V20; [Anonymous], 2020, THE PEOPLES DAILY; Badran S, 2022, CLEFT PALATE-CRAN J, V59, P522, DOI 10.1177/10556656211014077; Benjamin-Chung J, 2021, AM J PUBLIC HEALTH, V111, P1078, DOI 10.2105/AJPH.2021.306177; Bernstein David N, 2022, Hand (N Y), V17, P1242, DOI 10.1177/15589447211017220; Bugra K., 2021, J MED VIROL; Chang ZY., 2020, TAKING ZHOUZHUANG AN; Chen JZ, 2022, NEURAL COMPUT APPL, V34, P2233, DOI 10.1007/s00521-021-06526-1; Elemam NM, 2021, CURR MED RES OPIN, V37, P929, DOI 10.1080/03007995.2021.1906637; Fang JC, 2021, FRONT PUBLIC HEALTH, V9, DOI 10.3389/fpubh.2021.685141; Gan JZ., 2021, S CHINA PREVENTIVE M, V47, P600; [高楠 Gao Nan], 2020, [自然资源学报, Journal of Natural Resources], V35, P1068; Gerhards C., 2021, INT J INFECT DIS, P107; Govindarajan KK, 2021, BRIT J SURG, V108, pE49, DOI 10.1093/bjs/znaa036; Guo XJ, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18083879; Jin SH, 2020, TOURISM MANAGE, V78, DOI 10.1016/j.tourman.2019.104070; Julian JA, 2021, ANN EMERG MED, V77, P654, DOI 10.1016/j.annemergmed.2021.02.011; Kumar S, 2021, INDIAN J RADIOL IMAG, V31, pS154, DOI 10.4103/ijri.IJRI_367_20; Lefrancq N, 2021, LANCET REG HEALTH-EU, V5, DOI 10.1016/j.lanepe.2021.100087; Li HQ., 2019, RESOURCES ENV ARID A, V33, P178; Li MC., 2021, HUMAN GEOGRAPHY, V36; Li P, 2021, MOL MED REP, V23, DOI 10.3892/mmr.2021.12081; Li YJ., 2020, ASIA PACIFIC TRADITI, V16, P15; [李玉恒 Li Yuheng], 2020, [中国科学院院刊, Bulletin of the Chinese Academy of Sciences], V35, P345; Ma XM., 2020, S ARCHITECTURE, P6, DOI [10.3969/j.issn.1000-0232.2020.04.006, DOI 10.3969/J.ISSN.1000-0232.2020.04.006]; National Health Commission of the People's Republic of China, NOT PROV NAM NEW COR; Olliaro P, 2021, LANCET INFECT DIS, V21, P769, DOI 10.1016/S1473-3099(21)00075-X; Prange P, 2021, ENERG ECON, V99, DOI 10.1016/j.eneco.2021.105282; Qian XS., 2021, FINANCIAL RES, V47, P4; Rischin A, 2021, INTERN MED J, V51, P788, DOI 10.1111/imj.15309; Sayeed S, 2021, JCPSP-J COLL PHYSICI, V31, P388, DOI 10.29271/jcpsp.2021.04.388; Shi F., 2020, SCI TECHNOLOGY IND, V20, P17; Steuwer B, 2021, INT J INFECT DIS, V105, DOI 10.1016/j.ijid.2021.02.038; Tian GZ., 2020, J SHAOGUAN U, V41, P100; Tu BZ, 2021, BMC INFECT DIS, V21, DOI 10.1186/s12879-020-05740-x; Ulhaq ZS, 2020, MED CLIN-BARCELONA, V155, P548, DOI 10.1016/j.medcli.2020.07.002; [王波 Wang Bo], 2013, [地理研究, Geographical Research], V32, P380; Wang L., 2021, DATA SCI MANAGEMENT, V2; Wang QH., 2021, J ANHUI ADM COLL, P63; Wang QL., 2021, J SW NORMAL U NATURA, V46, P64; Wen JM, 2019, CHINA TOURISM, V02, P197; Xiao JQ., 2007, CHINESE HLTH EC, P20; Yang J, 2021, J HOSP TOUR MANAG, V47, P35, DOI 10.1016/j.jhtm.2021.02.008; Yang J, 2020, J CLEAN PROD, V275, DOI 10.1016/j.jclepro.2020.123767; Zang HX., 2020, INT J FRONTIERS SOCI, V2; Zhang Shengyu, 2020, Clin Drug Investig, V40, P511, DOI 10.1007/s40261-020-00917-3; Zhao R., 2021, J HENAN U NATURAL SC, V51, P268; Zhao YL., 2021, FUTURE INTERNET, V13	49	0	0	13	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2021	16	9							e0257291	10.1371/journal.pone.0257291	http://dx.doi.org/10.1371/journal.pone.0257291			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	WG5YY	34529727	Green Published, gold			2022-12-26	WOS:000707071500045
J	Kim, SS; Hudgins, AD; Yang, JP; Zhu, YZ; Tu, ZD; Rosenfeld, MG; DiLorenzo, TP; Suh, Y				Kim, Seung-Soo; Hudgins, Adam D.; Yang, Jiping; Zhu, Yizhou; Tu, Zhidong; Rosenfeld, Michael G.; DiLorenzo, Teresa P.; Suh, Yousin			A comprehensive integrated post-GWAS analysis of Type 1 diabetes reveals enhancer-based immune dysregulation	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; T-CELLS; RISK; SUSCEPTIBILITY; MOUSE; LOCI; METAANALYSIS; CTLA4-IG; INSIGHTS; ISLETS	Type 1 diabetes (T1D) is an organ-specific autoimmune disease, whereby immune cell-mediated killing leads to loss of the insulin-producing beta cells in the pancreas. Genome-wide association studies (GWAS) have identified over 200 genetic variants associated with risk for T1D. The majority of the GWAS risk variants reside in the non-coding regions of the genome, suggesting that gene regulatory changes substantially contribute to T1D. However, identification of causal regulatory variants associated with T1D risk and their affected genes is challenging due to incomplete knowledge of non-coding regulatory elements and the cellular states and processes in which they function. Here, we performed a comprehensive integrated post-GWAS analysis of T1D to identify functional regulatory variants in enhancers and their cognate target genes. Starting with 1,817 candidate T1D SNPs defined from the GWAS catalog and LDlink databases, we conducted functional annotation analysis using genomic data from various public databases. These include 1) Roadmap Epigenomics, ENCODE, and RegulomeDB for epigenome data; 2) GTEx for tissue-specific gene expression and expression quantitative trait loci data; and 3) lncRNASNP2 for long non-coding RNA data. Our results indicated a prevalent enhancer-based immune dysregulation in T1D pathogenesis. We identified 26 high-probability causal enhancer SNPs associated with T1D, and 64 predicted target genes. The majority of the target genes play major roles in antigen presentation and immune response and are regulated through complex transcriptional regulatory circuits, including those in HLA (6p21) and non-HLA (16p11.2) loci. These candidate causal enhancer SNPs are supported by strong evidence and warrant functional follow-up studies.	[Kim, Seung-Soo; Hudgins, Adam D.; Yang, Jiping; Zhu, Yizhou; Suh, Yousin] Columbia Univ, Dept Obstet & Gynecol, Irving Med Ctr, New York, NY 10027 USA; [Tu, Zhidong] Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA; [Rosenfeld, Michael G.] Univ Calif San Diego, Howard Hughes Med Inst, Dept Med, La Jolla, CA 92093 USA; [DiLorenzo, Teresa P.] Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10467 USA; [DiLorenzo, Teresa P.] Albert Einstein Coll Med, Dept Med, Div Endocrinol, Bronx, NY 10467 USA; [DiLorenzo, Teresa P.] Albert Einstein Coll Med, Einstein Mt Sinai Diabet Res Ctr, Bronx, NY 10467 USA; [DiLorenzo, Teresa P.] Albert Einstein Coll Med, Fleischer Inst Diabet & Metab, Bronx, NY 10467 USA; [Suh, Yousin] Columbia Univ, Dept Genet & Dev, Irving Med Ctr, New York, NY 10027 USA	Columbia University; NewYork-Presbyterian Hospital; Icahn School of Medicine at Mount Sinai; Howard Hughes Medical Institute; University of California System; University of California San Diego; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Columbia University; NewYork-Presbyterian Hospital	Suh, Y (corresponding author), Columbia Univ, Dept Obstet & Gynecol, Irving Med Ctr, New York, NY 10027 USA.; Suh, Y (corresponding author), Columbia Univ, Dept Genet & Dev, Irving Med Ctr, New York, NY 10027 USA.	ys3214@cumc.columbia.edu		Kim, Seungsoo/0000-0002-6602-633X	National Institute of Health [AG069750, DK127778, AG055501, HL150521, AG061521, AG017242, AG056278, AG057341, AG057433, AG057706]; Global Consortium for Reproductive LoEquality [GCRLE-1320, GCRLE-1520]	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Global Consortium for Reproductive LoEquality	This work was supported by the National Institute of Health Grants to Y. Suh (AG069750, DK127778, AG055501, HL150521, AG061521, AG017242, AG056278, AG057341, AG057433, AG057706), and Grants from the Global Consortium for Reproductive LoEquality to Y. Suh (GCRLE-1320) and S. Kim (GCRLE-1520). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.ngevity and	Altshuler DM, 2015, NATURE, V526, P68, DOI 10.1038/nature15393; Ardlie KG, 2015, SCIENCE, V348, P648, DOI 10.1126/science.1262110; Atkinson MA, 2014, LANCET, V383, P69, DOI 10.1016/S0140-6736(13)60591-7; Barge-Schaapveld DQCM, 2011, AM J MED GENET A, V155A, P1066, DOI 10.1002/ajmg.a.33991; Barrett JC, 2009, NAT GENET, V41, P703, DOI 10.1038/ng.381; Bassi R, 2016, DIABETOLOGIA, V59, P21, DOI 10.1007/s00125-015-3766-6; Beer MA, 2020, ANNU REV GENOM HUM G, V21, P37, DOI 10.1146/annurev-genom-121719-010946; Ben Nasr M, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aam7543; Bochukova EG, 2010, NATURE, V463, P666, DOI 10.1038/nature08689; Boyle AP, 2012, GENOME RES, V22, P1790, DOI 10.1101/gr.137323.112; Bradfield JP, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002293; Charmet R, 2018, CARDIOVASC DIABETOL, V17, DOI 10.1186/s12933-018-0705-0; Clayton DG, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000540; Corradin O, 2014, GENOME RES, V24, P1, DOI 10.1101/gr.164079.113; Dellepiane S, 2018, PHARMACOL RES, V133, P1, DOI 10.1016/j.phrs.2018.04.018; Ernst J, 2012, NAT METHODS, V9, P215, DOI 10.1038/nmeth.1906; Fadason T, 2017, FRONT GENET, V8, DOI 10.3389/fgene.2017.00150; Farh KKH, 2015, NATURE, V518, P337, DOI 10.1038/nature13835; Ferris ST, 2014, IMMUNITY, V41, P657, DOI 10.1016/j.immuni.2014.09.012; Frumento D, 2017, J ENDOCRINOL INVEST, V40, P803, DOI 10.1007/s40618-017-0641-y; Gao P, 2019, P NATL ACAD SCI USA, V116, P7581, DOI 10.1073/pnas.1815336116; Ghanbari M, 2018, J HUM GENET, V63, P431, DOI 10.1038/s10038-017-0403-x; Heinz S, 2015, NAT REV MOL CELL BIO, V16, P144, DOI 10.1038/nrm3949; Hermann-Kleiter N, 2006, BLOOD, V107, P4841, DOI 10.1182/blood-2005-10-4044; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Hnisz D, 2013, CELL, V155, P934, DOI 10.1016/j.cell.2013.09.053; Hotta-Iwamura C, 2016, J LEUKOCYTE BIOL, V100, P65, DOI 10.1189/jlb.3MR1115-500R; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Igo RP, 2011, AM J NEPHROL, V33, P381, DOI 10.1159/000326763; Insel RA, 2015, DIABETES CARE, V38, P1964, DOI 10.2337/dc15-1419; Jin FL, 2013, NATURE, V503, P290, DOI 10.1038/nature12644; Kasela S, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006643; Krischer JP, 2015, DIABETOLOGIA, V58, P980, DOI 10.1007/s00125-015-3514-y; Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248; Lawson JM, 2008, CLIN EXP IMMUNOL, V154, P353, DOI 10.1111/j.1365-2249.2008.03810.x; Levine M, 2010, CURR BIOL, V20, pR754, DOI 10.1016/j.cub.2010.06.070; Li GL, 2012, CELL, V148, P84, DOI 10.1016/j.cell.2011.12.014; Lipner EM, 2015, J DIABETES RES, V2015, DOI 10.1155/2015/694107; Lizio M, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-014-0560-6; Lv Z, 2017, MUTAT RES-REV MUTAT, V771, P1, DOI 10.1016/j.mrrev.2016.10.002; MacArthur J, 2017, NUCLEIC ACIDS RES, V45, pD896, DOI 10.1093/nar/gkw1133; Machiela MJ, 2015, BIOINFORMATICS, V31, P3555, DOI 10.1093/bioinformatics/btv402; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; Meka RR, 2015, AUTOIMMUN REV, V14, P1131, DOI 10.1016/j.autrev.2015.08.001; Miao YR, 2018, NUCLEIC ACIDS RES, V46, pD276, DOI 10.1093/nar/gkx1004; Morahan G, 2012, CURR OPIN ENDOCRINOL, V19, P263, DOI 10.1097/MED.0b013e328355b7fe; Mosenden R, 2011, CELL SIGNAL, V23, P1009, DOI 10.1016/j.cellsig.2010.11.018; Musunuru K, 2010, NATURE, V466, P714, DOI 10.1038/nature09266; Nicolae DL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000888; Notkins AL, 2002, J BIOL CHEM, V277, P43545, DOI 10.1074/jbc.R200012200; Nyaga DM, 2018, FRONT GENET, V9, DOI 10.3389/fgene.2018.00535; Onengut-Gumuscu S, 2015, NAT GENET, V47, P381, DOI 10.1038/ng.3245; Parkkola A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188402; Pociot F, 2016, LANCET, V387, P2331, DOI 10.1016/S0140-6736(16)30582-7; Pugliese A, 2017, J CLIN INVEST, V127, P2881, DOI 10.1172/JCI94549; Rachid O, 2020, EXPERT OPIN INV DRUG, V29, P221, DOI 10.1080/13543784.2020.1727885; Ram Ramesh, 2016, J Immunol, V196, P3043, DOI 10.4049/jimmunol.1502056; Rao SSP, 2014, CELL, V159, P1665, DOI 10.1016/j.cell.2014.11.021; Richardson SJ, 2016, DIABETOLOGIA, V59, P2448, DOI 10.1007/s00125-016-4067-4; Sanyal A, 2012, NATURE, V489, P109, DOI 10.1038/nature11279; Schneider A, 2008, J IMMUNOL, V181, P7350, DOI 10.4049/jimmunol.181.10.7350; Slowikowski K, 2014, BIOINFORMATICS, V30, P2496, DOI 10.1093/bioinformatics/btu326; Smith MJ, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.123384; Stitzel ML, 2010, CELL METAB, V12, P443, DOI 10.1016/j.cmet.2010.09.012; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Tak YG, 2015, EPIGENET CHROMATIN, V8, DOI 10.1186/s13072-015-0050-4; Tan TT, 2014, CLIN REV ALLERG IMMU, V47, P234, DOI 10.1007/s12016-014-8440-0; Torn C, 2015, DIABETES, V64, P1818, DOI 10.2337/db14-1497; Trynka G, 2013, NAT GENET, V45, P124, DOI 10.1038/ng.2504; Veyrieras JB, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000214; Voltarelli JC, 2007, JAMA-J AM MED ASSOC, V297, P1568, DOI 10.1001/jama.297.14.1568	71	3	4	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2021	16	9							e0257265	10.1371/journal.pone.0257265	http://dx.doi.org/10.1371/journal.pone.0257265			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	WG5YY	34529725	Green Published, gold			2022-12-26	WOS:000707071500039
J	Nagy, K; Febel, H; Bazar, G; Grosz, G; Gaspar, R; Szucs, KF; Toth, T				Nagy, Katalin; Febel, Hedvig; Bazar, George; Grosz, Gyorgy; Gaspar, Robert; Szucs, Kalman Ferenc; Toth, Tamas			Non-invasive smooth muscle electromyography (SMEMG) as a novel monitoring technology of the gastrointestinal tract of awake, free-moving pigs-A pilot study	PLOS ONE			English	Article							SLOW-WAVE; DIETARY FIBER; MODEL; ENERGY; DIGESTIBILITY; INDOMETHACIN; PHYSIOLOGY; NUTRIENTS; DIGESTION	There are several mathematical models and measurements to determine the efficiency of the digestibility of different feedstuffs. However, there is lack of information regarding the direct methods or measurement techniques used to analyse the physical response of the different parts of the gastrointestinal tract (GIT) of growing pigs to different diets. Smooth muscle electromyography (SMEMG) is a non-invasive method for the measurement of gastrointestinal myoelectrical activity. In the present study, SMEMG methodology has been adapted from laboratory rats to pigs, and the effects of feedstuffs with control (CTR) or experimentally increased (EXP) amounts of fibre were investigated on gastrointestinal tract motility. Nine barrow pigs ((Danish Landrace x Danish Yorkshire) x Danish Duroc) were used (30 +/- 3 kg), and their CTR and EXP feedstuffs contained 29 and 49 g/kg crude fibre (CF), respectively. Myoelectric activities of the stomach, ileum and caecum were detected in the awake pigs by a pair of electrodes. The recorded myoelectric signals were analysed with fast Fourier transformation (FFT), and the spectra were expressed in GIT section-specific cycles per minutes (cpm) values and the maximum power spectrum density (PsD(max)). A significant increase (P < 0.001) was observed in the value of the PsD(max) of the small intestine (20-25 cpm) as a consequence of the EXP diet. The PsDmax values of the stomach (3-5 cpm) and large intestine (1-3 cpm) did not show any significant change in pigs fed the EXP diet. As a direct and non-invasive method, SMEMG is suitable for the rapid evaluation of the effects of diets with different fibre contents on the GIT of non-anaesthetised, free-moving pigs.	[Nagy, Katalin; Bazar, George; Toth, Tamas] Hungarian Univ Agr & Life Sci, Inst Anim Physiol & Nutr, Kaposvar, Hungary; [Febel, Hedvig] Hungarian Univ Agr & Life Sci, Inst Anim Physiol & Nutr, Herceghalom, Hungary; [Bazar, George; Toth, Tamas] ADEXGO Kft, Balatonfured, Hungary; [Grosz, Gyorgy] MSB MET Kft, Balatonfured, Hungary; [Gaspar, Robert; Szucs, Kalman Ferenc] Univ Szeged, Fac Med, Dept Pharmacol & Pharmacotherapy, Szeged, Hungary	Hungarian University of Agriculture & Life Sciences; Hungarian University of Agriculture & Life Sciences; Szeged University	Bazar, G (corresponding author), Hungarian Univ Agr & Life Sci, Inst Anim Physiol & Nutr, Kaposvar, Hungary.; Bazar, G (corresponding author), ADEXGO Kft, Balatonfured, Hungary.	bazar@agrilab.hu		Szucs, Kalman Ferenc/0000-0002-5878-4691	Ministry of Human Capacities, Hungary [EFOP-3.6.3-VEKOP-16-2017-00005]; Szechenyi Istvan University; Hungarian University of Agricultural and Life Sciences	Ministry of Human Capacities, Hungary; Szechenyi Istvan University; Hungarian University of Agricultural and Life Sciences	This publication was prepared within the framework of the predoctoral scholarship program of the Ministry of Human Capacities, Hungary (project number: EFOP-3.6.3-VEKOP-16-2017-00005). The results discussed in this publication are the outcome of an independent research that was part of a PhD work. The conditions (stable, animals, human resources) were provided and financed by Szechenyi Istvan University and Hungarian University of Agricultural and Life Sciences, which has been recognized in the,Acknowledgements"section. Commercial R&D companies, ADEXGO Kft. and MSB-MET Kft. provided support in the form of salaries for authors [G. Bazar, Gy. Grosz, T. Toth], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the author contributions' section.	AOAC International, 2006, AOAC OFFICIAL METHOD; Bastianelli D, 1996, J ANIM SCI, V74, P1873; Bures J, 2011, HUM EXP TOXICOL, V30, P1955, DOI 10.1177/0960327111403174; Bures J, 2011, WORLD J GASTROENTERO, V17, P609, DOI 10.3748/wjg.v17.i5.609; CHEN JDZ, 1994, AM J PHYSIOL, V266, pG90, DOI 10.1152/ajpgi.1994.266.1.G90; Hocke M, 2009, AM J PHYSIOL-GASTR L, V296, pG709, DOI 10.1152/ajpgi.90318.2008; Jorgensen H, 1996, BRIT J NUTR, V75, P365, DOI 10.1079/BJN19960140; KARARLI TT, 1995, BIOPHARM DRUG DISPOS, V16, P351, DOI 10.1002/bdd.2510160502; Kopacova M, 2010, DIGEST DIS SCI, V55, P626, DOI 10.1007/s10620-009-0779-3; Kunes M, 2010, NEUROENDOCRINOL LETT, V31, P57; Kvetina J, 2008, NEUROENDOCRINOL LETT, V29, P763; Lahaye L, 2004, ANIM FEED SCI TECH, V113, P141, DOI 10.1016/j.anifeedsci.2003.07.005; Laplace J P, 1981, Prog Clin Biol Res, V77, P847; Le Goff G, 2001, J ANIM SCI, V79, P2418; Murakami Haruaki, 2013, J Smooth Muscle Res, V49, P78; NOBLET J, 1994, LIVEST PROD SCI, V37, P323, DOI 10.1016/0301-6226(94)90126-0; Obioha Chibuike, 2013, J Gastroenterol Hepatol Res, V2, P513; Prats-Boluda G, 2011, MED ENG PHYS, V33, P446, DOI 10.1016/j.medengphy.2010.11.009; Qin SJ, 2015, BIO-MED MATER ENG, V26, pS1515, DOI 10.3233/BME-151450; Rivest J, 2000, J ANIM SCI, V78, P328; SAUVANT D, 1992, REPROD NUTR DEV, V32, P217, DOI 10.1051/rnd:19920301; Sola-Oriol D, 2010, LIVEST SCI, V133, P67, DOI 10.1016/j.livsci.2010.06.027; Suenderhauf C, 2013, PHARM RES-DORDR, V30, P1, DOI 10.1007/s11095-012-0911-5; Szucs KF, 2018, LIFE SCI, V205, P1, DOI 10.1016/j.lfs.2018.05.015; Szucs KF, 2016, J PHARMACOL TOX MET, V82, P37, DOI 10.1016/j.vascn.2016.07.005; Tacheci I, 2013, BMC GASTROENTEROL, V13, DOI 10.1186/1471-230X-13-48; Tacheci I, 2010, DIGEST DIS SCI, V55, P2471, DOI 10.1007/s10620-009-1066-z; USRY JL, 1991, T ASAE, V34, P1879; van Leeuwen P, 2006, CURR NUTR FOOD SCI, V2, P97, DOI 10.2174/157340106775472001; Varayil J. E., 2009, FOLIA GASTROENTEROL, V7, P98; Wenk C, 2001, ANIM FEED SCI TECH, V90, P21, DOI 10.1016/S0377-8401(01)00194-8; Yin JY, 2013, J NEUROGASTROENTEROL, V19, P5, DOI 10.5056/jnm.2013.19.1.5	32	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2021	16	9							e0257311	10.1371/journal.pone.0257311	http://dx.doi.org/10.1371/journal.pone.0257311			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	WG6OR	34516588	Green Published, gold, Green Accepted			2022-12-26	WOS:000707114200027
J	Jo, DJ; Seo, EM				Jo, Dae-Jean; Seo, Eun-Min			Efficacy and radiographic analysis of oblique lumbar interbody fusion in treating adult spinal deformity	PLOS ONE			English	Article							DEGENERATIVE SCOLIOSIS; SURGICAL-TREATMENT; LATERAL APPROACH; OUTCOMES; PARAMETERS; COMPLICATIONS; DIFFERENCE; STRATEGIES	Adult spinal deformity (ASD) is usually rigid and requires a combined anterior-posterior approach for deformity correction. Anterior lumbar interbody fusion (ALIF) allows direct access to the disc space and placement of a large interbody graft. A larger interbody graft facilitates correction of ASD. However, an anterior approach carries significant risks. Lateral lumbar interbody fusion (LLIF) through a minimally invasive approach has recently been used for ASD. The present study was performed to evaluate the effectiveness of oblique lumbar interbody fusion (OLIF) in the treatment of ASD. We performed a retrospective study utilizing the data of 74 patients with ASD. The inclusion criteria were lumbar coronal Cobb angle > 20 degrees, pelvic incidence (PI)-lumbar lordosis (LL) mismatch > 10 degrees, and minimum follow-up of 2 years. Patients were divided into two groups: ALIF combined with posterior spinal fixation (ALIF+PSF) (n = 38) and OLIF combined with posterior spinal fixation (OLIF+PSF) (n = 36). The perioperative spinal deformity radiographic parameters, complications, and health-related quality of life (HRQoL) outcomes were assessed and compared between the two groups. The preoperative sagittal vertical axis (SVA), LL, PI-LL mismatch, and lumbar Cobb angles were similar between the two groups. Patients in the OLIF+PSF group had a slightly higher mean number of interbody fusion levels than those in the ALIF+PSF group. At the final follow-up, all radiographic parameters and HRQoL scores were similar between the two groups. However, the rates of perioperative complications were higher in the ALIF+PSF than OLIF+PSF group. The ALIF+PSF and OLIF+PSF groups showed similar radiographic and HRQoL outcomes. These observations suggest that OLIF is a safe and reliable surgical treatment option for ASD.	[Jo, Dae-Jean] Kyung Hee Univ, Hosp Gangdong, Spine Ctr, Dept Neurosurg, Seoul, South Korea; [Seo, Eun-Min] Hallym Univ, Chuncheon Sacred Heart Hosp, Coll Med, Dept Orthoped Surg, Chunchon, South Korea	Kyung Hee University; Kyung Hee University Hospital; Hallym University	Seo, EM (corresponding author), Hallym Univ, Chuncheon Sacred Heart Hosp, Coll Med, Dept Orthoped Surg, Chunchon, South Korea.	seoem@hallym.or.kr		Seo, Eun-Min/0000-0001-7964-9694				Acosta FL, 2011, J NEUROSURG-SPINE, V15, P92, DOI 10.3171/2011.3.SPINE10425; Aghayev K, 2013, EUR SPINE J, V22, P2113, DOI 10.1007/s00586-013-2931-1; Anand N, 2010, NEUROSURG FOCUS, V28, DOI 10.3171/2010.1.FOCUS09278; Bae J, 2018, J NEUROSURG-SPINE, V28, P40, DOI 10.3171/2017.5.SPINE161370; Baghdadi YMK, 2014, SPINE, V39, pE166, DOI 10.1097/BRS.0000000000000073; Baron EM, 2006, SPINE, V31, pS106, DOI 10.1097/01.brs.0000232713.69342.df; Bergey DL, 2004, SPINE, V29, P1681, DOI 10.1097/01.BRS.0000133643.75795.EF; Berjano P, 2012, EUR SPINE J, V21, pS37, DOI 10.1007/s00586-012-2217-z; Birknes JK, 2008, NEUROSURGERY, V63, pA94, DOI 10.1227/01.NEU.0000325485.49323.B2; Bradford DS, 1999, SPINE, V24, P2617, DOI 10.1097/00007632-199912150-00009; Burkus JK, 2002, J SPINAL DISORD TECH, V15, P337, DOI 10.1097/00024720-200210000-00001; Caputo AM, 2013, J CLIN NEUROSCI, V20, P1558, DOI 10.1016/j.jocn.2012.12.024; Cho MS, 2021, NEUROSURG REV, V44, P2181, DOI 10.1007/s10143-020-01390-4; Crandall DG, 2009, SPINE, V34, P2126, DOI 10.1097/BRS.0b013e3181b612db; Crawford CH, 2015, SPINE, V40, P377, DOI 10.1097/BRS.0000000000000761; Dakwar E, 2011, J NEUROSURG-SPINE, V14, P290, DOI 10.3171/2010.10.SPINE10395; Dakwar E, 2010, NEUROSURG FOCUS, V28, DOI 10.3171/2010.1.FOCUS09282; Dandaleh NS, 2014, NEUROSURG CLIN N AM, V25, P353, DOI 10.1016/j.nec.2013.12.013; Daubs MD, 2013, SPINE, V38, P476, DOI 10.1097/BRS.0b013e3182846eb3; Davis TT, 2011, J BONE JOINT SURG AM, V93A, P1482, DOI 10.2106/JBJS.J.00962; Dickson DD, 2014, SPINE, V39, P1190, DOI 10.1097/BRS.0000000000000380; Fujibayashi S, 2015, SPINE, V40, pE175, DOI 10.1097/BRS.0000000000000703; Glassman SD, 2005, SPINE, V30, P682, DOI 10.1097/01.brs.0000155425.04536.f7; Guerin P, 2012, SURG RADIOL ANAT, V34, P151, DOI 10.1007/s00276-011-0881-z; Hassanzadeh H, 2013, SPINE, V38, P726, DOI 10.1097/BRS.0b013e31827c2415; Isaacs RE, 2010, SPINE, V35, pS322, DOI 10.1097/BRS.0b013e3182022e04; Kim KT, 2018, NEUROSURG REV, V41, P355, DOI 10.1007/s10143-017-0927-8; Knight RQ, 2009, J SPINAL DISORD TECH, V22, P34, DOI 10.1097/BSD.0b013e3181679b8a; Lafage V, 2009, SPINE, V34, pE599, DOI 10.1097/BRS.0b013e3181aad219; Lippman Caleb R, 2003, Neurosurg Focus, V14, pe5; Liu S, 2016, SPINE J, V16, P210, DOI 10.1016/j.spinee.2015.10.043; Mundis GM, 2010, SPINE, V35, pS312, DOI 10.1097/BRS.0b013e318202495f; Nakamura H, 2000, J AM COLL SURGEONS, V191, P686, DOI 10.1016/S1072-7515(00)00716-X; Park P, 2015, J NEUROSURG-SPINE, V22, P374, DOI 10.3171/2014.9.SPINE131004; Phillips FM, 2013, SPINE, V38, P1853, DOI 10.1097/BRS.0b013e3182a43f0b; Schwab FJ, 2013, SPINE, V38, pE803, DOI 10.1097/BRS.0b013e318292b7b9; Sharma AK, 2011, J SPINAL DISORD TECH, V24, P242, DOI 10.1097/BSD.0b013e3181ecf995; Tempel ZJ, 2014, NEUROSURG FOCUS, V36, DOI 10.3171/2014.3.FOCUS13368; Than KD, 2011, NEUROSURG FOCUS, V31, DOI 10.3171/2011.7.FOCUS11141; Tormenti MJ, 2010, NEUROSURG FOCUS, V28, DOI 10.3171/2010.1.FOCUS09263; Vaccaro AR, 2012, J BONE JOINT SURG AM, V94A, P1088, DOI 10.2106/JBJS.K.00671; Williams E Lynne, 2002, Anesthesiol Clin North Am, V20, P605; Wood KB, 2010, SPINE, V35, pS66, DOI 10.1097/BRS.0b013e3181d83411; Zdeblick TA, 2000, SPINE, V25, P2682, DOI 10.1097/00007632-200010150-00023	44	3	3	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2021	16	9							e0257316	10.1371/journal.pone.0257316	http://dx.doi.org/10.1371/journal.pone.0257316			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XM9EM	34506593	gold, Green Published			2022-12-26	WOS:000729120700009
J	Kwok, ABC; Haering, R; Travers, SK; Stathis, P				Kwok, Alan B. C.; Haering, Ron; Travers, Samantha K.; Stathis, Peter			Trends in wildlife rehabilitation rescues and animal fate across a six-year period in New South Wales, Australia	PLOS ONE			English	Article							CENTERS; ADMISSION; OUTCOMES; MORBIDITY; MORTALITY; BIRDS; SURVEILLANCE; SALMONELLA; FREQUENCY; FACILITY	Globally, millions of animals are rescued and rehabilitated by wildlife carers each year. Information gathered in this process is useful for uncovering threats to native wildlife, particularly those from anthropogenic causes. However, few studies using rehabilitation data include a diverse range of fauna, cover large geographical areas, and consider long-term trends. Furthermore, few studies have statistically modelled causes of why animals come into care, and what are their chances of survival. This study draws on 469,553 rescues reported over six years by wildlife rehabilitators for 688 species of bird, reptile, and mammal from New South Wales, Australia. For birds and mammals, 'abandoned/orphaned' and 'collisions with vehicles' were the dominant causes for rescue, however for reptiles this was 'unsuitable environment'. Overall rescue numbers were lowest in winter, and highest in spring, with six-times more 'abandoned/orphaned' individuals in spring than winter. Of the 364,461 rescues for which the fate of an animal was known, 92% fell within two categories: 'dead', 'died or euthanased' (54.8% of rescues with known fate) and animals that recovered and were subsequently released (37.1% of rescues with known fate). Modelling of the fate of animals indicated that the likelihood of animal survival (i.e. chance of: being released, left and observed, or permanent care), was related to the cause for rescue. In general, causes for rescue involving physical trauma (collisions, attacks, etc.) had a much lower likelihood of animals surviving than other causes such as 'unsuitable environment', 'abandoned/orphaned', and this also showed some dependence upon whether the animal was a bird, reptile, or mammal. This suggests rehabilitation efforts could be focused on particular threats or taxa to maximise success, depending on the desired outcomes. The results illustrate the sheer volume of work undertaken by rehabilitation volunteers and professionals toward both animal welfare and to the improvement of wildlife rehabilitation in the future.	[Haering, Ron; Stathis, Peter] New South Wales Natl Pk & Wildlife Serv Ind & Env, New South Wales Dept Planning, Parramatta, Australia; [Travers, Samantha K.] New South Wales Dept Planning Ind & Environm, Parramatta, Australia; [Travers, Samantha K.] Univ New South Wales, Sch Biol Earth & Environm Sci, Ctr Ecosyst Sci, Sydney, NSW, Australia	University of New South Wales Sydney	Haering, R (corresponding author), New South Wales Natl Pk & Wildlife Serv Ind & Env, New South Wales Dept Planning, Parramatta, Australia.	ron.haering@environment.nsw.gov.au		Kwok, Alan/0000-0003-3212-2654				AAMI Insurance, 2019, AAMI AN CAR ACC DAT; Molina-Lopez RA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181331; Aslan L, 2018, INDIAN J ANIM RES, V52, P623, DOI 10.18805/ijar.B-877; Brown JD, 2002, J WILDLIFE DIS, V38, P699, DOI 10.7589/0090-3558-38.4.699; Burton E, 2016, ANIMALS, V6, DOI 10.3390/ani6090056; Camacho M, 2016, PREV VET MED, V130, P106, DOI 10.1016/j.prevetmed.2016.06.012; Clarke K.R., 2006, PRIMER V6 USER MANUA; Martinez JC, 2014, HYSTRIX, V25, P107, DOI 10.4404/hystrix-25.2-10248; DPIE, 2020, NSW VOL WILDL REH SE; Englefield B, 2018, WILDLIFE RES, V45, P103, DOI 10.1071/WR17099; Garces A, 2020, ANIMALS-BASEL, V10, DOI 10.3390/ani10081305; Garces A, 2019, BIRD STUDY, V66, P484, DOI 10.1080/00063657.2020.1726874; Garcia ME, 2007, VET MED-CZECH, V52, P464, DOI 10.17221/2049-VETMED; Goldsworthy SD, 2000, WILDLIFE RES, V27, P573, DOI 10.1071/WR99076; Green-Barber JM, 2019, BMC ZOOL, V4, DOI 10.1186/s40850-019-0047-8; Griffith JE, 2012, AUST VET J, V90, P457, DOI 10.1111/j.1751-0813.2012.00963.x; Griffith JE, 2013, J WILDLIFE DIS, V49, P18, DOI 10.7589/2012-05-135; Guy AJ, 2012, AUST MAMMAL, V34, P108, DOI 10.1071/AM10046; Haering Ron, 2021, Australian Zoologist, V41, P254, DOI 10.7882/AZ.2020.045; Haering Ron, 2020, Australian Zoologist, V40, P605, DOI 10.7882/AZ.2019.018; Hameau O, 2019, J ORNITHOL, V160, P581, DOI 10.1007/s10336-019-01633-2; Hanger J., 2005, NAT WILDL REH C GOLD; Harden J, 2002, J WILDLIFE REHABIL, V25, P4; Heathcote G, 2019, WILDLIFE RES, V46, P415, DOI 10.1071/WR18127; Janssen K, 2020, ANIMALS-BASEL, V10, DOI 10.3390/ani10091500; Jijon S, 2007, J ZOO WILDLIFE MED, V38, P409, DOI 10.1638/1042-7260(2007)38[409:SEIFWA]2.0.CO;2; Kelly A, 2006, J RAPTOR RES, V40, P231, DOI 10.3356/0892-1016(2006)40[231:ADAOFE]2.0.CO;2; Kelly G, 2020, J NAT CONSERV, V57, DOI 10.1016/j.jnc.2020.125897; Klocker U, 2006, WILDLIFE RES, V33, P5, DOI 10.1071/WR04066; Lloyd Hannah B., 2015, Australian Zoologist, V37, P492, DOI 10.7882/AZ.2015.015; Long RB, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0238805; Lopez G, 2011, VECTOR-BORNE ZOONOT, V11, P285, DOI 10.1089/vbz.2009.0232; Mariacher A, 2016, AVIAN BIOL RES, V9, P282, DOI 10.3184/175815516X14739467542487; McAlpine C, 2017, LANDSCAPE ECOL, V32, P663, DOI 10.1007/s10980-016-0479-2; Mo M, 2021, PAC CONSERV BIOL, V27, P61, DOI 10.1071/PC20031; Molina-Lopez RA, 2011, ANIM BIODIV CONSERV, V34, P401; Molina-Lopez RA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060242; Molina-Lopez RA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024603; Molony SE, 2007, ANIM WELFARE, V16, P361; Montesdeoca N, 2017, BIRD STUDY, V64, P523, DOI 10.1080/00063657.2017.1411464; Mullineaux E, 2014, J SMALL ANIM PRACT, V55, P293, DOI 10.1111/jsap.12213; NSW Department of Planning Industry and Environment, 2020, ANN REP 2017 18; NSW Office of Environment and Heritage, 2019, REV NSW VOL WILDL RE; NSW Office of Environment and Heritage, 2011, COD PRACT INJ SICK O; Oros J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149398; Orr B, 2018, AUST VET J, V96, P475, DOI 10.1111/avj.12765; Pyke GH, 2018, CONSERV BIOL, V32, P50, DOI 10.1111/cobi.12937; R Core Team, 2021, R LANGUAGE ENV STAT; Randall NJ, 2012, J WILDLIFE DIS, V48, P646, DOI 10.7589/0090-3558-48.3.646; Rodriguez B, 2010, J RAPTOR RES, V44, P30, DOI 10.3356/JRR-09-40.1; Scheelings TF, 2015, J WILDLIFE DIS, V51, P712, DOI 10.7589/2014-09-230; Schenk A., 2017, J VET SCI ANIM HUSBA, V5, P1; Schenk AN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093517; Schmidt-French B, 2006, J WILDLIFE REHABIL, V28, P6; Shine R, 2001, BIOL CONSERV, V102, P271, DOI 10.1016/S0006-3207(01)00102-1; Skaug H., 2018, GLMMADMB GEN LINEAR; Smith WA, 2002, J ZOO WILDLIFE MED, V33, P228, DOI 10.1638/1042-7260(2002)033[0228:SICWSP]2.0.CO;2; Taylor-Brown A, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0206958; Tribe Andrew, 2000, Human Dimensions of Wildlife, V5, P69; Turnbull D., 2007, NATL WILDLIFE REHABI; Vidal-Valles D, 2018, ANIM BIODIV CONSERV, V41, P379, DOI 10.32800/abc.2018.41.0379; Wimberger K, 2010, ANIM WELFARE, V19, P481	62	7	8	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2021	16	9							e0257209	10.1371/journal.pone.0257209	http://dx.doi.org/10.1371/journal.pone.0257209			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XM9EM	34506558	Green Published, gold			2022-12-26	WOS:000729120700121
J	Vo, PTD; Choi, SS; Park, HR; Lee, A; Jeong, SH; Choi, Y; Singh, K; Singh, K; Singh, K				Vo, Phuc Thi-Duy; Choi, Sun Shim; Park, Hae Ryoun; Lee, Ahreum; Jeong, Sung-Hee; Choi, Youngnim; Singh, Kanhaiya; Singh, Kanhaiya; Singh, Kanhaiya			Gene signatures associated with barrier dysfunction and infection in oral lichen planus identified by analysis of transcriptomic data	PLOS ONE			English	Article							LIQUEFACTION DEGENERATION; EXPRESSION; EPITHELIUM; CYTOKINE; DIFFERENTIATION	Oral lichen planus (OLP) is one of the most prevalent oral mucosal diseases, but there is no cure for OLP yet. The aim of this study was to gain insights into the role of barrier dysfunction and infection in OLP pathogenesis through analysis of transcriptome datasets available in public databases. Two transcriptome datasets were downloaded from the Gene Expression Omnibus database and analyzed as whole and as partial sets after removing outliers. Differentially expressed genes (DEGs) upregulated in the dataset of OLP versus healthy epithelium were significantly enriched in epidermal development, keratinocyte differentiation, keratinization, responses to bacterial infection, and innate immune response. In contrast, the upregulated DEGs in the dataset of the mucosa predominantly reflected chemotaxis of immune cells and inflammatory/immune responses. Forty-three DEGs overlapping in the two datasets were identified after removing outliers from each dataset. The overlapping DEGs included genes associated with hyperkeratosis (upregulated LCE3E and TMEM45A), wound healing (upregulated KRT17, IL36G, TNC, and TGFBI), barrier defects (downregulated FRAS1 and BCL11A), and response to infection (upregulated IL36G, ADAP2, DFNA5, RFTN1, LITAF, and TMEM173). Immunohistochemical examination of IL-36 gamma, a protein encoded by one of the DEGs IL36G, in control (n = 7) and OLP (n = 25) tissues confirmed the increased expression of IL-36 gamma in OLP. Collectively, we identified gene signatures associated with hyperkeratosis, wound healing, barrier defects, and response to infection in OLP. IL-36 gamma, a cytokine involved in both wound repair and antimicrobial defense, may be a possible therapeutic target in OLP.	[Vo, Phuc Thi-Duy; Lee, Ahreum; Choi, Youngnim] Seoul Natl Univ, Sch Dent, Dept Immunol & Mol Microbiol, Seoul, South Korea; [Vo, Phuc Thi-Duy; Lee, Ahreum; Choi, Youngnim] Seoul Natl Univ, Dent Res Inst, Seoul, South Korea; [Choi, Sun Shim] Kangwon Natl Univ, Inst Biosci & Biotechnol, Coll Biomed Sci, Div Biomed Convergence, Chunchon, Gangwon, South Korea; [Park, Hae Ryoun] Pusan Natl Univ, Dept Oral Pathol, Sch Dent, Yangsan, Gyeongnam, South Korea; [Jeong, Sung-Hee] Pusan Natl Univ, Dept Oral Med, Sch Dent, Dent & Life Sci Inst,Dent Res Inst, Yangsan, Gyeongnam, South Korea	Seoul National University (SNU); Seoul National University (SNU); Kangwon National University; Pusan National University; Pusan National University Hospital; Pusan National University; Pusan National University Hospital	Choi, Y (corresponding author), Seoul Natl Univ, Sch Dent, Dept Immunol & Mol Microbiol, Seoul, South Korea.; Choi, Y (corresponding author), Seoul Natl Univ, Dent Res Inst, Seoul, South Korea.; Jeong, SH (corresponding author), Pusan Natl Univ, Dept Oral Med, Sch Dent, Dent & Life Sci Inst,Dent Res Inst, Yangsan, Gyeongnam, South Korea.	drcookie@pusan.ac.kr; youngnim@snu.ac.kr		Choi, Youngnim/0000-0002-6496-5560	National Research Foundation of Korea (Daejun, Korea) [2018R1A5A2024418, 2020R1A2C2007038, 2019R1A2C1002350]	National Research Foundation of Korea (Daejun, Korea)	This study was supported by the National Research Foundation of Korea (Daejun, Korea) through the grants 2018R1A5A2024418 and 2020R1A2C2007038 awarded to Youngnim Choi and 2019R1A2C1002350 awarded to Sun Shim Choi. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Sadi R, 2009, FRONT BIOSCI-LANDMRK, V14, P2765, DOI 10.2741/3413; Baek K, 2018, MOL ORAL MICROBIOL, V33, P22, DOI 10.1111/omi.12197; Baek K, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-60449-w; Bascones-Ilundain C, 2007, CLIN EXP DERMATOL, V32, P556, DOI 10.1111/j.1365-2230.2007.02457.x; Bassoy EY, 2018, IMMUNOL REV, V281, P169, DOI 10.1111/imr.12610; BETZ P, 1993, INT J LEGAL MED, V105, P325, DOI 10.1007/BF01222116; Blumberg H, 2010, J IMMUNOL, V185, P4354, DOI 10.4049/jimmunol.1000313; Buhl AL, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01162; Chen XY, 2020, BMC BIOINFORMATICS, V21, DOI 10.1186/s12859-020-03608-0; D'Erme AM, 2015, J INVEST DERMATOL, V135, P1025, DOI 10.1038/jid.2014.532; Danielsson K, 2017, ACTA DERM-VENEREOL, V97, P214, DOI 10.2340/00015555-2533; Danielsson K, 2014, ACTA DERM-VENEREOL, V94, P526, DOI 10.2340/00015555-1803; Duell BL, 2012, J IMMUNOL, V188, P781, DOI 10.4049/jimmunol.1101231; Epp N, 2007, J CELL BIOL, V177, P173, DOI 10.1083/jcb.200612116; Gassling V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063015; Gonzalez-Moles MA, 2021, ORAL DIS, V27, P1908, DOI 10.1111/odi.13741; Gonzalez-Moles MA, 2021, ORAL DIS, V27, P813, DOI 10.1111/odi.13323; Hayez A, 2014, EXP DERMATOL, V23, P339, DOI 10.1111/exd.12403; Huber W, 2015, NAT METHODS, V12, P115, DOI [10.1038/NMETH.3252, 10.1038/nmeth.3252]; Iglesias-Bartolome R, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aap8798; Ishikawa H, 2008, NATURE, V455, P674, DOI 10.1038/nature07317; Jiang ZW, 2017, J INVEST DERMATOL, V137, P2620, DOI 10.1016/j.jid.2017.07.820; Kiyozumi D, 2006, P NATL ACAD SCI USA, V103, P11981, DOI 10.1073/pnas.0601011103; Kovacs SB, 2017, TRENDS CELL BIOL, V27, P673, DOI 10.1016/j.tcb.2017.05.005; Lessard JC, 2012, J INVEST DERMATOL, V132, P1384, DOI 10.1038/jid.2012.6; Li S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13347-7; Liu Y, 2017, J ORAL PATHOL MED, V46, P1015, DOI 10.1111/jop.12595; Lu R, 2015, J ORAL PATHOL MED, V44, P1, DOI 10.1111/jop.12142; Makino T, 2016, ARCH DERMATOL RES, V308, P213, DOI 10.1007/s00403-016-1627-x; Pavlakis E, 2011, INT J BIOCHEM CELL B, V43, P487, DOI 10.1016/j.biocel.2010.12.016; Roopashree MR, 2010, J ORAL PATHOL MED, V39, P729, DOI 10.1111/j.1600-0714.2010.00946.x; Salem A, 2017, AM J DERMATOPATH, V39, P811, DOI 10.1097/DAD.0000000000000807; Sandilands A, 2009, J CELL SCI, V122, P1285, DOI 10.1242/jcs.033969; Shu Q, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005150; Smit MA, 2010, AGING-US, V2, P735, DOI 10.18632/aging.100209; Tang XR, 2006, P NATL ACAD SCI USA, V103, P13777, DOI 10.1073/pnas.0605988103; Tao XA, 2009, J ORAL PATHOL MED, V38, P427, DOI 10.1111/j.1600-0714.2009.00764.x; Tatematsu M, 2016, J IMMUNOL, V196, P3865, DOI 10.4049/jimmunol.1501734; Thapa N, 2007, INT J BIOCHEM CELL B, V39, P2183, DOI 10.1016/j.biocel.2007.06.004; Yang QZ, 2017, ONCOL REP, V37, P2355, DOI 10.3892/or.2017.5487; Zhang XW, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8080807; Zhong EF, 2020, PATHOGENS, V9, DOI 10.3390/pathogens9110952	42	2	2	3	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2021	16	9							e0257356	10.1371/journal.pone.0257356	http://dx.doi.org/10.1371/journal.pone.0257356			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XM9EM	34506598	gold, Green Published			2022-12-26	WOS:000729120700076
J	Bernhardt, A; Haberer, S; Xu, JJ; Damerau, H; Steffen, J; Reichardt, C; Wolters, K; Steffen, H; Isermann, B; Borucki, K; Artelt, N; Endlich, N; Kozyraki, R; Brandt, S; Lindquist, JA; Mertens, PR				Bernhardt, Anja; Haeberer, Saskia; Xu, JingJing; Damerau, Hannah; Steffen, Johannes; Reichardt, Charlotte; Wolters, Katharina; Steffen, Hannes; Isermann, Berend; Borucki, Katrin; Artelt, Nadine; Endlich, Nicole; Kozyraki, Renata; Brandt, Sabine; Lindquist, Jonathan A.; Mertens, Peter R.			High salt diet-induced proximal tubular phenotypic changes and sodium-glucose cotransporter-2 expression are coordinated by cold shock Y-box binding protein-1	FASEB JOURNAL			English	Article						cold shock protein; high salt diet; sodium glucose transporter; tubular damage	ALBUMIN REABSORPTION; EPITHELIAL POLARITY; RENIN SYNTHESIS; BLOOD-PRESSURE; YB-1; AQUAPORIN-2; ACTIVATION; PREVENTION; EXCRETION; TRANSPORT	High salt diet (HSD) is a hallmark of blood pressure elevations, weight gain and diabetes onset in the metabolic syndrome. In kidney, compensatory mechanisms are activated to balance salt turnover and maintain homeostasis. Data on the long-term effects of HSD with respect to tubular cell functions and kidney architecture that exclude confounding indirect blood pressure effects are scarce. Additionally we focus on cold shock Y-box binding protein-1 as a tubular cell protective factor. A HSD model (4% NaCl in chow; 1% NaCl in water) was compared to normal salt diet (NSD, standard chow) over 16 months using wild type mice and an inducible conditional whole body knockout for cold shock Y-box binding protein-1 (BL6J/N, Ybx1). HSD induced no difference in blood pressure over 16 months, comparing NSD/HSD and Ybx1 wild type/knockout. Nevertheless, marked phenotypic changes were detected. Glucosuria and subnephrotic albuminuria ensued in wild type animals under HSD, which subsided in Ybx1-deficient animals. At the same time megalin receptors were upregulated. The sodium-glucose cotransporter-2 (SGLT2) was completely downregulated in wild type HSD animals that developed glucosuria. In Ybx1 knockouts, expression of AQP1 and SGLT2 was maintained under HSD; proximal tubular widening and glomerular tubularization developed. Concurrently, amino aciduria of neutral and hydrophobic amino acids was seen. In vitro translation confirmed that YB-1 translationally represses Sglt2 transcripts. Our data reveal profound effects of HSD primarily within glomeruli and proximal tubular segments. YB-1 is regulated by HSD and orchestrates HSD-dependent changes; notably, sets reabsorption thresholds for amino acids, proteins and glucose.	[Bernhardt, Anja; Haeberer, Saskia; Xu, JingJing; Damerau, Hannah; Steffen, Johannes; Reichardt, Charlotte; Wolters, Katharina; Steffen, Hannes; Brandt, Sabine; Lindquist, Jonathan A.; Mertens, Peter R.] Otto von Guericke Univ, Diabet & Endocrinol, Clin Nephrol & Hypertens, Leipziger Str 44, D-39120 Magdeburg, Germany; [Isermann, Berend; Borucki, Katrin] Otto von Guericke Univ, Inst Clin Chem & Pathobiochem, Magdeburg, Germany; [Artelt, Nadine; Endlich, Nicole] Univ Med Greifswald, Inst Anat & Cell Biol, Greifswald, Germany; [Artelt, Nadine; Endlich, Nicole] NIPOKA GmbH, Greifswald, Germany; [Kozyraki, Renata] Univ Paris, Ctr Rech Cordeliers, INSERM, UMRS 1138, Paris, France	Otto von Guericke University; Otto von Guericke University; Greifswald Medical School; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite	Mertens, PR (corresponding author), Otto von Guericke Univ, Diabet & Endocrinol, Clin Nephrol & Hypertens, Leipziger Str 44, D-39120 Magdeburg, Germany.	peter.mertens@med.ovgu.de		Steffen, Johannes/0000-0002-0647-4157	Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) [97850925-SFB 854, GRK 2408, ME-1365/7-2, ME-1365/9-2, LI-1031/4-1]; federal state Saxony-Anhalt; European Structural and Investment Funds (ESF) [ZS/2016/08/80645]; BMBF (Bundesministerium fur Bildung und Forschung) STOP-FSGS [01GM1518B]	Deutsche Forschungsgemeinschaft (DFG, German Research Foundation)(German Research Foundation (DFG)); federal state Saxony-Anhalt; European Structural and Investment Funds (ESF); BMBF (Bundesministerium fur Bildung und Forschung) STOP-FSGS	This work was funded by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation)-Project-ID 97850925-SFB 854: PRM (Project A01), BI (Project B26N) GRK 2408, project 7 to BI, project 8 to PRM, grants ME-1365/7-2 and ME-1365/9-2 to PRM and LI-1031/4-1 to JAL, also by the federal state Saxony-Anhalt and the European Structural and Investment Funds (ESF, 2014-2020), project number ZS/2016/08/80645 to PRM as well as by the BMBF (Bundesministerium fur Bildung und Forschung) STOP-FSGS 01GM1518B to NE	Amsellem S, 2010, J AM SOC NEPHROL, V21, P1859, DOI 10.1681/ASN.2010050492; Ansermet C, 2020, ACTA PHYSIOL, V229, DOI 10.1111/apha.13457; Artelt N, 2018, FRONT MED-LAUSANNE, V5, DOI 10.3389/fmed.2018.00292; Bobulescu IA, 2009, PFLUG ARCH EUR J PHY, V458, P5, DOI 10.1007/s00424-008-0595-1; Boero R, 2002, J NEPHROL, V15, P225; Ding J, 2011, AGE, V33, P291, DOI 10.1007/s11357-010-9179-z; Dong W, 2015, J AM SOC NEPHROL, V26, P2789, DOI 10.1681/ASN.2014080846; du Cailar G, 2002, AM J HYPERTENS, V15, P222, DOI 10.1016/S0895-7061(01)02287-7; Duranton F, 2014, CLIN J AM SOC NEPHRO, V9, P37, DOI 10.2215/CJN.06000613; Eliseeva IA, 2011, BIOCHEMISTRY-MOSCOW+, V76, P1402, DOI 10.1134/S0006297911130049; Farquhar WB, 2015, J AM COLL CARDIOL, V65, P1042, DOI 10.1016/j.jacc.2014.12.039; Feng MJ, 2008, AM J HYPERTENS, V21, P1288, DOI 10.1038/ajh.2008.301; Figueira MF, 2017, PHYSIOL REP, V5, DOI 10.14814/phy2.13335; Graffe CC, 2012, AM J PHYSIOL-RENAL, V302, pF264, DOI 10.1152/ajprenal.00442.2010; Greger R, 2000, AM J MED SCI, V319, P51, DOI 10.1097/00000441-200001000-00005; Hohlfeld Raphael, 2018, Oncotarget, V9, P19039, DOI 10.18632/oncotarget.24886; Hosohata K, 2016, HYPERTENS RES, V39, P19, DOI 10.1038/hr.2015.103; Hucke S, 2016, J AUTOIMMUN, V67, P90, DOI 10.1016/j.jaut.2015.11.001; Humphreys BD, 2018, SCIENCE, V360, P709, DOI 10.1126/science.aat7271; Isaac J, 2007, NEPHRON EXP NEPHROL, V105, pE33, DOI 10.1159/000097017; Jantsch J, 2015, CELL METAB, V21, P493, DOI 10.1016/j.cmet.2015.02.003; Jobin K, 2021, TRENDS IMMUNOL, V42, P469, DOI 10.1016/j.it.2021.04.002; Kluger AY, 2019, CARDIOVASC DIABETOL, V18, DOI 10.1186/s12933-019-0903-4; Kohno K, 2003, BIOESSAYS, V25, P691, DOI 10.1002/bies.10300; Korte S, 2014, FASEB J, V28, P4015, DOI 10.1096/fj.14-250282; Kotchen TA, 2013, NEW ENGL J MED, V368, P1229, DOI 10.1056/NEJMra1212606; Kurtz A, 2012, AM J HYPERTENS, V25, P839, DOI 10.1038/ajh.2011.246; Kwon E, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04092-0; Lambers Heerspink HJ, 2012, J AM SOC NEPHROL, V23, P1136, DOI 10.1681/ASN.2012010099; Lantelme P, 2002, HYPERTENSION, V39, P1007, DOI 10.1161/01.HYP.0000016177.20565.A0; Ledoussal C, 2001, AM J PHYSIOL-RENAL, V281, pF718, DOI 10.1152/ajprenal.2001.281.4.F718; Li CN, 2017, BMC PHARMACOL TOXICO, V18, DOI 10.1186/s40360-017-0143-8; Lindquist JA, 2018, CELL COMMUN SIGNAL, V16, DOI 10.1186/s12964-018-0274-6; Loffing J, 2000, AM J PHYSIOL-RENAL, V278, pF530, DOI 10.1152/ajprenal.2000.278.4.F530; Lu ZH, 2005, MOL CELL BIOL, V25, P4625, DOI 10.1128/MCB.25.11.4625-4637.2005; Lu ZH, 2006, MOL CELL BIOL, V26, P8410, DOI 10.1128/MCB.01196-06; Lyabin DN, 2020, RNA BIOL, V17, P487, DOI 10.1080/15476286.2019.1710050; Mehta S, 2020, CANCERS, V12, DOI 10.3390/cancers12020315; Meneton P, 2005, PHYSIOL REV, V85, P679, DOI 10.1152/physrev.00056.2003; MOLITORIS BA, 1989, J CLIN INVEST, V84, P1334, DOI 10.1172/JCI114302; MOLITORIS BA, 1989, J MEMBRANE BIOL, V107, P119, DOI 10.1007/BF01871717; Molitoris BA, 1996, KIDNEY INT, V49, P1592, DOI 10.1038/ki.1996.231; Mukherjee M, 2019, J AM SOC NEPHROL, V30, P110, DOI 10.1681/ASN.2018040440; Ohta Y, 2013, HYPERTENS RES, V36, P172, DOI 10.1038/hr.2012.155; Perkovic V, 2019, NEW ENGL J MED, V380, P2295, DOI 10.1056/NEJMoa1811744; Rakova N, 2013, CELL METAB, V17, P125, DOI 10.1016/j.cmet.2012.11.013; SAHALI D, 1993, AM J PATHOL, V142, P1654; Schock-Kusch D, 2009, NEPHROL DIAL TRANSPL, V24, P2997, DOI 10.1093/ndt/gfp225; Siegerist F, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11553-x; Skalweit A, 2003, CIRC RES, V92, P419, DOI 10.1161/01.RES.0000059300.67152.4E; Staruschenko A, 2012, COMPR PHYSIOL, V2, P1541, DOI 10.1002/cphy.c110052; Stockand JD, 2002, AM J PHYSIOL-RENAL, V282, pF559, DOI 10.1152/ajprenal.00320.2001; Tabatabai NM, 2014, J MEMBRANE BIOL, V247, P675, DOI 10.1007/s00232-014-9686-4; Takesue H, 2018, MOL PHARMACOL, V94, P953, DOI 10.1124/mol.118.111807; Theilig F, 2015, AM J PHYSIOL-RENAL, V308, pF1047, DOI 10.1152/ajprenal.00164.2014; Tikellis C, 2012, HYPERTENSION, V60, P98, DOI 10.1161/HYPERTENSIONAHA.112.191767; Titze J, 2015, CURR OPIN NEPHROL HY, V24, P14, DOI 10.1097/MNH.0000000000000085; Tojo A, 2001, HISTOCHEM CELL BIOL, V116, P269, DOI 10.1007/s004180100317; Turck D, 2019, EFSA J, V17, DOI 10.2903/j.efsa.2019.5778; Udwan K, 2017, J PHYSIOL-LONDON, V595, P6905, DOI 10.1113/JP274927; Verhave JC, 2004, J INTERN MED, V256, P324, DOI 10.1111/j.1365-2796.2004.01390.x; Vlotides G, 2015, NEPHROL DIAL TRANSPL, V30, P1272, DOI 10.1093/ndt/gfu299; Wenzel UO, 2019, BRIT J PHARMACOL, V176, P1853, DOI 10.1111/bph.14359; Weyer K, 2011, NEPHROL DIAL TRANSPL, V26, P3446, DOI 10.1093/ndt/gfr525; Wheeler DC, 2020, NEPHROL DIAL TRANSPL, V35, P1700, DOI 10.1093/ndt/gfaa234; WHO, 2012, GUID SOD INT AD CHIL; Xiao YZ, 2020, CELL METAB, V31, P534, DOI 10.1016/j.cmet.2020.01.002; Yu Qianli, 2004, Cardiovasc Toxicol, V4, P37; Zaika O, 2013, CURR HYPERTENS REP, V15, P17, DOI 10.1007/s11906-012-0316-1; Zhang J, 2012, J ZHEJIANG UNIV-SC B, V13, P511, DOI 10.1631/jzus.B1200042; Zhao Y, 2016, CELL METAB, V23, P699, DOI 10.1016/j.cmet.2016.02.019; Zhu C, 2016, J AM SOC NEPHROL, V27, P3678, DOI 10.1681/ASN.2015121367	72	0	0	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2021	35	10							e21912	10.1096/fj.202100667RR	http://dx.doi.org/10.1096/fj.202100667RR			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	UZ5IH	34533842	hybrid, Green Published			2022-12-26	WOS:000702238200043
J	Gopalakrishnan, R; Winston, F				Gopalakrishnan, Rajaraman; Winston, Fred			The histone chaperone Spt6 is required for normal recruitment of the capping enzyme Abd1 to transcribed regions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; FACTORS REPRESS TRANSCRIPTION; QUALITY-CONTROL MECHANISM; ELONGATION-FACTOR SPT6; SACCHAROMYCES-CEREVISIAE; CAP METHYLTRANSFERASE; CHROMATIN-STRUCTURE; IN-VIVO; CONDITIONAL MUTANTS; SH2 DOMAIN	The histone chaperone Spt6 is involved in promoting elongation of RNA polymerase II (RNAPII), maintaining chromatin structure, regulating cotranscriptional histone modifications, and controlling mRNA processing. These diverse functions of Spt6 are partly mediated through its interactions with RNAPII and other factors in the transcription elongation complex. In this study, we used mass spectrometry to characterize the differences in RNAPII-interacting factors between wildtype cells and those depleted for Spt6, leading to the identification of proteins that depend on Spt6 for their interaction with RNAPII. The altered association of some of these factors could be attributed to changes in steady-state protein levels. However, Abd1, the mRNA cap methyltransferase, had decreased association with RNAPII after Spt6 depletion despite unchanged Abd1 protein levels, showing a requirement for Spt6 in mediating the Abd1-RNAPII interaction. Genome-wide studies showed that Spt6 is required for maintaining the level of Abd1 over transcribed regions, as well as the level of Spt5, another protein known to recruit Abd1 to chromatin. Abd1 levels were particularly decreased at the 50 ends of genes after Spt6 depletion, suggesting a greater need for Spt6 in Abd1 recruitment over these regions. Together, our results show that Spt6 is important in regulating the composition of the transcription elongation complex and reveal a previously unknown function for Spt6 in the recruitment of Abd1.	[Gopalakrishnan, Rajaraman; Winston, Fred] Harvard Med Sch, Blavatnik Inst, Dept Genet, Boston, MA 02115 USA; [Gopalakrishnan, Rajaraman] Novartis Inst BioMed Res, Cambridge, MA USA	Harvard University; Harvard Medical School; Novartis	Winston, F (corresponding author), Harvard Med Sch, Blavatnik Inst, Dept Genet, Boston, MA 02115 USA.	winston@genetics.med.harvard.edu			National Institutes of Health [R01GM32967, R01GM120038]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Acknowledgments-We thank Ryan Kunz for advice and help with the MS experiments and analysis, Beate Schwer for providing us with the ABD1 and CEG1 plasmids, and Steve Buratowski for providing us with the CET1 plasmids and helpful discussions. We are very grateful to Art Alekseyenko and Mitzi Kuroda for advice on BioTAP-XL. We also thank Catherine Weiner and James Warner for helpful comments on the article. Funding and additional information-This work was supported by the National Institutes of Health grants R01GM32967 and R01GM120038 to F. W. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alekseyenko Artyom A, 2015, Curr Protoc Mol Biol, V109, DOI 10.1002/0471142727.mb2130s109; Amberg DC., 2005, METHODS YEAST GENETI; Andrulis ED, 2000, GENE DEV, V14, P2635, DOI 10.1101/gad.844200; Ardehali MB, 2009, EMBO J, V28, P1067, DOI 10.1038/emboj.2009.56; Ballance LT, 2006, PROG OCEANOGR, V69, P360, DOI 10.1016/j.pocean.2006.03.013; Bortvin A, 1996, SCIENCE, V272, P1473, DOI 10.1126/science.272.5267.1473; Bourbon HM, 2002, MECH DEVELOP, V110, P71, DOI 10.1016/S0925-4773(01)00566-4; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chang JH, 2012, NAT STRUCT MOL BIOL, V19, P1011, DOI 10.1038/nsmb.2381; Cheung V, 2008, PLOS BIOL, V6, P2550, DOI 10.1371/journal.pbio.0060277; Chu YY, 2006, MOL CELL BIOL, V26, P3029, DOI 10.1128/MCB.26.8.3029-3038.2006; Close D, 2011, J MOL BIOL, V408, P697, DOI 10.1016/j.jmb.2011.03.002; DeGennaro CM, 2013, MOL CELL BIOL, V33, P4779, DOI 10.1128/MCB.01068-13; Dengl S, 2009, J MOL BIOL, V389, P211, DOI 10.1016/j.jmb.2009.04.016; Diebold ML, 2010, EMBO J, V29, P3979, DOI 10.1038/emboj.2010.272; Diebold ML, 2010, J BIOL CHEM, V285, P38389, DOI 10.1074/jbc.M110.146696; Doris SM, 2018, MOL CELL, V72, P687, DOI 10.1016/j.molcel.2018.09.005; Duina AA, 2011, GENET RES INT, V2011, DOI 10.4061/2011/625210; Endoh M, 2004, MOL CELL BIOL, V24, P3324, DOI 10.1128/MCB.24.8.3324-3336.2004; Gopalakrishnan R, 2019, NUCLEIC ACIDS RES, V47, P3888, DOI 10.1093/nar/gkz119; Hartzog GA, 1998, GENE DEV, V12, P357, DOI 10.1101/gad.12.3.357; Ivanovska I, 2011, MOL CELL BIOL, V31, P531, DOI 10.1128/MCB.01068-10; Jiao XF, 2013, MOL CELL, V50, P104, DOI 10.1016/j.molcel.2013.02.017; Jiao XF, 2010, NATURE, V467, P608, DOI 10.1038/nature09338; Kaplan CD, 2005, J BIOL CHEM, V280, P913, DOI 10.1074/jbc.M411108200; Kaplan CD, 2003, SCIENCE, V301, P1096, DOI 10.1126/science.1087374; Kharchenko PV, 2008, NAT BIOTECHNOL, V26, P1351, DOI 10.1038/nbt.1508; Kok FO, 2007, DEV BIOL, V307, P214, DOI 10.1016/j.ydbio.2007.04.039; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lidschreiber M, 2013, MOL CELL BIOL, V33, P3805, DOI 10.1128/MCB.00361-13; Lindstrom DL, 2003, MOL CELL BIOL, V23, P1368, DOI 10.1128/MCB.23.4.1368-1378.2003; Liu JP, 2011, J BIOL CHEM, V286, P29218, DOI 10.1074/jbc.M111.252130; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Mayer A, 2010, NAT STRUCT MOL BIOL, V17, P1272, DOI 10.1038/nsmb.1903; McCullough L, 2015, GENETICS, V201, P1031, DOI 10.1534/genetics.115.180794; McDonald SM, 2010, MOL CELL, V40, P725, DOI 10.1016/j.molcel.2010.11.014; Meyers RM, 2017, NAT GENET, V49, P1779, DOI 10.1038/ng.3984; Mosley AL, 2013, MOL CELL PROTEOMICS, V12, P1530, DOI 10.1074/mcp.M112.024034; Oqani RK, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-40358-3; Orlando DA, 2014, CELL REP, V9, P1163, DOI 10.1016/j.celrep.2014.10.018; Pei Y, 2002, J BIOL CHEM, V277, P19639, DOI 10.1074/jbc.M200015200; Perales R, 2013, EMBO J, V32, P2645, DOI 10.1038/emboj.2013.194; Ramirez F, 2014, NUCLEIC ACIDS RES, V42, pW187, DOI 10.1093/nar/gku365; Reim NI, 2020, NUCLEIC ACIDS RES, V48, P10241, DOI 10.1093/nar/gkaa745; Schroeder SC, 2000, GENE DEV, V14, P2435, DOI 10.1101/gad.836300; Schroeder SC, 2004, MOL CELL, V13, P377, DOI 10.1016/S1097-2765(04)00007-3; Schwer B, 1998, NUCLEIC ACIDS RES, V26, P2050, DOI 10.1093/nar/26.9.2050; Schwer B, 2000, GENETICS, V155, P1561; Sdano MA, 2017, ELIFE, V6, DOI 10.7554/eLife.28723; Sun M, 2010, J BIOL CHEM, V285, P41597, DOI 10.1074/jbc.M110.144568; SWANSON MS, 1990, MOL CELL BIOL, V10, P4935, DOI 10.1128/MCB.10.9.4935; SWANSON MS, 1992, GENETICS, V132, P325; Takase Y, 2000, MOL CELL BIOL, V20, P9307, DOI 10.1128/MCB.20.24.9307-9316.2000; Tardiff DF, 2007, P NATL ACAD SCI USA, V104, P19948, DOI 10.1073/pnas.0710179104; Thompson A, 2003, ANAL CHEM, V75, P1895, DOI 10.1021/ac0262560; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Ting L, 2011, NAT METHODS, V8, P937, DOI [10.1038/NMETH.1714, 10.1038/nmeth.1714]; Tyanova S, 2016, NAT METHODS, V13, P731, DOI [10.1038/nmeth.3901, 10.1038/NMETH.3901]; Uwimana N, 2017, NUCLEIC ACIDS RES, V45, P6417, DOI 10.1093/nar/gkx242; van Bakel H, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003479; Van Oss SB, 2017, TRENDS BIOCHEM SCI, V42, P788, DOI 10.1016/j.tibs.2017.08.003; Varshney D, 2018, CELL REP, V23, P1530, DOI 10.1016/j.celrep.2018.04.004; Venkatesh S, 2015, NAT REV MOL CELL BIO, V16, P178, DOI 10.1038/nrm3941; Vos SM, 2018, NATURE, V560, P607, DOI 10.1038/s41586-018-0440-4; Yoh SM, 2007, GENE DEV, V21, P160, DOI 10.1101/gad.1503107; Yoh SM, 2008, GENE DEV, V22, P3422, DOI 10.1101/gad.1720008; Youdell ML, 2008, MOL CELL BIOL, V28, P4915, DOI 10.1128/MCB.00001-08; Zhou Q, 2012, ANNU REV BIOCHEM, V81, P119, DOI 10.1146/annurev-biochem-052610-095910	68	0	0	0	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT	2021	297	4							101205	10.1016/j.jbc.2021.101205	http://dx.doi.org/10.1016/j.jbc.2021.101205			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	WP2YR	34543624	Green Published, Green Submitted, gold			2022-12-26	WOS:000713003600004
J	Jin, DN; Wek, SA; Kudlapur, NT; Cantara, WA; Bakhtina, M; Wek, RC; Musier-Forsyth, K				Jin, Danni; Wek, Sheree A.; Kudlapur, Nathan T.; Cantara, William A.; Bakhtina, Marina; Wek, Ronald C.; Musier-Forsyth, Karin			Disease-associated mutations in a bifunctional aminoacyl-tRNA synthetase gene elicit the integrated stress response	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSLATIONAL CONTROL; NONCANONICAL FUNCTION; PROTEIN-SYNTHESIS; GLUTAMYL; PHOSPHORYLATION; KINASE; GCN2; EPRS; ACTIVATION; MECHANISMS	Aminoacyl-tRNA synthetases (ARSs) catalyze the charging of specific amino acids onto cognate tRNAs, an essential process for protein synthesis. Mutations in ARSs are frequently associated with a variety of human diseases. The human EPRS1 gene encodes a bifunctional glutamyl-prolyl-tRNA synthetase (EPRS) with two catalytic cores and appended domains that contribute to nontranslational functions. In this study, we report compound heterozygous mutations in EPRS1, which lead to amino acid substitutions P14R and E205G in two patients with diabetes and bone diseases. While neither mutation affects tRNA binding or association of EPRS with the multisynthetase complex, E205G in the glutamyl-tRNA synthetase (ERS) region of EPRS is defective in amino acid activation and tRNA(Glu) charging. The P14R mutation induces a conformational change and altered tRNA charging kinetics in vitro. We propose that the altered catalytic activity and conformational changes in the EPRS variants sensitize patient cells to stress, triggering an increased integrated stress response (ISR) that diminishes cell viability. Indeed, patient-derived cells expressing the compound heterozygous EPRS show heightened induction of the ISR, suggestive of disruptions in protein homeostasis. These results have important implications for understanding ARS-associated human disease mechanisms and development of new therapeutics.	[Jin, Danni; Kudlapur, Nathan T.; Cantara, William A.; Bakhtina, Marina; Musier-Forsyth, Karin] Ohio State Univ, Ctr RNA Biol, Dept Chem & Biochem, Columbus, OH 43210 USA; [Wek, Sheree A.; Wek, Ronald C.] Indiana Univ, Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN USA	University System of Ohio; Ohio State University; Indiana University System; Indiana University-Purdue University Indianapolis	Musier-Forsyth, K (corresponding author), Ohio State Univ, Ctr RNA Biol, Dept Chem & Biochem, Columbus, OH 43210 USA.	musier-forsyth.1@osu.edu	Cantara, William/GRF-5853-2022	Jin, Danni/0000-0002-2878-9950	National Institutes of Health (NIH) [R35 GM141880]; NIH [R35 GM136331]; Eli Lilly and Company	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Eli Lilly and Company(Eli Lilly)	This work was supported by National Institutes of Health (NIH) grants R35 GM141880 (to K. M.-F.) and NIH grant R35 GM136331 (to R. C. W.). R. C. W. has received grant support from Eli Lilly and Company. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Arif A, 2018, WIRES RNA, V9, DOI 10.1002/wrna.1441; Arif A, 2011, P NATL ACAD SCI USA, V108, P1415, DOI 10.1073/pnas.1011275108; Arif A, 2009, MOL CELL, V35, P164, DOI 10.1016/j.molcel.2009.05.028; Baird TD, 2014, MOL BIOL CELL, V25, P1686, DOI 10.1091/mbc.E14-02-0704; Baird TD, 2012, ADV NUTR, V3, P307, DOI 10.3945/an.112.002113; Baxter E. W., 2002, ORGANIC REACTIONS, V59, P1, DOI [DOI 10.1002/0471264180.OR059.01, DOI 10.1002/0471264180.0R059.01]; Boczonadi V, 2018, FEBS LETT, V592, P703, DOI 10.1002/1873-3468.12962; Chiu J, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh172; Chiu J, 2008, J MICROBIOL METH, V73, P195, DOI 10.1016/j.mimet.2008.02.013; Cho HY, 2019, J MOL BIOL, V431, P4475, DOI 10.1016/j.jmb.2019.08.013; Cho HY, 2015, J BIOL CHEM, V290, P29313, DOI 10.1074/jbc.M115.690867; Cui HS, 2021, NUCLEIC ACIDS RES, V49, P3603, DOI 10.1093/nar/gkaa1183; DELARUE M, 1993, BIOESSAYS, V15, P675, DOI 10.1002/bies.950151007; Delepine M, 2000, NAT GENET, V25, P406, DOI 10.1038/78085; Dong JS, 2000, MOL CELL, V6, P269, DOI 10.1016/S1097-2765(00)00028-9; Eswarappa SM, 2018, J BIOL CHEM, V293, P19148, DOI 10.1074/jbc.RA118.004276; Francklyn CS, 2008, METHODS, V44, P100, DOI 10.1016/j.ymeth.2007.09.007; Gomez MAR, 2020, RNA, V26, P910, DOI 10.1261/rna.071720.119; Gruic-Sovulj I, 2005, J BIOL CHEM, V280, P23978, DOI 10.1074/jbc.M414260200; Guo M, 2013, NAT CHEM BIOL, V9, P145, DOI [10.1038/nchembio.1158, 10.1038/NCHEMBIO.1158]; Halawani D, 2018, J BIOL CHEM, V293, P8843, DOI 10.1074/jbc.M117.807503; Han J, 2013, NAT CELL BIOL, V15, P481, DOI 10.1038/ncb2738; Harding HP, 2001, MOL CELL, V7, P1153, DOI 10.1016/S1097-2765(01)00264-7; Heacock D, 1996, BIOORG CHEM, V24, P273, DOI 10.1006/bioo.1996.0025; Hu GL, 2020, J BONE MINER RES, V35, P2004, DOI 10.1002/jbmr.4091; Jia J, 2008, MOL CELL, V29, P679, DOI 10.1016/j.molcel.2008.01.010; Jiang Lei, 2020, Enzymes, V48, P277, DOI 10.1016/bs.enz.2020.06.009; Johnson KA, 2009, ANAL BIOCHEM, V387, P20, DOI 10.1016/j.ab.2008.12.024; Kelly SM, 2005, BBA-PROTEINS PROTEOM, V1751, P119, DOI 10.1016/j.bbapap.2005.06.005; Konno M, 2009, FEBS J, V276, P4763, DOI 10.1111/j.1742-4658.2009.07178.x; Kyriacou SV, 2008, MOL CELL, V29, P419, DOI 10.1016/j.molcel.2007.11.038; LANKER S, 1992, CELL, V70, P647, DOI 10.1016/0092-8674(92)90433-D; Lee EY, 2016, NAT IMMUNOL, V17, P1252, DOI 10.1038/ni.3542; Longo PA, 2013, METHOD ENZYMOL, V529, P227, DOI 10.1016/B978-0-12-418687-3.00018-5; Marciniak SJ, 2004, GENE DEV, V18, P3066, DOI 10.1101/gad.1250704; Mendes MI, 2018, AM J HUM GENET, V102, P676, DOI 10.1016/j.ajhg.2018.02.011; Meyer-Schuman R, 2017, HUM MOL GENET, V26, pR114, DOI 10.1093/hmg/ddx231; MILLIGAN JF, 1989, METHOD ENZYMOL, V180, P51; MITRA SK, 1967, J BIOL CHEM, V242, P5490; Mukhopadhyay R, 2009, TRENDS BIOCHEM SCI, V34, P324, DOI 10.1016/j.tibs.2009.03.004; Park SG, 2008, P NATL ACAD SCI USA, V105, P11043, DOI 10.1073/pnas.0802862105; RAVEL JM, 1965, J BIOL CHEM, V240, P432; Ray PS, 2007, TRENDS BIOCHEM SCI, V32, P158, DOI 10.1016/j.tibs.2007.02.003; Ray PS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098493; Rodriguez-Hernandez A, 2013, J MOL BIOL, V425, P3888, DOI 10.1016/j.jmb.2013.05.018; Rye-McCurdy Tiffiny, 2015, Methods Mol Biol, V1259, P385, DOI 10.1007/978-1-4939-2214-7_23; Sampath P, 2004, CELL, V119, P195, DOI 10.1016/j.cell.2004.09.030; Sampath P, 2003, MOL CELL BIOL, V23, P1509, DOI 10.1128/MCB.23.5.1509-1519.2003; Sauter C, 2015, SCI REP-UK, V5, DOI 10.1038/srep17332; Schwarz MA, 2018, INT J BIOCHEM CELL B, V99, P197, DOI 10.1016/j.biocel.2018.04.015; SIVARAM P, 1990, P NATL ACAD SCI USA, V87, P3665, DOI 10.1073/pnas.87.10.3665; Ta-Shma A, 2017, J MED GENET, V54, P278, DOI 10.1136/jmedgenet-2016-104259; Tabas I, 2011, NAT CELL BIOL, V13, P184, DOI 10.1038/ncb0311-184; Uter NT, 2005, J BIOL CHEM, V280, P23966, DOI 10.1074/jbc.M414259200; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Wei JW, 2008, J CELL PHYSIOL, V217, P693, DOI 10.1002/jcp.21543; Wek RC, 2006, BIOCHEM SOC T, V34, P7, DOI 10.1042/BST0340007; WEK RC, 1989, P NATL ACAD SCI USA, V86, P4579, DOI 10.1073/pnas.86.12.4579; Wek RC, 2018, CSH PERSPECT BIOL, V10, DOI 10.1101/cshperspect.a032870; Wek RC, 2009, CELL METAB, V10, P1, DOI 10.1016/j.cmet.2009.06.005; WEK SA, 1995, MOL CELL BIOL, V15, P4497; Yang XG, 2004, CELL, V117, P387, DOI 10.1016/S0092-8674(04)00344-7; Young SK, 2016, J BIOL CHEM, V291, P10824, DOI 10.1074/jbc.M116.722256; Zhang PC, 2002, MOL CELL BIOL, V22, P3864, DOI 10.1128/MCB.22.11.3864-3874.2002	64	4	4	1	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT	2021	297	4							101203	10.1016/j.jbc.2021.101203	http://dx.doi.org/10.1016/j.jbc.2021.101203			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	YZ2PR	34537243	Green Published, gold			2022-12-26	WOS:000755323700016
J	Liu, QW; Wang, DZ; Yu, M; Cong, B; Yu, XP				Liu, Qiwei; Wang, Dezheng; Yu, Miao; Cong, Biao; Yu, Xiaopeng			The influences of electric field intensity and driving force on the slip behaviour of water flow in a nanochannel	PLOS ONE			English	Article							MOLECULAR-DYNAMICS SIMULATIONS; FLUID TRANSPORT-PROPERTIES	In the present work, non-equilibrium molecular dynamics (MD) simulations are used to investigate the flow of liquid water between two metallic solid atomistic smooth walls. The present work focuses on the combined effect of external electric field and driving force on the slip behaviour and structure of liquid water at the solid-water interface. The upper wall of the set model is positively charged, and the lower wall of the model is negatively charged. The simulation results show that as the driving force increases, the slip length also increases. At a given driving force, no matter how the electric field intensity changes, there is almost no change in the slip length, so the slip length is independent of the electric field strength. In addition, the results found that there is a linear relationship between the slip length and the normalised main peak of the static structure factor under different driving forces.	[Liu, Qiwei; Cong, Biao; Yu, Xiaopeng] Jilin Normal Univ, Jilin Prov Key Lab Numer Simulat, Siping, Jilin, Peoples R China; [Wang, Dezheng] Beijing Inst Mech & Elect Engn, Beijing, Peoples R China; [Yu, Miao] Jiangsu Univ, Sch Mat Sci & Engn, Inst Adv Mat, Zhenjiang, Jiangsu, Peoples R China	Jilin Normal University; Jiangsu University	Cong, B; Yu, XP (corresponding author), Jilin Normal Univ, Jilin Prov Key Lab Numer Simulat, Siping, Jilin, Peoples R China.	cbiao@jlnu.edu.cn; yyxxpp@jlnu.edu.cn						Alipour P, 2019, J MOL LIQ, V275, P192, DOI 10.1016/j.molliq.2018.11.057; Bao LY, 2017, PHYS REV E, V96, DOI 10.1103/PhysRevE.96.033110; Bao LY, 2016, SCI REP-UK, V6, DOI 10.1038/srep29786; BARANYAI A, 1994, J CHEM PHYS, V101, P5070, DOI 10.1063/1.467363; Borhani DW, 2012, J COMPUT AID MOL DES, V26, P15, DOI 10.1007/s10822-011-9517-y; Celebi AT, 2018, MICROFLUID NANOFLUID, V22, DOI 10.1007/s10404-017-2027-z; Dysthe DK, 1999, J CHEM PHYS, V110, P4047, DOI 10.1063/1.478286; Dysthe DK, 1999, J CHEM PHYS, V110, P4060, DOI 10.1063/1.478287; Falk K, 2010, NANO LETT, V10, P4067, DOI 10.1021/nl1021046; Ghorbanian J, 2016, J CHEM PHYS, V145, DOI 10.1063/1.4967294; Hoseinzadeh S, 2020, INT J NUMER METHOD H, V30, P3721, DOI 10.1108/HFF-09-2019-0671; Hoseinzadeh S, 2020, INT J NUMER METHOD H, V30, P1149, DOI 10.1108/HFF-06-2019-0485; Hoseinzadeh S, 2018, J MOL LIQ, V271, P655, DOI 10.1016/j.molliq.2018.08.128; Hoseinzadeh S, 2017, EUR PHYS J PLUS, V132, DOI 10.1140/epjp/i2017-11455-3; Hoseinzadeh S, 2021, THERM SCI ENG PROG, V23, DOI 10.1016/j.tsep.2021.100901; Hoseinzadeh S, 2022, J THERM ANAL CALORIM, V147, P4403, DOI 10.1007/s10973-021-10811-5; Hu HB, 2017, J CHEM PHYS, V146, DOI 10.1063/1.4973640; Liakopoulos A, 2016, MICROFLUID NANOFLUID, V20, DOI 10.1007/s10404-015-1699-5; Park S, 2009, NANO LETT, V9, P1325, DOI 10.1021/nl802962t; PLIMPTON S, 1995, J COMPUT PHYS, V117, P1, DOI 10.1006/jcph.1995.1039; Priezjev NV, 2007, J CHEM PHYS, V127, DOI 10.1063/1.2796172; Priezjev NV, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.051605; Richard R, 2016, MOL PHYS, V114, P2655, DOI 10.1080/00268976.2016.1170219; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Shannon MA, 2008, NATURE, V452, P301, DOI 10.1038/nature06599; Sofos F, 2019, MOL SIMULAT, V45, P1395, DOI 10.1080/08927022.2019.1637520; Suk ME, 2010, J PHYS CHEM LETT, V1, P1590, DOI 10.1021/jz100240r; Voronov RS, 2006, J CHEM PHYS, V124, DOI 10.1063/1.2194019; Yong X, 2013, MICROFLUID NANOFLUID, V14, P299, DOI 10.1007/s10404-012-1048-x; Yong X, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.056313; Yoshida H, 2014, J CHEM PHYS, V140, DOI 10.1063/1.4879547; Zhang H, 2017, COMP MATER SCI, V131, P100, DOI 10.1016/j.commatsci.2017.01.039	32	0	0	8	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2021	16	9							e0257589	10.1371/journal.pone.0257589	http://dx.doi.org/10.1371/journal.pone.0257589			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YS4WS	34551001	gold, Green Published			2022-12-26	WOS:000750679800028
J	Neumann, RP; Schulzke, SM; Pohl, C; Wellmann, S; Metze, B; Burdensky, AK; Boos, V; Barikbin, P; Buhrer, C; Czernik, C				Neumann, Roland P.; Schulzke, Sven M.; Pohl, Christian; Wellmann, Sven; Metze, Boris; Burdensky, Ann-Katrin; Boos, Vinzenz; Barikbin, Payman; Buhrer, Christoph; Czernik, Christoph			Right ventricular function and vasoactive peptides for early prediction of bronchopulmonary dysplasia	PLOS ONE			English	Article							PRETERM INFANTS; PULMONARY-HYPERTENSION; IMMUNOLUMINOMETRIC ASSAY; NATRIURETIC PEPTIDE; LUNG-FUNCTION; ENDOTHELIN-1; ASSOCIATION; PERFORMANCE; OUTCOMES; SOCIETY	Background To assess the prognostic value of early echocardiographic indices of right ventricular function and vasoactive peptides for prediction of bronchopulmonary dysplasia (BPD) or death in very preterm infants. Methods Prospective study involving 294 very preterm infants (median [IQR] gestational age 28.4 [26.4-30.4] weeks, birth weight 1065 [800-1380] g), of whom 57 developed BPD (oxygen supplementation at 36 weeks postmenstrual age) and 10 died. Tricuspid annular plane systolic excursion (TAPSE), right ventricular index of myocardial performance (RIMP), plasma concentrations of mid-regional pro-atrial natriuretic peptide (MR-proANP) and C-terminal pro-endothelin-1 (CT-proET1) were measured on day 7 of life. Results RIMP was significantly increased (median [IQR] 0.3 [0.23-0.38] vs 0.22 [0.15-0.29]), TAPSE decreased (median [IQR] 5.0 [5.0-6.0] vs 6.0 [5.4-7.0] mm), MR-proANP increased (median [IQR] 784 [540-936] vs 353 [247-625] pmol/L), and CT-proET1 increased (median [IQR] 249 [190-345] vs 199 [158-284] pmol/L) in infants who developed BPD or died, as compared to controls. All variables showed significant but weak correlations with each other (r(S) -0.182 to 0.359) and predicted BPD/death with similar accuracy (areas under receiver operator characteristic curves 0.62 to 0.77). Multiple regression revealed only RIMP and birth weight as independent predictors of BPD or death. Conclusions Vasoactive peptide concentrations and echocardiographic assessment employing standardized measures, notably RIMP, on day 7 of life are useful to identify preterm infants at increased risk for BPD or death.	[Neumann, Roland P.; Schulzke, Sven M.; Pohl, Christian; Wellmann, Sven] Univ Basel, Univ Childrens Hosp Basel UKBB, Dept Neonatol, Basel, Switzerland; [Wellmann, Sven] Univ Regensburg, Univ Regensburg Childrens Hosp KUNO, Dept Neonatol, Regensburg, Germany; [Metze, Boris; Burdensky, Ann-Katrin; Boos, Vinzenz; Barikbin, Payman; Buhrer, Christoph; Czernik, Christoph] Charite Univ Med Berlin, Dept Neonatol, Berlin, Germany; [Boos, Vinzenz] Hosp Zollikerberg, Dept Neonatol, Zollikerberg, Switzerland; [Barikbin, Payman] Vivantes Hosp Friedrichshain, Dept Pediat, Berlin, Germany	University of Basel; University of Regensburg; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Neumann, RP (corresponding author), Univ Basel, Univ Childrens Hosp Basel UKBB, Dept Neonatol, Basel, Switzerland.	roland.neumann@ukbb.ch	Boos, Vinzenz/AAW-3558-2020	Boos, Vinzenz/0000-0001-6895-4861; Schulzke, Sven/0000-0002-5475-6239; Pohl, Christian/0000-0002-1864-2584; Neumann, Roland P/0000-0002-7536-5341				Baumann P, 2015, NEONATOLOGY, V108, P293, DOI 10.1159/000438979; Behere S, 2019, PEDIATR CARDIOL, V40, P973, DOI 10.1007/s00246-019-02100-8; Berkelhamer SK, 2013, SEMIN PERINATOL, V37, P124, DOI 10.1053/j.semperi.2013.01.009; Coalson Jacqueline J, 2003, Semin Neonatol, V8, P73, DOI 10.1016/S1084-2756(02)00193-8; Czernik C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038352; Czernik C, 2011, PEDIATRICS, V128, pE545, DOI 10.1542/peds.2011-0603; Di Maria MV, 2015, J AM SOC ECHOCARDIOG, V28, P1045, DOI 10.1016/j.echo.2015.04.016; Doyle LW, 2006, PEDIATRICS, V118, P108, DOI 10.1542/peds.2005-2522; El Sayed M, 2011, AM J PERINAT, V28, P129, DOI 10.1055/s-0030-1263295; Fagan KA, 2001, RESP RES, V2, P90, DOI 10.1186/rr44; HISLOP AA, 1990, PEDIATR PULM, V9, P152, DOI 10.1002/ppul.1950090306; Horbar JD, 2017, JAMA PEDIATR, V171, DOI 10.1001/jamapediatrics.2016.4396; James AT, 2014, EARLY HUM DEV, V90, P829, DOI 10.1016/j.earlhumdev.2014.09.004; Koestenberger M, 2011, NEONATOLOGY, V100, P85, DOI 10.1159/000322006; Lopez L, 2010, J AM SOC ECHOCARDIOG, V23, P465, DOI 10.1016/j.echo.2010.03.019; Mendez-Abed P, 2020, FRONT PEDIATR, V7, DOI 10.3389/fped.2019.00556; Mirza H, 2014, J PEDIATR-US, V165, P909, DOI 10.1016/j.jpeds.2014.07.040; Morgenthaler NG, 2004, CLIN CHEM, V50, P234, DOI 10.1373/clinchem.2003.021204; Mourani PM, 2015, CLIN PERINATOL, V42, P839, DOI 10.1016/j.clp.2015.08.010; Mourani PM, 2015, AM J RESP CRIT CARE, V191, P87, DOI 10.1164/rccm.201409-1594OC; Mourani PM, 2014, AM J RESP CRIT CARE; Papassotiriou J, 2006, CLIN CHEM, V52, P1144, DOI 10.1373/clinchem.2005.065581; Sahni Rakesh, 2005, J Perinatol, V25, P41, DOI 10.1038/sj.jp.7211210; Sehgal A, 2016, NEONATOLOGY, V109, P289, DOI 10.1159/000442967; Sellmer A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140079; Seo Yo Han, 2017, J Cardiovasc Ultrasound, V25, P124, DOI 10.4250/jcu.2017.25.4.124; SHENNAN AT, 1988, PEDIATRICS, V82, P527; Simpson SJ, 2018, LANCET CHILD ADOLESC, V2, P350, DOI 10.1016/S2352-4642(18)30064-6; Stoll BJ, 2015, JAMA-J AM MED ASSOC, V314, P1039, DOI 10.1001/jama.2015.10244; Stoll BJ, 2010, PEDIATRICS, V126, P443, DOI 10.1542/peds.2009-2959; Sugiura T, 2003, PEDIATR RES, V53, P927, DOI 10.1203/01.PDR.0000061540.81669.2A; Tei C, 1996, J Am Soc Echocardiogr, V9, P838, DOI 10.1016/S0894-7317(96)90476-9; Thebaud B, 2019, NAT REV DIS PRIMERS, V5, DOI 10.1038/s41572-019-0127-7; Um-Bergstrom P, 2017, BMC PULM MED, V17, DOI 10.1186/s12890-017-0441-3; Warwick G, 2008, EUR RESPIR J, V32, P503, DOI 10.1183/09031936.00160307; Xiong T, 2020, J PERINATOL, V40, P607, DOI 10.1038/s41372-019-0588-2; Zaidi A, 2020, ECHO RES PRACT, V7, pG19, DOI 10.1530/ERP-19-0051	37	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2021	16	9							e0257571	10.1371/journal.pone.0257571	http://dx.doi.org/10.1371/journal.pone.0257571			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YS4WS	34550991	Green Published, gold			2022-12-26	WOS:000750679800025
J	Pokharel, SM; Chiok, K; Shil, NK; Mohanty, I; Bose, S				Pokharel, Swechha M.; Chiok, Kim; Shil, Niraj K.; Mohanty, Indira; Bose, Santanu			Tumor Necrosis Factor-alpha utilizes MAPK/NF kappa B pathways to induce cholesterol-25 hydroxylase for amplifying pro-inflammatory response via 25-hydroxycholesterol-integrin-FAK pathway	PLOS ONE			English	Article							FIBROBLAST-LIKE SYNOVIOCYTES; TNF-ALPHA; KINASE ACTIVATION; CELL-LINE; INHIBITION; MECHANISMS; EXPRESSION; MIGRATION; RANTES; MOUSE	Exaggerated inflammatory response results in pathogenesis of various inflammatory diseases. Tumor Necrosis Factor-alpha (TNF) is a multi-functional pro-inflammatory cytokine regulating a wide spectrum of physiological, biological, and cellular processes. TNF induces Focal Adhesion Kinase (FAK) for various activities including induction of pro-inflammatory response. The mechanism of FAK activation by TNF is unknown and the involvement of cell surface integrins in modulating TNF response has not been determined. In the current study, we have identified an oxysterol 25-hydroxycholesterol (25HC) as a soluble extracellular lipid amplifying TNF mediated innate immune pro-inflammatory response. Our results demonstrated that 25HC-integrin-FAK pathway amplifies and optimizes TNF-mediated pro-inflammatory response. 25HC generating enzyme cholesterol 25-hydroxylase (C25H) was induced by TNF via NF kappa B and MAPK pathways. Specifically, chromatin immunoprecipitation assay identified binding of AP-1 (Activator Protein-1) transcription factor ATF2 (Activating Transcription Factor 2) to the C25H promoter following TNF stimulation. Furthermore, loss of C25H, FAK and alpha 5 integrin expression and inhibition of FAK and alpha 5 beta 1 integrin with inhibitor and blocking antibody, respectively, led to diminished TNF-mediated pro-inflammatory response. Thus, our studies show extracellular 25HC linking TNF pathway with integrin-FAK signaling for optimal pro-inflammatory activity and MAPK/NF kappa B-C25H-25HC-integrin-FAK signaling network playing an essential role to amplify TNF dependent pro-inflammatory response. Thus, we have identified 25HC as the key factor involved in FAK activation during TNF mediated response and further demonstrated a role of cell surface integrins in positively regulating TNF dependent pro-inflammatory response.	[Pokharel, Swechha M.; Chiok, Kim; Shil, Niraj K.; Mohanty, Indira; Bose, Santanu] Washington State Univ, Coll Vet Med, Dept Vet Microbiol & Pathol, Pullman, WA 99164 USA; [Shil, Niraj K.] Symbio Labs, Brooklyn, Vic, Australia	Washington State University	Bose, S (corresponding author), Washington State Univ, Coll Vet Med, Dept Vet Microbiol & Pathol, Pullman, WA 99164 USA.	santanu.bose@wsu.edu	Chiok, Kim Lam/AAR-2935-2021	Chiok, Kim Lam/0000-0002-2892-0998	National Institutes of Health (NIH) [AI083387]	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Research was supported by National Institutes of Health (NIH) grant AI083387 to Santanu Bose. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad Rasheed, 2019, Cell Physiol Biochem, V52, P908, DOI 10.33594/000000063; ANGEL P, 1987, CELL, V49, P729, DOI 10.1016/0092-8674(87)90611-8; Aomatsu T, 2012, INT J MOL MED, V30, P1152, DOI 10.3892/ijmm.2012.1094; Bauman DR, 2009, P NATL ACAD SCI USA, V106, P16764, DOI 10.1073/pnas.0909142106; Blanc M, 2013, IMMUNITY, V38, P106, DOI 10.1016/j.immuni.2012.11.004; Brenner D, 2015, NAT REV IMMUNOL, V15, P362, DOI 10.1038/nri3834; Burgos-Moron E, 2019, J CLIN MED, V8, DOI 10.3390/jcm8091385; Choe JY, 2016, RHEUMATOLOGY, V55, P928, DOI 10.1093/rheumatology/kev422; Corredor J, 2003, AM J PHYSIOL-CELL PH, V284, pC953, DOI 10.1152/ajpcell.00309.2002; Diczfalusy U, 2009, J LIPID RES, V50, P2258, DOI 10.1194/jlr.M900107-JLR200; Dinarello CA, 2016, NAT REV RHEUMATOL, V12, DOI 10.1038/nrrheum.2015.180; Du HY, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01620; Funakoshi-Tago M, 2003, J BIOL CHEM, V278, P29359, DOI 10.1074/jbc.M213115200; Gold ES, 2014, P NATL ACAD SCI USA, V111, P10666, DOI 10.1073/pnas.1404271111; Guo WJ, 2004, NAT REV MOL CELL BIO, V5, P816, DOI 10.1038/nrm1490; Hashimoto S, 2000, CLIN EXP ALLERGY, V30, P48; Hashimoto S, 1999, ALLERGY, V54, P1168, DOI 10.1034/j.1398-9995.1999.00224.x; Hayden MS, 2014, SEMIN IMMUNOL, V26, P253, DOI 10.1016/j.smim.2014.05.004; Holbrook Jonathan, 2019, F1000Res, V8, DOI 10.12688/f1000research.17023.1; Hu Z, 2018, INT J ONCOL, V53, P1691, DOI 10.3892/ijo.2018.4497; Huang SH, 2018, CLIN EXP RHEUMATOL, V36, P185; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Jeong K, 2019, BIOCHEM BIOPH RES CO, V509, P1034, DOI 10.1016/j.bbrc.2019.01.050; Kalliolias GD, 2016, NAT REV RHEUMATOL, V12, P49, DOI 10.1038/nrrheum.2015.169; Karin M, 2009, IMMUNOL REV, V228, P225, DOI 10.1111/j.1600-065X.2008.00755.x; Kong LW, 2015, INT IMMUNOPHARMACOL, V29, P401, DOI 10.1016/j.intimp.2015.10.023; Kulakovskiy IV, 2018, NUCLEIC ACIDS RES, V46, pD252, DOI 10.1093/nar/gkx1106; Lee CC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070339; LEE W, 1987, CELL, V49, P741, DOI 10.1016/0092-8674(87)90612-X; Lim ST, 2012, J CELL BIOL, V197, P907, DOI 10.1083/jcb.201109067; Liu J, 2012, P NATL ACAD SCI USA, V109, P191, DOI 10.1073/pnas.1105176108; Liu L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078253; Liu SY, 2013, IMMUNITY, V38, P92, DOI 10.1016/j.immuni.2012.11.005; Lund EG, 1998, J BIOL CHEM, V273, P34316, DOI 10.1074/jbc.273.51.34316; Magoro T, 2019, J BIOL CHEM, V294, P14591, DOI 10.1074/jbc.RA119.007555; McDonald JG, 2010, J LEUKOCYTE BIOL, V88, P1071, DOI 10.1189/jlb.0710418; Mizgerd JP, 2018, CLIN CHEST MED, V39, P669, DOI 10.1016/j.ccm.2018.07.002; Mon NN, 2006, CANCER RES, V66, P6778, DOI 10.1158/0008-5472.CAN-05-4159; Nedeva C, 2019, FRONT CELL DEV BIOL, V7, DOI 10.3389/fcell.2019.00108; Nelson JD, 2006, NAT PROTOC, V1, P179, DOI 10.1038/nprot.2006.27; Nguyen J, 2006, IMMUNOL LETT, V106, P34, DOI 10.1016/j.imlet.2006.04.003; Nishitsuji H, 2016, P NATL ACAD SCI USA, V113, P10388, DOI 10.1073/pnas.1525022113; O'Grady NP, 2002, CLIN INFECT DIS, V35, P1281, DOI 10.1086/344188; Pan W, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147034; Plotnikov A, 2011, BBA-MOL CELL RES, V1813, P1619, DOI 10.1016/j.bbamcr.2010.12.012; Pober JS, 2002, ARTHRITIS RES THER, V4, pS109, DOI 10.1186/ar576; Pokharel SM, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09453-x; Rani A, 2019, AM J PATHOL, V189, P2119, DOI 10.1016/j.ajpath.2019.07.007; Reboldi A, 2014, SCIENCE, V345, P679, DOI 10.1126/science.1254790; Salameh A, 2010, J BIOL CHEM, V285, P23094, DOI 10.1074/jbc.M109.087221; Schlaepfer DD, 2007, J BIOL CHEM, V282, P17450, DOI 10.1074/jbc.M610672200; Sedger LM, 2014, CYTOKINE GROWTH F R, V25, P453, DOI 10.1016/j.cytogfr.2014.07.016; TRACEY KJ, 1994, ANNU REV MED, V45, P491, DOI 10.1146/annurev.med.45.1.491; Tseng WP, 2010, J CELL PHYSIOL, V223, P389, DOI 10.1002/jcp.22047; Wang HY, 2019, BIOMED PHARMACOTHER, V118, DOI 10.1016/j.biopha.2019.109379; Wong CK, 2006, ALLERGY, V61, P289, DOI 10.1111/j.1398-9995.2006.00972.x; Yang YN, 2012, OPHTHALMIC RES, V48, P165, DOI 10.1159/000338819; Ye J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134; Zhang MH, 2016, MOL MED REP, V14, P551, DOI 10.3892/mmr.2016.5250; Zhang P, 2015, EUR J ORAL SCI, V123, P249, DOI 10.1111/eos.12191; Zhou P, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00464	61	1	1	3	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2021	16	9							e0257576	10.1371/journal.pone.0257576	http://dx.doi.org/10.1371/journal.pone.0257576			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YS4WS	34551004	Green Published, gold			2022-12-26	WOS:000750679800026
J	Anastasiadou, E; Ceccarelli, S; Messina, E; Gerini, G; Megiorni, F; Pontecorvi, P; Camero, S; Onesti, MG; Trivedi, P; Faenza, M; Coscioni, E; Nicoletti, GF; Napoli, C; Marchese, C				Anastasiadou, Eleni; Ceccarelli, Simona; Messina, Elena; Gerini, Giulia; Megiorni, Francesca; Pontecorvi, Paola; Camero, Simona; Onesti, Maria Giuseppina; Trivedi, Pankaj; Faenza, Mario; Coscioni, Enrico; Nicoletti, Giovanni Francesco; Napoli, Claudio; Marchese, Cinzia			MiR-200c-3p maintains stemness and proliferative potential in adipose-derived stem cells by counteracting senescence mechanisms	PLOS ONE			English	Article							MESENCHYMAL STROMAL CELLS; CANCER-CELLS; HLA-G; INHIBITION; EXPRESSION; FAMILY; NANOG; DIFFERENTIATION; PLURIPOTENCY; BIOGENESIS	Adipose-derived mesenchymal stem cells (ASCs) are promising therapeutic tools in regenerative medicine because they possess self-renewal, differentiation and immunomodulatory capacities. After isolation, ASCs are passaged multiple times in vitro passages to obtain a sufficient amount of cells for clinical applications. During this time-consuming procedure, ASCs become senescent and less proliferative, compromising their clinical efficacy. Here, we sought to investigate how in vitro passages impact ASC proliferation/senescence and expression of immune regulatory proteins. MicroRNAs are pivotal regulators of ASC physiology. Particularly, miR-200c is known to maintain pluripotency and targets the immune checkpoint Programmed death-ligand 1 (PD-L1). We therefore investigated its involvement in these critical characteristics of ASCs during in vitro passages. We found that when transiently expressed, miR-200c-3p promotes proliferation, maintains stemness, and contrasts senescence in late passaged ASCs. Additionally, this miRNA modulates PD-L1 and Indoleamine 2,3-Dioxygenase (IDO1) expression, thus most likely interfering with the immunoregulatory capacity of ASCs. Based on our results, we suggest that expression of miR-200c-3p may prime ASC towards a self-renewing phenotype by improving their in vitro expansion. Contrarily, its inhibition is associated with senescence, reduced proliferation and induction of immune regulators. Our data underline the potential use of miR-200c-3p as a switch for ASCs reprogramming and their clinical application.	[Anastasiadou, Eleni; Ceccarelli, Simona; Messina, Elena; Gerini, Giulia; Megiorni, Francesca; Pontecorvi, Paola; Trivedi, Pankaj; Marchese, Cinzia] Sapienza Univ Rome, Dept Expt Med, Rome, Italy; [Camero, Simona] Sapienza Univ Rome, Dept Maternal Infantile & Urol Sci, Rome, Italy; [Onesti, Maria Giuseppina] Sapienza Univ Rome, Dept Surg P Valdoni, Plast Surg Unit, Rome, Italy; [Faenza, Mario; Nicoletti, Giovanni Francesco] Univ Campania Luigi Vanvitelli, Multidisciplinary Dept Med Surg & Dent Sci, Plast Surg Unit, Naples, Italy; [Coscioni, Enrico] Azienda Osped Univ San Giovanni Dio & Ruggi Arago, Dept Cardiac Surg, Salerno, Italy; [Napoli, Claudio] Univ Campania Luigi Vanvitelli, Dept Adv Med & Surg Sci DAMSS, Naples, Italy	Sapienza University Rome; Sapienza University Rome; Sapienza University Rome; Universita della Campania Vanvitelli; Universita della Campania Vanvitelli	Anastasiadou, E (corresponding author), Sapienza Univ Rome, Dept Expt Med, Rome, Italy.	eleni.anastasiadou@uniroma1.it	Pontecorvi, Paola/HCG-8957-2022; Messina, Elena/HGB-1187-2022; Faenza, Mario/E-1140-2018; ANASTASIADOU, ELENI/AAU-6080-2021; Megiorni, Francesca/AAC-1597-2019	Messina, Elena/0000-0002-7182-2883; Faenza, Mario/0000-0002-0077-8977; ANASTASIADOU, ELENI/0000-0003-0212-6734; Megiorni, Francesca/0000-0003-3705-3248; CAMERO, SIMONA/0000-0001-8286-3640	PRIN 2017 [F8ZB89]; Ateneo 2020 grant [RM1201729DF399F4]	PRIN 2017(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); Ateneo 2020 grant	Initials of the authors who received each award: CM, CN, FM Grant numbers awarded to each author: CN and CM, PRIN 2017 (n. F8ZB89). FM, Ateneo 2020 grant (n. RM1201729DF399F4). URL of each funder website: not applicable The full name of each funder: Cinzia Marchese, Claudio Napoli, Francesca Megiorni The funders have read, edited and approved the manuscript before submission.	Anastasiadou E, 2021, CELLS-BASEL, V10, DOI 10.3390/cells10030519; Anastasiadou E, 2019, LEUKEMIA, V33, P132, DOI 10.1038/s41375-018-0178-x; Balzano F, 2018, MOLECULES, V23, DOI 10.3390/molecules23020282; Bourguignon LYW, 2008, J BIOL CHEM, V283, P17635, DOI 10.1074/jbc.M800109200; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Camero S, 2020, CANCER LETT, V479, P71, DOI 10.1016/j.canlet.2020.03.011; Carter JV, 2019, ONCOL LETT, V18, P3994, DOI 10.3892/ol.2019.10753; Ceccarelli S, 2020, FRONT CELL DEV BIOL, V8, DOI 10.3389/fcell.2020.00236; Ceccarelli S, 2018, STEM CELLS INT, V2018, DOI 10.1155/2018/1075156; Cheng HC, 2011, MOL BIOL REP, V38, P5161, DOI 10.1007/s11033-010-0665-2; Ciavarella S, 2012, BRIT J HAEMATOL, V157, P586, DOI 10.1111/j.1365-2141.2012.09082.x; Do DV, 2013, GENE DEV, V27, P1378, DOI 10.1101/gad.221176.113; Espagnolle N, 2020, STEM CELLS INT, V2020, DOI 10.1155/2020/4173578; Francisco LM, 2010, IMMUNOL REV, V236, P219, DOI 10.1111/j.1600-065X.2010.00923.x; Gieseke F, 2010, BLOOD, V116, P3770, DOI 10.1182/blood-2010-02-270777; Herreros MD, 2019, STEM CELLS INT, V2019, DOI 10.1155/2019/6132340; Huang HN, 2014, STEM CELL RES, V12, P338, DOI 10.1016/j.scr.2013.11.009; Jain AK, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001268; Kim KW, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0197-8; Kim Y, 2017, INT J STEM CELLS, V10, P28, DOI 10.15283/ijsc17013; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; Mashayekhi P, 2019, CELL J, V21, P179, DOI 10.22074/cellj.2019.5903; Mbongue JC, 2015, VACCINES-BASEL, V3, P703, DOI 10.3390/vaccines3030703; Miyoshi N, 2011, CELL STEM CELL, V8, P633, DOI 10.1016/j.stem.2011.05.001; Mokhberian N, 2020, LIFE SCI, V257, DOI 10.1016/j.lfs.2020.118055; Morin RD, 2008, GENOME RES, V18, P610, DOI 10.1101/gr.7179508; Najar M, 2010, EXP HEMATOL, V38, P922, DOI 10.1016/j.exphem.2010.05.007; Truong NC, 2019, ADV EXP MED BIOL, V1084, P109, DOI 10.1007/5584_2018_235; Pan Q, 2017, CANCER LETT, V392, P26, DOI 10.1016/j.canlet.2017.01.039; Park CW, 2010, RNA BIOL, V7, P606, DOI 10.4161/rna.7.5.13215; Park H, 2015, DIFFERENTIATION, V90, P91, DOI 10.1016/j.diff.2015.10.010; Park SM, 2008, GENE DEV, V22, P894, DOI 10.1101/gad.1640608; Patsoukis N, 2020, SCI ADV, V6, DOI 10.1126/sciadv.abd2712; Pepin ME, 2020, FRONT GENET, V11, DOI 10.3389/fgene.2020.00346; Pierantozzi E, 2011, STEM CELLS DEV, V20, P915, DOI 10.1089/scd.2010.0353; Pitrone M, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18061107; Pyzer AR, 2017, LEUKEMIA, V31, P2780, DOI 10.1038/leu.2017.163; Ren S, 2019, STEM CELL RES THER, V10, DOI 10.1186/s13287-019-1152-x; Sato A, 2013, STEM CELL RES, V11, P601, DOI 10.1016/j.scr.2013.04.004; Savickiene J, 2016, STEM CELLS INT, V2016, DOI 10.1155/2016/2019498; Schiano C, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0236951; Solozobova Valeriya, 2011, World J Biol Chem, V2, P202, DOI 10.4331/wjbc.v2.i9.202; Sommese L, 2019, EXPERT REV ENDOCRINO, V14, P233, DOI 10.1080/17446651.2019.1620103; Sommese L, 2018, ADV MED SCI-POLAND, V63, P317, DOI 10.1016/j.advms.2018.04.004; Tang R, 2012, CELL RES, V22, P504, DOI 10.1038/cr.2011.137; Teklemariam T, 2014, BIOCHEM BIOPH RES CO, V452, P753, DOI 10.1016/j.bbrc.2014.08.152; Ueyama H, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-60041-2; Vescarelli E, 2020, J EXP CLIN CANC RES, V39, DOI 10.1186/s13046-019-1490-7; Wagner W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002213; Xu N, 2009, CELL, V137, P647, DOI 10.1016/j.cell.2009.02.038; Yang HM, 2012, CYTOTHERAPY, V14, P70, DOI 10.3109/14653249.2011.613926; Zhang ML, 2019, MODERN PATHOL, V32, P511, DOI 10.1038/s41379-018-0160-1; Zheng GP, 2017, RESP RES, V18, DOI 10.1186/s12931-017-0599-5; Zhou KJ, 2018, STEM CELLS DEV, V27, P1191, DOI 10.1089/scd.2018.0033	54	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2021	16	9							e0257070	10.1371/journal.pone.0257070	http://dx.doi.org/10.1371/journal.pone.0257070			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	WG5ZQ	34534238	Green Published, gold			2022-12-26	WOS:000707073300017
J	Davis, AJ; MacCarron, P; Cohen, E				Davis, Arran J.; MacCarron, Padraig; Cohen, Emma			Social reward and support effects on exercise experiences and performance: Evidence from parkrun	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; HEALTH; PAIN; LONELINESS; MECHANISMS; PARTICIPATION; INACTIVITY; MEDIATION; COHESION; RUN	There is growing academic, civic and policy interest in the public health benefits of community-based exercise events. Shifting the emphasis from competitive sport to communal activity, these events have wide appeal. In addition to physical health benefits, regular participation can reduce social isolation and loneliness through opportunities for social connection. Taking a broad evolutionary and social psychological perspective, we suggest that social factors warrant more attention in current approaches to physical (in)activity and exercise behavior. We develop and test the hypothesis that social reward and support in exercise are associated with positive exercise experiences and greater performance outputs. Using a repeated-measures design, we examine the influence of social perceptions and behavior on subjective enjoyment, energy, fatigue, effort, and objective performance (run times) among a UK sample of parkrun participants. Social factors were associated with greater subjective enjoyment and energy. Higher subjective energy, in turn, was associated with faster run times, without any corresponding increase in perceived effort. No significant main effects of social factors on fatigue, performance or effort were detected. The role of social structural factors has long been recognized in public health approaches to physical activity. Our results indicate that there should be greater research attention on how positive and rewarding social behaviors and experiences-particularly subjective enjoyment and energy, and perceptions of community social support and belonging-influence exercise-related behavior, psychology and physiology, and promote health through collective physical activity. The research also supplements traditional emphases on social facilitation and team sport that have dominated sport and exercise psychology and offers new avenues for understanding the deep connections among psychological, social and physical function in everyday health.	[Davis, Arran J.; Cohen, Emma] Univ Oxford, Inst Human Sci, Social Body Lab, Oxford, England; [MacCarron, Padraig] Univ Limerick, Math Applicat Consortium Sci & Ind, Limerick, Ireland; [Cohen, Emma] Wadham Coll, Oxford, England	University of Oxford; University of Limerick; University of Oxford	Cohen, E (corresponding author), Univ Oxford, Inst Human Sci, Social Body Lab, Oxford, England.; Cohen, E (corresponding author), Wadham Coll, Oxford, England.	emma.cohen@anthro.ox.ac.uk		Davis, Arran/0000-0002-8561-7768; Cohen, Emma/0000-0002-5465-3440	Clarendon Scholarship, University of Oxford; British Academy Fellowship [MD130076]; British Academy; Science Foundation Ireland [16/IA/4470]	Clarendon Scholarship, University of Oxford; British Academy Fellowship; British Academy; Science Foundation Ireland(Science Foundation IrelandEuropean Commission)	AD: Clarendon Scholarship, University of Oxford; https://www.ox.ac.uk/clarendon EC: British Academy Fellowship (ref: MD130076). The British Academy. (www.britishacademy.ac.uk) PMC: Science Foundation Ireland, grant number 16/IA/4470 The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acevedo BP, 2012, SOC COGN AFFECT NEUR, V7, P145, DOI 10.1093/scan/nsq092; Aiello JR, 2001, GROUP DYN-THEOR RES, V5, P163, DOI 10.1037//1089-2699.5.3.163; Barkley JE, 2012, PEDIATRICS, V129, pE659, DOI 10.1542/peds.2011-0496; Bauer DJ, 2006, PSYCHOL METHODS, V11, P142, DOI 10.1037/1082-989X.11.2.142; Bauman A, 2009, BRIT J SPORT MED, V43, P44, DOI 10.1136/bjsm.2008.054189; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Boecker H, 2008, CEREB CORTEX, V18, P2523, DOI 10.1093/cercor/bhn013; Bolin JH, 2014, J EDUC MEAS, V51, P335, DOI 10.1111/jedm.12050; Bonferroni C.E, 1936, PUBBL R 1 SUPER SCI, V8, P3; BORG GAV, 1982, MED SCI SPORT EXER, V14, P377, DOI 10.1249/00005768-198205000-00012; Burke SM., 2008, INT REV SPORT EXER P, V1, P107, DOI [DOI 10.1080/17509840802227065, 10.1080/17509840802227065]; Cacioppo JT, 2018, LANCET, V391, P426, DOI 10.1016/S0140-6736(18)30142-9; Carnes AJ., 2016, J EXER PHYSL ONLINE, V19, P24; Carron A.V., 1998, ADV SPORT EXERCISE P, V213
226; Christensen U, 2006, HEALTH EDUC BEHAV, V33, P677, DOI 10.1177/1090198105277397; Cohen EEA, 2010, BIOL LETTERS, V6, P106, DOI 10.1098/rsbl.2009.0670; Davis A, 2018, ADAPT HUM BEHAV PHYS, V4, P171, DOI 10.1007/s40750-017-0086-8; Davis A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136705; Davis AJ, 2021, PHYSIOL BEHAV, V239, DOI 10.1016/j.physbeh.2021.113490; Dunbar RIM, 2012, P ROY SOC B-BIOL SCI, V279, P1161, DOI 10.1098/rspb.2011.1373; Dunbar RIM, 2010, BEHAVIOUR, V147, P775, DOI 10.1163/000579510X501151; Durcan D., 2015, REDUCING SOCIAL ISOL; Eisenberger NI, 2011, P NATL ACAD SCI USA, V108, P11721, DOI 10.1073/pnas.1108239108; Ekkekakis P, 2013, PSYCHOL SPORT EXERC, V14, P751, DOI 10.1016/j.psychsport.2013.04.007; Field A., 2012, DISCOVERING STAT USI; Galper DI, 2006, MED SCI SPORT EXER, V38, P173, DOI 10.1249/01.mss.0000180883.32116.28; Gibson AS, 2018, EUR J SPORT SCI, V18, P25, DOI 10.1080/17461391.2017.1321688; Graupensperger S, 2019, SPORT EXERC PERFORM, V8, P290, DOI 10.1037/spy0000157; GROVE JR, 1992, INT J SPORT PSYCHOL, V23, P93; Grunseit AC, 2020, PREV MED REP, V20, DOI 10.1016/j.pmedr.2020.101231; Guthold R, 2020, LANCET CHILD ADOLESC, V4, P23, DOI 10.1016/S2352-4642(19)30323-2; Guthold R, 2018, LANCET GLOB HEALTH, V6, pE1077, DOI [10.1016/s2214-109x(18)30357-7, 10.1016/S2214-109X(18)30357-7]; Hartman ME, 2019, J EXP BIOL, V222, DOI 10.1242/jeb.186585; Harvey SB, 2010, BRIT J PSYCHIAT, V197, P357, DOI 10.1192/bjp.bp.109.075176; Hawkley LC, 2010, ANN BEHAV MED, V40, P218, DOI 10.1007/s12160-010-9210-8; Hawkley LC, 2009, HEALTH PSYCHOL, V28, P354, DOI 10.1037/a0014400; Hennessy MB, 2009, FRONT NEUROENDOCRIN, V30, P470, DOI 10.1016/j.yfrne.2009.06.001; Hettinga FJ, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00118; Hickson, 2014, IEEE T POWER ELECTR, P1; Hindley D, 2020, LEISURE SCI, V42, P85, DOI 10.1080/01490400.2017.1410741; Hornstein EA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175891; Imai K, 2010, STAT SCI, V25, P51, DOI 10.1214/10-STS321; Inagaki TK, 2016, SOC COGN AFFECT NEUR, V11, P728, DOI 10.1093/scan/nsw006; Inagaki TK, 2013, PSYCHOL SCI, V24, P2272, DOI 10.1177/0956797613492773; Jaremka LM, 2011, SELF IDENTITY, V10, P44, DOI 10.1080/15298860903513881; Karhson DS, 2016, TRANSL PSYCHIAT, V6, DOI 10.1038/tp.2016.169; Kockelman P., 2017, DISTRIBUTED AGENCY, P141; Kohl HW, 2012, LANCET, V380, P294, DOI 10.1016/S0140-6736(12)60898-8; Krach S, 2010, FRONT BEHAV NEUROSCI, V4, DOI 10.3389/fnbeh.2010.00022; Kuznetsova A., 2015, R PACKAGE VERSION PA; Leknes S, 2008, NAT REV NEUROSCI, V9, P314, DOI 10.1038/nrn2333; Marcora S., 2019, ENDURANCE PERFORMANC, P15, DOI DOI 10.4324/9781315167312-2; McLennan AK, 2018, LANCET, V391, P1480, DOI 10.1016/S0140-6736(18)30577-4; McNair D., 1971, MANUAL PROFILE MOOD; McNeill LH, 2006, SOC SCI MED, V63, P1011, DOI 10.1016/j.socscimed.2006.03.012; McPherson M, 2006, AM SOCIOL REV, V71, P353, DOI 10.1177/000312240607100301; Morris P, 2019, ADV MENT HEALTH, V17, P110, DOI 10.1080/18387357.2018.1509011; Nakagawa S, 2013, METHODS ECOL EVOL, V4, P133, DOI 10.1111/j.2041-210x.2012.00261.x; O'Connor PJ, 2005, MED SCI SPORT EXER, V37, P299, DOI 10.1249/01.MSS.0000152802.89770.CF; Park J, 2013, J HEALTH PSYCHOL, V18, P226, DOI 10.1177/1359105312439731; Pattyn N, 2018, FRONT PSYCHOL, V9, DOI 10.3389/fpsyg.2018.01246; Prapavessis H, 1997, SMALL GR RES, V28, P294, DOI 10.1177/1046496497282006; Raedeke TD, 2007, J APPL SPORT PSYCHOL, V19, P105, DOI 10.1080/10413200601113638; Raichlen DA, 2013, EUR J APPL PHYSIOL, V113, P869, DOI 10.1007/s00421-012-2495-5; Raichlen DA, 2012, J EXP BIOL, V215, P1331, DOI 10.1242/jeb.063677; Scheipl F., 2020, LINEAR MIXED EFFECTS, DOI 10.18637/jss.v067.i01; Schnall S, 2008, J EXP SOC PSYCHOL, V44, P1246, DOI 10.1016/j.jesp.2008.04.011; Schnijder T.A.B., 2012, MULTILEVEL ANAL INTR, V2nd ed; Shvedko A, 2018, PSYCHOL SPORT EXERC, V34, P128, DOI 10.1016/j.psychsport.2017.10.003; Snijders T. A. B., 2011, MULTILEVEL ANAL INTR; Sparling PB, 2003, NEUROREPORT, V14, P2209, DOI 10.1097/00001756-200312020-00015; Spink KS., 2013, PSYCHOL SPORT EXERC; Stevens M, 2017, SPORTS MED, V47, P1911, DOI 10.1007/s40279-017-0720-4; Stevinson C, 2014, J PUBLIC HEALTH-UK, V36, P268, DOI 10.1093/pubmed/fdt082; Stevinson C, 2015, INT J BEHAV MED, V22, P170, DOI 10.1007/s12529-014-9431-5; Sullivan P., 2012, INT J SPORT EXERC PS, P1; Tarr B, 2015, BIOL LETTERS, V11, DOI 10.1098/rsbl.2015.0767; Tingley D, 2014, J STAT SOFTW, V59; Trezza V, 2010, TRENDS PHARMACOL SCI, V31, P463, DOI 10.1016/j.tips.2010.06.008; Tuncgenc B, 2018, DEVELOPMENTAL SCI, V21, DOI 10.1111/desc.12505; Uchida Y, 2008, PERS SOC PSYCHOL B, V34, P741, DOI 10.1177/0146167208315157; Uchino BN, 1996, PSYCHOL BULL, V119, P488, DOI 10.1037/0033-2909.119.3.488; Umberson D, 2010, J HEALTH SOC BEHAV, V51, pS54, DOI 10.1177/0022146510383501; Wei D, 2015, P NATL ACAD SCI USA, V112, P14084, DOI 10.1073/pnas.1509795112; Williams DM, 2008, J SPORT EXERCISE PSY, V30, P471, DOI 10.1123/jsep.30.5.471; Wiltshire GR, 2018, SOCIOL HEALTH ILL, V40, P3, DOI 10.1111/1467-9566.12622; Wiltshire G, 2018, QUAL RES SPORT EXERC, V10, P47, DOI 10.1080/2159676X.2017.1376347	87	3	3	3	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2021	16	9							e0256546	10.1371/journal.pone.0256546	http://dx.doi.org/10.1371/journal.pone.0256546			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	WG6DR	34525097	Green Submitted, Green Published, gold			2022-12-26	WOS:000707084400016
J	Wen, XR; Wang, S; Taveira, TH; Akhlaghi, F				Wen, Xuerong; Wang, Shuang; Taveira, Tracey H.; Akhlaghi, Fatemeh			Required warfarin dose and time in therapeutic range in patients with diagnosed Nonalcoholic Fatty Liver Disease (NAFLD) or Nonalcoholic Steatohepatitis (NASH)	PLOS ONE			English	Article							ATRIAL-FIBRILLATION; ORAL ANTICOAGULATION; DRUG-DRUG; PREVALENCE; QUALITY; RISK; METAANALYSIS; MANAGEMENT; INTENSITY; OUTCOMES	Warfarin has been widely used to treat thromboembolism. The effect of nonalcoholic fatty liver disease (NAFLD) or nonalcoholic steatohepatitis (NASH), on warfarin dosing remains unknown. This study aims to examine the effects of NAFLD/NASH on the average daily dose (ADD) of warfarin and the time in therapeutic range (TTR). This is a retrospective study utilizing an administrative data. We included patients with at least 2 months of warfarin dispensing and two subsequent consecutive INR measures. The ADD of warfarin to achieve therapeutic range INR levels, and TTR were compared between patients with and without NAFLD/NASH in four subgroups of patients accounting for the presence of obesity and diabetes. Generalized linear models (GLM) with Propensity score (PS) fine stratification were applied to evaluate the relative differences (RD) of warfarin ADD and TTR (>60%) in four subgroups. A total of 430 NAFLD/NASH patients and 38,887 patients without NAFLD/NASH were included. The ADD and TTR, were not significant in the overall cohort between those with and without NAFLD/NASH. However, GLM results in patients without diabetes or obesity (N = 26,685) showed a significantly lower warfarin ADD (RD: -0.38; 95%CI: -0.74--0.02) and shorter TTR (OR: 0.71; 95%CI: 0.52-0.97) in patients diagnosed with NAFLD/NASH. The effects of NAFLD/NASH on warfarin dose or TTR were observed in patients without obesity and diabetes. Obesity and diabetes appear to be significant modifiers for the effects of NAFLD/NASH on warfarin dose and TTR.	[Wen, Xuerong; Wang, Shuang; Taveira, Tracey H.] Univ Rhode Isl, Coll Pharm, Hlth Outcomes, Dept Pharm Practice, Kingston, RI 02881 USA; [Taveira, Tracey H.] Providence Vet Affairs Med Ctr, Cardiovasc Dept, Providence, RI USA; [Taveira, Tracey H.] Brown Univ, Warren Alpert Sch Med, Providence, RI 02912 USA; [Akhlaghi, Fatemeh] Univ Rhode Isl, Coll Pharm, Clin Pharmacokinet Res Lab, Dept Biomed & Pharmaceut Sci, Kingston, RI 02881 USA	University of Rhode Island; US Department of Veterans Affairs; Veterans Health Administration (VHA); Providence VA Medical Center; Brown University; University of Rhode Island	Wen, XR (corresponding author), Univ Rhode Isl, Coll Pharm, Hlth Outcomes, Dept Pharm Practice, Kingston, RI 02881 USA.	xuerongwen@uri.edu		Wen, Xuerong/0000-0002-4803-7895	CVS Health through University of Rhode Island, College of Pharmacy Healthcare Research Operating Fund program	CVS Health through University of Rhode Island, College of Pharmacy Healthcare Research Operating Fund program	This study was supported by an internal funding from the CVS Health through University of Rhode Island, College of Pharmacy Healthcare Research Operating Fund program.Xuerong Wen, Shuang Wang, Fetameh Akhlaghi received summer salaries from this internal grant in the summer of 2019. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen AM, 2018, HEPATOLOGY, V68, P2230, DOI 10.1002/hep.30094; Baker WL, 2009, J MANAGE CARE PHARM, V15, P244, DOI 10.18553/jmcp.2009.15.3.244; Ballestri S, 2020, ADV THER, V37, P1910, DOI 10.1007/s12325-020-01307-z; Bell DSH, 2018, DIABETES OBES METAB, V20, P2327, DOI 10.1111/dom.13371; Boulanger L, 2006, INT J CLIN PRACT, V60, P258, DOI 10.1111/j.1368-5031.2006.00790.x; Caldeira Daniel, 2014, BMC Res Notes, V7, P891, DOI 10.1186/1756-0500-7-891; Chen A, 2020, J AM HEART ASSOC, V9, DOI 10.1161/JAHA.120.017559; Ciurus T, 2015, KARDIOCHIR TORAKOCHI, V12, P334, DOI 10.5114/kitp.2015.56784; Clark JM, 2003, AM J GASTROENTEROL, V98, P960, DOI [10.1016/S0002-9270(03)00265-X, 10.1111/j.1572-0241.2003.07486.x]; Cobbina E, 2017, DRUG METAB REV, V49, P197, DOI 10.1080/03602532.2017.1293683; Crader M.F., 2022, STATPEARLS INTER NET; Dharmalingam Mala, 2018, Indian J Endocrinol Metab, V22, P421, DOI 10.4103/ijem.IJEM_585_17; Di Minno MND, 2010, WORLD J GASTROENTERO, V16, P6119, DOI 10.3748/wjg.v16.i48.6119; Efird LM, 2014, CIRC-CARDIOVASC QUAL, V7, P461, DOI 10.1161/CIRCOUTCOMES.113.000817; Fuchs Michael, 2019, Fed Pract, V36, P12; Gage BF, 2008, CLIN PHARMACOL THER, V84, P326, DOI 10.1038/clpt.2008.10; Gage BF, 2000, AM J MED, V109, P481, DOI 10.1016/S0002-9343(00)00545-3; Go AS, 2001, JAMA-J AM MED ASSOC, V285, P2370, DOI 10.1001/jama.285.18.2370; GOLDSTEIN LB, 1995, STROKE, V26, P1607, DOI 10.1161/01.STR.26.9.1607; Holbrook AM, 2005, ARCH INTERN MED, V165, P1095, DOI 10.1001/archinte.165.10.1095; Hylek EM, 1996, NEW ENGL J MED, V335, P540, DOI 10.1056/NEJM199608223350802; Jamwal R, 2018, MOL PHARMACEUT, V15, P2621, DOI 10.1021/acs.molpharmaceut.8b00159; January CT, 2014, CIRCULATION, V130, P2071, DOI 10.1161/CIR.0000000000000040; Johnson JA, 2017, CLIN PHARMACOL THER, V102, P397, DOI 10.1002/cpt.668; Kasner SE, 2016, AM J MED, V129, P431, DOI 10.1016/j.amjmed.2015.11.012; Kirley K, 2012, CIRC-CARDIOVASC QUAL, V5, P615, DOI 10.1161/CIRCOUTCOMES.112.967299; Klein TE, 2009, NEW ENGL J MED, V360, P753, DOI 10.1056/NEJMoa0809329; Lonardo A, 2015, DIGEST LIVER DIS, V47, P181, DOI 10.1016/j.dld.2014.09.020; Mantovani A, 2019, LIVER INT, V39, P758, DOI 10.1111/liv.14044; Mantovani A, 2018, DIABETES CARE, V41, P372, DOI 10.2337/dc17-1902; Marchesini G, 1999, AM J MED, V107, P450, DOI 10.1016/S0002-9343(99)00271-5; Menichelli D, 2021, EUR J CLIN INVEST, V51, DOI 10.1111/eci.13397; Miao LY, 2007, EUR J CLIN PHARMACOL, V63, P1135, DOI 10.1007/s00228-007-0381-6; Morgan CL, 2009, THROMB RES, V124, P37, DOI 10.1016/j.thromres.2008.09.016; Mueller JA, 2014, ANN PHARMACOTHER, V48, P584, DOI 10.1177/1060028013517541; Park HE, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-61750-4; Qamar A, 2018, J AM COLL CARDIOL, V71, P2162, DOI 10.1016/j.jacc.2018.03.023; Rassen JA, 2011, AM J EPIDEMIOL, V173, P1404, DOI 10.1093/aje/kwr001; Reynolds MW, 2004, CHEST, V126, P1938, DOI 10.1378/chest.126.6.1938; Rose AJ, 2010, J THROMB HAEMOST, V8, P2182, DOI 10.1111/j.1538-7836.2010.03996.x; Rose DK, 2018, J STROKE CEREBROVASC, V27, P2049, DOI 10.1016/j.jstrokecerebrovasdis.2018.04.004; ROSENDAAL FR, 1993, THROMB HAEMOSTASIS, V69, P236; Ruff CT, 2014, LANCET, V383, P955, DOI 10.1016/S0140-6736(13)62343-0; Rydberg DM, 2020, EUR J CLIN PHARMACOL, V76, P867, DOI 10.1007/s00228-020-02856-6; Sansone RA., 2009, PSYCHIAT EDGMONT, V6, P24; Schwabedissen CMZ, 2006, EUR J CLIN PHARMACOL, V62, P713, DOI 10.1007/s00228-006-0158-3; Senoo K, 2016, STROKE, V47, P523, DOI 10.1161/STROKEAHA.115.011876; Serfaty L, 2008, DIABETES METAB, V34, P634, DOI 10.1016/S1262-3636(08)74597-X; Serper M, 2021, HEPATOLOGY, V73, P219, DOI 10.1002/hep.31264; Shaik AN, 2016, J PHARM SCI-US, V105, P1976, DOI 10.1016/j.xphs.2016.03.011; Spinosa M, 2020, CURR PHARM DESIGN, V26, P1036, DOI [10.2174/138161282666600131101553, 10.2174/1381612826666200131101553]; Stine JG, 2018, CLIN TRANSL GASTROEN, V9, DOI 10.1038/s41424-018-0002-y; Teklay G, 2014, THROMB J, V12, DOI 10.1186/1477-9560-12-20; Tripodi A, 2011, J THROMB HAEMOST, V9, P1713, DOI 10.1111/j.1538-7836.2011.04429.x; Tripodi A, 2017, AM J GASTROENTEROL, V112, P274, DOI 10.1038/ajg.2016.498; Tripodi A, 2014, J HEPATOL, V61, P148, DOI 10.1016/j.jhep.2014.03.013; Tripodi A, 2011, NEW ENGL J MED, V365, P147, DOI 10.1056/NEJMra1011170; Urbonas G, 2019, MEDICINA-LITHUANIA, V55, DOI 10.3390/medicina55010015; Utzschneider KM, 2006, J CLIN ENDOCR METAB, V91, P4753, DOI 10.1210/jc.2006-0587; Wallace JL, 2013, J THROMB THROMBOLYS, V36, P96, DOI 10.1007/s11239-012-0811-x; Witt DM, 2016, J THROMB THROMBOLYS, V41, P187, DOI 10.1007/s11239-015-1319-y; Yamagishi S, 2019, CARDIOVASC DIABETOL, V18, DOI 10.1186/s12933-019-0818-0; Yoo SH, 2012, EUR J NEUROL, V19, P1547, DOI 10.1111/j.1468-1331.2012.03772.x; Zhang K, 2006, J MANAGE CARE PHARM, V12, P640, DOI 10.18553/jmcp.2006.12.8.640	64	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2021	16	9							e0251665	10.1371/journal.pone.0251665	http://dx.doi.org/10.1371/journal.pone.0251665			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	WG6DR	34525124	Green Published, gold			2022-12-26	WOS:000707084400004
J	Liljeroos, M; Milberg, P; Krevers, B; Milberg, A				Liljeroos, Maria; Milberg, Per; Krevers, Barbro; Milberg, Anna			Dying within dyads: Stress, sense of security and support during palliative home care	PLOS ONE			English	Article							QUALITY-OF-LIFE; FAMILY CAREGIVERS; CANCER-PATIENTS; HEART-FAILURE; ATTACHMENT; BURDEN; RELATIVES; DISTRESS; IMPACT; INSTRUMENT	Objectives To examine similarities and dissimilarities in patient and family caregiver dyads in their experience of stress, support, and sense of security. Methods 144 patients and their family caregivers participated. Patients were admitted to six Swedish specialist palliative home care units and diagnosed with a non-curable disease with an expected short survival. We analysed similarity patterns of answers within dyads (correlations) as well as dissimilarities, expressed as the difference between within-dyad responses. The latter were subjected to a model-building procedure using GLM, with 13 sociodemographic and clinical characteristics as independent variables. Results Within dyads, patients and family caregivers scored similar in their perception of support and sense of security with care. There was also dissimilarity within dyad responses in their perception of stress and support that could be attributed to sociodemographic or clinical characteristics. When patients scored higher levels of stress than family caregivers, the family caregiver was more likely to be male. Also family caregiver attachment style (attachment anxiety), patient age and the relationship of the family caregiver to the patient explained dissimilarities within the dyads. Conclusions Patients and family caregivers within the dyads often, but not always, had similar scores. We suggest that it is important that the healthcare staff identify situations in which perceptions within the dyads regarding stress and perception of support differ, such that they can recognise patients' and family caregivers' unique needs in different situations, to be able to provide adequate support and facilitate dyadic coping.	[Liljeroos, Maria; Krevers, Barbro; Milberg, Anna] Linkoping Univ, Dept Hlth Med & Caring Sci, Linkoping, Sweden; [Liljeroos, Maria] Uppsala Univ, Ctr Clin Res Sormland, Eskilstuna, Sweden; [Milberg, Per] Linkoping Univ, IFM Biol, Linkoping, Sweden; [Milberg, Anna] Linkoping Univ, Dept Adv Home Care, Norrkoping, Sweden; [Milberg, Anna] Linkoping Univ, Dept Med & Hlth Sci, Norrkoping, Sweden	Linkoping University; Uppsala University; Linkoping University; Linkoping University; Linkoping University	Liljeroos, M (corresponding author), Linkoping Univ, Dept Hlth Med & Caring Sci, Linkoping, Sweden.; Liljeroos, M (corresponding author), Uppsala Univ, Ctr Clin Res Sormland, Eskilstuna, Sweden.	maria.liljeroos@liu.se	Liljeroos, Maria/S-6410-2019	Liljeroos, Maria/0000-0002-7957-8600	Medical Research Council of Southeast Sweden [LIO-126821]; Swedish Society of Medicine [2008-21732]; Konung Gustaf V:s och Drottning Victorias Frimurarestiftelse [104821]	Medical Research Council of Southeast Sweden(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Swedish Society of Medicine; Konung Gustaf V:s och Drottning Victorias Frimurarestiftelse	AM This work was supported by the Medical Research Council of Southeast Sweden [grant number LIO-126821], the Swedish Society of Medicine [grant number 2008-21732], and `Konung Gustaf V:s och Drottning Victorias Frimurarestiftelse [grant number 104821] The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arambasic J, 2019, PSYCHO-ONCOLOGY, V28, P1134, DOI 10.1002/pon.5068; Balducci C, 2008, GERONTOLOGIST, V48, P276, DOI 10.1093/geront/48.3.276; Banerjee SC, 2017, TRANSL BEHAV MED, V7, P615, DOI 10.1007/s13142-017-0473-5; Bosscher RJ, 1998, BEHAV RES THER, V36, P339, DOI 10.1016/S0005-7967(98)00025-4; Boyes AW, 2011, J AFFECT DISORDERS, V135, P184, DOI 10.1016/j.jad.2011.07.016; Brooks R, 1996, HEALTH POLICY, V37, P53, DOI 10.1016/0168-8510(96)00822-6; Buck HG, 2018, INT J NURS STUD, V77, P232, DOI 10.1016/j.ijnurstu.2017.10.007; Chesla CA, 2003, FAM PROCESS, V42, P375, DOI 10.1111/j.1545-5300.2003.00375.x; COHEN S, 1983, J HEALTH SOC BEHAV, V24, P385, DOI 10.2307/2136404; Cook WL, 2001, CHILD DEV, V72, P1179, DOI 10.1111/1467-8624.00341; Doherty LC, 2016, EUR J CARDIOVASC NUR, V15, P203, DOI 10.1177/1474515115585237; Francis LE, 2016, SUPPORT CARE CANCER, V24, P3987, DOI 10.1007/s00520-016-3219-x; Ge LX, 2017, CANCER NURS, V40, P471, DOI 10.1097/NCC.0000000000000445; Hagedoorn M, 2008, PSYCHOL BULL, V134, P1, DOI 10.1037/0033-2909.134.1.1; Haley W E, 2001, Hosp J, V15, P1, DOI 10.1300/J011v15n04_01; Henoch I, 2007, J PAIN SYMPTOM MANAG, V34, P370, DOI 10.1016/j.jpainsymman.2006.12.005; Henoch I, 2012, J CLIN NURS, V21, P585, DOI 10.1111/j.1365-2702.2011.03923.x; Hodges LJ, 2005, SOC SCI MED, V60, P1, DOI 10.1016/j.socscimed.2004.04.018; Hudson P, 2003, MED J AUSTRALIA, V179, pS35; Krevers B, 2015, J PAIN SYMPTOM MANAG, V49, P586, DOI 10.1016/j.jpainsymman.2014.06.019; Krevers B, 2014, PSYCHO-ONCOLOGY, V23, P914, DOI 10.1002/pon.3502; Larsson BW, 2004, J CLIN NURS, V13, P226, DOI 10.1046/j.1365-2702.2003.00866.x; Lee KC, 2013, J PALLIAT MED, V16, P632, DOI 10.1089/jpm.2012.0499; Livingston G, 2017, LANCET, V390, P2673, DOI 10.1016/S0140-6736(17)31363-6; Lo C, 2009, PSYCHO-ONCOLOGY, V18, P490, DOI 10.1002/pon.1417; Macionis JJ, 2011, SOCIOLOGY GLOBAL INT, DOI [10.1016/j.jht.2011.05.003, DOI 10.1016/J.JHT.2011.05.003]; Mathews G, 2017, CURR OPIN SUPPORT PA, V11, P315, DOI 10.1097/SPC.0000000000000303; Milberg A, 2012, PSYCHO-ONCOLOGY, V21, P886, DOI 10.1002/pon.1982; Milberg A, 2014, PSYCHO-ONCOLOGY, V23, P1340, DOI 10.1002/pon.3564; Milberg A, 2011, PALLIAT SUPPORT CARE, V9, P251, DOI 10.1017/S1478951511000204; Murray SA, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2581; Nissen KG, 2016, PSYCHO-ONCOLOGY, V25, P1017, DOI 10.1002/pon.4057; O'Connor L, 2009, COLLEGIAN, V16, P201, DOI 10.1016/j.colegn.2009.04.005; Petry H, 2019, INT J NURS STUD, V96, P44, DOI 10.1016/j.ijnurstu.2018.11.008; Pitceathly C, 2003, EUR J CANCER, V39, P1517, DOI 10.1016/S0959-8049(03)00309-5; Reblin M, 2017, PSYCHO-ONCOLOGY, V26, P2285, DOI 10.1002/pon.4361; Rha SY, 2015, EUR J ONCOL NURS, V19, P376, DOI 10.1016/j.ejon.2015.01.004; Riffin C, 2018, J AM GERIATR SOC, V66, P1992, DOI 10.1111/jgs.15501; Sand L, 2009, J PAIN SYMPTOM MANAG, V37, P13, DOI 10.1016/j.jpainsymman.2008.01.013; Shaffer KM, 2017, SUPPORT CARE CANCER, V25, P965, DOI 10.1007/s00520-016-3488-4; Stajduhar KI, 2008, CANCER NURS, V31, P77, DOI 10.1097/01.NCC.0000305686.36637.b5; Tsilika E, 2015, SUPPORT CARE CANCER, V23, P87, DOI 10.1007/s00520-014-2329-6; Vehling S, 2019, J PSYCHOSOM RES, V116, P93, DOI 10.1016/j.jpsychores.2018.11.018; Vehling S, 2018, PSYCHO-ONCOLOGY, V27, P2525, DOI 10.1002/pon.4872; Ventura AD, 2014, PALLIATIVE MED, V28, P391, DOI 10.1177/0269216313511141; von Heymann-Horan A, 2019, PSYCHO-ONCOLOGY, V28, P264, DOI 10.1002/pon.4932; Watanabe SM, 2011, J PAIN SYMPTOM MANAG, V41, P456, DOI 10.1016/j.jpainsymman.2010.04.020; Yabroff KR, 2004, JNCI-J NATL CANCER I, V96, P1322, DOI 10.1093/jnci/djh255; Zaider TI, 2016, FAM SYST HEALTH, V34, P204, DOI 10.1037/fsh0000159; ZARIT SH, 1980, GERONTOLOGIST, V20, P649, DOI 10.1093/geront/20.6.649	50	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2021	16	9							e0257274	10.1371/journal.pone.0257274	http://dx.doi.org/10.1371/journal.pone.0257274			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	WG5RP	34520480	Green Published, gold			2022-12-26	WOS:000707052100017
J	Phatihattakorn, C; Wongsa, A; Pongpan, K; Anuwuthinawin, S; Mungmanthong, S; Wongprasert, M; Tassaneetrithep, B				Phatihattakorn, Chayawat; Wongsa, Artit; Pongpan, Kirakorn; Anuwuthinawin, Sanitra; Mungmanthong, Sakita; Wongprasert, Manthana; Tassaneetrithep, Boonrat			Seroprevalence of Zika virus in pregnant women from central Thailand	PLOS ONE			English	Article							CROSS-REACTIVITY; DENGUE VIRUS; INFECTION; PATHOGENESIS; ENHANCEMENT; ANTIBODIES; INFANTS	Zika virus (ZKV) infection in a pregnant woman, especially during the first trimester, often results in congenital anomalies. However, the pathogenic mechanism is unknown and one-third of ZKV infected pregnancies are asymptomatic. Neutralizing antibodies against ZKV has been reported in 70% of Thai adults, but the prevalence among pregnant women is unknown. Currently, vaccines and specific treatments for ZKV are under development. A better understanding of the immune status of pregnant women will increase the success of effective prevention guidelines. The prevalence of ZKV infection in pregnant women in antenatal care clinics was investigated during the rainy season from May to October 2019 at Siriraj Hospital, Bangkok, Thailand. We recruited 650 pregnant women (39.42% first, 52.26% second and 7.36% third trimester) and found that 30.77% had ZKV-specific IgG, and 39.81% had neutralizing antibodies (nAb) against ZKV (titer >= 10). Specific and neutralizing antibody levels varied by maternal age, trimester, and month. We further characterized the cross-reaction between ZKV and the four Dengue virus (DENV) serotypes by focused reduction neutralization test (FRNT) and found that cross-reactions were common. In conclusion, about 60% of pregnant women who living in central Thailand may be at risk of ZKV infection due to the absence of neutralizing antibodies against ZKV. The functions of cross-reactive antibodies between related viral genotypes require further study. These findings have implications for health care monitoring in pregnant women including determining the risk of ZKV infection, assisting the development of a flavivirus vaccine, and informing the development of preventative health policies.	[Phatihattakorn, Chayawat; Anuwuthinawin, Sanitra; Mungmanthong, Sakita] Mahidol Univ, Fac Med Siriraj Hosp, Dept Obstet & Gynecol, Bangkok, Thailand; [Phatihattakorn, Chayawat; Wongsa, Artit; Pongpan, Kirakorn; Tassaneetrithep, Boonrat] Mahidol Univ, Fac Med Siriraj Hosp, Ctr Res Excellence Immunoregulat, Bangkok, Thailand; [Wongprasert, Manthana] Siriraj Hosp, Dept Nursing, Div Obstet & Gynecol Nursing, Bangkok, Thailand	Mahidol University; Mahidol University; Mahidol University	Tassaneetrithep, B (corresponding author), Mahidol Univ, Fac Med Siriraj Hosp, Ctr Res Excellence Immunoregulat, Bangkok, Thailand.	boonrat.tas@mahidol.ac.th	Tassaneetrithep, Boonrat/AAF-5715-2022; Tassaneetrithep, Boonrat/ACF-0768-2022	Tassaneetrithep, Boonrat/0000-0001-9617-3659	Faculty of Medicine Siriraj Hospital, Mahidol University [R016236002]	Faculty of Medicine Siriraj Hospital, Mahidol University	The project was supported by a grant from the Faculty of Medicine Siriraj Hospital, Mahidol University, Grant Number (R016236002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agha SB, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2598-2; Barba-Spaeth G, 2016, NATURE, V536, P48, DOI 10.1038/nature18938; Bardina SV, 2017, SCIENCE, V356, P175, DOI 10.1126/science.aal4365; Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; Bhaumik SK, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11010019; Brasil P, 2016, NEW ENGL J MED, V375, P2321, DOI 10.1056/NEJMoa1602412; Britt WJ, 2018, SEMIN PERINATOL, V42, P155, DOI 10.1053/j.semperi.2018.02.003; Buathong R, 2015, AM J TROP MED HYG, V93, P380, DOI 10.4269/ajtmh.15-0022; Carteaux G, 2016, NEW ENGL J MED, V374, P1595, DOI 10.1056/NEJMc1602964; Cordeiro MT, 2016, J INFECT DIS, V214, P1897, DOI 10.1093/infdis/jiw477; Dash AP, 2013, J VECTOR DIS, V50, P77; de Teive E Argolo Angela Ferreira Lopes, 2016, BMC Infect Dis, V16, P546; Dejnirattisai W, 2016, NAT IMMUNOL, V17, P1102, DOI 10.1038/ni.3515; Department of Disease Control MoPH, 2018, ZIK VIR DIS SIT THAI; Dussupt V, 2020, NAT MED, V26, P228, DOI 10.1038/s41591-019-0746-2; Henderson AD, 2020, ELIFE, V9, DOI 10.7554/eLife.48460; Henderson AD, 2021, J NEURO-OPHTHALMOL, V41, pE598, DOI 10.1097/WNO.0000000000001127; Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006; Huzly D, 2016, EUROSURVEILLANCE, V21, P9, DOI 10.2807/1560-7917.ES.2016.21.16.30203; Ioos S, 2014, MED MALADIES INFECT, V44, P302, DOI 10.1016/j.medmal.2014.04.008; Kourtis AP, 2014, NEW ENGL J MED, V370, P2211, DOI 10.1056/NEJMra1213566; Lai LL, 2018, CLIN INFECT DIS, V66, P1, DOI 10.1093/cid/cix732; Leao VHP, 2020, CURR NEUROL NEUROSCI, V20, DOI 10.1007/s11910-020-01072-0; Li C, 2018, CELL REP, V23, P1424, DOI 10.1016/j.celrep.2018.04.005; Maciejewski S, 2020, SCI TRANSL MED, V12, DOI 10.1126/scitranslmed.aaw9066; Marban-Castro E, 2020, ANTIBODIES, V9, DOI 10.3390/antib9040056; Martins PR, 2020, PEDIATR NEUROL, V110, P20, DOI 10.1016/j.pediatrneurol.2020.05.007; Melo A, 2020, PRENATAL DIAG, V40, P1732, DOI 10.1002/pd.5831; Montecillo-Aguado MR, 2019, J IMMUNOL RES, V2019, DOI 10.1155/2019/7239347; Moreira-Soto A, 2020, VIRUS GENES, V56, P632, DOI 10.1007/s11262-020-01772-2; Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15; Mwaliko C, 2021, PATHOG GLOB HEALTH, V115, P21, DOI 10.1080/20477724.2020.1845005; Netto EM, 2017, MBIO, V8, DOI [10.1128/mBio.01390-17, 10.1128/mbio.01390-17]; Nurtop E, 2018, VIROL J, V15, DOI 10.1186/s12985-018-1105-5; Ospina ML, 2020, NEW ENGL J MED, V383, P537, DOI 10.1056/NEJMoa1911023; Paixao ES, 2018, OPEN FORUM INFECT DI, V5, DOI 10.1093/ofid/ofy073; Pedroso C, 2019, EMERG INFECT DIS, V25, P1485, DOI 10.3201/eid2508.190113; Petersen LR, 2016, NEW ENGL J MED, V374, P1552, DOI 10.1056/NEJMra1602113; Priyamvada L, 2017, EMERG MICROBES INFEC, V6, DOI 10.1038/emi.2017.42; Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338; Robbiani DF, 2017, CELL, V169, P597, DOI 10.1016/j.cell.2017.04.024; Ruchusatsawat K, 2019, LANCET INFECT DIS, V19, P439, DOI 10.1016/S1473-3099(18)30718-7; Scolari F, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.02036; Sharma V, 2020, CAN J MICROBIOL, V66, P87, DOI 10.1139/cjm-2019-0331; Silva NM, 2020, TROP MED INFECT DIS, V5, DOI 10.3390/tropicalmed5040150; Sornjai W, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-35643-6; Stettler K, 2016, SCIENCE, V353, P823, DOI 10.1126/science.aaf8505; Swamy GK, 2015, OBSTET GYNECOL, V125, P212, DOI 10.1097/AOG.0000000000000581; WHO, 2009, WHO TECH REP SER, V958, P1; Wikan N, 2016, ASIAN PAC J TROP MED, V9, P136, DOI 10.1016/j.apjtm.2016.01.017	50	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2021	16	9							e0257205	10.1371/journal.pone.0257205	http://dx.doi.org/10.1371/journal.pone.0257205			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	WG6OR	34516583	gold, Green Published			2022-12-26	WOS:000707114200018
J	Hochfeld, LM; Bertolini, M; Broadley, D; Botchkareva, NV; Betz, RC; Schoch, S; Nothen, MM; Heilmann-Heimbach, S				Hochfeld, Lara M.; Bertolini, Marta; Broadley, David; Botchkareva, Natalia V.; Betz, Regina C.; Schoch, Susanne; Nothen, Markus M.; Heilmann-Heimbach, Stefanie			Evidence for a functional interaction of WNT10A and EBF1 in male-pattern baldness	PLOS ONE			English	Article							SUSCEPTIBILITY VARIANTS; GENE; IDENTIFICATION; ALOPECIA; SUGGEST	More than 300 genetic risk loci have been identified for male pattern baldness (MPB) but little is known about the exact molecular mechanisms through which the associated variants exert their effects on MPB pathophysiology. Here, we aimed at further elucidating the regulatory architecture of the MPB risk locus on chromosome (chr.) 2q35, where we have previously reported a regulatory effect of the MPB lead variant on the expression of WNT10A. A HaploReg database research for regulatory annotations revealed that the association signal at 2q35 maps to a binding site for the transcription factor EBF1, whose gene is located at a second MPB risk locus on chr. 5q33.3. To investigate a potential interaction between EBF1 and WNT10A during MPB development, we performed in vitro luciferase reporter assays as well as expression analyses and immunofluorescence co-stainings in microdissected human hair follicles. Our experiments confirm that EBF1 activates the WNT10A promoter and that the WNT10A/EBF1 interaction is impacted by the allelic expression of the MPB risk allele at 2q35. Expression analyses across different hair cycle phases and immunhistochemical (co)stainings against WNT10A and EBF1 suggest a predominant relevance of EBF1/WNT10A interaction for hair shaft formation during anagen. Based on these findings we suggest a functional mechanism at the 2q35 risk locus for MPB, where an MPB-risk allele associated reduction in WNT10A promoter activation via EBF1 results in a decrease in WNT10A expression that eventually results in anagen shortening, that is frequently observed in MPB affected hair follicles. To our knowledge, this study is the first follow-up study on MPB that proves functional interaction between two MPB risk loci and sheds light on the underlying pathophysiological mechanism at these loci.	[Hochfeld, Lara M.; Betz, Regina C.; Nothen, Markus M.; Heilmann-Heimbach, Stefanie] Univ Bonn, Inst Human Genet, Sch Med, Bonn, Germany; [Hochfeld, Lara M.; Betz, Regina C.; Nothen, Markus M.; Heilmann-Heimbach, Stefanie] Univ Hosp Bonn, Bonn, Germany; [Bertolini, Marta] Skin & Hair Res Solut GmbH, Monasterium Lab, Munster, Germany; [Broadley, David; Botchkareva, Natalia V.] Univ Bradford, Ctr Skin Sci, Fac Life Sci, Bradford, W Yorkshire, England; [Schoch, Susanne] Univ Bonn, Med Ctr, Dept Neuropathol, Bonn, Germany	University of Bonn; University of Bonn; University of Bradford; University of Bonn	Heilmann-Heimbach, S (corresponding author), Univ Bonn, Inst Human Genet, Sch Med, Bonn, Germany.; Heilmann-Heimbach, S (corresponding author), Univ Hosp Bonn, Bonn, Germany.	sheilman@uni-bonn.de	Heilmann-Heimbach, Stefanie/H-5942-2018	Heilmann-Heimbach, Stefanie/0000-0003-1057-465X; Hochfeld, Lara/0000-0002-2808-0693	Monasterium Laboratory, Skin & Hair Research Solutions GmbH	Monasterium Laboratory, Skin & Hair Research Solutions GmbH	Monasterium Laboratory, Skin & Hair Research Solutions GmbH provided support in form of salaries for authors (M.B., D.B., N.V.B.) but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Beckstette M, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-389; Brockschmidt FF, 2011, BRIT J DERMATOL, V165, P1293, DOI 10.1111/j.1365-2133.2011.10708.x; Down TA, 2002, GENOME RES, V12, P458, DOI 10.1101/gr.216102; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Gisler R, 2000, BLOOD, V96, P1457, DOI 10.1182/blood.V96.4.1457.h8001457_1457_1464; Hagenaars SP, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006594; Hawkshaw NJ, 2020, BRIT J DERMATOL, V182, P1184, DOI 10.1111/bjd.18356; Heilmann S, 2013, J INVEST DERMATOL, V133, P1489, DOI 10.1038/jid.2013.43; Heilmann-Heimbach S, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14694; Heilmann-Heimbach S, 2016, EXP DERMATOL, V25, P251, DOI 10.1111/exd.12965; Hillmer AM, 2008, NAT GENET, V40, P1279, DOI 10.1038/ng.228; Kaufman KD, 2002, MOL CELL ENDOCRINOL, V198, P89, DOI 10.1016/S0303-7207(02)00372-6; Knudsen S, 1999, BIOINFORMATICS, V15, P356, DOI 10.1093/bioinformatics/15.5.356; Langan EA, 2015, EXP DERMATOL, V24, P903, DOI 10.1111/exd.12836; Lappalainen T, 2015, GENOME RES, V25, P1427, DOI 10.1101/gr.190983.115; Li R, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002746; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Matys V, 2003, NUCLEIC ACIDS RES, V31, P374, DOI 10.1093/nar/gkg108; McGuire AL, 2020, NAT REV GENET, V21, P581, DOI 10.1038/s41576-020-0272-6; Nyholt DR, 2003, J INVEST DERMATOL, V121, P1561, DOI 10.1111/j.1523-1747.2003.12615.x; Odenwald WF, 2005, P NATL ACAD SCI USA, V102, P14700, DOI 10.1073/pnas.0506915102; Ohn J, 2019, J DERMATOL SCI, V93, P144, DOI 10.1016/j.jdermsci.2019.02.004; Pickrell JK, 2016, NAT GENET, V48, P709, DOI 10.1038/ng.3570; Pirastu N, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01490-8; Pollard KS, 2010, GENOME RES, V20, P110, DOI 10.1101/gr.097857.109; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Richards JB, 2008, NAT GENET, V40, P1282, DOI 10.1038/ng.255; Rishikaysh P, 2014, INT J MOL SCI, V15, P1647, DOI 10.3390/ijms15011647; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Sun H, 2006, NUCLEIC ACIDS RES, V34, pD98, DOI 10.1093/nar/gkj096; Wang J, 2013, NUCLEIC ACIDS RES, V41, pD171, DOI 10.1093/nar/gks1221; WHITING DA, 1993, J AM ACAD DERMATOL, V28, P755, DOI 10.1016/0190-9622(93)70106-4; Wingender E, 2000, NUCLEIC ACIDS RES, V28, P316, DOI 10.1093/nar/28.1.316; Yap CX, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07862-y	34	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2021	16	9							e0256846	10.1371/journal.pone.0256846	http://dx.doi.org/10.1371/journal.pone.0256846			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XM9EM	34506541	gold, Green Published			2022-12-26	WOS:000729120700045
J	Jelani, QUA; Mena-Hurtado, C; Gosch, K; Mohammed, M; Labrosciano, C; Regan, C; Scierka, LE; Spertus, JA; Nagpal, S; Smolderen, KG				Jelani, Qurat-ul-ain; Mena-Hurtado, Carlos; Gosch, Kensey; Mohammed, Moghniuddin; Labrosciano, Clementine; Regan, Christopher; Scierka, Lindsey E.; Spertus, John A.; Nagpal, Sameer; Smolderen, Kim G.			Association of sleep apnea with outcomes in peripheral artery disease: Insights from the PORTRAIT study	PLOS ONE			English	Article							POSITIVE AIRWAY PRESSURE; QUALITY-OF-LIFE; CORONARY-HEART-DISEASE; CARDIOVASCULAR EVENTS; LOWER-EXTREMITY; RISK-FACTORS; HEALTH-STATUS; DEPRESSIVE SYMPTOMS; PREVALENCE; COMORBIDITY	Background Sleep apnea is a predictor of adverse cardiovascular outcome in many cardiovascular diseases but whether it is associated with worse health status outcomes or mortality in peripheral artery disease (PAD) is unknown. Methods PORTRAIT is an international (US, Netherlands, Australia) prospective PAD registry that consecutively enrolled patients who presented with new-onset or recent exacerbations of PAD symptoms to any of 16 vascular specialty clinics. Health status was assessed upon presentation and at 12 months with the disease-specific Peripheral Artery Questionnaire (PAQ). Higher PAQ scores indicate better health status. A sequentially-adjusted hierarchical linear regression model examined the association between sleep apnea and 1-year PAQ symptoms, quality of life, and summary scores. Five-year survival curves by comorbid sleep apnea status for US patients were compared using the log-rank test. Results The mean age of the 1204 PORTRAIT participants was 67.6 +/- 9.4 years with 37.5% women and 8.3% (n = 100) having sleep apnea. Patients with sleep apnea were more likely to be from the US, more sedentary, and to have diabetes, obesity, coronary disease, more depressive symptoms and a history of prior peripheral interventions. Paradoxically, they also had higher ankle-brachial indices, but lower PAQ Summary scores at presentation and 12 months (41.2 +/- 22.0 vs. 49.9 +/- 21.6 and 58.6 +/- 27.9 vs. 71.3 +/- 24.9, respectively, p = <0.05). The association between sleep apnea and 1-year health status persisted after multivariable adjustment, but there were no differences in all-cause mortality over 5 years (28.0% vs. 23.4%, p = 0.76). Conclusion In patients presenting with PAD, comorbid sleep apnea is independently associated with worse health status over time. Future studies should test whether better treatment of sleep apnea can improve the health status of patients with PAD.	[Jelani, Qurat-ul-ain; Mena-Hurtado, Carlos; Regan, Christopher; Scierka, Lindsey E.; Nagpal, Sameer; Smolderen, Kim G.] Yale Univ, Sch Med, Dept Internal Med, Vasc Med Outcomes Program,Sect Cardiovasc Med, New Haven, CT 06510 USA; [Gosch, Kensey; Mohammed, Moghniuddin; Spertus, John A.] Univ Missouri, St Lukes Mid Amer Heart Inst, Kansas City, MO 64110 USA; [Labrosciano, Clementine] Basil Hetzel Inst Translat Res, Woodville, South Africa; [Spertus, John A.] Univ Missouri, Kansas City, MO 64110 USA	Yale University; Saint Luke's Mid America Heart Institute; University of Missouri System; University of Missouri Kansas City; University of Missouri System; University of Missouri Kansas City	Smolderen, KG (corresponding author), Yale Univ, Sch Med, Dept Internal Med, Vasc Med Outcomes Program,Sect Cardiovasc Med, New Haven, CT 06510 USA.	kim.smolderen@yale.edu	Mohammed, Moghniuddin/ADI-2979-2022	Labrosciano, Clementine/0000-0001-5995-4616; Scierka, Lindsey/0000-0002-1338-0589	Cardiva; Gore; Abbott; Merck; Johnson Johnson; Myokadia; Janssen	Cardiva; Gore; Abbott(Abbott Laboratories); Merck(Merck & Company); Johnson Johnson(Johnson & JohnsonJohnson & Johnson USA); Myokadia; Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc)	Dr. Smolderen is supported by an unrestricted research grant from Cardiva, Gore, Abbott, Merck, and Johnson & Johnson. She is a consultant for Optum Labs and Abbott. Dr. Spertus is a consultant to Bayer, Janssen, Merck, Myokardia, Novartis, Terumo and United Healthcare. He receives grant support from Janssen and Myokadia. He holds the copyright to the Peripheral Artery Questionnaire, Kansas City Cardiomyopathy Questionnaires, and the Seattle Angina Questionnaire. He serves on the Board of Blue Cross/Blue Shield of Kansas City. Dr. Mena is a consultant for Abbott Vascular, Boston Scientific, Cook, Medtronic, Cardinal Health, and Optum Labs. Other authors report no disclosure.	Allison MA, 2007, AM J PREV MED, V32, P328, DOI 10.1016/j.amepre.2006.12.010; Appleton SL, 2018, SLEEP HEALTH, V4, P13, DOI 10.1016/j.sleh.2017.10.006; Armstrong EJ, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.113.000697; Arzt M, 2005, AM J RESP CRIT CARE, V172, P1447, DOI 10.1164/rccm.200505-702OC; Avlonitou E, 2012, SLEEP BREATH, V16, P563, DOI 10.1007/s11325-011-0543-8; Baldwin CM, 2001, SLEEP, V24, P96, DOI 10.1093/sleep/24.1.96; Basta M, 2008, J CLIN SLEEP MED, V4, P19; Benjafield AV, 2019, LANCET RESP MED, V7, P687, DOI 10.1016/S2213-2600(19)30198-5; Bjornsdottir E, 2016, J CLIN SLEEP MED, V12, P105, DOI 10.5664/jcsm.5406; Bradley TD, 2005, NEW ENGL J MED, V353, P2025, DOI 10.1056/NEJMoa051001; Cadby G, 2015, CHEST, V148, P945, DOI 10.1378/chest.15-0229; Cherr GS, 2008, J GEN INTERN MED, V23, P629, DOI 10.1007/s11606-008-0560-x; Ciccone MM, 2012, RESP MED, V106, P740, DOI 10.1016/j.rmed.2011.12.016; Ciccone MM, 2012, INT J CARDIOL, V158, P383, DOI 10.1016/j.ijcard.2011.01.065; Criqui MH, 2015, CIRC RES, V116, P1509, DOI 10.1161/CIRCRESAHA.116.303849; D'Ambrosio C, 1999, CHEST, V115, P123, DOI 10.1378/chest.115.1.123; Donovan LM, 2016, SLEEP, V39, P1353, DOI 10.5665/sleep.5962; ENGLEMAN HM, 1994, LANCET, V343, P572, DOI 10.1016/S0140-6736(94)91522-9; Finn L, 1998, SLEEP, V21, P701; Fowkes FGR, 2013, LANCET, V382, P1329, DOI 10.1016/S0140-6736(13)61249-0; FOWKES FGR, 1988, INT J EPIDEMIOL, V17, P248, DOI 10.1093/ije/17.2.248; FRASURESMITH N, 1993, JAMA-J AM MED ASSOC, V270, P1819, DOI 10.1001/jama.270.15.1819; Garbarino S, 2020, BEHAV SLEEP MED, V18, P35, DOI 10.1080/15402002.2018.1545649; Gottlieb DJ, 2010, CIRCULATION, V122, P352, DOI 10.1161/CIRCULATIONAHA.109.901801; Gupta MA, 2015, J CLIN SLEEP MED, V11, P165, DOI 10.5664/jcsm.4466; Hirsch AT, 2006, CIRCULATION, V113, pE463, DOI 10.1161/CIRCULATIONAHA.106.174526; Hirsch AT, 2001, JAMA-J AM MED ASSOC, V286, P1317, DOI 10.1001/jama.286.11.1317; Holmqvist F, 2015, AM HEART J, V169, P647, DOI 10.1016/j.ahj.2014.12.024; Isidoro SI, 2015, HEALTH QUAL LIFE OUT, V13, DOI 10.1186/s12955-015-0253-1; Jaff Michael R, 2015, Ann Vasc Dis, V8, P343, DOI 10.3400/avd.tasc.15-01000; Kawahara S, 2005, INTERNAL MED, V44, P422, DOI 10.2169/internalmedicine.44.422; Kroenke K, 2007, ANN INTERN MED, V146, P317, DOI 10.7326/0003-4819-146-5-200703060-00004; Kroenke K, 2009, J AFFECT DISORDERS, V114, P163, DOI 10.1016/j.jad.2008.06.026; Lash TL, 2001, EPIDEMIOLOGY, V12, P259, DOI 10.1097/00001648-200103000-00021; Lee CH, 2016, CIRCULATION, V133, P2008, DOI 10.1161/CIRCULATIONAHA.115.019392; Lewis EF, 2017, AM HEART J, V189, P59, DOI 10.1016/j.ahj.2017.03.001; Liu LP, 2016, J CLIN HYPERTENS, V18, P153, DOI 10.1111/jch.12639; Loke YK, 2012, CIRC-CARDIOVASC QUAL, V5, P720, DOI 10.1161/CIRCOUTCOMES.111.964783; Mahoney EM, 2008, CIRC-CARDIOVASC QUAL, V1, P38, DOI 10.1161/CIRCOUTCOMES.108.775247; Marin JM, 2005, LANCET, V365, P1046, DOI 10.1016/S0140-6736(05)71141-7; McEvoy RD, 2016, NEW ENGL J MED, V375, P919, DOI 10.1056/NEJMoa1606599; Meerlo P, 2008, SLEEP MED REV, V12, P197, DOI 10.1016/j.smrv.2007.07.007; MILLMAN RP, 1989, J CLIN PSYCHIAT, V50, P348; Mokhlesi B, 2016, EUR RESPIR J, V47, P1162, DOI 10.1183/13993003.01618-2015; Muhlestein JB, 2013, J AM COLL CARDIOL, V61, pE1155, DOI 10.1016/j.jacc.2013.01.004; Ohayon MM, 2003, J CLIN PSYCHIAT, V64, P1195, DOI 10.4088/JCP.v64n1009; Parashar S, 2009, CIRC-CARDIOVASC QUAL, V2, P33, DOI 10.1161/CIRCOUTCOMES.108.818500; Patel MR, 2015, J AM COLL CARDIOL, V65, P931, DOI 10.1016/j.jacc.2014.12.036; Pizarro C, 2015, RESPIRATION, V89, P214, DOI 10.1159/000371355; Redline S, 2010, AM J RESP CRIT CARE, V182, P269, DOI 10.1164/rccm.200911-1746OC; Reimer MA, 2003, SLEEP MED REV, V7, P335, DOI 10.1053/smrv.2001.0220; Robichaud-Halle L, 2012, BMC PULM MED, V12, DOI 10.1186/1471-2466-12-60; Ruo B, 2007, PSYCHOSOM MED, V69, P415, DOI 10.1097/PSY.0b013e318063ef5c; Rutherford RB, 1997, J VASC SURG, V26, P517, DOI 10.1016/S0741-5214(97)70045-4; Selvin E, 2004, CIRCULATION, V110, P738, DOI 10.1161/01.CIR.0000137913.26087.F0; Senaratna CV, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3703-8; Shahar E, 2001, AM J RESP CRIT CARE, V163, P19, DOI 10.1164/ajrccm.163.1.2001008; Singh J, 2013, BASICS CENTRAL SLEEP; Smolderen KG, 2018, CIRC-CARDIOVASC QUAL, V11, DOI 10.1161/CIRCOUTCOMES.117.003860; Song PG, 2019, LANCET GLOB HEALTH, V7, pE1020, DOI 10.1016/S2214-109X(19)30255-4; Spertus J, 2004, AM HEART J, V147, P301, DOI 10.1016/j.ahj.2003.08.001; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; Tietjens JR, 2019, J AM HEART ASSOC, V8, DOI 10.1161/JAHA.118.010440; Tveit RL, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192671; Utriainen KT, 2014, EUR RESPIR J, V43, P1652, DOI 10.1183/09031936.00130913; Valham F, 2008, CIRCULATION, V118, P955, DOI 10.1161/CIRCULATIONAHA.108.783290; von Elm E, 2014, INT J SURG, V12, P1495, DOI 10.1016/j.ijsu.2014.07.013; Wang HQ, 2007, J AM COLL CARDIOL, V49, P1625, DOI 10.1016/j.jacc.2006.12.046; WILLIAMS A, 1990, HEALTH POLICY, V16, P199; Yaggi HK, 2005, NEW ENGL J MED, V353, P2034, DOI 10.1056/NEJMoa043104; Young T, 2005, J APPL PHYSIOL, V99, P1592, DOI 10.1152/japplphysiol.00587.2005; YOUNG T, 1993, NEW ENGL J MED, V328, P1230, DOI 10.1056/NEJM199304293281704; Zeitlhofer J, 2000, ACTA NEUROL SCAND, V102, P249, DOI 10.1034/j.1600-0404.2000.102004249.x; Zhao YY, 2017, SLEEP, V40, DOI 10.1093/sleep/zsx040	74	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2021	16	9							e0256933	10.1371/journal.pone.0256933	http://dx.doi.org/10.1371/journal.pone.0256933			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	XM9EM	34506511	Green Published, gold			2022-12-26	WOS:000729120700087
J	Miroslaw-Swiatek, D; Popielski, P; Sliwinski, P; Cwalina, T; Skutnik, Z				Miroslaw-Swiatek, Dorota; Popielski, Pawel; Sliwinski, Piotr; Cwalina, Tomasz; Skutnik, Zdzislaw			Analysis of factors influencing levee safety using the DEMATEL method	PLOS ONE			English	Article							PERFORMANCE; RISK; PROJECT; MODEL	River embankments are the basic and the oldest measures of protecting areas potentially subjected to flooding, and at the same time pose a serious threat to their environment in the event of damage or failure. The technical condition of the levees and its regular evaluation is a key element of their safety. A general assessment of the technical condition of a levee is the result of many interacting factors and parameters that depend on each other to a varying degree. Therefore, it is necessary to consider the cause-and-effect links between the interrelationships of numerous parameters and sensors of significant impact. In this article the decision-making trial and evaluation laboratory (DEMATEL) method was applied to develop a cause-and-effect model for factors impacting the condition and safety of levees. Effective factors impacting the technical condition of a levee were identified; relationships between these factors were determined; a cause-and-effect model was developed based on identified factors; factors were categorized based on the dependence scale and influential indicators of each factors used in the DEMATEL method. The obtained results demonstrate that three following factors: hydrological factor, type and condition of soils in levee body and condition of levee areas (inter-levee and landside) play the most important role for levee safety. The results of this study can support traditional assessments of hydrotechnical structure or assist entities managing levees.	[Miroslaw-Swiatek, Dorota] Warsaw Univ Life Sci SGGW, Inst Environm Engn, Dept Hydrol Meteorol & Water Management, Warsaw, Poland; [Popielski, Pawel] Warsaw Univ Technol, Fac Bldg Serv Hydro & Environm Engn, Warsaw, Poland; [Sliwinski, Piotr] Inst Meteorol & Water Management IMGW PIB, Dam Tech Supervis Ctr, Off Geotech Filtrat & Concrete Qual Hydroengn Str, Warsaw, Poland; [Skutnik, Zdzislaw] Warsaw Univ Life Sci SGGW, Inst Civil Engn, Warsaw, Poland	Warsaw University of Life Sciences; Warsaw University of Technology; Warsaw University of Life Sciences	Miroslaw-Swiatek, D (corresponding author), Warsaw Univ Life Sci SGGW, Inst Environm Engn, Dept Hydrol Meteorol & Water Management, Warsaw, Poland.	dorota_miroslaw_swiatek@sggw.edu.pl	Skutnik, Zdzisław/AAC-3513-2021; Popielski, Pawel/F-9032-2019	Skutnik, Zdzisław/0000-0003-3228-4936; Popielski, Pawel/0000-0002-5425-5821				Alfieri L, 2017, EARTHS FUTURE, V5, P171, DOI 10.1002/2016EF000485; [Anonymous], 1972, WORLD PROBLEMS INVIT; Bonelli S, 2013, CIV ENG GEOMECH SER, P1, DOI 10.1002/9781118577165; Borys, 2013, GUIDELINES ANN INSPE; Bridle, 2014, P B, V164; Bridle R., 2013, BULLETIN, V164; Chen YF, 2015, ENVIRON SCI POLLUT R, V22, P6372, DOI 10.1007/s11356-015-4229-9; Chien KF, 2014, AUTOMAT CONSTR, V45, P1, DOI 10.1016/j.autcon.2014.04.012; Chuang HM, 2013, SCI WORLD J, DOI 10.1155/2013/751728; CIRIA, 2013, INT LEV HDB C731; Department of Natural Resources-Mines and Energy, 2018, GUID CONSTR MOD CAT; Division of Flood Management Flood Operations Branch, 2012, LEV THREAT MON GUID; Dytczak M., 2011, CIV ENVIRON ENG, V2, P235; Fauchard C, 2007, GEOPHYS GEOTECHNICAL; FloodProbe, 2012, WP03011224 FLOODPROB; Folton C., 2001, SURVEILLANCE ENTRETI; Guo W, 2013, APPL MECH MATER, V368-370, P1472, DOI 10.4028/www.scientific.net/AMM.368-370.1472; Tzeng GH, 2007, EXPERT SYST APPL, V32, P1028, DOI 10.1016/j.eswa.2006.02.004; Hossain, 2011, J ENVIRON SCI, V7, P102, DOI [10.3844/ajessp.2011.102.107, DOI 10.3844/AJESSP.2011.102.107]; Hughes SA, 2015, J MAR SCI ENG, V3, P128, DOI 10.3390/jmse3010128; Hwang WL, 2016, PROJ MANAG J, V47, P59, DOI 10.1002/pmj.21563; Jamshidi Navid B., 2012, MANAGEMENT SCI LETT, V2, P369, DOI [10.5267/j.msl.2011.07.008, DOI 10.5267/J.MSL.2011.07.008]; Kledynski Z., 2011, NOWOCZ BUD INZ, V2, P54; Kool JJ, 2019, FORENSIC ANAL LEVEE, V5, P70, DOI [10.4417/IJGCH-05-02-02, DOI 10.4417/IJGCH-05-02-02]; Lech M, 2020, APPL SCI-BASEL, V10, DOI 10.3390/app10072263; Li CW, 2009, APPL MATH COMPUT, V215, P2001, DOI 10.1016/j.amc.2009.07.059; Mosiej K., 2008, ASSESSMENT LEVEE TEC; Ozer IE, 2020, WATER-SUI, V12, DOI 10.3390/w12010119; Peyras L, 2017, J FLOOD RISK MANAG, V10, P393, DOI 10.1111/jfr3.12178; Sab G A, 2019, 17 ECSMGE 2019 GEOT, P8; Sara J, 2015, INT J GREENH GAS CON, V41, P336, DOI 10.1016/j.ijggc.2015.07.008; Shustikova I, 2020, WATER-SUI, V12, DOI 10.3390/w12040942; Si SL, 2018, MATH PROBL ENG, V2018, DOI 10.1155/2018/3696457; Sliwinski P., 2020, GUID TESTS MEAS ASS; Sterpi D., 2018, LECT NOTES CIVIL ENG, V17, DOI [10.1007/978-3-319-99423-9_31, DOI 10.1007/978-3-319-99423-9_31]; US Army Corps of Engineers, 2014, ENG PAMPHLET EP; Vuillet M, 2013, EUR J ENVIRON CIV EN, V17, P329, DOI 10.1080/19648189.2013.785723; Wang WC, 2014, J CIV ENG MANAG, V20, P497, DOI 10.3846/13923730.2013.801922; Wang WC, 2012, EXPERT SYST APPL, V39, P4978, DOI 10.1016/j.eswa.2011.10.016; Wu JS, 2018, WATER-SUI, V10, DOI 10.3390/w10091112; Wu WW, 2007, EXPERT SYST APPL, V32, P499, DOI 10.1016/j.eswa.2005.12.005; Wu WM, 2011, J HYDRAUL ENG, V137, P1549, DOI 10.1061/(ASCE)HY.1943-7900.0000498; Zhang LM, 2013, GEORISK, V7, P122, DOI 10.1080/17499518.2013.790733	43	1	1	3	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2021	16	9							e0255755	10.1371/journal.pone.0255755	http://dx.doi.org/10.1371/journal.pone.0255755			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XM9EM	34506486	gold, Green Published			2022-12-26	WOS:000729120700047
J	Carr, SC; Torres, MA; Morris, JS; Facchini, PJ; Ng, KKS				Carr, Samuel C.; Torres, Megan A.; Morris, Jeremy S.; Facchini, Peter J.; Ng, Kenneth K. S.			Structural studies of codeinone reductase reveal novel insights into aldo-keto reductase function in benzylisoquinoline alkaloid biosynthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MORPHINE BIOSYNTHESIS; DEHYDROGENASE; EXPRESSION; NEOPINONE; FUSION; ENZYME; AKRS	Benzylisoquinoline alkaloids (BIAs) are a class of specialized metabolites with a diverse range of chemical structures and physiological effects. Codeine and morphine are two closely related BIAs with particularly useful analgesic properties. The aldo-keto reductase (AKR) codeinone reductase (COR) catalyzes the final and penultimate steps in the biosynthesis of codeine and morphine, respectively, in opium poppy (Papaver somniferum). However, the structural determinants that mediate substrate recognition and catalysis are not well defined. Here, we describe the crystal structure of apo-COR determined to a resolution of 2.4 angstrom by molecular replacement using chalcone reductase as a search model. Structural comparisons of COR to closely related plant AKRs and more distantly related homologues reveal a novel conformation in the beta 1o1 loop adjacent to the BIA-binding pocket. The proximity of this loop to several highly conserved active-site residues and the expected location of the nicotinamide ring of the NADP(H) cofactor suggest a model for BIA recognition that implies roles for several key residues. Using site-directed mutagenesis, we show that substitutions at Met-28 and His 120 of COR lead to changes in AKR activity for the major and minor substrates codeinone and neopinone, respectively. Our findings provide a framework for understanding the molecular basis of substrate recognition in COR and the closely related 1,2-dehydroreticuline reductase responsible for the second half of a stereochemical inversion that initiates the morphine biosynthesis pathway.	[Carr, Samuel C.; Torres, Megan A.; Morris, Jeremy S.; Facchini, Peter J.; Ng, Kenneth K. S.] Univ Calgary, Dept Biol Sci, Calgary, AB, Canada; [Ng, Kenneth K. S.] Univ Windsor, Dept Chem & Biochem, Windsor, ON, Canada	University of Calgary; University of Windsor	Ng, KKS (corresponding author), Univ Calgary, Dept Biol Sci, Calgary, AB, Canada.; Ng, KKS (corresponding author), Univ Windsor, Dept Chem & Biochem, Windsor, ON, Canada.	kksng@uwindsor.ca		Facchini, Peter/0000-0002-7693-290X; Carr, Samuel/0000-0001-7060-5038	Natural Sciences and Engineering Research Council of Canada [05728, 183573]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was supported in part by Discovery Grants from the Natural Sciences and Engi-neering Research Council of Canada (05728 to K. K. S. N. and 183573 to P. J. F.) .	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Agius F, 2003, NAT BIOTECHNOL, V21, P177, DOI 10.1038/nbt777; Agrawal AA, 2009, ANNU REV ECOL EVOL S, V40, P311, DOI 10.1146/annurev.ecolsys.110308.120307; BALLANCE GM, 1995, PLANT PHYSIOL, V107, P1027, DOI 10.1104/pp.107.3.1027; Bomati EK, 2005, J BIOL CHEM, V280, P30496, DOI 10.1074/jbc.M502239200; Chen M, 2012, J BIOL CHEM, V287, P16609, DOI 10.1074/jbc.M111.338780; Dastmalchi M, 2019, NAT CHEM BIOL, V15, P384, DOI 10.1038/s41589-019-0247-0; Dastmalchi M, 2018, PLANT J, V95, P631, DOI 10.1111/tpj.13975; Dastmalchi M, 2018, PHYTOCHEM REV, V17, P249, DOI 10.1007/s11101-017-9519-z; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Di Costanzo L, 2009, MOL CELL ENDOCRINOL, V301, P191, DOI 10.1016/j.mce.2008.09.013; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Farrow SC, 2015, NAT CHEM BIOL, V11, P728, DOI [10.1038/NCHEMBIO.1879, 10.1038/nchembio.1879]; Fossati E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124459; Friesner RA, 2006, J MED CHEM, V49, P6177, DOI 10.1021/jm051256o; Galanie S, 2015, SCIENCE, V349, P1095, DOI 10.1126/science.aac9373; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; GOLLWITZER J, 1993, TETRAHEDRON LETT, V34, P5703, DOI 10.1016/S0040-4039(00)73838-X; Guo L, 2018, SCIENCE, V362, P343, DOI 10.1126/science.aat4096; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; International Narcotics Control Board, 2019, NARC DRUGS TECHN REP; Jez JM, 1998, BIOCHEMISTRY-US, V37, P9695, DOI 10.1021/bi980294p; Jez JM, 1997, BIOCHEM J, V326, P625, DOI 10.1042/bj3260625; Jez JM, 2001, CHEM-BIOL INTERACT, V130, P499, DOI 10.1016/S0009-2797(00)00295-7; Jirschitzka J, 2012, P NATL ACAD SCI USA, V109, P10304, DOI 10.1073/pnas.1200473109; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Li Y, 2020, PLANT COMMUN, V1, DOI 10.1016/j.xplc.2020.100029; Madeira F, 2019, NUCLEIC ACIDS RES, V47, pW636, DOI 10.1093/nar/gkz268; Marks C, 2017, BIOINFORMATICS, V33, P1346, DOI 10.1093/bioinformatics/btw823; Nahoum V, 2001, J BIOL CHEM, V276, P42091, DOI 10.1074/jbc.M105610200; Penning TM, 2015, CHEM-BIOL INTERACT, V234, P236, DOI 10.1016/j.cbi.2014.09.024; Sengupta D, 2015, J PLANT PHYSIOL, V179, P40, DOI 10.1016/j.jplph.2015.03.004; Sherman W, 2006, J MED CHEM, V49, P534, DOI 10.1021/jm050540c; Simpson PJ, 2009, J MOL BIOL, V392, P465, DOI 10.1016/j.jmb.2009.07.023; Singh A, 2019, PHYTOCHEM REV, V18, P1457, DOI 10.1007/s11101-019-09644-w; Thodey K, 2014, NAT CHEM BIOL, V10, P837, DOI [10.1038/NCHEMBIO.1613, 10.1038/nchembio.1613]; Unterlinner B, 1999, PLANT J, V18, P465, DOI 10.1046/j.1365-313X.1999.00470.x; Webb Benjamin, 2016, Curr Protoc Protein Sci, V86, DOI [10.1002/cpbi.3, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50, 10.1002/cpps.20]; WELLE R, 1988, FEBS LETT, V236, P221, DOI 10.1016/0014-5793(88)80318-1; Winzer T, 2015, SCIENCE, V349, P309, DOI 10.1126/science.aab1852; World Health Organization (WHO), 2019, WHO MOD LIST ESS MED, DOI DOI 10.1002/14651858.CD002207.PUB4; Zheng L, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh110	43	1	1	3	11	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT	2021	297	4							101211	10.1016/j.jbc.2021.101211	http://dx.doi.org/10.1016/j.jbc.2021.101211			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	WP4JL	34547292	gold, Green Published			2022-12-26	WOS:000713100100011
J	Ishikura, S; Yoshida, K; Hashimoto, S; Nakabayashi, K; Tsunoda, T; Shirasawa, S				Ishikura, Shuhei; Yoshida, Kazumasa; Hashimoto, Sayuri; Nakabayashi, Kazuhiko; Tsunoda, Toshiyuki; Shirasawa, Senji			CENP-B promotes the centromeric localization of ZFAT to control transcription of noncoding RNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-SATELLITE DNA; HUMAN INTERACTOME; PROTEIN; SEQUENCE; CHROMOSOME; BINDING; IDENTIFICATION; ARCHITECTURE	The centromere is a chromosomal locus that is essential for the accurate segregation of chromosomes during cell division. Transcription of noncoding RNA (ncRNA) at the centromere plays a crucial role in centromere function. The zinc -finger transcriptional regulator ZFAT binds to a specific 8-bp DNA sequence at the centromere, named the ZFAT box, to control ncRNA transcription. However, the precise molecular mechanisms by which ZFAT localizes to the centromere remain elusive. Here we show that the centromeric protein CENP-B is required for the centromeric localization of ZFAT to regulate ncRNA transcription. The ectopic expression of CENP-B induces the accumulation of both endogenous and ectopically expressed ZFAT protein at the centromere in human cells, suggesting that the centromeric localization of ZFAT requires the presence of CENP-B. Coimmunoprecipitation analysis reveals that ZFAT interacts with the acidic domain of CENP-B, and depletion of endogenous CENP-B reduces the centromeric levels of ZFAT protein, further supporting that CENP-B is required for the centromeric localization of ZFAT. In addition, knockdown of CENP-B significantly decreased the expression levels of ncRNA at the centromere where ZFAT regulates the transcription, suggesting that CENP-B is involved in the ZFAT-regulated centromeric ncRNA transcription. Thus, we concluded that CENP-B contributes to the establishment of the centromeric localization of ZFAT to regulate ncRNA transcription.	[Ishikura, Shuhei; Yoshida, Kazumasa; Hashimoto, Sayuri; Tsunoda, Toshiyuki; Shirasawa, Senji] Fukuoka Univ, Dept Cell Biol, Fac Med, Fukuoka, Japan; [Ishikura, Shuhei; Yoshida, Kazumasa; Tsunoda, Toshiyuki; Shirasawa, Senji] Fukuoka Univ, Ctr Adv Mol Med, Fukuoka, Japan; [Nakabayashi, Kazuhiko] Natl Res Inst Child Hlth & Dev, Dept Maternal Fetal Biol, Tokyo, Japan	Fukuoka University; Fukuoka University; National Center for Child Health & Development - Japan	Shirasawa, S (corresponding author), Fukuoka Univ, Dept Cell Biol, Fac Med, Fukuoka, Japan.; Shirasawa, S (corresponding author), Fukuoka Univ, Ctr Adv Mol Med, Fukuoka, Japan.	sshirasa@fukuoka-u.ac.jp		Shirasawa, Senji/0000-0003-3076-3474; Yoshida, Kazumasa/0000-0002-0181-9857	JSPS KAKENHI; Fukuoka University [925]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Fukuoka University	This work was supported by JSPS KAKENHI (20K07317to S. I.) and by funding from Fukuoka University (Grant No. 925) .	Arunkumar G, 2020, GENES-BASEL, V11, DOI 10.3390/genes11080911; Bouzinba-Segard H, 2006, P NATL ACAD SCI USA, V103, P8709, DOI 10.1073/pnas.0508006103; Doi K, 2012, BIOCHEM BIOPH RES CO, V425, P107, DOI 10.1016/j.bbrc.2012.07.065; EARNSHAW WC, 1987, J CELL BIOL, V104, P817, DOI 10.1083/jcb.104.4.817; EARNSHAW WC, 1989, CHROMOSOMA, V98, P1, DOI 10.1007/BF00293329; Fachinetti D, 2015, DEV CELL, V33, P314, DOI 10.1016/j.devcel.2015.03.020; Ferri F, 2009, NUCLEIC ACIDS RES, V37, P5071, DOI 10.1093/nar/gkp529; Gamba R, 2020, EXP CELL RES, V390, DOI 10.1016/j.yexcr.2020.111959; Hartley G, 2019, GENES-BASEL, V10, DOI 10.3390/genes10030223; Hein MY, 2015, CELL, V163, P712, DOI 10.1016/j.cell.2015.09.053; Hoffmann S, 2020, EMBO J, V39, DOI 10.15252/embj.2020105505; Huttlin EL, 2017, NATURE, V545, P505, DOI 10.1038/nature22366; Ideue T, 2014, GENES CELLS, V19, P528, DOI 10.1111/gtc.12149; Ishikura S, 2021, J CELL BIOCHEM, V122, P626, DOI 10.1002/jcb.29890; Ishikura S, 2020, NUCLEIC ACIDS RES, V48, P10848, DOI 10.1093/nar/gkaa815; Ishikura S, 2016, J BIOL CHEM, V291, P15282, DOI 10.1074/jbc.M116.723734; Ishikura S, 2015, J CELL BIOCHEM, V116, P149, DOI 10.1002/jcb.24954; Iwaihara Y, 2015, ANTICANCER RES, V35, P4419; Kasinathan S, 2018, MOL BIOL EVOL, V35, P949, DOI 10.1093/molbev/msy010; Koyanagi M, 2008, GENOMICS, V91, P451, DOI 10.1016/j.ygeno.2008.01.009; Leclerc S, 2021, FRONT MOL BIOSCI, V8, DOI 10.3389/fmolb.2021.642732; Li X, 2015, MOL SYST BIOL, V11, DOI 10.15252/msb.20145504; Liu Q, 2021, GENES GENOM, V43, P217, DOI 10.1007/s13258-021-01041-y; MASUMOTO H, 1989, J CELL BIOL, V109, P1963, DOI 10.1083/jcb.109.5.1963; McKinley KL, 2016, NAT REV MOL CELL BIO, V17, DOI 10.1038/nrm.2015.5; McNulty SM, 2018, CHROMOSOME RES, V26, P115, DOI 10.1007/s10577-018-9582-3; Miga KH, 2014, GENOME RES, V24, P697, DOI 10.1101/gr.159624.113; Muller S, 2017, NAT REV GENET, V18, P192, DOI 10.1038/nrg.2016.157; MURO Y, 1992, J CELL BIOL, V116, P585, DOI 10.1083/jcb.116.3.585; Nishi K, 2017, CELL DEATH DIS, V8, DOI 10.1038/s41419-017-0006-7; Ogawa M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076254; Ohzeki J, 2012, EMBO J, V31, P2391, DOI 10.1038/emboj.2012.82; Okada T, 2007, CELL, V131, P1287, DOI 10.1016/j.cell.2007.10.045; Perea-Resa C, 2018, MOL CELL BIOL, V38, DOI 10.1128/MCB.00263-18; PLUTA AF, 1992, J CELL BIOL, V116, P1081, DOI 10.1083/jcb.116.5.1081; Romanova LY, 1996, J MOL BIOL, V261, P334, DOI 10.1006/jmbi.1996.0466; Rosandic M, 2006, CHROMOSOME RES, V14, P735, DOI 10.1007/s10577-006-1078-x; Shirasawa S, 2004, HUM MOL GENET, V13, P2221, DOI 10.1093/hmg/ddh245; Sullivan LL, 2020, EXP CELL RES, V389, DOI 10.1016/j.yexcr.2020.111896; Talbert PB, 2018, TRENDS GENET, V34, P587, DOI 10.1016/j.tig.2018.05.001; Tochio Naoya, 2015, Journal of Structural and Functional Genomics, V16, P55, DOI 10.1007/s10969-015-9196-3; Tsunoda T, 2010, P NATL ACAD SCI USA, V107, P14199, DOI 10.1073/pnas.1002494107; Verdaasdonk JS, 2011, NAT REV MOL CELL BIO, V12, P320, DOI 10.1038/nrm3107; Westhorpe FG, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a015818	44	2	2	0	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT	2021	297	4							101213	10.1016/j.jbc.2021.101213	http://dx.doi.org/10.1016/j.jbc.2021.101213			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	WP4JL	34547289	gold, Green Published			2022-12-26	WOS:000713100100006
J	Yellurkar, ML; Singh, V; Prasanna, VS; Das, P; Nanjappan, S; Velayutham, R; Arumugam, S				Yellurkar, Manoj Limbraj; Singh, Vibhavana; Prasanna, Vani Sai; Das, Pamelika; Nanjappan, Satheeshkumar; Velayutham, Ravichandiran; Arumugam, Somasundaram			Evaluation of a natural compound extracted from Dolichandrone atrovirens as a novel antioxidant agent using Caenorhabditis elegans	PLOS ONE			English	Article							OXIDATIVE-STRESS; PREVENTION; RATS	The compound methyl cinnamoyl catalpol (DAM-1) was isolated from the methanol extract of Dolichandrone atrovirens. Studies have already reported the antioxidant activity of Dolichandrone atrovirens bark extract, but till date the antioxidant activity of the isolated compound DAM-1, remains unexplored. The endogenous process of reactive oxygen species generation which leads to various degenerative diseases, can be broken down using these exogenous moieties from plant origin, herein this study we sought to evaluate the antioxidant potential of the DAM-1 compound using Caenorhabditis elegans (C. elegans), which is the primary model to study the antioxidant activity of compounds. Cytotoxicity assay results showed that DAM-1 treatment in the concentration of 10, 25 and 50 mu g/ml has shown 100%, 91%, and 50% survival respectively with overall p< 0.0001 (treatment v/s control group). 3(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide-Formazan (MTT) assay results showed that treatment had better survival rates than the control group at different time intervals i.e. 48 h, and 72 h with p< 0.01. Mechanosensation (behavioral study) as well as in vivo study results showed that at 0 h, 10 mu g/ml of DAM-1 treatment showed a better anti-oxidative activity than the control group, 25 and 50 mu g/ml of DAM-1 treated groups with p< 0.001 but at 2.5 h incubation with 10, 25, 50 mu g/ml of DAM-1 showed an increased anti-oxidative activity than the control group with p< 0.001. Thermoresistance assay confirmed that the treatment group had more survival than control group with p<0.001. Absorption study of DAM-1 in C. elegans has shown that the absorption of the drug increases up to 180 mins with a slight decrease after 360 mins and then constant absorption up to 1440 mins. This study paves the way towards the initiative to explore the pharmacological role of DAM-1 in various oxidative stress mediated diseases at molecular levels and the absorption study points out its potential role which could be utilized in the metabolomics and proteomics analysis of this compound in other studies.	[Yellurkar, Manoj Limbraj; Singh, Vibhavana; Prasanna, Vani Sai; Das, Pamelika; Velayutham, Ravichandiran; Arumugam, Somasundaram] Natl Inst Pharmaceut Educ & Res NIPER Kolkata, Dept Pharmacol & Toxicol, Kolkata, W Bengal, India; [Singh, Vibhavana; Velayutham, Ravichandiran; Arumugam, Somasundaram] Natl Inst Pharmaceut Educ & Res NIPER Hajipur, Dept Pharmacol & Toxicol, Hajipur, Bihar, India; [Nanjappan, Satheeshkumar; Velayutham, Ravichandiran] Natl Inst Pharmaceut Educ & Res NIPER Kolkata, Dept Nat Prod, Kolkata, W Bengal, India	National Institute of Pharmaceutical Education & Research (NIPER)	Arumugam, S (corresponding author), Natl Inst Pharmaceut Educ & Res NIPER Kolkata, Dept Pharmacol & Toxicol, Kolkata, W Bengal, India.; Arumugam, S (corresponding author), Natl Inst Pharmaceut Educ & Res NIPER Hajipur, Dept Pharmacol & Toxicol, Hajipur, Bihar, India.	somasundaram143@gmail.com	VELAYUTHAM, RAVICHANDIRAN/HGU-8028-2022	RAVICHANDIRAN, V/0000-0001-7820-9486; Arumugam, Somasundaram/0000-0002-2096-2552				Alqahtani SN, 2014, POLYPHENOLS HUMAN HL, P119; Altemimi A, 2017, PLANTS-BASEL, V6, DOI 10.3390/plants6040042; Asase A, 2008, PHYTOTHER RES, V22, P1013, DOI 10.1002/ptr.2392; Backer, 1996, J Travel Med, V3, P1, DOI 10.1111/j.1708-8305.1996.tb00686.x; Ding Y, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0073919, 10.1371/journal.pone.0056877]; Ekor M, 2014, FRONT PHARMACOL, V4, DOI 10.3389/fphar.2013.00177; Epstein HF, 1995, CAENORHIBDITIS ELEGA; FOX RB, 1984, J CLIN INVEST, V74, P1456, DOI 10.1172/JCI111558; HALLIWELL B, 1991, AM J MED, V91, pS14, DOI 10.1016/0002-9343(91)90279-7; Halliwell B., 2007, FREE RADICAL BIO MED, P187; Jagadeshan K., 2011, J PHARMACOGNOSY PHYT, V6, P1270; James CE, 2007, PARASITOL RES, V101, P975, DOI 10.1007/s00436-007-0572-1; Kahn NW, 2008, BIOCHEM J, V409, P205, DOI 10.1042/BJ20070521; Katiyar D, 2015, MED CHEM RES, V24, P1, DOI 10.1007/s00044-014-1080-3; Kavimani S, 2014, INT J PHYTOPHARM, V5, P293; Kumsta C, 2011, ANTIOXID REDOX SIGN, V14, P1023, DOI 10.1089/ars.2010.3203; Miranda-Vizuete A, 2017, REDOX BIOL, V11, P708, DOI 10.1016/j.redox.2016.12.020; Modak M, 2007, J CLIN BIOCHEM NUTR, V40, P163, DOI 10.3164/jcbn.40.163; Nasri H., 2013, J HERBMED PHARM, V2; Osadebe P. O., 2014, African Journal of Pharmacy and Pharmacology, V8, P292; Poli G, 2004, CURR MED CHEM, V11, P1163, DOI 10.2174/0929867043365323; Rahimi R, 2005, BIOMED PHARMACOTHER, V59, P365, DOI 10.1016/j.biopha.2005.07.002; Rajkapoor B., 2010, PHARMACOLOGYONLINE, V1, P1117; Rangsinth P, 2019, BMC COMPLEM ALTERN M, V19, DOI 10.1186/s12906-019-2578-5; Shi YC, 2012, FREE RADICAL BIO MED, V52, P109, DOI 10.1016/j.freeradbiomed.2011.09.034; Shrestha PM, 2003, J ETHNOPHARMACOL, V86, P81, DOI 10.1016/S0378-8741(03)00051-5; Singh SK, 2008, EVID-BASED COMPL ALT, V5, P415, DOI 10.1093/ecam/nem044; Thabit S, 2018, PEERJ, V6, DOI 10.7717/peerj.5159; Valko M, 2004, MOL CELL BIOCHEM, V266, P37, DOI 10.1023/B:MCBI.0000049134.69131.89; Wang CC, 2020, MOLECULES, V25, DOI 10.3390/molecules25020287; Willcox JK, 2004, CRIT REV FOOD SCI, V44, P275, DOI 10.1080/10408690490468489	31	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2021	16	9							e0257702	10.1371/journal.pone.0257702	http://dx.doi.org/10.1371/journal.pone.0257702			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YS4WS	34551009	Green Published, gold			2022-12-26	WOS:000750679800044
J	Hu, GJ; Ma, G				Hu, Gaojian; Ma, Gang			Size effect of parallel-joint spacing on uniaxial compressive strength of rock	PLOS ONE			English	Article							REPRESENTATIVE ELEMENTARY VOLUME; NUMERICAL-SIMULATION; MODELS	The existence of parallel joints has an impact on the size effect of the uniaxial compressive strength of rock, but the relationship is yet to be obtained. In this paper, the influence of parallel-joint spacing on the size effect and characteristic size of rock uniaxial compressive strength is studied by establishing five types of parallel-joint-spacing simulation schemes. The influence of parallel-joint spacing on the size effect of rock uniaxial compressive strength is explored by analyzing the stress-strain curves of rocks with different parallel-joint spacings and rock sizes. The relationship between the uniaxial compressive strength and the size of the rock with parallel joints and its special mathematical model are obtained, and the particular form of the compressive-strength characteristic size and parallel-joint spacing is obtained.	[Hu, Gaojian; Ma, Gang] Shaoxing Univ, Sch Civil Engn, Shaoxing, Zhejiang, Peoples R China; [Hu, Gaojian] Key Lab Rock Mech & Geohazards Zhejiang Prov, Shaoxing, Zhejiang, Peoples R China; [Hu, Gaojian] Zhejiang Collaborat Innovat Ctr Prevent & Control, Shaoxing, Zhejiang, Peoples R China	Shaoxing University	Hu, GJ (corresponding author), Shaoxing Univ, Sch Civil Engn, Shaoxing, Zhejiang, Peoples R China.; Hu, GJ (corresponding author), Key Lab Rock Mech & Geohazards Zhejiang Prov, Shaoxing, Zhejiang, Peoples R China.; Hu, GJ (corresponding author), Zhejiang Collaborat Innovat Ctr Prevent & Control, Shaoxing, Zhejiang, Peoples R China.	hugaojian8@163.com			Zhejiang Collaborative Innovation Center for Prevention and Control of Mountain Geological Hazards [PCMGH-2017-Y-05]; Key Laboratory of Rock Mechanics and Geohazards of Zhejiang Province [ZGRMG-2019-07]	Zhejiang Collaborative Innovation Center for Prevention and Control of Mountain Geological Hazards; Key Laboratory of Rock Mechanics and Geohazards of Zhejiang Province	The author(s) received specific funding for this work from Zhejiang Collaborative Innovation Center for Prevention and Control of Mountain Geological Hazards (PCMGH-2017-Y-05), Key Laboratory of Rock Mechanics and Geohazards of Zhejiang Province (ZGRMG-2019-07).	Bao H, 2019, J STRUCT GEOL, V128, DOI 10.1016/j.jsg.2019.103886; Chen QF, 2018, ARAB J GEOSCI, V11, DOI 10.1007/s12517-018-3645-9; Chen YF, 2021, ENVIRON EARTH SCI, V80, DOI 10.1007/s12665-021-09485-x; Chong ZH, 2020, ARAB J GEOSCI, V13, DOI 10.1007/s12517-020-05303-z; Fu W. B., 2019, RESOURCES ENV ENG, V33, P232, DOI DOI 10.16536/J.CNKI.ISSN.1671-1211.2019.02.018; Gasmi H, 2019, ENG TECHNOL APPL SCI, V9, P4448; Li Y, 2018, ROCK SOIL MECH, V39, P2951, DOI 10.16285/j.rsm.2016.2525; Liang ZZ, 2019, ROCK MECH ROCK ENG, V52, P4387, DOI 10.1007/s00603-019-01859-9; [梁正召 Liang Zhengzhao], 2013, [岩石力学与工程学报, Chinese Journal of Rock Mechanics and Engineering], V32, P1157; Liu B.C., 1998, CHIN J ROCK MECH ENG, V17, P611; Liu Y, 2018, INT J ROCK MECH MIN, V103, P289, DOI 10.1016/j.ijrmms.2018.01.046; Liu Y, 2018, ROCK MECH ROCK ENG, V51, P47, DOI 10.1007/s00603-017-1327-7; Liu Y, 2017, ROCK MECH ROCK ENG, V50, P89, DOI 10.1007/s00603-016-1085-y; Liu Y, 2018, APPL SCI-BASEL, V8, DOI 10.3390/app8050800; Loyola AC, 2021, ROCK MECH ROCK ENG, V54, P1841, DOI 10.1007/s00603-021-02374-6; [吕龙龙 Lu Longlong], 2018, [地下空间与工程学报, Chinese Journal of Underground Space and Engineering], V14, P1571; Luo Z., 2019, B SCI TECHNOLOGY, V35, P13; Ma C, 2018, KSCE J CIV ENG, V22, P4872, DOI 10.1007/s12205-017-1581-y; Meng MQ, 2020, ROCK SOIL MECH, V41, P2953, DOI 10.16285/j.rsm.2019.2000; Niazmandi MM, 2020, IJST-T CIV ENG, V44, P587, DOI 10.1007/s40996-020-00348-2; Song Y., 2019, CHINESE J GEOLOGICAL, V28, DOI [10.16031/j.cnki.issn.1003-8035.2019.01.16, DOI 10.16031/J.CNKI.ISSN.1003-8035.2019.01.16]; Tang CA, 1997, INT J ROCK MECH MIN, V34, P249, DOI 10.1016/S0148-9062(96)00039-3; Wang C.Y., 2018, IND MINER PROCESS, V47, P28; Wang Z., 2016, NUMERICAL SIMULATION; Yan Y., 2017, LOW TEM PERATURE ARC, V39, P130; Yang WD, 2019, INT J DAMAGE MECH, V28, P1490, DOI 10.1177/1056789519832651	26	3	3	15	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2021	16	9							e0257245	10.1371/journal.pone.0257245	http://dx.doi.org/10.1371/journal.pone.0257245			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	WG6BN	34543295	gold, Green Published			2022-12-26	WOS:000707078200024
J	Larebo, YM; Abame, DE				Larebo, Yilma Markos; Abame, Desta Erkalo			Knowledge, attitudes, and practices of face mask utilization and associated factors in COVID-19 pandemic among Wachemo University Students, Southern Ethiopia: A cross-sectional study	PLOS ONE			English	Article								Introduction The widespread use of face masks by the general public may help to prevent the spread of viruses. Face masks are thought to be a good strategy to protect against respiratory diseases such as the Coronavirus. Identifying student knowledge, attitude, and practice about the use of face masks is crucial to detect vulnerabilities and respond rapidly to avoid the spread of the infection. This study aimed to determine the knowledge, attitude, and practices of face mask utilization and associated factors in the COVID-19 pandemic among college students. Methods A cross-sectional study was performed from February to March 2021 among 764 students from Wachemo University, Southern Ethiopia. A multistage sampling technique was used in the study. The sample size for each department was allocated in proportion to the number of students in that department, and each respondent was chosen using a simple random sampling procedure. Data were collected using a pre-tested self-administered questionnaire and analyzed using SPSS version 26. To predict the relationship between the predictor and outcome variables, a logistic regression model was used. At a p-value of 0.05, statistical significance was declared. Results The study showed that the overall knowledge of the students was 223 (29.2%), their attitude was 673 (88.1%), and their practice was 684 (89.5%). The students from the college natural and computational sciences (AOR: 0.23; 95%CI: 0.13, 0.40) and students having good knowledge (AOR = 4.40; 95%CI; 2.13, 9.14) were found to be independently associated with face mask utilization. Conclusion When compared to other researches, the knowledge about the usage of face masks in this study was low, but the attitudes and practices were high. Authorities in areas that are in danger of a COVID-19 pandemic should plan and implement public awareness and education initiatives.	[Larebo, Yilma Markos] Wachemo Univ, Coll Med & Hlth Sci, Dept Epidemiol, Hossana, Ethiopia; [Abame, Desta Erkalo] Wachemo Univ, Coll Med & Hlth Sci, Dept Reprod Hlth, Hossana, Ethiopia	University of Gondar; University of Gondar	Larebo, YM (corresponding author), Wachemo Univ, Coll Med & Hlth Sci, Dept Epidemiol, Hossana, Ethiopia.	yilmamark@gmail.com		markos, yilma/0000-0001-7084-1313; Erkalo, Desta/0000-0001-5981-439X	Wachemo University (WCU)	Wachemo University (WCU)	This study was sponsored by the Wachemo University (WCU), as one of the 3rd generations higher Institution University, Hossana, Ethiopia, as part of the community research submitted to research and community service. The funder had no role in the design of the study, data collection, and analysis, interpretation of the data, and preparation of the manuscript.	Al Naam YA, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0247313; Azlan AA, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0233668; Bai Y, 2020, JAMA-J AM MED ASSOC, V323, P1406, DOI [10.1056/NEJMoa2001316, 10.1001/jama.2020.2565]; Barrios LC, 2021, MMWR-MORBID MORTAL W, V70, P208, DOI 10.15585/mmwr.mm7006e1; Betsch C, 2020, P NATL ACAD SCI USA, V117, P21851, DOI 10.1073/pnas.2011674117; Central Statistical Agency [Ethiopia], 2014, ETH MIN DEM HLTH SUR; Cheng KK, 2022, LANCET, V399, pE39, DOI 10.1016/S0140-6736(20)30918-1; Egan M, 2021, BMC PUBLIC HEALTH, V21, DOI 10.1186/s12889-021-10356-0; Federal Democratic Republic of Ethiopia Central Statistical Agency, 2013, POPULATION PROJECTIO; Gezie H, 2019, CLIN J NURS CARE PRA, V3, P059, DOI [10.29328/journal.cjncp.1001019, DOI 10.29328/JOURNAL.CJNCP.1001019]; Hadiya Zone Health Department, 2020, ANN REP HAD ZON; Haischer MH, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0240785; Ho HSW, 2012, PUBLIC HEALTH, V126, P1001, DOI 10.1016/j.puhe.2012.09.010; MacIntyre CR, 2020, INT J NURS STUD, V108, DOI 10.1016/j.ijnurstu.2020.103629; National Planning and Development Commission [NPC], 2018, POV EC GROWTH ETH 19; Nct, 2020, RED COVID 19 INF US; Picard J, 2020, J HOSP INFECT, V106, P617, DOI 10.1016/j.jhin.2020.08.009; Piche-Renaud PP, 2021, INFECT CONT HOSP EP, V42, P261, DOI 10.1017/ice.2020.415; Tadesse T, 2020, J MULTIDISCIP HEALTH, V13, P1203, DOI 10.2147/JMDH.S277133; Tirupathi Raghavendra, 2020, Infez Med, V28, P57; Tucho GT, 2021, RISK MANAG HEALTHC P, V14, P511, DOI 10.2147/RMHP.S298687; WHO, 2020, 72 WHO; WHO, 2020, TECHN SPEC PERS PROT; Worby CJ, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17922-x; Worldometer, 2020, COR UPD LIV 1925224	25	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2021	16	9							e0257609	10.1371/journal.pone.0257609	http://dx.doi.org/10.1371/journal.pone.0257609			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	WG6BN	34543358	Green Published, gold			2022-12-26	WOS:000707078200059
J	Martin, EG; Ansari, B; Hart-Malloy, R; Smith, DK; Delaney, KP; Gift, TL; Berruti, AA; Trigg, M; Rosenberg, ES				Martin, Erika G.; Ansari, Bahareh; Hart-Malloy, Rachel; Smith, Dawn K.; Delaney, Kevin P.; Gift, Thomas L.; Berruti, Andres A.; Trigg, Monica; Rosenberg, Eli S.			Racial and ethnic disparities in HIV diagnoses among heterosexually active persons in the United States nationally and by state, 2018	PLOS ONE			English	Article							REPRODUCTIVE HEALTH; TRANSMISSION RISK; METAANALYSIS; INFECTION; HIV/AIDS; SERVICES; WOMEN; CARE; MEN; SEX	Background Despite declining HIV infection rates, persistent racial and ethnic disparities remain. Appropriate calculations of diagnosis rates by HIV transmission category, race and ethnicity, and geography are needed to monitor progress towards reducing systematic disparities in health outcomes. We estimated the number of heterosexually active adults (HAAs) by sex and state to calculate appropriate HIV diagnosis rates and disparity measures within subnational regions. Methods The analysis included all HIV diagnoses attributed to heterosexual transmission in 2018 in the United States, in 50 states and the District of Columbia. Logistic regression models estimated the probability of past-year heterosexual activity among adults in three national health surveys, by sex, age group, race and ethnicity, education category, and marital status. Model-based probabilities were applied to estimated counts of HAAs by state, which were synthesized through meta-analysis. HIV diagnoses were overlaid to calculate racial- and ethnic-specific rates, rate differences (RDs), and rate ratios (RRs) among HAAs by sex and state. Results Nationally, HAA women have a two-fold higher HIV diagnosis rate than HAA men (rate per 100,000 HAAs, women: 6.57; men: 3.09). Compared to White non-Hispanic HAAs, Black HAAs have a 20-fold higher HIV diagnosis rate (RR, men: 21.28, women: 19.55; RD, men: 15.40, women: 31.78) and Hispanic HAAs have a 4-fold higher HIV diagnosis rate (RR, men: 4.68, RD, women: 4.15; RD, men: 2.79, RD, women: 5.39). Disparities were ubiquitous across regions, with >75% of states in each region having Black-to-White RR >= 10. Conclusion The racial and ethnic disparities across regions suggests a system-wide failure particularly with respect to preventing HIV among Black and Hispanic women. Pervasive disparities emphasize the role for coordinated federal responses such as the current Ending the HIV Epidemic (EHE) initiative.	[Martin, Erika G.] SUNY Albany, Rockefeller Coll Publ Affairs & Policy, Dept Publ Adm & Policy, Albany, NY 12222 USA; [Martin, Erika G.; Hart-Malloy, Rachel; Rosenberg, Eli S.] SUNY Albany, Sch Publ Hlth, Ctr Collaborat HIV Res Practice & Policy, Albany, NY 12222 USA; [Ansari, Bahareh] SUNY Albany, Coll Emergency Preparedness Homeland Secur & Cybe, Dept Informat Sci, Albany, NY 12222 USA; [Hart-Malloy, Rachel] AIDS Inst, New York State Dept Hlth, Off Sexual Hlth & Epidemiol, Albany, NY USA; [Hart-Malloy, Rachel; Rosenberg, Eli S.] SUNY Albany, Sch Publ Hlth, Dept Epidemiol & Biostat, Albany, NY USA; [Smith, Dawn K.; Delaney, Kevin P.; Gift, Thomas L.; Berruti, Andres A.] Ctr Dis Control & Prevent, Div HIV AIDS Prevent, Natl Ctr HIV Viral Hepatitis STD & TB Prevent, Atlanta, GA USA; [Trigg, Monica] Emory Univ, Rollins Sch Publ Hlth, Dept Epidemiol, Atlanta, GA 30322 USA	State University of New York (SUNY) System; State University of New York (SUNY) Albany; State University of New York (SUNY) System; State University of New York (SUNY) Albany; State University of New York (SUNY) System; State University of New York (SUNY) Albany; State University of New York (SUNY) System; State University of New York (SUNY) System; State University of New York (SUNY) Albany; Centers for Disease Control & Prevention - USA; Emory University; Rollins School Public Health	Martin, EG (corresponding author), SUNY Albany, Rockefeller Coll Publ Affairs & Policy, Dept Publ Adm & Policy, Albany, NY 12222 USA.; Martin, EG (corresponding author), SUNY Albany, Sch Publ Hlth, Ctr Collaborat HIV Res Practice & Policy, Albany, NY 12222 USA.	emartin@albany.edu	Delaney, Kevin/HHS-1060-2022; Ansari, Bahareh/ABD-8310-2020	Ansari, Bahareh/0000-0001-5064-6481; Martin, Erika/0000-0003-2607-8933; Berruti, Andres/0000-0003-4674-290X	CDC/NCHHSTP Epidemiological and Economic Modeling Agreement (NEEMA) [5U38PS004650]	CDC/NCHHSTP Epidemiological and Economic Modeling Agreement (NEEMA)	This work was supported by the CDC/NCHHSTP Epidemiological and Economic Modeling Agreement (NEEMA) (#5U38PS004650) to ESR (https://www.cdc.gov/nchhstp/neema/index.html).Authors DKS, KPD, TLG, and AAB are employed by the CDC and participated in the study design and preparation of the manuscript. The findings and conclusions are solely the responsibility of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention or the Department of Health and Human Services.	Borenstein M, 2010, RES SYNTH METHODS, V1, P97, DOI 10.1002/jrsm.12; Centers for Disease Control and Prevention, 2020, HIV SURV REP; Centers for Disease Control and Prevention, 2020, NCHHSTP ATLASPLUS; Centers for Disease Control and Prevention, 2020, PREVENTING INTIMATE; Centers for Disease Control and Prevention National Center for Health Statistics, 2020, NATL HLTH NUTR EXAMI; Centers for Disease Control and Prevention National Center for Health Statistics, 2020, NAT SURV FAM GROWTH; Crepaz N, 2020, JAIDS-J ACQ IMM DEF, V83, P334, DOI 10.1097/QAI.0000000000002277; Dennis AM, 2011, CLIN INFECT DIS, V53, P480, DOI 10.1093/cid/cir434; Giroir BP, 2020, AM J PUBLIC HEALTH, V110, P22, DOI 10.2105/AJPH.2019.305380; Grey Jeremy A, 2016, JMIR Public Health Surveill, V2, pe14, DOI 10.2196/publichealth.5365; Hill A., 2020, US STATES HEXGRID DA; Howell EA, 2018, CLIN OBSTET GYNECOL, V61, P387, DOI 10.1097/GRF.0000000000000349; Huang YLA, 2018, MMWR-MORBID MORTAL W, V67, P1147, DOI 10.15585/mmwr.mm6741a3; Johnson AS, 2021, SEX TRANSM DIS, V48, P285, DOI 10.1097/OLQ.0000000000001354; Kerani RP, 2020, PUBLIC HEALTH REP, V135, P611, DOI 10.1177/0033354920942623; Kimball A, 2020, MMWR-MORBID MORTAL W, V69, P661, DOI 10.15585/mmwr.mm6922a1; Kimmel AD, 2018, AIDS CARE, V30, P1459, DOI 10.1080/09540121.2018.1476656; Kwakwa HA, 2003, CLIN INFECT DIS, V36, pE40, DOI 10.1086/345462; Lansky A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133543; Li FF, 2018, AM J PUBLIC HEALTH, V108, pS292, DOI [10.2105/AJPH.2018.304506, 10.2105/ajph.2018.304506]; McCree DH, 2020, JAIDS-J ACQ IMM DEF, V85, P588, DOI 10.1097/QAI.0000000000002495; McCree DH, 2020, AIDS BEHAV, V24, P1118, DOI 10.1007/s10461-019-02736-w; McCree DH, 2016, PUBLIC HEALTH REP, V131, P526, DOI 10.1177/0033354916662209; National Alliance of State and Territorial AIDS Directors, END HIV EP JUR PLANS; National Cancer Institute Surveillance Epidemiology and End Results Program, SEER CANC STAT REV; National Center for HIV/AIDS Viral Hepatitis STD and TB Prevention, 2019, HIV WOM; National Interagency Coordination Center (NICC), 2020, NAT DIAB STAT REP WE; Oster AM, 2015, JAIDS-J ACQ IMM DEF, V70, P444, DOI 10.1097/QAI.0000000000000809; Oster AM, 2015, J URBAN HEALTH, V92, P733, DOI 10.1007/s11524-015-9970-3; Patel P, 2014, AIDS, V28, P1509, DOI 10.1097/QAD.0000000000000298; Prather C, 2018, HEALTH EQUITY, V2, P249, DOI 10.1089/heq.2017.0045; Prather C, 2016, J WOMENS HEALTH, V25, P664, DOI 10.1089/jwh.2015.5637; Price-Haywood EG, 2020, NEW ENGL J MED, V382, P2534, DOI 10.1056/NEJMsa2011686; R Core Team, 2021, R LANG ENV STAT; Racial inequalities in HIV, 2020, LANCET HIV, V7; Randolph SD, 2020, J ASSOC NURSE AIDS C, V31, P598, DOI 10.1097/JNC.0000000000000189; Rao SR, 2008, HEALTH SERV OUTCOME, V8, P98, DOI 10.1007/s10742-008-0032-0; Reif SS, 2014, AIDS CARE, V26, P351, DOI 10.1080/09540121.2013.824535; Rosenberg ES, 2018, ANN EPIDEMIOL, V28, P865, DOI 10.1016/j.annepidem.2018.04.008; Ross J, 2019, AIDS PATIENT CARE ST, V33, P336, DOI 10.1089/apc.2019.0036; Ruggles Steven, 2020, IPUMS US VERSION 10, DOI [10.18128/D010.V10.0, DOI 10.18128/D010.V10.0]; Saha S, 2013, J GEN INTERN MED, V28, P622, DOI 10.1007/s11606-012-2298-8; SAS Institute. SAS, 2013, SAS VERS 9 4; Senn S, 2011, STAT PROBABIL LETT, V81, P842, DOI 10.1016/j.spl.2011.02.010; Sheehan DM, 2017, AIDS CARE, V29, P311, DOI 10.1080/09540121.2016.1211609; Smith TW., 2020, GEN SOCIAL SURVEY DA; Su JR, 2016, AM J OBSTET GYNECOL, V214, DOI 10.1016/j.ajog.2015.10.007; Sutton MY, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197216; The White House, 2020, NAT HIV AIDS STRAT; US Centers for Disease Control and Prevention, 2021, END HIV EP COMM INV; Waldrop-Valverde Drenna, 2018, Health Lit Res Pract, V2, pe205, DOI 10.3928/24748307-20180925-01; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1	52	3	3	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2021	16	9							e0257583	10.1371/journal.pone.0257583	http://dx.doi.org/10.1371/journal.pone.0257583			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	WG6BN	34543322	Green Published, gold			2022-12-26	WOS:000707078200053
J	Vafaizadeh, V; Buechel, D; Rubinstein, N; Kalathur, RKR; Bazzani, L; Saxena, M; Valenta, T; Hausmann, G; Cantu, C; Basler, K; Christofori, G				Vafaizadeh, Vida; Buechel, David; Rubinstein, Natalia; Kalathur, Ravi K. R.; Bazzani, Lorenzo; Saxena, Meera; Valenta, Tomas; Hausmann, George; Cantu, Claudio; Basler, Konrad; Christofori, Gerhard			The interactions of Bcl9/Bcl9L with beta-catenin and Pygopus promote breast cancer growth, invasion, and metastasis	ONCOGENE			English	Article							EXPRESSION; CELLS; GENE; INACTIVATION; TRANSITION; ONCOGENE; DELETION; BCL9-2; MODEL; B9L	Canonical Wnt/beta-catenin signaling is an established regulator of cellular state and its critical contributions to tumor initiation, malignant tumor progression and metastasis formation have been demonstrated in various cancer types. Here, we investigated how the binding of beta-catenin to the transcriptional coactivators B-cell CLL/lymphoma 9 (Bcl9) and Bcl9-Like (Bcl9L) affected mammary gland carcinogenesis in the MMTV-PyMT transgenic mouse model of metastatic breast cancer. Conditional knockout of both Bcl9 and Bcl9L resulted into tumor cell death. In contrast, disrupting the interaction of Bcl9/Bcl9L with beta-catenin, either by deletion of their HD2 domains or by a point mutation in the N-terminal domain of beta-catenin (D164A), diminished primary tumor growth and tumor cell proliferation and reduced tumor cell invasion and lung metastasis. In comparison, the disruption of HD1 domain-mediated binding of Bcl9/Bcl9L to Pygopus had only moderate effects. Interestingly, interfering with the beta-catenin-Bcl9/Bcl9L-Pygo chain of adapters only partially impaired the transcriptional response of mammary tumor cells to Wnt3a and TGF beta treatments. Together, the results indicate that Bcl9/Bcl9L modulate but are not critically required for canonical Wnt signaling in its contribution to breast cancer growth and malignant progression, a notion consistent with the "just-right" hypothesis of Wnt-driven tumor progression.	[Vafaizadeh, Vida; Buechel, David; Kalathur, Ravi K. R.; Bazzani, Lorenzo; Saxena, Meera; Christofori, Gerhard] Univ Basel, Dept Biomed, Basel, Switzerland; [Rubinstein, Natalia] Univ Buenos Aires, Inst Biociencias Biotecnol & Biol Traslac, Dept Fisiol Biol Mol & Celular, Fac Ciencias Exactas & Nat, Buenos Aires, DF, Argentina; [Kalathur, Ravi K. R.] Royal Childrens Hosp, Murdoch Childrens Res Inst, Parkville, Vic, Australia; [Bazzani, Lorenzo] Univ Siena, Dept Life Sci, Siena, Italy; [Valenta, Tomas; Hausmann, George; Basler, Konrad] Univ Zurich, Dept Mol Life Sci, Zurich, Switzerland; [Cantu, Claudio] Linkoping Univ, Wallenberg Ctr Mol Med, Linkoping, Sweden; [Cantu, Claudio] Linkoping Univ, Fac Med & Hlth Sci, Dept Biomed & Clin Sci, Div Mol Med & Virol, Linkoping, Sweden	University of Basel; University of Buenos Aires; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; University of Siena; University of Zurich; Linkoping University; Linkoping University	Vafaizadeh, V; Christofori, G (corresponding author), Univ Basel, Dept Biomed, Basel, Switzerland.	vidavafaizadeh@gmail.com; gerhard.christofori@unibas.ch		Rubinstein, Natalia/0000-0002-5690-1516; Hausmann, George/0000-0002-2146-6665; Cantu, Claudio/0000-0003-1547-5415; Vafaizadeh, Vida/0000-0002-0875-6246	SystemsX.ch MTD project MetastasiX [2014/268]; Swiss National Science Foundation [310030B_163471]; Swiss National Science Foundation Sinergia [CRSII3_136274]; Knut and Alice Wallenberg Foundation; Cancerfonden [CAN 2018/542]; Universitat Basel (Universitatsbibliothek Basel)	SystemsX.ch MTD project MetastasiX; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss National Science Foundation Sinergia(Swiss National Science Foundation (SNSF)); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Cancerfonden(Swedish Cancer Society); Universitat Basel (Universitatsbibliothek Basel)	We acknowledge funding for this work by the SystemsX.ch MTD project MetastasiX (2014/268), a project grant by the Swiss National Science Foundation (310030B_163471), and the Swiss National Science Foundation Sinergia grant CRSII3_136274. CC is a WCMM fellow supported by the Knut and Alice Wallenberg Foundation and by Cancerfonden (CAN 2018/542). Open Access funding provided by Universitat Basel (Universitatsbibliothek Basel).	Andrews PGP, 2018, CELL REP, V23, P1516, DOI 10.1016/j.celrep.2018.04.020; Borrelli C, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-21591-9; Brault V, 2001, DEVELOPMENT, V128, P1253; Cantu C, 2018, GENE DEV, V32, P1443, DOI 10.1101/gad.315531.118; Cantu C, 2017, SCI SIGNAL, V10, DOI 10.1126/scisignal.aah4598; Cantu C, 2014, GENE DEV, V28, P1879, DOI 10.1101/gad.246140.114; Chaffer CL, 2007, CELLS TISSUES ORGANS, V185, P7, DOI 10.1159/000101298; de la Roche M, 2014, CANCER RES, V74, P1495, DOI 10.1158/0008-5472.CAN-13-2682; Deka J, 2010, CANCER RES, V70, P6619, DOI 10.1158/0008-5472.CAN-10-0148; Derynck R, 2019, DEV CELL, V49, P313, DOI 10.1016/j.devcel.2019.04.026; El-Hage P, 2015, MOL CANCER RES, V13, P902, DOI 10.1158/1541-7786.MCR-14-0180; Elsarraj HS, 2020, NPJ BREAST CANCER, V6, DOI 10.1038/s41523-020-0157-z; Elsarraj HS, 2015, BREAST CANCER RES, V17, DOI 10.1186/s13058-015-0630-z; Feng M, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aau5240; Fluck MM, 2009, MICROBIOL MOL BIOL R, V73, P542, DOI 10.1128/MMBR.00009-09; Gay DM, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08586-3; GUY CT, 1992, MOL CELL BIOL, V12, P954, DOI 10.1128/MCB.12.3.954; He X, 2006, CELL, V127, P40, DOI 10.1016/j.cell.2006.09.016; Herr P, 2012, TRENDS MOL MED, V18, P483, DOI 10.1016/j.molmed.2012.06.008; Jia W, 2011, MOL CANCER RES, V9, P1732, DOI 10.1158/1541-7786.MCR-11-0245; Jiang M, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-13842-7; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Katoh M, 2018, INT J MOL MED, V42, P713, DOI 10.3892/ijmm.2018.3689; Kramps T, 2002, CELL, V109, P47, DOI 10.1016/S0092-8674(02)00679-7; Li J, 2013, CELL REP, V5, P1650, DOI 10.1016/j.celrep.2013.11.037; Lin EY, 2003, AM J PATHOL, V163, P2113, DOI 10.1016/S0002-9440(10)63568-7; Liu X, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07193-w; Luna JM, 2017, MOL CELL, V67, P400, DOI 10.1016/j.molcel.2017.06.025; Mani M, 2009, CANCER RES, V69, P7577, DOI 10.1158/0008-5472.CAN-09-0773; Meyer-Schaller N, 2019, DEV CELL, V48, P539, DOI 10.1016/j.devcel.2018.12.023; Micalizzi DS, 2010, J MAMMARY GLAND BIOL, V15, P117, DOI 10.1007/s10911-010-9178-9; Mieszczanek J, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-08164-z; MIETTINEN PJ, 1994, J CELL BIOL, V127, P2021, DOI 10.1083/jcb.127.6.2021; Moor AE, 2015, EBIOMEDICINE, V2, P1932, DOI 10.1016/j.ebiom.2015.10.030; Moses H, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003277; Muraoka RS, 2002, J CLIN INVEST, V109, P1551, DOI 10.1172/JCI200215234; Nik-Zainal S, 2016, NATURE, V534, P47, DOI 10.1038/nature17676; Parker DS, 2002, DEVELOPMENT, V129, P2565; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Sannino G, 2016, ONCOTARGET, V7, P73725, DOI 10.18632/oncotarget.12455; Saxena M, 2020, CANCER RES, V80, P3631, DOI 10.1158/0008-5472.CAN-19-2910; Saxena M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-30640-1; Shang ZS, 2019, J BIOL CHEM, V294, P9844, DOI 10.1074/jbc.RA119.007655; Thompson B, 2002, NAT CELL BIOL, V4, P367, DOI 10.1038/ncb786; Toya H, 2007, CANCER SCI, V98, P484, DOI 10.1111/j.1349-7006.2007.00430.x; Valenta T, 2012, EMBO J, V31, P2714, DOI 10.1038/emboj.2012.150; Valenta T, 2011, GENE DEV, V25, P2631, DOI 10.1101/gad.181289.111; van Schie EH, 2020, FRONT CELL DEV BIOL, V8, DOI 10.3389/fcell.2020.00025; Wagner KU, 1997, NUCLEIC ACIDS RES, V25, P4323, DOI 10.1093/nar/25.21.4323; Waldmeier L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048651; Xie Q, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054507; Xu WQ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07978-z; Yang C, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.356; Yang G, 2020, NANOTECHNOLOGY, V31, DOI 10.1088/1361-6528/ab5a03; Yang J, 2020, NAT REV MOL CELL BIO, V21, P341, DOI 10.1038/s41580-020-0237-9; Zatula N, 2014, ONCOTARGET, V5, P6770, DOI 10.18632/oncotarget.2252; Zhang Y, 2018, LIFE SCI, V208, P284, DOI 10.1016/j.lfs.2018.07.023; Zimmerli D, 2020, ELIFE, V9, DOI 10.7554/eLife.58123	58	4	4	1	5	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 28	2021	40	43					6195	6209		10.1038/s41388-021-02016-9	http://dx.doi.org/10.1038/s41388-021-02016-9		SEP 2021	15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	WO5HW	34545187	Green Published, hybrid			2022-12-26	WOS:000698130400001
J	Pathirage, DRK; Weeraratne, TC; Senanayake, SC; Karunaratne, SHPP; Karunaweera, ND				Pathirage, Dulani Ruwanika K.; Weeraratne, Thilini C.; Senanayake, Sanath C.; Karunaratne, S. H. P. Parakrama; Karunaweera, Nadira D.			Genetic diversity and population structure of Phlebotomus argentipes: Vector of Leishmania donovani in Sri Lanka	PLOS ONE			English	Article							FLIES DIPTERA PSYCHODIDAE; INSECTICIDE RESISTANCE; CUTANEOUS LEISHMANIASIS; CULEX-PIPIENS; SAND; IDENTIFICATION; INTROGRESSION; MOSQUITOS; EAST	Phlebotomus argentipes is the vector of Leishmania donovani which causes the disease leishmaniasis, a neglected tropical disease and a growing health problem in Sri Lanka. A proper understanding of the population genetic structure of sand fly vectors is considered important prior to planning and implementation of a successful vector control program. Thus, the present study was conducted to determine the population genetic structure of sand fly vectors in Sri Lanka. Two mitochondrial genes namely Cytochrome c oxidase subunit 1 (Cox 1) and Cytochrome b (Cytb), and the internal transcribed spacer 2 (ITS2) region from the nuclear ribosomal DNA were used for molecular characterization. Analyses included maximum likelihood method, network analysis and DNA polymorphisms. The outcome revealed unique sequences of all genomic regions studied except the cox 1 gene had a relationship with sand flies isolated previously from Sri Lanka, India and Israel and cytb gene of 4 sand flies that aligned with those isolated earlier from Sri Lanka and 3 from Madagascar. Furthermore, cox 1 gene and ITS 2 region analyses based on F-ST values indicated a possible gene flow between the study sites whereas cytb gene analysis favoured the existence of genetically distinct populations of P. argentipes in each of the study sites. Poor population differentiation of P. argentipes, a possible consequence of a gene flow, is indeed of concern due to the risk imposed by promoting the spread of functionally important phenotypes such as insecticide resistance across the country, making future vector control efforts challenging.	[Pathirage, Dulani Ruwanika K.; Senanayake, Sanath C.; Karunaweera, Nadira D.] Univ Colombo, Fac Med, Dept Parasitol, Colombo, Sri Lanka; [Weeraratne, Thilini C.; Karunaratne, S. H. P. Parakrama] Univ Peradeniya, Fac Sci, Dept Zool, Peradeniya, Sri Lanka	University of Colombo; University of Peradeniya	Karunaweera, ND (corresponding author), Univ Colombo, Fac Med, Dept Parasitol, Colombo, Sri Lanka.	nadira@parasit.cmb.ac.lk		Karunaweera, Nadira/0000-0003-3985-1817	National Institute of Allergy and Infectious Diseases of the National Institutes of Health, USA [U01AI136033]	National Institute of Allergy and Infectious Diseases of the National Institutes of Health, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institute of Allergy and Infectious Diseases of the National Institutes of Health, USA, under award number U01AI136033. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	[Anonymous], 2016, ANN REPORTS, V80, pS9; [Anonymous], 2020, WEEKLY EPIDEMIOLOGIC; Balbino VD, 2006, ACTA TROP, V98, P15, DOI 10.1016/j.actatropica.2006.01.007; Barnes KG, 2017, P NATL ACAD SCI USA, V114, P286, DOI 10.1073/pnas.1615458114; Cywinska A, 2006, MED VET ENTOMOL, V20, P413, DOI 10.1111/j.1365-2915.2006.00653.x; Desjeux P, 1996, CLIN DERMATOL, V14, P417, DOI 10.1016/0738-081X(96)00057-0; Esseghir S, 1997, INSECT MOL BIOL, V6, P211, DOI 10.1046/j.1365-2583.1997.00175.x; Esseghir S, 2000, BIOL J LINN SOC, V70, P189, DOI 10.1111/j.1095-8312.2000.tb00207.x; Fonseca DM, 2004, SCIENCE, V303, P1535, DOI 10.1126/science.1094247; Gajapathy K, 2016, ACTA TROP, V161, P1, DOI 10.1016/j.actatropica.2016.05.001; Gajapathy K, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-302; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Ilango K, 2010, J MED ENTOMOL, V47, P1, DOI 10.1603/033.047.0101; Karunaweera ND, 2009, TRENDS PARASITOL, V25, P458, DOI 10.1016/j.pt.2009.07.002; Karunaweera ND, 2003, T ROY SOC TROP MED H, V97, P380, DOI 10.1016/S0035-9203(03)90061-7; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Konradsen F, 2000, MALARIA SRI LANKA CU; Kumar NP, 2012, MOL ECOL RESOUR, V12, P414, DOI 10.1111/j.1755-0998.2012.03117.x; Latrofa MS, 2011, ACTA TROP, V119, P91, DOI 10.1016/j.actatropica.2011.04.013; Lewis D.J., 1978, BULLETIN OF THE BRITISH MUSEUM (NATURAL HISTORY) ENTOMOLOGY SUPPLEMENT, V37, P217; NAOTUNNE TD, 1990, TROP GEOGR MED, V42, P72; Pasteur N, 1996, J HERED, V87, P444, DOI 10.1093/oxfordjournals.jhered.a023035; Pathirage DRK, 2020, PARASITE VECTOR, V13, DOI 10.1186/s13071-020-04117-y; Pech-May A, 2013, INFECT GENET EVOL, V16, P254, DOI 10.1016/j.meegid.2013.02.004; Picado A, 2012, INDIAN J MED RES, V136, P22; Prudhomme J, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-71319-w; Raymond M, 2001, GENETICA, V112, P287, DOI 10.1023/A:1013300108134; Senanayake SASC, 2015, SE ASIAN J TROP MED, V46, P994; Surendran SN, 2005, B ENTOMOL RES, V95, P371, DOI 10.1079/BER2005368; Testa JM, 2002, ACTA TROP, V84, P205, DOI 10.1016/S0001-706X(02)00187-0; Walton C, 2001, MOL ECOL, V10, P569, DOI 10.1046/j.1365-294x.2001.01201.x; WHEATLEY D, 1984, PHARMATHERAPEUTICA, V3, P607; World Health Organization, 2019, LEISHMANIASIS	33	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2021	16	9							e0256819	10.1371/journal.pone.0256819	http://dx.doi.org/10.1371/journal.pone.0256819			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	WG5YY	34529694	Green Published, gold			2022-12-26	WOS:000707071500021
J	Wang, YF; Li, MZ; Xin, Y; Yang, GC; Tang, QF; Zhu, HL; Yang, YX; Chen, YL				Wang, Yunfeng; Li, Mingzhen; Xin, Yang; Yang, Guangcan; Tang, Qifeng; Zhu, Hongliang; Yang, Yixian; Chen, Yuling			Exchanging registered users' submitting reviews towards trajectory privacy preservation for review services in Location-Based Social Networks	PLOS ONE			English	Review								In Location-Based Social Networks (LBSNs), registered users submit their reviews for visited point-of-interests (POIs) to the system providers (SPs). The SPs anonymously publish submitted reviews to build reputations for POIs. Unfortunately, the user profile and trajectory contained in reviews can be easily obtained by adversaries who SPs has compromised with. Even worse, existing techniques, such as cryptography and generalization, etc., are infeasible due to the necessity of public publication of reviews and the facticity of reviews. Inspired by pseudonym techniques, we propose an approach to exchanging reviews before users submit reviews to SPs. In our approach, we introduce two attacks, namely review-based location correlation attack (RLCA) and semantic-based long-term statistical attack (SLSA). RLCA can be exploited to link the real user by reconstructing the trajectory, and SLSA can be launched to establish a connection between locations and users through the difference of semantic frequency. To resist RLCA, we design a method named User Selection to Resist RLCA (USR-RLCA) to exchange reviews. We propose a metric to measure the correlation between a user and a trajectory. Based on the metric, USR-RLCA can select reviews resisting RLCA to exchange by suppressing the number of locations on each reconstructed trajectory below the correlation. However, USR-RLCA fails to resist SLSA because of ignoring the essential semantics. Hence, we design an enhanced USR-RLCA named User Selection to Resist SLSA (USR-SLSA). We first propose a metric to measure the indistinguishability of locations concerning the difference of semantic frequency in a long term. Then, USR-SLSA can select reviews resisting SLSA to exchange by allowing two reviews whose indistinguishability is below the probability difference after the exchange to be exchanged. Evaluation results verify the effectiveness of our approach in terms of privacy and utility.	[Wang, Yunfeng; Li, Mingzhen; Xin, Yang; Yang, Guangcan; Zhu, Hongliang; Yang, Yixian] Beijing Univ Posts & Telecommun, Informat Secur Ctr, Natl Engn Lab Disaster Backup & Recovery, Sch Cyberspace Secur, Beijing, Peoples R China; [Li, Mingzhen] Hechi Univ, Sch Comp & Informat Engn, Hechi, Guangxi, Peoples R China; [Wang, Yunfeng; Xin, Yang; Yang, Yixian; Chen, Yuling] Guizhou Univ, Coll Comp Sci & Technol, State Key Lab Publ Big Data, Guiyang, Peoples R China; [Tang, Qifeng] Shanghai Data Exchange Corp, Natl Engn Lab Big Data Distribut & Exchange Techn, Shanghai, Peoples R China	Beijing University of Posts & Telecommunications; Hechi University; Guizhou University	Wang, YF; Xin, Y (corresponding author), Beijing Univ Posts & Telecommun, Informat Secur Ctr, Natl Engn Lab Disaster Backup & Recovery, Sch Cyberspace Secur, Beijing, Peoples R China.; Wang, YF; Xin, Y; Chen, YL (corresponding author), Guizhou Univ, Coll Comp Sci & Technol, State Key Lab Publ Big Data, Guiyang, Peoples R China.	wangyunfeng@bupt.edu.cn; yangxin@bupt.edu.cn; ylchen3@gzu.edu.cn		WANG, Yunfeng/0000-0001-6021-9045	Major Scientific and Technological Special Project of Guizhou Province [20183001]; Foundation of Guizhou Provincial Key Laboratory of Public Big Data [2017BDKFJJ015, 2018BDKFJJ008, 2018BDKFJJ020, 2018BDKFJJ021]; Basic Ability Improvement Program for Young and Middle-aged Teachers of Guangxi [2021KY0615, 2021KY0620]	Major Scientific and Technological Special Project of Guizhou Province; Foundation of Guizhou Provincial Key Laboratory of Public Big Data; Basic Ability Improvement Program for Young and Middle-aged Teachers of Guangxi	This research was funded by the "Major Scientific and Technological Special Project of Guizhou Province (20183001)", the "Foundation of Guizhou Provincial Key Laboratory of Public Big Data (2017BDKFJJ015, 2018BDKFJJ008, 2018BDKFJJ020, 2018BDKFJJ021)", and the "Basic Ability Improvement Program for Young and Middle-aged Teachers of Guangxi (2021KY0615 and 2021KY0620).	Al-Smadi M, 2018, J COMPUT SCI-NETH, V27, P386, DOI 10.1016/j.jocs.2017.11.006; Andrienkoa G, 2013, MOB COMPUT COMMUN RE, V17, P7, DOI 10.1145/2505395.2505398; Bindschaedler V, 2016, P IEEE S SECUR PRIV, P546, DOI 10.1109/SP.2016.39; Chen P., 2012, COMP ADV BIO MED SCI, P1; Chen R, 2013, INFORM SCIENCES, V231, P83, DOI 10.1016/j.ins.2011.07.035; Fei F, 2019, IEEE T SUST COMPUT, V4, P156, DOI 10.1109/TSUSC.2017.2733018; Gao S, 2014, J NETW COMPUT APPL, V38, P125, DOI 10.1016/j.jnca.2013.03.010; Ge YF, 2021, IEEE T CYBERNETICS, V51, P4808, DOI 10.1109/TCYB.2020.3027962; Ge YF, 2019, PROCEEDINGS OF THE 2019 GENETIC AND EVOLUTIONARY COMPUTATION CONFERENCE (GECCO'19), P771, DOI 10.1145/3321707.3321778; Gong XW, 2017, IEEE ACM T NETWORK, V25, P1703, DOI 10.1109/TNET.2017.2653102; Kato R., 2012, P 20 INT C ADV GEOGR, P249, DOI DOI 10.1145/2424321.2424354; Lu RX, 2014, IEEE INFOCOM SER, P763, DOI 10.1109/INFOCOM.2014.6848003; Ni LN, 2018, PROCEDIA COMPUT SCI, V129, P420, DOI 10.1016/j.procs.2018.03.018; Niu B, 2014, IEEE INFOCOM SER, P754, DOI 10.1109/INFOCOM.2014.6848002; Olumofin F, 2012, LECT NOTES COMPUT SC, V7035, P158; Peng T, 2017, INFORM SCIENCES, V387, P165, DOI 10.1016/j.ins.2016.08.010; Scellato S, 2012, 5 INT AAAI C WEBL SO, P329; Sun G, 2019, INFORM SCIENCES, V481, P616, DOI 10.1016/j.ins.2019.01.008; Sun G, 2017, FUTURE GENER COMP SY, V74, P375, DOI 10.1016/j.future.2016.08.023; Sun YM, 2017, FUTURE GENER COMP SY, V70, P48, DOI 10.1016/j.future.2016.06.017; Terrovitis M, 2017, IEEE T KNOWL DATA EN, V29, P1466, DOI 10.1109/TKDE.2017.2675420; Vimalachandran P, 2020, HEALTH INF SCI SYST, V8, DOI 10.1007/s13755-020-00126-4; Wu XC, 2014, 2014 IEEE INTERNATIONAL CONFERENCE ON DATA MINING WORKSHOP (ICDMW), P1120, DOI 10.1109/ICDMW.2014.122; Xin Y, 2017, INFORM SCIENCES, V378, P131, DOI 10.1016/j.ins.2016.10.038; Xu FL, 2017, PROCEEDINGS OF THE 26TH INTERNATIONAL CONFERENCE ON WORLD WIDE WEB (WWW'17), P1241, DOI 10.1145/3038912.3052620; Ye A, 2017, IEEE TRUST BIG, P510, DOI 10.1109/Trustcom/BigDataSE/ICESS.2017.278; YELP, YELP ACAD DAT ONL; Yi X, 2014, PROC INT CONF DATA, P640, DOI 10.1109/ICDE.2014.6816688; Zhang L, 2019, WIRELESS PERS COMMUN, V109, P2411, DOI 10.1007/s11277-019-06688-1; Zhang L, 2019, J CIRCUIT SYST COMP, V28, DOI 10.1142/S0218126619501470; Zhang L, 2018, WIRELESS PERS COMMUN, V101, P943, DOI 10.1007/s11277-018-5735-0; Zhang SB, 2018, SOFT COMPUT, V22, P6121, DOI 10.1007/s00500-017-2676-6; Zhang SB, 2018, IEEE INTERNET THINGS, V5, P4191, DOI 10.1109/JIOT.2018.2842470; Zhen XT, 2018, IEEE T NEUR NET LEAR, V29, P1575, DOI 10.1109/TNNLS.2017.2651068	34	0	0	4	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2021	16	9							e0256892	10.1371/journal.pone.0256892	http://dx.doi.org/10.1371/journal.pone.0256892			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	WG5YY	34529699	gold, Green Published			2022-12-26	WOS:000707071500023
J	Cai, LJ; Guo, ZH; Zhang, JT; Gai, ZJ; Liu, JQ; Meng, QY; Liu, XH				Cai, Lijun; Guo, Zhenhua; Zhang, Jingtao; Gai, Zhijia; Liu, Jingqi; Meng, Qingying; Liu, Xiaohu			No tillage and residue mulching method on bacterial community diversity regulation in a black soil region of Northeastern China	PLOS ONE			English	Article							MICROBIAL COMMUNITIES; ORGANIC-MATTER; CROP-ROTATION; CARBON; MANAGEMENT; FERTILIZATION; RHIZOSPHERE; RESPONSES; NITROGEN; BIOMASS	Soil microorganisms are important components of agricultural ecosystems; they are important in agricultural soil nutrient cycle and are easily affected by soil tillage. The response of soil microbial community to tillage is very complex, and the effect of the no tillage and residue mulching method on soil microbial diversity remains unclear. In 2019, the soil was collected from an experimental field after 10 years of continuous cultivation in the black soil area of the Sanjiang Plain in Northeastern China. In this study, the diversity and composition of the soil bacterial community and their relationship with soil properties were explored via high-throughput sequencing under no tillage with four residue mulching treatments. No tillage with 60% residue mulching (NTR3) significantly increased the alpha diversity of the rhizosphere soil bacteria and changed the composition of the bacterial community-consistent with changes in soil physicochemical properties. Proteobacteria, Acidobacteria, and Actinobacteria were the dominant phyla in the sample soil. Soil physicochemical properties explained 80.6% of the changes in soil diversity and composition, of which soil organic carbon, soil pH, and soil temperature were the principal contributors. Our results suggest that no tillage and residue mulching is conducive to increasing soil organic carbon and soil nutrient content, which is a beneficial conservation tillage measure for black soil protection in Sanjiang Plain of Northeast China. The no tillage with residue mulching, especially 60% residue mulching, alters soil bacterial community and highlights the importance of soil physicochemical properties in shaping the diversity and composition of the soil bacterial community. Our findings contribute to a broad understanding of the effects of no tillage and residue mulching on bacterial community differences and provide a scientific basis for the optimization of no tillage measures and sustainable utilization of the black soil of the Sanjiang Plain in Northeastern China.	[Cai, Lijun; Liu, Xiaohu] Shenyang Agr Univ, Dept Land & Environm, Shenyang, Liaoning, Peoples R China; [Cai, Lijun; Zhang, Jingtao; Gai, Zhijia; Liu, Jingqi; Meng, Qingying] Heilongjiang Acad Agr Sci, Jiamusi Branch, Jiamusi, Heilongjiang, Peoples R China; [Guo, Zhenhua] Heilongjiang Acad Agr Sci, Rice Res Inst, Jiamusi, Heilongjiang, Peoples R China	Shenyang Agricultural University; Heilongjiang Academy of Agricultural Sciences; Heilongjiang Academy of Agricultural Sciences	Liu, XH (corresponding author), Shenyang Agr Univ, Dept Land & Environm, Shenyang, Liaoning, Peoples R China.	liuxiaohu-mail@163.com	Zhang, Jing/HII-4294-2022; Zhang, Jing/GWZ-7332-2022		Heilongjiang Academy of Agricultural Sciences "Agricultural science and technology innovation leap project" [HNK2019CX01-2]	Heilongjiang Academy of Agricultural Sciences "Agricultural science and technology innovation leap project"	The work supported by the Heilongjiang Academy of Agricultural Sciences "Agricultural science and technology innovation leap project" (HNK2019CX01-2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alami MM, 2020, DIVERSITY-BASEL, V12, DOI 10.3390/d12020057; Aslam Z, 2013, J MICROBIOL, V51, P747, DOI 10.1007/s12275-013-2528-8; Bai J., 2017, CHIN J SOIL SCI, V48, P1185; Behnke GD, 2021, MICROORGANISMS, V9, DOI 10.3390/microorganisms9061244; Berendsen RL, 2012, TRENDS PLANT SCI, V17, P478, DOI 10.1016/j.tplants.2012.04.001; Bergmann GT, 2011, SOIL BIOL BIOCHEM, V43, P1450, DOI 10.1016/j.soilbio.2011.03.012; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Bremner J.M., 1982, METHODS SOIL ANAL, P575, DOI [DOI 10.2134/AGRONMONOGR9.2.2ED.C31, DOI 10.2134/AGR0NM0N0GR9.2.2ED.C31]; Campbell BJ, 2010, ENVIRON MICROBIOL, V12, P1842, DOI 10.1111/j.1462-2920.2010.02189.x; Cederlund H, 2014, APPL SOIL ECOL, V84, P62, DOI 10.1016/j.apsoil.2014.06.003; Dai ZJ, 2021, AGR ECOSYST ENVIRON, V309, DOI 10.1016/j.agee.2020.107288; DICK RP, 1992, AGR ECOSYST ENVIRON, V40, P25, DOI 10.1016/0167-8809(92)90081-L; Dong WY, 2014, APPL SOIL ECOL, V84, P140, DOI 10.1016/j.apsoil.2014.06.007; Fazi S, 2005, ENVIRON MICROBIOL, V7, P1633, DOI 10.1111/j.1462-2920.2005.00857.x; Feng Y, 2003, SOIL BIOL BIOCHEM, V35, P1693, DOI 10.1016/j.soilbio.2003.08.016; Gao HongJun, 2020, Scientia Agricultura Sinica, V53, P4613, DOI 10.3864/j.issn.0578-1752.2020.22.008; Gao ZY, 2021, BMC MICROBIOL, V21, DOI 10.1186/s12866-021-02120-6; Govaerts B, 2007, APPL SOIL ECOL, V37, P18, DOI 10.1016/j.apsoil.2007.03.006; [韩晓增 Han Xiaozeng], 2019, [中国科学院院刊, Bulletin of the Chinese Academy of Sciences], V34, P362; Hu YJ, 2014, SOIL BIOL BIOCHEM, V77, P51, DOI 10.1016/j.soilbio.2014.06.014; Huang M, 2013, BIOL FERT SOILS, V49, P373, DOI 10.1007/s00374-013-0778-6; Jenkins SN, 2010, SOIL BIOL BIOCHEM, V42, P1624, DOI 10.1016/j.soilbio.2010.06.002; Jones DL, 2008, PLANT SOIL, V312, P1, DOI 10.1007/s11104-008-9774-2; Jones RT, 2009, ISME J, V3, P442, DOI 10.1038/ismej.2008.127; Karlen D. L., 1992, American Journal of Alternative Agriculture, V7, P48, DOI 10.1017/S0889189300004458; Karlen D, 2019, SOIL TILL RES, V195, DOI 10.1016/j.still.2019.104365; Li CH, 2014, SOIL BIOL BIOCHEM, V75, P264, DOI 10.1016/j.soilbio.2014.04.023; [李文华 Li Wenhua], 2013, [湿地科学, Wetland Science], V11, P413; Li Y, 2021, SOIL TILL RES, V205, DOI 10.1016/j.still.2020.104758; Liu C, 2020, MICROORGANISMS, V8, DOI 10.3390/microorganisms8060836; Liu EK, 2014, GEODERMA, V213, P379, DOI 10.1016/j.geoderma.2013.08.021; Liu JJ, 2014, SOIL BIOL BIOCHEM, V70, P113, DOI 10.1016/j.soilbio.2013.12.014; Liu XB, 2010, PLANT SOIL ENVIRON, V56, P87, DOI 10.17221/155/2009-PSE; Liu YanHui, 2016, Acta Agronomica Sinica, V42, P1037; Lou YL, 2011, SOIL TILL RES, V113, P70, DOI 10.1016/j.still.2011.01.007; Lu R.K, 2000, ANAL METHOD SOIL AGR; Luo ZB, 2020, MICROORGANISMS, V8, DOI 10.3390/microorganisms8040477; Magoc T, 2011, BIOINFORMATICS, V27, P2957, DOI 10.1093/bioinformatics/btr507; Mathew R. P., 2012, Applied and Environmental Soil Science, V2012, P548620; Moraru PI, 2010, J FOOD AGRIC ENVIRON, V8, P309; Nannipieri P, 2003, EUR J SOIL SCI, V54, P655, DOI 10.1046/j.1351-0754.2003.0556.x; Navarrete AA, 2013, FEMS MICROBIOL ECOL, V83, P607, DOI 10.1111/1574-6941.12018; Navarro-Noya YE, 2013, SOIL BIOL BIOCHEM, V65, P86, DOI 10.1016/j.soilbio.2013.05.009; Nelson D. W., 1982, Methods of soil analysis. Part 2. Chemical and microbiological properties, P539; Pankhurst C.E., 1995, ADV PLANT PATHOL, V11, P229, DOI [10.1016/S0736-4539(06)80014-0, DOI 10.1016/S0736-4539(06)80014-0]; Partey ST, 2014, J SOIL SCI PLANT NUT, V14, P518, DOI 10.4067/S0718-95162014005000041; Roger-Estrade J, 2010, SOIL TILL RES, V111, P33, DOI 10.1016/j.still.2010.08.010; Rousk J, 2010, ISME J, V4, P1340, DOI 10.1038/ismej.2010.58; Sapkota TB, 2012, AGRON SUSTAIN DEV, V32, P853, DOI 10.1007/s13593-011-0079-0; Sengupta A, 2015, MICROB ECOL, V70, P853, DOI 10.1007/s00248-015-0609-4; Sheehy J, 2015, SOIL TILL RES, V150, P107, DOI 10.1016/j.still.2015.01.015; [时学双 Shi Xueshuang], 2016, [农业机械学报, Transactions of the Chinese Society for Agricultural Machinery], V47, P151; Singh D, 2013, J MICROBIOL, V51, P439, DOI 10.1007/s12275-013-2446-9; Sjoberg G, 2004, SOIL BIOL BIOCHEM, V36, P1761, DOI 10.1016/j.soilbio.2004.03.010; Smalla K, 2001, APPL ENVIRON MICROB, V67, P4742, DOI 10.1128/AEM.67.10.4742-4751.2001; Su Y, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-68527-9; Sun Feng-xia, 2010, Yingyong Shengtai Xuebao, V21, P2792; Tiquia SM, 2002, APPL SOIL ECOL, V21, P31, DOI 10.1016/S0929-1393(02)00040-9; Waldrop MP, 2017, ECOLOGY, V98, P1957, DOI 10.1002/ecy.1883; Wang Qiu-ju, 2018, Yingyong Shengtai Xuebao, V29, P2943, DOI 10.13287/j.1001-9332.201809.025; Wang ZT, 2017, AGRON SUSTAIN DEV, V37, DOI 10.1007/s13593-017-0454-6; Wu JS., 2006, MICROBIAL BIOMASS DE; Xu M, 2021, GLOBAL CHANGE BIOL, V27, P2061, DOI 10.1111/gcb.15553; Yang L, 2018, CAN J MICROBIOL, V64, P167, DOI 10.1139/cjm-2017-0443; Yu DL, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198087; Zeng J, 2016, SOIL BIOL BIOCHEM, V92, P41, DOI 10.1016/j.soilbio.2015.09.018; Zhalnina K, 2015, MICROB ECOL, V69, P395, DOI 10.1007/s00248-014-0530-2; Zhang G., 2012, SOIL SURVEY LAB METH; Zhang Peng, 2011, Journal of Agro-Environment Science, V30, P2518; Zhang Wei, 2006, Transactions of the Chinese Society of Agricultural Engineering, V22, P70; Zhang YY, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0218563; Zhou D.X., 2018, CHIN J SOIL SCI, V49, P848, DOI [10.19336/j.cnki.trtb.2018.04.13, DOI 10.19336/J.CNKI.TRTB.2018.04.13]	72	5	5	21	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2021	16	9							e0256970	10.1371/journal.pone.0256970	http://dx.doi.org/10.1371/journal.pone.0256970			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XM9EM	34506513	Green Published, gold			2022-12-26	WOS:000729120700022
J	Jakubowski, TD; Sitko-Dominik, MM				Jakubowski, Tomasz Daniel; Sitko-Dominik, Magdalena Maja			Teachers' mental health during the first two waves of the COVID-19 pandemic in Poland	PLOS ONE			English	Article							TRAIT EMOTIONAL INTELLIGENCE; SOCIAL SUPPORT; SELF-EFFICACY; JOB-SATISFACTION; MEDIATING ROLE; SCHOOL CLIMATE; CHILD-CARE; STRESS; BURNOUT; ANXIETY	Background Teaching work is stressful, moreover during the pandemic teachers' stress might have been intensified by distance education as well as by limited access to social support, which functions as a buffer in experiencing stress. The aim of the research was to investigate the relation between distance education and teachers' well-being, and their close relations and other social relations during the first two waves of the COVID-19 pandemic. Methods The research was conducted in two stages on 285 Polish primary and secondary school teachers who were recruited by means of the chain referral method. The following measures were used: The Depression Anxiety & Stress Scales-21, Berlin Social Support Scales, The Relationship Satisfaction Scale and The Injustice Experience Questionnaire. Results The teachers experienced at least mild levels of stress, anxiety and depression, both during the first as well as the second waves of the COVID-19 pandemic in Poland. It has been confirmed that there is a negative relation between relationship quality change and social relations quality change, and stress, anxiety and depression. The variables taken into consideration in the research have provided the explanation for the variation of stress-from 6% in the first stage of the research to 47% in the second stage; for the variation of anxiety-from 21% to 31%; and for the variation of depression-from 12% to 46%, respectively. Conclusions The research results show that due to distance work the distinction between professional work and family life might have been blurred, and as a consequence teachers' well-being could have been worsened. The isolation put on to stop the spreading of the virus might have contributed to changes in social relations, in close relations in particular, and at the same time negatively influenced teachers' abilities to effectively cope with the crisis situations.	[Jakubowski, Tomasz Daniel; Sitko-Dominik, Magdalena Maja] Univ Silesia Katowice, Inst Psychol, Fac Social Sci, Katowice, Poland	University of Silesia in Katowice	Jakubowski, TD (corresponding author), Univ Silesia Katowice, Inst Psychol, Fac Social Sci, Katowice, Poland.	tomasz.jakubowski@us.edu.pl		Jakubowski, Tomasz/0000-0002-1918-4028; Sitko-Dominik, Magdalena/0000-0002-4823-2009	Research Excellence Initiative of the University of Silesia in Katowice	Research Excellence Initiative of the University of Silesia in Katowice	The publication has been financed by the funds granted under the Research Excellence Initiative of the University of Silesia in Katowice. The funders had no role in the study design, data collection and analysis, decision to publish, or the preparation of the manuscript.	Addis ME, 2003, AM PSYCHOL, V58, P5, DOI 10.1037/0003-066X.58.1.5; Ahmed I., 2019, INT J MANAGEMENT BUS, V1, P1; Aliyyah R.R., 2020, J ETHN CULT STUD, V7, P90, DOI [10.29333/ejecs/388, DOI 10.29333/EJECS/388]; Alves R, 2021, IJERI-INT J EDUC RES, P203, DOI 10.46661/ijeri.5120; Alzueta E, 2021, J CLIN PSYCHOL, V77, P556, DOI 10.1002/jclp.23082; Anderson RC, 2021, FRONT PSYCHOL, V11, DOI 10.3389/fpsyg.2020.614774; [Anonymous], 2012, PSYCHOTHERAPY AUSTR; [Anonymous], 2020, GLOWNY URZAD STATYST; Aperribai L, 2020, FRONT PSYCHOL, V11, DOI 10.3389/fpsyg.2020.577886; Austin Vicky, 2005, Occup Ther Int, V12, P63, DOI 10.1002/oti.16; Baka L, 2015, INT J OCCUP MED ENV, V28, P335, DOI 10.13075/ijomeh.1896.00246; Batalova JA, 2002, J MARRIAGE FAM, V64, P743, DOI 10.1111/j.1741-3737.2002.00743.x; Beck JS, 2011, COGNITIVE BEHAV THER; Bergdahl N, 2021, TECHNOL KNOWL LEARN, V26, P443, DOI 10.1007/s10758-020-09470-6; Birolim MM, 2019, CIENC SAUDE COLETIVA, V24, P1255, DOI 10.1590/1413-81232018244.08542017; Bizer GY, 2020, PERS INDIV DIFFER, V159, DOI 10.1016/j.paid.2020.109882; Bondu R, 2020, J AFFECT DISORDERS, V272, P198, DOI 10.1016/j.jad.2020.03.167; Bottiani JH, 2019, J SCHOOL PSYCHOL, V77, P36, DOI 10.1016/j.jsp.2019.10.002; Brannon L., 2002, PSYCHOLOGIA RODZAJU; Brown SM, 2020, CHILD ABUSE NEGLECT, V110, DOI 10.1016/j.chiabu.2020.104699; Bubb S, 2020, IMPROV SCH, V23, P209, DOI 10.1177/1365480220958797; Martinez-Monteagudo MC, 2019, PERS INDIV DIFFER, V142, P53, DOI 10.1016/j.paid.2019.01.036; Centrum Badania Opinii Spolecznej, 2012, KOM BAD BS1732012; Centrum Badania Opinii Spolecznych, 2019, KOM BAD PAL TYT, V104; Cheng XL, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17218212; Chirico F, 2020, FRONT PSYCHOL, V10, DOI 10.3389/fpsyg.2019.02933; Cinamon RG, 2005, TEACH TEACH EDUC, V21, P365, DOI 10.1016/j.tate.2004.06.009; Collie RJ, 2012, J EDUC PSYCHOL, V104, P1189, DOI 10.1037/a0029356; Craig L, 2021, GENDER WORK ORGAN, V28, P66, DOI 10.1111/gwao.12497; Davey G. C. L., 1994, WILEY SERIES CLIN PS, P35; Davey GCL, 1996, COGNITIVE THER RES, V20, P499, DOI 10.1007/BF02227910; Desouky D, 2017, J EPIDEMIOL GLOB HEA, V7, P191, DOI 10.1016/j.jegh.2017.06.002; Dhawan S, 2020, J ED TECHNOL SYST, V49, P5, DOI [10.1177/0047239520934018, DOI 10.1177/0047239520934018]; DiCarlo CF, 2020, EARLY CHILD EDUC J, V48, P485, DOI 10.1007/s10643-019-01015-6; Donaldson C, 2007, BEHAV RES THER, V45, P2664, DOI 10.1016/j.brat.2007.07.002; Donato S, 2021, FRONT PSYCHOL, V11, DOI 10.3389/fpsyg.2020.578395; Donker MH, 2020, FRONT PSYCHOL, V11, DOI 10.3389/fpsyg.2020.00867; Erdiller ZB, 2015, EARLY CHILD DEV CARE, V185, P631, DOI 10.1080/03004430.2014.946502; Eurofound, 2016, 6 EUR WORK COND SURV; Eurostat, 2020, TEACHERS EU; Ferguson K, 2017, BROCK EDUC, V26, P62; Ferguson K, 2012, J TEACH LEARN, V8, P27; Fernandez-Batanero JM, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18020548; Fiorilli C, 2015, EUR REV APPL PSYCHOL, V65, P275, DOI 10.1016/j.erap.2015.10.003; Fiorilli C, 2017, SCAND J EDUC RES, V61, P127, DOI 10.1080/00313831.2015.1119722; Goldsmith RE, 2013, J TRAUMA STRESS, V26, P376, DOI 10.1002/jts.21819; Gonzalez A, 2017, CAMB J EDUC, V47, P513, DOI 10.1080/0305764X.2016.1214237; Green F.J., 2021, MOTHERS MOTHERING CO; Herman KC, 2020, J SCHOOL PSYCHOL, V78, P69, DOI 10.1016/j.jsp.2020.01.001; Herman KC, 2018, J POSIT BEHAV INTERV, V20, P90, DOI 10.1177/1098300717732066; Ho SK, 2017, EDUC PSYCHOL-UK, V37, P272, DOI 10.1080/01443410.2015.1120859; Hofstede G., 2001, CULTURES CONSEQUENCE; Jean-Baptiste C.O., 2020, SOCIAL SCI HUMANITIE, V2, DOI 10.1016/j.ssaho.2020.100057; Joshi A, 2021, INTERACT TECHNOL SMA, V18, P205, DOI 10.1108/ITSE-06-2020-0087; Ju CT, 2015, TEACH TEACH EDUC, V51, P58, DOI 10.1016/j.tate.2015.06.001; Kabito GG, 2020, BMC RES NOTES, V13, DOI 10.1186/s13104-020-4901-0; Karczewska A., 2014, ZESZYTY NAUKOWE POLI, V15, P90; Kim LE, 2020, BRIT J EDUC PSYCHOL, V90, P1062, DOI 10.1111/bjep.12381; Klapproth F., 2020, J PEDAGOGICAL RES, V4, P444, DOI [10.33902/JPR.2020062805, DOI 10.33902/JPR.2020062805]; Klassen RM, 2010, J EDUC PSYCHOL, V102, P741, DOI 10.1037/a0019237; Konig J, 2020, EUR J TEACH EDUC, V43, P608, DOI 10.1080/02619768.2020.1809650; Kourmousi N, 2016, FRONT PUBLIC HEALTH, V4, DOI 10.3389/fpubh.2016.00073; Kuwato M, 2020, BMC PUBLIC HEALTH, V20, DOI 10.1186/s12889-020-09475-x; Kyriacou C, 2001, EDUC REV, V53, P27, DOI 10.1080/00131910120033628; La Torre G, 2019, INT ARCH OCC ENV HEA, V92, P13, DOI 10.1007/s00420-018-1352-1; Lachowska B., 2012, KONFLIKT CZY SYNERGI; Landsbergis PA, 2020, NEW SOLUT, V30, P192, DOI 10.1177/1048291120956369; Leahy RL, 2012, INT J COGN THER, V5, P359, DOI 10.1521/ijct.2012.5.4.359; Lestiyanawati R., 2020, CLLIENT CULT LIT LIN, V2, P71, DOI [DOI 10.32699/CLLIENT.V2I1.1271, 10.32699/cllient.v2i1.1271]; Levant RF, 2011, AM PSYCHOL, V66, P765, DOI 10.1037/a0025034; Li QM, 2020, J AFFECT DISORDERS, V277, P153, DOI 10.1016/j.jad.2020.08.017; Lovibond SH, 1995, MANUAL DEPRESSION AN; Luszczynska A., 2006, STUD PSYCHOL, V44, P17; MacIntyre PD, 2020, SYSTEM, V94, DOI 10.1016/j.system.2020.102352; Mahfoudh A, 2019, G ITAL MED LAV ERGON, V41, P236; Makela K, 2014, RES Q EXERCISE SPORT, V85, P234, DOI 10.1080/02701367.2014.893052; Marshall DT, 2020, PHI DELTA KAPPAN, V102, P46, DOI 10.1177/0031721720970702; Merida-Lopez S, 2017, OCCUP MED-OXFORD, V67, P540, DOI 10.1093/occmed/kqx125; Merida-Lopez S, 2017, INT J EDUC RES, V85, P121, DOI 10.1016/j.ijer.2017.07.006; Ministerstwo Edukacji i Nauki [Ministry of National Education], 2021, PODS ROK SZKOLN 2020; Ministerstwo Edukacji Narodowej, 2020, PODS ROK SZKOLN 2019; Nasser-Abu Alhija F, 2015, PROCD SOC BEHV, V185, P374, DOI 10.1016/j.sbspro.2015.03.415; Orhan G, 2020, SOCIAL SCI ED RES RE, V7, P8; Overall NC, 2022, SOC PSYCHOL PERS SCI, V13, P285, DOI 10.1177/1948550621992973; Ozamiz-Etxebarria N, 2021, REV ESP SALUD PUBLIC, V95; Ozamiz-Etxebarria N, 2021, FRONT PSYCHOL, V11, DOI 10.3389/fpsyg.2020.620718; Ozamiz-Etxebarria N, 2020, FRONT PSYCHOL, V11, DOI 10.3389/fpsyg.2020.01491; Panisoara IO, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17218002; Martinez JP, 2020, FRONT PSYCHOL, V11, DOI 10.3389/fpsyg.2020.00591; Pietromonaco PR, 2021, AM PSYCHOL, V76, P438, DOI 10.1037/amp0000714; Poortman AR, 2009, J MARRIAGE FAM, V71, P526, DOI 10.1111/j.1741-3737.2009.00617.x; Power K., 2020, Sustainability: Science, Practice & Policy, V17, P67, DOI 10.1080/15487733.2020.1776561; Prilleltensky I, 2016, THEOR PRACT, V55, P104, DOI 10.1080/00405841.2016.1148986; Prime H, 2020, AM PSYCHOL, V75, P631, DOI 10.1037/amp0000660; Purwanto A., 2020, INT J ADV SCI TECHNO, V29, P6235; Putwain DW, 2019, EDUC PSYCHOL-UK, V39, P51, DOI 10.1080/01443410.2018.1500681; Roysamb E., 2014, Norsk Epidemiologi, V24, P187; Saksri S., 2018, INT J RECENT INNOVAT, V2, P206; Schonfeld IS, 2017, ALIGNING PERSP HEALT, P55, DOI 10.1007/978-3-319-53053-6_3; Schulz U, 2003, DIAGNOSTICA, V49, P73, DOI 10.1026//0012-1924.49.2.73; Shockley KM, 2021, J APPL PSYCHOL, V106, P15, DOI 10.1037/apl0000857; Skaalvik EM, 2018, SOC PSYCHOL EDUC, V21, P1251, DOI 10.1007/s11218-018-9464-8; Skaalvik EM, 2017, ALIGNING PERSP HEALT, P101, DOI 10.1007/978-3-319-53053-6_5; Sokal L., 2020, INT J ED RES OPEN, V1, P100016, DOI [10.1016/j.ijedro.2020.100016, DOI 10.1016/J.IJEDRO.2020.100016]; Ssenyonga J, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18052315; Stachteas P, 2020, Psychiatriki, V31, P293, DOI 10.22365/jpsych.2020.314.293; Stanley SM, 2020, FAM PROCESS, V59, P937, DOI 10.1111/famp.12575; Stevens, 2018, J SPECIAL ED LEADERS, V31, P99; Sullivan M.J.L., 2008, USER MANUAL INJUSTIC; Swadba U., 2012, WARTOSCI PRACY RODZI; Syed F, 2021, J GEN PSYCHOL, V148, P168, DOI 10.1080/00221309.2020.1747968; Tai KL, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0217430; Talidong KJB, 2020, J LOSS TRAUMA, V25, P573, DOI 10.1080/15325024.2020.1759225; Taylor SG, 2021, TEACH TEACH EDUC, V100, DOI 10.1016/j.tate.2021.103284; Thomas N., 2003, AUST J EDUC, V47, P73, DOI [10.1177/000494410304700106, DOI 10.1177/000494410304700106]; Thompson E.H., 1995, NEW PSYCHOL MEN; Titheradge D, 2019, PUBLIC HEALTH, V166, P53, DOI 10.1016/j.puhe.2018.09.022; Titkow A., 2004, NIEODPLATNA PRACA KO; Titkow A., 2007, TOZSAMOSC POLSKICH K; UNESCO, 2020, COVID 19 ED DISRUPTI; UNESCO, 2020, GEND TEACH KEY DIM I; Usher K, 2020, INT J MENT HEALTH NU, V29, P549, DOI 10.1111/inm.12735; Vaziri H, 2020, J APPL PSYCHOL, V105, P1073, DOI 10.1037/apl0000819; Wang H, 2018, FRONT PSYCHOL, V9, DOI 10.3389/fpsyg.2018.02305; Watkins E, 2002, BEHAV RES THER, V40, P1179, DOI 10.1016/S0005-7967(01)00098-5; Wells A, 2011, METACOGNITIVE THERAP; Whisman MA, 2020, J AFFECT DISORDERS, V260, P680, DOI 10.1016/j.jad.2019.09.035; Wierzbicka M, 2020, EDUKACJA ZDALNA CZAS; Wolgast A, 2017, SOC PSYCHOL EDUC, V20, P97, DOI 10.1007/s11218-017-9366-1; Xu XH, 2019, STRESS HEALTH, V35, P491, DOI 10.1002/smi.2882; Yang X, 2009, PUBLIC HEALTH, V123, P750, DOI 10.1016/j.puhe.2009.09.018; Yao XP, 2015, INT J ENV RES PUB HE, V12, P12505, DOI 10.3390/ijerph121012505; Yuh J, 2017, SOC SCI J, V54, P450, DOI 10.1016/j.soscij.2017.08.002; Zhao Y, 2020, MED SCI MONITOR, V26, DOI 10.12659/MSM.925591; Zhou L., 2020, BEST EVIDENCE CHINES, V5, P549, DOI [10.15354/bece.20.re040, DOI 10.15354/BECE.20.RE040]; Zhou X, 2020, EUR J PSYCHOTRAUMATO, V11, DOI 10.1080/20008198.2020.1779494	136	22	22	9	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2021	16	9							e0257252	10.1371/journal.pone.0257252	http://dx.doi.org/10.1371/journal.pone.0257252			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XH8RH	34555049	gold, Green Published			2022-12-26	WOS:000725694500022
J	Tounsi, B; Acheche, A; Lelard, T; Tabka, Z; Trabelsi, Y; Ahmaidi, S				Tounsi, Bilel; Acheche, Amal; Lelard, Thierry; Tabka, Zouhair; Trabelsi, Yassine; Ahmaidi, Said			Effects of specific inspiratory muscle training combined with whole-body endurance training program on balance in COPD patients: Randomized controlled trial	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; POSTURAL CONTROL; HUMAN DIAPHRAGM; INDIVIDUALS; REHABILITATION; PEOPLE; ACTIVATION; PRESSURE	Purpose This study aims to assess the effect of inspiratory muscle training (IMT) combined with endurance training (ET) on balance in patients with chronic obstructive pulmonary disease (COPD). Methods We studied 32 male patients (62 6 years) with moderate to very severe COPD. They were randomly assigned to an experimental group (IMT+ET) n = 16 or a control group (ET) n = 16 with similar characteristics. The evaluations were carried out at inclusion and after eight weeks of the training period. Functional balance was assessed by the Berg Balance Scale (BBS), the Timed-up and Go (TUG), the Single Leg Stance test (SLS), and the Activities-specific Balance Confidence (ABC) scale. The strength of the inspiratory muscles (PImax) was assessed by maximal inspiratory mouth pressure. Functional exercise performance was assessed by the 6 minutes walking test (6MWT). IMT program consists in performing two daily sets of 30 inspirations with 50% of PImax increased by 10% every two weeks. ET program consists in performing 30 min treadmill exercise at 60% to 80% of the average speed achieved during the 6MWT three days per week. Results After the training period, the experimental group demonstrated greater improvements in BBS (IMT+ET vs. ET; p = 0.019), and in ABC (IMT+ET vs. ET; p = 0.014). However, no significant differences between groups were observed for TUG, SLS, and 6MWT. There was a significant difference between groups in PImax (IMT+ET vs. ET; p = 0.030). Significant moderate correlations were obtained between Delta PImax and Delta BBS for both groups (IMT+ET: r = 0.624, p = 0.010; ET r = 0.550, p = 0.027) as well as for Delta ABC but only in the experimental group (IMT+ET: r = 0.550, p = 0.027). Conclusion Compared to ET alone, the results suggest that IMT combined with ET enhances inspiratory muscle function and functional balance according to BBS and ABC in patients with COPD. We suggest that inspiratory muscle training might be introduced as additional training to pulmonary rehabilitation programs aimed at improving balance in COPD patients. Trial registration The trial registry name: Clinical Trials; Registration number: NCT04084405; URL: https://clinicaltrials.gov/ct2/show/NCT04084405.	[Tounsi, Bilel; Lelard, Thierry; Ahmaidi, Said] Picardie Jules Verne Univ, Sport Sci Dept, UR EA 3300, Lab Exercise Physiol & Rehabil APERE, Amiens, France; [Tounsi, Bilel; Acheche, Amal; Tabka, Zouhair; Trabelsi, Yassine] Univ Sousse, Fac Med Sousse, Res Lab Exercise Physiol Pathophysiol Integral Mo, Sousse, Tunisia; [Tounsi, Bilel; Lelard, Thierry; Ahmaidi, Said] Picardie Jules Verne Univ, Dept Sports Sci, Amiens, France; [Acheche, Amal; Tabka, Zouhair; Trabelsi, Yassine] Univ Sousse, Fac Med Sousse, Res Lab Exercise Physiol & Pathophysiol, Sousse, Tunisia	Picardie Universites; Universite de Picardie Jules Verne (UPJV); Universite de Sousse; Picardie Universites; Universite de Picardie Jules Verne (UPJV); Universite de Sousse	Tounsi, B (corresponding author), Picardie Jules Verne Univ, Sport Sci Dept, UR EA 3300, Lab Exercise Physiol & Rehabil APERE, Amiens, France.; Tounsi, B (corresponding author), Univ Sousse, Fac Med Sousse, Res Lab Exercise Physiol Pathophysiol Integral Mo, Sousse, Tunisia.; Tounsi, B (corresponding author), Picardie Jules Verne Univ, Dept Sports Sci, Amiens, France.	bilel.tounsi@u-picardie.fr		Acheche, Amal/0000-0003-1677-5508; TOUNSI, Bilel/0000-0001-9268-526X				Ambrosino N, 2018, EUR RESPIR J, V51, DOI 10.1183/13993003.02285-2017; Beauchamp MK, 2009, RESP MED, V103, P1885, DOI 10.1016/j.rmed.2009.06.008; Beauchamp MK, 2010, MULTIDISCIP RESP MED, V5, P417, DOI 10.1186/2049-6958-5-6-417; Beauchamp MK, 2013, CHEST, V144, P1803, DOI 10.1378/chest.13-1093; Beauchamp MK, 2010, ARCH PHYS MED REHAB, V91, P1460, DOI 10.1016/j.apmr.2010.06.021; Beaumont M, 2018, EUR RESPIR J, V51, DOI 10.1183/13993003.01107-2017; Bernard S, 1998, AM J RESP CRIT CARE, V158, P629, DOI 10.1164/ajrccm.158.2.9711023; Bohannon RW, 2006, TOP GERIATR REHABIL, V22, P70; CASABURI R, 1991, AM REV RESPIR DIS, V143, P9, DOI 10.1164/ajrccm/143.1.9; Charususin N, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003101; Crisan AF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120573; Daldoul H, 2013, INT J ENV RES PUB HE, V10, P7257, DOI 10.3390/ijerph10127257; de Castro LA, 2016, RESP CARE, V61, P1488, DOI 10.4187/respcare.04749; Delbressine JM, 2020, J CARDIOPULM REHABIL, V40, P152, DOI 10.1097/HCR.0000000000000513; Diagnosis C., 2019, GOLD REP; Evans RA, 2015, CHEST, V147, P673, DOI 10.1378/chest.14-1079; Ferraro FV, 2019, PHYSIOL REP, V7, DOI 10.14814/phy2.14076; Gosselink R, 2011, EUR RESPIR J, V37, P416, DOI 10.1183/09031936.00031810; GRILLNER S, 1978, ACTA PHYSIOL SCAND, V103, P275, DOI 10.1111/j.1748-1716.1978.tb06215.x; Hamaoui A, 2010, NEUROSCI LETT, V475, P141, DOI 10.1016/j.neulet.2010.03.064; Hodges PW, 2000, J PHYSIOL-LONDON, V522, P165, DOI 10.1111/j.1469-7793.2000.t01-1-00165.xm; Hodges PW, 1997, J PHYSIOL-LONDON, V505, P539, DOI 10.1111/j.1469-7793.1997.539bb.x; Hodges PW, 2000, J APPL PHYSIOL, V89, P967, DOI 10.1152/jappl.2000.89.3.967; Hodges PW, 2001, J PHYSIOL-LONDON, V537, P999; Holland AE, 2014, EUR RESPIR J, V44, P1428, DOI 10.1183/09031936.00150314; Hudson AL, 2010, J NEUROPHYSIOL, V103, P1622, DOI 10.1152/jn.00887.2009; Janssens L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057949; Langer D, 2015, PHYS THER, V95, P1264, DOI 10.2522/ptj.20140245; Laveneziana P, 2019, EUR RESPIR J, V53, DOI 10.1183/13993003.01214-2018; Liwsrisakun C, 2019, MEDICINA-LITHUANIA, V55, DOI 10.3390/medicina55050171; Marques A, 2015, J CARDIOPULM REHABIL, V35, P154, DOI 10.1097/HCR.0000000000000097; McLay R, 2020, CHRON RESP DIS, V17, DOI 10.1177/1479973120922538; McMeeken J, 1999, Physiother Res Int, V4, P55; Mesquita R, 2016, CHRON RESP DIS, V13, P344, DOI 10.1177/1479972316647178; Mkacher W, 2015, J CARDIOPULM REHABIL, V35, P207, DOI 10.1097/HCR.0000000000000109; Myers AM, 1998, J GERONTOL A-BIOL, V53, pM287, DOI 10.1093/gerona/53A.4.M287; Oliveira CC, 2013, ARCH PHYS MED REHAB, V94, P1784, DOI 10.1016/j.apmr.2013.04.012; Polkey MI, 1996, AM J RESP CRIT CARE, V154, P1310, DOI 10.1164/ajrccm.154.5.8912741; Porto EF, 2015, INT J CHRONIC OBSTR, V10, P1233, DOI 10.2147/COPD.S63955; Porto EF, 2017, J CARDIOPULM REHABIL, V37, P139, DOI 10.1097/HCR.0000000000000246; Ramirez-Sarmiento A, 2002, AM J RESP CRIT CARE, V166, P1491, DOI 10.1164/rccm.200202-075OC; Ramsook AH, 2016, MED SCI SPORT EXER, V48, P1179, DOI 10.1249/MSS.0000000000000881; RIMMER KP, 1995, J APPL PHYSIOL, V79, P1556, DOI 10.1152/jappl.1995.79.5.1556; Roig M, 2009, RESP MED, V103, P1257, DOI 10.1016/j.rmed.2009.03.022; Smith MD, 2016, GAIT POSTURE, V43, P101, DOI 10.1016/j.gaitpost.2015.09.004; Smith MD, 2010, GAIT POSTURE, V31, P456, DOI 10.1016/j.gaitpost.2010.01.022; Tinetti ME, 2010, JAMA-J AM MED ASSOC, V303, P258, DOI 10.1001/jama.2009.2024; Tinetti ME., 1994, J GERONTOL INTERNET, V49, P8; Vanfleteren LEGW, 2013, AM J RESP CRIT CARE, V187, P728, DOI 10.1164/rccm.201209-1665OC; Wouters EFM, 2002, THORAX, V57, P1067, DOI 10.1136/thorax.57.12.1067; Yamada Y, 2017, EUR J RADIOL, V87, P76, DOI 10.1016/j.ejrad.2016.12.014; Yazici O, 2021, INT J CLIN PRACT, V75, DOI 10.1111/ijcp.13901	52	2	2	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2021	16	9							e0257595	10.1371/journal.pone.0257595	http://dx.doi.org/10.1371/journal.pone.0257595			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XH8RH	34555068	Green Published, gold			2022-12-26	WOS:000725694500046
J	Saito-Abe, M; Yamamoto-Hanada, K; Shoji, K; Sato, M; Irahara, M; Taniguchi, Y; Sekiyama, M; Mise, N; Ikegami, A; Shimono, M; Suga, R; Sanefuji, M; Ohga, S; Oda, M; Mitsubuchi, H; Miyairi, I; Ohya, Y				Saito-Abe, Mayako; Yamamoto-Hanada, Kiwako; Shoji, Kensuke; Sato, Miori; Irahara, Makoto; Taniguchi, Yu; Sekiyama, Makiko; Mise, Nathan; Ikegami, Akihiko; Shimono, Masayuki; Suga, Reiko; Sanefuji, Masafumi; Ohga, Shouichi; Oda, Masako; Mitsubuchi, Hiroshi; Miyairi, Isao; Ohya, Yukihiro			Measles antibody seropositivity among children with allergic diseases: A cross-sectional study in the Japan Environment & Children's Pilot Study	PLOS ONE			English	Article							IMMUNITY; ASTHMA	Background The relationship between allergic individuals and their responsiveness to routine vaccines has rarely been investigated. This study examined whether the seroprevalence of measles antibody differed between children with and without allergic diseases in the general pediatric population. Methods The cross-sectional study was performed within a prospective general birth cohort (a pilot study of the Japan Environment & Children's Pilot Study [JECS]) of children aged 8 years. The clinical history of allergic diseases, measles, and the concentration of measles immunoglobulin G titers in serum enzyme immunoassay were examined. Fisher's exact tests were used to assess the relationships between the allergic characteristics of the children and their measles antibody positivity rates. Results This study included 162 children. Any allergic disease was reported in 75 (46.3%). The measles antibody positivity rate was 94.7% among children with any allergic diseases and 92.0% among children without allergic diseases. Our results revealed no differences in measles antibody seropositivity between children with allergies and controls. Conclusions Children with allergies mount and maintain a comparable immune response to the measles vaccine.	[Saito-Abe, Mayako; Yamamoto-Hanada, Kiwako; Sato, Miori; Irahara, Makoto; Ohya, Yukihiro] Natl Ctr Child Hlth & Dev, Med Support Ctr Japan Environm & Childrens Study, Tokyo, Japan; [Shoji, Kensuke; Miyairi, Isao] Natl Ctr Child Hlth & Dev, Div Infect Dis, Tokyo, Japan; [Taniguchi, Yu; Sekiyama, Makiko] Natl Inst Environm Studies, Japan Environm & Childrens Study Programme Off, Ibaraki, Japan; [Mise, Nathan; Ikegami, Akihiko] Jichi Med Univ, Dept Environm & Prevent Med, Shimotsuke, Tochigi, Japan; [Shimono, Masayuki; Suga, Reiko] Univ Occupat & Environm Hlth, Reg Ctr Pilot Study Japan Environm & Childrens St, Sch Med, Fukuoka, Japan; [Sanefuji, Masafumi; Ohga, Shouichi] Kyushu Univ, Res Ctr Environm & Dev Med Sci, Fukuoka, Japan; [Sanefuji, Masafumi; Ohga, Shouichi] Kyushu Univ, Grad Sch Med Sci, Dept Pediat, Fukuoka, Japan; [Oda, Masako] Kumamoto Univ, Fac Life Sci, Dept Publ Hlth, Kumamoto, Japan; [Mitsubuchi, Hiroshi] Kumamoto Univ Hosp, Dept Neonatol, Kumamoto, Japan	National Center for Child Health & Development - Japan; National Center for Child Health & Development - Japan; National Institute for Environmental Studies - Japan; Jichi Medical University; University of Occupational & Environmental Health - Japan; Kyushu University; Kyushu University; Kumamoto University; Kumamoto University	Saito-Abe, M (corresponding author), Natl Ctr Child Hlth & Dev, Med Support Ctr Japan Environm & Childrens Study, Tokyo, Japan.	saito-myk@ncchd.go.jp	Sanefuji, Masafumi/GRO-5252-2022; Shoji, Kensuke/J-3316-2019; Yamamoto-Hanada, Kiwako/AAR-3094-2020; Yamamoto-Hanada, Kiwako/GQH-6445-2022	Sanefuji, Masafumi/0000-0001-6036-5528; Yamamoto-Hanada, Kiwako/0000-0003-1288-9620; Yamamoto-Hanada, Kiwako/0000-0003-1288-9620	Ministry of the Environment in Japan	Ministry of the Environment in Japan(Ministry of the Environment, Japan)	This study was funded and supported by the Ministry of the Environment in Japan. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Charman CR, 2004, ARCH DERMATOL, V140, P1513, DOI 10.1001/archderm.140.12.1513; Hanania NA, 2004, J ALLERGY CLIN IMMUN, V113, P717, DOI 10.1016/j.jaci.2003.12.584; Juhn YJ, 2006, ANN ALLERG ASTHMA IM, V97, P469, DOI 10.1016/S1081-1206(10)60937-4; Kawamoto T, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-25; Lee MS, 2000, J MED VIROL, V62, P511, DOI 10.1002/1096-9071(200012)62:4&lt;511::AID-JMV17&gt;3.0.CO;2-Z; National Institute of Infectious Diseases Jw, 1998, MEASL JAP; Orenstein WA, 2007, J INFECT DIS, V196, P1433, DOI 10.1086/522868; Paulke-Korinek M, 2013, VACCINE, V31, P1293, DOI 10.1016/j.vaccine.2012.12.075; Sheen YH, 2020, J ASTHMA, V57, P381, DOI 10.1080/02770903.2019.1575394; Shimazu S, 1995, ALLERGOL IMMUNOL, V2, P920; Whittle HC, 1999, LANCET, V353, P98, DOI 10.1016/S0140-6736(98)02364-2; Wiedermann U, 2016, HUM VACC IMMUNOTHER, V12, P239, DOI 10.1080/21645515.2015.1093263; Yamamoto-Hanada K, 2020, CYTOKINE, V130, DOI 10.1016/j.cyto.2020.155051; Yasuoka, 2014, JPN J INFECT PREV S3, V29, pS1	14	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2021	16	9							e0257721	10.1371/journal.pone.0257721	http://dx.doi.org/10.1371/journal.pone.0257721			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YS4WS	34551012	gold, Green Published			2022-12-26	WOS:000750679800050
J	Pal, S; Myburgh, J; Bansil, P; Hann, A; Robertson, L; Gerth-Guyette, E; Ambler, G; Bizilj, G; Kahn, M; Zobrist, S; Manis, MR; Styke, NA; Allan, V; Ansbro, R; Akingbade, T; Bryan, A; Murphy, SC; Kublin, JG; Layton, M; Domingo, GJ				Pal, Sampa; Myburgh, Jane; Bansil, Pooja; Hann, Amanda; Robertson, Lynn; Gerth-Guyette, Emily; Ambler, Gwen; Bizilj, Greg; Kahn, Maria; Zobrist, Stephanie; Manis, Michelle R.; Styke, Nickolas A.; Allan, Vajra; Ansbro, Richard; Akingbade, Tobi; Bryan, Andrew; Murphy, Sean C.; Kublin, James G.; Layton, Mark; Domingo, Gonzalo J.			Reference and point-of-care testing for G6PD deficiency: Blood disorder interference, contrived specimens, and fingerstick equivalence and precision	PLOS ONE			English	Article							GLUCOSE-6-PHOSPHATE-DEHYDROGENASE DEFICIENCY; PREVENT RELAPSE; TAFENOQUINE	Certain clinical indications and treatments such as the use of rasburicase in cancer therapy and 8-aminoquinolines for Plasmodium vivax malaria treatment would benefit from a point-of-care test for glucose-6-phosphate dehydrogenase (G6PD) deficiency. Three studies were conducted to evaluate the performance of one such test: the STANDARD((TM)) G6PD Test (SD BIOSENSOR, South Korea). First, biological interference on the test performance was evaluated in specimens with common blood disorders, including high white blood cell (WBC) counts. Second, the test precision on fingerstick specimens was evaluated against five individuals of each, deficient, intermediate, and normal G6PD activity status. Third, clinical performance of the test was evaluated at three point-of-care settings in the United States. The test performed equivalently to the reference assay in specimens with common blood disorders. High WBC count blood samples resulted in overestimation of G6PD activity in both the reference assay and the STANDARD G6PD Test. The STANDARD G6PD Test showed good precision on multiple fingerstick specimens from the same individual. The same G6PD threshold values (U/g Hb) were applied for a semiquantitative interpretation for fingerstick- and venous-derived results. The sensitivity/specificity values (95% confidence intervals) for the test for G6PD deficiency were 100 (92.3-100.0)/97 (95.2-98.2) and 100 (95.7-100.0)/97.4 (95.7-98.5) for venous and capillary specimens, respectively. The same values for females with intermediate (> 30% to <= 70%) G6PD activity were 94.1 (71.3-99.9)/88.2 (83.9-91.7) and 82.4 (56.6-96.2)/87.6(83.3-91.2) for venous and capillary specimens, respectively. The STANDARD G6PD Test enables point-of-care testing for G6PD deficiency.	[Pal, Sampa; Bansil, Pooja; Gerth-Guyette, Emily; Ambler, Gwen; Bizilj, Greg; Kahn, Maria; Zobrist, Stephanie; Allan, Vajra; Domingo, Gonzalo J.] PATH, Seattle, WA 98121 USA; [Myburgh, Jane; Hann, Amanda; Robertson, Lynn; Layton, Mark] Hammersmith Hosp, Special Haematol Lab, London, England; [Manis, Michelle R.; Styke, Nickolas A.; Bryan, Andrew] Univ Washington, Sch Med, Dept Lab Med, Seattle, WA 98195 USA; [Manis, Michelle R.; Styke, Nickolas A.; Bryan, Andrew] Univ Washington, Sch Med, Dept Microbiol, Seattle, WA 98195 USA; [Akingbade, Tobi; Kublin, James G.] Fred Hutchinson Canc Res Ctr, Vaccine & Infect Dis Div, Seattle, WA USA; [Murphy, Sean C.] Univ Washington, Dept Lab Med & Pathol, Seattle, WA USA; [Murphy, Sean C.] Univ Washington, Ctr Emerging & Re Emerging Infect Dis, Seattle, WA USA	Imperial College London; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Domingo, GJ (corresponding author), PATH, Seattle, WA 98121 USA.	gdomingo@path.org		Zobrist, Stephanie/0000-0001-9436-9885; Allan, Vajra/0000-0001-9875-2742	United Kingdom's Foreign, Commonwealth & Development Office (FCDO) [204139]; Bill & Melinda Gates Foundation [OPP1107113]; Bill & Melinda Gates Foundation; FCDO	United Kingdom's Foreign, Commonwealth & Development Office (FCDO); Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); FCDO	This work was funded in part by the United Kingdom's Foreign, Commonwealth & Development Office (FCDO), grant number 204139. The work was supported, in part, by the Bill & Melinda Gates Foundation [OPP1107113]. Under the grant conditions of the Gates Foundation, a Creative Commons Attribution 4.0 Generic License has been assigned to the Author Accepted Manuscript version that might arise from this submission. The findings and conclusions contained within are those of the authors and do not necessarily reflect the positions of FCDO or the Gates Foundation. The FCDO and Bill & Melinda Gates Foundation awards to PATH support the availability of point-of-care tests for G6PD deficiency. Neither PATH, nor the co-authors have any financial interests in the commercial availability of any of the products discussed in this article. All authors read the journal's authorship statement. All authors have read the journal's policy on conflict of interest and do not have a conflict of interest to disclose.	Alam MS, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0206331; [Anonymous], 1989, B WORLD HEALTH ORGAN, V67, P601; Baird JK, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0531-0; Baird JK, 2015, TRANSL RES, V165, P677, DOI 10.1016/j.trsl.2014.09.009; Bancone G, 2015, AM J TROP MED HYG, V92, P818, DOI 10.4269/ajtmh.14-0696; Bhutani VK, 2008, NEONATOLOGY, V94, P63, DOI 10.1159/000113463; Calvaresi EC, 2020, AM J CLIN PATHOL, V154, P248, DOI 10.1093/ajcp/aqaa040; Chu Cindy S, 2020, Wellcome Open Res, V5, P21, DOI [10.12688/wellcomeopenres.15700.2, 10.12688/wellcomeopenres.15700.1]; Commons RJ, 2020, MED J AUSTRALIA, V212, P152, DOI 10.5694/mja2.50474; Devine A, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005602; Domingo GJ, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-391; Haston JC, 2019, MMWR-MORBID MORTAL W, V68, P1062, DOI 10.15585/mmwr.mm6846a4; Howes RE, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-418; Jain SK, 2020, FREE RADICAL BIO MED, V161, P84, DOI 10.1016/j.freeradbiomed.2020.10.002; Jamerson BD, 2020, ARCH MED RES, V51, P743, DOI 10.1016/j.arcmed.2020.06.006; Kalnoky M, 2018, EUR J HAEMATOL, V100, P294, DOI 10.1111/ejh.13013; Lacerda MVG, 2019, NEW ENGL J MED, V380, P215, DOI 10.1056/NEJMoa1710775; LaRue N, 2014, AM J TROP MED HYG, V91, P854, DOI 10.4269/ajtmh.14-0194; Llanos-Cuentas A, 2019, NEW ENGL J MED, V380, P229, DOI 10.1056/NEJMoa1802537; Luzzatto L, 2020, BLOOD, V136, P1225, DOI 10.1182/blood.2019000944; Luzzatto L, 2016, HEMATOL ONCOL CLIN N, V30, P373, DOI 10.1016/j.hoc.2015.11.006; Luzzatto L, 2014, BRIT J HAEMATOL, V164, P469, DOI 10.1111/bjh.12665; Minucci A, 2012, BLOOD CELL MOL DIS, V48, P154, DOI 10.1016/j.bcmd.2012.01.001; Onori ME, 2021, MOL BIOL REP, V48, P2973, DOI 10.1007/s11033-021-06234-y; Organization WH, 2015, GUID TREATM MAL; PAL S, 2018, AM J TROP MED HYG; Pathologists CoA, 2015, ED DISC GLUC 6 PHOSP; Peixoto HM, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1140-x; Pfeffer DA, 2020, PLOS MED, V17, DOI 10.1371/journal.pmed.1003084; Powers JL, 2018, J APPL LAB MED, V2, P841, DOI 10.1373/jalm.2017.024935; Prequalification WHO, 2017, WHO PQ DIAGNOSTICS T; Roca-Feltrer A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0116143; Roper DR, 2017, INT J LAB HEMATOL, V39, P308, DOI 10.1111/ijlh.12627; Roper D, 2020, BRIT J HAEMATOL, V189, P24, DOI 10.1111/bjh.16366; Satyagraha AW, 2021, PLOS NEGLECT TROP D, V15, DOI 10.1371/journal.pntd.0009610; Tinley KE, 2010, AM J TROP MED HYG, V82, P210, DOI 10.4269/ajtmh.2010.09-0416; Vidavalur R, 2021, J MATERN-FETAL NEO M, DOI 10.1080/14767058.2021.1892067; WHO, 2011, WHONMHNHDMNM111; Wong RJ, 2021, SEMIN PERINATOL, V45, DOI 10.1016/j.semperi.2020.151356; Yang HC, 2021, FREE RADICAL RES, V55, P364, DOI 10.1080/10715762.2020.1866757; YOSHIDA A, 1971, B WORLD HEALTH ORGAN, V45, P243; Youssef JG, 2021, ANN HEMATOL, V100, P667, DOI 10.1007/s00277-021-04395-1; Zobrist S, 2021, PLOS NEGLECT TROP D, V15, DOI 10.1371/journal.pntd.0009649	43	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2021	16	9							e0257560	10.1371/journal.pone.0257560	http://dx.doi.org/10.1371/journal.pone.0257560			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	WG6BN	34543346	gold, Green Published			2022-12-26	WOS:000707078200051
J	Jin, Z; Liu, LP; Yu, YR; Li, D; Zhu, X; Yan, DM; Zhu, ZH				Jin, Zheng; Liu, Liping; Yu, Youran; Li, Dong; Zhu, Xun; Yan, Dongmei; Zhu, Zhenhua			TRIM59: A potential diagnostic and prognostic biomarker in human tumors	PLOS ONE			English	Article							PROMOTES CELL-PROLIFERATION; OVARIAN-CANCER; MIGRATION; KNOCKDOWN; INVASION; PROGRESSION	TRIM59 is a protein that is highly expressed in a variety of tumors and promotes tumor development. However, the use of TRIM59 as tumor diagnosis and prognosis biomarker has not been fully explored. We collected datasets from the cancer genome atlas (TCGA) and gene expression omnibus (GEO) to investigate its potential as a biomarker for diagnosis and prognosis. A total of 46 studies, including 11,558 patients were included in this study. Here, we showed that TRIM59 was significantly upregulated in 15 type of human solid tumors in comparison to their adjacent tissues. Receiver operating characteristic curve (ROC) results provided further evidence for the use of TRIM59 as a potential tumor diagnosis biomarker. Overall survival (OS) was compared between TRIM59 high expression and low expression groups. High expression of TRIM59 indicated a poor prognosis in multiple solid tumors. Taken together, these analyses showed that TRIM59 was upregulated in various types of tumors and had the potential to be used as a diagnostic and prognostic biomarker in human solid tumors.	[Jin, Zheng; Liu, Liping; Li, Dong; Zhu, Xun; Yan, Dongmei] Jilin Univ, Coll Basic Med Sci, Dept Immunol, Changchun, Jilin, Peoples R China; [Yu, Youran] Shanghai Univ Med & Hlth Sci, Coll Pharm, Shanghai, Peoples R China; [Zhu, Zhenhua] Southern Med Univ, Affiliated Hosp 3, Dept Orthopaed Trauma, Ctr Orthopaed Surg, Guangzhou, Guangdong, Peoples R China	Jilin University; Shanghai University of Medicine & Health Sciences; Southern Medical University - China	Yan, DM (corresponding author), Jilin Univ, Coll Basic Med Sci, Dept Immunol, Changchun, Jilin, Peoples R China.; Zhu, ZH (corresponding author), Southern Med Univ, Affiliated Hosp 3, Dept Orthopaed Trauma, Ctr Orthopaed Surg, Guangzhou, Guangdong, Peoples R China.	dmyan@jlu.edu.cn; zhuzhenhua93@hotmail.com	liu, li/HGC-0900-2022; Li, Dong/D-5419-2016	Li, Dong/0000-0002-2508-3282; Zhu, Zhenhua/0000-0002-1529-4369	National Natural Science Foundation of China [81871245]; Department of Education of Jilin Province [JJKH20190095KJ]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Department of Education of Jilin Province	This work was supported by the National Natural Science Foundation of China (No. 81871245) and Department of Education of Jilin Province (JJKH20190095KJ).	Aierken G, 2017, ONCOL RES, V25, P381, DOI 10.3727/096504016X14741511303522; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Chen G, 2019, BIOSCIENCE REP, V39, DOI 10.1042/BSR20181277; Chistiakov DA, 2018, SEMIN CANCER BIOL, V52, P9, DOI 10.1016/j.semcancer.2018.01.012; Ding WB, 2019, EPIGENETICS-US, V14, P67, DOI 10.1080/15592294.2019.1568178; Gao R, 2018, ONCOL LETT, V15, P8253, DOI 10.3892/ol.2018.8432; Gelband H, 2016, LANCET, V387, P2133, DOI 10.1016/S0140-6736(15)00755-2; Geng B, 2019, J CELL MOL MED, V23, P1458, DOI 10.1111/jcmm.14052; Han TY, 2018, AUTOPHAGY, V14, P2035, DOI 10.1080/15548627.2018.1491493; Hao L, 2017, ONCOL LETT, V14, P2153, DOI 10.3892/ol.2017.6467; Khatamianfar V, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001410; Li RK, 2020, J CELL BIOCHEM, V121, P1986, DOI 10.1002/jcb.29433; Liang JQ, 2016, MOL MED REP, V13, P5200, DOI 10.3892/mmr.2016.5183; Lin WY, 2016, EUR REV MED PHARMACO, V20, P4864; Liu YX, 2018, MOL CARCINOGEN, V57, P1792, DOI 10.1002/mc.22897; Napolitano LM, 2012, IUBMB LIFE, V64, P64, DOI 10.1002/iub.580; Sang YZ, 2018, CANCER RES, V78, P1792, DOI 10.1158/0008-5472.CAN-17-2774; Shen H, 2019, GENE, V698, P50, DOI 10.1016/j.gene.2019.02.044; Spolnicka M, 2018, INT J LEGAL MED, V132, P1, DOI 10.1007/s00414-017-1636-0; Su XM, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0370-y; Sun G, 2017, PHARMAZIE, V72, P674, DOI 10.1691/ph.2017.7659; Sun Y, 2017, ONCOL REP, V38, P43, DOI 10.3892/or.2017.5654; Tan P, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.3000051; Wang Y, 2018, INT J BIOL SCI, V14, P2073, DOI 10.7150/ijbs.28757; Wu W, 2017, ONCOL REP, V38, P2480, DOI 10.3892/or.2017.5896; YOUDEN WJ, 1950, BIOMETRICS, V6, P172, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3; Zhan WH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142596; Zhang P, 2019, MED SCI MONITOR, V25, P3366, DOI 10.12659/MSM.916299; Zhang Y, 2017, BIOMED PHARMACOTHER, V89, P462, DOI 10.1016/j.biopha.2017.02.039; Zhou ZC, 2014, GASTROENTEROLOGY, V147, P1043, DOI 10.1053/j.gastro.2014.07.021	30	2	2	8	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2021	16	9							e0257445	10.1371/journal.pone.0257445	http://dx.doi.org/10.1371/journal.pone.0257445			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	WG5ZQ	34534244	Green Published, gold			2022-12-26	WOS:000707073300029
J	Moehs, CP; Austill, WJ; Facciotti, D; Holm, A; Loeffler, D; Lu, ZJ; Mullenberg, JC; Slade, AJ; Steine, MN; van Boxtel, J; McGuire, C				Moehs, Charles P.; Austill, William J.; Facciotti, Daniel; Holm, Aaron; Loeffler, Dayna; Lu, Zhongjin; Mullenberg, Jessica C.; Slade, Ann J.; Steine, Michael N.; van Boxtel, Jos; McGuire, Cate			Development of non-transgenic glyphosate tolerant wheat by TILLING	PLOS ONE			English	Article							AMINO-ACID SUBSTITUTION; 5-ENOLPYRUVYLSHIKIMATE-3-PHOSPHATE SYNTHASE; DOUBLE MUTATION; RESISTANCE; GENE	Glyphosate (N-phosphonomethyl-glycine) is the world's most widely used broad spectrum, post-emergence herbicide. It inhibits the chloroplast-targeted enzyme 5-enolpyruvylshikimate-3-phosphate synthase (EPSPS; EC 2.5.1.19), a component of the plant and microorganism-specific shikimate pathway and a key catalyst in the production of aromatic amino acids. Variants of EPSPS that are not inhibited by glyphosate due to particular amino acid alterations in the active site of the enzyme are known. Some of these variants have been identified in weed species that have developed resistance to glyphosate because of the strong selective pressure of continuous, heavy glyphosate use. We have used TILLING (Targeting Induced Local Lesions in Genomes), a non-transgenic, target-selected, reverse genetics, mutation breeding technique, and conventional genetic crosses, to identify and combine, through two rounds of mutagenesis, wheat lines having both T102I and P106S (so-called TIPS enzyme) mutations in both the A and the D sub-genome homoeologous copies of the wheat EPSPS gene. The combined effects of the T102I and P106S mutations are known from previous work in multiple species to minimize the binding of the herbicide while maintaining the affinity of the catalytic site for its native substrates. These novel wheat lines exhibit substantial tolerance to commercially relevant levels of glyphosate.	[Moehs, Charles P.; Austill, William J.; Facciotti, Daniel; Holm, Aaron; Loeffler, Dayna; Lu, Zhongjin; Mullenberg, Jessica C.; Slade, Ann J.; Steine, Michael N.; van Boxtel, Jos; McGuire, Cate] Arcadia Biosci, Davis, CA 95618 USA		Moehs, CP (corresponding author), Arcadia Biosci, Davis, CA 95618 USA.	cpmmoe@gmail.com		Moehs, Charles/0000-0002-8907-4852				Acevedo-Garcia J, 2017, PLANT BIOTECHNOL J, V15, P367, DOI 10.1111/pbi.12631; Anderson JA, 2005, PLANT DIS, V89, P1136, DOI 10.1094/PD-89-1136; Aramrak A, 2018, CROP SCI, V58, P84, DOI 10.2135/cropsci2016.10.0861; Aramrak A, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2084-1; Callaway E, 2018, NATURE, V560, P16, DOI 10.1038/d41586-018-05814-6; CHAO S, 1989, THEOR APPL GENET, V78, P495, DOI 10.1007/BF00290833; Colbert T, 2001, PLANT PHYSIOL, V126, P480, DOI 10.1104/pp.126.2.480; Dill GM, 2005, PEST MANAG SCI, V61, P219, DOI 10.1002/ps.1008; Dong YX, 2019, J BIOL CHEM, V294, P716, DOI 10.1074/jbc.RA118.006134; Duke S.O., 2018, OUTLOOKS PEST MANAG, V29, P247, DOI [10.1564/v29_dec_03, DOI 10.1564/v29_dec_03, DOI 10.1564/V29_DEC_03]; Duke S.O., 2003, ENCY AGROCHEMICALS, P708, DOI [DOI 10.1002/047126363X.AGR119/FULL, 10.1002/047126363X.AGR119, DOI 10.1002/047126363X.AGR119]; Duke SO, 2008, PEST MANAG SCI, V64, P319, DOI 10.1002/ps.1518; Feng PCC, 2005, P NATL ACAD SCI USA, V102, P17290, DOI 10.1073/pnas.0508873102; Funke T, 2006, P NATL ACAD SCI USA, V103, P13010, DOI 10.1073/pnas.0603638103; Funke T, 2009, J BIOL CHEM, V284, P9854, DOI 10.1074/jbc.M809771200; Gaines TA, 2020, J BIOL CHEM, V295, P10307, DOI 10.1074/jbc.REV120.013572; Gaines TA, 2019, NEW PHYTOL, V223, P1770, DOI 10.1111/nph.15858; Gaines TA, 2010, P NATL ACAD SCI USA, V107, P1029, DOI 10.1073/pnas.0906649107; Ge X, 2014, PLANT PHYSIOL, V166, P1255, DOI 10.1104/pp.114.247197; Gherekhloo J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06772-1; Green JM, 2018, PEST MANAG SCI, V74, P1035, DOI 10.1002/ps.4462; Greene EA, 2003, GENETICS, V164, P731; Han HP, 2017, PLANT CELL ENVIRON, V40, P3031, DOI 10.1111/pce.13067; Heap I, 2018, PEST MANAG SCI, V74, P1040, DOI 10.1002/ps.4760; Liu B., 2020, CURR ROBOT REP, V1, P19, DOI [10.1007/s43154-020-00001-w, DOI 10.1007/S43154-020-00001-W]; McCallum CM, 2000, NAT BIOTECHNOL, V18, P455, DOI 10.1038/74542; Moehs CP, 2019, PLANT PHYSIOL, V179, P1692, DOI 10.1104/pp.18.00771; NEWHOUSE KE, 1992, PLANT PHYSIOL, V100, P882, DOI 10.1104/pp.100.2.882; Ostlie M, 2015, THEOR APPL GENET, V128, P343, DOI 10.1007/s00122-014-2434-4; Perotti VE, 2019, PEST MANAG SCI, V75, P1242, DOI 10.1002/ps.5303; Pozniak CJ, 2004, CROP SCI, V44, P1434, DOI 10.2135/cropsci2004.1434; Sammons RD, 2014, PEST MANAG SCI, V70, P1367, DOI 10.1002/ps.3743; Sidhu RS, 2000, J AGR FOOD CHEM, V48, P2305, DOI 10.1021/jf000172f; Slade AJ, 2005, NAT BIOTECHNOL, V23, P75, DOI 10.1038/nbt1043; Slade AJ, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-69; Takano HK, 2020, PEST MANAG SCI, V76, P95, DOI 10.1002/ps.5535; Tzin Vered, 2010, Arabidopsis Book, V8, pe0132, DOI 10.1199/tab.0132; Varah A, 2020, NAT SUSTAIN, V3, P63, DOI 10.1038/s41893-019-0450-8; Vila-Aiub MM, 2019, NEW PHYTOL, V223, P532, DOI 10.1111/nph.15733; Xu JW, 2002, SCI CHINA SER C, V45, P251, DOI 10.1360/02yc9028; Yin KQ, 2017, NAT PLANTS, V3, DOI 10.1038/nplants.2017.107; Yu Q, 2015, PLANT PHYSIOL, V167, P1440, DOI 10.1104/pp.15.00146; Zhou H, 2003, CROP SCI, V43, P1072, DOI 10.2135/cropsci2003.1072	43	2	2	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2021	16	9							e0245802	10.1371/journal.pone.0245802	http://dx.doi.org/10.1371/journal.pone.0245802			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	WG6DR	34525118	gold, Green Published, Green Submitted			2022-12-26	WOS:000707084400001
J	Adeyemo, OO; Tu, S; Keene, D				Adeyemo, Oluwatosin O.; Tu, Stephanie; Keene, Danya			How to lead health care workers during unprecedented crises: A qualitative study of the COVID-19 pandemic in Connecticut, USA	PLOS ONE			English	Article							LESSONS	Health Care Leaders (HCLs) faced unprecedented challenges during the initial phases of the COVID-19 pandemic. Leaders played an important role in shaping the experiences of Health Care Workers (HCWs) during this time. However, research is needed on how HCWs experienced and characterized HCLs' response and support. The aim of our study was to examine HCWs' experiences with leadership and to identify aspects of HCLs' response that were effective in supporting HCWs in their roles during the early phases of the pandemic. This was a qualitative study based on open-ended semi-structured interviews conducted (June 1- July 18, 2020) with frontline HCWs during the first wave of the COVID-19 pandemic in Connecticut, USA. Participants (N = 45) included physicians, nurses, respiratory therapists and patient care assistants who worked in inpatient and outpatient settings in various specialties, roles and 3 health systems across Connecticut, USA during the COVID-19 pandemic. Participants were offered a $25 gift card as an incentive for participation. We used inductive techniques derived from grounded theory to develop themes. We identified 6 main themes related to leadership response and support of HCWs during the pandemic namely: 1) Effective communication and transparency; 2) Prioritizing their health and safety; 3) Employee scheduling considerations: autonomy, assignment support and respite; 4) Appreciation- financial and nonfinancial; 5) Showing up and listening and 6) Stepping up with resources. Our findings can inform leadership responses to future pandemics and other unanticipated crises leading to strengthening of the health care system as a whole.	[Adeyemo, Oluwatosin O.] Yale Sch Med, Dept Obstet Gynecol & Reprod Sci, New Haven, CT 06510 USA; [Tu, Stephanie] Yale Sch Med, New Haven, CT USA; [Keene, Danya] Yale Sch Publ Hlth, Dept Social & Behav Sci, New Haven, CT USA	Yale University; Yale University; Yale University	Adeyemo, OO (corresponding author), Yale Sch Med, Dept Obstet Gynecol & Reprod Sci, New Haven, CT 06510 USA.	Oluwatosin.adeyemo@yale.edu		adeyemo, oluwatosin/0000-0002-8039-4892				Adams JG, 2020, JAMA-J AM MED ASSOC, V323, P1439, DOI 10.1001/jama.2020.3972; [Anonymous], 2020, CDC COVID DATA TRACK; Association of American Medical Schools, 2020, IS ALL PPE; Butler CR, 2021, BMJ OPEN, V11, DOI 10.1136/bmjopen-2020-047782; Butler CR, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.27315; Covello VT, 2003, J HEALTH COMMUN, V8, P5, DOI 10.1080/10810730390224802; Edwards JA, 2021, AM J SURG, V221, P62, DOI 10.1016/j.amjsurg.2020.07.029; Gonzalez A, 2020, PSYCHOL TRAUMA-US, V12, pS168, DOI 10.1037/tra0000893; Hennein R, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0240646; Hofmann PB, 2021, J AMBUL CARE MANAG, V44, P66, DOI 10.1097/JAC.0000000000000364; Kinman G, 2020, OCCUP MED-OXFORD, V70, P294, DOI 10.1093/occmed/kqaa096; O'donovan R, 2020, INT J QUAL HEALTH C, V32, P240, DOI 10.1093/intqhc/mzaa025; Ohta R, 2021, J GEN FAM MED, V22, P134, DOI 10.1002/jgf2.410; Pappa S, 2020, BRAIN BEHAV IMMUN, V88, P901, DOI [10.1016/j.bbi.2020.05.026, 10.1016/j.bbi.2020.11.023]; Ranney ML, 2020, NEW ENGL J MED, V382, DOI 10.1056/NEJMp2006141; Ripp J, 2020, ACAD MED, V95, P1136, DOI 10.1097/ACM.0000000000003414; Seeger MW, 2006, J APPL COMMUN RES, V34, P232, DOI 10.1080/00909880600769944; Shanafelt T, 2020, JAMA-J AM MED ASSOC, V323, P2133, DOI 10.1001/jama.2020.5893; Shechter A, 2020, GEN HOSP PSYCHIAT, V66, P1, DOI 10.1016/j.genhosppsych.2020.06.007; Sterling MR, 2020, JAMA INTERN MED, V180, P1453, DOI 10.1001/jamainternmed.2020.3930; Strauss A., 2014, BASICS QUALITATIVE R; Tannenbaum SI, 2021, BMJ QUAL SAF, V30, P59, DOI 10.1136/bmjqs-2020-011447; Tham KY, 2020, BMJ LEAD, V4, P201, DOI 10.1136/leader-2020-000288; Vindegaard N, 2020, BRAIN BEHAV IMMUN, V89, P531, DOI 10.1016/j.bbi.2020.05.048; Wu AW, 2020, ANN INTERN MED, V172, P822, DOI 10.7326/M20-1236	25	3	3	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2021	16	9							e0257423	10.1371/journal.pone.0257423	http://dx.doi.org/10.1371/journal.pone.0257423			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	WG5RP	34520505	gold, Green Published			2022-12-26	WOS:000707052100027
J	Bayleyegn, B; Kifle, ZD; Geremew, D				Bayleyegn, Biruk; Kifle, Zemene Demelash; Geremew, Demeke			Virological failure and associated factors among children receiving anti-retroviral therapy, Northwest Ethiopia	PLOS ONE			English	Article							HIV	Background Virological failure is under-recognized issue among children living with human immunodeficiency virus in developing countries. This partly may lead to failure to achieve the global goal of 90-90-90 targets in most developing countries including Ethiopia. Objectives This study aimed to assess the virological failure and its predictors among children receiving antiretroviral therapy at the University of Gondar comprehensive specialized hospital, Northwest Ethiopia. Methods An institutional based cross-sectional study was conducted among 253 study cohorts from January 2020-April 2021. Socio-demographic characteristics were collected using a structured questionnaire via a face-to-face interview, while detailed clinical data of the children were collected by reviewing the medical record. About 5 ml of blood were collected for the analysis of complete blood count and viral load quantification. Data were analyzed using SPSS version 20 and variables at p-value < 0.05 in the multivariable analysis were considered as statistically significant. Results In this study, the viral load suppression rate among antiretroviral therapy experienced children was 68.8%. Meanwhile, the overall virological failure among study participants was 19.4%. Children living without family (AOR = 3.63; 95%CI: 1.27-10.24), children with unemployed family (AOR = 4.95; 95%CI: 1.74-14.12), being wasted (AOR = 3.02; 95%CI: 1.19-7.67) being stunted (AOR = 2.38;95%CI:1.03-5.46), anemia (AOR = 5.50:95%CI;1.37-22.04) and being lymphopenic (AOR = 2.69:95%CI;1.04-7.75) were significantly associated with virological failure among children under treatment. Conclusion Higher virological failure among children was noteworthy in the present study. Caretakers other than immediate family, unemployed family, wasted, stunted, anemia, and lymphopenia were significant independent predictors of virological failure. Hence, standard, and optimal management of children under treatment should be warranted.	[Bayleyegn, Biruk] Univ Gondar, Coll Med & Hlth Sci, Sch Biomed & Lab Sci, Dept Hematol & Immunohematol, Gondar, Ethiopia; [Kifle, Zemene Demelash] Univ Gondar, Coll Med & Hlth Sci, Sch Pharm, Dept Pharmacol, Gondar, Ethiopia; [Geremew, Demeke] Univ Gondar, Coll Med & Hlth Sci, Sch Biomed & Lab Sci, Dept Immunol & Mol Biol, Gondar, Ethiopia	University of Gondar; University of Gondar; University of Gondar	Bayleyegn, B (corresponding author), Univ Gondar, Coll Med & Hlth Sci, Sch Biomed & Lab Sci, Dept Hematol & Immunohematol, Gondar, Ethiopia.	birukbayle@gmail.com	Geremew, Demeke/ABE-5034-2020	Geremew, Demeke/0000-0001-8493-1512	Department of Hematology and Immunohematology, School of Biomedical and Laboratory Science, College of Medicine and Health Science, University of Gondar	Department of Hematology and Immunohematology, School of Biomedical and Laboratory Science, College of Medicine and Health Science, University of Gondar	Our heartful gratitude goes to Mr Abrarew Gebrie for their tireless effort at the time of data collection. Moreover, our deepest gratitude also gives to the study participants and their family for goes to their valuable information without hesitation. Lastly, the authors would like to acknowledge the Department of Hematology and Immunohematology, School of Biomedical and Laboratory Science, College of Medicine and Health Science, University of Gondar for giving us any support.	Bayleyegn B, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0247878; Bhaisara B.B., 2019, SOCIAL MED, V44, P152, DOI [10.4103/ijcm.IJCM_326_18, DOI 10.4103/IJCM.IJCM_326_18]; Brhane GBN.E., 2020, ADV HEMA ONCO RES, V3; Bunupuradah T, 2011, AIDS RES THER, V8, DOI 10.1186/1742-6405-8-40; Castro H, 2011, LANCET, V377, P1580, DOI 10.1016/S0140-6736(11)60208-0; Chandrasekaran P, 2018, AIDS RES THER, V15, DOI 10.1186/s12981-018-0208-9; Cisse AM, 2019, BMC PEDIATR, V19, DOI 10.1186/s12887-019-1420-z; Davies MA, 2011, JAIDS-J ACQ IMM DEF, V56, P270, DOI 10.1097/QAI.0b013e3182060610; Endalamaw A, 2020, BMC PUBLIC HEALTH, V20, DOI 10.1186/s12889-020-8160-8; Federal HIV/AIDS Prevention and Control Office (FHAPCO), 2018, HIV PREV ETH NAT ROA; Federal Ministry of Health (FMOH) Ethiopia, 2018, NATL CONS GUID COMP; Fentaw Mulaw Getahun, 2020, Adv Hematol, V2020, P9643901, DOI 10.1155/2020/9643901; Gelaw B, 2021, ITAL J PEDIATR, V47, DOI 10.1186/s13052-021-01030-7; Getawa S, 2021, HIV AIDS-RES PALLIAT, V13, P229, DOI 10.2147/HIV.S294046; Gunda DW, 2018, CAN J INFECT DIS MED, V2018, DOI 10.1155/2018/1346104; Haile GS, 2019, BMC PEDIATR, V19, DOI 10.1186/s12887-019-1402-1; Huibers MHW, 2018, J ANTIMICROB CHEMOTH, V73, P3471, DOI 10.1093/jac/dky348; Kadima J, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0200242; Kamya MR, 2007, JAIDS-J ACQ IMM DEF, V46, P187, DOI 10.1097/QAI.0b013e31814278c0; Kityo C, 2017, J ANTIMICROB CHEMOTH, V72, P2587, DOI 10.1093/jac/dkx188; Kwantwi Louis Boafo, 2017, J Biomark, V2017, P7907352, DOI 10.1155/2017/7907352; Likie A, 2019, RATE PREDICTORS TREA, DOI 10.33696/aids.1.009; Nash D, 2018, J VIRUS ERAD, V4, P1; Negash H, 2020, INFECT DRUG RESIST, V13, P1863, DOI 10.2147/IDR.S251619; Ngo-Malabo ET, 2017, VIROL J, V14, DOI 10.1186/s12985-017-0893-3; Obirikorang C, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-128; Osman FT, 2020, OPEN AIDS J, V14, P61, DOI [DOI 10.2174/1874613602014010061, /10.2174/1874613602014010061]; Owusu M., 2017, BMJ GLOB HEALTH, V2, DOI [10.1136/bmjgh-2016-000260, DOI 10.1136/BMJGH-2016-000260]; Resino S, 2004, CLIN INFECT DIS, V38, P412, DOI 10.1086/380793; Riyanti R, 2017, UNEJ E P, P145; Roy Chowdhury S, 2016, FACTORS INFLUENCING, V5; Ruhinda EN, 2012, BMC PEDIATR, V12, DOI 10.1186/1471-2431-12-170; Shiferaw MB, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-019-4058-4; Shoko C, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-019-3781-1; Sovershaeva E, 2019, INT J INFECT DIS, V78, P65, DOI 10.1016/j.ijid.2018.10.019; Stevens WS, 2010, J INFECT DIS, V201, pS78, DOI 10.1086/650383; Tadesse BT, 2021, PEDIATR INFECT DIS J, V40, P60, DOI 10.1097/INF.0000000000002898; Teklu T, 2020, BIOMED RES INT, V2020, DOI 10.1155/2020/7360190; WHO, 2011, WHO TECH REP SER, V959, P1; WHO, PAN ANT THER MED MAN, P2021; World Health Organization, WHATS NEW TREATM MON; World Health Organization, 2013, GUID UPD MAN SEV AC; Yihun BA, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0215300	43	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2021	16	9							e0257204	10.1371/journal.pone.0257204	http://dx.doi.org/10.1371/journal.pone.0257204			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XM9EM	34506553	gold, Green Published			2022-12-26	WOS:000729120700118
J	Liu, JY; Duan, X; Zhang, R; Sun, YQ; Guan, L; Lin, BJ				Liu, Jianyi; Duan, Xi; Zhang, Ru; Sun, Youqiang; Guan, Lei; Lin, Bingjie			Relation classification via BERT with piecewise convolution and focal loss	PLOS ONE			English	Article								Recent relation extraction models' architecture are evolved from the shallow neural networks to natural language model, such as convolutional neural networks or recurrent neural networks to Bert. However, these methods did not consider the semantic information in the sequence or the distance dependence problem, the internal semantic information may contain the useful knowledge which can help relation classification. Focus on these problems, this paper proposed a BERT-based relation classification method. Compare with the existing Bert-based architecture, the proposed model can obtain the internal semantic information between entity pair and solve the distance semantic dependence better. The pre-trained BERT model after fine tuning is used in this paper to abstract the semantic representation of sequence, then adopt the piecewise convolution to obtain semantic information which influence the extraction results. Compare with the existing methods, the proposed method can achieve a better accuracy on relational extraction task because of the internal semantic information extracted in the sequence. While, the generalization ability is still a problem that cannot be ignored, and the numbers of the relationships are difference between different categories. In this paper, the focal loss function is adopted to solve this problem by assigning a heavy weight to less number or hard classify categories. Finally, comparing with the existing methods, the F1 metric of the proposed method can reach a superior result 89.95% on the SemEval-2010 Task 8 dataset.	[Liu, Jianyi; Duan, Xi; Zhang, Ru; Sun, Youqiang] Beijing Univ Posts & Telecommun, Sch Cyberspace Secur, Beijing, Peoples R China; [Guan, Lei] Tsinghua Univ, Sch Elect Engn, Beijing, Peoples R China; [Lin, Bingjie] State Grid Informat & Telecommun Branch, Beijing, Peoples R China	Beijing University of Posts & Telecommunications; Tsinghua University	Zhang, R (corresponding author), Beijing Univ Posts & Telecommun, Sch Cyberspace Secur, Beijing, Peoples R China.	zhangru@bupt.edu.cn		zhang, ru/0000-0001-6641-3236	National Natural Science Foundation of China [U1836108, U1936216]; Fundamental Research Funds for the Central Universities (Beijing university of posts and telecommunications) for Action Plan [2021XD-A11-1]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities (Beijing university of posts and telecommunications) for Action Plan	This work is supported by the National Natural Science Foundation of China under Grant U1836108 and U1936216, and supported by the Fundamental Research Funds for the Central Universities (Beijing university of posts and telecommunications) for Action Plan under Grant 2021XD-A11-1. These awards were received by Ru Zhang and Jianyi Liu. The funders played a role in study design, data collection and analysis, decision to publish, and preparation of the manuscript.	[Anonymous], 2013, P 2013 C EMP METH NA; Appelt D. E., 1995, P 6 MESS UND C MUC 6, P237; Collobert R, 2011, J MACH LEARN RES, V12, P2493; Culotta A., 2004, P 42 ANN M ASS COMP, P423, DOI [10.3115/1218955.1219009, DOI 10.3115/1218955.1219009]; Devlin J., 2019, BERT PRETRAINING DEE, V1, P4171, DOI [10.18653/v1/N19-1423, DOI 10.18653/V1/N19-1423]; Grishman, 1998, 7 MESS UND C MUC 7 P; Hu RH, 2019, IEEE I CONF COMP VIS, P10293, DOI 10.1109/ICCV.2019.01039; Huang YiYao, 2017, EMNLP, P1803, DOI [10.18653/v1/d17-1191, DOI 10.18653/V1/D17-1191]; Ji GL, 2017, AAAI CONF ARTIF INTE, P3060; [焦李成 Jiao Licheng], 2016, [计算机学报, Chinese Journal of Computers], V39, P1697; Kambhatla N., 2004, ACL 2004, P22, DOI DOI 10.3115/1219044.1219066; Katiyar A, 2016, PROCEEDINGS OF THE 54TH ANNUAL MEETING OF THE ASSOCIATION FOR COMPUTATIONAL LINGUISTICS, VOL 1, P919; Katiyar A, 2017, PROCEEDINGS OF THE 55TH ANNUAL MEETING OF THE ASSOCIATION FOR COMPUTATIONAL LINGUISTICS (ACL 2017), VOL 1, P917, DOI 10.18653/v1/P17-1085; Kim Y., 2014, P 2014 C EMP METH NA, P1746; LEE J, 2019, SYMMETRY-BASEL, V11; Li F, 2016, ABS160807720 CORR; Lin TY, 2020, IEEE T PATTERN ANAL, V42, P318, DOI 10.1109/TPAMI.2018.2858826; [刘克彬 Liu Kebin], 2007, [计算机研究与发展, Journal of Computer Research and Development], V44, P1406, DOI 10.1360/crad20070818; [刘峤 Liu Qiao], 2016, [计算机研究与发展, Journal of Computer Research and Development], V53, P582; Mao Jiayuan, 2019, NEUROSYMBOLIC CONCEP; McCallum, 2016, MULTILINGUAL RELATIO, P886, DOI [10.18653/v1/n16-1103, DOI 10.18653/V1/N16-1103]; McCallum A., 2018, SIMULTANEOUSLY SELF, V1, P872; Ren X, 2017, PROCEEDINGS OF THE 26TH INTERNATIONAL CONFERENCE ON WORLD WIDE WEB (WWW'17), P1015, DOI 10.1145/3038912.3052708; Soares LB, 2019, 57TH ANNUAL MEETING OF THE ASSOCIATION FOR COMPUTATIONAL LINGUISTICS (ACL 2019), P2895; Socher R, 2012, P EMNLP, P1201, DOI DOI 10.1162/153244303322533223; Sun X, 2009, PROCEEDINGS OF THE 2009 INTERNATIONAL CONFERENCE ON SIGNAL PROCESSING SYSTEMS, P410, DOI 10.1109/ICSPS.2009.79; Vaswani A, 2017, ADV NEUR IN, V30; Vu Ngoc Thang, 2016, P NAACL, P534, DOI DOI 10.18653/V1/N16-1065; Wang LL, 2016, PROCEEDINGS OF THE 54TH ANNUAL MEETING OF THE ASSOCIATION FOR COMPUTATIONAL LINGUISTICS, VOL 1, P1298; Wu F, 2010, ACL 2010: 48TH ANNUAL MEETING OF THE ASSOCIATION FOR COMPUTATIONAL LINGUISTICS, P118; Wu SC, 2019, PROCEEDINGS OF THE 28TH ACM INTERNATIONAL CONFERENCE ON INFORMATION & KNOWLEDGE MANAGEMENT (CIKM '19), P2361, DOI 10.1145/3357384.3358119; Xiao M, 2016, P COLING 2016 26 INT, P1254; Xu Y, 2015, CLASSIFYING RELATION, P1785, DOI DOI 10.18653/V1/D15-1206; Yu H., 2012, EXTRACTING VISUALIZI, P99; Yu M, 2017, PROCEEDINGS OF THE 55TH ANNUAL MEETING OF THE ASSOCIATION FOR COMPUTATIONAL LINGUISTICS (ACL 2017), VOL 1, P571, DOI 10.18653/v1/P17-1053; Zelenko D, 2003, J MACH LEARN RES, V3, P1083, DOI 10.1162/153244303322533205; Zeng D., 2014, COLING; Zeng D., 2015, P 2015 C EMP METH NA, P1753, DOI DOI 10.18653/V1/D15-1203; Zhang R, 2020, IEEE T INF FOREN SEC, V15, P1138, DOI 10.1109/TIFS.2019.2936913; Zhang S., 2015, P 29 PAC AS C LANG I, P73; Zheng SC, 2017, PROCEEDINGS OF THE 55TH ANNUAL MEETING OF THE ASSOCIATION FOR COMPUTATIONAL LINGUISTICS (ACL 2017), VOL 1, P1227, DOI 10.18653/v1/P17-1113; Zhou F. Y., 2017, CHIN J COMPUT, V40, P1229, DOI [DOI 10.11897/SP.J.1016.2017.01229, 10.11897/SP.J.1016.2017.01229]	45	4	4	6	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2021	16	9							e0257092	10.1371/journal.pone.0257092	http://dx.doi.org/10.1371/journal.pone.0257092			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XM9EM	34506554	Green Published, gold			2022-12-26	WOS:000729120700034
J	Osaki, T; Souri, M; Ichinose, A				Osaki, Tsukasa; Souri, Masayoshi; Ichinose, Akitada			Important roles of the human leukocyte antigen class I and II molecules and their associated genes in the autoimmune coagulation factor XIII deficiency via whole-exome sequencing analysis	PLOS ONE			English	Article							INHIBITOR DEVELOPMENT; SUSCEPTIBILITY; ANTIBODIES; SARCOIDOSIS; BTNL2	Autoimmune coagulation factor XIII deficiency is a bleeding disorder caused by the formation of autoantibodies against the coagulation factor XIII (FXIII); however, the molecular mechanism underlying this process is unknown. Therefore, in the present study, we aimed to elucidate this mechanism by performing whole-exome sequencing analysis of 20 cases of autoimmune FXIII deficiency. We identified approximately 21,788-23,916 variants in each case. In addition to their ability to activate T cells, present antigens, and immune tolerance, the candidate alleles were further narrowed down according to their allelic frequencies and the magnitude of damage caused by the substitution of amino acids. After selecting 44 candidate alleles, we investigated whether they were associated with the FXIII inhibitory titers and/or the anti-FXIII autoantibodies. We found that two polymorphisms whose variant allele frequencies were significantly lower in the patients tended to decrease FXIII inhibitory titers as the number of variant alleles increased. We also found that five polymorphisms whose variant allele frequencies were significantly higher in the patients tended to increase the levels of the anti-FXIII autoantibodies as the number of variant alleles increased. All of these polymorphisms were found in the human leukocyte antigen (HLA) class I and II molecules and their associated genes. In particular, the HLA class II molecule and its associated genes were found to be involved in the presentation of foreign antigens as well as the negative regulation of the proliferation of T-cells and the release of cytokines. Polymorphisms in the HLA class II molecules and the cytotoxic T lymphocyte antigen 4 have been reported to be associated with the development of autoantibodies in acquired hemophilia A. Therefore, we hypothesized that these polymorphisms may be associated with the development of autoantibodies in autoimmune FXIII deficiency.	[Osaki, Tsukasa; Souri, Masayoshi; Ichinose, Akitada] Japanese Minist Hlth Labor & Welf, Japanese Collaborat Res Grp Autoimmune Coagulat F, Yamagata, Japan; [Osaki, Tsukasa; Souri, Masayoshi; Ichinose, Akitada] Yamagata Univ, Sch Med, Dept Mol Pathobiochem & Pathobiol, Yamagata, Japan; [Osaki, Tsukasa; Souri, Masayoshi] Yamagata Univ, Fac Med, Dept Publ Hlth & Hyg, Yamagata, Japan	Yamagata University; Yamagata University	Osaki, T (corresponding author), Japanese Minist Hlth Labor & Welf, Japanese Collaborat Res Grp Autoimmune Coagulat F, Yamagata, Japan.; Osaki, T (corresponding author), Yamagata Univ, Sch Med, Dept Mol Pathobiochem & Pathobiol, Yamagata, Japan.	tosaki@med.id.yamagata-u.ac.jp		Osaki, Tsukasa/0000-0002-9487-3253	Japan Society for the Promotion of Science [16K09820, 201911070A]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	Japan Society for the Promotion of Science, 16K09820, Akitada Ichinose Health and Labor Sciences Research Grant, 201911070A, Akitada Ichinose.	Bachelet D, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0218258; Daniel R, 2015, FORENSIC SCI INT-GEN, V14, P50, DOI 10.1016/j.fsigen.2014.08.013; Dorgalaleh A, 2016, BLOOD REV, V30, P461, DOI 10.1016/j.blre.2016.06.002; Franchini M, 2013, J THROMB THROMBOLYS, V36, P109, DOI 10.1007/s11239-012-0818-3; Gorski MM, 2016, BLOOD, V127, P2924, DOI 10.1182/blood-2015-12-685735; Hwang Sung Ho, 2011, Korean J Hematol, V46, P49, DOI 10.5045/kjh.2011.46.1.49; Ichinose A, 2017, BLOOD REV, V31, P37, DOI 10.1016/j.blre.2016.08.002; Ichinose A, 2016, THROMB HAEMOSTASIS, V116, P772, DOI 10.1160/TH16-05-0362; Ichinose A, 2012, INT J HEMATOL, V95, P362, DOI 10.1007/s12185-012-1064-3; Karimi M, 2018, INT J LAB HEMATOL, V40, P3, DOI 10.1111/ijlh.12756; Khoury SJ, 2004, IMMUNITY, V20, P529, DOI 10.1016/S1074-7613(04)00116-5; Komaromi I, 2011, J THROMB HAEMOST, V9, P9, DOI 10.1111/j.1538-7836.2010.04070.x; Mackay IR, 2000, BMJ-BRIT MED J, V321, P93, DOI 10.1136/bmj.321.7253.93; Mahendra A, 2012, BRIT J HAEMATOL, V156, P3, DOI 10.1111/j.1365-2141.2011.08890.x; Nguyen T, 2006, J IMMUNOL, V176, P7354, DOI 10.4049/jimmunol.176.12.7354; Oldenburg J, 2010, HAEMOPHILIA, V16, P41, DOI 10.1111/j.1365-2516.2010.02259.x; Osaki T, 2015, THROMB HAEMOSTASIS, V113, P1347, DOI 10.1160/TH14-09-0745; Pavlova A, 2008, HAEMOPHILIA, V14, P355, DOI 10.1111/j.1365-2516.2007.01618.x; Pavlova A, 2010, HAEMOPHILIA, V16, P107, DOI 10.1111/j.1365-2516.2008.01976.x; Pavlova A, 2009, J THROMB HAEMOST, V7, P2006, DOI 10.1111/j.1538-7836.2009.03636.x; Pearce SHS, 2006, TRENDS MOL MED, V12, P90, DOI 10.1016/j.molmed.2005.12.005; Price P, 2004, TISSUE ANTIGENS, V64, P575, DOI 10.1111/j.1399-0039.2004.00310.x; Riley JL, 2005, BLOOD, V105, P13, DOI 10.1182/blood-2004-04-1596; Rybicki BA, 2005, AM J HUM GENET, V77, P491, DOI 10.1086/444435; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Souri M, 2015, J THROMB HAEMOST, V13, P802, DOI 10.1111/jth.12877; Ueda H, 2003, NATURE, V423, P506, DOI 10.1038/nature01621; Valentonyte R, 2005, NAT GENET, V37, P357, DOI 10.1038/ng1519; Yan MTS, 2018, TRANSFUS APHER SCI, V57, P724, DOI 10.1016/j.transci.2018.10.013; YEE VC, 1994, P NATL ACAD SCI USA, V91, P7296, DOI 10.1073/pnas.91.15.7296	30	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2021	16	9							e0257322	10.1371/journal.pone.0257322	http://dx.doi.org/10.1371/journal.pone.0257322			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XM9EM	34506591	Green Published, gold			2022-12-26	WOS:000729120700130
J	Tsai, YT; Baldwin, SA; Gopaluni, B				Tsai, Yiting; Baldwin, Susan A.; Gopaluni, Bhushan			Identifying indicator species in ecological habitats using Deep Optimal Feature Learning	PLOS ONE			English	Article							DIMENSIONALITY REDUCTION TECHNIQUES; DIAGNOSIS	Much of the current research on supervised modelling is focused on maximizing outcome prediction accuracy. However, in engineering disciplines, an arguably more important goal is that of feature extraction, the identification of relevant features associated with the various outcomes. For instance, in microbial communities, the identification of keystone species can often lead to improved prediction of future behavioral shifts. This paper proposes a novel feature extractor based on Deep Learning, which is largely agnostic to underlying assumptions regarding the training data. Starting from a collection of microbial species abundance counts, the Deep Learning model first trains itself to classify the selected distinct habitats. It then identifies indicator species associated with the habitats. The results are then compared and contrasted with those obtained by traditional statistical techniques. The indicator species are similar when compared at top taxonomic levels such as Domain and Phylum, despite visible differences in lower levels such as Class and Order. More importantly, when our estimated indicators are used to predict final habitat labels using simpler models (such as Support Vector Machines and traditional Artificial Neural Networks), the prediction accuracy is improved. Overall, this study serves as a preliminary step that bridges modern, black-box Machine Learning models with traditional, domain expertise-rich techniques.	[Tsai, Yiting; Baldwin, Susan A.; Gopaluni, Bhushan] Univ British Columbia, Dept Chem & Biol Engn, Vancouver, BC, Canada	University of British Columbia	Tsai, YT (corresponding author), Univ British Columbia, Dept Chem & Biol Engn, Vancouver, BC, Canada.	yttsai@chbe.ubc.ca		Tsai, Yiting/0000-0001-6098-8944				Abdi H, 2010, WIRES COMPUT STAT, V2, P433, DOI 10.1002/wics.101; Alvarez Jose M, 2016, ADV NEURAL INFORM PR, P2270; Antonelli L, 2016, PARASITOL RES, V115, P561, DOI 10.1007/s00436-015-4772-9; Balamurugan M, 2017, BIOMED PHARMACOL J, V10, P1823, DOI [10.13005/bpj/1299, DOI 10.13005/bpj/1299]; Bishop C. M., 2006, PATTERN RECOGN, DOI DOI 10.1117/1.2819119.ARNING; Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; Callahan BJ, 2017, ISME J, V11, P2639, DOI 10.1038/ismej.2017.119; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Cox M.A., 2008, HDB DATA VISUALIZATI, P315; de Ridder D, 2003, LECT NOTES COMPUT SC, V2714, P333; Doukim C. A., 2010, 2010 10th International Conference on Information Sciences, Signal Processing and their Applications (ISSPA 2010), P606, DOI 10.1109/ISSPA.2010.5605430; Dufrene M, 1997, ECOL MONOGR, V67, P345, DOI 10.1890/0012-9615(1997)067[0345:SAAIST]2.0.CO;2; Fisher RA, 1936, ANN EUGENIC, V7, P179, DOI 10.1111/j.1469-1809.1936.tb02137.x; Gadekallu TR, 2020, J AMB INTEL HUM COMP, DOI 10.1007/s12652-020-01963-7; Gadekallu TR, 2020, ELECTRONICS-SWITZ, V9, DOI 10.3390/electronics9020274; Gang P, 2018, PROCEEDINGS OF 2018 TENTH INTERNATIONAL CONFERENCE ON ADVANCED COMPUTATIONAL INTELLIGENCE (ICACI), P878, DOI 10.1109/ICACI.2018.8377579; Garris HW, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196032; Goodfellow I, 2016, ADAPT COMPUT MACH LE, P1; Han H, 2016, INT CONF SOFTW ENG, P219, DOI 10.1109/ICSESS.2016.7883053; Hilario M, 2008, BRIEF BIOINFORM, V9, P102, DOI 10.1093/bib/bbn005; Hofmann T, 2008, ANN STAT, V36, P1171, DOI 10.1214/009053607000000677; James Melville, 2020, Arxiv, DOI arXiv:1802.03426; Kaiser E, 2018, P ROY SOC A-MATH PHY, V474, DOI 10.1098/rspa.2018.0335; Kratsios, 2019, ARXIV PREPRINT ARXIV; Legendre P., 2012, NUMERICAL ECOLOGY; Likas A, 2003, PATTERN RECOGN, V36, P451, DOI 10.1016/S0031-3203(02)00060-2; Nguyen NP, 2016, NPJ BIOFILMS MICROBI, V2, DOI 10.1038/npjbiofilms.2016.4; Ng A. Y., 2004, P 21 INT C MACH LEAR, P78, DOI DOI 10.1145/1015330.1015435; Penczak T, 2009, ECOL MODEL, V220, P419, DOI 10.1016/j.ecolmodel.2008.11.005; Petticrew EL, 2015, GEOPHYS RES LETT, V42, P3347, DOI 10.1002/2015GL063345; Podani J, 2010, ECOL INDIC, V10, P1119, DOI 10.1016/j.ecolind.2010.03.010; Rajput DS, 2021, J AMB INTEL HUM COMP, DOI 10.1007/s12652-021-03154-4; Reddy GT, 2020, IEEE ACCESS, V8, P54776, DOI 10.1109/ACCESS.2020.2980942; Roweis ST, 2000, SCIENCE, V290, P2323, DOI 10.1126/science.290.5500.2323; Segovia F, 2018, LOG J IGPL, V26, P618, DOI 10.1093/jigpal/jzy026; Shaw P, 2009, MULTIVARIATE STAT EN; Shawe-Taylor J, 2004, KERNEL METHODS PATTE; Sonnewald M, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aay4740; Tenenbaum JB, 2000, SCIENCE, V290, P2319, DOI 10.1126/science.290.5500.2319; van der Maaten L, 2008, J MACH LEARN RES, V9, P2579; Winkler DA, 2017, MOL INFORM, V36, DOI 10.1002/minf.201600118	41	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2021	16	9							e0256782	10.1371/journal.pone.0256782	http://dx.doi.org/10.1371/journal.pone.0256782			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XM9EM	34506523	gold, Green Published			2022-12-26	WOS:000729120700072
J	Villoteau, A; Asfar, M; Otekpo, M; Loison, J; Gautier, J; Annweiler, C				Villoteau, Adeline; Asfar, Marine; Otekpo, Marie; Loison, Jocelyne; Gautier, Jennifer; Annweiler, Cedric		GERIA Covid Study Grp	Elevated C-reactive protein in early COVID-19 predicts worse survival among hospitalized geriatric patients	PLOS ONE			English	Article							INFLAMMATION; PERSPECTIVE	Background The objective of this cohort study was to determine whether elevated CRP in early COVID-19 was associated with 14-day mortality in geriatric patients. Methods Plasma CRP levels at hospital admission and 14-day all-cause mortality were assessed in geriatric inpatients hospitalized for COVID-19. Potential confounders were age, sex, functional abilities, history of malignancies, hypertension, cardiomyopathy, albuminemia, number of acute health issues, use of antibiotics and respiratory treatments. Results Ninety-five participants (mean +/- SD 88.0 +/- 5.5years; 49.5%women; mean CRP, 76.7 +/- 77.5mg/L; mean albuminemia, 32.9 +/- 6.0g/L) were included. Sixteen participants who did not survive at day 14 exhibited higher CRP level at baseline than the others (120.3 +/- 71.2 versus 67.9 +/- 76.1 mg/L, P = 0.002). There was no difference in albuminemia (P = 0.329). Plasma CRP level was directly associated with 14-day mortality (fully adjusted HR = 1.11, P = 0.025). The cut-off for CRP associated with 14-day mortality was set at 35mg/L (sensitivity = 0.88; specificity = 0.56). Those with CRP<35mg/L had longer survival time than the others (log-rank P<0.001). Conclusions Elevated CRP levels were associated with poorer 14-day survival in hospitalized geriatric COVID-19 patients.	[Villoteau, Adeline; Asfar, Marine; Otekpo, Marie; Annweiler, Cedric] Univ Angers, Sch Med, Hlth Fac, Angers, France; [Villoteau, Adeline; Asfar, Marine; Otekpo, Marie; Loison, Jocelyne; Gautier, Jennifer; Annweiler, Cedric] Univ Hosp, Dept Geriatr Med, Res Ctr Auton & Longev, Angers, France; [Villoteau, Adeline; Asfar, Marine; Otekpo, Marie; Loison, Jocelyne; Gautier, Jennifer; Annweiler, Cedric] Univ Hosp, Memory Clin, Res Ctr Auton & Longev, Angers, France; [Annweiler, Cedric] Univ Angers, UPRES EA 4638, Angers, France; [Annweiler, Cedric] Gerontopo Auton Longevite Pays Loire, Pays De La Loire, France; [Annweiler, Cedric] Univ Western Ontario, Robarts Res Inst, Schulich Sch Med & Dent, Dept Med Biophys, London, ON, Canada	Universite d'Angers; Universite de Franche-Comte; Universite d'Angers; Centre Hospitalier Universitaire d'Angers; Universite d'Angers; Centre Hospitalier Universitaire d'Angers; Universite d'Angers; Western University (University of Western Ontario)	Annweiler, C (corresponding author), Univ Angers, Sch Med, Hlth Fac, Angers, France.; Annweiler, C (corresponding author), Univ Hosp, Dept Geriatr Med, Res Ctr Auton & Longev, Angers, France.; Annweiler, C (corresponding author), Univ Hosp, Memory Clin, Res Ctr Auton & Longev, Angers, France.; Annweiler, C (corresponding author), Univ Angers, UPRES EA 4638, Angers, France.; Annweiler, C (corresponding author), Gerontopo Auton Longevite Pays Loire, Pays De La Loire, France.; Annweiler, C (corresponding author), Univ Western Ontario, Robarts Res Inst, Schulich Sch Med & Dent, Dept Med Biophys, London, ON, Canada.	Cedric.Annweiler@chu-angers.fr		OTEKPO, Marie/0000-0001-7791-7376; Annweiler, Cedric/0000-0002-7199-8109				Alzoughool F, 2021, CLIN HEMORHEOL MICRO, V77, P311, DOI 10.3233/CH-201002; Annweiler G, 2020, NUTRIENTS, V12, DOI 10.3390/nu12113377; [Anonymous], 2020, ACR RECOMMENDATIONS; Bajwa EK, 2009, CHEST, V136, P471, DOI 10.1378/chest.08-2413; Bannaga AS, 2020, CLIN MED, V20, P463, DOI 10.7861/clinmed.2020-0424; Bektas A, 2017, J LEUKOCYTE BIOL, V102, P977, DOI 10.1189/jlb.3RI0716-335R; Danwang C, 2020, BIOMARK RES, V8, DOI 10.1186/s40364-020-00217-0; De Martinis M, 2005, FEBS LETT, V579, P2035, DOI 10.1016/j.febslet.2005.02.055; del Galy AS, 2009, J AM GERIATR SOC, V57, P1721, DOI 10.1111/j.1532-5415.2009.02408.x; Franceschi C, 2000, ANN NY ACAD SCI, V908, P244; Franceschi C, 2007, MECH AGEING DEV, V128, P92, DOI 10.1016/j.mad.2006.11.016; Franceschi C, 2014, J GERONTOL A-BIOL, V69, pS4, DOI 10.1093/gerona/glu057; Helms J, 2020, INTENS CARE MED, V46, P1089, DOI 10.1007/s00134-020-06062-x; Herold T, 2020, J ALLERGY CLIN IMMUN, V146, P128, DOI 10.1016/j.jaci.2020.05.008; Hoeboer SH, 2015, BMC PULM MED, V15, DOI 10.1186/s12890-015-0015-1; Kovacs EJ, 2017, CLIN GERIATR MED, V33, P459, DOI 10.1016/j.cger.2017.06.002; Li L., 2021, EUR RADIOL, P1, DOI [10.1007/s00330-020-07108-w, DOI 10.1007/S00330-020-07108-W]; Liu F, 2020, J CLIN VIROL, V127, DOI 10.1016/j.jcv.2020.104370; Liu W, 2020, CHINESE MED J-PEKING, V133, P1032, DOI 10.1097/CM9.0000000000000775; Luo XM, 2020, CLIN INFECT DIS, V71, P2174, DOI 10.1093/cid/ciaa641; Mahrous AA, 2015, EGYPT J CHEST DIS TU, V64, P225, DOI 10.1016/j.ejcdt.2014.10.006; Mangialardi RJ, 2000, CRIT CARE MED, V28, P3137, DOI 10.1097/00003246-200009000-00001; Michaud M, 2013, J AM MED DIR ASSOC, V14, P877, DOI 10.1016/j.jamda.2013.05.009; Miesbach W, 2020, CLIN APPL THROMB-HEM, V26, DOI 10.1177/1076029620938149; Moore JB, 2020, SCIENCE, V368, P473, DOI 10.1126/science.abb8925; Nehme J, 2020, AGING CELL, V19, DOI 10.1111/acel.13237; Rochon J, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-81; Tan CC, 2020, J MED VIROL, V92, P856, DOI 10.1002/jmv.25871; Tsivgoulis G, 2020, STROKE, V51, P1924, DOI 10.1161/STROKEAHA.120.030791; Valerio L, 2021, THROMB HAEMOSTASIS, V121, P98, DOI 10.1055/s-0040-1721317; Vetel J M, 1998, Soins Gerontol, P23; Wang L, 2020, MED MALADIES INFECT, V50, P332, DOI 10.1016/j.medmal.2020.03.007; Wu CM, 2020, JAMA INTERN MED, V180, P934, DOI 10.1001/jamainternmed.2020.0994	33	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2021	16	9							e0256931	10.1371/journal.pone.0256931	http://dx.doi.org/10.1371/journal.pone.0256931			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XM9EM	34506514	gold, Green Published			2022-12-26	WOS:000729120700092
J	Zhuang, XJ; Feng, X; Tang, WH; Zhu, JL; Li, M; Li, JS; Zheng, XY; Li, R; Liu, P; Qiao, J				Zhuang, Xin-jie; Feng, Xue; Tang, Wen-hao; Zhu, Jin-liang; Li, Ming; Li, Jun-sheng; Zheng, Xiao-ying; Li, Rong; Liu, Ping; Qiao, Jie			FAM9B serves as a novel meiosis-related protein localized in meiotic chromosome cores and is associated with human gametogenesis	PLOS ONE			English	Article							SYNAPTONEMAL COMPLEX; CENTRAL ELEMENT; SYCP3; MUTATION; SYCE1; INTERACTS; SCP1; SLX2	Meiosis is a complex process involving the expression and interaction of numerous genes in a series of highly orchestrated molecular events. Fam9b localized in Xp22.3 has been found to be expressed in testes. However, FAM9B expression, localization, and its role in meiosis have not been previously reported. In this study, FAM9B expression was evaluated in the human testes and ovaries by RT-PCR, qPCR, and western blotting. FAM9B was found in the nuclei of primary spermatocytes in testes and specifically localized in the synaptonemal complex (SC) region of spermatocytes. FAM9B was also evident in the follicle cell nuclei and diffusely dispersed in the granular cell cytoplasm. FAM9B was partly co-localized with SYCP3, which is essential for both formation and maintenance of lateral SC elements. In addition, FAM9B had a similar distribution pattern and co-localization as gamma H2AX, which is a novel biomarker for DNA double-strand breaks during meiosis. All results indicate that FAM9B is a novel meiosis-associated protein that is co-localized with SYCP3 and gamma H2AX and may play an important role in SC formation and DNA recombination during meiosis. These findings offer a new perspective for understanding the molecular mechanisms involved in meiosis of human gametogenesis.	[Zhuang, Xin-jie; Feng, Xue; Zhu, Jin-liang; Li, Ming; Li, Jun-sheng; Zheng, Xiao-ying; Li, Rong; Liu, Ping; Qiao, Jie] Peking Univ Third Hosp, Dept Obstet & Gynecol, Ctr Reprod Med, Beijing, Peoples R China; [Zhuang, Xin-jie; Feng, Xue; Zhu, Jin-liang; Li, Ming; Li, Jun-sheng; Zheng, Xiao-ying; Li, Rong; Liu, Ping; Qiao, Jie] Peking Univ, Minist Educ, Key Lab Assisted Reprod, Beijing, Peoples R China; [Zhuang, Xin-jie; Feng, Xue; Zhu, Jin-liang; Li, Ming; Li, Jun-sheng; Zheng, Xiao-ying; Li, Rong; Liu, Ping; Qiao, Jie] Beijing Key Lab Reprod Endocrinol & Assisted Repr, Beijing, Peoples R China; [Zhuang, Xin-jie; Feng, Xue; Zhu, Jin-liang; Li, Ming; Li, Jun-sheng; Zheng, Xiao-ying; Li, Rong; Liu, Ping; Qiao, Jie] Peking Univ Third Hosp, Res Ctr Obstet & Gynecol, Beijing, Peoples R China; [Tang, Wen-hao] Third Hosp Peking Univ, Dept Urol, Beijing, Peoples R China	Peking University; Peking University	Zhuang, XJ; Liu, P (corresponding author), Peking Univ Third Hosp, Dept Obstet & Gynecol, Ctr Reprod Med, Beijing, Peoples R China.; Zhuang, XJ; Liu, P (corresponding author), Peking Univ, Minist Educ, Key Lab Assisted Reprod, Beijing, Peoples R China.; Zhuang, XJ; Liu, P (corresponding author), Beijing Key Lab Reprod Endocrinol & Assisted Repr, Beijing, Peoples R China.; Zhuang, XJ; Liu, P (corresponding author), Peking Univ Third Hosp, Res Ctr Obstet & Gynecol, Beijing, Peoples R China.	Bysylp@sina.com; zhuangxinjie902@163.com			National Natural Science Foundation of China [8217060945, 81671513, 81200466]; Beijing Natural Science Foundation [7172236]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation)	This study was supported by the National Natural Science Foundation of China (NO. 8217060945, 81671513 and 81200466) and Beijing Natural Science Foundation (NO.7172236).	Blanco-Rodriguez J, 2012, REPRODUCTION, V144, P699, DOI 10.1530/REP-12-0326; Blanco-Rodriguez J, 2009, MICROSC RES TECHNIQ, V72, P823, DOI 10.1002/jemt.20730; Bolcun-Filas E, 2007, J CELL BIOL, V176, P741, DOI 10.1083/jcb.200610027; Bolcun-Filas E, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000393; Bolor H, 2009, AM J HUM GENET, V84, P14, DOI 10.1016/j.ajhg.2008.12.002; Boroujeni PB, 2018, J BRAS REPROD ASSIST, V22, P185, DOI 10.5935/1518-0557.20180030; Davies OR, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120099; de la Fuente R, 2007, PLOS GENET, V3, P2122, DOI 10.1371/journal.pgen.0030198; de Vries L, 2014, J CLIN ENDOCR METAB, V99, pE2129, DOI 10.1210/jc.2014-1268; Dunne OM, 2019, J BIOL CHEM, V294, P9260, DOI 10.1074/jbc.RA119.008404; Escobar ML, 2019, ANAT REC, V302, P2082, DOI 10.1002/ar.24187; Feng JR, 2017, PROTEIN CELL, V8, P538, DOI 10.1007/s13238-016-0354-6; Hernandez-Lopez D, 2020, MOL HUM REPROD, V26, P485, DOI 10.1093/molehr/gaaa032; Jiang HW, 2018, PLOS GENET, V14, DOI 10.1371/journal.pgen.1007300; Kolas NK, 2004, CYTOGENET GENOME RES, V105, P182, DOI 10.1159/000078188; Liu JG, 1996, EXP CELL RES, V226, P11, DOI 10.1006/excr.1996.0197; Maor-Sagie E, 2015, J ASSIST REPROD GEN, V32, P887, DOI 10.1007/s10815-015-0445-y; Martinez-Garay I, 2002, GENOMICS, V80, P259, DOI 10.1006/geno.2002.6834; Mizutani E, 2011, HUM REPROD, V26, P1259, DOI 10.1093/humrep/der035; Ollinger R, 2005, MOL BIOL CELL, V16, P212; Pashaei M, 2020, J ASSIST REPROD GEN, V37, P451, DOI 10.1007/s10815-019-01660-1; Roos A, 2013, ARCH GYNECOL OBSTET, V288, P1153, DOI 10.1007/s00404-013-2861-5; Schilit SLP, 2020, AM J HUM GENET, V106, P41, DOI 10.1016/j.ajhg.2019.11.013; Shi YQ, 2013, GENE, V527, P352, DOI 10.1016/j.gene.2013.06.033; Stouffs K, 2005, FERTIL STERIL, V84, P1019, DOI 10.1016/j.fertnstert.2005.04.033; Vertika S, 2020, MITOCHONDRION, V54, P26, DOI 10.1016/j.mito.2020.06.003; Winkel K, 2009, CHROMOSOMA, V118, P259, DOI 10.1007/s00412-008-0194-0; Zhuang XJ, 2017, INT J CLIN EXP PATHO, V10, P9427; Zhuang XJ, 2016, CELL CYCLE, V15, P2576, DOI 10.1080/15384101.2016.1174796; Zhuang XJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130087; Zhuang XJ, 2014, CELL CYCLE, V13, P2230, DOI 10.4161/cc.29265; Zhuang XJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020866	32	1	1	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2021	16	9							e0257248	10.1371/journal.pone.0257248	http://dx.doi.org/10.1371/journal.pone.0257248			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XM9EM	34507348	gold, Green Published			2022-12-26	WOS:000729120700056
J	Du, M; Yang, L; Liu, B; Yang, LY; Mao, XX; Liang, ML; Huang, K				Du, Meng; Yang, Liu; Liu, Bing; Yang, Liuye; Mao, Xiaoxiang; Liang, Minglu; Huang, Kai			Inhibition of NFAT suppresses foam cell formation and the development of diet-induced atherosclerosis	FASEB JOURNAL			English	Article						atherosclerosis; cholesterol efflux; foam cell formation; NFAT	ACTIVATED T-CELLS; NUCLEAR FACTOR; MACROPHAGE DIFFERENTIATION; PPAR-GAMMA; CYCLOSPORINE; PROTEIN; TRANSPLANTATION; TRANSCRIPTION	Deciphering the molecular and cellular processes involved in foam cell formation is critical for us to understand the pathogenesis of atherosclerosis. Nuclear factor of activated T cells (NFAT) is a transcription factor originally identified as a key player in the differentiation of T cells and maturation of immune system. Nowadays it has been brought into attention that NFAT also regulates multiple pathophysiological processes and targeted intervention in NFAT may be effective in the treatment of some cardiovascular diseases. However, whether NFAT is involved in foam cell formation remains elusive. NFAT in human monocyte-derived macrophage was activated by ox-LDL and translocated from the cytoplasm to the nucleus. NFAT then directly bound to peroxisome proliferator-activated receptor gamma (PPAR gamma) in the nucleus and negatively regulated its transcriptional activity. NFATc2 knockdown or NFAT inhibitor 11R-VIVIT increased cholesterol efflux (by activating PPAR gamma-LXR alpha-ABCA1 cascade) and reduced the uptake of modified lipoprotein (in a PPAR gamma-independent way) in macrophage, thus prevented foam cell formation. Besides, 11R-VIVIT also exerted a protective role in the development of atherosclerosis in western diet-fed ApoE(-/-) mice. These results suggest NFAT inhibition as a potential therapeutic strategy in atherosclerosis.	[Du, Meng; Yang, Liu; Liu, Bing; Yang, Liuye; Mao, Xiaoxiang; Huang, Kai] Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Dept Cardiol, 1277 Jiefang Ave, Wuhan 430000, Hubei, Peoples R China; [Du, Meng; Yang, Liu; Liu, Bing; Yang, Liuye; Mao, Xiaoxiang; Liang, Minglu; Huang, Kai] Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Clin Ctr Human Gene Res, Wuhan, Peoples R China; [Du, Meng; Huang, Kai] Huazhong Univ Sci & Technol, Tongji Med Coll, Liyuan Cardiovasc Ctr, Wuhan, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology	Du, M; Huang, K (corresponding author), Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Dept Cardiol, 1277 Jiefang Ave, Wuhan 430000, Hubei, Peoples R China.	D201378184@alumni.hust.edu.cn; unionhuang@163.com		yang, liuye/0000-0002-5773-8036	National Natural Science Foundation of China (NSFC) [82071794, 81400235, 91949201, 81830014]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	National Natural Science Foundation of China (NSFC), Grant/Award Number: 82071794, 81400235, 91949201 and 81830014	Aramburu J, 1999, SCIENCE, V285, P2129, DOI 10.1126/science.285.5436.2129; Chawla A, 2001, MOL CELL, V7, P161, DOI 10.1016/S1097-2765(01)00164-2; Chinetti G, 2000, CIRCULATION, V101, P2411, DOI 10.1161/01.CIR.101.20.2411; Clark RB, 2000, J IMMUNOL, V164, P1364, DOI 10.4049/jimmunol.164.3.1364; CRABTREE GR, 1994, ANNU REV BIOCHEM, V63, P1045, DOI 10.1146/annurev.biochem.63.1.1045; Du M, 2019, THERANOSTICS, V9, P4688, DOI 10.7150/thno.36862; Furuhashi M, 2007, NATURE, V447, P959, DOI 10.1038/nature05844; Glass CK, 2001, CELL, V104, P503, DOI 10.1016/S0092-8674(01)00238-0; Hojo M, 1999, NATURE, V397, P530, DOI 10.1038/17401; Horsley V, 2002, J CELL BIOL, V156, P771, DOI 10.1083/jcb.200111073; Im SH, 2004, MOL CELLS, V18, P1; Kuriyama M, 2006, CHEM BIOL DRUG DES, V67, P238, DOI 10.1111/j.1747-0285.2006.00360.x; Kzhyshkowska J, 2012, IMMUNOBIOLOGY, V217, P492, DOI 10.1016/j.imbio.2012.02.015; Lahoute C, 2011, NAT REV CARDIOL, V8, P348, DOI 10.1038/nrcardio.2011.62; Li AC, 2002, NAT MED, V8, P1235, DOI 10.1038/nm1102-1235; Liu QH, 2012, CIRC RES, V110, P1077, DOI 10.1161/CIRCRESAHA.111.260729; Liu ZM, 2005, J BIOL CHEM, V280, P14700, DOI 10.1074/jbc.M500322200; Liu ZM, 2004, J BIOL CHEM, V279, P41218, DOI 10.1074/jbc.M406917200; Lopez-Rodriguez C, 1999, P NATL ACAD SCI USA, V96, P7214, DOI 10.1073/pnas.96.13.7214; Lusis AJ, 2000, NATURE, V407, P233, DOI 10.1038/35025203; Macian F, 2005, NAT REV IMMUNOL, V5, P472, DOI 10.1038/nri1632; Macian F, 2001, ONCOGENE, V20, P2476, DOI 10.1038/sj.onc.1204386; Moore KJ, 2001, NAT MED, V7, P41, DOI 10.1038/83328; Natarajan C, 2002, GENES IMMUN, V3, P59, DOI 10.1038/sj.gene.6363832; Nilsson LM, 2007, AM J PHYSIOL-CELL PH, V292, pC1167, DOI 10.1152/ajpcell.00590.2005; Noguchi H, 2004, NAT MED, V10, P305, DOI 10.1038/nm994; Pascual M, 1998, IMMUNOL TODAY, V19, P514, DOI 10.1016/S0167-5699(98)01324-3; PLATZ KP, 1994, TRANSPLANTATION, V58, P170, DOI 10.1097/00007890-199405820-00007; Rahaman SO, 2006, CELL METAB, V4, P211, DOI 10.1016/j.cmet.2006.06.007; Rao A, 1997, ANNU REV IMMUNOL, V15, P707, DOI 10.1146/annurev.immunol.15.1.707; Schulz RA, 2004, DEV BIOL, V266, P1, DOI 10.1016/j.ydbio.2003.10.008; Shashkin P, 2005, CURR PHARM DESIGN, V11, P3061, DOI 10.2174/1381612054865064; SIGAL NH, 1991, J EXP MED, V173, P619, DOI 10.1084/jem.173.3.619; Silva AR, 2019, EUR J PHARMACOL, V854, P272, DOI 10.1016/j.ejphar.2019.04.008; Timmerman LA, 1996, NATURE, V383, P837, DOI 10.1038/383837a0; VANVLIJMEN BJM, 1994, J CLIN INVEST, V93, P1403, DOI 10.1172/JCI117117; Wu H, 2007, TRENDS CELL BIOL, V17, P251, DOI 10.1016/j.tcb.2007.04.006; Yu HX, 2007, CARDIOVASC DRUG REV, V25, P175, DOI 10.1111/j.1527-3466.2007.00011.x	38	3	3	1	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2021	35	10							e21951	10.1096/fj.202100947R	http://dx.doi.org/10.1096/fj.202100947R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	UZ5IH	34551141				2022-12-26	WOS:000702238200034
J	Goda, Y; Yamanaka, D; Nishi, H; Masuda, M; Kamei, H; Kumano, M; Ito, K; Katsumata, M; Yamanouchi, K; Kataoka, N; Hakuno, F; Takahashi, SI				Goda, Yuki; Yamanaka, Daisuke; Nishi, Hiroki; Masuda, Masato; Kamei, Hiroyasu; Kumano, Mikako; Ito, Koichi; Katsumata, Masaya; Yamanouchi, Keitaro; Kataoka, Naoyuki; Hakuno, Fumihiko; Takahashi, Shin-Ichiro			Dietary lysine restriction induces lipid accumulation in skeletal muscle through an increase in serum threonine levels in rats	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTERMUSCULAR ADIPOSE-TISSUE; INSULIN-RESISTANCE; METABOLISM; OXIDATION; FAT	We previously reported that dietary amino acid restrictioninduces the accumulation of triglycerides (TAG) in the liver ofgrowing rats. However, differences in TAG accumulation inindividual cell types or other tissues were not examined. In thisstudy, we show that TAG also accumulates in the muscle andadipose tissues of rats fed a low amino acid (low-AA) diet. Inaddition, dietary lysine restriction (low-Lys) induces lipidaccumulation in muscle and adipose tissues. In adjusting thenitrogen content to that of the control diet, we found thatglutamic acid supplementation to the low-AA diet blockedlipid accumulation, but supplementation with the low-Lys dietdid not, suggesting that a shortage of nitrogen caused lipids toaccumulate in the skeletal muscle in the rats fed a low-AA diet.Serum amino acid measurement revealed that, in rats fed alow-Lys diet, serum lysine levels were decreased, while serumthreonine levels were significantly increased compared with thecontrol rats. When the threonine content was restricted in thelow-Lys diet, TAG accumulation induced by the low-Lys dietwas completely abolished in skeletal muscle. Moreover, in L6myotubes cultured in medium containing high threonine andlow lysine, fatty acid uptake was enhanced compared with thatin cells cultured in control medium. Thesefindings suggestthat the increased serum threonine in rats fed a low-Lys dietresulted in lipid incorporation into skeletal muscle, leading tothe formation of fatty muscle tissue. Collectively, we proposeconceptual hypothesis that"amino-acid signal"based on lysineand threonine regulates lipid metabolism.	[Goda, Yuki; Nishi, Hiroki; Masuda, Masato; Kamei, Hiroyasu; Kumano, Mikako; Kataoka, Naoyuki; Hakuno, Fumihiko; Takahashi, Shin-Ichiro] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Anim Sci, Tokyo, Japan; [Goda, Yuki; Nishi, Hiroki; Masuda, Masato; Kamei, Hiroyasu; Kumano, Mikako; Kataoka, Naoyuki; Hakuno, Fumihiko; Takahashi, Shin-Ichiro] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Appl Biol Chem, Tokyo, Japan; [Yamanaka, Daisuke; Ito, Koichi; Yamanouchi, Keitaro] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Vet Med Sci, Tokyo, Japan; [Katsumata, Masaya] Azabu Univ, Sch Vet Sci, Sagamihara, Kanagawa, Japan	University of Tokyo; University of Tokyo; University of Tokyo; Azabu University	Hakuno, F; Takahashi, SI (corresponding author), Univ Tokyo, Grad Sch Agr & Life Sci, Dept Anim Sci, Tokyo, Japan.; Hakuno, F; Takahashi, SI (corresponding author), Univ Tokyo, Grad Sch Agr & Life Sci, Dept Appl Biol Chem, Tokyo, Japan.	hakuno@g.ecc.u-tokyo.ac.jp; atkshin@g.ecc.u-tokyo.ac.jp		KAMEI, HIROYASU/0000-0001-7123-040X	Japan Society for the Promotion of Science (JSPS) [15H04583, 24380152]; R&D matching funds on the field for Knowledge Integration and Innovation from Bio-oriented Technology Research Advancement Institution, BRAIN, Cabinet Office, Government of Japan; Crossministerial Moonshot Agriculture, Forestry, and Fisheries Research and Development Program, "Technologies for Smart Bioindustry and Agriculture" from Bio-oriented Technology Research Advancement Institution, BRAIN, Cabinet Office, Government of Japan; JSPS [25221204, 18H03972, JPJSCCA20210007]	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); R&D matching funds on the field for Knowledge Integration and Innovation from Bio-oriented Technology Research Advancement Institution, BRAIN, Cabinet Office, Government of Japan; Crossministerial Moonshot Agriculture, Forestry, and Fisheries Research and Development Program, "Technologies for Smart Bioindustry and Agriculture" from Bio-oriented Technology Research Advancement Institution, BRAIN, Cabinet Office, Government of Japan; JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by Grants-in-Aid for Scientific Research (B) #15H04583 and Scientific Research (B) #24380152 from the Japan Society for the Promotion of Science (JSPS) to F. H.; Grant-in-Aid for the Scientific Research (S) #25221204 and Scientific Research (A) #18H03972, and Core-to-Core Program A. Advanced Research Networks #JPJSCCA20210007 from JSPS, and R&D matching funds on the field for Knowledge Integration and Innovation, and Crossministerial Moonshot Agriculture, Forestry, and Fisheries Research and Development Program, "Technologies for Smart Bioindustry and Agriculture" from Bio-oriented Technology Research Advancement Institution, BRAIN, Cabinet Office, Government of Japan, to S.-I. T.	Boesch C, 2006, NMR BIOMED, V19, P968, DOI 10.1002/nbm.1096; Bosma M, 2016, EXP CELL RES, V340, P180, DOI 10.1016/j.yexcr.2015.10.023; Cho IC, 2019, PLOS GENET, V15, DOI 10.1371/journal.pgen.1008279; DAGENAIS GR, 1976, J CLIN INVEST, V58, P421, DOI 10.1172/JCI108486; Delzenne NM, 2002, BRIT J NUTR, V87, pS255, DOI 10.1079/BJN/2002545; Morales PE, 2017, J DIABETES RES, V2017, DOI 10.1155/2017/1789395; FOLCH J, 1957, J BIOL CHEM, V226, P497; Goodpaster BH, 2001, J CLIN ENDOCR METAB, V86, P5755, DOI 10.1210/jc.86.12.5755; Jeppesen J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029391; Katsumata Masaya, 2005, Animal Science Journal, V76, P237, DOI 10.1111/j.1740-0929.2005.00261.x; Kelley DE, 2001, J CLIN ENDOCR METAB, V86, P5412, DOI 10.1210/jc.86.11.5412; Kersten S, 2014, BBA-MOL CELL BIOL L, V1841, P919, DOI 10.1016/j.bbalip.2014.03.013; KOHONEN T, 1982, BIOL CYBERN, V43, P59, DOI 10.1007/BF00337288; Komiya Y, 2017, J MUSCLE RES CELL M, V38, P163, DOI 10.1007/s10974-017-9468-6; Kouba M, 2011, MEAT SCI, V88, P213, DOI 10.1016/j.meatsci.2011.01.003; Malenfant P, 2001, INT J OBESITY, V25, P1316, DOI 10.1038/sj.ijo.0801733; Masuda Masato, 2012, Journal of Computational Science and Technology, V6, P16, DOI 10.1299/jcst.6.16; Nickerson JG, 2009, J BIOL CHEM, V284, P16522, DOI 10.1074/jbc.M109.004788; Nishi H, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-79234-w; Nishi H, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23640-8; Otani K, 2020, CIRCULATION, V141, P571, DOI 10.1161/CIRCULATIONAHA.119.039761; Pan DA, 1997, DIABETES, V46, P983, DOI 10.2337/diabetes.46.6.983; Pette D, 1997, Int Rev Cytol, V170, P143, DOI 10.1016/S0074-7696(08)61622-8; Sabag A, 2017, DIABETES METAB, V43, P195, DOI 10.1016/j.diabet.2016.12.006; Saxton RA, 2016, NATURE, V536, P229, DOI 10.1038/nature19079; Stephens FB, 2007, J PHYSIOL-LONDON, V581, P431, DOI 10.1113/jphysiol.2006.125799; Tiwari S, 2012, ARTERIOSCL THROM VAS, V32, P1079, DOI 10.1161/ATVBAHA.111.241471; Toyoshima Y, 2014, ENDOCR J, V61, P499, DOI 10.1507/endocrj.EJ13-0514; Vettor R, 2009, AM J PHYSIOL-ENDOC M, V297, pE987, DOI 10.1152/ajpendo.00229.2009; Wolfson RL, 2016, SCIENCE, V351, P43, DOI 10.1126/science.aab2674	30	4	4	3	15	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT	2021	297	4							101179	10.1016/j.jbc.2021.101179	http://dx.doi.org/10.1016/j.jbc.2021.101179			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	WP4BY	34508782	Green Published, gold			2022-12-26	WOS:000713080600004
J	Huang, XK; Zhang, XB; Zong, L; Gao, QQ; Zhang, C; Wei, R; Guan, YT; Huang, L; Zhang, LJ; Lyu, GL; Tao, W				Huang, Xiaoke; Zhang, Xuebin; Zong, Le; Gao, Qianqian; Zhang, Chao; Wei, Ran; Guan, Yiting; Huang, Li; Zhang, Lijun; Lyu, Guoliang; Tao, Wei			Gene body methylation safeguards ribosomal DNA transcription by preventing PHF6-mediated enrichment of repressive histone mark H4K20me3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA GENES; RDNA TRANSCRIPTION; PHF6 MUTATIONS; METHYLTRANSFERASE-1; ACETYLATION; INHERITANCE; DISRUPTION; METHYLOME; COMPONENT; PROMOTER	DNA methylation shows complex correlations with gene expression, and the role of promoter hypermethylation in repressing gene transcription has been well addressed. Emerging evidence indicates that gene body methylation promotes transcription; however, the underlying mechanisms remain to be further investigated. Here, using methylated DNA immunoprecipitation sequencing (MeDIP-seq), bisulfite genomic sequencing, and immunofluorescent labeling, we show that gene body methylation is indeed positively correlated with rRNA gene (rDNA) transcription. Mechanistically, gene body methylation is largely maintained by DNA methyltransferase 1 (DNMT1), deficiency or downregulation of which during myoblast differentiation or nutrient deprivation results in decreased gene body methylation levels, leading to increased gene body occupancy of plant homeodomain (PHD) finger protein 6 (PHF6). PHF6 binds to hypomethylated rDNA gene bodies where it recruits histone methyltransferase SUV4-20H2 to establish the repressive histone modification, H4K20me3, ultimately inhibiting rDNA transcription. These findings demonstrate that DNMT1-mediated gene body methylation safeguards rDNA transcription by preventing enrichment of repressive histone modifications, suggesting that gene body methylation serves to maintain gene expression in response to developmental and/or environmental stresses.	[Huang, Xiaoke; Zhang, Xuebin; Zong, Le; Gao, Qianqian; Zhang, Chao; Wei, Ran; Guan, Yiting; Huang, Li; Zhang, Lijun; Lyu, Guoliang; Tao, Wei] Peking Univ, Sch Life Sci, MOE Key Lab Cell Proliferat & Differentiat, Beijing, Peoples R China	Peking University	Lyu, GL; Tao, W (corresponding author), Peking Univ, Sch Life Sci, MOE Key Lab Cell Proliferat & Differentiat, Beijing, Peoples R China.	guolianglyu@pku.edu.cn; weitao@pku.edu.cn	tao, wei/GXN-4445-2022; Wei, ran/GXF-3452-2022; wei, wei/HHR-8613-2022	Zhang, Chao/0000-0003-4167-4872; Zhang, Xuebin/0000-0002-0563-6994	National Key Research and Development Project [2020YFC2002903]; National Natural Science Foundation of China [31871312, 31471205, 31671426]	National Key Research and Development Project; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	TWe thank Prof Jingwei Xiong for his assistance with the CRISPR/Cas9 systems. We appreciate the staff of the National Center for Protein Sciences at Peking University (Beijing, China), particularly Liying Du, Hongxia Lyu, Guilan Li, and Zhi Dong for their help with biochemical experiments. This work was supported by the National Key Research and Development Project (Grant No. 2020YFC2002903) and the National Natural Science Foundation of China (Grant No. 31871312, 31471205, 31671426).	Aran D, 2011, HUM MOL GENET, V20, P670, DOI 10.1093/hmg/ddq513; Arechederra M, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05550-5; Ball MP, 2009, NAT BIOTECHNOL, V27, P361, DOI 10.1038/nbt.1533; BESTOR TH, 1992, EMBO J, V11, P2611, DOI 10.1002/j.1460-2075.1992.tb05326.x; Bierhoff H, 2014, MOL CELL, V54, P675, DOI 10.1016/j.molcel.2014.03.032; CONCONI A, 1989, CELL, V57, P753, DOI 10.1016/0092-8674(89)90790-3; Espada J, 2004, J BIOL CHEM, V279, P37175, DOI 10.1074/jbc.M404842200; Espada J, 2007, NUCLEIC ACIDS RES, V35, P2191, DOI 10.1093/nar/gkm118; Feng SH, 2010, SCIENCE, V330, P622, DOI 10.1126/science.1190614; Gagnon-Kugler T, 2009, MOL CELL, V35, P414, DOI 10.1016/j.molcel.2009.07.008; Hellman A, 2007, SCIENCE, V315, P1141, DOI 10.1126/science.1136352; HENDERSON AS, 1972, P NATL ACAD SCI USA, V69, P3394, DOI 10.1073/pnas.69.11.3394; Jones PA, 2012, NAT REV GENET, V13, P484, DOI 10.1038/nrg3230; Kangaspeska S, 2008, NATURE, V452, P112, DOI 10.1038/nature06640; Khan A, 2015, P NATL ACAD SCI USA, V112, P8338, DOI 10.1073/pnas.1424705112; LARSEN F, 1992, GENOMICS, V13, P1095, DOI 10.1016/0888-7543(92)90024-M; Laurent L, 2010, GENOME RES, V20, P320, DOI 10.1101/gr.101907.109; Liao J, 2015, NAT GENET, V47, P469, DOI 10.1038/ng.3258; Liu ZH, 2015, J BIOL CHEM, V290, P6630, DOI 10.1074/jbc.M114.610196; Liu ZH, 2014, J BIOL CHEM, V289, P10069, DOI 10.1074/jbc.M113.535351; Lower KM, 2002, NAT GENET, V32, P661, DOI 10.1038/ng1040; Lyu GL, 2019, J MOL CELL BIOL, V11, P78, DOI 10.1093/jmcb/mjy023; Majumder S, 2018, J BIOL CHEM, V293, P3591, DOI 10.1074/jbc.W118.002433; Martienssen RA, 2001, SCIENCE, V293, P1070, DOI 10.1126/science.293.5532.1070; Mayer C, 2006, MOL CELL, V22, P351, DOI 10.1016/j.molcel.2006.03.028; Meacham CE, 2015, GENE DEV, V29, P483, DOI 10.1101/gad.254151.114; Metivier R, 2008, NATURE, V452, P45, DOI 10.1038/nature06544; Neri F, 2017, NATURE, V543, P72, DOI 10.1038/nature21373; Okamoto K, 2017, INT J ONCOL, V50, P1372, DOI 10.3892/ijo.2017.3908; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Rauch TA, 2009, P NATL ACAD SCI USA, V106, P671, DOI 10.1073/pnas.0812399106; Santoro R, 2001, MOL CELL, V8, P719, DOI 10.1016/S1097-2765(01)00317-3; Sharma GG, 2010, MOL CELL BIOL, V30, P3582, DOI 10.1128/MCB.01476-09; Shogren-Knaak M, 2006, SCIENCE, V311, P844, DOI 10.1126/science.1124000; SINSHEIMER RL, 1955, J BIOL CHEM, V215, P579; Smith ZD, 2013, NAT REV GENET, V14, P204, DOI 10.1038/nrg3354; Soto-Feliciano YM, 2017, GENE DEV, V31, P973, DOI 10.1101/gad.295857.117; STEIN R, 1982, P NATL ACAD SCI-BIOL, V79, P61, DOI 10.1073/pnas.79.1.61; Su JZ, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-018-1492-3; Suzuki MM, 2008, NAT REV GENET, V9, P465, DOI 10.1038/nrg2341; TATE PH, 1993, CURR OPIN GENET DEV, V3, P226, DOI 10.1016/0959-437X(93)90027-M; Todd MAM, 2012, J PROTEOME RES, V11, P4326, DOI 10.1021/pr3004369; Todd MA, 2016, EUR J HUM GENET, V24, P1453, DOI 10.1038/ejhg.2016.40; Van Vlierberghe P, 2011, LEUKEMIA, V25, P130, DOI 10.1038/leu.2010.247; Van Vlierberghe P, 2010, NAT GENET, V42, P338, DOI 10.1038/ng.542; Wang JD, 2013, J BIOL CHEM, V288, P3174, DOI 10.1074/jbc.M112.414839; Wu H, 2010, SCIENCE, V329, P444, DOI 10.1126/science.1190485; Xie WB, 2012, P NATL ACAD SCI USA, V109, P8161, DOI 10.1073/pnas.1201262109; Yang XJ, 2014, CANCER CELL, V26, P577, DOI 10.1016/j.ccr.2014.07.028; Zhang C, 2013, NEURON, V78, P986, DOI 10.1016/j.neuron.2013.04.021	50	6	6	1	9	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT	2021	297	4							101195	10.1016/j.jbc.2021.101195	http://dx.doi.org/10.1016/j.jbc.2021.101195			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	WP4BY	34520760	gold, Green Published			2022-12-26	WOS:000713080600012
J	Guure, C; Dery, S; Afagbedzi, S; Tun, W; Weir, SS; Quaye, S; Ankomah, A; Torpey, K				Guure, Chris; Dery, Samuel; Afagbedzi, Seth; Tun, Waimar; Weir, Sharon Stucker; Quaye, Silas; Ankomah, Augustine; Torpey, Kwasi			National and subnational size estimation of female sex workers in Ghana 2020: Comparing 3-source capture-recapture with other approaches	PLOS ONE			English	Article							TO-REACH POPULATIONS	Background Key Population size estimation (PSE) is instrumental for HIV/STI preventive, treatment and care services planning, implementation and delivery. The objective was to estimate the overall population of female sex workers (FSW) in all the 16 regions of Ghana using different PSE methods. Method Mapping of venues and complete enumeration of seaters was conducted at the formative stage prior to the bio-behavioral survey (BBS). Three PSE methods were used to derive the size estimates of FSW in the 16 regions. These include: Capture-recapture (CRC), service multiplier and three-source capture recapture (3SCRC) methods. The final choice of the estimation method used to estimate the roamer population was 3SCRC. This method was chosen because of its perfect record-linkage-hierarchic combination of three names that minimizes overmatching as well as the addition of an interaction term in the model which corrects for the dependencies in CRC. Results The total population size estimate of the female sex workers in the country obtained for roamers using capture re-capture was 41,746 (95% CI: 41,488-41,932). Using the service multiplier, the total population for both the roamers and seaters was 41,153 (95% CI: 37,242-45,984). The 3-source capture re-capture yielded 55,686 roamers FSW (95% CI: 47,686-63,686). The seater population was 4,363 FSW based on census/complete enumeration. The total population size estimate of FSW (seaters and roamers) in Ghana was 60,049 when 3SCRC and census were added. This represents about 0.76% of all estimated adult females aged 15-49yrs in Ghana. Conclusion We report population size estimates (PSE) for FSW in Ghana. These estimates are the results of 3SCRC. These findings provide a valid and reliable source of information that should be referenced by government officials and policymakers to plan, implement and provide HIV/STI preventive, treatment, and care services for FSW in Ghana.	[Guure, Chris; Dery, Samuel; Afagbedzi, Seth] Univ Ghana, Sch Publ Hlth, Dept Biostat, Accra, Ghana; [Tun, Waimar] Populat Council, HIV & AIDS Program, Washington, DC USA; [Weir, Sharon Stucker] Univ N Carolina, Carolina Populat Ctr, Dept Epidemiol, Chapel Hill, NC 27515 USA; [Quaye, Silas] US Ctr Dis Control & Prevent CDC, Ctr Global Hlth, Div Global HIV TB, Accra, Ghana; [Ankomah, Augustine] Populat Council, Dept HIV & AIDS, Accra, Ghana; [Torpey, Kwasi] Univ Ghana, Sch Publ Hlth, Dept Populat Family & Reprod Hlth, Accra, Ghana	University of Ghana; Population Council; University of North Carolina; University of North Carolina Chapel Hill; University of Ghana	Torpey, K (corresponding author), Univ Ghana, Sch Publ Hlth, Dept Populat Family & Reprod Hlth, Accra, Ghana.	ktorpey@hotmail.com		Weir, Sharon/0000-0001-6014-1460; Guure, Chris/0000-0001-6595-9587; Dery, Samuel/0000-0002-5076-6704	Global Fund/West African Program to Combat AIDS	Global Fund/West African Program to Combat AIDS	The Global Fund/West African Program to Combat AIDS funded this work but the funder did not play a role in the design, conduct or analysis of the study, nor in the drafting of this manuscript.	Abdul-Quader AS, 2014, CURR OPIN HIV AIDS, V9, P107, DOI 10.1097/COH.0000000000000041; Billong SC, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0212315; Bozicevic I, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0227689; Chao A, 2001, STAT MED, V20, P3123, DOI 10.1002/sim.996.abs; Clague A., 2001, INTRO NOTE CENSUS EN; Doshi RH, 2019, JMIR PUBLIC HLTH SUR, V5, P75, DOI 10.2196/12118; Ghana AIDS Commission, 2015, BIOB SURV FEM SEX WO; Ghana AIDS Commission, 2011, MAPP POP SIZ EST FEM; Global HIV Strategic Information Working Group, 2017, BIOB SURV GUID POP; GSS, 2020, PROJ POP AG SEX 260; Heraud-Bousquet Vanina, 2012, BMC Infect Dis, V12, P251, DOI 10.1186/1471-2334-12-251; Johnston LG, 2013, SEX TRANSM DIS, V40, P304, DOI 10.1097/OLQ.0b013e31827fd650; Poorolajal J, 2017, EPIDEMIOL HEALTH, V39, DOI 10.4178/epih.e2017042; Quaye S, 2015, AIDS BEHAV, V19, pS16, DOI 10.1007/s10461-014-0943-4; Sathane I, 2020, SEX TRANSM DIS, V47, P602, DOI 10.1097/OLQ.0000000000001214; Sulaberidze L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147413; UNAIDS/WHO Working Group on Global HIV/AIDS and STI Surveillance, 2010, GUID EST SIZ POP MOS; Weikum D, 2019, JMIR PUBLIC HLTH SUR, V5, P173, DOI 10.2196/11285; Wesson P, 2017, AIDS BEHAV, V21, P2188, DOI 10.1007/s10461-017-1678-9; WHO; UNAIDS, 2016, EST SIZ KEP POP GUID	21	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2021	16	9							e0256949	10.1371/journal.pone.0256949	http://dx.doi.org/10.1371/journal.pone.0256949			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YS4WS	34550978	gold, Green Published			2022-12-26	WOS:000750679800009
J	Panraksa, Y; Amin, AG; Graham, B; Henry, CS; Chatterjee, D				Panraksa, Yosita; Amin, Anita G.; Graham, Barbara; Henry, Charles S.; Chatterjee, Delphi			Immobilization of Proteinase K for urine pretreatment to improve diagnostic accuracy of active tuberculosis	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; LIPOARABINOMANNAN; HIV; ASSAY; LAM; TB	The World Health Organization (WHO) calls for the development of a rapid, biomarker-based, non-sputum test capable of detecting all forms of tuberculosis (TB) at the point-of-care to enable immediate treatment initiation. Lipoarabinomannan (LAM) is the only WHO-endorsed TB biomarker that can be detected in urine, an easily collected sample matrix. For obtaining optimal sensitivity, we and others have shown that some form of sample pretreatment is necessary to remove background from patient urine samples. A number of systems are paper-based often destined for resource limited settings. Our current work presents incorporation of one such sample pretreatment, proteinase K (ProK) immobilized on paper (IPK) and test its performance in comparison to standard proteinase K (SPK) treatment that involves addition and deactivation at high temperature prior to performing a capture ELISA. Herein, a simple and economical method was developed for using ProK immobilized strips to pretreat urine samples. Simplification and cost reduction of the proposed pretreatment strip were achieved by using Whatman no.1 paper and by minimizing the concentration of ProK (an expensive but necessary reagent) used to pretreat the clinical samples prior to ELISA. To test the applicability of IPK, capture ELISA was carried out on either LAM-spiked urine or the clinical samples after pretreatment with ProK at 400 mu g/mL for 30 minutes at room temperature. The optimal conditions and stability of the IPK were tested and validation was performed on a set of 25 previously analyzed archived clinical urine samples with known TB and HIV status. The results of IPK and SPK treated samples were in agreement showing that the urine LAM test currently under development has the potential to reach adult and pediatric patients regardless of HIV status or site of infection, and to facilitate global TB control to improve assay performance and ultimately treatment outcomes.	[Panraksa, Yosita; Amin, Anita G.; Chatterjee, Delphi] Colorado State Univ, Dept Microbiol Immunol & Pathol, Mycobacteria Res Labs, Ft Collins, CO 80523 USA; [Graham, Barbara] Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA; [Henry, Charles S.] Colorado State Univ, Dept Chem, Ft Collins, CO 80523 USA; [Henry, Charles S.] Colorado State Univ, Sch Biomed Engn, Ft Collins, CO 80523 USA	Colorado State University; Colorado State University; Colorado State University; Colorado State University	Chatterjee, D (corresponding author), Colorado State Univ, Dept Microbiol Immunol & Pathol, Mycobacteria Res Labs, Ft Collins, CO 80523 USA.	delphi.chatterjee@colostate.edu		Graham, Barbara/0000-0002-4221-1979	National Institutes of Health, NIH [AI R01 AI132680]	National Institutes of Health, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The work was funded through National Institutes of Health, NIH AI R01 AI132680 (to DC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alderwick LJ, 2007, BIOCHEM SOC T, V35, P1325, DOI 10.1042/BST0351325; Amin AG, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-82445-4; Amin AG, 2018, TUBERCULOSIS, V111, P178, DOI 10.1016/j.tube.2018.06.004; BRENNAN PJ, 1995, ANNU REV BIOCHEM, V64, P29, DOI 10.1146/annurev.bi.64.070195.000333; Briken V, 2004, MOL MICROBIOL, V53, P391, DOI 10.1111/j.1365-2958.2004.04183.x; BRITTON WJ, 1985, J IMMUNOL, V135, P4171; Broger T, 2019, LANCET INFECT DIS, V19, P852, DOI 10.1016/S1473-3099(19)30001-5; Cate DM, 2015, ANAL CHEM, V87, P19, DOI 10.1021/ac503968p; CHATTERJEE D, 1992, J BIOL CHEM, V267, P6234; CHATTERJEE D, 1993, GLYCOBIOLOGY, V3, P497, DOI 10.1093/glycob/3.5.497; CHATTERJEE D, 1992, J BIOL CHEM, V267, P6228; Chatterjee D, 2009, MICROBIAL GLYCOBIOLOGY: STRUCTURES, RELEVANCE AND APPLICATIONS, P147; Choudhary A, 2018, J IMMUNOL, V200, P3053, DOI 10.4049/jimmunol.1701673; De P, 2020, ACS INFECT DIS, V6, P291, DOI 10.1021/acsinfecdis.9b00355; De P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144088; GAYLORD H, 1987, INFECT IMMUN, V55, P2860, DOI 10.1128/IAI.55.11.2860-2863.1987; Gong MM, 2017, CHEM REV, V117, P8447, DOI 10.1021/acs.chemrev.7b00024; Gupta-Wright A, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0603-9; Hong W, 2018, BIOTECHNOL BIOPROC E, V23, P686, DOI 10.1007/s12257-018-0430-2; HUNTER SW, 1990, J BIOL CHEM, V265, P9272; Kaur D, 2008, P NATL ACAD SCI USA, V105, P17973, DOI 10.1073/pnas.0807761105; Kerkhoff AD, 2016, LANCET, V387, P1139, DOI 10.1016/S0140-6736(16)00146-X; Khoo HH, 2001, J BIOL CHEM, V276, P3863, DOI 10.1074/jbc.M004010200; Kuchler A, 2017, ACS APPL MATER INTER, V9, P11308, DOI 10.1021/acsami.7b03355; Kuchler A, 2015, ACS APPL MATER INTER, V7, P25970, DOI 10.1021/acsami.5b09301; Lawn SD, 2016, T ROY SOC TROP MED H, V110, P180, DOI 10.1093/trstmh/trw008; Lawn SD, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-103; Lawn SD, 2012, LANCET INFECT DIS, V12, P201, DOI 10.1016/S1473-3099(11)70251-1; Mitamura K, 2013, J VIROL METHODS, V194, P123, DOI 10.1016/j.jviromet.2013.08.018; Saenger W, 2013, HANDBOOK OF PROTEOLYTIC ENZYMES, VOLS 1 AND 2, 3RD EDITION, P3240, DOI 10.1016/B978-0-12-382219-2.00714-6; Shah M, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011420.pub2; Shi Libin, 2008, V465, P23, DOI 10.1007/978-1-59745-207-6_3; Sigal GB, 2018, J CLIN MICROBIOL, V56, DOI 10.1128/JCM.01338-18; Torrelles JB, 2012, GLYCOBIOLOGY, V22, P1118, DOI 10.1093/glycob/cws078; WHO, 2010, WORLD MALARIA REPORT 2010, P1; Yang YY, 2017, ANAL CHEM, V89, P71, DOI 10.1021/acs.analchem.6b04581; Yetisen AK, 2013, LAB CHIP, V13, P2210, DOI 10.1039/c3lc50169h	37	3	3	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2021	16	9							e0257615	10.1371/journal.pone.0257615	http://dx.doi.org/10.1371/journal.pone.0257615			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YM4DR	34547058	gold, Green Published			2022-12-26	WOS:000746527400028
J	Jarnevich, CS; Belamaric, PN; Fricke, K; Houts, M; Rossi, L; Beauprez, G; Cooper, B; Martin, R				Jarnevich, Catherine S.; Belamaric, Pairsa N.; Fricke, Kent; Houts, Mike; Rossi, Liza; Beauprez, Grant; Cooper, Brett; Martin, Russell			Challenges in updating habitat suitability models: An example with the lesser prairie-chicken	PLOS ONE			English	Article							SPECIES DISTRIBUTIONS; ENERGY DEVELOPMENT; SPACE USE; CONSERVATION; SELECTION; POPULATIONS; IMPACTS; RANGE	Habitat loss from land-use change is one of the top causes of declines in wildlife species of concern. As such, it is critical to assess and reassess habitat suitability as land cover and anthropogenic features change for both monitoring and developing current information to inform management decisions. However, there are obstacles that must be overcome to develop consistent assessments through time. A range-wide lek habitat suitability model for the lesser prairie-chicken (Tympanuchus pallidicinctus), currently under review by the U. S. Fish and Wildlife Service for potential listing under the Endangered Species Act, was published in 2016. This model was based on lek data from 2002 to 2012, land cover data ranging from 2001 to 2013, and anthropogenic features from circa 2011, and has been used to help guide lesser prairie-chicken management and anthropogenic development actions. We created a second iteration model based on new lek surveys (2015 to 2019) and updated predictors (2016 land cover and cleaned/updated anthropogenic data) to evaluate changes in lek suitability and to quantify current range-wide habitat suitability. Only three of 11 predictor variables were directly comparable between the iterations, making it difficult to directly assess what predicted changes resulted from changes in model inputs versus actual landscape change. The second iteration model showed a similar positive relationship with land cover and negative relationship with anthropogenic features to the first iteration, but exhibited more variation among candidate models. Range-wide, more suitable habitat was predicted in the second iteration. The Shinnery Oak Ecoregion, however, exhibited a loss in predicted suitable habitat that could be due to predictor source changes. Iterated models such as this are important to ensure current information is being used in conservation and development decisions.	[Jarnevich, Catherine S.; Belamaric, Pairsa N.] US Geol Survey, Ft Collins Sci Ctr, Ft Collins, CO 80521 USA; [Fricke, Kent] Kansas Dept Wildlife Pk & Tourism, Emporia, KS USA; [Houts, Mike] Univ Kansas, Kansas Biol Survey, Lawrence, KS 66045 USA; [Rossi, Liza] Colorado Pk & Wildlife, Steamboat Springs, CO USA; [Beauprez, Grant] New Mexico Dept Game & Fish, Texico, NM USA; [Cooper, Brett] Oklahoma Dept Wildlife Conservat, Woodward, OK USA; [Martin, Russell] Texas Parks & Wildlife Dept, Canyon, TX USA	United States Department of the Interior; United States Geological Survey; University of Kansas; New Mexico Department of Game and Fish	Jarnevich, CS (corresponding author), US Geol Survey, Ft Collins Sci Ctr, Ft Collins, CO 80521 USA.	jarnevichc@usgs.gov		Jarnevich, Catherine/0000-0002-9699-2336	Kansas Department of Wildlife, Parks and Tourism; Fish and Wildlife Service, a division of the United States Department of Interior; Colorado Parks and Wildlife	Kansas Department of Wildlife, Parks and Tourism; Fish and Wildlife Service, a division of the United States Department of Interior; Colorado Parks and Wildlife	We would like to thank the Kansas Department of Wildlife, Parks and Tourism and Colorado Parks and Wildlife for funding this work. The data and analysis, which is the subject of this manuscript has been financed, in part, with federal funds from the Fish and Wildlife Service, a division of the United States Department of Interior, and administered by the Kansas Department of Wildlife, Parks and Tourism.	[Anonymous], 2012, SPAT MOD SUMM; Boal Clint W., 2012, U S Geological Survey Open-File Report, V1073, P1; Boggie MA, 2017, RANGELAND ECOL MANAG, V70, P68, DOI 10.1016/j.rama.2016.09.006; Charrad M, 2014, J STAT SOFTW, V61, P1; Cook G, 2019, FORESTS, V10, DOI 10.3390/f10020108; Didan K., 2015, MOD13A2 MODIS TERRA, DOI [DOI 10.5067/MODIS/MOD13A2.006, 10.5067/MODIS/MOD13Q1.006, DOI 10.5067/MODIS/MOD13Q1.006]; Dormann CF, 2013, ECOGRAPHY, V36, P27, DOI 10.1111/j.1600-0587.2012.07348.x; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Elliot LF, 2014, ECOLOGICAL MAPPING S; Fritts SR, 2018, ECOL EVOL, V8, P9550, DOI 10.1002/ece3.4432; Fuhlendorf SD, 2002, LANDSCAPE ECOL, V17, P617, DOI 10.1023/A:1021592817039; Garton E.O., 2016, ECOLOGY CONSERVATION, P49; Gehrt JM, 2020, AM MIDL NAT, V183, P52, DOI 10.1637/19-020; Gorelick N, 2017, REMOTE SENS ENVIRON, V202, P18, DOI 10.1016/j.rse.2017.06.031; Gregory AJ, 2011, STUD AVIAN BIOL, P21; Grisham BA, 2014, J WILDLIFE MANAGE, V78, P857, DOI 10.1002/jwmg.716; Grisham BA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068225; Guisan A, 2013, ECOL LETT, V16, P1424, DOI 10.1111/ele.12189; Hagen CA, 2004, WILDLIFE SOC B, V32, P69, DOI 10.2193/0091-7648(2004)32[69:GFMLPP]2.0.CO;2; Hagen CA., 2005, BIRDS N AM ONLINE IT; Hagen CA, 2017, WILDLIFE SOC B, V41, P624, DOI 10.1002/wsb.836; Hagen CA, 2016, CONDOR, V118, P597, DOI 10.1650/CONDOR-16-14.1; Hagen CA, 2013, WILDLIFE SOC B, V37, P750, DOI 10.1002/wsb.313; Hagen CA, 2011, STUD AVIAN BIOL, P63; Hak JC, 2017, ECOL INDIC, V82, P206, DOI 10.1016/j.ecolind.2017.06.049; Hamerstrom F., 1973, WIS DEP NAT RESOUR T, V64; Harryman SWH, 2019, J FISH WILDL MANAG, V10, P126, DOI 10.3996/012018-JFWM-005; Haukos D.A., 2016, ECOLOGY CONSERVATION, P376; Hijmans RJ, RASTER GEOGRAPHIC DA; Homer C, 2020, ISPRS J PHOTOGRAMM, V162, P184, DOI 10.1016/j.isprsjprs.2020.02.019; Jarnevich CS, 2016, AVIAN CONSERV ECOL, V11, DOI 10.5751/ACE-00807-110102; Jarnevich CS, 2011, ENVIRON MANAGE, V47, P926, DOI 10.1007/s00267-011-9651-2; Jarnevich CS., 2021, US GEOLOGICAL SURVEY; Lautenbach JM, 2017, RANGELAND ECOL MANAG, V70, P78, DOI 10.1016/j.rama.2016.07.008; Liu CR, 2005, ECOGRAPHY, V28, P385, DOI 10.1111/j.0906-7590.2005.03957.x; Morisette JT, 2013, ECOGRAPHY, V36, P129, DOI 10.1111/j.1600-0587.2012.07815.x; Nasman K, 2018, RANGE WIDE POPULATIO; Ott JP., 2020, RANGELAND ECOL MANAG; Petchey OL, 2015, ECOL LETT, V18, P597, DOI 10.1111/ele.12443; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Phillips SJ, 2017, ECOGRAPHY, V40, P887, DOI 10.1111/ecog.03049; Phillips SJ, 2009, ECOL APPL, V19, P181, DOI 10.1890/07-2153.1; Pitman JC, 2006, WILSON J ORNITHOL, V118, P23, DOI 10.1676/1559-4491(2006)118[0023:NEOLPI]2.0.CO;2; Pitman JC, 2005, J WILDLIFE MANAGE, V69, P1259, DOI 10.2193/0022-541X(2005)069[1259:LASOLP]2.0.CO;2; Plumb RT, 2019, J WILDLIFE MANAGE, V83, P216, DOI 10.1002/jwmg.21561; Pruett CL, 2009, BIOSCIENCE, V59, P257, DOI 10.1525/bio.2009.59.3.10; R Core Team, 2021, R LANG ENV STAT; Robel RJ, 2004, TRANS N AM WILDL NAT, V69, P251; Robinson SG, 2018, AM MIDL NAT, V180, P66, DOI 10.1674/0003-0031-180.1.66; Ross BE, 2016, GLOB ECOL CONSERV, V6, P179, DOI 10.1016/j.gecco.2016.03.003; Sofaer HR, 2019, BIOSCIENCE, V69, P544, DOI 10.1093/biosci/biz045; Sohl Terry, 2019, Rangelands, V41, P79, DOI 10.1016/j.rala.2018.12.001; Spencer D, 2017, GLOB ECOL CONSERV, V9, P21, DOI 10.1016/j.gecco.2016.11.004; State Wildlife Agencies of the Western United States, W WID CRUC HAB DAT S; Sullins DS, 2019, BIOL CONSERV, V238, DOI 10.1016/j.biocon.2019.108213; Sullins DS, 2018, J WILDLIFE MANAGE, V82, P1617, DOI 10.1002/jwmg.21553; Timmer JM, 2014, J WILDLIFE MANAGE, V78, P142, DOI 10.1002/jwmg.646; Uden DR, 2015, BIOL INVASIONS, V17, P2831, DOI 10.1007/s10530-015-0914-3; US Fish and Wildlife Service, 2014, FED REG, V79, P19974; van Pelt W.E., 2013, LESSER PRAIRIE CHICK; Warton DI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079168; White EP, 2019, METHODS ECOL EVOL, V10, P332, DOI 10.1111/2041-210X.13104; Wickham H., 2017, TIDYVERSE EASILY INS; Wisdom MJ, 1997, J WILDLIFE MANAGE, V61, P302, DOI 10.2307/3802585; Yang LM, 2018, ISPRS J PHOTOGRAMM, V146, P108, DOI 10.1016/j.isprsjprs.2018.09.006	66	0	0	3	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2021	16	9							e0256633	10.1371/journal.pone.0256633	http://dx.doi.org/10.1371/journal.pone.0256633			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	WG6BN	34543290	Green Published, gold			2022-12-26	WOS:000707078200016
J	Quinlan, GM; Milbrath, MO; Otto, CRV; Isaacs, R				Quinlan, Gabriela M.; Milbrath, Meghan O.; Otto, Clint R., V; Isaacs, Rufus			Honey bee (Apis mellifera) colonies benefit from grassland/ pasture while bumble bee (Bombus impatiens) colonies in the same landscapes benefit from non-corn/soybean cropland	PLOS ONE			English	Article							WILD BEES; PERFORMANCE; HYMENOPTERA; RESOURCES; ABUNDANCE; DECLINE; APIDAE	Agriculturally important commercially managed pollinators including honey bees (Apis mellifera L., 1758) and bumble bees (Bombus impatiens Cresson, 1863) rely on the surrounding landscape to fulfill their dietary needs. A previous study in Europe demonstrated that managed honey bee foragers and unmanaged native bumble bee foragers are associated with different land uses. However, it is unclear how response to land use compares between managed honey bees and a managed native bumble bee species in the United States, where honey bees are an imported species. Furthermore, to our knowledge, no such direct comparisons of bee responses to land use have been made at the colony level. To better understand how two different social bees respond to variation in land use, we monitored the weights of A. mellifera and B. impatiens colonies placed in 12 apiaries across a range of land use in Michigan, United States in 2017. Bombus impatiens colonies gained more weight and produced more drones when surrounded by diverse agricultural land (i.e., non-corn/soybean cropland such as tree fruits and grapes), while honey bee colonies gained more weight when surrounded by more grassland/pasture land. These findings add to our understanding of how different bee species respond to agricultural landscapes, highlighting the need for further species-specific land use studies to inform tailored land management.	[Quinlan, Gabriela M.; Milbrath, Meghan O.; Isaacs, Rufus] Michigan State Univ, Dept Entomol, E Lansing, MI 48824 USA; [Otto, Clint R., V] US Geol Survey, Northern Prairie Wildlife Res Ctr, Jamestown, ND USA	Michigan State University; United States Department of the Interior; United States Geological Survey	Quinlan, GM (corresponding author), Michigan State Univ, Dept Entomol, E Lansing, MI 48824 USA.	gmq5021@psu.edu		Otto, Clint/0000-0002-7582-3525	United States Department of Agriculture Farm Service Agency [16IAMRECRPHBTA1]; National Science Foundation Graduate Research Fellowship [DGE-1848739]	United States Department of Agriculture Farm Service Agency; National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF))	Funding was provided by United States Department of Agriculture Farm Service Agency [https://www.fsa.usda.gov/] through Inter-agency Agreement 16IAMRECRPHBTA1, granted to CRVO. This material is based upon research supported by the National Science Foundation Graduate Research Fellowship [https://www.nsfgrfp.org/] under Grant No. DGE-1848739, awarded to GMQ. We would like to acknowledge Skip Hyberg (FSA) for their contributions to initial project development.	Aizen MA, 2009, CURR BIOL, V19, P915, DOI 10.1016/j.cub.2009.03.071; Artz DR, 2011, J ECON ENTOMOL, V104, P1153, DOI 10.1603/EC10431; Bansch S, 2020, AGR ECOSYST ENVIRON, V291, DOI 10.1016/j.agee.2019.106792; Bertone R., 2017, FARM FLAVOR; Bivand R., 2019, INTERFACE GEOMETRY E; Bretagnolle V, 2015, AGRON SUSTAIN DEV, V35, P891, DOI 10.1007/s13593-015-0302-5; Calderone NW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037235; Cameron SA, 2020, ANNU REV ENTOMOL, V65, P209, DOI 10.1146/annurev-ento-011118-111847; Cameron SA, 2011, P NATL ACAD SCI USA, V108, P662, DOI 10.1073/pnas.1014743108; Caron DM., 2018, HONEY BEE BIOL BEEKE; Charlton NL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012186; Colla SR, 2012, BIODIVERS CONSERV, V21, P3585, DOI 10.1007/s10531-012-0383-2; Duchateau MJ, 2004, BEHAV ECOL, V15, P71, DOI 10.1093/beheco/arg087; Evans E, 2018, AGR ECOSYST ENVIRON, V268, P162, DOI 10.1016/j.agee.2018.09.014; Fox J., 2021, CAR COMPANION APPL R; Goulson D, 2015, SCIENCE, V347, DOI 10.1126/science.1255957; Grixti JC, 2009, BIOL CONSERV, V142, P75, DOI 10.1016/j.biocon.2008.09.027; Hanley M. E., 2003, Weed Biology and Management, V3, P204, DOI 10.1046/j.1444-6162.2003.00108.x; Heinrich B., 2004, BUMBLEBEE EC; Hemberger J, 2021, ECOL LETT, V24, P1800, DOI 10.1111/ele.13786; Hendriksma HP, 2019, FRONT ECOL EVOL, V7, DOI 10.3389/fevo.2019.00177; Hijmans R.J., 2020, PACKAGE RASTER, P1; Jaeger B., 2017, R2GLMM COMPUTES R SQ; Koh I, 2016, P NATL ACAD SCI USA, V113, P140, DOI 10.1073/pnas.1517685113; Leonhardt SD, 2012, APIDOLOGIE, V43, P449, DOI 10.1007/s13592-011-0112-y; Liczner AR, 2020, INSECT CONSERV DIVER, V13, P558, DOI 10.1111/icad.12419; Mallinger RE, 2016, LANDSCAPE ECOL, V31, P1523, DOI 10.1007/s10980-015-0332-z; Michener C. D., 2000, The bees of the world; Milano NJ, 2019, AGR ECOSYST ENVIRON, V284, DOI 10.1016/j.agee.2019.106594; Minahan DF, 2018, FRONT ECOL EVOL, V6, DOI 10.3389/fevo.2018.00156; Mola JM, 2021, J APPL ECOL, V58, P1431, DOI 10.1111/1365-2664.13886; Otto CRV, 2016, P NATL ACAD SCI USA, V113, P10430, DOI 10.1073/pnas.1603481113; Pelletier L, 2003, OIKOS, V103, P688, DOI 10.1034/j.1600-0706.2003.12592.x; Pollinator Health Task Force, 2014, PRES MEM CREAT FED S; R Core Team, 2020, R LANG ENV STAT COMP; Rollin O, 2013, AGR ECOSYST ENVIRON, V179, P78, DOI 10.1016/j.agee.2013.07.007; Samuelson AE, 2018, P ROY SOC B-BIOL SCI, V285, DOI 10.1098/rspb.2018.0807; SEELEY TD, 1986, BEHAV ECOL SOCIOBIOL, V19, P343, DOI 10.1007/BF00295707; Smart M, 2018, AGRICULTURE-BASEL, V8, DOI 10.3390/agriculture8010002; Steffan-Dewenter I, 2002, ECOLOGY, V83, P1421, DOI 10.1890/0012-9658(2002)083[1421:SDEOLC]2.0.CO;2; Steffan-Dewenter I, 2003, P ROY SOC B-BIOL SCI, V270, P569, DOI 10.1098/rspb.2002.2292; Stubbs CS, 2001, J ECON ENTOMOL, V94, P609, DOI 10.1603/0022-0493-94.3.609; Urban-Mead KR, 2021, FOREST ECOL MANAG, V482, DOI 10.1016/j.foreco.2020.118903; US Department of Agriculture National Agricultural Statistics Service, 2019, FARMS LAND FARMS 201; US Department of Agriculture National Agricultural Statistics Service, 2017, CROPL DAT LAYER; vanEngelsdorp D, 2010, J INVERTEBR PATHOL, V103, pS80, DOI 10.1016/j.jip.2009.06.011; Vaudo AD, 2020, INSECTS, V11, DOI 10.3390/insects11020132; Vaudo AD, 2015, CURR OPIN INSECT SCI, V10, P133, DOI 10.1016/j.cois.2015.05.008; Vaughan M., 2008, USING FARM BILL PROG, P16; Velthuis HHW, 2006, APIDOLOGIE, V37, P421, DOI 10.1051/apido:2006019; Williams NM, 2012, ECOLOGY, V93, P1049, DOI 10.1890/11-1006.1; Williams PH, 2014, BUMBLE BEES N AM IDE; Wood TJ, 2020, APIDOLOGIE, V51, P1100, DOI 10.1007/s13592-020-00788-9; Wood TJ, 2019, ECOLOGY, V100, DOI 10.1002/ecy.2697	54	1	1	5	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2021	16	9							e0257701	10.1371/journal.pone.0257701	http://dx.doi.org/10.1371/journal.pone.0257701			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	WG6BN	34543363	Green Published, gold			2022-12-26	WOS:000707078200074
J	Shin, H; Kawai, HD				Shin, Hyeryun; Kawai, Hideki Derek			Sensitive timing of undifferentiation in oligodendrocyte progenitor cells and their enhanced maturation in primary visual cortex of binocularly enucleated mice	PLOS ONE			English	Article							LATERAL GENICULATE-NUCLEUS; CROSS-MODAL NEUROPLASTICITY; CRITICAL PERIOD; POSTNATAL-DEVELOPMENT; CORTICAL PLASTICITY; PROJECTION NEURONS; WHITE-MATTER; GLIAL-CELLS; PROLIFERATION; DIFFERENTIATION	Sensory experience modulates proliferation, differentiation, and migration of oligodendrocyte progenitor cells (OPCs). In the mouse primary visual cortex (V1), visual deprivation-dependent modulation of OPCs has not been demonstrated. Here, we demonstrate that undifferentiated OPCs developmentally peaked around postnatal day (P) 25, and binocular enucleation (BE) from the time of eye opening (P14-15) elevated symmetrically-divided undifferentiated OPCs in a reversible G0/G1 state even more at the bottom lamina of the cortex by reducing maturing oligodendrocyte (OL) lineage cells. Experiments using the sonic hedgehog (Shh) signaling inhibitor cyclopamine in vivo suggested that Shh signaling pathway was involved in the BE-induced undifferentiation process. The undifferentiated OPCs then differentiated within 5 days, independent of the experience, becoming mostly quiescent cells in control mice, while altering the mode of sister cell symmetry and forming quiescent as well as maturing cells in the enucleated mice. At P50, BE increased mature OLs via symmetric and asymmetric modes of cell segregation, resulting in more populated mature OLs at the bottom layer of the cortex. These data suggest that fourth postnatal week, corresponding to the early critical period of ocular dominance plasticity, is a developmentally sensitive period for OPC state changes. Overall, the visual loss promoted undifferentiation at the early period, but later increased the formation of mature OLs via a change in the mode of cell type symmetry at the bottom layer of mouse V1.	[Shin, Hyeryun; Kawai, Hideki Derek] Soka Univ, Grad Sch Engn, Dept Bioinformat, Hachioji, Tokyo, Japan; [Kawai, Hideki Derek] Soka Univ, Grad Sch Sci & Engn, Dept Biosci, Hachioji, Tokyo, Japan	Soka University; Soka University	Kawai, HD (corresponding author), Soka Univ, Grad Sch Engn, Dept Bioinformat, Hachioji, Tokyo, Japan.; Kawai, HD (corresponding author), Soka Univ, Grad Sch Sci & Engn, Dept Biosci, Hachioji, Tokyo, Japan.	kawai@soka.ac.jp		Kawai, Hideki/0000-0003-2113-6866	Japan Society for the Promotion of Science [23500402]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by Japan Society for the Promotion of Science (https://www.jsps.go.jp/english/) KAKENHI Grant Number 23500402 (H.D.K). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aerts J, 2014, JOVE-J VIS EXP, DOI 10.3791/51936; Aguirre A, 2007, NAT NEUROSCI, V10, P990, DOI 10.1038/nn1938; ASANUMA C, 1990, NEUROSCIENCE, V39, P533, DOI 10.1016/0306-4522(90)90241-U; Baydyuk M, 2020, NEUROCHEM RES, V45, P630, DOI 10.1007/s11064-020-02967-7; Benoit J, 2015, P NATL ACAD SCI USA, V112, P8094, DOI 10.1073/pnas.1509323112; Bergles DE, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a020453; Boda E, 2015, GLIA, V63, P271, DOI 10.1002/glia.22750; BOGLER O, 1990, P NATL ACAD SCI USA, V87, P6368, DOI 10.1073/pnas.87.16.6368; Bronchti G, 2002, EUR J NEUROSCI, V16, P311, DOI 10.1046/j.1460-9568.2002.02063.x; Bu J, 2004, GLIA, V48, P51, DOI 10.1002/glia.20055; Cai J, 2007, DEVELOPMENT, V134, P1887, DOI 10.1242/dev.02847; Chabot N, 2008, NEUROSCI LETT, V433, P129, DOI 10.1016/j.neulet.2008.01.003; Chabot N, 2007, EUR J NEUROSCI, V26, P2334, DOI 10.1111/j.1460-9568.2007.05854.x; Charbonneau V, 2012, EUR J NEUROSCI, V36, P2949, DOI 10.1111/j.1460-9568.2012.08215.x; Coppi E, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00155; Corvetti L, 2003, GLIA, V41, P404, DOI 10.1002/glia.10194; Cruz-Martin A, 2014, NATURE, V507, P358, DOI 10.1038/nature12989; Dawson MRL, 2003, MOL CELL NEUROSCI, V24, P476, DOI 10.1016/S1044-7431(03)00210-0; Dawson MRL, 2000, J NEUROSCI RES, V61, P471, DOI 10.1002/1097-4547(20000901)61:5<471::AID-JNR1>3.3.CO;2-E; Daynac M, 2016, STEM CELL REP, V7, P735, DOI 10.1016/j.stemcr.2016.08.016; Deloulme JC, 2004, MOL CELL NEUROSCI, V27, P453, DOI 10.1016/j.mcn.2004.07.008; Dimou L, 2015, GLIA, V63, P1429, DOI 10.1002/glia.22859; Dimou L, 2008, J NEUROSCI, V28, P10434, DOI 10.1523/JNEUROSCI.2831-08.2008; DORON N, 1994, NEUROREPORT, V5, P2697, DOI 10.1097/00001756-199412000-00072; Espinosa JS, 2012, NEURON, V75, P230, DOI 10.1016/j.neuron.2012.06.009; Fancy SPJ, 2004, MOL CELL NEUROSCI, V27, P247, DOI 10.1016/j.mcn.2004.06.015; Fancy SPJ, 2009, GENE DEV, V23, P1571, DOI 10.1101/gad.1806309; Farmer WT, 2016, SCIENCE, V351, P849, DOI 10.1126/science.aab3103; Ferent J, 2013, J NEUROSCI, V33, P1759, DOI 10.1523/JNEUROSCI.3334-12.2013; Franklin K.B.J., 2008, MOUSE BRAIN STEREOTA; GALLO V, 1995, J NEUROSCI, V15, P394; Gallo V, 2014, NEURON, V83, P283, DOI 10.1016/j.neuron.2014.06.010; Garcia ADR, 2010, J NEUROSCI, V30, P13597, DOI 10.1523/JNEUROSCI.0830-10.2010; Ge WP, 2009, P NATL ACAD SCI USA, V106, P328, DOI 10.1073/pnas.0811353106; GERDES J, 1984, J IMMUNOL, V133, P1710; Ghoumari AM, 2005, NEUROSCIENCE, V135, P47, DOI 10.1016/j.neuroscience.2005.05.023; Gibson EM, 2014, SCIENCE, V344, P487, DOI 10.1126/science.1252304; Gordon JA, 1996, J NEUROSCI, V16, P3274; Hammond E, 2015, J NEUROSCI, V35, P5007, DOI 10.1523/JNEUROSCI.4787-14.2015; Harwell CC, 2012, NEURON, V73, P1116, DOI 10.1016/j.neuron.2012.02.009; HEUMANN D, 1980, EXP BRAIN RES, V38, P75; Hill RA, 2014, NAT NEUROSCI, V17, P1518, DOI 10.1038/nn.3815; Hill SA, 2019, ELIFE, V8, DOI 10.7554/eLife.45545; Hrvatin S, 2018, NAT NEUROSCI, V21, P120, DOI 10.1038/s41593-017-0029-5; Hughes EG, 2018, NAT NEUROSCI, V21, P696, DOI 10.1038/s41593-018-0121-5; Ishibashi T, 2006, NEURON, V49, P823, DOI 10.1016/j.neuron.2006.02.006; Ishibashi T, 2009, J NEUROSCI RES, V87, P3343, DOI 10.1002/jnr.22173; Izraeli R, 2002, EUR J NEUROSCI, V15, P693, DOI 10.1046/j.1460-9568.2002.01902.x; Ji XY, 2016, CEREB CORTEX, V26, P2612, DOI 10.1093/cercor/bhv099; Kahn DM, 2002, P NATL ACAD SCI USA, V99, P11429, DOI 10.1073/pnas.162342799; Kang SH, 2010, NEURON, V68, P668, DOI 10.1016/j.neuron.2010.09.009; Karlen SJ, 2009, CEREB CORTEX, V19, P1360, DOI 10.1093/cercor/bhn176; Kremer D, 2016, TRENDS NEUROSCI, V39, P246, DOI 10.1016/j.tins.2016.02.004; Kukley M, 2008, FASEB J, V22, P2957, DOI 10.1096/fj.07-090985; Laemle LK, 2006, NEUROSCI LETT, V396, P108, DOI 10.1016/j.neulet.2005.11.020; Levine JM, 1999, EXP NEUROL, V160, P333, DOI 10.1006/exnr.1999.7224; Li Q, 2010, NEUROSCI LETT, V479, P128, DOI 10.1016/j.neulet.2010.05.043; Lyckman AW, 2008, P NATL ACAD SCI USA, V105, P9409, DOI 10.1073/pnas.0710172105; Maffei A, 2010, J NEUROSCI, V30, P3304, DOI 10.1523/JNEUROSCI.5340-09.2010; Mallon BS, 2002, J NEUROSCI, V22, P876, DOI 10.1523/JNEUROSCI.22-03-00876.2002; Mangin JM, 2012, NAT NEUROSCI, V15, P1192, DOI 10.1038/nn.3190; Marshall CAG, 2005, J NEUROSCI, V25, P7289, DOI 10.1523/JNEUROSCI.1924-05.2005; McGee AW, 2005, SCIENCE, V309, P2222, DOI 10.1126/science.1114362; McKenzie IA, 2014, SCIENCE, V346, P318, DOI 10.1126/science.1254960; MCKINNON RD, 1990, NEURON, V5, P603, DOI 10.1016/0896-6273(90)90215-2; Miller I, 2018, CELL REP, V24, P1105, DOI 10.1016/j.celrep.2018.06.110; National Research Council (US) Committee for the Update of the Guide for the Care and Use of Laboratory Animals, 2011, GUIDE CARE USE LAB A, V8th, DOI [10.1258/la.2010.010031, DOI 10.1258/LA.2010.010031]; OBST K, 1995, J BRAIN RES, V36, P209; Piche M, 2004, EUR J NEUROSCI, V20, P3463, DOI 10.1111/j.1460-9568.2004.03823.x; Pitter KL, 2014, GLIA, V62, P1595, DOI 10.1002/glia.22702; Podbielska M, 2013, BRAIN SCI, V3, P1282, DOI 10.3390/brainsci3031282; Rebsam A, 2002, J NEUROSCI, V22, P8541; REESE BE, 1986, J COMP NEUROL, V250, P8, DOI 10.1002/cne.902500103; Rivell A, 2019, BIOL OPEN, V8, DOI 10.1242/bio.040592; Rivers LE, 2008, NAT NEUROSCI, V11, P1392, DOI 10.1038/nn.2220; Schumacher M, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00010; Shin H, 2021, IBRO NEUROSCI REP, V11, P29, DOI 10.1016/j.ibneur.2021.06.004; Simon C, 2011, GLIA, V59, P869, DOI 10.1002/glia.21156; Takebayashi H, 2002, CURR BIOL, V12, P1157, DOI 10.1016/S0960-9822(02)00926-0; Toldi J, 1996, PROG NEUROBIOL, V48, P191, DOI 10.1016/0301-0082(95)00038-0; Tong CK, 2015, STEM CELL REP, V5, P461, DOI 10.1016/j.stemcr.2015.08.013; van den Brink GR, 2001, GASTROENTEROLOGY, V121, P317, DOI 10.1053/gast.2001.26261; Wake H, 2011, SCIENCE, V333, P1647, DOI 10.1126/science.1206998; Wang Y, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0085234, 10.1371/journal.pone.0110024, 10.1371/journal.pone.0096339, 10.1371/journal.pone.0108223]; Watanabe M, 2002, J NEUROSCI RES, V69, P826, DOI 10.1002/jnr.10338; Yang H, 2012, STEM CELL RES, V9, P156, DOI 10.1016/j.scr.2012.06.002; Young KM, 2013, NEURON, V77, P873, DOI 10.1016/j.neuron.2013.01.006; Zhang S, 2018, J NEUROSCI, V38, P1802, DOI 10.1523/JNEUROSCI.1291-17.2018; Zhao C, 2015, J NEUROSCI, V35, P11482, DOI 10.1523/JNEUROSCI.3655-14.2015; Zhou Q, 2002, CELL, V109, P61, DOI 10.1016/S0092-8674(02)00677-3; Zhu XQ, 2008, DEVELOPMENT, V135, P145, DOI 10.1242/dev.004895; Zhu XQ, 2012, DEVELOPMENT, V139, P2299, DOI 10.1242/dev.078873	92	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2021	16	9							e0257395	10.1371/journal.pone.0257395	http://dx.doi.org/10.1371/journal.pone.0257395			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	WG5ZQ	34534256	gold, Green Published			2022-12-26	WOS:000707073300027
J	Yamashita, J; Terashima, H; Yoneya, M; Maruya, K; Koya, H; Oishi, H; Nakamura, H; Kumada, T				Yamashita, Jumpei; Terashima, Hiroki; Yoneya, Makoto; Maruya, Kazushi; Koya, Hidetaka; Oishi, Haruo; Nakamura, Hiroyuki; Kumada, Takatsune			Pupillary fluctuation amplitude before target presentation reflects short-term vigilance level in Psychomotor Vigilance Tasks	PLOS ONE			English	Article							LOCUS-COERULEUS; ATTENTION; AROUSAL; PERFORMANCE; DECREMENT; DILATION; FATIGUE	Our daily activities require vigilance. Therefore, it is useful to externally monitor and predict our vigilance level using a straightforward method. It is known that the vigilance level is linked to pupillary fluctuations via Locus Coeruleus and Norepinephrine (LC-NE) system. However, previous methods of estimating long-term vigilance require monitoring pupillary fluctuations at rest over a long period. We developed a method of predicting the short-term vigilance level by monitoring pupillary fluctuation for a shorter period consisting of several seconds. The LC activity also fluctuates at a timescale of seconds. Therefore, we hypothesized that the short-term vigilance level could be estimated using pupillary fluctuations in a short period and quantified their amplitude as the Micro-Pupillary Unrest Index (M-PUI). We found an intra-individual trial-by-trial positive correlation between Reaction Time (RT) reflecting the short-term vigilance level and M-PUI in the period immediately before the target onset in a Psychomotor Vigilance Task (PVT). This relationship was most evident when the fluctuation was smoothed by a Hanning window of approximately 50 to 100 ms (including cases of down-sampled data at 100 and 50 Hz), and M-PUI was calculated in the period up to one or two seconds before the target onset. These results suggest that M-PUI can monitor and predict fluctuating levels of vigilance. M-PUI is also useful for examining pupillary fluctuations in a short period for elucidating the psychophysiological mechanisms of short-term vigilance.	[Yamashita, Jumpei; Koya, Hidetaka; Oishi, Haruo; Nakamura, Hiroyuki] NTT Corp, NTT Access Network Serv Syst Labs, Access Operat Project, Yokosuka, Kanagawa, Japan; [Yamashita, Jumpei; Kumada, Takatsune] Kyoto Univ, Grad Sch Informat, Dept Intelligence Sci & Technol, Kyoto, Japan; [Terashima, Hiroki; Yoneya, Makoto; Maruya, Kazushi] NTT Corp, Human Informat Sci Lab, NTT Commun Sci Labs, Atsugi, Kanagawa, Japan	Nippon Telegraph & Telephone Corporation; Kyoto University; Nippon Telegraph & Telephone Corporation	Yamashita, J (corresponding author), NTT Corp, NTT Access Network Serv Syst Labs, Access Operat Project, Yokosuka, Kanagawa, Japan.; Yamashita, J (corresponding author), Kyoto Univ, Grad Sch Informat, Dept Intelligence Sci & Technol, Kyoto, Japan.	junpei.yamashita.vd@hco.ntt.co.jp	Yamashita, Jumpei/AHH-5039-2022	Yamashita, Jumpei/0000-0001-9411-0523; Terashima, Hiroki/0000-0002-8825-5299				Anderson C, 2012, SLEEP, V35, P1137, DOI 10.5665/sleep.2004; Aston-Jones G, 2005, ANNU REV NEUROSCI, V28, P403, DOI 10.1146/annurev.neuro.28.061604.135709; Devilbiss DM, 2011, J NEUROPHYSIOL, V105, P69, DOI 10.1152/jn.00445.2010; Drummond SPA, 2005, SLEEP, V28, P1059; Engbert R, 2003, VISION RES, V43, P1035, DOI 10.1016/S0042-6989(03)00084-1; Fan J, 2002, J COGNITIVE NEUROSCI, V14, P340, DOI 10.1162/089892902317361886; Fan J, 2005, NEUROIMAGE, V26, P471, DOI 10.1016/j.neuroimage.2005.02.004; Geva R, 2013, FRONT BEHAV NEUROSCI, V7, DOI 10.3389/fnbeh.2013.00145; Klimesch W, 2012, TRENDS COGN SCI, V16, P606, DOI 10.1016/j.tics.2012.10.007; Korber M, 2015, PROCEDIA MANUF, V3, P2403, DOI 10.1016/j.promfg.2015.07.499; KOSS MC, 1986, J PHARMACOL METHOD, V15, P1, DOI 10.1016/0160-5402(86)90002-1; Langner R, 2013, PSYCHOL BULL, V139, P870, DOI 10.1037/a0030694; Langner R, 2010, ACTA PSYCHOL, V133, P64, DOI 10.1016/j.actpsy.2009.10.001; Loh S, 2004, BEHAV RES METH INS C, V36, P339, DOI 10.3758/BF03195580; LOWENSTEIN O, 1963, INVEST OPHTH VISUAL, V2, P138; Maccora J, 2019, J SLEEP RES, V28, DOI 10.1111/jsr.12739; Marois R, 2000, NEURON, V28, P299, DOI 10.1016/S0896-6273(00)00104-5; Mather M, 2016, BEHAV BRAIN SCI, V39, DOI 10.1017/S0140525X15000667; Matthews G, 2002, EMOTION, V2, P315, DOI 10.1037//1528-3542.2.4.315; Menon V, 2010, BRAIN STRUCT FUNCT, V214, P655, DOI 10.1007/s00429-010-0262-0; Mueller ST, 2014, J NEUROSCI METH, V222, P250, DOI 10.1016/j.jneumeth.2013.10.024; Nishiyama J, 2007, P ANN INT IEEE EMBS, P1586, DOI 10.1109/IEMBS.2007.4352608; Oken BS, 2006, CLIN NEUROPHYSIOL, V117, P1885, DOI 10.1016/j.clinph.2006.01.017; Samuels ER, 2008, CURR NEUROPHARMACOL, V6, P254, DOI 10.2174/157015908785777193; Shapiro KL, 1997, TRENDS COGN SCI, V1, P291, DOI 10.1016/S1364-6613(97)01094-2; SILVER NC, 1987, J APPL PSYCHOL, V72, P146, DOI 10.1037/0021-9010.72.1.146; Singh G., 2013, ICORD 13 LECT NOTES, P991, DOI [10.1007/978-81-322-1050-4%5F78, DOI 10.1007/978-81-322-1050-4%5F78]; Steinborn MB, 2016, APPL COGNITIVE PSYCH, V30, P92, DOI 10.1002/acp.3172; Steinborn MB, 2012, ACTA PSYCHOL, V139, P65, DOI 10.1016/j.actpsy.2011.10.010; Taylor-Phillips S, 2019, BRIT J RADIOL, V92, DOI 10.1259/bjr.20190043; Tucker AM, 2009, SLEEP, V32, P1393, DOI 10.1093/sleep/32.10.1393; Unsworth N, 2018, J COGNITIVE NEUROSCI, V30, P1241, DOI 10.1162/jocn_a_01251; Usher M, 1999, SCIENCE, V283, P549, DOI 10.1126/science.283.5401.549; Voisin S, 2013, MED PHYS, V40, DOI 10.1118/1.4820536; Warga M, 2009, VISION RES, V49, P295, DOI 10.1016/j.visres.2008.09.019; Wierda SM, 2012, P NATL ACAD SCI USA, V109, P8456, DOI 10.1073/pnas.1201858109; Wiggins MW, 2011, APPL COGNITIVE PSYCH, V25, P229, DOI 10.1002/acp.1668; Wilhelm B, 1998, SLEEP, V21, P258; WILKINSON RT, 1982, HUM FACTORS, V24, P487, DOI 10.1177/001872088202400409; Yang FN, 2018, SLEEP, V41, DOI 10.1093/sleep/zsy189	40	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2021	16	9							e0256953	10.1371/journal.pone.0256953	http://dx.doi.org/10.1371/journal.pone.0256953			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	WG5ZQ	34534237	Green Published, gold			2022-12-26	WOS:000707073300014
J	Hamdi, R; Saadallah-Kallel, A; Ferchichi-Trimeche, S; Mokdad-Gargouri, R; Miled, A; Benarba, B				Hamdi, Radhia; Saadallah-Kallel, Amana; Ferchichi-Trimeche, Slima; Mokdad-Gargouri, Raja; Miled, Abdelhedi; Benarba, Bachir			Lower p66Shc promoter methylation in subjects with chronic renal failure	PLOS ONE			English	Article							OXIDATIVE STRESS; DNA METHYLATION; HIGH-GLUCOSE; ENDOTHELIAL DYSFUNCTION; EPIGENETIC CHANGES; GENE-EXPRESSION; KIDNEY-FUNCTION; INJURY; INFLAMMATION; PROTECTS	Objective To determine the correlation between DNA methylation of p66Shc promoter and some markers of inflammatory and oxidative stress in chronic renal failure (CRF) patients compared with healthy subjects. Methods An observational cross-sectional study was conducted in the nephrology department at Sidi Bouzid Regional Hospital (Tunisia). In total, 39 patients with CRF and 37 healthy subjects were included. Several biochemical parameters were measured. Furthermore, markers of the oxidative and inflammatory status (MDA, TAS, SOD, and CRP) were evaluated. The p66Shc methylation status was determined using the methylation-specific PCR. Results Our results showed that levels of blood glucose, urea, creatinine, uric acid, ChT, TG, albuminuria, CRP and MDA were significantly elevated in CRF patients compared to controls. Furthermore, p66Shc promoter region was highly demethylated in CRF patients compared to healthy controls (84% vs 4%). Our data showed a positive correlation between p66Shc hypomethylation and levels of MDA (r = 0.93; p<0, 05) and CRP (r = 0.89; P <0, 05), as well as a significant negative correlation between p66Shc hypomethylation, TAS (r = -0.76; P <0, 05) and SOD (r = -0.77; p<0, 05) levels. Similarly, there was a positive correlation between p66Shc hypomethylation and the disease stages. Importantly, multiple regression analysis showed that p66shc DNA hypomethylation remains strongly correlated with MDA, CRP and stages of CRF. Conclusion This study indicates that the DNA hypomethylation of p66shc promoter was correlated with oxidative and inflammatory stress and the disease stages in CRF patients.	[Hamdi, Radhia; Ferchichi-Trimeche, Slima] Univ Monastir, Dept Biochem, Fac Pharm, Res Unit Clin & Mol Biol UR17ES29, Monastir, Tunisia; [Hamdi, Radhia] Sidi Bouzid Reg Hosp, Lab Biochem, Sidi Bouzid, Tunisia; [Saadallah-Kallel, Amana; Mokdad-Gargouri, Raja] Univ Sfax, Biotechnol Ctr, Lab Mol Biotechnol Eukaryotes, Sfax, Tunisia; [Ferchichi-Trimeche, Slima; Miled, Abdelhedi] CHU Res Unit Farhat Hached, Sousse, Tunisia; [Benarba, Bachir] Univ Mascara, Fac Nat & Life, Lab Res Biol Syst & Geomat, Mascara, Algeria	Universite de Monastir; Centre de Biotechnologie de Borj Cedria; Universite de Sfax; Universite de Mascara	Hamdi, R (corresponding author), Univ Monastir, Dept Biochem, Fac Pharm, Res Unit Clin & Mol Biol UR17ES29, Monastir, Tunisia.; Hamdi, R (corresponding author), Sidi Bouzid Reg Hosp, Lab Biochem, Sidi Bouzid, Tunisia.	hamdi.radia@yahoo.fr						Araujo M, 2014, ANTIOXID REDOX SIGN, V20, P74, DOI 10.1089/ars.2013.5259; Benmoussa M., 2015, BATNA J MED SCI, V2, P50; Cai HD, 2018, J ETHNOPHARMACOL, V212, P153, DOI 10.1016/j.jep.2017.09.021; Camici GG, 2007, P NATL ACAD SCI USA, V104, P5217, DOI 10.1073/pnas.0609656104; Costantino S, 2018, INT J CARDIOL, V268, P179, DOI 10.1016/j.ijcard.2018.04.082; D'Apolito M, 2015, ATHEROSCLEROSIS, V239, P393, DOI 10.1016/j.atherosclerosis.2015.01.034; Daroux M, 2009, PRESSE MED, V38, P1667, DOI 10.1016/j.lpm.2008.12.027; Ding RQ, 2017, CHEM-BIOL INTERACT, V278, P162, DOI 10.1016/j.cbi.2017.10.005; Donato AJ, 2015, J MOL CELL CARDIOL, V89, P122, DOI 10.1016/j.yjmcc.2015.01.021; Dwivedi RS, 2011, KIDNEY INT, V79, P23, DOI 10.1038/ki.2010.335; El-Osta A, 2008, J EXP MED, V205, P2409, DOI 10.1084/jem.20081188; Findikli E, 2018, CLIN PSYCHOPHARM NEU, V16, P88, DOI 10.9758/cpn.2018.16.1.88; Francia P, 2004, CIRCULATION, V110, P2889, DOI 10.1161/01.CIR.0000147731.24444.4D; FRIDOVICH I, 1983, ANNU REV PHARMACOL, V23, P239, DOI 10.1146/annurev.pa.23.040183.001323; Fusco R, 2020, ANTIOXIDANTS-BASEL, V9, DOI 10.3390/antiox9060511; Galimov ER, 2010, ACTA NATURAE, V2, P44, DOI 10.32607/20758251-2010-2-4-44-51; Geisel J, 2007, CLIN CHEM LAB MED, V45, P1764, DOI 10.1515/CCLM.2007.357; Gupta J, 2012, CLIN J AM SOC NEPHRO, V7, P1938, DOI 10.2215/CJN.03500412; Heidari R, 2018, BIOMED PHARMACOTHER, V107, P834, DOI 10.1016/j.biopha.2018.08.050; Hoshino Y, 2019, BIOCHEM BIOPHYS REP, V17, P169, DOI 10.1016/j.bbrep.2019.01.003; Huang YT, 2016, EPIGENETICS-US, V11, P227, DOI 10.1080/15592294.2016.1146853; Kim CS, 2011, CARDIOVASC RES, V92, P466, DOI 10.1093/cvr/cvr250; Kim YR, 2012, AM J PHYSIOL-HEART C, V303, pH189, DOI 10.1152/ajpheart.01218.2011; Kottgen A, 2010, NAT GENET, V42, P376, DOI 10.1038/ng.568; Li YY, 2011, METHODS MOL BIOL, V791, P11, DOI 10.1007/978-1-61779-316-5_2; Lim DHK, 2010, OBSTET GYNAECOL, V12, P37, DOI 10.1576/toag.12.1.037.27556; Magenta A, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/193095; Melamed ML, 2008, CLIN J AM SOC NEPHRO, V3, P1569, DOI 10.2215/CJN.02370508; Oberg BP, 2004, KIDNEY INT, V65, P1009, DOI 10.1111/j.1523-1755.2004.00465.x; Pagnin E, 2005, J CLIN ENDOCR METAB, V90, P1130, DOI 10.1210/jc.2004-1283; Pallos D, 2015, ARCH ORAL BIOL, V60, P1784, DOI 10.1016/j.archoralbio.2015.09.008; Paneni F, 2012, CIRC RES, V111, P278, DOI 10.1161/CIRCRESAHA.112.266593; Pavaneh E., 2020, EPIGENETICS-US, V15, DOI [10.1080/15592294.2020.1788325, DOI 10.1080/15592294.2020.1788325]; Pinto AR, 2016, SLEEP BREATH, V20, P339, DOI 10.1007/s11325-015-1240-9; Rankinen T, 2000, THROMB RES, V99, P453, DOI 10.1016/S0049-3848(00)00271-1; Ratliff BB, 2016, ANTIOXID REDOX SIGN, V25, P119, DOI 10.1089/ars.2016.6665; Sato F, 2011, FEBS J, V278, P1598, DOI 10.1111/j.1742-4658.2011.08089.x; Siracusa R, 2020, NUTRIENTS, V12, DOI 10.3390/nu12030834; Stenvinkel P, 2007, J INTERN MED, V261, P488, DOI 10.1111/j.1365-2796.2007.01777.x; Sun L, 2010, AM J PHYSIOL-RENAL, V299, pF1014, DOI 10.1152/ajprenal.00414.2010; Tain YL, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18020381; Wang J, 2019, ACTA BIOCH BIOPH SIN, V51, P197, DOI 10.1093/abbs/gmy167; Wojciechowska C, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/147040; Wright KD, 2018, AM J PHYSIOL-RENAL, V314, pF143, DOI 10.1152/ajprenal.00414.2017; Xu XX, 2016, SCI REP-UK, V6, DOI 10.1038/srep29302; Yang HT, 2017, INT J CLIN EXP MED, V10, P15704; Zhang CL, 2010, J CELL PHYSIOL, V222, P444, DOI 10.1002/jcp.21966; Zhao MH, 2018, BMC OPHTHALMOL, V18, DOI 10.1186/s12886-018-0724-3; Zhong Q, 2011, DIABETES, V60, P1304, DOI 10.2337/db10-0133; Zhou S, 2011, CIRC RES, V109, P639, DOI 10.1161/CIRCRESAHA.111.243592	50	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2021	16	9							e0257176	10.1371/journal.pone.0257176	http://dx.doi.org/10.1371/journal.pone.0257176			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	WG5YY	34529688	Green Published, gold			2022-12-26	WOS:000707071500032
J	Dong, CP; Cesarano, A; Bombaci, G; Reiter, JL; Yu, CY; Wang, Y; Jiang, ZY; Abu Zaid, M; Huang, K; Lu, XB; Walker, BA; Perna, F; Liu, YL				Dong, Chuanpeng; Cesarano, Annamaria; Bombaci, Giuseppe; Reiter, Jill L.; Yu, Christina Y.; Wang, Yue; Jiang, Zhaoyang; Abu Zaid, Mohammad; Huang, Kun; Lu, Xiongbin; Walker, Brian A.; Perna, Fabiana; Liu, Yunlong			Intron retention-induced neoantigen load correlates with unfavorable prognosis in multiple myeloma	ONCOGENE			English	Article							INTERNATIONAL STAGING SYSTEM; CHECKPOINT BLOCKADE; CELL; EXPRESSION; PATHWAY; FAMILY	Neoantigen peptides arising from genetic alterations may serve as targets for personalized cancer vaccines and as positive predictors of response to immune checkpoint therapy. Mutations in genes regulating RNA splicing are common in hematological malignancies leading to dysregulated splicing and intron retention (IR). In this study, we investigated IR as a potential source of tumor neoantigens in multiple myeloma (MM) patients and the relationship of IR-induced neoantigens (IR-neoAg) with clinical outcomes. MM-specific IR events were identified in RNA-sequencing data from the Multiple Myeloma Research Foundation CoMMpass study after removing IR events that also occurred in normal plasma cells. We quantified the IR-neoAg load by assessing IR-induced novel peptides that were predicted to bind to major histocompatibility complex (MHC) molecules. We found that high IR-neoAg load was associated with poor overall survival in both newly diagnosed and relapsed MM patients. Further analyses revealed that poor outcome in MM patients with high IR-neoAg load was associated with high expression levels of T-cell co-inhibitory molecules and elevated interferon signaling activity. We also found that MM cells exhibiting high IR levels had lower MHC-II protein abundance and treatment of MM cells with a spliceosome inhibitor resulted in increased MHC-I protein abundance. Our findings suggest that IR-neoAg may represent a novel biomarker of MM patient clinical outcome and further that targeting RNA splicing may serve as a potential therapeutic strategy to prevent MM immune escape and promote response to checkpoint blockade.	[Dong, Chuanpeng; Reiter, Jill L.; Wang, Yue; Jiang, Zhaoyang; Huang, Kun; Lu, Xiongbin; Walker, Brian A.; Liu, Yunlong] Indiana Univ Sch Med, Ctr Computat Biol & Bioinformat, Indianapolis, IN 46202 USA; [Dong, Chuanpeng; Huang, Kun; Liu, Yunlong] Indiana Univ Purdue Univ, Sch Informat & Comp, Dept BioHlth Informat, Indianapolis, IN 46202 USA; [Cesarano, Annamaria; Bombaci, Giuseppe; Yu, Christina Y.; Abu Zaid, Mohammad; Walker, Brian A.; Perna, Fabiana] Indiana Univ, Sch Med, Dept Med, Indianapolis, IN 46202 USA; [Reiter, Jill L.; Wang, Yue; Lu, Xiongbin; Liu, Yunlong] Indiana Univ Sch Med, Dept Med & Mol Genet, Indianapolis, IN 46202 USA; [Jiang, Zhaoyang] Zionsville Community High Sch, Boone, IN 46077 USA; [Abu Zaid, Mohammad; Huang, Kun; Lu, Xiongbin; Walker, Brian A.; Perna, Fabiana; Liu, Yunlong] Indiana Univ Sch Med, Melvin & Bren Simon Canc Ctr, Indianapolis, IN 46202 USA; [Huang, Kun] Indiana Univ Sch Med, Dept Biostat & Hlth Data Sci, Indianapolis, IN 46202 USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	Liu, YL (corresponding author), Indiana Univ Sch Med, Ctr Computat Biol & Bioinformat, Indianapolis, IN 46202 USA.; Liu, YL (corresponding author), Indiana Univ Purdue Univ, Sch Informat & Comp, Dept BioHlth Informat, Indianapolis, IN 46202 USA.; Perna, F (corresponding author), Indiana Univ, Sch Med, Dept Med, Indianapolis, IN 46202 USA.; Liu, YL (corresponding author), Indiana Univ Sch Med, Dept Med & Mol Genet, Indianapolis, IN 46202 USA.; Perna, F; Liu, YL (corresponding author), Indiana Univ Sch Med, Melvin & Bren Simon Canc Ctr, Indianapolis, IN 46202 USA.	fabperna@iu.edu; yunliu@iu.edu	Abu Zaid, Mohammad/AFO-3625-2022; Reiter, Jill L/J-3335-2013; Reiter, Jill/AGZ-7331-2022	Reiter, Jill L/0000-0001-5460-2355; Reiter, Jill/0000-0001-5460-2355; Wang, Yue/0000-0003-4671-8547; Dong, Chuanpeng/0000-0001-5068-0495; Huang, Kun/0000-0002-8530-370X	Indiana University Grand Challenge Precision Health Initiative; NIH, National Cancer Institute (NCI) [P30 CA082709]; NIH, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [U54 DK106846]; NIH instrumentation grant [1S10D012270]; Leukemia Research Foundation grant	Indiana University Grand Challenge Precision Health Initiative; NIH, National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)National Research Council of Science & Technology (NST), Republic of Korea); NIH, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIH instrumentation grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia Research Foundation grant	The work was supported by the Indiana University Grand Challenge Precision Health Initiative. This study used the Multiple Myeloma Research Foundation (MMRF) CoMMpass Dataset. The authors acknowledge the efforts of the MMRF research consortium to provide the fundamental resource for our study. MM cell lines were provided by Dr. David Roodman, Indiana University School of Medicine. The authors thank the members of the Indiana University Melvin and Bren Simon Cancer Center (IUSCCC) Flow Cytometry Resource Facility (FCRF) for their outstanding technical support. The IUSCCC FCRF is funded in part by NIH, National Cancer Institute (NCI) grant P30 CA082709 and National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) grant U54 DK106846. The FCRF is supported in part by NIH instrumentation grant 1S10D012270. F.P. is supported by a Leukemia Research Foundation grant and G.B. is a Kroemer Family Fellow in Myeloma Research.	Agirre X, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08679-z; Ahmad IA, 1996, AM STAT, V50, P324, DOI 10.2307/2684929; Anczukow O, 2012, NAT STRUCT MOL BIOL, V19, P220, DOI 10.1038/nsmb.2207; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Apcher S, 2011, P NATL ACAD SCI USA, V108, P11572, DOI 10.1073/pnas.1104104108; Bailey P, 2016, SCI REP-UK, V6, DOI 10.1038/srep35848; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Braunschweig U, 2014, GENOME RES, V24, P1774, DOI 10.1101/gr.177790.114; Brogna S, 2009, NAT STRUCT MOL BIOL, V16, P107, DOI 10.1038/nsmb.1550; Buchner M, 2014, CURR OPIN HEMATOL, V21, P341, DOI 10.1097/MOH.0000000000000048; Chabot B, 2016, J CELL BIOL, V212, P13, DOI 10.1083/jcb.201510032; Chen LP, 2004, NAT REV IMMUNOL, V4, P336, DOI 10.1038/nri1349; Chretien ML, 2015, BLOOD, V126, P2713, DOI 10.1182/blood-2015-06-650242; Cowan AJ, 2018, JAMA ONCOL, V4, P1221, DOI 10.1001/jamaoncol.2018.2128; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dufva O, 2020, CANCER CELL, V38, P380, DOI 10.1016/j.ccell.2020.06.002; Frankiw L, 2019, NAT REV IMMUNOL, V19, P675, DOI 10.1038/s41577-019-0195-7; Goldman MJ, 2020, NAT BIOTECHNOL, V38, P675, DOI 10.1038/s41587-020-0546-8; Greipp PR, 2005, J CLIN ONCOL, V23, P3412, DOI 10.1200/JCO.2005.04.242; Gu SS, 2021, CANCER DISCOV, V11, P1524, DOI 10.1158/2159-8290.CD-20-0812; Hanzelmann S, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-7; Hoyos LE, 2018, CANCER CELL, V34, P181, DOI 10.1016/j.ccell.2018.07.008; Hugo W, 2016, CELL, V165, P35, DOI 10.1016/j.cell.2016.02.065; Jacob AG, 2017, HUM GENET, V136, P1043, DOI 10.1007/s00439-017-1791-x; Jensen MA, 2014, NAT STRUCT MOL BIOL, V21, P189, DOI 10.1038/nsmb.2756; Jimenez-Vacas JM, 2020, EBIOMEDICINE, V51, DOI 10.1016/j.ebiom.2019.11.008; Kadash-Edmondson KE, 2019, IRIS BIG DATA INFORM; Kawano Y, 2018, J CLIN INVEST, V128, P2487, DOI 10.1172/JCI88169; Lesokhin AM, 2019, CANCER IMMUNOL RES, V7, P1224, DOI 10.1158/2326-6066.CIR-19-0148; Liu J, 2012, ONKOLOGIE, V35, P335, DOI 10.1159/000338941; Lopes R, 2021, CANCERS, V13, DOI 10.3390/cancers13040625; Lu SX, 2021, CELL, V184, P4032, DOI 10.1016/j.cell.2021.05.038; McGranahan N, 2016, SCIENCE, V351, P1463, DOI 10.1126/science.aaf1490; Merryman RW, 2017, BLOOD ADV, V1, P2643, DOI 10.1182/bloodadvances.2017012534; Miller A, 2017, BLOOD CANCER J, V7, DOI 10.1038/bcj.2017.94; Mohamed A, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0227455; Nilsen TW, 2010, NATURE, V463, P457, DOI 10.1038/nature08909; Orenbuch R, 2020, BIOINFORMATICS, V36, P33, DOI 10.1093/bioinformatics/btz474; Palumbo A, 2015, J CLIN ONCOL, V33, P2863, DOI 10.1200/JCO.2015.61.2267; Patro R, 2017, NAT METHODS, V14, P417, DOI 10.1038/nmeth.4197; Perumal D, 2020, CLIN CANCER RES, V26, P450, DOI 10.1158/1078-0432.CCR-19-2309; Rahman MA, 2020, CELL, V180, P208, DOI 10.1016/j.cell.2019.12.011; Ren YX, 2020, ONCOIMMUNOLOGY, V9, DOI 10.1080/2162402X.2020.1744947; Reynisson B, 2020, NUCLEIC ACIDS RES, V48, pW449, DOI 10.1093/nar/gkaa379; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; SCHEMPER M, 1992, STATISTICIAN, V41, P455, DOI 10.2307/2349009; Schumacher TN, 2015, SCIENCE, V348, P69, DOI 10.1126/science.aaa4971; Sedgwick P, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e509; Shen LH, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-50738-4; Shien K, 2016, LUNG CANCER, V99, P79, DOI 10.1016/j.lungcan.2016.06.016; Smart AC, 2018, NAT BIOTECHNOL, V36, P1056, DOI 10.1038/nbt.4239; Tan DJ, 2020, NPJ GENOM MED, V5, DOI 10.1038/s41525-020-00159-4; Teoh PJ, 2018, BLOOD, V132, P1304, DOI 10.1182/blood-2018-02-832576; Walker BA, 2019, LEUKEMIA, V33, P159, DOI 10.1038/s41375-018-0196-8; Wei SC, 2018, CANCER DISCOV, V8, P1069, DOI 10.1158/2159-8290.CD-18-0367; Wong JJL, 2013, CELL, V154, P583, DOI 10.1016/j.cell.2013.06.052; Xie RH, 2019, CANCER LETT, V449, P31, DOI 10.1016/j.canlet.2019.01.041; Yang RY, 2018, BIORXIV; Yap K, 2012, GENE DEV, V26, P1209, DOI 10.1101/gad.188037.112; Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118; Zelle-Rieser C, 2016, J HEMATOL ONCOL, V9, DOI 10.1186/s13045-016-0345-3; Zhang D, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16649-z; Zhang J, 2019, COMMUN BIOL, V2, DOI 10.1038/s42003-019-0369-7; Zhao RH, 2013, P NATL ACAD SCI USA, V110, P9879, DOI 10.1073/pnas.1303524110	64	7	7	0	1	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 21	2021	40	42					6130	6138		10.1038/s41388-021-02005-y	http://dx.doi.org/10.1038/s41388-021-02005-y		SEP 2021	9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	WK6OK	34504297	hybrid, Green Published			2022-12-26	WOS:000694570400001
J	Sun, BD; Tang, JC; Yu, DH; Song, ZW				Sun, Baodi; Tang, Jingchao; Yu, Dehu; Song, Zhiwen			Coupling coordination relationship between ecosystem services and water-land resources for the Daguhe River Basin, China	PLOS ONE			English	Article							HIERARCHY PROCESS; ECONOMIC VALUE; BIODIVERSITY; CARBON; URBANIZATION; PROVINCE; CLIMATE; HEALTH; AHP	Water and land resource utilization is an important driving force of changes in ecosystem services; therefore, research on multi-parameter coupling systems that consider "ecosystem services, water resources, and land resources" together has key significance for river basins. This study aims to reveal the interaction and mutual influence of ecosystem services and water and land resources in the Daguhe River Basin, China, based on the coupling coordination degree model. The results showed that during the period from 2000 to 2010, the coupling coordination degree values for the years 2000, 2005, and 2010 were 0.6005, 0.7292, and 0.8037. The corresponding coupling coordination classifications were categorized as "primary coordinated development", "intermediate coordinated development," and "well-coordinated development", respectively. These results reflected the fact that the relationship between water and land resource utilization and the environment tends to evolve in the direction of coordinated development (an improvement in one part corresponds to an improvement in another part) with variation in water and land utilization types, and eventually pushes the whole resource, as well as ecological and environmental systems, from low to high levels of coupling coordination degrees as observed in case of the Daguhe River Basin, China. Our research provides an overview of the interaction between ecosystem services and water and land resources in the Daguhe Basin and even in the Shandong Province. With our results, we offer new perspectives on river basin management and for planning future eco-environmental policies (the policy is specifically designed for the ecological environment) by combining water and land resource utilization.	[Sun, Baodi] Qingdao Univ Technol, Coll Architecture & Urban Planning, Qingdao, Peoples R China; [Tang, Jingchao; Song, Zhiwen] Qingdao Univ Technol, Sch Environm & Municipal Engn, Qingdao, Peoples R China; [Yu, Dehu] Qingdao Univ Technol, Sch Civil Engn, Qingdao, Peoples R China	Qingdao University of Technology; Qingdao University of Technology; Qingdao University of Technology	Yu, DH (corresponding author), Qingdao Univ Technol, Sch Civil Engn, Qingdao, Peoples R China.	yudehu@126.com	Tang, Jingchao/ABG-8314-2021		Chinese Postdoctoral Fund [2018M630765]; Provincial key R&D Program of Shandong [2019GGX101013]; Qingdao Postdoctoral Science Foundation [40100020078]	Chinese Postdoctoral Fund; Provincial key R&D Program of Shandong; Qingdao Postdoctoral Science Foundation	This work was funded by projects of the Chinese Postdoctoral Fund, http://jj.chinapostdoctor.org.cn/V1/Program3/Default.aspx, (founder: China Postdoctoral Science Foundation, no. 2018M630765, received by BS); the Provincial key R&D Program of Shandong, http://www.sdstc.gov.cn/, (founder: Department of Science and Technology of Shandong province, no. 2019GGX101013, received by DY) and Qingdao Postdoctoral Science Foundation, http://hrss.qingdao.gov.cn/n28356070/index.html, (founder: Qingdao Municipal Bureau of Human Resource and Social Security, no. 40100020078, received by JT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barros C, 2017, J APPL ECOL, V54, P39, DOI 10.1111/1365-2664.12742; Booth BBB, 2012, ENVIRON RES LETT, V7, DOI 10.1088/1748-9326/7/2/024002; Burcher CL, 2007, ECOLOGY, V88, P228, DOI 10.1890/0012-9658(2007)88[228:TLCRCL]2.0.CO;2; Chai J, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14111435; Chaikumbung M, 2016, ECOL ECON, V124, P164, DOI 10.1016/j.ecolecon.2016.01.022; Collard SJ, 2006, AGR ECOSYST ENVIRON, V117, P185, DOI 10.1016/j.agee.2006.04.004; Costanza R, 1997, NATURE, V387, P253, DOI 10.1038/387253a0; Cui SF., 2015, THESIS SHANDONG NORM; Di Sabatino A, 2013, ECOL INDIC, V32, P259, DOI 10.1016/j.ecolind.2013.03.034; [方创琳 FANG Chuanglin], 2006, [干旱区地理, Arid Land Geography], V29, P1; Fang HW., 2008, ADV SCI TECHNOLOGY W, V28, P66; Fetahi T, 2011, ECOL MODEL, V222, P804, DOI 10.1016/j.ecolmodel.2010.09.038; Gashaw T, 2018, ECOSYST SERV, V31, P219, DOI 10.1016/j.ecoser.2018.05.001; Groot RS., 2006, VALUING WETLANDS GUI; Guo Y., 2016, THESIS ZHENGZHOU U; He JQ, 2017, ECOL INDIC, V77, P185, DOI 10.1016/j.ecolind.2017.01.017; Li GenMing, 2010, Research of Environmental Sciences, V23, P1136; Li Kai, 2016, Shengtaixue Zazhi, V35, P1108, DOI 10.13292/j.1000-4890.201604.015; [李伟 Li Wei], 2014, [生态环境学报, Ecology and Environmental Sciences], V23, P1716; Liu D, 2018, ECOL INDIC, V91, P203, DOI 10.1016/j.ecolind.2018.04.011; Liu JX., 2006, MARINE GEOLOGY LETT, V22, P9; Liu NN, 2018, ECOL INDIC, V93, P1163, DOI 10.1016/j.ecolind.2018.06.013; Lu Haiyuan, 2011, Water Resources and Power, V29, P21; Luu C, 2018, NAT HAZARDS, V90, P1031, DOI 10.1007/s11069-017-3083-0; Lv J, 2014, APPL MECH MATER, V444-445, P1260, DOI 10.4028/www.scientific.net/AMM.0.1260; MA, 2005, ECOSYSTEMS HUMAN WEL; [马晓波 Ma Xiaobo], 2015, [中国海洋大学学报. 自然科学版, Periodical of Ocean University of China], V45, P100; Mamat Z, 2018, LAND DEGRAD DEV, V29, P47, DOI 10.1002/ldr.2835; McClellan M, 2018, BIOTROPICA, V50, P510, DOI 10.1111/btp.12536; Mondal M, 2018, J CHEM SCI, V130, DOI 10.1007/s12039-018-1487-3; Nakazato T, 2010, AM J BOT, V97, P680, DOI 10.3732/ajb.0900216; Nie Y, 2018, GEOMORPHOLOGY, V308, P91, DOI 10.1016/j.geomorph.2018.02.002; Pinder RA, 2009, HUM MOVEMENT SCI, V28, P468, DOI 10.1016/j.humov.2009.02.003; Robledano-Aymerich F, 2014, AGR ECOSYST ENVIRON, V197, P222, DOI 10.1016/j.agee.2014.08.006; Rockstrom J, 2010, AGR WATER MANAGE, V97, P543, DOI 10.1016/j.agwat.2009.09.009; Rost S, 2008, WATER RESOUR RES, V44, DOI 10.1029/2007WR006331; SAATY TL, 1977, J MATH PSYCHOL, V15, P234, DOI 10.1016/0022-2496(77)90033-5; Saaty TL, 2013, EUR J OPER RES, V42, P107; Shen LY, 2018, ECOL INDIC, V94, P357, DOI 10.1016/j.ecolind.2018.06.068; Shi MJ, 2021, SUSTAINABILITY-BASEL, V13, DOI 10.3390/su13031577; Smiraglia D, 2016, ENVIRON RES, V147, P590, DOI 10.1016/j.envres.2015.11.030; Sun BD, 2019, OCEAN COAST MANAGE, V168, P41, DOI 10.1016/j.ocecoaman.2018.10.026; Sun BD, 2018, ESTUAR COAST SHELF S, V200, P349, DOI 10.1016/j.ecss.2017.11.006; Sutadian AD, 2017, ECOL INDIC, V75, P220, DOI 10.1016/j.ecolind.2016.12.043; Taheri K, 2015, GEOMORPHOLOGY, V234, P64, DOI 10.1016/j.geomorph.2015.01.005; Taylor CM, 2002, J CLIMATE, V15, P3615, DOI [10.1175/1520-0442(2002)015<3615:TIOLUC>2.0.CO;2, 10.1175/1520-0442(2002)015&lt;3615:TIOLUC&gt;2.0.CO;2]; Tzilivakis J, 2019, MITIG ADAPT STRAT GL, V24, P205, DOI 10.1007/s11027-018-9807-y; Verones F, 2015, ENVIRON SCI TECHNOL, V49, P3584, DOI 10.1021/es504995r; Vollmer D, 2018, SCI TOTAL ENVIRON, V627, P304, DOI 10.1016/j.scitotenv.2018.01.040; Voss BM, 2017, GLOBAL BIOGEOCHEM CY, V31, P1271, DOI 10.1002/2017GB005699; Wang Jie, 2012, Environmental Science & Technology (China), V35, P199; Wu X, 2016, AGR WATER MANAGE, V163, P380, DOI 10.1016/j.agwat.2015.08.022; [谢高地 XIE Gao-di], 2008, [自然资源学报, Journal of Natural Resources], V23, P911; [谢高地 Xie Gaodi], 2015, [自然资源学报, Journal of Natural Resources], V30, P1243; Xu WJ, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12031246; [严登华 Yan Chenghua], 2005, [水科学进展, Advances in Water Science], V16, P747; Yang YY, 2020, ECOL INDIC, V117, DOI 10.1016/j.ecolind.2020.106512; Yi H, 2018, SCI TOTAL ENVIRON, V619, P1259, DOI 10.1016/j.scitotenv.2017.10.302; Zhang ZQ., 2018, WATER RESOURCES DEV, V35, P7; [邹桂红 ZOU Guihong], 2008, [资源科学, Resources Science], V30, P288	60	0	0	18	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2021	16	9							e0257123	10.1371/journal.pone.0257123	http://dx.doi.org/10.1371/journal.pone.0257123			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XM9EM	34506542	Green Published, gold			2022-12-26	WOS:000729120700061
J	Watanabe, Y; Spangenberg, GC; Shinozuka, H				Watanabe, Yugo; Spangenberg, German C.; Shinozuka, Hiroshi			Fungus-originated glucanase and monooxygenase genes in creeping bent grass (Agrostis stolonifera L.)	PLOS ONE			English	Article							FLAVIN-CONTAINING MONOOXYGENASES; PLANTS	Recent studies have revealed presence of fungus-originated genes in genomes of cool-season grasses, suggesting occurrence of multiple ancestral gene transfer events between the two distant lineages. The current article describes identification of glucanase-like and monooxygenase-like genes from creeping bent grass, as lateral gene transfer candidates. An in silico analysis suggested presence of the glucanase-like gene in Agrostis, Deyeuxia, and Polypogon genera, but not in other species belonging to the clade 1 of the Poeae tribe. Similarly, the monooxygenase-like gene was confined to Agrostis and Deyeuxia genera. A consistent result was obtained from PCR-based screening. The glucanase-like gene was revealed to be ubiquitously expressed in young seedlings of creeping bent grass. Although expression of the monooxygenase-like gene was suggested in plant tissues, the levels were considerably lower than those of the glucanase-like gene. A phylogenetic analysis revealed close relationships of the two genes between the corresponding genes in fungal endophyte species of the Epichloe genus, suggesting that the genes originated from the Epichloe lineage.	[Watanabe, Yugo; Spangenberg, German C.; Shinozuka, Hiroshi] La Trobe Univ, Ctr AgriBiosci, Agr Victoria, AgriBio, Bundoora, Vic, Australia; [Spangenberg, German C.] La Trobe Univ, Sch Appl Syst Biol, Bundoora, Vic, Australia	La Trobe University; La Trobe University	Shinozuka, H (corresponding author), La Trobe Univ, Ctr AgriBiosci, Agr Victoria, AgriBio, Bundoora, Vic, Australia.	hiroshi.shinozuka@agriculture.vic.gov.au			Agriculture Victoria	Agriculture Victoria	This work was supported by funding from Agriculture Victoria. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrose KV, 2014, SCI REP-UK, V4, DOI 10.1038/srep05562; Atia A, 2011, PLANT BIOLOGY, V13, P541, DOI 10.1111/j.1438-8677.2010.00401.x; Borner J, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3504-1; Comte A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173495; de la Cruz J, 1999, EUR J BIOCHEM, V265, P145, DOI 10.1046/j.1432-1327.1999.00698.x; Dunning LT, 2019, P NATL ACAD SCI USA, V116, P4416, DOI 10.1073/pnas.1810031116; Ghatnekar L, 2006, P ROY SOC B-BIOL SCI, V273, P395, DOI 10.1098/rspb.2005.3355; Hibdige SGS, 2021, NEW PHYTOL, V230, P2474, DOI 10.1111/nph.17328; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Li L, 2017, SCI REP-UK, V7, DOI 10.1038/srep43150; Reichman JR, 2006, MOL ECOL, V15, P4243, DOI 10.1111/j.1365-294X.2006.03072.x; Richards TA, 2009, PLANT CELL, V21, P1897, DOI 10.1105/tpc.109.065805; Rossner R, 2017, J BIOL CHEM, V292, P11138, DOI 10.1074/jbc.R117.779678; Ruiz-Villalba A, 2021, LIFE-BASEL, V11, DOI 10.3390/life11060496; Schardl CL, 2008, SYST BIOL, V57, P483, DOI 10.1080/10635150802172184; Schardl CL, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003323; Schlaich NL, 2007, TRENDS PLANT SCI, V12, P412, DOI 10.1016/j.tplants.2007.08.009; Shinozuka H, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-76478-4; Shinozuka H, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07886-2; Soreng RJ, 2017, J SYST EVOL, V55, P259, DOI 10.1111/jse.12262; Taylor SC, 2019, TRENDS BIOTECHNOL, V37, P761, DOI 10.1016/j.tibtech.2018.12.002; Vallenback P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013529; Wang HW, 2020, SCIENCE, V368, P844, DOI 10.1126/science.aba5435; Weber E., 2003, INVASIVE PLANT SPECI; Xiao G Z, 2016, Genet Mol Res, V15, DOI 10.4238/gmr15049034; Yang ZZ, 2016, P NATL ACAD SCI USA, V113, pE7010, DOI 10.1073/pnas.1608765113; Yoshida S, 2010, SCIENCE, V328, P1128, DOI 10.1126/science.1187145	27	0	0	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2021	16	9							e0257173	10.1371/journal.pone.0257173	http://dx.doi.org/10.1371/journal.pone.0257173			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XM9EM	34506557	Green Published, gold			2022-12-26	WOS:000729120700099
J	Fenton, BA; Tomberg, J; Sciandra, CA; Nicholas, RA; Davies, C; Zhou, P				Fenton, Benjamin A.; Tomberg, Joshua; Sciandra, Carly A.; Nicholas, Robert A.; Davies, Christopher; Zhou, Pei			Mutations in PBP2 from ceftriaxone-resistant Neisseria gonorrhoeae alter the dynamics of the beta 3-beta 4 loop to favor a low-affinity drug-binding state	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXPANDED-SPECTRUM CEPHALOSPORINS; HIGH-LEVEL RESISTANCE; TREATMENT GUIDELINES; FUSION TECHNOLOGY; PROTEIN-2; STRAINS; EXPRESSION; SYSTEMS; GENE; SUMO	Resistance to the extended-spectrum cephalosporin ceftriaxone in the pathogenic bacteria Neisseria gonorrhoeae is conferred by mutations in penicillin-binding protein 2 (PBP2), the lethal target of the antibiotic, but how these mutations exert their effect at the molecular level is unclear. Using solution NMR, X-ray crystallography, and isothermal titration calorimetry, we report that WT PBP2 exchanges dynamically between a low-affinity state with an extended beta 3-beta 4 loop conformation and a high-affinity state with an inward beta 3-beta 4 loop conformation. Histidine-514, which is located at the boundary of the beta 4 strand, plays an important role during the exchange between these two conformational states. We also find that mutations present in PBP2 from H041, a ceftriaxone-resistant strain of N. gonorrhoeae, increase resistance to ceftriaxone by destabilizing the inward beta 3-beta 4 loop conformation or stabilizing the extended beta 3-beta 4 loop conformation to favor the low-affinity drug-binding state. These observations reveal a unique mechanism for ceftriaxone resistance, whereby mutations in PBP2 lower the proportion of target molecules in the high-affinity drug-binding state and thus reduce inhibition at lower drug concentrations.	[Fenton, Benjamin A.; Sciandra, Carly A.; Zhou, Pei] Duke Univ, Sch Med, Dept Biochem, Durham, NC 27708 USA; [Tomberg, Joshua; Nicholas, Robert A.] Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27515 USA; [Tomberg, Joshua; Nicholas, Robert A.] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27515 USA; [Davies, Christopher] Med Univ South Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA; [Davies, Christopher] Univ S Alabama, Dept Biochem & Mol Biol, Mobile, AL 36688 USA	Duke University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Medical University of South Carolina; University of South Alabama	Zhou, P (corresponding author), Duke Univ, Sch Med, Dept Biochem, Durham, NC 27708 USA.; Nicholas, RA (corresponding author), Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27515 USA.; Nicholas, RA (corresponding author), Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27515 USA.; Davies, C (corresponding author), Med Univ South Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA.; Davies, C (corresponding author), Univ S Alabama, Dept Biochem & Mol Biol, Mobile, AL 36688 USA.	nicholas@med.unc.edu; cdavies@southalabama.edu; peizhou@biochem.duke.edu		Nicholas, Robert/0000-0003-2507-8974; Davies, Christopher/0000-0002-6687-4064; Zhou, Pei/0000-0002-7823-3416				Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Bignell C, 2013, INT J STD AIDS, V24, P85, DOI 10.1177/0956462412472837; Cai YF, 2014, J CHEM THEORY COMPUT, V10, P3438, DOI 10.1021/ct4010454; Cauet E, 2005, J CHEM THEORY COMPUT, V1, P472, DOI 10.1021/ct049875k; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Eyre DW, 2018, EUROSURVEILLANCE, V23, P2, DOI 10.2807/1560-7917.ES.2018.23.27.1800323; Fedarovich A, 2014, BIOCHEMISTRY-US, V53, P7596, DOI 10.1021/bi5011317; Hare S, 2010, P NATL ACAD SCI USA, V107, P20057, DOI 10.1073/pnas.1010246107; Hill SA, 2016, MICROB CELL, V3, P371, DOI 10.15698/mic2016.09.524; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Lisi GP, 2016, PROG NUCL MAG RES SP, V92-93, P1, DOI 10.1016/j.pnmrs.2015.11.001; Liu JJ, 2012, SCIENCE, V335, P1106, DOI 10.1126/science.1215802; Macheboeuf P, 2006, FEMS MICROBIOL REV, V30, P673, DOI 10.1111/j.1574-6976.2006.00024.x; Marblestone JG, 2006, PROTEIN SCI, V15, P182, DOI 10.1110/ps.051812706; Moriarty NW, 2009, ACTA CRYSTALLOGR D, V65, P1074, DOI 10.1107/S0907444909029436; Newman L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143304; Ohnishi M, 2011, ANTIMICROB AGENTS CH, V55, P3538, DOI 10.1128/AAC.00325-11; Ohnishi M, 2011, EMERG INFECT DIS, V17, P148, DOI 10.3201/eid1701.100397; Panavas Tadas, 2009, V497, P303, DOI 10.1007/978-1-59745-566-4_20; Powell AJ, 2009, J BIOL CHEM, V284, P1202, DOI 10.1074/jbc.M805761200; Rani S, 2022, SPAT INF RES, V30, P417, DOI 10.1007/s41324-022-00442-9; Sauvage E, 2008, FEMS MICROBIOL REV, V32, P234, DOI 10.1111/j.1574-6976.2008.00105.x; Seckler JM, 2013, PROTEINS, V81, P1792, DOI 10.1002/prot.24325; Shaw DJ, 2017, CHEM SCI, V8, P8384, DOI 10.1039/c7sc03336b; Singh A, 2020, J BIOL CHEM, V295, P7529, DOI 10.1074/jbc.RA120.012617; Singh A, 2019, J BIOL CHEM, V294, P14020, DOI 10.1074/jbc.RA119.009942; SPRATT BG, 1988, NATURE, V332, P173, DOI 10.1038/332173a0; St Cyr S, 2020, MMWR-MORBID MORTAL W, V69, P1911, DOI 10.15585/mmwr.mm6950a6; Tomberg J, 2013, ANTIMICROB AGENTS CH, V57, P3029, DOI 10.1128/AAC.00093-13; Tomberg J, 2010, BIOCHEMISTRY-US, V49, P8062, DOI 10.1021/bi101167x; Turnbull WB, 2003, J AM CHEM SOC, V125, P14859, DOI 10.1021/ja036166s; Unemo M, 2019, SEX HEALTH, V16, P412, DOI 10.1071/SH19023; Whiley DM, 2018, LANCET INFECT DIS, V18, P717, DOI 10.1016/S1473-3099(18)30340-2; Xie T, 2020, SCIENCE, V370, P189, DOI 10.1126/science.abc2754; Ye LB, 2015, J BIOMOL NMR, V62, P97, DOI 10.1007/s10858-015-9922-y; Zhao SQ, 2009, ANTIMICROB AGENTS CH, V53, P3744, DOI 10.1128/AAC.00304-09	37	2	2	0	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT	2021	297	4							101188	10.1016/j.jbc.2021.101188	http://dx.doi.org/10.1016/j.jbc.2021.101188			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	YZ2PR	34529975	Green Published, gold			2022-12-26	WOS:000755323700015
J	Karan, YB; Sanli, OG				Karan, Yasin Bedrettin; Sanli, Ozlem Gultekin			The assessment of yield and quality traits of sweet potato (Ipomoea batatas L.) genotypes in middle Black Sea region, Turkey	PLOS ONE			English	Article							PHENOLIC-COMPOUNDS; ANTHOCYANINS; STRESS; GROWTH	Sweet potato (Ipomoea batatas L.) cultivation in Turkey is concentrated in one province situated in Mediterranean region only, which would not fulfill the domestic needs of the country soon. Therefore, cultivation of the crop in other provinces/climatic regions should be initiated to fulfill the domestic needs. The cultivation in other provinces requires thorough assessment of yield and quality traits of target crop. Therefore, yield and quality characteristics of four sweet potato genotypes (i.e., 'Hatay Krmzs', 'Hatay Yerlisi', 'Havuc' and 'Kalem') were assessed in the current study in Kazova and Niksar counties of Tokat province of the country having middle Black Sea climate in field experiments during 2018 and 2019. The cuttings of the genotypes were planted in Niksar during the second fortnight of April and first week of May in Kazova. The planting density was kept 90 x 45 cm. Data relating to number of storage roots, storage root weight, storage root yield per hill and storage root yield per hectare were recorded. Furthermore, quality traits, including dry matter ratio (%), protein ratio (%) and antioxidant ratio (%) of storage roots were also determined. The highest total storage root yield was recorded for 'Havuc' genotype during both years and locations, followed by 'Hatay Yerlisi' and 'Hatay Krmzs' genotypes. Overall, storage root yield (60.06 and 62.40 tons ha(-1) during first and second year) recorded for the experiment at Niksar was higher than the storage root yield recorded for Kazova experiment (53.50 and 52.84 tons ha(-1) during first and second year, respectively). The highest dry matter was produced by 'Kalem' and 'Hatay Yerlisi' genotypes during both years and at both locations, followed by 'Hatay Krmzs' and 'Havuc' genotypes. The storage roots of the tested genotypes accumulated higher dry matter at Kazova during both years. The highest protein content was obtained from the 'Kalem' genotype, and the protein contents of the 'Hatay Yerlisi' and 'Hatay Krmzs' genotypes were close to the 'Kalem' genotype. The results indicated that tested genotypes can successfully be cultivated in middle Black Sea climate. Therefore, production of sweet potato can be initiated in the future to meet the domestic needs for sweet potato in the country.	[Karan, Yasin Bedrettin; Sanli, Ozlem Gultekin] Tokat Gaziosmanpasa Univ, Fac Agr, Field Crops Dept, Tokat, Turkey	Gaziosmanpasa University	Karan, YB (corresponding author), Tokat Gaziosmanpasa Univ, Fac Agr, Field Crops Dept, Tokat, Turkey.	yasinb.karan@gop.edu.tr			Tokat Governorship Secretary General of Special Provincial Administration	Tokat Governorship Secretary General of Special Provincial Administration	The authors gratefully thank Tokat Governorship Secretary General of Special Provincial Administration for financial support of the project (Determining the Adaptation of Some Sweet Potato Genotypes in Tokat Conditions). There were no additional external funding involved in the study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adebola P. O., 2013, Journal of Plant Breeding and Crop Science, V5, P182; Afuape S. O., 2011, African Journal of Plant Science, V5, P123; Arslanoglu F, 2011, AFR J BIOTECHNOL, V10, P922; BLOIS MS, 1958, NATURE, V181, P1199, DOI 10.1038/1811199a0; Bovell-Benjamin AC, 2007, ADV FOOD NUTR RES, V52, P1, DOI 10.1016/S1043-4526(06)52001-7; Brohi AR., 1991, FERTILIZERS FERTILIZ, V10, P880; Caliskan ME., 2001, TURK 4 FIELD CROPS C; Caliskan ME., 2011, TURK 4 SEED C SAMS; Caliskan ME, 2007, TURK J AGRIC FOR, V31, P213; Cevallos-Casals BA, 2003, J AGR FOOD CHEM, V51, P3313, DOI 10.1021/jf034109c; Duman M., 2020, TURKEY INT J AGR ENV, DOI [10.14445/23942568/ijaes-v7i1p104, DOI 10.14445/23942568/IJAES-V7I1P104]; Geren H., 2010, Ege Universitesi Ziraat Fakultesi Dergisi, V47, P171; Gruneberg WJ, 2005, CROP SCI, V45, P2160, DOI 10.2135/cropsci2003.0533; Gurmu F, 2017, OPEN AGRIC, V2, P473, DOI 10.1515/opag-2017-0052; IBM C IBM SPSS Inc, 2012, SPSS STAT WIND; Islam J., 2002, PAKISTAN J BIOL SCI, V5, P537; Ji Hua, 2015, Food and Nutrition Sciences, V6, P161, DOI 10.4236/fns.2015.61017; Karan T., 2018, WORLD J PHARM RES, V7, P1123; Karar H, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0236340; Kosieradzka I, 2004, J ANIM FEED SCI, V13, P87; Laban TF., 2015, GLOB J SCI FRONT RES, V15, P25; Laurie SM, 2015, EUPHYTICA, V204, P433, DOI 10.1007/s10681-015-1359-6; Lestari S. U., 2019, Journal of Degraded and Mining Lands Management, V6, P1763; Lewthwaite S. L., 2012, Agronomy New Zealand, V42, P1; MAITY S, 1977, POTATO RES, V20, P337, DOI 10.1007/BF02362245; Manrique K., 2000, EFFECT GXE INTERACTI, P281; Martin FW., 1988, 1 PLANN C EXPL MAINT; Musembi KB, 2015, EUPHYTICA, V201, P423, DOI 10.1007/s10681-014-1230-1; Mutlu C, 2020, PHYTOPARASITICA, V48, P191, DOI 10.1007/s12600-020-00785-9; Mwanga ROM, 2016, HORTSCIENCE, V51, P291, DOI 10.21273/HORTSCI.51.3.291; Mwanga ROM, 2011, HORTSCIENCE, V46, P317, DOI 10.21273/HORTSCI.46.2.317; Mwanga ROM, 2009, HORTSCIENCE, V44, P828, DOI 10.21273/HORTSCI.44.3.828; Nakitandwe J., 2005, African Crop Science Journal, V13, P107; Nedunchezhiyan M., 2007, J ROOT CROP, V33, P26; Ngailo S, 2019, HELIYON, V5, DOI 10.1016/j.heliyon.2019.e01448; NGEVE JM, 1992, TROP AGR, V69, P43; Nhanala SEC, 2021, CROP SCI, V61, P234, DOI 10.1002/csc2.20363; Oduro, 2013, GENETIC CONTROL SUGA; Oki T, 2002, J FOOD SCI, V67, P1752, DOI 10.1111/j.1365-2621.2002.tb08718.x; Ozturk G, 2021, TURK J FIELD CROPS, V26, P54, DOI 10.17557/tjfc.943571; Rabah IO, 2004, J AGR FOOD CHEM, V52, P7152, DOI 10.1021/jf049368w; Reddy R., 2018, Indian Journal of Agricultural Research, V52, P46, DOI 10.18805/IJARe.A-4798; Rukundo P., 2013, Australian Journal of Crop Science, V7, P2054; SHAPIRO SS, 1965, BIOMETRIKA, V52, P591, DOI 10.2307/2333709; Shih PH, 2007, J AGR FOOD CHEM, V55, P9427, DOI 10.1021/jf071933i; Shumbusha D, 2014, HORTSCIENCE, V49, P1349, DOI 10.21273/HORTSCI.49.10.1349; Steel R. G. D., 1980, Principles and procedures of statistics, a biometrical approach.; Teow CC, 2007, FOOD CHEM, V103, P829, DOI 10.1016/j.foodchem.2006.09.033; Wariboko C., 2014, African Journal of Environmental Science and Technology, V8, P48; Woolfe J.A., 1992, SWEET POTATO UNTAPPE, DOI 10.5860/choice.30-2081; Yildirim Z, 2011, TURK J FIELD CROPS, V16, P48	51	1	1	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2021	16	9							e0257703	10.1371/journal.pone.0257703	http://dx.doi.org/10.1371/journal.pone.0257703			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	WG6BN	34543362	Green Published, gold			2022-12-26	WOS:000707078200075
J	Marquez, C; Kerkhoff, AD; Naso, J; Contreras, MG; Diaz, EC; Rojas, S; Peng, J; Rubio, L; Jones, D; Jacobo, J; Rojas, S; Gonzalez, R; Fuchs, JD; Black, D; Ribeiro, S; Nossokoff, J; Tulier-Laiwa, V; Martinez, J; Chamie, G; Pilarowski, G; DeRisi, J; Petersen, M; Havlir, DV				Marquez, Carina; Kerkhoff, Andrew D.; Naso, Jamie; Contreras, Maria G.; Diaz, Edgar Castellanos; Rojas, Susana; Peng, James; Rubio, Luis; Jones, Diane; Jacobo, Jon; Rojas, Susy; Gonzalez, Rafael; Fuchs, Jonathan D.; Black, Douglas; Ribeiro, Salustiano; Nossokoff, Jen; Tulier-Laiwa, Valerie; Martinez, Jacqueline; Chamie, Gabriel; Pilarowski, Genay; DeRisi, Joseph; Petersen, Maya; Havlir, Diane, V			A multi-component, community-based strategy to facilitate COVID-19 vaccine uptake among Latinx populations: From theory to practice	PLOS ONE			English	Article							KNOWLEDGE; HESITANCY; IMPACT	Background COVID-19 vaccine coverage in the Latinx community depends on delivery systems that overcome barriers such as institutional distrust, misinformation, and access to care. We hypothesized that a community-centered vaccination strategy that included mobilization, vaccination, and "activation" components could successfully reach an underserved Latinx population, utilizing its social networks to boost vaccination coverage. Methods Our community-academic-public health partnership, "Unidos en Salud," utilized a theory-informed approach to design our "Motivate, Vaccinate, and Activate" COVID-19 vaccination strategy. Our strategy's design was guided by the PRECEDE Model and sought to address and overcome predisposing, enabling, and reinforcing barriers to COVID-19 vaccination faced by Latinx individuals in San Francisco. We evaluated our prototype outdoor, "neighborhood" vaccination program located in a central commercial and transport hub in the Mission District in San Francisco, using the Reach, Effectiveness, Adoption, Implementation and Maintenance (RE-AIM) framework during a 16-week period from February 1, 2021 to May 19, 2021. Programmatic data, city-wide COVID-19 surveillance data, and a survey conducted between May 2, 2021 and May 19, 2021 among 997 vaccinated clients >= 16 years old were used in the evaluation. Results There were 20,792 COVID-19 vaccinations administered at the neighborhood site during the 16-week evaluation period. Vaccine recipients had a median age of 43 (IQR 32-56) years, 53.9% were male and 70.5% were Latinx, 14.1% white, 7.7% Asian, 2.4% Black, and 5.3% other. Latinx vaccinated clients were substantially more likely than non-Latinx clients to have an annual household income of less than $50,000 a year (76.1% vs. 33.5%), be a first-generation immigrant (60.2% vs. 30.1%), not have health insurance (47.3% vs. 16.0%), and not have access to primary care provider (62.4% vs. 36.2%). The most frequently reported reasons for choosing vaccination at the site were its neighborhood location (28.6%), easy and convenient scheduling (26.9%) and recommendation by someone they trusted (18.1%); approximately 99% reported having an overall positive experience, regardless of ethnicity. Notably, 58.3% of clients reported that they were able to get vaccinated earlier because of the neighborhood vaccination site, 98.4% of clients completed both vaccine doses, and 90.7% said that they were more likely to recommend COVID-19 vaccination to family and friends after their experience; these findings did not substantially differ according to ethnicity. There were 40.3% of vaccinated clients who said they still knew at least one unvaccinated person (64.6% knew >= 3). Among clients who received both vaccine doses (n = 729), 91.0% said that after their vaccination experience, they had personally reached out to at least one unvaccinated person they knew (61.6% reached out to >= 3) to recommend getting vaccinated; 83.0% of clients reported that one or more friends, and/or family members got vaccinated as a result of their outreach, including 18.9% who reported 6 or more persons got vaccinated as a result of their influence. Conclusions A multi-component, "Motivate, Vaccinate, and Activate" community-based strategy addressing barriers to COVID-19 vaccination for the Latinx population reached the intended population, and vaccinated individuals served as ambassadors to recruit other friends and family members to get vaccinated.	[Marquez, Carina; Kerkhoff, Andrew D.; Peng, James; Rubio, Luis; Black, Douglas; Chamie, Gabriel; Havlir, Diane, V] Univ Calif San Francisco, Zuckerberg San Francisco Gen Hosp, Div HIV Infect Dis & Global Med, San Francisco, CA 94143 USA; [Marquez, Carina; Kerkhoff, Andrew D.; Peng, James; Rubio, Luis; Black, Douglas; Chamie, Gabriel; Havlir, Diane, V] Univ Calif San Francisco, Trauma Ctr, San Francisco, CA 94143 USA; [Naso, Jamie; Contreras, Maria G.; Diaz, Edgar Castellanos; Jones, Diane; Martinez, Jacqueline] Unidos Salud, San Francisco, CA USA; [Contreras, Maria G.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Contreras, Maria G.; Diaz, Edgar Castellanos] Clin Martin Baro, San Francisco, CA USA; [Contreras, Maria G.; Rojas, Susana; Jacobo, Jon; Rojas, Susy; Tulier-Laiwa, Valerie] San Francisco Latino Task Force Response COVID 19, San Francisco, CA USA; [Diaz, Edgar Castellanos] Univ Calif San Francisco, Dept Radiol & Biomed Imaging, San Francisco, CA 94143 USA; [Gonzalez, Rafael; Fuchs, Jonathan D.] San Francisco Dept Publ Hlth, San Francisco, CA USA; [Ribeiro, Salustiano; Nossokoff, Jen] Bay Area Phlebot & Lab Serv BayPLS, San Francisco, CA USA; [Pilarowski, Genay] Stanford Univ, Dept Pathol, Stanford, CA 94305 USA; [DeRisi, Joseph] Chan Zuckerberg Biohub, San Francisco, CA USA; [DeRisi, Joseph] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA USA; [Petersen, Maya] Univ Calif Berkeley, Sch Publ Hlth, Div Epidemiol & Biostat, Berkeley, CA 94720 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; San Francisco Department of Public Health; Stanford University; University of California System; University of California San Francisco; University of California System; University of California Berkeley	Marquez, C (corresponding author), Univ Calif San Francisco, Zuckerberg San Francisco Gen Hosp, Div HIV Infect Dis & Global Med, San Francisco, CA 94143 USA.; Marquez, C (corresponding author), Univ Calif San Francisco, Trauma Ctr, San Francisco, CA 94143 USA.	Carina.Marquez@ucsf.edu		Marquez, Carina/0000-0002-7622-6562	University of California, San Francisco; Chan Zuckerberg Initiative; San Francisco Department of Public Health;  [T32 AI060530]	University of California, San Francisco(University of California System); Chan Zuckerberg Initiative; San Francisco Department of Public Health; 	This work was supported by University of California, San Francisco (http://www.ucsf.edu), the Chan Zuckerberg Initiative (https://urldefense.com/v3/__https://chanzuckerberg.com__;!!LQC6C pwp!_kOZyaVmp6cASxENUlQH2bpstcBdps63uoc YYCdsMxaO5vd9CxrZckurtdxZ0dDkrqqPlw$), and the San Francisco Department of Public Health. A. D.K and L.R. was funded by T32 AI060530. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdul-Mutakabbir JC., 2021, LANCET GLOBAL HEAL, V9, P749, DOI [10.1016/S2214-109X%2821%2900099-1, DOI 10.1016/S2214-109X%2821%2900099-1]; [Anonymous], 2020, SAN FRANCISCO LATINO; Baden LR, 2021, NEW ENGL J MED, V384, P403, DOI 10.1056/NEJMoa2035389; Banerjee AV, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2220; Benenson S, 2021, NEW ENGL J MED, V384, P1775, DOI 10.1056/NEJMc2101951; Bibbins-Domingo Kirsten, 2021, JAMA Health Forum, V2, pe210213, DOI 10.1001/jamahealthforum.2021.0213; Cabanatuan M, 2021, SAN FRANCISCO CHRONI; California Department of Public Health, VACC PROGR DAT COR C; Census Reporter, ZIP COD TAB AR 94110; Chamie G, 2021, CLIN INFECT DIS, V73, pS127, DOI 10.1093/cid/ciaa1234; Drahota A, 2016, MILBANK Q, V94, P163, DOI 10.1111/1468-0009.12184; Fields J., 2021, NEJM CATAL; Fisher EB, 2015, HEALTH AFFAIR, V34, P1523, DOI 10.1377/hlthaff.2015.0365; Funnell MM, 2010, FAM PRACT, V27, pI17, DOI 10.1093/fampra/cmp027; Gil RM, 2020, J INFECT DIS, V222, P1592, DOI 10.1093/infdis/jiaa474; Glasgow RE, 2019, FRONT PUBLIC HEALTH, V7, DOI 10.3389/fpubh.2019.00064; Gottvall M, 2010, INT J STD AIDS, V21, P558, DOI 10.1258/ijsa.2010.010063; Haas EJ, 2021, LANCET, V397, P1819, DOI 10.1016/S0140-6736(21)00947-8; Hunter RF, 2019, PLOS MED, V16, DOI 10.1371/journal.pmed.1002890; Jarrett C, 2015, VACCINE, V33, P4180, DOI 10.1016/j.vaccine.2015.04.040; Kaiser Family Foundation, 2021, KFF COV 19 VACC MON; Kerkhoff AD, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0239400; Kriss JL, 2021, MMWR-MORBID MORTAL W, V70, P389, DOI 10.15585/mmwr.mm7011e2; Kullar R, 2020, J INFECT DIS, V222, P890, DOI 10.1093/infdis/jiaa372; MacDonald NE, 2015, VACCINE, V33, P4161, DOI 10.1016/j.vaccine.2015.04.036; Marcelin JR., 2021, OPEN FORUM INFECT DI, DOI [10.1093/ofid/ofab417, DOI 10.1093/OFID/OFAB417]; Martinez O, 2015, J IMMIGR MINOR HEALT, V17, P947, DOI 10.1007/s10903-013-9968-4; McNamara D, 2021, MEDSCAPE MED NEWS; Medicine NA of S Engineering, 2021, STRATEGIES BUILDING; Morey BN, 2018, AM J PUBLIC HEALTH, V108, P460, DOI [10.2105/ajph.2017.304266, 10.2105/AJPH.2017.304266]; Ndugga N., LATEST DATA COVID 19; Nuriddin A, 2020, LANCET, V396, P949, DOI 10.1016/S0140-6736(20)32032-8; Peng J, 2021, OPEN FORUM INFECT DI, V8, DOI 10.1093/ofid/ofab202; Peterson P, 2019, PUBLIC HEALTH REP, V134, P241, DOI 10.1177/0033354919834579; Pilarowski G, 2021, J INFECT DIS, V223, P1139, DOI 10.1093/infdis/jiaa802; Polack FP, 2020, NEW ENGL J MED, V383, P2603, DOI 10.1056/NEJMoa2034577; Porter CM, 2016, HEALTH EDUC J, V75, P753, DOI 10.1177/0017896915619645; Prevention C for DC and, MMWR MORB MORTAL WKL, P1; Rodriguez-Diaz CE, 2020, ANN EPIDEMIOL, V52, P46, DOI 10.1016/j.annepidem.2020.07.007; Rubio Luis A, 2021, Open Forum Infect Dis, V8, pofab023, DOI 10.1093/ofid/ofab023; Saadi A, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.3028; San Francisco Department of Public Health, COVID 19 DAT REP; Shelton RC, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00134; Spleen AM, 2012, J CANCER EDUC, V27, P312, DOI 10.1007/s13187-011-0294-z; Urban Displacement Project, 2018, RIS HOUS COSTS RES S; Vavreck L, 2021, NEW YORK TIMES; Hooper MW, 2021, J GEN INTERN MED, V36, P2130, DOI 10.1007/s11606-021-06698-5; Weiland N, 2021, NEW YORK TIMES; Williams DR, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16040606; Zaveri M, 2021, NEW YORK TIMES; Zhang Y., 1999, AM ECON REV, V5, P51	51	18	18	3	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2021	16	9							e0257111	10.1371/journal.pone.0257111	http://dx.doi.org/10.1371/journal.pone.0257111			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	WG6BN	34543291	Green Published, gold, Green Submitted			2022-12-26	WOS:000707078200021
J	Andleeb, S; Abbasi, WA; Mustafa, RG; Ul Islam, G; Naseer, A; Shafique, I; Parween, A; Shaheen, B; Shafiq, M; Altaf, M; Abbas, SA				Andleeb, Saiqa; Abbasi, Wajid Arshad; Mustafa, Rozina Ghulam; Ul Islam, Ghafoor; Naseer, Anum; Shafique, Irsa; Parween, Asma; Shaheen, Bushra; Shafiq, Muhamad; Altaf, Muhammad; Abbas, Syed Ali			ESIDE: A computationally intelligent method to identify earthworm species (E. fetida) from digital images: Application in taxonomy	PLOS ONE			English	Article							BINDING-AFFINITY; EISENIA-FOETIDA; LUMBRICIDAE; OLIGOCHAETA; SEQUENCES; RDNA; 16S; 18S	Earthworms (Crassiclitellata) being ecosystem engineers significantly affect the physical, chemical, and biological properties of the soil by recycling organic material, increasing nutrient availability, and improving soil structure. The efficiency of earthworms in ecology varies along with species. Therefore, the role of taxonomy in earthworm study is significant. The taxonomy of earthworms cannot reliably be established through morphological characteristics because the small and simple body plan of the earthworm does not have anatomical complex and highly specialized structures. Recently, molecular techniques have been adopted to accurately classify the earthworm species but these techniques are time-consuming and costly. To combat this issue, in this study, we propose a machine learning-based earthworm species identification model that uses digital images of earthworms. We performed a stringent performance evaluation not only through 10-fold cross-validation and on an external validation dataset but also in real settings by involving an experienced taxonomist. In all the evaluation settings, our proposed model has given state-of-the-art performance and justified its use to aid earthworm taxonomy studies. We made this model openly accessible through a cloud-based webserver and python code available at https://sites.google.com/view/wajidarshad/software and https://github.com/wajidarshad/ESIDE.	[Andleeb, Saiqa; Mustafa, Rozina Ghulam; Ul Islam, Ghafoor; Naseer, Anum; Shafique, Irsa; Parween, Asma; Shaheen, Bushra] Univ Azad Jammu & Kashmir, Dept Zool, Biotechnol Lab, King Abdullah Campus, Muzaffarabad, AJ&K, Pakistan; [Abbasi, Wajid Arshad; Abbas, Syed Ali] Univ Azad Jammu & Kashmir, Dept Comp Sci & Informat Technol, Computa Biol & Data Anal Lab, King Abdullah Campus, Muzaffarabad, AJ&K, Pakistan; [Shafiq, Muhamad] Govt Azad Jammu & Kashmir, Environm Protect Agcy AJK EPA, Muzaffarabad, AJ&K, Pakistan; [Altaf, Muhammad] Islamia Univ Bahawalpur, Dept Forestry Range & Wildlife Management, Bahawalpur, Pakistan	University of Azad Jammu & Kashmir; University of Azad Jammu & Kashmir; Islamia University of Bahawalpur	Abbasi, WA (corresponding author), Univ Azad Jammu & Kashmir, Dept Comp Sci & Informat Technol, Computa Biol & Data Anal Lab, King Abdullah Campus, Muzaffarabad, AJ&K, Pakistan.	wajidarshad@gmail.com	Andleeb, Saiqa/J-1016-2019; Abbasi, Wajid Arshad/I-6594-2019	Andleeb, Saiqa/0000-0001-7888-6444; Abbasi, Wajid Arshad/0000-0001-7691-5715	Higher Education Commission (HEC) of Pakistan [NRPU-2907, TDF-02006]	Higher Education Commission (HEC) of Pakistan(Higher Education Commission of Pakistan)	Saiqa Andleeb acknowledges the support of the Higher Education Commission (HEC) of Pakistan for granting research projects under the National Research Program for Universities (NRPU) and Technology Development Fund (TDF) (Grant ids: NRPU-2907 & TDF-02006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbasi WA., 2017, ISLAND SILICO PREDIC; Abbasi WA, 2016, J BIOINF COMPUT BIOL, V14, DOI 10.1142/S0219720016500116; Andleeb S, 2016, PAK J PHARM SCI, V29, P969; Andrew Zisserman, 2015, Arxiv, DOI arXiv:1409.1556; Ballester PJ, 2010, BIOINFORMATICS, V26, P1169, DOI 10.1093/bioinformatics/btq112; Belliturk K, 2016, VERMICOMPOSTING TECH; Bergstra J, 2012, J MACH LEARN RES, V13, P281; Bonkowski M, 2000, PEDOBIOLOGIA, V44, P666, DOI 10.1078/S0031-4056(04)70080-3; Boyer S, 2010, ZOOL MIDDLE EAST, P31; Bradski G., 2008, LEARNING OPENCV COMP; Breiman L., 2001, MACH LEARN, V45, P5; Chandra TB, 2021, EXPERT SYST APPL, V165, DOI 10.1016/j.eswa.2020.113909; Chen TQ, 2016, KDD'16: PROCEEDINGS OF THE 22ND ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P785, DOI 10.1145/2939672.2939785; Chollet F, 2017, PROC CVPR IEEE, P1800, DOI 10.1109/CVPR.2017.195; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Dalal N, 2005, PROC CVPR IEEE, P886, DOI 10.1109/cvpr.2005.177; Davis J., 2006, P 23 INT C MACH LEAR, P233, DOI [10.1145/1143844.1143874, DOI 10.1145/1143844.1143874]; Deng J, 2009, PROC CVPR IEEE, P248, DOI 10.1109/CVPRW.2009.5206848; Dominguez J, 2005, PEDOBIOLOGIA, V49, P81, DOI 10.1016/j.pedobi.2004.08.005; Dominguez J, 2012, MANAG ORG WASTE, DOI [10.5772/33874, DOI 10.5772/33874]; Edwards CA, 2021, BIOL ECOLOGY EARTHWO, V4th ed.; Friedman JH, 2001, ANN STAT, V29, P1189, DOI 10.1214/aos/1013203451; He K., 2016, CVPR, P770; Huang G, 2017, PROC CVPR IEEE, P2261, DOI 10.1109/CVPR.2017.243; HUMMEL R, 1977, COMPUT VISION GRAPH, V6, P184, DOI 10.1016/S0146-664X(77)80011-7; Krizaj J, 2010, LECT NOTES COMPUT SC, V6111, P394, DOI 10.1007/978-3-642-13772-3_40; Li HJ, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-291; Matausic-Pisl M, 2011, EUR REV MED PHARMACO, V15, P71; Moal IH, 2011, BIOINFORMATICS, V27, P3002, DOI 10.1093/bioinformatics/btr513; Ojala T, 1996, PATTERN RECOGN, V29, P51, DOI 10.1016/0031-3203(95)00067-4; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Perez-Losada M, 2009, MOL PHYLOGENET EVOL, V52, P293, DOI 10.1016/j.ympev.2009.04.003; Pop AA, 2003, PEDOBIOLOGIA, V47, P428, DOI 10.1016/S0031-4056(04)70217-6; Pop AA, 2007, EUR J SOIL BIOL, V43, pS43, DOI 10.1016/j.ejsobi.2007.08.007; Rodriguez-Fdez I, 2015, IEEE INT FUZZY SYST; Singh S, 2017, 2017 5TH INTERNATIONAL SYMPOSIUM ON COMPUTATIONAL AND BUSINESS INTELLIGENCE (ISCBI), P20, DOI 10.1109/ISCBI.2017.8053537; Szegedy C, 2016, PROC CVPR IEEE, P2818, DOI 10.1109/CVPR.2016.308; Tabak MA, 2019, METHODS ECOL EVOL, V10, P585, DOI 10.1111/2041-210X.13120; Tharwat A., 2018, APPL COMPUT INFORM, V17, P168, DOI [10.1016/j.aci.2018.08.003, DOI 10.1016/J.ACI.2018.08.003]; Tola E, 2010, IEEE T PATTERN ANAL, V32, P815, DOI 10.1109/TPAMI.2009.77; van der Walt S, 2014, PEERJ, V2, DOI 10.7717/peerj.453; Viola P, 2001, PROC CVPR IEEE, P511, DOI 10.1109/cvpr.2001.990517; Waldchen J, 2018, METHODS ECOL EVOL, V9, P2216, DOI 10.1111/2041-210X.13075; Zoph B, 2018, PROC CVPR IEEE, P8697, DOI 10.1109/CVPR.2018.00907	44	2	2	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2021	16	9							e0255674	10.1371/journal.pone.0255674	http://dx.doi.org/10.1371/journal.pone.0255674			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	WG5YY	34529673	gold, Green Published			2022-12-26	WOS:000707071500009
J	Ho, JPTF; Donders, HCM; Zhou, N; Schipper, K; Su, N; de Lange, J				Ho, J. P. T. F.; Donders, H. C. M.; Zhou, N.; Schipper, K.; Su, N.; de Lange, J.			Association between the degree of obstructive sleep apnea and the severity of COVID-19: An explorative retrospective cross-sectional study	PLOS ONE			English	Article							RISK	Obstructive sleep apnea (OSA) on its own, as well as its risk factors, have been found to be associated with the outcome of Coronavirus disease 2019 (COVID-19). However, the association between the degree of OSA and COVID-19 severity is unclear. Therefore, the aim of the study was to evaluate whether or not parameters to clinically evaluate OSA severity and the type of OSA treatment are associated with COVID-19 severity. Patient data from OSA patients diagnosed with COVID-19 were reviewed from outpatients from the Isala Hospital and patients admitted to the Isala Hospital, starting from March until December 2020. Baseline patient data, sleep study parameters, OSA treatment information and hospital admission data were collected. Apnea hypopnea index (AHI), low oxyhemoglobin desaturation (LSAT), oxygen desaturation index (ODI), respiratory disturbance index (RDI), and the type of OSA treatment were regarded as the independent variables. COVID-19 severity-based on hospital or intensive care unit (ICU) admission, the number of days of hospitalization, and number of intubation and mechanical ventilation days-were regarded as the outcome variables. Multinomial regression analysis, binary logistic regression analysis, and zero-inflated negative binomial regression analysis were used to assess the association between the parameters to clinically evaluate OSA severity and COVID-19 severity. A total of 137 patients were included. Only LSAT was found to be significantly associated with the COVID-19 severity (p<0.05) when COVID-19 severity was dichotomized as non-hospitalized or hospitalized and ICU admission or death. Therefore, our findings showed that LSAT seems to be a significant risk factor for COVID-19 severity. However, the degree of OSA-based on AHI, ODI, and RDI-and OSA treatment were not found to be risk factors for COVID-19 severity when looking at hospital or ICU admission, the number of days of hospitalization, and number of intubation and mechanical ventilation days.	[Ho, J. P. T. F.; Donders, H. C. M.; Zhou, N.; de Lange, J.] Univ Amsterdam, Amsterdam UMC, Dept Oral & Maxillofacial Surg, Amsterdam, Netherlands; [Ho, J. P. T. F.; Donders, H. C. M.; Zhou, N.; de Lange, J.] Univ Amsterdam, Acad Ctr Dent Amsterdam ACTA, Amsterdam, Netherlands; [Ho, J. P. T. F.; Schipper, K.; de Lange, J.] Vrije Univ Amsterdam Med Ctr, Dept Oral & Maxillofacial Surg Oral Pathol, Acad Ctr Dent Amsterdam ACTA, Amsterdam, Netherlands; [Ho, J. P. T. F.] Northwest Clin, Dept Oral & Maxillofacial Surg, Alkmaar, Netherlands; [Donders, H. C. M.; de Lange, J.] Isala, Dept Oral & Maxillofacial Surg, Zwolle, Netherlands; [Zhou, N.] Univ Amsterdam, Acad Ctr Dent Amsterdam ACTA, Dept Orofacial Pain & Dysfunct, Amsterdam, Netherlands; [Zhou, N.] Vrije Univ Amsterdam, Amsterdam, Netherlands; [Su, N.] Univ Amsterdam, Acad Ctr Dent Amsterdam ACTA, Dept Oral Publ Hlth, Amsterdam, Netherlands; [Su, N.] Vrije Univ Amsterdam, Amsterdam, Netherlands	University of Amsterdam; Academic Center for Dentistry Amsterdam; University of Amsterdam; Vrije Universiteit Amsterdam; Academic Center for Dentistry Amsterdam; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Academic Center for Dentistry Amsterdam; University of Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Academic Center for Dentistry Amsterdam; University of Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam	Ho, JPTF (corresponding author), Univ Amsterdam, Amsterdam UMC, Dept Oral & Maxillofacial Surg, Amsterdam, Netherlands.; Ho, JPTF (corresponding author), Univ Amsterdam, Acad Ctr Dent Amsterdam ACTA, Amsterdam, Netherlands.; Ho, JPTF (corresponding author), Vrije Univ Amsterdam Med Ctr, Dept Oral & Maxillofacial Surg Oral Pathol, Acad Ctr Dent Amsterdam ACTA, Amsterdam, Netherlands.; Ho, JPTF (corresponding author), Northwest Clin, Dept Oral & Maxillofacial Surg, Alkmaar, Netherlands.	j.p.ho@amsterdamumc.nl		Ho, Jean-Pierre/0000-0001-8396-2501				Angeli E, 2021, EUR J RADIOL, V137, DOI 10.1016/j.ejrad.2021.109612; Arentz M, 2020, JAMA-J AM MED ASSOC, V323, P1612, DOI 10.1001/jama.2020.4326; Atkins DC, 2007, J FAM PSYCHOL, V21, P726, DOI 10.1037/0893-3200.21.4.726; Azarbarzin A, 2019, EUR HEART J, V40, P1149, DOI 10.1093/eurheartj/ehy624; Berry RB, 2012, J CLIN SLEEP MED, V8, P597, DOI 10.5664/jcsm.2172; Bhatraju PK, 2020, NEW ENGL J MED, V382, P2012, DOI 10.1056/NEJMoa2004500; Cade BE, 2020, AM J RESP CRIT CARE, V202, P1462, DOI 10.1164/rccm.202006-2252LE; Cariou B, 2020, DIABETOLOGIA, V63, P1500, DOI 10.1007/s00125-020-05180-x; Chu DK, 2020, LANCET, V395, P1973, DOI 10.1016/S0140-6736(20)31142-9; Fadl N, 2021, SCAND J IMMUNOL, V93, DOI 10.1111/sji.13039; Feuth T, 2020, SLEEP MED DISORD INT, V4, P61; Guo T, 2020, JAMA CARDIOL, V5, P811, DOI 10.1001/jamacardio.2020.1017; Gupta N, 2020, MONALDI ARCH CHEST D, V90, DOI 10.4081/monaldi.2020.1294; Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5; Leppanen T, 2019, EUR HEART J, V40, P2991, DOI 10.1093/eurheartj/ehz271; Liang WH, 2020, NEW ENGL J MED, V382, P1708, DOI DOI 10.1038/s41586-020-2349-y; Lighter J, 2020, CLIN INFECT DIS, V71, P896, DOI 10.1093/cid/ciaa415; Maas MB, 2021, SLEEP BREATH, V25, P1155, DOI [10.1007/s11325-020-02203-0, 10.1007/s11325-020-02271-2]; Malhotra A, 2002, LANCET, V360, P237, DOI 10.1016/S0140-6736(02)09464-3; Marshall JC, 2020, LANCET INFECT DIS, V20, pE192, DOI 10.1016/S1473-3099(20)30483-7; Memtsoudis SG, 2020, BRIT J ANAESTH, V125, pE262, DOI 10.1016/j.bja.2020.04.078; Messineo L, 2021, CRIT CARE, V25, DOI 10.1186/s13054-021-03630-5; Miller MA, 2021, SLEEP MED REV, V55, DOI 10.1016/j.smrv.2020.101382; Mittal A, 2020, CUREUS J MED SCIENCE, V12, DOI 10.7759/cureus.7849; R Core Team RF for SC, R LANG ENV STAT COMP; Rahman A, 2021, MOL BIOL REP, V48, P3863, DOI 10.1007/s11033-021-06358-1; Ramanathan K, 2020, LANCET, V2020, P19; Sanche S, 2020, EMERG INFECT DIS, V26, P1470, DOI 10.3201/eid2607.200282; Saxena K, 2021, SLEEP MED, V79, P223, DOI 10.1016/j.sleep.2020.11.013; Strausz S, 2021, BMJ OPEN RESPIR RES, V8, DOI 10.1136/bmjresp-2020-000845; Williamson EJ, 2020, NATURE, V584, P430, DOI 10.1038/s41586-020-2521-4; World Health Organization, DEF CARD DIS; Wu ZY, 2020, JAMA-J AM MED ASSOC, V323, P1239, DOI 10.1001/jama.2020.2648; Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017	34	3	3	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2021	16	9							e0257483	10.1371/journal.pone.0257483	http://dx.doi.org/10.1371/journal.pone.0257483			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	WG5YY	34529732	Green Published, gold			2022-12-26	WOS:000707071500065
J	Ullah, R; Shams, S; Khan, MA; Ayaz, S; ul Akbar, N; Din, QU; Khan, A; Leon, R; Zeb, J				Ullah, Raqeeb; Shams, Sumaira; Khan, Munsif Ali; Ayaz, Sultan; ul Akbar, Noor; Din, Qeyam Ud; Khan, Adil; Leon, Renato; Zeb, Jehan			Epidemiology and molecular characterization of Theileria annulata in cattle from central Khyber Pakhtunkhwa, Pakistan	PLOS ONE			English	Article							TROPICAL THEILERIOSIS; RISK-FACTORS; FRIESIAN CATTLE; INFECTED CATTLE; CARRIER-STATE; PREVALENCE; DISTRICT; IMMUNITY; BABESIA; TICKS	Theileria annulata is a tick-borne hemoprotozoan parasite responsible for tropical theileriosis in the bovine population, which causes substantial economic losses to the livestock sector. The present study has investigated, characterized, and shaped epidemiologic and phylogenetic profiles of T. annulata infection in the cattle population of central Khyber Pakhtunkhwa, Pakistan. A total of 600 blood samples were collected from cattle. Microscopy and PCR (18S rRNA taxonomic marker) assays were performed to detect T. annulata infection in cattle from the study area. The overall relative prevalence rates of T. annulata in the examined cattle population were 12.8% (microscopy) and 23.7% (PCR). District-wise analysis (microscopy/PCR) showed that cattle from district Mardan were found more infected (16.0%/28.0%), as compared to cattle from district Charsadda (13.5%/25.5%) and district Peshawar (9.0%/17.5%). Based on host demographic and ecological parameters analysis, theileriosis was found to be higher in young, female, crossbred, freely grazing, tick-infested, and irregular/no acaricides treated cattle. The univariate logistic analysis showed that host age, tick infestation, acaricides use, and feeding method were significant risk factors (P<0.05) whereas multivariate analysis indicated that host age, gender, tick infestation, acaricidal application, and feeding method were potential risk factors (P<0.05) for tropical theileriosis in the cattle population. Phylogenetic and sequence analysis showed that T. annulata 18S rRNA isolates shared homology and phylogeny with other isolates from Asia and Europe. This study has addressed the epidemiology and phylogeny of T. annulata circulating in bovid in the study area where gaps were still present. These findings will serve as a baseline and will facilitate future large-scale epidemiological investigations on tropical theileriosis in the cattle population at a national level.	[Ullah, Raqeeb; Shams, Sumaira; Khan, Munsif Ali; Khan, Adil; Zeb, Jehan] Abdul Wali Khan Univ Mardan, Dept Zool, Mardan, Pakistan; [Khan, Munsif Ali; Ayaz, Sultan; Khan, Adil; Zeb, Jehan] Abdul Wali Khan Univ Mardan, Coll Vet Sci & Anim Husb, Mardan, Pakistan; [ul Akbar, Noor] Kohat Univ Sci & Technol, Dept Zool, Kohat, Pakistan; [Din, Qeyam Ud] Univ Peshawar, Dept Geog, Peshawar, Pakistan; [Leon, Renato] Univ San Francisco Quito, Med Entomol & Trop Med Lab LEMMT, Quito, Ecuador	Kohat University of Science & Technology; University of Peshawar	Zeb, J (corresponding author), Abdul Wali Khan Univ Mardan, Dept Zool, Mardan, Pakistan.; Zeb, J (corresponding author), Abdul Wali Khan Univ Mardan, Coll Vet Sci & Anim Husb, Mardan, Pakistan.	zebjehan2012@gmail.com			Higher Education Commission of Pakistan (HEC Project) [20-4722]	Higher Education Commission of Pakistan (HEC Project)	This research work was funded by the Higher Education Commission of Pakistan (HEC Project No. 20-4722).	Ahmed JS, 2008, INNATE IMMUN, V14, P5, DOI 10.1177/1753425907087258; Ali A, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.00793; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; [Anonymous], 2006, PAKISTAN LIVESTOCK C; Azizi H., 2008, Biotechnology, V7, P574; Benjamin M., 1986, OUTLINE VET CLIN PAT, V3rdEdn; Bilgic HB, 2010, VET PARASITOL, V174, P341, DOI 10.1016/j.vetpar.2010.08.025; Bishop Richard P., 2009, P191, DOI 10.1007/978-3-540-74042-1_6; Brown C., 2008, FOREIGN ANIMAL DIS, P401; Caccio C, 2000, INT J PARASITOL, V30, P1181, DOI 10.1016/S0020-7519(00)00105-3; Calleja-Bueno L, 2017, TICKS TICK-BORNE DIS, V8, P936, DOI 10.1016/j.ttbdis.2017.08.006; Chaudhry U, 2019, TICKS TICK-BORNE DIS, V10, DOI 10.1016/j.ttbdis.2019.101276; Chauhan H., VET WORLD; De Meneghi D, 2016, FRONT PUBLIC HEALTH, V4, DOI 10.3389/fpubh.2016.00239; DEKOK JB, 1993, EXP APPL ACAROL, V17, P839, DOI 10.1007/BF00225857; DOLIVEIRA C, 1995, J CLIN MICROBIOL, V33, P2665, DOI 10.1128/JCM.33.10.2665-2669.1995; Dumanli N, 2005, VET PARASITOL, V127, P9, DOI 10.1016/j.vetpar.2004.08.006; Durrani AZ, 2008, TROP ANIM HEALTH PRO, V40, P441, DOI 10.1007/s11250-007-9117-y; Durrani AZ, 2010, PAK J ZOOL, V42, P467; Farooqi SH, 2017, J ANIM PLANT SCI, V27, P1836; George N, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1075-z; Gharbi M, 2014, PARASITE, V21, DOI 10.1051/parasite/2014002; Glass EJ, 2001, RES VET SCI, V70, P71, DOI 10.1053/rvsc.2000.0428; Glidden CK, 2020, ECOL EVOL, V10, P70, DOI 10.1002/ece3.5758; Hassan MA, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-018-3035-x; Hassan MA, 2018, TICKS TICK-BORNE DIS, V9, P1002, DOI 10.1016/j.ttbdis.2018.03.028; Hayati MA, 2020, PARASITE EPIDEM CONT, V10, DOI 10.1016/j.parepi.2020.e00148; Hoghooghi-Rad N., 2011, World Applied Sciences Journal, V12, P324; Ilhan T, 1998, ANN NY ACAD SCI, V849, P109, DOI 10.1111/j.1749-6632.1998.tb11040.x; Inci A, 2008, TURK J VET ANIM SCI, V32, P57; Jabbar A, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0894-2; Javid K, 2019, APPL WATER SCI, V9, DOI 10.1007/s13201-019-1028-3; Kabir MHB, 2011, AFR J MICROBIOL RES, V5, P346; Khan A., 2017, AM SCI RES J ENG TEC, V32, P8; Khan MK, 2013, INFECT GENET EVOL, V13, P124, DOI 10.1016/j.meegid.2012.09.007; Khattak RM, 2012, PARASITE, V19, P91, DOI 10.1051/parasite/2012191091; Kumar S, 2018, MOL BIOL EVOL, V35, P1547, DOI 10.1093/molbev/msy096; Leemans I, 1999, VET PARASITOL, V82, P179, DOI 10.1016/S0304-4017(99)00013-8; Lew-Tabor AE, 2016, TICKS TICK-BORNE DIS, V7, P573, DOI 10.1016/j.ttbdis.2015.12.012; MOLL G, 1984, PREV VET MED, V2, P801, DOI 10.1016/0167-5877(84)90035-7; Moumouni PFA, 2018, TICKS TICK-BORNE DIS, V9, P450, DOI 10.1016/j.ttbdis.2017.12.015; Nayel M, 2012, PARASITOL RES, V111, P1019, DOI 10.1007/s00436-012-2926-6; Noaman Vahid, 2014, J Parasit Dis, V38, P64, DOI 10.1007/s12639-012-0196-y; Parveen A, 2021, EXP APPL ACAROL, V83, P461, DOI 10.1007/s10493-021-00595-6; Pienaar R, 2020, INT J PARASITOL-PAR, V11, P136, DOI 10.1016/j.ijppaw.2020.01.009; Ponnudurai G., 2017, J ADV DAIRY RES, V5, P177, DOI DOI 10.4172/2329-888X.1000177; PURNELL RE, 1978, VET SCI COMMUN, V2, P3, DOI 10.1007/BF02291428; Qayyum A, 2010, J ANIM PLANT SCI-PAK, V20, P266; Rehman A, 2019, TRANSBOUND EMERG DIS, V66, P526, DOI 10.1111/tbed.13059; Rehman A, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-017-2138-0; Rizk MA, 2017, ACTA PARASITOL, V62, P796, DOI 10.1515/ap-2017-0096; ROBINSON PM, 1982, TROP ANIM HEALTH PRO, V14, P3, DOI 10.1007/BF02281092; Ros-Garcia A, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-171; Sajid MS, 2009, PREV VET MED, V92, P386, DOI 10.1016/j.prevetmed.2009.09.001; Salih DA, 2007, PREV VET MED, V81, P323, DOI 10.1016/j.prevetmed.2007.05.008; Selim AM, 2020, IRAN J VET RES, V21, P250, DOI 10.22099/ijvr.2020.37685.5476; Shahnawaz S, 2011, PARASITOL RES, V109, P1155, DOI 10.1007/s00436-011-2360-1; Shamshad KM., 1988, METEOROLOGY PAKISTAN; Shayan P, 1998, ANN NY ACAD SCI, V849, P88, DOI 10.1111/j.1749-6632.1998.tb11038.x; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Thrusfield M., 2018, VET EPIDEMIOLOGY; Tuli A, 2015, ACTA PARASITOL, V60, P378, DOI 10.1515/ap-2015-0053; Uilenberg G, 2001, ENCY ARTHROPOD TRANS, P53; Zahid I. A., 2005, Pakistan Veterinary Journal, V25, P137; Zeb J, 2020, VET PARASITOL, V279, DOI 10.1016/j.vetpar.2020.109044; Zeb J, 2019, EXP APPL ACAROL, V79, P233, DOI 10.1007/s10493-019-00418-9; Zorner RJ, 2008, AGR ECOSYST ENVIRON, V126, P67, DOI 10.1016/j.agee.2008.01.014	67	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2021	16	9							e0249417	10.1371/journal.pone.0249417	http://dx.doi.org/10.1371/journal.pone.0249417			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	WG5YY	34529664	Green Published, gold			2022-12-26	WOS:000707071500001
J	Bevacqua, A; Bakshi, S; Xia, Y				Bevacqua, Alexander; Bakshi, Sachit; Xia, Yu			Principal component analysis of alpha-helix deformations in transmembrane proteins	PLOS ONE			English	Article							MEMBRANE; CONSTRAINTS; MUTATIONS; RESIDUES; DYNAMICS; PATTERNS; DATABASE; PEPTIDE	alpha -helices are deformable secondary structural components regularly observed in protein folds. The overall flexibility of an alpha -helix can be resolved into constituent physical deformations such as bending in two orthogonal planes and twisting along the principal axis. We used Principal Component Analysis to identify and quantify the contribution of each of these dominant deformation modes in transmembrane alpha -helices, extramembrane alpha -helices, and alpha -helices in soluble proteins. Using three alpha -helical samples from Protein Data Bank entries spanning these three cellular contexts, we determined that the relative contributions of these modes towards total deformation are independent of the alpha -helix's surroundings. This conclusion is supported by the observation that the identities of the top three deformation modes, the scaling behaviours of mode eigenvalues as a function of alpha -helix length, and the percentage contribution of individual modes on total variance were comparable across all three alpha -helical samples. These findings highlight that alpha -helical deformations are independent of cellular location and will prove to be valuable in furthering the development of flexible templates in de novo protein design.	[Bevacqua, Alexander; Xia, Yu] McGill Univ, Dept Bioengn, Montreal, PQ, Canada; [Bakshi, Sachit] Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA	McGill University; Boston University	Xia, Y (corresponding author), McGill Univ, Dept Bioengn, Montreal, PQ, Canada.	brandon.xia@mcgill.ca		Xia, Yu/0000-0002-5596-5518	Natural Sciences and Engineering Research Council of Canada [RGPIN-2019-05952, RGPAS-2019-00012]; Canada Foundation for Innovation [JELF-33732, IF-33122]; Canada Research Chairs program	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Canada Research Chairs program(Canada Research Chairs)	This work was supported by Natural Sciences and Engineering Research Council of Canada grants RGPIN-2019-05952 (YX) and RGPAS-2019-00012 (YX), Canada Foundation for Innovation grants JELF-33732 (YX) and IF-33122 (YX), and Canada Research Chairs program (YX). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baeza-Delgado C, 2013, EUR BIOPHYS J BIOPHY, V42, P199, DOI 10.1007/s00249-012-0813-9; Bavi N, 2017, CHANNELS, V11, P209, DOI 10.1080/19336950.2016.1249077; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; BROOKS B, 1983, P NATL ACAD SCI-BIOL, V80, P6571, DOI 10.1073/pnas.80.21.6571; del Val C, 2012, J MEMBRANE BIOL, V245, P717, DOI 10.1007/s00232-012-9452-4; Deupi X, 2004, BIOPHYS J, V86, P105, DOI 10.1016/S0006-3495(04)74088-6; Emberly EG, 2003, J MOL BIOL, V327, P229, DOI 10.1016/S0022-2836(03)00097-4; Franzosa EA, 2013, GENOME BIOL EVOL, V5, P734, DOI 10.1093/gbe/evt039; Fung HK, 2008, IND ENG CHEM RES, V47, P993, DOI 10.1021/ie071286k; GO N, 1983, P NATL ACAD SCI-BIOL, V80, P3696, DOI 10.1073/pnas.80.12.3696; Hall SE, 2009, J MOL GRAPH MODEL, V27, P944, DOI 10.1016/j.jmgm.2009.02.004; Joh NH, 2008, NATURE, V453, P1266, DOI 10.1038/nature06977; KIDERA A, 1990, P NATL ACAD SCI USA, V87, P3718, DOI 10.1073/pnas.87.10.3718; Larmuth KM, 2016, FEBS J, V283, P1060, DOI 10.1111/febs.13647; Lomize MA, 2012, NUCLEIC ACIDS RES, V40, pD370, DOI 10.1093/nar/gkr703; Nugent T, 2012, J STRUCT BIOL, V179, P327, DOI 10.1016/j.jsb.2011.10.008; Oberai A, 2009, P NATL ACAD SCI USA, V106, P17747, DOI 10.1073/pnas.0906390106; Partridge AW, 2004, PROTEINS, V54, P648, DOI 10.1002/prot.10611; Partridge AW, 2002, BIOPOLYMERS, V66, P350, DOI 10.1002/bip.10313; RAMACHANDRAN GN, 1963, J MOL BIOL, V7, P95, DOI 10.1016/S0022-2836(63)80023-6; Simons KT, 1999, PROTEINS, P171; Simons KT, 2001, J MOL BIOL, V306, P1191, DOI 10.1006/jmbi.2000.4459; Tourasse NJ, 2000, MOL BIOL EVOL, V17, P656, DOI 10.1093/oxfordjournals.molbev.a026344; University of Michigan, 2020, OR PROT MEMBR OPM; White S., 2020, MEMBRANE PROTEINS KN, DOI [10.1016/j.str.2020.05.002, DOI 10.1016/J.STR.2020.05.002]; Wu JP, 2015, SCIENCE, V350, DOI 10.1126/science.aad2395	27	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2021	16	9							e0257318	10.1371/journal.pone.0257318	http://dx.doi.org/10.1371/journal.pone.0257318			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	WG6DR	34525125	Green Published, gold			2022-12-26	WOS:000707084400031
J	Bezard, M; Oghina, S; Vitiello, D; Kharoubi, M; Kordeli, E; Galat, A; Zaroui, A; Guendouz, S; Gilles, F; Shourick, J; Hamon, D; Audard, V; Teiger, E; Poullot, E; Molinier-Frenkel, V; Lemonnier, F; Agbulut, O; Le Bras, F; Damy, T				Bezard, Melanie; Oghina, Silvia; Vitiello, Damien; Kharoubi, Mounira; Kordeli, Ekaterini; Galat, Arnault; Zaroui, Amira; Guendouz, Soulef; Gilles, Floriane; Shourick, Jason; Hamon, David; Audard, Vincent; Teiger, Emmanuel; Poullot, Elsa; Molinier-Frenkel, Valerie; Lemonnier, Francois; Agbulut, Onnik; Le Bras, Fabien; Damy, Thibaud			Dexamethasone is associated with early deaths in light chain amyloidosis patients with severe cardiac involvement	PLOS ONE			English	Article							DOSE DEXAMETHASONE; STAGING SYSTEM; CYCLOPHOSPHAMIDE; BORTEZOMIB; DIAGNOSIS	Background Cardiac light chain amyloidosis (AL-CA) patients often die within three months of starting chemotherapy. Chemotherapy for non-immunoglobulin M gammopathy with AL-CA frequently includes bortezomib (Bor), cyclophosphamide (Cy), and dexamethasone (D). We previously reported that NT-ProBNP levels can double within 24h of dexamethasone administration, suggesting a deleterious impact on cardiac function. In this study, we evaluate the role of dexamethasone in early cardiovascular mortality during treatment. Methods and findings We retrospectively assessed 100 de novo cardiac AL patients (62% male, mean age 68 years) treated at our institute between 2009 and 2018 following three chemotherapy regimens: CyBorDComb (all initiated on day 1; 34 patients), DCyBorSeq (D, day 1; Cy, day 8; Bor, day 15; 17 patients), and CyBorDSeq (Cy, day 1; Bor, day 8; D, day 15; 49 patients). The primary endpoint was cardiovascular mortality and cardiac transplantation at days 22 and 455. At day 22, mortality was 20.6% with CyBorDComb, 23.5% with DCyBorSeq, and 0% with CyBorDSeq (p = 0.003). At day 455, mortality was not significantly different between regimens (p = 0.195). Acute toxicity of dexamethasone was evaluated on myocardial function using a rat model of isolated perfused heart. Administration of dexamethasone induced a decrease in left ventricular myocardium contractility and relaxation (p<0.05), supporting a potential negative inotropic effect of dexamethasone in AL-CA patients with severe cardiac involvement. Conclusion Delaying dexamethasone during the first chemotherapy cycle reduces the number of early deaths without extending survival. It is clear that dexamethasone is beneficial in the long-term treatment of patients with AL-CA. However, the initial introduction of dexamethasone during treatment is critical, but may be associated with early cardiac deaths in severe CA. Thus, it is important to consider the dosage and timing of dexamethasone introduction on a patient-severity basis. The impact of dexamethasone in the treatment of AL-CA needs further investigation.	[Bezard, Melanie; Oghina, Silvia; Kharoubi, Mounira; Galat, Arnault; Zaroui, Amira; Guendouz, Soulef; Gilles, Floriane; Teiger, Emmanuel; Damy, Thibaud] Reseau Amylose Mondor, French Cardiac Amyloidosis Reference Ctr, GRC Amyloid Res Inst, Creteil, France; [Bezard, Melanie; Oghina, Silvia; Kharoubi, Mounira; Galat, Arnault; Zaroui, Amira; Guendouz, Soulef; Gilles, Floriane; Teiger, Emmanuel; Damy, Thibaud] DHU A TVB, Creteil, France; [Bezard, Melanie; Oghina, Silvia; Kharoubi, Mounira; Galat, Arnault; Zaroui, Amira; Guendouz, Soulef; Gilles, Floriane; Hamon, David; Teiger, Emmanuel; Damy, Thibaud] Univ Hosp Henri Mondor, AP HP, Cardiol Dept, Creteil, France; [Vitiello, Damien] Paris Univ, Sport & Hlth Sci Inst I3SP EA3625, Paris, France; [Vitiello, Damien; Kordeli, Ekaterini; Agbulut, Onnik] Sorbonne Univ, Inst Biol Paris Seine IBPS, Adaptat Biol & Vieillissement, CNRS,UMR 8256,Inserm ERL U1164, Paris, France; [Shourick, Jason] UPEC, EA 7379, EpiDermE, Creteil, France; [Audard, Vincent] Univ Hosp Henri Mondor, AP HP, Nephrol & Transplantat Dept, Rare Dis Reference Ctr Syndrome Nephrot Idiopath, Creteil, France; [Teiger, Emmanuel; Poullot, Elsa; Molinier-Frenkel, Valerie; Damy, Thibaud] Univ Paris Est Creteil UPEC, INSERM, Inst Mondor Rech Biomed IMRB, U955, Creteil, France; [Poullot, Elsa] Univ Hosp Henri Mondor, AP HP, Anat & Cytopathol, Creteil, France; [Molinier-Frenkel, Valerie] Immunol Lab, Creteil, France; [Lemonnier, Francois; Le Bras, Fabien] Univ Hosp Henri Mondor, AP HP, Hematopathol Lymphoid Unit, Creteil, France	Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP	Bezard, M (corresponding author), Univ Hosp Henri Mondor, AP HP, Cardiol Dept, Creteil, France.	melanie.bezard@aphp.fr		Kordeli, Ekaterini/0000-0002-5115-2202; Bezard, Melanie/0000-0003-1793-4099; Vitiello, Damien/0000-0003-3048-1880; Agbulut, Onnik/0000-0003-1923-8871; Oghina, Silvia/0000-0003-0108-5598; Molinier-Frenkel, Valerie/0000-0002-7250-7295	ARMDC (Association pour la Recherche Multi-Disciplinaire en Cardiologie)	ARMDC (Association pour la Recherche Multi-Disciplinaire en Cardiologie)	This work was supported by the ARMDC (Association pour la Recherche Multi-Disciplinaire en Cardiologie), a non-profit organization. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abeykoon JP, 2019, LEUKEMIA, V33, P531, DOI 10.1038/s41375-018-0262-2; Chamarthi B, 1997, AM J CARDIOL, V80, P1242, DOI 10.1016/S0002-9149(97)00653-X; Dispenzieri A, 2004, J CLIN ONCOL, V22, P3751, DOI 10.1200/JCO.2004.03.029; Einsele H, 2017, BRIT J HAEMATOL, V179, P586, DOI 10.1111/bjh.14920; Falk RH, 2016, J AM COLL CARDIOL, V68, P1324, DOI 10.1016/j.jacc.2016.06.053; Falk RH, 2011, CIRCULATION, V124, P1079, DOI 10.1161/CIRCULATIONAHA.110.010447; Gillmore JD, 2015, BRIT J HAEMATOL, V168, P207, DOI 10.1111/bjh.13156; Guimaraes FD, 2017, MOL CELL BIOCHEM, V424, P87, DOI 10.1007/s11010-016-2846-3; Hillengass J, 2019, LANCET ONCOL, V20, pE302, DOI 10.1016/S1470-2045(19)30309-2; Jaccard A, 2014, HAEMATOLOGICA, V99, P1479, DOI 10.3324/haematol.2014.104109; Kaufman GP, 2017, BLOOD, V130, P900, DOI 10.1182/blood-2017-01-763599; Kropff M, 2007, BRIT J HAEMATOL, V138, P330, DOI 10.1111/j.1365-2141.2007.06656.x; Kumar S, 2012, J CLIN ONCOL, V30, P989, DOI 10.1200/JCO.2011.38.5724; Le Bras F, 2017, EUR J CANCER, V76, P183, DOI 10.1016/j.ejca.2017.02.004; Lilleness B, 2019, BLOOD, V133, P215, DOI 10.1182/blood-2018-06-858951; Manwani R, 2019, BLOOD, V134, P2271, DOI 10.1182/blood.2019000834; Palladini G, 2001, BRIT J HAEMATOL, V113, P1044, DOI 10.1046/j.1365-2141.2001.02859.x; Palladini G, 2015, BLOOD, V126, P612, DOI 10.1182/blood-2015-01-620302; Qi D, 2007, AM J PHYSIOL-ENDOC M, V292, pE654, DOI 10.1152/ajpendo.00453.2006; Quarta CC, 2012, CIRCULATION, V126, pE178, DOI 10.1161/CIRCULATIONAHA.111.069195; Sayed RH, 2015, EUR HEART J, V36, P1098, DOI 10.1093/eurheartj/ehu506; Sutherland FJ, 2000, PHARMACOL RES, V41, P613, DOI 10.1006/phrs.1999.0653; Venner CP, 2014, LEUKEMIA, V28, P2304, DOI 10.1038/leu.2014.218; Vranian MN, 2015, CURR CARDIOL REP, V17, DOI 10.1007/s11886-015-0653-1; Wechalekar AD, 2013, BLOOD, V121, P3420, DOI 10.1182/blood-2012-12-473066	25	5	5	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2021	16	9							e0257189	10.1371/journal.pone.0257189	http://dx.doi.org/10.1371/journal.pone.0257189			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	WG6DR	34525116	Green Published, gold			2022-12-26	WOS:000707084400025
J	Brune, C; Stentzel, U; Hoffmann, W; van den Berg, N				Brune, Cedric; Stentzel, Ulrike; Hoffmann, Wolfgang; van den Berg, Neeltje			Attitudes of legal guardians and legally supervised persons with and without previous research experience towards participation in research projects: A quantitative cross-sectional study	PLOS ONE			English	Article							ALTERNATIVE DECISION-MAKERS; ALZHEIMERS-DISEASE; CLINICAL-RESEARCH; MENTAL-DISORDERS; INFORMED CONSENT; DEMENTIA; PREVALENCE; GERMANY; PEOPLE; PROXY	Background Vulnerable groups, e.g. persons with mental illness, neurological deficits or dementia, are often excluded as participants from research projects because obtaining informed consent can be difficult and tedious. This may have the consequence that vulnerable groups benefit less from medical progress. Vulnerable persons are often supported by a legal guardian in one or more demands of their daily life. We examined the attitudes of legal guardians and legally supervised persons towards medical research and the conditions and motivations to participate in studies. Methods We conducted a cross-sectional study with standardized surveys of legal guardians and legally supervised persons. Two separate questionnaires were developed for the legal guardians and the supervised persons to asses previous experiences with research projects and the reasons for participation or non-participation. The legal guardians were recruited through various guardianship organizations. The supervised persons were recruited through their legal guardian and from a previous study among psychiatric patients. The data were analysed descriptively. Results Alltogether, 82 legal guardians and 20 legally supervised persons could be recruited. Thereof 13 legal guardians (15.6%) and 13 legally supervised persons (65.0%) had previous experience with research projects. The majority of the guardians with experience in research projects had consented the participation of their supervised persons (n = 12 guardians, 60.0%; in total n = 16 approvals). The possible burden on the participating person was given as the most frequent reason not to participate both by the guardians (n = 44, 54.4%) and by the supervised persons (n = 3, 30.0%). The most frequent motivation to provide consent to participate in a research study was the desire to help other patients by gaining new scientific knowledge (guardians: n = 125, 78.1%; supervised persons: n = 10, 66.6%). Conclusions Overall, an open attitude towards medical research can be observed both among legal guardians and supervised persons. Perceived risks and no sense recognized in the study are reasons for not participating in medical research projects.	[Brune, Cedric; Stentzel, Ulrike; Hoffmann, Wolfgang; van den Berg, Neeltje] Univ Med Greifswald, Inst Community Med, Greifswald, Germany	Greifswald Medical School	Brune, C (corresponding author), Univ Med Greifswald, Inst Community Med, Greifswald, Germany.	cedric.brune@stud.uni-greifswald.de	Stentzel, Ulrike/AGO-5128-2022	Stentzel, Ulrike/0000-0002-9723-8677	DFG (German Research Foundation) [393148499]; Open Access Publication Fund of the University of Greifswald	DFG (German Research Foundation)(German Research Foundation (DFG)); Open Access Publication Fund of the University of Greifswald	We acknowledge support for the Article Processing Charge from the DFG (German Research Foundation, 393148499) and the Open Access Publication Fund of the University of Greifswald. The funders had no role instudy design, data collection and analysis, decision to publish, or preparation of themanuscript.	Alonso J, 2004, ACTA PSYCHIAT SCAND, V109, P21; Black BS, 2013, AM J GERIAT PSYCHIAT, V21, P355, DOI 10.1016/j.jagp.2012.11.009; BMFSJ-Bundesministerium fur Familie Senioren, 2005, ABSCHLUSSBERICHT ZUM; Bundesamt fur Justiz, 2017, JUST GU 2 AMTSG 2005; Dunn Laura B, 2011, Narrat Inq Bioeth, V1, P107, DOI 10.1353/nib.2011.0034; Dunn LB, 2013, AM J GERIAT PSYCHIAT, V21, P337, DOI 10.1016/j.jagp.2012.11.014; Guhne U, 2015, PSYCHIAT PRAX, V42, P415, DOI 10.1055/s-0035-1552715; Helmchen H, 2008, NERVENARZT, V79, P1036, DOI 10.1007/s00115-008-2523-1; Horst Bickel, 2018, HAUFIGKEIT DEMENZERK; Jacobi F, 2014, NERVENARZT, V85, P77, DOI 10.1007/s00115-013-3961-y; Jaworska A., 2009, STANFORD ENCY PHILOS; Kim SYH, 2009, NEUROLOGY, V72, P149, DOI 10.1212/01.wnl.0000339039.18931.a2; Kim SYH, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0054790, 10.1371/journal.pone.0053908, 10.1371/journal.pone.0063749, 10.1371/journal.pone.0068092]; Kim SYH, 2001, AM J PSYCHIAT, V158, P712, DOI 10.1176/appi.ajp.158.5.712; Nerius M, 2020, GESUNDHEITSWESEN, V82, P761, DOI 10.1055/a-0829-6494; Overton E, 2013, AM J GERIAT PSYCHIAT, V21, P346, DOI 10.1016/j.jagp.2013.01.027; Prince M, 2013, ALZHEIMERS DEMENT, V9, P63, DOI 10.1016/j.jalz.2012.11.007; Roberts LW, 2015, J PSYCHIATR RES, V71, P70, DOI 10.1016/j.jpsychires.2015.09.014; Schussler N, 2014, Z GERONTOL GERIATR, V47, P686, DOI 10.1007/s00391-013-0591-8; Seichter J., 2019, EINFUHRUNG BETREUUNG; Shalowitz DI, 2006, ARCH INTERN MED, V166, P493, DOI 10.1001/archinte.166.5.493; Shepherd V, 2016, BMC MED ETHICS, V17, DOI 10.1186/s12910-016-0138-9; Statistisches Bundesamt (Destatis), 2016, ALT MENSCH DEUTSCHL; Stentzel U, 2015, BMC PSYCHIATRY, V15, DOI 10.1186/s12888-015-0659-7; Sugarman J, 2001, J AM GERIATR SOC, V49, P1110, DOI 10.1046/j.1532-5415.2001.49218.x; Sutton LB, 2003, J PROF NURS, V19, P106, DOI 10.1053/jpnu.2003.16; WARREN JW, 1986, NEW ENGL J MED, V315, P1124, DOI 10.1056/NEJM198610303151804; World Med Assoc, 2013, JAMA-J AM MED ASSOC, V310, P2191, DOI 10.1001/jama.2013.281053; Wright MS, 2017, KENNEDY INST ETHIC J, V27, P43, DOI 10.1353/ken.2017.0003	29	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2021	16	9							e0256689	10.1371/journal.pone.0256689	http://dx.doi.org/10.1371/journal.pone.0256689			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	WG6DR	34525101	gold, Green Published			2022-12-26	WOS:000707084400017
J	Ezzalfani, M; Porcher, R; Savignoni, A; Delaloge, S; Filleron, T; Robain, M; Perol, D				Ezzalfani, Monia; Porcher, Raphael; Savignoni, Alexia; Delaloge, Suzette; Filleron, Thomas; Robain, Mathieu; Perol, David			Addressing the issue of bias in observational studies: Using instrumental variables and a quasi-randomization trial in an ESME research project	PLOS ONE			English	Article							PACLITAXEL PLUS BEVACIZUMAB; PROPENSITY SCORE METHODS; SURVIVAL	Purpose Observational studies using routinely collected data are faced with a number of potential shortcomings that can bias their results. Many methods rely on controlling for measured and unmeasured confounders. In this work, we investigate the use of instrumental variables (IV) and quasi-trial analysis to control for unmeasured confounders in the context of a study based on the retrospective Epidemiological Strategy and Medical Economics (ESME) database, which compared overall survival (OS) with paclitaxel plus bevacizumab or paclitaxel alone as first-line treatment in patients with HER2-negative metastatic breast cancer (MBC). Patients and methods Causal interpretations and estimates can be made from observation data using IV and quasi-trial analysis. Quasi-trial analysis has the same conceptual basis as IV, however, instead of using IV in the analysis, a "superficial" or "pseudo" randomized trial is used in a Cox model. For instance, in a multicenter trial, instead of using the treatment variable, quasi-trial analysis can consider the treatment preference in each center, which can be informative, and then comparisons of results between centers or clinicians can be informative. Results In the original analysis, the OS adjusted for major factors was significantly longer with paclitaxel and bevacizumab than with paclitaxel alone. Using the center-treatment preference as an instrument yielded to concordant results. For the quasi-trial analysis, a Cox model was used, adjusted on all factors initially used. The results consolidate those obtained with a conventional multivariate Cox model. Conclusion Unmeasured confounding is a major concern in observational studies, and IV or quasi-trial analysis can be helpful to complement analysis of studies of this nature.	[Ezzalfani, Monia; Savignoni, Alexia] Inst Curie, Dept Biostat, Pole Biometrie, Paris, France; [Porcher, Raphael] Univ Paris, Ctr Res Epidemiol & Stat, INSERM, U1153, Paris, France; [Delaloge, Suzette] Inst Gustave Roussy, Dept Canc Med, Villejuif, France; [Filleron, Thomas] IUCT Oncopole, Biostat Unit, Toulouse, France; [Robain, Mathieu] R&D Unicanc, Dept Res & Dev, Paris, France; [Perol, David] Ctr Leon Berard, Dept Biostat, DRCI, Lyon, France	UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UNICANCER; Gustave Roussy; UNICANCER; UNICANCER; Centre Leon Berard	Ezzalfani, M (corresponding author), Inst Curie, Dept Biostat, Pole Biometrie, Paris, France.	monia.ezzalfani@curie.fr	d, p/GWC-4283-2022; filleron, thomas/C-3554-2014	filleron, thomas/0000-0003-0724-0659; Ezzalfani, Monia/0000-0002-2062-7041	Roche; Pfizer; AstraZeneca; MSD; Eisai; Daiichi Sankyo; RD Unicancer	Roche(Roche Holding); Pfizer(Pfizer); AstraZeneca(AstraZeneca); MSD; Eisai(Eisai Co Ltd); Daiichi Sankyo(Daiichi Sankyo Company Limited); RD Unicancer	The ESME MBC database receives financial support from an industrial consortium comprising Roche, Pfizer, AstraZeneca, MSD, Eisai and Daiichi Sankyo. Data collection, analysis and publication is managed entirely by R&D Unicancer independently of the industrial consortium. This work was supported by R&D Unicancer. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AALEN OO, 1989, STAT MED, V8, P907, DOI 10.1002/sim.4780080803; Austin PC, 2013, STAT MED, V32, P2837, DOI 10.1002/sim.5705; Baiocchi M, 2014, STAT MED, V33, P2297, DOI 10.1002/sim.6128; Baiocchia Michael., TUTORIAL BIOSTATISTI; Brookhart MA, 2010, PHARMACOEPIDEM DR S, V19, P537, DOI 10.1002/pds.1908; Brueckner M, 2019, BIOMETRICS, V75, P110, DOI 10.1111/biom.12952; Buyse M, 2017, ANN ONCOL, V28, P182, DOI 10.1093/annonc/mdw539; D'Agostino RB, 1998, STAT MED, V17, P2265, DOI 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO;2-B; de Gramont A, 2007, J CLIN ONCOL, V25, P3224, DOI 10.1200/JCO.2006.10.4380; Delaloge S, 2016, ANN ONCOL, V27, P1725, DOI 10.1093/annonc/mdw260; Ezzalfani M., 2018, REV EPIDEMIOLOGIE SA, V66, pS141; Garabedian LF, 2014, ANN INTERN MED, V161, P131, DOI 10.7326/M13-1887; Gayat E, 2012, PHARM STAT, V11, P222, DOI 10.1002/pst.537; Hemkens LG, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i493; Kwiatkowski F, 2007, B CANCER, V94, P680; Li JL, 2015, BIOMETRICS, V71, P122, DOI 10.1111/biom.12244; Martinez-Camblor P., 2017, BIOSTATISTICS, DOI [10.1093/biostatistics/kxx062/4753665, DOI 10.1093/BIOSTATISTICS/KXX062/4753665]; Martinussen T., 2017, BIOSTAT OXF ENGL; Miller K, 2007, NEW ENGL J MED, V357, P2666, DOI 10.1056/NEJMoa072113; Perol D, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-023568; Robert NJ, 2011, J CLIN ONCOL, V29, P1252, DOI 10.1200/JCO.2010.28.0982; Shadish WR, 2002, EXPT QUASIEXPERIMENT, P171; Tchetgen EJT, 2015, EPIDEMIOLOGY, V26, P402, DOI 10.1097/EDE.0000000000000262; Terza JV, 2008, J HEALTH ECON, V27, P531, DOI 10.1016/j.jhealeco.2007.09.009; Terza JV, 2008, HEALTH SERV RES, V43, P1102, DOI 10.1111/j.1475-6773.2007.00807.x; VAUPEL JW, 1979, DEMOGRAPHY, V16, P439, DOI 10.2307/2061224; Wan F, 2015, STAT MED, V34, P2235, DOI 10.1002/sim.6470	27	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2021	16	9							e0255017	10.1371/journal.pone.0255017	http://dx.doi.org/10.1371/journal.pone.0255017			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	WG6DR	34525119	Green Published, gold			2022-12-26	WOS:000707084400007
J	Zviedrite, N; Hodis, JD; Jahan, F; Gao, HJ; Uzicanin, A				Zviedrite, Nicole; Hodis, Jeffrey D.; Jahan, Ferdous; Gao, Hongjiang; Uzicanin, Amra			COVID-19-associated school closures and related efforts to sustain education and subsidized meal programs, United States, February 18-June 30, 2020	PLOS ONE			English	Article							PUBLIC-HEALTH RESPONSE; INFLUENZA; COVID-19; INTERVENTIONS; OUTBREAK	Pre-emptive school closures are frontline community mitigation measures recommended by the US Centers for Disease Control and Prevention (CDC) for implementation during severe pandemics. This study describes the spatiotemporal patterns of publicly announced school closures implemented in response to the coronavirus disease 2019 (COVID-19) pandemic and assesses how public K-12 districts adjusted their methods of education delivery and provision of subsidized meals. During February 18-June 30, 2020, we used daily systematic media searches to identify publicly announced COVID-19-related school closures lasting >= 1 day in the United States (US). We also collected statewide school closure policies from state government websites. Data on distance learning and subsidized meal programs were collected from a stratified sample of 600 school districts. The first COVID-19-associated school closure occurred on February 27, 2020 in Washington state. By March 30, 2020, all but one US public school districts were closed, representing the first-ever nearly synchronous nationwide closure of public K-12 schools in the US. Approximately 100,000 public schools were closed for >= 8 weeks because of COVID-19, affecting >50 million K-12 students. Of 600 districts sampled, the vast majority offered distance learning (91.0%) and continued provision of subsidized meal programs (78.8%) during the closures. Despite the sudden and prolonged nature of COVID-19-associated school closures, schools demonstrated flexibility by implementing distance learning and alternate methods to continue subsidized meal programs.	[Zviedrite, Nicole; Hodis, Jeffrey D.; Gao, Hongjiang; Uzicanin, Amra] Ctr Dis Control & Prevent, Atlanta, GA 30333 USA; [Hodis, Jeffrey D.] Oak Ridge Inst Sci & Educ, Oak Ridge, TN USA; [Jahan, Ferdous] Kapili Serv LLC, Atlanta, GA USA	Centers for Disease Control & Prevention - USA; Oak Ridge Associated Universities; United States Department of Energy (DOE); Oak Ridge Institute for Science & Education	Zviedrite, N (corresponding author), Ctr Dis Control & Prevent, Atlanta, GA 30333 USA.	AUzicanin@cdc.gov		Hodis, Jeffrey/0000-0002-5217-2483	United States Centers for Disease Control and Prevention	United States Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This study was supported by the United States Centers for Disease Control and Prevention (http://www.cdc.gov/).The co-authors are or were employees (NZ HG AU), ORISE Fellows (JH), or contractors (FJ) of the US CDC at the time of the study. Ferdous Jahan (FJ) is employed by Kapili Services. The funder (Kapili Services) provided support in the form of salary for the author (FJ), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of all authors are articulated in the `Author Contributions' section.	American Psychological Association Presidential Task Force on Educational Disparities., ETHN RAC DISP ED PSY; Aucejo EM, 2016, ECON EDUC REV, V55, P70, DOI 10.1016/j.econedurev.2016.08.007; Auger KA, 2020, JAMA-J AM MED ASSOC, V324, P859, DOI 10.1001/jama.2020.14348; Brenan M., 2020, 42 PARENTS WORRY COV; Calderon VJ., 2020, US PARENTS SAY COVID; Cauchemez S, 2011, P NATL ACAD SCI USA, V108, P2825, DOI 10.1073/pnas.1008895108; CDC COVID-19 Response Team, 2020, MMWR-MORBID MORTAL W, V69, P465, DOI 10.15585/mmwr.mm6915e4; Chen TM, 2020, J INT MED RES, V48, DOI 10.1177/0300060518764268; Chen TM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177672; Courtemanche C, 2020, HEALTH AFFAIR, V39, P1237, DOI 10.1377/hlthaff.2020.00608; Davis BM, 2015, CLIN INFECT DIS, V60, pE90, DOI 10.1093/cid/civ182; Dong ES, 2020, LANCET INFECT DIS, V20, P533, DOI 10.1016/S1473-3099(20)30120-1; Downey D., 2019, DOES INEQUALITY GROW; Dunn CG, 2020, NEW ENGL J MED, V382, DOI 10.1056/NEJMp2005638; Education Trust, 2020, PAR OV THEIR CHILDR; EdWeek Research Center Survey, 2020, SURV TRACK MON K 12; Fong MW, 2020, EMERG INFECT DIS, V26, P976, DOI 10.3201/eid2605.190995; Germann TC, 2019, EPIDEMICS-NETH, V28, DOI 10.1016/j.epidem.2019.100348; Goldstein D., 2020, NEW YORK TIMES; Hansen B, 2020, SOCIAL SCI RES NETWO; Hatchett RJ, 2007, P NATL ACAD SCI USA, V104, P7582, DOI 10.1073/pnas.0610941104; Hoffman JA, 2020, WORLD MED HEALTH POL, V12, P300, DOI 10.1002/wmh3.365; Hsiang S, 2020, NATURE, V584, P262, DOI 10.1038/s41586-020-2404-8; Hutchins SS, 2009, AM J PUBLIC HEALTH, V99, pS261, DOI 10.2105/AJPH.2009.161505; Jackson C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097297; Juni P, 2020, CAN MED ASSOC J, V192, pE566, DOI 10.1503/cmaj.200920; Kawano S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144839; Keni R, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00216; Kersten CA, 2022, DISASTER MED PUBLIC, V16, P1362, DOI 10.1017/dmp.2020.496; Kinsey EW, 2020, AM J PUBLIC HEALTH, V110, P1635, DOI 10.2105/AJPH.2020.305875; Kirkbride JB, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-001998; Litvinova M, 2019, P NATL ACAD SCI USA, V116, P13174, DOI 10.1073/pnas.1821298116; Markel H, 2007, JAMA-J AM MED ASSOC, V298, P644, DOI 10.1001/jama.298.6.644; Miller K., 2020, PRAISE INEQUITY KALA; Moore JT, 2020, MMWR-MORBID MORTAL W, V69, P1122, DOI 10.15585/mmwr.mm6933e1; National Center for Education Statistics, 2012, IMPROVING MEASUREMEN; National Center for Education Statistics, 2020, COMM COR DAT PUBL SC; Olson DR, 2020, MMWR-MORBID MORTAL W, V69, P603, DOI 10.15585/mmwr.mm6919e5; Owens A, 2016, AM EDUC RES J, V53, P1159, DOI 10.3102/0002831216652722; Patel A, 2020, MMWR-MORBID MORTAL W, V69, P140, DOI 10.15585/mmwr.mm6905e1; Qualls N, 2017, MMWR RECOMM REP, V66, P1, DOI 10.15585/mmwr.rr6601a1; Quinn D. M., 2017, SUMMER LEARNING LOSS; Ralston K., 2017, CHILDRENS FOOD SECUR, DOI 10.22004/ag.econ.259730; Rothan HA, 2020, J AUTOIMMUN, V109, DOI 10.1016/j.jaut.2020.102433; Russell ES, 2016, OPEN FORUM INFECT DI, V3, DOI 10.1093/ofid/ofw113; Sato Tomoki, 2013, Nihon Koshu Eisei Zasshi, V60, P204, DOI 10.11236/jph.60.4_204; Saunders-Hastings PR, 2016, PATHOGENS, V5, DOI 10.3390/pathogens5040066; Schuchat A, 2020, MMWR-MORBID MORTAL W, V69, P551, DOI 10.15585/mmwr.mm6918e2; Schwartz AE, 2020, J POLICY ANAL MANAG, V39, P376, DOI 10.1002/pam.22175; Schwartz HL, 2020, RAND; Stern AM, 2009, HEALTH AFFAIR, V28, pW1066, DOI 10.1377/hlthaff.28.6.w1066; Stern AM, 2010, PUBLIC HEALTH REP, V125, P63, DOI 10.1177/00333549101250S309; The U.S. Community Preventive Services Task Force (CPSTF), 2015, EM PREP RESP SCH DIS; US Centers for Disease Control and Prevention, 2020, INT GUID ADM US K 12; Uscher-Pines L, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5302-3; Wahl V., 2020, CRONKITE NEWS; Wong KK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113755; Yehya N., 2020, CLIN INFECT DIS, DOI [10.1093/cid/ciaa923, DOI 10.1093/CID/CIAA923]; Zviedrite N, 2019, P OPT 10 CONTR INFL	59	9	9	3	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2021	16	9							e0248925	10.1371/journal.pone.0248925	http://dx.doi.org/10.1371/journal.pone.0248925			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	WG5RP	34520475	Green Published, Green Submitted, gold			2022-12-26	WOS:000707052100002
J	Gonzalez-Rincon, J; Garcia-Vela, JA; Gomez, S; Fernandez-Cuevas, B; Nova-Gurumeta, S; Perez-Sanz, N; Alcoceba, M; Gonzalez, M; Anguita, E; Lopez-Jimenez, J; Gonzalez-Barca, E; Yanez, L; Perez-Persona, E; de la Serna, J; Fernaadez-Zarzoso, M; Deben, G; Penalver, FJ; Fernandez, MC; de Oteyza, JP; Andreu, MA; Ruiz-Guinaldo, MA; Paz-Arias, R; Garcia-Malo, MD; Recasens, V; Collado, R; Cordoba, R; Navarro-Matilla, B; Sanchez-Beato, M; Garcia-Marco, JA				Gonzalez-Rincon, Julia; Garcia-Vela, Jose A.; Gomez, Sagrario; Fernandez-Cuevas, Belen; Nova-Gurumeta, Sara; Perez-Sanz, Nuria; Alcoceba, Miguel; Gonzalez, Marcos; Anguita, Eduardo; Lopez-Jimenez, Javier; Gonzalez-Barca, Eva; Yanez, Lucrecia; Perez-Persona, Ernesto; de la Serna, Javier; Fernandez-Zarzoso, Miguel; Deben, Guillermo; Penalver, Francisco J.; Fernandez, Maria C.; de Oteyza, Jaime Perez; Andreu, M. angeles; Ruiz-Guinaldo, M. angeles; Paz-Arias, Raquel; Garcia-Malo, M. Dolores; Recasens, Valle; Collado, Rosa; Cordoba, Raul; Navarro-Matilla, Belen; Sanchez-Beato, Margarita; Garcia-Marco, Jose A.			Genomic mutation profile in progressive chronic lymphocytic leukemia patients prior to first-line chemoimmunotherapy with FCR and rituximab maintenance (REM)	PLOS ONE			English	Article							RECURRENT MUTATIONS; CLINICAL IMPACT; CODING GENOME; CLL; FLUDARABINE; NOTCH1; SURVIVAL; SF3B1; TP53; CYCLOPHOSPHAMIDE	Chronic Lymphocytic Leukemia (CLL) is the most prevalent leukemia in Western countries and is notable for its variable clinical course. This variability is partly reflected by the mutational status of IGHV genes. Many CLL samples have been studied in recent years by next-generation sequencing. These studies have identified recurrent somatic mutations in NOTCH1, SF3B1, ATM, TP53, BIRC3 and others genes that play roles in cell cycle, DNA repair, RNA metabolism and splicing. In this study, we have taken a deep-targeted massive sequencing approach to analyze the impact of mutations in the most frequently mutated genes in patients with CLL enrolled in the REM (rituximab en mantenimiento) clinical trial. The mutational status of our patients with CLL, except for the TP53 gene, does not seem to affect the good results obtained with maintenance therapy with rituximab after front-line FCR treatment.	[Gonzalez-Rincon, Julia; Gomez, Sagrario; Sanchez-Beato, Margarita] Inst Invest Sanitaria Puerta de Hierro Segovia de, Lymphoma Res Grp, Madrid, Spain; [Gonzalez-Rincon, Julia; Alcoceba, Miguel; Gonzalez, Marcos; Sanchez-Beato, Margarita] Ctr Invest Biomed Red Canc CIBERONC, Madrid, Spain; [Garcia-Vela, Jose A.] Hosp Univ Getafe, Hematol Dept, Madrid, Spain; [Fernandez-Cuevas, Belen; Nova-Gurumeta, Sara; Perez-Sanz, Nuria; Navarro-Matilla, Belen; Garcia-Marco, Jose A.] Hosp Univ Puerta de Hierro, Hematol Dept, Madrid, Spain; [Fernandez-Cuevas, Belen; Nova-Gurumeta, Sara; Perez-Sanz, Nuria; Navarro-Matilla, Belen; Garcia-Marco, Jose A.] Inst Invest Sanitaria Puerta de Hierro Segovia de, Madrid, Spain; [Alcoceba, Miguel; Gonzalez, Marcos] Hosp Univ Salamanca, Hematol, Salamanca, Spain; [Anguita, Eduardo] UCM, IdISSC, Hosp Clin San Carlos, Hematol, Madrid, Spain; [Lopez-Jimenez, Javier] Hosp Ramon & Cajal, Hematol, Madrid, Spain; [Gonzalez-Barca, Eva] Inst Catala Oncol, IDIBELL, Hematol, Lhospitalet De Llobregat, Spain; [Yanez, Lucrecia] Hosp Univ Marques de Valdecilla, Hematol, Santander, Spain; [Perez-Persona, Ernesto] Hosp Txagorritxu, Hematol, Vitoria, Spain; [de la Serna, Javier] Hosp Doce Octubre, Hematol, Madrid, Spain; [Fernandez-Zarzoso, Miguel] Hosp Univ Dr Peset, Hematol, Valencia, Spain; [Deben, Guillermo] CHU Juan Canalejo, Hematol, La Coruna, Spain; [Penalver, Francisco J.] Fdn Hosp Alcorcon, Hematol, Madrid, Spain; [Fernandez, Maria C.] Hosp Univ Puerta del Mar, Hematol, Cadiz, Spain; [de Oteyza, Jaime Perez] Hosp Madrid Norte Sanchinarro, Hematol, Madrid, Spain; [Andreu, M. angeles] Hosp Gen Mostoles, Hematol, Madrid, Spain; [Ruiz-Guinaldo, M. angeles] Hosp Francesc Borja, Hematol, Valencia, Spain; [Paz-Arias, Raquel] Hosp Univ La Paz, Hematol, Madrid, Spain; [Garcia-Malo, M. Dolores] Hosp Morales Meseguer, Hematol, Murcia, Spain; [Recasens, Valle] Hosp Miguel Servet, Hematol, Zaragoza, Spain; [Collado, Rosa] Consorcio Hosp Gen Univ, Citogenet & Mol Biol Lab, Valencia, Spain; [Cordoba, Raul] Hosp Fdn Jimenez Diaz, Hematol, Madrid, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBERONC; Hospital Universitario de Getafe; Hospital Puerta de Hierro-Majadahonda; Complutense University of Madrid; Hospital Clinico San Carlos; Hospital Universitario Ramon y Cajal; Catalan Institute of Oncology; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Hospital Universitario Marques de Valdecilla (HUMV); University Hospital of Araba; Hospital Universitario 12 de Octubre; Complejo Hospitalario Universitario A Coruna; Alcorcon Foundation University Hospital; Universidad de Cadiz; Hospital Universitario Puerta del Mar; Hospital Universitario La Paz; Miguel Servet University Hospital	Sanchez-Beato, M (corresponding author), Inst Invest Sanitaria Puerta de Hierro Segovia de, Lymphoma Res Grp, Madrid, Spain.; Sanchez-Beato, M (corresponding author), Ctr Invest Biomed Red Canc CIBERONC, Madrid, Spain.; Garcia-Marco, JA (corresponding author), Hosp Univ Puerta de Hierro, Hematol Dept, Madrid, Spain.; Garcia-Marco, JA (corresponding author), Inst Invest Sanitaria Puerta de Hierro Segovia de, Madrid, Spain.	msbeato@idiphim.org; jagarciam@aehh.org	Collado Nieto, Rosa María/GZK-9557-2022; Sanchez-Beato, Margarita/G-8753-2012; Alcoceba, Miguel/AAH-2784-2020; Anguita, Eduardo/AAA-2097-2019; Alcoceba, Miguel/GXH-4002-2022	Sanchez-Beato, Margarita/0000-0002-0058-7599; Anguita, Eduardo/0000-0003-1386-4943; Alcoceba, Miguel/0000-0002-3819-4846; Collado, Rosa/0000-0002-8205-6192; PEREZ DE OTEYZA, JAIME/0000-0002-8338-2037; Perez Persona, Ernesto/0000-0002-2082-4213	Instituto de Salud Carlos III (ISCII) of the Spanish Ministry of Economy and Competence (MINECO) ISCIII-MINECO AES-FEDER [RD12/0036/0060, PI14/00221, PIE14/0064, PI17/00272, CB16/12/00291, CB16/12/00233]; Comunidad Autonoma de Madrid [B2017/BMD3778]; Fundacion de la Asociacion Espanola Contra el Cancer; Roche Farma, S.A., Madrid, Spain; iPFIS predoctoral fellowship [IFI14/00003]; ISCIII-MINECO AES-FEDER (Plan Estatal I+D+I 2013-2016) [CPII16/00024]; Fundacion de Investigacion Biomedica Puerta de Hierro	Instituto de Salud Carlos III (ISCII) of the Spanish Ministry of Economy and Competence (MINECO) ISCIII-MINECO AES-FEDER; Comunidad Autonoma de Madrid(Comunidad de Madrid); Fundacion de la Asociacion Espanola Contra el Cancer; Roche Farma, S.A., Madrid, Spain; iPFIS predoctoral fellowship; ISCIII-MINECO AES-FEDER (Plan Estatal I+D+I 2013-2016); Fundacion de Investigacion Biomedica Puerta de Hierro	This work was supported by the Instituto de Salud Carlos III (ISCII) of the Spanish Ministry of Economy and Competence (MINECO) ISCIII-MINECO AES-FEDER (Plan Estatal de I+D+I 2008-2011 and 2013-2016 https://www.isciii.es/QueHacemos/Financiacion/Paginas/Accion-Estrategica-en-Salud.aspx) (MSB: RD12/0036/0060, PI14/00221, PIE14/0064, PI17/00272; MSB and JGR: CIBERONC CB16/12/00291, MA and MG: CB16/12/00233), Comunidad Auto ' noma de Madrid (https://www.comunidad.madrid/servicios/educacion/convocatorias-ayudas-investigacion) (MSB: B2017/BMD3778), MSB: Fundacion de la Asociacion Espanola Contra el Cancer (https://www.aecc.es/es/investigacion/fundacion-cientificaaecc) and JAGM: Roche Farma, S.A., Madrid, Spain. JGR was a recipient of an iPFIS predoctoral fellowship (IFI14/00003) and MSB held a Miguel Servet II contract (CPII16/00024), supported by ISCIII-MINECO AES-FEDER (Plan Estatal I+D+I 2013-2016) and the Fundacion de Investigacion Biomedica Puerta de Hierro. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benedetti D, 2018, LEUKEMIA, V32, P654, DOI 10.1038/leu.2017.296; Blakemore SJ, 2020, LEUKEMIA, V34, P1760, DOI 10.1038/s41375-020-0723-2; Bottcher S, 2012, J CLIN ONCOL, V30, P980, DOI 10.1200/JCO.2011.36.9348; Bradburn MJ, 2003, BRIT J CANCER, V89, P605, DOI 10.1038/sj.bjc.6601120; Burns A, 2018, LEUKEMIA, V32, P573, DOI 10.1038/leu.2017.311; Damm F, 2014, CANCER DISCOV, V4, P1088, DOI 10.1158/2159-8290.CD-14-0104; Domenech E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038158; Fabbri G, 2011, J EXP MED, V208, P1389, DOI 10.1084/jem.20110921; Fischer K, 2019, NEW ENGL J MED, V380, P2225, DOI 10.1056/NEJMoa1815281; Fischer K, 2016, BLOOD, V127, P208, DOI 10.1182/blood-2015-06-651125; Garcia-Marco JA, 2019, HAEMATOLOGICA, V104, P2249, DOI 10.3324/haematol.2018.204891; Guieze R, 2015, BLOOD, V126, P2110, DOI 10.1182/blood-2015-05-647578; Guieze R, 2015, BLOOD, V126, P445, DOI 10.1182/blood-2015-02-585042; Hamblin TJ, 1999, BLOOD, V94, P1848, DOI 10.1182/blood.V94.6.1848; Kater AP, 2020, J CLIN ONCOL, V38, DOI 10.1200/JCO.20.00948; Landau DA, 2015, NATURE, V526, P525, DOI 10.1038/nature15395; Landau DA, 2013, CELL, V152, P714, DOI 10.1016/j.cell.2013.01.019; Ljungstrom V, 2016, BLOOD, V127, P1007, DOI 10.1182/blood-2015-10-674572; Nadeu F, 2016, BLOOD, V127, P2122, DOI 10.1182/blood-2015-07-659144; Perez C, 2015, HAEMATOLOGICA, V100, pE450, DOI 10.3324/haematol.2015.132837; Puente XS, 2011, NATURE, V475, P101, DOI 10.1038/nature10113; Quesada V, 2012, NAT GENET, V44, P47, DOI 10.1038/ng.1032; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Rosenquist R, 2017, LEUKEMIA, V31, P1477, DOI 10.1038/leu.2017.125; Rosenwald A, 2001, J EXP MED, V194, P1639, DOI 10.1084/jem.194.11.1639; Rossi D, 2015, BLOOD, V126, P1921, DOI 10.1182/blood-2015-05-647925; Rossi D, 2012, J EXP MED, V209, P1537, DOI 10.1084/jem.20120904; Rossi D, 2012, BLOOD, V119, P2854, DOI 10.1182/blood-2011-12-395673; Schnaiter A, 2013, BLOOD, V122, P1266, DOI 10.1182/blood-2013-03-488197; Shanafelt TD, 2019, NEW ENGL J MED, V381, P432, DOI 10.1056/NEJMoa1817073; Stilgenbauer S, 2014, BLOOD, V123, P3247, DOI 10.1182/blood-2014-01-546150; Thompson PA, 2016, BLOOD, V127, P303, DOI 10.1182/blood-2015-09-667675; Wang LL, 2011, NEW ENGL J MED, V365, P2497, DOI 10.1056/NEJMoa1109016	33	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2021	16	9							e0257353	10.1371/journal.pone.0257353	http://dx.doi.org/10.1371/journal.pone.0257353			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XM9EM	34506616	Green Published, gold			2022-12-26	WOS:000729120700073
J	Miranda, SP; Baiao, FA; Fleck, JL; Piccolo, SR				Miranda, Sofia P.; Baiao, Fernanda A.; Fleck, Julia L.; Piccolo, Stephen R.			Predicting drug sensitivity of cancer cells based on DNA methylation levels	PLOS ONE			English	Article							CPG ISLAND HYPERMETHYLATION; MESENCHYMAL TRANSITION; LINES; TEMOZOLOMIDE; DISCOVERY; CARCINOMA; RESOURCE; PROFILE	Cancer cell lines, which are cell cultures derived from tumor samples, represent one of the least expensive and most studied preclinical models for drug development. Accurately predicting drug responses for a given cell line based on molecular features may help to optimize drug-development pipelines and explain mechanisms behind treatment responses. In this study, we focus on DNA methylation profiles as one type of molecular feature that is known to drive tumorigenesis and modulate treatment responses. Using genome-wide, DNA methylation profiles from 987 cell lines in the Genomics of Drug Sensitivity in Cancer database, we used machine-learning algorithms to evaluate the potential to predict cytotoxic responses for eight anti-cancer drugs. We compared the performance of five classification algorithms and four regression algorithms representing diverse methodologies, including tree-, probability-, kernel-, ensemble-, and distance-based approaches. We artificially subsampled the data to varying degrees, aiming to understand whether training based on relatively extreme outcomes would yield improved performance. When using classification or regression algorithms to predict discrete or continuous responses, respectively, we consistently observed excellent predictive performance when the training and test sets consisted of cell-line data. Classification algorithms performed best when we trained the models using cell lines with relatively extreme drug-response values, attaining area-under-the-receiver-operating-characteristic-curve values as high as 0.97. The regression algorithms performed best when we trained the models using the full range of drug-response values, although this depended on the performance metrics we used. Finally, we used patient data from The Cancer Genome Atlas to evaluate the feasibility of classifying clinical responses for human tumors based on models derived from cell lines. Generally, the algorithms were unable to identify patterns that predicted patient responses reliably; however, predictions by the Random Forests algorithm were significantly correlated with Temozolomide responses for low-grade gliomas.	[Miranda, Sofia P.; Baiao, Fernanda A.] Pontificia Univ Catolica Rio de Janeiro, Dept Ind Engn, Rio De Janeiro, RJ, Brazil; [Fleck, Julia L.] Univ Clermont Auvergne, CNRS, UMR 6158, Mines St Etienne,LIMOS,Ctr CIS, St Etienne, France; [Piccolo, Stephen R.] Brigham Young Univ, Dept Biol, Provo, UT 84602 USA	Centre National de la Recherche Scientifique (CNRS); Universite Clermont Auvergne (UCA); IMT - Institut Mines-Telecom; Mines Saint-Etienne; Brigham Young University	Fleck, JL (corresponding author), Univ Clermont Auvergne, CNRS, UMR 6158, Mines St Etienne,LIMOS,Ctr CIS, St Etienne, France.; Piccolo, SR (corresponding author), Brigham Young Univ, Dept Biol, Provo, UT 84602 USA.	julia.fleck@emse.fr; stephen_piccolo@byu.edu	; Lima Fleck, Julia/H-7354-2014	Baiao, Fernanda/0000-0001-7932-7134; Lima Fleck, Julia/0000-0001-7980-1887	Coordination for the Improvement of Higher Education Personnel (CAPES) [001]	Coordination for the Improvement of Higher Education Personnel (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported in part by the Coordination for the Improvement of Higher Education Personnel (CAPES) - Finance Code 001. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali M, 2018, BIOINFORMATICS, V34, P1353, DOI 10.1093/bioinformatics/btx766; Ammad-Ud-Din M, 2017, BIOINFORMATICS, V33, pI359, DOI 10.1093/bioinformatics/btx266; Ammad-ud-din M, 2016, BIOINFORMATICS, V32, P455, DOI 10.1093/bioinformatics/btw433; Arany I, 2004, AM J PHYSIOL-RENAL, V287, pF543, DOI 10.1152/ajprenal.00112.2004; Arechederra M, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05550-5; Azuaje F, 2017, BRIEF BIOINFORM, V18, P820, DOI 10.1093/bib/bbw065; Baldi P, 2000, BIOINFORMATICS, V16, P412, DOI 10.1093/bioinformatics/16.5.412; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Basu A, 2013, CELL, V154, P1151, DOI 10.1016/j.cell.2013.08.003; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bischl B, 2016, J MACH LEARN RES, V17; Borisov N, 2018, CELL CYCLE, V17, P486, DOI 10.1080/15384101.2017.1417706; Breiman, 1997, 486 U CAL STAT DEP; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Breiman L., 2001, MACH LEARN, V45, P5; Cameron AC, 1997, J ECONOMETRICS, V77, P329; Chang Y, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-27214-6; Chen T., 2015, XGBOOST EXTREME GRAD, V1, P1; Chen TH, 2017, BIOSTATISTICS, V18, P1, DOI 10.1093/biostatistics/kxw022; Chiu YC, 2019, BMC MED GENOMICS, V12, DOI 10.1186/s12920-018-0460-9; Choi M, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02160-5; Cortes-Ciriano I, 2016, BIOINFORMATICS, V32, P85, DOI 10.1093/bioinformatics/btv529; Costello JC, 2014, NAT BIOTECHNOL, V32, P1202, DOI 10.1038/nbt.2877; COVER TM, 1967, IEEE T INFORM THEORY, V13, P21, DOI 10.1109/TIT.1967.1053964; Dhruba SR, 2018, BMC BIOINFORMATICS, V19, DOI 10.1186/s12859-018-2465-y; Ding MQ, 2018, MOL CANCER RES, V16, P269, DOI 10.1158/1541-7786.MCR-17-0378; Ding ZJ, 2016, BIOINFORMATICS, V32, P2891, DOI 10.1093/bioinformatics/btw344; Dong ZL, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1492-6; Emdadi A, 2020, FRONT GENET, V11, DOI 10.3389/fgene.2020.00075; Esteller M, 2002, ONCOGENE, V21, P5427, DOI 10.1038/sj.onc.1205600; Esteller M, 2001, CANCER RES, V61, P3225; Faivre S, 2006, SEMIN ONCOL, V33, P407, DOI 10.1053/j.seminoncol.2006.04.005; Fan Jerome, 2006, CJEM, V8, P19; Fleck JL, 2019, MOL OMICS, V15, P399, DOI 10.1039/c9mo00119k; Fleck JL, 2016, BMC SYST BIOL, V10, DOI 10.1186/s12918-016-0255-6; Forbes SA, 2017, NUCLEIC ACIDS RES, V45, pD777, DOI 10.1093/nar/gkw1121; Forman G., 2003, Journal of Machine Learning Research, V3, P1289, DOI 10.1162/153244303322753670; Frederick BA, 2007, MOL CANCER THER, V6, P1683, DOI 10.1158/1535-7163.MCT-07-0138; Geeleher P, 2017, GENOME RES, V27, P1743, DOI 10.1101/gr.221077.117; Geeleher P, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-3-r47; Guan NN, 2019, MOL THER-NUCL ACIDS, V17, P164, DOI 10.1016/j.omtn.2019.05.017; Gupta S, 2016, SCI REP-UK, V6, DOI 10.1038/srep23857; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hegi ME, 2005, NEW ENGL J MED, V352, P997, DOI 10.1056/NEJMoa043331; Hirohashi S, 2003, CANCER SCI, V94, P575, DOI 10.1111/j.1349-7006.2003.tb01485.x; Huang C, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-34753-5; Huang EW, 2020, PLOS COMPUT BIOL, V16, DOI 10.1371/journal.pcbi.1007607; Hudson TJ, 2010, NATURE, V464, P993, DOI 10.1038/nature08987; Hutter C, 2018, CELL, V173, P283, DOI 10.1016/j.cell.2018.03.042; Iorio F, 2016, CELL, V166, P740, DOI 10.1016/j.cell.2016.06.017; Leek JT, 2010, NAT REV GENET, V11, P733, DOI 10.1038/nrg2825; Leek JT., 2020, R PACKAGE VERSION 33; Liberzon A, 2011, BIOINFORMATICS, V27, P1739, DOI 10.1093/bioinformatics/btr260; Lipson KE, 2012, FIBROGENESIS TISSUE, V5, DOI 10.1186/1755-1536-5-S1-S24; MARON ME, 1961, J ACM, V8, P404, DOI 10.1145/321075.321084; Masters JRW, 2000, NAT REV MOL CELL BIO, V1, P233, DOI 10.1038/35043102; McLeod HL, 2013, SCIENCE, V339, P1563, DOI 10.1126/science.1234139; Menden MP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061318; Meyer David, 2021, CRAN; Moughari FA, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-71257-7; Naik UP, 2003, J BIOL REG HOMEOS AG, V17, P341; Nguyen GTT, 2018, PROCEEDINGS OF THE NINTH INTERNATIONAL SYMPOSIUM ON INFORMATION AND COMMUNICATION TECHNOLOGY (SOICT 2018), P410, DOI 10.1145/3287921.3287974; Oskooei A, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-52093-w; Parca L, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-50720-0; R Core Team, 2020, R LANG ENV STAT COMP; Rahman R, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11665-4; Rees J, 2015, J NEUROL NEUROSUR PS, V86, P359, DOI 10.1136/jnnp-2014-308880; Schiffner J., 2016, ARXIV PREPRINT ARXIV; Schliep K., 2016, R PACKAGE VERSION, V1; Sebaugh JL, 2011, PHARM STAT, V10, P128, DOI 10.1002/pst.426; Shen LL, 2007, CANCER RES, V67, P11335, DOI 10.1158/0008-5472.CAN-07-1502; Spearman C, 1904, AM J PSYCHOL, V15, P72, DOI 10.2307/1412159; Stanfield Z, 2017, ACM-BCB' 2017: PROCEEDINGS OF THE 8TH ACM INTERNATIONAL CONFERENCE ON BIOINFORMATICS, COMPUTATIONAL BIOLOGY,AND HEALTH INFORMATICS, P638, DOI [10.1145/3107411.3107459, 10.1038/srep40321, 10.1038/srep44961]; Stetson LC, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-S7-S2; Su R, 2020, BRIEF BIOINFORM, V21, P996, DOI 10.1093/bib/bbz022; Su R, 2019, METHODS, V166, P91, DOI 10.1016/j.ymeth.2019.02.009; Suphavilai C, 2018, BIOINFORMATICS, V34, P3907, DOI 10.1093/bioinformatics/bty452; Szyf M, 2008, CURR ONCOL, V15, P72; SZYF M, 1994, TRENDS PHARMACOL SCI, V15, P233, DOI 10.1016/0165-6147(94)90317-4; Thomson S, 2005, CANCER RES, V65, P9455, DOI 10.1158/0008-5472.CAN-05-1058; Tomczak Katarzyna, 2015, Contemp Oncol (Pozn), V19, pA68, DOI 10.5114/wo.2014.47136; Turki T, 2017, IEEE ACCESS, V5, P7381, DOI 10.1109/ACCESS.2017.2696523; Vapnik V, 1998, NONLINEAR MODELING, P55; Veeck J, 2010, J CLIN ONCOL, V28, pE563, DOI 10.1200/JCO.2010.30.1010; Wang L, 2017, BMC CANCER, V17, DOI 10.1186/s12885-017-3500-5; Wang XW, 2019, BMC MED GENOMICS, V12, DOI 10.1186/s12920-018-0449-4; Webber JT, 2018, CELL SYST, V7, P526, DOI 10.1016/j.cels.2018.10.001; Witta SE, 2006, CANCER RES, V66, P944, DOI 10.1158/0008-5472.CAN-05-1988; Xu XL, 2019, FRONT GENET, V10, DOI 10.3389/fgene.2019.00233; Yang WJ, 2013, NUCLEIC ACIDS RES, V41, pD955, DOI 10.1093/nar/gks1111; Yao Yixin, 2014, J Carcinog Mutagen, V5; Yauch RL, 2005, CLIN CANCER RES, V11, P8686, DOI 10.1158/1078-0432.CCR-05-1492; Yuan H, 2016, SCI REP-UK, V6, DOI 10.1038/srep31619; Yuan Y, 2014, NAT BIOTECHNOL, V32, P644, DOI 10.1038/nbt.2940; Zawadzki Z., 2020, **DATA OBJECT**; Zhang NQ, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004498; Zhao Q, 2015, BRIEF BIOINFORM, V16, P291, DOI 10.1093/bib/bbu003	98	0	0	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2021	16	9							e0238757	10.1371/journal.pone.0238757	http://dx.doi.org/10.1371/journal.pone.0238757			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XM9EM	34506489	gold, Green Submitted, Green Published			2022-12-26	WOS:000729120700012
J	Rachev, NR; Han, HM; Lacko, D; Gelpi, R; Yamada, Y; Lieberoth, A				Rachev, Nikolay R.; Han, Hyemin; Lacko, David; Gelpi, Rebekah; Yamada, Yuki; Lieberoth, Andreas			Replicating the Disease framing problem during the 2020 COVID-19 pandemic: A study of stress, worry, trust, and choice under risk	PLOS ONE			English	Article							DECISION-MAKING; ATTITUDES; ANGER; HYPOTHESIS; APPRAISAL; DISTRUST; DISTRESS; EMOTION; VALUES; FEAR	In the risky-choice framing effect, different wording of the same options leads to predictably different choices. In a large-scale survey conducted from March to May 2020 and including 88,181 participants from 47 countries, we investigated how stress, concerns, and trust moderated the effect in the Disease problem, a prominent framing problem highly evocative of the COVID-19 pandemic. As predicted by the appraisal-tendency framework, risk aversion and the framing effect in our study were larger than under typical circumstances. Furthermore, perceived stress and concerns over coronavirus were positively associated with the framing effect. Contrary to predictions, however, they were not related to risk aversion. Trust in the government's efforts to handle the coronavirus was associated with neither risk aversion nor the framing effect. The proportion of risky choices and the framing effect varied substantially across nations. Additional exploratory analyses showed that the framing effect was unrelated to reported compliance with safety measures, suggesting, along with similar findings during the pandemic and beyond, that the effectiveness of framing manipulations in public messages might be limited. Theoretical and practical implications of these findings are discussed, along with directions for further investigations.	[Rachev, Nikolay R.] Sofia Univ St Kliment Ohridski, Dept Gen Expt Dev & Hlth Psychol, Sofia, Bulgaria; [Han, Hyemin] Univ Alabama, Educ Psychol Program, Tuscaloosa, AL USA; [Lacko, David] Masaryk Univ, Fac Social Stud, Interdisciplinary Res Team Internet & Soc, Brno, Czech Republic; [Gelpi, Rebekah] Univ Toronto, Dept Psychol, Toronto, ON, Canada; [Yamada, Yuki] Kyushu Univ, Fac Arts & Sci, Fukuoka, Japan; [Lieberoth, Andreas] Aarhus Univ, Danish Sch Educ, Aarhus, Denmark	University of Sofia; University of Alabama System; University of Alabama Tuscaloosa; Masaryk University Brno; University of Toronto; Kyushu University; Aarhus University	Rachev, NR (corresponding author), Sofia Univ St Kliment Ohridski, Dept Gen Expt Dev & Hlth Psychol, Sofia, Bulgaria.	nrrachev@phls.uni-sofia.bg	Han, Hyemin/D-2808-2014; Lacko, David/A-4297-2019; Rachev, Nikolay/X-3012-2018; Yamada, Yuki/B-2671-2008	Han, Hyemin/0000-0001-7181-2565; Lacko, David/0000-0002-2904-8118; Lieberoth, Andreas/0000-0003-0214-5791; Gelpi, Rebekah/0000-0001-6899-0520; Rachev, Nikolay/0000-0002-5654-2883; Yamada, Yuki/0000-0003-1431-568X	Japan Society for the Promotion of Science KAKENHI [JP20H04581]	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The authors disclose receipt of the following financial support for the publication of this article after the decision of acceptance: Japan Society for the Promotion of Science (https://www.jsps.go.jp/english/) KAKENHI Grant Numbers JP20H04581 (Y.Y.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychological Association, STRESS AM 2019 INT G; American Psychological Association, 2014, STRESS AM SURV METH; Bates D, 2020, **DATA OBJECT**; Benjamin DJ, 2018, NAT HUM BEHAV, V2, P6, DOI 10.1038/s41562-017-0189-z; BERGER JO, 1987, J AM STAT ASSOC, V82, P112, DOI 10.2307/2289131; Brumagim AL, 2005, MULTINATL BUS REV, V13, P67, DOI 10.1108/1525383X200500015; Bu Di., 2020, COVID EC, V5, P106, DOI DOI 10.2139/SSRN.3559870; Buarkner P.-C., 2020, BRMS BAYESIAN REGRES; BYRNE BM, 1989, PSYCHOL BULL, V105, P456, DOI 10.1037/0033-2909.105.3.456; Campos-Mercade P, 2021, J PUBLIC ECON, V195, DOI 10.1016/j.jpubeco.2021.104367; Cassotti M, 2012, EMOTION, V12, P926, DOI 10.1037/a0026788; Chaaya M, 2010, BMC PSYCHIATRY, V10, DOI 10.1186/1471-244X-10-111; Chen FF, 2007, STRUCT EQU MODELING, V14, P464, DOI 10.1080/10705510701301834; Cheung E, 2011, EMOTION, V11, P852, DOI 10.1037/a0022854; COHEN S, 1983, J HEALTH SOC BEHAV, V24, P385, DOI 10.2307/2136404; COHEN S, 1988, CLAR SYMP, P31; Cohen S, 2012, J APPL SOC PSYCHOL, V42, P1320, DOI 10.1111/j.1559-1816.2012.00900.x; Davidov E, 2018, SURV RES METHODS-GER, V12, P15, DOI 10.18148/srm/2018.v12i1.7212; De Martino B, 2006, SCIENCE, V313, P684, DOI 10.1126/science.1128356; Dimoka A, 2010, MIS QUART, V34, P373; Dohmen T, 2011, J EUR ECON ASSOC, V9, P522, DOI 10.1111/j.1542-4774.2011.01015.x; Dorison CA, COVID 19 PUBLIC HLTH; Druckman JN, 2008, POLIT BEHAV, V30, P297, DOI 10.1007/s11109-008-9056-y; Dunn JR, 2005, J PERS SOC PSYCHOL, V88, P736, DOI 10.1037/0022-3514.88.5.736; Eckel CC, 2002, EVOL HUM BEHAV, V23, P281, DOI 10.1016/S1090-5138(02)00097-1; Fagley NS, 2010, PERS INDIV DIFFER, V48, P264, DOI 10.1016/j.paid.2009.10.008; Fischer R, 2019, FRONT PSYCHOL, V10, DOI 10.3389/fpsyg.2019.01507; Fischhoff B, 2005, J EXP PSYCHOL-APPL, V11, P124, DOI [10.1037/1076-898X.11.2.124, 10.1037/a0027959]; Gong JJ, 2013, PSYCHOL HEALTH MED, V18, P645, DOI 10.1080/13548506.2013.766352; Habersaat KB, 2020, NAT HUM BEHAV, V4, P677, DOI 10.1038/s41562-020-0906-x; Habib M, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00253; Hameleers M, 2021, MASS COMMUN SOC, V24, P479, DOI 10.1080/15205436.2020.1870144; Han H, 2021, PERS INDIV DIFFER, V176, DOI 10.1016/j.paid.2021.110787; Han H, 2020, COGN NEUROSCI-UK, V11, P157, DOI [10.1080/17588928.2019.1700222, 10.1080/17588928.2019.1570103]; Han H, 2018, J MORAL EDUC, V47, P519, DOI 10.1080/03057240.2018.1463204; Han S, 2007, J CONSUM PSYCHOL, V17, P158, DOI 10.1016/S1057-7408(07)70023-2; Hoff Ahna L, 2002, Res Theory Nurs Pract, V16, P223, DOI 10.1891/rtnp.16.4.223.53023; Holt CA, 2002, AM ECON REV, V92, P1644, DOI 10.1257/000282802762024700; Jang S, 2017, J CROSS CULT PSYCHOL, V48, P560, DOI 10.1177/0022022117697844; Jorgensen T. D., 2019, SEMTOOLS USEFUL TOOL; KAHNEMAN D, 1984, AM PSYCHOL, V39, P341, DOI 10.1037/0003-066X.39.4.341; Kahneman D., 2011, THINKING FAST SLOW; Kensinger EA, 2020, ANNU REV PSYCHOL, V71, P251, DOI 10.1146/annurev-psych-010419-051123; Keysers C, 2020, NAT NEUROSCI, V23, P788, DOI 10.1038/s41593-020-0660-4; Klein RA, 2014, SOC PSYCHOL-GERMANY, V45, P142, DOI 10.1027/1864-9335/a000178; Kuhberger A, 1998, ORGAN BEHAV HUM DEC, V75, P23, DOI 10.1006/obhd.1998.2781; l'Haridon O, 2019, QUANT ECON, V10, P185, DOI 10.3982/QE898; Leonard TC, 2008, CONST POLITICAL ECON, V19, P356, DOI 10.1007/s10602-008-9056-2; Lerner JS, 2003, PSYCHOL SCI, V14, P144, DOI 10.1111/1467-9280.01433; Lerner JS, 2001, J PERS SOC PSYCHOL, V81, P146, DOI 10.1037//0022-3514.81.1.146; Lieberoth A, 2020, COVIDISTRESS FRAMING; Lieberoth A, 2021, ROY SOC OPEN SCI, V8, DOI 10.1098/rsos.200589; Liu MN, 2010, COMMUN RES, V37, P443, DOI 10.1177/0093650210362681; Ma QG, 2015, NEUROREPORT, V26, P325, DOI 10.1097/WNR.0000000000000346; Mandel DR, 2014, J EXP PSYCHOL GEN, V143, P1185, DOI 10.1037/a0034207; Marshall R, 2011, J BUS RES, V64, P871, DOI 10.1016/j.jbusres.2010.09.009; Milfont TL, 2010, INT J PSYCHOL RES, V3, P111; Muller S, 2021, J PUBLIC ECON, V194, DOI 10.1016/j.jpubeco.2020.104322; Otterbring T, 2021, SAFETY SCI, V134, DOI 10.1016/j.ssci.2020.105065; Pierce M, 2020, LANCET PSYCHIAT, V7, P883, DOI 10.1016/S2215-0366(20)30308-4; Pinon A, 2005, PSICOTHEMA, V17, P325; R Core Team, 2020, R LANG ENV STAT COMP; Reyna V. F., 1991, Journal of Behavioral Decision Making, V4, P249, DOI 10.1002/bdm.3960040403; Rieger MO, 2015, MANAGE SCI, V61, P637, DOI 10.1287/mnsc.2013.1869; Roberti JW, 2006, J COLL COUNS, V9, P135, DOI 10.1002/j.2161-1882.2006.tb00100.x; Rosseel Y, 2012, J STAT SOFTW, V48, P1, DOI 10.18637/jss.v048.i02; Rouder JN, 2012, MULTIVAR BEHAV RES, V47, P877, DOI 10.1080/00273171.2012.734737; Rutkowski L, 2014, EDUC PSYCHOL MEAS, V74, P31, DOI 10.1177/0013164413498257; Sanders M, 2021, ECON LETT, V199, DOI 10.1016/j.econlet.2020.109433; Seo MG, 2010, ACAD MANAGE J, V53, P411, DOI 10.5465/AMJ.2010.49389383; Shanahan L, 2022, PSYCHOL MED, V52, P824, DOI 10.1017/S003329172000241X; Sher S, 2006, COGNITION, V101, P467, DOI 10.1016/j.cognition.2005.11.001; SMITH CA, 1985, J PERS SOC PSYCHOL, V48, P813, DOI 10.1037/0022-3514.48.4.813; Stan Development Team, 2020, STAN US GUID VERS 2; Stanton SJ, 2014, JUDGM DECIS MAK, V9, P167; Steiger A, 2018, Z PSYCHOL, V226, P45, DOI 10.1027/2151-2604/a000321; Stiegelis HE, 2004, PSYCHO-ONCOLOGY, V13, P248, DOI 10.1002/pon.738; TVERSKY A, 1981, SCIENCE, V211, P453, DOI 10.1126/science.7455683; TVERSKY A, 1986, J BUS, V59, pS251, DOI 10.1086/296365; Van Bavel JJ, 2020, NAT HUM BEHAV, V4, P460, DOI 10.1038/s41562-020-0884-z; Vieider FM, 2015, J EUR ECON ASSOC, V13, P421, DOI 10.1111/jeea.12102; Wagenmakers EJ, 2018, PSYCHON B REV, V25, P58, DOI [10.3758/s13423-017-1323-7, 10.3758/s13423-017-1343-3]; Yamada Y, 2021, SCI DATA, V8, DOI 10.1038/s41597-020-00784-9	84	6	6	4	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2021	16	9							e0257151	10.1371/journal.pone.0257151	http://dx.doi.org/10.1371/journal.pone.0257151			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	XM9EM	34506543	Green Published, gold			2022-12-26	WOS:000729120700003
J	Iwamoto, M; Masuya, T; Hosose, M; Tagawa, K; Ishibashi, T; Suyama, K; Nose, T; Yoshihara, E; Downes, M; Evans, RM; Matsushima, A				Iwamoto, Masaki; Masuya, Takahiro; Hosose, Mari; Tagawa, Koki; Ishibashi, Tomoka; Suyama, Keitaro; Nose, Takeru; Yoshihara, Eiji; Downes, Michael; Evans, Ronald M.; Matsushima, Ayami			Bisphenol A derivatives act as novel coactivator-binding inhibitors for estrogen receptor beta	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNITED-STATES; ER-ALPHA; ANALOGS; IDENTIFICATION; METHOXYCHLOR; CHEMICALS; LIGANDS	Bisphenol A and its derivatives are recognized as endocrine disruptors based on their complex effects on estrogen receptor (ER) signaling. While the effects of bisphenol derivatives on ER alpha have been thoroughly evaluated, how these chemicals affect ER beta signaling is less well understood. Herein, we sought to identify novel ER beta ligands using a radioligand competitive binding assay to screen a chemical library of bisphenol derivatives. Many of the compounds identified showed intriguing dual activities as both ER alpha agonists and ER beta antagonists. Docking simulations of these compounds and ER beta suggested that they bound not only to the canonical binding site of ER beta but also to the coactivator binding site located on the surface of the receptor, suggesting that they act as coactivator-binding inhibitors (CBIs). Receptor-ligand binding experiments using WT and mutated ER beta support the presence of a second ligand-interaction position at the coactivator-binding site in ER beta, and direct binding experiments of ER beta and a coactivator peptide confirmed that these compounds act as CBIs. Our study is the first to propose that bisphenol derivatives act as CBIs, presenting critical insight for the future development of ER signaling-based drugs and their potential to function as endocrine disruptors.	[Iwamoto, Masaki; Masuya, Takahiro; Hosose, Mari; Tagawa, Koki; Ishibashi, Tomoka; Suyama, Keitaro; Nose, Takeru; Matsushima, Ayami] Kyushu Univ, Fac Sci, Dept Chem, Fukuoka, Japan; [Yoshihara, Eiji; Downes, Michael; Evans, Ronald M.] Salk Inst Biol Studies, Gene Express Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA; [Yoshihara, Eiji] Harbor UCLA Med Ctr, Lundquist Inst Biomed Innovat, Torrance, CA 90509 USA; [Yoshihara, Eiji] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA	Kyushu University; Salk Institute; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Matsushima, A (corresponding author), Kyushu Univ, Fac Sci, Dept Chem, Fukuoka, Japan.	ayami@chem.kyushu-univ.jp	Suyama, Keitaro/ABE-4606-2022	Nose, Takeru/0000-0001-9771-7267; Yoshihara, Eiji/0000-0001-6324-6495; Downes, Michael/0000-0002-6351-9585; Matsushima, Ayami/0000-0001-9751-577X	NOMIS Foundation-Science of Health [JP17H01881, JP18K19147, 18KK0320, 20H00635];  [P42ES010337]	NOMIS Foundation-Science of Health; 	This work was supported by a grant-in-aid for scientific research JSPS KAKENHI JP17H01881, JP18K19147, 18KK0320, and 20H00635, to A. M. R. M. E. is supported by the NOMIS Foundation-Science of Health. M. D. and R. M. E. were supported in part by the National Institute of Environmental Health Sciences of the NIH under Award Number P42ES010337. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Auwerx J, 1999, CELL, V97, P161; Bauza A, 2015, CHEMPHYSCHEM, V16, P2496, DOI 10.1002/cphc.201500314; Cavallo G, 2016, CHEM REV, V116, P2478, DOI 10.1021/acs.chemrev.5b00484; Corbeil CR, 2012, J COMPUT AID MOL DES, V26, P775, DOI 10.1007/s10822-012-9570-1; Couse JF, 1999, SCIENCE, V286, P2328, DOI 10.1126/science.286.5448.2328; Deceuninck Y, 2015, ANAL BIOANAL CHEM, V407, P2485, DOI 10.1007/s00216-015-8469-9; Delfosse V, 2014, ENVIRON HEALTH PERSP, V122, P1306, DOI 10.1289/ehp.1408453; Delfosse V, 2012, P NATL ACAD SCI USA, V109, P14930, DOI 10.1073/pnas.1203574109; DOBKOWSKI Z, 1984, J APPL POLYM SCI, V29, P2683, DOI 10.1002/app.1984.070290901; DODDS E. C, 1936, NATURE [LONDON], V137, P996, DOI 10.1038/137996a0; Dupont S, 2000, DEVELOPMENT, V127, P4277; Evans RM, 2014, CELL, V157, P255, DOI 10.1016/j.cell.2014.03.012; FACTOR A, 1980, J POLYM SCI POL CHEM, V18, P579, DOI 10.1002/pol.1980.170180218; Gaido KW, 2000, MOL PHARMACOL, V58, P852, DOI 10.1124/mol.58.4.852; Gaido KW, 1999, ENDOCRINOLOGY, V140, P5746, DOI 10.1210/en.140.12.5746; Glustrom LW, 2002, J NATL CANCER I, V94, P1337; Hewitt SC, 2005, ANNU REV PHYSIOL, V67, P285, DOI 10.1146/annurev.physiol.67.040403.115914; Jurs JL, 2003, POLYMER, V44, P3709, DOI 10.1016/S0032-3861(03)00277-5; Kojima H, 2019, TOXICOLOGY, V413, P48, DOI 10.1016/j.tox.2018.12.001; Krege J. H., 1998, P NATL ACAD SCI USA, V90, P11162; Krege JH, 1998, P NATL ACAD SCI USA, V95, P15677, DOI 10.1073/pnas.95.26.15677; Kuiper GGJM, 1998, ENDOCRINOLOGY, V139, P4252, DOI 10.1210/en.139.10.4252; Kuiper GGJM, 1996, P NATL ACAD SCI USA, V93, P5925, DOI 10.1073/pnas.93.12.5925; Kuiper GGJM, 1997, ENDOCRINOLOGY, V138, P863, DOI 10.1210/en.138.3.863; Kumar S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5537; Li Y, 2018, ENVIRON HEALTH PERSP, V126, DOI [10.1289/EHP2505, 10.1289/ehp2505]; Liao CY, 2012, ENVIRON SCI TECHNOL, V46, P11558, DOI 10.1021/es303191g; Liao CY, 2012, ENVIRON SCI TECHNOL, V46, P9138, DOI 10.1021/es302004w; Lu SY, 2020, ENVIRON INT, V145, DOI 10.1016/j.envint.2020.106101; Masuya T, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-46272-y; Matsushima A, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19051377; Matsushima A, 2010, ENVIRON HEALTH PERSP, V118, P1267, DOI 10.1289/ehp.0901819; Moore JT, 2006, CHEMMEDCHEM, V1, P504, DOI 10.1002/cmdc.200600006; Pelch K.E., 2017, 4 NAT TOX PROGR RES; Pelch K, 2019, TOXICOLOGY, V424, DOI 10.1016/j.tox.2019.06.006; Perez P, 1998, ENVIRON HEALTH PERSP, V106, P167, DOI 10.1289/ehp.98106167; Renoir JM, 2013, BIOCHEM PHARMACOL, V85, P449, DOI 10.1016/j.bcp.2012.10.018; Richter CA, 2007, REPROD TOXICOL, V24, P199, DOI 10.1016/j.reprotox.2007.06.004; SCATCHARD G, 1949, ANN NY ACAD SCI, V51, P660, DOI 10.1111/j.1749-6632.1949.tb27297.x; Shanle EK, 2011, CHEM RES TOXICOL, V24, P6, DOI 10.1021/tx100231n; Shapiro DJ, 2011, J BIOL CHEM, V286, P4043, DOI 10.1074/jbc.R110.203026; Skowron KJ, 2019, MOL CELL ENDOCRINOL, V493, DOI 10.1016/j.mce.2019.110471; Soga S, 2007, J CHEM INF MODEL, V47, P2287, DOI 10.1021/ci7002363; Staudinger JL, 2019, MOL CELL ENDOCRINOL, V485, P61, DOI 10.1016/j.mce.2019.02.002; Stauffer SR, 2000, J MED CHEM, V43, P4934, DOI 10.1021/jm000170m; STOESSEL S, 1986, J STEROID BIOCHEM, V25, P677, DOI 10.1016/0022-4731(86)90010-5; Terasaki M, 2005, ENVIRON SCI TECHNOL, V39, P3703, DOI 10.1021/es048932g; Tice CM, 2016, BIOORG MED CHEM LETT, V26, P4157, DOI 10.1016/j.bmcl.2016.07.067; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Usman A, 2016, CHEMOSPHERE, V158, P131, DOI 10.1016/j.chemosphere.2016.05.070; Yang YJ, 2014, CHEMOSPHERE, V112, P481, DOI 10.1016/j.chemosphere.2014.05.004; Zhang ZB, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14585	52	4	4	0	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV	2021	297	5							101173	10.1016/j.jbc.2021.101173	http://dx.doi.org/10.1016/j.jbc.2021.101173			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	YZ3FU	34499926	gold, Green Published, Green Submitted			2022-12-26	WOS:000755365700001
J	Estrada-Cortes, E; Ortiz, W; Rabaglino, MB; Block, J; Rae, O; Jannaman, EA; Xiao, Y; Hansen, PJ				Estrada-Cortes, Eliab; Ortiz, William; Rabaglino, Maria B.; Block, Jeremy; Rae, Owen; Jannaman, Elizabeth A.; Xiao, Yao; Hansen, Peter J.			Choline acts during preimplantation development of the bovine embryo to program postnatal growth and alter muscle DNA methylation	FASEB JOURNAL			English	Article							COLONY-STIMULATING FACTOR-2; FETAL-GROWTH; IN-VITRO; METHIONINE; SUPPLEMENTATION; CONSEQUENCES; PROPORTION; CONTRIBUTE; PHENOTYPE; EXPOSURE	The preimplantation period of embryonic development can be a key window for programming of postnatal development because extensive epigenetic remodeling occurs during this time. It was hypothesized that modification of one-carbon metabolism of the bovine embryo by addition of the methyl-donor choline to culture medium would change postnatal phenotype through epigenetic modification. Embryos produced in vitro were cultured with 1.8 mM choline chloride or control medium. Blastocysts were transferred into females and pregnancy outcomes and postnatal phenotype of the resultant calves determined. Exposure of embryos to choline increased gestation length and calf birth weight. Calves derived from choline-treated embryos were also heavier at weaning and had increased ratio of body weight to hip height than control calves. Choline altered muscle DNA methylation of calves 4 months after birth. A total of 670 of the 8149 CpG examined were differentially methylated, with the predominant effect of choline being hypomethylation. Among the genes associated with differentially methylated CpG were ribosomal RNAs and genes in AMPK, mTOR, integrin, and BEX2 canonical pathways and cellular functions involved in growth and proliferation. Results demonstrate that provision of the methyl-donor choline to the preimplantation embryo can alter its developmental program to increase gestation length, birth weight, and weaning weight and cause postnatal changes in muscle DNA methylation including those associated with genes related to anabolic processes and cellular growth. The importance of the nutritional status of the embryo with respect to one-carbon metabolism for ensuring health and well-being after birth is emphasized by these observations.	[Estrada-Cortes, Eliab; Ortiz, William; Jannaman, Elizabeth A.; Xiao, Yao; Hansen, Peter J.] Univ Florida, Dept Anim Sci, POB 110910, Gainesville, FL 32611 USA; [Estrada-Cortes, Eliab; Ortiz, William; Jannaman, Elizabeth A.; Xiao, Yao; Hansen, Peter J.] Univ Florida, DH Barron Reprod & Perinatal Biol Res Program, POB 110910, Gainesville, FL 32611 USA; [Estrada-Cortes, Eliab; Ortiz, William; Jannaman, Elizabeth A.; Xiao, Yao; Hansen, Peter J.] Univ Florida, Genet Inst, POB 110910, Gainesville, FL 32611 USA; [Estrada-Cortes, Eliab] Inst Nacl Invest Forestales Agr & Pecuarias, Campo Expt Ctr Altos Jalisco, Tepatitlan De Morelos, Mexico; [Rabaglino, Maria B.] Tech Univ Denmark, Dept Appl Math & Comp Sci, Quantitat Genet Bioinformat & Computat Biol Grp, Lyngby, Denmark; [Block, Jeremy] Univ Wyoming, Dept Anim Sci, Laramie, WY 82071 USA; [Rae, Owen] Univ Florida, Coll Vet Med, Dept Large Anim Clin Sci, Gainesville, FL 32611 USA; [Ortiz, William] Dept Nutr Anim Grp Matsuda, Rodovia Raposo Tavares,SP 270,Km 575, Alvares Machado, SP, Brazil; [Rabaglino, Maria B.] Univ Coll Dublin, Sch Agr & Food Sci, Dublin 4, Ireland; [Jannaman, Elizabeth A.] CCRM Colorado, Lone Tree, CO USA; [Xiao, Yao] Shandong Acad Agr Sci, Inst Anim Sci & Vet Med, Jinan 250100, Shandong, Peoples R China	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; Technical University of Denmark; University of Wyoming; State University System of Florida; University of Florida; University College Dublin; Shandong Academy of Agricultural Sciences	Hansen, PJ (corresponding author), Univ Florida, Dept Anim Sci, POB 110910, Gainesville, FL 32611 USA.; Hansen, PJ (corresponding author), Univ Florida, DH Barron Reprod & Perinatal Biol Res Program, POB 110910, Gainesville, FL 32611 USA.; Hansen, PJ (corresponding author), Univ Florida, Genet Inst, POB 110910, Gainesville, FL 32611 USA.	pjhansen@ufl.edu		Jannaman, Elizabeth/0000-0003-2461-6793; Rabaglino, Maria/0000-0002-0099-045X; Xiao, Yao/0000-0002-5153-6839; ESTRADA CORTES, ELIAB/0000-0003-0226-9794; Block, Jeremy/0000-0002-6279-8543; Ortiz, William/0000-0002-7335-3961; Hansen, Peter/0000-0003-3061-9333	USDA-NIFA [2020-67015-30821]; CONACyT-Mexico; LE "Red" Larson Endowment; Florida Cattlemen's Association	USDA-NIFA(United States Department of Agriculture (USDA)); CONACyT-Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); LE "Red" Larson Endowment; Florida Cattlemen's Association	Research was supported by USDA-NIFA 2020-67015-30821, LE "Red" Larson Endowment, Florida Cattlemen's Association, an unrestricted gift from Balchem Corporation and funding for E. Estrada-Cortes by CONACyT-Mexico	Acosta DAV, 2016, THERIOGENOLOGY, V85, P1669, DOI 10.1016/j.theriogenology.2016.01.024; Adam MA, 2017, EPIGENOMES, V1, DOI 10.3390/epigenomes1030015; Akalin A, 2012, GENOME BIOL, V13, DOI [10.1186/gb-2012-13-10-r87, 10.1186/gb-2012-13-10-R87]; Ardalan M, 2010, J ANIM PHYSIOL AN N, V94, pE259, DOI 10.1111/j.1439-0396.2009.00966.x; Barker DJP, 2013, PLACENTA, V34, P841, DOI 10.1016/j.placenta.2013.07.063; Bernadzki KM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09590-7; Block J, 2010, J DAIRY SCI, V93, P5234, DOI 10.3168/jds.2010-3443; Bonilla L, 2010, J REPROD DEVELOP, V56, P527, DOI 10.1262/jrd.10-037H; Bromfield JJ, 2014, P NATL ACAD SCI USA, V111, P2200, DOI 10.1073/pnas.1305609111; Burns BM, 2018, J ANIM SCI, V96, P4186, DOI 10.1093/jas/sky290; Caudill MA, 2010, J AM DIET ASSOC, V110, P1198, DOI 10.1016/j.jada.2010.05.009; Chaillou T, 2014, J CELL PHYSIOL, V229, P1584, DOI 10.1002/jcp.24604; Cruickshank MN, 2013, GENOME MED, V5, DOI 10.1186/gm500; Eckersley-Maslin MA, 2018, NAT REV MOL CELL BIO, V19, P436, DOI 10.1038/s41580-018-0008-z; Estrada-Cortes E, 2020, J DAIRY SCI, V103, P10784, DOI 10.3168/jds.2020-18598; Estrada-Cortes E, 2021, J ANIM SCI, V99, DOI 10.1093/jas/skab180; Figueiredo VC, 2021, J CACHEXIA SARCOPENI, V12, P130, DOI 10.1002/jcsm.12636; Freedman R, 2022, SCHIZOPHR RES, V247, P16, DOI 10.1016/j.schres.2021.03.008; Fu Q, 2009, FASEB J, V23, P2438, DOI 10.1096/fj.08-124768; Gluckman PD, 2007, AM J HUM BIOL, V19, P1, DOI 10.1002/ajhb.20590; Gould JM, 2018, P NATL ACAD SCI USA, V115, pE7398, DOI 10.1073/pnas.1721876115; Greenberg MVC, 2019, NAT REV MOL CELL BIO, V20, P590, DOI 10.1038/s41580-019-0159-6; Hansen PJ, 2020, ANNU REV ANIM BIOSCI, V8, P395, DOI 10.1146/annurev-animal-021419-084010; Hansen PJ, 2016, CELL TISSUE RES, V363, P237, DOI 10.1007/s00441-015-2287-4; Hofstee P, 2018, CLIN EXP PHARMACOL P, V45, P871, DOI 10.1111/1440-1681.12954; Hoyo C, 2011, EPIGENETICS-US, V6, P928, DOI 10.4161/epi.6.7.16263; Ishitani H, 2020, J ASSIST REPROD GEN, V37, P1807, DOI 10.1007/s10815-020-01898-0; Jiang XY, 2012, FASEB J, V26, P3563, DOI 10.1096/fj.12-207894; Kannampuzha-Francis J, 2015, MOL REPROD DEV, V82, P892, DOI 10.1002/mrd.22533; Koch JM, 2010, J ANIM SCI, V88, P1619, DOI 10.2527/jas.2009-2392; Kovacheva VP, 2007, J BIOL CHEM, V282, P31777, DOI 10.1074/jbc.M705539200; Krueger F, 2011, BIOINFORMATICS, V27, P1571, DOI 10.1093/bioinformatics/btr167; Kudo M, 2015, J NUTR BIOCHEM, V26, P1664, DOI 10.1016/j.jnutbio.2015.08.009; Lafuente E, 2019, FRONT GENET, V10, DOI 10.3389/fgene.2019.00720; Liu HY, 2020, REPROD SCI, V27, P963, DOI 10.1007/s43032-020-00161-2; Maloney CA, 2013, GENES NUTR, V8, P181, DOI 10.1007/s12263-012-0314-6; McGee M, 2018, NUTR REV, V76, P469, DOI 10.1093/nutrit/nuy006; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Ortiz WG, 2019, J DAIRY SCI, V102, P6587, DOI 10.3168/jds.2019-16251; Oster M, 2016, EUR J NUTR, V55, P1717, DOI 10.1007/s00394-015-0990-2; Pfeffer PL, 2018, BIOLOGY-BASEL, V7, DOI 10.3390/biology7030041; Santoro R, 2001, MOL CELL, V8, P719, DOI 10.1016/S1097-2765(01)00317-3; Sinclair KD, 2007, P NATL ACAD SCI USA, V104, P19351, DOI 10.1073/pnas.0707258104; Tobi EW, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6592; Toledo MZ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189117; Tribulo P, 2017, J ANIM SCI, V95, P4407, DOI 10.2527/jas2017.1927; Tribulo P, 2019, MOL REPROD DEV, V86, P75, DOI 10.1002/mrd.23082; Vineis P, 2011, EPIGENETICS-US, V6, P195, DOI 10.4161/epi.6.2.13573; von Walden F, 2019, J APPL PHYSIOL, V127, P591, DOI 10.1152/japplphysiol.00963.2018; Wang HQ, 2011, BIOINFORMATICS, V27, P225, DOI 10.1093/bioinformatics/btq650; Watkins AJ, 2008, BIOL REPROD, V78, P299, DOI 10.1095/biolreprod.107.064220; Watson ZL, 2019, CLIN EPIGENETICS, V11, DOI 10.1186/s13148-019-0758-2; Williams CL, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-49; Williams TC, 2019, PHILOS T R SOC B, V374, DOI 10.1098/rstb.2018.0121; Wood CE, 1999, J REPROD FERTIL, P115; Yadav VR, 2018, AM J PHYSIOL-LUNG C, V314, pL724, DOI 10.1152/ajplung.00243.2017; Zhang BH, 2015, FASEB J, V29, P1069, DOI 10.1096/fj.14-261131	57	2	2	2	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2021	35	10							e21926	10.1096/fj.202100991R	http://dx.doi.org/10.1096/fj.202100991R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	UZ5IH	34533870	Green Published			2022-12-26	WOS:000702238200004
J	Ma, X; Takahashi, Y; Wu, WJ; Liang, WT; Chen, JL; Chakraborty, D; Li, YX; Du, YH; Benyajati, S; Ma, JX				Ma, Xiang; Takahashi, Yusuke; Wu, Wenjing; Liang, Wentao; Chen, Jianglei; Chakraborty, Dibyendu; Li, Yangxiong; Du, Yanhong; Benyajati, Siribhinya; Ma, Jian-Xing			ADAM17 mediates ectodomain shedding of the soluble VLDL receptor fragment in the retinal epithelium	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DENSITY-LIPOPROTEIN RECEPTOR; WNT SIGNALING PATHWAY; PATHOGENIC ROLE; EXPRESSION; METALLOPROTEINASE; DEGENERATION; INFLAMMATION	Very low-density lipoprotein receptor (VLDLR) is a multi-functional transmembrane protein. Beyond the function of the full-length VLDLR in lipid transport, the soluble ectodomain of VLDLR (sVLDLR) confers anti-inflammatory and anti-angiogenic roles in ocular tissues through inhibition of canonical Wnt signaling. However, it remains unknown how sVLDLR is shed into the extracellular space. In this study, we present the first evidence that a disintegrin and metalloprotease 17 (ADAM17) is responsible for sVLDLR shedding in human retinal pigment epithelium cells using pharmacological and genetic approaches. Among selected proteinase inhibitors, an ADAM17 inhibitor demonstrated the most potent inhibitory effect on sVLDLR shedding. siRNA-mediated knockdown or CRISPR/Cas9-mediated KO of ADAM17 diminished, whereas plasmid-mediated overexpression of ADAM17 promoted sVLDLR shedding. The amount of shed sVLDLR correlated with an inhibitory effect on the Wnt signaling pathway. Consistent with these in vitro findings, intravitreal injection of an ADAM17 inhibitor reduced sVLDLR levels in the extracellular matrix in the mouse retina. In addition, our results demonstrated that ADAM17 cleaved VLDLR only in cells coexpressing these proteins, suggesting that shedding occurs in a cis manner. Moreover, our study demonstrated that aberrant activation of Wnt signaling was associated with decreased sVLDLR levels, along with down-regulation of ADAM17 in ocular tissues of an age-related macular degeneration model. Taken together, our observations reveal the mechanism underlying VLDLR cleavage and identify a potential therapeutic target for the treatment of disorders associated with dysregulation of Wnt signaling.	[Ma, Xiang; Takahashi, Yusuke; Wu, Wenjing; Liang, Wentao; Chen, Jianglei; Chakraborty, Dibyendu; Li, Yangxiong; Du, Yanhong; Benyajati, Siribhinya; Ma, Jian-Xing] Univ Oklahoma, Hlth Sci Ctr, Dept Physiol, Oklahoma City, OK 73019 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center	Ma, JX (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Physiol, Oklahoma City, OK 73019 USA.	jian-xing-ma@ouhsc.edu		Ma, Xiang/0000-0002-2307-1309; Liang, Wentao/0000-0002-0609-6280	National Institutes of Health [EY019309, EY012231, EY028949, EY032930, EY032931]; Diabetic Animal Core and Histology and Image Core of diabetic COBRE [GM122744]; NEI [EY021725]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Diabetic Animal Core and Histology and Image Core of diabetic COBRE; NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This study was supported by the National Institutes of Health grants (EY019309, EY012231, EY028949, EY032930, and EY032931). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The authors like to thank the technical support from the Diabetic Animal Core and Histology and Image Core of diabetic COBRE (GM122744) and the Vision Core supported by NEI P30 (EY021725). In addition, Dr Qian Chen at Xiamen University provided kind assistance and critical discussion in this project.	Alabi A, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-22167-3; Nguyen A, 2014, J BIOL CHEM, V289, P1688, DOI 10.1074/jbc.M113.515320; Argraves WS, 2001, FRONT BIOSCI, V6, pD406, DOI 10.2741/Argraves; Buchanan PC, 2017, J BIOL CHEM, V292, P6339, DOI 10.1074/jbc.M116.746859; Burgy O, 2018, MATRIX BIOL, V68-69, P67, DOI 10.1016/j.matbio.2018.03.017; Campbell MA, 2019, INVEST OPHTH VIS SCI, V60; Chen Q, 2016, MOL CELL BIOL, V36, P2645, DOI 10.1128/MCB.00235-16; Chen Y, 2007, J BIOL CHEM, V282, P34420, DOI 10.1074/jbc.M611289200; Chen Y, 2009, MICROVASC RES, V78, P119, DOI 10.1016/j.mvr.2009.02.005; Cheung CMG, 2013, LANCET, V382, P1230, DOI 10.1016/S0140-6736(13)61580-9; Dlugosz P, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19103090; Fritsche LG, 2016, NAT GENET, V48, P134, DOI 10.1038/ng.3448; Fuhrmann S, 2014, EXP EYE RES, V123, P141, DOI 10.1016/j.exer.2013.09.003; Go Gwang-woong, 2012, Yale Journal of Biology and Medicine, V85, P19; Gooz M, 2010, CRIT REV BIOCHEM MOL, V45, P146, DOI 10.3109/10409231003628015; Goth CK, 2015, P NATL ACAD SCI USA, V112, P14623, DOI 10.1073/pnas.1511175112; Grotzinger J, 2017, BBA-MOL CELL RES, V1864, P2088, DOI 10.1016/j.bbamcr.2017.05.024; Heath RB, 2007, AM J PHYSIOL-ENDOC M, V292, pE732, DOI 10.1152/ajpendo.00409.2006; Herzog C, 2014, J BIOL CHEM, V289, P13308, DOI 10.1074/jbc.M114.559088; Hu WZ, 2008, INVEST OPHTH VIS SCI, V49, P407, DOI 10.1167/iovs.07-0870; Hu Y, 2013, INVEST OPHTH VIS SCI, V54, P141, DOI 10.1167/iovs.12-10281; Hundhausen C, 2003, BLOOD, V102, P1186, DOI 10.1182/blood-2002-12-3775; Ishikawa M, 2015, EXP EYE RES, V133, P3, DOI 10.1016/j.exer.2015.02.017; Kiser PD, 2014, CHEM REV, V114, P194, DOI 10.1021/cr400107q; Lee K, 2014, J CELL SCI, V127, P4857, DOI 10.1242/jcs.149302; Leeb C, 2014, J BIOL CHEM, V289, P4161, DOI 10.1074/jbc.M113.529271; Lichtenthaler SF, 2018, EMBO J, V37, DOI 10.15252/embj.201899456; Liu C, 2009, MOL CELL, V35, P26, DOI 10.1016/j.molcel.2009.06.018; Liu XC, 2013, DIABETES, V62, P4228, DOI 10.2337/db12-1710; Lorenzen I, 2016, SCI REP-UK, V6, DOI 10.1038/srep35067; Ma B, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00378; Maeda A, 2008, J BIOL CHEM, V283, P26684, DOI 10.1074/jbc.M804505200; Mitchell P, 2018, LANCET, V392, P1147, DOI 10.1016/S0140-6736(18)31550-2; Moss ML, 1997, NATURE, V385, P733, DOI 10.1038/385733a0; Muliyil S, 2020, EMBO J, V39, DOI 10.15252/embj.2020104415; Murphy G, 2008, NAT REV CANCER, V8, P929, DOI 10.1038/nrc2459; Perusek L, 2015, J BIOL CHEM, V290, P29035, DOI 10.1074/jbc.M115.682310; Qiu FF, 2020, CLIN SCI, V134, P1613, DOI 10.1042/CS20200085; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Sakai K, 2009, BRAIN RES, V1276, P11, DOI 10.1016/j.brainres.2009.04.030; Semenov MV, 2008, J BIOL CHEM, V283, P21427, DOI 10.1074/jbc.M800014200; Tuo JS, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0683-x; Wang ZX, 2015, ARTERIOSCL THROM VAS, V35, P855, DOI 10.1161/ATVBAHA.114.304627	43	3	3	1	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT	2021	297	4							101185	10.1016/j.jbc.2021.101185	http://dx.doi.org/10.1016/j.jbc.2021.101185			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	YZ2PR	34509473	Green Published, gold			2022-12-26	WOS:000755323700014
J	Coathup, V; Carson, C; Kurinczuk, JJ; Macfarlane, AJ; Boyle, E; Johnson, S; Petrou, S; Quigley, MA				Coathup, Victoria; Carson, Claire; Kurinczuk, Jennifer J.; Macfarlane, Alison J.; Boyle, Elaine; Johnson, Samantha; Petrou, Stavros; Quigley, Maria A.			Associations between gestational age at birth and infection-related hospital admission rates during childhood in England: Population-based record linkage study	PLOS ONE			English	Article							RESPIRATORY-INFECTION; PRETERM BIRTH; WEIGHT; INTERVENTIONS; DELIVERY; OUTCOMES; RISK	Background Children born preterm (<37 completed weeks' gestation) have a higher risk of infection-related morbidity than those born at term. However, few large, population-based studies have investigated the risk of infection in childhood across the full spectrum of gestational age. The objectives of this study were to explore the association between gestational age at birth and infection-related hospital admissions up to the age of 10 years, how infection-related hospital admission rates change throughout childhood, and whether being born small for gestational age (SGA) modifies this relationship. Methods and findings Using a population-based, record-linkage cohort study design, birth registrations, birth notifications and hospital admissions were linked using a deterministic algorithm. The study population included all live, singleton births occurring in NHS hospitals in England from January 2005 to December 2006 (n = 1,018,136). The primary outcome was all infection-related inpatient hospital admissions from birth to 10 years of age, death or study end (March 2015). The secondary outcome was the type of infection-related hospital admission, grouped into broad categories. Generalised estimating equations were used to estimate adjusted rate ratios (aRRs) with 95% confidence intervals (CIs) for each gestational age category (<28, 28-29, 30-31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41 and 42 weeks) and the models were repeated by age at admission (<1, 1-2, 3-4, 5-6, and 7-10 years). An interaction term was included in the model to test whether SGA status modified the relationship between gestational age and infection-related hospital admissions. Gestational age was strongly associated with rates of infection-related hospital admissions throughout childhood. Whilst the relationship attenuated over time, at 7-10 years of age those born before 40 weeks gestation were still significantly higher in comparison to those born at 40 weeks. Children born <28 weeks had an aRR of 6.53 (5.91-7.22) during infancy, declining to 3.16 (2.50-3.99) at ages 7-10 years, in comparison to those born at 40 weeks; whilst in children born at 38 weeks, the aRRs were 1 center dot 24 (1.21-1.27) and 1.18 (1.13-1.23), during infancy and aged 7-10 years, respectively. SGA status modified the effect of gestational age (interaction P<0.0001), with the highest rate among the children born at <28 weeks and SGA. Finally, study findings indicated that the associations with gestational age varied by subgroup of infection. Whilst upper respiratory tract infections were the most common type of infection experienced by children in this cohort, lower respiratory tract infections (LRTIs) (<28 weeks, aRR = 10.61(9.55-11.79)) and invasive bacterial infections (<28 weeks, aRR = 6.02 (4.56-7.95)) were the most strongly associated with gestational age at birth. Of LRTIs experienced, bronchiolitis (<28 weeks, aRR = 11.86 (10.20-13.80)), and pneumonia (<28 weeks, aRR = 9.49 (7.95-11.32)) were the most common causes. Conclusions Gestational age at birth was strongly associated with rates of infection-related hospital admissions during childhood and even children born a few weeks early remained at higher risk at 7-10 years of age. There was variation between clinical subgroups in the strength of relationships with gestational age. Effective infection prevention strategies should include focus on reducing the number and severity of LRTIs during early childhood.	[Coathup, Victoria; Carson, Claire; Kurinczuk, Jennifer J.; Quigley, Maria A.] Univ Oxford, Nuffield Dept Populat Hlth NDPH, Natl Perinatal Epidemiol Unit NPEU, Oxford, England; [Macfarlane, Alison J.] Univ London, Sch Hlth Sci, London, England; [Boyle, Elaine; Johnson, Samantha] Univ Leicester, Dept Hlth Sci, Leicester, Leics, England; [Petrou, Stavros] Univ Oxford, Nuffield Dept Primary Hlth Care Sci, Oxford, England	University of Oxford; University of London; University of Leicester; University of Oxford	Coathup, V (corresponding author), Univ Oxford, Nuffield Dept Populat Hlth NDPH, Natl Perinatal Epidemiol Unit NPEU, Oxford, England.	victoria.coathup@npeu.ox.ac.uk	Boyle, Elaine/I-6298-2018; Petrou, Stavros/ABD-8323-2021	Boyle, Elaine/0000-0002-5038-3148; Petrou, Stavros/0000-0003-3121-6050; Kurinczuk, Jennifer/0000-0001-9554-6337; Quigley, Maria/0000-0002-8058-6181; Carson, Claire/0000-0001-5490-699X; Macfarlane, Alison/0000-0003-0977-7214	Medical Research Council [MR/M01228X/1]	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The TIGAR study was funded by a research grant from the Medical Research Council (MR/M01228X/1). MQ was the recipient of the award. MRC website: https://mrc.ukri.org/.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel GA, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-012750; Allen EC, 2004, PEDIATRICS, V113, P267, DOI 10.1542/peds.113.2.267; Almqvist C, 2020, CLIN EXP ALLERGY, V50, P222, DOI 10.1111/cea.13542; Althubaiti A, 2016, J MULTIDISCIP HEALTH, V9, P211, DOI 10.2147/JMDH.S104807; BARKER DJP, 1991, BRIT MED J, V303, P671, DOI 10.1136/bmj.303.6804.671; Bentley JP, 2018, ACTA OBSTET GYN SCAN, V97, P988, DOI 10.1111/aogs.13371; Bentley JP, 2016, BMC PEDIATR, V16, DOI 10.1186/s12887-016-0591-0; Biasucci G, 2010, EARLY HUM DEV, V86, pS13, DOI 10.1016/j.earlhumdev.2010.01.004; Bolton CE, 2015, THORAX, V70, P574, DOI 10.1136/thoraxjnl-2014-206590; Coathup V, 2020, BMJ-BRIT MED J, V371, DOI 10.1136/bmj.m4075; Coathup V, 2020, BMJ OPEN, V10, DOI 10.1136/bmjopen-2020-037885; Crippa BL, 2019, NUTRIENTS, V11, DOI 10.3390/nu11020312; Datta-Nemdharry P, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001088; Drife J, 2006, BJOG-INT J OBSTET GY, V113, P81, DOI 10.1111/j.1471-0528.2006.01129.x; Frank Nicole M, 2019, BMC Pediatr, V19, P339, DOI 10.1186/s12887-019-1693-2; Fuchs F, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191002; Green CA, 2016, ARCH DIS CHILD, V101, P140, DOI 10.1136/archdischild-2015-308723; Hawker JI, 2003, RESP MED, V97, P1219, DOI 10.1016/S0954-6111(03)00252-X; Heidkamp R, 2017, J NUTR, V147, p2188S, DOI 10.3945/jn.116.243667; Helfrich AM, 2015, EARLY HUM DEV, V91, P541, DOI 10.1016/j.earlhumdev.2015.06.009; Johnson L, 2019, BMC HEALTH SERV RES, V19, DOI 10.1186/s12913-019-3922-7; Jones LL, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-5; Keeble E., 2017, FOCUS EMERGENCY HOSP, P1; Koshy E, 2012, ARCH DIS CHILD, V97, P1064, DOI 10.1136/archdischild-2012-301755; Kotecha SJ, 2013, THORAX, V68, P760, DOI 10.1136/thoraxjnl-2012-203079; Li YM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195146; Macfarlane A., 2019, HEAL SERV DELIV RES, V7, P1, DOI [10.3310/hsdr07180, DOI 10.3310/HSDR07180]; Macfarlane PI, 2003, ARCH DIS CHILD-FETAL, V88, P199, DOI 10.1136/fn.88.3.F199; Melville JM, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00079; Miller JE, 2016, LANCET INFECT DIS, V16, P952, DOI 10.1016/S1473-3099(16)00150-X; Miller JE, 2018, INT J EPIDEMIOL, V47, P561, DOI 10.1093/ije/dyx272; Montgomery S, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-004034; Morris RK, 2013, ACTA OBSTET GYN SCAN, V92, P143, DOI 10.1111/aogs.12029; Murray J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089186; Ospina M, 2020, BMJ OPEN, V10, DOI 10.1136/bmjopen-2019-033296; Paranjothy S, 2013, PEDIATRICS, V132, pE1562, DOI 10.1542/peds.2013-1737; Pelkonen AS, 1999, ARCH DIS CHILD-FETAL, V81, pF188, DOI 10.1136/fn.81.3.F188; Public Health England NHS Digital, 2020, CHILDH VACC COV STAT, P5; Ray Kristin N, 2013, Hosp Pediatr, V3, P194; Reeves Shane, 2008, Expert Rev Obstet Gynecol, V3, P719, DOI 10.1586/17474108.3.6.719; Romero R, 2007, NUTR REV, V65, pS194, DOI 10.1301/nr.2007.dec.S194-S202; Sebghati M, 2021, BEST PRACT RES CL OB, V76, P53, DOI 10.1016/j.bpobgyn.2021.03.007; Shah PS, 2011, MATERN CHILD HLTH J, V15, P1097, DOI 10.1007/s10995-010-0654-z; Shah PS, 2010, ACTA OBSTET GYN SCAN, V89, P862, DOI 10.3109/00016349.2010.486827; Shan J, 2021, INFLUENZA OTHER RESP, V15, P539, DOI 10.1111/irv.12850; Skirrow H, 2019, ARCH DIS CHILD, V104, P658, DOI 10.1136/archdischild-2018-316317; Srinivasjois R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130535; StataCorp, 2015, STAT STAT SOFTW REL; Taylor LK, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-210; Tickell KD, 2016, J MATERN-FETAL NEO M, V29, P1871, DOI 10.3109/14767058.2015.1066774; van den Elsen LWJ, 2019, FRONT PEDIATR, V7, DOI 10.3389/fped.2019.00047; Videholm S, 2019, ARCH DIS CHILD, V104, P58, DOI 10.1136/archdischild-2017-314628; Williams TC, 2021, ARCH DIS CHILD, V106, P911, DOI 10.1136/archdischild-2020-321008; Zhang DD, 2019, ITAL J PEDIATR, V45, DOI 10.1186/s13052-019-0702-2; Zhuge Y., 2020, SCI REP-UK, V10, P1, DOI [10.1038/s41598-019-56847-4, DOI 10.1038/S41598-019-56847-4]	55	3	3	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2021	16	9							e0257341	10.1371/journal.pone.0257341	http://dx.doi.org/10.1371/journal.pone.0257341			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XH8RH	34555039	Green Published, gold, Green Accepted			2022-12-26	WOS:000725694500025
J	Matchett-Oates, L; Braich, S; Spangenberg, GC; Rochfort, S; Cogan, NOI				Matchett-Oates, L.; Braich, S.; Spangenberg, G. C.; Rochfort, S.; Cogan, N. O., I			In silico analysis enabling informed design for genome editing in medicinal cannabis; gene families and variant characterisation	PLOS ONE			English	Article							ISOPENTENYL DIPHOSPHATE ISOMERASES; MEVALONATE PATHWAY; ACID SYNTHASE; ENZYME; BIOSYNTHESIS; CHEMOTYPE; ALIGNMENT; STACKING	Background Cannabis has been used worldwide for centuries for industrial, recreational and medicinal use, however, to date no successful attempts at editing genes involved in cannabinoid biosynthesis have been reported. This study proposes and develops an in silico best practices approach for the design and implementation of genome editing technologies in cannabis to target all genes involved in cannabinoid biosynthesis. Results A large dataset of reference genomes was accessed and mined to determine copy number variation and associated SNP variants for optimum target edit sites for genotype independent editing. Copy number variance and highly polymorphic gene sequences exist in the genome making genome editing using CRISPR, Zinc Fingers and TALENs technically difficult. Evaluation of allele or additional gene copies was determined through nucleotide and amino acid alignments with comparative sequence analysis performed. From determined gene copy number and presence of SNPs, multiple online CRISPR design tools were used to design sgRNA targeting every gene, accompanying allele and homologs throughout all involved pathways to create knockouts for further investigation. Universal sgRNA were designed for highly homologous sequences using MultiTargeter and visualised using Sequencher, creating unique sgRNA avoiding SNP and shared nucleotide locations targeting optimal edit sites. Conclusions Using this framework, the approach has wider applications to all plant species regardless of ploidy number or highly homologous gene sequences. Significance statement Using this framework, a best-practice approach to genome editing is possible in all plant species, including cannabis, delivering a comprehensive in silico evaluation of the cannabinoid pathway diversity from a large set of whole genome sequences. Identification of SNP variants across all genes could improve genome editing potentially leading to novel applications across multiple disciplines, including agriculture and medicine.	[Matchett-Oates, L.; Braich, S.; Spangenberg, G. C.; Rochfort, S.; Cogan, N. O., I] Agr Victoria, AgriBio, Ctr AgriBiosci, Bundoora, Vic, Australia; [Matchett-Oates, L.; Braich, S.; Spangenberg, G. C.; Rochfort, S.; Cogan, N. O., I] La Trobe Univ, Sch Appl Syst Biol, Bundoora, Vic, Australia	La Trobe University; La Trobe University	Matchett-Oates, L (corresponding author), Agr Victoria, AgriBio, Ctr AgriBiosci, Bundoora, Vic, Australia.; Matchett-Oates, L (corresponding author), La Trobe Univ, Sch Appl Syst Biol, Bundoora, Vic, Australia.	lennon.matchett-oates@agriculture.vic.gov.au		Matchett-Oates, Lennon/0000-0002-4953-7402	Agriculture Victoria; Agriculture Victoria Services	Agriculture Victoria; Agriculture Victoria Services	Funding for research was provided by Agriculture Victoria and Agriculture Victoria Services.	Ainley WM, 2013, PLANT BIOTECHNOL J, V11, P1126, DOI 10.1111/pbi.12107; Alexander SPH, 2016, PROG NEURO-PSYCHOPH, V64, P157, DOI 10.1016/j.pnpbp.2015.07.001; Alonge M, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1829-6; Araki N, 2000, PHYSIOL PLANTARUM, V108, P19, DOI 10.1034/j.1399-3054.2000.108001019x./; Belhaj K, 2013, PLANT METHODS, V9, DOI 10.1186/1746-4811-9-39; Bielecka M, 2014, PLANT BIOTECHNOL J, V12, P613, DOI 10.1111/pbi.12167; Booth JK, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173911; Braich S., 2020, GIGABYTE, V10, P1, DOI [10.46471/gigabyte.10, DOI 10.46471/GIGABYTE.10]; Braich S, 2019, REFERENCE GENOME WHO; Braich S, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-53023-6; Cascio M. G., 2017, CANNABIS SATIVA L BO, P207; Corporation GC, 2011, SEQ VERS 5 4 6 DNA S; Cui YB, 2018, INTERDISCIP SCI, V10, P455, DOI 10.1007/s12539-018-0298-z; Devinsky O, 2016, LANCET NEUROL, V15, P270, DOI 10.1016/S1474-4422(15)00379-8; DOORENBOS NJ, 1971, ANN NY ACAD SCI, V191, P3, DOI 10.1111/j.1749-6632.1971.tb13982.x; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; ElSohly MA, 2017, PROG CHEM ORG NAT PR, V103, P1, DOI 10.1007/978-3-319-45541-9_1; EMBODEN WA, 1974, ECON BOT, V28, P304, DOI 10.1007/BF02861427; Estevez JM, 2001, J BIOL CHEM, V276, P22901, DOI 10.1074/jbc.M100854200; Fellermeier M, 2001, EUR J BIOCHEM, V268, P1596, DOI 10.1046/j.1432-1327.2001.02030.x; FETTERMAN PS, 1971, J PHARM SCI-US, V60, P1246, DOI 10.1002/jps.2600600832; Flores-Sanchez Isvett Josefina, 2008, Phytochemistry Reviews, V7, P615, DOI 10.1007/s11101-008-9094-4; Fu YF, 2013, NAT BIOTECHNOL, V31, P822, DOI 10.1038/nbt.2623; Gagne SJ, 2012, P NATL ACAD SCI USA, V109, P12811, DOI 10.1073/pnas.1200330109; Gorbunova V, 1997, NUCLEIC ACIDS RES, V25, P4650, DOI 10.1093/nar/25.22.4650; Grassa CJ, 2021, NEW PHYTOL, V230, P1665, DOI 10.1111/nph.17243; Haeussler M, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1012-2; Hillig KW, 2005, GENET RESOUR CROP EV, V52, P161, DOI 10.1007/s10722-003-4452-y; Hsieh MH, 2006, PLANTA, V223, P779, DOI 10.1007/s00425-005-0140-9; Hwang WY, 2013, NAT BIOTECHNOL, V31, P227, DOI 10.1038/nbt.2501; Jiang WZ, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt780; Joung JK, 2013, NAT REV MOL CELL BIO, V14, P49, DOI 10.1038/nrm3486; Kalant H, 2001, Pain Res Manag, V6, P80; Kim SM, 2008, PLANTA, V227, P287, DOI 10.1007/s00425-007-0616-x; Kim YG, 1996, P NATL ACAD SCI USA, V93, P1156, DOI 10.1073/pnas.93.3.1156; Kumar S, 2015, J BIOTECHNOL, V207, P12, DOI 10.1016/j.jbiotec.2015.04.006; Labun K, 2016, NUCLEIC ACIDS RES, V44, pW272, DOI 10.1093/nar/gkw398; Lavania U. C., 2005, Plant Genetic Resources Characterization and Utilization, V3, P170, DOI 10.1079/PGR200576; Laverty KU, 2019, GENOME RES, V29, P146, DOI 10.1101/gr.242594.118; Li H., 2013, ARXIV, DOI DOI 10.48550/ARXIV.1303.3997; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; LI HL, 1974, ECON BOT, V28, P437; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; McKernan K., 2020, SEQUENCE ANNOTATION, P1, DOI [10.1101/2020.01.03.894428, DOI 10.1101/2020.01.03.894428]; Numa H, 2014, PLANT CELL PHYSIOL, V55, DOI 10.1093/pcp/pct157; Office on Drugs and Crime UN, 2017, WORLD DRUG REPORT 20; Okada K, 2008, PLANT CELL PHYSIOL, V49, P604, DOI 10.1093/pcp/pcn032; Pacifico D, 2006, MOL BREEDING, V17, P257, DOI 10.1007/s11032-005-5681-x; Perez J, 2008, EXPERT OPIN PHARMACO, V9, P1189, DOI 10.1517/14656566.9.7.1189; Phillips MA, 2008, PLANT CELL, V20, P677, DOI 10.1105/tpc.107.053926; Piomelli D, 2016, CANNABIS CANNABINOID, V1, P1, DOI [10.1089/can.2015.29003.ebr, 10.1089/can.2015.29002.edi]; Prykhozhij SV, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119372; Ramer R, 2008, J NATL CANCER I, V100, P59, DOI 10.1093/jnci/djm268; Seetang-Nun Y, 2008, J PLANT PHYSIOL, V165, P991, DOI 10.1016/j.jplph.2007.06.014; Shukla VK, 2009, NATURE, V459, P437, DOI 10.1038/nature07992; Siebert R, 2002, PLANT CELL, V14, P1121, DOI 10.1105/tpc.001727; SMALL E, 1976, TAXON, V25, P405, DOI 10.2307/1220524; Solovyev V, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-s1-s10; Soyars CL, 2018, PLANT CELL PHYSIOL, V59, P1608, DOI 10.1093/pcp/pcy079; Springer NM, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000734; Stout JM, 2012, PLANT J, V71, P353, DOI 10.1111/j.1365-313X.2012.04949.x; TAURA F, 1995, J AM CHEM SOC, V117, P9766, DOI 10.1021/ja00143a024; Taura F, 1996, J BIOL CHEM, V271, P17411, DOI 10.1074/jbc.271.29.17411; Taura F, 2007, FEBS LETT, V581, P2929, DOI 10.1016/j.febslet.2007.05.043; Trofin IG, 2012, REV CHIM-BUCHAREST, V63, P293; van Bakel H, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-10-r102; van Gent DC, 2007, ONCOGENE, V26, P7731, DOI 10.1038/sj.onc.1210871; Vergara D, 2019, AOB PLANTS, V11, DOI 10.1093/aobpla/plz074; Voytas DF, 2013, ANNU REV PLANT BIOL, V64, P327, DOI 10.1146/annurev-arplant-042811-105552; Walter MH, 2002, PLANT J, V31, P243, DOI 10.1046/j.1365-313X.2002.01352.x; Wang GD, 2009, P NATL ACAD SCI USA, V106, P9914, DOI 10.1073/pnas.0904069106; Wolfe SA, 2000, ANNU REV BIOPH BIOM, V29, P183, DOI 10.1146/annurev.biophys.29.1.183; Xu C, 2016, GENES-BASEL, V7, DOI 10.3390/genes7100078	73	3	3	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2021	16	9							e0257413	10.1371/journal.pone.0257413	http://dx.doi.org/10.1371/journal.pone.0257413			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YS4WS	34551006	Green Published, gold			2022-12-26	WOS:000750679800019
J	Zichello, J; Gupta, P; Scott, M; Desai, B; Cohen, R; Halderman, L; Perkins, S; Porzecanski, A; Planet, PJ; Wyner, Y; Blaser, M; Burk, R; Diamond, J; Kennett, R; Borland, J; DeSalle, R				Zichello, Julia; Gupta, Preeti; Scott, Monique; Desai, Bella; Cohen, Ruth; Halderman, Lauri; Perkins, Susan; Porzecanski, Ana; Planet, Paul J.; Wyner, Yael; Blaser, Martin; Burk, Robert; Diamond, Judy; Kennett, Rod; Borland, Jennifer; DeSalle, Rob			A natural history museum visitor survey of perception, attitude and knowledge (PAK) of microbes and antibiotics	PLOS ONE			English	Article							PUBLIC-HEALTH; EDUCATION; SCIENCE; COVID-19; NEED	A kiosk-based survey at the American Museum of Natural History in New York City in 2016-2018 allowed us to assess public knowledge of antibiotics and public attitudes toward microbes in museum goers. Over 22,000 visitors from 172 countries and territories answered several carefully designed questions about microbes and antibiotics. These visitors also entered age, gender, and country demographic data that allowed for stratification along these demographic and geographic divisions. Because museum goers are likely to be better informed about these and other science-based topics, the results described here can set a potential upper bound for public knowledge on these topics. Surprisingly, the results of our analysis of museum goers' answers about microbes and antibiotics indicate a substantial lack of familiarity with both topics. For example, overall only about 50% of respondents can correctly identify penicillin as an antibiotic and less than 50% of museum visitors view microbes as beneficial. The results described here suggest that we are perhaps off target with our educational efforts in this area and that a major shift in approach toward more basic microbial topics is warranted in our educational efforts.	[Zichello, Julia; Gupta, Preeti; Scott, Monique; Desai, Bella; Cohen, Ruth] Amer Museum Nat Hist, Educ Dept, New York, NY 10024 USA; [Scott, Monique] Bryn Mawr Coll, Museum Studies Dept, Bryn Mawr, PA 19010 USA; [Halderman, Lauri] Amer Museum Nat Hist, Exhibit Dept, New York, NY 10024 USA; [Perkins, Susan; DeSalle, Rob] Amer Museum Nat Hist, Sackler Inst Comparat Genom, New York, NY 10024 USA; [Porzecanski, Ana] Amer Museum Nat Hist, Ctr Biodivers & Conservat, New York, NY 10024 USA; [Planet, Paul J.] Univ Penn, Perelman Sch Med, Div Infect Dis, Philadelphia, PA 19104 USA; [Planet, Paul J.] Univ Penn, Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA; [Wyner, Yael] CUNY City Coll, Sch Educ, New York, NY USA; [Blaser, Martin] Rutgers State Univ, Robert Wood Johnson Med Sch, Dept Med & Microbiol, RBHS, Piscataway, NJ USA; [Burk, Robert] Albert Einstein Univ, Dept Pediat, New York, NY USA; [Diamond, Judy] Univ Nebraska State Museum, Lincoln, NE USA; [Kennett, Rod] Questacon, Natl Sci & Technol Ctr Australia, King Edward Terrace, Parkes, ACT, Australia; [Borland, Jennifer] Rockman Et Al, Bloomington, IN USA	American Museum of Natural History (AMNH); Bryn Mawr College; American Museum of Natural History (AMNH); American Museum of Natural History (AMNH); American Museum of Natural History (AMNH); University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; City University of New York (CUNY) System; City College of New York (CUNY); Rutgers State University New Brunswick; Rutgers State University Medical Center; Yeshiva University; University of Nebraska System; University of Nebraska Lincoln	DeSalle, R (corresponding author), Amer Museum Nat Hist, Sackler Inst Comparat Genom, New York, NY 10024 USA.	desalle@amnh.org			Office of The Director, National Institutes Of Health [5R25OD016514-04]; Fulbright Foundation	Office of The Director, National Institutes Of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fulbright Foundation	The research in and the writing of this article was supported by the Office of The Director, National Institutes Of Health under Award Number 5R25OD016514-04. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. RD Acknowledges the Fulbright Foundation for support. EB is an employee of Rockman et al, (now Rockman et al Cooperative Inc.), and receives support in the form of a salary. The company did not play a role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed H, 2020, LANCET INFECT DIS, V20, P777, DOI 10.1016/S1473-3099(20)30226-7; Almond P., 2019, HLTH SAFETY CONT BRI, P21; Auta A, 2013, TROP J PHARM RES, V12, P1087, DOI 10.4314/tjpr.v12i6.33; Barberan A, 2016, J MICROBIOL BIOL EDU, V17, P23, DOI 10.1128/jmbe.v17i1.984; Beovic B, 2019, J ANTIMICROB CHEMOTH, V74, P3611, DOI 10.1093/jac/dkz375; Bert F, 2017, EUR J PUBLIC HEALTH, V27, P506, DOI 10.1093/eurpub/ckw209; Blaser MJ, 2016, SCIENCE, V352, P544, DOI 10.1126/science.aad9358; Blaser MJ, 2014, J CLIN INVEST, V124, P4162, DOI 10.1172/JCI78366; Butler MI, 2019, ANNU REV CLIN PSYCHO, V15, P371, DOI 10.1146/annurev-clinpsy-050718-095432; Cho I, 2012, NAT REV GENET, V13, P260, DOI 10.1038/nrg3182; Cirstea M, 2018, CELL HOST MICROBE, V23, P10, DOI 10.1016/j.chom.2017.12.008; Clarke LJ, 2020, BIOSCIENCE, V70, P589, DOI 10.1093/biosci/biaa057; Courtenay M, 2019, J HOSP INFECT, V101, P426, DOI 10.1016/j.jhin.2019.02.019; Department of Health, 2019, TACKL STRESS; Dickenson V., 1992, CULTURAL EC, P141; Dodemaide P, 2020, PROCEEDINGS OF THE AUSTRALASIAN COMPUTER SCIENCE WEEK MULTICONFERENCE (ACSW 2020), DOI 10.1145/3373017.3373054; Dudo A, 2018, J MICROBIOL BIOL EDU, V19, DOI 10.1128/jmbe.v19i1.1402; Evans JR, 2018, INTERNET RES, V28, P854, DOI 10.1108/IntR-03-2018-0089; Ewald HAS, 2018, YALE J BIOL MED, V91, P445; Falk J. H., 2016, MUSEUM EXPERIENCE RE; Falk JH, 2016, SCI EDUC, V100, P849, DOI 10.1002/sce.21225; Falk JH, 2013, J RES SCI TEACH, V50, P431, DOI 10.1002/tea.21080; Falk JH, 2011, J RES SCI TEACH, V48, P1, DOI 10.1002/tea.20394; Falk John H., 2014, INT SCI CTR IMPACT S, P45; Gonzales R, 2012, SALUD PUBLICA MEXICO, V54, P152, DOI 10.1590/S0036-36342012000200011; Gunther CF., 1999, ED ROLE MUSEUM, V2, P118; Hahn RA, 2015, INT J HEALTH SERV, V45, P657, DOI 10.1177/0020731415585986; Hamdiyati Y, 2017, J PHYS CONF SER, V812, DOI 10.1088/1742-6596/812/1/012027; Hammerness K, 2016, CURATOR, V59, P353, DOI 10.1111/cura.12178; Hein GE., 2006, COMPANION MUSEUM STU, P340, DOI DOI 10.1002/9780470996836.CH20; Hornik R, 1997, ADVERT CONS, P45; Hui Sien Koo, 2018, P PAKISTAN ACAD SCI, V55, P1; Inacio J, 2017, CURR PHARM TEACH LEA, V9, P551, DOI 10.1016/j.cptl.2017.03.021; Janmejaya Samal., 2018, J TUBERCULOSIS RES, V6, P148; Jones G, 2013, INT J SCI EDUC PART, V3, P199, DOI 10.1080/21548455.2012.684434; Kenneth Timmis, 2019, ENVIRON MICROBIOL; Kirchberg V, 1996, POETICS, V24, P239, DOI 10.1016/S0304-422X(96)00007-1; Klein EY, 2018, P NATL ACAD SCI USA, V115, pE3463, DOI 10.1073/pnas.1717295115; Kurt H, 2013, J BALT SCI EDUC, V12, P608; Leung CC, 2020, LANCET, V395, P945, DOI 10.1016/S0140-6736(20)30520-1; Li DD, 2020, PREV MED, V141, DOI 10.1016/j.ypmed.2020.106262; Li L, 2020, LANCET RESP MED, V8, pE23, DOI 10.1016/S2213-2600(20)30125-9; Lim Ka Keat, 2012, South Med Rev, V5, P26; Louisa Ha, 2020, INTERNET RES; Marty PF, 2007, MUS MANAGE CURATOR, V22, P337, DOI 10.1080/09647770701757708; Matthew Loo, 2016, BCIT ENV HLTH J; Mbwambo G., 2017, African Journal of Microbiology Research, V11, P1018, DOI 10.5897/ajmr2017.8583; McNeil JN, 2010, BIOCONTROL, V55, P445, DOI 10.1007/s10526-010-9273-2; MORGAN MS, 1995, J CLIN PATHOL, V48, P915, DOI 10.1136/jcp.48.10.915; Mouhieddine TH, 2015, J INFECT PUBLIC HEAL, V8, P20, DOI 10.1016/j.jiph.2014.07.010; Murphy J. F, 2018, MOJ IMMUNOL, V6, P54; Nalinidevi Jayabalan, 2018, INT J BASIC CLIN PHA, V7, P1991; Nepal A, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-7924-5; Norris P, 2010, J IMMIGR MINOR HEALT, V12, P107, DOI 10.1007/s10903-008-9224-5; Oppenheimer AJ, 2011, PLAST RECONSTR SURG, V128, P299, DOI 10.1097/PRS.0b013e3182174413; Parimi Neeta, 2002, Rev Panam Salud Publica, V12, P11, DOI 10.1590/S1020-49892002000700003; Pietrzak B, 2018, SCIENCE, V360, P1409, DOI 10.1126/science.aau3877; Proctor LM, 2019, NATURE, V569, P641, DOI 10.1038/s41586-019-1238-8; Rabano-Blanco A, 2019, ANTIBIOTICS-BASEL, V8, DOI 10.3390/antibiotics8040203; Ramchurren K, 2018, SOUTH AFR J INFECT D, V33, DOI 10.1080/23120053.2018.1516393; Raupach-Rosin H, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.00776; Resnick B, 2018, PUBLIC HEALTH REP, V133, P619, DOI 10.1177/0033354918784911; Sariola S, 2020, MICROORGANISMS, V8, DOI 10.3390/microorganisms8050746; Savage N, 2016, CELL, V164, P1085, DOI 10.1016/j.cell.2016.02.051; Sazak Ovecoglu Hesna, 2019, INT J SCI RES DENT M, V1, P57; Schneider M, 2017, PEOPLE TRUST MUSEUMS; Senturk E, 2014, INT J SCI EDUC PART, V4, P1, DOI 10.1080/21548455.2012.726754; Solmaz Aydin., 2015, INT J BIOL ED, V4; Stulberg E, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2015.15, 10.1038/nmicrobiol.2015.15]; Suter LE, 2014, SCI EDUC, V98, P815, DOI 10.1002/sce.21116; Tadvi NA, 2019, J RES MED DENT SCI, V7, P75; Teolis MG, 2010, J CONS HLTH INTERNET, V14, P126, DOI 10.1080/15398281003780966; Thaler DS, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-019-3715-y; Tshokey T, 2017, ASIA-PAC J PUBLIC HE, V29, P580, DOI 10.1177/1010539517734682; Verran J, 2019, J BIOL EDUC, V53, P34, DOI 10.1080/00219266.2017.1420678; Yanti Hamdiyati, 2018, EDUSAINS, V10, P74; Yeo SK, 2019, PUBLIC UNDERST SCI, V28, P433, DOI 10.1177/0963662519832200; Zaidi SF, 2020, PHARMACY-BASEL, V8, DOI 10.3390/pharmacy8010005; Zajacova A, 2018, ANNU REV PUBL HEALTH, V39, P273, DOI 10.1146/annurev-publhealth-031816-044628	79	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2021	16	9							e0257085	10.1371/journal.pone.0257085	http://dx.doi.org/10.1371/journal.pone.0257085			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	YS4WS	34550986	Green Submitted, Green Published, gold			2022-12-26	WOS:000750679800014
J	Jahun, I; Said, I; El-Imam, I; Ehoche, A; Dalhatu, I; Yakubu, A; Greby, S; Bronson, M; Brown, K; Bamidele, M; Boyd, AT; Bachanas, P; Dirlikov, E; Agbakwuru, C; Abutu, A; Williams-Sherlock, M; Onotu, D; Odafe, S; Williams, DB; Bassey, O; Ogbanufe, O; Onyenuobi, C; Adeola, A; Meribe, C; Efuntoye, T; Fagbamigbe, OJ; Fagbemi, A; Ene, U; Nguhemen, T; Mgbakor, I; Alagi, M; Asaolu, O; Oladipo, A; Amafah, J; Nzelu, C; Dakum, P; Mensah, C; Aliyu, A; Okonkwo, P; Oyeledun, B; Oko, J; Ikpeazu, A; Gambo, A; Charurat, M; Ellerbrock, T; Aliyu, S; Swaminathan, M				Jahun, Ibrahim; Said, Ishaq; El-Imam, Ibrahim; Ehoche, Akipu; Dalhatu, Ibrahim; Yakubu, Aminu; Greby, Stacie; Bronson, Megan; Brown, Kristin; Bamidele, Moyosola; Boyd, Andrew T.; Bachanas, Pamela; Dirlikov, Emilio; Agbakwuru, Chinedu; Abutu, Andrew; Williams-Sherlock, Michelle; Onotu, Denis; Odafe, Solomon; Williams, Daniel B.; Bassey, Orji; Ogbanufe, Obinna; Onyenuobi, Chibuzor; Adeola, Ayo; Meribe, Chidozie; Efuntoye, Timothy; Fagbamigbe, Omodele J.; Fagbemi, Ayodele; Ene, Uzoma; Nguhemen, Tingir; Mgbakor, Ifunanya; Alagi, Matthias; Asaolu, Olugbenga; Oladipo, Ademola; Amafah, Joy; Nzelu, Charles; Dakum, Patrick; Mensah, Charles; Aliyu, Ahmad; Okonkwo, Prosper; Oyeledun, Bolanle; Oko, John; Ikpeazu, Akudo; Gambo, Aliyu; Charurat, Manhattan; Ellerbrock, Tedd; Aliyu, Sani; Swaminathan, Mahesh			Optimizing community linkage to care and antiretroviral therapy Initiation: Lessons from the Nigeria HIV/AIDS Indicator and Impact Survey (NAIIS) and their adaptation in Nigeria ART Surge	PLOS ONE			English	Article							HIV CARE	Background Ineffective linkage to care (LTC) is a known challenge for community HIV testing. To overcome this challenge, a robust linkage to care strategy was adopted by the 2018 Nigeria HIV/AIDS Indicator and Impact Survey (NAIIS). The NAIIS linkage to care strategy was further adapted to improve Nigeria's programmatic efforts to achieve the 1(st) 90 as part of the Nigeria Antiretroviral Therapy (ART) Surge initiative, which also included targeted community testing. In this paper we provide an overview of the NAIIS LTC strategy and describe the impact of this strategy on both the NAIIS and the Surge initiatives. Methods The NAIIS collaborated with community-based organizations (CBOs) and deployed mobile health (mHealth) technology with real-time dashboards to manage and optimize community LTC for people living with HIV (PLHIV) diagnosed during the survey. In NAIIS, CBOs' role was to facilitate linkage of identified PLHIV in community to facility of their choice. For the ART Surge, we modified the NAIIS LTC strategy by empowering both CBOs and mobile community teams as responsible for not only active LTC but also for community testing, ART initiation, and retention in care. Results Of the 2,739 PLHIV 15 years and above identified in NAIIS, 1,975 (72.1%) were either unaware of their HIV-positive status (N = 1890) or were aware of their HIV-positive status but not receiving treatment (N = 85). Of these, 1,342 (67.9%) were linked to care, of which 952 (70.9%) were initiated on ART. Among 1,890 newly diagnosed PLHIV, 1,278 (67.6%) were linked to care, 33.7% self-linked and 66.3% were linked by CBOs. Among 85 known PLHIV not on treatment, 64 (75.3%) were linked; 32.8% self-linked and 67.2% were linked by a CBO. In the ART Surge, LTC and treatment initiation rates were 98% and 100%, respectively. Three-month retention for monthly treatment initiation cohorts improved from 76% to 90% over 6 months. Conclusions Active LTC strategies by local CBOs and mobile community teams improved LTC and ART initiation in the ART Surge initiative. The use of mHealth technology resulted in timely and accurate documentation of results in NAIIS. By deploying mHealth in addition to active LTC, CBOs and mobile community teams could effectively scale up ART with real-time documentation of client-level outcomes.	[Jahun, Ibrahim; Dalhatu, Ibrahim; Yakubu, Aminu; Greby, Stacie; Bamidele, Moyosola; Abutu, Andrew; Onotu, Denis; Odafe, Solomon; Bassey, Orji; Ogbanufe, Obinna; Onyenuobi, Chibuzor; Adeola, Ayo; Meribe, Chidozie; Efuntoye, Timothy; Fagbamigbe, Omodele J.; Fagbemi, Ayodele; Ene, Uzoma; Nguhemen, Tingir; Mgbakor, Ifunanya; Alagi, Matthias; Asaolu, Olugbenga; Oladipo, Ademola; Amafah, Joy; Swaminathan, Mahesh] Nigeria Country Off, Ctr Dis Control & Prevent, Abuja, Federal Capital, Nigeria; [Said, Ishaq; El-Imam, Ibrahim; Ehoche, Akipu; Agbakwuru, Chinedu; Charurat, Manhattan] Univ Maryland, Maryland Global Initiat, Abuja, Federal Capital, Nigeria; [Bronson, Megan; Brown, Kristin; Boyd, Andrew T.; Bachanas, Pamela; Dirlikov, Emilio; Williams-Sherlock, Michelle; Williams, Daniel B.; Ellerbrock, Tedd] Ctr Dis Control & Prevent, Atlanta, GA USA; [Nzelu, Charles; Ikpeazu, Akudo] Fed Minist Hlth, Abuja, Nigeria; [Dakum, Patrick; Mensah, Charles; Aliyu, Ahmad] Inst Human Virol IHVN, Abuja, Federal Capital, Nigeria; [Okonkwo, Prosper] AIDS Prevent Initiat Nigeria APIN, Abuja, Federal Capital, Nigeria; [Oyeledun, Bolanle] Ctr Integrated Hlth Program CIHP, Abuja, Federal Capital, Nigeria; [Oko, John] Catholic Caritas Fdn Nigeria CCFN, Abuja, Federal Capital, Nigeria; [Gambo, Aliyu; Aliyu, Sani] Natl Agcy Control Aids, Abuja, Federal Capital, Nigeria	Centers for Disease Control & Prevention - USA	Jahun, I (corresponding author), Nigeria Country Off, Ctr Dis Control & Prevent, Abuja, Federal Capital, Nigeria.	drjahun@yahoo.co.uk	Alagi, Matthias/GYQ-5474-2022	Brown, Kristin/0000-0001-9256-533X; Dirlikov, Emilio/0000-0003-4631-2643; Bamidele, Moyosola/0000-0001-8444-7966; Jahun, Ibrahim/0000-0003-4190-1289	President's Emergency Plan for AIDS Relief (PEPFAR) through the Centers for Disease Control and Prevention (CDC) [CDC-RFAGH00-2018-01, CDC-RFAGH17-1753]	President's Emergency Plan for AIDS Relief (PEPFAR) through the Centers for Disease Control and Prevention (CDC)(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This research has been supported by the President's Emergency Plan for AIDS Relief (PEPFAR) through the Centers for Disease Control and Prevention (CDC) under the terms of CDC Cooperative Agreement No. CDC-RFAGH00-2018-01 and No. CDC-RFAGH17-1753. The findings and conclusions in this report are those of the authors and do not necessarily represent the official position of the funding agencies.	Bukenya D., 2020, SAGE Open, V10, punpaginated; Bunda BA, 2019, CURR OPIN HIV AIDS, V14, P494, DOI 10.1097/COH.0000000000000579; Dirlikov E, 2021, MMWR-MORBID MORTAL W, V70, P421, DOI 10.15585/mmwr.mm7012a3; Dorward J, 2017, JAIDS-J ACQ IMM DEF, V76, P453, DOI 10.1097/qai.0000000000001550; Federal Ministry of Health Nigeria, 2019, NIG HIV AIDS IND IMP; Fogel JM, 2013, J INFECT DIS, V208, P1624, DOI 10.1093/infdis/jit390; Godfrey Katy, IAS 2021; Govindasamy D, 2012, AIDS, V26, P2059, DOI 10.1097/QAD.0b013e3283578b9b; Horter S, 2017, SOC SCI MED, V176, P52, DOI 10.1016/j.socscimed.2017.01.006; Jahun I, 2021, HIV AIDS-RES PALLIAT, V13, P839, DOI 10.2147/HIV.S316480; Kahle EM, 2014, JAIDS-J ACQ IMM DEF, V65, pE90, DOI 10.1097/QAI.0b013e3182a2db02; Katbi M, 2019, INT J INFECT DIS, V87, P185, DOI 10.1016/j.ijid.2019.08.014; Losina E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009538; Marsh K, 2019, AIDS, V33, pS213, DOI 10.1097/QAD.0000000000002355; Maughan-Brown B, 2021, AIDS CARE, V33, P70, DOI 10.1080/09540121.2020.1719025; Maughan-Brown B, 2019, J BEHAV MED, V42, P883, DOI 10.1007/s10865-018-0005-x; Nakibuuka J, 2019, STUD HEALTH TECHNOL, V262, P162, DOI 10.3233/SHTI190042; Nyato D, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0219032; Odimegwu CO, 2017, AIDS RES TREAT, V2017, DOI 10.1155/2017/5812650; Oladele EA, 2018, J INT AIDS SOC, V21, DOI 10.1002/jia2.25108; Onyeonoro UU, 2016, HEALTH SERV INSIGHTS, V9, P29, DOI [10.4137/hsi.s31865, 10.4137/HSI.S31865]; Owusu KK, 2019, HIV AIDS-RES PALLIAT, V11, P321, DOI 10.2147/HIV.S216093; Pandhi Deepika, 2014, Indian J Sex Transm Dis AIDS, V35, P1, DOI 10.4103/0253-7184.132399; Riehman KS, 2013, AIDS CARE, V25, pS67, DOI 10.1080/09540121.2013.778383; Rohr JK, 2017, J INT AIDS SOC, V20, DOI 10.7448/IAS.20.1.21691; Sanga ES, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-6691-7; Srivastava M, 2018, J INT AIDS SOC, V21, DOI 10.1002/jia2.25053; Sulat JS, 2018, J HEALTH RES, V32, P152, DOI 10.1108/JHR-01-2018-015; Tun W, 2019, AIDS BEHAV, V23, pS142, DOI 10.1007/s10461-019-02549-x; Vojnov L, 2017, JAIDS-J ACQ IMM DEF, V76, P522, DOI [10.1097/QAI.0000000000001526, 10.1097/qai.0000000000001526]; WHO Global Observatory for eHealth, 2011, MHEALTH NEW HORIZONS	31	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2021	16	9							e0257476	10.1371/journal.pone.0257476	http://dx.doi.org/10.1371/journal.pone.0257476			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	WG6BN	34543306	Green Published, gold			2022-12-26	WOS:000707078200036
J	Tang, YB; Kline, KT; Zhong, XYS; Xiao, Y; Lian, HF; Peng, J; Liu, XW; Powell, DW; Tang, GD; Li, QJ				Tang, Yanbo; Kline, Kevin T.; Zhong, Xiaoying S.; Xiao, Ying; Lian, Haifeng; Peng, Jun; Liu, Xiaowei; Powell, Don W.; Tang, Guodu; Li, Qingjie			Chronic colitis upregulates microRNAs suppressing brain-derived neurotrophic factor in the adult heart	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; MYOCARDIAL-INFARCTION; ENHANCED PRODUCTION; CROHNS COLITIS; FAILURE; EXPRESSION; INTERLEUKIN-1; PROTECTS; MODELS; RISK	Ulcerative colitis and Crohn's disease are classified as chronic inflammatory bowel diseases (IBD) with known extraintestinal manifestations. The interplay between heart and gut in IBD has previously been noted, but the mechanisms remain elusive. Our objective was to identify microRNAs mediating molecular remodeling and resulting cardiac impairment in a rat model of colitis. To induce chronic colitis, dextran sodium sulfate (DSS) was given to adult rats for 5 days followed by 9 days with normal drinking water for 4 cycles over 8 weeks. Echocardiography was performed to evaluate heart function. DSS-induced colitis led to a significant decrease in ejection fraction, increased left ventricular mass and size, and elevated B-type natriuretic protein. MicroRNA profiling showed a total of 56 miRNAs significantly increased in the heart by colitis, 8 of which are predicted to target brain-derived neurotrophic factor (BDNF). RT-qPCR validated the increases of miR-1b, Let-7d, and miR-155. Transient transfection revealed that miR-155 significantly suppresses BDNF in H9c2 cells. Importantly, DSS colitis markedly decreased BDNF in both myocardium and serum. Levels of various proteins critical to cardiac homeostasis were also altered. Functional studies showed that BDNF increases cell viability and mitigates H2O2-induced oxidative damage in H9c2 cells, demonstrating its protective role in the adult heart. Mechanistically, cellular experiments identified IL-1 beta as the inflammatory mediator upregulating cardiac miR-155; this effect was confirmed in adult rats. Furthermore, IL-1 beta neutralizing antibody ameliorated the DSS-induced increase in miR-155 and concurrent decrease in BDNF in the adult heart, showing therapeutic potential. Our findings indicate that chronic colitis impairs heart function through an IL-1 beta -> miR-155 -> BDNF signaling axis.	[Tang, Yanbo; Tang, Guodu] Guangxi Med Univ, Affiliated Hosp 1, Dept Gastroenterol, Nanning, Peoples R China; [Kline, Kevin T.; Zhong, Xiaoying S.; Xiao, Ying; Powell, Don W.; Li, Qingjie] Univ Texas Med Branch Galveston, Dept Internal Med, Div Gastroenterol, Galveston, TX 77555 USA; [Xiao, Ying; Liu, Xiaowei] Cent South Univ, Xiangya Hosp, Dept Gastroenterol, Changsha, Peoples R China; [Lian, Haifeng] Binzhou Med Univ Hosp, Dept Gastroenterol, Binzhou, Peoples R China; [Peng, Jun] Cent South Univ, Xiangya Sch Pharmaceut Sci, Dept Pharmacol, Changsha, Peoples R China	Guangxi Medical University; University of Texas System; University of Texas Medical Branch Galveston; Central South University; Binzhou Medical University; Central South University	Tang, GD (corresponding author), Guangxi Med Univ, Affiliated Hosp 1, Dept Gastroenterol, Nanning, Peoples R China.; Li, QJ (corresponding author), Univ Texas Med Branch Galveston, Dept Internal Med, Div Gastroenterol, Galveston, TX 77555 USA.	tguodu02@126.com; quli@utmb.edu		Li, Qingjie/0000-0003-1405-7000	National Institutes of Health [R01 HL152683, R21 AI126097]; American Heart Association [17GRNT33460395]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association)	This work was supported, in part, by grants from the National Institutes of Health (R01 HL152683 and R21 AI126097 to Q. Li) and by American Heart Association Grant-in-Aid 17GRNT33460395 (to Q. Li) (heart.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. We confirm that the funders provided support in the form of salaries for authors [QL, XSZ, and YX], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	Aniwan S, 2018, CLIN GASTROENTEROL H, V16, P1607, DOI 10.1016/j.cgh.2018.04.031; Anker SD, 2004, HEART, V90, P464, DOI 10.1136/hrt.2002.007005; Arimura Y, 2011, METHODS MOL BIOL, V762, P409, DOI 10.1007/978-1-61779-185-7_29; Bagnall RD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044744; Bao MH, 2013, INT J MOL SCI, V14, P23086, DOI 10.3390/ijms141123086; Beres NJ, 2016, INFLAMM BOWEL DIS, V22, P327, DOI 10.1097/MIB.0000000000000687; Brown JB, 2010, GASTROENTEROLOGY, V138, P595, DOI 10.1053/j.gastro.2009.10.038; Cacciapaglia F, 2011, AUTOIMMUN REV, V10, P631, DOI 10.1016/j.autrev.2011.04.014; Chaanine AH, 2011, EUR J HEART FAIL, V13, P825, DOI 10.1093/eurjhf/hfr080; Chapman CG, 2015, THER ADV GASTROENTER, V8, P4, DOI 10.1177/1756283X14547360; Choi YJ, 2019, ALIMENT PHARM THER, V50, P769, DOI 10.1111/apt.15446; Colpaert RMW, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8070737; Dinarello CA, 2010, CURR OPIN ENDOCRINOL, V17, P314, DOI 10.1097/MED.0b013e32833bf6dc; Ertem FU, 2017, INT J CANCER, V140, P460, DOI 10.1002/ijc.30458; Feng N, 2015, P NATL ACAD SCI USA, V112, P1880, DOI 10.1073/pnas.1417949112; Fischer P, 2007, BASIC RES CARDIOL, V102, P393, DOI 10.1007/s00395-007-0674-z; Fulgenzi G, 2015, J CELL BIOL, V210, P1003, DOI 10.1083/jcb.201502100; Gustafsson AB, 2007, AM J PHYSIOL-CELL PH, V292, pC45, DOI 10.1152/ajpcell.00229.2006; Hakansson A, 2011, GASTROENT RES PRACT, V2011, DOI 10.1155/2011/924045; Hang PZ, 2015, INT J BIOL SCI, V11, P536, DOI 10.7150/ijbs.10754; Huang WS, 2014, EUR J INTERN MED, V25, P561, DOI 10.1016/j.ejim.2014.05.009; Iqbal N, 2012, CARDIOVASC DIAGN THE, V2, P147, DOI 10.3978/j.issn.2223-3652.2012.06.03; Jakubowska K, 2016, GASTROENT RES PRACT, V2016, DOI 10.1155/2016/2456179; Jan MI, 2021, ACTA RADIOL, V62, P603, DOI 10.1177/0284185120933530; Jeyabal P, 2016, BIOCHEM BIOPH RES CO, V471, P423, DOI 10.1016/j.bbrc.2016.02.065; Jiang YB, 2000, ARTHRITIS RHEUM, V43, P1001, DOI 10.1002/1529-0131(200005)43:5<1001::AID-ANR7>3.0.CO;2-P; Jose FA, 2008, J PEDIATR GASTR NUTR, V46, P124, DOI 10.1097/MPG.0b013e318093f4b0; Kadowaki S, 2016, HEART VESSELS, V31, P535, DOI 10.1007/s00380-015-0628-6; Kappelman MD, 2011, GUT, V60, P937, DOI 10.1136/gut.2010.228585; Keppner A, 2016, INFLAMM BOWEL DIS, V22, P2824, DOI 10.1097/MIB.0000000000000940; Kiesler P, 2015, CELL MOL GASTROENTER, V1, P154, DOI 10.1016/j.jcmgh.2015.01.006; Kitajima S, 1999, J VET MED SCI, V61, P67, DOI 10.1292/jvms.61.67; Kline KT, 2020, J IMMUNOL, V204, P980, DOI 10.4049/jimmunol.1900639; Kristensen SL, 2014, CIRC-HEART FAIL, V7, P717, DOI 10.1161/CIRCHEARTFAILURE.114.001152; Lee CY, 2017, CARDIOVASC PATHOL, V31, P9, DOI 10.1016/j.carpath.2017.07.003; Li QJ, 2013, AM J PHYSIOL-GASTR L, V305, pG503, DOI 10.1152/ajpgi.00160.2013; Li QJ, 2009, GASTROENTEROLOGY, V137, P1051, DOI 10.1053/j.gastro.2009.03.040; LIGUMSKY M, 1990, GUT, V31, P686, DOI 10.1136/gut.31.6.686; MAHIDA YR, 1989, GUT, V30, P835, DOI 10.1136/gut.30.6.835; Mizuta Y, 2000, GASTROENTEROLOGY, V118, P714, DOI 10.1016/S0016-5085(00)70141-7; Moustafa A, 2018, CLIN TRANSL GASTROEN, V9, DOI 10.1038/ctg.2017.58; Nakagawa A, 2016, SCI REP-UK, V6, DOI 10.1038/srep25009; Nyuyki KD, 2018, FRONT BEHAV NEUROSCI, V12, DOI 10.3389/fnbeh.2018.00058; Okada S, 2012, ARTERIOSCL THROM VAS, V32, P1902, DOI 10.1161/ATVBAHA.112.248930; Panhwar MS, 2019, INFLAMM BOWEL DIS, V25, P1080, DOI 10.1093/ibd/izy354; Paraskevi A, 2012, J CROHNS COLITIS, V6, P900, DOI 10.1016/j.crohns.2012.02.006; Pascual-Figal DA, 2019, J AM COLL CARDIOL, V73, P1016, DOI 10.1016/j.jacc.2018.11.054; Pius-Sadowska E, 2017, J MOL CELL CARDIOL, V110, P54, DOI 10.1016/j.yjmcc.2017.07.007; Rao PK, 2009, CIRC RES, V105, P585, DOI 10.1161/CIRCRESAHA.109.200451; Renema P, 2020, AM J PHYSIOL-LUNG C, V319, pL380, DOI 10.1152/ajplung.00508.2019; Rodriguez A, 2007, SCIENCE, V316, P608, DOI 10.1126/science.1139253; Rogler G, 2014, EUR HEART J, V35, P426, DOI 10.1093/eurheartj/eht271; Sandek A, 2007, J AM COLL CARDIOL, V50, P1561, DOI 10.1016/j.jacc.2007.07.016; Schonauen K, 2018, INFLAMM BOWEL DIS, V24, P1547, DOI 10.1093/ibd/izy046; Seok HY, 2014, CIRC RES, V114, P1585, DOI 10.1161/CIRCRESAHA.114.303784; Shi XZ, 2011, AM J PHYSIOL-GASTR L, V300, pG41, DOI 10.1152/ajpgi.00358.2010; Sinagra E, 2013, EUR J INTERN MED, V24, P385, DOI 10.1016/j.ejim.2012.12.015; Watson LE, 2004, J AM SOC ECHOCARDIOG, V17, P161, DOI 10.1016/j.echo.2003.10.010; Watts Megan N, 2014, Pathophysiology, V21, P301, DOI 10.1016/j.pathophys.2014.08.001; Winston JH, 2013, AM J PHYSIOL-GASTR L, V305, pG295, DOI 10.1152/ajpgi.00052.2013; Yarur AJ, 2011, AM J GASTROENTEROL, V106, P741, DOI 10.1038/ajg.2011.63; Zhong XYS, 2018, CELL MOL GASTROENTER, V6, P65, DOI 10.1016/j.jcmgh.2018.02.014	62	3	3	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2021	16	9							e0257280	10.1371/journal.pone.0257280	http://dx.doi.org/10.1371/journal.pone.0257280			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	WG6BN	34543287	Green Published, gold			2022-12-26	WOS:000707078200026
J	Helepciuc, FE; Todor, A				Helepciuc, Florenta-Elena; Todor, Arpad			Evaluating the effectiveness of the EU's approach to the sustainable use of pesticides	PLOS ONE			English	Article							INTEGRATED PEST-MANAGEMENT; VISION; EUROPE	By adopting the 2009 "pesticide package," the EU proposed a common approach to limiting the harmful effects of pesticides, promoting Integrated Pest Management, and the progressive replacement of the most dangerous pesticides with low-risk alternatives through a comprehensive but flexible framework for all EU Member States. Each EU Member State had to develop a National Action Plan that would propose measures to achieve the package's goals. Nevertheless, the choice of actions and indicators remained to be established at the national level. A series of recent evaluations of how Directive 2009/128/EC of the European Parliament and the Council on the Sustainable Use of Pesticides Directive (SUD), a central piece of the "pesticide package," was implemented showed limited success in achieving its goals. Aiming to explain these failures, we compare the National Action Plans eight EU Member States adopted after the SUD. We assess the degree to which the countries' proposed measures and indicators would achieve the Directive's three overarching objectives (reduce risks and impact; promote Integrated Pest Management; promote approaches and techniques to reduce reliance on pesticides). We develop the comparative analysis along three dimensions: the promotion of measures to achieve SUD's three goals; the evolution of the pre-and post-Directive action plans of some of the old EU Member States; and the differences between old and the new EU Member States. The comparison along ten variables shows that the SUD had a minimal effect in homogenizing different states' approaches to develop their National Action Plans to systematically treat problems, propose measures, and timetables for implementation and indicators. Given that the overall effect in generating a common EU approach to raise the sustainability of pesticide use and agriculture, in general, was still limited, as no common measures, indicators, or process to planning were identified, we discuss some suggestions to improve the situation.	[Helepciuc, Florenta-Elena] Romanian Acad, Inst Biol Bucharest, Bucharest, Romania; [Todor, Arpad] Natl Univ Polit Studies & Publ Adm, Bucharest, Romania	Romanian Academy of Sciences; National University of Political Studies & Public Administration	Todor, A (corresponding author), Natl Univ Polit Studies & Publ Adm, Bucharest, Romania.	todor.arpad@politice.ro						[Anonymous], 2020, ROL ORG SECT GREEN D; [Anonymous], 2017, COM2017587; Barzman M, 2011, PEST MANAG SCI, V67, P1481, DOI 10.1002/ps.2283; Buckwell A., 2020, CROP PROTECTION EU F; Buurma JS, 2017, CROP PROT, V97, P94, DOI 10.1016/j.cropro.2016.11.013; Department for Environment Food & Rural Affairs, 2013, UK NAT ACT PLAN SUST; DG Health and Food Safety, 2017, DGSANTE20176291; EU, 2017, RES 16 FEBR 2017 REC; European Comission, 2016, PEST; European Comission, 2019, TRENDS HARM RISK IND; European Comission, 2020, ORG GLANC; European Court of Auditors, 2020, 052020 EUR COURT AUD; European Parliament and the Council, DIRECTIVE 2009128E; Federal Ministry of Food Agriculture and Consumer Protection of Germany, 2012, NAT ACT PLAN SUST US; Government of Romania, 2013, NAT ACT PLAN MIT RIS; Kudsk P, 2018, LAND USE POLICY, V70, P384, DOI 10.1016/j.landusepol.2017.11.010; Lamichhane JR, 2019, ADV AGRON, V154, P81, DOI 10.1016/bs.agron.2018.11.003; Lamichhane JR, 2018, INT J PEST MANAGE, V64, P352, DOI 10.1080/09670874.2018.1435924; Lamichhane JR, 2017, PEST MANAG SCI, V73, P14, DOI 10.1002/ps.4423; Lamichhane JR, 2016, CROP PROT, V89, P139, DOI 10.1016/j.cropro.2016.07.011; Lechenet M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097922; Meissle M, 2010, J APPL ENTOMOL, V134, P357, DOI 10.1111/j.1439-0418.2009.01491.x; Minister for Food Agriculture and Fisheries of Denmark, 2013, PROT WAT NAT HUM HLT; Minister of Agriculture and Rural Development of Poland, 2013, NAT ACT PLAN RED RIS; Ministry of Agriculture and Food, 2015, ECOPHYTO PLAN 2; Ministry of Environment and Food of Denmark, 2017, DAN NAT ACT PLAN PES; Ministry of Rural Development of Hungary, 2012, NAT PLANT PROT ACT P; Pesticide Action Network Europe, 2018, PEST US EUR; Pesticide Action Network Europe, 2015, PEST US EUR; Sedelmeier U, 2016, MAXIMIZING INTEGRATI; The European Commission, 2016, NAT ACT PLANS; Todor A., 2021, EUROPEANISATION ENV; van der Linden T., 2014, PESTICIDE RISK INDIC	33	4	4	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2021	16	9							e0256719	10.1371/journal.pone.0256719	http://dx.doi.org/10.1371/journal.pone.0256719			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	WG5YY	34529677	Green Published, gold			2022-12-26	WOS:000707071500018
J	Kim, DV; Kulishova, LM; Torgasheva, NA; Melentyev, VS; Dianov, GL; Medvedev, SP; Zakian, SM; Zharkov, DO				Kim, Daria, V; Kulishova, Liliya M.; Torgasheva, Natalia A.; Melentyev, Vasily S.; Dianov, Grigory L.; Medvedev, Sergey P.; Zakian, Suren M.; Zharkov, Dmitry O.			Mild phenotype of knockouts of the major apurinic/apyrimidinic endonuclease APEX1 in a non-cancer human cell line	PLOS ONE			English	Article							BASE EXCISION-REPAIR; DNA-POLYMERASE-BETA; HUMAN AP ENDONUCLEASE; ABASIC SITES; MAMMALIAN-CELLS; DAMAGING AGENTS; GENE-EXPRESSION; PROTEIN; GLYCOSYLASE; SENSITIVITY	The major human apurinic/apyrimidinic (AP) site endonuclease, APEX1, is a central player in the base excision DNA repair (BER) pathway and has a role in the regulation of DNA binding by transcription factors. In vertebrates, APEX1 knockouts are embryonic lethal, and only a handful of knockout cell lines are known. To facilitate studies of multiple functions of this protein in human cells, we have used the CRISPR/Cas9 system to knock out the APEX1 gene in a widely used non-cancer hypotriploid HEK 293FT cell line. Two stable knockout lines were obtained, one carrying two single-base deletion alleles and one single-base insertion allele in exon 3, another homozygous in the single-base insertion allele. Both mutations cause a frameshift that leads to premature translation termination before the start of the protein's catalytic domain. Both cell lines totally lacked the APEX1 protein and AP site-cleaving activity, and showed significantly lower levels of the APEX1 transcript. The APEX1-null cells were unable to support BER on uracil- or AP site-containing substrates. Phenotypically, they showed a moderately increased sensitivity to methyl methanesulfonate (MMS; ~2-fold lower EC50 compared with wild-type cells), and their background level of natural AP sites detected by the aldehyde-reactive probe was elevated ~1.5-2-fold. However, the knockout lines retained a nearly wild-type sensitivity to oxidizing agents hydrogen peroxide and potassium bromate. Interestingly, despite the increased MMS cytotoxicity, we observed no additional increase in AP sites in knockout cells upon MMS treatment, which could indicate their conversion into more toxic products in the absence of repair. Overall, the relatively mild cell phenotype in the absence of APEX1-dependent BER suggests that mammalian cells possess mechanisms of tolerance or alternative repair of AP sites. The knockout derivatives of the extensively characterized HEK 293FT cell line may provide a valuable tool for studies of APEX1 in DNA repair and beyond.	[Kim, Daria, V; Melentyev, Vasily S.; Dianov, Grigory L.; Zharkov, Dmitry O.] Novosibirsk State Univ, Dept Nat Sci, Novosibirsk, Russia; [Kim, Daria, V; Kulishova, Liliya M.; Torgasheva, Natalia A.; Zharkov, Dmitry O.] SB RAS Inst Chem Biol & Fundamental Med, Novosibirsk, Russia; [Melentyev, Vasily S.; Dianov, Grigory L.; Medvedev, Sergey P.; Zakian, Suren M.] SB RAS Inst Cytol & Genet, Novosibirsk, Russia; [Dianov, Grigory L.] Univ Oxford, MRC Oxford Inst Radiat Oncol, Dept Oncol, Oxford, England	Novosibirsk State University; Institute of Chemical Biology & Fundamental Medicine, Siberian Branch of the RAS; Russian Academy of Sciences; Russian Academy of Sciences; Institute of Cytology & Genetics ICG SB RAS; University of Oxford	Zharkov, DO (corresponding author), Novosibirsk State Univ, Dept Nat Sci, Novosibirsk, Russia.; Zharkov, DO (corresponding author), SB RAS Inst Chem Biol & Fundamental Med, Novosibirsk, Russia.	dzharkov@niboch.nsc.ru	Zharkov, Dmitry/K-2158-2012; Kulishova, Liliya/M-8942-2016	Zharkov, Dmitry/0000-0001-5013-0194; Kulishova, Liliya/0000-0003-2077-564X	Russian Foundation for Basic Research [17-0000261/17-00-00265-komfi]; Russian Science Foundation [19-7420069]; Russian Ministry of Science and Higher Education [AAAA-A17117020210023-1, FSUS-2020-0035]; Russian Foundation for Basic Research Graduate Student Fellowship [20-34-90092]; Ministry of Science and Higher Education of the Russian Federation; German Academic Exchange Services (DAAD) [DAAD-2330-21]	Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Russian Science Foundation(Russian Science Foundation (RSF)); Russian Ministry of Science and Higher Education; Russian Foundation for Basic Research Graduate Student Fellowship; Ministry of Science and Higher Education of the Russian Federation; German Academic Exchange Services (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD))	This research was supported by Russian Foundation for Basic Research (grant 17-0000261/17-00-00265-komfi to D.O.Z). The part concerning gene expression profiling was funded by Russian Science Foundation (grant 19-7420069 to G.L.D.) Partial salary support from the Russian Ministry of Science and Higher Education (state-funded budget projectsAAAA-A17117020210023-1 and FSUS-2020-0035) is acknowledged. D.V.K. is partly supported by the Russian Foundation for Basic Research Graduate Student Fellowship (20-34-90092). D.V.K. is a recipient of joint scholarship from the Ministry of Science and Higher Education of the Russian Federation and German Academic Exchange Services (DAAD) Michael Lomonosov program DAAD-2330-21. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre AJ, 2016, CANCER DISCOV, V6, P914, DOI 10.1158/2159-8290.CD-16-0154; Ahuja D, 2005, ONCOGENE, V24, P7729, DOI 10.1038/sj.onc.1209046; Antoniali G, 2017, DNA REPAIR, V56, P65, DOI 10.1016/j.dnarep.2017.06.008; Asaeda A, 1998, NUCLEOS NUCLEOT, V17, P503, DOI 10.1080/07328319808005194; Atamna H, 2000, P NATL ACAD SCI USA, V97, P686, DOI 10.1073/pnas.97.2.686; Ballmaier D, 2006, TOXICOLOGY, V221, P166, DOI 10.1016/j.tox.2006.01.009; Behan FM, 2019, NATURE, V568, P511, DOI 10.1038/s41586-019-1103-9; BERANEK DT, 1990, MUTAT RES, V231, P11, DOI 10.1016/0027-5107(90)90173-2; Berk AJ, 2005, ONCOGENE, V24, P7673, DOI 10.1038/sj.onc.1209040; BLAKELY WF, 1990, RADIAT RES, V121, P338, DOI 10.2307/3577785; Brinkman EK, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku936; Burkovics P, 2006, NUCLEIC ACIDS RES, V34, P2508, DOI 10.1093/nar/gkl259; Chen T., 2017, TUMOR BIOL, V39, p1010428317713390, DOI [10.1177/1010428317713390, DOI 10.1177/1010428317713390]; Condie AG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131330; CUNNINGHAM RP, 1986, J BACTERIOL, V168, P1120, DOI 10.1128/jb.168.3.1120-1127.1986; Das A, 2006, DNA REPAIR, V5, P1439, DOI 10.1016/j.dnarep.2006.07.003; Demple B, 2005, DNA REPAIR, V4, P1442, DOI 10.1016/j.dnarep.2005.09.004; Dianov GL, 2013, NUCLEIC ACIDS RES, V41, P3483, DOI 10.1093/nar/gkt076; Doench JG, 2016, NAT BIOTECHNOL, V34, P184, DOI 10.1038/nbt.3437; Doetsch PW, 2002, MUTAT RES-FUND MOL M, V510, P131, DOI 10.1016/S0027-5107(02)00258-0; Engelward BP, 1996, EMBO J, V15, P945, DOI 10.1002/j.1460-2075.1996.tb00429.x; Fan ZS, 2003, NAT IMMUNOL, V4, P145, DOI 10.1038/ni885; Fisher LA, 2011, CHEM RES TOXICOL, V24, P1876, DOI 10.1021/tx200221j; FOSTER PL, 1990, J BACTERIOL, V172, P4719, DOI 10.1128/jb.172.8.4719-4720.1990; Friedberg E.C., 2006, DNA REPAIR MUTAGENES, P1118; Fung H, 2011, J BIOL CHEM, V286, P4968, DOI 10.1074/jbc.M110.146498; Geiger T, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.014050; Golato T, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12963-7; Greenberg MM, 2014, ACCOUNTS CHEM RES, V47, P646, DOI 10.1021/ar400229d; Guillet M, 2002, EMBO J, V21, P2833, DOI 10.1093/emboj/21.11.2833; Hadi MZ, 2000, NUCLEIC ACIDS RES, V28, P3871, DOI 10.1093/nar/28.20.3871; Hadi MZ, 2002, J MOL BIOL, V316, P853, DOI 10.1006/jmbi.2001.5382; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Huamani J, 2004, MOL CELL BIOL, V24, P8145, DOI 10.1128/MCB.24.18.8145-8153.2004; Illuzzi JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065922; Izumi T, 2005, P NATL ACAD SCI USA, V102, P5739, DOI 10.1073/pnas.0500986102; Janion C, 2003, ENVIRON MOL MUTAGEN, V41, P237, DOI 10.1002/em.10154; Jeon BH, 2004, CIRC RES, V95, P902, DOI 10.1161/01.RES.0000146947.84294.4c; Jin CL, 2015, EPIGENETICS-US, V10, P1006, DOI 10.1080/15592294.2015.1091145; Jung SB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065415; Kanno SI, 2007, EMBO J, V26, P2094, DOI 10.1038/sj.emboj.7601663; Karczewski KJ, 2020, NATURE, V581, P434, DOI 10.1038/s41586-020-2308-7; Kim DV, 2019, CURR PHARM DESIGN, V25, P298, DOI 10.2174/1381612825666190319112930; KUBO K, 1992, BIOCHEMISTRY-US, V31, P3703, DOI 10.1021/bi00129a020; KUMAR A, 1990, J BIOL CHEM, V265, P2124; Liang JB, 2020, CANCER RES, V80, P510, DOI 10.1158/0008-5472.CAN-18-3374; Lin YC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5767; Lindahl T, 2000, COLD SPRING HARB SYM, V65, P127, DOI 10.1101/sqb.2000.65.127; LINDAHL T, 1972, BIOCHEMISTRY-US, V11, P3610, DOI 10.1021/bi00769a018; Liu ZJ, 2019, NAT CHEM, V11, P629, DOI 10.1038/s41557-019-0279-9; Ludwig DL, 1998, MUTAT RES-DNA REPAIR, V409, P17, DOI 10.1016/S0921-8777(98)00039-1; MacLeod G, 2019, CELL REP, V27, P971, DOI 10.1016/j.celrep.2019.03.047; Malfatti MC, 2020, MUTAGENESIS, V35, P129, DOI 10.1093/mutage/gez051; Masani S, 2013, MOL CELL BIOL, V33, P1468, DOI 10.1128/MCB.00026-13; Matsuzaki Y, 2015, REGEN THER, V1, P91, DOI 10.1016/j.reth.2015.04.003; McCullough AK, 1999, ANNU REV BIOCHEM, V68, P255, DOI 10.1146/annurev.biochem.68.1.255; McCullough AK, 2001, BIOCHEMISTRY-US, V40, P561, DOI 10.1021/bi002404+; McNeill DR, 2020, MUTAGENESIS, V35, P27, DOI 10.1093/mutage/gez046; Meira LB, 2001, CANCER RES, V61, P5552; Miller H, 2000, BIOCHEMISTRY-US, V39, P1029, DOI 10.1021/bi991789x; Nikolova T, 2010, DNA REPAIR, V9, P1050, DOI 10.1016/j.dnarep.2010.07.005; Olivieri M, 2020, CELL, V182, P481, DOI 10.1016/j.cell.2020.05.040; Pachva MC, 2020, FRONT CELL DEV BIOL, V8, DOI 10.3389/fcell.2020.607045; Parsons JL, 2000, MUTAGENESIS, V15, P311, DOI 10.1093/mutage/15.4.311; Pogozelski WK, 1998, CHEM REV, V98, P1089, DOI 10.1021/cr960437i; Pommier Y, 2014, DNA REPAIR, V19, P114, DOI 10.1016/j.dnarep.2014.03.020; Popov AV, 2020, J MOL BIOL, V432, P1747, DOI 10.1016/j.jmb.2019.12.020; Pourquier P, 1997, J BIOL CHEM, V272, P7792, DOI 10.1074/jbc.272.12.7792; Quinones JL, 2016, DNA REPAIR, V44, P103, DOI 10.1016/j.dnarep.2016.05.014; Raffoul JJ, 2004, J BIOL CHEM, V279, P18425, DOI 10.1074/jbc.M313983200; Rahimoff R, 2017, J AM CHEM SOC, V139, P10359, DOI 10.1021/jacs.7b04131; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Roth RB, 2002, CANCER RES, V62, P656; Sengupta S, 2011, ONCOGENE, V30, P482, DOI 10.1038/onc.2010.435; Shafirovich V, 2017, FREE RADICAL BIO MED, V107, P53, DOI 10.1016/j.freeradbiomed.2016.10.507; Shalem O, 2015, NAT REV GENET, V16, P299, DOI 10.1038/nrg3899; Shen JC, 2014, SCI REP-UK, V4, DOI 10.1038/srep04894; Sidorenko VS, 2007, DNA REPAIR, V6, P317, DOI 10.1016/j.dnarep.2006.10.022; Silber JR, 2002, CLIN CANCER RES, V8, P3008; Sobol RW, 2000, NATURE, V405, P807, DOI 10.1038/35015598; Strauss BS, 2002, DNA REPAIR, V1, P125, DOI 10.1016/S1568-7864(01)00014-3; Taylor JS, 2002, MUTAT RES-FUND MOL M, V510, P55, DOI 10.1016/S0027-5107(02)00252-X; Tell G, 2010, CELL MOL LIFE SCI, V67, P3589, DOI 10.1007/s00018-010-0486-4; Tell G, 2009, ANTIOXID REDOX SIGN, V11, P601, DOI 10.1089/ars.2008.2194; Toledo CM, 2015, CELL REP, V13, P2425, DOI 10.1016/j.celrep.2015.11.021; WALKER LJ, 1994, NUCLEIC ACIDS RES, V22, P4884, DOI 10.1093/nar/22.23.4884; Wang D, 2004, MOL CANCER THER, V3, P679; Wang MC, 2015, PROTEOMICS, V15, P3163, DOI 10.1002/pmic.201400441; Wang Y, 2006, MOL CELL BIOL, V26, P9083, DOI 10.1128/MCB.01216-06; Wiederhold L, 2004, MOL CELL, V15, P209, DOI 10.1016/j.molcel.2004.06.003; Wyatt MD, 2006, CHEM RES TOXICOL, V19, P1580, DOI 10.1021/tx060164e; XANTHOUDAKIS S, 1992, EMBO J, V11, P3323, DOI 10.1002/j.1460-2075.1992.tb05411.x; Xanthoudakis S, 1996, P NATL ACAD SCI USA, V93, P8919, DOI 10.1073/pnas.93.17.8919; XANTHOUDAKIS S, 1994, P NATL ACAD SCI USA, V91, P23, DOI 10.1073/pnas.91.1.23; Xia LQ, 2005, J MOL BIOL, V346, P1259, DOI 10.1016/j.jmb.2005.01.014; Xiong JJ, 2008, BIOSCI BIOTECH BIOCH, V72, P3206, DOI 10.1271/bbb.80415	96	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2021	16	9							e0257473	10.1371/journal.pone.0257473	http://dx.doi.org/10.1371/journal.pone.0257473			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	WG5YY	34529719	Green Published, gold			2022-12-26	WOS:000707071500064
J	Varadarajan, J; Brown, AM; Chalkley, R				Varadarajan, Janani; Brown, Abigail M.; Chalkley, Roger			Biomedical graduate student experiences during the COVID-19 university closure	PLOS ONE			English	Article							TIME MANAGEMENT; UNITED-STATES; MENTAL-HEALTH; OUTBREAK; STRESS	COVID-19-associated university closures moved classes online and interrupted ongoing research in universities throughout the US. In Vanderbilt University, first year biomedical sciences PhD students were in the middle of their spring semester coursework and in the process of identifying a thesis research lab, while senior students who had already completed the first year were at various stages of their graduate training and were working on their thesis research projects. To learn how the university closure and resulting interruptions impacted our students' learning and well-being, we administered two surveys, one to the first year students and the other to the senior students. Our main findings show that the university closure negatively impacted the overall psychological health of about one-third of the survey respondents, time management was the aspect of remote learning that caused the highest stress for close to 50% of the students, and interaction with their peers and in-person discussions were the aspects of on-campus learning that students missed the most during the remote learning period. Additionally, survey responses also show that students experienced positive outcomes as a result of remote learning that included spending increased time on additional learning interests, with family, on self-care, and for dissertation or manuscript writing. Though a variety of supportive resources are already available to students in our institution, results from our survey suggest enhancing these measures and identifying new ones targeted to addressing the academic and emotional needs of PhD students would be beneficial. Such support measures may be appropriate for students in other institutions as well.	[Varadarajan, Janani; Brown, Abigail M.; Chalkley, Roger] Vanderbilt Univ, Sch Med, Off Biomed Res Educ & Training, Nashville, TN 37212 USA	Vanderbilt University	Chalkley, R (corresponding author), Vanderbilt Univ, Sch Med, Off Biomed Res Educ & Training, Nashville, TN 37212 USA.	roger.g.chalkley@vanderbilt.edu		Brown, Abigail/0000-0001-9504-3465				Adams RV, 2019, SAGE OPEN, V9, DOI 10.1177/2158244018824506; [Anonymous], 2018, NAT CELL BIOL, V20, P363, DOI 10.1038/s41556-018-0085-4; [Anonymous], 2020, RETURN CAMPUS MESSAG; [Anonymous], 2011, STRESS REL AM GRAD S; Berkeley Graduate Division, 2020, GRAD STUD COVID 19 S; Czeisler ME, 2020, MMWR-MORBID MORTAL W, V69, P1049, DOI [10.1101/2020.04.22.20076141v1, 10.15585/mmwr.mm6932a1]; Eleftheriades Renee, 2020, F1000Res, V9, P104, DOI 10.12688/f1000research.21066.1; Elmer T, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0236337; Evans TM, 2018, NAT BIOTECHNOL, V36, P282, DOI 10.1038/nbt.4089; Ferrel MN, 2020, CUREUS, V12, DOI 10.7759/cureus.7492; Flowers A., 2020, WASH POST; Furlong K, 2020, COMMUNITY MESSAGES; Hafner A, 2015, EUR J PSYCHOL EDUC, V30, P81, DOI 10.1007/s10212-014-0229-2; Hafner A, 2014, EDUC PSYCHOL-UK, V34, P403, DOI 10.1080/01443410.2013.785065; Huckins JF, 2020, J MED INTERNET RES, V22, DOI 10.2196/20185; Jernigan DB, 2020, MMWR-MORBID MORTAL W, V69, P216, DOI 10.15585/mmwr.mm6908e1; Kearns H., 2007, HIGHER ED RES DEV, V26, P235, DOI [10.1080/07294360701310839, DOI 10.1080/07294360701310839]; Levecque K, 2017, RES POLICY, V46, P868, DOI 10.1016/j.respol.2017.02.008; MACAN TH, 1990, J EDUC PSYCHOL, V82, P760, DOI 10.1037/0022-0663.82.4.760; Misra R., 2000, AM J HLTH STUDIES, V16, P41, DOI DOI 10.4236/CE.2015.61007; Nagy GA, 2019, CBE-LIFE SCI EDUC, V18, DOI 10.1187/cbe.18-09-0198; Nashville COVID-19 Response, 2020, SAF HOM ORD; Smith E., 2015, TUCSON NATL ASS GRAD; Soria K. M., 2020, OBSTACLES REMOTE LEA; University of California Berkeley Graduate Assembly, 2014, GRAD STUD HAPP WELL; Woolston, 2017, NATURE, V550, P549, DOI [10.1038/nj7677-549a, DOI 10.1038/NJ7677-549A]; Woolston C, 2020, NATURE, V585, P147, DOI 10.1038/d41586-020-02439-6; Woolston C, 2019, NATURE, V575, P403, DOI 10.1038/d41586-019-03459-7; Xin MQ, 2020, AM PSYCHOL, V75, P607, DOI 10.1037/amp0000692	29	5	5	3	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2021	16	9							e0256687	10.1371/journal.pone.0256687	http://dx.doi.org/10.1371/journal.pone.0256687			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	WG5YY	34529681	Green Published, gold			2022-12-26	WOS:000707071500017
J	Abdelwahab, GM; Mira, A; Cheng, YB; Abdelaziz, TA; Lahloub, MFI; Khalil, AT				Abdelwahab, Ghada Mahmoud; Mira, Amira; Cheng, Yuan-Bin; Abdelaziz, Tarek A.; Lahloub, Mohamed Farid I.; Khalil, Ashraf Taha			Acetylcholine esterase inhibitory activity of green synthesized nanosilver by naphthopyrones isolated from marine-derived Aspergillus niger	PLOS ONE			English	Article							SILVER NANOPARTICLES; MEDICAL APPLICATIONS; ALZHEIMERS-DISEASE; OXIDATIVE STRESS; GAMMA-PYRONES; AMYLOID-BETA; GLYCOSIDES; SEEDS; NANOTECHNOLOGY; PERFORMANCE	Aspergillus niger metabolites exhibited a wide range of biological properties including antioxidant and neuro-protective effects and some physical properties as green synthesis of silver nanoparticles AgNP. The present study presents a novel evidence for the various biological activities of green synthesized AgNPs. For the first time, some isolated naphtho-gamma-pyrones from marine-derived Aspergillus niger, flavasperone (1), rubrofusarin B (2), aurasperone A (3), fonsecinone A (4) in addition to one alkaloid aspernigrin A (7) were invistigated for their inhibitory activity of acetylcholine esterase AChE, a hallmark of Alzheimer's disease (AD). The ability to synthesize AgNPs by compounds 3, 4 and 7 has been also tested for the first time. Green synthesized AgNPs were well-dispersed, and their size was ranging from 8-30 nm in diameter, their morphology was obviously spherical capped with the organic compounds. Further biological evaluation of their AChE inhibitory activity was compared to the parent compounds. AgNps dramatically increased the inhibitory activity of Compounds 4, 3 and 7 by 84, 16 and 13 fold, respectively to be more potent than galanthamine as a positive control with IC50 value of 1.43 compared to 0.089, 0.311 and 1.53 of AgNPs of Compounds 4, 3 and 7, respectively. Also compound 2 showed moderate inhibitory activity. This is could be probably explained by closer fitting to the active sites or the synergistic effect of the stabilized AgNPs by the organic compouds. These results, in addition to other intrinsic chemical and biological properties of naphtho-gamma-pyrones, suggest that the latter could be further explored with a view towards other neuroprotective studies for alleviating AD.	[Abdelwahab, Ghada Mahmoud; Mira, Amira; Lahloub, Mohamed Farid I.; Khalil, Ashraf Taha] Mansoura Univ, Dept Pharmacognosy, Mansoura, Egypt; [Abdelwahab, Ghada Mahmoud] Horus Univ, Dept Pharmacognosy, New Damietta, Egypt; [Cheng, Yuan-Bin] Natl Sun Yat Sen Univ, Dept Marine Biotechnol & Resources, Kaohsiung, Taiwan; [Abdelaziz, Tarek A.] Natl Inst Oceanog & Fisheries, Red Sea Branch, Marine Invertebrates, Hurghada, Egypt	Egyptian Knowledge Bank (EKB); Mansoura University; National Sun Yat Sen University; Egyptian Knowledge Bank (EKB); National Institute of Oceanography & Fisheries (NIOF)	Abdelwahab, GM (corresponding author), Mansoura Univ, Dept Pharmacognosy, Mansoura, Egypt.; Abdelwahab, GM (corresponding author), Horus Univ, Dept Pharmacognosy, New Damietta, Egypt.; Abdelwahab, GM (corresponding author), Natl Sun Yat Sen Univ, Dept Marine Biotechnol & Resources, Kaohsiung, Taiwan.	ghabdelwahab@horus.edu.eg		abdelwahab, ghada/0000-0001-5184-3882				Akiyama K, 2003, J NAT PROD, V66, P136, DOI 10.1021/np020174p; Aliev G, 2014, CURR MED CHEM, V21, P2208, DOI 10.2174/0929867321666131227161303; Alzheimer's Assoc, 2018, ALZHEIMERS DEMENT, V14, P367, DOI 10.1016/j.jalz.2018.02.001; [Anonymous], 2013, AFR J BIOTECHNOL, DOI [10.5897/AJB12, DOI 10.5897/AJB12.2481, 10.5897/AJB12.2481]; Ashraf JM, 2016, SCI REP-UK, V6, DOI 10.1038/srep20414; Baruwati B, 2013, ACS SUSTAIN CHEM ENG, V1, P753, DOI 10.1021/sc400024a; Bloom GS, 2014, JAMA NEUROL, V71, P505, DOI 10.1001/jamaneurol.2013.5847; Briggs R, 2016, CLIN MED, V16, P247, DOI 10.7861/clinmedicine.16-3-247; Campos FR, 2005, MAGN RESON CHEM, V43, P962, DOI 10.1002/mrc.1654; Carboue Q, 2020, BIOMOLECULES, V10, DOI 10.3390/biom10010029; Chauhan R.P., 2012, INT J BIOASSAYS; Chen X, 2008, TOXICOL LETT, V176, P1, DOI 10.1016/j.toxlet.2007.10.004; Choi JS, 1997, PLANTA MED, V63, P11, DOI 10.1055/s-2006-957593; Choque E, 2015, APPL MICROBIOL BIOT, V99, P1081, DOI 10.1007/s00253-014-6295-1; Crous-Bou M, 2017, ALZHEIMERS RES THER, V9, DOI 10.1186/s13195-017-0297-z; Cruz I, 2017, J CHEM-NY, V2017, DOI 10.1155/2017/8587260; Cummings JL, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/alzrt269; Devi Lamabam Sophiya, 2015, J Microsc Ultrastruct, V3, P29, DOI 10.1016/j.jmau.2014.10.004; Docea AO, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21041233; ELLMAN GL, 1961, BIOCHEM PHARMACOL, V7, P88, DOI 10.1016/0006-2952(61)90145-9; Fang W, 2016, MOLECULES, V21, DOI 10.3390/molecules21070941; Feng XL, 2015, INT J NANOMED, V10, P4321, DOI 10.2147/IJN.S78308; Ferdous Z, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21072375; Ge LP, 2014, INT J NANOMED, V9, P2399, DOI 10.2147/IJN.S55015; Ghazilou A, 2019, MAR ECOL PROG SER, V626, P135, DOI 10.3354/meps13060; Gonzalez-Carter DA, 2017, SCI REP-UK, V7, DOI 10.1038/srep42871; GORSTALLMAN CP, 1980, J CHEM SOC PERK T 1, P2474; Graham JG, 2004, J NAT PROD, V67, P225, DOI 10.1021/np030348i; HAREL M, 1993, P NATL ACAD SCI USA, V90, P9031, DOI 10.1073/pnas.90.19.9031; Hassan SA, 2019, INT J BIOL BIOTECHN, V16, P255; Hatano T, 1999, CHEM PHARM BULL, V47, P1121, DOI 10.1248/cpb.47.1121; Havel H, 2016, AAPS J, V18, P1373, DOI 10.1208/s12248-016-9961-7; Hou K, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18525-2; Husain S, 2021, MAT SCI ENG C-MATER, V122, DOI 10.1016/j.msec.2021.111888; Iravani S, 2014, RES PHARM SCI, V9, P385; Kamat PK, 2016, MOL NEUROBIOL, V53, P648, DOI 10.1007/s12035-014-9053-6; Kennedy AJ, 2012, ENVIRON SCI TECHNOL, V46, P10772, DOI 10.1021/es302322y; Khan SU, 2018, INT J NANOMED, V13, P733, DOI 10.2147/IJN.S153167; Khatoon A, 2018, LIFE SCI, V209, P430, DOI 10.1016/j.lfs.2018.08.046; Kitanaka S, 1998, CHEM PHARM BULL, V46, P1650, DOI 10.1248/cpb.46.1650; Kjer J, 2010, NAT PROTOC, V5, P479, DOI 10.1038/nprot.2009.233; Korkina L G, 1997, Adv Pharmacol, V38, P151; Leszek J, 2017, CURR ALZHEIMER RES, V14, P1182, DOI 10.2174/1567205014666170203125008; Li H, 2017, CURR OPIN GREEN SUST, V6, P48, DOI 10.1016/j.cogsc.2017.05.005; Lima MAS, 2019, J BRAZIL CHEM SOC, V30, P2029, DOI 10.21577/0103-5053.20190080; Logothetidis S, 2006, HIPPOKRATIA, V10, P7; Lopez de Leon Lilia, 2019, J Microbiol Biotechnol, V29, P1412, DOI 10.4014/jmb.1905.05015; Lu SQ, 2014, MOLECULES, V19, P7169, DOI 10.3390/molecules19067169; Mira A, 2015, MOLECULES, V20, P4813, DOI 10.3390/molecules20034813; Mohammed A. A., 2015, INT J CURRENT MICROB, V4, P522; Mossello E, 2012, THER ADV CHRONIC DIS, V3, P183, DOI 10.1177/2040622312452387; Mukherjee PK, 2007, PLANTA MED, V73, P283, DOI 10.1055/s-2007-967114; Murphy MP, 2010, J ALZHEIMERS DIS, V19, P311, DOI [10.3233/JAD-2009-1221, 10.3233/JAD-2010-1221]; Naqvi S, 2020, FRONT NEUROSCI-SWITZ, V14, DOI 10.3389/fnins.2020.00494; Nazim A, 2011, INSCIENCES J, V1, P169, DOI DOI 10.5640/INSC.0104169; Nielsen KF, 2009, ANAL BIOANAL CHEM, V395, P1225, DOI 10.1007/s00216-009-3081-5; Nikalje A.P., 2015, MED CHEM, V5, P1, DOI [10.4172/2161-0444.1000247, DOI 10.4172/2161-0444.1000247]; Ojha R, 2017, EXPERT OPIN THER PAT, V27, P311, DOI 10.1080/13543776.2017.1261111; Pohanka M, 2018, BRATISL MED J, V119, P535, DOI 10.4149/BLL_2018_097; Sagar G., 2012, EUR J EXP BIOL, V2, P1654, DOI DOI 10.1016/j.jfoodeng.2012.08.021; Sakai K, 2008, J ANTIBIOT, V61, P568, DOI 10.1038/ja.2008.76; Sallam A, 2016, PHYTOMEDICINE, V23, P1005, DOI 10.1016/j.phymed.2016.06.014; Sastry M, 1997, COLLOID SURFACE A, V127, P221, DOI 10.1016/S0927-7757(97)00087-3; Shrestha S, 2018, MOLECULES, V23, DOI 10.3390/molecules23010069; Silva GA, 2005, SURG NEUROL, V63, P301, DOI 10.1016/j.surneu.2004.06.008; Sinegani AAS, 2005, J COLLOID INTERF SCI, V290, P39, DOI 10.1016/j.jcis.2005.04.030; Sinko G, 2014, ENVIRON SCI POLLUT R, V21, P1391, DOI 10.1007/s11356-013-2016-z; Sonawane SK, 2019, ACS OMEGA, V4, P12833, DOI 10.1021/acsomega.9b01411; Sussman JL, 1992, CURR OPIN STRUC BIOL, V2, P721; Tang JL, 2008, APPL SURF SCI, V255, P502, DOI 10.1016/j.apsusc.2008.06.058; Teleanu DM, 2018, J CLIN MED, V7, DOI 10.3390/jcm7120490; Vassar R, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/s13195-014-0089-7; Verma SK, 2017, RSC ADV, V7, P40034, DOI 10.1039/c7ra05943d; Weller Jason, 2018, F1000Res, V7, DOI 10.12688/f1000research.14506.1; WONG SM, 1989, PLANTA MED, P276, DOI 10.1055/s-2006-962003; Xu K, 2019, MAR DRUGS, V17, DOI 10.3390/md17040207; Xu L, 2020, THERANOSTICS, V10, P8996, DOI 10.7150/thno.45413; Ye YH, 2005, J NAT PROD, V68, P1106, DOI 10.1021/np050059p; Youssif KA, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0223781; Yurchenko EA, 2018, MAR DRUGS, V16, DOI 10.3390/md16110457	80	4	4	5	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2021	16	9							e0257071	10.1371/journal.pone.0257071	http://dx.doi.org/10.1371/journal.pone.0257071			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XM9EM	34506550	Green Published, gold			2022-12-26	WOS:000729120700066
J	Aushev, VN; Li, Q; Deyssenroth, M; Zhang, W; Finik, J; Hurd, YL; Nomura, Y; Chen, J				Aushev, Vasily N.; Li, Qian; Deyssenroth, Maya; Zhang, Wei; Finik, Jackie; Hurd, Yasmin L.; Nomura, Yoko; Chen, Jia			Placental gene network modules are associated with maternal stress during pregnancy and infant temperament	FASEB JOURNAL			English	Article						infant temperament; maternal stress; placental genes	SYMPTOMS; BEHAVIOR; ORIGINS; HEALTH	Maternal psychosocial stress during pregnancy (MPSP) is a known contributor to maladaptive neurobehavioral development of the offspring; however, the underlying molecular mechanisms linking MPSP with childhood outcome remain largely unknown. Transcriptome-wide gene expression data were generated using RNA-seq from placenta samples collected in a multi-ethnic urban birth cohort in New York City (n = 129). Weighted gene co-expression network analysis (WGCNA) was used to characterize placental co-expression modules, which were then evaluated for their associations with MPSP and infant temperament. WGCNA revealed 16 gene coexpression modules. One module, enriched for regulation of chromosome organization/gene expression, was positively associated with MPSP and negatively associated with Regulatory Capacity (REG), a component of infant temperament. Two other modules, enriched for cotranslational protein targeting and cell cycle regulation, respectively, displayed negative associations with MPSP and positive associations with REG. A module enriched with oxidative phosphorylation/mitochondrial translation was positively associated with REG. These findings support the notion that the placenta provides a functional in utero link between MPSP and infant temperament, possibly through transcriptional regulation of placental gene expression.	[Aushev, Vasily N.; Li, Qian; Nomura, Yoko; Chen, Jia] Icahn Sch Med Mt Sinai, Dept Environm Med & Publ Hlth, New York, NY 10029 USA; [Deyssenroth, Maya] Columbia Univ, Dept Environm Hlth Sci, New York, NY USA; [Zhang, Wei] New Jersey City Univ, Dept Psychol, Jersey City, NJ USA; [Finik, Jackie; Nomura, Yoko] CUNY, Dept Psychol, Queens Coll, Flushing, NY USA; [Finik, Jackie] CUNY, Dept Epidemiol & Biostat, Grad Sch Publ Hlth & Hlth Policy, New York, NY 10021 USA; [Hurd, Yasmin L.] Icahn Sch Med Mt Sinai, Addict Inst Mt Sinai, Psychiat & Neurosci, New York, NY 10029 USA; [Chen, Jia] Icahn Sch Med Mt Sinai, Dept Pediat, New York, NY 10029 USA; [Chen, Jia] Icahn Sch Med Mt Sinai, Dept Med Hematol & Med Oncol, New York, NY 10029 USA; [Chen, Jia] Icahn Sch Med Mt Sinai, Dept Oncol Sci, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai; Columbia University; City University of New York (CUNY) System; Queens College NY (CUNY); City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Nomura, Y; Chen, J (corresponding author), Icahn Sch Med Mt Sinai, Dept Environm Med & Publ Hlth, New York, NY 10029 USA.	yoko.nomura@qc.cuny.edu; jia.chen@mssm.edu			National Institutes of Health [R01 MH102729, R01ES029212, P30ES023515, R01HD067611]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the grant from the National Institutes of Health (R01 MH102729) and in part by grants (R01ES029212; P30ES023515, R01HD067611).	Bonnin A, 2011, NATURE, V472, P347, DOI 10.1038/nature09972; Boyd RC, 2006, MATERN CHILD HLTH J, V10, P139, DOI 10.1007/s10995-005-0042-2; Bridgett DJ, 2009, INFANT BEHAV DEV, V32, P103, DOI 10.1016/j.infbeh.2008.10.007; Buckberry S, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-016-3384-9; Chen EY, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-128; Cox B, 2019, FRONT GENET, V10, DOI 10.3389/fgene.2019.00354; Deyssenroth MA, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3878-0; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Edhborg M, 2001, J REPROD INFANT PSYC, V19, P61, DOI 10.1080/02646830123255; Finik J, 2017, INT J EPIDEMIOL, V46, P1388, DOI 10.1093/ije/dyw264; Fleming TP, 2018, LANCET, V391, P1842, DOI [10.1016/S0140-6736(18)30312-X, 10.1016/s0140-6736(18)30312-x]; Gartstein MA, 2003, INFANT BEHAV DEV, V26, P64, DOI 10.1016/S0163-6383(02)00169-8; Gray J. A., 1991, EXPLORATIONS TEMPERA, P105, DOI [DOI 10.1007/978-1-4899-0643-4_8, 10.1007/978-1-4899-0643-4_8, 10.1007/978-1-4899-0643-4]; Hemberger M, 2020, NAT REV GENET, V21, P27, DOI 10.1038/s41576-019-0169-4; Hsiao EY, 2012, DEV NEUROBIOL, V72, P1317, DOI 10.1002/dneu.22045; Kramer A, 2014, BIOINFORMATICS, V30, P523, DOI 10.1093/bioinformatics/btt703; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Nomura Y, 2019, INFANT MENT HEALTH J, V40, P204, DOI 10.1002/imhj.21766; O'Connor TG, 2003, J CHILD PSYCHOL PSYC, V44, P1025, DOI 10.1111/1469-7610.00187; O'Donnell KJ, 2017, AM J PSYCHIAT, V174, P319, DOI 10.1176/appi.ajp.2016.16020138; Pauli-Pott U, 2004, DEV PSYCHOPATHOL, V16, P19, DOI 10.1017/S0954579404040398; Pehme PM, 2018, INFANT CHILD DEV, V27, DOI 10.1002/icd.2094; Peterson ER, 2018, EARLY EDUC DEV, V29, P435, DOI 10.1080/10409289.2018.1457391; Putnam SP, 2008, INFANT CHILD DEV, V17, P387, DOI 10.1002/ICD.582; Rahnenfuhrer J, 2021, TOPGO ENRICHMENT ANA; Rodriguez A, 2005, J CHILD PSYCHOL PSYC, V46, P246, DOI 10.1111/j.1469-7610.2004.00359.x; Rothbart M.K., 1998, HDB CHILD PSYCHOL, P105, DOI DOI 10.1002/9780470147658.CHPSY0303; ROTHBART MK, 1994, MERRILL PALMER QUART, V40, P21; St-Pierre J, 2018, PSYCHONEUROENDOCRINO, V94, P38, DOI 10.1016/j.psyneuen.2018.04.027; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Tingley D, 2014, J STAT SOFTW, V59; Toffol E, 2019, EUR CHILD ADOLES PSY, V28, P847, DOI 10.1007/s00787-018-1243-8; Wyatt SM, 2005, PLACENTA, V26, P372, DOI 10.1016/j.placenta.2004.07.003; Zhang W, 2018, J NEUROENDOCRINOL, V30, DOI 10.1111/jne.12581; Zhang W, 2018, J AFFECT DISORDERS, V234, P335, DOI 10.1016/j.jad.2018.02.067; Zhao XM, 2019, MOL GENET GENOM MED, V7, DOI 10.1002/mgg3.515	38	1	1	1	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2021	35	10							e21922	10.1096/fj.202100144RRR	http://dx.doi.org/10.1096/fj.202100144RRR			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	UZ5IH	34533879	Green Accepted			2022-12-26	WOS:000702238200022
J	Butenko, S; Ben Jashar, N; Sheffer, T; Sabo, E; Schif-Zuck, S; Ariel, A				Butenko, Sergei; Ben Jashar, Nofar; Sheffer, Tsofiya; Sabo, Edmond; Schif-Zuck, Sagie; Ariel, Amiram			ACKR2 limits skin fibrosis and hair loss through IFN-beta	FASEB JOURNAL			English	Article						ACKR2; collagen deposition; IFN-beta; resolving inflammation; skin fibrosis	CHEMOKINE RECEPTOR D6; TISSUE-REPAIR; INFLAMMATION; INTERFERON; RESOLUTION; MACROPHAGES; TRANSITION; MEDIATORS	The resolution of inflammation facilitates proper wound healing and limits tissue repair short of exaggerated fibrotic scarring. The atypical chemokine receptor (ACKR)2/D6 scavenges inflammatory chemokines, while IFN-beta is a recently unveiled pro-resolving cytokine. Both effector molecules limit acute inflammatory episodes and promote their resolution in various organs. Here, we found fibrotic skin lesions from ACKR2(-/-) mice presented increased epidermal and dermal thickening, atrophy of the subcutaneous adipose tissue, augmented disorientation of collagen deposition, and enhanced deformation and loss of hair follicles compared to WT counterparts. In addition, affected skin sections from ACKR2(-/-) mice contained reduced levels of the pro-resolving mediators IFN-beta and IL-10, but increased levels of the pro-inflammatory chemokines CCL2 and 3, the pro-fibrotic cytokine TGF-beta, and the immune-stimulating cytokine IL-12. Notably, treatment with exogenous IFN-beta rescued, at least in part, all the pro-fibrotic outcomes and lesion size in ACKR2(-/-) mice and promoted expression of the pro-resolving enzyme 12/15-lipoxygenase (LO) in both ACKR2(-/-) and WT mice. Moreover, Ifnb(-/-) mice displayed enhanced pro-fibrotic indices upon exposure to bleomycin. These findings suggest ACKR2 is an important mediator in limiting inflammatory skin fibrosis and acts via IFN-beta production to promote the resolution of inflammation and minimize tissue scaring.	[Butenko, Sergei; Ben Jashar, Nofar; Sheffer, Tsofiya; Schif-Zuck, Sagie; Ariel, Amiram] Univ Haifa, Dept Biol & Human Biol, Haifa, Israel; [Sabo, Edmond] Carmel Hosp, Inst Pathol, Haifa, Israel	University of Haifa; Clalit Health Services; Carmel Medical Center	Ariel, A (corresponding author), Univ Haifa, Dept & Luman Biol, 199 Aba Khoushy Ave, IL-3498838 Haifa, Israel.	amiram@research.haifa.ac.il	Butenko, Sergei/ABE-6515-2021	Butenko, Sergei/0000-0001-9759-9897	Israel Science Foundation [678/13]; Rosetrees Trust; Wolfson Family Charitable Trust; University of Haifa	Israel Science Foundation(Israel Science Foundation); Rosetrees Trust(Rosetrees Trust); Wolfson Family Charitable Trust; University of Haifa	The study was supported by grants from the Israel Science Foundation (Grant No. 678/13), the Rosetrees Trust, and the Wolfson Family Charitable Trust. S.B. is a recipient of a presidential scholarship from the University of Haifa.	Ariel A, 2005, J BIOL CHEM, V280, P43079, DOI 10.1074/jbc.M509796200; Ariel A, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00004; Aswad M, 2017, J IMMUNOL, V199, P1393, DOI 10.4049/jimmunol.1502542; Avouac J, 2014, METHODS MOL BIOL, V1142, P91, DOI 10.1007/978-1-4939-0404-4_11; Azuma A, 2005, AM J RESP CELL MOL, V32, P93, DOI 10.1165/rcmb.2003-0374OC; Banchereau J, 2006, IMMUNITY, V25, P383, DOI 10.1016/j.immuni.2006.08.010; Bazzan E, 2013, CHEST, V143, P98, DOI 10.1378/chest.11-3220; Bideak A, 2018, KIDNEY INT, V93, P826, DOI 10.1016/j.kint.2017.11.013; Borthwick LA, 2013, BBA-MOL BASIS DIS, V1832, P1049, DOI 10.1016/j.bbadis.2012.09.014; Brennan EP, 2017, MOL ASPECTS MED, V58, P102, DOI 10.1016/j.mam.2017.05.001; Butenko S, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.00405; Chen Y, 2017, INT J CLIN EXP MED, V10, P14904; Cho JS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162758; Dalli J, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01400; Darby IA, 2014, CLIN COSMET INV DERM, V7, P301, DOI 10.2147/CCID.S50046; de la Torre YM, 2007, P NATL ACAD SCI USA, V104, P2319, DOI 10.1073/pnas.0607514104; de la Torre YM, 2005, EUR J IMMUNOL, V35, P1342, DOI 10.1002/eji.200526114; Delaney TA, 2016, J IMMUNOL, V197, P42, DOI 10.4049/jimmunol.1502190; Distler JHW, 2019, NAT REV RHEUMATOL, V15, P705, DOI 10.1038/s41584-019-0322-7; Elliott MR, 2016, DEV CELL, V38, P147, DOI 10.1016/j.devcel.2016.06.029; Eming SA, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009337; Eshleman EM, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00431; Goncalves RSG, 2019, EXP DERMATOL, V28, P1172, DOI 10.1111/exd.13982; HARALICK RM, 1973, IEEE T SYST MAN CYB, VSMC3, P610, DOI 10.1109/TSMC.1973.4309314; Haub J, 2019, J INVEST DERMATOL, V139, P2144, DOI 10.1016/j.jid.2019.04.006; Ishikawa M, 2021, EXP DERMATOL, V30, P179, DOI 10.1111/exd.14088; Jamieson T, 2005, NAT IMMUNOL, V6, P403, DOI 10.1038/ni1182; Jordan PM, 2020, CELL REP, V33, DOI 10.1016/j.celrep.2020.108247; Kania G, 2019, NAT REV RHEUMATOL, V15, P288, DOI 10.1038/s41584-019-0212-z; Kronke G, 2012, ANN RHEUM DIS, V71, P1081, DOI 10.1136/annrheumdis-2011-200745; Landen NX, 2016, CELL MOL LIFE SCI, V73, P3861, DOI 10.1007/s00018-016-2268-0; Lech M, 2013, BBA-MOL BASIS DIS, V1832, P989, DOI 10.1016/j.bbadis.2012.12.001; Lee KM, 2011, BLOOD, V118, P6220, DOI 10.1182/blood-2011-03-344044; Liu LP, 2006, J IMMUNOL, V177, P17, DOI 10.4049/jimmunol.177.1.17; Lux M, 2019, AM J PATHOL, V189, P231, DOI 10.1016/j.ajpath.2018.09.016; Mantovani A, 2006, NAT REV IMMUNOL, V6, P907, DOI 10.1038/nri1964; Massara M, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03080-8; McKimmie CS, 2008, J IMMUNOL, V181, P3353, DOI 10.4049/jimmunol.181.5.3353; Do NN, 2018, J IMMUNOL, V201, P663, DOI 10.4049/jimmunol.1701791; Nibbs RJB, 2013, NAT REV IMMUNOL, V13, P815, DOI 10.1038/nri3544; Ortega-Gomez A, 2013, EMBO MOL MED, V5, P661, DOI 10.1002/emmm.201202382; Osman OS, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-260; Pashover-Schallinger E, 2012, FASEB J, V26, P3891, DOI 10.1096/fj.11-194894; Perkins DJ, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003479; Satyanarayanan SK, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10903-9; Savino B, 2012, BLOOD, V119, P5250, DOI 10.1182/blood-2011-10-388082; Schif-Zuck S, 2011, EUR J IMMUNOL, V41, P366, DOI 10.1002/eji.201040801; Schulz JN, 2018, MATRIX BIOL, V68-69, P522, DOI 10.1016/j.matbio.2018.01.025; Serhan CN, 2017, FASEB J, V31, P1273, DOI [10.1096/fj.201601222R, 10.1096/fj.201601222r]; Shams K, 2017, J INVEST DERMATOL, V137, P85, DOI 10.1016/j.jid.2016.07.039; Sharif MN, 2006, J EXP MED, V203, P1891, DOI 10.1084/jem.20051725; Shi JH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098228; Castanheira FVES, 2018, SHOCK, V49, P682, DOI 10.1097/SHK.0000000000000969; Stone RC, 2016, CELL TISSUE RES, V365, P495, DOI 10.1007/s00441-016-2464-0; Taylor Samuel E, 2013, Curr Protoc Essent Lab Tech, V95; Uderhardt S, 2012, IMMUNITY, V36, P834, DOI 10.1016/j.immuni.2012.03.010; Wynn TA, 2016, IMMUNITY, V44, P450, DOI 10.1016/j.immuni.2016.02.015; Wynn TA, 2012, NAT MED, V18, P1028, DOI 10.1038/nm.2807; Xue ML, 2015, ADV WOUND CARE, V4, P119, DOI 10.1089/wound.2013.0485; Yamamoto T, 2003, J INVEST DERMATOL, V121, P510, DOI 10.1046/j.1523-1747.2003.12408.x; Yoo CH, 2014, SCI REP-UK, V4, DOI 10.1038/srep04220; Zheng SR, 2016, J DIABETES RES, V2016, DOI 10.1155/2016/5362506; Zhou Z, 2020, AM J PATHOL, V190, P614, DOI 10.1016/j.ajpath.2019.11.012	63	3	3	3	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2021	35	10							e21917	10.1096/fj.202002395RR	http://dx.doi.org/10.1096/fj.202002395RR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	UZ5IH	34533865				2022-12-26	WOS:000702238200025
J	Kulminskaya, N; Radler, C; Viertlmayr, R; Heier, C; Hofer, P; Colaco-Gaspar, M; Owens, RJ; Zimmermann, R; Schreiber, R; Zechner, R; Oberer, M				Kulminskaya, Natalia; Radler, Claudia; Viertlmayr, Roland; Heier, Christoph; Hofer, Peter; Colaco-Gaspar, Mariana; Owens, Raymond J.; Zimmermann, Robert; Schreiber, Renate; Zechner, Rudolf; Oberer, Monika			Optimized expression and purification of adipose triglyceride lipase improved hydrolytic and transacylation activities in vitro	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HORMONE-SENSITIVE LIPASE; LIPID DROPLET PROTEINS; ENZYMES; GENE; LIPOLYSIS; CGI-58; TISSUE; IDENTIFICATION; MOBILIZATION; DESNUTRIN	Adipose triglyceride lipase (ATGL) plays a key role in intracellular lipolysis, the mobilization of stored triacylglycerol. This work provides an important basis for generating reproducible and detailed data on the hydrolytic and transacylation activities of ATGL. We generated full-length and C-terminally truncated ATGL variants fused with various affinity tags and analyzed their expression in different hosts, namely E. coli, the insect cell line Sf9, and the mammalian cell line human embryonic kidney 293T. Based on this screen, we expressed a fusion protein of ATGL covering residues M1-D288 flanked with N-terminal and C-terminal purification tags. Using these fusions, we identified key steps in expression and purification protocols, including production in the E. coli strain ArcticExpress (DE3) and removal of copurified chaperones. The resulting purified ATGL variant demonstrated improved lipolytic activity compared with previously published data, and it could be stimulated by the coactivator protein comparative gene identification-58 and inhibited by the protein G0/G1 switch protein 2. Shock freezing and storage did not affect the basal activity but reduced coactivation of ATGL by comparative gene identification 58. In vitro, the truncated ATGL variant demonstrated acyl-CoA-independent transacylation activity when diacylglycerol was offered as substrate, resulting in the formation of fatty acid as well as triacylglycerol and monoacylglycerol. However, the ATGL variant showed neither hydrolytic activity nor transacylation activity upon offering of monoacylglycerol as substrate. To understand the role of ATGL in different physiological contexts, it is critical for future studies to identify all its different functions and to determine under what conditions these activities occur.	[Kulminskaya, Natalia; Radler, Claudia; Viertlmayr, Roland; Heier, Christoph; Hofer, Peter; Colaco-Gaspar, Mariana; Zimmermann, Robert; Schreiber, Renate; Zechner, Rudolf; Oberer, Monika] Karl Franzens Univ Graz, Inst Mol Biosci, Graz, Austria; [Owens, Raymond J.] Univ Oxford, Welcome Ctr Human Genet, Div Struct Biol, Oxford, England; [Owens, Raymond J.] Res Complex Harwell, Prot Prod UK, Didcot, Oxon, England; [Zimmermann, Robert; Zechner, Rudolf; Oberer, Monika] BioTechMed, Graz, Austria; [Zimmermann, Robert; Zechner, Rudolf; Oberer, Monika] Karl Franzens Univ Graz, BioHlth Field Excellence, Graz, Austria	University of Graz; University of Oxford; Wellcome Centre for Human Genetics; University of Graz	Oberer, M (corresponding author), Karl Franzens Univ Graz, Inst Mol Biosci, Graz, Austria.; Oberer, M (corresponding author), BioTechMed, Graz, Austria.; Oberer, M (corresponding author), Karl Franzens Univ Graz, BioHlth Field Excellence, Graz, Austria.	m.oberer@uni-graz.at		Kulminskaya, Natalia/0000-0002-2330-888X; Zimmermann, Robert/0000-0002-7354-870X; Schreiber, Renate/0000-0002-3475-157X; Colaco-Gaspar, Mariana/0000-0003-2297-7798; Hofer, Peter/0000-0002-0788-7519; Heier, Christoph/0000-0001-6858-408X; Oberer, Monika/0000-0003-2525-9513	Austrian Science Fund Grant SFB Lipid Hydrolysis [FWF F73]; doc.fund Molecular Metabolism by the FWF [DOC 50]; State of Styria; City of Graz	Austrian Science Fund Grant SFB Lipid Hydrolysis; doc.fund Molecular Metabolism by the FWF; State of Styria; City of Graz	This work was supported by Austrian Science Fund Grant SFB Lipid Hydrolysis (FWF F73) (to M. O., Robert Zimmermann, and Rudolf Zechner) . We further acknowledge the doc.fund Molecular Metabolism (to M. O., Robert Zimmermann, and Rudolf Zechner) sponsored by the FWF (DOC 50) , the State of Styria, and the City of Graz.	Albert JS, 2014, NEW ENGL J MED, V370, P2307, DOI 10.1056/NEJMoa1315496; Berrow NS, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm047; Bezaire V, 2009, J BIOL CHEM, V284, P18282, DOI 10.1074/jbc.M109.008631; Blum M, 2021, NUCLEIC ACIDS RES, V49, pD344, DOI 10.1093/nar/gkaa977; Brejchova K, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2020999118; Camus G, 2014, J BIOL CHEM, V289, P35770, DOI 10.1074/jbc.M114.587816; Cerk IK, 2014, J BIOL CHEM, V289, DOI 10.1074/jbc.M114.602599; Cerk IK, 2018, CURR PROTEIN PEPT SC, V19, P221, DOI 10.2174/1389203718666170918160110; Cornaciu I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026349; Das KMP, 2018, J LIPID RES, V59, P531, DOI 10.1194/jlr.M082388; Duncan RE, 2010, J LIPID RES, V51, P309, DOI 10.1194/jlr.M000729; Eichmann TO, 2015, J LIPID RES, V56, P1972, DOI 10.1194/jlr.M062372; Eichmann TO, 2012, J BIOL CHEM, V287, P41446, DOI 10.1074/jbc.M112.400416; Feifel B, 1996, EUR J BIOCHEM, V237, P318, DOI 10.1111/j.1432-1033.1996.0318n.x; Ferrer M, 2003, NAT BIOTECHNOL, V21, P1266, DOI 10.1038/nbt1103-1266; Fischer J, 2007, NAT GENET, V39, P28, DOI 10.1038/ng1951; Granneman JG, 2007, J BIOL CHEM, V282, P5726, DOI 10.1074/jbc.M610580200; Gross DA, 2014, CRIT REV BIOCHEM MOL, V49, P304, DOI 10.3109/10409238.2014.931337; Hofer P, 2020, METABOLITES, V10, DOI 10.3390/metabo10040147; Jenkins CM, 2004, J BIOL CHEM, V279, P48968, DOI 10.1074/jbc.M407841200; Jumper J, 2021, NATURE, V596, P583, DOI 10.1038/s41586-021-03819-2; Katayama Hiroo, 2009, Journal of Structural and Functional Genomics, V10, P57, DOI 10.1007/s10969-008-9053-8; Klibanov AM, 1997, TRENDS BIOTECHNOL, V15, P97, DOI 10.1016/S0167-7799(97)01013-5; Kulminskaya N, 2020, BIOCHIMIE, V169, P62, DOI 10.1016/j.biochi.2019.08.004; Lass A, 2006, CELL METAB, V3, P309, DOI 10.1016/j.cmet.2006.03.005; LEHNER R, 1993, J BIOL CHEM, V268, P8781; Liu Q, 2012, PROG LIPID RES, V51, P350, DOI 10.1016/j.plipres.2012.06.001; Mairal A, 2006, DIABETOLOGIA, V49, P1629, DOI 10.1007/s00125-006-0272-x; Melkani GC, 2003, BIOMETALS, V16, P479, DOI 10.1023/A:1022536219800; Nagy HM, 2014, BBA-MOL CELL BIOL L, V1841, P588, DOI 10.1016/j.bbalip.2014.01.005; Nettleship JE, 2019, METHODS MOL BIOL, V2025, P33, DOI 10.1007/978-1-4939-9624-7_2; Nettleship JE, 2010, J STRUCT BIOL, V172, P55, DOI 10.1016/j.jsb.2010.02.006; O'Neil PT, 2018, FRONT MOL BIOSCI, V5, DOI 10.3389/fmolb.2018.00046; Osuga J, 2000, P NATL ACAD SCI USA, V97, P787, DOI 10.1073/pnas.97.2.787; Savinainen JR, 2012, ACTA PHYSIOL, V204, P267, DOI 10.1111/j.1748-1716.2011.02280.x; Schweiger M, 2014, METHOD ENZYMOL, V538, P171, DOI 10.1016/B978-0-12-800280-3.00010-4; Schweiger M, 2006, J BIOL CHEM, V281, P40236, DOI 10.1074/jbc.M608048200; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Sztalryd C, 2017, BBA-MOL CELL BIOL L, V1862, P1221, DOI 10.1016/j.bbalip.2017.07.009; Tan S, 2005, PROTEIN EXPRES PURIF, V40, P385, DOI 10.1016/j.pep.2004.12.002; VAUGHAN M, 1964, J BIOL CHEM, V239, P401; Villena JA, 2004, J BIOL CHEM, V279, P47066, DOI 10.1074/jbc.M403855200; Wang H, 2017, BBA-MOL CELL BIOL L, V1862, P1131, DOI 10.1016/j.bbalip.2017.06.010; Wang SP, 2001, OBES RES, V9, P119, DOI 10.1038/oby.2001.15; Xu SM, 2018, BBA-MOL BASIS DIS, V1864, P1968, DOI 10.1016/j.bbadis.2017.07.019; Yamashita A, 2017, BIOLOGY-BASEL, V6, DOI 10.3390/biology6020023; Yang A, 2020, BIOCHEM J, V477, P985, DOI 10.1042/BCJ20190468; Yang XY, 2010, CELL METAB, V11, P194, DOI 10.1016/j.cmet.2010.02.003; Yen CLE, 2008, J LIPID RES, V49, P2283, DOI 10.1194/jlr.R800018-JLR200; Zechner R, 2015, EMBO MOL MED, V7, P359, DOI 10.15252/emmm.201404846; Zhang X, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8050395; Zimmermann R, 2004, SCIENCE, V306, P1383, DOI 10.1126/science.1100747	52	4	4	2	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT	2021	297	4							101206	10.1016/j.jbc.2021.101206	http://dx.doi.org/10.1016/j.jbc.2021.101206			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	WP2YR	34543623	Green Published, gold			2022-12-26	WOS:000713003600010
J	Wang, PL; Hua, XM; Sun, Y; Li, HY; Bryner, YH; Hsung, RP; Dai, J				Wang, Peiling; Hua, Xiangmei; Sun, Yang; Li, Hongyu; Bryner, Yuge Han; Hsung, Richard P.; Dai, Jun			Loss of haspin suppresses cancer cell proliferation by interfering with cell cycle progression at multiple stages	FASEB JOURNAL			English	Article						cell cycle; haspin; kinase; mitosis; p21	HISTONE H3; THR-3 PHOSPHORYLATION; CENTROSOME LOSS; KINASE HASPIN; AURORA B; INHIBITOR; COHESION; IDENTIFICATION; REVEAL; ARREST	Our recent studies have shown that haspin, a protein kinase imperative for mitosis, is engaged in the interphase progression of HeLa and U2OS cancer cells. In this investigation, we employed the Fucci reporter system and time-lapse imaging to examine the impact of haspin gene silencing on cell cycle progressions at a single-cell level. We found that the loss of haspin induced multiple cell cycle defects. Specifically, the S/G2 duration was greatly prolonged by haspin gene depletion or inhibition in synchronous HeLa cells. Haspin gene depletion in asynchronous HeLa and U2OS cells led to a similarly protracted S/G2 phase, followed by mitotic cell death or postmitotic G1 arrest. In addition, haspin deficiency resulted in robust induction of the p21(CIP1/WAF1) checkpoint protein, a target of the p53 activation. Also, co-depleting haspin with either p21 or p53 could rescue U2OS cells from postmitotic G1 arrest and partially restore their proliferation. These results substantiate the haspin's capacity to regulate interphase and mitotic progression, offering a broader antiproliferative potential of haspin loss in cancer cells.	[Wang, Peiling] Tianjin Univ, Sch Pharmaceut Sci & Technol, Tianjin, Peoples R China; [Wang, Peiling; Hua, Xiangmei; Sun, Yang; Li, Hongyu; Bryner, Yuge Han; Hsung, Richard P.; Dai, Jun] Univ Wisconsin, Sch Pharm, Div Pharmaceut Sci, 5121 Rennebohm Hall,777 Highland Ave, Madison, WI 53705 USA	Tianjin University; University of Wisconsin System; University of Wisconsin Madison	Dai, J (corresponding author), Univ Wisconsin, Sch Pharm, Div Pharmaceut Sci, 5121 Rennebohm Hall,777 Highland Ave, Madison, WI 53705 USA.	jdai32@wisc.edu			Wisconsin Alumni Research Foundation; School of Pharmacy of the University of Wisconsin-Madison	Wisconsin Alumni Research Foundation; School of Pharmacy of the University of Wisconsin-Madison	The authors thank the Flow Cytometry Laboratory of the University of Wisconsin-Madison Carbone Cancer Center for cell sorting. J. Dai would thank the Wisconsin Alumni Research Foundation and the School of Pharmacy of the University of Wisconsin-Madison for financial support. R. P. Hsung would like to thank the Laura and Edward Kremers Family Foundation for a generously endowed chairship in natural products chemistry and the Vilas Trust and the University of Wisconsin-Madison for a Distinguished Achievement Professorship.	Aspinall CF, 2015, ONCOTARGET, V6, P36472, DOI 10.18632/oncotarget.5507; Balzano D, 2011, CHEM BIOL, V18, P966, DOI 10.1016/j.chembiol.2011.04.013; Blagosklonny MV, 2007, CELL CYCLE, V6, P70, DOI 10.4161/cc.6.1.3682; Chen JG, 2003, CANCER RES, V63, P7891; Cuny GD, 2012, BIOORG MED CHEM LETT, V22, P2015, DOI 10.1016/j.bmcl.2012.01.028; Dai J, 2005, GENE DEV, V19, P472, DOI 10.1101/gad.1267105; Dai J, 2006, DEV CELL, V11, P741, DOI 10.1016/j.devcel.2006.09.018; Dai J, 2009, J CELL SCI, V122, P4168, DOI 10.1242/jcs.054122; De Antoni A, 2012, J CELL BIOL, V199, P269, DOI 10.1083/jcb.201205119; Eswaran J, 2009, P NATL ACAD SCI USA, V106, P20198, DOI 10.1073/pnas.0901989106; Fong CS, 2016, ELIFE, V5, DOI [10.7554/eLite.16270, 10.7554/eLife.16270]; Fresan U, 2020, PLOS GENET, V16, DOI 10.1371/journal.pgen.1008962; Goto Y, 2017, CURR BIOL, V27, P1005, DOI 10.1016/j.cub.2017.02.066; Hadders MA, 2020, J CELL BIOL, V219, DOI 10.1083/jcb.201907087; Han LL, 2017, J CANCER, V8, P2933, DOI 10.7150/jca.20319; Higgins JMG, 2010, CHROMOSOMA, V119, P137, DOI 10.1007/s00412-009-0250-4; Hindriksen S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179514; Huang M, 2020, ONCOGENE, V39, P4312, DOI 10.1038/s41388-020-1296-2; Huertas D, 2012, ONCOGENE, V31, P1408, DOI 10.1038/onc.2011.335; Kestav K, 2017, CURR MED CHEM, V24, P2276, DOI 10.2174/0929867324666170414155520; Kurihara D, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-73; Lambrus BG, 2016, J CELL BIOL, V214, P143, DOI 10.1083/jcb.201604054; Liang C, 2018, EMBO REP, V19, P43, DOI 10.15252/embr.201744737; Maiolica A, 2014, MOL CELL PROTEOMICS, V13, P1724, DOI 10.1074/mcp.M113.034819; MASSILLON D, 1994, BIOCHEM J, V299, P123, DOI 10.1042/bj2990123; MAY E, 1991, ONCOGENE, V6, P1363; Meitinger F, 2016, J CELL BIOL, V214, P155, DOI 10.1083/jcb.201604081; Melms JC, 2020, CANCER RES, V80, P798, DOI 10.1158/0008-5472.CAN-19-2330; Nelson L, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-14551-2; Nguyen AL, 2014, J CELL SCI, V127, P5066, DOI 10.1242/jcs.158840; Nishida-Fukuda H, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0249912; Panigada D, 2013, DEV CELL, V26, P483, DOI 10.1016/j.devcel.2013.07.013; Patnaik D, 2008, J BIOMOL SCREEN, V13, P1025, DOI 10.1177/1087057108326081; Sakaue-Sawano A, 2008, CELL, V132, P487, DOI 10.1016/j.cell.2007.12.033; Tanaka H, 2020, EUR J CANCER PREV, V29, P481, DOI 10.1097/CEJ.0000000000000562; Uetake Y, 2010, CURR BIOL, V20, P1666, DOI 10.1016/j.cub.2010.08.018; Wang FW, 2012, J CELL BIOL, V199, P251, DOI 10.1083/jcb.201205106; Wang FW, 2010, SCIENCE, V330, P231, DOI 10.1126/science.1189435; Wang PL, 2020, J CELL PHYSIOL, V235, P4508, DOI 10.1002/jcp.29328; Wang Q, 2016, CELL CYCLE, V15, P213, DOI 10.1080/15384101.2015.1121330; Xie J, 2015, CELL, V163, P920, DOI 10.1016/j.cell.2015.10.002; Yi Q, 2018, EMBO REP, V19, DOI 10.15252/embr.201745484; Zhou LL, 2017, CURR BIOL, V27, P992, DOI 10.1016/j.cub.2017.02.019; Zhu DW, 2020, EXP CELL RES, V390, DOI 10.1016/j.yexcr.2020.111863	44	3	3	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2021	35	10							e21923	10.1096/fj.202100099R	http://dx.doi.org/10.1096/fj.202100099R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	UZ5IH	34551143				2022-12-26	WOS:000702238200024
J	Li, Y; Chi, YM; Han, SL; Zhao, CJ; Miao, YA				Li, Yong; Chi, Yanmeng; Han, Shanling; Zhao, Chaojie; Miao, Yanan			Pore-throat structure characterization of carbon fiber reinforced resin matrix composites: Employing Micro-CT and Avizo technique	PLOS ONE			English	Article							IMAGE SEGMENTATION; EVOLUTION	Micro-CT technique poses significant applications in characterizing the microstructure of materials. Based on the CT three-dimensional(3D) reconstruction technology and "Avizo" 3D visualization software, the microscopic pore-throat structure of porous media can be quantitatively characterized. This paper takes the carbon fiber reinforced resin matrix composites as an example to introduce the operation process of "Avizo" in details, which mainly covers the following modules: Volume Edit, Interactive Thresholding, Fill Holes, Mask, Separate Objects and Generate Pore Network Model, then further discuss the difficult problems when the "Avizo" is employed to analyze. The microstructures of carbon fiber reinforced resin matrix composites illustrate that pores in the upper part of sample are dramatically dispersed, and mainly concentrated in the lower part of sample. The porosity of adopted cuboid is 3.6%, accordingly the numbers of pores and throats reach 268 and 7, respectively. The equivalent radius of pores seems mainly distributed in the range of 0.7-0.8 mu m, accounting for 28.73% of the total pore number. The surface area of pore ranges from 5 to 10 mu m(2), accounting for 14.16% of the total pore number. The pore volume concentrates in the range of 1-20 mu m(3), accounting for 57.46% of the total pore number. In addition, the equivalent radius of throat mainly concentrates in the range of 1-5 mu m, the overall length of throat is distributed in the range of 37-60 mu m, and the equivalent area of throat is distributed non-uniformly in the range of 5-75 mu m(2). This work provides a basis for the further investigation of fluid migration mechanism and law in the composite materials by the numerical simulation methodology.	[Li, Yong; Chi, Yanmeng; Han, Shanling] Shandong Univ Sci & Technol, Coll Mech & Elect Engn, Qingdao, Peoples R China; [Zhao, Chaojie] Sinopec Res Inst Safety Engn, Qingdao, Peoples R China; [Miao, Yanan] Shandong Univ Sci & Technol, Coll Safety & Environm Engn, Qingdao, Peoples R China	Shandong University of Science & Technology; Sinopec; Shandong University of Science & Technology	Miao, YA (corresponding author), Shandong Univ Sci & Technol, Coll Safety & Environm Engn, Qingdao, Peoples R China.	miao_yanan@sdust.edu.cn		Li, Yong/0000-0001-7228-7790	National Natural Science Foundation Projects of China [52104208]	National Natural Science Foundation Projects of China(National Natural Science Foundation of China (NSFC))	This project was funded by the National Natural Science Foundation Projects of China (https://isisn.nsfc.gov.cn/egrantweb/) through a grant awarded to YM (Grant No. 52104208). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, 21650 GBT; Che Jianfei., 2006, NONDESTRUCTIVE TESTI; Chen Jiaxiang., 2000, THERMOSETTING RESIN, V15, P37; Chen Jimao, 1987, NONDESTRUCTIVE TESTI; Cuevas E, 2010, EXPERT SYST APPL, V37, P5265, DOI 10.1016/j.eswa.2010.01.013; Dewanckele J, 2012, SCI TOTAL ENVIRON, V416, P436, DOI 10.1016/j.scitotenv.2011.11.018; Dirami A, 2013, SIGNAL PROCESS, V93, P139, DOI 10.1016/j.sigpro.2012.07.010; Fan N, 2020, J NAT GAS SCI ENG, V81, DOI 10.1016/j.jngse.2020.103384; Gonzalez R. C., 2009, DIGITAL IMAGE PROCES, DOI 10.1117/1.3115362; Guo Jinshu, 2009, MANUFACTURABILITY TE; He Fang-cheng, 2006, Journal of Aeronautical Materials, V26, P355; Li Y, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-95178-1; Liu Jinghong, 2009, FIBER COMPOSITES, V10, P29; Miao YN, 2020, J PETROL SCI ENG, V190, DOI 10.1016/j.petrol.2020.107112; Miao YN, 2019, J NAT GAS SCI ENG, V63, P1, DOI 10.1016/j.jngse.2019.01.002; Miao YN, 2018, J PETROL SCI ENG, V168, P533, DOI 10.1016/j.petrol.2018.05.028; PAL NR, 1993, PATTERN RECOGN, V26, P1277, DOI 10.1016/0031-3203(93)90135-J; VINCENT L, 1991, IEEE T PATTERN ANAL, V13, P583, DOI 10.1109/34.87344; Youssef S., 2007, HIGH RESOLUTION CT P; Zhang R, 2018, MED PHYS; Zhao CJ, 2021, J NAT GAS SCI ENG, V95, DOI 10.1016/j.jngse.2021.104190; Zhao CJ, 2020, J PETROL SCI ENG, V188, DOI 10.1016/j.petrol.2019.106885; Zhao CJ, 2019, J NAT GAS SCI ENG, V66, P244, DOI 10.1016/j.jngse.2019.04.003; Zhou HW, 2018, INT J COAL GEOL, V189, P35, DOI 10.1016/j.coal.2018.02.007; Zhou Zhenggan, 2009, AERONAUTICAL MANUFAC, P104	25	3	3	23	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2021	16	9							e0257640	10.1371/journal.pone.0257640	http://dx.doi.org/10.1371/journal.pone.0257640			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YS4WS	34551013	Green Published, gold			2022-12-26	WOS:000750679800035
J	Hartvigsen, G				Hartvigsen, Gregg			Network assessment and modeling the management of an epidemic on a college campus with testing, contact tracing, and masking	PLOS ONE			English	Article							DYNAMICS	There remains a great challenge to minimize the spread of epidemics, especially in high-density communities such as colleges and universities. This is particularly true on densely populated, residential college campuses. To construct class and residential networks data from a four-year, residential liberal arts college with 5539 students were obtained from SUNY College at Geneseo, a rural, residential, undergraduate institution in western NY, USA. Equal-sized random networks also were created for each day. Different levels of compliance with mask use (none to 100%), mask efficacy (50% to 100%), and testing frequency (daily, or every 2, 3, 7, 14, 28, or 105 days) were assessed. Tests were assumed to be only 90% accurate and positive results were used to isolate individuals. The effectiveness of contact tracing, and the effect of quarantining neighbors of infectious individuals, was tested. The structure of the college course enrollment and residence networks greatly influenced the dynamics of the epidemics, as compared to the random networks. In particular, average path lengths were longer in the college networks compared to random networks. Students in larger majors generally had shorter average path lengths than students in smaller majors. Average transitivity (clustering) was lower on days when students most frequently were in class (MWF). Degree distributions were generally large and right skewed, ranging from 0 to 719. Simulations began by inoculating twenty students (10 exposed and 10 infectious) with SARS-CoV-2 on the first day of the fall semester and ended once the disease was cleared. Transmission probability was calculated based on an R-0 = 2.4. Without interventions epidemics resulted in most students becoming infected and lasted into the second semester. On average students in the college networks experienced fewer infections, shorter duration, and lower epidemic peaks when compared to the dynamics on equal-sized random networks. The most important factors in reducing case numbers were the proportion masking and the frequency of testing, followed by contact tracing and mask efficacy. The paper discusses further high-order interactions and other implications of non-pharmaceutical interventions for disease transmission on a residential college campus.	[Hartvigsen, Gregg] SUNY Coll Geneseo, Biol Dept, Geneseo, NY 14454 USA	State University of New York (SUNY) System; SUNY Geneseo	Hartvigsen, G (corresponding author), SUNY Coll Geneseo, Biol Dept, Geneseo, NY 14454 USA.	hartvig@geneseo.edu		Hartvigsen, Gregg/0000-0002-2277-7692				Aleta A, 2020, NAT HUM BEHAV, V4, P964, DOI 10.1038/s41562-020-0931-9; Baker RE, 2020, P NATL ACAD SCI USA, V117, P30547, DOI 10.1073/pnas.2013182117; Bar-Yam Y, 2020, IMPACT NONPHARMACEUT; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Barthelemy M, 2005, J THEOR BIOL, V235, P275, DOI 10.1016/j.jtbi.2005.01.011; Centers for Disease Control and Prevention, CONS I HIGH ED; Csardi G., 2005, INTERJ COMPLEX SYST, P1695; Eames KTD, 2003, P ROY SOC B-BIOL SCI, V270, P2565, DOI 10.1098/rspb.2003.2554; Eubank S, 2020, B MATH BIOL, V82, DOI 10.1007/s11538-020-00726-x; Flaxman S, 2020, NATURE, V584, P257, DOI 10.1038/s41586-020-2405-7; Hartvigsen G, 2007, J THEOR BIOL, V246, P205, DOI 10.1016/j.jtbi.2006.12.027; He X, 2020, NAT MED, V26, DOI 10.1038/s41591-020-0869-5; Hutchins HJ, 2020, MMWR-MORBID MORTAL W, V69, P1584, DOI 10.15585/mmwr.mm6943e4; Ledford Heidi, 2021, Nature, DOI 10.1038/d41586-021-00071-6; Lindsley WG, 2021, AEROSOL SCI TECH, V55, P449, DOI 10.1080/02786826.2020.1862409; Paltiel AD, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.16818; Peeples L, 2020, NATURE, V586, P186, DOI 10.1038/d41586-020-02801-8; R Core Team, 2021, R LANGUAGE ENV STAT; Sanche S, 2020, EMERG INFECT DIS, V26, P1470, DOI 10.3201/eid2607.200282; Van Dyke ME, 2020, MMWR-MORBID MORTAL W, V69, P1777, DOI 10.15585/mmwr.mm6947e2; Verma S, 2020, PHYS FLUIDS, V32, DOI 10.1063/5.0016018; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Wells Chad R, 2021, Nat Commun, V12, P356, DOI [10.1101/2020.10.27.20211631, 10.1038/s41467-020-20742-8]	23	2	2	4	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2021	16	9							e0257052	10.1371/journal.pone.0257052	http://dx.doi.org/10.1371/journal.pone.0257052			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	WG5ZQ	34534212	Green Submitted, Green Published, gold			2022-12-26	WOS:000707073300016
J	Graff, TC; Fitzgerald, JR; Luke, SG; Birmingham, WC				Graff, Tyler C.; Fitzgerald, Joseph R.; Luke, Steven G.; Birmingham, Wendy C.			Spousal emotional support and relationship quality buffers pupillary response to horror movies	PLOS ONE			English	Article							AMBULATORY BLOOD-PRESSURE; SOCIAL SUPPORT; MARITAL-STATUS; CARDIOVASCULAR REACTIVITY; PSYCHOLOGICAL STRESS; INTERPERSONAL PROCESS; MARRIED-COUPLES; SELF-DISCLOSURE; TOUCH SUPPORT; LIGHT REFLEX	Being satisfied in marriage provides protective stress buffering benefits to various health complications but the causal mechanisms and speed at which this is accomplished is less well understood. Much of the research on health and marriage has conceptualized marital quality in a unidimensional way, with high levels of either positivity or negativity. This conceptualization may not fully capture the nuanced benefits of marital relationships. Pupillometry is an innovative method which captures the effects of marital stress buffering on the body's autonomic nervous system in real time; pupil dilation occurs within 200ms to stress exposure. Additionally, this method records hundreds of readings per second, providing precision and sensitivity. This preregistered experiment aimed to conceptually replicate previous pupillometry stress buffering results and extend the previous findings by including a generalizable, real-life stressor-viewing a horror movie-and multidimensional relationship quality effects. Eighty-three couples (166 participants) were quasi-grouped, based on a self-reported multidimensional relationship quality scale, to either supportive or ambivalent marital relationship conditions. They were then randomly assigned to either a spousal support (i.e., handholding) or non-support (spousal absence) condition and watched clips from both horror and nature movies while pupil dilation was measured. Tonic pupillary response results revealed that the horror video clips elicited a stress response and there were significant differences between the support and non-support conditions, as well as marital relationship quality conditions. These results frame the precision, speed, and sensitivity of pupillometry as a potentially fruitful method to investigate the causal mechanisms linking stress buffering and supportive marital relationships.	[Graff, Tyler C.; Luke, Steven G.; Birmingham, Wendy C.] Brigham Young Univ, Dept Psychol, Provo, UT 84602 USA; [Graff, Tyler C.] Wartburg Coll, Dept Social Sci, Waverly, IA 50677 USA; [Fitzgerald, Joseph R.] Arizona State Univ, Sch Publ Affairs, Tempe, AZ USA	Brigham Young University; Arizona State University; Arizona State University-Tempe	Graff, TC (corresponding author), Brigham Young Univ, Dept Psychol, Provo, UT 84602 USA.; Graff, TC (corresponding author), Wartburg Coll, Dept Social Sci, Waverly, IA 50677 USA.	tygraff@gmail.com		, tyler/0000-0003-0838-0442				Aizer AA, 2013, J CLIN ONCOL, V31, P3869, DOI 10.1200/JCO.2013.49.6489; Araújo Alexandre Xavier Gomes de, 2019, Rev. latinoam. psicopatol. fundam., V22, P360, DOI 10.1590/1415-4714.2019v22n2p360.11; Avellar S, 2007, EFFECTS MARRIAGE HLT; Bali A, 2015, REV NEUROSCIENCE, V26, P555, DOI 10.1515/revneuro-2015-0004; Barrera M., 2000, HDB COMMUNITY PSYCHO, P215; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Beach S.R., 2014, INTERPERSONAL RELATI, P133, DOI [DOI 10.1093/ACPROF:OSO/9780199936632.003.0007, 10.1093/acprof:oso/9780199936632.003.0007]; Beatty J., 2000, HDB PSYCHOPHYSIOLOGY, P142; BERG JH, 1982, J EXP SOC PSYCHOL, V18, P501, DOI 10.1016/0022-1031(82)90069-5; BERKMAN LF, 1995, PSYCHOSOM MED, V57, P245, DOI 10.1097/00006842-199505000-00006; Birmingham WC, 2019, ANN BEHAV MED, V53, P1069, DOI 10.1093/abm/kaz017; Birmingham WC, 2015, ANN BEHAV MED, V49, P743, DOI 10.1007/s12160-015-9709-0; Bitsios P, 2002, INT J PSYCHOPHYSIOL, V43, P177, DOI 10.1016/S0167-8760(01)00173-8; Bradley MM, 2008, PSYCHOPHYSIOLOGY, V45, P602, DOI 10.1111/j.1469-8986.2008.00654.x; Broadbent E, 2003, PSYCHOSOM MED, V65, P865, DOI 10.1097/01.PSY.0000088589.92699.30; Broadwell SD, 1999, INT J BEHAV MED, V6, P40, DOI 10.1207/s15327558ijbm0601_4; Burleson BR, 2003, LEA COMMUN SER, P551; Cacioppo JT, 2007, HANDBOOK OF PSYCHOPHYSIOLOGY, 3RD EDITION, P1, DOI 10.2277/ 0521844711; Campo RA, 2009, J COMMUNITY PSYCHOL, V37, P471, DOI 10.1002/jcop.20308; Cannon D., 1998, STILL KNOW WHAT YOU; Coan JA, 2006, PSYCHOL SCI, V17, P1032, DOI 10.1111/j.1467-9280.2006.01832.x; COBB S, 1976, PSYCHOSOM MED, V38, P300, DOI 10.1097/00006842-197609000-00003; COHEN S, 1985, PSYCHOL BULL, V98, P310, DOI 10.1037/0033-2909.98.2.310; COHEN S, 1988, HEALTH PSYCHOL, V7, P269, DOI 10.1037/0278-6133.7.3.269; COHEN S, 1991, NEW ENGL J MED, V325, P606, DOI 10.1056/NEJM199108293250903; Cundiff JM., 2015, ANN BEHAV MED; Cutrona C. E., 1990, SOCIAL SUPPORT INTER, P319, DOI DOI 10.1111/J.1083-6101.2007.00367.X; de Rooij SR, 2010, PSYCHONEUROENDOCRINO, V35, P866, DOI 10.1016/j.psyneuen.2009.11.011; Dickerson SS, 2004, J PERS, V72, P1191, DOI 10.1111/j.1467-6494.2004.00295.x; Dickerson SS, 2004, PSYCHOL BULL, V130, P355, DOI 10.1037/0033-2909.130.3.355; Ditzen B, 2014, RESTOR NEUROL NEUROS, V32, P149, DOI 10.3233/RNN-139008; ELLIS CJK, 1981, BRIT J OPHTHALMOL, V65, P754, DOI 10.1136/bjo.65.11.754; Engstrom M, 2006, ARTERIOSCL THROM VAS, V26, P643, DOI 10.1161/01.ATV.0000200100.14612.bb; Everly Jr GS, 2019, CLIN GUIDE TREATMENT, P19; Feldman R, 2010, DEVELOPMENTAL SCI, V13, P271, DOI 10.1111/j.1467-7687.2009.00890.x; Giannakakis G, 2019, 2019 8TH INTERNATIONAL CONFERENCE ON AFFECTIVE COMPUTING AND INTELLIGENT INTERACTION WORKSHOPS AND DEMOS (ACIIW), P273, DOI 10.1109/TAFFC.2019.2927337; Gillespie J., 1997, KNOW WHAT YOU DID LA; Gilman TL, 2017, BEHAV RES METHODS, V49, P2061, DOI 10.3758/s13428-016-0842-x; Gottlieb BH, 2010, J PSYCHOSOM RES, V69, P511, DOI 10.1016/j.jpsychores.2009.10.001; GOVE WR, 1973, AM J SOCIOL, V79, P45, DOI 10.1086/225505; Graff TC, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0212703; Greenberg T, 2013, BIOL PSYCHOL, V92, P2, DOI 10.1016/j.biopsycho.2011.12.007; Gunnar MR, 2015, SOC NEUROSCI-UK, V10, P479, DOI 10.1080/17470919.2015.1070747; Hardesty T., 1997, ALASKAS WILD DENALI; Harris RJ, 2000, MEDIA PSYCHOL, V2, P245, DOI 10.1207/S1532785XMEP0203_3; Hayashi N, 2009, PHYSIOL BEHAV, V98, P441, DOI 10.1016/j.physbeh.2009.07.008; Holt-Lunstad J, 2008, ANN BEHAV MED, V35, P239, DOI 10.1007/s12160-008-9018-y; Holt-Lunstad J, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000316; Holt-Lunstad J, 2008, PSYCHOSOM MED, V70, P976, DOI 10.1097/PSY.0b013e318187aef7; Hostinar CE, 2015, CURR OPIN PSYCHOL, V5, P90, DOI 10.1016/j.copsyc.2015.05.004; HOUSE JS, 1988, SCIENCE, V241, P540, DOI 10.1037/0003-066X.59.8.676; Howard S, 2017, BIOL PSYCHOL, V125, P70, DOI 10.1016/j.biopsycho.2017.02.006; Isowa T, 2004, BIOL PSYCHOL, V65, P101, DOI 10.1016/S0301-0511(03)00115-7; Jakubiak BK, 2017, PERS SOC PSYCHOL REV, V21, P228, DOI 10.1177/1088868316650307; Jakubiak BK, 2016, J EXP SOC PSYCHOL, V65, P59, DOI 10.1016/j.jesp.2016.04.001; Johnson NJ, 2000, ANN EPIDEMIOL, V10, P224, DOI 10.1016/S1047-2797(99)00052-6; JUST MA, 1993, CAN J EXP PSYCHOL, V47, P310, DOI 10.1037/h0078820; KAHNEMAN D, 1966, SCIENCE, V154, P1583, DOI 10.1126/science.154.3756.1583; KAMARCK TW, 1990, PSYCHOSOM MED, V52, P42, DOI 10.1097/00006842-199001000-00004; Kang MJ, 2009, PSYCHOL SCI, V20, P963, DOI 10.1111/j.1467-9280.2009.02402.x; Kemeny ME, 2003, CURR DIR PSYCHOL SCI, V12, P124, DOI 10.1111/1467-8721.01246; KiecoltGlaser JK, 1996, P NATL ACAD SCI USA, V93, P3043, DOI 10.1073/pnas.93.7.3043; Kreibig SD, 2007, PSYCHOPHYSIOLOGY, V44, P787, DOI 10.1111/j.1469-8986.2007.00550.x; Kuznetsova A., 2015, R PACKAGE VERSION PA; Laeng B, 2012, PERSPECT PSYCHOL SCI, V7, P18, DOI 10.1177/1745691611427305; Laeng B, 2011, COGN PROCESS, V12, P13, DOI 10.1007/s10339-010-0370-z; Laurenceau JP, 2005, J FAM PSYCHOL, V19, P314, DOI 10.1037/0893-3200.19.2.314; Laurenceau JP, 1998, J PERS SOC PSYCHOL, V74, P1238, DOI 10.1037/0022-3514.74.5.1238; Leuchs L, 2019, PSYCHOPHYSIOLOGY, V56, DOI 10.1111/psyp.13283; Leuchs L, 2017, NEUROIMAGE, V147, P186, DOI 10.1016/j.neuroimage.2016.11.072; Liu H, 2016, J GERONTOL B-PSYCHOL, V71, P1070, DOI 10.1093/geronb/gbw061; Luke SG, 2017, BEHAV RES METHODS, V49, P1494, DOI 10.3758/s13428-016-0809-y; Maddock C, 2001, Epidemiol Psichiatr Soc, V10, P153; MARTEAU TM, 1992, BRIT J CLIN PSYCHOL, V31, P301, DOI 10.1111/j.2044-8260.1992.tb00997.x; Mirman D, 2008, J MEM LANG, V59, P475, DOI 10.1016/j.jml.2007.11.006; Neuman MD, 2016, JAMA SURG, V151, P194, DOI 10.1001/jamasurg.2015.3240; OBRIST PA, 1978, PSYCHOPHYSIOLOGY, V15, P102, DOI 10.1111/j.1469-8986.1978.tb01344.x; Partala T, 2003, INT J HUM-COMPUT ST, V59, P185, DOI 10.1016/S1071-5819(03)00017-X; Pascualy M, 2000, BIOL PSYCHIAT, V48, P247, DOI 10.1016/S0006-3223(00)00879-9; Pedrotti M, 2014, INT J HUM-COMPUT INT, V30, P220, DOI 10.1080/10447318.2013.848320; Qin SZ, 2012, J NEUROSCI, V32, P4032, DOI 10.1523/JNEUROSCI.3101-11.2012; Reblin M, 2020, J COMMUNITY PSYCHOL, V48, P2221, DOI 10.1002/jcop.22392; Reinhard G, 2006, PSYCHOPHYSIOLOGY, V43, P73, DOI 10.1111/j.1469-8986.2006.00374.x; Ren P, 2014, ANN BIOMED ENG, V42, P162, DOI 10.1007/s10439-013-0880-9; Robles TF, 2003, PHYSIOL BEHAV, V79, P409, DOI 10.1016/S0031-9384(03)00160-4; Rohleder N, 2019, PSYCHONEUROENDOCRINO, V105, P164, DOI 10.1016/j.psyneuen.2019.02.021; Samuels ER, 2008, CURR NEUROPHARMACOL, V6, P235, DOI 10.2174/157015908785777229; Sapolsky R.M., 2004, WHY ZEBRAS DONT GET, V3rd ed.; Schaefer A, 2010, COGNITION EMOTION, V24, P1153, DOI 10.1080/02699930903274322; Schulz U, 2003, DIAGNOSTICA, V49, P73, DOI 10.1026//0012-1924.49.2.73; Sirois S, 2014, WIRES COGN SCI, V5, P679, DOI 10.1002/wcs.1323; Smith TW, 2012, HEALTH PSYCHOL, V31, P763, DOI 10.1037/a0026947; Steinhauer SR, 2004, INT J PSYCHOPHYSIOL, V52, P77, DOI 10.1016/j.ijpsycho.2003.12.005; Straube T, 2010, HUM BRAIN MAPP, V31, P36, DOI 10.1002/hbm.20843; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; STURGEON RS, 1989, PERCEPT MOTOR SKILL, V69, P1351, DOI 10.2466/pms.1989.69.3f.1351; Tomaka J, 1997, J PERS SOC PSYCHOL, V73, P63, DOI 10.1037/0022-3514.73.1.63; Troxel WM, 2009, BEHAV SLEEP MED, V7, P2, DOI 10.1080/15402000802577736; Troxel WM, 2005, ARCH INTERN MED, V165, P1022, DOI 10.1001/archinte.165.9.1022; Uchino BN, 2014, PSYCHOL SCI, V25, P1037, DOI 10.1177/0956797613520015; Uchino BN, 2013, HEALTH PSYCHOL, V32, P1067, DOI 10.1037/a0033515; Uchino BN, 2009, PERSPECT PSYCHOL SCI, V4, P236, DOI 10.1111/j.1745-6924.2009.01122.x; Uchino BN, 2001, J BEHAV MED, V24, P361, DOI 10.1023/A:1010634902498; Ursache A, 2015, BEHAV MED, V41, P145, DOI 10.1080/08964289.2015.1024604; Waller DG., 2018, MED PHARM THERAPEUTI, VFifth Edition, P569; White TL, 1999, J PERS SOC PSYCHOL, V77, P863, DOI 10.1037/0022-3514.77.4.863; Willemsen G, 2002, PSYCHOPHYSIOLOGY, V39, P222, DOI 10.1017/S048577201392132; Yamanaka K, 2009, INT J OCCUP SAF ERGO, V15, P447, DOI 10.1080/10803548.2009.11076824; Zhai D, 2006, BIOMED SCI INSTRUM, V42, P495	109	0	0	4	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2021	16	9							e0256823	10.1371/journal.pone.0256823	http://dx.doi.org/10.1371/journal.pone.0256823			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	WG6DR	34525117	gold, Green Published			2022-12-26	WOS:000707084400020
J	Smigasiewicz, K; Servant, M; Ambrosi, S; Blaye, A; Burle, B				Smigasiewicz, Kamila; Servant, Mathieu; Ambrosi, Solene; Blaye, Agnes; Burle, Boris			Speeding-up while growing-up: Synchronous functional development of motor and non-motor processes across childhood and adolescence	PLOS ONE			English	Article							NERVOUS-SYSTEM MYELINATION; REACTION-TIME; ELECTROMYOGRAPHIC ACTIVITY; EXECUTIVE CONTROL; BRAIN MATURATION; AGE-DIFFERENCES; HUMAN INFANCY; MODEL; INFORMATION; MATTER	Describing the maturation of information processing in children is fundamental for developmental science. Although non-linear changes in reaction times have been well-documented, direct measurement of the development of the different processing components is lacking. In this study, electromyography was used to quantify the maturation of premotor and motor processes on a sample of 114 children (6-14 years-old) and 15 adults. Using a model-based approach, we show that the development of these two components is well-described by an exponential decrease in duration, with the decay rate being equal for the two components. These findings provide the first unbiased evidence in favour of the common developmental rate of nonmotor and motor processes by directly confronting rates of development of different processing components within the same task. This common developmental rate contrasts with the differential physical maturation of region-specific cerebral gray and white matter. Tentative paths of interpretation are proposed in the discussion.	[Smigasiewicz, Kamila; Burle, Boris] Aix Marseille Univ, Lab Neurosci Cognit, CNRS, Marseille, France; [Servant, Mathieu] Univ Franche Comte, Lab Rech Integrat Neurosci & Psychol Cognit, Besancon, France; [Ambrosi, Solene; Blaye, Agnes] Aix Marseille Univ, Lab Psychol Cognit, CNRS, Marseille, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Universite de Franche-Comte; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Smigasiewicz, K; Burle, B (corresponding author), Aix Marseille Univ, Lab Neurosci Cognit, CNRS, Marseille, France.	k.smigasiewicz@gmail.com; boris.burle@univ-amu.fr	Blaye, Agnes/AAA-3972-2019	Servant, Mathieu/0000-0002-1864-5881	French Agence Nationale de la Recherche [ANR-15-CE280008]	French Agence Nationale de la Recherche(French National Research Agency (ANR))	This work was supported by French Agence Nationale de la Recherche (ANR-15-CE280008, DOPCONTROL) awarded to A.B and B.B. https://anr.fr.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1978, J ROY STAT SOC D-STA, V27, P217, DOI 10.2307/2988185; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Allain S, 2004, PSYCHOPHYSIOLOGY, V41, P113, DOI 10.1111/j.1469-8986.2003.00136.x; Averell L, 2011, J MATH PSYCHOL, V55, P25, DOI 10.1016/j.jmp.2010.08.009; BASHORE TR, 1994, ACTA PSYCHOL, V86, P295, DOI 10.1016/0001-6918(94)90006-X; Blampied NM, 2017, BEHAV THER, V48, P115, DOI 10.1016/j.beth.2016.09.002; BOTWINICK J, 1966, J EXP PSYCHOL, V71, P9, DOI 10.1037/h0022634; Brinley JF, 1965, BEHAV AGING NERVOUS, P114; BRODY BA, 1987, J NEUROPATH EXP NEUR, V46, P283, DOI 10.1097/00005072-198705000-00005; Burle B, 2002, PSYCHOL RES-PSYCH FO, V66, P324, DOI 10.1007/s00426-002-0105-6; Burle B., 2008, INT J BIOELECTRO, V10, P17; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; CALLAWAY E, 1984, PSYCHOPHYSIOLOGY, V21, P571; CERELLA J, 1994, ACTA PSYCHOL, V86, P109, DOI 10.1016/0001-6918(94)90002-7; CHI MTH, 1977, DEV PSYCHOL, V13, P543, DOI 10.1037/0012-1649.13.5.543; COLES MGH, 1985, J EXP PSYCHOL HUMAN, V11, P529, DOI 10.1037/0096-1523.11.5.529; Dubarry AS, 2017, PSYCHOL SCI, V28, P414, DOI 10.1177/0956797616681296; Favilla M, 2006, EXP BRAIN RES, V169, P122, DOI 10.1007/s00221-005-0291-8; Fluchere F, 2018, NEUROPSYCHOLOGIA, V117, P167, DOI 10.1016/j.neuropsychologia.2018.02.016; Giorgio A, 2010, NEUROIMAGE, V49, P94, DOI 10.1016/j.neuroimage.2009.08.003; Gogtay N, 2004, P NATL ACAD SCI USA, V101, P8174, DOI 10.1073/pnas.0402680101; GRATTON G, 1988, J EXP PSYCHOL HUMAN, V14, P331, DOI 10.1037/0096-1523.14.3.331; Grayson D., 1983, THESIS U SYDNEY; HALE S, 1990, CHILD DEV, V61, P653, DOI 10.1111/j.1467-8624.1990.tb02809.x; Hasbroucq T, 2009, PSYCHOPHYSIOLOGY, V46, P1160, DOI 10.1111/j.1469-8986.2009.00865.x; Heathcote A, 2000, PSYCHON B REV, V7, P185, DOI 10.3758/BF03212979; Heathcote A., 2015, INTRO MODEL BASED CO, P25, DOI [DOI 10.1111/jcpp.12217, DOI 10.1007/978-1-4939-2236-9_2]; Hodges PW, 1996, ELECTROMYOGR MOTOR C, V101, P511, DOI 10.1016/S0013-4694(96)95190-5; ILAN AB, 1994, J EXP PSYCHOL HUMAN, V20, P520, DOI 10.1037/0096-1523.20.3.520; Jeffreys H., 1948, INT SERIES MONOGRAPH, V2a; KAIL R, 1986, CHILD DEV, V57, P969, DOI 10.2307/1130372; KAIL R, 1991, PSYCHOL BULL, V109, P490, DOI 10.1037/0033-2909.109.3.490; Keene MFL, 1931, J ANAT, V66, P1; KINNEY HC, 1988, J NEUROPATH EXP NEUR, V47, P217, DOI 10.1097/00005072-198805000-00003; Krongold M, 2017, CEREB CORTEX, V27, P1125, DOI 10.1093/cercor/bhv307; KUKULKA CG, 1981, BRAIN RES, V219, P45, DOI 10.1016/0006-8993(81)90266-3; Lebel C, 2008, NEUROIMAGE, V40, P1044, DOI 10.1016/j.neuroimage.2007.12.053; Leys C, 2013, J EXP SOC PSYCHOL, V49, P764, DOI 10.1016/j.jesp.2013.03.013; Liu J, 2016, BIOMED SIGNAL PROCES, V24, P19, DOI 10.1016/j.bspc.2015.09.004; MADDEN DJ, 1992, J GERONTOL, V47, pP59, DOI 10.1093/geronj/47.2.P59; Meckler C, 2010, BIOL PSYCHOL, V85, P386, DOI 10.1016/j.biopsycho.2010.08.011; MEIJERS LMM, 1976, BIOL CYBERN, V25, P7; Miller LT, 1997, DEV PSYCHOL, V33, P549, DOI 10.1037/0012-1649.33.3.549; Motulsky Harvey J., 2004, P1; NELDER JA, 1965, COMPUT J, V7, P308, DOI 10.1093/comjnl/7.4.308; O'Muircheartaigh J, 2014, HUM BRAIN MAPP, V35, P4475, DOI 10.1002/hbm.22488; Peirce JW, 2007, J NEUROSCI METH, V162, P8, DOI 10.1016/j.jneumeth.2006.11.017; Possamai CA, 2002, ACTA PSYCHOL, V111, P125, DOI 10.1016/S0001-6918(02)00019-7; Ratcliff R, 2003, PERCEPT PSYCHOPHYS, V65, P523, DOI 10.3758/BF03194580; Ratcliff R, 2001, PSYCHOL AGING, V16, P323, DOI 10.1037//0882-7974.16.2.323; Reynolds JE, 2019, NEUROIMAGE, V196, P49, DOI 10.1016/j.neuroimage.2019.04.004; Ridderinkhof KR, 1997, BIOL PSYCHOL, V45, P241, DOI 10.1016/S0301-0511(96)05230-1; ROMAIGUERE P, 1993, COGNITIVE BRAIN RES, V1, P197, DOI 10.1016/0926-6410(93)90028-4; Servant M, 2020, PSYCHOL AGING, V35, P831, DOI 10.1037/pag0000546; Servant M, 2016, J COGNITIVE NEUROSCI, V28, P1501, DOI 10.1162/jocn_a_00989; Shaw P, 2008, J NEUROSCI, V28, P3586, DOI 10.1523/JNEUROSCI.5309-07.2008; Simmons JP, 2011, PSYCHOL SCI, V22, P1359, DOI 10.1177/0956797611417632; Simon JR., 1990, ADV PSYCHOL, P31, DOI [10.1016/s0166-4115(08)61218-2, DOI 10.1016/S0166-4115(08)61218-2]; Smigasiewicz K, 2020, DEV COGN NEUROS-NETH, V41, DOI 10.1016/j.dcn.2019.100742; Sowell ER, 1999, NAT NEUROSCI, V2, P859, DOI 10.1038/13154; STERNBERG S, 1969, AM SCI, V57, P421; Tamnes CK, 2010, CEREB CORTEX, V20, P534, DOI 10.1093/cercor/bhp118; The jamovi project, 2020, JAM VERS 16 COMP SOF; van den Wildenberg WPM, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00222; Virtanen P, 2020, NAT METHODS, V17, P261, DOI 10.1038/s41592-019-0686-2; Wagenmakers EJ, 2004, PSYCHON B REV, V11, P192, DOI 10.3758/BF03206482; Weindel G, 2021, J EXP PSYCHOL GEN, V150, P1528, DOI 10.1037/xge0001010	67	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2021	16	9							e0255892	10.1371/journal.pone.0255892	http://dx.doi.org/10.1371/journal.pone.0255892			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	WG6DR	34525103	Green Published, gold			2022-12-26	WOS:000707084400013
J	Hosseini, M; Saikia, U; Dasvarma, G				Hosseini, Maryam; Saikia, Udoy; Dasvarma, Gouranga			The gap between desired and expected fertility among women in Iran: A case study of Tehran city	PLOS ONE			English	Article							SEX PREFERENCE; SON PREFERENCE; FAMILY-SIZE; CONTRACEPTIVE USE; CHILDREN BORN; EMPLOYMENT; BEHAVIOR; EDUCATION; AMERICA; NUMBER	The 2016 Iranian Census reveals that 14 of the country's 31 provinces have sub-replacement fertility. The province of Tehran, where a woman on average gives birth to 1.5 children during her reproductive period, has the lowest fertility in Iran. However, the 'two-child' norm prevails in the country and even a woman of young reproductive age still values having at least two children on average. In other words, there exists a gap between a woman's actual and desired fertility. This paper examines the demographic and socio-economic factors influencing the gap between actual and desired fertility in Tehran city based on a sample survey of 400 married women aged 15-49 years, conducted in 2015. The findings of the study reveal that the women of Tehran would be able to meet their fertility desires of two or more children if they were able to achieve their intended number of children they stated in the survey. However, should these women face any socio-economic constraint, they would be very likely to restrain their fertility desires and have fewer additional children than they initially intended, and thus continue with the sub-replacement fertility as being observed in Iran today.	[Hosseini, Maryam; Saikia, Udoy; Dasvarma, Gouranga] Flinders Univ S Australia, Coll Humanities Arts & Social Sci, Adelaide, SA, Australia	Flinders University South Australia	Saikia, U (corresponding author), Flinders Univ S Australia, Coll Humanities Arts & Social Sci, Adelaide, SA, Australia.	udoy.saikia@flinders.edu.au		Dasvarma, Gouranga/0000-0002-1784-7967; Saikia, Udoy/0000-0001-5572-3925	Australian Postgraduate Research Scholarship at Flinders University under the Flinders University [6748]	Australian Postgraduate Research Scholarship at Flinders University under the Flinders University	The first author received an Australian Postgraduate Research Scholarship to pursue PhD studies at Flinders University under the Flinders University, Project no. 6748 approved on 24 February 2015. This paper is a part of that PhD study.	Abbasi MohammadJalal., 2002, J POPUL RES, V19, P25; Abbasi-Shavazi MJ., 2008, ED WORLDS MOST RAPID; Abbasi-Shavazi MJ., 2000, WORKING PAPERS DEMOG; Abbasi-Shavazi MJ., 2013, J SOCIAL SCI, V16, P105; Abbasi-Shavazi MJ., 2005, FERTILITY TRANSITION; Abbasi-Shavazi MJ., 2001, LOW FERTILITY ADV CO; Abbasi-Shavazi MJ., 2002, J SOCIAL SCI, V10, P160; Abbasi-Shavazi MJ., 2002, EXP GROUP M CONT FER; AbbasiShavazi MJ, 2009, FERTILITY TRANSITION IN IRAN: REVOLUTION AND REPRODUCTION, P1; Adsera A., 2006, REV ECON HOUSEHOLD, V4, P75, DOI [10.1007/s11150-005-6698-y, DOI 10.1007/S11150-005-6698-Y]; Aghajanian A, 1999, INT FAM PLAN PERSPEC, V25, P98, DOI 10.2307/2991948; Aghajanian A, 1994, INT FAM PLAN PERSPEC, V20, P66; Akmam W., 2002, EUBIOS J ASIAN INT B, V12, P138; Amani M., 1970, BIRTHS FERTILITY IRA; ARNOLD F, 1985, DEMOGRAPHY, V22, P280, DOI 10.2307/2061182; ARNOLD F, 1986, POPUL DEV REV, V12, P221, DOI 10.2307/1973109; ASKARINODOUSHAN A, 2009, WOMENS STRATEGIC STU, V44, P7; BARRO RJ, 1993, J MONETARY ECON, V32, P363, DOI 10.1016/0304-3932(93)90023-9; Basu AM, 1996, GIRLS' SCHOOLING, WOMEN'S AUTONOMY AND FERTILITY CHANGE IN SOUTH ASIA, P48; Becker Gary S., 1991, TREATISE FAMILY, DOI DOI 10.4159/9780674020665; BONGAARTS J, 1982, STUD FAMILY PLANN, V13, P179, DOI 10.2307/1965445; Bongaarts J, 2002, POPUL DEV REV, V28, P419, DOI 10.1111/j.1728-4457.2002.00419.x; Bongaarts J, 2013, FERTILITY BIOL BEHAV; Bongaarts J, 2001, POPUL DEV REV, V27, P260; Brewster KL, 2000, ANNU REV SOCIOL, V26, P271, DOI 10.1146/annurev.soc.26.1.271; Clark S, 2000, DEMOGRAPHY, V37, P95, DOI 10.2307/2648099; Cochran W.G., 1977, SAMPLING TECHNIQUE, V3rd ed.; d'Addio A. C., 2005, TRENDS DETERMINANTS; Das Gupta M, 2003, J DEV STUD, V40, P153, DOI 10.1080/00220380412331293807; DAS N, 1987, DEMOGRAPHY, V24, P517, DOI 10.2307/2061389; Dastjerdi M., 2012, REMOVAL POPULATION C; DAVIDSON M, 1978, SOC ECON STUD, V27, P481; DeJong J, 2005, REPROD HEALTH MATTER, V13, P49, DOI 10.1016/S0968-8080(05)25181-9; DESAI S, 1991, AM SOCIOL REV, V56, P551, DOI 10.2307/2096274; Easterlin R. A., 1978, EC SOCIOLOGY FERTILI; EASTERLIN RA, 1976, POPUL DEV REV, V2, P417, DOI 10.2307/1971619; EASTERLIN RA, 1991, PUBLIC OPIN QUART, V55, P499, DOI 10.1086/269280; Edlund L, 1999, J POLIT ECON, V107, P1275, DOI 10.1086/250097; Erfani A., 2013, CTR ASIAL PACIFIC DE; Erfani A, 2011, INT PERSPECT SEX R H, V37, P134, DOI 10.1363/3713411; FREEDMAN R, 1975, DEMOGRAPHY, V12, P407, DOI 10.2307/2060824; FREEDMAN R, 1980, DEMOGRAPHY, V17, P365, DOI 10.2307/2061151; Goldstein J, 2003, POPUL RES POLICY REV, V22, P479, DOI 10.1023/B:POPU.0000020962.80895.4a; Gunther I, 2016, DEMOGRAPHY, V53, P55, DOI 10.1007/s13524-015-0451-9; Hagewen KJ, 2005, POPUL DEV REV, V31, P507, DOI 10.1111/j.1728-4457.2005.00081.x; Hossein-Chavoshi M., 2006, POPULATION, V61, P701, DOI DOI 10.3917/POPE.605.0701; Hosseini M., 2015, THESIS FLINDERS U AU; Hosseini-Chavoshi M, 2016, POPULATION HORIZONS, V13, P31, DOI DOI 10.1515/POPHZN-2016-0005; Hosseini-Chavoshi Meimanat, 2012, POPULATION DYNAMICS, P97; Hynes K, 2005, J MARRIAGE FAM, V67, P222, DOI 10.1111/j.0022-2445.2005.00017.x; Ibisomi L, 2011, J BIOSOC SCI, V43, P233, DOI 10.1017/S0021932010000684; Isen A., 2010, NATL BUREAU EC RES; Jejeebhoy SJ., 1995, INT STUDIES DEMOGRAP; Karim MS., 1997, REPROD BEHAV MUSLIM; Kelly GailP., 1982, WOMENS ED 3 WORLD CO; Kent MM., 1982, FAMILY SIZE PREFEREN; Khalajabadi Farahani F, 2014, 2014 ANN M POP ASS A; King EM., 1997, WOMENS ED DEVELOPING; Lam D, 1999, J HUM RESOUR, V34, P160, DOI 10.2307/146306; LEHRER E, 1986, ANNU REV SOCIOL, V12, P181, DOI 10.1146/annurev.so.12.080186.001145; LESTHAEGHE R, 1988, POPUL DEV REV, V14, P1, DOI 10.2307/1972499; Lesthaeghe RJ, 1985, COLLECTION ANAL COMM, P31; Mahmoudian H., 2014, WOMENS STRATEGIC STU, V16, P97; Mahmoudian H., 2010, WOMEN DEV POLITICS, V7, P51; MARTIN TC, 1995, STUD FAMILY PLANN, V26, P187, DOI 10.2307/2137845; MARTIN TC, 1995, INT FAM PLAN PERSPEC, V21, P52, DOI 10.2307/2133523; Mason K.O., 1986, SOCIOLOGICAL FORUM, V1, P284, DOI [https://doi.org/10.1007/BF01115740, DOI 10.1007/BF01115740]; Mirsadeghi P., 2016, URBAN CHANGE IRAN; Mirzaee M., 2014, J POPULATION ASS IRA, V9, P113; Modiri F., 2017, J POPULATION ASS IRA, V11, P9; Monnier A, 1989, Popul, V44, P237; Morgan SP, 2005, PENN STATE UNIV FAM, P3; Moshfegh M., 2013, WOMEN STRATEGIC STUD, P93; Nanzy P., 2014, J FAM WELFARE, V60, P59; Nations United., 1995, WOM ED FERT BEH REC; Nishimura T, 2012, 81 KWANS GAK U SCH E; PRITCHETT LH, 1994, POPUL DEV REV, V20, P1, DOI 10.2307/2137629; Quesnel-Vallee A, 2003, POPUL RES POLICY REV, V22, P497, DOI 10.1023/B:POPU.0000021074.33415.c1; Razeghi Nasrabad H., 2012, J POPULATION ASS IRA, V7, P149; Razeghi Nasrabad H., 2019, IRAN J MIDWIFERY REP, V7, P1962; ROSENZWEIG MR, 1985, AM ECON REV, V75, P992; ROSENZWEIG MR, 1989, INT ECON REV, V30, P457, DOI 10.2307/2526657; Roy TK, 2008, INT FAM PLAN PERSPEC, V34, P138, DOI [10.1363/3413808, 10.1363/ifpp.34.138.08]; Saei Gharenaz M., 2017, IRAN J RES RELIG HLT, V3, P79; Schearer SB., 1983, DETERMINANTS FERTILI, V2, P89; Schultz T.P., 1981, EC POPULATION; Schultz TP., 1994, DEMAND CHILDREN LOW; Sheykhi MT., 2007, J SOCIAL SCI, V15, P153; Statistical Center of Iran, 2011, NAT POP HOUS CENS; Statistical center of Iran, 2011, RES POP HOUS CENS IR; Statistical Center of Iran (SCI), 2017, 2016 NAT POP HOUS CE; Statistical Centre of Iran, 2006, DET RES GEN CENS IND; Testa MR, 2012, FAMILY SIZES EUROPE; THOMSON E, 1990, DEMOGRAPHY, V27, P579, DOI 10.2307/2061571; Togunde OR., 1998, INT J SOCIOL FAM, P31; Vahidnia F, 2007, POPUL ENVIRON, V28, P259, DOI 10.1007/s11111-007-0050-9; Van de Kaa D.J., 2002, IDEA 2 DEMOGRAPHIC T; Van de Walle E., 1982, MULTILINGUAL DEMOGRA, DOI [10.1007/BF00378160, DOI 10.1007/BF00378160]; Weinberger M. B., 1987, International Family Planning Perspectives, V13, P35, DOI 10.2307/2947826	99	1	1	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2021	16	9							e0257128	10.1371/journal.pone.0257128	http://dx.doi.org/10.1371/journal.pone.0257128			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	WG5RP	34520504	gold, Green Published			2022-12-26	WOS:000707052100013
J	Arthithanyaroj, S; Chankhamhaengdecha, S; Chaisri, U; Aunpad, R; Aroonnual, A				Arthithanyaroj, Sirirak; Chankhamhaengdecha, Surang; Chaisri, Urai; Aunpad, Ratchaneewan; Aroonnual, Amornrat			Effective inhibition of Clostridioides difficile by the novel peptide CM-A	PLOS ONE			English	Article							ANTIMICROBIAL PEPTIDES; ANTIBACTERIAL PEPTIDES; MELITTIN; SMAP-29; HYBRIDS; DAMAGE; CELLS; NISIN; MODE	Clostridioides difficile infection is the most common cause of nosocomial and antibiotic-associated diarrhea. C. difficile treatment is increasingly likely to fail, and the recurrence rate is high. Antimicrobial peptides are considered an alternative treatment for many infectious diseases, including those caused by antibiotic resistant bacteria. In the present study, we identified a CM peptide, a hybrid of cecropin A and melittin, and its derivative which possesses potent antimicrobial activity against C. difficile strain 630. CM peptide exhibited antibacterial activity with minimum inhibitory concentration of 3.906 mu g/ml (2.21 mu M). A modified derivative of CM, CM-A, exhibited even greater activity with a minimum inhibitory concentration of 1.953 mu g/ml (1.06 mu M) and a minimum bactericidal concentration of 7.8125 mu g/ml (4.24 mu M), which indicates that CM-A peptide is more efficient than its parent peptide. A fluorescence-activated cell sorter analysis revealed that the membrane of C. difficile 630 could be an important target for CM-A. This peptide induced high levels of cell depolarization and cell permeability on C. difficile cell membrane. Moreover, electron microscopy imaging showed that CM-A interferes with the C. difficile cell membrane. Hence, the antimicrobial peptide CM-A may represent a promising novel approach for the treatment of C. difficile infections.	[Arthithanyaroj, Sirirak; Aroonnual, Amornrat] Mahidol Univ, Fac Trop Med, Dept Trop Nutr & Food Sci, Bangkok, Thailand; [Chankhamhaengdecha, Surang] Mahidol Univ, Fac Sci, Dept Biol, Bangkok, Thailand; [Chaisri, Urai] Mahidol Univ, Fac Trop Med, Dept Trop Pathol, Bangkok, Thailand; [Aunpad, Ratchaneewan] Thammasat Univ, Fac Allied Hlth Sci, Grad Program Biomed Sci, Pathum Thani, Thailand	Mahidol University; Mahidol University; Mahidol University; Thammasat University	Aroonnual, A (corresponding author), Mahidol Univ, Fac Trop Med, Dept Trop Nutr & Food Sci, Bangkok, Thailand.	amornrat.aro@mahidol.ac.th		Aroonnual, Amornrat/0000-0002-6549-4916	National Research Council of Thailand	National Research Council of Thailand(National Research Council of Thailand (NRCT))	This study was supported by a grant from the National Research Council of Thailand.	Alam MZ, 2015, ANTIMICROB AGENTS CH, V59, P5165, DOI 10.1128/AAC.01087-15; ANDREU D, 1992, FEBS LETT, V296, P190, DOI 10.1016/0014-5793(92)80377-S; Arzese A, 2003, J ANTIMICROB CHEMOTH, V52, P375, DOI 10.1093/jac/dkg372; Bala P., 2014, PHARMACEUTICALS, V3, P62; Banawas SS, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/8414257; Bartlett JG, 2002, NEW ENGL J MED, V346, P334, DOI 10.1056/NEJMcp011603; BOMAN HG, 1989, FEBS LETT, V259, P103, DOI 10.1016/0014-5793(89)81505-4; Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098; Cezard C, 2011, FORMATEX, V02, P926; Chu M, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005946; Coronel-Leon J, 2016, FOOD CONTROL, V63, P1, DOI 10.1016/j.foodcont.2015.10.050; Epand RM, 1999, BBA-BIOMEMBRANES, V1462, P11, DOI 10.1016/S0005-2736(99)00198-4; FENNELL JF, 1968, P SOC EXP BIOL MED, V127, P707; Furci L, 2015, INFECT IMMUN, V83, P986, DOI 10.1128/IAI.02955-14; Gajski G, 2016, TOXICON, V110, P56, DOI 10.1016/j.toxicon.2015.12.005; Gautier R, 2008, BIOINFORMATICS, V24, P2101, DOI 10.1093/bioinformatics/btn392; Giuliani A, 2007, CENT EUR J BIOL, V2, P1, DOI 10.2478/s11535-007-0010-5; Guh AY, 2018, ANN INTERN MED, V169, pITC49, DOI 10.7326/AITC201810020; Hall IC, 1935, AM J DIS CHILD, V49, P390, DOI 10.1001/archpedi.1935.01970020105010; Hui LL, 2018, J INT MED RES, V46, P4731, DOI 10.1177/0300060518799267; Jindal HM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128532; Kang JK, 2011, ANTIMICROB AGENTS CH, V55, P4850, DOI 10.1128/AAC.00177-11; Kelly Ciaran P, 2008, N Engl J Med, V359, P1932, DOI 10.1056/NEJMra0707500; Khan FY, 2014, ASIAN PAC J TROP MED, V7, pS6, DOI 10.1016/S1995-7645(14)60197-8; Klubthawee N, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-65688-5; Kutty PK, 2010, EMERG INFECT DIS, V16, P197, DOI 10.3201/eid1602.090953; Le Lay C, 2016, J MED MICROBIOL, V65, P169, DOI 10.1099/jmm.0.000202; Lee E, 2013, BBA-BIOMEMBRANES, V1828, P271, DOI 10.1016/j.bbamem.2012.10.028; LEE JY, 1989, P NATL ACAD SCI USA, V86, P9159, DOI 10.1073/pnas.86.23.9159; Leffler DA, 2015, NEW ENGL J MED, V372, P1539, DOI 10.1056/NEJMra1403772; Lubbert C, 2014, DTSCH ARZTEBL INT, V111, P723, DOI 10.3238/arztebl.2014.0723; Neville F, 2010, BBA-BIOMEMBRANES, V1798, P851, DOI 10.1016/j.bbamem.2009.09.017; Nuding S., 2013, J BACTERIOL PARASI S, V5, P1; Nuding S, 2014, ANTIMICROB AGENTS CH, V58, P5719, DOI 10.1128/AAC.02542-14; Pepin J, 2005, CLIN INFECT DIS, V41, P1254, DOI 10.1086/496986; Rea MC, 2010, P NATL ACAD SCI USA, V107, P9352, DOI 10.1073/pnas.0913554107; Rineh A, 2014, EXPERT REV ANTI-INFE, V12, P131, DOI 10.1586/14787210.2014.866515; Rivas L., 2003, CECROPIN MELITTIN HY, P209, DOI [10.1201/9780203986646.ch11, DOI 10.1201/9780203986646.CH11]; Rodriguez-Hernandez MJ, 2006, J ANTIMICROB CHEMOTH, V58, P95, DOI 10.1093/jac/dkl145; RUHR E, 1985, ANTIMICROB AGENTS CH, V27, P841, DOI 10.1128/AAC.27.5.841; Shin SY, 1997, J PEPT RES, V50, P279; STEINER H, 1981, NATURE, V292, P246, DOI 10.1038/292246a0; Sun XM, 2015, MOL IMMUNOL, V63, P193, DOI 10.1016/j.molimm.2014.09.005; Tan TT, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18020339; WADE D, 1990, P NATL ACAD SCI USA, V87, P4761, DOI 10.1073/pnas.87.12.4761; WADE D, 1992, INT J PEPT PROT RES, V40, P429; Xu W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098935; Yang HT, 2018, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02635; Yang Y, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21041470	49	0	0	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2021	16	9							e0257431	10.1371/journal.pone.0257431	http://dx.doi.org/10.1371/journal.pone.0257431			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	WG6OR	34516580	gold, Green Published			2022-12-26	WOS:000707114200034
J	Mendes, IV; Garcia, MB; Bitencourt, ACA; Santana, RH; Lins, PD; Silveira, R; Simmons, BA; Gladden, JM; Kruger, RH; Quirino, BF				Mendes, Isis Viana; Garcia, Mariana Botelho; Araujo Bitencourt, Ana Carolina; Santana, Renata Henrique; Lins, Philippe de Castro; Silveira, Rafaella; Simmons, Blake A.; Gladden, John M.; Kruger, Ricardo Henrique; Quirino, Betania Ferraz			Bacterial diversity dynamics in microbial consortia selected for lignin utilization	PLOS ONE			English	Article							AZO DYES; DEGRADATION; BIODEGRADATION; CONVERSION; SEQUENCE; SYK-6; PULP	Lignin is nature's largest source of phenolic compounds. Its recalcitrance to enzymatic conversion is still a limiting step to increase the value of lignin. Although bacteria are able to degrade lignin in nature, most studies have focused on lignin degradation by fungi. To understand which bacteria are able to use lignin as the sole carbon source, natural selection over time was used to obtain enriched microbial consortia over a 12-week period. The source of microorganisms to establish these microbial consortia were commercial and backyard compost soils. Cultivation occurred at two different temperatures, 30 degrees C and 37 degrees C, in defined culture media containing either Kraft lignin or alkaline-extracted lignin as carbon source. iTag DNA sequencing of bacterial 16S rDNA gene was performed for each of the consortia at six timepoints (passages). The initial bacterial richness and diversity of backyard compost soil consortia was greater than that of commercial soil consortia, and both parameters decreased after the enrichment protocol, corroborating that selection was occurring. Bacterial consortia composition tended to stabilize from the fourth passage on. After the enrichment protocol, Firmicutes phylum bacteria were predominant when lignin extracted by alkaline method was used as a carbon source, whereas Proteobacteria were predominant when Kraft lignin was used. Bray-Curtis dissimilarity calculations at genus level, visualized using NMDS plots, showed that the type of lignin used as a carbon source contributed more to differentiate the bacterial consortia than the variable temperature. The main known bacterial genera selected to use lignin as a carbon source were Altererythrobacter, Aminobacter, Bacillus, Burkholderia, Lysinibacillus, Microvirga, Mycobacterium, Ochrobactrum, Paenibacillus, Pseudomonas, Pseudoxanthomonas, Rhizobiales and Sphingobium. These selected bacterial genera can be of particular interest for studying lignin degradation and utilization, as well as for lignin-related biotechnology applications.	[Mendes, Isis Viana; Garcia, Mariana Botelho; Araujo Bitencourt, Ana Carolina; Lins, Philippe de Castro; Quirino, Betania Ferraz] Embrapa Agroenergia, Parque Estacao Biol PqEB, PqEB S-N, Brasilia, DF, Brazil; [Mendes, Isis Viana; Araujo Bitencourt, Ana Carolina; Lins, Philippe de Castro; Silveira, Rafaella; Kruger, Ricardo Henrique; Quirino, Betania Ferraz] Univ Brasilia, Brasilia, DF, Brazil; [Garcia, Mariana Botelho; Quirino, Betania Ferraz] Univ Catolica Brasilia, Brasilia, DF, Brazil; [Santana, Renata Henrique] Inst Fed Brasilia, Brasilia, DF, Brazil; [Simmons, Blake A.; Gladden, John M.] Joint BioEnergy Inst, Deconstruct Div, Emeryville, CA USA; [Gladden, John M.] Sandia Natl Labs, Dept Biomass Sci & Convers Technol, Livermore, CA USA	Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Universidade de Brasilia; Universidade Catolica de Brasilia; Instituto Federal de Brasilia; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; United States Department of Energy (DOE); Sandia National Laboratories	Quirino, BF (corresponding author), Embrapa Agroenergia, Parque Estacao Biol PqEB, PqEB S-N, Brasilia, DF, Brazil.; Quirino, BF (corresponding author), Univ Brasilia, Brasilia, DF, Brazil.	betania.quirino@embrapa.br		Quirino, Betania/0000-0002-7578-6314	FAP-DF; CNPq; CAPES [DOE-JBEI DE-AC0205CH11231]	FAP-DF(Fundacao de Apoio a Pesquisa do Distrito Federal (FAPDF)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by grants from FAP-DF (B.F.Q.), CNPq (B.F.Q.), CAPES (I.V.M., M. B.G., A.C.A.B. and P.C.L.) and DOE-JBEI DE-AC0205CH11231 (J.M.G. and B.A.S.).	Akita H., 2016, ISOLATION CHARACTERI, V5, DOI [10.1186/s40064-016-2237-y, DOI 10.1186/S40064-016-2237-Y]; Alcalde M, 2015, TRENDS BIOTECHNOL, V33, P155, DOI 10.1016/j.tibtech.2014.12.007; Azadfar M, 2015, INT J BIOL MACROMOL, V75, P58, DOI 10.1016/j.ijbiomac.2014.12.049; Baptista NMQ., 2012, SCI PLENA, V8; Boerjan W, 2003, ANNU REV PLANT BIOL, V54, P519, DOI 10.1146/annurev.arplant.54.031902.134938; Boudet AM, 2000, PLANT PHYSIOL BIOCH, V38, P81, DOI 10.1016/S0981-9428(00)00166-2; Bugg TDH, 2015, CURR OPIN CHEM BIOL, V29, P10, DOI 10.1016/j.cbpa.2015.06.009; Bugg TDH, 2011, NAT PROD REP, V28, P1883, DOI 10.1039/c1np00042j; Bugg TDH, 2011, CURR OPIN BIOTECH, V22, P394, DOI 10.1016/j.copbio.2010.10.009; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Carlos C, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00364; Chantarasiri A., 2017, AACL Bioflux, V10, P200; Curtis TP, 2002, P NATL ACAD SCI USA, V99, P10494, DOI 10.1073/pnas.142680199; de Gonzalo G, 2016, J BIOTECHNOL, V236, P110, DOI 10.1016/j.jbiotec.2016.08.011; DeAngelis KM, 2010, BIOENERG RES, V3, P146, DOI 10.1007/s12155-010-9089-z; Fang XX, 2018, BIORESOURCE TECHNOL, V254, P247, DOI 10.1016/j.biortech.2018.01.058; Figueiredo P, 2018, PROG MATER SCI, V93, P233, DOI 10.1016/j.pmatsci.2017.12.001; Gall DL, 2017, CURR OPIN BIOTECH, V45, P120, DOI 10.1016/j.copbio.2017.02.015; Heberle H, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0611-3; Irannia Zohreh Baharvand, 2016, [Quantitative Biology, 定量生物学], V4, P149; Jimenez DJ, 2016, APPL MICROBIOL BIOT, V100, P10463, DOI 10.1007/s00253-016-7713-3; Kamimura N, 2017, ENV MICROBIOL REP, V9, P679, DOI 10.1111/1758-2229.12597; Knezevic A, 2013, BIORESOURCE TECHNOL, V138, P117, DOI 10.1016/j.biortech.2013.03.182; Koljalg U, 2013, MOL ECOL, V22, P5271, DOI 10.1111/mec.12481; Kumar N, 2020, AGRICULTURE-LONDON; Kumar V, 2018, WORLD J MICROB BIOT, V34, DOI 10.1007/s11274-018-2416-9; LABAT GAA, 2008, EST CIN OX LING OBT; Lambais M.R., 2005, TOPICOS CIENCIA SOLO, V4, P43; Louren?o A., 2018, LIGNIN TRENDS APPL; Low KB., 1974, Q REV BIOL, V49, P151, DOI [10.1086/408025, DOI 10.1086/408025]; Martins LO, 2002, J BIOL CHEM, V277, P18849, DOI 10.1074/jbc.M200827200; Masai E, 2012, J BACTERIOL, V194, P534, DOI 10.1128/JB.06254-11; Menezes FP., 2013, DEGRADACAO BIOSSOLID; Meux E, 2012, FEBS LETT, V586, P3944, DOI 10.1016/j.febslet.2012.09.036; Miranda RLde., 2019, DESENVOLV SOCIOECONO, V5, P94, DOI [10.18616/rdsd.v5i1.4829, DOI 10.18616/RDSD.V5I1.4829]; Moraes EC, 2018, BIOTECHNOL BIOFUELS, V11, DOI 10.1186/s13068-018-1073-4; Moreira FMS., 2002, MICROBIOLOGIA BIOQU, V2nd; Nannipieri P, 2017, EUR J SOIL SCI, V68, P12, DOI 10.1111/ejss.4_12398; Nielsen T.K., 2018, DIV SOIL WATER MANAG, P307967, DOI [10.1101/307967, DOI 10.1101/307967]; Nordhaus W, 2018, AM ECON J-ECON POLIC, V10, P333, DOI 10.1257/pol.20170046; Padmavathy S, 2003, CHEM BIOCHEM ENG Q, V17, P147; Pastore RAA., 2016, DIVERSIDADE TAXONOMI; Pereira JH, 2016, J BIOL CHEM, V291, P10228, DOI 10.1074/jbc.M115.700427; Puentes-Tellez PE, 2020, MICROB ECOL, V79, P312, DOI 10.1007/s00248-019-01403-w; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; R Core Team, 2016, R FDN STAT COMP; Raj A, 2007, BIODEGRADATION, V18, P783, DOI 10.1007/s10532-007-9107-9; Raj A, 2014, ECOL ENG, V71, P355, DOI 10.1016/j.ecoleng.2014.07.002; Rashid GMM, 2015, ACS CHEM BIOL, V10, P2286, DOI 10.1021/acschembio.5b00298; Rivers AR, 2016, ITAG AMPLICON SEQUEN, DOI [10.1111/1462-2920.13023.Price, DOI 10.1111/1462-2920.13023.PRICE]; Rodrigues C., 2017, BIOTECNOLOGIA APLICA, V1st, P1069; Rodrigues D de S., 2013, MICRORGANISMOS PRODU, V1st ed, P145; Safronova VI, 2017, INT J SYST EVOL MICR, V67, P94, DOI 10.1099/ijsem.0.001577; Sainsbury PD, 2013, ACS CHEM BIOL, V8, P2151, DOI 10.1021/cb400505a; Santana CAM., 2013, BULL MUS ANTHR PREHI, P17; Santos FA, 2012, QUIM NOVA, V35, P1004, DOI 10.1590/S0100-40422012000500025; Santos GHF., 2017, REV UNINGA, V29, P6; Solis M, 2012, PROCESS BIOCHEM, V47, P1723, DOI 10.1016/j.procbio.2012.08.014; Souza CS de., 2006, DERIVACAO QUIMICA CA; Tortora G. G., 2015, MICROBIOLOGY INTRO; Tremblay Julien, 2015, Front Microbiol, V6, P771, DOI 10.3389/fmicb.2015.00771; van Elsas JD, 2008, TRENDS BIOTECHNOL, V26, P591, DOI 10.1016/j.tibtech.2008.07.004; Wang YX, 2013, BIORESOURCE TECHNOL, V139, P113, DOI 10.1016/j.biortech.2013.04.033; Whitman WB., 2012, BERGEYS MANUAL SYSTE, V3, DOI [10.1007/b92997, DOI 10.1007/B92997]; Wong DWS, 2009, APPL BIOCHEM BIOTECH, V157, P174, DOI 10.1007/s12010-008-8279-z; Yoo CG, 2020, BIORESOURCE TECHNOL, V301, DOI 10.1016/j.biortech.2020.122784; Yu CW, 2015, BIOTECHNOL BIOFUELS, V8, DOI 10.1186/s13068-015-0392-y; Zakzeski J, 2010, CHEM REV, V110, P3552, DOI 10.1021/cr900354u; Zhu DC, 2017, BIOTECHNOL BIOFUELS, V10, DOI 10.1186/s13068-017-0735-y	69	2	2	6	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2021	16	9							e0255083	10.1371/journal.pone.0255083	http://dx.doi.org/10.1371/journal.pone.0255083			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	WG6OR	34516585	gold, Green Published			2022-12-26	WOS:000707114200003
J	Kim, D; Kim, DY; Kim, JS; Hong, SK; Byun, SS; Lee, SE				Kim, Dowook; Kim, Dong-Yun; Kim, Jae-Sung; Hong, Sung Kyu; Byun, Seok-Soo; Lee, Sang Eun			Clinical outcomes of salvage treatment in lymph node-positive prostate cancer patients after radical prostatectomy	PLOS ONE			English	Article							TERM-FOLLOW-UP; ADJUVANT RADIOTHERAPY; DISSECTION; SURVIVAL; ANTIGEN; MEN; PROGRESSION; METASTASES; THERAPY; IMPACT	Introduction The optimal salvage treatment strategies for lymph node-positive (LNP) patients after radical surgery have not been clearly defined in prostate cancer with biochemical recurrence or persistence of elevated prostate-specific antigen (PSA). In this study, we compared the clinical outcomes of two different salvage treatments, androgen deprivation therapy (ADT) alone versus ADT with radiotherapy (RT). We also investigated prognostic factors that could support the use of ADT with RT in LNP prostate cancer. Materials and methods We retrospectively reviewed 94 LNP prostate cancer patients who underwent radical prostatectomy (RP) followed by salvage treatment between 2004 and 2018. Salvage treatments involved either ADT alone or ADT with RT according to the clinical judgment of the physician. We analyzed clinicopathological and treatment factors related to 2(nd) biochemical failure (2(nd) BCF), clinical progression (CP), and progression-free survival (PFS). The cumulative failure after salvage treatment was defined as including both 2(nd) BCF and CP. Results The median duration of follow-up was 55 months (interquartile range, 35-97 months). Thirty-seven (39.4%) patients were treated with ADT alone, and 57 patients (60.6%) were treated with a combination of ADT with RT. During follow-up period, the incidence of failure after salvage treatment in the ADT alone group and the combined treatment group was 89.2% and 45.6%, respectively (HR, 22.4; 95% CI 5.43-92.1; P < 0.001). The combination of ADT with RT was associated with better 2(nd) BCF and PFS than ADT alone (P = 0.007 and P = 0.015, respectively). In multivariate analyses, number of positive LN >= 2 and PSA nadir >= 0.005 ng/ml after RP were associated with poor 2(nd) BCF, CP, and PFS after salvage treatment. Salvage by combined ADT plus RT showed better 2(nd) BCF and PFS than ADT alone. Specifically, patients with number of positive LN >= 2 or PSA nadir >= 0.005 ng/ml after RP showed better 2(nd) BCF (P = 0.004) or PFS (P = 0.011) when treated with ADT plus RT rather than ADT alone. Conclusions In patients with LNP prostate cancer, salvage ADT plus RT improved 2(nd) BCF and PFS compared to ADT alone. In particular, when the patients had more than two positive lymph nodes or PSA nadir >= 0.005 ng/ml after RP, ADT with RT seems to be a more beneficial salvage treatment resulting in better 2(nd) BCF and PFS.	[Kim, Dowook; Kim, Dong-Yun] Seoul Natl Univ, Coll Med, Seoul Natl Univ Hosp, Dept Radiat Oncol, Seoul, South Korea; [Kim, Jae-Sung] Seoul Natl Univ, Coll Med, Bundang Hosp, Dept Radiat Oncol, Seongnam, South Korea; [Hong, Sung Kyu; Byun, Seok-Soo; Lee, Sang Eun] Seoul Natl Univ, Coll Med, Bundang Hosp, Dept Urol, Seongnam, South Korea	Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University (SNU)	Kim, JS (corresponding author), Seoul Natl Univ, Coll Med, Bundang Hosp, Dept Radiat Oncol, Seongnam, South Korea.	jaeskim@snu.ac.kr		Kim, Jae-Sung/0000-0001-5348-9178; Kim, Dowook/0000-0002-6620-7085				Abdollah F, 2014, J CLIN ONCOL, V32, P3939, DOI 10.1200/JCO.2013.54.7893; Abdollah F, 2010, EUR UROL, V58, P882, DOI 10.1016/j.eururo.2010.09.029; Bartkowiak D, 2016, RADIOTHER ONCOL, V118, P131, DOI 10.1016/j.radonc.2015.10.028; Bernstein AN, 2018, J UROLOGY, V199, P1511, DOI 10.1016/j.juro.2017.12.048; Bivalacqua TJ, 2013, UROLOGY, V82, P653, DOI 10.1016/j.urology.2013.03.086; Bolla M, 2012, LANCET, V380, P2018, DOI 10.1016/S0140-6736(12)61253-7; Briganti A, 2009, EUR UROL, V55, P261, DOI 10.1016/j.eururo.2008.09.043; Chang JH, 2015, INT J UROL, V22, P82, DOI 10.1111/iju.12604; Da Pozzo LF, 2009, EUR UROL, V55, P1003, DOI 10.1016/j.eururo.2009.01.046; Kim JK, 2019, J CANCER, V10, P2237, DOI 10.7150/jca.29714; Kneebone A, 2020, LANCET ONCOL, V21, P1331, DOI 10.1016/S1470-2045(20)30456-3; Marra G, 2020, EUR UROL ONCOL, V3, P565, DOI 10.1016/j.euo.2020.08.005; McDonald ML, 2018, UROL ONCOL-SEMIN ORI, V36, DOI 10.1016/j.urolonc.2018.01.005; Messing EM, 2006, LANCET ONCOL, V7, P472, DOI 10.1016/S1470-2045(06)70700-8; Moris L, 2016, FRONT SURG, V3, DOI 10.3389/fsurg.2016.00065; Moschini M, 2016, EUR UROL, V69, P135, DOI 10.1016/j.eururo.2015.03.036; National Comprehensive Cancer Network, PROSTATE CANC VERSIO; Parker CC, 2020, LANCET, V396, P1413, DOI 10.1016/S0140-6736(20)31553-1; Rans K, 2020, CLIN ONCOL-UK, V32, P156, DOI 10.1016/j.clon.2020.01.003; Roy S, 2019, CLIN ONCOL-UK, V31, P91, DOI 10.1016/j.clon.2018.10.005; Sargos P, 2020, LANCET ONCOL, V21, P1341, DOI 10.1016/S1470-2045(20)30454-X; Shen S, 2005, J UROLOGY, V173, P777, DOI 10.1097/01.ju.0000153619.33446.60; Song C, 2010, BJU INT, V106, P188, DOI 10.1111/j.1464-410X.2009.09136.x; Stephenson AJ, 2007, J CLIN ONCOL, V25, P2035, DOI 10.1200/JCO.2006.08.9607; Stish BJ, 2016, J CLIN ONCOL, V34, P3864, DOI 10.1200/JCO.2016.68.3425; Thompson IM, 2009, J UROLOGY, V181, P956, DOI 10.1016/j.juro.2008.11.032; Touijer KA, 2021, EUR UROL ONCOL, V4, P532, DOI 10.1016/j.euo.2021.03.006; Touijer KA, 2018, EUR UROL, V73, P890, DOI 10.1016/j.eururo.2017.09.027; Vale CL, 2020, LANCET, V396, P1422, DOI 10.1016/S0140-6736(20)31952-8; Yokomizo A, 2020, EUR UROL, V77, P689, DOI 10.1016/j.eururo.2019.11.023; Zheng YX, 2020, PRECIS MED SCI, V9, P23, DOI 10.1002/prm2.12005	31	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2021	16	9							e0256778	10.1371/journal.pone.0256778	http://dx.doi.org/10.1371/journal.pone.0256778			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XM9EM	34506516	gold, Green Published			2022-12-26	WOS:000729120700088
J	O'Connor, RD; Barten, DG; Latten, GHP				O'Connor, Rory D.; Barten, Dennis G.; Latten, Gideon H. P.			Preparations of Dutch emergency departments for the COVID-19 pandemic: A questionnaire-based study	PLOS ONE			English	Article								Background The onset of the COVID-19 pandemic was characterized by rapid increases in Emergency department (ED) patient visits. EDs required an appropriate transformation. The main challenges were: adapting capacity to respond to surges in the number of patient visits, protection of high risk (frontline) staff and the segregation of suspect-COVID-19 patients. To date, only a few studies have assessed the nation-wide response of EDs to the COVID-19 pandemic. This study was designed to review the preparations of Dutch EDs during the initial phase of this public health crisis. Methods The study was designed as a nation-wide, cross-sectional, questionnaire-based study of Dutch hospital organizations having one or more EDs. One respondent completed the questionnaire for each hospital. The questionnaire was conducted between the first and the second COVID-19 wave in the Netherlands. It contained close-ended and open-ended questions on changes in ED infrastructure, ED workforce adaptions and the role of emergency physicians (EPs) in each hospital crisis management team. Results The questionnaire was completed by 58 respondents. This represented 80% of the total number of EDs. All respondents had made preparations in anticipation of a COVID-19 patient surge. Treatment capacity was expanded in 70% of EDs, with a median increase of 49% (IQR 33-73%). Suspect-COVID-19 was segregated from non-COVID-19 patients in 89% of EDs. Alternative locations (such as outpatient departments) were more often used to assess non-COVID-19 patients, than for suspect-COVID-19 patients. Staff was expanded in 82% of EDs. This largely concerned nursing staff. A formal role for Emergency Physicians (EPs) in the hospital's crisis management team was reported by 94% of hospital organizations employing EPs. Conclusion All Dutch EDs responded to the COVID-19 pandemic in a very short time span despite much uncertainty. Preparations predominantly concerned expansion of treatment capacity and segregation of COVID-19 ED care. EPs played a prominent role, both in direct COVID-19 care and in the hospital crises management team. It is vital for EDs to adapt to community needs swiftly. The ability of EDs to respond to the pandemic varied considerably.	[O'Connor, Rory D.] Jeroen Bosch Hosp, Dept Emergency Med, Shertogenbosch, Netherlands; [Barten, Dennis G.] VieCuri Med Ctr, Dept Emergency Med, Venlo, Netherlands; [Latten, Gideon H. P.] Zuyderland Med Ctr, Dept Emergency Med, Heerlen, Netherlands	Jeroen Bosch Ziekenhuis; VieCuri Medical Center	O'Connor, RD (corresponding author), Jeroen Bosch Hosp, Dept Emergency Med, Shertogenbosch, Netherlands.	r.o.connor@jbz.nl		Barten, Dennis/0000-0002-7185-9491	Dutch Society of Emergency Physicians	Dutch Society of Emergency Physicians	We would like to thank all participating EDs for their participation in this study. We also want to thank the Dutch Society of Emergency Physicians for its support in distributing the questionnaire.	Alderweireld Christian E A, 2020, Ned Tijdschr Geneeskd, V164; [Anonymous], COVID 19 DATASET; Asplin BR, 2003, ANN EMERG MED, V42, P173, DOI 10.1067/mem.2003.302; Barten DG, 2022, DISASTER MED PUBLIC, V16, P1190, DOI 10.1017/dmp.2020.430; Barten DG, 2022, DISASTER MED PUBLIC, V16, P36, DOI 10.1017/dmp.2020.303; Berkeveld E, 2022, DISASTER MED PUBLIC, V16, P1194, DOI 10.1017/dmp.2020.446; Casalino E, 2022, DISASTER MED PUBLIC, V16, P245, DOI 10.1017/dmp.2020.331; Faccincani R, 2018, PREHOSP DISASTER MED, V33, P459, DOI 10.1017/S1049023X18000742; Fistera D, 2020, INT J EMERG MED, V13, DOI 10.1186/s12245-020-00302-z; Gaakeer M I, 2016, Ned Tijdschr Geneeskd, V160, pD970; Gopinathan V, 2022, DISASTER MED PUBLIC, V16, P1910, DOI 10.1017/dmp.2021.73; Joshi AU, 2020, EMERG MED J, V37, P637, DOI 10.1136/emermed-2020-209846; Kommer G.J., LOCATIES ZIEKENHUIZE; Lewis C. Phuli, 1996, Emergency Medicine Clinics of North America, V14, P439, DOI 10.1016/S0733-8627(05)70261-3; Nadarajan GD, 2020, SCAND J TRAUMA RESUS, V28, DOI 10.1186/s13049-020-00809-7; Paganini M, 2020, DISASTER MED PUBLIC, V14, P541, DOI 10.1017/dmp.2020.57; Schmitz D, 2021, EUR J EMERG MED, V28, P202, DOI 10.1097/MEJ.0000000000000766; Schreyer KE, 2020, J EMERG MED, V59, P946, DOI 10.1016/j.jemermed.2020.07.022; Tan RMR, 2020, EMERG MED J, V37, P252, DOI 10.1136/emermed-2020-209634; von Elm E, 2008, J CLIN EPIDEMIOL, V61, P344, DOI 10.2471/BLT.07.045120; World Health Organization, WHO DIR GEN OP REM M, DOI DOI 10.1016/J.ENVPOL.2020.114280	21	5	5	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2021	16	9							e0256982	10.1371/journal.pone.0256982	http://dx.doi.org/10.1371/journal.pone.0256982			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XM9EM	34506521	Green Submitted, gold, Green Published			2022-12-26	WOS:000729120700007
J	Kim, SE; Zhang, J; Jiang, E; Overholtzer, M				Kim, Sung Eun; Zhang, Justin; Jiang, Enoch; Overholtzer, Michael			Amino acids and mechanistic target of rapamycin regulate the fate of live engulfed cells	FASEB JOURNAL			English	Article						amino acids; cell death; entosis; metabolism; mTOR	DEATH PROCESS; ENTOSIS; PATHWAY	Metabolic stress contributes to the regulation of cell death in normal and diseased tissues. While different forms of cell death are known to be regulated by metabolic stress, how the cell engulfment and killing mechanism entosis is regulated is not well understood. Here we find that the death of entotic cells is regulated by the presence of amino acids and activity of the mechanistic target of rapamycin (mTOR). Amino acid withdrawal or mTOR inhibition induces apoptosis of engulfed cells and blocks entotic cell death that is associated with the lipidation of the autophagy protein microtubule-associated protein light chain 3 (LC3) to entotic vacuoles. Two other live cell engulfment programs, homotypic cell cannibalism (HoCC) and anti-CD47 antibody-mediated phagocytosis, known as phagoptosis, also undergo a similar vacuole maturation sequence involving LC3 lipidation and lysosome fusion, but only HoCC involves mTOR-dependent regulation of vacuole maturation and engulfed cell death similar to entosis. We further find that the regulation of cell death by mTOR is independent of autophagy activation and instead involves the 4E-BP1/2 proteins that are known regulators of mRNA translation. Depletion of 4E-BP1/2 proteins can restore the mTOR-regulated changes of entotic death and apoptosis rates of engulfed cells. These results identify amino acid signaling and the mTOR-4E-BP1/2 pathway as an upstream regulation mechanism for the fate of live engulfed cells formed by entosis and HoCC.	[Kim, Sung Eun; Zhang, Justin; Jiang, Enoch; Overholtzer, Michael] Sloan Kettering Inst Canc Res, Cell Biol Program, New York, NY USA; [Kim, Sung Eun; Overholtzer, Michael] Weill Cornell Med Coll, BCMB Allied Program, New York, NY USA; [Overholtzer, Michael] Mem Sloan Kettering Canc Ctr, Louis V Gerstner Jr Grad Sch Biomed Sci, 411 East 67th St,Rm RRL 629, New York, NY 10065 USA; [Kim, Sung Eun] Korea Univ, Coll Hlth Sci, Dept Biosyst & Biomed Sci, Seoul 02841, South Korea; [Kim, Sung Eun] Korea Univ, Coll Hlth Sci, Dept Integrated Biomed & Life Sci, Seoul 02841, South Korea	Memorial Sloan Kettering Cancer Center; Cornell University; Memorial Sloan Kettering Cancer Center; Korea University; Korea University	Overholtzer, M (corresponding author), Mem Sloan Kettering Canc Ctr, Louis V Gerstner Jr Grad Sch Biomed Sci, 411 East 67th St,Rm RRL 629, New York, NY 10065 USA.; Kim, SE (corresponding author), Korea Univ, Coll Hlth Sci, Sch Biosyst & Biomed Sci, Hana Sci Bldg B,Rm 165,145 Anam Ro, Seoul 02841, South Korea.	sek19@korea.ac.kr; overhom1@mskcc.org		Kim, Sung Eun/0000-0002-4281-5625	National Research Foundation of Korea (NRF) [NRF-2020R1C1C1013220]; Korea University Grant [K1926621]; National Cancer Institute [RO1CA154649]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Korea University Grant; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	National Research Foundation of Korea (NRF), Grant/Award Number: NRF-2020R1C1C1013220; Korea University Grant, Grant/Award Number: K1926621; National Cancer Institute, Grant/Award Number: RO1CA154649	Benseler V, 2011, P NATL ACAD SCI USA, V108, P16735, DOI 10.1073/pnas.1112251108; Brown GC, 2012, TRENDS BIOCHEM SCI, V37, P325, DOI 10.1016/j.tibs.2012.05.002; Cano CE, 2012, EMBO MOL MED, V4, P964, DOI 10.1002/emmm.201201255; Chao MP, 2012, CURR OPIN IMMUNOL, V24, P225, DOI 10.1016/j.coi.2012.01.010; Debnath J, 2002, CELL, V111, P29, DOI 10.1016/S0092-8674(02)01001-2; Durgan J, 2017, ELIFE, V6, DOI 10.7554/eLife.27134; Florey O, 2012, TRENDS CELL BIOL, V22, P374, DOI 10.1016/j.tcb.2012.04.005; Florey O, 2011, NAT CELL BIOL, V13, P1335, DOI 10.1038/ncb2363; Galluzzi L, 2012, CELL DEATH DIFFER, V19, P107, DOI 10.1038/cdd.2011.96; Hamann JC, 2017, CELL REP, V20, P201, DOI 10.1016/j.celrep.2017.06.037; Lee Y, 2019, CELL REP, V26, P3212, DOI 10.1016/j.celrep.2019.02.073; Linkermann A, 2014, NEW ENGL J MED, V370, P455, DOI 10.1056/NEJMra1310050; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; Metayer LE, 2017, ONCOTARGET, V8, P60892, DOI 10.18632/oncotarget.18492; Overholtzer M, 2008, NAT REV MOL CELL BIO, V9, P796, DOI 10.1038/nrm2504; Overholtzer M, 2007, CELL, V131, P966, DOI 10.1016/j.cell.2007.10.040; Sanjuan MA, 2007, NATURE, V450, P1253, DOI 10.1038/nature06421; Tait SWG, 2014, J CELL SCI, V127, P2135, DOI 10.1242/jcs.093575; Wang S, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.352; Yuan JY, 2010, GENE DEV, V24, P2592, DOI 10.1101/gad.1984410	20	3	3	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2021	35	10							e21909	10.1096/fj.202100870R	http://dx.doi.org/10.1096/fj.202100870R			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	UZ5IH	34547144	hybrid, Green Published			2022-12-26	WOS:000702238200050
J	Liu, X; Shi, BS; Suo, R; Xiong, SL; Wang, XW; Liang, X; Li, XJ; Li, GP				Liu, Xing; Shi, Bingshuo; Suo, Rong; Xiong, Shenglin; Wang, Xuewen; Liang, Xue; Li, Xinjian; Li, Guangping			Itaconate regulates macrophage function through stressful iron-sulfur cluster disrupting and iron metabolism rebalancing	FASEB JOURNAL			English	Article						aconitase; IL-1 beta; IRG1; iron metabolism; iron-sulfur cluster; itaconate	NLRP3 INFLAMMASOME; SUCCINATE-DEHYDROGENASE; K+ EFFLUX; ACTIVATION; INHIBITION; GENE-1; POLARIZATION; ACONITASE; PROTEINS; PROGRAMS	Lipopolysaccharide (LPS)-stimulated macrophages express an aconitate decarboxylase (IRG1, also called ACOD1), leading to accumulation of the endogenous metabolite itaconate. However, the precise mechanisms by which elevated itaconate levels alter macrophage function are not clear. Our hypothesis is itaconate affects macrophage function through some uncertain mechanism. Based on this, we established a transcriptional and proteomic signature of macrophages stimulated by itaconate and identified the pathways of IL-1 beta secretion and altered iron metabolism. Consistently, the effect of IRG1 deficiency on IL-1 beta secretion and iron metabolism was confirmed in IRG1 knockout THP-1 cell lines. Several common inhibitors and other compounds were used to examine the molecular mechanisms involved. Only cysteine and antioxidants (catechin hydrate) could inhibit. caspase-1 activation and IL-1 beta secretion in itaconate-stimulated macrophages. We further found that aconitase activity was decreased by itaconate stimulation. Our results demonstrate the counteracting effects of overexpression of mitochondria] aconitase (ACO2, a tricarboxylic acid cycle enzyme) or cytosolic aconitase (ACO1, an iron regulatory protein) on IL-1 beta secretion and altered iron metabolism. Both enzyme activities were inhibited by itaconate because of iron-sulfur (Fe-S) cluster destruction. Our findings indicate that the immunoregulatory functions of IRG1 and itaconate in macrophages are stressful Fe-S cluster of aconitases disrupting and iron metabolism rebalancing.	[Liu, Xing; Shi, Bingshuo; Wang, Xuewen; Liang, Xue; Li, Xinjian; Li, Guangping] Tianjin Med Univ, Tianjin Inst Cardiol, Dept Cardiol, Hosp 2,Tianjin Key Lab Ion Mol Funct Cardiovasc D, 23 Pingjiang Rd, Tianjin 300211, Peoples R China; [Suo, Rong] Tianjin Hosp, Dept Cardiol, Tianjin, Peoples R China; [Xiong, Shenglin] You Country Peoples Hosp, Dept Cardiol, Zhuzhou, Peoples R China	Tianjin Medical University	Liu, X; Li, GP (corresponding author), Tianjin Med Univ, Tianjin Inst Cardiol, Dept Cardiol, Hosp 2,Tianjin Key Lab Ion Mol Funct Cardiovasc D, 23 Pingjiang Rd, Tianjin 300211, Peoples R China.	liuxing0626@163.com; tjcardiol@126.com			National Natural Science Foundation of China [81900314]; Science & Technology Development Fund of Tianjin Education Commission for Higher Education [2017KJ205]; Scientific Research Fund Project of Key Laboratory of Second Hospital of Tianjin Medical University [2019ZDSYS16, 2019ZDSYS11]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science & Technology Development Fund of Tianjin Education Commission for Higher Education; Scientific Research Fund Project of Key Laboratory of Second Hospital of Tianjin Medical University	National Natural Science Foundation of China, Grant/Award Number: 81900314; Science & Technology Development Fund of Tianjin Education Commission for Higher Education, Grant/Award Number: 2017KJ205; Scientific Research Fund Project of Key Laboratory of Second Hospital of Tianjin Medical University, Grant/Award Number: 2019ZDSYS16 and 2019ZDSYS11	An YA, 2019, FASEB J, V33, P12515, DOI 10.1096/fj.201802805RR; Andrews SC, 2003, FEMS MICROBIOL REV, V27, P215, DOI 10.1016/S0168-6445(03)00055-X; Basler T, 2006, J LEUKOCYTE BIOL, V79, P628, DOI 10.1189/jlb.0905520; Beloborodova N, 2019, METABOLITES, V9, DOI 10.3390/metabo9100196; Bronner DN, 2015, IMMUNITY, V43, P451, DOI 10.1016/j.immuni.2015.08.008; Chinetti-Gbaguidi G, 2015, NAT REV CARDIOL, V12, P10, DOI 10.1038/nrcardio.2014.173; Cho H, 2013, NAT MED, V19, P458, DOI 10.1038/nm.3108; Cordes T, 2016, J BIOL CHEM, V291, P14274, DOI 10.1074/jbc.M115.685792; Curi R, 2017, CLIN SCI, V131, P1329, DOI 10.1042/CS20170220; de Couto G, 2017, CIRCULATION, V136, P200, DOI 10.1161/CIRCULATIONAHA.116.024590; de Couto G, 2015, J CLIN INVEST, V125, P3147, DOI 10.1172/JCI81321; Ganta VC, 2017, CIRCULATION, V135, P2403, DOI 10.1161/CIRCULATIONAHA.116.025490; Ghosh MC, 2013, CELL METAB, V17, P271, DOI 10.1016/j.cmet.2012.12.016; Hansen JB, 2012, CELL METAB, V16, P449, DOI 10.1016/j.cmet.2012.09.001; Imlay JA, 2003, ANNU REV MICROBIOL, V57, P395, DOI 10.1146/annurev.micro.57.030502.090938; Karmakar M, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10555; Katsnelson MA, 2016, AM J PHYSIOL-CELL PH, V311, pC83, DOI 10.1152/ajpcell.00298.2015; Katsnelson MA, 2015, J IMMUNOL, V194, P3937, DOI 10.4049/jimmunol.1402658; Konert G, 2015, NEW PHYTOL, V205, P1250, DOI 10.1111/nph.13097; Lampropoulou V, 2016, CELL METAB, V24, P158, DOI 10.1016/j.cmet.2016.06.004; Latonen L, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03573-6; Lehmann JS, 2017, JOVE-J VIS EXP, DOI 10.3791/56440; Li JC, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-52013-y; Li YK, 2013, J BIOL CHEM, V288, P16225, DOI 10.1074/jbc.M113.454538; Lill R, 2008, ANNU REV BIOCHEM, V77, P669, DOI 10.1146/annurev.biochem.76.052705.162653; Lin SJ, 2015, J VIROL, V89, P1083, DOI 10.1128/JVI.02318-14; Liu X, 2017, INT IMMUNOPHARMACOL, V48, P76, DOI 10.1016/j.intimp.2017.04.012; Mariano LL, 2020, SCI ADV, V6, DOI 10.1126/sciadv.abc5739; Franco JLM, 2020, CELL REP, V33, DOI 10.1016/j.celrep.2020.108547; Matulova M, 2013, VET RES, V44, DOI 10.1186/1297-9716-44-37; Michelucci A, 2013, P NATL ACAD SCI USA, V110, P7820, DOI 10.1073/pnas.1218599110; Mills EL, 2018, NATURE, V556, P113, DOI 10.1038/nature25986; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Nakamura K, 2016, EXP HEMATOL, V44, P116, DOI 10.1016/j.exphem.2015.11.002; Nnah IC, 2020, J NEUROCHEM, V154, P177, DOI 10.1111/jnc.14906; PHILPOTT CC, 1994, P NATL ACAD SCI USA, V91, P7321, DOI 10.1073/pnas.91.15.7321; Piccolo V, 2017, NAT IMMUNOL, V18, P530, DOI 10.1038/ni.3710; Qin W, 2019, NAT CHEM BIOL, V15, P983, DOI 10.1038/s41589-019-0323-5; Sottile R, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00224; Taxman DJ, 2010, CELL HOST MICROBE, V8, P7, DOI 10.1016/j.chom.2010.06.005; Tong WH, 2007, BIOMETALS, V20, P549, DOI 10.1007/s10534-006-9047-6; Tucey TM, 2018, CELL METAB, V27, P988, DOI 10.1016/j.cmet.2018.03.019; Velayudhan J, 2014, INFECT IMMUN, V82, P1390, DOI 10.1128/IAI.01022-13; Wilkinson N, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00176; Williams NC, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00141; Wynosky-Dolfi MA, 2014, J EXP MED, V211, P653, DOI 10.1084/jem.20130627; Zou YL, 2020, NAT CHEM BIOL, V16, P302, DOI 10.1038/s41589-020-0472-6	47	2	2	5	12	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2021	35	10							e21936	10.1096/fj.202100726RR	http://dx.doi.org/10.1096/fj.202100726RR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	UZ5IH	34547129				2022-12-26	WOS:000702238200079
J	Asfaw, DM				Asfaw, Dagmawe Menelek			Analysis of technical efficiency of smallholder tomato producers in Asaita district, Afar National Regional State, Ethiopia	PLOS ONE			English	Article							IRRIGATION; POTATO	The tomato had nutritional, economic and health benefits to the societies, however, its production and productivity were low in developing countries and particularly in Ethiopia. This might be due to technical inefficiency caused by institutional, governmental, and farmers related factors. Therefore this study tried to investigate the factors that affecting technical efficiency and estimating the mean level of technical efficiency of tomato producers in Asaita district, Afar Regional State, Ethiopia. Both primary and secondary data sources were used; the primary data was collected from 267 tomato producers from the study area cross-sectional by using a multistage sampling technique. The single-stage stochastic frontier model and Cobb Douglas production function were applied and statistical significance was declared at 0.05. The maximum likelihood estimates of the stochastic frontier model showed that land, labor, tomato seed, and oxen have a significant effect on tomato output; and education, extension contact, training, and access to credit have a positive and significant effect on technical efficiency, whereas household size, off-farm income, livestock ownership, distance to market, and pesticides have a worthy and significant effect on technical efficiency; and also estimated mean technical efficiency of tomato producer in a study area was 80.9%. In a line with this, the responsible body should prioritize rural infrastructure development in areas such as education, marketplace, and farmer training centers; demonstrate access to credit and extension services; use the recommended amount of pesticides per hectare, and give more intension to mixed farming rather than animal husbandry exclusively.	[Asfaw, Dagmawe Menelek] Samara Univ, Coll Business & Econ, Dept Econ, Samara, Ethiopia	Samara University	Asfaw, DM (corresponding author), Samara Univ, Coll Business & Econ, Dept Econ, Samara, Ethiopia.	dagmawemenelek@gmail.com		Menelek, Dagmawe/0000-0003-2237-1112				Abate T.M., 2019, J EC STRUCTURES, V8, P1, DOI [10.1186/s40008-019-0167-x, DOI 10.1186/S40008-019-0167-X]; Abebe D., 2018, THESIS U GONDAR; Abera G, 2020, HELIYON, V6, DOI 10.1016/j.heliyon.2020.e03749; Aigner D., 1977, J ECONOMETRICS, V6, P21, DOI DOI 10.1016/0304-4076(77)90052-5; Ali S, 2017, FOODS, V6, DOI 10.3390/foods6060039; Ambecha OG., 2012, RESILIENCE AGR SYSTE, V12, P19; Asaita District Agricultural Office, 2017, AS AF; Asgedom S, 2011, AFR J AGR RES, V6, P956; Battese G. E., 1995, EMPIR ECON, V20, P325, DOI DOI 10.1007/BF01205442; Battese G.E., 1995, EMPIR ECON, V20, P325, DOI [10.1007/BF01205442, DOI 10.1007/BF01205442]; Bedassa C.B., 2020, ADV BIOSCIENCE BIOEN, V8, P1; Beyan Ahmed J.H., 2013, J AGR ENV SCI, V13, P1615; Binalfew T., 2016, INT J RES AGR FOREST, V25; Birhanu K., 2010, African Journal of Food, Agriculture, Nutrition and Development, V10, P2139; Bisrat G.H., 2012, ACCESS IRRIGATION TE; Bogale T, 2005, J AGR RURAL DEV TROP, V106, P59; Brasesco F., 2019, STRATEGIC ANAL INTER; Chefebo D.E., 2020, ANAL TECHNICAL EFFIC; CSA, 2012, POPULATION HOUSING C; CSA, 2020, CENTR STAT AUTH ETH, P1; Dassa A.R., 2019, AM INT J AGR STUDIES, V2, P39; Degefa K., 2020, J AGRI SCI FOOD RES, V11, P273, DOI [10.35248/2593-9173.20.11.273, DOI 10.35248/2593-9173.20.11.273]; Desalegn Regassa, 2016, Journal of Plant Breeding and Crop Science, V8, P206; Emana B., 2011, POTATO VALUE CHAIN A; Ethiopian Ministry of Agriculture and Rural Development (MoARD), 2016, PEST MANAGEMENT SUPP, P1; Ethiopian Ministry of Agriculture (MoA), 2010, CROP VAR REG ISS; FAO, 2018, STAT DAT FOOD AGR OR; Gebrehaweria Gebregziabher, 2012, Quarterly Journal of International Agriculture, V51, P203; Gebresilassie W.L., 2018, INT J VEGETABLE SCI, V24, P456; Gemechis A.O., 2012, TROPENTAG 2012 INT R, V373; Gemechu G.E., 2019, EVALUATION-US, V89; Getu K., 2018, PROGRAMME AGRIBUSINE; Gujarati D.N., 2006, BASIC ECONOMETRICS, V4th edition ed, DOI [10.1300/J500v04n01%5F07, DOI 10.1300/J500V04N01%5F07]; Hailemaraim L., 2015, TECHNICAL EFFICIENCY; Hailsellasie A., 2005, THESIS ALEMAYA U ETH; Hailu Gebremichael D., 2016, THESIS HAWASSA U HAW; Haji J, 2008, EC EFFICIENCY MARKET; Hazarika C., 1999, Indian Journal of Agricultural Economics, V54, P201; Jote A, 2018, EXP AGR, V54, P491, DOI 10.1017/S0014479717000199; Kanna P.C.R.a.N., 2016, INT J EC BUSINESS MA, V2, P90; Kassa Melese A., 2015, AFR J BASIC APPL SCI, V7, P328; Khan H., 2011, INT C MAN EC SOC SCI, P459; Khan R. E. A., 2013, World Applied Sciences Journal, V28, P1389; Kitila G.M., 2014, SCI TECHNOLOGY ARTS, V3, P204, DOI DOI 10.4314/STAR.V3I3.33; Kothari C.R., 2014, REMETHODOLOGY METH; Lagiso D., 2020, IND ENG LETT RED, V10; Lemma D., 2002, RES REPORTS, P43; Makombe G, 2017, WATER SA, V43, P48, DOI 10.4314/wsa.v43i1.08; MEEUSEN W, 1977, INT ECON REV, V18, P435, DOI 10.2307/2525757; Mekonnen E., 2015, CURR RES AGRIC SCI, V2, P8; Mersha A., 2008, LYCOPERSICON ESCULEN, P10; Moges Dessale, 2019, Agriculture and Food Security, V8, DOI 10.1186/s40066-018-0250-9; Mohammed Kasso, 2018, Journal of the Saudi Society of Agricultural Sciences, V17, P88, DOI 10.1016/j.jssas.2016.01.005; Murthy D. S., 2009, Agricultural Economics Research Review, V22, P215; Ng'ombe J., 2015, Sustainable Agriculture Research, V4, P31; Nyagaka D.O., 2009, ANAL PRODUCTION EFFI; ONeill S., 1999, TRINITY COLL DUBLIN, V9912; Quintin G., 2013, TOM PROD ETH CHALL P; Robinson W., 2006, CROP FOOD SUPPLY ASS; State A.N.R., 2010, PROGRAM PLAN ADAPTAT; Tabe-Ojong M. P. Jr., 2017, Journal of Management and Sustainability, V7, P27, DOI 10.5539/jms.v7n4p27; Wassihun A.N., 2019, J EC STRUCT, V8, P1, DOI 10.1186/s40008-019-0166; Willy C., 2015, TECHNICAL EFFICIENCY; Wudineh Getahun Tiruneh, 2016, Journal of Development and Agricultural Economics, V8, P39, DOI 10.5897/JDAE2015.0660; Yenihebit N., 2020, Journal of Development and Agricultural Economics, V12, P1, DOI 10.5897/JDAE2019.1090; Yeshiwas Y., 2016, WORLD J AGR SCI, V12, P404, DOI DOI 10.5829/IDOSI.WJAS.2016.404.408	66	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2021	16	9							e0257366	10.1371/journal.pone.0257366	http://dx.doi.org/10.1371/journal.pone.0257366			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XH8RH	34555066	Green Published, gold			2022-12-26	WOS:000725694500031
J	Rani, P; Saini, I; Singh, N; Kaushik, P; Wijaya, L; Al-Barty, A; Darwish, H; Noureldeen, A				Rani, Preeti; Saini, Ishan; Singh, Narender; Kaushik, Prashant; Wijaya, Leonard; Al-Barty, Amal; Darwish, Hadeer; Noureldeen, Ahmed			Effect of potassium fertilizer on the growth, physiological parameters, and water status of Brassica juncea cultivars under different irrigation regimes	PLOS ONE			English	Article							STRESS; DROUGHT; COTTON; L.; PHOTOSYNTHESIS; ANTIOXIDANTS; TOLERANCE; RESPONSES; INSIGHTS; DEFENSE	Abiotic stress, especially a lack of water, can significantly reduce crop yields. In this study, we evaluated the physiological and biochemical effects of potassium sulfate (K2SO4) fertilizer and varied irrigation regimes on the economically significant oilseed crop, Brassica juncea L, under open field conditions. Two cultivars (RH-725 and RH-749) of B. juncea were used in a randomized complete block design experiment with three replicates. Irrigation regimes consisted of a control (double irrigation: once at the 50% flowering and another at 50% fruiting stages), early irrigation (at 50% flowering only), late irrigation (at 50% fruiting only) and stress (no irrigation). The K2SO4 applications were: control (K-0, no fertilization); K-1, 10 kg ha(-1); and K-2, 20 kg ha(-1). We measured growth via fresh and dry plant weight, plant height, root length, and leaf area. All the growth parameters were higher in RH-749. The physiological attributes, including the membrane stability index and relative water content, were higher at the 50% flowering stage in RH-749. The amount of antioxidant enzymes (catalase (CAT), guaiacol peroxidase (POX), ascorbate peroxidase (APX), and superoxide dismutase (SOD)) was enhanced when both plants were fertilized during water stress. All of these enzymes had higher activity in RH-749. The total chlorophyll content and photosynthesis rate were considerably higher in RH-749, which leaked fewer electrolytes and maintained a less destructive osmotic potential under limited water conditions. The results indicated that it is water-stress tolerant when given a high concentration of K2SO4, which alleviated the adverse effects of water stress on growth and physiology.	[Rani, Preeti; Saini, Ishan; Singh, Narender] Kurukshetra Univ, Dept Bot, Kurukshetra, Haryana, India; [Kaushik, Prashant] Univ Politecn Valencia, Inst Conservac & Mejora Agrodiversidad Valenciana, Valencia, Spain; [Wijaya, Leonard] Inst Teknol Sumatera, Dept Biol, Jalan Terusan Ryacudu, Jati Agung, South Lampung, Indonesia; [Al-Barty, Amal; Noureldeen, Ahmed] Taif Univ, Coll Sci, Dept Biol, At Taif, Saudi Arabia; [Darwish, Hadeer] Taif Univ, Dept Biotechnol, Coll Sci, At Taif, Saudi Arabia	Kurukshetra University; Universitat Politecnica de Valencia; Taif University; Taif University	Kaushik, P (corresponding author), Univ Politecn Valencia, Inst Conservac & Mejora Agrodiversidad Valenciana, Valencia, Spain.; Wijaya, L (corresponding author), Inst Teknol Sumatera, Dept Biol, Jalan Terusan Ryacudu, Jati Agung, South Lampung, Indonesia.	prashantumri@gmail.com; lwijaya@ksu.edu.sa	Noureldeen, Ahmed/GRS-9678-2022	Wijaya, Leonard/0000-0003-0504-5040	King Saud University, Riyadh, Saudi Arabia [RSP-2020/180]; Institut Teknologi Sumatera under Research Grant for Hibah Mandiri ITERA 2021; Deanship of Scientific Research at Taif University through Taif University Researchers Supporting Project, Taif University, Taif, Saudi Arabia [TURSP-2020/203]; Institut Teknologi Sumatera under Research Grant for Hibah Publikasi [GBU-45]	King Saud University, Riyadh, Saudi Arabia(King Saud University); Institut Teknologi Sumatera under Research Grant for Hibah Mandiri ITERA 2021; Deanship of Scientific Research at Taif University through Taif University Researchers Supporting Project, Taif University, Taif, Saudi Arabia; Institut Teknologi Sumatera under Research Grant for Hibah Publikasi	The authors would like to extend their sincere appreciation to the Researchers Supporting Project Number (RSP-2020/180), King Saud University, Riyadh, Saudi Arabia. The Research in LW lab is supported by Institut Teknologi Sumatera under Research Grant for Hibah Mandiri ITERA 2021.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank the Deanship of Scientific Research at Taif University for supporting this work through Taif University Researchers Supporting Project Number (TURSP-2020/203), Taif University, Taif, Saudi Arabia. The research in LW lab is supported by Institut Teknologi Sumatera under Research Grant for Hibah Publikasi GBU-45.	Aebi H., 1983, METHOD ENZYMOL, P273; Ahanger MA, 2017, PROTOPLASMA, V254, P1471, DOI 10.1007/s00709-016-1037-0; Ahanger MA, 2015, J PLANT INTERACT, V10, P211, DOI 10.1080/17429145.2015.1056260; Ahmad P, 2010, CRIT REV BIOTECHNOL, V30, P161, DOI 10.3109/07388550903524243; Akram NA, 2018, PROTOPLASMA, V255, P163, DOI 10.1007/s00709-017-1140-x; Al Mahmud J, 2018, ECOTOX ENVIRON SAFE, V147, P990, DOI 10.1016/j.ecoenv.2017.09.045; Ali Q, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-49481-7; Ali S, 2018, ENVIRON EXP BOT, V156, P183, DOI 10.1016/j.envexpbot.2018.07.004; Alinejad S, 2020, IND CROP PROD, V143, DOI 10.1016/j.indcrop.2019.111916; Bai LQ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156188; Bandyopadhyay K.K., 2012, PRACTICAL MANUAL MEA, P62; Begum N, 2019, PLANTS-BASEL, V8, DOI 10.3390/plants8120579; Benito B, 2014, J PLANT PHYSIOL, V171, P723, DOI 10.1016/j.jplph.2013.10.014; Chen GD, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.01679; Coskun D, 2017, PLANT CELL ENVIRON, V40, P2029, DOI 10.1111/pce.12671; Daniel E., 2016, POTASSIUM CROP PRODU; Dionisio-Sese ML, 1998, PLANT SCI, V135, P1, DOI 10.1016/S0168-9452(98)00025-9; El-Mogy M. M., 2019, Agriculture (Pol'nohospodarstvo), V65, P59, DOI 10.2478/agri-2019-0007; Elumalai RP, 2002, PLANT CELL, V14, P119, DOI 10.1105/tpc.010322; Farooq A, 2020, PLANTS-BASEL, V9, DOI 10.3390/plants9010104; Gurajala HK, 2019, ENVIRON POLLUT, V254, DOI 10.1016/j.envpol.2019.113085; Hafeez A, 2018, IND CROP PROD, V124, P369, DOI 10.1016/j.indcrop.2018.08.006; HALLIWELL B, 1978, PLANTA, V139, P9, DOI 10.1007/BF00390803; Hasanuzzaman M, 2018, AGRONOMY-BASEL, V8, DOI 10.3390/agronomy8030031; Hu W, 2016, FIELD CROP RES, V196, P51, DOI 10.1016/j.fcr.2016.06.005; Jaiswal D.K., 2016, POTASSIUM SOLUBILIZI, P21, DOI [10.1007/978-81-322-2776-2_2, DOI 10.1007/978-81-322-2776-2_2]; Jan S, 2019, PROTOPLASMA, V256, P313, DOI 10.1007/s00709-018-1310-5; Jha Y., 2017, BRAZ J BIOL SCI, V4, P333, DOI [10.21472/bjbs.040812, DOI 10.21472/BJBS.040812]; Jovanovic V.S., 2018, ANTIOXIDANTS ANTIOXI, P269, DOI [10.1007/978-3-319-75088-0, DOI 10.1007/978-3-319-75088-0, DOI 10.1007/978-3-319-75088-0_13]; Kaya C, 2019, PLANT PHYSIOL BIOCH, V143, P119, DOI 10.1016/j.plaphy.2019.08.024; Kohli SK, 2019, ANTIOXIDANTS-BASEL, V8, DOI 10.3390/antiox8120641; Kosar F, 2021, PHYSIOL PLANTARUM, V172, P317, DOI 10.1111/ppl.13155; Kruashvili I., 2016, ANN AGRARIAN SCI, V14, P217, DOI DOI 10.1016/J.AASCI.2016.08.006; Maathuis FJM, 1996, PHYSIOL PLANTARUM, V96, P158, DOI 10.1111/j.1399-3054.1996.tb00197.x; Martineau E, 2017, ENVIRON EXP BOT, V134, P62, DOI 10.1016/j.envexpbot.2016.11.004; Munene R., 2017, Tropical Plant Research, V4, P81, DOI 10.22271/tpr.2017.v4.i1.012; NAKANO Y, 1981, PLANT CELL PHYSIOL, V22, P867; NISHIKIMI M, 1972, BIOCHEM BIOPH RES CO, V46, P849, DOI 10.1016/S0006-291X(72)80218-3; Oosterhuis DM, 2014, ADV AGRON, V126, P203, DOI 10.1016/B978-0-12-800132-5.00003-1; Pilbeam DJ., 2016, HDB PLANT NUTR, P107; Raja V, 2020, 3 BIOTECH, V10, DOI 10.1007/s13205-020-02206-4; Ray K, 2015, PLANT SOIL ENVIRON, V61, P6, DOI 10.17221/860/2014-PSE; Rouphael Y, 2020, FRONT PLANT SCI, V11, DOI 10.3389/fpls.2020.00040; Saini I, 2020, INDIAN J EXP BIOL, V58, P730; Saini I, 2019, AGRICULTURE-BASEL, V9, DOI 10.3390/agriculture9030051; Schwalm CR, 2017, NATURE, V548, P202, DOI 10.1038/nature23021; Sindhi V, 2017, REACTIVE OXYGEN SPEC, P1, DOI DOI 10.1007/978-981-10-5254-5_1; Singh I, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01943; Wanasundara JPD, 2017, SUSTAINABLE PROTEIN SOURCES, P285, DOI 10.1016/B978-0-12-802778-3.00018-4; Wang F, 2020, FRONT PLANT SCI, V10, DOI 10.3389/fpls.2019.01738; Wang M, 2013, INT J MOL SCI, V14, P7370, DOI 10.3390/ijms14047370; Wang R, 2016, PLANT PHYSIOL BIOCH, V107, P137, DOI 10.1016/j.plaphy.2016.05.035; [王英珍 Wang Yingzhen], 2017, [南京农业大学学报, Journal of Nanjing Agricultural University], V40, P60; Wilson RA, 2014, J ENVIRON BIOL, V35, P383; Xu XX, 2020, FRONT PLANT SCI, V11, DOI 10.3389/fpls.2020.00904; Zahoor R, 2017, ENVIRON EXP BOT, V137, P73, DOI 10.1016/j.envexpbot.2017.02.002; Zain NAM, 2016, AGR WATER MANAGE, V164, P83, DOI 10.1016/j.agwat.2015.09.022; Zhou S, 2015, J PLANT PHYSIOL, V183, P64, DOI 10.1016/j.jplph.2015.05.012	58	3	3	4	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2021	16	9							e0257023	10.1371/journal.pone.0257023	http://dx.doi.org/10.1371/journal.pone.0257023			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XH8RH	34555032	gold, Green Published			2022-12-26	WOS:000725694500016
J	Chen, XY; Xu, RS; He, D; Zhang, Y; Chen, HT; Zhu, YX; Cheng, YX; Liu, R; Zhu, RR; Gong, L; Xiao, MQ; Wang, ZW; Deng, LP; Cao, K				Chen, Xingyu; Xu, Runshi; He, Dong; Zhang, Yao; Chen, Haotian; Zhu, Yuxing; Cheng, YaXin; Liu, Rui; Zhu, Rongrong; Gong, Lian; Xiao, Mengqing; Wang, Zhanwang; Deng, Liping; Cao, Ke			CD8(+) T effector and immune checkpoint signatures predict prognosis and responsiveness to immunotherapy in bladder cancer	ONCOGENE			English	Article							MORTALITY; CXCL13	Immune-checkpoint blockade (ICB) has been routinely implemented to treat bladder cancer; however, most patients have little or no clinical benefit. In this study, 348 pretreated metastatic urothelial cancer samples from the IMvigor210 cohort were used to identify important genes significantly associated with CD8+ T effector and immune checkpoint signatures. The immune checkpoint inhibitor score (IMS) scoring system was constructed to predict the immunotherapy responsiveness. Transcriptome analysis confirmed that the high IMS score group had significant immune activation with better prognosis and higher immunotherapy responsiveness, which was a powerful biomarker for predicting the prognosis and responsiveness of ICB. Tumor immune dysfunction and exclusion (TIDE) scores were calculated using 2031 external bladder cancer samples for further validation. We selected the important Hub genes as potential therapeutic targets, and validated the genes using genomic, transcriptomic, immunomic, and other multi-omics methods. In addition, we construct a risk prediction model which could stratify patients with bladder cancer and predict patient prognosis and ICB treatment responsiveness. In conclusion, this study identified effective biomarkers for the prediction of immune checkpoint inhibitor treatment responsiveness in bladder cancer patients and provided new immunotherapeutic targets.	[Chen, Xingyu; Zhang, Yao; Chen, Haotian; Zhu, Yuxing; Cheng, YaXin; Liu, Rui; Zhu, Rongrong; Gong, Lian; Xiao, Mengqing; Wang, Zhanwang; Deng, Liping; Cao, Ke] Cent South Univ, Xiangya Hosp 3, Dept Oncol, 283 Tongzipo Rd, Changsha 410013, Peoples R China; [Xu, Runshi] Hunan Univ Chinese Med, Med Sch, 300 Xueshi Rd,Hanpu Kejiao Pk, Changsha 410208, Peoples R China; [He, Dong] Hunan Univ Chinese Med, Peoples Hosp Hunan Prov 2, Dept Resp, Changsha 410000, Peoples R China	Central South University; Hunan University of Chinese Medicine; Hunan University of Chinese Medicine	Cao, K (corresponding author), Cent South Univ, Xiangya Hosp 3, Dept Oncol, 283 Tongzipo Rd, Changsha 410013, Peoples R China.	csucaoke@163.com	Xu, Runshi/AEI-9782-2022		National Natural Science Foundation of China [81874137]; science and technology innovation Program of Hunan Province [2020RC4011]; Outstanding Youth Foundation of Hunan Province [2018JJ1047]; Hunan Province Science and Technology Talent Promotion Project [2019TJ-Q10]; Young Scholars of "Furong Scholar Program" in Hunan Province [206030106]; Wisdom Accumulation and Talent Cultivation Project of the Third Xiangya Hospital of Central South University [BJ202001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); science and technology innovation Program of Hunan Province; Outstanding Youth Foundation of Hunan Province; Hunan Province Science and Technology Talent Promotion Project; Young Scholars of "Furong Scholar Program" in Hunan Province; Wisdom Accumulation and Talent Cultivation Project of the Third Xiangya Hospital of Central South University	We would like to thank the TCGA, GEO, and TIMER databases for the availability of the data. We would like to thank TissueGnostics Aisa Pacific limited for their technical support, And the help of hongzhe Sun and Xiaojing Liu, the technical engineer. This work was supported by the National Natural Science Foundation of China (81874137), the science and technology innovation Program of Hunan Province (2020RC4011), the Outstanding Youth Foundation of Hunan Province (2018JJ1047), the Hunan Province Science and Technology Talent Promotion Project (2019TJ-Q10), Young Scholars of "Furong Scholar Program" in Hunan Province(206030106), and the Wisdom Accumulation and Talent Cultivation Project of the Third Xiangya Hospital of Central South University (BJ202001).	Ai LY, 2020, ADV EXP MED BIOL, V1248, P33, DOI 10.1007/978-981-15-3266-5_3; Ammirante M, 2014, P NATL ACAD SCI USA, V111, P14776, DOI 10.1073/pnas.1416498111; Ansell SM, 2015, NEW ENGL J MED, V372, P311, DOI 10.1056/NEJMoa1411087; Antoni S, 2017, EUR UROL, V71, P96, DOI 10.1016/j.eururo.2016.06.010; Biswas S, 2014, BREAST CANCER RES TR, V143, P265, DOI 10.1007/s10549-013-2811-8; Brahmer JR, 2012, NEW ENGL J MED, V366, P2455, DOI 10.1056/NEJMoa1200694; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Chen LP, 2015, J CLIN INVEST, V125, P3384, DOI 10.1172/JCI80011; Chen XY, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.672158; Choucair K, 2020, CANCER GENE THER, V27, P841, DOI 10.1038/s41417-020-0174-y; Darvin P, 2018, EXP MOL MED, V50, DOI 10.1038/s12276-018-0191-1; Das M, 2017, IMMUNOL REV, V276, P97, DOI 10.1111/imr.12520; Diskin B, 2020, NAT IMMUNOL, V21, P442, DOI 10.1038/s41590-020-0620-x; Garon EB, 2015, NEW ENGL J MED, V372, P2018, DOI 10.1056/NEJMoa1501824; Groeneveld CS, 2021, EUR J CANCER, V148, P181, DOI 10.1016/j.ejca.2021.01.036; Hasan S, 2020, ANN SURG, V271, P716, DOI 10.1097/SLA.0000000000003051; Hu J, 2021, THERANOSTICS, V11, P3089, DOI 10.7150/thno.53649; Jiang P, 2018, NAT MED, V24, P1550, DOI 10.1038/s41591-018-0136-1; Jimenez-Sanchez A, 2020, NAT GENET, V52, P582, DOI 10.1038/s41588-020-0630-5; Joseph A, 2020, ANN INTENSIVE CARE, V10, DOI 10.1186/s13613-020-00761-w; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Lees JR, 2020, CELL IMMUNOL, V357, DOI 10.1016/j.cellimm.2020.104212; Lino AC, 2018, IMMUNITY, V49, P120, DOI 10.1016/j.immuni.2018.06.007; Marin-Acevedo JA, 2019, MAYO CLIN PROC, V94, P1321, DOI 10.1016/j.mayocp.2019.03.012; Middha S, 2019, JCO PRECIS ONCOL, V3, DOI 10.1200/PO.18.00321; Powles T, 2014, NATURE, V515, P558, DOI 10.1038/nature13904; Prokunina L, 2002, NAT GENET, V32, P666, DOI 10.1038/ng1020; Robert C, 2019, LANCET ONCOL, V20, P1239, DOI 10.1016/S1470-2045(19)30388-2; Roh W, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aah3560; Saginala Kalyan, 2020, Med Sci (Basel), V8, DOI 10.3390/medsci8010015; Sell V, 2020, WORLD J UROL, V38, P1001, DOI 10.1007/s00345-019-02841-4; Spangler JB, 2015, ANNU REV IMMUNOL, V33, P139, DOI 10.1146/annurev-immunol-032713-120211; Sunshine J, 2015, CURR OPIN PHARMACOL, V23, P32, DOI 10.1016/j.coph.2015.05.011	33	17	17	10	29	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 28	2021	40	43					6223	6234		10.1038/s41388-021-02019-6	http://dx.doi.org/10.1038/s41388-021-02019-6		SEP 2021	12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	WO5HW	34552192				2022-12-26	WOS:000698327300001
J	John, L; Odero, N; Nziku, J; Njau, B				John, Lugata; Odero, Nesister; Nziku, Jackson; Njau, Bernard			Gap analysis between expectations and perceptions of pregnant women attending Prevention of Maternal to Child Transmission of HIV services in a private referral hospital in northern Tanzania: A cross-sectional descriptive study	PLOS ONE			English	Article							QUALITY; CARE; KAZAKSTAN	Objective Pregnant women satisfaction with the Prevention of Mother-To-Child HIV Transmission services is an essential parameter in the determination of the quality of care and performance. This study aimed to measure the gap between pregnant women expectations of PMTCT services and perceptions of the actual PMTCT services and the relationship between their service gap scores and socio-demographic characteristics. Methods A cross-sectional descriptive study design was conducted from August to September 2020 on a sample of 105 participants. A pre-tested SERVIQUAL questionnaire was used to collect data and paired sample t-test, independent one-sample t-test, and one-way ANOVA was used to compare mean service gap scores. A p-value of < 0.05 was considered statistically significant. Results The overall mean gap score was (+ 0.31) indicating pregnant women perceived value of the quality of care of PMTCT services. The gap score in the 5 service dimensions was as follows: empathy (+0.49), tangibles (+0.43), assurance (+0.22), responsiveness (+0.20), and reliability (+0.19). Marital status (p-value 0.031) was the only social demographic characteristic associated with pregnant women service gap scores. Conclusion Overall, pregnant women perceptions of PMTCT services provided in the RCH clinic at KCMC were meet. Marital status was associated with the overall pregnant women service gap scores and perceived quality of care with PMTCT services. Pregnant women who were married had small service gap scores compared to either divorced or widowed or cohabiting women.	[John, Lugata; Odero, Nesister; Nziku, Jackson] Kilimanjaro Christian Med Univ Collage, Moshi, Tanzania; [Njau, Bernard] Kilimanjaro Christian Med Ctr, Moshi, Tanzania	Kilimanjaro Christian Medical Centre	Njau, B (corresponding author), Kilimanjaro Christian Med Ctr, Moshi, Tanzania.	biesein2007@gmail.com	Njau, Bernard/AAI-5432-2021	Njau, Bernard/0000-0002-7143-8400				Abodunrin OL, 2014, SKY J MED MED SCI, V2, P45; Al-Momani MM, 2016, MED PRIN PRACT, V25, P79, DOI 10.1159/000441000; Alizadeh S, 2016, INT J QUAL RELIAB MA, V33, P298, DOI 10.1108/IJQRM-05-2014-0062; Asefa A, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-57; Cochran W.G., 1977, SAMPLING TECHNIQUE, V3rd ed.; Craig BJ, 2015, HEALTH CARE WOMEN IN, V36, P41, DOI 10.1080/07399332.2014.942904; Cronbach LJ, 1951, PSYCHOMETRIKA, V16, P297; Das Palas, 2010, Indian J Community Med, V35, P478, DOI 10.4103/0970-0218.74344; Dauletyarova M, 2016, IRAN J PUBLIC HEALTH, V45, P729; Dauletyarova MA, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15020325; Essiam J.O, 2013, EUR J BUS MANAGE, V5; Galle A, 2015, BMC WOMENS HEALTH, V15, DOI 10.1186/s12905-015-0266-2; Ghosh S., 2014, INT J HEALTHCARE SCI, V2, P107; Golipour R, 2019, J CLIN DIAGN RES; Ibraheem W.A., 2013, AFRICAN J HLTH SCI, V12, P87; Kamanda Simon, 2020, East Afr Health Res J, V4, P51, DOI 10.24248/eahrj.v4i1.621; KCMC, 2017, ANN REP 2017; Kinfe A, 2020, HIVAIDS RES PALLIATI, V12, P611; Lyatuu M B, 2008, East Afr J Public Health, V5, P174; Megbelayin E.O., 2014, INT ARCH INTEG MED, V1, P1; Naburi H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165121; Nwaeze I L, 2013, Ann Ib Postgrad Med, V11, P22; Odetola TD, 2015, PAN AFR MED J, V20, DOI 10.11604/pamj.2015.20.151.5845; Olomi G., 2017, J PATIENT CARE, V03; PARASURAMAN A, 1985, J MARKETING, V49, P41, DOI 10.2307/1251430; Rahman MM, 2016, SPRINGERPLUS, V5, DOI 10.1186/s40064-016-2447-3; Rehaman B., 2018, J HOSP MEDICAL MANAG, V4, P1; Rezaei Satar, 2018, Med J Islam Repub Iran, V32, P59, DOI 10.14196/mjiri.32.59; Srivastava A, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0525-0; Umeano-Enemuoh J., 2014, INT RES J BASIC CLIN, V2, P14; Umoke M, 2020, SAGE OPEN MED, V8, DOI 10.1177/2050312120945129; UNAIDS, 2020, GLOB AIDS UPD SEIZ M; United Republic of Tanzania N.B.S., 2012, TANZ POP HOUS CENS 2; Zarei E., 2015, GLOBAL J HLTH SCI, V7, P1	34	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2021	16	9							e0257771	10.1371/journal.pone.0257771	http://dx.doi.org/10.1371/journal.pone.0257771			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YS4WS	34551008	gold, Green Published			2022-12-26	WOS:000750679800052
J	Altawalbeh, SM; Hijazi, B; Kufoof, L; Basheti, IA				Altawalbeh, Shoroq M.; Hijazi, Bushra; Kufoof, Lara; Basheti, Iman A.			Health expenditures of asthma-COPD overlap in Northern Jordan	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; ECONOMIC BURDEN; INCREASED RISK; COSTS; INHALER	Objective To investigate the characteristics and medical expenditures of patients with Asthma- chronic obstructive pulmonary disease (COPD) overlap (ACO) compared to asthma and COPD patients. Methods This was a retrospective cohort study involving patients diagnosed with ACO, asthma or COPD as of January 2016. Medical records for patients attending King Abdullah University Hospital (KAUH), in northern Jordan, during the years 2015-2016 were used to identify eligible patients and all relevant clinical characteristics. Both respiratory and all-cause charges were extracted from KAUH billing system during the year 2016. Total, inpatient, outpatient, and pharmacy charges were described and compared across the three disease categories. Charges were measured in Jordanian Dinar (JOD, equal to 1.41 US Dollar). Results Of a total of 761, 87 ACO patients, 494 asthmatic patients and 180 COPD patients were identified and included in this study. The average total respiratory-related charges were significantly higher in patients with ACO compared to patients with asthma (601.4 versus 354.3 JODs; P value < 0.001). Average all-cause charges were higher in case of ACO and COPD compared to patients with asthma (1830.8 and 1705.4 versus 1251.7 JODs; P value < 0.001). ACO was a significant predictor of higher respiratory and all-cause related charges. Respiratory charges were also higher in older patients and those with higher disease severity. Conclusions ACO is a risk factor for incurring higher health expenditures in Jordan. Higher respiratory expenditures are also associated with older ages and higher disease severity.	[Altawalbeh, Shoroq M.; Hijazi, Bushra] Jordan Univ Sci & Technol, Sch Pharm, Dept Clin Pharm, Irbid, Jordan; [Kufoof, Lara] Plan Int Org, Amman, Jordan; [Basheti, Iman A.] Appl Sci Private Univ, Fac Pharm, Dept Clin Pharm & Therapeut, Amman, Jordan	Jordan University of Science & Technology	Altawalbeh, SM (corresponding author), Jordan Univ Sci & Technol, Sch Pharm, Dept Clin Pharm, Irbid, Jordan.	smaltawalbeh@just.edu.jo	Basheti, Iman/Q-8917-2017	Basheti, Iman/0000-0002-8460-1158	Deanship of Scientific Research at Jordan University of Science and Technology [265/2016]	Deanship of Scientific Research at Jordan University of Science and Technology	This study is supported by the Deanship of Scientific Research at Jordan University of Science and Technology, grant number 265/2016. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen SC, 2003, AGE AGEING, V32, P299, DOI 10.1093/ageing/32.3.299; Alshabanat A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136065; Altawalbeh SM, 2020, J ASTHMA, V57, P231, DOI 10.1080/02770903.2019.1568454; Andersen H, 2013, CLIN RESPIR J, V7, P342, DOI 10.1111/crj.12013; Barker BL, 2013, CLIN SCI, V124, P371, DOI 10.1042/CS20120340; Bellia V, 2003, CHEST, V123, P1066, DOI 10.1378/chest.123.4.1066; Bhatt SP, 2016, ANN AM THORAC SOC, V13, P158, DOI 10.1513/AnnalsATS.201512-795ED; Blanchette CM, 2008, J MANAGE CARE PHARM, V14, P176, DOI 10.18553/jmcp.2008.14.2.176; de Marco R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062985; de Verdier MG, 2015, VALUE HEALTH, V18, P759, DOI 10.1016/j.jval.2015.04.010; Diaz-Guzman E, 2011, COPD, V8, P400, DOI 10.3109/15412555.2011.611200; Ehteshami-Afshar S, 2016, INT J TUBERC LUNG D, V20, P11, DOI 10.5588/ijtld.15.0472; Gibson PG, 2009, THORAX, V64, P728, DOI 10.1136/thx.2008.108027; Giraud V, 2002, EUR RESPIR J, V19, P246, DOI 10.1183/09031936.02.00218402; Hardin M, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-127; Health Information Act Advisory Committee, 2016, HLTH INF ACT ADV COM; Hosseini M, 2019, RESP RES, V20, DOI 10.1186/s12931-019-1198-4; IMF, 2018, PUBL EXP REV RAT ISS; Jahnz-Rozyk Karina, 2003, Pol Merkur Lekarski, V14, P676; Kauppi P, 2011, J ASTHMA, V48, P279, DOI 10.3109/02770903.2011.555576; Kim J, 2017, J THORAC DIS, V9, P1547, DOI 10.21037/jtd.2017.05.07; Kim MA, 2015, INT J TUBERC LUNG D, V19, P864, DOI 10.5588/ijtld.14.0327; Lewis A, 2016, BMC HEALTH SERV RES, V16, DOI 10.1186/s12913-016-1482-7; Menezes AMB, 2014, CHEST, V145, P297, DOI 10.1378/chest.13-0622; Miravitlles M, 2013, RESP MED, V107, P1053, DOI 10.1016/j.rmed.2013.03.007; Tho NV, 2016, RESPIROLOGY, V21, P410, DOI 10.1111/resp.12653; Pellegrino R, 2005, EUR RESPIR J, V26, P948, DOI 10.1183/09031936.05.00035205; Postma DS, 2015, NEW ENGL J MED, V373, P1241, DOI 10.1056/NEJMra1411863; Rhee CK, 2014, COPD, V11, P163, DOI 10.3109/15412555.2013.831061; Shantakumar S, 2018, BMC PULM MED, V18, DOI 10.1186/s12890-017-0571-7; Shaya FT, 2008, CHEST, V134, P14, DOI 10.1378/chest.07-2317; Sin DD, 2016, EUR RESPIR J, V48, P664, DOI 10.1183/13993003.00436-2016; Wurst KE, 2016, RESP MED, V110, P1, DOI 10.1016/j.rmed.2015.10.004	33	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2021	16	9							e0257566	10.1371/journal.pone.0257566	http://dx.doi.org/10.1371/journal.pone.0257566			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YM4DR	34547051	Green Published, gold			2022-12-26	WOS:000746527400018
J	Bjork, M; Asplund, ME; Deyanova, D; Gullstrom, M				Bjork, Mats; Asplund, Maria E.; Deyanova, Diana; Gullstrom, Martin			The amount of light reaching the leaves in seagrass (Zostera marina) meadows	PLOS ONE			English	Article							POSIDONIA-OCEANICA; EELGRASS; PHOTOSYNTHESIS; EPIPHYTES; PH	Seagrass meadows, and other submerged vegetated habitats, support a wide range of essential ecological services, but the true extents of these services are in many ways still not quantified. One important tool needed to assess and model many of these services is accurate estimations of the systems, primary productivity. Such productivity estimations require an understanding of the underwater light field, especially regarding the amount of light that actually reaches the plants' photosynthetic tissue. In this study, we tested a simple practical approach to estimate leaf light exposure, relative to incoming light at the canopy, by attaching light sensitive film at different positions on leaves of Zostera marina, eelgrass, in four seagrass meadows composed of different shoot density and at two different depths. We found that the light reaching the leaves decreased linearly down through the canopy. While the upper parts of the leaves received approximately the same level of light (photosynthetic photon flux density, PPFD) as recorded with a PAR meter at the canopy top, the average light that the seagrass leaves were exposed to varied between 40 and 60% of the light on top of the canopy, with an overall average of 48%. We recommend that actual light interception is measured when assessing or modelling light depending processes in submerged vegetation, but if this is not achievable a rough estimation for vegetation similar to Z. marina would be to use a correction factor of 0.5 to compensate for the reduced light due to leaf orientation and internal shading.	[Bjork, Mats] Stockholm Univ, Dept Ecol Environm & Plant Sci, Stockholm, Sweden; [Asplund, Maria E.; Deyanova, Diana] Univ Gothenburg, Dept Biol & Environm Sci, Kristineberg, Fiskebackskil, Sweden; [Gullstrom, Martin] Sodertorn Univ, Sch Nat Sci Technol & Environm Studies, Huddinge, Sweden	Stockholm University; University of Gothenburg; Sodertorn University	Bjork, M (corresponding author), Stockholm Univ, Dept Ecol Environm & Plant Sci, Stockholm, Sweden.	mats.bjork@su.se	Bjork, Mats/B-4299-2010	Bjork, Mats/0000-0003-0363-110X				Beer S., 2014, PHOTOSYNTHESIS MARIN; Bjork M., 2008, MANAGING SEAGRASSES; Brush MJ, 2002, MAR ECOL PROG SER, V238, P73, DOI 10.3354/meps238073; Buapet P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083804; Carr GM, 1997, AQUAT BOT, V59, P195, DOI 10.1016/S0304-3770(97)00071-5; Chernkhunthod C., 2020, J JAPANESE SOC REVEG, V46, P202, DOI [10.7211/jjsrt.46.202, DOI 10.7211/JJSRT.46.202]; Dattolo E, 2014, MAR ENVIRON RES, V101, P225, DOI 10.1016/j.marenvres.2014.07.010; DENNISON WC, 1982, OECOLOGIA, V55, P137, DOI 10.1007/BF00384478; Deyanova D, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181386; DREW EA, 1979, AQUAT BOT, V7, P139, DOI 10.1016/0304-3770(79)90018-4; Falster DS, 2003, NEW PHYTOL, V158, P509, DOI 10.1046/j.1469-8137.2003.00765.x; Fukushima S., 1998, T 109 M JAP FOR SOC, P289; Gullstrom M, 2006, THESIS U GOTHENBURG; Higashide T, 2009, AGR FOREST METEOROL, V149, P756, DOI 10.1016/j.agrformet.2008.10.017; Hikosaka K, 2001, FUNCT ECOL, V15, P642, DOI 10.1046/j.0269-8463.2001.00557.x; Iluz D, 2012, ARTIFICIAL PHOTOSYNT, P115, DOI DOI 10.5772/31040; Jephson T, 2008, MAR ECOL PROG SER, V369, P63, DOI 10.3354/meps07646; Kawamura K, 2005, J FOREST RES-JPN, V10, P247, DOI 10.1007/s10310-004-0141-8; Kumar M, 2017, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.02023; Long MH, 2012, LIMNOL OCEANOGR-METH, V10, P416, DOI 10.4319/lom.2012.10.416; Mcleod E, 2011, FRONT ECOL ENVIRON, V9, P552, DOI 10.1890/110004; Mvungi EF, 2012, AQUAT BOT, V102, P44, DOI 10.1016/j.aquabot.2012.04.007; Nielsen SL, 2002, ESTUARIES, V25, P1025, DOI 10.1007/BF02691349; Nordlund LM, 2018, MAR POLLUT BULL, V134, P145, DOI 10.1016/j.marpolbul.2017.09.014; Park J.E., 2011, P 18 IFAC INT FED AU, P621; Rasmusson LM, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-49184-z; Rasmusson LM, 2017, MAR BIOL, V164, DOI 10.1007/s00227-017-3168-z; Rasmusson LM, 2014, BOT MAR, V57, P483, DOI 10.1515/bot-2014-0046; SAND-JENSEN K, 1977, Aquatic Botany, V3, P55, DOI 10.1016/0304-3770(77)90004-3; Schubert H, 2001, HELGOLAND MAR RES, V55, P12, DOI 10.1007/s101520000064; Serra IA, 2012, MAR BIOL, V159, P1269, DOI 10.1007/s00227-012-1907-8; Strydom S, 2017, MAR ECOL PROG SER, V572, P103, DOI 10.3354/meps12105; Yamato M, 2008, ECOL RES, V23, P329, DOI 10.1007/s11284-007-0381-0; Zhou T, 2021, FIELD CROP RES, V262, DOI 10.1016/j.fcr.2020.108054; Zimmerman RC, 2003, LIMNOL OCEANOGR, V48, P568, DOI 10.4319/lo.2003.48.1_part_2.0568; ZIMMERMAN RC, 1994, MAR ECOL PROG SER, V114, P185, DOI 10.3354/meps114185; Zimmerman RC, 2006, SEAGRASSES: BIOLOGY, ECOLOGY AND CONSERVATION, P303	37	1	1	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2021	16	9							e0257586	10.1371/journal.pone.0257586	http://dx.doi.org/10.1371/journal.pone.0257586			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YM4DR	34547042	Green Published, gold			2022-12-26	WOS:000746527400025
J	Khojasteh, D; Chen, SY; Felder, S; Heimhuber, V; Glamore, W				Khojasteh, Danial; Chen, Shengyang; Felder, Stefan; Heimhuber, Valentin; Glamore, William			Estuarine tidal range dynamics under rising sea levels	PLOS ONE			English	Article							RIVER DISCHARGE; WAVE PROPAGATION; SALT INTRUSION; SALINITY INTRUSION; SEDIMENT TRANSPORT; FRESH-WATER; LONG-TERM; TIDES; RISE; HYDRODYNAMICS	How an estuary responds to sea level rise (SLR) is complex and depends on energy drivers (e.g., tides and river inflows), estuarine geometry (e.g., length and depth), intrinsic fluid properties (e.g., density), and bed/bank roughness. While changes to the tidal range under SLR can impact estuarine sediment transport, water quality, and vegetation communities, studies on the altered tidal range under SLR are often based on case studies with outcomes applicable to a specific site. As such, this study produced a large ensemble of estuarine hydrodynamic models (>1800) to provide a systematic understanding of how tidal range dynamics within different estuary types may change under various SLR and river inflow scenarios. The results indicated that SLR often amplifies the tidal range of different estuary types, except for short estuaries with a low tidal range at the mouth where SLR attenuates the tides. SLR alters the location of the points with minimum tidal range and overall tidal range patterns in an estuary. Variations in tidal range were more evident in converging estuaries, shallower systems, or in estuaries with strong river inflows. These findings provide an indication of how different estuary types may respond to estuaries and may assist estuarine managers and decision makers.	[Khojasteh, Danial; Chen, Shengyang; Felder, Stefan; Heimhuber, Valentin; Glamore, William] UNSW Sydney, Water Res Lab, Sch Civil & Environm Engn, Sydney, NSW, Australia	University of New South Wales Sydney	Khojasteh, D (corresponding author), UNSW Sydney, Water Res Lab, Sch Civil & Environm Engn, Sydney, NSW, Australia.	danial.khojasteh@unsw.edu.au	Khojasteh, Danial/AAI-3906-2020	Khojasteh, Danial/0000-0002-6095-2885	UNSW Scientia PhD Scholarship	UNSW Scientia PhD Scholarship	Danial Khojasteh is supported by a UNSW Scientia PhD Scholarship.	ALLEN GP, 1980, SEDIMENT GEOL, V26, P69, DOI 10.1016/0037-0738(80)90006-8; Arcement G, 1989, S GEOL SURV WATER SU, DOI [10.3133/wsp2339, DOI 10.3133/WSP2339]; Bamber JL, 2019, P NATL ACAD SCI USA, V116, P11195, DOI 10.1073/pnas.1817205116; Barbier EB, 2011, ECOL MONOGR, V81, P169, DOI 10.1890/10-1510.1; Boerema A, 2017, ECOL ENG, V98, P172, DOI 10.1016/j.ecoleng.2016.10.051; Burchard H, 2018, ANNU REV MAR SCI, V10, P371, DOI 10.1146/annurev-marine-010816-060535; Cai H, 2014, HYDROL EARTH SYST SC, V18, P287, DOI 10.5194/hess-18-287-2014; Cai HY, 2018, OCEAN SCI, V14, P769, DOI 10.5194/os-14-769-2018; Cai HY, 2016, COAST ENG J, V58, DOI 10.1142/S0578563416500091; Cai HY, 2016, HYDROLOG SCI J, V61, P402, DOI 10.1080/02626667.2015.1027206; Cai HY, 2012, J HYDRAUL ENG, V138, P885, DOI 10.1061/(ASCE)HY.1943-7900.0000594; Cai HY, 2012, J GEOPHYS RES-OCEANS, V117, DOI 10.1029/2012JC008000; Chua VP, 2014, J MARINE SYST, V139, P58, DOI 10.1016/j.jmarsys.2014.05.012; Dalrymple RW, 2007, EARTH-SCI REV, V81, P135, DOI 10.1016/j.earscirev.2006.10.002; de Jonge VN, 2014, ESTUAR COAST SHELF S, V139, P46, DOI 10.1016/j.ecss.2013.12.030; de Swart HE, 2009, ANNU REV FLUID MECH, V41, P203, DOI 10.1146/annurev.fluid.010908.165159; Diez-Minguito M, 2012, J GEOPHYS RES-OCEANS, V117, DOI 10.1029/2011JC007344; Dronkers J., 2005, DYNAMICS COASTAL SYS; Dronkers J, 2017, CONT SHELF RES, V144, P120, DOI 10.1016/j.csr.2017.06.012; Du JB, 2018, GEOPHYS RES LETT, V45, P227, DOI 10.1002/2017GL075963; Dyer K.R., 1997, ESTUARIES PHYS INTRO, Vsecond; Elmoustafa AM, 2017, J APPL WATER ENG RES, V5, P31, DOI 10.1080/23249676.2015.1118364; Ensing E, 2015, OCEAN DYNAM, V65, P933, DOI 10.1007/s10236-015-0844-8; Ferguson RI, 2012, WATER RESOUR RES, V48, DOI 10.1029/2011WR010850; FRIEDRICHS CT, 1994, J GEOPHYS RES-OCEANS, V99, P3321, DOI 10.1029/93JC03219; Friedrichs CT., 2010, CONT ISSUES ESTUARIN, P27, DOI [10.1017/CBO9780511676567.004, DOI 10.1017/CBO9780511676567.004]; Geyer WR, 2014, ANNU REV FLUID MECH, V46, P175, DOI 10.1146/annurev-fluid-010313-141302; GIESE BS, 1989, ESTUAR COAST SHELF S, V29, P549, DOI 10.1016/0272-7714(89)90010-3; Gisen JIA, 2015, HYDROL EARTH SYST SC, V19, P2791, DOI 10.5194/hess-19-2791-2015; Glamore W, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0254701; GODIN G, 1985, J WATERW PORT C-ASCE, V111, P257, DOI 10.1061/(ASCE)0733-950X(1985)111:2(257); Godin G, 1999, ESTUAR COAST SHELF S, V48, P307, DOI 10.1006/ecss.1998.0422; Goelzer H, 2020, CRYOSPHERE, V14, P3071, DOI 10.5194/tc-14-3071-2020; Guo LC, 2016, J GEOPHYS RES-EARTH, V121, P1000, DOI 10.1002/2016JF003821; Haddout S, 2019, INT J RIVER BASIN MA, V17, P353, DOI 10.1080/15715124.2018.1546721; Haigh ID, 2020, REV GEOPHYS, V58, DOI 10.1029/2018RG000636; Helaire LT, 2020, J GEOPHYS RES-OCEANS, V125, DOI 10.1029/2019JC015928; Hillman JR, 2020, ECOL APPL, V30, DOI 10.1002/eap.2090; Hoitink AJF, 2016, REV GEOPHYS, V54, P240, DOI 10.1002/2015RG000507; Hong B, 2020, J MARINE SYST, V201, DOI 10.1016/j.jmarsys.2019.103245; Horrevoets AC, 2004, J HYDROL, V294, P213, DOI 10.1016/j.jhydrol.2004.02.012; Horton BP, 2020, NPJ CLIM ATMOS SCI, V3, DOI 10.1038/s41612-020-0121-5; Ijaz MW, 2019, ESTUAR COAST SHELF S, V224, P51, DOI 10.1016/j.ecss.2019.04.039; JAY DA, 1991, J GEOPHYS RES-OCEANS, V96, P20585, DOI 10.1029/91JC01633; Jay DA, 2015, ESTUAR COAST, V38, P415, DOI 10.1007/s12237-014-9819-0; Ji Z.G., 2017, HYDRODYNAMICS WATER; Kastner K, 2019, J FLUID MECH, V872, P39, DOI 10.1017/jfm.2019.331; Kennish MJ, 2019, ECOLOGY ESTUARIES, V2, DOI [10.1016/j.eururo.2018.12.001, DOI 10.1016/J.EURURO.2018.12.001]; Khojasteh D., 2019, IMPLICATIONS TIDAL R; Khojasteh D, 2021, SCI TOTAL ENVIRON, V780, DOI 10.1016/j.scitotenv.2021.146470; Khojasteh D, 2020, ESTUAR COAST SHELF S, V244, DOI 10.1016/j.ecss.2020.106941; King I, 1978, RECENT APPL RMAS FIN; King I., 2015, DOCUMENTATION RMA2 2; King I., 2013, 2 DIMENSIONAL FINITE; King I, 1997, USERS GUIDE RMA2 WES, P240; Kirezci E, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-67736-6; Kukulka T, 2003, J GEOPHYS RES-OCEANS, V108, DOI 10.1029/2002JC001382; Kulp SA, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12808-z; Lanzoni S, 1998, J GEOPHYS RES-OCEANS, V103, P30793, DOI 10.1029/1998JC900015; Binh LTH, 2019, HYDROLOG SCI J, V64, P318, DOI 10.1080/02626667.2019.1581363; Lee J, 2012, CONT SHELF RES, V41, P77, DOI 10.1016/j.csr.2012.04.006; Lee SB, 2017, J GEOPHYS RES-OCEANS, V122, P3917, DOI 10.1002/2016JC012597; Leuven JRFW, 2019, NAT CLIM CHANGE, V9, P986, DOI 10.1038/s41558-019-0608-4; Lieberthal B, 2019, J GEOPHYS RES-OCEANS, V124, P955, DOI 10.1029/2018JC014039; Lowe RJ, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1600825; Machineni N, 2019, ESTUAR COAST SHELF S, V231, DOI 10.1016/j.ecss.2019.106466; Meyers SD, 2020, MARIT POLICY MANAG, V47, P920, DOI 10.1080/03088839.2020.1723810; Moftakhari HR, 2016, J GEOPHYS RES-OCEANS, V121, P2078, DOI 10.1002/2015JC010983; Moftakhari HR, 2017, P NATL ACAD SCI USA, V114, P9785, DOI 10.1073/pnas.1620325114; Mogensen LA, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19695-2; Naik V., 2021, CLIMATE CHANGE 2021, DOI [10.1038/s41597-021-00916-9, DOI 10.1038/S41597-021-00916-9]; Neill SP, 2014, RENEW ENERG, V68, P337, DOI 10.1016/j.renene.2014.01.052; Nguyen AD, 2006, HYDROL EARTH SYST SC, V10, P743, DOI 10.5194/hess-10-743-2006; Ongsomwang S, 2017, SCI TECHNOLOGY ASIA, P143; Palmer K, 2019, ESTUAR COAST SHELF S, V225, DOI 10.1016/j.ecss.2019.106247; Pareja-Roman LF, 2020, J GEOPHYS RES-OCEANS, V125, DOI 10.1029/2020JC016256; Passeri DL, 2015, CONT SHELF RES, V111, P150, DOI 10.1016/j.csr.2015.08.001; Passeri DL, 2015, EARTHS FUTURE, V3, P159, DOI 10.1002/2015EF000298; Passeri DL, 2015, NAT HAZARDS, V75, P1599, DOI 10.1007/s11069-014-1386-y; Pickering MD, 2012, CONT SHELF RES, V35, P1, DOI 10.1016/j.csr.2011.11.011; Prandle D, 2009, ESTUARIES: DYNAMICS, MIXING, SEDIMENTATION AND MORPHOLOGY, P1, DOI 10.1017/CBO9780511576096; Pye K, 2014, ESTUAR COAST SHELF S, V150, P196, DOI 10.1016/j.ecss.2014.05.014; Ralston DK, 2019, J GEOPHYS RES-OCEANS, V124, P196, DOI 10.1029/2018JC014313; Rao P, 2005, ENVIRON MODELL SOFTW, V20, P47, DOI 10.1016/j.envsoft.2003.12.008; Rayner D, 2021, SCI TOTAL ENVIRON, V766, DOI 10.1016/j.scitotenv.2020.144237; ROBINSON IS, 1980, GEOPHYS J ROY ASTR S, V62, P77, DOI 10.1111/j.1365-246X.1980.tb04845.x; Rodriguez JF, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms16094; Ross AC, 2017, J GEOPHYS RES-OCEANS, V122, P8102, DOI 10.1002/2017JC012887; Sadat-Noori M, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-80977-3; Sanchez M, 2014, ENERGY, V77, P802, DOI 10.1016/j.energy.2014.09.053; Savage C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042708; Savenije H. H. G., 2005, SALINITY TIDES ALLUV, DOI 10.1016/B978-0-444-52107-1.X5000-X; Savenije HHG, 2001, J HYDROL, V243, P205, DOI 10.1016/S0022-1694(00)00414-5; Savenije HHG, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2007JC004408; Sirisena TAJG, 2018, J HYDROL-REG STUD, V19, P265, DOI 10.1016/j.ejrh.2018.10.005; Sweet W., 2017, NOAA TECHNICAL REPOR, DOI 10.7289/v5/tr-nos-coops-083; Talke SA, 2020, J GEOPHYS RES-OCEANS, V125, DOI 10.1029/2019JC015656; Talke SA, 2020, ANNU REV MAR SCI, V12, P121, DOI 10.1146/annurev-marine-010419-010727; Talke SA, 2013, J COASTAL RES, V29, P118, DOI 10.2112/JCOASTRES-D-12-00181.1; Thorne K, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aao3270; Uncles RJ, 2013, OCEAN COAST MANAGE, V79, P83, DOI 10.1016/j.ocecoaman.2012.05.006; Valle-Levinson A., 2010, CONT ISSUES ESTUARIN, P1, DOI [10.1017/CBO9780511676567.002, DOI 10.1017/CBO9780511676567.002]; Van Rijn L, 2011, COMP HYDRODYNAMICS S; van Rijn LC, 2011, OCEAN DYNAM, V61, P1719, DOI 10.1007/s10236-011-0453-0; Wei X, 2020, QUATERN INT, V553, P118, DOI 10.1016/j.quaint.2020.05.047; Williams J, 2018, OCEAN SCI, V14, P1057, DOI 10.5194/os-14-1057-2018; Woodroffe CD, 2016, ANNU REV MAR SCI, V8, P243, DOI 10.1146/annurev-marine-122414-034025; Zhang M, 2016, EARTH SURF PROC LAND, V41, P98, DOI 10.1002/esp.3790; Zhang ZL, 2017, HYDROL EARTH SYST SC, V21, P3287, DOI 10.5194/hess-21-3287-2017; Zhong LJ, 2008, CONT SHELF RES, V28, P2565, DOI 10.1016/j.csr.2008.07.007	110	9	9	4	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2021	16	9							e0257538	10.1371/journal.pone.0257538	http://dx.doi.org/10.1371/journal.pone.0257538			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	WG6BN	34543343	Green Published, gold			2022-12-26	WOS:000707078200044
J	Lingens, SP; Schulz, F; Muller, I; Schulz, H; Bleich, C				Lingens, Solveigh P.; Schulz, Florian; Mueller, Isabell; Schulz, Holger; Bleich, Christiane			Associations between self-efficacy, distress and anxiety in cancer patient-relative dyads visiting psychosocial cancer support services: Using actor-partner interdependence modelling	PLOS ONE			English	Article							QUALITY-OF-LIFE; PSYCHOLOGICAL DISTRESS; FAMILY CAREGIVERS; INFORMAL CAREGIVERS; PERCEIVED CONTROL; MENTAL-DISORDERS; PRIME-MD; CARE; HEALTH; UTILITY	Background Patients with cancer and their relatives often suffer from psychosocial burdens following a cancer diagnosis. Psychosocial cancer support services offer support for cancer patients and their relatives. Only a few studies have focused on associations of psychological factors within patient-relative dyads. This study aims to assess associations between the patients' or relatives' self-efficacy and their levels of distress and anxiety who seek help together at psychosocial cancer support centres. Methods Participants were recruited at two psychosocial cancer support centres in a major city in Germany. Patients with cancer and their relatives seeking support together received the questionnaire before their first support session. Self-efficacy was assessed with the Pearlin sense of mastery scale, distress with the distress thermometer and anxiety with the General Anxiety Disorder questionnaire (GAD-7). For the analysis, the actor-partner interdependence model was applied. Results The data analysis was based on 41 patient-relative dyads (patients: 39% women, mean age 53.5; relatives: 66% women, mean age 52.16). A significant actor effect from self-efficacy to distress was found for patients (r = -0.47) but not for relatives (r = -0.15). Partner effects from self-efficacy to distress were not significant (r = -0.03, r = -0.001). The actor effect from self-efficacy to anxiety for patients (r = -0.61) as well as relatives was significant (r = -0.62), whereas the partner effect was significant for patients (r = 0.16) but not for relatives (r = -0.46). Conclusion The results suggest that patients' and relatives' self-efficacy is associated with their distress and anxiety. Partner effects were visible for patients' self-efficacy and relatives' anxiety. These findings suggest that self-efficacy is an important factor for the psychological well-being of patients and relatives and that it may additionally be associated with the partners' well-being. Longitudinal research with larger samples is needed to support the findings.	[Lingens, Solveigh P.; Schulz, Florian; Mueller, Isabell; Schulz, Holger; Bleich, Christiane] Univ Med Ctr Hamburg Eppendorf, Dept Med Psychol, Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf	Lingens, SP (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Med Psychol, Hamburg, Germany.	s.lingens@uke.de		Lingens, Solveigh/0000-0003-4230-0389	Hamburger Krebsgesellschaft e.V. (Cancer Society Hamburg)	Hamburger Krebsgesellschaft e.V. (Cancer Society Hamburg)	This study was funded by the Hamburger Krebsgesellschaft e.V. (Cancer Society Hamburg). HS and CB received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerman RA, 2016, APIMPOWERR INTERACTI; Badura B., 1987, LEBEN HERZINFARKT, DOI DOI 10.1007/978-3-642-71713-0; Barez M, 2009, J BEHAV MED, V32, P187, DOI 10.1007/s10865-008-9180-5; Becker S, 2010, AIDS BEHAV, V14, P558, DOI 10.1007/s10461-009-9607-1; Bernard DSM, 2011, J CLIN ONCOL, V29, P2821, DOI 10.1200/JCO.2010.33.0522; Bidwell JT, 2018, HEART LUNG, V47, P32, DOI 10.1016/j.hrtlng.2017.11.001; Chirico A, 2017, ONCOTARGET, V8, P36800, DOI 10.18632/oncotarget.15758; Cook WL, 2005, INT J BEHAV DEV, V29, P101, DOI 10.1080/01650250444000405; Ellis KR, 2017, SUPPORT CARE CANCER, V25, P185, DOI 10.1007/s00520-016-3385-x; Ernst J, 2014, PSYCHOTHER PSYCH MED, V64, P421, DOI 10.1055/s-0034-1374604; Gropper S, 2016, SUPPORT CARE CANCER, V24, P2351, DOI 10.1007/s00520-015-3042-9; Hagedoorn M, 2002, BRIT J HEALTH PSYCH, V7, P481, DOI 10.1348/135910702320645435; Hagedoorn M, 2008, PSYCHOL BULL, V134, P1, DOI 10.1037/0033-2909.134.1.1; Hirai K, 2002, PSYCHO-ONCOLOGY, V11, P221, DOI 10.1002/pon.561; Holland Jimmie C, 2007, J Natl Compr Canc Netw, V5, P3; Jacobs JM, 2017, ANN BEHAV MED, V51, P519, DOI 10.1007/s12160-017-9875-3; Kenny DA, 1996, J SOC PERS RELAT, V13, P279, DOI 10.1177/0265407596132007; Kenny DA, 2014, HANDBOOK OF RESEARCH METHODS IN SOCIAL AND PERSONALITY PSYCHOLOGY, SECOND EDITION, P589; Kershaw T, 2015, ANN BEHAV MED, V49, P901, DOI 10.1007/s12160-015-9743-y; Kim Y, 2008, CANCER-AM CANCER SOC, V112, P2556, DOI 10.1002/cncr.23449; Lev E L, 2001, Sch Inq Nurs Pract, V15, P277; Lingens SP, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2019-032889; Mackenzie CS, 2006, AGING MENT HEALTH, V10, P574, DOI 10.1080/13607860600641200; Mehnert A, 2006, Z PSYCHIATR PSYCH PS, V54, P213, DOI 10.1024/1661-4747.54.3.213; Mehnert A, 2014, J CLIN ONCOL, V32, P3540, DOI 10.1200/JCO.2014.56.0086; Mystakidou K, 2013, EUR J CANCER CARE, V22, P188, DOI 10.1111/ecc.12012; Northouse L, 2012, J CLIN ONCOL, V30, P1227, DOI 10.1200/JCO.2011.39.5798; Northouse LL, 2002, J CLIN ONCOL, V20, P4050, DOI 10.1200/JCO.2002.02.054; Norton TR, 2005, HEALTH PSYCHOL, V24, P143, DOI 10.1037/0278-6133.24.2.143; PEARLIN LI, 1978, J HEALTH SOC BEHAV, V19, P2, DOI 10.2307/2136319; Pitceathly C, 2003, EUR J CANCER, V39, P1517, DOI 10.1016/S0959-8049(03)00309-5; Porter LS, 2008, PAIN, V137, P306, DOI 10.1016/j.pain.2007.09.010; Rosenberger C, 2012, PSYCHOTHER PSYCH MED, V62, P185, DOI 10.1055/s-0032-1304994; Ruesch P., 2003, PSYCHISCHE GESUNDHEI; Ruesch P., 2006, EVALUATION MESSINSTR; Sharp L, 2013, PSYCHO-ONCOLOGY, V22, P745, DOI 10.1002/pon.3055; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Sklenarova H, 2015, CANCER-AM CANCER SOC, V121, P1513, DOI 10.1002/cncr.29223; SPITZER RL, 1994, JAMA-J AM MED ASSOC, V272, P1749, DOI 10.1001/jama.272.22.1749; Spitzer RL, 1999, JAMA-J AM MED ASSOC, V282, P1737, DOI 10.1001/jama.282.18.1737; Spitzer RL, 2000, AM J OBSTET GYNECOL, V183, P759, DOI 10.1067/mob.2000.106580; Stas L, 2018, PERS RELATIONSHIP, V25, P103, DOI 10.1111/pere.12230; Stiegelis HE, 2004, PSYCHO-ONCOLOGY, V13, P248, DOI 10.1002/pon.738; Thomson P, 2012, PSYCHOL HEALTH MED, V17, P35, DOI 10.1080/13548506.2011.579988; Vallerand AH, 2007, CANCER NURS, V30, P31, DOI 10.1097/00002820-200701000-00006; van Ryn M, 2011, PSYCHO-ONCOLOGY, V20, P44, DOI 10.1002/pon.1703; WALLHAGEN MI, 1993, INT J AGING HUM DEV, V36, P219, DOI 10.2190/BA90-AQX3-T6CE-ABEK; Weis J, 2007, ONKOLOGE, V13, P185, DOI 10.1007/s00761-006-1165-9	48	2	2	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2021	16	9							e0255318	10.1371/journal.pone.0255318	http://dx.doi.org/10.1371/journal.pone.0255318			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	WG5ZQ	34534225	gold, Green Published			2022-12-26	WOS:000707073300006
J	Tchicaya, A; Lorentz, N; Leduc, K; de Lanchy, G				Tchicaya, Anastase; Lorentz, Nathalie; Leduc, Kristell; de Lanchy, Gaetan			COVID-19 mortality with regard to healthcare services availability, health risks, and socio-spatial factors at department level in France: A spatial cross-sectional analysis	PLOS ONE			English	Article								Background The 2019 coronavirus (COVID-19) epidemic began in Wuhan, China in December 2019 and quickly spread to the rest of the world. This study aimed to analyse the associations between the COVID-19 mortality rate in hospitals, the availability of health services, and socio-spatial and health risk factors at department level. Methods and findings This spatial cross-sectional study used cumulative mortality data due to the COVID-19 pandemic in hospitals until 30 November 2020 as a main outcome, across 96 departments of mainland France. Data concerning health services, health risk factors, and socio-spatial factors were used as independent variables. Independently, we performed negative binomial, spatial and geographically weighted regression models. Our results revealed substantial geographic disparities. The spatial exploratory analysis showed a global positive spatial autocorrelation in each wave indicating a spatial dependence of the COVID-19 deaths across departments. In first wave about 75% of COVID-19 deaths were concentrated in departments of five regions compared to a total of 13 regions. The COVID-19 mortality rate was associated with the physicians density, and not the number of resuscitation beds. Socio-spatial factors were only associated with the COVID-19 mortality rate in first wave compared to wave 2. For example, the COVID-19 mortality rate increased by 35.69% for departments densely populated. Health risk factors were associated with the COVID-19 mortality rate depending on each wave. This study had inherent limitations to the ecological analysis as ecological bias risks and lack of individual data. Conclusions Our results suggest that the COVID-19 pandemic has spread more rapidly and takes more severe forms in environments where there is already a high level of vulnerability due to social and health factors. This study showed a different dissemination pattern of COVID-19 mortality between the two waves: a spatial non-stationarity followed by a spatial stationarity in the relationships between the COVID-19 mortality rate and its potential drivers.	[Tchicaya, Anastase; Lorentz, Nathalie; Leduc, Kristell; de Lanchy, Gaetan] Luxembourg Inst Socioecon Res, Living Condit Dept, Esch Sur Alzette, Luxembourg		Tchicaya, A (corresponding author), Luxembourg Inst Socioecon Res, Living Condit Dept, Esch Sur Alzette, Luxembourg.	anastase.tchicaya@liser.lu						Allison P.D., 2005, FIXED EFFECTS REGRES; Amdaoud M, 20204 U PAR NANT; Anselin L, 2001, AM J AGR ECON, V83, P705, DOI 10.1111/0002-9092.00194; Apicella M, 2020, LANCET DIABETES ENDO, V8, P782, DOI 10.1016/S2213-8587(20)30238-2; Bloom DE., 2020, FINANCE DEV; Caussy C, 2020, LANCET DIABETES ENDO, V8, P562, DOI [10.1016/S2213-8587(20)30160-0, 10.1016/S2213-8587(20)30160-1]; Centers for Disease Control and Prevention (CDC), 2020, COVID 19; Chen VYJ, 2012, GEOGR ANAL, V44, P134, DOI 10.1111/j.1538-4632.2012.00841.x; da Silva AR, 2014, STAT COMPUT, V24, P769, DOI 10.1007/s11222-013-9401-9; DREES, 2020, NUMB RES INT CAR CON; Emanuel EJ, 2020, NEW ENGL J MED, V382, P2049, DOI 10.1056/NEJMsb2005114; Ertur C, LEG DOCUMENT TRAVAIL; Fattorini D, 2020, ENVIRON POLLUT, V264, DOI 10.1016/j.envpol.2020.114732; FNORS, 2020, APP DEC PROF TERR; French Ministry of Health/General Health Direction, 2020, HOSP DAT REL COVID 1; Gandre C., 2020, COVID 19 HLTH SYSTEM; Gaudart J, 2021, LANCET PUBLIC HEALTH, V6, pE222, DOI 10.1016/S2468-2667(21)00006-2; Hick JL, 2020, NEW ENGL J MED, V382, DOI 10.1056/NEJMp2005118; Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5; Inglesby TV, 2020, JAMA-J AM MED ASSOC, V323, P2186, DOI 10.1001/jama.2020.7878; Jackson DJ, 2020, J ALLERGY CLIN IMMUN, V146, P203, DOI 10.1016/j.jaci.2020.04.009; Karmakar M, 2021, JAMA NETW OPEN, V4, DOI 10.1001/jamanetworkopen.2020.36462; Leon DA, 2020, LANCET, V395, pE81, DOI 10.1016/S0140-6736(20)30933-8; Mari-Dell'Olmo M, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18031256; Mattiuzzi C, 2021, PUBLIC HEALTH, V193, P41, DOI 10.1016/j.puhe.2021.01.027; Morais-Almeida M, 2020, INT ARCH ALLERGY IMM, V181, P680, DOI 10.1159/000509057; Nishiga M, 2020, NAT REV CARDIOL, V17, P543, DOI 10.1038/s41569-020-0413-9; OECD, 2020, HLTH SYSTEM RESPONSE; Onder G, 2020, JAMA-J AM MED ASSOC, V323, P1775, DOI 10.1001/jama.2020.4683; Qi H, 2020, SCI TOTAL ENVIRON, V728, P138778, DOI [DOI 10.1016/J.SCITOTENV.2020.138778, 10.1016/j.scitotenv.2020.138778]; Rozenberg S, 2020, MATURITAS, V138, P62, DOI 10.1016/j.maturitas.2020.05.009; Semenzato L, 2021, LANCET REG HEALTH-EU, V8, DOI 10.1016/j.lanepe.2021.100158; Simonnet A, 2020, OBESITY, V28, P1195, DOI 10.1002/oby.22831; Whittle RS, 2020, BMC MED, V18, DOI 10.1186/s12916-020-01731-6; World Health Organization, 2020, ETH COVID 19 RES ALL; World Health Organization [WHO], 2020, ROLL UPD COR DIS; Wu X, 2020, MANAGEMENT TRANSFORMATION OF HUAWEI, P1, DOI 10.1017/9781108550987; Zaldo-Aubanell Q, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18073768; Zeitoun JD, 2020, PUBLIC HEALTH, V189, P104, DOI 10.1016/j.puhe.2020.09.015; Zhang CH, 2020, J RURAL HEALTH, V36, P433, DOI 10.1111/jrh.12476	40	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2021	16	9							e0256857	10.1371/journal.pone.0256857	http://dx.doi.org/10.1371/journal.pone.0256857			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	WG5ZQ	34534226	Green Published, gold			2022-12-26	WOS:000707073300010
J	Edelmann, MR; Hauri, S				Edelmann, Martin R.; Hauri, Simon			Functional in vitro assessment of modified antibodies: Impact of label on protein properties	PLOS ONE			English	Article							THERAPEUTIC PROTEINS; CLEARANCE; CHROMATOGRAPHY; STABILITY	Labelling of therapeutic antibodies with radionuclides or fluorophores is routinely used to study their pharmacokinetic properties. A critical assumption in utilizing labelled therapeutic antibodies is that the label has no unfavourable effects on antibody charge, hydrophobicity, or receptor affinity. Ideally, the labelled protein should not have any significant deviations from the physiological properties of the original molecule. This article describes an established quality in vitro assessment workflow for labelled antibodies that ensures better prediction of changes in antibody pharmacokinetic (PK) properties after modifications. This analysis package considers degradation and aggregation analysis by size-exclusion chromatography, changes in neonatal-Fc-receptor (FcRn) affinity, and heparin interaction. FcRn binding is important for antibody recycling and half-life extension, whereas heparin affinity provides estimates on the rate of endocytosis through unspecific cell surface binding. Additionally, mass spectrometric analysis to determine the degree of labelling (DoL) completes the package and the combined analysis data allow to predict the label contribution to the PK properties of the modified antibody. This analytical strategy for labelling 11 IgGs has been investigated using 2 different IgG(1) constructs and applying 7 different types of labels. Each labelling resulted in a change in the physicochemical properties of the protein. Not only can the DoL of modified IgGs lead to a change in protein properties, but the type of label also can. Furthermore, it was demonstrated that the labelling process can also influence the behaviour of labelled mAbs. An identical label on different constructs of IgG(1) can cause different affinities for FcRn and heparin. Considering the assessment data, only 6 of the 11 modified antibodies from this study can be recommended for subsequent experiments. In conclusion, a suitability assessment of labelled antibodies prior to any pharmacokinetic studies is essential to reduce cost, allocate resources and reduce the number of animal experiments during pre-clinical drug development.	[Edelmann, Martin R.] Univ Bath, Dept Pharm & Pharmacol, Bath, Avon, England; [Edelmann, Martin R.; Hauri, Simon] F Hoffmann La Roche & Cie AG, Roche Innovat Ctr Basel, Roche Pharma Res & Early Dev, Basel, Switzerland	University of Bath; Roche Holding	Edelmann, MR (corresponding author), Univ Bath, Dept Pharm & Pharmacol, Bath, Avon, England.; Edelmann, MR (corresponding author), F Hoffmann La Roche & Cie AG, Roche Innovat Ctr Basel, Roche Pharma Res & Early Dev, Basel, Switzerland.	martin.edelmann@roche.com	Edelmann, Martin R./HIK-2467-2022	Edelmann, Martin R./0000-0002-6116-1516				Al-Ejeh F, 2009, NUCL MED BIOL, V36, P395, DOI 10.1016/j.nucmedbio.2009.01.001; Allen KJH, 2018, PHARMACEUTICS, V10, DOI 10.3390/pharmaceutics10040262; Beck A, 2014, MABS-AUSTIN, V6, P15, DOI 10.4161/mabs.27436; Bernhard Wendy, 2018, Oncotarget, V9, P6213, DOI 10.18632/oncotarget.23557; Borrok MJ, 2015, J BIOL CHEM, V290, P4282, DOI 10.1074/jbc.M114.603712; COONS AH, 1950, J EXP MED, V91, P1, DOI 10.1084/jem.91.1.1; Cordoba-Rodriguez RV, 2008, BIOPHARM INT, V21, P44; Cymer F, 2017, BIOANALYSIS, V9, P1305, DOI 10.4155/bio-2017-0109; EDELMAN GM, 1969, P NATL ACAD SCI USA, V63, P78, DOI 10.1073/pnas.63.1.78; Edelmann MR, 2019, J LABELLED COMPD RAD, V62, P751, DOI 10.1002/jlcr.3793; Eigenmann MJ, 2017, MABS-AUSTIN, V9, P1007, DOI 10.1080/19420862.2017.1337619; FRAKER PJ, 1978, BIOCHEM BIOPH RES CO, V80, P849, DOI 10.1016/0006-291X(78)91322-0; GREENWOOD FC, 1963, BIOCHEM J, V89, P114, DOI 10.1042/bj0890114; HEMPEL K., 1963, EXPTL CELL RES, V31, P594, DOI 10.1016/0014-4827(63)90407-5; Jaramillo CAC, 2017, MABS-AUSTIN, V9, P781, DOI 10.1080/19420862.2017.1320008; KNIGHT LC, 1978, BIOCHIM BIOPHYS ACTA, V534, P185, DOI 10.1016/0005-2795(78)90001-6; Kraeber-Bodere F, 2014, SEMIN ONCOL, V41, P613, DOI 10.1053/j.seminoncol.2014.07.004; Kraft TE, 2020, MABS-AUSTIN, V12, DOI 10.1080/19420862.2019.1683432; Liu HC, 2012, MABS-AUSTIN, V4, P17, DOI 10.4161/mabs.4.1.18347; Lo M, 2017, J BIOL CHEM, V292, P3900, DOI 10.1074/jbc.M116.767749; MALEY F, 1989, ANAL BIOCHEM, V180, P195, DOI 10.1016/0003-2697(89)90115-2; Meneghetti MCZ, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2015.0589; MULLER GH, 1980, J CELL SCI, V43, P319; Pan H, 2009, PROTEIN SCI, V18, P424, DOI 10.1002/pro.45; Schadt S, 2019, DRUG METAB DISPOS, V47, P1443, DOI 10.1124/dmd.119.088997; Schlothauer T, 2013, MABS-AUSTIN, V5, P576, DOI 10.4161/mabs.24981; SIMISTER NE, 1989, NATURE, V337, P184, DOI 10.1038/337184a0; Tabrizi MA, 2006, DRUG DISCOV TODAY, V11, P81, DOI 10.1016/S1359-6446(05)03638-X; Vira S, 2010, ANAL BIOCHEM, V402, P146, DOI 10.1016/j.ab.2010.03.036; Wang LT, 2005, PROTEIN SCI, V14, P2436, DOI 10.1110/ps.051478705; Wang WR, 2011, MOL IMMUNOL, V48, P860, DOI 10.1016/j.molimm.2010.12.009; WILBUR DS, 1992, BIOCONJUGATE CHEM, V3, P433, DOI 10.1021/bc00018a001	32	2	1	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2021	16	9							e0257342	10.1371/journal.pone.0257342	http://dx.doi.org/10.1371/journal.pone.0257342			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	WG5YY	34529712	Green Published, gold			2022-12-26	WOS:000707071500049
J	Leitner, MC; Guetlin, DC; Hawelka, S				Leitner, Michael Christian; Guetlin, Dirk Christoph; Hawelka, Stefan			Salzburg Visual Field Trainer (SVFT): A virtual reality device for (the evaluation of) neuropsychological rehabilitation	PLOS ONE			English	Article							RESTORATION; RECOVERY; DEFECTS	Objective "Visual Restitution Therapies" (VRT) claim to ameliorate visual field defects of neurological patients by repeated visual light stimulation, leading to training-related neuroplasticity and resulting in reconnection of lesioned neurons in early cortical areas. Because existing systems are stationary, uncomfortable, and unreliable, we developed a training instrument based on virtual reality goggles. The goal of the "Salzburg Visual Field Trainer" (SVFT) is twofold: (1) The device facilitates the clinical evaluation of established neuropsychological rehabilitation approaches, such as VRT. (2) The device enables patients to independently perform VRT based (or other) neuropsychological training methodologies flexibly and comfortably. Methods and analysis The SVFT was developed on the principles of VRT. Individual configuration of the SVFT is based on perimetric data of the respective patient's visual field. To validate the utmost important aspect of neuropsychological rehabilitation methodologies-that is displaying stimuli precisely in desired locations in the user's visual field-two steps were conducted in this proof-of-concept study: First, we assessed the individual "blind spots" location and extent of 40 healthy, normal sighted participants. This was done with the help of our recently developed perimetric methodology "Eye Tracking Based Visual Field Analysis" (EFA). Second, depending on the individual characteristics of every participant's blind spots, we displayed-by means of the SVFT-15 stimuli in the respective locations of every participants' blind spots and 85 stimuli in the surrounding, intact visual area. The ratio between visible and non-visible stimuli, which is reflected in the behavioral responses (clicks on a remote control) of the 40 participants, provides insight into the accuracy of the SVFT to display training stimuli in areas desired by the investigator. As the blind spot is a naturally occurring, absolute scotoma, we utilized this blind area as an objective criterion and a "simulated" visual field defect to evaluate the theoretical applicability of the SVFT. Results Outcomes indicate that the SVFT is highly accurate in displaying training stimuli in the desired areas of the user's visual field with an accuracy of 99.0%. Data analysis further showed a sensitivity of .98, specificity of .99, a positive predictive value of .96, a negative predictive value of .996, a hit rate of .99, a random hit rate of .74 and a RATZ-Index of .98. This translates to 14.7% correct non-reactions, 0.7% false non-reactions, 0.3% false reactions and 84.3% correct reactions to displayed test stimuli during the evaluation study. Reports from participants further indicate that the SVFT is comfortable to wear and intuitive to use. Conclusions The SVFT can help to investigate the true effects of VRT based methodologies (or other neuropsychological approaches) and the underlying mechanisms of training-related neuroplasticity in the visual cortex in neurological patients suffering from visual field defects.	[Leitner, Michael Christian; Hawelka, Stefan] Univ Salzburg, Ctr Cognit Neurosci CCNS, Salzburg, Austria; [Leitner, Michael Christian; Hawelka, Stefan] Univ Salzburg, Dept Psychol, Salzburg, Austria; [Guetlin, Dirk Christoph] Univ Osnabruck, Inst Cognit Sci, Osnabruck, Germany	Salzburg University; Salzburg University; University Osnabruck	Leitner, MC (corresponding author), Univ Salzburg, Ctr Cognit Neurosci CCNS, Salzburg, Austria.; Leitner, MC (corresponding author), Univ Salzburg, Dept Psychol, Salzburg, Austria.	michael.leitner@plus.ac.at	Leitner, Michael/AGG-5142-2022; Leitner, Michael/GQZ-7596-2022	Leitner, Michael/0000-0002-9341-854X; Hawelka, Stefan/0000-0002-5304-8521	Austrian Science Fund (FWF) [P31299]	Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	The following study is based on the funded project "Advanced Perimetry for the Evaluation of Neuroplasticity in the Visual Cortex" by the Austrian Science Fund (FWF) (Reference No. P31299). MCL received funding. The sponsor or funding organization had no role in the design or conduct of this research.	Bergsma DP, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00681; Birnbaum FA, 2015, J MED HYPOTHESES IDE, V9, pS8, DOI 10.1016/j.jmhi.2015.12.001; Burk A., 2011, CHECKLISTE AUGENHEIL; Deutsche Ophthalmologische Gesellschaft, 2017, GESELLSCHAFT AUGENHE; Foerster RM, 2019, NEUROPSYCHOLOGY, V33, P309, DOI 10.1037/neu0000517; Foerster RM, 2016, SCI REP-UK, V6, DOI 10.1038/srep37016; Frolov A, 2017, NEUROL CLIN, V35, P29, DOI 10.1016/j.ncl.2016.08.010; Glisson CC, 2006, CURR OPIN OPHTHALMOL, V17, P504, DOI 10.1097/ICU.0b013e328010852e; Google LLC, ANDROID PIE VERSION; Google LLC, GOOGL CARDB VERS 1 9; Horton JC, 2005, BRIT J OPHTHALMOL, V89, P1, DOI 10.1136/bjo.2004.058214; Huxlin KR, 2004, CEREB CORTEX, V14, P81, DOI 10.1093/cercor/bhg106; Leitner MC, 2021, NEUROCASE, V27, P308, DOI 10.1080/13554794.2021.1951302; Leitner MC, 2021, BMJ OPEN OPHTHALMOL, V6, DOI 10.1136/bmjophth-2019-000429; Lenhard W., BERECHNUNG TESTG TEK; Marshall RS, 2010, CLIN REHABIL, V24, P1027, DOI 10.1177/0269215510362323; Mueller I, 2007, RESTOR NEUROL NEUROS, V25, P563; Niedeggen M., 2005, VISUELLE WAHRNEHMUNG; Reinhard J, 2005, BRIT J OPHTHALMOL, V89, P30, DOI 10.1136/bjo.2003.040543; Sabel B A, 2000, Curr Opin Ophthalmol, V11, P430, DOI 10.1097/00055735-200012000-00008; Sabel BA, 2005, BRIT J OPHTHALMOL, V89, P522, DOI 10.1136/bjo.2005.068163; Sabel BA, 2013, RESTOR NEUROL NEUROS, V31, P787, DOI 10.3233/RNN-139019; Schweigart G, 2002, EUR J NEUROSCI, V15, P1585, DOI 10.1046/j.1460-9568.2002.01996.x; STEINMAN RM, 1965, J OPT SOC AM, V55, P1158, DOI 10.1364/JOSA.55.001158; TREISMAN M, 1976, BEHAV RES METH INSTR, V8, P489, DOI 10.3758/BF03202193; Unity Technologies, 2019, UNITY VERSION 201916	26	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2021	16	9							e0249762	10.1371/journal.pone.0249762	http://dx.doi.org/10.1371/journal.pone.0249762			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	WG5YY	34529704	Green Submitted, Green Published, gold			2022-12-26	WOS:000707071500002
J	Bojanowska, A; Kaczmarek, LD; Koscielniak, M; Urbanska, B				Bojanowska, Agnieszka; Kaczmarek, Lukasz D.; Koscielniak, Maciej; Urbanska, Beata			Changes in values and well-being amidst the COVID-19 pandemic in Poland	PLOS ONE			English	Article							LIFE EVENTS; HAPPINESS; INTERVENTION; SATISFACTION; PERSONALITY; NEUROTICISM; VALIDATION; TESTS; CARE	COVID-19 caused a global change in the lifestyles of people around the world. It provided a unique opportunity to examine how external circumstances impact two crucial aspects of functioning relating to "who I am" (values) and "how I feel" (well-being). Participants (N = 215) reported their values and subjective and eudaimonic well-being, nine months before the first lockdown in Poland and two weeks and four weeks into the first lockdown. We observed increased valuing of self-direction, security, conformity, humility, caring, and universalism and a decrease in valuing hedonism. Individuals experienced decreased subjective and eudaimonic well-being, with women responding with stronger negative affect intensity relative to men. Finally, we identified that individuals who were more open to change before the COVID-19 pandemic responded with higher eudaimonic well-being two weeks into lockdown relative to their less open to change peers. This study is unique in that it shows that well-being and individually held values are flexible and adaptive systems that react to external circumstances such as global critical events.	[Bojanowska, Agnieszka; Koscielniak, Maciej; Urbanska, Beata] SWPS Univ Social Sci & Humanities, Inst Psychol, Warsaw, Poland; [Kaczmarek, Lukasz D.] Adam Mickiewicz Univ, Dept Psychol & Cognit Sci, Poznan, Poland	SWPS University of Social Sciences & Humanities; Adam Mickiewicz University	Bojanowska, A (corresponding author), SWPS Univ Social Sci & Humanities, Inst Psychol, Warsaw, Poland.	abojanowska@swps.edu.pl	Bojanowska, Agnieszka/ABC-5728-2021; Kościelniak, Maciej/AAH-4265-2021	Kościelniak, Maciej/0000-0003-3452-864X; Bojanowska, Agnieszka/0000-0003-0932-6915; Kaczmarek, Lukasz/0000-0001-5565-8334	Polish National Science Center [2017/26/D/HS6/00439]	Polish National Science Center	The study was supported by the Polish National Science Center, grant number 2017/26/D/HS6/00439, awarded to AB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed MZ, 2020, ASIAN J PSYCHIATR, V51, DOI 10.1016/j.ajp.2020.102092; Anusic I, 2014, J RES PERS, V51, P69, DOI 10.1016/j.jrp.2014.04.009; Arieli S, 2014, J PERS, V82, P15, DOI 10.1111/jopy.12029; Bardi A, 2003, PERS SOC PSYCHOL B, V29, P1207, DOI 10.1177/0146167203254602; Bardi A, 2011, J CROSS CULT PSYCHOL, V42, P271, DOI 10.1177/0022022110396916; Batz C., 2018, HDB WELL BEING; Bojanowska A, 2016, J HAPPINESS STUD, V17, P793, DOI 10.1007/s10902-015-9620-1; Bonetto E, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0253430; Brickman P., 1971, ADAPTATION LEVEL THE, P287, DOI DOI 10.3389/FPSYG.2018.01158; Cao JY, 2020, PSYCHOTHER PSYCHOSOM, V89, P252, DOI 10.1159/000507453; Cieciuch J., 2013, KSZTALTOWANIE SIE SY, DOI [10.1111/jopy.12065, DOI 10.1111/JOPY.12065]; COSTA PT, 1980, J PERS SOC PSYCHOL, V38, P668, DOI 10.1037/0022-3514.38.4.668; Daniel E, 2013, J ADOLESCENCE, V36, P651, DOI 10.1016/j.adolescence.2013.03.009; Diener E, 2000, AM PSYCHOL, V55, P34, DOI 10.1037/0003-066X.55.1.34; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; Feather NT, 1996, ONT SYMP P, V8, P215; Gibson J.J., 1977, PERCEIVING ACTING KN, V1, P67, DOI [DOI 10.2307/1421838, 10.4324/9781315740218]; Gudmundsdottir DG, 2013, SOC INDIC RES, V110, P1083, DOI 10.1007/s11205-011-9973-8; HEADEY B, 1989, J PERS SOC PSYCHOL, V57, P731, DOI 10.1037/0022-3514.57.4.731; Holmes EA, 2020, LANCET PSYCHIAT, V7, P547, DOI 10.1016/S2215-0366(20)30168-1; Inglehart R, 2000, AM SOCIOL REV, V65, P19, DOI 10.2307/2657288; Jankowski KS, 2015, BIOL RHYTHM RES, V46, P237, DOI 10.1080/09291016.2014.985000; Kachanoff F., 2020, MEASURING 2 DISTINCT, DOI [10.1037/pspi0000217, DOI 10.1037/PSPI0000217]; Kashdan T.B., 2008, J POSIT PSYCHOL, V8, P219, DOI [10.1080/17439760802303044, https://doi.org/10.1080/17439760802303044, DOI 10.1080/17439760802303044]; Kim-Prieto C., 2005, J HAPPINESS STUD, V6, P261, DOI [10.1007/s10902-005-7226-8, DOI 10.1007/S10902-005-7226-8]; Klym-Guba M, 2018, HEALTH PSYCHOL REP, V6, P273, DOI 10.5114/hpr.2018.75684; Lades LK, 2020, BRIT J HEALTH PSYCH, V25, P902, DOI 10.1111/bjhp.12450; Lewin K., 1952, READINGS SOCIAL PSYC, P459; Lucas RE, 2004, PSYCHOL SCI, V15, P8, DOI 10.1111/j.0963-7214.2004.01501002.x; Lykken D, 1996, PSYCHOL SCI, V7, P186, DOI 10.1111/j.1467-9280.1996.tb00355.x; Lynn R, 1997, J SOC PSYCHOL, V137, P369, DOI 10.1080/00224549709595447; Lyubomirsky S, 2005, REV GEN PSYCHOL, V9, P111, DOI 10.1037/1089-2680.9.2.111; Lyubomirsky S, 2011, EMOTION, V11, P391, DOI 10.1037/a0022575; Maio GR, 2009, J PERS SOC PSYCHOL, V97, P699, DOI 10.1037/a0016420; Mongrain M, 2012, J CLIN PSYCHOL, V68, DOI 10.1002/jclp.21839; Odou N, 2013, SOC INDIC RES, V110, P111, DOI 10.1007/s11205-011-9919-1; Rohan MJ, 2000, PERS SOC PSYCHOL REV, V4, P255, DOI 10.1207/S15327957PSPR0403_4; Sagiv L, 2000, EUR J SOC PSYCHOL, V30, P177, DOI 10.1002/(SICI)1099-0992(200003/04)30:2<177::AID-EJSP982>3.0.CO;2-Z; Schwartz S. H., 2018, HDB WELL BEING, P1; SCHWARTZ S.H., 2012, ONLINE READINGS PSYC, V2, DOI [10.9707/2307-0919.1116, DOI 10.9707/2307-0919.1116]; SCHWARTZ SH, 1992, ADV EXP SOC PSYCHOL, V25, P1, DOI 10.1016/s0065-2601(08)60281-6; Schwartz SH, 2022, ASSESSMENT, V29, P1005, DOI 10.1177/1073191121998760; Seligman MEP, 2005, AM PSYCHOL, V60, P410, DOI 10.1037/0003-066X.60.5.410; Sheldon K. M, 2006, J POSIT PSYCHOL, V1, P73, DOI DOI 10.1080/17439760500510676; Sibley CG, 2020, AM PSYCHOL, V75, P618, DOI 10.1037/amp0000662; Sin NL, 2009, J CLIN PSYCHOL, V65, P467, DOI 10.1002/jclp.20593; Sortheix FM, 2019, SOC PSYCHOL PERS SCI, V10, P15, DOI 10.1177/1948550617732610; Sortheix FM, 2017, EUR J PERSONALITY, V31, P187, DOI 10.1002/per.2096; Ueda M, 2020, PSYCHIAT CLIN NEUROS, V74, P505, DOI 10.1111/pcn.13105; VEENHOVEN R, 1994, SOC INDIC RES, V32, P101, DOI 10.1007/BF01078732; Verkasalo M, 2006, J APPL SOC PSYCHOL, V36, P144, DOI 10.1111/j.0021-9029.2006.00007.x; Waterman AS, 2010, J POSIT PSYCHOL, V5, P41, DOI 10.1080/17439760903435208; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; Xiang YT, 2020, LANCET PSYCHIAT, V7, P228, DOI 10.1016/S2215-0366(20)30046-8	54	9	9	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2021	16	9							e0255491	10.1371/journal.pone.0255491	http://dx.doi.org/10.1371/journal.pone.0255491			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	WG6DR	34525095	Green Published, gold			2022-12-26	WOS:000707084400010
J	Gottschalk, A; Scafidi, S; Toung, TJK				Gottschalk, Allan; Scafidi, Susanna; Toung, Thomas J. K.			Brain water as a function of age and weight in normal rats	PLOS ONE			English	Article							RESONANCE; FUROSEMIDE; MANNITOL	Rats are frequently used for studying water content of normal and injured brain, as well as changes in response to various osmotherapeutic regimens. Magnetic resonance imaging in humans has shown that brain water content declines with age as a result of progressive myelination and other processes. The purpose of this study was to quantify changes in brain water content during rat development and aging. Brain water content was measured by standard techniques in 129 normal male Sprague-Dawley rats that ranged in age (weight) from 13 to 149 days (18 to 759 g). Overall, the results demonstrated a decrease in water content from 85.59% to 76.56% with increasing age (weight). Nonlinear allometric functions relating brain water to age and weight were determined. These findings provide age-related context for prior rat studies of brain water, emphasize the importance of using similarly aged controls in studies of brain water, and indicate that age-related changes in brain water content are not specific to humans.	[Gottschalk, Allan; Scafidi, Susanna; Toung, Thomas J. K.] Johns Hopkins Univ, Dept Anesthesiol, Baltimore, MD 21218 USA; [Gottschalk, Allan; Scafidi, Susanna; Toung, Thomas J. K.] Johns Hopkins Univ, Dept Crit Care Med, Baltimore, MD 21218 USA; [Gottschalk, Allan] Johns Hopkins Univ, Dept Neurosurg, Baltimore, MD 21218 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Gottschalk, A (corresponding author), Johns Hopkins Univ, Dept Anesthesiol, Baltimore, MD 21218 USA.; Gottschalk, A (corresponding author), Johns Hopkins Univ, Dept Crit Care Med, Baltimore, MD 21218 USA.; Gottschalk, A (corresponding author), Johns Hopkins Univ, Dept Neurosurg, Baltimore, MD 21218 USA.	agottschalk@jhmi.edu		Gottschalk, Allan/0000-0003-0471-728X	NICHD NIH HHS [P50 HD103538] Funding Source: Medline; NINDS NIH HHS [R01 NS111230, R01 NS110808] Funding Source: Medline	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ELLIOTT KAC, 1949, AM J PHYSIOL, V157, P122, DOI 10.1152/ajplegacy.1949.157.1.122; Farhat MY, 1996, FASEB J, V10, P615, DOI 10.1096/fasebj.10.5.8621060; Filo S, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11319-1; GIRARD N, 1991, J NEURORADIOLOGY, V18, P291; KREIS R, 1993, MAGNET RESON MED, V30, P424, DOI 10.1002/mrm.1910300405; NOHYNEK GJ, 1993, HUM EXP TOXICOL, V12, P87, DOI 10.1177/096032719301200201; Papangelou A, 2013, NEUROCRIT CARE, V18, P106, DOI 10.1007/s12028-012-9768-z; Quinn R, 2005, NUTRITION, V21, P775, DOI 10.1016/j.nut.2005.04.002; de Santiago HAR, 2015, ACTA CIR BRAS, V30, P743, DOI 10.1590/S0102-865020150110000004; Semple BD, 2013, PROG NEUROBIOL, V106, P1, DOI 10.1016/j.pneurobio.2013.04.001; Stevens Charles F, 2009, J Biol, V8, P14, DOI 10.1186/jbiol119; Sulyok E, 2001, BIOL NEONATE, V79, P67, DOI 10.1159/000047068; Taubert M, 2020, NEUROBIOL AGING, V88, P108, DOI 10.1016/j.neurobiolaging.2020.01.006; Thenuwara K, 2002, ANESTHESIOLOGY, V96, P416, DOI 10.1097/00000542-200202000-00029; Wang LC, 2013, ANESTHESIOLOGY, V118, P903, DOI 10.1097/ALN.0b013e31828156ff; Welker KM, 2012, SEMIN NEUROL, V32, P15, DOI 10.1055/s-0032-1306382; Wozniak JR, 2006, NEUROSCI BIOBEHAV R, V30, P762, DOI 10.1016/j.neubiorev.2006.06.003; Zelenina M, 2005, PEDIATR RES, V57, p47R, DOI 10.1203/01.PDR.0000159572.79074.0B	18	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2021	16	9							e0249384	10.1371/journal.pone.0249384	http://dx.doi.org/10.1371/journal.pone.0249384			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	WG6DR	34525113	gold, Green Published, Green Submitted			2022-12-26	WOS:000707084400002
J	Gundala, RR; Singh, A				Gundala, Raghava R.; Singh, Anupam			What motivates consumers to buy organic foods? Results of an empirical study in the United States	PLOS ONE			English	Article							REASONED ACTION; SUSTAINABLE CONSUMPTION; HEALTH CONSCIOUSNESS; PURCHASE INTENTION; SUBJECTIVE NORMS; BEHAVIOR; DETERMINANTS; ATTITUDES; KNOWLEDGE; PRODUCTS	Consumers perceive organic foods as more nutritious, natural, and environmentally friendly than non-organic or conventional foods. Since organic foods developed, studies on consumer behavior and organic foods have contributed significantly to its development. The presesent study aims to identify the factors affecting consumer buying behaviour toward organic foods in the United States. Survey data are collected from 770 consumers in the Midwest, United States. ANOVA, multiple linear regression, factor analysis, independent t-tests, and hierarchical multiple regression analysis are used to analyze the collected primary data. This research confirms health consciousness, consumer knowledge, perceived or subjective norms, and perception of price influence consumers' attitudes toward buying organic foods. Availability is another factor that affected the purchase intentions of consumers. Age, education, and income are demographic factors that also impact consumers' buying behavior. The findings help marketers of organic foods design strategies to succeed in the US's fast-growing organic foods market.	[Gundala, Raghava R.] Univ Wisconsin Parkside, Dept Business, Kenosha, WI USA; [Singh, Anupam] Nicolaus Copernicus Univ, Fac Econ Sci & Management, Torun, Poland	University of Wisconsin System; University of Wisconsin Parkside; Nicolaus Copernicus University	Singh, A (corresponding author), Nicolaus Copernicus Univ, Fac Econ Sci & Management, Torun, Poland.	anupam.nitb@gmail.com		Singh, Anupam/0000-0002-4085-2537				Aertsens J, 2009, BRIT FOOD J, V111, P1140, DOI 10.1108/00070700910992961; AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T; Aryal K. P., 2009, Journal of Agriculture and Environment, V10, P12; BAGOZZI RP, 1992, J CONSUM RES, V18, P505, DOI 10.1086/209277; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Bhaskaran S, 2006, BRIT FOOD J, V108, P677, DOI 10.1108/00070700610682355; Bourn D, 2002, CRIT REV FOOD SCI, V42, P1, DOI 10.1080/10408690290825439; Chakrabarti S, 2010, BRIT FOOD J, V112, P902, DOI 10.1108/00070701011067497; Chang MK, 1998, J BUS ETHICS, V17, P1825, DOI 10.1023/A:1005721401993; Chen MF, 2009, BRIT FOOD J, V111, P165, DOI 10.1108/00070700910931986; Chinnici G., 2002, British Food Journal, V104, P187, DOI 10.1108/00070700210425651; Chiou J.-S., 1998, PROCE NAT SCI COUN R, V9, P298; Compagnoni A, 2000, ORGANIC AGR EUROPE C; Cranfield J.A., 2003, INT FOOD AGRIBUS MAN, V6, P14; Cunningham R., 2002, GROW ORG C RED DEER; D'Souza C, 2006, CORP COMMUN, V11, P162, DOI 10.1108/13563280610661697; Davies A., 1995, British Food Journal, V97, P17, DOI 10.1108/00070709510104303; Demeritt L., ALL THINGS ORGANIC 2; Dettmann R., 2007, J FOOD DISTRIBUTION, V16, P49; Dholakia Jalpa, 2012, Journal of Human Ecology, V37, P221; Diekmann A, 1999, ENVIRON BEHAV, V31, P540, DOI 10.1177/00139169921972227; Dipeolu A. O., 2009, Asian Journal of Food and Agro-Industry, V2, pS57; Eff endi I., 2015, J BUSINESS MANAGEMEN, V4, P44; Environics International Ltd, 2001, FOOD ISS MON SURV; Finlay KA, 1999, J APPL SOC PSYCHOL, V29, P2381, DOI 10.1111/j.1559-1816.1999.tb00116.x; Fishbein M., 1975, BELIEF ATTITUDE INTE; Fotopoulos C., 2002, BRIT FOOD J, V104, P233; Garcia-Gallego A, 2011, STRATEG BEHAV ENVIRO, V1, P71, DOI 10.1561/102.00000001; Gil JM., 2000, INT FOOD AGRIBUS MAN, V3, P207, DOI [10.1016/S1096-7508(01)00040-4, DOI 10.1016/S1096-7508(01)00040-4]; Gotschi E, 2009, J ENVIRON EDUC, V41, P88, DOI 10.1080/00958960903295225; Govindasamy R., 1999, Journal of Food Distribution Research, V30, P44; Gracia A, 2007, SPAN J AGRIC RES, V5, P439, DOI 10.5424/sjar/2007054-5356; Grossman M., 1972, DEMAND HLTH THEORETI, DOI 10.7312/gros17900; Harper G. C., 2002, British Food Journal, V104, P287, DOI 10.1108/00070700210425723; Hughner R.S., 2007, J CONSUM BEHAV, V6, P94, DOI 10.1002/cb.210; Hutchins R. K., 1997, British Food Journal, V99, P336, DOI 10.1108/00070709710193998; Jensen KO, 2011, NJAS-WAGEN J LIFE SC, V58, P79, DOI 10.1016/j.njas.2011.01.005; JOLLY DA, 1989, FOOD TECHNOL-CHICAGO, V43, P60; Kao, 2008, INNOV MARKET, V4, P93; Kim HY, 2011, J CONSUM MARK, V28, P40, DOI 10.1108/07363761111101930; Liu ME, 2007, THESIS TEXAS TU LUBB; Lockie S, 2004, APPETITE, V43, P135, DOI 10.1016/j.appet.2004.02.004; Loureiro ML, 2001, J AGR RESOUR ECON, V26, P404; Mahmoud AB, 2021, SCAND J PSYCHOL, V62, P586, DOI 10.1111/sjop.12742; Mahmoud AB, 2020, BMC PUBLIC HEALTH, V20, DOI 10.1186/s12889-020-09556-x; Mahmoud AB, 2022, J FAM STUD, V28, P89, DOI 10.1080/13229400.2019.1682642; Makatouni A., 2002, British Food Journal, V104, P345, DOI 10.1108/00070700210425769; Michaelidou N, 2008, INT J CONSUM STUD, V32, P163, DOI 10.1111/j.1470-6431.2007.00619.x; Minton AP, 1997, J BUS RES, V40, P37, DOI 10.1016/S0148-2963(96)00209-3; MISRA SK, 1991, WESTERN J AGR ECON, V16, P218; Nunnally J., 1978, PSYCHOMETRIC THEORY; O'Donovan P., 2002, British Food Journal, V104, P353, DOI 10.1108/00070700210425778; Padel S, 2005, BRIT FOOD J, V107, P626, DOI 10.1108/00070700510611011; Paul J, 2012, J CONSUM MARK, V29, P412, DOI 10.1108/07363761211259223; Peattie K, 2005, QUAL MARK RES, V8, P357, DOI 10.1108/13522750510619733; Radman M, 2005, BRIT FOOD J, V107, P263, DOI 10.1108/00070700510589530; Ragavan N., 2013, PARIPEX INDIAN J RES, V2, P111; Rimal AP, 2005, BRIT FOOD J, V107, P84, DOI 10.1108/00070700510579162; Saleki ZS., 2012, INT J BUSINESS SOCIA, V3, P278; SAPP SG, 1991, J NUTR EDUC, V23, P214; Schifferstein HNJ, 1998, FOOD QUAL PREFER, V9, P119, DOI 10.1016/S0950-3293(97)00044-X; Shepherd R, 2005, AMBIO, V34, P352, DOI 10.1639/0044-7447(2005)034[0352:DOCBRT]2.0.CO;2; SHEPPARD BH, 1988, J CONSUM RES, V15, P325, DOI 10.1086/209170; SHIMP TA, 1984, J CONSUM RES, V11, P795, DOI 10.1086/209015; Singh A, 2017, J CLEAN PROD, V167, P473, DOI 10.1016/j.jclepro.2017.08.106; Smith S, 2010, AUSTRALAS MARK J, V18, P93, DOI 10.1016/j.ausmj.2010.01.001; Smith T. A., 2009, Journal of Agricultural and Applied Economics, V41, P731; Stobbelaar D. J., 2007, International Journal of Consumer Studies, V31, P349, DOI 10.1111/j.1470-6431.2006.00560.x; Tabachnick BG., 2011, USING MULTIVARIATE S, V6th; Tanner C, 2003, PSYCHOL MARKET, V20, P883, DOI 10.1002/mar.10101; Tarkiainen A, 2005, BRIT FOOD J, V107, P808, DOI 10.1108/00070700510629760; TechSci, 2017, GLOB ORG FOOD MARK P; Thogersen J, 2016, J CLEAN PROD, V134, P214, DOI 10.1016/j.jclepro.2015.06.036; Thompson GD, 1998, AM J AGR ECON, V80, P1113, DOI 10.2307/1244214; Tregear A., 1994, British Food Journal, V96, P21, DOI 10.1108/00070709410061032; van Doorn J, 2011, INT J RES MARK, V28, P167, DOI 10.1016/j.ijresmar.2011.02.005; Vermeir I, 2004, 121 GHENT U; Vermeir I, 2008, ECOL ECON, V64, P542, DOI 10.1016/j.ecolecon.2007.03.007; Voon JP, 2011, INT FOOD AGRIBUS MAN, V14, P103; Wheale P., 2007, BUS STRATEG ENVIRON, V16, P302; WILKINS JL, 1994, J NUTR EDUC, V26, P26; Young W, 2010, SUSTAIN DEV, V18, P20, DOI 10.1002/sd.394	82	4	5	5	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2021	16	9							e0257288	10.1371/journal.pone.0257288	http://dx.doi.org/10.1371/journal.pone.0257288			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	XM9EM	34506582	gold, Green Published			2022-12-26	WOS:000729120700128
J	Zhang, NN; Teng, ZW; Li, PT; Fu, T; Lian, HX; Wang, LF; Gao, TY				Zhang, Ningning; Teng, Zhanwei; Li, Pengtao; Fu, Tong; Lian, Hongxia; Wang, Linfeng; Gao, Tengyun			Oscillating dietary crude protein concentrations increase N retention of calves by affecting urea-N recycling and nitrogen metabolism of rumen bacteria and epithelium	PLOS ONE			English	Article							QUALITY; SUPPLEMENTATION; PERFORMANCE; TRANSPORT; CELLS; ACIDS	The purpose of this study was to investigate the effects of oscillating crude protein (CP) concentration diet on the nitrogen utilization efficiency (NUE) of calves and determine its mechanism. Twelve Holstein calves were assigned randomly into static protein diet (SP, 149 g/kg CP) and oscillating protein diet (OP, 125 and 173 g/kg CP diets oscillated at 2-d intervals) groups. After 60 days of feeding, the weights of total stomach, rumen and omasum tended to increase in calves fed OP. The apparent crude fat digestibility, NUE and energy metabolism also increased. In terms of urea-N kinetics evaluated by urea-(NN)-N-15-N-15 isotope labeling method, the urea-N production and that entry to gastrointestinal tended to increase, and urea-N reused for anabolism increased significantly in calves fed OP during the low protein phase. These data indicate that urea-N recycling contributed to improving NUE when dietary protein concentration was low. In addition, the differentially expressed genes in rumen epithelium and the rumen bacteria involved in protein and energy metabolism promoted the utilization of dietary protein in calves fed OP.	[Zhang, Ningning; Teng, Zhanwei; Li, Pengtao; Fu, Tong; Lian, Hongxia; Wang, Linfeng; Gao, Tengyun] Henan Agr Univ, Coll Anim Sci & Technol, Zhengzhou, Henan, Peoples R China	Henan Agricultural University	Gao, TY (corresponding author), Henan Agr Univ, Coll Anim Sci & Technol, Zhengzhou, Henan, Peoples R China.	dairycow@163.com	wang, lin/GSE-3040-2022; wang, lili/HDL-7210-2022		China Agriculture Research System [CARS-36]; National Natural Science Foundation of China [31702138]	China Agriculture Research System; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	TG received funding from the China Agriculture Research System (grant number CARS-36). HL received funding from the National Natural Science Foundation of China (grant number 31702138). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archibeque SL, 2007, J ANIM SCI, V85, P997, DOI 10.2527/jas.2006-547; Berends H, 2014, J NUTR, V144, P1043, DOI 10.3945/jn.114.191353; Berry D, 2016, ENVIRON MICROBIOL, V18, P2081, DOI 10.1111/1462-2920.13225; BRODERICK GA, 1980, J DAIRY SCI, V63, P64, DOI 10.3168/jds.S0022-0302(80)82888-8; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Cole NA, 2003, J ANIM SCI, V81, P2660; Cole NA, 1999, J ANIM SCI, V77, P215; Cui HX, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01560-3; Doranalli K, 2011, J NUTR, V141, P560, DOI 10.3945/jn.110.133876; Elfers K, 2015, BRIT J NUTR, V114, P1949, DOI 10.1017/S000711451500375X; Evans CC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092193; Kim D, 2015, NAT METHODS, V12, P357, DOI [10.1038/NMETH.3317, 10.1038/nmeth.3317]; Lagkouvardos I, 2019, MICROBIOME, V7, DOI 10.1186/s40168-019-0637-2; Lapebie P, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10068-5; Latham EA, 2018, J ANIM SCI, V96, P1032, DOI 10.1093/jas/sky023; Li FY, 2019, MICROBIOME, V7, DOI 10.1186/s40168-019-0618-5; Li ZP, 2020, FRONT MICROBIOL, V11, DOI 10.3389/fmicb.2020.00244; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lobley GE, 2000, BRIT J NUTR, V84, P459, DOI 10.1017/S0007114500001768; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Lu ZY, 2015, AM J PHYSIOL-REG I, V308, pR283, DOI 10.1152/ajpregu.00323.2014; Ludden PA, 2002, J ANIM SCI, V80, P3021; Matthews C, 2019, GUT MICROBES, V10, P115, DOI 10.1080/19490976.2018.1505176; Moedas MF, 2017, ANAL BIOCHEM, V535, P47, DOI 10.1016/j.ab.2017.07.025; Mori Hiroshi, 2014, DNA Res, V21, P217, DOI 10.1093/dnares/dst052; Muscher AS, 2010, J ANIM SCI, V88, P3390, DOI 10.2527/jas.2010-2949; Ogunade I, 2019, ANIMALS-BASEL, V9, DOI 10.3390/ani9010028; Ormerod KL, 2016, MICROBIOME, V4, DOI 10.1186/s40168-016-0181-2; Pan XH, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01818; Reynolds C K, 2008, J Anim Sci, V86, pE293; Saeedi S, 2017, J ANIM PHYSIOL AN N, V101, P81, DOI 10.1111/jpn.12511; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; Shi L, 2018, CELL BIOL TOXICOL, V34, P109, DOI 10.1007/s10565-017-9405-x; Smith BJ, 2019, BMC MICROBIOL, V19, DOI 10.1186/s12866-019-1494-7; Steele MA, 2015, J DAIRY SCI, V98, P2583, DOI 10.3168/jds.2014-8640; Sun ZQ, 2019, MICROORGANISMS, V7, DOI 10.3390/microorganisms7110562; Wang LZ, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.00239; Wickersham TA, 2008, J ANIM SCI, V86, P3089, DOI 10.2527/jas.2007-0326	39	1	1	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2021	16	9							e0257417	10.1371/journal.pone.0257417	http://dx.doi.org/10.1371/journal.pone.0257417			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XM9EM	34506606	Green Published, gold			2022-12-26	WOS:000729120700040
J	Stromberg, BR; Singh, M; Torres, AE; Burrows, AC; Pal, D; Insinna, C; Rhee, Y; Dickson, AS; Westlake, CJ; Summers, MK				Stromberg, Benjamin R.; Singh, Mayank; Torres, Adrian E.; Burrows, Amy C.; Pal, Debjani; Insinna, Christine; Rhee, Yosup; Dickson, Andrew S.; Westlake, Christopher J.; Summers, Matthew K.			The deubiquitinating enzyme USP37 enhances CHK1 activity to promote the cellular response to replication stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-DAMAGE CHECKPOINT; FORK PROGRESSION; TARGETS CHK1; E3 LIGASE; CLASPIN; ACTIVATION; STABILITY; PHOSPHORYLATION; DEGRADATION; MYC	The deubiquitinating enzyme USP37 is known to contribute to timely onset of S phase and progression of mitosis. However, it is not clear if USP37 is required beyond S-phase entry despite expression and activity of USP37 peaking within S phase. We have utilized flow cytometry and microscopy to analyze populations of replicating cells labeled with thymidine analogs and monitored mitotic entry in synchronized cells to determine that USP37-depleted cells exhibited altered S-phase kinetics. Further analysis revealed that cells depleted of USP37 harbored increased levels of the replication stress and DNA damage markers gamma H2AX and 53BP1 in response to perturbed replication. Depletion of USP37 also reduced cellular proliferation and led to increased sensitivity to agents that induce replication stress. Underlying the increased sensitivity, we found that the checkpoint kinase 1 is destabilized in the absence of USP37, attenuating its function. We further demonstrated that USP37 deubiquitinates checkpoint kinase 1, promoting its stability. Together, our results establish that USP37 is required beyond S-phase entry to promote the efficiency and fidelity of replication. These data further define the role of USP37 in the regulation of cell proliferation and contribute to an evolving understanding of USP37 as a multifaceted regulator of genome stability.	[Stromberg, Benjamin R.; Singh, Mayank; Torres, Adrian E.; Pal, Debjani; Rhee, Yosup; Summers, Matthew K.] Ohio State Univ, Dept Radiat Oncol, Arthur G James Comprehens Canc Ctr, Columbus, OH 43210 USA; [Stromberg, Benjamin R.; Singh, Mayank; Torres, Adrian E.; Pal, Debjani; Rhee, Yosup; Summers, Matthew K.] Ohio State Univ, Richard L Solove Res Inst, Columbus, OH 43210 USA; [Stromberg, Benjamin R.] Ohio State Univ, Biomed Sci Grad Program, Columbus, OH 43210 USA; [Burrows, Amy C.; Dickson, Andrew S.] Cleveland Clin, Lerner Res Inst, Dept Canc Biol, Cleveland, OH 44106 USA; [Insinna, Christine; Westlake, Christopher J.] NCI, Frederick Natl Lab, Lab Cellular & Dev Signaling, Frederick, MD 21701 USA; [Singh, Mayank] BRAIRCH AIIMS Delhi, Dept Med Oncol Lab, Delhi 110029, India; [Pal, Debjani] Oak Ridge Natl Lab, Biosci Div, Oak Ridge, TN 37830 USA	James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Cleveland Clinic Foundation; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); United States Department of Energy (DOE); Oak Ridge National Laboratory	Summers, MK (corresponding author), Ohio State Univ, Dept Radiat Oncol, Arthur G James Comprehens Canc Ctr, Columbus, OH 43210 USA.; Summers, MK (corresponding author), Ohio State Univ, Richard L Solove Res Inst, Columbus, OH 43210 USA.	matthew.summers@osumc.edu	Singh, Mayank/ABE-5733-2021	Singh, Mayank/0000-0003-0728-1936; Burrows, Amy/0000-0002-3988-5673	Ohio State University Comprehensive Cancer Center/Depart-ment of Radiation Oncology start-up funds; NIH [R01 GM112895, R01 GM108743]	Ohio State University Comprehensive Cancer Center/Depart-ment of Radiation Oncology start-up funds; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by The Ohio State University Comprehensive Cancer Center/Depart-ment of Radiation Oncology start-up funds and the NIH grants R01 GM112895 and R01 GM108743 to M. K. S. The content of this work is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.	Alonso-de Vega I, 2014, CELL CYCLE, V13, P3921, DOI 10.4161/15384101.2014.973324; Bartkova J, 2006, NATURE, V444, P633, DOI 10.1038/nature05268; Bassermann F, 2008, CELL, V134, P256, DOI 10.1016/j.cell.2008.05.043; Bester AC, 2011, CELL, V145, P435, DOI 10.1016/j.cell.2011.03.044; Burrows AC, 2012, J BIOL CHEM, V287, P39021, DOI 10.1074/jbc.M112.390328; Cassidy KB, 2020, FEBS J, V287, P1985, DOI 10.1111/febs.15132; Cimprich KA, 2008, NAT REV MOL CELL BIO, V9, P616, DOI 10.1038/nrm2450; Das CM, 2013, ONCOGENE, V32, P1691, DOI 10.1038/onc.2012.182; Dimri M, 2015, ZEBRAFISH, V12, P33, DOI 10.1089/zeb.2014.0992; Faustrup H, 2009, J CELL BIOL, V184, P13, DOI 10.1083/jcb.200807137; Gao DM, 2009, MOL BIOL CELL, V20, P3305, DOI 10.1091/mbc.E09-01-0092; Ghiselli G, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-52; Gong EY, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-35616-9; Guervilly JH, 2011, HUM MOL GENET, V20, P2171, DOI 10.1093/hmg/ddr103; Halazonetis TD, 2008, SCIENCE, V319, P1352, DOI 10.1126/science.1140735; Han XZ, 2016, J BIOL CHEM, V291, P12951, DOI 10.1074/jbc.M115.713248; Hao J, 2015, EMBO J, V34, P2096, DOI 10.15252/embj.201488016; Hernandez-Perez S, 2016, MOL ONCOL, V10, P1196, DOI 10.1016/j.molonc.2016.05.008; Hoglund A, 2011, CLIN CANCER RES, V17, P7067, DOI 10.1158/1078-0432.CCR-11-1198; Huang XD, 2011, MOL CELL, V42, P511, DOI 10.1016/j.molcel.2011.03.027; Huh J, 2013, MOL CELL BIOL, V33, P213, DOI 10.1128/MCB.00847-12; Ishaq O, 2013, I S BIOMED IMAGING, P902; Kim JO, 2015, ONCOTARGET, V6, P36551, DOI 10.18632/oncotarget.5336; Koundrioukoff S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003643; Kurose A, 2006, CELL PROLIFERAT, V39, P231, DOI 10.1111/j.1365-2184.2006.00380.x; Langheinrich U, 2002, CURR BIOL, V12, P2023, DOI 10.1016/S0960-9822(02)01319-2; Lee KY, 2013, J CELL BIOL, V200, P31, DOI 10.1083/jcb.201206084; Leung-Pineda V, 2009, CANCER RES, V69, P2630, DOI 10.1158/0008-5472.CAN-08-3382; Mailand N, 2006, MOL CELL, V23, P307, DOI 10.1016/j.molcel.2006.06.016; Mamely I, 2006, CURR BIOL, V16, P1950, DOI 10.1016/j.cub.2006.08.026; Martin Y, 2015, ONCOGENE, V34, P1058, DOI 10.1038/onc.2014.38; Maya-Mendoza A, 2007, EMBO J, V26, P2719, DOI 10.1038/sj.emboj.7601714; McGarry E, 2016, CANCER RES, V76, P2384, DOI 10.1158/0008-5472.CAN-15-2890; Merry C, 2010, CELL CYCLE, V9, P279, DOI 10.4161/cc.9.2.10445; Moses N, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9102237; Murga M, 2011, NAT STRUCT MOL BIOL, V18, P1331, DOI 10.1038/nsmb.2189; Nusinow DP, 2020, CELL, V180, P387, DOI 10.1016/j.cell.2019.12.023; Pal D, 2020, CELL DEATH DIS, V11, DOI 10.1038/s41419-020-2493-1; Pan J, 2015, ONCOGENE, V34, P3957, DOI 10.1038/onc.2014.327; Peschiaroli A, 2006, MOL CELL, V23, P319, DOI 10.1016/j.molcel.2006.06.013; Petermann E, 2006, MOL CELL BIOL, V26, P3319, DOI 10.1128/MCB.26.8.3319-3326.2006; Petermann E, 2010, P NATL ACAD SCI USA, V107, P16090, DOI 10.1073/pnas.1005031107; Qin T, 2018, J EXP CLIN CANC RES, V37, DOI 10.1186/s13046-018-0934-9; Robu ME, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047658; Sato K, 2012, CURR BIOL, V22, P1659, DOI 10.1016/j.cub.2012.07.034; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schoppy DW, 2012, J CLIN INVEST, V122, P241, DOI 10.1172/JCI58928; Shanmugam I, 2014, J BIOL CHEM, V289, P22739, DOI 10.1074/jbc.M114.550459; Tu YF, 2017, NUCLEIC ACIDS RES, V45, P4532, DOI 10.1093/nar/gkx095; Typas D, 2015, NUCLEIC ACIDS RES, V43, P6919, DOI 10.1093/nar/gkv613; Wang JN, 2012, CANCER RES, V72, P3786, DOI 10.1158/0008-5472.CAN-12-0523; Wang X, 2006, MOL CELL, V23, P331, DOI 10.1016/j.molcel.2006.06.022; Yeh C, 2015, CURR BIOL, V25, P2290, DOI 10.1016/j.cub.2015.07.025; Yoshizawa-Sugata N, 2009, J BIOL CHEM, V284, P20718, DOI 10.1074/jbc.M806711200; Yuan J, 2014, NUCLEIC ACIDS RES, V42, P13110, DOI 10.1093/nar/gku1034; Zhang D, 2006, CELL, V126, P529, DOI 10.1016/j.cell.2006.06.039; Zhang P, 2014, NAT CELL BIOL, V16, P864, DOI 10.1038/ncb3013; Zhang YW, 2009, MOL CELL, V35, P442, DOI 10.1016/j.molcel.2009.06.030; Zhang YW, 2005, MOL CELL, V19, P607, DOI 10.1016/j.molcel.2005.07.019; Zhu M, 2014, NUCLEIC ACIDS RES, V42, P13074, DOI 10.1093/nar/gku978	60	1	1	0	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT	2021	297	4							101184	10.1016/j.jbc.2021.101184	http://dx.doi.org/10.1016/j.jbc.2021.101184			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	WP4BY	34509474	Green Published, gold			2022-12-26	WOS:000713080600014
J	Wang, YF; Shin, I; Li, JS; Liu, AM				Wang (Amber), Yifan; Shin, Inchul; Li, Jiasong; Liu, Aimin			Crystal structure of human cysteamine dioxygenase provides a structural rationale for its function as an oxygen sensor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYSTEINE DIOXYGENASE; THIOL DIOXYGENASE; MERCAPTOSUCCINATE DIOXYGENASE; IRON CENTER; DIFFRACTION; HOMOLOG; PROLINE; ENZYME; CRYSTALLIZATION; INTERMEDIATE	Cysteamine dioxygenase (ADO) plays a vital role in regulating thiol metabolism and preserving oxygen homeostasis in humans by oxidizing the sulfur of cysteamine and N-terminal cysteine-containing proteins to their corresponding sulfinic acids using O2 as a cosubstrate. However, as the only thiol dioxygenase that processes both small-molecule and protein substrates, how ADO handles diverse substrates of disparate sizes to achieve various reactions is not understood. The knowledge gap is mainly due to the three-dimensional structure not being solved, as ADO cannot be directly compared with other known thiol dioxygenases. Herein, we report the first crystal structure of human ADO at a resolution of 1.78 angstrom with a nickel-bound metal center. Crystallization was achieved through both metal substitution and C18S/C239S double mutations. The metal center resides in a tunnel close to an entry site flanked by loops. While ADO appears to use extensive flexibility to handle substrates of different sizes, it also employs proline and proline pairs to maintain the core protein structure and to retain the residues critical for catalysis in place. This feature distinguishes ADO from thiol dioxygenases that only oxidize small-molecule substrates, possibly explaining its divergent substrate specificity. Our findings also elucidate the structural basis for ADO functioning as an oxygen sensor by modifying N-degron substrates to transduce responses to hypoxia. Thus, this work fills a gap in structure-function relationships of the thiol dioxygenase family and provides a platform for further mechanistic investigation and therapeutic intervention targeting impaired oxygen sensing.	[Wang (Amber), Yifan; Shin, Inchul; Li, Jiasong; Liu, Aimin] Univ Texas San Antonio, Dept Chem, San Antonio, TX 78249 USA	University of Texas System; University of Texas at San Antonio (UTSA)	Liu, AM (corresponding author), Univ Texas San Antonio, Dept Chem, San Antonio, TX 78249 USA.	Feradical@utsa.edu	; Liu, Aimin/C-1572-2017	Wang, Yifan/0000-0003-0378-2469; Liu, Aimin/0000-0002-4182-8176; Shin, Inchul/0000-0001-8111-8948; Li, Jiasong (Jason)/0000-0003-0341-2038	National Science Foundation [CHE-1808637]; Uni-versity of Texas at San Antonio (Lutcher Brown Endowment)	National Science Foundation(National Science Foundation (NSF)); Uni-versity of Texas at San Antonio (Lutcher Brown Endowment)	The work is supported by National Science Foundation Grants CHE-1808637 and the Uni-versity of Texas at San Antonio (Lutcher Brown Endowment) (to A. L.).	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Aloi S, 2019, BIOCHEMISTRY-US, V58, P2398, DOI 10.1021/acs.biochem.9b00079; Birtley JR, 2005, ACTA CRYSTALLOGR D, V61, P646, DOI 10.1107/S0907444905007924; Brandt U, 2019, ENZYME MICROB TECH, V120, P61, DOI 10.1016/j.enzmictec.2018.09.007; Brandt U, 2014, J BIOL CHEM, V289, P30800, DOI 10.1074/jbc.M114.579730; Bruland N, 2009, J BIOL CHEM, V284, P660, DOI 10.1074/jbc.M806762200; CAVALLINI D, 1963, J BIOL CHEM, V238, P2999; Chen Y, 2013, STRUCTURE FUNCTION S; Chen ZZ, 2021, J STRUCT BIOL, V213, DOI 10.1016/j.jsb.2020.107663; Cisbani G, 2015, NEUROBIOL DIS, V82, P430, DOI 10.1016/j.nbd.2015.07.012; Dominy JE, 2008, J BIOL CHEM, V283, P12188, DOI 10.1074/jbc.M800044200; Dominy JE, 2006, J BACTERIOL, V188, P5561, DOI 10.1128/JB.00291-06; Driggers CM, 2015, PROTEIN SCI, V24, P154, DOI 10.1002/pro.2587; Driggers CM, 2013, J MOL BIOL, V425, P3121, DOI 10.1016/j.jmb.2013.05.028; Dominy J, 2007, J BIOL CHEM, V282, P25189, DOI 10.1074/jbc.M703089200; Elias RD, 2020, P NATL ACAD SCI USA, V117, P24274, DOI 10.1073/pnas.2010635117; Fernandez RL, 2020, BIOCHEMISTRY-US, V59, P2450, DOI 10.1021/acs.biochem.0c00267; Forbes DL, 2020, BIOCHEMISTRY-US, V59, P2022, DOI 10.1021/acs.biochem.9b01085; Huter P, 2017, MOL CELL, V68, P515, DOI 10.1016/j.molcel.2017.10.014; Kay BK, 2000, FASEB J, V14, P231, DOI 10.1096/fasebj.14.2.231; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Li JS, 2019, BIOCHEMISTRY-US, V58, P2218, DOI 10.1021/acs.biochem.9b00006; Li JS, 2018, NAT CHEM BIOL, V14, P853, DOI 10.1038/s41589-018-0085-5; Li W, 2013, BIOCHEMISTRY-US, V52, P9104, DOI 10.1021/bi4010232; Liu FG, 2015, J BIOL CHEM, V290, P15621, DOI 10.1074/jbc.M115.650259; Martin ACR, 1995, PROTEIN ENG, V8, P1093; Masson N, 2019, SCIENCE, V365, P65, DOI 10.1126/science.aaw0112; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McCoy JG, 2006, P NATL ACAD SCI USA, V103, P3084, DOI 10.1073/pnas.0509262103; Mi W, 2008, BIOCHEM BIOPH RES CO, V368, P919, DOI 10.1016/j.bbrc.2008.02.021; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; Nishimura T, 2015, PLACENTA, V36, P693, DOI 10.1016/j.placenta.2015.02.014; Otterbein LR, 2001, SCIENCE, V293, P708, DOI 10.1126/science.1059700; Patel SB, 2004, BBA-PROTEINS PROTEOM, V1696, P67, DOI 10.1016/j.bbapap.2003.09.009; Paul BD, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.01315; Pavlov MY, 2009, P NATL ACAD SCI USA, V106, P50, DOI 10.1073/pnas.0809211106; Perschbacher KJ, 2018, PHYSIOL GENOMICS, V50, P590, DOI 10.1152/physiolgenomics.00037.2018; Pierce BS, 2015, BIOCHEMISTRY-US, V54, P7477, DOI 10.1021/acs.biochem.5b00636; Sardar S, 2019, BIOCHEMISTRY-US, V58, P5135, DOI 10.1021/acs.biochem.9b00674; Sarkar B, 2017, INT J EXP PATHOL, V98, P52, DOI 10.1111/iep.12222; Simmons CR, 2008, BIOCHEMISTRY-US, V47, P11390, DOI 10.1021/bi801546n; Simmons CR, 2006, J BIOL CHEM, V281, P18723, DOI 10.1074/jbc.M601555200; Simmons CR, 2005, ACTA CRYSTALLOGR F, V61, P1013, DOI 10.1107/S1744309105033737; Slordahl R. W. J., 2021, IL 32 IS METABOLIC R, DOI [10.1101/2021. 02.22.431638, DOI 10.1101/2021.02.22.431638]; Stipanuk MH, 2011, AMINO ACIDS, V41, P91, DOI 10.1007/s00726-010-0518-2; Tanner DR, 2009, J BIOL CHEM, V284, P34809, DOI 10.1074/jbc.M109.039040; Tchesnokov EP, 2015, J BIOL CHEM, V290, P24424, DOI 10.1074/jbc.M114.635672; Wang YF, 2020, J BIOL CHEM, V295, P11789, DOI 10.1074/jbc.RA120.013915; Wang YF, 2020, P NATL ACAD SCI USA, V117, P19720, DOI 10.1073/pnas.2005327117; Wang YF, 2018, ANGEW CHEM INT EDIT, V57, P8149, DOI 10.1002/anie.201803907; White MD, 2020, P NATL ACAD SCI USA, V117, P23140, DOI 10.1073/pnas.2000206117; White MD, 2018, J BIOL CHEM, V293, P11786, DOI 10.1074/jbc.RA118.003496; White MD, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14690; Xiong T., 2016, THESIS GEORGIA STATE; Ye S, 2007, J BIOL CHEM, V282, P3391, DOI 10.1074/jbc.M609337200; Yoon C, 2000, EMBO J, V19, P3530, DOI 10.1093/emboj/19.14.3530; York NJ, 2021, J BIOL CHEM, V296, DOI 10.1016/j.jbc.2021.100492	57	3	3	3	10	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT	2021	297	4							101176	10.1016/j.jbc.2021.101176	http://dx.doi.org/10.1016/j.jbc.2021.101176			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	WP3CW	34508780	gold, Green Published			2022-12-26	WOS:000713015100002
J	Ayala-Ortiz, CO; Farriester, JW; Pratt, CJ; Goldkamp, AK; Matts, J; Hoback, WW; Gustafson, JE; Hagen, DE				Ayala-Ortiz, Christian O.; Farriester, Jacob W.; Pratt, Carrie J.; Goldkamp, Anna K.; Matts, Jessica; Hoback, W. Wyatt; Gustafson, John E.; Hagen, Darren E.			Effect of food source availability in the salivary gland transcriptome of the unique burying beetle Nicrophorus pustulatus (Coleoptera: Silphidae)	PLOS ONE			English	Article							DIFFERENTIAL EXPRESSION ANALYSIS; MITES ACARI; CD-HIT; IDENTIFICATION; ANNOTATION; EVOLUTION; BEHAVIOR; IMMUNITY; GENOME; GENES	Nicrophorus is a genus of beetles that bury and transform small vertebrate carcasses into a brood ball coated with their oral and anal secretions to prevent decay and that will serve as a food source for their young. Nicrophorus pustulatus is an unusual species with the ability to overtake brood of other burying beetles and whose secretions, unlike other Nicrophorus species, has been reported not to exhibit antimicrobial properties. This work aims to better understand how the presence or absence of a food source influences the expression of genes involved in the feeding process of N. pustulatus. To achieve that, total RNA was extracted from pooled samples of salivary gland tissue from N. pustulatus and sequenced using an Illumina platform. The resulting reads were used to assemble a de novo transcriptome using Trinity. Duplicates with more than 95% similarity were removed to obtain a "unigene" set. Annotation of the unigene set was done using the Trinotate pipeline. Transcript abundance was determined using Kallisto and differential gene expression analysis was performed using edgeR. A total of 651 genes were found to be differentially expressed, including 390 upregulated and 261 downregulated genes in fed insects compared to starved. Several genes upregulated in fed beetles are associated with the insect immune response and detoxification processes with only one transcript encoding for the antimicrobial peptide (AMP) defensin. These results confirm that N. pustulatus does not upregulate the production of genes encoding AMPs during feeding. This study provides a snapshot of the changes in gene expression in the salivary glands of N. pustulatus following feeding while providing a well described transcriptome for the further analysis of this unique burying beetle.	[Ayala-Ortiz, Christian O.; Goldkamp, Anna K.; Hagen, Darren E.] Oklahoma State Univ, Dept Anim & Food Sci, Stillwater, OK 74078 USA; [Ayala-Ortiz, Christian O.; Farriester, Jacob W.; Pratt, Carrie J.; Hoback, W. Wyatt] Oklahoma State Univ, Dept Entomol & Plant Pathol, Stillwater, OK 74078 USA; [Matts, Jessica; Gustafson, John E.] Oklahoma State Univ, Dept Biochem & Mol Biol, Stillwater, OK 74078 USA	Oklahoma State University System; Oklahoma State University - Stillwater; Oklahoma State University System; Oklahoma State University - Stillwater; Oklahoma State University System; Oklahoma State University - Stillwater	Hagen, DE (corresponding author), Oklahoma State Univ, Dept Anim & Food Sci, Stillwater, OK 74078 USA.	darren.hagen@okstate.edu		Hagen, Darren/0000-0001-8295-020X; Ayala-Ortiz, Christian/0000-0001-8154-2378; Goldkamp, Anna/0000-0002-1510-465X; Hoback, William/0000-0002-8927-9102	United States Department of Agriculture [USDA-NIFA 1019561, USDA-NIFA 1006570]; Office of The Vice President for Research at Oklahoma State University	United States Department of Agriculture(United States Department of Agriculture (USDA)); Office of The Vice President for Research at Oklahoma State University	Support was provided by the United States Department of Agriculture (USDA-NIFA 1019561, WWH) and USDA-NIFA 1006570,JEG) and by funds from the Office of The Vice President for Research at Oklahoma State University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexa A., 2021, TOPGO ENRICHMENT ANA; Altincicek B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052004; Andrews S., 2010, FASTQC QUALITY CONTR; Arce AN, 2012, J EVOLUTION BIOL, V25, P930, DOI 10.1111/j.1420-9101.2012.02486.x; Bajerlein D, 2012, ARTHROPOD STRUCT DEV, V41, P245, DOI 10.1016/j.asd.2012.02.006; Bang Kyeongrin, 2015, J Insect Sci, V15, DOI 10.1093/jisesa/iev120; Banville N, 2012, VIRULENCE, V3, P497, DOI 10.4161/viru.21972; Bedick JC, 2004, COLEOPTS BULL, V58, P57, DOI 10.1649/602; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Benowitz KM, 2017, EVOLUTION, V71, P1999, DOI 10.1111/evo.13273; Blouin-Demers G, 2000, ECOSCIENCE, V7, P395, DOI 10.1080/11956860.2000.11682609; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Boutet Emmanuel, 2007, V406, P89; Bray NL, 2016, NAT BIOTECHNOL, V34, P888, DOI 10.1038/nbt0816-888d; Bryant DM, 2017, CELL REP, V18, P762, DOI 10.1016/j.celrep.2016.12.063; Burmester T, 1999, EUR J ENTOMOL, V96, P213; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Cunningham CB, 2015, GENOME BIOL EVOL, V7, P3383, DOI 10.1093/gbe/evv194; Degenkolb T, 2011, J CHEM ECOL, V37, P724, DOI 10.1007/s10886-011-9978-4; Eddy SR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002195; Eggert AK, 1998, ANIM BEHAV, V55, P97, DOI 10.1006/anbe.1997.0588; Esteves E, 2017, FRONT CELL INFECT MI, V7, DOI 10.3389/fcimb.2017.00476; Feyereisen R, 2012, INSECT MOLECULAR BIOLOGY AND BIOCHEMISTRY, P236, DOI 10.1016/B978-0-12-384747-8.10008-X; Finn RD, 2016, NUCLEIC ACIDS RES, V44, pD279, DOI 10.1093/nar/gkv1344; Fu LM, 2012, BIOINFORMATICS, V28, P3150, DOI 10.1093/bioinformatics/bts565; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Halffter G., 1982, BIOL SOC INS P 9 C I; Hall CL, 2011, ENVIRON ENTOMOL, V40, P669, DOI 10.1603/EN10137; Hoback WW, 2004, J CHEM ECOL, V30, P719, DOI 10.1023/B:JOEC.0000028427.53141.41; Issa N, 2018, MOL CELL, V69, P539, DOI 10.1016/j.molcel.2018.01.029; Jacobs CGC, 2016, SCI REP-UK, V6, DOI 10.1038/srep25409; Jacques BJ, 2009, J CHEM ECOL, V35, P871, DOI 10.1007/s10886-009-9680-y; Jiang H, 2010, ADV EXP MED BIOL, V708, P181; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Knee W, 2012, MOL PHYLOGENET EVOL, V65, P276, DOI 10.1016/j.ympev.2012.06.013; Koehbach J, 2017, FRONT CHEM, V5, DOI 10.3389/fchem.2017.00045; Kumar A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086012; Lagesen K, 2007, NUCLEIC ACIDS RES, V35, P3100, DOI 10.1093/nar/gkm160; LAMBERT J, 1989, P NATL ACAD SCI USA, V86, P262, DOI 10.1073/pnas.86.1.262; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; McCarthy DJ, 2012, NUCLEIC ACIDS RES, V40, P4288, DOI 10.1093/nar/gks042; Moriya Y, 2007, NUCLEIC ACIDS RES, V35, pW182, DOI 10.1093/nar/gkm321; Namazi M R, 2009, J Autoimmune Dis, V6, P4, DOI 10.1186/1740-2557-6-4; Nehring V, 2017, ECOL EVOL, V7, P10743, DOI 10.1002/ece3.3591; O'Leary NA, 2016, NUCLEIC ACIDS RES, V44, pD733, DOI 10.1093/nar/gkv1189; Palmer WJ, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2015.2733; Parker DJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9449; Parthasarathy R, 2011, INSECT BIOCHEM MOLEC, V41, P294, DOI 10.1016/j.ibmb.2011.01.006; PUKOWSKI ERNA, 1933, ZEITSCHR WISS BIOL ABT A ZEITSCHR MORPH U OKOL TIERE, V27, P518, DOI 10.1007/BF00403155; R Core Team, 2020, R LANG ENV STAT COMP; Rana RL, 1997, COMP BIOCHEM PHYS B, V118, P375, DOI 10.1016/S0305-0491(97)00105-3; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rozen DE, 2008, P NATL ACAD SCI USA, V105, P17890, DOI 10.1073/pnas.0805403105; Sayadi A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158565; Schwarz HH, 1998, J NAT HIST, V32, P159, DOI 10.1080/00222939800770101; Scott MP, 1998, ANNU REV ENTOMOL, V43, P595, DOI 10.1146/annurev.ento.43.1.595; SIKES DS, 2008, ENCY ENTOMOLOGY, P749; Simao FA, 2015, BIOINFORMATICS, V31, P3210, DOI 10.1093/bioinformatics/btv351; Smith G, 2007, J EVOLUTION BIOL, V20, P2389, DOI 10.1111/j.1420-9101.2007.01404.x; Suzuki Seizi, 2001, Entomological Science, V4, P403; TELFER WH, 1991, ANNU REV ENTOMOL, V36, P205, DOI 10.1146/annurev.en.36.010191.001225; TRUMBO ST, 1994, OIKOS, V69, P241, DOI 10.2307/3546144; Trumbo ST, 2007, BEHAV ECOL SOCIOBIOL, V61, P1717, DOI 10.1007/s00265-007-0403-5; Trumbo ST, 2007, HORM BEHAV, V51, P281, DOI 10.1016/j.yhbeh.2006.11.002; USFWS, 2016, REG 6 PRES ABS SURV; Vogel H, 2011, INSECT MOL BIOL, V20, P787, DOI 10.1111/j.1365-2583.2011.01109.x; Wang Y, 2017, APPL ENVIRON MICROB, V83, DOI 10.1128/AEM.03250-16; Waterhouse RM, 2018, MOL BIOL EVOL, V35, P543, DOI 10.1093/molbev/msx319; Won Harim I, 2018, J Genomics, V6, P41, DOI 10.7150/jgen.24228; Xu XL, 2016, INFECT GENET EVOL, V38, P62, DOI 10.1016/j.meegid.2015.12.005; Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118	72	0	0	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2021	16	9							e0255660	10.1371/journal.pone.0255660	http://dx.doi.org/10.1371/journal.pone.0255660			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XH8RH	34555059	Green Published, gold			2022-12-26	WOS:000725694500009
J	Yin, YH; Shi, FG; Zhang, YY; Zhang, XL; Ye, JY; Zhang, JX				Yin, Yuhuan; Shi, Fugui; Zhang, Yiyin; Zhang, Xiaoli; Ye, Jianying; Zhang, Juxia			Evaluation of reporting quality of randomized controlled trials in patients with COVID-19 using the CONSORT statement	PLOS ONE			English	Article							METHODOLOGICAL QUALITY; CLINICAL-TRIALS; REGISTRATION; GUIDELINES; OUTCOMES; SURGERY	Objective To evaluate the reporting quality of randomized controlled trials (RCTs) regarding patients with COVID-19 and analyse the influence factors. Methods PubMed, Embase, Web of Science and the Cochrane Library databases were searched to collect RCTs regarding patients with COVID-19. The retrieval time was from the inception to December 1, 2020. The CONSORT 2010 statement was used to evaluate the overall reporting quality of these RCTs. Results 53 RCTs were included. The study showed that the average reporting rate for 37 items in CONSORT checklist was 53.85% with mean overall adherence score of 13.023.546 (ranged: 7 to 22). The multivariate linear regression analysis showed the overall adherence score to the CONSORT guideline was associated with journal impact factor (P = 0.006), and endorsement of CONSORT statement (P = 0.014). Conclusion Although many RCTs of COVID-19 have been published in different journals, the overall reporting quality of these articles was suboptimal, it can not provide valid evidence for clinical decision-making and systematic reviews. Therefore, more journals should endorse the CONSORT statement, authors should strictly follow the relevant provisions of the CONSORT guideline when reporting articles. Future RCTs should particularly focus on improvement of detailed reporting in allocation concealment, blinding and estimation of sample size.	[Yin, Yuhuan; Zhang, Yiyin; Zhang, Xiaoli; Ye, Jianying] Gansu Univ Chinese Med, Sch Nursing, Lanzhou, Peoples R China; [Shi, Fugui] Lanzhou Hand & Foot Surg Hosp, Lanzhou, Gansu, Peoples R China; [Zhang, Juxia] Gansu Prov Hosp, Clin Educ Dept, Lanzhou, Gansu, Peoples R China	Gansu University of Chinese Medicine	Zhang, JX (corresponding author), Gansu Prov Hosp, Clin Educ Dept, Lanzhou, Gansu, Peoples R China.	1425331412@qq.com			Horizontal project of School of Public Health of Lanzhou University "Research on the Thinking, difficulties and Countermeasures of High-quality Development of Lanzhou Hand and Foot Surgery Hospital" [071100278]; Gansu Science and Technology Plan (Innovation Base and Talent Plan) project [21JR7RA607]; Health industry scientific research project of Gansu Province [GSWSKY-2019-50]	Horizontal project of School of Public Health of Lanzhou University "Research on the Thinking, difficulties and Countermeasures of High-quality Development of Lanzhou Hand and Foot Surgery Hospital"; Gansu Science and Technology Plan (Innovation Base and Talent Plan) project; Health industry scientific research project of Gansu Province	The study was funded by Horizontal project of School of Public Health of Lanzhou University "Research on the Thinking, difficulties and Countermeasures of High-quality Development of Lanzhou Hand and Foot Surgery Hospital" (071100278), Gansu Science and Technology Plan (Innovation Base and Talent Plan) project (21JR7RA607), and Health industry scientific research project of Gansu Province (GSWSKY-2019-50), received by Fugui Shi and Juxia Zhang.	Agha RA, 2014, EUR J PLAST SURG, V37, P55, DOI 10.1007/s00238-013-0893-5; Aslam A, 2013, N AM J MED SCI, V5, P713, DOI 10.4103/1947-2714.123266; Begg C, 1996, JAMA-J AM MED ASSOC, V276, P637, DOI 10.1001/jama.276.8.637; Bigna JJR, 2016, BMC MED RES METHODOL, V16, DOI 10.1186/s12874-016-0243-y; Butcher NJ, 2020, TRIALS, V21, DOI 10.1186/s13063-020-04440-w; Calvert M, 2013, JAMA-J AM MED ASSOC, V309, P814, DOI 10.1001/jama.2013.879; Canagarajah NA, 2021, EUR ARCH OTO-RHINO-L, V278, P4125, DOI 10.1007/s00405-021-06694-9; Chen JS, 2018, J DENT, V74, P23, DOI 10.1016/j.jdent.2018.04.025; Chen YL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011926; Ghimire S, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-77; Hajibandeh S, 2015, EUR J VASC ENDOVASC, V50, P664, DOI 10.1016/j.ejvs.2015.06.114; Hajibandeh S, 2017, VASCULAR, V25, P196, DOI 10.1177/1708538116653289; Hannink G, 2013, ANN SURG, V257, P818, DOI 10.1097/SLA.0b013e3182864fa3; Hopewell S, 2008, TRIALS, V9, DOI 10.1186/1745-6215-9-20; Hrobjartsson A, 2014, INT J EPIDEMIOL, V43, P1272, DOI 10.1093/ije/dyu115; Huang YQ, 2018, J OTOLARYNGOL-HEAD N, V47, DOI 10.1186/s40463-018-0277-8; Karpouzis F, 2016, CHIROPR MAN THER, V24, DOI 10.1186/s12998-016-0099-6; Moher D, 2001, JAMA-J AM MED ASSOC, V285, P1987, DOI 10.1001/jama.285.15.1987; Ntala C, 2013, PRIM CARE RESP J, V22, P417, DOI 10.4104/pcrj.2013.00089; Pratoomsoot C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0108681; Qian GF, 2020, EVID-BASED COMPL ALT, V2020, DOI 10.1155/2020/4308380; Reveiz L, 2013, CAD SAUDE PUBLICA, V29, P1095, DOI [10.1590/S0102-311X2013000600006, 10.1590/S0102-311X2013001000006]; Savovic J, 2012, HEALTH TECHNOL ASSES, V16, P1, DOI 10.3310/hta16350; Schulz KF, 2010, J CLIN EPIDEMIOL, V63, P834, DOI [10.1016/j.jclinepi.2010.02.005, 10.1186/1741-7015-8-18, 10.1016/j.ijsu.2011.09.004, 10.4103/0976-500X.72352]; Seehra J, 2013, J EVID-BASED DENT PR, V13, P1, DOI 10.1016/j.jebdp.2012.11.001; Song F, 2010, HEALTH TECHNOL ASSES, V14, P1, DOI 10.3310/hta14080; Stevanovic A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128061; Vassar M, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2019-032024; Weber EJ, 2018, EMERG MED J, V35, P755, DOI 10.1136/emermed-2018-207763; Yao AC, 2014, EYE, V28, P1341, DOI 10.1038/eye.2014.206	30	4	4	3	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2021	16	9							e0257093	10.1371/journal.pone.0257093	http://dx.doi.org/10.1371/journal.pone.0257093			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XH8RH	34555033	Green Published, gold			2022-12-26	WOS:000725694500018
J	Kassa, GM; Arowojolu, AO; Odukogbe, ATA; Yalew, AW				Kassa, Getachew Mullu; Arowojolu, Ayodele O.; Odukogbe, Akin Tunde A.; Yalew, Alemayehu Worku			Adverse maternal outcomes of adolescent pregnancy in Northwest Ethiopia: A prospective cohort study	PLOS ONE			English	Article							COMMON MENTAL-DISORDERS; POSTPARTUM DEPRESSION; POSTNATAL-DEPRESSION; TEENAGE PREGNANCIES; PSYCHOLOGICAL DISTRESS; NEONATAL OUTCOMES; MOTHERS; CHILDBIRTH; HEALTH; DEATH	Background Adolescent pregnancy is considered a major contributor to maternal and child morbidity and mortality, the greatest concern of developing countries and an important public health issue globally. Adolescents are responsible for eleven percent of births worldwide and they face several pregnancy and childbirth related complications. However, in low-income countries like Ethiopia, there are limited researches conducted to investigate outcomes of adolescent pregnancy. Therefore, this study was conducted to assess the adverse maternal outcomes of adolescent pregnancy in Northwest Ethiopia. Methods A prospective cohort study was conducted in 12 health facilities from seven districts in East Gojjam zone, Northwest Ethiopia. A total of 418 adolescents (15-19 years old) and 836 adult women (20-34 years old) who attended randomly selected health facilities in East Gojjam zone were included. Data were collected starting from admission to the maternity ward for labor and delivery, and postnatal depression was measured at six weeks' postpartum period using the Edinburgh Postnatal Depression Scale. Generalized estimating equations (GEE) was used to account for the within subject correlation and assess the effect of different known factors that could influence the outcome of this study. Results A lower percentage of adolescent (58.4%) than adult (71.2%) women had their first antenatal care booking before 16 weeks of gestation. After adjusting for different confounding factors, the adverse outcome that was significantly associated with adolescent pregnancy was postpartum depression (AOR: 2.29; 95% CI, 1.42, 3.7, p-value = 0.001). Assisted vaginal delivery (AOR: 0.44; 95% CI, 0.23, 0.86, p-value 0.016) and cesarean section (AOR: 0.43; 95% CI, 0.19, 0.97, p-value = 0.042) were significantly lower among adolescent women. Conclusions Adolescent pregnancy is associated with higher odds of postpartum depression, and lower odds to undergo cesarean section and assisted vaginal delivery than adult women. Perinatal care services should be more adolescent-friendly to ensure early diagnosis and treatment of postpartum depression. School and community-based awareness programs regarding use of contraception to prevent unwanted adolescent pregnancy, early antenatal care booking and adverse pregnancy outcomes of adolescent pregnancy and provision of psychosocial support are recommended.	[Kassa, Getachew Mullu] Univ Ibadan, Pan African Univ Life & Earth Sci Inst, Coll Med, Dept Obstet & Gynaecol, Ibadan, Nigeria; [Kassa, Getachew Mullu] Debre Markos Univ, Coll Hlth Sci, Debre Markos, Ethiopia; [Arowojolu, Ayodele O.; Odukogbe, Akin Tunde A.] Univ Ibadan, Univ Coll Hosp, Coll Med, Dept Obstet & Gynaecol, Ibadan, Nigeria; [Yalew, Alemayehu Worku] Addis Ababa Univ, Coll Hlth Sci, Sch Publ Hlth, Addis Ababa, Ethiopia	University of Ibadan; University of Ibadan; University College Hospital, Ibadan; Addis Ababa University	Kassa, GM (corresponding author), Univ Ibadan, Pan African Univ Life & Earth Sci Inst, Coll Med, Dept Obstet & Gynaecol, Ibadan, Nigeria.; Kassa, GM (corresponding author), Debre Markos Univ, Coll Hlth Sci, Debre Markos, Ethiopia.	getachew_kassa@dmu.edu.et	Arowojolu, Ayodele/GPP-0996-2022	Arowojolu, Ayodele/0000-0002-2623-7546; Kassa, Getachew Mullu/0000-0002-8095-7376	African Union Commission (AU), Addis Ababa, Ethiopia through the Pan African University Life and Earth Science Institute (PAULESI), UI, Nigeria	African Union Commission (AU), Addis Ababa, Ethiopia through the Pan African University Life and Earth Science Institute (PAULESI), UI, Nigeria	This work was supported by the African Union Commission (AU), Addis Ababa, Ethiopia through the Pan African University Life and Earth Science Institute (PAULESI), UI, Nigeria. GMK received funding.	Abedzadeh-Kalahroudi M, 2015, NURS MIDWIFERY STUD, V4, DOI 10.17795/nmsjournal29641; Adeyinka DA, 2010, J MATERN-FETAL NEO M, V23, P785, DOI 10.3109/14767050903572166; Adhikari R, 2016, BMC WOMENS HEALTH, V16, DOI 10.1186/s12905-016-0305-7; Ali Unzila A, 2009, Rev Obstet Gynecol, V2, P5; Althabe F, 2015, REPROD HEALTH, V12, DOI 10.1186/1742-4755-12-S2-S8; Aquino Estela M. L., 2003, Cad. Saúde Pública, V19, pS377, DOI 10.1590/S0102-311X2003000800019; Atuhaire C, 2018, PAN AFR MED J, V30, DOI 10.11604/pamj.2018.30.170.15333; Ayuba II, 2012, ETHIOP J HEALTH SCI, V22, P45; Ballinger GA, 2004, ORGAN RES METHODS, V7, P127, DOI 10.1177/1094428104263672; Berhan Y, 2014, ETHIOP J HEALTH SCI, V24, P15, DOI 10.4314/ejhs.v24i0.3S; Biney AAE, 2017, REPROD HEALTH, V14, DOI 10.1186/s12978-017-0378-2; Biratu A, 2015, REPROD HEALTH, V12, DOI 10.1186/s12978-015-0092-x; Sant'Anna MJC, 2007, THESCIENTIFICWORLDJO, V7, P187, DOI 10.1100/tsw.2007.12; CDC, 2019, STATCALC STAT CALC C; Central Statistical Agency [Ethiopia] ICF International, 2012, ETH DEM HLTH SURV 20; Central statistical agency-CSA/Ethiopia ICF, 2017, ETH DEM HLTH SURV 20; Clarke K, 2014, J AFFECT DISORDERS, V156, P76, DOI 10.1016/j.jad.2013.11.018; Coley RL, 1998, AM PSYCHOL, V53, P152, DOI 10.1037/0003-066X.53.2.152; Conde-Agudelo A, 2005, AM J OBSTET GYNECOL, V192, P342, DOI 10.1016/j.ajog.2004.10.593; COX JL, 1987, BRIT J PSYCHIAT, V150, P782, DOI 10.1192/bjp.150.6.782; CSA. Central Statistical Agency, 2007, ETH POP HOUS CENS 20; de Azevedo WF, 2015, EINSTEIN-SAO PAULO, V13, P618, DOI 10.1590/S1679-45082015RW3127; de Vienne CM, 2009, EUR J OBSTET GYN R B, V147, P151, DOI 10.1016/j.ejogrb.2009.08.006; Dennis CLE, 2004, ACTA PSYCHIAT SCAND, V110, P338, DOI 10.1111/j.1600-0447.2004.00337.x; Dibaba Y, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-135; Dinwiddie KJ, 2018, J PSYCHOSOM OBST GYN, V39, P168, DOI 10.1080/0167482X.2017.1334051; East Gojjam Zone Health Office, 2017, ANN ACT REP YEAR 201; Fahim NK, 2019, ADV J EMERG MED, V3, DOI [10.22114/ajem.v0i0.104s, 10.22114/AJEM.v0i0.104s]; Fall CHD, 2015, LANCET GLOB HEALTH, V3, pE366, DOI 10.1016/S2214-109X(15)00038-8; Fleming N, 2013, J OBSTET GYNAECOL CA, V35, P234, DOI 10.1016/S1701-2163(15)30995-6; Forman DN, 2000, BRIT J OBSTET GYNAEC, V107, P1210; Fouelifack FY, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-102; Ganchimeg T, 2014, BJOG-INT J OBSTET GY, V121, P40, DOI 10.1111/1471-0528.12630; Gennari PJ., 2013, INT J CHILDBIRTH ED, V28; Gupta N, 2008, EUR J OBSTET GYN R B, V137, P165, DOI 10.1016/j.ejogrb.2007.06.013; Hanlon C, 2008, J AFFECT DISORDERS, V108, P251, DOI 10.1016/j.jad.2007.10.023; Hipwell AE, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155641; Hoffman SD., 2006, NUMBERS PUBLIC COSTS; Huang CC, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-260; Hymas R, 2019, J AFFECT DISORDERS, V246, P873, DOI 10.1016/j.jad.2018.12.041; Kassa GM, 2018, REPROD HEALTH, V15, DOI 10.1186/s12978-018-0640-2; Kassa GM, 2019, EFFECTIVENESS ADOLES; Kawakita T, 2016, J PEDIATR ADOL GYNEC, V29, P130, DOI 10.1016/j.jpag.2015.08.006; Kayastha S, 2014, NEPAL J OBSTET GYNAE, V7, P29; Khan KS, 2006, LANCET, V367, P1066, DOI 10.1016/S0140-6736(06)68397-9; Kleiber BV., 2014, POSTPARTUM DEPRESSIO; Koniak-Griffin D, 2001, J PERINAT NEONAT NUR, V15, P1; Leftwich HK, 2017, PEDIATR CLIN N AM, V64, P381, DOI 10.1016/j.pcl.2016.11.007; Lyamuya R, 2002, OBSTET OUTCOME ADOLE; Mahavarkar SH, 2008, J OBSTET GYNAECOL, V28, P604, DOI 10.1080/01443610802281831; Mayor S, 2004, BRIT MED J, V328, P1152, DOI 10.1136/bmj.328.7449.1152-a; Medhi R, 2016, ADOLESC HEALTH MED T, V7, P37, DOI 10.2147/AHMT.S91853; Mkhantswa SG, 2014, CONTRIBUTORY FACTORS; Mohammad KI, 2011, MIDWIFERY, V27, pE238, DOI 10.1016/j.midw.2010.10.008; Mollborn S, 2009, J HEALTH SOC BEHAV, V50, P310, DOI 10.1177/002214650905000305; Moraes Albertina Ngomah, 2018, Matern Health Neonatol Perinatol, V4, P20, DOI 10.1186/s40748-018-0088-y; Morris JL, 2015, INT J GYNECOL OBSTET, V131, pS40, DOI 10.1016/j.ijgo.2015.02.006; Motzfeldt I, 2013, INT J CIRCUMPOL HEAL, V72, P548, DOI 10.3402/ijch.v72i0.21114; Nabila JS, 1997, MAGNITUDE DETERMINAN; Nakku Juliet E M, 2006, Afr Health Sci, V6, P207; Narukhutrpichai Piriya, 2016, Journal of the Medical Association of Thailand, V99, P361; Naz U, 2014, JCPSP-J COLL PHYSICI, V24, P131, DOI 02.2014/JCPSP.131134; Neal S, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-1120-8; Ngowa J. D. K., 2015, OPEN J OBSTET GYNECO, V5, P88; Nove A, 2014, LANCET GLOB HEALTH, V2, pE155, DOI 10.1016/S2214-109X(13)70179-7; Oliveira FC, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-77; Paladugu RK, 2018, INT J COMMUNITY MED, V5, P4408, DOI DOI 10.18203/2394-6040.IJCMPH20183984; Pascal F, 2017, INT J REPROD CONTRAC, V5, P2228; Philemon MN, 2009, FACTORS CONTRIBUTING; Phillips SJ, 2016, INT J GYNECOL OBSTET, V132, P1, DOI 10.1016/j.ijgo.2015.10.005; Raatikainen K, 2006, EUR J PUBLIC HEALTH, V16, P157, DOI 10.1093/eurpub/cki158; Rahman A, 2004, ARCH GEN PSYCHIAT, V61, P946, DOI 10.1001/archpsyc.61.9.946; Rahman A, 2002, CHILD CARE HLTH DEV, V28, P51, DOI 10.1046/j.1365-2214.2002.00239.x; Reid Vanessa, 2007, J Pediatr Health Care, V21, P289, DOI 10.1016/j.pedhc.2006.05.010; Say Lale, 2014, Lancet Glob Health, V2, pe323, DOI 10.1016/S2214-109X(14)70227-X; Shakeel N, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-014-0420-0; Sjetne IS, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0611-3; Socolov DG, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/9205016; Stewart D.E., 2003, U HLTH NETWORK WOMEN; Tadesse E, 2000, E AFR MED J, V77, P431; Taffa Negussie, 2003, Int J Adolesc Med Health, V15, P321; Tesfaye M, 2010, J AFFECT DISORDERS, V122, P102, DOI 10.1016/j.jad.2009.06.020; Thapar A, 2012, LANCET, V379, P1056, DOI 10.1016/S0140-6736(11)60871-4; The DHS Program, 2015, DHS QUEST MAN; Vivatkusol Y, 2017, INT J WOMENS HEALTH, V9, P347, DOI 10.2147/IJWH.S128941; Walker M, 2003, AM J OBSTET GYNECOL, V189, pS153, DOI 10.1016/j.ajog.2003.10.336; Walker MC, 2004, BJOG-INT J OBSTET GY, V111, P1294, DOI 10.1111/j.1471-0528.2004.00345.x; WHO, 2014, ADOLESCENT PREGNANCY; WHO, 2018, AD HLTH RISKS SOL; Wolde Michael K, 1997, PREGNANCY OUT COME R; World Health Organization, ADOLESCENT PREGNANCY; World Health Organization, 2014, WHO REC POSTN CAR MO; World Health Organization WHO, 2012, RECOMMENDATIONS PREV; Yakubu I, 2018, REPROD HEALTH, V15, DOI 10.1186/s12978-018-0460-4; Zeteroglu S, 2005, EUR J CONTRACEP REPR, V10, P119, DOI 10.1080/13625180500131600	95	1	1	3	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2021	16	9							e0257485	10.1371/journal.pone.0257485	http://dx.doi.org/10.1371/journal.pone.0257485			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	YS4WS	34550977	Green Published, gold			2022-12-26	WOS:000750679800022
J	Alvarez-Esteban, PC; Del Barrio, E; Rueda, OM; Rueda, C				Alvarez-Esteban, Pedro C.; Del Barrio, Eustasio; Rueda, Oscar M.; Rueda, Cristina			Predicting COVID-19 progression from diagnosis to recovery or death linking primary care and hospital records in Castilla y Leon (Spain)	PLOS ONE			English	Article								This paper analyses COVID-19 patients' dynamics during the first wave in the region of Castilla y Leon (Spain) with around 2.4 million inhabitants using multi-state competing risk survival models. From the date registered as the start of the clinical process, it is assumed that a patient can progress through three intermediate states until reaching an absorbing state of recovery or death. Demographic characteristics, epidemiological factors such as the time of infection and previous vaccinations, clinical history, complications during the course of the disease and drug therapy for hospitalised patients are considered as candidate predictors. Regarding risk factors associated with mortality and severity, consistent results with many other studies have been found, such as older age, being male, and chronic diseases. Specifically, the hospitalisation (death) rate for those over 69 is 27.2% (19.8%) versus 5.3% (0.7%) for those under 70, and for males is 14.5%(7%) versus 8.3%(4.6%)for females. Among patients with chronic diseases the highest rates of hospitalisation are 26.1% for diabetes and 26.3% for kidney disease, while the highest death rate is 21.9% for cerebrovascular disease. Moreover, specific predictors for different transitions are given, and estimates of the probability of recovery and death for each patient are provided by the model. Some interesting results obtained are that for patients infected at the end of the period the hazard of transition from hospitalisation to ICU is significatively lower (p < 0.001) and the hazard of transition from hospitalisation to recovery is higher (p < 0.001). For patients previously vaccinated against pneumococcus the hazard of transition to recovery is higher (p < 0.001). Finally, internal validation and calibration of the model are also performed.	[Alvarez-Esteban, Pedro C.; Del Barrio, Eustasio; Rueda, Cristina] Univ Valladolid, Dept Stat & Operat Res, Valladolid, Spain; [Rueda, Oscar M.] Univ Cambridge, MRC Biostat Unit, Cambridge, England	Universidad de Valladolid; MRC Biostatistics Unit; University of Cambridge	Alvarez-Esteban, PC (corresponding author), Univ Valladolid, Dept Stat & Operat Res, Valladolid, Spain.	pedrocesar.alvarez@uva.es	Alvarez Esteban, Pedro Cesar/A-4446-2017; del Barrio, Eustasio/L-1019-2014	Alvarez Esteban, Pedro Cesar/0000-0002-8818-0194; Rueda Sabater, Cristina/0000-0001-9179-3154; Rueda, Oscar/0000-0003-0008-4884; del Barrio, Eustasio/0000-0003-3764-5411	NIHR Cambridge Biomedical Research Centre [BRC-1215-20014]; Medical Research Council (United Kingdom) [MC_UU_00002/16];  [MTM2017-86061-C2-0-P];  [PID2019-106363RB-I00]	NIHR Cambridge Biomedical Research Centre(National Institute for Health Research (NIHR)); Medical Research Council (United Kingdom)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); ; 	The authors are grateful to the Regional Health Service of Castilla y Leon (SACyL) for access to the data that made this study possible, and specially to M. Pilar Lobato and Teresa Sanz. PCAE and EdB are partially supported by MTM2017-86061-C2-0-P, CR by PID2019-106363RB-I00 and OMR is supported by NIHR Cambridge Biomedical Research Centre (BRC-1215-20014) and and the Medical Research Council (United Kingdom; MC_UU_00002/16).	Bhandari S, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.585850; Burn E, 2020, NATURAL HIST SYMPTOM, DOI 10.1101/2020.07.13.20152454; Calman YBL, 2020, DEV VALIDATION MACHI; Docherty AB, 2021, LANCET RESP MED, V9, P773, DOI 10.1016/S2213-2600(21)00175-2; Harrell FE, 2015, SPRINGER SER STAT, P1, DOI 10.1007/978-3-319-19425-7_1; Harrell Jr FE, 2021, **DATA OBJECT**; Kirwan PD., 2021, TRENDS RISKS SEVERE; Klein J.P., 2006, SURVIVAL ANAL TECHNI; Lin H, 2002, MODELING SURVIVAL DA, V44, P85; Mody A., 2020, AM J EPIDEMIOL; Navaratnam AV, 2021, LANCET RESP MED, V9, P397, DOI 10.1016/S2213-2600(20)30579-8; Petrilli CM, 2020, BMJ-BRIT MED J, V369, DOI [10.1136/bmj.m1966, 10.12890/2020_001747]; Pollan M, 2020, LANCET, V396, P535, DOI 10.1016/S0140-6736(20)31483-5; Putter H, 2007, STAT MED, V26, P2389, DOI 10.1002/sim.2712; Rieg S, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0242127; Rossman H, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-22214-z; Rueda OM, 2019, NATURE, V567, P399, DOI 10.1038/s41586-019-1007-8; Williamson EJ, 2020, NATURE, V584, P430, DOI 10.1038/s41586-020-2521-4; Wolkewitz M, 2020, CLIN EPIDEMIOL, V12, P925, DOI 10.2147/CLEP.S256735; Wynants L, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1328; Xu J., 2021, J INTENSIVE MED, DOI [10.1016/j.jointm.2021.03.001, DOI 10.1016/J.JOINTM.2021.03.001]; Yang Z., 2020, PROGNOSTIC VALUE SOF; Zuccaro V, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-020-80679-2	23	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2021	16	9							e0257613	10.1371/journal.pone.0257613	http://dx.doi.org/10.1371/journal.pone.0257613			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	WG6BN	34543345	gold, Green Published, Green Submitted			2022-12-26	WOS:000707078200060
J	Qi, Y; Wang, W; Qi, QJ; Ning, ZX; Yao, YL				Qi, Yun; Wang, Wei; Qi, Qingjie; Ning, Zhangxuan; Yao, Youli			Distribution of spontaneous combustion three zones and optimization of nitrogen injection location in the goaf of a fully mechanized top coal caving face	PLOS ONE			English	Article							PREVENTION	In order to effectively prevent and control spontaneous combustion of residual coal in the goaf and reduce the waste of nitrogen caused by setting the position of nitrogen injection, 1303 fully mechanized coal caving faces of the Jinniu Mine are studied. By deploying a bundle tube monitoring system in the inlet air side and return air side of the goaf, changes in gas concentration in the goaf are continuously monitored. In addition, the distribution area for spontaneous combustion three-zone in the goaf is divided into heat dissipation zone, oxidized spontaneous combustion zone, and suffocation zone. Simulations from the COMSOL Multiphysics 5.3 software provide insight based on the three zones division standard of spontaneous combustion in the goaf. The gradual deepening of the nitrogen injection position into the goaf affects the lower limit of the oxidized spontaneous combustion zone significantly, but the impact on the upper limit of the oxidized spontaneous combustion zone is not obvious and is negligible. With regard to the width of the oxidized spontaneous combustion zone, it initially decreases followed by a gradual increase. Numerical calculations suggest the optimal nitrogen injection position is 40 m from the roof cutting line, with an oxidized spontaneous combustion zone width of 28 m. Based on the simulation analysis results, nitrogen injection controlling measures have been adopted for spontaneous combustion of residual coal in the goaf of the 1303 fully mechanized coal caving faces, and coal self-ignition in the goaf has been successfully extinguished.	[Qi, Yun; Wang, Wei; Ning, Zhangxuan; Yao, Youli] Shanxi Datong Univ, Sch Coal Engn, Datong, Shanxi, Peoples R China; [Qi, Yun; Wang, Wei; Qi, Qingjie] Liaoning Tech Univ, Coll Safety Sci & Engn, Fuxing, Liaoning, Peoples R China; [Qi, Qingjie] Emergency Res Inst, China Coal Technol Engn Grp, Beijing, Peoples R China	Shanxi Datong University; Liaoning Technical University	Qi, Y; Wang, W (corresponding author), Shanxi Datong Univ, Sch Coal Engn, Datong, Shanxi, Peoples R China.; Qi, Y; Wang, W (corresponding author), Liaoning Tech Univ, Coll Safety Sci & Engn, Fuxing, Liaoning, Peoples R China.	qiyun_sx@sxdtdx.edu.cn; wangwei@sxdtdx.edu.cn			Key Laboratory of Mine Thermodynamic disasters and Control of Ministry of Education (Liaoning Technical University), Huludao, China; National Natural Science Foundation of China [51274113]; Key special-funded projects of the State key RD program [2018YFC0807900]	Key Laboratory of Mine Thermodynamic disasters and Control of Ministry of Education (Liaoning Technical University), Huludao, China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key special-funded projects of the State key RD program	The research presented in this paper was supported by the Key Laboratory of Mine Thermodynamic disasters and Control of Ministry of Education (Liaoning Technical University), Huludao, China. Thanks to "The National Natural Science Foundation of China (Grant: 51274113); Key special-funded projects of the State key R&D program (2018YFC0807900)" for the financial support. The recipient of these funds is Qi Qingjie. Qi Qingjie is my doctoral supervisor and co-author of this paper.	[高科 Gao Ke], 2014, [安全与环境学报, Journal of Safety and Environment], V14, P49; Jingqing CAO., 2017, COAL SCI TECHNOLOGY, V45, P89; Jurgen FB, 2017, INT J MIN SCI TECHNO, V27, P999, DOI 10.1016/j.ijmst.2017.06.026; [李宗翔 Li Zongxiang], 2018, [中国安全生产科学技术, Journal of Safety Science and Technology], V14, P30; [李宗翔 Li Zongxiang], 2003, [中国安全科学学报, China Safety Science], V13, P53; [罗新荣 Luo Xinrong], 2016, [中国安全科学学报, China Safety Science Journal（CSSJ）], V26, P69; Pan RK, 2018, ENVIRON EARTH SCI, V77, DOI 10.1007/s12665-018-7540-1; [齐庆杰 Qi Qingjie], 2019, [中国安全科学学报, China Safety Science Journal（CSSJ）], V29, P120; Ren WX, 2019, GEOMAT NAT HAZ RISK, V10, P353, DOI 10.1080/19475705.2018.1523237; SAQIB A, 2016, GOB VENTILATION BORE; Szlazak J., 2001, ARCH MIN SCI, V64, P451; Wang W.G., 2014, COAL SCI TECHNOL, V42, P75; Wang Y., 2016, INT J EARTH SCI ENG, V9, P1922; [吴玉国 WU Yuguo], 2011, [煤炭学报, Journal of China Coal Society], V36, P964; [尹晓雷 Yin Xiaolei], 2014, [中国安全生产科学技术, Journal of Safety Science and Technology], V10, P137; Zhao YX, 2014, APPL MECH MATER, V598, P753, DOI 10.4028/www.scientific.net/AMM.598.753; [周西华 Zhou Xihua], 2015, [中国安全生产科学技术, Journal of Safety Science and Technology], V11, P105; [朱红青 Zhu Hongqing], 2012, [煤炭学报, Journal of China Coal Society], V37, P1015; ZUO Qiuling., THERM SCI, V2020, P308	20	5	5	35	90	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2021	16	9							e0256911	10.1371/journal.pone.0256911	http://dx.doi.org/10.1371/journal.pone.0256911			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	WG6BN	34543303	Green Published, gold			2022-12-26	WOS:000707078200018
J	Jones, L; Bakre, A; Naikare, H; Kolhe, R; Sanchez, S; Mosley, YYC; Tripp, RA				Jones, Les; Bakre, Abhijeet; Naikare, Hemant; Kolhe, Ravindra; Sanchez, Susan; Mosley, Yung-Yi C.; Tripp, Ralph A.			Isothermal amplification and fluorescent detection of SARS-CoV-2 and SARS-CoV-2 variant virus in nasopharyngeal swabs	PLOS ONE			English	Article							VISUAL DETECTION; LESSONS; ENTRY; LAMP	The COVID-19 pandemic caused by the SARS-CoV-2 is a serious health threat causing worldwide morbidity and mortality. Real-time reverse transcription PCR (RT-qPCR) is currently the standard for SARS-CoV-2 detection. Although various nucleic acid-based assays have been developed to aid the detection of SARS-CoV-2 from COVID-19 patient samples, the objective of this study was to develop a diagnostic test that can be completed in 30 minutes without having to isolate RNA from the samples. Here, we present an RNA amplification detection method performed using reverse transcription loop-mediated isothermal amplification (RT-LAMP) reactions to achieve specific, rapid (30 min), and sensitive (<100 copies) fluorescent detection in real-time of SARS-CoV-2 directly from patient nasopharyngeal swab (NP) samples. When compared to RT-qPCR, positive NP swab samples assayed by fluorescent RT-LAMP had 98% (n = 41/42) concordance and negative NP swab samples assayed by fluorescent RT-LAMP had 87% (n = 59/68) concordance for the same samples. Importantly, the fluorescent RT-LAMP results were obtained without purification of RNA from the NP swab samples in contrast to RT-qPCR. We also show that the fluorescent RT-LAMP assay can specifically detect live virus directly from cultures of both SARS-CoV-2 wild type (WA1/2020), and a SARS-CoV-2 B.1.1.7 (alpha) variant strain with equal sensitivity to RT-qPCR. RT-LAMP has several advantages over RT-qPCR including isothermal amplification, speed (<30 min), reduced costs, and similar sensitivity and specificity.	[Jones, Les; Bakre, Abhijeet; Naikare, Hemant; Sanchez, Susan; Mosley, Yung-Yi C.; Tripp, Ralph A.] Univ Georgia, Dept Infect Dis, Coll Vet Med, Athens, GA 30602 USA; [Jones, Les; Bakre, Abhijeet; Kolhe, Ravindra; Sanchez, Susan; Tripp, Ralph A.] State Georgia COVID 19 Taskforce, Athens, GA 30602 USA; [Naikare, Hemant; Mosley, Yung-Yi C.] Univ Georgia, Tifton Diagnost & Invest Lab, Athens, GA 30602 USA; [Kolhe, Ravindra] Augusta Univ, Med Coll Georgia, Augusta, GA USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; University System of Georgia; Augusta University	Tripp, RA (corresponding author), Univ Georgia, Dept Infect Dis, Coll Vet Med, Athens, GA 30602 USA.; Tripp, RA (corresponding author), State Georgia COVID 19 Taskforce, Athens, GA 30602 USA.	ratripp@uga.edu		KOLHE, RAVINDRA/0000-0002-8283-2403; Tripp, Ralph/0000-0002-2924-9956	Georgia COVID19 Task Force; Georgia Research Alliance	Georgia COVID19 Task Force; Georgia Research Alliance	Funding was through the Georgia COVID19 Task Force and the Georgia Research Alliance to RT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allam M, 2020, DIAGNOSTICS, V10, DOI 10.3390/diagnostics10060409; Alturki SO, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.01880; Attaway AH, 2021, BMJ-BRIT MED J, V372, DOI 10.1136/bmj.n436; Augustine R, 2020, BIOLOGY-BASEL, V9, DOI 10.3390/biology9080182; Bakre AA, 2021, J VIROL METHODS, V288, DOI 10.1016/j.jviromet.2020.114015; Canedo-Marroquin G, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.569760; Chaouch M, 2021, REV MED VIROL, V31, DOI 10.1002/rmv.2215; Costa LB, 2020, FRONT CELL DEV BIOL, V8, DOI 10.3389/fcell.2020.559841; Das A, 2021, GENE REP, V23, DOI 10.1016/j.genrep.2021.101122; Ganguli A, 2020, P NATL ACAD SCI USA, V117, P22727, DOI 10.1073/pnas.2014739117; Garneret P, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0243712; Ge HP, 2020, EUR J CLIN MICROBIOL, V39, P1011, DOI 10.1007/s10096-020-03874-z; Gonzalez-Gonzalez E, 2021, ANAL METHODS-UK, V13, DOI 10.1039/d0ay01658f; Hoffmann M, 2020, CELL, V181, P271, DOI 10.1016/j.cell.2020.02.052; Irving AT, 2021, NATURE, V589, P363, DOI 10.1038/s41586-020-03128-0; Ji J, 2020, POULTRY SCI, V99, P791, DOI 10.1016/j.psj.2019.12.024; Krammer F, 2020, NATURE, V586, P516, DOI 10.1038/s41586-020-2798-3; Ngan L, 2020, J VIROL METHODS, V277, DOI 10.1016/j.jviromet.2019.113801; Mahdy MAA, 2020, FRONT VET SCI, V7, DOI 10.3389/fvets.2020.596391; Moehling TJ, 2021, EXPERT REV MOL DIAGN, V21, P43, DOI 10.1080/14737159.2021.1873769; Moore NM, 2020, J CLIN MICROBIOL, V58, DOI 10.1128/JCM.00938-20; Naji E, 2020, JPN J INFECT DIS, V73, P19, DOI 10.7883/yoken.JJID.2019.009; Nygaard V, 2009, FRONT BIOSCI-LANDMRK, V14, P552, DOI 10.2741/3262; Ouassou H, 2020, J IMMUNOL RES, V2020, DOI 10.1155/2020/1357983; Pan Y, 2020, LANCET INFECT DIS, V20, P411, DOI 10.1016/S1473-3099(20)30113-4; Park JY, 2016, J VIROL METHODS, V237, P10, DOI 10.1016/j.jviromet.2016.08.008; Poland GA, 2020, LANCET, V396, P1595, DOI 10.1016/S0140-6736(20)32137-1; Rai P, 2021, APPL MICROBIOL BIOT, V105, P441, DOI 10.1007/s00253-020-11061-5; Sagredo-Olivares K, 2021, MED ORAL PATOL ORAL, V26, pE526, DOI 10.4317/medoral.24424; Schermer B, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0238612; Shabani E, 2021, EUR J CLIN MICROBIOL, V40, P225, DOI 10.1007/s10096-020-04001-8; Sosnowski TR, 2021, CURR OPIN COLLOID IN, V54, DOI 10.1016/j.cocis.2021.101451; Syangtan G, 2021, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.587374; To KKW, 2021, EMERG MICROBES INFEC, V10, P507, DOI 10.1080/22221751.2021.1898291; Tomita N, 2008, NAT PROTOC, V3, P877, DOI 10.1038/nprot.2008.57; Wei S, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-84792-8; Whittaker GR, 2021, CURR OPIN VIROL, V47, P113, DOI 10.1016/j.coviro.2021.02.006; Wiersinga WJ, 2020, JAMA-J AM MED ASSOC, V324, P782, DOI 10.1001/jama.2020.12839; Zhang XZ, 2014, BIOSENS BIOELECTRON, V61, P491, DOI 10.1016/j.bios.2014.05.039	39	4	4	5	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2021	16	9							e0257563	10.1371/journal.pone.0257563	http://dx.doi.org/10.1371/journal.pone.0257563			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	WG5ZQ	34534259	Green Published, gold			2022-12-26	WOS:000707073300037
J	Stringer, DN; Bertozzi, T; Meusemann, K; Delean, S; Guzik, MT; Tierney, SM; Mayer, C; Cooper, SJB; Javidkar, M; Zwick, A; Austin, AD				Stringer, Danielle N.; Bertozzi, Terry; Meusemann, Karen; Delean, Steven; Guzik, Michelle T.; Tierney, Simon M.; Mayer, Christoph; Cooper, Steven J. B.; Javidkar, Mohammad; Zwick, Andreas; Austin, Andrew D.			Development and evaluation of a custom bait design based on 469 single-copy protein-coding genes for exon capture of isopods (Philosciidae: Haloniscus)	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; PHYLOGENETIC ANALYSIS; GENERATION; IDENTIFICATION; PHYLOGENOMICS; PERFORMANCE; ENRICHMENT; ACCURACY	Transcriptome-based exon capture approaches, along with next-generation sequencing, are allowing for the rapid and cost-effective production of extensive and informative phylogenomic datasets from non-model organisms for phylogenetics and population genetics research. These approaches generally employ a reference genome to infer the intron-exon structure of targeted loci and preferentially select longer exons. However, in the absence of an existing and well-annotated genome, we applied this exon capture method directly, without initially identifying intron-exon boundaries for bait design, to a group of highly diverse Haloniscus (Philosciidae), paraplatyarthrid and armadillid isopods, and examined the performance of our methods and bait design for phylogenetic inference. Here, we identified an isopod-specific set of single-copy protein-coding loci, and a custom bait design to capture targeted regions from 469 genes, and analysed the resulting sequence data with a mapping approach and newly-created post-processing scripts. We effectively recovered a large and informative dataset comprising both short (<100 bp) and longer (>300 bp) exons, with high uniformity in sequencing depth. We were also able to successfully capture exon data from up to 16-year-old museum specimens along with more distantly related outgroup taxa, and efficiently pool multiple samples prior to capture. Our well-resolved phylogenies highlight the overall utility of this methodological approach and custom bait design, which offer enormous potential for application to future isopod, as well as broader crustacean, molecular studies.	[Stringer, Danielle N.; Bertozzi, Terry; Guzik, Michelle T.; Tierney, Simon M.; Cooper, Steven J. B.; Javidkar, Mohammad; Austin, Andrew D.] Univ Adelaide, Australian Ctr Evolutionary Biol & Biodivers, Sch Biol Sci, Adelaide, SA, Australia; [Stringer, Danielle N.; Bertozzi, Terry; Cooper, Steven J. B.; Austin, Andrew D.] South Australian Museum, Adelaide, SA, Australia; [Meusemann, Karen] Univ Freiburg, Inst Biol 1, Evolutionary Biol & Ecol, Freiburg, Germany; [Meusemann, Karen; Zwick, Andreas] CSIRO Natl Res Collect Australia, Australian Natl Insect Collect, Acton, ACT, Australia; [Meusemann, Karen; Mayer, Christoph] Zool Res Museum Alexander Koenig, Ctr Mol Biodivers Res, Bonn, Germany; [Delean, Steven] Univ Adelaide, Sch Biol Sci, Adelaide, SA, Australia; [Delean, Steven] Univ Adelaide, Environm Inst, Adelaide, SA, Australia; [Tierney, Simon M.] Western Sydney Univ, Hawkesbury Inst Environm, Richmond, NSW, Australia	University of Adelaide; South Australian Museum; University of Freiburg; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Zoologisches Forschungsmuseum Alexander Koenig (ZFMK); University of Adelaide; University of Adelaide; Western Sydney University	Stringer, DN (corresponding author), Univ Adelaide, Australian Ctr Evolutionary Biol & Biodivers, Sch Biol Sci, Adelaide, SA, Australia.; Stringer, DN (corresponding author), South Australian Museum, Adelaide, SA, Australia.	danielle.stringer@adelaide.edu.au	Zwick, Andreas/A-5735-2015; Bertozzi, Terry/E-2748-2013; Tierney, Simon/H-2410-2015	Zwick, Andreas/0000-0002-7532-1752; Bertozzi, Terry/0000-0001-6665-3395; Mayer, Christoph/0000-0001-5104-6621; Tierney, Simon/0000-0002-8812-6753; Stringer, Danielle/0000-0002-6562-5031	Australian Research Council [LP0669062, LP140100555]; Department for Environment and Water; South Australian Museum; BHP Billiton; Nature Foundation; Biota Environmental Sciences; Western Australian Museum; Department of Biodiversity, Conservation and Attractions; Bennelongia; Australian Biological Resources Study Capacity Building grant [CT214-11]; Nature Conservancy - Thomas Foundation; Bioplatforms Australia; Australian Government Research Training Program Scholarship	Australian Research Council(Australian Research Council); Department for Environment and Water; South Australian Museum; BHP Billiton; Nature Foundation; Biota Environmental Sciences; Western Australian Museum; Department of Biodiversity, Conservation and Attractions; Bennelongia; Australian Biological Resources Study Capacity Building grant; Nature Conservancy - Thomas Foundation; Bioplatforms Australia; Australian Government Research Training Program Scholarship(Australian GovernmentDepartment of Industry, Innovation and Science)	This project was funded by the Australian Research Council (LP0669062 and LP140100555) to ADA and SJBC with the following industry partners: the Department for Environment and Water (SA), the South Australian Museum, BHP Billiton, Nature Foundation (SA), Biota Environmental Sciences, the Western Australian Museum, Department of Biodiversity, Conservation and Attractions (WA), and Bennelongia. Additional funding was provided by an Australian Biological Resources Study Capacity Building grant to DNS (CT214-11), the Nature Conservancy, kindly supported by The Thomas Foundation, to DNS, and Bioplatforms Australia (Research Contract to ADA and SJBC) for sequencing costs. DNS acknowledges the support of an Australian Government Research Training Program Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelkrim J, 2018, MOL BIOL EVOL, V35, P2355, DOI 10.1093/molbev/msy144; Andermann T, 2020, FRONT GENET, V10, DOI 10.3389/fgene.2019.01407; Andrews S., 2010, FASTQC QUALITY CONTR; Bailey SE, 2016, BIOL J LINN SOC, V117, P58, DOI 10.1111/bij.12620; Ballance LT, 2006, PROG OCEANOGR, V69, P360, DOI 10.1016/j.pocean.2006.03.013; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Bi K, 2013, MOL ECOL, V22, P6018, DOI 10.1111/mec.12516; Bi K, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-403; Bragg JG, 2016, MOL ECOL RESOUR, V16, P1059, DOI 10.1111/1755-0998.12449; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Chilton C, 1920, VICTORIA P LINN SOC, V44, P723; Cooper SJB, 2008, INVERTEBR SYST, V22, P195, DOI 10.1071/IS07039; Derkarabetian S, 2019, MOL ECOL RESOUR, V19, P1531, DOI 10.1111/1755-0998.13072; Dietz L, 2019, MOL PHYLOGENET EVOL, V136, P206, DOI 10.1016/j.ympev.2019.04.017; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Faircloth BC, 2012, SYST BIOL, V61, P717, DOI 10.1093/sysbio/sys004; Garrison E., 2012, ARXIV PREP ARXIV, V1207, P3907, DOI [10.48550/arXiv.1207.3907, DOI 10.48550/ARXIV.1207.3907]; Glenn TC, 2019, PEERJ, V7, DOI 10.7717/peerj.7755; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Guschanski K, 2013, SYST BIOL, V62, P539, DOI 10.1093/sysbio/syt018; Guzik MT, 2019, INVERTEBR SYST, V33, P556, DOI 10.1071/IS18070; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; Hugall AF, 2016, MOL BIOL EVOL, V33, P281, DOI 10.1093/molbev/msv216; Johnson MG, 2016, APPL PLANT SCI, V4, DOI 10.3732/apps.1600016; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Klopfstein S, 2019, SYST ENTOMOL, V44, P361, DOI 10.1111/syen.12333; Klopfstein S, 2017, SYST BIOL, V66, P769, DOI 10.1093/sysbio/syx051; Lanfear R, 2017, MOL BIOL EVOL, V34, P772, DOI 10.1093/molbev/msw260; Lanfear R, 2014, BMC EVOL BIOL, V14, DOI 10.1186/1471-2148-14-82; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Leache AD, 2011, SYST BIOL, V60, P126, DOI 10.1093/sysbio/syq073; Lemmon AR, 2012, SYST BIOL, V61, P727, DOI 10.1093/sysbio/sys049; Lemmon EM, 2013, ANNU REV ECOL EVOL S, V44, P99, DOI 10.1146/annurev-ecolsys-110512-135822; Li CH, 2013, BIOTECHNIQUES, V54, P321, DOI 10.2144/000114039; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Mayer C, 2016, MOL BIOL EVOL, V33, P1875, DOI 10.1093/molbev/msw056; McCartney-Melstad E, 2016, MOL ECOL RESOUR, V16, P1084, DOI 10.1111/1755-0998.12538; McCormack JE, 2013, MOL PHYLOGENET EVOL, V66, P526, DOI 10.1016/j.ympev.2011.12.007; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Meyer B., 2011, MARE VERSION 0 1 2 R; Meyer Matthias, 2010, Cold Spring Harb Protoc, V2010, DOI 10.1101/pdb.prot5448; Miller M.A., 2010, P GAT COMP ENV WORKS; Miller MR, 2007, GENOME RES, V17, P240, DOI 10.1101/gr.5681207; Misof B, 2014, SCIENCE, V346, P763, DOI 10.1126/science.1257570; Misof B, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-348; Murphy NP, 2015, ZOOL SCR, V44, P693, DOI 10.1111/zsc.12129; O'Hara TD, 2019, MOL PHYLOGENET EVOL, V130, P67, DOI 10.1016/j.ympev.2018.10.003; Peters RS, 2017, CURR BIOL, V27, P1013, DOI 10.1016/j.cub.2017.01.027; Petersen M, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1529-8; Portik DM, 2016, MOL ECOL RESOUR, V16, P1069, DOI 10.1111/1755-0998.12541; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; R Core Team, 2021, R LANG ENV STAT; Rambaut A., 2014, FIGTREE V 1 4 2 GRAP; Roy SW, 2003, P NATL ACAD SCI USA, V100, P7158, DOI 10.1073/pnas.1232297100; Salichos L, 2013, NATURE, V497, P327, DOI 10.1038/nature12130; Slater GS, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-31; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Stringer DN, 2019, J CRUSTACEAN BIOL, V39, P651, DOI 10.1093/jcbiol/ruz044; Suyama M, 2006, NUCLEIC ACIDS RES, V34, pW609, DOI 10.1093/nar/gkl315; Teasdale LC, 2016, MOL ECOL RESOUR, V16, P1107, DOI 10.1111/1755-0998.12552; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Waterhouse RM, 2011, NUCLEIC ACIDS RES, V39, pD283, DOI 10.1093/nar/gkq930; Wolfe JM, 2019, P ROY SOC B-BIOL SCI, V286, DOI 10.1098/rspb.2019.0079; Wood HM, 2018, MOL PHYLOGENET EVOL, V127, P907, DOI 10.1016/j.ympev.2018.06.038; Wortley AH, 2005, SYST BIOL, V54, P697, DOI 10.1080/10635150500221028; Zhang JJ, 2014, BIOINFORMATICS, V30, P614, DOI 10.1093/bioinformatics/btt593	67	1	1	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2021	16	9							e0256861	10.1371/journal.pone.0256861	http://dx.doi.org/10.1371/journal.pone.0256861			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	WG5ZQ	34534224	Green Published, gold			2022-12-26	WOS:000707073300012
J	Matyal, R; Qureshi, NQ; Mufarrih, SH; Sharkey, A; Bose, R; Chu, LM; Liu, DC; Senthilnathan, V; Mahmood, F; Khabbaz, KR				Matyal, Robina; Qureshi, Nada Qaisar; Mufarrih, Syed Hamza; Sharkey, Aidan; Bose, Ruma; Chu, Louis M.; Liu, David C.; Senthilnathan, Venkatachalam; Mahmood, Feroze; Khabbaz, Kamal R.			Update: Gender differences in CABG outcomes-Have we bridged the gap?	PLOS ONE			English	Article							CORONARY-ARTERY SURGERY; STERNAL WOUND-INFECTION; IN-HOSPITAL MORTALITY; SEX-DIFFERENCES; BYPASS-SURGERY; ANGIOGRAPHIC PREDICTORS; OPERATIVE MORTALITY; WOMEN; DISEASE; RISK	Background Appreciation of unique presentation, patterns and underlying pathophysiology of coronary artery disease in women has driven gender based risk stratification and risk reduction efforts over the last decade. Data regarding whether these advances have resulted in unequivocal improvements in outcomes of CABG in women is conflicting. The objective of our study was to assess gender differences in post-operative outcomes following CABG. Methods Retrospective analyses of institutional data housed in the Society of Thoracic Surgeons (STS) database for patients undergoing CABG between 2002 and 2020 were conducted. Multivariable regression analysis was conducted to investigate gender differences in post-operative outcomes. P-values were adjusted using Bonferroni correction to reduce type-I errors. Results Our final cohort of 6,250 patients had fewer women than men (1,339 vs. 4,911). more women were diabetic (52.0% vs. 41.2%, p<0.001) and hypertensive (89.1% vs. 84.0%, p<0.001). Women had higher adjusted odds of developing ventilator dependence >48 hours (OR: 1.65 [1.21, 2.45], p = 0.002) and cardiac readmissions (OR: 1.56 [1.27, 2.30], p = 0.003). After adjustment for comorbidity burden, mortality rates in women were comparable to those of age-matched men. Conclusion The findings of our study indicate that despite apparent reduction of differences in mortality, the burden of postoperative morbidity is still high among women.	[Matyal, Robina; Qureshi, Nada Qaisar; Mufarrih, Syed Hamza; Sharkey, Aidan; Bose, Ruma; Mahmood, Feroze] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Dept Anesthesia Crit Care & Pain Med, Boston, MA USA; [Chu, Louis M.; Liu, David C.; Senthilnathan, Venkatachalam; Khabbaz, Kamal R.] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Dept Surg, Div Cardiac Surg, Boston, MA 02115 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Khabbaz, KR (corresponding author), Harvard Med Sch, Beth Israel Deaconess Med Ctr, Dept Surg, Div Cardiac Surg, Boston, MA 02115 USA.	kkhabbaz@bidmc.harvard.edu						Berger JS, 2008, AM HEART J, V156, P816, DOI 10.1016/j.ahj.2008.06.039; Blomkalns AL, 2005, J AM COLL CARDIOL, V45, P832, DOI 10.1016/j.jacc.2004.11.055; Culler SD, 2008, ARCH INTERN MED, V168, P2317, DOI 10.1001/archinte.168.21.2317; Czech B, 2007, KARDIOL POL, V65, P627; Hamm CW, 2011, EUR HEART J, V32, P2999, DOI 10.1093/eurheartj/ehr236; Hulley S, 1998, JAMA-J AM MED ASSOC, V280, P605, DOI 10.1001/jama.280.7.605; Hussey L C, 2001, Am J Crit Care, V10, P112; Jneid H, 2008, CIRCULATION, V118, P2803, DOI 10.1161/CIRCULATIONAHA.108.789800; Johnston N, 2011, EUR HEART J, V32, P1331, DOI 10.1093/eurheartj/ehr009; Kawamoto KR, 2016, CURR ATHEROSCLER REP, V18, DOI 10.1007/s11883-016-0629-7; KENNEDY JW, 1980, J THORAC CARDIOV SUR, V80, P876; KENNEDY JW, 1981, CIRCULATION, V63, P793, DOI 10.1161/01.CIR.63.4.793; Khan E, 2018, MED J AUSTRALIA, V209, P118, DOI 10.5694/mja17.01109; Kieser TM, 2014, J THORAC CARDIOV SUR, V148, P1887, DOI 10.1016/j.jtcvs.2014.02.022; Koch CG, 1996, J CARDIOTHOR VASC AN, V10, P839, DOI 10.1016/S1053-0770(96)80042-5; Kurlansky PA, 1996, ANN THORAC SURG, V62, P63, DOI 10.1016/0003-4975(96)00275-5; Lewis WR, 2009, CIRC-CARDIOVASC QUAL, V2, P633, DOI 10.1161/CIRCOUTCOMES.108.824763; Mannacio VA, 2018, J THORAC DIS, V10, pS2157, DOI 10.21037/jtd.2018.06.149; Mohamed MO, 2020, CAN J CARDIOL, V36, P69, DOI 10.1016/j.cjca.2019.08.012; Moser D K, 1993, Prog Cardiovasc Nurs, V8, P6; OCONNOR GT, 1993, CIRCULATION, V88, P2104, DOI 10.1161/01.CIR.88.5.2104; Price JD, 2013, J AM COLL SURGEONS, V216, P412, DOI 10.1016/j.jamcollsurg.2012.11.009; Rubens FD, 2016, ANN THORAC SURG, V101, P1677, DOI 10.1016/j.athoracsur.2015.10.031; Stewart RD, 2000, ANN THORAC SURG, V70, P169, DOI 10.1016/S0003-4975(00)01386-2; Taggart DP, 2002, HEART, V88, P7, DOI 10.1136/heart.88.1.7; Vaccarino V, 2003, CIRCULATION, V108, P2642, DOI 10.1161/01.CIR.0000097117.28614.D8; Vaccarino V, 2002, CIRCULATION, V105, P1176, DOI 10.1161/hc1002.105133; Vaina S, 2015, WORLD J CARDIOL, V7, P10, DOI 10.4330/wjc.v7.i1.10; Yerokun BA, 2016, CORONARY ARTERY DIS, V27, P319, DOI 10.1097/MCA.0000000000000364	29	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2021	16	9							e0255170	10.1371/journal.pone.0255170	http://dx.doi.org/10.1371/journal.pone.0255170			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	WG6DR	34525123	Green Published, gold			2022-12-26	WOS:000707084400008
J	Teshome, B; Trabitzsch, J; Afework, T; Addissie, A; Kaba, M; Kantelhardt, EJ; Getachew, S				Teshome, Bethel; Trabitzsch, Josephin; Afework, Tsion; Addissie, Adamu; Kaba, Mirgissa; Kantelhardt, Eva Johanna; Getachew, Sefonias			Perceived barriers to timely treatment initiation and social support status among women with breast cancer in Ethiopia	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; SURVIVAL; NETWORKS	Timely care is essential to increase breast cancer survival. However, patients in Ethiopia still face multilevel barriers on their pathway to timely treatment initiation. This cross-sectional study at Tikur Anbessa Specialized Hospital Oncology Unit in Addis Ababa assessed systemic treatment initiation intervals of breast cancer patients and quantified the impact of socio-demographic and clinical factors, perceived barriers, and the patients ' perceived social support status on timely systemic treatment initiation (chemotherapy or hormonal therapy). A structured questionnaire was designed based on Pechansky ' s "Concept of Access". Applying simple and multivariate logistic regression we analysed the influence of patients ' characteristics as well as their perceived barriers on timely treatment initiation. We measured social support with the Multidimensional Score of Perceived Social Support (MSPSS) and used the Wilcoxon Rank-Sum Test to assess its relationship with timely treatment initiation. Of 196 patients included into the study, 53% received systemic treatment within 90 days of their pathological diagnosis-the median treatment initiation interval was 85 days (IQR 123.5). Older women and patients diagnosed at late stages had higher odds of timely treatment initiation. Not being able to pay for services and lack of transport were most often perceived as barriers towards timely care. However, none of the perceived barriers showed a substantial influence on timely treatment initiation in the multivariate regression model. The patients ' perceived social support was found to be high, with an average MSPSS score of 73 out of 84 (SD 13,63). No impact of the perceived social support status on timely treatment initiation was found. The percentage of breast cancer patients waiting longer than 90 days from pathological diagnosis to systemic treatment initiation in Ethiopia remains unacceptably high. While women generally feel well supported by their social environment, costs and accessibility of treatment are perceived to be major barriers towards timely treatment initiation.	[Teshome, Bethel; Afework, Tsion; Addissie, Adamu; Kaba, Mirgissa; Getachew, Sefonias] Addis Ababa Univ, Sch Publ Hlth, Dept Prevent Med, Addis Ababa, Ethiopia; [Trabitzsch, Josephin; Addissie, Adamu; Kantelhardt, Eva Johanna; Getachew, Sefonias] Martin Luther Univ Halle Wittenberg, Inst Med Epidemiol Biometr & Informat, Halle, Saale, Germany; [Kantelhardt, Eva Johanna] Martin Luther Univ Halle Wittenberg, Dept Gynaecol, Halle, Saale, Germany	Addis Ababa University; Martin Luther University Halle Wittenberg; Martin Luther University Halle Wittenberg	Kantelhardt, EJ (corresponding author), Martin Luther Univ Halle Wittenberg, Inst Med Epidemiol Biometr & Informat, Halle, Saale, Germany.; Kantelhardt, EJ (corresponding author), Martin Luther Univ Halle Wittenberg, Dept Gynaecol, Halle, Saale, Germany.	eva.kantelhardt@uk-halle.de	Afework, Tsion/GMW-5040-2022; Kaba, Mirgissa/HGB-6272-2022	Afework, Tsion/0000-0002-8531-2876; Kantelhardt, Eva Johanna/0000-0001-7935-719X	Masters Program of the School of Public Health, Addis Ababa University	Masters Program of the School of Public Health, Addis Ababa University	This study was funded within the Masters Program of the School of Public Health, Addis Ababa University. BT received the fund from the University. The funding body was not involved in the design of the study and collection, analysis and interpretation of data and in writing the manuscript.	Aberaraw R, 2020, BMC WOMENS HEALTH, V20, DOI 10.1186/s12905-020-00908-8; Bhatia RK, 2018, J GLOB ONCOL, V4, DOI 10.1200/JGO.18.00088; Bleicher RJ, 2018, ANN SURG ONCOL, V25, P2829, DOI 10.1245/s10434-018-6615-2; Brand NR, 2019, ONCOLOGIST, V24, pE1371, DOI 10.1634/theoncologist.2019-0057; Brown CA, 2018, ONCOLOGIST, V23, P1453, DOI 10.1634/theoncologist.2017-0643; Espina C, 2017, ANN EPIDEMIOL, V27, P659, DOI 10.1016/j.annepidem.2017.09.007; Ferlay J, GLOBAL CANC OBSERVAT, DOI DOI 10.1016/J.EJCA.2020.09.035; Feuchtner J, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0219519; Foerster M, 2019, BREAST CANCER RES, V21, DOI 10.1186/s13058-019-1174-4; Frie KG, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0207928; Frie KG, 2018, BREAST CARE, V13, P39, DOI 10.1159/000481087; Gebremariam A, 2021, BREAST CANCER RES TR, V187, P877, DOI 10.1007/s10549-021-06131-9; Gouda HN, 2019, LANCET GLOB HEALTH, V7, pE1375, DOI 10.1016/S2214-109X(19)30374-2; Joko-Fru WY, 2020, INT J CANCER, V146, P1208, DOI 10.1002/ijc.32406; Kantelhardt EJ, 2014, INT J CANCER, V135, P702, DOI 10.1002/ijc.28691; Kroenke CH, 2006, J CLIN ONCOL, V24, P1105, DOI 10.1200/JCO.2005.04.2846; Moodley J, 2018, BMC CANCER, V18, DOI 10.1186/s12885-018-4219-7; PENCHANSKY R, 1981, MED CARE, V19, P127, DOI 10.1097/00005650-198102000-00001; REYNOLDS P, 1994, CANCER EPIDEM BIOMAR, V3, P253; Tigeneh W, 2015, INT J CANC RES MOL M, P1, DOI [10.16966/2381-3318.103, DOI 10.16966/2381-3318.103]; Walter F, 2012, J HEALTH SERV RES PO, V17, P110, DOI 10.1258/jhsrp.2011.010113; Wondimagegnehu A, 2019, BMC CANCER, V19, DOI 10.1186/s12885-019-6007-4; World Health Organization, 2017, GUID EARL CANC DIAGN; ZIMET GD, 1988, J PERS ASSESS, V52, P30, DOI 10.1207/s15327752jpa5201_2	24	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2021	16	9							e0257163	10.1371/journal.pone.0257163	http://dx.doi.org/10.1371/journal.pone.0257163			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	WG6OR	34516552	gold, Green Accepted, Green Published			2022-12-26	WOS:000707114200013
J	Banerjee, SJ; Schonbrun, A; Eizadshenass, S; Benji, S; Cantor, YT; Eliach, L; Lubin, M; Narrowe, Z; Purow, J; Shulman, B; Wiener, L; Steinhauer, J				Banerjee, Surya Jyoti; Schonbrun, Adina; Eizadshenass, Sogol; Benji, Shimshon; Cantor, Yaakov Tzvi; Eliach, Liam; Lubin, Matthew; Narrowe, Zev; Purow, Jeremy; Shulman, Benjamin; Wiener, Leib; Steinhauer, Josefa			iPLA(2)-VIA is required for healthy aging of neurons, muscle, and the female germline in Drosophila melanogaster	PLOS ONE			English	Article							INDEPENDENT PHOSPHOLIPASE A(2); IN-SITU HYBRIDIZATION; NEUROAXONAL DYSTROPHY; MITOCHONDRIAL-FUNCTION; EXPRESS GROUP; PLA2G6; HOMEOSTASIS; INTERACTS; PROTEIN; PARKIN	Neurodegenerative disease (ND) is a growing health burden worldwide, but its causes and treatments remain elusive. Although most cases of ND are sporadic, rare familial cases have been attributed to single genes, which can be investigated in animal models. We have generated a new mutation in the calcium-independent phospholipase A(2) (iPLA(2)) VIA gene CG6718, the Drosophila melanogaster ortholog of human PLA2G6/PARK14, mutations in which cause a suite of NDs collectively called PLA2G6-associated neurodegeneration (PLAN). Our mutants display age-related loss of climbing ability, a symptom of neurodegeneration in flies. Although phospholipase activity commonly is presumed to underlie iPLA(2)-VIA function, locomotor decline in our mutants is rescued by a transgene carrying a serine-to-alanine mutation in the catalytic residue, suggesting that important functional aspects are independent of phospholipase activity. Additionally, we find that iPLA(2)-VIA knockdown in either muscle or neurons phenocopies locomotor decline with age, demonstrating its necessity in both neuronal and non-neuronal tissues. Furthermore, RNA in situ hybridization shows high endogenous iPLA(2)-VIA mRNA expression in adult germ cells, and transgenic HA-tagged iPLA(2)-VIA colocalizes with mitochondria there. Mutant males are fertile with normal spermatogenesis, while fertility is reduced in mutant females. Mutant female germ cells display age-related mitochondrial aggregation, loss of mitochondrial potential, and elevated cell death. These results suggest that iPLA(2)-VIA is critical for mitochondrial integrity in the Drosophila female germline, which may provide a novel context to investigate its functions with parallels to PLAN.	[Banerjee, Surya Jyoti; Schonbrun, Adina; Eizadshenass, Sogol; Benji, Shimshon; Cantor, Yaakov Tzvi; Eliach, Liam; Lubin, Matthew; Narrowe, Zev; Purow, Jeremy; Shulman, Benjamin; Wiener, Leib; Steinhauer, Josefa] Yeshiva Univ, Dept Biol, New York, NY 10033 USA	Yeshiva University	Steinhauer, J (corresponding author), Yeshiva Univ, Dept Biol, New York, NY 10033 USA.	jsteinha@yu.edu		Schonbrun, Adina/0000-0002-0831-5053; Banerjee, Surya/0000-0001-7196-4315	HHS | NIH | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD): Josefa M. Steinhauer [R15HD080511]	HHS | NIH | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD): Josefa M. Steinhauer	HHS | NIH | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD): Josefa M. Steinhauer R15HD080511.	Ali YO, 2011, JOVE-J VIS EXP, DOI 10.3791/2504; Baburina I, 1999, J BIOL CHEM, V274, P9400, DOI 10.1074/jbc.274.14.9400; Baker NE, 2007, CURR OPIN GENET DEV, V17, P287, DOI 10.1016/j.gde.2007.05.005; Balsinde J, 2005, CELL SIGNAL, V17, P1052, DOI 10.1016/j.cellsig.2005.03.002; Bao S, 2007, J BIOL CHEM, V282, P27100, DOI 10.1074/jbc.M701316200; Bao SZ, 2004, DIABETES, V53, pS186, DOI 10.2337/diabetes.53.2007.S186; Bao SZ, 2004, J BIOL CHEM, V279, P38194, DOI 10.1074/jbc.M406489200; Barbour SE, 1999, BBA-MOL CELL BIOL L, V1439, P77, DOI 10.1016/S1388-1981(99)00078-5; Beck G, 2011, J NEUROSCI, V31, P11411, DOI 10.1523/JNEUROSCI.0345-11.2011; Ben-David G., 2015, SPERMATOGENESIS, V5, pe1006089, DOI [10.1080/21565562.2015.1006089, DOI 10.1080/21565562.2015.1006089]; Betarbet R, 2000, NAT NEUROSCI, V3, P1301, DOI 10.1038/81834; Bradley RM, 2016, MOL NUTR FOOD RES, V60, P1804, DOI 10.1002/mnfr.201500966; Brooks AI, 1999, BRAIN RES, V823, P1, DOI 10.1016/S0006-8993(98)01192-5; Chiu CC, 2019, MOL NEUROBIOL, V56, P3835, DOI 10.1007/s12035-018-1118-5; Chiu CC, 2017, ONCOTARGET, V8, P79046, DOI 10.18632/oncotarget.20893; Clark IE, 2006, NATURE, V441, P1162, DOI 10.1038/nature04779; Cox RT, 2009, DIS MODEL MECH, V2, P490, DOI 10.1242/dmm.002378; Delventhal R, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0230912; Engel LA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012897; Erkkinen MG, 2018, CSH PERSPECT BIOL, V10, DOI 10.1101/cshperspect.a033118; Fabrizio JJ, 1998, DEVELOPMENT, V125, P1833; Fernandez-Murray JP, 2007, BBA-MOL CELL BIOL L, V1771, P331, DOI 10.1016/j.bbalip.2006.04.004; Gregory A, 1993, GENEREVIEWS R; Henchcliffe C, 2008, NAT CLIN PRACT NEURO, V4, P600, DOI 10.1038/ncpneuro0924; Hewitt VL, 2017, CURR TOP DEV BIOL, V121, P173, DOI 10.1016/bs.ctdb.2016.07.005; Hsu YH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059267; Iliadi KG, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21343-8; Kamel F, 2013, SCIENCE, V341, P722, DOI 10.1126/science.1243619; Katsnelson A, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aal2074; Khateeb S, 2006, AM J HUM GENET, V79, P942, DOI 10.1086/508572; Kienesberger PC, 2009, J LIPID RES, V50, pS63, DOI 10.1194/jlr.R800082-JLR200; Kinghorn KJ, 2015, BRAIN, V138, P1801, DOI 10.1093/brain/awv132; Lands WEM, 2000, BBA-MOL CELL BIOL L, V1483, P1, DOI 10.1016/S1388-1981(99)00177-8; LANGSTON JW, 1983, SCIENCE, V219, P979, DOI 10.1126/science.6823561; Lieber T, 2019, NATURE, V570, P380, DOI 10.1038/s41586-019-1213-4; Lin G, 2018, CELL METAB, V28, P605, DOI 10.1016/j.cmet.2018.05.019; Malhotra A, 2009, P NATL ACAD SCI USA, V106, P2337, DOI 10.1073/pnas.0811224106; Malik I, 2008, AM J PATHOL, V172, P406, DOI 10.2353/ajpath.2008.070823; Malley KR, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03193-0; Manguikian AD, 2004, J BIOL CHEM, V279, P52881, DOI 10.1074/jbc.M410659200; Maruzs T, 2019, FRONT CELL DEV BIOL, V7, DOI 10.3389/fcell.2019.00140; Meltzer S, 2017, CELL REP, V21, P859, DOI 10.1016/j.celrep.2017.09.089; Morgan NV, 2006, NAT GENET, V38, P752, DOI 10.1038/ng1826; Mori A, 2019, P NATL ACAD SCI USA, V116, P20689, DOI 10.1073/pnas.1902958116; Morris CA, 2009, NAT PROTOC, V4, P1807, DOI 10.1038/nprot.2009.192; Murakami M, 2011, PROG LIPID RES, V50, P152, DOI 10.1016/j.plipres.2010.12.001; Nagaso H, 2001, J HISTOCHEM CYTOCHEM, V49, P1177, DOI 10.1177/002215540104900911; Narendra DP, 2010, AUTOPHAGY, V6, P1090, DOI 10.4161/auto.6.8.13426; Okatsu K, 2010, GENES CELLS, V15, P887, DOI 10.1111/j.1365-2443.2010.01426.x; Paisan-Ruiz C, 2009, ANN NEUROL, V65, P19, DOI 10.1002/ana.21415; Park J, 2006, NATURE, V441, P1157, DOI 10.1038/nature04788; PAVLIDIS P, 1994, CELL, V79, P23, DOI 10.1016/0092-8674(94)90397-2; Pickles S, 2018, CURR BIOL, V28, pR170, DOI 10.1016/j.cub.2018.01.004; Riedel F, 2016, BIOL OPEN, V5, P987, DOI 10.1242/bio.018937; Riparbelli MG, 2007, DEV BIOL, V303, P108, DOI 10.1016/j.ydbio.2006.10.038; Salih MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076831; Schlame M, 2017, J BIOL CHEM, V292, P5499, DOI 10.1074/jbc.M116.769182; Schlame M, 2013, BBA-MOL CELL BIOL L, V1831, P582, DOI 10.1016/j.bbalip.2012.11.007; Schlame M, 2012, CHEM PHYS LIPIDS, V165, P512, DOI 10.1016/j.chemphyslip.2012.03.001; Seleznev K, 2006, J BIOL CHEM, V281, P22275, DOI 10.1074/jbc.M604330200; Sen A, 2015, DIS MODEL MECH, V8, P577, DOI 10.1242/dmm.019208; Shinzawa K, 2008, J NEUROSCI, V28, P2212, DOI 10.1523/JNEUROSCI.4354-07.2008; Song HW, 2014, J BIOL CHEM, V289, P14194, DOI 10.1074/jbc.M114.561910; Song HW, 2010, BBA-MOL CELL BIOL L, V1801, P547, DOI 10.1016/j.bbalip.2010.01.006; Steinhauer J, 2005, DEVELOPMENT, V132, P5515, DOI 10.1242/dev.02159; Trinh J, 2013, NAT REV NEUROL, V9, P445, DOI 10.1038/nrneurol.2013.132; Turk J, 2019, BBA-MOL CELL BIOL L, V1864, P846, DOI 10.1016/j.bbalip.2018.10.010; Villa E, 2018, TRENDS CELL BIOL, V28, P882, DOI 10.1016/j.tcb.2018.07.004; Wada H, 2009, AM J PATHOL, V175, P2257, DOI 10.2353/ajpath.2009.090343; Weber U, 2003, DEV CELL, V5, P559, DOI 10.1016/S1534-5807(03)00273-9; Wyss-Coray T, 2016, NATURE, V539, P180, DOI 10.1038/nature20411; Xu Y, 2006, P NATL ACAD SCI USA, V103, P11584, DOI 10.1073/pnas.0603242103; Ye CQ, 2016, J BIOENERG BIOMEMBR, V48, P113, DOI 10.1007/s10863-014-9591-7; Zhao ZS, 2010, ENDOCRINOLOGY, V151, P3038, DOI 10.1210/en.2010-0016; Zhou QD, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10332	75	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2021	16	9							e0256738	10.1371/journal.pone.0256738	http://dx.doi.org/10.1371/journal.pone.0256738			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XM9EM	34506510	Green Published, Green Submitted, gold			2022-12-26	WOS:000729120700027
J	Chang, Y; Han, JA; Kang, SM; Jeong, SW; Ryu, T; Park, HS; Yoo, JJ; Lee, SH; Kim, SG; Kim, YS; Kim, HS; Jin, SY; Ryu, S; Jang, JY				Chang, Young; Han, Jae-A.; Kang, Suk Min; Jeong, Soung Won; Ryu, Tom; Park, Han Seul; Yoo, Jeong-Ju; Lee, Sae Hwan; Kim, Sang Gyune; Kim, Young Seok; Kim, Hong Soo; Jin, So Young; Ryu, Seongho; Jang, Jae Young			Clinical impact of serum exosomal microRNA in liver fibrosis	PLOS ONE			English	Article							HEPATIC STELLATE CELL; SIMPLE NONINVASIVE INDEX; CIRCULATING MICRORNAS; MIR-122; ACTIVATION; ELASTOGRAPHY; EXPRESSION; BIOMARKER; PREDICT; BIOPSY	Background/aim We investigated alterations in the expression of serum exosomal miRNAs with the progression of liver fibrosis and evaluated their clinical applicability as biomarkers. Methods This study prospectively enrolled 71 patients who underwent liver biopsy at an academic hospital in Korea. Exosomes were extracted from serum samples, followed by next-generation sequencing (NGS) of miRNAs and targeted real-time quantitative polymerase chain reaction. A model was derived to discriminate advanced fibrosis based on miRNA levels and the performance of this model was evaluated. Validation of the effect of miRNA on liver fibrosis in vitro was followed. Results NGS data revealed that exosomal miR-660-5p, miR-125a-5p, and miR-122 expression were changed significantly with the progression of liver fibrosis, of which miR-122 exhibited high read counts enough to be used as a biomarker. The level of exosomal miR-122 decreased as the pathologic fibrosis grade progressed and patients with biopsy-proven advanced fibrosis had significantly lower levels of exosomal miR-122 (P < 0.001) than those without advanced fibrosis. Exosomal miR-122 exhibited a fair performance in discriminating advanced fibrosis especially in combination with fibrosis-4 score and transient elastography. In a subgroup of patients with a non-viral etiology of liver disease, the performance of exosomal miR-122 as a biomarker was greatly improved. Inhibition of miR-122 expression increased the proliferation of the human hepatic stellate cell line, LX-2, and upregulated the expression of various fibrosis related proteins. Conclusion Exosomal miR-122 may serve as a useful non-invasive biomarker for liver fibrosis, especially in patients with non-viral etiologies of chronic liver disease.	[Chang, Young; Kang, Suk Min; Jeong, Soung Won; Ryu, Tom; Park, Han Seul; Jang, Jae Young] Soonchunhyang Univ, Coll Med, Ctr Digest Dis, Inst Digest Res,Dept Internal Med, Seoul, South Korea; [Han, Jae-A.; Ryu, Seongho] Soonchunhyang Univ, Soonchunhyang Inst Medibio Sci SIMS, Cheonan, South Korea; [Yoo, Jeong-Ju; Kim, Sang Gyune; Kim, Young Seok] Soonchunhyang Univ, Coll Med, Dept Internal Med, Bucheon, South Korea; [Lee, Sae Hwan; Kim, Hong Soo] Soonchunhyang Univ, Coll Med, Dept Internal Med, Cheonan, South Korea; [Jin, So Young] Soonchunhyang Univ, Coll Med, Dept Pathol, Seoul, South Korea	Soonchunhyang University; Soonchunhyang University; Soonchunhyang University; Soonchunhyang University; Soonchunhyang University	Jang, JY (corresponding author), Soonchunhyang Univ, Coll Med, Ctr Digest Dis, Inst Digest Res,Dept Internal Med, Seoul, South Korea.; Ryu, S (corresponding author), Soonchunhyang Univ, Soonchunhyang Inst Medibio Sci SIMS, Cheonan, South Korea.	jyjang@schmc.ac.kr; ryu@sch.ac.kr		Yoo, Jeong-Ju/0000-0002-7802-0381	Soonchunhyang University Research Fund	Soonchunhyang University Research Fund	This work was supported by the Soonchunhyang University Research Fund.	Bala S, 2012, HEPATOLOGY, V56, P1946, DOI 10.1002/hep.25873; Bihrer V, 2011, AM J GASTROENTEROL, V106, P1663, DOI 10.1038/ajg.2011.161; Brenner David A, 2009, Trans Am Clin Climatol Assoc, V120, P361; Cadranel JF, 2012, PRESSE MED, V41, P1064, DOI 10.1016/j.lpm.2012.01.034; Cermelli S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023937; Chen C, 2011, EXP CELL RES, V317, P1714, DOI 10.1016/j.yexcr.2011.05.001; Chen L, 2014, HEPATOLOGY, V59, P1118, DOI 10.1002/hep.26768; Creemers EE, 2012, CIRC RES, V110, P483, DOI 10.1161/CIRCRESAHA.111.247452; Deng XG, 2014, LIVER INT, V34, P281, DOI 10.1111/liv.12239; Endzelins E, 2017, BMC CANCER, V17, DOI 10.1186/s12885-017-3737-z; Girard M, 2008, J HEPATOL, V48, P648, DOI 10.1016/j.jhep.2008.01.019; Guo CJ, 2009, FEBS J, V276, P5163, DOI 10.1111/j.1742-4658.2009.07213.x; Guo CJ, 2009, J HEPATOL, V50, P766, DOI 10.1016/j.jhep.2008.11.025; Halasz T, 2015, WORLD J GASTROENTERO, V21, P7814, DOI 10.3748/wjg.v21.i25.7814; Hsu SH, 2012, J CLIN INVEST, V122, P2871, DOI 10.1172/JCI63539; Ji JL, 2009, FEBS LETT, V583, P759, DOI 10.1016/j.febslet.2009.01.034; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; Laudadio I, 2012, GASTROENTEROLOGY, V142, P119, DOI 10.1053/j.gastro.2011.09.001; Lee YR, 2019, INT J CANCER, V144, P1444, DOI 10.1002/ijc.31931; Lemoinne S, 2014, NAT REV GASTRO HEPAT, V11, DOI 10.1038/nrgastro.2014.7; Lewis PJS, 2011, HEPATOLOGY, V54, P1767, DOI 10.1002/hep.24538; Li J, 2013, J HEPATOL, V58, P522, DOI 10.1016/j.jhep.2012.11.011; Li J, 2011, MOL PHARMACOL, V80, P191, DOI 10.1124/mol.110.068247; Li TF, 2013, STEM CELLS DEV, V22, P845, DOI 10.1089/scd.2012.0395; Lurie Y, 2015, WORLD J GASTROENTERO, V21, P11567, DOI 10.3748/wjg.v21.i41.11567; Masyuk AI, 2013, J HEPATOL, V59, P621, DOI 10.1016/j.jhep.2013.03.028; Momen-Heravi F, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0623-9; Nakamura M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177302; Nakamura M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144295; Pan QW, 2012, GUT, V61, P1330, DOI 10.1136/gutjnl-2011-300449; Puche JE, 2013, COMPR PHYSIOL, V3, P1473, DOI 10.1002/cphy.c120035; Raposo G, 2013, J CELL BIOL, V200, P373, DOI 10.1083/jcb.201211138; Sakaida I, 1996, HEPATOLOGY, V23, P755, DOI 10.1002/hep.510230416; Sato K, 2016, J HEPATOL, V65, P213, DOI 10.1016/j.jhep.2016.03.004; Shaker OG, 2017, J VIRAL HEPATITIS, V24, P636, DOI 10.1111/jvh.12696; Singh S, 2015, CLIN GASTROENTEROL H, V13, P440, DOI 10.1016/j.cgh.2014.09.046; Sohn W, 2015, EXP MOL MED, V47, DOI 10.1038/emm.2015.68; Sterling RK, 2006, HEPATOLOGY, V43, P1317, DOI 10.1002/hep.21178; Tanaka Y, 2013, CANCER-AM CANCER SOC, V119, P1159, DOI 10.1002/cncr.27895; Tapper EB, 2017, NEW ENGL J MED, V377, P756, DOI 10.1056/NEJMra1610570; Tapper EB, 2015, CLIN GASTROENTEROL H, V13, P27, DOI 10.1016/j.cgh.2014.04.039; Tsai WC, 2012, J CLIN INVEST, V122, P2884, DOI 10.1172/JCI63455; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Valencia-Sanchez MA, 2006, GENE DEV, V20, P515, DOI 10.1101/gad.1399806; van der Meer AJ, 2013, J VIRAL HEPATITIS, V20, P158, DOI 10.1111/jvh.12001; Vlassov AV, 2012, BBA-GEN SUBJECTS, V1820, P940, DOI 10.1016/j.bbagen.2012.03.017; Vogt J, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0220406; Wai CT, 2003, HEPATOLOGY, V38, P518, DOI 10.1053/jhep.2003.50346; Waidmann O, 2012, J VIRAL HEPATITIS, V19, pE58, DOI 10.1111/j.1365-2893.2011.01536.x; Xu H, 2010, HEPATOLOGY, V52, P1431, DOI 10.1002/hep.23818; Yang BF, 2009, CLIN EXP PHARMACOL P, V36, P951, DOI 10.1111/j.1440-1681.2009.05245.x	51	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2021	16	9							e0255672	10.1371/journal.pone.0255672	http://dx.doi.org/10.1371/journal.pone.0255672			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XM9EM	34506494	Green Published, gold			2022-12-26	WOS:000729120700102
J	Joachimdass, RJ; Subramaniam, K; Sit, NW; Lim, YM; Teo, CH; Ng, CJ; Yusof, AS; Loganathan, A				Joachimdass, Raphael Joe; Subramaniam, Kavitha; Sit, Nam Weng; Lim, Yang Mooi; Teo, Chin Hai; Ng, Chirk Jenn; Yusof, Afzaninawati Suria; Loganathan, Annaletchumy			Self-management using crude herbs and the health-related quality of life among adult patients with hypertension living in a suburban setting of Malaysia	PLOS ONE			English	Article							MEDICINE CAM USE; ALTERNATIVE MEDICINE; COMPLEMENTARY; FREQUENCY	Purpose To determine the prevalence of crude herbs' use in the self-management of hypertension and the health-related quality of life (HRQOL) in patients with hypertension. Methods This cross-sectional study was performed among patients with hypertension attending a government health clinic. Socio-demographic characteristics, lifestyle modifications, medical history and predictors of crude herbs users were obtained. The diversity of crude herbs used was assessed using a modified international complementary and alternative medicine questionnaire (I-CAM-Q) and the HRQOL was assessed using the SF36 instrument. Results Out of the 294 patients recruited, 52.4% were female, 41.5% were Malay and 38.8% were within the 60 to69 age category. The prevalence of crude herbs users was 30.6% and the most common herbs used were pegaga (Centella asiatica), peria (Momordica charantia) and betik (Carica papaya). Using the regression analysis, significantly higher odds of using crude herbs are noted among Malay or Indian patients who have these characteristics: attained secondary education, experienced falls or muscle pain, and had systolic blood pressure of more than 140 mmHg. There was no significant difference in HRQOL domains between the crude herb users and non-users (p>0.05). Conclusion Besides taking allopathic medications, certain patients with hypertension use crude herbs as a form of self-management. Although patients are adamant about integrating crude herbs as a form of self-management, the effects of doing so have not been properly investigated. This implies that the healthcare staff members need to communicate with the patients regarding the use of crude herbs together with conventional drugs.	[Joachimdass, Raphael Joe; Subramaniam, Kavitha; Sit, Nam Weng; Loganathan, Annaletchumy] Univ Tunku Abdul Rahman, Fac Sci, Kampar, Malaysia; [Lim, Yang Mooi] Univ Tunku Abdul Rahman, Dept Preclin Sci, Sungai Long, Malaysia; [Lim, Yang Mooi] Univ Tunku Abdul Rahman, Ctr Canc Res, Fac Med & Hlth Sci, Kajang, Selangor, Malaysia; [Teo, Chin Hai; Ng, Chirk Jenn] Univ Malaya, Fac Med, Kuala Lumpur, Malaysia; [Yusof, Afzaninawati Suria] Kementerian Kesihatan Malaysia, Perak State Hlth Dept, Ipoh, Malaysia	Universiti Tunku Abdul Rahman (UTAR); Universiti Tunku Abdul Rahman (UTAR); Universiti Malaya; Kementerian Kesihatan Malaysia	Loganathan, A (corresponding author), Univ Tunku Abdul Rahman, Fac Sci, Kampar, Malaysia.	annal@utar.edu.my	Teo, Chin Hai/F-9636-2018; Sit, Nam Weng/D-2113-2016; LIM, YANG MOOI/J-1311-2014	Teo, Chin Hai/0000-0003-0642-9759; Sit, Nam Weng/0000-0002-5949-491X; Joachimdass, Raphael Joe/0000-0002-5576-4513; LIM, YANG MOOI/0000-0003-1377-7655	Universiti Tunku Abdul Rahman Research Fund (UTARRF) [6200/A48]	Universiti Tunku Abdul Rahman Research Fund (UTARRF)	This study was funded by Universiti Tunku Abdul Rahman Research Fund (UTARRF) vote no. 6200/A48. The fund was awarded to Annaletchumy Loganathan.	Adeniyi O, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0245163; Adnan N, 2012, PROCD SOC BEHV, V42, P231, DOI 10.1016/j.sbspro.2012.04.186; Aekthammarat D, 2020, CLIN EXP HYPERTENS, V42, P490, DOI 10.1080/10641963.2020.1714640; Al-Hadid D., 2020, Pharmacognosy Journal, V12, P1612, DOI 10.5530/pj.2020.12.221; Alexander MR, 2019, HYPERTENSION MEDSCAP; Ali-Shtayeh MS, 2013, COMPLEMENT THER CLIN, V19, P256, DOI 10.1016/j.ctcp.2013.09.001; Amira Oluwatoyin C, 2007, BMC Complement Altern Med, V7, P30, DOI 10.1186/1472-6882-7-30; [Anonymous], 2017, HLTH SCI J INDONESIA, DOI DOI 10.22435/HSJI.V8I1.5600; [Anonymous], 2020, NONC DIS RISK FACT; Azizah N, 2021, J MULTIDISCIP HEALTH, V14, P259, DOI 10.2147/JMDH.S289156; Bachok MF, 2014, ASIA PAC J CLIN NUTR, V23, P369, DOI 10.6133/apjcn.2014.23.3.01; Bahar Z, 2013, AFR J TRADIT COMPLEM, V10, P292, DOI 10.4314/ajtcam.v10i2.14; Chao MT, 2008, J NATL MED ASSOC, V100, P1341, DOI 10.1016/S0027-9684(15)31514-5; Chui PL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139952; Chung VCH, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-207; Devkota S, 2016, FRONT CARDIOVASC MED, V3, DOI 10.3389/fcvm.2016.00026; Fantoukh OI, 2019, PHYTOMEDICINE, V60, DOI 10.1016/j.phymed.2019.153010; Harwoko, 2014, International Food Research Journal, V21, P149; Hashim YZHY, 2016, COLORECTAL CANCER - FROM PATHOGENESIS TO TREATMENT, P377, DOI 10.5772/62868; Hu HH, 2013, INT J HYPERTENS, V2013, DOI 10.1155/2013/526949; James PB, 2018, COMPLEMENT THER CLIN, V31, P7, DOI 10.1016/j.ctcp.2018.01.001; Khan Huma, 2019, Recent Pat Biotechnol, V13, P239, DOI 10.2174/1872208313666190211114229; Kretchy IA, 2014, BMC COMPLEM ALTERN M, V14, DOI 10.1186/1472-6882-14-44; Liwa A, 2017, INT J HYPERTENS, V2017, DOI 10.1155/2017/5692572; Loganathan A, 2016, BMC GERIATR, V16, DOI 10.1186/s12877-016-0274-6; Ma HY, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-222; Mahfudz A S, 2005, Med J Malaysia, V60, P454; Meamarbashi A, 2017, AVICENNA J PHYTOMEDI, V7, P16; Mollaoglu M, 2013, ACTA CLIN CROAT, V52, P181; Musini VM., 2017, COCHRANE DB SYST REV, V2017, pCD008284, DOI [10.1002/14651858.CD008284.pub3, DOI 10.1002/14651858.CD008284.PUB3]; Nahas R, 2008, CAN FAM PHYSICIAN, V54, P1529; Naing C, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000002417; Ng CW, 2017, HEALTH SYST REFORM, V3, P159, DOI 10.1080/23288604.2017.1342746; Ohn Mar S., 2017, CHIN J INTEGR MED, DOI [10.1007/s11655-017-2780-6, DOI 10.1007/S11655-017-2780-6]; Olisa Nwako S, 2009, Int J Pharm Pract, V17, P101; Opheim R, 2016, GASTROENT RES PRACT, V2016, DOI 10.1155/2016/6453657; Peltzer K, 2019, J MULTIDISCIP HEALTH, V12, P573, DOI 10.2147/JMDH.S212953; Poljicanin T, 2010, J MED SCI, V10, P12, DOI [10.3923/jms.2011.84.89, DOI 10.3923/JMS.2011.84.89]; Priya J., 2017, IMPACT YOGA BLOOD PR, V9; Quandt SA, 2009, J ALTERN COMPLEM MED, V15, P331, DOI 10.1089/acm.2008.0521; Showande SJ, 2019, FOOD SCI NUTR, V7, P44, DOI 10.1002/fsn3.789; Siew-Mooi C., 2013, LIFE SCI J, V10, P2526; Sooi LK, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/438139; Suchanova B, 2008, EUR J PHARM SCI, V33, P91, DOI 10.1016/j.ejps.2007.10.003; Tajadini H, 2015, J EVID-BASED INTEGR, V20, P199, DOI 10.1177/2156587215573141; Than M., 2019, FOOD RES, V3, P604, DOI [DOI 10.26656/FR.2017.3(5).118, 10.26656/fr.2017.3(5).118]; Vooradi S., 2016, REV SYSTEMIC REV LIF, P1; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Wazaify M, 2013, COMPLEMENT THER CLIN, V19, P153, DOI 10.1016/j.ctcp.2013.03.001; Welz AN, 2018, BMC COMPLEM ALTERN M, V18, DOI 10.1186/s12906-018-2160-6; Xu XL, 2016, INT J HYPERTENS, V2016, DOI 10.1155/2016/7404957	51	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2021	16	9							e0257336	10.1371/journal.pone.0257336	http://dx.doi.org/10.1371/journal.pone.0257336			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XM9EM	34506588	Green Published, gold			2022-12-26	WOS:000729120700100
J	Li, SS; Chen, BX; Chen, H; Hua, Z; Shao, Y; Yin, H; Wang, JW				Li, Shaoshuo; Chen, Baixing; Chen, Hao; Hua, Zhen; Shao, Yang; Yin, Heng; Wang, Jianwei			Analysis of potential genetic biomarkers and molecular mechanism of smoking-related postmenopausal osteoporosis using weighted gene co-expression network analysis and machine learning	PLOS ONE			English	Article							HNRNP-C; EXPRESSION; RISK; CYTOSCAPE; PATTERNS; PACKAGE; COMPLEX; WOMEN; RNA	Objectives Smoking is a significant independent risk factor for postmenopausal osteoporosis, leading to genome variations in postmenopausal smokers. This study investigates potential biomarkers and molecular mechanisms of smoking-related postmenopausal osteoporosis (SRPO). Materials and methods The GSE13850 microarray dataset was downloaded from Gene Expression Omnibus (GEO). Gene modules associated with SRPO were identified using weighted gene co-expression network analysis (WGCNA), protein-protein interaction (PPI) analysis, and pathway and functional enrichment analyses. Feature genes were selected using two machine learning methods: support vector machine-recursive feature elimination (SVM-RFE) and random forest (RF). The diagnostic efficiency of the selected genes was assessed by gene expression analysis and receiver operating characteristic curve. Results Eight highly conserved modules were detected in the WGCNA network, and the genes in the module that was strongly correlated with SRPO were used for constructing the PPI network. A total of 113 hub genes were identified in the core network using topological network analysis. Enrichment analysis results showed that hub genes were closely associated with the regulation of RNA transcription and translation, ATPase activity, and immune-related signaling. Six genes (HNRNPC, PFDN2, PSMC5, RPS16, TCEB2, and UBE2V2) were selected as genetic biomarkers for SRPO by integrating the feature selection of SVM-RFE and RF. Conclusion The present study identified potential genetic biomarkers and provided a novel insight into the underlying molecular mechanism of SRPO.	[Li, Shaoshuo] Nanjing Univ Chinese Med, Nanjing, Peoples R China; [Chen, Baixing] Univ Leuven, KU Leuven, Dept Dev & Regenerat, Leuven, Belgium; [Chen, Hao; Hua, Zhen; Shao, Yang; Yin, Heng; Wang, Jianwei] Univ Chinese Med, Wuxi Affiliated Hosp, Dept Traumatol & Orthoped, Wuxi, Jiangsu, Peoples R China	Nanjing University of Chinese Medicine; KU Leuven	Wang, JW (corresponding author), Univ Chinese Med, Wuxi Affiliated Hosp, Dept Traumatol & Orthoped, Wuxi, Jiangsu, Peoples R China.	wxwangjianwei1963@126.com		Wang, Jianwei/0000-0002-2484-7922	National Natural Science Foundation of China [81873320, 81973878]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China (No. 81873320, 81973878). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahuja K, 2019, MICROSYST NANOENG, V5, DOI 10.1038/s41378-019-0073-2; Alberg AJ, 2014, AM J EPIDEMIOL, V179, P403, DOI 10.1093/aje/kwt335; Albrecht E, 2014, EUR RESPIR J, V43, P983, DOI 10.1183/09031936.00046213; Bijelic Radojka, 2017, Med Arch, V71, P25, DOI 10.5455/medarh.2017.71.25-28; Bogard N, 2019, CELL, V178, P91, DOI 10.1016/j.cell.2019.04.046; Broer L, 2011, J ALZHEIMERS DIS, V25, P93, DOI 10.3233/JAD-2011-101560; Brook JS, 2012, PSYCHOL REP, V110, P351, DOI 10.2466/13.18.PR0.110.2.351-362; Brown C, 2017, NATURE, V550, pS15, DOI 10.1038/550S15a; Burge R, 2007, J BONE MINER RES, V22, P465, DOI [10.1359/jbmr.061113, 10.1359/JBMR.061113]; Chang DC, 2017, DIABETES-METAB RES, V33, DOI 10.1002/dmrr.2922; Chaves-Perez A, 2018, ADV EXP MED BIOL, V1106, P95, DOI 10.1007/978-3-030-00737-9_7; David CC, 2014, METHODS MOL BIOL, V1084, P193, DOI 10.1007/978-1-62703-658-0_11; Deng Z, 2016, ONCOL REP, V35, P359, DOI 10.3892/or.2015.4388; Faienza MF, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/575936; Giulietti M, 2018, FRONT ONCOL, V8, DOI 10.3389/fonc.2018.00450; Gohlke-Barwolf C, 2000, BASIC RES CARDIOL, V95, P77, DOI 10.1007/s003950070014; Grissa D, 2016, FRONT MOL BIOSCI, V3, DOI 10.3389/fmolb.2016.00030; Gruebner O, 2017, SOC SCI MED, V189, P167, DOI 10.1016/j.socscimed.2017.07.018; Guo LY, 2020, CANCER CELL INT, V20, DOI 10.1186/s12935-020-01274-z; Hamzeh O, 2019, DIAGNOSTICS, V9, DOI 10.3390/diagnostics9040219; Hua ZD, 2021, APPL IMMUNOHISTO M M, V29, P585, DOI 10.1097/PAI.0000000000000928; Huang YY, 2020, PEERJ, V8, DOI 10.7717/peerj.8456; Jang ER, 2015, J CELL SCI, V128, P4428, DOI 10.1242/jcs.177543; Kachroo P, 2019, NAT GENET, V51, P548, DOI 10.1038/s41588-018-0343-1; KANIS JA, 1994, J BONE MINER RES, V9, P1137, DOI 10.1002/jbmr.5650090802; Kanis JA, 2008, BONE, V42, P467, DOI 10.1016/j.bone.2007.11.001; Kim K, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-76510-7; Korkor Adel B, 2009, WMJ, V108, P181; Langfelder P, 2008, BIOINFORMATICS, V24, P719, DOI 10.1093/bioinformatics/btm563; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Lee JJK, 2019, CELL, V177, P1842, DOI 10.1016/j.cell.2019.05.013; Lee J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035567; Lin XH, 2012, J CHROMATOGR B, V910, P149, DOI 10.1016/j.jchromb.2012.05.020; Marom-Haham L, 2016, CURR OPIN OBSTET GYN, V28, P230, DOI 10.1097/GCO.0000000000000283; Miller C, 2004, ANN NEUROL, V56, P734, DOI 10.1002/ana.20282; Niu Yamei, 2013, Genomics Proteomics & Bioinformatics, V11, P8, DOI 10.1016/j.gpb.2012.12.002; Oncken C, 2020, NICOTINE TOB RES, V22, P1587, DOI 10.1093/ntr/ntz176; Park YM, 2012, MOL CELL BIOL, V32, P4237, DOI 10.1128/MCB.00443-12; Petzold AM, 2009, P NATL ACAD SCI USA, V106, P18662, DOI 10.1073/pnas.0908247106; Phiel KL, 2005, IMMUNOL LETT, V97, P107, DOI 10.1016/j.imlet.2004.10.007; Prasadam I, 2010, BONE, V46, P226, DOI 10.1016/j.bone.2009.10.014; Qian GF, 2019, MOL MED REP, V20, P3202, DOI 10.3892/mmr.2019.10570; Rousseau E, 2009, J BIOL CHEM, V284, P1917, DOI 10.1074/jbc.M806256200; Saad FA, 2020, ANN NY ACAD SCI, V1462, P37, DOI 10.1111/nyas.14231; Santarpia L, 2013, ONCOLOGIST, V18, P1063, DOI 10.1634/theoncologist.2013-0163; Schipani E, 2009, J BONE MINER RES, V24, P1347, DOI [10.1359/JBMR.090602, 10.1359/jbmr.090602]; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shetty S, 2005, MOL CELL BIOCHEM, V272, P107, DOI 10.1007/s11010-005-7644-2; Sinha KM, 2013, J CELL BIOCHEM, V114, P975, DOI 10.1002/jcb.24439; Skerrett-Byrne DA, 2021, RESPIROLOGY, V26, P960, DOI 10.1111/resp.14111; St-Arnaud R, 1999, J CELL BIOCHEM, P32; Stebbins CE, 1999, SCIENCE, V284, P455, DOI 10.1126/science.284.5413.455; Sulahian R, 2006, NUCLEIC ACIDS RES, V34, P1351, DOI 10.1093/nar/gkl012; Taguchi A, 2007, DENTOMAXILLOFAC RAD, V36, P149, DOI 10.1259/dmfr/31116116; Tang N, 2019, J CELL PHYSIOL, V234, P5023, DOI 10.1002/jcp.27304; Tang Y, 2015, BIOSYSTEMS, V127, P67, DOI 10.1016/j.biosystems.2014.11.005; Toth R, 2019, CLIN EPIGENETICS, V11, DOI 10.1186/s13148-019-0736-8; Tshitoyan V, 2019, NATURE, V571, P95, DOI 10.1038/s41586-019-1335-8; Walline HM, 2016, MOL CANCER RES, V14, P941, DOI 10.1158/1541-7786.MCR-16-0105; Wang H, 2020, EUR REV MED PHARMACO, V24, P2181, DOI 10.26355/eurrev_202003_20483; Wang LC, 2020, FRONT ONCOL, V10, DOI 10.3389/fonc.2020.536875; Wang Z, 2020, J CANCER, V11, P2032, DOI 10.7150/jca.39671; Wei SY, 2020, FRONT GENET, V11, DOI 10.3389/fgene.2020.00663; Xiao P, 2008, J BONE MINER RES, V23, P644, DOI [10.1359/jbmr.080105, 10.1359/JBMR.080105]; Xing SQ, 2020, BIOSCIENCE REP, V40, DOI 10.1042/BSR20200935; Xu T, 2018, EVID-BASED COMPL ALT, V2018, DOI 10.1155/2018/2582843; Yan SL, 2018, MOL MED REP, V18, P2789, DOI 10.3892/mmr.2018.9277; Yoon V, 2012, OSTEOPOROSIS INT, V23, P2081, DOI 10.1007/s00198-012-1940-y; Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118; Yuan FL, 2015, BONE, V75, P128, DOI 10.1016/j.bone.2015.02.017; Zarnack K, 2013, CELL, V152, P453, DOI 10.1016/j.cell.2012.12.023; Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128; Zhang F, 2021, J ALZHEIMERS DIS, V79, P1691, DOI 10.3233/JAD-201254; Zhang Y, 2020, J CELL PHYSIOL, V235, P5511, DOI 10.1002/jcp.29261; Zhao Y, 2018, ACS CENTRAL SCI, V4, P246, DOI 10.1021/acscentsci.7b00556; Zhu K, 2015, CURR OSTEOPOROS REP, V13, P52, DOI 10.1007/s11914-014-0248-6; Zhu SP, 2018, BIOL REV, V93, P469, DOI 10.1111/brv.12353	78	1	1	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2021	16	9							e0257343	10.1371/journal.pone.0257343	http://dx.doi.org/10.1371/journal.pone.0257343			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XH8RH	34555052	Green Published, gold			2022-12-26	WOS:000725694500026
J	Ambounda, NL; Woromogo, SH; Yagata-Moussa, FE; Ossouka, LAO; Tekem, VNS; Ango, EO; Kouanang, AJ				Ambounda, Nathalie Ledaga; Woromogo, Sylvain Honore; Yagata-Moussa, Felicite-Emma; Ossouka, Liela Agnes Okoyi; Tekem, Vicky Noel Simo; Ango, Eliane Okira; Kouanang, Alain Jepang			Primary postpartum haemorrhage at the Libreville University Hospital Centre: Epidemiological profile of women	PLOS ONE			English	Article							MATERNAL MORTALITY; RISK-FACTORS; MORBIDITY; DEATH	In Gabon, the proportion of maternal deaths directly related to Primary PostPartum Haemorrhage (PPPH) is 15 to 25%, despite the different means that the World Health Organization has made available to the providers of Emergency Obstetrical and Neonatal Care (EmONC). The objective of this study was to determine the prevalence and epidemiological characteristics of Primary PostPartum Haemorrhage to improve its management and reduce the rate of maternal deaths. An analytical retrospective study involved 42,728 records, whose data were collected using a chart collection form on the basis of information contained in partograms and other patient records. Sociodemographic variables were expressed using percentage. The relationship between the etiologies of PPPH and certain characteristics of the women was established using the ORs with their 95% confidence intervals. The difference was significant if p < 0.05. The prevalence of PPPH was 1.6%. Delivery haemorrhages accounted for 65.5% of PPPH. The main factors associated with delivery haemorrhages were pauci parity and multiparity (p = 0.003 and 0.051), post-term (p = 0.042), and birth weight >4,000 g (p = 0.006). Those associated with genital tract injuries were young maternal age (p = 0.008) and multiparity (p = 0.028). The most common etiology was haemorrhage from delivery. Multiparity remains the most common risk factor and the young age of the patients. It is important to improve management through better assessment of blood loss in the primary postpartum period as well as capacity building of health providers on EmONC.	[Ambounda, Nathalie Ledaga; Kouanang, Alain Jepang] Univ Hosp Ctr Libreville, Gynecol & Obstetr Serv, Liberville, Gabon; [Woromogo, Sylvain Honore] InterStates Ctr Higher Publ Hlth Educ Cent Africa, Brazzaville, Rep Congo; [Yagata-Moussa, Felicite-Emma] Univ Bangui, Fac Hlth Sci, Bangui, Cent Afr Republ; [Ossouka, Liela Agnes Okoyi] Army Training Hosp Omar Mbongo Ondimba, Libreville, Gabon; [Tekem, Vicky Noel Simo] Minist Publ Hlth, Natl Canc Prevent & Control Programme, Libreville, Gabon; [Ango, Eliane Okira] Hlth Ctr Nzeng Ayong, Libreville, Gabon		Woromogo, SH (corresponding author), InterStates Ctr Higher Publ Hlth Educ Cent Africa, Brazzaville, Rep Congo.	woromogos@gmail.com		WOROMOGO, SYLVAIN HONORE/0000-0002-4459-0597				Abouchadi S, 2013, TROP MED INT HEALTH, V18, P444, DOI 10.1111/tmi.12065; Andrikopoulou M, 2019, SEMIN PERINATOL, V43, P11, DOI 10.1053/j.semperi.2018.11.003; Beucher G, 2008, J GYNECOL OBST BIO R, V37, pS244, DOI 10.1016/S0368-2315(08)74762-8; Chaouki M., 2013, ANN AFR MED, V6, P1492; Deneux-Tharaux C, 2014, J GYNECOL OBST BIO R, V43, P936, DOI 10.1016/j.jgyn.2014.09.023; Dolley P, 2014, J GYNECOL OBST BIO R, V43, P998, DOI 10.1016/j.jgyn.2014.09.026; Dupont C, 2014, J GYNECOL OBST BIO R, V43, P244, DOI 10.1016/j.jgyn.2013.05.003; Firmin M, 2019, J GYNECOL OBSTET HUM, V48, P55, DOI 10.1016/j.jogoh.2018.11.006; Karlsson H, 2009, AN SIST SANIT NAVAR, V32, P159, DOI 10.4321/s1137-66272009000200014; Khan KS, 2006, LANCET, V367, P1066, DOI 10.1016/S0140-6736(06)68397-9; King JC, 2013, CURR OPIN OBSTET GYN, V25, P117, DOI 10.1097/GCO.0b013e32835e1505; Lacomme M., 1960, PRATIQUE OBSTETRIQUE, VI, P127; Lori JR, 2012, MIDWIFERY, V28, P67, DOI 10.1016/j.midw.2010.12.001; Madoue G.B, 2015, S SUDAN MED J, V8, P28; Ministry of Economy Employment and Sustainable Development/ UNDP and ICF International, 2013, GAB DEM HLTH SURV 20; Ministry of Health/ UNFPA, NAT REP MAT DEATHS G; Ngbale R. N., 2012, Medecine d'Afrique Noire, V59, P39; Nyflot LT, 2017, BMC PREGNANCY CHILDB, V17, DOI 10.1186/s12884-016-1217-0; Ononge S, 2016, REPROD HEALTH, V13, DOI 10.1186/s12978-016-0154-8; Oyelese Y, 2010, CLIN OBSTET GYNECOL, V53, P147, DOI 10.1097/GRF.0b013e3181cc406d; Rakotozanany B., 2019, INT J REPROD CONTRAC, V8, P121; Say L, 2014, LANCET GLOB HEALTH, V2, pE323, DOI 10.1016/S2214-109X(14)70227-X; Subtil D., 2004, J GYNECOL OBST BIO R, V33, p4S9; Tuncalp O, 2013, INT J GYNECOL OBSTET, V123, P254, DOI 10.1016/j.ijgo.2013.06.024; Vendittelli F, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-1008-7; Waterstone M, 2001, BMJ-BRIT MED J, V322, P1089, DOI 10.1136/bmj.322.7294.1089	26	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2021	16	9							e0257544	10.1371/journal.pone.0257544	http://dx.doi.org/10.1371/journal.pone.0257544			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	WG6BN	34543331	Green Published, gold			2022-12-26	WOS:000707078200046
J	Grebonval, C; Trosseille, X; Petit, P; Wang, XG; Beillas, P				Grebonval, Cyrille; Trosseille, Xavier; Petit, Philippe; Wang, Xuguang; Beillas, Philippe			Effects of seat pan and pelvis angles on the occupant response in a reclined position during a frontal crash	PLOS ONE			English	Article								Current highly automated vehicle concepts include reclined seat layouts that could allow occupants to relax during the drive. The main objective of this study was to investigate the effects of seat pan and pelvis angles on the kinematics and injury risk of a reclined occupant by numerical simulation of a frontal sled test. The occupant, represented by a detailed 50th percentile male human body model, was positioned on a semi-rigid seat. Three seat pan angles (5, 15, and 25 degrees from the horizontal) were used, all with a seatback angle of 40 degrees from the vertical. Three pelvis angles (60, 70, and 80 degrees from the vertical), representing a nominal and two relaxed sitting positions, were used for each seat pan angle. The model was restrained using a pre-inflated airbag and a three-point seatbelt equipped with a pretensioner and a load limiter before being subjected to two frontal crash pulses. Both model kinematic response and predicted injury risk were affected by the seat pan and the pelvis angles in a reclined seatback position. Submarining occurrence and injury risk increased with lower seat pan angle, higher pelvis angle, and acceleration pulse severity. In some cases (in particular for a 15 degrees seat pan), a small variation in seat pan or pelvis angle resulted in large differences in terms of kinematics and predicted injury. This study highlights the potential effects of the seat pan and pelvis angles for reclined occupant protection. These parameters should be assessed experimentally with volunteers to determine which combinations are most likely to be adopted for comfort and with post mortem human surrogates to confirm their significance during impact and to provide data for model validation. The sled and restraint models used in this study are provided under an open-source license to facilitate further comparisons.	[Grebonval, Cyrille; Wang, Xuguang; Beillas, Philippe] Univ Lyon, Univ Claude Bernard Lyon 1, Univ Gustave Eiffel, IFSTTAR,LBMC UMR T, F-9406 Lyon, France; [Trosseille, Xavier; Petit, Philippe] Lab PSA Peugeot Citroen Renault, Lab Accidentol & Biomech, Nanterre, France	UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Universite Gustave-Eiffel; Renault SA	Grebonval, C (corresponding author), Univ Lyon, Univ Claude Bernard Lyon 1, Univ Gustave Eiffel, IFSTTAR,LBMC UMR T, F-9406 Lyon, France.	cyrille.grebonval@univ-eiffel.fr		Grebonval, Cyrille/0000-0002-0846-4593	SURCA French project	SURCA French project	This study received funding from the SURCA French project. The funder provided support in the form of salaries for author [CG], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The author specific roles are articulated in the 'author contributions' section.	Arun Mike W J, 2017, Stapp Car Crash J, V61, P1; Beillas P, 2018, P INT RES C BIOM IMP; Bohrmann B, 2019, P INT C HUM SYST ENG; Boyle K., 2019 IRCOBI C; Dissanaike S, 2008, J TRAUMA, V64, P614, DOI 10.1097/TA.0b013e318164d071; Gepner B, 2019, P INT TECHN C ENH SA; Gepner BD, 2019, P INT RES C BIOM C B; Global Human Body Models Consortium LLC, 2016, US MAN M50 DET OCC V; Izumiyama T, 2018, P INT RES C BIOM IMP; Janak T, 2018, P INT RES C BIOM IMP; Louden AE, 2019, 812746 NAT HIGHW TRA; Luet Carole, 2012, Stapp Car Crash J, V56, P411; Peng JF, 2018, HUM FACTORS, V60, P172, DOI 10.1177/0018720817741040; Pfleging B, 2016, 15TH INTERNATIONAL CONFERENCE ON MOBILE AND UBIQUITOUS MULTIMEDIA (MUM 2016), P91, DOI 10.1145/3012709.3012735; Poplin GS, 2017, ACCIDENT ANAL PREV, V106, P122, DOI 10.1016/j.aap.2017.05.007; Reed MP, 2018, UMTRI20182; Richardson R, 2020, P INT RES C BIOM IMP; Richardson R, 2019, P 26 INT TECHN C ENH; Richardson Rachel, 2020, Stapp Car Crash J, V64, P83; Richardson R, 2020, TRAFFIC INJ PREV, V21, pS66, DOI 10.1080/15389588.2020.1837365; Theodorakos I, 2018, ADV INTELLIGENT SYST, V823; Trosseille X., 2019, STAPP CAR CRASH J, V63, P291, DOI [10.4271/2019-22-0012, DOI 10.4271/2019-22-0012]; Uriot J., 2015, P IRCOBI C LYON FRAN; Uriot Jerome, 2015, Stapp Car Crash J, V59, P203; Yang Y., 2018, ADV INTELLIGENT SYST, V823	25	1	1	8	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2021	16	9							e0257292	10.1371/journal.pone.0257292	http://dx.doi.org/10.1371/journal.pone.0257292			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	WG6BN	34543333	Green Published, gold			2022-12-26	WOS:000707078200027
J	Hune, M; Friedlander, AM; Ballesteros, E; Caselle, JE; Sala, E				Hune, Mathias; Friedlander, Alan M.; Ballesteros, Enric; Caselle, Jennifer E.; Sala, Enric			Assemblage structure and spatial diversity patterns of kelp forest-associated fishes in Southern Patagonia	PLOS ONE			English	Article							WATERS BEAGLE CHANNEL; TEMPERATE REEF FISHES; MACROCYSTIS-PYRIFERA; GIANT-KELP; COMMUNITY STRUCTURE; MAGELLAN; HABITAT; CHILE; ECOSYSTEMS; ABUNDANCE	Knowledge of the ecology of the fish fauna associated with kelp (primarily Macrocystis pyrifera) forests in Southern Patagonia is scarce, especially in how abiotic and biotic variables influence their structure, diversity, and distribution. This information is important for the management and conservation of this unique ecosystem, which has minimal anthropogenic impacts at present. We analyzed data from 122 quantitative underwater transects conducted within kelp forests at 61 stations from Chile's southern Patagonian fjords to the Cape Horn and Diego Ramirez archipelagos and the southern tip of Argentina, including the Mitre Peninsula and Isla de los Estados. In total, 25 fish species belonging to 13 families were observed. Multivariate analysis indicated that there are significant differences in fish assemblage structure among locations and wave exposures, which was driven primarily by Patagonotothen sima and Paranotothenia magellanica, which occurred on exposed and semi-exposed stations. P. cornucola was mainly distributed across sheltered stations of the Kawesqar National Park. Temperature, salinity, depth, and kelp density influenced fish assemblage structure, with the highest diversity in areas with the lowest temperature and greater depth at Isla de los Estados. In contrast, species richness, diversity, abundance, and biomass were all lower in areas with high density of the understory kelp Lessonia spp., which might be driven by the absence of P. tessellata, P. squamiceps and P. cornucola, the most important species in terms of occurrence, abundance, and biomass. Our study provides the first broad-scale description of the fish assemblages associated with kelp forests along the southern cone of South America based on non-invasive visual transects, improving our knowledge of the distribution of fish assemblages across several environmental conditions in this vast and little-studied area.	[Hune, Mathias] Ctr Invest Conservac Ecosistemas Australes ICEA, Punta Arenas, Chile; [Friedlander, Alan M.; Sala, Enric] Natl Geog Soc, Pristine Seas, Washington, DC 20036 USA; [Friedlander, Alan M.] Univ Hawaii, Hawaii Inst Marine Biol, Kaneohe, HI 96744 USA; [Ballesteros, Enric] Ctr Estudis Avancats Blanes CSIC, Blanes, Girona, Spain; [Caselle, Jennifer E.] Univ Calif Santa Barbara, Marine Sci Inst, Santa Barbara, CA 93106 USA	National Geographic Society; University of Hawaii System; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centre d'Estudis Avancats de Blanes (CEAB); University of California System; University of California Santa Barbara	Friedlander, AM (corresponding author), Natl Geog Soc, Pristine Seas, Washington, DC 20036 USA.; Friedlander, AM (corresponding author), Univ Hawaii, Hawaii Inst Marine Biol, Kaneohe, HI 96744 USA.	alan.friedlander@hawaii.edu	Hüne, Mathias/ABE-6000-2020		National Geographic Society and Pristine Seas donors	National Geographic Society and Pristine Seas donors	We received funding from the National Geographic Society and Pristine Seas donors. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson M.J., 2008, PERMANOVA PRIMER GUI; Andrade S, 1991, I PAT, V20, P135; Antezana T, 1999, SCI MAR, V63, P23, DOI 10.3989/scimar.1999.63s123; Arkema KK, 2009, ECOLOGY, V90, P3126, DOI 10.1890/08-1213.1; Avaria S, 2017, 201448 FIP; Barneche DR, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2015.2186; Beaton EC, 2020, POLAR BIOL, V43, P573, DOI 10.1007/s00300-020-02662-x; Borcard D, 2011, USE R, P1, DOI 10.1007/978-1-4419-7976-6; Brown JH, 1996, ANNU REV ECOL SYST, V27, P597, DOI 10.1146/annurev.ecolsys.27.1.597; Bruno DO, 2018, POLAR BIOL, V41, P365, DOI 10.1007/s00300-017-2196-y; Buschmann AH, 2004, MAR BIOL, V145, P849, DOI 10.1007/s00227-004-1393-8; Cardenas CA, 2015, POLAR BIOL, V38, P1631, DOI 10.1007/s00300-015-1729-5; Chao A, 2009, ECOLOGY, V90, P1125, DOI 10.1890/07-2147.1; CLAPPERTON CM, 1995, QUATERNARY RES, V44, P133, DOI 10.1006/qres.1995.1058; Clarke K.R., 2014, CHANGE MARINE COMMUN; Colwell R. K., 2016, ESTIMATES VERSION 9; Cousseau MB, 2020, J BIOGEOGR, V47, P220, DOI 10.1111/jbi.13735; Cruz-Jimenez AM., 2019, THESIS U NACL PLATA; DAYTON PK, 1985, ECOL MONOGR, V55, P447, DOI 10.2307/2937131; Eastman JT, 2019, POLAR BIOL, V42, P1131, DOI 10.1007/s00300-019-02502-7; Eastman JT, 2017, POLAR BIOL, V40, P2077, DOI 10.1007/s00300-017-2128-x; Efird TP, 2014, ENVIRON BIOL FISH, V97, P1253, DOI 10.1007/s10641-013-0211-x; Fernandez DA, 2019, J APPL ICHTHYOL, V35, P597, DOI 10.1111/jai.13833; Fernandez DA, 2012, POLAR BIOL, V35, P99, DOI 10.1007/s00300-011-1037-7; Fortt A, 2007, REV CHIL INFECTOL, V24, P14; Friedlander AM, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0249413; Friedlander AM, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0229259; Friedlander AM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0189930; Friedlander AM, 2003, CORAL REEFS, V22, P291, DOI 10.1007/s00338-003-0317-2; Froese R., 2021, FISHBASE; Haro D, 2020, ECOL INDIC, V109, DOI 10.1016/j.ecolind.2019.105796; HOLBROOK SJ, 1990, B MAR SCI, V47, P104; Hune M, 2015, POLAR BIOL, V38, P1613, DOI 10.1007/s00300-015-1726-8; Hulton NRJ, 2002, QUATERNARY SCI REV, V21, P233, DOI 10.1016/S0277-3791(01)00103-2; Hune M., 2019, LISTA SISTEM TICA AC, DOI [10.15468/er28jy, DOI 10.15468/ER28JY]; Hune M, 2018, POLAR RES-SWEDEN, V37, DOI 10.1080/17518369.2018.1435107; Hune M, 2016, POLAR BIOL, V39, P2253, DOI 10.1007/s00300-016-1892-3; Huovinen P, 2010, MAR FRESHWATER RES, V61, P330, DOI 10.1071/MF09054; Iriarte JL, 2005, J PLANKTON RES, V27, P159, DOI 10.1093/plankt/fbh167; Iriarte JL, 2018, FRONT MAR SCI, V5, DOI 10.3389/fmars.2018.00360; Johnson DW, 2006, ECOLOGY, V87, P1179, DOI 10.1890/0012-9658(2006)87[1179:PHCAVI]2.0.CO;2; Levin PS, 1996, MAR ECOL PROG SER, V134, P37, DOI 10.3354/meps134037; Lloris D., 1991, ICTIOFAUNA CANAL BEA; Iriarte JL, 2010, AMBIO, V39, P463, DOI 10.1007/s13280-010-0049-9; Luiz OJ, 2015, MAR FRESHWATER RES, V66, P739, DOI 10.1071/MF14150; McInnes JC, 2017, FRONT MAR SCI, V4, DOI 10.3389/fmars.2017.00277; Miller RJ, 2015, OECOLOGIA, V179, P1199, DOI 10.1007/s00442-015-3441-0; Miloslavich P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014631; Moller AP, 2002, OECOLOGIA, V132, P492, DOI 10.1007/s00442-002-0952-2; Mora-Soto A, 2020, REMOTE SENS-BASEL, V12, DOI 10.3390/rs12040694; MORENO CA, 1984, MAR ECOL PROG SER, V15, P99, DOI 10.3354/meps015099; Niklitschek EJ., 2011, 200830 FIP; Ojeda FP, 2000, REV CHIL HIST NAT, V73, P625; Oksanen J., 2020, VEGAN COMMUNITY ECOL; Pais MP, 2018, PEERJ, V6, DOI 10.7717/peerj.5378; Palacios M, 2021, SCI TOTAL ENVIRON, V751, DOI 10.1016/j.scitotenv.2020.141810; Pantoja S, 2011, CONT SHELF RES, V31, P149, DOI 10.1016/j.csr.2010.10.013; Perez-Matus A, 2007, MAR FRESHWATER RES, V58, P1069, DOI 10.1071/MF06200; Perez-Matus A, 2012, REV CHIL HIST NAT, V85, P29, DOI 10.4067/S0716-078X2012000100003; Quimbayo JP, 2019, ECOGRAPHY, V42, P77, DOI 10.1111/ecog.03506; R Core Team, 2020, R LANG ENV STAT COMP; Rabosky DL, 2018, NATURE, V559, P392, DOI 10.1038/s41586-018-0273-1; Reyes P., 2012, PECES CHILE; Riccialdelli L, 2015, MEDIDAS PARAMETROS A, P5; Riccialdelli L, 2013, POLAR BIOL, V36, P617, DOI 10.1007/s00300-013-1289-5; Rios C, 2007, POLAR BIOL, V31, P89, DOI 10.1007/s00300-007-0337-4; Salas-Berrios F, 2013, POLAR BIOL, V36, P1401, DOI 10.1007/s00300-013-1359-8; Sepulveda M, 2013, AQUACULT ENV INTERAC, V4, P273, DOI 10.3354/aei00089; Silva S. Nelson, 2002, Ciencia y Tecnologia del Mar, V25, P23; Soto D, 2001, ECOL APPL, V11, P1750, DOI 10.2307/3061093; Steneck RS, 2002, ENVIRON CONSERV, V29, P436, DOI 10.1017/S0376892902000322; Sugden DE, 2002, QUATERN INT, V95-6, P55, DOI 10.1016/S1040-6182(02)00027-7; Vanella FA, 2005, SCI MAR, V69, P317, DOI 10.3989/scimar.2005.69s2317; Vanella FA, 2007, POLAR BIOL, V30, P449, DOI 10.1007/s00300-006-0202-x; Veccia M, 2017, OCEANOGRAFIA FISICA, P162; Verges A, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0846; Wessel P, 1996, J GEOPHYS RES-SOL EA, V101, P8741, DOI 10.1029/96JB00104; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279; Wood Simon, 2021, CRAN; Zamora E, 1979, I PAT, V10, P109; Zeng X, 2020, AQUAT BIOL, V29, P137, DOI 10.3354/ab00731	81	2	2	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2021	16	9							e0257662	10.1371/journal.pone.0257662	http://dx.doi.org/10.1371/journal.pone.0257662			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	WG6BN	34543325	gold, Green Published			2022-12-26	WOS:000707078200066
J	Shimizutani, S; Yamada, E				Shimizutani, Satoshi; Yamada, Eiji			Resilience against the pandemic: The impact of COVID-19 on migration and household welfare in Tajikistan	PLOS ONE			English	Article							INTERNATIONAL MIGRATION; MIGRANT REMITTANCES; INVESTMENT	The COVID-19 pandemic is likely to have adverse effects on the economy through damage to migration and remittances. We use a unique monthly household panel dataset that covers the period both before and after the outbreak to examine the impacts of COVID-19 on a variety of household welfare outcomes in Tajikistan, where remittance inflows in recent years have exceeded a quarter of annual GDP. We provide several findings. First, after April 2020, the adverse effects of the pandemic on household welfare were significantly observed and were particularly pronounced in the second quarter of 2020. Second, in contrast to expectation, the pandemic had a sharp but only transitory effect on the stock of migrants working abroad in the spring. Some expected migrants were forced to remain in their home country during the border closures, while some incumbent migrants expecting to return were unable to do so and remained employed in their destination countries. Both departures and returns started to increase again from summer. Employment and remittances of the migrants quickly recovered to levels seen in previous years after a sharp decline in April and May. Third, regression analyses reveal that both migration and remittances have helped to mitigate the adverse economic outcomes at home during the "with-COVID-19" period, suggesting that they served as a form of insurance. Overall, the unfavorable effects of the COVID-19 pandemic were severe and temporary right after the outbreak, but households with migrants were more resilient against the pandemic.	[Shimizutani, Satoshi; Yamada, Eiji] JICA Ogata Sadako Res Inst Peace & Dev, Tokyo, Japan		Shimizutani, S (corresponding author), JICA Ogata Sadako Res Inst Peace & Dev, Tokyo, Japan.	Shimizutani.Satoshi@jica.go.jp						Ai CR, 2003, ECON LETT, V80, P123, DOI 10.1016/S0165-1765(03)00032-6; Amare M., 2020, IFPRI - Discussion Papers; Amare M, 2016, J DEV STUD, V52, P1463, DOI 10.1080/00220388.2016.1139696; Asian Development Bank, 2020, STRENGTH SUPP LAB MI; Baker SR, 2020, REV ASSET PRICING ST, V10, P834, DOI 10.1093/rapstu/raaa009; Barker N., 2020, WIDER Working Papers; Chen H., 2020, IMPACT COVID 19 PAND, DOI [DOI 10.2139/SSRN.3568574, http://dx.doi.org/10.2139/ssrn.3568574]; Halliday T, 2006, ECON DEV CULT CHANGE, V54, P893, DOI 10.1086/503584; Hawks A.S, 2020, COVID 19 UPDATE NEW; Honorati Maddalena, 2020, WORLD BANK DISCUSSIO; International Organization for Migration (IOM), 2020, COVID 19 ANAL SNAPSH; Javed M, 2017, SOC INDIC RES, V130, P779, DOI 10.1007/s11205-015-1199-8; Jena F, 2018, J DEV STUD, V54, P312, DOI 10.1080/00220388.2017.1288219; JICA Ogata Sadako Research Institute for Peace and Development (JICA-RI), 2020, MIGR LIV COND SKILLS; Kangmennaang J., 2018, MIGRATION DEV, V7, P55, DOI [10.1080/21632324.2017.1325551, DOI 10.1080/21632324.2017.1325551]; Kansiime MK, 2021, WORLD DEV, V137, DOI 10.1016/j.worlddev.2020.105199; Kikkawa Aiko, 2020, COVID 19 IMPACT INT; Mobarak AM, 2020, SEASONAL POVERTY COV; Mohapatra Sanket, 2012, Environment Development and Sustainability, V14, P365, DOI 10.1007/s10668-011-9330-8; Murakami Enerelt, 2021, Econ Disaster Clim Chang, V5, P97, DOI 10.1007/s41885-020-00078-9; Naude WA, 2014, ATLANTIC ECON J, V42, P79, DOI 10.1007/s11293-014-9403-9; Cuong NV, 2018, J INT MIGR INTEGR, V19, P945, DOI 10.1007/s12134-018-0571-3; Ullah Ahsan AKM., 2021, SOCIAL SCI HUMANITIE, V3; Wadood SN, 2017, BUS ECON HORIZ, V13, P10, DOI 10.15208/beh.2017.02; World Bank, 2020, MIGR DEV BRIEF 32 CO; World Bank, 2020, REM DAT; Yang D, 2008, ECON J, V118, P591, DOI 10.1111/j.1468-0297.2008.02134.x; Yang D, 2007, WORLD BANK ECON REV, V21, P219, DOI 10.1093/wber/lhm003	28	2	2	3	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2021	16	9							e0257469	10.1371/journal.pone.0257469	http://dx.doi.org/10.1371/journal.pone.0257469			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	WG6BN	34543292	Green Published, gold			2022-12-26	WOS:000707078200034
J	Li, XH; Li, J; Zhang, P; Deng, HF; Yang, MG; He, HB; Wang, RR				Li, Xuehan; Li, Jun; Zhang, Pei; Deng, Huifei; Yang, Mingan; He, Hongbo; Wang, Rurong			The minimum effective concentration (MEC90) of ropivacaine for ultrasound-guided caudal block in anorectal surgery. A dose finding study	PLOS ONE			English	Article							LOCAL ANALGESIC CONCENTRATION; EPIDURAL-ANESTHESIA; SEX-DIFFERENCES; SACRAL HIATUS; PAIN; AGE; BUPIVACAINE; CHILDREN; VOLUME; SPACE	Background Caudal epidural block (CEB) provides reliable anesthesia for adults undergoing anorectal surgery. Despite the widely utilization, the minimum effective concentration for 90% patients (MEC90) of ropivacaine for CEB remains unknown. Objective To estimate MEC of ropivacaine for CEB in anorectal surgery. Design A prospective dose-finding study using biased coin design up-and-down sequential method. Setting Operating room and postoperative recovery area of Chengdu Shangjin Nanfu Hospital, from October 2019 to January 2020. Patients 50 males and 51 females scheduled for anorectal surgery. Interventions We conducted two independent biased coin design up-and down trials by genders. The concentration of ropivacaine administered to the first patient of male and female were 0.25% with fixed volume of 14ml for male and 12ml for female patients based on our previous study. In case of failure, the concentration was increased by 0.05% in the next subject. Otherwise, the next subject was randomized to a concentration 0.05% less with a probability of 0.11, or the same concentration with a probability of 0.89. Success was defined as complete sensory blockade of perineal area 15 min after the block evidenced by the presence of a lax anal sphincter and pain-free surgery. Main outcome measures The MEC of ropivacaine to achieve a successful CEB in 90%(MEC90) of the patients. Results The MEC90 of ropivacaine for CEB were estimated to be 0.35% (95% CI 0.29 to 0.4%) for male and 0.353% (95%CI 0.22 to 0.4%) for female. By extrapolation to MEC in 99% of subjects (MEC99) and pooled adjacent violators algorithm (PAVA) adjusted responses, it would be optimal to choose 0.4% ropivacaine with a volume of 14ml for male and 12ml for female. Conclusions A concentration of 0.35% ropivacaine with a volume of 14ml provided a successful CEB in 90% of the male patients, while 0.353% ropivacaine with a volume of 12ml provided a successful CEB in 90% of the female patients. A concentration of 0.4% and a volume of 14ml for male and 12 ml for female would be successful in 99% of the patients. Trial registration Chictr.org.cn identifier: No. ChiCTR 1900024315.	[Li, Xuehan; Li, Jun; Zhang, Pei; Deng, Huifei; Wang, Rurong] Sichuan Univ, Dept Anesthesiol, Lab Anesthesia & Intens Care Med, West China Hosp, Chengdu, Sichuan, Peoples R China; [Yang, Mingan] San Diego State Univ, Div Biostat & Epidemiol, Sch Publ Hlth, San Diego, CA 92182 USA; [He, Hongbo] Sichuan Univ, Benign Coloproctol Dis Ctr, West China Hosp, Chengdu, Sichuan, Peoples R China	Sichuan University; California State University System; San Diego State University; Sichuan University	Wang, RR (corresponding author), Sichuan Univ, Dept Anesthesiol, Lab Anesthesia & Intens Care Med, West China Hosp, Chengdu, Sichuan, Peoples R China.	wangrurong@scu.edu.cn		wang, rurong/0000-0002-9213-3104	National Natural Science Foundation of China [81900064]; Science and Technology Support Project of Sichuan Province [2018SZ0113]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Support Project of Sichuan Province	Dr Xuehan Li has no conflict of interest to declare. She received a grant from National Natural Science Foundation of China (Grant No. 81900064) and a grant from Science and Technology Support Project of Sichuan Province (No. 2020YJ0050) for this study. Dr Hongbo He has no conflict of interest to declare. He received a grant from Science and Technology Support Project of Sichuan Province (No. 2018SZ0113) for this study. Dr. Jun Li, Dr Pei Zhang, Dr Huifei Deng, Dr Mingan Yang and Dr Rurong Wang have no conflict of interest to declare and did not receive funds for this study.	Abukawa Y, 2015, BMC ANESTHESIOL, V15, DOI 10.1186/s12871-015-0082-0; Aggarwal A, 2009, SURG RADIOL ANAT, V31, P793, DOI 10.1007/s00276-009-0529-4; Ala-Kokko TI, 2000, ACTA ANAESTH SCAND, V44, P1099, DOI 10.1034/j.1399-6576.2000.440911.x; Asghar A, 2013, J CLIN DIAGN RES, V7, P2659, DOI 10.7860/JCDR/2013/6287.3724; Campesi Ilaria, 2012, Handb Exp Pharmacol, P265, DOI 10.1007/978-3-642-30726-3_13; Casati A, 2002, ANESTH ANALG, V94, P987, DOI 10.1097/00000539-200204000-00039; Chen CP, 2010, ARCH PHYS MED REHAB, V91, P358, DOI 10.1016/j.apmr.2009.11.019; Chia YY, 2002, CAN J ANAESTH, V49, P249, DOI 10.1007/BF03020523; Ciccone GK, 1999, BRIT J ANAESTH, V82, P255, DOI 10.1093/bja/82.2.255; Crighton IM, 1997, BRIT J ANAESTH, V78, P391, DOI 10.1093/bja/78.4.391; Da Conceicao MJ, 1998, BRIT J ANAESTH, V80, P507, DOI 10.1093/bja/80.4.507; Deng XM, 2010, ANAESTHESIA, V65, P991, DOI 10.1111/j.1365-2044.2010.06454.x; Fam MD, 2018, J NEUROL SURG PART B, V79, P614, DOI 10.1055/s-0038-1651501; Forestier J, 2017, BRIT J ANAESTH, V119, P972, DOI 10.1093/bja/aex280; Gudaityte Jurate, 2004, Medicina (Kaunas), V40, P101; Higuchi H, 2004, ANESTHESIOLOGY, V101, P451, DOI 10.1097/00000542-200408000-00027; Huang BW, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-024912; Ingelmo P, 2009, ANESTH ANALG, V108, P805, DOI 10.1213/ane.0b013e3181935aa5; Ivanova A, 2003, STAT MED, V22, P69, DOI 10.1002/sim.1336; Kao SC, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/9217145; Khalil S, 1999, ANESTHESIOLOGY, V91, P1279, DOI 10.1097/00000542-199911000-00018; Lee B, 2017, BRIT J ANAESTH, V118, P781, DOI 10.1093/bja/aex078; Li YH, 2006, ANESTH ANALG, V102, P1847, DOI 10.1213/01.ane.0000215999.60513.da; Li YH, 2010, ANESTH ANALG, V110, P1490, DOI 10.1213/ANE.0b013e3181d6bade; Maurer AJ, 2016, PAIN MANAG, V6, P285, DOI 10.2217/pmt-2015-0002; Nofal WH, 2017, EGYPT J ANAESTH, V33, P67, DOI 10.1016/j.egja.2016.10.008; PARK WY, 1979, ANESTHESIOLOGY, V51, P81, DOI 10.1097/00000542-197907000-00019; Parrish AB, 2018, WORLD J SURG, V42, P1929, DOI 10.1007/s00268-017-4414-8; Robinson ME, 1998, PAIN, V77, P143, DOI 10.1016/S0304-3959(98)00088-8; Sanghvi C., 2020, CAUDAL ANESTHESIA ST; Sekiguchi M, 2004, CLIN J PAIN, V20, P51, DOI 10.1097/00002508-200401000-00010; Senoglu N, 2005, BRIT J ANAESTH, V95, P692, DOI 10.1093/bja/aei236; Siddiqui ZI, 2007, J CLIN ANESTH, V19, P269, DOI 10.1016/j.jclinane.2006.12.004; Simpson D, 2005, DRUGS, V65, P2675, DOI 10.2165/00003495-200565180-00013; Stylianou M, 2003, STAT MED, V22, P535, DOI 10.1002/sim.1351; Stylianou M, 2002, BIOMETRICS, V58, P171, DOI 10.1111/j.0006-341X.2002.00171.x; Wiegele M, 2019, BRIT J ANAESTH, V122, P509, DOI 10.1016/j.bja.2018.11.030; Xuehan Li PZ, 2020, EUR J ANAESTH, V37, P7; Ye F, 2007, J INT MED RES, V35, P307, DOI 10.1177/147323000703500304	39	1	1	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2021	16	9							e0257283	10.1371/journal.pone.0257283	http://dx.doi.org/10.1371/journal.pone.0257283			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	WG5ZQ	34534232	gold, Green Published			2022-12-26	WOS:000707073300022
J	Datta, S; Chilakala, K; Vempati, S; Oleti, T; Kulkarni, J; Murki, S; Gaddam, P; Satgunam, P				Datta, Sourav; Chilakala, Koteswararao; Vempati, Sandeep; Oleti, Tejopratap; Kulkarni, Jaishree; Murki, Srinivas; Gaddam, Pramod; Satgunam, PremNandhini			Quantification of gaze reaction time in infants with Pediatric Perimeter	PLOS ONE			English	Article							COORDINATION; CHILDREN; EYE	Purpose We quantified the eye/head (gaze) reaction time in infants to establish a normative database for the Pediatric Perimeter device. Additionally, we tested the hypothesis that gaze reaction time will reduce with age. Methods A cross-sectional study was conducted. Healthy infants between 3 to 10 months of age were recruited. Peripheral visual field stimuli (hemifield and quadrant stimuli) were presented in the Pediatric Perimeter device. Infant's gaze to these stimuli was observed, documented in real time, and video recorded for offline analysis. Results A total of 121 infants were tested in three age group bins [3-5 months, n = 44; >5-7 months, n = 30 and >7-10 months, n = 47]. Overall, 3-5 months old had longer reaction time when compared to the older infants particularly for stimuli presented in the quadrants (Kruskal-Wallis, p<0.038). A significantly asymmetric difference (p = 0.025) in reaction time was observed between the upper (median = 820ms, IQR = 659-1093ms) and lower quadrants (median = 601ms, IQR = 540-1052ms) only for the 3-5 months old infants. Conclusion This study provides the normative gaze reaction time of healthy infants. With increase in age, there is reduction in reaction time and disappearance of reaction time asymmetry in quadrant stimuli. The longer reaction time for upward gaze could be due to delayed maturation of neural mechanisms and/or decreased visual attention.	[Datta, Sourav; Satgunam, PremNandhini] LV Prasad Eye Inst, Hyderabad Eye Res Fdn, Brien Holden Inst Optometry & Vis Sci, Hyderabad, India; [Chilakala, Koteswararao; Vempati, Sandeep] LV Prasad Eye Inst, Hyderabad Eye Res Fdn, Ctr Innovat, Hyderabad, India; [Oleti, Tejopratap; Kulkarni, Jaishree; Murki, Srinivas; Gaddam, Pramod] Fernandez Hosp, Hyderabad, India	L. V. Prasad Eye Institute; L. V. Prasad Eye Institute	Satgunam, P (corresponding author), LV Prasad Eye Inst, Hyderabad Eye Res Fdn, Brien Holden Inst Optometry & Vis Sci, Hyderabad, India.	premnandhini@lvpei.org		Satgunam, PremNandhini/0000-0001-8631-733X; Oleti, Tejo pratap/0000-0003-4597-0978; datta, sourav/0000-0002-7604-8444	Hyderabad Eye Research Foundation; Department of Biotechnology, Ministry of Science and Technology [BT/PR32404/MED/30/2136/2019]; Wellcome Trust DBT India Alliance [IA/R/16/1/502633]	Hyderabad Eye Research Foundation; Department of Biotechnology, Ministry of Science and Technology; Wellcome Trust DBT India Alliance(Wellcome TrustWellcome Trust DBT India Alliance)	This study was supported by Hyderabad Eye Research Foundation in the form of funds awarded to PNS, the Department of Biotechnology, Ministry of Science and Technology (http://dbtindia.gov.in/) in the form of a grant awarded to PNS (BT/PR32404/MED/30/2136/2019), and the Wellcome Trust DBT India Alliance (https://www.indiaalliance.org/) in the form of a grant awarded to SD (IA/R/16/1/502633). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abegg M, 2015, J EYE MOVEMENT RES, V8; Alahyane N, 2016, J VISION, V16, DOI 10.1167/16.1.6; ASLIN RN, 1975, PERCEPT PSYCHOPHYS, V17, P293, DOI 10.3758/BF03203214; Ballantyne JW, 1916, BMJ-BRIT MED J, V1916, P189, DOI 10.1136/bmj.1.2875.189; Bucci MP, 2014, EXP BRAIN RES, V232, P927, DOI 10.1007/s00221-013-3805-9; Butcher PR, 2000, INFANT BEHAV DEV, V23, P3, DOI 10.1016/S0163-6383(00)00031-X; CANFIELD RL, 1995, INFANT BEHAV DEV, V18, P351, DOI 10.1016/0163-6383(95)90023-3; Dobson V, 1998, VISION RES, V38, P2743, DOI 10.1016/S0042-6989(97)00437-9; GOODKIN F, 1980, EARLY HUM DEV, V4, P373, DOI 10.1016/0378-3782(80)90042-0; Grobbel J, 2016, TRANSL VIS SCI TECHN, V5, DOI 10.1167/tvst.5.2.5; He S, 1996, NATURE, V383, P334, DOI 10.1038/383334a0; Heidary G, 2017, J PEDIATR NEUROL, V15, P10, DOI 10.1055/s-0036-1593741; Huttermann S, 2017, RES Q EXERCISE SPORT, V88, P169, DOI 10.1080/02701367.2017.1293228; Irving EL, 2006, INVEST OPHTH VIS SCI, V47, P2478, DOI 10.1167/iovs.05-1311; Irving Elizabeth L, 2019, Exp Eye Res, V183, P38, DOI 10.1016/j.exer.2018.08.020; JOHNSON MH, 1991, J COGNITIVE NEUROSCI, V3, P335, DOI 10.1162/jocn.1991.3.4.335; Kooiker MJG, 2016, JOVE-J VIS EXP, DOI 10.3791/54031; Kulke L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142505; Leat SJ, 2011, CLIN EXP OPTOM, V94, P514, DOI 10.1111/j.1444-0938.2011.00600.x; REGAL DM, 1983, BEHAV BRAIN RES, V10, P125, DOI 10.1016/0166-4328(83)90158-4; Rose SA, 2002, CHILD DEV, V73, P47, DOI 10.1111/1467-8624.00391; Satgunam P, 2017, TRANSL VIS SCI TECHN, V6, DOI 10.1167/tvst.6.4.3; SCHWARTZ TL, 1987, VISION RES, V27, P2163, DOI 10.1016/0042-6989(87)90130-1; Simons K, 1993, EARLY VISUAL DEV NOR; Soon BT., 2012, GLOBAL ACTION REPORT	25	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2021	16	9							e0257459	10.1371/journal.pone.0257459	http://dx.doi.org/10.1371/journal.pone.0257459			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	WG5YY	34529713	Green Published, gold			2022-12-26	WOS:000707071500060
J	Hou, CH; Lee, JS; Lin, KK; Liu, L; Lee, YS; Pu, C				Hou, Chiun-Ho; Lee, Jiahn-Shing; Lin, Ken-Kuo; Liu, Laura; Lee, Yung-Sung; Pu, Christy			Accuracy of perceived glaucoma risk by patients in a clinical setting	PLOS ONE			English	Article							SELF-RATED HEALTH; OPEN-ANGLE GLAUCOMA; SOCIOECONOMIC-STATUS; PREDICTIVE POWER; PREVALENCE; MORTALITY; ASSOCIATION; AMERICANS; SEX	Objective To determine whether patients attending the ophthalmology department underestimate their glaucoma risks. Method We conducted a cross-sectional survey with a final study population of 1203 individuals from two medical centers in Taiwan during January 1-June 30, 2019. The "High concern" group was defined as the set of patients who rated themselves as having low risk but who had been rated by physicians as having medium or high risk of developing glaucoma over the next year. Results Approximately 12% of the respondents belonged to the "High concern" group. For those with education at the college level or higher, the interaction term was estimated to be 0.294 (95% CI = 0.136-0.634). Marginal effect calculations revealed significant sex-based differences in the effect of knowledge at specific age intervals. Conclusions A considerable proportion of patients attending the ophthalmology department underestimate their glaucoma risks. Misjudgment of glaucoma risks can lead to delays in seeking of medical attention. Glaucoma education should be designed according to each patient's education level and sex, as its effect is not consistent across different education and sex clusters.	[Hou, Chiun-Ho; Lee, Jiahn-Shing; Lin, Ken-Kuo; Liu, Laura; Lee, Yung-Sung] Linkou Chang Gung Mem Hosp, Dept Ophthalmol, Taoyuan, Taiwan; [Hou, Chiun-Ho; Pu, Christy] Natl Yang Ming Chiao Tung Univ, Sch Med, Inst Publ Hlth, Tainan, Taiwan; [Hou, Chiun-Ho] Xiaman Chang Gung, Dept Ophthalmol, Xiaman, Peoples R China; [Hou, Chiun-Ho; Lee, Jiahn-Shing; Lin, Ken-Kuo; Liu, Laura; Lee, Yung-Sung] Chang Gung Univ, Coll Med, Dept Med, Taoyuan, Taiwan	Chang Gung Memorial Hospital; National Yang Ming Chiao Tung University; Chang Gung University	Pu, C (corresponding author), Natl Yang Ming Chiao Tung Univ, Sch Med, Inst Publ Hlth, Tainan, Taiwan.	cypu@nycu.edu.tw		Lee, Jiahn-Shing/0000-0001-7007-939X	Ministry of Science and Technology, Taiwan [109-2314-B-010 -049 -MY2]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan)	This study was supported by Ministry of Science and Technology, Taiwan (Grant number: 109-2314-B-010 -049 -MY2). Grant recipient: C Pu. URL: https://www.most.gov.tw/?l=en The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addo J, 2017, J EPIDEMIOL COMMUN H, V71, P633, DOI 10.1136/jech-2016-208322; Aghamollaei H, 2019, J OPHTHAL VIS RES, V14, P121, DOI 10.4103/jovr.jovr_55_18; Allana S, 2018, HEART LUNG, V47, P584, DOI 10.1016/j.hrtlng.2018.06.009; Bovbjerg DH, 2019, ACTA ONCOL, V58, P763, DOI 10.1080/0284186X.2019.1574023; Delbaere K, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c4165; Dowd JB, 2007, INT J EPIDEMIOL, V36, P1214, DOI 10.1093/ije/dym214; Eldaly M, 2007, BRIT J OPHTHALMOL, V91, P1274, DOI 10.1136/bjo.2006.111757; Lima-Costa MF, 2012, ANN EPIDEMIOL, V22, P644, DOI 10.1016/j.annepidem.2012.06.101; FLANAGAN DW, 1993, BRIT J OPHTHALMOL, V77, P1, DOI 10.1136/bjo.77.1.1; Fraser S, 2001, BMJ-BRIT MED J, V322, P639, DOI 10.1136/bmj.322.7287.639; GRANT WM, 1982, OPHTHALMOLOGY, V89, P991; Heeringa SG., 2017, APPL SURVEY DATA ANA; Higginbotham E, 2004, ARCH OPHTHALMOL-CHIC, V122, P374, DOI 10.1001/archopht.122.3.374; Higginbotham EJ, 2006, ARCH OPHTHALMOL-CHIC, V124, P1185, DOI 10.1001/archopht.124.8.1185; Hoevenaars JGMM, 2006, ACTA OPHTHALMOL SCAN, V84, P84, DOI 10.1111/j.1600-0420.2005.00587.x; Ko YC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149698; MCKENNEY JL, 1995, EPIDEMIOLOGY, V6, P612, DOI 10.1097/00001648-199511000-00009; Newman-Casey PA, 2019, J GLAUCOMA, V28, P415, DOI 10.1097/IJG.0000000000001192; Oh SA, 2019, CURR EYE RES, V44, P436, DOI 10.1080/02713683.2018.1548129; Shaikh Y, 2014, AM J OPHTHALMOL, V158, P1121, DOI 10.1016/j.ajo.2014.08.023; Shweikh Y, 2015, EYE, V29, P1360, DOI 10.1038/eye.2015.157; Signorello LB, 2007, AM J PUBLIC HEALTH, V97, P2260, DOI 10.2105/AJPH.2006.094482; Sleath B, 2014, J OPHTHALMOL, V2014, DOI 10.1155/2014/238939; SOMMER A, 1991, ARCH OPHTHALMOL-CHIC, V109, P1090, DOI 10.1001/archopht.1991.01080080050026; Suresh S, 2011, J EPIDEMIOL, V21, P337, DOI 10.2188/jea.JE20100142; Susanna R, 2015, TRANSL VIS SCI TECHN, V4, DOI 10.1167/tvst.4.2.1; Tarkkanen A, 2008, ACTA OPHTHALMOL, V86, P697, DOI 10.1111/j.1600-0420.2007.01109.x; Valliant R, 2018, SURVEY WEIGHRS STEP	28	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2021	16	9							e0257453	10.1371/journal.pone.0257453	http://dx.doi.org/10.1371/journal.pone.0257453			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	WG5YY	34529708	Green Published, gold			2022-12-26	WOS:000707071500059
J	Kusztrits, I; Marquardt, L; Hugdahl, K; Hirnstein, M				Kusztrits, Isabella; Marquardt, Lynn; Hugdahl, Kenneth; Hirnstein, Marco			Transcranial direct current stimulation (tDCS) enhances internal source monitoring abilities in healthy participants	PLOS ONE			English	Article							HALLUCINATING PATIENTS; AUDITORY HALLUCINATIONS; PREFRONTAL CORTEX; BROCAS AREA; INFORMATION; SPEECH; SCHIZOPHRENIA; METAANALYSIS; MECHANISMS; HANDEDNESS	Source monitoring refers to the ability to identify the origin of a memory, for example, whether you remember saying something or thinking about it, and confusions of these sources have been associated with the experience of auditory verbal hallucinations (AVHs). Both AVHs and source confusions are reported to originate from dysfunctional brain activations in the prefrontal cortex (PFC) and the superior temporal gyrus (STG); specifically, it is assumed that a hypoactive PFC and a hyperactive STG gives rise to AVHs and source confusions. We set out to test this assumption by trying to mimic this hypertemporal/hypofrontal model in healthy individuals with transcranial direct current stimulation (tDCS): the inhibitory cathode was placed over the left PFC and the excitatory anode over the left dorsolateral STG. Participants completed a reality monitoring task (distinguishing between external and internal memory sources) and an internal source monitoring task (distinguishing between two or more internal memory sources) in two separate experiments (offline vs. online tDCS). In the offline experiment (n = 34), both source monitoring tasks were completed after tDCS stimulation, and in the online experiment (n = 27) source monitoring tasks were completed while simultaneously being stimulated with tDCS. We found that internal source monitoring abilities were significantly enhanced during active online tDCS, while reality monitoring abilities were unaffected by stimulation in both experiments. We speculate, based on combining the present findings with previous studies, that there might be different brain areas involved in reality and internal source monitoring. While internal source monitoring seems to involve speech production areas, specifically Broca's area, as suggested in the present study, reality monitoring seems to rely more on the STG and DLPFC, as shown in other studies of the field.	[Kusztrits, Isabella; Marquardt, Lynn; Hugdahl, Kenneth; Hirnstein, Marco] Univ Bergen, Dept Biol & Med Psychol, Bergen, Norway; [Kusztrits, Isabella; Marquardt, Lynn; Hugdahl, Kenneth; Hirnstein, Marco] Univ Bergen, NORMENT Norwegian Ctr Mental Hlth Disorders Res, Bergen, Norway; [Kusztrits, Isabella; Marquardt, Lynn; Hugdahl, Kenneth; Hirnstein, Marco] Haukeland Hosp, Bergen, Norway; [Hugdahl, Kenneth] Haukeland Hosp, Dept Radiol, Bergen, Norway; [Hugdahl, Kenneth] Haukeland Hosp, Div Psychiat, Bergen, Norway	University of Bergen; University of Bergen; University of Bergen; Haukeland University Hospital; University of Bergen; Haukeland University Hospital	Kusztrits, I (corresponding author), Univ Bergen, Dept Biol & Med Psychol, Bergen, Norway.; Kusztrits, I (corresponding author), Univ Bergen, NORMENT Norwegian Ctr Mental Hlth Disorders Res, Bergen, Norway.; Kusztrits, I (corresponding author), Haukeland Hosp, Bergen, Norway.	isabella_kusztrits@hotmail.com	Hirnstein, Marco/D-2450-2013	Hirnstein, Marco/0000-0002-6291-0929	Bergen Research Foundation [BFS2016REK03]; European Research Council (ERC) [693124]	Bergen Research Foundation; European Research Council (ERC)(European Research Council (ERC)European Commission)	The current research has been funded by the Bergen Research Foundation (grant BFS2016REK03 to MH). The contribution of KH was funded by a grant from the European Research Council (ERC), #693124. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aleman A, 2003, SCHIZOPHR RES, V64, P175, DOI 10.1016/S0920-9964(03)00060-4; Allen P, 2007, BRIT J PSYCHIAT, V190, P162, DOI 10.1192/bjp.bp.106.025700; BRADLEY MM, 1994, J BEHAV THER EXP PSY, V25, P49, DOI 10.1016/0005-7916(94)90063-9; Brunelin J, 2006, SCHIZOPHR RES, V81, P41, DOI 10.1016/j.schres.2005.10.009; Brunelin J, 2006, EUR PSYCHIAT, V21, P259, DOI 10.1016/j.eurpsy.2006.01.015; Brunelin J, 2015, BRAIN STIMUL, V8, P1225, DOI 10.1016/j.brs.2015.08.002; Brunelin J, 2012, AM J PSYCHIAT, V169, P719, DOI 10.1176/appi.ajp.2012.11071091; Brunoni AR, 2011, INT J NEUROPSYCHOPH, V14, P1133, DOI 10.1017/S1461145710001690; Buch ER, 2017, CLIN NEUROPHYSIOL, V128, P589, DOI 10.1016/j.clinph.2017.01.004; Burgess PW, 2007, TRENDS COGN SCI, V11, P290, DOI 10.1016/j.tics.2007.05.004; Carey DP, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.01128; Chein JM, 2002, PHYSIOL BEHAV, V77, P635, DOI 10.1016/S0031-9384(02)00899-5; Chen CMA, 2011, J COGNITIVE NEUROSCI, V23, P2892, DOI 10.1162/jocn.2010.21589; Dedoncker J, 2016, BRAIN STIMUL, V9, P501, DOI 10.1016/j.brs.2016.04.006; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149; Flinker A, 2015, P NATL ACAD SCI USA, V112, P2871, DOI 10.1073/pnas.1414491112; Gandiga PC, 2006, CLIN NEUROPHYSIOL, V117, P845, DOI 10.1016/j.clinph.2005.12.003; Garrison JR, 2017, CORTEX, V91, P197, DOI 10.1016/j.cortex.2016.11.011; Guevara ER, 2010, P NAACL HLT 2010 6 W; Henquet C, 2005, PSYCHIAT RES, V133, P57, DOI 10.1016/j.psychres.2004.08.009; Hugdahl K, 2015, WORLD J PSYCHIATR, V5, P193, DOI 10.5498/wjp.v5.i2.193; Hugdahl K, 2009, SCAND J PSYCHOL, V50, P553, DOI 10.1111/j.1467-9450.2009.00775.x; Jacobson L, 2012, EXP BRAIN RES, V216, P1, DOI 10.1007/s00221-011-2891-9; JOHNSON MK, 1993, PSYCHOL BULL, V114, P3, DOI 10.1037/0033-2909.114.1.3; JOHNSON MK, 1981, PSYCHOL REV, V88, P67, DOI 10.1037/0033-295X.88.1.67; Keefe RSE, 1999, PSYCHOL MED, V29, P903, DOI 10.1017/S0033291799008673; Kompus K, 2011, NEUROPSYCHOLOGIA, V49, P3361, DOI 10.1016/j.neuropsychologia.2011.08.010; LANSKY LM, 1988, NEUROPSYCHOLOGIA, V26, P465, DOI 10.1016/0028-3932(88)90099-1; Marquardt L, 2021, EUR J NEUROSCI, V53, P449, DOI 10.1111/ejn.14932; Martin DM, 2014, EXP BRAIN RES, V232, P3345, DOI 10.1007/s00221-014-4022-x; Maxwell S.E., 2017, DESIGNING EXPT ANAL, V3rd; Mitchell KJ, 2017, CORTEX, V96, P129, DOI 10.1016/j.cortex.2017.07.009; Mitchell KJ, 2009, PSYCHOL BULL, V135, P638, DOI 10.1037/a0015849; Mondino M, 2018, J ECT, V34, P164, DOI 10.1097/YCT.0000000000000525; Mondino M, 2016, NEUROPSYCHOLOGIA, V89, P478, DOI 10.1016/j.neuropsychologia.2016.07.022; Mondino M, 2015, SCHIZOPHR RES, V161, P515, DOI 10.1016/j.schres.2014.10.054; Moseley P, 2018, NEUROPSYCHOLOGIA, V120, P113, DOI 10.1016/j.neuropsychologia.2018.10.001; Nitsche MA, 2008, BRAIN STIMUL, V1, P206, DOI 10.1016/j.brs.2008.06.004; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Palm U, 2013, BRAIN STIMUL, V6, P690, DOI 10.1016/j.brs.2013.01.005; Rasmussen T, 1977, Ann N Y Acad Sci, V299, P355, DOI 10.1111/j.1749-6632.1977.tb41921.x; Sahin NT, 2009, SCIENCE, V326, P445, DOI 10.1126/science.1174481; Schoemann A. M., 2020, MONTE CARLO POWER AN; Simons JS, 2006, NEUROIMAGE, V32, P696, DOI 10.1016/j.neuroimage.2006.04.209; Stagg CJ, 2011, NEUROSCIENTIST, V17, P37, DOI 10.1177/1073858410386614; Sugimori E, 2014, PSYCHOL SCI, V25, P403, DOI 10.1177/0956797613505776; Wang B, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199002; Waters F, 2012, SCHIZOPHRENIA BULL, V38, P741, DOI 10.1093/schbul/sbq144; [Anonymous], 2000, JAMA, V284, P3043, DOI 10.1001/jama.2013.281053; Zvyagintsev M, 2013, EUR J NEUROSCI, V37, P1421, DOI 10.1111/ejn.12140	51	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2021	16	9							e0257010	10.1371/journal.pone.0257010	http://dx.doi.org/10.1371/journal.pone.0257010			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	WG5YY	34529676	Green Published, gold			2022-12-26	WOS:000707071500025
J	Nonyong, P; Ekalaksananan, T; Phanthanawiboon, S; Aromseree, S; Phadungsombat, J; Nakayama, EE; Shioda, T; Sawaswong, V; Payungporn, S; Thaewnongiew, K; Overgaard, HJ; Bangs, MJ; Alexander, N; Pientong, C				Nonyong, Patcharaporn; Ekalaksananan, Tipaya; Phanthanawiboon, Supranee; Aromseree, Sirinart; Phadungsombat, Juthamas; Nakayama, Emi E.; Shioda, Tatsuo; Sawaswong, Vorthon; Payungporn, Sunchai; Thaewnongiew, Kesorn; Overgaard, Hans J.; Bangs, Michael J.; Alexander, Neal; Pientong, Chamsai			Dengue virus in humans and mosquitoes and their molecular characteristics in northeastern Thailand 2016-2018	PLOS ONE			English	Article							AEDES-AEGYPTI; SEROTYPES; OUTBREAK; EPIDEMIOLOGY; INFECTIONS; DIVERSITY; CULICIDAE; GUANGDONG; DIPTERA; PATIENT	Dengue is hyperendemic in most Southeast Asian countries including Thailand, where all four dengue virus serotypes (DENV-1 to -4) have circulated over different periods and regions. Despite dengue cases being annually reported in all regions of Thailand, there is limited data on the relationship of epidemic DENV infection between humans and mosquitoes, and about the dynamics of DENV during outbreaks in the northeastern region. The present study was conducted in this region to investigate the molecular epidemiology of DENV and explore the relationships of DENV infection in humans and in mosquitoes during 2016-2018. A total of 292 dengue suspected patients from 11 hospitals and 902 individual mosquitoes (at patient's houses and neighboring houses) were recruited and investigated for DENV serotypes infection using PCR. A total of 103 patients and 149 individual mosquitoes were DENV -positive. Among patients, the predominant DENV serotypes in 2016 and 2018 were DENV-4 (74%) and DENV-3 (53%) respectively, whereas in 2017, DENV-1, -3 and -4 had similar prevalence (38%). Additionally, only 19% of DENV infections in humans and mosquitoes at surrounding houses were serotypically matched, while 81% of infections were serotypically mismatched, suggesting that mosquitoes outside the residence may be an important factor of endemic dengue transmission. Phylogenetic analyses based on envelope gene sequences showed the genotype I of both DENV-1 and DENV-4, and co-circulation of the Cosmopolitan and Asian I genotypes of DENV-2. These strains were closely related to concurrent strains in other parts of Thailand and also similar to strains in previous epidemiological profiles in Thailand and elsewhere in Southeast Asia. These findings highlight genomic data of DENV in this region and suggest that people's movement in urban environments may result in mosquitoes far away from the residential area being key determinants of DENV epidemic dynamics.	[Nonyong, Patcharaporn; Ekalaksananan, Tipaya; Phanthanawiboon, Supranee; Aromseree, Sirinart; Pientong, Chamsai] Khon Kaen Univ, Fac Med, Dept Microbiol, Khon Kaen, Thailand; [Ekalaksananan, Tipaya; Aromseree, Sirinart; Pientong, Chamsai] Khon Kaen Univ, HPV & EBV & Carcinogenesis Res Grp, Khon Kaen, Thailand; [Phadungsombat, Juthamas; Nakayama, Emi E.; Shioda, Tatsuo] Mahidol Univ, Fac Trop Med, Mahidol Osaka Ctr Infect Dis, Bangkok, Thailand; [Nakayama, Emi E.; Shioda, Tatsuo] Osaka Univ, Res Inst Microbial Dis, Osaka, Japan; [Sawaswong, Vorthon] Chulalongkorn Univ, Grad Sch, Program Bioinformat & Computat Biol, Bangkok, Thailand; [Sawaswong, Vorthon; Payungporn, Sunchai] Chulalongkorn Univ, Fac Med, Dept Biochem, Bangkok, Thailand; [Thaewnongiew, Kesorn] Minist Publ Hlth, Dept Dis Control, Off Dis Prevent & Control, Reg 7 Khon Kaen, Khon Kaen, Thailand; [Overgaard, Hans J.] Norwegian Univ Life Sci, Fac Sci & Technol, As, Norway; [Bangs, Michael J.] PT Freeport Indonesia Int Sos, Publ Hlth & Malaria Control, Papua, Indonesia; [Bangs, Michael J.] Kasetsart Univ, Fac Agr, Dept Entomol, Bangkok, Thailand; [Alexander, Neal] London Sch Hyg & Trop Med, Trop Epidemiol Grp, MRC, London, England	Khon Kaen University; Khon Kaen University; Mahidol University; Osaka University; Chulalongkorn University; Chulalongkorn University; Ministry of Public Health - Thailand; Norwegian University of Life Sciences; Kasetsart University; University of London; London School of Hygiene & Tropical Medicine	Pientong, C (corresponding author), Khon Kaen Univ, Fac Med, Dept Microbiol, Khon Kaen, Thailand.; Pientong, C (corresponding author), Khon Kaen Univ, HPV & EBV & Carcinogenesis Res Grp, Khon Kaen, Thailand.; Alexander, N (corresponding author), London Sch Hyg & Trop Med, Trop Epidemiol Grp, MRC, London, England.	Neal.Alexander@lshtm.ac.uk; chapie@kku.ac.th			Research Council of Norway [250443]; Invitation Research Grant, Faculty of Medicine, Khon Kaen University, Thailand [IN62113]; Japan Agency for Medical Research and Development (AMED) [JP19fm0108003, 20wm0225010h0101]	Research Council of Norway(Research Council of Norway); Invitation Research Grant, Faculty of Medicine, Khon Kaen University, Thailand; Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED))	This work was supported by the Research Council of Norway (project no. 250443); the Invitation Research Grant, Faculty of Medicine, Khon Kaen University, Thailand, grant number IN62113; the Japan Agency for Medical Research and Development (AMED) JP19fm0108003 and 20wm0225010h0101.	AbuBakar S, 2002, J GEN VIROL, V83, P2437, DOI 10.1099/0022-1317-83-10-2437; Achee NL, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0006822; Aranda C., 2015, ARBOVIRUS SURVEILLAN, P10; Balingit JC, 2020, PARASITE VECTOR, V13, DOI 10.1186/s13071-020-04470-y; Bharaj P, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-1; Bustamante DM, 2010, AM J TROP MED HYG, V82, P1172, DOI 10.4269/ajtmh.2010.09-0323; Colombo TE, 2013, REV INST MED TROP SP, V55, P275, DOI 10.1590/S0036-46652013000400009; Diaz Y, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11080764; Fahri S, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002354; Fustec B, 2020, PLOS NEGLECT TROP D, V14, DOI 10.1371/journal.pntd.0008703; Goncalvez AP, 2002, VIROLOGY, V303, P110, DOI 10.1006/viro.2002.1686; Gu WD, 2004, AM J TROP MED HYG, V71, P636, DOI 10.4269/ajtmh.2004.71.636; Guedes DRD, 2010, J VECTOR DIS, V47, P67; Hamel R, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0221179; Harapan H, 2020, VIRUSES-BASEL, V12, DOI 10.3390/v12080829; Harapan H, 2019, BMC RES NOTES, V12, DOI 10.1186/s13104-019-4379-9; Harapan H, 2019, REV MED VIROL, V29, DOI 10.1002/rmv.2037; Haryanto S, 2016, PATHOG GLOB HEALTH, V110, P119, DOI 10.1080/20477724.2016.1184864; Hu TS, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2401-1; Huang JH, 2012, AM J TROP MED HYG, V87, P349, DOI 10.4269/ajtmh.2012.11-0666; Huang L, 2016, EUR J CLIN MICROBIOL, V35, P269, DOI 10.1007/s10096-015-2540-5; Hutamai Songwut, 2007, Southeast Asian Journal of Tropical Medicine and Public Health, V38, P448; Islam A, 2020, J INFECT PUBLIC HEAL, V13, P1912, DOI 10.1016/j.jiph.2020.10.009; Jarman RG, 2008, J VIROL, V82, P5494, DOI 10.1128/JVI.02728-07; Kerdpanich P, 2021, AM J TROP MED HYG, V104, P1058, DOI 10.4269/ajtmh.20-0396; Khan J, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195706; Klungthong C, 2004, VIROLOGY, V329, P168, DOI 10.1016/j.virol.2004.08.003; LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992; Lee KS, 2010, EMERG INFECT DIS, V16, P847, DOI 10.3201/eid1605.091006; Limkittikul K, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003241; Lorono-Pino MA, 1999, AM J TROP MED HYG, V61, P725, DOI 10.4269/ajtmh.1999.61.725; Mammen MP, 2008, PLOS MED, V5, P1605, DOI 10.1371/journal.pmed.0050205; Megawati D, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005483; Mendez F, 2006, AM J TROP MED HYG, V74, P678, DOI 10.4269/ajtmh.2006.74.678; Perez-Castro R, 2016, MEM I OSWALDO CRUZ, V111, P233, DOI 10.1590/0074-02760150363; Phadungsombat J, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0207220; Rattanarithikul R., 2010, TRIBE AEDINI SE ASIA, V41, P38; Reddy MN, 2017, PEERJ, V5, DOI 10.7717/peerj.2970; Rueda LM, 2004, ZOOTAXA, P1, DOI 10.11646/zootaxa.589.1.1; Salvo MA, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0212947; Scott TW, 2000, J MED ENTOMOL, V37, P89, DOI 10.1603/0022-2585-37.1.89; Senaratne UTN, 2020, EPIDEMIOL INFECT, V148, DOI 10.1017/S0950268820000229; Shu PY, 2009, AM J TROP MED HYG, V80, P1039, DOI 10.4269/ajtmh.2009.80.1039; Shu PY, 2003, J CLIN MICROBIOL, V41, P2408, DOI 10.1128/JCM.41.6.2408-2416.2003; Sim S, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004052; Siriyasatien P, 2010, SE ASIAN J TROP MED, V41, P43; Sithiprasasna Ratana, 2004, Southeast Asian Journal of Tropical Medicine and Public Health, V35, P918; Sun JF, 2016, J INFECTION, V72, P80, DOI 10.1016/j.jinf.2015.10.007; Suphanchaimat R., 2019, OUTBREAK SURVEILL IN, V12, P9; Teerasut C., 2012, SE ASIAN J TROP MED, V43, P5; Thavara Usavadee, 2006, Southeast Asian Journal of Tropical Medicine and Public Health, V37, P468; Thongrungkiat S, 2011, J VECTOR ECOL, V36, P147, DOI 10.1111/j.1948-7134.2011.00151.x; Twiddy SS, 2002, VIROLOGY, V298, P63, DOI 10.1006/viro.2002.1447; Vazeille M, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1666-0; Vazquez-Prokopec GM, 2009, J MED ENTOMOL, V46, P1256, DOI 10.1603/033.046.0602; Wardhani P, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178443; Warrilow D, 2012, EMERG INFECT DIS, V18, P1850, DOI 10.3201/eid1811.120014; Yang CF, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006773; Yoon IK, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001730; Zhang CL, 2005, J VIROL, V79, P15123, DOI 10.1128/JVI.79.24.15123-15130.2005	62	4	4	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2021	16	9							e0257460	10.1371/journal.pone.0257460	http://dx.doi.org/10.1371/journal.pone.0257460			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	WG5RP	34520486	Green Published, gold, Green Accepted			2022-12-26	WOS:000707052100032
J	Mena, G; Blanco, B; Casas, I; Huertas, A; Sanchez, MA; Aunon, M; Vinas, J; Esteve, M				Mena, Guillermo; Blanco, Beatriz; Casas, Irma; Huertas, Antonia; Sanchez, Maria-Araceli; Aunon, Mario; Vinas, Jordi; Esteve, Maria			Attitudes of Spanish hospital staff towards COVID-19 vaccination and vaccination rates	PLOS ONE			English	Article							INFLUENZA VACCINATION; PREVALENCE; WORKERS	Background COVID-19 vaccine hesitancy seems to be universal across countries and subgroups, and so are its determinants. We studied the willingness and factors associated with the decision to be vaccinated against COVID-19 in healthcare workers (HCW) in a Spanish tertiary hospital. Furthermore, we compared the percentage of willingness to vaccinate against COVID with actual vaccination rates among HCW in our hospital. Methods From December 21, 2020 to January 4, 2021, before initiation of the COVID-19 HCW vaccination campaign at Germans Trias i Pujol University Hospital (HUGTiP), an anonymous self-administered questionnaire was administered to HCW. Univariate and multivariate logistic regression of the association of variables with the outcome "intention to receive the COVID-19 vaccine as soon as possible" was conducted. Vaccination rates were extracted from the hospital information systems. Results Forty-four percent of HCW included in the study declared a willingness to be vaccinated against COVID-19 as soon as possible. This was associated with male sex [1.66 (95%CI 1.13-2.43); p = 0.009], older age [1.02 (95%CI 1.00-1.03); p = 0.014], belonging to the occupational groups "physician" or "other" [5.76 (95%CI 3.44-9.63) and 2.15 (95%CI 1.25-3.70); p<0.001], respectively, and reporting influenza vaccination during the last three seasons or at least one of the last three seasons [3.84 (95%CI 2.56-5.75) and 2.49 (95%CI 1.71-3.63); p<0.001]. One in ten hospital workers reported they were unwilling to receive COVID-19 vaccination. Actual COVID-19 vaccination uptake among HCW was higher (80.4%) than the percentage of willingness to vaccinate estimated from the questionnaire. Physicians not only had the highest vaccination rate, but also the highest correlation between the reported intention to vaccinate and the final decision to receive COVID-19 vaccination. Conclusions COVID-19 vaccination uptake was higher than previously estimated according to the stated intentions of HCW. Doubts and fears must be addressed, particularly in persons less inclined to be vaccinated: females, younger people and those not vaccinated against influenza in recent seasons. The study of barriers and strategies aimed at promoting COVID-19 vaccination must be adapted in relation to occupational groups' attitudes, understanding their idiosyncrasies with respect to this and other vaccines.	[Mena, Guillermo; Blanco, Beatriz; Casas, Irma; Huertas, Antonia; Sanchez, Maria-Araceli; Aunon, Mario; Esteve, Maria] Germans Trias & Pujol Univ Hosp, Prevent Med Dept, Badalona, Spain; [Mena, Guillermo; Casas, Irma; Huertas, Antonia; Vinas, Jordi; Esteve, Maria] Autonomous Univ Barcelona, Badalona, Spain; [Mena, Guillermo; Casas, Irma; Aunon, Mario] Germans Trias & Pujol Res Inst IGTP, Badalona, Spain	Autonomous University of Barcelona; Fundacio Institut d'Investigacio en Ciencies de la Salut Germans Trias i Pujol (IGTP)	Casas, I (corresponding author), Germans Trias & Pujol Univ Hosp, Prevent Med Dept, Badalona, Spain.; Casas, I (corresponding author), Autonomous Univ Barcelona, Badalona, Spain.; Casas, I (corresponding author), Germans Trias & Pujol Res Inst IGTP, Badalona, Spain.	icasas.germanstrias@gencat.cat		Blanco Rojas, Beatriz Julieta/0000-0002-3745-0975; MENA PINILLA, GUILLERMO/0000-0003-0147-6302; Casas, Irma/0000-0002-5902-5777	Innovative Medicines Initiative 2 Joint Undertaking [777363]; European Union; EFPIA	Innovative Medicines Initiative 2 Joint Undertaking; European Union(European Commission); EFPIA	This study received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No 777363. This Joint Undertaking receives support from the European Union Horizon 2020 research and innovation program and EFPIA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bajgain KT, 2021, AM J INFECT CONTROL, V49, P238, DOI 10.1016/j.ajic.2020.06.213; Banegas J R, 2017, Hipertens Riesgo Vasc, V34 Suppl 2, P2, DOI 10.1016/S1889-1837(18)30066-7; Bellia C, 2013, INFLUENZA OTHER RESP, V7, P97, DOI 10.1111/irv.12088; Corace K, 2013, AM J INFECT CONTROL, V41, P679, DOI 10.1016/j.ajic.2013.01.014; Aguilar-Diaz FD, 2011, ARCH MED RES, V42, P652, DOI 10.1016/j.arcmed.2011.12.006; Doornekamp L, 2020, VACCINES-BASEL, V8, DOI 10.3390/vaccines8030480; European Centre for Disease Prevention and Control, COVID 19 VACC PRIOR; European Centre for Disease Prevention and Control, COVID 19 SIT UPD WOR; European Medicines Agency, 2020, TREATM VACC COVID 19; Flanagan KL, 2017, ANNU REV CELL DEV BI, V33, P577, DOI 10.1146/annurev-cellbio-100616-060718; Gagneux-Brunon A, 2021, J HOSP INFECT, V108, P168, DOI [10.1016/j.jhin.2020.11.0200195-6701, 10.1016/j.jhin.2020.11.020]; Galanis P.A., INTENTION HLTH CARE, DOI [10.1101/2020.12.08.20246041v1, DOI 10.1101/2020.12.08.20246041V1]; Godin G, 2010, INFECT CONT HOSP EP, V31, P689, DOI 10.1086/653614; Hopman CE, 2011, J HOSP INFECT, V77, P327, DOI 10.1016/j.jhin.2010.10.009; La Torre G, 2011, HUM VACCINES, V7, P728, DOI 10.4161/hv.7.7.15413; Lazarus JV, 2021, NAT MED, V27, P225, DOI 10.1038/s41591-020-1124-9; Lin C, 2021, VACCINES-BASEL, V9, DOI 10.3390/vaccines9010016; Mannocci A, 2010, REV HEALTH CARE, V1, P27, DOI 10.7175/rhc.v1i1.15; Mesas AE, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0241742; Ministry of Health of Spain, COV 19 VACC STRAT SP; Shekhar R, 2021, VACCINES-BASEL, V9, DOI 10.3390/vaccines9020119; Sobrino J, 2013, BLOOD PRESS MONIT, V18, P326, DOI 10.1097/MBP.0000000000000002; Verger P, 2021, EUROSURVEILLANCE, V26, DOI 10.2807/1560-7917.ES.2021.26.3.2002047; World Med Assoc, 2013, JAMA-J AM MED ASSOC, V310, P2191, DOI 10.1001/jama.2013.281053	24	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2021	16	9							e0257002	10.1371/journal.pone.0257002	http://dx.doi.org/10.1371/journal.pone.0257002			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XM9EM	34506487	gold, Green Published			2022-12-26	WOS:000729120700062
J	Baumgen, M; Dutschei, T; Bartosik, D; Suster, C; Reisky, L; Gerlach, N; Stanetty, C; Mihovilovic, MD; Schweder, T; Hehemann, JH; Bornscheuer, UT				Baeumgen, Marcus; Dutschei, Theresa; Bartosik, Daniel; Suster, Christoph; Reisky, Lukas; Gerlach, Nadine; Stanetty, Christian; Mihovilovic, Marko D.; Schweder, Thomas; Hehemann, Jan-Hendrik; Bornscheuer, Uwe T.			A new carbohydrate-active oligosaccharide dehydratase is involved in the degradation of ulvan	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UTILIZATION LOCI; POLYSACCHARIDES; ENZYMES; LYASE; MECHANISM	Marine algae catalyze half of all global photosynthetic production of carbohydrates. Owing to their fast growth rates, Ulva spp. rapidly produce substantial amounts of carbohydrate-rich biomass and represent an emerging renewable energy and carbon resource. Their major cell wall polysaccharide is the anionic carbohydrate ulvan. Here, we describe a new enzymatic degradation pathway of the marine bacterium Formosa agariphila for ulvan oligosaccharides involving unsaturated uronic acid at the nonreducing end linked to rhamnose-3-sulfate and glucuronic or iduronic acid (Delta-Rha3S-GlcA/IdoA-Rha3S). Notably, we discovered a new dehydratase (P29_PDnc) acting on the nonreducing end of ulvan oligosaccharides, i.e., GlcA/IdoARha3S, forming the aforementioned unsaturated uronic acid residue. This residue represents the substrate for GH105 glycoside hydrolases, which complements the enzymatic degradation pathway including one ulvan lyase, one multimodular sulfatase, three glycoside hydrolases, and the dehydratase P29_PDnc, the latter being described for the first time. Our research thus shows that the oligosaccharide dehydratase is involved in the degradation of carboxylated polysaccharides	[Baeumgen, Marcus; Dutschei, Theresa; Reisky, Lukas; Bornscheuer, Uwe T.] Univ Greifswald, Inst Biochem, Dept Biotechnol & Enzyme Catalysis, Greifswald, Germany; [Bartosik, Daniel; Schweder, Thomas] Univ Greifswald, Inst Pharm, Dept Pharmaceut Biotechnol, Greifswald, Germany; [Suster, Christoph; Stanetty, Christian; Mihovilovic, Marko D.] TU Wien, Inst Appl Synthet Chem, Vienna, Austria; [Gerlach, Nadine; Hehemann, Jan-Hendrik] Max Planck Inst Marine Microbiol, Bremen, Germany; [Hehemann, Jan-Hendrik] Univ Bremen, Ctr Marine Environm Sci MARUM, Bremen, Germany	Ernst Moritz Arndt Universitat Greifswald; Ernst Moritz Arndt Universitat Greifswald; Technische Universitat Wien; Max Planck Society; University of Bremen	Bornscheuer, UT (corresponding author), Univ Greifswald, Inst Biochem, Dept Biotechnol & Enzyme Catalysis, Greifswald, Germany.	uwe.bornscheuer@uni-greifswald.de		Stanetty, Christian/0000-0001-7692-6932; Hehemann, Jan-Hendrik/0000-0002-8700-2564; Suster, Christoph/0000-0002-9245-9286; Schweder, Thomas/0000-0002-7213-3596; Dutschei, Theresa/0000-0003-3053-9536	German Research Foundation (DFG) [FOR2406, BO 1862/17-2, HE 7217/2-2, SCHW 595/10-2]; Emmy-Noether-Program of the DFG [HE 7217/1-1]	German Research Foundation (DFG)(German Research Foundation (DFG)); Emmy-Noether-Program of the DFG(German Research Foundation (DFG))	This study was supported by the German Research Foundation (DFG) for the Research Unit FOR2406 "Proteogenomics of Marine Polysaccharide Utilization" (POMPU) by grants of U. T. B. (BO 1862/17-2), J.-H. H. (HE 7217/2-2), and T. S. (SCHW 595/10-2). J.-H. H. acknowledges funding by the Emmy-Noether-Program of the DFG, grant number HE 7217/1-1.	Allard STM, 2002, STRUCTURE, V10, P81, DOI 10.1016/S0969-2126(01)00694-3; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ashkenazy H, 2016, NUCLEIC ACIDS RES, V44, pW344, DOI 10.1093/nar/gkw408; Barbeyron T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164846; Berezin C, 2004, BIOINFORMATICS, V20, P1322, DOI 10.1093/bioinformatics/bth070; Cesario TM, 2018, BIOTECHNOL ADV, V36, P798, DOI 10.1016/j.biotechadv.2018.02.006; Collen PN, 2014, J BIOL CHEM, V289, P6199, DOI 10.1074/jbc.M113.537480; Eddy SR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002195; Field CB, 1998, SCIENCE, V281, P237, DOI 10.1126/science.281.5374.237; Foran E, 2017, ALGAL RES, V25, P39, DOI 10.1016/j.algal.2017.04.036; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hehemann JH, 2014, CURR OPIN STRUC BIOL, V28, P77, DOI 10.1016/j.sbi.2014.07.009; Hehemann JH, 2010, NATURE, V464, P908, DOI 10.1038/nature08937; Horn SJ, 2004, CARBOHYD POLYM, V56, P35, DOI 10.1016/j.carbpol.2003.11.011; Itoh T, 2006, J MOL BIOL, V360, P573, DOI 10.1016/j.jmb.2006.04.047; Jongkees SAK, 2011, J AM CHEM SOC, V133, P19334, DOI 10.1021/ja209067v; Kidgell JT, 2019, ALGAL RES, V39, DOI 10.1016/j.algal.2019.101422; Kim HT, 2012, BIORESOURCE TECHNOL, V107, P301, DOI 10.1016/j.biortech.2011.11.120; Konasani VR, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-32922-0; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Ladner CL, 2004, ANAL BIOCHEM, V326, P13, DOI 10.1016/j.ab.2003.10.047; Lahaye M, 1998, CARBOHYD RES, V314, P1, DOI 10.1016/S0008-6215(98)00293-6; Lahaye M, 1997, CARBOHYD RES, V304, P325, DOI 10.1016/S0008-6215(97)00270-X; Lahaye M, 2007, BIOMACROMOLECULES, V8, P1765, DOI 10.1021/bm061185q; Lefort V, 2017, MOL BIOL EVOL, V34, P2422, DOI 10.1093/molbev/msx149; Leiro JM, 2007, INT IMMUNOPHARMACOL, V7, P879, DOI 10.1016/j.intimp.2007.02.007; Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529; Li CK, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-92; Mann AJ, 2013, APPL ENVIRON MICROB, V79, P6813, DOI 10.1128/AEM.01937-13; Melcher RLJ, 2017, SCI REP-UK, V7, DOI 10.1038/srep44115; Potter SC, 2018, NUCLEIC ACIDS RES, V46, pW200, DOI 10.1093/nar/gky448; Qin HM, 2018, RSC ADV, V8, P2610, DOI 10.1039/c7ra12294b; Reisky L, 2019, NAT CHEM BIOL, V15, P803, DOI 10.1038/s41589-019-0311-9; Reisky L, 2018, APPL MICROBIOL BIOT, V102, P6987, DOI 10.1007/s00253-018-9142-y; Robic A, 2009, BIOPOLYMERS, V91, P652, DOI 10.1002/bip.21195; Salinas A, 2017, ALGAL RES, V27, P335, DOI 10.1016/j.algal.2017.09.025; Somoza JR, 2000, STRUCTURE, V8, P123, DOI 10.1016/S0969-2126(00)00088-5; Song MY, 2015, RENEW SUST ENERG REV, V50, P782, DOI 10.1016/j.rser.2015.05.021; Terrapon N, 2015, BIOINFORMATICS, V31, P647, DOI 10.1093/bioinformatics/btu716; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Ulaganathan T, 2018, J BIOL CHEM, V293, P11564, DOI 10.1074/jbc.RA118.003659; Ulaganathan T, 2018, J BIOL CHEM, V293, P4026, DOI 10.1074/jbc.RA117.001642; Ulaganathan T, 2017, GLYCOBIOLOGY, V27, P176, DOI 10.1093/glycob/cww096; Wargacki AJ, 2012, SCIENCE, V335, P308, DOI 10.1126/science.1214547; Zhang H, 2018, NUCLEIC ACIDS RES, V46, pW95, DOI 10.1093/nar/gky418	45	3	3	4	19	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT	2021	297	4							101210	10.1016/j.jbc.2021.101210	http://dx.doi.org/10.1016/j.jbc.2021.101210			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	WP4JL	34547290	Green Published, gold			2022-12-26	WOS:000713100100013
J	Zhu, YK; Huang, D; Zhao, ZY; Lu, CS				Zhu, Yike; Huang, Dan; Zhao, Zhongyan; Lu, Chuansen			Bioinformatic analysis identifies potential key genes of epilepsy	PLOS ONE			English	Article							PLASMINOGEN-ACTIVATOR RECEPTOR; ENCODING NEUTROPHIL ELASTASE; PROTEIN-COUPLED RECEPTORS; TRAUMATIC BRAIN-INJURY; T-CELL-RECEPTOR; ALZHEIMERS-DISEASE; HORMONAL INFLUENCES; NEURONAL MIGRATION; STATUS EPILEPTICUS; MOUSE MODELS	Background Epilepsy is one of the most common brain disorders worldwide. It is usually hard to be identified properly, and a third of patients are drug-resistant. Genes related to the progression and prognosis of epilepsy are particularly needed to be identified. Methods In our study, we downloaded the Gene Expression Omnibus (GEO) microarray expression profiling dataset GSE143272. Differentially expressed genes (DEGs) with a fold change (FC) >1.2 and a P-value <0.05 were identified by GEO2R and grouped in male, female and overlapping DEGs. Functional enrichment analysis and Protein-Protein Interaction (PPI) network analysis were performed. Results In total, 183 DEGs overlapped (77 ups and 106 downs), 302 DEGs (185 ups and 117 downs) in the male dataset, and 750 DEGs (464 ups and 286 downs) in the female dataset were obtained from the GSE143272 dataset. These DEGs were markedly enriched under various Gene Ontology (GO) terms and Kyoto Encyclopedia of Genes and Genomes (KEGG) terms. 16 following hub genes were identified based on PPI network analysis: ADCY7, C3AR1, DEGS1, CXCL1 in male-specific DEGs, TOLLIP, ORM1, ELANE, QPCT in female-specific DEGs and FCAR, CD3G, CLEC12A, MOSPD2, CD3D, ALDH3B1, GPR97, PLAUR in overlapping DEGs. Conclusion This discovery-driven study may be useful to provide a novel insight into the diagnosis and treatment of epilepsy. However, more experiments are needed in the future to study the functional roles of these genes in epilepsy.	[Zhu, Yike] Hainan Gen Hosp, Dept Resp Med, Haikou, Hainan, Peoples R China; [Huang, Dan; Zhao, Zhongyan; Lu, Chuansen] Hainan Gen Hosp, Dept Neurol, Haikou, Hainan, Peoples R China		Lu, CS (corresponding author), Hainan Gen Hosp, Dept Neurol, Haikou, Hainan, Peoples R China.	luchuansen@outlook.com	Lu, Chuansen/GXF-8692-2022	Lu, Chuansen/0000-0002-7452-6000				Achiron A, 2004, Clin Dev Immunol, V11, P299, DOI 10.1080/17402520400001603; ALAM T, 1992, BIOCHEMISTRY-US, V31, P1928, DOI 10.1021/bi00122a005; Alavi MS, 2018, BIOMED PHARMACOTHER, V98, P222, DOI 10.1016/j.biopha.2017.12.056; Alexandru A, 2011, J NEUROSCI, V31, P12790, DOI 10.1523/JNEUROSCI.1794-11.2011; Aleyd E, 2015, IMMUNOL REV, V268, P123, DOI 10.1111/imr.12337; Amini E, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.00416; ARNAIZVILLENA A, 1992, NEW ENGL J MED, V327, P529, DOI 10.1056/NEJM199208203270805; Baart VM, 2020, EJNMMI RES, V10, DOI 10.1186/s13550-020-00673-7; BAUMANN H, 1990, MOL BIOL MED, V7, P147; Beghi E, 2020, NEUROEPIDEMIOLOGY, V54, P185, DOI 10.1159/000503831; Breedveld A, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00553; Burgess Darren J, 2015, Nat Rev Genet, V16, P129, DOI 10.1038/nrg3910; Burns K, 2000, NAT CELL BIOL, V2, P346, DOI 10.1038/35014038; Calabrese M, 2018, EUR J NEUROL, V25, P1103, DOI 10.1111/ene.13727; Call ME, 2005, ANNU REV IMMUNOL, V23, P101, DOI 10.1146/annurev.immunol.23.021704.115625; Campbell DB, 2008, AUTISM RES, V1, P159, DOI 10.1002/aur.27; Chin CH, 2014, BMC SYST BIOL, V8, DOI 10.1186/1752-0509-8-S4-S11; Chin J, 2013, EPILEPSY BEHAV, V26, P343, DOI 10.1016/j.yebeh.2012.11.040; Christensen J, 2005, EPILEPSIA, V46, P956, DOI 10.1111/j.1528-1167.2005.51204.x; Clark RSB, 1996, J NEUROTRAUM, V13, P333, DOI 10.1089/neu.1996.13.333; Coeytaux A, 2000, NEUROLOGY, V55, P693, DOI 10.1212/WNL.55.5.693; Cooper DMF, 2006, TRENDS PHARMACOL SCI, V27, P426, DOI 10.1016/j.tips.2006.06.002; Costa C, 2019, NEUROBIOL AGING, V73, P61, DOI 10.1016/j.neurobiolaging.2018.09.006; Costa C, 2016, NEUROBIOL AGING, V48, P161, DOI 10.1016/j.neurobiolaging.2016.08.025; Coulthard LG, 2015, J IMMUNOL, V194, P3542, DOI 10.4049/jimmunol.1403068; Crespo-Biel N, 2007, NEUROCHEM INT, V50, P435, DOI 10.1016/j.neuint.2006.10.002; Cruz MT, 2011, FRONT NEUROSCI-SWITZ, V4, DOI 10.3389/fnins.2010.00207; Cynis H, 2008, J MOL BIOL, V379, P966, DOI 10.1016/j.jmb.2008.03.078; Dale DC, 2000, BLOOD, V96, P2317, DOI 10.1182/blood.V96.7.2317.h8002317_2317_2322; de Saint Basile G, 2004, J CLIN INVEST, V114, P1512, DOI 10.1172/JCI200422588; Dessauer CW, 2017, PHARMACOL REV, V69, P93, DOI 10.1124/pr.116.013078; Dolgin V, 2019, EUR J HUM GENET, V27, P1668, DOI 10.1038/s41431-019-0444-z; Doncheva NT, 2019, J PROTEOME RES, V18, P623, DOI 10.1021/acs.jproteome.8b00702; Dyment DA, 2015, NEUROBIOL AGING, V36, DOI 10.1016/j.neurobiolaging.2014.09.005; ESTERBAUER H, 1991, FREE RADICAL BIO MED, V11, P81, DOI 10.1016/0891-5849(91)90192-6; Fedin A I, 2019, Zh Nevrol Psikhiatr Im S S Korsakova, V119, P97, DOI 10.17116/jnevro201911901197; Fisher RS, 2017, EPILEPSIA, V58, P522, DOI 10.1111/epi.13670; Friedman D, 2012, CNS NEUROSCI THER, V18, P285, DOI 10.1111/j.1755-5949.2011.00251.x; Frye CA, 2008, INT REV NEUROBIOL, V83, P27, DOI 10.1016/S0074-7742(08)00003-2; Fukuda M, 2009, BIOMED RES-TOKYO, V30, P227, DOI 10.2220/biomedres.30.227; Geis C, 2019, J CLIN INVEST, V129, P926, DOI 10.1172/JCI125178; Gokturk B, 2014, SCAND J IMMUNOL, V80, P354, DOI 10.1111/sji.12200; Gorrasi A, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9122531; Grassi S, 2019, J NEUROCHEM, V148, P600, DOI 10.1111/jnc.14540; Greter M, 2005, NAT MED, V11, P328, DOI 10.1038/nm1197; Han H, 2017, AAPS J, V19, P973, DOI 10.1208/s12248-017-0096-2; Hannun YA, 2018, NAT REV MOL CELL BIO, V19, P175, DOI 10.1038/nrm.2017.107; HAUSER WA, 1993, EPILEPSIA, V34, P453, DOI 10.1111/j.1528-1157.1993.tb02586.x; Hesdorffer DC, 1998, NEUROLOGY, V50, P735, DOI 10.1212/WNL.50.3.735; Horwitz M, 1999, NAT GENET, V23, P433, DOI 10.1038/70544; Hsu LC, 1997, GENE, V189, P89, DOI 10.1016/S0378-1119(96)00839-6; HSU LC, 1994, GENE, V151, P285, DOI 10.1016/0378-1119(94)90672-6; Humbert-Claude M, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0766-5; IWATSUBO T, 1994, NEURON, V13, P45, DOI 10.1016/0896-6273(94)90458-8; Jalink K, 2010, BIOESSAYS, V32, P13, DOI 10.1002/bies.200900153; JENNE DE, 1994, AM J RESP CRIT CARE, V150, pS147, DOI 10.1164/ajrccm/150.6_Pt_2.S147; Johnson EA, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-41; Kanazawa N, 2007, J DERMATOL SCI, V45, P77, DOI 10.1016/j.jdermsci.2006.09.001; Karsai G, 2019, J CLIN INVEST, V129, P1229, DOI 10.1172/JCI124159; Klein P, 2018, EPILEPSIA, V59, P37, DOI 10.1111/epi.13965; Kleveland G, 1998, SEIZURE-EUR J EPILEP, V7, P31, DOI 10.1016/S1059-1311(98)90005-X; Korkmaz B, 2010, PHARMACOL REV, V62, P726, DOI 10.1124/pr.110.002733; Kotsopoulos IAW, 2002, EPILEPSIA, V43, P1402, DOI 10.1046/j.1528-1157.2002.t01-1-26901.x; Laciak AR, 2020, FEBS J, V287, P173, DOI 10.1111/febs.14997; Lahtinen L, 2009, NEUROSCIENCE, V163, P316, DOI 10.1016/j.neuroscience.2009.06.019; LAINE E, 1990, INFLAMMATION, V14, P1, DOI 10.1007/BF00914025; Lapato AS, 2017, NEUROSCIENCE, V346, P409, DOI 10.1016/j.neuroscience.2017.01.035; Liang ZH, 2009, J ALZHEIMERS DIS, V17, P531, DOI 10.3233/JAD-2009-1069; Lino N, 2014, DEV DYNAM, V243, P676, DOI 10.1002/dvdy.24114; Litvinchuk A, 2018, NEURON, V100, P1337, DOI 10.1016/j.neuron.2018.10.031; Liu C, 2017, J CLIN NEUROSCI, V36, P43, DOI 10.1016/j.jocn.2016.10.012; Loscher W, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21020591; Lucki Natasha C., 2008, V49, P387, DOI 10.1007/978-1-4020-8831-5_15; Luo ZM, 2015, J PHYSIOL BIOCHEM, V71, P329, DOI 10.1007/s13105-015-0389-9; Maes M, 2020, MOL NEUROBIOL, V57, P3334, DOI 10.1007/s12035-020-01949-8; Marchitti SA, 2007, PHARMACOL REV, V59, P125, DOI 10.1124/pr.59.2.1; Marchitti SA, 2007, BIOCHEM BIOPH RES CO, V356, P792, DOI 10.1016/j.bbrc.2007.03.046; Marchitti SA, 2010, FREE RADICAL BIO MED, V49, P1432, DOI 10.1016/j.freeradbiomed.2010.08.004; Mariuzza RA, 2020, J BIOL CHEM, V295, P914, DOI 10.1074/jbc.REV119.009411; MATTAMMAL MB, 1995, NEURODEGENERATION, V4, P271, DOI 10.1016/1055-8330(95)90016-0; McHugh JC, 2008, INT REV NEUROBIOL, V83, P11, DOI 10.1016/S0074-7742(08)00002-0; Mendel I, 2017, J IMMUNOL, V198, P2125, DOI 10.4049/jimmunol.1601662; Merino P, 2017, J BIOL CHEM, V292, P2741, DOI 10.1074/jbc.M116.761650; Mestriner FLAC, 2007, P NATL ACAD SCI USA, V104, P19595, DOI 10.1073/pnas.0709681104; Mills PB, 2006, NAT MED, V12, P307, DOI 10.1038/nm1366; Mills PB, 2010, BRAIN, V133, P2148, DOI 10.1093/brain/awq143; Mons N, 1998, BRAIN RES, V788, P251, DOI 10.1016/S0006-8993(98)00005-5; MONTEIRO RC, 1990, J EXP MED, V171, P597, DOI 10.1084/jem.171.3.597; Ndode-Ekane XE, 2013, MOL NEUROBIOL, V47, P914, DOI 10.1007/s12035-012-8386-2; Olsen ASB, 2017, OPEN BIOL, V7, DOI 10.1098/rsob.170069; Palop JJ, 2007, NEURON, V55, P697, DOI 10.1016/j.neuron.2007.07.025; Pant DC, 2019, J CLIN INVEST, V129, P1240, DOI 10.1172/JCI123959; Pasquier B, 2005, IMMUNITY, V22, P31, DOI 10.1016/j.immuni.2004.11.017; Paudel YN, 2019, ACS CHEM NEUROSCI, V10, P4199, DOI 10.1021/acschemneuro.9b00460; Pearson-Smith JN, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18112365; Peng YM, 2011, J LEUKOCYTE BIOL, V90, P735, DOI 10.1189/jlb.0211092; Piccini A, 2005, J BIOL CHEM, V280, P34186, DOI 10.1074/jbc.M501694200; Poser CM, 2003, EPILEPSY BEHAV, V4, P6, DOI 10.1016/S1525-5050(02)00646-7; Powell EM, 2003, J NEUROSCI, V23, P622, DOI 10.1523/JNEUROSCI.23-02-00622.2003; Puttachary S, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/745613; Qureshi IA, 2014, NEUROBIOL DIS, V72, P210, DOI 10.1016/j.nbd.2014.06.019; Rakhade SN, 2009, NAT REV NEUROL, V5, P380, DOI 10.1038/nrneurol.2009.80; Rana A, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1192-7; Roberson ED, 2011, J NEUROSCI, V31, P700, DOI 10.1523/JNEUROSCI.4152-10.2011; Sagar D, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03027-x; SAIDO TC, 1995, NEURON, V14, P457, DOI 10.1016/0896-6273(95)90301-1; Sandhoff K, 2016, BIOCHIMIE, V130, P146, DOI 10.1016/j.biochi.2016.05.004; Sawant KV, 2016, SCI REP-UK, V6, DOI 10.1038/srep33123; Scharfman HE, 2012, FUTUR NEUROL, V7, P177, DOI 10.2217/FNL.12.8; Schilling S, 2004, FEBS LETT, V563, P191, DOI 10.1016/S0014-5793(04)00300-X; Schlenzig D, 2009, BIOCHEMISTRY-US, V48, P7072, DOI 10.1021/bi900818a; Semina E, 2016, EUR J CELL BIOL, V95, P295, DOI 10.1016/j.ejcb.2016.05.003; Sen A, 2007, EPILEPSIA, V48, P1447, DOI 10.1111/j.1528-1167.2007.01107.x; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shi JP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131461; Shi JP, 2016, SCI REP-UK, V6, DOI 10.1038/srep24649; Smith HW, 2010, NAT REV MOL CELL BIO, V11, P23, DOI 10.1038/nrm2821; Spatola M, 2017, CURR OPIN NEUROL, V30, P345, DOI 10.1097/WCO.0000000000000449; Spiller F, 2012, DIABETES, V61, P1584, DOI 10.2337/db11-0825; Sudha K, 2001, CLIN CHIM ACTA, V303, P19, DOI 10.1016/S0009-8981(00)00337-5; Szklarczyk D, 2021, NUCLEIC ACIDS RES, V49, pD605, DOI 10.1093/nar/gkaa1074; Tai XY, 2016, BRAIN, V139, P2441, DOI 10.1093/brain/aww187; Tak PP, 2001, J CLIN INVEST, V107, P7, DOI 10.1172/JCI11830; Thijs RD, 2019, LANCET, V393, P689, DOI 10.1016/S0140-6736(18)32596-0; Thom M, 2011, BRAIN, V134, P2969, DOI 10.1093/brain/awr209; Tian FF, 2010, CLIN LAB, V56, P127; Tokgoz H, 2013, PEDIAT ALLERG IMM-UK, V24, P257, DOI 10.1111/pai.12063; Aguiar CCT, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/795259; Treiman DM, 2001, EPILEPSIA, V42, P8, DOI 10.1046/j.1528-1157.2001.042suppl.3008.x; Vasiliou V, 1999, PHARMACOGENETICS, V9, P421, DOI 10.1097/00008571-199910000-00004; Veerhuis R, 2011, MOL IMMUNOL, V48, P1592, DOI 10.1016/j.molimm.2011.04.003; Veliskova J, 2013, HORM BEHAV, V63, P267, DOI 10.1016/j.yhbeh.2012.03.018; Vezzani A, 2005, EPILEPSIA, V46, P1724, DOI 10.1111/j.1528-1167.2005.00298.x; Vezzani A, 2016, ACTA NEUROPATHOL, V131, P211, DOI 10.1007/s00401-015-1481-5; Waaler PE, 2000, EPILEPSIA, V41, P802, DOI 10.1111/j.1528-1157.2000.tb00246.x; Wang JJ, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.346; Wang JJ, 2018, ACTA BIOCH BIOPH SIN, V50, P666, DOI 10.1093/abbs/gmy060; Wang ZY, 2018, FISH SHELLFISH IMMUN, V78, P299, DOI 10.1016/j.fsi.2018.04.059; Wigmore SJ, 1997, AM J PHYSIOL-ENDOC M, V273, pE720, DOI 10.1152/ajpendo.1997.273.4.E720; Wu L, 2014, BRAIN RES BULL, V109, P88, DOI 10.1016/j.brainresbull.2014.09.007; Yacov N, 2020, CLIN EXP IMMUNOL, V201, P105, DOI 10.1111/cei.13448; Yamasaki R, 2014, J EXP MED, V211, P1533, DOI 10.1084/jem.20132477; Yuan W, 2010, MICROVASC RES, V80, P148, DOI 10.1016/j.mvr.2010.03.011; Zhou ZY, 2016, SCI REP-UK, V6, DOI 10.1038/srep23695	145	1	1	3	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2021	16	9							e0254326	10.1371/journal.pone.0254326	http://dx.doi.org/10.1371/journal.pone.0254326			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XH8RH	34555062	gold, Green Published			2022-12-26	WOS:000725694500006
J	Akinmolayemi, O; Saldanha, S; Joshi, PH; Deodhar, S; Ayers, CR; Neeland, IJ; Rohatgi, A				Akinmolayemi, Oludamilola; Saldanha, Suzanne; Joshi, Parag H.; Deodhar, Sneha; Ayers, Colby R.; Neeland, Ian J.; Rohatgi, Anand			Cholesterol efflux capacity and its association with prevalent metabolic syndrome in a multi-ethnic population (Dallas Heart Study)	PLOS ONE			English	Article							HIGH-DENSITY-LIPOPROTEIN; INCIDENT CARDIOVASCULAR-DISEASE; HDL CHOLESTEROL; ETHNIC-DIFFERENCES; LIPID EFFLUX; SR-BI; ROLES; PREDICTOR; MORTALITY; PATHWAYS	Metabolic syndrome (MetS) is characterized by adiposity and atherogenic dyslipidemia consisting of elevated triglyceride and decreased high density lipoprotein cholesterol (HDL-C) levels however, cholesterol concentration alone does not reflect HDL functionality. Cholesterol efflux capacity (CEC) captures a key anti-atherosclerotic function of HDL; studies linking CEC to MetS have yielded inconsistent findings and lacked racial/ethnic diversity. The aim of this study was to evaluate the association between CEC and MetS in a large multiethnic population utilizing two different CEC assays interrogating overlapping but distinct reverse cholesterol transport pathways. A cross-sectional study was performed using the Dallas Heart Study cohort and cholesterol efflux was measured with radiolabeled and fluorescent cholesterol assays. The relationship between CEC and MetS was assessed using multivariable regression analyses. A total of 2241 participants were included (mean age was 50 years; 38% men and 53% Blacks). CEC was independently and inversely associated with MetS irrespective of efflux assay (CEC-radiolabeled, adjusted OR 0.71 [95% CI 0.65-0.80]. CEC-fluorescent, adjusted OR 0.85 [95% CI 0.77-0.94]). Both CEC measures were inversely associated with waist circumference and directly associated with HDL-C but not with other MetS components. There was an interaction by sex but not by race such that the inverse associations between CEC and MetS were somewhat attenuated in men (OR 0.86, 95%CI 0.74-1.01). In this large multi-ethnic cohort, impaired CEC is linked to MetS irrespective of efflux assay and race/ethnicity but less so among men. Future studies are needed to assess whether CEC mediates the atherosclerotic cardiovascular disease risk of MetS.	[Akinmolayemi, Oludamilola] Columbia Univ, Irving Med Ctr, Dept Internal Med, New York, NY USA; [Akinmolayemi, Oludamilola] NewYork Presbyterian Hosp, New York, NY USA; [Saldanha, Suzanne; Joshi, Parag H.; Deodhar, Sneha; Ayers, Colby R.; Rohatgi, Anand] Univ Texas Southwestern Med Ctr Dallas, Dept Internal Med, Div Cardiol, Dallas, TX 75390 USA; [Neeland, Ian J.] Univ Hosp Harrington, Heart & Vasc Inst, Cleveland, OH USA; [Neeland, Ian J.] Case Western Reserve Univ, Sch Med, Cleveland, OH USA	Columbia University; NewYork-Presbyterian Hospital; NewYork-Presbyterian Hospital; University of Texas System; University of Texas Southwestern Medical Center Dallas; Case Western Reserve University	Rohatgi, A (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Internal Med, Div Cardiol, Dallas, TX 75390 USA.	anand.rohatgi@utsouthwestern.edu		Akinmolayemi, Oludamilola/0000-0001-9813-9980	National Center for Advancing Translational Science, National Institutes of Health [UL1TR001105]; National Heart, Lung, and Blood Institute, National Institutes of Health [R01HL136724, K24HL146838]	National Center for Advancing Translational Science, National Institutes of Health; National Heart, Lung, and Blood Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by grant UL1TR001105 from the National Center for Advancing Translational Science, National Institutes of Health (https://ncats.nih.gov/).A.R.is supported by grant R01HL136724 and K24HL146838 from the National Heart, Lung, and Blood Institute, National Institutes of Health (https://www.nhlbi.nih.gov/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adorni MP, 2007, J LIPID RES, V48, P2453, DOI 10.1194/jlr.M700274-JLR200; Alenezi MY, 2004, J CLIN ENDOCR METAB, V89, P761, DOI 10.1210/jc.2003-031213; Annema W, 2016, SCI REP-UK, V6, DOI 10.1038/srep27367; Benjamin EJ, 2019, CIRCULATION, V139, pE56, DOI 10.1161/CIR.0000000000000659; Borja MS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182217; Catalano G, 2008, J LIPID RES, V49, P635, DOI 10.1194/jlr.M700510-JLR200; Chen K, 2008, DIABETES VASC DIS RE, V5, P96, DOI 10.3132/dvdr.2008.016; de Vries R, 2008, ATHEROSCLEROSIS, V196, P733, DOI 10.1016/j.atherosclerosis.2006.12.027; Dullaart RPF, 2008, EUR J ENDOCRINOL, V158, P53, DOI 10.1530/EJE-07-0451; Ebtehaj S, 2019, ARTERIOSCL THROM VAS, V39, P1874, DOI 10.1161/ATVBAHA.119.312645; Favari E, 2004, J BIOL CHEM, V279, P9930, DOI 10.1074/jbc.M312476200; Francone OL, 2005, ARTERIOSCL THROM VAS, V25, P1198, DOI 10.1161/01.ATV.0000166522.69552.99; Gall J, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.116.004808; Grundy SM, 1999, AM J CARDIOL, V83, p25F; Ishikawa T, 2015, ATHEROSCLEROSIS, V242, P318, DOI 10.1016/j.atherosclerosis.2015.06.028; KARHAPAA P, 1994, DIABETES, V43, P411, DOI 10.2337/diabetes.43.3.411; Khera AV, 2017, CIRCULATION, V135, P2494, DOI 10.1161/CIRCULATIONAHA.116.025678; Khera AV, 2011, NEW ENGL J MED, V364, P127, DOI 10.1056/NEJMoa1001689; Lakoski SG, 2014, MED SCI SPORT EXER, V46, P1124, DOI 10.1249/MSS.0000000000000211; Liu CQ, 2016, ATHEROSCLEROSIS, V249, P116, DOI 10.1016/j.atherosclerosis.2015.10.111; Lucero D, 2015, ATHEROSCLEROSIS, V242, P236, DOI 10.1016/j.atherosclerosis.2015.07.019; McNeill AM, 2005, DIABETES CARE, V28, P385, DOI 10.2337/diacare.28.2.385; Moriyama K, 2020, METAB SYNDR RELAT D, V18, P260, DOI 10.1089/met.2019.0123; Ogura M, 2016, ARTERIOSCL THROM VAS, V36, P181, DOI 10.1161/ATVBAHA.115.306665; Oram JF, 2000, BBA-MOL CELL BIOL L, V1529, P321, DOI 10.1016/S1388-1981(00)00157-8; Rohatgi A, 2014, NEW ENGL J MED, V371, P2383, DOI 10.1056/NEJMoa1409065; Rosenson RS, 2012, CIRCULATION, V125, P1905, DOI 10.1161/CIRCULATIONAHA.111.066589; Saleheen D, 2015, LANCET DIABETES ENDO, V3, P507, DOI 10.1016/S2213-8587(15)00126-6; Sankaranarayanan S, 2011, J LIPID RES, V52, P2332, DOI 10.1194/jlr.D018051; Shea S, 2019, ARTERIOSCL THROM VAS, V39, P89, DOI 10.1161/ATVBAHA.118.311366; Sokka T, 2008, CLIN EXP RHEUMATOL, V26, pS35, DOI 10.1161/CIRCULATIONAHA.109.192644; Talbot CPJ, 2018, PROG LIPID RES, V69, P21, DOI 10.1016/j.plipres.2017.12.001; Victor RG, 2004, AM J CARDIOL, V93, P1473, DOI 10.1016/j.amjcard.2004.02.058; Wilson PWF, 2005, CIRCULATION, V112, P3066, DOI 10.1161/CIRCULATIONAHA.105.539528; Yancey PG, 2004, J LIPID RES, V45, P337, DOI 10.1194/jlr.M300231-JLR200; Zhao Y, 2010, CURR OPIN LIPIDOL, V21, P441, DOI 10.1097/MOL.0b013e32833dedaa	36	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2021	16	9							e0257574	10.1371/journal.pone.0257574	http://dx.doi.org/10.1371/journal.pone.0257574			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YM4DR	34547056	Green Published, gold			2022-12-26	WOS:000746527400023
J	Noda-Narita, S; Kawachi, A; Okuyama, A; Sadachi, R; Hirakawa, A; Goto, Y; Fujiwara, Y; Higashi, T; Yonemori, K				Noda-Narita, Shoko; Kawachi, Asuka; Okuyama, Ayako; Sadachi, Ryo; Hirakawa, Akihiro; Goto, Yasushi; Fujiwara, Yasuhiro; Higashi, Takahiro; Yonemori, Kan			First-line treatment for lung cancer among Japanese older patients: A real-world analysis of hospital-based cancer registry data	PLOS ONE			English	Article							ELDERLY-PATIENTS; AMERICAN SOCIETY; PHASE-III; CHEMOTHERAPY; VINORELBINE; PATTERNS; CARE	Aging of the population has led to an increase in the prevalence of cancer among older adults. In Japan, single agent chemotherapy was recommended for advanced non-small cell lung cancer (NSCLC) for those, who were aged >= 75 years, while the Western guidelines did not recommend a specific regimen. In clinical practice, physicians are required to decide the treatment based on a lack of enough evidence. This study aimed to examine the prescribing patterns of first-line chemotherapy according to age in the real-world practice. Data from the survey database of Diagnostic Procedure Combination and hospital-based cancer registries of designated cancer centers nationwide were used. The first-line chemotherapy regimens among 9,737 patients who were diagnosed with advanced lung cancer between January and December 2013, were identified and compared based on age. We found that the proportion of patients receiving chemotherapy decreased with age; 80.0%, 70.4%, 50.6%, and 30.2% of patients aged 70-74, 75-79, 80-84, and >= 85 years, respectively, received chemotherapy. Among them, platinum doublets were prescribed for 62.7% of the patients who were aged >= 70 years, and 60.7% of the patients who were aged >= 75 years with no driver mutations in NSCLC; only 37.6% of them received single agents. Patients who were aged >= 80 years also preferred platinum doublets (35.6%). Carboplatin was commonly prescribed in all age groups; only 28.4% of those receiving platinum doublets selected cisplatin. In this study, platinum doublets were identified as the most commonly prescribed regimen in those who were aged >= 70 years. Despite recommendations of Japanese guidelines for NSCLC, 60.7% of those who were aged >= 75 years received platinum doublets. Additionally, patients who were aged >= 80 years also received systemic chemotherapy, including platinum doublets; age did not solely influence regimen selection.	[Noda-Narita, Shoko; Kawachi, Asuka; Fujiwara, Yasuhiro; Yonemori, Kan] Natl Canc Ctr, Dept Breast & Med Oncol, Tokyo, Japan; [Okuyama, Ayako; Higashi, Takahiro] Natl Canc Ctr, Ctr Canc Registries, Ctr Canc Control & Informat Serv, Tokyo, Japan; [Sadachi, Ryo; Hirakawa, Akihiro] Univ Tokyo, Grad Sch Med, Dept Biostat & Bioinformat, Tokyo, Japan; [Goto, Yasushi] Natl Canc Ctr, Dept Thorac Oncol, Tokyo, Japan	National Cancer Center - Japan; National Cancer Center - Japan; University of Tokyo; National Cancer Center - Japan	Yonemori, K (corresponding author), Natl Canc Ctr, Dept Breast & Med Oncol, Tokyo, Japan.	kyonemor@ncc.go.jp	Okuyama, Ayako/GPF-7048-2022					Akamatsu H, 2019, INT J CLIN ONCOL, V24, P731, DOI 10.1007/s10147-019-01431-z; Fruh M, 2013, ANN ONCOL, V24, P99, DOI 10.1093/annonc/mdt178; Gridelli C, 1999, JNCI-J NATL CANCER I, V91, P66; Gridelli C, 2003, JNCI-J NATL CANCER I, V95, P362, DOI 10.1093/jnci/95.5.362; Hanna N, 2017, J CLIN ONCOL, V35, P3484, DOI 10.1200/JCO.2017.74.6065; Hayashida K, 2021, J EPIDEMIOL, V31, P1, DOI 10.2188/jea.JE20200288; Higashi T, 2014, JPN J CLIN ONCOL, V44, P2, DOI 10.1093/jjco/hyt013; Higashi T, 2013, JPN J CLIN ONCOL, V43, P225, DOI 10.1093/jjco/hyt001; Inoue A, 2009, J CLIN ONCOL, V27, P1394, DOI 10.1200/JCO.2008.18.7658; Isobe H, 2017, LUNG CANCER-TARGETS, V8, P191, DOI 10.2147/LCTT.S140491; Karve SJ, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/s12913-014-0555-8; Kudoh S, 2006, J CLIN ONCOL, V24, P3657, DOI 10.1200/JCO.2006.06.1044; Lee YG, 2018, LUNG CANCER, V122, P88, DOI 10.1016/j.lungcan.2018.05.028; Noda W, 2002, NEW ENGL J MED, V346, P85, DOI 10.1056/NEJMoa003034; Okamoto I, 2020, JAMA ONCOL, V6, DOI 10.1001/jamaoncol.2019.6828; Owonikoko TK, 2013, ONCOLOGIST, V18, P600, DOI 10.1634/theoncologist.2012-0480; Peters S, 2012, ANN ONCOL, V23, P56, DOI 10.1093/annonc/mds226; Quoix E, 2011, LANCET, V378, P1079, DOI 10.1016/S0140-6736(11)60780-0; Rudin CM, 2015, J CLIN ONCOL, V33, P4106, DOI 10.1200/JCO.2015.63.7918; Santos FN, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010463.pub2; Wang F, 2017, CLIN THER, V39, P1146, DOI 10.1016/j.clinthera.2017.04.010	21	1	1	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2021	16	9							e0257489	10.1371/journal.pone.0257489	http://dx.doi.org/10.1371/journal.pone.0257489			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	WG6BN	34543332	Green Published, gold			2022-12-26	WOS:000707078200039
J	Winn, CB; Hwang, SK; Morin, J; Bluette, CT; Manickam, B; Jiang, ZK; Giddabasappa, A; Liu, CN; Matthews, K				Winn, Caroline B.; Hwang, Seo-Kyoung; Morin, Jeffrey; Bluette, Crystal T.; Manickam, Balasubramanian; Jiang, Ziyue K.; Giddabasappa, Anand; Liu, Chang-Ning; Matthews, Kristin			Automated monitoring of respiratory rate as a novel humane endpoint: A refinement in mouse metastatic lung cancer models	PLOS ONE			English	Article							MICE; DAMAGE; TOOL	In oncology research, while xenograft tumor models are easily visualized and humane endpoints can be clearly defined, metastatic tumor models are often based on more subjective clinical observations as endpoints. This study aimed at identifying objective non-invasive criteria for predicting imminent distress and mortality in metastatic lung tumor-bearing mice. BALB/c and C57BL/6 mice were inoculated with CT26 or B16F10 cells, respectively. The mice were housed in Vium smart cages to continuously monitor and stream respiratory rate and locomotion for up to 28 days until scheduled euthanasia or humane endpoint criteria were met. Body weight and body temperature were measured during the study. On days 11, 14, 17 and 28, lungs of subsets of animals were microCT imaged in vivo to assess lung metastasis progression and then euthanized for lung microscopic evaluations. Beginning at day 21, most tumor-bearing animals developed increased respiratory rates followed by decreased locomotion 1-2 days later, compared with the baseline values. Increases in respiratory rate did not correlate to surface tumor nodule counts or lung weight. Body weight measurement did not show significant changes from days 14-28 in either tumor-bearing or control animals. We propose that increases in respiratory rate (1.3-1.5 X) can be used to provide an objective benchmark to signal the need for increased clinical observations or euthanasia. Adoption of this novel humane endpoint criterion would allow investigators time to collect tissue samples prior to spontaneous morbidity or death and significantly reduce the distress of mice in the terminal stages of these metastatic lung tumor models.	[Winn, Caroline B.; Morin, Jeffrey; Bluette, Crystal T.] Pfizer Worldwide Res, Dev & Med, Comparat Med, Cambridge, MA USA; [Hwang, Seo-Kyoung; Liu, Chang-Ning] Pfizer Worldwide Res, Dev & Med, Comparat Med, Groton, CT 06340 USA; [Manickam, Balasubramanian] Pfizer Worldwide Res, Dev & Med, Global Pathol & Investigative Toxicol, Groton, CT USA; [Jiang, Ziyue K.; Giddabasappa, Anand; Matthews, Kristin] Pfizer Worldwide Res, Dev & Med, Comparat Med, San Diego, CA USA	Pfizer; Pfizer; Pfizer; Pfizer	Liu, CN (corresponding author), Pfizer Worldwide Res, Dev & Med, Comparat Med, Groton, CT 06340 USA.	chang-ning.liu@pfizer.com		Hwang, Seo-Kyoung/0000-0003-0866-5376; Liu, Chang-Ning/0000-0002-2094-1401; Winn, Caroline/0000-0002-2512-4566				Bains R S, 2020, F1000Res, V9, P20, DOI 10.12688/f1000research.21633.1; Baran SW, 2020, FRONT PHYSIOL, V11, DOI 10.3389/fphys.2020.569001; Bates JHT, 2003, J APPL PHYSIOL, V94, P1297, DOI 10.1152/japplphysiol.00706.2002; Box GM, 2011, METHODS MOL BIOL, V769, P311, DOI 10.1007/978-1-61779-207-6_21; Christine VI., 2018, J IMMUNOL, V200; Gonzalez-Sanchez C, 2016, SENSORS-BASEL, V16, DOI 10.3390/s16071052; Hanai Y, 2012, CANCER CELL INT, V12, DOI 10.1186/1475-2867-12-7; Hoymann Heinz Gerd, 2007, Journal of Pharmacological and Toxicological Methods, V55, P16, DOI 10.1016/j.vascn.2006.04.006; KARPATKIN S, 1984, CANCER RES, V44, P3880; Lalwani K, 2013, COMPARATIVE MED, V63, P482; LIAO ZX, 1995, INT J RADIAT ONCOL, V32, P1359, DOI 10.1016/0360-3016(94)00660-D; Lim MA, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00818; Liu CN, 2019, J PHARMACOL TOX MET, V96, P67, DOI 10.1016/j.vascn.2019.02.003; Liu X, 2012, J THORAC DIS, V4, P141, DOI 10.3978/j.issn.2072-1439.2012.03.04; Montgomery MK, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0252950; Morton D B, 2000, ILAR J, V41, P80; Nemzek JA, 2004, SHOCK, V21, P17, DOI 10.1097/01.shk.0000101667.49265.fd; Paster EV, 2009, COMPARATIVE MED, V59, P234; Paulus MJ, 2000, NEOPLASIA, V2, P62, DOI 10.1038/sj.neo.7900069; Peng QH, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0210995; Ramirez J, 71 AM ASS LAB AN SCI; Ruggeri BA, 2014, BIOCHEM PHARMACOL, V87, P150, DOI 10.1016/j.bcp.2013.06.020; Shimada K, 2018, CANCER CHEMOTH PHARM, V82, P265, DOI 10.1007/s00280-018-3616-6; TRAVIS EL, 1979, BRIT J RADIOL, V52, P67, DOI 10.1259/0007-1285-52-613-67; TRAVIS EL, 1981, BRIT J RADIOL, V54, P50, DOI 10.1259/0007-1285-54-637-50; Wallace J, 2000, ILAR J, V41, P87; Welch DR, 1997, CLIN EXP METASTAS, V15, P272, DOI 10.1023/A:1018477516367; Weng YL, 2010, MOL NUTR FOOD RES, V54, P259, DOI 10.1002/mnfr.200900049; Workman P, 2010, BRIT J CANCER, V102, P1555, DOI 10.1038/sj.bjc.6605642	29	1	1	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2021	16	9							e0257694	10.1371/journal.pone.0257694	http://dx.doi.org/10.1371/journal.pone.0257694			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	WG6BN	34543354	Green Published, gold			2022-12-26	WOS:000707078200072
J	Choudhary, KK; Das, S; Ghodajkar, P				Choudhary, Krishna Kumar; Das, Sayan; Ghodajkar, Prachinkumar			Trends of adult height in India from 1998 to 2015: Evidence from the National Family and Health Survey	PLOS ONE			English	Article							NUTRITION; CHILDHOOD; GROWTH	Aim The aim of the study is to investigate the trends in adult height between two consecutive surveys of NHFS and explore differences across variables such as gender, wealth, social groups etc. Methods We used the NFHS-II (1998-99), NFHS-III (2005-2006) and NFHS-IV (2015-16) (all three for women and last two for men) data to examine the trends in average height. Comparison was done between the two age strata of 15-25 and 26-50 years, across both male and female, to assess the trends. Results Between NFHS-III and NFHS-IV, the average height of women in the age group of 15-25 showed a decline by 0.12 cm [95% CI, -0.24 to 0.00, p-0.051] while in the 26-50 years age strata it demonstrated significant improvement in the mean height by 0.13 cm [95% CI, 0.02 to 0.023, p-0.015]. However, Between NFHS III and IV, the average height of women in the poorest wealth index category registered a significant decline [-0.57cm, 95% CI, -076 to -0.37, p-0.000]. Between NFHS III and IV, the average height of Scheduled Tribe (ST) women in the age group of 15-25 years also exhibited a significant decline by 0.42 cm, [95% CI, -0.73 to -0.12, p-0.007]. Among men, between the two surveys, both the age groups of 15-25 years and 26-50 years showed significant decline in average height: 1.10 cm [95% CI, -1.31 to -.099 cm, p-0.00] and 0.86 cm [95% CI, -1.03 to -0.69, p-0.000], respectively. Conclusion In the context of an overall increase in average heights worldwide the decline in average height of adults in India is alarming and demands an urgent enquiry. The argument for different standards of height for Indian population as different genetic group needs further scrutiny. However, the trends from India clearly underline the need to examine the non-genetic factors also to understand the interplay of genetic, nutritional and other social and environmental determinants on height.	[Choudhary, Krishna Kumar; Das, Sayan; Ghodajkar, Prachinkumar] JNU, Ctr Social Med & Community Hlth, New Delhi, India	Jawaharlal Nehru University, New Delhi	Choudhary, KK (corresponding author), JNU, Ctr Social Med & Community Hlth, New Delhi, India.	krishnavagda@gmail.com		Choudhary, Krishna Kumar/0000-0001-8819-8389; Das, Sayan/0000-0003-4880-2224				Akachi Y, 2007, ANN HUM BIOL, V34, P397, DOI 10.1080/03014460701452868; Bailey RE, 2016, ECON HIST REV, V69, P35, DOI 10.1111/ehr.12099; Banerjee A V., 2011, POOR EC RADICAL RETH; BARKER DJP, 1993, LANCET, V341, P938, DOI 10.1016/0140-6736(93)91224-A; Baten J., 2014, WAS LIFE GLOBAL WELL, P118, DOI DOI 10.1787/9789264214262-11-EN; Case A, 2002, AM ECON REV, V92, P1308, DOI 10.1257/000282802762024520; Choudhary KK., 2017, HEIGHT INTERGENERATI; CLEMENTS EMB, 1954, ARCH DIS CHILD, V29, P147, DOI 10.1136/adc.29.144.147; Coffery D., 2013, EC POLIT WKLY, V48, P68; Coffey D., 2019, RURAL INDIA SEGREGAT; Coffey D, 2019, DEMOGRAPHY, V56, P1427, DOI 10.1007/s13524-019-00794-2; Deaton A, 2008, AM ECON REV, V98, P468, DOI 10.1257/aer.98.2.468; Ganguly P., 1976, PHYS ANTHR NICOBARES; Gillespie S, 2013, ECON POLIT WEEKLY, V48, P64; Gopalan C., 1988, NESTLE NUTR WORKSHOP; Gupta A., 2013, ECON POLIT WEEKLY, V48, P73; Hoddinott J, 2013, MATERN CHILD NUTR, V9, P69, DOI 10.1111/mcn.12080; Huang W, 2013, AM ECON J-APPL ECON, V5, P86, DOI 10.1257/app.5.2.86; Huffman KM, 2012, AM HEART J, V164, P117, DOI 10.1016/j.ahj.2012.04.014; HULANICKA B, 1983, ANN HUM BIOL, V10, P429, DOI 10.1080/03014468300006621; International Institute for Population Sciences, 2017, NATL FAMILY HLTH SUR; International Institute for Population Sciences, 2007, NATL FAMILY HLTH SUR; Jayachandran S., 2013, ECON POLIT WEEKLY, V48, P77; Komlos J, 2004, ECON HUM BIOL, V2, P57, DOI 10.1016/j.ehb.2003.12.006; Komlos J, 2010, ECON HUM BIOL, V8, P58, DOI 10.1016/j.ehb.2009.12.004; KUSIN JA, 1992, LANCET, V340, P623, DOI 10.1016/0140-6736(92)92168-F; Lodha R., 2013, ECON POLIT WEEKLY, V48, P70; Mamidi RS, 2011, FOOD NUTR BULL, V32, P23, DOI 10.1177/156482651103200103; Panagariya Arvind, 2013, ECON POLIT WEEKLY, V48, P98; Priya R., 2000, STUDY ILLNESS DIS WE; Rama Baru, 2010, Economic and Political Weekly, V45, P49; RILEY JC, 1994, J INTERDISCIPL HIST, V24, P465, DOI 10.2307/206681; Sharma DC, 2012, INDIA TODAY; srinivas DP., 2017, IOSR J DENT MED SCI, V16, P27, DOI [10.9790/0853-1607012732, DOI 10.9790/0853-1607012732]; Steckel RH, 1995, J ECON LIT, V33, P1903; STECKEL RH, 1987, ANN HUM BIOL, V14, P111, DOI 10.1080/03014468700006852; STECKEL RH, 1983, HIST METHOD, V16, P1; Steckel RH, 2009, EXPLOR ECON HIST, V46, P1, DOI 10.1016/j.eeh.2008.12.001; Subramanian SV, 2010, PEDIATRICS, V126, pE663, DOI 10.1542/peds.2010-0222; The U.S. Agency for International Development, 2012, BIOM MAN DEM HLTH SU; The U.S. Agency for International Development, 2012, BIOM FIELD MAN; Varela-Silva I., 2013, GENETIC POTENTIAL DE; Wable G., 2013, ECON POLIT WEEKLY, V48, P60; Young LivesAn International study of Childhood Poverty, 2010, IMP MIDD MEAL SCHEM	44	2	2	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2021	16	9							e0255676	10.1371/journal.pone.0255676	http://dx.doi.org/10.1371/journal.pone.0255676			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	WG5ZQ	34534216	Green Published, gold			2022-12-26	WOS:000707073300007
J	Zhang, H; Zhang, B; Wu, C; Chen, K				Zhang, Hong; Zhang, Bang; Wu, Can; Chen, Kun			Macro and micro analysis on coal-bearing soil slopes instability based on CFD-DEM coupling method	PLOS ONE			English	Article							DISCRETE PARTICLE SIMULATION; GAS-SOLID FLOW; NUMERICAL-SIMULATION; FLUIDIZED-BED; MODEL	By combining the discrete element method (DEM) with computational fluid dynamics (CFD), this study proposes a three-dimensional CFD-DEM fluid-solid coupling microscopic computational model for analyzing the micromechanisms of instability and failure in a coal-bearing soil slope during rainfall. The CFD-DEM fluid-solid coupling model indicated that the main failure mode of the coal-bearing soil slopes was rainwater washing, and the slope sliding surface was predicted as an approximately linear segment. The adaptability of this numerical method was verified by comparing its results with those of rain-washed slopes in an outdoor model test. Rainfall changed the microscopic parameters such as the force chain, coordination number, and porosity of the slope soil particles. The porosity of the slope's top particles increased from 0.35 in the initial state to 0.80 in the unstable state. This change was directly related to the macroscopic mechanics of the slope soil. By analyzing the changes in the microscopic parameters of the particles, the failure evolution law of the coal-bearing soil slopes during rainfall was explored from a microscopic perspective. This study not only provides a theoretical basis for the protection design and construction of coal-bearing soil slopes in the region but can also analyze macroscopic mechanical laws of discrete media from a micro-macro perspective in geotechnical engineering.	[Zhang, Hong; Zhang, Bang; Wu, Can; Chen, Kun] Nanchang Inst Technol, Sch Civil & Architectural Engn, Nanchang, Jiangxi, Peoples R China	Nanchang Institute Technology	Zhang, H (corresponding author), Nanchang Inst Technol, Sch Civil & Architectural Engn, Nanchang, Jiangxi, Peoples R China.	hongzhang@nit.edu.cn		zhang, hong/0000-0002-5411-8253	National Natural Science Foundation of China [52068053]; Superiority Science and Technology Innovation Team Project of Nanchang City [2017CXTD012]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Superiority Science and Technology Innovation Team Project of Nanchang City	Hong Zhang received the following two specific funding for this work: 1.The National Natural Science Foundation of China (Grant No. 52068053). http://www.nsfc.gov.cn/.2.The Superiority Science and Technology Innovation Team Project of Nanchang City (Grant No. 2017CXTD012). http://kjj.nc.gov.cn/.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adema AT, 2010, ISIJ INT, V50, P954, DOI 10.2355/isijinternational.50.954; Amritkar A, 2014, J COMPUT PHYS, V256, P501, DOI 10.1016/j.jcp.2013.09.007; ANDERSON TB, 1967, IND ENG CHEM FUND, V6, P527, DOI 10.1021/i160024a007; Chiesa M, 2005, COMPUT CHEM ENG, V29, P291, DOI 10.1016/j.compchemeng.2004.09.002; Chong S., 2018, ROCK SOIL MECH, V39, P36; Chu KW, 2008, POWDER TECHNOL, V179, P104, DOI 10.1016/j.powtec.2007.06.017; Chu KW, 2011, CHEM ENG SCI, V66, P834, DOI 10.1016/j.ces.2010.11.026; Di Renzo A, 2007, CHEM ENG SCI, V62, P116, DOI 10.1016/j.ces.2006.08.009; Duraes Renata, 2001, Iheringia Serie Zoologia, V90, P183; El Shamy U, 2005, J ENG MECH, V131, P413, DOI 10.1061/(ASCE)0733-9399(2005)131:4(413); Guo Y, 2009, AICHE J, V55, P49, DOI 10.1002/aic.11734; ISSA RI, 1986, J COMPUT PHYS, V62, P40, DOI 10.1016/0021-9991(86)90099-9; [蒋明镜 Jiang Mingjing], 2014, [岩土工程学报, Chinese Journal of Geotechnical Engineering], V36, P793; Khalili Y, 2014, PARTICUOLOGY, V15, P138, DOI 10.1016/j.partic.2013.07.005; Lewis RW, 1987, FINITE ELEMENT METHO, P3; Li TW, 2012, POWDER TECHNOL, V220, P138, DOI 10.1016/j.powtec.2011.09.020; Li X., 2016, JAPANESE GEOTECHNICA, V2, P691; [梁敬轩 Liang Jingxuan], 2017, [工程地质学报, Journal of Engineering Geology], V25, P1537; [刘洋 LIU Yang], 2009, [水利学报, Journal of Hydraulic Engineering], V40, P250; Luo Yong, 2007, Journal of Zhejiang University, V41, P1932; Mazari M., 1993, P INT C VER NUM PROC, P179; Nakamura H, 2006, CHEM PHARM BULL, V54, P839, DOI 10.1248/cpb.54.839; Trussell RR, 1999, J ENVIRON ENG-ASCE, V125, P998, DOI 10.1061/(ASCE)0733-9372(1999)125:11(998); Tsuji T, 2008, POWDER TECHNOL, V184, P132, DOI 10.1016/j.powtec.2007.11.042; TSUJI Y, 1993, POWDER TECHNOL, V77, P79, DOI 10.1016/0032-5910(93)85010-7; Tsuji Y, 2007, CHEM ENG SCI, V62, P3410, DOI 10.1016/j.ces.2006.12.090; Wang Y, 2017, ROCK SOIL MECH, V38, P1771, DOI 10.16285/j.rsm.2017.06.027; Xu BH, 2000, POWDER TECHNOL, V109, P13, DOI 10.1016/S0032-5910(99)00223-5; Xu BH, 1997, CHEM ENG SCI, V52, P2785, DOI 10.1016/S0009-2509(97)00081-X; Yu AB, 2003, J CHEM TECHNOL BIOT, V78, P111, DOI 10.1002/jctb.788; Zhao JD, 2013, POWDER TECHNOL, V239, P248, DOI 10.1016/j.powtec.2013.02.003; Zhou J., 2010, J HYDRAUL ENG, V39, P17; Zhou J, 2013, SCI WORLD J, DOI 10.1155/2013/603130; Zhou ZY, 2010, J FLUID MECH, V661, P482, DOI 10.1017/S002211201000306X; Zhu HP, 2007, CHEM ENG SCI, V62, P3378, DOI 10.1016/j.ces.2006.12.089; Zienkiewicz AHC, 2015, INT J NUMERICAL ANAL, V25, P107	36	1	1	12	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2021	16	9							e0257362	10.1371/journal.pone.0257362	http://dx.doi.org/10.1371/journal.pone.0257362			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	WG5ZQ	34534257	Green Submitted, gold, Green Published			2022-12-26	WOS:000707073300026
J	Yang, YQ; Sun, Y; Hu, R; Yan, J; Wang, ZH; Li, WL; Jiang, H				Yang, Yaqiong; Sun, Yu; Hu, Rong; Yan, Jia; Wang, Ziheng; Li, Wenlong; Jiang, Hong			Morphine promotes microglial activation by upregulating the EGFR/ERK signaling pathway	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; GLIAL ACTIVATION; PROTEIN-KINASE; TOLERANCE; PAIN; MIGRATION; MODEL; NEUROINFLAMMATION; TRANSACTIVATION; MODULATION	Although they represent the cornerstone of analgesic therapy, opioids, such as morphine, are limited in efficacy by drug tolerance, hyperalgesia and other side effects. Activation of microglia and the consequent production of proinflammatory cytokines play a key pathogenic role in morphine tolerance, but the exact mechanisms are not well understood. This study aimed to investigate the regulatory mechanism of epidermal growth factor receptor (EGFR) on microglial activation induced by morphine in mouse microglial BV-2 cells. In this research, BV-2 cells were stimulated with morphine or pretreated with AG1478 (an inhibitor of EGFR). Expression levels of cluster of differentiation molecule 11b (CD11b), EGFR, and phospho-EGFR were detected by immunofluorescence staining. Cell signaling was assayed by Western blot. The migration ability of BV-2 cells was tested by Transwell assay. The production of interleukin-1beta (IL-1 beta) and tumor necrosis factor-alpha (TNF-alpha) in the cell supernatant was determined by ELISA. We observed that the expression of CD11b induced by morphine was increased in a dose- and time- dependent manner in BV-2 cells. Phosphorylation levels of EGFR and ERK1/2, migration of BV-2 cells, and production of IL-1 beta and TNF alpha were markedly enhanced by morphine treatment. The activation, migration, and production of proinflammatory cytokines in BV-2 cells were inhibited by blocking the EGFR signaling pathway with AG1478. The present study demonstrated that the EGFR/ERK signaling pathway may represent a novel pharmacological strategy to suppress morphine tolerance through attenuation of microglial activation.	[Yang, Yaqiong; Sun, Yu; Hu, Rong; Yan, Jia; Wang, Ziheng; Li, Wenlong; Jiang, Hong] Shanghai Jiao Tong Univ, Ctr Specialty Strategy Res, Shanghai Peoples Hosp 9, Dept Anesthesiol,Sch Med,China Hosp Dev Inst, Shanghai, Peoples R China	Shanghai Jiao Tong University	Jiang, H (corresponding author), Shanghai Jiao Tong Univ, Ctr Specialty Strategy Res, Shanghai Peoples Hosp 9, Dept Anesthesiol,Sch Med,China Hosp Dev Inst, Shanghai, Peoples R China.	dr_jianghong@163.com			National Natural Science Foundation of China [81801094, 82071177]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was funded by the National Natural Science Foundation of China [grant numbers 81801094 by Yaqiong Yang, 82071177 by Hong Jiang].	de Oliveira CMB, 2011, REV BRAS ANESTESIOL, V61, P255, DOI 10.1016/S0034-7094(11)70029-0; Belcheva MM, 2001, J BIOL CHEM, V276, P33847, DOI 10.1074/jbc.M101535200; Belcheva MM, 2003, MOL PHARMACOL, V64, P1391, DOI 10.1124/mol.64.6.1391; Berta T, 2013, NEUROSCIENCE, V247, P376, DOI 10.1016/j.neuroscience.2013.05.018; Borges JP, 2021, FRONT PHARMACOL, V12, DOI 10.3389/fphar.2021.642820; Cai Y, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0520-z; Cui Y, 2006, BRAIN RES, V1069, P235, DOI 10.1016/j.brainres.2005.11.066; Dominguini D, 2021, NEUROSCI BIOBEHAV R, V127, P504, DOI 10.1016/j.neubiorev.2021.05.009; Eidson LN, 2013, J NEUROSCI, V33, P15952, DOI 10.1523/JNEUROSCI.1609-13.2013; Ferrini F, 2013, NAT NEUROSCI, V16, P183, DOI 10.1038/nn.3295; Fischer Oliver M., 2006, V327, P85; Garrett TPJ, 2002, CELL, V110, P763, DOI 10.1016/S0092-8674(02)00940-6; Han Y, 2014, EUR J PAIN, V18, P1458, DOI 10.1002/ejp.511; Henn A, 2009, ALTEX-ALTERN TIEREXP, V26, P83; Horvath RJ, 2008, J NEUROCHEM, V107, P557, DOI 10.1111/j.1471-4159.2008.05633.x; Horvath RJ, 2010, PAIN, V150, P401, DOI 10.1016/j.pain.2010.02.042; Horvath RJ, 2009, J NEUROSCI, V29, P998, DOI 10.1523/JNEUROSCI.4595-08.2009; Hutchinson MR, 2010, NEUROSCIENCE, V167, P880, DOI 10.1016/j.neuroscience.2010.02.011; Hutchinson MR, 2011, PHARMACOL REV, V63, P772, DOI 10.1124/pr.110.004135; Jacobsen JHW, 2014, INT REV NEUROBIOL, V118, P129, DOI 10.1016/B978-0-12-801284-0.00006-3; Jia JJ, 2019, CELL MOL NEUROBIOL, V39, P1125, DOI 10.1007/s10571-019-00707-2; Johnston IN, 2004, J NEUROSCI, V24, P7353, DOI 10.1523/JNEUROSCI.1850-04.2004; Jokinen V, 2018, NEUROSCIENCE, V375, P10, DOI 10.1016/j.neuroscience.2018.01.048; Labuzek K, 2010, N-S ARCH PHARMACOL, V381, P41, DOI 10.1007/s00210-009-0472-2; Lacagnina MJ, 2018, PHARMACOL THERAPEUT, V184, P145, DOI 10.1016/j.pharmthera.2017.10.006; Li CX, 2019, CELL BIOL INT, V43, P360, DOI 10.1002/cbin.10975; Martin LJ, 2017, J CLIN INVEST, V127, P3359, DOI 10.1172/JCI87406; Matsushita Y, 2013, CURR PHARM DESIGN, V19, P7355; Miron VE, 2013, NAT NEUROSCI, V16, P1211, DOI 10.1038/nn.3469; Pan YB, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0754-9; Panigone S, 2008, MOL ENDOCRINOL, V22, P924, DOI 10.1210/me.2007-0246; Puig S, 2020, ENEURO, V7, DOI 10.1523/ENEURO.0460-18.2020; Qin LY, 2005, GLIA, V52, P78, DOI 10.1002/glia.20225; Qu WS, 2015, NEUROCHEM INT, V90, P85, DOI 10.1016/j.neuint.2015.07.007; Qu WS, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-178; Shavit Y, 2005, PAIN, V115, P50, DOI 10.1016/j.pain.2005.02.003; Shen CH, 2011, ANESTH ANALG, V112, P454, DOI 10.1213/ANE.0b013e3182025b15; Taves S, 2013, NEURAL PLAST, V2013, DOI 10.1155/2013/753656; Tawfik VL, 2005, J PHARMACOL EXP THER, V313, P1239, DOI 10.1124/jpet.104.082420; Tu HA, 2021, TISSUE CELL, V68, DOI 10.1016/j.tice.2020.101438; Vacca V, 2013, BRAIN BEHAV IMMUN, V32, P40, DOI 10.1016/j.bbi.2013.01.088; Volkow ND, 2016, NEW ENGL J MED, V374, P1253, DOI 10.1056/NEJMra1507771; Wang LJ, 2020, CELL MOL NEUROBIOL, V40, P1117, DOI 10.1007/s10571-020-00797-3; Wang XH, 2012, P NATL ACAD SCI USA, V109, P6325, DOI 10.1073/pnas.1200130109; Yan PH, 2019, J MOL NEUROSCI, V68, P181, DOI 10.1007/s12031-019-01297-w; Yang YQ, 2021, NEUROPHARMACOLOGY, V196, DOI 10.1016/j.neuropharm.2021.108703; Yang YQ, 2015, BIOMED PHARMACOTHER, V70, P181, DOI 10.1016/j.biopha.2015.01.018; Yang YQ, 2012, NEOPLASIA, V14, P509, DOI 10.1593/neo.12328; Zeng X, 2014, EUR J PAIN, V18, P1323, DOI 10.1002/j.1532-2149.2014.493.x; Zhang L, 2011, PAIN, V152, P419, DOI 10.1016/j.pain.2010.11.014	50	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2021	16	9							e0256870	10.1371/journal.pone.0256870	http://dx.doi.org/10.1371/journal.pone.0256870			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	WG5RP	34520454	Green Published, gold			2022-12-26	WOS:000707052100008
J	Carrieri, V; De Paola, M; Gioia, F				Carrieri, Vincenzo; De Paola, Maria; Gioia, Francesca			The health-economy trade-off during the Covid-19 pandemic: Communication matters	PLOS ONE			English	Article							PROSPECT-THEORY; DECISIONS; MESSAGES; VALUES; CHOICE	How do people balance concerns for general health and economic outcomes during a pandemic? And, how does the communication of this trade-off affect individual preferences? We address these questions using a field experiment involving around 2000 students enrolled in a large university in Italy. We design four treatments where the trade-off is communicated using different combinations of a positive framing that focuses on protective strategies and a negative framing which refers to potential costs. We find that positive framing on the health side induces students to give greater relevance to the health dimension. The effect is sizeable and highly effective among many different audiences, especially females. Importantly, this triggers a higher level of intention to adhere to social distancing and precautionary behaviors. Moreover, irrespective of the framing, we find a large heterogeneity in students' preferences over the trade-off. Economics students and students who have directly experienced the economic impact of the pandemic are found to give greater value to economic outcomes.	[Carrieri, Vincenzo] Magna Graecia Univ Catanzaro, Dept Law Econ & Sociol, Catanzaro, Italy; [Carrieri, Vincenzo] RWI Leibniz Inst Econ Res, Essen, Germany; [Carrieri, Vincenzo] Leibniz Sci Campus Ruhr, Essen, Germany; [Carrieri, Vincenzo; De Paola, Maria] IZA, Bonn, Germany; [De Paola, Maria] Univ Calabria, Dept Econ Stat & Finance Giovanni Anania, Arcavacata Di Rende, Italy; [Gioia, Francesca] Univ Milan, Dept Law Cesare Beccaria, Milan, Italy	Magna Graecia University of Catanzaro; RWI - Leibniz Institut fur Wirtschaftsforschung; IZA Institute Labor Economics; University of Calabria; University of Milan	Gioia, F (corresponding author), Univ Milan, Dept Law Cesare Beccaria, Milan, Italy.	francesca.gioia@unimi.it		Carrieri, Vincenzo/0000-0001-8742-3820	University of Milan through the APC initiative	University of Milan through the APC initiative	The authors acknowledge support from the University of Milan through the APC initiative.	Acemoglu D., 2020, MULTIRISK SIR MODEL, DOI [10.1920/wp.cem.2020.1420, DOI 10.1920/WP.CEM.2020.1420]; Allcott A., 2020, 3610422 SSRN; Alva-Manchego F, 2020, COMPUT LINGUIST, V46, P135, DOI [10.1162/coli_a_00370, 10.1162/COLI_a_00370]; Bank of Italy, 2020, B EC 2 2020; Barari S., 2020, EVALUATING COVID 19, DOI [10.1101/2020.03.27.20042820, DOI 10.1101/2020.03.27.20042820]; Barro R., 2020, 27049 NBER, DOI [10.3386/w27049, DOI 10.3386/W27049]; Bertoni M, 2020, AM J HEALTH ECON, V6, P372, DOI 10.1086/708930; Boettcher WA, 2004, POLIT PSYCHOL, V25, P331, DOI 10.1111/j.1467-9221.2004.00375.x; Briscese G, 2020, NBER WORKING PAPER S; Carrieri V., 2020, VETTED REAL TIME PAP, V25, P3; Centro Studi Confindustria, 2020, IT EC OUTL 2020 2021; Chong D, 2007, AM POLIT SCI REV, V101, P637, DOI 10.1017/S0003055407070554; Daoust JF, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0249914; DAVIS MA, 1986, ORGAN BEHAV HUM DEC, V37, P121, DOI 10.1016/0749-5978(86)90048-8; Di Novi C, 2019, REG SCI URBAN ECON, V78, DOI 10.1016/j.regsciurbeco.2019.103465; Dybowski TP, 2018, EUR J POLIT ECON, V55, P511, DOI 10.1016/j.ejpoleco.2018.05.001; Eichenbaum M.S., 2020, 26882 NBER, DOI [10.3386/w26882, DOI 10.3386/W26882]; Friedson A. I., 2020, Working Paper Series - National Bureau of Economic Research (Massachusetts), DOI 10.3386/w26992; Galasso V, 2020, P NATL ACAD SCI USA, V117, P27285, DOI 10.1073/pnas.2012520117; Gibson J., 2020, UNDERSTANDING EC IMP, V14; Gilbody S, 2007, J GEN INTERN MED, V22, P1596, DOI 10.1007/s11606-007-0333-y; Hargreaves Heap S.P., 2020, VETTED REAL TIME PAP, V22; ISS, 2020, B UFF APR 2020; Jain G, 2020, ORGAN BEHAV HUM DEC, V161, P109, DOI 10.1016/j.obhdp.2020.04.006; KAHNEMAN D, 1984, AM PSYCHOL, V39, P341, DOI 10.1037/0003-066X.39.4.341; KAHNEMAN D, 1979, ECONOMETRICA, V47, P263, DOI 10.2307/1914185; Krishnamurthy P, 2001, ORGAN BEHAV HUM DEC, V85, P382, DOI 10.1006/obhd.2001.2962; Kuehnhanss CR, 2015, EUR J POLIT ECON, V40, P360, DOI 10.1016/j.ejpoleco.2015.06.001; Kuhberger A, 1998, ORGAN BEHAV HUM DEC, V75, P23, DOI 10.1006/obhd.1998.2781; Larsen M., 2020, J BEHAV PUBL ADM, V3, P1, DOI [10.30636/jbpa.32.164, DOI 10.30636/JBPA.32.164]; Lee S., 2020, 27100 NBER; Levy JS, 1997, INT STUD QUART, V41, P87, DOI 10.1111/0020-8833.00034; Lin ZhiXian, 2020, Working Paper Series - National Bureau of Economic Research (Massachusetts), DOI 10.3386/w27099; Linde J., 2014, BEHAV THEORIES PROSP; Loewen P., 2014, BEH MOD POL C DUK U; McDermott R, 2004, POLIT PSYCHOL, V25, P289, DOI 10.1111/j.1467-9221.2004.00372.x; McKibbin W, 2021, ASIAN ECON PAP, V20, P1, DOI 10.1162/asep_a_00796; Mercer J, 2005, ANNU REV POLIT SCI, V8, P1, DOI 10.1146/annurev.polisci.8.082103.104911; Mikels JA, 2016, PSYCHOL AGING, V31, P409, DOI 10.1037/pag0000040; Montenovo L., 2020, 27132 NBER, DOI [10.3386/w27132, DOI 10.3386/W27132]; O'Keefe DJ, 2007, J HEALTH COMMUN, V12, P623, DOI 10.1080/10810730701615198; Piscitelli P, 2019, LANCET PUBLIC HEALTH, V4, pE605, DOI 10.1016/S2468-2667(19)30229-4; QUATTRONE GA, 1988, AM POLIT SCI REV, V82, P719, DOI 10.2307/1962487; Rammstedt B, 2007, EUR J PSYCHOL ASSESS, V23, P193, DOI 10.1027/1015-5759.23.3.193; Schnellenbach J, 2015, EUR J POLIT ECON, V40, P395, DOI 10.1016/j.ejpoleco.2015.05.002; Settele S., 2020, 1920 CEBI; Stock, 2005, IDENTIFICATION INFER; THALER R, 1980, J ECON BEHAV ORGAN, V1, P39, DOI 10.1016/0167-2681(80)90051-7; Toth F, 2014, HEALTH ECON POLICY L, V9, P231, DOI 10.1017/S1744133114000012; TVERSKY A, 1981, SCIENCE, V211, P453, DOI 10.1126/science.7455683; Wren-Lewis S., 2020, EC TIME COVID 19, P109, DOI [10.1126/sciadv.abb6914, DOI 10.1126/SCIADV.ABB6914]	51	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2021	16	9							e0256103	10.1371/journal.pone.0256103	http://dx.doi.org/10.1371/journal.pone.0256103			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	WG6OR	34516549	Green Published, gold			2022-12-26	WOS:000707114200007
J	Gardiner, E; Lai, JF; Khanna, D; Meza, G; de Wildt, G; Taylor, B				Gardiner, Esme; Lai, Jo Freda; Khanna, Divya; Meza, Graciella; de Wildt, Gilles; Taylor, Beck			Exploring women's decisions of where to give birth in the Peruvian Amazon; why do women continue to give birth at home? A qualitative study	PLOS ONE			English	Article							MATERNAL MORTALITY; HEALTH; CHILDBIRTH; INTERVIEWS; DELIVERY; INDIA; CARE	Background Despite improvements in maternal mortality globally, hundreds of women continue to die daily. The World Health Organisation therefore advises all women in low-and-middle income countries to give birth in healthcare facilities. Barriers to seeking intrapartum care have been described in Thaddeus and Maine's Three Delays Model, however these decisions are complex and often unique to different settings. Loreto, a rural province in Peru has one of the highest homebirth rates in the country at 31.8%. The aim of this study was to explore facilitators and barriers to facility births and explore women's experiences of intrapartum care in Amazonian Peru. Methods Through purposive sampling, postnatal women were recruited for semi-structured interviews (n = 25). Interviews were transcribed verbatim and thematically analysed. A combination of deductive and inductive coding was used. Analytical triangulation was undertaken, and data saturation was used to determine when no further interviews were necessary. Results Five themes were generated from the data: 1) Financial barriers; 2) Accessing care; 3) Fear of healthcare facilities; 4) Importance of seeking care and 5) Comfort and traditions of home. Generally, participants realised the importance of seeking skilled care however barriers persisted, across all areas of the Three Delays Model. Barriers identified included fear of healthcare facilities and interventions, direct and indirect costs, continuation of daily activities, distance and availability of transport. Women who delivered in healthcare facilities had mixed experiences, many reporting good attention, however a selection experienced poor treatment including abusive behaviour. Conclusion Despite free care, women continue to face barriers seeking obstetric care in Amazonian Peru, including fear of hospitals, cost and availability of transport. However, women accessing care do not always receive positive care experiences highlighting implications for changes in accessibility and provision of care. Minimising these barriers is critical to improve maternal and neonatal outcomes in rural Peru.	[Gardiner, Esme; Lai, Jo Freda; Khanna, Divya; de Wildt, Gilles] Univ Birmingham, Coll Med & Dent Sci, Birmingham, W Midlands, England; [Meza, Graciella] Univ Nacl Amazonia Peruana, Fac Med Human, Iquitos, Peru; [Taylor, Beck] Univ Birmingham, Inst Appl Hlth Res, Birmingham, W Midlands, England	University of Birmingham; Universidad Nacional de la Amazonia Peruana; University of Birmingham	Gardiner, E (corresponding author), Univ Birmingham, Coll Med & Dent Sci, Birmingham, W Midlands, England.	esmegardiner@btinternet.com		Taylor, Beck/0000-0002-3559-7922; Gardiner, Esme/0000-0002-3746-3370; Khanna, Divya/0000-0002-8767-2760	University of Birmingham; Topham Bursary Fund; National Institute for Health Research (NIHR) Applied Research Centre (ARC) West Midlands	University of Birmingham; Topham Bursary Fund; National Institute for Health Research (NIHR) Applied Research Centre (ARC) West Midlands	This work was supported by the University of Birmingham and an intercalated bursary award from the Topham Bursary Fund (EG). Support was also provided by the National Institute for Health Research (NIHR) Applied Research Centre (ARC) West Midlands (BT). The views expressed are those of the author and not necessarily those of the NIHR or the Department of Health and Social Care. The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Adatara P, 2020, BMC PREGNANCY CHILDB, V20, DOI 10.1186/s12884-020-03198-y; Adatara P, 2019, INT J WOMENS HEALTH, V11, P353, DOI 10.2147/IJWH.S190402; Amnesty International, 2008, FAT FLAWS BARR MAT H; Barbour RS, 2001, BMJ-BRIT MED J, V322, P1115, DOI 10.1136/bmj.322.7294.1115; Bedford J, 2013, MATERN CHILD HLTH J, V17, P230, DOI 10.1007/s10995-012-0965-3; Belton S, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-39; Berkwits M, 1998, J GEN INTERN MED, V13, P195, DOI 10.1046/j.1525-1497.1998.00054.x; Bohren MA, 2019, LANCET, V394, P1750, DOI 10.1016/S0140-6736(19)31992-0; Bohren MA, 2019, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD012449.pub2; Bohren MA, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001847; Bohren MA, 2014, REPROD HEALTH, V11, DOI 10.1186/1742-4755-11-71; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Caulfield T, 2016, BMC WOMENS HEALTH, V16, DOI 10.1186/s12905-016-0333-3; City Population, IQUITOS DISTRICT PER; Das J, 2018, BMJ-BRIT MED J, V361, DOI 10.1136/bmj.k1716; de Jonge A, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f3263; del Carpio Ancaya Lucy, 2013, Rev. perú. med. exp. salud publica, V30, P461; Fugard A, 2019, SAGE RES METHODS; Gage AD, 2019, HEALTH AFFAIR, V38, P1576, DOI 10.1377/hlthaff.2018.05397; Gill P, 2008, BRIT DENT J, V204, P291, DOI 10.1038/bdj.2008.192; Godlonton S, 2016, J DEV ECON, V118, P112, DOI 10.1016/j.jdeveco.2015.09.001; Graham WJ, 2001, SAFE MOTHERHOOD STRA; Hancock B., 2009, QUAL RES, V39; Hennink MM, 2017, QUAL HEALTH RES, V27, P591, DOI 10.1177/1049732316665344; Hodin S, 2017, MATERNITY WAITING HO; Holloway I, 2017, QUALITATIVE RES NURS, VFourth; Hollowell J., 2015, HLTH SERV DELIV RES, V3, P1, DOI [10.3310/hsdr03360, DOI 10.3310/HSDR03360]; Instituto Nacional de Estadistica e Informatic, FORM ACC AG SAN BAS; Kawakatsu Y, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-265; Kifle MM, 2018, J HEALTH POPUL NUTR, V37, DOI 10.1186/s41043-018-0153-1; Kim Y, 2011, QUAL SOC WORK, V10, P190, DOI 10.1177/1473325010362001; Kisianganr I, 2020, BMC PREGNANCY CHILDB, V20, DOI 10.1186/s12884-020-02955-3; Knoema, PER LOR DAT STAT; Kouanda S, 2016, INT J GYNECOL OBSTET, V135, pS39, DOI 10.1016/j.ijgo.2016.08.009; Kruk ME, 2018, LANCET, V392, P2203, DOI [10.1016/S0140-6736(18)31668-4, 10.1016/s0140-6736(18)31668-4]; Kumbani L, 2013, REPROD HEALTH, V10, DOI 10.1186/1742-4755-10-9; Lerberg PM, 2014, AFR J REPROD HEALTH, V18, P35; Lonely Planet, IQ TRAV; Marsland H, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0209736; Mason L, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0453-z; Mera KC., 2014, IDENTIFICACION PRIOR; Milne L, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0564-6; Mohanan M, 2014, B WORLD HEALTH ORGAN, V92, P187, DOI 10.2471/BLT.13.124644; Montagu D, 2017, HEALTH POLICY PLANN, V32, P1146, DOI 10.1093/heapol/czx060; Moshi F, 2017, REPROD HEALTH, V14, DOI 10.1186/s12978-017-0397-z; N'Gbichi C, 2019, BMC PREGNANCY CHILDB, V19, DOI 10.1186/s12884-019-2477-2; Newman Dana E, 2010, Rural Remote Health, V10, P1256; NICE, 2014, ANT POSTN MENT HLTH; Nowell LS, 2017, INT J QUAL METH, V16, DOI 10.1177/1609406917733847; Nygaard SS, 2018, ACTA OBSTET GYN SCAN, V97, P1155, DOI 10.1111/aogs.13441; Ochieng CA, 2019, BMC PREGNANCY CHILDB, V19, DOI 10.1186/s12884-019-2485-2; Pan American Health Organization, REV FUND VACC PRIC 2; Pazandeh F, 2017, MIDWIFERY, V53, P63, DOI 10.1016/j.midw.2017.07.001; Powell-Jackson T, 2015, J HEALTH ECON, V43, P154, DOI 10.1016/j.jhealeco.2015.07.001; Punch KF., 2014, INTRO RES METHODS ED, V2nd ed; Roro Meselech Assegid, 2014, BMC Res Notes, V7, P556, DOI 10.1186/1756-0500-7-556; Rullier HB, RESPONSABLES ESTUDIO, P308; Sato C, 2019, TROP MED HEALTH, V47, DOI 10.1186/s41182-019-0177-2; Saunders B, 2018, QUAL QUANT, V52, P1893, DOI 10.1007/s11135-017-0574-8; Scott S, 2009, TROP MED INT HEALTH, V14, P1523, DOI 10.1111/j.1365-3156.2009.02402.x; SERFOR, 2017, ESTR NAC RED TRAF IL; Shah R, 2018, REPROD HEALTH, V15, DOI 10.1186/s12978-018-0553-0; Shiferaw S, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-5; Smith JN, 2018, BMC PREGNANCY CHILDB, V18, DOI 10.1186/s12884-018-1733-1; Some TD, 2011, REPROD HEALTH, V8, DOI 10.1186/1742-4755-8-3; Squires A, 2020, J ADV NURS, V76, P706, DOI 10.1111/jan.14007; Squires A, 2009, INT J NURS STUD, V46, P277, DOI 10.1016/j.ijnurstu.2008.08.006; Sustainable Development Goals Knowledge Platform, TRANSF OUR WORLD 203; Tancred T, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-0945-5; THADDEUS S, 1994, SOC SCI MED, V38, P1091, DOI 10.1016/0277-9536(94)90226-7; The World Bank, HOSP BED PER 1000 PE; Titaley CR, 2010, BMC PREGNANCY CHILDB, V10, DOI 10.1186/1471-2393-10-43; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; UN, 2015, SUSTAINABLE DEV GOAL; UNICEF, MATERNAL NEWBORN HLT; United Nations Children's Fund (UNICEF) World Health Organization International Bank for Reconstruction and Development/The World Bank, 2019, ZAMB HLTH BUDG BRIEF; United Nations Development Programme (UNDP), 2019, HUM DEV REP 2019 INC; Utz B, 2013, ACTA OBSTET GYN SCAN, V92, P1063, DOI 10.1111/aogs.12166; Westgard CM, 2019, INT J EQUITY HEALTH, V18, DOI 10.1186/s12939-019-1056-5; WHO, 2019, WHO CONS GUID DRUG R, DOI DOI 10.30978/TB2021-2-86; World Health Organisation, BMI BOD MASS IND; World Health Organisation, 1996, MAT WAIT HOM REV EXP	82	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2021	16	9							e0257135	10.1371/journal.pone.0257135	http://dx.doi.org/10.1371/journal.pone.0257135			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	XM9EM	34506573	Green Published, gold			2022-12-26	WOS:000729120700050
J	Uday, RVS; Misra, R; Harika, A; Dolui, S; Saha, A; Pal, U; Ravichandiran, V; Maiti, NC				Uday, R. V. Sriram; Misra, Rajdip; Harika, Annaram; Dolui, Sandip; Saha, Achintya; Pal, Uttam; Ravichandiran, V.; Maiti, Nakul C.			Dabrafenib, idelalisib and nintedanib act as significant allosteric modulator for dengue NS3 protease	PLOS ONE			English	Article							IN-SILICO; VIRUS; DOCKING; VALIDATION; INHIBITORS; DISEASE	Dengue virus (DENV) encodes a unique protease (NS3/NS2B) essential for its maturation and infectivity and, it has become a key target for anti-viral drug design to treat dengue and other flavivirus related infections. Present investigation established that some of the drug molecules currently used mainly in cancer treatment are susceptible to bind non-active site (allosteric site/ cavity) of the NS3 protease enzyme of dengue virus. Computational screening and molecular docking analysis found that dabrafenib, idelalisib and nintedanib can bind at the allosteric site of the enzyme. The binding of the molecules to the allosteric site found to be stabilized via pi-cation and hydrophobic interactions, hydrogen-bond formation and pi-stacking interaction with the molecules. Several interacting residues of the enzyme were common in all the five serotypes. However, the interaction/stabilizing forces were not uniformly distributed; the pi-stacking was dominated with DENV3 proteases, whereas, a charged/ionic interaction was the major force behind interaction with DENV2 type proteases. In the allosteric cavity of protease from DENV1, the residues Lys73, Lys74, Thr118, Glu120, Val123, Asn152 and Ala164 were involved in active interaction with the three molecules (dabrafenib, idelalisib and nintedanib). Molecular dynamics (MD) analysis further revealed that the molecules on binding to NS3 protease caused significant changes in structural fluctuation and gained enhanced stability. Most importantly, the binding of the molecules effectively perturbed the protein conformation. These changes in the protein conformation and dynamics could generate allosteric modulation and thus may attenuate/alter the NS3 protease functionality and mobility at the active site. Experimental studies may strengthen the notion whether the binding reduce/enhance the catalytic activity of the enzyme, however, it is beyond the scope of this study.	[Uday, R. V. Sriram; Harika, Annaram; Ravichandiran, V.] Natl Inst Pharmaceut Educ & Res, Kolkata, W Bengal, India; [Misra, Rajdip; Dolui, Sandip; Pal, Uttam; Maiti, Nakul C.] Indian Inst Chem Biol, Council Sci & Ind Res, Struct Biol & Bioinformat Div, Kolkata, W Bengal, India; [Saha, Achintya] Univ Calcutta, Dept Chem Technol, Kolkata, W Bengal, India; [Pal, Uttam] SN Bose Natl Ctr Basic Sci, Kolkata, W Bengal, India	National Institute of Pharmaceutical Education & Research (NIPER); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB); University of Calcutta; Department of Science & Technology (India); SN Bose National Centre for Basic Science (SNBNCBS)	Ravichandiran, V (corresponding author), Natl Inst Pharmaceut Educ & Res, Kolkata, W Bengal, India.; Pal, U; Maiti, NC (corresponding author), Indian Inst Chem Biol, Council Sci & Ind Res, Struct Biol & Bioinformat Div, Kolkata, W Bengal, India.; Pal, U (corresponding author), SN Bose Natl Ctr Basic Sci, Kolkata, W Bengal, India.	ncmaiti@iicb.res.in; director@niperkolkata.edu.in; uttam2707@gmail.com	Pal, Uttam/A-8544-2013; VELAYUTHAM, RAVICHANDIRAN/HGU-8028-2022; Maiti, Nakul/GLR-3207-2022; SAHA, ACHINTYA/R-1387-2016	Pal, Uttam/0000-0003-2110-4610; Maiti, Nakul/0000-0002-8498-6502; RAVICHANDIRAN, V/0000-0001-7820-9486; SAHA, ACHINTYA/0000-0002-0205-7719; MISRA, RAJDIP/0000-0003-4698-3922				Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; Biswas P, 2020, SOFT MATTER, V16, P3050, DOI 10.1039/c9sm02479d; Chambers TJ, 1997, VACCINE, V15, P1494, DOI 10.1016/S0264-410X(97)00195-3; Dallakyan S, 2015, METHODS MOL BIOL, V1263, P243, DOI 10.1007/978-1-4939-2269-7_19; Dighe SN, 2019, EUR J MED CHEM, V176, P431, DOI 10.1016/j.ejmech.2019.05.010; Dwivedi VD, 2021, J BIOMOL STRUCT DYN, V39, P1417, DOI 10.1080/07391102.2020.1734485; Erbel P, 2006, NAT STRUCT MOL BIOL, V13, P372, DOI 10.1038/nsmb1073; Gore S, 2017, STRUCTURE, V25, P1916, DOI 10.1016/j.str.2017.10.009; Hassandarvish P, 2016, RSC ADV, V6, P31235, DOI 10.1039/c6ra00817h; HIGGINS DG, 1988, GENE, V73, P237, DOI 10.1016/0378-1119(88)90330-7; Jacob RB, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002499; Katzelnick LC, 2017, SCIENCE, V358, P929, DOI 10.1126/science.aan6836; Kharisma V.D., 2021, INDIAN J FORENSIC ME, V15, P1627; Lim L, 2020, ACS OMEGA, V5, P25677, DOI 10.1021/acsomega.0c00039; LIPMAN DJ, 1989, P NATL ACAD SCI USA, V86, P4412, DOI 10.1073/pnas.86.12.4412; Luo D, 2008, J VIROL, V82, P173, DOI 10.1128/JVI.01788-07; McInnes C, 2007, CURR OPIN CHEM BIOL, V11, P494, DOI 10.1016/j.cbpa.2007.08.033; Millies B, 2019, J MED CHEM, V62, P11359, DOI 10.1021/acs.jmedchem.9b01697; Mukhametov A, 2014, J MOL GRAPH MODEL, V52, P103, DOI 10.1016/j.jmgm.2014.06.008; Normile D, 2013, SCIENCE, V342, P415, DOI 10.1126/science.342.6157.415; Othman R, 2008, J CHEM INF MODEL, V48, P1582, DOI 10.1021/ci700388k; Pagadala Nataraj S, 2017, Biophys Rev, V9, P91, DOI 10.1007/s12551-016-0247-1; Pal U., 2017, J PROTEINS PROTEOMIC, V9, P1; Pal U, 2014, J PHYS CHEM A, V118, P1024, DOI 10.1021/jp411488a; Panda K, 2021, MOLECULES, V26, DOI 10.3390/molecules26103016; Raafat N, 2019, T ROY SOC TROP MED H, V113, P653, DOI 10.1093/trstmh/trz068; Rabelo VWH, 2019, J STEROID BIOCHEM, V185, P189, DOI 10.1016/j.jsbmb.2018.09.001; Rawlinson SM, 2006, CURR DRUG TARGETS, V7, P1623, DOI 10.2174/138945006779025383; Rees CA, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007111; Rodenhuis-Zybert IA, 2010, CELL MOL LIFE SCI, V67, P2773, DOI 10.1007/s00018-010-0357-z; Shoichet BK, 2004, NATURE, V432, P862, DOI 10.1038/nature03197; Simanjuntak Y, 2015, J INFECT DIS, V211, P394, DOI 10.1093/infdis/jiu377; Smart OS, 2018, ACTA CRYSTALLOGR D, V74, P237, DOI 10.1107/S2059798318003303; Teixeira RR, 2014, MOLECULES, V19, P8151, DOI 10.3390/molecules19068151; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Wu HM, 2015, ANTIMICROB AGENTS CH, V59, P1100, DOI 10.1128/AAC.03543-14; Yildiz M, 2013, ACS CHEM BIOL, V8, P2744, DOI 10.1021/cb400612h	38	1	1	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2021	16	9							e0257206	10.1371/journal.pone.0257206	http://dx.doi.org/10.1371/journal.pone.0257206			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XM9EM	34506566	Green Published, gold			2022-12-26	WOS:000729120700119
J	Zeng, Z; Gao, S; Wang, HN; Huang, LY; Wang, XL				Zeng, Zan; Gao, Shan; Wang, Hao-Ning; Huang, Li-Ya; Wang, Xiao-Long			A predictive analysis on the risk of peste des petits ruminants in livestock in the Trans-Himalayan region and validation of its transboundary transmission paths	PLOS ONE			English	Article							SPECIES DISTRIBUTION MODELS; PSEUDOIS-NAYAUR; VIRUS-INFECTION; DIAGNOSIS; HABITAT; DISTRIBUTIONS; CONSERVATION; ECOSYSTEM; OUTBREAK; ECOLOGY	Although the Trans-Himalayan region (THR) is an important endemic and rendezvous area of peste des petits ruminants (PPR), monitoring and prevention measurements are difficult to execute because of the rough geographical conditions. Besides, a heterogeneous breeding system and the poor veterinary service of susceptible animals compound the existing problems. Here, we propose a forecasting system to define the key points of PPR prevention and aid the countries in saving time, labor, and products to achieve the goal of the global eradication project of PPR. The spatial distribution of PPR was predicted in the THR for the first time using a niche model that was constructed with a combination of eco-geographical, anthropoid, meteorological, and host variables. The transboundary least-cost paths (LCPs) of small ruminants in the THR were also calculated. Our results reveal that the low-elevation area of the THR had a higher PPR risk and was mainly dominated by human variables. The high-elevation area had lower risk and was mainly dominated by natural variables. Eight LCPs representing corridors among India, Nepal, Bhutan, Bangladesh, and China were obtained. This confirmed the potential risk of transboundary communication by relying on PPR contamination on the grasslands for the first time. The predicted potential risk communication between the two livestock systems and landscapes (high and low elevation) might play a role in driving PPR transboundary transmission.	[Zeng, Zan; Gao, Shan; Wang, Xiao-Long] Northeast Forestry Univ, Minist Educ, Coll Wildlife & Protected Area, Harbin, Heilongjiang, Peoples R China; [Zeng, Zan; Gao, Shan; Wang, Xiao-Long] Key Lab Wildlife Dis & Biosecur Management Heilon, Harbin, Heilongjiang, Peoples R China; [Wang, Hao-Ning] Harbin Univ, Sch Geog & Tourism, Harbin, Heilongjiang, Peoples R China; [Huang, Li-Ya] Changbai Mt Acad Sci, Jilin, Jilin, Peoples R China	Northeast Forestry University - China; Harbin University	Wang, XL (corresponding author), Northeast Forestry Univ, Minist Educ, Coll Wildlife & Protected Area, Harbin, Heilongjiang, Peoples R China.; Wang, XL (corresponding author), Key Lab Wildlife Dis & Biosecur Management Heilon, Harbin, Heilongjiang, Peoples R China.	wxlhrb@nefu.edu.cn		Wang, Xiaolong/0000-0002-9293-5289	National Key R&D Program for the 13th Five-Year Plan of the Ministry of Science and Technology, China [2017YFD05 01800]; State Key Laboratory of Veterinary Biotechnology Foundation [SKLVBF201904]	National Key R&D Program for the 13th Five-Year Plan of the Ministry of Science and Technology, China; State Key Laboratory of Veterinary Biotechnology Foundation	This work was supported by the National Key R&D Program for the 13th Five-Year Plan of the Ministry of Science and Technology, China (Grant No. 2017YFD05 01800); State Key Laboratory of Veterinary Biotechnology Foundation (Grant No.SKLVBF201904).	Abu Elzein EME, 2004, J VET MED B, V51, P68, DOI 10.1111/j.1439-0450.2004.00731.x; Abubakar M, 2011, TROP ANIM HEALTH PRO, V43, P745, DOI 10.1007/s11250-010-9776-y; Acharya Narayan, 2018, VirusDisease, V29, P173, DOI 10.1007/s13337-018-0449-1; Adriaensen F, 2003, LANDSCAPE URBAN PLAN, V64, P233, DOI 10.1016/S0169-2046(02)00242-6; Aguilar XF, 2020, VIRUSES-BASEL, V12, DOI 10.3390/v12030293; Aguilar XF, 2018, SCIENCE, V362, P165, DOI 10.1126/science.aav4096; Arnfield A.J., 2020, KOPPEN CLIMATE CLASS; Austin M, 2007, ECOL MODEL, V200, P1, DOI 10.1016/j.ecolmodel.2006.07.005; Aziz-ul-Rahman, 2018, TROP ANIM HEALTH PRO, V50, P1815, DOI 10.1007/s11250-018-1623-6; Banyard AC, 2015, PESTE PETITS RUMINAN, P69, DOI [10.1007/97836624516565, DOI 10.1007/97836624516565]; Banyard AC, 2014, EMERG INFECT DIS, V20, P2176, DOI 10.3201/eid2012.140907; Banyard AC, 2010, J GEN VIROL, V91, P2885, DOI 10.1099/vir.0.025841-0; Bao JY, 2011, RES VET SCI, V90, P238, DOI 10.1016/j.rvsc.2010.05.031; Benfield CTO, 2021, VIRUS EVOL, V7, DOI 10.1093/ve/veab062; Bernstein I., 1988, APPL MULTIVARIATE AN, DOI [10.1007/978-1-4613-8740-4, DOI 10.1007/978-1-4613-8740-4]; Bro-Jorgensen J, 2008, OIKOS, V117, P729, DOI 10.1111/j.0030-1299.2008.16069.x; Burns RJL, 2019, TRANSBOUND EMERG DIS, V66, P939, DOI 10.1111/tbed.13109; Caron A, 2015, VET RES, V46, DOI 10.1186/s13567-015-0217-9; Chetkiewicz CLB, 2006, ANNU REV ECOL EVOL S, V37, P317, DOI 10.1146/annurev.ecolsys.37.091305.110050; Clarke BD, 2018, TRANSBOUND EMERG DIS, V65, P1597, DOI 10.1111/tbed.12911; Cromsigt JPGM, 2009, DIVERS DISTRIB, V15, P513, DOI 10.1111/j.1472-4642.2008.00554.x; DANIEL C, 1973, J AM STAT ASSOC, V68, P353, DOI 10.2307/2284076; Duque-Lazo J, 2016, ECOL MODEL, V320, P62, DOI 10.1016/j.ecolmodel.2015.09.019; FAO, 2020, PEST PET RUM IND; Fekede RJ, 2021, TRANSBOUND EMERG DIS, V68, P1465, DOI 10.1111/tbed.13814; Fekede RJ, 2019, TRANSBOUND EMERG DIS, V66, P852, DOI 10.1111/tbed.13094; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; Fine AE, 2020, FRONT VET SCI, V7, DOI 10.3389/fvets.2020.00050; Fourcade Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097122; FURLEY CW, 1987, VET REC, V121, P443, DOI 10.1136/vr.121.19.443; GARGADENNEC L., 1942, Bulletin des Services zootechniques et des epizooties de l'Afrique occidentale francaise, V5, P16; Harris RB, 2014, PSEUDOIS NAYAUR IUCN, DOI [10.2305/IUCN.UK.2014-3.RLTS.T61513537A64313015.en, DOI 10.2305/IUCN.UK.2014-3.RLTS.T61513537A64313015.EN]; Hashmi MM, 2017, ENVIRON MONIT ASSESS, V189, DOI 10.1007/s10661-017-6189-7; Hernandez PA, 2006, ECOGRAPHY, V29, P773, DOI 10.1111/j.0906-7590.2006.04700.x; Himeidan YE, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-234; Hoffmann B, 2012, TRANSBOUND EMERG DIS, V59, P173, DOI 10.1111/j.1865-1682.2011.01270.x; IUCN/SSC Antelope Specialist Group, 2017, TAX POL VERS 2 0; Jahel C, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-65132-8; Jones BA, 2021, VIRUSES-BASEL, V13, DOI 10.3390/v13050838; Jones BA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149982; Khanyari M, 2021, J APPL ECOL, V58, P1838, DOI 10.1111/1365-2664.13937; Kinne J, 2010, EPIDEMIOL INFECT, V138, P1211, DOI 10.1017/S0950268809991592; Kock RA, 2006, PREV VET MED, V75, P63, DOI 10.1016/j.prevetmed.2006.01.016; Kohli RK, 2004, WEED TECHNOL, V18, P1296, DOI 10.1614/0890-037X(2004)018[1296:IOIPOT]2.0.CO;2; Kumar N, 2014, VIRUSES-BASEL, V6, P2287, DOI 10.3390/v6062287; Landau S., 2003, HDB STAT ANAL USING; Libeau G., 2014, Animal Frontiers, V4, P14, DOI 10.2527/af.2014-0003; Lipiec A., 2012, BIODIVERSITY REGIONA, P199; Liu BY, 2019, PEST MANAG SCI, V75, P3076, DOI 10.1002/ps.5424; Liu CR, 2005, ECOGRAPHY, V28, P385, DOI 10.1111/j.0906-7590.2005.03957.x; LOVARI S, 1993, REV ECOL-TERRE VIE, V48, P365; Lu Z., 2008, CHINA ANIMAL HLTH IN, V25, P44; Ma J, 2019, TRANSBOUND EMERG DIS, V66, P1784, DOI 10.1111/tbed.13217; Mahapatra M, 2015, EMERG INFECT DIS, V21, P2230, DOI 10.3201/eid2112.150223; Maria B, 2017, ECOL MODEL, V359, P92, DOI 10.1016/j.ecolmodel.2017.05.021; Michel S, 2015, CAPRA FALCONERI ERRA, DOI [10.2305/IUCN.UK.2015-4.RLTS.T3787A82028427.en, DOI 10.2305/IUCN.UK.2015-4.RLTS.T3787A82028427.EN]; Ntassiou K, 2015, 7 INT C INF COMM TEC; O'Brien D, 2006, BIOL CONSERV, V130, P70, DOI 10.1016/j.biocon.2005.12.014; OIE, 2019, TERR MAN PEST PET RU; OIE, 2018, TERR AN HLTH COD; OIE FAO, 2015, GLOB STRAT CONTR ERR; Pandey KR., 2018, NEPALESE VET J, V35, P41, DOI [10.3126/nvj.v35i0.25215, DOI 10.3126/NVJ.V35I0.25215]; Parida S, 2015, VET MICROBIOL, V181, P90, DOI 10.1016/j.vetmic.2015.08.009; Pearson RG, 2007, J BIOGEOGR, V34, P102, DOI 10.1111/j.1365-2699.2006.01594.x; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Pruvot M, 2020, EMERG INFECT DIS, V26, P51, DOI 10.3201/eid2601.181998; Rao PP, 2005, INDIAN J ANIM SCI, V75, P1233; Regmi B, 2020, ANN EPIDEMIOLOGICAL, DOI [10.13140/RG.2.2.13375.53928, DOI 10.13140/RG.2.2.13375.53928]; Salami H, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.00772-14; Saltelli A, 2006, RELIAB ENG SYST SAFE, V91, P1109, DOI 10.1016/j.ress.2005.11.014; Santhamani R, 2016, ARCH VIROL, V161, P2953, DOI 10.1007/s00705-016-3009-2; Shackleton DM, 1997, WILD SHEEP GOATS THE; Sharawi SS, 2010, VET WORLD, V3, P489; Singh A, 2018, MAJOR ANIMAL HUSBAND; Singh RP, 2004, REV SCI TECH OIE, V23, P807, DOI 10.20506/rst.23.3.1522; STRAUS LG, 1987, J ARCHAEOL SCI, V14, P163; Sun YW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098690; van Gils H, 2014, J NAT CONSERV, V22, P23, DOI 10.1016/j.jnc.2013.08.001; Virender Kumar, 2012, Agricultural Economics Research Review, V25, P501; Wang Dianlai, 2019, Journal of Applied Sciences - Electronics and Information Engineering, V37, P519, DOI 10.3969/j.issn.0255-8297.2019.04.009; Wang X., 2009, PLATEAU MOUNTAIN MET, V29, P81; Wang ZL, 2009, EMERG INFECT DIS, V15, P299, DOI 10.3201/eid1502.080817; Wangmo C, 2020, KUENSEL ONLINE 1111; WILSON P, 1981, BIOL CONSERV, V21, P55, DOI 10.1016/0006-3207(81)90068-9; Yang J., 2014, CHINA HERBIVORE SCI, P445; Zhang D., 2017, GANSU ANIMAL HUSBAND, V47, P96; Zhang S, 1994, CHINESE TIBETOLOGY, P61; Zobel G, 2019, TRANSL ANIM SCI, V3, P212, DOI 10.1093/tas/txy145	88	4	4	7	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2021	16	9							e0257094	10.1371/journal.pone.0257094	http://dx.doi.org/10.1371/journal.pone.0257094			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XM9EM	34506571	Green Published, gold			2022-12-26	WOS:000729120700035
J	Penney, MD; Yargic, Y; Smolin, L; Thommes, EW; Anand, M; Bauch, CT				Penney, Mark D.; Yargic, Yigit; Smolin, Lee; Thommes, Edward W.; Anand, Madhur; Bauch, Chris T.			"Hot-spotting" to improve vaccine allocation by harnessing digital contact tracing technology: An application of percolation theory	PLOS ONE			English	Article							STRATEGIES; NETWORKS; OUTBREAK; BEHAVIOR; DISEASE	Vaccinating individuals with more exposure to others can be disproportionately effective, in theory, but identifying these individuals is difficult and has long prevented implementation of such strategies. Here, we propose how the technology underlying digital contact tracing could be harnessed to boost vaccine coverage among these individuals. In order to assess the impact of this "hot-spotting" proposal we model the spread of disease using percolation theory, a collection of analytical techniques from statistical physics. Furthermore, we introduce a novel measure which we call the efficiency, defined as the percentage decrease in the reproduction number per percentage of the population vaccinated. We find that optimal implementations of the proposal can achieve herd immunity with as little as half as many vaccine doses as a non-targeted strategy, and is attractive even for relatively low rates of app usage.	[Penney, Mark D.; Yargic, Yigit; Smolin, Lee] Perimeter Inst Theoret Phys, Waterloo, ON, Canada; [Penney, Mark D.; Bauch, Chris T.] Univ Waterloo, Dept Appl Math, Waterloo, ON, Canada; [Yargic, Yigit] Univ Waterloo, Dept Phys & Astron, Waterloo, ON, Canada; [Thommes, Edward W.] Sanofi Pasteur, Vaccine Epidemiol & Modeling, Toronto, ON, Canada; [Thommes, Edward W.] Univ Guelph, Dept Math & Stat, Guelph, ON, Canada; [Thommes, Edward W.] York Univ, Dept Math & Stat, Toronto, ON, Canada; [Anand, Madhur] Univ Guelph, Sch Environm Sci, Guelph, ON, Canada	Perimeter Institute for Theoretical Physics; University of Waterloo; University of Waterloo; Sanofi-Aventis; University of Guelph; York University - Canada; University of Guelph	Penney, MD (corresponding author), Perimeter Inst Theoret Phys, Waterloo, ON, Canada.; Penney, MD (corresponding author), Univ Waterloo, Dept Appl Math, Waterloo, ON, Canada.	m2penney@uwaterloo.ca			NSERC COVID-19 Alliance Grant ALLRP [ALLRP 554380-20]; Ontario Ministry of Colleges and Universities COVID19 Rapid Response Grant [C-299-137-BAUCH]; NSERC COVID19 Alliance Grant	NSERC COVID-19 Alliance Grant ALLRP; Ontario Ministry of Colleges and Universities COVID19 Rapid Response Grant; NSERC COVID19 Alliance Grant	This work was supported by the NSERC COVID-19 Alliance Grant ALLRP 554380-20 (MDP, MA, CTB) and the Ontario Ministry of Colleges and Universities COVID19 Rapid Response Grant C-299-137-BAUCH (MA, CTB). The NSERC COVID19 Alliance Grant was held in partnership with Sanofi Pasteur who made only a contribution in-kind in the form of their employee (EWT). The funders provided support in the form of salaries for authors (MDP, EWT), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Aharony A., 2018, INTRO PERCOLATION TH; Alvarez-Zuzek LG, 2019, PHYS REV E, V99, DOI 10.1103/PhysRevE.99.012302; Bansal S, 2007, J R SOC INTERFACE, V4, P879, DOI 10.1098/rsif.2007.1100; Braithwaite I, 2020, LANCET DIGIT HEALTH, V2, pE607, DOI 10.1016/S2589-7500(20)30184-9; Caramelo F, 2020, ESTIMATION RISK FACT, DOI [10.1101/2020.02.24.20027268, DOI 10.1101/2020.02.24.20027268]; Chang S, 2021, NATURE, V589, P82, DOI 10.1038/s41586-020-2923-3; Cohen R, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.247901; Dushoff J, 2007, PLOS MED, V4, P921, DOI 10.1371/journal.pmed.0040174; Endo Akira, 2020, Wellcome Open Res, V5, P67, DOI [10.12688/wellcomeopenres.15842.1, 10.12688/wellcomeopenres.15842.3]; Fenner F., 1988, SMALLPOX ITS ERADICA, V6; GRASSBERGER P, 1983, MATH BIOSCI, V63, P157, DOI 10.1016/0025-5564(82)90036-0; Gsell PS, 2017, LANCET INFECT DIS, V17, P1276, DOI 10.1016/S1473-3099(17)30541-8; Holme P, 2004, EUROPHYS LETT, V68, P908, DOI 10.1209/epl/i2004-10286-2; Ingle M, 2020, IEEE DATA ENG B, P12; Johnson NL, 2005, WILEY SER PROBAB ST, P1, DOI 10.1002/0471715816; Keeling MJ, 2005, J R SOC INTERFACE, V2, P295, DOI 10.1098/rsif.2005.0051; Kim H., 2020, ARXIV PREPRINT ARXIV; Lurie N, 2020, NEW ENGL J MED, V382, P1969, DOI 10.1056/NEJMp2005630; MACKAY G, 1984, J PHYS A-MATH GEN, V17, pL757, DOI 10.1088/0305-4470/17/14/006; Matrajt Laura, 2020, medRxiv, DOI [10.1126/sciadv.abf1374, 10.1101/2020.08.14.20175257]; McKenzie D, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1731; Meyers LA, 2005, J THEOR BIOL, V232, P71, DOI 10.1016/j.jtbi.2004.07.026; Meyers LA, 2007, B AM MATH SOC, V44, P63; Mossong J, 2008, PLOS MED, V5, P381, DOI 10.1371/journal.pmed.0050074; Mulberry Nicola, VACCINE ROLLOUT STRA; MURPHY PJ, 1991, CAN J FOREST RES, V21, P540, DOI 10.1139/x91-075; Newman MEJ, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.026118; Newman MEJ, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.026126; Newman MEJ, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.016128; O'Grady NP, 2002, CLIN INFECT DIS, V35, P1281, DOI 10.1086/344188; Pastor-Satorras R, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.036104; Persad G, 2020, JAMA-J AM MED ASSOC, V324, P1601, DOI 10.1001/jama.2020.18513; Phillips Jennie, EXPLORING USER UPTAK; PRENTISS MARA G, 2020, SUPERSPREADING EVENT; Sahimi M., 2003, APPL PERCOLATION THE; Serrano MA, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.088701; Vassallo L, 2020, PHYS REV E, V101, DOI 10.1103/PhysRevE.101.052309; White LF, 2009, INFLUENZA OTHER RESP, V3, P267, DOI 10.1111/j.1750-2659.2009.00106.x	38	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2021	16	9							e0256889	10.1371/journal.pone.0256889	http://dx.doi.org/10.1371/journal.pone.0256889			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YS4WS	34551000	gold, Green Published			2022-12-26	WOS:000750679800008
J	Duan, JL; Li, MH; Wu, ZF; Zhang, ZW				Duan, Jialiang; Li, Minhao; Wu, Zhifeng; Zhang, Zhengwei			Total venous nature of retinal deep capillary plexus inferred by continuity of prominent middle limiting membrane sign in optical coherence tomography	PLOS ONE			English	Article							MACULOPATHY; OCCLUSION; ANGIOGRAPHY; ISCHEMIA; SPECTRUM	This study aimed to theoretically identify the vascular nature of the deep capillary plexus (DCP) by examining patients presenting with both paracentral acute middle maculopathy (PAMM) and prominent middle limiting membrane (p-MLM) sign and p-MLM sign alone in spectral-domain optical coherence tomography (SD-OCT). A retrospective review of the medical records of patients with retinal vein or artery occlusion from two tertiary medical centers was performed. Consecutive patients with a clinical diagnosis of all categories of retinal artery occlusion (RAO) and retinal vein occlusion (RVO) (branch or central and ischemic or non-ischemic) who had undergone SD-OCT imaging from January 2015 to May 2020 were recruited and their p-MLM signs and PAMM lesions were assessed. We included 118 patients who presented with p-MLM sign with or without PAMM lesions. Amon them, 40 were female and 78 were male, with a mean age of 61.1 years. Of the 109 patients with both p-MLM sign and PAMM lesions, 23 had branch RAO, two had branch RVO, 67 had central RAO, 13 had central RVO, and four had a combination of central RAO and central RVO. All nine patients with the p-MLM sign alone had central RVO accompanied by cystoid macular edema. In all the enrolled patients, the hyperreflective lines of the p-MLM sign were continuous, regardless of the type of PAMM lesions. In conclusion, when PAMM and p-MLM sign are examined together, further proof regarding the possible complete venous nature of the vasculature of the retinal DCP might be speculated.	[Duan, Jialiang; Li, Minhao] Hebei Med Univ, Dept Ophthalmol, Hosp 2, Shijiazhuang, Hebei, Peoples R China; [Wu, Zhifeng; Zhang, Zhengwei] Nantong Univ, Dept Ophthalmol, Affiliated Wuxi Clin Coll, Wuxi, Jiangsu, Peoples R China; [Wu, Zhifeng; Zhang, Zhengwei] Nanjing Med Univ, Dept Ophthalmol, Affiliated Wuxi 2 Peoples Hosp, Wuxi, Jiangsu, Peoples R China	Hebei Medical University; Nantong University; Nanjing Medical University	Zhang, ZW (corresponding author), Nantong Univ, Dept Ophthalmol, Affiliated Wuxi Clin Coll, Wuxi, Jiangsu, Peoples R China.; Zhang, ZW (corresponding author), Nanjing Med Univ, Dept Ophthalmol, Affiliated Wuxi 2 Peoples Hosp, Wuxi, Jiangsu, Peoples R China.	weir2008@ntu.edu.cn	wu, zhi/GXH-3041-2022	Zhang, Zhengwei/0000-0002-5376-8537	Top Talent Support Program for Young and MiddleAged People of the Wuxi Health Committee [HB2020030]; Development Fund of Wuxi Science and Technology [WX18IIAN019]; Natural Science Foundation of Hebei Province [H2020206063]	Top Talent Support Program for Young and MiddleAged People of the Wuxi Health Committee; Development Fund of Wuxi Science and Technology; Natural Science Foundation of Hebei Province(Natural Science Foundation of Hebei Province)	This study was supported by the Top Talent Support Program for Young and MiddleAged People of the Wuxi Health Committee (Grant No. HB2020030), Development Fund of Wuxi Science and Technology (Grant No. WX18IIAN019), and the Natural Science Foundation of Hebei Province (Grant No. H2020206063). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An D, 2020, INVEST OPHTH VIS SCI, V61, DOI 10.1167/iovs.61.10.3; Bakhoum MF, 2018, AM J OPHTHALMOL, V195, P143, DOI 10.1016/j.ajo.2018.07.031; Bernal-Morales C, 2022, EYE, V36, P219, DOI 10.1038/s41433-021-01481-6; Cabral D, 2020, INVEST OPHTH VIS SCI, V61, DOI 10.1167/iovs.61.6.44; Campbell JP, 2017, SCI REP-UK, V7, DOI 10.1038/srep42201; Chu S, 2018, INVEST OPHTH VIS SCI, V59, P2913, DOI 10.1167/iovs.18-24112; Chu YK, 2013, RETINA-J RET VIT DIS, V33, P2110, DOI 10.1097/IAE.0b013e3182899205; Falavarjani KG, 2017, AM J OPHTHALMOL, V177, P131, DOI 10.1016/j.ajo.2017.02.015; Fouquet S, 2017, INVEST OPHTH VIS SCI, V58, P5746, DOI 10.1167/iovs.17-22097; Fragiotta S, 2019, EYE, V33, P724, DOI 10.1038/s41433-018-0296-8; Freund KB, 2018, JAMA OPHTHALMOL, V136, P1262, DOI 10.1001/jamaophthalmol.2018.3586; Garrity ST, 2017, RETINA-J RET VIT DIS, V37, P1809, DOI 10.1097/IAE.0000000000001784; Grimes DR, 2016, J R SOC INTERFACE, V13, DOI 10.1098/rsif.2016.0070; Hirano T, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-27536-5; Hormel TT, 2021, PROG RETIN EYE RES, V80, DOI 10.1016/j.preteyeres.2020.100878; Mcleod D, 2019, AM J OPHTHALMOL, V205, P153, DOI 10.1016/j.ajo.2019.03.015; McLeod D, 2015, PROG RETIN EYE RES, V49, P82, DOI 10.1016/j.preteyeres.2015.06.001; Michl M, 2021, ACTA OPHTHALMOL, V99, P418, DOI 10.1111/aos.14621; Moura-Coelho N, 2020, GRAEF ARCH CLIN EXP, V258, P2583, DOI 10.1007/s00417-020-04826-1; Nesper PL, 2019, INVEST OPHTH VIS SCI, V60, P694, DOI 10.1167/iovs.18-25478; Nesper PL, 2018, INVEST OPHTH VIS SCI, V59, P3858, DOI 10.1167/iovs.18-24710; Osborne NN, 2004, PROG RETIN EYE RES, V23, P91, DOI 10.1016/j.preteyeres.2003.12.001; Park JJ, 2016, RETINA-J RET VIT DIS, V36, P2039, DOI 10.1097/IAE.0000000000001077; Phasukkijwatana N, 2016, OSLI RETINA, V47, P862, DOI 10.3928/23258160-20160901-10; Provis JM, 2001, PROG RETIN EYE RES, V20, P799, DOI 10.1016/S1350-9462(01)00012-X; Riazi-Esfahani H, 2021, INT J RETINA VITR, V7, DOI 10.1186/s40942-021-00283-y; Scharf J, 2021, PROG RETIN EYE RES, V81, DOI 10.1016/j.preteyeres.2020.100884; Yu DY, 2019, PROG RETIN EYE RES, V70, P23, DOI 10.1016/j.preteyeres.2019.01.001; Yu Dao-Yi, 1994, American Journal of Physiology, V267, pH2498; Yu SQ, 2015, AM J OPHTHALMOL, V159, P53, DOI 10.1016/j.ajo.2014.09.027	30	0	0	3	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2021	16	9							e0257698	10.1371/journal.pone.0257698	http://dx.doi.org/10.1371/journal.pone.0257698			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YM4DR	34547044	Green Published, gold			2022-12-26	WOS:000746527400036
J	Zhang, N; Zheng, CY; Sun, QW				Zhang, Ni; Zheng, Chenyang; Sun, Qingwei			Creep behavior of reinforced concrete-filled steel tubular columns under axial compression	PLOS ONE			English	Article								The reinforced concrete-filled steel tube (RCFST) column solves several of the problems of the concrete-filled steel tube (CFST) column in practical engineering applications. Moreover, RCFST has a simple joint structure, high bearing capacity, good ductility, and superior fire resistance. From a structural safety perspective, designers prioritize the creep performance of CFST members in structural design. Therefore, the creep behavior of RCFST columns should be thoroughly investigated in practical engineering design. To study the influence of the creep behavior of RCFST columns under axial compression, this work analyzed the mechanical behavior of composite columns based on their mechanical characteristics under axial compression and established a creep formula suitable for RCFST columns under axial compression. A creep analysis program was also developed to obtain the creep strain-time curve, and its correctness was verified by existing tests. On this basis, the effects of the main design parameters, such as the stress level, steel ratio, and reinforcement ratio, on the creep behavior were determined and analyzed. The creep of the tested composite columns increased rapidly in the early stages (28 days) of load action; the growth rate was relatively low after 28 days and tended to stabilize after approximately six months. The stress level had the greatest influence on the creep of RCFST columns under axial compression, followed by the steel ratio. The influence of the reinforcement ratio on the creep behavior was less. The results of this study can provide a reference for engineering practice.	[Zhang, Ni; Zheng, Chenyang; Sun, Qingwei] Liaoning Tech Univ, Sch Civil Engn, Fuxing, Peoples R China	Liaoning Technical University	Zhang, N (corresponding author), Liaoning Tech Univ, Sch Civil Engn, Fuxing, Peoples R China.	418688814@qq.com			Liaoning Provincial Department of Education Youth Science and Technology Talent Seedling Project [LJ2020QNL006]	Liaoning Provincial Department of Education Youth Science and Technology Talent Seedling Project	The work described in this paper was fully supported by the Liaoning Provincial Department of Education Youth Science and Technology Talent Seedling Project (No. LJ2020QNL006).	[Anonymous], 2003, CAN; Furlong RW., 1967, J STRUCTURAL DIVISIO, V93, P113, DOI [10.1061/JSDEAG.0001761, DOI 10.1061/JSDEAG.0001761]; [甘丹 Gan Dan], 2018, [建筑结构学报, Journal of Building Structures], V39, P96; Gao C., 2019, J BUILDING STRUCTURE, V40; [郭薇薇 Guo Weiwei], 2003, [工程力学, Engineering Mechanics], V20, P91; Guo Z, 2019, THIN WALL STRUCT, V142, P52, DOI 10.1016/j.tws.2019.04.057; HAN B, 2001, ENG MECH, V18, P111; Ichinose LH, 2001, J CONSTR STEEL RES, V57, P453, DOI 10.1016/S0143-974X(00)00021-3; Lei Y., 2005, J HARBIN I TECHNOLOG, V37, P507; Li X., 2019, CREEP BEHAV AXIALLY; Liu JP, 2010, J CONSTR STEEL RES, V66, P28, DOI 10.1016/j.jcsr.2009.08.006; Mao R., 1988, P 2 INT SPEC C CONCR; Naguib W, 2003, J CONSTR STEEL RES, V59, P1327, DOI 10.1016/S0143-974X(03)00085-3; Neville A.M., 1983, CONSTRUCTION PR; Qu L., 2019, LONG TERM BEH AX LOA; TERREY PJ, 1994, TUBULAR STRUCTURES VI, P293; Uy B, 2001, ACI STRUCT J, V98, P96; WANG YF, 2000, CHINA J HIGHWAY TRAN, V13, P57; Yang DD, 2021, STRUCTURES, V29, P1286, DOI 10.1016/j.istruc.2020.12.014; Ye Y, 2020, J SHENYANG JIANZHU U, V36, P604; Zhang X, 2009, J BUILDING STRUCTU S, V37, P27; [张小冬 Zhang Xiaodong], 2011, [建筑结构, Building Structure], V41, P49; Zhong S, 1987, J HARBIN I ARCHITECT, P1; [周绪红 Zhou Xuhong], 2018, [建筑结构学报, Journal of Building Structures], V39, P11; 韩冰, 1999, 铁道学报, V21, P87	25	0	0	12	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2021	16	9							e0255603	10.1371/journal.pone.0255603	http://dx.doi.org/10.1371/journal.pone.0255603			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	WG6BN	34543296	gold, Green Published			2022-12-26	WOS:000707078200008
J	Ahmed, F; Oni, FA; Hossen, SS				Ahmed, Firoz; Oni, Fahmida Akter; Hossen, Sk Sharafat			Does gender inequality matter for access to and utilization of maternal healthcare services in Bangladesh?	PLOS ONE			English	Article							INTIMATE PARTNER VIOLENCE; SKILLED BIRTH ATTENDANCE; ANTENATAL CARE; WOMENS EMPOWERMENT; AUTONOMY; STRATEGIES; PREGNANCY; NEPAL	There is a high prevalence of gender gap in Bangladesh which might affect women's likelihood to receive maternal healthcare services. In this backdrop, we aim to investigate how gender inequality measured by intrahousehold bargaining power (or autonomy) of women and their attitudes towards intimate partner violence (IPV) affects accessing and utilizing maternal health care services. We used Bangladesh Demographic and Health Survey (BDHS) data of 2014 covering 5460 women who gave birth at least one child in the last three years preceding the survey. We performed logistic regression to estimate the effect of women's autonomy and their attitude towards IPV on access to and utilization of maternal healthcare services. Besides, we employed different channels to understand the heterogeneous effect of gender inequality on access to maternal healthcare services. We observed that women having autonomy positively influenced attaining five required antenatal care (ANC) services (AOR: 1.17; 95% CI: 0.98-1.41) and women's negative attitudes towards IPV were positively associated with five ANC services (AOR: 1.42; 95% CI: 1.02-1.97), sufficient ANC visits (COR: 1.55; CI: 1.19-2.01), skilled birth attendant (SBA) (AOR: 1.43; 95% CI: 1.05-1.94) and postnatal care (PNC) services (AOR: 1.44; 95% CI: 1.12-1.84). Besides, rural residency, religion, household wealth, education of both women and husband were found to have some of the important channels which were making stronger effect of gender inequality on access to maternal healthcare services. The findings of our study indicate a significant association between access to maternal healthcare services and women's autonomy as well as attitude towards IPV in Bangladesh. We, therefore, recommend to protect women from violence at home and mprove their intrahousehold bargaining power to increase their access to and utilization of required maternal healthcare services.	[Ahmed, Firoz; Oni, Fahmida Akter; Hossen, Sk Sharafat] Khulna Univ, Social Sci Sch, Econ Discipline, Khulna, Bangladesh	Khulna University	Ahmed, F (corresponding author), Khulna Univ, Social Sci Sch, Econ Discipline, Khulna, Bangladesh.	firoz.ahmed@econ.ku.ac.bd	Oni, Fahmida Akter/HCI-0931-2022; Ahmed, Firoz/F-9760-2014	Oni, Fahmida/0000-0001-8580-4080; Ahmed, Firoz/0000-0003-4978-3993				Acharya DR, 2010, REPROD HEALTH, V7, DOI 10.1186/1742-4755-7-15; Adegoke AA, 2009, BJOG-INT J OBSTET GY, V116, P33, DOI 10.1111/j.1471-0528.2009.02336.x; Adjiwanou V, 2014, HEALTH PLACE, V29, P67, DOI 10.1016/j.healthplace.2014.06.001; Alkema L, 2019, TRENDS MATERNAL MORT; Amin A, 2015, J INT AIDS SOC, V18, P4, DOI 10.7448/IAS.18.6.20302; [Anonymous], 1999, DEV FREEDOM; Ashraf N, 2014, AM ECON REV, V104, P2210, DOI 10.1257/aer.104.7.2210; Austin A, 2015, INT J WOMENS HEALTH, V7, P345, DOI 10.2147/IJWH.S79573; Banda PC, 2017, WOMEN HEALTH, V57, P405, DOI 10.1080/03630242.2016.1170092; Bangladesh Bureau of Statistics, 2016, REP VIOL WOM VAW SUR; Banik BK, 2017, J HEALTH MANAG, V19, P523, DOI 10.1177/0972063417727614; Bengesai AV, 2021, CULT HEALTH SEX, V23, P927, DOI 10.1080/13691058.2020.1743880; Bhalotra S, 2011, J PUBLIC ECON, V95, P286, DOI 10.1016/j.jpubeco.2010.10.016; Bhowmik J, 2019, PUBLIC HEALTH, V170, P113, DOI 10.1016/j.puhe.2019.02.027; Biswas RK, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187884; Bloom SS, 2001, DEMOGRAPHY, V38, P67, DOI 10.1353/dem.2001.0001; Bullough C, 2005, BJOG-INT J OBSTET GY, V112, P1180, DOI 10.1111/j.1471-0528.2005.00718.x; Campbell JC, 2002, LANCET, V359, P1331, DOI 10.1016/S0140-6736(02)08336-8; Campbell OMR, 2006, LANCET, V368, P1284, DOI 10.1016/S0140-6736(06)69381-1; Chandrasekhar S, 2011, POPUL RES POLICY REV, V30, P25, DOI 10.1007/s11113-010-9175-0; Chola M., INT J POPULATION RES, V2016, P1; Field E, 2010, AM ECON REV, V100, P125, DOI 10.1257/aer.100.2.125; Gage AJ, 2007, SOC SCI MED, V65, P1666, DOI 10.1016/j.socscimed.2007.06.001; Garcia-Moreno C, 2006, LANCET, V368, P1260, DOI 10.1016/S0140-6736(06)69523-8; Islam MA, 2019, J BIOMOL STRUCT DYN, V37, P4104, DOI 10.1080/07391102.2018.1544509; Islam TM, 2015, J FAM VIOLENCE, V30, P433, DOI 10.1007/s10896-015-9683-0; Joshi S, 2013, DEMOGRAPHY, V50, P149, DOI 10.1007/s13524-012-0172-2; Kifle D, 2017, REPROD HEALTH, V14, DOI 10.1186/s12978-016-0270-5; Kitui J, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-40; Klomegah RY, 2008, J COMP FAM STUD, V39, P557, DOI 10.3138/jcfs.39.4.557; Klugman J., 2014, VOICE AGENCY EMPOWER; Mai V, 2020, J HEALTH RES, V34, P100, DOI 10.1108/JHR-03-2019-0046; Ministry of Health and Family Welfare (MOHFW), 2019, HLTH POP NUTR ETOOLK; Mishra PS, 2021, CLIN EPIDEMIOL GLOB, V11, DOI 10.1016/j.cegh.2021.100744; Namasivayam A, 2012, INT J WOMENS HEALTH, V4, P351, DOI 10.2147/IJWH.S32569; National Institute of Population Research and Training Mitra and Associates ICF International, 2015, BANGL DEM HLTH SURV; Naved RT., 2017, UNDERSTANDING INTIMA; Neupane S, 2012, J COMMUN HEALTH, V37, P865, DOI 10.1007/s10900-011-9521-0; NIPORT Mitra and Associates ICF International and ICBBRB, 2012, BANGL MAT MORT HLTH; Ochako R, 2011, BMC PREGNANCY CHILDB, V11, DOI 10.1186/1471-2393-11-1; Ononokpono D.N., 2014, PAN AFR MED J, V17 Suppl 1, P2, DOI [10.11694/pamj.supp.2014.17.1.3596, DOI 10.11694/PAMJ.SUPP.2014.17.1.3596, https://doi.org/10.11694/pamj.supp.2014.17.1.3596]; Pallikadavath S, 2004, SOC SCI MED, V59, P1147, DOI 10.1016/j.socscimed.2003.11.045; Rahman M, 2011, J FAM VIOLENCE, V26, P411, DOI 10.1007/s10896-011-9375-3; Rahman M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082423; Ridgeway CL, 2004, J SOC ISSUES, V60, P683, DOI 10.1111/j.0022-4537.2004.00380.x; Sado L, 2014, SOC SCI MED, V114, P169, DOI 10.1016/j.socscimed.2014.05.047; Schuler SR, 2018, WORLD DEV, V101, P284, DOI 10.1016/j.worlddev.2017.09.005; Shahabuddin ASM, 2015, TROP MED INT HEALTH, V20, P822, DOI 10.1111/tmi.12503; Shimamoto K, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0591-3; Silverman JG, 2007, BJOG-INT J OBSTET GY, V114, P1246, DOI 10.1111/j.1471-0528.2007.01481.x; Simkhada B, 2008, J ADV NURS, V61, P244, DOI 10.1111/j.1365-2648.2007.04532.x; Singh Kavita, 2012, Afr J Reprod Health, V16, P123; Subramanian SV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018962; Tenkorang EY, 2018, INT PERSPECT SEX R H, V44, P51, DOI 10.1363/44e6118; Vrana-Diaz CJ., 2019, GLOB SOC WELFARE, P1, DOI [10.1007/s40609-019-00144-5, DOI 10.1007/S40609-019-00144-5]; Wado YD, 2018, WOMEN HEALTH, V58, P729, DOI 10.1080/03630242.2017.1353573; WHO, 2016, WHO TECH REP SER, V997, P1; World Health Organisation, 2015, MDG 5 IMPR MAT HLTH; World Health Organization, 2009, WOMEN AND HEALTH: TODAY'S EVIDENCE TOMORROW'S AGENDA, P1	59	1	1	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2021	16	9							e0257388	10.1371/journal.pone.0257388	http://dx.doi.org/10.1371/journal.pone.0257388			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	WG5YY	34529701	Green Published, gold			2022-12-26	WOS:000707071500052
J	Nakano, M; Sabido-Bozo, S; Okazaki, K; Aguilera-Romero, A; Rodriguez-Gallardo, S; Cortes-Gomez, A; Lopez, S; Ikeda, A; Funato, K; Muniz, M				Nakano, Miyako; Sabido-Bozo, Susana; Okazaki, Kouta; Aguilera-Romero, Auxiliadora; Rodriguez-Gallardo, Sofia; Cortes-Gomez, Alejandro; Lopez, Sergio; Ikeda, Atsuko; Funato, Kouichi; Muniz, Manuel			Structural analysis of the GPI glycan	PLOS ONE			English	Article							ANCHORED PROTEINS; BIOSYNTHESIS; TRANSPORT	Glycosylphosphatidylinositol (GPI) anchoring of proteins is an essential post-translational modification in all eukaryotes that occurs at the endoplasmic reticulum (ER) and serves to deliver GPI-anchored proteins (GPI-APs) to the cell surface where they play a wide variety of vital physiological roles. This paper describes a specialized method for purification and structural analysis of the GPI glycan of individual GPI-APs in yeast. The protocol involves the expression of a specific GPI-AP tagged with GFP, enzymatic release from the cellular membrane fraction, immunopurification, separation by electrophoresis and analysis of the peptides bearing GPI glycans by mass spectrometry after trypsin digestion. We used specifically this protocol to address the structural remodeling that undergoes the GPI glycan of a specific GPI-AP during its transport to the cell surface. This method can be also applied to investigate the GPI-AP biosynthetic pathway and to directly confirm predicted GPI-anchoring of individual proteins.	[Nakano, Miyako; Okazaki, Kouta; Ikeda, Atsuko; Funato, Kouichi] Hiroshima Univ, Grad Sch Integrated Sci Life, Higashihiroshima, Hiroshima, Japan; [Sabido-Bozo, Susana; Aguilera-Romero, Auxiliadora; Rodriguez-Gallardo, Sofia; Cortes-Gomez, Alejandro; Lopez, Sergio; Muniz, Manuel] Univ Seville, Hosp Univ Virgen Rocio, Fac Biol, Dept Biol Celular,CSIC, Seville, Spain; [Sabido-Bozo, Susana; Aguilera-Romero, Auxiliadora; Rodriguez-Gallardo, Sofia; Cortes-Gomez, Alejandro; Lopez, Sergio; Muniz, Manuel] Inst Biomed Sevilla IBiS, Seville, Spain	Hiroshima University; Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; Virgen del Rocio University Hospital; Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS)	Nakano, M; Funato, K (corresponding author), Hiroshima Univ, Grad Sch Integrated Sci Life, Higashihiroshima, Hiroshima, Japan.; Muniz, M (corresponding author), Univ Seville, Hosp Univ Virgen Rocio, Fac Biol, Dept Biol Celular,CSIC, Seville, Spain.; Muniz, M (corresponding author), Inst Biomed Sevilla IBiS, Seville, Spain.	minakano@hiroshima-u.ac.jp; kfunato@hiroshima-u.ac.jp; mmuniz@us.es	muñiz, manuel/Q-2890-2019; Lopez, Sergio/G-3300-2016; Rodriguez-Gallardo, Sofia/AAR-1613-2021	muñiz, manuel/0000-0001-8011-6991; Lopez, Sergio/0000-0001-5952-3568; Rodriguez-Gallardo, Sofia/0000-0002-5189-5671; Ikeda, Atsuko/0000-0002-4710-5112	FEDER/Ministerio de Ciencia, Innovacion y Universidades - Agencia Estatal de Investigacion [BFU2017-89700-P]; Japan Society for the Promotion of Science [JP19H02922]	FEDER/Ministerio de Ciencia, Innovacion y Universidades - Agencia Estatal de Investigacion; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	MM. BFU2017-89700-P. FEDER/Ministerio de Ciencia, Innovacion y Universidades - Agencia Estatal de Investigacion. http://www.aei.gob.es/.MN and KF. JP19H02922. Japan Society for the Promotion of Science. https://www.jsps.go.jp/english/.The funders had and will not have a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benachour A, 1999, J BIOL CHEM, V274, P15251, DOI 10.1074/jbc.274.21.15251; Bhunchoth A, 2016, VIROLOGY, V494, P56, DOI 10.1016/j.virol.2016.03.028; Eisenhaber B, 1999, J MOL BIOL, V292, P741, DOI 10.1006/jmbi.1999.3069; Fujita M, 2009, CELL, V139, P352, DOI 10.1016/j.cell.2009.08.040; Kinoshita T, 2016, J LIPID RES, V57, P6, DOI 10.1194/jlr.R063313; Lebreton S, 2018, CRIT REV BIOCHEM MOL, V53, P403, DOI 10.1080/10409238.2018.1485627; Lehto MT, 2002, BIOCHEMISTRY-US, V41, P1398, DOI 10.1021/bi011579w; Manzano-Lopez J, 2015, CURR BIOL, V25, P152, DOI 10.1016/j.cub.2014.11.039; Muniz M, 2016, J LIPID RES, V57, P352, DOI 10.1194/jlr.R062760; Pittet M, 2007, BBA-MOL CELL BIOL L, V1771, P405, DOI 10.1016/j.bbalip.2006.05.015; Popolo L, 1999, BBA-GEN SUBJECTS, V1426, P385, DOI 10.1016/S0304-4165(98)00138-X; Rodriguez-Gallardo S, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aba8237; Takahashi S, 2016, GLYCOCONJUGATE J, V33, P471, DOI 10.1007/s10719-016-9653-7; Vazquez HM, 2014, MOL BIOL CELL, V25, P3375, DOI 10.1091/mbc.E14-06-1033	14	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2021	16	9							e0257435	10.1371/journal.pone.0257435	http://dx.doi.org/10.1371/journal.pone.0257435			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	WG5YY	34529709	Green Published, gold			2022-12-26	WOS:000707071500057
J	Takahashi, S; Takada, S; Yamanaka, H; Masuda, R; Kasai, A				Takahashi, Sayaka; Takada, Shingo; Yamanaka, Hiroki; Masuda, Reiji; Kasai, Akihide			Intraspecific genetic variability and diurnal activity affect environmental DNA detection in Japanese eel	PLOS ONE			English	Article							COMMON CARP; SURVEY TOOL; ABUNDANCE; EDNA; MIGRATION; SEQUENCE; REVEALS; BIOMASS	Environmental DNA (eDNA) analysis with species-specific primer/probe sets is promising as a tool to quantify fish abundance and distribution. Nevertheless, several factors could reduce the accuracy of this method. Here, we aimed to analyze whether intraspecific variability and diel activity rhythm affect eDNA detection in Japanese eels (Anguilla japonica). For this purpose, we performed tank experiments focusing on two points. First, we assessed the effects of base pair sequences with probe region polymorphism on eDNA detection. Next, we evaluated the influences of diel rhythm, activity, and individual differences in eDNA release rate on eDNA concentration. We examined the base pair sequences of the probe regions of 20 individuals and found genetic mismatches in two of them. The eDNA concentration was estimated to be much lower in these variants than it was in the other individuals. We conducted a rearing experiment on four non-variant individuals to explore the influences of diel activity and inter-individual differences in eDNA detection. Nocturnal eel activity was reflected in the eDNA detection but the inter-individual differences remained large. The observed weak positive correlations between eDNA concentration and activity suggest that eDNA emission is highly dependent on basal metabolism. The present study suggests that consideration of polymorphic sites at the probe region and diel activity rhythms should improve the accuracy and precision of abundance estimation through eDNA. Such fine-tuning is applicable not only for eels but also for other fishes to be targeted by eDNA technology.	[Takahashi, Sayaka] Oita Jr Coll, Oita, Japan; [Takahashi, Sayaka] Shimane Univ, Fac Life & Environm Sci, Matsue, Shimane, Japan; [Takahashi, Sayaka; Masuda, Reiji] Kyoto Univ, Maizuru Fisheries Res Stn, Maizuru, Kyoto, Japan; [Takada, Shingo] Hokkaido Univ, Grad Sch Fisheries Sci, Div Marine Bioresource & Environm Sci, Hakodate, Hokkaido, Japan; [Yamanaka, Hiroki] Ryukoku Univ, Fac Adv Sci & Technol, Ecol & Environm Engn Course, Otsu, Shiga, Japan; [Yamanaka, Hiroki] Ryukoku Univ, Ctr Biodivers Sci, Otsu, Shiga, Japan; [Kasai, Akihide] Hokkaido Univ, Fac Fisheries Sci, Div Marine Bioresource & Environm Sci, Hakodate, Hokkaido, Japan	Shimane University; Kyoto University; Hokkaido University; Ryukoku University; Ryukoku University; Hokkaido University	Takahashi, S (corresponding author), Oita Jr Coll, Oita, Japan.; Takahashi, S (corresponding author), Shimane Univ, Fac Life & Environm Sci, Matsue, Shimane, Japan.; Takahashi, S (corresponding author), Kyoto Univ, Maizuru Fisheries Res Stn, Maizuru, Kyoto, Japan.	takahashi.sayaka.k35@kyoto-u.jp		Takahashi, Sayaka/0000-0001-5752-3687	CREST program of the Japan Science and Technology Agency [JPMJCR13A2]; JSPS KAKENHI [19H05641]	CREST program of the Japan Science and Technology Agency(Core Research for Evolutional Science and Technology (CREST)); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the CREST program of the Japan Science and Technology Agency (Grant No. JPMJCR13A2), JSPS KAKENHI (Grant No. 17H01412), and JSPS KAKENHI (Grant No. 19H05641). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoyama J, 2005, J FISH BIOL, V67, P1534, DOI 10.1111/j.1095-8649.2005.00860.x; Arya M, 2005, EXPERT REV MOL DIAGN, V5, P209, DOI 10.1586/14737159.5.2.209; Barnes MA, 2016, CONSERV GENET, V17, P1, DOI 10.1007/s10592-015-0775-4; Bergman PS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153500; Bohmann K, 2014, TRENDS ECOL EVOL, V29, P358, DOI 10.1016/j.tree.2014.04.003; Bylemans J, 2017, METHODS ECOL EVOL, V8, P646, DOI 10.1111/2041-210X.12709; Doi H, 2017, FRESHWATER BIOL, V62, P30, DOI 10.1111/fwb.12846; Dou S, 2003, J FISH BIOL, V63, P152, DOI 10.1111/j.1095-8649.2003.00211.x; Dou SZ, 2003, ENVIRON BIOL FISH, V67, P389, DOI 10.1023/A:1025894010739; Eichmiller JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112611; Ficetola GF, 2008, BIOL LETTERS, V4, P423, DOI 10.1098/rsbl.2008.0118; Ghosal R, 2018, ECOL EVOL, V8, P6714, DOI 10.1002/ece3.4169; Gollock M., 2014, IUCN RED LIST THREAT, DOI [10.2305/IUCN.UK.2014-1.RLTS.T166184A1117791.en, DOI 10.2305/IUCN.UK.2014-1.RLTS.T166184A1117791.EN]; Herrero B, 2010, J AGR FOOD CHEM, V58, P4794, DOI 10.1021/jf904018h; Horiuchi T, 2019, J FISH BIOL, V95, P979, DOI 10.1111/jfb.14095; Itakura H, 2019, AQUAT CONSERV, V29, P361, DOI 10.1002/aqc.3058; Kasai A, 2021, FRONT ECOL EVOL, V9, DOI 10.3389/fevo.2021.621461; Kasai A, 2020, FISHERIES SCI, V86, P465, DOI 10.1007/s12562-020-01409-1; Kelly RP, 2014, SCIENCE, V344, P1455, DOI 10.1126/science.1251156; Kelly RP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086175; KIMURA S, 1994, MAR BIOL, V119, P185, DOI 10.1007/BF00349555; Klobucar SL, 2017, CAN J FISH AQUAT SCI, V74, P2030, DOI 10.1139/cjfas-2017-0114; Kutyavin IV, 2000, NUCLEIC ACIDS RES, V28, P655, DOI 10.1093/nar/28.2.655; Maruyama A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114639; Minamoto T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173073; Pilliod DS, 2014, MOL ECOL RESOUR, V14, P109, DOI 10.1111/1755-0998.12159; Pilliod DS, 2013, CAN J FISH AQUAT SCI, V70, P1123, DOI 10.1139/cjfas-2013-0047; R Development Core Team, 2020, R STAT SOFTW VERS 3; Rees HC, 2014, J APPL ECOL, V51, P1450, DOI 10.1111/1365-2664.12306; Roussel JM, 2015, J APPL ECOL, V52, P823, DOI 10.1111/1365-2664.12428; Ruijter JM, 2014, MICROCHIM ACTA, V181, P1689, DOI 10.1007/s00604-013-1155-8; Spear SF, 2015, BIOL CONSERV, V183, P38, DOI 10.1016/j.biocon.2014.11.016; Takahara T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035868; Takahashi MK, 2018, J WILDLIFE MANAGE, V82, P217, DOI 10.1002/jwmg.21349; Takahashi S, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0231718; Takeuchi A, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-44402-0; Takeuchi A, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-42641-9; Takeuchi A, 2019, MAR ECOL PROG SER, V609, P187, DOI 10.3354/meps12828; Tesch F.-W., 2003, EEL BIOL MANAGEMENT; Thalinger B, 2021, FRONT ECOL EVOL, V9, DOI 10.3389/fevo.2021.623718; The eDNA Society,, 2019, ENV DNA SAMPL EXP MA; Thomsen PF, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165252; Thomsen PF, 2012, MOL ECOL, V21, P2565, DOI 10.1111/j.1365-294X.2011.05418.x; Tsukamoto K, 2006, NATURE, V439, P929, DOI 10.1038/439929a; Tsukamoto K, 1998, NATURE, V396, P635, DOI 10.1038/25264; Tsukamoto Katsumi, 2009, P21; Uchii K, 2017, ECOL EVOL, V7, P8515, DOI 10.1002/ece3.3346; Wilcox TM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059520; Yamamoto S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149786; Yao Y, 2006, MOL CELL PROBE, V20, P311, DOI 10.1016/j.mcp.2006.03.003; Yates MC, 2021, MOL ECOL, V30, P3068, DOI 10.1111/mec.15543; Yoshitake K, 2019, MAR BIOTECHNOL, V21, P813, DOI 10.1007/s10126-019-09926-6	52	2	2	3	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2021	16	9							e0255576	10.1371/journal.pone.0255576	http://dx.doi.org/10.1371/journal.pone.0255576			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	WG5YY	34529685	Green Published, gold			2022-12-26	WOS:000707071500008
J	Baatiema, L; Tanle, A; Darteh, EKM; Ameyaw, EK				Baatiema, Linus; Tanle, Augustine; Maafo Darteh, Eugene Kofuor; Kwabena Ameyaw, Edward			Is quality maternal healthcare all about successful childbirth? Views of mothers in the Wa Municipality, Ghana	PLOS ONE			English	Article							MORTALITY; RESPONSIVENESS	Introduction In spite of the countless initiatives of the Ghana government to improve the quality of maternal healthcare, Upper West Region still records poor childbirth outcomes. This study, therefore, explored women's perception of the quality of maternal healthcare they receive in the Wa Municipality of the Upper West Region of Ghana. Materials and methods This is a qualitative cross-sectional study of 62 women who accessed maternal healthcare in the Wa Municipality of Ghana. We analysed the transcripts using the analytic inductive technique. An inter-coding technique (testing for inter-coding agreement) was employed. The iterative coding process resulted in a coding scheme with four main themes. We used peer-debriefing technique in ensuring credibility and trustworthiness. Results Logistics and equipment; referral service; empathic service delivery; inadequacy of care providers; affordability of service; satisfaction with services received; as well as experience and service delivery were the parameters used by the women in assessing quality maternity care. A number of gaps were reported in the healthcare system including limited healthcare providers, limited beds and inefficient referral system. Conversely, some of them reported that some healthcare providers offered empathetic healthcare. Contrary views were expressed with respect to satisfaction with maternity care. Conclusion Government and all stakeholders seeking to enhance quality of maternal health and accelerate the attainment of the third Sustainable Development Goal need to reconsider the financing of service delivery at health institutions. Indeed, our findings have illustrated that routine workshops on empathetic healthcare are required in efforts to increase the rate of facility-based childbirth, and thereby subside maternal mortality and all adverse pregnancy outcomes.	[Baatiema, Linus] Upper West Reg Hlth Directorate, Ghana Hlth Serv, Wa, Ghana; [Tanle, Augustine; Maafo Darteh, Eugene Kofuor] Univ Cape Coast, Coll Humanities & Legal Studies, Dept Populat & Hlth, Cape Coast, Ghana; [Kwabena Ameyaw, Edward] Univ Technol Sydney, Fac Hlth, Australian Ctr Publ & Populat Hlth Res, Sydney, NSW, Australia	University of Cape Coast; University of Technology Sydney	Baatiema, L (corresponding author), Upper West Reg Hlth Directorate, Ghana Hlth Serv, Wa, Ghana.	baatiemalinus@gmail.com	Darteh, Eugene Kofuor Maafo/H-1670-2015	Darteh, Eugene Kofuor Maafo/0000-0003-4689-8891; Ameyaw, Edward Kwabena/0000-0002-6617-237X				Afari H, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005052; Agbanyo R, 2020, AFR DEV REV, V32, P27, DOI 10.1111/1467-8268.12412; Andoh-Adjei FX, 2018, BMC FAM PRACT, V19, DOI 10.1186/s12875-018-0727-4; [Anonymous], 2016, ANN REP ACCR; Ansong-Tornui Janet, 2007, Ghana Med J, V41, P125; Apanga PA, 2017, J HEALTH CARE POOR U, V28, P1056, DOI 10.1353/hpu.2017.0097; Atinga RA, 2011, INT J HEALTH CARE Q, V24, P548, DOI 10.1108/09526861111160580; Beyai PL., 2013, IMPLEMENTATION MDG A; Bosu Wk, 2007, Ghana Med J, V41, P118; Bowling A., 2014, RES METHODS HLTH INV, Vfourth; Browne JL, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-008175; D'Ambruoso L, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-140; DEYO RA, 1991, CONTROL CLIN TRIALS, V12, pS142, DOI 10.1016/S0197-2456(05)80019-4; Donabedian A., 1985, J HEALTHCARE QUAL, V7, P15; Duysburgh E, 2014, BJOG-INT J OBSTET GY, V121, P117, DOI 10.1111/1471-0528.12905; Eebolawala BV, 2018, THESIS U GHANA GHANA; Escribano-Ferrer Blanca, 2016, Ghana Med J, V50, P238, DOI 10.4314/gmj.v50i4.7; Ganle JK, 2015, BMC INT HEALTH HUM R, V15, DOI 10.1186/s12914-015-0048-9; Ghana Statistical Service (GSS) Ghana Health Service (GHS) and ICF, 2018, GHAN MAT HLTH SURV 2; GSS, 2010, POPULATION HOUSING C; Hsieh HF, 2005, QUAL HEALTH RES, V15, P1277, DOI 10.1177/1049732305276687; ICHHEISER G, 1966, PHILOS PHENOMEN RES, V26, P546, DOI 10.2307/2106220; Karkee R, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-45; Kelley K, 2003, INT J QUAL HEALTH C, V15, P261, DOI 10.1093/intqhc/mzg031; Kwamie A, 2014, HEALTH RES POLICY SY, V12, DOI 10.1186/1478-4505-12-29; Lambert J, 2018, MIDWIFERY, V62, P256, DOI 10.1016/j.midw.2018.04.007; Lassi ZS., 2019, F1000RESEARCH, V8, DOI [10.12688/f1000research.17047.1, DOI 10.12688/F1000RESEARCH.17047.1]; Mays N., 2018, SOCIOLOGY APPL HLTH, P377; Merriam S. B., 2009, QUALITATIVE RES GUID; Merton R. K., 1957, SOCIAL THEORY SOCIAL; Nations United., 2015, MILLENNIUM DEV GOALS; Nesbitt RC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081089; Norhayati MN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130452; Ojelade OA, 2017, INT J GYNECOL OBSTET, V139, P27, DOI 10.1002/ijgo.12380; Parsons T., 1951, SOCIAL SYSTEM; Parsons T, 1937, STRUCTURE SOCIAL ACT, V1; Patton M.Q., 2002, QUAL SOC WORK, V1, P261, DOI [10.1177/1473325002001003636, DOI 10.1177/1473325002001003636]; Prata N, 2010, WOMENS HEALTH, V6, P311, DOI 10.2217/WHE.10.8; Souza JP, 2013, LANCET, V381, P1747, DOI 10.1016/S0140-6736(13)60686-8; Terwee CB, 2003, QUAL LIFE RES, V12, P349, DOI 10.1023/A:1023499322593; THADDEUS S, 1994, SOC SCI MED, V38, P1091, DOI 10.1016/0277-9536(94)90226-7; Tuyisenge G, 2015, MOTHERSPERCEPTIONS E; United Nations, 2015, SUSTAINABLE DEV GOAL, DOI DOI 10.1163/157180910X12665776638740; Wa Municipal Health Directorate, 2016, ANN PERF REP; Weiser TG, 2015, ESSENTIAL SURG DIS C, V1	45	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2021	16	9							e0257401	10.1371/journal.pone.0257401	http://dx.doi.org/10.1371/journal.pone.0257401			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	WG6DR	34525128	gold, Green Published			2022-12-26	WOS:000707084400034
J	Whitney, NM; Lear, KO; Morris, JJ; Hueter, RE; Carlson, JK; Marshall, HM				Whitney, Nicholas M.; Lear, Karissa O.; Morris, John J.; Hueter, Robert E.; Carlson, John K.; Marshall, Heather M.			Connecting post-release mortality to the physiological stress response of large coastal sharks in a commercial longline fishery	PLOS ONE			English	Article							AT-VESSEL MORTALITY; FISHING MORTALITY; PELAGIC SHARKS; PRIONACE-GLAUCA; CAPTURE STRESS; J-HOOKS; SURVIVAL; CAUGHT; BEHAVIOR; RELEASE	Bycatch mortality is a major factor contributing to shark population declines. Post-release mortality (PRM) is particularly difficult to quantify, limiting the accuracy of stock assessments. We paired blood-stress physiology with animal-borne accelerometers to quantify PRM rates of sharks caught in a commercial bottom longline fishery. Blood was sampled from the same individuals that were tagged, providing direct correlation between stress physiology and animal fate for sandbar (Carcharhinus plumbeus, N = 130), blacktip (C. limbatus, N = 105), tiger (Galeocerdo cuvier, N = 52), spinner (C. brevipinna, N = 14), and bull sharks (C. leucas, N = 14). PRM rates ranged from 2% and 3% PRM in tiger and sandbar sharks to 42% and 71% PRM in blacktip and spinner sharks, respectively. Decision trees based on blood values predicted mortality with >67% accuracy in blacktip and spinner sharks, and >99% accuracy in sandbar sharks. Ninety percent of PRM occurred within 5 h after release and 59% within 2 h. Blood physiology indicated that PRM was primarily associated with acidosis and increases in plasma potassium levels. Total fishing mortality reached 62% for blacktip and 89% for spinner sharks, which may be under-estimates given that some soak times were shortened to focus on PRM. Our findings suggest that no-take regulations may be beneficial for sandbar, tiger, and bull sharks, but less effective for more susceptible species such as blacktip and spinner sharks.	[Whitney, Nicholas M.] Anderson Cabot Ctr Ocean Life, New England Aquarium, Boston, MA 02110 USA; [Lear, Karissa O.] Murdoch Univ, Ctr Sustainable Aquat Ecosyst, Harry Butler Inst, Murdoch, WA, Australia; [Morris, John J.; Hueter, Robert E.; Marshall, Heather M.] Ctr Shark Res, Mote Marine Lab, Sarasota, FL USA; [Hueter, Robert E.] OCEARCH, Park City, UT USA; [Carlson, John K.] Natl Ocean & Atmospher Adm, Southeast Fisheries Sci Ctr, Panama City, FL USA; [Marshall, Heather M.] State Coll Florida, Bradenton, FL USA	Murdoch University; Mote Marine Laboratory & Aquarium; National Oceanic Atmospheric Admin (NOAA) - USA	Whitney, NM (corresponding author), Anderson Cabot Ctr Ocean Life, New England Aquarium, Boston, MA 02110 USA.	nwhitney@neaq.org		Whitney, Nicholas/0000-0001-8797-6927	NOAA Cooperative Research Program [NA13NMF4540056, NA15NMF4540102]; NOAA Bycatch Reduction and Engineering program [NA14NMF4720320]	NOAA Cooperative Research Program; NOAA Bycatch Reduction and Engineering program	This project was funded by grants to NMW, JJM, and REH from NOAA Cooperative Research Program (https://www.fisheries.noaa.gov/grant/cooperative-research-program) grants NA13NMF4540056, NA15NMF4540102 and NOAA Bycatch Reduction and Engineering program (https://www.fisheries.noaa.gov/national/bycatch/bycatch-reduction-engineering-program) grant NA14NMF4720320. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afonso AS, 2014, J EXP MAR BIOL ECOL, V454, P55, DOI 10.1016/j.jembe.2014.02.008; Aronson PS, 2011, J AM SOC NEPHROL, V22, P1981, DOI 10.1681/ASN.2011040414; Barnes CJ, 2016, ENDANGER SPECIES RES, V30, P193, DOI 10.3354/esr00730; Bouyoucos IA, 2018, CONSERV PHYSIOL, V6, DOI 10.1093/conphys/coy074; Bouyoucos IA, 2017, COMP BIOCHEM PHYS A, V207, P65, DOI 10.1016/j.cbpa.2017.02.023; Brooks EJ, 2012, COMP BIOCHEM PHYS A, V162, P94, DOI 10.1016/j.cbpa.2011.04.012; Butcher PA, 2015, GLOB ECOL CONSERV, V3, P878, DOI 10.1016/j.gecco.2015.04.012; Campana SE, 2016, ICES J MAR SCI, V73, P520, DOI 10.1093/icesjms/fsv234; Campana SE, 2009, MAR ECOL PROG SER, V396, P161, DOI 10.3354/meps08433; Claiborne JB, 2002, J EXP ZOOL, V293, P302, DOI 10.1002/jez.10125; Cooke SJ, 2005, BIODIVERS CONSERV, V14, P1195, DOI 10.1007/s10531-004-7845-0; Cortes E, 2004, CRC MAR BIOL SER, P449; Cortes E, 1999, ICES J MAR SCI, V56, P707, DOI 10.1006/jmsc.1999.0489; Danylchuk AJ, 2014, CONSERV PHYSIOL, V2, DOI 10.1093/conphys/cot036; Dapp DR, 2016, FRONT MAR SCI, V2, DOI 10.3389/fmars.2015.00126; Dapp DR, 2016, FISH FISH, V17, P507, DOI 10.1111/faf.12124; Dulvy NK, 2014, ELIFE, V3, DOI 10.7554/eLife.00590; Eddy C, 2016, FISH RES, V174, P109, DOI 10.1016/j.fishres.2015.09.008; Ellis JR, 2017, J FISH BIOL, V90, P653, DOI 10.1111/jfb.13197; French RP, 2015, CONSERV PHYSIOL, V3, DOI 10.1093/conphys/cov044; Frick LH, 2012, COMP BIOCHEM PHYS A, V162, P88, DOI 10.1016/j.cbpa.2011.02.023; Frick LH, 2010, J EXP MAR BIOL ECOL, V385, P29, DOI 10.1016/j.jembe.2010.01.013; Gallagher AJ, 2014, MAR ECOL PROG SER, V496, P207, DOI 10.3354/meps10490; Gallagher AJ, 2017, CAN J FISH AQUAT SCI, V74, P1, DOI 10.1139/cjfas-2016-0165; Gillooly JF, 2001, SCIENCE, V293, P2248, DOI 10.1126/science.1061967; Goel Manish Kumar, 2010, Int J Ayurveda Res, V1, P274, DOI 10.4103/0974-7788.76794; Goodyear CP, 2002, AM FISH S S, V30, P172; Guida L, 2017, J EXP MAR BIOL ECOL, V497, P120, DOI 10.1016/j.jembe.2017.09.011; Gulak SJB, 2015, AFR J MAR SCI, V37, P267, DOI 10.2989/1814232X.2015.1026842; Hale LF., 2009, CHARACTERIZATION SHA; Hale LF., 2011, CHARACTERIZATION SHA; Harter TS, 2015, CONSERV PHYSIOL, V3, DOI 10.1093/conphys/cov002; Havn TB, 2015, J FISH BIOL, V87, P342, DOI 10.1111/jfb.12722; Heberer C, 2010, FISH RES, V106, P495, DOI 10.1016/j.fishres.2010.09.024; HOENIG J M, 1990, NOAA Technical Report NMFS, P1; Hoffmayer ER, 2001, FISH PHYSIOL BIOCHEM, V25, P277, DOI 10.1023/A:1023210620904; Hoolihan JP, 2011, ICES J MAR SCI, V68, P880, DOI 10.1093/icesjms/fsr024; Horodysky AZ, 2016, CONSERV PHYSIOL, V4, DOI 10.1093/conphys/cov059; Horodysky AZ, 2005, FISH B-NOAA, V103, P84; Hueter RE, 2006, T AM FISH SOC, V135, P500, DOI 10.1577/T05-065.1; Hutchinson MR, 2015, MAR ECOL PROG SER, V521, P143, DOI 10.3354/meps11073; Hyatt MW, 2018, J COASTAL RES, V34, P818, DOI 10.2112/JCOASTRES-D-17-00118.1; James KC, 2016, ENVIRON CONSERV, V43, P3, DOI 10.1017/S0376892915000168; Jenkins J.A., 2014, GUIDELINES USE FISHE; Kerstetter DW, 2006, FISH B-NOAA, V104, P434; Kneebone J, 2013, FISH RES, V147, P103, DOI 10.1016/j.fishres.2013.04.009; Lear KO, 2019, OECOLOGIA, V191, P829, DOI 10.1007/s00442-019-04547-1; Lear KO., 2016, ANIM BIOTELEM, V4, P1, DOI [10.1186/s40317-016-0105-8, DOI 10.1186/S40317-016-0105-8]; Lennox RJ, 2017, BIOL CONSERV, V209, P150, DOI 10.1016/j.biocon.2017.01.022; Mandelman JW, 2007, ICES J MAR SCI, V64, P122, DOI 10.1093/icesjms/fsl003; Mandelman JW, 2009, J COMP PHYSIOL B, V179, P267, DOI 10.1007/s00360-008-0306-4; Manire C, 2001, T AM FISH SOC, V130, P1038, DOI 10.1577/1548-8659(2001)130&lt;1038:SCAWGN&gt;2.0.CO;2; Marshall H, 2015, FISH RES, V172, P373, DOI 10.1016/j.fishres.2015.07.011; Marshall H, 2012, COMP BIOCHEM PHYS A, V162, P121, DOI 10.1016/j.cbpa.2012.02.008; Mathers AN., 2020, CHARACTERIZATION SHA; McDonald G., 1997, P119; Mohan JA, 2020, CONSERV PHYSIOL, V8, DOI 10.1093/conphys/coaa041; Molina JM, 2012, REV FISH BIOL FISHER, V22, P719, DOI 10.1007/s11160-012-9269-3; Morgan A., 2009, MAR FISH REV, V71, P23; Morgan Alexia, 2007, Gulf and Caribbean Research, V19, P123; Morgan A, 2010, FISH RES, V101, P32, DOI 10.1016/j.fishres.2009.09.004; Moyes CD, 2006, T AM FISH SOC, V135, P1389, DOI 10.1577/T05-224.1; Musyl MK, 2019, FISH FISH, V20, P466, DOI 10.1111/faf.12358; Musyl MK, 2018, REV FISH BIOL FISHER, V28, P567, DOI 10.1007/s11160-018-9517-2; Musyl MK, 2011, FISH B-NOAA, V109, P341; Myers RA, 2003, NATURE, V423, P280, DOI 10.1038/nature01610; National Oceanic and Atmospheric Administration, 2018, 54 SEDAR; National Oceanic and Atmospheric Administration, 2011, 21 SEDAR; National Oceanic and Atmospheric Administration NMFS, 2008, FIN AM 2 CONS ATL HI; National Oceanic and Atmospheric Administration NMFS, 2006, FIN CONS ATL HIGHL M; Perry SF, 2006, RESP PHYSIOL NEUROBI, V154, P199, DOI 10.1016/j.resp.2006.04.010; Poisson F, 2014, CAN J FISH AQUAT SCI, V71, P795, DOI 10.1139/cjfas-2013-0561; Rodriguez-Cabello C, 2017, J SEA RES, V130, P248, DOI 10.1016/j.seares.2017.04.004; Sakamoto KQ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005379; Sepulveda CA, 2015, FISH RES, V161, P102, DOI 10.1016/j.fishres.2014.06.014; Skomal GB, 2007, FISHERIES MANAG ECOL, V14, P81, DOI 10.1111/j.1365-2400.2007.00528.x; Skomal GB, 2002, AM FISH S S, V30, P57; Skomal GB, 2006, PHYSIOLOGICAL EFFECT; Skomal G, 2010, CRC MAR BIOL SER, P459; Skomal GB, 2012, COMP BIOCHEM PHYS A, V162, P146, DOI 10.1016/j.cbpa.2011.10.002; Talwar BS, 2020, ICES J MAR SCI, V77, P2763, DOI 10.1093/icesjms/fsaa146; Therneau T, 2019, PACKAGE RPART V 4 1; Van Leeuwen TE, 2020, CAN J FISH AQUAT SCI, V77, P1518, DOI 10.1139/cjfas-2019-0400; Weber DN, 2020, FISH B-NOAA, V118, P297, DOI 10.7755/FB.118.3.8; Weber DN., 2020, ICES J MAR SCI; WELLS RMG, 1986, COMP BIOCHEM PHYS A, V84, P565, DOI 10.1016/0300-9629(86)90366-X; Whitmore BM, 2016, J EXP MAR BIOL ECOL, V475, P49, DOI 10.1016/j.jembe.2015.11.002; Whitney NM, 2017, FISH B-NOAA, V115, P532, DOI 10.7755/FB.115.4.9; Whitney NM, 2016, FISH RES, V183, P210, DOI 10.1016/j.fishres.2016.06.003; Winter J.D., 1983, P371; WOOD CM, 1983, J FISH BIOL, V22, P189, DOI 10.1111/j.1095-8649.1983.tb04739.x; Worm B, 2013, MAR POLICY, V40, P194, DOI 10.1016/j.marpol.2012.12.034	92	7	8	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2021	16	9							e0255673	10.1371/journal.pone.0255673	http://dx.doi.org/10.1371/journal.pone.0255673			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	WG6DR	34525094	Green Published, gold			2022-12-26	WOS:000707084400012
J	Alperstein, AM; Molnar, KS; Dicke, SS; Farrell, KM; Makley, LN; Zanni, MT; Andley, UP				Alperstein, Ariel M.; Molnar, Kathleen S.; Dicke, Sidney S.; Farrell, Kieran M.; Makley, Leah N.; Zanni, Martin T.; Andley, Usha P.			Analysis of amyloid-like secondary structure in the Cryab-R120G knock-in mouse model of hereditary cataracts by two-dimensional infrared spectroscopy	PLOS ONE			English	Article							ALPHA-B-CRYSTALLIN; FIBRIL FORMATION; CHAPERONE; PROTEINS; MUTATION; LENSES; R120G	alpha B-crystallin is a small heat shock protein that forms a heterooligomeric complex with alpha A-crystallin in the ocular lens. It is also widely distributed in tissues throughout the body and has been linked with neurodegenerative diseases such as Alzheimer's, where it is associated with amyloid fibrils. Crystallins can form amorphous aggregates in cataracts as well as more structured amyloid-like fibrils. The arginine 120 to glycine (R120G) mutation in alpha B-crystallin (Cryab-R120G) results in high molecular weight crystallin protein aggregates and loss of the chaperone activity of the protein in vitro, and it is associated with human hereditary cataracts and myopathy. Characterizing the amorphous (unstructured) versus the highly ordered (amyloid fibril) nature of crystallin aggregates is important in understanding their role in disease and important to developing pharmacological treatments for cataracts. We investigated protein secondary structure in wild-type (WT) and Cryab-R120G knock-in mutant mouse lenses using two-dimensional infrared (2DIR) spectroscopy, which has been used to detect amyloid-like fibrils in human lenses and measure UV radiation-induced changes in porcine lenses. Our goal was to compare the aggregated proteins in this mouse lens model to human lenses and evaluate the protein structural relevance of the Cryab-R120G knock-in mouse model to general age-related cataract disease. In the 2DIR spectra, amide I diagonal peak frequencies were red-shifted to smaller wavenumbers in mutant mouse lenses as compared to WT mouse lenses, consistent with an increase in ordered secondary structure. The cross peak frequency and intensity indicated the presence of amyloid in the mutant mouse lenses. While the diagonal and cross peak changes in location and intensity from the 2DIR spectra indicated significant structural differences between the wild type and mutant mouse lenses, these differences were smaller than those found in human lenses; thus, the Cryab-R120G knock-in mouse lenses contain less amyloid-like secondary structure than human lenses. The results of the 2DIR spectroscopy study confirm the presence of amyloid-like secondary structure in Cryab-R120G knock-in mice with cataracts and support the use of this model to study age-related cataract.	[Alperstein, Ariel M.; Dicke, Sidney S.; Farrell, Kieran M.; Zanni, Martin T.] Univ Wisconsin, Dept Chem, 1101 Univ Ave, Madison, WI 53706 USA; [Molnar, Kathleen S.; Makley, Leah N.] ViewPoint Therapeut, San Francisco, CA USA; [Andley, Usha P.] Washington Univ, Sch Med, Dept Ophthalmol & Visual Sci St Louis, St Louis, MO 63110 USA; [Alperstein, Ariel M.] Univ Minnesota, Dept Chem, 207 Pleasant St SE, Minneapolis, MN 55455 USA	University of Wisconsin System; University of Wisconsin Madison; Washington University (WUSTL); University of Minnesota System; University of Minnesota Twin Cities	Zanni, MT (corresponding author), Univ Wisconsin, Dept Chem, 1101 Univ Ave, Madison, WI 53706 USA.; Andley, UP (corresponding author), Washington Univ, Sch Med, Dept Ophthalmol & Visual Sci St Louis, St Louis, MO 63110 USA.	zanni@chem.wisc.edu; andley@wustl.edu		Dicke, Sidney/0000-0002-5925-9207; Alperstein, Ariel/0000-0003-1310-1081; Farrell, Kieran/0000-0003-4075-1311	NIH [R01GM102387, 1R21AG061602]; NSF through the University of Wisconsin Materials Research Science and Engineering Center [DMR-1720415]; NIH from Research to Prevent Blindness, Inc. [EY05681-33]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF through the University of Wisconsin Materials Research Science and Engineering Center; NIH from Research to Prevent Blindness, Inc.	This work is supported by grants to Martin Zanni (NIH grant R01GM102387 and 1R21AG061602) and Usha Andley (NIH grant EY05681-33, an unrestricted grant to the Department of Ophthalmology and Visual Sciences from Research to Prevent Blindness, Inc.) and ViewPoint Therapeutics. The UW-Madison DWisconsin Centers for Nanoscale Technology (wcnt.wisc.edu) is partially supported by the NSF through the University of Wisconsin Materials Research Science and Engineering Center (DMR1720415). The funder ViewPoint Therapeutics provided support in the form of salaries for authors [K.S.M. and L.N.M.], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section. The funder PhaseTech Spectroscopy, Inc. provided support in the form of salary for an author [M.T.Z.] but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the `author contributions' section.	Alperstein AM, 2019, P NATL ACAD SCI USA, V116, P6602, DOI 10.1073/pnas.1821534116; Andley UP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017671; Baiz CR, 2020, CHEM REV, V120, P7152, DOI 10.1021/acs.chemrev.9b00813; Baiz CR, 2013, J PHYS CHEM A, V117, P5955, DOI 10.1021/jp310689a; Benson MD, 2020, AMYLOID, V27, P217, DOI 10.1080/13506129.2020.1835263; Bova MP, 1999, P NATL ACAD SCI USA, V96, P6137, DOI 10.1073/pnas.96.11.6137; Buchanan LE, 2014, P NATL ACAD SCI USA, V111, P5796, DOI 10.1073/pnas.1401587111; Calero Miguel, 2005, Methods Mol Biol, V299, P129; Der Perng M, 1999, J BIOL CHEM, V274, P33235, DOI 10.1074/jbc.274.47.33235; Ecroyd H, 2009, CELL MOL LIFE SCI, V66, P62, DOI 10.1007/s00018-008-8327-4; Farnsworth PN, 1997, INT J BIOL MACROMOL, V20, P283, DOI 10.1016/S0141-8130(97)00028-7; Garvey M, 2017, BIOMOLECULES, V7, DOI 10.3390/biom7030067; Goldstein LE, 2003, LANCET, V361, P1258, DOI 10.1016/S0140-6736(03)12981-9; Hamm P., 2011, CONCEPTS METHODS 2D; Lampi KJ, 1998, EXP EYE RES, V67, P31, DOI 10.1006/exer.1998.0481; Lomont JP, 2018, J PHYS CHEM B, V122, P144, DOI 10.1021/acs.jpcb.7b10765; Makley LN, 2015, SCIENCE, V350, P674, DOI 10.1126/science.aac9145; Meehan S, 2004, J BIOL CHEM, V279, P3413, DOI 10.1074/jbc.M308203200; Meehan S, 2007, J MOL BIOL, V372, P470, DOI 10.1016/j.jmb.2007.06.060; Micsonai A, 2015, P NATL ACAD SCI USA, V112, pE3095, DOI 10.1073/pnas.1500851112; Molnar KS, 2019, INVEST OPHTH VIS SCI, V60, P3320, DOI 10.1167/iovs.18-25647; Moran SD, 2014, J PHYS CHEM LETT, V5, P1984, DOI 10.1021/jz500794d; Rekas A, 2007, FEBS J, V274, P6290, DOI 10.1111/j.1742-4658.2007.06144.x; Schmeltz M, 2019, OPT EXPRESS, V27, P22685, DOI [10.1364/OE.27.022686, 10.1364/OE.27.022685]; Strasfeld DB, 2008, J AM CHEM SOC, V130, P6698, DOI 10.1021/ja801483n; Vicart P, 1998, NAT GENET, V20, P92, DOI 10.1038/1765; Wang JP, 2006, J PHYS CHEM B, V110, P3798, DOI 10.1021/jp0530092; Zandomeneghi G, 2004, PROTEIN SCI, V13, P3314, DOI 10.1110/ps.041024904; Zhang TO, 2017, J MOL BIOL, V429, P1705, DOI 10.1016/j.jmb.2017.04.014; Zhuang W, 2010, P NATL ACAD SCI USA, V107, P15687, DOI 10.1073/pnas.1002131107	30	3	3	4	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2021	16	9							e0257098	10.1371/journal.pone.0257098	http://dx.doi.org/10.1371/journal.pone.0257098			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	WG5RP	34520490	Green Published, gold			2022-12-26	WOS:000707052100012
J	Bryson, H; Mensah, F; Price, A; Gold, L; Mudiyanselage, SB; Kenny, B; Dakin, P; Bruce, T; Noble, K; Kemp, L; Goldfeld, S				Bryson, Hannah; Mensah, Fiona; Price, Anna; Gold, Lisa; Mudiyanselage, Shalika Bohingamu; Kenny, Bridget; Dakin, Penelope; Bruce, Tracey; Noble, Kristy; Kemp, Lynn; Goldfeld, Sharon			Clinical, financial and social impacts of COVID-19 and their associations with mental health for mothers and children experiencing adversity in Australia	PLOS ONE			English	Article							DEPRESSION; CHILDHOOD; ANXIETY	Background Australia has maintained low rates of SARS-COV-2 (COVID-19) infection, due to geographic location and strict public health restrictions. However, the financial and social impacts of these restrictions can negatively affect parents' and children's mental health. In an existing cohort of mothers recruited for their experience of adversity, this study examined: 1) families' experiences of the COVID-19 pandemic and public health restrictions in terms of clinical exposure, financial hardship family stress, and family resilience (termed 'COVID-19 impacts'); and 2) associations between COVID-19 impacts and maternal and child mental health. Methods Participants were mothers recruited during pregnancy (2013-14) across two Australian states (Victoria and Tasmania) for the 'right@home' trial. A COVID-19 survey was conducted from May-December 2020, when children were 5.9-7.2 years old. Mothers reported COVID-19 impacts, their own mental health (Depression, Anxiety, Stress Scales short-form) and their child's mental health (CoRonavIruS Health and Impact Survey subscale). Associations between COVID-19 impacts and mental health were examined using regression models controlling for pre-COVID-19 characteristics. Results 319/406 (79%) mothers completed the COVID-19 survey. Only one reported having had COVID-19. Rates of self-quarantine (20%), job or income loss (27%) and family stress (e.g., difficulty managing children's at-home learning (40%)) were high. Many mothers also reported family resilience (e.g., family found good ways of coping (49%)). COVID-19 impacts associated with poorer mental health (standardised coefficients) included self-quarantine (mother: beta = 0.46, child: beta = 0.46), financial hardship (mother: beta = 0.27, child: beta = 0.37) and family stress (mother: beta = 0.49, child: beta = 0.74). Family resilience was associated with better mental health (mother: beta = -0.40, child: beta = -0.46). Conclusions The financial and social impacts of Australia's public health restrictions have substantially affected families experiencing adversity, and their mental health. These impacts are likely to exacerbate inequities arising from adversity. To recover from COVID-19, policy investment should include income support and universal access to family health services.	[Bryson, Hannah; Price, Anna; Kenny, Bridget; Goldfeld, Sharon] Royal Childrens Hosp, Ctr Community Child Hlth, Parkville, Vic, Australia; [Bryson, Hannah; Mensah, Fiona; Price, Anna; Kenny, Bridget; Goldfeld, Sharon] Murdoch Childrens Res Inst, Populat Hlth, Parkville, Vic, Australia; [Mensah, Fiona; Price, Anna; Goldfeld, Sharon] Univ Melbourne, Dept Paediat, Parkville, Vic, Australia; [Gold, Lisa; Mudiyanselage, Shalika Bohingamu] Deakin Univ, Sch Hlth & Social Dev, Burwood, Vic, Australia; [Dakin, Penelope; Noble, Kristy] Australian Res Alliance Children & Youth, Canberra, ACT, Australia; [Bruce, Tracey; Kemp, Lynn] Western Sydney Univ, Ingham Inst, Sydney, NSW, Australia	Royal Children's Hospital Melbourne; Murdoch Children's Research Institute; University of Melbourne; Deakin University; Ingham Institute for Applied Medical Research; Western Sydney University	Goldfeld, S (corresponding author), Royal Childrens Hosp, Ctr Community Child Hlth, Parkville, Vic, Australia.; Goldfeld, S (corresponding author), Murdoch Childrens Res Inst, Populat Hlth, Parkville, Vic, Australia.; Goldfeld, S (corresponding author), Univ Melbourne, Dept Paediat, Parkville, Vic, Australia.	sharon.goldfeld@rch.org.au		Bryson, Hannah/0000-0002-3294-620X; Gold, Lisa/0000-0002-2733-900X	Victorian Department of Education and Training; Tasmanian Department of Health and Human Services; Ian Potter Foundation; Sabemo Trust; Sidney Myer Fund; Australian National Health and Medical Research Council (NHMRC) [1079148]; Victorian Department of Health and Human Services; Vincent Chiodo Charitable Trust; Victorian Government's Operational Infrastructure Support Program; NHMRC Career Development Fellowship [1111160]; NHMRC Practitioner Fellowship [1155290]	Victorian Department of Education and Training; Tasmanian Department of Health and Human Services; Ian Potter Foundation; Sabemo Trust; Sidney Myer Fund; Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Victorian Department of Health and Human Services; Vincent Chiodo Charitable Trust; Victorian Government's Operational Infrastructure Support Program; NHMRC Career Development Fellowship(National Health and Medical Research Council (NHMRC) of Australia); NHMRC Practitioner Fellowship(National Health and Medical Research Council (NHMRC) of Australia)	"right@home" is funded by the Victorian Department of Education and Training (https://www.education.vic.gov.au/), the Tasmanian Department of Health and Human Services (https://www.health.tas.gov.au/, the Ian Potter Foundation (https://www.ianpotter.org.au/), Sabemo Trust, Sidney Myer Fund (https://www.myerfoundation.org.au/), the Vincent Fairfax Family Foundation (https://vfff.org.au/) and the Australian National Health and Medical Research Council (NHMRC, Project Grant 1079148 -https://www.nhmrc.gov.au/).The right@home COVID-19 data collection was supported by the Victorian Department of Health and Human Services (https://www.dhhs.vic.gov.au/), Morgan Stanley (https://www.morganstanley.com.au/) and the Vincent Chiodo Charitable Trust. Research at the MCRI is supported by the Victorian Government's Operational Infrastructure Support Program. FM is supported by NHMRC Career Development Fellowship 1111160. SG is supported by NHMRC Practitioner Fellowship 1155290. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2021, AUSTR TEMPERAMENT PR; Australian Bureau of Statistics, 2021, LAB FORC AUSTR; Australian Government, 2020, NEWS AND UPDATES; Broadway B, 2020, COPING COVID 19 RETH; Brookman S, 2021, LANCET CHILD ADOLESC, V5, pE9, DOI 10.1016/S2352-4642(21)00030-4; Brooks SK, 2020, LANCET, V395, P912, DOI [10.1016/S0140-6736(20)30460-8., 10.1016/S0140-6736(20)30460-8]; Brown N., 2020, LEARNING HOME COVID; Bryson H, 2021, ARCH WOMEN MENT HLTH, V24, P987, DOI 10.1007/s00737-021-01145-0; Cameron EE, 2020, J AFFECT DISORDERS, V276, P765, DOI 10.1016/j.jad.2020.07.081; Cassells R., 2020, JOBKEEPERS JOBSEEKER; CSDH, 2008, CLOS GAP GEN HLTH EQ; Dawel A, 2020, FRONT PSYCHIATRY, V11, DOI 10.3389/fpsyt.2020.579985; Department of Health and Human Services, 2020, UPD OUTBR COR DIS CO; Dickerson J., 2021, WELLCOME OPEN RES, V5, P228, DOI [10.12688/wellcomeopenres.16317.2, DOI 10.12688/WELLCOMEOPENRES.16317.2]; Evans S, 2020, FRONT PSYCHOL, V11, DOI 10.3389/fpsyg.2020.588667; Fancourt D, 2021, LANCET PSYCHIAT, V8, P141, DOI 10.1016/S2215-0366(20)30482-X; Gartland D, 2011, MATERN CHILD HLTH J, V15, P570, DOI 10.1007/s10995-010-0638-z; Gassman-Pines A, 2020, PEDIATRICS, V146, DOI 10.1542/peds.2020-007294; Goldfeld, 2020, COVID 19 VICTORIAN S; Goldfeld S, 2018, J PAEDIATR CHILD H, V54, P754, DOI 10.1111/jpc.13860; Goldfeld S, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-013307; Henry JD, 2005, BRIT J CLIN PSYCHOL, V44, P227, DOI 10.1348/014466505X29657; Kiernan KE, 2009, J SOC POLICY, V38, P569, DOI 10.1017/S0047279409003250; Kingston D, 2014, MATERN CHILD HLTH J, V18, P1728, DOI 10.1007/s10995-013-1418-3; Linver MR, 2002, DEV PSYCHOL, V38, P719, DOI 10.1037//0012-1649.38.5.719; Loades ME, 2020, J AM ACAD CHILD PSY, V59, P1218, DOI 10.1016/j.jaac.2020.05.009; Lovibond SH, 1995, MANUAL DEPRESSION AN, V2nd; Luca DL, 2019, SOC COSTS UNTREATED; Merikangas K., 2020, CORONAVIRUS HLTH IMP; Nearchou F, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17228479; Nikolaidis Aki, 2021, Sci Rep, V11, P8139, DOI [10.1101/2020.08.24.20181123, 10.1038/s41598-021-87270-3]; O'Connor M., 2021, INEQUALITIES DISTRIB; O'Connor M, 2020, ACAD PEDIATR, V20, P609, DOI 10.1016/j.acap.2019.12.004; Patrick SW, 2020, PEDIATRICS, V146, DOI 10.1542/peds.2020-016824; Phillips B., 2020, COVID 19 JOBKEEPER J; Price A, 2019, BMC HEALTH SERV RES, V19, DOI 10.1186/s12913-019-4698-5; Ravens-Sieberer U, 2022, EUR CHILD ADOLES PSY, V31, P879, DOI 10.1007/s00787-021-01726-5; RICHTERS JE, 1992, PSYCHOL BULL, V112, P485, DOI 10.1037/0033-2909.112.3.485; Rossell SL, 2021, PSYCHIAT RES, V296, DOI 10.1016/j.psychres.2020.113660; Roubinov D, 2020, JAMA PEDIATR, V174, P1131, DOI 10.1001/jamapediatrics.2020.2354; Royal Children's Hospital National Child Health Poll, 2020, COVID 19 PAND EFF LI; Schmidt SJ, 2021, EUR J PSYCHOTRAUMATO, V12, DOI 10.1080/20008198.2021.1901407; Sciberras E, 2022, J ATTEN DISORD, V26, P549, DOI 10.1177/1087054720978549; Stein A, 2014, LANCET, V384, P1800, DOI 10.1016/S0140-6736(14)61277-0; Tasmanian Government, 2020, COR DIS COVID 19 CUR; Wilkins R, 2018, HOUSEHOLD INCOME LAB; World Health Organization, 2021, NOV COR 2019 NCOV SI; Zimmermann P, 2021, ARCH DIS CHILD, V106, P429, DOI 10.1136/archdischild-2020-320338	48	5	5	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2021	16	9							e0257357	10.1371/journal.pone.0257357	http://dx.doi.org/10.1371/journal.pone.0257357			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	WG6OR	34516564	Green Published, gold, Green Submitted			2022-12-26	WOS:000707114200028
J	Devalraju, KP; Neela, VSK; Krovvidi, SS; Vankayalapati, R; Valluri, VL				Devalraju, Kamakshi Prudhula; Neela, Venkata Sanjeev Kumar; Krovvidi, Siva Sai; Vankayalapati, Ramakrishna; Valluri, Vijaya Lakshmi			Defective expansion and function of memory like natural killer cells in HIV plus individuals with latent tuberculosis infection	PLOS ONE			English	Article							NK-CELLS; DENDRITIC CELLS; CC-CHEMOKINES; CUTTING EDGE; ACTIVATION; EXPRESSION; VIRUS; CYTOKINE; INTERLEUKIN-32; REINFECTION	Purpose Tuberculosis (TB) is the leading cause of infectious disease related mortality, and only 10% of the infected individuals develop active disease. The likelihood of progression of latent tuberculosis infection (LTBI) to active TB disease is high in HIV infected individuals. Identification of HIV+ individuals at risk would allow treating targeted population, facilitating completion of therapy for LTBI and prevention of TB development. NK cells have an important role in T cell independent immunity against TB, but the exact role of NK cell subsets in LTBI and HIV is not well characterized. Methods In this study, we compared the expansion and function of memory like NK cells from HIV-LTBI+ individuals and treatment naive HIV+LTBI+ patients in response to Mtb antigens ESAT-6 and CFP-10. Results In freshly isolated PBMCs, percentages of CD3(-)CD56(+) NK cells were similar in HIV+LTBI+ patients and healthy HIV-LTBI+ individuals. However, percentages of CD3(-)CD56(+)CD16(+) NK cells were higher in healthy HIV-LTBI+ individuals compared to HIV+LTBI+ patients. HIV infection also inhibited the expansion of memory like NK cells, production of IL-32 alpha, IL-15 and IFN-gamma in response to Mtb antigens in LTBI+ individuals. Conclusion We studied phenotypic, functional subsets and activation of memory like-NK cells during HIV infection and LTBI. We observed that HIV+LTBI+ patients demonstrated suboptimal NK cell and monocyte interactions in response to Mtb, leading to reduced IL-15, IFN-gamma and granzyme B and increased CCL5 production. Our study highlights the effect of HIV and LTBI on modulation of NK cell activity to understand their role in development of interventions to prevent progression to TB in high risk individuals.	[Devalraju, Kamakshi Prudhula; Neela, Venkata Sanjeev Kumar; Valluri, Vijaya Lakshmi] LEPRA Soc, Immunol & Mol Biol Div, Blue Peter Publ Hlth & Res Ctr, Hyderabad, Telangana, India; [Krovvidi, Siva Sai] Sreenidhi Inst Sci & Technol, Dept Biotechnol, Hyderabad, Telangana, India; [Vankayalapati, Ramakrishna] Univ Texas Hlth Ctr Tyler, Ctr Biomed Res, Dept Pulm Immunol, Tyler, TX 75708 USA; [Devalraju, Kamakshi Prudhula; Neela, Venkata Sanjeev Kumar; Valluri, Vijaya Lakshmi] Bhagwan Mahavir Med Res Ctr, Immunol & Mol Biol Dept, Hyderabad, India	Sreenidhi Institute of Science & Technology; University of Texas System; University of Texas-Health Sciences Center at Tyler (UTHSCT)	Valluri, VL (corresponding author), LEPRA Soc, Immunol & Mol Biol Div, Blue Peter Publ Hlth & Res Ctr, Hyderabad, Telangana, India.; Vankayalapati, R (corresponding author), Univ Texas Hlth Ctr Tyler, Ctr Biomed Res, Dept Pulm Immunol, Tyler, TX 75708 USA.; Valluri, VL (corresponding author), Bhagwan Mahavir Med Res Ctr, Immunol & Mol Biol Dept, Hyderabad, India.	krishna.vankayalapati@uthct.edu; vijayavalluri@gmail.com		Valluri, Vijaya Lakshmi/0000-0002-0462-4174	National Institutes of Health [AI123310, AI120257, A127178]; CRDF global; Cain Foundation for Infectious Disease Research; Indian Council of Medical Research [HIV/INDO-US/170/7/2018ECD-II, 5/8/3(13)/2009-ECD-I (A)]; Department of Biotechnology [BT/PR9622/MED/15/109/2013]; Department of Pulmonary Immunology, UTHCT	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CRDF global; Cain Foundation for Infectious Disease Research; Indian Council of Medical Research(Indian Council of Medical Research (ICMR)); Department of Biotechnology; Department of Pulmonary Immunology, UTHCT	This work was supported by grants from the National Institutes of Health (AI123310, AI120257 and A127178 to R.V), CRDF global, and The Cain Foundation for Infectious Disease Research and The Department of Pulmonary Immunology, UTHCT, TX. VLV received grants from Indian Council of Medical Research [No: 5/8/3(13)/2009-ECD-I (A)] and Department of Biotechnology [No: BT/PR9622/MED/15/109/2013]. VSKN received grant from Indian Council of Medical Research [No: HIV/INDO-US/170/7/2018ECD-II]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Alter G, 2005, BLOOD, V106, P3366, DOI 10.1182/blood-2005-03-1100; Alter G, 2011, TRENDS IMMUNOL, V32, P219, DOI 10.1016/j.it.2011.02.003; Bonaparte MI, 2004, BLOOD, V104, P2087, DOI 10.1182/blood-2004-02-0696; Brunetta E, 2010, AIDS, V24, P27, DOI 10.1097/QAD.0b013e3283328d1f; Cheon S, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.159756; Chiossone L, 2009, BLOOD, V113, P5488, DOI 10.1182/blood-2008-10-187179; Chung AW, 2011, JAIDS-J ACQ IMM DEF, V58, P127, DOI 10.1097/QAI.0b013e31822c62b9; Costanzo MC, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03618-w; Cota M, 2000, J NEUROVIROL, V6, P75, DOI 10.3109/13550280009006384; Crampin AC, 2010, AIDS, V24, P417, DOI 10.1097/QAD.0b013e32832f51cf; Dhiman R, 2012, J IMMUNOL, V189, P897, DOI 10.4049/jimmunol.1102833; Dhiman R, 2009, J IMMUNOL, V183, P6639, DOI 10.4049/jimmunol.0902587; Fang M., 2013, J CLIN CELL IMMUNOL, VS13, DOI DOI 10.4172/2155-9899.S13-006; Feng CG, 2006, J IMMUNOL, V177, P7086, DOI 10.4049/jimmunol.177.10.7086; Fogli M, 2004, EUR J IMMUNOL, V34, P2313, DOI 10.1002/eji.200425251; Foreman TW, 2016, P NATL ACAD SCI USA, V113, pE5636, DOI 10.1073/pnas.1611987113; Ghadially H, 2012, AIDS, V26, P429, DOI 10.1097/QAD.0b013e32834f98ea; Hayakawa Y, 2006, J IMMUNOL, V176, P1517, DOI 10.4049/jimmunol.176.3.1517; Hirsch CS, 1999, J INFECT DIS, V180, P2069, DOI 10.1086/315114; Horowitz A, 2012, FRONT IMMUNOL, V2, DOI 10.3389/fimmu.2011.00088; Huntington ND, 2007, J IMMUNOL, V178, P4764, DOI 10.4049/jimmunol.178.8.4764; Katano I, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17442-7; Kennedy MK, 2000, J EXP MED, V191, P771, DOI 10.1084/jem.191.5.771; Khawar MB, 2016, MEDIAT INFLAMM, V2016, DOI 10.1155/2016/8413768; Kim SH, 2005, IMMUNITY, V22, P131, DOI 10.1016/j.immuni.2004.12.003; Kottilil S, 2003, J INFECT DIS, V187, P1038, DOI 10.1086/368222; Le Page C, 2000, Rev Immunogenet, V2, P374; Liu KB, 2002, P NATL ACAD SCI USA, V99, P6192, DOI 10.1073/pnas.092675799; Luna JI, 2017, EXPERT OPIN BIOL TH, V17, P313, DOI 10.1080/14712598.2017.1271874; Maghazachi AA, 1996, EUR J IMMUNOL, V26, P315, DOI 10.1002/eji.1830260207; Marcenaro E, 2008, INT IMMUNOL, V20, P1155, DOI 10.1093/intimm/dxn073; Mavilio D, 2006, J EXP MED, V203, P2339, DOI 10.1084/jem.20060894; Melki MT, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000862; Montoya D, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009546; Oliva A, 1998, J CLIN INVEST, V102, P223, DOI 10.1172/JCI2323; Pak-Wittel MA, 2013, P NATL ACAD SCI USA, V110, pE50, DOI 10.1073/pnas.1220456110; Park MH, 2012, IMMUNOLOGY, V135, P63, DOI 10.1111/j.1365-2567.2011.03513.x; Polansky JK, 2016, SCI REP-UK, V6, DOI 10.1038/srep19699; Pydi SS, 2019, TUBERCULOSIS, V116, pS123, DOI 10.1016/j.tube.2019.04.020; Robbins SH, 2002, J IMMUNOL, V168, P2585, DOI 10.4049/jimmunol.168.6.2585; Sahiratmadja E, 2007, INFECT IMMUN, V75, P820, DOI 10.1128/IAI.00602-06; Schluns KS, 2002, J IMMUNOL, V168, P4827, DOI 10.4049/jimmunol.168.10.4827; Shah A, 2011, BIOCHEM BIOPH RES CO, V414, P112, DOI 10.1016/j.bbrc.2011.09.033; Smith AJ, 2011, J IMMUNOL, V186, P6576, DOI 10.4049/jimmunol.1100277; Sonnenberg P, 2001, LANCET, V358, P1687, DOI 10.1016/S0140-6736(01)06712-5; Swingler S, 1999, NAT MED, V5, P997, DOI 10.1038/12433; Tasca S, 2003, AIDS, V17, P2291, DOI 10.1097/00002030-200311070-00003; TAUB DD, 1995, J IMMUNOL, V155, P3877; Thomas R, 2016, J IMMUNOL RES, V2016, DOI 10.1155/2016/6374379; Tiemessen CT, 2010, J INFECT DIS, V202, P1444, DOI 10.1086/656535; Venkatasubramanian S, 2017, MUCOSAL IMMUNOL, V10, P1031, DOI 10.1038/mi.2016.105; Waldmann TA, 1999, ANNU REV IMMUNOL, V17, P19, DOI 10.1146/annurev.immunol.17.1.19; World Health Organization, 2021, 10 THREATS GLOB HLTH; Zhang XH, 1998, IMMUNITY, V8, P591, DOI 10.1016/S1074-7613(00)80564-6	54	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2021	16	9							e0257185	10.1371/journal.pone.0257185	http://dx.doi.org/10.1371/journal.pone.0257185			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	WG6OR	34516566	gold, Green Published			2022-12-26	WOS:000707114200016
J	Liu, X; Yamaguchi, K; Takane, K; Zhu, C; Hirata, M; Hikiba, Y; Maeda, S; Furukawa, Y; Ikenoue, T				Liu, Xun; Yamaguchi, Kiyoshi; Takane, Kiyoko; Zhu, Chi; Hirata, Makoto; Hikiba, Yoko; Maeda, Shin; Furukawa, Yoichi; Ikenoue, Tsuneo			Cancer-associated IDH mutations induce Glut1 expression and glucose metabolic disorders through a PI3K/Akt/mTORC1-Hif1 alpha axis	PLOS ONE			English	Article							ISOCITRATE DEHYDROGENASE MUTATIONS; GLIOMA; PROLIFERATION; GLUCOSE-TRANSPORTER-1; 2-HYDROXYGLUTARATE; MECHANISMS; DECREASES; SURVIVAL; TARGET; ALPHA	Isocitrate dehydrogenase 1 and 2 (IDH1/2) mutations and their key effector 2-hydroxyglutarate (2-HG) have been reported to promote oncogenesis in various human cancers. To elucidate molecular mechanism(s) associated with IDH1/2 mutations, we established mouse embryonic fibroblasts (MEF) cells and human colorectal cancer cells stably expressing cancer-associated IDH1(R132C) or IDH2(R172S), and analyzed the change in metabolic characteristics of the these cells. We found that IDH1/2 mutants induced intracellular 2-HG accumulation and inhibited cell proliferation. Expression profile analysis by RNA-seq unveiled that glucose transporter 1 (Glut1) was induced by the IDH1/2 mutants or treatment with 2-HG in the MEF cells. Consistently, glucose uptake and lactate production were increased by the mutants, suggesting the deregulation of glucose metabolism. Furthermore, PI3K/Akt/mTOR pathway and Hif1 alpha expression were involved in the up-regulation of Glut1. Together, these results suggest that Glut1 is a potential target regulated by cancer-associated IDH1/2 mutations.	[Liu, Xun; Yamaguchi, Kiyoshi; Takane, Kiyoko; Zhu, Chi; Furukawa, Yoichi; Ikenoue, Tsuneo] Univ Tokyo, Adv Clin Res Ctr, Inst Med Sci, Div Clin Genome Res,Minato Ku, Tokyo, Japan; [Hirata, Makoto] Univ Tokyo, Inst Med Sci, Lab Genome Technol, Minato Ku, Tokyo, Japan; [Hirata, Makoto] Natl Canc Ctr, Dept Genet Med & Serv, Chuo Ku, Tokyo, Japan; [Hikiba, Yoko; Maeda, Shin] Yokohama City Univ, Dept Gastroenterol, Grad Sch Med, Yokohama, Kanagawa, Japan	University of Tokyo; University of Tokyo; National Cancer Center - Japan; Yokohama City University	Ikenoue, T (corresponding author), Univ Tokyo, Adv Clin Res Ctr, Inst Med Sci, Div Clin Genome Res,Minato Ku, Tokyo, Japan.	ikenoue@g.ecc.u-tokyo.ac.jp		ZHU, CHI/0000-0001-9529-7000; Hirata, Makoto/0000-0002-9994-9958				Adekola K, 2012, CURR OPIN ONCOL, V24, P650, DOI 10.1097/CCO.0b013e328356da72; Barthel A, 1999, J BIOL CHEM, V274, P20281, DOI 10.1074/jbc.274.29.20281; Bralten LBC, 2011, ANN NEUROL, V69, P455, DOI 10.1002/ana.22390; Byun JK, 2019, EMBO REP, V20, DOI 10.15252/embr.201847451; Cairns RA, 2013, CANCER DISCOV, V3, P730, DOI 10.1158/2159-8290.CD-13-0083; Carbonneau M, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12700; Chen CH, 2001, J BIOL CHEM, V276, P9519, DOI 10.1074/jbc.M010144200; Clark O, 2016, CLIN CANCER RES, V22, P1837, DOI 10.1158/1078-0432.CCR-13-1333; Cui DM, 2016, INT J BIOCHEM CELL B, V73, P72, DOI 10.1016/j.biocel.2016.02.007; Dang L, 2016, ANN ONCOL, V27, P599, DOI 10.1093/annonc/mdw013; Dang L, 2009, NATURE, V462, P739, DOI 10.1038/nature08617; Dodd KM, 2015, ONCOGENE, V34, P2239, DOI 10.1038/onc.2014.164; Donohoe DR, 2012, MOL CELL, V48, P612, DOI 10.1016/j.molcel.2012.08.033; Fang J, 2015, MOL MED REP, V11, P1573, DOI 10.3892/mmr.2014.2888; Figueroa ME, 2010, CANCER CELL, V18, P553, DOI 10.1016/j.ccr.2010.11.015; Fu XD, 2015, CELL METAB, V22, P508, DOI 10.1016/j.cmet.2015.06.009; Fujiwara H, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-55211-w; Gagne LM, 2017, TRENDS CELL BIOL, V27, P738, DOI 10.1016/j.tcb.2017.06.002; Garg M, 2014, EXPERT OPIN THER TAR, V18, P979, DOI 10.1517/14728222.2014.934814; Goradel NH, 2019, J CELL PHYSIOL, V234, P5683, DOI 10.1002/jcp.27411; Han S, 2020, BRIT J CANCER, V122, P1580, DOI 10.1038/s41416-020-0814-x; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hayashi M, 2004, J ENDOCRINOL, V183, P145, DOI 10.1677/joe.1.05599; Hudson CC, 2002, MOL CELL BIOL, V22, P7004, DOI 10.1128/MCB.22.20.7004-7014.2002; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Koivunen P, 2012, NATURE, V483, P485, DOI 10.1038/nature10898; Lenting K, 2019, FASEB J, V33, P557, DOI 10.1096/fj.201800907RR; Liberti MV, 2016, TRENDS BIOCHEM SCI, V41, P211, DOI 10.1016/j.tibs.2015.12.001; Lu C, 2012, NATURE, V483, P474, DOI 10.1038/nature10860; Majmundar AJ, 2010, MOL CELL, V40, P294, DOI 10.1016/j.molcel.2010.09.022; Nie QM, 2015, MOL MED REP, V12, P6695, DOI 10.3892/mmr.2015.4241; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Plas DR, 2001, J BIOL CHEM, V276, P12041, DOI 10.1074/jbc.M010551200; Qing Y, 2021, MOL CELL, V81, P922, DOI 10.1016/j.molcel.2020.12.026; Reitman ZJ, 2010, CANCER CELL, V17, P215, DOI 10.1016/j.ccr.2010.02.024; Tommasini-Ghelfi S, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aaw4543; Ward PS, 2013, J BIOL CHEM, V288, P3804, DOI 10.1074/jbc.M112.435495; Ward PS, 2010, CANCER CELL, V17, P225, DOI 10.1016/j.ccr.2010.01.020; Wiernan HL, 2007, MOL BIOL CELL, V18, P1437, DOI 10.1091/mbc.E06-07-0593; Xu W, 2011, CANCER CELL, V19, P17, DOI 10.1016/j.ccr.2010.12.014; Yang H, 2012, CLIN CANCER RES, V18, P5562, DOI 10.1158/1078-0432.CCR-12-1773; Zambrano A, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20133374; Zhang Z, 2018, MOL MED REP, V18, P3547, DOI 10.3892/mmr.2018.9375; Zhao SM, 2009, SCIENCE, V324, P261, DOI 10.1126/science.1170944	44	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2021	16	9							e0257090	10.1371/journal.pone.0257090	http://dx.doi.org/10.1371/journal.pone.0257090			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	WG6OR	34516556	gold, Green Published			2022-12-26	WOS:000707114200012
J	Park, JH; Chung, YE; Seo, N; Choi, JY; Park, MS; Kim, MJ				Park, Jae Hyon; Chung, Yong Eun; Seo, Nieun; Choi, Jin-Young; Park, Mi-Suk; Kim, Myeong-Jin			Hepatobiliary phase signal intensity: A potential method of diagnosing HCC with atypical imaging features among LR-M observations	PLOS ONE			English	Article							COMBINED HEPATOCELLULAR-CHOLANGIOCARCINOMA; DISODIUM-ENHANCED MRI; LIVER-TRANSPLANTATION; LI-RADS; INTRAHEPATIC CHOLANGIOCARCINOMA; CARCINOMA; DIFFERENTIATION; TRANSPORTERS; EXPRESSION; LESIONS	Herein, we assessed whether hepatobiliary phase (HBP) signal intensity (SI) can be used to differentiate HCC and non-HCC malignancies within LR-M observations. 106 LR-M patients based on LI-RADS v2018 who underwent gadoxetate-disodium magnetic resonance imaging and surgery from January 2009 to December 2018 were included. SI of LR-M observation on HBP was analyzed by two radiologists and categorized into dark, low and iso-to-high groups. Tumor was classified as dark when more than 50% of tumor showed hypointensity compared to spleen, as low when more than 50% of tumor showed hyperintensity compared to spleen but hypointensity compared to liver parenchyma, and as iso-to-high if there was even a focal iso-intensity or hyperintensity compared to liver parenchyma. Analysis of clinicopathological factors and association between imaging and histology was performed. Out of 106 LR-M, 42 (40%) were showed dark, 61 (58%) showed low, and 3 (3%) showed iso-to-high SI in HBP. Three iso-to-high SI LR-M were HCCs (P = 0.060) and their major histologic differentiation was Edmondson grade 1 (P = 0.001). 43 out of 61 (71%) low SI LR-M were iCCA or cHCC-CCA (P = 0.002). Inter-reader agreement of HBP SI classification was excellent, with a kappa coefficient of 0.872. LR-M with iso-to-high SI in HBP is prone to being HCC while LR-M with low SI in HBP is prone to being tumor with fibrous stroma such as iCCA and cHCC-CCA. Classification of LR-M based on HBP SI may be a helpful method of differentiating HCC from non-HCC malignancies.	[Park, Jae Hyon; Chung, Yong Eun; Seo, Nieun; Choi, Jin-Young; Park, Mi-Suk; Kim, Myeong-Jin] Yonsei Univ, Dept Radiol, Coll Med, Seoul, South Korea	Yonsei University; Yonsei University Health System	Chung, YE (corresponding author), Yonsei Univ, Dept Radiol, Coll Med, Seoul, South Korea.	yelv@yuhs.ac	; Kim, Myeong-Jin/E-1623-2011	Chung, Yong Eun/0000-0003-0811-9578; Kim, Myeong-Jin/0000-0001-7949-5402; Park, Mi-Suk/0000-0001-5817-2444; Seo, Nieun/0000-0001-8745-6454; Choi, Jin-Young/0000-0002-9025-6274	Yonsei University College of Medicine [6-2019-0118]	Yonsei University College of Medicine(General Electric)	Y.E.C. received faculty research grant of Yonsei University College of Medicine (No. 6-2019-0118). The funder did not play any role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Chernyak V, 2018, RADIOLOGY, V289, P816, DOI 10.1148/radiol.2018181494; Choi JW, 2013, RADIOLOGY, V267, P776, DOI 10.1148/radiol.13120775; Choi SH, 2019, RADIOLOGY, V290, P388, DOI 10.1148/radiol.2018181290; Chong YS, 2012, CLIN RADIOL, V67, P766, DOI 10.1016/j.crad.2012.01.004; Cruite I, 2010, AM J ROENTGENOL, V195, P29, DOI 10.2214/AJR.10.4538; EDMONDSON HA, 1954, CANCER-AM CANCER SOC, V7, P462, DOI 10.1002/1097-0142(195405)7:3<462::AID-CNCR2820070308>3.0.CO;2-E; Feng ST, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1039-x; Gabata T, 1998, ABDOM IMAGING, V23, P309, DOI 10.1007/s002619900347; Huppertz A, 2005, RADIOLOGY, V234, P468, DOI 10.1148/radiol.2342040278; Jeon TY, 2010, ABDOM IMAGING, V35, P337, DOI 10.1007/s00261-009-9509-8; Jeong HT, 2013, AM J ROENTGENOL, V201, pW603, DOI 10.2214/AJR.12.10262; Jiang HY, 2021, EUR RADIOL, V31, P3638, DOI 10.1007/s00330-020-07488-z; Kim MY, 2020, ABDOM RADIOL, V45, P2440, DOI 10.1007/s00261-020-02545-z; Kim SS, 2020, ABDOM RADIOL, V45, P3743, DOI 10.1007/s00261-020-02562-y; Kim SH, 2012, J COMPUT ASSIST TOMO, V36, P704, DOI 10.1097/RCT.0b013e3182706562; Kim SS., 2018, SYNCHRONOUS OCCURREN, V15; Kim YY, 2019, RADIOLOGY, V291, P71, DOI 10.1148/radiol.2019181995; Kim YY, 2019, CLIN MOL HEPATOL, V25, P223, DOI 10.3350/cmh.2018.0107; Kitao A, 2011, EUR RADIOL, V21, P2056, DOI 10.1007/s00330-011-2165-8; Kitao A, 2010, RADIOLOGY, V256, P817, DOI 10.1148/radiol.10092214; Koh J, 2016, EUR RADIOL, V26, P407, DOI 10.1007/s00330-015-3846-5; KONDO Y, 1987, CANCER-AM CANCER SOC, V60, P1032, DOI 10.1002/1097-0142(19870901)60:5<1032::AID-CNCR2820600518>3.0.CO;2-K; Lee HS, 2019, EUR RADIOL, V29, P2408, DOI 10.1007/s00330-018-5893-1; Llovet JM, 1999, SEMIN LIVER DIS, V19, P329, DOI 10.1055/s-2007-1007122; Magistri P, 2017, DIGEST LIVER DIS, V49, P467, DOI 10.1016/j.dld.2017.01.166; Mazzaferro V, 1996, NEW ENGL J MED, V334, P693, DOI 10.1056/NEJM199603143341104; Oestmann PM, 2021, EUR RADIOL, V31, P4981, DOI 10.1007/s00330-020-07559-1; Park JH, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0242344; Park MJ, 2013, J COMPUT ASSIST TOMO, V37, P872, DOI 10.1097/RCT.0b013e31829d44c1; Radiology ACo, CTMRI LI RADS V2018; Ren AH, 2019, J MAGN RESON IMAGING, V50, P746, DOI 10.1002/jmri.26640; Rhee H, 2018, CANCER RES, V78, P1619, DOI 10.1158/0008-5472.CAN-17-0988; Sapisochin G, 2020, TRANSPLANTATION, V104, P1125, DOI 10.1097/TP.0000000000003212; Tang A, 2018, RADIOLOGY, V286, P29, DOI 10.1148/radiol.2017170554; Tsuboyama T, 2010, RADIOLOGY, V255, P824, DOI 10.1148/radiol.10091557; Vavricka SR, 2004, J HEPATOL, V40, P212, DOI 10.1016/j.jhep.2003.10.008; Vernuccio F, 2019, AM J ROENTGENOL, V213, pW57, DOI 10.2214/AJR.18.20979; Vogel A, 2018, ANN ONCOL, V29, P238, DOI 10.1093/annonc/mdy308; Zech CJ, 2020, EUR RADIOL, V30, P370, DOI 10.1007/s00330-019-06369-4	39	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2021	16	9							e0257308	10.1371/journal.pone.0257308	http://dx.doi.org/10.1371/journal.pone.0257308			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	WG6OR	34516587	Green Published, gold			2022-12-26	WOS:000707114200026
J	Ansar, A; Lewis, V; McDonald, CF; Liu, CJ; Rahman, MA				Ansar, Adnan; Lewis, Virginia; McDonald, Christine Faye; Liu, Chaojie; Rahman, Muhammad Aziz			Duration of intervals in the care seeking pathway for lung cancer in Bangladesh: A journey from symptoms triggering consultation to receipt of treatment	PLOS ONE			English	Article							DIAGNOSTIC EVALUATION; 1ST SYMPTOM; PATIENT; GUIDELINES; AUSTRALIA; QUALITY; DENMARK; NORWAY; SWEDEN; HEALTH	Timeliness in seeking care is critical for lung cancer patients' survival and better prognosis. The care seeking trajectory of patients with lung cancer in Bangladesh has not been explored, despite the differences in health systems and structures compared to high income countries. This study investigated the symptoms triggering healthcare seeking, preferred healthcare providers (including informal healthcare providers such as pharmacy retailers, village doctors, and "traditional healers"), and the duration of intervals in the lung cancer care pathway of patients in Bangladesh. A cross-sectional study was conducted in three tertiary care hospitals in Bangladesh among diagnosed lung cancer patients through face-to-face interview and medical record review. Time intervals from onset of symptom and care seeking events were calculated and compared between those who sought initial care from different providers using Wilcoxon rank sum tests. Among 418 study participants, the majority (90%) of whom were males, with a mean age of 57 +/- 9.86 years, cough and chest pain were the most common (23%) combination of symptoms triggering healthcare seeking. About two-thirds of the total respondents (60%) went to informal healthcare providers as their first point of contact. Living in rural areas, lower levels of education and lower income were associated with seeking care from such providers. The median duration between onset of symptom to confirmation of diagnosis was 121 days, between confirmation of diagnosis and initiation of treatment was 22 days, and between onset of symptom and initiation of treatment was 151 days. Pre-diagnosis durations were longer for those who had sought initial care from an informal provider (p<0.05). Time to first contact with a health provider was shorter in this study compared to other developed and developing countries but utilizing informal healthcare providers caused delays in diagnosis and initiation of treatment. Encouraging people to seek care from a formal healthcare provider may reduce the overall duration of the care seeking pathway.	[Ansar, Adnan; Lewis, Virginia] La Trobe Univ, Coll Sci Hlth & Engn, Sch Nursing & Midwifery, Melbourne, Vic, Australia; [Ansar, Adnan; McDonald, Christine Faye; Rahman, Muhammad Aziz] Inst Breathing & Sleep IBAS, Melbourne, Vic, Australia; [Lewis, Virginia; Rahman, Muhammad Aziz] La Trobe Univ, Australian Inst Primary Care & Aging, Melbourne, Vic, Australia; [McDonald, Christine Faye] Austin Hlth, Dept Resp & Sleep Med, Melbourne, Vic, Australia; [McDonald, Christine Faye] Univ Melbourne, Melbourne, Vic, Australia; [Liu, Chaojie] La Trobe Univ, Sch Psychol & Publ Hlth, Melbourne, Vic, Australia; [Rahman, Muhammad Aziz] Federat Univ Australia, Sch Hlth, Berwick, Australia; [Rahman, Muhammad Aziz] Bangladesh Univ Hlth Sci BUHS, Dept Noncommunicable Dis, Dhaka, Bangladesh; [Rahman, Muhammad Aziz] Airlangga Univ, Fac Publ Hlth, Surabaya, Indonesia	La Trobe University; Institute for Breathing & Sleep (IBAS); La Trobe University; Austin Research Institute; Florey Institute of Neuroscience & Mental Health; University of Melbourne; La Trobe University; Federation University Australia; Bangladesh University of Health Sciences (BUHS); Airlangga University	Ansar, A (corresponding author), La Trobe Univ, Coll Sci Hlth & Engn, Sch Nursing & Midwifery, Melbourne, Vic, Australia.; Ansar, A (corresponding author), Inst Breathing & Sleep IBAS, Melbourne, Vic, Australia.	dr.adnan.ansar@gmail.com	Ansar, Adnan/N-2520-2017; Rahman, Muhammad Aziz/B-3380-2009	Ansar, Adnan/0000-0001-6052-8657; Rahman, Muhammad Aziz/0000-0003-1665-7966; Liu, Chaojie/0000-0003-0877-0424; Lewis, Virginia/0000-0001-7802-625X				Ahmed K, 2013, ASIAN PAC J CANCER P, V14, P595, DOI 10.7314/APJCP.2013.14.1.595; Ahmed SM, 2013, LANCET, V382, P1746, DOI 10.1016/S0140-6736(13)62147-9; Ahmed SM, 2011, HUM RESOUR HEALTH, V9, DOI 10.1186/1478-4491-9-3; Akhtar K, 2018, EUR J BREAST HEALTH, V14, P166, DOI 10.5152/ejbh.2018.3929; Alam DS, 2015, COPD, V12, P658, DOI 10.3109/15412555.2015.1041101; Alanen V, 2019, ACTA ONCOL, V58, P1056, DOI 10.1080/0284186X.2019.1590635; Allemani C, 2015, LANCET, V385, P977, DOI 10.1016/S0140-6736(14)62038-9; Alok Kumar D., 2012, HEALTH, V4, DOI [10.4236/health.2012.42012, DOI 10.4236/HEALTH.2012.42012]; [Anonymous], 1998, Thorax, V53 Suppl 1, pS1; [Anonymous], 2020, WORLD CANC REP CANC; [Anonymous], 2018, SEER CANC STAT REV 1; Asch SM, 2000, QUALITY CARE ONCOLOG; Bai CX, 2016, CHEST, V150, P877, DOI 10.1016/j.chest.2016.02.650; Bartlett JE, 2000, INFORM TECHNOLOGY LE, V19, P43, DOI DOI 10.1109/LPT.2009.2020494; Broom A, 2012, HEALTH-LONDON, V16, P250, DOI 10.1177/1363459311403949; Brousselle A, 2017, BMC HEALTH SERV RES, V17, DOI 10.1186/s12913-017-2390-1; Butler J, 2013, HEALTH POLICY, V112, P148, DOI 10.1016/j.healthpol.2013.03.021; Carter-Harris L, 2015, J AM ASSOC NURSE PRA, V27, P240, DOI 10.1002/2327-6924.12227; Chandra S, 2009, ASIAN PAC J CANCER P, V10, P453; Chowienczyk S, 2020, BRIT J GEN PRACT, V70, pE193, DOI 10.3399/bjgp20X708137; Christensen NL, 2017, ACTA ONCOL, V56, P943, DOI 10.1080/0284186X.2017.1315172; Coxon D, 2018, BMC HEALTH SERV RES, V18, DOI 10.1186/s12913-018-3476-0; Curtin F, 1998, BIOL PSYCHIAT, V44, P775, DOI 10.1016/S0006-3223(98)00043-2; Deffebach ME, 2015, SURG CLIN N AM, V95, P967, DOI 10.1016/j.suc.2015.05.006; Saul EE, 2020, NAT CANCER, V1, P1140, DOI 10.1038/s43018-020-00142-z; Flora MS, 2009, TOB CONTROL, V18, P445, DOI 10.1136/tc.2008.028142; Gomez DR, 2015, RADIOTHER ONCOL, V115, P257, DOI 10.1016/j.radonc.2015.04.010; Haque MA, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-202; Haque MI, 2018, BMC COMPLEM ALTERN M, V18, DOI 10.1186/s12906-018-2129-5; Hussain Syed Md Akram, 2013, South Asian J Cancer, V2, P279, DOI 10.4103/2278-330X.119901; Jacobsen MM, 2017, LUNG CANCER, V112, P156, DOI 10.1016/j.lungcan.2017.08.011; Kourlaba G, 2019, CANCER EPIDEMIOL, V60, P193, DOI 10.1016/j.canep.2019.04.014; Lovgren M, 2008, ACTA ONCOL, V47, P397, DOI 10.1080/02841860701592392; Lyratzopoulos G, 2015, BRIT J CANCER, V112, pS84, DOI 10.1038/bjc.2015.47; Marlow LAV, 2015, LUNG CANCER, V88, P104, DOI 10.1016/j.lungcan.2015.01.024; Merriam S, 2013, ASIAN PAC J CANCER P, V14, P3593, DOI 10.7314/APJCP.2013.14.6.3593; Murray SR, 2017, FAM PRACT, V34, P740, DOI 10.1093/fampra/cmx057; Neal RD, 2015, PRIM HEALTH CARE RES, V16, P436, DOI 10.1017/S1463423614000516; Nwagbara UI, 2020, GLOBALIZATION HEALTH, V16, DOI 10.1186/s12992-020-00553-8; Panda Abinash, 2017, Perspect Clin Res, V8, P79, DOI 10.4103/2229-3485.203043; Parveen R, 2018, J THORAC ONCOL, V13, pS21, DOI 10.1016/S1556-0864(18)30318-6; Quaife SL, 2015, BRIT J CANCER, V112, P1799, DOI 10.1038/bjc.2015.148; Rakib A., 2015, BANGLADESH PHARM J, V18, P137, DOI [10.3329/bpj.v18i2, DOI 10.3329/BPJ.V18I2]; Shim J, 2014, FAM PRACT, V31, P137, DOI 10.1093/fampra/cmt076; Smith CF, 2016, THORAX, V71, P659, DOI 10.1136/thoraxjnl-2015-208063; Stirling RG, 2014, LUNG, V192, P749, DOI 10.1007/s00408-014-9603-8; Sudhinaraset M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054978; Thapa B, 2014, ASIAN PAC J CANCER P, V15, P175, DOI 10.7314/APJCP.2014.15.1.175; Vashistha V, 2019, APPL CANC RES, V39, P11; Vidaver RM, 2016, J ONCOL PRACT, V12, P553, DOI 10.1200/JOP.2015.009605; Vinas F, 2016, CLIN RESPIR J, V10, P267, DOI 10.1111/crj.12217; Wai ES, 2012, AM J CLIN ONCOL-CANC, V35, P373, DOI 10.1097/COC.0b013e3182143cce; Walter F, 2012, J HEALTH SERV RES PO, V17, P110, DOI 10.1258/jhsrp.2011.010113; WHO, 2015, BANGLADESH HLTH SYST; World Health Organization, 2020, CANC COUNTR PROF 202; Yurdakul AS, 2015, CANCER EPIDEMIOL, V39, P216, DOI 10.1016/j.canep.2014.12.015	56	3	3	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2021	16	9							e0257301	10.1371/journal.pone.0257301	http://dx.doi.org/10.1371/journal.pone.0257301			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XM9EM	34506592	Green Published, gold			2022-12-26	WOS:000729120700032
J	Malfatti, G; Racano, E; Delle Site, R; Gios, L; Micocci, S; Dianti, M; Molini, PB; Allegrini, F; Ravagni, M; Moz, M; Nicolini, A; Romanelli, F				Malfatti, Giulia; Racano, Elisabetta; Delle Site, Roberta; Gios, Lorenzo; Micocci, Stefano; Dianti, Marco; Molini, Pietro Benedetto; Allegrini, Francesca; Ravagni, Mariangela; Moz, Monica; Nicolini, Andrea; Romanelli, Federica			Enabling teleophthalmology during the COVID-19 pandemic in the Province of Trento, Italy: Design and implementation of a mHealth solution	PLOS ONE			English	Article							VISUAL-ACUITY; PHONE	Background Due to the many restrictions imposed during the COVID-19 emergency, the normal clinical activities have been stopped abruptly in view of limiting the circulation of the virus. The extraordinary containment measures have had a dramatic impact on the undertaking and follow-up of ophthalmic outpatients. Objective In order to guarantee proper monitoring and routine care, the Pediatric Ophthalmology equipe of Rovereto Hospital (North-East of Italy) supported by the Competence Center on Digital Health TrentinoSalute4.0, designed and implemented a digital platform, TreC Oculistica, enabling teleophthalmology. We report our innovative-albeit restricted-experience aiming at testing and maximizing the efficacy of remote ophthalmic and orthoptic visits. Methods A multidisciplinary team created the TreC Oculistica platform and defined a teleophthalmology protocol. The system consists of a clinician web interface and a patient mobile application. Clinicians can prescribe outpatients with the App and some preliminary measurements to be self-collected before the televisit. The App conveys the clinician's requests (i.e. measurements) and eases the share of the collected information in a secure digital environment, promoting a new health care workflow. Results Four clinicians took part in the testing phase (2 ophthalmologists and 2 orthoptists) and recruited 37 patients (mostly pediatric) in 3 months. Thanks to a continuous feedback between the testing and the technical implementation, it has been possible to identify pros and cons of the implemented functionalities, considering possible improvements. Digital solutions such as TreC Oculistica advance the digitalization of the Italian health care system, promoting a structured and effective reorganization of the workload supported by digital systems. Conclusions The study tested an innovative digital solution in the teleophthalmology context and represented the first experience within the Italian healthcare system. This solution opens up new possibilities and scenarios that can be effective not only during the pandemic, but also in the traditional management of public health services.	[Malfatti, Giulia; Gios, Lorenzo; Moz, Monica; Nicolini, Andrea] Competence Ctr Digital Hlth Prov Trento, TrentinoSalute40, Trento, Italy; [Racano, Elisabetta; Delle Site, Roberta; Allegrini, Francesca; Ravagni, Mariangela; Romanelli, Federica] Azienda Prov & Serv Sanitari, UO Oculist Osped Rovereto, Trento, Italy; [Micocci, Stefano; Dianti, Marco; Molini, Pietro Benedetto] Fnd Bruno Kessler, Digital Hlth Lab, Povo, Italy		Malfatti, G (corresponding author), Competence Ctr Digital Hlth Prov Trento, TrentinoSalute40, Trento, Italy.	gmalfatti@fbk.eu		Racano, Elisabetta/0000-0002-8896-7202; Malfatti, Giulia/0000-0002-9655-5064; dianti, marco/0000-0002-1404-1423				Abbadessa G, 2021, J CLIN MED, V10, DOI 10.3390/jcm10061160; All About Vision, 2021, SNELL EYE CHART; All About Vision, AMSL GRID; [Anonymous], 2019, GLOBAL MOBILE MARKET; Balasopoulou A, 2017, BMC OPHTHALMOL, V17, P1, DOI [10.4103/ijo.IJO, DOI 10.4103/IJO.IJO]; Bombaci A, 2021, NEUROL SCI, V42, P9, DOI 10.1007/s10072-020-04783-x; Botti A, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12135263; Bradford NK, 2016, RURAL REMOTE HEALTH, V16; Chodosh J, 2020, IMPORTANT CORONAVIRU; Cotter SA, 2015, OPTOMETRY VISION SCI, V92, P6, DOI 10.1097/OPX.0000000000000429; Das AV, 2019, INT J TELEMED APPL, V2019, DOI 10.1155/2019/8107064; Dragoni M, 2019, P 2 INT WORKSH SEM W, V2515, P30; Eccher C, 2020, J BIOMED INFORM, V102, DOI 10.1016/j.jbi.2019.103359; Eze ND, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0237585; Gioia Gianfranco, 2019, Rom J Ophthalmol, V63, P197; Gios, 2021, JMIR FORM RES; Harrison C, 2021, J CLIN MICROBIOL, V59, DOI 10.1128/JCM.02304-20; Hogarty DT, 2020, SURV OPHTHALMOL, V65, P250, DOI 10.1016/j.survophthal.2019.09.001; Lavorgna L, 2022, NEUROL SCI, V43, P1007, DOI 10.1007/s10072-021-05389-7; Li JPO, 2021, PROG RETIN EYE RES, V82, DOI 10.1016/j.preteyeres.2020.100900; Madanian S, 2019, BMJ HEALTH CARE INFO, V26, DOI 10.1136/bmjhci-2019-100071; Maines M, 2020, IJC HEART VASC, V30, DOI 10.1016/j.ijcha.2020.100625; Margolis KL, 2013, JAMA-J AM MED ASSOC, V310, P46, DOI 10.1001/jama.2013.6549; Mastropasqua L, 2021, EYE, V35, P2319, DOI 10.1038/s41433-020-01135-z; ME M., TUTORIAL MD EYECARE; Moccia M, 2020, NEUROL SCI, V41, P1369, DOI 10.1007/s10072-020-04470-x; Moccia M, 2016, MULT SCLER RELAT DIS, V7, P41, DOI 10.1016/j.msard.2016.03.001; Nagata JM, 2021, J RURAL HEALTH, V37, P145, DOI 10.1111/jrh.12433; Ophthalmology UC s H of PD of, 2020, TAK 9 GAZ PHOT HOM; Optometrists Network, HIDD IM STER; P council, 2020, PROV TEL OTH PROV DE; Parikh D, 2020, SEMIN OPHTHALMOL, V35, P210, DOI 10.1080/08820538.2020.1789675; Pathipati AS, 2016, GRAEF ARCH CLIN EXP, V254, P1175, DOI 10.1007/s00417-016-3291-4; Pekmezaris R, 2018, HEALTH AFFAIR, V37, P1983, DOI 10.1377/hlthaff.2018.05087; Perera C, 2015, EYE, V29, P888, DOI 10.1038/eye.2015.60; Rodin Alexander, 2017, JMIR Mhealth Uhealth, V5, pe84, DOI 10.2196/mhealth.7055; Rosenbaum AJ, 2014, INT J GYNECOL OBSTET, V126, P156, DOI 10.1016/j.ijgo.2014.02.026; Saleem SM, 2020, AM J OPHTHALMOL, V216, P237, DOI 10.1016/j.ajo.2020.04.029; Scanzera AC, 2021, EYE, V35, P1529, DOI 10.1038/s41433-020-01323-x; Seaman CP, 2019, J CLIN VIROL, V118, P28, DOI 10.1016/j.jcv.2019.07.010; Shahbaz R, 2021, EUR J OPHTHALMOL, V31, P13, DOI 10.1177/1120672120934405; Sharma M, 2020, INDIAN J OPHTHALMOL, V68, P1328, DOI 10.4103/ijo.IJO_1784_20; Silverstein E, 2021, AM J OPHTHALMOL, V221, P199, DOI 10.1016/j.ajo.2020.08.007; Skrzypecki J, 2019, CLIN EXP OPTOM, V102, P180, DOI 10.1111/cxo.12830; Spina E, 2021, NEUROL SCI, V42, P3553, DOI 10.1007/s10072-021-05396-8; Stewart C, 2022, BRIT J OPHTHALMOL, V106, P1157, DOI 10.1136/bjophthalmol-2020-318385; Tan SY, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0244417; Telehealth Resources Testing Vision & Eye Movements, 2020, ORTHOPT AUST, P7; Teo KYC, 2020, EYE, V34, P1161, DOI 10.1038/s41433-020-0960-7; Torres Elmar, 2018, Med Hypothesis Discov Innov Ophthalmol, V7, P57; Tschan CA, 2019, ACTA NEUROCHIR, V161, P1605, DOI 10.1007/s00701-019-03959-5; UPMC Children' s Hospital of Pittsburgh Department of Ophthalmology, 2020, MEAS VIS AC HOM; Wallace DK, 2018, OPHTHALMOLOGY, V125, P1961, DOI 10.1016/j.ophtha.2018.05.001; Wang C, 2020, LANCET, V395, P470, DOI 10.1016/S0140-6736(20)30185-9; Wiersinga WJ, 2020, JAMA-J AM MED ASSOC, V324, P782, DOI 10.1001/jama.2020.12839; Wu MT, 2017, BMC OPHTHALMOL, V17, DOI 10.1186/s12886-017-0624-y; Yoon CK, 2014, AM J OPHTHALMOL, V158, P924, DOI 10.1016/j.ajo.2014.07.035	57	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2021	16	9							e0257250	10.1371/journal.pone.0257250	http://dx.doi.org/10.1371/journal.pone.0257250			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XM9EM	34506578	Green Published, gold			2022-12-26	WOS:000729120700037
J	Mamtani, M; Jaisinghani, MT; Jaiswal, SG; Pipal, KV; Patel, AA; Kulkarni, H				Mamtani, Manju; Jaisinghani, Manisha T.; Jaiswal, Sujeet G.; Pipal, Kanchan V.; Patel, Ashwini A.; Kulkarni, Hemant			Genetic association of anthropometric traits with type 2 diabetes in ethnically endogamous Sindhi families	PLOS ONE			English	Article							CARDIOVASCULAR RISK-FACTORS; SKINFOLD THICKNESS; BETA-THALASSEMIA; LINKAGE ANALYSIS; HERITABILITY; PREVALENCE; MELLITUS; AMERICANS; INDIA	Background Ethnically endogamous populations can shed light on the genetics of type 2 diabetes. Such studies are lacking in India. We conducted this study to determine the genetic and environmental contributions of anthropometric traits to type 2 diabetes risk in the Sindhi families in central India. Methods We conducted a family study in Indian Sindhi families with at least one case of type 2 diabetes. Variance components methods were used to quantify the genetic association of 18 anthropometric traits with eight type 2 diabetes related traits. Univariate and bivariate polygenic models were used to determine the heritability, genetic and environmental correlation of anthropometric traits with type 2 diabetes related traits. Results We included 1,152 individuals from 112 phenotyped families. The ascertainment-bias corrected prevalence of type 2 diabetes was 35%. Waist circumference, hip circumference and the biceps, triceps, subscapular and medial calf skinfold thicknesses were polygenically and significantly associated with type 2 diabetes. The range of heritability of the anthropometric traits and type 2 diabetes related traits was 0.27-0.73 and 0.00-0.39, respectively. Heritability of type 2 diabetes as a discrete trait was 0.35. Heritability curves demonstrated a substantial local influence of type 2 diabetes related traits. Bivariate trait analyses showed that biceps and abdominal skinfold thickness and all waist-containing indexes were strongly genetically correlated with type 2 diabetes. Conclusions In this first study of Sindhi families, we found evidence for genetic and environmental concordance of anthropometric traits with type 2 diabetes. Future studies need to probe into the genetics of type 2 diabetes in this population.	[Mamtani, Manju; Jaisinghani, Manisha T.; Jaiswal, Sujeet G.; Pipal, Kanchan V.; Patel, Ashwini A.; Kulkarni, Hemant] Lata Med Res Fdn, Nagpur, Maharashtra, India; [Mamtani, Manju; Kulkarni, Hemant] LLC, M&H Res, San Antonio, TX USA		Mamtani, M (corresponding author), Lata Med Res Fdn, Nagpur, Maharashtra, India.; Mamtani, M (corresponding author), LLC, M&H Res, San Antonio, TX USA.	manju.mamtani@mnhresearch.com	Kulkarni, Hemant/AEM-5750-2022		Lata Medical Research Foundation, Nagpur, India	Lata Medical Research Foundation, Nagpur, India	MM received funding for this study internally through the Lata Medical Research Foundation, Nagpur, India. The funder provided support in the form of salaries for authors MTJ, SGJ, KVP and AAP, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section. MM and HK are also affiliated with M&H Research, LLC, San Antonio, Texas, USA. This affiliation only provided hardware and software support required for the analyses and manuscript writing but had no role in study conceptualization, data collection or decision to publish the manuscript.	Adediran Olufemi Sola, 2013, BMC Res Notes, V6, P123, DOI 10.1186/1756-0500-6-123; Almasy L, 1997, GENET EPIDEMIOL, V14, P953, DOI 10.1002/(SICI)1098-2272(1997)14:6<953::AID-GEPI65>3.0.CO;2-K; Almasy L, 1998, AM J HUM GENET, V62, P1198, DOI 10.1086/301844; Anand S., 1996, P IND HIST C, V57, P633; Andrade S, 2002, AM J CLIN NUTR, V75, P587, DOI 10.1093/ajcn/75.3.587; Angi A, 2020, BIOMEDICINES, V8, DOI 10.3390/biomedicines8110478; Anju Choudhary, 2012, International Journal of Medicine and Public Health, V2, P46; Anoop S, 2017, J DIABETES RES, V2017, DOI 10.1155/2017/2376016; Austin MA, 2004, ANN HUM GENET, V68, P179, DOI 10.1046/j.1529-8817.2004.00078.x; BARNOUW V, 1966, PHYLON, V27, P40, DOI 10.2307/273320; Bellis C, 2014, CIRC-CARDIOVASC GENE, V7, P854, DOI 10.1161/CIRCGENETICS.114.000600; Berentsen GD., 2020, ARXIV200408584, DOI [10.1002/sim.8845, DOI 10.1002/SIM.8845]; Bowen PG, 2017, J AM ASSOC NURSE PRA, V29, P70, DOI 10.1002/2327-6924.12393; Carter M., 2008, INDIANS COLONIAL DIA; Chatterjee N, 2010, HEMOGLOBIN, V34, P548, DOI 10.3109/03630269.2010.526488; Crouch DJM, 2020, P NATL ACAD SCI USA, V117, P18924, DOI 10.1073/pnas.2005634117; Danaei G, 2011, LANCET, V378, P31, DOI 10.1016/S0140-6736(11)60679-X; de Onis Mercedes, 2004, Food Nutr Bull, V25, pS27; Diabet Prevention Program Res Grp, 2006, OBESITY, V14, P2107; Ebrahim S, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000268; Ehm MG, 2000, AM J HUM GENET, V66, P1871, DOI 10.1086/302950; Gonzalez-Dominguez A, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21155529; Goropashnaya AV, 2009, METABOLISM, V58, P22, DOI 10.1016/j.metabol.2008.09.002; Gupta S., 2013, INT J ANAT RES, V2, P115; Hadgraft NT, 2021, BRIT J SPORT MED, V55, P144, DOI 10.1136/bjsports-2019-101154; Hoch D, 2019, MOL ASPECTS MED, V66, P21, DOI 10.1016/j.mam.2018.11.002; Il Son J, 2013, DIABETES METAB J, V37, P343, DOI 10.4093/dmj.2013.37.5.343; Jaacks LM, 2019, ENVIRON INT, V133, DOI 10.1016/j.envint.2019.105089; Jawahirani A, 2007, PUBLIC HEALTH, V121, P193, DOI 10.1016/j.puhe.2006.10.017; Jenum AK, 2019, DIABETOLOGIA, V62, P1337, DOI 10.1007/s00125-019-4905-2; Kataria SK, 2013, INT J ANAT RES, V3, P171; Kinra S, 2020, PLOS MED, V17, DOI 10.1371/journal.pmed.1003234; Kulkarni H, 2017, BMC GENET, V18, DOI 10.1186/s12863-017-0515-5; Leighton E, 2017, DIABETES THER, V8, P475, DOI 10.1007/s13300-017-0265-4; Ley SH., 2018, DIABETES AM; Loh WJ, 2018, INT J OBESITY, V42, P1939, DOI 10.1038/s41366-018-0034-0; Lovic D, 2020, CURR VASC PHARMACOL, V18, P104, DOI 10.2174/1570161117666190405165911; Mamtani M, 2014, DIABETIC MED, V31, P31, DOI 10.1111/dme.12266; Mamtani M, 2016, CLIN EPIGENETICS, V8, DOI 10.1186/s13148-016-0173-x; Mamtani M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059153; Mathias RA, 2009, METABOLISM, V58, P1439, DOI 10.1016/j.metabol.2009.04.041; Mengesha B, 1997, E AFR MED J, V74, P37; Misra A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140447; Mitchell BD, 1996, CIRCULATION, V94, P2159, DOI 10.1161/01.CIR.94.9.2159; Moorjani P, 2013, AM J HUM GENET, V93, P422, DOI 10.1016/j.ajhg.2013.07.006; Namazi N, 2018, NUTR METAB CARDIOVAS, V28, P657, DOI 10.1016/j.numecd.2018.03.006; Ortega MA, 2020, NUTRIENTS, V12, DOI 10.3390/nu12092749; Pankow JS, 2001, ATHEROSCLEROSIS, V154, P681, DOI 10.1016/S0021-9150(00)00586-4; Piche ME, 2020, CIRC RES, V126, P1477, DOI 10.1161/CIRCRESAHA.120.316101; Reich D, 2009, NATURE, V461, P489, DOI 10.1038/nature08365; Reinauer H., 2002, LAB DIAGNOSIS MONITO; Ruiz-Alejos A, 2020, PUBLIC HEALTH NUTR, V23, P63, DOI 10.1017/S1368980019001307; Saklayen MG, 2018, CURR HYPERTENS REP, V20, DOI 10.1007/s11906-018-0812-z; Shrestha S, 2019, J EPIDEMIOL COMMUN H, V73, P681, DOI 10.1136/jech-2018-211567; Sinnwell J., 2020, KINSHIP2 PEDIGREE FU; Surendar J, 2016, POSTGRAD MED J, V92, P379, DOI 10.1136/postgradmedj-2015-133363; Kumar US, 2020, GENES-BASEL, V11, DOI 10.3390/genes11111256; Vasileva LV, 2018, FOOD CHEM TOXICOL, V121, P173, DOI 10.1016/j.fct.2018.08.071; Verma S, 2017, DIABETES METAB SYND, V11, P73, DOI 10.1016/j.dsx.2016.06.017; Warrew DM, 2005, HUM BIOL, V77, P1, DOI 10.1353/hub.2005.0034; World Health Organization (WHO), 2011, HEM CONC DIAGN AN AS; Yaghootkar H, 2020, J INTERN MED, V288, P271, DOI 10.1111/joim.13082; Zabaneh D, 2009, DIABETOLOGIA, V52, P2585, DOI 10.1007/s00125-009-1504-7; Zaitlen N, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003032; Zhang D, 2019, QUANT IMAG MED SURG, V9, P1000, DOI 10.21037/qims.2019.05.18; Zimmet P, 2001, NATURE, V414, P782, DOI 10.1038/414782a	66	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2021	16	9							e0257390	10.1371/journal.pone.0257390	http://dx.doi.org/10.1371/journal.pone.0257390			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XM9EM	34506595	gold, Green Published			2022-12-26	WOS:000729120700001
J	Peraud, W; Quintard, B; Constant, A				Peraud, William; Quintard, Bruno; Constant, Aymery			Factors associated with violence against women following the COVID-19 lockdown in France: Results from a prospective online survey	PLOS ONE			English	Article								Background The aim of this research was to investigate the impact of the first COVID-19 lockdown (March 17(th)-May 11(th) 2020) on violence against women in France. Methods A prospective survey was conducted online between April 2th 2020 and July 5(th) 2020. Female respondents were recruited from social media networks using the snowball sampling method. Data were collected three times: during (2-19 April) and at the end (11-25 May) of the first lockdown, and following the first lockdown (20 June- 05 July). Sociodemographic variables, lockdown living conditions, financial impact of COVID, and history of psychiatric disorder were evaluated, together with changes in psychological distress over the lockdown period, and the risk of being assaulted post lockdown. Results Psychological distress was elevated and remained stable for most of the 1538 female respondents during lockdown. More than 7% of women were affected by physical or sexual violence post lockdown. Unwanted sexual contact accounted for the majority of abuse, but physical and sexual assault were also prevalent. The risk of being abused was higher for participants who had changed anxiety/insomnia symptoms over the lockdown period, and a history of abuse. Discussion Women who experienced changes in anxiety/insomnia symptoms during the COVID-19 lockdown were at higher risk than others of being assaulted post lockdown, especially when they were already socially vulnerable. While social and psychological factors accounting for these changes warrant further investigation, communication and preventive measures during pandemics should include initiatives tailored to women more vulnerable to violence.	[Peraud, William; Quintard, Bruno] Bordeaux Univ, Dept Psychol, Bordeaux, France; [Constant, Aymery] EHESP Sch Publ Hlth, Dept Social & Behav Sci, Rennes, France		Constant, A (corresponding author), EHESP Sch Publ Hlth, Dept Social & Behav Sci, Rennes, France.	aymery.constant@ehesp.fr	constant, aymery/ABD-9537-2021	constant, aymery/0000-0001-9282-3036				Ashraf A, 2021, ASIAN J SOC HEAL BEH, V4, P47, DOI 10.4103/shb.shb_45_20; Bacchus LJ, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-019995; Bartoszek A, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17207417; Brooks SK, 2020, LANCET, V395, P912, DOI [10.1016/S0140-6736(20)30460-8., 10.1016/S0140-6736(20)30460-8]; Campbell A.M., 2020, FORENSIC SCI INT REP, V2, DOI [10.1016/j.fsir.2020.100089, DOI 10.1016/J.FSIR.2020.100089]; Cenat JM, 2021, PSYCHIAT RES, V295, DOI 10.1016/j.psychres.2020.113599; Chiasson M, 2018, PRAT PSYCHOL, V24, P21, DOI 10.1016/j.prps.2017.02.002; Constant A, 2020, FRONT PSYCHOL, V11, DOI 10.3389/fpsyg.2020.579460; De Mont-Marin F., 1993, Encephale, V19, P293; Dillon Gina, 2013, Int J Family Med, V2013, P313909, DOI 10.1155/2013/313909; Evans DP, 2020, BMC WOMENS HEALTH, V20, DOI 10.1186/s12905-020-01115-1; Every-Palmer S, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0241658; Flury M, 2010, SWISS MED WKLY, V140, P23, DOI 10.4414/smw.2010.13099; Gosangi B, 2021, RADIOLOGY, V298, pE38, DOI 10.1148/radiol.2020202866; Hellmann DF, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15081613; Humphreys KL, 2020, PEDIATRICS, V146, DOI 10.1542/peds.2020-0982; Husky MM, 2020, COMPR PSYCHIAT, V102, DOI 10.1016/j.comppsych.2020.152191; Lal Abhishek, 2020, Eur J Dent, V14, pS27, DOI 10.1055/s-0040-1718644; Mazza M, 2020, PSYCHIAT RES, V289, DOI 10.1016/j.psychres.2020.113046; Mwiine AmonAshaba., 2020, CHIK WORLDW OV; Odriozola-Gonzalez P, 2022, J HEALTH PSYCHOL, V27, P825, DOI 10.1177/1359105320967086; Olashore AA, 2021, ASIAN J SOC HEAL BEH, V4, P85, DOI 10.4103/shb.shb_32_21; PARIENTE P D, 1992, European Psychiatry, V7, P15; Peretti-Watel P, 2020, BMC PUBLIC HEALTH, V20, DOI 10.1186/s12889-020-10048-1; Rajabimajd N, 2021, ASIAN J SOC HEAL BEH, V4, P51, DOI 10.4103/shb.shb_24_21; Ryerson NC, 2022, PSYCHOL REP, V125, P200, DOI 10.1177/0033294120978160; Salari N, 2020, HUM RESOUR HEALTH, V18, DOI 10.1186/s12960-020-00544-1; Salari N, 2020, GLOBALIZATION HEALTH, V16, DOI 10.1186/s12992-020-00589-w; Sanz-Barbero B, 2018, J EPIDEMIOL COMMUN H, V72, P611, DOI 10.1136/jech-2017-209701; Scholle SH, 1998, J GEN INTERN MED, V13, P607, DOI 10.1046/j.1525-1497.1998.00183.x; Shah SMA, 2021, COMMUNITY MENT HLT J, V57, P101, DOI 10.1007/s10597-020-00728-y; Sharma R, 2021, ASIAN J SOC HEAL BEH, V4, P98, DOI 10.4103/shb.shb_9_21; Stahlman S, 2015, J TRAUMA STRESS, V28, P167, DOI 10.1002/jts.22009; Stanton R, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17114065; Topolovec-Vranic J, 2016, J MED INTERNET RES, V18, DOI 10.2196/jmir.5698; Trevillion K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051740; Viero A, 2021, FORENSIC SCI INT, V319, DOI 10.1016/j.forsciint.2020.110650; Whitaker C, 2017, J MED INTERNET RES, V19, DOI 10.2196/jmir.7071; Williamson HC, 2020, PSYCHOL SCI, V31, P1479, DOI 10.1177/0956797620972688; World Health O, 2013, GLOB REG EST VIOL WO; World Health Organization, 2020, MENTAL HLTH PSYCHOSO; Yakubovich AR, 2018, AM J PUBLIC HEALTH, V108, pE1, DOI 10.2105/AJPH.2018.304428; Zhang Y, 2020, J PSYCHOSOM RES, V138, DOI 10.1016/j.jpsychores.2020.110253	43	2	2	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2021	16	9							e0257193	10.1371/journal.pone.0257193	http://dx.doi.org/10.1371/journal.pone.0257193			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	XM9EM	34506545	Green Published, gold			2022-12-26	WOS:000729120700067
J	Li, J; Guo, C; Rood, C; Zhang, JS				Li, Jian; Guo, Chun; Rood, Christopher; Zhang, Jinsong			A C terminus-dependent conformational change is required for HDAC3 activation by nuclear receptor corepressors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTONE-DEACETYLASE; CLASS-I; INTERDOMAIN COMMUNICATION; LIGAND-BINDING; SMRT; COMPLEX; TRANSCRIPTION; MECHANISM; PROTEINS; INSIGHTS	Histone deacetylase 3 (HDAC3) plays an important role in signal-dependent transcription and is dysregulated in diseases such as cancer. Previous studies have shown that the function of HDAC3 requires an activation step, which is mediated by the interactions of HDAC3 with the deacetylase-activation domain (DAD) of nuclear receptor corepressors and inositol tetra phosphate (IP4). However, the role of the unique HDAC3 C terminal region in HDAC3 activation is elusive. Here multiple biochemical, structural, and functional studies show that HDAC3 activation requires a priming step mediated by the C terminus to remodel HDAC3 conformation. We show that multiple C-terminal mutations prevent HDAC3 activation by preventing this C terminus-dependent conformational change. Mechanistically, we demonstrate that the C terminus- mediated function in altering HDAC3 conformation is required for proper complex formation of HDAC3 with DAD and IP4 by allowing HDAC3 to undergo IP4-dependent interaction with DAD. Remarkably, we found that this C terminus function is conformation dependent, being necessary for HDAC3 activation prior to but not after the conformational change. Together, our study defines two functional states of free HDAC3, reveals the complete HDAC3 activation pathway, and links the C terminus function to the specific interaction between HDAC3 and DAD. These results also have implications in how signaling pathways may converge on the C terminus to regulate HDAC3 and suggest that the C terminus- mediated conformational change could represent a new target for inhibiting HDAC3 in diseases such as cancer.	[Li, Jian; Guo, Chun; Rood, Christopher; Zhang, Jinsong] St Louis Univ, Sch Med, Dept Physiol & Pharmacol, St Louis, MO 63103 USA	Saint Louis University	Zhang, JS (corresponding author), St Louis Univ, Sch Med, Dept Physiol & Pharmacol, St Louis, MO 63103 USA.	jinsong.zhang@health.slu.edu		Zhang, Jinsong/0000-0002-8798-7316; Rood, Christopher/0000-0002-7742-4026	National Institutes of Health [R21CA178513]; Saint Louis University; Siteman Investment Program (SIP) Award from the Siteman Cancer Center at Barnes-Jewish; Washington University School of Medicine	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Saint Louis University; Siteman Investment Program (SIP) Award from the Siteman Cancer Center at Barnes-Jewish; Washington University School of Medicine	This work is supported by National Institutes of Health Grants R21CA178513, President's Research fund from Saint Louis University, Siteman Investment Program (SIP) Award from the Siteman Cancer Center at Barnes-Jewish and Washington University School of Medicine (to J. Z.) . The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Arrar M, 2013, PROTEIN SCI, V22, P83, DOI 10.1002/pro.2190; Case D. A., 2018, AMBER 2019; Codina A, 2005, P NATL ACAD SCI USA, V102, P6009, DOI 10.1073/pnas.0500299102; Emmett MJ, 2019, NAT REV MOL CELL BIO, V20, P102, DOI 10.1038/s41580-018-0076-0; Escaffit F, 2007, MOL CELL BIOL, V27, P554, DOI 10.1128/MCB.00869-06; Finnin MS, 1999, NATURE, V401, P188, DOI 10.1038/43710; Gordon JC, 2005, NUCLEIC ACIDS RES, V33, pW368, DOI 10.1093/nar/gki464; Guenther MG, 2000, GENE DEV, V14, P1048; Guenther MG, 2002, GENE DEV, V16, P3130, DOI 10.1101/gad.1037502; Guenther MG, 2001, MOL CELL BIOL, V21, P6091, DOI 10.1128/MCB.21.18.6091-6101.2001; Guo C, 2012, J BIOL CHEM, V287, P12111, DOI 10.1074/jbc.M111.327023; Hassig CA, 1997, CURR OPIN CHEM BIOL, V1, P300, DOI 10.1016/S1367-5931(97)80066-X; He B, 1999, J BIOL CHEM, V274, P37219, DOI 10.1074/jbc.274.52.37219; Karagianni P, 2007, ONCOGENE, V26, P5439, DOI 10.1038/sj.onc.1210612; Krishna MMG, 2005, P NATL ACAD SCI USA, V102, P1053, DOI 10.1073/pnas.0409114102; Kuo MH, 1998, BIOESSAYS, V20, P615, DOI 10.1002/(SICI)1521-1878(199808)20:8<615::AID-BIES4>3.0.CO;2-H; Kuo MH, 2000, MOL CELL, V6, P1309, DOI 10.1016/S1097-2765(00)00129-5; Lauffer BEL, 2013, J BIOL CHEM, V288, P26926, DOI 10.1074/jbc.M113.490706; Leipe DD, 1997, NUCLEIC ACIDS RES, V25, P3693, DOI 10.1093/nar/25.18.3693; Lewandowski SL, 2015, J BIOL CHEM, V290, P27067, DOI 10.1074/jbc.M115.684753; Li JW, 2000, EMBO J, V19, P4342, DOI 10.1093/emboj/19.16.4342; Milazzo G, 2020, GENES-BASEL, V11, DOI 10.3390/genes11050556; Millard CJ, 2017, TRENDS PHARMACOL SCI, V38, P363, DOI 10.1016/j.tips.2016.12.006; Millard CJ, 2013, MOL CELL, V51, P57, DOI 10.1016/j.molcel.2013.05.020; Nguyen HCB, 2020, NATURE, V584, P286, DOI 10.1038/s41586-020-2576-2; Pang YP, 2000, PROTEIN SCI, V9, P1857; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Roe DR, 2013, J CHEM THEORY COMPUT, V9, P3084, DOI 10.1021/ct400341p; Schultz BE, 2004, BIOCHEMISTRY-US, V43, P11083, DOI 10.1021/bi0494471; Sever R, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a016709; Shao DL, 1998, NATURE, V396, P377, DOI 10.1038/24634; Somoza JR, 2004, STRUCTURE, V12, P1325, DOI 10.1016/j.str.2004.04.012; Sullivan SM, 2008, P NATL ACAD SCI USA, V105, P13829, DOI 10.1073/pnas.0805364105; Sun Z, 2013, MOL CELL, V52, P769, DOI 10.1016/j.molcel.2013.10.022; Vannini A, 2004, P NATL ACAD SCI USA, V101, P15064, DOI 10.1073/pnas.0404603101; Watson PJ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11262; Watson PJ, 2012, NATURE, V481, P335, DOI 10.1038/nature10728; Xia Y, 2007, MOL CELL, V25, P219, DOI 10.1016/j.molcel.2007.01.005; Yang WM, 2002, J BIOL CHEM, V277, P9447, DOI 10.1074/jbc.M105993200; Yang XJ, 2007, ONCOGENE, V26, P5310, DOI 10.1038/sj.onc.1210599; You SH, 2013, NAT STRUCT MOL BIOL, V20, P182, DOI 10.1038/nsmb.2476; Zhang JS, 1999, MOL CELL BIOL, V19, P6448; Zhang JS, 2002, MOL CELL, V9, P611, DOI 10.1016/S1097-2765(02)00468-9; Zhang XH, 2005, GENE DEV, V19, P827, DOI 10.1101/gad.1286005	44	1	1	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT	2021	297	4							101192	10.1016/j.jbc.2021.101192	http://dx.doi.org/10.1016/j.jbc.2021.101192			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	WP4BY	34520758	gold, Green Published			2022-12-26	WOS:000713080600011
J	Putta, P; Smith, AH; Chaudhuri, P; Guardia-Wolff, R; Rosenbaum, MA; Graham, LM				Putta, Priya; Smith, Andrew H.; Chaudhuri, Pinaki; Guardia-Wolff, Rocio; Rosenbaum, Michael A.; Graham, Linda M.			Activation of the cytosolic calcium-independent phospholipase A(2) beta isoform contributes to TRPC6 externalization via release of arachidonic acid	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOTHELIAL REGENERATION; LYSOPHOSPHATIDYLCHOLINE; CHANNEL; MIGRATION; ENZYMES; LYSOPHOSPHOLIPIDS; INHIBITION; METABOLISM; A(2)-ALPHA; MECHANISM	During vascular interventions, oxidized low-density lipoprotein and lysophosphatidylcholine (lysoPC) accumulate at the site of arterial injury, inhibiting endothelial cell (EC) migration and arterial healing. LysoPC activates canonical transient receptor potential 6 (TRPC6) channels, leading to a prolonged increase in intracellular calcium ion concentration that inhibits EC migration. However, an initial increase in intracellular calcium ion concentration is required to activate TRPC6, and this mechanism remains elusive. We hypothesized that lysoPC activates the lipid-cleaving enzyme phospholipase A(2) (PLA(2)), which releases arachidonic acid (AA) from the cellular membrane to open arachidonate-regulated calcium channels, allowing calcium influx that promotes externalization and activation of TRPC6 channels. The focus of this study was to identify the roles of calcium-dependent and/or calcium independent PLA(2) in lysoPC-induced TRPC6 externalization. We show that lysoPC induced PLA(2) enzymatic activity and caused AA release in bovine aortic ECs. To identify the specific subgroup and the isoform(s) of PLA(2) involved in lysoPCinduced TRPC6 activation, transient knockdown studies were performed in the human endothelial cell line EA.hy926 using siRNA to inhibit the expression of genes encoding cPLA(2)alpha , cPLA(2)gamma , iPLA(2)beta , or iPLA(2)gamma. Downregulation of the beta isoform of iPLA(2) blocked lysoPC-induced release of AA from EC membranes and TRPC6 externalization, as well as preserved EC migration in the presence of lysoPC. We propose that blocking TRPC6 activation and promoting endothelial healing could improve the outcomes for patients undergoing cardiovascular interventions.	[Putta, Priya; Chaudhuri, Pinaki; Guardia-Wolff, Rocio; Graham, Linda M.] Cleveland Clin, Dept Biomed Engn, Cleveland, OH 44106 USA; [Smith, Andrew H.; Graham, Linda M.] Cleveland Clin, Dept Vasc Surg, Cleveland, OH 44106 USA; [Rosenbaum, Michael A.] Louis Stokes Cleveland Vet Affairs Med Ctr, Surg Serv, Cleveland, OH USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University; Louis Stokes Cleveland Veterans Affairs Medical Center	Putta, P (corresponding author), Cleveland Clin, Dept Biomed Engn, Cleveland, OH 44106 USA.	puttaP@ccf.org		Putta, Priya/0000-0002-6499-3836	NIH National Heart, Lung, and Blood Institute [R01-HL064357]; United States Department of Veterans Affairs Biomedical Laboratory Research and Development Service [IK2BX003628]	NIH National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); United States Department of Veterans Affairs Biomedical Laboratory Research and Development Service	This work was supported by NIH National Heart, Lung, and Blood Institute Grant R01-HL064357 (to L. M. G.) and by Career Development Award #IK2BX003628 from the United States Department of Veterans Affairs Biomedical Laboratory Research and Development Service (to M. A. R). The contents of this article are solely the responsibility of the authors and do not represent the views of the National Institutes of Health, U.S. Department of Veterans Affairs, or the United States government.	Al-Shawaf E, 2011, CELL CALCIUM, V50, P343, DOI 10.1016/j.ceca.2011.06.003; Alberghina M, 2010, MICROVASC RES, V80, P280, DOI 10.1016/j.mvr.2010.03.013; Andersson DA, 2007, J NEUROSCI, V27, P3347, DOI 10.1523/JNEUROSCI.4846-06.2007; Balboa MA, 2002, J BIOL CHEM, V277, P40384, DOI 10.1074/jbc.M206155200; Balsinde J, 1997, ADV EXP MED BIOL, V407, P99; Balsinde J, 1996, J BIOL CHEM, V271, P6758, DOI 10.1074/jbc.271.12.6758; Barton M, 2001, J CARDIOVASC PHARM, V38, pS23, DOI 10.1097/00005344-200111002-00007; Beech DJ, 2012, ACTA PHYSIOL, V204, P227, DOI 10.1111/j.1748-1716.2011.02311.x; Cayouette S, 2004, J BIOL CHEM, V279, P7241, DOI 10.1074/jbc.M312042200; Chaudhuri P, 2005, CIRC RES, V97, P674, DOI 10.1161/01.RES.0000184667.82354.b1; Chaudhuri P, 2003, ARTERIOSCL THROM VAS, V23, P218, DOI 10.1161/01.ATV.0000052673.77316.01; Chaudhuri P, 2008, MOL BIOL CELL, V19, P3203, DOI 10.1091/mbc.E07-08-0765; Chaudhuri P, 2017, AM J PHYSIOL-CELL PH, V313, pC541, DOI 10.1152/ajpcell.00028.2017; Chaudhuri P, 2016, P NATL ACAD SCI USA, V113, P2110, DOI 10.1073/pnas.1600371113; Chiu CC, 2017, ONCOTARGET, V8, P79046, DOI 10.18632/oncotarget.20893; Dennis EA, 2011, CHEM REV, V111, P6130, DOI 10.1021/cr200085w; Flemming PK, 2006, J BIOL CHEM, V281, P4977, DOI 10.1074/jbc.M510301200; GROSS RW, 1995, J BIOL CHEM, V270, P14855, DOI 10.1074/jbc.270.25.14855; Hanna VS, 2018, J ADV RES, V11, P23, DOI 10.1016/j.jare.2018.03.005; HAUDENSCHILD CC, 1979, LAB INVEST, V41, P407; Herbert SP, 2009, J BIOL CHEM, V284, P5784, DOI 10.1074/jbc.M807282200; Herbert SP, 2005, MOL BIOL CELL, V16, P3800, DOI 10.1091/mbc.E05-02-0164; Hooks SB, 2008, BIOCHEM PHARMACOL, V76, P1059, DOI 10.1016/j.bcp.2008.07.044; Isshiki M, 2002, J CELL SCI, V115, P475; Janks L, 2019, J IMMUNOL, V202, P883, DOI 10.4049/jimmunol.1801101; LEHMAN JJ, 1993, J BIOL CHEM, V268, P20713; Lei XY, 2010, BIOCHIMIE, V92, P627, DOI 10.1016/j.biochi.2010.01.005; Lupo G, 2005, BBA-MOL CELL BIOL L, V1735, P135, DOI 10.1016/j.bbalip.2005.05.008; Murugesan G, 1996, J CLIN INVEST, V97, P2736, DOI 10.1172/JCI118728; MURUGESAN G, 1993, J CELL BIOL, V120, P1011, DOI 10.1083/jcb.120.4.1011; Osterhout JL, 2000, J BIOL CHEM, V275, P8248, DOI 10.1074/jbc.275.11.8248; Perez R, 2004, J BIOL CHEM, V279, P40385, DOI 10.1074/jbc.M402562200; Quach ND, 2014, BIOCHEM PHARMACOL, V90, P338, DOI 10.1016/j.bcp.2014.05.022; Riederer M, 2010, J LIPID RES, V51, P2957, DOI 10.1194/jlr.M006536; Rosenbaum MA, 2015, J VASC SURG, V62, P1040, DOI 10.1016/j.jvs.2014.04.033; SCHWARTZ SM, 1978, LAB INVEST, V38, P568; Sharma J, 2011, AM J PHYSIOL-CELL PH, V300, pC872, DOI 10.1152/ajpcell.00289.2010; Shishehbor MH, 2006, FREE RADICAL BIO MED, V41, P1678, DOI 10.1016/j.freeradbiomed.2006.09.001; Shuttleworth TJ, 2009, CELL CALCIUM, V45, P602, DOI 10.1016/j.ceca.2009.02.001; Smani T, 2004, NAT CELL BIOL, V6, P113, DOI 10.1038/ncb1089; Sommerfelt RM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119088; Tran POT, 1999, EXP CELL RES, V246, P319, DOI 10.1006/excr.1998.4239; Wong JT, 1998, J BIOL CHEM, V273, P6830, DOI 10.1074/jbc.273.12.6830	43	1	1	1	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT	2021	297	4							101180	10.1016/j.jbc.2021.101180	http://dx.doi.org/10.1016/j.jbc.2021.101180			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	WP4BY	34509476	gold, Green Published			2022-12-26	WOS:000713080600001
J	Zheng, WW; Sun, LP; Yang, LY; Xu, TJ				Zheng, Weiwei; Sun, Lingping; Yang, Liyuan; Xu, Tianjun			The circular RNA circBCL2L1 regulates innate immune responses via microRNA-mediated downregulation of TRAF6 in teleost fish	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; ACTIVATION; TLRS; MIR-146A; FAMILY; DOMAIN; ROLES; RLRS; AP-1; NLRS	Growing numbers of studies have shown that circular RNAs (circRNAs) can function as regulatory factors to regulate the innate immune response, cell proliferation, cell migration, and other important processes in mammals. However, the function and regulatory mechanism of circRNAs in lower vertebrates are still unclear. Here, we discovered a novel circRNA derived from the gene encoding Bcl-2-like protein 1 (BCL2L1) gene, named circBCL2L1, which was related to the innate immune responses in teleost fish. Results indicated that circBCL2L1 played essential roles in host antiviral immunity and antibacterial immunity. Our study also identified a microRNA, miR-30c-33p, which could inhibit the innate immune response by targeting inflammatory mediator TRAF6. And TRAF6 is a key signal transduction factor in innate immune response mediated by TLRs. Moreover, we also found that the antiviral and antibacterial effects inhibited by miR-30c-3-3p could be reversed with the expression of circBCL2L1. Our data revealed that circBCL2L1 functioned as a competing endogenous RNA (ceRNA) of TRAF6 by competing for binding with miR-30c-33p, leading to activation of the NF-kappa B/IRF3 inflammatory pathway and then enhancing the innate immune responses. Our results suggest that circRNAs can play an important role in the innate immune response of teleost fish.	[Zheng, Weiwei; Sun, Lingping; Yang, Liyuan; Xu, Tianjun] Shanghai Ocean Univ, Coll Fisheries & Life Sci, Lab Fish Mol Immunol, Shanghai, Peoples R China; [Xu, Tianjun] Qingdao Natl Lab Marine Sci & Technol, Lab Marine Biol & Biotechnol, Qingdao, Peoples R China; [Xu, Tianjun] Shanghai Ocean Univ, Minist Educ, Key Lab Explorat & Utilizat Aquat Genet Resources, Shanghai, Peoples R China; [Xu, Tianjun] Shanghai Ocean Univ, Natl Pathogen Collect Ctr Aquat Anim, Shanghai, Peoples R China	Shanghai Ocean University; Qingdao National Laboratory for Marine Science & Technology; Shanghai Ocean University; Shanghai Ocean University	Xu, TJ (corresponding author), Shanghai Ocean Univ, Coll Fisheries & Life Sci, Lab Fish Mol Immunol, Shanghai, Peoples R China.; Xu, TJ (corresponding author), Qingdao Natl Lab Marine Sci & Technol, Lab Marine Biol & Biotechnol, Qingdao, Peoples R China.; Xu, TJ (corresponding author), Shanghai Ocean Univ, Minist Educ, Key Lab Explorat & Utilizat Aquat Genet Resources, Shanghai, Peoples R China.; Xu, TJ (corresponding author), Shanghai Ocean Univ, Natl Pathogen Collect Ctr Aquat Anim, Shanghai, Peoples R China.	tianjunxu@163.com			National Natural Science Foundation of China [31822057]; National Key Research and Development Project [2018YFD0900503]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Research and Development Project	This study was supported by National Natural Science Foundation of China (31822057) and National Key Research and Development Project (2018YFD0900503) .	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Baccala R, 2005, IMMUNOL REV, V204, P9, DOI 10.1111/j.0105-2896.2005.00252.x; Bagchi A, 2007, J IMMUNOL, V178, P1164, DOI 10.4049/jimmunol.178.2.1164; Becker CE, 2007, SEMIN IMMUNOPATHOL, V29, P239, DOI 10.1007/s00281-007-0081-4; Beutler BA, 2009, BLOOD, V113, P1399, DOI 10.1182/blood-2008-07-019307; Borden KLB, 1996, CURR OPIN STRUC BIOL, V6, P395, DOI 10.1016/S0959-440X(96)80060-1; Chen DS, 2018, CELL CYCLE, V17, P2080, DOI 10.1080/15384101.2018.1515553; Chen YH, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17071076; Chu Q, 2021, J VIROL, V95, DOI 10.1128/JVI.02145-20; Chu Q, 2021, SCI CHINA LIFE SCI, V64, P803, DOI 10.1007/s11427-020-1777-y; Chu Q, 2020, PLOS PATHOG, V16, DOI 10.1371/journal.ppat.1008670; Chu Q, 2017, J BIOL CHEM, V292, P5282, DOI [10.1074/jbc.M117.777078, 10.1074/jbc.m117.777078]; Cooper SJ, 2007, CURR CANCER DRUG TAR, V7, P325, DOI 10.2174/156800907780809714; Creagh EM, 2006, TRENDS IMMUNOL, V27, P352, DOI 10.1016/j.it.2006.06.003; Deng L, 2000, CELL, V103, P351, DOI 10.1016/S0092-8674(00)00126-4; Du WW, 2016, NUCLEIC ACIDS RES, V44, P2846, DOI 10.1093/nar/gkw027; Funami K, 2017, BIOCHEM SOC T, V45, P929, DOI 10.1042/BST20160259; Gao WY, 2021, FISH SHELLFISH IMMUN, V113, P61, DOI 10.1016/j.fsi.2021.03.015; Gao WY, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.647202; Ha Hyunil, 2009, Curr Protoc Immunol, VChapter 11, DOI 10.1002/0471142735.im1109ds87; Hansen TB, 2013, NATURE, V495, P384, DOI 10.1038/nature11993; Hatfield SD, 2005, NATURE, V435, P974, DOI 10.1038/nature03816; Inoue J, 2000, EXP CELL RES, V254, P14, DOI 10.1006/excr.1999.4733; Jiang ZF, 2004, P NATL ACAD SCI USA, V101, P3533, DOI 10.1073/pnas.0308496101; Kawai T, 2009, INT IMMUNOL, V21, P317, DOI 10.1093/intimm/dxp017; Kim HH, 1999, FEBS LETT, V443, P297, DOI 10.1016/S0014-5793(98)01731-1; Koshiba T, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001147; Landstrom M, 2010, INT J BIOCHEM CELL B, V42, P585, DOI 10.1016/j.biocel.2009.12.023; Liu ZG, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-2089-9; Matsuo A, 2008, J IMMUNOL, V181, P3474, DOI 10.4049/jimmunol.181.5.3474; Rosenberger CM, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006305; Salzman J, 2016, TRENDS GENET, V32, P309, DOI 10.1016/j.tig.2016.03.002; Salzman J, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003777; Salzman J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030733; SANGER HL, 1976, P NATL ACAD SCI USA, V73, P3852, DOI 10.1073/pnas.73.11.3852; Sharma P, 2007, P NATL ACAD SCI USA, V104, P3967, DOI 10.1073/pnas.0611618104; Shi N, 2021, VET MICROBIOL, V254, DOI 10.1016/j.vetmic.2021.108995; Shi ZB, 2015, J BIOL CHEM, V290, P26811, DOI 10.1074/jbc.M115.666578; Slezak-Prochazka I, 2010, RNA, V16, P1087, DOI 10.1261/rna.1804410; Su H, 2021, J VIROL, V95, DOI 10.1128/JVI.02296-20; Takeuchi M, 1996, J BIOL CHEM, V271, P19935, DOI 10.1074/jbc.271.33.19935; Tegeder I, 2001, FASEB J, V15, P595, DOI 10.1096/fasebj.15.3.595; Tseng PH, 2010, NAT IMMUNOL, V11, P70, DOI 10.1038/ni.1819; Walsh MC, 2015, IMMUNOL REV, V266, P72, DOI 10.1111/imr.12302; Wixted JHF, 2012, J BIOL CHEM, V287, P3691, DOI 10.1074/jbc.M111.322677; Wu SY, 2013, J INFECTION, V67, P329, DOI 10.1016/j.jinf.2013.05.003; Xie Ping, 2013, J Mol Signal, V8, P7, DOI 10.1186/1750-2187-8-7; Xu Tianjun, 2021, Aquaculture and Fisheries, V6, P178, DOI 10.1016/j.aaf.2020.08.001; Xu TJ, 2018, J IMMUNOL, V201, P982, DOI 10.4049/jimmunol.1800377; Xu TJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep21902; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Yao ZC, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-2176-y; Yoon K, 2008, BIOCHEM BIOPH RES CO, V371, P118, DOI 10.1016/j.bbrc.2008.04.007; Zhang L, 2020, J IMMUNOL, V205, P1620, DOI 10.4049/jimmunol.2000341; Zhang ML, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06862-2; Zhang X, 2016, MOL CELL, V64, P803, DOI 10.1016/j.molcel.2016.10.002; Zheng CZ, 2017, EUR REV MED PHARMACO, V21, P1041; Zheng C, 2020, FRONT MOL NEUROSCI, V12, DOI 10.3389/fnmol.2019.00314; Zheng WW, 2021, J BIOL CHEM, V296, DOI 10.1016/j.jbc.2021.100414; Zheng WW, 2021, PLOS PATHOG, V17, DOI 10.1371/journal.ppat.1009438; Zheng WW, 2021, J BIOL CHEM, V296, DOI 10.1016/j.jbc.2021.100304; Zhou B, 2017, BIOCHEM BIOPH RES CO, V487, P769, DOI 10.1016/j.bbrc.2017.04.044	62	7	7	4	12	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT	2021	297	4							101199	10.1016/j.jbc.2021.101199	http://dx.doi.org/10.1016/j.jbc.2021.101199			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	WP2YR	34536420	gold, Green Published			2022-12-26	WOS:000713003600009
J	Giavina-Bianchi, M; de Sousa, RM; Paciello, VZD; Vitor, WG; Okita, AL; Proa, R; Severino, GLD; Schinaid, AA; Santo, RE; Machado, BS				Giavina-Bianchi, Mara; de Sousa, Raquel Machado; de Almeida Paciello, Vitor Zago; Vitor, William Gois; Okita, Aline Lissa; Proa, Renata; dos Santos Severino, Gian Lucca; Schinaid, Anderson Alves; Santo, Rafael Espirito; Machado, Birajara Soares			Implementation of artificial intelligence algorithms for melanoma screening in a primary care setting	PLOS ONE			English	Article							SKIN-CANCER; POPULATION; US; COSTS	Skin cancer is currently the most common type of cancer among Caucasians. The increase in life expectancy, along with new diagnostic tools and treatments for skin cancer, has resulted in unprecedented changes in patient care and has generated a great burden on healthcare systems. Early detection of skin tumors is expected to reduce this burden. Artificial intelligence (AI) algorithms that support skin cancer diagnoses have been shown to perform at least as well as dermatologists' diagnoses. Recognizing the need for clinically and economically efficient means of diagnosing skin cancers at early stages in the primary care attention, we developed an efficient computer-aided diagnosis (CAD) system to be used by primary care physicians (PCP). Additionally, we developed a smartphone application with a protocol for data acquisition (i.e., photographs, demographic data and short clinical histories) and AI algorithms for clinical and dermoscopic image classification. For each lesion analyzed, a report is generated, showing the image of the suspected lesion and its respective Heat Map; the predicted probability of the suspected lesion being melanoma or malignant; the probable diagnosis based on that probability; and a suggestion on how the lesion should be managed. The accuracy of the dermoscopy model for melanoma was 89.3%, and for the clinical model, 84.7% with 0.91 and 0.89 sensitivity and 0.89 and 0.83 specificity, respectively. Both models achieved an area under the curve (AUC) above 0.9. Our CAD system can screen skin cancers to guide lesion management by PCPs, especially in the contexts where the access to the dermatologist can be difficult or time consuming. Its use can enable risk stratification of lesions and/or patients and dramatically improve timely access to specialist care for those requiring urgent attention.	[Giavina-Bianchi, Mara; de Sousa, Raquel Machado; de Almeida Paciello, Vitor Zago; Vitor, William Gois; Okita, Aline Lissa; Proa, Renata; dos Santos Severino, Gian Lucca; Schinaid, Anderson Alves; Santo, Rafael Espirito; Machado, Birajara Soares] Hosp Israelite Albert Einstein, Image Res Ctr, Sao Paulo, SP, Brazil	Hospital Israelita Albert Einstein	Giavina-Bianchi, M (corresponding author), Hosp Israelite Albert Einstein, Image Res Ctr, Sao Paulo, SP, Brazil.	marahgbianchi@gmail.com		Machado de Sousa, Raquel/0000-0002-0934-5852; Zago Paciello, Vitor/0000-0003-1719-7711; Vitor, William/0000-0001-7820-8993; GIAVINA-BIANCHI, MARA/0000-0001-7059-4068	Brazilian Ministry of Health, PROADI-SUS [25000.121674/2018-13]	Brazilian Ministry of Health, PROADI-SUS	This work was supported by the Brazilian Ministry of Health, PROADI-SUS process number: 25000.121674/2018-13.	[Anonymous], 1988, CONST REP FED BRAS 1; Apalla Z, 2017, DERMATOLOGY THER, V7, pS5, DOI 10.1007/s13555-016-0165-y; Australian Government Department of Health Therapeutic Goods Administration, AUSTR CONF ASS BOD M; Brooks J., 2020, COCO ANNOTATOR; Codella NCF, 2018, I S BIOMED IMAGING, P168; Combalia C, 2019, BCN20000 DERMOSCOPIC; Elliott TM, 2017, APPL HEALTH ECON HEA, V15, P805, DOI 10.1007/s40258-017-0341-y; Esteva A, 2017, NATURE, V542, P115, DOI 10.1038/nature21056; Garbe C, 2020, J EUR ACAD DERMATOL, V34, P2183, DOI 10.1111/jdv.16849; Giavina-Bianchi M, 2020, ECLINICALMEDICINE, V29-30, DOI 10.1016/j.eclinm.2020.100641; Guy GP, 2015, AM J PREV MED, V48, P183, DOI 10.1016/j.amepre.2014.08.036; Haenssle HA, 2018, ANN ONCOL, V29, P1836, DOI 10.1093/annonc/mdy166; He KM, 2017, IEEE I CONF COMP VIS, P2980, DOI [10.1109/ICCV.2017.322, 10.1109/TPAMI.2018.2844175]; Iandola F., 2014, ARXIV14041869; IBGE, PAIS MAIS EXT MUND 2; ISIC, 2019, ISIC CHALL; Karras Tero, 2020, 2020 IEEE/CVF Conference on Computer Vision and Pattern Recognition (CVPR). Proceedings, P8107, DOI 10.1109/CVPR42600.2020.00813; Lin TY, 2017, IEEE I CONF COMP VIS, P2999, DOI 10.1109/ICCV.2017.324; Lomas A, 2012, BRIT J DERMATOL, V166, P1069, DOI 10.1111/j.1365-2133.2012.10830.x; Mendonca T, 2013, IEEE ENG MED BIO, P5437; Mirza FN, 2020, BRIT J DERMATOL; Najita JS, 2016, J INVEST DERMATOL, V136, P1894, DOI 10.1016/j.jid.2016.03.044; Pooch Eduardo H. P., 2020, Thoracic Image Analysis. Second International Workshop, TIA 2020. Held in Conjunction with MICCAI 2020. Proceedings. Lecture Notes in Computer Science (LNCS 12502), P74, DOI 10.1007/978-3-030-62469-9_7; Population USCBC,, TOP 10 MOST POP COUN; Rigel DS, 1996, J AM ACAD DERMATOL, V35, P1012, DOI 10.1016/S0190-9622(96)90139-5; Samarasinghe Venura, 2012, J Cutan Aesthet Surg, V5, P3, DOI 10.4103/0974-2077.94323; Saude Md,, DIR ESTR; Saude Md. SAPS, SERV AT PRIM SAUD 20; Schmitt JV, 2014, AN BRAS DERMATOL, V89, P1013, DOI 10.1590/abd1806-4841.20143276; Schroff F, 2015, PROC CVPR IEEE, P815, DOI 10.1109/CVPR.2015.7298682; Selvaraju RR, 2020, INT J COMPUT VISION, V128, P336, DOI 10.1007/s11263-019-01228-7; Simonyan K., 2015, PROC 3 INT C LEARN R; Tan MX, 2019, PR MACH LEARN RES, V97; Tschandl P, 2020, NAT MED, V26, P1229, DOI 10.1038/s41591-020-0942-0; Tschandl P, 2019, LANCET ONCOL, V20, P938, DOI 10.1016/S1470-2045(19)30333-X; Vestergaard T, 2020, J EUR ACAD DERMATOL, V34, P1601, DOI 10.1111/jdv.16275	36	0	0	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2021	16	9							e0257006	10.1371/journal.pone.0257006	http://dx.doi.org/10.1371/journal.pone.0257006			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YS4WS	34550970	gold, Green Published			2022-12-26	WOS:000750679800010
J	Efjestad, AS; Ihle-Hansen, H; Hjellvik, V; Engedal, K; Blix, HS				Efjestad, Anne Sverdrup; Ihle-Hansen, Hege; Hjellvik, Vidar; Engedal, Knut; Blix, Hege Salvesen			Sex differences in psychotropic and analgesic drug use before and after initiating treatment with acetylcholinesterase inhibitors	PLOS ONE			English	Article							GENDER-DIFFERENCES; PSYCHOLOGICAL SYMPTOMS; ALZHEIMERS-DISEASE; PREVALENCE; ANTIDEPRESSANTS; POLYPHARMACY; MORTALITY; WOMEN	Background/aims The aim was to explore the impact of sex on prevalence, patterns and trends in the prescription of psychotropics and analgesics in users of acetylcholinesterase inhibitors (AChEIs), before and after AChEI initiation, compared to the general population. Methods A prospective study applying data from the Norwegian Prescription Database (NorPD) in the period 2004-2016. Prescription of antidepressants, antipsychotics, analgesics including opioids, benzodiazepines and z-hypnotics in persistent AChEI users was studied in a follow-up period from four years before to two years after AChEI initiation in men and women of four age groups: 37-64, 65-72, 73-80 and 81-88 years. Results Use of antidepressants, antipsychotics and weaker analgesics increased in both sexes during the follow-up period in 11.764 persistent AChEI users. Women with pre-dementia and dementia stages of AD showed a prescription pattern with more use of psychotropics and opioids than men, except for antipsychotics. Conclusion Female sex showed to have a significant influence on the prescriptions of psychotropics and analgesics in AD patients in a pre-dementia and dementia stage. The exception is for antipsychotics, that men used more than women. The prescription pattern showed a higher extent of polypharmacy of psychotropics and/or opioids in women than in men. The total prescription pattern of analgesics could indicate an undertreatment of pain in pre-dementia and dementia stages, most pronounced in men.	[Efjestad, Anne Sverdrup] Hosp Pharm Ahus, Loerenskog, Norway; [Efjestad, Anne Sverdrup] Hosp Pharm Enterprices, Oslo, Norway; [Ihle-Hansen, Hege] Oslo Univ Hosp, Dept Neurol, Oslo, Norway; [Ihle-Hansen, Hege] Univ Oslo, Oslo, Norway; [Hjellvik, Vidar; Blix, Hege Salvesen] Norwegian Inst Publ Hlth, Oslo, Norway; [Engedal, Knut] Vestfold Cty Hosp, Norwegian Natl Advisory Unit Ageing & Hlth, Tonsberg, Norway; [Engedal, Knut] Oslo Univ Hosp, Dept Geriatr, Oslo, Norway; [Blix, Hege Salvesen] Univ Oslo, Dept Pharm, Oslo, Norway	University of Oslo; University of Oslo; Norwegian Institute of Public Health (NIPH); University of Oslo; University of Oslo	Efjestad, AS (corresponding author), Hosp Pharm Ahus, Loerenskog, Norway.; Efjestad, AS (corresponding author), Hosp Pharm Enterprices, Oslo, Norway.	anne.efjestad@sykehusapotekene.no			Hospital Pharmacies Enterprise, South Eastern Norway	Hospital Pharmacies Enterprise, South Eastern Norway	We thank the Norwegian Institute of Public Health for help in obtaining data from the NorPD and the Hospital Pharmacies Enterprise, South Eastern Norway, for support.	[Anonymous], 2020, NAT PROF GUID DEM; [Anonymous], DEMENTIA ASSESSMENT; [Anonymous], ATC Classification Index with DDDs; Backryd E, 2018, INT J WOMENS HEALTH, V10, P55, DOI 10.2147/IJWH.S142052; Boudreau DM, 2011, J AM GERIATR SOC, V59, P2069, DOI 10.1111/j.1532-5415.2011.03654.x; Canevelli M, 2017, PHARMACOL RES, V115, P218, DOI 10.1016/j.phrs.2016.11.035; Crediblemeds, LIST DRUGS PROL QT C; de Mauleon A, 2014, J AM MED DIR ASSOC, V15, P812, DOI 10.1016/j.jamda.2014.06.015; Efjestad AS, 2019, DEMENT GER COGN D EX, V9, P196, DOI 10.1159/000497307; Efjestad AS, 2017, DEMENT GER COGN D EX, V7, P30, DOI 10.1159/000454948; Fog AF, 2019, BMC GERIATR, V19, DOI 10.1186/s12877-019-1064-8; Fog AF, 2017, SCAND J PRIM HEALTH, V35, P329, DOI 10.1080/02813432.2017.1397246; FOR-2003-10-17-1246, FOR200310171246; Gerlach LB, 2018, PSYCHIAT CLIN N AM, V41, P127, DOI 10.1016/j.psc.2017.10.010; Goyal AR, 2018, J AFFECT DISORDERS, V235, P117, DOI 10.1016/j.jad.2018.04.015; Gulla C, 2016, BMC GERIATR, V16, DOI 10.1186/s12877-016-0287-1; Heun R, 2013, EUR PSYCHIAT, V28, P40, DOI 10.1016/j.eurpsy.2011.06.001; Hsieh S-W, AGING MENT HEALTH, DOI [10.1080/13607863.2019.15903112019, DOI 10.1080/13607863.2019.15903112019]; Jobski K, 2017, EUR J CLIN PHARMACOL, V73, P105, DOI 10.1007/s00228-016-2145-7; Johnell K, 2009, ANN PHARMACOTHER, V43, P1233, DOI 10.1345/aph.1M147; Koons AL, 2018, CLIN THER, V40, P190, DOI 10.1016/j.clinthera.2017.12.016; Lee J, 2017, ASIAN J PSYCHIATR, V26, P124, DOI 10.1016/j.ajp.2017.01.027; Lee J, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204413; Lovheim H, 2009, INT PSYCHOGERIATR, V21, P469, DOI 10.1017/S1041610209008497; Moga D, 2017, DRUG AGING, V34, P55, DOI 10.1007/s40266-016-0419-5; Norgaaard A, 2017, J NEUROL SCI, V381, P1028, DOI 10.1016/j.jns.2017.08.2902; Norgaard A, 2017, J ALZHEIMERS DIS, V56, P707, DOI 10.3233/JAD-160828; Nowrangi MA, 2011, PSYCHIAT CLIN N AM, V34, P275, DOI 10.1016/j.psc.2011.02.004; Orsel K, 2018, EUR NEUROPSYCHOPHARM, V28, P1260, DOI 10.1016/j.euroneuro.2018.04.005; R Core TeamR, LANG ENV STAT COMP; Santalucia P, 2015, EUR J INTERN MED, V26, P483, DOI 10.1016/j.ejim.2015.07.006; Sundbom LT, 2017, BJPSYCH BULL, V41, P145, DOI 10.1192/pb.bp.116.054270; Trenaman SC, 2019, SAGE OPEN MED, V7, DOI 10.1177/2050312119845715; Tseng LY, 2020, NEUROTHERAPEUTICS, V17, P156, DOI 10.1007/s13311-019-00801-9; Van der Heyden JHA, 2009, PHARMACOEPIDEM DR S, V18, P1101, DOI 10.1002/pds.1827; Volicer L, 2018, CLIN GERIATR MED, V34, P637, DOI 10.1016/j.cger.2018.06.009; Zhu L, 2019, DRUG AGING, V36, P875, DOI 10.1007/s40266-019-00690-9	37	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2021	16	9							e0243804	10.1371/journal.pone.0243804	http://dx.doi.org/10.1371/journal.pone.0243804			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	WG6BN	34543268	gold, Green Published			2022-12-26	WOS:000707078200002
J	Takeuchi, M; Higa, Y; Esaki, A; Nabeshima, Y; Nakazono, A				Takeuchi, Masaaki; Higa, Yukie; Esaki, Akina; Nabeshima, Yosuke; Nakazono, Akemi			Does reactogenicity after a second injection of the BNT162b2 vaccine predict spike IgG antibody levels in healthy Japanese subjects?	PLOS ONE			English	Article							SARS-COV-2 INFECTION	Background Adverse reactions are more common after the second injection of messenger RNA vaccines such as Pfizer/BioNTech's BNT162b2. We hypothesized that the degree and severity of reactogenicity after the second injection reflects the magnitude of antibody production against the SARS CoV-2 virus spike protein (spike IgG). Methods and results Blood samples were obtained from 67 Japanese healthcare workers three weeks after the first injection and two weeks after the second injection of the BNT162b2 vaccine to measure spike IgG levels. Using questionnaires, we calculated an adverse event (AE) score (0-11) for each participant. The geometric mean of spike IgG titers increased from 1,047 antibody units (AU/mL) (95% confidence interval (95% CI): 855-1282 AU/mL) after the first injection to 17,378 AU/mL (95% CI: 14,622-20,663 AU/mL) after the second injection. The median AE score increased from 2 to 5. Spike IgG levels after the second injection were negatively correlated with age and positively correlated with spike IgG after the first injection. AE scores after the second injection were not significantly associated with log-transformed spike IgG after the second injection, when adjusted for age, sex, AE score after the first injection, and log-transformed spike IgG after the first injection. Conclusions Although the sample size was relatively small, reactogenicity after the second injection may not accurately reflect antibody production.	[Takeuchi, Masaaki; Higa, Yukie; Esaki, Akina; Nakazono, Akemi] Hosp Univ Occupat & Environm Hlth, Sch Med, Dept Lab & Transfus Med, Kitakyushu, Fukuoka, Japan; [Nabeshima, Yosuke] Univ Occupat & Environm Hlth, Sch Med, Dept Internal Med 2, Kitakyushu, Fukuoka, Japan	University of Occupational & Environmental Health - Japan; University of Occupational & Environmental Health - Japan	Takeuchi, M (corresponding author), Hosp Univ Occupat & Environm Hlth, Sch Med, Dept Lab & Transfus Med, Kitakyushu, Fukuoka, Japan.	takeuchi@med.uoeh-u.ac.jp		Takeuchi, Masaaki/0000-0001-7606-1537				Amit S, 2021, LANCET, V397, P875, DOI 10.1016/S0140-6736(21)00448-7; Angel Y, 2021, JAMA-J AM MED ASSOC, V325, P2457, DOI 10.1001/jama.2021.7152; Baden LR, 2021, NEW ENGL J MED, V384, P403, DOI 10.1056/NEJMoa2035389; Chapin-Bardales J, 2021, JAMA-J AM MED ASSOC, V325, P2201, DOI 10.1001/jama.2021.5374; Coggins SA, 2022, OPEN FORUM INFECT DI, V9, DOI [10.1093/ofid/ofab575, 10.1101/2021.06.25.21259544]; Dagan N, 2021, NEW ENGL J MED, V384, P1412, DOI 10.1056/NEJMoa2101765; Debes AK, 2021, JAMA INTERN MED, V181, P1660, DOI 10.1001/jamainternmed.2021.4580; Grupper A, 2021, CLIN J AM SOC NEPHRO, V16, P1037, DOI 10.2215/CJN.03500321; Hinton D, BRATCHER BOWMAN ACTI; Kounis NG, 2021, VACCINES-BASEL, V9, DOI 10.3390/vaccines9030221; Mazzoni A, 2021, J CLIN INVEST, V131, DOI 10.1172/JCI149150; Muller L, 2021, CLIN INFECT DIS, V73, P2065, DOI 10.1093/cid/ciab381; Narasimhan M, 2021, J CLIN MICROBIOL, V59, DOI 10.1128/JCM.00388-21; Polack FP, 2020, NEW ENGL J MED, V383, P2603, DOI 10.1056/NEJMoa2034577; Prendecki M, 2021, LANCET, V397, P1178, DOI 10.1016/S0140-6736(21)00502-X; Subbarao S, 2021, EUROSURVEILLANCE, V26, P2, DOI 10.2807/1560-7917.ES.2021.26.12.2100329; Tang L, 2021, JAMA-J AM MED ASSOC, V325, P2500, DOI 10.1001/jama.2021.6564; Velasco Maria, 2021, Open Forum Infect Dis, V8, pofab299, DOI 10.1093/ofid/ofab299; Walsh EE, 2020, NEW ENGL J MED, V383, P2439, DOI 10.1056/NEJMoa2027906	19	12	12	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2021	16	9							e0257668	10.1371/journal.pone.0257668	http://dx.doi.org/10.1371/journal.pone.0257668			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	WG6BN	34543337	Green Submitted, Green Published, gold			2022-12-26	WOS:000707078200068
J	Hewamana, S; Skandarajah, T; Jayasinghe, C; Deshapriya, S; Senarathna, D; Arseculeratne, G; Harischandra, M; Somasundaram, G; Srinivasan, V; Somiah, S; Munasinghe, N; Hewawasam, S; Ekanayake, L; Wadanamby, R; Galagoda, G; Lin, TT; Balawardena, J				Hewamana, Saman; Skandarajah, Thurairajah; Jayasinghe, Chathuri; Deshapriya, Samadhi; Senarathna, Dhananjani; Arseculeratne, Gehan; Harischandra, Mahesh; Somasundaram, Gnani; Srinivasan, Vadivelu; Somiah, Surjit; Munasinghe, Nihal; Hewawasam, Sangeetha; Ekanayake, Lalith; Wadanamby, Rohini; Galagoda, Geethani; Lin, Thet Thet; Balawardena, Jayantha			Blood cancer care in a resource limited setting during the Covid-19 outbreak; a single center experience from Sri Lanka	PLOS ONE			English	Article								Background The Covid-19 pandemic has caused significant morbidity and mortality among patients with cancer. Most countries employed measures to prevent spread of Covid-19 infection which include shielding, quarantine, lockdown, travel restrictions, physical distancing and the use of personal protective equipment. This study was carried out to assess the change in patient attendance and the efficacy of newly implemented strategies to mitigate the impact of Covid-19 on services at the Lanka Hospital Blood Cancer Centre (LHBCC) in Colombo, Sri Lanka. Methodology Telephone consultation, infection control, personal protective measures and emergency admission policy were implemented with the aim of having a Covid-19 free ward and to prevent cross-infections. This descriptive cross-sectional study was conducted with 1399 patient episodes (in-patient care or day-case review). We analysed patients treated as in-patient as well as day-case basis between 01(st) April 2020 and 31(st) December 2020. Results There were 977 day-case based episodes and 422 in-patient based episodes. There was a 14% drop in episode numbers compared to same period in 2019. There was no cross infection and no patients with Covid-19 related symptoms or positive test results entered the LHBCC during the study period. Conclusion Services in blood cancer care were maintained to prevent late stage presentation and adverse outcome. Measures implemented to prevent Covid-19 were effective to allow continuation of treatment. This study highlights the importance of implementing strict protocols, clinical screening, use of appropriate personal protective equipment in delivering blood cancer care during the Covid-19 pandemic. This is the only documented study relating to outcome and successful applicability of measures to prevent spread of Covid-19 infection and maintaining services among blood cancer patients in Sri Lanka.	[Hewamana, Saman; Deshapriya, Samadhi; Senarathna, Dhananjani] Lanka Hosp, Clin Haematol Unit, Colombo, Sri Lanka; [Skandarajah, Thurairajah] Natl Canc Inst, Colombo, Sri Lanka; [Jayasinghe, Chathuri] Univ Sri Jayewardenepura, Colombo, Sri Lanka; [Arseculeratne, Gehan; Harischandra, Mahesh; Somasundaram, Gnani; Srinivasan, Vadivelu; Somiah, Surjit; Munasinghe, Nihal; Hewawasam, Sangeetha; Ekanayake, Lalith] Lanka Hosp, Colombo, Sri Lanka; [Wadanamby, Rohini; Galagoda, Geethani] Lanka Hosp Diagnost, Colombo, Sri Lanka; [Lin, Thet Thet] Coventry Univ, Fac Hlth & Life Sci, Coventry, W Midlands, England; [Balawardena, Jayantha] Sir John Kotelawala Def Univ, Werahera, Colombo, Sri Lanka	University Sri Jayewardenepura; Coventry University; General Sir John Kotelawala Defence University	Hewamana, S (corresponding author), Lanka Hosp, Clin Haematol Unit, Colombo, Sri Lanka.	samanhewamana@live.co.uk		Hewamana, Saman/0000-0002-5439-8398; Jayasinghe, Chathuri/0000-0003-2891-742X				[Anonymous], 2021, LANCET ONCOL, V22, P411, DOI 10.1016/S1470-2045(21)00148-0; Beaver K, 2010, J CLIN NURS, V19, P2916, DOI 10.1111/j.1365-2702.2010.03197.x; Cervino G, 2020, MEDICINA-LITHUANIA, V56, DOI 10.3390/medicina56050250; Chan JFW, 2020, LANCET, V395, P514, DOI 10.1016/S0140-6736(20)30154-9; Chang D, 2020, LANCET RESP MED, V8, pE13, DOI 10.1016/S2213-2600(20)30066-7; CHANG HY, 1976, MEDICINE, V55, P259, DOI 10.1097/00005792-197605000-00005; de la Cruz-Benito B, 2020, BRIT J HAEMATOL, V191, P386, DOI 10.1111/bjh.17066; Di Ciaccio P, 2020, INTERN MED J, V50, P667, DOI 10.1111/imj.14859; Edelsberg J, 2020, CURR MED RES OPIN, V36, P483, DOI 10.1080/03007995.2019.1703665; Fox TA, 2020, BRIT J HAEMATOL, V191, P194, DOI 10.1111/bjh.17027; Guan W, 2020, NEW ENGL J MED, V382, P1708, DOI 10.1056/NEJMoa2002032; Hewamana Saman, 2021, EJHaem, V2, P555, DOI 10.1002/jha2.191; Hewamana S, 2021, ECLINICALMEDICINE, V38, DOI 10.1016/j.eclinm.2021.100998; Khalil Md Musab, 2020, SN Compr Clin Med, V2, P1733, DOI 10.1007/s42399-020-00471-1; Kweon OJ, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0249972; Lai THT, 2020, GRAEF ARCH CLIN EXP, V258, P1049, DOI 10.1007/s00417-020-04641-8; Lan FY, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0235460; Mei H, 2020, LANCET ONCOL, V21, P634, DOI 10.1016/S1470-2045(20)30238-2; Needleman J, 2019, BMJ QUAL SAF, V28, P603, DOI 10.1136/bmjqs-2018-009266; Needleman J, 2011, NEW ENGL J MED, V364, P1037, DOI 10.1056/NEJMsa1001025; Nishiura H., 2020, MEDRXIV, DOI 10.1101/2020.02.28.20029272; Okuhara T, 2020, HEALTHCARE-BASEL, V8, DOI 10.3390/healthcare8040475; Oran DP, 2020, ANN INTERN MED, V173, P362, DOI 10.7326/M20-3012; Palandri F, 2021, BRIT J HAEMATOL, V192, pE48, DOI 10.1111/bjh.17208; Palandri F, 2020, LEUKEMIA, V34, P2805, DOI 10.1038/s41375-020-0953-3; Shah V, 2020, BRIT J HAEMATOL, V190, pE279, DOI 10.1111/bjh.16935; Smith L, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.548708; Terpos E, 2020, AM J HEMATOL, V95, P834, DOI 10.1002/ajh.25829; Turk C, 2020, EUR REV MED PHARMACO, V24, P8606, DOI 10.26355/eurrev_202008_22660; Weinkove R, 2020, MED J AUSTRALIA, V212, P481, DOI 10.5694/mja2.50607; WHO, 2020, MODES TRANSMISSION V; Willan J, 2020, BRIT J HAEMATOL, V189, pE224, DOI 10.1111/bjh.16782; World Health Organization, 2021, NOV COR 2019 NCOV SI; Worldometer, 2020, COV 19 COR PAND	34	1	1	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2021	16	9							e0256941	10.1371/journal.pone.0256941	http://dx.doi.org/10.1371/journal.pone.0256941			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	WG5ZQ	34534228	Green Published, gold			2022-12-26	WOS:000707073300013
J	Sapkota, B; Chaudhary, S; Gurung, P; Humagain, A; Sapkota, S				Sapkota, Binaya; Chaudhary, Suraj; Gurung, Prakash; Humagain, Anisha; Sapkota, Sujan			Dosage individualization proposed for anti-gout medications among the patients with gout	PLOS ONE			English	Article							MANAGEMENT; ARTHRITIS	Background The conventional one-size-fits-all approach has been criticized for almost all drugs used especially for chronic diseases, including gout. The present study was aimed to explore the need of individualization and optimization of the dose of anti-gout medications among gout patients. Methods Cross-sectional study was carried out among 384 randomly selected new gout patients visiting two gout treatment centers at Lalitpur Metropolitan City, Nepal and who were taking antigout medications. Patients not taking anti-gout medications and not showing willingness to participate were excluded. The eGFR was calculated with the CKD Epidemiology Collaboration (CKD-EPI) creatinine equation (2009). Doses to be individualized were decided based on the Renal Drug Handbook and verified with the BNF 80. Data were analyzed via R 4.0.3 by applying the multinomial logistic regression to analyze statistical significance of risk with various predictors, and considering a p-value <0.05 statistically significant. Comorbidities were coded as per the ICD-11 coding and medicines were coded according to the WHO Guidelines for ATC classification and DDD assignment 2020. Results The high risk of progression to CKD increased in the age range 54-63 and <greater than or equal to>84 years by 17.77 and 43.02 times, respectively. Also, high risk increased by 29.83 and 20.2 times for the overweight and the obese respectively. Aceclofenac 100mg was prescribed for maximum patients (30.5%). Need of dose individualization was realized in 30 patients, with maximum (7) in case of etoricoxib 90mg. Various glucocorticoids were prescribed for 36.9% patients, out of whom 3.8%required dose individualization and 15.9% patients with xanthine oxidase inhibitors, out of whom 1.3% required dose individualization. Conclusion Thirty cases required dose individualization, which was although minimal but could have meaningful impact on the clinical success of the individual patient. Based on the recommendation on dose individualization, those patients could be optimized on their therapy on future follow ups.	[Sapkota, Binaya; Chaudhary, Suraj; Humagain, Anisha; Sapkota, Sujan] Pokhara Univ, Nobel Coll Fac Hlth Sci, Kathmandu, Nepal; [Gurung, Prakash] Manmohan Mem Med Coll & Teaching Hosp, Kathmandu, Nepal		Sapkota, B (corresponding author), Pokhara Univ, Nobel Coll Fac Hlth Sci, Kathmandu, Nepal.	binaya@nobelcollege.edu.np	Sapkota, Binaya/J-9496-2019	Sapkota, Binaya/0000-0002-4125-9866				Ali Saman, 2009, Med Health R I, V92, P369; [Anonymous], 2019, IBM SPSS VERS 26; Ashley C, 2014, RENAL DRUG HDB ULTIM, V4th edition, P1; Aslam F, 2017, MAYO CLIN PROC, V92, P1234, DOI 10.1016/j.mayocp.2017.05.026; AVENAWOODS C, 2010, P & T, V35, P82; Azevedo VF, 2017, REV BRAS REUMATOL, V57, P346, DOI [10.1016/j.rbre.2017.03.002, 10.1016/j.rbr.2016.06.009]; Benn CL, 2018, FRONT MED-LAUSANNE, V5, DOI 10.3389/fmed.2018.00160; BNF 80, BRIT NATL FORMULARY, P1; Cassagnol M, 2013, US PHARM, V38, P22; CDC, DEF AD OV OB; Claus LW, 2018, PATIENT-RELAT OUTCOM, V9, P231, DOI 10.2147/PROM.S108868; Conway Nazli, 2009, Med Health R I, V92, P356; Dalbeth N, 2017, NAT REV RHEUMATOL, V13, DOI 10.1038/nrrheum.2017.126; Davies K, 2018, RHEUMATOLOGY, V57, P951, DOI 10.1093/rheumatology/kex343; Doghramji PP, 2011, POSTGRAD MED, V123, P56, DOI 10.3810/pgm.2011.05.2284; EMA, 2019, GUID CLIN INV MED PR, P3; Fam AG, 1998, DRUG AGING, V13, P229, DOI 10.2165/00002512-199813030-00006; Finch A, 2016, AUST PRESCR, V39, P119, DOI 10.18773/austprescr.2016.047; Graf SW, 2015, INT J RHEUM DIS, V18, P341, DOI 10.1111/1756-185X.12557; Hu Miao, 2008, Ther Clin Risk Manag, V4, P1209; Hui M, 2017, RHEUMATOLOGY, V56, P1056, DOI 10.1093/rheumatology/kex150; Kumar S, 2010, J COLL MED SCI NEPAL, V6, P18, DOI [10.3126/jcmsn.v6i2.3612, DOI 10.3126/jcmsn.v6i2.3612]; Lesko LJ, 2012, CLIN PHARMACOL THER, V92, P458, DOI 10.1038/clpt.2012.113; Liu XZ, 2018, EXP THER MED, V16, P1859, DOI 10.3892/etm.2018.6367; McClory Jill, 2009, Med Health R I, V92, P363; NKF, 2020, GFR CALC; Nuki G, 2017, POL ARCH INTERN MED, V127, P267, DOI 10.20452/pamw.4001; Pokhrel K, 2011, J NEPAL MED ASSOC, V50, P15; Poon Samuel H, 2009, Med Health R I, V92, P359; R Core Team, 2020, R LANG ENV STAT COMP; Rees F, 2014, NAT REV RHEUMATOL, V10, P271, DOI 10.1038/nrrheum.2014.32; Sachs Larissa, 2009, Med Health R I, V92, P353; Stamp LK, 2014, DRUG AGING, V31, P777, DOI 10.1007/s40266-014-0214-0; Terkeltaub R, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2738; Wang YG, 2014, INT J MED SCI, V11, P880, DOI 10.7150/ijms.9165; WHO WHO, 2019, WHO GUID ATC CLASS D, P10; Wise CM, 2005, CLIN GERIATR MED, V21, P491, DOI 10.1016/j.cger.2005.02.003; World Health Organization, 2020, INT STAT CLASS DIS R, V11th; Wright DFB, 2016, BRIT J CLIN PHARMACO, V81, P277, DOI 10.1111/bcp.12799; Yuan HY, 2014, EXPERT OPIN THER PAT, V24, P555, DOI 10.1517/13543776.2014.895325	40	0	0	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2021	16	9							e0257082	10.1371/journal.pone.0257082	http://dx.doi.org/10.1371/journal.pone.0257082			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	WG5ZQ	34534233	Green Published, gold			2022-12-26	WOS:000707073300018
J	Khan, A; Ali, M; Iqbal, W; Imran, M				Khan, Adnan; Ali, Mohsin; Iqbal, Wizda; Imran, Mudassar			Effect of high and low risk susceptibles in the transmission dynamics of COVID-19 and control strategies	PLOS ONE			English	Article							MODEL	In this study, we formulate and analyze a deterministic model for the transmission of COVID-19 and evaluate control strategies for the epidemic. It has been well documented that the severity of the disease and disease related mortality is strongly correlated with age and the presence of co-morbidities. We incorporate this in our model by considering two susceptible classes, a high risk, and a low risk group. Disease transmission within each group is modelled by an extension of the SEIR model, considering additional compartments for quarantined and treated population groups first and vaccinated and treated population groups next. Cross Infection across the high and low risk groups is also incorporated in the model. We calculate the basic reproduction number R0 and show that for R0<1 the disease dies out, and for R0>1 the disease is endemic. We note that varying the relative proportion of high and low risk susceptibles has a strong effect on the disease burden and mortality. We devise optimal medication and vaccination strategies for effective control of the disease. Our analysis shows that vaccinating and medicating both groups is needed for effective disease control and the controls are not very sensitive to the proportion of the high and low risk populations.	[Khan, Adnan; Ali, Mohsin] Lahore Univ Management Sci Opposite Sect U, Dept Math, DHA Lahore, Lahore, Pakistan; [Iqbal, Wizda] Natl Coll Business Adm & Econ, Lahore, Pakistan; [Imran, Mudassar] Namal Inst Mianwali, Dept Math, Punjab, Pakistan		Imran, M (corresponding author), Namal Inst Mianwali, Dept Math, Punjab, Pakistan.	mimran@asu.edu	Ali, Mohsin/GRY-0476-2022; Farhad, Mohsin Ali/GOP-2831-2022	Farhad, Mohsin Ali/0000-0001-9737-3273; Ali, Mohsin/0000-0001-6526-331X; Khan, Adnan/0000-0002-1394-9309				Ahmed HM, 2021, MATHEMATICS-BASEL, V9, DOI 10.3390/math9060659; Ali M, 2020, J BIOL DYNAM, V14, P389, DOI 10.1080/17513758.2020.1773000; Biospace(dot)com, 2021, UPDATED COMP COVID 1; Brauer Fred, 2017, Infect Dis Model, V2, P113, DOI 10.1016/j.idm.2017.02.001; CDC gov, 2020, COR DIS 2019 COVID 1; Changoiwala P, 2021, WHY S ASIAS COVID 19; Demir M, 2020, MODELING COVID 19 FO; Dowd JB, 2020, P NATL ACAD SCI USA, V117, P9696, DOI 10.1073/pnas.2004911117; Eikenberry SE, 2020, INFECT DIS MODEL, V5, P293, DOI 10.1016/j.idm.2020.04.001; Eubank S, 2020, B MATH BIOL, V82, DOI 10.1007/s11538-020-00726-x; Fleming W. H., 2012, DETERMINISTIC STOCHA; Hethcote HW, 2000, SIAM REV, V42, P599, DOI 10.1137/S0036144500371907; Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5; Imran M, 2016, JPN J IND APPL MATH, V33, P269, DOI 10.1007/s13160-016-0210-3; Jia WR, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-019-4311-x; Kirschner D, 1997, J MATH BIOL, V35, P775, DOI 10.1007/s002850050076; Kucharski AJ, 2020, LANCET INFECT DIS, V20, P553, DOI 10.1016/S1473-3099(20)30144-4; Lee S, 2010, J THEOR BIOL, V265, P136, DOI 10.1016/j.jtbi.2010.04.003; Lin QY, 2020, INT J INFECT DIS, V93, P211, DOI 10.1016/j.ijid.2020.02.058; Mandal S, 2020, INDIAN J MED RES, V151, P190, DOI 10.4103/ijmr.IJMR_504_20; Omar OAM, 2021, RESULTS PHYS, V23, DOI 10.1016/j.rinp.2021.104018; Pang LY, 2020, J BIOL SYST, V28, P543, DOI 10.1142/S0218339020500096; Perkins T Alex, 2020, Bull Math Biol, V82, P118, DOI 10.1007/s11538-020-00795-y; Pontryagin LS., 1987, MATH THEORY OPTIMAL; Thieme HR., 2018, MATH POPULATION BIOL; van den Driessche P, 2002, MATH BIOSCI, V180, P29, DOI 10.1016/S0025-5564(02)00108-6; WHO int, 2020, COR; Yang J, 2020, INT J INFECT DIS, V94, P91, DOI 10.1016/j.ijid.2020.03.017; Zhao S, 2020, INT J INFECT DIS, V92, P214, DOI 10.1016/j.ijid.2020.01.050	29	0	0	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2021	16	9							e0257354	10.1371/journal.pone.0257354	http://dx.doi.org/10.1371/journal.pone.0257354			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	WG6DR	34525112	Green Published, gold			2022-12-26	WOS:000707084400032
J	Kanshana, JS; Mattila, PE; Ewing, MC; Wood, AN; Schoiswohl, G; Meyer, AC; Kowalski, A; Rosenthal, SL; Gingras, S; Kaufman, BA; Lu, R; Weeks, DE; McGarvey, ST; Minster, RL; Hawley, NL; Kershaw, EE				Kanshana, Jitendra S.; Mattila, Polly E.; Ewing, Michael C.; Wood, Ashlee N.; Schoiswohl, Gabriele; Meyer, Anna C.; Kowalski, Aneta; Rosenthal, Samantha L.; Gingras, Sebastien; Kaufman, Brett A.; Lu, Ray; Weeks, Daniel E.; McGarvey, Stephen T.; Minster, Ryan L.; Hawley, Nicola L.; Kershaw, Erin E.			A murine model of the human CREBRFR457Q obesity-risk variant does not influence energy or glucose homeostasis in response to nutritional stress	PLOS ONE			English	Article							BODY-MASS INDEX; LUMAN/CREB3 RECRUITMENT FACTOR; GENOME-WIDE ASSOCIATION; AUTOPHAGY; GLIOBLASTOMA; CRISPR-CAS9; METABOLISM; LOCI; MICE	Obesity and diabetes have strong heritable components, yet the genetic contributions to these diseases remain largely unexplained. In humans, a missense variant in Creb3 regulatory factor (CREBRF) [rs373863828 (p.Arg457Gln); CREBRFR457Q] is strongly associated with increased odds of obesity but decreased odds of diabetes. Although virtually nothing is known about CREBRF's mechanism of action, emerging evidence implicates it in the adaptive transcriptional response to nutritional stress downstream of TORC1. The objectives of this study were to generate a murine model with knockin of the orthologous variant in mice (CREBRFR458Q) and to test the hypothesis that this CREBRF variant promotes obesity and protects against diabetes by regulating energy and glucose homeostasis downstream of TORC1. To test this hypothesis, we performed extensive phenotypic analysis of CREBRFR458Q knockin mice at baseline and in response to acute (fasting/refeeding), chronic (low- and high-fat diet feeding), and extreme (prolonged fasting) nutritional stress as well as with pharmacological TORC1 inhibition, and aging to 52 weeks. The results demonstrate that the murine CREBRFR458Q model of the human CREBRFR457Q variant does not influence energy/glucose homeostasis in response to these interventions, with the exception of possible greater loss of fat relative to lean mass with age. Alternative preclinical models and/or studies in humans will be required to decipher the mechanisms linking this variant to human health and disease.	[Kanshana, Jitendra S.; Mattila, Polly E.; Ewing, Michael C.; Wood, Ashlee N.; Meyer, Anna C.; Kowalski, Aneta; Kershaw, Erin E.] Univ Pittsburgh, Dept Med, Div Endocrinol & Metab, Pittsburgh, PA 15260 USA; [Schoiswohl, Gabriele] Karl Franzens Univ Graz, Dept Pharmacol & Toxicol, Graz, Austria; [Rosenthal, Samantha L.] Univ Pittsburgh, Ctr Craniofacial & Dent Genet, Dept Oral & Craniofacial Sci, Pittsburgh, PA USA; [Gingras, Sebastien] Univ Pittsburgh, Dept Immunol, Pittsburgh, PA USA; [Kaufman, Brett A.] Univ Pittsburgh, Dept Med, Div Cardiol, Pittsburgh, PA USA; [Lu, Ray] Univ Guelph, Coll Biol Sci, Dept Mol & Cellular Biol, Guelph, ON, Canada; [Weeks, Daniel E.; Minster, Ryan L.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Human Genet, Pittsburgh, PA 15261 USA; [Weeks, Daniel E.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Biostat, Pittsburgh, PA 15261 USA; [McGarvey, Stephen T.] Brown Univ, Sch Publ Hlth, Dept Epidemiol, Int Hlth Inst, Providence, RI 02912 USA; [McGarvey, Stephen T.] Brown Univ, Dept Anthropol, Providence, RI 02912 USA; [Hawley, Nicola L.] Yale Sch Publ Hlth, Dept Chron Dis Epidemiol, New Haven, CT USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Graz; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Guelph; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Brown University; Brown University; Yale University	Kershaw, EE (corresponding author), Univ Pittsburgh, Dept Med, Div Endocrinol & Metab, Pittsburgh, PA 15260 USA.	kershawe@pitt.edu	Kanshana, Jitendra/AEW-5567-2022; Kershaw, Erin E/G-9587-2013	Kershaw, Erin E/0000-0002-3887-4868; Manna, Samantha/0000-0002-5593-7656; Weeks, Daniel/0000-0001-9410-7228; Kaufman, Brett/0000-0003-4767-4937; Schoiswohl, Gabriele/0000-0002-7346-2834	National Heart, Lung, and Blood Institute [R01 HL093093]; Howard Hughes Medical Institute, Medical Student Research Fellowship; National Institute of Diabetes and Digestive and Kidney Diseases, NIH [T32 DK007052]; American Diabetes Association, Basic Science Award [1-17IBS-128]; Pittsburgh Foundation [MR2018-98421]	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Howard Hughes Medical Institute, Medical Student Research Fellowship(Howard Hughes Medical Institute); National Institute of Diabetes and Digestive and Kidney Diseases, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); American Diabetes Association, Basic Science Award; Pittsburgh Foundation	This work was supported by the following: National Heart, Lung, and Blood Institute, R01 HL093093, Erin E. Kershaw, Daniel E. Weeks, Stephen T. McGarvey, Ryan L. Minster, Nicola L. Hawley; Howard Hughes Medical Institute, Medical Student Research Fellowship, Aneta Kowalski; National Institute of Diabetes and Digestive and Kidney Diseases, NIH T32 DK007052, Samantha L Rosenthal; American Diabetes Association, Basic Science Award 1-17IBS-128, Erin E Kershaw; Pittsburgh Foundation, MR2018-98421, Erin E Kershaw.	Arslanian KJ, 2021, INT J OBESITY, V45, P45, DOI 10.1038/s41366-020-00659-4; Audas TE, 2008, MOL CELL BIOL, V28, P3952, DOI 10.1128/MCB.01439-07; Audas TE, 2016, EUR J CELL BIOL, V95, P611, DOI 10.1016/j.ejcb.2016.10.006; Basantani MK, 2011, J LIPID RES, V52, P318, DOI 10.1194/jlr.M011205; Berry SD, 2018, INT J OBESITY, V42, P603, DOI 10.1038/ijo.2017.230; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Carlson JC, 2020, AM J HUM BIOL, V32, DOI 10.1002/ajhb.23414; Cho YS, 2009, NAT GENET, V41, P527, DOI 10.1038/ng.357; Falabella M, 2017, G3-GENES GENOM GENET, V7, P3533, DOI 10.1534/g3.117.300123; Fang YM, 2013, CELL METAB, V17, P456, DOI 10.1016/j.cmet.2013.02.008; Feng S, 2020, CANCER CELL INT, V20, DOI 10.1186/s12935-020-01182-2; Fuchsberger C, 2016, NATURE, V536, P41, DOI 10.1038/nature18642; Han FJ, 2020, EPIGENOMICS-UK, V12, P935, DOI 10.2217/epi-2019-0352; Han JM, 2018, CELL MOL BIOL, V64, P40, DOI 10.14715/cmb/2018.64.5.6; Hanson RL, 2019, DIABETOLOGIA, V62, P1647, DOI 10.1007/s00125-019-4932-z; Jensen TL, 2013, LAB ANIM-UK, V47, P225, DOI 10.1177/0023677213501659; Karczewski KJ, 2020, NATURE, V581, P434, DOI 10.1038/s41586-020-2308-7; Kienesberger PC, 2009, J BIOL CHEM, V284, P30218, DOI 10.1074/jbc.M109.047787; Krishnan M, 2020, DIABETOLOGIA, V63, P2169, DOI 10.1007/s00125-020-05202-8; Krishnan M, 2018, DIABETOLOGIA, V61, P1603, DOI 10.1007/s00125-018-4623-1; Lee K., 2021, MINOR ALLELE CREBRF, DOI [10.1101/2021.07.13.21260462, DOI 10.1101/2021.07.13.21260462]; Lin M, 2020, HUM MOL GENET, V29, P2275, DOI 10.1093/hmg/ddaa083; Locke AE, 2015, NATURE, V518, P197, DOI 10.1038/nature14177; Loos RJF, 2016, NAT GENET, V48, P976, DOI 10.1038/ng.3653; Martyn AC, 2012, MOL CELL BIOL, V32, P5140, DOI 10.1128/MCB.01142-12; Metcalfe LK, 2020, INT J OBESITY, V44, P748, DOI 10.1038/s41366-019-0437-6; Mills MC, 2020, NAT GENET, V52, P242, DOI 10.1038/s41588-020-0580-y; Minster RL, 2016, NAT GENET, V48, P1049, DOI 10.1038/ng.3620; Naka I, 2017, J HUM GENET, V62, P847, DOI 10.1038/jhg.2017.44; Pelletier S, 2015, IMMUNITY, V42, P18, DOI 10.1016/j.immuni.2015.01.004; Penney J, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00352; Schoiswohl G, 2015, ENDOCRINOLOGY, V156, P3610, DOI 10.1210/en.2015-1322; Shungin D, 2015, NATURE, V518, P187, DOI 10.1038/nature14132; Sitnick MT, 2013, DIABETES, V62, P3350, DOI 10.2337/db13-0500; Spracklen CN, 2020, NATURE, V582, P240, DOI 10.1038/s41586-020-2263-3; Tiebe M, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-56407-w; Tiebe M, 2015, DEV CELL, V33, P272, DOI 10.1016/j.devcel.2015.03.013; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Wen WQ, 2014, HUM MOL GENET, V23, P5492, DOI 10.1093/hmg/ddu248; Winkler TW, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005378; Wong NKP, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19071903; Wu KR, 2019, AM J TRANSL RES, V11, P5776; Xue H, 2016, AUTOPHAGY, V12, P1129, DOI 10.1080/15548627.2016.1178446; Xue H, 2016, INT J ONCOL, V49, P519, DOI 10.3892/ijo.2016.3576; Yang DQ, 2018, BIOL REPROD, V98, P713, DOI 10.1093/biolre/ioy044; Zakeri NSS, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-69249-8	46	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2021	16	9							e0251895	10.1371/journal.pone.0251895	http://dx.doi.org/10.1371/journal.pone.0251895			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	WG5RP	34520472	gold, Green Submitted, Green Published			2022-12-26	WOS:000707052100003
J	Enane, LA; Apondi, E; Aluoch, J; Bakoyannis, G; Kulzer, JL; Kwena, Z; Kantor, R; Chory, A; Gardner, A; Scanlon, M; Goodrich, S; Wools-Kaloustian, K; Elul, B; Vreeman, RC				Enane, Leslie A.; Apondi, Edith; Aluoch, Josephine; Bakoyannis, Giorgos; Lewis Kulzer, Jayne; Kwena, Zachary; Kantor, Rami; Chory, Ashley; Gardner, Adrian; Scanlon, Michael; Goodrich, Suzanne; Wools-Kaloustian, Kara; Elul, Batya; Vreeman, Rachel C.			Social, economic, and health effects of the COVID-19 pandemic on adolescents retained in or recently disengaged from HIV care in Kenya	PLOS ONE			English	Article							MENTAL-HEALTH; TREATMENT INTERRUPTIONS; CHILDREN; IMPACT; RETENTION; LOCKDOWN; ADULTS	Introduction Adolescents living with HIV (ALHIV, ages 10-19) experience complex challenges to adhere to antiretroviral therapy (ART) and remain in care, and may be vulnerable to wide-scale disruptions during the COVID-19 pandemic. We assessed for a range of effects of the pandemic on ALHIV in western Kenya, and whether effects were greater for ALHIV with recent histories of being lost to program (LTP). Methods ALHIV were recruited from an ongoing prospective study at 3 sites in western Kenya. The parent study enrolled participants from February 2019-September 2020, into groups of ALHIV either 1) retained in care or 2) LTP and traced in the community. Phone interviews from July 2020-January 2021 assessed effects of the pandemic on financial and food security, healthcare access and behaviors, and mental health. Responses were compared among the parent study groups. Results Phone surveys were completed with 334 ALHIV or their caregivers, including 275/308 (89.3%) in the retained group and 59/70 (84.3%) among those LTP at initial enrollment. During the pandemic, a greater proportion of LTP adolescents were no longer engaged in school (45.8% vs. 36.4%, p = 0.017). Over a third (120, 35.9%) of adolescents reported lost income for someone they relied on. In total, 135 (40.4%) did not have enough food either some (121, 36.2%) or most (14, 4.2%) of the time. More LTP adolescents (4/59, 6.8% vs. 2/275, 0.7%, p = 0.010) reported increased difficulties refilling ART. Adolescent PHQ-2 and GAD-2 scores were >= 3 for 5.6% and 5.2%, respectively. Conclusions The COVID-19 pandemic has had devastating socioeconomic effects for Kenyan ALHIV and their households. ALHIV with recent care disengagement may be especially vulnerable. Meanwhile, sustained ART access and adherence potentially signal resilience and strengths of ALHIV and their care programs. Findings from this survey indicate the critical need for support to ALHIV during this crisis.	[Enane, Leslie A.] Indiana Univ Sch Med, Dept Pediat, Ryan White Ctr Pediat Infect Dis & Global Hlth, Indianapolis, IN 46202 USA; [Enane, Leslie A.; Gardner, Adrian; Scanlon, Michael; Wools-Kaloustian, Kara] Indiana Univ, Ctr Global Hlth, Indianapolis, IN 46204 USA; [Apondi, Edith; Aluoch, Josephine] Acad Model Providing Access Healthcare AMPATH, Eldoret, Kenya; [Apondi, Edith] Moi Teaching & Referral Hosp, Eldoret, Kenya; [Bakoyannis, Giorgos] Indiana Univ, Dept Biostat & Hlth Data Sci, Indianapolis, IN 46204 USA; [Lewis Kulzer, Jayne] Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, San Francisco, CA USA; [Kwena, Zachary] Kenya Govt Med Res Ctr, Ctr Microbiol Res, Res Care & Treatment Programme, Nairobi, Kenya; [Kantor, Rami] Brown Univ, Apert Med Sch, Dept Med, Div Infect Dis, Providence, RI USA; [Chory, Ashley; Vreeman, Rachel C.] Icahn Sch Med Mt Sinai, Dept Hlth Syst Design & Global Hlth, New York, NY 10029 USA; [Vreeman, Rachel C.] Arnhold Inst Global Hlth, New York, NY USA; [Gardner, Adrian; Goodrich, Suzanne; Wools-Kaloustian, Kara] Indiana Univ Sch Med, Div Infect Dis, Dept Med, Indianapolis, IN 46202 USA; [Elul, Batya] Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; University of California System; University of California San Francisco; Kenya Medical Research Institute; Brown University; Icahn School of Medicine at Mount Sinai; Indiana University System; Indiana University Bloomington; Columbia University	Enane, LA (corresponding author), Indiana Univ Sch Med, Dept Pediat, Ryan White Ctr Pediat Infect Dis & Global Hlth, Indianapolis, IN 46202 USA.; Enane, LA (corresponding author), Indiana Univ, Ctr Global Hlth, Indianapolis, IN 46204 USA.	lenane@iu.edu		Enane, Leslie A./0000-0001-8390-5881	Eunice Kennedy Shriver National Institute of Child Health & Human Development of the NIH [K23HD095778]; East Africa International Epidemiology Databases to Evaluate AIDS (IeDEA) regional consortium - NIH [U01 AI069911]; National Institute of Allergy and Infectious Disease of the NIH [K24AI134359, P30AI042853]	Eunice Kennedy Shriver National Institute of Child Health & Human Development of the NIH; East Africa International Epidemiology Databases to Evaluate AIDS (IeDEA) regional consortium - NIH; National Institute of Allergy and Infectious Disease of the NIH	Research reported in this publication was supported by the Eunice Kennedy Shriver National Institute of Child Health & Human Development of the NIH under Award Number K23HD095778. Dr. Wools-Kaloustian's and Dr. Vreeman's time, and the infrastructure of the ACE cohort, was supported in part by the East Africa International Epidemiology Databases to Evaluate AIDS (IeDEA) regional consortium, which is funded by multiple institutes of the NIH, through award U01 AI069911. Dr. Kantor was supported by the National Institute of Allergy and Infectious Disease of the NIH, under award numbers K24AI134359 and P30AI042853. The content of this manuscript is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Akseer N, 2020, AM J CLIN NUTR, V112, P251, DOI 10.1093/ajcn/nqaa171; Armbruster M, 2020, J ADOLESCENT HEALTH, V67, P290, DOI 10.1016/j.jadohealth.2020.05.021; Armstrong WS, 2021, CLIN INFECT DIS, V72, P9, DOI 10.1093/cid/ciaa1532; Ballester-Arnal R, 2020, AIDS BEHAV, V24, P2253, DOI 10.1007/s10461-020-02877-3; Ballivian J, 2020, JAIDS-J ACQ IMM DEF, V85, P475, DOI 10.1097/QAI.0000000000002493; Bamrah S, 2013, PREHOSP DISASTER MED, V28, P43, DOI 10.1017/S1049023X12001665; Binagwaho A, 2016, BMC PEDIATR, V16, DOI 10.1186/s12887-016-0565-2; Chenneville T, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17124548; Chory A, 2022, AIDS BEHAV, V26, P232, DOI 10.1007/s10461-021-03376-9; Coker M, 2021, PEDIATR RES, V89, P1078, DOI 10.1038/s41390-020-01174-y; CSSE at Johns Hopkins University, 2020, COVID 19 DASHB CTR S; DeLong SM, 2020, AM J PUBLIC HEALTH, V110, P1650, DOI 10.2105/AJPH.2020.305915; Desmonde S, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002565; Dong ES, 2020, LANCET INFECT DIS, V20, P533, DOI 10.1016/S1473-3099(20)30120-1; Dorward J, 2021, LANCET HIV, V8, pe158, DOI 10.1016/S2352-3018(20)30359-3; Dow DE, 2016, AIDS CARE, V28, P825, DOI 10.1080/09540121.2016.1139043; Dyer J, 2021, AIDS BEHAV, V25, P68, DOI 10.1007/s10461-020-03005-x; Enane LA, 2021, J INT AIDS SOC, V24, DOI 10.1002/jia2.25695; Enane LA, 2020, AIDS CARE, V32, P104, DOI 10.1080/09540121.2019.1668530; Enane LA, 2018, J VIRUS ERAD, V4, P40; Enane LA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195372; Enane LA, 2018, CURR OPIN HIV AIDS, V13, P212, DOI [10.1097/COH.0000000000000459, 10.1097/coh.0000000000000459]; Gill MJ, 2009, INT J STD AIDS, V20, P540, DOI 10.1258/ijsa.2008.008422; Goodrich Suzanne, 2013, Confl Health, V7, P25, DOI 10.1186/1752-1505-7-25; Govender K, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00504; Hogan AB, 2020, LANCET GLOB HEALTH, V8, pE1132, DOI 10.1016/S2214-109X(20)30288-6; Iversen J, 2020, J INT AIDS SOC, V23, DOI 10.1002/jia2.25632; Jensen C, 2020, S Afr Med J, V0, P13185; Joint United Nations Programme on HIV/AIDS (UNAIDS), 2017, END AIDS PROGR 90 90; Kamau JW, 2012, AIDS CARE, V24, P836, DOI 10.1080/09540121.2011.644234; Kariminia Azar, 2018, J Int AIDS Soc, V21, pe25215, DOI 10.1002/jia2.25215; Kasera K., 2021, ASSESSING INDIRECT H, V2021; Kim MH, 2015, BMC PSYCHIATRY, V15, DOI 10.1186/s12888-015-0649-9; Kim MH, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.18965; Kroenke K, 2010, GEN HOSP PSYCHIAT, V32, P345, DOI 10.1016/j.genhosppsych.2010.03.006; Mann M, 2013, AIDS REV, V15, P15; Mann M, 2013, JAIDS-J ACQ IMM DEF, V64, P220, DOI 10.1097/QAI.0b013e31829ec485; Monahan PO, 2009, J GEN INTERN MED, V24, P189, DOI 10.1007/s11606-008-0846-z; Nosyk B, 2015, AIDS, V29, P1681, DOI 10.1097/QAD.0000000000000746; Ombuor R., 2020, VOICE AM 0313; Plummer F, 2016, GEN HOSP PSYCHIAT, V39, P24, DOI 10.1016/j.genhosppsych.2015.11.005; Prabhu S, 2020, J VIRUS ERAD, V6, DOI 10.1016/j.jve.2020.100019; Pyne-Mercier LD, 2011, AIDS CARE, V23, P562, DOI 10.1080/09540121.2010.525615; Ramaiya MK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165936; Rebeiro Peter, 2013, J Acquir Immune Defic Syndr, V62, P356, DOI 10.1097/QAI.0b013e31827f578a; Rhodes SD, 2021, AIDS BEHAV, V25, P58, DOI 10.1007/s10461-020-03014-w; Roberton T, 2020, LANCET GLOB HEALTH, V8, pE901, DOI 10.1016/S2214-109X(20)30229-1; Sherbuk JE, 2020, OPEN FORUM INFECT DI, V7, DOI 10.1093/ofid/ofaa423; Fodjo JNS, 2020, JAIDS-J ACQ IMM DEF, V85, P257, DOI 10.1097/QAI.0000000000002468; UNAIDS, 2020, UNAIDS EST; Vreeman RC, 2019, J INT AIDS SOC, V22, DOI 10.1002/jia2.25304; Vreeman RC, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191848; Vreeman RC, 2017, J INT AIDS SOC, V20, DOI 10.7448/IAS.20.4.21497; Vreeman Rachel C, 2014, J Int AIDS Soc, V17, P19227, DOI 10.7448/IAS.17.1.19227; Vreeman RC, 2015, AIDS CARE, V27, P6, DOI 10.1080/09540121.2015.1026307; Vreeman RC, 2015, AIDS BEHAV, V19, P626, DOI 10.1007/s10461-015-0998-x; Vreeman Rachel C, 2009, Confl Health, V3, P5, DOI 10.1186/1752-1505-3-5; Yusuf M., 2021, VOICE AM 0326; Zar HJ, 2020, PAEDIATR RESPIR REV, V35, P70, DOI 10.1016/j.prrv.2020.06.016	59	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2021	16	9							e0257210	10.1371/journal.pone.0257210	http://dx.doi.org/10.1371/journal.pone.0257210			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	XM9EM	34506555	Green Published, gold			2022-12-26	WOS:000729120700106
J	Chen, QC; Fang, W; Cui, K; Chen, Q; Xiang, XJ; Zhang, JZ; Zhang, YQ; Mai, KS; Ai, QH				Chen, Qiuchi; Fang, Wei; Cui, Kun; Chen, Qiang; Xiang, Xiaojun; Zhang, Junzhi; Zhang, Yunqiang; Mai, Kangsen; Ai, Qinghui			Endoplasmic reticulum stress induces hepatic steatosis by transcriptional upregulating lipid droplet protein perilipin2	FASEB JOURNAL			English	Article						ER stress; hepatic steatosis; lipid droplet; lipoprotein; perilipin2	DIFFERENTIATION-RELATED PROTEIN; ER STRESS; FATTY LIVER; PPAR-ALPHA; EXPRESSION; SECRETION; ACCUMULATION; LIPOGENESIS; ROLES; ACTIVATION	Previous studies have shown that endoplasmic reticulum (ER) stress contributes to hepatic steatosis in several manners. However, how lipid droplet (LD) proteins participate in this process has rarely been reported. In the present study, ER stress was induced at both in vitro and in vivo levels with tunicamycin in large yellow croaker (Larimichthys crocea). Effects of LD protein perilipin2 (PLIN2) on hepatic lipid accumulation and lipoprotein transport under normal physiological condition and ER stress were then explored using dsRNA mediated knockdown. Subsequently, the transcriptional regulation of plin2 expression by transcription factors generated in the unfolded protein response (UPR) was determined by dual-luciferase reporter assays, chromatin immunoprecipitation and electrophoretic mobility-shift assay. We demonstrated that ER stress could promote LDs accumulation and inhibit lipoprotein transport by transcriptionally upregulating PLIN2 in liver. Among the transcription factors generated by UPR, spliced X-box binding protein1 can directly upregulated the expression of plin2, whereas C/EBP homologous protein can upregulate the expression of plin2 through peroxisome proliferator activated-receptor alpha. These results revealed that the LD protein PLIN2 played an important role in ER stress-induced hepatic steatosis, which might be a novel mechanism explaining hepatic steatosis triggered by ER stress.	[Chen, Qiuchi; Fang, Wei; Cui, Kun; Chen, Qiang; Xiang, Xiaojun; Zhang, Junzhi; Zhang, Yunqiang; Mai, Kangsen; Ai, Qinghui] Ocean Univ China, Key Lab Aquaculture Nutr & Feed, Minist Agr & Rural Affairs, 5 Yushan Rd, Qingdao 266003, Shandong, Peoples R China; [Chen, Qiuchi; Fang, Wei; Cui, Kun; Chen, Qiang; Xiang, Xiaojun; Zhang, Junzhi; Zhang, Yunqiang; Mai, Kangsen; Ai, Qinghui] Ocean Univ China, Key Lab Mariculture, Minist Educ, 5 Yushan Rd, Qingdao 266003, Shandong, Peoples R China; [Mai, Kangsen; Ai, Qinghui] Qingdao Natl Lab Marine Sci & Technol, Lab Marine Fisheries Sci & Food Prod Proc, Qingdao, Peoples R China	Ministry of Agriculture & Rural Affairs; Ocean University of China; Ocean University of China; Qingdao National Laboratory for Marine Science & Technology	Ai, QH (corresponding author), Ocean Univ China, Key Lab Aquaculture Nutr & Feed, Minist Agr & Rural Affairs, 5 Yushan Rd, Qingdao 266003, Shandong, Peoples R China.; Ai, QH (corresponding author), Ocean Univ China, Key Lab Mariculture, Minist Educ, 5 Yushan Rd, Qingdao 266003, Shandong, Peoples R China.	qhai@ouc.edu.cn			National Science Fund for Distinguished Young Scholars of China [31525024]; Key Program of National Natural Science Foundation of China [31830103]; Scientific and Technological Innovation of Blue Granary [2018YFD0900402]	National Science Fund for Distinguished Young Scholars of China(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); Key Program of National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Scientific and Technological Innovation of Blue Granary	The National Science Fund for Distinguished Young Scholars of China, Grant/Award Number: 31525024; Key Program of National Natural Science Foundation of China, Grant/Award Number: 31830103; The Scientific and Technological Innovation of Blue Granary, Grant/Award Number: 2018YFD0900402	Almanza A, 2019, FEBS J, V286, P241, DOI 10.1111/febs.14608; Basseri S, 2012, BIOCHEM RES INT, V2012, DOI 10.1155/2012/841362; Borgese N, 2006, CURR OPIN CELL BIOL, V18, P358, DOI 10.1016/j.ceb.2006.06.008; Caviglia JM, 2011, J LIPID RES, V52, P1636, DOI 10.1194/jlr.M016931; Chandrahas VK., 2018, COORDINATING ORGANIS; Chang BHJ, 2010, J LIPID RES, V51, P2132, DOI 10.1194/jlr.M004515; Chang BHJ, 2006, MOL CELL BIOL, V26, P1063, DOI 10.1128/MCB.26.3.1063-1076.2006; Dalen KT, 2006, J LIPID RES, V47, P931, DOI 10.1194/jlr.M500459-JLR200; DeZwaan-McCabe D, 2017, CELL REP, V19, P1794, DOI 10.1016/j.celrep.2017.05.020; Fei WH, 2009, BIOCHEM J, V424, P61, DOI 10.1042/BJ20090785; Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034; Itabe H, 2017, LIPIDS HEALTH DIS, V16, DOI 10.1186/s12944-017-0473-y; Jacquier N, 2013, J CELL SCI, V126, P5198, DOI 10.1242/jcs.131896; Jo H, 2013, HEPATOLOGY, V57, P1366, DOI 10.1002/hep.26126; Kammoun HL, 2009, J CLIN INVEST, V119, P1201, DOI 10.1172/JCI37007; Kaplowitz N, 2007, SEMIN LIVER DIS, V27, P367, DOI 10.1055/s-2007-991513; Kersten S, 2017, BIOCHIMIE, V136, P75, DOI 10.1016/j.biochi.2016.12.019; Lee AH, 2008, SCIENCE, V320, P1492, DOI 10.1126/science.1158042; Lee JS, 2012, AM J TRANSL RES, V4, P102; Lefebvre P, 2006, J CLIN INVEST, V116, P571, DOI 10.1172/JCI27989; Li XH, 2012, J LIPID RES, V53, P1877, DOI 10.1194/jlr.M026591; Liao K, 2017, COMP BIOCHEM PHYS B, V203, P53, DOI 10.1016/j.cbpb.2016.09.005; Libby AE, 2016, J BIOL CHEM, V291, P24231, DOI 10.1074/jbc.M116.759795; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Magnusson B, 2006, ARTERIOSCL THROM VAS, V26, P1566, DOI 10.1161/01.ATV.0000223345.11820.da; Malhotra JD, 2008, P NATL ACAD SCI USA, V105, P18525, DOI 10.1073/pnas.0809677105; Moncan M, 2021, J CELL MOL MED, V25, P1359, DOI 10.1111/jcmm.16255; Najt CP, 2016, AM J PHYSIOL-GASTR L, V310, pG726, DOI 10.1152/ajpgi.00436.2015; Ota T, 2008, J CLIN INVEST, V118, P316, DOI 10.1172/JCI32752; Petschnigg J, 2009, J BIOL CHEM, V284, P30981, DOI 10.1074/jbc.M109.024752; Pyper Sean R, 2010, Nucl Recept Signal, V8, pe002, DOI 10.1621/nrs.08002; Rahman K, 2016, LAB INVEST, V96, P895, DOI 10.1038/labinvest.2016.61; Schubert M, 2020, MOL PHARMACOL, V97, P212, DOI 10.1124/mol.119.117887; Seo YS, 2008, J GASTROEN HEPATOL, V23, P102, DOI 10.1111/j.1440-1746.2006.04819.x; Sztalryd C, 2014, BIOCHIMIE, V96, P96, DOI 10.1016/j.biochi.2013.08.026; Velazquez AR, 2016, J CELL BIOL, V212, P621, DOI 10.1083/jcb.201508102; Wang SY, 2015, MOL BIOL CELL, V26, P594, DOI 10.1091/mbc.E14-08-1274; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Yu K, 2015, J CELL BIOCHEM, V116, P192, DOI 10.1002/jcb.24958; Zhang CY, 2017, PROTEIN CELL, V8, P796, DOI 10.1007/s13238-017-0467-6; Zhang JZ, 2020, FISH SHELLFISH IMMUN, V98, P112, DOI 10.1016/j.fsi.2019.12.089; Zhou HP, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00112	43	6	6	15	32	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2021	35	10							e21900	10.1096/fj.202100739RR	http://dx.doi.org/10.1096/fj.202100739RR			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	UZ5IH	34547130				2022-12-26	WOS:000702238200060
J	Chen, ZS; Zhang, YP; Guan, QQ; Zhang, HF; Luo, J; Li, JL; Wei, W; Xu, X; Liao, LJ; Wong, JM; Li, JW				Chen, Zhaosu; Zhang, Yunpeng; Guan, Qingqing; Zhang, Huifang; Luo, Jing; Li, Jialun; Wei, Wei; Xu, Xiang; Liao, Lujian; Wong, Jiemin; Li, Jiwen			Linking nuclear matrix-localized PIAS1 to chromatin SUMOylation via direct binding of histones H3 and H2A.Z	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUMO-MEDIATED REGULATION; SACCHAROMYCES-CEREVISIAE; ANDROGEN RECEPTOR; LIGASE PIAS1; PROTEIN; UBIQUITIN; TRANSCRIPTION; ORGANIZATION; E3-LIGASES; RESPONSES	As a conserved posttranslational modification, SUMOylation has been shown to play important roles in chromatin-related biological processes including transcription. However, how the SUMOylation machinery associates with chromatin is not clear. Here, we present evidence that multiple SUMOylation machinery components, including SUMO E1 proteins SAE1 and SAE2 and the PIAS (protein inhibitor of activated STAT) family SUMO E3 ligases, are primarily associated with the nuclear matrix rather than with chromatin. We show using nuclease digestion that all PIAS family proteins maintain nuclear matrix association in the absence of chromatin. Of importance, we identify multiple histones including H3 and H2A.Z as directly interacting with PIAS1 and demonstrate that this interaction requires the PIAS1 SAP (SAF-A/B, Acinus, and PIAS) domain. We demonstrate that PIAS1 promotes SUMOylation of histones H3 and H2B in both a SAP domain- and an E3 ligase activity-dependent manner. Furthermore, we show that PIAS1 binds to heat shock-induced genes and represses their expression and that this function also requires the SAP domain. Altogether, our study reveals for the first time the nuclear matrix as the compartment most enriched in SUMO E1 and PIAS family E3 ligases. Our finding that PIAS1 interacts directly with histone proteins also suggests a molecular mechanism as to how nuclear matrix-associated PIAS1 is able to regulate transcription and other chromatin-related processes.	[Chen, Zhaosu; Zhang, Yunpeng; Guan, Qingqing; Zhang, Huifang; Luo, Jing; Li, Jialun; Wei, Wei; Xu, Xiang; Liao, Lujian; Wong, Jiemin; Li, Jiwen] East China Normal Univ, Shanghai Key Lab Regulatory Biol, Fengxian Dist Cent Hosp, Inst Biomed Sci,ECNU Joint Ctr Transla, Shanghai, Peoples R China; [Chen, Zhaosu; Zhang, Yunpeng; Guan, Qingqing; Zhang, Huifang; Luo, Jing; Li, Jialun; Wei, Wei; Xu, Xiang; Liao, Lujian; Wong, Jiemin; Li, Jiwen] East China Normal Univ, Sch Life Sci, Shanghai, Peoples R China; [Wong, Jiemin] Fengxian Dist Cent Hosp, Joint Ctr Translat Med, Shanghai, Peoples R China	East China Normal University; East China Normal University	Wong, JM; Li, JW (corresponding author), East China Normal Univ, Shanghai Key Lab Regulatory Biol, Fengxian Dist Cent Hosp, Inst Biomed Sci,ECNU Joint Ctr Transla, Shanghai, Peoples R China.; Wong, JM; Li, JW (corresponding author), East China Normal Univ, Sch Life Sci, Shanghai, Peoples R China.; Wong, JM (corresponding author), Fengxian Dist Cent Hosp, Joint Ctr Translat Med, Shanghai, Peoples R China.	jmweng@bio.ecnu.edu.cn; jwli@bio.ecnu.edu.cn	Zhang, Hui/HHN-8494-2022; zhang, hui/GXH-6098-2022	Wong, Jiemin/0000-0002-5311-842X; Zhang, Yunpeng/0000-0001-5144-3803	National Natural Science Foundation of China [32070643, 31730048]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study is supported by grants from the National Natural Science Foundation of China (32070643 to Jiwen Li and 31730048 to J. W.) .	Abad PC, 2007, MOL BIOL CELL, V18, P348, DOI 10.1091/mbc.E06-06-0551; Albrethsen J, 2009, J PROTEOMICS, V72, P71, DOI 10.1016/j.jprot.2008.09.005; Cubenas-Potts C, 2013, DEV CELL, V24, P1, DOI 10.1016/j.devcel.2012.11.020; Dhingra N, 2019, GENE DEV, V33, P1346, DOI [10.1101/gad.328534, 10.1101/gad.328534.119]; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Flotho A, 2013, ANNU REV BIOCHEM, V82, P357, DOI 10.1146/annurev-biochem-061909-093311; Fu JJ, 2009, J BIOL CHEM, V284, P6832, DOI 10.1074/jbc.M808988200; Galanty Y, 2009, NATURE, V462, P935, DOI 10.1038/nature08657; Giaimo BD, 2019, EPIGENET CHROMATIN, V12, DOI 10.1186/s13072-019-0274-9; Gill G, 2004, GENE DEV, V18, P2046, DOI 10.1101/gad.1214604; Girdwood DWH, 2004, SEMIN CELL DEV BIOL, V15, P201, DOI 10.1016/j.semcdb.2003.12.001; Hay RT, 2013, BIOCHEM SOC T, V41, P463, DOI 10.1042/BST20130015; Hendriks IA, 2016, NAT REV MOL CELL BIO, V17, P581, DOI 10.1038/nrm.2016.81; Hendriks IA, 2014, NAT STRUCT MOL BIOL, V21, P927, DOI 10.1038/nsmb.2890; Huang J, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1919; Jackson SP, 2013, MOL CELL, V49, P795, DOI 10.1016/j.molcel.2013.01.017; Jalal D, 2017, NUCLEIC ACIDS RES, V45, P2242, DOI 10.1093/nar/gkw1369; Kahyo T, 2001, MOL CELL, V8, P713, DOI 10.1016/S1097-2765(01)00349-5; Koh A, 2018, CELL, V175, P947, DOI 10.1016/j.cell.2018.09.055; Lallemand-Breitenbach V., 2010, CSH PERSPECT BIOL, V2, DOI [10.1101/cshperspect.a000661, DOI 10.1101/cshperspect.a000661]; Li CY, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-14581-w; Li R, 2013, CANCER RES, V73, P5742, DOI 10.1158/0008-5472.CAN-13-0538; Lin X, 2003, J BIOL CHEM, V278, P31043, DOI 10.1074/jbc.C300112200; Liu B, 1998, P NATL ACAD SCI USA, V95, P10626, DOI 10.1073/pnas.95.18.10626; Lumpkin RJ, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01271-3; MAHESWARAN S, 1994, MOL CELL BIOL, V14, P1147, DOI 10.1128/MCB.14.2.1147; Matafora V, 2009, MOL CELL PROTEOMICS, V8, P2243, DOI 10.1074/mcp.M900079-MCP200; Nathan D, 2006, GENE DEV, V20, P966, DOI 10.1101/gad.1404206; Neyret-Kahn H, 2013, GENOME RES, V23, P1563, DOI 10.1101/gr.154872.113; Nishida T, 2002, J BIOL CHEM, V277, P41311, DOI 10.1074/jbc.M206741200; Niskanen EA, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0717-y; Okubo S, 2004, J BIOL CHEM, V279, P31455, DOI 10.1074/jbc.M403561200; Pathak RU, 2007, MOL CELL BIOL, V27, P4796, DOI 10.1128/MCB.00305-07; Peng Y, 2019, J BIOL CHEM, V294, P19155, DOI 10.1074/jbc.RA119.010624; Rabellino A, 2017, CANCER RES, V77, P1542, DOI 10.1158/0008-5472.CAN-16-2958; Rabellino A, 2012, CANCER RES, V72, P2275, DOI 10.1158/0008-5472.CAN-11-3159; Razin SV, 2014, CHROMOSOMA, V123, P217, DOI 10.1007/s00412-014-0459-8; Reyes JC, 1997, J CELL BIOL, V137, P263, DOI 10.1083/jcb.137.2.263; Rytinki MM, 2009, CELL MOL LIFE SCI, V66, P3029, DOI 10.1007/s00018-009-0061-z; Ryu HY, 2020, NUCLEIC ACIDS RES, V48, P12151, DOI 10.1093/nar/gkaa1093; Sachdev S, 2001, GENE DEV, V15, P3088, DOI 10.1101/gad.944801; Sarangi P, 2015, TRENDS BIOCHEM SCI, V40, P233, DOI 10.1016/j.tibs.2015.02.006; Shilo Y, 2003, P NATL ACAD SCI USA, V100, P13225, DOI 10.1073/pnas.1735528100; Subramanian Vidya, 2015, F1000Prime Rep, V7, P01, DOI 10.12703/P7-01; Sureka R, 2018, MOL CELL PROTEOMICS, V17, P1965, DOI 10.1074/mcp.RA118.000591; Tan JAT, 2010, MOL CELL BIOL, V30, P2823, DOI 10.1128/MCB.01603-09; Toropainen S, 2015, NUCLEIC ACIDS RES, V43, P848, DOI 10.1093/nar/gku1375; Varejao N, 2020, BIOCHEM SOC T, V48, P123, DOI 10.1042/BST20190357; Wu CS, 2014, GENE DEV, V28, P1472, DOI 10.1101/gad.238535.114; Yang SH, 2004, MOL CELL, V13, P611, DOI 10.1016/S1097-2765(04)00060-7; Zhao Q, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12464; Zhao XL, 2018, MOL CELL, V71, P409, DOI 10.1016/j.molcel.2018.07.027; Zhou S, 2008, J BIOL CHEM, V283, P20137, DOI 10.1074/jbc.M801307200	53	1	1	1	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT	2021	297	4							101200	10.1016/j.jbc.2021.101200	http://dx.doi.org/10.1016/j.jbc.2021.101200			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	WP2YR	34537242	gold, Green Published			2022-12-26	WOS:000713003600008
J	Zafar, A; Ng, HP; Kim, GD; Chan, ER; Mahabeleshwar, GH				Zafar, Atif; Ng, Hang Pong; Kim, Gun-Dong; Chan, E. Ricky; Mahabeleshwar, Ganapati H.			BHLHE40 promotes macrophage pro-inflammatory gene expression and functions	FASEB JOURNAL			English	Article						BHLHE40; glycolysis; HIF1 alpha; hypoxia; inflammation; macrophages	TRANSCRIPTIONAL REGULATION; INNATE; IMMUNITY; STRA13; CELLS	Macrophages are the principal innate immune cells that populate all major organs and provide the first line of cellular defense against infections and/or injuries. The immediate and early-responding macrophages must mount a robust pro-inflammatory response to protect the host by eliminating deleterious agents. The effective pro-inflammatory macrophage response requires the activation of complex transcriptional programs that modulate the dynamic regulation of inflammatory and metabolic gene expression. Therefore, transcription factors that govern pro-inflammatory and metabolic gene expression play an essential role in shaping the macrophage inflammatory response. Herein, we identify the basic helix-loop-helix family member e40 (BHLHE40), as a critical transcription factor that promotes broad pro-inflammatory and glycolytic gene expression by elevating HIF1 alpha levels in macrophages. Our in vivo studies revealed that myeloid-BHLHE40 deficiency significantly attenuates macrophage and neutrophil recruitment to the site of inflammation. Our integrated transcriptomics and gene set enrichment analysis (GSEA) studies show that BHLHE40 deficiency broadly curtails inflammatory signaling pathways, hypoxia response, and glycolytic gene expression in macrophages. Utilizing complementary gain- and loss-of-function studies, our analyses uncovered that BHLHE40 promotes LPS-induced HIF1 alpha mRNA and protein expression in macrophages. More importantly, forced overexpression of oxygen stable form of HIF1 alpha completely reversed attenuated pro-inflammatory and glycolytic gene expression in BHLHE40-deficient macrophages. Collectively, these results demonstrate that BHLHE40 promotes macrophage pro-inflammatory gene expression and functions by elevating expression in macrophages.	[Zafar, Atif; Ng, Hang Pong; Kim, Gun-Dong; Mahabeleshwar, Ganapati H.] Case Western Reserve Univ, Dept Pathol, Sch Med, 2103 Cornell Rd,Room WRB5527, Cleveland, OH 44106 USA; [Chan, E. Ricky] Case Western Reserve Univ, Cleveland Inst Computat Biol, Sch Med, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University	Mahabeleshwar, GH (corresponding author), Case Western Reserve Univ, Dept Pathol, Sch Med, 2103 Cornell Rd,Room WRB5527, Cleveland, OH 44106 USA.	ghm4@case.edu			Crohn's and Colitis Foundation of America (CCFA) [421904]; National Institutes of Health [HL126626, HL141423]	Crohn's and Colitis Foundation of America (CCFA); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Crohn's and Colitis Foundation of America (CCFA), Grant/Award Number: 421904; National Institutes of Health, Grant/Award Number: HL126626 and HL141423	Backer V, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0190074; Choudhry H, 2018, CELL METAB, V27, P281, DOI 10.1016/j.cmet.2017.10.005; Cook ME, 2020, TRENDS IMMUNOL, V41, P1023, DOI 10.1016/j.it.2020.09.002; Cramer T, 2003, CELL, V112, P645, DOI 10.1016/S0092-8674(03)00154-5; Date D, 2014, J BIOL CHEM, V289, P10318, DOI 10.1074/jbc.M113.526749; Gosselin D, 2014, CELL, V159, P1327, DOI 10.1016/j.cell.2014.11.023; Hamidzadeh K, 2017, ANNU REV PHYSIOL, V79, P567, DOI 10.1146/annurev-physiol-022516-034348; Huynh JP, 2018, J EXP MED, V215, P1823, DOI 10.1084/jem.20171704; Ivanova AV, 2004, J MOL BIOL, V340, P641, DOI 10.1016/J.Jmb.2004.05.025; Jarjour NN, 2020, J IMMUNOL, V204, P923, DOI 10.4049/jimmunol.1900978; Jarjour NN, 2019, NAT IMMUNOL, V20, P687, DOI 10.1038/s41590-019-0382-5; Kanda M, 2016, P NATL ACAD SCI USA, V113, pE3394, DOI 10.1073/pnas.1604178113; Kim GD, 2021, AM J PATHOL, V191, P1118, DOI 10.1016/j.ajpath.2021.03.008; Kim GD, 2020, FASEB J, V34, P3209, DOI 10.1096/fj.201902221R; Kim GD, 2018, MOL CELL BIOL, V38, DOI 10.1128/MCB.00452-17; Kiss Zsofia, 2020, Genes Cancer, V11, P1, DOI 10.18632/genesandcancer.201; Lin CC, 2016, J EXP MED, V213, P251, DOI 10.1084/jem.20150568; Lin CC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4551; Lin N, 2016, J CLIN INVEST, V126, P3661, DOI 10.1172/JCI84426; Locati M, 2020, ANNU REV PATHOL-MECH, V15, P123, DOI 10.1146/annurev-pathmechdis-012418-012718; Metsalu T, 2015, NUCLEIC ACIDS RES, V43, pW566, DOI 10.1093/nar/gkv468; Monticelli S, 2017, NAT REV IMMUNOL, V17, P595, DOI 10.1038/nri.2017.51; Newson J, 2014, BLOOD, V124, P1748, DOI 10.1182/blood-2014-03-562710; Nizet V, 2009, NAT REV IMMUNOL, V9, P609, DOI 10.1038/nri2607; Ow JR, 2014, CURR TOP DEV BIOL, V110, P317, DOI 10.1016/B978-0-12-405943-6.00009-9; Palazon A, 2014, IMMUNITY, V41, P518, DOI 10.1016/j.immuni.2014.09.008; Piper C, 2020, BLOOD, V135, P568, DOI 10.1182/blood.2019001696; Rauschmeier R, 2019, EMBO J, V38, DOI 10.15252/embj.2018101233; Rius J, 2008, NATURE, V453, P807, DOI 10.1038/nature06905; Sadiku P, 2019, EMBO REP, V20, DOI 10.15252/embr.201847388; Segal BH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009631; SEMENZA GL, 1994, J BIOL CHEM, V269, P23757; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sun H, 2001, NAT IMMUNOL, V2, P1040, DOI 10.1038/ni721; Van den Bossche J, 2017, TRENDS IMMUNOL, V38, P395, DOI 10.1016/j.it.2017.03.001; Yan Q, 2007, MOL CELL BIOL, V27, P2092, DOI 10.1128/MCB.01514-06; Yu F, 2018, J EXP MED, V215, P1813, DOI 10.1084/jem.20170155; Yun Z, 2002, DEV CELL, V2, P331, DOI 10.1016/S1534-5807(02)00131-4; Zhang F, 2018, J PERIODONTAL RES, V53, P883, DOI 10.1111/jre.12578; Zhang L, 2018, NATURE, V564, P268, DOI 10.1038/s41586-018-0694-x	40	3	3	3	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2021	35	10							e21940	10.1096/fj.202100944R	http://dx.doi.org/10.1096/fj.202100944R			19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	UZ5IH	34551158	Green Accepted			2022-12-26	WOS:000702238200053
J	Zapateria, B; Sevillano, J; Sanchez-Alonso, MG; Limones, M; Pizarro-Delgado, J; Zuccaro, A; Herradon, G; Medina-Gomez, G; Ramos-Alvarez, MP				Zapateria, Begona; Sevillano, Julio; Gracia Sanchez-Alonso, Maria; Limones, Maria; Pizarro-Delgado, Javier; Zuccaro, Agata; Herradon, Gonzalo; Medina-Gomez, Gema; Pilar Ramos-Alvarez, Maria			Deletion of pleiotrophin impairs glucose tolerance and liver metabolism in pregnant mice: Moonlighting role of glycerol kinase	FASEB JOURNAL			English	Article						glycerol kinase; liver; metabolism; pleiotrophin; pregnancy	LIPID-METABOLISM; INSULIN-RESISTANCE; FAT; RAT; EXPRESSION; RECEPTORS; MITOGEN; MIDKINE	Pleiotrophin is a pleiotropic cytokine that has been demonstrated to have a critical role in regulating energy metabolism, lipid turnover and plasticity of adipose tissue. Here, we hypothesize that this cytokine can be involved in regulatory processes of glucose and lipid homeostasis in the liver during pregnancy. Using 18-days pregnant Ptn-deficient mice, we evaluated the biochemical profile (circulating variables), tissue mRNA expression (qPCR) and protein levels of key enzymes and transcription factors involved in main metabolic pathways. Ptn deletion was associated with a reduction in body weight gain, hyperglycemia and glucose intolerance. Moreover, we observed an impairment in glucose synthesis and degradation during late pregnancy in Ptn(-/-) mice. Hepatic lipid content was significantly lower (73.6%) in Ptn(-/-) mice and was associated with a clear reduction in fatty acid, triacylglycerides and cholesterol synthesis. Ptn deletion was accompanying with a diabetogenic state in the mother and a decreased expression of key proteins involved in glucose and lipid uptake and metabolism. Moreover, Ptn(-/-) pregnant mice have a decreased expression of transcription factors, such as PPAR-alpha, regulating lipid uptake and glucose and lipid utilization. Furthermore, the augmented expression and nuclear translocation of glycerol kinase, and the decrease in NUR77 protein levels in the knock-out animals can further explain the alterations observed in hepatic glucose metabolism. Our results point out for the first time that pleiotrophin is an important player in maintaining hepatic metabolic homeostasis during late gestation, and further highlighted the moonlighting role of glycerol kinase in the regulation of maternal glucose homeostasis during pregnancy.	[Zapateria, Begona; Sevillano, Julio; Gracia Sanchez-Alonso, Maria; Limones, Maria; Pizarro-Delgado, Javier; Zuccaro, Agata; Pilar Ramos-Alvarez, Maria] Univ San Pablo CEU, CEU Univ, Fac Farm, Dept Chem & Biochem, Alcorcon, Spain; [Herradon, Gonzalo] Univ San Pablo CEU, CEU Univ, Fac Farm, Dept Pharmaceut & Hlth Sci, Alcorcon, Spain; [Medina-Gomez, Gema] Univ Rey Juan Carlos, Fac Ciencias Salud, Dept Basic Sci Hlth, Alcorcon, Spain	San Pablo CEU University; San Pablo CEU University; Universidad Rey Juan Carlos	Ramos-Alvarez, MP (corresponding author), Univ San Pablo CEU, CEU Univ, Fac Farm, Dept Chem & Biochem, Madrid 28925, Spain.	pramos@ceu.es	PIZARRO-DELGADO, JAVIER/E-7268-2012; Medina-Gomez, Gema/CAF-4668-2022; Medina-Gomez, Gema/CAI-1063-2022; Zuccaro, Agata/ABE-7801-2021; Herradon, Gonzalo/C-8305-2012; Ramos-Alvarez, Maria P./B-6359-2011; Sevillano, Julio/K-6387-2014; Sanchez, Maria Gracia/K-6404-2014	Medina-Gomez, Gema/0000-0001-8169-681X; Medina-Gomez, Gema/0000-0001-8169-681X; Herradon, Gonzalo/0000-0002-1578-3744; Ramos-Alvarez, Maria P./0000-0002-7727-7783; Sevillano, Julio/0000-0001-7726-6673; Zuccaro, Agata/0000-0003-2298-6379; Sanchez, Maria Gracia/0000-0001-7788-8923; PIZARRO-DELGADO, JAVIER/0000-0002-3735-844X	Comunidad de Madrid [S2017/BMD-3684]; Ministerio de Ciencia e Innovacion (MICINN) [RTI2018-095615-B-I00]	Comunidad de Madrid(Comunidad de Madrid); Ministerio de Ciencia e Innovacion (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	Comunidad de Madrid, Grant/Award Number: S2017/BMD-3684; Ministerio de Ciencia e Innovacion (MICINN), Grant/Award Number: RTI2018-095615-B-I00	Ambuhl P, 1998, J CLIN INVEST, V101, P170, DOI 10.1172/JCI62; Amet LEA, 2001, MOL CELL NEUROSCI, V17, P1014, DOI 10.1006/mcne.2001.0998; Asahina K, 2002, AM J PATHOL, V160, P2191, DOI 10.1016/S0002-9440(10)61167-4; Ball M, 2009, PLACENTA, V30, P649, DOI 10.1016/j.placenta.2009.05.001; Carrara MA, 2012, LIFE SCI, V90, P831, DOI 10.1016/j.lfs.2012.03.037; Catalano PM, 2010, REPRODUCTION, V140, P365, DOI 10.1530/REP-10-0088; DARMADY JM, 1982, BRIT J OBSTET GYNAEC, V89, P211, DOI 10.1111/j.1471-0528.1982.tb03616.x; FOLCH J, 1957, J BIOL CHEM, V226, P497; Gu DY, 2007, FEBS LETT, V581, P382, DOI 10.1016/j.febslet.2006.12.043; Haggarty P, 2010, ANNU REV NUTR, V30, P237, DOI 10.1146/annurev.nutr.012809.104742; Herradon G, 2004, BIOCHEM BIOPH RES CO, V324, P1041, DOI 10.1016/j.bbrc.2004.09.161; Herrera E, 2002, ENDOCRINE, V19, P43, DOI 10.1385/ENDO:19:1:43; HERRERA E, 1994, BRAZ J MED BIOL RES, V27, P2499; HERRERA E, 1988, AM J OBSTET GYNECOL, V158, P1575, DOI 10.1016/0002-9378(88)90193-7; Herrera E, 2000, EUR J CLIN NUTR, V54, pS47, DOI 10.1038/sj.ejcn.1600984; Herrera E, 2010, J PHYSIOL BIOCHEM, V66, P245, DOI 10.1007/s13105-010-0031-9; Horton JD, 2003, P NATL ACAD SCI USA, V100, P12027, DOI 10.1073/pnas.1534923100; Kalra S, 2016, DIABETES THER, V7, P1, DOI 10.1007/s13300-016-0160-4; Krellman JW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100597; LOPEZLUNA P, 1991, BIOL NEONATE, V60, P29, DOI 10.1159/000243385; LOPEZLUNA P, 1986, LIFE SCI, V39, P1389, DOI 10.1016/0024-3205(86)90338-3; MacLennan NK, 2006, HUM MOL GENET, V15, P405, DOI 10.1093/hmg/ddi457; Miao LL, 2019, FASEB J, V33, P6736, DOI 10.1096/fj.201800945RR; Michelotti GA, 2016, GUT, V65, P683, DOI 10.1136/gutjnl-2014-308176; Ochiai K, 2004, LIVER INT, V24, P484, DOI 10.1111/j.1478-3231.2004.0990.x; Pei LM, 2006, NAT MED, V12, P1048, DOI 10.1038/nm1471; Rakhshandehroo M, 2010, PPAR RES, V2010, DOI 10.1155/2010/612089; Ramos MP, 2003, AM J PHYSIOL-ENDOC M, V285, pE318, DOI 10.1152/ajpendo.00456.2002; Ruiz JI, 1997, J LIPID RES, V38, P1482; Sarkar M, 2020, J HEPATOL, V73, P516, DOI 10.1016/j.jhep.2020.03.049; Sato H, 1999, EXP CELL RES, V246, P152, DOI 10.1006/excr.1998.4304; Sevillano J, 2019, DIABETOLOGIA, V62, P123, DOI 10.1007/s00125-018-4746-4; Sriram G, 2010, METAB ENG, V12, P332, DOI 10.1016/j.ymben.2010.04.001; Sweeney TR, 2006, AM J PHYSIOL-ENDOC M, V290, pE1313, DOI 10.1152/ajpendo.00071.2005; Torres N, 2010, AM J PHYSIOL-ENDOC M, V298, pE270, DOI 10.1152/ajpendo.00437.2009; VILLAR J, 1992, AM J OBSTET GYNECOL, V167, P1344, DOI 10.1016/S0002-9378(11)91714-1; Wang YP, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21062061; Wolska A, 2017, ATHEROSCLEROSIS, V267, P49, DOI 10.1016/j.atherosclerosis.2017.10.025; Xu CY, 2014, BIOL PHARM BULL, V37, P511, DOI 10.1248/bpb.b13-00845; Zarraga-Granados G, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0222072; Zhang L, 2017, CELL DEATH DIFFER, V24, P1530, DOI 10.1038/cdd.2017.29	41	2	2	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2021	35	10							e21911	10.1096/fj.202101181R	http://dx.doi.org/10.1096/fj.202101181R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	UZ5IH	34551152	Green Published			2022-12-26	WOS:000702238200041
J	Wood, SN; Wit, EC; Rizzo, A				Wood, Simon N.; Wit, Ernst C.; Rizzo, Alessandro			Was R < 1 before the English lockdowns? On modelling mechanistic detail, causality and inference about Covid-19	PLOS ONE			English	Article								Detail is a double edged sword in epidemiological modelling. The inclusion of mechanistic detail in models of highly complex systems has the potential to increase realism, but it also increases the number of modelling assumptions, which become harder to check as their possible interactions multiply. In a major study of the Covid-19 epidemic in England, Knock et al. (2020) fit an age structured SEIR model with added health service compartments to data on deaths, hospitalization and test results from Covid-19 in seven English regions for the period March to December 2020. The simplest version of the model has 684 states per region. One main conclusion is that only full lockdowns brought the pathogen reproduction number, R, below one, with R >> 1 in all regions on the eve of March 2020 lockdown. We critically evaluate the Knock et al. epidemiological model, and the semi-causal conclusions made using it, based on an independent reimplementation of the model designed to allow relaxation of some of its strong assumptions. In particular, Knock et al. model the effect on transmission of both non-pharmaceutical interventions and other effects, such as weather, using a piecewise linear function, b(t), with 12 breakpoints at selected government announcement or intervention dates. We replace this representation by a smoothing spline with time varying smoothness, thereby allowing the form of b(t) to be substantially more data driven, and we check that the corresponding smoothness assumption is not driving our results. We also reset the mean incubation time and time from first symptoms to hospitalisation, used in the model, to values implied by the papers cited by Knock et al. as the source of these quantities. We conclude that there is no sound basis for using the Knock et al. model and their analysis to make counterfactual statements about the number of deaths that would have occurred with different lockdown timings. However, if fits of this epidemiological model structure are viewed as a reasonable basis for inference about the time course of incidence and R, then without very strong modelling assumptions, the pathogen reproduction number was probably below one, and incidence in substantial decline, some days before either of the first two English national lockdowns. This result coincides with that obtained by more direct attempts to reconstruct incidence. Of course it does not imply that lockdowns had no effect, but it does suggest that other non-pharmaceutical interventions (NPIs) may have been much more effective than Knock et al. imply, and that full lockdowns were probably not the cause of R dropping below one.	[Wood, Simon N.] Univ Edinburgh, Sch Math, Edinburgh, Midlothian, Scotland; [Wit, Ernst C.] Univ Svizzera Italiana, Inst Comp, Lugano, Switzerland	University of Edinburgh; Universita della Svizzera Italiana	Wood, SN (corresponding author), Univ Edinburgh, Sch Math, Edinburgh, Midlothian, Scotland.	simon.wood@ed.ac.uk	Wood, Simon N/B-3058-2010	Wood, Simon N/0000-0002-2034-7453				Anderson R.M., 2020, R SOC, V2020; Baguelin M, 2021, SIRCOVID SIR MOD COV; Bernabeu-Wittel M, 2020, ARCH GERONTOL GERIAT, V91, DOI 10.1016/j.archger.2020.104240; Bhutta ZA, 2021, DIRECT INDIRECT EFFE; Briggs A., 2020, NHS TEST TRACE JOURN; Deng YH, 2021, BIOMETRICS, V77, P929, DOI 10.1111/biom.13325; DHSC, 2020, DIR IND IMP COVID 19; DIEKMANN O, 1990, J MATH BIOL, V28, P365; Discombe M, 2020, HEALTH SERV J; Docherty AB, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1985; Flaxman S, 2020, NATURE, V584, P257, DOI 10.1038/s41586-020-2405-7; Funk S., 2020, SOCIALMIXR SOCIAL MI; Gillespie DT, 2001, J CHEM PHYS, V115, P1716, DOI 10.1063/1.1378322; Knock ES, 2021, SCI TRANSL MED, V13, DOI 10.1126/scitranslmed.abg4262; Lauer SA, 2020, ANN INTERN MED, V172, P577, DOI 10.7326/M20-0504; Lees J., 2020, 41 IMP COLL LOND; Marmot M, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m693; McAloon C, 2020, BMJ OPEN, V10, DOI 10.1136/bmjopen-2020-039652; McKeigue PM, 2021, BMC MED, V19, DOI 10.1186/s12916-021-02021-5; Mossong J, 2017, POLYMOD SOCIAL CONTA, DOI [10.5281/zenodo.1157934, DOI 10.5281/ZENODO.1157934]; NHS, 2021, COVID 19 HOSP ACT; ONS, 2021, COR COV 19 INF SURV; Pearl J, 2016, J CAUSAL INFERENCE, V4, DOI 10.1515/jci-2016-0021; PIB India, 2020, GOV IND PRESS BRIEF; Pritchard M, 2020, ISARIC CLIN DATA RE; Teukolsky S.A., 2007, NUMERICAL RECIPES, V3rd; Ward H, REACT 2 ROUND 5 INCR, V2021; Williamson EJ, 2020, NATURE, V584, P430, DOI 10.1038/s41586-020-2521-4; Wood S., 2017, GEN ADDITIVE MODELS, V2nd Edn; Wood SN, 2022, BIOMETRICS, V78, P1127, DOI 10.1111/biom.13462; Wood SN, 2017, BIOMETRICS, V73, P1071, DOI 10.1111/biom.12666	31	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2021	16	9							e0257455	10.1371/journal.pone.0257455	http://dx.doi.org/10.1371/journal.pone.0257455			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YS4WS	34550990	Green Published, gold, Green Submitted			2022-12-26	WOS:000750679800021
J	Mahdipour-Afra, M; AghaAlikhani, M; Abbasi, S; Mokhtassi-Bidgoli, A				Mahdipour-Afra, Maryam; AghaAlikhani, Majid; Abbasi, Soleiman; Mokhtassi-Bidgoli, Ali			Growth, yield and quality of two guar (Cyamopsis tetragonoloba L.) ecotypes affected by sowing date and planting density in a semi-arid area	PLOS ONE			English	Article							DRY-MATTER; SEED YIELD; VARIETIES; CULTIVARS	The growth period, phenology, grain yield and gum content of two different guar ecotypes were studied in response to different sowing dates and plant densities. A two-year field experiment was conducted as a split-factorial in a randomized complete block design (RCBD) with three replicates in the research field of Tarbiat Modares University during 2016 and 2017 growing season. Main plots consisted of four sowing dates (May 21, June 4, June 21 and July 5 in 2016 and May 10, May 26, June 10 and June 26 in 2017), and subplots including three plant densities (13, 20 and 40 plants m(-2)) and two ecotypes (Pakistani and Indian). Based on findings, the phenological traits, plant height, grain yield and harvest index were significantly affected by plant density. The effect of ecotypes was statistically significant (p< 0.05) on all traits except harvest index in the first year. Furthermore, the seed sowings on May 21 and May 26 with 13 plants m(-2) led to highest grain yield (3004.8 and 2826.10 kg.ha(-1) for two consecutive years). The high gum content (33.68 and 33.78% for two consecutive years) was also recorded for Pakistani ecotype while for gravity, Indian ecotype showed higher value in both crop years. By and large, the Pakistani ecotype showed better response compared to the Indian one in both years, especially in 1st and 2nd sowing dates.	[Mahdipour-Afra, Maryam; AghaAlikhani, Majid; Mokhtassi-Bidgoli, Ali] Tarbiat Modares Univ, Fac Agr, Dept Agron, Tehran, Iran; [Abbasi, Soleiman] Tarbiat Modares Univ, Fac Agr, Dept Food Sci & Technol, Tehran, Iran	Tarbiat Modares University; Tarbiat Modares University	AghaAlikhani, M (corresponding author), Tarbiat Modares Univ, Fac Agr, Dept Agron, Tehran, Iran.	maghaalikhani@modares.ac.ir			Tarbiat Modares University, Iran	Tarbiat Modares University, Iran	The authors gratefully acknowledge the support provided for this survey by the Tarbiat Modares University, Iran.	Abbas ZM, 2017, EGYPT J AGRON, V39, P293, DOI 10.21608/agro.2017.1447.1072; Akhilesh Sharma, 2013, African Journal of Agricultural Research, V8, P6196; Akhtar LH, 2012, PAK J AGR SCI, V49, P469; Ali Z., 2004, J AGR RES, V42, P33; Candan N, 2018, J PLANT NUTR SOIL SC, V181, P388, DOI 10.1002/jpln.201800014; Cober ER, 2010, THEOR APPL GENET, V120, P1005, DOI 10.1007/s00122-009-1228-6; Deka K. K., 2015, Indian Journal of Agricultural Research, V49, P250, DOI 10.5958/0976-058X.2015.00039.6; Ghosh SK, 2015, MAT SCI ENG C-MATER, V46, P521, DOI 10.1016/j.msec.2014.10.080; Gresta F, 2013, IND CROP PROD, V41, P46, DOI 10.1016/j.indcrop.2012.04.007; Kalyani D. L., 2011, Agricultural Reviews, V32, P209; Kalyani DL, 2012, LEGUME RES, V35, P154; Khalil SK, 2010, PAK J BOT, V42, P3831; Lilley J., 2017, "Doing More with Less", Proceedings of the 18th Australian Agronomy Conference 2017, Ballarat, Victoria, Australia, 24-28 September 2017, P1; Liyanage S, 2015, IND CROP PROD, V74, P388, DOI 10.1016/j.indcrop.2015.05.013; Lone BA, 2010, AFR J AGR RES, V5, P322; Meftahizadeh H, 2019, IND CROP PROD, V140, DOI 10.1016/j.indcrop.2019.111606; Meftahizadeh H, 2019, SCI HORTIC-AMSTERDAM, V256, DOI 10.1016/j.scienta.2019.108577; Naik CSR, 2013, INT J VEGETABLE SCI, V40, P50; Nandini KM., 2017, INT J PURE APPL BIOS, V5, P320, DOI [10.18782/2320-7051.2499, DOI 10.18782/2320-7051.2499]; NIAM, 2014, IN4035 NIAM GAIN; OCONNOR N, 1981, DIABETOLOGIA, V20, P612, DOI 10.1007/BF00257429; Pareek V., 2015, THESIS U KOTA; Przulj N, 2001, EUR J AGRON, V15, P241, DOI 10.1016/S1161-0301(01)00109-5; Rai DR., 2015, TRENDS EC DYNAMICS G; Rao SC, 2009, CROP SCI, V49, P1103, DOI 10.2135/cropsci2008.08.0469; Reddy DR, 2017, INT J CURRENT MICROB, V6, P3685; Sadeghi S, 2009, BOT RES INT, V2, P94; Siddaraju R., 2010, Mysore Journal of Agricultural Sciences, V44, P16; Sudhir Singla, 2016, American Journal of Plant Sciences, V7, P1246, DOI 10.4236/ajps.2016.78120; Thapa S, 2018, IND CROP PROD, V120, P198, DOI 10.1016/j.indcrop.2018.04.060; Tiwana U.S., 1992, FORAGE RES, V18, P151; Tiwari R, 2014, INDIAN J HORTIC, V71, P288; Zhang QY, 2010, AFR J AGR RES, V5, P2556	33	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2021	16	9							e0257692	10.1371/journal.pone.0257692	http://dx.doi.org/10.1371/journal.pone.0257692			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YM4DR	34547054	Green Published, gold			2022-12-26	WOS:000746527400034
J	Molina, AI; Cerrato, RM; Nye, JA				Molina, Adelle, I; Cerrato, Robert M.; Nye, Janet A.			Population level differences in overwintering survivorship of blue crabs (Callinectes sapidus): A caution on extrapolating climate sensitivities along latitudinal gradients	PLOS ONE			English	Article							TEMPERATURE-DEPENDENT GROWTH; NORTHEAST CONTINENTAL-SHELF; WINTER MORTALITY; CHESAPEAKE BAY; THERMAL TOLERANCE; WARMING RESPONSES; FISH ASSEMBLAGE; SIZE RULE; SALINITY; SURVIVAL	Winter mortality can strongly affect the population dynamics of blue crabs (Callinectes sapidus) near poleward range limits. We simulated winter in the lab to test the effects of temperature, salinity, and estuary of origin on blue crab winter mortality over three years using a broad range of crab sizes from both Great South Bay and Chesapeake Bay. We fit accelerated failure time models to our data and to data from prior blue crab winter mortality experiments, illustrating that, in a widely distributed, commercially valuable marine decapod, temperature, salinity, size, estuary of origin, and winter duration were important predictors of winter mortality. Furthermore, our results suggest that extrapolation of a Chesapeake Bay based survivorship model to crabs from New York estuaries yielded poor fits. As such, the severity and duration of winter can impact northern blue crab populations differently along latitudinal gradients. In the context of climate change, future warming could possibility confer a benefit to crab populations near the range edge that are currently limited by temperature-induced winter mortality by shifting their range edge poleward, but care must be taken in generalizing from models that are developed based on populations from one part of the range to populations near the edges, especially for species that occupy large geographical areas.	[Molina, Adelle, I; Cerrato, Robert M.] SUNY Stony Brook, Sch Marine & Atmospher Sci, Stony Brook, NY 11794 USA; [Nye, Janet A.] Univ N Carolina, Chapel Hill, NC 27515 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of North Carolina; University of North Carolina Chapel Hill	Molina, AI (corresponding author), SUNY Stony Brook, Sch Marine & Atmospher Sci, Stony Brook, NY 11794 USA.	adelle.molina@stonybrook.edu		Molina, Adelle/0000-0002-2547-606X	New York State Department of Environmental Conservation [AM08782]	New York State Department of Environmental Conservation	This project was supported by the New York State Department of Environmental Conservation project AM08782, "Blue crab abundance, life history and climate change on Long Island". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbe GR, 1996, J SHELLFISH RES, V15, P751; Aguilar R, 2005, J EXP MAR BIOL ECOL, V319, P117, DOI 10.1016/j.jembe.2004.08.030; Angilletta MJ, 2003, AM NAT, V162, P332; Angilletta MJ, 2009, BIO HABIT, P1, DOI 10.1093/acprof:oso/9780198570875.001.1; ATKINSON D, 1994, ADV ECOL RES, V25, P1, DOI 10.1016/s0065-2504(08)60212-3; Bauer LJ, 2010, ESTUAR COAST, V33, P678, DOI 10.1007/s12237-009-9237-x; Bauer LJ, 2010, ESTUAR COAST, V33, P668, DOI 10.1007/s12237-010-9277-2; Belkin IM, 2009, PROG OCEANOGR, V81, P207, DOI 10.1016/j.pocean.2009.04.011; Belkovskiy N. M., 1991, Journal of Ichthyology, V31, P134; Brylawski BJ, 2006, CAN J FISH AQUAT SCI, V63, P1298, DOI 10.1139/F06-011; Burnham KP, 2002, PRACTICAL INFORM THE, V2nd, P2; Burrows MT, 2019, NAT CLIM CHANGE, V9, P959, DOI 10.1038/s41558-019-0631-5; Canning-Clode J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029657; Churchill EP, 1919, LIFE HIST BLUE CRAB; Clark NJ, 2020, NAT CLIM CHANGE, V10, P862, DOI 10.1038/s41558-020-0838-5; Cox C, 2007, STAT MED, V26, P4352, DOI 10.1002/sim.2836; Cumillaf JP, 2016, BIOL OPEN, V5, P220, DOI 10.1242/bio.013516; Cunningham SR, 2015, J SHELLFISH RES, V34, P505, DOI 10.2983/035.034.0246; Davis JLD, 2004, T AM FISH SOC, V133, P1, DOI 10.1577/T03-004; Gaitan-Espitia JD, 2014, J EXP BIOL, V217, P4379, DOI 10.1242/jeb.108217; Donelson JM, 2019, PHILOS T R SOC B, V374, DOI 10.1098/rstb.2018.0186; Eggleston DB, 2015, BIOL LETTERS, V11, DOI 10.1098/rsbl.2014.0936; Eggleston DB, 2010, FISH OCEANOGR, V19, P89, DOI 10.1111/j.1365-2419.2009.00530.x; Eggleston DB, 1998, J EXP MAR BIOL ECOL, V223, P111, DOI 10.1016/S0022-0981(97)00154-8; Etherington LL, 2000, MAR ECOL PROG SER, V204, P179, DOI 10.3354/meps204179; Faulkner KT, 2014, FUNCT ECOL, V28, P895, DOI 10.1111/1365-2435.12219; Feng XJ, 2017, J SHELLFISH RES, V36, P231, DOI 10.2983/035.036.0126; Fitzgerald-Dehoog L, 2012, BIOL BULL-US, V223, P205, DOI 10.1086/BBLv223n2p205; Forster J, 2012, FUNCT ECOL, V26, P483, DOI 10.1111/j.1365-2435.2011.01958.x; Fredston-Hermann A, 2020, GLOBAL CHANGE BIOL, V26, P2908, DOI 10.1111/gcb.15035; Fry F.E.J., 1971, P1; Fry F. E. J., 1947, University of Toronto Studies Biological Series, VNo. 55, P1; Fusi M, 2017, HYDROBIOLOGIA, V803, P251, DOI 10.1007/s10750-017-3151-1; Fygenson M, 2008, STAT SINICA, V18, P9; Glandon HL, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0219555; Hines A.H., 2010, BIOL MANAGEMENT EXPL, P109, DOI DOI 10.4027/BMECPCC.2010.22; Hinrichs C, 2018, ESTUAR COAST, V41, P2172, DOI 10.1007/s12237-018-0423-6; Hurst TP, 2007, J FISH BIOL, V71, P315, DOI 10.1111/j.1095-8649.2007.01596.x; Hurst TP, 1998, CAN J FISH AQUAT SCI, V55, P1122, DOI 10.1139/cjfas-55-5-1122; Jackson CH, 2016, J STAT SOFTW, V70, P1, DOI 10.18637/jss.v070.i08; Jensen OP, 2005, T AM FISH SOC, V134, P1582, DOI 10.1577/T04-218.1; Johnson DS, 2015, J CRUSTACEAN BIOL, V35, P105, DOI 10.1163/1937240X-00002293; Johnson EG, 2011, J EXP MAR BIOL ECOL, V402, P35, DOI 10.1016/j.jembe.2011.03.013; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Kavanaugh MT, 2017, J GEOPHYS RES-OCEANS, V122, P9399, DOI 10.1002/2017JC012953; Kleisner KM, 2017, PROG OCEANOGR, V153, P24, DOI 10.1016/j.pocean.2017.04.001; LEFFLER CW, 1972, MAR BIOL, V14, P104, DOI 10.1007/BF00373209; Levinton J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018849; LONSDALE DJ, 1985, ECOLOGY, V66, P1397, DOI 10.2307/1938002; Lucey SM, 2010, MAR ECOL PROG SER, V415, P23, DOI 10.3354/meps08743; Lynch HJ, 2014, ECOL MONOGR, V84, P131, DOI 10.1890/12-2235.1; Macedo D, 2019, PEERJ, V7, DOI 10.7717/peerj.7780; MALLOY KD, 1994, T AM FISH SOC, V123, P182, DOI 10.1577/1548-8659(1994)123<0182:EORLAL>2.3.CO;2; McMillen-Jackson AL, 2004, MAR BIOL, V145, P769, DOI 10.1007/s00227-004-1353-3; Moore D.F., 2016, APPL SURVIVAL ANAL U, DOI DOI 10.1007/978-3-319-31245-3; Morley JW, 2017, GLOBAL CHANGE BIOL, V23, P2590, DOI 10.1111/gcb.13578; Neigel J, 2020, AUTHOREA PREPRINTS; Nye JA, 2009, MAR ECOL PROG SER, V393, P111, DOI 10.3354/meps08220; Olin JA, 2019, ESTUAR COAST, P1; Pearson GA, 2009, J ECOL, V97, P450, DOI 10.1111/j.1365-2745.2009.01481.x; Pinsky ML, 2020, ANNU REV MAR SCI, V12, P153, DOI 10.1146/annurev-marine-010419-010916; Pinsky ML, 2013, SCIENCE, V341, P1239, DOI 10.1126/science.1239352; Plough LV, 2017, J SHELLFISH RES, V36, P249, DOI 10.2983/035.036.0128; Portner HO, 2010, J FISH BIOL, V77, P1745, DOI 10.1111/j.1095-8649.2010.02783.x; PRENTICE RL, 1974, BIOMETRIKA, V61, P539, DOI 10.1093/biomet/61.3.539; Provan J., 2013, FRONT BIOGEOGR, V5, P60, DOI [10.21425/F5FBG14732, DOI 10.21425/F55114732]; R Core Team, 2021, R LANGUAGE ENV STAT; Rome MS, 2005, J EXP MAR BIOL ECOL, V319, P129, DOI 10.1016/j.jembe.2004.06.014; Schultz ET, 1998, CAN J FISH AQUAT SCI, V55, P1149, DOI 10.1139/cjfas-55-5-1149; Simpson SD, 2011, CURR BIOL, V21, P1565, DOI 10.1016/j.cub.2011.08.016; Sinclair BJ, 2016, ECOL LETT, V19, P1372, DOI 10.1111/ele.12686; Stachowicz JJ, 2002, P NATL ACAD SCI USA, V99, P15497, DOI 10.1073/pnas.242437499; STANLEY JG, 1971, T AM FISH SOC, V100, P624, DOI 10.1577/1548-8659(1971)100<624:EOTOEB>2.0.CO;2; STEVENS GC, 1989, AM NAT, V133, P240, DOI 10.1086/284913; STOCKHOFF BA, 1991, OECOLOGIA, V88, P422, DOI 10.1007/BF00317588; Sunday JM, 2011, P ROY SOC B-BIOL SCI, V278, P1823, DOI 10.1098/rspb.2010.1295; TAGATZ M E, 1971, Chesapeake Science, V12, P14, DOI 10.2307/1350497; TAGATZ ME, 1969, T AM FISH SOC, V98, P713, DOI 10.1577/1548-8659(1969)98[713:SROTAA]2.0.CO;2; TAN ENG-CHOW, 1966, CHESAPEAKE SCI, V7, P30, DOI 10.1007/BF02688377; Telesh IV, 2010, MAR POLLUT BULL, V61, P149, DOI 10.1016/j.marpolbul.2010.02.008; Therneau T., 2021, PACKAGE SURVIVAL ANA, DOI DOI 10.1198/TECH.2004.S740; TODD ME, 1960, BIOL BULL, V118, P150, DOI 10.2307/1539065; Turner HV, 2003, J EXP MAR BIOL ECOL, V295, P107, DOI 10.1016/S0022-0981(03)00290-9; Twiname A, 2019, MAR ECOL PROG SER, V624, P1, DOI 10.3354/meps13054; VERNBERG FJ, 1969, AM ZOOL, V9, P333; Whitfield PE, 2014, MAR ECOL PROG SER, V509, P241, DOI 10.3354/meps10882; WILLIAMS AB, 1974, FISH B-NOAA, V72, P685; Williams EP, 2017, J SHELLFISH RES, V36, P263, DOI 10.2983/035.036.0129; Wingate RL, 2008, T AM FISH SOC, V137, P1147, DOI 10.1577/T07-098.1; Woodhead P, 1959, P ZOOL SOC LOND; Yamahira K, 2002, ECOLOGY, V83, P1252, DOI 10.1890/0012-9658(2002)083[1252:IVILVI]2.0.CO;2; Young AC, 2008, REV FISH SCI, V16, P254, DOI 10.1080/10641260701684122; Zohar Y, 2008, REV FISH SCI, V16, P24, DOI 10.1080/10641260701681623	93	1	1	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2021	16	9							e0257569	10.1371/journal.pone.0257569	http://dx.doi.org/10.1371/journal.pone.0257569			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YM4DR	34547045	Green Published, gold			2022-12-26	WOS:000746527400020
J	Yan, HJ; Qian, T; Xie, L; Chen, SG				Yan, Huijiong; Qian, Tao; Xie, Liang; Chen, Shanguang			Unsupervised cross-lingual model transfer for named entity recognition with contextualized word representations	PLOS ONE			English	Article								Named entity recognition (NER) is one fundamental task in the natural language processing (NLP) community. Supervised neural network models based on contextualized word representations can achieve highly-competitive performance, which requires a large-scale manually-annotated corpus for training. While for the resource-scarce languages, the construction of such as corpus is always expensive and time-consuming. Thus, unsupervised cross-lingual transfer is one good solution to address the problem. In this work, we investigate the unsupervised cross-lingual NER with model transfer based on contextualized word representations, which greatly advances the cross-lingual NER performance. We study several model transfer settings of the unsupervised cross-lingual NER, including (1) different types of the pretrained transformer-based language models as input, (2) the exploration strategies of the multilingual contextualized word representations, and (3) multisource adaption. In particular, we propose an adapter-based word representation method combining with parameter generation network (PGN) better to capture the relationship between the source and target languages. We conduct experiments on a benchmark ConLL dataset involving four languages to simulate the cross-lingual setting. Results show that we can obtain highly-competitive performance by cross-lingual model transfer. In particular, our proposed adapter-based PGN model can lead to significant improvements for cross-lingual NER.	[Yan, Huijiong; Chen, Shanguang] Taiyuan Univ Technol, Coll Mech & Vehicle Engn, Taiyuan, Peoples R China; [Yan, Huijiong; Xie, Liang] Acad Mil Sci AMS, Def Innovat Inst, Beijing, Peoples R China; [Yan, Huijiong; Chen, Shanguang] China Astronaut Res & Training Ctr, Natl Key Lab Human Factors Engn, Beijing, Peoples R China; [Qian, Tao] Hubei Univ Sci & Technol, Sch Comp Sci & Technol, Xianning, Peoples R China	Taiyuan University of Technology; Chinese Academy of Sciences; Hubei University of Science & Technology	Chen, SG (corresponding author), Taiyuan Univ Technol, Coll Mech & Vehicle Engn, Taiyuan, Peoples R China.; Chen, SG (corresponding author), China Astronaut Res & Training Ctr, Natl Key Lab Human Factors Engn, Beijing, Peoples R China.	shanguangchen@126.com		Chen, Shanguang/0000-0003-1027-6265	National Natural Science Foundation of China [62076250, 61901505]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China, grants 62076250 and 61901505. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbik Alan, 2018, P 27 INT C COMP LING, P1638; Chen XL, 2019, 57TH ANNUAL MEETING OF THE ASSOCIATION FOR COMPUTATIONAL LINGUISTICS (ACL 2019), P3098; Conneau Alexis, 2020, P ACL, P8440, DOI DOI 10.18653/V1/2020.ACLMAIN.747; Cui LY, 2019, 2019 CONFERENCE ON EMPIRICAL METHODS IN NATURAL LANGUAGE PROCESSING AND THE 9TH INTERNATIONAL JOINT CONFERENCE ON NATURAL LANGUAGE PROCESSING (EMNLP-IJCNLP 2019), P4115; Devlin J., 2018, ARXIV181004805; diaeresis>ackstrom Oscar T<spacing, 2012, P 2012 C N AM CHAPT, P477; Erik F., 2002, COLING 02; Fei H., 2020, P ACL, P7014; Houlsby N, 2019, PR MACH LEARN RES, V97; Huang L., 2019, LONG SHORT PAPERS, VVolume 1 (Long and Short Papers), P3823; Huang ZH, 2015, COMPUT INTEL NEUROSC, V2015, DOI 10.1155/2015/685404; Jia C, 2019, 57TH ANNUAL MEETING OF THE ASSOCIATION FOR COMPUTATIONAL LINGUISTICS (ACL 2019), P2464; Lafferty John D., 2001, ICML 01, P282, DOI DOI 10.5555/645530.655813; Lample Guillaume, 2016, P NAACL HLT, P260, DOI [DOI 10.18653/V1/N16-1030, 10.18653/v1/N16-1030]; Lee K., 2017, ARXIV PREPRINT ARXIV; Li Xiaoya, 2020, UNIFIED MRC FRAMEWOR, P5849, DOI DOI 10.18653/V1/2020.ACL-MAIN.519; Loshchilov Ilya, 2018, P INT C LEARN REPR I, P5; Lukovnikov D, 2017, PROCEEDINGS OF THE 26TH INTERNATIONAL CONFERENCE ON WORLD WIDE WEB (WWW'17), P1211, DOI 10.1145/3038912.3052675; Luo Y, 2021, IEEE T KNOWL DATA EN; Luo Y, 2020, AAAI CONF ARTIF INTE, V34, P8441; Mayhew S, 2020, AAAI CONF ARTIF INTE, V34, P8480; Mayhew Stephen, 2017, P 2017 C EMP METH NA, P2536, DOI DOI 10.18653/V1/D17-1269; McCallum Andrew, 2003, P 7 C NATURAL LANGUA, P188; Moon Taesun, 2019, ARXIV PREPRINT ARXIV; Nadeau D, 2007, LINGUIST INVESTIG, V30, P3; Ni J, 2017, PROCEEDINGS OF THE 55TH ANNUAL MEETING OF THE ASSOCIATION FOR COMPUTATIONAL LINGUISTICS (ACL 2017), VOL 1, P1470, DOI 10.18653/v1/P17-1135; Pfeiffer J, 2020, PROCEEDINGS OF THE 2020 CONFERENCE ON EMPIRICAL METHODS IN NATURAL LANGUAGE PROCESSING (EMNLP), P7654; Pires T, 2019, 57TH ANNUAL MEETING OF THE ASSOCIATION FOR COMPUTATIONAL LINGUISTICS (ACL 2019), P4996; Platanios E.A., 2018, P 2018 C EMP METH NA, P425, DOI [10.18653/v1/D18-1039, DOI 10.18653/V1/D18-1039]; Rahimi A, 2019, 57TH ANNUAL MEETING OF THE ASSOCIATION FOR COMPUTATIONAL LINGUISTICS (ACL 2019), P151; Rebuffi SA, 2018, PROC CVPR IEEE, P8119, DOI 10.1109/CVPR.2018.00847; Sang Erik F. Tjong Kim, 2003, P 7 C NAT LANG LEARN, P142; Stickland AC, 2019, PR MACH LEARN RES, V97; Strakova J, 2019, 57TH ANNUAL MEETING OF THE ASSOCIATION FOR COMPUTATIONAL LINGUISTICS (ACL 2019), P5326; Tackstrom O., 2012, NAACL HLT 2012 WORKS; Tsai Chen-Tse, 2016, P 20 SIGNLL C COMP N, P219, DOI DOI 10.18653/V1/K16-1022; Ustun A, 2020, PROCEEDINGS OF THE 2020 CONFERENCE ON EMPIRICAL METHODS IN NATURAL LANGUAGE PROCESSING (EMNLP), P2302; Vaswani A, 2017, ADV NEUR IN, V30; Wang M, 2014, T ASSOC COMPUT LING, V2, P55, DOI [DOI 10.1162/TACLTACLA00165, DOI 10.1162/tacl_a_00165]; Wu QH, 2020, AAAI CONF ARTIF INTE, V34, P9274; Wu Qianhui, 2020, P 58 ANN M ASS COMP; Wu SJ, 2019, 2019 CONFERENCE ON EMPIRICAL METHODS IN NATURAL LANGUAGE PROCESSING AND THE 9TH INTERNATIONAL JOINT CONFERENCE ON NATURAL LANGUAGE PROCESSING (EMNLP-IJCNLP 2019), P833; Xie Jiateng, 2018, P 2018 C EMP METH NA, P369, DOI DOI 10.18653/V1/D18-1034; Xue Mengge, 2020, EMNLP, P6345; Zirikly A, 2015, PROCEEDINGS OF THE 53RD ANNUAL MEETING OF THE ASSOCIATION FOR COMPUTATIONAL LINGUISTICS (ACL) AND THE 7TH INTERNATIONAL JOINT CONFERENCE ON NATURAL LANGUAGE PROCESSING (IJCNLP), VOL 2, P390	48	0	0	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2021	16	9							e0257230	10.1371/journal.pone.0257230	http://dx.doi.org/10.1371/journal.pone.0257230			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YM4DR	34547014	Green Published, gold			2022-12-26	WOS:000746527400007
J	Quiroz-Juarez, MA; Torres-Gomez, A; Hoyo-Ulloa, I; Leon-Montiel, RD; U'Ren, AB				Quiroz-Juarez, Mario A.; Torres-Gomez, Armando; Hoyo-Ulloa, Irma; Leon-Montiel, Roberto de J.; U'Ren, Alfred B.			Identification of high-risk COVID-19 patients using machine learning	PLOS ONE			English	Article								The current COVID-19 public health crisis, caused by SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2), has produced a devastating toll both in terms of human life loss and economic disruption. In this paper we present a machine-learning algorithm capable of identifying whether a given patient (actually infected or suspected to be infected) is more likely to survive than to die, or vice-versa. We train this algorithm with historical data, including medical history, demographic data, as well as COVID-19-related information. This is extracted from a database of confirmed and suspected COVID-19 infections in Mexico, constituting the official COVID-19 data compiled and made publicly available by the Mexican Federal Government. We demonstrate that the proposed method can detect high-risk patients with high accuracy, in each of four identified clinical stages, thus improving hospital capacity planning and timely treatment. Furthermore, we show that our method can be extended to provide optimal estimators for hypothesis-testing techniques commonly-used in biological and medical statistics. We believe that our work could be of use in the context of the current pandemic in assisting medical professionals with real-time assessments so as to determine health care priorities.	[Quiroz-Juarez, Mario A.] Univ Autonoma Metropolitana Unidad Iztapalapa, Dept Fis, Ciudad De Mexico, Mexico; [Torres-Gomez, Armando; Hoyo-Ulloa, Irma] ABC Med Ctr, Ciudad De Mexico, Mexico; [Leon-Montiel, Roberto de J.; U'Ren, Alfred B.] Univ Nacl Autonoma Mexico, Inst Ciencias Nucl, Ciudad De Mexico, Mexico	Universidad Autonoma Metropolitana - Mexico; Universidad Nacional Autonoma de Mexico	Quiroz-Juarez, MA (corresponding author), Univ Autonoma Metropolitana Unidad Iztapalapa, Dept Fis, Ciudad De Mexico, Mexico.	maqj@xanum.uam.mx	Quiroz-Juarez, Mario Alan/X-8786-2018; Quiroz-Juarez, Mario Alan/GLV-1972-2022	Quiroz-Juarez, Mario Alan/0000-0002-5995-9510; Quiroz-Juarez, Mario Alan/0000-0002-5995-9510	Consejo Nacional de Ciencia y Tecnologia Mexico (CONACyT) [CB-2016-01/284372]; Direccio General de Asuntos del Personal Academico, Universidad Nacional Autonoma de Mexico (DGAPA-UNAM) [UNAM-PAPIIT IN102920, UNAM-PAPIIT IN103521]; Air Force Office of Scientific Research (AFOSR) [FA9550-21-1-0147]	Consejo Nacional de Ciencia y Tecnologia Mexico (CONACyT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Direccio General de Asuntos del Personal Academico, Universidad Nacional Autonoma de Mexico (DGAPA-UNAM); Air Force Office of Scientific Research (AFOSR)(United States Department of DefenseAir Force Office of Scientific Research (AFOSR))	This study was supported by Consejo Nacional de Ciencia y Tecnologia Mexico (CONACyT) in the form of a grant awarded to RJLM and MAQJ (CB-2016-01/284372), Direccio General de Asuntos del Personal Academico, Universidad Nacional Autonoma de Mexico (DGAPA-UNAM) in the form of grants awarded to RJLM and MAQJ (UNAM-PAPIIT IN102920) and AU (UNAM-PAPIIT IN103521), and Air Force Office of Scientific Research (AFOSR) in the form of a grant awarded to AU (FA9550-21-1-0147).	Acuna-Zegarra MA, 2020, MATH BIOSCI, V325, DOI 10.1016/j.mbs.2020.108370; Ahamad MM, 2020, EXPERT SYST APPL, V160, DOI 10.1016/j.eswa.2020.113661; Ahmad A, 2021, ARCH COMPUT METHOD E, V28, P2645, DOI 10.1007/s11831-020-09472-8; [Anonymous], 2021, VIG CENT; [Anonymous], 2020, DIRECCION GEN EPIDEM; Ardabili SF, 2020, ALGORITHMS, V13, DOI 10.3390/a13100249; Assaf D, 2020, INTERN EMERG MED, V15, P1435, DOI 10.1007/s11739-020-02475-0; de Leon UAP, 2020, CHAOS SOLITON FRACT, V140, DOI 10.1016/j.chaos.2020.110165; Bezzan V, ARXIV PREPRINT ARXIV; Bishop C. M, 2006, PATTERN RECOGNITION; Broemeling L.D., 2007, BAYESIAN BIOSTATISTI; Chen XY, 2020, INT J BIOL MACROMOL, V164, P331, DOI 10.1016/j.ijbiomac.2020.07.106; Chinazzi M, 2020, SCIENCE, V368, P395, DOI 10.1126/science.aba9757; Dhama K, 2020, HUM VACC IMMUNOTHER, V16, P1232, DOI 10.1080/21645515.2020.1735227; Drew DA, 2020, SCIENCE, V368, P1362, DOI 10.1126/science.abc0473; Elaziz MA, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0235187; Gelman A, 2013, BAYESIAN DATA ANAL, V3rd; Goodfellow I, 2016, ADAPT COMPUT MACH LE, P1; Ivorra B, 2020, COMMUN NONLINEAR SCI, V88, DOI 10.1016/j.cnsns.2020.105303; Jamshidi MB, 2020, IEEE ACCESS, V8, P109581, DOI 10.1109/ACCESS.2020.3001973; Kana EBG., 2020, WEB BASED DIAGNOSTIC, DOI 10.1101/2020.04.21.20063263; Karan O, 2012, EXPERT SYST APPL, V39, P54, DOI 10.1016/j.eswa.2011.06.046; Kim E, 2020, EBIOMEDICINE, V55, DOI 10.1016/j.ebiom.2020.102743; Kleinbaum D. G., 2002, LOGISTIC REGRESSION; Lalmuanawma S, 2020, CHAOS SOLITON FRACT, V139, DOI 10.1016/j.chaos.2020.110059; Lan YJ, 2017, EARLY WARNING FOR INFECTIOUS DISEASE OUTBREAK: THEORY AND PRACTICE, P35, DOI 10.1016/B978-0-12-812343-0.00003-5; Lesaffre E., 2012, BAYESIAN BIOSTATISTI, DOI [10.1002/9781119942412, DOI 10.1002/9781119942412]; Liu C, 2020, ACS CENTRAL SCI, V6, P315, DOI 10.1021/acscentsci.0c00272; Liu J, 2020, SSRN ELECT J, DOI [10.2139/ssrn.3638427, 10.2139/Ssrn.3638427, DOI 10.2139/SSRN.3638427]; McRae MP, 2020, J MED INTERNET RES, V22, DOI 10.2196/22033; Melin P, 2020, HEALTHCARE-BASEL, V8, DOI 10.3390/healthcare8020181; Mena RH, 2020, PHYS BIOL, V17, DOI 10.1088/1478-3975/abb115; Michie D., 1994, MACHINE LEARNING NEU; Mohri M., 2018, FDN MACHINE LEARNING; Nemati M, 2020, PATTERNS, V1, DOI 10.1016/j.patter.2020.100074; Noble WS, 2006, NAT BIOTECHNOL, V24, P1565, DOI 10.1038/nbt1206-1565; Pal R, 2020, APPL SCI-BASEL, V10, DOI 10.3390/app10186448; Quiroz-Juarez MA, 2021, IDECOVID19 IDENTIFIC; Ramsey J. B., 2001, ELEMENTS STAT APPL E; Sarkar J., 2020, MACHINE LEARNING MOD, DOI [DOI 10.1101/2020.03.25.20043331, 10.1101/2020.03.25.20043331]; Singh J, 2021, TELEMED E-HEALTH, V27, P261, DOI 10.1089/tmj.2020.0186; Sistema de Vigilancia Epidemiologica, 2021, DIR GEN EP SECR SAL; Rao ASRS, 2020, INFECT CONT HOSP EP, V41, P826, DOI 10.1017/ice.2020.61; Subudhi S., 2020, COMP MACHINE LEARNIN; Vafea MT, 2020, CELL MOL BIOENG, V13, P249, DOI 10.1007/s12195-020-00629-w; Vaishya R, 2020, DIABETES METAB SYND, V14, P337, DOI 10.1016/j.dsx.2020.04.012; Yamamoto K, 2020, JMIR MHEALTH UHEALTH, V8, DOI 10.2196/19902; YAN L, 2020, PHOSPHORUS SULFUR SI; Yan L, 2020, NAT MACH INTELL, V2, P283, DOI 10.1038/s42256-020-0180-7; Yang Q, 2019, ACM T INTEL SYST TEC, V10, DOI 10.1145/3298981; Zairi H, 2020, NEURAL COMPUT APPL, V32, P4105, DOI 10.1007/s00521-019-04081-4; Zawiah M, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00419; Zens M, 2020, J MED INTERNET RES, V22, DOI 10.2196/21956; Zhang ZH, 2016, ANN TRANSL MED, V4, DOI 10.21037/atm.2016.03.37	55	15	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2021	16	9							e0257234	10.1371/journal.pone.0257234	http://dx.doi.org/10.1371/journal.pone.0257234			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	WG6BN	34543294	Green Published, gold, Green Submitted			2022-12-26	WOS:000707078200023
J	Klein, J; Low, M; Thor, G; Sjogren, J; Lindberg, E; Eggers, S				Klein, Julian; Low, Matthew; Thor, Goran; Sjogren, Jorgen; Lindberg, Eva; Eggers, Sonke			Tree species identity and composition shape the epiphytic lichen community of structurally simple boreal forests over vast areas	PLOS ONE			English	Article							CRUSTOSE LICHENS; PINUS-SYLVESTRIS; POPULUS-TREMULA; NORTHERN EUROPE; PICEA-ABIES; OLD-GROWTH; DEAD WOOD; DIVERSITY; BIODIVERSITY; CONSERVATION	Greatly simplified ecosystems are often neglected for biodiversity studies. However, these simplified systems dominate in many regions of the world, and a lack of understanding of what shapes species occurrence in these systems can have consequences for biodiversity and ecosystem services at a massive scale. In Fennoscandia, ~90% of the boreal forest (~21Mha) is structurally simplified with little knowledge of how forest structural elements shape the occurrence and diversity of for example epiphytic lichens in these managed forests. One form of structural simplification is the reduction of the number and frequency of different tree species. As many lichen species have host tree preferences, it is particularly likely that this simplification has a huge effect on the lichen community in managed forests. In a 40-70 years old boreal forest in Sweden, we therefore related the occurrence and richness of all observed epiphytic lichens to the host tree species and beta and gamma lichen diversity at the forest stand level to the stand's tree species composition and stem diameter. Picea abies hosted the highest lichen richness followed by Pinus sylvestris, Quercus robur, Alnus glutinosa, Betula spp., and Populus tremula. However, P. tremula hosted twice as many uncommon species as any of the other tree species. Stand level beta and gamma diversity was twice as high on stands with four compared to one tree species, and was highest when either coniferous or deciduous trees made up 40-50% of the trees. The stem diameter was positively related to lichen richness at the tree and stand level, but negatively to beta diversity. For biodiversity, these findings imply that leaving a few trees of a different species during forest thinning is unlikely as effective as combining life-boat trees for endangered species with an even tree species mixture.	[Klein, Julian; Low, Matthew; Thor, Goran; Eggers, Sonke] Swedish Univ Agr Sci SLU, Dept Ecol, Uppsala, Sweden; [Klein, Julian] SLU, Swedish Species Informat Ctr, Uppsala, Sweden; [Sjogren, Jorgen] SLU, Dept Wildlife Fish & Environm Studies, Umea, Sweden; [Lindberg, Eva] SLU, Dept Forest Resource Management, Umea, Sweden	Swedish University of Agricultural Sciences; Swedish University of Agricultural Sciences; Swedish University of Agricultural Sciences; Swedish University of Agricultural Sciences	Klein, J (corresponding author), Swedish Univ Agr Sci SLU, Dept Ecol, Uppsala, Sweden.; Klein, J (corresponding author), SLU, Swedish Species Informat Ctr, Uppsala, Sweden.	julian.klein@slu.se	Sjögren, Jörgen/GXG-8007-2022; Lindberg, Eva/AAN-1643-2021	Sjögren, Jörgen/0000-0002-0538-8265; Lindberg, Eva/0000-0002-1792-0773; Klein, Julian/0000-0002-4269-4974; Low, Matthew/0000-0002-7345-6063	Swedish Research Council Formas [942-215-57]	Swedish Research Council Formas(Swedish Research CouncilSwedish Research Council Formas)	The Swedish Research Council Formas (Grant 942-215-57) to SE, JS, and EL. https://formas.se/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHMADJIAN V, 1995, BIOSCIENCE, V45, P124, DOI 10.1093/bioscience/45.3.124; Allen JL, 2019, BIODIVERS CONSERV, V28, P3103, DOI 10.1007/s10531-019-01827-3; [Anonymous], 2020, FOREST ECOL MANAG, DOI [10.5281/zenodo.3899848, DOI 10.5281/ZENODO.3899848]; [Anonymous], 2014, SKOGSST ARSB 2014; Backlund S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147004; Bartels SF, 2015, FOREST ECOL MANAG, V347, P149, DOI 10.1016/j.foreco.2015.03.025; Berg D.R., 1997, CREATING FORESTRY 21, P111; Boakes EH, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000385; Boch S, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0055461, 10.1371/journal.pone.0084913]; Brumelis G, 2011, SILVA FENN, V45, P807, DOI 10.14214/sf.446; Caruso A, 2007, SCAND J FOREST RES, V22, P219, DOI 10.1080/02827580701346031; Cavard X, 2011, ENVIRON REV, V19, P142, DOI [10.1139/a11-004, 10.1139/A11-004]; Dettki H, 1998, ECOGRAPHY, V21, P613, DOI 10.1111/j.1600-0587.1998.tb00554.x; Dettki H, 2000, ECOSCIENCE, V7, P317, DOI 10.1080/11956860.2000.11682601; Ellis CJ, 2012, PERSPECT PLANT ECOL, V14, P131, DOI 10.1016/j.ppees.2011.10.001; Felton A, 2010, FOREST ECOL MANAG, V260, P939, DOI 10.1016/j.foreco.2010.06.011; Frisch A, 2015, BIOTROPICA, V47, P542, DOI 10.1111/btp.12237; Gamfeldt L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2328; Gelman A., 1992, STAT SCI, V7, P457, DOI [10.1214/ss/1177011136, DOI 10.1214/SS/1177011136]; Gelman A, 2008, ANN APPL STAT, V2, P1360, DOI 10.1214/08-AOAS191; Gjerde I, 2012, ECOLOGY, V93, P749, DOI 10.1890/11-1018.1; Gotelli NJ, 2001, ECOL LETT, V4, P379, DOI 10.1046/j.1461-0248.2001.00230.x; Hamilton N, 2018, GGTERN EXTENSION GGP; Hanski IK, 1998, WILDLIFE BIOL, V4, P33, DOI 10.2981/wlb.1998.013; Hauck M, 2011, FLORA, V206, P81, DOI 10.1016/j.flora.2010.02.001; Holm SO, 2015, J SUSTAIN FOREST, V34, P358, DOI 10.1080/10549811.2015.1009633; Iknayan KJ, 2014, TRENDS ECOL EVOL, V29, P97, DOI 10.1016/j.tree.2013.10.012; Johansson P, 2007, ECOSCIENCE, V14, P81, DOI 10.2980/1195-6860(2007)14[81:TARWEL]2.0.CO;2; Johansson V, 2018, BIOL CONSERV, V225, P53, DOI 10.1016/j.biocon.2018.06.016; Johansson V, 2010, J VEG SCI, V21, P332, DOI 10.1111/j.1654-1103.2009.01146.x; Jonsson BG, 1999, BIODIVERS CONSERV, V8, P1417, DOI 10.1023/A:1008900309571; Jonsson M, 2019, NAT PLANTS, V5, P141, DOI 10.1038/s41477-018-0346-z; Juriado I, 2003, BIODIVERS CONSERV, V12, P1587, DOI 10.1023/A:1023645730446; Kiraly I, 2013, BIODIVERS CONSERV, V22, P209, DOI 10.1007/s10531-012-0415-y; Klein J, 2020, FOREST ECOL MANAG, V473, DOI 10.1016/j.foreco.2020.118327; Kuuluvainen T, 2009, AMBIO, V38, P309, DOI 10.1579/08-A-490.1; KUUSINEN M, 1994, ANN BOT FENN, V31, P245; Larsson S, 2001, SCAND J FOREST RES, P5, DOI 10.1080/028275801300090528; Lindenmayer D, 2016, FRONT ECOL ENVIRON, V14, P561, DOI 10.1002/fee.1434; Lohmus A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0208535; Lommi S, 2010, FOREST ECOL MANAG, V259, P883, DOI 10.1016/j.foreco.2009.11.028; Marmor L, 2011, ECOL INDIC, V11, P1270, DOI 10.1016/j.ecolind.2011.01.009; Marmor L, 2013, LICHENOLOGIST, V45, P51, DOI 10.1017/S0024282912000564; Martikainen P, 2000, BIOL CONSERV, V94, P199, DOI 10.1016/S0006-3207(99)00175-5; McCune B, 2000, BRYOLOGIST, V103, P353, DOI 10.1639/0007-2745(2000)103[0353:LCAIOF]2.0.CO;2; McMullin RT, 2010, FOREST ECOL MANAG, V260, P744, DOI 10.1016/j.foreco.2010.05.032; Nascimbene J, 2009, BIODIVERS CONSERV, V18, P1509, DOI 10.1007/s10531-008-9537-7; Nash TH, 2008, LICHEN BIOLOGY, 2ND EDITION, P1, DOI 10.1017/CBO9780511790478.002; Nitare J, 2019, SKYDDSVARD SKOG NATU; Nordin A., 2019, SANTESSONS CHECKLIST; Ostlund L, 1997, CAN J FOREST RES, V27, P1198, DOI 10.1139/x97-070; Parrott L, 2010, ECOL INDIC, V10, P1069, DOI 10.1016/j.ecolind.2010.03.014; Peipoch M, 2015, BIOSCIENCE, V65, P1057, DOI 10.1093/biosci/biv120; Plummer M., 2015, RJAGS BAYESIAN GRAPH; Plummer M., 2003, JAGS PROGRAM ANAL BA, DOI DOI 10.1.1.13.3406; R Development Core Team, 2019, R VERS 3 6 1 LANG EN; Ranius T, 2008, J VEG SCI, V19, P653, DOI 10.3170/2008-8-18433; Roberge JM, 2008, BIODIVERS CONSERV, V17, P2479, DOI 10.1007/s10531-008-9394-4; SLU Artdatabanken, 2020, RED LIST SPEC SWED 2; Spribille T, 2016, SCIENCE, V353, P488, DOI 10.1126/science.aaf8287; Sundberg S., 2019, IMPORTANCE VASCULAR; Svensson M, 2016, FUNGAL ECOL, V20, P166, DOI 10.1016/j.funeco.2015.12.010; Svensson M, 2014, J VEG SCI, V25, P819, DOI 10.1111/jvs.12131; Svensson M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062825; Swedish National Forest Inventory (NFI), 2019, SWED NAT FOR INV; Thor G, 2010, BIODIVERS CONSERV, V19, P2307, DOI 10.1007/s10531-010-9843-8; TIBELL L, 1992, NORD J BOT, V12, P427, DOI 10.1111/j.1756-1051.1992.tb01325.x; Tikkanen OP, 2006, ANN ZOOL FENN, V43, P373; Vitousek PM, 1997, SCIENCE, V277, P494, DOI 10.1126/science.277.5325.494; WHITTAKER RH, 1965, SCIENCE, V147, P250, DOI 10.1126/science.147.3655.250; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wilson JRU, 2007, FRONT ECOL ENVIRON, V5, P409, DOI 10.1890/060077.01	72	3	3	3	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2021	16	9							e0257564	10.1371/journal.pone.0257564	http://dx.doi.org/10.1371/journal.pone.0257564			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	WG5ZQ	34534251	gold, Green Published			2022-12-26	WOS:000707073300038
J	Guedes, MBOG; de Assis, SJC; Sanchis, GJB; Araujo, DN; Oliveira, AGRD; Lopes, JM				Otoni Goncalves Guedes, Marcello Barbosa; Costa de Assis, Sanderson Jose; Bouzas Sanchis, Geronimo Jose; Araujo, Diego Neves; Roncalli Da Costa Oliveira, Angelo Giuseppe; Lopes, Johnnatas Mikael			COVID-19 in Brazilian cities: Impact of social determinants, coverage and quality of primary health care	PLOS ONE			English	Article								Background Brazil, as many other countries, have been heavily affected by COVID-19. This study aimed to analyze the impact of Primary health care and the family health strategy (FHS) coverage, the scores of the National Program for Improving Primary Care Access and Quality (PMAQ), and socioeconomic and social indicators in the number of COVID-19 cases in Brazilian largest cities. Methods This is an ecological study, carried out through the analysis of secondary data on the population of all Brazilian main cities, based on the analysis of a 26-week epidemiological epidemic week series by COVID-19. Statistical analysis was performed using Generalized Linear Models with an Autoregressive work correlation matrix. Results It was shown that greater PHC coverage and greater FHS coverage together with an above average PMAQ score are associated with slower dissemination and lower burden of COVID-19. Conclusion It is evident that cities with less social inequality and restrictions of social protection combined with social development have a milder pandemic scenario. It is necessary to act quickly on these conditions for COVID-19 dissemination by timely actions with high capillarity. Expanding access to PHC and social support strategies for the vulnerable are essential.	[Otoni Goncalves Guedes, Marcello Barbosa] Univ Fed Rio Grande do Norte, Phys Therapy Dept, Natal, RN, Brazil; [Costa de Assis, Sanderson Jose; Bouzas Sanchis, Geronimo Jose; Roncalli Da Costa Oliveira, Angelo Giuseppe] Univ Fed Rio Grande do Norte, Publ Hlth Program, Natal, RN, Brazil; [Araujo, Diego Neves] Univ Ctr Unifacisa, Fac Hlth Sci, Campina Grande, Paraiba, Brazil; [Lopes, Johnnatas Mikael] Univ Fed Vale Sao Francisco, Med Dept, Juazeiro, BA, Brazil	Universidade Federal do Rio Grande do Norte; Universidade Federal do Rio Grande do Norte; Universidade Federal do Vale do Sao Francisco	Lopes, JM (corresponding author), Univ Fed Vale Sao Francisco, Med Dept, Juazeiro, BA, Brazil.	johnnatas.lopes@univasf.edu.br	Araujo, Diego Neves/ABA-1934-2020; Mikael Lopes, Johnnatas/ABG-5002-2021; Lopes, Johnnatas Mikael/Q-5211-2017	Araujo, Diego Neves/0000-0002-9541-5852; Bouzas Sanchis, Geronimo Jose/0000-0002-7320-5520; BARBOSA OTONI GONCALVES GUEDES, MARCELLO/0000-0001-6166-1273; Lopes, Johnnatas Mikael/0000-0002-9679-5287				[Anonymous], 2002, Bull World Health Organ, V80, P983; Barbazza E, 2019, BMC HEALTH SERV RES, V19, DOI 10.1186/s12913-019-4853-z; Bastos ML, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182336; Gomes CBES, 2020, CIENC SAUDE COLETIVA, V25, P1327, DOI 10.1590/1413-81232020254.31512019; de Assis SJC, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0250493; de Peralta AM, 2019, J HEALTH CARE POOR U, V30, P1103, DOI 10.1353/hpu.2019.0076; Department of Informatics of the Unified Health System, DATASUS; Facchini Luiz Augusto, 2018, Saúde debate, V42, P208, DOI 10.1590/0103-11042018s114; He F, 2020, J MED VIROL, V92, P719, DOI 10.1002/jmv.25766; Heymann DL, 2020, LANCET, V395, P542, DOI 10.1016/S0140-6736(20)30374-3; Huang XY, 2020, ARCH IRAN MED, V23, P268, DOI 10.34172/aim.2020.09; Jenq GY, 2020, JAMA INTERN MED, V180, P1106, DOI 10.1001/jamainternmed.2020.2224; Pirtle WNL, 2020, HEALTH EDUC BEHAV, V47, P504, DOI 10.1177/1090198120922942; Lopes JM., 2019, FISIOTERAPIA ATENCAO, V1; Ministry of Health Brazil, 2017, POL NAC AT BAS; Ministry of Health Brazil, 2020, COR CLIN MAN PROT CO; Moreira Kênia Souto, 2016, Saúde debate, V40, P117, DOI 10.1590/0103-1104201611109; Neves RG, 2018, EPIDEMIOL SERV SAUDE, V27, DOI [10.5123/S1679-49742018000300008, 10.5123/s1679-49742018000300008]; Oliveira Bruno Luciano Carneiro Alves de, 2019, Rev. bras. epidemiol., V22, pe190036, DOI 10.1590/1980-549720190036; Pan A, 2020, JAMA-J AM MED ASSOC, V323, P1915, DOI 10.1001/jama.2020.6130; Pinto, 2014, SAUDE DEBATE RIO JAN, V38, P358, DOI [10.5935/0103-1104.2014S027, DOI 10.5935/0103-1104.2014S027]; Pinto LF, 2018, CIENC SAUDE COLETIVA, V23, P1903, DOI 10.1590/1413-81232018236.05592018; PNUD, 2019, REL DES HUM 2019 AL; Ribeiro ALP, 2016, CIRCULATION, V133, P422, DOI 10.1161/CIRCULATIONAHA.114.008727; Sarti TD, 2020, EPIDEMIOL SERV SAUDE, V29, DOI [10.5123/S1679-49742020000200024, 10.5123/s1679-49742020000200024]; Wang ML, 2020, TRANSL BEHAV MED, V10, P516, DOI 10.1093/tbm/ibaa055; Zhai P, 2020, INT J ANTIMICROB AG, V55, DOI 10.1016/j.ijantimicag.2020.105955	27	2	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2021	16	9							e0257347	10.1371/journal.pone.0257347	http://dx.doi.org/10.1371/journal.pone.0257347			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	WG5ZQ	34534235	Green Published, gold			2022-12-26	WOS:000707073300025
J	Denechaud, C; Geffen, AJ; Smolinski, S; Godiksen, JA				Denechaud, Come; Geffen, Audrey J.; Smolinski, Szymon; Godiksen, Jane A.			Otolith "spawning zones" across multiple Atlantic cod populations: Do they accurately record maturity and spawning?	PLOS ONE			English	Article							NORTH-SEA PLAICE; GADUS-MORHUA; SEXUAL MATURITY; FISH OTOLITHS; EGG SIZE; GROWTH; AGE; REPRODUCTION; MATURATION; EVOLUTION	Specific changes identified in the otolith macrostructure of Northeast Arctic cod as "spawning zones" are presumed to represent spawning events, but recent experimental studies have challenged this relationship. Because these zones are not routinely recorded outside of Norway, otoliths from multiple Atlantic cod populations with different life history and environmental traits were first examined to see if spawning zones could be identified as a general characteristic of cod. Then, a large archival collection of cod otoliths was used to investigate temporal changes in the occurrence of spawning zones and test for correlations between maturity at age derived from otolith spawning zones and gonad maturity stages. This study shows that spawning zones likely are a universal trait of Atlantic cod and not limited to certain environments or migratory behaviors as previously proposed. Maturity at age derived from spawning zone data showed trends consistent with those from gonad examinations. However, spawning zones appear to form with a one- or two-year lag with sexual maturity, which is suspected to reflect a stabilizing of energy partitioning after the first spawning events. Our results illustrate the potential for use of spawning zones, for example in species or populations with limited available maturity data, and highlights the need for addressing the physiological processes behind their formation.	[Denechaud, Come; Geffen, Audrey J.; Smolinski, Szymon; Godiksen, Jane A.] Inst Marine Res HI, Demersal Fish Res Grp, Bergen, Norway; [Denechaud, Come; Geffen, Audrey J.] Univ Bergen UiB, Dept Biol Sci, Bergen, Norway; [Smolinski, Szymon] Natl Marine Fisheries Res Inst, Dept Fisheries Resources, Gdynia, Poland	Institute of Marine Research - Norway; University of Bergen; National Marine Fisheries Research Institute	Denechaud, C (corresponding author), Inst Marine Res HI, Demersal Fish Res Grp, Bergen, Norway.; Denechaud, C (corresponding author), Univ Bergen UiB, Dept Biol Sci, Bergen, Norway.	come.denechaud@hi.no		Smolinski, Szymon/0000-0003-2715-984X; Denechaud, Come/0000-0002-8298-4423	Icelandic Research Fund [173906-051]	Icelandic Research Fund	Funding for this work was provided by the Icelandic Research Fund Grant 173906-051. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade H, 2020, POLAR BIOL, V43, P409, DOI 10.1007/s00300-020-02642-1; Armstrong MJ, 2004, ICES J MAR SCI, V61, P98, DOI 10.1016/j.icesjms.2003.10.005; Borisov V.M., 1978, J ICHTHYOL+, V18, P896; CAMPANA SE, 1990, CAN J FISH AQUAT SCI, V47, P2219, DOI 10.1139/f90-246; Campana SE, 2005, MAR FRESHWATER RES, V56, P485, DOI 10.1071/MF04147; Denechaud C, 2020, GLOBAL CHANGE BIOL, V26, P5661, DOI 10.1111/gcb.15298; Enberg K, 2012, MAR ECOL-EVOL PERSP, V33, P1, DOI 10.1111/j.1439-0485.2011.00460.x; Engelhard GH, 2014, GLOBAL CHANGE BIOL, V20, P2473, DOI 10.1111/gcb.12513; Folkvord A, 2014, CAN J FISH AQUAT SCI, V71, P1106, DOI 10.1139/cjfas-2013-0600; Fotland A., 2008, WORKING DOCUMENT ICE, P1; Francis RICC, 1997, MAR BIOL, V129, P681, DOI 10.1007/s002270050211; Geffen A.J., 2002, P99; Gulland J. A, 1964, RAPPORTS PROCES VERB, V155, P126; Hansen P. M., 1949, Rapport Conseil Exploration Mer Copenhague, V123, P1; Heino M, 2002, B MAR SCI, V70, P639; Heino M, 1999, J EVOLUTION BIOL, V12, P423; Hoie H, 2008, J APPL ICHTHYOL, V24, P138, DOI 10.1111/j.1439-0426.2007.01014.x; Hoie H, 2009, FISH RES, V96, P319, DOI 10.1016/j.fishres.2008.12.007; Hussy K, 2004, CAN J FISH AQUAT SCI, V61, P1021, DOI [10.1139/f04-038, 10.1139/F04-038]; Hylen A., 2008, NORWEGIAN SPRING SPA, P83; ICES, 2012, 1IBTS ICES SISP; ICES, 2020, ICES SCI REP, V2, P52, DOI [10.17895/ices.pub.6051, DOI 10.17895/ICES.PUB.6051]; ICES, 2018, 2018ACOM30 ICES CM; ICES, 2018, 2018ACOM06 ICES; ICES, 2020, ARCT FISH WORK GROUP, V2; ICES ACFM, 2001, ACFM19 ICES CM; Irgens C, 2020, CAN J FISH AQUAT SCI, V77, P113, DOI 10.1139/cjfas-2019-0033; Jolivet A, 2013, CAN J FISH AQUAT SCI, V70, P711, DOI 10.1139/cjfas-2012-0298; Jorgensen C, 2006, CAN J FISH AQUAT SCI, V63, P200, DOI 10.1139/F05-210; JORGENSEN T, 1990, J CONSEIL, V46, P235; KALISH JM, 1991, MAR ECOL PROG SER, V75, P191, DOI 10.3354/meps075191; KALISH JM, 1989, J EXP MAR BIOL ECOL, V132, P151, DOI 10.1016/0022-0981(89)90126-3; KJESBU OS, 1991, CAN J FISH AQUAT SCI, V48, P2333, DOI 10.1139/f91-274; Koster FW, 2014, ICES J MAR SCI, V71, P1311, DOI 10.1093/icesjms/fsu160; Lambert Y, 2000, CAN J FISH AQUAT SCI, V57, P815, DOI 10.1139/cjfas-57-4-815; LAW R, 1989, EVOL ECOL, V3, P343, DOI 10.1007/BF02285264; Law R, 2000, ICES J MAR SCI, V57, P659, DOI 10.1006/jmsc.2000.0731; Marshall CT, 2007, MAR ECOL PROG SER, V335, P301, DOI 10.3354/meps335301; Morales-Nin B, 2012, FISH RES, V127, P154, DOI 10.1016/j.fishres.2012.02.012; Morales-Nin B, 2015, ICES J MAR SCI, V72, P2073, DOI 10.1093/icesjms/fsv150; MOSEGAARD H, 1988, CAN J FISH AQUAT SCI, V45, P1514, DOI 10.1139/f88-180; Munday PL, 2009, CORAL REEFS, V28, P623, DOI 10.1007/s00338-009-0499-3; Nash RDM, 2010, FISH RES, V104, P89, DOI 10.1016/j.fishres.2010.03.001; Nedreaas K.H., 2006, 2006N05 ICES CM; Olsen EM, 2004, NATURE, V428, P932, DOI 10.1038/nature02430; OPDAL AF, 2008, NW ART FISH SCI, V41, P13; Opdal AF, 2015, GLOBAL CHANGE BIOL, V21, P1521, DOI 10.1111/gcb.12773; Pinsky ML, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2025453118; PULLIAINEN E, 1994, ENVIRON BIOL FISH, V40, P149, DOI 10.1007/BF00002541; Reglero P, 2006, J FISH BIOL, V68, P1091, DOI 10.1111/j.0022-1112.2006.01000.x; Reibisch J., 1899, WISSENSCHAFTLICHE ME, V4, P233; Reinert Thomas R., 2004, Gulf and Caribbean Research, V16, P11; Rideout RM, 2011, MAR COAST FISH, V3, P176, DOI 10.1080/19425120.2011.556943; Rideout RM, 2005, FISH FISH, V6, P50, DOI 10.1111/j.1467-2679.2005.00174.x; Rijnsdorp AD, 1995, BEL BAR LIB, P581; RIJNSDORP AD, 1990, NETH J SEA RES, V25, P279, DOI 10.1016/0077-7579(90)90027-E; ROLLEFSEN G., 1933, FISKERIDIREK SKR SER HAVUNDERS REP NORWEGIAN FISH AND MAR INVEST, V4, P1; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Skjaeraasen JE, 2004, FISH PHYSIOL BIOCHEM, V30, P163, DOI 10.1007/s10695-005-4319-6; Skjaeraasen JE, 2012, P NATL ACAD SCI USA, V109, P8995, DOI 10.1073/pnas.1200223109; Skjaeraasen JE, 2009, CAN J FISH AQUAT SCI, V66, P1582, DOI 10.1139/F09-102; Smolinski S, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-73652-6; SOOS, 2017, SO OCEAN OBSERVING S; Sturrock AM, 2015, METHODS ECOL EVOL, V6, P806, DOI 10.1111/2041-210X.12381; SWAIN DP, 2019, DEP FISHERIES OCEANS; Trippel EA, 1998, T AM FISH SOC, V127, P339, DOI 10.1577/1548-8659(1998)127&lt;0339:ESAVAS&gt;2.0.CO;2; Uriarte A, 2016, MAR FRESHWATER RES, V67, P951, DOI 10.1071/MF15092; Wright P.J., 2002, P31; Yaragina NA, 2009, MAR BIOL RES, V5, P54, DOI 10.1080/17451000802454882; Zuykova NV, 2009, MAR BIOL RES, V5, P66, DOI 10.1080/17451000802454874	70	1	1	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2021	16	9							e0257218	10.1371/journal.pone.0257218	http://dx.doi.org/10.1371/journal.pone.0257218			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	WG6OR	34516576	Green Published, gold			2022-12-26	WOS:000707114200019
J	Eizenberg, YH; Fromant, A; Lec'hvien, A; Arnould, JPY				Eizenberg, Yonina H.; Fromant, Aymeric; Lec'hvien, Arnaud; Arnould, John P. Y.			Contrasting impacts of environmental variability on the breeding biology of two sympatric small procellariiform seabirds in south-eastern Australia	PLOS ONE			English	Article							PETRELS PELECANOIDES-URINATRIX; DIVING PETRELS; CLIMATE-CHANGE; BASS STRAIT; REPRODUCTIVE-PERFORMANCE; INTERANNUAL VARIABILITY; PACHYPTILA-DESOLATA; MARINE CONSERVATION; FOOD AVAILABILITY; ANTARCTIC PRION	Seabirds play a vital role in marine ecosystems and the long-term study of their responses to environmental variations can be used to monitor the effects of climate change on marine fauna. However, slight differences in similar seabird species result in a range of responses which complicates our understanding of the effects of environmental changes to marine ecosystems. The present study investigated inter-annual differences in the breeding biology (breeding phenology, chick growth rates and breeding success) and environmental conditions (seasonal sea surface temperatures) of important foraging areas in two sympatric small Procellariiform species, the fairy prion (Pachyptila turtur) and the common diving petrel (Pelecanoides urinatrix), over four reproductive seasons (2017-2020) in Bass Strait, south-eastern Australia. Marine heatwaves occurred during the years of 2018/19 and 2019/20 and coincided with years of delayed laying dates, slower chick growth and reduced breeding success, in both species. While fairy prions maintained a relatively high breeding success and broadly constant breeding phenology, common diving petrels delayed the start of the breeding season by up to 50 days and experienced dramatic collapses in breeding success in years of high marine heat wave occurrence. The difference in foraging ecology and physiological capacity (largely in the production of stomach oils and fasting abilities of adults and chicks) between both species are likely to influence the variability and phenology in the observed breeding seasons.	[Eizenberg, Yonina H.; Fromant, Aymeric; Lec'hvien, Arnaud; Arnould, John P. Y.] Deakin Univ, Sch Life & Environm Sci, Burwood, Vic, Australia; [Eizenberg, Yonina H.; Fromant, Aymeric] La Rochelle Univ, Ctr Etud Biol Chize CEBC, CNRS, UMR 7372, Villiers En Bois, France	Deakin University; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE)	Eizenberg, YH (corresponding author), Deakin Univ, Sch Life & Environm Sci, Burwood, Vic, Australia.; Eizenberg, YH (corresponding author), La Rochelle Univ, Ctr Etud Biol Chize CEBC, CNRS, UMR 7372, Villiers En Bois, France.	yeizenberg@deakin.edu.au	Arnould, John/E-8386-2011	Arnould, John/0000-0003-1124-9330; Eizenberg, Yonina/0000-0001-6080-5650; Fromant, Aymeric/0000-0002-3024-7659	Birdlife Australia; Sea World Research and Rescue Foundation Inc.	Birdlife Australia; Sea World Research and Rescue Foundation Inc.	This study was supported logistically and financially by Sea World Research and Rescue Foundation Inc., and Birdlife Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armbrecht LH, 2015, J MARINE SYST, V144, P92, DOI 10.1016/j.jmarsys.2014.11.008; Barbraud C, 2006, P NATL ACAD SCI USA, V103, P6248, DOI 10.1073/pnas.0510397103; Barbraud C, 2003, P ROY SOC B-BIOL SCI, V270, P2111, DOI 10.1098/rspb.2003.2488; Barbraud C, 2012, MAR ECOL PROG SER, V454, P285, DOI 10.3354/meps09616; Bocher P, 2000, J ZOOL, V251, P517, DOI 10.1111/j.1469-7998.2000.tb00807.x; Boersma PD, 1999, ECOL ECON, V31, P287, DOI 10.1016/S0921-8009(99)00085-3; Bost CA, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9220; Both C, 2001, NATURE, V411, P296, DOI 10.1038/35077063; Boyd C, 2017, J APPL ECOL, V54, P1362, DOI 10.1111/1365-2664.12832; Boyd PW, 2008, BIOGEOSCIENCES, V5, P847, DOI 10.5194/bg-5-847-2008; BROTHERS NP, 1984, AUST WILDLIFE RES, V11, P113; Burke CM, 2009, J ZOOL, V278, P354, DOI 10.1111/j.1469-7998.2009.00584.x; Camprasse ECM, 2017, MAR BIOL, V164, DOI 10.1007/s00227-017-3193-y; Catry T, 2013, MAR BIOL, V160, P1189, DOI 10.1007/s00227-013-2171-2; Chambers LE, 2014, INT J BIOMETEOROL, V58, P603, DOI 10.1007/s00484-013-0711-6; Chambers LE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075514; Chambers LE, 2011, EMU, V111, P235, DOI 10.1071/MU10033; CHASTEL O, 1995, ECOLOGY, V76, P2240, DOI 10.2307/1941698; Cherel Y, 2002, MAR ECOL PROG SER, V228, P263, DOI 10.3354/meps228263; Chevin LM, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000357; Cochrane K, 2009, CLIMATE CHANGE IMPLI; Constable AJ, 2014, GLOBAL CHANGE BIOL, V20, P3004, DOI 10.1111/gcb.12623; CRAWFORD RJM, 1991, S AFR J MARINE SCI, V11, P357, DOI 10.2989/025776191784287709; CRESSWELL G, 2000, PAP P R SOC TASMANIA, V133, P21, DOI DOI 10.26749/RSTPP.133.3.21; Crick HQP, 1997, NATURE, V388, P526, DOI 10.1038/41453; Croxall JP, 2012, BIRD CONSERV INT, V22, P1, DOI 10.1017/S0959270912000020; DEEBOERSMA P, 1979, CONDOR, V81, P157, DOI 10.2307/1367282; Dias MP, 2017, BIOL CONSERV, V211, P76, DOI 10.1016/j.biocon.2017.05.009; Dobson FS, 2007, P ROY SOC B-BIOL SCI, V274, P275, DOI 10.1098/rspb.2006.3724; Dupont SM, 2020, POLAR BIOL, V43, P637, DOI 10.1007/s00300-020-02666-7; Durant JM, 2007, CLIM RES, V33, P271, DOI 10.3354/cr033271; Evans R, 2020, ESTUAR COAST SHELF S, V235, DOI 10.1016/j.ecss.2019.106538; Feng M, 2003, J GEOPHYS RES-OCEANS, V108, DOI 10.1029/2002JC001763; Frederiksen M, 2004, GLOBAL CHANGE BIOL, V10, P1214, DOI 10.1111/j.1529-8817.2003.00794.x; Frederiksen M, 2007, MAR ECOL PROG SER, V352, P205, DOI 10.3354/meps07071; Fromant Aymeric, 2020, Australian Field Ornithology, V37, P166; Fromant A, 2020, ROY SOC OPEN SCI, V7, DOI 10.1098/rsos.200670; Fromant A, 2020, POLAR BIOL, V43, P435, DOI 10.1007/s00300-020-02645-y; Fromant A, 2020, PEERJ, V8, DOI 10.7717/peerj.8700; Fromant A, 2016, SCI TOTAL ENVIRON, V544, P754, DOI 10.1016/j.scitotenv.2015.11.114; Gaglio D, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190444; GIBBS CF, 1986, AUST J MAR FRESH RES, V37, P451; Gremillet D, 2012, MAR ECOL PROG SER, V454, P197, DOI 10.3354/meps09590; Harding AMA, 2011, OECOLOGIA, V167, P49, DOI 10.1007/s00442-011-1971-7; Harley CDG, 2006, ECOL LETT, V9, P228, DOI 10.1111/j.1461-0248.2005.00871.x; HARPER PC, 1976, NEW ZEAL J ZOOL, V3, P351, DOI 10.1080/03014223.1976.9517925; Hobday AJ, 2016, PROG OCEANOGR, V141, P227, DOI 10.1016/j.pocean.2015.12.014; HOBDAY DK, 1992, EMU, V91, P342, DOI 10.1071/MU9910342; Hoegh-Guldberg O, 2019, SCIENCE, V365, P1263, DOI 10.1126/science.aaw6974; Huang Z, 2019, REMOTE SENS ENVIRON, V227, P90, DOI 10.1016/j.rse.2019.04.002; Inchausti P, 2003, J AVIAN BIOL, V34, P170, DOI 10.1034/j.1600-048X.2003.03031.x; Jaeger A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197291; Jones CW, 2020, MAR BIOL, V167, DOI 10.1007/s00227-020-3645-7; Lewison R., 2012, Endangered Species Research, V17, P93, DOI 10.3354/esr00419; LIDDLE GM, 1994, J ZOOL, V234, P125, DOI 10.1111/j.1469-7998.1994.tb06060.x; Lindstrom J, 1999, TRENDS ECOL EVOL, V14, P343, DOI 10.1016/S0169-5347(99)01639-0; Manno K, 2014, AUSTRAL ECOL, V39, P548, DOI 10.1111/aec.12115; Marchant S., 1990, P1; Marra PP, 1998, SCIENCE, V282, P1884, DOI 10.1126/science.282.5395.1884; Mills JA, 2008, J ANIM ECOL, V77, P1129, DOI 10.1111/j.1365-2656.2008.01383.x; Mirman D., 2014, P ANN M COGNITIVE SC, V36; Navarro J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062897; Nussey DH, 2005, SCIENCE, V310, P304, DOI 10.1126/science.1117004; Oliver ECJ, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms16101; Oppel S, 2018, MAR POLICY, V98, P37, DOI 10.1016/j.marpol.2018.08.024; Orians G.H., 1979, P155; Pakhomov EA, 1996, POLAR BIOL, V16, P271, DOI 10.1007/s003000050054; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; PAYNE MR, 1979, NEW ZEAL J ZOOL, V6, P299, DOI 10.1080/03014223.1979.10428368; Perkins-Kirkpatrick SE, 2019, B AM METEOROL SOC, V100, pS105, DOI 10.1175/BAMS-D-18-0116.1; Pinheiro J., 2013, R DEV CORE TEAM, P31; Ponchon A, 2014, ECOSPHERE, V5, DOI 10.1890/ES13-00233.1; PRINCE P A, 1990, Notornis, V37, P59; Ramos JA, 2018, CONDOR, V120, P283, DOI 10.1650/CONDOR-17-220.1; Regehr HM, 1997, MAR ECOL PROG SER, V155, P249, DOI 10.3354/meps155249; Ridgway KR, 2007, J GEOPHYS RES-OCEANS, V112, DOI 10.1029/2006JC003898; ROBY DD, 1986, PHYSIOL ZOOL, V59, P661, DOI 10.1086/physzool.59.6.30158613; Roby DD, 1997, AUK, V114, P725, DOI 10.2307/4089292; ROBY DD, 1989, ANTARCT SCI, V1, P337, DOI 10.1017/S0954102089000507; Rodriguez A, 2019, FRONT MAR SCI, V6, DOI 10.3389/fmars.2019.00094; Ropert-Coudert Y, 2015, ECOGRAPHY, V38, P111, DOI 10.1111/ecog.01182; Ross G.J.B., 2001, STATE MARINE ENV REP, P167; Saffer VM, 2000, EMU, V100, P49, DOI 10.1071/MU9712; Sagar RL, 2019, GEN COMP ENDOCR, V272, P1, DOI 10.1016/j.ygcen.2018.11.004; Sandery PA, 2007, ESTUAR COAST SHELF S, V74, P684, DOI 10.1016/j.ecss.2007.05.011; Schreiber EA, 2001, BIOL MARINE BIRDS; Schumann N, 2014, EMU, V114, P234, DOI 10.1071/MU13048; Schumann N, 2013, J FIELD ORNITHOL, V84, P69, DOI 10.1111/jofo.12007; Schumann N, 2008, WATERBIRDS, V31, P620; Seress G, 2020, J ANIM ECOL, V89, P1570, DOI 10.1111/1365-2656.13211; Sheard K., 1953, BANZ Antarctic Research Expedition Report (B), V8, P1; SOUTHWARD AJ, 1995, J THERM BIOL, V20, P127, DOI 10.1016/0306-4565(94)00043-I; THORESEN A C, 1969, Notornis, V16, P241; Velarde E, 2018, CONDOR, V120, P388, DOI 10.1650/CONDOR-17-5.1; WARHAM J, 1976, J EXP MAR BIOL ECOL, V23, P1, DOI 10.1016/0022-0981(76)90081-2; WARHAM J, 1990, PETRELS THEIR ECOLOG; Watanuki Y, 2009, MAR ECOL PROG SER, V393, P259, DOI 10.3354/meps08264; Waugh SM, 2000, CONDOR, V102, P804, DOI 10.1650/0010-5422(2000)102[0804:CSOPAC]2.0.CO;2; Weimerskirch H, 2001, BEHAV ECOL, V12, P22, DOI 10.1093/oxfordjournals.beheco.a000374; Weimerskirch H, 2012, SCIENCE, V335, P211, DOI 10.1126/science.1210270; YOUNG JW, 1993, MAR BIOL, V116, P9, DOI 10.1007/BF00350726; Zhang JJ, 2019, EMU, V119, P126, DOI 10.1080/01584197.2018.1558997; Zuur AF, 2010, METHODS ECOL EVOL, V1, P3, DOI 10.1111/j.2041-210X.2009.00001.x	103	4	4	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2021	16	9							e0250916	10.1371/journal.pone.0250916	http://dx.doi.org/10.1371/journal.pone.0250916			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	WG6OR	34516559	Green Submitted, gold, Green Published			2022-12-26	WOS:000707114200002
J	Eom, H; Choi, S; Choi, SO				Eom, Haneul; Choi, Sungyun; Choi, Sang Ok			Marketable value estimation of patents using ensemble learning methodology: Focusing on US patents for the electricity sector	PLOS ONE			English	Article							INTELLECTUAL PROPERTY; VALUATION; EVENT	Patent valuation is required to revitalize patent transactions, but calculating a reasonable value that consumers and suppliers could satisfy is difficult. When machine learning is used, a quantitative evaluation based on a large volume of data is possible, and evaluation can be conducted quickly and inexpensively, contributing to the activation of patent transactions. However, due to patent characteristics, securing the necessary training data is challenging because most patents are traded privately to prevent technical information leaks. In this study, the derived marketable value of a patent through event study is used for patent value evaluation, matching it with the semantic information from the patent calculated using latent Dirichlet allocation (LDA)-based topic modeling. In addition, an ensemble learning methodology that combines the predicted values of multiple predictive models was used to determine the prediction stability. Base learners with high predictive power for each fold were different, but the ensemble model that was trained on the base learners' predicted values exceeded the predictive power of the individual models. The Wilcoxon rank-sum test indicated that the superiority of the accuracy of the ensemble model was statistically significant at the 95% significance level.	[Eom, Haneul] Korea Univ, Program Sci & Technol Studies, Seoul, South Korea; [Choi, Sungyun] Korea Univ, Sch Elect Engn, Seoul, South Korea; [Choi, Sang Ok] Korea Univ, Dept Publ Adm, Seoul, South Korea	Korea University; Korea University; Korea University	Choi, SO (corresponding author), Korea Univ, Dept Publ Adm, Seoul, South Korea.	sangchoi@korea.ac.kr	Choi, Sungyun/AAP-7219-2020	Choi, Sungyun/0000-0001-8802-2535; eom, haneul/0000-0003-1701-6490	Korea University; National Research Foundation of Korea (NRF) - MSIT [2020R1A4A1019405]	Korea University; National Research Foundation of Korea (NRF) - MSIT	The work was supported in part by the Korea University Grant and in part by the Basic Research Program through the National Research Foundation of Korea (NRF) funded by the MSIT (No. 2020R1A4A1019405). The funders provided advice in the study design, data collection, analysis, decision to publish, and provided comments on the draft manuscript.	Abbas A, 2014, WORLD PAT INF, V37, P3, DOI 10.1016/j.wpi.2013.12.006; ALBERT MB, 1991, RES POLICY, V20, P251, DOI 10.1016/0048-7333(91)90055-U; Anthony Trippe., 2015, GUIDELINES PREPARING; AUSTIN DH, 1993, AM ECON REV, V83, P253; Bader M.A., 2009, WORLD INTELLECTUAL P; Blei DM, 2003, J MACH LEARN RES, V3, P993, DOI 10.1162/jmlr.2003.3.4-5.993; Brown P. F., 1992, Computational Linguistics, V18, P31; BROWN SJ, 1980, J FINANC ECON, V8, P205, DOI 10.1016/0304-405X(80)90002-1; CHANEY PK, 1991, J BUS, V64, P573, DOI 10.1086/296552; Chang J., 2009, ADV NEURAL INFORM PR, P288, DOI DOI 10.5555/2984093.2984126; Chen HS, 2015, IEEE INT FUZZY SYST, DOI 10.1109/FUZZ-IEEE.2015.7337980; Copara J, 2020, ABS200712569 ARXIV, P22, DOI 10.18653/v1/2020.wnut-1.40]; Corrado C. J., 2008, PAC-BASIN FINANC J, V16, P493, DOI [10.1016/j.pacfin.2007.10.005, DOI 10.1016/J.PACFIN.2007.10.005]; Corrado CJ, 2011, ACCOUNT FINANC, V51, P207, DOI 10.1111/j.1467-629X.2010.00375.x; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Dongseok B., 2015, INTELLECTUAL PROPERT, V23; DYCKMAN T, 1984, J ACCOUNTING RES, V22, P1, DOI 10.2307/2490855; European Commission, 2014, FINAL REPORT EXPERT; Friedl G, 2018, J WORLD INTELLECT PR, V21, P369, DOI 10.1111/jwip.12104; Girotra K, 2007, MANAGE SCI, V53, P1452, DOI 10.1287/mnsc.1070.0703; Griffiths TL, 2004, P NATL ACAD SCI USA, V101, P5228, DOI 10.1073/pnas.0307752101; Guellec D, 2000, ECON LETT, V69, P109, DOI 10.1016/S0165-1765(00)00265-2; Harhoff D, 1999, REV ECON STAT, V81, P511, DOI 10.1162/003465399558265; Hofmann T, 1999, SIGIR'99: PROCEEDINGS OF 22ND INTERNATIONAL CONFERENCE ON RESEARCH AND DEVELOPMENT IN INFORMATION RETRIEVAL, P50, DOI 10.1145/312624.312649; Jo H.J, 2018, PREDICTION PATENT QU; Karius Tim, 2016, EIKVSCHRIFTENREIHE Z; Kim G., 2014, SOFT COMPUTING BIG D, P71, DOI [10.1007/978-3-319-05527-5_8, DOI 10.1007/978-3-319-05527-5_8]; Kim YG, 2008, EXPERT SYST APPL, V34, P1804, DOI 10.1016/j.eswa.2007.01.033; Korkeamaki T, 2013, EUR MANAG REV, V10, P197, DOI 10.1111/emre.12016; Lagrost C, 2010, J INTELLECT CAP, V11, P481, DOI 10.1108/14691931011085641; Lee J, 2018, SUSTAINABILITY-BASEL, V10, DOI 10.3390/su10072278; Lin HJ, 2018, LECT NOTES COMPUT SC, V10828, P474, DOI 10.1007/978-3-319-91458-9_29; Lupu M, 2017, WORLD PAT INF, V49, pA1, DOI 10.1016/j.wpi.2017.06.002; Ma W, 2017, J WEB ENG, V16, P653; Martinez-Ruiz A, 2009, REVSTAT-STAT J, V7, P265; Mitsuyama N., 2013, J KNOWLEDGE MANAGEME, VIII; Nam Sohee, 2019, Journal of The Korean Data Analysis Society, V21, P2789, DOI 10.37727/jkdas.2019.21.6.2789; Newman David, 2010, HUMAN LANGUAGE TECHN, P100, DOI DOI 10.5555/1857999.1858011; Oldham GR, 2016, ORGAN BEHAV HUM DEC, V136, P20, DOI 10.1016/j.obhdp.2016.05.002; Park H.-W., 2012, J SUPPLY CHAIN OPER, V10, P76; Pitkethly R., 1997, VALUATION PATENTS RE; Reilly R.F, 2017, VALUATION PRACTICES; Saidens S., 2010, SOFTWARE SYSTEMS GUI, P479; Samala J., 2014, LICENSING J, V34, P1; Shih M J, 2010, PACIS, P95; Smith G., 2000, VALUATION INTELLECTU; Sood A, 2009, MARKET SCI, V28, P442, DOI 10.1287/mksc.1080.0407; Tang J., 2012, P 18 ACM SIGKDD INT, P1366, DOI DOI 10.1145/2339530.2339741; Unlu R, 2019, ANN OPER RES, V276, P229, DOI 10.1007/s10479-017-2716-8; Winer D, 2017, ELECT ENG COMPUTER S; Woo M., 2014, KOREAN J SECURITIES, V15, P353	51	0	0	11	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2021	16	9							e0257086	10.1371/journal.pone.0257086	http://dx.doi.org/10.1371/journal.pone.0257086			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	WG6OR	34516562	gold, Green Published			2022-12-26	WOS:000707114200011
J	Singh, SK; Kumar, S; Viswakarma, N; Principe, DR; Das, S; Sondarva, G; Nair, RS; Srivastava, P; Sinha, SC; Grippo, PJ; Thatcher, GRJ; Rana, B; Rana, A				Singh, Sunil Kumar; Kumar, Sandeep; Viswakarma, Navin; Principe, Daniel R.; Das, Subhasis; Sondarva, Gautam; Nair, Rakesh Sathish; Srivastava, Piush; Sinha, Subhash C.; Grippo, Paul J.; Thatcher, Gregory R. J.; Rana, Basabi; Rana, Ajay			MAP4K4 promotes pancreatic tumorigenesis via phosphorylation and activation of mixed lineage kinase 3	ONCOGENE			English	Article							PROTEIN-KINASE; SCAFFOLD PROTEINS; FAMILY KINASES; STE20 KINASE; STRESS; CELLS; ADENOCARCINOMA; INHIBITOR; REGULATOR; APOPTOSIS	MAP4K4 is a Ste20 member and reported to play important roles in various pathologies, including in cancer. However, the mechanism by which MAP4K4 promotes pancreatic cancer is not fully understood. It is suggested that MAP4K4 might function as a cancer promoter via specific downstream target(s) in an organ-specific manner. Here we identified MLK3 as a direct downstream target of MAP4K4. The MAP4K4 and MLK3 associates with each other, and MAP4K4 phosphorylates MLK3 on Thr738 and increases MLK3 kinase activity and downstream signaling. The phosphorylation of MLK3 by MAP4K4 promotes pancreatic cancer cell proliferation, migration, and colony formation. Moreover, MAP4K4 is overexpressed in human pancreatic tumors and directly correlates with the disease progression. The MAP4K4-specific pharmacological inhibitor, GNE-495, impedes pancreatic cancer cell growth, migration, induces cell death, and arrests cell cycle progression. Additionally, the GNE-495 reduced the tumor burden and extended survival of the KPC mice with pancreatic cancer. The MAP4K4 inhibitor also reduced MAP4K4 protein expression, tumor stroma, and induced cell death in murine pancreatic tumors. These findings collectively suggest that MLK3 phosphorylation by MAP4K4 promotes pancreatic cancer, and therefore therapies targeting MAP4K4 might alleviate the pancreatic cancer tumor burden in patients.	[Singh, Sunil Kumar; Kumar, Sandeep; Viswakarma, Navin; Principe, Daniel R.; Das, Subhasis; Sondarva, Gautam; Nair, Rakesh Sathish; Srivastava, Piush; Rana, Basabi; Rana, Ajay] Univ Illinois, Dept Surg, Div Surg Oncol, Chicago, IL 60612 USA; [Sinha, Subhash C.] Weill Cornell Med, New York, NY 10021 USA; [Grippo, Paul J.] Univ Illinois, Dept Med, Chicago, IL 60612 USA; [Thatcher, Gregory R. J.] Univ Arizona, Dept Pharmacol & Toxicol, Tucson, AZ 85721 USA; [Rana, Basabi; Rana, Ajay] Univ Illinois, Univ Illinois Hosp, Chicago, IL 60612 USA; [Rana, Basabi; Rana, Ajay] Univ Illinois, Hlth Sci Syst Canc Ctr, Chicago, IL 60612 USA; [Rana, Basabi; Rana, Ajay] Jesse Brown VA Med Ctr, Chicago, IL 60612 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Cornell University; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Arizona; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); Jesse Brown VA Medical Center	Rana, A (corresponding author), Univ Illinois, Dept Surg, Div Surg Oncol, Chicago, IL 60612 USA.; Rana, A (corresponding author), Univ Illinois, Univ Illinois Hosp, Chicago, IL 60612 USA.; Rana, A (corresponding author), Univ Illinois, Hlth Sci Syst Canc Ctr, Chicago, IL 60612 USA.; Rana, A (corresponding author), Jesse Brown VA Med Ctr, Chicago, IL 60612 USA.	arana@uic.edu	Singh, Sunil/AAA-1630-2022; Das, Subhasis/O-8421-2017	Singh, Sunil/0000-0001-7639-9212; Principe, Daniel/0000-0003-4355-6597; Srivastava, Piush/0000-0003-4646-9392; Sinha, Subhash/0000-0001-8916-5677; Das, Subhasis/0000-0003-1032-4407	Veterans Affairs Merit Award [BX004903]; Career Scientist Award [BX004855]; VA-Merit [BX003296]; National Cancer Institute [CA216410, CA176846, CA178063, CA219764]; UIC-Cancer Center pilot grant; NIH shared instrument grant [S100D018445]	Veterans Affairs Merit Award(US Department of Veterans Affairs); Career Scientist Award; VA-Merit; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); UIC-Cancer Center pilot grant; NIH shared instrument grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We acknowledge funding support from Veterans Affairs Merit Award (BX004903) and Career Scientist Award (BX004855) to A.R., and VA-Merit to B.R. (BX003296). This work is partly supported through grants from the National Cancer Institute to A.R. (CA216410 and CA176846), and B.R. (CA178063 and CA219764), and UIC-Cancer Center pilot grant award to BR. We also acknowledge the NIH shared instrument grant # S100D018445, awarded to U.A.M.S. Proteomics Core Lab, Little Rock, Arkansas, USA. Per the funding policy of the Department of Veterans Affairs, we are required to state that these contents do not represent the views of the Department of Veterans Affairs or the United States Government.	Aouadi M, 2009, NATURE, V458, P1180, DOI 10.1038/nature07774; Bos PH, 2019, CELL CHEM BIOL, V26, P1703, DOI 10.1016/j.chembiol.2019.10.005; Chuang HC, 2016, ADV IMMUNOL, V129, P277, DOI 10.1016/bs.ai.2015.09.006; Chuang HC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5602; Collins CS, 2006, P NATL ACAD SCI USA, V103, P3775, DOI 10.1073/pnas.0600040103; Das S, 2020, ONCOGENE, V39, P722, DOI 10.1038/s41388-019-1011-3; Das S, 2015, J BIOL CHEM, V290, P21705, DOI 10.1074/jbc.M115.655563; Delpire E, 2009, PFLUG ARCH EUR J PHY, V458, P953, DOI 10.1007/s00424-009-0674-y; Dhanasekaran A, 2004, J BIOL CHEM, V279, P37575, DOI 10.1074/jbc.M404003200; Dhanasekaran DN, 2007, ONCOGENE, V26, P3185, DOI 10.1038/sj.onc.1210411; Egberts JH, 2008, CANCER RES, V68, P1443, DOI 10.1158/0008-5472.CAN-07-5704; Farrow B, 2002, SURG ONCOL, V10, P153, DOI 10.1016/S0960-7404(02)00015-4; Flach RJR, 2016, MOL CELL BIOL, V36, P1740, DOI 10.1128/MCB.01121-15; Flach RJR, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9995; Gao X, 2017, MOL ONCOL, V11, P628, DOI 10.1002/1878-0261.12055; Gao X, 2016, CELL BIOSCI, V6, DOI 10.1186/s13578-016-0121-7; Hingorani SR, 2005, CANCER CELL, V7, P469, DOI 10.1016/j.ccr.2005.04.023; Jin M, 2016, ENVIRON TOXICOL PHAR, V46, P246, DOI 10.1016/j.etap.2016.08.006; Kumar S, 2016, MOL ONCOL, V10, P949, DOI 10.1016/j.molonc.2016.03.007; Kyriakis JM, 2001, PHYSIOL REV, V81, P807, DOI 10.1152/physrev.2001.81.2.807; Larhammar M, 2017, J NEUROSCI, V37, P11074, DOI 10.1523/JNEUROSCI.0905-17.2017; Liang JJ, 2008, CLIN CANCER RES, V14, P7043, DOI 10.1158/1078-0432.CCR-08-0381; Liu HZ, 1999, CURR BIOL, V9, P101, DOI 10.1016/S0960-9822(99)80023-2; Maroney AC, 2001, J BIOL CHEM, V276, P25302, DOI 10.1074/jbc.M011601200; Ndubaku CO, 2015, ACS MED CHEM LETT, V6, P913, DOI 10.1021/acsmedchemlett.5b00174; Prolo LM, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-50160-w; Rana A, 1996, J BIOL CHEM, V271, P19025, DOI 10.1074/jbc.271.32.19025; Rana Ajay, 2013, Genes Cancer, V4, P334, DOI 10.1177/1947601913485415; Rangasamy V, 2012, P NATL ACAD SCI USA, V109, P8149, DOI 10.1073/pnas.1200804109; Rangasamy V, 2010, CANCER RES, V70, P1731, DOI 10.1158/0008-5472.CAN-09-3492; Rattanasinchai C, 2016, CANCERS, V8, DOI 10.3390/cancers8050051; Sathyanarayana P, 2002, MOL CELL, V10, P1527, DOI 10.1016/S1097-2765(02)00734-7; Schroder P, 2015, ANGEW CHEM INT EDIT, V54, P12398, DOI 10.1002/anie.201501515; Schwaid AG, 2015, ACS CHEM BIOL, V10, P2667, DOI 10.1021/acschembio.5b00679; Tang XQ, 2006, P NATL ACAD SCI USA, V103, P2087, DOI 10.1073/pnas.0507660103; Torres MP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080580; Vitorino P, 2015, NATURE, V519, P425, DOI 10.1038/nature14323; Whitmarsh AJ, 1998, TRENDS BIOCHEM SCI, V23, P481, DOI 10.1016/S0968-0004(98)01309-7; Wright JH, 2003, MOL CELL BIOL, V23, P2068, DOI 10.1128/MCB.23.6.2068-2082.2003; Xue YZ, 2001, DEVELOPMENT, V128, P1559; Yao ZB, 1999, J BIOL CHEM, V274, P2118, DOI 10.1074/jbc.274.4.2118; Yue JP, 2014, DEV CELL, V31, P572, DOI 10.1016/j.devcel.2014.10.025; Zhao XD, 2016, ONCOTARGET, V7, P81110, DOI 10.18632/oncotarget.13212	43	4	4	0	5	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 28	2021	40	43					6153	6165		10.1038/s41388-021-02007-w	http://dx.doi.org/10.1038/s41388-021-02007-w		SEP 2021	13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	WO5HW	34511598	hybrid, Green Published			2022-12-26	WOS:000695127400001
J	Bucris, E; Indenbaum, V; Azar, R; Erster, O; Haas, E; Mendelson, E; Zuckerman, NS				Bucris, Efrat; Indenbaum, Victoria; Azar, Roberto; Erster, Oran; Haas, Eric; Mendelson, Ella; Zuckerman, Neta S.			Direct sequencing of measles virus complete genomes in the midst of a large-scale outbreak	PLOS ONE			English	Article								Measles outbreaks escalated globally despite worldwide elimination efforts. Molecular epidemiological investigations utilizing partial measles virus (MeV) genomes are challenged by reduction in global genotypes and low evolutionary rates. Greater resolution was reached using MeV complete genomes, however time and costs limit the application to numerous samples. We developed an approach to unbiasedly sequence complete MeV genomes directly from patient urine samples. Samples were enriched for MeV using filtration or nucleases and the minimal number of sequence reads to allocate per sample based on its MeV content was assessed using in-silico reduction of sequencing depth. Application of limited-resource sequencing to treated MeV-positive samples demonstrated that 1-5 million sequences for samples with high/medium MeV quantities and 10-15 million sequences for samples with lower MeV quantities are sufficient to obtain >98% MeV genome coverage and over X50 average depth. This approach enables real-time high-resolution molecular epidemiological investigations of large-scale MeV outbreaks.	[Bucris, Efrat; Indenbaum, Victoria; Azar, Roberto; Erster, Oran; Mendelson, Ella; Zuckerman, Neta S.] Chaim Sheba Med Ctr, Minist Hlth, Cent Virol Lab, Ramat Gan, Israel; [Haas, Eric] Israel Minist Hlth, Div Epidemiol, Jerusalem, Israel; [Haas, Eric] Ben Gurion Univ Negev, Fac Hlth Sci, Beer Sheva, Israel; [Mendelson, Ella] Tel Aviv Univ, Sch Publ Hlth, Tel Aviv, Israel	Chaim Sheba Medical Center; Ben Gurion University; Tel Aviv University	Zuckerman, NS (corresponding author), Chaim Sheba Med Ctr, Minist Hlth, Cent Virol Lab, Ramat Gan, Israel.	Neta.Zuckerman@sheba.health.gov.il	Haas, Eric/HGB-7336-2022	Haas, Eric/0000-0002-4605-6566; Zuckerman, Neta/0000-0001-6074-2100				[Anonymous], 2018, Wkly Epidemiol Rec, V93, P55; CENTERS FOR DISEASE CONTROL AND PREVENTION, 2011, MULT REAL TIM PCR DE; Ewels P, 2016, BIOINFORMATICS, V32, P3047, DOI 10.1093/bioinformatics/btw354; Gardy JL, 2015, J INFECT DIS, V212, P1574, DOI 10.1093/infdis/jiv271; Hall RJ, 2014, J VIROL METHODS, V195, P194, DOI 10.1016/j.jviromet.2013.08.035; Huang BX, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-41830-w; Hubschen JM, 2008, J VIROL METHODS, V149, P246, DOI 10.1016/j.jviromet.2008.01.032; Lewandowska DW, 2017, MICROBIOME, V5, DOI 10.1186/s40168-017-0351-x; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; NuTonomy, 2019, NEW MEASL SURV DAT 2; Penedos AR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143081; Phan MVT, 2018, GENOME ANNOUNCEMENTS, V6, DOI 10.1128/genomeA.00184-18; Rosseel T, 2015, J VIROL METHODS, V222, P72, DOI 10.1016/j.jviromet.2015.05.010; Shu B, 2011, J CLIN MICROBIOL, V49, P2614, DOI 10.1128/JCM.02636-10; World Health Organization (WHO), 2014, WHO INF MOL DIAGN IN	15	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2021	16	9							e0255663	10.1371/journal.pone.0255663	http://dx.doi.org/10.1371/journal.pone.0255663			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XM9EM	34506497	gold, Green Published			2022-12-26	WOS:000729120700117
J	Stephenson, R; Walsh, AR; Chavanduka, TMD; Sallabank, G; Horvath, KJ; Castel, AD; Bonar, EE; Hightow-Weidman, L; Bauermeister, JA; Sullivan, PS				Stephenson, Rob; Walsh, Alison R.; Chavanduka, Tanaka M. D.; Sallabank, Gregory; Horvath, Keith J.; Castel, Amanda D.; Bonar, Erin E.; Hightow-Weidman, Lisa; Bauermeister, Jose A.; Sullivan, Patrick S.			Widespread closure of HIV prevention and care services places youth at higher risk during the COVID-19 pandemic	PLOS ONE			English	Article							ADOLESCENT	Background Central to measuring the impact of the COVID-19 pandemic on HIV is understanding the role of loss of access to essential HIV prevention and care services created by clinic and community-based organization closures. In this paper, we use a comprehensive list of HIV prevention services in four corridors of the US heavily impacted by HIV, developed as part of a large RCT, to illustrate the potential impact of service closure on LGBTQ+ youth. Methods We identified and mapped LGBTQ+ friendly services offering at least one of the following HIV-related services: HIV testing; STI testing; PrEP/PEP; HIV treatment and care; and other HIV-related services in 109 counties across four major interstate corridors heavily affected by HIV US Census regions: Pacific (San Francisco, CA to San Diego, CA); South-Atlantic (Washington, DC to Atlanta, GA); East-North-Central (Chicago, IL to Detroit, MI); and East-South-Central (Memphis, TN to New Orleans, LA). Results There were a total of 831 LGBTQ+ youth-friendly HIV service providers across the 109 counties. There was a range of LGBTQ+ youth-friendly HIV-service provider availability across counties (range: 0-14.33 per 10,000 youth aged 13-24 (IQR: 2.13), median: 1.09); 9 (8.26%) analyzed counties did not have any LGBTQ+ youth-friendly HIV service providers. The Pearson correlation coefficient for the correlation between county HIV prevalence and LGBTQ+ youth-friendly HIV service provider density was 0.16 (p = 0.09), suggesting only a small, non-statistically significant linear relationship between a county's available LGBTQ+ youth-friendly HIV service providers and their HIV burden. Conclusions As the COVID-19 pandemic continues, we must find novel, affordable ways to continue to provide sexual health, mental health and other support services to LGBTQ+ youth.	[Stephenson, Rob; Walsh, Alison R.] Univ Michigan, Sch Nursing, Dept Syst Populat & Leadership, Ann Arbor, MI 48109 USA; [Stephenson, Rob; Walsh, Alison R.; Chavanduka, Tanaka M. D.; Sallabank, Gregory; Bonar, Erin E.] Univ Michigan, Ctr Sexual & Hlth Dispar, Ann Arbor, MI 48109 USA; [Horvath, Keith J.] San Diego State Univ, Dept Psychol, San Diego, CA 92182 USA; [Castel, Amanda D.] George Washington Univ, Sch Publ Hlth, Milken Inst, Washington, DC USA; [Bonar, Erin E.] Univ Michigan, Dept Psychiat, Addict Ctr, Ann Arbor, MI 48109 USA; [Bonar, Erin E.] Univ Michigan, Injury Prevent Ctr, Ann Arbor, MI 48109 USA; [Hightow-Weidman, Lisa] Univ N Carolina, Inst Global Hlth & Infect Dis, Chapel Hill, NC 27515 USA; [Bauermeister, Jose A.] Univ Penn, Sch Nursing, Dept Family & Community Hlth, Philadelphia, PA 19104 USA; [Sullivan, Patrick S.] Emory Univ, Rollins Sch Publ Hlth, Dept Epidemiol, Atlanta, GA 30322 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; California State University System; San Diego State University; George Washington University; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of North Carolina; University of North Carolina Chapel Hill; University of Pennsylvania; Emory University; Rollins School Public Health	Stephenson, R (corresponding author), Univ Michigan, Sch Nursing, Dept Syst Populat & Leadership, Ann Arbor, MI 48109 USA.; Stephenson, R (corresponding author), Univ Michigan, Ctr Sexual & Hlth Dispar, Ann Arbor, MI 48109 USA.	rbsteph@umich.edu	Walsh, Alison (Ali) R./ABF-3163-2021; Bauermeister, Jose/X-8960-2018	Walsh, Alison (Ali) R./0000-0002-6123-5730; Sullivan, Patrick Sean/0000-0002-7728-0587; Bauermeister, Jose/0000-0002-9276-2306	National Institutes of Health, National Institute on Minority Health and Disparities [U01MDO11274]	National Institutes of Health, National Institute on Minority Health and Disparities	Financial support for the research was received by RS, BJ & PS: U01MDO11274: Reducing HIV vulnerability through a multilevel life skills intervention for adolescent men. National Institutes of Health, National Institute on Minority Health and Disparities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AIDSinfo NUSNL of M, AIDSINFO; [Anonymous], 2013 2017 AM COMM SU; Armstrong WS, 2020, CLIN INFECT DIS, DOI [10.1093/cid/ciaa1532, DOI 10.1093/CID/CIAA1532]; Bauermeister J, 2018, JMIR RES PROTOC, V7, DOI 10.2196/10174; Bonar EE, 2021, TRANSL BEHAV MED, V11, P1299, DOI [10.1093/tbm/ibab025, 10.1093/tbm/lbab025]; Carrico AW, 2020, AIDS BEHAV, V24, P3020, DOI 10.1007/s10461-020-02854-w; CDC. Centers for Disease Control and Prevention, 2019, HIV SURV REP, V30; Centers for Disease Control and Prevention (CDC), 2020, COVIDVIEW WEEKL SURV; Davey DJ, 2020, AIDS BEHAV, V24, P2229, DOI 10.1007/s10461-020-02861-x; Davoren MP, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-006045; Doll M, 2018, J ADOLESCENT HEALTH, V62, P424, DOI 10.1016/j.jadohealth.2017.09.009; Dumas TM, 2020, J ADOLESCENT HEALTH, V67, P354, DOI 10.1016/j.jadohealth.2020.06.018; Emory University Rollins School of Public Health, 2020, DAT METH NAT DAT STA; Gentry MT, 2021, TELEMED E-HEALTH, V27, P1385, DOI 10.1089/tmj.2020.0575; Gervasoni C, 2020, CLIN INFECT DIS, V71, P2276, DOI 10.1093/cid/ciaa579; Hargreaves J, 2020, LANCET HIV, V7, pE309, DOI 10.1016/S2352-3018(20)30110-7; (HHS) O of ID and HP, 2020, END HIV EP PLAN AM; Hightow-Weidman L, 2020, AIDS BEHAV, V24, P2239, DOI 10.1007/s10461-020-02870-w; Jiang HB, 2020, LANCET HIV, V7, pE308, DOI 10.1016/S2352-3018(20)30105-3; Johnson S., 2019, HIV SURVEILL REP, V30; Kay ES, 2020, AIDS BEHAV, V24, P2461, DOI 10.1007/s10461-020-02879-1; Lin L, 2020, JAMA PSYCHIAT, V77, P1209, DOI 10.1001/jamapsychiatry.2020.1698; Liu CH, 2020, PSYCHIAT RES, V290, DOI 10.1016/j.psychres.2020.113172; Logie CH, 2020, AIDS BEHAV, V24, P2003, DOI 10.1007/s10461-020-02856-8; Millett GA, 2020, ANN EPIDEMIOL, V47, P37, DOI 10.1016/j.annepidem.2020.05.003; Okonkwo NE, 2021, BMJ EVID-BASED MED, V26, P176, DOI 10.1136/bmjebm-2020-111426; Operario D, 2020, AIDS BEHAV, V24, P2748, DOI 10.1007/s10461-020-02896-0; Perisetti A, 2021, DIGEST DIS SCI, V66, P945, DOI 10.1007/s10620-021-06874-x; Philbin MM, 2017, AIDS CARE, V29, P1227, DOI 10.1080/09540121.2017.1338655; Ridgway JP, 2020, AIDS BEHAV, V24, P2770, DOI 10.1007/s10461-020-02905-2; Sanchez TH, 2020, AIDS BEHAV, V24, P2024, DOI 10.1007/s10461-020-02894-2; Shiau S, 2020, AIDS BEHAV, V24, P2244, DOI 10.1007/s10461-020-02871-9; Stephenson R, 2018, JMIR RES PROTOC, V7, DOI [10.2196/resprot.9414, 10.2196/resprot.7341]; Stephenson Rob, 2017, JMIR Res Protoc, V6, pe237, DOI 10.2196/resprot.8562; Tang K, 2020, REPROD HEALTH, V17, DOI 10.1186/s12978-020-0900-9; Valdiserri RO, 2020, AIDS BEHAV, V24, P1980, DOI 10.1007/s10461-020-02859-5; Valdiserri RO, 2018, AIDS EDUC PREV, V30, P26, DOI 10.1521/aeap.2018.30.1.26; van Dorn A, 2020, LANCET, V395, P1243, DOI 10.1016/S0140-6736(20)30893-X; Vizcarra P, 2020, LANCET HIV, V7, pE554, DOI 10.1016/S2352-3018(20)30164-8; World Health Organization, 2020, ROLL UPD COR DIS COV; Young SD, 2020, AIDS BEHAV, V24, P2000, DOI 10.1007/s10461-020-02924-z	41	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2021	16	9							e0249740	10.1371/journal.pone.0249740	http://dx.doi.org/10.1371/journal.pone.0249740			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	XM9EM	34506488	Green Published, gold			2022-12-26	WOS:000729120700039
J	Li, F; Cai, YH; Deng, SH; Yang, L; Liu, N; Chang, XH; Jing, LK; Zhou, YF; Li, H				Li, Fang; Cai, Yuhan; Deng, Sihan; Yang, Lin; Liu, Na; Chang, Xiaohan; Jing, Lankai; Zhou, Yifeng; Li, Hua			A peptide CORO1C-47aa encoded by the circular noncoding RNA circ-0000437 functions as a negative regulator in endometrium tumor angiogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYPOXIA-INDUCIBLE FACTOR; CANCER; TRANSLATION; COACTIVATORS	Circular RNAs (circRNAs) are a novel class of widespread noncoding RNAs that regulate gene expression in mammals. Recent studies demonstrate that functional peptides can be encoded by short open reading frames in noncoding RNAs, including circRNAs. However, the role of circRNAs in various physiological and pathological states, such as cancer, is not well understood. In this study, through deep RNA sequencing on human endometrial cancer (EC) samples and their paired adjacent normal tissues, we uncovered that the circRNA hsa-circ-0000437 is significantly reduced in EC compared with matched paracancerous tissue. The hsa-circ-0000437 contains a short open reading frame encoding a functional peptide termed CORO1C-47aa. Overexpression of CORO1C-47aa is capable of inhibiting angiogenesis at the initiation stage by suppressing endothelial cell proliferation, migration, and differentiation through competition with transcription factor TACC3 to bind to ARNT and suppress VEGF. CORO1C-47aa directly bound to ARNT through the PAS-B domain, and blocking the association between ARNT and TACC3, which led to reduced expression of VEGF, ultimately lead to reduced angiogenesis. The antitumor effects of CORO1C-47aa on EC progression suggest that CORO1C-47aa has potential value in anticarcinoma therapies and warrants further investigation.	[Li, Fang; Cai, Yuhan; Yang, Lin; Chang, Xiaohan; Jing, Lankai; Li, Hua] Peking Univ, Hosp 3, Dept Obstet & Gynecol, Beijing, Peoples R China; [Li, Fang; Zhou, Yifeng] Soochow Univ, Dept Genet, Med Coll, Suzhou, Peoples R China; [Li, Fang] Guangzhou Med Univ, Affiliated Hosp 1, Sch Publ Hlth, State Key Lab Resp Dis, Guangzhou, Peoples R China; [Deng, Sihan] Cent South Univ, Xiangya Med Sch, Changsha, Peoples R China; [Liu, Na] 6 Hosp, Dept Obstet & Gynecol, Beijing, Peoples R China	Peking University; Soochow University - China; Guangzhou Medical University; State Key Laboratory of Respiratory Disease; Central South University	Li, H (corresponding author), Peking Univ, Hosp 3, Dept Obstet & Gynecol, Beijing, Peoples R China.	hual_gyn@163.com			National Natural Science Foundation of China [81872120]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	We thank all individuals who took part in this research. This work was supported by the grants from the National Natural Science Foundation of China (81872120).	Aghajanian C, 2011, J CLIN ONCOL, V29, P2259, DOI 10.1200/JCO.2010.32.6397; Anderson DM, 2015, CELL, V160, P595, DOI 10.1016/j.cell.2015.01.009; Andrews SJ, 2014, NAT REV GENET, V15, P193, DOI 10.1038/nrg3520; Aspden JL, 2014, ELIFE, V3, DOI 10.7554/eLife.03528; CAPEL B, 1993, CELL, V73, P1019, DOI 10.1016/0092-8674(93)90279-Y; Chen HX, 2017, CELL PHYSIOL BIOCHEM, V41, P933, DOI 10.1159/000460510; Chen HJ, 2016, CANCER LETT, V382, P44, DOI 10.1016/j.canlet.2016.08.020; Chiodelli P, 2017, ONCOGENE, V36, P6531, DOI 10.1038/onc.2017.243; Dorland YL, 2017, CELL MOL LIFE SCI, V74, P279, DOI 10.1007/s00018-016-2325-8; Du WW, 2016, NUCLEIC ACIDS RES, V44, P2846, DOI 10.1093/nar/gkw027; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Gilbert WV, 2007, SCIENCE, V317, P1224, DOI 10.1126/science.1144467; Glazar P, 2014, RNA, V20, P1666, DOI 10.1261/rna.043687.113; Guo YR, 2015, J BIOL CHEM, V290, P7707, DOI 10.1074/jbc.M114.632786; Hansen TB, 2013, NATURE, V495, P384, DOI 10.1038/nature11993; He Y, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000012968; Huang JZ, 2017, MOL CELL, V68, P171, DOI 10.1016/j.molcel.2017.09.015; Jeck WR, 2013, RNA, V19, P141, DOI 10.1261/rna.035667.112; Kewley RJ, 2004, INT J BIOCHEM CELL B, V36, P189, DOI 10.1016/S1357-2725(03)00211-5; Lee I, 2016, ONCOGENE, V35, P5191, DOI 10.1038/onc.2016.56; Lee TY, 2018, FRONT ONCOL, V8, DOI 10.3389/fonc.2018.00341; Legnini I, 2017, MOL CELL, V66, P22, DOI 10.1016/j.molcel.2017.02.017; Li N, 2014, CARCINOGENESIS, V35, P2687, DOI 10.1093/carcin/bgu201; Li W, 2017, J BIOL CHEM, V292, P5801, DOI 10.1074/jbc.M116.758508; Memczak S, 2013, NATURE, V495, P333, DOI 10.1038/nature11928; Pamudurti NR, 2017, MOL CELL, V66, P9, DOI 10.1016/j.molcel.2017.02.021; Park JH, 2016, PHYTOMEDICINE, V23, P1716, DOI 10.1016/j.phymed.2016.10.010; Partch CL, 2011, P NATL ACAD SCI USA, V108, P7739, DOI 10.1073/pnas.1101357108; Partch CL, 2010, J CELL PHYSIOL, V223, P553, DOI 10.1002/jcp.22067; Perez-Riverol Y, 2019, NUCLEIC ACIDS RES, V47, pD442, DOI 10.1093/nar/gky1106; Potischman N, 1996, J NATL CANCER I, V88, P1127, DOI 10.1093/jnci/88.16.1127; Servick K, 2017, SCIENCE, V355, P1363, DOI 10.1126/science.355.6332.1363; Stabile H, 2007, BLOOD, V109, P1834, DOI 10.1182/blood-2006-06-032276; Stefansson IM, 2006, CANCER RES, V66, P3303, DOI 10.1158/0008-5472.CAN-05-1163; Tan ZY, 2018, THERANOSTICS, V8, P5143, DOI 10.7150/thno.27310; Vincent HA, 2006, J BIOL CHEM, V281, P29769, DOI 10.1074/jbc.M606744200; Vincent HA, 2009, J MOL BIOL, V387, P570, DOI 10.1016/j.jmb.2009.01.068; Xu HY, 2015, SCI REP-UK, V5, DOI 10.1038/srep12453; Yang YB, 2018, JNCI-J NATL CANCER I, V110, DOI 10.1093/jnci/djx166; Yang Y, 2017, CELL RES, V27, P626, DOI 10.1038/cr.2017.31; Yu CY, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01216-w; Yu L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158347; Zhang J, 2017, MOL CANCER, V16, DOI 10.1186/s12943-017-0719-3; Zhang ML, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06862-2; Zheng QP, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11215	45	8	8	2	11	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV	2021	297	5							101182	10.1016/j.jbc.2021.101182	http://dx.doi.org/10.1016/j.jbc.2021.101182			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	YZ3FU	34534547	Green Published, gold			2022-12-26	WOS:000755365700003
J	Gandelman, M; Dansithong, W; Kales, SC; Paul, S; Maag, G; Aoyama, E; Zakharov, A; Rai, G; Dexheimer, T; Whitehill, BM; Sun, HM; Jadhav, A; Simeonov, A; Henderson, MJ; Huynh, DP; Pulst, SM; Scoles, DR				Gandelman, Mandi; Dansithong, Warunee; Kales, Stephen C.; Paul, Sharan; Maag, Gentrie; Aoyama, Erika; Zakharov, Alexey; Rai, Ganesha; Dexheimer, Thomas; Whitehill, Brooke M.; Sun, Hongmao; Jadhav, Ajit; Simeonov, Anton; Henderson, Mark J.; Huynh, Duong P.; Pulst, Stefan M.; Scoles, Daniel R.			The AKT modulator A-443654 reduces alpha-synuclein expression and normalizes ER stress and autophagy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PARKINSONS-DISEASE; MODEL; PHOSPHORYLATION; DUPLICATION; INHIBITION; TOXICITY; DELIVERY; KINASES; NEURONS; RISK	Accumulation of alpha-synuclein is a main underlying patho-logical feature of Parkinson's disease and alpha-synucleinopathies, for which lowering expression of the alpha-synuclein gene (SNCA) is a potential therapeutic avenue. Using a cell-based luciferase reporter of SNCA expression we performed a quantitative high-throughput screen of 155,885 compounds and identified A-443654, an inhibitor of the multiple functional kinase AKT, as a potent inhibitor of SNCA. HEK-293 cells with CAG repeat expanded ATXN2 (ATXN2-Q58 cells) have increased levels of alpha-synuclein. We found that A-443654 normalized levels of both SNCA mRNA and alpha-synuclein monomers and oligomers in ATXN2-Q58 cells. A-443654 also normalized levels of alpha-syn-uclein in fibroblasts and iPSC-derived dopaminergic neurons from a patient carrying a triplication of the SNCA gene. Analysis of autophagy and endoplasmic reticulum stress markers showed that A-443654 successfully prevented alpha-syn-uclein toxicity and restored cell function in ATXN2-Q58 cells, normalizing the levels of mTOR, LC3-II, p62, STAU1, BiP, and CHOP. A-443654 also decreased the expression of DCLK1, an inhibitor of alpha-synuclein lysosomal degradation. Our study identifies A-443654 and AKT inhibition as a potential strategy for reducing SNCA expression and treating Parkinson's disease pathology.	[Gandelman, Mandi; Dansithong, Warunee; Paul, Sharan; Maag, Gentrie; Aoyama, Erika; Huynh, Duong P.; Pulst, Stefan M.; Scoles, Daniel R.] Univ Utah, Dept Neurol, Salt Lake City, UT 84112 USA; [Kales, Stephen C.; Zakharov, Alexey; Rai, Ganesha; Whitehill, Brooke M.; Sun, Hongmao; Jadhav, Ajit; Simeonov, Anton; Henderson, Mark J.] Natl Ctr Adv Translat Sci NCATS, Dept Neurol, Rockville, MD USA; [Dexheimer, Thomas] Michigan State Univ, Dept Pharmacol & Toxicol, E Lansing, MI 48824 USA	Utah System of Higher Education; University of Utah; Michigan State University	Scoles, DR (corresponding author), Univ Utah, Dept Neurol, Salt Lake City, UT 84112 USA.	Daniel.Scoles@hsc.utah.edu	Resource Center, NINDS Human Genetics/AGF-2474-2022; gandelman, mandi/V-7659-2019	gandelman, mandi/0000-0003-2697-0390; Rai, Ganesha/0000-0001-9763-9641; Henderson, Mark/0000-0001-8590-7338	Michael J Fox Foundation for Parkinson's Research [11742]; NCATS Intramural Research Program; NINDS, National Institutes of Health (NIH) [R21NS103009, R01NS097903, R37NS033123, U01NS103883]	Michael J Fox Foundation for Parkinson's Research; NCATS Intramural Research Program; NINDS, National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We dedicate this work to the memory of Duong P. Huynh, for more than 2 decades of collaboration and friendship. We thank Cordelle Tanega for preparing PubChem depositions. Support was provided by the Michael J Fox Foundation for Parkinson's Research (Grant ID 11742) and the NCATS Intramural Research Program. This work was also supported in part by NINDS, National Institutes of Health (NIH) grants R21NS103009, R01NS097903, R37NS033123, and U01NS103883. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alarcon-Aris D, 2018, MOL THER, V26, P550, DOI 10.1016/j.ymthe.2017.11.015; Bengoa-Vergniory N, 2017, ACTA NEUROPATHOL, V134, P819, DOI 10.1007/s00401-017-1755-1; Chan TO, 2011, P NATL ACAD SCI USA, V108, pE1120, DOI 10.1073/pnas.1109879108; Chartier-Harlin MC, 2004, LANCET, V364, P1167, DOI 10.1016/S0140-6736(04)17103-1; Chiba-Falek O, 2006, MOVEMENT DISORD, V21, P1703, DOI 10.1002/mds.21007; Choi I, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15119-w; Dansithong W, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136930; Deng H, 2014, AGEING RES REV, V15, P161, DOI 10.1016/j.arr.2014.04.002; Gandelman M, 2020, CELL DEATH DIFFER, V27, P2942, DOI 10.1038/s41418-020-0553-9; Gilbert LA, 2013, CELL, V154, P442, DOI 10.1016/j.cell.2013.06.044; Goedert M, 2017, J PARKINSON DIS, V7, pS53, DOI 10.3233/JPD-179005; Gronich N, 2018, MOVEMENT DISORD, V33, P1465, DOI 10.1002/mds.108; Grundemann J, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn084; Han EKH, 2007, ONCOGENE, V26, P5655, DOI 10.1038/sj.onc.1210343; Hebron ML, 2013, HUM MOL GENET, V22, P3315, DOI 10.1093/hmg/ddt192; Helmschrodt C, 2017, MOL THER-NUCL ACIDS, V9, P57, DOI 10.1016/j.omtn.2017.08.013; Ibanez P, 2004, LANCET, V364, P1169, DOI 10.1016/S0140-6736(04)17104-3; Inglese J, 2006, P NATL ACAD SCI USA, V103, P11473, DOI 10.1073/pnas.0604348103; Jiang PZ, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08149-w; Khodr CE, 2011, BRAIN RES, V1395, P94, DOI 10.1016/j.brainres.2011.04.036; Kumar VB, 2019, EUR J PHARMACOL, V845, P65, DOI 10.1016/j.ejphar.2018.12.027; Kuo Yien-Ming, 2019, Am J Neurodegener Dis, V8, P1; Landeck N, 2020, MOL NEURODEGENER, V15, DOI 10.1186/s13024-020-00380-w; Lee BR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023939; Lim Y, 2011, J NEUROSCI, V31, P10076, DOI 10.1523/JNEUROSCI.0618-11.2011; Lo Bianco C, 2002, P NATL ACAD SCI USA, V99, P10813, DOI 10.1073/pnas.152339799; Luo Y, 2005, MOL CANCER THER, V4, P977, DOI 10.1158/1535-7163.MCT-05-0005; Masliah E, 2000, SCIENCE, V287, P1265, DOI 10.1126/science.287.5456.1265; McCormack AL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012122; McCormack AL, 2009, CURR PROTEIN PEPT SC, V10, P476, DOI 10.2174/138920309789351912; Mikkilineni S, 2012, PARKINSONS DIS-US, V2012, DOI 10.1155/2012/142372; Mittal S, 2017, SCIENCE, V357, P891, DOI 10.1126/science.aaf3934; Niu SQ, 2017, THERANOSTICS, V7, P344, DOI 10.7150/thno.16562; Nuber S, 2011, NEUROBIOL DIS, V44, P192, DOI 10.1016/j.nbd.2011.06.017; Okochi M, 2000, J BIOL CHEM, V275, P390, DOI 10.1074/jbc.275.1.390; Okuzumi T, 2009, NAT CHEM BIOL, V5, P484, DOI 10.1038/nchembio.183; Pagan FL, 2020, JAMA NEUROL, V77, P309, DOI 10.1001/jamaneurol.2019.4200; Paul S, 2021, ANN NEUROL, V89, P1114, DOI 10.1002/ana.26069; Paul S, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06041-3; Puschmann A, 2013, PARKINSONISM RELAT D, V19, P407, DOI 10.1016/j.parkreldis.2013.01.020; Raichur A, 2006, NEUROSCIENCE, V142, P859, DOI 10.1016/j.neuroscience.2006.06.052; Roberts HL, 2015, BIOMOLECULES, V5, P282, DOI 10.3390/biom5020282; Ruesink H, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0216764; Santini E, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000308; Scoles D. R., 2019, STAUFEN BLOCKS AUTOP, DOI [10.1101/659649, DOI 10.1101/659649]; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Sun JD, 2016, CELL MOL LIFE SCI, V73, P4303, DOI 10.1007/s00018-016-2269-z; Uehara T, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-43772-9; Vazquez-Velez GE, 2020, J NEUROSCI, V40, P459, DOI 10.1523/JNEUROSCI.1076-19.2019; Winblad B, 2010, J ALZHEIMERS DIS, V22, P1201, DOI 10.3233/JAD-2010-101311; Zhang GX, 2018, FRONT AGING NEUROSCI, V10, DOI 10.3389/fnagi.2018.00370; Zhu Z, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20030728	52	3	3	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT	2021	297	4							101191	10.1016/j.jbc.2021.101191	http://dx.doi.org/10.1016/j.jbc.2021.101191			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	WP4BY	34520759	Green Published, gold			2022-12-26	WOS:000713080600013
J	Bazydlo-Guzenda, K; Buda, P; Mach, M; Pieczykolan, J; Kozlowska, I; Janiszewski, M; Drzazga, E; Dominowski, J; Ziolkowski, H; Wieczorek, M; Gad, SC				Bazydlo-Guzenda, Katarzyna; Buda, Pawel; Mach, Mateusz; Pieczykolan, Jerzy; Kozlowska, Izabela; Janiszewski, Michal; Drzazga, Ewa; Dominowski, Jakub; Ziolkowski, Hubert; Wieczorek, Maciej; Gad, Shayne Cox			Evaluation of the hepatotoxicity of the novel GPR40 (FFAR1) agonist CPL207280 in the rat and monkey	PLOS ONE			English	Article							INDUCED LIVER-INJURY; BILE-ACID TRANSPORTERS; RECEPTOR 40 AGONIST; FASIGLIFAM TAK-875; JAPANESE PATIENTS; DOUBLE-BLIND; INSULIN-SECRETION; FATTY-ACIDS; SAFETY; DISCOVERY	GPR40 (FFAR1) is a promising target for the managing type 2 diabetes (T2D). The most advanced GPR40 agonist TAK-875 exhibited satisfactory glucose-lowering effects in phase II and III studies. However, the phase III studies of TAK-875 revealed drug-induced liver injury (DILI). It is unknown whether DILI is a consequence of a specific GPR40 agonist or is an inherent feature of all GPR40 agonists. CPL207280 is a novel GPR40 agonist that improves diabetes in Zucker Diabetic Fatty (ZDF) rats, Goto Kakizaki (GK) rats and db/db mice. In this report, the DILI-related toxicity of CPL207280 was compared directly with that of TAK-875. In vitro studies evaluating hepatic biliary transporter inhibition, mitochondrial function, and metabolic profiling were performed in hepatocytes from different species. The long term toxicity of CPL207280 was studied in vivo in rats and monkeys. Activity of CPL207280 was one order of magnitude lesser than that of TAK-875 for the inhibition of bile acid transporters. CPL207280 had a negligible effect on the hepatic mitochondria. In contrast to TAK-875, which was metabolized through toxic glucuronidation, CPL207280 was metabolized mainly through oxidation. No deleterious hepatic effects were observed in chronically treated healthy and diabetic animals. The study presents promising data on the feasibility of creating a liver-safe GPR40 agonist. Additionally, it can be concluded that DILI is not a hallmark of GPR40 agonists; it is linked to the intrinsic properties of an individual agonist.	[Bazydlo-Guzenda, Katarzyna; Buda, Pawel; Mach, Mateusz; Pieczykolan, Jerzy; Kozlowska, Izabela; Janiszewski, Michal; Drzazga, Ewa; Dominowski, Jakub; Wieczorek, Maciej] Celon Pharma SA, Innovat Drugs R&D Dept, Lomianki, Poland; [Bazydlo-Guzenda, Katarzyna] Postgrad Sch Mol Med, Warsaw, Poland; [Ziolkowski, Hubert] Univ Warmia & Mazury, Fac Vet Med, Dept Pharmacol & Toxicol, Olsztyn, Poland; [Gad, Shayne Cox] Gad Consulting Serv, Raleigh, NC USA	University of Warmia & Mazury	Buda, P (corresponding author), Celon Pharma SA, Innovat Drugs R&D Dept, Lomianki, Poland.	pawel.buda@celonpharma.com	Szewski, Mike/GRJ-4491-2022	Mach, Mateusz/0000-0003-2560-9587; Ziolkowski, Hubert/0000-0002-9314-8666	Celon Pharma SA; National Center of Research and Development grant on behalf of European Regional Development Fund [POIR.01.01.01-00-0334/17]; Ministry of Science and Higher Education [50//DW/2017/01/1]	Celon Pharma SA; National Center of Research and Development grant on behalf of European Regional Development Fund; Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland)	The study was co-financed by Celon Pharma SA and the National Center of Research and Development grant number "POIR.01.01.01-00-0334/17" (awarded: MW) on behalf of European Regional Development Fund. The funder provided support in the form of salaries for authors KB-G, PB, MM, JP, MJ, ED, IK, JD, HZ, MWbut did not have any additional role in the study design,data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section. Study was created under the contract with the Ministry of Science and Higher Education No. 50//DW/2017/01/1 as a part of the "Implementation doctorate" program (awarded: KBG). Gad Consulting Services had no role in funding of the study, SCG affiliated to it merely provided the external scientific expertise.	Ackerson T, 2019, J BIOCHEM MOL TOXIC, V33, DOI 10.1002/jbt.22345; Aleo MD, 2014, HEPATOLOGY, V60, P1015, DOI 10.1002/hep.27206; Alrefai WA, 2007, PHARM RES-DORDR, V24, P1803, DOI 10.1007/s11095-007-9289-1; [Anonymous], 2014, NAT REV DRUG DISCOV, V13, P91, DOI 10.1038/nrd4246; [Anonymous], 2010, OFF J EUR UNION, VL 276, P33; Bazydlo-Guzenda K, 2021, MOL PHARMACOL, V100, P335, DOI 10.1124/molpharm.121.000260; Bradshaw PR, 2020, DRUG DISCOV TODAY, V25, P1639, DOI 10.1016/j.drudis.2020.07.009; Briscoe CP, 2006, BRIT J PHARMACOL, V148, P619, DOI 10.1038/sj.bjp.0706770; Brown SP, 2012, ACS MED CHEM LETT, V3, P726, DOI 10.1021/ml300133f; Chen MJ, 2015, J HEPATOL, V63, P503, DOI 10.1016/j.jhep.2015.04.016; Chen XD, 2019, J DIABETES RES, V2019, DOI 10.1155/2019/5487962; Christiansen E, 2008, J MED CHEM, V51, P7061, DOI 10.1021/jm8010178; Christiansen E, 2012, J MED CHEM, V55, P6624, DOI 10.1021/jm3002026; Council N. R., 1996, GUIDE CARE USE LAB A; Dawson S, 2012, DRUG METAB DISPOS, V40, P130, DOI 10.1124/dmd.111.040758; Doshi LS, 2009, METABOLISM, V58, P333, DOI 10.1016/j.metabol.2008.10.005; El-Assaad W, 2003, ENDOCRINOLOGY, V144, P4154, DOI 10.1210/en.2003-0410; Governa P, 2021, BIOORG MED CHEM LETT, V41, DOI 10.1016/j.bmcl.2021.127969; Halilbasic E, 2013, J HEPATOL, V58, P155, DOI 10.1016/j.jhep.2012.08.002; Hamdouchi C, 2016, J MED CHEM, V59, P10891, DOI 10.1021/acs.jmedchem.6b00892; Harwood H James Jr, 2012, J Diabetes Sci Technol, V6, P503; Hendriks DFG, 2016, SCI REP-UK, V6, DOI 10.1038/srep35434; Ito R, 2013, BRIT J PHARMACOL, V170, P568, DOI 10.1111/bph.12297; Jain MR, 2018, DIABETES, V67, DOI 10.2337/db18-1194-P; Kaku K, 2016, DIABETES OBES METAB, V18, P925, DOI 10.1111/dom.12693; Kaku K, 2015, DIABETES OBES METAB, V17, P675, DOI 10.1111/dom.12467; Kaku K, 2013, DIABETES CARE, V36, P245, DOI 10.2337/dc12-0872; KIM DOO-YOUNG, 2017, INT DIABETES FEDERAT, DOI [10.26226/morressier.59d51844d462b80296ca38ad, DOI 10.26226/MORRESSIER.59D51844D462B80296CA38AD]; Kock K, 2012, CLIN PHARMACOL THER, V92, P599, DOI 10.1038/clpt.2012.79; Kogame A, 2019, DRUG METAB DISPOS, V47, P525, DOI 10.1124/dmd.118.084889; Kogame A, 2019, XENOBIOTICA, V49, P433, DOI 10.1080/00498254.2018.1453100; Krug AW, 2017, CTS-CLIN TRANSL SCI, V10, P404, DOI 10.1111/cts.12479; Lai E, 2008, AM J PHYSIOL-ENDOC M, V294, pE540, DOI 10.1152/ajpendo.00478.2007; Leifke E, 2012, CLIN PHARMACOL THER, V92, P29, DOI 10.1038/clpt.2012.43; Li Z, 2020, EXPERT OPIN THER PAT, V30, P27, DOI 10.1080/13543776.2020.1698546; Lin DCH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027270; Longo DM, 2019, TOXICOL SCI, V167, P458, DOI 10.1093/toxsci/kfy253; Mancini AD, 2013, TRENDS ENDOCRIN MET, V24, P398, DOI 10.1016/j.tem.2013.03.003; Marcinak JF, 2018, DRUG SAFETY, V41, P625, DOI 10.1007/s40264-018-0642-6; Matloka M., 2019, PCT Patent Application, Patent No. [2019/134984 A1, 2019134984]; Naik H, 2012, J CLIN PHARMACOL, V52, P1007, DOI 10.1177/0091270011409230; Nair Anroop B, 2016, J Basic Clin Pharm, V7, P27, DOI 10.4103/0976-0105.177703; Negoro N, 2010, ACS MED CHEM LETT, V1, P290, DOI 10.1021/ml1000855; Otieno MA, 2018, TOXICOL SCI, V163, P374, DOI 10.1093/toxsci/kfx040; Panse M, 2015, CELL PHYSIOL BIOCHEM, V35, P1537, DOI 10.1159/000373969; Rani L, 2021, MINI-REV MED CHEM, V21, P426, DOI 10.2174/1389557520666201023141326; Sawamura R, 2010, DRUG METAB DISPOS, V38, P1857, DOI 10.1124/dmd.110.034173; Schuetz JD, 2014, DRUG METAB DISPOS, V42, P541, DOI 10.1124/dmd.114.057539; Segawa M, 2018, J TOXICOL SCI, V43, P339, DOI 10.2131/jts.43.339; Shang J, 2020, CHEM RES TOXICOL, V33, P191, DOI 10.1021/acs.chemrestox.9b00226; Staup M, 2016, JOVE-J VIS EXP, DOI 10.3791/52895; Tanaka H, 2013, J PHARMACOL EXP THER, V346, P443, DOI 10.1124/jpet.113.206466; Tujios S, 2011, NAT REV GASTRO HEPAT, V8, P202, DOI 10.1038/nrgastro.2011.22; Urano Y, 2018, CHEM-BIOL INTERACT, V296, P185, DOI 10.1016/j.cbi.2018.09.011; Walles M, 2020, CHEM RES TOXICOL, V33, P1551, DOI 10.1021/acs.chemrestox.0c00131; Wang YC, 2013, ACS MED CHEM LETT, V4, P551, DOI 10.1021/ml300427u; Watkins PB, 2011, CLIN PHARMACOL THER, V89, P788, DOI 10.1038/clpt.2011.63; Weaver RJ, 2020, NAT REV DRUG DISCOV, V19, P131, DOI 10.1038/s41573-019-0048-x; Wolenski FS, 2017, TOXICOL SCI, V157, P50, DOI 10.1093/toxsci/kfx018	59	1	1	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2021	16	9							e0257477	10.1371/journal.pone.0257477	http://dx.doi.org/10.1371/journal.pone.0257477			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XH8RH	34555055	Green Published, gold			2022-12-26	WOS:000725694500039
J	Schulz, J; Bauer, I; Herminghaus, A; Picker, O; Truse, R; Vollmer, C				Schulz, Jan; Bauer, Inge; Herminghaus, Anna; Picker, Olaf; Truse, Richard; Vollmer, Christian			Sub-therapeutic vasopressin but not therapeutic vasopressin improves gastrointestinal microcirculation in septic rats: A randomized, placebo-controlled, blinded trial	PLOS ONE			English	Article							V-1A RECEPTORS MEDIATE; ARGININE-VASOPRESSIN; MICROVASCULAR OXYGENATION; MUCOSAL MICROCIRCULATION; SPLANCHNIC HEMODYNAMICS; SEPSIS; SHOCK; HYPERCAPNIA; GUT; PERFUSION	Introduction Sepsis impairs gastrointestinal microcirculation and it is hypothesized that this might increase patient's mortality. Sub-therapeutic vasopressin improves gastric microcirculation under physiologic conditions whereas a therapeutic dosing regimen seems to be rather detrimental. However, the effects of sub-therapeutic vasopressin on gastrointestinal microcirculation in sepsis are largely unknown. Therefore, we conducted this trial to investigate the effect of sub-therapeutic as well as therapeutic vasopressin on gastrointestinal microcirculation in sepsis. Methods 40 male Wistar rats were randomized into 4 groups. Colon ascendens stent peritonitis (CASP)-surgery was performed to establish mild or moderate sepsis. 24 hours after surgery, animals received either vasopressin with increasing dosages every 30 min (6.75, 13.5 (sub-therapeutic), 27 mU . kg(-1) . h(-1) (therapeutic)) or vehicle. Microcirculatory oxygenation (mu HBO2) of the colon was recorded for 90 min using tissue reflectance spectrophotometry. Intestinal microcirculatory perfusion (total vessel density (TVD; mm/mm(2)) and perfused vessel density (PVD; mm/mm(2))) were measured using incident dark field-Imaging at baseline and after 60 min. Results In mild as well as in moderate septic animals with vehicle-infusion intestinal mu HbO(2), TVD and PVD remained constant. In contrast, in moderate sepsis, sub-therapeutic vasopressin with 13.5 mU . kg(-1) . h(-1) elevated intestinal mu HBO2 (+ 6.1 5.3%; p < 0.05 vs. baseline) and TVD (+ 5.2 +/- 3.0 mm/mm(2); p < 0.05 vs. baseline). mu HBO2, TVD and PVD were significantly increased compared to moderate sepsis alone. However, therapeutic vasopressin did not change intestinal microcirculation. In mild septic animals sub-therapeutic as well as therapeutic vasopressin had no relevant effect on gastrointestinal microcirculation. Systemic blood pressure remained constant in all groups. Conclusion Sub-therapeutic vasopressin improves gastrointestinal microcirculatory oxygenation in moderate sepsis without altering systemic blood pressure. This protective effect seems to be mediated by an enhanced microcirculatory perfusion and thereby increased oxygen supply. In contrast, therapeutic vasopressin did not show this beneficial effect.	[Schulz, Jan; Bauer, Inge; Herminghaus, Anna; Picker, Olaf; Truse, Richard; Vollmer, Christian] Univ Hosp Duesseldorf, Dept Anesthesiol, Dusseldorf, North Rhine Wes, Germany		Schulz, J (corresponding author), Univ Hosp Duesseldorf, Dept Anesthesiol, Dusseldorf, North Rhine Wes, Germany.	Jan.Schulz@med.uni-duesseldorf.de						Asfar P, 2003, CRIT CARE MED, V31, P215, DOI 10.1097/00003246-200301000-00033; Asfar P, 2008, BEST PRACT RES-CLIN, V22, P351, DOI 10.1016/j.bpa.2008.02.009; Assimakopoulos SF, 2018, INFECTION, V46, P751, DOI 10.1007/s15010-018-1178-5; Aykut Guclu, 2015, Intensive Care Med Exp, V3, P40, DOI 10.1186/s40635-015-0040-7; Bludau M, 2008, DIS ESOPHAGUS, V21, P668, DOI 10.1111/j.1442-2050.2008.00856.x; Bomberg H, 2019, J SURG RES, V235, P410, DOI 10.1016/j.jss.2018.10.028; Carsetti A, 2017, J CLIN MONIT COMPUT, V31, P669, DOI 10.1007/s10877-016-9928-3; Clark JA, 2007, SHOCK, V28, P384, DOI 10.1097/shk.0b013e31805569df; De Backer D, 2021, CURR OPIN ANESTHESIO, V34, P85, DOI 10.1097/ACO.0000000000000957; De Backer D, 2014, VIRULENCE, V5, P73, DOI 10.4161/viru.26482; De Backer D, 2013, CRIT CARE MED, V41, P791, DOI 10.1097/CCM.0b013e3182742e8b; FORSLING ML, 1975, J ENDOCRINOL, V67, pP62; Forst Thomas, 2008, J Diabetes Sci Technol, V2, P1151; Hawiger J, 2015, J THROMB HAEMOST, V13, P1743, DOI 10.1111/jth.13061; Herminghaus A, 2015, MITOCHONDRION, V24, P122, DOI 10.1016/j.mito.2015.08.001; Herminghaus A, 2019, INTENS CARE MED EXP, V7, DOI 10.1186/s40635-018-0219-9; Hessler M, 2016, BEST PRAC RES-CL ANA, V30, P465, DOI 10.1016/j.bpa.2016.10.010; Hiltebrand LB, 2007, ANESTHESIOLOGY, V106, P1156, DOI 10.1097/01.anes.0000267599.02140.86; Hoyle CHV, 1999, BRAIN RES, V848, P1, DOI 10.1016/S0006-8993(99)01975-7; Hua TF, 2018, SHOCK, V49, P591, DOI 10.1097/SHK.0000000000000954; Ince C, 2018, INTENS CARE MED, V44, P281, DOI 10.1007/s00134-018-5070-7; Klein KU, 2010, J NEUROSURG ANESTH, V22, P38, DOI 10.1097/ANA.0b013e3181bea439; Klijn E, 2008, CLIN CHEST MED, V29, P643, DOI 10.1016/j.ccm.2008.06.008; Klinzing S, 2011, ANESTHESIOLOGY, V114, P1396, DOI 10.1097/ALN.0b013e318219d74f; Knotzer H, 2006, INTENS CARE MED, V32, P170, DOI 10.1007/s00134-005-2858-z; Landry DW, 1997, CIRCULATION, V95, P1122; Lee YC, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20071678; Lelubre C, 2018, NAT REV NEPHROL, V14, P417, DOI 10.1038/s41581-018-0005-7; Lustig MK, 2007, SHOCK, V28, P59, DOI 10.1097/SHK.0b013e31802e454f; Martikainen TJ, 2003, ANESTH ANALG, V97, P1756, DOI 10.1213/01.ANE.0000087039.60041.2E; Massey MJ, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1213-9; Massey MJ, 2013, J CRIT CARE, V28, P913, DOI 10.1016/j.jcrc.2013.06.015; Mayer K, 2016, CURR OPIN CRIT CARE, V22, P437, DOI 10.1097/MCC.0000000000000336; Morisaki H, 2009, INTENS CARE MED, V35, P129, DOI 10.1007/s00134-008-1212-7; PHILBIN DM, 1970, ANESTHESIOLOGY, V33, P345, DOI 10.1097/00000542-197009000-00016; Qiu XH, 2014, J SURG RES, V188, P503, DOI 10.1016/j.jss.2014.01.053; Rhodes A, 2017, CRIT CARE MED, V45, P486, DOI 10.1097/CCM.0000000000002255; Russell JA, 2008, NEW ENGL J MED, V358, P877, DOI 10.1056/NEJMoa067373; Russell JA, 2017, CRIT CARE MED, V45, P940, DOI 10.1097/CCM.0000000000002323; SAWYER WH, 1974, ENDOCRINOLOGY, V94, P1106, DOI 10.1210/endo-94-4-1106; Schoneborn S, 2016, MICROVASC RES, V106, P24, DOI 10.1016/j.mvr.2016.03.002; Schulz J, 2018, SHOCK, V49, P326, DOI 10.1097/SHK.0000000000000920; Siegemund M, 1999, INTENS CARE MED, V25, P1044, DOI 10.1007/s001340051011; Stubs CCM, 2013, MICROVASC RES, V90, P180, DOI 10.1016/j.mvr.2013.07.008; Sturm T, 2018, J INTENSIVE CARE MED, V33, P256, DOI 10.1177/0885066616671689; Treschan TA, 2006, ANESTHESIOLOGY, V105, P599, DOI 10.1097/00000542-200609000-00026; Truse R, 2019, CRIT CARE, V23, DOI 10.1186/s13054-019-2643-y; Truse R, 2017, J VASC RES, V54, P109, DOI 10.1159/000464262; Trzeciak S, 2008, INTENS CARE MED, V34, P2210, DOI 10.1007/s00134-008-1193-6; van Haren FMP, 2003, CHEST, V124, P2256, DOI 10.1378/chest.124.6.2256; Vollmer C, 2013, J ENDOCRINOL, V217, P59, DOI 10.1530/JOE-12-0526; Westphal M, 2004, CRIT CARE MED, V32, P194, DOI 10.1097/01.CCM.0000104201.62736.12; Yeh YC, 2016, ANESTHESIOLOGY, V125, P355, DOI 10.1097/ALN.0000000000001135	53	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2021	16	9							e0257034	10.1371/journal.pone.0257034	http://dx.doi.org/10.1371/journal.pone.0257034			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XH8RH	34555053	gold, Green Published			2022-12-26	WOS:000725694500017
J	Stephens, Z; O'Brien, D; Dehankar, M; Roberts, LR; Iyer, RK; Kocher, JP				Stephens, Zachary; O'Brien, Daniel; Dehankar, Mrunal; Roberts, Lewis R.; Iyer, Ravishankar K.; Kocher, Jean-Pierre			Exogene: A performant workflow for detecting viral integrations from paired-end next-generation sequencing data	PLOS ONE			English	Article							HEPATITIS-B-VIRUS; EPSTEIN-BARR-VIRUS; HEPATOCELLULAR-CARCINOMA; BURKITTS-LYMPHOMA; GENE; DNA	The integration of viruses into the human genome is known to be associated with tumorigenesis in many cancers, but the accurate detection of integration breakpoints from short read sequencing data is made difficult by human-viral homologies, viral genome heterogeneity, coverage limitations, and other factors. To address this, we present Exogene, a sensitive and efficient workflow for detecting viral integrations from paired-end next generation sequencing data. Exogene's read filtering and breakpoint detection strategies yield integration coordinates that are highly concordant with long read validation. We demonstrate this concordance across 6 TCGA Hepatocellular carcinoma (HCC) tumor samples, identifying integrations of hepatitis B virus that are also supported by long reads. Additionally, we applied Exogene to targeted capture data from 426 previously studied HCC samples, achieving 98.9% concordance with existing methods and identifying 238 high-confidence integrations that were not previously reported. Exogene is applicable to multiple types of paired-end sequence data, including genome, exome, RNA-Seq and targeted capture.	[Stephens, Zachary; Iyer, Ravishankar K.] Univ Illinois, Dept Elect & Comp Engn, Urbana, IL USA; [O'Brien, Daniel; Dehankar, Mrunal; Kocher, Jean-Pierre] Mayo Clin, Dept Hlth Sci Res, Rochester, MN 55905 USA; [Roberts, Lewis R.] Mayo Clin, Dept Internal Med, Rochester, MN USA	University of Illinois System; University of Illinois Urbana-Champaign; Mayo Clinic; Mayo Clinic	Kocher, JP (corresponding author), Mayo Clin, Dept Hlth Sci Res, Rochester, MN 55905 USA.	kocher.jeanpierre@mayo.edu		Roberts, Lewis/0000-0001-7885-8574	Mayo Clinic Center for Individualized Medicine	Mayo Clinic Center for Individualized Medicine	This study was funded by the Mayo Clinic Center for Individualized Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azam F, 2008, ANN HEPATOL, V7, P125, DOI 10.1016/S1665-2681(19)31867-8; Baheti S, 2018, BMC BIOINFORMATICS, V19, DOI 10.1186/s12859-018-2260-9; Chen X, 2019, BRIEF BIOINFORM, V20, P2088, DOI 10.1093/bib/bby070; Daibata M, 1998, BRIT J HAEMATOL, V102, P1307, DOI 10.1046/j.1365-2141.1998.00903.x; Derse D, 2007, J VIROL, V81, P6731, DOI 10.1128/JVI.02752-06; Fan H, 2007, P NATL ACAD SCI USA, V104, P1449, DOI 10.1073/pnas.0610912104; GULLEY ML, 1992, CANCER, V70, P185, DOI 10.1002/1097-0142(19920701)70:1<185::AID-CNCR2820700129>3.0.CO;2-J; Hayer J, 2013, NUCLEIC ACIDS RES, V41, pD566, DOI 10.1093/nar/gks1022; HENLE G, 1969, J NATL CANCER I, V43, P1147; Ho DWH, 2015, ONCOTARGET, V6, P20959, DOI 10.18632/oncotarget.4187; Jiang ZS, 2012, GENOME RES, V22, P593, DOI 10.1101/gr.133926.111; Leinonen R, 2011, NUCLEIC ACIDS RES, V39, pD19, DOI 10.1093/nar/gkq1019; Li H, 2018, BIOINFORMATICS, V34, P3094, DOI 10.1093/bioinformatics/bty191; Li WY, 2013, GENOMICS, V102, P338, DOI 10.1016/j.ygeno.2013.07.002; MINCHEVA A, 1987, MED MICROBIOL IMMUN, V176, P245, DOI 10.1007/bf00190531; Morgulis A, 2006, J COMPUT BIOL, V13, P1028, DOI 10.1089/cmb.2006.13.1028; Nault JC, 2016, CLIN RES HEPATOL GAS, V40, P9, DOI 10.1016/j.clinre.2015.07.006; Nonoyama M, 1975, Bibl Haematol, P577; Pagano JS, 2004, SEMIN CANCER BIOL, V14, P453, DOI 10.1016/j.semcancer.2004.06.009; Popescu NC, 2002, J CELL MOL MED, V6, P151, DOI 10.1111/j.1582-4934.2002.tb00183.x; Saigo K, 2008, HUM MUTAT, V29, P703, DOI 10.1002/humu.20701; Sulovari A, 2020, GENOMICS, V112, P207, DOI 10.1016/j.ygeno.2019.01.015; Syrjanen S, 2005, J CLIN VIROL, V32, pS59, DOI 10.1016/j.jcv.2004.11.017; Tamori A, 2005, CLIN CANCER RES, V11, P5821, DOI 10.1158/1078-0432.CCR-04-2055; Tennakoon C, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1470-x; Toh TB, 2019, CLIN TRANSL MED, V8, DOI 10.1186/s40169-019-0230-0; Tsuchiya H, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20225714; Wang X., 2019, HKU THESES ONLINE HK; White MK, 2014, CLIN MICROBIOL REV, V27, P463, DOI 10.1128/CMR.00124-13; Xia YC, 2019, BMC MED GENOMICS, V12, DOI 10.1186/s12920-018-0461-8; Zhao LH, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12992	31	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2021	16	9							e0250915	10.1371/journal.pone.0250915	http://dx.doi.org/10.1371/journal.pone.0250915			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YS4WS	34550971	gold, Green Submitted, Green Published			2022-12-26	WOS:000750679800002
J	Abramovich, A; Pang, N; Moss, A; Logie, CH; Chaiton, M; Kidd, SA; Hamilton, HA				Abramovich, Alex; Pang, Nelson; Moss, Amanda; Logie, Carmen H.; Chaiton, Michael; Kidd, Sean A.; Hamilton, Hayley A.			Investigating the impacts of COVID-19 among LGBTQ2S youth experiencing homelessness	PLOS ONE			English	Article							MIXED METHODS RESEARCH; TRANSGENDER YOUTH; MENTAL-HEALTH; METHODOLOGY; DISORDER; CARE	Background LGBTQ2S youth are overrepresented among youth experiencing homelessness and experience significantly higher rates of mental health issues compared to heterosexual and cis-gender youth. COVID-19 related challenges for LGBTQ2S youth experiencing homelessness remain unknown. To address this gap, this study aimed to understand the impacts of the COVID-19 pandemic on LGBTQ2S youth at risk of, and experiencing, homelessness in the Greater Toronto Area, Ontario, Canada and surrounding areas. Methods Utilizing a mixed-methods convergent parallel design, LGBTQ2S youth experiencing homelessness were recruited to participate in virtual surveys and in-depth one-on-one interviews. Surveys included standardized measures and were administered to measure mental health outcomes and collect information on demographic characteristics, and health service use. Survey data were analyzed with descriptive statistics and statistical tests for difference of proportions. Interviews were analyzed using an iterative thematic content approach. Results Sixty-one youth completed surveys and 20 youth participated in one-on-one interviews. Quantitative and qualitative data showed that youth have been significantly impacted by the COVID-19 pandemic in various ways, including experiencing poor mental health, such as suicidality, depression, anxiety, and increased substance use, and lack of access to health and social support services. Conclusion Our study highlights the need for LGBTQ2S inclusive and affirming health care and support services for precariously housed adolescents to address the pre-existing social and health issues that have been exacerbated by the pandemic.	[Abramovich, Alex; Pang, Nelson; Moss, Amanda; Chaiton, Michael; Hamilton, Hayley A.] Ctr Addict & Mental Hlth, Inst Mental Hlth Policy Res, Toronto, ON, Canada; [Abramovich, Alex; Chaiton, Michael; Hamilton, Hayley A.] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Logie, Carmen H.] Univ Toronto, Factor Inwentash Fac Social Work, Toronto, ON, Canada; [Logie, Carmen H.] Womens Coll Hosp, Womens Coll Res Inst, Toronto, ON, Canada; [Kidd, Sean A.] Univ Toronto, Dept Psychiat, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Womens College Hospital; University of Toronto	Abramovich, A (corresponding author), Ctr Addict & Mental Hlth, Inst Mental Hlth Policy Res, Toronto, ON, Canada.; Abramovich, A (corresponding author), Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada.	Alex.Abramovich@camh.ca	Pang, Nelson/GQA-4907-2022	Abramovich, Alex/0000-0002-4803-8724; Chaiton, Michael/0000-0002-9589-2122; Pang, Nelson/0000-0002-6399-8272	Making the Shift (MtS) Network of Centres of Excellence;  [R900206526]	Making the Shift (MtS) Network of Centres of Excellence; 	Funding for this research study was provided by Making the Shift (MtS) Network of Centres of Excellence (https://makingtheshiftinc.ca/ ). AA was awarded this 2020 MtS COVID-19 targeted call, Grant #R900206526. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramovich A, 2016, SOC INCL, V4, P86, DOI 10.17645/si.v4i4.669; Abramovich Alex, 2017, AM GOING GO INTERSEC; Abramovich IA, 2012, CAN J FAM YOUTH, V4, P29, DOI 10.29173/cjfy16579; [Anonymous], 2020, LANCET INFECT DIS, V20, P1217, DOI 10.1016/S1473-3099(20)30797-0; [Anonymous], 2020, LANCET PSYCHIAT, V7, P463, DOI 10.1016/S2215-0366(20)30194-2; [Anonymous], 2000, OTT GLBT WELLN LIT R; Attride-Stirling J, 2001, QUAL RES, V1, P385, DOI DOI 10.1177/146879410100100307; Bandini E, 2013, J SEX MED, V10, P1012, DOI 10.1111/jsm.12062; Bauer GR, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1867-2; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Buchnea A., 2020, SUMMARY REPORT YOUTH; Canadian Observatory on Homelessness, CAN DEF YOUTH HOM; Castro FG, 2010, J MIX METHOD RES, V4, P342, DOI 10.1177/1558689810382916; Choi S.K., 2015, SERVING OUR YOUTH 20; Cleverley K, 2011, J ADOLESCENCE, V34, P1049, DOI 10.1016/j.adolescence.2010.11.003; Connolly MD, 2016, J ADOLESCENT HEALTH, V59, P489, DOI 10.1016/j.jadohealth.2016.06.012; Creswell J.W., 2003, HDB MIXED METHODS SO, V209, P209, DOI DOI 10.4135/9781506335193; de Vries ALC, 2011, J CHILD PSYCHOL PSYC, V52, P1195, DOI 10.1111/j.1469-7610.2011.02426.x; DeMulder J, 2020, SEX REPROD HLTH MATT, V28, DOI 10.1080/26410397.2020.1804717; Durso L.E., 2012, SERVING OUR YOUTH FI; Egale, 2020, IMP COVID 19 CAN LGB; EWING JA, 1984, JAMA-J AM MED ASSOC, V252, P1905, DOI 10.1001/jama.252.14.1905; Fish JN, 2020, J ADOLESCENT HEALTH, V67, P450, DOI 10.1016/j.jadohealth.2020.06.002; Fraser B, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16152677; Gadermann AC, 2021, BMJ OPEN, V11, DOI 10.1136/bmjopen-2020-042871; Gaetz S, 2012, CANADIAN DEFINITION; Green AE., 2020, IMPLICATIONS COVID 1; Harris PA, 2019, J BIOMED INFORM, V95, DOI 10.1016/j.jbi.2019.103208; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Johnson GA, 2017, SOC SCI MED, V189, P63, DOI 10.1016/j.socscimed.2017.07.029; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Lewinsohn PM, 1996, CLIN PSYCHOL-SCI PR, V3, P25, DOI 10.1111/j.1468-2850.1996.tb00056.x; Moyer DN, 2019, J PEDIATR ENDOCR MET, V32, P71, DOI 10.1515/jpem-2018-0408; Nguyen HB, 2018, CURR PSYCHIAT REP, V20, DOI 10.1007/s11920-018-0973-0; Olson J, 2015, J ADOLESCENT HEALTH, V57, P374, DOI 10.1016/j.jadohealth.2015.04.027; Prokopenko E., 2020, VULNERABILITIES RELA; Public Health Agency of Canada, 2020, GUID PROV SERV PEOPL; R Core Team, 2021, R LANGUAGE ENV STAT; Reisner SL, 2015, J ADOLESCENT HEALTH, V56, P274, DOI 10.1016/j.jadohealth.2014.10.264; Rolfe S, 2020, BMC PUBLIC HEALTH, V20, DOI 10.1186/s12889-020-09224-0; Saewyc E, 2016, 2341278X U BRIT COL; Sanchez TH, 2020, AIDS BEHAV, V24, P2024, DOI 10.1007/s10461-020-02894-2; Schoonenboom J, 2017, KOLNER Z SOZIOL SOZ, V69, P107, DOI 10.1007/s11577-017-0454-1; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; Taliaferro LA, 2019, ARCH SUICIDE RES, V23, P203, DOI 10.1080/13811118.2018.1430639; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Veale JF, 2017, J ADOLESCENT HEALTH, V60, P44, DOI 10.1016/j.jadohealth.2016.09.014; Williams AJ, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0245268; Williams Nerys, 2014, Occup Med (Lond), V64, P473, DOI 10.1093/occmed/kqu058	49	10	10	3	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2021	16	9							e0257693	10.1371/journal.pone.0257693	http://dx.doi.org/10.1371/journal.pone.0257693			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	YM4DR	34547037	Green Published, gold			2022-12-26	WOS:000746527400035
J	Quaye, T; Narkwa, PW; Domfeh, SA; Kattah, G; Mutocheluh, M				Quaye, Theophilus; Narkwa, Patrick Williams; Domfeh, Seth A.; Kattah, Gloria; Mutocheluh, Mohamed			Immunosurveillance and molecular detection of hepatitis B virus infection amongst vaccinated children in the West Gonja District in Savanna Region of Ghana	PLOS ONE			English	Article							IMMUNITY; PROTECTION; EGYPT	Hepatitis B vaccination is the most effective preventive measure in reducing the incidence of chronic hepatitis B virus (HBV) infection and its consequences such as cirrhosis, hepatocellular carcinoma, liver failure and death. Ghana introduced the universal HBV vaccination in the national Expanded Programme on Immunization in 2002. The current study sought to determine the sero-protection rate and the prevalence of HBV infection among fully vaccinated children in the West Gonja District in the Savanna Region of Ghana. This cross-sectional study recruited three hundred and fifty (350) fully vaccinated children who visited West Gonja Catholic Hospital from September to December 2019 for healthcare. Structured questionnaires were administered to obtain information on the demographics. The clinical history of the participants was obtained from the hospital records. Sera were separated from 2-5ml of blood sample collected from each participant after informed consent had been sought from their parents/guardians. Sera were tested for HBsAg, anti-HBs and anti-HBc using ELISA. Samples positive for HBsAg or anti-HBc were tested for HBV DNA by Real-Time Polymerase Chain Reaction. The overall sero-protection rate (anti-HBs titers >= 10 mIU/mL) among the studied participants was 56% with anti-HBs geometric mean titer (GMT) of 95.7 mIU/mL (+/- 6.0; 95% CI) compared with GMT of 2.8 mIU/mL (+/- 0.2; 95% CI) among non-seroprotected participants. There was no statistically significant difference in sero-protection rate between males and females (p-value = 0.93) and in relation to age (p-value = 0.20). The prevalence of HBV infection among studied participants as determined by the HBV DNA/HBsAg positivity was 1.4% while anti-HBc sero-positivity was 2%. Even though the sero-protection rate and HBV infection rate reported in the current study compares with that of other international studies further studies need to be conducted to understand the factors related to sero-protection and HBV infection rate in the Savanna Region of Ghana.	[Quaye, Theophilus; Narkwa, Patrick Williams; Kattah, Gloria; Mutocheluh, Mohamed] Kwame Nkrumah Univ Sci & Technol, Sch Med & Dent, Dept Clin Microbiol, Kumasi, Ghana; [Domfeh, Seth A.] Univ Ghana, Dept Biochem Cell & Mol Biol, Sch Biol Sci, Legon, Accra, Ghana; [Domfeh, Seth A.] Univ Ghana, West African Ctr Cell Biol Infect Pathogens, Legon, Accra, Ghana; [Kattah, Gloria] Radford Univ Coll, Dept Med Lab Technol, Accra, Ghana	Kwame Nkrumah University Science & Technology; University of Ghana; University of Ghana	Narkwa, PW (corresponding author), Kwame Nkrumah Univ Sci & Technol, Sch Med & Dent, Dept Clin Microbiol, Kumasi, Ghana.	pnarkwa.chs@knust.edu.gh		Kattah, Gloria/0000-0003-1982-7246; Narkwa, Patrick/0000-0003-2490-7902; Agyei Domfeh, Seth/0000-0002-1689-7663				Abhijit Guho, 2010, Journal of Medicine, V11, P143; Afifi S. S., 2009, Australian Journal of Basic and Applied Sciences, V3, P3239; [Anonymous], 2011, GHAN STAT SERV POP H; Apiung Thomas, 2017, Ghana Med J, V51, P13, DOI 10.4314/gmj.v51i1.3; Dahifar H., 2004, ARCH IRAN MED, V7, P89; Dionne-Odom J, 2018, CLIN THER, V40, P1255, DOI 10.1016/j.clinthera.2018.05.016; El Sherbini A, 2006, AM J INFECT CONTROL, V34, P600, DOI 10.1016/j.ajic.2005.12.018; El-Sayed B., 2009, ZAGAZIG J OCCUP HLTH, V2, P17; Hammitt LL, 2007, VACCINE, V25, P6958, DOI 10.1016/j.vaccine.2007.06.059; Kolev G., 2022, GLOBAL VALUE CHAINS; Mele A, 2001, J INFECT DIS, V184, P905, DOI 10.1086/323396; Mutocheluh Mohamed, 2014, BMC Res Notes, V7, P873, DOI 10.1186/1756-0500-7-873; Odusanya OO, 2011, HUM VACCINES, V7, P625, DOI 10.4161/hv.7.6.14990; Ofori-Asenso R, 2016, BMC INFECT DIS, V16, DOI 10.1186/s12879-016-1467-5; Puvacic Sandra, 2005, Bosn J Basic Med Sci, V5, P50; Reda AA, 2003, EUR J EPIDEMIOL, V18, P1007, DOI 10.1023/A:1025805817101; Ribeiro Tereza Monteiro, 2006, Clinics, V61, P387, DOI 10.1590/S1807-59322006000500004; Salama II, 2015, WORLD J HEPATOL, V7, P2418, DOI 10.4254/wjh.v7.i22.2418; Shaaban F. A., 2007, Eastern Mediterranean Health Journal, V13, P750; Soliman A. G. A., 2013, The Journal of American Science, V9, P404; Stanaway JD, 2016, LANCET, V388, P1081, DOI 10.1016/S0140-6736(16)30579-7; Su FH, 2007, VACCINE, V25, P8085, DOI 10.1016/j.vaccine.2007.09.013; TILZEY AJ, 1995, LANCET, V345, P1000, DOI 10.1016/S0140-6736(95)90751-3; Tsebe KV, 2001, VACCINE, V19, P3919, DOI 10.1016/S0264-410X(01)00120-7; WAINWRIGHT RB, 1991, ARCH INTERN MED, V151, P1634, DOI 10.1001/archinte.151.8.1634; World Health Organization, 2015, GUIDELINES PREVENTIO, P166; Wu WS, 2005, CHIN J VACCINES IMMU, V11, P276; Yazdanpanah B, 2010, HEPAT MON, V10, P17; Yuen MF, 2011, J GASTROEN HEPATOL, V26, P138, DOI 10.1111/j.1440-1746.2010.06545.x	29	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2021	16	9							e0257103	10.1371/journal.pone.0257103	http://dx.doi.org/10.1371/journal.pone.0257103			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	WG5ZQ	34534234	gold, Green Published			2022-12-26	WOS:000707073300019
J	Yanaso, S; Phrutivorapongkul, A; Hongwiset, D; Piyamongkol, S; Intharuksa, A				Yanaso, Suthira; Phrutivorapongkul, Ampai; Hongwiset, Darunee; Piyamongkol, Sirivipa; Intharuksa, Aekkhaluck			Verification of Thai ethnobotanical medicine "Kamlang Suea Khrong" driven by multiplex PCR and powerful TLC techniques	PLOS ONE			English	Article							AUTHENTICATION; PLANTS; IDENTIFICATION	Kamlang Suea Khrong (KSK) crude drug, a traditional Thai medicine used for oral tonic and analgesic purposes, is obtained from three origins: the inner stem bark of Betula alnoides (BA) or the stems of Strychnos axillaris (SA) or Ziziphus attopensis (ZA). According to the previous reports, SA contains strychnine-type alkaloids that probably cause poisoning; however, only organoleptic approaches are insufficient to differentiate SA from the other plant materials. To ensure the botanical origin of KSK crude drug, powerful and reliable tools are desperately needed. Therefore, molecular and chemical identification methods, DNA barcoding and thin-layer chromatography (TLC), were investigated. Reference databases, i.e., the ITS region and phytochemical profile of the authentic plant species, were conducted. In case of molecular analysis, multiplex polymerase chain reaction (PCR) based on species-specific primers was applied. Regarding species-specific primers designation, the suitability of three candidate barcode regions (ITS, ITS1, and ITS2) was evaluated by genetic distance using K2P model. ITS2 presented the highest interspecific variability was verified its discrimination power by tree topology. Accordingly, ITS2 was used to create primers that successfully specified plant species of authentic samples. For chemical analysis, TLC with toluene:ethyl acetate:ammonia (1:9:0.025) and hierarchical clustering were operated to identify the authentic crude drugs. The developed multiplex PCR and TLC methods were then applied to identify five commercial KSK crude drugs (CK1-CK5). Both methods correspondingly indicated that CK1-CK2 and CK3-CK5 were originated from BA and ZA, respectively. Molecular and chemical approaches are convenient and effective identification methods that can be performed for the routine quality-control of the KSK crude drugs for consumer reliance. According to chemical analysis, the results indicated BA, SA, and ZA have distinct chemical profiles, leading to differences in pharmacological activities. Consequently, further scientific investigations are required to ensure the quality and safety of Thai ethnobotanical medicine known as KSK.	[Yanaso, Suthira; Phrutivorapongkul, Ampai; Hongwiset, Darunee; Piyamongkol, Sirivipa; Intharuksa, Aekkhaluck] Chiang Mai Univ, Fac Pharm, Dept Pharmaceut Sci, Chiang Mai, Thailand; [Yanaso, Suthira] Huachiew Chalermprakiet Univ, Fac Pharmaceut Sci, Dept Pharmaceut Chem & Pharmacognosy, Bang Phli, Samutprakan, Thailand	Chiang Mai University	Intharuksa, A (corresponding author), Chiang Mai Univ, Fac Pharm, Dept Pharmaceut Sci, Chiang Mai, Thailand.	identity.int@gmail.com			Faculty of Pharmacy, Chiang Mai University; Chiang Mai University, Thailand	Faculty of Pharmacy, Chiang Mai University; Chiang Mai University, Thailand	This study was carried out with the support of the "Research Fund for Fiscal Year 2019", Faculty of Pharmacy, Chiang Mai University and the "Teaching Assistant and Research Assistant Scholarships for the Academic Year 2018-2020", Chiang Mai University, Thailand.	Abubakar BM, 2017, EVID-BASED COMPL ALT, V2017, DOI 10.1155/2017/1352948; Achava-Amrung P, 2018, HERBAL VOCABULARY, V2002, P14; Ali MA., 2015, APPL PLANT DNA BARCO, P109; Balslav H, 2020, FLORA THAILAND 4, V14, P511; Bele AA, 2011, INT J PHARM SCI RES, V2, P256, DOI 10.13040/IJPSR.0975-8232.2(2).256-67; Chaniad P, 2019, EVID-BASED COMPL ALT, V2019, DOI 10.1155/2019/2324679; Cheng T, 2016, MOL ECOL RESOUR, V16, P138, DOI 10.1111/1755-0998.12438; Chiou SJ, 2007, PLANTA MED, V73, P1421, DOI 10.1055/s-2007-990227; Chuang LY, 2013, BIOTECHNOL LETT, V35, P1541, DOI 10.1007/s10529-013-1249-8; Chumnan T, 2008, TXB HERBAL MED; Dechbumroong P, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0202625; Eloff JN, 2011, AFR J TRADIT COMPLEM, V8, P1, DOI 10.4314/ajtcam.v8i5S.11; Gesto-Borroto R, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0217313; Ghasemzadeh A, 2016, BMC COMPLEM ALTERN M, V16, DOI 10.1186/s12906-016-1072-6; Heubl G, 2010, PLANTA MED, V76, P1963, DOI 10.1055/s-0030-1250519; Hollingsworth PM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019254; Jelinek L, 2012, CZECH J FOOD SCI, V30, P541, DOI 10.17221/50/2012-CJFS; Jiao LC, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20381-6; Kim WJ, 2016, MOLECULES, V21, DOI 10.3390/molecules21030270; Kunle O. F., 2012, International Journal of Biodiversity and Conservation, V4, P101, DOI 10.5897/IJBC11.163; Li M, 2012, FOOD CHEM, V135, P1653, DOI 10.1016/j.foodchem.2012.06.049; Li YQ, 2020, PLANT PHYSIOL BIOCH, V148, P80, DOI 10.1016/j.plaphy.2020.01.006; Liu ZX, 2019, FRONT PLANT SCI, V10, DOI 10.3389/fpls.2019.00086; Lo YT, 2015, CHIN MED-UK, V10, DOI 10.1186/s13020-015-0029-x; Manosroi J., 2009, LANNA MED PLANT DICT, V1st, P40; Mishra P, 2016, PLANT BIOTECHNOL J, V14, P8, DOI 10.1111/pbi.12419; Pai SR, 2014, PLANT SCI TODAY, V1, P103, DOI 10.14719/pst.2014.1.3.58; Panichayupakaranant P, 2011, QUALITY CONTROL STAN; Parveen I, 2016, PLANTA MED, V82, P1225, DOI 10.1055/s-0042-111208; Philippe G, 2004, TOXICON, V44, P405, DOI 10.1016/j.toxicon.2004.05.006; Pitiporn S, 2015, RECORD COUNTRY 8 FAR; Pitiporn S, 2011, J THAI TRAD ALT MED, V9, P143; Pooma R., 2014, THAI PLANT NAMES TEM, DOI [10.3897/BDJ.2.e1073, DOI 10.3897/BDJ.2.E1073]; Quattrocchi U., 2012, CRC world dictionary of medicinal and poisonous plants: common names, scientific names, eponyms, synonyms, and etymology; Roberts MF, 2013, ALKALOIDS BIOCH ECOL, P79; Ross HA, 2008, SYST BIOL, V57, P216, DOI 10.1080/10635150802032990; Saleem M, 2009, CANCER LETT, V285, P109, DOI 10.1016/j.canlet.2009.04.033; Sireeratawong Seewaboon, 2012, ISRN Pharmacol, V2012, P789651, DOI 10.5402/2012/789651; Steenis V, 1972, FLORA MALESIANA, P358; Suwanchaikasem P, 2013, SCIENCEASIA, V39, P124, DOI 10.2306/scienceasia1513-1874.2013.39.124; Thai ministry of public health, 2013, NOT THAI MIN PUBL HL; The royal society (Thailand), 1995, PLANT TAX ROYAL SOC, V1st; World Health Organization, 2014, World Health Organ Tech Rep Ser, P1; World Health Organization, 2018, TRADITIONAL COMPLEME; Wutithamawech W, 2007, DRUG RECIPES RATTANA; Yip Pui Ying, 2007, Chin Med, V2, P9, DOI 10.1186/1749-8546-2-9; Yu J, 2021, ECOTOX ENVIRON SAFE, V208, DOI 10.1016/j.ecoenv.2020.111691; Yu N, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195240; Yu N, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04674-w	49	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2021	16	9							e0257243	10.1371/journal.pone.0257243	http://dx.doi.org/10.1371/journal.pone.0257243			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	WG5ZQ	34534243	gold, Green Published			2022-12-26	WOS:000707073300021
J	Castro, LS; de Rezende, GR; Fernandes, FRP; Bandeira, LM; Cesar, GA; do Lago, BV; Gouvea, MSG; Motta-Castro, ARC				Castro, Lisie Souza; de Rezende, Grazielli Rocha; Pires Fernandes, Fernanda Rodas; Bandeira, Larissa Melo; Cesar, Gabriela Alves; do Lago, Barbara Vieira; Gomes Gouvea, Michele Soares; Motta-Castro, Ana R. C.			HAV infection in Brazilian men who have sex with men: The importance of surveillance to avoid outbreaks	PLOS ONE			English	Article							HEPATITIS-A VIRUS	Background Hepatitis A is a fecal-oral infection caused by hepatitis A virus (HAV). Men who have sex with men (MSM) and transgender women (TW) have been reported as target groups for HAV infection. This study aimed to determine the seroprevalence, risk factors, and circulating strains associated with HAV infection among MSM and TW in Central Brazil. Methods A cross-sectional study was conducted from November 2011 to September 2013. Serum samples were collected from 425 individuals for anti-HAV antibody testing and HAV molecular characterization. Of them, 149 (35.1%) participants were self-identified as transgender women. Statistical analysis was performed to evaluate the risk factors of HAV seropositivity. Results The seroprevalence of HAV exposure was 69.7% (95% Confidence Interval: 65.3-74.0%). Serological evidence of HAV was significantly higher in participants who self-identified as transgender women (83.2%) than MSM (62.3%). Increasing age, non-white race, and lower monthly household income were independently associated with HAV exposure among MSM. Only lower monthly household income was independently associated with HAV exposure among TW. One anti-HAV IgM positive sample, from a transgender woman (0.2%), was detected and classified as subgenotype IA. Conclusions High HAV prevalence was observed, markedly among TW. Considering the risky sexual behaviors this population is exposed to, HAV vaccination and prevention programs targeting this population should be considered to prevent outbreaks and the burden of the disease.	[Castro, Lisie Souza; de Rezende, Grazielli Rocha; Pires Fernandes, Fernanda Rodas; Bandeira, Larissa Melo; Cesar, Gabriela Alves; Motta-Castro, Ana R. C.] Univ Fed Mato Grosso do Sul, Campo Grande, MS, Brazil; [Castro, Lisie Souza] Univ Fed Mato Grosso, Rondonopolis, Brazil; [Pires Fernandes, Fernanda Rodas] Minist Agr Livestock & Food Supply, Natl Agr Lab, MAPA LANAGRO, Pedro Leopoldo, MG, Brazil; [do Lago, Barbara Vieira] Fiocruz MS, Lab Viral Hepatitis, Oswaldo Cruz Fdn, Rio De Janeiro, Brazil; [Gomes Gouvea, Michele Soares] Univ Sao Paulo, Inst Trop Med, Sao Paulo, Brazil; [Motta-Castro, Ana R. C.] Fiocruz MS, Oswaldo Cruz Fdn, Rio De Janeiro, MS, Brazil	Universidade Federal de Mato Grosso do Sul; Universidade Federal de Mato Grosso; Fundacao Oswaldo Cruz; Universidade de Sao Paulo; Fundacao Oswaldo Cruz	Motta-Castro, ARC (corresponding author), Univ Fed Mato Grosso do Sul, Campo Grande, MS, Brazil.; do Lago, BV (corresponding author), Fiocruz MS, Lab Viral Hepatitis, Oswaldo Cruz Fdn, Rio De Janeiro, Brazil.; Motta-Castro, ARC (corresponding author), Fiocruz MS, Oswaldo Cruz Fdn, Rio De Janeiro, MS, Brazil.	barbaravlago@gmail.com; arcm.castro@hotmail.com	Gomes-Gouvea, Michele S/G-4216-2012	Gomes-Gouvea, Michele S/0000-0001-5932-2360; Motta-Castro, Ana Rita/0000-0003-3070-1337	FUNDECT [23/200.283/2009]	FUNDECT(Fundacao de Apoio ao Desenvolvimento do Ensino Ciencia e Tecnologia do Estado de Mato Grosso do Sul (FUNDECT MS))	FUNDECT grant number: 23/200.283/2009. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberts CJ, 2019, VACCINE, V37, P2849, DOI 10.1016/j.vaccine.2019.03.048; Fernandez MDB, 2012, CLIN MICROBIOL INFEC, V18, pE548, DOI 10.1111/1469-0691.12034; Bogart LM, 2014, ANN BEHAV MED, V47, P1, DOI 10.1007/s12160-013-9574-7; Ximenes RAD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094622; De Oliveira TM, 2020, J MED VIROL, V92, P1343, DOI 10.1002/jmv.25694; Paula Vanessa Salete de, 2003, Braz J Infect Dis, V7, P135, DOI 10.1590/S1413-86702003000200007; Souto FJD, 2019, VACCINE, V37, P771, DOI 10.1016/j.vaccine.2018.12.054; Greco L, 2018, J MED VIROL, V90, P1323, DOI 10.1002/jmv.25052; Hosmer DW, 2013, WILEY SER PROBAB ST, P153; Jacobsen KH, 2018, CSH PERSPECT MED, V8, DOI 10.1101/cshperspect.a031716; Kerr L, 2018, MEDICINE, V97, pS9, DOI [10.1097/MD.0000000000010573, 10.1097/md.0000000000010573]; Kozlowski AG, 2007, MEM I OSWALDO CRUZ, V102, P121, DOI 10.1590/S0074-02762007000100021; Mangla N, 2017, EUR J GASTROEN HEPAT, V29, P1215, DOI 10.1097/MEG.0000000000000950; Mayer KH, 2012, LANCET, V380, P378, DOI 10.1016/S0140-6736(12)60835-6; Mello VM, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11030281; Polanski Piotr, 2019, Przegl Epidemiol, V73, P487, DOI 10.32394/pe.73.46; Siconolfi DE, 2013, J ADOLESCENT HEALTH, V52, P620, DOI 10.1016/j.jadohealth.2012.10.002; Vaughan G, 2014, INFECT GENET EVOL, V21, P227, DOI 10.1016/j.meegid.2013.10.023; Williamson DA, 2020, NEW ENGL J MED, V382, P2023, DOI 10.1056/NEJMra1907194; World Health Organization, 2017, HEP OUTBR MOSTL AFF	20	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2021	16	9							e0256818	10.1371/journal.pone.0256818	http://dx.doi.org/10.1371/journal.pone.0256818			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	WG5YY	34529672	gold, Green Published			2022-12-26	WOS:000707071500020
J	Huang, KM; Sant'Anna, AC; Etienne, X				Huang, Kuan-Ming; Sant'Anna, Ana Claudia; Etienne, Xiaoli			How did Covid-19 impact US household foods? an analysis six months in	PLOS ONE			English	Article							NATIONAL DISASTERS	Using a nationwide survey of primary grocery shoppers conducted in August 2020, we examine household food spending when the economy had partially reopened and consumers had different spending opportunities in comparison to when the Covid-19 lockdown began. We estimate the impact of Covid-19 on household spending using interval and Order Probit regressions. Income levels, age, access to grocery stores and farmers markets, household demographic information, along with other independent variables are controlled in the model. Findings show that middle-class households (with income below $50,000, or with income between $50,000 and $99,999) are less likely to increase their grocery expenditures during the pandemic. Households with children or elderlies that usually require higher food quality and nutrition intakes had a higher probability of increasing their spending during Covid-19 than before. Furthermore, consumers' spending behaviors were also significantly affected by their safe handing levels and the Covid-19 severity and food accessibility in their residences.	[Huang, Kuan-Ming] Univ Florida, Gulf Coast Res & Educ Ctr, Wimauma, FL 33598 USA; [Sant'Anna, Ana Claudia] West Virginia Univ, Div Resource Econ & Management, Morgantown, WV 26506 USA; [Etienne, Xiaoli] Dept Agr Econ & Rural Sociol, Moscow, ID USA	State University System of Florida; University of Florida; West Virginia University	Huang, KM (corresponding author), Univ Florida, Gulf Coast Res & Educ Ctr, Wimauma, FL 33598 USA.	khuang2@ufl.edu	Etienne, Xiaoli/GQB-5494-2022	Huang, Kuan-Ming/0000-0001-8770-1333; Etienne, Xiaoli/0000-0003-4519-9028; Sant'Anna, Ana Claudia/0000-0002-5292-8551	USDA-National Institute of Food Agriculture [2018-70001-28938]	USDA-National Institute of Food Agriculture	This work is funded by USDA-National Institute of Food & Agriculture, project #2019-68008-29828 and USDA-National Institute of Food & Agriculture, project #2018-70001-28938. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was not additional external funding received for this study.	Ahn S, 2021, APPL ECON PERSPECT P, V43, P162, DOI 10.1002/aepp.13069; Baker S.R., 2020, 27097 NBER; Baker SR, 2020, REV ASSET PRICING ST, V10, P834, DOI 10.1093/rapstu/raaa009; Baskin K., 2020, FOOD INSECURITY AGE; Cakir M., APPL ECON PERSPECT P; Cranfield JA., 2003, INT FOOD AGRIBUS MAN, V6, P1; Dube LF, 2010, INT J CONSUM STUD, V34, P333, DOI 10.1111/j.1470-6431.2009.00813.x; Ellison B., APPL ECON PERSPECT P; Enriquez D., 2020, SOCIUS, V6, P1, DOI [10.1177/2378023120970794, DOI 10.1177/2378023120970794]; FAO IFAD UNICEF WFP and WHO., 2020, BRIEF STATE FOOD SEC, DOI [10.4060/ca9699-n, DOI 10.4060/CA9699-N]; Farnsworth D, 2020, CHOICES, V35; Frank B, 2016, J RETAIL CONSUM SERV, V28, P199, DOI 10.1016/j.jretconser.2015.08.005; Frank B, 2014, J CONTING CRISIS MAN, V22, P197, DOI 10.1111/1468-5973.12058; Funk S, 2015, EPIDEMICS-NETH, V10, P21, DOI 10.1016/j.epidem.2014.09.005; Global Alliance for Improved Nutrition, 2020, COVID 19 CRIS FOOD S; Greene W.H., 2010, MODELING ORDERED CHO, DOI [10.1017/CBO9780511845062, DOI 10.1017/CBO9780511845062]; Gundersen Craig, 2021, Appl Econ Perspect Policy, V43, P153, DOI 10.1002/aepp.13100; Han J., 2020, INCOME POVERTY COVID; Hori M., 2014, JPN POLIT EC, V40, P69, DOI [10.2753/JES2329-194X400103, DOI 10.2753/JES2329-194X400103]; Kim J., J RETAIL CONSUM SERV; Knotek E.S., 2020, EC COMMENTARY, V8, P1, DOI [10.26509/frbc-ec-202008, DOI 10.26509/FRBC-EC-202008]; Lai J., 2020, CHOICES, V35; Levy JK., 2010, J NAT RESOUR POL RES, V2, P297, DOI [10.1080/19390459.2010.500462, DOI 10.1080/19390459.2010.500462]; Lian JW, 2014, COMPUT HUM BEHAV, V37, P133, DOI 10.1016/j.chb.2014.04.028; Lusk J, FOOD DEMAND SURVEY F; McFadden BR, 2021, AM J AGR ECON, V103, P486, DOI 10.1111/ajae.12188; Mead D, 2020, MON LABOR REV, DOI 10.21916/mlr.2020.18; Melo, 2020, CHOICES, V35; Nicola M, 2020, INT J SURG, V78, P185, DOI 10.1016/j.ijsu.2020.04.018; Pena-Levano L., 2020, CHOICES, V35; Perez-Escamilla R, 2020, MATERN CHILD NUTR, V16, DOI 10.1111/mcn.13036; Richards TJ, 2020, CAN J AGR ECON, V68, P189, DOI 10.1111/cjag.12231; Rizou M, 2020, TRENDS FOOD SCI TECH, V102, P293, DOI 10.1016/j.tifs.2020.06.008; Statista, WEEKL HOUS GROC SPEN; Tertilt M, 2020, IMPACT COVID 19 GEND, DOI DOI 10.3386/W26947; Thilmany D., APPL ECON PERSPECT P; Tighe D, 2020, GROCERY SHOPPING RES; U.S. Bureau of Labor Statistics, 2020, CONS EXP 2018; U.S. Bureau of Labor Statistics, CONS PRIC IND; U.S. Bureau of Labor Statistics, EMPL POP RAT 2020; U.S. Department of Agriculture, ON 3 US COUNT 2018 H; U.S. Department of Agriculture, USDA 2019 NAT FARM M; U.S. Department of Agriculture and U.S. Department of Health and Human Services, 2015, DIET GUID AM 2015 20; Vilar-Compte M, 2015, PUBLIC HEALTH NUTR, V18, P2934, DOI 10.1017/S1368980014002493; Wang EP, 2020, FOOD SECUR, V12, P739, DOI 10.1007/s12571-020-01092-1; Zeballos Eliana., 2021, COVID 19 WORKING PAP; Ziliak JP, 2021, APPL ECON PERSPECT P, V43, P132, DOI 10.1002/aepp.13099	47	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2021	16	9							e0256921	10.1371/journal.pone.0256921	http://dx.doi.org/10.1371/journal.pone.0256921			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	WG6DR	34525120	Green Published, gold			2022-12-26	WOS:000707084400021
J	Kural, E; Dellmuth, LM; Gustafsson, MT				Kural, Ece; Dellmuth, Lisa Maria; Gustafsson, Maria-Therese			International organizations and climate change adaptation: A new dataset for the social scientific study of adaptation, 1990-2017	PLOS ONE			English	Article							ENVIRONMENTAL-POLICY INTEGRATION; REGIME COMPLEX	This article introduces a new dataset on the climate change adaptation activities of international organizations (IOs). While climate change adaptation has been studied at the local level and in the context of major climate organizations, such as the United Nations Framework Convention on Climate Change, we provide a first quantitative dataset on non-environmental IOs that can be linked to different social scientific datasets relevant for adaptation. Our new dataset contains information on the governance activities of 30 IOs from 1990 to 2017. Based on this dataset, we introduce different types of adaptation-related activities and develop a quantitative measure of IOs' climate adaptation engagement. We map the adaptation engagement of the 30 IOs across organizations, across issue areas, and over time. This dataset can be used to compare adaptation activities across and within IOs, but also as an empirical foundation for the emerging research field of global adaptation governance, for which IO climate change adaptation activities are relevant.	[Kural, Ece; Dellmuth, Lisa Maria] Stockholm Univ, Dept Econ Hist & Int Relat, Stockholm, Sweden; [Gustafsson, Maria-Therese] Stockholm Univ, Dept Polit Sci, Stockholm, Sweden	Stockholm University; Stockholm University	Dellmuth, LM (corresponding author), Stockholm Univ, Dept Econ Hist & Int Relat, Stockholm, Sweden.	lisa.dellmuth@su.se	Dellmuth, Lisa/AFR-8126-2022	Dellmuth, Lisa/0000-0002-1298-8525	Svenska Forskningsradet Formas; Swedish Foundation for Strategic Environmental Research (Mistra) [2016/11, 5]	Svenska Forskningsradet Formas(Swedish Research Council Formas); Swedish Foundation for Strategic Environmental Research (Mistra)(Swedish Foundation for Strategic Research)	LD, MTG, EK were financially supported by the Svenska Forskningsradet Formas under grant number for the Glocalizing Climate Governance (GlocalClim) project, and by the Swedish Foundation for Strategic Environmental Research (Mistra) under grant number 2016/11 #5 for the Mistra Geopolitics project. www.formas.se www.mistra-geopolitics.se The funding agencies did not play any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADB, 2017, MAINSTREAMING CLIMAT; Adger WN, 2006, GLOBAL ENVIRON CHANG, V16, P268, DOI 10.1016/j.gloenvcha.2006.02.006; ASEAN, 2012, ASEAN ANN REP 2011 2; ASEAN, 2010, ASEAN ANN REP 2009 2; Barnett M, 2005, INT STUD QUART, V49, P593, DOI 10.1111/j.1468-2478.2005.00380.x; Barnett Michael, 2004, RULES WORLD INT ORG; Barros V, 2014, CLIMATE CHANGE 2014: IMPACTS, ADAPTATION, AND VULNERABILITY, PT A: GLOBAL AND SECTORAL ASPECTS, pIX; Betts A, 2013, GLOBAL GOV, V19, P69, DOI 10.1163/19426720-01901006; BEXELL M, 2020, J INT RELAT DEV, DOI DOI 10.1057/S41268-020-00203-X; Biagini B, 2014, GLOBAL ENVIRON CHANG, V25, P97, DOI 10.1016/j.gloenvcha.2014.01.003; Biermann F., 2010, GLOBAL CLIMATE GOBER, P255, DOI DOI 10.1017/CBO9781139107150.002; BIESBROEK G, 2010, GLOBAL ENVIRON CHANG, DOI DOI 10.1016/J.GLOENVCHA.2010.05.003; Biesbroek R, 2020, ENVIRON RES LETT, V15, DOI 10.1088/1748-9326/ab8fd1; Biesbroek R, 2018, WIRES CLIM CHANGE, V9, DOI 10.1002/wcc.548; Buchner B., 2019, CLIMATE POLICY INITI, P15; Bulkeley H., 2010, GOVERNING CLIMATE CH; de Bruin K, 2009, CLIMATIC CHANGE, V95, P23, DOI 10.1007/s10584-009-9576-4; Dellmuth LM, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2018293118; Dingwerth K., 2019, INT ORG PRESSURE LEG; Donner SD, 2016, ENVIRON RES LETT, V11, DOI 10.1088/1748-9326/11/5/054006; Dupont, 2015, CLIMATE POLICY INTEG, P1; EC, 2016, EU 2015 GEN REP ACT; EC, 2001, EU 2000 GEN REP ACT; Engen L., 2018, GUIDE MULTILATERAL D; Fang SY, 2012, INT ORGAN, V66, P537, DOI 10.1017/S0020818312000276; Gehring T., 2006, I INTERACTION GLOBAL, P1; Grigorescu A., 2015, DEMOCRATIC INTERGOVE, P1; Hall N, 2016, ROUTL GLOB INST S, P1; Hall N, 2017, INT ENVIRON AGREEM-P, V17, P37, DOI 10.1007/s10784-016-9345-6; Hall N, 2015, GLOBAL ENVIRON POLIT, V15, P79, DOI 10.1162/GLEP_a_00299; Hooghe L., 2017, MEASURING INT AUTHOR, VIII; Hooghe L, 2015, REV INT ORGAN, V10, P305, DOI 10.1007/s11558-014-9194-4; IOM, 2007, 94 SESS COUNC DISC N; Jordan A, 2010, ENVIRON POLICY GOV, V20, P147, DOI 10.1002/eet.539; Keohane RO, 2011, PERSPECT POLIT, V9, P7, DOI 10.1017/S1537592710004068; Khan MR, 2013, WIRES CLIM CHANGE, V4, P171, DOI 10.1002/wcc.212; Kok MTJ, 2007, ENVIRON SCI POLICY, V10, P587, DOI 10.1016/j.envsci.2007.07.003; Kongsager R, 2016, ENVIRON MANAGE, V57, P271, DOI 10.1007/s00267-015-0605-y; Lesnikowski AC, 2011, ENVIRON RES LETT, V6, DOI 10.1088/1748-9326/6/4/044009; Lesnikowski A, 2019, WIRES CLIM CHANGE, V10, DOI 10.1002/wcc.576; Lesnikowski A, 2016, NAT CLIM CHANGE, V6, P261, DOI [10.1038/nclimate2863, 10.1038/NCLIMATE2863]; Lesnikowski AC, 2015, MITIG ADAPT STRAT GL, V20, P277, DOI 10.1007/s11027-013-9491-x; Margulis ME, 2013, GLOBAL GOV, V19, P53, DOI 10.1163/19426720-01901005; Maria DL, 2020, ENVIRON SCI POLICY, V114, P204, DOI 10.1016/j.envsci.2020.07.027; Marks G., 2019, THEORY INT ORG THEOR; Masson-Delmotte V., 2018, SUMMARY POLICYMAKERS; Meehl GA, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P747; Moravcsik A, 1999, INT ORGAN, V53, P267, DOI 10.1162/002081899550887; Nilsson M, 2017, ENVIRON SCI POLICY, V78, P36, DOI 10.1016/j.envsci.2017.09.003; OECD, 2021, DEV FIN DAT; Pachauri RK, 2014, 2014 IEEE STUDENTS' CONFERENCE ON ELECTRICAL, ELECTRONICS AND COMPUTER SCIENCE (SCEECS); Persson A, 2019, WIRES CLIM CHANGE, V10, DOI 10.1002/wcc.618; Pevehouse J, 2004, CONFLICT MANAG PEACE, V21, P101, DOI 10.1080/07388940490463933; Purdon M, 2019, RESEARCH HANDBOOK ON CLIMATE CHANGE ADAPTATION POLICY, P157; Rietig K, 2019, ENVIRON POLIT, V28, P228, DOI 10.1080/09644016.2019.1549781; Rudloff A., 2018, CLIMATIC CHANGE, V147, DOI DOI 10.1007/S10584-018-2171-9; Runhaar H, 2018, REG ENVIRON CHANGE, V18, P1201, DOI 10.1007/s10113-017-1259-5; Schipper ELF, 2016, INT J DISASTER RESIL, V7, P216, DOI 10.1108/IJDRBE-03-2015-0014; Scott SV, 2018, CLIMATE CHANGE AND THE UN SECURITY COUNCIL, P1; Tosun J, 2018, ENVIRON SCI POLICY, V82, P90, DOI 10.1016/j.envsci.2018.01.014; UNDP, 2018, UN DEV PROGR NEP; Union of International Associations, 2017, YB INT ORG; UNSC, 2011, STATEMENT PRESIDENT; UNSCEB, 2021, FIN BUDG DAT; WHO, 1990, POT HLTH EFF CLIM CH; Widerberg O, 2016, WIRES CLIM CHANGE, V7, P486, DOI 10.1002/wcc.396; Wilkerson J, 2017, ANNU REV POLIT SCI, V20, P529, DOI 10.1146/annurev-polisci-052615-025542; World Bank Group, 2017, WORLD BANK ANN REPOR; World Bank Group, 2009, WORLD BANK ANN REPOR; WTO, 2011, ANN REP 2011	70	2	2	3	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2021	16	9							e0257101	10.1371/journal.pone.0257101	http://dx.doi.org/10.1371/journal.pone.0257101			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	XM9EM	34506547	gold, Green Published			2022-12-26	WOS:000729120700090
J	Popat, R; Dhillon, K; Mahapatra, P; Khan, H; Nathwani, D				Popat, Ravi; Dhillon, Kieran; Mahapatra, Piyush; Khan, Hasaan; Nathwani, Dinesh			The Imperial Joint Line Congruency Measurement is a valuable tool in total knee arthroplasty	PLOS ONE			English	Article							RESTORATION; REPLACEMENT; POSITION	Background Preservation of joint line height is an important factor in post-operative function after Total Knee Arthroplasty (TKA). This is the first study investigating the reliability of the novel Imperial Joint Line Congruency Measurement (IJLCM) technique for the assessment of joint line height using plain radiographs. Methods The reliability of two techniques used to measure joint line height on pre-operative and post-operative plain radiographs is presented. 120 patients that underwent TKA from 6 different international centres were included. Measurements were performed using each technique by two senior orthopaedic surgeons at two different timepoints (test-retest). Two undergraduate medical students performed joint line measurements using the most reproducible of the two techniques on 40 pre-operative and post-operative images to establish the reliability of the measurement technique. Results The IJLCM demonstrated an average absolute difference of 1.83mm (CI 1.56-2.10mm) and excellent inter and intra-rater reliability between senior orthopaedic surgeons (>0.92 (CI 0.88-0.94) when measuring joint line height on plain radiographs. Overall Crohnbach's alpha over 0.92 confirmed internal consistency. Measurements performed using the control technique as previously described by Figgie et al. had an average absolute difference of 5.75mm (5.17-6.32mm). Comparison of measurements by senior orthopaedic surgeons and medical students using the IJLCM technique with ANOVA and student's t-test demonstrated acceptable agreement and inter-rater reliability of >0.92 (0.87-0.95). Conclusion This study shows excellent accuracy, precision, and reliability of the novel IJLCM technique. Furthermore, excellent agreement between senior orthopaedic surgeons and medical students when using the IJLCM could be shown. The IJLCM technique is reliable for joint line assessment.	[Popat, Ravi; Mahapatra, Piyush; Nathwani, Dinesh] Imperial Coll Healthcare NHS Trust, Dept Trauma & Orthopaed Surg, London, England; [Popat, Ravi; Dhillon, Kieran; Khan, Hasaan; Nathwani, Dinesh] Imperial Coll London, London, England	Imperial College London; Imperial College London	Popat, R (corresponding author), Imperial Coll Healthcare NHS Trust, Dept Trauma & Orthopaed Surg, London, England.; Popat, R (corresponding author), Imperial Coll London, London, England.	r.popat14@imperial.ac.uk		Dhillon, Kieran/0000-0001-9496-3219; Nathwani, Dinesh/0000-0001-8043-229X				Babazadeh S, 2011, J BONE JOINT SURG BR, V93B, P1223, DOI 10.1302/0301-620X.93B9.26950; Bin Abd Razak HR, 2013, ARCH ORTHOP TRAUM SU, V133, P853, DOI 10.1007/s00402-013-1738-1; FIGGIE HE, 1986, J BONE JOINT SURG AM, V68A, P1035, DOI 10.2106/00004623-198668070-00009; Goh GSH, 2017, J ARTHROPLASTY, V32, P61, DOI 10.1016/j.arth.2016.06.018; Goh GSH, 2016, J ARTHROPLASTY, V31, P92, DOI 10.1016/j.arth.2015.06.048; Hofmann AA, 2006, J ARTHROPLASTY, V21, P1154, DOI 10.1016/j.arth.2005.10.026; Insall J, 1972, Clin Orthop Relat Res, V88, P67, DOI 10.1097/00003086-197210000-00012; Jawhar A, 2013, KNEE SURG SPORT TR A, V21, P2355, DOI 10.1007/s00167-013-2580-2; Jawhar A, 2015, J ORTHOP SCI, V20, P93, DOI 10.1007/s00776-014-0647-7; Kawamura H, 2001, J Orthop Sci, V6, P248, DOI 10.1007/s007760100043; Konig C, 2010, J ORTHOP RES, V28, P1, DOI 10.1002/jor.20952; MALGHEM J, 1989, RADIOLOGY, V170, P507, DOI 10.1148/radiology.170.2.2911676; MARTIN JW, 1990, CLIN ORTHOP RELAT R, P146; Pang HN, 2013, KNEE SURG SPORT TR A, V21, P2363, DOI 10.1007/s00167-013-2390-6; Partington PF, 1999, CLIN ORTHOP RELAT R, P165; Ryu J., 1993, FACTORS INFLUENCING, V53; SINGERMAN R, 1995, J ARTHROPLASTY, V10, P651, DOI 10.1016/S0883-5403(05)80210-4; Snider MG, 2009, J ARTHROPLASTY, V24, P1093, DOI 10.1016/j.arth.2008.08.009; Wyss TF, 2006, ARCH ORTHOP TRAUM SU, V126, P480, DOI 10.1007/s00402-006-0171-0; Yoshii I, 1991, J Arthroplasty, V6, P169, DOI 10.1016/S0883-5403(11)80013-6	20	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2021	16	9							e0257325	10.1371/journal.pone.0257325	http://dx.doi.org/10.1371/journal.pone.0257325			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XM9EM	34506586	Green Published, gold			2022-12-26	WOS:000729120700116
J	Poppe, KL; Rybczyk, JM				Poppe, Katrina L.; Rybczyk, John M.			Tidal marsh restoration enhances sediment accretion and carbon accumulation in the Stillaguamish River estuary, Washington	PLOS ONE			English	Article							BLUE CARBON; COASTAL; WETLAND; CS-137; SOILS	Tidal marshes have been recognized globally for their ability to sequester "blue carbon" but there is still a need for studies investigating the marsh response to restoration, particularly in the Pacific Northwest United States. Here we report carbon stocks and accumulation rates for restored and natural tidal marshes in the Stillaguamish River estuary in Puget Sound, Washington, where a 60-hectare marsh was reintroduced to the tidal regime from its previous use as diked and drained farmland. We found that the restoration not only maximized carbon accumulation but also enhanced resilience to rising sea levels. Four years after restoration, mean sediment carbon stocks in the upper 30 cm within the restored marsh (4.43 kg C m(-2)) were slightly lower than those measured in the adjacent natural marshes (5.95 kg C m(-2)). Mean carbon accumulation rates, however, were nearly twice as high in the restored marsh (230.49 g C m(-2) yr(-1)) compared to the natural marshes (123.00 g C m(-2) yr(-1)) due to high rates of accretion in the restored marsh (1.57 cm yr(-1)). Mean elevation change rates were nearly twice that of corresponding Pb-210 accretion rates, but all were greater than the current rate of sea level rise.	[Poppe, Katrina L.; Rybczyk, John M.] Western Washington Univ, Dept Environm Sci, Bellingham, WA 98225 USA	Western Washington University	Poppe, KL (corresponding author), Western Washington Univ, Dept Environm Sci, Bellingham, WA 98225 USA.	poppek@wwu.edu	Poppe, Katrina/AAV-4251-2020	Poppe, Katrina/0000-0003-2830-4578	Washington Sea Grant, University of Washington [NA14OAR4170078]	Washington Sea Grant, University of Washington(University of Washington)	This study was funded by Washington Sea Grant, University of Washington, pursuant to National Oceanic and Atmospheric Administration Award No. NA14OAR4170078, awarded to JMR and KLP. The views expressed herein are those of the authors and do not necessarily reflect the views of NOAA or any of its sub-agencies. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2021, NOAA TID CURR SEA LE; Bauer JE, 2013, NATURE, V504, P61, DOI 10.1038/nature12857; Bayraktarov E, 2016, ECOL APPL, V26, P1055, DOI 10.1890/15-1077; Breithaupt JL, 2018, LIMNOL OCEANOGR, V63, pS477, DOI 10.1002/lno.10783; Brophy LS, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0218558; Callaway JC, 2012, ESTUAR COAST, V35, P1163, DOI 10.1007/s12237-012-9508-9; Cornu C., 2020, SCOPING ASSESSMENT P; Costanza R, 2014, GLOBAL ENVIRON CHANG, V26, P152, DOI 10.1016/j.gloenvcha.2014.04.002; CRAFT CB, 1991, ESTUARIES, V14, P175, DOI 10.2307/1351691; Crooks S., 2014, COASTAL BLUE CARBON; Diefenderfer Heida L., 2008, Ecohydrology & Hydrobiology, V8, P339, DOI 10.2478/v10104-009-0027-7; Drexler JZ, 2020, ESTUAR COAST, V43, P1345, DOI 10.1007/s12237-020-00748-7; Drexler JZ, 2019, RESTOR ECOL, V27, P1117, DOI 10.1111/rec.12941; Drexler JZ, 2018, QUATERNARY SCI REV, V199, P83, DOI 10.1016/j.quascirev.2018.08.028; Foster IDL, 2006, J PALEOLIMNOL, V35, P881, DOI 10.1007/s10933-005-6187-6; Fuller R., 2017, STILLAGUAMISH ESTUAR; Gailis M., CARBON STOCKS UNPUB; Holmquist JR, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26948-7; Howe AJ, 2009, ESTUAR COAST SHELF S, V84, P75, DOI 10.1016/j.ecss.2009.06.006; Lovelock CE, 2014, ESTUAR COAST, V37, P763, DOI 10.1007/s12237-013-9702-4; Lynch J.C., 2015, NPSNCBNNRR20151078 U, DOI DOI 10.13140/RG.2.1.5171.976; Mcleod E, 2011, FRONT ECOL ENVIRON, V9, P552, DOI 10.1890/110004; Needelman BA, 2018, ESTUAR COAST, V41, P2159, DOI 10.1007/s12237-018-0429-0; Nelleman C, 2009, BLUE CARBON RAPID RE; Nowacki DJ, 2020, ESTUAR COAST SHELF S, V242, DOI 10.1016/j.ecss.2020.106869; Ouyang X, 2014, BIOGEOSCIENCES, V11, P5057, DOI 10.5194/bg-11-5057-2014; Peck E.K., 2018, SO FLOW CORRIDOR EFF; Peck EK., 2017, BLUE CARBON ECOSYS 2; Peck EK, 2020, J GEOPHYS RES-BIOGEO, V125, DOI 10.1029/2019JG005464; Pendleton L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043542; R Core Team, 2020, R LANG ENV STAT COMP; ROBBINS JA, 1978, QUATERNARY RES, V10, P256, DOI 10.1016/0033-5894(78)90105-9; Rogers K, 2014, ESTUAR COAST, V37, P67, DOI 10.1007/s12237-013-9664-6; Spivak AC, 2019, NAT GEOSCI, V12, P685, DOI 10.1038/s41561-019-0435-2; Troxler T.G., 2019, BLUE CARBON PRIMER S, P217; Wang ZA, 2016, LIMNOL OCEANOGR, V61, P1916, DOI 10.1002/lno.10347; WESTLAKE DF, 1963, BIOL REV, V38, P385, DOI 10.1111/j.1469-185X.1963.tb00788.x; Wollenberg JT, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193930; Wylie L, 2016, MAR POLICY, V65, P76, DOI 10.1016/j.marpol.2015.12.020	39	1	1	5	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2021	16	9							e0257244	10.1371/journal.pone.0257244	http://dx.doi.org/10.1371/journal.pone.0257244			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XM9EM	34506575	Green Published, gold			2022-12-26	WOS:000729120700060
J	Das, P; Mukherjee, A; Adak, S				Das, Priya; Mukherjee, Aditi; Adak, Subrata			Glyceraldehyde-3-phosphate dehydrogenase present in extracellular vesicles from Leishmania major suppresses host	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							URACIL DNA-GLYCOSYLASE; TRYPANOSOMA-BRUCEI; PHOSPHATE DEHYDROGENASE; NUCLEAR TRANSLOCATION; PROTEIN; BINDING; RNA; GAPDH; IDENTIFICATION; VIRULENCE	Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) ful-fills various physiological roles that are unrelated to its glyco-lytic function. However, to date, the nonglycolytic function of GAPDH in trypanosomal parasites is absent from the litera-ture. Exosomes secreted from Leishmania, like entire parasites, were found to have a significant impact on macrophage cell signaling and function, indicating cross talk with the host im-mune system. In this study, we demonstrate that the Leish-mania GAPDH (LmGAPDH) protein is highly enriched within the extracellular vesicles (EVs) secreted during infection. To understand the function of LmGAPDH in EVs, we generated control, overexpressed, half-knockout (HKO), and complement cell lines. HKO cells displayed lower virulence compared with control cells when macrophages and BALB/c mice were infected with them, implying a crucial role for LmGAPDH in Leishmania infection and disease progression. Furthermore, upon infection of macrophages with HKO mutant Leishmania and its EVs, despite no differences in TNFA mRNA expression, there was a considerable increase in TNF-alpha protein expression compared with control, overexpressed, and complement para-sites as determined by ELISA, RT-PCR, and immunoblot data. In vitro protein translation studies suggest that LmGAPDH-mediated TNF-alpha suppression occurs in a concentration-dependent manner. Moreover, mRNA binding assays also verified that LmGAPDH binds to the AU-rich 3 '-UTR region of TNFA mRNA, limiting its production. Together, these findings confirmed that the LmGAPDH contained in EVs inhibits TNF-alpha expression in macrophages during infection via post-transcriptional repression.	[Das, Priya; Mukherjee, Aditi; Adak, Subrata] Indian Inst Chem Biol, CSIR, Div Struct Biol & Bioinformat, Kolkata, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB)	Adak, S (corresponding author), Indian Inst Chem Biol, CSIR, Div Struct Biol & Bioinformat, Kolkata, India.	adaks@iicb.res.in		Adak, Subrata/0000-0001-7376-4755	Council of Scientific and Industrial Research (CSIR) NCP Project [MLP-136]; CSIR fellowships	Council of Scientific and Industrial Research (CSIR) NCP Project; CSIR fellowships(Council of Scientific & Industrial Research (CSIR) - India)	Funding and additional information-This work was supported by Council of Scientific and Industrial Research (CSIR) NCP Project MLP-136, CSIR fellowships (to P. D. and A. M.) .	Adhikari A, 2019, BIOCHEM J, V476, P1303, DOI 10.1042/BCJ20190041; Aguilera L, 2012, INT J BIOCHEM CELL B, V44, P955, DOI 10.1016/j.biocel.2012.03.002; Alvarez RA, 2003, MOL MICROBIOL, V48, P1417, DOI 10.1046/j.1365-2958.2003.03518.x; BAXI MD, 1995, BIOCHEMISTRY-US, V34, P9700, DOI 10.1021/bi00030a007; Biswas S, 2020, FEBS J, V287, P5183, DOI 10.1111/febs.15305; Brune B, 1996, METHOD ENZYMOL, V269, P400; CAPUT D, 1986, P NATL ACAD SCI USA, V83, P1670, DOI 10.1073/pnas.83.6.1670; Chakravarti R, 2010, P NATL ACAD SCI USA, V107, P18004, DOI 10.1073/pnas.1008133107; Chang CH, 2013, CELL, V153, P1239, DOI 10.1016/j.cell.2013.05.016; CHEN CYA, 1995, TRENDS BIOCHEM SCI, V20, P465, DOI 10.1016/S0968-0004(00)89102-1; Colasante Claudia, 2013, F1000Res, V2, P27, DOI 10.12688/f1000research.2-27.v1; Dastoor Z, 2001, J CELL SCI, V114, P1643; Dolai S, 2008, FREE RADICAL BIO MED, V45, P1520, DOI 10.1016/j.freeradbiomed.2008.08.029; DURRIEU C, 1987, MOL CELL BIOCHEM, V74, P55; GLASER PE, 1995, BIOCHEMISTRY-US, V34, P12193, DOI 10.1021/bi00038a013; Gomez MA, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000213; Guhaniyogi J, 2001, GENE, V265, P11, DOI 10.1016/S0378-1119(01)00350-X; HANNAERT V, 1992, MOL BIOCHEM PARASIT, V55, P115, DOI 10.1016/0166-6851(92)90132-4; Hara MR, 2005, NAT CELL BIOL, V7, P665, DOI 10.1038/ncb1268; Hessler RJ, 1998, J LEUKOCYTE BIOL, V63, P331, DOI 10.1002/jlb.63.3.331; Hubel A, 1997, MOL CELL BIOL, V17, P5987; Joshi PB, 2002, MOL BIOCHEM PARASIT, V120, P33, DOI 10.1016/S0166-6851(01)00432-7; KAWAMOTO RM, 1986, BIOCHEMISTRY-US, V25, P656, DOI 10.1021/bi00351a022; KERR LD, 1995, METHOD ENZYMOL, V254, P619; KIM HD, 1995, BIOCHEMISTRY-US, V34, P14975, DOI 10.1021/bi00046a004; Klein C, 1999, BIOCHEM J, V344, P775, DOI 10.1042/0264-6021:3440775; LAMBEIR AM, 1991, EUR J BIOCHEM, V198, P429, DOI 10.1111/j.1432-1033.1991.tb16032.x; Lancaster GI, 2005, J BIOL CHEM, V280, P23349, DOI 10.1074/jbc.M502017200; Lotvall J, 2014, J EXTRACELL VESICLES, V3, DOI 10.3402/jev.v3.26913; Madureira P, 2007, J IMMUNOL, V178, P1379, DOI 10.4049/jimmunol.178.3.1379; Marti M, 2004, SCIENCE, V306, P1930, DOI 10.1126/science.1102452; MEYERSIEGLER K, 1991, P NATL ACAD SCI USA, V88, P8460, DOI 10.1073/pnas.88.19.8460; Millet P, 2016, J IMMUNOL, V196, P2541, DOI 10.4049/jimmunol.1501345; MISSET O, 1987, EUR J BIOCHEM, V162, P501, DOI 10.1111/j.1432-1033.1987.tb10668.x; MORGENEGG G, 1986, J NEUROCHEM, V47, P54; Mukherjee A, 2018, BIOCHEM BIOPH RES CO, V503, P371, DOI 10.1016/j.bbrc.2018.06.037; NAGY E, 1995, J BIOL CHEM, V270, P2755, DOI 10.1074/jbc.270.6.2755; Nandan D, 2002, J BIOL CHEM, V277, P50190, DOI 10.1074/jbc.M209210200; Nandan D, 2007, BIOCHEM BIOPH RES CO, V364, P601, DOI 10.1016/j.bbrc.2007.10.065; Pal S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011271; PANCHOLI V, 1992, J EXP MED, V176, P415, DOI 10.1084/jem.176.2.415; Peacock CS, 2007, NAT GENET, V39, P839, DOI 10.1038/ng2053; Rogers MB, 2011, GENOME RES, V21, P2129, DOI 10.1101/gr.122945.111; Scianimanico S, 1999, CELL MICROBIOL, V1, P19, DOI 10.1046/j.1462-5822.1999.00002.x; Sen N, 2008, NAT CELL BIOL, V10, P866, DOI 10.1038/ncb1747; Silverman JM, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-2-r35; Silverman JM, 2012, FRONT CELL INFECT MI, V1, DOI 10.3389/fcimb.2011.00026; Silverman JM, 2010, J IMMUNOL, V185, P5011, DOI 10.4049/jimmunol.1000541; Silverman JM, 2010, J CELL SCI, V123, P842, DOI 10.1242/jcs.056465; SINGH R, 1993, SCIENCE, V259, P365, DOI 10.1126/science.8420004; Sirover MA, 2017, GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE (GAPDH): THE QUINTESSENTIAL MOONLIGHTING PROTEIN IN NORMAL CELL FUNCTION AND IN HUMAN DISEASE, P1; Sirover MA, 2020, CRIT REV BIOCHEM MOL, V55, P354, DOI 10.1080/10409238.2020.1787325; Souza DHF, 1998, FEBS LETT, V424, P131, DOI 10.1016/S0014-5793(98)00154-9; Ty MC, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0225588; VANNIERSANTOS MA, 1995, EUR J CELL BIOL, V67, P112; VELLIEUX FMD, 1995, ACTA CRYSTALLOGR D, V51, P575, DOI 10.1107/S0907444995003015; Zhang WW, 2013, EUKARYOT CELL, V12, P70, DOI 10.1128/EC.00263-12	57	4	4	1	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT	2021	297	4							101198	10.1016/j.jbc.2021.101198	http://dx.doi.org/10.1016/j.jbc.2021.101198			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	WP2YR	34534548	Green Published, gold			2022-12-26	WOS:000713003600006
J	Faraldi, F; Lavia, CA; Nassisi, M; Kilian, RA; Bacherini, D; Rizzo, S				Faraldi, Francesco; Lavia, Carlo Alessandro; Nassisi, Marco; Kilian, Raphael A.; Bacherini, Daniela; Rizzo, Stanislao			Swept-source OCT reduces the risk of axial length measurement errors in eyes with cataract and epiretinal membranes	PLOS ONE			English	Article							VITRECTOMY; SURGERY; LAYERS	Aims To compare the biometric data from partial coherence interferometry (PCI) and swept-source OCT (SS-OCT) in patients with age-related cataract and epiretinal membrane (ERM): ERM, ERM with foveoschisis and macular pseudohole. Methods 49 eyes of 49 subjects including 36 ERM, 9 ERM foveoschisis and 4 macular pseudohole were analysed to evaluate the axial length (AL) measurements and the presence of AL measurement errors, defined basing on the shape of the biometric output graphs and on the concordance of AL values between instruments. Eyes with ERM were divided in four stages according to OCT features (i.e. presence/absence of the foveal pit, presence of ectopic inner foveal layers, disrupted retinal layers). Results The devices provided similar mean AL measurements in all subgroups, with differences <0.1 mm in 41/49 cases (83.6%). AL measurement errors were observed in ERM stages 3 and 4, characterized by ectopic inner foveal layers, and were significantly more frequent with the PCI (8/17, 47%) as compared with the SS-OCT device (2/17, 12%), p = 0.02. The refractive prediction error in cases with AL measurement errors was significantly greater using the PCI compared to the SS-OCT device (p<0.05). Conclusion Both devices provide reliable biometric data in the majority of patients and can be used in the preoperative assessment of patients with age-related cataract and ERM. In eyes with ectopic inner foveal layers, attention should be paid as AL measurement and refractive prediction errors may occur, more frequently with the PCI device.	[Faraldi, Francesco; Lavia, Carlo Alessandro] Azienda Sanit Locale TO5, Ophthalmol Serv, Surg Dept, Chieri, Italy; [Nassisi, Marco] Osped Maggiore Policlin, Ophthalmol Unit, Fdn IRCCS Ca Granda, Milan, Italy; [Nassisi, Marco] Univ Milan, Dept Clin Sci & Community Hlth, Milan, Italy; [Kilian, Raphael A.] Univ Verona, Dept Neurosci Biomed & Movement Sci, Ophthalm Unit, Verona, Italy; [Bacherini, Daniela] Univ Florence, Dept Neurosci Psychol Drug Res & Child Hlth, AOU Careggi, Eye Clin, Florence, Italy; [Rizzo, Stanislao] Univ Cattolica Sacro Cuore, Ophthalmol Unit, Rome, Italy; [Rizzo, Stanislao] Fdn Policlin Univ A Gemelli, IRCCS, Rome, Italy; [Rizzo, Stanislao] Consiglio Nazl Ric CNR, Pisa, Italy	IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; University of Verona; University of Florence; Azienda Ospedaliero Universitaria Careggi; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli	Faraldi, F (corresponding author), Azienda Sanit Locale TO5, Ophthalmol Serv, Surg Dept, Chieri, Italy.	faraldi@retinatorino.it	Nassisi, Marco/P-9939-2019	Nassisi, Marco/0000-0002-9354-9005				Abou Shousha M, 2010, CURR OPIN OPHTHALMOL, V21, P45, DOI 10.1097/ICU.0b013e32833303bf; Asam J.S., 2019, HIGH RESOLUTION IMAG, P285; CHERFAN GM, 1991, AM J OPHTHALMOL, V111, P434, DOI 10.1016/S0002-9394(14)72377-3; Doguizi S, 2018, EYE, V32, P1652, DOI 10.1038/s41433-018-0153-9; Duker JS, 2013, OPHTHALMOLOGY, V120, P2611, DOI 10.1016/j.ophtha.2013.07.042; Falkner-Radler CI, 2008, J CATARACT REFR SURG, V34, P1754, DOI 10.1016/j.jcrs.2008.06.021; Govetto A, 2019, RETINA-J RET VIT DIS, V39, P347, DOI 10.1097/IAE.0000000000001940; Govetto A, 2017, AM J OPHTHALMOL, V175, P99, DOI 10.1016/j.ajo.2016.12.006; Hamoudi H, 2018, ACTA OPHTHALMOL, V96, P243, DOI 10.1111/aos.13572; Hirnschall N, 2018, OPHTHALMOL THER, V7, P119, DOI 10.1007/s40123-018-0122-1; Hoffer KJ, 2015, AM J OPHTHALMOL, V160, P403, DOI 10.1016/j.ajo.2015.05.029; Hubschman JP, 2020, BRIT J OPHTHALMOL, V104, P1741, DOI 10.1136/bjophthalmol-2019-315432; Jackson TL, 2015, RETINA-J RET VIT DIS, V35, P1615, DOI 10.1097/IAE.0000000000000523; Kim M, 2015, YONSEI MED J, V56, P805, DOI 10.3349/ymj.2015.56.3.805; Kojima T, 2010, OPHTHALMOLOGY, V117, P1750, DOI 10.1016/j.ophtha.2010.01.018; Kovacs I, 2007, ACTA OPHTHALMOL SCAN, V85, P88, DOI 10.1111/j.1600-0420.2006.00772.x; Kuriyan AE, 2019, OPHTHALMOL RETINA, V3, P371, DOI 10.1016/j.oret.2018.11.009; Kymionis GD, 2018, SEMIN OPHTHALMOL, V33, P488, DOI 10.1080/08820538.2017.1303520; Moisseiev E, 2016, CURR EYE RES, V41, P1387, DOI 10.3109/02713683.2015.1114654; Nakashizuka H, 2019, BMC OPHTHALMOL, V19, DOI 10.1186/s12886-019-1185-z; Oh R, 2021, BMC OPHTHALMOL, V21, DOI 10.1186/s12886-021-01826-5; Pardeshi AA, 2020, TRANSL VIS SCI TECHN, V9, DOI 10.1167/tvst.9.9.14; Port AD, 2021, GRAEF ARCH CLIN EXP, V259, P45, DOI 10.1007/s00417-020-04877-4; Rizzo S, 2017, EUR J OPHTHALMOL, V27, P565, DOI 10.5301/ejo.5000986; Ruiz-Mesa R, 2020, EXPERT REV MED DEVIC, V17, P591, DOI 10.1080/17434440.2020.1772050; Santodomingo-Rubido J, 2002, BRIT J OPHTHALMOL, V86, P458, DOI 10.1136/bjo.86.4.458; Tana-Rivero P, 2021, J CATARACT REFR SURG, V47, P488, DOI 10.1097/j.jcrs.0000000000000483; Toprak I, 2014, EYE, V28, P1126, DOI 10.1038/eye.2014.147; van der Geest LJ, 2016, J CATARACT REFR SURG, V42, P840, DOI 10.1016/j.jcrs.2016.03.034; Vounotrypidis E, 2019, J CATARACT REFR SURG, V45, P48, DOI 10.1016/j.jcrs.2018.08.027; Yeu E, 2021, OPHTHALMOLOGY, V128, pE132, DOI 10.1016/j.ophtha.2020.08.025	31	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2021	16	9							e0257654	10.1371/journal.pone.0257654	http://dx.doi.org/10.1371/journal.pone.0257654			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YS4WS	34550998	Green Published, gold			2022-12-26	WOS:000750679800036
J	Glogowsky, U; Hansen, E; Schachtele, S				Glogowsky, Ulrich; Hansen, Emanuel; Schachtele, Simeon			How effective are social distancing policies? Evidence on the fight against COVID-19	PLOS ONE			English	Article							CORONAVIRUS	To fight the spread of COVID-19, many countries implemented social distancing policies. This is the first paper that examines the effects of the German social distancing policies on behavior and the epidemic's spread. Exploiting the staggered timing of COVID-19 outbreaks in extended event-study models, we find that the policies heavily reduced mobility and contagion. In comparison to a no-social-distancing benchmark, within three weeks, the policies avoided 84% of the potential COVID-19 cases (point estimate: 499.3K) and 66% of the potential fatalities (5.4K). The policies' relative effects were smaller for individuals above 60 and in rural areas.	[Glogowsky, Ulrich] Johannes Kepler Univ Linz, Dept Econ, Linz, Austria; [Hansen, Emanuel] Univ Cologne, Ctr Macroecon Res, Cologne, Germany; [Schachtele, Simeon] Interamer Dev Bank, Washington, DC USA	Johannes Kepler University Linz; University of Cologne; Inter-American Development Bank	Glogowsky, U (corresponding author), Johannes Kepler Univ Linz, Dept Econ, Linz, Austria.	ulrich.glogowsky@jku.at	Hansen, Emanuel/ABF-8604-2021	Glogowsky, Ulrich/0000-0002-0781-1119; Hansen, Emanuel/0000-0003-3070-997X	Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) [CRC TRR 190]; Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) under Germany's Excellence Strategy [EXC2126/1 - 390838866]	Deutsche Forschungsgemeinschaft (DFG, German Research Foundation)(German Research Foundation (DFG)); Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) under Germany's Excellence Strategy(German Research Foundation (DFG))	Ulrich Glogowsky (UG) received financial support by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation): CRC TRR 190, Rationality and Competition. Emanuel Hansen (EH) received financial support by Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) under Germany's Excellence Strategy - EXC2126/1 - 390838866. The funder provided support in the form of salaries for author SS, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkeson A., 2020, Working Paper Series - National Bureau of Economic Research (Massachusetts); Bartscher A. K., 2020, ZEW Discussion Paper; Cheng ZKJ, 2020, INFECTION, V48, P155, DOI 10.1007/s15010-020-01401-y; Chinazzi M, 2020, SCIENCE, V368, P395, DOI 10.1126/science.aba9757; Courtemanche C, 2020, HEALTH AFFAIR, V39, P1237, DOI 10.1377/hlthaff.2020.00608; Dehning J, 2020, SCIENCE, V369, P160, DOI 10.1126/science.abb9789; Donsimoni JR, 2020, GER ECON REV, V21, P181, DOI 10.1515/ger-2020-0031; Eubank S, 2020, B MATH BIOL, V82, DOI 10.1007/s11538-020-00726-x; Fang HM, 2020, J PUBLIC ECON, V191, DOI 10.1016/j.jpubeco.2020.104272; Fernandez-Villaverde J, 2020, 27128 NBER; Ferretti L, 2020, SCIENCE, V368, P619, DOI 10.1126/science.abb6936; Goodman-Bacon A, 2020, SURV RES METHODS-GER, V14, P153, DOI 10.18148/srm/2020.v14i2.7723; Greenstone M., 2020, DOES SOCIAL DISTANCI, DOI DOI 10.2139/SSRN.3561244; Hellewell J, 2020, LANCET GLOB HEALTH, V8, pE488, DOI 10.1016/S2214-109X(20)30074-7; Juranek S, 2021, J POPUL ECON, V34, P1299, DOI 10.1007/s00148-021-00868-9; Kleven H, 2019, AM ECON J-APPL ECON, V11, P181, DOI 10.1257/app.20180010; Korolev I, 2021, J ECONOMETRICS, V220, P63, DOI 10.1016/j.jeconom.2020.07.038; Kuhbandner C, 2020, SCIENCE; Lu RJ, 2020, LANCET, V395, P565, DOI 10.1016/S0140-6736(20)30251-8; Maier BF, 2020, SCIENCE, V368, P742, DOI 10.1126/science.abb4557; Oliver N, 2020, SCI ADV, V6, DOI 10.1126/sciadv.abc0764; Robert Koch-Institut, 2020, FALLZ DEUTSCHL; Robert Koch-Institut, 2020, COVID 19 DAT; Robert Koch-Institut, 2020, ERL SCHATZ ZEITL VAR; Roda WC, 2020, INFECT DIS MODEL, V5, P271, DOI 10.1016/j.idm.2020.03.001; Schmidheiny Kurt, 2019, IZA DISCUSSION PAPER, V12079; Stafford N, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1395; Tian HY, 2020, SCIENCE, V368, P638, DOI 10.1126/science.abb6105; UNESCO, 2021, SCH SHUT GEND IMP CO; Wagschal U, 2020, POLITIKPANEL DEUTSCH; Wang C, 2020, LANCET, V395, P470, DOI 10.1016/S0140-6736(20)30185-9; WHO, 2019, REP WHO CHIN JOINT M; Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017	34	8	8	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2021	16	9							e0257363	10.1371/journal.pone.0257363	http://dx.doi.org/10.1371/journal.pone.0257363			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	YS4WS	34550995	Green Submitted, Green Published, gold			2022-12-26	WOS:000750679800017
J	Olaya-Galan, NN; Salas-Cardenas, SP; Rodriguez-Sarmiento, JL; Ibanez-Pinilla, M; Monroy, R; Corredor-Figueroa, AP; Rubiano, W; de la Pena, J; Shen, H; Buehring, GC; Patarroyo, MA; Gutierrez, MF				Olaya-Galan, Nury N.; Salas-Cardenas, Sandra P.; Rodriguez-Sarmiento, Jorge L.; Ibanez-Pinilla, Milciades; Monroy, Ricardo; Corredor-Figueroa, Adriana P.; Rubiano, Wilson; de la Pena, Jairo; Shen, HuaMin; Buehring, Gertrude C.; Patarroyo, Manuel A.; Gutierrez, Maria F.			Risk factor for breast cancer development under exposure to bovine leukemia virus in Colombian women: A case-control study	PLOS ONE			English	Article							DNA; SELECTION	Viruses have been implicated in cancer development in both humans and animals. The role of viruses in cancer is typically to initiate cellular transformation through cellular DNA damage, although specific mechanisms remain unknown. Silent and long-term viral infections need to be present, in order to initiate cancer disease. In efforts to establish a causative role of viruses, first is needed to demonstrate the strength and consistency of associations in different populations. The aim of this study was to determine the association of bovine leukemia virus (BLV), a causative agent of leukemia in cattle, with breast cancer and its biomarkers used as prognosis of the severity of the disease (Ki67, HER2, hormonal receptors) in Colombian women. An unmatched, observational case-control study was conducted among women undergoing breast surgery between 2016-2018. Malignant samples (n = 75) were considered as cases and benign samples (n = 83) as controls. Nested-liquid PCR, in-situ PCR and immunohistochemistry were used for viral detection in blood and breast tissues. For the risk assessment, only BLV positive samples from breast tissues were included in the analysis. BLV was higher in cases group (61.3%) compared with controls (48.2%), with a statistically significant association between the virus and breast cancer in the unconditional logistic regression (adjusted-OR = 2.450,95%CI:1.088-5.517, p = 0.031). In this study, BLV was found in both blood and breast tissues of participants and an association between breast cancer and the virus was confirmed in Colombia, as an intermediate risk factor.	[Olaya-Galan, Nury N.] Univ Rosario, PhD Program Biomed & Biol Sci, Bogota, Colombia; [Olaya-Galan, Nury N.; Salas-Cardenas, Sandra P.; Corredor-Figueroa, Adriana P.; Gutierrez, Maria F.] Pontificia Univ Javeriana, Dept Microbiol, Lab Virol, Grp Enfermedades Infecciosas, Bogota, Colombia; [Rodriguez-Sarmiento, Jorge L.] Pontificia Univ Javeriana, Dept Pathol, Hosp Univ San Ignacio, Bogota, Colombia; [Ibanez-Pinilla, Milciades; Monroy, Ricardo; Rubiano, Wilson; de la Pena, Jairo] Univ Rosario, Hosp Univ Mayor Mederi, Bogota, Colombia; [Shen, HuaMin; Buehring, Gertrude C.] Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA; [Patarroyo, Manuel A.] Fdn Inst Inmunol Colombia FIDIC, Mol Biol & Immunol Dept, Bogota, Colombia; [Patarroyo, Manuel A.] Univ Nacl Colombia, Fac Med, Microbiol Dept, Bogota, Colombia; [Patarroyo, Manuel A.] Univ Santo Tomas, Hlth Sci Div, Main Campus, Bogota, Colombia	Universidad del Rosario; Pontificia Universidad Javeriana; Hospital Universitario San Ignacio; Pontificia Universidad Javeriana; Universidad del Rosario; University of California System; University of California Berkeley; Universidad Nacional de Colombia; Universidad Santo Tomas USTA	Olaya-Galan, NN (corresponding author), Univ Rosario, PhD Program Biomed & Biol Sci, Bogota, Colombia.; Olaya-Galan, NN (corresponding author), Pontificia Univ Javeriana, Dept Microbiol, Lab Virol, Grp Enfermedades Infecciosas, Bogota, Colombia.	nury.olaya@urosario.edu.co	Olaya-Galan, Nury-Nathalia/L-9782-2016	Olaya-Galan, Nury-Nathalia/0000-0002-4282-4951	DEPARTMENTO ADMINISTRATIVO DE CIENCIA, TECNOLOGIA E INNOVACION from Colombia [657/2014]; HOSPITAL UNIVERSITARIO MAYOR MEDERI - Universidad del Rosario, Bogota, Colombia by COLCIENCIAS; FULBRIGHT COLOMBIA	DEPARTMENTO ADMINISTRATIVO DE CIENCIA, TECNOLOGIA E INNOVACION from Colombia; HOSPITAL UNIVERSITARIO MAYOR MEDERI - Universidad del Rosario, Bogota, Colombia by COLCIENCIAS; FULBRIGHT COLOMBIA	This work was supported by the DEPARTMENTO ADMINISTRATIVO DE CIENCIA, TECNOLOGIA E INNOVACION (COLCIENCIAS -https://minciencias.gov.co/convocatorias), from Colombia, grant number 657/2014 in national calls for projects. Data analysis and statistical support was funded by HOSPITAL UNIVERSITARIO MAYOR MEDERI - Universidad del Rosario, Bogota, Colombia (https://www.mederi.com.co/hospital-universitario/investigacion.Grant for national doctorate programs was awarded to NOG by COLCIENCIAS (national call 647/2014) for the accomplishment of her PhD in Biological and Biomedical Sciences at Universidad del Rosario and grant by FULBRIGHT COLOMBIA (2017 - https://www.fulbright.edu.co/estudiante-doctoral-colombiano/) was also awarded to NOG as a visiting student researcher for partially fulfilling experiments (IN-PCR and IHC techniques) at UC Berkeley in the US. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aida Y, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00328; Al-Alem U, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112916; Aluko R., 2012, MILK MILK PRODUCTS, P109; Armstrong CL, 2004, JOURNALISM MASS COMM, V81, P139, DOI 10.1177/107769900408100110; Bai LL, 2019, FASEB J, V33, P14516, DOI 10.1096/fj.201901528R; Barez PY, 2015, VIRUSES-BASEL, V7, P6080, DOI 10.3390/v7112929; Bosch FX, 2002, J CLIN PATHOL, V55, P244, DOI 10.1136/jcp.55.4.244; Buehring GC, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-019-3891-9; Buehring GC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179367; Buehring GC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134304; Buehring GC, 2014, EMERG INFECT DIS, V20, P772, DOI 10.3201/eid2005.131298; Burrell CJ, 2017, FENNER WHITES MED VI, P121; Carioli G, 2018, BREAST, V37, P163, DOI 10.1016/j.breast.2017.12.004; Chang Y, 2017, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2016.0264; Currer R, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00406; Manta FSD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075145; De Paoli P, 2013, INT J CANCER, V133, P1517, DOI 10.1002/ijc.27995; Di Sibio A, 2016, CANCER EPIDEMIOL, V44, pS110, DOI 10.1016/j.canep.2016.08.010; Editorial-BoardWC of T, 2019, WHO CLASSIFICATION T; Egawa N, 2015, VIRUSES-BASEL, V7, P3863, DOI 10.3390/v7072802; Fitzgibbons PL, 2018, COLL AM PATHOLOGISTS, P1; Francies FZ, 2020, AM J CANCER RES, V10, P1568; Gaglia MM, 2018, CURR OPIN VIROL, V32, P48, DOI 10.1016/j.coviro.2018.09.003; Gillet N, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-18; Gillet NA, 2016, RETROVIROLOGY, V13, DOI 10.1186/s12977-016-0308-3; Ginsburg O, 2018, CURR BREAST CANCER R, V10, P179, DOI 10.1007/s12609-018-0286-7; GIOVANNA M., 2013, OPEN J MED MICROBIOL, V3, P84, DOI [https://doi.org/10.4236/ojmm.2013.31013, DOI 10.4236/OJMM.2013.31013]; Gutierrez C, 2011, ARCH PATHOL LAB MED, V135, P55, DOI 10.1043/2010-0454-RAR.1; Hamada T, 2019, J PATHOL, V247, P615, DOI 10.1002/path.5236; Institute NC, 2021, WHAT IS CANC, DOI DOI 10.1002/9780470041000.CEDT005; Jimenez M, 2019, COMPLEXITY, DOI 10.1155/2019/9656938; Kamihira S, 2005, CLIN LAB HAEMATOL, V27, P235, DOI 10.1111/j.1365-2257.2005.00698.x; Khalilian M, 2019, MICROB PATHOGENESIS, V135, DOI 10.1016/j.micpath.2019.103566; Kundi M, 2006, ENVIRON HEALTH PERSP, V114, P969, DOI 10.1289/ehp.8297; Lawson JS, 2018, FRONT ONCOL, V8, DOI 10.3389/fonc.2018.00001; Lehrer S, 2019, DISCOV MED, V27, P163; Lendez P.A., 2018, MULTIDISCIP CANC INV, V2, P16, DOI 10.30699/acadpub.mci.4.16; Malaspinas AS, 2016, NATURE, V538, P207, DOI 10.1038/nature18299; Murakami H, 2016, J GEN VIROL, V97, P2753, DOI 10.1099/jgv.0.000583; Niermann GL, 1997, VIROLOGY, V239, P249, DOI 10.1006/viro.1997.8868; NUOVO GJ, 1995, PCR METH APPL, V4, pS151; Olaya-Galan NN, 2017, EPIDEMIOL INFECT, V145, P3125, DOI [10.1017/S0950268817002229, 10.1017/s0950268817002229]; Ossa H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164414; Corredor AP, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199397; Philpott SM, 1999, J NATL CANCER I, V91, P933, DOI 10.1093/jnci/91.11.933; Polat M, 2017, VIROL J, V14, DOI 10.1186/s12985-017-0876-4; Rakha EA, 2017, PATHOLOGY, V49, P111, DOI 10.1016/j.pathol.2016.10.012; Robinson LA, 2016, BRIT J CANCER, V115, P497, DOI 10.1038/bjc.2016.213; Salamat F, 2018, IRAN J MED SCI, V43, P355; Schwingel D, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-39834-7; Smith AJ, 2016, PROGR MOL BIOL TRANS, V1st; Tarver T, 2012, J CONS HLTH INTERNET, V16, P366, DOI 10.1080/15398285.2012.701177; United Nations Food and Agriculture Organization (FAO), 2019, LIV PROD LAT AM CAR; Uribe A, 2006, ESTUDIO POTENCIAL ZO, P31; Vineis P, 2014, LANCET, V383, P549, DOI 10.1016/S0140-6736(13)62224-2; WACHOLDER S, 1992, AM J EPIDEMIOL, V135, P1019, DOI 10.1093/oxfordjournals.aje.a116396; WACHOLDER S, 1992, AM J EPIDEMIOL, V135, P1029, DOI 10.1093/oxfordjournals.aje.a116397; WACHOLDER S, 1992, AM J EPIDEMIOL, V135, P1042, DOI 10.1093/oxfordjournals.aje.a116398; Wu S, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05467-z; Zhang R, 2016, BREAST CANCER RES, V18, DOI 10.1186/s13058-016-0763-8; Zhao XR, 2007, VIROLOGY, V366, P150, DOI 10.1016/j.virol.2007.03.058; Zhong P, 2013, CURR OPIN VIROL, V3, P44, DOI 10.1016/j.coviro.2012.11.004	62	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2021	16	9							e0257492	10.1371/journal.pone.0257492	http://dx.doi.org/10.1371/journal.pone.0257492			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YM4DR	34547016	Green Published, gold			2022-12-26	WOS:000746527400013
J	Fan, QD; Du, FT; Li, H; Zhang, CM				Fan, Qindong; Du, Fengtian; Li, Hu; Zhang, Chenming			Thermal-comfort evaluation of and plan for public space of Maling Village, Henan, China	PLOS ONE			English	Article							URBAN PARK; CLIMATE; HOT; DESIGN; SUMMER; TEMPERATURE; MICROCLIMATE; ENVIRONMENTS; ARCHITECTURE; PERFORMANCE	The thermal environment of village public space affects the comfort of people ' s outdoor activities, and then affects the willingness of residents to outdoor activities, which has an important impact on the villagers' quality of life. Previously published studies of thermal comfort mostly focused on the evaluation of thermal comfort index, few studies on the application of thermal comfort planning. The study was carried out in Maling Village, Changdai Town, Mengjin County, Luoyang City, Henan Province, China. Square, street, green space were chosen as three typical public spaces where thermal comfort indexes were measured by questionnaire survey and field measurement during summer. Subsequently, the village's microclimate environment was simulated with ArcGIS 10.6 and ENVI-met. The results indicate that during the summer, the influences of temperature, solar radiation, wind speed, and relative humidity on the subjective comfort conditions of the outdoor environment gradually decreased. The spatial form of village has an important influence on thermal comfort. Finally, based on the results, this study put forward the thermal comfort process and planning scheme of the village outdoor space.	[Fan, Qindong; Li, Hu; Zhang, Chenming] North China Univ Water Resources & Elect Power, Sch Architecture, Zhengzhou, Peoples R China; [Du, Fengtian] North China Univ Water Resources & Elect Power, Sch Art & Design, Zhengzhou, Peoples R China	North China University of Water Resources & Electric Power; North China University of Water Resources & Electric Power	Du, FT (corresponding author), North China Univ Water Resources & Elect Power, Sch Art & Design, Zhengzhou, Peoples R China.	dufengtian@126.com			2019 Key R&D and Promotion Projects in Henan Province [192102310004]; Henan Ecological Civilization City Theory and Application Innovative Scientific and Technological Team; 2020 Henan Science and Technology Think Tank Research Project [HNKJZK-2020-02C, HNKJZK-2020-25C]	2019 Key R&D and Promotion Projects in Henan Province; Henan Ecological Civilization City Theory and Application Innovative Scientific and Technological Team; 2020 Henan Science and Technology Think Tank Research Project	This study was supported by 2019 Key R&D and Promotion Projects in Henan Province (No. 192102310004), Henan Ecological Civilization City Theory and Application Innovative Scientific and Technological Team, 2020 Henan Science and Technology Think Tank Research Project (HNKJZK-2020-02C and HNKJZK-2020-25C).	Aboelata A, 2020, BUILD ENVIRON, V172, DOI 10.1016/j.buildenv.2020.106712; Acero JA, 2020, THEOR APPL CLIMATOL, V139, P659, DOI 10.1007/s00704-019-02992-9; Acero JA, 2019, BUILD SIMUL-CHINA, V12, P973, DOI 10.1007/s12273-019-0537-1; Al-Motawakel M. K., 1986, APPL ENERG; Ali SB, 2018, URBAN CLIM, V24, P954, DOI 10.1016/j.uclim.2017.11.006; Ali-Toudert F, 2007, SOL ENERGY, V81, P742, DOI 10.1016/j.solener.2006.10.007; ALP AV, 1991, ENERG BUILDINGS, V16, P809; Amindeldar S, 2017, SUSTAIN CITIES SOC, V32, P153, DOI 10.1016/j.scs.2017.03.024; Andrade H, 2011, INT J BIOMETEOROL, V55, P665, DOI 10.1007/s00484-010-0379-0; [Anonymous], 2020, SAT IM FIGS 1 A 2 18; Berkovic S, 2012, SOL ENERGY, V86, P1173, DOI 10.1016/j.solener.2012.01.010; Blazejczyk K, 2012, INT J BIOMETEOROL, V56, P515, DOI 10.1007/s00484-011-0453-2; Bruse M, 1998, ENVIRON MODELL SOFTW, V13, P373, DOI 10.1016/S1364-8152(98)00042-5; Cantin R, 2010, BUILD ENVIRON, V45, P473, DOI 10.1016/j.buildenv.2009.07.010; Chen L, 2015, BUILD ENVIRON, V94, P644, DOI 10.1016/j.buildenv.2015.10.020; Chen L, 2012, CITIES, V29, P118, DOI 10.1016/j.cities.2011.08.006; Cheung PK, 2018, BUILD ENVIRON, V130, P49, DOI 10.1016/j.buildenv.2017.12.013; Chow WTL, 2012, BUILD ENVIRON, V47, P170, DOI 10.1016/j.buildenv.2011.07.027; Concepts R., 2014, THERMAL ENV CONDITIO, P5; Hirashima SQD, 2018, URBAN CLIM, V23, P219, DOI 10.1016/j.uclim.2016.08.007; Dili AS, 2010, ENERG BUILDINGS, V42, P2139, DOI 10.1016/j.enbuild.2010.07.004; Ehsan S., 2018, INT J BIOMETEOROL, P1; Fang ZS, 2019, SUSTAIN CITIES SOC, V44, P676, DOI 10.1016/j.scs.2018.10.022; FANGER P. O., 1970, Thermal comfort. Analysis and applications in environmental engineering.; Fathy H, 1986, NATURAL ENERGY VERNA; Gao S, 2017, APPL THERM ENG, V122, P461, DOI 10.1016/j.applthermaleng.2017.05.044; Gao Y F, 2016, RES MICROCLIMATE ENV; Gold E., 1935, Q J R METEOROL SOC, V61, P316, DOI [10.1002/qj.49706126104, DOI 10.1002/QJ.49706126104]; Hamdan DMA, 2019, ENERG BUILDINGS, V200, P86, DOI 10.1016/j.enbuild.2019.07.028; He BJ, 2021, ENVIRON RES, V193, DOI 10.1016/j.envres.2020.110584; He BJ, 2020, SUSTAIN CITIES SOC, V60, DOI 10.1016/j.scs.2020.102289; He BJ, 2020, J BUILD ENG, V29, DOI 10.1016/j.jobe.2019.101145; He BJ, 2020, URBAN CLIM, V31, DOI 10.1016/j.uclim.2019.100567; He BJ., SUSTAIN CITIES SOC, V60; He XY, 2020, BUILD ENVIRON, V172, DOI 10.1016/j.buildenv.2020.106739; Huang QD, 2018, SUSTAINABILITY-BASEL, V10, DOI 10.3390/su10093227; Hwang RL, 2011, BUILD ENVIRON, V46, P863, DOI 10.1016/j.buildenv.2010.10.017; Indraganti M, 2010, BUILD ENVIRON, V45, P2709, DOI 10.1016/j.buildenv.2010.05.030; Inji K., 2018, SUSTAIN CITIES SOC, V43; Jin H, 2019, ENERG BUILDINGS, V198, P197, DOI 10.1016/j.enbuild.2019.05.054; Johansson E., 2017, INT J BIOMETEOROL, V62; Johansson E., 2017, INT J BIOMETEOROL, V62; Johansson E, 2006, BUILD ENVIRON, V41, P1326, DOI 10.1016/j.buildenv.2005.05.022; Kantor N, 2018, LANDSCAPE URBAN PLAN, V170, P241, DOI 10.1016/j.landurbplan.2017.09.030; Knez I, 2008, BUILD ENVIRON, V43, P1483, DOI 10.1016/j.buildenv.2007.08.002; Kottek M, 2006, METEOROL Z, V15, P259, DOI 10.1127/0941-2948/2006/0130; Lai DY, 2014, BUILD ENVIRON, V77, P110, DOI 10.1016/j.buildenv.2014.03.026; Lenzholzer S, 2012, RESOUR CONSERV RECY, V64, P39, DOI 10.1016/j.resconrec.2011.06.015; Lenzholzer S, 2010, LANDSCAPE URBAN PLAN, V95, P1, DOI 10.1016/j.landurbplan.2009.10.013; Lin TP, 2013, BUILD ENVIRON, V59, P599, DOI 10.1016/j.buildenv.2012.10.005; Lin TP, 2012, LANDSCAPE URBAN PLAN, V107, P137, DOI 10.1016/j.landurbplan.2012.05.011; Liu JP, 2011, BUILD ENVIRON, V46, P1709, DOI 10.1016/j.buildenv.2011.02.012; Liu X, 2015, STUDY MICROCLIMATE S; Liu Z., 2019, INT J ENV RES PUB HE, V16; Lu J, 2017, SUSTAIN CITIES SOC, V32, P513, DOI 10.1016/j.scs.2017.04.017; Ma K, 2019, SUSTAINABILITY-BASEL, V11, DOI 10.3390/su11020368; Ma Y Y, 2018, RES SIMULATION OPTIM; Matzarakis A, 1999, INT J BIOMETEOROL, V43, P76, DOI 10.1007/s004840050119; Matzarakis A, 2010, INT J BIOMETEOROL, V54, P131, DOI [10.1007/s00484-006-0061-8, 10.1007/s00484-009-0261-0]; Mayer H, 2008, METEOROL Z, V17, P241, DOI 10.1127/0941-2948/2008/0285; Milosevic DD, 2017, URBAN FOR URBAN GREE, V23, P113, DOI 10.1016/j.ufug.2017.03.011; Morakinyo TE, 2018, BUILD ENVIRON, V137, P157, DOI 10.1016/j.buildenv.2018.04.012; Morakinyo TE, 2017, ENERG BUILDINGS, V145, P226, DOI 10.1016/j.enbuild.2017.03.066; Morakinyo TE, 2017, BUILD ENVIRON, V115, P1, DOI 10.1016/j.buildenv.2017.01.005; Muhaisen AS, 2006, BUILD ENVIRON, V41, P1050, DOI 10.1016/j.buildenv.2005.04.027; Nasrollahi N, 2017, SUSTAIN CITIES SOC, V35, P449, DOI 10.1016/j.scs.2017.08.017; Niu JL, 2015, BUILD ENVIRON, V91, P263, DOI 10.1016/j.buildenv.2015.02.017; Park CY, 2019, SUSTAIN CITIES SOC, V48, DOI 10.1016/j.scs.2019.101521; Park S, 2014, LANDSCAPE URBAN PLAN, V125, P146, DOI 10.1016/j.landurbplan.2014.02.014; Qi Y, 2020, BUILD ENVIRON, V168, DOI 10.1016/j.buildenv.2019.106524; Singh MK, 2009, BUILD ENVIRON, V44, P878, DOI 10.1016/j.buildenv.2008.06.008; Stewart ID, 2012, B AM METEOROL SOC, V93, P1879, DOI 10.1175/BAMS-D-11-00019.1; Stewart ID, 2014, INT J CLIMATOL, V34, P1062, DOI 10.1002/joc.3746; Taleghani M, 2015, BUILD ENVIRON, V83, P65, DOI 10.1016/j.buildenv.2014.03.014; Thorsson S, 2004, INT J BIOMETEOROL, V48, P149, DOI 10.1007/s00484-003-0189-8; Vanos JK, 2010, INT J BIOMETEOROL, V54, P319, DOI 10.1007/s00484-010-0301-9; Wen B, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12041316; Xi TY, 2012, BUILD ENVIRON, V52, P162, DOI 10.1016/j.buildenv.2011.11.006; Xiao Y., 2019, SUSTAINABILITY-BASEL, V12, P314; Xu M, 2018, SUSTAIN CITIES SOC, V43, P208, DOI 10.1016/j.scs.2018.08.034; Xu XY, 2017, ENERG BUILDINGS, V149, P91, DOI 10.1016/j.enbuild.2017.05.052; Yan HY., 2017, NO HORTICULTURE, P114; Yang J, 2021, SUSTAIN CITIES SOC, V69, DOI 10.1016/j.scs.2021.102818; Yang J, 2020, URBAN CLIM, V34, DOI 10.1016/j.uclim.2020.100700; Yang J, 2020, J CLEAN PROD, V275, DOI 10.1016/j.jclepro.2020.123767; Yang J, 2019, SUSTAIN CITIES SOC, V47, DOI 10.1016/j.scs.2019.101487; Yang J, 2019, IEEE ACCESS, V7, P4195, DOI 10.1109/ACCESS.2018.2888976; Zaki SA, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12031053; Zhang AX, 2017, BUILD ENVIRON, V124, P369, DOI 10.1016/j.buildenv.2017.08.024; Zhang L, 2018, BUILD ENVIRON, V130, P27, DOI 10.1016/j.buildenv.2017.12.014; Zhang LLL, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12051961; Zolch T, 2019, BUILD ENVIRON, V149, P640, DOI 10.1016/j.buildenv.2018.12.051; Zou LL, 2020, HABITAT INT, V100, DOI 10.1016/j.habitatint.2020.102182	93	2	2	20	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2021	16	9							e0256439	10.1371/journal.pone.0256439	http://dx.doi.org/10.1371/journal.pone.0256439			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	WG6BN	34543300	Green Published, gold			2022-12-26	WOS:000707078200014
J	Anafo, RB; Atiase, Y; Kotey, FCN; Dayie, NTKD; Tetteh-Quarcoo, PB; Duodu, S; Osei, MM; Alzahrani, KJ; Donkor, ES				Anafo, Ramzy B.; Atiase, Yacoba; Kotey, Fleischer C. N.; Dayie, Nicholas T. K. D.; Tetteh-Quarcoo, Patience B.; Duodu, Samuel; Osei, Mary-Magdalene; Alzahrani, Khalid J.; Donkor, Eric S.			Methicillin-resistant Staphylococcus aureus (MRSA) nasal carriage among patients with diabetes at the Korle Bu Teaching Hospital	PLOS ONE			English	Article							RISK-FACTORS; COLONIZATION; PREVALENCE; INFECTION; CEFTAROLINE; POPULATION; BACTEREMIA; EPIDEMIOLOGY; MECHANISMS; IMPACT	Aim To investigate the epidemiology of S. aureus and MRSA nasal carriage among people with diabetes at the Korle Bu Teaching Hospital in Accra, including the prevalence, predictors of carriage, and antibiotic resistance. Methodology This study was cross-sectional, involving 300 diabetes patients and 106 non-diabetic individuals. Swab specimens of the nares were obtained from the participants and bacteriologically-cultured. Identification and characterization of S. aureus and MRSA were based on standard bacteriological methods; antimicrobial susceptibility testing was by the Kirby-Bauer method. Results The prevalence of staphylococcal carriage, the diabetes group relative to the non-diabetes group, were 31.0% and 10.4% (S. aureus), and 3.3% and 0.0% (MRSA). Presence of diabetes predisposed to S. aureus carriage, but not MRSA nor coagulase-negative staphylococci (CoNS) carriage (OR = 3.88; p < 0.0001). Colonization with CoNS was protective of S. aureus (OR = 0.039, p < 0.001) and MRSA (OR = 0.115, p = 0.043) colonization among the diabetics. The antimicrobial resistance patterns recorded among the S. aureus isolated from the diabetic individuals relative to the non-diabetics were as follows: penicillin (95% vs. 91%), tetracycline (37% vs. 27%), cotrimoxazole (30% vs. 36%), erythromycin (17% vs. 0%), norfloxacin (13% vs. 0%), clindamycin (12% vs. 0%), gentamicin (9% vs. 0%), fusidic acid (10% vs. 9%), linezolid (4% vs. 0%), and rifampicin (5% vs. 0%). The proportion of multidrug resistant S. aureus was 41% (n = 38) in the diabetes group and 0% in the non-diabetes group; this difference was statistically significant (p = 0.01). Conclusions The presence of diabetes predisposed the participants to S. aureus carriage by almost four folds, but not MRSA carriage. Colonization with CoNS was protective of S. aureus and MRSA carriage in the diabetes group. Finally, linezolid remains a good therapeutic agent for anti-MRSA therapy.	[Anafo, Ramzy B.; Kotey, Fleischer C. N.; Dayie, Nicholas T. K. D.; Tetteh-Quarcoo, Patience B.; Osei, Mary-Magdalene; Donkor, Eric S.] Univ Ghana, Dept Med Microbiol, Med Sch, Korle Bu, Accra, Ghana; [Atiase, Yacoba] Univ Ghana, Dept Med, Med Sch, Korle Bu, Accra, Ghana; [Kotey, Fleischer C. N.; Osei, Mary-Magdalene] FleRhoLife Res Consult, Teshie, Accra, Ghana; [Duodu, Samuel] Univ Ghana, Dept Biochem Cell & Mol Biol, Legon, Accra, Ghana; [Duodu, Samuel] Univ Ghana, West African Ctr Cell Biol Infect Pathogens, Legon, Accra, Ghana; [Alzahrani, Khalid J.] Taif Univ, Coll Appl Med Sci, Dept Clin Lab Sci, At Taif, Saudi Arabia	University of Ghana; University of Ghana; University of Ghana; University of Ghana; Taif University	Donkor, ES (corresponding author), Univ Ghana, Dept Med Microbiol, Med Sch, Korle Bu, Accra, Ghana.	esampane-donkor@ug.edu.gh	Alzahrani, Khalid/AAJ-4886-2021	Alzahrani, Khalid/0000-0002-6688-0106; Dayie, Nicholas T.K.D./0000-0003-4491-6902; Kotey, Fleischer/0000-0003-0286-3638; Donkor, Eric S./0000-0002-9368-0636	Taif University Researchers Supporting Program [TURSP-2020/128]; Taif University, Saudi Arabia	Taif University Researchers Supporting Program; Taif University, Saudi Arabia	This study was supported by Taif University Researchers Supporting Program (Project Number: TURSP-2020/128), Taif University, Saudi Arabia. Although FCNK and MMO are affiliated with FleRhoLife Research Consult, the firm didnot provide financial support nor play a role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahluwalia A, 2000, DIABETIC MED, V17, P487; Appiah VA, 2020, PATHOGENS, V9, DOI 10.3390/pathogens9050329; Bogaert D, 2004, LANCET, V363, P1871, DOI 10.1016/S0140-6736(04)16357-5; Camargo CH, 2013, DIAGN MICR INFEC DIS, V76, P372, DOI 10.1016/j.diagmicrobio.2013.03.013; Casey JA, 2013, EPIDEMIOL INFECT, V141, P1166, DOI 10.1017/S0950268812001872; Cenizal MJ, 2008, JAIDS-J ACQ IMM DEF, V48, P567, DOI 10.1097/QAI.0b013e31817e9b79; Chambers HF, 2009, NAT REV MICROBIOL, V7, P629, DOI 10.1038/nrmicro2200; Chambers HF, 1997, CLIN MICROBIOL REV, V10, P781, DOI 10.1128/CMR.10.4.781; Chen CC, 2013, AM J INFECT CONTROL, V41, P1100, DOI 10.1016/j.ajic.2013.01.035; de Kraker MEA, 2011, ANTIMICROB AGENTS CH, V55, P1598, DOI 10.1128/AAC.01157-10; Donkor ES, 2019, PATHOGENS, V8, DOI 10.3390/pathogens8010035; Donkor ES, 2018, INFECT DRUG RESIST, V11, P1757, DOI 10.2147/IDR.S167639; Egyir B, 2016, J INFECT DEV COUNTR, V10, P453, DOI 10.3855/jidc.7428; Egyir B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096119; Egyir B, 2013, J GLOB ANTIMICROB RE, V1, P189, DOI 10.1016/j.jgar.2013.05.006; Elixhauser A., 2007, INFECT METHICILLIN R; ERIKSEN NHR, 1995, EPIDEMIOL INFECT, V115, P51, DOI 10.1017/S0950268800058118; Farley JE, 2015, AM J INFECT CONTROL, V43, P329, DOI 10.1016/j.ajic.2014.12.024; File TM, 2012, CLIN INFECT DIS, V55, pS173, DOI 10.1093/cid/cis559; Foster TJ, 2005, NAT REV MICROBIOL, V3, P948, DOI 10.1038/nrmicro1289; Haenni M, 2012, J ANTIMICROB CHEMOTH, V67, P326, DOI 10.1093/jac/dkr499; Hall GS., 2003, MICROBIOLOGY FRONTLI, V3, P1; Han LL, 2007, J CLIN MICROBIOL, V45, P1350, DOI 10.1128/JCM.02274-06; Hart J, 2015, J DIABETES COMPLICAT, V29, P1092, DOI 10.1016/j.jdiacomp.2015.06.005; Ho TT, 2012, J ANTIMICROB CHEMOTH, V67, P1267, DOI 10.1093/jac/dks006; HU L, 1995, J MED MICROBIOL, V42, P127, DOI 10.1099/00222615-42-2-127; Huifen Y., 2015, CHIN J DISINFECT, V32, P24; International Diabetes Federation,, 2019, IDF DIABETES ATLAS; Iwase T, 2010, NATURE, V465, P346, DOI 10.1038/nature09074; Joore IKCW, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-002505; Klevens RM, 2007, PUBLIC HEALTH REP, V122, P160, DOI 10.1177/003335490712200205; Kluytmans J, 1997, CLIN MICROBIOL REV, V10, P505, DOI 10.1128/CMR.10.3.505; Kotpal Ruchi, 2016, J Int Assoc Provid AIDS Care, V15, P141, DOI 10.1177/2325957414554005; Kutlu SS, 2012, AM J INFECT CONTROL, V40, P365, DOI 10.1016/j.ajic.2011.05.009; Kyaw WM, 2012, AIDS RES THER, V9, DOI 10.1186/1742-6405-9-33; Lin JL, 2017, J DIABETES INVEST, V8, P383, DOI 10.1111/jdi.12591; Lin SY, 2020, J MICROBIOL IMMUNOL, V53, P292, DOI 10.1016/j.jmii.2018.03.005; Loeffler A, 2013, VET DERMATOL, V24, P538, DOI 10.1111/vde.12062; Moran GJ, 2006, NEW ENGL J MED, V355, P666, DOI 10.1056/NEJMoa055356; Nouwen J, 2004, INFECT IMMUN, V72, P6685, DOI 10.1128/IAI.72.11.6685-6688.2004; Obeng-Nkrumah Noah, 2015, BMC Res Notes, V8, P742, DOI 10.1186/s13104-015-1701-z; Olson ME, 2014, J BACTERIOL, V196, P3482, DOI 10.1128/JB.01882-14; Omar N., 2007, EGYPTIAN J MED MICRO, V16, P29; Paharik AE, 2017, CELL HOST MICROBE, V22, P746, DOI 10.1016/j.chom.2017.11.001; Peacock SJ, 2015, ANNU REV BIOCHEM, V84, P577, DOI 10.1146/annurev-biochem-060614-034516; Polenakovik HM, 2013, INT J ANTIMICROB AG, V42, P450, DOI 10.1016/j.ijantimicag.2013.07.005; Quitoco Isidorio Mebinda Zuco, 2013, BMC Res Notes, V6, P336, DOI 10.1186/1756-0500-6-336; Sampane-Donkor Eric, 2017, Pan Afr Med J, V26, P60, DOI 10.11604/pamj.2017.26.60.10981; Saxena AK, 2002, RENAL FAILURE, V24, P763, DOI 10.1081/JDI-120015679; Tacconelli E, 2004, J ANTIMICROB CHEMOTH, V53, P474, DOI 10.1093/jac/dkh107; von Eiff C, 2001, NEW ENGL J MED, V344, P11, DOI 10.1056/NEJM200101043440102; Wertheim HFL, 2005, LANCET INFECT DIS, V5, P751, DOI 10.1016/S1473-3099(05)70295-4; WILLIAMS RE, 1963, BACTERIOL REV, V27, P56, DOI 10.1128/MMBR.27.1.56-71.1963; Yan L., 2015, JPRACT MED, V31, P4133	54	2	2	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2021	16	9							e0257004	10.1371/journal.pone.0257004	http://dx.doi.org/10.1371/journal.pone.0257004			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	WG5ZQ	34534230	Green Published, gold			2022-12-26	WOS:000707073300015
J	Tateyama-Makino, R; Abe-Yutori, M; Iwamoto, T; Tsutsumi, K; Tsuji, M; Morishita, S; Kurita, K; Yamamoto, Y; Nishinaga, E; Tsukinoki, K				Tateyama-Makino, Riho; Abe-Yutori, Mari; Iwamoto, Taku; Tsutsumi, Kota; Tsuji, Motonori; Morishita, Satoru; Kurita, Kei; Yamamoto, Yukio; Nishinaga, Eiji; Tsukinoki, Keiichi			The inhibitory effects of toothpaste and mouthwash ingredients on the interaction between the SARS-CoV-2 spike protein and ACE2, and the protease activity of TMPRSS2 in vitro	PLOS ONE			English	Article							DOCKING; ACID	SARS-CoV-2 enters host cells when the viral spike protein is cleaved by transmembrane protease serine 2 (TMPRSS2) after binding to the host angiotensin-converting enzyme 2 (ACE2). Since ACE2 and TMPRSS2 are expressed in the tongue and gingival mucosa, the oral cavity is a potential entry point for SARS-CoV-2. This study evaluated the inhibitory effects of general ingredients of toothpastes and mouthwashes on the spike protein-ACE2 interaction and the TMPRSS2 protease activity using an in vitro assay. Both assays detected inhibitory effects of sodium tetradecene sulfonate, sodium N-lauroyl-N-methyltaurate, sodium N-lauroylsarcosinate, sodium dodecyl sulfate, and copper gluconate. Molecular docking simulations suggested that these ingredients could bind to inhibitor-binding site of ACE2. Furthermore, tranexamic acid exerted inhibitory effects on TMPRSS2 protease activity. Our findings suggest that these toothpaste and mouthwash ingredients could help prevent SARS-CoV-2 infection.	[Tateyama-Makino, Riho; Abe-Yutori, Mari; Iwamoto, Taku; Tsutsumi, Kota; Morishita, Satoru; Kurita, Kei; Yamamoto, Yukio; Nishinaga, Eiji] Lion Corp, Res & Dev Headquarters, Edogawa Ku, Tokyo, Japan; [Tsuji, Motonori] Inst Mol Funct, Misato, Saitama, Japan; [Tsukinoki, Keiichi] Kanagawa Dent Univ, Dept Oral Sci, Div Environm Pathol, Yokosuka, Kanagawa, Japan	Lion Corporation; Kanagawa Dental College	Tateyama-Makino, R (corresponding author), Lion Corp, Res & Dev Headquarters, Edogawa Ku, Tokyo, Japan.	riho-t@lion.co.jp	; Tsuji, Motonori/O-1205-2016	Tateyama-Makino, Riho/0000-0001-5206-8339; Yutori, Mari/0000-0001-5388-1962; Tsuji, Motonori/0000-0003-0734-0334; Tsutsumi, Kota/0000-0003-1371-2915; Iwamoto, Taku/0000-0002-6267-2801	Lion Corporation	Lion Corporation	This work was fully funded by Lion Corporation (https://www.lion.co.jp/en/).R Tateyama-Makino, M Abe-Yutori, T Iwamoto, K Tsutsumi, S Morishita, K Kurita, Y Yamamoto, and E Nishinaga are employees of Lion Corporation. The Lion Corporation provided support in the form of salaries for authors R Tateyama-Makino, M AbeYutori, T Iwamoto, K Tsutsumi, S Morishita, K Kurita, Y Yamamoto, and E Nishinaga. M Tsuji is a President of the Institute of Molecular Function (Saitama, Japan). Molecular docking simulation was performed by the Institute of Molecular Function under a consignment from the Lion Corporation. K Tsukinoki has received fees for technical guidance from the Lion Corporation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions" section.	Abdel-Moneim AS, 2021, VIROLOGY, V558, P1, DOI 10.1016/j.virol.2021.02.007; Ali Fedaa, 2021, Med Drug Discov, V10, P100086, DOI 10.1016/j.medidd.2021.100086; Andleeb S., 2020, INT J CLIN MICROBIOL, V3, P1, DOI [10.29328/journal.ijcmbt.1001008, DOI 10.29328/JOURNAL.IJCMBT.1001008]; Baliga Sharmila, 2013, J Indian Soc Periodontol, V17, P461, DOI 10.4103/0972-124X.118317; Carrouel F, 2021, J DENT RES, V100, P124, DOI 10.1177/0022034520967933; Creeth J, 2019, J CLIN PERIODONTOL, V46, P1105, DOI 10.1111/jcpe.13175; Hoffmann M, 2021, EBIOMEDICINE, V65, DOI 10.1016/j.ebiom.2021.103255; Hoffmann M, 2020, CELL, V181, P271, DOI 10.1016/j.cell.2020.02.052; Huang N, 2021, NAT MED, V27, P892, DOI 10.1038/s41591-021-01296-8; Ikeda K., 1981, J JPN SOC PERIODONTO, V23, P437, DOI [10.2329/perio.23.437, DOI 10.2329/PERIO.23.437]; Ishii S., 2019, JPN J CONSERV DENT, V62, P286, DOI [10.11471/shikahozon.62.286, DOI 10.11471/SHIKAHOZON.62.286]; Ishii S, 2019, Composition for Oral Cavity, Patent No. [WO2019/230710, 2019230710]; Ishizuka Y, 2020, CARIES RES, V54, P343, DOI 10.1159/000510181; Jelinska A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175838; Jensen GV, 2020, FRONT MOL BIOSCI, V7, DOI 10.3389/fmolb.2020.00125; Kabir MA, 2021, MICROBES INFECT, V23, DOI 10.1016/j.micinf.2021.104832; Krebs F, 2021, ELECTROPHORESIS, V42, P687, DOI 10.1002/elps.202100015; Kwofie SK, 2019, TOXINS, V11, DOI 10.3390/toxins11030181; Lan J, 2020, NATURE, V581, P215, DOI 10.1038/s41586-020-2180-5; Lippert F, 2013, MONOGR ORAL SCI, V23, P1, DOI 10.1159/000350456; Ma HC, 2020, INT J BIOL MACROMOL, V162, P1546, DOI 10.1016/j.ijbiomac.2020.08.020; Ministry of Health Labor and Welfare, 2015, MARK APPR STAND MED; Neufurth M, 2020, BIOCHEM PHARMACOL, V182, DOI 10.1016/j.bcp.2020.114215; Ohbu K., 1980, J JPN OIL CHEM SOC, V29, P866, DOI [10.5650/jos1956.29.866, DOI 10.5650/JOS1956.29.866]; Otten MPT, 2011, EUR J ORAL SCI, V119, P151, DOI 10.1111/j.1600-0722.2011.00812.x; Ozono S, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-21118-2; Pavlova A., 2021, CRITICAL INTERACTION, V2021, P2021, DOI [10.1021/acs.jpclett.1c01494, DOI 10.1021/ACS.JPCLETT.1C01494]; Pooja M, 2021, EUR J PHARMACOL, V890, DOI 10.1016/j.ejphar.2020.173688; Rahman N, 2020, MOLECULES, V25, DOI 10.3390/molecules25102271; Reznikov LR, 2021, BIOCHEM BIOPH RES CO, V538, P173, DOI 10.1016/j.bbrc.2020.11.095; Ritz C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0146021; Sakaguchi W, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21176000; Shrimp JH, 2020, ACS PHARMACOL TRANSL, V3, P997, DOI 10.1021/acsptsci.0c00106; Simon M, 2021, CURR OPIN COLLOID IN, V55, DOI 10.1016/j.cocis.2021.101479; TAKADA A, 1979, THROMB RES, V14, P915, DOI 10.1016/0049-3848(79)90009-4; Tchesnokova V, 2021, J CLIN MICROBIOL, V59, DOI [10.1128/JCM.00921-21, 10.1101/2021.02.22.432189]; ten Cate J M, 1995, Adv Dent Res, V9, P332; Tian F., 2021, MUTATION N501Y RBD S, DOI [10.1101/2021.02.14.431117, DOI 10.1101/2021.02.14.431117]; Towler P, 2004, J BIOL CHEM, V279, P17996, DOI 10.1074/jbc.M311191200; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Tsuji M., 2007, MOL SCI, V1, pNP004; Tsuji M, 2020, FEBS OPEN BIO, V10, P995, DOI 10.1002/2211-5463.12875; Tsuji M, 2015, J COMPUT AID MOL DES, V29, P975, DOI 10.1007/s10822-015-9869-9; Waterhouse A, 2018, NUCLEIC ACIDS RES, V46, pW296, DOI 10.1093/nar/gky427; Xu H, 2020, INT J ORAL SCI, V12, DOI [10.1038/s41368-020-0074-X, 10.1038/s41368-020-0074-x]; Yan CH., 2020, INT FORUM ALLERGY RH, V10, P806, DOI [10.1002/alr.22579, DOI 10.1002/alr.22579]; Zhong ZF, 2019, CHIN MED-UK, V14, DOI 10.1186/s13020-019-0260-y	47	9	9	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2021	16	9							e0257705	10.1371/journal.pone.0257705	http://dx.doi.org/10.1371/journal.pone.0257705			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	WG5ZQ	34534255	Green Published, Green Submitted, gold			2022-12-26	WOS:000707073300046
J	Kwon, JA; Dore, GJ; Hajarizadeh, B; Alavi, M; Valerio, H; Grebely, J; Guy, R; Gray, RT				Kwon, Jisoo A.; Dore, Gregory J.; Hajarizadeh, Behzad; Alavi, Maryam; Valerio, Heather; Grebely, Jason; Guy, Rebecca; Gray, Richard T.			Australia could miss the WHO hepatitis C virus elimination targets due to declining treatment uptake and ongoing burden of advanced liver disease complications	PLOS ONE			English	Article							HCV GENOTYPE 1; INJECT DRUGS; HEPATOCELLULAR-CARCINOMA; VIRAL-HEPATITIS; INFECTION; PEOPLE; IMPACT; CARE; COMBINATION; SOFOSBUVIR	Australia was one of the first countries to introduce government-funded unrestricted access to direct-acting antiviral (DAA) therapy, with 88,790 treated since March 2016. However, treatment uptake is declining which could potentially undermine Australia's progress towards the WHO HCV elimination targets. Using mathematical modelling, we updated estimates for those living with chronic HCV in Australia, new cases of decompensated cirrhosis (DC), hepatocellular carcinoma (HCC), and liver-related mortality among the HCV-cured and viraemic populations from 2015 to 2030. We considered various DAA treatment scenarios incorporating annual treatment numbers to 2020, and subsequent uptake per year of 6,790 (pessimistic), 8,100 (intermediate), and 11,310 (optimistic). We incorporated the effects of excess alcohol consumption and reduction in progression to DC and HCC among cirrhosis-cured versus viraemic individuals. At the end of 2020, we estimated 117,810 Australians were living with chronic HCV. New cases per year of DC, HCC, and liver-related mortality among the HCV viraemic population decreased rapidly from 2015 (almost eliminated by 2030). In contrast, the growing population size of those cured with advanced liver disease meant DC, HCC, and liver-related mortality declined slowly. The estimated reduction in liver-related mortality from 2015 to 2030 in the combined HCV viraemic and cured population is 25% in the intermediate scenario. With declining HCV treatment uptake and ongoing individual-level risk of advanced liver disease complications, including among cirrhosis-cured individuals, Australia is unlikely to achieve all WHO HCV elimination targets by 2030.	[Kwon, Jisoo A.; Dore, Gregory J.; Hajarizadeh, Behzad; Alavi, Maryam; Valerio, Heather; Grebely, Jason; Guy, Rebecca; Gray, Richard T.] UNSW Sydney, Kirby Inst, Sydney, NSW, Australia	University of New South Wales Sydney; Kirby Institute	Kwon, JA (corresponding author), UNSW Sydney, Kirby Inst, Sydney, NSW, Australia.	akwon@kirby.unsw.edu.au	Dore, Gregory John/ABD-5665-2021; Hajarizadeh, Behzad/AAY-9361-2021	Dore, Gregory John/0000-0002-4741-2622; Hajarizadeh, Behzad/0000-0003-2212-2028; Grebely, Jason/0000-0002-1833-2017; Kwon, Jisoo Amy/0000-0003-2829-6694; Gray, Richard/0000-0002-2885-0483	Australian Government Department of Health; Gilead; Merck; Abbvie; Camurus; Cepheid; Hologic; Indivior; Australian National Health and Medical Research Council (NHMRC) Investigator Grant [1176131]	Australian Government Department of Health(Australian GovernmentDepartment of Health & Ageing); Gilead(Gilead Sciences); Merck(Merck & Company); Abbvie(AbbVie); Camurus; Cepheid; Hologic; Indivior; Australian National Health and Medical Research Council (NHMRC) Investigator Grant(National Health and Medical Research Council (NHMRC) of Australia)	The Kirby Institute is funded by the Australian Government Department of Health and is affiliated with the Faculty of Medicine, UNSW Sydney. The views expressed in this publication do not necessarily represent the position of the Australian Government. GJD has received research grant funding from Gilead, Merck, and Abbvie. JG has received research grant funding from Camurus, Cepheid, Gilead, Hologic, Indivior, Merck, and Abbvie unrelated to this work. JG is supported by an Australian National Health and Medical Research Council (NHMRC) Investigator Grant (#1176131). Funders did not have any additional role in the study design, data collection, and analysis, decision to publish, or preparation of the manuscript. The specific roles of each author are articulated in the `author contributions' section.	Abe CM, 2019, PUBLIC HEALTH REP, V134, P626, DOI 10.1177/0033354919874081; Altekruse SF, 2014, AM J GASTROENTEROL, V109, P542, DOI 10.1038/ajg.2014.11; Averhoff F, 2019, J HEPATOL, V71, P645, DOI 10.1016/j.jhep.2019.06.026; Bajis S, 2017, INT J DRUG POLICY, V47, P34, DOI 10.1016/j.drugpo.2017.07.002; Bartholomew TS, 2020, INT J DRUG POLICY, V83, DOI 10.1016/j.drugpo.2020.102821; Bartlett SR, 2019, LIVER INT, V39, P2261, DOI 10.1111/liv.14227; Bernfort L, 2006, SCAND J INFECT DIS, V38, P497, DOI 10.1080/00365540500532803; Blach S, 2021, J HEPATOL, V74, P31, DOI 10.1016/j.jhep.2020.07.042; Blach S, 2017, LANCET GASTROENTEROL, V2, P161, DOI 10.1016/S2468-1253(16)30181-9; Bottero Julie, 2015, Open Forum Infect Dis, V2, pofv162, DOI 10.1093/ofid/ofv162; Cassell M., 2019, IMPROVED LINKAGE HEP; Coats JT, 2015, INT J DRUG POLICY, V26, P1050, DOI 10.1016/j.drugpo.2015.05.001; Davies L, EASL DIG INT LIV C 2; Deming R, 2018, J VIRAL HEPATITIS, V25, P1236, DOI 10.1111/jvh.12929; Dhaliwal H.K, 2018, IMMUNOSUPPRESSIVE TH; Di Marco V, 2016, GASTROENTEROLOGY, V151, P130, DOI 10.1053/j.gastro.2016.03.036; Dore GJ, 2018, INFECT DIS CLIN N AM, V32, P269, DOI 10.1016/j.idc.2018.02.006; Feld JJ, 2015, NEW ENGL J MED, V373, P2599, DOI 10.1056/NEJMoa1512610; Ford MM, 2017, CLIN INFECT DIS, V64, P685, DOI 10.1093/cid/ciw806; Frimpong JA, 2020, MED CARE, V58, P445, DOI 10.1097/MLR.0000000000001311; Gane EJ, 2014, GASTROENTEROLOGY, V146, P736, DOI 10.1053/j.gastro.2013.11.007; Gidding HF, 2012, MED J AUSTRALIA, V196, P633, DOI 10.5694/mja12.10014; Grebely J, 2016, ADDICTION, V111, P311, DOI 10.1111/add.13197; Hajarizadeh B., 2017, J VIRAL HEPATITIS, DOI [10.1111/jgh.13453, DOI 10.1111/JGH.13453]; Hajarizadeh B, 2016, LANCET GASTROENTEROL, V1, P317, DOI 10.1016/S2468-1253(16)30075-9; Harris RJ, 2014, J HEPATOL, V61, P530, DOI 10.1016/j.jhep.2014.05.008; He S., 2020, AUSTR JHEP REPORTS; Hirsch AA, 2014, JT COMM J QUAL PATIE, V40, P351, DOI 10.1016/S1553-7250(14)40046-1; Hsiang JC, 2022, SINGAP MED J, V63, P86, DOI 10.11622/smedj.2020116; Hutchinson SJ, 2005, CLIN GASTROENTEROL H, V3, P1150, DOI 10.1016/S1542-3565(05)00407-6; Hutchinson SJ, 2005, HEPATOLOGY, V42, P711, DOI 10.1002/hep.20836; Japaridze M., 2019, APPROACHES PROVIDING; Kirby Institute, 2018, HIV VIR HEP SEX TRAN; Kwon JA, 2019, J VIRAL HEPATITIS, V26, P83, DOI 10.1111/jvh.13013; Lawitz E, 2014, LANCET, V383, P515, DOI 10.1016/S0140-6736(13)62121-2; Morgan RL, 2013, ANN INTERN MED, V158, P329, DOI 10.7326/0003-4819-158-5-201303050-00005; Nahon P, 2017, GASTROENTEROLOGY, V152, P142, DOI 10.1053/j.gastro.2016.09.009; NSW Ministry of Health, 2017, GUID CAV INT INF DIS; Peters MG, 2002, HEPATOLOGY, V36, pS220, DOI 10.1053/jhep.2002.36811; Poordad F, 2013, NEW ENGL J MED, V368, P45, DOI 10.1056/NEJMoa1208809; Ries LAG, 2007, SEER SURVIVAL MONOGR; Roberts SK, 2009, HEPATOLOGY, V50, P1045, DOI 10.1002/hep.23130; Sahajian F, 2011, J PUBLIC HEALTH-UK, V33, P182, DOI 10.1093/pubmed/fdq071; Scott N, 2020, MED J AUSTRALIA, V212, P365, DOI 10.5694/mja2.50544; Shkolnikov V, HUMAN MORTALITY DATA; Sievert W, 2014, J GASTROEN HEPATOL, V29, P1, DOI 10.1111/jgh.12677; The Kirby Institute, 2021, MON HEP C TREATM UPT; The Kirby Institute, 2019, HEP C EL NSW MON EV; The Kirby Institute, 2016, ANN SURVEILLANCE REP; Thein HH, 2008, AIDS, V22, P1979, DOI 10.1097/QAD.0b013e32830e6d51; Ustianowski A, 2020, J HEPATOL, V73, pS793; Valerio H., HIGH HEPATITS C TREA; Valerio H, 2019, J HEPATOL, V70, pE42, DOI 10.1016/S0618-8278(19)30076-3; WHO Collaborating Centre for Viral Hepatitis Doherty Institute for Infection and Immunity, 2020, IMP COVID 19 BBVSTI; World Health Organization (WHO), GLOB HLTH SECT STRAT; World Health Organization (WHO), 2021, INT GUID COUNTR VAL; Zhou K, 2016, LANCET INFECT DIS, V16, P1409, DOI 10.1016/S1473-3099(16)30208-0	57	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2021	16	9							e0257369	10.1371/journal.pone.0257369	http://dx.doi.org/10.1371/journal.pone.0257369			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	WG5YY	34529711	gold, Green Published			2022-12-26	WOS:000707071500050
J	Liang, SB; Jiao, TT; Du, WC; Qu, SM				Liang, Shengbin; Jiao, Tongtong; Du, Wencai; Qu, Shenming			An improved ant colony optimization algorithm based on context for tourism route planning	PLOS ONE			English	Article								To solve the problem of one-sided pursuit of the shortest distance but ignoring the tourist experience in the process of tourism route planning, an improved ant colony optimization algorithm is proposed for tourism route planning. Contextual information of scenic spots significantly effect people's choice of tourism destination, so the pheromone update strategy is combined with the contextual information such as weather and comfort degree of the scenic spot in the process of searching the global optimal route, so that the pheromone update tends to the path suitable for tourists. At the same time, in order to avoid falling into local optimization, the sub-path support degree is introduced. The experimental results show that the optimized tourism route has greatly improved the tourist experience, the route distance is shortened by 20.5% and the convergence speed is increased by 21.2% compared with the basic algorithm, which proves that the improved algorithm is notably effective.	[Liang, Shengbin; Jiao, Tongtong; Qu, Shenming] Henan Univ, Sch Software, Kaifeng, Henan, Peoples R China; [Du, Wencai] Univ St Joseph, Inst Data Engn & Sci, Macau, Peoples R China	Henan University; University of Saint Joseph (Macao)	Qu, SM (corresponding author), Henan Univ, Sch Software, Kaifeng, Henan, Peoples R China.	qsm@vip.henu.edu.cn		LIANG, Shengbin/0000-0001-9804-6928	Key Scientific Research Projects of Colleges and Universities in Henan Province [20A520008]	Key Scientific Research Projects of Colleges and Universities in Henan Province	Author: Liang Shengbin Grant number: No.20A520008 Funder: Key Scientific Research Projects of Colleges and Universities in Henan Province URL: http://jyt.henan.gov.cn/2019/07-31/1604951.html Did the sponsors or funders play any role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript? No.	Abdi A, 2020, J CLEAN PROD, V250, DOI 10.1016/j.jclepro.2019.119437; Ahmed Z.H., 2010, INT J BIOMETRIC BIOI, V3, P96; Akbarpour N, 2021, SOFT COMPUT, V25, P6707, DOI 10.1007/s00500-021-05669-6; Akka K, 2018, INT J ADV ROBOT SYST, V15, DOI 10.1177/1729881418774673; Amiri SAHS, 2020, COMPUT IND ENG, V139, DOI 10.1016/j.cie.2019.106156; AXSATER S, 1993, OPER RES, V41, P777, DOI 10.1287/opre.41.4.777; AXSATER S, 1990, OPER RES, V38, P64, DOI 10.1287/opre.38.1.64; Cerda J., 2021, HIGH FREQUENCY DYNAM; Che GF, 2020, J AMB INTEL HUM COMP, V11, P3349, DOI 10.1007/s12652-019-01531-8; COLORNI A, 1992, FROM ANIM ANIMAT, P134; Deng W, 2019, IEEE ACCESS, V7, P20281, DOI 10.1109/ACCESS.2019.2897580; Feng YJ., 2014, ADV MAT RES, V912, P1900; Guan BX, 2021, EXPERT SYST APPL, V164, DOI 10.1016/j.eswa.2020.114021; Hajiaghaei-Keshteli M, 2011, INT J ADV MANUF TECH, V55, P831, DOI 10.1007/s00170-010-3112-6; Hajiaghaei-Keshteli M, 2010, INT J ADV MANUF TECH, V50, P343, DOI 10.1007/s00170-009-2486-9; Han ZP, 2021, FRONT MECH ENG-PRC, V16, P393, DOI 10.1007/s11465-020-0613-3; Han-Chen Huang, 2013, Journal of Theoretical and Applied Information Technology, V52, P343; Hao M, 2010, INT C MECH AUT; Hicham E. H., 2015, INT J COMPUTER APPL, V117, P28, DOI [10.5120/20674-3466, DOI 10.5120/20674-3466]; Jia ZH, 2022, APPL INTELL, V52, P1752, DOI 10.1007/s10489-021-02336-z; Kanso B, 2021, RAIRO-OPER RES, V55, P639, DOI 10.1051/ro/2021034; Liang Y, 2020, SOFT COMPUT, V24, P8199, DOI 10.1007/s00500-019-04414-4; Liu YH, 2021, COMPLEX INTELL SYST, V7, P1711, DOI 10.1007/s40747-020-00138-3; Liu Z, 2010, 2010 3 INT C ADV COM, V2, P2; Lu YL, 2021, INFORM SCIENCES, V564, P144, DOI 10.1016/j.ins.2021.02.053; Ma WP, 2021, PATTERN RECOGN, V116, DOI 10.1016/j.patcog.2021.107933; Maheshwari P, 2021, AD HOC NETW, V110, DOI 10.1016/j.adhoc.2020.102317; Mei Y, 2018, J INTELL FUZZY SYST, V35, P2761, DOI 10.3233/JIFS-169628; Miao CW, 2021, COMPUT IND ENG, V156, DOI 10.1016/j.cie.2021.107230; Pashakhanloo F., 2021, APPL INTELL; Qi X., 2021, NEURAL COMPUT APPL; Qian XH, 2019, MULTIMED TOOLS APPL, V78, P22099, DOI 10.1007/s11042-019-7537-0; Shi BH, 2021, ENERGIES, V14, DOI 10.3390/en14061709; St?tzle T., 1998, ARTIFICIAL NEURAL NE, P245, DOI DOI 10.1007/978-3-7091-6492-1_54; Wang P, 2020, J INF PROCESS SYST, V16, P1169, DOI 10.3745/JIPS.01.0059; Wang Y, 2021, J AMB INTEL HUM COMP, DOI 10.1007/s12652-021-03212-x; Wu HG, 2021, COMPLEX INTELL SYST, DOI 10.1007/s40747-021-00401-1; Xiao Z, 2022, J INTELL MANUF, V33, P1829, DOI 10.1007/s10845-021-01766-3; Yang K, 2020, APPL INTELL, V50, P4529, DOI 10.1007/s10489-020-01799-w; Yang Z., 2021, CONTROLLING SCATTERE, V144; Yong W, 2015, SOFT COMPUT, V19, P585, DOI 10.1007/s00500-014-1279-8; Yu J., 2021, ANT COLONY ALGORITHM, P1; Zahedi A, 2021, APPL SOFT COMPUT, V104, DOI 10.1016/j.asoc.2021.107210; Zhang S., 2021, ARXIV210100833V1	44	6	6	10	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2021	16	9							e0257317	10.1371/journal.pone.0257317	http://dx.doi.org/10.1371/journal.pone.0257317			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	WG5YY	34529729	Green Published, gold			2022-12-26	WOS:000707071500046
J	San Juan, NV; Shah, P; Schlief, M; Appleton, R; Nyikavaranda, P; Birken, M; Foye, U; Lloyd-Evans, B; Morant, N; Needle, JJ; Simpson, A; Lyons, N; Rains, LS; Dedat, Z; Johnson, S				San Juan, Norha Vera; Shah, Prisha; Schlief, Merle; Appleton, Rebecca; Nyikavaranda, Patrick; Birken, Mary; Foye, Una; Lloyd-Evans, Brynmor; Morant, Nicola; Needle, Justin J.; Simpson, Alan; Lyons, Natasha; Rains, Luke Sheridan; Dedat, Zainab; Johnson, Sonia			Service user experiences and views regarding telemental health during the COVID-19 pandemic: A co-produced framework analysis	PLOS ONE			English	Article							TELEPSYCHIATRY; BARRIERS; CARE	Background The prominence of telemental health, including providing care by video call and telephone, has greatly increased during the COVID-19 pandemic. However, there are clear variations in uptake and acceptability, and concerns that digital exclusion may exacerbate previous inequalities in access to good quality care. Greater understanding is needed of how service users experience telemental health, and what determines whether they engage and find it acceptable. Methods We conducted a collaborative framework analysis of data from semi-structured interviews with a sample of people already experiencing mental health problems prior to the pandemic. Data relevant to participants' experiences and views regarding telemental health during the pandemic were identified and extracted. Data collection and analysis used a participatory, coproduction approach where researchers with relevant lived experience, contributed to all stages of data collection, analysis and interpretation of findings alongside clinical and academic researchers. Findings The experiences and preferences regarding telemental health care of the forty-four participants were dynamic and varied across time and settings, as well as between individuals. Participants' preferences were shaped by reasons for contacting services, their relationship with care providers, and both parties' access to technology and their individual preferences. While face-to-face care tended to be the preferred option, participants identified benefits of remote care including making care more accessible for some populations and improved efficiency for functional appointments such as prescription reviews. Participants highlighted important challenges related to safety and privacy in online settings, and gave examples of good remote care strategies they had experienced, including services scheduling regular phone calls and developing guidelines about how to access remote care tools. Discussion Participants in our study have highlighted advantages of telemental health care, as well as significant limitations that risk hindering mental health support and exacerbate inequalities in access to services. Some of these limitations are seen as potentially removable, for example through staff training or better digital access for staff or service users. Others indicate a need to maintain traditional face-to-face contact at least for some appointments. There is a clear need for care to be flexible and individualised to service user circumstances and preferences. Further research is needed on ways of minimising digital exclusion and of supporting staff in making effective and collaborative use of relevant technologies.	[San Juan, Norha Vera; Foye, Una; Simpson, Alan] Kings Coll London, Dept Hlth Serv & Populat Res, NIHR Mental Hlth Policy Res Unit, London, England; [Shah, Prisha; Nyikavaranda, Patrick] NIHR Mental Hlth Policy Res Unit COVID 19 Coprod, London, England; [Schlief, Merle; Appleton, Rebecca; Birken, Mary; Lloyd-Evans, Brynmor; Morant, Nicola; Lyons, Natasha; Rains, Luke Sheridan; Dedat, Zainab; Johnson, Sonia] UCL, Div Psychiat, NIHR Mental Hlth Policy Res Unit, London, England; [Needle, Justin J.] City Univ London, Div Hlth Serv Res & Management, London, England	University of London; King's College London; University of London; University College London; City University London	San Juan, NV (corresponding author), Kings Coll London, Dept Hlth Serv & Populat Res, NIHR Mental Hlth Policy Res Unit, London, England.	norha.vera@kcl.ac.uk	Needle, Justin J/B-7589-2008; Johnson, Sonia/A-5220-2008	Needle, Justin J/0000-0003-0727-1391; Johnson, Sonia/0000-0002-2219-1384; Birken, Mary/0000-0001-8828-2118; Simpson, Alan/0000-0003-3286-9846; Appleton, Rebecca/0000-0003-4097-3512; Foye, Una/0000-0002-3414-2854; Nyikavaranda, Patrick/0000-0002-9896-6078; Morant, Nicola/0000-0003-4022-8133; Lloyd-Evans, Brynmor/0000-0001-9866-788X	National Institute for Health Research (NIHR) Policy Research Programme	National Institute for Health Research (NIHR) Policy Research Programme(National Institute for Health Research (NIHR))	This paper presents independent research commissioned and funded by the National Institute for Health Research (NIHR) Policy Research Programme, conducted by the NIHR Policy Research Unit (PRU) in Mental Health. https://www.nihr.ac.uk/explore-nihr/fundingprogrammes/policy-research.htm The views expressed are those of the authors and not necessarily those of the NIHR, the Department of Health and social care, or its arm's length bodies or other government departments	AHRQ, TEL AHRQ DIG HEALTHC; Barnett P, 2020, REMOTE WORKING MENTA, DOI [10.1101/2020.11.30.20240721, DOI 10.1101/2020.11.30.20240721]; Bashshur RL, 2016, TELEMED E-HEALTH, V22, P87, DOI 10.1089/tmj.2015.0206; Chen JA, 2020, GEN HOSP PSYCHIAT, V66, P89, DOI 10.1016/j.genhosppsych.2020.07.002; Christensen H, 2009, J MED INTERNET RES, V11, DOI 10.2196/jmir.1194; Christensen LF, 2020, J PSYCHIATR MENT HLT, V27, P258, DOI 10.1111/jpm.12574; Connolly SL, 2020, CLIN PSYCHOL-SCI PR, V27, DOI 10.1111/cpsp.12311; Cowan KE, 2019, MAYO CLIN PROC, V94, P2510, DOI 10.1016/j.mayocp.2019.04.018; Dorstyn DS, 2013, J TELEMED TELECARE, V19, P338, DOI 10.1177/1357633X13501767; Fisk M, 2020, J MED INTERNET RES, V22, DOI 10.2196/19264; Fletcher TL, 2018, CURR PSYCHIAT REP, V20, DOI 10.1007/s11920-018-0922-y; Gale NK, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-117; Gentry MT, 2019, J TELEMED TELECARE, V25, P327, DOI 10.1177/1357633X18775855; Gillard S, 2020, MEDRXIV, DOI [10.1101/2020.11.03.20225169, DOI 10.1101/2020.11.03.20225169]; Gillard S, 2012, QUAL HEALTH RES, V22, P1126, DOI 10.1177/1049732312448541; Gloff NE, 2015, INT REV PSYCHIATR, V27, P513, DOI 10.3109/09540261.2015.1086322; Gondek D, 2017, CLIN PSYCHOL PSYCHOT, V24, P870, DOI 10.1002/cpp.2052; Grover S, 2020, SCHIZOPHR RES, V222, P489, DOI 10.1016/j.schres.2020.05.062; Harerimana B, 2019, INT J MENT HEALTH NU, V28, P657, DOI 10.1111/inm.12571; Hilty DM, 2002, CNS DRUGS, V16, P527, DOI 10.2165/00023210-200216080-00003; Hilty DM, 2013, TELEMED E-HEALTH, V19, P444, DOI 10.1089/tmj.2013.0075; Hoffman DA, 2020, J LAW BIOSCI, V7, DOI 10.1093/jlb/lsaa043; Holmes EA, 2020, LANCET PSYCHIAT, V7, P547, DOI 10.1016/S2215-0366(20)30168-1; Hubley S, 2016, WORLD J PSYCHIATR, V6, P269, DOI 10.5498/wjp.v6.i2.269; Hutchings R., NUFFIELD TRUST HLTH; Johnson S, 2021, SOC PSYCH PSYCH EPID, V56, P25, DOI 10.1007/s00127-020-01927-4; Juan NVS, 2021, REDEPLOYMENT TRAININ, DOI [10.1101/2021.01.21.21250230, DOI 10.1101/2021.01.21.21250230]; Lin L, 2019, J SUBST ABUSE TREAT, V101, P38, DOI 10.1016/j.jsat.2019.03.007; Lustgarten SD, 2017, AM PSYCHOL, V72, P159, DOI 10.1037/a0040321; Luxton DD, 2016, J CONSULT CLIN PSYCH, V84, P923, DOI 10.1037/ccp0000135; Molodynski A, 2021, INT J SOC PSYCHIATR, V67, P823, DOI 10.1177/0020764020932592; Moreno C, 2020, LANCET PSYCHIAT, V7, P813, DOI 10.1016/S2215-0366(20)30307-2; Norwood C, 2018, CLIN PSYCHOL PSYCHOT, V25, P797, DOI 10.1002/cpp.2315; Object Planet, COND ONL SURV US OP; Primm AB, 2010, PREV CHRONIC DIS, V7; Rains LS, 2021, SOC PSYCH PSYCH EPID, V56, P13, DOI 10.1007/s00127-020-01924-7; Richardson SJ, 2020, AGE AGEING, V49, P901, DOI 10.1093/ageing/afaa149; Salmoiraghi A, 2015, J PSYCHIATR PRACT, V21, P389, DOI 10.1097/PRA.0000000000000103; Santesteban-Echarri O, 2020, J TELEMED TELECARE, V26, P14, DOI 10.1177/1357633X18794100; Scott TM, 2009, DISS ABSTR INT B; Shore JH, 2020, JAMA PSYCHIAT, V77, P1211, DOI 10.1001/jamapsychiatry.2020.1643; Stoll J, 2020, FRONT PSYCHIATRY, V10, DOI 10.3389/fpsyt.2019.00993; Telebehavioural Health Institute, TBHIS TEL HLTH REF B; Torous J, 2020, JMIR MENT HEALTH, V7, DOI 10.2196/18848; Tullio Valeria, 2020, Med Leg J, V88, P73, DOI 10.1177/0025817220926942; Turgoose D, 2018, J TELEMED TELECARE, V24, P575, DOI 10.1177/1357633X17730443; Varker T, 2019, PSYCHOL SERV, V16, P621, DOI 10.1037/ser0000239; Vis Christiaan, 2018, JMIR Ment Health, V5, pe20, DOI 10.2196/mental.9769; Watkins S., S WATKINS TWITTER MO; Whaibeh Emile, 2020, Curr Treat Options Psychiatry, V7, P198, DOI 10.1007/s40501-020-00210-2; Wind TR, 2020, INTERNET INTERV, V20, DOI 10.1016/j.invent.2020.100317	51	6	6	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2021	16	9							e0257270	10.1371/journal.pone.0257270	http://dx.doi.org/10.1371/journal.pone.0257270			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	WG5YY	34529705	Green Published, Green Accepted, Green Submitted, gold			2022-12-26	WOS:000707071500041
J	Lee, SH; Kwon, HJ; Park, S; Il Kim, C; Ryu, H; Kim, SS; Park, JB; Kwon, JT				Lee, Shin Heon; Kwon, Hyung Joon; Park, Saewhan; Il Kim, Chan; Ryu, Haseo; Kim, Sung Soo; Park, Jong Bae; Kwon, Jeong Taik			Macrophage migration inhibitory factor (MIF) inhibitor 4-IPP downregulates stemness phenotype and mesenchymal trans-differentiation after irradiation in glioblastoma multiforme	PLOS ONE			English	Article							D-DOPACHROME TAUTOMERASE; CELL-SURVIVAL; PATHWAY; GENE; ACTIVATION; EXPRESSION; RESISTANCE; CYTOKINE; ROLES	Radiation therapy is among the most essential treatment methods for glioblastoma multiforme (GBM). Radio-resistance and cancer stem cell properties can cause therapeutic resistance, cancer heterogeneity, and poor prognoses in association with GBM. Furthermore, the GBM subtype transition from proneural to the most malignant mesenchymal subtype after radiation therapy also accounts for high resistance to conventional treatments. Here, we demonstrate that the inhibition of macrophage migration inhibitory factor (MIF) and D-dopachrome tautomerase (DDT) by 4-iodo-6-phenylpyrimidine (4-IPP), a dual inhibitor targeting MIF and DDT, downregulates stemness phenotype, intracellular signaling cascades, mesenchymal trans-differentiation, and induces apoptosis in proneural glioma stem cells (GSCs). In an analysis of The Cancer Genome Atlas, high MIF and DDT expression were associated with poor prognosis. GSC growth was effectively inhibited by 4-IPP in a time- and dose-dependent manner, and 4-IPP combined with radiation therapy led to significantly reduced proliferation compared with radiation therapy alone. The expression of stemness factors, such as Olig2 and SOX2, and the expression of pAKT, indicating PI3K signaling pathway activation, were decreased in association with both 4-IPP monotherapy and combination treatment. The expression of mesenchymal markers, TGM2 and NF-kappa B, and expression of pERK (indicating MAPK signaling pathway activation) increased in association with radiation therapy alone but not with 4-IPP monotherapy and combination therapy. In addition, the combination of 4-IPP and radiation therapy significantly induced apoptosis compared to the monotherapy of 4-IPP or radiation. In vivo results demonstrated a significant tumor-suppressing effect of 4-IPP when combined with radiation therapy. Collectively, our results showed that the targeted inhibition of MIF and DDT has the potential to strengthen current clinical strategies by enhancing the anticancer effects of radiation therapy.	[Lee, Shin Heon] Chung Ang Univ, Grad Sch, Dept Med, Seoul, South Korea; [Lee, Shin Heon] Sungkyunkwan Univ, Samsung Med Ctr, Dept Neurosurg, Sch Med, Seoul, South Korea; [Kwon, Hyung Joon] Natl Canc Ctr, Grad Sch Canc Sci & Policy, Dept Canc Control & Populat Hlth, Goyang, South Korea; [Park, Saewhan; Il Kim, Chan; Ryu, Haseo; Park, Jong Bae] Natl Canc Ctr, Grad Sch Canc Sci & Policy, Dept Canc Biomed Sci, Goyang, South Korea; [Kim, Sung Soo; Park, Jong Bae] Res Inst & Hosp, Natl Canc Ctr, Dept Clin Res, Goyang, South Korea; [Kim, Sung Soo] Natl Canc Ctr, Grad Sch Canc Sci & Policy R&D Fdn, Goyang, South Korea; [Kwon, Jeong Taik] Chung Ang Univ, Chung Ang Univ Hosp, Dept Neurosurg, Coll Med, Seoul, South Korea	Chung Ang University; Sungkyunkwan University (SKKU); Samsung Medical Center; National Cancer Center - Korea (NCC); National Cancer Center - Korea (NCC); National Cancer Center - Korea (NCC); National Cancer Center - Korea (NCC); Chung Ang University; Chung Ang University Hospital	Park, JB (corresponding author), Natl Canc Ctr, Grad Sch Canc Sci & Policy, Dept Canc Biomed Sci, Goyang, South Korea.; Park, JB (corresponding author), Res Inst & Hosp, Natl Canc Ctr, Dept Clin Res, Goyang, South Korea.; Kwon, JT (corresponding author), Chung Ang Univ, Chung Ang Univ Hosp, Dept Neurosurg, Coll Med, Seoul, South Korea.	jbp@ncc.re.kr; jtkwon@cau.ac.kr		Lee, Shin-Heon/0000-0002-5424-1374; Kwon, Jeong-taik/0000-0002-7889-7634	National Cancer Center [1810121-2]	National Cancer Center	This study was supported by research grants from the National Cancer Center (No. 1810121-2) to JBP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anjum K, 2017, BIOMED PHARMACOTHER, V92, P681, DOI 10.1016/j.biopha.2017.05.125; Bhat KPL, 2013, CANCER CELL, V24, P331, DOI 10.1016/j.ccr.2013.08.001; Cao Z, 2019, CANCER LETT, V459, P30, DOI 10.1016/j.canlet.2019.05.025; Fedele M, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20112746; Fukaya R, 2016, CANCER RES, V76, P2813, DOI 10.1158/0008-5472.CAN-15-1011; Goldman MJ, 2020, NAT BIOTECHNOL, V38, P675, DOI 10.1038/s41587-020-0546-8; Gupta K, 2018, FRONT ONCOL, V8, DOI 10.3389/fonc.2018.00503; Gupta Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146482; Ha W, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-39427-4; Hein AL, 2014, INT J ONCOL, V45, P1813, DOI 10.3892/ijo.2014.2614; Johler SM, 2016, CANCER IMMUNOL IMMUN, V65, P1465, DOI 10.1007/s00262-016-1896-4; Kim MJ, 2017, CELL SIGNAL, V34, P110, DOI 10.1016/j.cellsig.2017.03.007; Kim SH, 2016, CANCER CELL, V29, P201, DOI 10.1016/j.ccell.2016.01.005; Lue H, 2007, ONCOGENE, V26, P5046, DOI 10.1038/sj.onc.1210318; Manning BD, 2017, CELL, V169, P381, DOI 10.1016/j.cell.2017.04.001; McCubrey JA, 2007, BBA-MOL CELL RES, V1773, P1263, DOI 10.1016/j.bbamcr.2006.10.001; Merk M, 2011, P NATL ACAD SCI USA, V108, pE577, DOI 10.1073/pnas.1102941108; Mitchell RA, 2014, CELL SIGNAL, V26, P2969, DOI 10.1016/j.cellsig.2014.09.012; Mitchell RA, 2012, MIF HANDBOOK, P161; Mittelbronn M, 2011, ACTA NEUROPATHOL, V122, P353, DOI 10.1007/s00401-011-0858-3; Multhoff G, 2012, FRONT ONCOL, V2, P1, DOI 10.3389/fonc.2012.00058; Osuka S, 2017, J CLIN INVEST, V127, P415, DOI 10.1172/JCI89587; Otvos B, 2016, STEM CELLS, V34, P2026, DOI 10.1002/stem.2393; Pasupuleti V, 2014, J BIOL CHEM, V289, P3713, DOI 10.1074/jbc.M113.500694; Porter AG, 1999, CELL DEATH DIFFER, V6, P99, DOI 10.1038/sj.cdd.4400476; Rajasekaran D, 2014, FASEB J, V28, P4961, DOI 10.1096/fj.14-256636; Sakamoto D, 2019, ANTICANCER RES, V39, P597, DOI 10.21873/anticanres.13153; Trivedi-Parmar V, 2018, J MED CHEM, V61, P8104, DOI 10.1021/acs.jmedchem.8b00589; Ulukaya E, 2004, CHEMOTHERAPY, V50, P43, DOI 10.1159/000077285; Wang XB, 2012, J NEURO-ONCOL, V106, P43, DOI 10.1007/s11060-011-0640-3; Wang ZH, 2016, ONCOL REP, V35, P2733, DOI 10.3892/or.2016.4652; Wen PY, 2008, NEW ENGL J MED, V359, P492, DOI 10.1056/NEJMra0708126; Yin J, 2017, CANCER RES, V77, P4973, DOI 10.1158/0008-5472.CAN-17-0388; Youn H, 2015, J CELL BIOCHEM, V116, P2504, DOI 10.1002/jcb.25195; Zanotto-Filho A, 2017, CANCER LETT, V390, P176, DOI 10.1016/j.canlet.2016.12.015	35	1	1	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2021	16	9							e0257375	10.1371/journal.pone.0257375	http://dx.doi.org/10.1371/journal.pone.0257375			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	WG6OR	34516577	gold, Green Published			2022-12-26	WOS:000707114200031
J	Moni, ASB; Abdullah, S; Bin Abdullah, MFIL; Kabir, MS; Alif, SM; Sultana, F; Salehin, M; Islam, SMS; Cross, W; Rahman, MA				Bahar Moni, Ahmed Suparno; Abdullah, Shalimar; Bin Abdullah, Mohammad Farris Iman Leong; Kabir, Mohammed Shahjahan; Alif, Sheikh M.; Sultana, Farhana; Salehin, Masudus; Islam, Sheikh Mohammed Shariful; Cross, Wendy; Rahman, Muhammad Aziz			Psychological distress, fear and coping among Malaysians during the COVID-19 pandemic	PLOS ONE			English	Article							MENTAL-HEALTH; DEPRESSION; OUTBREAK; ANXIETY	Introduction The COVID-19 pandemic has enormously affected the psychological well-being, social and working life of millions of people across the world. This study aimed to investigate the psychological distress, fear and coping strategies as a result of the COVID-19 pandemic and its associated factors among Malaysian residents. Methods Participants were invited to an online cross-sectional survey from Aug-Sep 2020. The study assessed psychological distress using the Kessler Psychological Distress Scale, level of fear using the Fear of COVID-19 Scale, and coping strategies using the Brief Resilient Coping Scale. Univariate and multivariate logistic regression analyses were conducted to adjust for potential confounders. Results The mean age (+/- SD) of the participants (N = 720) was 31.7 (+/- 11.5) years, and most of them were females (67.1%). Half of the participants had an income source, while 216 (30%) identified themselves as frontline health or essential service workers. People whose financial situation was impacted due to COVID-19 (AOR 2.16, 95% CIs 1.54-3.03), people who drank alcohol in the last four weeks (3.43, 1.45-8.10), people who were a patient (2.02, 1.39-2.93), and had higher levels of fear of COVID-19 (2.55, 1.70-3.80) were more likely to have higher levels of psychological distress. Participants who self-isolated due to exposure to COVID-19 (3.12, 1.04-9.32) and who had moderate to very high levels of psychological distress (2.56, 1.71-3.83) had higher levels of fear. Participants who provided care to a family member/patient with a suspected case of COVID-19 were more likely to be moderately to highly resilient compared to those who did not. Conclusion Vulnerable groups of individuals such as patients and those impacted financially during COVID-19 should be supported for their mental wellbeing. Behavioural interventions should be targeted to reduce the impact of alcohol drinking during such crisis period.	[Bahar Moni, Ahmed Suparno; Bin Abdullah, Mohammad Farris Iman Leong] Univ Sains Malaysia, Adv Med & Dent Inst, Kepala Batas, Penang, Malaysia; [Abdullah, Shalimar] Pusat Perubatan Univ Kebangsaan Malaysia, Fac Med, Kuala Lumpur, Malaysia; [Kabir, Mohammed Shahjahan] Quest Int Univ, Fac Med, Ipoh, Perak, Malaysia; [Alif, Sheikh M.] Monash Univ, Sch Publ Hlth & Prevent Med, Melbourne, Vic, Australia; [Sultana, Farhana] Telstra Hlth, Melbourne, Vic, Australia; [Sultana, Farhana] Univ Melbourne, Melbourne Sch Populat & Global Hlth, Carlton, Vic, Australia; [Salehin, Masudus; Cross, Wendy; Rahman, Muhammad Aziz] Federat Univ Australia, Sch Hlth, Berwick, Vic, Australia; [Islam, Sheikh Mohammed Shariful] Deakin Univ, Inst Phys Act & Nutr, Burwood, Vic, Australia; [Rahman, Muhammad Aziz] La Trobe Univ, Australian Inst Primary Care & Ageing, Melbourne, Vic, Australia; [Rahman, Muhammad Aziz] Bangladesh Univ Hlth Sci BUHS, Dept Noncommunicable Dis, Dhaka, Bangladesh; [Rahman, Muhammad Aziz] Univ Airlangga, Fac Publ Hlth, Surabaya, Indonesia	Universiti Sains Malaysia; Universiti Kebangsaan Malaysia; Quest International University Perak; Monash University; University of Melbourne; Federation University Australia; Deakin University; La Trobe University; Bangladesh University of Health Sciences (BUHS); Airlangga University	Moni, ASB (corresponding author), Univ Sains Malaysia, Adv Med & Dent Inst, Kepala Batas, Penang, Malaysia.; Rahman, MA (corresponding author), Federat Univ Australia, Sch Hlth, Berwick, Vic, Australia.; Rahman, MA (corresponding author), La Trobe Univ, Australian Inst Primary Care & Ageing, Melbourne, Vic, Australia.; Rahman, MA (corresponding author), Bangladesh Univ Hlth Sci BUHS, Dept Noncommunicable Dis, Dhaka, Bangladesh.; Rahman, MA (corresponding author), Univ Airlangga, Fac Publ Hlth, Surabaya, Indonesia.	suparno1978@gmail.com; ma.rahman@federation.edu.au	Moni, Ahmed Suparno Bahar/AAU-9075-2021; Islam, Mohammed Shariful/B-1219-2011; Moni, Ahmed Suparno Bahar/M-2159-2018; Leong Abdullah, Mohammad Farris Iman/I-9583-2017; Alif, Sheikh M/M-7949-2016; Kabir, Mohammed Shahjahan/GSD-3110-2022; Rahman, Muhammad Aziz/B-3380-2009	Moni, Ahmed Suparno Bahar/0000-0002-6434-5679; Islam, Mohammed Shariful/0000-0001-7926-9368; Moni, Ahmed Suparno Bahar/0000-0002-6434-5679; Leong Abdullah, Mohammad Farris Iman/0000-0002-7762-4052; Alif, Sheikh M/0000-0002-0783-8848; Rahman, Muhammad Aziz/0000-0003-1665-7966				Ahmed MZ, 2020, ASIAN J PSYCHIATR, V51, DOI 10.1016/j.ajp.2020.102092; Ahorsu DK, 2020, GERONTOL GERIATR MED, V6, DOI 10.1177/2333721420966081; Ahorsu DK, 2022, INT J MENT HEALTH AD, V20, P1537, DOI 10.1007/s11469-020-00270-8; Aktekin M, 2001, MED EDUC, V35, P12, DOI 10.1046/j.1365-2923.2001.00726.x; Brooks SK, 2020, LANCET, V395, P912, DOI [10.1016/S0140-6736(20)30460-8., 10.1016/S0140-6736(20)30460-8]; Cai WP, 2020, ASIAN J PSYCHIATR, V51, DOI 10.1016/j.ajp.2020.102111; Cao WJ, 2020, PSYCHIAT RES, V287, DOI 10.1016/j.psychres.2020.112934; de Figueiredo CS, 2021, PROG NEURO-PSYCHOPH, V106, DOI 10.1016/j.pnpbp.2020.110171; Elengoe Asita, 2020, Osong Public Health Res Perspect, V11, P93, DOI 10.24171/j.phrp.2020.11.3.08; Furukawa TA, 2003, PSYCHOL MED, V33, P357, DOI 10.1017/S0033291702006700; Gunnell D, 2020, LANCET PSYCHIAT, V7, P468, DOI 10.1016/S2215-0366(20)30171-1; Guo Q, 2020, BRAIN BEHAV IMMUN, V88, P17, DOI 10.1016/j.bbi.2020.05.038; Jurblum M, 2020, AUST J GEN PRACT, V49, P778, DOI 10.31128/AJGP-06-20-5481; Kalok A, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17228522; Kassim MAM, 2021, INT J MENT HEALTH AD, DOI 10.1007/s11469-021-00622-y; Khanna RC, 2020, INDIAN J OPHTHALMOL, V68, P994, DOI 10.4103/ijo.IJO_1458_20; Liu X, 2020, INFECT DIS POVERTY, V9, DOI 10.1186/s40249-020-00678-3; Lu W, 2020, PSYCHIAT RES, V288, DOI 10.1016/j.psychres.2020.112936; Makela P, 2015, EUR J PUBLIC HEALTH, V25, P225, DOI 10.1093/eurpub/cku133; Mazza C, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17093165; Ni MY, 2020, JMIR MENT HEALTH, V7, DOI 10.2196/19009; Pramukti I, 2020, J MED INTERNET RES, V22, DOI 10.2196/24487; Rahman MA, 2021, INT J MENT HEALTH NU, V30, P745, DOI 10.1111/inm.12845; Rahman MA, 2020, GLOBALIZATION HEALTH, V16, DOI 10.1186/s12992-020-00624-w; Reuters, REUTERS 0323; Rodriguez-Hidalgo AJ, 2020, FRONT PSYCHOL, V11, DOI 10.3389/fpsyg.2020.591797; Shah AUM, 2020, INT J INFECT DIS, V97, P108, DOI 10.1016/j.ijid.2020.05.093; Shamsuddin K, 2013, ASIAN J PSYCHIATR, V6, P318, DOI 10.1016/j.ajp.2013.01.014; Sinclair VG, 2004, ASSESSMENT, V11, P94, DOI 10.1177/1073191103258144; Smith L, 2020, PSYCHIAT RES, V291, DOI 10.1016/j.psychres.2020.113138; Sundarasen S, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17176206; Thombs BD, 2020, J PSYCHOSOM RES, V133, DOI 10.1016/j.jpsychores.2020.110113; Wang YL, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0244630; Wang YN, 2021, PSYCHOL HEALTH MED, V26, P13, DOI 10.1080/13548506.2020.1746817; Worldometer, COVID 19 COR PAND; Xiao H, 2020, MED SCI MONITOR, V26, DOI 10.12659/MSM.923549; Yahaya SN, 2018, WORLD J EMERG MED, V9, P178, DOI 10.5847/wjem.j.1920-8642.2018.03.003; Zhang WR, 2020, PSYCHOTHER PSYCHOSOM, V89, P242, DOI 10.1159/000507639	38	13	13	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2021	16	9							e0257304	10.1371/journal.pone.0257304	http://dx.doi.org/10.1371/journal.pone.0257304			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	XM9EM	34506576	Green Published, gold			2022-12-26	WOS:000729120700020
J	Bouille, L; Sichitiu, J; Favre, J; Desseauve, D				Bouille, Lisa; Sichitiu, Joanna; Favre, Julien; Desseauve, David			Assessing feasibility and maternal acceptability of a biomechanically-optimized supine birth position: A pilot study	PLOS ONE			English	Article							LABOR; DELIVERY	Background In order to manage a protracted second stage of labor, "eminence-based" birth positions have been suggested by some healthcare professionals. Recent biomechanical studies have promoted the use of an optimized supine birthing position in this setting. However, uncertainty exists regarding the feasibility of this posture, and its acceptability by women. This pilot study primarily aimed to assess these characteristics. Objective and methods In this monocentric prospective study, 20 women with a protracted second stage of labor were asked to maintain a biomechanically-optimized position for at least 20 minutes at full dilatation. This posture is similar to the McRoberts' maneuver. Maintaining the position for 20 minutes or more was considered clinically relevant and indicative of feasibility and acceptability. Satisfaction with the position was assessed using a Visual Analogue Scale (VAS). A sub-group analysis was performed to assess eventual differences between more and less satisfied patients, according to the median of patients' satisfaction scores. Results Seventeen patients (85%) maintained the optimized position for at least 20 minutes. The median satisfaction score of these participants was 8 (interquartile range: 1) out of 10. No significant differences were found between the two sub-groups (satisfaction score <8 vs satisfaction score >= 8) regarding general and obstetric characteristics, as well as obstetrical and fetal outcomes. Conclusion The optimized position is acceptable and feasible for women experiencing a protracted second stage of labor. Further clinical studies are needed to assess the efficiency of such positions when women undergo an obstructed labor.	[Bouille, Lisa; Sichitiu, Joanna; Desseauve, David] Lausanne Univ Hosp, Women Mother Child Dept, Lausanne, Vaud, Switzerland; [Favre, Julien] Lausanne Univ Hosp, Dept Musculoskeletal Med, Swiss Biomot Lab, Lausanne, Vaud, Switzerland; [Favre, Julien] Univ Lausanne, CHUV, UNIL, Lausanne, Vaud, Switzerland	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Desseauve, D (corresponding author), Lausanne Univ Hosp, Women Mother Child Dept, Lausanne, Vaud, Switzerland.	david.desseauve@chuv.ch		Desseauve, David/0000-0003-1308-7750				Abalos E, 2018, EUR J OBSTET GYN R B, V223, P123, DOI 10.1016/j.ejogrb.2018.02.026; [Anonymous], IMPACT RECOMMENDED C; [Anonymous], THIRDAND 4 DEGREE PE; [Anonymous], 2019, 1921170005 OFS; Boerma T, 2018, LANCET, V392, P1341, DOI 10.1016/S0140-6736(18)31928-7; Borges M, 2021, COMPUT METH PROG BIO, V200, DOI 10.1016/j.cmpb.2020.105921; Desbriere R, 2013, AM J OBSTET GYNECOL, V208, DOI 10.1016/j.ajog.2012.10.882; Desseauve D, 2017, J GYNECOL OBSTET HUM, V46, P189, DOI 10.1016/j.jogoh.2016.10.002; Desseauve D., 2019, SCI REP-UK, V9, P1; Desseauve D, 2020, J BIOMECH, V105, DOI 10.1016/j.jbiomech.2020.109783; Desseauve D, 2020, BMC PREGNANCY CHILDB, V20, DOI 10.1186/s12884-020-02952-6; Desseauve D, 2019, BMC PREGNANCY CHILDB, V19, DOI 10.1186/s12884-019-2408-2; Desseauve D, 2017, EUR J OBSTET GYN R B, V208, P46, DOI 10.1016/j.ejogrb.2016.11.006; Epidural and Position Trial Collaborative Group, 2017, BMJ, V359, pj4471, DOI 10.1136/bmj.j4471; Fitzpatrick M, 2001, OBSTET GYNECOL, V98, P1027, DOI 10.1016/S0029-7844(01)01600-3; Guittier MJ, 2016, BJOG-INT J OBSTET GY, V123, P2199, DOI 10.1111/1471-0528.13855; Hanley GE, 2010, OBSTET GYNECOL, V115, P1201, DOI 10.1097/AOG.0b013e3181dd918c; Jowitt M., 2014, DYNAMIC POSITIONS BI; Le Ray C, 2016, AM J OBSTET GYNECOL, V215, DOI 10.1016/j.ajog.2016.05.033; Leenaards fondation, 2019, FOND LEENAARDS FAVOR; Wong CA, 2010, BEST PRACT RES CL OB, V24, P367, DOI 10.1016/j.bpobgyn.2009.11.008; Zhu BP, 2006, AM J OBSTET GYNECOL, V195, P121, DOI 10.1016/j.ajog.2005.12.016	22	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2021	16	9							e0257285	10.1371/journal.pone.0257285	http://dx.doi.org/10.1371/journal.pone.0257285			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XM9EM	34506580	Green Published, gold			2022-12-26	WOS:000729120700124
J	Hauke, L; Narasimhan, S; Primessnig, A; Kaverina, I; Rehfeldt, F				Hauke, Lara; Narasimhan, Shwetha; Primessnig, Andreas; Kaverina, Irina; Rehfeldt, Florian			A Focal Adhesion Filament Cross-correlation Kit for fast, automated segmentation and correlation of focal adhesions and actin stress fibers in cells	PLOS ONE			English	Article							IMAGE; RAC1	Focal adhesions (FAs) and associated actin stress fibers (SFs) form a complex mechanical system that mediates bidirectional interactions between cells and their environment. This linked network is essential for mechanosensing, force production and force transduction, thus directly governing cellular processes like polarization, migration and extracellular matrix remodeling. We introduce a tool for fast and robust coupled analysis of both FAs and SFs named the Focal Adhesion Filament Cross-correlation Kit (FAFCK). Our software can detect and record location, axes lengths, area, orientation, and aspect ratio of focal adhesion structures as well as the location, length, width and orientation of actin stress fibers. This enables users to automate analysis of the correlation of FAs and SFs and study the stress fiber system in a higher degree, pivotal to accurately evaluate transmission of mechanocellular forces between a cell and its surroundings. The FAFCK is particularly suited for unbiased and systematic quantitative analysis of FAs and SFs necessary for novel approaches of traction force microscopy that uses the additional data from the cellular side to calculate the stress distribution in the substrate. For validation and comparison with other tools, we provide datasets of cells of varying quality that are labelled by a human expert. Datasets and FAFCK are freely available as open source under the GNU General Public License.	[Hauke, Lara; Primessnig, Andreas; Rehfeldt, Florian] Georg August Univ Gottingen, Inst Phys Biophys 3, Gottingen, Germany; [Narasimhan, Shwetha; Kaverina, Irina] Vanderbilt Univ, Dept Cell & Dev Biol, 221 Kirkland Hall, Nashville, TN 37235 USA; [Rehfeldt, Florian] Univ Bayreuth, Expt Phys 1, Bayreuth, Germany	University of Gottingen; Vanderbilt University; University of Bayreuth	Rehfeldt, F (corresponding author), Georg August Univ Gottingen, Inst Phys Biophys 3, Gottingen, Germany.; Kaverina, I (corresponding author), Vanderbilt Univ, Dept Cell & Dev Biol, 221 Kirkland Hall, Nashville, TN 37235 USA.; Rehfeldt, F (corresponding author), Univ Bayreuth, Expt Phys 1, Bayreuth, Germany.	irina.kaverina@vanderbilt.edu; florian.rehfeldt@uni-bayreuth.de	Rehfeldt, Florian/A-1078-2007	Rehfeldt, Florian/0000-0001-9086-3835; Narasimhan, Shwetha/0000-0002-8027-7880; Hauke, Lara/0000-0003-0777-6859	National Institute of General Medical Sciences (NIGMS) of the National Institutes of Health (NIH) [R35-GM127098]; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) of the National Institutes of Health (NIH) [R01-DK106228]; American Heart Association (AHA) [18PRE33990479]; Deutsche Forschungsgemeinschaft (DFG) [SFB 755, SFB 937]; University of Bayreuth	National Institute of General Medical Sciences (NIGMS) of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); American Heart Association (AHA)(American Heart Association); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); University of Bayreuth	I.K.; R35-GM127098; The National Institute of General Medical Sciences (NIGMS) of the National Institutes of Health (NIH); https://www.nigms.nih.gov/I.K.; R01-DK106228; The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) of the National Institutes of Health (NIH); https://www.niddk.nih.gov/S.N.; 18PRE33990479; https://www.heart.org/; the American Heart Association (AHA); https://www.heart.org/F.R.SFB 755 -B08, Deutsche Forschungsgemeinschaft (DFG), www.dfg.de F.R. SFB 937 - A13, Deutsche Forschungsgemeinschaft (DFG), www.dfg.de F.R. Open Access Publishing funding programme of the University of Bayreuth and the German Research Foundation (DFG), https://www.ub.uni-bayreuth.de/en/index.html, www.dfg.de The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bach CTT, 2009, MOL CELL BIOL, V29, P1506, DOI 10.1128/MCB.00857-08; Berginski Matthew E, 2013, F1000Res, V2, P68, DOI 10.12688/f1000research.2-68.v1; Broussard JA, 2015, SCI REP-UK, V5, DOI 10.1038/srep08124; Buskermolen ABC, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195201; Ciobanasu Corina, 2012, Int J Cell Biol, V2012, P941292, DOI 10.1155/2012/941292; Eltzner B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126346; Feng YF, 2013, EXP CELL RES, V319, P1124, DOI 10.1016/j.yexcr.2013.02.009; Guo FK, 2006, J BIOL CHEM, V281, P18652, DOI 10.1074/jbc.M603508200; Kanellos G, 2015, CELL REP, V13, P1949, DOI 10.1016/j.celrep.2015.10.056; Kovac B, 2013, J CELL SCI, V126, P263, DOI 10.1242/jcs.115063; Nowak J, 2020, BIOINFORMATICS, V36, P2950, DOI 10.1093/bioinformatics/btaa035; Parsons JT, 2010, NAT REV MOL CELL BIO, V11, P633, DOI 10.1038/nrm2957; Pellegrin S, 2007, J CELL SCI, V120, P3491, DOI 10.1242/jcs.018473; Rogge H, 2017, J MICROSC-OXFORD, V268, P129, DOI 10.1111/jmi.12593; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Soine JRD, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004076; Vallenius T, 2013, OPEN BIOL, V3, DOI 10.1098/rsob.130001; Zemel A, 2010, NAT PHYS, V6, P468, DOI 10.1038/NPHYS1613; Zemel A, 2010, J PHYS-CONDENS MAT, V22, DOI 10.1088/0953-8984/22/19/194110; Zhang Z, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1684-y	21	5	5	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2021	16	9							e0250749	10.1371/journal.pone.0250749	http://dx.doi.org/10.1371/journal.pone.0250749			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XM9EM	34506490	Green Published, gold, Green Submitted			2022-12-26	WOS:000729120700018
J	Ochi, R; Fujita, N; Goto, N; Takaishi, K; Oshima, T; Nguyen, ST; Nishijo, H; Urakawa, S				Ochi, Ryosuke; Fujita, Naoto; Goto, Natsuki; Takaishi, Kaho; Oshima, Takaya; Nguyen, Son Tien; Nishijo, Hisao; Urakawa, Susumu			Medial prefrontal area reductions, altered expressions of cholecystokinin, parvalbumin, and activating transcription factor 4 in the corticolimbic system, and altered emotional behavior in a progressive rat model of type 2 diabetes	PLOS ONE			English	Article							ANXIETY-LIKE BEHAVIOR; CORTICOTROPIN-RELEASING-FACTOR; SPATIAL MEMORY; BRAIN; RECEPTOR; SYMPTOMS; INSULIN; GENE; ASSOCIATIONS; DEPRESSION	Metabolic disorders are associated with a higher risk of psychiatric disorders. We previously reported that 20-week-old Otsuka Long-Evans Tokushima fatty (OLETF) rats, a model of progressive type 2 diabetes, showed increased anxiety-like behavior and regional area reductions and increased cholecystokinin-positive neurons in the corticolimbic system. However, in which stages of diabetes these alterations in OLETF rats occur remains unclear. We aimed to investigate anxiety-like behavior and its possible mechanisms at different stages of type 2 diabetes in OLETF rats. Eight- and 30-week-old OLETF rats were used as diabetic animal models at the prediabetic and progressive stages of type 2 diabetes respectively, and age-matched Long-Evans Tokushima Otsuka rats served as non-diabetic controls. In the open-field test, OLETF rats showed less locomotion in the center zone and longer latency to leave the center zone at 8 and 30 weeks old, respectively. The areas of the medial prefrontal cortex were smaller in the OLETF rats, regardless of age. The densities of cholecystokinin-positive neurons in OLETF rats were higher in the lateral and basolateral amygdala only at 8 weeks old and in the anterior cingulate and infralimbic cortices and hippocampal cornu ammonis area 3 at both ages. The densities of parvalbumin-positive neurons of OLETF rats were lower in the cornu ammonis area 2 at 8 weeks old and in the prelimbic and infralimbic cortices at both ages. No apoptotic cell death was detected in OLETF rats, but the percentage of neurons co-expressing activating transcription factor 4 and cholecystokinin and parvalbumin was higher in OLETF rats at both ages in the anterior cingulate cortex and basolateral amygdala, respectively. These results suggest that altered emotional behavior and related neurological changes in the corticolimbic system are already present in the prediabetic stage of OLETF rats.	[Ochi, Ryosuke; Fujita, Naoto; Goto, Natsuki; Takaishi, Kaho; Oshima, Takaya; Nguyen, Son Tien; Urakawa, Susumu] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Musculoskeletal Funct Res & Regenerat, Minami Ku, Hiroshima, Japan; [Nishijo, Hisao] Toyama Univ, Syst Emot Sci, Fac Med, Sugitani, Toyama, Japan	Hiroshima University; University of Toyama	Urakawa, S (corresponding author), Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Musculoskeletal Funct Res & Regenerat, Minami Ku, Hiroshima, Japan.	urakawas@hiroshima-u.ac.jp		Nguyen Tien, Son/0000-0002-3220-234X; Ochi, Ryosuke/0000-0002-4473-022X	Japanese Ministry of Education, Culture, Sports, Science, and Technology [16K01505, 19K11346, 17K01503]; Japanese Physical Therapy Association [JPTA19-A36, JPTA20-A23]; Hiroshima University	Japanese Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japanese Physical Therapy Association; Hiroshima University	This work was supported by a Grant-in-Aid for Scientific Research from the Japanese Ministry of Education, Culture, Sports, Science, and Technology (16K01505 and 19K11346; FN and 17K01503; SU), research funds from Japanese Physical Therapy Association (JPTA19-A36 and JPTA20-A23; RO) and research funds from Hiroshima University. The funders had no role in study design, data collection and interpretation, or the decision to publish.	Abu Fanne R, 2011, AM J PHYSIOL-REG I, V301, pR668, DOI 10.1152/ajpregu.00058.2011; Alagiakrishnan K, 2012, AM J GERIAT PSYCHIAT, V20, P645, DOI 10.1097/JGP.0b013e31823038db; Baleriola J, 2014, CELL, V158, P1159, DOI 10.1016/j.cell.2014.07.001; BELCHEVA I, 1994, NEUROPHARMACOLOGY, V33, P995, DOI 10.1016/0028-3908(94)90158-9; Bocarsly ME, 2015, P NATL ACAD SCI USA, V112, P15731, DOI 10.1073/pnas.1511593112; Clark RSB, 2000, J NEUROCHEM, V74, P740, DOI 10.1046/j.1471-4159.2000.740740.x; de la Mora MP, 2007, EUR J NEUROSCI, V26, P3614, DOI 10.1111/j.1460-9568.2007.05963.x; Del Boca C, 2012, NEUROSCIENCE, V218, P185, DOI 10.1016/j.neuroscience.2012.05.022; Deschenes SS, 2016, J PSYCHOSOM RES, V89, P85, DOI 10.1016/j.jpsychores.2016.08.011; Dinel AL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024325; Estanislau C, 2019, PHYSIOL BEHAV, V209, DOI 10.1016/j.physbeh.2019.112585; Fujita N, 2019, J DIABETES RES, V2019, DOI 10.1155/2019/2694215; Goto N, 2020, BIOMED RES-TOKYO, V41, P23, DOI 10.2220/biomedres.41.23; Gulyas M, 2016, NEUROINFORMATICS, V14, P479, DOI 10.1007/s12021-016-9303-z; Gupta D, 2014, METAB BRAIN DIS, V29, P737, DOI 10.1007/s11011-014-9540-5; Hernandez-Gomez AM, 2002, AMINO ACIDS, V23, P283, DOI 10.1007/s00726-001-0139-x; Hu H, 2014, SCIENCE, V345, P529, DOI 10.1126/science.1255263; Huang Q, 2006, J MOL ENDOCRINOL, V37, P213, DOI 10.1677/jme.1.02103; Hussain S, 2014, J ALZHEIMERS DIS, V41, P551, DOI 10.3233/JAD-131958; Iuvone L, 1996, EXP NEUROL, V139, P25, DOI 10.1006/exnr.1996.0077; KAWANO K, 1992, DIABETES, V41, P1422, DOI 10.2337/diabetes.41.11.1422; Kim GW, 2018, CLIN IMAG, V50, P164, DOI 10.1016/j.clinimag.2018.03.008; Kobayashi S, 1996, NEUROSCI LETT, V214, P61; Kong FJ, 2018, CLIN SCI, V132, P111, DOI 10.1042/CS20171432; Krukowski K, 2020, ELIFE, V9, DOI 10.7554/eLife.62048; Larsson M, 2016, BIOSCIENCE REP, V36, DOI 10.1042/BSR20160437; Li XL, 2002, PHYSIOL BEHAV, V75, P15, DOI 10.1016/S0031-9384(01)00627-8; Lietzau G, 2017, PSYCHONEUROENDOCRINO, V82, P46, DOI 10.1016/j.psyneuen.2017.04.012; Lin YW, 2018, INT J MOL MED, V42, P182, DOI 10.3892/ijmm.2018.3607; Luo ZY, 2020, BIOL PSYCHIAT, V87, P926, DOI 10.1016/j.biopsych.2019.10.021; Mascagni F, 2003, BRAIN RES, V976, P171, DOI 10.1016/S0006-8993(03)02625-8; Miyasaka K, 2002, NEUROSCI LETT, V335, P115, DOI 10.1016/S0304-3940(02)01176-X; Naicker K, 2017, DIABETES CARE, V40, P352, DOI 10.2337/dc16-2018; Ochi R, 2020, J PHYSIOL SCI, V70, DOI 10.1186/s12576-020-00771-0; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Raffield LM, 2016, J DIABETES COMPLICAT, V30, P143, DOI 10.1016/j.jdiacomp.2015.09.010; Rebolledo-Solleiro D, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176554; Rezayat M, 2005, PHYSIOL BEHAV, V84, P775, DOI 10.1016/j.physbeh.2005.03.002; Sampedro-Piquero P, 2016, NEUROSCIENCE, V330, P17, DOI 10.1016/j.neuroscience.2016.05.032; Schroeder M, 2010, BEHAV BRAIN RES, V211, P198, DOI 10.1016/j.bbr.2010.03.038; Sherrin T, 2009, MOL PSYCHIATR, V14, P291, DOI 10.1038/sj.mp.4002121; SINGH L, 1991, P NATL ACAD SCI USA, V88, P1130, DOI 10.1073/pnas.88.4.1130; Smith KJ, 2013, J PSYCHOSOM RES, V74, P89, DOI 10.1016/j.jpsychores.2012.11.013; Takiguchi S, 1997, GENE, V197, P169, DOI 10.1016/S0378-1119(97)00259-X; Truitt WA, 2009, NEUROSCIENCE, V160, P284, DOI 10.1016/j.neuroscience.2009.01.083; Urakawa S, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-13; VANDERHAEGHEN JJ, 1980, P NATL ACAD SCI-BIOL, V77, P1190, DOI 10.1073/pnas.77.2.1190; Vereczki VK, 2016, FRONT NEUROANAT, V10, DOI 10.3389/fnana.2016.00020; Vialou V, 2014, J NEUROSCI, V34, P3878, DOI 10.1523/JNEUROSCI.1787-13.2014; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Whissell PD, 2019, ENEURO, V6, DOI 10.1523/ENEURO.0360-18.2019; Whissell PD, 2015, FRONT NEUROANAT, V9, DOI 10.3389/fnana.2015.00124; Yamamoto Y, 2000, BRAIN RES BULL, V53, P789, DOI 10.1016/S0361-9230(00)00407-X; Yang LD, 2019, J BIOPHOTONICS, V12, DOI 10.1002/jbio.201800359; Zborowski VA, 2021, PHYSIOL BEHAV, V237, DOI 10.1016/j.physbeh.2021.113346	55	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2021	16	9							e0256655	10.1371/journal.pone.0256655	http://dx.doi.org/10.1371/journal.pone.0256655			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XM9EM	34506507	gold, Green Published, Green Submitted			2022-12-26	WOS:000729120700093
J	Li, D; Zhang, J; Yang, WP; Li, P; Ru, Y; Kang, WF; Li, LL; Ran, Y; Zheng, HX				Li, Dan; Zhang, Jing; Yang, Wenping; Li, Pan; Ru, Yi; Kang, Weifang; Li, LuLu; Ran, Yong; Zheng, Haixue			African swine fever virus protein MGF-505-7R promotes virulence and pathogenesis by inhibiting JAK1-and JAK2-mediated signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENOME SEQUENCES; INTERFERON-GAMMA; T-CELLS; GENE; REPLICATION; MACROPHAGES; PROTECTION; ATTENUATION; CHEMOKINE; RECEPTOR	African swine fever virus (ASFV) is a large DNA virus that is highly contagious and pathogenic in domestic pigs with a mortality rate up to 100%. However, how ASFV suppresses JAK-STAT1 signaling to evade the immune response remains unclear. In this study, we found that the ASFV-encoded protein MGF-505-7R inhibited proinflammatory IFN-gamma-mediated JAK-STAT1 signaling. Mechanistically, MGF-505-7R was found to interact with JAK1 and JAK2 and mediate their degradation. Further study indicated that MGF-505-7R promoted degradation of JAK1 and JAK2 by upregulating the E3 ubiquitin ligase RNF125 expression and inhibiting expression of Hes5, respectively. Consistently, MGF-505-7R-deficient ASFV induced high levels of IRF1 expression and displayed compromised replication both in primary porcine alveolar macrophages and pigs compared with wild-type ASFV. Furthermore, MGF-505-7R deficiency attenuated the virulence of the ASFV and pathogenesis of ASF in pigs. These findings suggest that the JAK-STAT1 axis mediates the innate immune response to the ASFV and that MGF-505-7R plays a critical role in the virulence of the ASFV and pathogenesis of ASF by antagonizing this axis. Thus, we conclude that deletion of MGF-505-7R may serve as a strategy to develop attenuated vaccines against the ASFV.	[Li, Dan; Zhang, Jing; Yang, Wenping; Li, Pan; Ru, Yi; Kang, Weifang; Li, LuLu; Zheng, Haixue] Chinese Acad Agr Sci, Lanzhou Vet Res Inst, State Key Lab Vet Etiol Biol, Lanzhou, Gansu, Peoples R China; [Li, Dan; Zhang, Jing; Yang, Wenping; Li, Pan; Ru, Yi; Kang, Weifang; Li, LuLu; Zheng, Haixue] Chinese Acad Agr Sci, Lanzhou Vet Res Inst, OIE Natl Foot & Mouth Dis Reference Lab, Lanzhou, Gansu, Peoples R China; [Ran, Yong] Chinese Acad Sci, Wuhan Inst Virol, State Key Lab Virol, Wuhan, Peoples R China	Chinese Academy of Agricultural Sciences; Lanzhou Veterinary Research Institute, CAAS; Chinese Academy of Agricultural Sciences; Lanzhou Veterinary Research Institute, CAAS; Chinese Academy of Sciences; Wuhan Institute of Virology, CAS	Zheng, HX (corresponding author), Chinese Acad Agr Sci, Lanzhou Vet Res Inst, State Key Lab Vet Etiol Biol, Lanzhou, Gansu, Peoples R China.; Zheng, HX (corresponding author), Chinese Acad Agr Sci, Lanzhou Vet Res Inst, OIE Natl Foot & Mouth Dis Reference Lab, Lanzhou, Gansu, Peoples R China.	haixuezheng@163.com			Gansu major science and technology projects [20ZD7NA006]; National Key Research and Development Program [2018YFC0840402]; National Natural Science Foundation of China [31941002]; Special Fund for Basic Scientific Research of Chinese Academy of Agricultural Sciences [Y2019YJ07-01]	Gansu major science and technology projects; National Key Research and Development Program; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Fund for Basic Scientific Research of Chinese Academy of Agricultural Sciences	We thank Prof. Hong-Bing Shu (Wuhan University) for providing plasmids (including pRK-flag, pRL-TK Renilla luciferase reporter plasmid) and Prof. Shu Zhu (Zhejiang University) for critically reviewing this manuscript. This work was supported by grants from the Gansu major science and technology projects (20ZD7NA006), National Key Research and Development Program (2018YFC0840402), National Natural Science Foundation of China (31941002), and Special Fund for Basic Scientific Research of Chinese Academy of Agricultural Sciences (Y2019YJ07-01).	Afonso CL, 2004, J VIROL, V78, P1858, DOI 10.1128/JVI.78.4.1858-1864.2004; Bach EA, 1997, ANNU REV IMMUNOL, V15, P563, DOI 10.1146/annurev.immunol.15.1.563; Boehm U, 1997, ANNU REV IMMUNOL, V15, P749, DOI 10.1146/annurev.immunol.15.1.749; Borca MV, 2020, J VIROL, V94, DOI 10.1128/JVI.02017-19; Carlson J, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8100291; CARRASCOSA AL, 1982, J VIROL METHODS, V3, P303, DOI 10.1016/0166-0934(82)90034-9; Chapman DAG, 2008, J GEN VIROL, V89, P397, DOI 10.1099/vir.0.83343-0; Cockwell P, 2002, NEPHROL DIAL TRANSPL, V17, P734, DOI 10.1093/ndt/17.5.734; Cole KE, 1998, J EXP MED, V187, P2009, DOI 10.1084/jem.187.12.2009; Correia S, 2013, VIRUS RES, V173, P87, DOI 10.1016/j.virusres.2012.10.013; Darwich L, 2009, IMMUNOLOGY, V126, P386, DOI 10.1111/j.1365-2567.2008.02905.x; De la Torre A, 2015, TRANSBOUND EMERG DIS, V62, P272, DOI 10.1111/tbed.12129; de Villiers EP, 2010, VIROLOGY, V400, P128, DOI 10.1016/j.virol.2010.01.019; Demmers MWHJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064916; Dixon LK, 2013, VIRUS RES, V173, P3, DOI 10.1016/j.virusres.2012.10.020; Fraczyk M, 2016, VET MICROBIOL, V193, P133, DOI 10.1016/j.vetmic.2016.08.018; Garcia-Belmonte R, 2019, J VIROL, V93, DOI [10.1128/JVI.02298-18, 10.1128/jvi.02298-18]; Ge SQ, 2018, EMERG INFECT DIS, V24, P2131, DOI 10.3201/eid2411.181274; Golding JP, 2016, VIROLOGY, V493, P154, DOI 10.1016/j.virol.2016.03.019; Kamakura S, 2004, NAT CELL BIOL, V6, P547, DOI 10.1038/ncb1138; Kim HJ, 2020, TRANSBOUND EMERG DIS, V67, P473, DOI 10.1111/tbed.13483; Kim H, 2015, CELL REP, V11, P1458, DOI 10.1016/j.celrep.2015.04.049; King DP, 2003, J VIROL METHODS, V107, P53, DOI 10.1016/S0166-0934(02)00189-1; King K, 2011, VACCINE, V29, P4593, DOI 10.1016/j.vaccine.2011.04.052; Krug PW, 2015, J VIROL, V89, P2324, DOI 10.1128/JVI.03250-14; Lewis T, 2000, J VIROL, V74, P1275, DOI 10.1128/JVI.74.3.1275-1285.2000; Li D, 2021, J IMMUNOL, V206, P1844, DOI 10.4049/jimmunol.2001110; Li D, 2021, VIROL SIN, V36, P187, DOI 10.1007/s12250-021-00350-6; Lu B, 1999, EUR J IMMUNOL, V29, P3804, DOI 10.1002/(SICI)1521-4141(199911)29:11<3804::AID-IMMU3804>3.0.CO;2-9; LUSTER AD, 1985, NATURE, V315, P672, DOI 10.1038/315672a0; Malmgaard L, 2004, J INTERF CYTOK RES, V24, P439, DOI 10.1089/1079990041689665; MALMQUIST WA, 1960, AM J VET RES, V21, P104; Moore DM, 1998, J VIROL, V72, P10310, DOI 10.1128/JVI.72.12.10310-10315.1998; O'Donnell V, 2017, J VIROL, V91, DOI 10.1128/JVI.01760-16; O'Donnell V, 2015, J VIROL, V89, P8556, DOI 10.1128/JVI.00969-15; O'Donnell V, 2015, J VIROL, V89, P6048, DOI 10.1128/JVI.00554-15; PEREZ J, 1994, J VET DIAGN INVEST, V6, P360, DOI 10.1177/104063879400600314; Rai A, 2021, BIO-PROTOCOL, V11, DOI 10.21769/BioProtoc.3955; Ramirez-Medina E, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11070599; RAMIROIBANEZ F, 1995, J VIROL METHODS, V55, P339, DOI 10.1016/0166-0934(95)00071-1; REED L. J., 1938, AMER JOUR HYG, V27, P493; Reis AL, 2017, J VIROL, V91, DOI 10.1128/JVI.02338-16; Schoenborn JR, 2007, ADV IMMUNOL, V96, P41, DOI 10.1016/S0065-2776(07)96002-2; SIMS SH, 1993, MOL CELL BIOL, V13, P690, DOI 10.1128/MCB.13.1.690; Stark GR, 2012, IMMUNITY, V36, P503, DOI 10.1016/j.immuni.2012.03.013; Stark GR, 1998, ANNU REV BIOCHEM, V67, P227, DOI 10.1146/annurev.biochem.67.1.227; Le VP, 2019, EMERG INFECT DIS, V25, P1433, DOI 10.3201/eid2507.190303; Wang XX, 2018, BIOCHEM BIOPH RES CO, V506, P437, DOI 10.1016/j.bbrc.2018.10.103; Wei J, 2017, P NATL ACAD SCI USA, V114, P13000, DOI 10.1073/pnas.1713462114; Wen XX, 2019, EMERG MICROBES INFEC, V8, P303, DOI 10.1080/22221751.2019.1565915; YANEZ RJ, 1995, VIROLOGY, V208, P249, DOI 10.1006/viro.1995.1149; Zhao DM, 2019, EMERG MICROBES INFEC, V8, P438, DOI 10.1080/22221751.2019.1590128; Zsak L, 1998, J VIROL, V72, P1028, DOI 10.1128/JVI.72.2.1028-1035.1998; Zsak L, 1996, J VIROL, V70, P8865, DOI 10.1128/JVI.70.12.8865-8871.1996	54	17	21	2	12	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV	2021	297	5							101190	10.1016/j.jbc.2021.101190	http://dx.doi.org/10.1016/j.jbc.2021.101190			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	YZ3FU	34517008	gold, Green Published			2022-12-26	WOS:000755365700004
J	Dhakal, P; Fitzgerald, HC; Kelleher, AM; Liu, HY; Spencer, TE				Dhakal, Pramod; Fitzgerald, Harriet C.; Kelleher, Andrew M.; Liu, Hongyu; Spencer, Thomas E.			Uterine glands impact embryo survival and stromal cell decidualization in mice	FASEB JOURNAL			English	Article						decidualization; endometrium; FOXA2; gland; pregnancy	PLACENTAL DEVELOPMENT; HUMAN ENDOMETRIUM; MOUSE; FOXA2; IMPLANTATION; EXPRESSION; PREGNANCY; CONCEPTUS; TROPHOBLAST; MECHANISMS	Uterine glands are essential for the establishment of pregnancy and have critical roles in endometrial receptivity to blastocyst implantation, stromal cell decidualization, and placentation. Uterine gland dysfunction is considered a major contributing factor to pregnancy loss, however our understanding of how glands impact embryo survival and stromal cell decidualization is incomplete. Forkhead box A2 (FOXA2) is expressed only in the glandular epithelium and regulates its development and function. Mice with a conditional deletion of FOXA2 in the uterus are infertile due to defective embryo implantation arising from a lack of leukemia inhibitory factor (LIF), a critical factor of uterine gland origin. Here, a glandless FOXA2-deficient mouse model, coupled with LIF repletion to rescue the implantation defect, was used to investigate the roles of uterine glands in embryo survival and decidualization. Studies found that embryo survival and decidualization were compromised in glandless FOXA2-deficient mice on gestational day 6.5, resulting in abrupt pregnancy loss by day 7.5. These findings strongly support the hypothesis that uterine glands secrete factors other than LIF that impact embryo survival and stromal cell decidualization for pregnancy success.	[Dhakal, Pramod; Fitzgerald, Harriet C.; Kelleher, Andrew M.; Liu, Hongyu; Spencer, Thomas E.] Univ Missouri, Div Anim Sci, Columbia, MO 65211 USA; [Kelleher, Andrew M.; Spencer, Thomas E.] Univ Missouri, Div Obstet Gynecol & Womens Hlth, Columbia, MO 65211 USA	University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia	Spencer, TE (corresponding author), Univ Missouri, Div Anim Sci, Columbia, MO 65211 USA.	spencerte@missouri.edu		Spencer, Thomas/0000-0003-2815-766X	HHS | NIH | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) [R01 HD096266]	HHS | NIH | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)	HHS | NIH | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), Grant/Award Number: R01 HD096266	Allen MP, 1998, J IMMUNOL, V161, P2772; Arora R, 2016, DEVELOPMENT, V143, P4749, DOI 10.1242/dev.144386; Bardou P, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-293; Bu HJ, 2011, PROSTATE, V71, P575, DOI 10.1002/pros.21273; Burton GJ, 2007, PLACENTA, V28, pS64, DOI 10.1016/j.placenta.2007.01.007; Burton GJ, 2002, J CLIN ENDOCR METAB, V87, P2954, DOI 10.1210/jc.87.6.2954; Cha JY, 2012, NAT MED, V18, P1754, DOI 10.1038/nm.3012; Cheng JG, 2017, ENDOCRINOLOGY, V158, P1916, DOI 10.1210/en.2017-00103; Conrad KP, 2020, OBSTET GYN CLIN N AM, V47, P163, DOI 10.1016/j.ogc.2019.10.011; Cooke PS, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.097188; Dalton CF, 1998, HUM REPROD, V13, P3197, DOI 10.1093/humrep/13.11.3197; Das SK, 2010, MOL REPROD DEV, V77, P387, DOI 10.1002/mrd.21133; Das SK, 2009, REPRODUCTION, V137, P889, DOI 10.1530/REP-08-0539; Dey SK, 2004, ENDOCR REV, V25, P341, DOI 10.1210/er.2003-0020; Dhakal P, 2021, MOL REPROD DEV, V88, P482, DOI 10.1002/mrd.23473; Dhakal P, 2020, P NATL ACAD SCI USA, V117, P23952, DOI 10.1073/pnas.2014272117; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; ENDERS AC, 1969, AM J ANAT, V125, P1, DOI 10.1002/aja.1001250102; Filant J, 2014, FASEB J, V28, P230, DOI 10.1096/fj.13-237446; Filant J, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.113.107631; Garrido-Gomez T, 2017, P NATL ACAD SCI USA, V114, pE8468, DOI 10.1073/pnas.1706546114; Gellersen B, 2007, SEMIN REPROD MED, V25, P445, DOI 10.1055/s-2007-991042; Gellersen B, 2014, ENDOCR REV, V35, P851, DOI 10.1210/er.2014-1045; Goolam M, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16603-z; Gray CA, 2002, REPRODUCTION, V124, P289, DOI 10.1530/rep.0.1240289; Gray CA, 2001, BIOL REPROD, V64, P1608, DOI 10.1095/biolreprod64.6.1608; Haller M, 2019, P NATL ACAD SCI USA, V116, P19541, DOI 10.1073/pnas.1907652116; Hemberger M, 2020, NAT REV GENET, V21, P27, DOI 10.1038/s41576-019-0169-4; HEUSEL JW, 1994, CELL, V76, P977, DOI 10.1016/0092-8674(94)90376-X; Hrstka R, 2017, CANCER INVEST, V35, P313, DOI 10.1080/07357907.2017.1309546; Huhn O, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-14123-z; Jeong JW, 2010, BIOL REPROD, V83, P396, DOI 10.1095/biolreprod.109.083154; Kelleher AM, 2019, ENDOCR REV, V40, P1424, DOI 10.1210/er.2018-00281; Kelleher AM, 2019, FASEB J, V33, P8543, DOI 10.1096/fj.201900013R; Kelleher AM, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04848-8; Kelleher AM, 2017, P NATL ACAD SCI USA, V114, pE1018, DOI 10.1073/pnas.1618433114; Kelleher AM, 2016, SCI REP-UK, V6, DOI 10.1038/srep38078; Kipp A, 2007, BIOL CHEM, V388, P1027, DOI 10.1515/BC.2007.137; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lucas ES, 2020, COMMUN BIOL, V3, DOI 10.1038/s42003-020-0763-1; McConaha ME, 2011, REPRODUCTION, V141, P511, DOI 10.1530/REP-10-0358; Moser G, 2015, HUM REPROD, V30, P2747, DOI 10.1093/humrep/dev266; Moser G, 2010, HUM REPROD, V25, P1127, DOI 10.1093/humrep/deq035; Pertea M, 2016, NAT PROTOC, V11, P1650, DOI 10.1038/nprot.2016.095; Qi QR, 2015, CELL CYCLE, V14, P1842, DOI 10.1080/15384101.2015.1033593; Ramathal CY, 2010, SEMIN REPROD MED, V28, P17, DOI 10.1055/s-0029-1242989; Renaud SJ, 2017, BIOL REPROD, V96, P145, DOI 10.1095/biolreprod.116.142752; Sebastian-Leon P, 2018, HUM REPROD, V33, P626, DOI 10.1093/humrep/dey023; Soyal SM, 2005, GENESIS, V41, P58, DOI 10.1002/gene.20098; Spencer TE, 2019, ANNU REV ANIM BIOSCI, V7, P125, DOI 10.1146/annurev-animal-020518-115321; STEWART CL, 1992, NATURE, V359, P76, DOI 10.1038/359076a0; STEWART CL, 1994, ANN NY ACAD SCI, V734, P157, DOI 10.1111/j.1749-6632.1994.tb21743.x; Sund NJ, 2000, MOL CELL BIOL, V20, P5175, DOI 10.1128/MCB.20.14.5175-5183.2000; Tan J, 2002, MECH DEVELOP, V111, P99, DOI 10.1016/S0925-4773(01)00614-1; Vanderlaag KE, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2586; Villacorte M, 2013, ONCOGENE, V32, P3477, DOI 10.1038/onc.2012.376; Wang J, 2013, NUCLEIC ACIDS RES, V41, pW77, DOI 10.1093/nar/gkt439; Woods L, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00570; Woods L, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00308-x; Yuan JB, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03092-4; Zhang S, 2013, MOL ASPECTS MED, V34, P939, DOI 10.1016/j.mam.2012.12.011; Zhao M, 2017, REPRODUCTION, V153, P645, DOI 10.1530/REP-16-0486	62	2	2	1	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2021	35	10							e21938	10.1096/fj.202101170RR	http://dx.doi.org/10.1096/fj.202101170RR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	UZ5IH	34547143				2022-12-26	WOS:000702238200064
J	Hughes, MP; Goldschmidt, L; Eisenberg, DS				Hughes, Michael P.; Goldschmidt, Lukasz; Eisenberg, David S.			Prevalence and species distribution of the low-complexity, amyloid-like, reversible, kinked segment structural motif in amyloid-like fibrils	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-BINDING PROTEINS; PRION-LIKE DOMAINS; PHASE-SEPARATION; ATOMIC STRUCTURES; LIQUID DROPLETS; GRANULES; TRANSITION; SEQUENCES	Membraneless organelles (MLOs) are vital and dynamic reaction centers in cells that compartmentalize the cytoplasm in the absence of a membrane. Multivalent interactions between protein low-complexity domains contribute to MLO organization. Previously, we used computational methods to identify structural motifs termed low-complexity amyloid-like reversible kinked segments (LARKS) that promote phase transition to form hydrogels and that are common in human proteins that participate in MLOs. Here, we searched for LARKS in the proteomes of six model organisms: Homo sapiens, Drosophila melanogaster, Plasmodium falciparum, Saccharomyces cerevisiae, Mycobacterium tuberculosis, and Escherichia coli to gain an understanding of the distribution of LARKS in the proteomes of various species. We found that LARKS are abundant in M. tuberculosis, D. melanogaster, and H. sapiens but not in S. cerevisiae or P. falciparum. LARKS have high glycine content, which enables kinks to form as exemplified by the known LARKS-rich amyloidogenic structures of TDP43, FUS, and hnRNPA2, three proteins that are known to participate in MLOs. These results support the idea of LARKS as an evolved structural motif. Based on these results, we also established the LARKSdb Web server, which permits users to search for LARKS in their protein sequences of interest.	[Hughes, Michael P.] St Jude Childrens Res Hosp, Dept Cell & Mol Biol, 332 N Lauderdale St, Memphis, TN 38105 USA; [Goldschmidt, Lukasz] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Eisenberg, David S.] Univ Calif Los Angeles, Dept Biol Chem, DOE Inst, HHMI, Los Angeles, CA 90024 USA; [Eisenberg, David S.] Univ Calif Los Angeles, Mol Biol Inst, Los Angeles, CA 90095 USA	St Jude Children's Research Hospital; University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Eisenberg, DS (corresponding author), Univ Calif Los Angeles, Dept Biol Chem, DOE Inst, HHMI, Los Angeles, CA 90024 USA.; Eisenberg, DS (corresponding author), Univ Calif Los Angeles, Mol Biol Inst, Los Angeles, CA 90095 USA.	david@mbi.ucla.edu		Hughes, Michael/0000-0002-6239-4151; Goldschmidt, Lukasz/0000-0002-2925-1159; Eisenberg, David/0000-0003-2432-5419	Division of Molecular and Cellular Biosciences, National Science Foundation [1616265]; NIH [AG048120]	Division of Molecular and Cellular Biosciences, National Science Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank Dr J. P. Taylor for support and discussion and the Division of Molecular and Cellular Biosciences, National Science Foundation (Grant 1616265), and NIH (Grant AG048120) for support.	Alberti S, 2019, CELL, V176, P419, DOI 10.1016/j.cell.2018.12.035; Brennan MJ, 2017, INFECT IMMUN, V85, DOI [10.1128/IAI.00969-16, 10.1128/iai.00969-16]; Cao Q, 2019, NAT STRUCT MOL BIOL, V26, P619, DOI 10.1038/s41594-019-0248-4; Cascarina SM, 2017, PRION, V11, P323, DOI 10.1080/19336896.2017.1356560; Goldschmidt L, 2010, P NATL ACAD SCI USA, V107, P3487, DOI 10.1073/pnas.0915166107; Guo Q, 2018, CELL, V172, P696, DOI 10.1016/j.cell.2017.12.030; Hennig S, 2015, J CELL BIOL, V210, P529, DOI 10.1083/jcb.201504117; Hervas R, 2020, SCIENCE, V367, P1230, DOI 10.1126/science.aba3526; Hughes MP, 2018, SCIENCE, V359, P698, DOI 10.1126/science.aan6398; Kato M, 2018, ANNU REV BIOCHEM, V87, P351, DOI 10.1146/annurev-biochem-061516-044700; Kato M, 2012, CELL, V149, P753, DOI 10.1016/j.cell.2012.04.017; King OD, 2012, BRAIN RES, V1462, P61, DOI 10.1016/j.brainres.2012.01.016; Kroschwald S, 2015, ELIFE, V4, DOI 10.7554/eLife.06807; Lee M, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-19512-3; Li PL, 2012, NATURE, V483, P336, DOI 10.1038/nature10879; Li YR, 2013, J CELL BIOL, V201, P361, DOI 10.1083/jcb.201302044; Liebman SW, 2012, GENETICS, V191, P1041, DOI 10.1534/genetics.111.137760; Lin Y, 2015, MOL CELL, V60, P208, DOI 10.1016/j.molcel.2015.08.018; Linding R, 2003, NUCLEIC ACIDS RES, V31, P3701, DOI 10.1093/nar/gkg519; Lu JH, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17905-y; Molliex A, 2015, CELL, V163, P123, DOI 10.1016/j.cell.2015.09.015; Murakami T, 2015, NEURON, V88, P678, DOI 10.1016/j.neuron.2015.10.030; Murray DT, 2017, CELL, V171, P615, DOI 10.1016/j.cell.2017.08.048; Otzen D, 2019, CSH PERSPECT BIOL, V11, DOI 10.1101/cshperspect.a033860; Patel A, 2015, CELL, V162, P1066, DOI 10.1016/j.cell.2015.07.047; Peran I, 2020, CURR OPIN STRUC BIOL, V60, P17, DOI 10.1016/j.sbi.2019.09.007; Protter DSW, 2018, CELL REP, V22, P1401, DOI 10.1016/j.celrep.2018.01.036; Quiroz FG, 2020, SCIENCE, V367, P1210, DOI 10.1126/science.aax9554; Radwan M, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0233247; Richardson JS, 2002, P NATL ACAD SCI USA, V99, P2754, DOI 10.1073/pnas.052706099; Russell DG, 2016, CELL MICROBIOL, V18, P1065, DOI 10.1111/cmi.12623; Sawaya MR, 2007, NATURE, V447, P453, DOI 10.1038/nature05695; Schwartz JC, 2013, CELL REP, V5, P918, DOI 10.1016/j.celrep.2013.11.017; Shin Y, 2017, SCIENCE, V357, DOI 10.1126/science.aaf4382; Thomas PD, 2003, GENOME RES, V13, P2129, DOI 10.1101/gr.772403; Vogler TO, 2018, NATURE, V563, P508, DOI 10.1038/s41586-018-0665-2; WOOTTON JC, 1994, COMPUT CHEM, V18, P269, DOI 10.1016/0097-8485(94)85023-2	37	11	11	0	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT	2021	297	4							101194	10.1016/j.jbc.2021.101194	http://dx.doi.org/10.1016/j.jbc.2021.101194			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	WP4BY	34537246	Green Published, gold			2022-12-26	WOS:000713080600009
J	Hagani, JS; Kross, SM; Clark, M; Wynn-Grant, R; Blair, M				Hagani, Jason S.; Kross, Sara M.; Clark, Michael; Wynn-Grant, Rae; Blair, Mary			Mapping and modeling human-black bear interactions in the Catskills region of New York using resource selection probability functions	PLOS ONE			English	Article							CONSERVATION; CONFLICT; CARNIVORE; RISK; DOGS	Black bears (Ursus americanus) are an iconic and common species throughout much of the United States and people regularly interact with these large predators without conflict. However, negative interactions between people and bears can manifest in conflicts that can hinder conservation efforts. Black bears are highly attracted to anthropogenic sources of food, and negative interactions with people are primarily a product of trash mismanagement. In the Catskills region of New York State, home to a large population of black bears, over 400 such conflicts are reported each year. While the New York Department of Environmental Conservation (DEC) has seen progress recently in educating residents of the region on how to reduce unwanted interactions with bears, they have had less success educating the 12 million tourists that visit the Catskills each year. Understanding where conflict may occur in the future, and the environmental and anthropogenic factors that precede it, may help guide management strategies to reduce these unwanted interactions. Therefore, we designed resource selection probability functions (RSPFs) to examine the relationship between human-black bear conflicts in the Catskills with a suite of landscape and anthropogenic data, using conflicts reported to the DEC across the state of New York in 2018-2019. We found that human-black bear conflicts were more likely to occur in the residential areas of the Catskills on the urban-wildland interface; areas with relatively higher human population densities, away from dense forest, and further from heavily urbanized areas. While future work is needed to continuously validate our model predictions, our results will provide the DEC and other conservation managers in the Catskills the ability to create more targeted plans for mitigating unwanted human-black bear interactions, and provide a better understanding of the mechanisms driving human-carnivore interactions at an urban-wildland interface more generally.	[Hagani, Jason S.; Kross, Sara M.] Columbia Univ, Dept Ecol Evolut & Environm Biol, New York, NY 10027 USA; [Clark, Michael] New York Dept Environm Conservat Reg 4, Schenectady, NY USA; [Wynn-Grant, Rae] Univ Calif Santa Barbara, Bren Sch Environm Sci & Management, Santa Barbara, CA USA; [Blair, Mary] Amer Museum Nat Hist, Ctr Biodivers & Conservat, New York, NY USA	Columbia University; University of California System; University of California Santa Barbara; American Museum of Natural History (AMNH)	Hagani, JS (corresponding author), Columbia Univ, Dept Ecol Evolut & Environm Biol, New York, NY 10027 USA.	jsh2207@columbia.edu		Hagani, Jason/0000-0002-4578-7375	Cary Institute of Ecosystem Studies	Cary Institute of Ecosystem Studies	This study was funded by the Cary Institute of Ecosystem Studies. Funding was awarded jointly to authors JH and SK. Information about the funding institute can be found here: https://www.caryinstitute.org/.The funders were notified to approve any changes to the general study design made during the duration of their financial support, and were included in our decision to publish this research.	Aiello-Lammens ME, 2015, ECOGRAPHY, V38, P541, DOI 10.1111/ecog.01132; Barto n, 2015, MODEL SELECTION MODE; Baruch-Mordo S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085122; Beckmann JP, 2015, WEST N AM NATURALIST, V75, P396, DOI 10.3398/064.075.0410; Beckmann JP, 2004, WILDLIFE SOC B, V32, P1141, DOI 10.2193/0091-7648(2004)032[1141:EODTAD]2.0.CO;2; Bierwagen BG, 2010, P NATL ACAD SCI USA, V107, P20887, DOI 10.1073/pnas.1002096107; Big Game Management Team New York State Department of Environmental Conservation (DEC), 2014, BLACK BEAR MAN PLAN; Bruskotter JT, 2017, BIOSCIENCE, V67, P646, DOI 10.1093/biosci/bix049; Burdett CL, 2010, ECOSPHERE, V1, DOI 10.1890/ES10-00005.1; Bureau of Wildlife-Black Bear Management Team, 2007, BLACK BEARS NEW YORK; Bursac Z, 2008, SOURCE CODE BIOL MED, V3, DOI 10.1186/1751-0473-3-17; Carter NH, 2010, URSUS, V21, P57, DOI 10.2192/09GR011.1; CLARK JD, 1993, J WILDLIFE MANAGE, V57, P519, DOI 10.2307/3809276; Clark PE, 2020, RANGELAND ECOL MANAG, V73, P30, DOI 10.1016/j.rama.2019.08.012; Dellinger JA, 2020, J WILDLIFE MANAGE, V84, P359, DOI 10.1002/jwmg.21798; Department of Environmental Conservation (DEC), 2019, BLACK BEAR; Department of Environmental Conservation (DEC), 2014, BLACK BEAR HARV SUMM; Department of Environmental Conservation (DEC), 2013, BLACK BEAR HARV SUMM; Dickman AJ, 2010, ANIM CONSERV, V13, P458, DOI 10.1111/j.1469-1795.2010.00368.x; Drake MD, 2020, ANTHROZOOS, V33, P5, DOI 10.1080/08927936.2020.1694302; ESRI, 2020, ARCGIS DESKT REL 10; Estes JA, 2011, SCIENCE, V333, P301, DOI 10.1126/science.1205106; Evans MJ, 2014, J WILDLIFE MANAGE, V78, P1477, DOI 10.1002/jwmg.796; Foderaro LW, 2005, NEW YORK TIMES; Fowler NL, 2019, BIOL CONSERV, V236, P385, DOI 10.1016/j.biocon.2019.05.048; Freeman EA, 2008, ECOL MODEL, V217, P48, DOI 10.1016/j.ecolmodel.2008.05.015; Garshelis David L., 1999, Ursus, V11, P219; Garshelis DL, 2006, URSUS, V17, P1, DOI 10.2192/1537-6176(2006)17[1:SAPEOA]2.0.CO;2; Garshelis DL, 2016, IUCN RED LIST THREAT, DOI [10.1242/jeb.141549, DOI 10.1242/JEB.141549]; Gore ML, 2008, CONSERV LETT, V1, P136, DOI 10.1111/j.1755-263X.2008.00017.x; Gore ML, 2006, URSUS, V17, P75, DOI 10.2192/1537-6176(2006)17[75:EPFRAB]2.0.CO;2; Harrison XA, 2018, PEERJ, V6, DOI 10.7717/peerj.4794; Hijmans RJ, 2012, RASTER GEOGRAPHIC AN; Hijmans RJ, 2012, ECOLOGY, V93, P679, DOI 10.1890/11-0826.1; Hobbs N.T., 2015, BAYESIAN MODELS, DOI [DOI 10.1515/9781400866557, 10.1515/9781400866557]; Johnson HE, 2018, J APPL ECOL, V55, P663, DOI 10.1111/1365-2664.13021; Kretser H. E., 2009, Human Dimensions of Wildlife, V14, P102, DOI 10.1080/10871200802695594; Lele SR, 2009, J WILDLIFE MANAGE, V73, P122, DOI 10.2193/2007-535; Levin R, 2019, NEW YORK TIMES; Little A.R., 2017, J SE ASS FISH WILDLI, V4, P130; Litvaitis JA, 2015, ENVIRON MANAGE, V55, P1366, DOI 10.1007/s00267-015-0468-2; Merkle JA, 2013, J MAMMAL, V94, P378, DOI 10.1644/12-MAMM-A-002.1; Merkle JA, 2011, J WILDLIFE MANAGE, V75, P1121, DOI 10.1002/jwmg.153; Miles J., 2005, ENCY STAT BEHAV SCI; Miller JRB, 2016, WILDLIFE SOC B, V40, P806, DOI 10.1002/wsb.720; New York Governor's Office, 2018, GOV CUOM ANN NEW INV; O'Brien RM, 2007, QUAL QUANT, V41, P673, DOI 10.1007/s11135-006-9018-6; O'Bryan CJ, 2018, NAT ECOL EVOL, V2, P229, DOI 10.1038/s41559-017-0421-2; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Pooley S, 2017, CONSERV BIOL, V31, P513, DOI 10.1111/cobi.12859; R Core Team, 2020, R LANG ENV STAT COMP; R Studio Team, 2020, RSTUDIO INT DEV R RS; Redpath SM, 2013, TRENDS ECOL EVOL, V28, P100, DOI 10.1016/j.tree.2012.08.021; Ryan CW, 2007, URSUS, V18, P46, DOI 10.2192/1537-6176(2007)18[46:IOMPOB]2.0.CO;2; Scheick BK, 2014, URSUS, V25, P24, DOI 10.2192/URSUS-D-12-00020.1; Smith JB, 2014, J WILDLIFE MANAGE, V78, P930, DOI 10.1002/jwmg.718; Spencer RD, 2007, URSUS, V18, P217, DOI 10.2192/1537-6176(2007)18[217:HARTHB]2.0.CO;2; TAYLOR R, 1990, J DIAGN MED SONOG, V6, P35, DOI 10.1177/875647939000600106; Thornton Clarisse, 2009, Human-Wildlife Conflicts, V3, P282; Treves A, 2004, CONSERV BIOL, V18, P114, DOI 10.1111/j.1523-1739.2004.00189.x; Treves A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180043; Treves A, 2016, FRONT ECOL ENVIRON, V14, P380, DOI 10.1002/fee.1312; Williamson DF, 2002, BLACK STATUS MANAGEM; Wilson SM, 2006, BIOL CONSERV, V130, P47, DOI 10.1016/j.biocon.2005.12.001; Wynn-Grant R, 2018, GLOB ECOL CONSERV, V16, DOI 10.1016/j.gecco.2018.e00443	66	1	1	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2021	16	9							e0257716	10.1371/journal.pone.0257716	http://dx.doi.org/10.1371/journal.pone.0257716			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YS4WS	34551021	Green Published, gold			2022-12-26	WOS:000750679800048
J	Myerson, J; Strube, MJ; Green, L; Hale, S				Myerson, Joel; Strube, Michael J.; Green, Leonard; Hale, Sandra			Individual differences in COVID-19 mitigation behaviors: The roles of age, gender, psychological state, and financial status	PLOS ONE			English	Article							HOSPITAL ANXIETY; DEPRESSION SCALE; FEAR; CONSEQUENCES; METAANALYSIS; POPULATION; LONELINESS; VACCINE; ADULTS	The present study examined individual characteristics potentially associated with changes in mitigation behaviors (social distancing and hygiene) recommended by the Centers for Disease Control and Prevention. Analysis of online survey responses from 361 adults, ages 20-78, with US IP addresses, identified significant correlates of adaptive behavioral changes, with implications for preventive strategies and mental health needs. The extent to which individuals changed their mitigation behaviors was unrelated to self-rated health or concern regarding the personal effects of COVID-19 but was related to concern regarding the effects of the pandemic on others. Thus, mitigation behaviors do not appear to be primarily motivated by self-protection. Importantly, adaptive changes in mitigation behaviors increased with age. However, these changes, particularly those related to the frequency of close proximity encounters, appear to be due to age-related decreases in anxiety and depression. Taken together, the present results argue against over-reliance on 'fear appeals' in public health messages as they may increase anxiety and depression. Instead, the present findings argue for more appeals to people's concern for others to motivate mitigation as well as indicating an immediate need to address individual mental health concerns for the sake of society as a whole.	[Myerson, Joel; Strube, Michael J.; Green, Leonard; Hale, Sandra] Washington Univ, Dept Psychol & Brain Sci, St Louis, MO 63130 USA	Washington University (WUSTL)	Myerson, J (corresponding author), Washington Univ, Dept Psychol & Brain Sci, St Louis, MO 63130 USA.	myerson.joel@gmail.com			National Institute on Aging of the National Institutes of Health [R01AG058885]	National Institute on Aging of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported by the National Institute on Aging of the National Institutes of Health under Award Number R01AG058885 to J.M. and L.G. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson G, 2003, J PSYCHOSOM RES, V55, P259, DOI 10.1016/S0022-3999(02)00575-5; Applewhite A, 2020, J PRIM CARE COMMUNIT, V11, DOI 10.1177/2150132720958532; Bechard LE, 2021, FRONT PSYCHOL, V12, DOI 10.3389/fpsyg.2021.609893; Bjelland I, 2002, J PSYCHOSOM RES, V52, P69, DOI 10.1016/S0022-3999(01)00296-3; Blendon RJ, 2004, CLIN INFECT DIS, V38, P925, DOI 10.1086/382355; Breslau J, 2021, PREV MED, V143, DOI 10.1016/j.ypmed.2020.106362; Brooks SK, 2020, LANCET, V395, P912, DOI [10.1016/S0140-6736(20)30460-8., 10.1016/S0140-6736(20)30460-8]; Bui DC, 2015, PSYCHOL REC, V65, P649, DOI 10.1007/s40732-015-0135-2; Cacioppo JT, 2006, J RES PERS, V40, P1054, DOI 10.1016/j.jrp.2005.11.007; CHAPLIN WF, 1988, J PERS SOC PSYCHOL, V54, P541, DOI 10.1037/0022-3514.54.4.541; Crawford JR, 2001, BRIT J CLIN PSYCHOL, V40, P429, DOI 10.1348/014466501163904; Daly M, 2021, J AFFECT DISORDERS, V286, P296, DOI 10.1016/j.jad.2021.02.054; de Bruin WB, 2021, J GERONTOL B-PSYCHOL, V76, pE24, DOI 10.1093/geronb/gbaa074; Fisher KA, 2020, ANN INTERN MED, V173, P964, DOI 10.7326/M20-3569; Grant AM, 2011, PSYCHOL SCI, V22, P1494, DOI 10.1177/0956797611419172; Hawkley LC, 2010, ANN BEHAV MED, V40, P218, DOI 10.1007/s12160-010-9210-8; Herrmann C, 1997, J PSYCHOSOM RES, V42, P17, DOI 10.1016/S0022-3999(96)00216-4; Howard MC, 2021, PERS INDIV DIFFER, V170, DOI 10.1016/j.paid.2020.110417; Jordan RE, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m1198; Julian LJ, 2011, ARTHRIT CARE RES, V63, pS467, DOI 10.1002/acr.20561; La EM, 2018, HUM VACC IMMUNOTHER, V14, P430, DOI 10.1080/21645515.2017.1403697; Myerson J, 2021, EXP AGING RES, V47, P203, DOI 10.1080/0361073X.2021.1884472; Naeim A, 2021, JMIR PUBLIC HLTH SUR, V7, DOI 10.2196/24277; National Center for Health Statistics, 2020, MENT HLTH; Peters GJY, 2013, HEALTH PSYCHOL REV, V7, pS8, DOI 10.1080/17437199.2012.703527; Petrilli CM, 2020, BMJ-BRIT MED J, V369, DOI [10.1136/bmj.m1966, 10.12890/2020_001747]; Rayner K, 2016, PSYCHOL SCI PUBL INT, V17, P4, DOI 10.1177/1529100615623267; Reiter PL, 2020, VACCINE, V38, P6500, DOI 10.1016/j.vaccine.2020.08.043; Richardson S., 2020, JAMA-J AM MED ASSOC, V323, P2052, DOI [10.1001/jama.2020.6775, DOI 10.1001/JAMA.2020.6775, 10.1001/jama.2020.7681]; Rosi A, 2021, FRONT PSYCHOL, V12, DOI 10.3389/fpsyg.2021.646558; Ruiter RAC, 2014, INT J PSYCHOL, V49, P63, DOI 10.1002/ijop.12042; Shah AK, 2012, SCIENCE, V338, P682, DOI 10.1126/science.1222426; Tannenbaum MB, 2015, PSYCHOL BULL, V141, P1178, DOI 10.1037/a0039729; Williamson EJ, 2020, NATURE, V584, P430, DOI 10.1038/s41586-020-2521-4; Witte K, 2000, HEALTH EDUC BEHAV, V27, P591, DOI 10.1177/109019810002700506; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	36	4	4	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2021	16	9							e0257658	10.1371/journal.pone.0257658	http://dx.doi.org/10.1371/journal.pone.0257658			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	YM4DR	34547057	Green Published, gold			2022-12-26	WOS:000746527400032
J	Srednik, ME; Lantz, K; Hicks, JA; Morningstar-Shaw, BR; Mackie, TA; Schlater, LK				Srednik, Mariela E.; Lantz, Kristina; Hicks, Jessica A.; Morningstar-Shaw, Brenda R.; Mackie, Tonya A.; Schlater, Linda K.			Antimicrobial resistance and genomic characterization of Salmonella Dublin isolates in cattle from the United States	PLOS ONE			English	Article								Salmonella enterica subspecies enterica serotype Dublin is a host-adapted serotype in cattle, associated with enteritis and systemic disease. The primary clinical manifestation of Salmonella Dublin infection in cattle, especially calves, is respiratory disease. While rare in humans, it can cause severe illness, including bacteremia, with hospitalization and death. In the United States, S. Dublin has become one of the most multidrug-resistant serotypes. The objective of this study was to characterize S. Dublin isolates from sick cattle by analyzing phenotypic and genotypic antimicrobial resistance (AMR) profiles, the presence of plasmids, and phylogenetic relationships. S. Dublin isolates (n = 140) were selected from submissions to the NVSL for Salmonella serotyping (2014-2017) from 21 states. Isolates were tested for susceptibility against 14 class-representative antimicrobial drugs. Resistance profiles were determined using the ABRicate with Resfinder and NCBI databases, AMRFinder and Point-Finder. Plasmids were detected using ABRicate with PlasmidFinder. Phylogeny was determined using vSNP. We found 98% of the isolates were resistant to more than 4 antimicrobials. Only 1 isolate was pan-susceptible and had no predicted AMR genes. All S. Dublin isolates were susceptible to azithromycin and meropenem. They showed 96% resistance to sulfonamides, 97% to tetracyclines, 95% to aminoglycosides and 85% to beta-lactams. The most common AMR genes were: sulf2 and tetA (98.6%), aph(6)-Id (97.9%), aph (3'')-Ib, (97.1%), floR (94.3%), and blaCMY-2 (85.7%). All quinolone resistant isolates presented mutations in gyrA. Ten plasmid types were identified among all isolates with IncA/C2, IncX1, and IncFII(S) being the most frequent. The S. Dublin isolates show low genomic genetic diversity. This study provided antimicrobial susceptibility and genomic insight into S. Dublin clinical isolates from cattle in the U.S. Further sequence analysis integrating food and human origin S. Dublin isolates may provide valuable insight on increased virulence observed in humans.	[Srednik, Mariela E.; Lantz, Kristina; Hicks, Jessica A.; Morningstar-Shaw, Brenda R.; Mackie, Tonya A.; Schlater, Linda K.] USDA, Anim & Plant Hlth Inspect Serv, Natl Vet Serv Labs, Ames, IA 50010 USA	United States Department of Agriculture (USDA)	Srednik, ME (corresponding author), USDA, Anim & Plant Hlth Inspect Serv, Natl Vet Serv Labs, Ames, IA 50010 USA.	mariela.srednik@gmail.com		Srednik, Mariela/0000-0002-7387-1793	U.S. Department of Energy; USDA APHIS	U.S. Department of Energy(United States Department of Energy (DOE)); USDA APHIS(United States Department of Agriculture (USDA))	This project was supported in part by an appointment to the Research Participation Program at the Animal and Plant Health Inspection Service, United States Department of Agriculture, administered by the Oak Ridge Institute for Science and Education through an interagency agreement between the U.S. Department of Energy and USDA APHIS.	Adzitey F, 2019, J GLOB ANTIMICROB RE, V18, P179, DOI 10.1016/j.jgar.2019.03.014; Bearson BL, 2020, GENES-BASEL, V11, DOI 10.3390/genes11111291; Cadel-Six S, 2019, MICROBIOL RESOUR ANN, V8, DOI [10.1128/MRA.01361-18, 10.1128/mra.01361-18]; Carattoli A, 2014, ANTIMICROB AGENTS CH, V58, P3895, DOI 10.1128/AAC.02412-14; Carroll LM, 2017, APPL ENVIRON MICROB, V83, DOI [10.1128/AEM.00140-17, 10.1128/aem.00140-17]; Caudell MA, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0220274; CDC Centers for Disease Control and Prevention, OUTBR SALM INF LINK; Cohen E, 2020, ENVIRON MICROBIOL, V22, P413, DOI 10.1111/1462-2920.14858; Day MR, 2018, J ANTIMICROB CHEMOTH, V73, P365, DOI 10.1093/jac/dkx379; Edgar R, 1997, J BACTERIOL, V179, P2274, DOI 10.1128/jb.179.7.2274-2280.1997; Feldgarden M, 2019, ANTIMICROB AGENTS CH, V63, DOI 10.1128/AAC.00483-19; Garrison E., 2012, ARXIV12073907; Harvey RR, 2017, EMERG INFECT DIS, V23, P1493, DOI 10.3201/eid2309.170136; Holschbach CL, 2018, VET CLIN N AM-FOOD A, V34, P133, DOI 10.1016/j.cvfa.2017.10.005; Hsu CH, 2019, MICROB DRUG RESIST, V25, P1238, DOI 10.1089/mdr.2019.0045; Lee HY, 2009, ANTIMICROB AGENTS CH, V53, P2696, DOI 10.1128/AAC.01297-08; Li H., 2013, ALIGNING SEQUENCE RE; Mangat CS, 2019, ANTIMICROB AGENTS CH, V63, DOI [10.1128/AAC.00108-19, 10.1128/aac.00108-19]; McDermott PF, 2016, ANTIMICROB AGENTS CH, V60, P5515, DOI 10.1128/AAC.01030-16; McDonough PL, 1999, J CLIN MICROBIOL, V37, P2418, DOI 10.1128/JCM.37.8.2418-2427.1999; McMillan EA, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.00832; Mohammed M, 2016, EPIDEMIOL INFECT, V144, P2430, DOI 10.1017/S0950268816000492; Mohammed M, 2020, ONE HEALTH OUTLOOK, V2, DOI 10.1186/s42522-020-00016-5; Mohammed M, 2019, MICROBIOL RESOUR ANN, V8, DOI [10.1128/MRA.00028-19, 10.1128/mra.00028-19]; Mohammed M, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2628-x; Morningstar-Shaw BR., 2018, P 122 ANN M US AN HL, P280; Nurjadi D, 2021, FRONT MICROBIOL, V11, DOI 10.3389/fmicb.2020.607842; Paudyal N, 2019, BMC MICROBIOL, V19, DOI 10.1186/s12866-019-1598-0; Salipante SJ, 2003, MOL BIOL EVOL, V20, P653, DOI 10.1093/molbev/msg074; Seemann T., ABRICATE GITHUB; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Tyson GH, 2021, MICROB DRUG RESIST, V27, P792, DOI 10.1089/mdr.2020.0389; Vasimuddin M, 2019, INT PARALL DISTRIB P, P314, DOI 10.1109/IPDPS.2019.00041; Yasir M, 2020, J INFECT PUBLIC HEAL, V13, P94, DOI 10.1016/j.jiph.2019.06.011; Zankari E, 2017, J ANTIMICROB CHEMOTH, V72, P2764, DOI 10.1093/jac/dkx217; Zankari E, 2012, J ANTIMICROB CHEMOTH, V67, P2640, DOI 10.1093/jac/dks261	36	2	2	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2021	16	9							e0249617	10.1371/journal.pone.0249617	http://dx.doi.org/10.1371/journal.pone.0249617			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YM4DR	34547028	Green Published, gold, Green Submitted			2022-12-26	WOS:000746527400002
J	Fukuda, Y; Ando, S; Fukuda, K				Fukuda, Yasue; Ando, Shuji; Fukuda, Koji			Knowledge and preventive actions toward COVID-19, vaccination intent, and health literacy among educators in Japan: An online survey	PLOS ONE			English	Article							STUDENTS; UNIVERSITY; ATTITUDES; CLUSTERS	Countermeasures against the spread of COVID-19 have become an urgent issue in educational settings, where many group activities are necessary. Educators are key to preventing the spread of COVID-19 in educational settings. Infection prevention behavior requires comprehensive and complex measures such as self-restraint. disinfection care, hand washing, wearing masks and recommendation and implementation of vaccination. Improvement in the knowledge, skills, and preventive actions of educators vis-a-vis COVID-19 could allow for the continued provision of educational services while ensuring safety in educational settings. Therefore, the objective of this study was to explore the knowledge and preventive actions of educators regarding COVID-19 and vaccination awareness to provide appropriate support for educators. The study used data collected from 1,000 Japanese educators in January 2021 when the third wave of viral infections spread. Online surveys and multivariate linear regression analysis were used to determine age and whether respondents were being cared for by a doctor. We investigated the effects of factors on educators' willingness to be vaccinated and changes in their behavior. This study found that factors such as age, gender, whether a respondent was under a physician's care, and health literacy, affected the willingness of educators to receive vaccinations and engage in preventive actions. The study also suggests that the reliability of national government public relations efforts is lower than the reliability of local government public relations and that of information from family physicians, pharmacies, and mass media. It is therefore necessary to reexamine how information is disseminated by the national government and to increase the degree of trust in that information among the public. The findings of the study also revealed the importance of improving the provision of appropriate information and health literacy for the behavior of educators, not only during the initial outbreak, but also during the subsequent period of pandemic life.	[Fukuda, Yasue] Suzuka Univ Med Sci, Fac Pharmaceut Sci, Suzuka, Mie, Japan; [Ando, Shuji] Tokyo Univ Sci, Dept Informat & Comp Technol, Tokyo, Japan; [Fukuda, Koji] Waseda Univ, Fac Polit Sci & Econ, Shinjuku Ku, Tokyo, Japan	Tokyo University of Science; Waseda University	Fukuda, Y (corresponding author), Suzuka Univ Med Sci, Fac Pharmaceut Sci, Suzuka, Mie, Japan.	yfukuda@suzuka-u.ac.jp		FUKUDA, Yasue/0000-0001-7182-2552	JSPS KAKENHI [20K10359, 18K01450]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	No.JSPS KAKENHI grant number20K10359 and grant number18K01450. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akalu Y, 2020, INFECT DRUG RESIST, V13, P1949, DOI 10.2147/IDR.S258736; Angelo AT, 2021, INFECT DRUG RESIST, V14, P349, DOI 10.2147/IDR.S299576; [Anonymous], 2020, IMP COVID 19 STUD EQ; [Anonymous], UPD CAMBR INT MAY JU; [Anonymous], RCCE action plan guidance, COVID-19 preparedness and response; Burke RM, 2020, MMWR-MORBID MORTAL W, V69, P245, DOI 10.15585/mmwr.mm6909e1; CDC, KEY THINGS KNOW COVI; Denuwara HMBH, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4543-x; Dong YT, 2020, SIGNAL TRANSDUCT TAR, V5, DOI 10.1038/s41392-020-00352-y; ElBagoury M, 2021, J INFECT PUBLIC HEAL, V14, P389, DOI 10.1016/j.jiph.2020.12.025; Engler JO, 2021, SUSTAIN SCI, V16, P317, DOI 10.1007/s11625-020-00852-4; Geldsetzer P, 2020, J MED INTERNET RES, V22, DOI 10.2196/18790; Geldsetzer P, 2020, ANN INTERN MED, V173, P157, DOI 10.7326/M20-0912; Giordano G, 2020, NAT MED, V26, P855, DOI 10.1038/s41591-020-0883-7; Gold JAW, 2021, MMWR-MORBID MORTAL W, V70, P289, DOI 10.15585/mmwr.mm7008e4; Hatabu A, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0244350; Kaur SP, 2020, VIRUS RES, V288, DOI 10.1016/j.virusres.2020.198114; Lazarus JV, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0240011; Lee J, 2020, LANCET CHILD ADOLESC, V4, P421, DOI 10.1016/S2352-4642(20)30109-7; Leigh JP, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0241259; Lusk P, 2020, J CHILD ADOL PS NURS, V33, P185, DOI 10.1111/jcap.12297; Masonbrink AR, 2020, PEDIATRICS, V146, DOI 10.1542/peds.2020-1440; Ministry of Education Culture Sports Science and Technology, 2020, PREV NEW COR INF; Ministry of Education Culture Sports Science and Technology, PREV SPREAD NEW COR; Ministry of Education Culture Sports Science and Technology, REG IMPL TEMP CLOS R; Ministry of Education Culture Sports Science and Technology Advisory Panel on Countermeasures for Coronavirus Infectious Diseases in Schools, 2020, REC SCH ED ACT BAS C; Ministry of Education Culture Sports Science and Technology of Japan, SCH BAS SURV; Mohamed AAO, 2021, BMC PUBLIC HEALTH, V21, DOI 10.1186/s12889-021-10319-5; Nakayama K, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1835-x; Newton K, 2020, POLIT QUART, V91, P502, DOI 10.1111/1467-923X.12901; Ngwewondo A, 2020, PLOS NEGLECT TROP D, V14, DOI 10.1371/journal.pntd.0008700; NHS, COR COVID 19; Noreen K, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0243696; Notification of Ministry of Education Culture Sports Science and Technology, 2020, GUID SUST SCH MAN CO; Rampal L, 2020, Med J Malaysia, V75, P95; Rod JE, 2020, REV SAUDE PUBL, V54, DOI 10.11606/s1518-8787.2020054002481; Singh JP, 2020, J HEALTH MANAG, V22, P281, DOI 10.1177/0972063420935669; Sorensen K, 2015, EUR J PUBLIC HEALTH, V25, P1053, DOI 10.1093/eurpub/ckv043; Sorensen K, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-948; St Leger L, 2001, HEALTH PROMOT INT, V16, P197, DOI 10.1093/heapro/16.2.197; UNESCO, COVID 19 IMP ED GLOB; Unger S., 2020, INT J TECHNOL ED SCI, V4, P256, DOI [DOI 10.46328/IJTES.V4I4.107, 10.46328/ijtes.v4i4.107]; UNICEF, 2020, FRAM REOP SCH; United Nations, 2020, ED COVID 19; Velasco JM, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18020674; Wayne W.D., 2018, BIOSTATISTICS FDN AN, V11th Edn; WHO, WHO COR DIS COVID 19; Wilson E, 2020, MMWR-MORBID MORTAL W, V69, P1416, DOI 10.15585/mmwr.mm6939e3; World Health Organization, **NON-TRADITIONAL**; Yang KH, 2021, J ADV NURS, V77, P1839, DOI 10.1111/jan.14718; Zhong BL, 2020, INT J BIOL SCI, V16, P1745, DOI 10.7150/ijbs.45221	51	10	10	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2021	16	9							e0257552	10.1371/journal.pone.0257552	http://dx.doi.org/10.1371/journal.pone.0257552			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	WG6BN	34543315	Green Published, gold			2022-12-26	WOS:000707078200049
J	Hoshino, S; Seino, S; Funahashi, T; Hoshino, T; Clauss, M; Matsuda, I; Yayota, M				Hoshino, Satoru; Seino, Satoru; Funahashi, Takashi; Hoshino, Tomonori; Clauss, Marcus; Matsuda, Ikki; Yayota, Masato			Apparent diet digestibility of captive colobines in relation to stomach types with special reference to fibre digestion	PLOS ONE			English	Article							MONKEY NASALIS-LARVATUS; GUT FILL; FOOD-INTAKE; BODY-SIZE; PASSAGE; RETENTION; PATTERNS; RUMINANT; PRIMATES; LANGURS	Colobine monkeys are known for the anatomical complexity of their stomachs, making them distinct within the primate order. Amongst foregut fermenters, they appear peculiar because of the occurrence of two different stomach types, having either three ('tripartite') or four ('quadripartite', adding the praesaccus) chambers. The functional differences between tri and quadripartite stomachs largely remain to be explained. In this study, we aim to compare the apparent digestibility (aD) in tripartite and quadripartite colobines. Hence, we measured the aD in two colobine species, Nasalis larvatus (quadripartite) and Trachypithecus cristatus (tripartite), in two zoos. We also included existing colobine literature data on the aD and analysed whether the aD of fibre components is different between the stomach types to test the hypothesis of whether quadripartite colobines show higher aD of fibre components than tripartite colobines did. Our captive N. larvatus specimen had a more distinctively varying nutrient intake across seasons with a larger seasonal variation in aD than that of a pair of T. cristatus, which mostly consumed commercial foods with a lower proportion of browse and less seasonal variation. We observed higher aD of dry matter (DM), neutral detergent fibre (NDF) and acid detergent fibre (ADF) in the N. larvatus specimen, suggesting a higher gut capacity of N. larvatus provided by the additional praesaccus forestomach chamber. Based on the analysis of literature data for aD, we also found that quadripartite species achieved higher fibre digestibility at similar dietary fibre levels compared with tripartite species, supporting the hypothesis that the additional gut capacity offered by the praesaccus facilitates a longer retention and hence more thorough microbial fermentation of plant fibre.	[Hoshino, Satoru] Gifu Univ, United Grad Sch Agr Sci, Gifu, Japan; [Hoshino, Satoru; Yayota, Masato] Gifu Univ, Zoo Biol Res Ctr, Gifu, Japan; [Seino, Satoru] City Yokohama, Preservat & Res Ctr, Yokohama, Kanagawa, Japan; [Funahashi, Takashi; Hoshino, Tomonori; Matsuda, Ikki] Japan Monkey Ctr, Inuyama, Aichi, Japan; [Clauss, Marcus] Univ Zurich, Vetsuisse Fac, Clin Zoo Anim Exot Pets & Wildlife, Zurich, Switzerland; [Matsuda, Ikki] Chubu Univ, Acad Emerging Sci, Kasugai, Aichi, Japan; [Matsuda, Ikki] Kyoto Univ, Wildlife Res Ctr, Sakyo Ku, Kyoto, Japan; [Matsuda, Ikki] Univ Malaysia Sabah, Inst Trop Biol & Conservat, Kota Kinabalu, Sabah, Malaysia; [Yayota, Masato] Gifu Univ, Fac Appl Biol Sci, Gifu, Japan	Gifu University; Gifu University; Kyoto University; University of Zurich; Chubu University; Kyoto University; Universiti Malaysia Sabah; Gifu University	Yayota, M (corresponding author), Gifu Univ, Zoo Biol Res Ctr, Gifu, Japan.; Yayota, M (corresponding author), Gifu Univ, Fac Appl Biol Sci, Gifu, Japan.	yayo@gifu-u.ac.jp	Clauss, Marcus/GRR-7996-2022; Clauss, Marcus/M-8702-2019	Clauss, Marcus/0000-0003-3841-6207; Clauss, Marcus/0000-0003-3841-6207; Hoshino, Satoru/0000-0002-3306-1075; Yayota, Masato/0000-0001-8056-1315; Matsuda, Ikki/0000-0002-0861-7801	Japan Science Society [2018-4051]; JSPS Core-to-Core Program, Advanced Research Networks [JPJSCCA20170005]; JSPS KAKENHI [19H03308, 19KK0191]	Japan Science Society; JSPS Core-to-Core Program, Advanced Research Networks(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was partly financed by the Sasagawa Scientific Research Grant from the Japan Science Society (#2018-4051 to SH), JSPS Core-to-Core Program, Advanced Research Networks (#JPJSCCA20170005 to S. Kohshima) and JSPS KAKENHI (#19H03308 and #19KK0191 to IM). There was no additional external funding received for this study.	BAUCHOP T, 1968, SCIENCE, V161, P698, DOI 10.1126/science.161.3842.698; Campbell Christina J., 2011, PRIMATES PERSPECTIVE; Caton M.J., 1998, NATURAL HIST DOUCS S, P129; Chivers David J., 1994, P205; Clauss M, 2008, COMP BIOCHEM PHYS A, V150, P274, DOI 10.1016/j.cbpa.2008.03.012; Clauss M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068714; Clauss Marcus, 2008, P444; Coudrat Camille, 2019, Vietnamese Journal of Primatology, V3, P71; DEMMENT MW, 1985, AM NAT, V125, P641, DOI 10.1086/284369; DIERENFELD ES, 1992, PRIMATES, V33, P399, DOI 10.1007/BF02381201; Edwards MS, 1999, ZOO BIOL, V18, P537, DOI 10.1002/(SICI)1098-2361(1999)18:6&lt;537::AID-ZOO8&gt;3.0.CO;2-F; Hayakawa T, 2018, ENV MICROBIOL REP, V10, P655, DOI 10.1111/1758-2229.12677; Hollihn U., 1973, International Zoo Yearbook, V13, P185, DOI 10.1111/j.1748-1090.1973.tb02146.x; Hummel J, 2020, MAMMALIAN TEETH FORM; Idalan N, 2019, J ANIM PHYSIOL AN N, V103, P1015, DOI 10.1111/jpn.13116; Ishida M, 2001, EXPT METHODS ANIMAL, P190; Lambert JE, 1998, EVOL ANTHROPOL, V7, P8, DOI 10.1002/(SICI)1520-6505(1998)7:1<8::AID-EVAN3>3.0.CO;2-C; Langer P., 2017, AFROTHERIA XENARTHRA; Langer P., 1988, MAMMALIAN HERBIVORE; Latimer G.W., 2019, OFFICIAL METHODS ANA, V21; Levey DJ, 1999, PHYSIOL BIOCHEM ZOOL, V72, P369, DOI 10.1086/316663; Lhota S, 2019, CAM S BIO EVOL ANTHR, V82, P182; Matsuda I., COLOBINES NATURAL HI; Matsuda I, 2019, J MORPHOL, V280, P1608, DOI 10.1002/jmor.21052; Matsuda I, 2019, PHYSIOL BEHAV, V208, DOI 10.1016/j.physbeh.2019.112558; Matsuda I, 2018, FRONT VET SCI, V4, DOI 10.3389/fvets.2017.00246; Matsuda I, 2015, PHYSIOL BEHAV, V149, P45, DOI 10.1016/j.physbeh.2015.05.020; Matsuda I, 2014, OECOLOGIA, V174, P1127, DOI 10.1007/s00442-013-2863-9; Matsuda I, 2011, BIOL LETTERS, V7, P786, DOI 10.1098/rsbl.2011.0197; Muller DWH, 2013, COMP BIOCHEM PHYS A, V164, P129, DOI 10.1016/j.cbpa.2012.09.018; Munn A, 2015, CAN J ZOOL, V93, P747, DOI 10.1139/cjz-2014-0314; Munn AJ, 2012, COMP BIOCHEM PHYS A, V161, P243, DOI 10.1016/j.cbpa.2011.11.003; Nijboer J, 2001, VET QUART, V23, P76, DOI 10.1080/01652176.2001.9695086; Nijboer J, 1996, ZOO BIOL, V15, P499; Nijboer J., 2006, FIBRE INTAKE FAECES; Oftedal OT., 1982, ANN P AM ASS ZOO VET, V33; SAKAGUCHI EI, 1991, PRIMATOLOGY TODAY, P671; Schwarm A, 2013, MAMM BIOL, V78, P412, DOI 10.1016/j.mambio.2013.04.001; Schwarm A, 2009, J EXP ZOOL PART A, V311A, P647, DOI 10.1002/jez.552; Steuer P, 2014, FUNCT ECOL, V28, P1127, DOI 10.1111/1365-2435.12275; Struhsaker TT, 2010, RED COLOBUS MONKEYS: VARIATION IN DEMOGRAPHY, BEHAVIOR, AND ECOLOGY OF ENDANGERED SPECIES, P1, DOI 10.1093/acprof:oso/9780198529583.001.0001; Suzuki-Hashido N, 2021, INT J SYST EVOL MICR, V71, DOI 10.1099/ijsem.0.004787; van Nijboer Joeke, 2007, Zoologische Garten, V77, P36, DOI 10.1016/j.zoolgart.2007.06.004; VANSOEST PJ, 1991, J DAIRY SCI, V74, P3583, DOI 10.3168/jds.S0022-0302(91)78551-2; WATKINS BE, 1985, AM J PRIMATOL, V9, P137, DOI 10.1002/ajp.1350090207; Zeitz JO, 2016, SMALL RUMINANT RES, V136, P7, DOI 10.1016/j.smallrumres.2015.12.029; Zhou XM, 2014, NAT GENET, V46, P1303, DOI 10.1038/ng.3137	47	5	5	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2021	16	9							e0256548	10.1371/journal.pone.0256548	http://dx.doi.org/10.1371/journal.pone.0256548			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	WG6BN	34543310	Green Accepted, Green Published, gold, Green Submitted			2022-12-26	WOS:000707078200015
J	Musacchio, E; Binotto, P; Perissinotto, E; Sergi, G; Zambon, S; Corti, MC; Frigo, AC; Sartori, L				Musacchio, Estella; Binotto, Pierluigi; Perissinotto, Egle; Sergi, Giuseppe; Zambon, Sabina; Corti, Maria-Chiara; Frigo, Anna-Chiara; Sartori, Leonardo			Tooth retention predicts good physical performance in older adults	PLOS ONE			English	Article							LOWER-EXTREMITY FUNCTION; ORAL-HEALTH; DISABILITY; MORTALITY; ASSOCIATION; DISEASES; EDENTULISM	Background Oral health is closely related to both physical and psychological well-being, as it enables individuals to eat, speak, and socialize. The number of teeth is the most used indicator of oral health. Several reports document a relationship of dental status with a variety of indicators of general health but longitudinal studies employing standardized physical performance tests are infrequent in the scientific literature. Subjects and methods The Italian elderly participating in the Pro.V.A. longitudinal Study (3099 subjects aged 65+ at baseline, 2196 at the 5-year follow-up 1 and 1641 at the 7-year follow- up 2) underwent detailed interview and extensive clinical and instrumental examination that included validated physical performance measures. Participants were classified into 4 groups according to the number of remaining teeth: 0, 1-7, 8-19, and 20+. To explore the association of the number of remaining teeth with physical function and disability, we performed logistic regression analyses with models progressively adjusted for a wide number of covariates, namely anthropometric (gender, age, BMI), comorbidity (cardio-vascular, osteoarticular, and neurological diseases including depression), muscle strength (assessed for upper and lower limbs), lifestyle (smoking status, alcohol use, leisure time activities) and socioeconomical status (education, income, marital status, loneliness). Results Dental status correlated with most comorbidities, lifestyle, and socio-economic variables at the univariate analysis at baseline and at follow-ups. A good dental status was significantly associated with better physical functioning and lower disability. The presence of 20+ teeth resulted significantly protective (reference group: 0 teeth) versus mobility-related disability (OR = 0.67), disability (OR = 0.54) and inability to perform heavy duties (OR = 0.62), at follow up 1 and low physical performance score (OR = 0.59) at follow up 2. Conversely, the detrimental effect of edentulism, explored in subjects with or without dentures, was present but not as straightforward. Conclusion. The assessment of a geriatric patient should include an oral evaluation as a good dental status is a crucial component of successful aging.	[Musacchio, Estella; Sergi, Giuseppe; Zambon, Sabina; Sartori, Leonardo] Univ Padua, Dept Med DIMED, Padua, Italy; [Perissinotto, Egle; Frigo, Anna-Chiara] Univ Padua, Dept Cardiol Thorac & Vasc Sci, Unit Biostat Epidemiol & Publ Hlth, Padua, Italy; [Corti, Maria-Chiara] Azienda Zero, Epidemiol Div, Padua, Italy	University of Padua; University of Padua; Azienda Zero	Musacchio, E (corresponding author), Univ Padua, Dept Med DIMED, Padua, Italy.	estella.musacchio@unipd.it		Musacchio, Estella/0000-0001-9811-9103	Fondazione Cassa di Risparmio di Padova e Rovigo; University of Padova; Veneto Regional Local Health and Social Care Unit 15 (Azienda Unita Locale Socio Sanitaria 15); Veneto Regional Local Health and Social Care Unit 18 (Azienda Unita Locale Socio Sanitaria 18)	Fondazione Cassa di Risparmio di Padova e Rovigo(Fondazione Cariparo); University of Padova; Veneto Regional Local Health and Social Care Unit 15 (Azienda Unita Locale Socio Sanitaria 15); Veneto Regional Local Health and Social Care Unit 18 (Azienda Unita Locale Socio Sanitaria 18)	The study was supported by the Fondazione Cassa di Risparmio di Padova e Rovigo, the University of Padova,; the Veneto Regional Local Health and Social Care Units 15 and 18 (Azienda Unita Locale Socio Sanitaria 15 and 18). The sponsor had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aida J, 2012, J AM GERIATR SOC, V60, P338, DOI 10.1111/j.1532-5415.2011.03791.x; Armellini D, 2004, J PROSTHET DENT, V92, P531, DOI 10.1016/j.prosdent.2004.08.013; BERKMAN LF, 1986, AM J EPIDEMIOL, V124, P372, DOI 10.1093/oxfordjournals.aje.a114408; Corti MC, 2002, J AM GERIATR SOC, V50, P1535, DOI 10.1046/j.1532-5415.2002.50409.x; Corti MC, 1996, J CLIN EPIDEMIOL, V49, P519, DOI 10.1016/0895-4356(95)00562-5; Cunha-Cruz J, 2007, J DENT RES, V86, P131, DOI 10.1177/154405910708600205; Darnaud C, 2020, J DENT RES, V99, P152, DOI 10.1177/0022034519889021; Desvarieux M, 2003, STROKE, V34, P2120, DOI 10.1161/01.STR.0000085086.50957.22; FOLSTEIN MF, 1983, ARCH GEN PSYCHIAT, V40, P812; Friedman PK, 2016, PERIODONTOL 2000, V72, P142, DOI 10.1111/prd.12128; Grabe HJ, 2009, J CLIN PERIODONTOL, V36, P550, DOI 10.1111/j.1600-051X.2009.01426.x; Guralnik JM, 2000, J GERONTOL A-BIOL, V55, pM221, DOI 10.1093/gerona/55.4.M221; GURALNIK JM, 1995, NEW ENGL J MED, V332, P556, DOI 10.1056/NEJM199503023320902; GURALNIK JM, 1994, J GERONTOL, V49, pM85, DOI 10.1093/geronj/49.2.M85; Hakeem FF, 2019, GERODONTOLOGY, V36, P205, DOI 10.1111/ger.12406; Hamer M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066222; Henke Christian, 2016, BMC Res Notes, V9, P274, DOI 10.1186/s13104-016-2079-2; Kaufman LB, 2014, J AM GERIATR SOC, V62, P1168, DOI 10.1111/jgs.12842; Koka S, 2018, J PROSTHODONT RES, V62, P134, DOI 10.1016/j.jpor.2017.08.003; Kotronia E, 2019, J AM MED DIR ASSOC, V20, DOI 10.1016/j.jamda.2019.06.010; Lee HJ, 2019, J DENT RES, V98, P164, DOI 10.1177/0022034518814829; Matsuyama Y, 2021, J AM GERIATR SOC, V69, P1319, DOI 10.1111/jgs.17021; Merchant AT, 2003, EUR J EPIDEMIOL, V18, P891, DOI 10.1023/A:1025622815579; Morita Ichizo, 2006, Gerodontology, V23, P214, DOI 10.1111/j.1741-2358.2006.00134.x; Moriya S, 2012, GERODONTOLOGY, V29, pE793, DOI 10.1111/j.1741-2358.2011.00563.x; Musacchio E, 2007, ACTA ODONTOL SCAND, V65, P78, DOI 10.1080/00016350601058069; Peng JX, 2019, BIOSCIENCE REP, V39, DOI 10.1042/BSR20181773; Peres MA, 2019, LANCET, V394, P249, DOI 10.1016/S0140-6736(19)31146-8; R Core Team, 2020, R LANG ENV STAT COMP; Ren C, 2017, GERODONTOLOGY, V34, P195, DOI 10.1111/ger.12249; ROWE JW, 1987, SCIENCE, V237, P143, DOI 10.1126/science.3299702; Rowe JW, 1997, GERONTOLOGIST, V37, P433, DOI 10.1093/geront/37.4.433; Sarita PTN, 2003, COMMUNITY DENT ORAL, V31, P328, DOI 10.1034/j.1600-0528.2003.t01-1-00011.x; Schmidt Christopher J, 2006, Curr Opin Otolaryngol Head Neck Surg, V14, P254, DOI 10.1097/01.moo.0000233596.68928.39; Shimazaki Y, 2001, J DENT RES, V80, P340, DOI 10.1177/00220345010800010801; Tada A, 2003, ARCH GERONTOL GERIAT, V37, P109, DOI 10.1016/S0167-4943(03)00026-8; Tonetti MS, 2017, J CLIN PERIODONTOL, V44, pS135, DOI 10.1111/jcpe.12681; Tu YK, 2007, HEART, V93, P1098, DOI 10.1136/hrt.2006.097410; Urtamo Annele, 2019, Acta Biomed, V90, P359, DOI 10.23750/abm.v90i2.8376; Watanabe Y, 2020, GERIATR GERONTOL INT, V20, P526, DOI 10.1111/ggi.13921; WHO, 1994, WORLD HLTH STAT Q, V47, P42; Yamanaka K, 2008, INT DENT J, V58, P146, DOI 10.1922/IDJ_1924Yamanaka05; YESAVAGE JA, 1983, J PSYCHIATR RES, V17, P37, DOI 10.1016/0022-3956(82)90033-4; Yin XH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149653	44	4	4	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2021	16	9							e0255741	10.1371/journal.pone.0255741	http://dx.doi.org/10.1371/journal.pone.0255741			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	WG6BN	34543320	Green Published, gold			2022-12-26	WOS:000707078200009
J	Siu, CT; Wolfe, Z; Dela Torre, M; Rehim, E; Decker, R; Zaffiri, K; Lash, B				Siu, Chun Ting; Wolfe, Zachary; Dela Torre, Martin; Rehim, Erafat; Decker, Robert; Zaffiri, Kathryn; Lash, Bradley			Evaluation of thrombophilia testing in the inpatient setting: A single institution retrospective review	PLOS ONE			English	Review							RISK	Background Thrombophilia workup is typically inappropriate in the inpatient setting as testing may be skewed by anticoagulation, acute thrombosis, or acute illness. Objective To determine adherence of inpatient thrombophilia testing with institutional guidelines. Patients and methods A retrospective study to evaluate thrombophilia testing practices of adult patients who were admitted to Lehigh Valley Hospital at Cedar Crest with either venous thromboembolism or ischemic stroke in 2019. Testing included inherited and acquired thrombophilia. Patient charts were individually reviewed for three measured outcomes: 1) the number of appropriate thrombophilia testing in the inpatient setting; 2) the indications used for thrombophilia testing; 3) the proportion of positive thrombophilia tests with change in clinical management. Results 201 patients were included in our study. 26 patients (13%) were tested appropriately in accordance with institution guidelines and 175 (87%) patients were tested inappropriately. The most common reason for the inappropriate testing was testing during acute thrombosis. 28 of the 201 patients had positive thrombophilia tests, but the reviewers only noted 7 patients with change in clinical management-involving anticoagulation change. Conclusion Our study revealed that a majority of inpatient thrombophilia testing did not follow institutional guidelines for appropriate testing and did not change patient management. These thrombophilia tests are often overutilized and have minimal clinical utility in the inpatient setting.	[Siu, Chun Ting; Dela Torre, Martin; Zaffiri, Kathryn] Lehigh Valley Hlth Network, Dept Med, Allentown, PA 18105 USA; [Wolfe, Zachary; Decker, Robert; Lash, Bradley] Lehigh Valley Hlth Network, Div Hematol Oncol, Dept Med, Allentown, PA USA; [Rehim, Erafat] Lehigh Valley Hlth Network, Dept Neurol, Allentown, PA USA	Lehigh Valley Health Network; Lehigh Valley Health Network; Lehigh Valley Health Network	Siu, CT (corresponding author), Lehigh Valley Hlth Network, Dept Med, Allentown, PA 18105 USA.	chun.siu@lvhn.org		Siu, Chun/0000-0003-3587-4544				Baglin T, 2010, BRIT J HAEMATOL, V149, P209, DOI 10.1111/j.1365-2141.2009.08022.x; Chong LY, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e3979; Cox N, 2017, J HOSP MED, V12, P705, DOI 10.12788/jhm.2804; Croles FN, 2018, SEMIN THROMB HEMOST, V44, P315, DOI 10.1055/s-0038-1625983; Gupta A, 2019, J COMMUNITY HOSP INT, V9, P392, DOI 10.1080/20009666.2019.1655627; Hicks LK, 2013, BLOOD, V122, P3879, DOI 10.1182/blood-2013-07-518423; Ho WK, 2006, ARCH INTERN MED, V166, P729, DOI 10.1001/archinte.166.7.729; Middeldorp S, 2008, BRIT J HAEMATOL, V143, P321, DOI 10.1111/j.1365-2141.2008.07339.x; Mou E, 2017, J HOSP MED, V12, P735, DOI 10.12788/jhm.2819; Shen YM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155326; Smith TW, 2014, J CLIN PATHOL, V67, P345, DOI 10.1136/jclinpath-2013-201840	11	1	1	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2021	16	9							e0257687	10.1371/journal.pone.0257687	http://dx.doi.org/10.1371/journal.pone.0257687			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	WG6BN	34543355	gold, Green Published			2022-12-26	WOS:000707078200071
J	Wolski, GJ; Sadowska, B; Fol, M; Podsedek, A; Kajszczak, D; Kobylinska, A				Wolski, Grzegorz J.; Sadowska, Beata; Fol, Marek; Podsedek, Anna; Kajszczak, Dominika; Kobylinska, Agnieszka			Cytotoxicity, antimicrobial and antioxidant activities of mosses obtained from open habitats	PLOS ONE			English	Article							ANTIBACTERIAL ACTIVITY; METHANOLIC EXTRACT; FLAVONOIDS; BRYOPHYTES; CONSTITUENTS; DIVERSITY; BIOSYNTHESIS; FRACTIONS; BRANCHES; STRESS	Mosses are mainly the object of ecological and taxonomic research. This group of plants are still underestimated by scientists in other aspects of research. Recent research has shown that these plants contain remarkable and unique substances with high biological activity. Five species of mosses from a large urban ecosystem were identified for present study. In order to determine their biological potential, multifaceted studies were carried out, including: total phenolics content, antioxidant activity, antimicrobial and antifungal study, cytotoxicity evaluation, and scratch assay to assess pro-regenerative effect in the context of their possible use as the ingredients of biologically active cosmetics. Additionally, determination of individual phenolic compounds in selected extracts of the tested mosses was made. Research showed that Ceratodon purpureus and Dryptodon pulvinatus extracts had the greatest potential as antioxidants and antimicrobial activity. The cytotoxicity assessment indicated that the extracts from Dryptodon pulvinatus and Rhytidiadelphus squarossus exerted the strongest negative effect on mouse fibroblast line L929 viability at higher concentrations. While, the extract from Tortulla muralis best stimulated human foreskin fibroblast line HFF-1 proliferation and wound healing. The research on individual phenolic compounds content in the extracts tested indicated over 20 peaks on UPLC chromatograms. The conducted study has shown that mosses, especially so far unexplored species of open ecosystems, and e.g. epilytic habitats, may be a valuable source of biologically active substances and thus may constitute important medical and cosmetic possibilities.	[Wolski, Grzegorz J.] Univ Lodz, Fac Biol & Environm Protect, Dept Geobot & Plant Ecol, Lodz, Poland; [Sadowska, Beata; Fol, Marek] Univ Lodz, Fac Biol & Environm Protect, Inst Microbiol, Dept Immunol & Infect Biol, Lodz, Poland; [Podsedek, Anna; Kajszczak, Dominika] Lodz Univ Technol, Fac Biotechnol & Food Sci, Inst Mol & Ind Biotechnol, Lodz, Poland; [Kobylinska, Agnieszka] Univ Lodz, Fac Biol & Environm Protect, Dept Plant Ecophysiol, Lodz, Poland	University of Lodz; University of Lodz; Lodz University of Technology; University of Lodz	Wolski, GJ (corresponding author), Univ Lodz, Fac Biol & Environm Protect, Dept Geobot & Plant Ecol, Lodz, Poland.; Kobylinska, A (corresponding author), Univ Lodz, Fac Biol & Environm Protect, Dept Plant Ecophysiol, Lodz, Poland.	grzegorz.wolski@biol.uni.lodz.pl; agnieszka.kobylinska@biol.uni.lodz.pl	Podsędek, Anna/M-4197-2018; Kobylinska, Agnieszka/S-6294-2018; Wolski, Grzegorz J./K-8817-2018	Podsędek, Anna/0000-0001-6654-4818; Kobylinska, Agnieszka/0000-0001-9206-6880; Sadowska, Beata/0000-0001-6383-3972; Wolski, Grzegorz J./0000-0003-1480-8003; Kajszczak, Dominika/0000-0002-3122-0685; Fol, Marek/0000-0002-8041-1920				Agati G, 2013, PLANT PHYSIOL BIOCH, V72, P35, DOI 10.1016/j.plaphy.2013.03.014; Agati G, 2012, PLANT SCI, V196, P67, DOI 10.1016/j.plantsci.2012.07.014; Agati G, 2011, J PLANT PHYSIOL, V168, P204, DOI 10.1016/j.jplph.2010.07.016; Ahmadian S., 2009, J VIS EXP, DOI [10.3791/1191, DOI 10.3791/1191]; Ahn MR, 2007, FOOD CHEM, V101, P1383, DOI 10.1016/j.foodchem.2006.03.045; Amparo TR, 2018, NAT PROD RES, V32, P1951, DOI 10.1080/14786419.2017.1354182; Asakawa Y., 1990, PHYTOCHEMISTRY, DOI [10.1016/0031-9422%2890%2980125-Z, DOI 10.1016/0031-9422%2890%2980125-Z]; Asakawa Y, 2007, PURE APPL CHEM, V79, P557, DOI 10.1351/pac200779040557; Asakawa Y, 2013, METHODS MOL BIOL, V1055, P1, DOI 10.1007/978-1-62703-577-4_1; Aslanbaba B., 2017, J SCI PERSPECTIVES, V1, P1, DOI [10.26900/jsp.2017.0, DOI 10.26900/JSP.2017.0]; Atalay H, 2018, CHEM-BIOL INTERACT, V296, P98, DOI 10.1016/j.cbi.2018.09.017; Aydogan S, 2017, TURK J BOT, V41, P464, DOI 10.3906/bot-1608-33; Bartosz G, 2003, ADV CLIN CHEM, V37, P219, DOI 10.1016/S0065-2423(03)37010-6; Basile A, 1999, PHYTOCHEMISTRY, V52, P1479, DOI 10.1016/S0031-9422(99)00286-1; Benzie IFF, 1996, ANAL BIOCHEM, V239, P70, DOI 10.1006/abio.1996.0292; Bhattarai HD, 2009, Z NATURFORSCH C, V64, P197; Bittkau KS, 2019, MAR DRUGS, V17, DOI 10.3390/md17080441; Bodade R. G., 2008, Journal of Medicinal Plants, V7, P23; Brunetti C, 2013, INT J MOL SCI, V14, P3540, DOI 10.3390/ijms14023540; Calhelha RC, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/897361; Cannella V, 2019, BIOMED RES INT, V2019, DOI 10.1155/2019/3469525; Cheng XX, 2012, J ETHNOPHARMACOL, V143, P49, DOI 10.1016/j.jep.2012.05.054; Chobot V, 2008, Z NATURFORSCH C, V63, P476; Chytry M, 2019, BOREAS, V48, P36, DOI 10.1111/bor.12338; Cielinski S., 1996, BIA OWIESKI PARK NAR; Cielinski S., 1996, FUNCTIONAL GROUPS AN; Dandannavar V. S., 2019, National Journal of Physiology, Pharmacy and Pharmacology, V9, P813, DOI 10.5455/njppp.2019.9.0623404072019; de Barros M, 2016, N-S ARCH PHARMACOL, V389, P403, DOI 10.1007/s00210-015-1208-0; Dey A, 2015, J ACUTE DIS, V4, P236, DOI 10.1016/j.joad.2015.04.011; Donaldson L, 2020, MOLECULES, V25, DOI 10.3390/molecules25102393; Erturk O., 2015, Herba Polonica, V61, P52; Frahm JP, 2004, REV PALAEOBOT PALYNO, V129, P81, DOI 10.1016/j.revpalbo.2003.11.004; Friedel A., 2006, Feddes Repertorium, V117, P172, DOI 10.1002/fedr.200511084; Friederich S, 1999, PHYTOCHEMISTRY, V50, P589, DOI 10.1016/S0031-9422(98)00557-3; Fudali E, 2015, HERZOGIA, V28, P87, DOI 10.13158/heia.28.1.2015.87; Glime JM, 2007, PHYSL ECOL, V1; Gokbulut A, 2012, TURK J BIOL, V36, P381, DOI 10.3906/biy-1106-15; Graidist P, 2015, NUTRIENTS, V7, P2707, DOI 10.3390/nu7042707; Gupta N, 2011, AFR J TRADIT COMPLEM, V8, P98; Habbu P. V., 2007, Pharmacognosy Reviews, V1, P271; Hanif U, 2014, ASIAN J CHEM, V26, P4339, DOI 10.14233/ajchem.2014.16431; ICHIKAWA T, 1983, TETRAHEDRON LETT, V24, P3337, DOI 10.1016/S0040-4039(00)86263-2; JUNG M, 1994, Z NATURFORSCH C, V49, P697; Kadam Pratima S, 2017, INT J LIFE SCI, V5, P405; Kadam PS., 2016, ASIAN J MULTIDISCIP, V4, P103; Kandpal V., 2016, INT J PHARM PHARM SC, V8, P65; Klama H., 1999, MSZAKI NAZIEMNE STRU, DOI [10.1046/j.1537-2995.1999.39399219278.x, DOI 10.1046/J.1537-2995.1999.39399219278.X]; Klama H, 2002, DISTRIBUTION PATTERN; Klavina L, 2015, MOLECULES, V20, P17221, DOI 10.3390/molecules200917221; Krestov PV, 2003, GEOBOTANT, V28, P93; Krzaczkowski L, 2009, FUND CLIN PHARMACOL, V23, P473, DOI 10.1111/j.1472-8206.2009.00698.x; Kucuk M, 2007, FOOD CHEM, V100, P526, DOI 10.1016/j.foodchem.2005.10.010; Lewinska A, 2007, CLIN EXP PHARMACOL P, V34, P781, DOI 10.1111/j.1440-1681.2007.04637.x; Lillo C, 2008, PLANT CELL ENVIRON, V31, P587, DOI 10.1111/j.1365-3040.2007.01748.x; Manoj GS., 2012, INT J PHARM PHARM SC, V4, P222; Manoj GS., 2012, INDIAN J NAT PROD RE; Matuszkiewicz J.M., 2001, ZESPOLY LESNE POLSKI; Mewari N, 2008, PHARM BIOL, V46, P819, DOI 10.1080/13880200802315725; Moghadam SE, 2019, MOLECULES, V24, DOI 10.3390/molecules24102022; Moodley D., 2005, CYTOTOXICITY DENTINE; Nair Anoop V, 2018, J Contemp Dent Pract, V19, P656; Nowicka P, 2019, ANTIOXIDANTS-BASEL, V8, DOI 10.3390/antiox8080308; Opelt K, 2007, ENVIRON MICROBIOL, V9, P2795, DOI 10.1111/j.1462-2920.2007.01391.x; Ozcan T., 2014, International Journal of Chemical Engineering and Applications, V5, P393; Pagare S., 2015, CURR TRENDS BIOTECHN, V9, P293; Pejin B, 2013, NAT PROD RES, V27, P900, DOI 10.1080/14786419.2012.665915; Pejin B, 2012, HEM IND, V66, P723, DOI 10.2298/HEMIND120131022P; Pereira RF, 2016, ADV WOUND CARE, V5, P208, DOI 10.1089/wound.2013.0506; Podsedek A, 2020, J FUNCT FOODS, V73, DOI 10.1016/j.jff.2020.104111; Puerto M, 2009, TOXICON, V54, P161, DOI 10.1016/j.toxicon.2009.03.030; Qu JB, 2007, HELV CHIM ACTA, V90, P2109, DOI 10.1002/hlca.200790218; Rashmi M., 2014, INT J PHARM SCI RES; Re R, 1999, FREE RADICAL BIO MED, V26, P1231, DOI 10.1016/S0891-5849(98)00315-3; RiceEvans CA, 1996, FREE RADICAL BIO MED, V20, P933, DOI 10.1016/0891-5849(95)02227-9; Saroya AS, 2011, HERBALISM, PHYTOCHEMISTRY AND ETHNOPHARMACOLOGY, P1, DOI 10.1201/b10878; Senica M, 2017, J AGR FOOD CHEM, V65, P10621, DOI 10.1021/acs.jafc.7b03408; Shaw AJ, 2011, AM J BOT, V98, P352, DOI 10.3732/ajb.1000316; SIEVERS H, 1994, PHYTOCHEMISTRY, V35, P795, DOI 10.1016/S0031-9422(00)90608-3; SIEVERS H, 1992, PHYTOCHEMISTRY, V31, P3233, DOI 10.1016/0031-9422(92)83482-E; Singh M, 2006, J ETHNOPHARMACOL, V107, P67, DOI 10.1016/j.jep.2006.02.007; SINGLETON V. L., 1965, AMER J ENOL VITICULT, V16, P144; Sun SQ, 2009, ENVIRON MONIT ASSESS, V149, P291, DOI 10.1007/s10661-008-0203-z; Ucuncu O, 2010, TURK J CHEM, V34, P825, DOI 10.3906/kim-1002-62; Vanderpoorten A, 2004, ECOGRAPHY, V27, P567, DOI 10.1111/j.0906-7590.2004.03890.x; Veljic M, 2008, PHARM BIOL, V46, P871, DOI [10.1080/13890200802367502, 10.1080/13880200802367502]; Vijayarathna Soundararajan, 2012, Asian Pacific Journal of Tropical Biomedicine, V2, P826, DOI 10.1016/S2221-1691(12)60237-8; Wang XN, 2005, CHEM BIODIVERS, V2, P139, DOI 10.1002/cbdv.200490165; Wilczynska A., 2010, POLISH J FOOD NUTR S; Wolski GJ, 2020, ECOL INDIC, V113, DOI 10.1016/j.ecolind.2020.106160; Yaglioglu Muhammet Samil, 2017, Anatolian Bryology, V3, P31; Yamamoto A, 1999, J BIOMED MATER RES, V47, P396, DOI 10.1002/(SICI)1097-4636(19991205)47:3<396::AID-JBM15>3.0.CO;2-R; Yayintas OT, 2017, NAT PROD RES, V31, P2169, DOI 10.1080/14786419.2016.1277355; Zheng W, 2001, J AGR FOOD CHEM, V49, P5165, DOI 10.1021/jf010697n; ZINSMEISTER HD, 1991, ANGEW CHEM INT EDIT, V30, P130, DOI 10.1002/anie.199101301	94	1	1	4	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2021	16	9							e0257479	10.1371/journal.pone.0257479	http://dx.doi.org/10.1371/journal.pone.0257479			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	WG6BN	34543304	Green Published, gold			2022-12-26	WOS:000707078200037
J	Saeed, BQ; Elbarazi, I; Barakat, M; Adrees, AO; Fahady, KS				Saeed, Balsam Qubais; Elbarazi, Iffat; Barakat, Mai; Adrees, Ahmed Omer; Fahady, Kubais Saeed			COVID-19 health awareness among the United Arab Emirates population	PLOS ONE			English	Article							NONMEDICAL UNIVERSITY-STUDENTS; ATTITUDES; KNOWLEDGE	In response to the global COVID-19 epidemic, the United Arab Emirates (UAE) government is taking precautionary action to mitigate the spread of the virus. The aim of this study was to evaluate the knowledge and practices toward COVID-19 among the general public in the UAE during the current outbreak. A cross-sectional online survey of 1356 respondents in the UAE was conducted during the epidemic outbreak between 9(th) to 24(th) June-2020. The questionnaire consisted of three sections: Socio-demographic, knowledge, practices. Independent-samples t-test, one-way analysis of variance (ANOVA), chi-square and binary logistic regression was used. A p-value of (p < 0.05) was considered statistically significant. The total correct score of knowledge and practice questions was high 85% and 90%, respectively. Male's sex, other marital status, and illiterate/primary educational levels had a lower level of knowledge and practices than others. Participants aged 18-29 had little higher knowledge than other ages but had a lower level in practices, people who live in Abu Dhabi had better knowledge and practices than other emirates, employed people had a lower level of knowledge but higher in practices. Binary logistic regression analysis presented that females, 18-29 years, and married participants significantly associated with a higher score of knowledge, while female, over 30 years old, the martial status of singles, college-level and higher, unemployed, were significantly associated with high mean practices score. This study provided a full screening of the knowledge and practices among a sample of residents in The UAE toward COVID-19, continuing to implement the health education programs pursued by the UAE is highly important to maintain the appropriate level of awareness among the public.	[Saeed, Balsam Qubais; Adrees, Ahmed Omer] Univ Sharjah, Coll Med, Sharjah, U Arab Emirates; [Saeed, Balsam Qubais] Univ Sharjah, Sharjah Inst Med Res, Sharjah, U Arab Emirates; [Elbarazi, Iffat] United Arab Emirates Univ, Inst Publ Hlth, Sharjah, U Arab Emirates; [Barakat, Mai] Mansoura Univ, Fac Vet Med, Dept Biochem, Mansoura, Egypt; [Fahady, Kubais Saeed] Ajman Univ, Coll Humanities & Sci, Ajman, U Arab Emirates	University of Sharjah; University of Sharjah; Egyptian Knowledge Bank (EKB); Mansoura University; Ajman University	Saeed, BQ (corresponding author), Univ Sharjah, Coll Med, Sharjah, U Arab Emirates.; Saeed, BQ (corresponding author), Univ Sharjah, Sharjah Inst Med Res, Sharjah, U Arab Emirates.	bsaeed@sharjah.ac.ae		Ibrahim, Mai/0000-0003-2861-2685; Elbarazi, Iffat/0000-0001-7151-2175	University of Sharjah, UAE	University of Sharjah, UAE	This research was funded by the University of Sharjah, UAE.	Al-Hanawi MK, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00217; Alzoubi H, 2020, J PURE APPL MICROBIO, V14, P17, DOI 10.22207/JPAM.14.1.04; [Anonymous], 2020, UNITED ARAB EMIRATES; Baniyas N, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0246226; Brennan Ramirez LK., 2008, PROMOTING HLTH EQUIT, DOI [10.1097/01.PHH.0000311889.83380.9b, DOI 10.1097/01.PHH.0000311889.83380.9B]; Centers for Diseases Control and Prevention, 2020, COR DIS 2019 COVID 1; Guo YR, 2020, MILITARY MED RES, V7, DOI 10.1186/s40779-020-00240-0; Hasan H, 2021, AM J TROP MED HYG, V104, P75, DOI 10.4269/ajtmh.20-0857; Jin YH, 2020, MILITARY MED RES, V7, DOI 10.1186/s40779-020-0233-6; Khasawneh AI, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00253; Li JY, 2020, MICROBES INFECT, V22, P80, DOI 10.1016/j.micinf.2020.02.002; Moukaddam N., 2020, PSYCHIAT TIMES, V37, P3; Olapegba PO, PRELIMINARY ASSESSME; Ramaci T, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12093834; Saddik B, 2020, RISK MANAG HEALTHC P, V13, P2395, DOI 10.2147/RMHP.S273333; Saeed BQ, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0249310; Torales J, 2020, INT J SOC PSYCHIATR, V66, P317, DOI 10.1177/0020764020915212; Wakefield MA, 2010, LANCET, V376, P1261, DOI 10.1016/S0140-6736(10)60809-4; World Health Organization, 2020, CLIN CAR SEV AC RESP; World Med Assoc, 2013, JAMA-J AM MED ASSOC, V310, P2191, DOI 10.1001/jama.2013.281053; Zhong BL, 2020, INT J BIOL SCI, V16, P1745, DOI 10.7150/ijbs.45221	21	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2021	16	9							e0255408	10.1371/journal.pone.0255408	http://dx.doi.org/10.1371/journal.pone.0255408			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	WG6OR	34516548	gold, Green Published			2022-12-26	WOS:000707114200004
J	Chin, AZ; Avoi, R; Atil, A; Lukman, KA; Rahim, SSSA; Ibrahim, MY; Ahmed, K; Jeffree, MS				Chin, Abraham Zefong; Avoi, Richard; Atil, Azman; Awang Lukman, Khamisah; Syed Abdul Rahim, Syed Sharizman; Ibrahim, Mohd Yusof; Ahmed, Kamruddin; Jeffree, Mohammad Saffree			Risk factor of plasmodium knowlesi infection in Sabah Borneo Malaysia, 2020: A population-based case-control study	PLOS ONE			English	Article							MALARIA; TRANSMISSION; EXPOSURE; DISEASE	Background In the Malaysian state of Sabah, P. knowlesi notifications increased from 2% (59/2,741) of total malaria notifications in 2004 to 98% (2030/2,078) in 2017. There was a gap regarding P. knowlesi acquisition risk factors related to practice specifically in working age group. The main objective of this study was to identify the risk factors for acquiring P. knowlesi infection in Sabah among the working age group. Methods and methods This retrospective population-based case-control study was conducted in Ranau district to assess sociodemographic, behavioural and medical history risk factors using a pretested questionnaire. The data were entered and analyzed using IBM SPSS version 23. Bivariate analysis was conducted using binary logistic regression whereas multivariate analysis was conducted using multivariable logistic regression. We set a statistical significance at p-value less than or equal to 0.05. Results A total of 266 cases and 532 controls were included in the study. Male gender (AOR = 2.71; 95% CI: 1.63-4.50), spending overnight in forest (AOR = 1.92; 95% CI: 1.20-3.06), not using mosquito repellent (AOR = 2.49; 95% CI: 1.36-4.56) and history of previous malaria infection (AOR = 49.34; 95% CI: 39.09-78.32) were found to be independent predictors of P. knowlesi infection. Conclusions This study showed the need to strengthen the strategies in preventing and controlling P. knowlesi infection specifically in changing the practice of spending overnight in forest and increasing the usage of personal mosquito repellent.	[Chin, Abraham Zefong; Avoi, Richard; Atil, Azman; Awang Lukman, Khamisah; Syed Abdul Rahim, Syed Sharizman; Ibrahim, Mohd Yusof; Jeffree, Mohammad Saffree] Univ Malaysia Sabah, Dept Publ Hlth Med, Fac Med & Hlth Sci, Kota Kinabalu, Sabah, Malaysia; [Atil, Azman] Univ Kebangsaan Malaysia, Dept Community Hlth, Fac Med, Med Ctr, Jalan Yaacob Latiff, Kuala Lumpur, Malaysia; [Ahmed, Kamruddin; Jeffree, Mohammad Saffree] Univ Malaysia Sabah, Borneo Med & Hlth Res Ctr, Kota Kinabalu, Sabah, Malaysia; [Ahmed, Kamruddin] Univ Malaysia Sabah, Dept Pathol & Microbiol, Fac Med & Hlth Sci, Kota Kinabalu, Sabah, Malaysia	Universiti Malaysia Sabah; Universiti Kebangsaan Malaysia; Universiti Malaysia Sabah; Universiti Malaysia Sabah	Jeffree, MS (corresponding author), Univ Malaysia Sabah, Dept Publ Hlth Med, Fac Med & Hlth Sci, Kota Kinabalu, Sabah, Malaysia.; Jeffree, MS (corresponding author), Univ Malaysia Sabah, Borneo Med & Hlth Res Ctr, Kota Kinabalu, Sabah, Malaysia.	saffree@ums.edu.my	SYED ABDUL RAHIM, SYED SHARIZMAN/AAL-9658-2020; Avoi, Richard/T-7650-2019; Jeffree, Mohammad Saffree/G-1156-2017	SYED ABDUL RAHIM, SYED SHARIZMAN/0000-0002-9090-2563; Avoi, Richard/0000-0002-1957-0965; Chin, Abraham/0000-0002-6231-5476; Ibrahim, Mohd Yusof/0000-0001-5691-7772; Jeffree, Mohammad Saffree/0000-0002-0373-4451	Universiti Malaysia Sabah [GUG0370-1/2019]	Universiti Malaysia Sabah	AZC received funding by Postgraduate Research Grant (UMSGreat) from Universiti Malaysia Sabah (Grant Code: GUG0370-1/2019). URL of funder Website: https://www.ums.edu.my/ppiv2/en The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad R, 2018, SE ASIAN J TROP MED, V49, P566; Baird JK, 2009, TRAVEL MED INFECT DI, V7, P269, DOI 10.1016/j.tmaid.2009.06.004; Banks SD, 2014, MED VET ENTOMOL, V28, P14, DOI 10.1111/mve.12068; Barber BE, 2013, CLIN INFECT DIS, V56, P383, DOI 10.1093/cid/cis902; Barber BE, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-401; Barber BE, 2011, EMERG INFECT DIS, V17, P814, DOI 10.3201/eid1705.101489; Blanden J, 2004, OXFORD REV ECON POL, V20, P245, DOI 10.1093/oxrep/grh014; Brock PM, 2016, PARASITOLOGY, V143, P389, DOI 10.1017/S0031182015001821; Brodie JF, 2015, CONSERV BIOL, V29, P110, DOI 10.1111/cobi.12389; CHIN W, 1968, AM J TROP MED HYG, V17, P355, DOI 10.4269/ajtmh.1968.17.355; Chua TH, 2019, PARASITE VECTOR, V12, DOI 10.1186/s13071-019-3627-0; Cooper DJ, 2020, CLIN INFECT DIS, V70, P361, DOI 10.1093/cid/ciz237; Cox-Singh J, 2009, MALARIA J, V8, P1; Crawshaw AF, 2017, MALARIA J, V16, DOI 10.1186/s12936-017-1737-8; Daneshvar C, 2009, CLIN INFECT DIS, V49, P852, DOI 10.1086/605439; Department of Statistics Malaysia, 2020, HOUS INC BAS AM SURV; Forero DA, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-165; Fornace KM, 2019, LANCET PLANET HEALTH, V3, pE179, DOI 10.1016/S2542-5196(19)30045-2; Fornace KM, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006432; Fornace KM, 2016, EMERG INFECT DIS, V22, P201, DOI 10.3201/eid2202.150656; Froeschl G, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-3059-z; Grigg MJ, 2017, LANCET PLANET HEALTH, V1, pE97, DOI [10.1016/S2542-5196(17)30031-1, 10.1016/s2542-5196(17)30031-1]; Gryseels C, 2015, SCI REP-UK, V5, DOI 10.1038/srep16847; Herdiana H, 2018, MALARIA J, V17, DOI 10.1186/s12936-018-2334-1; Herdiana H, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1523-z; Jones-Engel L, 2004, AM J PRIMATOL, V62, P71, DOI 10.1002/ajp.20008; Lee KS, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002015; Li MI, 2021, PLOS NEGLECT TROP D, V15, DOI 10.1371/journal.pntd.0009110; Lombogia PJ., 2015, EBIOMEDIK, V3; Lowassa A, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-129; Maule AL, 2020, AM J TROP MED HYG, V102, P1455, DOI 10.4269/ajtmh.19-0543; Most B, 2017, PARASITOL RES, V116, P677, DOI 10.1007/s00436-016-5333-6; Moyes CL, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1527-0; Naing DKS, 2011, INT J COLLAB RES INT, V3, P391; Ngo DT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007369; Sallum MAM, 2005, REV BRAS ENTOMOL, V49, P1, DOI 10.1590/S0085-56262005000500001; Singh B, 2013, CLIN MICROBIOL REV, V26, P165, DOI 10.1128/CMR.00079-12; Siri JG, 2014, ECOL SOC, V19, DOI 10.5751/ES-06134-190133; Sochantha T, 2010, TROP MED INT HEALTH, V15, P336, DOI 10.1111/j.1365-3156.2009.02457.x; Sullivan KM, 2019, PARASITE VECTOR, V12, DOI 10.1186/s13071-019-3314-1; Tan CH, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-52; Van den Eede P, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-249; Vythilingam I, 2006, T ROY SOC TROP MED H, V100, P1087, DOI 10.1016/j.trstmh.2006.02.006; Vythilingam I, 2008, PARASITE VECTOR, V1, DOI 10.1186/1756-3305-1-26; WHO, 2011, WORLD MALARIA REPORT 2011, P1; William T, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-390; Wong ML, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004135; World Health Organization, 2018, PRESS RELEASE AFD FA; Worrall E, 2005, TROP MED INT HEALTH, V10, P1047, DOI 10.1111/j.1365-3156.2005.01476.x; Yadav K, 2014, INFECT DIS POVERTY, V3, DOI 10.1186/2049-9957-3-19	50	3	3	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2021	16	9							e0257104	10.1371/journal.pone.0257104	http://dx.doi.org/10.1371/journal.pone.0257104			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XM9EM	34506556	gold, Green Published			2022-12-26	WOS:000729120700094
J	Gallucci, G; Santucci, N; Diaz, A; Bongiovanni, B; Bertola, D; Gardenez, W; Rassetto, M; Bay, ML; Bottasso, O; D'Attilio, L				Gallucci, Georgina; Santucci, Natalia; Diaz, Ariana; Bongiovanni, Bettina; Bertola, Diego; Gardenez, Walter; Rassetto, Mauricio; Bay, Maria Luisa; Bottasso, Oscar; D'Attilio, Luciano			Increased levels of circulating LPS during Tuberculosis prevails in patients with advanced pulmonary involvement	PLOS ONE			English	Article							C-REACTIVE PROTEIN; BLOOD MONONUCLEAR-CELLS; CYTOKINE PRODUCTION; IMMUNE; ENDOTOXEMIA; ACTIVATION; MECHANISMS; MICROBIOTA	Our earlier studies in tuberculosis (TB) patients indicate that in those where the process evolves to a larger pulmonary involvement, the immune endocrine response may promote an unfavorable environment. Chronic infectious diseases, and their persistent proinflammatory response, may affect mucosal barriers integrity favoring the translocation of gastrointestinal bacteria, leading to an increase of circulating lipopolysaccharides (LPS). Consequently, we quantified LPS levels in TB patients, with different degrees of pulmonary involvement, and controls (Co) and analyzed the possible relationship between LPS and inflammatory mediators i.e., C reactive protein (CRP), interleukin 6 (IL-6) and Interferon-gamma (IFN-gamma), Erythrocyte Sedimentation Rate (ESR), steroid hormones (Cortisol and Dehydroepiandrosterone, DHEA), and inflammatory transcripts from peripheral blood mononuclear cells (IL-1 beta, IL-6, IFN-gamma). LPS was assessed by the Limulus amoebocyte lysate assay and the ELISA technique was used to quantify hormones and cytokines in the plasma samples. Cytokine transcripts from PBMC were evaluated by qRT-PCR. Non-parametric tests were used. LPS levels were increased in TB patients, as did levels of CRP, IL-6, IFN-gamma, cortisol and ESR. Severe patients had the highest amounts of circulating LPS; with moderate and severe cases showing much higher levels of CRP, ESR, IL-6, IFN-gamma and cortisol/DHEA ratio, as an endocrine imbalance. Only in PBMC from severe cases was mRNA for IL-1 beta increased. Correlation analysis showed that levels of LPS from severe patients were positively associated with IL-6 and IFN-gamma plasma concentrations and with IL-1 beta transcripts, while IL-6 had a positive correlation with the cortisol/DHEA ratio. The higher levels of circulating LPS during progressive TB may emerge as a contributing factor for the persistence of the greater immune endocrine imbalance distinctive of advanced disease, which might suggest a vicious cycle among LPS, inflammation and endocrine imbalance.	[Gallucci, Georgina; Santucci, Natalia; Diaz, Ariana; Bongiovanni, Bettina; Bay, Maria Luisa; Bottasso, Oscar; D'Attilio, Luciano] UNR, CONICET, Inst Inmunol Clin & Expt Rosario IDICER, Rosario, Santa Fe, Argentina; [Santucci, Natalia; Diaz, Ariana; Bay, Maria Luisa; Bottasso, Oscar; D'Attilio, Luciano] Univ Nacl Rosario, Fac Ciencias Med, Rosario, Santa Fe, Argentina; [Bertola, Diego] Hosp Prov Centenario, Serv Clin Med, Rosario, Santa Fe, Argentina; [Gardenez, Walter] Hosp Prov Centenario, Serv Neumol, Rosario, Santa Fe, Argentina; [Rassetto, Mauricio] Ctr Invest & Biotecnol CIBIO, Wiener Lab, Rosario, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Rosario; National University of Rosario	D'Attilio, L (corresponding author), UNR, CONICET, Inst Inmunol Clin & Expt Rosario IDICER, Rosario, Santa Fe, Argentina.; D'Attilio, L (corresponding author), Univ Nacl Rosario, Fac Ciencias Med, Rosario, Santa Fe, Argentina.	dattilio@idicer-conicet.gob.ar	Santucci, Natalia Estefanía/AAE-2602-2022	Santucci, Natalia Estefanía/0000-0002-2440-2296	Foundation for Scientific and Technological Research-FONCyT-Argentina [PICT 2016-0279]; National University of Rosario [1MED479]	Foundation for Scientific and Technological Research-FONCyT-Argentina; National University of Rosario	This work was supported by the Foundation for Scientific and Technological Research-FONCyT- (PICT 2016-0279) Argentina, and a Grant from National University of Rosario (1MED479). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adukauskiene D, 2016, MEDICINA-LITHUANIA, V52, P1, DOI 10.1016/j.medici.2015.12.001; Altet N, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0182998; Bailey MT, 2012, HORM BEHAV, V62, P286, DOI 10.1016/j.yhbeh.2012.02.006; Berkowitz L, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00074; Bozza VV, 2007, SCAND J IMMUNOL, V66, P97, DOI 10.1111/j.1365-3083.2007.01952.x; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Caroff M, 2002, MICROBES INFECT, V4, P915, DOI 10.1016/S1286-4579(02)01612-X; D'Attilio L, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00214; D'Attlio L, 2011, BRAIN BEHAV IMMUN, V25, P461, DOI 10.1016/j.bbi.2010.11.006; de Punder K, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00223; del Rey A, 2007, BRAIN BEHAV IMMUN, V21, P171, DOI 10.1016/j.bbi.2006.06.005; Diaz A, 2017, PATHOG DIS, V75, DOI 10.1093/femspd/ftx087; Feruglio SL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069896; Glaros Trevor G, 2013, Front Biosci (Schol Ed), V5, P754; Haider DG, 2006, CLIN EXP IMMUNOL, V146, P533, DOI 10.1111/j.1365-2249.2006.03224.x; He JQ, 2008, EUR RESPIR J, V32, P755, DOI 10.1183/09031936.00129107; Jansky L, 2003, PHYSIOL RES, V52, P593; Jayashree B, 2014, MOL CELL BIOCHEM, V388, P203, DOI 10.1007/s11010-013-1911-4; Juffermans NP, 1998, J INFECT DIS, V178, P1839, DOI 10.1086/314492; Kumar NP, 2019, OPEN FORUM INFECT DI, V6, DOI 10.1093/ofid/ofz257; Lin HH, 2007, PLOS MED, V4, P173, DOI 10.1371/journal.pmed.0040020; Mahuad C, 2004, SCAND J IMMUNOL, V60, P639, DOI 10.1111/j.0300-9475.2004.01514.x; Manco M, 2010, ENDOCR REV, V31, P817, DOI 10.1210/er.2009-0030; Mourik BC, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00294; Ng PML, 2004, J ENDOTOXIN RES, V10, P163, DOI 10.1179/096805104225004833; O'Garra A, 2013, ANNU REV IMMUNOL, V31, P475, DOI 10.1146/annurev-immunol-032712-095939; Pell JP, 2011, INT J EPIDEMIOL, V40, P1128, DOI 10.1093/ije/dyq236; Philips L, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2657-5; Pizzolato E, 2014, CLIN CHEM LAB MED, V52, P1395, DOI 10.1515/cclm-2014-0199; Rao S., 2009, INFECT DIS CLIN PRAC, V17, P314; Raparelli V, 2017, HEPATOLOGY, V65, P571, DOI 10.1002/hep.28853; Reguleiro V, 2009, EUR RESPIR J, V33, P273, DOI 10.1183/09031936.00087708; Rosso M, 2011, CRIT REV IMMUNOL, V31, P379, DOI 10.1615/CritRevImmunol.v31.i5.20; Santucci N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026363; Schildberger A, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/697972; Scriba TJ, 2017, MICROBIOL SPECTR, V5, DOI 10.1128/microbiolspec.TBTB2-0016-2016; Shen L, 2012, ANN NY ACAD SCI, V1258, P9, DOI 10.1111/j.1749-6632.2012.06613.x; Steinman L, 2004, NAT IMMUNOL, V5, P575, DOI 10.1038/ni1078; Sun Y, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/167572; Turnbull AV, 1999, PHYSIOL REV, V79, P1, DOI 10.1152/physrev.1999.79.1.1; Vassallo M, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-174; Wiedermann CJ, 1999, J AM COLL CARDIOL, V34, P1975, DOI 10.1016/S0735-1097(99)00448-9; Zahs A, 2013, SHOCK, V39, P373, DOI 10.1097/SHK.0b013e318289d6c6; Zuo LG, 2014, J CROHNS COLITIS, V8, P1710, DOI 10.1016/j.crohns.2014.08.008	44	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2021	16	9							e0257214	10.1371/journal.pone.0257214	http://dx.doi.org/10.1371/journal.pone.0257214			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XM9EM	34506568	gold, Green Published			2022-12-26	WOS:000729120700112
J	Numan, M; Bukhari, SA; Rehman, MU; Mustafa, G; Sadia, B				Numan, Muhammad; Bukhari, Shazia Anwer; Rehman, Mahmood-ur-; Mustafa, Ghulam; Sadia, Bushra			Phylogenetic analyses, protein modeling and active site prediction of two pathogenesis related (PR2 and PR3) genes from bread wheat	PLOS ONE			English	Article							SECONDARY STRUCTURE PREDICTION; 3-DIMENSIONAL STRUCTURES; BEAUVERIA-BASSIANA; CHITINASE GENE; CLONING; RECOGNITION; ERRORS	Wheat is a major staple food and has been extensively grown around the globe. Sessile nature of plants has exposed them to a lot of biotic and abiotic stresses including fungal pathogen attack. Puccinia graminis f.sp. tritici causes stem rust in the wheat crop and leads to 70% decrease in its production. Pathogenesis-related (PR) proteins provide plants with defense against different fungal pathogens as these proteins have antifungal activities. This study was designed to screen Pakistani wheat varieties for PR2 and PR3 proteins and their in silico characterization. PR2 and PR3 genes were screened and isolated by PCR amplification from wheat variety Chenab-70 and Frontana, respectively. The nucleotide sequences of PR2 and PR3 genes were deposited in GenBank with accession numbers MT303867 and MZ766118, respectively. Physicochemical properties, secondary and tertiary structure predictions, and molecular docking of protein sequences of PR2 and PR3 were performed using different bioinformatics tools and software. PR2 and PR3 genes were identified to encode beta-1,3-glucanase and chitinase proteins, respectively. Molecular docking of both PR2 and PR3 proteins with beta-glucan and chitin (i.e. their respective ligands) showed crucial amino acid residues involved in molecular interactions. Conclusively, molecular docking analysis of beta-1,3-glucanase and chitinase proteins revealed crucial amino acid residues which are involved in ligand binding and important interactions which might have important role in plant defense against fungal pathogens. Moreover, the active residues in the active sties of these proteins can be identified through mutational studies and resulting information might help understanding how these proteins are involved in plant defense mechanisms.	[Numan, Muhammad; Bukhari, Shazia Anwer; Mustafa, Ghulam] Govt Coll Univ, Dept Biochem, Faisalabad, Pakistan; [Rehman, Mahmood-ur-] Govt Coll Univ, Dept Bioinformat & Biotechnol, Faisalabad, Pakistan; [Sadia, Bushra] Univ Agr Faisalabad, Ctr Agr Biochem & Biotechnol CABB, Faisalabad, Pakistan	Government College University Faisalabad; Government College University Faisalabad; University of Agriculture Faisalabad	Bukhari, SA (corresponding author), Govt Coll Univ, Dept Biochem, Faisalabad, Pakistan.	shaziabukhari@gcuf.edu.pk		Numan, Muhammad/0000-0003-0987-660X	Higher Education Commission (HEC), Islamabad, Government of Pakistan [TDF02150]	Higher Education Commission (HEC), Islamabad, Government of Pakistan	are highly thankful to Higher Education Commission (HEC), Islamabad, Government of Pakistan for financial assistance to this research work through a project No. TDF02150.	Akeed Y, 2020, HELIYON, V6, DOI 10.1016/j.heliyon.2020.e03858; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; An LL, 2005, LEUKEMIA RES, V29, P535, DOI 10.1016/j.leukres.2004.11.009; Arakane Y, 2010, CELL MOL LIFE SCI, V67, P201, DOI 10.1007/s00018-009-0161-9; Barboza-Corona JE, 1999, BIOTECHNOL LETT, V21, P1125, DOI 10.1023/A:1005626208193; Bashir S, 2019, INT J AGRIC BIOL, V21, P1013, DOI 10.17957/IJAB/15.0987; Bekhit M, 2018, ANN AGR SCI MOSHTOHO, V56, P1031; Bhagwat P, 2021, PROCESS BIOCHEM, V100, P207, DOI 10.1016/j.procbio.2020.10.012; Bowyer P., 1999, MOL FUNGAL BIOL; Bukhari SA, 2018, J BIOL REG HOMEOS AG, V32, P1191; Bukhari SA, 2020, 3 BIOTECH, V10, DOI 10.1007/s13205-020-02185-6; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; COLOVOS C, 1993, PROTEIN SCI, V2, P1511, DOI 10.1002/pro.5560020916; Combet C, 2000, TRENDS BIOCHEM SCI, V25, P147, DOI 10.1016/S0968-0004(99)01540-6; Devi E.L., 2017, MED PLANTS ENV CHALL, P359; Dogra V, 2015, GENE, V554, P25, DOI 10.1016/j.gene.2014.10.012; Eisenberg D, 1997, METHOD ENZYMOL, V277, P396, DOI 10.1016/S0076-6879(97)77022-8; Fang WG, 2005, APPL ENVIRON MICROB, V71, P363, DOI 10.1128/AEM.71.1.363-370.2005; FILIZ E., 2014, J BIOSCI BIOTECHNOL, V3, P61; Food and Agriculture Organization, 2020, The state of food and agriculture 2020: overcoming water challenges in agriculture, DOI 10.4060/cb1447en; Geourjon C, 1995, COMPUT APPL BIOSCI, V11, P681; Gouripur G.C., 2016, J BIOINFORM SEQ ANAL, V8, P1, DOI [10.5897/JBSA2015.0101, DOI 10.5897/JBSA2015.0101]; Hughes AL, 2012, IMMUNOGENETICS, V64, P549, DOI 10.1007/s00251-012-0610-8; Inc CCG, 2012, MOL OP ENV MOE, V10; Jabbir F, 2019, CRIT REV EUKAR GENE, V29, P551, DOI 10.1615/CritRevEukaryotGeneExpr.2019030785; Jaroszewski L, 2009, METHODS MOL BIOL, V569, P129, DOI 10.1007/978-1-59745-524-4_7; Katiyar A., 2009, Genomics Proteomics & Bioinformatics, V7, P185, DOI 10.1016/S1672-0229(08)60048-0; Khan FI, 2015, J THEOR BIOL, V374, P107, DOI 10.1016/j.jtbi.2015.03.035; Kopp J, 2004, PHARMACOGENOMICS, V5, P405, DOI 10.1517/14622416.5.4.405; Kouza M, 2017, METHODS MOL BIOL, V1484, P7, DOI 10.1007/978-1-4939-6406-2_2; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Leubner-Metzger G., 1999, PATHOGENESIS RELATED, DOI [10.1007/s004250050622, DOI 10.1007/S004250050622]; Mishra A., 2015, STRUCTURAL FUNCTIONA; Mistry J, 2021, NUCLEIC ACIDS RES, V49, pD412, DOI 10.1093/nar/gkaa913; Mohan C, 2020, ARCH PHYTOPATH PLANT, V53, P199, DOI 10.1080/03235408.2020.1736739; Mustafa G, 2018, PAK J PHARM SCI, V31, P709; O'Leary NA, 2016, NUCLEIC ACIDS RES, V44, pD733, DOI 10.1093/nar/gkv1189; Pan MY, 2019, ENZYME MICROB TECH, V124, P54, DOI 10.1016/j.enzmictec.2019.01.012; Rishad KS, 2020, ENZYME MICROB TECH, V140, DOI 10.1016/j.enzmictec.2020.109624; Schuttelkopf AW, 2010, BIOORGAN MED CHEM, V18, P8334, DOI 10.1016/j.bmc.2010.09.062; Schumann GL., 2011, STEM RUST WHEAT; Searle AJ., 2012, OPEN J MED MICROBIOL, V2, P1; Shin SY, 2008, J EXP BOT, V59, P2371, DOI 10.1093/jxb/ern103; Simbolo M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062692; SIMMONS CR, 1994, CRIT REV PLANT SCI, V13, P325, DOI 10.1080/07352680490484569; Singh A, 2007, PROTEIN EXPRES PURIF, V56, P100, DOI 10.1016/j.pep.2007.06.013; Sinha M, 2014, SCI WORLD J, DOI 10.1155/2014/543195; SIPPL MJ, 1993, PROTEINS, V17, P355, DOI 10.1002/prot.340170404; Steinegger M, 2019, BMC BIOINFORMATICS, V20, DOI 10.1186/s12859-019-3019-7; STICHER L, 1992, PLANTA, V188, P559, DOI 10.1007/BF00197049; Suma K, 2013, BIORESOURCE TECHNOL, V133, P213, DOI 10.1016/j.biortech.2013.01.103; United Nations Department of Economic and Social Affairs Population Division, 2018, STAT YB, V61st; Vaaje-Kolstad G, 2010, SCIENCE, V330, P219, DOI 10.1126/science.1192231; Waterhouse A, 2018, NUCLEIC ACIDS RES, V46, pW296, DOI 10.1093/nar/gky427; Wiederstein M, 2007, NUCLEIC ACIDS RES, V35, pW407, DOI 10.1093/nar/gkm290	56	1	1	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2021	16	9							e0257392	10.1371/journal.pone.0257392	http://dx.doi.org/10.1371/journal.pone.0257392			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XM9EM	34506613	Green Published, gold			2022-12-26	WOS:000729120700002
J	Shaheen, MJ; Bekdash, AM; Itani, HA; Borjac, JM				Shaheen, Mariam J.; Bekdash, Amira M.; Itani, Hana A.; Borjac, Jamilah M.			Saffron extract attenuates neuroinflammation in rmTBI mouse model by suppressing NLRP3 inflammasome activation via SIRT1	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; FIBRILLARY ACIDIC PROTEIN; HUMAN SERUM-ALBUMIN; CROCUS-SATIVUS L.; CROCETIN; EXPRESSION; PATHWAY; SYSTEM; CAROTENOIDS; INVOLVEMENT	Traumatic brain injury (TBI) remains a major cause of morbidity and disability worldwide and a healthcare burden. TBI is an important risk factor for neurodegenerative diseases hallmarked by exacerbated neuroinflammation. Neuroinflammation in the cerebral cortex plays a critical role in secondary injury progression following TBI. The NOD-like receptors (NLR) family pyrin domain containing 3 (NLRP3) inflammasome is a key player in initiating the inflammatory response in various central nervous system disorders entailing TBI. This current study aims to investigate the role of NLRP3 in repetitive mild traumatic brain injury (rmTBI) and identify the potential neuroprotective effect of saffron extract in regulating the NLRP3 inflammasome. 24 hours following the final injury, rmTBI causes an upregulation in mRNA levels of NLRP3, caspase-1, the apoptosis-associated speck-like protein containing a CARD (ASC), nuclear factor kappa B (NF-kappa B), interleukin-1Beta (IL-1 beta), interleukin 18 (IL-18), nuclear factor erythroid 2-related factor 2 (NRF2) and heme oxygenase 1 (HMOX1). Protein levels of NLRP3, sirtuin 1 (SIRT1), glial fibrillary acidic protein (GFAP), ionized calcium-binding adaptor molecule 1 (Iba1), and neuronal nuclei (Neu N) also increased after rmTBI. Administration of saffron alleviated the degree of TBI, as evidenced by reducing the neuronal damage, astrocyte, and microglial activation. Pretreatment with saffron inhibited the activation of NLRP3, caspase-1, and ASC concurrent to reduced production of the inflammatory cytokines IL-1 beta and IL-18. Additionally, saffron extract enhanced SIRT1 expression, NRF2, and HMOX1 upregulation. These results suggest that NLRP3 inflammasome activation and the subsequent inflammatory response in the mice cortex are involved in the process of rmTBI. Saffron blocked the inflammatory response and relieved TBI by activating detoxifying genes and inhibiting NLRP3 activation. The effect of saffron on the NLRP3 inflammasome may be SIRT1 and NF-kappa B dependent in the rmTBI model. Thus, brain injury biomarkers will help in identifying a potential therapeutic target in treating TBI-induced neurodegenerative diseases.	[Shaheen, Mariam J.; Borjac, Jamilah M.] Beirut Arab Univ, Dept Biol Sci, Debbieh, Lebanon; [Bekdash, Amira M.; Itani, Hana A.] Amer Univ Beirut, Fac Med, Dept Pharmacol & Toxicol, Beirut, Lebanon; [Itani, Hana A.] Vanderbilt Univ, Med Ctr, Dept Med, Div Clin Pharmacol, Nashville, TN 37235 USA	Beirut Arab University; American University of Beirut; Vanderbilt University	Borjac, JM (corresponding author), Beirut Arab Univ, Dept Biol Sci, Debbieh, Lebanon.; Itani, HA (corresponding author), Amer Univ Beirut, Fac Med, Dept Pharmacol & Toxicol, Beirut, Lebanon.; Itani, HA (corresponding author), Vanderbilt Univ, Med Ctr, Dept Med, Div Clin Pharmacol, Nashville, TN 37235 USA.	hi40@aub.edu.lb; j.borjac@bau.edu.lb		Bekdash, Amira/0000-0002-5065-5131	HAI through the AUB Medical Practice Plan fund; Carl W. Gottschalk Research Scholar Award [M0048845]; American University of Beirut Faculty of Medicine Medical Practice Plan [MPP 320174]	HAI through the AUB Medical Practice Plan fund; Carl W. Gottschalk Research Scholar Award; American University of Beirut Faculty of Medicine Medical Practice Plan	This study has been supported by MS, the first author of this paper, who purchased the kits needed to measure the cytokines levels, the primers, and the kits needed to measure the gene expression, and by HAI through the AUB Medical Practice Plan fund who covered for the reagents used in western blot experiment along with 3 antibodies (NLRP3, SIRT1, and Beta tubulin). The lab assistant AB received a salary from the American Society of Nephrology (ASN), Carl W. Gottschalk Research Scholar Award (M0048845), and the American University of Beirut Faculty of Medicine Medical Practice Plan (MPP 320174). The funders had role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abedimanesh N, 2020, PHYTOTHER RES, V34, P1114, DOI 10.1002/ptr.6580; Alavizadeh SH, 2014, FOOD CHEM TOXICOL, V64, P65, DOI 10.1016/j.fct.2013.11.016; Amin B, 2015, EXCLI J, V14, P411, DOI 10.17179/excli2014-510; Asai A, 2005, J AGR FOOD CHEM, V53, P7302, DOI 10.1021/jf0509355; Baldwin KT, 2017, CURR OPIN NEUROBIOL, V45, P113, DOI 10.1016/j.conb.2017.05.006; Bauernfeind FG, 2009, J IMMUNOL, V183, P787, DOI 10.4049/jimmunol.0901363; Bian YQ, 2020, FRONT PHARMACOL, V11, DOI 10.3389/fphar.2020.579052; Bostan HB, 2017, IRAN J BASIC MED SCI, V20, P110, DOI 10.22038/ijbms.2017.8230; Brickler T, 2016, MEDIAT INFLAMM, V2016, DOI 10.1155/2016/6373506; Burda JE, 2016, EXP NEUROL, V275, P305, DOI 10.1016/j.expneurol.2015.03.020; Cabezas R, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00211; Cafferty WBJ, 2007, J NEUROSCI, V27, P2176, DOI 10.1523/JNEUROSCI.5176-06.2007; CCAC-Canadian Council of Animal Care, 1993, GUID HANDL US EXP AN; Cederberg D, 2010, CHILD NERV SYST, V26, P221, DOI 10.1007/s00381-009-1029-x; Chalatsa I, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00249; Christodoulou E, 2015, J PHARM PHARMACOL, V67, P1634, DOI 10.1111/jphp.12456; Das N, 2016, CELL REP, V17, P1128, DOI 10.1016/j.celrep.2016.09.076; Dempsey C, 2017, BRAIN BEHAV IMMUN, V61, P306, DOI 10.1016/j.bbi.2016.12.014; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; Diao M, 2017, EXP THER MED, V13, P117, DOI 10.3892/etm.2016.3912; Donmez G, 2013, EMBO MOL MED, V5, P344, DOI 10.1002/emmm.201302451; Donmez G, 2012, TRENDS PHARMACOL SCI, V33, P494, DOI 10.1016/j.tips.2012.05.007; Ettehadi H., 2013, J BEHAV BRAIN SCI, V3, P315, DOI [10.4236/jbbs.2013.33031, DOI 10.4236/JBBS.2013.33031]; Fan KH, 2017, CHEM-BIOL INTERACT, V271, P15, DOI 10.1016/j.cbi.2017.04.021; Farokhnia M, 2014, HUM PSYCHOPHARM CLIN, V29, P351, DOI 10.1002/hup.2412; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; Fernandez-Albarral JA, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20174110; Ge XT, 2018, BRAIN RES, V1697, P10, DOI 10.1016/j.brainres.2018.06.008; Giza CC, 2011, SPORTS HEALTH, V3, P46, DOI 10.1177/1941738110391732; Gout B, 2010, NUTR RES, V30, P305, DOI 10.1016/j.nutres.2010.04.008; Gudarzi S, 2022, NUTR NEUROSCI, V25, P1137, DOI 10.1080/1028415X.2020.1840118; Gusel'nikova VV, 2015, ACTA NATURAE, V7, P42, DOI 10.32607/20758251-2015-7-2-42-47; Hatziagapiou K, 2019, CURR NEUROPHARMACOL, V17, P377, DOI 10.2174/1570159X16666180321095705; Hol EM, 2015, CURR OPIN CELL BIOL, V32, P121, DOI 10.1016/j.ceb.2015.02.004; Hosseinzadeh H, 2008, DNA CELL BIOL, V27, P657, DOI 10.1089/dna.2008.0767; Huang KP, 2015, MOL CELL ENDOCRINOL, V399, P178, DOI 10.1016/j.mce.2014.08.014; Huang KP, 2013, FREE RADICAL BIO MED, V65, P528, DOI 10.1016/j.freeradbiomed.2013.07.029; Hwang JW, 2013, FREE RADICAL BIO MED, V61, P95, DOI 10.1016/j.freeradbiomed.2013.03.015; Irrera N, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00459; Jafarisani M, 2018, J BIOMOL STRUCT DYN, V36, P1681, DOI 10.1080/07391102.2017.1331865; Jaliani HZ, 2013, IRAN J BASIC MED SCI, V16, P101; Jiao FZ, 2020, OXID MED CELL LONGEV, V2020, DOI 10.1155/2020/6782872; Bagur MJ, 2018, MOLECULES, V23, DOI 10.3390/molecules23010030; Kabadi SV, 2014, INT J MOL SCI, V15, P1216, DOI 10.3390/ijms15011216; Kanakis CD, 2007, J AGR FOOD CHEM, V55, P970, DOI 10.1021/jf062638l; Kigerl KA, 2018, BRAIN BEHAV IMMUN, V72, P22, DOI 10.1016/j.bbi.2017.11.018; Kim JH, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/728709; Kopitar-Jerata N, 2015, FRONT MOL NEUROSCI, V8, DOI 10.3389/fnmol.2015.00073; Kuwar R, 2019, J NEUROINFLAMM, V16, DOI 10.1186/s12974-019-1471-y; Langer L, 2020, J HEAD TRAUMA REHAB, V35, pE60, DOI 10.1097/HTR.0000000000000503; Lautenschlager M, 2015, PHYTOMEDICINE, V22, P36, DOI 10.1016/j.phymed.2014.10.009; Lazaridis C, 2019, NEUROPHARMACOLOGY, V145, P145, DOI 10.1016/j.neuropharm.2018.06.005; Li D, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0841-6; Lin C, 2017, EXP NEUROL, V290, P115, DOI 10.1016/j.expneurol.2017.01.005; Liu HD, 2013, NEUROCHEM RES, V38, P2072, DOI 10.1007/s11064-013-1115-z; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luo H, 2017, ASIAN PAC J TROP MED, V10, P1185, DOI 10.1016/j.apjtm.2017.10.027; Ma MW, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/6057609; Mannix R, 2013, ANN NEUROL, V74, P65, DOI 10.1002/ana.23858; Mashmoul M, 2014, J FUNCT FOODS, V8, P180, DOI 10.1016/j.jff.2014.03.017; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Meehan WP, 2012, NEUROSURGERY, V71, P885, DOI 10.1227/NEU.0b013e318265a439; Miyamoto A, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00070; Morganti-Kossmann MC, 2019, ACTA NEUROPATHOL, V137, P731, DOI 10.1007/s00401-018-1944-6; Mortezaee K, 2018, J CELL PHYSIOL, V233, P5160, DOI 10.1002/jcp.26287; Naghshineh A, 2015, CHEM-BIOL INTERACT, V238, P151, DOI 10.1016/j.cbi.2015.06.023; Ohsawa K, 2004, J NEUROCHEM, V88, P844, DOI 10.1046/j.1471-4159.2003.02213.x; Parker RS, 1996, FASEB J, V10, P542, DOI 10.1096/fasebj.10.5.8621054; Pathophysiology KwonB., 2004, SPINE J, V4, DOI [10.1016/j.spinee.2003.07.007, DOI 10.1016/J.SPINEE.2003.07.007]; Ramli FN, 2020, BIOMED RES INT, V2020, DOI 10.1155/2020/1247946; Saadoun S, 2005, J CELL SCI, V118, P5691, DOI 10.1242/jcs.02680; Salman M, 2020, DIS MODEL MECH, V13, DOI 10.1242/dmm.045021; Salminen A, 2008, BIOESSAYS, V30, P939, DOI 10.1002/bies.20799; Saresella M, 2016, MOL NEURODEGENER, V11, DOI 10.1186/s13024-016-0088-1; Simon DW, 2017, NAT REV NEUROL, V13, P171, DOI 10.1038/nrneurol.2017.13; Sofroniew MV, 2015, NAT REV NEUROSCI, V16, P249, DOI 10.1038/nrn3898; Sofroniew MV, 2009, TRENDS NEUROSCI, V32, P638, DOI 10.1016/j.tins.2009.08.002; Swanson KV, 2019, NAT REV IMMUNOL, V19, P477, DOI 10.1038/s41577-019-0165-0; Toy Dana, 2013, Exp Neurobiol, V22, P68, DOI 10.5607/en.2013.22.2.68; Vaccari JPD, 2014, J CEREBR BLOOD F MET, V34, P369, DOI 10.1038/jcbfm.2013.227; Wang H, 2020, J NEUROINFLAMM, V17, DOI 10.1186/s12974-020-01863-9; Wang K, 2015, NEUROSCI LETT, V591, P53, DOI 10.1016/j.neulet.2015.02.016; WHO, 2003, GUID GOOD AGR COLL P; Xiong YY, 2015, IMMUNOPHARM IMMUNOT, V37, P236, DOI 10.3109/08923973.2015.1021356; Yang F, 2014, J CEREBR BLOOD F MET, V34, P660, DOI 10.1038/jcbfm.2013.242; Yang HY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046364; Yang Y, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1413-8; Yoshino F, 2011, J CLIN BIOCHEM NUTR, V49, P182, DOI 10.3164/jcbn.11-01; Zhang XJ, 2018, CELL PHYSIOL BIOCHEM, V48, P1088, DOI 10.1159/000491975; Zhang YQ, 2020, EUR J PHARMACOL, V867, DOI 10.1016/j.ejphar.2019.172847; Ziaee T, 2014, JUNDISHAPUR J NAT PH, V9, P3; Zou P, 2018, MOL MED REP, V17, P3212, DOI 10.3892/mmr.2017.8241	92	8	8	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2021	16	9							e0257211	10.1371/journal.pone.0257211	http://dx.doi.org/10.1371/journal.pone.0257211			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XM9EM	34506597	Green Published, gold			2022-12-26	WOS:000729120700107
J	Stewart, TJ; Murthy, V; Dugan, SP; Baker, JE				Stewart, Travis J.; Murthy, Vidya; Dugan, Sam P.; Baker, Josh E.			Velocity of myosin-based actin sliding depends on attachment and detachment kinetics and reaches a maximum when myosin-binding sites on actin saturate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SKELETAL-MUSCLE MYOSIN; MOLECULAR MOTORS; SMOOTH-MUSCLE; CALCIUM SENSITIVITY; LIGHT-CHAIN; FILAMENTS; MOVEMENT; FORCES; MECHANISM; SUBFRAGMENT-1	Molecular motors such as kinesin and myosin often work in groups to generate the directed movements and forces critical for many biological processes. Although much is known about how individual motors generate force and movement, surprisingly, little is known about the mechanisms underlying the macroscopic mechanics generated by multiple motors. For example, the observation that a saturating number, N, of myosin heads move an actin filament at a rate that is influenced by actin-myosin attachment and detachment kinetics is accounted for neither experimentally nor theoretically. To better understand the emergent mechanics of actin-myosin mechanochemistry, we use an in vitro motility assay to measure and correlate the N-dependence of actin sliding velocities, actin-activated ATPase activity, force generation against a mechanical load, and the calcium sensitivity of thin filament velocities. Our results show that both velocity and ATPase activity are strain dependent and that velocity becomes maximized with the saturation of myosin-binding sites on actin at a value that is 40% dependent on attachment kinetics and 60% dependent on detachment kinetics. These results support a chemical thermodynamic model for ensemble motor mechanochemistry and imply molecularly explicit mechanisms within this framework, challenging the assumption of independent force generation.	[Stewart, Travis J.; Dugan, Sam P.; Baker, Josh E.] Univ Nevada, Reno Sch Med, Dept Pharmacol, Reno, NV 89557 USA; [Murthy, Vidya] Univ Nevada, Dept Biomed Engn, Reno, NV 89557 USA	Nevada System of Higher Education (NSHE); University of Nevada Reno; Nevada System of Higher Education (NSHE); University of Nevada Reno	Baker, JE (corresponding author), Univ Nevada, Reno Sch Med, Dept Pharmacol, Reno, NV 89557 USA.	jebaker@unr.edu		Baker, Josh/0000-0002-2101-5215	NIH [R01AR071405-01A1]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was supported by NIH Grant R01AR071405-01A1. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Amrute-Nayak M, 2008, J BIOL CHEM, V283, P3773, DOI 10.1074/jbc.M706779200; Baker JE, 2000, BIOPHYS J, V79, P1731, DOI 10.1016/S0006-3495(00)76425-3; Baker JE, 2004, J THEOR BIOL, V228, P467, DOI 10.1016/j.jtbi.2004.02.013; Baker JE, 2004, P NATL ACAD SCI USA, V101, P5542, DOI 10.1073/pnas.0307247101; Baker JE, 2002, BIOPHYS J, V82, P2134, DOI 10.1016/S0006-3495(02)75560-4; Baker JE, 1998, P NATL ACAD SCI USA, V95, P2944, DOI 10.1073/pnas.95.6.2944; Baker JE, 1999, BIOPHYS J, V77, P2657, DOI 10.1016/S0006-3495(99)77100-6; Baker JE, 2000, J MUSCLE RES CELL M, V21, P335, DOI 10.1023/A:1005615925390; BARANY M, 1967, J GEN PHYSIOL, V50, P197, DOI 10.1085/jgp.50.6.197; Bray D., 2001, CELL MOVEMENT MOL MO; Brizendine RK, 2017, SCI ADV, V3, DOI 10.1126/sciadv.aao2267; Brizendine RK, 2015, P NATL ACAD SCI USA, V112, P11235, DOI 10.1073/pnas.1510241112; Campbell SG, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002156; Debold EP, 2012, J APPL PHYSIOL, V113, P1413, DOI 10.1152/japplphysiol.00775.2012; FABIATO A, 1979, J PHYSIOL-PARIS, V75, P463; Fenn WO, 1931, AM J PHYSIOL, V97, P1; Fenn WO, 1923, J PHYSIOL-LONDON, V58, P0175; FINER JT, 1994, NATURE, V368, P113, DOI 10.1038/368113a0; GOLDMAN YE, 1987, ANNU REV PHYSIOL, V49, P637, DOI 10.1146/annurev.ph.49.030187.003225; Greenberg MJ, 2010, CYTOSKELETON, V67, P273, DOI 10.1002/cm.20441; Guilford WH, 1997, BIOPHYS J, V72, P1006, DOI 10.1016/S0006-3495(97)78753-8; Haldeman BD, 2014, J BIOL CHEM, V289, P21055, DOI 10.1074/jbc.M114.564740; HARRIS DE, 1993, J BIOL CHEM, V268, P14764; Highsmith S, 2000, BIOPHYS J, V79, P1686, DOI 10.1016/S0006-3495(00)76418-6; Hill AV, 1938, PROC R SOC SER B-BIO, V126, P136, DOI 10.1098/rspb.1938.0050; Hill T.L., 1974, Progress Biophys Molec Biol, V28, P267, DOI 10.1016/0079-6107(74)90020-0; Hill TL, 1989, FREE ENERGY TRANSDUC; Holmes KC, 2000, PHILOS T R SOC B, V355, P419, DOI 10.1098/rstb.2000.0583; HOMSHER E, 1992, AM J PHYSIOL, V262, pC714, DOI 10.1152/ajpcell.1992.262.3.C714; Hooft AM, 2007, BIOCHEMISTRY-US, V46, P3513, DOI 10.1021/bi0614840; Howard J., 2001, MECH MOTOR PROTEINS; HUXLEY AF, 1957, PROG BIOPHYS MOL BIO, V7, P255, DOI 10.1016/S0096-4174(18)30128-8; HUXLEY AF, 1974, J PHYSIOL-LONDON, V243, P1; HUXLEY HE, 1990, J BIOL CHEM, V265, P8347; HUXLEY HE, 1969, SCIENCE, V164, P1356, DOI 10.1126/science.164.3886.1356; KABSCH W, 1990, NATURE, V347, P37, DOI 10.1038/347037a0; Kad NM, 2005, P NATL ACAD SCI USA, V102, P16990, DOI 10.1073/pnas.0506326102; Kaya M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms16036; Kovacs M, 2004, J BIOL CHEM, V279, P35557, DOI 10.1074/jbc.M405319200; LYMN RW, 1971, BIOCHEMISTRY-US, V10, P4617, DOI 10.1021/bi00801a004; Mansson A, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21218399; MARGOSSIAN SS, 1982, METHOD ENZYMOL, V85, P55; MOLLOY JE, 1995, NATURE, V378, P209, DOI 10.1038/378209a0; Palmiter KA, 1999, J PHYSIOL-LONDON, V519, P669, DOI 10.1111/j.1469-7793.1999.0669n.x; PARDEE JD, 1982, METHOD ENZYMOL, V85, P164; Pertici I, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21197372; Pertici I, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06073-9; Phillips R., 2010, PHYS BIOL CELL; POTTER JD, 1982, METHOD ENZYMOL, V85, P241; Prochniewicz E, 2008, AM J PHYSIOL-CELL PH, V294, pC613, DOI 10.1152/ajpcell.00232.2007; RAYMENT I, 1993, SCIENCE, V261, P50, DOI 10.1126/science.8316857; Ross JL, 2008, CURR OPIN CELL BIOL, V20, P41, DOI 10.1016/j.ceb.2007.11.006; Sabido-David C, 1998, J MOL BIOL, V279, P387, DOI 10.1006/jmbi.1998.1771; Sakamoto T, 2005, BIOCHEMISTRY-US, V44, P584, DOI 10.1021/bi0483357; Shi XH, 2010, ANAL CHEM, V82, P6132, DOI 10.1021/ac1008749; Sich NM, 2010, J BIOL CHEM, V285, P39150, DOI 10.1074/jbc.M110.142232; SIEMANKOWSKI RF, 1985, P NATL ACAD SCI USA, V82, P658, DOI 10.1073/pnas.82.3.658; SLEEP JA, 1976, BIOCHEMISTRY-US, V15, P5813, DOI 10.1021/bi00671a019; SMILLIE LB, 1982, METHOD ENZYMOL, V85, P234; SPUDICH JA, 1994, NATURE, V372, P515, DOI 10.1038/372515a0; Stewart TJ, 2013, CELL MOL BIOENG, V6, P26, DOI 10.1007/s12195-013-0274-y; SVOBODA K, 1994, CELL, V77, P773, DOI 10.1016/0092-8674(94)90060-4; Ucar MC, 2020, NANO LETT, V20, P669, DOI 10.1021/acs.nanolett.9b04445; UYEDA TQP, 1990, J MOL BIOL, V214, P699, DOI 10.1016/0022-2836(90)90287-V; Veigel C, 2003, NAT CELL BIOL, V5, P980, DOI 10.1038/ncb1060; Veigel C, 2002, NAT CELL BIOL, V4, P59, DOI 10.1038/ncb732; Walcott S, 2012, BIOPHYS J, V103, P501, DOI 10.1016/j.bpj.2012.06.031; Webb M, 2013, BIOCHEMISTRY-US, V52, P6437, DOI 10.1021/bi400262h	68	5	5	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV	2021	297	5							101178	10.1016/j.jbc.2021.101178	http://dx.doi.org/10.1016/j.jbc.2021.101178			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	YZ3FU	34508779	Green Published, gold			2022-12-26	WOS:000755365700002
J	Ingenpa, L; Abd El-Wahab, A; Ullrich, C; Kolln, M; Ahmed, MFE; Visscher, C; Kamphues, J				Ingenpa, Lena; Abd El-Wahab, Amr; Ullrich, Cristina; Koelln, Mareike; Ahmed, Marwa F. E.; Visscher, Christian; Kamphues, Josef			Nitrogen output in the urban environment using a vegetarian canine diet	PLOS ONE			English	Article							NUTRIENT DIGESTIBILITY; FERMENTATIVE ACTIVITY; DOGS; PROTEIN; ENERGY; FIBER; SIZE; CAT	Pet owners are increasingly concerned about the links between health status, animal welfare, environmental impacts, climate change and consumption of animal products. Accordingly, many owners are increasingly interested in vegetarian diets for themselves and their companion animals. However, such diets should be investigated nutritionally regards digestibility as well as on fecal quality and nitrogen output. In light of this trend, six Beagle dogs were included in a cross-over experimental design and offered a vegetarian diet containing wheat gluten (8.81%), rice protein (8.81%) and sunflower oil (6.84%) or an meat-based diet containing poultry meal (19.5%) and poultry fat (5.23%). The dogs received extruded complete diets for 12 days (adaptation and collection period, each 6 days). The dogs fed both diets showed a high and identical palatability (scoring of food intake) of the experimental diets. No significant differences occurred regarding digestibility of organic matter, crude protein and crude fat between vegetarian and meat-based diets. However, dogs fed the meat-based diet had higher (p < 0.05) nitrogen-free extract digestibility (89.5%) compared to those fed the vegetarian diet (88.6%). The amount of nitrogen excreted in feces (g)/kg BW0.75 was slightly, but not significantly, higher for dogs fed the vegetarian diet compared to those fed the meat-based diet (0.88 vs 0.79). The fecal consistency scores were considered to be within an acceptable range (well formed and firm). The mass of the feces between both groups were similar (62.9 g wet feces/100 g dry matter food) for vegetarian and meat-based diets. Additionally, the fecal dry matter content was comparable between both groups (29.0% and 29.6% for vegetarian and meat-based diets, respectively). In conclusion, the results of this study appear to indicate that virtually the only significant difference between the two diets was lower nitrogen-free extract digestibility in the vegetarian diet. However, the vegetarian diet did not result in a significant difference in amount of nitrogen excreted in feces.	[Ingenpa, Lena; Abd El-Wahab, Amr; Ullrich, Cristina; Koelln, Mareike; Visscher, Christian; Kamphues, Josef] Univ Vet Med Hannover, Inst Anim Nutr, Hannover, Germany; [Abd El-Wahab, Amr] Mansoura Univ, Fac Vet Med, Dept Nutr & Nutr Deficiency Dis, Mansoura, Egypt; [Ahmed, Marwa F. E.] Mansoura Univ, Fac Vet Med, Dept Hyg & Zoonoses, Mansoura, Egypt	University of Veterinary Medicine Hannover, Foundation; Egyptian Knowledge Bank (EKB); Mansoura University; Egyptian Knowledge Bank (EKB); Mansoura University	Ullrich, C (corresponding author), Univ Vet Med Hannover, Inst Anim Nutr, Hannover, Germany.	cristina.ullrich@tiho-hannover.de	Abd El-Wahab, Amr/U-4873-2019	Abd El-Wahab, Amr/0000-0002-2947-6737	German Research Foundation (Deutsche Forschungsgemeinschaft); University of Veterinary Medicine Hannover, Foundation, Germany; MERA Tiernahrung(C) GmbH	German Research Foundation (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG)); University of Veterinary Medicine Hannover, Foundation, Germany; MERA Tiernahrung(C) GmbH	This publication was supported by the German Research Foundation (Deutsche Forschungsgemeinschaft, https://www.dfg.de/) and University of Veterinary Medicine Hannover, Foundation, Germany (https://www.tiho-hannover.de/) within the funding program Open Access Publishing (CU, grant numbers not applicable). Furthermore by MERA Tiernahrung (c) GmbH (https://www.mera-petfood.com/de/) as funder of this research and supporter of LI (grant number not applicable). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	AAFCO-Association of American Feed Control Officials, 2014, MOD REG PET FOOD SPE; Abd El-Wahab A, 2021, ANIMALS-BASEL, V11, DOI 10.3390/ani11020496; Alexandratos N., 2012, 1203 ESA FAO UN AGR, DOI [10.22004/ag.econ.288998, DOI 10.22004/AG.ECON.288998]; Zafalon RVA, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0227046; AOAC, 2000, OFF METH AN, DOI [DOI 10.1007/978-3-642-31241-0, 10.3109/15563657608988149]; Bednar GE, 2000, ARCH ANIM NUTR, V53, P127, DOI 10.1080/17450390009381942; Bongaarts J., 2019, INTERGOVERNMENTAL PA; Brown W. Y., 2009, RECENT ADV ANIM NUTR, V17, P137; BURROWS CF, 1982, J NUTR, V112, P1726, DOI 10.1093/jn/112.9.1726; Debnath B. C., 2008, Indian Journal of Animal Research, V42, P219; Dodd SAS, 2021, BMC VET RES, V17, DOI 10.1186/s12917-021-02754-8; Dodd SAS, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0210806; Dodd SAS, 2018, JAVMA-J AM VET MED A, V253, P1425, DOI 10.2460/javma.253.11.1425; Fahey G, 1997, 97 PET FOOD FOR O MT, P12; FAHEY GC, 1990, J ANIM SCI, V68, P4221; FEDIAF-The European Pet Food Industry Federation, 2019, NUTR GUID COMPL COMP; Fricke S, 2002, VERTRAGLICHKEIT VERD; GERICKE S, 1952, FRESEN Z ANAL CHEM, V137, P15, DOI 10.1007/BF00452421; Godfray HCJ, 2018, SCIENCE, V361, DOI 10.1126/science.aam5324; Golder C, 2020, ANIMALS-BASEL, V10, DOI 10.3390/ani10030541; Hall JA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054405; Hill RC, 2001, J ANIM SCI, V79, P2162; HUBER TL, 1994, CANINE PRACT, V19, P11; Hussein H, 2000, RECENT ADV CANINE FE; Kamphues J., 2014, SUPPLEMENTE TIERERNA, Vtwelfth; KENDALL PT, 1982, J SCI FOOD AGR, V33, P823, DOI 10.1002/jsfa.2740330903; Kienzle E, 1998, J ANIM PHYSIOL AN N, V79, P46, DOI 10.1111/j.1439-0396.1998.tb00628.x; Knight A, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0253292; Knight A, 2016, ANIMALS, V6, DOI 10.3390/ani6090057; Koneswaran G, 2008, ENVIRON HEALTH PERSP, V116, P578, DOI 10.1289/ehp.11034; Laflamme D, 1997, CANINE PRACT, V22, P10; Leip A, 2015, ENVIRON RES LETT, V10, DOI 10.1088/1748-9326/10/11/115004; Leytem AB, 2021, AGRONOMY-BASEL, V11, DOI 10.3390/agronomy11051005; MACDONALD ML, 1984, ANNU REV NUTR, V4, P521, DOI 10.1146/annurev.nu.04.070184.002513; MERRITT AM, 1979, J AM VET MED ASSOC, V174, P59; Meyer H, 2016, ERNAHRUNG HUNDES GRU, V8; Meyer H., 1989, ADV ANIMAL PHYSL ANI; Morgan R., 2016, SLOW STEADY RISE VEG; Moxham G., 2001, WALTHAM FOCUS, V11, P24; Murray SM, 1999, J ANIM SCI, V77, P2180; National Research Council, 2006, NUTR REQ DOGS CATS, V10th; Naumann C., 2012, METHODEN LANDWIRTSCH, DOI [10.1007/978-3-319-19944-3_4, DOI 10.1007/978-3-319-19944-3_4]; Nery J, 2012, J ANIM SCI, V90, P2570, DOI 10.2527/jas.2011-4112; Nery J, 2010, J ANIM SCI, V88, P159, DOI 10.2527/jas.2008-1666; NRC-National Research Council, 1985, NUTR REQUIREMENTS DO; Rotz C. A., 2015, EM MAGAZINE      SEP, P12; Rubio NR, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-20061-y; Seto KC, 2016, SCIENCE, V352, P943, DOI 10.1126/science.aaf7439; Swanson KS, 2013, ADV NUTR, V4, P141, DOI 10.3945/an.112.003335; Tilman D, 2017, NATURE, V546, P73, DOI 10.1038/nature22900; Union IV, 2016, IVU WORLD VEGF DEF V; University College of London, 2020, UCL CONN LEARN BAS; Urrego Maria Isabel Gonzalez, 2017, J Nutr Sci, V6, pe43, DOI 10.1017/jns.2017.46; Wakefield LA, 2006, JAVMA-J AM VET MED A, V229, P70, DOI 10.2460/javma.229.1.70; Weber MP, 2004, J ANIM PHYSIOL AN N, V88, P356, DOI 10.1111/j.1439-0396.2004.00494.x; Wiernusz C. J., 1995, Veterinary Clinical Nutrition, V2, P49; Zahn S, 2010, UNTERSUCHUNGEN ZUM F; ZENTEK J, 1995, J ANIM PHYSIOL AN N, V74, P62, DOI 10.1111/j.1439-0396.1995.tb00437.x; Zieger A.L., 2015, UNTERSUCHUNGEN ZUM E; Zuo Y, 1996, J ANIM SCI, V74, P2441	60	1	1	4	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2021	16	9							e0257364	10.1371/journal.pone.0257364	http://dx.doi.org/10.1371/journal.pone.0257364			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XH8RH	34555067	gold, Green Published			2022-12-26	WOS:000725694500030
J	Ai, LY; Ren, TC; Yan, Q; Wan, MD; Peng, YJ; Xu, XY; Liu, XX				Ai, Luoyan; Ren, Tiancheng; Yan, Qin; Wan, Mengdan; Peng, Yajuan; Xu, Xiaoyun; Liu, Xinxin			Degradation efficiencies of 2,4,6-TCP by Fe-0-based advanced oxidation processes (AOPs) with common peroxides	PLOS ONE			English	Article							ZERO-VALENT IRON; TEXTILE WASTE-WATER; AQUEOUS-SOLUTION; ORGANIC POLLUTANTS; AROMATIC-COMPOUNDS; AZO DYES; 2,4,6-TRICHLOROPHENOL; PEROXYMONOSULFATE; REDUCTION; REMOVAL	Degradation of 2,4,6-trichlorophenol (2,4,6-TCP) by zero-valent iron (ZVI) activating three common peroxides (peroxymonosulfate (PMS), hydrogen peroxide (H2O2), and peroxydisulfate (PS)) was investigated. The effects of ZVI dosage, peroxides concentration, initial pH, and Cl- concentration were examined. The 2,4,6-TCP degradation efficiencies by Fe-0 / peroxides (PMS, H2O2, PS) were compared. Results showed that the order for degradation efficiency was H2O2 >= PMS>PS. The degradation efficiency of 2,4,6-TCP in ZVI/peroxides systems were optimal at c(Ox) = 1 mmol.L-1; c(Fe-0) = 0.1 g/L; initial pH = 3.2. Additionally, pH had a vital effect on 2,4,6-TCP degradation. At pH<3.2, ferrous play a vital role in all reaction, and accelerate the reaction rate rapidly. The existence of NaCl showed different results in the four systems. Chloride had little effect on 2,4,6-TCP degradation when chloride concentration at 5 mM, whereas the presence of 300 mM chloride significantly accelerated the degradation of 2,4,6-TCP from 72.7% to 95.2% in ZVI-PMS system. Notably, the other three systems showed opposite results. In contrast, the AOX (Absorbable Organic Halogen) values were highest in ZVI-PMS-Cl- system, due to the formation of lots of refractory chlorinated phenols as identified by GC-MS. These findings are good for choosing the most suitable technology for chlorophenol wastewater treatment.	[Ai, Luoyan; Yan, Qin; Wan, Mengdan; Peng, Yajuan; Xu, Xiaoyun; Liu, Xinxin] Nanchang Inst Sci & Technol, Sch Human Habitat & Environm, Nanchang, Jiangxi, Peoples R China; [Ren, Tiancheng] Jiangxi Acad Transportat Sci, Nanchang, Jiangxi, Peoples R China		Liu, XX (corresponding author), Nanchang Inst Sci & Technol, Sch Human Habitat & Environm, Nanchang, Jiangxi, Peoples R China.	huashuiliuxin@126.com			National Natural Science Foundation of China [52069013]; Youth Science Foundation of Jiangxi Province, China [20192BAB216039]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Youth Science Foundation of Jiangxi Province, China	The research work was supported by National Natural Science Foundation of China (Nos. 52069013), and the Youth Science Foundation of Jiangxi Province, China (Nos. 20192BAB216039). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. None of the authors received salary from any funders.	Agrawal A, 1996, ENVIRON SCI TECHNOL, V30, P153, DOI 10.1021/es950211h; Ahmed AE, 2007, MICROPOR MESOPOR MAT; Baycan N, 2007, J HAZARD MATER, V143, P171, DOI 10.1016/j.jhazmat.2006.09.010; Benitez FJ, 2000, CHEMOSPHERE, V41, P1271, DOI 10.1016/S0045-6535(99)00536-6; Buxton GV, 1999, PHYS CHEM CHEM PHYS, V1, P269, DOI 10.1039/a807808d; Choi JH, 2007, CHEMOSPHERE, V67, P1551, DOI 10.1016/j.chemosphere.2006.12.029; Choi JH, 2009, J HAZARD MATER, V166, P984, DOI 10.1016/j.jhazmat.2008.12.004; Daud NK, 2010, J HAZARD MATER, V176, P938, DOI 10.1016/j.jhazmat.2009.11.130; Deng J, 2014, INT J ENVIRON SCI TE, V11, P881, DOI 10.1007/s13762-013-0284-2; Dong YC, 2007, DYES PIGMENTS, V73, P261, DOI 10.1016/j.dyepig.2005.12.007; Fang CL, 2016, CHEMOSPHERE, V144, P2415, DOI 10.1016/j.chemosphere.2015.11.030; Ghanbari F, 2017, CHEM ENG J, V310, P41, DOI 10.1016/j.cej.2016.10.064; Ghanbari F, 2014, J ENVIRON CHEM ENG, V2, P1846, DOI 10.1016/j.jece.2014.08.003; GILLHAM RW, 1994, GROUND WATER, V32, P958, DOI 10.1111/j.1745-6584.1994.tb00935.x; Hou MF, 2011, CHEMOSPHERE, V83, P1279, DOI 10.1016/j.chemosphere.2011.03.005; Howard Ph., 1991, HDB ENV DEGRADATION; Jardim WF, 1997, WATER RES, V31, P1728, DOI 10.1016/S0043-1354(96)00349-1; Kallel M, 2009, CHEM ENG J, V150, P391, DOI 10.1016/j.cej.2009.01.017; Keenan CR, 2008, ABSTR PAP AM CHEM S, V236; Mandal A, 2004, CHEM ENG J, V102, P203, DOI 10.1016/j.cej.2004.05.007; MARUTHAMUTHU P, 1977, J PHYS CHEM-US, V81, P937, DOI 10.1021/j100525a001; Muruganandham M, 2004, DYES PIGMENTS, V62, P269, DOI 10.1016/j.dyepig.2003.12.006; Muthukumar M, 2004, DYES PIGMENTS, V62, P221, DOI 10.1016/j.dyepig.2003.11.002; Oh SY, 2010, SCI TOTAL ENVIRON, V408, P3464, DOI 10.1016/j.scitotenv.2010.04.032; Oh SY, 2012, J CHEM TECHNOL BIOT; Rengaraj S, 2006, J MOL CATAL A-CHEM, V243, P60, DOI 10.1016/j.molcata.2005.08.010; Sanchez I, 2007, CHEMOSPHERE, V68, P338, DOI 10.1016/j.chemosphere.2006.12.059; Saritha P, 2009, WATER AIR SOIL POLL, V200, P169, DOI 10.1007/s11270-008-9901-y; Sharma J, 2015, CHEM ENG J, V276, P193, DOI 10.1016/j.cej.2015.04.021; Sokmen M, 2002, J PHOTOCH PHOTOBIO A, V147, P77, DOI 10.1016/S1010-6030(01)00627-X; Sorokin A, 1996, J AM CHEM SOC, V118, P7410, DOI 10.1021/ja960177m; Volpe A, 2013, CHEMOSPHERE, V91, P1250, DOI 10.1016/j.chemosphere.2013.02.012; Wang ZH, 2017, RSC ADV, V7, P30941, DOI 10.1039/c7ra03872k; Wang ZH, 2011, J HAZARD MATER, V190, P1083, DOI 10.1016/j.jhazmat.2011.04.016; Wu JX, 2015, J ENVIRON MANAGE, V161, P11, DOI 10.1016/j.jenvman.2015.06.040; Xu L, 2013, CHEM ENG J, V217, P169, DOI 10.1016/j.cej.2012.11.112; Yuan RX, 2011, J HAZARD MATER, V196, P173, DOI 10.1016/j.jhazmat.2011.09.007; Zhang H, 2007, COLOR TECHNOL, V123, P203, DOI 10.1111/j.1478-4408.2007.00079.x; Zhao JY, 2010, SEP PURIF TECHNOL, V71, P302, DOI 10.1016/j.seppur.2009.12.010; Zhou HM, 2015, J HAZARD MATER, V284, P241, DOI 10.1016/j.jhazmat.2014.10.050; Zhou J, 2015, CHEMOSPHERE, V134, P446, DOI 10.1016/j.chemosphere.2015.05.027; Zou J, 2013, ENVIRON SCI TECHNOL, V47, P11685, DOI 10.1021/es4019145	42	0	0	16	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2021	16	9							e0257415	10.1371/journal.pone.0257415	http://dx.doi.org/10.1371/journal.pone.0257415			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YS4WS	34550979	gold, Green Published			2022-12-26	WOS:000750679800020
J	Berger, JJ; Harris, IM; Whittingham, KM; Terpening, Z; Watson, JDG; Thierry, G; Vousden, G				Berger, Joshua J.; Harris, Irina M.; Whittingham, Karen M.; Terpening, Zoe; Watson, John D. G.; Thierry, Guillaume; Vousden, George			Sharing the load: How a personally coloured calculator for grapheme-colour synaesthetes can reduce processing costs	PLOS ONE			English	Article							ANTERIOR CINGULATE CORTEX; STANDARDIZED TEST BATTERY; R PACKAGE; SYNESTHESIA; SOUND	Synaesthesia refers to a diverse group of perceptions. These unusual perceptions are defined by the experience of concurrents; these are conscious experiences that are catalysed by attention to some normally unrelated stimulus, the inducer. In grapheme-colour synaesthesia numbers, letters, and words can all cause colour concurrents, and these are independent of the actual colour with which the graphemes are displayed. For example, when seeing the numeral '3' a person with synaesthesia might experience green as the concurrent irrespective of whether the numeral is printed in blue, black, or red. As a trait, synaesthesia has the potential to cause both positive and negative effects. However, regardless of the end effect, synaesthesia incurs an initial cost when compared with its equivalent example from normal perception; this is the additional processing cost needed to generate the information on the concurrent. We contend that this cost can be reduced by mirroring the concurrent in the environment. We designed the Digital-Colour Calculator (DCC) app, allowing each user to personalise and select the colours with which it displays its digits; it is the first reported example of a device/approach that leverages the concurrent. In this article we report on the reactions to the DCC for a sample of fifty-three synaesthetes and thirty-five non-synaesthetes. The synaesthetes showed a strong preference for the DCC over its normal counterpart. The non-synaesthetes showed no obvious preference. When using the DCC a subsample of the synaesthete group showed consistent improvement in task speed (around 8%) whereas no synaesthete showed a decrement in their speed.	[Berger, Joshua J.; Watson, John D. G.] Univ Sydney, Fac Med & Hlth, Sydney, NSW, Australia; [Harris, Irina M.; Terpening, Zoe] Univ Sydney, Fac Sci, Sch Psychol, Sydney, NSW, Australia; [Whittingham, Karen M.] Univ New South Wales, Fac Sci, Sydney, NSW, Australia; [Terpening, Zoe; Watson, John D. G.] Univ New South Wales, Fac Med & Hlth, Sydney, NSW, Australia	University of Sydney; University of Sydney; University of New South Wales Sydney; University of New South Wales Sydney	Berger, JJ (corresponding author), Univ Sydney, Fac Med & Hlth, Sydney, NSW, Australia.	joshua.berger@sydney.edu.au		Watson, John/0000-0003-0988-2583; Berger, Joshua/0000-0002-9666-9352				Asano M, 2012, CONSCIOUS COGN, V21, P983, DOI 10.1016/j.concog.2012.02.005; Asher JE, 2013, OXFORD HDB SYNESTHES, P23, DOI [10.1093/oxfordhb/9780199603329.013.0002, DOI 10.1093/OXFORDHB/9780199603329.013.0002]; Banissy MJ, 2009, EXP BRAIN RES, V196, P565, DOI 10.1007/s00221-009-1888-0; Barnett KJ, 2008, COGNITION, V106, P871, DOI 10.1016/j.cognition.2007.05.003; Berger JJ, 2020, NEUROCASE, V26, P29, DOI 10.1080/13554794.2019.1695846; Brang D, 2019, CORTEX, V117, P89, DOI 10.1016/j.cortex.2019.02.025; Burkner PC, 2018, R J, V10, P395; Burkner PC, 2017, J STAT SOFTW, V80, P1, DOI 10.18637/jss.v080.i01; Carmichael DA, 2015, CONSCIOUS COGN, V33, P375, DOI 10.1016/j.concog.2015.02.001; Carmichael DA, 2019, BRIT J PSYCHOL, V110, P530, DOI 10.1111/bjop.12354; Chang WC, 2012, NEUROSCIENCE, V222, P302, DOI 10.1016/j.neuroscience.2012.07.014; Chin T, 2018, MEMORY, V26, P844, DOI 10.1080/09658211.2017.1414849; Delevich K, 2015, J NEUROSCI, V35, P5743, DOI 10.1523/JNEUROSCI.4565-14.2015; Dixon MJ, 2004, COGN AFFECT BEHAV NE, V4, P335, DOI 10.3758/CABN.4.3.335; Eagleman DM, 2007, J NEUROSCI METH, V159, P139, DOI 10.1016/j.jneumeth.2006.07.012; Goodman N, 2015, BRIT MEDICAL J OPINI; GrossTsur V, 1996, DEV MED CHILD NEUROL, V38, P25, DOI 10.1111/j.1469-8749.1996.tb15029.x; Hung WY, 2014, CONSCIOUS COGN, V24, P38, DOI 10.1016/j.concog.2013.12.009; Hupe JM, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00103; Jewanski J, 2020, J HIST NEUROSCI, V29, P175, DOI 10.1080/0964704X.2019.1636348; Jewanski J, 2009, J HIST NEUROSCI, V18, P293, DOI 10.1080/09647040802431946; Kadosh RC, 2008, NEUROPSYCHOLOGIA, V46, P2872, DOI 10.1016/j.neuropsychologia.2008.05.025; Kadosh RC, 2012, BRIT J PSYCHOL, V103, P20, DOI 10.1111/j.2044-8295.2010.02003.x; Levy AM, 2017, CONSCIOUS COGN, V56, P165, DOI 10.1016/j.concog.2017.09.003; Linson A, 2018, FRONT ROBOT AI, V5, DOI 10.3389/frobt.2018.00021; Mankin JL, 2016, COGNITION, V150, P1, DOI 10.1016/j.cognition.2016.01.007; Mattingley JB, 2006, CORTEX, V42, P213, DOI 10.1016/S0010-9452(08)70346-0; Mattingley JB, 2001, NATURE, V410, P580, DOI 10.1038/35069062; Meier B, 2009, NEUROPSYCHOLOGIA, V47, P1208, DOI 10.1016/j.neuropsychologia.2009.01.009; Melero H, 2014, NEUROIMAGE, V98, P416, DOI 10.1016/j.neuroimage.2014.05.019; Rich AN, 2006, NEUROPSYCHOLOGIA, V44, P2918, DOI 10.1016/j.neuropsychologia.2006.06.024; Rogowska A, 2011, REV GEN PSYCHOL, V15, P213, DOI 10.1037/a0024078; Root NB, 2018, CORTEX, V99, P375, DOI 10.1016/j.cortex.2017.12.003; Rothen N, 2013, J NEUROSCI METH, V215, P156, DOI 10.1016/j.jneumeth.2013.02.009; Rouw R, 2016, NEUROPSYCHOLOGIA, V88, P35, DOI 10.1016/j.neuropsychologia.2016.01.006; Sachs GTL., 1812, HISTORIAE NATURALIS; Scerri TS, 2010, EUR CHILD ADOLES PSY, V19, P179, DOI 10.1007/s00787-009-0081-0; Seth AK, 2014, COGN NEUROSCI-UK, V5, P97, DOI 10.1080/17588928.2013.877880; Shenhav A, 2013, NEURON, V79, P217, DOI 10.1016/j.neuron.2013.07.007; Simner J, 2006, PERCEPTION, V35, P1024, DOI 10.1068/p5469; Simner J, 2012, BRIT J PSYCHOL, V103, P1, DOI 10.1348/000712610X528305; Simner J, 2012, BRIT J PSYCHOL, V103, P24, DOI 10.1111/j.2044-8295.2011.02059.x; Stephan BB., 2005, 5 AM SYN ASS C HOUST; Terhune DB, 2013, COGNITION, V129, P123, DOI 10.1016/j.cognition.2013.06.009; Ward J, 2006, CORTEX, V42, P264, DOI 10.1016/S0010-9452(08)70352-6; Ward J, 2019, MEMORY, V27, P1299, DOI 10.1080/09658211.2019.1646771; Ward J, 2013, ANNU REV PSYCHOL, V64, P49, DOI 10.1146/annurev-psych-113011-143840; Wollen KA, 1983, J MENT IMAG, V7, P83	48	0	0	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2021	16	9							e0257713	10.1371/journal.pone.0257713	http://dx.doi.org/10.1371/journal.pone.0257713			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	YS4WS	34551015	gold, Green Published			2022-12-26	WOS:000750679800047
J	Lovasi, O; Lam, J; Schutzmann, R; Gaal, P				Lovasi, Orsolya; Lam, Judit; Schutzmann, Reka; Gaal, Peter			Acute Pain Service in Hungarian hospitals	PLOS ONE			English	Article							POSTOPERATIVE PAIN; POSTSURGICAL PAIN; MANAGEMENT; QUALITY; CARE; OUTCOMES; SURGERY; RELIEF; HEALTH	Background Surgical procedures play an increasing role among health technologies to treat diseases. Pain often accompanies such diseases, both as a result of their pathology, but also as the side-effect of the intervention itself, and it is not only a burdensome subjective feeling, but adversely affects the recovery process, can induce complications and increases treatment costs. Acute Pain Service Teams are becoming increasingly widespread in hospitals to address post-operative pain, yet we have so far no data on how many hospitals have actually adopted this technology in Hungary. Objectives The main objectives of our study were to assess the prevalence of Acute Pain Service Teams, map their structure and operation, as well as to understand the barriers and conducive factors of their establishment in Hungarian hospitals. Methods We carried out a survey among the 72 hospitals with surgical departments. The questionnaire was filled in by 52 providers, which gave us a response rate of 72.2%. Results Our results show, that only two of the responding hospitals have Acute Pain Service Teams albeit their structure and operation are in line with the literature. In the 50 hospitals without such teams, financing difficulties and human resources shortages are mentioned to be the most important obstacles of their establishment, but the lack of initiative and interest on the part of the specialities concerned are also an important barrier. Conclusions Lagging behind the more affluent EU member states, but similarly to other Central and Eastern European countries, Acute Pain Service has been hardly adopted by Hungarian hospitals. Hungarian health professionals know the technology and would support its wider introduction, if the technical feasibility barriers could be overcome. Health policy should play a more active role to facilitate change in this area, the investment in which promises a substantial return in terms of health gains and cost savings.	[Lovasi, Orsolya; Schutzmann, Reka] Semmelweis Univ, Sch PhD Studies, Budapest, Hungary; [Lam, Judit; Gaal, Peter] Semmelweis Univ, Hlth Serv Management Training Ctr, Budapest, Hungary	Semmelweis University; Semmelweis University	Lovasi, O (corresponding author), Semmelweis Univ, Sch PhD Studies, Budapest, Hungary.	lovasi.orsolya@gmail.com	Gaal, Peter/A-7818-2008	Gaal, Peter/0000-0002-6815-9021; Orsolya, Lovasi/0000-0002-6195-3097				Ahmed A, 2015, J PAK MED ASSOC, V65, P1164; Boezaart Andre P, 2013, F1000Prime Rep, V5, P54, DOI 10.12703/P5-54; Borracci T, 2016, BMC ANESTHESIOL, V16, DOI 10.1186/s12871-016-0179-0; Buckenmaier C, 2012, PAIN MED, V13, P919, DOI 10.1111/j.1526-4637.2012.01382.x; Castro AC, 2015, EUR J ANAESTH, V32, P277, DOI 10.1097/EJA.0000000000000182; Coluzzi F, 2015, EUR REV MED PHARMACO, V19, P4261; Darawad MW, 2014, PAIN MANAG NURS, V15, P116, DOI 10.1016/j.pmn.2012.07.005; Duncan F, 2014, PAIN MED, V15, P142, DOI 10.1111/pme.12284; Erlenwein J, 2016, EUR J PAIN, V20, P874, DOI 10.1002/ejp.812; Fang H, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178268; Gaal P, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d7657; Girasek E, 2017, BMC MED EDUC, V17, DOI 10.1186/s12909-017-1031-z; Girasek E, 2016, HUM RESOUR HEALTH, V14, DOI 10.1186/s12960-016-0139-2; Goldberg Stephen F, 2017, Adv Anesth, V35, P191, DOI 10.1016/j.aan.2017.07.010; Hayes K, 2015, ASSOC OPER ROOM NURS, V101, P328, DOI 10.1016/j.aorn.2014.11.019; Hungarian Medical Research Council, 2021, COD BIOETH; Jain Parmanand N, 2015, J Anaesthesiol Clin Pharmacol, V31, P554, DOI 10.4103/0970-9185.169088; Khalkhali Rad Tahereh, 2015, Glob J Health Sci, V7, P55, DOI 10.5539/gjhs.v7n7p55; Kinstner C, 2011, ANAESTHESIST, V60, P827, DOI 10.1007/s00101-011-1911-2; Kovacs R, 2017, HUM RESOUR HEALTH, V15, DOI 10.1186/s12960-017-0247-7; Kubricht V, 2017, BRATISL MED J, V118, P746, DOI 10.4149/BLL_2017_141; Le-Wendling L, 2017, TECH ORTHOP, V32, P200, DOI 10.1097/BTO.0000000000000245; Lee A, 2010, ANESTH ANALG, V111, P1042, DOI 10.1213/ANE.0b013e3181ed1317; Lovasi O, 2018, NOVER, V31, P35; Lovasi O, 2019, NOVER, V32, P15; Lovasi O, 2020, ORVOSI HETILAP, V161, P575, DOI 10.1556/650.2020.31680; Meara JG, 2015, LANCET, V386, P569, DOI 10.1016/S0140-6736(15)60160-X; Meissner W, 2008, DTSCH ARZTEBL INT, V105, P865, DOI 10.3238/arztebl.2008.0865; Meissner W, 2018, CURR MED RES OPIN, V34, P187, DOI 10.1080/03007995.2017.1391081; Milutinovic D, 2009, VOJNOSANIT PREGL, V66, P156, DOI 10.2298/VSP0902156M; Montes A, 2017, ACTA ANAESTH SCAND, V61, P480, DOI 10.1111/aas.12876; Nasir D, 2011, PAIN RES TREAT, V2011, DOI 10.1155/2011/934932; Nielsen PR, 2012, ACTA ANAESTH SCAND, V56, P686, DOI 10.1111/j.1399-6576.2012.02662.x; Petti E, 2018, J PERIANESTH NURS, V33, P767, DOI 10.1016/j.jopan.2018.07.010; Pogatzki-Zahn EM, 2015, SCHMERZ, V29, P503, DOI 10.1007/s00482-015-0039-8; Pozek John-Paul J, 2018, Anesthesiol Clin, V36, P295, DOI 10.1016/j.anclin.2018.01.007; Pozek JPJ, 2016, MED CLIN N AM, V100, P17, DOI 10.1016/j.mcna.2015.08.005; Raja SN, 2020, PAIN, V161, P1976, DOI 10.1097/j.pain.0000000000001939; Rockett M, 2017, ANAESTHESIA, V72, P1237, DOI 10.1111/anae.14007; Samolsky Dekel BG, 2018, EC ANAESTH, V4, P192, DOI [10.31080/ecan.2018.04.00086, DOI 10.31080/ECAN.2018.04.00086]; Sinatra R, 2010, PAIN MED, V11, P1859, DOI 10.1111/j.1526-4637.2010.00983.x; Stamer UM, 2002, REGION ANESTH PAIN M, V27, P125, DOI 10.1053/rapm.2002.29258; Szocska MK, 2005, BRIT MED J, V331, P231, DOI 10.1136/bmj.331.7510.231; Tawfic QA, 2015, PAIN MANAG, V5, P47, DOI [10.2217/pmt.14.48, 10.2217/PMT.14.48]; Tran DQ, 2018, ANESTH ANALG, V127, P808, DOI 10.1213/ANE.0000000000003367; van Boekel RLM, 2015, PAIN PRACT, V15, P447, DOI 10.1111/papr.12192; Webb Christopher A J, 2018, Anesthesiol Clin, V36, P333, DOI 10.1016/j.anclin.2018.04.005; Weiser TG, 2016, B WORLD HEALTH ORGAN, V94, P201, DOI 10.2471/BLT.15.159293; WHEATLEY RG, 1991, BRIT J ANAESTH, V67, P353, DOI 10.1093/bja/67.3.353; Zaccagnino MP, 2017, ANESTH ANALG, V125, P1394, DOI 10.1213/ANE.0000000000002165	50	0	0	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2021	16	9							e0257585	10.1371/journal.pone.0257585	http://dx.doi.org/10.1371/journal.pone.0257585			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YS4WS	34550982	gold, Green Published			2022-12-26	WOS:000750679800027
J	Maroteau, C; Espuela-Ortiz, A; Herrera-Luis, E; Srinivasan, S; Carr, F; Tavendale, R; Wilson, K; Hernandez-Pacheco, N; Chalmers, JD; Turner, S; Mukhopadhyay, S; Maitland-van der Zee, AH; Burchard, EG; Pino-Yanes, M; Young, S; Lassi, G; Platt, A; Palmer, CNA				Maroteau, Cyrielle; Espuela-Ortiz, Antonio; Herrera-Luis, Esther; Srinivasan, Sundararajan; Carr, Fiona; Tavendale, Roger; Wilson, Karen; Hernandez-Pacheco, Natalia; Chalmers, James D.; Turner, Steve; Mukhopadhyay, Somnath; Maitland-van der Zee, Anke-Hilse; Burchard, Esteban G.; Pino-Yanes, Maria; Young, Simon; Lassi, Glenda; Platt, Adam; Palmer, Colin N. A.		PiCA Consortium	LTA4H rs2660845 association with montelukast response in early and late-onset asthma	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; CHILDHOOD-ONSET; 17Q21 VARIANTS; LEUKOTRIENE; GENETICS; CHILDREN; RISK; PHARMACOGENOMICS; EXACERBATIONS; HETEROGENEITY	Leukotrienes play a central pathophysiological role in both paediatric and adult asthma. However, 35% to 78% of asthmatics do not respond to leukotriene inhibitors. In this study we tested the role of the LTA4H regulatory variant rs2660845 and age of asthma onset in response to montelukast in ethnically diverse populations. We identified and genotyped 3,594 asthma patients treated with montelukast (2,514 late-onset and 1,080 early-onset) from seven cohorts (UKBiobank, GoSHARE, BREATHE, Tayside RCT, PAGES, GALA II and SAGE). Individuals under montelukast treatment experiencing at least one exacerbation in a 12-month period were compared against individuals with no exacerbation, using logistic regression for each cohort and meta-analysis. While no significant association was found with European late-onset subjects, a meta-analysis of 523 early-onset individuals from European ancestry demonstrated the odds of experiencing asthma exacerbations by carriers of at least one G allele, despite montelukast treatment, were increased (odds-ratio = 2.92, 95%confidence interval (CI): 1.04-8.18, I2 = 62%, p = 0.0412) compared to those in the AA group. When meta-analysing with other ethnic groups, no significant increased risk of asthma exacerbations was found (OR = 1.60, 95% CI: 0.61-4.19, I2 = 85%, p = 0.342). Our study demonstrates that genetic variation in LTA4H, together with timing of asthma onset, may contribute to variability in montelukast response. European individuals with early-onset (<= 18y) carrying at least one copy of rs2660845 have increased odd of exacerbation under montelukast treatment, presumably due to the up-regulation of LTA4H activity. These findings support a precision medicine approach for the treatment of asthma with montelukast.	[Maroteau, Cyrielle] AstraZeneca, Discovery Sci, BioPharmaceut R&D, Ctr Genom Res, Cambridge, England; [Maroteau, Cyrielle; Srinivasan, Sundararajan; Carr, Fiona; Tavendale, Roger; Wilson, Karen; Palmer, Colin N. A.] Univ Dundee, Sch Med, Div Populat Hlth & Genom, Dundee, Scotland; [Espuela-Ortiz, Antonio; Herrera-Luis, Esther; Hernandez-Pacheco, Natalia; Pino-Yanes, Maria] Univ La Laguna, Dept Biochem Microbiol Cell Biol & Genet, Genom & Hlth Grp, San Cristobal De Laguna, Santa Cruz De T, Spain; [Hernandez-Pacheco, Natalia] Univ La Laguna, Hosp Univ NS Candelaria, Res Unit, San Cristobal De Laguna, Spain; [Chalmers, James D.] Univ Dundee, Sch Med, Div Mol & Clin Med, Dundee, Scotland; [Turner, Steve] Univ Aberdeen, Child Hlth, Aberdeen, Scotland; [Mukhopadhyay, Somnath] Royal Alexandra Childrens Hosp, Acad Dept Pediat, Brighton & Sussex Med Sch, Brighton, E Sussex, England; [Maitland-van der Zee, Anke-Hilse] Univ Utrecht, Div Pharmacoepidemiol & Clin Pharmacol, Utrecht, Netherlands; [Maitland-van der Zee, Anke-Hilse] Univ Amsterdam, Acad Med Ctr, Dept Resp Med, Amsterdam, Netherlands; [Maitland-van der Zee, Anke-Hilse] Univ Amsterdam, Emmas Children Hosp, Acad Med Ctr AMC, Dept Pediat Resp Med & Allergy, Amsterdam, Netherlands; [Burchard, Esteban G.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Burchard, Esteban G.] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94143 USA; [Pino-Yanes, Maria] Inst Salud Carlos III, Comunidad Madrid, CIBER Enfermedades Resp, Madrid, Spain; [Pino-Yanes, Maria] Univ La Laguna, Inst Tecnol Biomed ITB, San Cristobal De Laguna, Santa Cruz De T, Spain; [Young, Simon] AstraZeneca, Oncol R&D, BioPharmaceut Precis Med, Cambridge, England; [Young, Simon] Sysmex, Res & Dev Ctr, Cambridge, England; [Lassi, Glenda; Platt, Adam] AstraZeneca, Translat Sci & Expt Med, BioPharmaceut R&D, Resp & Immunol,Res & Early Dev, Cambridge, England	AstraZeneca; University of Dundee; Universidad de la Laguna; Universidad de la Laguna; University of Dundee; University of Aberdeen; University of Brighton; University of Sussex; Utrecht University; University of Amsterdam; Academic Medical Center Amsterdam; Emma Children's Hospital; University of Amsterdam; Academic Medical Center Amsterdam; University of California System; University of California San Francisco; University of California System; University of California San Francisco; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Instituto de Salud Carlos III; Universidad de la Laguna; AstraZeneca; AstraZeneca	Maroteau, C (corresponding author), AstraZeneca, Discovery Sci, BioPharmaceut R&D, Ctr Genom Res, Cambridge, England.; Maroteau, C (corresponding author), Univ Dundee, Sch Med, Div Populat Hlth & Genom, Dundee, Scotland.	c.maroteau@dundee.ac.uk	Turner, Stephen/GXM-4654-2022; Palmer, Colin NA/C-7053-2008; Hernandez-Pacheco, Natalia/AAY-2619-2020; Herrera-Luis, Esther/AAY-2315-2020; Maitland-van der Zee, Anke/I-9572-2016	Palmer, Colin NA/0000-0002-6415-6560; Hernandez-Pacheco, Natalia/0000-0002-6313-1847; Espuela-Ortiz, Antonio/0000-0003-0572-9549; Herrera-Luis, Esther/0000-0003-4150-5454; Srinivasan, Sundararajan/0000-0002-3387-9889; Maitland-van der Zee, Anke/0000-0002-0414-3442; Turner, Steve/0000-0001-8393-5060	Scottish Enterprise Tayside; Gannochy trust; Perth and Kinross City Council; Brighton and Sussex Medical School; Merck, Sharpe & Dohme, United Kingdom; Chief Scientist Officer for Scotland; NHS Research Scotland; Wellcome Trust Biomedical Resource [099177/Z/12/Z]; Wellcome Trust [072960, 084726]; UK Medical Research Council [G0601261]; Instituto de Salud Carlos III (ISCIII) through Strategic Action for Health Research (AES) [AC15/00015]; European Community (EC) within the Active and Assisted Living (AAL); SysPharmPedia grant; ZonMW [9003035001]; Ministry of Education, Science and Sport of the Republic of Slovenia [C330-16-500106]; German Ministry of Education and Research (BMBF) [FKZ 031L0088]; Instituto de Salud Carlos III (ISCIII) through Strategic Action for Health Research (AES); European Community (EC) within the Active and Assisted Living (AAL) Programme [AC15/00015, AC15/00058]; PE I+D+i 2013-2016 - ISCIII [PT17/0019]; European Regional Development Fund (ERDF); NHLBI of the United States National Institutes of Health (NIH) [R01HL117004, X01HL134589]; Sandler Family Foundation; American Asthma Foundation; Amos Medical Faculty Development Program from the Robert Wood Johnson Foundation; Harry Wm. and Diana V. Hind Distinguished Professorship in Pharmaceutical Sciences II; National Institute of Environmental Health Sciences (NIEHS) [R01ES015794]; NHLBI [R01HL128439, R01HL135156, R01HL141992, R01HL141845]; NIEHS [R21ES24844]; National Institute on Minority Healthand Health Disparities (NIMHD) [P60MD006902, R01MD010443, R56MD013312]; National Institute of General Medical Sciences (NIGMS) [RL5GM118984]; Tobacco-Related Disease Research Program [24RT-0025, 27IR-0030]; National Human Genome Research Institute (NHGRI) [U01HG009080]; AstraZeneca; Spanish Ministry of Science, Innovation and Universities [PRE2018-083837]; Ramon y Cajal Program by the Spanish Ministry of Economy, Industry and Competitiveness [RYC-2015-17205]; Instituto de Salud Carlos III (ISCIII) [FI16/00136]; European Social Funds from the European Union (ESF) "ESF invests in your future"	Scottish Enterprise Tayside; Gannochy trust; Perth and Kinross City Council; Brighton and Sussex Medical School; Merck, Sharpe & Dohme, United Kingdom; Chief Scientist Officer for Scotland; NHS Research Scotland; Wellcome Trust Biomedical Resource(Wellcome Trust); Wellcome Trust(Wellcome TrustEuropean Commission); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Instituto de Salud Carlos III (ISCIII) through Strategic Action for Health Research (AES); European Community (EC) within the Active and Assisted Living (AAL); SysPharmPedia grant; ZonMW(Netherlands Organization for Health Research and Development); Ministry of Education, Science and Sport of the Republic of Slovenia; German Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Instituto de Salud Carlos III (ISCIII) through Strategic Action for Health Research (AES); European Community (EC) within the Active and Assisted Living (AAL) Programme; PE I+D+i 2013-2016 - ISCIII; European Regional Development Fund (ERDF)(European Commission); NHLBI of the United States National Institutes of Health (NIH); Sandler Family Foundation; American Asthma Foundation; Amos Medical Faculty Development Program from the Robert Wood Johnson Foundation; Harry Wm. and Diana V. Hind Distinguished Professorship in Pharmaceutical Sciences II; National Institute of Environmental Health Sciences (NIEHS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Institute on Minority Healthand Health Disparities (NIMHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); National Institute of General Medical Sciences (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Tobacco-Related Disease Research Program(University of California System); National Human Genome Research Institute (NHGRI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); AstraZeneca(AstraZeneca); Spanish Ministry of Science, Innovation and Universities(Spanish Government); Ramon y Cajal Program by the Spanish Ministry of Economy, Industry and Competitiveness; Instituto de Salud Carlos III (ISCIII)(Instituto de Salud Carlos IIIEuropean Commission); European Social Funds from the European Union (ESF) "ESF invests in your future"	The UKBB was accessed through AZ's MTA (application number 26041). BREATHE was funded by Scottish Enterprise Tayside, the Gannochy trust, the Perth and Kinross City Council and Brighton and Sussex Medical School. Tayside RCT is supported by Merck, Sharpe & Dohme, United Kingdom. PAGES was funded by the Chief Scientist Officer for Scotland. The SHARE Bioresource (GoSHARE) and SHARE have ongoing funding from NHS Research Scotland and established by funding from The Wellcome Trust Biomedical Resource [Grant No. 099177/Z/12/Z]. The GoDARTS study was funded by The Wellcome Trust (Award 072960 and 084726) and the UK Medical Research Council (Award G0601261). Genotyping of PAGES was funded by grant AC15/00015 by Instituto de Salud Carlos III (ISCIII) through Strategic Action for Health Research (AES) and European Community (EC) within the Active and Assisted Living (AAL) Programmed framework, and by the SysPharmPedia grant. The SysPharmPediA consortium is supported by ZonMW [project number: 9003035001], the Ministry of Education, Science and Sport of the Republic of Slovenia [contract number C330-16-500106], the German Ministry of Education and Research (BMBF) [project number FKZ 031L0088], Instituto de Salud Carlos III (ISCIII) through Strategic Action for Health Research (AES) and European Community (EC) within the Active and Assisted Living (AAL) Programme framework [award numbers AC15/00015 and AC15/00058] under the frame of the ERACoSysMed JTC-1 Call. Genotyping service was carried out at CEGEN-PRB3-ISCIII; supported by grant PT17/0019, of the PE I+D+i 2013-2016, funded by ISCIII and European Regional Development Fund (ERDF). GALA II and SAGE were supported by the NHLBI of the United States National Institutes of Health (NIH) through grants R01HL117004 and X01HL134589. Additional study enrolment was supported by the Sandler Family Foundation, the American Asthma Foundation, the Amos Medical Faculty Development Program from the Robert Wood Johnson Foundation, the Harry Wm. and Diana V. Hind Distinguished Professorship in Pharmaceutical Sciences II, and the National Institute of Environmental Health Sciences (NIEHS) grant R01ES015794. The generation, cleaning, quality control, and analysis of GALA II and SAGE data was funded by the NHLBI grants R01HL128439, R01HL135156, R01HL141992, and R01HL141845; the NIEHS grant R21ES24844; the National Institute on Minority Healthand Health Disparities (NIMHD) P60MD006902, R01MD010443, and R56MD013312; the National Institute of General Medical Sciences (NIGMS) grant RL5GM118984; the Tobacco-Related Disease Research Program under Award Numbers 24RT-0025 and 27IR-0030; and the National Human Genome Research Institute (NHGRI) U01HG009080 to EGB. CM is supported by an AstraZeneca postdoctoral fellowship. SY, GL and AP are employees of AstraZeneca and may own stock or stock options. EH-L is supported by a fellowship (PRE2018-083837) from the Spanish Ministry of Science, Innovation and Universities. MP-Y is funded by the Ramon y Cajal Program by the Spanish Ministry of Economy, Industry and Competitiveness (RYC-2015-17205). N.H-P was supported by a fellowship (FI16/00136) from Instituto de Salud Carlos III (ISCIII) and co-funded by the European Social Funds from the European Union (ESF) "ESF invests in your future".	Almomani B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060592; [Anonymous], 2011, VERS SAS 9 3 COMP SO; [Anonymous], 2019, GUID MAN ASTHM 2019; [Anonymous], 2018, GLOBAL ASTHMA REPORT; [Anonymous], 2017, 80 CEJNG HLTH NIF; Ardlie KG, 2015, SCIENCE, V348, P648, DOI 10.1126/science.1262110; Bouzigon E, 2008, NEW ENGL J MED, V359, P1985, DOI 10.1056/NEJMoa0806604; Bush Andrew, 2009, Proc Am Thorac Soc, V6, P712, DOI 10.1513/pats.200906-046DP; BUSSE W, 1995, AM J RESP CRIT CARE, V151, P1635, DOI 10.1164/ajrccm.151.5.7735626; Dijk FN, 2013, CURR OPIN ALLERGY CL, V13, P193, DOI 10.1097/ACI.0b013e32835eb707; Drake KA, 2008, PHARMACOGENOMICS, V9, P453, DOI 10.2217/14622416.9.4.453; Evans DJ, 1996, THORAX, V51, P1178, DOI 10.1136/thx.51.12.1178; Farzan N, 2018, PEDIATR PULM, V53, P836, DOI 10.1002/ppul.23976; Farzan N, 2017, PHARMACOGENOMICS, V18, P931, DOI 10.2217/pgs-2017-0035; Holloway JW, 2008, ALLERGY, V63, P1046, DOI 10.1111/j.1398-9995.2008.01667.x; Holloway JW, 2010, J ALLERGY CLIN IMMUN, V126, P200, DOI 10.1016/j.jaci.2010.06.006; Islam SA, 2006, BLOOD, V107, P444, DOI 10.1182/blood-2005-06-2362; Karczewski KJ., 2019, BIORXIV, DOI [DOI 10.1101/531210, 10.1101/531210]; Kotani H, 2012, J CLIN PHARM THER, V37, P112, DOI 10.1111/j.1365-2710.2011.01248.x; Kuruvilla ME, 2019, CLIN REV ALLERG IMMU, V56, P219, DOI 10.1007/s12016-018-8712-1; Lima JJ, 2006, AM J RESP CRIT CARE, V173, P379, DOI 10.1164/rccm.200509-1412OC; Lima JJ, 2007, MOL DIAGN THER, V11, P97, DOI 10.1007/BF03256228; Lima JJ, 2009, CURR OPIN PULM MED, V15, P57, DOI 10.1097/MCP.0b013e32831da8be; Lipworth BJ, 2013, CLIN SCI, V124, P521, DOI 10.1042/CS20120528; Malmstrom K, 1999, ANN INTERN MED, V130, P487, DOI 10.7326/0003-4819-130-6-199903160-00005; McKinstry B, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-013351; Montuschi P, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-119; Nishimura KK, 2013, AM J RESP CRIT CARE, V188, P309, DOI 10.1164/rccm.201302-0264OC; Ollier W, 2005, PHARMACOGENOMICS, V6, P639, DOI 10.2217/14622416.6.6.639; Palmer CNA, 2006, THORAX, V61, P940, DOI 10.1136/thx.2006.059386; Pino-Yanes M, 2015, J ALLERGY CLIN IMMUN, V135, P1502, DOI 10.1016/j.jaci.2014.10.033; Pividori M, 2019, LANCET RESP MED, V7, P509, DOI 10.1016/S2213-2600(19)30055-4; PURCELL S, 2003, BIOINFORMATICS, V19, P149, DOI [DOI 10.1093/BIOINFORMATICS/19.1.149, 10.1093/bioinformatics/19.1.149]; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rao NL, 2010, AM J RESP CRIT CARE, V181, P899, DOI 10.1164/rccm.200807-1158OC; Reddel HK, 2009, AM J RESP CRIT CARE, V180, P59, DOI 10.1164/rccm.200801-060ST; Sampson AP, 2000, THORAX, V55, pS28, DOI 10.1136/thorax.55.suppl_2.S28; SAMPSON AP, 1995, ARCH DIS CHILD, V73, P221, DOI 10.1136/adc.73.3.221; Sarnowski C, 2016, J ALLERGY CLIN IMMUN, V138, P1071, DOI 10.1016/j.jaci.2016.03.018; SHINDO K, 1995, EUR RESPIR J, V8, P605; Smit LAM, 2010, EUR RESPIR J, V36, P57, DOI 10.1183/09031936.00154509; Tiotiu Angelica, 2018, Asthma Res Pract, V4, P10, DOI 10.1186/s40733-018-0047-4; Torgerson DG, 2011, NAT GENET, V43, P887, DOI 10.1038/ng.888; Tulah AS, 2012, BMC MED GENET, V13, DOI 10.1186/1471-2350-13-110; Turner SW, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-107; Via M, 2010, CLIN EXP ALLERGY, V40, P582, DOI 10.1111/j.1365-2222.2009.03438.x; Viechtbauer W, 2010, J STAT SOFTW, V36, P1, DOI 10.18637/jss.v036.i03; Vijverberg SJH, 2018, EXPERT REV RESP MED, V12, P55, DOI 10.1080/17476348.2018.1403318; Wahn U, 2008, CLIN THER, V30, P1026, DOI 10.1016/j.clinthera.2008.05.018; Wenzel SE, 1997, PHARMACOTHERAPY, V17, pS3; Zeng B, 2018, UNRAVELING POLYGENIC; Zhernakova DV, 2017, NAT GENET, V49, P139, DOI 10.1038/ng.3737; Zhu ZZ, 2021, J ALLERGY CLIN IMMUN, V147, P796, DOI 10.1016/j.jaci.2020.07.004; Zhu ZZ, 2018, NAT GENET, V50, P857, DOI 10.1038/s41588-018-0121-0	54	3	3	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2021	16	9							e0257396	10.1371/journal.pone.0257396	http://dx.doi.org/10.1371/journal.pone.0257396			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YS4WS	34550981	Green Published, Green Submitted, Green Accepted, gold			2022-12-26	WOS:000750679800018
J	Johnson, EG; Dichiera, A; Goldberg, D; Swenarton, M; Gelsleichter, J				Johnson, Eric G.; Dichiera, Angelina; Goldberg, Danielle; Swenarton, MaryKate; Gelsleichter, James			Total mercury concentrations in invasive lionfish (Pterois volitans/miles) from the Atlantic coast of Florida	PLOS ONE			English	Article							INDO-PACIFIC LIONFISH; GULF-OF-MEXICO; STABLE-ISOTOPES; TRACE-ELEMENTS; HEAVY-METALS; MARINE FISH; FOOD-WEB; METHYLMERCURY; TISSUES; MUSCLE	Invasive lionfish (Pterois volitans/miles) pose a serious threat to marine ecosystems throughout the western Atlantic Ocean and Caribbean Sea. The development of a fishery for lionfish has been proposed as a strategy for controlling populations; however, there is concern about consumption of this species by humans due to its high trophic position and potential for bioaccumulation of mercury. We analyzed total mercury (THg) in tissues of lionfish from two locations on the east coast of Florida. THg in lionfish increased with size and differed by location and sex. THg was highest in muscle tissue and was strongly positively correlated among tissues. THg in lionfish was lower than other commonly consumed marine fishes, and falls into Florida's least restrictive advisory level. Consumption of lionfish poses a low risk and concerns over mercury bioaccumulation should not present a significant barrier to lionfish harvest.	[Johnson, Eric G.; Dichiera, Angelina; Goldberg, Danielle; Swenarton, MaryKate; Gelsleichter, James] Univ North Florida, Dept Biol, Jacksonville, FL 32224 USA; [Dichiera, Angelina] Univ Texas Austin, Marine Sci Inst, Port Aransas, TX USA; [Goldberg, Danielle] Univ N Carolina, Dept Biol & Marine Biol, Wilmington, NC USA; [Swenarton, MaryKate] US Fish & Wildlife Serv, Anchorage Fish & Wildlife Conservat Off, Anchorage, AK USA	State University System of Florida; University of North Florida; University of Texas System; University of Texas Austin; University of North Carolina; University of North Carolina Wilmington; United States Department of the Interior; US Fish & Wildlife Service	Johnson, EG (corresponding author), Univ North Florida, Dept Biol, Jacksonville, FL 32224 USA.	eric.johnson@unf.edu		Dichiera, Angelina/0000-0002-9635-0229	National Science Foundation Research Experiences for Undergraduates Program (REU -For Students \ NSF -National Science Foundation) [OCE1156659]; West Marine Marine Conservation Grant Program (Blue Future Grants \West Marine); University of North Florida Dean's Leadership Council Faculty Fellowship Program (UNF -College of Arts & Sciences -Dean's Leadership Council Faculty Fellowship Awards); UNF Department of Biology (UNF -COAS: Biology -Biology Home); UNF Coastal Biology Flagship Program (UNF COAS: Biology); Guy Harvey Ocean Foundation	National Science Foundation Research Experiences for Undergraduates Program (REU -For Students \ NSF -National Science Foundation); West Marine Marine Conservation Grant Program (Blue Future Grants \West Marine); University of North Florida Dean's Leadership Council Faculty Fellowship Program (UNF -College of Arts & Sciences -Dean's Leadership Council Faculty Fellowship Awards); UNF Department of Biology (UNF -COAS: Biology -Biology Home); UNF Coastal Biology Flagship Program (UNF COAS: Biology); Guy Harvey Ocean Foundation	This work was supported by grants from the National Science Foundation Research Experiences for Undergraduates Program (OCE1156659; REU -For Students broken vertical bar NSF -National Science Foundation) to JG, the West Marine Marine Conservation Grant Program (Blue Future Grants broken vertical bar West Marine) and University of North Florida Dean's Leadership Council Faculty Fellowship Program (UNF -College of Arts & Sciences -Dean's Leadership Council Faculty Fellowship Awards) to EGJ, the UNF Department of Biology (UNF -COAS: Biology -Biology Home) and UNF Coastal Biology Flagship Program (UNF COAS: Biology -about) to AD, and the Guy Harvey Ocean Foundation to MKS. The results and interpretations of this work are those of the authors and do not represent the official views of the NSF, West Marine, UNF or GHOF. The funders had and will not have a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams D, 2003, TR9 FLOR MAR RES I; Adams DH, 2005, MAR POLLUT BULL, V50, P291, DOI 10.1016/j.marpolbul.2004.10.049; Adams DH, 2013, ENVIRON RES, V126, P254, DOI 10.1016/j.envres.2013.05.010; Adams DH, 2010, SCI TOTAL ENVIRON, V408, P5808, DOI 10.1016/j.scitotenv.2010.08.019; Agusa T, 2007, ENVIRON POLLUT, V145, P766, DOI 10.1016/j.envpol.2006.04.034; Ahrenholz DW, 2010, ENVIRON BIOL FISH, V88, P305, DOI 10.1007/s10641-010-9647-4; Albins MA, 2008, MAR ECOL PROG SER, V367, P233, DOI 10.3354/meps07620; Alvarez S, 2012, B ENVIRON CONTAM TOX, V89, P836, DOI 10.1007/s00128-012-0782-9; Barbour AB, 2010, MAR ECOL PROG SER, V401, P291, DOI 10.3354/meps08373; Berg V, 2000, J ENVIRON MONITOR, V2, P375, DOI 10.1039/b002784g; Nevado JJB, 2011, ARCH ENVIRON CON TOX, V61, P642, DOI 10.1007/s00244-011-9666-y; BLOOM NS, 1992, CAN J FISH AQUAT SCI, V49, P1010, DOI 10.1139/f92-113; Buddo DSA, 2012, GULF CARIBBEAN FISHE, V1, P72; Burger J, 2013, SCI TOTAL ENVIRON, V443, P278, DOI 10.1016/j.scitotenv.2012.10.040; Chagaris D, 2017, FISHERIES, V42, P421, DOI 10.1080/03632415.2017.1340273; Chen CY, 2009, ENVIRON SCI TECHNOL, V43, P1804, DOI 10.1021/es8017122; Cizdziel J, 2003, J ENVIRON MONITOR, V5, P802, DOI 10.1039/b307641p; Claydon JAB, 2012, MAR ECOL PROG SER, V448, P119, DOI 10.3354/meps09534; Cote IM, 2013, MAR ECOL PROG SER, V472, P249, DOI 10.3354/meps09992; Crump KL, 2009, ENVIRON TOXICOL CHEM, V28, P895, DOI 10.1897/08-151.1; Cure K, 2014, MAR ECOL PROG SER, V506, P243, DOI 10.3354/meps10789; Dahl KA, 2016, MAR ECOL PROG SER, V558, P207, DOI 10.3354/meps11898; Dahl KA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105852; DAY RW, 1989, ECOL MONOGR, V59, P433, DOI 10.2307/1943075; Depew DC, 2012, ENVIRON TOXICOL CHEM, V31, P1536, DOI 10.1002/etc.1859; Driscoll CT, 2012, ENVIRON RES, V119, P118, DOI 10.1016/j.envres.2012.05.002; Edwards MA, 2014, B MAR SCI, V90, P953, DOI 10.5343/bms.2014.1022; Arias-Gonzalez JE, 2011, ENVIRON RES, V111, P917, DOI 10.1016/j.envres.2011.07.008; Evans DW, 2005, B MAR SCI, V77, P321; FDOH (Florida Department of Health), 2014, FLOR FISH ADV; Fincell Mark J., 2013, Prairie Naturalist, V45, P100; Fogg AQ, 2019, FISH B-NOAA, V117, P125, DOI 10.7755/FB.117.3.1; Frazer TK, 2012, REV FISH SCI, V20, P185, DOI 10.1080/10641262.2012.700655; Freshwater DW, 2009, MAR BIOL, V156, P1213, DOI 10.1007/s00227-009-1163-8; Fung LAH, 2013, FOOD CHEM TOXICOL, V60, P205, DOI 10.1016/j.fct.2013.07.044; Gomez Lozano R, 2013, REGIONAL STRATEGY CO, P1; Green SJ, 2009, CORAL REEFS, V28, P107, DOI 10.1007/s00338-008-0446-8; GREENHOUSE SW, 1959, PSYCHOMETRIKA, V24, P95, DOI 10.1007/BF02289823; GRIEB TM, 1990, ENVIRON TOXICOL CHEM, V9, P919, DOI [10.1897/1552-8618(1990)9[919:FAMAIF]2.0.CO;2, 10.1002/etc.5620090710]; Hackerott S, 2017, PEERJ, V5, DOI 10.7717/peerj.3270; Hamner RM, 2007, J FISH BIOL, V71, P214, DOI 10.1111/j.1095-8649.2007.01575.x; Harley J, 2015, POLAR BIOL, V38, P1535, DOI 10.1007/s00300-015-1716-x; Harms-Tuohy CA, 2018, MANAG BIOL INVASION, V9, P149, DOI 10.3391/mbi.2018.9.2.08; Harris HE, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-58886-8; Harris HE, 2019, FISH RES, V213, P22, DOI 10.1016/j.fishres.2019.01.002; Havelkova M, 2008, SENSORS-BASEL, V8, P4095, DOI 10.3390/s8074095; HOLM S, 1979, SCAND J STAT, V6, P65; HOOD PB, 1994, B MAR SCI, V54, P24; Houserova P, 2006, VET MED-CZECH, V51, P101, DOI 10.17221/5527-VETMED; Huge DH, 2014, MAR POLLUT BULL, V78, P51, DOI 10.1016/j.marpolbul.2013.11.019; Johnson EG, 2016, PEERJ, V4, DOI 10.7717/peerj.2730; Johnston MW, 2017, CORAL REEFS, V36, P169, DOI 10.1007/s00338-016-1511-3; Joiris CR, 2000, MAR POLLUT BULL, V40, P454, DOI 10.1016/S0025-326X(00)00013-8; Jud ZR, 2015, ENVIRON BIOL FISH, V98, P135, DOI 10.1007/s10641-014-0242-y; Karagas MR, 2012, ENVIRON HEALTH PERSP, V120, P799, DOI 10.1289/ehp.1104494; Karouna-Renier NK, 2011, MAR ENVIRON RES, V72, P96, DOI 10.1016/j.marenvres.2011.06.003; Khoshnamvand M, 2013, CHEMOSPHERE, V90, P1236, DOI 10.1016/j.chemosphere.2012.09.061; Kruzikova K, 2013, INT J ELECTROCHEM SC, V8, P45; Layman CA, 2012, MAR ECOL PROG SER, V448, P131, DOI 10.3354/meps09511; Lee CS, 2016, LIMNOL OCEANOGR, V61, P1626, DOI 10.1002/lno.10318; Lombardi-Carlson LA, 2009, US SE NAT, V7, P651; Luoma SN, 2005, ENVIRON SCI TECHNOL, V39, P1921, DOI 10.1021/es048947e; Martins I, 2006, MAR ECOL PROG SER, V320, P253, DOI 10.3354/meps320253; Mergler D, 2007, AMBIO, V36, P3, DOI 10.1579/0044-7447(2007)36[3:MEAHEI]2.0.CO;2; Mieiro CL, 2009, J ENVIRON MONITOR, V11, P1004, DOI 10.1039/b821253h; Morris J.A., 2009, NOAA TECH MEMO NOS N, V99, P1; Morris J. A. Jr., 2011, AACL Bioflux, V4, P21; Morris J.A. Jr., 2012, INVASIVE LIONFISH GU, V1; Mumby PJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021510; Munoz RC, 2011, MAR ECOL PROG SER, V432, P181, DOI 10.3354/meps09154; NRC, 2000, TOXICOLOGICAL EFFECT; Peake J, 2018, BIOL INVASIONS, V20, P2567, DOI 10.1007/s10530-018-1720-5; Peiffer F, 2017, PEERJ, V5, DOI 10.7717/peerj.3818; Pimentel D, 2005, ECOL ECON, V52, P273, DOI 10.1016/j.ecolecon.2004.10.002; Ratcliffe HE, 1996, J TOXICOL ENV HEALTH, V49, P221, DOI 10.1080/009841096160817; Ritger AL, 2018, MAR POLLUT BULL, V131, P38, DOI 10.1016/j.marpolbul.2018.03.035; Schofield Pamela J., 2009, Aquatic Invasions, V4, P473; Schofield PJ, 2016 USGS NONINDIGEN; Sikkel PC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095854; Simberloff D, 2013, TRENDS ECOL EVOL, V28, P58, DOI 10.1016/j.tree.2012.07.013; Sluis MZ, 2013, ENVIRON TOXICOL CHEM, V32, P434, DOI 10.1002/etc.2077; Sparling R, 2009, NAT GEOSCI, V2, P92, DOI 10.1038/ngeo428; Squadrone S, 2013, CHEMOSPHERE, V90, P358, DOI 10.1016/j.chemosphere.2012.07.028; Sweet LI, 2001, J TOXICOL ENV HEAL B, V4, P161, DOI 10.1080/109374001300339809; Swenarton MK, 2016, THESIS U N FLORIDA; Tremain DM, 2014, B MAR SCI, V90, P565, DOI 10.5343/bms.2013.1025; Tremain DM, 2012, T AM FISH SOC, V141, P1274, DOI 10.1080/00028487.2012.683232; U.S. EPA, 2001, 22967926 US EPA CASR; Usseglio P, 2017, PEERJ, V5, DOI 10.7717/peerj.3043; Verdouw JJ, 2011, WATER AIR SOIL POLL, V214, P297, DOI 10.1007/s11270-010-0424-y; Wagemann R, 1997, ENVIRON TOXICOL CHEM, V16, P1859, DOI 10.1002/etc.5620160914; Wang WX, 2012, AD ENVIRON RES, V1, P15, DOI 10.12989/aer.2012.1.1.015; Wang Y, 2014, SCI TOTAL ENVIRON, V487, P557, DOI 10.1016/j.scitotenv.2014.04.060; Weis JS, 2009, J ENVIRON SCI HEAL C, V27, P212, DOI 10.1080/10590500903310088; Wilcox CL, 2018, J HERED, V109, P162, DOI DOI 10.1093/jhered/esx056; WILCOX RR, 1987, BRIT J MATH STAT PSY, V40, P80, DOI 10.1111/j.2044-8317.1987.tb00869.x	96	0	0	3	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2021	16	9							e0234534	10.1371/journal.pone.0234534	http://dx.doi.org/10.1371/journal.pone.0234534			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YM4DR	34547024	Green Published, Green Submitted, gold			2022-12-26	WOS:000746527400001
J	Shrestha, K; Gilkerson, JR; Stevenson, MA; Flash, ML				Shrestha, Kshitiz; Gilkerson, James R.; Stevenson, Mark A.; Flash, Meredith L.			Drivers of exit and outcomes for Thoroughbred racehorses participating in the 2017-2018 Australian racing season	PLOS ONE			English	Article							RISK-FACTORS; INDUSTRY	The destinations of Thoroughbred (TB) racehorses exiting the racing industry is a high-profile issue with ethical and welfare implications of interest to both animal welfare groups and racing regulators. This cross-sectional study investigated the reasons that TBs temporarily or permanently exited racing and training in Australia in the 2017-2018 racing season and the outcomes for these horses post-racing. An online questionnaire was sent to the last registered trainers of a representative sample of 2,509 'inactive' TBs. Inactive horses were defined as those horses that were recorded as 'active' but had not trialled or raced in the last 6 months of the racing season or had an inactive status recorded in the Racing Australia database. Of the 1,750 responses received, the largest group of inactive TBs had permanently exited the racing industry (45% retired, 5.3% deceased). A relatively large group exited racing temporarily (43%) but participated in the racing industry in the following season. The reasons for retirement were predominantly voluntary, such as poor performance or owner's request. Almost one third of retirements were due to injuries with tendon or ligament problems the most frequently conditions listed. The median age at retirement was five (Q1 4; Q3 7) years. Extrapolation of the survey results to the population of horses racing or training in Australia in 2017-2018 (n = 37,750) show that that 17% of the population retire each year and 2.1% die. These estimates provide benchmarks for industry and animal welfare organisations to resource and measure the effectiveness of interventions.	[Shrestha, Kshitiz; Gilkerson, James R.; Stevenson, Mark A.; Flash, Meredith L.] Univ Melbourne, Fac Vet & Agr Sci, Asia Pacific Ctr Anim Hlth, Parkville, Vic, Australia	University of Melbourne	Flash, ML (corresponding author), Univ Melbourne, Fac Vet & Agr Sci, Asia Pacific Ctr Anim Hlth, Parkville, Vic, Australia.	meredith.flash@unimelb.edu.au	Shrestha, Kshitiz/ABX-1236-2022	Gilkerson, James/0000-0003-1801-4817; Flash, Meredith/0000-0002-5120-8632; Shrestha, Kshitiz/0000-0003-4822-7514	AgriFutures Australia, as part of the AgriFuturesT Thoroughbred Horses Program [PRJ-011271]	AgriFutures Australia, as part of the AgriFuturesT Thoroughbred Horses Program	This study was supported by AgriFutures Australia, as part of the AgriFuturesT Thoroughbred Horses Program (https://www.agrifutures.com.au), in the form of a grant awarded to MLF, JRG and MAS (PRJ-011271). The funders had no role in study design, data collection and analysis or preparation of the manuscript.	[Anonymous], 2016, ANN REP 2016; [Anonymous], 2004, J STAT SOFTW, V9; Bailey CJ, 1997, AUST VET J, V75, P64, DOI 10.1111/j.1751-0813.1997.tb13836.x; Boden LA, 2007, EQUINE VET J, V39, P430, DOI 10.2746/042516407X183162; Bourke J., 1995, P ANN SEM EQ BRANCH, P107; FEINSINGER P, 1981, ECOLOGY, V62, P27, DOI 10.2307/1936664; Flash ML, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0241273; Flash ML, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0237003; Gambino J., 2005, FUNCTIONS PPS SAMPLI; Gemmell N., 2017, WEEKEND AUSTR; Gunningham N, 2004, LAW SOCIAL INQUIRY, V29, P307, DOI 10.1086/423681; Harris Rob, 2020, SYDNEY MORNING HERAL; Hill AE, 2001, J AM VET MED ASSOC, V218, P1136, DOI 10.2460/javma.2001.218.1136; International Federation of Horseracing Authorities, 2014, IFHA ANN REP 2014; Kulldorff M, 1997, COMMUN STAT-THEOR M, V26, P1481, DOI 10.1080/03610929708831995; Lynch M., 2019, SYDNEY MORNING HERAL; Perkins NR, 2005, NEW ZEAL VET J, V53, P69, DOI 10.1080/00480169.2005.36471; Pfeiffer DU, 2008, Spatial Analysis in Epidemiology, P1, DOI 10.1093/acprof:oso/9780198509882.001.0001; R Core Team, 2021, R LANGUAGE ENV STAT; Reed SK, 2020, EQUINE VET EDUC, V32, P82, DOI 10.1111/eve.13185; Riggs CM, 2002, VET J, V163, P19, DOI 10.1053/tvjl.2001.0610; ROSEF O, 1985, APPL ENVIRON MICROB, V49, P1507, DOI 10.1128/AEM.49.6.1507-1510.1985; Stevens DL, 2004, J AM STAT ASSOC, V99, P262, DOI 10.1198/016214504000000250; Stevenson M., 2020, EPIR TOOLS ANAL EPID; Stevenson MA, 2021, FRONT VET SCI, V7, DOI 10.3389/fvets.2020.539573; THOMPSON SK, 1987, AM STAT, V41, P42, DOI 10.2307/2684318; Thomson PC, 2014, AUST VET J, V92, P303, DOI 10.1111/avj.12204; Tigerlily DJ., 2019, SYDNEY MORNING HERAL; Velie BD, 2013, EQUINE VET J, V45, P410, DOI 10.1111/j.2042-3306.2012.00651.x	29	1	1	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2021	16	9							e0257581	10.1371/journal.pone.0257581	http://dx.doi.org/10.1371/journal.pone.0257581			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YM4DR	34547036	Green Published, gold			2022-12-26	WOS:000746527400024
J	Stoehr, F; Muller, L; Brady, A; Trilla, A; Mahringer-Kunz, A; Hahn, F; Duber, C; Becker, N; Worns, MA; Chapiro, J; Hinrichs, JB; Akata, D; Ellmann, S; Huisman, M; Koff, D; Brinkmann, S; Bamberg, F; Zimmermann, O; Traikova, NI; Marquardt, JU; Chang, DH; Rengier, F; Auer, TA; Emrich, T; Muehler, F; Schmidberger, H; Baessler, B; Dos Santos, DP; Kloeckner, R				Stoehr, Fabian; Mueller, Lukas; Brady, Adrian; Trilla, Antoni; Maehringer-Kunz, Aline; Hahn, Felix; Dueber, Christoph; Becker, Nicole; Woerns, Marcus-Alexander; Chapiro, Julius; Hinrichs, Jan Bernd; Akata, Deniz; Ellmann, Stephan; Huisman, Merel; Koff, David; Brinkmann, Sebastian; Bamberg, Fabian; Zimmermann, Oscar; Traikova, Nikoleta, I; Marquardt, Jens U.; Chang, D-H; Rengier, Fabian; Auer, Timo A.; Emrich, Tilman; Muehler, Felix; Schmidberger, Heinz; Baessler, Bettina; Dos Santos, Daniel Pinto; Kloeckner, Roman			How COVID-19 kick-started online learning in medical education-The DigiMed study	PLOS ONE			English	Article							T-TEST; SIMULATION; STUDENTS	Background The coronavirus disease 2019 (COVID-19) pandemic led to far-reaching restrictions of social and professional life, affecting societies all over the world. To contain the virus, medical schools had to restructure their curriculum by switching to online learning. However, only few medical schools had implemented such novel learning concepts. We aimed to evaluate students' attitudes to online learning to provide a broad scientific basis to guide future development of medical education. Methods Overall, 3286 medical students from 12 different countries participated in this cross-sectional, web-based study investigating various aspects of online learning in medical education. On a 7-point Likert scale, participants rated the online learning situation during the pandemic at their medical schools, technical and social aspects, and the current and future role of online learning in medical education. Results The majority of medical schools managed the rapid switch to online learning (78%) and most students were satisfied with the quantity (67%) and quality (62%) of the courses. Online learning provided greater flexibility (84%) and led to unchanged or even higher attendance of courses (70%). Possible downsides included motivational problems (42%), insufficient possibilities for interaction with fellow students (67%) and thus the risk of social isolation (64%). The vast majority felt comfortable using the software solutions (80%). Most were convinced that medical education lags behind current capabilities regarding online learning (78%) and estimated the proportion of online learning before the pandemic at only 14%. In order to improve the current curriculum, they wish for a more balanced ratio with at least 40% of online teaching compared to on-site teaching. Conclusion This study demonstrates the positive attitude of medical students towards online learning. Furthermore, it reveals a considerable discrepancy between what students demand and what the curriculum offers. Thus, the COVID-19 pandemic might be the long-awaited catalyst for a new "online era" in medical education.	[Stoehr, Fabian; Mueller, Lukas; Maehringer-Kunz, Aline; Hahn, Felix; Dueber, Christoph; Emrich, Tilman; Kloeckner, Roman] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Diagnost & Intervent Radiol, Mainz, Germany; [Brady, Adrian] Mercy Univ Hosp, Radiol Dept, Cork, Ireland; [Brady, Adrian] Univ Coll Cork, Sch Med, Dept Radiol, Cork, Ireland; [Trilla, Antoni] Hosp Clin Barcelona Hosp, Prevent Med & Epidemiol, Barcelona, Spain; [Becker, Nicole] Johannes Gutenberg Univ Mainz, Ctr Qual Assurance & Dev, Mainz, Germany; [Woerns, Marcus-Alexander] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Internal Med 1, Mainz, Germany; [Chapiro, Julius] Yale Sch Med, Dept Radiol & Biomed Imaging, New Haven, CT USA; [Hinrichs, Jan Bernd] Hannover Med Sch, Inst Diagnost & Intervent Radiol, Hannover, Germany; [Akata, Deniz] Hacettepe Univ, Fac Med, Dept Radiol, Ankara, Turkey; [Ellmann, Stephan] Univ Erlangen Nurnberg, Inst Radiol, Erlangen, Germany; [Huisman, Merel] Meander Med Ctr, Inst Radiol, Utrecht, Netherlands; [Koff, David] McMaster Univ, Dept Radiol, Hamilton, ON, Canada; [Brinkmann, Sebastian] Univ Hosp Cologne, Dept Gen Visceral Tumor & Transplantat Surg, Cologne, Germany; [Bamberg, Fabian] Univ Freiburg, Med Ctr, Dept Radiol, Freiburg, Germany; [Zimmermann, Oscar] Univ Hosp Cologne, Cologne, Germany; [Traikova, Nikoleta, I] Med Univ Plovdiv, Dept Radiol, Plovdiv, Bulgaria; [Marquardt, Jens U.] Univ Hosp Schleswig Holstein UKSH, Dept Internal Med 1, Lubeck, Germany; [Chang, D-H; Rengier, Fabian] Heidelberg Univ Hosp, Dept Radiol, Heidelberg, Germany; [Auer, Timo A.] Charite Univ Med Berlin, Dept Radiol, Berlin, Germany; [Auer, Timo A.] Free Univ Berlin, Berlin, Germany; [Auer, Timo A.] Humboldt Univ, Berlin, Germany; [Auer, Timo A.] Berlin Inst Hlth, Berlin, Germany; [Emrich, Tilman] Med Univ South Carolina, Dept Radiol & Radiol Sci, Div Cardiovasc Imaging, Charleston, SC 29425 USA; [Emrich, Tilman] German Ctr Cardiovasc Res, Partner Site Rhine Main, Mainz, Germany; [Muehler, Felix] Univ Hosp Wurzburg, Wurzburg, Germany; [Schmidberger, Heinz] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Radiat Oncol, Mainz, Germany; [Baessler, Bettina] Univ Hosp Zurich, Inst Diagnost & Intervent Radiol, Zurich, Switzerland; [Dos Santos, Daniel Pinto] Univ Hosp Cologne, Dept Radiol, Cologne, Germany	Johannes Gutenberg University of Mainz; University College Cork; University College Cork; Johannes Gutenberg University of Mainz; Johannes Gutenberg University of Mainz; Yale University; Hannover Medical School; Hacettepe University; University of Erlangen Nuremberg; Meander Medisch Centrum; McMaster University; University of Cologne; University of Freiburg; University of Cologne; Medical University Plovdiv; University of Kiel; Schleswig Holstein University Hospital; Ruprecht Karls University Heidelberg; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Berlin Institute of Health; Medical University of South Carolina; German Centre for Cardiovascular Research; University of Wurzburg; Johannes Gutenberg University of Mainz; University of Zurich; University Zurich Hospital; University of Cologne	Kloeckner, R (corresponding author), Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Diagnost & Intervent Radiol, Mainz, Germany.	Roman.Kloeckner@unimedizin-mainz.de	Ellmann, Stephan/P-3824-2016; Zimmermann, Oscar/HGV-0364-2022	Ellmann, Stephan/0000-0003-2737-5526; Brady, Adrian/0000-0003-3473-0282; Zimmermann, Oscar/0000-0002-7342-6227; Auer, Timo Alexander/0000-0002-5763-689X; Emrich, Tilman/0000-0003-4156-7727	Clinician Scientist Fellowship "Else Kroner Research College" [2018_Kolleg.05]	Clinician Scientist Fellowship "Else Kroner Research College"	FS and LM are supported by the Clinician Scientist Fellowship "Else Kroner Research College: 2018_Kolleg.05". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Elq AH, 2010, J FAM COMMUNITY MED, V17, P35, DOI 10.4103/1319-1683.68787; Ali A, 2015, ISSUES INFORM SCI IN, V12, P011, DOI [10.28945/2258, DOI 10.28945/2258]; Ali Nagia S, 2004, Nurse Educ, V29, P111, DOI 10.1097/00006223-200405000-00009; Attardi SM, 2015, ANAT SCI EDUC, V8, P53, DOI 10.1002/ase.1465; Bedford J, 2020, LANCET, V395, P1015, DOI 10.1016/S0140-6736(20)30673-5; Bryer J, 2016, PACKAGE LIKERT; DeLisa JA, 2012, ACAD MED, V87, P1461, DOI 10.1097/ACM.0b013e31826b048c; Desalegn AA, 2014, BMC MED EDUC, V14, DOI 10.1186/1472-6920-14-81; Eysenbach G, 2004, J MED INTERNET RES, V6, P12, DOI 10.2196/jmir.6.3.e34; Finn GM, 2020, MED EDUC, V54, P1190, DOI 10.1111/medu.14242; FURNHAM A, 1986, PERS INDIV DIFFER, V7, P385, DOI 10.1016/0191-8869(86)90014-0; Hassan Zailinawati Abu, 2006, Malays Fam Physician, V1, P70; Huber T, 2018, INT J COMPUT ASS RAD, V13, P281, DOI 10.1007/s11548-017-1686-2; Huddart D, 2020, MED EDUC, V54, P951, DOI 10.1111/medu.14215; Hwang SY, 2006, NURS EDUC TODAY, V26, P315, DOI 10.1016/j.nedt.2005.11.002; Irby DM, 2010, ACAD MED, V85, P220, DOI 10.1097/ACM.0b013e3181c88449; KASSEBAUM DG, 1989, ACAD MED, V64, P446, DOI 10.1097/00001888-198908000-00006; KNAPP TR, 1990, NURS RES, V39, P121; Krosnick J, 2009, HDB SURVEY RES, V2nd; Laubert T, 2018, ZBL CHIR, V143, P412, DOI 10.1055/s-0043-106851; Lee K, 2009, GLOB INST, P1; Liu Q, 2016, J MED INTERNET RES, V18, DOI 10.2196/jmir.4807; Maloney S, 2012, J MED INTERNET RES, V14, DOI 10.2196/jmir.2040; McGaghie WC, 2016, MED EDUC, V50, P986, DOI 10.1111/medu.12795; Moszkowicz D, 2020, CLIN ANAT, V33, P927, DOI 10.1002/ca.23601; Mourad A, 2016, MED SCI ED, V26, P723, DOI 10.1007/s40670-016-0323-y; Mynbayeva A., 2018, NEW PEDAGOGICAL CHAL, DOI [10.5772/intechopen.72341, DOI 10.5772/INTECHOPEN.72341]; Neuert C., 2016, GESIS SURVEY GUIDELI; Nevins EJ, 2016, MEDEDPUBLISH, DOI [10.15694/mep.2016.000078, DOI 10.15694/MEP.2016.000078]; O'Doherty D, 2018, BMC MED EDUC, V18, DOI 10.1186/s12909-018-1240-0; Oliveira PC, 2013, EUR J ENG EDUC, V38, P417, DOI 10.1080/03043797.2013.780013; Plourde G, 2019, PHARMACOEPIDEMIOLOGY, P25, DOI [10.1016/B978-0-12-816183-8.00003-2, DOI 10.1016/B978-0-12-816183-8.00003-2]; Pottle Jack, 2019, Future Healthc J, V6, P181, DOI 10.7861/fhj.2019-0036; Rahm S, 2016, BMC SURG, V16, DOI 10.1186/s12893-016-0129-2; Ramnanan CJ, 2017, ADV MED EDUC PRACT, V8, P63, DOI 10.2147/AMEP.S109037; Rasch D, 2011, STAT PAP, V52, P219, DOI 10.1007/s00362-009-0224-x; Rose S, 2020, JAMA-J AM MED ASSOC, V323, P2131, DOI 10.1001/jama.2020.5227; Rowe M, 2012, MED TEACH, V34, pE216, DOI 10.3109/0142159X.2012.642831; Ruxton GD, 2006, BEHAV ECOL, V17, P688, DOI 10.1093/beheco/ark016; Saris WE, 2014, WILEY SER SURV METH, P1, DOI 10.1002/9781118634646; Skochelak SE, 2017, ACAD MED, V92, P16, DOI 10.1097/ACM.0000000000001160; So HY, 2019, J ROY COLL PHYS EDIN, V49, P52, DOI 10.4997/JRCPE.2019.112; Stoehr F, 2020, EUR RADIOL, V30, P4656, DOI 10.1007/s00330-019-06646-2; Tolks D, 2020, MEDEDPUBLISH, V9, DOI [10.15694/mep.2020.000113.1, DOI 10.15694/MEP.2020.000113.1]; von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Woolliscroft JO, 2020, ACAD MED, V95, P1140, DOI 10.1097/ACM.0000000000003402	47	13	13	5	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2021	16	9							e0257394	10.1371/journal.pone.0257394	http://dx.doi.org/10.1371/journal.pone.0257394			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	YM4DR	34547031	Green Published, gold			2022-12-26	WOS:000746527400012
J	Swann, JW; Tayler, S; Hall, H; Sparrow, R; Skelly, BJ; Glanemann, B				Swann, James W.; Tayler, Sarah; Hall, Harriet; Sparrow, Richard; Skelly, Barbara J.; Glanemann, Barbara			Cross-sectional study of approaches to diagnosis and management of dogs with immune-mediated haemolytic anaemia in primary care and referral veterinary practices in the United Kingdom	PLOS ONE			English	Article							BODY-SURFACE AREA; PROGNOSTIC-FACTORS; GLUCOCORTICOIDS; PREDNISONE; SURVIVAL; EFFICACY; CATS	Objectives To determine whether veterinarians in primary care practices (PCPs) and board-certified clinicians (BCCs) approach treatment of dogs with immune-mediated haemolytic anaemia (IMHA) similarly, and whether practitioners with more experience treat similarly to those with less experience. We hypothesised those in PCPs would show more variation in their approach to similar cases than BCCs. Methods A cross-sectional study was conducted by distributing a questionnaire to BCCs and veterinarians in PCPs. The questionnaire included direct questions and a number of clinical scenarios intended to capture approaches to common treatment problems. Results Questionnaire responses were received from 241 veterinarians, including 216 in PCPs and 25 BCCs. Veterinarians in both settings used similar tests for diagnosis of IMHA, but BCCs performed more tests to exclude underlying causes of 'associative' disease. All veterinarians reported use of similar initial dosages of glucocorticoids (median 2 mg/kg per day in both groups, p = 0.92) but those used by more experienced practitioners were higher than those with less experience. Most veterinarians made allowances for the weight of dogs, using lower prednisolone dosages in a clinical scenario involving a 40 kg dog compared to a 9 kg dog (p = 0.025 for PCP, p = 0.002 for BCC). BCCs reported greater use of combinations of immunosuppressive drugs (p<0.0001) and of antithrombotic drugs (p<0.0001); use of antithrombotic drugs was also less common among more experienced practitioners compared to less experienced. Conclusions Approaches to treatment of dogs with IMHA differ between BCCs and those in PCP. These differences may affect design and implementation of future research studies and clinical guidelines.	[Swann, James W.] Columbia Univ, Columbia Stem Cell Initiat, New York, NY 10027 USA; [Swann, James W.; Tayler, Sarah; Sparrow, Richard; Glanemann, Barbara] Royal Vet Coll, Dept Clin Sci & Serv, Hatfield, Herts, England; [Hall, Harriet; Skelly, Barbara J.] Univ Cambridge, Dept Vet Med, Cambridge, England	Columbia University; University of London; University of London Royal Veterinary College; University of Cambridge	Swann, JW (corresponding author), Columbia Univ, Columbia Stem Cell Initiat, New York, NY 10027 USA.; Swann, JW (corresponding author), Royal Vet Coll, Dept Clin Sci & Serv, Hatfield, Herts, England.	js5895@cumc.columbia.edu	Skelly, Barbara/AAY-7268-2020	Swann, James/0000-0001-7988-9997				Andres M, 2019, CAN VET J, V60, P1065; [Anonymous], 2016, REGULATION EU 201667, V119, P1, DOI DOI 10.1016/J.WOCN.2016.08.005; Balch A, 2007, COMP CONT EDUC PRACT, V29, P217; Carr AP, 2002, J VET INTERN MED, V16, P504, DOI 10.1892/0891-6640(2002)016&lt;0504:PFFMAT&gt;2.3.CO;2; Cook S, 2016, J SMALL ANIM PRACT, V57, P332, DOI 10.1111/jsap.12487; Davidow EB, 2021, J VET EMERG CRIT CAR, V31, P167, DOI 10.1111/vec.13045; Duval D, 1996, J VET INTERN MED, V10, P290, DOI 10.1111/j.1939-1676.1996.tb02064.x; Dye TL, 2013, J VET INTERN MED, V27, P1385, DOI 10.1111/jvim.12195; Garden OA, 2019, J VET INTERN MED, V33, P313, DOI 10.1111/jvim.15441; Goggs R, 2012, VET J, V191, P347, DOI 10.1016/j.tvjl.2011.03.015; Goggs R, 2019, J VET EMERG CRIT CAR, V29, P49, DOI 10.1111/vec.12791; Goggs R, 2016, J VET EMERG CRIT CAR, V26, P763, DOI 10.1111/vec.12546; Grundy SA, 2001, J AM VET MED ASSOC, V218, P543, DOI 10.2460/javma.2001.218.543; Hill RC, 2004, JAVMA-J AM VET MED A, V225, P689, DOI 10.2460/javma.2004.225.689; Maglaras CH, 2017, J VET EMERG CRIT CAR, V27, P108, DOI 10.1111/vec.12530; McManus PM, 2001, J AM VET MED ASSOC, V218, P1308, DOI 10.2460/javma.2001.218.1308; Moon A, 2019, J AM ANIM HOSP ASSOC, V55, P29, DOI 10.5326/JAAHA-MS-6868; Nam A, 2017, POL J VET SCI, V20, P611, DOI 10.1515/pjvs-2017-0076; O'Neill D, 2012, J SMALL ANIM PRACT, V53, P217, DOI 10.1111/j.1748-5827.2011.01190.x; Piek CJ, 2011, VET QUART, V31, P129, DOI 10.1080/01652176.2011.604979; Rhoades AC, 2016, JAVMA-J AM VET MED A, V248, P395, DOI 10.2460/javma.248.4.395; Sato M, 2017, J VET INTERN MED, V31, P1502, DOI 10.1111/jvim.14810; Swann JW, 2013, J VET INTERN MED, V27, P1, DOI 10.1111/jvim.12028; Swann JW, 2011, J SMALL ANIM PRACT, V52, P353, DOI 10.1111/j.1748-5827.2011.01074.x; Swann JW, 2019, VET REC, V184, P771, DOI 10.1136/vr.105104; Swann JW, 2019, J VET INTERN MED, V33, P1141, DOI 10.1111/jvim.15463; Wang A, 2013, J SMALL ANIM PRACT, V54, P399, DOI 10.1111/jsap.12107; Weinkle TK, 2005, JAVMA-J AM VET MED A, V226, P1869, DOI 10.2460/javma.2005.226.1869; Wilson HE, 2013, J SMALL ANIM PRACT, V54, P425, DOI 10.1111/jsap.12088; Woodward GM, 2020, AUST VET J, V98, P586, DOI 10.1111/avj.13016	30	0	0	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2021	16	9							e0257700	10.1371/journal.pone.0257700	http://dx.doi.org/10.1371/journal.pone.0257700			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	WG6BN	34543364	Green Published, gold			2022-12-26	WOS:000707078200073
J	Chacon-Diaz, M; Hernandez-Vasquez, A; Vargas-Fernandez, R; Bendezu-Quispe, G				Chacon-Diaz, Manuel; Hernandez-Vasquez, Akram; Vargas-Fernandez, Rodrigo; Bendezu-Quispe, Guido			Study protocol of the <underline>PE</underline>ruvian <underline>R</underline>egistry of <underline>ST</underline>-segment <underline>E</underline>levation <underline>M</underline>yocardial <underline>I</underline>nfarction II (PERSTEMI-II) study	PLOS ONE			English	Article							ELEVATION MYOCARDIAL-INFARCTION; REPERFUSION THERAPY; ST-ELEVATION; ADULTS	Background Myocardial infarction (MI) is the most prevalent cardiovascular disease globally and is considered a public health problem. In Peru, MI is the second leading cause of death at the national level, with a mortality rate that exceeds 10% in the hospital setting. The study aims to determine the clinical and epidemiological characteristics of ST-segment elevation myocardial infarction (STEMI) in tertiary care facilities belonging to the Peruvian public health system. Methods and analysis This will be a prospective, observational, multicenter study, with baseline and two follow-up assessments: at admission to the health service, and 30 days and 12 months after admission. This multicenter study will be conducted in 27 hospitals located in the main cities of Peru. The patients included in the study will be over 18 years of age, of either sex, and will have been admitted to the health facility with a diagnosis of acute coronary syndrome with ST-segment elevation. The Kaplan-Meier method will be used to estimate the cumulative in-hospital mortality of patients at 30 days and 12 months of follow-up, and the log-rank test will be used to evaluate the differences between the survival curves between reperfused and non-reperfused patients. Subsequently, to evaluate the risk factors for successful reperfusion and cardiovascular adverse events, generalized linear models of the binomial family with log link function will be used to estimate the bivariate and multivariate relative risk (RR) with their respective 95% confidence intervals. This project was approved by the Ethics and Research Committee of the National Cardiovascular Institute (Instituto Nacional Cardiovascular "Carlos Alberto Peschiera Carrillo"-INCOR [in Spanish]; Approval report 21/2019-CEI). Discussion Among the strengths, the observational design will allow the inclusion of a large sample of patients, which will significantly contribute to the knowledge base on STEMI in Peru. It should be noted that this study is the first to examine the clinical-epidemiological characteristics of STEMI in high-resolution hospital centers in Peru with follow-up one year after the event, providing knowledge of these observable characteristics in daily clinical routine. Likewise, the multicenter nature of the study will increase the external validity of the findings. In terms of limitations, the observational design of the study can only describe associations and not causality. Furthermore, since data from medical records will be used, there could be imprecision in the data.	[Chacon-Diaz, Manuel] EsSalud, Inst Nacl Cardiovasc, Lima, Peru; [Hernandez-Vasquez, Akram] Univ San Ignacio Loyola, Ctr Excelencia Invest Econom & Sociales Salud, Invest, Lima, Peru; [Vargas-Fernandez, Rodrigo] Univ Cient Sur, Lima, Peru; [Bendezu-Quispe, Guido] Univ Privada Norbert Wiener, Ctr Invest Epidemiol Salud Global, Lima, Peru	Seguro Social de Salud del Peru; Universidad San Ignacio de Loyola; Universidad Cientifica del Sur (CIENTIFICA); Universidad Norbert Wiener	Vargas-Fernandez, R (corresponding author), Univ Cient Sur, Lima, Peru.	jvargasf@cientifica.edu.pe	Bendezu-Quispe, Guido/H-7415-2014; Hernández-Vásquez, Akram/AAM-4868-2021	Bendezu-Quispe, Guido/0000-0002-5140-0843; Hernández-Vásquez, Akram/0000-0003-1431-2526; Vargas-Fernandez, Rodrigo/0000-0002-3310-8689				Chacon-Diaz M, 2018, ARCH CARDIOL MEX, V88, P403, DOI 10.1016/j.acmx.2017.11.009; Custodio-Sanchez P., 2020, APCYCCV, V1, P87, DOI 10.47487/apcyccv.v1i2.22; Gharacholou SM, 2010, AM HEART J, V159, P757, DOI 10.1016/j.ahj.2010.02.009; Hernandez-Vasquez A, 2020, INT J PREVENTIVE MED, V11, DOI 10.4103/ijpvm.IJPVM_326_19; Ibanez B, 2018, KARDIOL POL, V76, P229, DOI 10.5603/KP.2018.0041; Instituto Nacional de Estadistica e Informatica, 2020, PER ENF TRANSM TRANS; Jneid H, 2017, J AM COLL CARDIOL, V70, P2048, DOI 10.1016/j.jacc.2017.06.032; Khan MAB, 2020, CUREUS, V12, DOI 10.7759/cureus.9349; Khera S, 2015, J AM COLL CARDIOL, V66, P1961, DOI 10.1016/j.jacc.2015.08.865; Kristensen SD, 2014, EUR HEART J, V35, P1957, DOI 10.1093/eurheartj/eht529; Ministerio de Salud, 2018, CARG ENF PER EST AN; Mozaffarian, 2015, CIRCULATION, V131, pE535, DOI 10.1161/CIR.0000000000000219; Prommegger B, 2021, EUR J INFORM SYST, V30, P100, DOI 10.1080/0960085X.2020.1841573; Reyes Rocha M., 2008, REV PERU CARDIOL, P84; Reyes Rocha M., REV PERU CARDIOL, V29, P12; Thygesen K, 2019, EUR HEART J, V40, P237, DOI [10.1093/eurheartj/ehy462, 10.1016/j.jacc.2018.08.1038, 10.1016/j.rec.2018.11.011]; Vogel B, 2019, NAT REV DIS PRIMERS, V5, DOI 10.1038/s41572-019-0090-3; WHO, CARD DIS CVDS; Widimsky P, 2010, EUR HEART J, V31, P943, DOI 10.1093/eurheartj/ehp492; Zeymert U, 2021, EUR HEART J, V42, P4536, DOI 10.1093/eurheartj/ehab342	20	0	0	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2021	16	9							e0257618	10.1371/journal.pone.0257618	http://dx.doi.org/10.1371/journal.pone.0257618			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	WG5ZQ	34534262	gold, Green Published			2022-12-26	WOS:000707073300042
J	Fujii, R; Imai, R; Tanaka, S; Morioka, S				Fujii, Ren; Imai, Ryota; Tanaka, Shinichiro; Morioka, Shu			Kinematic analysis of movement impaired by generalization of fear of movement-related pain in workers with low back pain	PLOS ONE			English	Article							PREVALENCE; DISABILITY; SEVERITY	Purpose To identify impaired trunk movement during work-related activity in individuals with low back pain (LBP) and investigate whether abnormalities were caused by generalized fear of movement-related pain. Methods This cross-sectional study was conducted at a hospital in Japan. We recruited 35 participants with LBP (LBP group; 26 males, 9 females) and 20 healthy controls (HC group) via posters at our hospital. The task required lifting an object. We used a 3D motion capture system to calculate the peak angular velocity of trunk flexion and extension during a lifting task. Pain-related factors for the LBP group were assessed using the visual analogue scale (VAS) for pain intensity over the past 4 weeks and during the task, the Tampa Scale for Kinesiophobia (TSK), the Pain Catastrophizing Scale (PCS), and the Pain Anxiety Symptoms Scale-20 (PASS-20). We compared kinematic variables between groups with a generalized linear mixed model and investigated the relationship between kinematic variables, VAS scores, and psychological factors by performing a mediation analysis. Results The peak angular velocity of trunk extension showed significant main effects on the group factors (LBP group vs. HC group) and their interactions; the value of the kinematic variable was lower at Trial 1 in the LBP group. No LBP participant reported pain during the experiment. The mediation analysis revealed that the relationship between the VAS score for pain intensity over the past 4 weeks and the peak angular velocity of trunk extension in the first trial was completely mediated by the TSK (complete mediation model, 95% bootstrapped CI: 0.07-0.56). Conclusion Individuals with LBP had reduced trunk extension during a lifting task. Generalized fear of movement-related pain may contribute to such impaired trunk movement. Our findings suggest that intervention to ameliorate fear of movement may be needed to improve LBP-associated disability.	[Fujii, Ren; Morioka, Shu] Kio Univ, Grad Sch Hlth Sci, Dept Neurorehabil, Koryo, Japan; [Fujii, Ren] Musashigaoka Hosp, Dept Rehabil, Med Corp Tanakakai, Kumamoto, Japan; [Imai, Ryota] Osaka Kawasaki Rehabil Univ, Sch Rehabil, Kaizuka, Japan; [Tanaka, Shinichiro] Musashigaoka Hosp, Dept Rehabil Med, Med Corp Tanakakai, Kumamoto, Japan; [Morioka, Shu] Kio Univ, Neurorehabil Res Ctr, Koryo, Japan		Fujii, R (corresponding author), Kio Univ, Grad Sch Hlth Sci, Dept Neurorehabil, Koryo, Japan.; Fujii, R (corresponding author), Musashigaoka Hosp, Dept Rehabil, Med Corp Tanakakai, Kumamoto, Japan.	ren08150815@gmail.com	Imai, Ryota/B-6390-2019	Imai, Ryota/0000-0002-0276-6419; teng jing, lian/0000-0001-7615-4557; Morioka, Shu/0000-0003-2853-1789				BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Beurskens AJHM, 1996, PAIN, V65, P71, DOI 10.1016/0304-3959(95)00149-2; Cassidy JD, 1998, SPINE, V23, P1860, DOI 10.1097/00007632-199809010-00012; Coenen P, 2014, OCCUP ENVIRON MED, V71, P871, DOI 10.1136/oemed-2014-102346; Dionne CE, 2008, SPINE, V33, P95, DOI 10.1097/BRS.0b013e31815e7f94; Driessen MT, 2010, OCCUP ENVIRON MED, V67, P277, DOI 10.1136/oem.2009.047548; Fritz MS, 2007, PSYCHOL SCI, V18, P233, DOI 10.1111/j.1467-9280.2007.01882.x; Fujii T, 2013, EUR SPINE J, V22, P432, DOI 10.1007/s00586-012-2439-0; Hodges PW, 2015, CLIN J PAIN, V31, P97, DOI 10.1097/AJP.0000000000000098; Hoy D, 2010, BEST PRACT RES CL RH, V24, P769, DOI 10.1016/j.berh.2010.10.002; Karayannis NV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067779; Katsuhira J, 2013, SPINE, V38, pE832, DOI 10.1097/BRS.0b013e31829360e5; Kingma I, 2006, SPINE, V31, pE833, DOI 10.1097/01.brs.0000240670.50834.77; Kori SH, 1990, PAIN MANAG, V3, P35; Laird RA, 2018, BMC MUSCULOSKEL DIS, V19, DOI 10.1186/s12891-018-2233-1; Mallinckrodt B, 2006, J COUNS PSYCHOL, V53, P372, DOI 10.1037/0022-0167.53.3.372; Matheve T, 2019, EUR J PAIN, V23, P1171, DOI 10.1002/ejp.1384; Matsudaira K, 2015, IND HEALTH, V53, P368, DOI 10.2486/indhealth.2014-0260; McCracken Lance M, 2002, Pain Res Manag, V7, P45; Melloh M, 2009, INT ORTHOP, V33, P301, DOI 10.1007/s00264-008-0707-8; Meulders A, 2019, CURR OPIN BEHAV SCI, V26, P130, DOI 10.1016/j.cobeha.2018.12.007; Osumi M, 2019, EUR SPINE J, V28, P1572, DOI 10.1007/s00586-019-06010-4; Pedroza C, 2017, TRIALS, V18, DOI 10.1186/s13063-017-2248-1; ROLAND M, 1983, SPINE, V8, P141, DOI 10.1097/00007632-198303000-00004; Sanchez-Zuriaga D, 2011, SPINE, V36, P1279, DOI 10.1097/BRS.0b013e3181f471d8; Schmidt CO, 2007, SPINE, V32, P2005, DOI 10.1097/BRS.0b013e318133fad8; Shigetoh H, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0244111; Shimizu H., 2016, J MEDIA INFORM COMMU, V1, P59; Silfies SP, 2009, GAIT POSTURE, V29, P370, DOI 10.1016/j.gaitpost.2008.10.053; Sions JM, 2011, PHYS THER, V91, P525, DOI 10.2522/ptj.20100131; Snook SH, 2004, J ELECTROMYOGR KINES, V14, P153, DOI 10.1016/j.jelekin.2003.09.006; Sullivan MJL, 1995, PSYCHOL ASSESSMENT, V7, P524, DOI 10.1037/1040-3590.7.4.524; Susan H, 2002, AM J EPIDEMIOL, V156, P1028, DOI 10.1093/aje/kwf136; Swinkels-Meewisse IEJ, 2006, SPINE, V31, P658, DOI 10.1097/01.brs.0000203709.65384.9d; Thomas JS, 2008, EUR SPINE J, V17, P97, DOI 10.1007/s00586-007-0532-6; Tsuboi Y, 2019, EUR J PAIN, V23, P495, DOI 10.1002/ejp.1323; Vaisy M, 2015, CLIN J PAIN, V31, P876, DOI 10.1097/AJP.0000000000000190; van Dieen JH, 1999, CLIN BIOMECH, V14, P685, DOI 10.1016/S0268-0033(99)00031-5; Vlaeyen JWS, 1995, J OCCUP REHABIL, V5, P235, DOI 10.1007/BF02109988; VONKORFF M, 1992, PAIN, V50, P133, DOI 10.1016/0304-3959(92)90154-4; Vos T, 2012, LANCET, V380, P2163, DOI 10.1016/S0140-6736(12)61729-2; Walker BF, 2004, J MANIP PHYSIOL THER, V27, P238, DOI 10.1016/j.jmpt.2004.02.002	42	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2021	16	9							e0257231	10.1371/journal.pone.0257231	http://dx.doi.org/10.1371/journal.pone.0257231			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	WG5ZQ	34534260	gold, Green Published			2022-12-26	WOS:000707073300020
J	Li, BW; Xia, YW; Lv, JL; Wang, WZ; Xuan, Z; Chen, C; Jiang, TL; Fang, L; Wang, LJ; Li, Z; He, ZY; Li, QY; Xie, L; Qiu, SK; Zhang, L; Zhang, DC; Xu, H; Xu, ZK				Li, Bowen; Xia, Yiwen; Lv, Jialun; Wang, Weizhi; Xuan, Zhe; Chen, Cen; Jiang, Tianlu; Fang, Lang; Wang, Linjun; Li, Zheng; He, Zhongyuan; Li, Qingya; Xie, Li; Qiu, Shengkui; Zhang, Lu; Zhang, Diancai; Xu, Hao; Xu, Zekuan			miR-151a-3p-rich small extracellular vesicles derived from gastric cancer accelerate liver metastasis via initiating a hepatic stemness-enhancing niche	ONCOGENE			English	Article							PREMETASTATIC NICHE; PROSTATE-CANCER; KUPFFER CELLS; MICROENVIRONMENT; EXOSOMES; BONE; TRANSLATION; ACTIVATION; INHIBITOR; PHENOTYPE	Liver metastasis (LM) severely affects gastric cancer (GC) patients' prognosis. Small extracellular vesicles (sEVs) play key roles in intercellular communication. Specific sEV-miRNAs from several types of cancer were found to induce a premetastatic niche in target organs before tumor cell arrive. However, whether the primary GC affects hepatic microenvironment or the role of sEV-miRNAs in GC-LM is yet unclear. We report that GC-derived sEVs are primarily absorbed by Kupffer cells (KCs). sEV-miR-151a-3p is highly expressed in GC-LM patients' plasma and presents poor prognosis. Treating mice with sEVs-enriched in miR-151a-3p promotes GC-LM, whereas has no influence on the proliferation of GC cells in situ. Mechanistically, sEV-miR-151a-3p inhibits SP3 in KCs. Simultaneously, sEV-miR-151a-3p targets YTHDF3 to decrease the transcriptional inhibitory activity of SP3 by reducing SUMO1 translation in a N6-methyladenosine-dependent manner. These factors contribute to TGF-beta 1 transactivation in KCs, subsequently activating the SMAD2/3 pathway and enhancing the stem cell-like properties of incoming GC cells. Furthermore, sEV-miR-151a-3p induces miR-151a-3p transcription in KCs to form a positive feedback loop. In summary, our results reveal a previously unidentified regulatory axis initiated by sEV-miR-151a-3p that establishes a hepatic stemness-permissive niche to support GC-LM. sEV-miR-151a-3p could be a promising diagnostic biomarker and preventive treatment candidate for GC-LM.	[Li, Bowen; Xia, Yiwen; Lv, Jialun; Wang, Weizhi; Xuan, Zhe; Jiang, Tianlu; Fang, Lang; Wang, Linjun; Li, Zheng; He, Zhongyuan; Li, Qingya; Xie, Li; Qiu, Shengkui; Zhang, Lu; Zhang, Diancai; Xu, Hao; Xu, Zekuan] Nanjing Med Univ, Affiliated Hosp 1, Dept Gen Surg, Nanjing 210029, Jiangsu, Peoples R China; [Chen, Cen] Southern Med Univ, Sch Clin Med 1, Jinling Hosp, Dept Resp & Crit Care Med, Nanjing 210002, Jiangsu, Peoples R China; [Qiu, Shengkui] Nantong Univ, Affiliated Hosp 2, Dept Gen Surg, Nantong 226001, Jiangsu, Peoples R China; [Xu, Zekuan] Nanjing Med Univ, Collaborat Innovat Ctr Canc Personalized Med, Jiangsu Key Lab Canc Biomarkers Prevent & Treatme, Nanjing 211166, Jiangsu, Peoples R China	Nanjing Medical University; Southern Medical University - China; Nantong University; Nanjing Medical University	Xu, ZK (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Gen Surg, Nanjing 210029, Jiangsu, Peoples R China.; Xu, ZK (corresponding author), Nanjing Med Univ, Collaborat Innovat Ctr Canc Personalized Med, Jiangsu Key Lab Canc Biomarkers Prevent & Treatme, Nanjing 211166, Jiangsu, Peoples R China.	xuzekuan@njmu.edu.cn	wang, lin/GSE-3040-2022; wang, lili/HDL-7210-2022	xu, zekuan/0000-0001-5179-4128	National Natural Science Foundation of China [81871946, 82002558, 82072708]; Special Foundation for National Science and Technology Basic Research Program of China [2019FY101104]; Primary Research & Development Plan of Jiangsu Province [BE2016786]; Program for Development of Innovative Research Team in the First Affiliated Hospital of NJMU; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD) [JX10231801]; Jiangsu Key Medical Discipline (General Surgery) [ZDXKA2016005]; Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing Medical University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Foundation for National Science and Technology Basic Research Program of China; Primary Research & Development Plan of Jiangsu Province; Program for Development of Innovative Research Team in the First Affiliated Hospital of NJMU; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Jiangsu Key Medical Discipline (General Surgery); Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing Medical University	This work was partially supported by the National Natural Science Foundation of China (81871946, 82002558, 82072708); Special Foundation for National Science and Technology Basic Research Program of China (2019FY101104); the Primary Research & Development Plan of Jiangsu Province (BE2016786); the Program for Development of Innovative Research Team in the First Affiliated Hospital of NJMU; the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD, JX10231801); Jiangsu Key Medical Discipline (General Surgery) (ZDXKA2016005); Jiangsu Key Lab of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing Medical University. We would like to express our gratitude to Dr Xiaofei Zhi and Dr Zheng Chen for their valuable advice on our study. We also thank Prof. Xinyu Xu for her help on FACS experiments.	Badiola I, 2012, GUT, V61, P1465, DOI 10.1136/gutjnl-2011-300810; Bragado P, 2013, NAT CELL BIOL, V15, P1351, DOI 10.1038/ncb2861; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Brodt P, 2016, CLIN CANCER RES, V22, P5971, DOI 10.1158/1078-0432.CCR-16-0460; Celia-Terrassa T, 2017, NAT CELL BIOL, V19, P711, DOI 10.1038/ncb3533; Chang GQ, 2020, CANCER CELL, V38, P857, DOI 10.1016/j.ccell.2020.10.004; Chen J, 2013, EJSO-EUR J SURG ONC, V39, P701, DOI 10.1016/j.ejso.2013.03.023; Chen L, 2012, BIOMATERIALS, V33, P1437, DOI 10.1016/j.biomaterials.2011.10.056; Colletti M, 2020, J EXTRACELL VESICLES, V9, DOI 10.1080/20013078.2020.1774144; Costa-Silva B, 2015, NAT CELL BIOL, V17, P816, DOI 10.1038/ncb3169; Cui X, 2018, BIOMATERIALS, V161, P164, DOI 10.1016/j.biomaterials.2018.01.053; Dou CW, 2018, GASTROENTEROLOGY, V154, P2209, DOI 10.1053/j.gastro.2018.02.015; Fong MY, 2015, NAT CELL BIOL, V17, P183, DOI 10.1038/ncb3094; Gao H, 2012, CELL, V150, P764, DOI 10.1016/j.cell.2012.06.035; Ghajar CM, 2013, NAT CELL BIOL, V15, P807, DOI 10.1038/ncb2767; Gonzalez-Ramos M, 2013, INT J BIOCHEM CELL B, V45, P232, DOI 10.1016/j.biocel.2012.10.001; Grillet F, 2017, GUT, V66, P1802, DOI 10.1136/gutjnl-2016-311447; Grunwald B, 2016, GASTROENTEROLOGY, V151, P1011, DOI 10.1053/j.gastro.2016.07.043; Hashimoto K, 2018, P NATL ACAD SCI USA, V115, P2204, DOI 10.1073/pnas.1717363115; Hoshino A, 2015, NATURE, V527, P329, DOI 10.1038/nature15756; Hsu KW, 2016, ONCOTARGET, V7, P38036, DOI 10.18632/oncotarget.9342; Huang XY, 2015, EUR UROL, V67, P33, DOI 10.1016/j.eururo.2014.07.035; Ikushima H, 2009, CELL STEM CELL, V5, P504, DOI 10.1016/j.stem.2009.08.018; KAN ZX, 1995, HEPATOLOGY, V21, P487, DOI 10.1002/hep.1840210233; Kasar S, 2014, ONCOGENE, V33, P3307, DOI 10.1038/onc.2013.291; Kennett SB, 1997, NUCLEIC ACIDS RES, V25, P3110, DOI 10.1093/nar/25.15.3110; Kobayashi A, 2011, J EXP MED, V208, P2641, DOI 10.1084/jem.20110840; Lee D, 2015, HEPATOLOGY, V61, P1978, DOI 10.1002/hep.27721; Leek RD, 1999, BRIT J CANCER, V79, P991, DOI 10.1038/sj.bjc.6690158; Li A, 2017, CELL RES, V27, P444, DOI 10.1038/cr.2017.10; Li X, 2020, AGING-US, V12, P14157, DOI 10.18632/aging.103423; Lima CR, 2017, MOL CELL ENDOCRINOL, V456, P62, DOI 10.1016/j.mce.2017.03.015; Lissbrant IF, 2000, INT J ONCOL, V17, P445; Little AC, 2019, FRONT ONCOL, V9, DOI 10.3389/fonc.2019.00456; Liu BH, 2019, BRIEF FUNCT GENOMICS, V18, P255, DOI 10.1093/bfgp/elz002; Liu C, 2017, ACS NANO, V11, P6968, DOI 10.1021/acsnano.7b02277; Liu HB, 2019, BIOSCIENCE REP, V39, DOI 10.1042/BSR20191357; Liu TR, 2018, CANCER RES, V78, P6632, DOI 10.1158/0008-5472.CAN-18-0650; Liu YF, 2016, CANCER CELL, V30, P243, DOI 10.1016/j.ccell.2016.06.021; Luo Z, 2019, FRONT ONCOL, V9, DOI 10.3389/fonc.2019.01353; Luzzi KJ, 1998, AM J PATHOL, V153, P865, DOI 10.1016/S0002-9440(10)65628-3; Ma G, 2019, CANCER BIOMARK, V26, P491, DOI 10.3233/CBM-190256; Massague J, 2016, NATURE, V529, P298, DOI 10.1038/nature17038; Matsumura H, 2014, INT J ONCOL, V45, P2303, DOI 10.3892/ijo.2014.2662; O'Dea KP, 2020, J EXTRACELL VESICLES, V9, DOI 10.1080/20013078.2019.1706708; PAGET S, 1989, CANCER METAST REV, V8, P98; Peinado H, 2012, NAT MED, V18, P883, DOI 10.1038/nm.2753; Qiu XL, 2019, THERANOSTICS, V9, P2618, DOI 10.7150/thno.32363; Rosonina E, 2017, TRANSCR-AUSTIN, V8, P220, DOI 10.1080/21541264.2017.1311829; Ross S, 2002, MOL CELL, V10, P831, DOI 10.1016/S1097-2765(02)00682-2; Shi HL, 2017, CELL RES, V27, P315, DOI 10.1038/cr.2017.15; Stielow B, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001203; Vanharanta S, 2013, CANCER CELL, V24, P410, DOI 10.1016/j.ccr.2013.09.007; Wang YG, 2019, HEPATOLOGY, V70, P1409, DOI 10.1002/hep.30668; Wen SW, 2013, CANCER BIOL THER, V14, P606, DOI 10.4161/cbt.24593; Yeh HW, 2018, NAT CELL BIOL, V20, P479, DOI 10.1038/s41556-018-0062-y; Yeh TC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0168171; Yue CC, 2020, J BIOMED NANOTECHNOL, V16, P876, DOI 10.1166/jbn.2020.2941; Zhang HY, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15016; Zhang L, 2015, NATURE, V527, P100, DOI 10.1038/nature15376; Zhang XP, 2019, ONCOGENE, V38, P699, DOI 10.1038/s41388-018-0447-1; Zhang Y, 2019, P NATL ACAD SCI USA, V116, P976, DOI 10.1073/pnas.1812536116; Zhang ZK, 2019, MOL CELL, V73, P7, DOI 10.1016/j.molcel.2018.10.030; Zhang ZR, 2019, J EXP CLIN CANC RES, V38, DOI 10.1186/s13046-019-1139-6	64	7	7	1	11	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	OCT 28	2021	40	43					6180	6194		10.1038/s41388-021-02011-0	http://dx.doi.org/10.1038/s41388-021-02011-0		SEP 2021	15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	WO5HW	34535770				2022-12-26	WOS:000696766300002
J	Wu, HC; Wu, C; Lu, QB; Ding, ZY; Xue, M; Lin, JF				Wu, Haocheng; Wu, Chen; Lu, Qinbao; Ding, Zheyuan; Xue, Ming; Lin, Junfen			Spatiotemporal analysis and the characteristics of the case transmission network of 2019 novel coronavirus disease (COVID-19) in Zhejiang Province, China	PLOS ONE			English	Article							COMMUNITIES; INTERVAL	Background Zhejiang Province is one of the five provinces in China that had the highest incidence of novel coronavirus disease (COVID-19). Zhejiang, ranked fourth highest in COVID-19 incidence, is located in the Yangtze River Delta region of southeast China. This study was undertaken to identify the space-time characteristics of COVID-19 in Zhejiang. Methods Data on COVID-19 cases in Zhejiang Province from January to July 2020 were obtained from this network system. Individual information on cases and deaths was imported, and surveillance information, including demographic characteristics and geographic and temporal distributions, was computed by the system. The Knox test was used to identify possible space-time interactions to test whether cases that are close in distance were also close in time. Network analysis was performed to determine the relationship among the cases in a transmission community and to try to identify the key nodes. Results In total, 1475 COVID-19 cases and 1 fatal case were reported from January to July 2020 in Zhejiang Province, China. Most of the cases occurred before February 15(th), which accounted for 90.10%. The imported cases increased and became the main risk in Zhejiang Province after February 2020. The risk areas showed strong heterogeneity according to the Knox test. The areas at short distances within 1 kilometer and at brief periods within 5 days presented relatively high risk. The numbers of subcommunities for the four clusters were 12, 9, 6 and 4. There was obvious heterogeneity in the modularity of subcommunities. The maximum values of the node centrality for the four clusters were 2.9474, 4.3706, 4.1080 and 2.7500. Conclusions COVID-19 was brought under control over a short period in Zhejiang Province. Imported infections from outside of mainland China then became a new challenge. The effects of spatiotemporal interaction exhibited interval heterogeneity. The characteristics of transmission showed short range and short term risks. The importance to the cluster of each case was detected, and the key patients were identified. It is suggested that we should focus on key patients in complex conditions and in situations with limited control resources.	[Wu, Haocheng; Wu, Chen; Lu, Qinbao; Ding, Zheyuan; Lin, Junfen] Zhejiang Prov Ctr Dis Control & Prevent, Hangzhou, Zhejiang, Peoples R China; [Wu, Haocheng; Lin, Junfen] Key Lab Vaccine Prevent & Control Infect Dis Zhej, Hangzhou, Zhejiang, Peoples R China; [Xue, Ming] Hangzhou Ctr Dis Control & Prevent, Hangzhou, Zhejiang, Peoples R China	Zhejiang Provincial Center for Disease Control & Prevention	Lin, JF (corresponding author), Zhejiang Prov Ctr Dis Control & Prevent, Hangzhou, Zhejiang, Peoples R China.; Lin, JF (corresponding author), Key Lab Vaccine Prevent & Control Infect Dis Zhej, Hangzhou, Zhejiang, Peoples R China.	hchwu@cdc.zj.cn			Major Science and Technology Project of the Science and Technology Department of Zhejiang Province [2021C03038]	Major Science and Technology Project of the Science and Technology Department of Zhejiang Province	This work was supported by the Major Science and Technology Project of the Science and Technology Department of Zhejiang Province (2021C03038). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn YY, 2010, NATURE, V466, P761, DOI 10.1038/nature09182; Aldstadt J, 2007, STOCH ENV RES RISK A, V21, P487, DOI 10.1007/s00477-007-0132-3; Aldstadt J, 2012, TROP MED INT HEALTH, V17, P1076, DOI 10.1111/j.1365-3156.2012.03040.x; Chan JFW, 2020, LANCET, V395, P514, DOI 10.1016/S0140-6736(20)30154-9; Chen SY., 2017, S CHINA J PREV MED, V43, P106, DOI [10.13217/j.scjpm . 2017.0106, DOI 10.13217/J.SCJPM.2017.0106]; Chu DK, 2020, LANCET, V395, P1973, DOI 10.1016/S0140-6736(20)31142-9; Dong X C, 2020, Zhonghua Liu Xing Bing Xue Za Zhi, V41, P638, DOI 10.3760/cma.j.cn112338-20200221-00146; Epidemiology Working Group for NCIP Epidemic Response Chinese Center for Disease Control and Prevention, 2020, Zhonghua Liu Xing Bing Xue Za Zhi, V41, P145, DOI 10.3760/cma.j.issn.0254-6450.2020.02.003; Evans TS, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.016105; Fine PEM, 2003, AM J EPIDEMIOL, V158, P1039, DOI 10.1093/aje/kwg251; Gan H, 2020, Zhonghua Liu Xing Bing Xue Za Zhi, V41, P1004, DOI 10.3760/cma.j.cn112338-20200301-00223; Gao W J, 2020, Zhonghua Liu Xing Bing Xue Za Zhi, V41, P990, DOI 10.3760/cma.j.cn112338-20200404-00514; Gao W J, 2020, Zhonghua Liu Xing Bing Xue Za Zhi, V41, P485, DOI 10.3760/cma.j.cn112338-20200228-00207; Guo Y, 2020, Zhonghua Liu Xing Bing Xue Za Zhi, V41, P642, DOI 10.3760/cma.j.cn112338-20200301-00222; Holshue ML, 2020, NEW ENGL J MED, V382, P929, DOI 10.1056/NEJMoa2001191; Huang Y, 2020, J MED INTERNET RES, V22, DOI 10.2196/18718; Kalinka Alex T, 2011, Bioinformatics, V27, P2011, DOI 10.1093/bioinformatics/btr311; KNOX EG, 1964, ROY STAT SOC C-APP, V13, P25; Li Q, 2020, NEW ENGL J MED, V382, P1199, DOI 10.1056/NEJMoa2001316; Lin JF., 2020, J PREV MED, V32, P217, DOI [DOI 10.1136/BMJ.M1443, 10.1136/bmj.m1443]; Liu Qiao-Lan, 2007, Zhonghua Liu Xing Bing Xue Za Zhi, V28, P802; Mahase E, 2020, BMJ-BRIT MED J, V368, DOI 10.1136/bmj.m325; MANTEL N, 1967, CANCER RES, V27, P209; Munster VJ, 2020, NEW ENGL J MED, V382, P692, DOI 10.1056/NEJMp2000929; National Health Commission, 2021, COVID 19 DIAGNOSIS T; Qiu Jane, 2020, Nature, DOI 10.1038/d41586-020-00822-x; Radicchi F, 2004, P NATL ACAD SCI USA, V101, P2658, DOI 10.1073/pnas.0400054101; Special Expert Group for Control of the Epidemic of Novel Coronavirus Pneumonia of the Chinese Preventive Medicine Association, 2020, Zhonghua Liu Xing Bing Xue Za Zhi, V41, P139, DOI 10.3760/cma.j.issn.0254-6450.2020.02.002; Sun Wanwan, 2020, Zhonghua Yufang Yixue Zazhi, V54, P625, DOI 10.3760/cma.j.cn112150-20200227-00199; Tran A, 2004, EMERG INFECT DIS, V10, P615, DOI 10.3201/eid1004.030186; World Health Organization, COR DIS COV 19 SIT R; Wu Z Y, 2020, Zhonghua Liu Xing Bing Xue Za Zhi, V41, P801, DOI 10.3760/cma.j.cn112338-20200406-00517; Yang H Y, 2020, Zhonghua Liu Xing Bing Xue Za Zhi, V41, P623, DOI 10.3760/cma.j.cn112338-20200223-00153; Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017	34	1	1	9	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2021	16	9							e0257587	10.1371/journal.pone.0257587	http://dx.doi.org/10.1371/journal.pone.0257587			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	WG5ZQ	34534239	Green Published, gold			2022-12-26	WOS:000707073300039
J	Szegedi, N; Sallo, Z; Perge, P; Piros, K; Nagy, VK; Osztheimer, I; Merkely, B; Geller, L				Szegedi, Nandor; Sallo, Zoltan; Perge, Peter; Piros, Katalin; Nagy, Vivien Klaudia; Osztheimer, Istvan; Merkely, Bela; Geller, Laszlo			The role of local impedance drop in the acute lesion efficacy during pulmonary vein isolation performed with a new contact force sensing catheter-A pilot study	PLOS ONE			English	Article							PAROXYSMAL ATRIAL-FIBRILLATION; ABLATION; DECREASE; CAPTURE; SAFETY	Introduction Our pilot study aimed to evaluate the role of local impedance drop in lesion formation during pulmonary vein isolation with a novel contact force sensing ablation catheter that records local impedance as well and to find a local impedance cut-off value that predicts successful lesion formation. Materials and methods After completing point-by-point radiofrequency pulmonary vein isolation, the success of the applications was evaluated by pacing along the ablation line at 10 mA, 2 ms pulse width. Lesions were considered successful if loss of local capture was achieved. Results Out of 645 applications, 561 were successful and 84 were unsuccessful. Compared to the unsuccessful ablation points, the successful applications were shorter (p = 0.0429) and had a larger local impedance drop (p<0.0001). There was no difference between successful and unsuccessful applications in terms of mean contact force (p = 0.8571), force-time integral (p = 0.0699) and contact force range (p = 0.0519). The optimal cut-point for the local impedance drop indicating successful lesion formation was 21.80 Ohms on the anterior wall [AUC = 0.80 (0.75-0.86), p<0.0001], and 18.30 Ohms on the posterior wall [AUC = 0.77 (0.72-0.83), p<0.0001]. A local impedance drop larger than 21.80 Ohms on the anterior wall and 18.30 Ohms on the posterior wall was associated with an increased probability of effective lesion creation [OR = 11.21, 95%CI 4.22-29.81, p<0.0001; and OR = 7.91, 95%CI 3.77-16.57, p<0.0001, respectively]. Conclusion The measurement of the local impedance may predict optimal lesion formation. A local impedance drop > 21.80 Ohms on the anterior wall and > 18.30 Ohms on the posterior wall significantly increases the probability of creating a successful lesion.	[Szegedi, Nandor; Sallo, Zoltan; Perge, Peter; Piros, Katalin; Nagy, Vivien Klaudia; Osztheimer, Istvan; Merkely, Bela; Geller, Laszlo] Semmelweis Univ, Heart & Vasc Ctr, Budapest, Hungary	Semmelweis University	Szegedi, N (corresponding author), Semmelweis Univ, Heart & Vasc Ctr, Budapest, Hungary.	nandorszegedi@gmail.com		Sallo, Zoltan/0000-0002-2320-3535	National Research, Development and Innovation Office of Hungary (NKFIA) [NVKP_16-1-2016-0017]; Thematic Excellence Programme (Temateruleti Kivalosagi Program) of the Ministry for Innovation and Technology in Hungary, within Semmelweis University [2020-4.1.1.-TKP2020]	National Research, Development and Innovation Office of Hungary (NKFIA)(National Research, Development & Innovation Office (NRDIO) - Hungary); Thematic Excellence Programme (Temateruleti Kivalosagi Program) of the Ministry for Innovation and Technology in Hungary, within Semmelweis University	This study was supported by the National Research, Development and Innovation Office of Hungary (NKFIA; NVKP_16-1-2016-0017 National Heart Program). The research was financed by the Thematic Excellence Programme (Temateruleti Kivalosagi Program, 2020-4.1.1.-TKP2020) of the Ministry for Innovation and Technology in Hungary, within the framework of the Therapeutic Development and Bioimaging programmes of the Semmelweis University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barkagan M, 2018, J CARDIOVASC ELECTR, V29, P1287, DOI 10.1111/jce.13651; Bourier F, 2018, J CARDIOVASC ELECTR, V29, P1570, DOI 10.1111/jce.13724; Chinitz JS, 2016, J CARDIOVASC ELECTR, V27, P1390, DOI 10.1111/jce.13095; Das M, 2021, EUROPACE, V23, P1042, DOI 10.1093/europace/euab004; De Pooter J, 2019, JACC-CLIN ELECTROPHY, V5, P295, DOI 10.1016/j.jacep.2018.11.020; Garrott K, 2020, HEART RHYTHM, V17, P1371, DOI 10.1016/j.hrthm.2020.03.016; Gunawardene M, 2019, EUROPACE, V21, P34, DOI 10.1093/europace/euy273; Hindricks G, 2021, EUR HEART J, V42, P373, DOI [10.1093/eurheartj/ehaa612, 10.15829/1560-4071-2021-4701]; Hussein A, 2018, CIRC-ARRHYTHMIA ELEC, V11, DOI 10.1161/CIRCEP.118.006576; Kaneshiro T, 2020, CIRC-ARRHYTHMIA ELEC, V13, P1124, DOI 10.1161/CIRCEP.120.008602; Kautzner J, 2015, EUROPACE, V17, P1229, DOI 10.1093/europace/euv057; Leshem E, 2018, JACC-CLIN ELECTROPHY, V4, P467, DOI 10.1016/j.jacep.2017.11.018; Masuda M, 2020, J CARDIOVASC ELECTR, V31, P2584, DOI 10.1111/jce.14678; Moser Julia, 2017, JACC Clin Electrophysiol, V3, P1262, DOI 10.1016/j.jacep.2017.04.019; Phlips T, 2018, EUROPACE, V20, pF419, DOI 10.1093/europace/eux376; Reddy VY, 2015, CIRCULATION, V132, P907, DOI 10.1161/CIRCULATIONAHA.114.014092; Reichlin T, 2015, J CARDIOVASC ELECTR, V26, P390, DOI 10.1111/jce.12621; Schaeffer B, 2015, J CARDIOVASC ELECTR, V26, P1075, DOI 10.1111/jce.12759; Squara F, 2015, J CARDIOVASC ELECTR, V26, P242, DOI 10.1111/jce.12585; Steven D, 2010, HEART RHYTHM, V7, P323, DOI 10.1016/j.hrthm.2009.11.011; Szegedi N, 2019, EUROPACE, V21, P732, DOI 10.1093/europace/euy326; Taghji P, 2018, JACC-CLIN ELECTROPHY, V4, P99, DOI 10.1016/j.jacep.2017.06.023; Wielandts JY, 2021, CIRC-ARRHYTHMIA ELEC, V14, DOI 10.1161/CIRCEP.120.009112	23	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2021	16	9							e0257050	10.1371/journal.pone.0257050	http://dx.doi.org/10.1371/journal.pone.0257050			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	WG5YY	34529678	gold, Green Published			2022-12-26	WOS:000707071500027
J	Goo, E; Hwang, I				Goo, Eunhye; Hwang, Ingyu			Essential roles of Lon protease in the morpho-physiological traits of the rice pathogen Burkholderia glumae	PLOS ONE			English	Article							GENE; EXPRESSION	The highly conserved ATP-dependent Lon protease plays important roles in diverse biological processes. The lon gene is usually nonessential for viability; however, lon mutants of several bacterial species, although viable, exhibit cellular defects. Here, we show that a lack of Lon protease causes pleiotropic effects in the rice pathogen Burkholderia glumae. The null mutation of lon produced three colony types, big (BLONB), normal (BLONN), and small (BLONS), in Luria-Bertani (LB) medium. Colonies of the BLONB and BLONN types were re-segregated upon subculture, while those of the BLONS type were too small to manipulate. The BLONN type was chosen for further studies, as only this type was fully genetically complemented. BLONN-type cells did not reach the maximum growth capacity, and their population decreased drastically after the stationary phase in LB medium. BLONN-type cells were defective in the biosynthesis of quorum sensing (QS) signals and exhibited reduced oxalate biosynthetic activity, causing environmental alkaline toxicity and population collapse. Addition of excessive N-octanoyl-homoserine lactone (C8-HSL) to BLONN-type cell cultures did not fully restore oxalate biosynthesis, suggesting that the decrease in oxalate biosynthesis in BLONN-type cells was not due to insufficient C8-HSL. Co-expression of lon and tofR in Escherichia coli suggested that Lon negatively affects the TofR level in a C8-HSL-dependent manner. Lon protease interacted with the oxalate biosynthetic enzymes, ObcA and ObcB, indicating potential roles for the oxalate biosynthetic activity. These results suggest that Lon protease influences colony morphology, growth, QS system, and oxalate biosynthesis in B. glumae.	[Goo, Eunhye; Hwang, Ingyu] Seoul Natl Univ, Dept Agr Biotechnol, Seoul, South Korea; [Goo, Eunhye; Hwang, Ingyu] Seoul Natl Univ, Res Inst Agr & Life Sci, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU)	Goo, E (corresponding author), Seoul Natl Univ, Dept Agr Biotechnol, Seoul, South Korea.; Goo, E (corresponding author), Seoul Natl Univ, Res Inst Agr & Life Sci, Seoul, South Korea.	sourire11@snu.ac.kr	Goo, Eunhye/ERO-2624-2022	Goo, Eunhye/0000-0002-3247-5647	Basic Science Research ProResearch Foundation of Korea (NRF) - Ministry of the Education [2021R1I1A1A01040314]	Basic Science Research ProResearch Foundation of Korea (NRF) - Ministry of the Education	This work was supported by Basic Science Research ProResearch Foundation of Korea (NRF) funded by the Ministry of the Education (2021R1I1A1A01040314) (E.G.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.gram through the National	Bertani I, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-71; BONAS U, 1989, MOL GEN GENET, V218, P127, DOI 10.1007/BF00330575; Breidenstein EBM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049123; Ching C, 2019, J BACTERIOL, V201, DOI 10.1128/JB.00536-18; Ebel W, 1999, J BACTERIOL, V181, P2236, DOI 10.1128/JB.181.7.2236-2243.1999; Figaj D, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21103687; Goo E, 2012, P NATL ACAD SCI USA, V109, P19775, DOI 10.1073/pnas.1218092109; Goo E, 2010, J PROTEOME RES, V9, P3184, DOI 10.1021/pr100045n; Gottesman S, 1996, ANNU REV GENET, V30, P465, DOI 10.1146/annurev.genet.30.1.465; Kao TY, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.9; Kim J, 2004, MOL MICROBIOL, V54, P921, DOI 10.1111/j.1365-2958.2004.04338.x; Kim J, 2007, MOL MICROBIOL, V64, P165, DOI 10.1111/j.1365-2958.2007.05646.x; Li HQ, 1999, J BIOCHEM, V126, P243, DOI 10.1093/oxfordjournals.jbchem.a022429; Robertson GT, 2000, MOL MICROBIOL, V35, P577, DOI 10.1046/j.1365-2958.2000.01726.x; Roncarati D, 2017, FEMS MICROBIOL REV, V41, P549, DOI 10.1093/femsre/fux015; Ryall B, 2012, MICROBIOL MOL BIOL R, V76, P597, DOI 10.1128/MMBR.05028-11; Shin CS, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-020-20597-z; Su SC, 2006, MICROBIOL-SGM, V152, P1197, DOI 10.1099/mic.0.28657-0; Takaya A, 2002, J BACTERIOL, V184, P224, DOI 10.1128/JB.184.1.224-232.2002; Takaya A, 2008, J BACTERIOL, V190, P4181, DOI 10.1128/JB.01873-07; TOJO N, 1993, J BACTERIOL, V175, P2271, DOI 10.1128/JB.175.8.2271-2277.1993; TOJO N, 1993, J BACTERIOL, V175, P4545, DOI 10.1128/JB.175.14.4545-4549.1993; TORRESCABASSA AS, 1987, J BACTERIOL, V169, P981, DOI 10.1128/jb.169.3.981-989.1987; Tsilibaris V, 2006, RES MICROBIOL, V157, P701, DOI 10.1016/j.resmic.2006.05.004; VANMELDEREN L, 1994, MOL MICROBIOL, V11, P1151; Wright R, 1996, GENE DEV, V10, P1532, DOI 10.1101/gad.10.12.1532; Zhu J, 2001, P NATL ACAD SCI USA, V98, P1507, DOI 10.1073/pnas.98.4.1507	27	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2021	16	9							e0257257	10.1371/journal.pone.0257257	http://dx.doi.org/10.1371/journal.pone.0257257			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	WG6DR	34525127	Green Published, gold			2022-12-26	WOS:000707084400029
J	Muilwijk, T; Akand, M; Daelemans, S; Marien, K; Waumans, Y; Kockx, M; Baekelandt, L; Van den Broeck, T; Van der Aa, F; Gevaert, T; Joniau, S				Muilwijk, Tim; Akand, Murat; Daelemans, Sofie; Marien, Koen; Waumans, Yannick; Kockx, Mark; Baekelandt, Loic; Van den Broeck, Thomas; Van der Aa, Frank; Gevaert, Thomas; Joniau, Steven			Stromal marker fibroblast activation protein drives outcome in T1 non-muscle invasive bladder cancer	PLOS ONE			English	Article							EXPRESSION	Fibroblast activation protein-alpha (FAP) is a transmembrane peptidase and a surrogate marker for cancer-associated fibroblasts (CAFs). FAP has been linked to worse prognosis and therapy resistance in several cancers. We hypothesised that FAP might have a prognostic 3biomarker potential to stratify patients with high-grade (HG) T1 non-muscle-invasive bladder cancer (NMIBC). We selected 30 patients with HG T1 NMIBC that progressed to >= T2 disease which were pair-matched based on CUETO progression score variables with 90 patients that did not progress. After revision a final cohort of 86 patients was retained. Slides were stained for FAP, the luminal marker GATA3 and the basal marker CK5. All HG T1 tumour regions of interest (ROIs) within each patient were annotated, analysed and scored using image analysis software. FAP expression in HG T1 ROIs was significantly higher in progressors vs. non-progressors and was prognostic for recurrence-free survival, progression-free survival, cancer-specific survival, and overall survival. FAP expression in HG T1 ROIs remained strongly prognostic for these outcomes in a bivariable model corrected for adequate BCG per FDA definition. Expression of GATA3 and CK5 did not differ between progressors vs. non-progressors, and were not prognostic for these outcomes. FAP might serve as an easily applicable prognostic biomarker to risk-stratify patients with HG T1 NMIBC if these results are prospectively validated in a larger series.	[Muilwijk, Tim; Akand, Murat; Baekelandt, Loic; Van den Broeck, Thomas; Van der Aa, Frank; Gevaert, Thomas; Joniau, Steven] Univ Hosp Leuven, Dept Urol, Leuven, Belgium; [Muilwijk, Tim; Akand, Murat; Gevaert, Thomas] Katholieke Univ Leuven, Organ Syst, Leuven, Belgium; [Daelemans, Sofie; Marien, Koen; Waumans, Yannick; Kockx, Mark] CellCarta, Pathol Histol Imaging & Quantificat, Antwerp, Belgium; [Daelemans, Sofie] Univ Antwerp, Fac Pharmaceut Biomed & Vet Sci, Med Bioch, Antwerp, Belgium; [Gevaert, Thomas] AZ Klina, Dept Pathol, Brasschaat, Belgium	KU Leuven; University Hospital Leuven; KU Leuven; University of Antwerp	Muilwijk, T (corresponding author), Univ Hosp Leuven, Dept Urol, Leuven, Belgium.; Muilwijk, T (corresponding author), Katholieke Univ Leuven, Organ Syst, Leuven, Belgium.	tim.muilwijk@kuleuven.be	AKAND, Murat/H-7461-2019; joniau, steven/K-7655-2013	AKAND, Murat/0000-0001-8840-5771; joniau, steven/0000-0003-3195-9890; Baekelandt, loic/0000-0002-8962-9395	CellCarta	CellCarta	CellCarta provided support in the form of salaries for authors SD, KM, YW, and MK, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `CRediT author statement'.	Bessa A, 2019, EUR UROL, V76, P258, DOI 10.1016/j.eururo.2019.01.031; Calvete J, 2019, HUM PATHOL, V91, P61, DOI 10.1016/j.humpath.2019.07.002; Dadhania V, 2016, EBIOMEDICINE, V12, P105, DOI 10.1016/j.ebiom.2016.08.036; Fernandez-Gomez J, 2009, J UROLOGY, V182, P2195, DOI 10.1016/j.juro.2009.07.016; Fitzgerald AA, 2020, CANCER METAST REV, V39, P783, DOI 10.1007/s10555-020-09909-3; Hendry S, 2017, ADV ANAT PATHOL, V24, P311, DOI 10.1097/PAP.0000000000000161; Kamoun A, 2020, EUR UROL, V77, P420, DOI 10.1016/j.eururo.2019.09.006; Liu F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116683; Mariathasan S, 2018, NATURE, V554, P544, DOI 10.1038/nature25501; Mezheyeuski A, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-019-55013-0; Mhawech-Fauceglia P, 2015, CANCER MICROENVIRON, V8, P23, DOI 10.1007/s12307-014-0153-7; Powles T, 2019, NAT MED, V25, P1706, DOI 10.1038/s41591-019-0628-7; Windisch P, 2020, CANCERS, V12, DOI 10.3390/cancers12092629; Wynn TA, 2012, NAT MED, V18, P1028, DOI 10.1038/nm.2807; Zhang MZ, 2015, ONCOL LETT, V10, P34, DOI 10.3892/ol.2015.3151	15	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2021	16	9							e0257195	10.1371/journal.pone.0257195	http://dx.doi.org/10.1371/journal.pone.0257195			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	WG6DR	34525114	Green Published, gold			2022-12-26	WOS:000707084400026
J	Bae, JK; Kim, KI; Kim, JH; Gwak, HG; Kim, C				Bae, Jung-Kwon; Kim, Kang-Il; Kim, Jun-Ho; Gwak, Hyun-Gon; Kim, Chanwoo			Does postoperative quantitative bone scintigraphy reflect outcomes following medial open-wedge high tibial osteotomy?	PLOS ONE			English	Article							CARTILAGE REGENERATION; ARTICULAR-CARTILAGE; KNEE; OSTEOARTHRITIS; ALIGNMENT; HISTORY; PLATE; SLOPE	Purpose The present study evaluated changes in bone tracer uptake (BTU) after medial open-wedge high tibial osteotomy (MOWHTO) and determined whether postoperative BTU correlates with clinical symptoms, radiologic parameters, or cartilage regeneration following MOWHTO. Methods A total of 210 knees underwent MOWHTO for medial compartmental osteoarthritis (OA) were enrolled in this study. Mean follow-up period was 42.7 months. We assessed BTU for the medial compartment of the knee before MOWHTO and at the time of plate removal. Radiologic parameters included Kellgren-Lawrence (K-L) grade and Hip-Knee-Ankle angle (HKAA). Clinical evaluation included American Knee Society (AKS) score and cartilage status was graded at the time of MOWHTO and second-look arthroscopy according to the International Cartilage Repair Society (ICRS) grading system and articular cartilage regeneration stage. Statistical analysis performed to assess the relationships among postoperative BTU of the medial compartment, radiologic parameters, arthroscopic changes and clinical outcomes. Results BTU of medial femoral condyle and tibial plateau were significantly decreased at 2 years after MOWHTO (p<0.001). AKS scores and arthroscopic cartilage status were also significantly improved following MOWHTO. BMI and postoperative HKAA showed significant correlations with postoperative changes of BTU in uni- and multi-variable analysis. Meanwhile, postoperative changes of BTU did not show significant correlation with clinical outcomes or cartilage regeneration following MOWHTO. Conclusion Lower BMI and postoperative valgus alignment were significant predictor for postoperative BTU decrease of the medial compartment following MOWHTO. However, postoperative changes of BTU did not reflect cartilage regeneration or clinical outcomes until the midterm follow-up.	[Bae, Jung-Kwon; Kim, Kang-Il; Kim, Jun-Ho; Gwak, Hyun-Gon] Kyung Hee Univ Hosp Gangdong, Dept Orthopaed Surg, Seoul, South Korea; [Kim, Kang-Il] Kyung Hee Univ, Dept Orthopaed Surg, Sch Med, Seoul, South Korea; [Kim, Chanwoo] Kyung Hee Univ Hosp Gangdong, Dept Nucl Med, Seoul, South Korea	Kyung Hee University; Kyung Hee University Hospital; Kyung Hee University; Kyung Hee University; Kyung Hee University Hospital	Kim, KI (corresponding author), Kyung Hee Univ Hosp Gangdong, Dept Orthopaed Surg, Seoul, South Korea.; Kim, KI (corresponding author), Kyung Hee Univ, Dept Orthopaed Surg, Sch Med, Seoul, South Korea.	khuknee@gmail.com	KIM, KANG-IL/AAI-1784-2019; Kim, Chanwoo/AAY-7643-2021	KIM, KANG-IL/0000-0002-4010-1063; Kim, Chanwoo/0000-0001-9914-313X; Bae, Jung-Kwon/0000-0002-9235-1347				Aaboe J, 2011, OSTEOARTHR CARTILAGE, V19, P822, DOI 10.1016/j.joca.2011.03.006; Agneskirchner JD, 2007, ARTHROSCOPY, V23, P852, DOI 10.1016/j.arthro.2007.05.018; Bito H, 2009, KNEE SURG SPORT TR A, V17, P382, DOI 10.1007/s00167-008-0706-8; Bonasia DE, 2014, AM J SPORT MED, V42, P690, DOI 10.1177/0363546513516577; Brittberg M, 2003, J BONE JOINT SURG AM, V85A, P58, DOI 10.2106/00004623-200300002-00008; Buck FM, 2009, SKELETAL RADIOL, V38, P339, DOI 10.1007/s00256-008-0627-0; El-Azab HM, 2011, ORTHOPEDICS, V34, pE622, DOI 10.3928/01477447-20110826-02; FUJISAWA Y, 1979, ORTHOP CLIN N AM, V10, P585; Giffin JR, 2004, AM J SPORT MED, V32, P376, DOI 10.1177/0363546503258880; Goshima K, 2019, J ORTHOP SCI, V24, P680, DOI 10.1016/j.jos.2018.12.020; Hirschmann MT, 2013, J ORTHOP RES, V31, P268, DOI 10.1002/jor.22206; INSALL JN, 1989, CLIN ORTHOP RELAT R, P13; Jud L, 2020, BMC MUSCULOSKEL DIS, V21, DOI 10.1186/s12891-020-03449-1; Jung WH, 2015, ARTHROSCOPY, V31, P673, DOI 10.1016/j.arthro.2014.11.035; Jung WH, 2014, ARTHROSCOPY, V30, P72, DOI 10.1016/j.arthro.2013.10.008; Kanamiya T, 2002, ARTHROSCOPY, V18, P725, DOI 10.1053/jars.2002.35258; KELLGREN JH, 1957, ANN RHEUM DIS, V16, P494, DOI 10.1136/ard.16.4.494; Kim HR, 2008, OSTEOARTHR CARTILAGE, V16, P212, DOI 10.1016/j.joca.2007.05.025; Kim HJ, 2020, KNEE SURG RELAT RES, V32, DOI 10.1186/s43019-020-00071-2; Kim KI, 2021, J ARTHROPLASTY, V36, P423, DOI 10.1016/j.arth.2020.08.067; Kim KI, 2017, AM J SPORT MED, V45, P1615, DOI 10.1177/0363546517694864; Koh IJ, 2015, J ARTHROPLASTY, V30, P939, DOI 10.1016/j.arth.2015.01.002; Koshino T, 2003, KNEE, V10, P229, DOI 10.1016/S0968-0160(03)00005-X; Kraus VB, 2009, ANN RHEUM DIS, V68, P1673, DOI 10.1136/ard.2008.094722; LaPrade RF, 2010, AM J SPORT MED, V38, P160, DOI 10.1177/0363546509342701; Lee SC, 2010, CLIN ORTHOP SURG, V2, P47, DOI 10.4055/cios.2010.2.1.47; Matsushita T, 2021, KNEE SURG RELAT RES, V33, DOI 10.1186/s43019-021-00090-7; Meidinger G, 2011, KNEE SURG SPORT TR A, V19, P333, DOI 10.1007/s00167-010-1335-6; Mucha A, 2015, KNEE SURG SPORT TR A, V23, P2315, DOI 10.1007/s00167-014-3053-y; Mucha A, 2013, J ORTHOP SURG RES, V8, DOI 10.1186/1749-799X-8-46; Na YG, 2021, KNEE SURG RELAT RES, V33, DOI 10.1186/s43019-020-00076-x; Nakajima A, 2018, J ORTHOP SURG RES, V13, DOI 10.1186/s13018-018-1030-8; Niemeyer P, 2010, ARTHROSCOPY, V26, P1607, DOI 10.1016/j.arthro.2010.05.006; Spahn G, 2006, OSTEOARTHR CARTILAGE, V14, P190, DOI 10.1016/j.joca.2005.08.013; Staubli AE, 2003, INJURY, V34, P55, DOI 10.1016/j.injury.2003.09.025; Sterett WI, 2004, AM J SPORT MED, V32, P1243, DOI 10.1177/0363546503259301; TETSWORTH K, 1994, ORTHOP CLIN N AM, V25, P367; Zhang YR, 2019, GEN PSYCHIAT, V32, DOI 10.1136/gpsych-2019-100069	38	0	0	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2021	16	9							e0257315	10.1371/journal.pone.0257315	http://dx.doi.org/10.1371/journal.pone.0257315			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	WG5RP	34520482	Green Published, gold			2022-12-26	WOS:000707052100019
J	Ranganathan, SS; Wanigatunge, C; Senadheera, GPSG; Beneragama, BVSH				Ranganathan, Shalini Sri; Wanigatunge, Chandanie; Senadheera, G. P. S. G.; Beneragama, B. V. S. H.			A national survey of antibacterial consumption in Sri Lanka	PLOS ONE			English	Article							OUTPATIENT ANTIBIOTIC USE; RESISTANCE	Introduction Optimizing the use of antibacterial medicines is an accepted strategy to combat the antibacterial resistance. Availability of reliable antibacterial consumption (ABC) data is a prerequisite to implement this strategy. Objectives To quantify and describe the national ABC in Sri Lanka and to examine any differences in the consumption between public and private sector. Methods The methodology for this survey was adapted from World Health Organization (WHO) methodology for a global programme on surveillance of antimicrobial consumption. Aggregate data on national consumption of systemic antibacterials (J01- Anatomical Therapeutic Chemical Classification (ATC) for 2017 were retrospectively extracted from all available data sources and classified using ATC classification. Quantity of consumption was converted to Defined Daily Doses (DDDs). Data are presented as total consumption and comparison between the public and private sector. Selected key quality indicators of ABC were compared between these two sectors. Findings From the available data sources, the total ABC in 2017 was 343.46 million DDDs. Private sector consumption accounted for 246.76 million DDDs compared to 97.96 million DDDs distributed to entire public sector by the Ministry of Health. Beta-lactam-penicillins antibacterial group accounted for 58.79% in public sector compared to 27.48% in private sector while macrolides, quinolones and other beta-lactam antibacterials accounted for 60.51% in the private compared to 28.41% in public sector. Consumption of Reserve group antibacterials was negligible, and limited to private sector. Watch category antibacterials accounted for 46%, 24% and 54% of the total, public and private sector consumption, respectively. Conclusions A disproportionately higher use of broad spectrum and Watch category antibacterials was observed in the private sector which needs further study. This national consumption survey highlights the need and provides the opening for establishment of ABC surveillance in Sri Lanka.	[Ranganathan, Shalini Sri] Univ Colombo, Fac Med, Dept Pharmacol, Colombo, Sri Lanka; [Wanigatunge, Chandanie] Univ Sri Jayewardenepura, Fac Med Sci, Dept Pharmacol, Sri Jayewardenepura, Sri Lanka; [Senadheera, G. P. S. G.] Univ Sri Jayewardenepura, Fac Allied Hlth Sci, Dept Pharm & Pharmaceut Sci, Sri Jayewardenepura, Sri Lanka; [Beneragama, B. V. S. H.] Minist Hlth, Natl Focal Point Combating Antimicrobial Resistan, Colombo, Sri Lanka	University of Colombo; University Sri Jayewardenepura; University Sri Jayewardenepura	Ranganathan, SS (corresponding author), Univ Colombo, Fac Med, Dept Pharmacol, Colombo, Sri Lanka.	sshalini@pharm.cmb.ac.lk		Wanigatunge, Chandanie/0000-0002-4477-8979	Sri Lanka Association of Clinical Pharmacology and Therapeutics (SLACPT)	Sri Lanka Association of Clinical Pharmacology and Therapeutics (SLACPT)	We acknowledge the Sri Lanka Association of Clinical Pharmacology and Therapeutics (SLACPT) for funding the data entry personnel, Mr P.A.A.S.P. Kumara for assisting in data entry, Dr Malitha Rubesinghe for coordinating approvals and all the officials and pharmacists who facilitated data extraction.	Amarasinghe N., 2018, J HLTH SOCIAL SCI, V1, P27; [Anonymous], 2018, ANN HLTH B; [Anonymous], 2018, SURVEILLANCE MONITOR; [Anonymous], 2019, WHO MOD LIST ESS MED; [Anonymous], 2016, EMPIRICAL PROPHYLACT; ARSP Working Grp, 2013, CEYLON MED J, V58, P56, DOI 10.4038/cmj.v58i2.5680; Centers for Disease Control and Prevention, 2019, ANT RES THREATS US; Coenen S, 2007, QUAL SAF HEALTH CARE, V16, P440, DOI 10.1136/qshc.2006.021121; Costelloe C, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2096; European Centre for Disease Prevention and Control, 2018, ANN EPIDEMIOLOGICAL; Farooqui HH, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204805; Fernando MMPSC, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2250-y; Fernandopulle BMR., 2020, PHARM J SRI LANKA, V10, P54, DOI [10.4038/pjsl.v10i1.57, DOI 10.4038/PJSL.V10I1.57]; Goossens H, 2005, LANCET, V365, P579, DOI 10.1016/S0140-6736(05)17907-0; Gravatt LAH, 2013, CURR INFECT DIS REP, V15, P559, DOI 10.1007/s11908-013-0374-9; Jayatilleke S. K., 2016, SRI LANKAN J INFECT, V6, P17, DOI [10.4038/sljid.v6i1.8105, DOI 10.4038/SLJID.V6I1.8105]; Klein EY, 2021, LANCET INFECT DIS, V21, P107, DOI 10.1016/S1473-3099(20)30332-7; Klein EY, 2018, P NATL ACAD SCI USA, V115, pE3463, DOI 10.1073/pnas.1717295115; Kumudunie WGM, 2020, J INFECT PUBLIC HEAL, V13, P1330, DOI 10.1016/j.jiph.2020.04.010; Laxminarayan R, 2013, LANCET INFECT DIS, V13, P1057, DOI 10.1016/S1473-3099(13)70318-9; McGettigan P, 2017, LANCET GLOB HEALTH, V5, pE1075, DOI 10.1016/S2214-109X(17)30365-0; Perera V., 2014, B SRI LANKA COLL MIC, V12, P19; Senadheera GPS, 2017, CEYLON MED J, V62, P70, DOI 10.4038/cmj.v62i1.8439; Senadheera G.P.S.G., 2020, PHARM J SRI LANKA, V9, P28, DOI [10.4038/pjsl.v9i1.49, DOI 10.4038/PJSL.V9I1.49]; Tillekeratne LG, 2017, BMC FAM PRACT, V18, DOI 10.1186/s12875-017-0619-z; Ventola C Lee, 2015, P T, V40, P277; Versporten A, 2018, LANCET GLOB HEALTH, V6, pE619, DOI [10.1016/S2214-109X(18)30186-4, 10.1016/s2214-109x(18)30186-4]; World Health Organisation, 2018, WHO REP SURV ANT CON; World Health Organization, 2015, GLOB ACT PLAN ANT RE; World Health Organization, 2017, WHO METH GLOB PROGR; World Health Organization, WHO COLLABORATING CT; World Health Organization, 2020, GLASS METH SURV NAT; World Health Organization (WHO), ANTIMICROBIAL RESIST; Zawahir S, 2019, RES SOC ADMIN PHARM, V15, P584, DOI 10.1016/j.sapharm.2018.07.019; Zhang HL, 2021, BMC INFECT DIS, V21, DOI 10.1186/s12879-021-05804-6	35	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2021	16	9							e0257424	10.1371/journal.pone.0257424	http://dx.doi.org/10.1371/journal.pone.0257424			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	WG5RP	34520501	Green Published, gold			2022-12-26	WOS:000707052100028
J	Alam, NE; Islam, MS; Ullah, H; Mollal, MT; Shifat, SK; Akter, S; Aktar, S; Khatun, MM; Ali, MR; Sen, TC; Chowdhury, K; Pervin, R; Mohiuddin, AKM				Alam, Nur E.; Islam, Md Shariful; Ullah, Hedayet; Mollal, Md Tarek; Shifat, Siratul Kubra; Akter, Sumaiya; Aktar, Salma; Khatun, Mst Mahmuda; Ali, Md Rayhan; Sen, Tapon Chandra; Chowdhury, Kamal; Pervin, Rehana; Mohiuddin, A. K. M.			Evaluation of knowledge, awareness and attitudes towards breast cancer risk factors and early detection among females in Bangladesh: A hospital based cross-sectional study	PLOS ONE			English	Article							SELF-EXAMINATION; WOMEN; MAMMOGRAPHY	Background Breast cancer (BCa) is a leading cause of mortality among women in Bangladesh. Many young women in Bangladesh have poor knowledge about breast cancer screening, including risk factors, warning signs/symptoms, diagnosis and early detection. We investigated awareness about breast cancer risk factors as a screening tool among women at the Sheikh Hasina Medical College (SHMC) of Tangail district in Bangladesh. Methods A cross sectional survey was conducted to collect data via a structured questionnaire from SHMC during the period of February to December 2019. A total of 1,007 participants (aged 33.47 (12.37 years)) was considered for data analysis. Results Of the 1,007 women, about 50% were knowledgeable about the risk factors. Pain in the breast was identified as the most commonly warning sign/symptom of breast cancer. Only 32.2% of respondents knew at least one breast cancer screening method. The mean knowledge was scored 3.43 +/- 2.25 out of a total possible score of 8. Awareness of BCa was associated with residence, family history of breast cancer, marital, literacy and socio-economic status (p <0.05). Only 14.7% of women who knew about BSE said they were conducting regular breast self-examination. Unmarried women (aOR: 2.971; 95% CI: 1.108-7.968) were more likely to have performed BSE compared to married women (p <0.05). Conclusion Although most participants were aware of breast cancer; knowledge about risk factors, warning signs/symptoms, early diagnosis and detection was relatively poor. Knowledge about performing BSE was particularly low. This highlights the importance of increasing awareness about breast cancer risk factors and early detection among young women in Bangladesh.	[Alam, Nur E.; Ullah, Hedayet; Mollal, Md Tarek; Shifat, Siratul Kubra; Akter, Sumaiya; Aktar, Salma; Ali, Md Rayhan; Sen, Tapon Chandra; Mohiuddin, A. K. M.] Mawlana Bhashani Sci & Technol Univ, Dept Biotechnol & Genet Engn, Tangail, Bangladesh; [Islam, Md Shariful] Univ Kentucky, Dept Biol, Lexington, KY USA; [Khatun, Mst Mahmuda] Mawlana Bhashani Sci & Technol Univ, Dept Biochem & Mol Biol, Tangail, Bangladesh; [Chowdhury, Kamal] Claflin Univ, Dept Biol, Orangeburg, SC USA; [Pervin, Rehana] Tangail Med Coll, Dept Gynaecol & Obstet, Tangail, Bangladesh	Mawlana Bhashani Science & Technology University; University of Kentucky; Mawlana Bhashani Science & Technology University; Claflin University	Mohiuddin, AKM (corresponding author), Mawlana Bhashani Sci & Technol Univ, Dept Biotechnol & Genet Engn, Tangail, Bangladesh.	akmmohiu@yahoo.com		Ali, Rayhan/0000-0002-5449-681X; Alam, Nur E/0000-0003-4723-5256				Ahmad, 2019, ADV BIOSCI CLIN MED, V7, P41, DOI [10.7575/aiac.abcmed.v.7n.1p.41, DOI 10.7575/AIAC.ABCMED.V.7N.1P.41]; Ahmed Kawsar, 2015, Asian Pac J Cancer Prev, V16, P7507; Al-Dubai SAR, 2011, ASIAN PAC J CANCER P, V12, P2531; Amin MN, 2020, HELIYON, V6, DOI 10.1016/j.heliyon.2020.e03753; [Anonymous], HOSP CANC REG REP; [Anonymous], 2020, GLOBOCAN 2020 BANGLA, V745, P9; Begum S A, 2019, Mymensingh Med J, V28, P96; Bharathi KV., 2017, INDIAN J PATHOL ONCO, V4, P361, DOI [10.18231/2394-6792.2017.0076, DOI 10.18231/2394-6792.2017.0076]; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Chong P. N., 2002, SMJ Singapore Medical Journal, V43, P509; Dadzi R, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0226925; Esmail Hassan Ebtesam, 2017, Asian Pac J Cancer Prev, V18, P1623, DOI 10.22034/APJCP.2017.18.6.1623; Grunfeld EA, 2002, BRIT J CANCER, V86, P1373, DOI 10.1038/sj.bjc.6600260; Hossain MS, 2014, CANCER EPIDEMIOL, V38, P465, DOI 10.1016/j.canep.2014.08.004; Hussein DM, 2013, SAUDI MED J, V34, P681; Islam MS, 2019, ANN ONCOL, V30, DOI 10.1093/annonc/mdz338.049; Islam RM, 2016, MATURITAS, V84, P68, DOI 10.1016/j.maturitas.2015.11.002; Jahan S, 2006, SAUDI MED J, V27, P1737; Karadag G, 2014, ASIAN PAC J CANCER P, V15, P1093, DOI 10.7314/APJCP.2014.15.3.1093; Karayurt O, 2008, BMC PUBLIC HEALTH, V8, P1; Khudri MM., 2018, BIOMETRICS BIOSTAT I, V7, P15406, DOI [10.15406/bbij.2018.07.00235, DOI 10.15406/BBIJ.2018.07.00235]; Liu LY, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1004; Montazeri Ali, 2008, Asia Pac Fam Med, V7, P6, DOI 10.1186/1447-056X-7-6; Naqvi AA, 2018, J PAK MED ASSOC, V68, P576; Okobia Michael N, 2006, World J Surg Oncol, V4, P11, DOI 10.1186/1477-7819-4-11; Ozmen V, 2011, BREAST J, V17, P260, DOI 10.1111/j.1524-4741.2011.01065.x; Parsa P, 2010, ASIAN PAC J CANCER P, V11, P681; Parsa P, 2008, ASIAN PAC J CANCER P, V9, P221; Pohls UG, 2004, EUR J CANCER PREV, V13, P249, DOI [10.1097/01.01.cej.0000136718.03089.a5, 10.1097/01.cej.0000136718.03089.a5]; Radi SM, 2013, ASIAN PAC J CANCER P, V14, P4307, DOI 10.7314/APJCP.2013.14.7.4307; RANASINGHE H, 2013, BMC PUBLIC HEALTH, V13, P9, DOI DOI 10.1186/1471-2458-13-9; Story HL, 2012, INT J BREAST CANCER, V2012, DOI 10.1155/2012/423562; Sung H, 2021, CA-CANCER J CLIN, V71, P209, DOI 10.3322/caac.21660; Taber KS, 2018, RES SCI EDUC, V48, P1273, DOI 10.1007/s11165-016-9602-2; Tazhibi M, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/306352; Tfayli A, 2010, J ONCOL, V2010, DOI 10.1155/2010/490631; Uche EEO, 1999, TROP DOCT, V29, P39, DOI 10.1177/004947559902900114; Vahabi M, 2011, J COMMUN HEALTH, V36, P265, DOI 10.1007/s10900-010-9307-9; Yadav P, 2010, ASIAN PAC J CANCER P, V11, P319	39	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2021	16	9							e0257271	10.1371/journal.pone.0257271	http://dx.doi.org/10.1371/journal.pone.0257271			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	WG6OR	34516589	Green Published, gold			2022-12-26	WOS:000707114200021
J	Al Mutair, A; Al Mutairi, A; Alhumaid, S; Abdullah, SM; Zaidi, ARZ; Rabaan, AA; Al-Omari, A				Al Mutair, Abbas; Al Mutairi, Alya; Alhumaid, Saad; Maaz Abdullah, Syed; Zia Zaidi, Abdul Rehman; Rabaan, Ali A.; Al-Omari, Awad			Examining and investigating the impact of demographic characteristics and chronic diseases on mortality of COVID-19: Retrospective study	PLOS ONE			English	Article							NEW-YORK-CITY; CLINICAL CHARACTERISTICS; SAUDI-ARABIA; OUTCOMES	Background Epidemiological features characterization of COVID-19 is highly important for developing and implementing effective control measures. In Saudi Arabia mortality rate varies between 0.6% to 1.26%. The purpose of the study was to investigate whether demographic characteristics (age and gender) and non-communicable diseases (Hypertension and Diabetes mellitus) have a significant association with mortality in COVID-19 patients. Methods Prior to data collection, an expedite approval was obtained from Institutional Review Board (IRB Log No: RC. RC20.09.10) in Al Habib Research Center at Dr. Sulaiman Al-Habib Medical Group, Riyadh, Saudi Arabia. This is a retrospective design where we used descriptive and inferential analysis to analyse the data. Binary logistic regression was done to study the association between comorbidities and mortality of COVID-19. Results 43 (86%) of the male patients were non-survivors while 7 (14%) of the female patients were survivors. The odds of non-survivors among hypertensive patients are 3.56 times higher than those who are not having a history of Hypertension (HTN). The odds of non-survivors among diabetic patients are 5.17 times higher than those who are not having a history of Diabetes mellitus (DM). The odds of non-survivors are 2.77 times higher among those who have a history of HTN and DM as compared to those who did not have a history of HTN and DM. Conclusions Those patients that had a history of Hypertension and Diabetes had a higher probability of non-survival in contrast to those who did not have a history of Diabetes and hypertension. Further studies are required to study the association of comorbidities with COVID-19 and mortality.	[Al Mutair, Abbas] Almoosa Specialist Hosp, Al Hasa, Saudi Arabia; [Al Mutair, Abbas] Princess Norah Bint Abdulrahman Univ, Coll Nursing, Riyadh, Saudi Arabia; [Al Mutair, Abbas] Univ Wollongong, Sch Nursing, Wollongong, NSW, Australia; [Al Mutairi, Alya] Taibah Univ, Math Dept, Medina, Saudi Arabia; [Alhumaid, Saad] Minist Hlth, Drug Informat & Res Dept, Adm Pharmaceut Care, Al Hasa, Saudi Arabia; [Maaz Abdullah, Syed] King Edward Med Univ, Dept Med, Lahore, Pakistan; [Zia Zaidi, Abdul Rehman; Al-Omari, Awad] Dr Sulaiman Al Habib Med Grp, Res Ctr, Riyadh, Saudi Arabia; [Rabaan, Ali A.] Johns Hopkins Aramco Healthcare, Mol Diagnost Lab, Dhahran, Saudi Arabia; [Rabaan, Ali A.] Univ Haripur, Dept Publ Hlth & Nutr, Haripur, Pakistan; [Al-Omari, Awad] Alfaisal Univ, Coll Med, Riyadh, Saudi Arabia	Princess Nourah bint Abdulrahman University; University of Wollongong; Taibah University; John Hopkins Aramco Healthcare; Johns Hopkins University; Johns Hopkins Medicine; Alfaisal University	Al Mutairi, A (corresponding author), Taibah Univ, Math Dept, Medina, Saudi Arabia.	amutairi@taibahu.edu.sa	Al Mutair, Abbas Saleh/AAJ-5493-2020; Zaidi, Abdul Rehman Zia/AAC-8229-2019	Al Mutair, Abbas Saleh/0000-0002-9471-2767; Zaidi, Abdul Rehman Zia/0000-0003-0137-9633; AL MUTAIRI, ALYA/0000-0003-4181-6279				Al Mutair A, 2021, INT J GEN MED, V14, P3719, DOI 10.2147/IJGM.S313757; Al Mutair A, 2020, EUR J MED RES, V25, DOI 10.1186/s40001-020-00462-x; Al Mutair A, 2020, NURS REP, V10, P23, DOI 10.3390/nursrep10010004; Al-Omari A, 2020, J INFECT PUBLIC HEAL, V13, P1639, DOI 10.1016/j.jiph.2020.09.003; Alhumaid S, 2021, EUR J MED RES, V26, DOI 10.1186/s40001-021-00517-7; Alhumaid S, 2020, TROP MED INFECT DIS, V5, DOI 10.3390/tropicalmed5040180; Alsofayan YM, 2020, J INFECT PUBLIC HEAL, V13, P920, DOI 10.1016/j.jiph.2020.05.026; [Anonymous], PNEYM UNKN CAUS CHIN; Barron E, 2020, LANCET DIABETES ENDO, V8, P813, DOI 10.1016/S2213-8587(20)30272-2; Cummings MJ, 2020, LANCET, V395, P1763, DOI 10.1016/S0140-6736(20)31189-2; Guo WN, 2020, DIABETES-METAB RES, V36, DOI 10.1002/dmrr.3319; Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5; Li LQ, 2020, J MED VIROL, V92, P577, DOI 10.1002/jmv.25757; Liang X, 2020, J INFECTION, V81, pE44, DOI 10.1016/j.jinf.2020.06.060; Ministry of Health, COVID 19 DASHB SAUD; Ministry of Health, SAUD MOH REP 1 CAS C; Novel C. P. E. R. E, 2020, ZHONGHUA LIU XING BI, V41, p145 . 32064853; Onder G, 2020, JAMA-J AM MED ASSOC, V323, P1775, DOI 10.1001/jama.2020.4683; Pranata R, 2020, J RENIN-ANGIO-ALDO S, V21, DOI 10.1177/1470320320926899; Richardson S, 2020, JAMA-J AM MED ASSOC, V323, P2052, DOI 10.1001/jama.2020.6775; Sheshah E, 2021, DIABETES RES CLIN PR, V172, DOI 10.1016/j.diabres.2020.108538; Shi Q., 2020, DIABETIC PATIENTS CO; Sun PF, 2020, J MED VIROL, V92, P612, DOI 10.1002/jmv.25735; Wang DW, 2020, JAMA-J AM MED ASSOC, V323, P1061, DOI 10.1001/jama.2020.1585; Wang GY, 2020, OPEN FORUM INFECT DI, V7, DOI 10.1093/ofid/ofaa153; WHO, WHO COR DIS COVID 19; World Health Organization Regional Office for Europe, COR DIS COVID 19 OUT; Young BE, 2020, JAMA-J AM MED ASSOC, V323, P1488, DOI 10.1001/jama.2020.3204; Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3	29	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2021	16	9							e0257131	10.1371/journal.pone.0257131	http://dx.doi.org/10.1371/journal.pone.0257131			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XM9EM	34506551	Green Published, gold			2022-12-26	WOS:000729120700044
J	Fenta, HM; Zewotir, T; Muluneh, EK				Fenta, Haile Mekonnen; Zewotir, Temesgen; Muluneh, Essey Kebede			Disparities in childhood composite index of anthropometric failure prevalence and determinants across Ethiopian administrative zones	PLOS ONE			English	Article							LINEAR UNBIASED ESTIMATION; NUTRITIONAL-STATUS; PREDICTION; UNDERNUTRITION; MALNUTRITION; CHILDREN; PERFORMANCE; COMPONENTS; SELECTION; PLANT	Background The prevalence of under-five children's undernutrition in Ethiopia is among the highest in the world. This study aimed at exploring the prevalence and risk factors of the composite index for anthropometric failure (CIAF) of under-five children in Ethiopia by incorporating the zonal (district) effects. Methods The data was drawn from Ethiopian Demographic and Health Surveys (EDHSs), a population-based cross-sectional study of 29,599 under-five year children from 72 Zones in the years 2000, 2005, 2011, and 2016. Fixed effect variables related to child and maternal-household were included in the model. We adopted a generalized mixed model with CIAF as outcome variable and Zones as random effects. Results The prevalence of CIAF in Ethiopia was 53.78% with the highest prevalence of 61.30% in 2000 and the lowest prevalence of 46.58% in 2016. The model result revealed that being a female child, absence of comorbidity, singleton births, and the first order of birth showed significantly lower CIAF prevalence than their counterparts. Among the household characteristics, children from mothers of underweight body mass index, uneducated parents, poor household sanitation, and rural residents were more likely to be undernourished than their counterparts. Based on the best linear unbiased prediction for the zonal-level random effect, significant variations of CIAF among zones were observed. Conclusion The generalized linear mixed-effects model results identified gender of the child, size of child at birth, dietary diversity, birth type, place of residence, age of the child, parental level of education, wealth index, sanitation facilities, and media exposure as main drivers of CIAF. Disparities of CIAF were observed between and within the Ethiopian administrative Zones over time.	[Fenta, Haile Mekonnen] Bahir Dar Univ, Coll Sci, Dept Stat, Bahir Dar, Ethiopia; [Zewotir, Temesgen] Univ KwaZulu Natal, Coll Agr Engn & Sci, Sch Math Stat & Comp Sci, Durban, South Africa; [Muluneh, Essey Kebede] Bahir Dar Univ, Sch Publ Hlth, Bahir Dar, Ethiopia	Bahir Dar University; University of Kwazulu Natal; Bahir Dar University	Fenta, HM (corresponding author), Bahir Dar Univ, Coll Sci, Dept Stat, Bahir Dar, Ethiopia.	hailemekonnen@gmail.com	Fenta, Haile Mekonnen/AAV-2694-2020	Fenta, Haile Mekonnen/0000-0002-3919-2762; Muluneh, Essey Kebede/0000-0002-2469-5009				Abdulahi A, 2017, ETHIOP J HEALTH SCI, V27, P175, DOI 10.4314/ejhs.v27i2.10; Adekanmbi VT, 2013, MATERN CHILD NUTR, V9, P244, DOI 10.1111/j.1740-8709.2011.00361.x; Aheto JMK, 2015, PAEDIATR PERINAT EP, V29, P552, DOI 10.1111/ppe.12222; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Akombi BJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177338; Al-Sadeeq AH, 2018, E MEDITERR HEALTH J, V24, P1119, DOI 10.26719/2018.24.12.1119; Amugsi DA, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005340; Amugsi DA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136748; Bain LE, 2013, PAN AFR MED J, V15, DOI 10.11604/pamj.2013.15.120.2535; balaselan E.Y.s., 2000, ETHIOPIA DEMOGRAPHIC; Bantamen G., 2014, Journal of Nutrition and Food Sciences, V4, P256; Black RE, 2008, LANCET, V371, P243, DOI 10.1016/S0140-6736(07)61690-0; BRESLOW NE, 1993, J AM STAT ASSOC, V88, P9, DOI 10.1080/01621459.1993.10594284; Central Statistical Office M.o.H. and I. International, 2014, ZAMB DEM HLTH SURV 2; Chalashika P, 2017, J HUM NUTR DIET, V30, P779, DOI 10.1111/jhn.12517; Chowdhury MRK, 2016, J PEDIATR-US, V172, P194, DOI 10.1016/j.jpeds.2016.01.023; Corsi DJ, 2011, PUBLIC HEALTH NUTR, V14, P951, DOI 10.1017/S1368980010003356; Csa I.., 2016, ETH DEM HLTH SURV; Dao C, 2016, ANN MATH SCI APPL, V1, P195, DOI 10.4310/AMSA.2016.v1.n1.a6; Degarege D, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1714-5; Demographic E., 2011, HLTH SURVEY ADDIS AB; Dhok R. S., 2016, International Journal of Medical Science and Public Health, V5, P2013; Endris N, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/6587853; Fanzo J.., 2012, NUTR CHALLENGE SUBSA; Fenta HM, 2020, CLIN EPIDEMIOL GLOB, V8, P404, DOI 10.1016/j.cegh.2019.09.011; Forouzanfar MH, 2016, LANCET, V388, P1659, DOI 10.1016/S0140-6736(16)31679-8; Fotso Jean-Christophe, 2009, Reprod Health, V6, P9, DOI 10.1186/1742-4755-6-9; Furlani RCM, 2005, GENET MOL BIOL, V28, P271, DOI 10.1590/S1415-47572005000200017; Gautam S, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16050895; Gebre A, 2019, J NUTR METAB, V2019, DOI 10.1155/2019/9187609; Gebreyesus SH, 2016, PUBLIC HEALTH NUTR, V19, P1417, DOI 10.1017/S1368980015003377; Goldstein H., 2011, MULTILEVEL STAT MODE, V922; Griffiths P, 2004, HEALTH PLACE, V10, P183, DOI 10.1016/j.healthplace.2003.07.001; Habyarimana F., 2014, MEDITERR J SOC SCI, V5, P1642, DOI 10.5901/mjss.2014.v5n23p1642; Hasan MT, 2016, AM J CLIN NUTR, V104, P1121, DOI 10.3945/ajcn.115.111773; Henderson C.R., 1963, STAT GENETICS PLANT, V982, P141, DOI DOI 10.17226/20264; HENDERSON CR, 1975, BIOMETRICS, V31, P423, DOI 10.2307/2529430; Hooshmand S, 2013, ANN NUTR METAB, V63, P1398; Hox JJ., 2017, MULTILEVEL ANAL TECH, DOI DOI 10.4324/9781315650982; International I.., 2016, RWAND DEM HLTH SURV; Kang Y, 2019, MATERN CHILD NUTR, V15, DOI 10.1111/mcn.12821; Kasaye HK, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0225996; Kassie GW, 2020, BMC PUBLIC HEALTH, V20, DOI 10.1186/s12889-020-08539-2; Khamis AG, 2020, BMC NUTR, V6, DOI 10.1186/s40795-020-00366-3; Kleinknecht K, 2013, CROP SCI, V53, P1384, DOI 10.2135/cropsci2013.02.0073; Kumera G, 2018, NUTR METAB, V15, DOI 10.1186/s12986-018-0248-0; Lartey A, 2008, P NUTR SOC, V67, P105, DOI 10.1017/S0029665108006083; Mandal G., 2009, ASSESSMENT OVERALL P; McCulloch C.E.., 2008, GEN LINEAR MIXED MOD, V279, pM38; Milkias P.., 2011, ABC CLIO; Mills S, 2008, MATERN CHILD HLTH J, V12, P509, DOI 10.1007/s10995-007-0288-y; Nandy S, 2005, B WORLD HEALTH ORGAN, V83, P210; Nandy S., 2012, HDB ANTHROPOMETRY PH, P127; Nandy S, 2008, SOC SCI MED, V66, P1963, DOI 10.1016/j.socscimed.2008.01.021; NEUHAUS JM, 1991, INT STAT REV, V59, P25, DOI 10.2307/1403572; Obuchowski NA, 2003, RADIOLOGY, V229, P3, DOI 10.1148/radiol.2291010898; OlaOlorun FM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098702; Oliveira GHF, 2016, CHIL J AGR RES, V76, P294, DOI 10.4067/S0718-58392016000300005; Palmer E., 2015, J GLOBAL ETHICS, V11, P262, DOI DOI 10.1080/17449626.2015.1119928; Pei LL, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-121; Piepho HP, 2008, EUPHYTICA, V161, P209, DOI 10.1007/s10681-007-9449-8; Rasheed Waleed, 2018, Int J Pediatr Adolesc Med, V5, P24, DOI 10.1016/j.ijpam.2017.12.003; Roberts DJ, 2019, ANEMIA, V2019, DOI 10.1155/2019/1598920; ROBINSON GK, 1986, J DAIRY SCI, V69, P3106, DOI 10.3168/jds.S0022-0302(86)80774-3; Rutstein SO, 2015, STEPS CONSTRUCTING N; Savanur MS, 2015, J HEALTH POPUL NUTR, V33, DOI 10.1186/s41043-015-0017-x; Searle S. R., 2009, VARIANCE COMPONENTS, V391; Sen J, 2012, ANN HUM BIOL, V39, P129, DOI 10.3109/03014460.2012.655777; Shit Subhadeep, 2012, Indian J Public Health, V56, P305, DOI 10.4103/0019-557X.106421; Skrondal A, 2009, J R STAT SOC A STAT, V172, P659, DOI 10.1111/j.1467-985X.2009.00587.x; Solkner J, 2008, EUPHYTICA, V161, P273, DOI 10.1007/s10681-007-9507-2; Svedberg P., 2000, WIDER STUDY GROUP S; Svefors P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149700; Teshale AB, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0238957; UDHS I.., 2011, UG DEM HLTH SURV; United Nations Children's Fund W.H.O. International Bank for Reconstruction and D.T.W. Bank, 2019, LEVELS TRENDS CHILD; Vyas S, 2006, HEALTH POLICY PLANN, V21, P459, DOI 10.1093/heapol/czl029; Wamani H., 2007, BMC Pediatrics, V7; Woldemicael G, 2010, MATERN CHILD HLTH J, V14, P988, DOI 10.1007/s10995-009-0535-5; World Health Organization, 2010, Indicators for assessing infant and young child feeding practices, part 2: measurement; Wu L., 2009, MIXED EFFECTS MODELS, DOI [10.1201/9781420074086, DOI 10.1201/9781420074086]; Zewotir T, 2008, COMMUN STAT-THEOR M, V37, P1071, DOI 10.1080/03610920701713229; Zewotir T, 2012, S AFR J ECON MANAG S, V15, P44, DOI 10.4102/sajems.v15i1.62; Ziba M, 2018, S AFR J CLIN NUTR, V31, P43, DOI 10.1080/16070658.2017.1387433	84	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2021	16	9							e0256726	10.1371/journal.pone.0256726	http://dx.doi.org/10.1371/journal.pone.0256726			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XH8RH	34555038	gold, Green Published			2022-12-26	WOS:000725694500014
J	Sithey, G; Wen, LM; Dzed, L; Li, M				Sithey, Gyambo; Wen, Li Ming; Dzed, Laigden; Li, Mu			Noncommunicable diseases risk factors in Bhutan: A secondary analysis of data from Bhutan's nationwide STEPS survey 2014	PLOS ONE			English	Article							ALCOHOL-CONSUMPTION; SMOKING; MIDDLE; HYPERTENSION; PREVALENCE; OBESITY; MEN	Background Bhutan is facing an epidemic of noncommunicable diseases; they are responsible for 53% of all deaths. Four main modifiable risk factors, including tobacco use, harmful use of alcohol, physical inactivity, and unhealthy diet, are the causes of most noncommunicable diseases (NCDs). This study aimed to assess 1) the prevalence of NCDs modifiable risk factors in Bhutan's adult population and 2) associations between the sociodemographic factors and the NCDs modifiable risk factors with overweight or obesity, hypertension, and diabetes. Methods We used the 2014 Bhutan WHO Stepwise Approach to NCD Risk Factor Surveillance (STEPS) Survey dataset in this study. Data were analyzed using multiple logistic regressions, constructed with overweight or obesity, hypertension, and diabetes as outcome variables and modifiable risk factors as independent variables. Results The prevalence of tobacco use, harmful use of alcohol, unhealthy diet (low fruits and vegetables intake) and physically inactive was 24.8% (95% CI: 21.5, 28.5), 42.4% (95% CI: 39.4, 45.5), 66.9% (95% CI: 61.5, 71.8), and 6.2% (95% CI: 4.9, 7.8), respectively. The prevalence of overweight or obesity, hypertension and diabetes was 32.9% (95%CI: 30.0, 36.0), 35.7% (95% CI: 32.8, 38.7) and 6.4% (95% CI: 5.1, 7.9), respectively. Multiple logistic regression showed that older age groups were more likely to be overweight or obese, hypertensive, and diabetic. Our analysis also found that tobacco users were less likely to be overweight or obese (aOR 0.71, 95% CI 0.52, 0.96), and to be hypertensive (aOR 0.74, 95% CI 0.56, 0.97); but they were more likely to be diabetic (aOR 1.64, 95% CI 1.05, 2.56). Alcohol users were more likely to be hypertensive aOR 1.41 (95% CI 1.15, 1.74). Furthermore, vigorous physical activity could protect people from being overweight or obese, aOR 0.47 (95% CI 0.31, 0.70), and those consuming more than five serves of fruits and vegetables per day were more likely to be overweight or obese, aOR 1.46 (95% CI 1.17, 1.82). Conclusion The prevalence of NCDs modifiable risk factors and overweight or obesity and hypertension was high in Bhutan. We found strong associations between tobacco use and diabetes, alcohol use, hypertension, physically inactive, and overweight or obesity. The results suggest that the government should prioritize NCDs prevention and control programs, focusing on reducing modifiable risk factors. The health sector alone cannot address the NCDs epidemic in Bhutan, and we recommend the whole of government approach to tackle NCDs through the Bhutan Gross National Happiness framework.	[Sithey, Gyambo] Ctr Res Initiat, Changangkha, Thimphu, Bhutan; [Sithey, Gyambo; Wen, Li Ming; Li, Mu] Univ Sydney, Sydney Sch Publ Hlth, Sydney, NSW, Australia; [Wen, Li Ming] Sydney Local Hlth Dist, Populat Hlth Res & Evaluat Hub, Sydney, NSW, Australia; [Dzed, Laigden] Minist Hlth, Dept Publ Hlth, Nutr Program, Thimphu, Bhutan	University of Sydney	Li, M (corresponding author), Univ Sydney, Sydney Sch Publ Hlth, Sydney, NSW, Australia.	mu.li@sydney.edu.au	Wen, Li Ming/ABG-9005-2021	Wen, Li Ming/0000-0003-1381-4022				Aekplakorn Wichai, 2004, Journal of the Medical Association of Thailand, V87, P685; Anjana RM, 2017, LANCET DIABETES ENDO, V5, P585, DOI 10.1016/S2213-8587(17)30174-2; Aryal KK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134834; Beaglehole R, 2011, LANCET, V377, P1438, DOI 10.1016/S0140-6736(11)60393-0; Bertoia ML, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001878; Biswas T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177395; Bloom DE, 2011, GLOBAL EC BURDEN NON, DOI DOI 10.1192/BJP.184.5.393; Briasoulis A, 2012, J CLIN HYPERTENS, V14, P792, DOI 10.1111/jch.12008; Charlton K, 2014, NUTRIENTS, V6, P2305, DOI 10.3390/nu6062305; Chencho D., 2005, P 2 INT C GROSS NAT, P64; Dagenais GR, 2016, DIABETES CARE, V39, P780, DOI 10.2337/dc15-2338; DALLOSSO HM, 1984, INT J OBESITY, V8, P365; Deerochanawong C, 2013, GLOBALIZATION HEALTH, V9, DOI 10.1186/1744-8603-9-11; Dumith SC, 2011, PREV MED, V53, P24, DOI 10.1016/j.ypmed.2011.02.017; Ezzati M, 2013, NEW ENGL J MED, V369, P954, DOI 10.1056/NEJMra1203528; Ford ND, 2017, ANNU REV PUBL HEALTH, V38, P145, DOI 10.1146/annurev-publhealth-031816-044604; Fuchs FD, 2001, HYPERTENSION, V37, P1242, DOI 10.1161/01.HYP.37.5.1242; Gross National Happiness Commission, 2013, 11 5 YEAR PLAN; Gurung MS, 2016, POPUL HEALTH METR, V14, DOI 10.1186/s12963-016-0098-9; Kalyani RR, 2017, DIABETES CARE, V40, P440, DOI 10.2337/dci17-0005; Krishnani A., 2013, HYPERTENSION S E ASI, V17; Leone A, 2011, CARDIOL RES PRACT, V2011, DOI 10.4061/2011/264894; Lham D, 2012, ALCOHOL USE ABUSE BH; Little Matthew, 2016, BMC Obes, V3, P12, DOI 10.1186/s40608-016-0091-7; Ministry of Health, 2016, 2015 NAT NUTR SURV; Ministry of Health, 2014, 2012 NAT HLTH SURV; Ministry of Health Royal Government of Bhutan, 2009, REP 2007 STEPS SURV; Misra PJ, 2014, INDIAN J MED RES, V140, P370; Norbu Wang, 2017, Int J Adolesc Med Health, V31, DOI 10.1515/ijamh-2016-0143; O'Brien RM, 2007, QUAL QUANT, V41, P673, DOI 10.1007/s11135-006-9018-6; Pankova A, 2015, TOB INDUC DIS, V13, DOI 10.1186/s12971-015-0049-4; Parliament of Bhutan, 2014, TOB CONTR AM ACT BHU; Popkin BM, 2012, NUTR REV, V70, P3, DOI 10.1111/j.1753-4887.2011.00456.x; Regional Office for South-East Asia, 2016, NAT SURV NONC DIS RI; Sithey G, 2018, J PUBLIC HEALTH POL, V39, P327, DOI 10.1057/s41271-018-0135-y; Sithey G, 2017, J CLIN SLEEP MED, V13, P33, DOI 10.5664/jcsm.6382; Tobgay S., 2010, FIGHTING HUNGER RIGH; United Nations' Committee for Development Policy, 2021, LIST LEAST DEV COUNT; Virdis A, 2010, CURR PHARM DESIGN, V16, P2518, DOI 10.2174/138161210792062920; Willi C, 2007, JAMA-J AM MED ASSOC, V298, P2654, DOI 10.1001/jama.298.22.2654; World Health Organization, 2020, NONC DIS PROGR MON 2; World Health Organization, 2005, WHO STEPWISE APPR NO; World Health Organization, 2006, GLOB STRAT DIET PHYS; World Health Organization, 2016, GLOB REP DIAB; Zaman Mohammad Mostafa, 2016, Indian J Public Health, V60, P17, DOI 10.4103/0019-557X.177290	46	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2021	16	9							e0257385	10.1371/journal.pone.0257385	http://dx.doi.org/10.1371/journal.pone.0257385			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XH8RH	34555064	gold, Green Published			2022-12-26	WOS:000725694500032
J	Dabre, EE; Lee, SJ; Hijri, M; Favret, C				Dabre, Elisee Emmanuel; Lee, Soon-Jae; Hijri, Mohamed; Favret, Colin			The effects of mycorrhizal colonization on phytophagous insects and their natural enemies in soybean fields	PLOS ONE			English	Article							GROWTH-PROMOTING RHIZOBACTERIA; FOLIAR-FEEDING INSECTS; COLORED PAN TRAPS; PLANT-GROWTH; ARBUSCULAR MYCORRHIZA; GLOMUS-INTRARADICES; POPULATION-DYNAMICS; FUNGI; COMMUNITY; HERBIVORES	The use of belowground microorganisms in agriculture, with the aim to stimulate plant growth and improve crop yields, has recently gained interest. However, few studies have examined the effects of microorganism inoculation on higher trophic levels in natural conditions. We examined how the diversity of phytophagous insects and their natural enemies responded to the field-inoculation of soybean with a model arbuscular mycorrhizal fungus (AMF), Rhizophagus irregularis, combined with a nitrogen-fixing bacterium, Bradyrhizobium japonicum, and a plant growth-promoting bacterium, Bacillus pumilus. We also investigate if the absence or presence of potassium fertilizer can affect this interaction. We found an increase in the abundance of piercing-sucking insects with the triple inoculant irrespective of potassium treatment, whereas there were no differences among treatments for other insect groups. A decrease in the abundance of the soybean aphid, Aphis glycines, with the double inoculant Rhizophagus + Bradyrhizobium was observed in potassium enriched plots and in the abundance of Empoasca spp. with potassium treatment independent of inoculation type. Although it was not possible to discriminate the mycorrhization realized by inoculum from that of the indigenous AMF in the field, we confirmed global negative effects of overall mycorrhizal colonization on the abundance of phytophagous piercing-sucking insects, phytophagous chewing insects, and the alpha diversity of phytophagous insects. In perspective, the use of AMF/Rhizobacteria inoculants in the field should focus on the identity and performance of strains to better understand their impact on insects.	[Dabre, Elisee Emmanuel; Hijri, Mohamed; Favret, Colin] Univ Montreal, Biodivers Ctr, Plant Biol Res Inst, Dept Biol Sci, Montreal, PQ, Canada; [Lee, Soon-Jae] Univ Lausanne, Dept Ecol & Evolut, Lausanne, Switzerland; [Hijri, Mohamed] Mohammed VI Polytech Univ UM6P, AgroBioSci, Ben Guerir, Morocco	Universite de Montreal; University of Lausanne; Mohammed VI Polytechnic University	Dabre, EE (corresponding author), Univ Montreal, Biodivers Ctr, Plant Biol Res Inst, Dept Biol Sci, Montreal, PQ, Canada.	dabremmanuel@yahoo.fr	LEE, SOON-JAE/GSO-3184-2022; Hijri, Mohamed/ABC-5969-2021; Favret, Colin/F-7726-2012	LEE, SOON-JAE/0000-0002-7216-0236; Hijri, Mohamed/0000-0001-6112-8372; Favret, Colin/0000-0001-6243-3184; Dabre, Elisee Emmanuel/0000-0002-6635-9417	Natural Sciences and Engineering Research Council of Canada (NSERC) [RGPIN 2017-06287, RGPIN-2018-04178]; Islamic Development Bank	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Islamic Development Bank(Islamic Development Bank)	This work was supported by the Natural Sciences and Engineering Research Council of Canada (NSERC) Discovery grants to CF (RGPIN 2017-06287) and to MH (RGPIN-2018-04178). EED received a scholarship from the Islamic Development Bank to support education fees and living allowances. Premier Tech Biotechnologies provided the seeds and inoculants and, in collaboration with La Coop Fe ' de ' re ' e, the access to fields trials in for data collection.	Ahemad Munees, 2014, Journal of King Saud University Science, V26, P1, DOI 10.1016/j.jksus.2013.05.001; Antunes PM, 2006, J AGRON CROP SCI, V192, P373, DOI 10.1111/j.1439-037X.2006.00223.x; Antunes PM, 2009, PLANT SOIL, V317, P257, DOI 10.1007/s11104-008-9806-y; Artursson V, 2006, ENVIRON MICROBIOL, V8, P1, DOI 10.1111/j.1462-2920.2005.00942.x; Babikova Z, 2014, J EXP BOT, V65, P5231, DOI 10.1093/jxb/eru283; Bai YM, 2003, CROP SCI, V43, P1774, DOI 10.2135/cropsci2003.1774; Baidoo P. K., 2011, Journal of Applied Biosciences, V41, P2765; Bala K., 2018, J PHARMACOGNOSY PHYT, V7, P2737; Balog A, 2017, J PEST SCI, V90, P935, DOI 10.1007/s10340-017-0844-1; Beisel JN, 1997, ECOL MODEL, V99, P289, DOI 10.1016/S0304-3800(97)01954-6; Bennett AE, 2016, J ECOL, V104, P1734, DOI 10.1111/1365-2745.12620; Bhattacharyya PN, 2012, WORLD J MICROB BIOT, V28, P1327, DOI 10.1007/s11274-011-0979-9; Compant S, 2010, SOIL BIOL BIOCHEM, V42, P669, DOI 10.1016/j.soilbio.2009.11.024; Dean JM, 2014, INT J MOL SCI, V15, P1466, DOI 10.3390/ijms15011466; Dean JM, 2009, PLANT SOIL, V323, P187, DOI 10.1007/s11104-009-9924-1; Derraik JGB, 2002, CONSERV BIOL, V16, P1015, DOI 10.1046/j.1523-1739.2002.00358.x; Dietrick E. J., 1960, California Agriculture, V14, P9; Doxon ED, 2011, J FIELD ORNITHOL, V82, P60, DOI 10.1111/j.1557-9263.2010.00308.x; Favret C, 2019, INSECT CONSERV DIVER, V12, P373, DOI 10.1111/icad.12368; Gadhave KR, 2018, ECOL STUD-ANAL SYNTH, V234, P117, DOI 10.1007/978-3-319-91614-9_6; GANGE AC, 1994, NEW PHYTOL, V128, P79, DOI 10.1111/j.1469-8137.1994.tb03989.x; Gange AC, 1999, NEW PHYTOL, V142, P123, DOI 10.1046/j.1469-8137.1999.00371.x; Gange AC, 2002, ECOL LETT, V5, P11, DOI 10.1046/j.1461-0248.2002.00299.x; Gange AC, 2001, NEW PHYTOL, V150, P611, DOI 10.1046/j.1469-8137.2001.00137.x; GEHRING CA, 1994, TRENDS ECOL EVOL, V9, P251, DOI 10.1016/0169-5347(94)90290-9; Gehring CA, 2002, ECOL STU AN, V157, P295; Gehring C, 2009, ENVIRON ENTOMOL, V38, P93, DOI 10.1603/022.038.0111; GLICK BR, 1995, CAN J MICROBIOL, V41, P109, DOI 10.1139/m95-015; Graham PH, 2003, PLANT PHYSIOL, V131, P872, DOI 10.1104/pp.017004; Hartley SE, 2009, ANNU REV ENTOMOL, V54, P323, DOI 10.1146/annurev.ento.54.110807.090614; Hodge A, 2000, FEMS MICROBIOL ECOL, V32, P91, DOI 10.1111/j.1574-6941.2000.tb00702.x; Howe GA, 2008, ANNU REV PLANT BIOL, V59, P41, DOI 10.1146/annurev.arplant.59.032607.092825; Iffis B, 2016, ENVIRON MICROBIOL, V18, P2689, DOI 10.1111/1462-2920.13438; Jung SC, 2012, J CHEM ECOL, V38, P651, DOI 10.1007/s10886-012-0134-6; Katayama N, 2011, ECOL ENTOMOL, V36, P43, DOI 10.1111/j.1365-2311.2010.01242.x; Kloppholz S, 2011, CURR BIOL, V21, P1204, DOI 10.1016/j.cub.2011.06.044; Koricheva J, 2009, ECOLOGY, V90, P2088, DOI 10.1890/08-1555.1; MCGONIGLE TP, 1990, NEW PHYTOL, V116, P629, DOI 10.1111/j.1469-8137.1990.tb00548.x; Myers SW, 2006, ENVIRON ENTOMOL, V35, P219, DOI 10.1603/0046-225X-35.2.219; Myers SW, 2005, J ECON ENTOMOL, V98, P113, DOI 10.1603/0022-0493-98.1.113; Perez-Montano F, 2014, MICROBIOL RES, V169, P325, DOI 10.1016/j.micres.2013.09.011; Pineda A, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00318; Rasmann S, 2017, INSECT SCI, V24, P947, DOI 10.1111/1744-7917.12464; ROSS HERBERT H., 1963, ANN ENTOMOL SOC AMER, V56, P202; Russo A, 2008, J BIOTECHNOL, V134, P312, DOI 10.1016/j.jbiotec.2008.01.020; Schussler A, 2001, MYCOL RES, V105, P1413, DOI 10.1017/S0953756201005196; Schweiger R, 2014, MOL PLANT MICROBE IN, V27, P1403, DOI 10.1094/MPMI-05-14-0126-R; Tajini F, 2011, SYMBIOSIS, V53, P123, DOI 10.1007/s13199-011-0117-3; Takacs T, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.01631; Tedersoo L, 2018, FUNGAL DIVERS, V90, P135, DOI 10.1007/s13225-018-0401-0; Tomczak VV, 2017, J INSECT PHYSIOL, V98, P258, DOI 10.1016/j.jinsphys.2017.01.016; Tomczak VV, 2016, J CHEM ECOL, V42, P1247, DOI 10.1007/s10886-016-0785-9; Fuentes MT, 2018, AGR ECOSYST ENVIRON, V255, P20, DOI 10.1016/j.agee.2017.12.007; Ueda K, 2013, APPL ENTOMOL ZOOL, V48, P79, DOI 10.1007/s13355-012-0155-1; Vierheilig H, 1998, APPL ENVIRON MICROB, V64, P5004; Voegtlin DJ, 2004, ANN ENTOMOL SOC AM, V97, P227, DOI 10.1603/0013-8746(2004)097[0227:AGTSAG]2.0.CO;2; Vrdoljak SM, 2012, J INSECT CONSERV, V16, P345, DOI 10.1007/s10841-011-9420-9; Walter AJ, 2007, ENVIRON ENTOMOL, V36, P26, DOI 10.1603/0046-225X(2007)36[26:SPDASP]2.0.CO;2; Wang B, 2006, MYCORRHIZA, V16, P299, DOI 10.1007/s00572-005-0033-6; Wang XR, 2011, MYCORRHIZA, V21, P173, DOI 10.1007/s00572-010-0319-1; Xavier LJC, 2003, BIOL FERT SOILS, V37, P261, DOI 10.1007/s00374-003-0605-6; Zhang F, 1996, ANN BOT-LONDON, V77, P453, DOI 10.1006/anbo.1996.0055; Zuur AF, 2010, METHODS ECOL EVOL, V1, P3, DOI 10.1111/j.2041-210X.2009.00001.x	64	0	0	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2021	16	9							e0257712	10.1371/journal.pone.0257712	http://dx.doi.org/10.1371/journal.pone.0257712			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YS4WS	34551014	Green Published, gold			2022-12-26	WOS:000750679800046
J	Irungu, BN; Koech, LC; Ondicho, JM; Keter, LK				Irungu, Beatrice Njeri; Koech, Lilian C.; Ondicho, Joyce M.; Keter, Lucia K.			Quality assessment of selected co-trimoxazole suspension brands marketed in Nairobi County, Kenya	PLOS ONE			English	Article							PROPHYLAXIS; TABLETS	Introduction Quality of medicines in both developed and developing countries is sometimes compromised due to infiltration of counterfeit, substandard or degraded medicines into the markets. It is a public health concern as poor quality medicines endanger public health where patients are exposed to chemical toxins and/or sub-therapeutic doses. This could lead to reduced treatment efficacy and promote development of drug resistance. Co-trimoxazole, a fixed dose combination of sulfamethoxazole and trimethoprim, is a broad spectrum for bacterial diseases and is also used as a prophylaxis for opportunistic infections in HIV infected individuals. This study evaluated quality of selected co-trimoxazole suspension brands marketed in Nairobi County, Kenya. Methods A total of 106 samples were collected, categorized into 15 brands and evaluated for active pharmaceutical ingredient content (API) and pH following United States Pharmacopeia. Assay for API was conducted using High Performance Liquid Chromatography. Results were compared with pharmacopeia references. Visual examination of labels and confirmation of retention status of the brands with Pharmacy and Poisons Board retention register was carried out. Results The samples were primarily of local origin (86.7%). On October 23, 2019, retention status of six of the fifteen brands documented were no longer listed in the Pharmacy and Poisons Board retention register. Of the 106 samples tested 70.6% and 86.8% were compliant with United States Pharmacopeia (USP) specifications for pH and API respectively while 84.0% adhered to packaging and labelling requirements. Conclusion This study has demonstrated that majority of co-trimoxazole suspensions tested were compliant with USP requirements. Additionally, it has provided evidence of poor quality co-trimoxazole medicines that could compromise treatment of infectious diseases in children. This emphasizes the need for regular quality assurance tests to ensure only quality medicines are in the market.	[Irungu, Beatrice Njeri; Koech, Lilian C.; Ondicho, Joyce M.; Keter, Lucia K.] Ctr Tradit Med & Drug Res, Kenya Med Res Inst, Nairobi, Kenya	Kenya Medical Research Institute	Irungu, BN (corresponding author), Ctr Tradit Med & Drug Res, Kenya Med Res Inst, Nairobi, Kenya.	Blrungu@kemri.org		/0000-0002-9966-0572	Wellcome Trust; Health Research Capacity Strengthening Postdoctoral Grant [080883/E/06/D]	Wellcome Trust(Wellcome TrustEuropean Commission); Health Research Capacity Strengthening Postdoctoral Grant	BNI thanks Wellcome Trust; Health Research Capacity Strengthening Postdoctoral Grant for the funding (080883/E/06/D). https://wellcome.org/grant-funding/schemes The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abuga K, 2013, E CENTRAL AFRICAN J; Abuye H, 2020, INFECT DRUG RESIST, V13, P691, DOI 10.2147/IDR.S234684; Amin AA, 2005, J CLIN PHARM THER, V30, P559, DOI 10.1111/j.1365-2710.2005.00685.x; [Anonymous], 2017, USP 40 NF 35, V35, P4061; Atemnkeng MA, 2007, TROP MED INT HEALTH, V12, P68, DOI 10.1111/j.1365-3156.2006.01769.x; Bourke CD, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aav0537; Chikowe I, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0637-z; Daniels B, 2019, LANCET GLOB HEALTH, V7, pE1717, DOI 10.1016/S2214-109X(19)30422-X; Evans C, 2017, LANCET GLOB HEALTH, V5, pE468, DOI 10.1016/S2214-109X(17)30147-X; Ewen M, 2018, HLTH ACTION INT, V4, P1; Fadeyi I, 2015, AM J TROP MED HYG, V92, P87, DOI 10.4269/ajtmh.14-0539; Frimpong G, 2018, J TROP MED-US, V2018, DOI 10.1155/2018/1494957; Goldberg E, 2012, CLIN MICROBIOL INFEC, V18, P8, DOI 10.1111/j.1469-0691.2011.03613.x; Hadi U, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-203; Hetzel MW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096810; Jiang JJ, 2019, EMERG MICROBES INFEC, V8, P367, DOI 10.1080/22221751.2019.1588078; Johnston A, 2014, BRIT J CLIN PHARMACO, V78, P218, DOI 10.1111/bcp.12298; Kaale E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165785; Kenya National Bureau of Statistics, 2019, KEN POP HOUS CENS RE; Khuluza F, 2014, MALAWI MED J, V26, P38; Koech LC, 2020, BIOMED RES INT, V2020, DOI 10.1155/2020/7091278; Lawal MG, 2019, ASIAN J PHARM RES DE, V7, P6; Minyeto D, 2014, INVITRO COMP EVALUAT; Morgan, 1970, KENYA PROJECTS ORG, P1; Mostafa SA, 2018, J STAT THEORY PRACT, V12, P290, DOI 10.1080/15598608.2017.1353456; Nassiri R., 2019, PHARM DRUG ACTION ST, V2019, P1; Ndwigah S, 2018, MALARIA J, V17, DOI 10.1186/s12936-018-2482-3; Opuni KFM, 2019, MALARIA J, V18, DOI 10.1186/s12936-019-3045-y; Organization WH, 2018, WHO REP SURV ANT CON; Orwa J, 2008, QUALITY SOME PHARM P, V2008; Petersen A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184165; Pharmacy and Poisons Board, 2010, REG DRUGS GUID SUBM, P1; Rahman MS, 2019, AM J TROP MED HYG, V101, P1018, DOI 10.4269/ajtmh.19-0247; Sanada T, 2020, FORENSIC SCI INT, V307, DOI 10.1016/j.forsciint.2020.110143; Schiavetti B, 2018, AM J TROP MED HYG, V98, P894, DOI 10.4269/ajtmh.17-0732; Shankar P.R., 2017, J CHITWAN MED COLL, V6, P68, DOI [10.3126/jcmc.v6i4.16721, DOI 10.3126/JCMC.V6I4.16721]; Simonetti R., 2016, MAKING MED AFRICA PO, P25; Thoithi GN, 2008, E CENTRAL AFRICAN J, V11; Wafula Francis, 2017, Drugs Real World Outcomes, V4, P53, DOI 10.1007/s40801-016-0100-7; WHO,, 2015, WHO GUID IMPL WHO CE; World Bank, 2018, KEN EC UPD POL OPT A, DOI 10.1596/29676; World Bank Group, 2006, DEC MEET DRAFT REP K; World Health Organization, 2002, WHO TECHN REP SER, V902, P120; Yoshida N, 2014, BMC PHARMACOL TOXICO, V15, DOI 10.1186/2050-6511-15-13	44	0	0	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 22	2021	16	9							e0257625	10.1371/journal.pone.0257625	http://dx.doi.org/10.1371/journal.pone.0257625			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YS4WS	34551002	gold, Green Published			2022-12-26	WOS:000750679800032
J	Lim, JY; Cho, SR; Kim, GW; Kim, PJ; Jeong, ST				Lim, Ji Yeon; Cho, Song Rae; Kim, Gil Won; Kim, Pil Joo; Jeong, Seung Tak			Uncertainty of methane emissions coming from the physical volume of plant biomass inside the closed chamber was negligible during cropping period	PLOS ONE			English	Article							RICE ORYZA-SATIVA; SOIL-TEMPERATURE; STATIC CHAMBERS; GAS-TRANSPORT; FIELDS; CH4; MITIGATION; VEGETATION; CULTIVARS; CLIMATE	In rice paddy, the closed chamber method is broadly used to estimate methane (CH4) emission rate. Since rice plants can significantly affect CH4 production, oxidation and emission, rice plantation inside the chamber is standardized in IPCC guidelines. Methane emission rate is calculated using the increased concentration inside the headspace. Biomass growth might decrease the headspace volume, and thus CH4 emission rates might be overestimated. To evaluate the influence of chamber headspace decreased by rice plant development on CH4 emission rates, five Korean rice cultivars were cultivated in a typical rice paddy, and physical volume changes in rice biomass were assayed using water displacement method. The recommended acrylic closed chambers (H. 1.2 m x W. 0.6 m x L. 0.6 m) were installed, and eight rice plants were transplanted inside the chamber with the same space interval with the outside. Biomass growth significantly decreased the headspace volume of the chamber. However, this volume covered only 0.48-0.55% of the closed chamber volume at the maximum growth stage. During the whole cropping period, mean 0.24-0.28% of chamber headspace was allocated by plant biomass, and thus this level of total CH4 emissions was overestimated. However, this overestimation was much smaller than the errors coming from other investigation processes (i.e., chamber closing hour, temperature recording, inconstant flooding level, different soil environments, etc.) and rice physiological changes. In conclusion, the influence of physical biomass volume inside the closed chamber was negligible to make the error in total CH4 emission assessment in rice paddies.	[Lim, Ji Yeon; Kim, Gil Won; Kim, Pil Joo] Gyeongsang Natl Univ, BK 21 Program, Div Appl Life Sci, Jinju, South Korea; [Cho, Song Rae] Natl Inst Agr Sci, Soil & Fertilizer Management Div, Wonju, South Korea; [Kim, Pil Joo] Gyeongsang Natl Univ, Inst Agr & Life Sci, Jinju, South Korea; [Jeong, Seung Tak] Rural Dev Adm RDA, Natl Inst Hort & Herbal Sci, Hort & Herbal Crop Environm Div, Wonju, South Korea	Gyeongsang National University; National Institute of Agricultural Sciences; Gyeongsang National University; National Institute of Horticultural & Herbal Science (NIHHS), Republic of Korea; Rural Development Administration (RDA), Republic of Korea	Kim, PJ (corresponding author), Gyeongsang Natl Univ, BK 21 Program, Div Appl Life Sci, Jinju, South Korea.; Kim, PJ (corresponding author), Gyeongsang Natl Univ, Inst Agr & Life Sci, Jinju, South Korea.; Jeong, ST (corresponding author), Rural Dev Adm RDA, Natl Inst Hort & Herbal Sci, Hort & Herbal Crop Environm Div, Wonju, South Korea.	pjkim@gnu.ac.kr; jst0ry@hanmail.net		Kim, gil won/0000-0002-2141-7476	Basic Science Research Program through the National Research Foundation of Korea - Ministry of Education [NRF-2015R1A6A1A03031413]; BK21 plus program of Ministry of Education and Human Resources Development, Korea	Basic Science Research Program through the National Research Foundation of Korea - Ministry of Education(Ministry of Education (MOE), Republic of KoreaNational Research Foundation of Korea); BK21 plus program of Ministry of Education and Human Resources Development, Korea(Ministry of Education & Human Resources Development (MOEHRD), Republic of Korea)	This work was supported by Basic Science Research Program through the National Research Foundation of Korea funded by the Ministry of Education (NRF-2015R1A6A1A03031413). Ji Yeon Lim and Song Rae Cho were supported by scholarships from the BK21 plus program of Ministry of Education and Human Resources Development, Korea.	ARMSTRONG J, 1988, NEW PHYTOL, V108, P373, DOI 10.1111/j.1469-8137.1988.tb04177.x; Aulakh MS, 2001, PLANT SOIL, V230, P77, DOI 10.1023/A:1004817212321; Aulakh MS, 2001, PLANT BIOLOGY, V3, P139, DOI 10.1055/s-2001-12905; Bacilio-Jimenez M, 2003, PLANT SOIL, V249, P271, DOI 10.1023/A:1022888900465; Blacke G.R., 1986, METHODS SOIL ANAL 1, V9, P363, DOI [10.2136/sssabookser5.1.2-d.c13, 10.2134/agronmonogr9.1.c30]; Buendia LV, 1998, CHEMOSPHERE, V36, P395, DOI 10.1016/S0045-6535(97)00283-X; ButterbachBahl K, 1997, PLANT CELL ENVIRON, V20, P1175, DOI 10.1046/j.1365-3040.1997.d01-142.x; Cheng WG, 2006, BIOGEOCHEMISTRY, V77, P351, DOI 10.1007/s10533-005-1534-2; Christiansen JR, 2011, PLANT SOIL, V343, P171, DOI 10.1007/s11104-010-0701-y; Chun JA, 2016, PADDY WATER ENVIRON, V14, P123, DOI 10.1007/s10333-015-0484-0; CICERONE RJ, 1981, J GEOPHYS RES-OCEANS, V86, P7203, DOI 10.1029/JC086iC08p07203; Colmer TD, 2003, PLANT CELL ENVIRON, V26, P17, DOI 10.1046/j.1365-3040.2003.00846.x; Das K, 2008, PHYSIOL PLANTARUM, V134, P303, DOI 10.1111/j.1399-3054.2008.01137.x; DENMEAD OT, 1993, ASA SPEC P, V55, P19; Green SM, 2013, PLANT SOIL, V370, P31, DOI 10.1007/s11104-013-1790-1; HOLZAPFELPSCHORN A, 1986, J GEOPHYS RES-ATMOS, V91, P1803, DOI 10.1029/JD091iD11p11803; HOLZAPFELPSCHORN A, 1986, PLANT SOIL, V92, P223, DOI 10.1007/BF02372636; Huang Y, 1997, GLOBAL CHANGE BIOL, V3, P491, DOI 10.1046/j.1365-2486.1997.00106.x; IGAC, 1994, GLOB MEAS STAND METH; IPCC, 1996, REV 1996 IPCC GUID N, V3; JONES WJ, 1987, MICROBIOL REV, V51, P135, DOI 10.1128/MMBR.51.1.135-177.1987; Juszczak R, 2013, INT AGROPHYS, V27, P159, DOI 10.2478/v10247-012-0081-z; Kanno T, 1997, NUTR CYCL AGROECOSYS, V49, P147, DOI 10.1023/A:1009778517545; KMA, 2018, MONTHL REP AUT WEATH; Le Mer J, 2001, EUR J SOIL BIOL, V37, P25, DOI 10.1016/S1164-5563(01)01067-6; Liu CW, 2004, SCI TOTAL ENVIRON, V333, P195, DOI 10.1016/j.scitotenv.2004.05.013; Lu WF, 2000, NUTR CYCL AGROECOSYS, V58, P65, DOI 10.1023/A:1009830232650; Matthias AD, 1998, AGR FOREST METEOROL, V90, P27, DOI 10.1016/S0168-1923(97)00094-4; Meijide A, 2011, BIOGEOSCIENCES, V8, P3809, DOI 10.5194/bg-8-3809-2011; MIKKELA C, 1995, BIOGEOCHEMISTRY, V28, P93, DOI 10.1007/BF02180679; Minamikawa K., 2012, GREENHOUSE GAS MEAS, V2, P118, DOI DOI 10.1080/20430779.2012.729988; Minamikawa K., 2015, GUIDELINES MEASURING; MOORE TR, 1991, ATMOS OCEAN, V29, P102, DOI 10.1080/07055900.1991.9649395; NEUE HU, 1993, BIOSCIENCE, V43, P466, DOI 10.2307/1311906; NOUCHI I, 1990, PLANT PHYSIOL, V94, P59, DOI 10.1104/pp.94.1.59; Pachauri RK, 2014, 2014 IEEE STUDENTS' CONFERENCE ON ELECTRICAL, ELECTRONICS AND COMPUTER SCIENCE (SCEECS); Parkin T.B., 2010, SAMPLING PROTOCOLS, P1; Pihlatie MK, 2013, AGR FOREST METEOROL, V171, P124, DOI 10.1016/j.agrformet.2012.11.008; RDA, 1995, STAND INV METH AGR E; RDA, 2010, FERT STAND CROP PLAN, P16; Rolston D. E., 1986, Methods of soil analysis. Part 1. Physical and mineralogical methods, P1103; ROTHFUSS F, 1992, BIOGEOCHEMISTRY, V18, P137, DOI 10.1007/BF00003274; Saier MH, 2007, WATER AIR SOIL POLL, V181, P1, DOI 10.1007/s11270-007-9372-6; Sass RL, 1991, GLOBAL BIOGEOCHEM CY, V5, P335, DOI 10.1029/91GB02586; Saunois M, 2016, ENVIRON RES LETT, V11, DOI 10.1088/1748-9326/11/12/120207; SCHUTZ H, 1990, BIOGEOCHEMISTRY, V11, P77; Simmonds MB, 2015, J ENVIRON QUAL, V44, P103, DOI 10.2134/jeq2014.07.0286; Singh S, 1999, SOIL BIOL BIOCHEM, V31, P1219, DOI 10.1016/S0038-0717(99)00027-9; Topp E, 1997, CAN J SOIL SCI, V77, P167, DOI 10.4141/S96-107; WANG ZP, 1993, SOIL SCI SOC AM J, V57, P382, DOI 10.2136/sssaj1993.03615995005700020016x; YAGI K, 1993, BIOGEOCHEMISTRY OF GLOBAL CHANGE, P353; Yu KW, 1997, BIOL FERT SOILS, V24, P341, DOI 10.1007/s003740050254; Yusuf RO, 2012, RENEW SUST ENERG REV, V16, P5059, DOI 10.1016/j.rser.2012.04.008; Zou JW, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2004GB002401	54	0	0	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 20	2021	16	9							e0256796	10.1371/journal.pone.0256796	http://dx.doi.org/10.1371/journal.pone.0256796			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	WG6BN	34543286	Green Published, gold			2022-12-26	WOS:000707078200017
J	Musuva, RM; Odiere, MR; Mwinzi, PNM; Omondi, IO; Rawago, FO; Matendechero, SH; Kittur, N; Campbell, CH; Colley, DG				Musuva, Rosemary M.; Odiere, Maurice R.; Mwinzi, Pauline N. M.; Omondi, Isaiah O.; Rawago, Fredrick O.; Matendechero, Sultani H.; Kittur, Nupur; Campbell, Carl H., Jr.; Colley, Daniel G.			Unprotected water sources and low latrine coverage are contributing factors to persistent hotspots for schistosomiasis in western Kenya	PLOS ONE			English	Article							SUSTAINABLE CONTROL; MANSONI INFECTIONS; SCHOOL-CHILDREN; RISK-FACTORS; TRANSMISSION; PRAZIQUANTEL; CONTACT; HAEMATOBIUM; PREVALENCE; AREA	Background Evidence indicates that whereas repeated rounds of mass drug administration (MDA) programs have reduced schistosomiasis prevalence to appreciable levels in some communities referred to here as responding villages (R). However, prevalence has remained high or less than anticipated in other areas referred to here as persistent hotspot villages (PHS). Using a cross-sectional quantitative approach, this study investigated the factors associated with sustained high Schistosoma mansoni prevalence in some villages despite repeated high annual treatment coverage in western Kenya. Method Water contact sites selected based on observation of points where people consistently go to collect water, wash clothes, bathe, swim or play (young children), wash cars and harvest sand were mapped using hand-held smart phones on the Commcare platform. Quantitative cross-sectional surveys on behavioral characteristics were conducted using interviewer-based semi-structured questionnaires administered to assess water usage/contact patterns and open defecation. Questionnaires were administered to 15 households per village, 50 pupils per school and 1 head teacher per school. One stool and urine sample was collected from 50 school children aged 9-12 year old and 50 adults from both responding (R) and persistent hotspot (PHS) villages. Stool was analyzed by the Kato-Katz method for eggs of S. mansoni and soil-transmitted helminths. Urine samples were tested using the point-of-care circulating cathodic antigen (POC-CCA) test for detection of S. mansoni antigen. Results There was higher latrine coverage in R (n = 6) relative to PHS villages (n = 6) with only 33% of schools in the PHS villages meeting the WHO threshold for boy: latrine coverage ratio versus 83.3% in R, while no villages met the girl: latrine ratio requirement. A higher proportion of individuals accessed unprotected water sources for both bathing and drinking (68.5% for children and 89% for adults) in PHS relative to R villages. In addition, frequency of accessing water sources was higher in PHS villages, with swimming being the most frequent activity. As expected based upon selection criteria, both prevalence and intensity of S. mansoni were higher in the PHS relative to R villages (prevalence: 43.7% vs 20.2%; P < 0.001; intensity: 73.8 200.6 vs 22.2 <plus/minus> 96.0, P < 0.0001), respectively. Conclusion Unprotected water sources and low latrine coverage are contributing factors to PHS for schistosomiasis in western Kenya. Efforts to increase provision of potable water and improvement in latrine infrastructure is recommended to augment control efforts in the PHS areas.	[Musuva, Rosemary M.; Odiere, Maurice R.; Mwinzi, Pauline N. M.; Omondi, Isaiah O.; Rawago, Fredrick O.] Kenya Govt Med Res Ctr, Ctr Global Hlth, Neglected Trop Dis Unit, Kisumu, Kenya; [Matendechero, Sultani H.] Minist Hlth KNH Grounds, Neglected Trop Dis NTD Program, Nairobi, Kenya; [Kittur, Nupur; Campbell, Carl H., Jr.; Colley, Daniel G.] Univ Georgia, Schistosomiasis Consortium Operat Res & Evaluat S, Ctr Trop & Emerging Global Dis, Athens, GA 30602 USA; [Colley, Daniel G.] Univ Georgia, Dept Microbiol, Athens, GA 30602 USA	Kenya Medical Research Institute; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Musuva, RM (corresponding author), Kenya Govt Med Res Ctr, Ctr Global Hlth, Neglected Trop Dis Unit, Kisumu, Kenya.	rmusuva.m@gmail.com		Musuva, Rosemary/0000-0002-9138-5844; Sultani, Hadley/0000-0002-7766-4089	University of Georgia Research Foundation, Inc. - Bill & Melinda Gates Foundation	University of Georgia Research Foundation, Inc. - Bill & Melinda Gates Foundation	This work received financial support from the University of Georgia Research Foundation, Inc. which was funded by the Bill & Melinda Gates Foundation for the SCORE project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed AM, 2012, J HELMINTHOL, V86, P228, DOI 10.1017/S0022149X11000290; [Anonymous], 2013, Wkly Epidemiol Rec, V88, P81; Assare RK, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004329; Black CL, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000637; Clements ACA, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000431; Colley DG, 2014, LANCET, V383, P2253, DOI 10.1016/S0140-6736(13)61949-2; COSTA MFFLE, 1991, REV I MED TROP, V33, P58, DOI 10.1590/S0036-46651991000100011; Crellen T, 2016, CLIN INFECT DIS, V63, P1151, DOI 10.1093/cid/ciw506; DALTON PR, 1976, B WORLD HEALTH ORGAN, V54, P587; de Moira AP, 2007, TROP MED INT HEALTH, V12, P724, DOI 10.1111/j.1365-3156.2007.01842.x; Elmorshedy H, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0983-2; ESREY SA, 1991, B WORLD HEALTH ORGAN, V69, P609; FAROOQ M, 1966, B WORLD HEALTH ORGAN, V35, P293; Freeman MC, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002439; Freeman MC, 2013, AM J TROP MED HYG, V89, P875, DOI 10.4269/ajtmh.13-0237; Grimes JET, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003296; Grimes JET, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0766-9; Hajissa Khalid, 2018, BMC Res Notes, V11, P779, DOI 10.1186/s13104-018-3871-y; King JD, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002223; Kittur N, 2017, AM J TROP MED HYG, V97, P1810, DOI 10.4269/ajtmh.17-0368; Kloos H, 1997, SOC SCI MED, V44, P949, DOI 10.1016/S0277-9536(96)00218-3; Koukounari A, 2007, J INFECT DIS, V196, P659, DOI 10.1086/520515; Landoure A, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001774; Liang S, 2007, P NATL ACAD SCI USA, V104, P7110, DOI 10.1073/pnas.0701878104; Nyati-Jokomo Z, 2017, ACTA TROP, V175, P84, DOI 10.1016/j.actatropica.2017.03.033; Poggensee G, 2005, ACTA TROP, V93, P131, DOI 10.1016/j.actatropica.2004.10.003; Ross AGP, 2015, J INFECT DIS, V211, P283, DOI 10.1093/infdis/jiu416; Satayathum SA, 2006, AM J TROP MED HYG, V75, P83, DOI 10.4269/ajtmh.2006.75.83; Tallo VL, 2008, B WORLD HEALTH ORGAN, V86, P765, DOI 10.2471/BLT.07.047563; TAYO MA, 1980, ANN TROP MED PARASIT, V74, P347, DOI 10.1080/00034983.1980.11687351; Utzinger J, 2009, PARASITOLOGY, V136, P1859, DOI 10.1017/S0031182009991600; van der Werf MJ, 2003, ACTA TROP, V86, P125, DOI 10.1016/S0001-706X(03)00029-9; Wang LD, 2009, TROP MED INT HEALTH, V14, P1475, DOI 10.1111/j.1365-3156.2009.02403.x; Wang W, 2012, PARASITOL RES, V111, P1871, DOI 10.1007/s00436-012-3151-z; WHO, 2012, PREV CHEM DAT; WHO, 1994, WHOCTDSIP961; Wiegand RE, 2017, J INFECT DIS, V216, P1425, DOI 10.1093/infdis/jix496; World Health Organization, 2002, WHO TRADITIONAL MED, P1; WU ZW, 1993, ACTA TROP, V54, P83, DOI 10.1016/0001-706X(93)90053-E	39	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 17	2021	16	9							e0253115	10.1371/journal.pone.0253115	http://dx.doi.org/10.1371/journal.pone.0253115			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	WG5ZQ	34534220	gold, Green Published			2022-12-26	WOS:000707073300003
J	Cheng, YC; Guerra, Y; Morkos, M; Tahsin, B; Onyenwenyi, C; Fogg, L; Fogelfeld, L				Cheng, Yu-Chien; Guerra, Yannis; Morkos, Michael; Tahsin, Bettina; Onyenwenyi, Chioma; Fogg, Louis; Fogelfeld, Leon			Insulin management in hospitalized patients with diabetes mellitus on high-dose glucocorticoids: Management of steroid-exacerbated hyperglycemia	PLOS ONE			English	Article							PREDNISOLONE-INDUCED HYPERGLYCEMIA; PROTAMINE HAGEDORN INSULIN; DEXAMETHASONE; INSIGHTS; PROTOCOL; GLUCOSE	Background Glucocorticoid (GC)-exacerbated hyperglycemia is prevalent in hospitalized patients with diabetes mellitus (DM) but evidence-based insulin guidelines in inpatient settings are lacking. Methods and findings Retrospective cohort study with capillary blood glucose (CBG) readings and insulin use, dosed with 50% basal (glargine)-50% bolus (lispro) insulin, analyzed in hospitalized patients with insulin-treated DM given GC and matched controls without GC (n = 131 pairs). GC group (median daily prednisone-equivalent dose: 53.36 mg (IQR 30.00, 80.04)) had greatest CBG differences compared to controls at dinner (25469 vs. 184 +/- 63 mg/dL, P<0.001) and bedtime (260<plus/minus>72 vs. 182 +/- 55 mg/dL, P<0.001). In GC group, dinner CBG was 30% higher than lunch (254<plus/minus>69 vs. 199 +/- 77 mg/dL, P<0.001) when similar lispro to controls given at lunch. Bedtime CBG not different from dinner when 20% more lispro given at dinner (0.12 units/kg (IQR 0.08, 0.17) vs. 0.10 units/kg (0.06, 0.14), P<0.01). Despite receiving more lispro, bedtime hypoglycemic events were lower in GC group (0.0% vs. 5.9%, P = 0.03). Conclusions Since equal bolus doses inadequately treat large dinner and bedtime GC-exacerbated glycemic excursions, initiating higher bolus insulin at lunch and dinner with additional enhanced GC-specific insulin supplemental scale may be needed as initial insulin doses in setting of high-dose GC.	[Cheng, Yu-Chien; Guerra, Yannis; Morkos, Michael; Tahsin, Bettina; Onyenwenyi, Chioma; Fogelfeld, Leon] John H Stroger Jr Hosp Cook Cty, Div Endocrinol, Chicago, IL 60612 USA; [Cheng, Yu-Chien; Guerra, Yannis; Morkos, Michael; Tahsin, Bettina; Onyenwenyi, Chioma; Fogelfeld, Leon] Rush Univ, Med Ctr, Sect Endocrinol, Chicago, IL 60612 USA; [Fogg, Louis] Rush Univ, Dept Community Nursing, Med Ctr, Chicago, IL 60612 USA	John H Stroger Junior Hospital Cook County; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Rush University; Rush University	Guerra, Y (corresponding author), John H Stroger Jr Hosp Cook Cty, Div Endocrinol, Chicago, IL 60612 USA.; Guerra, Y (corresponding author), Rush Univ, Med Ctr, Sect Endocrinol, Chicago, IL 60612 USA.	yguerra@cookcountyhhs.org						Amer Diabet Assoc, 2014, DIABETES CARE, V37, pS14, DOI 10.2337/dc14-S014; Baker EH, 2006, THORAX, V61, P284, DOI 10.1136/thx.2005.051029; Bevier Wendy C, 2008, J Diabetes Sci Technol, V2, P578; Burt MG, 2015, INTERN MED J, V45, P261, DOI 10.1111/imj.12680; Burt MG, 2013, INTERN MED J, V43, P721, DOI 10.1111/imj.12157; Burt MG, 2011, J CLIN ENDOCR METAB, V96, P1789, DOI 10.1210/jc.2010-2729; ClinicalTrials.gov. National Library of Medicine (U.S.), MAN GLUC IND HYP HOS; Clore JN, 2009, ENDOCR PRACT, V15, P469, DOI 10.4158/EP08331.RAR; DEFRONZO RA, 1981, DIABETES, V30, P1000, DOI 10.2337/diab.30.12.1000; DERENDORF H, 1993, J CLIN PHARMACOL, V33, P115, DOI 10.1002/j.1552-4604.1993.tb03930.x; Dhital SM, 2012, ENDOCR PRACT, V18, P712, DOI 10.4158/EP11371.OR; Donihi Amy Calabrese, 2006, Endocr Pract, V12, P358; Draznin B, 2013, DIABETES CARE, V36, P1807, DOI 10.2337/dc12-2508; Gosmanov AR, 2013, ENDOCR PRACT, V19, P231, DOI 10.4158/EP12256.OR; Grommesh B, 2016, ENDOCR PRACT, V22, P180, DOI 10.4158/EP15818.OR; Horby P, 2021, NEW ENGL J MED, V384, P693, DOI [10.1056/NEJMoa2021436, 10.1056/NEJMoa2022926]; Hunter J., 1992, ANN RHEUM DIS, V51, P1192; Khazai NB, 2016, ENDOCRIN METAB CLIN, V45, P875, DOI 10.1016/j.ecl.2016.06.013; KOSKINEN PJ, 1993, DIABETES CARE, V16, P1049, DOI 10.2337/diacare.16.7.1049b; MEIKLE AW, 1977, AM J MED, V63, P200, DOI 10.1016/0002-9343(77)90233-9; Radhakutty A, 2018, EUR J ENDOCRINOL, V179, pR207, DOI 10.1530/EJE-18-0315; Radhakutty A, 2017, DIABETES OBES METAB, V19, P571, DOI 10.1111/dom.12859; Seggelke SA, 2011, J HOSP MED, V6, P175, DOI 10.1002/jhm.874; Spanakis Elias K, 2014, Hosp Pract (1995), V42, P23, DOI 10.3810/hp.2014.04.1100; Umpierrez GE, 2002, J CLIN ENDOCR METAB, V87, P978, DOI 10.1210/jc.87.3.978; Umpierrez GE, 2012, J CLIN ENDOCR METAB, V97, P16, DOI 10.1210/jc.2011-2098; van Raalte DH, 2009, EUR J CLIN INVEST, V39, P81, DOI 10.1111/j.1365-2362.2008.02067.x; van Raalte DH, 2010, EUR J ENDOCRINOL, V162, P729, DOI 10.1530/EJE-09-1034	28	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2021	16	9							e0256682	10.1371/journal.pone.0256682	http://dx.doi.org/10.1371/journal.pone.0256682			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	WG5YY	34529703	Green Published, gold			2022-12-26	WOS:000707071500016
J	Saraji, A; Offermann, A; Stegmann-Frehse, J; Hempel, K; Kang, D; Krupar, R; Watermann, C; Jonigk, D; Kuhnel, MP; Kirfel, J; Perner, S; Sailer, V				Saraji, Alireza; Offermann, Anne; Stegmann-Frehse, Janine; Hempel, Katharina; Kang, Duan; Krupar, Rosemarie; Watermann, Christian; Jonigk, Danny; Kuehnel, Mark Philipp; Kirfel, Jutta; Perner, Sven; Sailer, Verena			Cracking it - successful mRNA extraction for digital gene expression analysis from decalcified, formalin-fixed and paraffin-embedded bone tissue	PLOS ONE			English	Article							PROSTATE-CANCER; METASTASES; OPTIMIZATION; PURIFICATION	With the advance of precision medicine, the availability of tumor tissue for molecular analysis has become a limiting factor. This is particularly the case for bone metastases which are frequently occurring in cancer types such as prostate cancer. Due to the necessary decalcification process it was long thought that transcriptome analysis will not be feasible from decalcified formalin-fixed, paraffin-embedded (DFFPE) in a large manner. Here we demonstrate that mRNA extraction from DFFPE is feasible, quick, robust and reproducible and that decalcification does not hamper subsequent gene expression analysis. This might assist in implementing transcriptome analysis from DFFPE into every day practice.	[Saraji, Alireza; Offermann, Anne; Stegmann-Frehse, Janine; Hempel, Katharina; Kang, Duan; Watermann, Christian; Kirfel, Jutta; Perner, Sven; Sailer, Verena] Univ Hosp Schleswig Holstein, Pathol, Campus Luebeck, Lubeck, Germany; [Krupar, Rosemarie; Perner, Sven] Leibniz Lung Ctr, Res Ctr Borstel, Borstel, Germany; [Jonigk, Danny; Kuehnel, Mark Philipp] Hannover Med Sch, Inst Pathol, Hannover, Germany; [Jonigk, Danny; Kuehnel, Mark Philipp] German Ctr Lung Res, Biomed Res Endstage & Obstruct Lung Dis BREATH, Hannover, Germany	University of Kiel; Schleswig Holstein University Hospital; Forschungszentrum Borstel; Hannover Medical School	Sailer, V (corresponding author), Univ Hosp Schleswig Holstein, Pathol, Campus Luebeck, Lubeck, Germany.	Verena-Wilbeth.Sailer@uksh.de		Watermann, Christian/0000-0002-6960-5863; Saraji, Alireza/0000-0003-3053-8373				Alers JC, 1999, J HISTOCHEM CYTOCHEM, V47, P703, DOI 10.1177/002215549904700512; Bohmann K, 2009, CLIN CHEM, V55, P1719, DOI 10.1373/clinchem.2008.122572; Canouil M, 2020, BIOINFORMATICS, V36, P970, DOI 10.1093/bioinformatics/btz647; Chung JY, 2006, DIAGN MOL PATHOL, V15, P229, DOI 10.1097/01.pdm.0000213468.91139.2d; Farragher SM, 2008, HISTOCHEM CELL BIOL, V130, P435, DOI 10.1007/s00418-008-0479-7; Galazi M, 2014, EXPERT REV ANTICANC, V14, P1305, DOI 10.1586/14737140.2014.972948; Gandaglia G, 2015, EUR UROL, V68, P325, DOI 10.1016/j.eururo.2014.07.020; HAYWARD SJ, 1987, BRIT J RADIOL, V60, P79, DOI 10.1259/0007-1285-60-709-79; Liew M, 2015, INT J LAB HEMATOL, V37, P690, DOI 10.1111/ijlh.12388; Masuda N, 1999, NUCLEIC ACIDS RES, V27, P4436, DOI 10.1093/nar/27.22.4436; Mehra R, 2011, CLIN CANCER RES, V17, P3924, DOI 10.1158/1078-0432.CCR-10-3120; Mettlin CJ, 1996, CANCER, V77, P2162; Miquelestorena-Standley E, 2020, MODERN PATHOL, V33, P1505, DOI 10.1038/s41379-020-0503-6; Ritch Chad, 2018, F1000Res, V7, DOI 10.12688/f1000research.15382.1; Rove KO, 2011, ONCOLOGY-NY, V25, P1362; RUPP GM, 1988, BIOTECHNIQUES, V6, P56; Rycaj K, 2017, ONCOTARGET, V8, P88211, DOI 10.18632/oncotarget.21085; Sailer V, 2018, CANCER-AM CANCER SOC, V124, P1008, DOI 10.1002/cncr.31173; Schlunck G, 2020, KLIN MONATSBL AUGENH, V237, P860, DOI 10.1055/a-1187-1590; Siegel RL, 2016, CA-CANCER J CLIN, V66, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Tsang HF, 2017, EXPERT REV MOL DIAGN, V17, P95, DOI 10.1080/14737159.2017.1268533; Uhr Alex, 2020, Can J Urol, V27, P24; Veldman-Jones MH, 2015, CANCER RES, V75, P2587, DOI 10.1158/0008-5472.CAN-15-0262; von Ahlfen S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001261	24	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2021	16	9							e0257416	10.1371/journal.pone.0257416	http://dx.doi.org/10.1371/journal.pone.0257416			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	WG5YY	34529723	Green Published, gold			2022-12-26	WOS:000707071500055
J	Schleihauf, H; Hoehl, S				Schleihauf, Hanna; Hoehl, Stefanie			Evidence for a dual-process account of over-imitation: Children imitate anti- and prosocial models equally, but prefer prosocial models once they become aware of multiple solutions to a task	PLOS ONE			English	Article							YOUNG-CHILDREN; SOCIALIZATION GOALS; OVERIMITATION; BEHAVIOR; ENFORCE; INFANTS; PEOPLE	Children imitate actions that are perceivably unnecessary to achieve the instrumental goal of an action sequence, a behavior termed over-imitation. It is debated whether this behavior is based on the motivation to follow behavioral norms and affiliate with the model or whether it can be interpreted in terms of a behavioral heuristic to copy observed intentional actions without questioning the purpose of each action step. To resolve this question, we tested whether preschool-aged children (N = 89) over-imitate a prosocial model, a helper in a prior third-party moral transgression, but refuse to over-imitate an antisocial model, the perpetrator of the moral transgression. After first observing an inefficient way to extract a reward from a puzzle box from either a perpetrator or a helper, children over-imitated the perpetrator to the same degree as they over-imitated the helper. In a second phase, children were then presented the efficient solution by the respective other model, i.e. the helper or the perpetrator. Over-imitation rates then dropped in both conditions, but remained significantly higher than in a baseline condition only when children had observed the prosocial model demonstrate the inefficient action sequence and the perpetrator performed the efficient solution. In contrast, over-imitation dropped to baseline level when the perpetrator had modelled the inefficient actions and the prosocial model subsequently showed children the efficient solution. In line with a dual-process account of over-imitation, results speak to a strong initial tendency to imitate perceivably irrelevant actions regardless of the model. Imitation behavior is then adjusted according to social motivations after deliberate consideration of different options to attain the goal.	[Schleihauf, Hanna] Leibniz Inst Primate Res, Cognit Ethol Lab, German Primate Ctr, Gottingen, Germany; [Schleihauf, Hanna] Univ Calif Berkeley, Dept Psychol, Social Origins Lab, 3210 Tolman Hall, Berkeley, CA 94720 USA; [Schleihauf, Hanna; Hoehl, Stefanie] Max Planck Inst Human Cognit & Brain Sci, Leipzig, Germany; [Hoehl, Stefanie] Univ Vienna, Fac Psychol, Vienna, Austria	Deutsches Primatenzentrum (DPZ); University of California System; University of California Berkeley; Max Planck Society; University of Vienna	Schleihauf, H (corresponding author), Leibniz Inst Primate Res, Cognit Ethol Lab, German Primate Ctr, Gottingen, Germany.; Schleihauf, H (corresponding author), Univ Calif Berkeley, Dept Psychol, Social Origins Lab, 3210 Tolman Hall, Berkeley, CA 94720 USA.; Schleihauf, H (corresponding author), Max Planck Inst Human Cognit & Brain Sci, Leipzig, Germany.	hanna.schleihauf@gmail.com	Hoehl, Stefanie/N-2452-2014	Hoehl, Stefanie/0000-0003-0472-0374; Schleihauf, Hanna/0000-0003-4344-9070	Deutsche Forschungsgemeinschaft (DFG) [HO 4342/8-1]; Studienstiftung des deutschen Volkes; IMPRS NeuroCom of the Max Planck Institute for Human Cognitive and Brain Sciences, Leipzig	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Studienstiftung des deutschen Volkes; IMPRS NeuroCom of the Max Planck Institute for Human Cognitive and Brain Sciences, Leipzig	This work was supported by a grant from the Deutsche Forschungsgemeinschaft (DFG; grant number HO 4342/8-1, https://www.dfg.de) awarded to SH, a stipend from the Studienstiftung des deutschen Volkes awarded to HS (no grant number, https://www.studienstiftung.de), and the IMPRS NeuroCom of the Max Planck Institute for Human Cognitive and Brain Sciences, Leipzig (no award number, https://imprs-neurocom.mpg.de).	Baayen RH, 2008, J MEM LANG, V59, P390, DOI 10.1016/j.jml.2007.12.005; Bandura A., 1971, SOCIAL LEARNING THEO; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Berl REW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120180; Boyer P, 2006, BEHAV BRAIN SCI, V29, P595, DOI 10.1017/S0140525X06009332; Clay Z, 2018, CHILD DEV, V89, P1535, DOI 10.1111/cdev.12857; Clegg JM, 2016, DEV PSYCHOL, V52, P1435, DOI 10.1037/dev0000131; Flynn E, 2012, SOC PSYCHOL-GERMANY, V43, P185, DOI 10.1027/1864-9335/a000119; Frick A, 2017, ROY SOC OPEN SCI, V4, DOI 10.1098/rsos.170367; Hamlin JK, 2007, NATURE, V450, P557, DOI 10.1038/nature06288; Hamlin JK, 2012, COGNITIVE DEV, V27, P227, DOI 10.1016/j.cogdev.2012.05.005; Hamlin JK, 2011, P NATL ACAD SCI USA, V108, P19931, DOI 10.1073/pnas.1110306108; Hamlin JK, 2011, COGNITIVE DEV, V26, P30, DOI 10.1016/j.cogdev.2010.09.001; Henrich J, 2010, BEHAV BRAIN SCI, V33, P61, DOI 10.1017/S0140525X0999152X; Herrmann PA, 2013, COGNITION, V129, P536, DOI 10.1016/j.cognition.2013.08.010; Hobson JA, 2009, DEVELOPMENTAL SCI, V12, P249, DOI 10.1111/j.1467-7687.2008.00762.x; Hoehl S, 2019, DEV REV, V51, P90, DOI 10.1016/j.dr.2018.12.002; Hoehl S, 2014, J EXP CHILD PSYCHOL, V122, P122, DOI 10.1016/j.jecp.2013.12.012; Horner V, 2005, ANIM COGN, V8, P164, DOI 10.1007/s10071-004-0239-6; Kartner J, 2007, J CROSS CULT PSYCHOL, V38, P613, DOI 10.1177/0022022107305242; Kapitany R., 2016, RELIG BRAIN BEHAV, V2016, P1, DOI [10.1080/2153599x, DOI 10.1080/2153599X]; Kapitany R, 2015, COGNITION, V145, P13, DOI 10.1016/j.cognition.2015.08.002; Keller H, 2006, J CROSS CULT PSYCHOL, V37, P155, DOI 10.1177/0022022105284494; Kenward B, 2012, J EXP CHILD PSYCHOL, V112, P195, DOI 10.1016/j.jecp.2012.02.006; Kenward B, 2011, P ROY SOC B-BIOL SCI, V278, P1239, DOI 10.1098/rspb.2010.1399; Keupp S, 2013, J EXP CHILD PSYCHOL, V116, P392, DOI 10.1016/j.jecp.2013.07.002; Legare CH, 2015, COGNITION, V142, P351, DOI 10.1016/j.cognition.2015.05.020; Legare CH, 2012, COGNITION, V124, P1, DOI 10.1016/j.cognition.2012.03.004; Liebal K, 2011, J COGN EDUC PSYCHOL, V10, P113, DOI 10.1891/1945-8959.10.1.113; Lyons DE, 2007, P NATL ACAD SCI USA, V104, P19751, DOI 10.1073/pnas.0704452104; Margoni F, 2018, P NATL ACAD SCI USA, V115, pE8835, DOI 10.1073/pnas.1801677115; Marsh J., 2005, POPULAR CULTURE NEW, P21; Nielsen M., 2010, DEV PSYCHOL, P153; Nielsen M, 2014, J EXP CHILD PSYCHOL, V126, P384, DOI 10.1016/j.jecp.2014.05.008; Nielsen M, 2011, DEV PSYCHOL, V47, P1050, DOI 10.1037/a0023866; Nielsen M, 2010, PSYCHOL SCI, V21, P729, DOI 10.1177/0956797610368808; Over H, 2013, CHILD DEV PERSPECT, V7, P6, DOI 10.1111/cdep.12006; Over H, 2012, J COMP PSYCHOL, V126, P182, DOI 10.1037/a0024555; R Core Team, 2021, R LANG ENV STAT; Rossano MJ, 2012, PSYCHOL BULL, V138, P529, DOI 10.1037/a0027038; Schleihauf H, 2020, DEV REV, V55, DOI 10.1016/j.dr.2020.100896; Schleihauf H, 2019, COGNITIVE DEV, V50, P222, DOI 10.1016/j.cogdev.2019.04.004; Schmidt MFH, 2012, COGNITION, V124, P325, DOI 10.1016/j.cognition.2012.06.004; Stengelin R, 2020, J EXP CHILD PSYCHOL, V193, DOI 10.1016/j.jecp.2019.104796; Stengelin R, 2019, DEV PSYCHOL, V55, P2630, DOI 10.1037/dev0000832; Taniguchi Y, 2017, J EXP CHILD PSYCHOL, V159, P83, DOI 10.1016/j.jecp.2017.01.014; Vaish A, 2010, CHILD DEV, V81, P1661, DOI 10.1111/j.1467-8624.2010.01500.x; Vaish A, 2009, DEV PSYCHOL, V45, P534, DOI 10.1037/a0014322; Watson-Jones RE, 2014, EVOL HUM BEHAV, V35, P204, DOI 10.1016/j.evolhumbehav.2014.01.004; Wen NJ, 2016, EVOL HUM BEHAV, V37, P54, DOI 10.1016/j.evolhumbehav.2015.08.002; Whiten A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159920; Whiten A, 2009, PHILOS T R SOC B, V364, P2417, DOI 10.1098/rstb.2009.0069; Wilks M, 2019, J EXP CHILD PSYCHOL, V185, P164, DOI 10.1016/j.jecp.2019.04.018; Wilks M, 2018, DEVELOPMENTAL SCI, V21, DOI 10.1111/desc.12675	54	0	0	3	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2021	16	9							e0256614	10.1371/journal.pone.0256614	http://dx.doi.org/10.1371/journal.pone.0256614			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	WG5YY	34529702	Green Published, gold			2022-12-26	WOS:000707071500014
J	Yu, Y; Kim, YH; Cho, WH; Son, BS; Yeo, HJ				Yu, Yeuni; Kim, Yun Hak; Cho, Woo Hyun; Son, Bong Soo; Yeo, Hye Ju			Biofilm microbiome in extracorporeal membrane oxygenator catheters	PLOS ONE			English	Article							INDOLOGENES INFECTIONS; BACTERIAL BIOFILMS; BACTEREMIA	Despite the formation of biofilms on catheters for extracorporeal membrane oxygenation (ECMO), some patients do not show bacteremia. To elucidate the specific linkage between biofilms and bacteremia in patients with ECMO, an improved understanding of the microbial community within catheter biofilms is necessary. Hence, we aimed to evaluate the biofilm microbiome of ECMO catheters from adults with (n = 6) and without (n = 15) bacteremia. The microbiomes of the catheter biofilms were evaluated by profiling the V3 and V4 regions of bacterial 16s rRNA genes using the Illumina MiSeq sequencing platform. In total, 2,548,172 reads, with an average of 121,341 reads per sample, were generated. Although alpha diversity was slightly higher in the non-bacteremic group, the difference was not statistically significant. In addition, there was no difference in beta diversity between the two groups. We found 367 different genera, of which 8 were present in all samples regardless of group; Limnohabitans, Flavobacterium, Delftia, Massilia, Bacillus, Candidatus, Xiphinematobacter, and CL0-1 showed an abundance of more than 1% in the sample. In particular, Arthrobacter, SMB53, Neisseria, Ortrobactrum, Candidatus Rhabdochlamydia, Deefgae, Dyella, Paracoccus, and Pedobacter were highly abundant in the bacteremic group. Network analysis indicated that the microbiome of the bacteremic group was more complex than that of the non-bacteremic group. Flavobacterium and CL0.1, which were abundant in the bacteremic group, were considered important genera because they connected different subnetworks. Biofilm characteristics in ECMO catheters varied according to the presence or absence of bacteremia. There were no significant differences in diversity between the two groups, but there were significant differences in the community composition of the biofilms. The biofilm-associated community was dynamic, with the bacteremic group showing very complex network connections within the microbiome.	[Yu, Yeuni] Pusan Natl Univ, Interdisciplinary Program Genom Sci, Yagnsan, South Korea; [Kim, Yun Hak] Pusan Natl Univ, Sch Med, Dept Anat, Yagnsan, South Korea; [Kim, Yun Hak] Pusan Natl Univ, Sch Med, Dept Biomed Informat, Yagnsan, South Korea; [Cho, Woo Hyun; Yeo, Hye Ju] Pusan Natl Univ, Yangsan Hosp, Dept Internal Med, Div Pulm Allergy & Crit Care Med, Yagnsan, South Korea; [Son, Bong Soo] Pusan Natl Univ, Yangsan Hosp, Dept Thorac & Cardiovasc Surg, Yagnsan, South Korea; [Yeo, Hye Ju] Pusan Natl Univ, Yangsan Hosp, Res Inst Convergence Biomed Sci & Technol, Yagnsan, South Korea	Pusan National University; Pusan National University; Pusan National University; Pusan National University; Pusan National University Hospital; Pusan National University; Pusan National University Hospital; Pusan National University; Pusan National University Hospital	Yeo, HJ (corresponding author), Pusan Natl Univ, Yangsan Hosp, Dept Internal Med, Div Pulm Allergy & Crit Care Med, Yagnsan, South Korea.; Yeo, HJ (corresponding author), Pusan Natl Univ, Yangsan Hosp, Res Inst Convergence Biomed Sci & Technol, Yagnsan, South Korea.	hjyeo@pusan.ac.kr	Yeo, Hye Ju/U-3295-2017	Yeo, Hye Ju/0000-0002-8403-5790	Research institute for Convergence of biomedical science and technology, Pusan National University Yangsan Hospital [30-2019-014]	Research institute for Convergence of biomedical science and technology, Pusan National University Yangsan Hospital	This study was supported by the Research institute for Convergence of biomedical science and technology (30-2019-014), Pusan National University Yangsan Hospital. The funder provided support in the form of salaries for authors [HJY] but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `Author contributions' section.	Anma A., 2017, OPEN FORUM INFECT DI, V4, pS548; Arias MA, 2019, IDCases, V15, DOI 10.1016/j.idcr.2019.e00486; Bereza P, 2016, BMC MUSCULOSKEL DIS, V17, DOI 10.1186/s12891-016-0991-1; Bolyen E, 2019, NAT BIOTECHNOL, V37, P852, DOI 10.1038/s41587-019-0209-9; Braga RM, 2016, BRAZ J MICROBIOL, V47, P86, DOI 10.1016/j.bjm.2016.10.005; Brandwein M, 2016, NPJ BIOFILMS MICROBI, V2, DOI 10.1038/s41522-016-0004-z; Chen MF, 2019, BONE JOINT RES, V8, P367, DOI 10.1302/2046-3758.88.BJR-2019-0003.R2; CLSI, 2020, M100 PERF STAND ANT, V30th; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; Csardi G, 2006, INTERJOURNAL; Donlan RM, 2011, CLIN INFECT DIS, V52, P1038, DOI 10.1093/cid/cir077; Friedman J, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002687; Hsueh PR, 1996, CLIN INFECT DIS, V23, P550, DOI 10.1093/clinids/23.3.550; Hsueh PR, 1996, J CLIN MICROBIOL, V34, P1908, DOI 10.1128/JCM.34.8.1908-1913.1996; Jain V, 2018, INDIAN J CRIT CARE M, V22, P537, DOI [10.4103/ijccm.IJCCM_24_18, 10.4103/ijccm.ijccm_24_18]; Kim DW, 2016, J ARTIF ORGANS, V19, P128, DOI 10.1007/s10047-015-0882-5; Kiratisin P, 2007, EMERG INFECT DIS, V13, P1266, DOI 10.3201/eid1308.061204; Langille MGI, 2013, NAT BIOTECHNOL, V31, P814, DOI 10.1038/nbt.2676; Li SY, 2021, PATHOGENS, V10, DOI 10.3390/pathogens10040443; Pammi M, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0227967; Preiswerk B, 2011, J MED MICROBIOL, V60, P246, DOI 10.1099/jmm.0.021238-0; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Yeo HJ, 2018, ASAIO J, V64, pE48, DOI 10.1097/MAT.0000000000000750	24	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2021	16	9							e0257449	10.1371/journal.pone.0257449	http://dx.doi.org/10.1371/journal.pone.0257449			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	WG5YY	34529734	Green Submitted, gold, Green Published			2022-12-26	WOS:000707071500058
J	Keskin, H; Wang, SM; Etemadi, A; Fan, JH; Dawsey, SM; Abnet, CC; Qiao, YL; Taylor, PR				Keskin, Havva; Wang, Shao-Ming; Etemadi, Arash; Fan, Jin-Hu; Dawsey, Sanford M.; Abnet, Christian C.; Qiao, You-Lin; Taylor, Philip R.			Colorectal cancer in the Linxian China Nutrition Intervention Trial: Risk factors and intervention results	PLOS ONE			English	Article							BETA-CAROTENE SUPPLEMENTATION; VITAMIN-E; SELENIUM SUPPLEMENTATION; ALPHA-TOCOPHEROL; PROSTATE-CANCER; PREVENTION; MORTALITY; SHANGHAI; FRUIT; CALCIUM	Background Colorectal cancer (CRC) is among the most common cancers in economically developed countries and developing world. While dietary factors are associated with risk of CRC in the West and urban China, little is known about risk or protective factors in rural China. Methods The Linxian General Population Nutrition Intervention Trial (NIT) cohort was established over 30 years ago to test whether daily multivitamin/mineral supplements could reduce the incidence and mortality of esophageal/gastric cardia cancer. The cohort included a total of 29,553 healthy participants 40-69 years old who were randomly assigned to supplements or placebos via a 2(4) fractional factorial study design. We examined risk factors for the development of CRC as well as the effects of four different nutritional factors (Factor A: retinol, zinc; B: riboflavin, niacin; C: ascorbic acid, molybdenum; D: selenium, alpha-tocopherol, beta-carotene,) on CRC incidence following 5.25 years of supplementation in this randomized, placebo-controlled intervention trial. Results CRC risk increased with age and height as well as piped water usage, family history of CRC, and consumption of foods cooked in oil, eggs, and fresh fruits. No effect on CRC was seen for any of these four intervention factors tested in both genders, but CRC was reduced 37% in females who received Factor D (selenium/alpha-tocopherol/beta-carotene) (RR = 0.63, 95% CI = 0.43-0.92, P = 0.016) compared to females who did not receive Factor D. Conclusions In this undernourished rural Chinese population, CRC risk factors in this Chinese cohort showed both similarities and differences compared to Western and urban Asian Chinese populations. Intervention results suggested a potential benefit for women supplemented with selenium/alpha-tocopherol/beta-carotene.	[Keskin, Havva] Istanbul Medeniyet Univ, Goztepe Training & Res Hosp, Dept Internal Med, Istanbul, Turkey; [Wang, Shao-Ming] Chinese Acad Med Sci & Peking Union Med Coll, Natl Canc Ctr, Dept Canc Epidemiol, Natl Clin Res Ctr Canc,Canc Hosp, Beijing, Peoples R China; [Etemadi, Arash; Dawsey, Sanford M.; Abnet, Christian C.; Taylor, Philip R.] NCI, Metab Epidemiol Branch, Div Canc Epidemiol & Genet, NIH, Bethesda, MD 20892 USA; [Fan, Jin-Hu; Qiao, You-Lin] Chinese Acad Med Sci, Canc Inst, Beijing, Peoples R China	Istanbul Goztepe Training and Research Hospital; Istanbul Medeniyet University; Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Peking Union Medical College; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Chinese Academy of Medical Sciences - Peking Union Medical College	Keskin, H (corresponding author), Istanbul Medeniyet Univ, Goztepe Training & Res Hosp, Dept Internal Med, Istanbul, Turkey.	havva.drkeskin@gmail.com	Keskin, Havva/ABH-3101-2021; Abnet, Christian C/C-4111-2015; Qiao, You-Lin/B-4139-2012	Keskin, Havva/0000-0003-1794-4473; Abnet, Christian C/0000-0002-3008-7843; Qiao, You-Lin/0000-0001-6380-0871; fan, jinhu/0000-0003-3159-7893				Baron JA, 1999, NEW ENGL J MED, V340, P101, DOI 10.1056/NEJM199901143400204; Baron JA, 2015, NEW ENGL J MED, V373, P1519, DOI 10.1056/NEJMoa1500409; Bjelakovic G, 2007, JAMA-J AM MED ASSOC, V297, P842, DOI 10.1001/jama.297.8.842; Bjelakovic G, 2012, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD007176.pub2, 10.1590/1516-3180.20151332T1]; Bjelakovic G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074558; Blot W J, 1985, Natl Cancer Inst Monogr, V69, P29; BLOT WJ, 1993, JNCI-J NATL CANCER I, V85, P1483, DOI 10.1093/jnci/85.18.1483; Butler LM, 2008, BRIT J CANCER, V99, P1511, DOI 10.1038/sj.bjc.6604678; Calderwood AH, 2019, CANCER PREV RES, V12, P295, DOI 10.1158/1940-6207.CAPR-19-0023; Chan AT, 2010, GASTROENTEROLOGY, V138, P2029, DOI 10.1053/j.gastro.2010.01.057; Chen K, 2005, EUR J EPIDEMIOL, V20, P149, DOI 10.1007/s10654-004-2953-4; Chen K, 2005, EUR J PUBLIC HEALTH, V15, P652, DOI 10.1093/eurpub/cki027; Chen K, 2003, WORLD J GASTROENTERO, V9, P99, DOI 10.3748/wjg.v9.i1.99; Chen WQ, 2016, CA-CANCER J CLIN, V66, P115, DOI 10.3322/caac.21338; Chu DZJ, 2011, CLIN COLORECTAL CANC, V10, P310, DOI 10.1016/j.clcc.2011.06.005; Clark LC, 1996, JAMA-J AM MED ASSOC, V276, P1957, DOI 10.1001/jama.276.24.1957; Crockett SD, 2019, GUT, V68, P475, DOI 10.1136/gutjnl-2017-315242; Duffield-Lillico AJ, 2002, CANCER EPIDEM BIOMAR, V11, P630; Ebbing M, 2009, JAMA-J AM MED ASSOC, V302, P2119, DOI 10.1001/jama.2009.1622; Gandini S, 2000, EUR J CANCER, V36, P636, DOI 10.1016/S0959-8049(00)00022-8; Grau MV, 2007, JNCI-J NATL CANCER I, V99, P129, DOI 10.1093/jnci/djk016; HEINONEN OP, 1994, NEW ENGL J MED, V330, P1029; Hennekens CH, 1996, NEW ENGL J MED, V334, P1145, DOI 10.1056/NEJM199605023341801; Klein EA, 2011, JAMA-J AM MED ASSOC, V306, P1549, DOI 10.1001/jama.2011.1437; Kubo A, 2007, AM J GASTROENTEROL, V102, P2323, DOI 10.1111/j.1572-0241.2007.01374.x; Lee SA, 2009, NUTR CANCER, V61, P194, DOI 10.1080/01635580802419780; Leung WK, 2015, J GASTROEN HEPATOL, V30, P1726, DOI 10.1111/jgh.13018; Li B, 1993, Ann Epidemiol, V3, P577, DOI 10.1016/1047-2797(93)90078-I; Li H, 2013, INT J OBESITY, V37, P783, DOI 10.1038/ijo.2012.152; Lin J, 2009, JNCI-J NATL CANCER I, V101, P14, DOI 10.1093/jnci/djn438; Lippman SM, 2009, JAMA-J AM MED ASSOC, V301, P39, DOI 10.1001/jama.2008.864; Lock K, 2005, B WORLD HEALTH ORGAN, V83, P100; Malila N, 1999, CANCER EPIDEM BIOMAR, V8, P489; Manson JE, 2019, NEW ENGL J MED, V380, P33, DOI [10.1056/NEJMoa1809944, 10.1056/nejmoa1809944]; National Cancer lnstitute, 2019, COL CANC PREV; Nolfo F, 2013, BMC SURG, V13, DOI 10.1186/1471-2482-13-S2-S16; Odegaard AO, 2011, CANCER-AM CANCER SOC, V117, P3841, DOI 10.1002/cncr.25936; Terry P, 2001, JNCI-J NATL CANCER I, V93, P525, DOI 10.1093/jnci/93.7.525; Tran GD, 2005, INT J CANCER, V113, P456, DOI 10.1002/ijc.20616; Tsong WH, 2007, BRIT J CANCER, V96, P821, DOI 10.1038/sj.bjc.6603623; Virtamo J, 2003, JAMA-J AM MED ASSOC, V290, P476, DOI 10.1001/jama.290.4.476; Vogtmann E, 2013, CANCER CAUSE CONTROL, V24, P1935, DOI 10.1007/s10552-013-0268-z; World Cancer Research Fund American Institute for Cancer Research Continuous Update Project, 2017, DIET NUTR PHYS ACT C; World Health Organization,, 2018, INT AGENCY RES CANC; Yuan JM, 2007, INT J CANCER, V120, P1344, DOI 10.1002/ijc.22460; Yuan JM, 1996, JAMA-J AM MED ASSOC, V275, P1646, DOI 10.1001/jama.275.21.1646; Zhang QL, 2018, INT J CANCER, V142, P1093, DOI 10.1002/ijc.31126	47	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2021	16	9							e0255322	10.1371/journal.pone.0255322	http://dx.doi.org/10.1371/journal.pone.0255322			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	WG6DR	34525122	Green Published, gold			2022-12-26	WOS:000707084400009
J	Lamela, A; Ossorio, OG; Vinuesa, G; Sahelices, B				Lamela, Adrian; Ossorio, Oscar G.; Vinuesa, Guillermo; Sahelices, Benjamin			Off-chip prefetching based on Hidden Markov Model for non-volatile memory architectures	PLOS ONE			English	Article								Non-volatile memory technology is now available in commodity hardware. This technology can be used as a backup memory for an external dram cache memory without needing to modify the software. However, the higher read and write latencies of non-volatile memory may exacerbate the memory wall problem. In this work we present a novel off-chip prefetch technique based on a Hidden Markov Model that specifically deals with the latency problem caused by complexity of off-chip memory access patterns. Firstly, we present a thorough analysis of off-chip memory access patterns to identify its complexity in multicore processors. Based on this study, we propose a prefetching module located in the llc which uses two small tables, and where the computational complexity of which is linear with the number of computing threads. Our Markov-based technique is able to keep track and make clustering of several simultaneous groups of memory accesses coming from multiple simultaneous threads in a multicore processor. It can quickly identify complex address groups and trigger prefetch with very high accuracy. Our simulations show an improvement of up to 76% in the hit ratio of an off-chip dram cache for multicore architecture over the conventional prefetch technique (g/dc). Also, the overhead of prefetch requests (failed prefetches) is reduced by 48% in single core simulations and by 83% in multicore simulations.	[Lamela, Adrian; Sahelices, Benjamin] Univ Valladolid, Sch Informat Engn, Dept Comp Sci, Valladolid, Spain; [Ossorio, Oscar G.; Vinuesa, Guillermo] Univ Valladolid, Sch Informat Engn, Dept Elect, Valladolid, Spain	Universidad de Valladolid; Universidad de Valladolid	Sahelices, B (corresponding author), Univ Valladolid, Sch Informat Engn, Dept Comp Sci, Valladolid, Spain.	benja@infor.uva.es	Ossorio, Oscar González/I-7805-2017; Sahelices, Benjamin/I-8102-2017	Ossorio, Oscar González/0000-0003-3457-2317; Vinuesa, Guillermo/0000-0003-0389-3409; Sahelices, Benjamin/0000-0002-3380-3403	Spanish Ministry of Economy and Competitiveness [TEC2017-84321-C4-2-R]; Feder Funds; MINECO/AEI/ERDF (EU) [PID2019-105660RB-C21/AEI/10.13039/501100011033]; Aragon Government [T58_20R]; ERDF 2014-2020 "Construyendo Europa desde Aragon"	Spanish Ministry of Economy and Competitiveness(Spanish Government); Feder Funds(European Commission); MINECO/AEI/ERDF (EU); Aragon Government(Gobierno de Aragon); ERDF 2014-2020 "Construyendo Europa desde Aragon"	The work was supported by the Spanish Ministry of Economy and Competitiveness (Grant No. TEC2017-84321-C4-2-R) with support from Feder Funds and also by MINECO/AEI/ERDF (EU) (grant PID2019-105660RB-C21/AEI/10.13039/501100011033), Arago ' n Government (T58_20R research group), and ERDF 2014-2020 "Construyendo Europa desde Arago ' n". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakhshalipour M, 2018, INT S HIGH PERF COMP, P131, DOI 10.1109/HPCA.2018.00021; Bhattacharjee A, 2017, TWENTY-SECOND INTERNATIONAL CONFERENCE ON ARCHITECTURAL SUPPORT FOR PROGRAMMING LANGUAGES AND OPERATING SYSTEMS (ASPLOS XXII), P63, DOI 10.1145/3037697.3037705; Choi SG, 2021, APPL SCI-BASEL, V11, DOI 10.3390/app11030991; Conway P, 2010, IEEE MICRO, V30, P16, DOI 10.1109/MM.2010.31; Doshi K, 2016, INT S HIGH PERF COMP, P77, DOI 10.1109/HPCA.2016.7446055; Golshan F, 2020, IEEE COMPUT ARCHIT L, V19, P130, DOI 10.1109/LCA.2020.3019343; Hameed F, 2013, 2013 INT C COMP ARCH, P1; Haring RA, 2012, IEEE MICRO, V32, P48, DOI 10.1109/MM.2011.108; Huang CC, 2014, INT CONFER PARA, P51, DOI 10.1145/2628071.2628089; Jacob B., 2018, PREPRINT REPOSITORY; Jagasivamani M, 2019, MEMSYS 2019: PROCEEDINGS OF THE INTERNATIONAL SYMPOSIUM ON MEMORY SYSTEMS, P342, DOI 10.1145/3357526.3357561; Joseph D, 1997, ACM COMP AR, P252, DOI 10.1145/384286.264207; Joshi A, 2017, INT S HIGH PERF COMP, P361, DOI 10.1109/HPCA.2017.50; Kommareddy VR., 2020, MEMSYS; Lee Y, 2015, 2015 ACM/IEEE 42ND ANNUAL INTERNATIONAL SYMPOSIUM ON COMPUTER ARCHITECTURE (ISCA), P211, DOI 10.1145/2749469.2750383; Luk CK, 2005, ACM SIGPLAN NOTICES, V40, P190, DOI 10.1145/1064978.1065034; Mittal S, 2016, ACM COMPUT SURV, V49, DOI 10.1145/2907071; Nesbit KJ, 2004, 10TH INTERNATIONAL SYMPOSIUM ON HIGH PERFORMANCE COMPUTER ARCHITECTURE, PROCEEDINGS, P96, DOI 10.1109/HPCA.2004.10030; Papaphilippou P., 2019, 3 DAT PREF CHAMP DPC; Park CH, 2016, CONF PROC INT SYMP C, P217, DOI 10.1109/ISCA.2016.28; Peled L, 2015, 2015 ACM/IEEE 42ND ANNUAL INTERNATIONAL SYMPOSIUM ON COMPUTER ARCHITECTURE (ISCA), P285, DOI 10.1145/2749469.2749473; Pelley S, 2014, CONF PROC INT SYMP C, P265, DOI 10.1109/ISCA.2014.6853222; Qureshi MK, 2012, INT SYMP MICROARCH, P235, DOI 10.1109/MICRO.2012.30; Ren JL, 2015, PROCEEDINGS OF THE 48TH ANNUAL IEEE/ACM INTERNATIONAL SYMPOSIUM ON MICROARCHITECTURE (MICRO-48), P672, DOI 10.1145/2830772.2830802; Shevgoor M, 2015, PROCEEDINGS OF THE 48TH ANNUAL IEEE/ACM INTERNATIONAL SYMPOSIUM ON MICROARCHITECTURE (MICRO-48), P141, DOI 10.1145/2830772.2830793; Sodani A, 2016, IEEE MICRO, V36, P34, DOI 10.1109/MM.2016.25; Somogyi S, 2009, CONF PROC INT SYMP C, P69, DOI 10.1145/1555815.1555766; SPEC, SPEC CPU2006 BENCHM; Talati N, 2021, INT S HIGH PERF COMP, P654, DOI 10.1109/HPCA51647.2021.00061; Tschirhart P., 2016, MEMSYS; Ustiugov D., 2018, MEMSYS; Waddington D, 2019, MEMSYS 2019: PROCEEDINGS OF THE INTERNATIONAL SYMPOSIUM ON MEMORY SYSTEMS, P277, DOI 10.1145/3357526.3357528; WARD JH, 1963, J AM STAT ASSOC, V58, P236, DOI 10.2307/2282967; Young S., 2009, HTK BOOK; Young V, 2018, CONF PROC INT SYMP C, P328, DOI 10.1109/ISCA.2018.00036	35	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2021	16	9							e0257047	10.1371/journal.pone.0257047	http://dx.doi.org/10.1371/journal.pone.0257047			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	WG5RP	34520473	Green Published, gold			2022-12-26	WOS:000707052100011
J	Nakagawa, N; Mizuno, M; Kato, S; Maruyama, S; Sato, H; Nakaya, I; Sugiyama, H; Fujimoto, S; Miura, K; Matsumura, C; Gotoh, Y; Suzuki, H; Kuroki, A; Yoshino, A; Nakatani, S; Hiromura, K; Yamamoto, R; Yokoyama, H; Narita, I; Isaka, Y				Nakagawa, Naoki; Mizuno, Masashi; Kato, Sawako; Maruyama, Shoichi; Sato, Hiroshi; Nakaya, Izaya; Sugiyama, Hitoshi; Fujimoto, Shouichi; Miura, Kenichiro; Matsumura, Chieko; Gotoh, Yoshimitsu; Suzuki, Hitoshi; Kuroki, Aki; Yoshino, Atsunori; Nakatani, Shinya; Hiromura, Keiju; Yamamoto, Ryohei; Yokoyama, Hitoshi; Narita, Ichiei; Isaka, Yoshitaka			Demographic, clinical characteristics and treatment outcomes of immune-complex membranoproliferative glomerulonephritis and C3 glomerulonephritis in Japan: A retrospective analysis of data from the Japan Renal Biopsy Registry	PLOS ONE			English	Article							HEMOLYTIC-UREMIC SYNDROME; DENSE DEPOSIT DISEASE; NEPHROTIC SYNDROME; GLOMERULOPATHY; ECULIZUMAB; FEATURES; MPGN	The reclassification of membranoproliferative glomerulonephritis (MPGN) into immune-complex MPGN (IC-MPGN) and C3 glomerulopathy (C3G) based on immunofluorescence findings in kidney biopsies has provided insights into these two distinct diseases. C3G is further classified into dense deposit disease and C3 glomerulonephritis (C3GN) based on electron micrographic findings. Although these diseases have poor outcomes, limited Japanese literature confined to small, single-center cohorts exist on these diseases. We retrospectively analyzed 81 patients with MPGN type I and III from 15 hospitals in the Japan Renal Biopsy Registry to compare demographic, clinical characteristics and treatment outcomes of patients with IC-MPGN to those with C3GN. Of the 81 patients reviewed by immunofluorescence findings in kidney biopsies, 67 patients had IC-MPGN and 14 patients had C3GN. Age at diagnosis and systolic and diastolic pressure were higher and proteinuria and impaired renal function were significantly more prevalent in patients with IC-MPGN than those with C3GN. About 80% of the patients in both groups were treated with immunosuppressive therapy. At last follow-up (median 4.8 years), complete remission rate of proteinuria was significantly higher in patients with C3GN (64.3%) than in those with IC-MPGN (29.9%; P = 0.015). The renal survival rate was lower in patients with IC-MPGN when compared to C3GN (73.1% vs. 100%; log-rank, P = 0.031). Systolic blood pressure and renal function at baseline were independent predictors of progression to end-stage kidney disease. The overall prognosis of patients with C3GN is more favorable than for patients with IC-MPGN.	[Nakagawa, Naoki] Asahikawa Med Univ, Dept Internal Med, Div Cardiol Nephrol Pulmonol & Neurol, Asahikawa, Hokkaido, Japan; [Mizuno, Masashi; Kato, Sawako; Maruyama, Shoichi] Nagoya Univ, Dept Nephrol, Grad Sch Med, Nagoya, Aichi, Japan; [Mizuno, Masashi] Nagoya Univ, Renal Replacement Therapy, Grad Sch Med, Nagoya, Aichi, Japan; [Sato, Hiroshi] Tohoku Univ, Grad Sch Pharmaceut Sci, Clin Pharmacol & Therapeut, Sendai, Miyagi, Japan; [Nakaya, Izaya] Iwate Prefectural Cent Hosp, Dept Nephrol & Rheumatol, Morioka, Iwate, Japan; [Sugiyama, Hitoshi] Okayama Univ, Dept Human Resource Dev Dialysis Therapy Kidney D, Grad Sch Med Dent & Pharmaceut Sci, Okayama, Japan; [Fujimoto, Shouichi] Univ Miyazaki, Fac Med, Dept Hemovasc Med & Artificial Organs, Miyazaki, Japan; [Miura, Kenichiro] Tokyo Womens Med Univ, Dept Pediat Nephrol, Tokyo, Japan; [Matsumura, Chieko] Natl Hosp Org Chibahigashi Natl Hosp, Dept Pediat, Chiba, Japan; [Gotoh, Yoshimitsu] Japanese Red Cross Aichi Med Ctr Nagoya Daini Hos, Dept Pediat Nephrol, Nagoya, Aichi, Japan; [Suzuki, Hitoshi] Juntendo Univ, Fac Med, Dept Nephrol, Tokyo, Japan; [Kuroki, Aki] Showa Univ, Dept Med, Div Nephrol, Sch Med, Tokyo, Japan; [Yoshino, Atsunori] Dokkyo Med Univ, Dept Nephrol, Saitama Med Ctr, Koshigaya, Japan; [Nakatani, Shinya] Osaka City Univ, Dept Metab Endocrinol & Mol Med, Grad Sch Med, Osaka, Japan; [Hiromura, Keiju] Gunma Univ, Dept Nephrol & Rheumatol, Grad Sch Med, Maebashi, Gumma, Japan; [Yamamoto, Ryohei] Osaka Univ, Hlth & Counseling Ctr, Toyonaka, Osaka, Japan; [Yokoyama, Hitoshi] Kanazawa Med Univ, Dept Nephrol, Sch Med, Uchinada, Ishikawa, Japan; [Narita, Ichiei] Niigata Univ, Kidney Res Ctr, Div Clin Nephrol & Rheumatol, Grad Sch Med & Dent Sci, Niigata, Japan; [Isaka, Yoshitaka] Osaka Univ, Dept Nephrol, Grad Sch Med, Suita, Osaka, Japan	Asahikawa Medical College; Nagoya University; Nagoya University; Tohoku University; Iwate Prefectural Central Hospital; Okayama University; University of Miyazaki; Tokyo Women's Medical University; Juntendo University; Showa University; Dokkyo Medical University; Osaka Metropolitan University; Gunma University; Osaka University; Kanazawa Medical University; Niigata University; Osaka University	Nakagawa, N (corresponding author), Asahikawa Med Univ, Dept Internal Med, Div Cardiol Nephrol Pulmonol & Neurol, Asahikawa, Hokkaido, Japan.	naka-nao@asahikawa-med.ac.jp	Narita, Ichiei/G-5204-2017; Sugiyama, Hitoshi/B-2252-2011; YAMAMOTO, Ryohei/AAU-3059-2021	Narita, Ichiei/0000-0001-7692-3096; Sugiyama, Hitoshi/0000-0002-4127-6471; YAMAMOTO, Ryohei/0000-0003-2610-9824	Ministry of Health, Labour and Welfare of Japan [20FC1045]	Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	This study was supported in part by a Grant-in-Aid for Intractable Renal Diseases Research, Research on rare and intractable diseases, Health and Labour Sciences Research Grants from the Ministry of Health, Labour and Welfare of Japan (20FC1045). There was no additional external funding received for this study.	Bomback AS, 2018, KIDNEY INT, V93, P977, DOI 10.1016/j.kint.2017.10.022; Bomback AS, 2014, NEPHRON CLIN PRACT, V128, P270, DOI 10.1159/000368592; Fakhouri F, 2020, KIDNEY INT, V98, P1135, DOI 10.1016/j.kint.2020.05.053; Goodship THJ, 2017, KIDNEY INT, V91, P539, DOI 10.1016/j.kint.2016.10.005; Holle J, 2018, PEDIATR NEPHROL, V33, P2289, DOI 10.1007/s00467-018-4034-z; Iatropoulos P, 2016, MOL IMMUNOL, V71, P131, DOI 10.1016/j.molimm.2016.01.010; Kawasaki Y, 2016, PEDIATR NEPHROL, V31, P1091, DOI 10.1007/s00467-015-3307-z; Khandelwal P, 2021, PEDIATR NEPHROL, V36, P591, DOI 10.1007/s00467-020-04736-8; Kirpalani A, 2020, KIDNEY INT REP, V5, P2313, DOI 10.1016/j.ekir.2020.09.019; Komatsu H, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196955; Le Quintrec M, 2018, AM J KIDNEY DIS, V72, P84, DOI 10.1053/j.ajkd.2017.11.019; Little MA, 2006, KIDNEY INT, V69, P504, DOI 10.1038/sj.ki.5000084; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Nakagawa N, 2018, CLIN EXP NEPHROL, V22, P797, DOI 10.1007/s10157-017-1513-7; Nakano M, 2019, CLIN EXP NEPHROL, V23, P852, DOI 10.1007/s10157-019-01716-7; Nishi S, 2016, CLIN EXP NEPHROL, V20, P342, DOI 10.1007/s10157-015-1216-x; Noris M, 2015, AM J KIDNEY DIS, V66, P359, DOI 10.1053/j.ajkd.2015.03.040; Okuda Y, 2015, NEPHROLOGY, V20, P286, DOI 10.1111/nep.12382; Ozeki T, 2020, CLIN EXP NEPHROL, V24, P1058, DOI 10.1007/s10157-020-01932-6; Pickering MC, 2013, KIDNEY INT, V84, P1079, DOI 10.1038/ki.2013.377; Servais A, 2012, KIDNEY INT, V82, P454, DOI 10.1038/ki.2012.63; Sethi S, 2012, NEW ENGL J MED, V366, P1119, DOI 10.1056/NEJMra1108178; Smith RJH, 2019, NAT REV NEPHROL, V15, P129, DOI 10.1038/s41581-018-0107-2; Sugiyama H, 2013, CLIN EXP NEPHROL, V17, P155, DOI 10.1007/s10157-012-0746-8; Sugiyama H, 2011, CLIN EXP NEPHROL, V15, P493, DOI 10.1007/s10157-011-0430-4; Tran CL, 2016, PEDIATR NEPHROL, V31, P683, DOI 10.1007/s00467-015-3306-0; Uemura O, 2014, CLIN EXP NEPHROL, V18, P626, DOI 10.1007/s10157-013-0856-y; Wilson GJ, 2019, BMC NEPHROL, V20, DOI 10.1186/s12882-019-1605-6; Yamamoto R, 2020, CLIN EXP NEPHROL, V24, P526, DOI 10.1007/s10157-020-01864-1; Yokoyama H, 2015, CLIN EXP NEPHROL, V19, P496, DOI 10.1007/s10157-014-1022-x; Yokoyama H, 2012, CLIN EXP NEPHROL, V16, P903, DOI 10.1007/s10157-012-0673-8	31	3	4	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2021	16	9							e0257397	10.1371/journal.pone.0257397	http://dx.doi.org/10.1371/journal.pone.0257397			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	WG5RP	34520493	Green Published, gold			2022-12-26	WOS:000707052100025
J	van Polanen, V				van Polanen, Vonne			Grasp aperture corrections in reach-to-grasp movements do not reliably alter size perception	PLOS ONE			English	Article							OBJECT SIZE; ILLUSION; PERTURBATIONS; PREHENSION; ABSOLUTE; STREAMS; DORSAL	When grasping an object, the opening between the fingertips (grip aperture) scales with the size of the object. If an object changes in size, the grip aperture has to be corrected. In this study, it was investigated whether such corrections would influence the perceived size of objects. The grasping plan was manipulated with a preview of the object, after which participants initiated their reaching movement without vision. In a minority of the grasps, the object changed in size after the preview and participants had to adjust their grasping movement. Visual feedback was manipulated in two experiments. In experiment 1, vision was restored during reach and both visual and haptic information was available to correct the grasp and lift the object. In experiment 2, no visual information was provided during the movement and grasps could only be corrected using haptic information. Participants made reach-to-grasp movements towards two objects and compared these in size. Results showed that participants adjusted their grasp to a change in object size from preview to grasped object in both experiments. However, a change in object size did not bias the perception of object size or alter discrimination performance. In experiment 2, a small perceptual bias was found when objects changed from large to small. However, this bias was much smaller than the difference that could be discriminated and could not be considered meaningful. Therefore, it can be concluded that the planning and execution of reach-to-grasp movements do not reliably affect the perception of object size.	[van Polanen, Vonne] Katholieke Univ Leuven, Dept Movement Sci, Biomed Sci Grp, Movement Control & Neuroplast Res Grp, Leuven, Belgium; [van Polanen, Vonne] Katholieke Univ Leuven, Leuven Brain Inst, Leuven, Belgium	KU Leuven; KU Leuven	van Polanen, V (corresponding author), Katholieke Univ Leuven, Dept Movement Sci, Biomed Sci Grp, Movement Control & Neuroplast Res Grp, Leuven, Belgium.; van Polanen, V (corresponding author), Katholieke Univ Leuven, Leuven Brain Inst, Leuven, Belgium.	vonne.vanpolanen@kuleuven.be		van Polanen, Vonne/0000-0003-3111-6199	Fonds Wetenschappelijk Onderzoek grant [12X7118N]	Fonds Wetenschappelijk Onderzoek grant	This research was supported by a Fonds Wetenschappelijk Onderzoek grant to VVP (FWO post-doctoral fellowship, Belgium, 12X7118N, www.fwo.be).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGLIOTI S, 1995, CURR BIOL, V5, P679, DOI 10.1016/S0960-9822(95)00133-3; Bruno N, 2016, NEUROPSYCHOLOGIA, V91, P327, DOI 10.1016/j.neuropsychologia.2016.08.022; Camponogara I, 2019, J NEUROPHYSIOL, V122, P2614, DOI 10.1152/jn.00452.2019; Cesanek E, 2018, NEUROPSYCHOLOGIA, V117, P271, DOI 10.1016/j.neuropsychologia.2018.06.014; Cloutman LL, 2013, BRAIN LANG, V127, P251, DOI 10.1016/j.bandl.2012.08.003; Collier ES, 2017, ATTEN PERCEPT PSYCHO, V79, P2117, DOI 10.3758/s13414-017-1344-3; Ernst MO, 2002, NATURE, V415, P429, DOI 10.1038/415429a; Franz VH, 2009, NEUROPSYCHOLOGIA, V47, P1518, DOI 10.1016/j.neuropsychologia.2008.08.029; Franz V, 2008, COGN NEUROPSYCHOL, V25, P920, DOI 10.1080/02643290701862449; Ganel T, 2008, CURR BIOL, V18, pR599, DOI 10.1016/j.cub.2008.04.052; Geers L, 2018, NEUROPSYCHOLOGIA, V117, P211, DOI 10.1016/j.neuropsychologia.2018.06.003; Glover S, 2002, TRENDS COGN SCI, V6, P288, DOI 10.1016/S1364-6613(02)01920-4; GOODALE MA, 1992, TRENDS NEUROSCI, V15, P20, DOI 10.1016/0166-2236(92)90344-8; GOODALE MA, 1994, NEUROPSYCHOLOGIA, V32, P1159, DOI 10.1016/0028-3932(94)90100-7; Gutteling TP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017675; Haffenden AM, 1998, J COGNITIVE NEUROSCI, V10, P122, DOI 10.1162/089892998563824; Hesse C, 2009, J MOTOR BEHAV, V41, P253, DOI 10.3200/JMBR.41.3.253-273; Jazi SD, 2015, EXP BRAIN RES, V233, P2029, DOI 10.1007/s00221-015-4274-0; JEANNEROD M, 1995, TRENDS NEUROSCI, V18, P314, DOI 10.1016/0166-2236(95)93921-J; Jeannerod M., 1981, ATTENTION PERFORM, P153; Jeannerod M., 1988, NEURAL BEHAV ORG GOA; Jeffreys H., 1939, THEORY PROBABILITY, V1; Kopiske KK, 2016, CORTEX, V79, P130, DOI 10.1016/j.cortex.2016.03.020; Linkenauger SA, 2011, J EXP PSYCHOL HUMAN, V37, P1432, DOI 10.1037/a0024248; PAULIGNAN Y, 1991, EXP BRAIN RES, V87, P407; Pavani F, 1999, EXP BRAIN RES, V127, P95, DOI 10.1007/s002210050777; Schenk T, 2010, COGN NEUROSCI-UK, V1, P52, DOI 10.1080/17588920903388950; Schneider TR, 2019, J NEUROPHYSIOL, V121, P1289, DOI 10.1152/jn.00710.2018; Smeets JBJ, 1999, MOTOR CONTROL, V3, P237, DOI 10.1123/mcj.3.3.237; Smeets JBJ, 2006, J EXP PSYCHOL HUMAN, V32, P1501, DOI 10.1037/0096-1523.32.6.1501; Smeets JBJ, 2019, J NEUROPHYSIOL, V122, P1578, DOI 10.1152/jn.00123.2019; van de Kamp C, 2009, J MOTOR BEHAV, V41, P427, DOI 10.3200/35-08-033; van Polanen V, 2020, J NEUROPHYSIOL, V124, P557, DOI 10.1152/jn.00771.2019; van Polanen V, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-52102-y; van Polanen V, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00700; van Polanen V, 2015, NEUROPSYCHOLOGIA, V79, P186, DOI 10.1016/j.neuropsychologia.2015.07.010; Vishton PM, 1999, J EXP PSYCHOL HUMAN, V25, P1659, DOI 10.1037/0096-1523.25.6.1659; Wei XX, 2017, P NATL ACAD SCI USA, V114, P10244, DOI 10.1073/pnas.1619153114; Wichmann FA, 2001, PERCEPT PSYCHOPHYS, V63, P1293, DOI 10.3758/BF03194544; Wykowska A, 2011, INT J SOC ROBOT, V3, P223, DOI 10.1007/s12369-010-0078-3	40	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2021	16	9							e0248084	10.1371/journal.pone.0248084	http://dx.doi.org/10.1371/journal.pone.0248084			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	WG5RP	34520478	Green Published, gold			2022-12-26	WOS:000707052100001
J	Ivanov, D; Mironova, E; Polyakova, V; Evsyukova, I; Osetrov, M; Kvetnoy, I; Nasyrov, R				Ivanov, Dmitry; Mironova, Ekaterina; Polyakova, Victoria; Evsyukova, Inna; Osetrov, Michail; Kvetnoy, Igor; Nasyrov, Ruslan			Sudden infant death syndrome: Melatonin, serotonin, and CD34 factor as possible diagnostic markers and prophylactic targets	PLOS ONE			English	Article							CIRCADIAN-RHYTHMS; WHITE-MATTER; PINEAL-GLAND; BRAIN-INJURY; CELLS; SIDS; MT1; INFLAMMATION; RECEPTORS; NEUROPROTECTION	Sudden infant death syndrome (SIDS) is one of the primary causes of death of infants in the first year of life. According to the WHO's data, the global infant mortality rate is 0.64-2 per 1,000 live-born children. Molecular and cellular aspects of SIDS development have not been identified so far. The purpose of this paper is to verify and analyze the expression of melatonin 1 and 2 receptors, serotonin (as a melatonin precursor), and CD34 molecules (as hematopoietic and endothelial markers of cardiovascular damage) in the medulla, heart, and aorta in infants who died from SIDS. An immunohistochemical method was used to investigate samples of medulla, heart, and aorta tissues of infants 3 to 9 months of age who died from SIDS. The control group included children who died from accidents. It has been shown that the expression of melatonin receptors as well as serotonin and CD34 angiogenesis markers in tissues of the medulla, heart, and aorta of infants who died from SIDS is statistically lower as compared with their expression in the same tissues in children who died from accidents. The obtained data help to clarify in detail the role of melatonin and such signaling molecules as serotonin and CD34 in SIDS pathogenesis, which can open new prospects for devising novel methods for predictive diagnosis of development and targeted prophylaxis of SIDS.	[Ivanov, Dmitry; Polyakova, Victoria; Osetrov, Michail; Nasyrov, Ruslan] St Petersburg State Pediat Med Univ, St Petersburg, Russia; [Mironova, Ekaterina] St Petersburg Inst Bioregulat & Gerontol, St Petersburg, Russia; [Mironova, Ekaterina; Kvetnoy, Igor] St Petersburg Res Inst Phthisiopulmonol, St Petersburg, Russia; [Evsyukova, Inna] Ott Res Inst Obstet Gynecol & Reproductol, St Petersburg, Russia; [Kvetnoy, Igor] Univ Embankment, St Petersburg State Univ, St Petersburg, Russia	Saint Petersburg State Pediatric Medical University; St. Petersburg State Research Institute of Phthisiopulmonology; Russian Academy of Medical Sciences; Ott Institute of Obstetrics, Gynecology & Reproductology; Saint Petersburg State University	Mironova, E (corresponding author), St Petersburg Inst Bioregulat & Gerontol, St Petersburg, Russia.; Mironova, E (corresponding author), St Petersburg Res Inst Phthisiopulmonol, St Petersburg, Russia.	katerina.mironova@gerontology.ru		Brikhta, Mikhail/0000-0002-8385-5500; Mironova, Ekaterina/0000-0001-8134-5104				Acosta Maria, 2002, Adv Pediatr, V49, P1; Alonso-Alconada D, 2012, HISTOL HISTOPATHOL, V27, P771, DOI 10.14670/HH-27.771; Anderson TM, 2019, PEDIATRICS, V143, DOI 10.1542/peds.2018-3325; Annachhatre AS, 2019, ANN CARD ANAESTH, V22, P213, DOI 10.4103/aca.ACA_90_18; Arutjunyan AV, 2019, NEUROCHEM J+, V13, P240, DOI 10.1134/S1819712419030036; Banno K, 2018, PEDIATR RES, V83, P283, DOI 10.1038/pr.2017.231; Basile DP, 2018, ACTA PHYSIOL, V222, DOI 10.1111/apha.12914; Bennet L, 2018, J PHYSIOL-LONDON, V596, P5687, DOI 10.1113/JP274950; Blackburn J, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.594550; Boilson BA, 2008, NAT CLIN PRACT CARD, V5, P489, DOI 10.1038/ncpcardio1277; Bouslama M, 2007, NEUROSCIENCE, V150, P712, DOI 10.1016/j.neuroscience.2007.09.030; Broadbelt KG, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.009530; Brummelte S, 2017, NEUROSCIENCE, V342, P212, DOI 10.1016/j.neuroscience.2016.02.037; BUCK GM, 1989, AM J EPIDEMIOL, V129, P874, DOI 10.1093/oxfordjournals.aje.a115221; Carloni S, 2008, J PINEAL RES, V44, P157, DOI 10.1111/j.1600-079X.2007.00503.x; Carloni S, 2016, J PINEAL RES, V61, P370, DOI 10.1111/jpi.12354; Miquez MC, 2019, INT J PUBLIC HEALTH, V64, P1355, DOI 10.1007/s00038-019-01308-y; Cecon E, 2019, J PINEAL RES, V67, DOI 10.1111/jpi.12606; Comai S, 2019, PHARMACOL RES, V144, P343, DOI 10.1016/j.phrs.2019.04.015; Cummings KJ, 2016, EXP PHYSIOL, V101, P790, DOI 10.1113/EP085834; Cummings KJ, 2009, AM J PHYSIOL-REG I, V296, pR1783, DOI 10.1152/ajpregu.00122.2009; Davis MR, 2019, J APPL PHYSIOL, V126, P1175, DOI 10.1152/japplphysiol.00909.2018; Domingues CC, 2019, STEM CELL RES THER, V10, DOI 10.1186/s13287-019-1251-8; Duncan JR, 2010, JAMA-J AM MED ASSOC, V303, P430, DOI 10.1001/jama.2010.45; Duncan JR, 2018, SIDS SUDDEN INFANT E, DOI [10.20851/sids, DOI 10.20851/SIDS]; Ekmekcioglu C, 2003, J PINEAL RES, V35, P40, DOI 10.1034/j.1600-079X.2003.00051.x; Eleftheriou D, 2015, CEREBROVASC DIS EXTR, V5, P68, DOI 10.1159/000381963; Evsyukova I. I., 2013, Human Physiology, V39, P617, DOI 10.1134/S0362119713060030; Friedmann I, 2017, J MATERN-FETAL NEO M, V30, P2315, DOI 10.1080/14767058.2016.1247265; Fulia F, 2001, J PINEAL RES, V31, P343, DOI 10.1034/j.1600-079X.2001.310409.x; Garcia AJ, 2013, RESP PHYSIOL NEUROBI, V189, P288, DOI 10.1016/j.resp.2013.05.032; Gaspar P, 2003, NAT REV NEUROSCI, V4, P1002, DOI 10.1038/nrn1256; Getahun D, 2004, OBSTET GYNECOL, V103, P646, DOI 10.1097/01.AOG.0000117081.50852.04; Gobbi G, 2019, J PINEAL RES, V66, DOI 10.1111/jpi.12544; Goldwater PN, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-64; Goldwater PN, 2017, ARCH DIS CHILD, V102, P767, DOI 10.1136/archdischild-2016-312327; Guyenet PG, 2015, NEURON, V87, P946, DOI 10.1016/j.neuron.2015.08.001; Haduch A, 2016, DRUG METAB DISPOS, V44, P445, DOI 10.1124/dmd.115.067413; Hatta K, 2012, J CELL MOL MED, V16, P1392, DOI 10.1111/j.1582-4934.2012.01583.x; Hernandez-Valencia Marcelino, 2015, Ginecol Obstet Mex, V83, P408; Imbesi M, 2008, BRAIN RES, V1227, P19, DOI 10.1016/j.brainres.2008.06.082; Kasuda S, 2019, FORENSIC SCI MED PAT, V15, P300, DOI 10.1007/s12024-018-0066-8; Kaur C, 2008, CURR MED CHEM, V15, P3068, DOI 10.2174/092986708786848640; Khaldy H, 2002, NEUROENDOCRINOLOGY, V75, P201, DOI 10.1159/000048238; Kinney HC, 2011, J CHEM NEUROANAT, V41, P182, DOI 10.1016/j.jchemneu.2011.05.004; Kliman HJ, 2018, ENDOCRINOLOGY, V159, P1609, DOI 10.1210/en.2017-03025; Konstat-Korzenny E, 2019, CUREUS, V11, DOI 10.7759/cureus.6076; Kurhaluk N, 2020, CHRONOBIOL INT, V37, P781, DOI 10.1080/07420528.2020.1761372; Leach CEA, 1999, PEDIATRICS, V104, DOI 10.1542/peds.104.4.e43; Lopez A, 2009, J PINEAL RES, V46, P188, DOI 10.1111/j.1600-079X.2008.00647.x; Matturri L, 2000, CARDIOVASC PATHOL, V9, P137, DOI 10.1016/S1054-8807(00)00035-1; McGraw K, 1999, SLEEP, V22, P303, DOI 10.1093/sleep/22.3.303; Meredith EJ, 2005, IMMUNOLOGY, V115, P289, DOI 10.1111/j.1365-2567.2005.02166.x; Miller SL, 2005, DEV NEUROSCI-BASEL, V27, P200, DOI 10.1159/000085993; Mitchell Edwin A, 2009, Dev Psychobiol, V51, P215, DOI 10.1002/dev.20369; Mitchell EA, 2009, ACTA PAEDIATR, V98, P1712, DOI 10.1111/j.1651-2227.2009.01503.x; Moon RY, 2007, LANCET, V370, P1578, DOI 10.1016/S0140-6736(07)61662-6; Moon RY, 2011, PEDIATRICS, V128, P1030, DOI 10.1542/peds.2011-2284; Motta-Teixeira LC, 2018, HORM BEHAV, V105, P146, DOI 10.1016/j.yhbeh.2018.08.006; Munoz-Hoyos A, 2007, NEONATOLOGY, V92, P209, DOI 10.1159/000102957; Olivier P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007128; Osier ND, 2017, NEUROSCI LETT, V650, P18, DOI 10.1016/j.neulet.2017.03.053; Paltsev MA, 2016, ONCOTARGET, V7, P11972, DOI 10.18632/oncotarget.7863; Paulus EV, 2012, PHYSIOL BEHAV, V105, P257, DOI 10.1016/j.physbeh.2011.08.032; Pontes GN, 2006, J PINEAL RES, V41, P136, DOI 10.1111/j.1600-079X.2006.00345.x; Qin YS, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-54530-2; Reiter RJ, 2018, MOLECULES, V23, DOI 10.3390/molecules23020509; Rosenfeld CS, 2020, BIOL REPROD, V102, P532, DOI 10.1093/biolre/ioz204; Sagrillo-Fagundes L, 2014, Minerva Ginecol, V66, P251; Sawaguchi T, 2003, EARLY HUM DEV, V75, pS31, DOI 10.1016/j.earlhumdev.2003.08.006; Seron-Ferre M, 2012, MOL CELL ENDOCRINOL, V349, P68, DOI 10.1016/j.mce.2011.07.039; Siemerink MJ, 2010, DEV OPHTHALMOL, V46, P4, DOI 10.1159/000320006; Sivan Y, 1999, PEDIATR RES, V45, p30A, DOI 10.1203/00006450-199905020-00119; SPARKS DL, 1988, J PINEAL RES, V5, P111, DOI 10.1111/j.1600-079X.1988.tb00773.x; STURNER WQ, 1990, FORENSIC SCI INT, V45, P171, DOI 10.1016/0379-0738(90)90234-P; Tauman R, 2002, PEDIATR NEUROL, V26, P379, DOI 10.1016/S0887-8994(01)00417-9; Thomas L, 1998, INT J MOL MED, V1, P539; Thomas L, 2002, J PINEAL RES, V33, P218, DOI 10.1034/j.1600-079X.2002.02921.x; Tordjman S, 2017, CURR NEUROPHARMACOL, V15, P434, DOI 10.2174/1570159X14666161228122115; Torres-Farfan C, 2008, J PHYSIOL-LONDON, V586, P4017, DOI 10.1113/jphysiol.2008.154351; Villapol S, 2011, PEDIATR RES, V69, P51, DOI 10.1203/PDR.0b013e3181fcb40b; Wacker D, 2013, SCIENCE, V340, P615, DOI 10.1126/science.1232808; Welin AK, 2007, PEDIATR RES, V61, P153, DOI 10.1203/01.pdr.0000252546.20451.1a; Williams LM, 1997, J REPROD FERTIL, V110, P145, DOI 10.1530/jrf.0.1100145; Zeman Michal, 2013, Front Biosci (Schol Ed), V5, P743	85	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2021	16	9							e0256197	10.1371/journal.pone.0256197	http://dx.doi.org/10.1371/journal.pone.0256197			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XM9EM	34506527	Green Published, gold			2022-12-26	WOS:000729120700122
J	Asl, MM; Akbarabadi, SR				Madadi Asl, Mojtaba; Ramezani Akbarabadi, Saeideh			Voltage-dependent plasticity of spin-polarized conductance in phenyl-based single-molecule magnetic tunnel junctions	PLOS ONE			English	Article							ANCHORING GROUPS; HEBBS POSTULATE; MEMORY; CONNECTIVITY; MEMRISTOR; DEVICE	Synaptic strengths between neurons in brain networks are highly adaptive due to synaptic plasticity. Spike-timing-dependent plasticity (STDP) is a form of synaptic plasticity induced by temporal correlations between the firing activity of neurons. The development of experimental techniques in recent years enabled the realization of brain-inspired neuromorphic devices. Particularly, magnetic tunnel junctions (MTJs) provide a suitable means for the implementation of learning processes in molecular junctions. Here, we first considered a two-neuron motif subjected to STDP. By employing theoretical analysis and computer simulations we showed that the dynamics and emergent structure of the motif can be predicted by introducing an effective two-neuron synaptic conductance. Then, we considered a phenyl-based single-molecule MTJ connected to two ferromagnetic (FM) cobalt electrodes and investigated its electrical properties using the non-equilibrium Green's function (NEGF) formalism. Similar to the two-neuron motif, we introduced an effective spin-polarized conductance in the MTJ. Depending on the polarity, frequency and strength of the bias voltage applied to the MTJ, the system can learn input signals by adaptive changes of the effective conductance. Interestingly, this voltage-dependent plasticity is an intrinsic property of the MTJ where its behavior is reminiscent of the classical temporally asymmetric STDP. Furthermore, the shape of voltage-dependent plasticity in the MTJ is determined by the molecule-electrode coupling strength or the length of the molecule. Our results may be relevant for the development of single-molecule devices that capture the adaptive properties of synapses in the brain.	[Madadi Asl, Mojtaba] Inst Adv Studies Basic Sci IASBS, Dept Phys, Zanjan, Iran; [Ramezani Akbarabadi, Saeideh] Univ Guilan, Dept Phys, Rasht, Iran	Institute for Advanced Studies in Basic Sciences (IASBS); University of Guilan	Asl, MM (corresponding author), Inst Adv Studies Basic Sci IASBS, Dept Phys, Zanjan, Iran.	m.madadi@iasbs.ac.ir		Ramezani Akbarabadi, Saeideh/0000-0002-5407-1766; Madadi Asl, Mojtaba/0000-0002-2114-1588				Akbarabadi SR, 2017, CHINESE PHYS B, V26, DOI 10.1088/1674-1056/26/2/027303; Akbarabadi SR, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-88297-2; Albert FJ, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.226802; Alemani M, 2006, J AM CHEM SOC, V128, P14446, DOI 10.1021/ja065449s; Asl MM, 2019, BASIC CLIN NEUROSCI, V10, P1, DOI 10.32598/bcn.9.10.125; Asl MM, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.01849; Asl MM, 2018, CHAOS, V28, DOI 10.1063/1.5037309; Asl MM, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-30565-9; Asl MM, 2017, SCI REP-UK, V7, DOI 10.1038/srep39682; Bi GQ, 2001, ANNU REV NEUROSCI, V24, P139, DOI 10.1146/annurev.neuro.24.1.139; Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; Cai JL, 2019, PHYS REV APPL, V11, DOI 10.1103/PhysRevApplied.11.034015; Chen F, 2006, J AM CHEM SOC, V128, P15874, DOI 10.1021/ja065864k; Clopath Claudia, 2010, Front Synaptic Neurosci, V2, P25, DOI 10.3389/fnsyn.2010.00025; Clopath C, 2010, NAT NEUROSCI, V13, P344, DOI 10.1038/nn.2479; Comstock MJ, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.038301; Diao ZT, 2007, J PHYS-CONDENS MAT, V19, DOI 10.1088/0953-8984/19/16/165209; Gerstner W, 1996, NATURE, V383, P76, DOI 10.1038/383076a0; Grollier J, 2020, NAT ELECTRON, V3, P360, DOI 10.1038/s41928-019-0360-9; He NA, 2021, APPL PHYS LETT, V118, DOI 10.1063/5.0049349; Jeong H, 2019, J PHYS D APPL PHYS, V52, DOI 10.1088/1361-6463/aae223; Jo SH, 2010, NANO LETT, V10, P1297, DOI 10.1021/nl904092h; Kim S, 2015, NANO LETT, V15, P2203, DOI 10.1021/acs.nanolett.5b00697; Koga J, 2012, J PHYS CHEM C, V116, P20607, DOI 10.1021/jp3068156; Li SZ, 2013, J MATER CHEM C, V1, P5292, DOI 10.1039/c3tc30575a; Markram H, 1997, SCIENCE, V275, P213, DOI 10.1126/science.275.5297.213; Martin SJ, 2000, ANNU REV NEUROSCI, V23, P649, DOI 10.1146/annurev.neuro.23.1.649; Moresco F, 2001, PHYS REV LETT, V86, P672, DOI 10.1103/PhysRevLett.86.672; Morris RGM, 1999, BRAIN RES BULL, V50, P437, DOI 10.1016/S0361-9230(99)00182-3; Mosso N, 2019, NANO LETT, V19, P7614, DOI 10.1021/acs.nanolett.9b02089; Park Y, 2017, ACS NANO, V11, P8962, DOI 10.1021/acsnano.7b03347; Pershin YV, 2010, NEURAL NETWORKS, V23, P881, DOI 10.1016/j.neunet.2010.05.001; Prasad N, 2020, J APPL PHYS, V127, DOI 10.1063/1.5142418; Prezioso M, 2015, NATURE, V521, P61, DOI 10.1038/nature14441; Ramezani Akbarabadi S., 2014, CURRENT PHYS CHEM, V4, P285, DOI [10.2174/1877946805666150311234229, DOI 10.2174/1877946805666150311234229]; Ramezani Akbarabadi S, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-67964-w; Sangwan VK, 2020, NAT NANOTECHNOL, V15, P517, DOI 10.1038/s41565-020-0647-z; Sengupta A, 2016, SCI REP-UK, V6, DOI 10.1038/srep30039; Song S, 2005, PLOS BIOL, V3, P507, DOI 10.1371/journal.pbio.0030068; Song S, 2001, NEURON, V32, P339, DOI 10.1016/S0896-6273(01)00451-2; Song S, 2000, NAT NEUROSCI, V3, P919, DOI 10.1038/78829; STENT GS, 1973, P NATL ACAD SCI USA, V70, P997, DOI 10.1073/pnas.70.4.997; Taniguchi M, 2010, CHEM SCI, V1, P247, DOI 10.1039/c0sc00129e; Taylor J, 2003, PHYS REV B, V68, DOI 10.1103/PhysRevB.68.121101; Tehrani S, 2003, P IEEE, V91, P703, DOI 10.1109/JPROC.2003.811804; Thomas A, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00241; Thomas A, 2013, J PHYS D APPL PHYS, V46, DOI 10.1088/0022-3727/46/9/093001; Vogels TP, 2011, SCIENCE, V334, P1569, DOI 10.1126/science.1211095; Xue YQ, 2004, PHYS REV B, V69, DOI 10.1103/PhysRevB.69.085403; Yamada R, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3549190; Zhang ZZ, 2021, NANOSCALE RES LETT, V16, DOI 10.1186/s11671-021-03531-0; Zotti LA, 2010, SMALL, V6, P1529, DOI 10.1002/smll.200902227	53	4	4	3	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2021	16	9							e0257228	10.1371/journal.pone.0257228	http://dx.doi.org/10.1371/journal.pone.0257228			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XM9EM	34506579	gold, Green Published			2022-12-26	WOS:000729120700084
J	Searle, CE; Smit, JB; Cusack, JJ; Strampelli, P; Grau, A; Mkuburo, L; Macdonald, DW; Loveridge, AJ; Dickman, AJ				Searle, Charlotte E.; Smit, Josephine B.; Cusack, Jeremy J.; Strampelli, Paolo; Grau, Ana; Mkuburo, Lameck; Macdonald, David W.; Loveridge, Andrew J.; Dickman, Amy J.			Temporal partitioning and spatiotemporal avoidance among large carnivores in a human-impacted African landscape	PLOS ONE			English	Article							WILD DOGS; SPOTTED HYENAS; INTERSPECIFIC COMPETITION; PREY PREFERENCES; DIETARY OVERLAP; PANTHERA-PARDUS; NATIONAL-PARK; HABITAT USE; LIONS; RESPONSES	Africa is home to some of the world's most functionally diverse guilds of large carnivores. However, they are increasingly under threat from anthropogenic pressures that may exacerbate already intense intra-guild competition. Understanding the coexistence mechanisms employed by these species in human-impacted landscapes could help shed light on some of the more subtle ways in which humans may impact wildlife populations, and inform multi-species conservation planning. We used camera trap data from Tanzania's Ruaha-Rungwa landscape to explore temporal and spatiotemporal associations between members of an intact East African large carnivore guild, and determine how these varied across gradients of anthropogenic impact and protection. All large carnivores except African wild dog (Lycaon pictus) exhibited predominantly nocturnal road-travel behaviour. Leopard (Panthera pardus) appeared to employ minor temporal avoidance of lion (Panthera leo) in all sites except those where human impacts were highest, suggesting that leopard may have been freed up from avoidance of lion in areas where the dominant competitor was less abundant, or that the need for leopard to avoid humans outweighed the need to avoid sympatric competitors. Lion appeared to modify their activity patterns to avoid humans in the most impacted areas. We also found evidence of avoidance and attraction among large carnivores: lion and spotted hyaena (Crocuta crocuta) followed leopard; leopard avoided lion; spotted hyaena followed lion; and lion avoided spotted hyaena. Our findings suggest that large carnivores in Ruaha-Rungwa employ fine-scale partitioning mechanisms to facilitate coexistence with both sympatric species and humans, and that growing human pressures may interfere with these behaviours.	[Searle, Charlotte E.; Strampelli, Paolo; Macdonald, David W.; Loveridge, Andrew J.; Dickman, Amy J.] Univ Oxford, Recanati Kaplan Ctr, Wildlife Conservat Res Unit, Dept Zool, Tubney, England; [Searle, Charlotte E.; Strampelli, Paolo; Grau, Ana; Dickman, Amy J.] Ruaha Carnivore Project, Iringa, Tanzania; [Smit, Josephine B.; Mkuburo, Lameck] Southern Tanzania Elephant Program, Iringa, Tanzania; [Smit, Josephine B.] Univ Stirling, Dept Psychol, Stirling, Scotland; [Cusack, Jeremy J.] Univ Mayor, Ctr Modelac & Monitoreo Ecosistemas, Santiago, Chile; [Mkuburo, Lameck] Tanzanian Elephant Fdn, Kilimanjaro, Tanzania	University of Oxford; University of Stirling; Universidad Mayor	Searle, CE (corresponding author), Univ Oxford, Recanati Kaplan Ctr, Wildlife Conservat Res Unit, Dept Zool, Tubney, England.; Searle, CE (corresponding author), Ruaha Carnivore Project, Iringa, Tanzania.	charlotte.searle@zoo.ox.ac.uk		Smit, Josephine Belia/0000-0003-2974-6140	University of Oxford NERC Environmental Research DTP; National Geographic Society Early Career Grants [EC-348C-18]; Cleveland Metroparks Zoo Africa Seed Grants; Chicago Zoological Society Chicago Board of Trade (CBOT) Endangered Species Fund; Pittsburgh Zoo & PPG Aquarium Conservation & Sustainability Fund; Government of Tanzania; TAWIRI; Tanzania National Parks Authority (TANAPA); Tanzania Wildlife Management Authority (TAWA); Idodi-Pawaga MBOMIPA WMA; Recanati-Kaplan Fellowship	University of Oxford NERC Environmental Research DTP; National Geographic Society Early Career Grants(National Geographic Society); Cleveland Metroparks Zoo Africa Seed Grants; Chicago Zoological Society Chicago Board of Trade (CBOT) Endangered Species Fund; Pittsburgh Zoo & PPG Aquarium Conservation & Sustainability Fund; Government of Tanzania; TAWIRI; Tanzania National Parks Authority (TANAPA); Tanzania Wildlife Management Authority (TAWA); Idodi-Pawaga MBOMIPA WMA; Recanati-Kaplan Fellowship	Scholarship funding for CS and PS was provided by the University of Oxford NERC Environmental Research DTP (https://www.environmental-research.ox.ac.uk). AD is funded by a Recanati-Kaplan Fellowship (https://www.wildcru.org). Additional funding was awarded to CS for this research from National Geographic Society Early Career Grants (grant number EC-348C-18; https://www.nationalgeographic.org/funding-opportunities/grants/), Recanati-Kaplan Fellowship Cleveland Metroparks Zoo Africa Seed Grants (https://www.clevelandmetroparks.com/zoo), Chicago Zoological Society Chicago Board of Trade (CBOT) Endangered Species Fund (https://www.czs.org/Chicago-Zoological-Society/Conservation-Leadership/CBOT-Endangered-Species-Fund), and Pittsburgh Zoo & PPG Aquarium Conservation & Sustainability Fund (https://www.pittsburghzoo.org/conservation/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Fieldwork for this research was carried out under permits 2018-368-NA-2018-107, 2018-126NA-97-20, 2019-96-ER-97-20 and 2019-424-NA-2018-184, granted by the Tanzania Commission for Science and Technology (COSTECH) and Tanzania Wildlife Research Institute (TAWIRI). We would like to thank the Government of Tanzania, TAWIRI, Tanzania National Parks Authority (TANAPA), Tanzania Wildlife Management Authority (TAWA), and Idodi-Pawaga MBOMIPA WMA for their support of this research. We also thank the field staff of the Southern Tanzania Elephant Program (STEP) and Ruaha Carnivore Project (RCP) for their assistance with data collection, and MBOMIPA WMA Village Game Scouts, TANAPA Rangers, TAWA Game Scouts, and Tanzania Big Game Safaris for their assistance during fieldwork.	Abade L, 2020, J ZOOL, V310, P135, DOI 10.1111/jzo.12731; Abade L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096261; Abrahms B, 2016, ANIM CONSERV, V19, P247, DOI 10.1111/acv.12235; Amoros M, 2020, OIKOS, V129, P1820, DOI 10.1111/oik.06846; Balme G, 2019, POPUL ECOL, V61, P256, DOI 10.1002/1438-390X.1023; Balme GA, 2017, BEHAV ECOL, V28, P1348, DOI 10.1093/beheco/arx098; Balme GA, 2017, J ANIM ECOL, V86, P634, DOI 10.1111/1365-2656.12654; BERG WA, 2013, MAMMAL REV, V43, P89, DOI DOI 10.1111/J.1365-2907.2011.00209.X; Boydston EE, 2003, ANIM CONSERV, V6, P207, DOI 10.1017/S1367943003003263; Broekhuis F, 2013, J ANIM ECOL, V82, P1097, DOI 10.1111/1365-2656.12077; Caro TM, 2003, BIOL CONSERV, V110, P67, DOI 10.1016/S0006-3207(02)00177-5; Chapron G, 2016, TRENDS ECOL EVOL, V31, P578, DOI 10.1016/j.tree.2016.06.003; COOPER SM, 1991, AFR J ECOL, V29, P130, DOI 10.1111/j.1365-2028.1991.tb00993.x; Cozzi G, 2012, ECOLOGY, V93, P2590, DOI 10.1890/12-0017.1; Creel S, 1996, CONSERV BIOL, V10, P526, DOI 10.1046/j.1523-1739.1996.10020526.x; Creel S, 2018, J APPL ECOL, V55, P2908, DOI 10.1111/1365-2664.13227; Cusack JJ, 2017, OIKOS, V126, P812, DOI 10.1111/oik.03403; Dalerum F, 2009, BIOL LETTERS, V5, P35, DOI 10.1098/rsbl.2008.0520; Donadio E, 2006, AM NAT, V167, P524, DOI 10.1086/501033; Droge E, 2017, ECOL EVOL, V7, P189, DOI 10.1002/ece3.2616; du Preez B, 2017, J ZOOL, V302, P149, DOI 10.1111/jzo.12443; du Preez BD., 2014, THESIS U OXFORD; du Preez B, 2015, ANIM BEHAV, V100, P22, DOI 10.1016/j.anbehav.2014.10.025; Epaphras A. M., 2008, Wetlands Ecology and Management, V16, P183, DOI 10.1007/s11273-007-9065-3; Everatt KT, 2019, GLOB ECOL CONSERV, V20, DOI 10.1016/j.gecco.2019.e00758; Foley C., 2014, FIELD GUIDE LARGER M; Green DS, 2019, J MAMMAL, V100, P1941, DOI 10.1093/jmammal/gyz135; Hardouin M, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0242293; Harihar A, 2011, J APPL ECOL, V48, P806, DOI 10.1111/j.1365-2664.2011.01981.x; Havmoller RW, 2020, J ZOOL, V311, P175, DOI 10.1111/jzo.12774; Hayward MW, 2006, J ZOOL, V270, P606, DOI 10.1111/j.1469-7998.2006.00183.x; Hayward MW, 2009, S AFR J WILDL RES, V39, P109, DOI 10.3957/056.039.0207; Hayward MW, 2008, S AFR J WILDL RES, V38, P93, DOI 10.3957/0379-4369-38.2.93; Henschel P, 2011, J ZOOL, V285, P11, DOI 10.1111/j.1469-7998.2011.00826.x; Hetem RS, 2019, INTEGR ZOOL, V14, P30, DOI 10.1111/1749-4877.12341; Hunter JS, 2007, BEHAV ECOL SOCIOBIOL, V61, P1033, DOI 10.1007/s00265-006-0336-4; Jacobson AP, 2016, PEERJ, V4, DOI 10.7717/peerj.1974; Kissui BM, 2004, P ROY SOC B-BIOL SCI, V271, P1867, DOI 10.1098/rspb.2004.2797; Knapp, 2003, TECHNICAL REPORT WAT; LAURENSON MK, 1994, J ZOOL, V234, P387, DOI 10.1111/j.1469-7998.1994.tb04855.x; Linkie M, 2011, J ZOOL, V284, P224, DOI 10.1111/j.1469-7998.2011.00801.x; Linnell John D. C., 2000, Diversity and Distributions, V6, P169, DOI 10.1046/j.1472-4642.2000.00069.x; Meredith M., 2020, OVERVIEW OVERLAP PAC; Miller JRB, 2018, J ANIM ECOL, V87, P1709, DOI 10.1111/1365-2656.12883; Mills M.G.L., 1984, Koedoe, V27, P237; Odden M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112044; Oriol-Cotterill A, 2015, ANIM BEHAV, V101, P27, DOI 10.1016/j.anbehav.2014.11.020; Parsons AW, 2019, J APPL ECOL, V56, P1894, DOI 10.1111/1365-2664.13385; Periquet S, 2016, MAMM BIOL, V81, P227, DOI 10.1016/j.mambio.2015.10.005; Periquet S, 2015, J ZOOL, V297, P245, DOI 10.1111/jzo.12275; Periquet S, 2015, BIOL REV, V90, P1197, DOI 10.1111/brv.12152; Powers RP, 2019, NAT CLIM CHANGE, V9, P323, DOI 10.1038/s41558-019-0406-z; R Core Team, 2021, R LANG ENV STAT; Rafiq K, 2020, J ZOOL, V311, P246, DOI 10.1111/jzo.12781; Rasmussen GSA, 2012, J ZOOL, V286, P232, DOI 10.1111/j.1469-7998.2011.00874.x; Ridout, 2020, PACKAGE OVERLAP; Ridout MS, 2009, J AGR BIOL ENVIR ST, V14, P322, DOI 10.1198/jabes.2009.08038; Ripple WJ, 2014, SCIENCE, V343, P151, DOI 10.1126/science.1241484; Ritchie EG, 2009, ECOL LETT, V12, P982, DOI 10.1111/j.1461-0248.2009.01347.x; Rowcliffe M., 2016, PACKAGE ACTIVITY ANI; RStudio Team, RSTUDIO INT DEV R; Ruaha Carnivore Project, 2019, ANN REP 2019; Searle CE, 2021, BIOL CONSERV, V257, DOI 10.1016/j.biocon.2021.109120; Smith JE, 2008, ANIM BEHAV, V76, P619, DOI 10.1016/j.anbehav.2008.05.001; Stein AB, 2015, AFR J WILDL RES, V45, P247, DOI 10.3957/056.045.0247; STEP, 2019, SO TANZ EL PROGR 201; Strampelli P, 2018, MAMM BIOL, V89, P14, DOI 10.1016/j.mambio.2017.12.003; Swanson A, 2016, ECOL EVOL, V6, P8534, DOI 10.1002/ece3.2569; Swanson A, 2014, J ANIM ECOL, V83, P1418, DOI 10.1111/1365-2656.12231; Trinkel M, 2005, AFR J ECOL, V43, P220, DOI 10.1111/j.1365-2028.2005.00574.x; Van Cleave EK, 2018, BIOL CONSERV, V226, P224, DOI 10.1016/j.biocon.2018.08.003; van der Meer E, 2011, BEHAV ECOL, V22, P985, DOI 10.1093/beheco/arr079; Vanak AT, 2013, ECOLOGY, V94, P2619, DOI 10.1890/13-0217.1; Vazquez C, 2019, METHODS ECOL EVOL, V10, P2057, DOI 10.1111/2041-210X.13290; Watts HE, 2008, J ZOOL, V276, P402, DOI 10.1111/j.1469-7998.2008.00506.x; Watts HE, 2010, ETHOLOGY, V116, P1199, DOI 10.1111/j.1439-0310.2010.01833.x; Wolf C, 2017, ROY SOC OPEN SCI, V4, DOI 10.1098/rsos.170052; Wolf C, 2016, ROY SOC OPEN SCI, V3, DOI 10.1098/rsos.160252	78	3	3	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2021	16	9							e0256876	10.1371/journal.pone.0256876	http://dx.doi.org/10.1371/journal.pone.0256876			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XM9EM	34506529	gold, Green Published			2022-12-26	WOS:000729120700131
J	Venskus, A; Ferri, F; Migliorati, D; Spadone, S; Costantini, M; Hughes, G				Venskus, Agnese; Ferri, Francesca; Migliorati, Daniele; Spadone, Sara; Costantini, Marcello; Hughes, Gethin			Temporal binding window and sense of agency are related processes modifiable via occipital tACS	PLOS ONE			English	Article							JUDGMENT; TIME	The temporal binding window refers to the time frame within which temporal grouping of sensory information takes place. Sense of agency is the feeling of being in control of one's actions, and their associated outcomes. While previous research has shown that temporal cues and multisensory integration play a role in sense of agency, no studies have directly assessed whether individual differences in the temporal binding window and sense of agency are associated. In all three experiments, to assess sense of agency, participants pressed a button triggering, after a varying delay, the appearance of the circle, and reported their sense of agency over the effect. To assess the temporal binding window a simultaneity judgment task (Experiment 1) and a double-flash illusion task (Experiment 2 and 3) was also performed. As expected, the temporal binding window correlated with the sense of agency window. In Experiment 3, these processes were modulated by applying occipital tACS at either 14Hz or 8Hz. We found 14Hz tACS stimulation was associated with narrower temporal biding window and sense of agency window. Our results suggest the temporal binding window and the time window of sense of agency are related. They also point towards a possible underlying neural mechanism (alpha peak frequency) for this association.	[Venskus, Agnese; Hughes, Gethin] Univ Essex, Dept Psychol, Colchester, Essex, England; [Ferri, Francesca; Spadone, Sara] Univ G dAnnunzio, Dept Neurosci Imaging & Clin Sci, Chieti, Italy; [Migliorati, Daniele] SPC APC, Sch Cognit Psychotherapy, Rome, Italy; [Costantini, Marcello] G dAnnunzio Univ Chieti Pescara, Dept Psychol Hlth & Terr Sci, Chieti, Italy; [Costantini, Marcello] Univ G dAnnunzio, Inst Adv Biomed Technol ITAB, Chieti, Italy	University of Essex; G d'Annunzio University of Chieti-Pescara; G d'Annunzio University of Chieti-Pescara; G d'Annunzio University of Chieti-Pescara	Venskus, A (corresponding author), Univ Essex, Dept Psychol, Colchester, Essex, England.	avensk@essex.ac.uk	Ferri, Francesca/AAC-2527-2022; Spadone, Sara/GZL-0599-2022; Hughes, Gethin/J-6316-2012	Ferri, Francesca/0000-0003-1821-5870; Spadone, Sara/0000-0002-2304-4984; Hughes, Gethin/0000-0003-1518-9160; Venskus, Agnese/0000-0003-1120-7640				Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Cecere R, 2015, CURR BIOL, V25, P231, DOI 10.1016/j.cub.2014.11.034; Chambon V, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00320; Chambon V, 2012, COGNITION, V125, P441, DOI 10.1016/j.cognition.2012.07.011; Colonius H, 2004, J COGNITIVE NEUROSCI, V16, P1000, DOI 10.1162/0898929041502733; Donoghue T, 2020, NAT NEUROSCI, V23, P1655, DOI 10.1038/s41593-020-00744-x; Farrer C, 2008, BEHAV NEUROL, V19, P53, DOI 10.1155/2008/425267; Farrer C, 2013, CONSCIOUS COGN, V22, P1431, DOI 10.1016/j.concog.2013.09.010; Fenner B, 2020, CONSCIOUS COGN, V84, DOI 10.1016/j.concog.2020.102979; Ferri F, 2018, CONSCIOUS COGN, V65, P263, DOI 10.1016/j.concog.2018.09.006; Frith CD, 2000, BRAIN RES REV, V31, P357, DOI 10.1016/S0165-0173(99)00052-1; Hass K, 2017, COGN NEUROPSYCHIATRY, V22, P145, DOI 10.1080/13546805.2017.1287693; Hirst RJ, 2020, NEUROSCI BIOBEHAV R, V118, P759, DOI 10.1016/j.neubiorev.2020.09.006; Hughes G, 2018, NEUROPSYCHOLOGIA, V113, P1, DOI 10.1016/j.neuropsychologia.2018.03.020; Kawabe T, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0991; Keil J, 2020, FRONT NEUROSCI-SWITZ, V14, DOI 10.3389/fnins.2020.00298; Kleiner M, 2007, PERCEPTION, V36, P14; Knoblich G, 2004, J EXP PSYCHOL HUMAN, V30, P657, DOI 10.1037/0096-1523.30.4.657; Macaluso E, 2004, NEUROIMAGE, V21, P725, DOI 10.1016/j.neuroimage.2003.09.049; Migliorati D, 2020, J COGNITIVE NEUROSCI, V32, P1, DOI 10.1162/jocn_a_01464; Mioni Giovanna, 2020, Cereb Cortex Commun, V1, ptgaa064, DOI 10.1093/texcom/tgaa064; Moore JW, 2012, CONSCIOUS COGN, V21, P59, DOI 10.1016/j.concog.2011.08.010; Samaha J, 2015, CURR BIOL, V25, P2985, DOI 10.1016/j.cub.2015.10.007; Sato A, 2009, COGNITION, V110, P74, DOI 10.1016/j.cognition.2008.10.011; Shams L, 2002, COGNITIVE BRAIN RES, V14, P147, DOI 10.1016/S0926-6410(02)00069-1; SHANKS DR, 1989, Q J EXP PSYCHOL-B, V41, P139; Shimada S, 2010, EXP BRAIN RES, V201, P359, DOI 10.1007/s00221-009-2028-6; Shimojo S., 2001, Acoustical Science and Technology, V22, P61, DOI 10.1250/ast.22.61; Sidarus N, 2017, NEUROSCI CONSCIOUS, V3, DOI 10.1093/nc/nix012; Stecker GC, 2018, ATTEN PERCEPT PSYCHO, V80, P14, DOI 10.3758/s13414-017-1436-0; Vroomen J, 2010, ATTEN PERCEPT PSYCHO, V72, P871, DOI 10.3758/APP.72.4.871; Wallace MT, 2014, NEUROPSYCHOLOGIA, V64, P105, DOI 10.1016/j.neuropsychologia.2014.08.005; Wegner DM, 2002, BRADFORD BOOKS, P1; Wenke D, 2010, COGNITION, V115, P26, DOI 10.1016/j.cognition.2009.10.016; Zhang YY, 2019, P NATL ACAD SCI USA, V116, P17023, DOI 10.1073/pnas.1904160116	35	2	2	3	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2021	16	9							e0256987	10.1371/journal.pone.0256987	http://dx.doi.org/10.1371/journal.pone.0256987			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	XM9EM	34506528	Green Accepted, Green Published, gold			2022-12-26	WOS:000729120700015
J	Chen, X; Zhang, YH; Ren, X; Su, Q; Liu, Y; Dang, X; Qin, YY; Yang, XY; Xing, ZC; Shen, YJ; Wang, YY; Bai, ZT; Yeh, ETH; Wu, HM; Qi, YT				Chen, Xu; Zhang, Yuhong; Ren, Xiang; Su, Qi; Liu, Yan; Dang, Xing; Qin, Yuanyuan; Yang, Xinyi; Xing, Zhengcao; Shen, Yajie; Wang, Yaya; Bai, Zhantao; Yeh, Edward T. H.; Wu, Hongmei; Qi, Yitao			The SUMO-specific protease SENP2 plays an essential role in the regulation of Kv7.2 and Kv7.3 potassium channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUDDEN UNEXPLAINED DEATH; HYPER-SUMOYLATION; STRUCTURAL BASIS; K+ CHANNELS; C-TERMINUS; EPILEPSY; BINDING; PIP2; HYDROLYSIS; MODULATION	Sentrin /small ubiquitin-like modifier (SUMO)-specific pro-tease 2 (SENP2)-deficient mice develop spontaneous seizures in early life because of a marked reduction in M currents, which regulate neuronal membrane excitability. We have previously shown that hyper-SUMOylation of the Kv7.2 and Kv7.3 channels is critically involved in the regulation of the M currents conducted by these potassium voltage-gated channels. Here, we show that hyper-SUMOylation of the Kv7.2 and Kv7.3 proteins reduced binding to the lipid secondary messenger PIP2. CaM1has been shown to be tethered to the Kv7 subunitsviahy-drophobic motifs in its C termini and implicated in the channel assembly. Mutation of the SUMOylation sites on Kv7.2 andKv7.3 specifically resulted in decreased binding to CaM1 and enhanced CaM1-mediated assembly of Kv7.2 and Kv7.3,whereas hyper-SUMOylation of Kv7.2 and Kv7.3 inhibited channel assembly. SENP2-deficient mice exhibited increase dacetyl choline levels in the brain and the heart tissue because of increases in the vagal tone induced by recurrent seizures. TheSENP2-deficient mice develop seizures followed by a period of sinus pauses or atrioventricular conduction blocks. Chronic administration of the parasympathetic blocker atropine or unilateral vagotomy significantly prolonged the life of theSENP2-deficient mice. Furthermore, we showed that retigabine, an M-current opener, reduced the transcription of SUMO-activating enzyme SAE1 and inhibited SUMOylation of the Kv7.2 and Kv7.3 channels, and also prolonged the life of SENP2-deficient mice. Taken together, the previously demonstrated roles of PIP2, CaM1, and retigabine on the regulation ofKv7.2 and Kv7.3 channel function can be explained by their roles in regulating SUMOylation of this critical potassium channel.	[Chen, Xu; Zhang, Yuhong; Ren, Xiang; Su, Qi; Qin, Yuanyuan; Yang, Xinyi; Xing, Zhengcao; Shen, Yajie; Wu, Hongmei; Qi, Yitao] Shaanxi Normal Univ, Coll Life Sci, Key Lab,Minist Educ Med Resources & Nat Pharmaceu, Natl Engn Lab Resource Developing Endangered Chin, Xian, Shaanxi, Peoples R China; [Liu, Yan; Bai, Zhantao] Yanan Univ, Sch Life Sci, Yanan, Shaanxi, Peoples R China; [Liu, Yan; Bai, Zhantao] Yanan Univ, Res Ctr Peptide Drugs, Yanan, Shaanxi, Peoples R China; [Dang, Xing; Wang, Yaya] Xian Univ Sci & Technol, Coll Chem & Chem Engn, Xian, Shaanxi, Peoples R China; [Yeh, Edward T. H.] Univ Arkansas Med Sci, Dept Internal Med, Little Rock, AR 72205 USA	Shaanxi Normal University; Yanan University; Yanan University; Xi'an University of Science & Technology; University of Arkansas System; University of Arkansas Medical Sciences	Wu, HM; Qi, YT (corresponding author), Shaanxi Normal Univ, Coll Life Sci, Key Lab,Minist Educ Med Resources & Nat Pharmaceu, Natl Engn Lab Resource Developing Endangered Chin, Xian, Shaanxi, Peoples R China.	hq8479@snnu.edu.cn; qiyitao@snnu.edu.cn		xu, chen/0000-0002-3777-0514	National Natural Science Foundation of China [81671294, 81870241]; Fundamental Research Funds for the Central Universities [GK201903066]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by the National Natural Science Foundation of China (81671294 and 81870241 to Yitao Qi) and the Fundamental Research Funds for the Central Universities (GK201903066 to H. W.).	Abidi A, 2015, NEUROBIOL DIS, V80, P80, DOI 10.1016/j.nbd.2015.04.017; Ambrosino P, 2018, MOL NEUROBIOL, V55, P7009, DOI 10.1007/s12035-018-0883-5; Ambrosino P, 2015, BBA-MOL BASIS DIS, V1852, P1856, DOI 10.1016/j.bbadis.2015.06.012; Bernardo-Seisdedos G, 2018, P NATL ACAD SCI USA, V115, P2395, DOI 10.1073/pnas.1800235115; Brown DA, 2007, J PHYSIOL-LONDON, V582, P917, DOI 10.1113/jphysiol.2007.132498; Chang HM, 2020, PHYSIOL REV, V100, P1599, DOI 10.1152/physrev.00025.2019; Chen X, 2018, METHODS MOL BIOL, V1684, P63, DOI 10.1007/978-1-4939-7362-0_6; Choveau FS, 2018, J BIOL CHEM, V293, P19411, DOI 10.1074/jbc.RA118.005401; Glasscock E, 2010, J NEUROSCI, V30, P5167, DOI 10.1523/JNEUROSCI.5591-09.2010; Goldman AM, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000289; Gomis-Perez C, 2015, J CELL SCI, V128, P3155, DOI 10.1242/jcs.174128; Gunthorpe MJ, 2012, EPILEPSIA, V53, P412, DOI 10.1111/j.1528-1167.2011.03365.x; Haitin Y, 2008, J PHYSIOL-LONDON, V586, P1803, DOI 10.1113/jphysiol.2007.149187; Kang XL, 2010, MOL CELL, V38, P191, DOI 10.1016/j.molcel.2010.03.005; Kim KW, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20184419; Li T, 2021, MOL CELL, V81, P25, DOI 10.1016/j.molcel.2020.10.037; Liu J, 2014, J TRADIT CHIN MED, V34, P657, DOI 10.1016/S0254-6272(15)30079-0; Long XJ, 2020, FRONT PHYSIOL, V11, DOI 10.3389/fphys.2020.558220; Manville RW, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04266-w; Massey CA, 2014, NAT REV NEUROL, V10, P271, DOI 10.1038/nrneurol.2014.64; Nunez E, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21041285; Qi YT, 2014, NEURON, V83, P1159, DOI 10.1016/j.neuron.2014.07.042; Qi YT, 2014, J BIOL CHEM, V289, P3288, DOI 10.1074/jbc.M113.518282; Sillanpaa M, 2010, NEW ENGL J MED, V363, P2522, DOI 10.1056/NEJMoa0911610; Sills GJ, 2020, NEUROPHARMACOLOGY, V168, DOI 10.1016/j.neuropharm.2020.107966; Soldovieri MV, 2011, PHYSIOLOGY, V26, P365, DOI 10.1152/physiol.00009.2011; Stewart M, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.00765; Tatulian L, 2001, J NEUROSCI, V21, P5535, DOI 10.1523/JNEUROSCI.21-15-05535.2001; Taylor KC, 2017, BBA-BIOMEMBRANES, V1859, P586, DOI 10.1016/j.bbamem.2016.10.023; Telezhkin V, 2012, J GEN PHYSIOL, V140, P41, DOI 10.1085/jgp.201210796; Thomas Alison M., 2008, V491, P103, DOI 10.1007/978-1-59745-526-8_8; Wu HM, 2016, ADV PROTEIN CHEM STR, V103, P295, DOI 10.1016/bs.apcsb.2015.11.009; Yeh ETH, 2009, J BIOL CHEM, V284, P8223, DOI 10.1074/jbc.R800050200; Yeh ETH, 2000, GENE, V248, P1, DOI 10.1016/S0378-1119(00)00139-6; Yus-Najera E, 2002, J BIOL CHEM, V277, P28545, DOI 10.1074/jbc.M204130200; Zhang HL, 2003, NEURON, V37, P963, DOI 10.1016/S0896-6273(03)00125-9; Zhang QS, 2013, P NATL ACAD SCI USA, V110, P20093, DOI 10.1073/pnas.1312483110; Zhao BY, 2021, J CELL PHYSIOL, V236, P3466, DOI 10.1002/jcp.30143	38	1	1	2	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT	2021	297	4							101183	10.1016/j.jbc.2021.101183	http://dx.doi.org/10.1016/j.jbc.2021.101183			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	WP4BY	34509475	Green Published, gold			2022-12-26	WOS:000713080600006
J	Fu, N; Sugiura, K; Kondo, K; Nakamura, S; Wakabayashi, K; Hisabori, T				Fu, Nae; Sugiura, Kazunori; Kondo, Kumiko; Nakamura, Shungo; Wakabayashi, Ken-ichi; Hisabori, Toru			Monitoring cellular redox dynamics using newly developedBRET-based redox sensor proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DISULFIDE BOND FORMATION; FLUORESCENT PROTEIN; NADPH OXIDASE; ELECTRON-TRANSPORT; STRUCTURAL BASIS; LIGHT; VARIANTS; CELLS	Reactive oxygen species are key factors that strongly affectthe cellular redox state and regulate various physiological andcellular phenomena. To monitor changes in the redox state, wepreviously developedfluorescent redox sensors named Re-Q,the emissions of which are quenched under reduced condi-tions. However, suchfluorescent probes are unsuitable for usein the cells of photosynthetic organisms because they requirephotoexcitation that may change intracellular conditions andinduce autofluorescence, primarily in chlorophylls. In addition,the presence of various chromophore pigments may interferewithfluorescence-based measurements because of their strongabsorbance. To overcome these problems, we adopted thebioluminescence resonance energy transfer (BRET) mechanismfor the sensor and developed two BRET-based redox sensors byfusing cyanfluorescent protein-based or yellowfluorescentprotein-based Re-Q with the luminescent protein Nluc. Wenamed the resultingredox-sensitiveBRET-basedindicatorprobes"ROBINc"and"ROBINy."ROBINc is pH insensitive,which is especially vital for observation in photosynthetic or-ganisms. By using these sensors, we successfully observed dy-namic redox changes caused by an anticancer agent in HeLacells and light/dark-dependent redox changes in the cells ofphotosynthetic cyanobacteriumSynechocystissp. PCC 6803.Since the newly developed sensors do not require excitationlight, they should be especially useful for visualizing intracel-lular phenomena caused by redox changes in cells containingcolored pigments.	[Fu, Nae; Nakamura, Shungo; Wakabayashi, Ken-ichi; Hisabori, Toru] Tokyo Inst Technol, Sch Life Sci & Technol, Yokohama, Kanagawa, Japan; [Sugiura, Kazunori; Kondo, Kumiko; Wakabayashi, Ken-ichi; Hisabori, Toru] Tokyo Inst Technol, Lab Chem & Life Sci, Yokohama, Kanagawa, Japan; [Sugiura, Kazunori] Osaka Univ, Inst Sci & Ind Res, Ibaraki, Osaka 5670047, Japan	Tokyo Institute of Technology; Tokyo Institute of Technology; Osaka University	Hisabori, T (corresponding author), Tokyo Inst Technol, Sch Life Sci & Technol, Yokohama, Kanagawa, Japan.; Hisabori, T (corresponding author), Tokyo Inst Technol, Lab Chem & Life Sci, Yokohama, Kanagawa, Japan.	thisabor@res.titech.ac.jp	Hisabori, Toru/E-5205-2014; Wakabayashi, Ken-ichi/D-2440-2015	Hisabori, Toru/0000-0003-2046-0277; Wakabayashi, Ken-ichi/0000-0002-1025-9249	Japan Society for the Promotion of Science KAKENHI [16H06556]	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Japan Society for the Promotion of Science KAKENHI grant number 16H06556 (to T. H.).	Angers S, 2000, P NATL ACAD SCI USA, V97, P3684, DOI 10.1073/pnas.060590697; BABBS CF, 1989, PLANT PHYSIOL, V90, P1267, DOI 10.1104/pp.90.4.1267; Banach-Latapy A, 2013, FREE RADICAL BIO MED, V65, P436, DOI 10.1016/j.freeradbiomed.2013.07.033; Birk J, 2013, J CELL SCI, V126, P1604, DOI 10.1242/jcs.117218; Boisson-Dernier A, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001719; Brejc K, 1997, P NATL ACAD SCI USA, V94, P2306, DOI 10.1073/pnas.94.6.2306; Cabral H, 2013, P NATL ACAD SCI USA, V110, P11397, DOI 10.1073/pnas.1301348110; CLELAND WW, 1964, BIOCHEMISTRY-US, V3, P480, DOI 10.1021/bi00892a002; Couturier J, 2009, CELL MOL LIFE SCI, V66, P2539, DOI 10.1007/s00018-009-0054-y; Dooley CT, 2004, J BIOL CHEM, V279, P22284, DOI 10.1074/jbc.M312847200; Dos Santos CV, 2006, TRENDS PLANT SCI, V11, P329, DOI 10.1016/j.tplants.2006.05.005; Douthwright S, 2017, J CELL PHYSIOL, V232, P2461, DOI 10.1002/jcp.25588; Foreman J, 2003, NATURE, V422, P442, DOI 10.1038/nature01485; Forman HJ, 2009, MOL ASPECTS MED, V30, P1, DOI 10.1016/j.mam.2008.08.006; FORSTER T, 1946, NATURWISSENSCHAFTEN, V33, P166, DOI 10.1007/BF00585226; Fu CL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115318; Goedhart J, 2010, NAT METHODS, V7, P137, DOI [10.1038/nmeth.1415, 10.1038/NMETH.1415]; Hall MP, 2012, ACS CHEM BIOL, V7, P1848, DOI 10.1021/cb3002478; Hanson GT, 2004, J BIOL CHEM, V279, P13044, DOI 10.1074/jbc.M312846200; HEIM R, 1995, NATURE, V373, P663, DOI 10.1038/373663b0; HOSLER JP, 1987, PLANT PHYSIOL, V83, P965, DOI 10.1104/pp.83.4.965; Cejudo FJ, 2019, FRONT PLANT SCI, V10, DOI 10.3389/fpls.2019.00380; Kawarazaki T, 2013, BBA-MOL CELL RES, V1833, P2775, DOI 10.1016/j.bbamcr.2013.06.024; Laloi C, 2004, CURR OPIN PLANT BIOL, V7, P323, DOI 10.1016/j.pbi.2004.03.005; Liu YB, 2002, J NEUROCHEM, V80, P780, DOI 10.1046/j.0022-3042.2002.00744.x; Mathur S, 2014, J PHOTOCH PHOTOBIO B, V137, P116, DOI 10.1016/j.jphotobiol.2014.01.010; Meyer AJ, 2007, PLANT J, V52, P973, DOI 10.1111/j.1365-313X.2007.03280.x; Mishra D, 2021, PLANT J, V105, P1374, DOI 10.1111/tpj.15119; Monici M, 2005, BIOTECHNOL ANN REV, V11, P227, DOI 10.1016/S1387-2656(05)11007-2; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Nakamura S, 2021, J BIOL CHEM, V296, DOI 10.1074/jbc.RA120.016847; Ormo M, 1996, SCIENCE, V273, P1392, DOI 10.1126/science.273.5280.1392; Osanai T, 2011, J BIOL CHEM, V286, P30962, DOI 10.1074/jbc.M111.231183; Ostergaard H, 2004, J CELL BIOL, V166, P337, DOI 10.1083/jcb.200402120; Ostergaard H, 2001, EMBO J, V20, P5853, DOI 10.1093/emboj/20.21.5853; Patterson GH, 2000, ANAL BIOCHEM, V284, P438, DOI 10.1006/abio.2000.4708; Potocky M, 2007, NEW PHYTOL, V174, P742, DOI 10.1111/j.1469-8137.2007.02042.x; RIPPKA R, 1979, J GEN MICROBIOL, V111, P1, DOI 10.1099/00221287-111-1-1; Saito K, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2248; Saito K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009935; Sanchez-Riego AM, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00428; Satoh S, 2001, J BIOL CHEM, V276, P4293, DOI 10.1074/jbc.M008238200; Schieber M, 2014, CURR BIOL, V24, pR453, DOI 10.1016/j.cub.2014.03.034; Shin R, 2004, P NATL ACAD SCI USA, V101, P8827, DOI 10.1073/pnas.0401707101; Sierla M, 2016, PLANT PHYSIOL, V171, P1569, DOI 10.1104/pp.16.00328; Sugiura K, 2020, P NATL ACAD SCI USA, V117, P16019, DOI 10.1073/pnas.1918919117; Sugiura K, 2019, J BIOL CHEM, V294, P12091, DOI 10.1074/jbc.RA119.007616; Sugiura K, 2019, BBA-GEN SUBJECTS, V1863, P1098, DOI 10.1016/j.bbagen.2019.01.016; Sugiura K, 2015, BIOCHEM BIOPH RES CO, V457, P242, DOI 10.1016/j.bbrc.2014.12.095; Suzuki K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13718; TAKAHASHI M, 1988, ARCH BIOCHEM BIOPHYS, V267, P714, DOI 10.1016/0003-9861(88)90080-X; Wachter RM, 1998, STRUCTURE, V6, P1267, DOI 10.1016/S0969-2126(98)00127-0; Witman G. B., 2009, CHLAMYDOMONAS SOURCE, V1, P241; Wormuth D, 2007, J BIOTECHNOL, V129, P229, DOI 10.1016/j.jbiotec.2006.12.006; Xu Y, 1999, P NATL ACAD SCI USA, V96, P151, DOI 10.1073/pnas.96.1.151; Yang F, 1996, NAT BIOTECHNOL, V14, P1246, DOI 10.1038/nbt1096-1246; Zavrel T, 2015, ENG LIFE SCI, V15, P122, DOI 10.1002/elsc.201300165; Zhao YZ, 2015, CELL METAB, V21, P777, DOI 10.1016/j.cmet.2015.04.009	58	0	0	0	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT	2021	297	4							101186	10.1016/j.jbc.2021.101186	http://dx.doi.org/10.1016/j.jbc.2021.101186			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	WP4BY	34517006	gold, Green Published			2022-12-26	WOS:000713080600007
J	Yao, ZL; Chen, PY; Fan, LY; Chen, PS; Zhang, XR; Yu, B				Yao, Zilong; Chen, Pengyu; Fan, Liuyi; Chen, Peisheng; Zhang, Xianrong; Yu, Bin			CCL2 is a critical mechano-responsive mediator in crosstalk between osteoblasts and bone mesenchymal stromal cells	FASEB JOURNAL			English	Article						bone remodeling; chemokine; mechanical loading; progenitor; recruitment	MONOCYTE CHEMOATTRACTANT PROTEIN-1; STEM-CELLS; PROGENITOR CELLS; GENE-EXPRESSION; PRIMARY CILIA; ACTIVATION; MECHANOTRANSDUCTION; EXERCISE; SIGNALS; KINASE	It has been known that moderate mechanical loading, like that caused by exercise, promotes bone formation. However, its underlying mechanisms remain elusive. Here we showed that moderate running dramatically improved trabecular bone in mice tibias with an increase in bone volume fraction and trabecular number and a decrease in trabecular pattern factor. Results of immunohistochemical and histochemical staining revealed that moderate running mainly increased the number of osteoblasts but had no effect on osteoclasts. In addition, we observed a dramatic increase in the number of colony forming unit-fibroblast in endosteal bone marrow and the percentage of CD45(-)Leptin receptor(+) (CD45(-)LepR(+)) endosteal mesenchymal progenitors. Bioinformatics analysis of the transcriptional data from gene expression omnibus (GEO) database identified chemokine c-c-motif ligands (CCL2) as a critical candidate induced by mechanical loading. Interestingly, we found that CCL2 was up-regulated mainly in osteoblastic cells in the tibia of mice after moderate running. Further, we found that mechanical loading up-regulated the expression of CCL2 by activating ERK1/2 pathway, thereby stimulating migration of endosteal progenitors. Finally, neutralizing CCL2 abolished the recruitment of endosteal progenitors and the increased bone formation in mice after 4 weeks running. These results therefore uncover an unknown connection between osteoblasts and endosteal progenitors recruited in the increased bone formation induced by mechanical loading.	[Yao, Zilong; Chen, Pengyu; Fan, Liuyi; Zhang, Xianrong; Yu, Bin] Southern Med Univ, Nanfang Hosp, Dept Orthopaed, Div Orthopaed & Traumatol, Guangzhou, Peoples R China; [Yao, Zilong; Chen, Pengyu; Fan, Liuyi; Chen, Peisheng; Zhang, Xianrong; Yu, Bin] Southern Med Univ, Nanfang Hosp, Guangdong Prov Key Lab Bone & Cartilage Regenerat, Guangzhou, Peoples R China; [Chen, Peisheng] Xiamen Univ, Fuzhou Hosp Affiliated 2, Dept Orthoped, Fuzhou, Peoples R China	Southern Medical University - China; Southern Medical University - China; Xiamen University	Zhang, XR; Yu, B (corresponding author), Nanfang Hosp, Dept Orthopaed, Div Orthopaed & Traumatol, 1838 Guangzhou Ave North, Guangzhou 510515, Peoples R China.	xianrongzh@smu.edu.cn; yubin@smu.edu.cn	Chen, Peisheng/AAL-5382-2021	Chen, Peisheng/0000-0002-2472-2898; , xianrong/0000-0002-0992-5013	National Natural Science Foundation of China (NSFC) [81830079]; Guangdong Science and Technology Department (Science and Technology Department, Guangdong Province) [2019B020201013, 2019A1515110818]; Nanfang Hospital [2019Z012]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Guangdong Science and Technology Department (Science and Technology Department, Guangdong Province); Nanfang Hospital	National Natural Science Foundation of China (NSFC), Grant/Award Number: 81830079; Guangdong Science and Technology Department (Science and Technology Department, Guangdong Province), Grant/Award Number: 2019B020201013 and 2019A1515110818; Nanfang Hospital, Grant/Award Number: 2019Z012	Albiol L, 2020, CALCIFIED TISSUE INT, V106, P415, DOI 10.1007/s00223-019-00648-4; Bader GD, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-2; Barrett T, 2013, NUCLEIC ACIDS RES, V41, pD991, DOI 10.1093/nar/gks1193; Bohm AM, 2019, DEV CELL, V51, P236, DOI 10.1016/j.devcel.2019.08.013; Brylka LJ, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02182; Cambre I, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06933-4; Cao W, 2020, CURR OSTEOPOROS REP, V18, P541, DOI 10.1007/s11914-020-00610-6; Chen JC, 2016, FASEB J, V30, P1504, DOI 10.1096/fj.15-276402; Chen PS, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.01093; Crane JL, 2014, J CLIN INVEST, V124, P466, DOI 10.1172/JCI70050; Curtis KJ, 2018, BONE, V107, P78, DOI 10.1016/j.bone.2017.11.007; Deshmane SL, 2009, J INTERF CYTOK RES, V29, P313, DOI 10.1089/jir.2008.0027; Dirckx N, 2013, BIRTH DEFECTS RES C, V99, P170, DOI 10.1002/bdrc.21047; Eichholz KF, 2020, STEM CELL TRANSL MED, V9, P1431, DOI 10.1002/sctm.19-0405; Fantuzzi L, 2019, CELL MOL LIFE SCI, V76, P4869, DOI 10.1007/s00018-019-03255-6; Fu XR, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8080784; Galea GL, 2017, BONE, V96, P38, DOI 10.1016/j.bone.2016.10.008; Grayson WL, 2015, NAT REV ENDOCRINOL, V11, P140, DOI 10.1038/nrendo.2014.234; He J, 2015, AM J CHINESE MED, V43, P305, DOI 10.1142/S0192415X15500202; He Z, 2016, OSTEOARTHR CARTILAGE, V24, P892, DOI 10.1016/j.joca.2015.11.015; Hou YL, 2019, CLIN SCI, V133, P1297, DOI 10.1042/CS20181001; Huang J, 2018, THERANOSTICS, V8, P2435, DOI 10.7150/thno.22144; Josephson AM, 2019, P NATL ACAD SCI USA, V116, P6995, DOI 10.1073/pnas.1810692116; Kechagia JZ, 2019, NAT REV MOL CELL BIO, V20, P457, DOI 10.1038/s41580-019-0134-2; Kim J, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-19155-4; Lassen NE, 2017, J BONE MINER RES, V32, P1395, DOI 10.1002/jbmr.3091; Liu C, 2016, INTEGR BIOL-UK, V8, P785, DOI 10.1039/c6ib00070c; Ponte AL, 2007, STEM CELLS, V25, P1737, DOI 10.1634/stemcells.2007-0054; Lu N, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20153792; Metzger CE, 2017, BONE, V105, P26, DOI 10.1016/j.bone.2017.08.002; Moore ER, 2019, STEM CELLS INT, V2019, DOI 10.1155/2019/3094154; Morse A, 2018, J BONE MINER RES, V33, P486, DOI 10.1002/jbmr.3330; Ono N, 2019, CURR TOP DEV BIOL, V133, P1, DOI 10.1016/bs.ctdb.2019.01.006; Osman AM, 2019, NEUROSCIENCE, V405, P92, DOI 10.1016/j.neuroscience.2017.10.034; Ozcivici E, 2010, NAT REV RHEUMATOL, V6, P50, DOI 10.1038/nrrheum.2009.239; Park JES, 2014, THORAX, V69, P1120, DOI 10.1136/thoraxjnl-2013-204190; Qin L, 2020, BONE RES, V8, DOI 10.1038/s41413-020-0099-y; Reijnders CMA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079672; Roosa SMM, 2011, BONE, V48, P543, DOI 10.1016/j.bone.2010.11.006; Roosa SMM, 2011, J BONE MINER RES, V26, P100, DOI 10.1002/jbmr.193; Rubin J, 2002, J BONE MINER RES, V17, P1452, DOI 10.1359/jbmr.2002.17.8.1452; Sato T, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17099-3; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Tamasi JA, 2013, J BONE MINER RES, V28, P1975, DOI 10.1002/jbmr.1933; Thompson WR, 2012, GENE, V503, P179, DOI 10.1016/j.gene.2012.04.076; Vico L, 2018, NAT REV RHEUMATOL, V14, P229, DOI 10.1038/nrrheum.2018.37; Wang ML, 2018, J MATER CHEM B, V6, P4765, DOI 10.1039/c8tb01201f; Wang XE, 2019, STEM CELLS, V37, P150, DOI 10.1002/stem.2924; Wong SP, 2015, PHARMACOL THERAPEUT, V151, P107, DOI 10.1016/j.pharmthera.2015.03.006; Wong VW, 2012, NAT MED, V18, P148, DOI 10.1038/nm.2574; Wu J, 2018, STEM CELLS INT, V2018, DOI 10.1155/2018/1540148; Yan YX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035709; Yao ZL, 2019, J CELL PHYSIOL, V234, P17946, DOI 10.1002/jcp.28427; Ye DP, 2018, DIS MARKERS, V2018, DOI 10.1155/2018/9405738; Yuan Y, 2016, PROG BIOPHYS MOL BIO, V122, P122, DOI 10.1016/j.pbiomolbio.2015.11.005; Zannit HM, 2020, FASEB J, V34, P12739, DOI 10.1096/fj.202000614R; Zhang LL, 2017, J BONE MINER METAB, V35, P265, DOI 10.1007/s00774-016-0764-9	58	4	4	2	15	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2021	35	10							e21851	10.1096/fj.202002808RR	http://dx.doi.org/10.1096/fj.202002808RR			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	UZ5IH	34547121				2022-12-26	WOS:000702238200071
J	Dipnall, JF; Page, R; Du, L; Costa, M; Lyons, RA; Cameron, P; de Steiger, R; Hau, R; Bucknill, A; Oppy, A; Edwards, E; Varma, D; Jung, MC; Gabbe, BJ				Dipnall, Joanna F.; Page, Richard; Du, Lan; Costa, Matthew; Lyons, Ronan A.; Cameron, Peter; de Steiger, Richard; Hau, Raphael; Bucknill, Andrew; Oppy, Andrew; Edwards, Elton; Varma, Dinesh; Jung, Myong Chol; Gabbe, Belinda J.			Predicting fracture outcomes from clinical registry data using artificial intelligence supplemented models for evidence-informed treatment (PRAISE) study protocol	PLOS ONE			English	Article							DORSALLY DISPLACED FRACTURE; LOCKING-PLATE FIXATION; DISTAL RADIUS; PERCUTANEOUS FIXATION; KIRSCHNER WIRES; SURGERY; TRAUMA; CLASSIFICATION; EPIDEMIOLOGY; EXPERIENCES	Background Distal radius (wrist) fractures are the second most common fracture admitted to hospital. The anatomical pattern of these types of injuries is diverse, with variation in clinical management, guidelines for management remain inconclusive, and the uptake of findings from clinical trials into routine practice limited. Robust predictive modelling, which considers both the characteristics of the fracture and patient, provides the best opportunity to reduce variation in care and improve patient outcomes. This type of data is housed in unstructured data sources with no particular format or schema. The "Predicting fracture outcomes from clinical Registry data using Artificial Intelligence (AI) Supplemented models for Evidence-informed treatment (PRAISE)" study aims to use AI methods on unstructured data to describe the fracture characteristics and test if using this information improves identification of key fracture characteristics and prediction of patient-reported outcome measures and clinical outcomes following wrist fractures compared to prediction models based on standard registry data. Methods and design Adult (16+ years) patients presenting to the emergency department, treated in a short stay unit, or admitted to hospital for >24h for management of a wrist fracture in four Victorian hospitals will be included in this study. The study will use routine registry data from the Victorian Orthopaedic Trauma Outcomes Registry (VOTOR), and electronic medical record (EMR) information (e.g. X-rays, surgical reports, radiology reports, images). A multimodal deep learning fracture reasoning system (DLFRS) will be developed that reasons on EMR information. Machine learning prediction models will test the performance with/without output from the DLFRS. Discussion The PRAISE study will establish the use of AI techniques to provide enhanced information about fracture characteristics in people with wrist fractures. Prediction models using AI derived characteristics are expected to provide better prediction of clinical and patient-reported outcomes following distal radius fracture.	[Dipnall, Joanna F.; Lyons, Ronan A.; Jung, Myong Chol; Gabbe, Belinda J.] Monash Univ, Sch Publ Hlth & Prevent Med, Clin Registries, Melbourne, Vic, Australia; [Dipnall, Joanna F.] Deakin Univ, Sch Med, Inst Mental & Phys Hlth & Clin Translat, Geelong, Vic, Australia; [Page, Richard] Deakin Univ, St John God Hosp, Univ Hosp Geelong, Sch Med, Geelong, Vic, Australia; [Du, Lan; Jung, Myong Chol] Monash Univ, Fac Informat Technol, Dept Data Sci & AI, Clayton, Vic, Australia; [Costa, Matthew] Univ Oxford, Div Med Sci, Nuffield Dept Orthopaed Rheumatol & Musculoskelet, Oxford Trauma & Emergency Care, Oxford, England; [Lyons, Ronan A.] Swansea Univ, Hlth Data Res UK, Swansea, W Glam, Wales; [Lyons, Ronan A.] Swansea Univ, Natl Ctr Populat Hlth & Wellbeing Res, Swansea, W Glam, Wales; [Cameron, Peter; Edwards, Elton] Monash Univ, Sch Publ Hlth & Prevent Med, Dept Epidemiol & Prevent Med, Melbourne, Vic, Australia; [Cameron, Peter; Edwards, Elton] Alfred Hosp, Prahran, Vic, Australia; [de Steiger, Richard] Univ Melbourne, Epworth HealthCare, Dept Surg, Epworth, Richmond, Vic, Australia; [Hau, Raphael] Monash Univ, Eastern Hlth Clin Sch, Box Hill, Vic, Australia; [Bucknill, Andrew; Oppy, Andrew] Royal Melbourne Hosp, Dept Orthopaed Surg, Melbourne, Vic, Australia; [Bucknill, Andrew; Oppy, Andrew] Univ Melbourne, Melbourne, Vic, Australia; [Oppy, Andrew] Epworth Healthcare, Melbourne, Vic, Australia; [Varma, Dinesh] Monash Univ, Dept Surg, Melbourne, Vic, Australia; [Varma, Dinesh] Natl Trauma Res Inst, Melbourne, Vic, Australia; [Varma, Dinesh] Alfred Hosp, Dept Radiol, Melbourne, Vic, Australia	Monash University; Deakin University; Deakin University; Geelong Hospital; St John of God Health Care; Monash University; University of Oxford; Swansea University; Swansea University; Monash University; Florey Institute of Neuroscience & Mental Health; University of Melbourne; Monash University; Royal Melbourne Hospital; University of Melbourne; Monash University; Florey Institute of Neuroscience & Mental Health	Dipnall, JF (corresponding author), Monash Univ, Sch Publ Hlth & Prevent Med, Clin Registries, Melbourne, Vic, Australia.; Dipnall, JF (corresponding author), Deakin Univ, Sch Med, Inst Mental & Phys Hlth & Clin Translat, Geelong, Vic, Australia.	jo.dipnall@monash.edu		Jung, Myong Chol/0000-0002-8715-8120; Du, Lan/0000-0002-9925-0223; Dipnall, Joanna/0000-0001-7543-0687	Transport Accident Commission; National Health and Medical Research Council of Australia Ideas Grant [NHMRC-APP2003537]; Medical Research Future Fund Practitioner Fellowship [MRF1139686]	Transport Accident Commission; National Health and Medical Research Council of Australia Ideas Grant(National Health and Medical Research Council (NHMRC) of Australia); Medical Research Future Fund Practitioner Fellowship(Medical Research Future Fund (MRFF))	VOTOR is funded by the Transport Accident Commission. The PRAISE project is funded by the National Health and Medical Research Council of Australia Ideas Grant (NHMRC-APP2003537). PC is funded by a Medical Research Future Fund Practitioner Fellowship (MRF1139686).	Alsentzer E., 2019, PUBLICLY AVAILABLE C, P72; Andrew Zisserman, 2015, Arxiv, DOI arXiv:1409.1556; Andriole S, 2015, FORBES; Assale M, 2019, FRONT MED-LAUSANNE, V6, DOI 10.3389/fmed.2019.00066; Barrett JA, 1999, J CLIN EPIDEMIOL, V52, P243, DOI 10.1016/S0895-4356(98)00167-X; Bonato LJ, 2017, INJURY, V48, P946, DOI 10.1016/j.injury.2016.11.012; Bujang MA, 2016, J CLIN DIAGN RES, V10, pYE1, DOI 10.7860/JCDR/2016/18129.8744; Chen S, 2014, WIRES COMPUT STAT, V6, P10, DOI 10.1002/wics.1282; Costa ML, 2019, BONE JOINT J, V101B, P978, DOI 10.1302/0301-620X.101B8.BJJ-2018-1285.R1; Costa ML, 2015, HEALTH TECHNOL ASSES, V19, P1, DOI 10.3310/hta19170; Curtis EM, 2016, BONE, V87, P19, DOI 10.1016/j.bone.2016.03.006; De Brijun B, 2006, J AM MED INFORM ASSN, V13, P696, DOI 10.1197/jamia.M1995; de Steiger RN., 2020, BEST EVIDENCE DOES I; Devlin A, 2019, ACCIDENT ANAL PREV, V132, DOI 10.1016/j.aap.2019.105279; Devlin J., 2018, ARXIV181004805; Dy CJ, 2016, J BONE JOINT SURG AM, V98, DOI 10.2106/JBJS.O.00494; Ekegren CL, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15122845; Gabbe BJ, 2013, BONE JOINT J, V95B, P1396, DOI 10.1302/0301-620X.95B10.32134; Gabbe BJ, 2010, J TRAUMA, V69, P532, DOI 10.1097/TA.0b013e3181e5125b; Gan KF, 2019, ACTA ORTHOP, V90, P394, DOI 10.1080/17453674.2019.1600125; Gyftopoulos S, 2019, AM J ROENTGENOL, V213, P506, DOI 10.2214/AJR.19.21117; Hajjem A, 2014, J STAT COMPUT SIM, V84, P1313, DOI 10.1080/00949655.2012.741599; He K., 2016, CVPR, P770; Jackson R, 2018, BMC MED INFORM DECIS, V18, DOI 10.1186/s12911-018-0623-9; Jennison T, 2019, ANN ROY COLL SURG, V101, P208, DOI 10.1308/rcsann.2019.0002; Joshi R, 2020, ACCURACY PRECISION R; Kyriakedes James C, 2018, Hand (N Y), V13, P209, DOI 10.1177/1558944717691133; Lawson A, 2021, JAMA SURG, V156, P229, DOI 10.1001/jamasurg.2020.5672; Lee C, 2019, AM J ROENTGENOL, V212, P734, DOI 10.2214/AJR.18.19869; Lee J, 2020, BIOINFORMATICS, V36, P1234, DOI 10.1093/bioinformatics/btz682; Liang J, 2019, ARXIV PREPRINT ARXIV; Luts J, 2012, COMPUT STAT DATA AN, V56, P611, DOI 10.1016/j.csda.2011.09.008; Mc Colgan R, 2019, BONE JOINT J, V101B, P1550, DOI 10.1302/0301-620X.101B12.BJJ-2018-1615.R3; Moran C., 2018, PATIENT INJURY DECIS, VThird, P73; Mullenbach James, 2018, NAACL HLT, V1, P1101; Nellans KW, 2012, HAND CLIN, V28, P113, DOI 10.1016/j.hcl.2012.02.001; Olczak J, 2017, ACTA ORTHOP, V88, P581, DOI 10.1080/17453674.2017.1344459; Pointer S., 2015, INJURY RES STAT SERI, V95; Polnaszek B, 2016, MED CARE, V54, pE65, DOI 10.1097/MLR.0000000000000108; Pugely AJ, 2015, J BONE JOINT SURG AM, V97A, P1799, DOI 10.2106/JBJS.O.00134; Pugely AJ, 2015, J BONE JOINT SURG AM, V97A, P1278, DOI 10.2106/JBJS.N.01260; Schelldorfer J, 2014, J COMPUT GRAPH STAT, V23, P460, DOI 10.1080/10618600.2013.773239; Stey AM, 2015, SURGERY, V157, P381, DOI 10.1016/j.surg.2014.08.097; Tanwar M, 2015, 2015 4TH INTERNATIONAL CONFERENCE ON RELIABILITY, INFOCOM TECHNOLOGIES AND OPTIMIZATION (ICRITO) (TRENDS AND FUTURE DIRECTIONS), DOI 10.1109/ICRITO.2015.7359270; Vannabouathong C, 2019, J AM ACAD ORTHOP SUR, V27, pE596, DOI 10.5435/JAAOS-D-18-00424; Watson NJ, 2018, CLIN REHABIL, V32, P841, DOI 10.1177/0269215518754614; Wigg AER, 2003, J TRAUMA, V55, P87, DOI 10.1097/01.TA.0000038544.45839.3D; Yang Z., 2016, P 2016 C N AM CHAPTE, P1480; Zhang DD, 2020, BMC MED INFORM DECIS, V20, DOI 10.1186/s12911-020-01297-6	49	0	0	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2021	16	9							e0257361	10.1371/journal.pone.0257361	http://dx.doi.org/10.1371/journal.pone.0257361			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	XH8RH	34555069	Green Published, gold			2022-12-26	WOS:000725694500029
J	Hopfer, S; Fields, EJ; Lu, YW; Ramakrishnan, G; Grover, T; Bai, QS; Huang, YC; Li, C; Mark, G				Hopfer, Suellen; Fields, Emilia J.; Lu, Yuwen; Ramakrishnan, Ganesh; Grover, Ted; Bai, Quishi; Huang, Yicong; Li, Chen; Mark, Gloria			The social amplification and attenuation of COVID-19 risk perception shaping mask wearing behavior: A longitudinal twitter analysis	PLOS ONE			English	Article							FRAMEWORK; HEALTH; AVAILABILITY; TRANSMISSION; TRUST; NORMS	Introduction Twitter represents a mainstream news source for the American public, offering a valuable vehicle for learning how citizens make sense of pandemic health threats like Covid-19. Masking as a risk mitigation measure became controversial in the US. The social amplification risk framework offers insight into how a risk event interacts with psychological, social, institutional, and cultural communication processes to shape Covid-19 risk perception. Methods Qualitative content analysis was conducted on 7,024 mask tweets reflecting 6,286 users between January 24 and July 7, 2020, to identify how citizens expressed Covid-19 risk perception over time. Descriptive statistics were computed for (a) proportion of tweets using hyperlinks, (b) mentions, (c) hashtags, (d) questions, and (e) location. Results Six themes emerged regarding how mask tweets amplified and attenuated Covid-19 risk: (a) severity perceptions (18.0%) steadily increased across 5 months; (b) mask effectiveness debates (10.7%) persisted; (c) who is at risk (26.4%) peaked in April and May 2020; (d) mask guidelines (15.6%) peaked April 3, 2020, with federal guidelines; (e) political legitimizing of Covid-19 risk (18.3%) steadily increased; and (f) mask behavior of others (31.6%) composed the largest discussion category and increased over time. Of tweets, 45% contained a hyperlink, 40% contained mentions, 33% contained hashtags, and 16.5% were expressed as a question. Conclusions Users ascribed many meanings to mask wearing in the social media information environment revealing that COVID-19 risk was expressed in a more expanded range than objective risk. The simultaneous amplification and attenuation of COVID-19 risk perception on social media complicates public health messaging about mask wearing.	[Hopfer, Suellen; Fields, Emilia J.] Univ Calif Irvine, Program Publ Hlth, Dept Hlth Soc & Behav, Irvine, CA 92697 USA; [Lu, Yuwen; Bai, Quishi; Huang, Yicong; Li, Chen] Univ Calif Irvine, Dept Comp Sci, Irvine, CA USA; [Ramakrishnan, Ganesh] Univ Calif Irvine, Dept Psychol Sci, Irvine, CA USA; [Grover, Ted; Mark, Gloria] Univ Calif Irvine, Dept Informat, Irvine, CA USA	University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine	Hopfer, S (corresponding author), Univ Calif Irvine, Program Publ Hlth, Dept Hlth Soc & Behav, Irvine, CA 92697 USA.	shopfer@hs.uci.edu		Huang, Yicong/0000-0002-1186-4803	National Science Foundation Covid19 award [2027254]	National Science Foundation Covid19 award(National Science Foundation (NSF))	Mark, G., Li, C., Hopfer, S. were awarded an National Science Foundation Covid19 award #2027254. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adjodah D, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0252315; [Anonymous], TWITTER; Auxier B., 2021, PEW RES CENT, V7, P1; Brady J, 2016, ADDICT BEHAV, V62, P83, DOI 10.1016/j.addbeh.2016.06.005; Breakwell GM, 2014, PSYCHOL RISK; Chung IJ, 2011, RISK ANAL, V31, P1883, DOI 10.1111/j.1539-6924.2011.01623.x; Cruwys T, 2020, BRIT J SOC PSYCHOL, V59, P584, DOI 10.1111/bjso.12391; Dong E., 2021, LANCET INFECT DIS; Engdahl E, 2014, PUBLIC UNDERST SCI, V23, P703, DOI 10.1177/0963662512460953; Fellenor J, 2018, J RISK RES, V21, P1163, DOI 10.1080/13669877.2017.1281339; Feng S, 2020, LANCET RESP MED, V8, P434, DOI 10.1016/S2213-2600(20)30134-X; Fisher KA, 2020, MMWR-MORBID MORTAL W, V69, P933, DOI 10.15585/mmwr.mm6928e3; Fung ICH, 2014, LANCET, V384, P2207, DOI 10.1016/S0140-6736(14)62418-1; Giles H., 2005, INTERGROUP COMMUNICA, P21; Greenhalgh T, 2021, LANCET, V397, P1603, DOI 10.1016/S0140-6736(21)00869-2; Haischer MH, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0240785; Hallgren Kevin A, 2012, Tutor Quant Methods Psychol, V8, P23; Haslam C., 2018, NEW PSYCHOL HLTH UNL, DOI DOI 10.3109/14992027.2013.839888; Hecht M.L., 2005, COMMUN THEOR, P257; Kasperson J.X., 2013, SOCIAL AMPLIFICATION, P13, DOI [10.1017/cbo9780511550461.002, DOI 10.1017/CBO9780511550461.002]; KASPERSON RE, 1992, SOCIAL THEORIES OF RISK, P153; KASPERSON RE, 1988, RISK ANAL, V8, P177, DOI 10.1111/j.1539-6924.1988.tb01168.x; Kasting ML, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0241662; Le GM, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0211931; LEARY MR, 1994, HEALTH PSYCHOL, V13, P461, DOI 10.1037/0278-6133.13.6.461; Leung NHL, 2020, NAT MED, V26, P676, DOI 10.1038/s41591-020-0843-2; Lidskog R., 2018, OXFORD ENCY HLTH RIS, P490; Lundgren R.E., 2013, RISK COMMUNICATION H, V393; Lundgren R.E., 2013, RISK COMMUNICATION H, V5th, P37; Martinelli L., 2021, FACE MASKS COVID19 P; Mase AS, 2015, J ENVIRON PSYCHOL, V41, P166, DOI 10.1016/j.jenvp.2014.12.004; Milosh M., 2020, POLITICAL POLARIZATI; Ng YJ, 2018, J RISK RES, V21, P1487, DOI 10.1080/13669877.2017.1313762; O'Connor C, 2020, INT J QUAL METH, V19, DOI 10.1177/1609406919899220; Oh SH, 2021, HEALTH COMMUN, V36, P972, DOI 10.1080/10410236.2020.1724639; Paek H., 2017, RISK PERCEPTION RISK, P504; Rader B, 2021, LANCET DIGIT HEALTH, V3, pE148, DOI 10.1016/S2589-7500(20)30293-4; Renn O., 1991, COMMUNICATING RISK P, P287; Renshaw SL, 2021, HEALTH SECUR, V19, P31, DOI 10.1089/hs.2020.0200; Rimal RN, 2010, J APPL SOC PSYCHOL, V40, P287, DOI 10.1111/j.1559-1816.2009.00574.x; Rimal RN, 2005, COMMUN RES, V32, P389, DOI 10.1177/0093650205275385; Rimal RN, 2003, HUM COMMUN RES, V29, P370, DOI 10.1111/j.1468-2958.2003.tb00844.x; Ruths D, 2014, SCIENCE, V346, P1063, DOI 10.1126/science.346.6213.1063; Shearer E., 2018, SOCIAL MEDIA OUTPACE; Sinnenberg L, 2017, AM J PUBLIC HEALTH, V107, pE1, DOI 10.2105/AJPH.2016.303512; Slovic P, 2005, HEALTH PSYCHOL, V24, pS35, DOI 10.1037/0278-6133.24.4.S35; SLOVIC P, 1987, SCIENCE, V236, P280, DOI 10.1126/science.3563507; Spinelli M.A, 2021, LANCET, DOI [10.1016/S1473-3099%2820%2930982-8, DOI 10.1016/S1473-3099%2820%2930982-8]; Steinert-Threlked Z., 2018, TWITTER DATA CAMBRID; Strekalova Y., 2018, SOCIAL AMPLIFICATION, P67; Strekalova YA, 2017, J HEALTH COMMUN, V22, P849, DOI 10.1080/10810730.2017.1367336; Stutt ROJH, 2020, P ROY SOC A-MATH PHY, V476, DOI 10.1098/rspa.2020.0376; Sunstein CR, 2006, CLIMATIC CHANGE, V77, P195, DOI 10.1007/s10584-006-9073-y; ter Bogt TFM, 2006, J ADOLESCENT HEALTH, V39, P27, DOI 10.1016/j.jadohealth.2005.09.007; Tombor I, 2015, HEALTH PSYCHOL, V34, P992, DOI 10.1037/hea0000191; Tracy Sarah J., 2018, [Journal of Qualitative Research, 질적연구], V19, P61, DOI 10.22284/qr.2018.19.2.61; Trope Y, 2010, PSYCHOL REV, V117, P440, DOI 10.1037/a0018963; TVERSKY A, 1974, SCIENCE, V185, P1124, DOI 10.1126/science.185.4157.1124; TVERSKY A, 1973, COGNITIVE PSYCHOL, V5, P207, DOI 10.1016/0010-0285(73)90033-9; van Asselt MBA, 2011, J RISK RES, V14, P431, DOI 10.1080/13669877.2011.553730; WHO, 2020, WHO COR COVID 19 DAS; Wirz CD, 2018, RISK ANAL, V38, P2599, DOI 10.1111/risa.13228; Wright, 2020, UNMASKING PARTISANSH; Wynne B., 1992, PUBLIC UNDERST SCI, V1, P281, DOI [10.1088/0963-6625/1/3/004, DOI 10.1088/0963-6625/1/3/004]; Zapf A, 2016, BMC MED RES METHODOL, V16, DOI 10.1186/s12874-016-0200-9; Zhang R, 2020, PNAS	68	6	6	6	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2021	16	9							e0257428	10.1371/journal.pone.0257428	http://dx.doi.org/10.1371/journal.pone.0257428			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XH8RH	34555060	gold, Green Published			2022-12-26	WOS:000725694500033
J	Merisaari, H; Federau, C				Merisaari, Harri; Federau, Christian			Signal to noise and b-value analysis for optimal intra-voxel incoherent motion imaging in the brain	PLOS ONE			English	Article							PERFUSION FRACTION; DIFFUSION; GLIOMAS; REPRODUCIBILITY; PARAMETERS; IMPACT; MRI	Intravoxel incoherent motion (IVIM) is a method that can provide quantitative information about perfusion in the human body, in vivo, and without contrast agent. Unfortunately, the IVIM perfusion parameter maps are known to be relatively noisy in the brain, in particular for the pseudo-diffusion coefficient, which might hinder its potential broader use in clinical applications. Therefore, we studied the conditions to produce optimal IVIM perfusion images in the brain. IVIM imaging was performed on a 3-Tesla clinical system in four healthy volunteers, with 16 b values 0, 10, 20, 40, 80, 110, 140, 170, 200, 300, 400, 500, 600, 700, 800, 900 s/mm(2), repeated 20 times. We analyzed the noise characteristics of the trace images as a function of b-value, and the homogeneity of the IVIM parameter maps across number of averages and sub-sets of the acquired b values. We found two peaks of noise of the trace images as function of b value, one due to thermal noise at high b-value, and one due to physiological noise at low b-value. The selection of b value distribution was found to have higher impact on the homogeneity of the IVIM parameter maps than the number of averages. Based on evaluations, we suggest an optimal b value acquisition scheme for a 12 min scan as 0 (7), 20 (4), 140 (19), 300 (9), 500 (19), 700 (1), 800 (4), 900 (1) s/mm(2).	[Merisaari, Harri] Univ Turku, Dept Diagnost Radiol, Turku, Finland; [Merisaari, Harri] Univ Turku, Dept Future Technol, Turku, Finland; [Federau, Christian] Swiss Fed Inst Technol, Inst Biomed Engn, Zurich, Switzerland; [Federau, Christian] Univ Zurich, Zurich, Switzerland; [Federau, Christian] AI Med, Zurich, Switzerland	University of Turku; University of Turku; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich	Merisaari, H (corresponding author), Univ Turku, Dept Diagnost Radiol, Turku, Finland.; Merisaari, H (corresponding author), Univ Turku, Dept Future Technol, Turku, Finland.	harri.merisaari@utu.fi		Merisaari, Harri/0000-0002-8515-5399	Cultural Foundation of Finland; Orion Pharma Research Fellowship; Swiss National Science Foundation	Cultural Foundation of Finland; Orion Pharma Research Fellowship; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	Harri Merisaari was supported by the Cultural Foundation of Finland, and Orion Pharma Research Fellowship. Christian Federau was supported by the Swiss National Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlgren A, 2016, NMR BIOMED, V29, P640, DOI 10.1002/nbm.3505; Becker AS, 2018, NEUROIMAGE, V169, P126, DOI 10.1016/j.neuroimage.2017.12.017; Birkbeck N., 2012, REGION SPECIFIC HIER; Bisdas S, 2013, NEURORADIOLOGY, V55, P537, DOI 10.1007/s00234-013-1192-3; Catanese A, 2018, NEURORADIOL J, V31, DOI 10.1177/1971400917693025; Chabert S, 2020, MAGN RESON MED SCI, V19, P216, DOI 10.2463/mrms.mp.2019-0061; Detsky JS, 2017, J NEURO-ONCOL, V134, P433, DOI 10.1007/s11060-017-2545-2; Dyvorne H, 2014, EUR J RADIOL, V83, P2109, DOI 10.1016/j.ejrad.2014.09.003; Federau C, 2014, NEURORADIOLOGY, V56, P629, DOI 10.1007/s00234-014-1370-y; Federau C, 2014, AM J NEURORADIOL, V35, P256, DOI 10.3174/ajnr.A3686; Federau C, 2016, NEUROVASCULAR IMAGIN, V2, P9, DOI [10.1186/s40809-016-0020-7, DOI 10.1186/S40809-016-0020-7]; Federau C, 2019, NEUROLOGY, V92, pE2462, DOI 10.1212/WNL.0000000000007538; Federau C, 2017, NMR BIOMED, V30, DOI 10.1002/nbm.3780; Federau C, 2017, CLIN NEURORADIOL, V27, P485, DOI 10.1007/s00062-016-0510-7; Federau C, 2015, NMR BIOMED, V28, P9, DOI 10.1002/nbm.3223; Federau C, 2014, J MAGN RESON IMAGING, V39, P624, DOI 10.1002/jmri.24195; Federau C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072856; Filli L, 2015, EUR RADIOL, V25, P2049, DOI 10.1007/s00330-014-3577-z; Grech-Sollars M, 2015, NMR BIOMED, V28, P468, DOI 10.1002/nbm.3269; Heit JJ, 2018, STROKE, V49, P741, DOI 10.1161/STROKEAHA.117.020395; Hu YC, 2020, BMC MED IMAGING, V20, DOI 10.1186/s12880-020-0419-0; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Keil VC., 2015, P INT SOC MAGN RES M, P348; Keil VC, 2017, J MAGN RESON IMAGING, V46, P1187, DOI 10.1002/jmri.25615; King DE, 2009, J MACH LEARN RES, V10, P1755; KWONG KK, 1991, MAGNET RESON MED, V21, P157, DOI 10.1002/mrm.1910210120; LEBIHAN D, 1988, RADIOLOGY, V168, P497, DOI 10.1148/radiology.168.2.3393671; Lee Y, 2015, RADIOLOGY, V274, P405, DOI 10.1148/radiol.14140759; Lemke A, 2011, MAGN RESON IMAGING, V29, P766, DOI 10.1016/j.mri.2011.03.004; Meeus EM, 2018, MAGN RESON MATER PHY, V31, P269, DOI 10.1007/s10334-017-0656-6; Merisaari H, 2017, P ISMRM 25 ANN M EXH, P3505; Merisaari H, 2017, MAGN RESON MED, V77, P1249, DOI 10.1002/mrm.26169; Merisaari H, 2015, MAGN RESON MED, V73, P1954, DOI 10.1002/mrm.25310; Pang YX, 2013, MAGN RESON MED, V69, P553, DOI 10.1002/mrm.24277; Puig J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158887; Rydhog AS, 2014, MAGN RESON IMAGING, V32, P1247, DOI 10.1016/j.mri.2014.07.013; Shen NX, 2016, J MAGN RESON IMAGING, V44, P620, DOI 10.1002/jmri.25191; Stieb S, 2016, NEUROIMAGE-CLIN, V11, P780, DOI 10.1016/j.nicl.2016.05.022; Su J., 2014, P JOINT ANN M ISMRM, P3206; Suo ST, 2016, NMR BIOMED, V29, P320, DOI 10.1002/nbm.3467; Surer E, 2018, NEURORADIOLOGY, V60, P413, DOI 10.1007/s00234-018-1995-3; Taouli B, 2016, J MAGN RESON IMAGING, V44, P521, DOI 10.1002/jmri.25196; ter Voert EEGW, 2016, INVEST RADIOL, V51, P90, DOI 10.1097/RLI.0000000000000207; Togao O, 2016, NEURO-ONCOLOGY, V18, P132, DOI 10.1093/neuonc/nov147; Wang X, 2019, CLIN RADIOL, V74, DOI 10.1016/j.crad.2019.03.020; Wong SM, 2018, AM J NEURORADIOL, V39, P226, DOI 10.3174/ajnr.A5474; Wong SM, 2017, NEUROIMAGE-CLIN, V14, P216, DOI 10.1016/j.nicl.2017.01.017; Wu WC, 2015, EUR RADIOL, V25, P2485, DOI 10.1007/s00330-015-3655-x; Yamashita K, 2016, J MAGN RESON IMAGING, V44, P1256, DOI 10.1002/jmri.25261; Yao Y, 2016, CLIN RADIOL, V71, DOI 10.1016/j.crad.2016.04.019; Zhang CE, 2017, STROKE, V48, P658, DOI 10.1161/STROKEAHA.116.015084; Zhang QW, 2013, IEEE ENG MED BIO, P511, DOI 10.1109/EMBC.2013.6609549; Zou TY, 2018, NMR BIOMED, V31, DOI 10.1002/nbm.3850	53	0	0	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 23	2021	16	9							e0257545	10.1371/journal.pone.0257545	http://dx.doi.org/10.1371/journal.pone.0257545			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XH8RH	34555054	Green Submitted, Green Published, gold			2022-12-26	WOS:000725694500044
J	Aparicio-Prat, E; Yan, D; Mariotti, M; Bassik, M; Hess, G; Fortin, JP; Weston, A; Xi, HS; Stanton, R				Aparicio-Prat, Estel; Yan, Dong; Mariotti, Marco; Bassik, Michael; Hess, Gaelen; Fortin, Jean-Philippe; Weston, Andrea; Xi, Hualin S.; Stanton, Robert			Roadmap for the use of base editors to decipher drug mechanism of action	PLOS ONE			English	Article							CRYSTAL-STRUCTURE; GENOMIC DNA; HUMAN-CELLS	CRISPR base editors are powerful tools for large-scale mutagenesis studies. This kind of approach can elucidate the mechanism of action of compounds, a key process in drug discovery. Here, we explore the utility of base editors in an early drug discovery context focusing on G-protein coupled receptors. A pooled mutagenesis screening framework was set up based on a modified version of the CRISPR-X base editor system. We determine optimized experimental conditions for mutagenesis where sgRNAs are delivered by cell transfection or viral infection over extended time periods (> 14 days), resulting in high mutagenesis produced in a short region located at -4/+8 nucleotides with respect to the sgRNA match. The beta 2 Adrenergic Receptor (B2AR) was targeted in this way employing a 6xCRE-mCherry reporter system to monitor its response to isoproterenol. The results of our screening indicate that residue 184 of B2AR is crucial for its activation. Based on our experience, we outline the crucial points to consider when designing and performing CRISPR-based pooled mutagenesis screening, including the typical technical hurdles encountered when studying compound pharmacology.	[Aparicio-Prat, Estel; Xi, Hualin S.; Stanton, Robert] Pfizer, Simulat & Modelling Sci, Cambridge, MA 02139 USA; [Yan, Dong; Fortin, Jean-Philippe] Pfizer, Internal Med Res Unit, Cambridge, MA USA; [Mariotti, Marco] Harvard Med Sch, Brigham & Womens Hosp, Dept Med, Div Genet, Boston, MA 02115 USA; [Mariotti, Marco] Univ Barcelona, Fac Biol, Dept Genet Microbiol & Estat, Barcelona, Spain; [Bassik, Michael; Hess, Gaelen] Stanford Univ, Dept Genet, Palo Alto, CA 94304 USA; [Weston, Andrea] Pfizer, Discovery Sci, Groton, CT USA	Pfizer; Pfizer; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Barcelona; Stanford University; Pfizer	Aparicio-Prat, E; Stanton, R (corresponding author), Pfizer, Simulat & Modelling Sci, Cambridge, MA 02139 USA.	estelaparicio@gmail.com; robert.stanton@pfizer.com			Pfizer, Inc.	Pfizer, Inc.(Pfizer)	The study was funded by Pfizer, Inc. The funder provided support in the form of salaries for authors EAP, DY, JPF, AW, HSX and RS, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Akcakaya P, 2018, NATURE, V561, P416, DOI 10.1038/s41586-018-0500-9; Anzalone AV, 2019, NATURE, V576, P149, DOI 10.1038/s41586-019-1711-4; Atwood Brady K, 2011, BMC Genomics, V12, P14, DOI 10.1186/1471-2164-12-14; Broughton JP, 2020, NAT BIOTECHNOL, V38, P870, DOI 10.1038/s41587-020-0513-4; Chen BH, 2013, CELL, V155, P1479, DOI 10.1016/j.cell.2013.12.001; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Cong L, 2013, MULTIPLEX GENOME ENG, P819; Gaudelli NM, 2017, NATURE, V551, P464, DOI 10.1038/nature24644; Gilbert LA, 2014, CELL, V159, P647, DOI 10.1016/j.cell.2014.09.029; Hess GT, 2016, NAT METHODS, V13, P1036, DOI [10.1038/NMETH.4038, 10.1038/nmeth.4038]; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Hu JH, 2018, NATURE, V556, P57, DOI 10.1038/nature26155; Insel PA, 2015, MOL PHARMACOL, V88, P181, DOI 10.1124/mol.115.098129; Isin B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050186; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Kim YB, 2017, NAT BIOTECHNOL, V35, P371, DOI 10.1038/nbt.3803; Komor AC, 2016, NATURE, V533, P420, DOI 10.1038/nature17946; Labun K, 2019, NUCLEIC ACIDS RES, V47, pW171, DOI 10.1093/nar/gkz365; Labun K, 2016, NUCLEIC ACIDS RES, V44, pW272, DOI 10.1093/nar/gkw398; Liu XY, 2017, NATURE, V548, P480, DOI 10.1038/nature23652; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Montague TG, 2014, NUCLEIC ACIDS RES, V42, pW401, DOI 10.1093/nar/gku410; Morrison KL, 2001, CURR OPIN CHEM BIOL, V5, P302, DOI 10.1016/S1367-5931(00)00206-4; Nishida K, 2016, SCIENCE, V353, DOI 10.1126/science.aaf8729; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Rasmussen SGF, 2007, NATURE, V450, P383, DOI 10.1038/nature06325; Rees HA, 2018, NAT REV GENET, V19, P770, DOI 10.1038/s41576-018-0059-1; Rosenbaum DM, 2007, SCIENCE, V318, P1266, DOI 10.1126/science.1150609; Salon JA, 2011, PHARMACOL REV, V63, P901, DOI 10.1124/pr.110.003350; Stadtmauer EA, 2020, SCIENCE, V367, P1001, DOI 10.1126/science.aba7365; Thuronyi BW, 2019, NAT BIOTECHNOL, V37, P1070, DOI 10.1038/s41587-019-0193-0; Uppada V, 2018, GENE, V656, P22, DOI 10.1016/j.gene.2018.02.066; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981	33	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 21	2021	16	9							e0257537	10.1371/journal.pone.0257537	http://dx.doi.org/10.1371/journal.pone.0257537			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	YM4DR	34547052	gold, Green Submitted, Green Published			2022-12-26	WOS:000746527400017
J	Zhu, ZH; Sami, A; Xu, QQ; Wu, LL; Zheng, WY; Chen, ZP; Jin, XZ; Zhang, H; Li, Y; Yu, Y; Zhou, KJ				Zhu, Zong He; Sami, Abdul; Xu, Qing Qing; Wu, Ling Ling; Zheng, Wen Yin; Chen, Zhi Peng; Jin, Xue Zhi; Zhang, Hong; Li, Yong; Yu, Yan; Zhou, Ke Jin			Effects of seed priming treatments on the germination and development of two rapeseed (Brassica napus L.) varieties under the co-influence of low temperature and drought	PLOS ONE			English	Article							IMPROVE GERMINATION; STRESS TOLERANCE; SALICYLIC-ACID; PLANT-GROWTH; NITRIC-OXIDE; VIGOR; SALT	The present study was performed to evaluate the effects of seed priming. This was done by soaking the seeds of two rapeseed cultivars, namely, ZY15 (tolerant to low temperature and drought) and HY49 (sensitive to low temperature and drought), for 12 h in varying solutions: distilled water, 138 mg/L salicylic acid (SA), 300 mg/L gibberellic acid (GA), 89.4 mg/L sodium nitroprusside (SNP), 3000 mg/L calcium chloride (CaCl2), and 30 mg/L abscisic acid (ABA). Primed and non-primed seeds were left to germinate at 15 degrees C and -0.15 MPa (T15W15) and at 25 degrees C and 0 MPa (T25W0), respectively. The results showed that SA, GA, SNP, CaCl2, and ABA significantly improved the germination potential (GP), germination rate (GR), germination index (GI), stem fresh weight (SFW), stem dry weight (SDW), root length (RL), stem length (SL), and seed vigor index (SVI) under T15W15. For ZY15 seeds under T25W0, GA, SNP, CaCl2, and ABA priming reduced the average germination time (96% after 5 days) compared to that of the control (88% after 5 days). For ZY15 seeds under T15W15, SA, SNP, CaCl2, and ABA priming, with respect to the control and water-treated groups, shortened the average germination time (92% after 5 days) compared to that of the control (80% after 5 days). For HY49 seeds under T25W0, GA, SNP, CaCl2, and ABA priming reduced the average germination time (92% after 5 days) compared to that of the control (85% after 5 days). Similarly, for HY49 seeds under T15W15, GA priming shortened the average germination time (89% after 5 days) compared to that of the control (83% after 5 days). These priming agents increased the net photosynthesis, stomatal conductivity, and transpiration rate of rape seedlings under conditions of low temperature and drought stress, while also decreasing intercellular carbon dioxide (CO2) concentrations. Additionally, SA, GA, SNP, CaCl2, and ABA increased superoxide dismutase concentrations (SOD) and ascorbic peroxidase (APX) activities of rape seedlings under stress conditions, while decreasing catalase (CAT) and peroxidase (POD) activities in ZY15 seedlings. In HY49, which is sensitive to low temperature and drought, all priming solutions, except for SNP, led to an increase in SOD activity levels and a decrease in CAT activity levels. Overall, SA, GA, SNP, and CaCl2 increased the concentrations of indoleacetic acid (IAA), GA, ABA, and cytokinin (CTK) in seedlings under stress conditions. Moreover, compared to SA, CaCl2, and ABA, GA (300 mg/L) and SNP (300 mol/L) showed improved priming effects for ZY15 and HY49 under stress conditions.	[Zhu, Zong He; Sami, Abdul; Xu, Qing Qing; Wu, Ling Ling; Zheng, Wen Yin; Chen, Zhi Peng; Jin, Xue Zhi; Zhang, Hong; Li, Yong; Yu, Yan; Zhou, Ke Jin] Anhui Agr Univ, Coll Agron, Hefei, Peoples R China	Anhui Agricultural University	Zhu, ZH (corresponding author), Anhui Agr Univ, Coll Agron, Hefei, Peoples R China.	zhuzonghe_74@163.com	Wu, Ling/GZN-2235-2022	Sami, Abdul/0000-0002-6098-5951	National Key R&D Program, Cultivation of New Mechanized Rapeseed Varieties with High Yield, Good Quality and Suitable Quality in the Lower Reaches of Yangtze River and Huang-Huai River [2018YFD0100600]	National Key R&D Program, Cultivation of New Mechanized Rapeseed Varieties with High Yield, Good Quality and Suitable Quality in the Lower Reaches of Yangtze River and Huang-Huai River	National Key R&D Program, Cultivation of New Mechanized Rapeseed Varieties with High Yield, Good Quality and Suitable Quality in the Lower Reaches of Yangtze River and Huang-Huai River (2018YFD0100600).	Abdel-Kader, 2001, PAK J BIOL SCI, V4, P1138; Afzal Z, 2016, J DEV BIOL, V4, DOI 10.3390/jdb4010009; Ahmad P, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-31917-1; Anjum SA, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00069; Anosheh H. P., 2011, Journal of Crop Science and Biotechnology, V14, P289, DOI 10.1007/s12892-011-0039-x; Ansari O., 2013, [Журнал стресс-физиологии и биохимии, Journal of Stress Physiology & Biochemistry, Zhurnal stress-fiziologii i biokhimii], V9, P61; Ashraf M, 2005, ADV AGRON, V88, P223, DOI 10.1016/S0065-2113(05)88006-X; Ashrafi A., 2010, J CROP ECOPHYSIOLOGY, V1, P34; Balabusta M, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00575; BATES LS, 1973, PLANT SOIL, V39, P205, DOI 10.1007/BF00018060; Begum N, 2019, PLANTS-BASEL, V8, DOI 10.3390/plants8120579; Bewley JD, 1997, PLANT CELL, V9, P1055, DOI 10.1105/tpc.9.7.1055; BOHNERT HJ, 1995, PLANT CELL, V7, P1099, DOI 10.1105/tpc.7.7.1099; Gouveia Geraldo Candido Cabral, 2017, Pesqui. Agropecu. Trop., V47, P328, DOI 10.1590/1983-40632016v4746560; Cai T, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.01886; Casenave EC, 2007, SEED SCI TECHNOL, V35, P88, DOI 10.15258/sst.2007.35.1.08; Chaves MM, 2009, ANN BOT-LONDON, V103, P551, DOI 10.1093/aob/mcn125; Cheng J, 2017, PLANT BIOLOGY, V19, P61, DOI 10.1111/plb.12438; Chowdhury J. A., 2017, SAARC Journal of Agriculture, V15, P163, DOI 10.3329/sja.v15i2.35146; Delachiave MEA, 2003, SEED SCI TECHNOL, V31, P225, DOI 10.15258/sst.2003.31.2.01; Demir AO, 2006, IRRIGATION SCI, V24, P279, DOI 10.1007/s00271-006-0028-x; Eastmond PJ, 2005, PLANT J, V44, P483, DOI 10.1111/j.1365-313X.2005.02544.x; Fallah S, 2018, J PLANT NUTR, V41, P29, DOI 10.1080/01904167.2017.1381719; Farooq A, 2020, PLANTS-BASEL, V9, DOI 10.3390/plants9010104; Farooq M, 2006, SEED SCI TECHNOL, V34, P181, DOI 10.15258/sst.2006.34.1.19; Fathi A., 2016, International Journal of Life Sciences, V10, P1, DOI 10.3126/ijls.v10i1.14509; Finch-Savage WE, 2016, J EXP BOT, V67, P567, DOI 10.1093/jxb/erv490; Footitt S, 2011, P NATL ACAD SCI USA, V108, P20236, DOI 10.1073/pnas.1116325108; Gall JE, 2009, BRASSICACEAE CHARACT, P121; Guan YJ, 2009, J ZHEJIANG UNIV-SC B, V10, P427, DOI 10.1631/jzus.B0820373; Guan YJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120695; He M, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.01771; Hu YC, 2005, J PLANT NUTR SOIL SC, V168, P541, DOI 10.1002/jpln.200420516; Hussain S, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01125; Ito S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119724; Jan S, 2019, PROTOPLASMA, V256, P313, DOI 10.1007/s00709-018-1310-5; Jiang CJ, 2010, MOL PLANT MICROBE IN, V23, P791, DOI 10.1094/MPMI-23-6-0791; Jisha KC, 2013, ACTA PHYSIOL PLANT, V35, P1381, DOI 10.1007/s11738-012-1186-5; Kaczmarek M, 2017, ACTA PHYSIOL PLANT, V39, DOI 10.1007/s11738-016-2336-y; Kaya C, 2020, J HAZARD MATER, V399, DOI 10.1016/j.jhazmat.2020.123020; Kaya C, 2020, PLANT PHYSIOL BIOCH, V153, P53, DOI 10.1016/j.plaphy.2020.04.038; Kaya C, 2020, J BIOTECHNOL, V316, P35, DOI 10.1016/j.jbiotec.2020.04.008; Kaya C, 2020, PLANT PHYSIOL BIOCH, V151, P486, DOI 10.1016/j.plaphy.2020.04.002; Kaya C, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-62669-6; Kaya C, 2020, ECOTOX ENVIRON SAFE, V196, DOI 10.1016/j.ecoenv.2020.110483; Kaya C, 2019, PLANT PHYSIOL BIOCH, V143, P119, DOI 10.1016/j.plaphy.2019.08.024; Kaya MD, 2006, EUR J AGRON, V24, P291, DOI 10.1016/j.eja.2005.08.001; Kohli SK, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-39712-2; Kohli SK, 2018, ENVIRON SCI POLLUT R, V25, P15159, DOI 10.1007/s11356-018-1742-7; Kojima M, 2009, PLANT CELL PHYSIOL, V50, P1201, DOI 10.1093/pcp/pcp057; Korres N., 2017, WATER RESOUR RURAL D, V9, P12, DOI DOI 10.1016/J.WRR.2016.10.001; Kosar F, 2021, PHYSIOL PLANTARUM, V172, P317, DOI 10.1111/ppl.13155; Kwon TR, 2009, J PLANT NUTR, V32, P644, DOI 10.1080/01904160802715455; Lal S.K., 2018, ADV SEED PRIMING, P41, DOI DOI 10.1007/978-981-13-0032-5_3; Lamichaney A, 2017, J ENVIRON BIOL, V38, P735, DOI 10.22438/jeb/38/5/MRN-340; Li GW, 2008, PLANT CELL PHYSIOL, V49, P1851, DOI 10.1093/pcp/pcn166; Li Z, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01153; Li Z, 2016, INT J AGRIC BIOL, V18, P86; Munns R, 2002, PLANT CELL ENVIRON, V25, P239, DOI 10.1046/j.0016-8025.2001.00808.x; Nezhadahmadi A, 2013, SCI WORLD J, DOI 10.1155/2013/610721; Niu XJ, 2013, CHEMOSPHERE, V93, P2239, DOI 10.1016/j.chemosphere.2013.07.074; Oliveira Alexandre Bosco de, 2010, Rev. bras. sementes, V32, P25, DOI 10.1590/S0101-31222010000300003; Omprakash G., 2017, INT J CURR MICROBIOL, V6, P66, DOI [10.20546/ijcmas.2017.604.009, DOI 10.20546/IJCMAS.2017.604.009]; Paparella S, 2015, PLANT CELL REP, V34, P1281, DOI 10.1007/s00299-015-1784-y; PERRY D A, 1978, Seed Science and Technology, V6, P159; Raja V, 2020, 3 BIOTECH, V10, DOI 10.1007/s13205-020-02206-4; Refka Z., 2013, International Journal of Ecology, V2013, P819810; Ren J, 2004, FOREST ECOL MANAG, V195, P291, DOI 10.1016/j.foreco.2004.01.046; Ritonga FN, 2020, PLANTS-BASEL, V9, DOI 10.3390/plants9050560; RIVIER L, 1977, PLANTA, V134, P23, DOI 10.1007/BF00390089; Sami A, 2020, PLANT BIOLOGY, V22, P679, DOI 10.1111/plb.13093; Sami A, 2019, BMC PLANT BIOL, V19, DOI 10.1186/s12870-019-2118-y; Siddiqui MH, 2020, J HAZARD MATER, V398, DOI 10.1016/j.jhazmat.2020.122882; Soltani A, 2006, ENVIRON EXP BOT, V55, P195, DOI 10.1016/j.envexpbot.2004.10.012; van Hulten M, 2006, P NATL ACAD SCI USA, V103, P5602, DOI 10.1073/pnas.0510213103; Wahid A, 2008, BOT STUD, V49, P343; Wang Y, 2013, EXP AGR, V49, P295, DOI 10.1017/S0014479712001329; WELLBURN AR, 1994, J PLANT PHYSIOL, V144, P307, DOI 10.1016/S0176-1617(11)81192-2; Xue-Xuan X, 2010, CRIT REV BIOTECHNOL, V30, P222, DOI 10.3109/07388551.2010.487186; Yadav SK, 2010, AGRON SUSTAIN DEV, V30, P515, DOI 10.1051/agro/2009050; Zhao TJ, 2007, FEBS LETT, V581, P3044, DOI 10.1016/j.febslet.2007.05.067; Zheng MM, 2016, PLANT GROWTH REGUL, V78, P167, DOI 10.1007/s10725-015-0083-5	82	9	9	6	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 16	2021	16	9							e0257236	10.1371/journal.pone.0257236	http://dx.doi.org/10.1371/journal.pone.0257236			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	WG5YY	34529689	gold, Green Published			2022-12-26	WOS:000707071500038
J	Lista, MJ; Matos, PM; Maguire, TJA; Poulton, K; Ortiz-Zapater, E; Page, R; Sertkaya, H; Ortega-Prieto, AM; Scourfield, E; O'Byrne, AM; Bouton, C; Dickenson, RE; Ficarelli, M; Jimenez-Guardeno, JM; Howard, M; Betancor, G; Galao, RP; Pickering, S; Signell, AW; Wilson, H; Cliff, P; Ik, MTK; Patel, A; MacMahon, E; Cunningham, E; Doores, K; Agromayor, M; Martin-Serrano, J; Perucha, E; Mischo, HE; Shankar-Hari, M; Batra, R; Edgeworth, J; Zuckerman, M; Malim, MH; Neil, S; Martinez-Nunez, RT				Lista, Maria Jose; Matos, Pedro M.; Maguire, Thomas J. A.; Poulton, Kate; Ortiz-Zapater, Elena; Page, Robert; Sertkaya, Helin; Ortega-Prieto, Ana M.; Scourfield, Edward; O'Byrne, Aoife M.; Bouton, Clement; Dickenson, Ruth E.; Ficarelli, Mattia; Jimenez-Guardeno, Jose M.; Howard, Mark; Betancor, Gilberto; Galao, Rui Pedro; Pickering, Suzanne; Signell, Adrian W.; Wilson, Harry; Cliff, Penelope; Ik, Mark Tan Kia; Patel, Amita; MacMahon, Eithne; Cunningham, Emma; Doores, Katie; Agromayor, Monica; Martin-Serrano, Juan; Perucha, Esperanza; Mischo, Hannah E.; Shankar-Hari, Manu; Batra, Rahul; Edgeworth, Jonathan; Zuckerman, Mark; Malim, Michael H.; Neil, Stuart; Martinez-Nunez, Rocio Teresa			Resilient SARS-CoV-2 diagnostics workflows including viral heat inactivation	PLOS ONE			English	Article							PCR	There is a worldwide need for reagents to perform SARS-CoV-2 detection. Some laboratories have implemented kit-free protocols, but many others do not have the capacity to develop these and/or perform manual processing. We provide multiple workflows for SARS-CoV-2 nucleic acid detection in clinical samples by comparing several commercially available RNA extraction methods: QIAamp Viral RNA Mini Kit (QIAgen), RNAdvance Blood/Viral (Beckman) and Mag-Bind Viral DNA/RNA 96 Kit (Omega Bio-tek). We also compared One-step RT-qPCR reagents: TaqMan Fast Virus 1-Step Master Mix (FastVirus, ThermoFisher Scientific), qPCRBIO Probe 1-Step Go Lo-ROX (PCR Biosystems) and Luna (R) Universal Probe One-Step RT-qPCR Kit (Luna, NEB). We used primer-probes that detect viral N (EUA CDC) and RdRP. RNA extraction methods provided similar results, with Beckman performing better with our primer-probe combinations. Luna proved most sensitive although overall the three reagents did not show significant differences. N detection was more reliable than that of RdRP, particularly in samples with low viral titres. Importantly, we demonstrated that heat treatment of nasopharyngeal swabs at 70 degrees C for 10 or 30 min, or 90 degrees C for 10 or 30 min (both original variant and B 1.1.7) inactivated SARS-CoV-2 employing plaque assays, and had minimal impact on the sensitivity of the qPCR in clinical samples. These findings make SARS-CoV-2 testing portable in settings that do not have CL-3 facilities. In summary, we provide several testing pipelines that can be easily implemented in other laboratories and have made all our protocols and SOPs freely available at https://osf.io/uebvj/.	[Lista, Maria Jose; Matos, Pedro M.; Maguire, Thomas J. A.; Poulton, Kate; Ortiz-Zapater, Elena; Page, Robert; Sertkaya, Helin; O'Byrne, Aoife M.; Bouton, Clement; Dickenson, Ruth E.; Ficarelli, Mattia; Howard, Mark; Betancor, Gilberto; Galao, Rui Pedro; Pickering, Suzanne; Signell, Adrian W.; Wilson, Harry; Doores, Katie; Agromayor, Monica; Martin-Serrano, Juan; Perucha, Esperanza; Mischo, Hannah E.; Shankar-Hari, Manu; Zuckerman, Mark; Malim, Michael H.; Neil, Stuart; Martinez-Nunez, Rocio Teresa] Kings Coll London Diagnost Team, Guys Campus, London, England; [Lista, Maria Jose; Matos, Pedro M.; Poulton, Kate; Sertkaya, Helin; Ortega-Prieto, Ana M.; Scourfield, Edward; Bouton, Clement; Dickenson, Ruth E.; Ficarelli, Mattia; Jimenez-Guardeno, Jose M.; Betancor, Gilberto; Galao, Rui Pedro; Pickering, Suzanne; Signell, Adrian W.; Wilson, Harry; Doores, Katie; Agromayor, Monica; Martin-Serrano, Juan; Mischo, Hannah E.; Shankar-Hari, Manu; Malim, Michael H.; Neil, Stuart; Martinez-Nunez, Rocio Teresa] Kings Coll London, Sch Immunol & Microbial Sci, Dept Infect Dis, London, England; [Maguire, Thomas J. A.] Kings Coll London, Asthma UK Ctr Allerg Mech Asthma, Sch Immunol & Microbial Sci, Dept Inflammat Biol, London, England; [Ortiz-Zapater, Elena] Kings Coll London, Randall Ctr Cell & Mol Biophys, London, England; [Ortiz-Zapater, Elena; Howard, Mark] Kings Coll London, Peter Gorer Dept Immunobiol, London, England; [Page, Robert] Kings Coll London, Guys Hosp, Kings Hlth Partners Integrated Canc Ctr, Sch Canc & Pharmaceut Sci, London, England; [O'Byrne, Aoife M.; Perucha, Esperanza] Kings Coll London, Ctr Inflammat Biol & Canc Immunol CIBCI, Ctr Rheumat Dis CRDEULAR Ctr Excellence, London, England; [Cliff, Penelope] St Thomas Hosp, Viapath Pathol Labs, London, England; [Ik, Mark Tan Kia; Patel, Amita; MacMahon, Eithne; Cunningham, Emma; Batra, Rahul; Edgeworth, Jonathan] St Thomas Hosp, Ctr Infect Dis Res, London, England; [Zuckerman, Mark] Kings Coll Hosp London, South London Specialist Virol Ctr, London, England	University of London; King's College London; University of London; King's College London; University of London; King's College London; University of London; King's College London; University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust; King's Health Partners; University of London; King's College London; University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust; Guy's & St Thomas' NHS Foundation Trust; King's College Hospital NHS Foundation Trust; King's College Hospital	Martinez-Nunez, RT (corresponding author), Kings Coll London Diagnost Team, Guys Campus, London, England.; Martinez-Nunez, RT (corresponding author), Kings Coll London, Sch Immunol & Microbial Sci, Dept Infect Dis, London, England.	rocio.martinez_nunes@kcl.ac.uk	Jimenez-Guardeno, Jose Manuel/AAG-8915-2019; Ortiz-Zapater, Elena/HCI-3340-2022; Ortega-Prieto, Ana Maria/M-6431-2019; Shankar-Hari, Manu/I-6948-2012; Ortega-Prieto, Ana Maria/AFN-6270-2022; Betancor, Gilberto/AAB-5872-2021	Jimenez-Guardeno, Jose Manuel/0000-0002-1726-8033; Ortega-Prieto, Ana Maria/0000-0002-9023-0103; Shankar-Hari, Manu/0000-0002-5338-2538; Betancor, Gilberto/0000-0003-0548-7690; Ortiz Zapater, Elena/0000-0002-7437-4772; Galao, Rui/0000-0003-3368-5053; Malim, Michael/0000-0002-7699-2064; Scourfield, Edward/0000-0002-3817-954X; Dickenson, Ruth/0000-0003-0027-6317; Tan, Kia Ik Mark/0000-0002-7774-3836; Martin-Serrano, Juan/0000-0002-8183-3914; Neil, Stuart/0000-0003-3306-5831; Cliff, Penelope/0000-0001-6558-6039; Maguire, Thomas/0000-0003-1034-4926; Signell, Adrian/0000-0003-4620-6891; Agromayor, Monica/0000-0001-6477-1750; Perucha, Esperanza/0000-0002-7802-0875; Bouton, Clement/0000-0001-9607-6533; Wilson, Harry David/0000-0002-3185-1073	King's Together Rapid COVID-19 Call awards; MRC [MC/PC/15068, MR/S023747/1, MR/R50225X/1, MR/S000844/1]; Huo Family Foundation; Wellcome Trust Investigator Award [106223/Z/14/Z]; NIAID [U54AI150472, R01AI076119]; MRC-KCL Doctoral Training Partnership in Biomedical Sciences [MR/N013700/1]; BBSRC [BB/P504609/1]; (NIHR) Biomedical Research Centre based at Guy's and St Thomas' NHS Foundation Trust; King's College London; Asthma UK at the Asthma UK Centre in Allergic Mechanisms of Asthma; Wellcome Trust [WT098049AIA]; European Union; KHP Challenge Fund; Kidney research UK [RP_007_20190305]; Wellcome Trust; Royal Society Sir Henry Dale Fellowship [218537/Z/19/Z];  [MR/S009191/1]	King's Together Rapid COVID-19 Call awards; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Huo Family Foundation; Wellcome Trust Investigator Award(Wellcome Trust); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); MRC-KCL Doctoral Training Partnership in Biomedical Sciences(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); (NIHR) Biomedical Research Centre based at Guy's and St Thomas' NHS Foundation Trust; King's College London(General Electric); Asthma UK at the Asthma UK Centre in Allergic Mechanisms of Asthma; Wellcome Trust(Wellcome TrustEuropean Commission); European Union(European Commission); KHP Challenge Fund; Kidney research UK(Kidney Research UK (KRUK)); Wellcome Trust(Wellcome TrustEuropean Commission); Royal Society Sir Henry Dale Fellowship; 	This work was funded by; King's Together Rapid COVID-19 Call awards to RTM-N, MHM, KD, SN, JE and MS-H, MRC Discovery Award MC/PC/15068 to SN, KD and MHM, a Huo Family Foundation Award to MHM, KD, RTM-N, SN, JE and MS-H, MRC Programme Grant MR/S023747/1 to MHM, Wellcome Trust Investigator Award 106223/Z/14/Z to MHM, NIAID Awards U54AI150472 and R01AI076119 to MHM. A.S., M. F. and R.E.D. were supported by the MRC-KCL Doctoral Training Partnership in Biomedical Sciences (MR/N013700/1); E. O-Z was supported by MR/S009191/1 to Parsons M and Santis G; M.F. was supported by the MRC (MR/R50225X/1); H.S was supported by the BBSRC (BB/P504609/1); R. P. was supported by the by the (NIHR) Biomedical Research Centre based at Guy's and St Thomas' NHS Foundation Trust and King's College London; T.J.A.M. was supported by Asthma UK at the Asthma UK Centre in Allergic Mechanisms of Asthma; P.M., S. P. and H.W. were supported by Wellcome Trust WT098049AIA to Neil S. and Swanson C.; M.J.L.B and C.B. were supported by MRC (MR/S000844/1) to Neil S. and Swanson C. This UK funded award is part of the EDCTP2 programme supported by the European Union; K.P. was funded by KHP Challenge Fund to R.T.M-N; M. H. was funded by RP_007_20190305 from Kidney research UK; H.M. was funded by the Wellcome Trust and Royal Society Sir Henry Dale Fellowship 218537/Z/19/Z. Links to funders website: MRC: https://mrc.ukri.org/Wellcome Trust: https://wellcome.org/King's Health Partners: https://www.kingshealthpartners.org/Asthma UK: https://www.asthma-allergy.ac.uk/King's Together: https://www.kcl.ac.uk/research/funding-opportunities/seedfund Huo Family Foundation: https://huofamilyfoundation.org/NIAID: https://www.niaid.nih.gov/KCL-MRC: https://kcl-mrcdtp.com/BBSRC: https://bbsrc.ukri.org/NIHR-GSTT: https://www.guysandstthomasbrc.nihr.ac.uk/EDCTP2: https://www.edctp.org/Kidney Research UK: https://kidneyresearchuk.org/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amen AM, 2020, NAT BIOTECHNOL, V38, P791, DOI 10.1038/s41587-020-0583-3; Auerswald H, 2021, J GEN VIROL, V102, DOI 10.1099/jgv.0.001539; Beltran-Pavez C, 2021, J VIROL METHODS, V287, DOI 10.1016/j.jviromet.2020.113969; Bruce EA, 2020, PLOS BIOL, V18, DOI 10.1371/journal.pbio.3000896; CDC, 2020, CDC 2019 NOVEL CORON; Chin AWH, 2020, LANCET MICROBE, V1, pE10, DOI [10.1016/S2666-5247(20)30003-3, 10.1016/S2666-5247(20)30095-1]; Corman VM, 2020, EUROSURVEILLANCE, V25, P23, DOI 10.2807/1560-7917.ES.2020.25.3.2000045; Dinnes J, 2020, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD013705, 10.1002/14651858.CD013705.pub2]; Fomsgaard AS, 2020, EUROSURVEILLANCE, V25, P6, DOI 10.2807/1560-7917.ES.2020.25.14.2000398; Genoud V, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0247792; Gillam TB, 2021, J PUBLIC HEALTH-UK, V43, P82, DOI 10.1093/pubmed/fdaa194; Jiang YQ, 2021, BIOTECHNOL BIOENG, V118, P2067, DOI 10.1002/bit.27720; Kim D, 2020, CELL, V181, P914, DOI 10.1016/j.cell.2020.04.011; Mancini F, 2020, EMERG MICROBES INFEC, V9, P1393, DOI 10.1080/22221751.2020.1775500; Merindol N, 2020, J CLIN VIROL, V128, DOI 10.1016/j.jcv.2020.104423; Nalla AK, 2020, J CLIN MICROBIOL, V58, DOI 10.1128/JCM.00557-20; Pan Y, 2020, CLIN CHEM, V66, P794, DOI 10.1093/clinchem/hvaa091; Patterson EI, 2020, J INFECT DIS, V222, P1462, DOI 10.1093/infdis/jiaa507; Public Health England, 2020, UND CYCL THRESH CT S; Rambaut A., 2020, COVID 19 GENOMICS CO; Reijns MAM, 2020, PLOS BIOL, V18, DOI 10.1371/journal.pbio.3001030; Richter A, 2020, NAT MICROBIOL, V5, P1452, DOI 10.1038/s41564-020-00818-3; Veldhoen M, 2021, EUR J IMMUNOL, V51, P13, DOI 10.1002/eji.202170015; Vogels CBF, 2020, NAT MICROBIOL, V5, P1299, DOI 10.1038/s41564-020-0761-6	24	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 15	2021	16	9							e0256813	10.1371/journal.pone.0256813	http://dx.doi.org/10.1371/journal.pone.0256813			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	WG6DR	34525109	Green Published, Green Submitted, gold			2022-12-26	WOS:000707084400019
J	Carr, C; Wilcox, H; Burton, JP; Menon, S; Al, KF; O'Gorman, D; Lanting, BA; Vasarhelyi, EM; Neufeld, M; Teeter, MG				Carr, Charles; Wilcox, Hannah; Burton, Jeremy P.; Menon, Sharanya; Al, Kait F.; O'Gorman, David; Lanting, Brent A.; Vasarhelyi, Edward M.; Neufeld, Michael; Teeter, Matthew G.			Deciphering the low abundance microbiota of presumed aseptic hip and knee implants	PLOS ONE			English	Article							PROSTHETIC JOINT INFECTION; RNA GENE PCR; DIAGNOSIS; IDENTIFICATION; ARTHROPLASTIES; MALTOPHILIA; REPLACEMENT; SENSITIVITY; ACNES	16S rRNA gene sequencing of DNA extracted from clinically uninfected hip and knee implant samples has revealed polymicrobial populations. However, previous studies assessed 16S rRNA gene sequencing as a technique for the diagnosis of periprosthetic joint infections, leaving the microbiota of presumed aseptic hip and knee implants largely unstudied. These communities of microorganisms might play important roles in aspects of host health, such as aseptic loosening. Therefore, this study sought to characterize the bacterial composition of presumed aseptic joint implant microbiota using next generation 16S rRNA gene sequencing, and it evaluated this method for future investigations. 248 samples were collected from implants of 41 patients undergoing total hip or knee arthroplasty revision for presumed aseptic failure. DNA was extracted using two methodologies-one optimized for high throughput and the other for human samples-and amplicons of the V4 region of the 16S rRNA gene were sequenced. Sequencing data were analyzed and compared with ancillary specific PCR and microbiological culture. Computational tools (SourceTracker and decontam) were used to detect and compensate for environmental and processing contaminants. Microbial diversity of patient samples was higher than that of open-air controls and differentially abundant taxa were detected between these conditions, possibly reflecting a true microbiota that is present in clinically uninfected joint implants. However, positive control-associated artifacts and DNA extraction methodology significantly affected sequencing results. As well, sequencing failed to identify Cutibacterium acnes in most culture- and PCR-positive samples. These challenges limited characterization of bacteria in presumed aseptic implants, but genera were identified for further investigation. In all, we provide further support for the hypothesis that there is likely a microbiota present in clinically uninfected joint implants, and we show that methods other than 16S rRNA gene sequencing may be ideal for its characterization. This work has illuminated the importance of further study of microbiota of clinically uninfected joint implants with novel molecular and computational tools to further eliminate contaminants and artifacts that arise in low bacterial abundance samples.	[Carr, Charles; Wilcox, Hannah; Burton, Jeremy P.; Menon, Sharanya; Al, Kait F.] Lawson Hlth Res Inst, Canadian Ctr Human Microbiome & Probiot Res, London, ON, Canada; [Burton, Jeremy P.; O'Gorman, David; Lanting, Brent A.; Vasarhelyi, Edward M.; Neufeld, Michael; Teeter, Matthew G.] Western Univ, Schulich Sch Med & Dent, Dept Surg, London, ON, Canada; [O'Gorman, David] Western Univ, Schulich Sch Med & Dent, Dept Biochem, London, ON, Canada; [Neufeld, Michael] Univ British Columbia, Dept Orthopaed, Adult Hip & Knee Reconstruct Serv, Vancouver, BC, Canada; [Teeter, Matthew G.] Western Univ, Schulich Sch Med & Dent, Dept Med Biophys, London, ON, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); University of British Columbia; Western University (University of Western Ontario)	Teeter, MG (corresponding author), Western Univ, Schulich Sch Med & Dent, Dept Surg, London, ON, Canada.; Teeter, MG (corresponding author), Western Univ, Schulich Sch Med & Dent, Dept Med Biophys, London, ON, Canada.	matthew.teeter@lhsc.on.ca	Teeter, Matt/GXH-3720-2022; O'Gorman, David/E-4095-2013; Vasarhelyi, Edward/G-7873-2015; Teeter, Matthew G/C-1102-2014	O'Gorman, David/0000-0001-6195-2644; Vasarhelyi, Edward/0000-0001-9942-9605; Teeter, Matthew G/0000-0002-3911-3171; Carr, Charles/0000-0002-1877-160X	MGT Schulich Collaborative Seed Research Grant, Schulich School of Medicine & Dentistry, Western University	MGT Schulich Collaborative Seed Research Grant, Schulich School of Medicine & Dentistry, Western University	MGT Schulich Collaborative Seed Research Grant, Schulich School of Medicine & Dentistry, Western University https://www.schulich.uwo.ca/research/funding/internal.html The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Askar M, 2019, MOL BIOL REP, V46, P6463, DOI 10.1007/s11033-019-05092-z; Ballance LT, 2006, PROG OCEANOGR, V69, P360, DOI 10.1016/j.pocean.2006.03.013; Bemer P, 2014, J CLIN MICROBIOL, V52, P3583, DOI 10.1128/JCM.01459-14; Bereza PL, 2013, INT ORTHOP, V37, P2037, DOI 10.1007/s00264-013-1955-9; Bereza P, 2016, BMC MUSCULOSKEL DIS, V17, DOI 10.1186/s12891-016-0991-1; Bi YL, 2021, GUT, V70, P853, DOI 10.1136/gutjnl-2020-320951; Bjerkan G, 2012, J MED MICROBIOL, V61, P572, DOI 10.1099/jmm.0.036087-0; Bozic KJ, 2010, CLIN ORTHOP RELAT R, V468, P45, DOI 10.1007/s11999-009-0945-0; Callahan BJ, 2016, NAT METHODS, V13, P581, DOI [10.1038/NMETH.3869, 10.1038/nmeth.3869]; Cazanave C, 2013, J CLIN MICROBIOL, V51, P2280, DOI 10.1128/JCM.00335-13; Clarridge JE, 2004, CLIN MICROBIOL REV, V17, P840, DOI 10.1128/CMR.17.4.840-862.2004; Davis NM, 2018, MICROBIOME, V6, DOI 10.1186/s40168-018-0605-2; de Oliveira-Garcia D, 2003, CELL MICROBIOL, V5, P625, DOI 10.1046/j.1462-5822.2003.00306.x; Dempsey KE, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2201; Fehring TK, 2001, CLIN ORTHOP RELAT R, P315; Fernandes AD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067019; Gontia-Mishra I, SIMPLE RAPID DNA EXT, P4; Gray JS, 2010, BIOLOGICALS, V38, P273, DOI 10.1016/j.biologicals.2009.09.006; Holmes S, 2017, J SHOULDER ELB SURG, V26, P179, DOI 10.1016/j.jse.2016.10.001; Hudek R, 2021, J SHOULDER ELB SURG, V30, P16, DOI 10.1016/j.jse.2020.04.020; Jacobs AME, 2017, BONE JOINT J, V99B, P1482, DOI [10.1302/0301-620X.99B11.BJJ-2016-0655.R2, 10.1302/0301-620x.99b11.bjj-2016-0655.r2]; Jucker BA, 1996, J BACTERIOL, V178, P5472, DOI 10.1128/jb.178.18.5472-5479.1996; Kapadia BH, 2016, LANCET, V387, P386, DOI 10.1016/S0140-6736(14)61798-0; Karstens L, 2019, MSYSTEMS, V4, DOI 10.1128/mSystems.00290-19; Kassambara A. ggpubr, 2020, **DATA OBJECT**; Knights D, 2011, NAT METHODS, V8, P761, DOI 10.1038/nmeth.1650; Kuo FC, 2018, BONE JOINT J, V100B, P1345, DOI 10.1302/0301-620X.100B10.BJJ-2018-0096.R1; Labek G, 2011, J BONE JOINT SURG BR, V93B, P293, DOI 10.1302/0301-620X.93B3.25467; Lauder AP, 2016, MICROBIOME, V4, DOI 10.1186/s40168-016-0172-3; Liu D, 2005, LETT APPL MICROBIOL, V40, P69, DOI 10.1111/j.1472-765X.2004.01629.x; Marin M, 2012, J CLIN MICROBIOL, V50, P583, DOI 10.1128/JCM.00170-11; McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217; Oksanen J., 2019, R PACKAGE VERSION; Palarea-Albaladejo J, 2015, CHEMOMETR INTELL LAB, V143, P85, DOI 10.1016/j.chemolab.2015.02.019; Parvizi J, 2014, J ARTHROPLASTY, V29, P1331, DOI 10.1016/j.arth.2014.03.009; Pitta M, 2018, J ARTHROPLASTY, V33, P407, DOI 10.1016/j.arth.2017.09.041; Pivec R, 2012, LANCET, V380, P1768, DOI 10.1016/S0140-6736(12)60607-2; Postler A, 2018, BMC MUSCULOSKEL DIS, V19, DOI 10.1186/s12891-018-1977-y; Price AJ, 2018, LANCET, V392, P1672, DOI 10.1016/S0140-6736(18)32344-4; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; R Core Team, 2020, R LANG ENV STAT COMP; Rao AJ, 2020, J SHOULDER ELB SURG, V29, P20, DOI 10.1016/j.jse.2019.07.039; Ryu SY, 2014, DIAGN MICR INFEC DIS, V79, P448, DOI 10.1016/j.diagmicrobio.2014.03.021; Salter SJ, 2014, BMC BIOL, V12, DOI 10.1186/s12915-014-0087-z; Sanschagrin S, 2014, JOVE-J VIS EXP, DOI 10.3791/51709; Sharkey PF, 2014, J ARTHROPLASTY, V29, P1774, DOI 10.1016/j.arth.2013.07.024; Singh JA, 2019, J RHEUMATOL, V46, P1134, DOI 10.3899/jrheum.170990; Tarabichi M, 2018, J BONE JOINT SURG AM, V100, P147, DOI 10.2106/JBJS.17.00434; Thoendel MJ, 2018, CLIN INFECT DIS, V67, P1333, DOI 10.1093/cid/ciy303; Tunney MM, 1999, J CLIN MICROBIOL, V37, P3281, DOI 10.1128/JCM.37.10.3281-3290.1999; Tunney MM, 1998, J BONE JOINT SURG BR, V80B, P568, DOI 10.1302/0301-620X.80B4.8473; Ulrich SD, 2008, INT ORTHOP, V32, P597, DOI 10.1007/s00264-007-0364-3; Walters W, 2016, MSYSTEMS, V1, DOI 10.1128/mSystems.00009-15; Wasko MK, 2016, J ORTHOP RES, V34, P1497, DOI 10.1002/jor.23292; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1	55	0	0	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2021	16	9							e0257471	10.1371/journal.pone.0257471	http://dx.doi.org/10.1371/journal.pone.0257471			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	WG5RP	34520499	gold, Green Published			2022-12-26	WOS:000707052100035
J	van Straten, B; Robertson, PD; Oussoren, H; Espindola, SP; Ghanbari, E; Dankelman, J; Picken, S; Horeman, T; Dhaka, MS				van Straten, B.; Robertson, P. D.; Oussoren, H.; Espindola, S. Pereira; Ghanbari, E.; Dankelman, J.; Picken, S.; Horeman, T.; Dhaka, Mahendra Singh			Can sterilization of disposable face masks be an alternative for imported face masks? A nationwide field study including 19 sterilization departments and 471 imported brand types during COVID-19 shortages	PLOS ONE			English	Article							MEDICAL DEVICES	Background Face masks, also referred to as half masks, are essential to protect healthcare professionals working in close contact with patients with COVID-19-related symptoms. Because of the Corona material shortages, healthcare institutions sought an approach to reuse face masks or to purchase new, imported masks. The filter quality of these masks remained unclear. Therefore, the aim of this study was to assess the quality of sterilized and imported FFP2/KN95 face masks. Methods A 48-minute steam sterilization process of single-use FFP2/KN95 face masks with a 15 minute holding time at 121 degrees C was developed, validated and implemented in the Central Sterilization Departments (CSSD) of 19 different hospitals. Masks sterilized by steam and H2O2 plasma as well as new, imported masks were tested for particle filtration efficiency (PFE) and pressure drop in a custom-made test setup. Results The results of 84 masks tested on the PFE dry particle test setup showed differences of 2.32% (mean +/- SD). Test data showed that the mean PFE values of 444 sterilized FFP2 face masks from the 19 CSSDs were 90 +/- 11% (mean +/- SD), and those of 474 new, imported KN95/FFP2 face masks were 83 +/- 16% (mean +/- SD). Differences in PFE of masks received from different sterilization departments were found. Conclusion Face masks can be reprocessed with 121 degrees C steam or H2O2 plasma sterilization with a minimal reduction in PFE. PFE comparison between filter material of sterilized masks and new, imported masks indicates that the filter material of most reprocessed masks of high quality brands can outperform new, imported face masks of unknown brands. Although the PFE of tested face masks from different sterilization departments remained efficient, using different types of sterilization equipment, can result in different PFE outcomes.	[van Straten, B.; Robertson, P. D.; Dankelman, J.; Horeman, T.; Dhaka, Mahendra Singh] Delft Univ Technol, Dept BioMech Engn, Delft, Netherlands; [Oussoren, H.] Univ Amsterdam, Med Ctr, Amsterdam, Netherlands; [Espindola, S. Pereira; Ghanbari, E.; Picken, S.] Delft Univ Technol, Dept Chem Engn, Delft, Netherlands	Delft University of Technology; University of Amsterdam; Delft University of Technology	van Straten, B (corresponding author), Delft Univ Technol, Dept BioMech Engn, Delft, Netherlands.	b.j.vanstraten@tudelft.nl	Dankelman, Jenny/H-9100-2017	Dankelman, Jenny/0000-0003-3951-2129; van Straten, Bart/0000-0003-0269-6593; Robertson, Daniel/0000-0002-3373-5113				ADDI RachidAit., 2020, J CLIN EXPT INVESTIG, V11; Bergman MS, 2010, J ENG FIBER FABR, V5, P33; CAMPBELL BA, 1987, AM J INFECT CONTROL, V15, P196, DOI 10.1016/0196-6553(87)90095-2; Code of China, 2006, 26262006 GB; de Man P, 2020, J HOSP INFECT, V105, P356, DOI 10.1016/j.jhin.2020.04.001; European Committee for Standardization, 2009, 79 CENTC; European Committee for Standardization, 2009, 149A1 NENEN; Harskamp RE, 2020, BMJ OPEN, V10, DOI 10.1136/bmjopen-2020-039454; Henwood AF, 2020, J HISTOTECHNOL, V43, P102, DOI 10.1080/01478885.2020.1734718; Lee SA, 2016, J HEALTHC ENG, V2016, DOI 10.1155/2016/8572493; Markus A, 2020, CISC VIS NETW IND GL; National Institute for Public Health and the Environment RIVM, 2020, REPR FFP TYP MASKS; Oberfeld B, 2020, CELL, V181, P954, DOI 10.1016/j.cell.2020.04.013; Panta G, 2019, J INFECT DEV COUNTR, V13, P858, DOI 10.3855/jidc.11433; Rosales-Mendoza S, 2020, VACCINES-BASEL, V8, DOI 10.3390/vaccines8020183; Schope H. J, 2020, ARXIV PREPRINT ARXIV; Teesing GR, 2020, J HOSP INFECT, V106, P246, DOI 10.1016/j.jhin.2020.07.024; Van Den Dobbelsteen J. J., 2020, COMP PARTICLE FILTER; van Straten B, 2021, SUSTAIN PROD CONSUMP, V27, P169, DOI 10.1016/j.spc.2020.10.030; van Straten B, 2020, STEAM STERILIZATION; Viscusi DJ, 2009, ANN OCCUP HYG, V53, P815, DOI 10.1093/annhyg/mep070; Zhang Q, 2020, INACTIVATING PORCINE	23	3	3	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 14	2021	16	9							e0257468	10.1371/journal.pone.0257468	http://dx.doi.org/10.1371/journal.pone.0257468			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	WG5RP	34520503	gold, Green Published			2022-12-26	WOS:000707052100034
J	Li, MN; Hu, M; Yue, ZJ; Zhang, YD; Yang, HL				Li, Mengnan; Hu, Min; Yue, Zhijing; Zhang, Yudan; Yang, Hailan			The interactive effects of non-alcoholic fatty liver disease and hemoglobin concentration in the first trimester on the development of gestational diabetes mellitus	PLOS ONE			English	Article							GLUCOSE-INTOLERANCE; DIAGNOSTIC-CRITERIA; EARLY-PREGNANCY; SERUM FERRITIN; RISK-FACTORS; ASSOCIATION; CLASSIFICATION; HYPERGLYCEMIA; WOMEN	Gestational diabetes mellitus (GDM) is associated with adverse perinatal and maternal outcomes. Epidemiological studies have reported that non-alcoholic fatty liver disease (NAFLD) and a high hemoglobin (Hb) concentration are risk factors for GDM in the middle trimester. However, no consistent conclusions have been reached, especially in Chinese pregnant women. A case-control study was conducted to better understand the associations between NAFLD and Hb concentration in the first trimester and the risk of GDM and their interactive effects. Multivariable logistic regression analysis and a cross-product term of Hb and steatosis were used to evaluate the associations between first trimester Hb concentration, steatosis, and GDM and their interactive effects. Odds ratios (ORs) and 95% confidence intervals (CIs) were calculated using two-sided statistical tests at an alpha level of 0.05. For the study, 1,017 normal pregnant women, and 343 pregnant women diagnosed with GDM (25.22%) were recruited from the First Hospital of Shanxi Medical University, Shanxi Province, China. NAFLD-associated steatosis was found to be independent risk factors for developing GDM compared with grade 0 steatosis, with ORs of 1.98 (95% CI: 1.35-2.89) and 2.27 (95% CI:1.29-3.96), respectively. Meanwhile, a high Hb concentration was found to be a risk factor for developing GDM compared with the normal Hb concentration (OR = 1.88; 95% CI:1.24-2.83). The risk of developing GDM was more pronounced among pregnant women who had both high-grade steatosis and higher Hb concentrations during their first trimester (OR = 6.24; 95% CI: 1.81-23.66). However, we found no significant interactions between Hb concentration and steatosis grade. In conclusion, our study confirmed that a high Hb concentration and NAFLD-associated steatosis during the first trimester play important roles in predicting the risk of GDM in Chinese women. Future studies are required to verify the interactive effects between NAFLD-associated steatosis and Hb concentration.	[Li, Mengnan; Yang, Hailan] Shanxi Med Univ, Dept Obstet, Hosp 1, Taiyuan, Shanxi, Peoples R China; [Hu, Min; Yue, Zhijing] Shanxi Med Univ, Dept Clin Lab, Hosp 1, Taiyuan, Shanxi, Peoples R China; [Zhang, Yudan] Shanxi Med Univ, Dept Ultrasonog, Hosp 1, Taiyuan, Shanxi, Peoples R China	Shanxi Medical University; Shanxi Medical University; Shanxi Medical University	Yang, HL (corresponding author), Shanxi Med Univ, Dept Obstet, Hosp 1, Taiyuan, Shanxi, Peoples R China.	lili-5y208@163.com						Agarwal MM, 2014, DIABETES RES CLIN PR, V103, P341, DOI 10.1016/j.diabres.2013.10.012; [Anonymous], 2018, DIABETES CARE, V41, pS1, DOI [10.2337/dc18-Sint01, 10.2337/dc18-SINT01]; Behboudi-Gandevani S, 2013, BIOL TRACE ELEM RES, V154, P7, DOI 10.1007/s12011-013-9703-y; Chen XH, 2006, DIABETES CARE, V29, P1077, DOI 10.2337/dc06-0164; Colagiuri S, 2014, DIABETES RES CLIN PR, V103, P364, DOI 10.1016/j.diabres.2014.02.012; Das K, 2010, HEPATOLOGY, V51, P1593, DOI 10.1002/hep.23567; De Souza LR, 2016, AM J GASTROENTEROL, V111, P665, DOI 10.1038/ajg.2016.43; Dou Y., 2018, ASS NONALCOHOLIC FAT; Yogev, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2010.01.024; Gou BH, 2019, CHINESE MED J-PEKING, V132, P154, DOI [10.1097/cm9.0000000000000036, 10.1097/CM9.0000000000000036]; Hao M, 2017, ENDOCR J, V64, P561, DOI [10.1507/endocrj.EJ16-0359, 10.1507/endocrj.ej16-0359]; IDF (International Diabetes Federation), 2021, CONSOLIDATED GUIDELI, V10th ed.; Juarez-Hernandez E, 2018, ANN HEPATOL, V17, P577, DOI 10.5604/01.3001.0012.0920; Kim JY, 2017, J HEPATOL, V67, P349, DOI 10.1016/j.jhep.2017.03.023; Kojima N, 2016, GYNECOL ENDOCRINOL, V32, P803, DOI 10.1080/09513590.2016.1177009; Lao TT, 2002, OBSTET GYNECOL, V99, P807, DOI 10.1016/S0029-7844(02)01941-5; Lavrentaki A, 2019, J DIABETES COMPLICAT, V33, DOI 10.1016/j.jdiacomp.2019.06.006; Lee SM, 2019, DIABETOLOGIA, V62, P238, DOI 10.1007/s00125-018-4779-8; Mangan NM, 2017, P ROY SOC A-MATH PHY, V473, DOI 10.1098/rspa.2017.0009; McCullough Arthur J, 2004, Clin Liver Dis, V8, P521, DOI 10.1016/j.cld.2004.04.004; Metzger BE, 2010, DIABETES CARE, V33, P676, DOI 10.2337/dc09-1848; Munang Yvonne Nangeh, 2017, BMC Res Notes, V10, P622, DOI 10.1186/s13104-017-2944-7; Pastakia SD, 2017, BMC PREGNANCY CHILDB, V17, DOI 10.1186/s12884-017-1415-4; Rasmussen S, 2005, EUR J OBSTET GYN R B, V123, P27, DOI 10.1016/j.ejogrb.2005.02.012; Retnakaran R, 2008, DIABETES CARE, V31, P2026, DOI 10.2337/dc08-0972; Saadeh S, 2002, GASTROENTEROLOGY, V123, P745, DOI 10.1053/gast.2002.35354; Si ST, 2021, J DIABETES, V13, P211, DOI 10.1111/1753-0407.13101; Sun DM, 2017, OBSTET GYNECOL SURV, V72, P730, DOI 10.1097/OGX.0000000000000510; Tanoglu A, 2015, EUR J GASTROEN HEPAT, V27, P1126, DOI 10.1097/MEG.0000000000000434; Trak-Smayra V, 2009, GUT, V58, P825, DOI 10.1136/gut.2007.140087; Wang C, 2018, BMC PREGNANCY CHILDB, V18, DOI 10.1186/s12884-018-1800-7; Zhang CL, 2016, DIABETOLOGIA, V59, P1385, DOI 10.1007/s00125-016-3979-3; Zhao P, 2016, DIABETOLOGIA, V59, P2339, DOI 10.1007/s00125-016-4062-9; Zhu BB, 2019, BIOL TRACE ELEM RES, V191, P45, DOI 10.1007/s12011-018-1595-4	34	1	1	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 13	2021	16	9							e0257391	10.1371/journal.pone.0257391	http://dx.doi.org/10.1371/journal.pone.0257391			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	WG6OR	34516586	gold, Green Published			2022-12-26	WOS:000707114200033
J	Dewaele, S; Delhaye, L; De Paepe, B; de Bony, EJ; De Wilde, J; Vanderheyden, K; Anckaert, J; Yigit, N; Nuytens, J; Vanden Eynde, E; Smet, J; Verschoore, M; Nemati, F; Decaudin, D; Rodrigues, M; Zhao, PH; Jochemsen, A; Leucci, E; Vandesompele, J; Van Dorpe, J; Marine, JC; Van Coster, R; Eyckerman, S; Mestdagh, P				Dewaele, Shanna; Delhaye, Louis; De Paepe, Boel; de Bony, Eric James; De Wilde, Jilke; Vanderheyden, Katrien; Anckaert, Jasper; Yigit, Nurten; Nuytens, Justine; Vanden Eynde, Eveline; Smet, Joel; Verschoore, Maxime; Nemati, Fariba; Decaudin, Didier; Rodrigues, Manuel; Zhao, Peihua; Jochemsen, Aart; Leucci, Eleonora; Vandesompele, Jo; Van Dorpe, Jo; Marine, Jean-Christophe; Van Coster, Rudy; Eyckerman, Sven; Mestdagh, Pieter			The long non-coding RNA SAMMSON is essential for uveal melanoma cell survival	ONCOGENE			English	Article							ESTABLISHMENT; GLYCYLCYCLINE; TIGECYCLINE; KI-67	Long non-coding RNAs (lncRNAs) can exhibit cell-type and cancer-type specific expression profiles, making them highly attractive as therapeutic targets. Pan-cancer RNA sequencing data revealed broad expression of the SAMMSON lncRNA in uveal melanoma (UM), the most common primary intraocular malignancy in adults. Currently, there are no effective treatments for UM patients with metastatic disease, resulting in a median survival time of 6-12 months. We aimed to investigate the therapeutic potential of SAMMSON inhibition in UM. Antisense oligonucleotide (ASO)-mediated SAMMSON inhibition impaired the growth and viability of a genetically diverse panel of uveal melanoma cell lines. These effects were accompanied by an induction of apoptosis and were recapitulated in two uveal melanoma patient derived xenograft (PDX) models through subcutaneous ASO delivery. SAMMSON pulldown revealed several candidate interaction partners, including various proteins involved in mitochondrial translation. Consequently, inhibition of SAMMSON impaired global, mitochondrial and cytosolic protein translation levels and mitochondrial function in uveal melanoma cells. The present study demonstrates that SAMMSON expression is essential for uveal melanoma cell survival. ASO-mediated silencing of SAMMSON may provide an effective treatment strategy to treat primary and metastatic uveal melanoma patients.	[Dewaele, Shanna; Delhaye, Louis; de Bony, Eric James; De Wilde, Jilke; Vanderheyden, Katrien; Anckaert, Jasper; Yigit, Nurten; Nuytens, Justine; Vanden Eynde, Eveline; Vandesompele, Jo; Mestdagh, Pieter] Univ Ghent, Ctr Med Genet CMGG, OncoRNALab, Ghent, Belgium; [Dewaele, Shanna; Delhaye, Louis; de Bony, Eric James; De Wilde, Jilke; Vanderheyden, Katrien; Anckaert, Jasper; Yigit, Nurten; Nuytens, Justine; Vanden Eynde, Eveline; Vandesompele, Jo; Van Dorpe, Jo; Eyckerman, Sven; Mestdagh, Pieter] Canc Res Inst Ghent CRIG, Ghent, Belgium; [Dewaele, Shanna; Delhaye, Louis; de Bony, Eric James; De Wilde, Jilke; Vanderheyden, Katrien; Anckaert, Jasper; Yigit, Nurten; Nuytens, Justine; Vanden Eynde, Eveline; Vandesompele, Jo; Eyckerman, Sven; Mestdagh, Pieter] Univ Ghent, Dept Biomol Med, Ghent, Belgium; [Delhaye, Louis; Eyckerman, Sven] VIB Ghent Univ, Ctr Med Biotechnol, Ghent, Belgium; [De Paepe, Boel; Smet, Joel; Verschoore, Maxime; Van Coster, Rudy] Ghent Univ Hosp, Dept Pediat, Div Pediat Neurol & Metab, Ghent, Belgium; [De Wilde, Jilke; Van Dorpe, Jo] Ghent Univ Hosp, Dept Pathol, Ghent, Belgium; [Nemati, Fariba; Decaudin, Didier] PSL Res Univ, Inst Curie, Lab Preclin Invest, Translat Res Dept, Paris, France; [Decaudin, Didier; Rodrigues, Manuel] PSL Res Univ, Inst Curie, Dept Med Oncol, Paris, France; [Rodrigues, Manuel] PSL Res Univ, Inserm U830, DNA Repair & Uveal Melanoma DRUM, Equipe Labellisee Ligue Natl Canc,Inst Curie, F-75005 Paris, France; [Zhao, Peihua] VIB KU Leuven Ctr Canc Biol, Ctr Med Biotechnol, Leuven, Belgium; [Zhao, Peihua; Leucci, Eleonora; Marine, Jean-Christophe] Katholieke Univ Leuven, Lab RNA Canc Biol, Dept Oncol, Leuven, Belgium; [Jochemsen, Aart] Leiden Univ, Dept Cell & Chem Biol, Med Ctr, Leiden, Netherlands; [Leucci, Eleonora] LKI Leuven Canc Inst, TRACE, Leuven, Belgium	Ghent University; Ghent University; Ghent University; Flanders Institute for Biotechnology (VIB); Ghent University; Ghent University; Ghent University Hospital; Ghent University; Ghent University Hospital; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris Cite; Flanders Institute for Biotechnology (VIB); KU Leuven; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Mestdagh, P (corresponding author), Univ Ghent, Ctr Med Genet CMGG, OncoRNALab, Ghent, Belgium.; Mestdagh, P (corresponding author), Canc Res Inst Ghent CRIG, Ghent, Belgium.; Mestdagh, P (corresponding author), Univ Ghent, Dept Biomol Med, Ghent, Belgium.	pieter.mestdagh@ugent.be	Rodrigues, Manuel/C-8506-2018; Vandesompele, Jo/W-3411-2018; Leucci, Eleonora/G-4938-2011; De Paepe, Boel/B-7548-2013; Marine, Jean-Christophe/K-3292-2016	Rodrigues, Manuel/0000-0002-5443-0802; Vandesompele, Jo/0000-0001-6274-0184; Leucci, Eleonora/0000-0002-2898-748X; Nuytens, Justine/0000-0002-4878-1200; de Bony, Eric James/0000-0002-1289-7199; De Paepe, Boel/0000-0001-9403-4401; Mestdagh, Pieter/0000-0001-7821-9684; Delhaye, Louis/0000-0001-8876-7385; Yigit, Nurten/0000-0003-1183-8688; De Wilde, Jilke/0000-0003-0392-7162; Vanden Eynde, Eveline/0000-0003-0454-4171; ANCKAERT, JASPER/0000-0001-8144-4639; Marine, Jean-Christophe/0000-0003-2433-9837; Dewaele, Shanna/0000-0002-2219-8930	Foundation Against Cancer grant (Stichting tegen Kanker); Standup Against Cancer grant (Kom op tegen Kanker); Ghent University Industrial Research Fund (IOF); Ghent University GOA research grant; Fund for Scientific Research Flanders (FWO Vlaanderen); Melanoma Research Alliance (MRA) Amanda; Jonathan Eilian young investigator award; Fund of Scientific Research Flanders (FWO Vlaanderen)	Foundation Against Cancer grant (Stichting tegen Kanker); Standup Against Cancer grant (Kom op tegen Kanker); Ghent University Industrial Research Fund (IOF); Ghent University GOA research grant; Fund for Scientific Research Flanders (FWO Vlaanderen)(FWO); Melanoma Research Alliance (MRA) Amanda; Jonathan Eilian young investigator award; Fund of Scientific Research Flanders (FWO Vlaanderen)(FWO)	We would like to thank the VIB proteomics core for performing LC-MS/MS analysis and Prof. Olivier De Wever for providing the CT5.3hTERT cell line. The authors would also like to thank the Animal PlatformCRP2-UMS 3612 CNRS-US25 Inserm-IRD (Faculty of Pharmacy, Paris University, Paris), and the Animal Platform of Institut Curie. They also thank Justine Fleury for her technical assistance (Laboratory of preclinical Investigation, Institut Curie). This work was supported by a Foundation Against Cancer grant (Stichting tegen Kanker), a Standup Against Cancer grant (Kom op tegen Kanker), a Ghent University Industrial Research Fund (IOF), a Ghent University GOA research grant and Fund for Scientific Research Flanders (FWO Vlaanderen). EL is the recipient of the Melanoma Research Alliance (MRA) Amanda and Jonathan Eilian young investigator award. SD, LD and JDW are recipients of a grant from the Fund of Scientific Research Flanders (FWO Vlaanderen).	Amirouchene-Angelozzi N, 2014, MOL ONCOL, V8, P1508, DOI 10.1016/j.molonc.2014.06.004; Bakalian S, 2008, CLIN CANCER RES, V14, P951, DOI 10.1158/1078-0432.CCR-06-2630; Bhan A, 2017, CANCER RES, V77, P3965, DOI 10.1158/0008-5472.CAN-16-2634; Cheng Z, 2019, NUCLEIC ACIDS RES, V47, P5061, DOI 10.1093/nar/gkz231; Coyne LP, 2018, FEBS LETT, V592, P759, DOI 10.1002/1873-3468.12894; De Paepe B, 2012, PEDIATR RES, V72, P232, DOI 10.1038/pr.2012.84; DEWAARDSIEBINGA I, 1995, INT J CANCER, V62, P155, DOI 10.1002/ijc.2910620208; Doan TL, 2006, CLIN THER, V28, P1079, DOI 10.1016/j.clinthera.2006.08.011; Harbour JW, 2010, SCIENCE, V330, P1410, DOI 10.1126/science.1194472; Helgadottir H, 2016, APPL CLIN GENET, V9, P147, DOI 10.2147/TACG.S69210; Hong D, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac5272; Khan MS, 2013, BRIT J CANCER, V108, P1838, DOI 10.1038/bjc.2013.156; Koripella RK, 2019, P NATL ACAD SCI USA, V116, P8283, DOI 10.1073/pnas.1815675116; Krantz BA, 2017, CLIN OPHTHALMOL, V11, P279, DOI 10.2147/OPTH.S89591; Leucci E, 2016, NATURE, V531, P518, DOI 10.1038/nature17161; Li XP, 2017, ONCOTARGET, V8, P103785, DOI 10.18632/oncotarget.21792; Lindahl L, 2020, BIORXIV2020202010153; Luyten GPM, 1996, INT J CANCER, V66, P380, DOI 10.1002/(SICI)1097-0215(19960503)66:3<380::AID-IJC19>3.0.CO;2-F; Matatall KA, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-371; MOOY CM, 1990, OPHTHALMOLOGY, V97, P1275; Nareyeck G, 2005, EXP EYE RES, V81, P361, DOI 10.1016/j.exer.2005.04.018; Ni HZ, 2021, CELL MOL NEUROBIOL, V41, P79, DOI 10.1007/s10571-020-00833-2; Nicholas D, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170975; Noskin GA, 2005, CLIN INFECT DIS, V41, pS303, DOI 10.1086/431672; OBRIEN TW, 1990, BIOCHIM BIOPHYS ACTA, V1050, P174, DOI 10.1016/0167-4781(90)90162-U; Papastefanou VP, 2011, J SKIN CANCER, V2011, DOI 10.1155/2011/573974; Park JJ, 2018, PIGM CELL MELANOMA R, V31, P661, DOI 10.1111/pcmr.12708; Richards JR, 2020, PIGM CELL MELANOMA R, V33, P264, DOI 10.1111/pcmr.12853; Robertson AG, 2017, CANCER CELL, V32, P204, DOI 10.1016/j.ccell.2017.07.003; Rodrigues M, 2020, JAMA OPHTHALMOL, V138, P182, DOI 10.1001/jamaophthalmol.2019.5403; Rodriguez A, 2016, MOL CLIN ONCOL, V5, P675, DOI 10.3892/mco.2016.1037; Roger AJ, 2017, CURR BIOL, V27, pR1177, DOI 10.1016/j.cub.2017.09.015; Rossi L, 2015, BRIT J CANCER, V113, P996, DOI 10.1038/bjc.2015.239; Saw PE, 2020, SCI CHINA LIFE SCI, V63, P485, DOI 10.1007/s11427-018-9438-y; Schmidt EK, 2009, NAT METHODS, V6, P275, DOI [10.1038/NMETH.1314, 10.1038/nmeth.1314]; Shao L, 2020, IUBMB LIFE, V72, P237, DOI 10.1002/iub.2158; Sharma A, 2018, CLIN GENET, V93, P952, DOI 10.1111/cge.13136; Sugase T, 2020, J TRANSL MED, V18, DOI 10.1186/s12967-020-02377-x; Van Maerken T, 2009, JNCI-J NATL CANCER I, V101, P1562, DOI 10.1093/jnci/djp355; Van Raamsdonk CD, 2009, NATURE, V457, P599, DOI 10.1038/nature07586; Vendramin R, 2018, NAT STRUCT MOL BIOL, V25, P1035, DOI 10.1038/s41594-018-0143-4; Verma, 2018, ASTROCYTE, V5, P81, DOI [10.4103/astrocyte.astrocyte_55_18, DOI 10.4103/ASTROCYTE.ASTROCYTE_55_18]; Wang A, 2016, J CLIN PATHOL, V69, P750, DOI 10.1136/jclinpath-2016-203866; Wang YH, 2019, CLIN EXP PHARMACOL P, V46, P890, DOI 10.1111/1440-1681.13126; Xie JW, 2019, NEUROREPORT, V30, P817, DOI 10.1097/WNR.0000000000001278; Yang H, 2008, MELANOMA RES, V18, P95, DOI 10.1097/CMR.0b013e3282f628df; Yang SZ, 2019, BIOSCIENCE REP, V39, DOI 10.1042/BSR20190615; Yang X, 2015, CELL BIOSCI, V5, DOI 10.1186/s13578-015-0005-2; Zhou X, 2015, J MOL CELL BIOL, V7, P92, DOI 10.1093/jmcb/mjv014	49	5	5	1	9	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 3	2022	41	1					15	25		10.1038/s41388-021-02006-x	http://dx.doi.org/10.1038/s41388-021-02006-x		SEP 2021	11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	YA0OI	34508176	Green Published, hybrid, Green Submitted			2022-12-26	WOS:000694774500001
J	Hosseini, B; Voegele, RT; Link, TI				Hosseini, Behnoush; Voegele, Ralf T.; Link, Tobias I.			Establishment of a quadruplex real-time PCR assay to distinguish the fungal pathogens Diaporthe longicolla, D. caulivora, D. eres, and D. novem on soybean	PLOS ONE			English	Article							PHOMOPSIS-LONGICOLLA; QUANTITATIVE PCR; SEED DECAY; PHASEOLORUM; DETECT; GENUS	Diaporthe species are fungal plant pathogens of many important crops. Seed decay is one of the most important diseases on soybean. It is caused by various species of the genus Diaporthe and responsible for significant economic damage. In central Europe the four species D. longicolla, D. caulivora, D. eres, and D. novem are considered the principal species of Diaporthe on soybean. Fast and accurate detection of these pathogens is of utmost importance. In this study four species-specific TaqMan primer-probe sets that can be combined into a quadruplex assay were designed based on TEF sequences. The specificity and efficiency of the primer-probe sets were tested using PCR products and genomic DNA from pure cultures of the four Diaporthe species and other soybean fungal pathogens. Our results indicate that the primer-probe sets DPCL, DPCC, DPCE, and DPCN allow discrimination of D. longicolla, D. caulivora, D. eres, and D. novem, respectively, and can be used to detect and quantify these four Diaporthe species in parallel using quadruplex real-time PCR. In addition, the quadruplex real-time PCR assay was evaluated on different plant materials including healthy and infected soybean seeds or seed lots, soybean stems, and soybean leaves. This assay is a rapid and effective method to detect and quantify Diaporthe species from samples relevant for disease control.	[Hosseini, Behnoush; Voegele, Ralf T.; Link, Tobias I.] Univ Hohenheim, Inst Phytomed, Fac Agr Sci, Dept Phytopathol, Stuttgart, Germany	University Hohenheim	Link, TI (corresponding author), Univ Hohenheim, Inst Phytomed, Fac Agr Sci, Dept Phytopathol, Stuttgart, Germany.	tobias.link@uni-hohenheim.de			German Federal Office for Agriculture and Food (SoySound) [2815EPS082]; Food Security Center (FSC) of University of Hohenheim	German Federal Office for Agriculture and Food (SoySound); Food Security Center (FSC) of University of Hohenheim	This research was supported by the German Federal Office for Agriculture and Food (SoySound; Grant number 2815EPS082; to TL) and the Food Security Center (FSC) of University of Hohenheim to BH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baird RE, 2001, PHYTOPROTECTION, V82, P1; Carbone I, 1999, MYCOLOGIA, V91, P553, DOI 10.2307/3761358; Gomes RR, 2013, PERSOONIA, V31, P1, DOI 10.3767/003158513X666844; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hosseini B, 2020, MYCOL PROG, V19, P455, DOI 10.1007/s11557-020-01570-y; Hu RB, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-93; Kontz B, 2016, PLANT DIS, V100, P1669, DOI 10.1094/PDIS-10-15-1204-RE; Krsmanovic S., 2020, Ratarstvo i Povrtarstvo, V57, P80, DOI 10.5937/ratpov57-27516; Liu D, 2000, J CLIN MICROBIOL, V38, P471; Mathew FM, 2015, PHYTOPATHOLOGY, V105, P990, DOI 10.1094/PHYTO-11-14-0336-FI; Petrovic K, 2016, PLANT DIS, V100, P2324, DOI 10.1094/PDIS-03-16-0353-PDN; Ramiro J, 2019, J PHYTOPATHOL, V167, P273, DOI 10.1111/jph.12796; REHNER SA, 1994, CAN J BOT, V72, P1666, DOI 10.1139/b94-204; Santos JM, 2010, FUNGAL BIOL-UK, V114, P255, DOI 10.1016/j.funbio.2010.01.007; Schaad NW, 2003, ANNU REV PHYTOPATHOL, V41, P305, DOI 10.1146/annurev.phyto.41.052002.095435; Schaad NW, 2002, CAN J PLANT PATHOL, V24, P250; Schena L, 2004, EUR J PLANT PATHOL, V110, P893, DOI 10.1007/s10658-004-4842-9; Schena L, 2013, J PLANT PATHOL, V95, P7; Schena L, 2006, MOL PLANT PATHOL, V7, P365, DOI 10.1111/j.1364-3703.2006.00345.x; Siebert L., 2020, VALUE CHAIN SOYBEANS; SINCLAIR JB, 1993, PLANT DIS, V77, P329, DOI 10.1094/PD-77-0329; SINCLAIR JB, 1992, PLANT DIS, V76, P1087, DOI 10.1094/PD-76-1087; Taylor E., 2001, Journal of Plant Pathology, V83, P75; Udayanga D, 2011, FUNGAL DIVERS, V50, P189, DOI 10.1007/s13225-011-0126-9; Walcott RR, 2003, HORTTECHNOLOGY, V13, P40, DOI 10.21273/HORTTECH.13.1.0040; Zhang AW, 1997, PLANT DIS, V81, P1143, DOI 10.1094/PDIS.1997.81.10.1143; Zhang AW, 1999, PHYTOPATHOLOGY, V89, P796, DOI 10.1094/PHYTO.1999.89.9.796	27	0	0	3	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2021	16	9							e0257225	10.1371/journal.pone.0257225	http://dx.doi.org/10.1371/journal.pone.0257225			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XM9EM	34506590	gold, Green Published			2022-12-26	WOS:000729120700095
J	Park, J; Park, J; Oh, S; Yea, JW; Lee, JE; Park, JW				Park, Jongmoo; Park, Jaehyeon; Oh, Sean; Yea, Ji Woon; Lee, Jeong Eun; Park, Jae Won			Multi-criteria optimization for planning volumetric-modulated arc therapy for prostate cancer	PLOS ONE			English	Article							CONFORMAL RADIATION-THERAPY; TOXICITY; RADIOTHERAPY; GENITOURINARY; IMPACT; LIFE	We aimed to compare the volumetric-modulated arc therapy (VMAT) plans with or without multi-criteria optimization (MCO) on commercial treatment-planning systems (Eclipse, Varian Medical System, Palo Alto, CA, USA) for patients with prostate cancer. We selected 25 plans of patients with prostate cancer who were previously treated on the basis of a VMAT plan. All plans were imported into the Eclipse Treatment Planning System version 15.6, and re-calculation and re-optimization were performed. The MCO plan was then generated. The dosimetric quality of the plans was evaluated using dosimetric parameters and dose indices that account for target coverage and sparing of the organs at risk (OARs). We defined the rectum, bladder, and bilateral femoral heads. The VMAT-MCO plan offers an improvement of gross treatment volume coverage with increased minimal dose and reduced maximal dose. In the planning treatment volume, the D-mean and better gradient, homogeneity, and conformity indexes improved despite the increasing hot and cold spots. When implemented through the MCO plan, a steeper fall off the adjacent OARs in the overlap area was achieved to obtain lower dose parameters. MCO generated better sparing of the rectum and bladder through a tradeoff of the increasing dose to the bilateral femoral heads within the tolerable dose constraints. Compared with re-optimization and re-calculation, respectively, significant dose reductions were observed in the bladder (241 cGy and 254 cGy; p<0.001) and rectum (474 cGy and 604 cGy, p<0.001) with the MCO. Planning evaluation and dosimetric measurements showed that the VMAT-MCO plan using visualized navigation can provide sparing of OAR doses without compromising the target coverage in the same OAR dose constraints.	[Park, Jongmoo] Kyungpook Natl Univ, Chilgok Hosp, Dept Radiat Oncol, Daegu, South Korea; [Park, Jaehyeon; Oh, Sean; Yea, Ji Woon; Park, Jae Won] Yeungnam Univ, Coll Med, Dept Radiat Oncol, Daegu, South Korea; [Lee, Jeong Eun] Kyungpook Natl Univ, Sch Med, Dept Radiat Oncol, Daegu, South Korea	Kyungpook National University; Yeungnam University; Kyungpook National University	Park, JW (corresponding author), Yeungnam Univ, Coll Med, Dept Radiat Oncol, Daegu, South Korea.; Lee, JE (corresponding author), Kyungpook Natl Univ, Sch Med, Dept Radiat Oncol, Daegu, South Korea.	jelee@knu.ac.kr; kapicap@naver.com		Park, Jaewon/0000-0003-1100-5301; Oh, SeAn/0000-0002-8835-2814	2019 Yeungnam University Research Grant - Korean government (MSIT); National Research Foundation of Korea [NRF-2019M3E5D1A02068143]	2019 Yeungnam University Research Grant - Korean government (MSIT); National Research Foundation of Korea(National Research Foundation of Korea)	This work was partially supported by the 2019 Yeungnam University Research Grant, funded by the the Korean government (MSIT). supported by the the National Research Foundation of Korea [NRF-2019M3E5D1A02068143] The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bekelman JE, 2018, J CLIN ONCOL, V36, P3251, DOI 10.1200/JCO.18.00606; Bokrantz R, 2012, MED PHYS, V39, P6712, DOI 10.1118/1.4754652; Carvalho IT, 2018, ACTA ONCOL, V57, P1003, DOI 10.1080/0284186X.2018.1478126; Chen HX, 2014, MED DOSIM, V39, P64, DOI 10.1016/j.meddos.2013.10.001; Cotrutz C, 2001, PHYS MED BIOL, V46, P2161, DOI 10.1088/0031-9155/46/8/309; Craft D, 2005, PHYS MED BIOL, V50, P5857, DOI 10.1088/0031-9155/50/24/007; Craft D, 2012, MED PHYS, V39, P686, DOI 10.1118/1.3675601; Craft David L, 2012, Int J Radiat Oncol Biol Phys, V82, pe83, DOI 10.1016/j.ijrobp.2010.12.007; de Crevoisier R, 2018, INT J RADIAT ONCOL, V102, P1420, DOI 10.1016/j.ijrobp.2018.07.2006; Fitzmaurice C, 2017, JAMA ONCOL, V3, P524, DOI 10.1001/jamaoncol.2016.5688; Ghadjar P, 2014, INT J RADIAT ONCOL, V88, P339, DOI 10.1016/j.ijrobp.2013.10.042; Ghandour S, 2015, J APPL CLIN MED PHYS, V16, P258, DOI 10.1120/jacmp.v16i3.5410; Guerrero M, 2020, MED DOSIM, V45, P7, DOI 10.1016/j.meddos.2019.04.003; Hamdy FC, 2016, NEW ENGL J MED, V375, P1415, DOI 10.1056/NEJMoa1606220; Kierkels RGJ, 2015, RADIAT ONCOL, V10, DOI 10.1186/s13014-015-0385-9; Kopp RW, 2011, MED DOSIM, V36, P365, DOI 10.1016/j.meddos.2010.09.004; Mattes MD, 2014, RADIAT ONCOL J, V32, P23, DOI 10.3857/roj.2014.32.1.23; McGarry CK, 2014, MED DOSIM, V39, P205, DOI 10.1016/j.meddos.2014.02.002; Michalski JM, 2013, INT J RADIAT ONCOL, V87, P932, DOI 10.1016/j.ijrobp.2013.07.041; Muller BS, 2017, RADIAT ONCOL, V12, DOI 10.1186/s13014-017-0903-z; Network N.C.C, 2020, PROSTATE CANC VERSIO; Olsson CE, 2018, INT J RADIAT ONCOL, V102, P1514, DOI 10.1016/j.ijrobp.2018.08.015; Palma D, 2008, INT J RADIAT ONCOL, V72, P996, DOI 10.1016/j.ijrobp.2008.02.047; Roach M, 2015, INT J RADIAT ONCOL, V93, P1064, DOI 10.1016/j.ijrobp.2015.08.005; Sanda MG, 2018, J UROLOGY, V199, P990, DOI 10.1016/j.juro.2018.01.002; Schaake W, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197757; Schaake W, 2016, RADIOTHER ONCOL, V119, P381, DOI 10.1016/j.radonc.2016.04.005; Schaake W, 2014, RADIOTHER ONCOL, V110, P284, DOI 10.1016/j.radonc.2013.11.011; Sutani S, 2015, RADIOTHER ONCOL, V117, P270, DOI 10.1016/j.radonc.2015.08.019; Wolff D, 2009, RADIOTHER ONCOL, V93, P226, DOI 10.1016/j.radonc.2009.08.011; Wortel RC, 2015, INT J RADIAT ONCOL, V91, P737, DOI 10.1016/j.ijrobp.2014.12.017; Zelefsky MJ, 2011, EUR UROL, V60, P1133, DOI 10.1016/j.eururo.2011.08.029	32	0	0	3	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2021	16	9							e0257216	10.1371/journal.pone.0257216	http://dx.doi.org/10.1371/journal.pone.0257216			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	XM9EM	34506581	gold, Green Published			2022-12-26	WOS:000729120700101
